<SEC-DOCUMENT>0001178913-25-001835.txt : 20250516
<SEC-HEADER>0001178913-25-001835.hdr.sgml : 20250516
<ACCEPTANCE-DATETIME>20250515174147
ACCESSION NUMBER:		0001178913-25-001835
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		218
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250516
DATE AS OF CHANGE:		20250515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TRINITY BIOTECH PLC
		CENTRAL INDEX KEY:			0000888721
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L2
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22320
		FILM NUMBER:		25956147

	BUSINESS ADDRESS:	
		STREET 1:		IDA BUSINESS PARK, BRAY, CO WICKLOW
		STREET 2:		IRELAND
		CITY:			DUBLIN IRELAND
		STATE:			L2
		ZIP:			18
		BUSINESS PHONE:		01135312955111

	MAIL ADDRESS:	
		STREET 1:		3 ROCK ROAD
		STREET 2:		SANDYFORD INDUSTRIAL ESTATES
		CITY:			DUBLIN IRELAND
		STATE:			L2
		ZIP:			18
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>zk2533151.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--INTEGIX by Ez-XBRL-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full" xmlns:trib="http://trinitybiotech.com/20241231" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:cyd-af-sub="http://xbrl.sec.gov/cyd-af-sub/2024" xmlns:cyd-af="http://xbrl.sec.gov/cyd-af/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024">
<!-- Field: Set; Name: Tidy Processed; Value: True -->
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
  <title>TRINITY BIOTECH PLC - 888721 - 2025</title>
</head>
<body style="font-size:10pt;font-family:Times New Roman, Times, serif;">

<div style="display:none">
<ix:header>
  <ix:hidden>
    <ix:footnote id="FN20250513194303268" xml:lang="en-US">No deferred tax asset was recognised because there was no reversing deferred tax liability in the same jurisdiction reversing in the same period and insufficient future projected taxable income in the same jurisdiction.</ix:footnote>
    <ix:footnote id="FN20230420130342130" xml:lang="en-US">Other items comprise items not chargeable to tax and expenses not deductible for tax purposes. In 2022, other items mainly related to the loss on disposal of the exchangeable notes which was non-recurring. In 2021 other items mainly related to the US$4.4 million income from the Paycheck Protection Program loans which was not chargeable for tax purposes. There was no Paycheck Protection Program income in 2023 or 2022.</ix:footnote>
    <ix:nonFraction name="trib:NumberOfOrdinarySharesIssuableOnExerciseOfOptions" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" id="Fxbrl_20230414123050603" unitRef="Shares" decimals="INF">0</ix:nonFraction>
    <ix:nonFraction name="trib:NumberOfOrdinarySharesIssuableOnExerciseOfOptions" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" id="Fxbrl_20250512171325106" unitRef="Shares" decimals="INF">0</ix:nonFraction>
    <ix:footnote id="FN20240427025912834" xml:lang="en-US">The weighted average number of shares issued during the year is calculated by taking the number of shares issued multiplied by the number of days in the year each share is in issue, divided by 365 days.</ix:footnote>
    <ix:footnote id="FN20240427025257016" xml:lang="en-US">The weighted average number of ADSs issued during the year is calculated by taking the number of ADSs issued multiplied by the number of days in the year each share is in issue, divided by 365 days.</ix:footnote>
    <ix:footnote id="FN20250512160603335" xml:lang="en-US">In 2024, US$204,000 was capitalised to research and development projects (2023: US$Nil) (2022: US$Nil).</ix:footnote>
    <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20240101to20241231" id="Fdei_EntityCentralIndexKey20220119133932127">0000888721</ix:nonNumeric>
    <ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20240101to20241231" id="Fdei_AmendmentFlag20220119134034239">false</ix:nonNumeric>
    <ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="C_20240101to20241231" id="Fdei_DocumentFiscalPeriodFocus20220119134133105">FY</ix:nonNumeric>
    <ix:footnote id="FN20240414183320494" xml:lang="en-US">The maturity of the exchangeable notes is based on the contractual maturity date of April 1, 2045.</ix:footnote>
    <ix:footnote id="FN20240413114732041" xml:lang="en-US">The senior secured term loan is a variable instrument. In January 2024, the amended term loan agreement reduced the annual rate of interest on the loan by 2.5% to 8.75% plus the greater of (a) Term Secured Overnight Financing Rate or (b) 4.0% per annum, and allows for a further 2.5% reduction in the base rate to 6.25% once the outstanding principal under the term loan falls below US$35 million. The loan matures in July 2026.</ix:footnote>
    <ix:footnote id="FN20240413114930201" xml:lang="en-US">The 7-year convertible note was issued in May 2022 and is a fixed rate instrument which bears a fixed rate of interest of 1.5% per annum.</ix:footnote>
    <ix:footnote id="FN20240413120034144" xml:lang="en-US">The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December 31, 2023</ix:footnote>
    <ix:footnote id="FN20240413120837416" xml:lang="en-US">The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December 31, 2022.</ix:footnote>
    <ix:footnote id="FN20250513165025082" xml:lang="en-US">Additions include US$0.9 million additions in ROU assets.</ix:footnote>
    <ix:footnote id="FN20250515105302222" xml:lang="en-US">The total impairment charge recognised against Property, Plant &amp; Equipment during the year was US$1.0 million. Of this, US$0.6 million, corresponding to the impairment loss allocated to property, plant and equipment as described above, is presented within &#8216;Impairment Charges&#8217; in the Consolidated Statement of Operations. The remaining US$0.4 million is included within &#8216;Restructuring Costs&#8217; (see Note 5).</ix:footnote>
    <ix:footnote id="FN20250513123429194" xml:lang="en-US">Revenue from customers in Ireland is not disclosed separately due to the immateriality of these revenues.</ix:footnote>
    <ix:footnote id="FN20230426150735027" xml:lang="en-US">Unallocated expenses represent head office general and administration costs of the Group, which cannot be allocated to the results of any specific geographical area.</ix:footnote>
    </ix:hidden>
  <ix:references> <link:schemaRef xlink:type="simple" xlink:href="trib-20241231.xsd"/>
    </ix:references>
  <ix:resources>
    <xbrli:context id="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:InventoryMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:InventoryMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:TaxValueOfLossCarryForwardsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:TaxValueOfLossCarryForwardsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:OtherItemsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:OtherItemsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:InventoryMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:TaxValueOfLossCarryForwardsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:OtherItemsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:InventoryMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:TaxValueOfLossCarryForwardsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:TaxValueOfLossCarryForwardsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:OtherItemsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:OtherItemsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:InventoryMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IE</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherRegionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherRegionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IE</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribUS1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:US1Member</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribUS1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:US1Member</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherCountriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherCountriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherCountriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IE</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherRegionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribUS1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:US1Member</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">trib:ProvisionalValueMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-01-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">trib:MeasurementPeriodAdjustmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-01-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-01-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-09-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-10-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-01-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-01-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-01-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240130to20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-30</xbrli:startDate>
        <xbrli:endDate>2024-01-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240930to20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-30</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241031to20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-31</xbrli:startDate>
        <xbrli:endDate>2024-10-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240930_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-09-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-09-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-10-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullDefinedBenefitPlansAxis_tribResearchAndDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:ResearchAndDevelopmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullDefinedBenefitPlansAxis_tribResearchAndDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:ResearchAndDevelopmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullDefinedBenefitPlansAxis_tribResearchAndDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:ResearchAndDevelopmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullDefinedBenefitPlansAxis_tribAdministrationAndSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:AdministrationAndSalesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullDefinedBenefitPlansAxis_tribAdministrationAndSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:AdministrationAndSalesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullDefinedBenefitPlansAxis_tribAdministrationAndSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:AdministrationAndSalesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullDefinedBenefitPlansAxis_tribManufacturingAndQualityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:ManufacturingAndQualityMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullDefinedBenefitPlansAxis_tribManufacturingAndQualityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:ManufacturingAndQualityMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullDefinedBenefitPlansAxis_tribManufacturingAndQualityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:ManufacturingAndQualityMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassATreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassATreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassATreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassATreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassATreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220501to20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:MicoLtdMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-05-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:MicoLtdMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-05-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20240131_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:WaveformTechnologiesIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-01-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20240131_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:WaveformTechnologiesIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-01-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240901to20240924_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:MetabolomicDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-09-24</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribCraigHallumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:CraigHallumMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-10</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNativeDesignLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:NativeDesignLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-10</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-25</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovusDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-25</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240901to20240924_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:MetabolomicDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-09-24</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribCraigHallumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:CraigHallumMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-10</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNativeDesignLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:NativeDesignLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-10</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-25</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovusDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-25</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241025_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovusDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-10-25</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechManufacturingLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribKonamiteLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:KonamiteLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTribBiosensorsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TribBiosensorsIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechInvestmentLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechInvestmentLtdMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovaCenturyScientificIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:NovaCenturyScientificIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribImmcoDiagnosticsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:ImmcoDiagnosticsIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechUkLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechUkLtdMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechDoBrasilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechDoBrasilMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsAbMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:FiomiDiagnosticsAbMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsHoldingAbMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:FiomiDiagnosticsHoldingAbMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPhoenixBioTechCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:PhoenixBioTechCorpMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPrimusCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:PrimusCorporationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiopoolUsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiopoolUsIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMardxDiagnosticsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:MardxDiagnosticsIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribClarkLaboratoriesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:ClarkLaboratoriesIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechLuxembourgSarlMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechLuxembourgSarlMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingServicesLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechManufacturingServicesLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityResearchLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityResearchLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechJointVentureLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechJointVentureLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicsDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ShareOptionMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ShareOptionMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ShareOptionMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ShareOptionMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ShareOptionMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhMember_ifrsfullClassesOfFinancialInstrumentsAxis_tribAdditionalSpaceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:MrOCaoimhMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:AdditionalSpaceMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribJrjMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:JrjMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhAndDrWalshMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:MrOCaoimhAndDrWalshMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2007-12-01</xbrli:startDate>
        <xbrli:endDate>2007-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20161201to20161231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:MrOCaoimhMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-12-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220701to20220701">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-07-01</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_tribJrjMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:JrjMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2007-12-01</xbrli:startDate>
        <xbrli:endDate>2007-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20161201to20161231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhAndDrWalshMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:MrOCaoimhAndDrWalshMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-12-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210701to20210701">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-07-01</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullCategoriesOfRelatedPartiesAxis_tribDrJimWalshMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DrJimWalshMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-09-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240901to20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullCategoriesOfRelatedPartiesAxis_tribDrJimWalshMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DrJimWalshMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:InstrumentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:InstrumentsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:InstrumentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:InstrumentsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTwoPercentageOfGrossInventoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TwoPercentageOfGrossInventoryMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTwoPercentageOfGrossInventoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TwoPercentageOfGrossInventoryMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTwoPercentageOfGrossInventoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TwoPercentageOfGrossInventoryMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230131_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">trib:StrategicPartnershipWithImawareIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-01-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">trib:StrategicPartnershipWithImawareIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20230131_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">trib:StrategicPartnershipWithImawareIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-01-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">trib:StrategicPartnershipWithImawareIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribHivOneByTwoRapidTestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:HivOneByTwoRapidTestMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribHivOneByTwoRapidTestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:HivOneByTwoRapidTestMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPremierInstrumentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:PremierInstrumentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPremierInstrumentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:PremierInstrumentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribMidTierHaemoglobinsInstrumentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:MidTierHaemoglobinsInstrumentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribMidTierHaemoglobinsInstrumentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:MidTierHaemoglobinsInstrumentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribOtherProjectsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:OtherProjectsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribOtherProjectsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:OtherProjectsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechDoBrasilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TrinityBiotechDoBrasilMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechDoBrasilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TrinityBiotechDoBrasilMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribBiopoolUsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:BiopoolUsIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribBiopoolUsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:BiopoolUsIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechManufacturingLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TrinityBiotechManufacturingLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechManufacturingLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TrinityBiotechManufacturingLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribWaveformTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:WaveformTechnologiesIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPrimusCorporationCguTradeNameMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:PrimusCorporationCguTradeNameMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPrimusCorporationCguTradeNameMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:PrimusCorporationCguTradeNameMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribImmcoDiagnosticsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:ImmcoDiagnosticsIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribClarkLaboratoriesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:ClarkLaboratoriesIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribClarkLaboratoriesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:ClarkLaboratoriesIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribPrimusCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:PrimusCorpMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribPrimusCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:PrimusCorpMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribImmcoDiagnosticsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:ImmcoDiagnosticsIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230601to20230630">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribContinuousGlucoseMonitoringTestingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:ContinuousGlucoseMonitoringTestingMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribContinuousGlucoseMonitoringTestingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:ContinuousGlucoseMonitoringTestingMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribT10HplcAnalyzerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:T10HplcAnalyzerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribSyphilisPointOfCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:SyphilisPointOfCareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribTrinscreenPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:TrinscreenPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribKansasRightOfUseAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:KansasRightOfUseAssetMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribTrinscreenPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:TrinscreenPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribKansasRightOfUseAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:KansasRightOfUseAssetMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribEpiCaptureLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribMetabolomicDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:MetabolomicDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribWaveformTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:WaveformTechnologiesIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribEpiCaptureLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribWaveformTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:WaveformTechnologiesIncMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribSyphilisPointOfCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:SyphilisPointOfCareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:LaterThanTwoYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:LaterThanTwoYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:LaterThanTwoYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:LaterThanTwoYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="trib:DiscontinuedOperationsAxis">trib:FiomiDiagnosticsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="trib:DiscontinuedOperationsAxis">trib:FiomiDiagnosticsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="trib:DiscontinuedOperationsAxis">trib:FiomiDiagnosticsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SE</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="trib:DiscontinuedOperationsAxis">trib:FiomiDiagnosticsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SE</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="trib:DiscontinuedOperationsAxis">trib:FiomiDiagnosticsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SE</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="trib:DiscontinuedOperationsAxis">trib:FiomiDiagnosticsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SE</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiosynthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230401to20230430_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiosynthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiosynthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiosynthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">trib:PostDisposalAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SE</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiosynthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:NoncurrentAssetsHeldForSaleMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SE</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiosynthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:CarryingAmountMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">trib:FairValueMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">trib:FairValueMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:CarryingAmountMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:FinanceLeaseReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:FinanceLeaseReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:FinanceLeaseReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:FinanceLeaseReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:FinanceLeaseReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:FinanceLeaseReceivableMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:ContractualCashFlowsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:ContractualCashFlowsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_srtCurrencyAxis_currencyEUR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_srtCurrencyAxis_currencyGBP">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_srtCurrencyAxis_currencySEK">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_srtCurrencyAxis_currencyCAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_srtCurrencyAxis_currencyBRL">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:BRL</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_srtCurrencyAxis_currencyXXX">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_srtCurrencyAxis_currencyXXX">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_srtCurrencyAxis_currencyBRL">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:BRL</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_srtCurrencyAxis_currencyCAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_srtCurrencyAxis_currencySEK">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_srtCurrencyAxis_currencyGBP">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_srtCurrencyAxis_currencyEUR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullTypesOfRisksAxis_tribTenPercentStrengtheningUSDollarMember_srtCurrencyAxis_currencyEUR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">trib:TenPercentStrengtheningUSDollarMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullTypesOfRisksAxis_tribTenPercentStrengtheningUSDollarMember_srtCurrencyAxis_currencyEUR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">trib:TenPercentStrengtheningUSDollarMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullTypesOfRisksAxis_tribTenPercentWeakeningUSDollarMember_srtCurrencyAxis_currencyEUR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">trib:TenPercentWeakeningUSDollarMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullTypesOfRisksAxis_tribTenPercentWeakeningUSDollarMember_srtCurrencyAxis_currencyEUR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">trib:TenPercentWeakeningUSDollarMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullGeographicalAreasAxis_countryUS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullGeographicalAreasAxis_countryUS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullGeographicalAreasAxis_tribEuroZoneCountriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:EuroZoneCountriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullGeographicalAreasAxis_tribEuroZoneCountriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:EuroZoneCountriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullGeographicalAreasAxis_countryGB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullGeographicalAreasAxis_countryGB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherRegionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherRegionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullTypesOfCustomersAxis_tribEndUserCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">trib:EndUserCustomersMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullTypesOfCustomersAxis_tribEndUserCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">trib:EndUserCustomersMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullTypesOfCustomersAxis_tribDistributorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">trib:DistributorsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullTypesOfCustomersAxis_tribDistributorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">trib:DistributorsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullTypesOfCustomersAxis_ifrsfullNongovernmentCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">ifrs-full:NongovernmentCustomersMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullTypesOfCustomersAxis_ifrsfullNongovernmentCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">ifrs-full:NongovernmentCustomersMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:LaterThanOneMonthsAndNotLaterThanFourMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:LaterThanOneMonthsAndNotLaterThanFourMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:LaterThanOneMonthsAndNotLaterThanFourMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:LaterThanOneMonthsAndNotLaterThanFourMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:LaterThanOneMonthsAndNotLaterThanFourMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:LaterThanOneMonthsAndNotLaterThanFourMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:GreaterThanFourMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:GreaterThanFourMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:GreaterThanFourMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:GreaterThanFourMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:GreaterThanFourMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:GreaterThanFourMonthsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">trib:FairValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:CarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ComputerEquipmentsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ComputerEquipmentsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ComputerEquipmentsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ComputerEquipmentsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ComputerEquipmentsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ComputerEquipmentsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ITAndOfficeEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ITAndOfficeEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ITAndOfficeEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ITAndOfficeEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ITAndOfficeEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ITAndOfficeEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryUS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:EliminationOfIntersegmentAmountsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:EliminationOfIntersegmentAmountsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryUS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:EliminationOfIntersegmentAmountsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryUS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AsiaOrAfricaMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AsiaOrAfricaMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AsiaOrAfricaMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribEuropeIncludingIrelandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:EuropeIncludingIrelandMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribEuropeIncludingIrelandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:EuropeIncludingIrelandMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribEuropeIncludingIrelandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:EuropeIncludingIrelandMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullGeographicalAreasAxis_countryIE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IE</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullGeographicalAreasAxis_countryIE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IE</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullGeographicalAreasAxis_countryIE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IE</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_srtMajorCustomersAxis_tribCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AsiaOrAfricaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherCountriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherCountriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullProductsAndServicesAxis_tribClinicalLaboratoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:ClinicalLaboratoryMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullProductsAndServicesAxis_tribClinicalLaboratoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:ClinicalLaboratoryMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullProductsAndServicesAxis_tribClinicalLaboratoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:ClinicalLaboratoryMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullProductsAndServicesAxis_tribLaboratoryServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:LaboratoryServicesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullProductsAndServicesAxis_tribLaboratoryServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:LaboratoryServicesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullProductsAndServicesAxis_tribLaboratoryServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:LaboratoryServicesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullProductsAndServicesAxis_tribPointOfCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:PointOfCareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullProductsAndServicesAxis_tribPointOfCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:PointOfCareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullProductsAndServicesAxis_tribPointOfCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:PointOfCareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_srtMajorCustomersAxis_tribCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AsiaOrAfricaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_srtMajorCustomersAxis_tribCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AsiaOrAfricaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:CurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:CurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:CurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:CurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember_ifrsfullClassesOfFinancialAssetsAxis_tribDerivativeFinancialAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember_ifrsfullClassesOfFinancialAssetsAxis_tribDerivativeFinancialAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220531_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:MicoLtdMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-05-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220501to20220531_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:MicoLtdMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-05-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:CurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:TermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:TermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:TermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:TermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:TermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanCreditFacilityOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-01-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:PerceptiveCreditHoldingsIiiLpMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:PerceptiveCreditHoldingsIiiLpMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:PerceptiveCreditHoldingsIiiLpMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanCreditFacilityOneMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-02-28</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230201to20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanCreditFacilityOneMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230401to20230427_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSaleOfFitzgeraldIndustriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SaleOfFitzgeraldIndustriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-04-27</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230427_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSaleOfFitzgeraldIndustriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SaleOfFitzgeraldIndustriesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-04-27</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220501to20220522_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanCreditFacilityOneMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-01</xbrli:startDate>
        <xbrli:endDate>2022-05-22</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanCreditFacilityOneMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:AmendmentAndRestatementOfTermLoanMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-01-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:AmendmentAndRestatementOfTermLoanMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-01-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240430_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:AmendmentAndRestatementOfTermLoanMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-04-30</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-01-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211201to20211210_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-01</xbrli:startDate>
        <xbrli:endDate>2021-12-10</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20240331_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20240331_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:AmendmentAndRestatementOfTermLoanMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240331_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:AmendmentAndRestatementOfTermLoanMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:AmendmentAndRestatementOfTermLoanMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribContingentLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribContingentLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesOneOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesOneOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesTwoOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesTwoOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesFiveOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesFiveOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesOneOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesOneOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesThreeOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesSixOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesThreeOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesFourOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesThreeOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesFourOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesThreeOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesSixOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230401to20230427_ifrsfullBusinessCombinationsAxis_tribBiosynthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:BiosynthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-04-27</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribBiosynthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:BiosynthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullBusinessCombinationsAxis_tribBiosynthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:BiosynthMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribPersonnelRelatedCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:PersonnelRelatedCostsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribOutsourcingCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:OutsourcingCostsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:SiteTransferCostsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribInventoryRelatedCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:InventoryRelatedCostsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribOtherRestructuringCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:OtherRestructuringCostsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241001to20241031_ifrsfullUnderlyingEquityInstrumentAndDepositaryReceiptsAxis_tribAmericanDepositarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnderlyingEquityInstrumentAndDepositaryReceiptsAxis">trib:AmericanDepositarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241031_ifrsfullUnderlyingEquityInstrumentAndDepositaryReceiptsAxis_tribAmericanDepositarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:UnderlyingEquityInstrumentAndDepositaryReceiptsAxis">trib:AmericanDepositarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-10-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241031_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribPaycheckProtectionProgramLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-10-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20250227_ifrsfullBorrowingsByNameAxis_tribFourthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">trib:FourthAmendmentToCreditAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2025-02-27</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">trib:FifthAmendmentToCreditAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2025-05-14</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20250514to20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">trib:FifthAmendmentToCreditAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-14</xbrli:startDate>
        <xbrli:endDate>2025-05-14</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCapitalisedDevelopmentExpenditureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribPropertyAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:PropertyAndEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullOtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCapitalisedDevelopmentExpenditureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241223_tribCreditAgreementAxis_tribAmendedCreditAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="trib:CreditAgreementAxis">trib:AmendedCreditAgreementMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-23</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241223to20241223_tribCreditAgreementAxis_tribAmendedCreditAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="trib:CreditAgreementAxis">trib:AmendedCreditAgreementMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-23</xbrli:startDate>
        <xbrli:endDate>2024-12-23</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20250228_ifrsfullBorrowingsByNameAxis_tribFourthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">trib:FourthAmendmentToCreditAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2025-02-28</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribContinuousGlucoseMonitoringTechnologyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:ContinuousGlucoseMonitoringTechnologyMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20251031_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">trib:FifthAmendmentToCreditAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2025-10-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_ifrsfullRestructuringProvisionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_ifrsfullRestructuringProvisionMember_tribInstalmentsAxis_tribWithinOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="trib:InstalmentsAxis">trib:WithinOneYearMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_ifrsfullRestructuringProvisionMember_tribInstalmentsAxis_tribMoreThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="trib:InstalmentsAxis">trib:MoreThanOneYearMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000888721</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:unit id="EUR">
      <xbrli:measure>iso4217:EUR</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="Employee">
      <xbrli:measure>trib:Employee</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="Share">
      <xbrli:measure>trib:Share</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="USD_per_ADS">
      <xbrli:measure>trib:USD_per_ADS</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="USD_per_share"><xbrli:divide>
      <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator>
      <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide>
      </xbrli:unit>
    <xbrli:unit id="Years">
      <xbrli:measure>trib:Years</xbrli:measure>
      </xbrli:unit>
    <ix:relationship fromRefs="Fxbrl_20220118015958552_27" toRefs="FN20250513194303268"/>
    <ix:relationship fromRefs="Fxbrl_20220118015958552_211" toRefs="FN20250513194303268"/>
    <ix:relationship fromRefs="Fxbrl_20220118015958552_711" toRefs="FN20230420130342130"/>
    <ix:relationship fromRefs="Fxbrl_20230413100256416" toRefs="FN20230420130342130"/>
    <ix:relationship fromRefs="Fxbrl_20230414175446320" toRefs="FN20250513194303268"/>
    <ix:relationship fromRefs="Fxbrl_20230414175634088" toRefs="FN20230420130342130"/>
    <ix:relationship fromRefs="Fxbrl_20220115161837833_73" toRefs="FN20240427025912834"/>
    <ix:relationship fromRefs="Fxbrl_20220115161837833_77" toRefs="FN20240427025912834"/>
    <ix:relationship fromRefs="Fxbrl_20220115161837833_711" toRefs="FN20240427025912834"/>
    <ix:relationship fromRefs="Fxbrl_20220115163702535_73" toRefs="FN20240427025257016"/>
    <ix:relationship fromRefs="Fxbrl_20220115163702535_77" toRefs="FN20240427025257016"/>
    <ix:relationship fromRefs="Fxbrl_20220115163702535_711" toRefs="FN20240427025257016"/>
    <ix:relationship fromRefs="Fxbrl_20220114180710749_93" toRefs="FN20250512160603335"/>
    <ix:relationship fromRefs="Fxbrl_20220114180710749_97" toRefs="FN20250512160603335"/>
    <ix:relationship fromRefs="Fxbrl_20220114180710749_911" toRefs="FN20250512160603335"/>
    <ix:relationship fromRefs="Fxbrl_20220119104905700_xbrl_20220119103015701_131" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20220119104905700_xbrl_20220119103015701_127" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20220119104905700_xbrl_20220119103015701_123" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20220119104905700_xbrl_20220119103015701_119" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20220119104905700_xbrl_20220119103015701_115" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20220119104905700_xbrl_20220119103015701_111" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20220119104905700_xbrl_20220119103015701_17" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_131" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_127" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_123" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_119" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_115" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_131" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_127" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_123" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_119" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_115" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_111" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_17" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_227" toRefs="FN20240413120034144"/>
    <ix:relationship fromRefs="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_223" toRefs="FN20240413120034144"/>
    <ix:relationship fromRefs="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_219" toRefs="FN20240413120034144"/>
    <ix:relationship fromRefs="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_215" toRefs="FN20240413120034144"/>
    <ix:relationship fromRefs="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_211" toRefs="FN20240413120034144"/>
    <ix:relationship fromRefs="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_27" toRefs="FN20240413120034144"/>
    <ix:relationship fromRefs="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_23" toRefs="FN20240413120034144"/>
    <ix:relationship fromRefs="Fxbrl_20240413104647018" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17" toRefs="FN20240414183320494"/>
    <ix:relationship fromRefs="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17" toRefs="FN20240413114930201"/>
    <ix:relationship fromRefs="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_227" toRefs="FN20240413120837416"/>
    <ix:relationship fromRefs="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_223" toRefs="FN20240413120837416"/>
    <ix:relationship fromRefs="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_219" toRefs="FN20240413120837416"/>
    <ix:relationship fromRefs="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_215" toRefs="FN20240413120837416"/>
    <ix:relationship fromRefs="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_211" toRefs="FN20240413120837416"/>
    <ix:relationship fromRefs="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_27" toRefs="FN20240413120837416"/>
    <ix:relationship fromRefs="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_23" toRefs="FN20240413120837416"/>
    <ix:relationship fromRefs="Fxbrl_20250513120950208" toRefs="FN20240413114732041"/>
    <ix:relationship fromRefs="Fxbrl_20220118111332977_113" toRefs="FN20250513165025082"/>
    <ix:relationship fromRefs="Fxbrl_20220118111332977_117" toRefs="FN20250513165025082"/>
    <ix:relationship fromRefs="Fxbrl_20220118111332977_1111" toRefs="FN20250513165025082"/>
    <ix:relationship fromRefs="Fxbrl_20220118111332977_1115" toRefs="FN20250513165025082"/>
    <ix:relationship fromRefs="Fxbrl_20220118111332977_1119" toRefs="FN20250513165025082"/>
    <ix:relationship fromRefs="Fxbrl_20220326182655798_xbrl_20220118111332977_2119" toRefs="FN20250515105302222"/>
    <ix:relationship fromRefs="Fxbrl_20220326182655798_xbrl_20220118111332977_2115" toRefs="FN20250515105302222"/>
    <ix:relationship fromRefs="Fxbrl_20220326182655798_xbrl_20220118111332977_2111" toRefs="FN20250515105302222"/>
    <ix:relationship fromRefs="Fxbrl_20220326182655798_xbrl_20220118111332977_217" toRefs="FN20250515105302222"/>
    <ix:relationship fromRefs="Fxbrl_20220326182655798_xbrl_20220118111332977_213" toRefs="FN20250515105302222"/>
    <ix:relationship fromRefs="Fxbrl_20220118220551225_33" toRefs="FN20250513123429194"/>
    <ix:relationship fromRefs="Fxbrl_20220118220551225_37" toRefs="FN20250513123429194"/>
    <ix:relationship fromRefs="Fxbrl_20220118220551225_311" toRefs="FN20250513123429194"/>
    <ix:relationship fromRefs="Fxbrl_20230426151110276_xbrl_20220118230546067_xbrl_20220118224340376_715" toRefs="FN20230426150735027"/>
    <ix:relationship fromRefs="Fxbrl_20240413195541011" toRefs="FN20230426150735027"/>
    <ix:relationship fromRefs="Fxbrl_20240413195556956" toRefs="FN20230426150735027"/>
    </ix:resources>
  </ix:header></div>

<div>

<div style="line-height:1.25"> <hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center"/>
</div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif">SECURITIES
AND EXCHANGE COMMISSION</span></span></div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Washington
D.C. 20549</span></span></div>

<div style="line-height:1.25">

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"> <hr style="background-color:#000000;border-bottom:medium none;border-left:medium none;border-right:medium none;border-top:medium none;margin:0px auto;height:2px;width:15%;color:#000000;text-align:center;text-align:center"/>
</div>

<div style="line-height:1.25">&#160;</div> </div>

<div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif">FORM
<ix:nonNumeric id="F20230427192706139_0" name="dei:DocumentType" contextRef="C_20240101to20241231">20-F</ix:nonNumeric></span></span></div>

<div style="line-height:1.25">

<div style="line-height:1.25">

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"> <hr style="background-color:#000000;border-bottom:medium none;border-left:medium none;border-right:medium none;border-top:medium none;margin:0px auto;height:2px;width:15%;color:#000000;text-align:center;text-align:center"/>
</div>

<div style="line-height:1.25">&#160;</div> </div> </div>

<div style="text-indent:-24.5pt;margin-left:24.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230427192706140_1" name="dei:DocumentRegistrationStatement" contextRef="C_20240101to20241231" format="ixt:fixed-false">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight:bold">REGISTRATION
STATEMENT PURSUANT TO SECTION 12(b) OR (g)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OR</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:-24.5pt;margin-left:24.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230427192706140_2" name="dei:DocumentAnnualReport" contextRef="C_20240101to20241231" format="ixt:fixed-true">&#9746;</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight:bold">ANNUAL
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For
the fiscal year ended <ix:nonNumeric id="F20230427192706140_4" name="dei:DocumentPeriodEndDate" contextRef="C_20240101to20241231" format="ixt:date-monthname-day-year-en"><ix:nonNumeric id="Fxbrl_20240415110852567" name="dei:CurrentFiscalYearEndDate" contextRef="C_20240101to20241231" format="ixt:date-monthname-day-en">December&#160;31</ix:nonNumeric>,
<ix:nonNumeric id="F20230427192706140_5" name="dei:DocumentFiscalYearFocus" contextRef="C_20240101to20241231">2024</ix:nonNumeric></ix:nonNumeric></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OR</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:-24.5pt;margin-left:24.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230427192706141_6" name="dei:DocumentTransitionReport" contextRef="C_20240101to20241231" format="ixt:fixed-false">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight:bold">TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For
the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:-24.5pt;margin-left:24.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230427192706141_7" name="dei:DocumentShellCompanyReport" contextRef="C_20240101to20241231" format="ixt:fixed-false">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight:bold">SHELL
COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Date
of event requiring this shell company report</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commission
file number: <ix:nonNumeric id="F20230427192706141_8" name="dei:EntityFileNumber" contextRef="C_20240101to20241231">0-2022</ix:nonNumeric></span></span></div>

<div style="line-height:1.25">

<div style="line-height:1.25">

<div style="line-height:1.25">

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"> <hr style="background-color:#000000;border-bottom:medium none;border-left:medium none;border-right:medium none;border-top:medium none;margin:0px auto;height:2px;width:15%;color:#000000;text-align:center;text-align:center"/>
</div>

<div style="line-height:1.25">&#160;</div> </div> </div> </div>

<div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:16pt;font-weight:bold"><span style="font-size:16pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230427192706141_9" name="dei:EntityRegistrantName" contextRef="C_20240101to20241231">Trinity
Biotech plc</ix:nonNumeric></span></span></div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Exact
name of Registrant as specified in its charter and translation of Registrant&#8217;s name into English)</span></span></div>

<div style="line-height:1.25">

<div style="text-align:center;margin-right:216pt;margin-left:216pt;line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25">

<div style="line-height:1.25"> <hr style="background-color:#000000;border-bottom:medium none;border-left:medium none;border-right:medium none;border-top:medium none;margin:0px auto;height:2px;width:15%;color:#000000;text-align:center;text-align:center"/>
</div>

<div style="line-height:1.25">&#160;</div> </div> </div> </div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230427192706141_10" name="dei:EntityIncorporationStateCountryCode" contextRef="C_20240101to20241231" format="ixt-sec:edgarprovcountryen">Ireland</ix:nonNumeric></span></span></div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Jurisdiction
of incorporation or organization)</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240414194056799" name="dei:EntityAddressAddressLine1" contextRef="C_20240101to20241231">IDA
Business Park</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20240414194147784" name="dei:EntityAddressCityOrTown" contextRef="C_20240101to20241231">Bray,
County Wicklow</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20240414194232994" name="dei:EntityAddressPostalZipCode" contextRef="C_20240101to20241231">A98
H5C8</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20240415103933774" name="dei:EntityAddressCountry" contextRef="C_20240101to20241231" format="ixt-sec:countrynameen">Ireland</ix:nonNumeric></span></span></div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Address
of principal executive offices)</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230427192706142_14" name="dei:ContactPersonnelName" contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Susan
O&#8217;Connor</ix:nonNumeric></span></span></div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interim
Chief Financial Officer</span></span></div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tel:
+<ix:nonNumeric id="F20230427192706142_15" name="dei:CityAreaCode" contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">353</ix:nonNumeric>&#160;<ix:nonNumeric id="F20230427192706143_16" name="dei:LocalPhoneNumber" contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">1276
9800</ix:nonNumeric></span></span></div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fax:
+353 <ix:nonNumeric id="F20230427192706143_17" name="dei:ContactPersonnelFaxNumber" contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">1276
9888</ix:nonNumeric></span></span></div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240415104441463" name="dei:EntityAddressAddressLine1" contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">IDA
Business Park</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20230428021721365" name="dei:EntityAddressCityOrTown" contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Bray,
County Wicklow</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20230428021744011" name="dei:EntityAddressPostalZipCode" contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">A98
H5C8</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20240415104232487" name="dei:EntityAddressCountry" contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember" format="ixt-sec:countrynameen">Ireland</ix:nonNumeric></span></span></div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Name,
Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Securities
registered or to be registered pursuant to Section&#160;12(b) of the Act:</span></span></div>

<div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:3pt">&#160;</div>

<div>&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:33%;vertical-align:bottom;white-space:nowrap">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Title
        of each class</span></span></span></div> </td>
    <td style="width:33%;vertical-align:bottom;white-space:nowrap">
        <div style="text-align:center;margin-right:54pt;margin-left:55.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline"><span style="font-weight:bold">Trading
        Symbol</span></span></span></span></div> </td>
    <td style="width:33%;vertical-align:top">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Name
        of each exchange on which registered</span></span></span></div> </td> </tr>
  <tr>
    <td style="width:33%;vertical-align:top">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20250513124045017" name="dei:Security12bTitle" contextRef="C_20240101to20241231" continuedAt="F20250513182028875">American
        Depositary Shares (each representing 20</ix:nonNumeric></span></span></div>
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><ix:continuation id="F20250513182028875" continuedAt="F20250513182045938">&#8216;A&#8217;
        Ordinary Shares, par value US$0.0109)</ix:continuation></span>
        <div style="display:none"> <ix:continuation id="F20250513182045938">
        <div><span style="font-size:10pt">&#160;</span></div> </ix:continuation> </div> </div> </td>
    <td style="width:33%;vertical-align:top">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230427192706144_21" name="dei:TradingSymbol" contextRef="C_20240101to20241231">TRIB</ix:nonNumeric></span></span></div>
        </td>
    <td style="width:33%;vertical-align:top">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230427192706144_22" name="dei:SecurityExchangeName" contextRef="C_20240101to20241231" format="ixt-sec:exchnameen">NASDAQ</ix:nonNumeric>
        Global Market</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Securities
registered or to be registered pursuant to Section&#160;12(g) of the Act: None</span></span></div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Securities
for which there is a reporting obligation pursuant to Section&#160;15(d) of the Act: None</span></span></div>

<div style="line-height:1.25">

<div style="line-height:1.25">&#160;</div> </div>

<div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate
the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of the close of the period covered
by the annual report:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230427192706144_23" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_20241231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">359,193,482</ix:nonFraction>
Class &#8216;A&#8217; Ordinary Shares (excluding Treasury Shares)</span></span></div>

<div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(as
of December&#160;31, 2024)</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
</div> </div>

<div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;</span></span></div>

<div style="text-indent:18pt;line-height:1.25">&#160;</div>

<div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Yes
&#9744;&#160;&#160;<ix:nonNumeric id="F20230427192706144_24" name="dei:EntityWellKnownSeasonedIssuer" contextRef="C_20240101to20241231">No</ix:nonNumeric>&#160;&#9746;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If this
report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13
or 15(d) of the Securities Exchange Act of 1934.&#160;&#160;</span></span></div>

<div style="text-indent:18pt;line-height:1.25">&#160;</div>

<div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Yes&#160;&#9744;&#160;&#160;<ix:nonNumeric id="F20230427192706144_25" name="dei:EntityVoluntaryFilers" contextRef="C_20240101to20241231">No</ix:nonNumeric>&#160;&#9746;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate
by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;</span></span></div>

<div style="text-indent:18pt;line-height:1.25">&#160;</div>

<div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230427192706145_26" name="dei:EntityCurrentReportingStatus" contextRef="C_20240101to20241231">Yes</ix:nonNumeric>&#160;&#9746;&#160;&#160;No&#160;&#9744;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was
required to submit such files).&#160;&#160;</span></span></div>

<div style="text-indent:18pt;line-height:1.25">&#160;</div>

<div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230427192706145_27" name="dei:EntityInteractiveDataCurrent" contextRef="C_20240101to20241231">Yes</ix:nonNumeric>&#160;&#9746;&#160;&#160;No&#160;&#9744;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of
&#8220;accelerated filer and large accelerated filer&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Large
accelerated filer&#160;&#160;&#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accelerated
filer&#160;&#160;&#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric id="Fxbrl_20240422145533820" name="dei:EntityFilerCategory" contextRef="C_20240101to20241231" format="ixt-sec:entityfilercategoryen">Non-accelerated
filer</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Emerging
growth company&#160;&#160;<ix:nonNumeric id="F20230427192706145_29" name="dei:EntityEmergingGrowthCompany" contextRef="C_20240101to20241231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If an
emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.&#160;&#160;&#9744;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of
its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public
accounting firm that prepared or issued its audit report. <ix:nonNumeric id="F20230427192706145_30" name="dei:IcfrAuditorAttestationFlag" contextRef="C_20240101to20241231" format="ixt:fixed-false">&#9744;</ix:nonNumeric>&#160;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If securities are registered
pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing
reflect the correction of an error to previously issued financial statements. &#160;&#160;<ix:nonNumeric id="Fxbrl_20240415125347377" name="dei:DocumentFinStmtErrorCorrectionFlag" contextRef="C_20240101to20241231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark
whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by
any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).&#160;&#160;&#9744;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark
which basis of accounting the registrant has used to prepare the financial statements included in this filing:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:3pt">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:33%;vertical-align:top">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S.&#160;GAAP&#160;&#160;&#9744;</span></span></div>
        </td>
    <td style="width:33%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230427192706145_31" name="dei:DocumentAccountingStandard" contextRef="C_20240101to20241231">International Financial Reporting Standards</ix:nonNumeric>&#160;as issued</span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">by the International
        Accounting Standards Board&#160;&#160;&#9746;</span></span></div> </td>
    <td style="width:33%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other&#160;&#160;&#9744;</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If
&#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant
has elected to follow.&#160;</span></span></div>

<div style="text-align:center;line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Item
17 <span>&#9744;</span> Item 18 <span>&#9744;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If
this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></span></div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Yes
<span>&#9744;</span> No <span><ix:nonNumeric id="F20230427192706146_32" name="dei:EntityShellCompany" contextRef="C_20240101to20241231" format="ixt:fixed-false">&#9746;</ix:nonNumeric></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">This Annual Report on
Form 20-F is incorporated by reference into our Registration Statements on Form S-8 File Nos. 333-182279,333-195232 and 333-253070 and
our Registration Statements on Form F-3 File Nos.333-239701, 333-267160 and&#160;333-264992.</span></span></div>

<p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:10pt;margin-bottom:10pt"/>
</div>

<p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>

<div style="line-height:1.25">

<!-- Field: Include-Text; File: pf\body.htm; Date: 2025%2D05%2D16T00:10:46; Size: 0x0013A28B; Options: XMLPreprocess -->
<div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: 400"> <br/> </div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">TABLE OF CONTENTS</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdc2d2cce603e48e0b5f92fddc17e4fb0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8.58%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 6.52%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Page</div> </td> </tr>
  <tr>
    <td style="width: 8.58%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#PRESENTATIONOFFINANCIALANDOTHERINFORMATION">PRESENTATION OF FINANCIAL AND OTHER INFORMATION</a></div>
        </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">1</td> </tr>
  <tr>
    <td style="width: 8.58%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#MARKETINDUSTRYANDOTHERDATA">MARKET, INDUSTRY AND OTHER DATA</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">1</td> </tr>
  <tr>
    <td style="width: 8.58%; vertical-align: top">&#160;</td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#CAUTIONARYSTATEMENTREGARDINGFORWARD-LOOKINGSTATEMENTS">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
        STATEMENTS</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">1</td> </tr>
  <tr>
    <td style="width: 8.58%; vertical-align: middle">&#160;</td>
    <td style="width: 84.9%; vertical-align: middle">&#160;</td>
    <td style="width: 6.52%; vertical-align: middle; text-align: center">&#160;</td> </tr>
  <tr>
    <td style="width: 8.58%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"><a href="#PARTI">PART I</a></div> </td>
    <td style="width: 6.52%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif">&#160;</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#IdentityofDirectorsSeniorManagementandAdvisers">Item 1</a></div>
        </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#IdentityofDirectorsSeniorManagementandAdvisers">Identity of Directors, Senior Management and
        Advisers</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">2</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#OfferStatisticsandExpectedTimetable">Item 2</a></div>
        </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#OfferStatisticsandExpectedTimetable">Offer Statistics and Expected Timetable</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">2</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#KeyInformation">Item 3</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#KeyInformation">Key Information</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">2</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">A.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Reserved</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">2</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">B.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Capitalization and Indebtedness</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">2</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">C.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Reasons for the Offer and Use of Proceeds</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">2</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">D.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Risk Factors</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">3</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#InformationontheCompany">Item 4</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#InformationontheCompany">Information on the Company</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">38<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">A.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">History and Development of the Company</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">38<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">B.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Business Overview</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">38<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">C.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Organizational Structure</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">56<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">D.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Property, Plants and Equipment</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">57<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#UnresolvedStaffComments">Item 4A.</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#UnresolvedStaffComments">Unresolved Staff Comments</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">58<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#OperatingandFinancialReviewandProspects">Item 5</a></div>
        </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#OperatingandFinancialReviewandProspects">Operating and Financial Review and Prospects</a></div>
        </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">59<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">A.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Operating Results</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">59<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">B.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Liquidity and Capital Resources</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">70<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">C.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Research and Development, Patents and Licenses, etc.</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">73<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">D.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Trend Information</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">74<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">E.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Critical Accounting Estimates</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">74<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#DirectorsSeniorManagementandEmployees">Item 6</a></div>
        </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#DirectorsSeniorManagementandEmployees">Directors, Senior Management and Employees</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">79<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">A.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Directors and Senior Management</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">79<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">B.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Compensation</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">81<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">C.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Board Practices</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">82<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">D.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Employees</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">83<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">E.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Share Ownership</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">84<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#MajorShareholdersandRelatedPartyTransactions">Item 7</a></div>
        </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#MajorShareholdersandRelatedPartyTransactions">Major Shareholders and Related Party Transactions</a></div>
        </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">87<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">A.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Major Shareholders</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">87<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">B.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Related Party Transactions</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">88<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">C.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Interests of Experts and Counsel</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">89<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#Item8.fnancialInformation">Item 8</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#Item8.fnancialInformation">Financial Information</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">89<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">A.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Consolidated Statements and Other Financial Information</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">89<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">B.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Significant Changes</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">90</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#Item9.TheOfferandListing">Item 9</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#Item9.TheOfferandListing">The Offer and Listing</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">90</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">A.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Offer and Listing Details</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">90</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">B.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Plan of Distribution</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">90</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">C.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Markets</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">90</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">D.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Selling Shareholders</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">90</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">E.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Dilution</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">90</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">F.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Expense of the Issue</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">90</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#Item10.AdditionalInformation">Item 10</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#Item10.AdditionalInformation">Additional Information</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">90</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">A.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Share Capital</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">90</td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">B.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Memorandum and Articles of Association</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">90<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">C.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Material Contracts</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">91<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">D.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Exchange Controls</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">94<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">E.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Taxation</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">94<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">F.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Dividends and Paying Agents</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">101<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">G.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Statement by Experts</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">101<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">H.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Documents on Display</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">101<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: bottom; text-align: right">
        <div style="margin: 0px 9pt 0px 0px; line-height: 1.25; font-family: Times New Roman,Times,serif">I.</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25">Subsidiary Information</div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">101<br/> </td> </tr>
  </table>

<div><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#Item11.QuantitativeandQualitativeDisclosuresaboutMarketRisk">Item
        11</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#Item11.QuantitativeandQualitativeDisclosuresaboutMarketRisk">Quantitative and Qualitative Disclosures
        about Market Risks</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">102<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#Item12.DescriptionofSecuritiesOtherthanEquitySecurities">Item
        12</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#Item12.DescriptionofSecuritiesOtherthanEquitySecurities">Description of Securities Other than
        Equity Securities</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">103<br/> </td> </tr>
  <tr>
    <td style="width: 8.58%; vertical-align: middle">&#160;</td>
    <td style="width: 84.9%; vertical-align: middle">&#160;</td>
    <td style="width: 6.52%; vertical-align: middle; text-align: center"><br/> </td> </tr>
  <tr>
    <td style="width: 8.58%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"><a href="#PartII">PART II</a></div> </td>
    <td style="width: 6.52%; vertical-align: bottom"><br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#Item13.DefaultsDividendAr">Item 13</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#Item13.DefaultsDividendAr">Defaults, Dividend Arrearages and Delinquencies</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">105<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#Item14.MaterialModificati">Item 14</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#Item14.MaterialModificati">Material Modification to the Rights of Security Holders and Use of
        Proceeds</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">105<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#Item15.ControlsandProcedu">Item 15</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#Item15.ControlsandProcedu">Controls and Procedures</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">105<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#Item16.Reserved">Item 16</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#Item16.Reserved">Reserved</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">106<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#A16A.AuditCommitteeFinanc">Item 16A</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#A16A.AuditCommitteeFinanc">Audit Committee Financial Expert</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">106<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#A16B.CodeofEthic">Item 16B</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#A16B.CodeofEthic">Code of Ethics</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">106<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#A16C.PrincipalAccountantF">Item 16C</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#A16C.PrincipalAccountantF">Principal Accountant Fees and Services</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">106<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#A16D.ExemptionsfromtheLis">Item 16D</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#A16D.ExemptionsfromtheLis">Exemptions from the Listing Standards for Audit Committees</a></div>
        </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">107<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#A16E.PurchasesofEquitySec">Item 16E</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#A16E.PurchasesofEquitySec">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</a></div>
        </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">107<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#A16F.ChangeinRegistrantsC">Item 16F</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#A16F.ChangeinRegistrantsC">Changes in Registrant&#8217;s Certifying Accountant</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">107<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#A16G.CorporateGovernanc">Item 16G</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#A16G.CorporateGovernanc">Corporate Governance</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">107<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#A16H.MineSafetyDisclosur">Item 16H</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#A16H.MineSafetyDisclosur">Mine Safety Disclosure</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">107<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#A16I.DisclosureRegardingF">Item 16I</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#A16I.DisclosureRegardingF">Disclosures Regarding Foreign Jurisdictions That Prevent Inspections</a></div>
        </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">107<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#Item16J">Item 16J</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#Item16J">Insider Trading Policies</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">108<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#Item16K">Item 16K</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#Item16K">Cybersecurity</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">108<br/> </td> </tr>
  <tr>
    <td style="width: 8.58%; vertical-align: middle">&#160;</td>
    <td style="width: 84.9%; vertical-align: middle">&#160;</td>
    <td style="width: 6.52%; vertical-align: middle; text-align: center"><br/> </td> </tr>
  <tr>
    <td style="width: 8.58%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"><a href="#PartIII">PART III</a></div> </td>
    <td style="width: 6.52%; vertical-align: bottom"><br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#Item17">Item 17</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#Item17">Financial Statements</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">109<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#Item18">Item 18</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#Item18">Financial Statements</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">109<br/> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 8.58%; vertical-align: top">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25"><a href="#e19">Item 19</a></div> </td>
    <td style="width: 84.9%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#e19">Exhibits</a></div> </td>
    <td style="white-space: nowrap; width: 6.52%; vertical-align: bottom; text-align: center">205</td> </tr>
  </table>
  </div> <br/>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<!--PROfilePageNumberReset%Num%1%%%-->

<div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PRESENTATIONOFFINANCIALANDOTHERINFORMATION"><!--Anchor--></span>PRESENTATION
OF FINANCIAL AND OTHER INFORMATION</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As used herein, references to &#8220;we&#8221;, &#8220;us&#8221;,
&#8220;Trinity Biotech&#8221; or the &#8220;Group&#8221; in this Annual Report on Form 20-F (the &#8220;Annual Report&#8221;) shall mean
Trinity Biotech plc and its subsidiaries. References to the &#8220;Company&#8221; in this annual report shall mean Trinity Biotech plc.,
the parent company. Our consolidated financial statements appearing in this Annual Report are prepared in accordance with International
Financial Reporting Standards (&#8220;IFRS&#8221;) both as issued by the International Accounting Standards Board (&#8220;IASB&#8221;)
and as adopted by the European Union (&#8220;EU&#8221;).&#160;The IFRS standards applied are those effective for accounting periods beginning
January 1, 2024. Consolidated financial statements are required by Irish law to comply with IFRS as adopted by the EU which differ in
certain respects from IFRS as issued by the IASB.&#160;These differences predominantly relate to the timing of adoption of new standards
by the EU.&#160;However, as none of the differences are relevant in the context of Trinity Biotech, the consolidated financial statements
for the periods presented comply with IFRS both as issued by the IASB and as adopted by the EU. We present our consolidated financial
statements in U.S. Dollars and except as otherwise stated herein, all monetary amounts in this annual report have been presented in US
Dollars. All references in this annual report to &#8220;Dollars&#8221; and &#8220;$&#8221; are to US Dollars, and all references to &#8220;Euro&#8221;
or &#8220;&#8364;&#8221; are to European Union Euro. For presentation purposes all financial information, including comparative figures
from prior periods, have been stated in round thousands, unless otherwise indicated. </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="MARKETINDUSTRYANDOTHERDATA"><!--Anchor--></span>MARKET,
INDUSTRY AND OTHER DATA</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">Unless otherwise indicated, information contained in this Annual Report concerning our
industry and the markets in which we operate, including our competitive position and market opportunity, is based on information from
our own management estimates and research, as well as from industry and general publications and research, surveys and studies conducted
by third parties. Management estimates are derived from publicly available information, our knowledge of our industry and assumptions
based on such information and knowledge, which we believe to be reasonable. Our management estimates have not been verified by any independent
source, and we have not independently verified any third-party information. In addition, assumptions and estimates of our and our industry&#8217;s
future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described
in Item 3.D. &#8220;<span style="font-style: italic">Risk Factors</span>&#8221; below.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">Statements made in this Annual Report concerning the contents of any contract, agreement
or other document are summaries of such contracts, agreements or documents and are not complete descriptions of all of their terms. If
we filed any of these documents as an exhibit to this Annual Report, you should read the document itself for a complete description of
its terms, and the summary included herein is qualified by reference to the full text of the document which is incorporated by reference
into this Annual Report.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="CAUTIONARYSTATEMENTREGARDINGFORWARD-LOOKINGSTATEMENTS"><!--Anchor--></span>CAUTIONARY
STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">This Annual Report contains statements that constitute &#8220;forward-looking statements&#8221;
within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements are neither historical facts nor assurances
of future performance. Although we believe that these estimates and forward-looking statements are based upon reasonable assumptions,
they are subject to numerous risks and uncertainties some of which are beyond our control and are made in light of information currently
available to us.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">In some cases, these forward-looking statements can be identified by words or phrases
such as &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;could,&#8221;
&#8220;should,&#8221; &#8220;anticipate,&#8221; &#8220;aim,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221;
&#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;is/are likely to&#8221; or other similar expressions. Forward-looking statements
contained in this Annual Report include, but are not limited to, statements about:</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="zc1e3441bf63e4521a6207e22009cb210" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the development of our products;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zcc47723805174efeb32720979d1a391d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the potential attributes and benefit of our products and their competitive position;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zab7e0fda981f491f85c2587a3a88f862" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our ability to successfully commercialize, or enter into strategic relationships with third parties to commercialize, our products;</div>
        </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zec3fd084270f43eabd9f368fa9590ad6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our estimates regarding expenses, future revenues, capital requirements and our need for additional financing;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z2edf1b8ce95344719b16fb1a5cd6b7f8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>statements of our plans and objectives;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z303d52aa6c7f44d2a8c499636051ea3a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>our ability to acquire or in-licence new product candidates;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z7484d4216be54d32bd70b5857b62289f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>potential strategic relationships;</div> </td> </tr>
  </table>

<div> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">1</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="zb0655979163c4fb2bbf2200e31048907" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the duration of our patent portfolio;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z513b17e0db6d42b396193f0502e4589e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the capabilities of our business operations;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z7d6a7a511e06449790a90995f0447838" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>expected future economic performance;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z3544603f3be54b0f8238e64c5c4c87ae" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>competition in our market; and</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z8e22b5de56a34caea83f153534467c93" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>assumptions underlying statements regarding us or our business.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">We operate in an evolving environment. New risks emerge from time to time, and it is not possible for our
management to predict all risks, nor can we assess the effect of all factors on our business or the extent to which any factor, or combination
of factors, may cause actual results to differ materially from those contained in any forward-looking statements.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are
beyond our control. In addition, these forward-looking statements reflect our current views with respect to future events and are not
a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements
as a result of a number of important factors, including, without limitation, the important risk factors set forth in Item 3.D. &#8220;<span style="font-style: italic">Risk
Factors</span>&#8221; of this Annual Report.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">The forward-looking statements made in this Annual Report relate only to events or information as of the
date on which the statements are made in this Annual Report. Except as required by law, we undertake no obligation to update or revise
publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the
statements are made or to reflect the occurrence of unanticipated events. You should read this Annual Report and the documents that we
have filed as exhibits hereto completely and with the understanding that our actual future results or performance may be materially different
from what we expect.</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PARTI"><!--Anchor--></span>PART I</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z218ba85b1cad4de8a34e5733c7b120e4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 48.95pt; vertical-align: top; font-weight: bold">Item&#160;1.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-style: italic; font-weight: bold"><span id="IdentityofDirectorsSeniorManagementandAdvisers"><!--Anchor--></span>Identity
        of Directors, Senior Management and Advisers</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zeb5502ad0acf4f5f8e77c5aae6175814" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 48.95pt; vertical-align: top; font-weight: bold">Item&#160;2.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-style: italic; font-weight: bold"><span id="OfferStatisticsandExpectedTimetable"><!--Anchor--></span>Offer Statistics
        and Expected Timetable</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd26295e8d013422eb9c06df8775848f6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 48.95pt; vertical-align: top; font-weight: bold">Item&#160;3.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-style: italic; font-weight: bold"><span id="KeyInformation"><!--Anchor--></span>Key Information</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zda65ebeb06584db5b576c61d6ed4dd62" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 22.5pt; vertical-align: top; font-family: Times New Roman,Times,serif; font-weight: bold">A.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Reserved</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za0545785e74e4c2b9638f1029c5b14b5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 22.5pt; vertical-align: top; font-weight: bold">B.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Capitalization and Indebtedness</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z32759219475940328ab980918d9db152" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 22.5pt; vertical-align: top; font-weight: bold">C.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">Reasons for the Offer and Use of Proceeds</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">2</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd5158e465c70488fb902bff6879bc418" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25"><span style="font-weight: bold">D.</span></div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25"><span style="font-weight: bold">Risk Factors</span></div> </td> </tr>
  </table> </div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"> <br/> </div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">SUMMARY OF RISK FACTORS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">An investment in our securities involves a high degree of risk. Our business, financial
condition or results of operations could be adversely affected by any of these risks. You should carefully consider the risks described
below and, in the information, contained or incorporated by reference in this prospectus. The risks and uncertainties we have described
are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also
affect our operations. Past financial performance may not be a reliable indicator of future performance, and historical trends should
not be used to anticipate results or trends in future periods. If any of these risks actually occurs, our business, business prospects,
financial condition or results of operations could be seriously harmed. This could cause the trading price of our American depositary
shares (&#8220;ADSs&#8221;) to decline, resulting in a loss of all or part of your investment.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Risks Related to our Business and Industry<br/>
<br/> </div>

<table cellspacing="0" cellpadding="0" id="z571e969eebf54d93a2b711a5b323119d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to sell products could be adversely affected by competition from new and existing diagnostic products, and changing conditions
        in the diagnostic market.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z566652812f614f0a9be4042f11c16317" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>
        <div style="line-height: 1.25">, including reductions in government funding and sector consolidation.</div> </div> </td> </tr>
  </table>

<div> <br/> </div>

<div> </div>

<table cellspacing="0" cellpadding="0" id="z95e150b62cc043699becf9040d545e02" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>changes in funding for staffing and operations of the FDA and other government agencies could negatively impact our business.</div>
        </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zb8ad8d91c88b4be79f078287c2b0af2c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our exclusion from one or more HIV testing algorithms, or a delay in the implementation of a HIV testing algorithm, could adversely
        affect our business and financial results.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z0d1b53738f5344c2985e907394b69906" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>we have a history of losses from operations and negative cash flows from operating activities, which may continue in the future.</div>
        </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z3b0e03614be94a30a873bf9da256af79" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>we have incurred substantial debt, which could impair our flexibility and access to capital and adversely affect our financial position.</div>
        </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z5501b2da234045069347f88b98be4752" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>
        <div style="line-height: 1.25">Failure<span style="font-weight: bold; font-style: italic">&#160;</span>to comply with the terms of the
        Credit Agreement could result in a default under its terms and, if uncured, could result in action against our pledged assets. Further
        our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly.</div>
        </div> </td> </tr>
  </table>

<div> <br/> </div>

<div> </div>

<table cellspacing="0" cellpadding="0" id="ze932ee4145df44ccb194415a6de994de" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>global trade issues including import and export license requirements, trade sanctions, tariffs and international trade disputes could
        increase our costs and have a material adverse effect on our business.<br/> </div> </td> </tr>
  </table>

<div>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>failure to achieve our financial and strategic objectives could have a material adverse impact on our business prospects.</div> </td>
        </tr>
  </table> </div>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z84e098457eda4cc3a2ca07809b56018b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to continue as a going concern depends on our ability to generate cash flows from operations and to conduct adequate
        financing activities. We expect we will require future additional capital.</div> </td> </tr>
  </table>

<div>

<div style="text-align: justify; line-height: 1.25"><br/> </div> </div>

<table cellspacing="0" cellpadding="0" id="z1471776e7a304b4ca3daf5fc9005202b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>we may encounter difficulties in realizing the potential financial or strategic benefits of recent business acquisitions.</div> </td>
        </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z15584785ebbb4ff3a50eb6810e9aa551" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>we may be required to return the proceeds, plus interest and penalties, on loans received in 2021 under the Paycheck Protection Program
        under the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) as there are enquires as to whether our U.S.
        subsidiaries were eligible to receive some or all of the funds.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z9adf965b3ea9474d932e86ea4f2f2af0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our long-term success depends upon the successful development and commercialization of new products, particularly in the biosensor
        area.</div> </td> </tr>
  </table>

<div>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our products may in the future be subject to product recalls that could harm our reputation, business and financial results.</div>
        </td> </tr>
  </table>

<div> <br/> </div> </div>

<table cellspacing="0" cellpadding="0" id="zff2249bd8f544577b277427e2af49800" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the large amount of intangible assets and goodwill recorded on our balance sheet may lead to significant impairment charges in the
        future.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z44cb7fb9818e4f5f917d950300e34dcd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>changes in global economic conditions may have a material adverse impact on our results.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zf8265fe880c74336984a7c4d3d382d73" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>significant interruptions in production at our principal manufacturing facilities and/or third-party manufacturing facilities would
        adversely affect our business and operating results.</div> </td> </tr>
  </table>

<div> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">3</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="zde173dd798af4a318aad06bc892df7cf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>we are highly dependent on our senior management team and other key employees, and the loss of one or more of these employees or
        the inability to attract and retain qualified personnel as necessary could adversely affect our operations.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z8a84b7a47bcb4617b50d3ce9359d06f9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>cybersecurity risks, including cyberattacks or data breaches, could disrupt our operations, compromise sensitive data, and adversely
        affect our business.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z11c3ee5161c84e1f95c2156a5395c5de" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our sales and operations are subject to the risks of fluctuations in currency exchange rates.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zfc10a02889994c299a5f5899b0595e43" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>any pandemic similar to the Covid-19 outbreak could significantly disrupt our operations and adversely affect our results of operations.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Risks Related to Government Regulation</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zd0b948e6e15f4c7a9b9708750b0e83a6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>clinical trials necessary to support future premarket submissions will be expensive and will require enrolment of suitable patients
        who may be difficult to identify and recruit.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zfc5bfe98849544f3a103d1bc17318eee" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>if the third parties on whom we rely to conduct our pre-clinical studies and clinical trials and to assist in pre-clinical development
        do not perform as contractually required or expected, we may not be able to obtain regulatory approval or commercialize our products.</div>
        </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z12f04e7ede254ce48a32aafc2204cb49" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the results of our clinical trials may not support our product candidate claims.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z510d47f5cc8241559ff74b6f045f3a77" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the FDA recently modified its policy of enforcement discretion with respect to our laboratory developed tests. We could incur substantial
        costs and delays associated with trying to obtain premarket clearance or other approvals.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="za2da9e8f10a74aa894da92265421d476" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div style="line-height: 1.25">if we are unable to obtain or fail to maintain regulatory approvals and clearances, or experience significant
        delays in obtaining, regulatory clearances or approvals for our future products or product enhancements, our ability to commercially distribute
        and market these products could suffer.</div> </td> </tr>
  </table>

<div> <br/> </div>

<div> </div>

<table cellspacing="0" cellpadding="0" id="za26188fa71b24877bcdfefa685c9307e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>failure to comply with FDA or other regulatory requirements may require us to suspend production of our products or institute a recall
        which could result in higher costs and a loss of revenues.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z6d2dc8c0f6104ba5b8510e6cfec04660" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>we are subject to export controls and economic sanctions laws, anti-corruption, anti-bribery and similar laws and our customers and
        distributors are subject to import and export controls that could subject us to liability if we are not in full compliance with applicable
        laws.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zec342689ac83444997f6235e79bc229f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>changes in healthcare regulation could affect our revenues, costs and financial condition.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify">our laboratory business could be harmed from the loss or suspension of a licence or imposition of a fine
        or penalties under, or future changes in, the law or regulations of the Clinical Laboratory Improvement Amendments of 1988 (&#8220;CLIA&#8221;),
        or those of other state or local agencies.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z6464bc12fc564d4e88696dd2a9bc8018" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>compliance with regulations governing public company corporate governance and reporting is complex and expensive.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Risks Related to Our Intellectual Property</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zfa4a79a180ec43c891619d6593613c4f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>we may be unable to protect or obtain proprietary rights that we utilize or intend to utilize.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z664986189a8d42459fae22b10b3819fd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>
        <div style="line-height: 1.25">our patent protection may not be sufficiently broad to compete effectively, the existing patents could
        be challenge, and trade secrets and confidential know-how could be obtained by competitors.</div> </div> </td> </tr>
  </table>

<div> <br/> </div>

<div> </div>

<table cellspacing="0" cellpadding="0" id="z45268de7cd0f46ec9e7854c3635bc2b4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and
        other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance
        with these requirements.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z6730293ef19a43a3930d30fda487112c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>product infringement claims by other companies could result in costly disputes and could limit our ability to sell our products,
        and we may be involved in lawsuits to enforce our patents, the patents of our licensors or our other intellectual property rights, which
        could be expensive, time consuming and unsuccessful.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Risks Related to Ownership of our American
Depository Shares</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z4b580c067c21430cb03f3feca52b1c40" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>affiliates of Perceptive Credit Holdings III, LP (&#8220;Perceptive&#8221;) and MiCo IVD Holdings, LLC (&#8220;MiCo&#8221;) own approximately
        9.6% and 12.5%, respectively, of the voting share capital of our Company (excluding ADS issuable with respect to warrants and a convertible
        note), which may give each of them significant influence over our management and affairs and may deter a change in control or other transaction
        that may be favorable to our shareholders.</div> </td> </tr>
  </table>

<div> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">4</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z88adaf7a6e03459d9ae09029da64a023" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our failure to meet the continued listing requirements of Nasdaq could result in a de-listing of our ADSs and penny stock trading<span style="font-weight: bold; font-style: italic">.</span></div>
        </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z7a77686e893b479db35764cb1486bcd7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the market price of our ADSs has been, and may continue to be, highly volatile.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zd3a162b38fc6499c955e4ba26f8e3ebb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>we expect we will need additional capital in the future.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z13374493219b4c228d05e61ea15865d2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the conversion of our outstanding employee share options, any new employee share options and existing warrants would dilute the ownership
        interest of existing shareholders.</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zd2f275da3842424785853934e86f52a9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>it could be difficult for U.S. holders of our ADSs to enforce any securities laws claims against us, our officers or directors in
        Irish Courts.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to our Business and Industry</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our ability to sell products could be adversely
affected by competition from new and existing diagnostic products, and changing conditions in the diagnostic market.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We have invested in research and development but there can be
no guarantees that our research and development (&#8220;R&amp;D&#8221;) programmes will not be rendered technologically obsolete or financially
non-viable by the technological advances of our competitors, which would also adversely affect our existing product lines and inventory.
Our main competitors (and their principal products with which we compete) include: Premier (First response&#8482;), Chembio (Stat-Pak&#8482;,
DPP HIV-Syphilis), Abbott (Determine&#8482;, SD BioLine&#8482;, Abon&#8482;, Afinion&#8482;, Architect&#8482;, FreeStyle Libre&#8482;),
SD Biosensor (Standard Q), Bejing Wantai Biological Pharmacy (Wantai), Roche (Cobas, TinaQuant 3&#8482;), Bio-Rad (Variant 2&#8482;, Variant
2 Turbo&#8482;, D 100&#8482;, BioPlex 2200) Tosoh (G8&#8482; and G11&#8482;), Arkray 8180&#8482;, Siemens DCA&#8482;, Sebia (Capyllaris
2&#8482; and Capyllaris 3&#8482;), Shanghai Kehua Bio-Engineering (KHB), Euroimmun&#8482;, Guangzhou Wondfo Biotech Co., Ltd (Wondfo),
Aesku&#8482;, Werfen, Copan&#8482;, Becton Dickenson&#8482;, Pointe Scientific, Dexcom &#8482; (G6, G7, Dexcom One, Stelo), Meril Life
(MeriScreen&#8482;) and DiaSorin Liaison.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The diagnostics industry is focused on the testing of biological
specimens in a laboratory or at the point-of-care and is highly competitive and rapidly changing. As new products enter the market, our
products may become obsolete or a competitor&#8217;s products may be more effective or more effectively marketed and sold than ours. If
we fail to maintain and enhance our competitive position, our customers may decide to use products developed by competitors which could
result in a loss of revenues and adversely affect our results of operations, cash flow and business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We may in certain instances also face competition from products
that are sold at a lower price. Where this occurs, customers may choose to buy lower cost products from third parties or we may be forced
to sell our products at a lower price, both of which could result in a loss of revenues or a lower gross margin contribution from the
sale of our products. We may also be required to increase our marketing efforts in order to compete effectively, which would increase
our costs.</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">&#160;

<div style="margin-left: 0.05pt; line-height: 1.25">Our tests compete with products made by our competitors. Multiple competitors are
making investments in competing technologies and products, and a number of our competitors have significantly greater financial, technical,
research and other resources. Some competitors offer broader product lines and may have greater market presence or name recognition than
we have. If we receive FDA or other regulatory clearance for new products, and in order to achieve market acceptance, we and/or our distributors
will likely be required to undertake substantial marketing efforts and spend significant funds to inform potential customers and the public
of the existence and perceived benefits of the products. Our marketing efforts for these products may not be successful. As such, there
can be no assurance that these products will obtain significant market acceptance and fill the market needs that are perceived to exist
on a timely basis, or at all.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our ability to sell products could be adversely
affected by reductions in government funding and sector consolidation.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">&#160;We are continuously monitoring the potential impact of the U.S. President&#8217;s Executive Order
on Reevaluating and Realigning United States Foreign Aid, and the resulting suspensions or termination of funding to HIV testing programs
that utilize the Company&#8217;s two rapid HIV tests.&#160; On January 20, 2025, the U.S. government paused, subject to certain exemptions,
all new funding obligations and sub-obligations of funding of foreign assistance programs, pending a 90-day review of such foreign assistance
programs.&#160; Although the U.S. government introduced a temporary waiver of the aforementioned funding pause for certain assistance,
which the U.S. government later confirmed applied to funding for HIV testing under the President's Emergency Plan for AIDS Relief (PEPFAR),
that waiver is temporary, and there can be no assurance that U.S. government funding for HIV programs that utilize the Company&#8217;s
rapid HIV tests will continue.&#160; Since the Executive Order, the Company has seen disruptions to ordering patterns and demand for our
rapid HIV tests, and it remains unclear at this time what impact these changes will have on the timing and quantity of rapid HIV tests
sold by the Company, and the receipt of funds for the sale of such tests. The outcome of the review aside from South Africa is that overall
U.S. government spending will be cut by an estimated 15-20% for development-related programs. However, commodity procurement for HIV rapid
tests outside of South Africa has been largely unaffected by these cuts. We continue to monitor the potential impact of these cuts closely,
and countries affected are attempting to fill this gap from local and other funding sources.</div> </div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">5</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Changes in funding for, or disruptions to the
staffing and operations of the FDA and other government agencies could hinder their ability to hire, retain or deploy key leadership and
other personnel, or otherwise prevent new or modified products from being developed, approved or commercialized in a timely manner or
at all, which could negatively impact our business.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Currently, federal agencies in the United States are operating under a continuing
resolution that is set to expire on September 30, 2025. Without appropriation of additional funding to federal agencies, our business
operations related to our product development activities for the U.S. market could be impacted. The ability of the FDA to review and/or
approve new products can be affected by a variety of factors, including government budget and funding levels, statutory, regulatory, and
policy changes, the FDA&#8217;s ability to hire and retain key personnel and accept the payment of user fees, and other events that may
otherwise affect the FDA&#8217;s ability to perform routine functions. Average review times at the FDA have fluctuated in recent years
as a result. In addition, government funding of other government agencies that fund research and development activities is subject to
the political process, which is inherently fluid and unpredictable.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Disruptions at the FDA and other federal agencies, including substantial leadership
departures, personnel cuts, and policy changes, may also slow the time necessary for new products to be reviewed and/or approved, which
would harm our business. Changes and cuts in FDA staffing also could result in delays in the FDA&#8217;s responsiveness or in its ability
to review IND submissions or applications, issue regulations or guidance, or implement or enforce regulatory requirements in a timely
fashion or at all.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">A prolonged government shutdown or significant leadership, personnel, and/or policy
changes, or other substantial modification in agency activities (including due to global health concerns or geopolitical factors) could
significantly impact the ability of the FDA or other regulatory authorities to timely review and process our regulatory submissions, which
could have a material adverse effect on our business. In addition, government funding of other agencies on which our operations may rely,
including those that fund research and development activities and clinical trials, is subject to the political process, which is inherently
fluid and unpredictable. Disruptions at agencies that fund our research and development activities and our clinical trials, or changes
to such agencies&#8217; budgets, may negatively impact our operations and ongoing clinical trials and may limit our ability to seek additional
funding in the future. Future shutdowns or other disruptions could also affect other government agencies such as the SEC, which may also
impact our business by delaying review of our public filings, to the extent such review is necessary, and our ability to access the public
markets.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">With the change in the U.S. presidential administration in 2025, there is substantial
uncertainty as to whether and how the Trump administration will seek to modify or revise the requirements and policies of the FDA and
other regulatory agencies with jurisdiction over our product candidates and any products for which we obtain approval. This uncertainty
could present new challenges and/or opportunities as we navigate development and approval of our product candidates. Additionally, the
new administration could issue or promulgate executive orders, regulations, policies or guidance that adversely affect us or create a
more challenging or costly environment to pursue the development of new products.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our sales of point-of-care HIV tests in Africa are dependent on
our inclusion in the applicable country&#8217;s&#160; HIV testing algorithms and our exclusion from one or more of those HIV testing algorithms,
or a delay in the implementation of a HIV testing algorithm, could adversely affect our business and financial results. Those HIV testing
algorithms can be subject to legal challenges from market participants competitors or other stakeholders which can result in delays in
the algorithm being implemented or the algorithm being revised to exclude the incumbent provider.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Most countries in Africa have an established national HIV testing algorithm. The algorithm determines which&#160;
provider&#8217;s HIV point-of-care test will be used. The World Health Organisation has indicated that national HIV algorithms should
contain a HIV screening test (A1) and two HIV confirmatory tests (A2 and A3). Our inclusion on a national HIV testing algorithm determines
whether we will be able to sell HIV tests in that country. HIV testing algorithms are not updated annually and typically run for between
five and seven years. Our Uni-gold HIV confirmatory test is included on many HIV testing algorithms throughout Africa and our newly launched
HIV screening test, TrinScreen, succeeded in being added to Kenya&#8217;s algorithm in 2023. In Kenya, the update to the HIV testing algorithm
was challenged through the courts by a competitor and that legal challenge caused a delay in purchase orders being placed by the Kenyan
health authorities under their revised algorithm. In 2024, another competitor began a court challenge in Kenya to the adopted HIV testing
algorithm. Although we are not party to this court case, and the judge did not suspend procurement while the case is ongoing, it could
have an adverse impact for us if the competitor succeeds in revising the current HIV testing algorithm. We understand that there were
a number of hearings regarding this case during 2024, and we continue to monitor the ongoing court case. Legal challenges to the HIV testing
algorithms from competitors, or other stakeholders, in any country in which we sell HIV tests could adversely affect our business and
financial results. <br/> </div> </div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">6</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We have a history of losses from operations
and negative cash flows from operating activities, which may continue in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">We have incurred net losses and negative cash flows from operating activities in the past two years and
we may not be able to achieve or maintain profitability or positive cash flow in the future. We have incurred losses of US$31.8 million
and US$24.0 million in the years ended December 31, 2024 and 2023, respectively, and had negative cash flows from operating activities
of US$4.2 million and US$11.6 million, respectively.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25">We expect to continue as a going&#160;concern. Our ability to continue as a going&#160;concern
depends on our ability to generate cash flows from operations and to conduct adequate financing activities. We believe that we have access
to sufficient cash reserves for our operating needs for at least the next twelve months from the date of this Annual Report. However,
if negative cash flow from operating activities persists in the long run, cash resources may become insufficient to satisfy our on-going
cash requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Additional funding may not be available on acceptable terms, or at all. In addition,
we may not be able to access a portion of our existing cash, cash equivalents and investments due to market conditions. Further, as a
result of geopolitical and macroeconomic events, including the Israel-Hamas and Russia-Ukraine wars, and the potential imposition or escalation
of U.S. tariffs on imported medical and laboratory equipment, components, or raw materials, the global credit and financial markets have
experienced volatility and disruptions, including severely diminished liquidity and credit availability, declines in consumer confidence,
declines in economic growth, increases in unemployment rates, and uncertainty about economic stability. If the equity and credit markets
deteriorate, it may make any necessary debt or equity financing more difficult, more costly or more dilutive.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Expansion into new businesses may present operating and marketing challenges different
from those we currently encounter, and we cannot assure that new business initiatives will be successful enough to justify the time, effort,
and resources that we devote to them or ultimately achieve profitability. We initially announced the adoption of a transformation plan
to improve the financial performance of our existing business in April 2024 and we continue to pursue and execute a strategic realignment
of our continuing business. Although we have implemented or are in the midst of implementing a number of these cost-saving initiatives,
including consolidating manufacturing, moving some manufacturing offshore to improve our operating margins, and moving significant aspects
of our business support functions to a lower cost and centralized location, we cannot assure you that these efforts will be successful
or that we can achieve our long-term profitability goals.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Any of the above events could significantly harm our business, prospects, financial
condition, and results of operations and cause the price of the ADSs to decline.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We have incurred substantial debt, which could
impair our flexibility and access to capital and adversely affect our financial position.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">As of December 31, 2024, we had total indebtedness
of approximately US$101.6 million (carrying value under IFRS), consisting of a senior secured term loan (the &#8220;Term Loan&#8221; or
&#8220;Credit Agreement&#8221;) from Perceptive Credit Holdings III, LP (&#8220;Perceptive&#8221;), a convertible note issued to MiCo
IVD Holdings, LLC. (&#8220;MiCo&#8221;),&#160; a derivative liability related to warrants issued to Perceptive, lease liabilities and
a residual amount owing for an exchangeable note which was almost completely retired in 2022. The Term Loan had a total outstanding amount
of US$75.5 million as of December 31, 2024. In connection with the third amendment and restatement of the credit agreement governing the
Term Loan on December 23, 2024, we agreed that certain interest payments payable in 2024 and 2025 would be paid-in-kind on the applicable
payment date by increasing the outstanding principal amount of the Term Loan.&#160; On February 27, 2025, we entered into the fourth amended
and restated credit agreement, which provided for an additional US$4.0 million increase to our outstanding Term Loan. In addition, a deferred
consideration payment of US$5.0 million related to the acquisition of the biosensor assets of Waveform Technologies, Inc. (&#8220;Waveform&#8221;)
has been extended to November 2025. On May 14<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup> , 2025,
we entered into a fifth amendment to the Credit Agreement, which provided for an additional US$2.0 million in term loan funding, extended
the maturity date of the Term Loan to July 27, 2026, and provided that interest payments for the months of April, May, and June 2025 will
be paid-in-kind.</div> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div> </div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">7</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div> In May 2022, we received a US$45.2 million investment from <span style="font-family: Times New Roman,Times,serif">MiCo. </span>The
investment consisted of an equity investment of US$25.2 million and a seven-year, unsecured junior<span style="font-family: Times New Roman,Times,serif">
convertible note of US$20.0 million, </span>The convertible note has an interest rate of 1.5% and interest is payable quarterly. The convertible
note <span style="font-family: Times New Roman,Times,serif">mandatorily converts into ADSs if the volume weighted average price of&#160;
our ADSs is at or above US$16.20 for any five consecutive NASDAQ trading days. Based on public filings, we understand that on December
17, 2024, MiCo was acquired by Dayli Trinity Holdings Limited as a result of a share purchase agreement with Mainstream Holdings Limited.</span>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">

<div style="line-height: 1.25">The convertible note is immediately repayable at par together with any accrued interest, if the Company
or any of its material subsidiaries ceases or threatens to cease carrying on its business or a part of its business which is material
to the Group. However, subject to the terms of an Investor Subordination Agreement between Perceptive and MiCo, MiCo may not, without
the prior written consent of Perceptive, take any enforcement action with respect to the convertible note. Such enforcement actions include
amongst other things any MiCo action to enforce payment of or to collect the whole or any part of the convertible note.</div> </div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">As a result of the debt we have incurred,
we may need to raise capital in one or more debt or equity offerings to fund our operations and obligations. There can be no assurance,
however, that we will be successful in raising the necessary capital or that any such offering will be available to us on terms acceptable
to us, or at all. If we are unable to raise additional capital that may be needed on terms in sufficient amounts or on terms acceptable
to us, it could have a material adverse effect on our company and we may have to significantly delay, scale back or discontinue our deliveries
under our outstanding customer purchase orders or the development or commercialization of one or more of our products or one or more of
our other research and development initiatives, sell assets and/or cease trading.</div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our debt may:</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zebf087897d5b4e1da2eabf27420faab0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">require us to use a substantial portion
        of our cash flow from operations to make debt service payments;</div> </td> </tr>
  </table> </div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z94cd9bb5cb174c5db487f4c750ef1c79" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">limit our ability to use our cash flow or
        obtain additional financing for working capital, capital expenditures, acquisitions or other general business purposes;</div> </td> </tr>
  </table> </div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z800a086d560a4238b10f745563570f52" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">limit our flexibility to plan for, or react
        to, changes in our business and industry;</div> </td> </tr>
  </table> </div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z2ef21a1bf8334db580a19497b2d9ad05" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">result in dilution to our existing shareholders
        in the event we issue equity to fund our debt obligations;</div> </td> </tr>
  </table> </div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z2105c03e1d6a4873bd6127de49009dd6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">place us at a competitive disadvantage compared
        to our less leveraged competitors; and</div> </td> </tr>
  </table> </div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z1de68f4392aa49109230b21536e2eb74" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">increase our vulnerability to the impact
        of adverse economic and industry conditions.</div> </td> </tr>
  </table> </div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">To the extent we are unable to repay our
debt as it becomes due with cash on hand or from other sources, we will need to refinance our debt, sell assets or repay the debt with
the proceeds from equity offerings in order to continue in business. Additional indebtedness or equity financing may not be available
to us in the future for the refinancing or repayment of existing debt, or if available, such additional debt or equity financing may not
be available on a timely basis, or on terms acceptable to us and within the limitations specified in our then existing debt instruments.
In addition, in the event we decide to sell additional assets, we can provide no assurance as to the timing of any asset sales or the
proceeds that could be realized by us from any such asset sale. Our ability to obtain additional funding may determine our ability to
continue as a going concern.</div>

<div style="line-height: 1.25">&#160;

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">The failure to comply with the terms of the
credit agreement with Perceptive could result in a default under its terms and, if uncured, could result in action against our pledged
assets.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">The Term Loan is secured by substantially
all of our property and assets, including our equity interests in our subsidiaries. The credit agreement governing the Term Loan (the
&#8220;Credit Agreement&#8221;) contains financial covenants requiring that we (a) maintain agreed levels of unrestricted cash, which
must be held in one or more accounts subject to the security interests of the lenders under the Credit Agreement, and (b) achieve specified
minimum total revenue requirements for the twelve months preceding each quarter end. In addition, the Credit Agreement contains covenants
that restrict our ability to finance future operations or capital needs or to engage in other business activities.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">8</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">The Credit Agreement restricts the ability of our company and the restricted subsidiaries
to, among other things:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z878182674b6640a1bd2ff9f1fdca7443" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>incur, assume or guarantee additional indebtedness;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z59b80853f931494090649920b7a4a139" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>repurchase capital stock;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z024a2e87e19b4ebc8eead8b3c600d704" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>make other restricted payments, including paying dividends and making investments;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfa94a739a7304d0bac96e460b5ed49f6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>create liens;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zcef8cda499cf42bca4dfce8a1c2d7d7a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>sell or otherwise dispose of assets, including capital stock of subsidiaries;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb898d781eeea426f8315fb125d0e45dc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>enter into agreements that restrict dividends from subsidiaries;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd4579ead2f474dbaa4a2e0581aded863" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>acquire another company or business or enter into mergers or consolidations;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>enter into certain inbound and outbound licenses of intellectual property, subject to certain exceptions; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>enter into transactions with affiliates.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">A breach of the revenue covenant or any other covenant in the Credit Agreement would
result in a default under the Credit Agreement. Upon an event of default under the Credit Agreement, the lender could elect to declare
all amounts outstanding thereunder, together with accrued interest, to be immediately due and payable. In such an event, there can be
no assurance that we would have sufficient liquidity to fund payment of the amounts that would be due under the Credit Agreement or that,
if such liquidity were not available, we would be successful in raising additional capital on acceptable terms, or at all, or in completing
any other endeavor to continue to be financially viable and continue as a going concern. If we were unable to pay such amounts due under
the Credit Agreement, the lenders could proceed against the collateral securing the loan. Our inability to raise additional capital on
acceptable terms in the near future, whether for purposes of funding payments required under the Credit Agreement or providing additional
liquidity needed for our operations, could have a material adverse effect on our business, prospects, results of operations, liquidity
and financial condition.</div> </div> </div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our variable rate indebtedness subjects us
to interest rate risk, which could cause our debt service obligations to increase significantly.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Borrowings under our Credit Agreement are at a variable rate of interest and expose us to interest rate
risk. On January 30, 2024, we entered into a second amended and restated senior secured term loan credit agreement which reduced the base
rate of interest by 2.5% to 8.75%. The Term Loan accrues interest at an annual rate equal to 8.75% plus the greater of (a) Term SOFR (Secured
Overnight Financing Rate) or (b) 4.0% per annum. On December 23, 2024, we amended the Credit Agreement, being third amended and restated
senior secured term loan credit agreement, to draw down an additional $2.0 million and capitalized unpaid interest of approximately $3.3
million, bringing the total outstanding to $75.5 million. On February 27, 2025, we entered into a fourth amended and restated credit agreement,
which provided for an additional US$4.0 million in term loan funding. On May 14th, 2025, we entered into a fifth amendment to the credit
agreement, which provided for an additional US$2.0 million in term loan funding, extended the maturity date of the Term Loan to July 27,
2026, and provided that interest payments for the months of April, May, and June 2025 will be paid-in-kind. If interest rates increase,
our debt service obligations on the variable rate indebtedness will increase, and our net income and cash flows, including cash available
for servicing our indebtedness, would correspondingly decrease.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">As of December 31, 2024, the total outstanding amount of our variable rate debt was US$75.5 million. The
indebtedness increased by US$9.4 million to US$84.9 million between January 2025 and May 2025, following the fourth and fifth amendments
to the Term Loan credit agreement, which included a US$6.0 million of total drawdowns and the capitalization of approximately US$3.4 million
of accrued interest for the first four months of 2025.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Our anticipated annual cash interest expense on US$84.9 million variable rate debt at the current rate
of approximately 12.75 percent would be approximately US$10.8 million. Every one percent increase in the interest rate results in additional
annual interest payable of approximately US$0.8 million, based on the current amount of indebtedness.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Global trade issues and changes in and uncertainties
with respect to trade policies and export regulations, including import and export license requirements, trade sanctions,&#160;tariffs&#160;and
international trade disputes, could increase our costs, reduce the competitiveness of our products and otherwise have a material adverse
effect on our business, financial condition, results of operations and growth prospects.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">There is inherent risk, based on the complex relationships among the United States
and the other countries in which we conduct our business, that political, diplomatic, and national security factors can lead to global
trade restrictions and changes in trade policies and export regulations that may adversely affect our business and operations. The United
States and other countries have imposed and may continue to impose new trade restrictions and export regulations, have levied&#160;tariffs&#160;and
taxes on certain goods, and could continue to significantly increase&#160;tariffs&#160;on a broad array of goods, including medical devices
and related components.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In 2025, President Trump signed a series of executive orders imposing various reciprocal
tariffs, and other governments have imposed and may continue to impose retaliatory tariffs, trade restrictions or other trade barriers.
Although we are an Irish company headquartered in Bray, Ireland, we derive a significant portion of our revenues from sales of our products
in the United States. In addition, we conduct business globally and our operations and third-party suppliers span numerous countries outside
the </div> <br/>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">9</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-family: Times New Roman, Times, serif">While we cannot at this time predict the ultimate impact of
such tariffs, we anticipate that our margins could be adversely affected depending on the scope and duration of the tariffs imposed.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Further, the continued threats of new or increased tariffs,
sanctions, trade restrictions and trade barriers as well as ongoing changes in U.S. and foreign government trade policies, including potential
modifications to existing trade agreements, have had and may continue to have a generally disruptive impact on the global economy and,
therefore, negatively impact revenues from sales of our products. Given the volatility and uncertainty regarding the scope and duration
of such tariffs and other aspects of U.S. and foreign government trade policies, the ultimate impact on our operations and financial results
is uncertain and could be significant. In any event, further trade restrictions and export regulations, or new or increased tariffs, including
further retaliatory measures, could increase our supply chain complexity and our manufacturing costs, decrease our margins, reduce the
competitiveness of our products, or restrict our ability to sell our products, provide services or purchase necessary equipment and supplies.
Any of these factors could have a material adverse effect on our business, financial condition, results of operations and growth prospects.</div>

<div style="line-height: 1.25; font-family: Times New Roman, Times, serif">While we cannot at this time predict the ultimate impact of
such tariffs, we anticipate that our margins could be adversely affected depending on the scope and duration of the tariffs imposed.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-family: Times New Roman, Times, serif">Further, the continued threats of new or increased tariffs,
sanctions, trade restrictions and trade barriers as well as ongoing changes in U.S. and foreign government trade policies, including potential
modifications to existing trade agreements, have had and may continue to have a generally disruptive impact on the global economy and,
therefore, negatively impact revenues from sales of our products. Given the volatility and uncertainty regarding the scope and duration
of such tariffs and other aspects of U.S. and foreign government trade policies, the ultimate impact on our operations and financial results
is uncertain and could be significant. In any event, further trade restrictions and export regulations, or new or increased tariffs, including
further retaliatory measures, could increase our supply chain complexity and our manufacturing costs, decrease our margins, reduce the
competitiveness of our products, or restrict our ability to sell our products, provide services or purchase necessary equipment and supplies.
Any of these factors could have a material adverse effect on our business, financial condition, results of operations and growth prospects.</div>

<div style="line-height: 1.25; font-family: Times New Roman, Times, serif"> <br/> </div> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Failure to achieve our financial and strategic
objectives could have a material adverse impact on our business prospects. We may not succeed in our efforts to implement a comprehensive
transformation plan to improve the financial performance of our existing business and realign our continuing business.</div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">As a result of any number of risk factors
identified herein, no assurance can be given that we will be successful in implementing our financial and strategic objectives. In addition,
the funds for research, clinical development and other projects have in the past come partly from our business operations. If our business
slows and we have less money available to fund research and development and clinical programs, we will have to decide at that time which
programs to cut, and by how much. Similarly, if adequate financial, personnel, equipment or other resources are not available, we may
be required to delay or scale back our business. Our operations will be adversely affected if our total revenue and gross profits do not
correspondingly increase or if our technology, product, clinical and market development efforts are unsuccessful or delayed. Furthermore,
our failure to successfully introduce new or enhanced products and develop new markets could have a material adverse effect on our business
and prospects.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">We initially announced the adoption of a
transformation plan to improve the financial performance of our existing business in April 2024 and we continue to pursue and execute
a strategic realignment of our continuing business. The plan has several key components, including:</div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="z4d433c24e1254720b28e69eed38da606" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 20.25pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Reducing complexity and cost by consolidating our main manufacturing operations into a considerably smaller number of sites and also
        moving to an outsourced model for a significant amount of our less complex manufacturing activities;</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="z570c4eb8c31f46e291d975cc9364b7c9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 20.25pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Reducing the cost of goods of many of our products by changing suppliers and negotiating new deals with existing suppliers;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="zc4c2bd254ee344f18fb5e95b1803696d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 20.25pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Continued market acceptance of our new TrinScreen&#8482; HIV rapid point-of-care test;</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="z2ef0c099c58147de80b9d48b248db3fe" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 20.25pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Simplifying our internal operations and optimizing and outsourcing some of our business support function locations; and</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="z2a88b3b7b69c405fb8e9068e7b7de5b4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 20.25pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Realigning our existing business portfolio to support our planned growth in the CGM space.</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">Although we have implemented or are in the
midst of implementing a number of these cost-saving initiatives, including consolidating manufacturing, moving some manufacturing offshore
to improve our operating margins, and moving significant aspects of our business support functions to a lower cost and centralized location,
we cannot assure you that these efforts will be successful or that we can achieve our long-term profitability goals. A failure to achieve
these goals will have a material adverse effect on our results of operations and financial condition.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">10</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">

<div style="line-height: 1.25"><span style="font-weight: bold; font-style: italic">Our ability to continue as a going concern depends
on our ability to generate cash flows from operations and to conduct adequate financing activities.</span>&#160;<span style="font-weight: bold; font-style: italic">We
expect we will require future additional capital.</span></div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">Our future liquidity and ability to meet
our future capital requirements will depend on numerous factors, including, but not limited to, the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf79fd3747e66498ab595621fbe7f361f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The success of our research and product development efforts, in particular the significant development effort required to develop
        and commercialise the biosensor technology, including the continuous glucose monitoring technology acquired in January 2024;</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd36c925450e14f3aadf51bdec1f5819e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The time, cost and degree of success of conducting clinical trials and obtaining regulatory approvals;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9f32e5a0ff2142858b4e5a35d70a3c3a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The costs and timing of expansion of sales and marketing activities;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc15cfbf961a84b4b97907678430b564b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The timing and size of any repayment requirements for existing debt obligations;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3c3dc16bbd2e437083b8eb070fb3962f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The timing and success of the commercial launch of new products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf13a8450f0c14fb1b6222c270e76e665" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The extent to which we gain or expand market acceptance for existing, new or enhanced products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3ccb2df74ab04bcdafab66fb224e8a5d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The costs and timing of the expansion of our manufacturing capacity;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z301c38982c2a42a58adc23498f535de8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The magnitude of capital expenditures;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5d297193fae447fcbbfc9bcdbeb7e132" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Changes in existing and potential relationships with distributors and other business partners;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z77df7cd3df7f4f19b189bbbb98212993" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The costs involved in obtaining and enforcing patents, proprietary rights and necessary licences;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1c5adb28781b4fba90466713a6669f74" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The costs and liability associated with patent infringement or other types of litigation;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z24d597b9a23a417e8cb399979edae33c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The costs related to, and the success of, our operational efficiency focused activities;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z915d327f6ba34159a2bb01f3b3038de8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Competing technological and market developments; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4afe0fb6b64441fb98be622db8dcfdb0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The scope and timing of strategic acquisitions.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">If additional financing is needed, we may
seek to raise funds through the sale of equity or other securities or through bank borrowings. There can be no assurance that financing
through the sale of securities, bank borrowings or otherwise will be available to us on satisfactory terms, or at all.</div> <br/>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">11</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may encounter difficulties in realizing
the potential financial or strategic benefits of recent business acquisitions. We expect to make additional acquisitions in the future
that could disrupt our operations and harm our operating results.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">A significant part of our business strategy
is to pursue acquisitions and other initiatives based on a strategy centered on adding complementary solutions to our portfolio&#8212;all
while we seek to ensure our continued high quality of services and product delivery. We have made numerous acquisitions including the
acquisition in 2024 of the biosensor assets of Waveform, and intend to develop a range of biosensor devices and related services, starting
with a continuous glucose monitoring (&#8220;CGM&#8221;) product. During 2024 we also acquired Metabolomic Diagnostics which will grow
our presence in the maternal health market, and we also entered the oncology space with the acquisition of Epicapture Limited.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">Mergers and acquisitions of companies and
assets are inherently risky and subject to many factors outside of our control and no assurance can be given that our future acquisitions
will be successful and will not adversely affect our business, operating results, or financial condition. In the future, we may seek to
acquire or make strategic investments in complementary businesses, technologies, services or products, or enter into strategic partnerships
or alliances with third parties in order to expand our business. Failure to manage and successfully integrate such acquisitions could
materially harm our business and operating results. Prior acquisitions have resulted in a wide range of outcomes, from successful introduction
of new products technologies and professional services to a failure to do so. There can be no assurance that new product enhancements
will be made in a timely manner or that pre-acquisition due diligence will have identified all possible issues that might arise with respect
to such products. If we acquire other businesses, we may face difficulties, including:</div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zbdd53f42844e47778994e41437b467ee" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25; font-family: Times New Roman,Times,serif">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Difficulties in integrating the operations, systems, technologies,
        products, and personnel of the acquired businesses or enterprises;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z4c4843f9a8174409b7625ffc4fe76140" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25; font-family: Times New Roman,Times,serif">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Diversion of management&#8217;s attention from normal daily operations
        of the business and the challenges of managing larger and more widespread operations resulting from acquisitions;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z3e05a1fd150a4a118d317330dbf12c50" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25; font-family: Times New Roman,Times,serif">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Integrating financial forecasting and controls, procedures and
        reporting cycles;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z5d0f620cd28a4e8791ab020307493824" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25; font-family: Times New Roman,Times,serif">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Potential difficulties in completing projects associated with
        in-process research and development;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z842912750ffc41fba6d37eeb411c3010" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25; font-family: Times New Roman,Times,serif">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Difficulties in entering markets in which we have no or limited
        direct prior experience and where competitors in such markets have stronger market positions; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zccf5fd26cdaa4e46bcc9ecc92273c15e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: left; line-height: 1.25; font-family: Times New Roman,Times,serif">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Insufficient revenue to offset increased expenses associated
        with acquisitions;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">In 2021, certain of our U.S. subsidiaries received
loans which were subsequently forgiven under the Paycheck Protection Program under the Coronavirus Aid, Relief, and Economic Security
Act (the &#8220;CARES Act&#8221;) which they may not have been eligible to receive. If it is determined that the subsidiaries were ineligible
to receive the loans, they may be required to return some or all of the proceeds, pay interest and may be subject to other penalties.</div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">

<div style="line-height: 1.25">In January 2021, two of our U.S. based subsidiaries applied for and received second round loans totaling
approximately $1.8 million under the Paycheck Protection Program (the &#8220;PPP&#8221;) of the CARES Act. In September 2021, the two
subsidiaries applied for forgiveness of the loans and those loans were subsequently forgiven. While our subsidiaries believed at the time
that they obtained the loans that they met all of the eligibility requirements under the CARES Act, they were notified by the U.S. Department
of Justice (&#8220;DOJ&#8221;) in late October 2024 that the two subsidiaries may have not been eligible to receive those loans since
the eligibility requirements for second round loans differed from the first round loans in several ways, including the number of employees
that an applicant, together with its affiliates, could employ to be eligible for a loan. We voluntarily conducted an internal review of
the circumstances surrounding the loan process and have made a preliminary determination that due to changes in the guidelines for those
loans, the two subsidiaries may have inadvertently not met the headcount eligibility criteria for the second round loans.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">During a January 28, 2025 videoconference
among outside U.S. counsel engaged by us to respond to questions from the DOJ about those second round loans obtained by the two US subsidiaries,
a lawyer employed by the DOJ raised, for the first time with us the question of whether our U.S. subsidiaries met the headcount eligibility
criteria for approximately $4.0 million of first round of PPP loans they received in 2020, which were subsequently forgiven. The criteria
for eligibility were different for the two rounds of loans, and we believe that the U.S. subsidiaries met the eligibility criteria for
the first round of loans based on guidance issued by the Small Business Administration at the time of the application for the first round
of loans. After further communication with the DOJ regarding those first found loans, representatives of the DOJ indicated to us that
the government is unlikely to pursue claims related to those first round loans.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">12</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">The DOJ has notified us that the U.S. government
is considering the filing in court of a civil claim related to the second round of loans under which treble damages (up to a maximum amount
of approximately $5.5 million) could be awarded if the government were to satisfy each of the essential elements of such a claim.&#160;&#160;
We continue to review the circumstances surrounding the second round loans and are in the early stages of settlement discussions with
the DOJ.&#160; Although we believe that the government&#8217;s potential claims relating to the second round loans will be resolved for
significantly less than treble damages, it is too early to predict a likely settlement outcome, or what the outcome would be in court
if the matter is not settled by agreement.&#160; A negative outcome in court or a significant settlement may result in adverse publicity
and damage to our reputation and have a material adverse effect on our results of operations and financial condition.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our long-term success depends upon the successful development and
commercialization of new products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">

<div style="margin-left: 0.05pt; line-height: 1.25">Our long-term viability and growth will depend upon the successful discovery, development
and commercialization of new and enhanced products from our activities. In order to remain competitive, we are committed to significant
expenditures on R&amp;D and the commercialization of new or enhanced products. The R&amp;D process generally takes a significant amount
of time from product inception to commercial launch. However, there is no certainty that this investment in research and development will
yield technically feasible or commercially viable products. We may have to abandon a new or enhanced product during its development phase
after our investment of substantial time and money. During the fiscal years ended December&#160;31, 2024, 2023 and 2022, we incurred US$10.9
million, US$1.8 million and US$4.5 million, respectively, in capitalised R&amp;D expenses. Included in the US$10.9 million in 2024, we
capitalised borrowing costs of US$2.1 million, in line with IAS 23. Due to the acquisition of the biosensor technology of Waveform in
January 2024, we expect to incur significantly higher costs related to our research and development activities for the foreseeable future.</div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Successful products require significant development and investment,
including testing to demonstrate their performance capabilities, cost-effectiveness or other benefits prior to commercialization. In addition,
unless exempt, regulatory clearance or approval must be obtained before our medical device products may be sold. Additional development
efforts on these products may be required before we are ready to submit applications for marketing authorisation to any regulatory authority.
Regulatory authorities may not clear or approve these products for commercial sale or may substantially delay or condition clearance or
approval. In addition, even if a product is successfully developed and all applicable regulatory clearances or approvals are obtained,
there may be little or no market for the product. Accordingly, if we fail to develop and gain commercial acceptance for our products,
or if we have to abandon a new product during its development phase, or if competitors develop more effective products or a greater number
of successful new products, customers may decide to use products developed by our competitors. This would result in a loss of revenues
and adversely affect our results of operations, cash flow and business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Our future growth in the U.S. is dependent in part on the U.S.
Food and Drug Administration (&#8220;FDA&#8221;) clearance of products. If FDA clearance is delayed or not achieved for these products,
it could have a material impact on the future growth of our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Similarly, future growth outside of U.S. is dependent on clearance
of products by the relevant regulatory authorities in those countries.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Consolidation of our customers or the formation
of group purchasing organisations could result in increased pricing pressure and other changing conditions that could adversely affect
our operating results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The health care industry has undergone significant consolidation
resulting in increased purchasing leverage for customers and consequently increased pricing pressures on our business. Additionally, some
of our customers have become affiliated with group purchasing organisations. Group purchasing organisations typically offer members price
discounts on laboratory supplies and equipment if they purchase a bundled group of one supplier&#8217;s products, which results in a reduction
in the number of manufacturers selected to supply products to the group purchasing organization and increases the group purchasing organization&#8217;s
ability to influence its members&#8217; buying decisions. Further consolidation among customers or their continued affiliation with group
purchasing organizations may result in significant pricing pressures and correspondingly reduce the gross margins of our business or may
cause our customers to reduce their purchases of our products, thereby adversely affecting our business, prospects, operating results
or financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The trend towards managed care, together with healthcare reform
of the delivery system in the U.S. and efforts to reform in Europe, has resulted in increased pressure on healthcare providers and other
participants in the healthcare industry to reduce selling prices. Consolidation among healthcare providers and consolidation among other
participants in the healthcare industry has resulted in fewer, more powerful groups, whose purchasing power gives them cost containment
leverage. In particular, there has been a consolidation of laboratories. These industry trends and competitive forces place constraints
on the levels of overall pricing, and thus could have a material adverse effect on our gross margins for products we sell in clinical
diagnostic markets.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">13</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">The diagnostics industry is in transition, with a number of changes that affect the
market for diagnostic test products. For example, major consolidation among reference laboratories through mergers and acquisitions and
the formation of multi-hospital alliances in the past several years has reduced the number of institutional customers for diagnostic test
products. There can be no assurance that we will be able to enter into and/or sustain contractual or other marketing or distribution arrangements
on a satisfactory commercial basis with these institutional customers. Further, this consolidation trend may result in the surviving companies
having greater financial resources and technological capabilities, thereby intensifying competition in the industry, which could have
a material adverse effect on our business.</div> <br/>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We are dependent on third-party suppliers for certain critical components
and the primary raw materials required for our test kits.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The primary raw materials required for Trinity Biotech&#8217;s
test kits consist of antibodies, antigens or other reagents, glass fibre and packaging materials which are acquired from third parties.
Our biosensor business and our HB A1C business, both rely on a supply of raw materials to manufacture polymers, electronics and specialist
engineered components. If our third-party suppliers are unable or unwilling to supply or manufacture a required component or product or
if they make changes to a component, product or manufacturing process or do not supply materials meeting our specifications, we may need
to find another source and/or manufacturer. This could require that we perform additional development work.</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">&#160;

<div style="margin-left: 0.05pt; line-height: 1.25">

<div style="margin-left: 0.05pt; line-height: 1.25">Some of our products, which we acquire from third parties, are highly technical and
are required to meet exacting specifications, and any quality control problems that we experience with respect to the products supplied
by third-party vendors could adversely and materially affect our reputation, our attempts to complete our clinical trials or commercialization
of our products and adversely and materially affect our business, operating results and prospects. We may also need to obtain FDA or other
regulatory authorisations for the use of an alternative component or for certain changes to our products or manufacturing process. We
may also have difficulty obtaining similar components from other suppliers that are acceptable to the FDA or other regulatory authorities
and the failure of our suppliers to comply with strictly enforced regulatory requirements could expose us to regulatory action including,
warning letters, product recalls, termination of distribution, product seizures, or civil penalties. Completing that development and obtaining
such authorisations could require significant time and expense and we may not obtain such authorisations on a timely basis, or at all.
The availability of critical components and products from other third parties could also reduce our control over pricing, quality and
timely delivery. These events could either disrupt our ability to manufacture and sell certain of our products into one or more markets
or completely prevent us from doing so and could increase our costs. Any such event could have a material adverse effect on our results
of operations, cash flow and business. Furthermore, since some of these suppliers are located outside of the United States, we are subject
to export laws and import and customs regulations in many jurisdictions, which complicate and could delay shipments of components to us.
In 2022, we experienced significant disruption to our international supply chain which caused some disruption to operations. There can
be no assurance that disruptions of a similar nature will not occur in the future which may create significant challenges in fulfilling
customer orders that we may not be able to overcome.</div> </div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The ongoing uncertainty regarding the upheaval to global trade
from significant international tariff changes represents a significant and growing risk to our business and could materially increase
our cost of goods sold, disrupt supply chains, and delay production or fulfilment schedules. Although typically we do not plan to be dependent
upon any one source for these critical components or raw materials, alternative sources of such raw materials or components with the characteristics
and quality desired by us may not be available or commercially viable. Such unavailability could affect the quality of our products and
our ability to meet orders for specific products.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">14</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If our products cause or contribute to a death
or a serious injury, or malfunction in certain ways, we will be subject to medical device reporting regulations, which can result in voluntary
corrective actions or agency enforcement actions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We are required to comply with the FDA&#8217;s Medical Device
Reporting (&#8220;MDR&#8221;) requirements in the United States and comparable regulations worldwide, such as the Health Products Regulatory
Authority (&#8220;HPRA&#8221;). For example, under the FDA&#8217;s MDR regulations, we are required to report to the FDA any incident
in which our product may have caused or contributed to a death or serious injury or in which our product malfunctioned and, if the malfunction
were to recur, would likely cause or contribute to death or serious injury. In addition, all manufacturers placing medical devices in
European Union markets are governed by the European In Vitro Diagnostic Medical Device Regulation (Regulation (EU) 2017/746) with three
of the product categories requiring review and approval by an independent company, known as a Notified Body, before the manufacturer can
affix a CE mark to the product to declare conformity to the regulation. We are legally bound to report any serious or potentially serious
incidents involving devices they produce or sell to the competent authority in whose jurisdiction the incident occurred.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Were this to happen to us, the relevant competent authority would
file an initial report, and there would then be a further inspection or assessment if there are particular issues. This would be carried
out either by the competent authority or it could require that our Notified Body, carry out the inspection or assessment.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We have reported MDRs in the past, and we anticipate that in
the future it is likely that we may experience events that would require reporting to the FDA pursuant to the MDR regulations. Any adverse
event involving our products could result in future voluntary corrective actions, or agency actions, such as inspection, mandatory recall
or other enforcement action.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Any corrective action, whether voluntary or involuntary, as well
as defending ourselves in a lawsuit, will require the dedication of our time and capital, distract management from operating our business,
and may harm our reputation and financial results.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may be subject to liability resulting from our products or services.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We may be subject to claims for personal injuries or other damages if any of our products,
services, or any product which is made with the use or incorporation of any of our technologies, causes injury of any type or is found
otherwise unsuitable during product testing, manufacturing, marketing, sale or usage. There is no assurance that we would be successful
in defending any product liability lawsuits brought against us. Regardless of merit or eventual outcome, product liability claims could
result in:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z36c98cb965c54df9a53324cf0960ca21" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Decreased demand for our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z466aad8c3bc14138b29a131bb87d601d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Lost revenues;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z87ba6dde2595485ebd7615daabcb73c9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Damage to our image or reputation;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze2517c535a4340868c35cd24a1240551" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Costs related to litigation; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z910efdbb35ba4c06a4933777735881d4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Diversion of management time and attention;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We have global product liability insurance in place for our manufacturing
subsidiaries up to a maximum of &#8364;6,500,000 (US$6,771,000) for any one accident, limited to a maximum of &#8364;6,500,000 (US$6,771,000)
in any one-year period of insurance and is subject to a deductible. We also have professional indemnity insurance for the laboratory services
business up to a maximum of US$5,000,000 for each claim and a US$7,000,000 aggregate limit. There can be no assurance that our product
liability insurance is sufficient to protect us against liability that could have a material adverse effect on our business. In addition,
although we believe that we will be able to continue to obtain adequate coverage in the future, there is no assurance that we will be
able to do so at acceptable costs.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our products may be subject to product recalls that could harm our
reputation, business and financial results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Manufacturers may, on their own initiative, initiate actions,
including a non-reportable market withdrawal, a correction, a safety alert or a reportable product recall, for the purpose of correcting
a material deficiency, improving device performance, or for other reasons. Additionally, the FDA and similar foreign health or governmental
authorities have the authority to require an involuntary recall of commercialized products in the event of material deficiencies or defects
in design, manufacturing or labelling or in the event that a product poses an unacceptable risk to health. In the case of the FDA, the
authority to require a recall must be based on an FDA finding that there is a reasonable probability that a device intended for human
use would cause serious, adverse health consequences or death. A government-mandated or voluntary recall by us or one of our distributors
could occur as a result of component failures, manufacturing errors, modifications, design or labelling defects or other deficiencies
and issues. Recalls of any of our products would divert managerial and financial resources and have an adverse effect on our financial
condition and results of operations. The FDA requires that certain classifications of recalls be reported to FDA within 10 working days
after the recall is initiated.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">15</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Companies are required to maintain certain records of post-market
actions, even if they determine such actions are not reportable to the FDA. If we determine that certain actions do not require notification
of the FDA, the FDA may disagree with our determinations and require us to report those actions as recalls. A future recall announcement
could harm our reputation with customers and negatively affect our sales. In addition, the FDA could take enforcement action for failing
to report the recalls when they were conducted or failing to timely report or initiate a reportable product action. Further, depending
on the corrective action we take to redress a product&#8217;s deficiencies or defects, the FDA may require, or we may decide, that we
will need to obtain new approvals or clearances before we may market or distribute the corrected device. Seeking such approvals or clearances
may delay our ability to replace the recalled devices in a timely manner.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">The large amount of intangible assets and goodwill
recorded on our balance sheet may lead to significant impairment charges in the future.</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">&#160;

<div style="margin-left: 0.05pt; line-height: 1.25">We regularly review our long-lived assets, including identifiable intangible assets
and goodwill, for impairment. Goodwill and acquired indefinite life intangible assets are subject to impairment review on a periodic basis
and whenever potential impairment indicators are present. Other long-lived assets are reviewed when there is an indication that an impairment
may have occurred. The amount of goodwill and identifiable intangible assets on our consolidated balance sheet as of December 31, 2024,
was US$51 million (December 31, 2023: US$16 million) (December 31, 2022: US$35 million). During 2024, the Company made a number of acquisitions
which significantly increased the Company&#8217;s long-lived assets, which will be assessed for impairment each year. In the year ended
December 31, 2024, we recorded total impairment charges of intangible assets of US$1.6 million (Year 2023: US$5.8 million) (Year 2022:
US$4.6 million) as a result of our periodic impairment review. We may record further significant impairment charges in the future if there
are changes in market conditions, a significant reduction in share price or other changes in the future outlook. In addition, we may from
time to time sell assets that we determine are not critical to our strategy or execution. Future events or decisions may lead to asset
impairments and/or related charges. Certain impairments may result from a change in our strategic goals, business direction or other factors
relating to the overall business environment. Any significant impairment charges could have a material adverse effect on our results of
operations.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Global economic conditions may have a material adverse impact on
our results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Uncertainty in global economic conditions may continue for the
foreseeable future and intensify. The invasion of Ukraine by Russia and the Israel &#8211; Hamas war have destabilised markets, increased
volatility and created uncertainty, particularly in energy supply and energy prices. This uncertainty poses a risk to the overall economy
that could impact demand for our products, as well as our ability to manage normal commercial relationships with our customers, suppliers
and creditors, including financial institutions. Volatile economic conditions have adversely affected and could continue to adversely
affect our financial performance and condition or those of our customers and suppliers. These circumstances could adversely affect our
access to liquidity needed to conduct or expand our business or conduct future acquisitions, refinance existing debts, or make other discretionary
investments. Many of our customers rely on public funding provided by federal, state and local governments, and this funding may be reduced
or deferred as a result of economic conditions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The ongoing uncertainty regarding the upheaval to global trade
from significant international tariff changes represents a significant and growing risk to our business and could materially increase
our cost of goods sold, disrupt supply chains, and delay production or fulfilment schedules.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">If global economic conditions deteriorate significantly, our
business could be negatively impacted, including such areas as reduced demand for our products from a slow-down in the general economy,
supplier or customer disruptions resulting from tighter credit markets and/or temporary interruptions in our ability to conduct day-to-day
transactions through our financial intermediaries involving the payment to or collection of funds from our customers, vendors and suppliers.
These circumstances may adversely impact our customers and suppliers, which, in turn, could adversely affect their ability to purchase
our products or supply us with necessary equipment, raw materials or components. Even with the improvement of economic conditions, it
may take time for our customers and suppliers to establish new budgets and return to normal purchasing and shipping patterns. We cannot
predict the reoccurrence of any economic slowdown or the strength or sustainability of the economic recovery.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">16</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Significant interruptions in production at
our principal manufacturing facilities and/or third-party manufacturing facilities would adversely affect our business and operating results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Products manufactured at our facilities in Bray, Ireland, Jamestown and Buffalo, New
York and Kansas City, Missouri accounted for the majority of our revenues during the fiscal year ended December&#160;31, 2024. Our global
supply of these products and services is dependent on the uninterrupted and efficient operation of these facilities. In addition, we currently
rely on a small number of third-party manufacturers to produce certain of our diagnostic products and product components. 2024 continued
to see interruptions to international supply chains which may continue for some time to come. If we do not negotiate long-term contracts,
our suppliers will likely not be required to provide us with any guaranteed minimum production levels. As a result, we cannot assure you
that we will be able to obtain sufficient quantities of product in the future. In addition, our reliance on third-party suppliers involves
a number of risks, including, among other things:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze90204a886114d6b9b7c6267c6929ce9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>contract manufacturers or suppliers may fail to comply with regulatory requirements or make errors in manufacturing that could negatively
        affect the efficacy or safety of our products or cause delays in shipments of our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc95991a87a09408b959e00e4112cb79e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>we or our contract manufacturers and suppliers may not be able to respond to unanticipated changes in customer orders, and if orders
        do not match forecasts, we or our suppliers may have excess or inadequate inventory of materials and components;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf6562131502a41288d7375ded22bae65" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>we or our contract manufacturers and suppliers may be subject to price fluctuations due to a lack of long-term supply arrangements
        for key components;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z69c4cadbe84c4bd5ab7f89d40f4e894e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>we or our contract manufacturers and suppliers may lose access to critical services and components, resulting in an interruption
        in the manufacture, assembly and shipment of our systems;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z61fa583503fc41b59ed744dbb8c801ed" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>we may experience delays in delivery by our contract manufacturers and suppliers due to changes in demand from us or their other
        customers;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf82a823f6c2d4cbfbc5b93e4d1b6a23d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>fluctuations in demand for products that our contract manufacturers and suppliers manufacture for others may affect their ability
        or willingness to deliver components to us in a timely manner;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z76c5621dea7e41889a0c0992c56080f7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our suppliers or those of our contract manufacturer may wish to discontinue supplying components or services to us for risk management
        reasons;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z046f018036bc4881a421796fe3d757e9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>we may not be able to find new or alternative components or reconfigure our system and manufacturing processes in a timely manner
        if the necessary components become unavailable;&#160;and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdec6519277ae43f7ac861eeff08fa518" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our contract manufacturers and suppliers may encounter financial hardships unrelated to our demand, which could inhibit their ability
        to fulfil our orders and meet our requirements.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The operations of our facilities or these third-party manufacturing
facilities could be adversely affected by fire, power failures, natural or other disasters, such as earthquakes, floods, pandemics, or
terrorist threats. Although we carry insurance to protect against certain business interruptions at our facilities, some pieces of manufacturing
equipment are difficult to replace and could require substantial replacement lead-time. There can be no assurance that such coverage will
be adequate or that such coverage will continue to remain available on acceptable terms, if at all.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">If any of these risks materialize, it could significantly increase
our costs and impact our ability to meet demand for our products and/or services. If we are unable to satisfy commercial demand for our
products in a timely manner, our ability to generate revenue would be impaired, market acceptance of our products could be adversely affected,
and customers may instead purchase or use our competitors&#8217; products. In addition, we could be forced to secure new or alternative
contract manufacturers or suppliers. Securing a replacement contract manufacturer or supplier could be difficult. The introduction of
new or alternative manufacturers or suppliers also may require design changes to our products that are subject to FDA and/or other regulatory
clearances or approvals.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We may also be required to assess the new manufacturer&#8217;s
compliance with all applicable regulations and guidelines, which could further impede our ability to manufacture our products in a timely
manner. As a result, we could incur increased production costs, experience delays in deliveries of our products, suffer damage to our
reputation, and experience an adverse effect on our business and financial results. Any significant interruption in our or third-party
manufacturing capabilities could materially and adversely affect our operating results.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">17</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our inability to manufacture products in accordance
with applicable specifications, performance standards or quality requirements could adversely affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The materials and processes used to manufacture our products
must meet detailed specifications, performance standards and quality requirements to ensure our products will perform in accordance with
their label claims, our customers&#8217; expectations and applicable regulatory requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">As a result, our products and the materials used in their manufacture
or assembly undergo regular inspections and quality testing. Factors such as defective materials or processes, mechanical failures, human
errors, environmental conditions, changes in materials or production methods by our vendors, and other events or conditions could cause
our products or the materials used to produce or assemble our products to fail inspections and quality testing or otherwise not perform
in accordance with our label claims or the expectations of our customers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Any failure or delay in our ability to meet the applicable specifications,
performance standards, quality requirements or customer expectations could adversely affect our ability to manufacture and sell our products
or comply with regulatory requirements. These events could, in turn, adversely affect our revenues and results of operations.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our revenues are highly dependent on a network of distributors worldwide.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We currently distribute our product portfolio through distributors
in approximately 100 countries worldwide. Our continuing economic success and financial security is dependent on our ability to secure
effective channels of distribution on favourable trading terms with suitable distributors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The loss or termination of our relationship with these key distributors
could significantly disrupt our existing business unless suitable alternatives were quickly found or lost sales to one distributor are
absorbed by another distributor. Finding a suitable alternative to a lost or terminated distributor may pose challenges in our industry&#8217;s
competitive environment, and another suitable distributor may not be found on satisfactory terms, if at all. For instance, some distributors
already have exclusive arrangements with our competitors, and others do not have the same level of penetration into our target markets
as our existing distributors. If total revenue from these or any of our other significant distributors were to decrease in any material
amount in the future or we are not successful in timely transitioning business to new distributors, our business, operating results and
financial condition could be materially and adversely affected.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our success depends on our ability to service and support our products
directly or in collaboration with our strategic partners.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">To the extent that we or our strategic partners fail to maintain
a high-quality level of service and support for diagnostic products, there is a risk that the perceived quality of our products will be
diminished in the marketplace. Likewise, we may fail to provide the level, quantity or quality of service expected by the marketplace.
This could result in slower adoption rates and lower than anticipated utilisation of our products which could have a material adverse
effect on our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We are highly dependent on our senior management
team and other key employees, and the loss of one or more of these employees or the inability to attract and retain qualified personnel
as necessary could adversely affect our operations.</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">&#160;

<div style="margin-left: 0.05pt; line-height: 1.25">Our success is dependent to a large extent upon the contributions of our key employees.
In December 2023, our then CFO, John Gillard, was appointed CEO &amp; President. Louise Tallon was appointed as CFO in August 2024. In
April 2025, Louise Tallon was replaced by Susan O&#8217;Connor now serving as Interim CFO. In addition, during 2024 and early 2025 there
were a number of changes to the Senior Management team reflecting the significant ongoing transformation and focus on new business areas.</div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The effectiveness of our senior leadership team generally, and
any further transition as a result of these changes, could have a significant impact on our results of operations. Management transition
is often difficult and inherently causes some loss of institutional knowledge, which could negatively affect our results of operations
and financial condition. Our ability to execute our business strategies may be adversely affected by the uncertainty associated with these
transitions. We may not be able to attract or retain a sufficient number of qualified employees in the future due to the intense competition
for qualified personnel among medical products and other life science businesses.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">If we are not able to attract and retain the necessary personnel
to accomplish our business objectives, we may experience constraints that will adversely affect our ability to effectively manufacture,
sell and market our products, to meet the demands of our strategic partners in a timely fashion, or to support research, development and
clinical programs. Although we believe we will be successful in attracting and retaining qualified personnel, competition for experienced
scientists and other personnel from numerous companies and academic and other research institutions may limit our ability to do so on
acceptable terms.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">18</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Cybersecurity risks, including cyberattacks
or data breaches, could disrupt our operations, compromise sensitive data, and adversely affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We rely extensively on information technology systems and networks to securely process,
transmit and store electronic information, including confidential and personal information relating to our employees, customers, and business
operations. These systems are critical to the operation of our global business, including product manufacturing, distribution, research
and development, clinical trials, customer service, and financial reporting.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">Like many other companies, we are subject to increasing cybersecurity threats, including
the risk of system breaches, ransomware, malware, phishing attacks, and other malicious activity. Security incidents, whether from external
actors or internal sources, can result in operational disruption, shutdowns, corruption or loss of critical data and software, unauthorised
access or disclosure of confidential information, and reputational harm.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">We invest in technologies and processes designed to protect our information assets
and mitigate cybersecurity threats. These include multi-factor authentication, data encryption, antivirus and endpoint protection, next-generation
firewalls, cloud backups, end-user training (including simulated phishing exercises), and comprehensive policies for information security
and data privacy. Despite these efforts, our IT systems and infrastructure may still be vulnerable to attack or breach due to the sophistication
of threat actors, human error, equipment failure, or other disruptions.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">We have experienced cyberattacks in the past, though none have had a material impact
on our operations to date.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">The age and configuration of our IT infrastructure varies by location, and our business
continuity and disaster recovery capabilities may be less robust at certain sites. As a result, our ability to respond to or recover from
a cybersecurity incident may be inconsistent across geographies.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">A significant breach of our systems could result in the unauthorised disclosure of
personal data, including personally identifiable information (PII) or protected health information (PHI), or other confidential business
information. This could subject us to legal liability, regulatory penalties, breach notification requirements, and damage to our reputation,
potentially resulting in loss of customers or revenue.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">We are also subject to a complex and evolving regulatory landscape in data privacy
and cybersecurity. Compliance with privacy and data protection laws, such as the EU&#8217;s General Data Protection Regulation (GDPR),
U.S. state-level privacy laws, and similar frameworks in other jurisdictions, may result in significant costs and operational changes.
In particular, Section 3305 of the Food and Drug Omnibus Reform Act of 2022 (FDORA) imposes specific cybersecurity obligations on manufacturers
of certain medical devices. This includes maintaining processes for monitoring and remediating vulnerabilities, providing a software bill
of materials, and ensuring continued security of the device and its related systems. A failure to comply with these requirements may constitute
a prohibited act.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">We have conducted appropriate cybersecurity assessments for relevant products in accordance
with FDA, AAMI, and ANSI standards applicable at the time of approval. However, as the regulatory landscape continues to evolve, we may
be required to make additional investments to maintain compliance and address emerging cybersecurity expectations for connected health
technologies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Cybersecurity incidents could also distract management or key
personnel from core business operations and negatively impact our financial condition, results of operations, or business strategy.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our sales and operations are subject to the risks of fluctuations
in currency exchange rates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">A substantial portion of our operations are based in Ireland,
and Europe is one of our main sales territories. As a result, changes in the exchange rate between the U.S.&#160;Dollar and the Euro can
have significant effects on our results of operations. In addition, in markets where we invoice in U.S. Dollars but where the local currency
has weakened, we have been required to reduce our pricing in order to preserve our competitiveness. We have an exposure to the Canadian
Dollar through our Canadian operations and to the Brazilian Real through our Brazilian subsidiary. We also have revenues and costs denominated
in British Sterling.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The ongoing geopolitical uncertainty, inflation and central bank
actions may lead to greater volatility in currency exchange rates globally. In the future, we may enter into hedging instruments to manage
our currency exchange rate risk. However, our attempts to hedge against these risks may not be successful. If we are unable to successfully
hedge against unfavourable foreign currency exchange rate movements, our consolidated financial results may be adversely impacted.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">19</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">&#160;<span style="font-weight: bold; font-style: italic">Tax matters, including disagreements
with taxing authorities, the changes in corporate tax rates and imposition of new taxes could impact our results of operations and financial
condition.</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We are subject to regular reviews, examinations, and audits by
tax authorities in a number of jurisdictions across the world with respect to our taxes. Although we believe our tax estimates are reasonable,
if a taxing authority disagrees with the positions we have taken, we could face additional tax liability, including interest and penalties.
There can be no assurance that payment of such additional amounts upon final adjudication of any disputes will not have a material impact
on our results of operations and financial position.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">A significant portion of our business is located in the U.S.
and is subject to income and other taxes in the U.S. and our operations, plans and results are affected by tax and other initiatives.
Changes to the US tax code could have a significant impact on our profitability. Changes to the tax code could also affect our valuation
of deferred tax assets and liabilities. Any such change in valuation would have a material impact on our income tax expense and deferred
tax balances.</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic; font-weight: bold">Public
health emergencies, epidemics or pandemics, such as the emergence and spread of pandemics, such as Covid-19, have the potential to significantly
impact our operations through a decrease in demand for our products, interruption to business and a reduction in staff availability.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25">

<div style="text-align: justify; line-height: 1.25">The Covid&#8209;19 pandemic had a material impact on the healthcare industry and specifically
the medical diagnostics sector in which we operate. The reduced but continuing uncertainty around global pandemics could have an adverse
effect on our operating results, cash flows, financial condition and/or prospects.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">The global spread of Covid&#8209;19 and the public healthcare measures implemented
by governments, such as quarantines and the temporary closure of businesses led and could again in the future lead to fewer patients presenting
themselves for medical check-ups resulting in a fall in demand for certain of our products which may or may not be offset by increased
demand within our Covid-19 related portfolio of products. Furthermore, funding allocated to combatting Covid-19 or other pandemics, may
result in a reduction or a postponement in the funding available for other diseases, conditions and disorders that our products are used
to diagnose.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">We operate in a labour&#8209;intensive industry where employees&#8217;, contractors&#8217;
and customers&#8217; activities can be adversely impacted by the availability of people to produce, manufacture or install our products.
Covid-19 lead to the temporary closure of our manufacturing sites and associated furloughing of some staff. Furthermore, Covid-19 reduced
our ability to visit customers and suppliers and required some of our staff to work from home in line with public health measures. Any
significant loss of employee resources for a sustained period of time due to lockdown restrictions, self&#8209;isolation or sickness as
a result of a public health emergency could impact our ability to produce, manufacture and deliver goods. Similarly, our customer facing
activities could be adversely impacted by similar employee availability issues.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Increasing scrutiny and changing expectations
from investors, lenders, customers and other market participants with respect to our Environmental, Social and Governance, or ESG, policies
may impose additional costs on us or expose us to additional risks.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Companies across all industries are facing increasing scrutiny relating to their ESG
policies. Investors, lenders and other market participants are increasingly focused on ESG practices and in recent years have placed increasing
importance on the implications and social cost of their investments. The increased focus and activism related to ESG may hinder our access
to capital, as investors and lenders may reconsider their capital investment allocation as a result of their assessment of our ESG practices.
If we do not adapt to or comply with investor, lender or other industry shareholder expectations and standards, which are evolving, or
if we are perceived to have not responded appropriately to the growing concern for ESG issues, regardless of whether there is a legal
requirement to do so, we may suffer from reputational damage and the business, financial condition and the price of our company&#8217;s
ADS&#8217;s could be materially and adversely affected.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Government Regulations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Clinical trials necessary to support future
premarket submissions will be expensive and will require enrolment of suitable patients who may be difficult to identify and recruit.
Delays or failures in our clinical trials will prevent us from commercializing any modified or new products and will adversely affect
our business, operating results and prospects.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Initiating and completing clinical trials necessary to support
approval of future products under development, is time consuming and expensive and the outcome uncertain. Moreover, the results of early
clinical trials are not necessarily predictive of future results, and any product we advance into clinical trials may not have favorable
results in later clinical trials.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">20</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Conducting successful clinical studies will require the enrolment
of patients who may be difficult to identify and recruit. Patient enrolment in clinical trials and completion of patient participation
and follow-up depends on many factors, including the size of the patient population, the nature of the trial protocol, and the availability
of appropriate clinical trial investigators. Patients may not participate in our clinical trials if they choose to participate in contemporaneous
clinical trials of competitive products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Development of sufficient and appropriate clinical protocols
to demonstrate safety and efficacy are required and we may not adequately develop such protocols to support clearance and approval. Further,
the FDA and/or other regulatory authorities may require us to submit data on a greater number of patients than we originally anticipated
and/or for a longer follow-up period or change the data collection requirements or data analysis applicable to our clinical trials. Any
challenges to patient enrolment may cause an increase in costs and delays in the approval and attempted commercialization of our products
or result in the failure of the clinical trial. In addition, despite considerable time and expense invested in our clinical trials, FDA
and/or other regulatory authorities may not consider our data adequate to demonstrate safety and efficacy. Such increased costs and delays
or failures could adversely affect our business, operating results and prospects.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Our facilities and our clinical investigational sites operate
under procedures that govern the conduct and management of FDA-regulated clinical studies under 21 CFR Parts 50, 56 and 812, and Good
Clinical Practices. Although the majority of our in-vitro diagnostic (&#8220;IVD&#8221;) clinical studies meet the definition of exempted
investigations under 21 Part 812 and are exempt from the Investigational Device Exemption (&#8220;IDE&#8221;) regulations in 21 CFR Part
812, we are still required to meet the requirements of 21 CFR Parts 50 and 56 for informed consent and Institutional Review Board (&#8220;IRB&#8221;)
approval. The FDA may conduct Bioresearch Monitoring (&#8220;BiMo&#8221;) inspections of us and/or our clinical sites to assess compliance
with FDA regulations, our procedures, and the clinical protocol. If the FDA were to find that we or our clinical investigators are not
operating in compliance with applicable regulations, we could be subject to the above FDA enforcement action as well as refusal to accept
all or part of our data in support of a 510(k) or PMA and/or we may need to conduct additional studies.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In relation to World Health Organisation (WHO) qualification, our IVD clinical studies
are required to meet all the requirements of the TSS-1: Human Immunodeficiency Virus (HIV) rapid diagnostic tests for professional use.
If we are not operating in compliance with this regulation, we could be subject to WHO enforcement action. In addition,&#160;our IVD clinical
studies are required to meet the requirements of:</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zadde10f2130a47598d001c52284af08b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>WMA Declaration of Helsinki &#8211; Ethical Principles for Medical Research Involving Human Subjects (2013);</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zb4c2bbb7d3ae4f66bc9920beda5486ef" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>ICH Harmonised Guidelines - Integrated Addendum to ICH E6 (R2) Guideline for Good Clinical Practice (Nov 2016);</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zc79ff1273cc942eaaf60b2422ba5ffdc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>ISO 20916:2019 In vitro diagnostic medical devices &#8212; Clinical performance studies using specimens from human subjects &#8212;
        Good study practice; and</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zfa3ce8b1614f4509b8f79a8a21bb3d1a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>ISO 14155:2020: Clinical investigation of medical devices for human subjects &#8211; Good clinical practice.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If the third parties on whom we rely to conduct
our pre-clinical studies and clinical trials and to assist in pre-clinical development do not perform as contractually required or expected,
we may not be able to obtain regulatory approval or commercialize our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We may not have the ability to independently conduct our pre-clinical
studies and clinical trials for our products and we may rely on third parties, such as contract research organizations, medical institutions,
clinical investigators and contract laboratories to conduct such trials. If these third parties do not successfully carry out their contractual
duties or regulatory obligations or meet expected deadlines, if these third parties need to be replaced, or if the quality or accuracy
of the data they obtain is compromised due to the failure to adhere to our pre-clinical or clinical protocols or regulatory requirements
or for other reasons, our pre-clinical development activities or clinical trials may be extended, delayed, suspended or terminated, and
we may not be able to obtain regulatory approval for, or successfully commercialize, our products on a timely basis, if at all, and our
business, operating results and prospects may be adversely affected. Furthermore, our third-party clinical trial investigators may be
delayed in conducting our clinical trials for reasons outside of their control.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The results of our clinical trials may not support our product candidate
claims.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Even if our clinical trials are completed as planned, we cannot
be certain that their results will support our product candidate claims or that the FDA or other regulatory authorities will agree with
our conclusions regarding them. The clinical trial process may fail to demonstrate that our product candidates are safe and effective
for the proposed indicated uses, which could cause us to abandon a product candidate and may delay development of others. Any delay or
termination of our clinical trials will delay the filing of our product submissions and, ultimately, our ability to commercialize our
product candidates and generate revenues.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">21</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may be subject to fines, penalties or injunctions
if we are determined to be promoting the use of our products for unapproved or &#8220;off-label&#8221; uses.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Our promotional materials must comply with FDA and other applicable
laws and regulations. We believe that the specific uses for which our products are marketed fall within the scope of the indications for
use that have been cleared or approved by the FDA or other relevant regulatory authorities. However, the FDA and/or the other relevant
regulatory authorities could disagree and require us to stop promoting our products for those specific uses until we obtain clearance
or approval for them. In addition, if the FDA or other relevant regulatory authorities determines that our promotional materials constitute
promotion of an unapproved use, it could demand that we modify our promotional materials or subject us to regulatory or enforcement actions,
including the issuance of an untitled letter, a warning letter, injunction, seizure, civil fine and criminal penalties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">It is also possible that other federal, state or foreign enforcement
authorities might take action if they consider our promotional materials to constitute promotion of an unapproved use, which could result
in significant fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement. In that
event, our reputation could be damaged and adoption of the products would be impaired.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25; font-style: italic; font-weight: bold">The FDA recently modified
its policy of enforcement discretion with respect to our laboratory developed tests. We could incur substantial costs and delays associated
with trying to obtain premarket clearance or other approvals.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Historically, the FDA has generally exercised its enforcement
discretion and not enforced applicable regulations with respect to laboratory developed tests (&#8220;LDTs&#8221;), although reagents,
instruments, software or components provided by third parties and used to perform LDTs may be subject to FDA regulation. The FDA defines
the term &#8220;laboratory developed test&#8221; as an in vitro diagnostics (&#8220;IVD&#8221;) test that is intended for clinical use
and designed, manufactured and used within a single laboratory. Until 2014, the FDA exercised enforcement discretion such that it did
not enforce provisions of the Food, Drug, and Cosmetic Act, or FDA Act, with respect to LDTs. In July 2014, due to the increased proliferation
of LDTs for complex diagnostic testing, and concerns with several high-risk LDTs related to lack of evidentiary support for claims and
erroneous results, the FDA provided notice that it intended to issue draft guidance to collect information from laboratories regarding
their current LDTs and newly developed LDTs through a notification process.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">

<div style="line-height: 1.25">On September 29, 2023, the FDA proposed a new rule which was adopted on April 29, 2024, which amended the
FDA&#8217;s regulations to make explicit that IVDs are devices under the Federal Food, Drug, and Cosmetic Act, including when the manufacturer
of the IVD is a laboratory. The FDA&#8217;s ruling of April 29<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup>,
2024, that significantly enhanced its regulatory authority over laboratory-developed tests (LDTs), which are developed and used within
a single laboratory was overturned on March 31<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">st</sup>, 2025.&#160;
The U.S. District Court for the Eastern District of Texas vacated the FDA's final rule, stating that the FDA exceeded its authority under
the Federal Food, Drug, and Cosmetic Act. This means that, for now, the FDA's new regulations will not go into effect, and laboratories
will not need to obtain FDA clearance to market their LDTs. If the district court&#8217;s decision stands, FDA&#8217;s regulation of LDTs
could be viewed as a legal nullity, as FDA could no longer regulate LDTs as medical devices under the ruling. This may mean that these
LDTs would continue to be marketed solely under the Clinical Laboratories Improvement Act of 1967 (CLIA).</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Ongoing compliance with FDA regulations increases the cost of
conducting our business, and may subject us to heightened regulation by the FDA and penalties in the event of failure to comply with these
requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">22</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If we fail to maintain regulatory approvals
and clearances, or are unable to obtain, or experience significant delays in obtaining, regulatory clearances or approvals for our future
products or product enhancements, our ability to commercially distribute and market these products could suffer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Our medical device products and operations are subject to rigorous
government regulation in the United States by the FDA, and numerous other federal, state and foreign governmental authorities, as well
as and by comparable regulatory authorities in other jurisdictions such as the HPRA in Ireland. In particular, we are subject to strict
governmental controls on the development, manufacture, labelling, storage, testing, advertising, promotion, marketing, distribution and
import and export of our products. In addition, we or our distributors are often required to register with and/or obtain clearances or
approvals from foreign governments or regulatory bodies before we can import and sell our products in foreign countries. The clearance
and approval process for our products, while variable across countries, is generally lengthy, time consuming, detailed and expensive.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The process of obtaining and maintaining regulatory clearances
or approvals to market a medical device can be costly and time consuming, and we may not be able to obtain these clearances or approvals
on a timely basis, if at all. In particular, the FDA permits commercial distribution of a new medical device only after the device has
received clearance under Section 510(k) of the Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;), or is the subject of an approved
premarket approval application (&#8220;PMA&#8221;) unless the device is specifically exempt from those requirements. The FDA will clear
marketing of a lower risk medical device through the 510(k) process if the manufacturer demonstrates that the new product is substantially
equivalent to other 510(k)-cleared products. High risk devices deemed to pose the greatest risk, such as life-sustaining, life-supporting,
or implantable devices, or devices not deemed substantially equivalent to a previously cleared device, require the approval of a PMA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The PMA process is more costly, lengthy and uncertain than the
510(k) clearance process. A PMA application must be supported by extensive data, including, but not limited to, technical, preclinical,
clinical trial, manufacturing and labelling data, to demonstrate to the FDA&#8217;s satisfaction the safety and efficacy of the device
for its intended use. The 510(k) clearance process usually takes from three to 12 months, but it can take longer. The process of obtaining
PMA approval is much more costly and uncertain than the 510(k) clearance process. It generally takes from one to three years, or even
longer, from the time the PMA application is submitted to the FDA, until an approval is obtained. There is no assurance that we will be
able to obtain FDA clearance or approval for any of our new products on a timely basis, or at all.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">In the United States, many of our currently commercialized products
have received pre-market clearance under Section 510(k) of the FDCA. If the FDA requires us to go through a lengthier, more rigorous examination
for future products or modifications to existing products than we had expected, our product introductions or modifications could be delayed
or cancelled, which could cause our sales to decline. In addition, the FDA may determine that future products will require the more costly,
lengthy and uncertain PMA process.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">The FDA can delay, limit or deny clearance or approval of a device
for many reasons, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9fb261780aab48cfa83dcaaa9d70c24a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our inability to demonstrate to the FDA&#8217;s satisfaction that our products are safe and effective for their intended users;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3e1c62bd31e043aba94cfae1133636d6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>insufficient data from our pre-clinical studies and clinical trials to support clearance or approval, where required; and</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z67bff6c6ca944c0598c33f89912b61d6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the failure of the manufacturing process or facilities we use to meet applicable requirements.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">In addition, the FDA may change its clearance and approval policies,
adopt additional regulations or revise existing regulations, or take other actions which may prevent or delay approval or clearance of
our products under development or impact our ability to modify our currently cleared products on a timely basis. Furthermore, regulatory
authorities, including the FDA, may not agree with our interpretation of its policies and regulations which may lead to enforced modifications,
restrictions, discontinuation, etc. of some of our products, even if they were previously approved.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Our continued success is dependent on our ability to develop
and market new or updated products, some of which are currently awaiting clearance or approval from the applicable regulatory authorities.
There is no certainty that such clearance or approval will be granted or, even once granted, will not be revoked during the continuing
review and monitoring process. Further, regulatory authorities, including the FDA, may not approve or clear our future products for the
indications that are necessary or desirable for successful commercialization. A regulatory authority may impose requirements as a condition
to granting a marketing authorisation, may include significant restrictions or limitations as part of a marketing authorisation it grants
and may delay or refuse to authorise a product for marketing, even though a product has been authorised for marketing without restrictions
or limitations in another country or by another agency. Failure to receive clearance or approval for our new products, or commercially
undesirable limitations on our clearances or approvals, would have an adverse effect on our ability to expand our business. Modifications
made to our products may invalidate previously granted regulatory approvals which may lead to revised regulatory clearances, enforced
modifications, restrictions, discontinuation, etc. of some of our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">23</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">

<div style="margin-left: 0.05pt; line-height: 1.25">

<div style="margin-left: 0.05pt; line-height: 1.25">On September 29, 2023, the FDA proposed a new rule which was adopted on April 29,
2024, which amended the FDA&#8217;s regulations to make explicit that IVDs are devices under the Federal Food, Drug, and Cosmetic Act,
including when the manufacturer of the IVD is a laboratory.</div> </div> </div>

<div style="line-height: 1.25">&#160;

<div style="text-align: justify; line-height: 1.25">The FDA&#8217;s ruling of April 29<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup>,
2024, that significantly enhanced its regulatory authority over laboratory-developed tests (LDTs), which are developed and used within
a single laboratory was overturned on March 31<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">st</sup>, 2025.&#160;
The U.S. District Court for the Eastern District of Texas vacated the FDA's final rule, stating that the FDA exceeded its authority under
the Federal Food, Drug, and Cosmetic Act. This means that, for now, the FDA's new regulations will not go into effect, and laboratories
will not need to obtain FDA clearance to market their LDTs. If the district court&#8217;s decision stands, FDA&#8217;s regulation of LDTs
could be viewed as a legal nullity, as FDA could no longer regulate LDTs as medical devices under the ruling. This may mean that these
LDTs would continue to be marketed solely under the Clinical Laboratories Improvement Act of 1967 (CLIA).</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Failure to comply with FDA or other regulatory
requirements may require us to suspend production of our products or institute a recall which could result in higher costs and a loss
of revenues.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Even after we obtain clearance or approval for our medical devices,
we are still subject to ongoing and extensive post market regulatory requirements. Regulation by the FDA and other federal, state and
foreign regulatory agencies, such as the HPRA in E.U., impacts many aspects of our operations, and the operations of our suppliers and
distributors, including manufacturing, labelling, packaging, adverse event reporting, storage, advertising, promotion, marketing, record
keeping, import and export. For example, the manufacture of medical devices must comply with the FDA&#8217;s Quality System Regulation
(&#8220;QSR&#8221;), which covers the methods and documentation of the design, testing, production, control, quality assurance, labelling,
packaging, sterilization, storage and shipping of our products. Our manufacturing facilities and those of our suppliers and distributors
are, or can be, subject to periodic regulatory inspections by the FDA to assess compliance with the QSR and other regulations, and by
other comparable foreign regulatory authorities with respect to similar requirements in other jurisdictions. The FDA and foreign regulatory
agencies may require post-marketing testing and surveillance to monitor the performance of approved products or place conditions on any
product clearances or approvals that could restrict the commercial applications of those products. The failure by us or one of our suppliers
to comply with applicable statutes and regulations administered by the FDA and other regulatory bodies, or the failure to timely and adequately
respond to any adverse inspectional observations or product safety issues, could result in, among other things, any of the following enforcement
actions:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zeb31ddcc532c4f22814a4452f0bfd65a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf5a1a72e65ea45c1ac7f62b2d7bd4410" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>unanticipated expenditures to address or defend such actions;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6c2d702d998c40de8333d9beada52714" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>customer notifications for repair, replacement and refunds;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf594921de49f46f2925fcd0ad0ac84a0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>recall, detention or seizure of our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z46f47ca3a73a4d3482b1590d2fe99f1d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>operating restrictions or partial suspension or total shutdown of production;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9584026312e2485c95ee213021b614c3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>refusing or delaying our requests for 510(k) clearance or premarket approval of new products or modified products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc2ef2f6816884923b529ae4867e1fe1e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>operating restrictions;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc0ebcc552b5f40a2851d229bb5512efe" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>withdrawing 510(k) clearances on PMA approvals that have already been granted;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z90ba29d5a09549028c3a2f2dff021857" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>refusal to grant export approval for our products; or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8890dc3896624f74a598118b7d5d356f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>criminal prosecution.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Other regulatory authorities have similar sanctions in their respective jurisdictions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">If any of these actions were to occur, they may harm our reputation and cause our
product sales and profitability to suffer and may prevent us from generating revenue. Furthermore, our key component suppliers may not
currently be or may not continue to be in compliance with all applicable regulatory requirements which could result in our failure to
produce our products on a timely basis and in the required quantities, if at all.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Even if regulatory clearance or approval of a product is granted,
such clearance or approval may be subject to limitations on the intended uses for which the product may be marketed and reduce our potential
to successfully commercialize the product and generate revenue from the product. If the FDA determines that our promotional materials,
labelling, training or other marketing or educational activities constitute promotion of an unapproved use, it could request that we cease
or modify our training or promotional materials or subject us to regulatory enforcement actions. It is also possible that other federal,
state or foreign enforcement authorities might take action if they consider our training or other promotional materials to constitute
promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting
false claims for reimbursement.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">24</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">In addition, we may be required to conduct costly post-market
testing and surveillance to monitor the safety or effectiveness of our products, and we must comply with medical device reporting requirements,
including the reporting of adverse events and malfunctions related to our products. Later discovery of previously unknown problems with
our products, including unanticipated adverse events or adverse events of unanticipated severity or frequency, manufacturing problems,
or failure to comply with regulatory requirements such as QSR, may result in changes to labelling, restrictions on such products or manufacturing
processes, withdrawal of the products from the market, voluntary or mandatory recalls, a requirement to repair, replace or refund the
cost of any medical device we manufacture or distribute, fines, suspension of regulatory approvals, product seizures, injunctions or the
imposition of civil or criminal penalties which would adversely affect our business, operating results and prospects.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">In the ordinary course of business, we must frequently make subjective
judgments with respect to compliance with applicable laws and regulations. If regulators subsequently disagree with the manner in which
we have sought to comply with these regulations, we could be subjected to substantial civil and criminal penalties, as well as product
recall, seizure or injunction with respect to the sale of our products. The assessment of any civil and criminal penalties against us
could severely impair our reputation within the industry and any limitation on our ability to manufacture and market our products could
have a material adverse effect on our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">In addition to the FDA and other regulations described above,
laws and regulations in some countries may restrict our ability to sell products in those countries. While we intend to comply with any
applicable restrictions, there is no guarantee we will be successful in these efforts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We must also comply with numerous laws relating to such matters
as safe working conditions, manufacturing practices, environmental protection, fire hazard control, disposal of hazardous substances and
labour or employment practices. Compliance with these laws or any new or changed laws regulating our business could result in substantial
costs. Because of the number and extent of the laws and regulations affecting our industry, and the number of governmental agencies whose
actions could affect our operations, it is impossible to reliably predict the full nature and impact of these requirements. To the extent
the costs and procedures associated with complying with these laws and requirements are substantial or it is determined that we do not
comply, our business and results of operations could be adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Modifications to our products, may require
new 510(k) clearances or pre-market approvals, or may require us to cease marketing or recall the modified products until clearances or
approvals are obtained.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Any modification to a 510(k)-cleared device in the United States
that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, design or manufacture,
requires a new 510(k) clearance or, possibly, approval of a PMA. The FDA requires every manufacturer to make this determination in the
first instance, but the FDA may review any manufacturer&#8217;s decision. The FDA may not agree with our decisions regarding whether new
clearances or approvals are necessary. If the FDA disagrees with our determination and requires us to submit new 510(k) notifications
or PMAs for modifications to previously cleared products for which we conclude that new clearances or approvals are unnecessary, we may
be required to cease marketing or to recall the modified product until we obtain clearance or approval, and we may be subject to significant
regulatory fines or penalties. Further, our products could be subject to recall if the FDA determines, for any reason, that our products
are not safe or effective. Any recall or FDA requirement that we seek additional approvals or clearances could result in significant delays,
fines, increased costs associated with modification of a product, loss of revenue and potential operating restrictions imposed by the
FDA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25; font-style: italic; font-weight: bold">We are subject to export
controls and economic sanctions laws, and our customers and distributors are subject to import controls that could subject us to liability
if we are not in full compliance with applicable laws.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Certain of our products are subject to U.S. export controls and
sanctions regulations and we would be permitted to export such solutions to certain destinations outside the U.S. only by first obtaining
an export license from the U.S. government, or by utilizing an existing export license exception/General License, or after clearing U.S.
government agency review. Obtaining the necessary export license or accomplishing a U.S. government review for a particular export may
be time-consuming and may result in the delay or loss of sales opportunities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Although we take precautions to prevent our products from being
provided in violation of U.S. export control and economic sanctions laws, our products may have been in the past, and could in the future
be, provided inadvertently in violation of such laws. If we were to fail to comply with U.S. export law requirements, U.S. customs regulations,
U.S. economic sanctions or other applicable U.S. laws, we could be subject to substantial civil and criminal penalties, including fines,
incarceration for responsible employees and managers and the possible loss of export or import privileges. U.S. export controls, sanctions
and regulations apply to our distributors as well as to us. Any failure by our distributors to comply with such laws, regulations or sanctions
could have negative consequences, including reputational harm, government investigations and penalties.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">25</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Changes or new versions of our products or changes in export
and import regulations may create delays in the introduction of our products into international markets, prevent our distributors from
deploying our products globally or, in some cases, prevent the export or import of our products to certain countries, governments or persons
altogether. In addition, any change in export or import regulations, economic sanctions or related legislation, shift in the enforcement
or scope of existing regulations, or change in the countries, governments, persons or technologies targeted by such regulations, could
result in decreased use of our products by, or in our decreased ability to export or sell our products to, existing or potential international
customers. Any decreased use of our principal products or limitation on our ability to export or sell such products would likely adversely
affect our business, financial condition and operating results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25; font-style: italic; font-weight: bold">We are subject to anti-corruption,
anti-bribery and similar laws, and non-compliance with such laws can subject us to criminal penalties or significant fines and harm our
business and reputation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We are subject to anti-corruption and anti-bribery and similar
laws, such as the U.S. Foreign Corrupt Practices Act of 1977, as amended, or the Foreign Corrupt Practices Act, the U.S. domestic bribery
statute contained in 18 U.S.C. &#167; 201, the U.S. Travel Act, the USA PATRIOT Act, the U.K. Bribery Act 2010 and other anti-corruption,
anti-bribery and anti-money laundering laws in countries in which we conduct activities. Anti-corruption and anti-bribery laws have been
enforced aggressively in recent years and are interpreted broadly and prohibit companies and their employees and agents from promising,
authorizing, making, offering, soliciting, or accepting, directly or indirectly, improper payments or other improper benefits to or from
any person whether in the public or private sector. As we increase our international sales and business, our risks under these laws may
increase. Noncompliance with these laws could subject us to investigations, sanctions, settlements, prosecution, other enforcement actions,
disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, adverse media coverage and other
consequences. Any investigations, actions or sanctions could adversely affect our business, results of operations and financial condition.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Changes in healthcare regulation could affect our revenues, costs
and financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">In the United States in recent years, there have been numerous
initiatives at the federal and state level for comprehensive reforms affecting the payment for, the availability of and reimbursement
for healthcare services. These initiatives have ranged from proposals to fundamentally change federal and state healthcare reimbursement
programs, including providing comprehensive healthcare coverage to the public under government-funded programs, to minor modifications
to existing programs. One example is the Patient Protection and Affordable Care Act, the Federal healthcare reform law enacted in 2010
(the &#8220;Affordable Care Act&#8221;). Similar reforms may occur internationally.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Third party payors, such as Medicare and Medicaid in the United
States, have reduced their reimbursements for certain medical products and services. Our business is impacted by the level of reimbursement
available for clinical tests from third party payors. In the United States payment for many diagnostic tests furnished to Medicare&#160;
fee-for-service beneficiaries is made based on the Medicare Clinical Laboratory Fee Schedule (CLFS), a fee schedule established and adjusted
from time to time by the Centers for Medicare and Medicaid Services (CMS). Some commercial payors are guided by the CLFS in establishing
their reimbursement rates. Laboratories and clinicians may decide not to order or perform certain clinical diagnostic tests if third party
payments are inadequate, and we cannot predict whether third party payors will offer adequate reimbursement for tests utilizing our products
to make them commercially attractive. Legislation, such as the Affordable Care Act, as amended by the Health Care and Education Reconciliation
Act and the Middle Class Tax Relief and Job Creation Act of 2012, has reduced the payments for clinical laboratory services paid under
the CLFS. In addition, the Medicare for All Act of 2021 (M4A) has made significant changes to the way Medicare will pay for clinical laboratory
services, which has further reduced reimbursement rates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Legislative and regulatory bodies are likely to continue to pursue
healthcare reform initiatives in many forms and may continue to reduce funding in an effort to lower overall federal healthcare spending.
The U.S. government recently enacted legislation that eliminated what is known as the &#8220;individual mandate&#8221; under the Affordable
Care Act and may enact other changes in the future. The ultimate content and timing of any of these types of changes in other healthcare
reform legislation and the resulting impact on us are impossible to predict. If significant reforms are made to the healthcare system
in the U.S., or in other jurisdictions, those reforms may increase our costs or otherwise have an adverse effect on our financial condition
and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">26</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our laboratory business could be harmed from
the loss or suspension of a licence or imposition of a fine or penalties under, or future changes in, the law or regulations of the Clinical
Laboratory Improvement Amendments of 1988 (&#8220;CLIA&#8221;), or those of other state or local agencies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Our laboratory operated by our subsidiary Immco Diagnostics Inc.
(&#8220;Immco&#8221;) is subject to CLIA, which is administered by CMS and extends federal oversight to virtually all clinical laboratories
by requiring that they be certified by the federal government or by a federally-approved accreditation agency. CLIA is designed to ensure
the quality and reliability of clinical laboratories by, among other things, mandating specific standards in the areas of personnel qualifications,
administration, and participation in proficiency testing, patient test management, quality control, quality assurance and inspections.
Laboratories must undergo on-site surveys at least every two years, which may be conducted by the Federal CLIA program or by a private
CMS approved accrediting agency such as the College of American Pathologists, among others. The sanction for failure to comply with CLIA
requirements may be suspension, revocation or limitation of a laboratory&#8217;s CLIA certificate, which is necessary to conduct business,
as well as significant fines and/or criminal penalties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We are also subject to regulation of laboratory operations under
state clinical laboratory laws of New York and of certain other states from where we accept specimens. State clinical laboratory laws
may require that laboratories and/or laboratory personnel meet certain qualifications, specify certain quality controls or require maintenance
of certain records. For example, California requires that we maintain a licence to conduct testing in California, and California law establishes
standards for our day-to-day laboratory operations, including the training and skill required of laboratory personnel and quality control.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">In some respects, notably with respect to qualifications of testing
personnel, California&#8217;s clinical laboratory laws impose more rigorous standards than does CLIA. Certain other states, including
Florida, Maryland, New York and Pennsylvania, require that we hold licences to test specimens from patients residing in those states,
and additional states may require similar licences in the future. Potential sanctions for violation of these statutes and regulations
include significant fines and the suspension or loss of various licences, certificates and authorisations, which could adversely affect
our business and results of operations.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We are also subject to various federal and state laws targeting
fraud and abuse in the healthcare industry.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">If we fail to comply with federal and state health care laws,
including fraud and abuse, false claims, physician payment transparency and privacy and security laws, we could face substantial penalties
and our business, operations and financial condition could be adversely affected. We are subject to anti-kickback laws, self-referral
laws, false claims laws, and laws constraining the sales, marketing and other promotional activities of manufacturers of medical devices
by limiting the kinds of financial arrangements we may enter into with physicians, hospitals, laboratories and other potential purchasers
of our products. The laws that may affect our ability to operate include, but are not limited to:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd57025a86eee4a3abfc1454df801b3e0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and wilfully soliciting, receiving,
        offering or paying remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual for, or the
        purchase, order or recommendation of, any good or service for which payment may be made under federal healthcare programs, such as the
        Medicare and Medicaid programs. A person or entity does not need to have actual knowledge of the federal Anti-Kickback Statute or specific
        intent to violate it to have committed a violation; in addition, the government may assert that a claim including items or services resulting
        from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3fb65b08b69c4ba992529e3daaa5603e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the Physician Self-Referral Law, also known as the &#8220;Stark Law&#8221;, which provides for strict liability for referrals by
        physicians to entities with which they or their immediate family members have a financial arrangement for certain designated health services,
        including clinical laboratory services provided by our CLIA-certified laboratory owned and operated by our subsidiary Immco Diagnostics
        Inc<span style="font-weight: bold">.</span>, that are reimbursable by federal healthcare programs, unless an exception applies. Penalties
        for violating the Stark Law include denial of payment, civil monetary penalties of up to fifteen thousand dollars per claim submitted,
        and exclusion from federal health care programs, as well as a penalty of up to one-hundred thousand dollars for attempts to circumvent
        the law;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdcf8efc90b01411199f79dda8f013b8a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>federal false claims laws which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be
        presented, claims for payment from Medicare, Medicaid or other federal third-party payers that are false or fraudulent. Suits filed under
        the False Claims Act, known as &#8220;qui tam&#8221; actions, can be brought by any individual on behalf of the government and such individuals,
        commonly known as &#8220;whistleblowers&#8221;, may share in any amounts paid by the entity to the government in fines or settlement.
        When an entity is determined to have violated the False Claims Act, it may be required to pay up to three times the actual damages sustained
        by the government, plus civil penalties for each separate false claim. Often, to avoid the threat of treble damages and penalties under
        the False Claims Act, which in 2020 were $11,665 to $23,331 per false claim, companies will resolve allegations in a settlement without
        admitting liability to avoid the potential treble damages. Any such settlement could materially affect our business, financial operations,
        and reputation;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">27</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z14e051eecc4846889888b35390c1dd69" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the federal Civil Monetary Penalties Law, which prohibits, among other things, offering or transferring remuneration to a federal
        healthcare beneficiary that a person knows or should know is likely to influence the beneficiary&#8217;s decision to order or receive
        items or services reimbursable by the government from a particular provider or supplier;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7b77e054b4b041129cad071a200f6f29" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>federal criminal laws that prohibit executing a scheme to defraud any federal healthcare benefit program or making false statements
        relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge
        of the statute or specific intent to violate it to have committed a violation;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z37fde03606e044dda391a2cd6d38e8f5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the federal Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic
        and Clinical Health Act, which governs the conduct of certain electronic healthcare transactions and protects the security and privacy
        of protected health information;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7e3407bb41b8472d8723baa80b4cb854" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the federal Physician Payment Sunshine Act, which requires manufacturers of drugs, devices, biologics and medical supplies for which
        payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) to report annually
        to the CMS, information related to payments or other &#8220;transfers of value&#8221; made to physicians (defined to include doctors,
        dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, and requires applicable manufacturers to report annually
        to the government ownership and investment interests held by the physicians described above and their immediate family members and payments
        or other &#8220;transfers of value&#8221; to such physician owners. Manufacturers are required to submit reports to CMS by the 90<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup>
        day of each calendar year. We cannot assure you that we have and will successfully report all transfers of value by us, and any failure
        to comply could result in significant fines and penalties. Failure to submit the required information may result in civil monetary penalties
        up to an aggregate of $150,000 per year (and up to an aggregate of $1&#160;million per year for &#8220;knowing failures&#8221;) for all
        payments, transfers of value or ownership or investment interests not reported in an annual submission, and may result in liability under
        other federal laws or regulations;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zaa5ff6b3db8044908bf4bbe1a95550cb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>federal and state laws governing the certification and licensing of clinical laboratories, including operational, personnel and quality
        requirements designed to ensure that testing services are accurate and timely, and federal and state laws governing the health and safety
        of clinical laboratory employees;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb1b6f6f619b04fc7adce34c37393d58f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the U.S. Foreign Corrupt Practices Act, or the FCPA, which prohibits corporations and individuals from paying, offering to pay or
        authorising the payment of anything of value to any foreign government official, government staff member, political party or political
        candidate in an attempt to obtain or retain business or to otherwise influence a person working in an official capacity; the UK Bribery
        Act, which prohibits both domestic and international bribery, as well as bribery across both public and private sectors; and bribery provisions
        contained in the German Criminal Code, which makes the corruption and corruptibility of physicians in private practice and other healthcare
        professionals a criminal offense; and</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="ze93aa41d9f4b4a1cb2766db2b17f96ac" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>analogous state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which
        may apply to items or services reimbursed by any payor, including commercial insurers; state laws that require device companies to comply
        with the industry&#8217;s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government
        or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state laws that require
        device manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers
        or marketing expenditures; and state laws governing the privacy and security of health information in certain circumstances, many of which
        differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Because of the breadth of these laws and the narrowness of the
statutory exceptions and safe harbours available under such laws, it is possible that some of our business activities, including our relationships
with physicians and other healthcare providers, some of whom may recommend, purchase and/or order our tests, our sales and marketing efforts
and certain arrangements with customers, including those where we provide our instrumentation for free in exchange for minimum purchase
requirements of our reagents, and our billing and claims processing practices, could be subject to challenge under one or more of such
laws. By way of example, some of our consulting arrangements with physicians do not meet all of the criteria of the personal services
safe harbour under the federal Anti-Kickback Statute. Accordingly, they do not qualify for safe harbour protection from government prosecution.
A business arrangement that does not substantially comply with a safe harbour, however, is not necessarily illegal under the Anti-Kickback
Statute, but may be subject to additional scrutiny by the government. We are also exposed to the risk that our employees, independent
contractors, principal investigators, consultants, vendors and distributors may engage in fraudulent or other illegal activity. Any action
against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses
and divert our management&#8217;s attention from the operation of our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">28</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">To enforce compliance with the federal laws, the U.S. Department
of Justice (&#8220;DOJ&#8221;), has recently increased its scrutiny of interactions between health care companies and health care providers,
which has led to a number of investigations, prosecutions, convictions and settlements in the health care industry. Dealing with investigations
can be time and resource consuming and can divert management&#8217;s attention from the business. In addition, settlements with the DOJ
or other law enforcement agencies have forced healthcare providers to agree to additional compliance and reporting requirements as part
of a consent decree or corporate integrity agreement. Any such investigation or settlement could increase our costs or otherwise have
an adverse effect on our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Many of the existing requirements are new and have not been definitively
interpreted by state authorities or courts, and available guidance is limited. In addition, changes in or evolving interpretations of
these laws, regulations, or administrative or judicial interpretations, may require us to change our business practices or subject our
business practices to legal challenges, which could have a material adverse effect on our business, financial condition and results of
operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We have not yet developed a comprehensive compliance program
that establishes internal controls to facilitate adherence to the rules and program requirements to which we are or may become subject.
Although the development and implementation of such compliance programs can mitigate the risk of investigation, prosecution, and penalties
assessed for violations of these laws, or any other laws that may apply to us, the risks cannot be entirely eliminated.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">If our operations are found to be in violation of any of the
laws described above or any other laws and regulations that apply to us, we could receive adverse publicity, face enforcement action and
be subject to penalties, including civil and criminal penalties, damages, fines, the curtailment or restructuring of our operations, the
exclusion from participation in federal and state healthcare programs and imprisonment, any of which could adversely affect our ability
to operate our business and our results of operations.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Compliance with regulations governing public company corporate governance
and reporting is complex and expensive.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Many laws and regulations impose obligations on public companies,
which have increased the scope, complexity and cost of corporate governance, reporting and disclosure practices. Our implementation of
certain aspects of these laws and regulations has required and will continue to require substantial management time and oversight and
may require us to incur significant additional accounting and legal costs. We continually evaluate and monitor developments with respect
to new and proposed rules and cannot predict or estimate the ultimate amount of additional costs we may incur or the timing of such costs.
These laws and regulations are also subject to varying interpretations, in many cases due to their lack of specificity, and as a result,
their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in
continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices.
Although we are committed to maintaining high standards of corporate governance and public disclosure, if we fail to comply with any of
these requirements, legal proceedings may be initiated against us, which may adversely affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25; font-weight: bold">Risks Related to Our Intellectual Property</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may be unable to protect or obtain proprietary rights that we
utilise or intend to utilise.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">In developing and manufacturing our products, we employ a variety
of proprietary and patented technologies. In addition, we have licenced, and expect to continue to licence, various complementary technologies
and methods from academic institutions and public and private companies. We cannot provide any assurance that the technologies that we
own or licence provide protection from competitive threats or from challenges to our intellectual property. In addition, we cannot provide
any assurances that we will be successful in obtaining licences or proprietary or patented technologies in the future, or that licences
granted to us by third parties will not be granted to other third parties who could potentially compete with us.</div> <br/>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">

<div style="line-height: 1.25">From time-to-time, certain companies have asserted exclusive patent, copyright and other intellectual property
rights to technologies that are important to the industry in which we operate. If any of such claims relate to our planned products, we
intend to evaluate such claims and, if appropriate, seek a licence to use the protected technology. There can be no assurance that we
would be able to obtain licences to use such technology or, obtain such licences on satisfactory commercial terms. If we or our suppliers
are unable to obtain or maintain a licence to any such protected technology that might be used in our products, we could be prohibited
from marketing such products. We could also incur substantial costs to redesign our products or to defend any legal action taken against
us. If Trinity Biotech&#8217;s products should be found to infringe protected technology, we could also be required to pay damages to
the infringed party.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">29</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Filing, prosecuting and defending patents covering our current
and future products throughout the world would be prohibitively expensive. Competitors may use our technologies in jurisdictions where
we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories
where we may obtain patent protection, but where patent enforcement is not as strong as that in the United States. These products may
compete with our products in jurisdictions where we do not have any issued or licenced patents and any future patent claims or other intellectual
property rights may not be effective or sufficient to prevent them from so competing.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">The scope of the patent protection we obtain
may not be sufficiently broad to compete effectively in our markets; our patent applications could be rejected or the existing patents
could be challenged; and trade secrets and confidential know-how could be obtained by competitors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Trinity Biotech currently owns a number of active patents, some
with protection across multiple countries.&#160;Patents have a life of up to 20 years, and we are generally filing new patents on an ongoing
basis to protect our intellectual property. We may fail to identify patentable aspects of our research and development output before it
is too late to obtain patent protection. The patent applications that we own, or in-licence, may fail to result in issued patents with
claims that cover our current products or any future products in the United States or in other foreign countries. There is no assurance
that all of the potentially relevant prior art relating to our patents and patent applications has been found, which can invalidate a
patent or prevent a patent from issuing from a pending patent application.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We can provide no assurance that third parties will not challenge
the validity, enforceability or scope of the patents Trinity Biotech may apply for, or obtain, which may result in such patents being
narrowed, invalidated, or held unenforceable. Any successful opposition to these patents or any other patents owned by or licenced to
us could deprive us of rights necessary for the successful commercialization of any products covered by those patents.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Further, if we encounter delays in regulatory approvals, the
period of time during which we could market a product under patent protection could be reduced. We can provide no assurance that our patents
will continue to be commercially valuable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Trade secrets and confidential know-how are important to our
scientific and commercial success. Although we seek to protect our proprietary information through confidentiality agreements and other
contracts, we can provide no assurance that others will not independently develop the same or similar information or gain access to our
proprietary information.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Obtaining and maintaining our patent protection
depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent
agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Periodic maintenance fees on any issued patent are due to be
paid to the United States Patent and Trademark Organization (&#8220;USPTO&#8221;) and other foreign patent agencies in several stages
over the lifetime of the patent. The USPTO and various foreign national or international patent agencies require compliance with a number
of procedural, documentary, fee payment and other similar provisions during the patent application process. While an inadvertent lapse
can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in
which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent
rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of patent rights include, but are
not limited to, failure to timely file national and regional stage patent applications based on our international patent application,
failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalise and submit
formal documents. If we or our licensors fail to maintain the patents and patent applications covering our current or future products,
our competitors might be able to enter the market, which would have an adverse effect on our business.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Changes in patent law could diminish the value of patents in general,
thereby impairing our ability to protect our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Depending on actions by the U.S. Congress, the federal Courts,
and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new
patents or to enforce patents that we have licenced or that we might obtain in the future. Similar changes could happen to patent laws
outside of the United States which would have the same consequences.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">30</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">For example, the United States has enacted and implemented wide-ranging
patent reform legislation, which could increase the uncertainties and costs surrounding the prosecution of our patent applications and
the enforcement or defence of our issued patents. On September 16, 2011, the Leahy-Smith America Invents Act, or the Leahy-Smith Act,
was signed into law. The Leahy-Smith Act includes a number of significant changes to United States patent law. These include provisions
that affect the way patent applications are prosecuted and may also affect patent litigation. The United States Patent Office developed
regulations and procedures to govern administration of the Leahy-Smith Act, and many of the substantive changes to patent law associated
with the Leahy-Smith Act, and in particular, the first to file provisions, only became effective on March 16, 2013. Accordingly, it is
not clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. However, the Leahy-Smith Act and its implementation
could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defence of our
issued patents, all of which could have an adverse effect on our business and financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Additionally, the U.S. Supreme Court has ruled on several patent
cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent
owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination
of events has created uncertainty with respect to the value of patents, once obtained.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Product infringement claims by other companies could result in costly
disputes and could limit our ability to sell our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Litigation over intellectual property rights is prevalent in
the diagnostic industry, including patent infringement lawsuits, interferences, derivation and administrative law proceedings, inter party
review, and post-grant review before the USPTO, as well as oppositions and similar processes in foreign jurisdictions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">As the market for diagnostics continues to grow and the number
of participants in the market increases, we may increasingly be subject to patent infringement claims. It is possible that a third-party
may claim infringement against us. For example, because patent applications can take many years to issue, there may be currently pending
patent applications which may later result in issued patents that our products may infringe. The biosensor industry, including the CGM
industry, is a highly innovative area with a number of industry participants developing intellectual property portfolios over many years.
As such there can be no guarantee that the technology acquired from Waveform or further developed by us, will not infringe on other parties
existing IP portfolios.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Defence of these claims, regardless of their merit, would involve
substantial litigation expense and would be a substantial diversion of managerial and financial resources from our business. Parties making
claims against us may obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialise
one or more of our products. The pendency of any litigation may cause our distributors and customers to reduce or terminate purchases
of our products. If found to infringe, we may have to pay substantial damages, including treble damages and attorneys&#8217; fees for
wilful infringement, obtain one or more licences from third parties, pay royalties or redesign our affected products, which may be impossible
or require substantial time and monetary expenditure. Any substantial loss resulting from such a claim could cause our revenues to decrease
and have a material adverse effect on our profitability, and the damage to our reputation in the industry could have a material adverse
effect on our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">If we need to obtain a licence as a result of litigation, we
cannot predict whether any such licence would be available at all or whether it would be available on commercially reasonable terms. Furthermore,
even in the absence of litigation, we may need to obtain licences from third parties to advance our research or allow commercialisation
of our products. We may fail to obtain any of these licences at a reasonable cost or on reasonable terms, if at all. In that event, we
would be unable to further develop and commercialise one or more of our products, which could harm our business significantly.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may be involved in lawsuits to enforce our
patents, the patents of our licensors or our other intellectual property rights, which could be expensive, time consuming and unsuccessful.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Competitors may infringe or otherwise violate our patents, the
patents of our licensors or our other intellectual property rights. To counter infringement or unauthorised use, we may be required to
file legal claims, which can be expensive and time-consuming. In addition, in an infringement proceeding, a Court may decide that a patent
of ours or our licensors is not valid or is unenforceable or may refuse to stop the other party from using the technology at issue on
the grounds that our patents do not cover the technology in question. An adverse result in any litigation or defence proceedings could
put one or more of our patents at risk of being invalidated or interpreted narrowly and could put our patent applications at risk of not
issuing. The initiation of a claim against a third party may also cause the third party to bring counter claims against us such as claims
asserting that our patents are invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity
or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements,
including lack of novelty, obviousness, non-enablement or lack of statutory subject matter. Grounds for an unenforceability assertion
could be an allegation that someone connected with prosecution of the patent withheld relevant material information from the USPTO, or
made a materially misleading statement, during prosecution. Third parties may also raise similar validity claims before the USPTO in post-grant
proceedings such as ex parte re-examinations, inter partes review, or post-grant review, or oppositions or similar proceedings outside
the United States, in parallel with litigation or even outside the context of litigation. The outcome following legal assertions of invalidity
and unenforceability is unpredictable.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">31</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We cannot be certain that there is no invalidating prior art,
of which we and the patent examiner were unaware during prosecution. For the patents and patent applications that we have licenced, we
may have limited or no right to participate in the defence of any licenced patents against challenge by a third party. If a defendant
were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of any future patent
protection on our current or future products. Such a loss of patent protection could harm our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">We may not be able to prevent, alone or with our licensors, misappropriation
of our intellectual property rights, particularly in countries where the laws may not protect those rights as fully as in the United States.
Our business could be harmed if in litigation the prevailing party does not offer us a licence on commercially reasonable terms. Any litigation
or other proceedings to enforce our intellectual property rights may fail, and even if successful, may result in substantial costs and
distract our management and other employees.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 0.05pt; line-height: 1.25">Furthermore, because of the substantial amount of discovery required
in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by
disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions or other interim
proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have an adverse effect
on the price of our ADSs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Ownership of our ADSs</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">MiCo and Perceptive own approximately 12.5% and 9.6% respectively
of the voting share capital of our Company, which may give each of these shareholders a significant influence over our management and
affairs and may deter a change in control or other transaction that may otherwise be favorable to our shareholders.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">MiCo owns 2.2 million of our ADSs, which represents approximately 12.5% of the outstanding voting share
capital of our Company (15.8% on a fully diluted basis, including shares issuable upon conversion of the convertible note issued to MiCo).
Based on public filings, we understand that on December 17, 2024, MiCo was acquired by Dayli Trinity Holdings Limited as a result of a
share purchase agreement with Mainstream Holdings Limited.&#160; Under the terms of the MiCo convertible note and the purchase agreement
for those ADSs, MiCo is entitled to nominate a total of up to four individuals, three of whom must be independent of MiCo, for consideration
by the nomination committee of the board of directors of the Company for appointment as directors for as long as MiCo continues to hold
qualifying amounts of ADSs or principal value of the convertible note or converted ADSs, as applicable. Because of its ownership interest
and right to nominate directors, MiCo may have significant influence over our management and affairs and over matters requiring shareholder
approval, including the election of directors and significant corporate transactions, such as a merger or other sale of our Company or
our assets, for the foreseeable future. This concentration of ownership may also delay, deter or prevent a change in control, and may
make some transactions more difficult or impossible to complete without the support of MiCo, regardless of the impact of such transactions
on our other shareholders. The interests of MiCo may differ from the interests of other shareholders and thus result in corporate decisions
that are disadvantageous to other shareholders.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Perceptive, our principal lender, owns 1.79 million of our ADSs which represents approximately
9.6% of the outstanding voting share capital of our Company. Perceptive also owns warrants to purchase an additional 2.5 million ADSs
with an exercise price of US$0.80 per ADS. Because of its ownership interest and its position as the Company&#8217;s principal lender,
Perceptive may have significant influence over our management and affairs for the foreseeable future. This concentration of ownership
may also delay, deter or prevent a change in control, and may make some transactions more difficult or impossible to complete without
the support of Perceptive, regardless of the impact of such transactions on our other shareholders.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">32</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">The Nasdaq Global Select Market imposes listing
standards on our ADSs that we may not be able to fulfill in the future, thereby leading to a possible delisting of our ADSs.</div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">As a listed Nasdaq Global Select Market company, we are subject to various listing
standards.&#160; There can be no assurance that we will be able to meet all of the criteria necessary for Nasdaq to allow our ADSs to
remain listed.</div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">On March 19, 2025, we received two deficiency letters from the Listing Qualifications
Department of Nasdaq (the &#8220;Staff&#8221;). One deficiency letter notified us that we are not in compliance with the minimum market
value of publicly held shares (&#8220;MVPHS&#8221;) requirement of the Nasdaq Listing Rules applicable to companies listed on the Nasdaq
Global Select Market. For continued listing, companies are required to maintain a minimum MVPHS of $15 million. A failure to meet the
minimum MVPHS requirement exists if the deficiency continues for a period of 30 consecutive business days. The other deficiency letter
notified us that for the preceding 30 consecutive business days, the ADSs did not maintain a minimum closing bid price of $1.00 (the &#8220;Minimum
Bid Price&#8221;) per ADS, as required by Nasdaq Listing Rule 5450(a)(1).</div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In accordance with the Nasdaq Listing Rules, we have 180 calendar days from the date
of the deficiency notices, or until September 10, 2025, to regain compliance with the minimum MVPHS requirement and the Minimum Bid Price
requirement.</div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">To regain compliance with the MVPHS requirement, the Company&#8217;s MVPHS must exceed
$15 million for a minimum of ten consecutive business days. If the Company does not regain compliance with the minimum MVPHS requirement
by September 10, 2025, Nasdaq will provide written notification to the Company that its ADSs are subject to delisting. At that time, the
Company may appeal the relevant delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq
Listing Rules; however, there can be no assurance that the Company will satisfy the minimum MVPHS requirement or that any such appeal
would be successful.</div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">To regain compliance with the Minimum Bid Price requirement, the closing bid price
of the Company&#8217;s ADSs must meet or exceed US $1.00 for at least ten consecutive business days during the 180-calendar day cure period.
In the event the Company does not regain compliance with the Minimum Bid Price Requirement in that period, we may be eligible for an additional
180 calendar day grace period if we meet the continued listing requirement for MVPHS and all other initial listing standards for The Nasdaq
Capital Market, with the exception of the bid price and provide written notice to the Staff of our intention to cure the deficiency during
the second compliance period. However, if it appears to the Staff that we will not be able to cure the deficiency, or if we are otherwise
not eligible, Nasdaq will provide notice to us that our ADSs will be subject to delisting.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">We also received deficiency letters from Nasdaq in 2023. In April 2023, Nasdaq notified
us that we were not in compliance with the Minimum Bid Price requirement. To regain compliance and to facilitate investment from a broader
pool of potential investors, we effected an ADS Ratio Change on February 23, 2024, pursuant to which the ADS to ordinary share ratio changed
from one ADS representing four ordinary shares to one ADS representing 20 ordinary shares.&#160; We received another deficiency letter
from Nasdaq in November 2023 notifying us that we were not in compliance with the MVPHS requirement at that time.&#160; Although Nasdaq
determined in November 2024 that we had regained compliance with the MVPHS requirement, it did not preclude Nasdaq from monitoring our
continued compliance and issuing the more recent deficiency letter regarding our current compliance with the MVPHS requirement.</div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">If our ADSs are ultimately delisted from Nasdaq and we are unable to successfully
transfer the listing of our ADSs to The Nasdaq Capital Market, our ADSs would likely then trade only in the over-the-counter market and
the market liquidity of our ADSs could be adversely affected and their market price could decrease. If our ADSs were to trade on the over-the-counter
market, selling our ADSs could be more difficult because smaller quantities of shares would likely be bought and sold, transactions could
be delayed, and we could face significant material adverse consequences, including: a limited availability of market quotations for our
securities; reduced liquidity with respect to our securities; a determination that our shares are a &#8220;penny stock,&#8221; which will
require brokers trading in our securities to adhere to more stringent rules, possibly resulting in a reduced level of trading activity
in the secondary trading market for our securities; a reduced amount of news and analyst coverage for our Company; and a decreased ability
to issue additional securities or obtain additional financing in the future. These factors could result in lower prices and larger spreads
in the bid and ask prices for our ADSs and would substantially impair our ability to raise additional funds and could result in a loss
of institutional investor interest and fewer development opportunities for us.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">33</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We are a foreign private issuer under the rules
and regulations of the SEC and are therefore exempt from a number of rules under the Exchange Act and are permitted to file less information
with the SEC than a domestic U.S. reporting company, which reduces the level and amount of disclosure that you receive.</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">&#160;</div>

<div style="text-align: justify; line-height: 1.25">As a foreign private issuer under the Exchange Act, we are exempt from certain rules
under the Exchange Act, including the proxy rules, which impose certain disclosure and procedural requirements for proxy solicitations.
Moreover, we are not required to file periodic reports and financial statements with the SEC as frequently or as promptly as domestic
U.S. companies with securities registered under the Exchange Act; and are not required to comply with Regulation FD, which imposes certain
restrictions on the selective disclosure of material information. In addition, our officers, directors and principal shareholders are
exempt from the reporting and &#8220;short-swing&#8221; profit recovery provisions of Section 16 of the Exchange Act and the rules under
the Exchange Act with respect to their purchases and sales of our ADSs. Accordingly, you receive less information about our company than
you would receive about a domestic U.S. company and are afforded less protection under the U.S. federal securities laws than you would
be afforded in holding securities of a domestic U.S. company.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">As a foreign private issuer whose ADSs are listed on NASDAQ, we are permitted to follow
certain home country corporate governance practices instead of certain requirements of the NASDAQ listing rules. Among other things, as
a foreign private issuer we may also follow home country practice with regard to, the composition of the board of directors, director
nomination procedure, compensation of officers and quorum at shareholders&#8217; meetings. In addition, we may follow our home country
law, instead of the NASDAQ listing rules, which require that we obtain shareholder approval for certain dilutive events, such as for the
establishment or amendment of certain equity based compensation plans, an issuance that will result in a change of control of the company,
certain transactions other than a public offering involving issuances of a 20% or more interest in the company and certain acquisitions
of the stock or assets of another company. Accordingly, our shareholders may not be afforded the same protection as provided under NASDAQ&#8217;s
corporate governance rules. In addition, as foreign private issuer, we are not required to file quarterly reviewed financial statements.
A foreign private issuer that elects to follow a home country practice instead of such requirements must submit to NASDAQ in advance a
written statement from an independent counsel in such issuer&#8217;s home country certifying that the issuer&#8217;s practices are not
prohibited by the home country&#8217;s laws.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may be classified as a passive foreign investment company, or
PFIC, which would subject our U.S. investors to adverse tax rules.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">

<div style="text-align: justify; line-height: 1.25">U.S. holders of our ADSs may face income tax risks. Based on the composition of our
income, assets (including the value of our goodwill, going-concern value or any other unbooked intangibles, which may be determined based
on the price of the ordinary shares), and operations, we believe we will not be classified as a &#8220;passive foreign investment company&#8221;,
or PFIC, for the 2024 taxable year. However, because PFIC status is based on our income, assets and activities for the entire taxable
year, it is not possible to determine whether we will be characterized as a PFIC for our current taxable year or future taxable years
until after the close of the applicable taxable year. Moreover, we must determine our PFIC status annually based on tests that are factual
in nature, and our status in the current year and future years will depend on our income, assets and activities in each of those years
and, as a result, cannot be predicted with certainty as of the date hereof. Furthermore, fluctuations in the market price of our ordinary
shares may cause our classification as a PFIC for the current or future taxable years to change because the aggregate value of our assets
for purposes of the asset test, including the value of our goodwill and unbooked intangibles, generally will be determined by reference
to the market price of our shares from time to time (which may be volatile). The IRS or a Court may disagree with our determinations,
including the manner in which we determine the value of our assets and the percentage of our assets that are passive assets under the
PFIC rules. Therefore, there can be no assurance that we will not be a PFIC for the current taxable year or for any future taxable year.
Our treatment as a PFIC could result in a reduction in the after-tax return to U.S. Holders (as defined below under Item 10E. &#8220;Additional
Information &#8211; Taxation&#8221;) of our ADSs and would likely cause a reduction in the value of such shares. A foreign corporation
will be treated as a PFIC for U.S. federal income tax purposes if either (1) at least 75% of its gross income for any taxable year consists
of certain types of &#8220;passive income,&#8221; or (2) at least 50% of the average value of the corporation&#8217;s gross assets produce,
or are held for the production of, such &#8220;passive income.&#8221; For purposes of these tests, &#8220;passive income&#8221; includes
dividends, interest, gains from the sale or exchange of investment property and rents and royalties other than rents and royalties that
are received from unrelated parties in connection with the active conduct of a trade or business. If we are treated as a PFIC, U.S. Holders
of ADSs would be subject to a special adverse U.S. federal income tax regime with respect to the income derived by us, the distributions
they receive from us, and the gain, if any, they derive from the sale or other disposition of their ADSs. U.S. Holders should carefully
read Item 10E. &#8220;Additional Information &#8211; Taxation&#8221; for a more complete discussion of the U.S. federal income tax risks
related to owning and disposing of ADSs.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">34</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">The market price of our ADSs has been, and
may continue to be, highly volatile, and such volatility could cause the market price of our ADSs to decrease and could cause you to lose
some or all of your investment in our ADSs.</div> </div>

<div style="margin-left: 15pt; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The stock market in general and the market prices of the ADSs on Nasdaq, in particular,
are or will be subject to fluctuation, and changes in these prices may be unrelated to our operating performance. During the first quarter
of 2025, the market price of our ADSs fluctuated from a high of US$1.36 per ADS to a low of US$0.57 per ADS, and the price of our ADSs
continues to fluctuate. We anticipate that the market prices of our securities will&#160;continue&#160;to be subject to wide fluctuations.
The market price of our securities may be subject to a number of factors, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zcacbb8e8b7224ea1aa87a16d073606fc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>announcements of new products by us or others;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zff65e1b261b749e7bbd0a2d2a04812b5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>announcements by us of significant acquisitions, disposals, strategic partnerships, in-licensing, joint ventures or capital commitments;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfca919d8fa4d48c2968f1bc5c104510b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the developments of the businesses and projects of our various subsidiaries;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze0af252609e94fd5a0b477cb05e78c43" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>expiration or terminations of licences, research contracts or other collaboration agreements;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8b9cd0d673cf4c89be6cebb58a33abc3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>public concern as to the safety of the products we sell;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbbb33417e676442a872e446f5dfaa200" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the volatility of market prices for shares of companies with whom we compete;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd11514af52f043f7902c4638a096658c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>developments concerning intellectual property rights or regulatory approvals;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5cf09334270a433fa568dac9f8a24ddd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>variations in our and our competitors&#8217; results of operations;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd542db5cb19447ef9d6aae2c96f22f18" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>changes in revenues, gross profits and earnings announced by us;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1c95c21bb3024c5aad4c55a08e2d21b8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>changes in estimates or recommendations by securities analysts, if the ADSs are covered by analysts;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9f452cd1754e44a98e2d4af2c5837eed" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>fluctuations in the share price of our publicly traded subsidiaries;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zec4f23c733d94b83ba697b56eebf224f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>changes in government regulations or patent decisions; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9d513f90a62e4f219d4790dccfc0b96f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>general market conditions and other factors, including factors unrelated to our operating performance.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">These&#160;factors may&#160;materially&#160;and adversely affect the market price
of our securities and result in substantial losses by our investors.</div>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We expect we will need additional capital in
the future. If additional capital is not available, we may not be able to continue to operate our business pursuant to our business plan
or we may have to discontinue our operations entirely.&#160;</div> </div>

<div style="line-height: 1.25">

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25">We expect we will require additional capital in the future. If we continue to incur
losses, we will need significant additional financing, which we may seek through a combination of private and public equity offerings,
debt financings, and asset sales, etc. To the extent that we raise additional capital through the sale of equity or convertible debt securities,
the ownership interest of our shareholders will be diluted, and the terms of any such offerings may include liquidation or other preferences
that may adversely affect the then existing shareholders&#8217; rights. Debt financing, if available, would result in increased fixed
payment obligations and may involve agreements that include covenants limiting or restricting our ability to take specific actions such
as incurring debt or making capital expenditures. If we raise additional funds through collaboration, strategic alliance or licensing
arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams or product candidates,
or grant licences on terms that are not favorable to us.&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic">&#160;</span>&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Future sales of our ADSs and additional ADSs issuable upon exercise
of warrants could reduce the market price of the ADSs.</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25">Substantial sales of our ADSs may cause the market price of our ADSs to decline. Sales
by us or our security holders of substantial amounts of our ADSs, or the perception that these sales may occur in the future, could cause
a reduction in the market price of our ADSs.&#160;The issuance of any additional ADSs, or any securities that are exercisable for or convertible
into our ADSs, may have an adverse effect on the market price of our ADSs and will have a dilutive effect on our existing holders of ADSs.
The fact that substantial amounts of ADSs could be sold in the public market, whether or not sales have occurred or are occurring, could
make it more difficult for the Company to raise additional financing through the sale of equity or equity-related securities in the future
at a time and price that it deems reasonable or appropriate.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">35</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The conversion of our outstanding share options and warrants would
dilute the ownership interest of existing shareholders.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The total share options exercisable as at March 31, 2025, are convertible into American
Depository Shares (ADSs), 1 ADS representing 20 ordinary shares. The exercise of the outstanding share options will likely occur only
when the conversion price is below the trading price of our ADSs and will dilute the ownership interests of existing shareholders. For
instance, if all of the vested and exercisable options outstanding at March 31, 2025 were exercised, the Company would have to issue 23,574,589
additional ordinary shares (1,178,729 ADSs). Similarly, if all of the outstanding warrants to purchase ordinary shares at March 31, 2025
were exercised, the Company would have to issue 51,200,000 A ordinary shares (2,560,000 ADSs).&#160;On the basis of 385,195,982 million
A ordinary shares outstanding at March 31, 2025, the exercise of both the share options and the warrants would effectively dilute the
ownership interest of the existing shareholders by approximately 16%.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">It could be difficult for U.S. holders of ADSs
to enforce any securities laws claims against us, our officers or our directors in Irish courts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">At present, no treaty exists between the United States and Ireland for the reciprocal
enforcement of foreign judgments. Therefore, a final judgment for the payment of money rendered by any U.S. federal or state court based
on civil liability, whether or not based solely on U.S. federal or state securities laws, would not automatically be recognized or enforceable
in Ireland. A judgment of the U.S. courts will be enforced by the Irish courts, by way of separate action in Ireland, if the following
general requirements are met:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5166deb67f8f4f84a82d66fd901f162e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the debt is for a liquidated or defined sum;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb00c1289910946be9dcfc34b9f45f917" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the procedural rules of the U.S. court must have been observed and the U.S. court must have had jurisdiction in relation to the particular
        defendant according to Irish conflict of law rules (the submission to jurisdiction by the defendant would satisfy this rule); and</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z90b8dc7b5fa745e09b13a608b2c91a93" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the judgment must be final and conclusive and the decree must be final and unalterable in the U.S. court which pronounces it. A judgment
        can be final and conclusive even if it is subject to appeal or even if an appeal is pending. If the effect of lodging an appeal under
        the applicable law is to stay execution of the judgment, it is possible that, in the meantime, the judgment should not be actionable in
        Ireland. It remains to be determined whether final judgment given in default of appearance is final and conclusive.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">However, the Irish courts may, in certain circumstances refuse to enforce a judgment
of the U.S. courts which meets the above requirements for one of the following reasons:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z40578d6328374d66aeee324267d01157" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>if the judgment is not for a debt or a definite sum of money;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z34432d2415c94be89a33233bf511d72d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>if the judgment was obtained or alleged to have been obtained by fraud;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd84a6f658dbb4381b0622778925cec02" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>if the process and decision of the U.S. courts were contrary to natural or constitutional justice under the laws of Ireland and if
        the enforcement of the judgment in Ireland would be contrary to natural or constitutional justice;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z523f867024d64c35baf4c29ebeb475c5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>if the judgment is contrary to Irish public policy or involves certain United States laws which will not be enforced in Ireland or
        constitute the enforcement of a judgment of a penal or taxation nature;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbe4d4c7ead0e4d76aa6de7a6aa7eb29b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>if jurisdiction cannot be obtained by the Irish courts over the judgment debtors in the enforcement proceedings by personal service
        in Ireland or outside Ireland under Order 11 of the Irish Superior Courts Rules;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za1a0dc7ba7c84657ad1ce1310ab8da15" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>there is no practical benefit to the party in whose favor the foreign judgment is made in seeking to have that judgment enforced
        in Ireland, or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za9d8361caf0f45d483a270287b2b4fce" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>if the judgment is not consistent with a judgment of an Irish court in respect of the same matter.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">36</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We have no plans to pay dividends on our ADSs,
and ADS holders may not receive funds without selling the ADSs.</div> </div>

<div style="margin-left: 36pt; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We do not expect to pay any cash dividends on our ADSs for the foreseeable future.
We currently intend to retain any additional future earnings to finance our operations and growth and, therefore, we have no plans to
pay cash dividends at this time. Any future determination to pay cash dividends will be at the discretion of our board of directors and
will be dependent on our earnings, financial condition, operating results, capital requirements, any contractual restrictions, and other
factors that our board of directors deems relevant. Accordingly, ADS holders may have to sell some or all of the ADSs in order to generate
cash from your investment. You may not receive a gain on your investment when you sell the ADSs and may lose the entire amount of your
investment.</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">The voting rights of holders of ADSs are limited
by the terms of the deposit agreement, and you may not be able to exercise your right to direct the voting of your Class A ordinary shares
underlying the ADSs.</div> </div>

<div style="margin-left: 36pt; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Holders of ADSs do not have the same rights as our registered shareholders. As a holder
of the ADSs, you will not have any direct right to attend general meetings of our shareholders, cast any votes at such meetings or otherwise
exercise the rights of registered shareholders set out in our articles of association or in Irish law. You will only be able to exercise
the voting rights which attach to the Class A ordinary shares underlying the ADSs indirectly by giving voting instructions to the depositary
in accordance with the provisions of the deposit agreement. Under the deposit agreement with the depositary, you may vote only by giving
voting instructions to the depositary, as the registered holder of the Class A ordinary shares underlying the ADSs. If the depositary
asks for your instructions, then upon receipt of such voting instructions, it will try to vote the underlying Class A ordinary shares
in accordance with these instructions. If we do not instruct the depositary to ask for your instructions, the depositary may still vote
in accordance with instructions you give, but it is not required to do so. You will not be able to directly exercise any right to vote
with respect to the underlying Class A ordinary shares unless you withdraw the shares underlying your ADSs and become the registered holder
of such shares prior to the record date for the general meeting. When a general meeting is convened, you may not receive sufficient advance
notice of the meeting to enable you to withdraw the shares underlying the ADSs and become the registered holder of such shares prior to
the record date for such general meeting to allow you to attend the general meeting and to vote directly with respect to any specific
matter or resolution to be considered and voted upon at the general meeting. Where any matter is to be put to a vote at a general meeting,
upon our instruction, the depositary will notify you of the upcoming vote and deliver our voting materials to you. We cannot assure you
that you will receive the voting materials in time to ensure you can direct the depositary to vote the Class A ordinary shares underlying
your ADSs in accordance with your instructions. In addition, the depositary and its agents are not responsible for failing to carry out
your voting instructions or for their manner of carrying out your voting instructions. This means that you may not be able to exercise
your right to direct how the shares underlying the ADSs are voted and you may have no legal remedy if the shares underlying the ADSs are
not voted as you instructed.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">37</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z6937cd484f264aa19d49ba88ef9d5c58" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 48.95pt; vertical-align: top; font-weight: bold">Item&#160;4.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold"><span id="InformationontheCompany"><!--Anchor--></span>Information on the Company</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z98d214ce0af94f17810d57101be68f2d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 22.5pt; vertical-align: top; font-family: Times New Roman,Times,serif; font-weight: bold">A.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-weight: bold">History and Development of the Company</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We were incorporated in Ireland in 1992 as a private limited company and re-registered
as a public limited company (&#8220;plc&#8221;) in July of that year. In October 1992 we completed an initial public offering of our securities
in the US and our ADS have traded on the Nasdaq Global Market since that time under the symbol &#8220;TRIB.&#8221;.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The principal offices of our company are located at IDA Business Park, Bray, County
Wicklow, Ireland. The Group has expanded its product base through internal development and acquisitions.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Our website address is <span style="text-decoration: underline">https://www.trinitybiotech.com/</span>.
The information contained on, or that can be accessed from, our website does not form part of this Annual Report. The SEC maintains an
Internet site that contains reports, proxy and information statements, and other information regarding issuers, such as we, that file
electronically, with the SEC at&#160;<span style="text-decoration: underline">www.sec.gov</span>.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 1pt/1.25 Times New Roman, serif; text-align: justify">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z179b2120e199498cb8230491157eb7c0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">B.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Business Overview</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">&#160;<span style="font-style: italic">Overview</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We and our subsidiaries develop, acquire, manufacture and market medical diagnostic
products for the clinical laboratory and point-of-care segments of the diagnostic market. These products are used to detect autoimmune,
infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. In January 2024, we entered into the
biosensor industry, with the acquisition of the biosensor assets of Waveform Technologies Inc. (&#8220;Waveform&#8221;) and are currently
developing a range of biosensor devices and related services, starting with a continuous glucose monitoring (&#8220;CGM&#8221;) product.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We market our portfolio of several hundred products to customers in approximately
100 countries around the world through our own sales force and a network of international distributors and strategic partners.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Organisational Structure</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">While our executive offices are located at Bray, Ireland, our research and development,
manufacturing and marketing activities are principally conducted by the following subsidiaries:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3aa93e776a504ba2b87942e87ce700cd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Trinity Biotech Manufacturing Limited, based in Bray, Ireland;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd0412fd3d84143d7b47e293e1654a09e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Konamite Limited, based in Bray, Ireland;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze6474afa66e742758baead36fb3a2537" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Clark Laboratories Inc, based in Jamestown, New York;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8599bbb457654781b7110d5fdec4ec9f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Primus Corporation, based in Kansas City;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za6b27869bcce442da14fd5a924f97f3a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Biopool US Inc (trading as Trinity Biotech USA), based in Jamestown, New York;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc2ffcb69c5ff4eba82743e030d17d9b1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Immco Diagnostics Inc, based in Buffalo, New York;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf3bc7197db7c42a885b5d5d282f0b41d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Trib Biosensors Inc, based in Wilsonville, Oregon;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc0a5f07484f9460b839f673914fd9d35" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Nova Century Scientific Inc, based in Burlington, Canada;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2bc579a66e1544b495140073e3bfa25e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Trinity Biotech Brazil based in Sao Paulo, Brazil;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdd97f3aaddc54308a8b7a511d89d38e0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Metabolomic Diagnostics Limited, based in Cork, Ireland; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z580430bda0b9449f88489eec6fc9e972" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>EpiCapture Limited, based in Bray, Ireland.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">38</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Principal Markets</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The brand names of the principal products of Trinity Biotech are listed below, organised
first by point of use and second by application.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<table cellspacing="0" cellpadding="2" border="0" id="z30b2aebbb28c4b078e10c0a7cb4b4500" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Point-of-care</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 81%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Clinical Laboratory</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="2" border="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 19%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Infectious&#160;Diseases</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 17%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Infectious&#160;Diseases</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 13.58%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Haemoglobin</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 14.67%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Autoimmune</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 16.86%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Clinical&#160;Chemistry</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 18.89%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Blood&#160;Bank&#160;Screening</div> </td> </tr>
  <tr>
    <td style="width: 19%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">UniGold</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 17%; vertical-align: bottom">
        <div style="text-align: center; margin-left: 6.75pt; line-height: 1.25">MarDx</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.58%; vertical-align: bottom">
        <div style="text-align: center; margin-right: 8.1pt; line-height: 1.25">Premier</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.67%; vertical-align: bottom">
        <div style="text-align: center; margin-right: 2.7pt; line-height: 1.25">ImmuBlot</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 16.86%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">EZ</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 18.89%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Captia</div> </td> </tr>
  <tr>
    <td style="width: 19%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">Recombigen</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 17%; vertical-align: bottom">
        <div style="text-align: center; margin-left: 6.75pt; line-height: 1.25">FlexTrans</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.58%; vertical-align: bottom">
        <div style="text-align: center; margin-right: 8.1pt; line-height: 1.25">Ultra</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.67%; vertical-align: bottom">
        <div style="text-align: center; margin-right: 2.7pt; line-height: 1.25">ImmuGlo</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 16.86%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 18.89%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 19%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">Trinscreen</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 17%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 13.58%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.67%; vertical-align: bottom">
        <div style="text-align: center; margin-right: 2.7pt; line-height: 1.25">ImmuLisa</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 16.86%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 18.89%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 19%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 17%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 13.58%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.67%; vertical-align: bottom">
        <div style="text-align: center; margin-right: 2.7pt; line-height: 1.25">OTOblot</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 16.86%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="width: 18.89%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td> </tr>
  </table> </div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">We sell our products through our direct sales organisations in the United States,
Brazil and to an extent in the United Kingdom, France and Germany and then through our network of principal distributors and non-governmental
bodies into approximately 100 countries globally.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In January 2024, the Company acquired the biosensor and Continuous Glucose Monitoring
(&#8220;CGM&#8221;) assets of privately held Waveform Technologies, Inc. (&#8220;Waveform&#8221;). We are currently developing the CGM
device for optimization for broad adoption, evolving the technology to measure and analyse other valuable biomarkers and related datapoints.
Our vision is to develop a portfolio of technologies that can offer users and clinicians valuable actionable health and wellness insights.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Point-of-care</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Point-of-care refers to diagnostic tests which are carried out in the presence of
the patient.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Uni-Gold&#8482; HIV</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We believe that Trinity Biotech makes a very significant contribution to the global
effort to meet the challenge of human immuno-deficiency virus, or HIV, with its principal product, Uni-Gold&#8482; HIV. In Africa, Uni-Gold&#8482;
HIV has been used for many years in voluntary counselling and testing centers in the sub-Saharan region where it is a cornerstone to early
detection and treatment intervention.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Trinscreen</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In Africa, HIV testing typically involves using a point-of-care rapid test for screening
followed by a different rapid test as the confirmatory test. Our Uni-Gold&#8482; HIV product is a leading confirmatory HIV test in the
African market.</div>

<div style="text-align: justify; line-height: 1.25">&#160;

<div style="line-height: 1.25">Point-of-care is key to the growth of Trinity Biotech. Central to this growth is our HIV screening test,
TrinScreen, which received World Health Organisation approval in February 2022. Trinity Biotech has not previously competed in the larger
screening market, which is estimated to be valued at approximately US$150 million p.a. During December 2023, Trinity Biotech began commercial
shipments of Trinscreen and this ramped up significantly in 2024.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Clinical Laboratory</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We supply the clinical laboratory segment of the <span style="font-style: italic">in-vitro</span>
diagnostic market with a range of diagnostic tests and instrumentation which detect:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfff5bf4612964d8ca3e72147e7b61def" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Infectious diseases;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbb5e3e2f586a4d4db58af4bce9addf64" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Glycated haemoglobin (for diabetes monitoring and diagnosis) and haemoglobin variants for the detection of haemoglobinopathies (haemoglobin
        abnormalities); and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0cc233be5c334133ab0a67dca5ce61dd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Autoimmune diseases.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech also supplies this market with other products through its clinical
chemistry business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Infectious Diseases</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">We manufacture kits for the detection of specialty and esoteric biomarkers of infectious
diseases and other associated laboratory products. The products are used in processing patient samples whose results aid physicians in
the diagnosis and clinical assessment of a broad range of infectious diseases. The key clinical laboratory disease areas that we serve
include:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z874c2e1145be467d95ae919757b9ebd6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Sexually transmitted diseases, including Syphilis and Herpes;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z706321b8b6cd42d3a460b60fce3ccc30" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Markers for Epstein Barr, Measles, Mumps, Toxoplasmosis, Cytomegalovirus, Rubella, Varicella and other viral pathogens, and</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z57c6c8bbc4484349b32d84ec0df42805" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>SARS-CoVS-2.</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: -18.35pt; margin-left: 48.95pt; line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">39</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">We also develop, manufacture and distribute products&#160;predominantly in enzyme-linked
immunosorbent assay (&#8220;ELISA&#8221;) format. As a complement to our product range, we also offer third party automated processors
to its customers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Many of the products in our infectious diseases product line are FDA cleared for sale
in the United States and CE marked in Europe. Products are sold in approximately 100 countries in total, with the focus on the Americas,
Europe and Asia. The infectious disease products are sold through our sales and marketing organisation to a variety of customers including
public health authorities, clinical and reference laboratories.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Diabetes and Haemoglobinopathies</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We manufacture products for in-vitro diagnostic measurement of haemoglobin A1c (&#8220;HbA1c&#8221;)
used in the monitoring and diagnosis of diabetes, as well identifying those who are at a high risk of developing diabetes (pre-diabetic).
The Premier Hb9210 uses boronate affinity technology to measure HbA1c which is a marker of a patient&#8217;s average blood sugar control
over the last 100 to 120 days. It is a highly accurate biomarker available for use in the diagnosis of diabetes and is a strong indicator
of a diabetic&#8217;s glycemic control. HbA1c is also used to identify those at risk of becoming diabetic; often referred to as impaired
glucose tolerance. Additionally, HbA1c is used in the assessment of diabetes complications.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We manufacture our own HbA1c instrument, the Premier Hb9210, which was launched in
Europe and obtained FDA approval in late 2011. In the USA and Brazil, we sell the Premier Hb9210 through our own direct sales organisations.
In the rest of the world, we sell the Premier Hb9210 through a network of distributors. The Premier&#8217;s unique features, cost structure
and core technology enable it to compete in most economies and settings.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We also sell products for haemoglobin variants, through the Premier Resolution (CE
cleared - meaning it can be sold in the EU). The Premier Resolution detects and identifies haemoglobinapothies. These are genetic defects
that result in abnormal structure of the haemoglobin molecule. Haemoglobinapathies include sickle-cell diseases, alpha and beta thalassemia
which are amongst the most common genetic disorders in the world.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 1pt/1.25 Times New Roman, serif; text-align: justify"><span style="font-size: 10pt; font-family: Times New Roman, Times, serif">We
have launched the Premier Resolution, our next generation Haemoglobinapothy Analyzer in Europe and the Middle East after undergoing rigorous
and successful field trials. In August 2023, the Premier Resolution was approved by the FDA allowing the instrument to be sold in the
U.S. </span>&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Autoimmune Diseases</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">Autoimmune diseases are diseases that involve an abnormal immune response in which
the immune system attacks the body&#8217;s own cells and tissues. In 2013, we acquired Immco Diagnostics (&#8220;Immco&#8221;), an autoimmunity
company known for novel assay development and high impact contributions to autoimmune disease diagnostic research. Immco develops, manufactures
and sells products in the following formats for diagnosis of autoimmune diseases:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z816d9f1dc0194b3bbaa8596df3ebe489" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Immunofluorescence Assay (&#8220;IFA&#8221;);</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6d60f6b9dd38484eb33d5f56e1c23e9d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Enzyme-linked immunosorbent (&#8220;ELISA&#8221;);</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za11a0f2ed44848d0aff7b8989bcd15d8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Western Blot (&#8220;WB&#8221;); and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdd72a317649f42ff928f62a29721be4f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Line immunoassay (&#8220;LIA&#8221;).</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Many of Immco&#8217;s products are FDA cleared for sale in the U.S. and CE marked
in Europe. The Immco product line addresses the lower throughput, specialty autoimmune segment. The principal autoimmune conditions in
this segment are Rheumatoid Arthritis, Vasculitis, Lupus, Celiac and Crohn&#8217;s Disease, Ulcerative Colitis, Neuropathy, Hashimoto&#8217;s
Disease and Grave&#8217;s Disease.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Immco products are sold through our sales and marketing organisation to clinical
and reference laboratories directly in the US and via distributors in other countries.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The diagnostic product line is complemented by Immco&#8217;s New York State Department
of Health licenced reference laboratory offering specialised services in diagnostic immunology, pathology and immunogenetics, and is marketed
to U.S.-based reference laboratories and hospitals.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In addition, Immco markets a panel of proprietary early markers for Sj&#246;grens
disease often referred to as &#8220;dry eye disorder&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">40</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Clinical Chemistry</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The speciality clinical chemistry business of Trinity Biotech includes reagent products
such as ACE, bile acids, oxalate and glucose-6-phosphate dehydrogenase (&#8220;G6PDH&#8221;) that are clearly differentiated in the marketplace.
These products are suitable for both manual and automated testing and have proven performance in the diagnosis of many disease states
from liver and kidney disease to G6PDH deficiency which is an indicator of haemolytic anaemia.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Blood Bank Screening</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We manufacture enzyme-linked immunosorbent assays, for the detection of syphilis and
malaria. These products are sold through distributors and are manufactured under original equipment manufacturer agreements for other
major third-party diagnostic companies. The business is not currently operating in the U.S.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic">Continuous Glucose Monitoring</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In January 2024, we acquired the biosensor and CGM assets of privately held Waveform
Technologies, Inc. (&#8220;Waveform&#8221;). We are currently redeveloping the CGM technology with a view to developing an innovative
CGM device and then evolve this platform technology to measure and analyse other valuable biomarkers and related datapoints. Our vision
is to develop a portfolio of technologies that can offer users and clinicians valuable actionable health and wellness insights based upon
what is happening in, on and around the body.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Waveform, a developer of novel and proprietary new technologies for diabetes care,
received a CE Mark for its Cascade CGM in 2019, which was commercially available in Europe. The primary use of the device being to continuously
monitor glucose in the human body. The Cascade CGM device and any subsequently developed sensor would be subject to regulatory oversight
from the FDA and country specific regulatory authorities and would be subject to the same risks identified in the Government Regulation
section of this Annual Report. Glucose in the blood diffuses from capillaries into the liquid between cells known as interstitial fluid.
The Waveform CGM device is an electrochemical biosensor which detects the concentration of glucose in interstitial fluid by means of an
enzyme immobilised at the surface of a sensor wire inserted into the skin. The action of the enzyme results in the generation of electrical
current that is relayed to an attached transmitter where it is converted by a firmware algorithm into a blood glucose concentration. The
transmitter then sends this blood glucose measurement to a smartphone or other device where the time within healthy range is tracked and
the user alerted to risks of hypo- or hyperglycaemic episodes.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The Waveform CGM technology contains innovative and proprietary aspects with what
we believe are important benefits. Significantly, the special composition of the sensor wire and the unique formulation of its protective
outer membrane contribute to the ability to achieve needle-free insertion. Needle free insertion has numerous benefits including a reuseable
applicator as no needle needs to be safely disposed. This, combined with a reusable transmitter which is also a feature of the acquired
CGM technology, allows for two clear benefits. Firstly, it allows for a lower cost of production of the redesigned CGM product compared
to the principal current CGM market players and secondly, it reduces the biological waste concerns associated with the currently marketed
single-use disposable systems.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Additionally, we believe that this innovative platform technology will allow us to
develop a broader suite of wearable biosensors to measure and analyse important health and wellness information. If successful, we intend
to target other analytes and data points that represent markers of health and function and make these devices available more broadly around
the globe.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The CGM technology acquired from Waveform was developed over many years and Waveform
has granted a perpetual, worldwide, non-exclusive license to DexCom, Inc. and its affiliates, for some of the patents acquired by us,
but to which we retain the right to use and exploit.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Sales and Marketing</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We sell our products through our own direct sales force in the U.S. Our sales team
in the U.S. is responsible for marketing and selling the Trinity Biotech range of point-of-care, infectious diseases, haemoglobins, autoimmune
and clinical chemistry products. Meanwhile the direct sales force in Brazil sells the Company&#8217;s haemoglobins product range.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">41</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Through its international sales and marketing organisation, which is located in Ireland,
Trinity Biotech sells:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zaf134d264e1e488083579e9a8112dd91" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Its clinical chemistry product range directly to hospitals and laboratories in Germany and France;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf1fc5fe48cf54e71ada7c6a1c364db30" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Infectious diseases and clinical chemistry product ranges directly to hospitals and laboratories in the UK; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z56d13199edf74ffda71e76744490a0da" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>All product lines through independent distributors and strategic partners in a further approximately 100 countries.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Competition</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The diagnostic industry is very competitive. There are many companies, both public
and private, engaged in the sale of medical diagnostic products and diagnostics-related research and development, including several well-known
pharmaceutical and chemical companies. Competition is based primarily on product reliability, customer service and price. This is a technology
driven market with an emphasis on automation and emerging biomarkers. Trinity actively works on increasing automation for the clinical
laboratory. Trinity seeks to bring novel biomarkers to market by licensing agreements with universities and innovative companies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Group&#8217;s competition includes several large companies such as, but not limited
to: Abbott Diagnostics, Arkray, Becton Dickenson, Bio-Rad, Copan, Dexcom Inc., Diasorin Inc., Johnson&#160;&amp; Johnson, Roche Diagnostics,
Sebia, Siemens (from the combined acquisitions of Bayer, Dade-Behring and DPC), Thermo Fisher, Tosoh and Werfen.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Research and Development</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Research&#160;and Development (&#8220;R&amp;D&#8221;) carried
out by third parties</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Certain R&amp;D activities of the Group are outsourced to third parties as required.
These activities are carried out in the normal course of business with these companies. The total amount paid to these R&amp;D consultants
and contractors in 2024 was US$4,397,000 (2023: US$226,000). R&amp;D activities carried out by third parties grew in&#160; 2024 as the
Company engaged with external consultants regarding the development of our newly acquired CGM biosensor technology.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Research and Products under Development</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech has research and development groups focusing separately on product
development in haemoglobins, infectious diseases and as a result of 2024 acquisitions, CGM, prostate cancer and pre-eclampsia. These groups
are located in Ireland and the U.S. In addition to in-house activities, Trinity Biotech sub-contracts some research and development from
time to time to independent researchers based in the U.S. and Europe.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Principal Development Projects</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The following table sets forth Trinity Biotech&#8217;s main development projects,
the costs incurred during each period presented and the cumulative costs (before amortization and impairment) incurred as at 31 December
2024:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<table cellspacing="0" cellpadding="0" id="z34ed9e22c5ce4485a4af85c549ffe915" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="text-indent: 7.5pt; line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic; font-weight: bold; text-indent: 9pt"> 2024</div>
        <div style="line-height: 1.25">
        <div style="line-height: 1.25"><span style="line-height: 1.25"> </span></div>
        <div style="text-align: center; line-height: 1.25; text-indent: 9pt"> </div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic; font-weight: bold; text-indent: 9pt">2023</div>
        <div style="line-height: 1.25">
        <div style="line-height: 1.25"><span style="line-height: 1.25"> </span></div>
        <div style="text-align: center; line-height: 1.25; text-indent: 9pt"> </div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic; font-weight: bold; text-indent: 9pt">Total project<br/> costs
        to<br/> December 31,<br/> 2024<sup style="font-family: Times New Roman Bold, serif; vertical-align: text-top; line-height: 1; font-size: smaller">1</sup></div>
        <div style="line-height: 1.25">
        <div style="line-height: 1.25"><span style="line-height: 1.25"> </span></div>
        <div style="text-align: center; line-height: 1.25; text-indent: 9pt"> </div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="margin-right: 236.35pt; line-height: 1.25; font-family: Times New Roman,Times,serif"><span style="font-weight: bold; font-style: italic">Product
        Name </span><br/> </div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic; font-weight: bold">US$&#8217;000</div>
        <div style="line-height: 1.25">
        <div style="line-height: 1.25"><span style="line-height: 1.25"> </span></div>
        <div style="text-align: center; line-height: 1.25; text-indent: 9pt"> </div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic; font-weight: bold">US$&#8217;000</div>
        <div style="line-height: 1.25">
        <div style="line-height: 1.25"><span style="line-height: 1.25"> </span></div>
        <div style="text-align: center; line-height: 1.25; text-indent: 9pt"> </div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic; font-weight: bold; text-indent: 9pt">US$&#8217;000</div>
        <div style="line-height: 1.25">
        <div style="line-height: 1.25"><span style="line-height: 1.25"> </span></div>
        <div style="text-align: center; line-height: 1.25; text-indent: 9pt"> </div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Premier Instruments for A1c and haemoglobinopathies testing</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,542</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,669</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">41,039</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 64%">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Continuous Glucose Monitoring</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">7,040</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">7,040</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  </table> </div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">&#185; Cumulative costs to December 31,
2024 is shown before deduction of amortization and impairment losses. Cumulative costs exclude amounts recognised as part of business
combinations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The costs in the preceding table mainly comprise the cost of internal resources, such
as the payroll costs for the development teams and attributable overheads. The remainder mainly comprises materials, consumables, regulatory
trial and third-party consultant costs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">There are inherent risks and uncertainties associated with completing development
projects on schedule. In the experience of Trinity Biotech, the main risks to the achievement of a project&#8217;s planned completion
date occur primarily during the product&#8217;s verification and validation phase. During these phases the product must attain successful
results from in-house product testing and from third-party clinical trials. Obtaining regulatory approval on a timely basis is another
variable in achieving a project&#8217;s planned completion date.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">42</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Some aspects of the development of a new product are outside of the control of Trinity
Biotech. Notwithstanding the uncertainty surrounding these external factors, Trinity Biotech believes the planned completion dates of
these projects are realistic and achievable. As the manufacturing lead time for these new products is relatively short, it is anticipated
that material cash inflows will commence shortly after each of the project&#8217;s planned completion date.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The following is a description of the principal projects which are currently being
undertaken by the research and development groups within Trinity Biotech:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Haemoglobin Development</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Premier Hb9210 Instrument for Haemoglobin A1c Testing</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">A product development plan focused on improvements in our flagship Premier 9210 instrument
is ongoing. The package of changes aims to expand the target market, reduce instrument downtime and service cost, and significantly expand
operating margins.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Our program to develop an improved, backward compatible column Diabetes HbA1c column
system is now complete. The results of this development program have exceeded expectations, with our new column system now delivering
up to four times the number of injections compared to the existing product. We are continuing the commercial launch of these new products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Premier Resolution Instrument for Haemoglobin Variant Testing</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We developed the Premier Resolution instrument which is utilised for haemoglobin variant
testing. The instrument achieved 510(k) approval from the FDA in August 2023. The instrument has been sold in certain international markets
outside of the U.S. for many years.&#160; Premier Resolution continues to be enhanced with unique features such as lot specific gradients,
an optimised internally designed column with extended column life, and a rapidly expanding on-board variant library.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 1pt/1.25 Times New Roman, serif; text-align: justify">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Point-of-care Development</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div> </div>

<div style="text-align: justify; line-height: 1.25">A combination HIV/Syphilis point-of-care rapid test is also being developed using
our existing lateral flow format, we expect this project to restart in 2025.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">Continuous Glucose Monitoring</span>&#160;<span style="font-weight: bold">Development</span></div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In January 2024, we acquired the biosensor and CGM assets of Waveform. We are currently
redeveloping the acquired CGM technology.&#160; The development work performed to date has focused on improving device performance and
usability by refining the sensor design and redesigning the hardware and user workflow.&#160; Clinical trials with modified sensors performed
in 2024 demonstrated significant improvements in signal quality, sensor accuracy and performance in the clinically important hypoglycemic
range.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">We have hired a number of research and development personnel and have engaged internationally
recognised and reputable development consulting organisations to augment our internal CGM development function. We expect to continue
to add to our biosensor and CGM research and development functions over time.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Patents and Licences</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Patents</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Due to the significant cost of putting patents in place for our wide range of products,
many of our tests are not protected by specific patents. However, we believe that substantially all our tests are protected by proprietary
know-how, manufacturing techniques and trade secrets.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">43</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">As part of the Waveform asset acquisition, we acquired a CGM patent portfolio that
includes numerous issued and pending patent applications in the U.S. and other parts of the world. We believe these patents to be of significant
importance in establishing and protecting our proprietary rights in relation to our CGM business. Since the acquisition, one additional
European patent has been granted, and a number of new provisional patent applications have been filed to protect novel inventions arising
from the development programme.</div>

<div style="text-align: justify; line-height: 1.25">&#160;

<div style="line-height: 1.25">From time-to-time, certain companies have asserted exclusive patent, copyright and other intellectual property
rights to technologies that are important to the industry in which we operate. If any of such claims relate to our planned products, we
intend to evaluate such claims and, if appropriate, seek a licence to use the protected technology. There can be no assurance that we
would be able to obtain licences to use such technology or, obtain such licences on satisfactory commercial terms. If we or our suppliers
are unable to obtain or maintain a licence to any such protected technology that might be used in our products, we could be prohibited
from marketing such products. We could also incur substantial costs to redesign our products or to defend any legal action taken against
us. If Trinity Biotech&#8217;s products should be found to infringe protected technology, we could also be required to pay damages to
the infringed party.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Licences</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We have entered into a number of licensing arrangements including the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9c995ceee7a74ec0a775b8493a606362" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Immco entered into a licence agreement on January 19, 2012, and subsequently an amended licence agreement on June 14, 2018. The licence
        pertains to any product or service relating to identifying indicators of Sjogren&#8217;s disease. The agreement is effective through January
        21, 2036 and is worldwide in scope. Royalties are payable based on agreement in place.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5f43f91343dc4353847dff6711cb8b69" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>In 2013, we entered into a licence agreement with a leading market participant, giving us a non-exclusive, worldwide licence to access
        a significant HIV-2 patent portfolio for the purpose of making, using and selling a HIV test kit, subject to certain limitations.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za0aef503d5f74e26a30604d965526df4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>On December&#160;19, 1999, we obtained a non-exclusive commercial licence from the National Institutes of Health (&#8220;NIH&#8221;)
        in the United States for NIH patents relating to the general method of producing HIV-1 in cell culture and methods of serological detection
        of antibodies to HIV-1.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Each of the licensing arrangements disclosed under this subheading terminates on the
date expiration or adjudication of invalidity or unenforceability of the last of the particular licenced patents covered by the respective
agreement. Each licensor has the right to terminate the arrangement in the event of our non-performance. The key licensing arrangements,
apart from the agreement entered into in 2013 which provides for the payment of a lump sum licence fee, require us to pay a royalty to
the licence holder based on sales of the products which utilise the relevant technology being licenced. The total amount paid by us under
key licensing arrangements in 2024 was US$142,000 (2023: US$210,000).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We acquired CGM technology from Waveform in January 2024. This technology has been
developed over many years and Waveform has granted a perpetual, worldwide, non-exclusive license to Dexcom, Inc. and its affiliates, for
some of the patents acquired by us, but to which we retain the right to use and exploit.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Government Regulation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The research, development, preclinical and clinical testing, as well as the manufacture,
labelling, marketing, sales, record-keeping, advertising, distribution, and promotion of Trinity Biotech&#8217;s products are subject
to extensive and rigorous government regulation in the United States and in other countries in which Trinity Biotech&#8217;s products
are sought to be marketed.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The process of obtaining authorisation to market our products varies, depending on
the product categorisation and the country, from merely notifying the authorities of intent to sell, to lengthy formal approval procedures
which often require detailed laboratory and clinical testing and other costly and time-consuming processes.&#160; The main regulatory
bodies which require extensive clinical testing are the FDA in the United States, the Health Products Regulatory Authority (as the authority
over Trinity Biotech in Europe), the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom and Health Canada.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">The process in each country varies considerably depending on the nature of the test, the perceived risk
to the user and patient, the facility at which the test is to be used and other factors.&#160; 49% of Trinity Biotech&#8217;s 2024 revenues
were generated in the Americas (with a large concentration of this in the United States) and as the United States represents a substantial
proportion of the worldwide diagnostics market, an overview of FDA regulation has been included below.&#160; <br/> </div> </div>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">44</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Food and Drug Administration</span>&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Many of our products sold in the United States are medical devices subject to the
Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;), as implemented and enforced by the U.S. Food and Drug Administration (&#8220;FDA&#8221;).
Certain products sold in the United States require FDA clearance to market under Section 510(k) of the FDCA.&#160; Other products sold
in the United States require premarket approval (&#8220;PMA&#8221;) to market.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Failure by us or by our suppliers to comply with applicable regulatory requirements
can result in enforcement action by the FDA or other regulatory authorities, which may result in sanctions including, but not limited
to:&#160;&#160;</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="za31cb5bd836840ffb2d3862f56efca8a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties;&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z88014e808da34962ae5a167b414a877f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>unanticipated expenditures to address or defend such actions;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z6bb5e45505b04508b2993e09ada9a1cb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>customer notifications for repair, replacement, refunds;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z2c2583e0b76d4409833662a1c91e5a75" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>recall, detention or seizure of our products;&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z732dbed47fe04b3e8c0a50a04d9a34fd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>operating restrictions or partial suspension or total shutdown of production;&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zd087237303f8490bb3c957d9def177de" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>refusing or delaying our requests for 510(k) clearance or premarket approval of new products or modified products;&#160;&#160;</div>
        </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z9be7ed5225e643d6810be09e7cdf0172" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>operating restrictions;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zbe1882f06b824dfaa067896450ebbed8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>withdrawing 510(k) clearances or PMA approvals that have already been granted;&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zf086c2fb8f9b41349ac685eab0019dff" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>refusal to grant export approval for our products; or&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z9ca4d2b197b14587a3bbb2af16a77dd9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>criminal prosecution.&#160;&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The FDA governs the following activities that we perform or that are performed on
our behalf, to ensure that medical products distributed domestically or exported internationally are safe and effective for their intended
uses:&#160;&#160;</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z5423cde9d3474540a2a416734d91eb35" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>product design, development and manufacture;&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="za39a36000c794954b0e1f5e2e9505891" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>product safety, testing, labelling and storage;&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zf4f8a1154fea426a9d09c2c745ee3a1b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>record keeping procedures;&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="ze7b2ce867de74f18b692c512d8338841" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>product marketing, sales and distribution; and&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z9c903bfa73224ba2a02bd5d6579a8bfc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>post-marketing surveillance, complaint handling, medical device reporting, reporting of deaths, serious injuries or device malfunctions
        and repair or recall of products.&#160;&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">FDA premarket clearance and approval requirements&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Access to U.S. Market.</span>&#160; Each medical
device that Trinity Biotech may wish to commercially distribute in the U.S. will require either pre-market notification (more commonly
known as 510(k)) clearance or approval of a pre-market approval (&#8220;PMA&#8221;) application prior to commercial distribution, unless
specifically exempt.&#160; Under the FDCA, medical devices are classified into one of three classes -- Class I, Class II or Class III
-- depending on the degree of risk associated with each medical device and the extent of control needed to ensure safety and effectiveness.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Class I devices are those for which safety and effectiveness can be assured by adherence
to FDA&#8217;s general regulatory controls for medical devices, which include compliance with the applicable portions of the FDA's Quality
System Regulation ("QSR"), facility registration and product listing, reporting of adverse medical events, and appropriate, truthful and
non-misleading labelling, advertising, and promotional materials (the &#8220;General Controls&#8221;).&#160; Some Class I devices also
require premarket clearance by the FDA through the 510(k) premarket notification process described below.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Class II devices are subject to FDA&#8217;s general controls, and any other special
controls as deemed necessary by FDA to ensure the safety and effectiveness of the device.&#160; Premarket review and clearance by the
FDA for Class II devices is accomplished through the 510(k) premarket notification process.&#160; Unless a specific exemption applies,
510(k) premarket notification submissions are subject to user fees.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">45</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Devices deemed by the FDA to pose the greatest risk, such as life sustaining, life-supporting
or implantable devices, or devices deemed not substantially equivalent to a previously 510(k)-cleared device are categorised as Class
III, requiring approval of a PMA.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">510(k) Clearance Pathway.</span>&#160; When a 510(k)
clearance is required, Trinity Biotech must submit a pre-market notification demonstrating that the proposed device is substantially equivalent
to a previously cleared 510(k) device, a device that was in commercial distribution before May 28, 1976 for which the U.S. Food and Drug
Administration has not yet called for the submission of pre-market approval applications, or is a device that has been reclassified from
Class III to either Class II or I.&#160; By regulation, the FDA is required to clear or deny a 510(k) premarket notification within 90
days of submission of the application. As a practical matter, clearance may take longer. As a practical matter, the FDA&#8217;s 510(k)
clearance pathway usually takes from 3 to 12 months, but it can take longer, and clearance is never assured.&#160; Although many 510(k)
pre-market notifications are cleared without clinical data, in some cases, the U.S. Food and Drug Administration requires significant
clinical data to support substantial equivalence.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In reviewing a pre-market notification, the FDA may request additional information,
including clinical data, which may significantly prolong the review process.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">After a device receives 510(k) clearance, any modification that could significantly
affect its safety or effectiveness, or that would constitute a major change in its intended use, requires a new 510(k) clearance or could
even require a PMA approval, if the change raises complex or novel scientific issues or the product has a new intended use. The FDA requires
each manufacturer to make this determination initially, but the FDA may review any such decision and may disagree with a manufacturer&#8217;s
determination.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">If the FDA disagrees with a manufacturer&#8217;s determination, the FDA may require
the manufacturer to cease marketing and/or recall the modified device until 510(k) clearance or pre-market approval is obtained.&#160;
We have modified aspects of some of our devices since receiving regulatory clearance.&#160; Some of those modifications we believe could
not significantly affect the safety or efficacy of the device, and therefore, we believe new 510(k) clearances or pre-market approvals
are not required.&#160; We have also obtained new 510(k) clearances from the FDA for other modifications to our devices.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In the future, we may make additional modifications to our products after they have
received FDA clearance or approval, and in appropriate circumstances, determine that new clearance or approval is unnecessary.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">However, the FDA may disagree with our determination and if the FDA requires us to
seek 510(k) clearance or pre-market approval for any modifications to a previously cleared product, we may be required to cease marketing
or recall the modified device until we obtain the required clearance or approval.&#160; Under these circumstances, we may also be subject
to significant regulatory fines or other penalties.&#160; In addition, the FDA continues to evaluate the 510(k) process and may make substantial
changes to industry requirements, including which devices are eligible for 510(k) clearance, the ability to rescind previously granted
510(k)s and additional requirements that may significantly impact the process.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">PMA Approval Pathway</span>.&#160; A device that
does not qualify for 510(k) clearance generally will be placed in Class III and required to obtain PMA approval, which requires proof
of the safety and effectiveness of the device to the FDA&#8217;s satisfaction for its intended use.&#160; A PMA application must provide
extensive technical, preclinical and clinical trial data and also information about the device and its components regarding, among other
things, device design, manufacturing and labelling.&#160; In addition, an advisory panel made up of clinicians and/or other appropriate
experts from outside the FDA is typically convened to evaluate the application and make recommendations to the FDA as to whether the device
should be approved.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Although the FDA is not bound by the advisory panel decision, the panel&#8217;s recommendation
is important to the FDA&#8217;s overall decision making process.&#160; The PMA approval pathway is more costly, lengthy and uncertain
than the 510(k) clearance process.&#160; After a premarket approval application is sufficiently complete, the FDA will accept the application
and begin an in-depth review of the submitted information.&#160; By statute, the FDA has 180 days to review the &#8220;accepted application&#8221;,
although, generally, review of the application can take between one and three years, but it may take significantly longer. During this
review period, the FDA may request additional information or clarification of information already provided.&#160; In addition, the FDA
will conduct a pre-approval inspection of the manufacturing facility to ensure compliance with Quality System Regulation, which imposes
elaborate design development, testing, control, documentation and other quality assurance procedures in the design and manufacturing process.&#160;
In February 2022, FDA published proposed regulation to update the Quality System Regulation to incorporate the international standard
specific for medical device quality management systems (ISO 13485).&#160; If finalized, the quality management system requirements for
FDA-regulated devices would be harmonized with the ISO 13485 standards. The FDA issued the Quality Management System Regulation (QMSR)
Final Rule to amend the device current good manufacturing practice (CGMP) requirements of the Quality System (QS) regulation (21 CFR Part
820), incorporating by reference the international standard specific for medical device quality management systems set by the International
Organization for Standardization (ISO), ISO 13485:2016 Medical devices &#8211; Quality management systems &#8211; Requirements for regulatory
purposes.&#160; This final rule is the latest action taken by the FDA to promote consistency in the regulation of devices. This action
will harmonize the FDA&#8217;s CGMP regulatory framework with that used by other regulatory authorities.&#160;</div>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">46</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">The rule is effective February 2, 2026, two years after publication. Until then, manufacturers
are required to comply with the QS regulation.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">After approval of a PMA, a new PMA or PMA supplement is required in the event of a
modification to the device, its labelling or its manufacturing process.&#160; The FDA imposes substantial user fees for the submission
and review of PMA applications.&#160; The FDA may approve a PMA application with post-approval conditions intended to ensure the safety
and effectiveness of the device including, among other things, restrictions on labelling, promotion, sale and distribution and collection
of long-term follow-up data from patients in the clinical study that supported approval. Failure to comply with the conditions of approval
can result in materially adverse enforcement action, including the loss or withdrawal of the approval.&#160; New PMA applications or PMA
supplements are required for significant modifications to the manufacturing process, labelling of the product and design of a device that
is approved through the PMA process.&#160; PMA supplements often require submission of the same type of information as the original PMA
application, except that the supplement is limited to information needed to support any changes from the device covered by the original
PMA application and may not require as extensive clinical data or the convening of an advisory panel.&#160;</div>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Clinical Studies</span>&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Devices that have not received FDA approval or clearance and are used in clinical
trials are considered to be and must be labelled as investigational devices.&#160; FDA regulates these products under the IDE regulations
(See 21 C.F.R. &#167; 812).&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Per the IDE regulations, clinical studies that involve investigational devices are
divided into two categories, based on the type of device.&#160; Studies of devices considered by the agency to present a significant risk
require prior approval by an Institutional Review Board (&#8220;IRB&#8221;), informed consent of patients, and FDA approval of an IDE
application, which details in part the clinical study protocol, pursuant to 21 C.F.R. &#167; 812.&#160; A significant risk device study
is defined as a study of a device that presents a potential for serious risk to the health, safety, or welfare of a subject and falls
into at least one of the following categories: (1) it is intended as an implant; (2) it is used in supporting or sustaining human life;
(3) it is of substantial importance in diagnosing, curing, mitigating or treating a disease, or otherwise prevents impairment of human
health; or (4) it otherwise presents a potential for serious risk to the health, safety, or welfare of a subject.&#160; See 21 C.F.R.
812.3(m).&#160; Studies of non-significant risk investigational devices require IRB approval and informed consent; however, the sponsor
of the study does not have to obtain FDA approval of an IDE application before beginning the study.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Most clinical studies of IVDs (all of which technically involve investigational use
only (&#8220;IUO&#8221;) devices) are exempted from the IDE regulation, so long as the IUO device and the study meet certain regulatory
criteria.&#160; Specifically, devices are exempt from IDE requirements if they are intended for IUO and:&#160;</div>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z808ddce434924a89a279a2ccf6e850e1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="text-align: justify; line-height: 1.25">Are non-invasive;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9a39b12c95d74fdab02b0018bc3170a7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="text-align: justify; line-height: 1.25">Do not require an invasive sampling procedure that poses a significant risk;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze2fcb5a80d5b439c99e43c21f9b4719f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="text-align: justify; line-height: 1.25">Do not introduce energy into a subject by design or intention;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z81ca9beef59c49c38713d653e91493ed" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="text-align: justify; line-height: 1.25">Are not to be used as a diagnostic procedure without confirmation of the diagnosis
        by another medically established diagnostic product or procedure; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z05b2895e9760442592a8cd87fa860b8b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 18pt">&#160;</td>
    <td style="text-align: right; vertical-align: top; width: 18pt">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="text-align: justify; line-height: 1.25">Comply with the labelling requirements for IUO devices, as outlined in 21 C.F.R. &#167;
        812.2(c)(3).</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">&#160;If an IUO device does not meet all the requirements for exemption, studies involving
that IUO device would be subject to the IDE regulations.&#160; The majority of our products are exempt from the IDE regulation.&#160;
However, we are required to have IRB approval prior to and during our clinical trials and must obtain informed consent from study participants.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">47</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Post-market Regulation&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">After the FDA permits a device to enter commercial distribution, numerous regulatory
requirements apply. These include:&#160;&#160;</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zebedf7d4e5e5414eb34dd464c8e73422" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>product listing and establishment registration, which helps facilitate FDA inspections and other regulatory action;&#160;</div> </td>
        </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z4e49fdddce9645f8a1abae3385d119f7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Quality System Regulation, (&#8220;QSR&#8221;), which requires manufacturers, including third-party manufacturers, to follow stringent
        design, testing, control, documentation and other quality assurance procedures during all aspects of the manufacturing process;&#160;&#160;</div>
        </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z48856907f78549d8bab7e918298d39ae" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>labelling regulations and FDA prohibitions against the promotion of products for uncleared, unapproved or off-label use or indication;&#160;&#160;</div>
        </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z1b10943a2981462695fe514260333a6c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>clearance of product modifications that could significantly affect safety or efficacy or that would constitute a major change in
        intended use of one of our cleared devices;&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zf00d3b6055624171843a6d1ecbbd2a45" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>approval of product modifications that affect the safety or effectiveness of one of our approved devices;&#160;&#160;</div> </td>
        </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z2573bf55cf7a490f93ed3cd1e87b6de2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>medical device reporting regulations, which require that manufacturers comply with FDA requirements to report if their device may
        have caused or contributed to a death or serious injury, or has malfunctioned in a way that would likely cause or contribute to a death
        or serious injury if the malfunction of the device or a similar device were to recur;&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z8cd8810d31ba4b7289eaff5b1b8fafa1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>post-approval restrictions or conditions, including post-approval study commitments;&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z7def79abddea4b749f5b691ead6818ea" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>post-market surveillance regulations, which apply when necessary to protect the public health or to provide additional safety and
        effectiveness data for the device;&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z2bf0abce288744c7a32f870eeedfb116" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the FDA's recall authority, whereby it can ask, or under certain conditions order, device manufacturers to recall from the market
        a product that is in violation of governing laws and regulations;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z543a5c5398824a3c8fa2d6a559973349" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>regulations pertaining to voluntary recalls; and&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z788990c3750b45f6a414c5df01baabcc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>notices of corrections or removals.&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We have registered our facilities with the FDA as medical device manufacturers. The
FDA has broad post-market and regulatory enforcement powers. We are subject to announced and unannounced inspections by the FDA to determine
our compliance with the QSR and other regulations and these inspections may include the manufacturing facilities of our suppliers. In
2017, the FDA closed its pilot program for MDSAP (Medical Device Single Audit Program) and began accepting third party inspection reports
from approved Auditing Organizations in lieu of conducting its own routine surveillance inspections. MDSAP audits are paid by the manufacturer
and conducted annually. The FDA receives and reviews the MDSAP report and may respond to the manufacturer with its own inspection if it
deems the facility is not in control. If the FDA finds any failure to comply, the agency can institute a wide variety of enforcement actions,
ranging from a public warning letter to more severe sanctions such as fines, injunctions, and civil penalties; recall or seizure of products;
the issuance of public notices or warnings; operating restrictions, partial suspension or total shutdown of production; refusing requests
for 510(k) clearance or PMA approval of new products; withdrawing 510(k) clearance or PMA approvals already granted; and criminal prosecution.&#160;&#160;&#160;</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Advertising and promotion of medical devices, in addition to being regulated by the
FDA, are also regulated by the Federal Trade Commission and by state regulatory and enforcement authorities. Recently, promotional activities
for FDA-regulated products of other companies have been the subject of enforcement action brought under healthcare reimbursement laws
and consumer protection statutes. In addition, under the federal Lanham Act and similar state laws, competitors and others can initiate
litigation relating to advertising claims. If the FDA determines that our promotional materials or training constitutes promotion of an
unapproved use, it could request that we modify our training or promotional materials or subject us to regulatory or enforcement actions,
including the issuance of an untitled letter, a warning letter, injunction, seizure, civil fine or criminal penalties.&#160; It is also
possible that other federal, state or foreign enforcement authorities might take action if they consider our promotional or training materials
to constitute promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities,
such as laws prohibiting false claims for reimbursement.&#160; In that event, our reputation could be damaged and adoption of the products
would be impaired. &#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Furthermore, our products could be subject to voluntary recall if we or the FDA determine,
for any reason, that our products pose a risk of injury or are otherwise defective.&#160; Moreover, the FDA can order a mandatory recall
if there is a reasonable probability that our device would cause serious adverse health consequences or death.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">48</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Unanticipated changes in existing regulatory requirements or adoption of new requirements
could have a material adverse effect on the Group.&#160; Any failure to comply with applicable QSR or other regulatory requirements could
have a material adverse effect on the Group&#8217;s revenues, earnings and financial standing.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">There can be no assurances that the Group will not be required to incur significant
costs to comply with laws and regulations in the future or that laws or regulations will not have a material adverse effect upon the Group&#8217;s
revenues, earnings and financial standing.&#160;</div>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Clinical Laboratory Improvement
Amendments of 1988 (&#8220;CLIA&#8221;)</span>&#160;</div>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Purchasers of Trinity Biotech&#8217;s clinical diagnostic products and our reference
laboratory in the United States may be regulated under The Clinical Laboratory Improvements Amendments of 1988 and related federal and
state regulations.&#160; CLIA is intended to ensure the quality and reliability of clinical laboratories in the United States by mandating
specific standards in the areas of personnel qualifications, administration and participation in proficiency testing, patient test management,
quality control, quality assurance and inspections.&#160; The regulations promulgated under CLIA established three levels of diagnostic
tests (&#8220;waived&#8221;, &#8220;moderately complex&#8221; and &#8220;highly complex&#8221;) and the standards applicable to a clinical
laboratory depend on the level of the tests it performs.&#160; Laboratories performing high complexity testing are required to meet more
stringent requirements than laboratories performing less complex tests.&#160; In addition, we and our customers are required to meet certain
laboratory licensing requirements for states with regulations beyond CLIA.&#160; For more information on state licensing requirements,
see the sections entitled &#8220;Government Regulation &#8211; New York Laboratory Licensing&#8221; and &#8220;Government Regulation &#8211;
Other States&#8217; Laboratory Licensing.&#8221;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Under CLIA, a laboratory is any facility that performs laboratory testing on specimens
derived from humans for the purpose of providing information for the diagnosis, prevention or treatment of disease, or the impairment
of or assessment of health.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">CLIA requires that a laboratory hold a certificate applicable to the type of laboratory
examinations it performs and that it complies with, among other things, standards covering operations, personnel, facilities administration,
quality systems and proficiency testing, which are intended to ensure that clinical laboratory testing services are accurate, reliable
and timely.&#160; Laboratories must register and list their tests with the CMS, the agency that oversees CLIA.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">CLIA compliance and certification is also a prerequisite to be eligible to bill for
services provided to governmental payor program beneficiaries and for many private payors.&#160; CLIA is user-fee funded.&#160; Therefore,
all costs of administering the program must be covered by regulated facilities, including certification and survey costs.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">To renew the CLIA certificate for our New York reference laboratory, we are subject
to survey and inspection every two years to assess compliance with program standards. We also may be subject to additional unannounced
inspections. Laboratories performing high complexity testing are required to meet more stringent requirements than laboratories performing
less complex tests.&#160; CLIA requires full validation including accuracy, precision, specificity, sensitivity and establishment of a
reference range for any test used in clinical testing.&#160; The regulatory and compliance standards applicable to the testing we perform
may change over time and any such changes could have a material effect on our business.&#160;&#160;&#160;</div>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold; font-style: italic">Federal Oversight of Laboratory
Developed Tests and Research Use Only Products</span>&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">Trinity Biotech supplies clinical laboratories with raw materials, such as reagent products, that may be
used by clinical laboratories in clinical laboratory tests, which are regulated under CLIA, as well as by applicable state laws. Although
the FDA has statutory authority to assure that medical devices are safe and effective for their intended uses, the FDA has generally exercised
its enforcement discretion and not enforced applicable regulations with respect to laboratory developed tests, or LDTs.&#160; The FDA
defines the term &#8220;laboratory developed test&#8221; as an in vitro diagnostic test that is intended for clinical use and designed,
manufactured and used within a single laboratory. Until 2014, the FDA exercised enforcement discretion such that it did not enforce provisions
of the Food, Drug and Cosmetic Act with respect to LDTs. In July 2014, due to the increased proliferation of LDTs for complex diagnostic
testing, and concerns with several high-risk LDTs related to lack of evidentiary support for claims and erroneous results, the FDA provided
notice that it intended to issue draft guidance to collect information from laboratories regarding their current LDTs and newly developed
LDTs through a notification process. As part of developing this framework, the FDA issued draft guidance in October 2014 that, when finalized,
would adopt a risk-based framework that would increase FDA oversight of LDTs. The FDA proposed to use this information to classify LDTs
and to prioritize enforcement of premarket review requirements for categories of LDTs based on risk, using a public process. Specifically,
FDA planned to use advisory panels to provide recommendations to the agency on LDT risks, classification and prioritization of enforcement
of applicable regulatory requirements on certain categories of LDTs, as appropriate.&#160; FDA issued a discussion paper on LDTs in January
2017 discussing possible approaches to oversight of LDTs.&#160; On May 6, 2024, the FDA issued a final rule aimed at helping to ensure
the safety and effectiveness of laboratory developed tests (LDTs). The rule amended the FDA's regulations to make explicit that in vitro
diagnostic products (IVDs) are devices under the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act) including when the manufacturer of
the IVD is a laboratory.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">The FDA&#8217;s ruling of April 29<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup>,
2024, that significantly enhanced its regulatory authority over laboratory-developed tests (LDTs), which are developed and used within
a single laboratory was overturned on March 31<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">st</sup>, 2025.&#160;
The U.S. District Court for the Eastern District of Texas vacated the FDA's final rule, stating that the FDA exceeded its authority under
the Federal Food, Drug, and Cosmetic Act. This means that, for now, the FDA's new regulations will not go into effect, and laboratories
will not need to obtain FDA clearance to market their LDTs. If the district court&#8217;s decision stands, FDA&#8217;s regulation of LDTs
could be viewed as a legal nullity, as FDA could no longer regulate LDTs as medical devices under the ruling. This may mean that these
LDTs would continue to be marketed solely under the Clinical Laboratories Improvement Act of 1967 (CLIA).</div> </div> </div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">49</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div> </div>

<div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Some products are for research use only (&#8220;RUO&#8221;), or for IUO. RUO and IUO
products are not intended for human clinical use and must be properly labelled in accordance with FDA guidance. Claims for RUOs and IUOs
related to safety, effectiveness, or diagnostic utility or that it is intended for human clinical diagnostic or prognostic use are prohibited.
In November 2013, the FDA issued guidance titled &#8220;Distribution of In Vitro Diagnostic Products Labelled for Research Use Only or
Investigational Use Only - Guidance for Industry and Food and Drug Administration Staff.&#8221; This guidance sets forth the requirements
to utilize such designations, labelling requirements and acceptable distribution practices, among other requirements. Mere placement of
an RUO or IUO label on an in vitro diagnostic product does not render the device exempt from otherwise applicable clearance, approval
or other requirements. The FDA may determine that the device is intended for use in clinical diagnosis based on other evidence, including
how the device is marketed.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We cannot predict the potential effect the FDA&#8217;s current and forthcoming guidance
on LDTs and IUOs/RUOs will have on our reagents, and that we may use in the development of assays in our reference laboratory. We cannot
be certain that the FDA might not promulgate rules or issue guidance documents that could affect our ability to sell these materials to
the market. Should any of the reagents marketed by us be affected by future regulatory actions, our business could be adversely affected
by those actions.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We cannot provide any assurance that FDA regulation, including premarket review, will
not be required in the future for LDTs that rely on our reagents or through our reference laboratory, whether through additional guidance
or regulations issued by the FDA, new enforcement policies adopted by the FDA or new legislation enacted by Congress.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Legislative proposals addressing oversight of LDTs were introduced in recent years
and we expect that new legislative proposals will be introduced from time to time. It is possible that legislation could be enacted into
law or regulations, or guidance could be issued by the FDA which may result in new or increased regulatory requirements.&#160;</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Product Imports/Exports</span>&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Products for export from the United States are subject to foreign countries&#8217;
import requirements and the exporting requirements of the FDA, as applicable. In particular, international sales of medical devices manufactured
in the United States that are not approved or cleared by the FDA for use in the United States, or are banned or deviate from lawful performance
standards, are subject to FDA export requirements.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Foreign countries often require, among other things, an FDA certificate for products
for export, also called a Certificate for Foreign Government (&#8220;CFG&#8221;). To obtain this certificate from the FDA, the device
manufacturer must apply to the FDA. The FDA certifies that the product has been granted clearance or approval in the United States and
that the manufacturing facilities were in compliance with QSR regulations at the time of the last FDA inspection. If the FDA determines
that our facilities or procedures do not comply with the QSR regulations, it may refuse to provide such certificates until we resolve
the issues to the FDA&#8217;s satisfaction. Failure to obtain a CFG could inhibit our ability to export our products to countries that
require such certificates.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Export of products subject to 510(k) notification requirements, but not yet cleared
to market, are permitted without FDA export approval, if statutory requirements are met.&#160; Unapproved products subject to PMA requirements
can be exported to any country without prior FDA approval provided, among other things, they are not contrary to the laws of the destination
country, they are manufactured in substantial compliance with the QSR, and have been granted valid marketing authorisation in Australia,
Canada, Israel, Japan, New Zealand, Switzerland, South Africa or member countries of the European Union or of the European Economic Area
(&#8220;EEA&#8221;).&#160; FDA approval must be obtained for exports of unapproved products subject to PMA requirements if these export
conditions are not met.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">50</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">There can be no assurance that Trinity Biotech will meet statutory requirements and/or
receive required export approval on a timely basis, if at all, for the marketing of its products outside the United States.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Foreign Corrupt Practices Act and Other Anti-Corruption Laws&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;), to which we are subject,
prohibits corporations and individuals from engaging in bribery and corruption when dealing with foreign government officials and foreign
political parties. It is illegal to corruptly offer, pay, promise, or authorize the giving of anything of value to any officer or employee
of a foreign government or public international organization, political party, political party official, or political candidate, in an
attempt to obtain or retain business or to otherwise improperly influence a person working in an official capacity on behalf of a foreign
government or public international organization. Our present and future business has and will continue to be subject to the FCPA and various
other laws, rules and/or regulations applicable to us as a result of our international sales. We also are subject to the FCPA&#8217;s
accounting provisions, which require us to keep accurate books and records and to maintain a system of internal accounting controls sufficient
to assure management&#8217;s control, authority, and responsibility over the company's assets. The failure to comply with the FCPA and
similar laws could result in civil or criminal sanctions or other adverse consequences.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The laws to which we are subject as a result of our international sales also include
the U.K. Bribery Act (the &#8220;Bribery Act&#8221;), which proscribes giving and receiving bribes in the public and private sectors,
bribing a foreign public official, and failing to have adequate procedures to prevent employees and other agents from giving bribes. U.S.
companies that conduct business in the United Kingdom generally will be subject to the Bribery Act. Penalties under the Bribery Act include
potentially unlimited fines for companies and criminal sanctions for corporate officers under certain circumstances.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Healthcare Reform</span>&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Protecting Access to Medicare Act of 2014 (&#8220;PAMA&#8221;), which was signed
into law on April 1, 2014, significantly alters the current payment methodology under the Medicare Clinical Laboratory Fee Schedule, or
CLFS. Under PAMA, beginning January 1, 2016, clinical laboratories must report laboratory test contracted payment data for each Medicare-covered
clinical diagnostic laboratory test that it furnishes during a time period to be defined by future regulations, which we expect will cover
the previous 12 months. The reported data must include the payment rate (reflecting all discounts, rebates, coupons and other price concessions)
and the volume of each test that was paid by each contracted private payor (including health insurance issuers, group health plans, Medicare
Advantage plans and Medicaid managed care organisations). Beginning in 2017, the Medicare payment rate for each clinical diagnostic lab
test is equal to the weighted median amount for the test from the most recent data collection period.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Other recent laws make changes impacting clinical laboratories, many of which have
already gone into effect.&#160; The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation
Act, collectively, the Affordable Care Act (&#8220;ACA&#8221;), enacted in March 2010, among other things:&#160;</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z595db6294591424da244338446b32a5c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>includes a reduction in the annual update factor used to adjust payments under the CLFS for inflation. This update factor reflects
        the consumer price index for all urban consumers, or CPI-U, and the ACA reduces the CPI-U by 1.75% for the years 2011 through 2015.&#160;
        The Affordable Care Act also imposes a multifactor productivity adjustment in addition to the CPI-U, which may further reduce payment
        rates;&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z90cc97feeb4245268ec5c15af134f6d5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>requires certain medical device manufacturers to pay an excise tax in an amount equal to 2.3% of the price for which such manufacturer
        sells its medical devices that are listed with the FDA; and&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z0022236d0544458fa1eff588ae5d8236" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>requires the coordination and promotion of research on comparative clinical effectiveness of different technologies and procedures,
        initiatives to revise Medicare payment methodologies, such as bundling of payments across the continuum of care by providers and clinicians
        and initiatives to promote quality indicators in payment methodologies.&#160;&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Budget Control Act of 2011, among other things, created measures for spending
reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least
$1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic
reduction (known as sequestration) to several government programs. This included aggregate reductions to Medicare payments to providers
of 2% per fiscal year, which went into effect on April 1, 2013 and, due to subsequent legislative amendments to the statute, will remain
in effect through 2024 unless additional Congressional action is taken.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">51</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Further, in February 2012, the Middle Class Tax Relief and Job Creation Act of 2012
was passed, which, among other things, reduced by 2% the 2013 Medicare CLFS and rebased payments at the reduced rate for subsequent years.
Overall, when adding this 2% reduction to the ACA&#8217;s 1.75% reduction to the update factor and the productivity adjustment, the payment
rates under the CLFS declined by 2.95% and 0.75% for 2013 and 2014, respectively.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">This reduction does not include the additional sequestration adjustment.&#160; Lastly,
on January 2, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, increased the statute of
limitations period for the government to recover overpayments to providers from three to five years.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">State and Federal Privacy and Security Laws&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Under the federal Health Insurance Portability and Accountability Act of 1996, as
amended by the Health Information Technology for Economic and Clinical Health Act, or collectively, HIPAA, the U.S. Department of Health
and Human Services (&#8220;HHS&#8221;), has issued regulations to protect the privacy and security of individually identifiable health
information, also known as protected health information (&#8220;PHI&#8221;), held, used or disclosed by health care providers, such as
our reference laboratory, and other covered entities.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">HIPAA also regulates standardisation of data content, codes and formats used in certain
electronic health care transactions and standardisation of identifiers for health plans and providers. HIPAA also governs patient access
to laboratory test reports. Effective October 6, 2014, individuals (or their personal representatives, as applicable) have the right to
access test reports directly from laboratories and to direct that copies of those reports be transmitted to persons or entities designated
by the individual.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">HIPAA&#8217;s Security Rule and certain provisions of the HIPAA Privacy Rule and Breach
Notification Rule apply to business associates of covered entities (i.e., entities that provide services to covered entities that may
require access and use of protected health information on behalf of covered entities), and business associates are subject to direct liability
for violation of these rules. In addition, a covered entity may be subject to criminal and civil penalties as a result of a business associate
violating HIPAA, if the business associate is found to be an agent of the covered entity. Covered entities must report breaches of unsecured
protected health information to affected individuals without unreasonable delay and notification must also be made to the U.S. Department
of Health &amp; Human Services, Office for Civil Rights (OCR) and, in certain situations involving large breaches, to the media. The OCR
enforces the HIPAA Rules and performs compliance audits and investigations. In addition to enforcement by OCR, HIPAA authorizes state
attorneys general to bring civil actions seeking either injunction or damages in response to HIPAA violations that impact state residents.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In addition to federal privacy regulations, there are a number of state laws governing
the privacy, confidentiality and security of individually identifiable health information and other personal information that are applicable
to our business.&#160; Where these state laws are stricter than the requirements imposed by HIPAA or impose different or additional requirements
than HIPAA, we may be subject to additional restrictions and liability above and beyond HIPAA&#8217;s requirements.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">There are numerous other laws, regulations and legislative and regulatory initiatives
at the federal and state levels addressing privacy and security of personal information. We also remain subject to federal and state privacy-related
laws that may be more restrictive or contain different requirements than the privacy regulations issued under HIPAA. These laws vary and
could impose additional penalties. For example, the Federal Trade Commission, or FTC, uses its consumer protection authority to initiate
enforcement actions against companies relating to their use and disclosure of personally identifiable information. Specifically, FTC has
asserted authority and issued enforcement actions in response to actual or perceived unfair or deceptive practices by a company in the
handling of consumer information. The FTC has also pursued enforcement actions against companies for violations of its Health Breach Notification
Rule and the Children&#8217;s Online Privacy Protection Act. Our use of personal information is also subject to our published privacy
policies and notices.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The laws governing privacy and security of health information and other personal information
are rapidly changing and new laws governing privacy and security may be adopted in the future as well. We can provide no assurance that
we are or will remain in compliance with diverse privacy and security requirements in all of the jurisdictions in which we do business
or process personal information, or in which our patients reside, or that we will be able to keep up with the cost of complying with new
or additional requirements. Failure to comply with privacy and security requirements could result in damage to our reputation, adversely
affect customer or investor confidence in us and reduce the demand for our services from existing and potential customers. In addition,
we could face litigation, penalties and regulatory actions including civil or criminal penalties and significant costs for compliance
with new or changing requirements, all of which could generate negative publicity and which could have a materially adverse effect on
our business.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">52</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Federal and State Anti-Kickback Laws&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Federal Anti-Kickback Statute makes it a felony for a person or entity, including
a laboratory, to knowingly and wilfully offer, pay, solicit or receive any remuneration, directly or indirectly, to induce or in return
for either the referral of an individual or the purchase, lease or order, or arranging for the purchase, lease or order, of items, services
or other business that is reimbursable under any federal health care program, including Medicare and Medicaid.&#160; Courts have stated
that an arrangement may violate the Anti-Kickback Statute if any one purpose of the arrangement is to encourage patient referrals or other
federal health care program business, regardless of whether there are other legitimate purposes for the arrangement.&#160; In addition,
a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a
violation. The definition of "remuneration" has been broadly interpreted to include anything of value, including for example, gifts, discounts,
the furnishing of supplies or equipment, credit arrangements, payments of cash, waivers of payments, ownership interests and providing
anything at less than its fair market value. The Anti-Kickback Statute is broad and prohibits many arrangements and practices that are
lawful in businesses outside of the healthcare industry.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Recognising that the Anti-Kickback Statute may technically prohibit innocuous or beneficial
arrangements within the healthcare industry, HHS has issued a series of regulatory safe harbours.&#160; Although full compliance with
these safe harbours protects health care providers and other parties against prosecution under the federal Anti-Kickback Statute, the
failure of a transaction or arrangement to fit within a specific safe harbour does not necessarily mean that the transaction or arrangement
is illegal or that prosecution under the federal Anti-Kickback Statute will be pursued. Instead, the legality of the arrangement will
be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances.&#160; Penalties for the Federal
Anti-Kickback Statute violations are severe and include imprisonment, criminal fines, civil money penalties and exclusion from participation
in federal health care programs.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Federal and state law enforcement authorities scrutinise arrangements between health
care entities or providers and potential referral sources to ensure that the arrangements are not designed as a mechanism to induce patient
care referrals or induce the purchase or prescribing of particular products or services.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The law enforcement authorities, the Courts and Congress have also demonstrated a
willingness to look behind the formalities of a transaction to determine the underlying purpose of payments between health care providers
or entities and actual or potential referral sources.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Many states have also adopted statutes similar to the federal Anti-Kickback Statute,
some of which apply to payments in connection with the referral of patients for healthcare items or services reimbursed by any source,
not only governmental payor programs.&#160; There can be no assurance that our relationships with physicians, hospitals, clinical laboratories
and other customers will not be subject to investigation or challenge under such laws.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Physician Self-Referral Prohibitions&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In addition to the Anti-Kickback Statute, a federal law directed at physician "self-referral,"
commonly known as the Stark Law, prohibits, among other things, physicians who personally or through an immediate family member, have
a financial relationship, including an investment, ownership or compensation relationship with an entity, including clinical laboratories,
from referring Medicare patients to that entity for designated health services, which include clinical laboratory services, unless an
exception applies. In addition, the clinical laboratory is prohibited from billing for any tests performed pursuant to a prohibited referral.&#160;
Recent Court cases have extended the Stark law's prohibition to referral of Medicaid patients as well.&#160; A person who engages in a
scheme to circumvent the Stark Law's referral prohibition may be fined up to US$100,000 for each such arrangement or scheme. In addition,
any person who presents or causes to be presented a claim to the Medicare or Medicaid programs in violation of the Stark Law is subject
to civil monetary penalties of up to US$15,000 per bill submission, an assessment of up to three times the amount claimed and possible
exclusion from participation in federal governmental payor programs. Bills submitted in violation of the Stark Law may not be paid by
Medicare or Medicaid and any person collecting any amounts with respect to any such prohibited bill is obligated to refund such amounts.
Many states also have anti- "self-referral" and other laws that are not limited to Medicare and Medicaid referrals.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Like the Anti-Kickback Statute, the Stark Law is broad in its application to health
care transactions and arrangements. Accordingly, the Stark Law contains many exceptions, which protect certain arrangements and transactions
from the Stark Law penalties. The Stark Law is a strict liability statute, however, so intent is irrelevant, i.e., a physician's financial
relationship with a laboratory must meet an exception under the Stark Law, or the referrals are prohibited.&#160; Thus, unlike the Anti-Kickback
Statute's safe harbours, if a laboratory's financial relationship with a referring physician does not meet the requirements of a Stark
Law exception, then the physician is prohibited from making Medicare and Medicaid referrals to the laboratory and any such referrals will
result in overpayments to the laboratory and subject the laboratory to the Stark Law's penalties.&#160; Many states have also adopted
statutes similar to the Stark Law, some of which apply to payments in connection with the referral of patients for healthcare items or
services reimbursed by any source, not only governmental payor programs.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">53</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Civil Monetary Penalties Law&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The federal Civil Monetary Penalties Law, among other things, prohibits the offering
or giving of remuneration, including the provision of free items and services, to a Medicare or Medicaid beneficiary that the person knows
or should know is likely to influence the beneficiary's selection of a particular supplier of items or services reimbursable by a federal
or state governmental program. Violations could lead to civil money penalties of up to $10,000 for each wrongful act, assessment of three
times the amount claimed for each item or service and exclusion from the federal healthcare programs.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Federal Physician Payment Sunshine Act&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The U.S. Physician Payment Sunshine Act requires certain manufacturers of drugs, biologics,
devise and medical supplies to record any transfers of value to certain U.S. healthcare providers and U.S. teaching hospitals.&#160; These
payments and transfers of value must be reported annually to CMS Open Payments.&#160; Sunshine Act reporting requirements were expanded
in 2021 to include any payments and transfers of value to physician assistants, nurse practitioners, clinical nurse specialists, certified
nurse anaesthetists, and certified nurse-midwives.&#160; Failure to comply with Sunshine Act reporting requirements may result in civil
monetary penalties of up to $100,000 for each knowing violation.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In addition, certain states also have laws and regulations related to payments and
other transfers of value provided to healthcare professionals and entities. Similar to the federal law, certain states have adopted marketing
and/or transparency laws relevant to device manufacturers, some of which are broader in scope. Certain states also mandate that device
manufacturers implement compliance programs. Other states impose restrictions on device manufacturer marketing practices and require tracking
and reporting of gifts, compensation, and other remuneration to healthcare professionals and entities. The need to build and maintain
a robust compliance program with different compliance and/or reporting requirements increases the possibility that a company may violate
one or more of the requirements, resulting in fines and penalties.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Other Federal and State Fraud and Abuse Laws&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In addition to the requirements discussed above, several other health care fraud and
abuse laws apply to our business. For example, provisions of the Social Security Act permit Medicare and Medicaid to exclude an entity
that charges the federal health care programs substantially in excess of its usual charges for its services. The terms "usual charge"
and "substantially in excess" are ambiguous and subject to varying interpretations.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">HIPAA also created federal criminal statutes that prohibit, among other actions, knowingly
and willfully executing or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors,
and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent
statement in connection with the delivery of or payment for healthcare benefits, items or services.&#160; Similar to the Anti-Kickback
Statute, a person or entity does not need to have actual knowledge of these statutes or specific intent to violate them in order to have
committed a violation.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">A violation of each of these statutes is a felony and may result in fines, imprisonment
or exclusion from governmental payor programs.&#160; Many states have similar statutes that may carry significant penalties.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Federal False Claims Act prohibits a person from knowingly submitting a claim,
making a false record or statement in order to secure payment or retaining an overpayment by the federal government. Actions which violate
the Anti-Kickback Statute or Stark Law also incur liability under the False Claims Act. In addition to actions initiated by the government
itself, the statute&#8217;s &#8220;qui tam&#8221; provisions authorise actions to be brought on behalf of the federal government by a
private party having knowledge of the alleged fraud.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Because the complaint is initially filed under seal, the action may be pending for
some time before the defendant is even aware of the action. If the government is ultimately successful in obtaining redress in the matter
or if the plaintiff succeeds in obtaining redress without the government's involvement, then the plaintiff will receive a percentage of
the recovery.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">54</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">When an entity is determined to have violated the False Claims Act, it may be required
to pay up to three times the actual damages sustained by the government, plus civil penalties ranging from $13,946 to $27,894 for each
7separate false claim, exclusion from participation in federal health care programs and criminal penalties.&#160; Several states have
also adopted comparable state false claims act, some of which apply to all payors.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The ACA, among other things, also imposed new reporting requirements on manufacturers
of certain devices, drugs and biologics for certain payments and transfers of value by them and in some cases their distributors to physicians
and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">&#160;<span style="font-style: italic">New York Laboratory Licensing&#160;</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Because our reference laboratory located in New York receives specimens from New York
State, our clinical reference laboratory is required to be licenced under New York laws and regulations, which establish standards for,
among other things:&#160;</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z0c4a1f687a5942e782567e02726e2a50" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>day-to-day operation of a clinical laboratory, including training and skill levels required of laboratory personnel;&#160;&#160;</div>
        </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zd75aa5d28c30459388de23f79775c59c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>physical requirements of a facility;&#160;&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z6487e2af58b64d67b7885db7dac75006" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>equipment; and&#160;</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zc1acfd140b3748bd8f8340f99b02c4ed" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>validation and quality control.&#160;&#160;</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">New York law also mandates proficiency testing for laboratories licenced under New
York state law, regardless of whether such laboratories are located in New York. If a laboratory is out of compliance with New York statutory
or regulatory standards, the state regulatory agency may suspend, limit, revoke or annul the laboratory's New York licence, censure the
holder of the licence or assess civil money penalties. Statutory or regulatory noncompliance may result in a laboratory's operator being
found guilty of a misdemeanor under New York law. The state regulatory agency also must approve any LDT before the test is offered in
New York. Should we be found out of compliance with New York laboratory requirements, we could be subject to such sanctions, which could
harm our business. We cannot provide assurance that the state will at all times find us to be in compliance with applicable laws.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Other States' Laboratory Licensing&#160;</span>&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In addition to New York, other states including California, Florida, Maryland, Pennsylvania
and Rhode Island, require licensing of out-of-state laboratories under certain circumstances. From time to time, we may become aware of
other states that require out-of-state laboratories to obtain licensure in order to accept specimens from the state and it is possible
that other states do have such requirements or will have such requirements in the future.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Regulation outside the United States</span>&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Distribution of Trinity Biotech&#8217;s products outside of the United States is also
subject to foreign regulation.&#160; Each country&#8217;s regulatory requirements for product approval and distribution are unique and
may require the expenditure of substantial time, money, and effort.&#160; We are also subject to regulations in foreign countries governing
products, human clinical trials and marketing, and may need to obtain approval (or pre-qualification or endorsement) from local regulators
in such countries or international public health agencies, such as the World Health Organization, in order to sell products in certain
countries. Approval processes vary from country to country, and the length of time required for approval or to obtain other clearances
may in some cases be longer than that required for U.S. governmental approvals. We generally pursue approval only in those countries that
we believe have a significant market opportunity.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The International Organization for Standardization (&#8220;ISO&#8221;) is a worldwide
federation of national standards bodies from some 130 countries, established in 1947. The mission of the ISO is to promote the development
of standardization and related activities in the world with a view to facilitating the international exchange of goods and services. ISO
13485 certification indicates that our quality system complies with standards applicable to activities ranging from initial product design
and development through production and distribution.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">55</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">In the European Union (EU), diagnostic products are also categorized into four risk
categories and the regulatory process, which is governed by the European In Vitro Diagnostic Medical Device Regulation (Regulation (EU)
2017/746) with 3 of the product categories requiring review and approval by an independent company, known as a Notified Body, before the
manufacturer can affix a CE mark to the product to declare conformity to the Regulation. The remaining product category, where - low patient
and public health risk is presented, only require a self-certification process.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In the medical devices segment, the research and development process begins with research
on a specific technology that is evaluated for feasibility and commercial viability. If the research program passes that hurdle, it moves
forward into development. The development process includes evaluation, selection and qualification of a product design, completion of
applicable clinical trials to test the product&#8217;s safety and efficacy, and validation of the manufacturing process to demonstrate
its repeatability and ability to consistently meet pre-determined specifications.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In the EU, medical devices are also categorized into different classes and the regulatory
process, which is governed by the European Medical Device Regulation (Regulation (EU) 2017/745, requires each product to bear a CE mark
to show compliance with the Regulation.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Some products require submission of a design dossier to the appropriate regulatory
authority for review and approval prior to CE marking of the device. For other products, the company is required to prepare a technical
file which includes testing results and clinical evaluations but can self-certify its ability to apply the CE mark to the product. Outside
the U.S. and the EU, the regulatory requirements vary across different countries and regions.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">There can be no assurance that new laws or regulations will not have a material adverse
effect on Trinity Biotech&#8217;s business, financial condition, and results of operation.&#160; The time required to obtain needed product
approval by particular foreign governments may be longer or shorter than that required for FDA clearance or approval.&#160; There can
be no assurance that Trinity Biotech will receive on a timely basis, if at all, any foreign government approval necessary for marketing
its products.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">&#160;In the EU, the General Data Protection Regulation (GDPR) protects the rights
of individuals regarding their personal data, including the right to access, correct, and erase their data. It also places a strong emphasis
on data security and breach notification. Trinity Biotech has appointed a Data Protection Office (DPO) to lead and co-ordinate data compliance
efforts. Organizations found violating GDPR can face fines up to 4% of their global annual revenue or &#8364;20 million, whichever is
higher. Violations of the GDPR can arise from non-compliance with: data processing being lawful, fair, and transparent to the data subject;
processing data for explicitly stated purposes; only collecting data that is absolutely necessary, accurate and contemporaneous; only
storing data for as long as is required; any data processing ensures appropriate security, integrity, and confidentiality; and that the
DPO is responsible to demonstrate GDPR compliance at all times.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Environmental Regulation&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The process of designing, developing and manufacturing our products can involve the
use of harmful and dangerous chemicals and materials. The use and handling of these dangerous substances is subject to federal, state
and local laws and regulations in all the countries in which we operate. In the U.S., Trinity is subject to the Toxic Substances Act (TSCA)
and Pollution Prevention Act (PCA) under the auspices of the Environmental Protection Agency (EPA). In Europe, the key environmental policy
is written into Articles 11 and 191 to 193 of the Treaty on the Functioning of the European Union (TFEU) and specifically the Regulation
on the Registration, Evaluation, Authorisation and restriction of Chemicals (REACH) is the main EU law to protect human health and the
environment from the risks that can be posed by chemicals. Failure to comply with these laws and regulations can result in financial penalties,
restriction of operation and adverse publicity. The Trinity facility in Bray, Ireland is certified to ISO 14001. This is an internationally
recognized standard for environmental management systems (EMS). This provides an externally assessed framework for improving resource
usage, waste management and monitoring of environmental performance. Trinity uses their EMS to minimize environmental footprint and ensure
compliance with relevant legal requirements.&#160;&#160;</div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z9daf982a942447ebb019912154791b99" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">C.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Organizational Structure</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Please refer to Note&#160;32 to our audited consolidated financial statements (&#8220;Group
Undertakings&#8221;) included elsewhere in this Annual Report for a listing of our significant subsidiaries, including name, country of
incorporation, and proportion of ownership interest.&#160;</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">56</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div>

<table cellspacing="0" cellpadding="0" id="zb3c8338c39a84e618dd476323342d510" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">D.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Property, Plants and Equipment</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Our headquarters, manufacturing and research and development facilities as well as
our sales offices are located in Bray Ireland. We have entered into a number of related party transactions with JRJ Investments (&#8220;JRJ&#8221;),
a partnership currently owned by Mr Ronan O&#8217;Caoimh and Dr Walsh, directors of the Company, and directly with Mr O&#8217;Caoimh,
to provide premises in Bray, Ireland.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">We entered into an agreement for a 25-year lease with JRJ effective from December
2003 for 15,780 square feet of offices at an annual rent of &#8364;381,000 (US$421,000).</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman, serif">In 2007, we entered into a 25-year lease agreement with JRJ for a
43,860 square foot manufacturing facility in Bray, Ireland with an annual rent of &#8364;787,000 (US$834,000). Subsequent to the signing
of this lease, the ownership of the building transferred from JRJ to Mr O&#8217;Caoimh solely. A rent review for this property became
effective 1 July 2022 and, following an independent valuation, the annual rent increased to &#8364;1,050,000, with backdated rent accruing
from that date. Included within overhead costs in cost of sales in 2024 is an amount of $659,000 in respect of backdated rent.</div> </div>
</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman, serif">In 2016, we entered into a 10-year lease with Mr. O&#8217;Caoimh for
a warehouse adjacent to our leased manufacturing facility in Bray, Ireland. The warehouse is 16,000 square feet with an annual rent of
&#8364;144,000 (US$159,000). A rent review for this property became effective 1 July 2021 and, following an independent valuation, the
annual rent increased to &#8364;170,560, with backdated rent accruing from that date. Included within overhead costs in cost of sales
in 2024 is an amount of $93,000 in respect of backdated rent.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Independent valuers advised the Group that the rent in respect of each of the leases
represented a fair market rent.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">See Item 7 &#8211; Major Shareholders and Related Party Transactions.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">We have six main manufacturing sites worldwide, five in the Americas (Buffalo and
Jamestown, NY, Kansas City, MO, Wilsonville, OR and Extrema, Brazil), and one in Bray, Ireland. An additional facility is owned in Burlington,
Canada which serves as a distribution centre and also carries out some research and development activities.</div>

<div style="text-align: justify; line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The U.S. and Irish facilities are each FDA registered and ISO certified facilities.
As part of our ongoing commitment to quality, each Trinity Biotech facility was granted the latest ISO 13485 certification. This certification
was granted by internationally recognised notified bodies. This serves as external verification that Trinity Biotech has established an
effective quality system in accordance with an internationally recognised standard. By having an established quality system there is a
presumption that we will consistently manufacture products in a controlled manner. To achieve this certification, each Trinity Biotech
facility performed an extensive review of the existing quality system and implemented any additional regulatory requirements.</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The facilities at Jamestown, NY, Kansas City, MO and Bray, Ireland also achieved certification
to the requirements of the Medical Device Single Audit Programme (MDSAP). The Medical Device Single Audit Program allows an MDSAP recognized
Auditing Organization to conduct a single regulatory audit of a medical device manufacturer that satisfies the relevant requirements of
the regulatory authorities participating in the program. International regulatory authorities that are participating in the MDSAP include,
US Food and Drug Administration, Therapeutic Goods Administration of Australia, Brazil&#8217;s Ag&#234;ncia Nacional de Vigil&#226;ncia
Sanit&#225;ria, Health Canada, Japan&#8217;s Ministry of Health, Labour and Welfare, and the Japanese Pharmaceuticals and Medical Devices
Agency, The World Health Organization (WHO) Prequalification of In Vitro Diagnostics (IVDs) Programme and the European Union (EU) are
Official Observers.</div> </div>

<div style="text-align: justify; line-height: 1.25">&#160;

<div style="line-height: 1.25">Trinity Biotech USA operates from a 25,610 square foot FDA registered facility in Jamestown, New York.
The facility was purchased in 1994. Additional warehousing space is rented in Jamestown, New York at an annual rental charge of US$221,000.
This lease has recently been renewed effective 1 July 2025 for five (5) additional one-year rental periods.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">TRIB Biosensors Inc. operates from a 26,000 square foot facility in Wilsonville, Oregon.
We took over the lease for this facility in January 2024 as part of the Waveform transaction. The lease term was extended to December
2025 with an annual rent of US$363,000.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Primus Corp. operates from a 39,000 square foot facility in Kansas City, Missouri
and an adjacent 13,500 square foot facility mainly used for warehousing. The leases on these properties run until October 2025 and March
2027 with annual rents of US$137,000 and US$61,000 respectively.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">57</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Immco operates from a 31,731 square foot facility in Buffalo, New York. The lease
for the site expires in 2034. The annual rent for the facility is US$428,000. An additional 5,120 square foot facility is owned by Trinity
Biotech in Burlington, Canada.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech Brazil operates from office and factory space is leased in Sao Paulo,
Brazil and Extrema, Brazil. The leases on these properties run have an annual cost of US$11,000 and US$57,000 respectively.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">As part of the acquisition of Metabolomics Diagnostics Ltd, we acquired a lease for
2,300 square foot of office space in Cork, Ireland. The annual rent is US$21,600. This lease expired in 2023 and is currently rented on
a rolling month-to-month basis.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">At present, we have sufficient productive capacity to cover demand for our product
range. We continue to review our level of capacity in the context of future revenue forecasts. In the event that these forecasts indicate
capacity constraints, we will either obtain new facilities, expand our existing facilities or outsource operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The following are the facilities where the Group currently manufactures products:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">Bray, Ireland </span>- Point-of-Care/HIV and Clinical
Chemistry products were manufactured at this site during 2024. Parts of the manufacturing process for Point-of-Care/HIV products is in
the process of being transferred to a contract manufacturing partner, with production expected to commence in Q2 2025. Clinical Chemistry
products continue to be manufactured in Bray. In 2025, certain manufacturing processes related to haemoglobin products began at this site.</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">Jamestown, New York -</span> this site specializes in the production of
Microtitre Plate EIA products for infectious diseases and auto-immunity. Viral Transport Media products are also manufactured at this
facility. In Q1 2025, in line with our consolidation strategy. significant aspects of the Group&#8217;s autoimmune test kits manufacturing
operations were transferred from the Buffalo site to Jamestown.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">Kansas City, Missouri </span>- this site is responsible
for the manufacture of the Group&#8217;s haemoglobin range of products and all haemoglobin R&amp;D activities. During 2024 and early 2025,
significant aspects of these manufacturing processes were transitioned to other Group manufacturing sites, in line with our strategy to
consolidate operations and reduce complexity across our manufacturing footprint.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">Buffalo, New York </span>- this site is responsible
for the manufacture of autoimmune test kits along with its reference laboratory business. In early 2025, consistent with our strategic
focus on operational consolidation, significant aspects of the manufacturing processes were transitioned to other Group sites. Buffalo
continues to operate as the Group&#8217;s reference laboratory.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">Extrema, Brazil </span>- this site is responsible
for the manufacture of certain haemoglobin products sold in Brazil. Manufacturing of the haemoglobin range will expand in 2025 as Kansas
City production reduces.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We are in material compliance with all environmental legislation, regulations and
rules applicable in each jurisdiction in which we operate.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-weight: bold">Principal Capital Expenditure and Divestitures</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Our principal capital expenditure in the last three financial years has been on developing
new products internally. The amount capitalized for development projects has been US$8.6 million, US$1.8 million, US$4.5 million, for
years ended December 31, 2024, 2023 and 2022 respectively. In 2025, we expect the capital expenditure on development projects will be
in the range US$10 million to US$12 million, primarily driven by the advancement of our CGM and biosensor technologies and the advancement
of a screening test for preeclampsia risk.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1edf364a3fc248da8740cf4c95e63548" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 72pt; vertical-align: top; font-weight: bold">Item&#160;4A.</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div style="font-style: italic; font-weight: bold"><span id="UnresolvedStaffComments"><!--Anchor--></span>Unresolved Staff Comments</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Not applicable.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">58</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div>

<table cellspacing="0" cellpadding="0" id="zedc92c1398734939a944bee5e917b462" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 72pt">
        <div style="text-align: left; line-height: 1.25"><span style="font-family: Times New Roman,Times,serif; font-weight: bold">Item 5.</span></div>
        </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25"><span id="OperatingandFinancialReviewandProspects"><!--Anchor--></span><span style="font-family: Times New Roman,Times,serif; font-weight: bold"><span style="font-style: italic">Operating
        and Financial Review and Prospects</span></span></div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z36b2b665810844bdbfaf68593a68ca3e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 27pt">&#160;</td>
    <td style="width: 22.5pt; vertical-align: top; font-family: Times New Roman,Times,serif; font-style: italic; font-weight: bold">A.</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div style="font-style: italic; font-weight: bold"> Operating Results</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Overview</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We are commercial stage biotechnology company focused on diabetes management solutions
and human diagnostics, including wearable biosensors. We develop, acquire, manufacture and market diagnostic systems, including both reagents
and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has recently entered the wearable
biosensor industry, with the acquisition of the biosensor assets of Waveform Technologies Inc. and intend to develop a range of biosensor
devices and related services, starting with a continuous glucose monitoring product. Our products are used to detect infectious diseases
and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. We sell our products directly
in the United States, and Brazil and somewhat directly in Germany, France and the U.K. and through a network of international distributors
and strategic partners in approximately 100 countries worldwide. This discussion covers the years ended December&#160;31, 2024 and December&#160;31,
2023 and should be read in conjunction with the consolidated financial statements and notes thereto appearing elsewhere in this Form 20-F.
The financial statements have been prepared in accordance with IFRS both as issued by the International Accounting Standards Board (&#8220;IASB&#8221;)
and as subsequently adopted by the European Union (&#8220;EU&#8221;) (together &#8220;IFRS&#8221;). Consolidated financial statements
are required by Irish law to comply with IFRS as adopted by the EU which differ in certain respects from IFRS as issued by the IASB.&#160;These
differences predominantly relate to the timing of adoption of new standards by the EU.&#160;However, as none of the differences are relevant
in the context of Trinity Biotech, the consolidated financial statements for the periods presented comply with IFRS both as issued by
the IASB and as adopted by the EU.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We have relied on an exemption under the SEC&#8217;s rules to prepare consolidated
financial statements without a reconciliation to U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) as at and for
the three-year period ended December&#160;31, 2024 as Trinity Biotech is a foreign private issuer and the financial statements have been
prepared in accordance with IFRS as issued by the IASB.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Factors affecting our results</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The global healthcare market is growing due to, among other reasons, lifestyle changes,
the growing incidences of diabetes and other autoimmune and infectious diseases and as a consequence there is an increasing demand for
rapid and continuous monitoring tests in a clinical and consumer environment.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Our revenues are directly related to our ability to identify significant revenue-generating
products, carry out the necessary development work and to bring them to market quickly and effectively. Efficient and productive research
and development is crucial in this environment as we, like our competitors, search for effective and cost-efficient solutions to diagnostic
problems. The growth in new technology will almost certainly have a fundamental effect on the diagnostics industry as a whole and upon
our future development.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The comparability of our financial results for the years ended December&#160;31, 2024
and 2023 were impacted by impairment losses as a result of impairment reviews during the years ended December 31, 2024 and 2023 (See Item
18, Note 12) and also as a result of restructuring costs and other once-off / exceptional costs (see Note 5) incurred in 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">For further information about the Group&#8217;s principal products, principal markets
and competition please refer to Item 4, &#8220;Information on the Company&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Going Concern<br/> <br/> </div>

<div style="text-align: justify; line-height: 1.25">The accompanying consolidated financial statements have been prepared assuming that
we will continue as a going concern, which contemplates the realization of assets and the discharge of liabilities in the normal course
of business for the foreseeable future.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">As reflected in the accompanying consolidated financial statements, for the years
ended December 31, 2024 and 2023, the Group recorded a loss of US$31.8 million and a loss of US$24.0 million, respectively. For the year
ended December 31, 2024 we reported cash inflows of US1.7 million compared to cash outflows of US$2.8 million for 2023. As of December
31, 2024, we had net current assets of US$9.0 million but had an accumulated deficit in equity attributable to the equity holders of the
Company of US$79.1 million.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">We have made significant progress on a multi-year transformation plan aimed at improving
profitability and simplifying our operating model. Key actions implemented include the consolidation and outsourcing of global manufacturing,
closure of underutilized facilities, relocation of certain business support functions to lower-cost jurisdictions, and a reduction in
overall headcount. These restructuring measures, largely completed by mid-2025, are expected to deliver significant annualized cost savings.
Additionally, the Group retains further levers to manage liquidity if required, including deferring projected research and development
spend.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">59</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div> <br/>

<div style="text-align: justify; line-height: 1.25">A temporary decline in revenue occurred during the first four months of 2025, primarily
due to transitional impacts associated with the Group&#8217;s restructuring initiatives, including the consolidation of manufacturing
operations and the transfer of Point-of-Care/HIV products to a third-party contract manufacturing partner. These initiatives have since
progressed materially. Sales were also affected by reduced HIV test volumes resulting from uncertainty surrounding potential changes to
U.S. foreign aid policy following a presidential executive order. In light of these temporary factors, the Group sought and received a
formal waiver from Perceptive in respect of the Q1 2025 minimum revenue covenant, to ensure that no breach occurred under the Perceptive
credit facility. In May 2025, the Group signed a buy-sell agreement with a contract manufacturing partner. We also have obtained World
Health Organisation (&#8220;WHO&#8221;) approval to commence assembly at the new site. It is expected that WHO approval for full production
of our Trinscreen product to be received in July 2025, with approval for full production of our UniGold product expected in August 2025.
The directors have alternative options and have prepared financial forecasts to address a scenario whereby WHO approval for production
with our contract manufacturing partner takes longer than expected to achieve and the facility takes longer than expected to get up to
full operational capacity. In such a scenario, management remain confident that all revenue covenants will be met through to 31 December
2025. In addition, the minimum revenue covenant thresholds for Q2, Q3 and Q4 2025 have been renegotiated to align with the Group&#8217;s
updated forecasts. Accordingly, management is confident in the Group&#8217;s ability to maintain compliance with its debt covenants for
the remainder of the going concern review period. Furthermore, Perceptive have a track record of supporting the Company and, when required,
have provided covenant waivers and amendment of terms which indicates an appreciation of the Company&#8217;s circumstances in terms of
our transformational plan for the business and temporary declines in revenue. If a similar need were to recur in the foreseeable future,
management are confident of their continued support.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">We have also launched a strategic realignment review of our businesses in partnership
with Barclays Bank. This process, is expected to make significant progress by the end of 2025 and may generate material capital proceeds
that can be potentially used to reduce debt and support investment, including CGM investment.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In addition, the Group has continued to benefit from strong support from Perceptive,
its principal lender and largest investor. On December 23, 2024, we entered into the third amendment and restatement of the credit agreement
governing the Term Loan. As part of this agreement, an additional US$2.0 million of funding was made available to us. We also agreed that
certain interest payments payable in 2024 and 2025 would be paid-in-kind on the applicable payment date by increasing the outstanding
principal amount of the Term Loan. In February 2025, we entered into a fourth amendment to the credit agreement, which provided for an
additional US$4.0 million in term loan funding. On May 14, 2025, we entered into a fifth amendment to the credit agreement, which provided
for a further US$2.0 million in funding, extended the maturity date of the Term Loan by six months from January 2026 to July 27, 2026,
and confirmed that interest payments for the months of April, May, and June 2025 would be paid-in-kind. There are no material debt maturities
until July 2026. These successive amendments demonstrate Perceptive&#8217;s continued support and demonstrate their willingness to flex
terms to preserve liquidity while the Company continues to execute its updated strategy, including its comprehensive transformation plan.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Under the fifth amendment to the credit agreement, the minimum liquidity covenant
was reduced to US$1 million through to October 31, 2025, after which it reverts to US$3 million. While management is confident in the
Group&#8217;s ability to maintain compliance with this covenant, it is noted that the Group has planned significant R&amp;D expenditure
related to its CGM development program in the second half of 2025. However, the Group retains full discretion over the timing and phasing
of these activities, which enables management to align expenditure with available funding and preserve liquidity if required.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In addition to lender support, our going concern forecasts include expected equity
raises. These funds are expected to support ongoing CGM development activities. The Group has a strong track record of capital raising,
including over US$7 million secured in 2024, and maintains active engagement with existing and potential investors. Management believes
that the equity raise is achievable based on the Group&#8217;s strategic focus and transformation progress to date.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The directors have considered the Group&#8217;s current financial position and cash
flow projections, taking into account all known events and developments including the amendment and restatement of the term loan with
Perceptive, The directors believe that, based on currently available information and reasonable assumptions, the Group will be able to
continue its operations for at least the next 12 months from the year-end date, and that it is appropriate to continue to prepare the
consolidated financial statements on a going concern basis.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Impact of Currency Fluctuation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech&#8217;s revenue and expenses are affected by fluctuations in currency
exchange rates especially the exchange rate between the US&#160;Dollar and the Euro, the Brazilian Real and Canadian Dollar. Trinity Biotech&#8217;s
revenues are primarily denominated in US Dollars and its expenses are incurred principally in US Dollars, Euro and Brazilian Real. The
weakening of the US&#160;Dollar could have an adverse impact on future profitability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech holds most of its cash assets in US Dollars. As Trinity Biotech reports
in US Dollars, fluctuations in exchange rates do not result in exchange differences on these cash assets. Fluctuations in the exchange
rate between the Euro or Brazilian Real and the US&#160;Dollar may impact on the Group&#8217;s Euro or Real monetary assets and liabilities
and on Euro, Swedish Krona or Real expenses and consequently the Group&#8217;s earnings.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Impact of Covid-19 Pandemic</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Sales volumes for PCR Viral Transport Media (&#8220;VTM&#8221;) products continued
to decrease in 2024, down 32.8% on 2023 revenues due to a significant scaling down of PCR testing programs for COVID-19. The impact of
COVID-19 in 2024 was otherwise insignificant on Group operations as quarantine restrictions were removed in most countries. Employees
who worked remotely during large parts of the pandemic have returned to their respective offices, withs some hybrid working arrangements
maintained. Health and safety policies implemented during the pandemic were relaxed where appropriate to allow for greater flexibility
of Group operations without impacting employee health and safety.</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">As widespread public testing programmes for COVID-19 using PCR tests have largely
been discontinued, we expect the amount of our COVID-19 portfolio of products as a percentage of total Group revenues to reduce further
in 2025.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">60</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Year ended December&#160;31, 2024 compared to the year ended December&#160;31,
2023</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Revenues &#8211; continuing operations</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Our revenues from continuing operations for the year ended December 31, 2024 were
US$61.6 million compared to revenues of US$56.8 million for the year ended December 31, 2023, which represents an increase of US$4.7 million
or 8.3%.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The increase is mainly due to sales of our HIV screening test, TrinScreen HIV of US$10.0
million for the year offset by decreases in our clinical laboratory sales and sales in legacy haemoglobinopathies product.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The following table sets forth selected sales data for each of the periods indicated.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z77374a4b402a40d187a5825de41b2620" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold; text-align: center"> 2024</div>
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold; text-align: center">US$&#8217;000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; text-align: center; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: center; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold; text-align: center">2023</div>
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold; text-align: center">US$&#8217;000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">% Change</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25; font-weight: bold">Revenues &#8211; continuing operations</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Clinical laboratory goods</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">39,372</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">42,288</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(6.9</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Clinical laboratory services</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">4,750</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">5,453</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(12.9</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 2px">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Point-of-Care</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">17,433</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">9,091</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">91.8</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="font: 1pt/1.25 Times New Roman, serif">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">61,555</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">56,832</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">8.3</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25; font-weight: bold">%</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Clinical Laboratory Goods</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Clinical Laboratory goods revenues decreased by US$2.9 million in 2024, which represents a decrease of
6.9%. The movement is driven by decreases within our haemoglobin business, our COVID-19 VTM products and our Infectious Diseases products.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Sales in our haemoglobin business declined by US$1.1 million (5.2%) due primarily to the continued downward
trend in revenues for our legacy haemoglobinopathies product, the Ultra II instrument.&#160; Our replacement for the Ultra II instrument,
the Premier Resolution, obtained FDA approval in August 2023.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25">There was a decrease of US$0.4 million in sales for our COVID-19 VTM products as public
health PCR testing programs for COVID-19 have largely been discontinued. We have retained the capability to flex manufacture volumes should
market conditions warrant it.</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Sales in our Infectious Diseases products have decreased by US$0.7 million which was primarily driven by
two larger customers changing infectious disease technology platform.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25; font-style: italic">Clinical Laboratory Services</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Our New York reference laboratory offers laboratory-testing services for autoimmune disorders, such as
Sjogren&#8217;s syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis and systemic sclerosis. Revenues for the laboratory
decreased by 12.9% to US$4.8 million, due primarily to a reduction in transplant related testing volumes in full year 2024 compared to
full year 2023. The laboratory had provided transplant testing services to a local healthcare provider for a number of years, however
in early 2023 that healthcare provider informed us that it was moving to a different service provider and this resulted in lost revenues
for the laboratory beginning in the second quarter of 2023.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Point-of-Care</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Point-of-Care revenues increased by 91.8% from US$9.1 million in 2023 to US$17.4 million in 2024. Sales
of our HIV screening test, TrinScreen HIV were US$10.0 million for the year (US$0.4 million in 2023) as we continued to see strong demand
following our initial shipments in late 2023. This was partially offset by a decrease of 14.3% in other Point-of-Care revenues, primarily
driven by decreased sales in our UniGold HIV range, primarily as a result of testing disruptions in two key markets, which we expect are
temporary disruptions.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">61</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Revenues by Geographical Region</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">The following table sets forth selected sales data, analysed by geographic region, based on location of
customer:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z22fdc8db4ef74820b03114fa1eb5c33e" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2024</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">US$&#8216;000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2023</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">US$&#8216;000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">% Change</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25; font-weight: bold">Revenues for continuing operations</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Americas</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">29,917</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">32,282</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(7.3</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Asia/Africa</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">24,775</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">18,909</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">31.0</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 2px">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Europe</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">6,863</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">5,641</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">21.7</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="font: 1pt/1.25 Times New Roman, serif">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 2px">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25; font-weight: bold">Total</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">61,555</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">56,832</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">8.3</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25; font-weight: bold">%</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In the Americas, revenues decreased US$2.4 million or 7.3%, primarily driven by lower
sales in our haemoglobin business in Brazil, a full-year impact of reduced volumes in our New York reference laboratory, and a decline
in demand for our COVID-19 VTM products. Sales in Brazil declined by US$0.8 million due to reduced demand for our legacy haemoglobinopathies
instrument. Revenues from the New York laboratory declined by US$0.7 million, reflecting the full-year impact of the loss of transplant
testing volumes beginning in the second quarter of 2023. In addition, COVID-19 VTM sales declined in the region as public health PCR testing
programs continued to wind down.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In Asia/Africa, revenues increased by 31%, or US$5.9 million compared to 2023. The
increase was primarily driven by strong growth in sales of our TrinScreen HIV screening test. TrinScreen continued to gain traction following
its launch in late 2023, with significant uptake across key African markets. This increase was partially offset by a decline in sales
of our UniGold HIV product range in Africa and modest reductions in revenues from our haemoglobin and infectious disease product lines
within the Asia region</div>

<div><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">In Europe, revenues decreased by US$1.2 million, or 21.7% compared to 2023. The by higher demand from our
main European distributor for haemoglobin products. This growth reflects stronger ordering within Western Europe year. The increase was
supported by growth in our clinical chemistry product line across the region.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Cost of sales, gross profit and gross margin</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Total cost of sales increased by US$2.7 million from US$37.4 million for the year ended December 31, 2023
to US$40.1 million, for the year ended December 31, 2024, an increase of 7.3%. This resulted in a gross profit for 2024 of US$21.4 million
compared to a gross profit for 2023 of US$19.5 million. The gross margin of 34.8% in 2024 compares to a gross margin of 34.2% in 2023.</div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">

<div style="line-height: 1.25"><span style="font-weight: bold; font-style: italic">Other operating (expense)/income</span></div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Other operating income decreased from US$0.1 million for the year ended December 31, 2023 to negative US$1.79
million for the year ended December 31, 2024. This is due to the reversal of $1.8 million income from loan forgiveness of second-round
Paycheck Protection Program (PPP) loans received by certain U.S. subsidiaries recognised in 2020 which is currently the subject of a U.S.
Department of Justice (DOJ) investigation. For further details, see Note 4.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The other operating income for 2024 relates to a transition services agreement with
the acquirer of Fitzgerald Industries.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">62</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Research and development expenses</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Research and development expenses increased from US$4.4 million for the year ended
December 31, 2023 to US$4.5 million for the year ended December 31, 2024, an increase of 3.7% mainly due to lower capitalisation of payroll
costs into product development intangible assets.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Selling, general and administrative expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">

<div style="line-height: 1.25">Selling, general and administrative expenses decreased for the year ended December 31, 2024 by US$2.3 million
to US$28.8 million when compared to the year ended December 31, 2023, representing a decrease of 7.5%. A significant element of the US$2.3
million decrease relates to:</div> </div> </div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd9f89b6b323149d892022f49d88952b8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">i)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>
        <div style="line-height: 1.25">a US$1.9 million decrease in salaries and related personnel costs, reflecting the impact of organisational
        realignment measures undertaken as part of the restructuring program.</div> </div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7572e833804c457cada63e1b3c20b5b3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">ii)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>lower non-cash share-based payments expense of US$0.8 million mainly due to forfeitures and expirations.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Impairment charges</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Impairment charges decreased from US$11.1 million for the year ended December 31, 2023 to US$1.4 million
for the year ended December 31, 2024. There are a number of factors taken into account in calculating the impairment, including the Company&#8217;s
period-end share price, calculation of the cost of capital, and future projected cash flows for individual cash-generating units in the
business. In addition, the Group examines individual development project assets for indicators of impairment.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The Company evaluated the value in use of each of its cash-generating units, which
is defined as the present value of expected future cash flows. Where this value in use was determined to be less than the carrying amount
of the respective unit's assets, excluding inventories, trade and other receivables, cash and cash equivalents, and deferred tax assets,
an impairment was recognised.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Biopool US Inc&#8217;s value in use was below the value of its relevant assets, and
an impairment was provided for as at June 30, 2024 (US$0.1 million) and as at December 31, 2024 (US$0.2 million).</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Immco Diagnostics&#8217;s value in use was below the value of its relevant assets,
and an impairment was provided for as at June 30, 2024 (US$0.1 million) and as at December 31, 2024 (US$0.1 million).</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Clark Laboratories Inc&#8217;s value in use was below the value of its relevant assets,
and an impairment was provided for as at June 30, 2024 (US$0.1 million) and as at December 31, 2024 (US$0.1 million).</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech do Brasil&#8217;s value in use was below the value of its relevant
assets, and an impairment was provided for as at June 30, 2024 (US$0.2 million) and as at December 31, 2024 (US$0.2 million).</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">During the year the Company reassessed the carrying value of its current development
projects. Specific impairments were recognized in respect of two projects totaling US$1.6 million.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">During 2023, the Company fully impaired its investment in imaware, comprising US$0.7 million paid and US$0.8
million accrued but unpaid, under a total committed investment of $1.5 million. In 2024, the Company reversed US$0.8 million of the previously
recognised impairment through profit or loss, corresponding to the accrued balance that was no longer payable under the terms of the investment
agreement.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">The impairment charges for the year ended December 31, 2023 related to impairment losses identified for
two cash generating units, namely Immco Diagnostics Inc (US$10.8 million) and Trinity Biotech Do Brasil (US$0.3 million. For further details,
see Item 18, Notes 11, 12, and <span style="font-family: Times New Roman,Times,serif">13</span>.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Restructuring Costs</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">As part of a strategic initiative to enhance operational efficiency and align the
Group&#8217;s structure with its long-term objectives, we undertook a comprehensive business transformation during the year ended December
31, 2024. This program involved targeted measures aimed at improving operational profitability, streamlining our organizational structure,
and consolidating certain business unit activities.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">63</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">As a result, we incurred restructuring costs of US$4.2 million during 2024 (2023:
US$nil), which were primarily related to personnel-related expenses, outsourcing of selected functions, site transfers, and stock-related
adjustments. These costs are presented separately within Selling, General and Administrative expenses and are not expected to recur.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman, serif">The restructuring activities are intended to deliver long-term cost
savings and operational benefits, supporting the Group&#8217;s strategy of focusing on core areas of growth and enhancing overall financial
performance. For further details, see Item 18, Note 5 &#8216;Impairment, restructuring and once off costs&#8217;.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Once-Off Costs</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">During the year ended December 31, 2024, the Group incurred exceptional, non-trading
costs totaling US$1.9 million (2023: US$nil). These costs were not related to the Group&#8217;s ongoing operations and are not expected
to recur.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Included within this amount was a charge of US$1.1 million relating to a non-refundable
retainer fee paid to a corporate finance advisor in connection with a planned future equity raise, settled through the issuance of 650,000
American Depositary Shares (&#8220;ADSs&#8221;).</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Operating Loss</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Operating loss for the year ended December 31, 2024 was US$21.2 million, compared to an operating loss
of US$27.0 million in the year ended December 31, 2023. The lower loss was mainly attributable to increased revenues and gross margins,
lower impairment charges and lower indirect costs, partly offset by restructuring costs and once off costs.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Operating Loss excluding Impairment, Restructuring
&amp; Once-off costs</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Operating loss excluding Impairment, Restructuring &amp; Once-off costs for the year ended December 31,
2024 was US$13.7 million, compared to US$15.9 million for the year ended December 31, 2023, reflecting the improvement in gross margins
and the savings in indirect costs.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Financial expenses</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Financial expenses in the year ended December 31, 2024 were US$9.6 million compared to US$11.1 million
in the year ended December 31, 2024, a decrease of US$1.5 million, broken down as follows:</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">

<table cellspacing="0" cellpadding="0" border="0" class="cfttable" id="zc866317d3a95449cbfec30246463e4f3" style="font: 10pt Times New Roman,Times,serif; text-align: left; color: rgb(0, 0, 0); width: 100%">
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">Year ended December 31, 2024</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: center; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">Year ended December 31, 2023</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">US$m</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: center; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">US$m</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: 10pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Interest on senior secured term loan</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">8.6</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">8.4</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%; padding-bottom: 2px">
        <div style="text-indent: 10pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Interest on convertible note</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">1.2</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">1.1</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: 10pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Penalty for early partial settlement of
        term loan</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">-</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">0.9</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%; padding-bottom: 2px">
        <div style="text-indent: 10pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Lease interest</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">0.6</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">0.6</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: 10pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Interest payable on repayment of PPP loans</div>
        </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">0.3</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">0.0</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%; padding-bottom: 2px">
        <div style="text-indent: 10pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Capitalised borrowing costs</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">(2.1</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">0.0</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: 10pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Other non-cash financial expense</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">1.0</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif">0.0</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%; padding-bottom: 2px">
        <div style="text-indent: 10pt; line-height: 1.25; font-family: Times New Roman, Times, serif">&#160;Total</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">9.6</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif; font-weight: bold">11.1</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Note: table above contains rounded numbers</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">64</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div> <br/>

<div style="text-align: justify; line-height: 1.25">The decrease of US$1.5 million in 2024 compared to 2023 is due to capitalization of
borrowing costs and non-reoccurrence of early payment penalties, partially offset by costs associated with fair value remeasurement of
embedded derivatives.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Interest on the senior secured term loan, comprising cash and non-cash interest, increased
from US$8.4 million in 2023 to US$ 8.6 million for 2024 mainly due to a higher term loan balance. Interest on the convertible note, comprising
cash and non-cash interest, increased from US$1.1 million in 2023 to US$1.2 million in 2024. An early repayment penalty of US$0.9 million
was incurred in Q2, 2023 because of an early partial settlement of the term loan of US$10.1 million. During 2024, we capitalized borrowing
costs totaling US$2.1 million into development costs (2023: US$nil). There was a net expense of US$1.0 million relating primarily to the
fair value remeasurement of embedded derivatives.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In October 2024, the Company was notified that it is the subject of a U.S. Department
of Justice (DOJ) investigation relating to second-round Paycheck Protection Program (PPP) loans received by certain U.S. subsidiaries.
At year-end, estimated interest of US$0.3 million was recorded in respect of the payable (see note 4 for further details).</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Financial income</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">

<div style="line-height: 1.25">Financial income for the year ended December 31, 2024 was US$nil compared to US$1.2 million for the year
ended December 31, 2023. In 2023, the financial income related to a fair value adjustment for the derivative liability related to warrants
granted to the Group&#8217;s principal lender.</div> </div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Income tax (expense)/credit</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">The Company recorded a tax expense on continuing operations of US$486,000 for the year ended December 31,
2024 compared to a tax credit of US$59,000 for the year ended December 31, 2023. The 2024 tax credit consists of approximately US$285,000
of current tax charge and US$299,000 of a deferred tax credit. The 2023 tax credit consists of approximately US$264,000 of current tax
charge and US$323,000 of a deferred tax credit. For further details on the Group&#8217;s tax charge please refer to Item 18, Note 7 and
Note 14 to the consolidated financial statements.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Loss before tax from continuing operations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">The loss before tax for continuing operations for the year ended December 31, 2024 was US$31.2 million,
in comparison to US$36.9 million for the year ended December 31, 2023.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Profit/(Loss) from discontinued operations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The discontinued operations comprise Fitzgerald Industries which was divested in April
2023 and the discontinued cardiac point-of-care business on the Meritas platform. Profit for the period from discontinued operations totalled
US$12.9 million, largely attributable to the gain of US$12.7 million on the divesture of Fitzgerald Industries. The gain comprises proceeds
of approximately US$30 million offset by transaction costs of US$1.3 million with net assets eliminated on disposal of US$16.3 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Following negotiations, a settlement agreement was finalised prior to December 31, 2024 and subsequently
signed in January 2025. Under the terms of the settlement, the Company agreed to pay Biosynth US$150,000 in full and final settlement
of all post-completion claims. Accordingly, a provision of US$150,000 has been recorded in the consolidated financial statements as at
December 31, 2024, see Note 22. The settlement fully resolves all disputes related to the sale of Fitzgerald Industries, and no further
liabilities are expected to arise.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">65</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">For further details, see Item 18, Note 8.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Year ended December&#160;31, 2023 compared to the year ended December&#160;31,
2022</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Revenues &#8211; continuing operations</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Our revenues from continuing operations for the year ended December 31, 2023 were
US$56.8 million compared to revenues of US$62.5 million for the year ended December 31, 2022, which represents a decrease of US$5.7 million
or 9.1%.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The decrease is mainly due to lower sales of our PCR Viral Transport Media (&#8220;VTM&#8221;)
products (US$1.8 million), lower laboratory services revenue (US$1.8 million) following the loss of our transplant testing service contract
and haemoglobins revenues were 8% lower due to the continued decrease in revenues for our legacy haemoglobinopathies product, the Ultra
II instrument and due to the deferral of year end shipments of products at sub-optimal pricing as we renegotiated contract terms with
a key customer in line with the new management team&#8217;s focus on profitability.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The following table sets forth selected sales data for each of the periods indicated.</div>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z672895de100d445fb5a7a15916e09489" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold; text-align: center"> 2023</div>
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold; text-align: center">US$&#8217;000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; text-align: center; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: center; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold; text-align: center">2022</div>
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold; text-align: center">US$&#8217;000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">% Change</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25; font-weight: bold">Revenues &#8211; continuing operations</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Clinical laboratory goods</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">42,288</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">46,036</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(8.1</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Clinical laboratory services</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">5,453</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">7,272</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(25.0</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 2px">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Point-of-Care</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">9,091</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">9,213</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(1.3</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25">)%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="font: 1pt/1.25 Times New Roman, serif">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">56,832</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">62,521</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">(9.1</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25; font-weight: bold">)%</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Clinical Laboratory Goods</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Clinical Laboratory goods revenues decreased by US$3.7 million in 2023, which represents
a decrease of 8.1%. The decrease is mainly due to a decrease of US$1.8 million in sales for our COVID-19 VTM products as public health
PCR testing programs for COVID-19 have largely been discontinued. We have retained the capability to flex manufacture volumes should market
conditions warrant it. The remainder of the decrease in clinical laboratory goods revenues is largely due to our haemoglobin business,
sales of which declined by 8% due to the continued downward trend in revenues for our legacy haemoglobinopathies product, the Ultra II
instrument and due to the deferral of shipments in the fourth quarter of 2023 of products at sub-optimal pricing as we renegotiated contract
terms with a key customer. In Q1, 2024, we agreed upon revised terms. Our replacement for the Ultra II instrument, the Premier Resolution,
obtained FDA approval in August 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Clinical Laboratory Services</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Our New York reference laboratory offers laboratory-testing services for autoimmune
disorders, such as Sjogren&#8217;s syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis and systemic sclerosis. Revenues
for the laboratory decreased by 25.0% to US$5.5 million. The laboratory had provided transplant testing services to a local healthcare
provider for a number of years, however in early 2023 that healthcare provider informed us that it was moving to a different service provider
and this resulted in lost revenues for the laboratory beginning in the second quarter of 2023. This decrease was partly offset by higher
services revenue for our proprietary Sjogren&#8217;s syndrome test which increased by 3% in 2023 compared to 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Point-of-Care</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Point-of-Care revenues decreased 1.3% from US$9.2 million in 2022 to US$9.1 million
in 2023. There was a slight decrease in sales of HIV tests in Africa which was largely offset by an increase in revenues for the syphilis
point-of-care test in U.S. Included in our HIV point-of-care revenues is US$0.4m for our new Trinscreen test, which commenced its first
shipments in December 2023.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">66</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Revenues by Geographical Region</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">The following table sets forth selected sales data, analysed by geographic region, based on location of
customer:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2637f84979174860a8155c96ff998941" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">US$&#8216;000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">US$&#8216;000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">% Change</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25; font-weight: bold">Revenues for continuing operations</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Americas</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">32,282</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">35,557</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(9.2</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Asia/Africa</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">18,909</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">20,401</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(7.3</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 2px">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Europe</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">5,641</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">6,563</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(14.0</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25">)%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="font: 1pt/1.25 Times New Roman, serif">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 2px">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25; font-weight: bold">Total</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">56,832</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">62,521</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">(9.1</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25; font-weight: bold">)%</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In the Americas, revenues decreased US$3.3 million or 9.2%, mainly due to a US$1.8
million decrease in sales of our VTM products which were used in the COVID-19 testing programs in U.S. and Canada. The other main contributor
to the drop in revenues in Americas was a US$1.8 million decrease in revenues for our New York laboratory due to the loss of a transplant
testing service contract. Offsetting these decreases was strong growth in our haemoglobins business, particularly in Brazil, where revenues
increased by 13% in 2023 compared to 2022.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In Asia/Africa, revenues decreased by 7.3%, or US$1.5 million compared to 2022. The
decrease was primarily due to lower haemoglobins revenues in Asia.&#160;In 2022, there was particularly strong demand for our diabetes
products in Asia with year-on-year revenue growth in 2022 of 36%, boosted by high instrument sales. Haemoglobins revenues in Asia decreased
in 2023 compared to 2022 due to lower number of instruments sold and due to the deferral of year end shipments of haemoglobins products
at sub-optimal pricing as we renegotiated contract terms with a key customer in line with our new management team&#8217;s focus on profitability.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In Europe, revenues decreased by US$0.9 million, or 14.0% compared to 2022. The decrease
was mainly caused by lower demand from our main European haemoglobins distributor due to customer attrition in their installed base following
tendering processes in Western Europe.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Cost of sales, gross profit and gross margin</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Total cost of sales decreased by US$7.9 million from US$45.3 million for the year
ended December 31, 2022 to US$37.4 million, for the year ended December 31, 2023, a decrease of 17.4%. This resulted in a gross profit
for 2023 of US$19.5 million compared to a gross profit for 2022 of US$17.3 million. The gross margin of 34.2% in 2023 compares to a gross
margin of 27.6% in 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The gross profit for the year ended December 31, 2022 reflected significant excess
inventory and obsolescence charges of US$4.7 million recorded in Q3 2022, consisting of VTM inventory write down (US$3.5 million) Tri-stat
inventory write down (US$0.3 million) and other inventory write downs (US$0.9 million). The remainder of the reduction in gross margin
in the year ended December 31, 2023 compared to year ended December 31, 2022 is largely due to sales mix changes, inflationary increases
in the price of raw materials which cannot always be passed onto customers in the form of higher prices due to contract terms.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Other operating income</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Other operating income decreased from US$0.3 million for the year ended December 31,
2022 to US$0.1 million for the year ended December 31, 2023. The other operating income for 2023 relates to a transition services agreement
with the acquirer of Fitzgerald Industries. The income for 2022 consisted of government grants in relation to R&amp;D activities and there
was no equivalent in 2023.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">67</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Research and development expenses</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Research and development expenses increased from US$4.1 million for the year ended
December 31, 2022 to US$4.4 million for the year ended December 31, 2023, an increase of 6% mainly due to lower capitalisation of payroll
costs into product development intangible assets.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Selling, general and administrative expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Selling, general and administrative expenses increased for the year ended December
31, 2023 by US$4.2 million to US$31.2 million when compared to the year ended December 31, 2022, representing an increase of 15.5%. A
significant element of the US$4.2 million increase relates to:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z08149fe6a00b403bb7c9ef685f1004ac" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">i)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>technical advisory, legal and professional fees were higher in 2023 compared to 2022 by US$1.6 million primarily due to costs associated
        with the acquisition of the biosensor assets of Waveform (which closed in January 2024) and other corporate development and corporate
        finance activities as we continue to assess strategic opportunities for inorganic growth and balance sheet optimization,</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z501b54b9f9224aa5842995a7ef30177f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">ii)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>an increase of US$1.5 million in foreign exchange losses largely relating to the accounting requirement to mark to market euro-denominated
        lease liabilities for right-of-use assets, and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z25a6a9dd4aa441b5807aa6e87b97af34" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">iii)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>higher non-cash share-based payments expense of US$0.3 million mainly due to the full year effect of options granted in 2022.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Impairment charges</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Impairment charges increased from US$5.8 million for the year ended December 31, 2022
to US$11.1 million for the year ended December 31, 2023. There are a number of factors taken into account in calculating the impairment,
including the Company&#8217;s period-end share price, calculation of the cost of capital, and future projected cash flows for individual
cash-generating units in the business. In addition, the Group examines individual development project assets for indicators of impairment.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The impairment charges for the year ended December 31, 2023 relate to Immco Diagnostics
Inc (US$10.8 million) and Trinity Biotech Do Brasil (US$0.3 million). As the Company has previously reported, Immco&#8217;s laboratory
had for a number of years provided transplant testing services to a local healthcare provider. However, in early 2023 that healthcare
provider informed Immco that it was moving to a different service provider, and this resulted in lost revenues for the laboratory beginning
in the second quarter of 2023. Additionally, the expected level of laboratory services revenue arising from its proposed partnership with
imaware, Inc (&#8220;imaware&#8221;) did not materialise. As a result, Immco&#8217;s value in use, defined as the present value of its
future cash flows, fell below the value of the carrying amount of its assets, other than inventories, accounts receivable, cash and cash
equivalents and deferred tax assets as at June 30, 2023 (US$10.7 million) and at December 31, 2023 (US$0.1 million).</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Included within the Immco impairment is a full impairment of the financial assets
associated with the Group&#8217;s investment in imaware. To date the Group has paid US$0.7 million of a proposed US$1.5 million investment
to imaware. As the investment agreement provided for a total investment of US$1.5 million, this amount was recognised in the balance sheet
as at March 31, 2023. Given the uncertainty over the future of imaware&#8217;s performance and thus the value of this investment, management
decided to impair the entire US$1.5 million at June 30, 2023. The Group has not to date paid the additional US$0.8 million to imaware
which remains on our balance sheet as an accrued payable.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Similarly, Trinity Biotech do Brasil&#8217;s value in use was below the value of its
relevant assets, and an impairment was provided for as at June 30, 2023 (US$0.1 million) and as at December 31, 2023 (US$0.2 million).</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">68</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">The impairment charges for the year ended December 31, 2022 related to impaired intangible assets relating
to R&amp;D projects (US$4.6 million) and impairment losses identified for three cash generating units, namely Trinity Biotech Do Brasil
(US$0.5 million), Clark Laboratories Inc. (US$0.4 million) and Biopool US Inc (US$0.4 million). For further details, see Item 18, Notes
11, 12, and 13.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Operating Loss</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Operating loss for the year ended December 31, 2023 was US$27.0 million, compared
to an operating loss of US$19.3 million in the year ended December 31, 2022. The higher loss was mainly attributable to decreased revenues,
lower other operating income, higher impairment charges and higher indirect costs, partly offset by a higher gross margin.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Financial expenses</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Financial expenses in the year ended December 31, 2023 were US$11.1 million compared
to US$24.7 million in the year ended December 31, 2022, a decrease of US$13.6 million, broken down as follows:</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="z68263d4523684d7f9438956a663a057b" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-style: italic">Year ended </div>
        <div style="line-height: 1.25; font-style: italic">December 31, 2023</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-style: italic">Year ended </div>
        <div style="line-height: 1.25; font-style: italic">December 31, 2022</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-style: italic">US$m</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="1" class="cftguttercell" style="white-space: nowrap; vertical-align: bottom; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-style: italic">US$m</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Interest on senior secured term loan</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">8.4</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">9.8</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Interest on convertible note</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">1.1</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">0.7</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Penalty for early partial settlement of term loan</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">0.9</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">3.5</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Lease interest</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">0.6</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">0.7</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Loss on disposal of exchangeable notes</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">0.0</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">9.7</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Interest on exchangeable notes</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">0.0</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">0.4</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Other non-cash financial expense</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">0.0</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">0.1</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: middle; width: 76%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Total</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold">11.1</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold">24.7</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  </table>

<div> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Note: table above contains rounded numbers</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The decrease of US$13.6 million in 2023 compared to 2022 is mainly due to two material
expenses incurred in the year ended December 31, 2022, which were a loss of US$9.7 million on the disposal of the Exchangeable Notes and
an early repayment penalty of just under US$3.5 million.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Interest on the senior secured term loan, comprising cash and non-cash interest, decreased
from US$9.8 million in 2022 to US$8.4 million for 2023 mainly due to a lower term loan balance, although this was partly offset by the
impact of higher prevailing interest rates during 2023. Interest on the convertible note, comprising cash and non-cash interest, increased
from US$0.7 million in 2022 to US$1.1 million in 2023 due to the full year effect (the convertible note was issued in Q2 2022). An early
repayment penalty of US$0.9 million was incurred in Q2, 2023 because of an early partial settlement of the term loan of US$10.1 million.
Interest on the exchangeable notes decreased from US$0.4 million in 2022 to US$8,000 in 2023 because 99.7% of the exchangeable notes were
retired during Q1, 2022.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Financial income</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Financial income for the year ended December 31, 2023 was US$1.2 million compared
to US$0.3 million for the year ended December 31, 2022. In both years, the financial income related to a fair value adjustment for the
derivative liability related to warrants granted to the Group&#8217;s principal lender.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Income tax credit</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Company recorded a tax credit on continuing operations of US$59,000 for the year
ended December 31, 2023 compared to a tax credit of US$0.2 million for the year ended December 31, 2022. The 2023 tax credit consists
of approximately US$264,000 of current tax charge and US$323,000 of a deferred tax credit. The 2022 tax credit consists of US$280,000
of current tax credit and US$86,000 of a deferred tax charge. For further details on the Group&#8217;s tax charge please refer to Item
18, Note 7 and Note 14 to the consolidated financial statements.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">69</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Loss before tax from continuing operations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The loss before tax for continuing operations for the year ended December 31, 2023
was US$36.9 million, in comparison to US$43.8 million for the year ended December 31, 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Profit from discontinued operations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The discontinued operations comprise Fitzgerald Industries which was divested in April
2023 and the discontinued cardiac point-of-care business on the Meritas platform. Profit for the period from discontinued operations totalled
US$12.9 million, largely attributable to the gain of US$12.7 million on the divesture of Fitzgerald Industries. The gain comprises proceeds
of approximately US$30 million offset by transaction costs of US$1.3 million with net assets eliminated on disposal of US$16.3 million.
For further details, see Item 18, Note 8.</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="zd8c0fd93fabf41bf90f92a95fc5d6872" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top; font-style: italic; font-weight: bold">B.</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div style="font-style: italic; font-weight: bold">Liquidity and Capital Resources</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The Group&#8217;s capital structure is a mixture of debt and equity. In February 2023,
we announced that we had entered into an amended and restated senior secured term loan credit facility to allow for an immediate US$5
million increase to the outstanding term loan. In April 2023, we announced that we had closed the sale of our Fitzgerald Industries life
sciences supply business, for cash proceeds of approximately US$30 million subject to customary adjustments. We used approximately US$11
million of the proceeds of this sale to repay approximately US$10.1 million of the senior secured debt held by Perceptive plus we incurred
an approximately US$0.9 million early repayment penalty.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">In January 2024, we entered into a further amendment to the Perceptive credit facility,
providing additional capital to fund the acquisition of the Waveform continuous glucose monitoring (CGM) assets. Subsequent amendments
to the facility during 2024 provided incremental funding flexibility to support the ongoing development of our CGM platform. In connection
with these amendments, Perceptive received new warrants to purchase 1.5 million ADSs and the exercise price of its existing warrants was
repriced to US$0.80 per ADS. These steps reflect our ongoing strategy to secure funding for strategic growth initiatives while actively
managing our capital structure.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Exchangeable notes</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Group originally issued US$115.0 million of 30-year exchangeable senior notes
in 2015. The notes are senior unsecured obligations and accrue interest at an annual rate of 4%, payable semi-annually in arrears. In
August 2018, the Group purchased US$15.1 million of the exchangeable notes. The nominal amount of the debt since this purchase had been
US$99.9 million. The notes are convertible into ordinary shares of the parent entity at the applicable exchange rate, at any time prior
to the close of business on the second business day immediately preceding the maturity date, at the option of the holder, or repayable
on April 1, 2045. The conversion rate is 9.422 ADSs per US$1,000 principal amount of notes, equivalent to an exchange price of approximately
US$109.40 per ADS. In February 2024, the Company adjusted its ADS ratio from 1 ADS: 4 ordinary shares to 1 ADS: 20 ordinary shares. The
ADS amounts in this paragraph reflect this change. The notes include a number of non-financial covenants, all of which were complied with
on December 31, 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In December 2021, we entered into agreements with five holders of the exchangeable
notes for the repurchase of approximately 99.7% of the outstanding notes. The agreements were conditioned on certain lending conditions
being met and required shareholder approval, which was obtained in January 2022. In January 2022, we paid approximately US$86.7 million
to the five note holders, using funds from a new term loan from Perceptive and our own cash resources. We also issued a total of 1.06
million ADSs to the five note holders as partial consideration for the exchange of the notes. The remaining outstanding amount owing for
exchangeable notes on December 31, 2024, was US$210,000.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Term loan with Perceptive</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">In December 2021, we entered into a US$81.3 million senior secured term loan credit facility with Perceptive.
The term loan was drawn down in January 2022. The loan was originally due to January 2026, however this has since been amended to a maturity
date of July 2026. The loan initially accrued interest at an annual rate equal to 11.25% plus the greater of (a) one-month LIBOR (later
changed to the Term SOFR Reference Rate effective from October 28, 2022) and (b) one percent per annum, and interest is payable monthly
in arrears in cash. The term loan does not require any amortization, and the entire unpaid balance will be payable upon maturity. The
term loan can be repaid, in part or in full, at a premium before the end of the four-year term.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In connection with the term loan, we agreed to issue warrants to Perceptive for 500,000
of our ADSs. The per ADS exercise price of the Warrants was US$6.50 (subsequently amended in 2023 and again in 2024). The warrants are
exercisable, in whole or part, until the seventh anniversary of the date of drawdown of the funding under the term loan.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">The Company made an early partial settlement of the term loan of US$34.5 million in May 2022 and in accordance
with the term loan&#8217;s credit agreement, there was an early repayment penalty of US$3.45 million. In February 2023, we announced that
we had entered into an amended and restated senior secured term loan credit facility to allow for an immediate US$5 million increase to
the outstanding Term Loan. On April 27, 2023, we used approximately US$11 million of the proceeds of the sale of Fitzgerald Industries
to repay approximately US$10.1 million of the senior secured debt held by Perceptive plus an approximately US$0.9 million early repayment
penalty.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">70</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">In January 2024, we closed the acquisition of the Waveform CGM assets and liabilities
and in connection with that acquisition, we drew down additional funding from Perceptive of US$22 million under an amended Credit Agreement.
The amended Credit Agreement also provided for a further US$6.5 million facility that may be drawn down by the Company between April and
December 2024. In April 2024 the Company drew down the additional funding of US$6.5 million as prescribed in the Amended Term Loan agreement.
This funding will be used for general corporate purposes, including the further development of our CGM offering.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The amended agreement also immediately reduced the annual rate of interest on the
loan by 2.5% to 8.75% (the &#8220;Base Rate&#8221;) plus the greater of (a) Term Secured Overnight Financing Rate (SOFR) or (b) 4.0% per
annum, and allows for a further 2.5% reduction in the Base Rate to 6.25% once the outstanding principal under the Amended Term Loan falls
below $35 million. Additionally, the early repayment penalty was reduced from a range of 8% to 7% to 4.0% to 3.5%, dependent on timing
of early repayment, and reduces the revenue covenants.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">

<div style="line-height: 1.25; color: #000000; font-family: Times New Roman, serif">On December 23, 2024 we entered into the third amendment
and restatement of the credit agreement governing the Term Loan. As part of this agreement, an additional US$2.0 million of funding was
made available to us. We also agreed that certain interest payments payable in 2024 and 2025 would be paid-in-kind on the applicable payment
date by increasing the outstanding principal amount of the Term Loan.&#160; Additional warrants were also provided that allow an additional
1,500,000 ADSs to be purchased (2.5 million ADSs in total) at $0.80 per ADS.&#160; This amendment to the term loan also saw the repricing
of the existing warrants to an exercise price of US$0.80 per ADS.</div> </div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">The outstanding amount owing for the term loan at December 31, 2024 is US$72.4 million.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Under the Amended Term loan, we are subject to a number of covenants and obligations.
Perceptive temporarily reduced the aggregate unrestricted cash covenant to US$2.0 million for the period up to and including April 30,
2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">On February 27, 2025, we entered into the fourth amended and restated credit agreement, which provided
for an additional US$4.0 million increase to our outstanding Term Loan. On May 14<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup>,
2025, we entered into a fifth amendment to the credit agreement, which provided for an additional US$2.0 million in term loan funding,
extended the maturity date of the Term Loan to July 27, 2026, and provided that interest payments for the months of April, May, and June
2025 will be paid-in-kind.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Investment from MiCo IVD Holdings, LLC</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In May 2022, the Company announced a US$45.2 million investment from MiCo IVD Holdings,
LLC. The investment consisted of an equity investment of US$25.2 million and a seven-year, unsecured junior convertible note of US$20.0
million. The convertible note has an interest rate of 1.5% and interest is payable quarterly. The convertible note mandatorily converts
into ADSs if the volume weighted average price of our ADSs is at or above US$12.96 for any five consecutive NASDAQ trading days.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Leases</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Group entered into sale and leaseback arrangements in 2018 with Allied Irish Bank
and Wells Fargo. In January 2022, the Group settled its outstanding lease liability with Allied Irish Bank. During 2023, the lease term
on the Wells Fargo agreement came to an end and the lease was not renewed. The Group also has lease liabilities relating to right-of-use
assets with lease maturities between 1 and 10 years.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Cash and cash equivalents</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">At December 31, 2024, the cash and cash equivalents balance was US$5.2 million. In
the future, the amount of cash generated from operations will depend on a number of factors which include the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf59e6f96325a42b282322c3a2939b248" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The ability of the Group to generate revenue growth from its existing product lines and from new products following the successful
        completion of its development projects;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z512ae36d15804557b31a0639ab35efba" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The extent to which capital expenditure is incurred on additional property plant and equipment;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z34fe80cfacdd4e0fa5e572828abe2deb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The level of investment required to undertake both new and existing development projects; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Successful working capital management in the context of a growing business.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">71</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Liquidity</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In our directors&#8217; opinion, we will have access to sufficient funds to support
its existing operations for at least the next 12 months by utilising existing cash resources and cash generated from operations and external
financing. The directors have considered the Group&#8217;s current financial position and cash flow projections, taking into account all
known events and developments.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">We have incurred net losses and negative cash flows from operating activities in the past two years and
we may not be able to achieve or maintain profitability or positive cash flow in the future. We have incurred losses of US$31.8 million
and US$24.0 million in the years ended December 31, 2024 and 2023, respectively and had negative cash flows from operating activities
of US$4.2 million and US$11.6 million, respectively.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25">We expect to continue as a going concern. Our ability to continue as a going concern depends on our ability
to generate cash flows from operations and to conduct adequate financing activities. We believe that we have access to sufficient cash
reserves for our operating needs for at least the next twelve months from the date of this Annual Report. However, if negative cash flow
from operating activities persists in the long run, cash resources may become insufficient to satisfy our on-going cash requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Additional funding may not be available on acceptable terms, or at all. In addition, we may not be able
to access a portion of our existing cash, cash equivalents and investments due to market conditions. Further, as a result of geopolitical
and macroeconomic events, including the Israel-Hamas and Russia-Ukraine wars, the global credit and financial markets have experienced
volatility and disruptions, including severely diminished liquidity and credit availability, declines in consumer confidence, declines
in economic growth, increases in unemployment rates, and uncertainty about economic stability. If the equity and credit markets deteriorate,
it may make any necessary debt or equity financing more difficult, more costly or more dilutive.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Expansion into new businesses may present operating and marketing challenges different from those we currently
encounter, and we cannot assure that new business initiatives will be successful enough to justify the time, effort, and resources that
we devote to them or ultimately achieve profitability.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">72</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Cash Flows</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">&#160;</div>

<div style="text-align: justify; line-height: 1.25">As at December 31, 2024, our consolidated cash and cash equivalents were US$5.2 million.
The following table presents the major components of net cash flows used in and provided by operating, investing and financing activities.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zcd519a0f34a0433bbab8bd6361d93adf" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2024</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">US$&#8216;000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2023</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">US$&#8216;000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Net cash used in operating activities</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(4,191</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(11,557</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">
        <div style="line-height: 1.25"><span style="font-weight: bold">Net cash (used in)/generated by investing activities</span></div> </div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(22,968</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">24,756</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">
        <div style="line-height: 1.25"><span style="font-weight: bold">Net cash generated by/(used in)from financing activities</span></div> </div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">28,810</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(16,042</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="font: 1pt/1.25 Times New Roman, serif">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 4px">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">Net increase/(decrease) in cash and cash equivalents and short-term investments</div> </div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,651</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(2,843</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px">
        <div style="line-height: 1.25">)</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Operating Activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Net cash used in operating activities for the year ended December 31, 2024 amounted to US$4.2 million (2023:
US$11.6 million), a decrease in cash used of US$7.4 million. The decrease in net cash generated from operating activities of US$7.4 million
is attributable to an increase in working capital outflows of US$6.7 million, and a decrease in operating cash flows before changes in
working capital of US$0.2 million, partially offset by an increase in taxes received of US$0.7 million. The decrease in operating cash
flows before changes in working capital is primarily driven by an increase in trade and other payables compared to the prior year.</div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Investing Activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Net cash used in investing activities for the year ended December 31, 2024 amounted to US$23.0 million
(2023: net cash generated of US$24.8 million) which were principally made up as follows:</div> </div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="zf04ea265ad7d48d3bc5e1c4475ec3d05" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Payments to acquire intangible assets of US$9.7 million (2023: US$1.9 million), which principally related to development expenditure
        capitalised as part of the Group&#8217;s on-going product development activities;</div> </td> </tr>
  </table>

<div> <br/> </div>

<div> </div>

<table cellspacing="0" cellpadding="0" id="z9bafbe45690842a78d6f77d326e24143" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>
        <div style="line-height: 1.25">Payments to acquire financial assets of US$nil million (2023: US$0.7 million);</div> </div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zbcfbc1cfc28f4615b1ffa565fec26735" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Acquisition of property, plant and equipment of US$0.4 million (2023: US$0.8 million) incurred as part of the Group&#8217;s investment
        programme for its manufacturing and distributing activities; and,</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z5a65b24584d7493cb8da8fdf5df1f09a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>
        <div style="line-height: 1.25">Payments to acquire trades or businesses of US$12.9 million (2023: US$nil) which relates primarily to the
        acquisition of the CGM assets of Waveform Technologies Inc.</div> </div> </td> </tr>
  </table>

<div> <br/> </div>

<div> </div>

<table cellspacing="0" cellpadding="0" id="z8ab756b5d9ae403fb7313bd2f66db1b5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Proceeds from the sale of a business of US$nil (2023: US$28.2 million).</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Financing Activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Net cash generated from financing activities for the year ended December 31, 2024 amounted to US$28.8 million
(2023: outflow of US$16.0 million). This inflow is due to additional draw down of the senior secured loan of US$30.2 million, additional
share issuances of $7.4 million, payments for lease liabilities of US$2.5 million and interest payments of US$5.9 million. In 2023 the
net outflow related to the partial early repayment of the term loan US$10.1 million, plus early payment penalty of US$0.9 million, payments
for lease liabilities of US$2.3 million, interest payments of US$7.6 million, partly offset by the draw down of the term loan of US$5.0
million.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc60066e88baf4c959886bc735628659f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top; font-style: italic; font-weight: bold">C.</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div style="font-style: italic; font-weight: bold">Research and Development, Patents and Licences, etc.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">For information on research and development, patents and licences see &#8220;Item
4. Information on the Company&#8212;Item 4.B Business overview.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">73</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z5eff9982ebbd445cb8e42d11fbb188b4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top; font-style: italic; font-weight: bold">D.</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div style="font-style: italic; font-weight: bold">Trend Information</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">For a discussion of trends, see Item 4.B&#8212;Business Overview, Item 5.A&#8212;Operating Results and
Item 5.B&#8212;Liquidity and Capital Resources.</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="z8ba0c7ccf9ab4076ad644c420234a12a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top; font-style: italic; font-weight: bold">E.</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div style="font-style: italic; font-weight: bold">Critical Accounting Policies and Estimates</div> </td> </tr>
  </table>

<div> <br/> </div>

<div style="text-align: justify; line-height: 1.25">Our discussion and analysis of our financial condition and results of operations are
based upon our consolidated financial statements, which have been prepared in accordance with IFRS. The preparation of these financial
statements requires us to make estimates and judgements that affect the reported amount of assets, liabilities, revenues and expenses,
and related disclosure of contingent assets and liabilities.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">On an on-going basis, we evaluate our estimates, including those related to intangible
assets, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed
to be reasonable under the circumstances, the results of which form the basis for making judgements about the carrying values of assets
and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions
or conditions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We believe the critical accounting policies described below reflect our more significant
judgements and estimates used in the preparation of our consolidated financial statements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Revenue Recognition</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Group recognises revenue when it transfers control over a good or service to a
customer. Revenue is recognised to the extent that it is probable that economic benefit will flow to the Group and the revenue can be
measured. No revenue is recognised if there is uncertainty regarding recovery of the consideration due at the outset of the transaction.
Revenue, including any amounts invoiced for shipping and handling costs, represents the value of goods and services supplied to external
customers, net of discounts and rebates and excluding sales taxes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The core principle in IFRS 15 is a five-step model framework: 1) identify the contract(s)
with a customer, 2) identify the performance obligations in the contract, 3) determine the transaction price, 4) allocate the transaction
price to the performance obligations in the contract and 5) recognise revenue when (or as) the entity satisfies a performance obligation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Revenue from products is generally recorded as of the date of shipment, consistent
with typical ex-works shipment terms. Where the shipment terms do not permit revenue to be recognised as of the date of shipment, revenue
is recognised when the Group has satisfied all of its performance obligations to the customer in accordance with the shipping terms.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Some contracts oblige the Group to ship product to the customer ahead of the agreed
payment schedule. For these shipments, a contract asset is recognised when control over the goods has transferred to the customer. The
financing component is insignificant as invoicing for these shipments occurs within a short period of time after shipment has occurred
and typically standard 30-day credit terms apply. Some contracts could be regarded as offering the customer a right of return. Due to
the uncertainty of the magnitude and likelihood of product returns, there is a level of estimation involved in assessing the amount of
revenue to be recognized for these types of contracts. In accordance with IFRS 15, when estimating the effect of an uncertainty on an
amount of variable consideration to which the Group will be entitled, all information that is reasonably available, including historical,
current and forecast, is considered.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Group operates a licenced referenced laboratory in the U.S. which provides testing
services to institutional customers and insurance companies. In the U.S., there are rules requiring all insurance companies to be billed
the same amount per test. However, the amount that each insurance company pays for a particular test varies according to their own internal
policies and this can typically be considerably less than the amount invoiced. We recognise lab services revenue for insurance companies
by taking the invoiced amount and reducing it by an estimated percentage based on historical payment data. We review the percentage reduction
annually based on the latest data. As a practical expedient, and in accordance with IFRS, we apply a portfolio approach to the insurance
companies as they have similar characteristics. We judge that the effect on the financial statements of using a portfolio approach for
the insurance companies will not differ materially from applying IFRS 15 to the individual contracts within that portfolio.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">74</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Revenue from services rendered is recognised in the statement of operations in proportion
to the stage of completion of the transaction at the balance sheet date.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Group leases instruments to customers typically as part of a bundled package.
Where a contract has multiple performance obligations and its duration is greater than one year, the transaction price is allocated to
the performance obligations in the contract by reference to their relative standalone selling prices. For contracts where control of the
instrument is transferred to the customer, the fair value of the instrument is recognised as revenue at the commencement of the lease
and is matched by the related cost of sale. Fair value is determined on the basis of standalone selling price. In the case where control
of the instrument does not transfer to the customer, revenue is recognised on the basis of customer usage of the instrument. See also
Note 1(v).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In obtaining these contracts, the Group incurs a number of incremental costs, such
as sales bonus paid to sales staff, commissions paid to distributors and royalty payments. As the amortisation period of these costs,
if capitalised, would be less than one year, the Group makes use of the practical expedient in IFRS 15.94 and expenses them as they incur.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">A receivable is recognised when the goods are delivered as this is the point in time
that the consideration is unconditional because only the passage of time is required before the payment is due.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Group&#8217;s obligation to provide a refund for faulty products under the standard
warranty terms is recognised as a provision, see Note 22 for details.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Research and development expenditures &#8211; capitalized development
costs</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Under IFRS as issued by IASB, we write-off research and development expenditures as
incurred, with the exception of expenditures on projects whose outcome has been assessed with reasonable certainty as to technical feasibility,
commercial viability and recovery of costs through future revenues. Such expenditure is capitalised at cost within intangible assets and
amortised over its expected useful life of 15 years, which commences when the product is launched.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Acquired in-process research and development (IPR&amp;D) is valued at its fair value
at acquisition date in accordance with IFRS 3. The Company determines this fair value by adopting the income approach valuation technique.
Once the fair value has been determined, the Company will recognise the IPR&amp;D as an intangible asset when it: (a)&#160;meets the definition
of an asset and (b)&#160;is identifiable (i.e., is separable or arises from contractual or other legal rights). IPR&amp;D is tested for
impairment on an annual basis, in the fourth quarter, or more frequently if impairment indicators are present, using projected discounted
cash flow models. If IPR&amp;D becomes impaired or is abandoned, the carrying value of the IPR&amp;D is written down to its revised fair
value with the related impairment charge recognised in the period in which the impairment occurs. If the fair value of the asset becomes
impaired as the result of unfavourable data from any ongoing or future clinical trial, changes in assumptions that negatively impact projected
cash flows, or because of any other information regarding the prospects of successfully developing or commercialising our programs, we
could incur significant charges in the period in which the impairment occurs. The valuation techniques utilised in performing impairment
tests incorporate significant assumptions and judgments to estimate the fair value, as described above. The use of different valuation
techniques or different assumptions could result in materially different fair value estimates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Factors which impact our judgement to capitalise certain research and development expenditure include the
degree of regulatory approval for products and the results of any market research to determine the likely future commercial success of
products being developed. We review these factors each year to determine whether our previous estimates as to feasibility, viability and
recovery should be changed. At December 31, 2024 the carrying value of capitalised development costs was US$20.9 million (2023: US$15.1
million) (see Note 12 to the consolidated financial statements). The increase in 2024 was mainly due to additions of US$8.6 million partly
offset by impairment charges of US$1.6 million and amortization of US$1.2 million.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Impairment of intangible assets and goodwill</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Definite lived intangible assets are reviewed for indicators of impairment periodically
while goodwill and indefinite lived assets are tested for impairment periodically, either individually or at the cash-generating unit
level. Factors considered important, as part of an impairment review, include the following:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb237af0e010644f4b17fb88c7424b723" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Significant underperformance relative to expected, historical or projected future operating results;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbd722a92d15a41029ea5befc7f4dd83d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Significant changes in the manner of our use of the acquired assets or the strategy for our overall business;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">75</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="zb3b23d36e25d4cdbbb26b1e959c3b886" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Obsolescence of products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd241753e97d74290b4f8ad48162b7c4e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Significant decline in our stock price for a sustained period; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfa243e140b144d128015577c94991a9f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Our market capitalisation relative to net book value.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">When we determine that the carrying value of intangibles, non-current assets and related
goodwill may not be recoverable based upon the existence of one or more of the above indicators of impairment, any impairment is measured
based on our estimates of projected net discounted cash flows expected to result from that asset, including eventual disposition. Our
estimated impairment could prove insufficient if our analysis overestimated the cash flows or conditions change in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Goodwill and other intangibles are subject to impairment testing on a periodic basis.
The recoverable amount of our nine cash-generating units (&#8220;CGUs&#8221;) is determined based on a value-in-use computation. The value-in-use
calculations use cash flow projections based on the 2025 projections for each CGU and a further four years projections using estimated
revenue and cost average growth rates of between 0% and 5%. At the end of the five-year forecast period, terminal values for each CGU,
based on a long term growth rate of 2%, are used in the value-in-use calculations. The value-in-use represents the present value of the
future cash flows, including the terminal value, discounted at a rate appropriate to each CGU. The pre-tax discount rates used range from
17% to 28% (2023 15% to 22%). Refer to Item 18, Note 12 for further information.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The cash flows have been arrived at taking into account the Group&#8217;s financial
position, its recent financial results and cash flow generation and the nature of the medical diagnostic industry, where product obsolescence
can be a feature. However, expected future cash flows are inherently uncertain and are therefore liable to material change over time.
The key assumptions employed in arriving at the estimates of future cash flows factored into impairment testing are subjective and include
projected EBITDA margins, net cash flows, discount rates used and the duration of the discounted cash flow model. Significant under-performance
in any of the Group&#8217;s major CGUs may give rise to a material impairment which would have a substantial impact on the Group&#8217;s
income and equity.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">Impairment charges decreased from US$11.1 million for the year ended December 31, 2023 to US$1.4 million
for the year ended December 31, 2024.&#160; In year ended December 31, 2024, impairment loss was identified for four CGUs and specific
development projects. Biopool US Inc&#8217;s value in use was below the value of its relevant assets, and an impairment was provided for
as at June 30, 2024 (US$0.1 million) and as at December 31, 2024 (US$0.2 million). Immco Diagnostics&#8217;s value in use was below the
value of its relevant assets, and an impairment was provided for as at June 30, 2024 (US$0.1 million) and as at December 31, 2024 (US$0.1
million). Clark Laboratories Inc&#8217;s value in use was below the value of its relevant assets, and an impairment was provided for as
at June 30, 2024 (US$0.1 million) and as at December 31, 2024 (US$0.1 million). Trinity Biotech do Brasil&#8217;s value in use was below
the value of its relevant assets, and an impairment was provided for as at June 30, 2024 (US$0.2 million) and as at December 31, 2024
(US$0.2 million). During the year the Company reassessed the carrying value of its current development projects. Specific impairments
were recognized in respect of two projects totaling US$1.2 million.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">During 2023, the Company fully impaired its investment in imaware which constituted an amount paid of $0.7
million of the committed US$1.5 million investment with the remaining US $0.8 million, which had not yet been funded, recognized as an
accrued liability. In 2024, the Company reversed US$0.8 million of the previously recognised impairment through profit or loss, corresponding
to the accrued balance that was no longer payable under the terms of the investment agreement.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The value-in-use calculation is subject to significant estimation, uncertainty and
accounting judgements and the following sensitivity analysis has been performed:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z229e682111e24e35b700e1cf31f8f24f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>In the event that there was a reduction of 10% in the assumed level of future growth in revenue growth rate, which would represent
        a reasonably likely range of outcomes, there would be no additional impairment loss recorded at December&#160;31, 2024.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9b663eb651be4f14bb5859d9c3024005" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>In the event there was a 10% increase in the discount rate used to calculate the potential impairment of the carrying values, which
        would represent a reasonably likely range of outcomes, there would be no additional impairment loss recorded at December&#160;31, 2024.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">76</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Allowance for slow-moving and obsolete inventory</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">We evaluate the realisability of our inventory on a case-by-case basis and adjust our inventory provision
based on our estimates of expected losses. We write off inventory that is approaching its &#8220;use-by&#8221; date and for which no further
re-processing can be performed. We also consider recent trends in revenues for various inventory items and instances where the realisable
value of inventory is likely to be less than its carrying value. Given the allowance is calculated on the basis of the actual inventory
on hand at the particular balance sheet date, there were no material changes in estimates made during 2024, 2023 or 2022 which would have
an impact on the carrying values of inventory during those periods, except as discussed below. At December&#160;31, 2024 our allowance
for slow moving and obsolete inventory was US$7.6 million which represents approximately 28.3% of gross inventory value. At December 31,
2023 our allowance for slow moving and obsolete inventory was US$11.3 million, which represented approximately 36.3% of gross inventory
value and at December 31, 2022 the provision was US$16.3 million, or approximately 42.0% of gross inventory value (see Note 16 to the
consolidated financial statements).</div> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">The allowance for slow moving and obsolete inventory has decreased by US$3.7 million between 2023 and 2024
primarily due to the utilisation of the provision through scrappage during the year.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25">Management is satisfied that the assumptions made with respect to future sales and
production levels of these products are reasonable to ensure the adequacy of this provision. In the event that the estimate of the provision
required for slow moving and obsolete inventory was to increase or decrease by 2% of gross inventory, which would represent a reasonably
likely range of outcomes, then a change in allowance of US$0.5 million at December&#160;31, 2024 (2023: US$0.6 million) (2022: US$0.8
million) would result.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Share-based payments</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">For equity-settled share-based payments (share options), the Group measures the services
received and the corresponding increase in equity at fair value at the measurement date (which is the grant date) using a trinomial model.
Given that the share options granted do not vest until the completion of a specified period of service, the fair value, which is assessed
at the grant date, is recognised on the basis that the services to be rendered by employees as consideration for the granting of share
options will be received over the vesting period.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Certain share options have been granted for which there is a condition that the options
only become exercisable into ADSs when the market price of an ADS reaches a certain level. This is deemed to be a non-vesting condition.
The term &#8216;non-vesting condition&#8217; is not explicitly defined in IFRS 2, Share based Payment, but is inferred to be any condition
that does not meet the definition of a vesting condition. The only condition for these options to vest is that the option holder continues
service and there were no other conditions which would be considered non-vesting conditions. Non-vesting conditions are reflected in measuring
the grant-date fair value of the share-based payment and there is no true-up in the measurement of the share-based payment for differences
between the expected and the actual outcome of non-vesting conditions. If all service conditions are met, then the share-based payment
cost will be recognized even if the option holder does not receive the share-based payment due to a failure to meet the non-vesting condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The expense in the statement of operations in relation to share options represents
the product of the total number of options anticipated to vest and the fair value of those options; this amount is allocated to accounting
periods on a straight-line basis over the vesting period.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Share based payments, to the extent they relate to direct labour involved in development
activities, are capitalised.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The proceeds received net of any directly attributable transaction costs are credited
to share capital (nominal value) and share premium when the options are exercised. The Group does not operate any cash-settled share-based
payment schemes or share-based payment transactions with cash alternatives as defined in IFRS 2.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Senior secured term loan and related derivative balances</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">In 2022, we completed the drawdown of a senior secured term loan credit facility with Perceptive. The term
loan is represented by three separate balances in our balance sheet. Firstly, included in long term liabilities is a senior secured term
loan balance, which, at initial recognition, comprised the principal loan amount of US$81.3 million less loan origination costs of US$3.6
million, less two derivative financial balances totaling US$1.7 million. This balance was reduced by an early partial payment of the loan
of US$34.5 million in early 2022. In early 2023, we completed a drawdown of US$5 million of additional funding on the term loan, and subsequently,
in quarter two of 2023, repaid US$10 million against the loan on the back of the sale of Fitzgerald Industries. The other two balances
are a derivative financial asset and a derivative financial liability, and these were initially recognised at fair value under IFRS 9.
The derivative financial asset is valued at US$0.2 million at December 31, 2024 (2023: US$0.2 million and represents an estimate of the
value to the Company of being able to repay the term loan early and potentially refinance at lower interest rate. The derivative financial
liability is valued at US$1.7 million at December 31, 2024 (2023: US$0.5 million) and represents the fair value of the warrants issued
to Perceptive. As part of the Credit Agreement, the Company agreed to issue warrants to Perceptive for 500,000 of the Company&#8217;s
ADSs. The initial per ADS exercise price of the warrants was US$6.50. The warrants are exercisable, in whole or part, until the seventh
anniversary of the date of drawdown of the funding under the term loan.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">77</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">In connection with the acquisition of the Waveform assets, the Company entered an
amended credit agreement in January 2024 with Perceptive. Under the revised agreement, an additional US$22 million of funding drawn down,
with US$12.5 million being used to acquire the Waveform assets. The remaining US$9.5 million is intended to be used for general corporate
purposes including for the further development of the CGM and biosensor technologies. In addition, the amended agreement provides for
additional liquidity of up to US$6.5 million, that may be drawn down between April and December 2024, and can be used for general corporate
purposes, thereby providing further liquidity to fund the development of the CGM and biosensor technologies. In April 2024 the Company
drew down the additional funding of US$6.5 million as prescribed in the Amended Term Loan agreement. This funding will be used for general
corporate purposes, including the further development of our CGM offering.</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">The amended agreement also immediately reduced the annual rate of interest on the loan by 2.5% to 8.75%
(the &#8220;Base Rate&#8221;) plus the greater of (a) Term Secured Overnight Financing Rate (SOFR) or (b) 4.0% per annum, and allows for
a further 2.5% reduction in the Base Rate to 6.25% once the outstanding principal under the Amended Term Loan falls below $35 million.
Additionally, the early repayment penalty was reduced from a range of 8% to 7% to 4.0% to 3.5%, dependent on timing of early repayment,
and reduces the revenue covenants. </div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman, serif"><span style="color: #000000">On December 23, 2024, we entered into
the third amendment and restatement of the credit agreement governing the Term Loan. As part of this agreement, an additional $2.0 m</span>illion<span style="color: #000000">
of funding was made available to us. We also agreed that certain interest payments payable in 2024 and 2025 would be paid-in-kind on the
applicable payment date by increasing the outstanding principal amount of the Term Loan. Additional warrants were also provided that allow
an additional 1,500,000 </span>ADS&#8217;s<span style="color: #000000"> to be purchased (2.5 million </span>ADS&#8217;s<span style="color: #000000">
in total) at US$0.80 per </span>ADS<span style="color: #000000">.&#160; This amendment to the term loan also saw the repricing of the
existing warrants to an exercise price of US$0.80 per </span>ADS<span style="color: #000000">. On February 27, 2025, we entered into the
fourth amended and restated credit agreement, which provided for an additional US$4.0 million increase to our outstanding Term Loan. In
addition, a deferred consideration payment of $5.0 million related to the acquisition of the biosensor assets of Waveform was extended
to November 2025. On May 14</span><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller">th</sup>,<span style="color: #000000">
2025, we entered into a fifth amendment to the credit agreement, which provided for an additional US$2.0 million in term loan funding,
extended the maturity date of the Term Loan to July 27, 2026, and provided that interest payments for the months of April, May, and June
2025 will be paid-in-kind.</span></div> </div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic">Litigation</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">From time to time, we may be subject to various claims and contingencies in the ordinary
course of business, including those related to litigation, business transactions, our intellectual property, regulatory compliance, employee-related
matters and taxes, and others. When we are aware of a claim or potential claim, we assess the likelihood of any loss or exposure. If it
is probable that a loss will result and the amount of the loss can be reasonably estimated, we will record a liability for the loss. In
addition to the estimated loss, the recorded liability includes probable and estimable legal costs associated with the claim or potential
claim. There is no assurance that such matters will not materially and adversely affect our business, financial position, and results
of operations or cash flows.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">78</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Item&#160;6. &#160;&#160;&#160;&#160;<span style="font-style: italic"><span id="DirectorsSeniorManagementandEmployees"><!--Anchor--></span>Directors,
Senior Management and Employees</span></div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zf63e51b14c684d538ee66bd1d5f19226" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">A.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Directors and Senior Management</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Executive Officers and Directors</div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We are managed by a board of directors, which is currently comprised of five members,
and our executive senior management.&#160;The following table presents information about our current executive officers and members of
our board of directors.&#160;The term&#160;executive officer refers to any person&#160;in charge of a principal business unit, division
or function (such as sales, administration or finance), any other officer who performs a policy making function or any other person who
performs similar policy making functions for the&#160;registrant.&#160;Executive officers&#160;of subsidiaries may be deemed&#160;executive
officers&#160;of the&#160;registrant&#160;if they perform such policy making functions for the&#160;registrant.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Directors and Senior Management</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="2" border="0" id="z44ecab1c41764819bd13b9e33e766ee6" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36.96%; vertical-align: bottom">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Name</div> </td>
    <td style="width: 63.04%; vertical-align: bottom">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Title</div> </td> </tr>
  <tr>
    <td style="width: 36.96%; vertical-align: bottom">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Directors</div> </td>
    <td style="width: 63.04%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="width: 36.96%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">John Gillard</div> </td>
    <td style="width: 63.04%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Director, President and Chief Executive Officer</div> </td> </tr>
  <tr>
    <td style="width: 36.96%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Ronan O&#8217;Caoimh</div> </td>
    <td style="width: 63.04%; vertical-align: bottom">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Director, Founder &amp; Executive Advisor</div> </td> </tr>
  <tr>
    <td style="width: 36.96%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Jim Walsh, PhD</div> </td>
    <td style="width: 63.04%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Executive Director of Business Development</div> </td> </tr>
  <tr>
    <td style="width: 36.96%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Tom Lindsay</div> </td>
    <td style="width: 63.04%; vertical-align: bottom">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Independent Director</div> </td> </tr>
  <tr>
    <td style="width: 36.96%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Andrew Omidvar PhD,MBA</div> </td>
    <td style="width: 63.04%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Independent Director</div> </td> </tr>
  </table>

<div><br/> </div>

<table cellspacing="0" cellpadding="2" border="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36.96%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Executive Officers</div> </td>
    <td style="width: 63.04%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="width: 36.96%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Matthew Wictome</div> </td>
    <td style="width: 63.04%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Vice President of Quality and Regulatory Affairs</div> </td>
        </tr>
  <tr>
    <td style="width: 36.96%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Susan O&#8217;Connor</div> </td>
    <td style="width: 63.04%; vertical-align: bottom">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Interim Chief Financial Officer</div> </td> </tr>
  <tr>
    <td style="width: 36.96%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Gary Keating, PhD</div> </td>
    <td style="width: 63.04%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Chief Technology Officer</div> </td> </tr>
  <tr>
    <td style="width: 36.96%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Eibhl&#237;n Kelly</div> </td>
    <td style="width: 63.04%; vertical-align: bottom">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Chief Information Officer</div> </td> </tr>
  <tr>
    <td style="width: 36.96%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Colm Molloy</div> </td>
    <td style="width: 63.04%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Group Director of Human Resources and Culture</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Changes in Executive Officers and Board composition</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman, serif">Des Fitzgerald, who has acted as interim CFO since December 2023 was
replaced by Louise Tallon who joined as Chief Financial Officer and Company Secretary in August 2024. Susan O&#8217;Connor was appointed
as Interim CFO in April 2025 succeeding Louise Tallon, who stepped down as CFO effective April 11, 2025. In addition, Matthew Wictome
succeeded Ian Wells as Vice President of Quality and Regulatory Affairs in April 2025</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">John Gillard, Director, President and Chief Executive
Officer, </span>joined Trinity Biotech in November 2020 as Chief Financial Officer, Secretary to the Board of Directors and was appointed
to the Board as Executive Director. Mr. Gillard assumed the role of CEO and President of Trinity Biotech in December 2023. Mr. Gillard
is both a Chartered Accountant and Chartered Tax Advisor, having trained at PWC. Prior to joining Trinity Biotech, Mr. Gillard held a
number of senior financial roles including from 2012 to 2016 at Alphabet Inc./Google, and from Nov 2016 to May 2020 at ION Investment
Group. From June 2020 until November 2020, Mr. Gillard also acted as a business consultant. Mr. Gillard holds a Bachelor of Commerce degree
from the National University of Ireland Galway and a Masters degree in Accounting from University College Dublin.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">Ronan O&#8217;Caoimh, Director, Founder &amp; Executive
Advisor,</span> co-founded Trinity Biotech in June 1992 and acted as Chief Financial Officer until March 1994 when he became Chief Executive
Officer. He was also elected Chairman in May 1995. On May 3, 2022, Mr. O&#8217;Caoimh stepped down as Chairman and was replaced as Chairman
by Seon Kyu Jeon. On October 3, 2022, Mr O&#8217;Caoimh stepped down as Chief Executive Officer. Prior to joining Trinity Biotech, Mr
O&#8217;Caoimh was Managing Director of Noctech Limited, an Irish diagnostics company. Mr O&#8217;Caoimh was Finance Director of Noctech
Limited from 1988 until January 1991 when he became Managing Director. Mr O&#8217;Caoimh holds a Bachelor of Commerce degree from University
College Dublin. On March&#160;30, 2011, the service agreement with Ronan O&#8217;Caoimh as Chief Executive Officer was terminated and
replaced by a management agreement with Darnick Company. This arrangement ceased with effect from December 31, 2018, with Ronan O&#8217;Caoimh
returning as an employee of the Company.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">79</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">Jim Walsh, PhD, Executive Director of Business Development,</span>
initially joined Trinity Biotech in October 1995 as Chief Operations Officer.&#160;Dr Walsh resigned from the role of Chief Operations
Officer in 2007 to become a Director of the Company. In October 2010, Dr Walsh rejoined the Company as Chief Scientific Officer. Dr Walsh
transferred from this position in 2015 and now provides strategic advice and technical diligence support, on a part time basis, with regards
to the Company&#8217;s business development activities. Prior to joining Trinity Biotech, Dr Walsh was Managing Director of Cambridge
Diagnostics Ireland Limited (&#8220;CDIL&#8221;).&#160;He was employed with CDIL since 1987.&#160;Before joining CDIL he worked with Fleming
GmbH as Research&#160;&amp; Development Manager.&#160;Dr. Walsh is a director of a number of private Irish companies in the biotechnology
and diagnostics sector, including EPONA Biotech since 2016, AllWorth Diagnostics since 2019 and AbacusLabs since 2020. Dr Walsh holds
a PhD degree in Chemistry from University College Galway.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">Tom Lindsay, Independent Director</span>, joined the
Board as a non-executive director in October 2022. Mr. Lindsay has more than 35 years of sales and marketing leadership experience in
the global medical diagnostics industry and was President of Alere Inc&#8217;s (now Abbotts&#8217;s) business in Africa for many years.
Most recently, Mr Lindsay has provided consultancy services to several international in vitro diagnostics businesses. He currently serves
as a non-executive director for Genedrive plc, a rapid, low-cost molecular diagnostics platform for the identification and treatment of
a selection of infectious diseases.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25"><span style="font-weight: bold">Andrew Omidvar, Independent Director</span> joined the Board of Trinity
Biotech in December 2023. With over twenty-five years of experience leading cross-functional teams to deliver cutting edge technology
solutions in a variety of industries. He brings experience in development and product support for data and AI based systems in the medical
device industry. Most recently Dr. Omidvar served as Vice President of Government R&amp;D and Enterprise for Philips.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Executive Officers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">Dr. Matthew Wictome, Vice President of Quality and
Regulatory Affairs</span>, was appointed to this<span style="font-weight: bold">&#160;</span>role in January 2025. He is also the Founder
and Managing Director of Datod Consulting, specialising in building world-class Quality organisations. With over 30 years of experience
in the healthcare sector, Dr. Wictome has held leadership roles in R&amp;D and Quality at Johnson &amp; Johnson, Ortho Clinical Diagnostics,
and the UK&#8217;s Health Protection Agency. He holds a BSc in Biochemistry from the University of Bath, a PhD in Biochemistry from the
University of Southampton, and an MSc in Strategy, Change and Leadership from the University of Bristol&#8217;s Executive Development
Program. Dr. Wictome is also the co-author of Transforming Quality Organizations: A Practical Guide (Business Expert Press, New York,
April 2023).</div>

<div style="text-align: justify; line-height: 1.25">&#160;

<div style="line-height: 1.25"><span style="font-weight: bold">Susan O&#8217;Connor, Interim Chief Financial Officer</span>, joined the
company in April 2025 as our CFO on an interim basis. She is a PwC-trained Chartered Accountant with over 20 years of diverse international
experience in Technology, High-tech manufacturing, Health and Life Sciences, Professional Services and Financial Services sectors in Ireland,
UK, Canada and Australia. Prior to joining Trinity Biotech, Ms. O&#8217;Connor was CFO of Glantus Holdings plc, where, having worked previously
on its successful IPO, she led its transition through a trade sale and post-acquisition integration. She has held CFO and consulting roles
in both public and private companies, supporting IPOs, M&amp;A transactions, and operational restructurings and scale-ups. Ms. O&#8217;Connor
holds a Master of Science in the Management of IT in Accounting from Dublin City University and a Diploma in Strategic Finance and Analytics
from Chartered Accountants Ireland.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">Gary Keating, Chief Technology Officer</span>, joined
us in October 2022. Dr Keating graduated from the University of Ulster at Jordanstown with a BSc in Applied Biochemical Sciences and pursued
his interest in biosensors in Prof Richard O&#8217;Kennedy&#8217;s Applied Biochemistry group at DCU, where he worked on the development
of antibody-based optical biosensors for the detection of small drug molecules.&#160; Dr Keating earned his PhD in 1998; the external
examiner for his doctorate was Prof George Guilbault, who described the first amperometric glucose electrode.&#160; Prior to joining Trinity
Biotech, Dr Keating held the position of CTO with Hibergene Diagnostics Ltd. from October 2014 to August 2022. Previous to Hibergene,
Dr Keating held a range of technical leadership roles in start-up and multinational diagnostics companies, including Transfer Manager
at Abbott Diagnostics and R&amp;D Manager at Diasorin Ireland.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">Eibhl&#237;n Kelly, Chief Information Officer, </span>has
served as our Chief Information Officer since September 2015. Previously, she served as Customer Services Manager at Lynq Limited between
2011 and 2015, and Service Delivery/Support Manager at Trinity Biotech between 2005 and 2011. She graduated with an honour&#8217;s degree
in Business Information Systems Development from Dublin Institute of Technology.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">Colm Molloy</span>, <span style="font-weight: bold">Group
Director of Human Resources and Culture</span>, has over 30 years Human Resources and training experience and joined Trinity Biotech in
January 2021. Prior to joining Trinity Biotech, he served as Head of Human Resources with Nuritas, a biotechnology company from June 2019
to July 2020. His previous roles included HR Director at Storm Technology from March 2015 to June 2019 and Head of Human Resources at
Grant Thornton Ireland from 2011 to 2015. He is a Fellow of the Chartered Institute of Personnel and Development (CIPD) and a Graduate
of the Marketing Institute of Ireland.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">80</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Additional Information</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">There are no family relationships between any of the directors or members of senior
management named above.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Our Memorandum and Articles of Association of the Company (the &#8220;Articles&#8221;)
provide for a board of directors of not less than four and not more than ten members with the exact number of directors, from time, to
time, determined solely by a resolution of our board of directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Our board of directors is currently composed of five directors. Officers serve at
the pleasure of the board of directors, subject to the terms of any agreement between the officer and us.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Pursuant to the terms of the Securities Purchase Agreement signed by Trinity Biotech
plc and MiCo IVD Holdings LLC (&#8220;MiCo&#8221;) on April 11, 2022, and the Redeemeable Unsecured Convertible Loan Note issued by us
on May 3, 2022, MiCo have the right to nominate up to four individuals for consideration by the Nomination Committee of the Board of Directors
for appointment to the Board of Directors, subject to certain minimum holding requirements. Three of MiCo's four nominees are required
to meet the independence standards set out in the NASDAQ stock Market Rules at all times and at least one of those nominees must have
substantial experience at a diagnostics testing business having annualised revenues of greater than US$1 billion. In considering MiCo's
nominees, the Nomination Committee of the Board of Directors is required to take into consideration the need for the Company to retain
its Irish tax status and status as a foreign private issuer under applicable federal securities laws.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We are not aware of any other arrangements or understandings with major shareholders,
customers, suppliers or others, pursuant to which any person referred to above was selected as a director or member of senior management.</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze8ee2d5e764a4c4b970be31930cd4755" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">B.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Compensation</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The 2024 remuneration scheme was approved by the Board of Directors.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Total directors and independent directors&#8217; remuneration, excluding pension and
share options, for the year ended December&#160;31, 2024 amounted to US$957,000. The pension charge for the year amounted to US$39,000.
See Item 18, Note 9 to the consolidated financial statements. The split of directors&#8217; remuneration set out by director is detailed
in the table below:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9d8d3c51f3ed48efb6de2af775006940" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 14%">
        <div style="line-height: 1.25; font-style: italic">Director</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: top; width: 14%">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25; font-style: italic">Title</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-style: italic">Salary/Other payments/</div>
        <div style="line-height: 1.25; font-style: italic">Benefits</div>
        <div style="line-height: 1.25; font-style: italic">US$&#8217;000</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-style: italic">Performance</div>
        <div style="line-height: 1.25; font-style: italic">related bonus</div>
        <div style="line-height: 1.25; font-style: italic">US$&#8217;000</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25"><span style="line-height: 1.25"> </span></div>
        <div style="line-height: 1.25"><span style="line-height: 1.25"> </span></div>
        <div style="line-height: 1.25; font-style: italic">Transaction</div>
        <div style="line-height: 1.25; font-style: italic">related bonus</div>
        <div style="line-height: 1.25; font-style: italic">US$&#8217;000</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-style: italic">Defined</div>
        <div style="line-height: 1.25; font-style: italic">contribution</div>
        <div style="line-height: 1.25; font-style: italic">pension</div>
        <div style="line-height: 1.25; font-style: italic">US$&#8217;000</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-style: italic">Total</div>
        <div style="line-height: 1.25; font-style: italic">2024</div>
        <div style="line-height: 1.25; font-style: italic">US$&#8217;000</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-style: italic">Total</div>
        <div style="line-height: 1.25; font-style: italic">2023</div>
        <div style="line-height: 1.25; font-style: italic">US$&#8217;000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">John Gillard</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">President and Chief Executive Officer</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">676</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">260*</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">0</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">39</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,213</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">710</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Ronan O&#8217;Caoimh</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">Director, Founder &amp; Executive Advisor</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">84</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">84</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">80</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Jim Walsh</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Executive Director Business Development</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">83</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">83</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">50</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Tom Lindsay</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">Independent Director</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">57</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">57</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">63</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Andrew Omidvar</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">Independent Director</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">57</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">57</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">10</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align: bottom; vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; vertical-align: top; width: 14%">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">957</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">260</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">0</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">39</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,494</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">913</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  </table>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">* Amount relates to a bonus provision for the year ended December
31, 2024. The final amount remains subject to confirmation.</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic"> <br/> </div> </div>

<div style="text-align: justify; line-height: 1.25">As at December&#160;31, 2024 there was US$260,000 (2023 US$753,000) accrued to provide
pay, pension, retirement or similar benefits for the directors.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman, serif">In 2024, net options granted by the directors to subscribe for &#8216;A&#8217;
ordinary shares was 2,606,000 (equivalent to 130,300 ADSs), comprising options granted to subscribe for up to 5,600,000 &#8216;A&#8217;
ordinary shares (equivalent to 280,000 ADSs) offset by options forfeited or expired to subscribe for 2,994,000 &#8216;A&#8217; ordinary
shares (equivalent to 149,700 ADSs) (2023: 2,160,000).</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">81</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">In addition, see Item 7 - Major Shareholders and Related Party Transactions for further
information on the compensation of Directors and Officers.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Compensation of Executive Senior Management</div>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Compensation of our executive officers is composed primarily of base salary and the
payment of short-term and mid-term cash bonuses. Cash bonuses are generally tied to the achievement of financial performance indicators
and strategic objectives, and they may vary as a percentage of base salary depending upon the level of responsibilities of the executive
officer. Our executive compensation package is also complemented by long-term incentives in the form of stock options.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">One of our key priorities is to build a performance culture and drive ownership and
accountability in the Company. A share-based compensation model that ensures shareholder alignment is regarded as core to this transformation
and is currently in the process being rolled out to staff and senior management across the Company. To facilitate this shareholder aligned
share-based compensation model for employees and senior management, on December 15, 2022, our Board approved an amendment to the Trinity
Biotech Employee Share Option Plan 2020 to increase the number of ordinary shares issuable under such plan by 30 million Class &#8220;A&#8221;
ordinary shares (the equivalent to 1.5 million ADS). Performance share-based compensation awards are intended to closely align the goals
of our broader team with those of our shareholders in the creation of shareholder value. The majority of Mr. Gillard&#8217;s options are
performance share options and are structured such that they are exercisable only if the market price of the Company's ADSs increases to
certain levels (US$5.00, US$7.50, US$10.00, US$15.00, US$20.00 and U$25.00 per ADS) during the term of the option.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">For the financial year ended December 31, 2024, our executive
officers as a group, received aggregate compensation of US$1,356,000 for services they rendered in all capacities during 2024, which amount
includes base salary, commissions, bonuses, ex gratia payments and benefits in kind, excluding share options.</div> </div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">This does not include any of the directors listed above. Compensation paid to Mr. Fitzgerald, Ms. Tallon
and Dr. Wells for their service during 2024 is included in the aggregate compensation disclosed for executive officers.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z638c99b7e6d64c2caec7398cacd1db5a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">C.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Board Practices</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Our Articles provide that one third of the directors for the time being other than
a director holding an executive office with us or, if their number is not three or a multiple of three, then the number nearest to, but
not exceeding, one third shall retire from office at each annual general meeting but if at any annual general meeting the number of directors
who are subject to retirement by rotation is two, one of such directors shall retire and, if the number of such directors is one, that
director shall retire. The directors to retire at each annual general meeting shall be the directors who have been longest in office since
their last appointment. As between directors of equal seniority the directors to retire shall, in the absence of agreement, be selected
from among them by lot. Subject as aforesaid, a retiring director shall be eligible for re-appointment and shall act as a director throughout
the meeting at which he retires.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Board of Directors has typically established audit, remuneration and employee
compensation committees. The Company typically has a Remuneration Committee which is responsible for approving executive directors&#8217;
remuneration including bonuses and share option grants. The Board has from time to time appointed independent consulting firms to advise
the Board on recruitment and compensation matters for directors and senior management.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Audit Committee reviews the Group&#8217;s annual and interim financial statements
and reviews reports from management on the effectiveness of the Group&#8217;s internal controls. It also appoints the external auditors,
reviews the scope and results of the external audit and monitors the relationship with the auditors. As a transitional arrangement, the
Audit Committee now comprises solely the independent director, Tom Lindsay.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Board of Directors formed an employee compensation committee consisting of the
CEO and CFO. This committee has delegated authority from the Board to approve share-based compensation grants to employees of the Group,
other than executive directors, pursuant to the terms of the Employee Share Option Plan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Company also typically operates a Nomination Committee for appointments to the
Board of Directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">82</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Because we are a foreign private issuer, it is not required to comply with all of
the corporate governance requirements set forth in NASDAQ Rule 5600 as they apply to U.S. domestic companies.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Indemnification of Directors and Officers and Limitations of Liability</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="text-align: justify; line-height: 1.25">Subject to exceptions, the Companies Act 2014 of Ireland, (the &#8220;Companies Act
2014&#8221;) does not permit a company to exempt a director or certain officers from, or indemnify a director against, liability in connection
with any negligence, default, breach of duty or breach of trust by a director in relation to the company.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The exceptions allow a company to: (a)&#160;purchase and maintain directors and officers
insurance against any liability attaching in connection with any negligence, default, breach of duty or breach of trust owed to the company;
and (b)&#160;indemnify a director or such other officer against any liability incurred in defending proceedings, whether civil or criminal,
(i)&#160;in which judgment is given in his or her favor or in which he or she is acquitted or (ii)&#160;in respect of which an Irish Court
grants him or her relief from any such liability on the grounds that he or she acted honestly and reasonably and that, having regard to
all the circumstances of the case, he or she ought fairly to be excused for the wrong concerned.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Articles includes a provision which, subject to the provisions of the Companies
Act 2014 as aforesaid, entitles every present and former director and other officer of the Company to be indemnified out of the assets
of the Company (other than any person (whether an officer or not) engaged by the Company as auditor) against any loss or liability incurred
by him or her for negligence, default, breach of duty or breach of trust in relation to the affairs of the Company or otherwise incurred
by him or her in the execution and discharge of his or her duties to the Company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Under the Companies Act 2014 and the Articles, the Company may purchase and maintain
directors&#8217; and officers&#8217; liability insurance, at the expense of the Company, for the benefit any of its present and former
Directors and other officers.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div> </div>

<table cellspacing="0" cellpadding="0" id="z5f4dc1977c374463a47153a764f24b5f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 22.5pt; vertical-align: top; font-family: Times New Roman,Times,serif; font-weight: bold">D.</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div style="font-weight: bold">Employees</div> </td> </tr>
  </table>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">The following table details certain data on the average number of employees of Trinity Biotech and its
consolidated subsidiaries, including full-time, part-time, and temporary personnel who work under the direction and control of the Company:</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="z0f41e2c3ea644207bf4e61406366b9c6" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year Ended December 31</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25"> </span></div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold"> 2024</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold">2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold">2022</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: middle; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-style: italic">Numbers of employees by geographic location</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: middle; width: 64%">
        <div style="line-height: 1.25">United States</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">174</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">203</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">203</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: middle; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Ireland</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">185</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">143</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">146</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: middle; width: 64%">
        <div style="line-height: 1.25">United Kingdom</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: middle; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Brazil</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">41</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">34</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">34</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: middle; width: 64%">
        <div style="line-height: 1.25; font-style: italic; font-weight: bold">Total workforce</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">401</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">380</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">384</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: middle; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-style: italic">Numbers of employees by category of activity</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 64%">
        <div style="line-height: 1.25">Research scientists &amp; technicians</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">33</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">23</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">26</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Manufacturing/Operations</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">246</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">207</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">197</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 64%">
        <div style="line-height: 1.25">Quality Assurance</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">40</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">51</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">56</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Finance/Administration</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">49</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">73</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">73</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 64%">
        <div style="line-height: 1.25">Sales &amp; Marketing</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">33</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">26</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">32</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: middle; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-style: italic; font-weight: bold">Total workforce</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">401</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">380</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">384</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">We consider our employees the most valuable asset of our company. We offer competitive
compensation and comprehensive benefits to attract and retain our employees. The remuneration and rewards include retention through share-based
compensation and performance-based bonuses. We generally provide our employees with benefits and working conditions beyond the required
minimums in each geographic and regulatory environment in which the Group operates.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">83</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">We believe that an engaged workforce is key to maintaining our ability to innovate.
We have been successful in integrating new employees into the business and keeping our employees engaged. Investing in our employees&#8217;
career growth and development is an important focus for us. We offer learning opportunities and training programs including workshops,
guest speakers and various conferences to enable our employees to advance in their chosen professional paths. We are committed to providing
a safe work environment for our employees.</div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zf59533043a7442d18599aff6e03c9302" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25"><span style="font-family: Times New Roman,Times,serif; font-weight: bold">E.</span></div>
        </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25"><span style="font-family: Times New Roman,Times,serif; font-weight: bold">Share Ownership</span></div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">

<div><br/> </div> <span style="font-weight: bold">Beneficial Ownership of Executive Officers and Directors</span></div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">&#160;</div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic; font-weight: bold">Stock Option Plans</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">The Board of Directors have adopted the
Employee Share Option Plans (the &#8220;Plans&#8221;) with the most recently adopted Share Option Plan being the Company&#8217;s 2020
Amended &amp; Restated Plan. The purpose of these Plans is to provide Trinity Biotech&#8217;s employees, consultants, officers and directors
with additional incentives to improve Trinity Biotech&#8217;s ability to attract, retain and motivate individuals upon whom Trinity Biotech&#8217;s
sustained growth and financial success depends. These Plans are administered by the Board of Directors. Options under the Plans may be
awarded only to employees, officers, directors and consultants of Trinity Biotech.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The exercise price of options is determined by the Board of Directors, through its
remuneration and employee compensation committees as the case may be. The term of an option will be determined by the Board, provided
that the term may not exceed ten years from the date of grant. All options will terminate 90 days after termination of the option holder&#8217;s
employment, service or consultancy with Trinity Biotech (or one year after such termination because of death or disability) except where
a longer period is approved by the board of directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Under certain circumstances involving a change in control of Trinity Biotech, the
Board may accelerate the exercisability and termination of options.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">As of&#160; March 31, 2025, our directors and executive officers as a group, then
consisting of 11 persons, held options to purchase an aggregate of 32,993,336&#8216;A&#8217; Ordinary shares (1,649,667 ADS equivalent),
having exercise prices ranging from US$0.12 per &#8216;A&#8217; ordinary share (US$2.40 per ADS) to US$0.73 per &#8216;A&#8217; ordinary
share (US$14.60 per ADS) and expiration dates ranging from 2024 to 2031. Any options granted prior to the fourth quarter of 2022 vest
over a two to four year period and have no performance conditions. The options granted in and since the fourth quarter of 2022 are performance
share options.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">The following table sets forth certain information as of March 31, 2025, regarding the beneficial ownership
by each of our directors and executive officers:</div>

<div style="line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z0daca2103346417893e5b402f1082c1d" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">Name</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25">Number of &#8216;A&#8217; Ordinary Shares Beneficially Owned <sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(1)</sup></div>
        </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25">Percentage of Ownership <sup style="vertical-align: text-top; line-height: 1; font-size: smaller">(2)</sup></div>
        </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Ronan O&#8217;Caoimh (3)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">17,246,663</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">4.5</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Jim Walsh (4)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">2,722,779</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">John Gillard (5)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">14,950,000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">3.9</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Tom Lindsay (6)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">729,167</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Andrew Omidvar (7)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">729,167</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Ian Wells</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Eibhl&#237;n Kelly</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Gary Keating</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Colm Molloy</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="line-height: 1.25">Jacqueline O&#8217;Neill</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">M&#237;che&#225;l Roche</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">Executive officers and directors as a group (11 persons)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">36,377,776</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">9.1</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  </table>

<div style="text-indent: -34.55pt; margin-left: 36pt; line-height: 1.25">&#160;</div>

<div style="font: 1pt/1.25 Times New Roman, serif">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z43c31427cb0349dfa67f3f8c72106fce" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 4.02%; vertical-align: top">
        <div style="line-height: 1.25">*</div> </td>
    <td style="width: 95.98%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">Less than 1%</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: -34.55pt; margin-left: 36pt; line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">84</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z550b82fbfb054cd48519a96bb6edc934" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 4.02%; vertical-align: top">
        <div style="line-height: 1.25">(1)</div> </td>
    <td style="width: 95.98%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Beneficial ownership is determined in accordance with the rules of the SEC and generally
        includes voting or investment power with respect to securities. Ordinary Shares relating to options currently exercisable or exercisable
        within 60 days of the date of this table are deemed outstanding for computing the percentage of the person holding such securities but
        are not deemed outstanding for computing the percentage of any other person. Share options that have a performance condition related to
        the share price of the equity of the Company are deemed to be exercisable irrespective of whether the performance condition has been,
        or is expected to be, satisfied within 60 days of the date of this table. Except as indicated by footnote, and subject to community property
        laws where applicable, the persons named in the table above have sole voting and investment power with respect to all shares shown as
        beneficially owned by them.</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: -34.55pt; margin-left: 36pt; line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb55b34fc1128490c94e5a0adff5dec32" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 4.02%; vertical-align: top">
        <div style="line-height: 1.25">(2)</div> </td>
    <td style="width: 95.98%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">The percentages shown are based on 372,640,384 &#8216;A&#8217; Ordinary Shares issued
        and outstanding as of March 31, 2025.</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" border="0" id="zf14502a6527c4d97abc031e4e8586d81" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 4%; vertical-align: top">&#160;</td>
    <td style="width: 96%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: top">
        <div style="line-height: 1.25">(3)</div> </td>
    <td style="width: 96%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Represents (a) 9,724,160 &#8216;A&#8217; ordinary shares and (b) 7,522,503 &#8216;A&#8217;
        ordinary shares underlying options that are currently vested and exercisable or that vest within sixty days of March 31, 2025. Includes
        options issued to Darnick Company which in the past provided Trinity Biotech with the services of Mr. O&#8217;Caoimh as Chief Executive
        Officer.</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: top">&#160;</td>
    <td style="width: 96%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: top">
        <div style="line-height: 1.25">(4)</div> </td>
    <td style="width: 96%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Represents (a) 1,393,612 &#8216;A&#8217; ordinary shares and (b) 1,329,167 &#8216;A&#8217;
        ordinary shares underlying options that are currently vested and exercisable or that vest within sixty days of March 31, 2025. Note that
        1,393,612 &#8216;A&#8217; ordinary shares of Dr Walsh&#8217;s shares are held in trust for the benefit of Dr Walsh&#8217;s immediate family.</div>
        </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: top">&#160;</td>
    <td style="width: 96%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: top">
        <div style="line-height: 1.25">(5)</div> </td>
    <td style="width: 96%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Represents (a) 200,000 &#8216;A&#8217; ordinary shares and (b) 14,750,000 &#8216;A&#8217;
        ordinary shares underlying options that are currently vested and exercisable or that vest within sixty days of March 31, 2025.</div> </td>
        </tr>
  <tr>
    <td style="width: 4%; vertical-align: top">&#160;</td>
    <td style="width: 96%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: top">
        <div style="line-height: 1.25">(6)</div> </td>
    <td style="width: 96%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Represents 729,167 &#8216;A&#8217; ordinary shares underlying options that are currently
        vested and exercisable or that vest within sixty days of March 31, 2025.</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: top">&#160;</td>
    <td style="width: 96%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: top">
        <div style="line-height: 1.25">(7)</div> </td>
    <td style="width: 96%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Represents 729,167 &#8216;A&#8217; ordinary shares underlying options that are currently
        vested and exercisable or that vest within sixty days of March 31, 2025.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">85</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">As of March 31, 2025, 32,993,336 (1,649,667 ADS equivalent) of the options outstanding
were held by the directors of Trinity Biotech as follows:</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="2" border="0" id="zf6beb31c7c934685bab138acbcebfb8e" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 18.64%; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">Director/Company Secretary</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 15.41%; vertical-align: bottom">
        <div style="text-align: center; margin-right: 5.05pt; margin-left: 5.05pt; line-height: 1.25"><span style="font-weight: bold">Number&#160;of</span><br/>
        <span style="font-weight: bold">Options &#8216;A&#8217;</span><br/> <span style="font-weight: bold">Shares</span></div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 14.13%; vertical-align: bottom">
        <div style="text-align: center; margin-right: 5.05pt; margin-left: 5.05pt; line-height: 1.25"><span style="font-weight: bold">Number&#160;
        of</span><br/> <span style="font-weight: bold">Options</span><br/> <span style="font-weight: bold">ADS</span><br/> <span style="font-weight: bold">Equivalent</span></div>
        </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; margin-right: 5.05pt; margin-left: 5.05pt; line-height: 1.25"><span style="font-weight: bold">Exercise</span><br/>
        <span style="font-weight: bold">Price&#160;(Per</span><br/> <span style="font-weight: bold">&#8216;A&#8217; Share)</span></div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 13.29%; vertical-align: bottom">
        <div style="text-align: center; margin-right: 5.05pt; margin-left: 5.05pt; line-height: 1.25"><span style="font-weight: bold">Exercise
        Price</span><br/> <span style="font-weight: bold">(Per&#160;ADS)</span></div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; width: 8.17%; vertical-align: top">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Hurdle</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Price <sup style="font-family: Times New Roman Bold, serif; vertical-align: text-top; line-height: 1; font-size: smaller">2</sup></div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">(Per ADS)</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25"><span style="font-weight: bold">Expiration&#160;Date of</span><br/> <span style="font-weight: bold">Options</span></div>
        </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">John Gillard</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">600,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">30,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.67</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">13.40</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">None</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">23/10/2027</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">&#160;</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">1,400,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">70,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.27</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">5.40</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">None</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">25/03/2029</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">&#160;</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">2,000,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">100,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.29</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">5.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">None</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">19/12/2029</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">666,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">33,333</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.29</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">5.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">$15.00</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">19/12/2029</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">666,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">33,333</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.29</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">5.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">$20.00</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">19/12/2029</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">666,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">33,333</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.29</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">5.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">$25.00</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">19/12/2029</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">7,000,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">350,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.12</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">2.40</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">None</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">18/12/2030</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25">2,333,333</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">116,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.12</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">2.40</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">$5.00</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">18/12/2030</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">2,333,333</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">116,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.12</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">2.40</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">$7.50</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">18/12/2030</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25">2,333,334</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">116,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.12</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">2.40</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">$10.00</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">18/12/2030</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Ronan O&#8217;Caoimh <sup style="vertical-align: text-top; line-height: 1; font-size: smaller">1</sup><span style="font-weight: bold">&#160;</span></div>
        </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">4,060,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">203,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.69</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">13.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">None</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">14/06/2026</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">&#160;</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">333,336</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">16,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.19</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">3.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">None</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">20/03/2027</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">&#160;</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">2,400,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">120,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.73</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">14.60</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">None</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">17/11/2027</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">700,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">35,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">None</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">233,333</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">11,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">$5.00</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">233,333</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">11,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">$7.50</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">233,334</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">11,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">$10.00</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">
        <div style="line-height: 1.25"><span style="font-weight: bold">&#160;</span>Jim Walsh</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">600,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">30,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.19</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">3.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">None</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">20/03/2027</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">700,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">35,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">None</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">233,333</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">11,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">$5.00</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">233,333</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">11,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">$7.50</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">233,334</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">11,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">$10.00</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Thomas Lindsay</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">700,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">35,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">None</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">233,333</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">11,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">$5.00</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">233,333</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">11,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">$7.50</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">233,334</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">11,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">$10.00</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Andrew Omidvar</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">700,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">35,000</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">None</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">233,333</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">11,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">$5.00</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">233,333</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; line-height: 1.25">11,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 8.17%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">$7.50</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  <tr>
    <td style="white-space: nowrap; width: 18.64%; vertical-align: bottom">&#160;</td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 15.41%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">233,334</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 14.13%; vertical-align: bottom">
        <div style="text-align: right; line-height: 1.25">11,667</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.05%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">0.14</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; width: 13.29%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">2.80</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 8.17%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">$10.00</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; width: 17.3%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">28/01/2031</div> </td> </tr>
  </table>

<div> <br/> </div>

<div style="text-align: justify; text-indent: -5.65pt; margin-left: 5.65pt; line-height: 1.25"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">1
</sup>Includes options issued to Darnick Company which in the past provided us with the services of Mr. O&#8217;Caoimh as Chief Executive
Officer.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: -5.65pt; margin-left: 5.65pt; line-height: 1.25"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">2</sup>
Share options with a hurdle price are structured such that they may only become exercisable into ADSs when the average closing price of
our ADSs, for ten trading days out of the thirty previous trading days, is equal to or greater than the relevant hurdle price of US$5.00,
US$7.50, US$10.00, $15.00, $20.00 and $25.00 per ADS (adjusted for any stock splits, reverse splits or equivalent reorganisations) during
the life of the option. At 31 March, 2025, none of the directors&#8217; share options with a hurdle price were exercisable as the hurdle
price condition has not been achieved.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">86</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">As of March 31, 2025 the following total options were outstanding:</div>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbf6ce675e9214150939233ea3b5191c5" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Number of &#8216;A&#8217;</div>
        <div style="text-align: center; line-height: 1.25">Ordinary Shares</div>
        <div style="text-align: center; line-height: 1.25">Subject to Options</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Range of</div>
        <div style="text-align: center; line-height: 1.25">Exercise Price</div>
        <div style="text-align: center; line-height: 1.25">per Ordinary Share</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">Range of Exercise Price</div>
        <div style="text-align: center; line-height: 1.25">per ADS</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Total options outstanding</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">40,476,672</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$&#160;</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">US0.12-US$1.10</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$&#160;</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">US2.40-US$25.80</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Item&#160;7. &#160;&#160;&#160;&#160;<span style="font-style: italic"><span id="MajorShareholdersandRelatedPartyTransactions"><!--Anchor--></span>Major
Shareholders and Related Party Transactions</span></div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6e804e11ea84422685d3aefbe4e266d1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 22.5pt; vertical-align: top; font-family: Times New Roman,Times,serif; font-weight: bold">A.</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div style="font-weight: bold">Major Shareholders</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">As of March 31, 2025, there were 372,640,384&#8216;A&#8217; Ordinary shares (excluding
treasury shares) outstanding. Such total excludes 40,476,672 Ordinary shares issuable upon the exercise of outstanding options and 51,200,000
Ordinary shares issuable upon the exercise of outstanding warrants.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The following table sets forth certain information regarding the beneficial ownership
of our ordinary shares, as of March 31, 2025, by each person who we believe beneficially owns 5% or more of our outstanding ordinary shares
and all of our directors and executive officers as a group.&#160;Except as otherwise noted, all of the persons and groups shown below
have sole voting and investment power with respect to the shares indicated.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" class="cfttable" id="z6fa508ae3d6d4ca3909e33f9e7b915ec" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: justify; line-height: 1.25; font-weight: bold">Name</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Number of &#8216;A&#8217;<br/> Ordinary Shares<br/> Beneficially</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Owned</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Number of<br/> ADSs<br/> Beneficially<br/> Owned</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Percentage</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">ownership (2)</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">MiCo IVD Holdings, LLC</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">44,759,388</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(3)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2,237,969</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(3)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">17.5</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%(3)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="line-height: 1.25">Perceptive Credit Holdings III, LP</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">85,800,000</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">(4)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">4,290,000</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">(4)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">20.9</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%(4)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">All directors and officers as a group</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">36,377,775</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(1)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,818,889</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(1)</div> </td>
    <td class="cftguttercell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftcurrcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td class="cftnumcell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">9.1</div> </td>
    <td class="cftfncell" colspan="1" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" border="0" id="zf623a54f74e649918a988ddccef895f8" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 4%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">(1)</div> </td>
    <td style="width: 96%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Beneficial ownership is determined in accordance with the rules
        of the SEC and generally includes voting or investment power with respect to securities. Ordinary Shares relating to options currently
        exercisable or exercisable within 60 days of the date of this table are deemed outstanding for computing the percentage of the person
        holding such securities but are not deemed outstanding for computing the percentage of any other person. Share options that have a performance
        condition related to the share price of the equity of the Company are deemed to be exercisable irrespective of whether the performance
        condition has been, or is expected to be, satisfied within 60 days of the date of this table. Except as indicated by footnote, and subject
        to community property laws where applicable, the persons named in the table above have sole voting and investment power with respect to
        all shares shown as beneficially owned by them.</div> </td> </tr>
  </table>

<div style="text-align: justify; text-indent: -34.55pt; margin-left: 36pt; line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" border="0" id="z85f317d096224c0fb41f2c72f803f17d" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 4%; vertical-align: top">
        <div style="line-height: 1.25">(2)</div> </td>
    <td style="width: 96%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">The percentages shown are based on 372,640,384 &#8216;A&#8217; Ordinary Shares outstanding
        (excluding treasury shares).</div> </td> </tr>
  </table>

<div><br/> </div>

<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 4%; vertical-align: top">
        <div style="line-height: 1.25">(3)</div> </td>
    <td style="width: 96%; vertical-align: top">
        <div style="line-height: 1.25">Based upon a Schedule 13D filed on December 17, 2024, by MiCo IVD Holdings, LLC with the SEC. The percentage
        ownership in the table above includes the conversion of the maximum number of &#8216;A&#8217; Ordinary Shares as permitted by the conversion
        terns of the Convertible Note. The principal business address of MiCo IVD Holdings, LLC is 85 Orchard Road. Skillman, New Jersey 08558
        United States.</div> </td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: top">&#160;</td>
    <td style="width: 96%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 4%; vertical-align: top">
        <div style="line-height: 1.25">(4)</div> </td>
    <td style="width: 96%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Based upon Schedule 13D filed on February 14, 2025, by Perceptive Credit Holdings
        III, LP. The principal business address of Perceptive Credit Holdings III, LP is 51 Astor Place 10th Floor, New York, NY 10003.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">87</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-weight: bold">Significant Changes in the Ownership of Major Shareholders</div>

<div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; font-weight: bold">&#160;</div>

<div style="text-align: justify; line-height: 1.25">To our knowledge, other than as disclosed in the tables below there has been no significant
change in the percentage ownership held by any major shareholder since January 1, 2021.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The following shareholders have disclosed ownership above 5% since January 1, 2021
but their ownership is below 5% as at March 31, 2025 according to their Schedule 13G filings, except as indicated otherwise.</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" border="0" id="z0353ee4c490f41e3b82b58d54afa5696" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 39%; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-weight: bold">Number of &#8216;A&#8217;<br/> Ordinary Shares<br/> Beneficially</div>
        <div style="line-height: 1.25; font-weight: bold">Owned</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-weight: bold">Number of<br/> ADSs<br/> Beneficially<br/> Owned (1)</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-weight: bold">Percentage</div>
        <div style="line-height: 1.25; font-weight: bold">&#8216;A&#8217; Ordinary<br/> Shares</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-weight: bold">Percentage<br/> Total</div>
        <div style="line-height: 1.25; font-weight: bold">Voting<br/> Power</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 13%; text-align: center">
        <div style="line-height: 1.25; font-weight: bold">Date of Filing</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 39%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Highbridge Capital Management, LLC</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">675,064</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">33,753</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">0.2</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">0.2</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: top; width: 13%; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif">April 14, 2022 (1)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 39%">
        <div style="line-height: 1.25">Renaissance Technologies LLC</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">5,573,752</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">278,688</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1.5</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1.5</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: top; width: 13%">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif">February 13, 2023</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 39%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Stonehill Capital Management LLC</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">6,690,592</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">334,530</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1.8</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1.8</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: top; width: 13%; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif">February 13, 2023</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8dfdff90f13c4637bfea7709ff709f89" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Based on information provided by Highbridge Capital Management, LLC to the Company in a letter dated April 14, 2022</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The ownership for the following shareholders rose above 5% since January 1, 2021:</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" border="0" id="z9d252a2bf707485d8793f51809a475b7" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 39%; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-weight: bold">Number of &#8216;A&#8217;<br/> Ordinary Shares<br/> Beneficially</div>
        <div style="line-height: 1.25; font-weight: bold">Owned</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-weight: bold">Number of<br/> ADSs<br/> Beneficially<br/> Owned (1)</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-weight: bold">Percentage</div>
        <div style="line-height: 1.25; font-weight: bold">&#8216;A&#8217; Ordinary<br/> Shares</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: center">
        <div style="line-height: 1.25; font-weight: bold">Percentage<br/> Total</div>
        <div style="line-height: 1.25; font-weight: bold">Voting<br/> Power</div> </td>
    <td colspan="1" class="cftfncell" style="white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center">&#160;</td>
    <td style="border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 13%; text-align: center">
        <div style="line-height: 1.25; font-weight: bold">Date of Filing</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 39%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">MiCo IVD Holdings, LLC</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">44,759,388</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2,237,969</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">15.8</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%(1)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">17.5</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%(1)</div> </td>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: top; width: 13%; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif">December 17, 2024</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 39%">
        <div style="line-height: 1.25">Perceptive Credit Holdings III, LP</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">85,800,000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">4,290,000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">20.9</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">20.9</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td>
    <td style="vertical-align: bottom; white-space: nowrap; vertical-align: top; width: 13%">
        <div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif">February 14, 2025</div> </td> </tr>
  </table>

<div> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z11aaadd8f2454dbfaccaf757d2e5d9ef" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>The percentage ownership in the table above for MiCo IVD Holdings, LLC includes the conversion of the maximum number of &#8216;A&#8217;
        Ordinary Shares as permitted by the conversion terns of the Convertible Note.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Major Shareholders Voting Rights</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Our major shareholders do not have different voting rights.</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">&#160;</span>&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z079e859d413f40b1b3b3f849346aa0b7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">B.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Related Party Transactions</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">The following is a description of our related party transactions since January&#160;1, 2022.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Group has entered into various arrangements with JRJ Investments (&#8220;JRJ&#8221;),
a partnership owned by Mr O&#8217;Caoimh and Dr Walsh, directors of Trinity Biotech, and directly with Mr O&#8217;Caoimh, to provide for
current and potential future needs to extend its premises at IDA Business Park, Bray, Co. Wicklow, Ireland.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Group entered into an agreement for a 25-year lease with JRJ effective from December
2003 for offices that adjacent to its then premises at IDA Business Park, Bray, Co. Wicklow, Ireland with an annual rent is &#8364;381,000
(US$421,000). Upward-only rent reviews are carried out every five years and there have been no increases arising from these rent reviews.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In 2007, the Group also entered into 25-year lease agreements with Mr O&#8217;Caoimh
and Dr Walsh for a 43,860 square foot manufacturing facility in Bray, Ireland. The annual rent for the manufacturing facility is &#8364;787,000
(US$869,000).&#160;Subsequent to the signing of this lease, the ownership of the building transferred from JRJ to Mr O&#8217;Caoimh solely.
A rent review became effective on 1 July 2022 and, following an independent valuation and arbitration process, the annual rent increased
to &#8364;1,050,000 (US$1,094,000), with backdated rent accruing from that date. Included within overhead costs in cost of sales in 2024
is an amount of US$659,000 in respect of this backdated rent.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In 2016 the Group also entered into 10-year lease agreement with Mr O&#8217;Caoimh
for a warehouse of 16,000 square feet adjacent to the leased manufacturing facility in Bray, Ireland. The annual rent for the warehouse
is &#8364;144,000 (US$159,000). A rent review became effective on 1 July 2021 and, following an independent valuation, the annual rent
increased to &#8364;170,560 (US$162,000), with backdated rent accruing from that date. Included within overhead costs in cost of sales
in 2024 is an amount of US$93,000 in respect of this backdated rent.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">88</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Independent valuers advised the Group that the rent in respect of each of the leases
represents a fair market rent.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">At the time that the arrangements were entered into, Trinity Biotech and its directors
(excepting Mr O&#8217;Caoimh and Dr Walsh who expressed no opinion on this point) believed they represented a fair and reasonable basis
on which the Group could meet its ongoing requirements for premises. Dr Walsh has no ownership interest in the additional space adjoining
the warehouse owned by Mr O&#8217;Caoimh and was therefore entitled to express an opinion on this arrangement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">In September 2024, the Company completed the acquisition of Metabolomics Diagnostics Ltd ("Metabolomics")
for consideration of approximately $0.9 million, satisfied through the issuance of approximately 0.27 million ADSs and the extinguishment
of amounts owed to the Company totalling $0.4 million. At the time of the acquisition, Dr. Jim Walsh, a director of the Company, held
a 6% minority shareholding in Metabolomics. Based on the net assets acquired and goodwill recognised, the value attributable to Mr. Walsh&#8217;s
interest was estimated at approximately $55,000. Dr. Walsh fully disclosed his interest, and the acquisition was approved unanimously
by the board, with appropriate procedures followed to manage the potential conflict of interest, including the passing of a resolution
under the Company's Constitution to authorise Mr. Walsh&#8217;s involvement in the decision-making process. The transaction was conducted
at arm&#8217;s length, and the board determined that it was in the best interests of the Company.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Indemnity Agreements</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">We have entered into customary agreements with each of our current directors and executive officers to
indemnify them to the fullest extent permitted by law, subject to limited exceptions.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Related Person Transaction Policy</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">Our Board of Directors has adopted an interested party transaction policy, which governs the identification,
reporting and approval of transactions with interested parties.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z28b777aa636a44a28316ed96160398c2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">C.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Interests of Experts and Counsel</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-weight: bold"><span id="Item8.fnancialInformation"><!--Anchor--></span>Item&#160;8. &#160;&#160;&#160;&#160;<span style="font-style: italic">Financial
Information</span></div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zb11b0e2c40224f8db28c5c4cfee46a70" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">A.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Consolidated Statements and Other Financial Information</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Consolidated Financial Statements</div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">See Item&#160;18. &#8220;<span style="font-style: italic">Financial Statements</span>.&#8221;</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Export Sales</div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">In the year ended December 31, 2024, the amount of our export sales (i.e., sales outside of Ireland) was
approximately US$61,447,000 which represents 99.83% of our total sales. In the year ended December 31, 2023, export sales were approximately
US$56,714,000, or 99.8% of total sales, while in the year ended December 31, 2022, export sales totalled approximately US$74,675,000,
representing 99.9% of total sales.</div> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-weight: bold">Legal and Arbitration Proceedings</div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">From time to time, we may be involved in various claims and legal proceedings related to claims arising
out of our operations. We are not currently a party to any material legal proceedings, including any such proceedings that are pending
or threatened, of which we are aware, other than as disclosed herein.&#160;</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-weight: bold">Dividend Policy</div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We have not paid a cash dividend on our ordinary shares or ADSs since 2015 and do
not intend to pay cash dividends on our ADSs in the foreseeable future. Our earnings and other cash resources will be used to continue
the development and expansion of our business. Any future dividend policy will be determined by our Board of Directors and will be based
upon conditions then-existing, including our results of operations, financial condition, current and anticipated cash needs, contractual
restrictions and other conditions.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">89</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc2a588d4a53d4b429e3fe19a90988a2e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">B.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Significant Changes</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">Except as otherwise disclosed in this Annual Report, no significant change has occurred since December
31, 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span id="Item9.TheOfferandListing"><!--Anchor--></span><span style="font-weight: bold">Item&#160;9.</span><span style="font-weight: bold; font-style: italic">&#160;</span><span style="font-weight: bold">&#160;&#160;&#160;&#160;</span><span style="font-weight: bold; font-style: italic">The
Offer and Listing</span></div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z179de00a11984bb08245390d8501a2c2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">A.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Offer and Listing Details</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech&#8217;s ADSs are listed on the NASDAQ Global Market under the symbol
&#8220;TRIB&#8221; and the depositary bank for the ADSs is The Bank of New York Mellon.</div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zae765501851f4192be98a0456b7741d7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">B.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Plan of Distribution</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z8023a70d0db7471ab28061f22ce22230" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">C.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Markets</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">Trinity Biotech&#8217;s ADSs, each representing twenty ordinary shares, are listed on the NASDAQ Global
Market under the symbol &#8220;TRIB&#8221; and the depositary bank for the ADSs is The Bank of New York Mellon.</div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z34ecda757a674d2d8af4bd071dd052b9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">D.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Selling Shareholders</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">Not Applicable.</div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z3a81ba26ae2c445ea07fa1b77ab2ecf4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">E.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Dilution</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z326d8b711ace412ab3ea211d2b524ce1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">F.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Expenses of the Issue</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">Not applicable.&#160;</div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; font-weight: bold"><span id="Item10.AdditionalInformation"><!--Anchor--></span>Item 10. Additional Information</div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zeb69ffc44a224fdab42982ca601bf834" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">A.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Share Capital</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6648d5f3721645d9b69eeabed97215d4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">B.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Memorandum and Articles of Association</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Copies of our Articles are filed as Exhibit 1.1 to this Annual Report. The information
called for by this Item 10.B. is included in Exhibit 2.1 to this Annual Report and is incorporated herein by reference.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Irish Law</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Each of Trinity Biotech&#8217;s principal subsidiary undertakings incorporated in
Ireland (refer to Item 18, Note 31) is registered as a private company limited by shares under the Companies Act 2014. Pursuant to Irish
law, Trinity Biotech must maintain a register of its members. This register is open to inspection by members free of charge and to any
individual on the payment of a small fee. The books containing the minutes of proceedings of the general meetings of Trinity Biotech are
required to be kept in Ireland and are kept at the registered office of the Company and are open to the inspection of any member without
charge. Minutes of meetings of the board of directors are not open to scrutiny by shareholders. Trinity Biotech is also obliged to keep
proper accounting records. Shareholders have no statutory right to inspect the accounting records of the Company. The only financial records,
which are open to the members, are the statutory financial statements, which are sent to members together with the annual report. Irish
law also obliges Trinity Biotech to file information regarding certain events relating to the Company (such as changes to share rights,
changes to the board of directors etc). This information is filed with the Companies Registration Office in Ireland and is open to public
inspection. The Companies Act 2014 permits members to approve corporate matters in writing provided that the relevant resolution is signed
by all the members for the time being entitled to vote and attend at general meeting. A general meeting can be convened by members which
hold not less than 50 per cent of the paid up share capital of the Company carrying the right of voting at general meetings of the Company.
In addition, the directors of the Company are required to convene a general meeting forthwith upon the deposit of a requisition signed
by members holding not less than one-tenth of the paid up capital of the Company carrying the right of voting at general meetings of the
Company. Trinity Biotech is generally permitted, subject to Irish company law, to issue shares with preferential rights, including preferential
rights as to voting, dividends or rights to a return of capital on a winding up of the Company. Any member who complains that the affairs
of the Company are being conducted or that the powers of the directors of the Company are being exercised in a manner oppressive to them
or any of the members (including themselves), or in disregard of their interests as members, may apply to the Irish Courts for relief.
Shareholders have no right to maintain proceedings in respect of wrongs done to the Company.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">90</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Directors have extensive and wide&#8211;ranging duties under Irish law. These arise
from both common law and statute (principally the Companies Act 2014, which codified a number of key fiduciary duties). Our directors
owe their duties individually and primarily to Trinity Biotech and not its shareholders (although there is a requirement that directors
consider the interests of employees in addition to those of the Company). Additionally, directors will also need to have regard to the
interests of creditors, where a director believes, or has reasonable cause to believe, that a company is, or is likely to be, unable to
pay its debts, or becomes aware of the company&#8217;s insolvency. All of the directors have equal and overall responsibility for the
management of the Company (although directors who also serve as employees will have additional responsibilities and duties arising under
their employment agreements and may be expected to exercise a greater degree of skill and diligence than non-executive directors). Those
duties include duties to act in good faith in the interests of Trinity Biotech, act honestly and responsibly in the conduct of the Company&#8217;s
affairs, act in accordance with the Company&#8217;s Constitution and exercise their powers only for purposes allowed by law, not use the
Company&#8217;s property for their own or a third party's, benefit (unless duly authorised), not agree to restrict their power to exercise
an independent judgment (subject to limited exceptions) and avoid conflicts of interests (unless they are properly released). A director
must exercise the care, skill and diligence which would be exercised in the same circumstances by a reasonable person having the knowledge
and experience that (a) may reasonably be expected of a person in the same position as the director and (b) which that particular director
has. Other statutory duties include ensuring the maintenance of proper books of account, having annual accounts prepared, having an annual
audit performed, maintaining certain registers and making certain filings as well as the disclosure of personal interests. When directors,
as agents in transactions, make contracts on behalf of the Company, they generally incur no personal liability under these contracts.
It is Trinity Biotech, as principal, which will be liable under them, as long as the directors have acted within Trinity Biotech&#8217;s
objects and within their own authority. A director who commits a breach of their duties shall be liable to Trinity Biotech for any profit
made by them or for any damage suffered by Trinity Biotech as a result of the breach. In addition to the above, a breach by a director
of their duties may (where relevant) lead to the summary dismissal of the director, civil or criminal sanction from a Court, including
penalties or imprisonment, and/or the imposition of orders restricting or disqualifying the director from acting as a director.</div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zac237fea0886416899048948271bd386" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">C.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Material Contracts</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Other than contracts entered into in the ordinary course of business, the following
represents the material contracts entered into by the Group:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Term loan agreement with Perceptive Advisors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">On December 15, 2021, the Company and its subsidiaries entered into a US$81.25 million
senior secured term loan credit facility (the &#8220;Term Loan&#8221;) with Perceptive Advisors (&#8220;Perceptive&#8221;), an investment
manager with an expertise in healthcare. Proceeds from the Term Loan, along with existing cash and the issuance of new American Depository
Shares (&#8220;ADS&#8221;) in the Company, were used to retire the exchangeable notes in January 2022. The Term Loan will mature on the
fourth anniversary of the drawdown date and accrues interest at an annual rate equal to 11.25% plus the greater of (a) one-month LIBOR
(later changed to the Term SOFR Reference Rate effective from October 28, 2022) and (b) one percent per annum, and interest will be payable
monthly in arrears in cash. The Term Loan does not require any amortization, and the entire unpaid balance will be payable upon maturity.
The Term Loan can be repaid, in part or in full, at a premium before the end of the four-year term.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">91</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">The drawdown of the Term Loan by the Company was subject to a number of conditions
precedent including the repayment of at least 99.7% of the exchangeable notes and approval by the Company&#8217;s shareholders of the
Term Loan, an increase in the authorized share capital of the Company and the issuance of the Warrants. At the Extraordinary General Meeting
held on January 25, 2022, the Company&#8217;s shareholders approved all of the four resolutions put to the meeting, with each resolution
being approved by at least 97% of votes cast. The term loan was drawn down on January 27, 2022. In May 2022, the Company made an early
partial settlement of the term loan amounting to US$34.5 million. In February 2023, the Company entered into an amended and restated senior
secured term loan credit agreement which allowed for an immediate US$5 million increase to its outstanding Term Loan and provided for
a US$20 million facility to fund potential acquisitions. In April 2023, the Company used approximately US$11 million of the proceeds of
the sale of Fitzgerald Industries to repay approximately US$10.1 million of the Term Loan plus an approximately US$0.9 million early repayment
penalty. In connection with this transaction, the Company entered into an amendment to its senior secured term loan credit facility with
Perceptive Advisors, which significantly reduces the Company&#8217;s minimum revenue covenants under that loan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In connection with the acquisition of the CGM assets of Waveform in January 2024,
the Company entered into another amended and restated term loan. Under the Amended Term Loan, an additional US$22 million of funding has
been made available to the Company, with US$12.5 million being used to acquire the CGM assets of Waveform. The remaining US$9.5 million
is available for general corporate purposes including for the further development of the CGM and biosensor technologies. In addition,
the Amended Term Loan provides for additional liquidity of up to US$6.5 million, that may be drawn down by the Company between April and
December 2024, and can be used for general corporate purposes. In April 2024 the Company drew down the additional funding of US$6.5 million
as prescribed in the Amended Term Loan agreement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Amended Term Loan also immediately reduced the annual rate of interest on the
loan by 2.5% to 8.75% (the &#8220;Base Rate&#8221;) plus the greater of (a) Term Secured Overnight Financing Rate (SOFR) or (b) 4.0% per
annum, and allows for a further 2.5% reduction in the Base Rate to 6.25% once the outstanding principal under the Amended Term Loan falls
below US$35 million. Additionally, the Amended Term Loan reduces the early repayment penalty from a range of 8% to 7% to 4.0% to 3.5%,
dependent on timing of early repayment, and also reduces the revenue covenants.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In December 2024 the Company entered into another amended agreement with Perceptive.
Under the terms of the agreement, a deferred consideration payment of US$5 million related to the acquisition of the biosensor assets
of Waveform Technologies has been extended to November 2025. In addition, further additional liquidity in the amount of approximately
US$5.5 million has been provided to Trinity Biotech through a combination of cash and payment-in-kind interest. This funding will be used
for general corporate purposes, including the further development of our CGM offering.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">On February 27, 2025, we entered into the fourth amended and restated credit agreement, which provided
for an additional US$4.0 million increase to our outstanding Term Loan. On May 14<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup>,
2025, we entered into a fifth amendment to the credit agreement, which provided for an additional US$2.0 million in term loan funding,
extended the maturity date of the Term Loan to July 27, 2026, and provided that interest payments for the months of April, May, and June
2025 will be paid-in-kind.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Warrant agreement with Perceptive Advisors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">On December 15, 2021, the Company agreed, subject to drawdown of the Term Loan, to
issue warrants exercisable for 500,000 of the Company&#8217;s ADSs to Perceptive. The warrants were issued in January 2022 following the
drawdown of the term loan. The per ADS exercise price of the Warrants is US$6.50, based on the lower of i) the 10-day volume weighted
average price (&#8220;VWAP&#8221;) for the Company&#8217;s ADSs for the 10 business days prior to the Closing Date of the Credit Agreement
for the Term Loan and ii) the 10-day VWAP for the Company&#8217;s ADSs for the 10 business days prior to the drawdown date of the funding
under the Term Loan. The Warrants are exercisable, in whole or part, until the seventh anniversary of the date of drawdown of the funding
under the Term Loan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In February 2023, in connection with an increased Term Loan facility, the Company
agreed to reprice the 500,000 warrants, originally issued to Perceptive, to a price of US$5.36 per ADS.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">On January 30, 2024, the Company entered into a further amendment to its senior secured
term loan credit facility with Perceptive. In connection with the Amended Term Loan, Perceptive received new warrants to purchase an additional
500,000 ADSs.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">92</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Additionally, on December 23, 2024, the Company entered into a further amendment to
its senior secured term loan credit facility with Perceptive. In connection with the Amended Term Loan, Perceptive received new warrants
to purchase an additional 1,500,000 ADSs, and reprice its existing ADS warrants at an exercise price of US$0.80 per ADS.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Securities Purchase Agreement and Convertible Note related to MiCo Investment</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In April 2022, the Company announced a US$45 million investment from MiCo IVD Holdings
LLP. The investment consisted of an equity investment of approximately US$25.2 million (2.24 million ADSs at a price of US$11.25 per ADS)
and a seven-year, unsecured US$20 million junior convertible note, with a fixed interest rate of 1.5% and an ADS conversion price of US$16.20
per ADS. The convertible note mandatorily converts into ADS if the volume weighted average price of the Company&#8217;s ADSs is at or
above US$16.20 for any five consecutive NASDAQ trading days.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25; font-style: italic">Transition Agreement with Bayer Healthcare LLC</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">The transition agreement with Bayer Healthcare LLC (&#8220;Bayer&#8221;) derives from the acquisition of
the CGM assets of Waveform Technologies, Inc in January 2024. As a portion of acquired intellectual property was developed originally
by Bayer, the transition agreement provides that the Company will pay Bayer a royalty on net sales of the CGM products.</div> </div>

<div style="line-height: 1.25"> <br/> </div>

<div style="line-height: 1.25; font-style: italic">Share Purchase Agreement in respect of Benen Trading Limited and Fitzgerald Industries
International Inc.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">On April 27, 2023, the Company announced it had closed the sale of its Fitzgerald
Industries life sciences supply business, consisting of Benen Trading Ltd and Fitzgerald Industries International, Inc, to Biosynth for
cash proceeds of approximately US$30 million subject to customary adjustments. The Fitzgerald life sciences supply business generated
revenue of approximately US$12 million in the year ended December 31, 2022, and was EBITDA positive. The cash proceeds from Biosynth includes
funding to Fitzgerald Industries to allow it to repay intercompany loans owed to Trinity Biotech.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Asset and share Purchase Agreement for CGM assets of Waveform Technologies, Inc.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">On January 30, 2024, the Company acquired the biosensor technology, including the CGM assets, of Waveform
for an initial consideration of US$12.5 million in cash and 1.8 million ADSs of the Company plus contingent consideration. The Company
intends to initially design an updated CGM sensor using the acquired Waveform assets together with a related data driven health and wellness
insights platform and to further evolve the platform technology acquired through the acquisition of the Waveform assets to measure and
analyse other valuable biomarkers and related datapoints.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Share Purchase Agreement for Metabolomics Diagnostics Ltd</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">On September 24, 2024, the Company completed the acquisition of 100% of Metabolomics Diagnostics Limited,
for consideration of approximately US$0.9 million paid through the issuance of approximately 0.27 million American Depository Shares (ADS)
of the Company alongside the extinguishment of monies owed to the company totalling US$0.4 million. The Company intends to develop and
commercialise a screening test for preeclampsia risk using Metabolomics&#8217;s Prepsia test.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Share Purchase Agreement for EpiCapture Limited</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">On October 22, 2024, the Group completed the acquisition of 100% of EpiCapture Limited, for initial consideration
of approximately US$3.3 million paid through the issuance of approximately 1.7 million American Depository Shares (ADS) of the Company,
with an additional consideration of US$0.5 million contingent on the achievement of future milestones. The Company intends to develop
a non-invasive test for monitoring the risk of aggressive prostate cancer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Share Purchase Agreement in respect of Novus Diagnostics Limited</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">On September 27, 2024, the Group completed a strategic investment in Novus Diagnostics
Limited, acquiring a 12.5% equity stake at that time. The consideration comprised approximately 1.4 million American Depository Shares
(ADS) of the Company, valued at approximately US$2.6 million. Novus Diagnostics is developing a rapid, point-of-care test for bloodstream
infections, and the investment is expected to support the advancement and commercialization of its sepsis detection platform. A subsequent
follow-on investment by another shareholder in 2025 resulted in a minor dilution of the Group&#8217;s interest, which remains strategic
in nature.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">93</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div>

<table cellspacing="0" cellpadding="0" id="z017e14f075e84b18af83c90e8a9b6818" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25"><span style="font-weight: bold">D.</span></div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25"><span style="font-weight: bold">Exchange Controls</span></div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Except as indicated below, there are no restrictions on non-residents of Ireland dealing
in Irish securities (including shares or depositary receipts of Irish companies such as the Company). Dividends and redemption proceeds
also continue to be freely transferable to non-resident holders of such securities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">As an EU Member State, EU Council Regulations which implement EU and UN sanctions
decisions automatically have direct effect in Irish law once they enter into force at EU level. Ireland does not currently operate an
autonomous sanctions policy which departs from EU and UN sanctions decisions. At present EU Council Regulations prohibit financial transfers
involving a number of persons, entities and bodies, which are subject to amendment on an ongoing, regular basis and currently include,
but are not limited to: certain persons and activities in Afghanistan, Belarus, Bosnia &amp; Herzegovina, Burundi, the Central African
Republic, Democratic Republic of Congo, the Republic of Guinea, the Republic of Guinea-Bissau, Haiti, the Democratic People's Republic
of Korea, Egypt, Eritrea, Iran, Iraq, Lebanon, Libya, Myanmar/Burma, Nicaragua, Russia, Syria, Somalia, South Sudan, Sudan, Tunisia, Turkey,
Ukraine, Venezuela, Yemen, and Zimbabwe without the prior permission of the Central Bank of Ireland.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Under the Financial Transfers Act 1992 (the &#8220;1992 Act&#8221;), the Minister
for Finance of Ireland may make provision for the restriction of financial transfers between Ireland and other countries. Financial transfers
are broadly defined, and the acquisition or disposal of the ADRs, which represent shares issued by an Irish incorporated company, the
acquisition or the disposal of Ordinary Shares and associated payments may fall within this definition. Dividends or payments on the redemption
or purchase of shares and payments on the liquidation of an Irish-incorporated company would fall within this definition.&#160;Any orders
made under the 1992 Act typically align with the EU and UN sanctions decisions as Ireland does not operate an autonomous sanctions policy
at present.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Any transfer of, or payment in respect of, an ADS involving the government of any
country that is currently the subject of EU or UN sanctions, any person or body controlled by any of the foregoing, or any person acting
on behalf of the foregoing, may be subject to restrictions pursuant to such sanctions as implemented into Irish law. The Company does
not anticipate that orders made under the 1992 Act or EU or UN sanctions implemented into Irish law will have a material effect on its
business.</div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zf0d44814bacf4484bc64e2740623bc30" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">E.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Taxation</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The following discussion is based on U.S. and Republic of Ireland tax law, statutes,
treaties, regulations, rulings and decisions all as of the date of this annual report. Taxation laws are subject to change, from time
to time, and no representation is or can be made as to whether such laws will change, or what impact, if any, such changes would have
on the statements contained in this summary. No assurance can be given that proposed amendments will be enacted as proposed, or that legislative
or judicial changes, or changes in administrative practice, will not modify or change the law as described herein.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">This summary is of a general nature only. It does not constitute legal or tax advice
nor does it discuss all aspects of Irish taxation that may be relevant to any particular Irish Holder or U.S. Holder of ordinary shares
or ADSs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">This summary does not discuss all aspects of Irish and U.S. federal income taxation
that may be relevant to a particular holder of Trinity Biotech ADSs in light of the holder&#8217;s own circumstances or to certain types
of investors subject to special treatment under applicable tax laws (for example, financial institutions, life insurance companies, tax-exempt
organisations, and non-U.S. taxpayers) and it does not discuss any tax consequences arising under the laws of taxing jurisdictions other
than the Republic of Ireland and the U.S. federal government. The tax treatment of holders of Trinity Biotech ADSs may vary depending
upon each holder&#8217;s own particular situation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Prospective purchasers of Trinity Biotech ADSs are advised to consult their own tax
advisors as to the US, Irish or other tax consequences of the purchase, ownership and disposition of such ADSs.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">94</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">U.S. Federal Income Tax Consequences to U.S. Holders</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The following is a summary of certain material U.S. federal income tax consequences
that generally would apply with respect to the ownership and disposition of Trinity Biotech ADSs, in the case of a holder of such ADSs
who is a U.S. Holder (as defined below) and who holds the ADSs as capital assets. This summary is based on the U.S. Internal Revenue Code
of 1986, as amended (the &#8220;Code&#8221;), Treasury Regulations promulgated thereunder, and judicial and administrative interpretations
thereof, all as in effect on the date hereof and all of which are subject to change either prospectively or retroactively. For the purposes
of this summary, a U.S. Holder is: an individual who is a citizen or tax resident of the U.S.; a corporation created or organised in or
under the laws of the U.S. or any political subdivision thereof; an estate whose income is subject to U.S. federal income tax regardless
of its source; or a trust that (a)&#160;is subject to the primary supervision of a court within the U.S. and control by one or more U.S.
persons or (b)&#160;has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">This summary does not address all tax considerations that may be relevant with respect
to an investment in ADSs. This summary does not discuss all the tax consequences that may be relevant to a U.S. Holder in light of such
Holder&#8217;s particular circumstances or to U.S. Holders or other persons subject to special rules, including persons that are not U.S.
Holders, broker dealers, financial institutions, certain insurance companies, investors liable for alternative minimum tax, tax exempt
organisations, regulated investment companies, non-resident aliens of the U.S. or taxpayers whose functional currency is not the U.S.&#160;Dollar,
persons who hold ADSs through partnerships or other pass-through entities, persons who acquired their ADSs through the exercise or cancellation
of employee stock options or otherwise as compensation for services, investors that actually or constructively own 10% or more of Trinity
Biotech&#8217;s shares by vote or value, and investors holding ADSs as part of a straddle or appreciated financial position or as part
of a hedging or conversion transaction.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">If an entity treated as a partnership for U.S. federal income tax purposes owns ADSs,
the U.S. federal income tax treatment of a partner in such a partnership will generally depend upon the status of the partner and the
activities of the partnership. The partners in a partnership that owns ADSs should consult their tax advisors about the U.S. federal income
tax consequences of holding and disposing of ADSs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">This summary does not address the effect of any U.S. federal taxation other than U.S.
federal income taxation. In addition, this summary does not include any discussion of state, local or foreign taxation. You are urged
to consult your tax advisors regarding the foreign and U.S. federal, state and local tax considerations of an investment in ADSs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">For U.S. federal income tax purposes, U.S. Holders of Trinity Biotech ADSs will be
treated as owning the underlying Class &#8216;A&#8217; Ordinary Shares represented by the ADSs held by them. This discussion assumes such
treatment is respected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Dividends and Other Distributions on ADSs</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The gross amount of any distribution made by Trinity Biotech to U.S. Holders with
respect to the underlying shares represented by the ADSs held by them, including the amount of any Irish taxes withheld from such distribution,
will be treated for U.S. federal income tax purposes as a dividend to the extent of Trinity Biotech&#8217;s current and accumulated earnings
and profits, as determined for U.S. federal income tax purposes. The amount of any such distribution that exceeds Trinity Biotech&#8217;s
current and accumulated earnings and profits will be applied against and reduce a U.S. Holder&#8217;s tax basis in the U.S. Holder&#8217;s
ADSs, and any amount of the distribution remaining after the U.S. Holder&#8217;s tax basis has been reduced to zero will constitute capital
gain. However, there can be no assurances we will calculate earnings and profits under U.S. federal income tax principles. Therefore,
any distribution we make to you may be reported as a dividend. The capital gain will be treated as a long-term or short-term capital gain
depending on whether or not the U.S. Holder&#8217;s ADSs have been held for more than one year as of the date of the distribution.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Dividends paid by Trinity Biotech generally will not qualify for the dividends received
deduction otherwise available to U.S. corporate shareholders.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Subject to complex limitations, any Irish withholding tax imposed on dividends will
be a foreign income tax eligible for credit against a U.S. Holder&#8217;s U.S. federal income tax liability (or, alternatively, for deduction
against income in determining such tax liability) where certain conditions are satisfied. The limitations set out in the Code include
computational rules under which foreign tax credits allowable with respect to specific classes of income, commonly referred to as &#8220;baskets,&#8221;
cannot exceed the U.S. federal income taxes otherwise payable with respect to each such class of income. Dividends generally will be treated
as foreign-source passive category income or, in the case of certain U.S. Holders, general category income for U.S. foreign tax credit
purposes. Further, there are special rules for computing the foreign tax credit limitation of a taxpayer who receives dividends subject
to a reduced tax, see discussion below.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">95</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">A U.S. Holder will be denied a foreign tax credit with respect to Irish income tax
withheld from dividends received on the ADSs to the extent such U.S. Holder has not held the ADSs for at least 16 days of the 31-day period
beginning on the date which is 15 days before the ex-dividend date, or to the extent such U.S. Holder is under an obligation to make related
payments with respect to substantially similar or related property. Any days during which a U.S. Holder has substantially diminished its
risk of loss on the ADSs are not counted toward meeting the 16-day holding period required by the Code. If a refund of the tax withheld
is available to you under the laws of Ireland or under the United States and Ireland income tax treaty (the &#8220;Treaty&#8221;), the
amount of tax withheld that is refundable will not be eligible for such credit against your U.S. federal income tax liability (and will
not be eligible for the deduction against your U.S. federal taxable income). The rules relating to the determination of the foreign tax
credit are complex, and you should consult with your personal tax advisors to determine whether and to what extent you would be entitled
to this credit against your U.S. federal income tax liability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Subject to certain limitations, including the PFIC rules discussed below, &#8220;qualified
dividend income&#8221; received by a noncorporate U.S. Holder will be subject to tax at lower rates. Distributions taxable as dividends
paid on the ADSs should qualify as qualified dividend income provided that either: (i)&#160;we are entitled to benefits under the Treaty
or (ii)&#160;the ADSs are readily tradable on an established securities market in the U.S. and certain other requirements are met. We
believe that we are entitled to benefits under the Treaty and that the ADSs currently are readily tradable on an established securities
market in the U.S. However, no assurance can be given that the ADSs will remain readily tradable. The rate reduction does not apply unless
certain holding period requirements are satisfied. With respect to the ADSs, the U.S. Holder must have held such ADSs for at least 61
days during the 121-day period beginning 60 days before the ex-dividend date. The rate reduction also does not apply to dividends received
from passive foreign investment companies, see discussion below, or in respect of certain hedged positions or in certain other situations.
The legislation enacting the reduced tax rate contains special rules for computing the foreign tax credit limitation of a taxpayer who
receives dividends subject to the reduced tax rate. U.S. Holders of ADSs should consult their own tax advisors regarding the effect of
these rules in their particular circumstances.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Dispositions of the ADSs</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Upon a sale or exchange of ADSs, a U.S. Holder will recognise a gain or loss for U.S.
federal income tax purposes in an amount equal to the difference between the amount realised on the sale or exchange and the U.S. Holder&#8217;s
adjusted tax basis in the ADSs sold or exchanged. Such gain or loss generally will be capital gain or loss and will be long-term or short-term
capital gain or loss depending on whether the U.S. Holder has held the ADSs sold or exchanged for more than one year at the time of the
sale or exchange. If you are a non-corporate U.S. Holder, long-term capital gains may be eligible for reduced tax rates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Passive Foreign Investment Company</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">For U.S. federal income tax purposes, a foreign corporation is treated as a &#8220;passive
foreign investment company&#8221; (or &#8220;PFIC&#8221;) in any taxable year in which, after taking into account the income and assets
of the corporation and certain of its subsidiaries pursuant to the applicable &#8220;look through&#8221; rules, either (1)&#160;at least
75% of the corporation&#8217;s gross income is passive income or (2)&#160;at least 50% of the average value of the corporation&#8217;s
assets is attributable to assets that produce passive income or are held for the production of passive income. Based on the nature of
its present business operations, assets and income, Trinity Biotech believes that for the year 2024, it was not a PFIC. However, no assurance
can be given that changes will not occur in Trinity Biotech&#8217;s business operations, assets and income that might cause it to be treated
as a PFIC at some future time.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">If Trinity Biotech were to become a PFIC, a U.S. Holder of ADSs would be required
to allocate to each day in the holding period for such U.S. Holder&#8217;s ADSs a pro rata portion of any distribution received (or deemed
to be received) by the U.S. Holder from Trinity Biotech, to the extent the distribution so received constitutes an &#8220;excess distribution,&#8221;
as defined under U.S. federal income tax law. Generally, a distribution received during a taxable year by a U.S. Holder with respect to
the underlying shares represented by any of the U.S. Holder&#8217;s ADSs would be treated as an &#8220;excess distribution&#8221; to the
extent that the distribution so received, plus all other distributions received (or deemed to be received) by the U.S. Holder during the
taxable year with respect to such underlying shares, is greater than 125% of the average annual distributions received by the U.S. Holder
with respect to such underlying shares during the three preceding years (or during such shorter period as the U.S. Holder may have held
the ADSs). Any portion of an excess distribution that is treated as allocable to one or more taxable years prior to the year of distribution
during which Trinity Biotech was classified as a PFIC would be subject to U.S. federal income tax at the highest tax rate applicable to
the U.S. Holder in the prior tax year or years to which it is allocated. The U.S. Holder also would be subject to an interest charge,
in the year in which the excess distribution is made, on the amount of taxes deemed under the PFIC rules to have been deferred with respect
to the excess distribution. In addition, any gain recognised on a sale or other disposition of a U.S. Holder&#8217;s ADSs, including any
gain recognised on a liquidation of Trinity Biotech, would be treated in the same manner as an excess distribution. Any such gain would
be treated as ordinary income rather than as capital gain.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">96</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">If Trinity Biotech became a PFIC, a U.S. Holder may be eligible to make a &#8220;qualifying
electing fund&#8221; (or &#8220;QEF&#8221;) election in the year Trinity Biotech first becomes a PFIC or in the year the U.S. Holder acquires
the ADSs, whichever is later. This election provides for a current inclusion of Trinity Biotech&#8217;s ordinary income and capital gain
income in the U.S. Holder&#8217;s U.S. taxable income. In return, any gain on sale or other disposition of a U.S. Holder&#8217;s ADSs
in Trinity Biotech, if it were classified as a PFIC, would be treated as capital, and the interest penalty would not be imposed. This
election is not made by Trinity Biotech, but by each U.S. Holder. In order for the U.S. Holder to maintain the election, Trinity Biotech
must make available certain information, which Trinity Biotech may choose not to provide. U.S. Holders should contact their tax advisor
for further information about the election.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Alternatively, if the ADSs are considered &#8220;marketable stock&#8221; a U.S. Holder
may elect to &#8220;mark-to-market&#8221; its ADSs, and such U.S. Holder would not be subject to the PFIC rules described above. Instead,
such U.S. Holder would generally include in income any excess of the fair market value of the ADSs at the close of each tax year over
its adjusted basis in the ADSs. If the fair market value of the ADSs had fallen below the U.S. Holder&#8217;s adjusted basis at the close
of the tax year, the U.S. Holder may generally deduct the excess of the adjusted basis of the ADSs over its fair market value at that
time. However, such deductions generally would be limited to the net mark-to-market gains, if any, that the U.S. Holder included in income
with respect to such ADSs in prior years. Income recognised and deductions allowed under the mark-to-market provisions, as well as any
gain or loss on the disposition of ADSs with respect to which the mark-to-market election is made, is treated as ordinary income or loss
(except that loss is treated as capital loss to the extent the loss exceeds the net mark-to-market gains, if any, that a U.S. Holder included
in income with respect to such ADSs in prior years). However, gain or loss from the disposition of ADSs (as to which a &#8220;mark-to-market&#8221;
election was made) in a year in which Trinity Biotech is no longer a PFIC, will be capital gain or loss. The ADSs should be considered
&#8220;marketable stock&#8221; if they traded at least 15 days during each calendar quarter of the relevant calendar year in more than
de minimis quantities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">If a U.S. Holder owns ADSs during any year in which we are a PFIC, the U.S. Holder
generally must file an IRS Form 8621 with respect to Trinity Biotech, generally with the U.S. Holder&#8217;s federal income tax return
for that year.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Information Reporting and Backup Withholding</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Distributions made with respect to underlying shares represented by ADSs and proceeds
from the sale, exchange or other disposition of ADSs may be subject to information reporting to the IRS and to US backup withholding tax.
Backup withholding will not apply, however, if the U.S. Holder (i)&#160;is a corporation or comes within certain exempt categories, and
demonstrates its eligibility for exemption when so required, or (ii)&#160;furnishes a correct taxpayer identification number and makes
any other required certification.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Backup withholding is not an additional tax. Amounts withheld under the backup withholding
rules may be credited against a U.S. Holder&#8217;s U.S. tax liability, and a U.S. Holder may obtain a refund of any excess amounts withheld
under the backup withholding rules by filing the appropriate claim for refund with the IRS.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Information with Respect to Foreign Financial Assets</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">U.S. persons that hold certain specified foreign financial assets, including stock
in a foreign corporation, with values in excess of certain thresholds are required to file with their U.S. federal income tax return Form
8938, on which information about the assets, including their value, is provided. Taxpayers who fail to file the form when required are
subject to penalties. An exemption from reporting applies to foreign assets held through certain financial institutions. Investors are
encouraged to consult with their own tax advisors regarding the possible application of this disclosure requirement to their investment
in ADSs.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">97</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Medicare Contribution Tax</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In addition to the income taxes described above, U.S. Holders that are individuals,
estates or trusts and whose income exceeds certain thresholds will be subject to a 3.8% Medicare contribution tax on net investment income,
which includes dividends and capital gains.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">U.S. Holders may be subject to state or local income and other
taxes with respect to their purchase, ownership and disposition of ADSs. U.S. Holders of ADSs should consult their own tax advisers as
to the applicability and effect of any such taxes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Irish Taxation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">For the purposes of this summary, an &#8220;Irish Holder&#8221; means a holder of
ordinary shares or ADSs evidenced by ADSs that (i)&#160;beneficially owns the ordinary shares or ADSs registered in its name; (ii)&#160;in
the case of individual holders, are resident, ordinarily resident and domiciled in Ireland under Irish taxation laws; (iii)&#160;in the
case of holders that are companies, are resident in Ireland under Irish taxation laws; and (iv)&#160;are not also resident in any other
country under any double taxation agreement entered into by Ireland.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">For Irish taxation purposes, Irish Holders of ADSs are effectively treated as the
owners of the underlying ordinary shares represented by such ADSs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Solely for the purposes of this summary of Irish Tax considerations, a &#8220;U.S.
Holder&#8221; means a holder of ordinary shares or ADSs evidenced by ADSs that (i)&#160;beneficially owns the ordinary shares or ADSs
registered in its name; (ii)&#160;is resident in the United States for the purposes of the Republic of Ireland/United States Double Taxation
Convention (the Treaty); (iii) in the case of an individual holder, is not also resident or ordinarily resident in Ireland for Irish tax
purposes; (iv)&#160;in the case of a corporate holder, is not a resident in Ireland for Irish tax purposes and is not ultimately controlled
by persons resident in Ireland; and (v)&#160;is not engaged in any trade or business in Ireland and does not perform independent personal
services through a permanent establishment or fixed base in Ireland.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In 2011, the Board decided that it was an appropriate time to commence a dividend
policy for the first time in the Company&#8217;s history but the payment of dividends has subsequently been suspended (see section below
on Dividend Policy). Up to 31 December 2019, the payment of a dividend was generally subject to dividend withholding tax (&#8220;DWT&#8221;)
at the standard rate of income tax in force at the time the dividend was paid (the applicable rate was 20% in 2019). However, the rate
of DWT has increased to 25% in respect of dividends paid on or after 1 January 2020. Under current legislation, where DWT applies, Trinity
Biotech will be responsible for withholding it at source.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">DWT will not be withheld where an exemption applies and where Trinity Biotech has
received all necessary documentation from the recipient prior to payment of the dividend.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Corporate Irish Holders will generally be entitled to claim an exemption from DWT
by delivering a declaration, which confirms that the company is resident in Ireland for tax purposes, to Trinity Biotech in the form prescribed
by the Irish Revenue Commissioners. Such corporate Irish Holders will generally not otherwise be subject to Irish tax in respect of dividends
received.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Individual Irish Holders will be subject to income tax on the gross amount of any
dividend (that is the amount of the dividend received plus any DWT withheld), at their marginal rate of income tax, currently either 20%
or 40% depending on the individual&#8217;s circumstances, excluding Pay Related Social Insurance (&#8220;PRSI&#8221;) and the Universal
Social Charge (&#8220;USC&#8221;). Individual Irish Holders will be able to claim a credit against their resulting income tax liability
and USC liability in respect of DWT withheld. Individual Irish Holders may, depending on their circumstances, also be subject to the Irish
USC of up to 8%, with a further 3% surcharge also arising on certain income in excess of &#8364;100,000 and a PRSI contribution of up
to 4.1% in respect of their dividend income.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Under the Irish Taxes Consolidation Act 1997, dividends paid by Trinity Biotech to
non-Irish shareholders will, unless exempted, be subject to DWT. Such non-Irish shareholders will not suffer DWT on dividends if the shareholder
is:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1ef6e4e76f51414885ca332de7f9395a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>an individual resident in the U.S. (or certain other countries with which Ireland has a double taxation treaty) and who is neither
        resident nor ordinarily resident in Ireland; or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc3526ca3fae94eb2a0777d22b6036cbc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>a U.S. tax resident corporation (or a corporation resident in certain other countries, with which Ireland has a double taxation treaty)
        not under the control of Irish residents; or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">98</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z4f4250204115417dbda34151a56ee666" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>a corporation that is not resident in Ireland and which is ultimately controlled by persons resident in the U.S. (or certain other
        countries with which Ireland has a double taxation treaty), with such person or persons not under the control of persons who are not so
        resident; or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z599e3d5f4557410a875d4303fc50d59f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>a corporation that is not resident in Ireland and the principal class of whose shares (or its 75% parent&#8217;s principal class
        of shares) is substantially or regularly traded on a recognised stock exchange in Ireland or a country with which Ireland has a double
        taxation treaty; or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfa69e5122fb342938e0e53ef5d05c972" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>is otherwise entitled to an exemption from DWT.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In order to avail of the above exemption, certain declarations must be made in advance
to the paying company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">A self-assessment system applies to a person tax resident in a treaty jurisdiction
receiving dividends, under which a non-resident person must provide a declaration and certain information to the dividend paying company
or intermediary to claim the exemption.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Special DWT arrangements are available in the case of shares in Irish companies held
by U.S. resident holders through American depository banks using ADSs where such banks enter into intermediary agreements with Irish Revenue
and are viewed as qualifying intermediaries under Irish Tax legislation. Under such agreements, American depository banks who receive
dividends from Irish companies and pay the dividends on to the U.S. resident ADS holders are allowed to receive and pass on a dividend
from the Irish company on a gross basis (without any withholding) if:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zce0e1a6086b843a6adc44cf2a0cebdf6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the recipient is the direct beneficial owner of the shares, and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z722a430486f847ed9769299de894722e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the recipient is the direct beneficial owner of the ADSs, and the depository bank&#8217;s ADS register shows that the direct beneficial
        owner of the dividends has a U.S. address on the register, and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf6ae3f8c0b3147298caef467c7041b70" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>there is an intermediary between the depository bank and the shareholder beneficially entitled to the dividend and the depository
        bank receives confirmation from the intermediary that such shareholder&#8217;s address in the intermediary&#8217;s records is in the U.S.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Where the above procedures have not been complied with and DWT is withheld from dividend
payments to U.S. Holders of ordinary shares or ADSs evidenced by ADSs, such U.S. Holders can apply to Irish Revenue claiming a full refund
of DWT paid by filing a declaration / claim in the form prescribed by Irish Revenue. Certain accompanying information should also be included
when making such claims.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The DWT rate applicable to U.S. Holders is reduced to 5% under the terms of the Treaty
for corporate U.S. Holders holding 10% or more of voting shares and to 15% for other U.S. Holders. While this will, subject to the application
of Article 23 of the Treaty, generally entitle U.S. Holders to claim a partial refund of DWT from the Irish Revenue Commissioners, U.S.
Holders will, in most circumstances, likely prefer to seek a full refund of DWT under Irish domestic legislation (see above).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Disposals of Ordinary Shares or ADSs</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Irish Holders that acquire ordinary shares or ADSs will generally be considered, for
Irish tax purposes, to have acquired their ordinary shares or ADSs at a base cost equal to the amount paid for the ordinary shares or
ADSs. On subsequent dispositions, ordinary shares or ADSs acquired at an earlier time will generally be deemed, for Irish tax purposes,
to be disposed of on a &#8220;first in first out&#8221; basis before ordinary shares or ADSs acquired at a later time (unless the ordinary
shares or ADSs were acquired within four weeks prior to the deposition). Irish Holders that dispose of their ordinary shares or ADSs will
be subject to Irish capital gains tax (&#8220;CGT&#8221;) to the extent that the proceeds realised from such dispositions exceed the indexed
base cost of the ordinary shares or ADSs disposed of and any incidental expenses. The current rate of CGT is 33% and this applies to disposals
made on or after 6&#160;December 2012. Indexation of the base cost of the ordinary shares or ADSs is available up to 31&#160;December
2002, and only in respect of ordinary shares or ADSs held for more than 12 months prior to their disposal.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Irish Holders that have unutilised capital losses from other sources in the current,
or any previous tax year, can generally apply such losses to reduce gains realised on the disposal of the ordinary shares or ADSs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">An annual exemption allows individuals to realise chargeable gains of up to &#8364;1,270
in each tax year without giving rise to CGT. This exemption is specific to the individual and cannot be transferred between spouses. Irish
Holders are required, under Ireland&#8217;s self-assessment system, to file tax returns reporting any chargeable gains arising to them
in a particular tax year.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">99</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Where disposal proceeds are received in a currency other than Euro, they must be translated
into Euro amounts to calculate the amount of any chargeable gain or loss. Similarly, acquisition costs denominated in a currency other
than Euro must be translated at the date of acquisition into Euro amounts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Irish Holders that realise a loss on the disposal of ordinary shares or ADSs will
generally be entitled to offset such allowable losses against capital gains realised from other sources in determining their CGT liability
in that year. Allowable losses which remain unrelieved in a year may generally be carried forward indefinitely for CGT purposes and applied
against capital gains in future years.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Transfers between spouses who live together will not give rise to any chargeable gain
or loss for CGT purposes with the acquiring spouse acquiring the same pro rata base cost and acquisition date as that of the transferring
spouse.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">U.S. Holders will not be subject to Irish CGT on the disposal of ordinary shares or
ADSs provided that such ordinary shares or ADSs are quoted on a stock exchange at the time of disposition. The stock exchange for this
purpose is the Nasdaq Global Market (&#8220;NASDAQ&#8221;). While it is our intention to continue the quotation of ADSs on NASDAQ, no
assurances can be given in this regard.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">If, for any reason, our ADSs cease to be quoted on the NASDAQ, U.S. Holders will not
be subject to CGT on the disposal of their ordinary shares or ADSs provided that the ordinary shares or ADSs do not, at the time of the
disposal, derive the greater part of their value from land, buildings, minerals, or mineral rights or exploration rights in Ireland.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">A gift or inheritance of ordinary shares will be, or in the case of ADSs may be, within
the charge to capital acquisitions tax, regardless of where the disponer or the donee/successor in relation to the gift/inheritance is
domiciled, resident or ordinarily resident. Capital acquisitions tax is levied at a rate of 33% on the taxable value of the gift or inheritance
above certain tax-free thresholds and this rate applies in respect of gifts and inheritances taken on or after 6&#160;December 2012. The
tax-free threshold is determined by the amount of the current benefit and of previous benefits received within the group threshold since
5 December 1991, which are within the charge to capital acquisitions tax and the relationship between the former holder and the successor.
Gifts and inheritances between spouses are not subject to the capital acquisitions tax. Gifts of up to &#8364;3,000 can be received each
year from any given individual without triggering a charge to capital acquisitions tax. Where a charge to Irish CGT and capital acquisitions
tax arises on the same event, capital acquisitions tax payable on the event can be reduced by the amount of the CGT payable. There should
be no clawback of the same event credit of CGT offset against capital acquisitions tax provided the donee does not dispose of the ordinary
shares or ADSs within two years from the date of gift.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Estate Tax Convention between Ireland and the United States generally provides
for Irish capital acquisitions tax paid on inheritances in Ireland to be credited, in whole or in part, against tax payable in the United
States, in the case where an inheritance of ordinary shares or ADSs is subject to both Irish capital acquisitions tax and U.S. federal
estate tax. The Estate Tax Convention does not apply to Irish capital acquisitions tax paid on gifts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Irish stamp duty, which is a tax imposed on certain documents, is payable on all transfers
of ordinary shares of an Irish registered company (other than transfers made between spouses, transfers made between 90% associated companies,
or certain other exempt transfers) regardless of where the document of transfer is executed. Irish stamp duty is also payable on electronic
transfers of ordinary shares. A transfer of ordinary shares made as part of a sale or gift will generally be stampable at the ad valorem
rate of 1% of the value of the consideration received for the transfer, or, if higher, the market value of the shares transferred. With
effect from 9 October 2019, stamp duty at a rate of 7.5% applies in certain circumstances to the sale or transfer of shares which derive
their value, or the greater part of their value, from non-residential property in Ireland. Any instrument executed on or after 24&#160;December
2008, which transfers stock or marketable securities on sale where the amount or value of the consideration is &#8364;1,000 or less may
be exempt from stamp duty. Where the consideration for a sale is expressed in a currency other than Euro, the duty will be charged on
the Euro equivalent calculated at the rate of exchange prevailing at the date of the transfer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Transfers of ordinary shares where no beneficial interest passes (e.g. a transfer
of shares from a beneficial owner to a nominee) will generally be exempt from stamp duty provided the transfer is not made in contemplation
of sale.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Transfers of ADSs are exempt from Irish stamp duty as long as the ADSs are quoted
on any recognised stock exchange in the U.S. or Canada. Finance Act 2023 introduced an exemption for any electronic transfers of interests
in Irish shares within central securities depositories in either the USA or Canada, where the aforementioned shares are dealt in on a
recognised stock exchange in either of those countries and the trade is settled through a securities settlement system located in the
US or Canada. Prior to Finance Act 2023, this exemption was available by way of an administrative practice and taxpayers were required
to seek Irish Revenue confirmation on a case-by-case basis as to whether this exemption applied.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">100</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Transfers of ordinary shares from the Depositary or the Depositary&#8217;s custodian
upon surrender of ADSs for the purposes of withdrawing the underlying ordinary shares from the ADS system, and transfers of ordinary shares
to the Depositary or the Depositary&#8217;s custodian for the purposes of transferring ordinary shares onto the ADS system, will be stampable
at the ad valorem rate of 1% of the value of the shares if there is a transfer of beneficial ownership or the transfer is made in contemplation
of sale. Such transfers will be exempt from Irish stamp duty if the transfer does not involve any change in the beneficial ownership in
the underlying ordinary shares and the transfer is not made in contemplation of a sale. The person accountable for the payment of stamp
duty is the transferee or, in the case of a transfer by way of gift or for consideration less than the market value, both parties to the
transfer. Stamp duty is normally payable within 44 days after the date of execution of the transfer. Late or inadequate payment of stamp
duty may result in liability for interest, penalties, surcharge and fines.</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z758e74bb99a54182ba932866c736b876" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25"><span style="font-weight: bold">F.</span></div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25"><span style="font-weight: bold">Dividends and Paying Agents</span></div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zcff00dd7680e4493b49663d643a96770" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">G.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Statement by Experts</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0d4ffe29960a40ceb3e8bbe05a93470a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">H.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Documents on Display</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We are subject to the reporting requirements of the Exchange Act, as applicable to
&#8220;foreign private issuers&#8221; as defined in Rule 3b-4 under the Exchange Act, and in accordance therewith, we file reports and
other information with the SEC, including annual reports on Form 20-F and reports on Form 6-K.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">As a foreign private issuer, we are exempt from certain provisions of the Exchange
Act. Accordingly, our proxy solicitations is not subject to the disclosure and procedural requirements of Regulation 14A under the Exchange
Act and transactions in our equity securities by our officers and directors is exempt from reporting and the &#8220;short-swing&#8221;
profit recovery provisions contained in Section 16 of the Exchange Act.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In addition, we are not required under the Exchange Act to file periodic reports and
financial statements as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The SEC maintains an internet website that contains reports and other information
regarding issuers that file electronically with the SEC. This annual report and the exhibits thereto and any other document we file pursuant
to the Exchange Act may be viewed on the SEC&#8217;s website at www.sec.gov and on our website at www.trinitybiotech.com. The information
contained on our website is not incorporated by reference into this Annual Report.&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The documents concerning our Company which are referred to in this Annual Report may
also be inspected at our offices located at IDA Business Park, Bray, County Wicklow, Ireland.</div>

<div style="line-height: 1.25"><br/> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zbdb5bbabda0543f3a5bebdbbeff92b4d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">I.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Subsidiary Information</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">101</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"><span id="Item11.QuantitativeandQualitativeDisclosuresaboutMarketRisk"><!--Anchor--></span><span style="font-weight: bold">Item
11.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold; font-style: italic">Quantitative
and Qualitative Disclosures about Market Risk</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Quantitative information about Market Risk</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Interest rate sensitivity</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech monitors its exposure to changes in interest and exchange rates by
estimating the impact of possible changes on reported profit before tax and net worth. The Group accepts interest rate and currency risk
as part of the overall risks of operating in different economies and seeks to manage these risks by following the policies set above.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech estimates that the maximum effect of a rise of one percentage point
in one of the principal variable interest rates to which the Group is exposed would be an increase in the loss before tax for 2024 by
approximately 2.0%.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Exchange rate sensitivity</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">At year-end 2024, the total net liability denominated in currencies other than the US&#160;Dollar, principally
the Euro, Brazilian Real, Canadian Dollar, Swedish Krona and Great British Pound was US$11.6 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">A strengthening or weakening of the US&#160;Dollar by 10% against all the other currencies
in which the Group operates, would have the approximate effect of increasing or reducing the Group&#8217;s 2024 year-end net worth by
approximately US$1.2 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Qualitative information about Market Risk</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech&#8217;s treasury policy is to manage financial risks arising in relation
to or as a result of underlying business needs. The activities of the treasury function, which does not operate as a profit centre, are
carried out in accordance with board approved policies and are subject to regular internal review. These activities include the Group
making use of spot and forward foreign exchange markets.</div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech uses a range of financial instruments (including cash, and finance
leases) to fund its operations. These instruments are used to manage the liquidity of the Group in a cost effective, low-risk manner.
Working capital management is a key additional element in the effective management of overall liquidity. Trinity Biotech does not trade
in financial instruments or derivatives.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The main risks arising from the utilisation of these financial instruments are interest
rate risk, liquidity risk and foreign exchange risk.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech&#8217;s reported net income and net assets are all affected by movements
in foreign exchange rates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25">At December&#160;31, 2024 the Group&#8217;s borrowings were at a mixture of variable and fixed rates of
interest. The senior secured term loan accrues interest at an annual rate equal to 8.75% plus the greater of (a) the Term SOFR Reference
Rate and (b) one percent per annum. The exchangeable notes are at a fixed rate of interest of 4% and the convertible note is at a fixed
rate of interest of 1.5%. At December&#160;31, 2024 the carrying value of the Group&#8217;s indebtedness totalled US$102,532,000 (2023:
US$67,954,000) (2022: US$73,769,000) at interest rates of 1.5% to 14.1% (2023: 1.5% to 16.3%).</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In broad terms, a one-percentage point increase in interest rates would increase interest
expense by US$755,000 (2023: increase in interest expense of US$417,000).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The majority of the Group&#8217;s activities are conducted in US Dollars. The primary
foreign exchange risk arises from the fluctuating value of the Group&#8217;s Euro and Brazilian Real denominated expenses as a result
of the movement in the exchange rate between the US&#160;Dollar and those currencies. The Group did not engage in foreign currency hedging
in 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Group had foreign currency denominated cash balances equivalent to US$851,000
at December&#160;31, 2024 (2023: US$1,283,000).</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">102</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25"><span id="Item12.DescriptionofSecuritiesOtherthanEquitySecurities"><!--Anchor--></span><span style="font-weight: bold">Item&#160;12.&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span><span style="font-weight: bold; font-style: italic">Description of Securities Other
than Equity Securities</span></div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zfaf8a2b208024ac49808a3487b7cb9bd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">A.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Debt Securities</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zaa9ea8b6f6b84abcbd7b8dd88e6b405f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25"><span style="font-weight: bold">B.</span></div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25"><span style="font-weight: bold">Warrants and Rights</span></div> </td> </tr>
  </table> </div>

<div style="text-align: justify; line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25">In February 2024, the Company adjusted its ADS ratio from 1 ADS: 4 ordinary shares
to 1 ADS: 20 ordinary shares. The ADS numbers shown hereunder reflect the revised ADS ratio.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">On December 15, 2021, the Company agreed to issue warrants exercisable for 500,000
of the Company&#8217;s ADSs to Perceptive. The warrants were issued in January 2022 following the drawdown of the term loan. The per ADS
exercise price of the Warrants was US$6.50. The warrants are exercisable, in whole or part, until the seventh anniversary of the date
of drawdown of the funding under the Term Loan. In February 2023, in connection with an increased Term Loan facility, the Company agreed
to reprice the 500,000 warrants originally issued to Perceptive to an exercise price of US$5.36 per ADS.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">On January 30, 2024, the Company entered into a further amendment to its senior secured
term loan credit facility with Perceptive. In connection with the Amended Term Loan, Perceptive received new warrants to purchase an additional
500,000 ADSs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Additionally, on December 23, 2024, the Company entered into a further amendment to
its senior secured term loan credit facility with Perceptive. In connection with the Amended Term Loan, Perceptive received new warrants
to purchase an additional 1,500,000 ADSs at an exercise price of US$0.80 per ADS, and the exercise price of its existing ADS warrants
was also reset to US$0.80 per ADS.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Also on January 30, 2024, the Company issued warrants to a consultant assisting with
our CGM business to purchase 60,000 ADSs with an exercise price of US$2.20 per ADS. The warrants are exercisable, in whole or part, until
the fifth anniversary of the issue date.</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6b0e901a40274206b29570d4044761e4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">C.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">Other Securities</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z42329b48c87a47eba11c7333127b9298" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: right; vertical-align: top; width: 22.5pt">
        <div style="text-align: left; line-height: 1.25; font-weight: bold">D.</div> </td>
    <td style="text-align: left; vertical-align: top; width: auto">
        <div style="line-height: 1.25; font-weight: bold">American Depositary Shares</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25; font-weight: bold">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Set forth below is a summary of certain provisions in relation to charges and other
payments under the Deposit Agreement with the Bank of New York Mellon, as depositary, and the owners and holders from time to time of
ADSs issued thereunder.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Fees and Charges Payable by ADS Holders</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The table below summarizes the fees and charges that a holder of our ADSs may have
to pay, directly or indirectly, to our depositary, The Bank of New York Mellon, pursuant to the deposit agreement (filed with the SEC
on January&#160;15, 2004 as an exhibit to our Form F-6, registration no. 333-111946) and the types of services and the amount of the fees
or charges paid for such services. The actual fees payable by Trinity Biotech and the holders of ADSs are negotiated between Trinity Biotech
and the depositary. In connection with these arrangements, Trinity Biotech has agreed to pay various fees and expenses of the depositary.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">103</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">The fees and charges that an ADS holder may be required to pay can be changed in the future upon mutual
agreement between Trinity Biotech and by the depositary and may include:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="2" border="0" id="z490434463af04bf7844c8bcaf4e87ae8" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 44.7%; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">Service</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 15.8%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Rate</div> </td>
    <td colspan="1" style="white-space: nowrap; width: 1%; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td style="white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; width: 39.5%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">By whom paid</div> </td> </tr>
  <tr>
    <td style="width: 44.7%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">(1) Issuance of ADSs upon deposit of ordinary shares.</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 15.8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Up&#160;to&#160;$10.00&#160;per&#160;100 ADSs (or portion thereof)
        issued.</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 39.5%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Persons depositing ordinary shares or person receiving ADSs.</div>
        </td> </tr>
  <tr>
    <td style="width: 44.7%; vertical-align: middle">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: middle">&#160;</td>
    <td style="width: 15.8%; vertical-align: middle">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: middle">&#160;</td>
    <td style="width: 39.5%; vertical-align: middle">&#160;</td> </tr>
  <tr>
    <td style="width: 44.7%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">(2) Delivery of deposited securities against surrender of ADSs.</div>
        </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 15.8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Up&#160;to&#160;$10.00&#160;per&#160;100 ADSs (or portion thereof)
        issued.</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 39.5%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Persons surrendering ADSs for the purpose of withdrawal of deposited
        securities or persons to whom deposited securities are delivered.</div> </td> </tr>
  <tr>
    <td style="width: 44.7%; vertical-align: middle">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: middle">&#160;</td>
    <td style="width: 15.8%; vertical-align: middle">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: middle">&#160;</td>
    <td style="width: 39.5%; vertical-align: middle">&#160;</td> </tr>
  <tr>
    <td style="width: 44.7%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">(3) Issuance of ADSs in connection with a distribution of shares.</div>
        </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 15.8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Up&#160;to&#160;$10.00&#160;per&#160;100 ADSs (or portion thereof)
        issued.</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 39.5%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Person to whom distribution is made.</div> </td> </tr>
  <tr>
    <td style="width: 44.7%; vertical-align: middle">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: middle">&#160;</td>
    <td style="width: 15.8%; vertical-align: middle">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: middle">&#160;</td>
    <td style="width: 39.5%; vertical-align: middle">&#160;</td> </tr>
  <tr>
    <td style="width: 44.7%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">(4) Distribution of cash dividends or other cash distributions,
        including distribution of cash proceeds following the sale of rights, shares or other property in accordance with the deposit agreement</div>
        </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 15.8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Up to $0.02 per 1 ADS</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 39.5%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Person to whom distribution is made.</div> </td> </tr>
  <tr>
    <td style="width: 44.7%; vertical-align: middle">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: middle">&#160;</td>
    <td style="width: 15.8%; vertical-align: middle">&#160;</td>
    <td colspan="1" style="width: 1%; vertical-align: middle">&#160;</td>
    <td style="width: 39.5%; vertical-align: middle">&#160;</td> </tr>
  <tr>
    <td style="width: 44.7%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">(5) Transfer of ADSs</div> </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 15.8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Up to $1.50 per certificate for ADRs or ADRs transferred</div>
        </td>
    <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 39.5%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Person to whom Receipt is transferred.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In addition, ADS holders are responsible for certain fees and expenses incurred by
the depositary and certain taxes and governmental charges such as:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z51f2f7e680a94f339df8d71ee16a57d7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>transfer and registration fees of securities on Trinity Biotech&#8217;s securities register to or from the name of the depositary
        or its agent when ADS holders deposit or withdrawal securities;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1275f8b73e48422cbe5b1305623551d3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>expenses for cable, telex and fax transmissions and for delivery of securities;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zde0b0895c39947e9b5dd9980874e2cdd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>expenses incurred for converting foreign currency into U.S. dollars; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zda7f734f57bb46389598b59a6f9f469e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt"><br/> </td>
    <td style="width: 18.35pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>taxes and duties upon the transfer of securities (i.e., when ordinary shares are deposited or withdrawn from deposit, other than
        taxes for which Trinity Biotech is liable).</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Depositary fees payable upon the issuance and cancellation of ADSs are typically paid
to the depositary by the brokers (on behalf of their clients) receiving the newly issued ADSs from the depositary and by the brokers (on
behalf of their clients) delivering the ADSs to the depositary for cancellation. The brokers in turn charge these fees to their clients.
Depositary fees payable in connection with distributions of cash or securities to ADS holders and the depositary services fee are charged
by the depositary to the holders of record of ADSs as of the applicable ADS record date.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">The Depositary fees payable for cash distributions are generally deducted from the
cash being distributed. In the case of distributions other than cash (e.g., stock dividend, rights), the depositary charges the applicable
fee to the ADS record date holders concurrent with the distribution. In the case of ADSs registered in the name of the investor, the depositary
sends invoices to the applicable record date ADS holders. In the case of ADSs held in brokerage and custodian accounts (via DTC), the
depositary generally collects its fees through the systems provided by DTC (whose nominee is the registered holder of the ADSs held in
DTC) from the brokers and custodians holding ADSs in their DTC accounts. The brokers and custodians who hold their clients&#8217; ADSs
in DTC accounts in turn charge their clients&#8217; accounts the amount of the fees paid to the depositary.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In the event of refusal to pay taxes or other governmental charges by the holder of
an ADS, the depositary may, under the terms of the deposit agreement, refuse the requested service until payment is received or may set
off the amount of such tax or other governmental charge from any distribution to be made to the ADS holder, and the ADS holder would remain
liable for any deficiency. The disclosure under this heading &#8220;Fees and Charges Payable by ADS Holders&#8221; is subject to and qualified
in its entirety by reference to the full text of the Deposit Agreement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">On February 15, 2024, Trinity Biotech Plc finalized a ratio change of our American
depositary shares (&#8220;ADSs&#8221;) from one (1) ADS representing four (4) Class A ordinary shares to one (1) ADS representing twenty
(20) Class A ordinary shares. The change in ADS ratio will have the same effect as a one-for-five reverse ADS split.</div> </div>
  <br/>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">104</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PartII"><!--Anchor--></span>Part II</div>

<div style="line-height: 1.25">&#160;</div> <span id="Item13.DefaultsDividendAr"><!--Anchor--></span>

<table cellspacing="0" cellpadding="0" id="zc250813660994acc847773cb4dac2945" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 61.2pt; vertical-align: top; font-weight: bold">Item&#160;13.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-style: italic; font-weight: bold">Defaults, Dividend Arrearages and Delinquencies</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div> <span id="Item14.MaterialModificati"><!--Anchor--></span>

<table cellspacing="0" cellpadding="0" id="z9e98a903eb7640fd8c03371f9eb5dd51" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 61.2pt; vertical-align: top; font-weight: bold">Item&#160; 14.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-style: italic; font-weight: bold">Material Modifications to the Rights of Security Holders and Use of Proceeds</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div> <span id="Item15.ControlsandProcedu"><!--Anchor--></span>

<table cellspacing="0" cellpadding="0" id="zb8ec39c945b3417f93de70c47ffacb47" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 61.2pt; vertical-align: top; font-weight: bold">Item&#160; 15.</td>
    <td style="width: auto; vertical-align: top">
        <div style="font-style: italic; font-weight: bold">Controls and Procedures</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Evaluation of Disclosure Controls and Procedures</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The Group&#8217;s disclosure and control procedures are designed so that information
required to be disclosed in reports filed or submitted under the Securities Exchange Act 1934 is prepared and reported on a timely basis
and communicated to management, to allow timely decisions regarding required disclosure<span style="font-weight: bold; font-style: italic">.
</span>Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, have evaluated the effectiveness
of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15(d) of the Securities Exchange Act of 1934
as of the end of the period covered by this Form 20-F. The Chief Executive Officer and Chief Financial Officer have concluded that disclosure
controls and procedures were effective as of December&#160;31, 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In designing and evaluating our disclosure controls and procedures, our management,
with the participation of the Chief Executive Officer and Chief Financial Officer, recognised that any controls and procedures, no matter
how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management
necessarily was required to apply its judgement in evaluating the cost-benefit relationship of possible controls and procedures. Because
of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and
instances of fraud, if any, within the Group have been detected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Management&#8217;s Annual Report on Internal Control over Financial Reporting</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The management of Trinity Biotech are responsible for establishing and maintaining
adequate internal control over financial reporting. Trinity Biotech&#8217;s internal control over financial reporting is a process designed
under the supervision and with the participation of the principal executive and principal financial officers to provide reasonable assurance
regarding the reliability of financial reporting and preparation of Trinity Biotech&#8217;s financial statements for external reporting
purposes in accordance with IFRS both as issued by the IASB and as subsequently adopted by the EU.</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech&#8217;s internal control over financial reporting includes policies
and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect transactions and dispositions
of assets; provide reasonable assurances that transactions are recorded as necessary to permit preparation of the financial statements
in accordance with IFRS and that receipts and expenditures are being made only in accordance with the authorisation of management and
the directors of Trinity Biotech; and provide reasonable assurance regarding prevention or timely detection of unauthorised acquisition,
use or disposition of Trinity Biotech&#8217;s assets that could have a material effect on our financial statements. Because of its inherent
limitations, internal control over financial reporting may not prevent or detect all misstatements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">It is not always possible to conduct an assessment of an acquired business&#8217;s
internal control over financial reporting in the period between the purchase date and the date of management&#8217;s assessment. In such
cases, management will note that it has excluded the acquired business or businesses from its report on internal control over financial
reporting. Also, projections of any evaluation of the effectiveness of internal control to future periods are subject to the risk that
controls may become inadequate because of changes in conditions, and that the degree of compliance with the policies or procedures may
deteriorate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Management has assessed the effectiveness of internal control over financial reporting
based on criteria established in the 2013 Internal Control &#8211; Integrated Framework issued by the Committee of Sponsoring Organizations
of the Treadway Commission (&#8220;COSO&#8221;). Based on this assessment, management has concluded that the Group&#8217;s internal control
over financial reporting was effective as of December&#160;31, 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">105</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25">Since Trinity Biotech is a non-accelerated filer, our auditor, Grant Thornton, an
independent registered public accounting firm, is not required to issue an attestation report on the Group&#8217;s internal control over
financial reporting as of December&#160;31, 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Changes in Internal Control over Financial
Reporting</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">There were no changes to our internal control over financial reporting that occurred
during the period covered by this Form 20-F that have materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="Item16.Reserved"><!--Anchor--></span>Item&#160;16. Reserved</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold"><span id="A16A.AuditCommitteeFinanc"><!--Anchor--></span>16A. Audit
Committee Financial Expert</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Mr Tom Lindsay is an independent director who joined as a member of the Audit Committee
in October 2022. Our board of directors has determined that Mr Tom Lindsay meet the definition of an audit committee financial expert,
as defined in Item 401 of Regulation S-K.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Management notes that due to changes in the composition of the Board of Directors,
the Audit Committee now consists of only one director. However, the Board of Directors are seeking to recruit at least one additional
suitably qualified independent director to join the Audit Committee in order to strengthen the internal control environment including
the Committee&#8217;s oversight of its external auditors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="A16B.CodeofEthic"><!--Anchor--></span>16B. Code of Ethics</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech has adopted a code of ethics that applies to the Chief Executive Officer,
Chief Financial Officer, Chief Accounting Officer and all organisation employees. Written copies of the code of ethics are available free
of charge upon written request to us at the address on the first page of this annual report. If we make any substantive amendments to
the code of ethics or grant any waivers, including any implicit waiver, from a provision of these codes to our Chief Executive Officer,
Chief Financial Officer or Chief Accounting Officer, we will disclose the nature of such amendment or waiver on our website.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="A16C.PrincipalAccountantF"><!--Anchor--></span>16C. Principal Accountant Fees
and Services</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Fees Billed by Independent Public Accountants</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">The following table sets forth, for each of the years indicated, the fees billed by
our independent public accountants and the percentage of each of the fees out of the total amount billed by the accountants.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5f5aec738b154bd1a33f69b72af3717e" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">Year ended December 31,</div>
        <div style="text-align: center; line-height: 1.25; font-style: italic">2024</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">Year ended December 31,</div>
        <div style="text-align: center; line-height: 1.25; font-style: italic">2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">US$&#8217;000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">%</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">US$&#8217;000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-style: italic">%</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Audit</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,244</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">90</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">909</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">66</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%; padding-bottom: 2px">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Tax</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">141</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px">
        <div style="line-height: 1.25">10</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25">%</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">463</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px">
        <div style="line-height: 1.25">34</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25">%</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="font: 1pt/1.25 Times New Roman, serif">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%; padding-bottom: 2px">
        <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25">Total</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,385</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; white-space: nowrap; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,372</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Audit services include audit of our consolidated financial statements including interim
financial statements, as well as work only the independent auditors can reasonably be expected to provide, including statutory audits.
Audit related services are for assurance and related services performed by the independent auditor, including any special procedures required
to meet certain regulatory requirements. Tax fees consist of fees for professional services for tax compliance and tax advice.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Pre-Approval Policies and Procedures</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Our Audit Committee has adopted policies and procedures for the pre-approval of audit
and non-audit services rendered by our independent public accountants, Grant Thornton. The policy generally pre-approves certain specific
services in the categories of audit services, audit-related services, and tax services up to specified amounts, and sets requirements
for specific case-by-case pre-approval of discrete projects, those which may have a material effect on our operations or services over
certain amounts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Pre-approval may be given as part of the Audit Committee&#8217;s approval of the scope
of the engagement of our independent auditor or on an individual basis. The pre-approval of services may be delegated to one or more of
the Audit Committee&#8217;s members, but the decision must be presented to the full Audit Committee at its next scheduled meeting. The
policy prohibits retention of the independent public accountants to perform the prohibited non-audit functions defined in Section&#160;201
of the Sarbanes-Oxley Act or the rules of the SEC, and also considers whether proposed services are compatible with the independence of
the public accountants.</div>

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">106</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold"><span id="A16D.ExemptionsfromtheLis"><!--Anchor--></span>16D. Exemptions
from the Listing Standards for Audit Committees</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="A16E.PurchasesofEquitySec"><!--Anchor--></span>16E. Purchases of Equity Securities
by the Issuer and Affiliated Purchasers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">None.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Share Buyback</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">Trinity Biotech did not purchase any of its own shares during 2024 or 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="A16F.ChangeinRegistrantsC"><!--Anchor--></span>16F. Change in Registrant&#8217;s
Certifying Accountant</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="A16G.CorporateGovernanc"><!--Anchor--></span>16G. Corporate Governance</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">NASDAQ Stock Market Rules and Home Country Practice</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25">Under NASDAQ Stock Market Rule 5615(a)(3), foreign private issuers, such as our company,
are permitted to follow certain home country corporate governance practices instead of certain provisions of the NASDAQ Stock Market Rules.
A foreign private issuer that elects to follow a home country practice instead of any of such NASDAQ requirements must submit to NASDAQ,
in advance, a written statement from an independent counsel in such issuer&#8217;s home country certifying that the issuer&#8217;s practices
are not prohibited by the home country&#8217;s laws. We provided NASDAQ with such a letter of non-compliance with respect to:</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" border="0" id="zb07ae51c17b04213a8ab440dcf915d3a" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt; vertical-align: top">&#160;</td>
    <td style="width: 18.35pt; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Rule 5605(b)(1) - The Rule requiring maintaining a majority of independent directors.
        Instead, under Irish law and practice, we are not required to appoint a majority of independent directors.</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z05b2269253894efdaeb9920c6011083c" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt; vertical-align: top">&#160;</td>
    <td style="width: 18.35pt; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Rule 5605(b)(2) -The Rule requiring that our independent directors have regularly
        scheduled meetings at which only independent directors are present. Instead, we follow Irish law according to which independent directors
        are not required to hold executive sessions.</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3a6a0b725ba64925a36674e5065d8a7b" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt; vertical-align: top">&#160;</td>
    <td style="width: 18.35pt; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Rule 5605(e) - The Rule regarding independent director oversight of director nominations
        process for directors. Instead, we follow Irish law and practice according to which our board of directors recommends directors for election/re-election
        by our shareholders.</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze4048b101a0e459fad6a81dbe1b7f479" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt; vertical-align: top">&#160;</td>
    <td style="width: 18.35pt; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Rule 5635(c) - The requirement to obtain shareholder approval for the establishment
        or amendment of certain equity based compensation plans, an issuance that will result in a change of control of the company (Rule 5635(b)),
        certain transactions other than a public offering involving issuances of a 20% or more interest in the company (Rule 5635(d)) and certain
        acquisitions of the stock or assets of another company (Rule 5635(a)). Instead, we follow Irish law and practice in approving such procedures,
        according to which Board approval may suffice in certain circumstances, depending on the extent existing general authorities to issue
        shares are in place.</div> </td> </tr>
  </table>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z696cfda29a834fd7bb82b7331f49e6df" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt; vertical-align: top">&#160;</td>
    <td style="width: 18.35pt; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Rule 5605(c)(2) - The Rule requiring maintaining an audit committee consisting of
        at least three independent directors.&#160; Instead, we follow Irish law that requires that an audit committee have at least one independent
        director.</div> </td> </tr>
  </table>

<div><br/> </div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt; vertical-align: top">&#160;</td>
    <td style="width: 18.35pt; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Rule 5605(d)(2) - The Rule requiring a compensation committee consisting of at least
        two independent directors. We have had a compensation committee, which we referred to as the remuneration committee. We have engaged an
        international consultancy to advise the Board on Board and executive compensation.</div> </td> </tr>
  </table>

<div><br/> </div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 30.6pt; vertical-align: top">&#160;</td>
    <td style="width: 18.35pt; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Rule 5620(c) - The Rule requiring a quorum of 33 1/3% at any meeting of shareholders
        (Rule 5620(c)). Instead, we follow the provisions of our Articles which require a quorum of 40%. If a quorum is not present within 30
        minutes (or such longer time not exceeding one hour as the chairperson of the meeting may decide to wait) after the time appointed for
        the holding of the meeting a quorum is not present, or if during the meeting a quorum ceases to be present, the meeting, if convened on
        the requisition of shareholders, shall be dissolved and in any other case, shall stand adjourned to the same day in the next week or to
        such other day and at such other time and place as the chairperson (or, in default, the board of directors) may, subject to the provisions
        of the Companies Act 2014, determine. If at such adjourned meeting a quorum is not present within 15 minutes after the time appointed
        for holding it, the members present in person or by proxy shall be a quorum, but so that not less than two individuals shall constitute
        a quorum.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="A16H.MineSafetyDisclosur"><!--Anchor--></span>16H. Mine Safety Disclosure</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25; font-variant: small-caps; font-weight: bold"><span id="A16I.DisclosureRegardingF"><!--Anchor--></span>16I.
Disclosure Regarding Foreign Jurisdictions That Prevent Inspections</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">Not applicable.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">107</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div> <br/> </div> </div>
<!-- Field: /Include-Text -->
<div style="line-height:1.25">

<div style="line-height:1.25;font-weight:bold"><span id="Item16J"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Item
16J. Insider Trading Policies</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
have <ix:nonNumeric id="Fxbrl_20250513105949175" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" contextRef="C_20240101to20241231" format="ixt:fixed-true">adopted
insider trading policies and procedures</ix:nonNumeric> governing the purchase, sale, and/or other dispositions of our ordinary shares
by directors, officers and employees, that are reasonably designed to promote compliance with insider trading laws, rules and regulations,
and the Nasdaq listing standards.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-weight:bold"><span id="Item16K"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Item
16K. Cybersecurity</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div> <ix:nonNumeric id="Fxbrl_20250513104449097" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Risk
management and strategy</span></span></span></span></div>

<div style="text-align:justify;line-height:1.25;font-style:italic">&#160;</div>

<div> <ix:nonNumeric id="Fxbrl_20250513174143889" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonNumeric id="Fxbrl_20250513105022356" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" contextRef="C_20240101to20241231" format="ixt:fixed-false">We
have not experienced any material cybersecurity incidents that have impacted our operations to date</ix:nonNumeric>. However, like most
companies, we are subject to frequent and evolving cybersecurity threats and attempted attacks from a range of sources, including opportunistic
hackers, organised threat actors, and internal vulnerabilities.</span></span></span></span></div> </div> </ix:nonNumeric>

<div style="text-align:justify;line-height:1.25">&#160;</div> </div> <ix:nonNumeric id="Fxbrl_20250513105055391" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonNumeric id="Fxbrl_20250513105128359" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" contextRef="C_20240101to20241231" format="ixt:fixed-true">To
identify, assess, and mitigate cybersecurity risks, we have implemented a cybersecurity program</ix:nonNumeric> covering the full scope
of our information systems and data assets. This includes internally managed systems, cloud environments, third party-hosted infrastructure,
and sensitive data such as intellectual property, clinical research information, strategic documents, personal data of employees and trial
participants, and confidential commercial information, collectively referred to as our &#8220;Information Systems and Data.&#8221;</span></span></span></span></div>
</div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonNumeric id="Fxbrl_20250513105454836" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" contextRef="C_20240101to20241231" escape="true"><span style="font-size:10pt;font-family:Times New Roman">Our
cybersecurity program is led by our <ix:nonNumeric id="Fxbrl_20250513105515676" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" contextRef="C_20240101to20241231" format="ixt:fixed-true">Chief
Information Officer (CIO)</ix:nonNumeric>, who has over 20 years of IT leadership experience, and is supported by an internal security
function that collaborates with our broader risk management team.</span></ix:nonNumeric> The CIO works across the organisation to ensure
that cybersecurity is embedded within our operations and treated as a core business risk.</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
use a variety of tools and practices to assess the cybersecurity threat landscape and evaluate our posture. These include internal and
external vulnerability scans, threat intelligence feeds, cyber risk assessments, penetration testing conducted by third-party firms, and
tabletop simulations to evaluate and improve our incident response readiness. We also monitor emerging regulatory developments and industry
standards to ensure our practices remain aligned with evolving expectations.</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>To
mitigate risks identified through these processes, we implement a combination of technical, administrative, and physical controls. These
include next-generation firewalls, endpoint protection and antivirus software, multi-factor authentication, access control protocols,
encryption of sensitive data, network segmentation, continuous system monitoring, secure configuration standards, data backup and recovery
protocols, and security awareness training for all staff, including phishing simulations. Our cybersecurity practices are regularly reviewed
and enhanced in response to changing threat dynamics.</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonNumeric id="Fxbrl_20250513050721079" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" contextRef="C_20240101to20241231" format="ixt:fixed-true">Cybersecurity
risk management is also extended to our <ix:nonNumeric id="Fxbrl_20250513050642590" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" contextRef="C_20240101to20241231" format="ixt:fixed-true">third-party
service providers</ix:nonNumeric>, who perform a wide range of business-critical services including data hosting, software delivery, clinical
research, supply chain management, distribution, and contract manufacturing. We assess the cybersecurity posture of key vendors through
a combination of tools, such as security questionnaires, audits, analysis of certifications (e.g., ISO 27001, SOC 2), reviews of written
security policies, and assessment of penetration test results. Where necessary, we engage in direct discussions with vendors' security
teams to evaluate controls. We also impose contractual obligations related to cybersecurity and data protection, including confidentiality
and breach notification requirements. These measures are designed to reduce the risk of vulnerabilities introduced through our supply
chain or external partners.</ix:nonNumeric></span></span></span></span></div>

<div style="text-align:justify;line-height:1.25">&#160;</div> </div>

<div><ix:exclude>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">108</span></span></span></div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
</div> </div> </ix:exclude></div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Cybersecurity
risks are addressed through our overall approach to operational and strategic risk management. Key risks are discussed at senior management
level and prioritised based on their potential to affect our systems, data, or business continuity.</span></span></span></div> </div>
</ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div> </div> <ix:nonNumeric id="Fxbrl_20250513105819081" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<div>

<div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Governance</span></span></span></span></div>

<div style="text-align:justify;line-height:1.25;font-style:italic">&#160;</div> <ix:nonNumeric id="Fxbrl_20250513105318095" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Oversight
of cybersecurity risk forms part of the Board of Directors&#8217; general risk oversight responsibilities. <ix:nonNumeric id="Fxbrl_20250513105538428" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" contextRef="C_20240101to20241231" escape="true"><ix:nonNumeric id="Fxbrl_20250513105344323" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" contextRef="C_20240101to20241231" escape="true"><span style="font-size:10pt;font-family:Times New Roman">Our
Chief Information Officer (CIO), who has over 20 years of experience in IT and security, is responsible for the day-to-day implementation
and ongoing development of our cybersecurity program.</span></ix:nonNumeric></ix:nonNumeric></span></span></span></span></div> </div>
</ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> </div> </div> <ix:nonNumeric id="Fxbrl_20250513105734275" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<div>

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
CIO is involved in reviewing security assessments, monitoring threat activity, approving key cybersecurity controls, and helping coordinate
incident preparedness across the organisation. In the event of a cybersecurity incident, our escalation procedures provide for involvement
of senior management, including the CIO and, where appropriate, other members of the executive team and relevant support functions.</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div> </div> </div> </div> <ix:nonNumeric id="Fxbrl_20250513105718381" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<div>

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonNumeric id="Fxbrl_20250513105758035" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" contextRef="C_20240101to20241231" format="ixt:fixed-true">Cybersecurity
matters are reported to senior management</ix:nonNumeric> as needed, particularly in cases where a threat or incident may have a broader
business impact. Our governance structure is designed to support informed decision-making around risk prioritisation, incident response,
and investment in cybersecurity measures. As of the date of this filing, we are not aware of any cybersecurity threats, including past
incidents, that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or
financial condition.</span></span></span></span></div> </div> </div> </div> </div> </ix:nonNumeric> </div> </ix:nonNumeric> </div> </ix:nonNumeric>

<div style="text-align:center;line-height:1.25">&#160;</div> </div>

<div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span id="PartIII"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Part
III</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:48.95pt;vertical-align:top;font-weight:bold"><span id="Item17"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Item&#160;17</span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        Statements</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The registrant has responded
to Item 18 in lieu of responding to this item.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-weight:bold">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:48.95pt;vertical-align:top;font-weight:bold"><span id="Item18"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Item&#160;18</span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">Financial
        Statements</span></span></span></div> </td> </tr>
  </table> </div>

<div style="text-indent:36pt;line-height:1.25"><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
audited consolidated financial statements as required under Item&#160;18 are attached hereto starting on page&#160;101 of this Annual
Report. The audit report of Grant Thornton (PCAOB ID <ix:nonNumeric id="Fxbrl_20220501170154287" name="dei:AuditorFirmId" contextRef="C_20240101to20241231">1402</ix:nonNumeric>),
independent registered public accounting firm, is included herein preceding the audited consolidated financial statements.</span></span></div>

<div style="text-indent:36pt;line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">109</span></span></span></div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
</div> </div>

<div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Board of Directors
and Shareholders</span></span></div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity Biotech plc</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Opinion
on the financial statements</span></span></div>

<div style="line-height:1.25;font-weight:bold">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
have audited the accompanying consolidated statements of financial position of Trinity Biotech plc and its subsidiaries (the &#8220;Company&#8221;)
as of December 31, 2024 and 2023, the related consolidated statements of operations, comprehensive income, changes in equity, and cash
flows for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the &#8220;financial
statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company
as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended
December 31, 2024, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards
Board.</span></span></div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25">

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Going
concern</strong></span></span></span></span></p>

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>As
discussed in Note 1(iii) to the financial statements, the Company has suffered recurring losses from operations and has a net capital
deficiency. &#160;Management&#8217;s evaluation of the events and conditions and managements&#8217; plans to mitigate these matters are
also described in Note 1(iii).</span></span></span></span></p> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basis
for opinion</span></span></div>

<div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide
a reasonable basis for our opinion.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Critical
audit matters</span></span></div>

<div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated
or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial
statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter
does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit
matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
of goodwill and non-current assets</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Refer
to Note 12 to the financial statements. As at December 31, 2024 prior to impairment analysis, the intangible assets of the Company totalled
$52.9 million, property, plant and equipment of the Company totalled $5.6 million and prepayments of the Company totalled $2.0 million.
&#160;The Company recognised $1.4 million impairment during the year ended December 31, 2024. &#160;In addition, the company acquired
intangible assets and goodwill amounting to $37.9 million and property plant and equipment amounting to $4.5 million in 2024.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Company&#8217;s evaluation of the carrying value of long-lived assets for impairment involves the comparison of the recoverable amount
of each cash generating unit (CGU) to its carrying value. The Company used the&#160;value-in-use&#160;approach, which deploys a discounted
cash flow model to estimate the recoverable amount.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">This
requires management to make significant estimates and assumptions related to discount rates, short-term forecasts of future revenues and
margins, and long-term growth rates which drive net cash flows. Changes in these assumptions could have a significant impact on the recoverable
amount, the amount of any impairment charge, or both.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
principal consideration for our determination that impairment of long-lived assets as a critical audit matter was the significant judgements
made by management to estimate the recoverable value of certain CGUs and the difference between their recoverable amounts and carrying
values. We focused on CGUs which have significant non-current assets in the current year collectively the &#8220;selected CGUs&#8221;).</span></span></div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">110</span></span></span></div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
</div> </div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div>

<div style="text-align:justify;line-height:1.25">

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">This
required a high degree of auditor judgement and an increased extent of effort, when performing audit procedures to evaluate the reasonableness
of management&#8217;s estimates and assumptions as described above.</span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25">

<div style="text-align:justify;line-height:1.25;font-style:italic">

<div style="text-align:left;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">How
the critical audit matter was addressed in the audit</span></span></div> </div>

<div style="text-align:justify;line-height:1.25;font-style:italic">&#160;</div> </div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our
audit procedures related to the assumptions, as described above, used by management to estimate the recoverable amounts of the selected
CGUs included the following, among others:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We evaluated the design effectiveness of controls
        over management&#8217;s selection of the discount rates, short-term forecasts of future revenues and margins, and long-term growth rates
        used to determine the recoverable amount of each selected CGU.</span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">

<div style="line-height:1.25">&#160;</div> </div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div>
        <div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We identified
        relevant CGUs with significant non-current assets for review.</span></span></div> </div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div> </div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div>
        <div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We agreed
        the underlying cash flow forecasts against budgets of the selected CGUs and we evaluated management&#8217;s ability to accurately forecast
        future revenue, margins and expenses by:</span></span></div> </div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">

<div style="line-height:1.25">&#160;</div> </div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:54pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">o</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div>
        <div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">performing
        a look-back analysis and comparing actual results to management&#8217;s historical forecasts; and</span></span></div> </div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:54pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">o</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div>
        <div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">assessing
        the reasonableness of cashflows of new and in-progress products.</span></span></div> </div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div> </div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We assessed the reasonableness of the valuation
        model used by the Company compared to generally accepted valuation practices and accounting standards.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div> </div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We tested the source information underlying the
        determination of the discount rates through use of observable inputs from independent external sources and we developed independent estimates
        and compared those to the discount rates selected by management.</span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">

<div style="line-height:1.25">&#160;</div> </div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We compared the long-term growth rates, used by
        management to grow cash flows in order to calculate a terminal value, to independent external sources to assess the reasonableness of
        these rates</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div> </div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We performed sensitivity analyses around significant
        management assumptions, such as discount rate and growth rate, to account for uncertainties around assumptions in the valuation model.</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">111</span></span></span></div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
</div> </div>

<div style="line-height:1.25">

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Business
combination and valuation of goodwill</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Refer
to Note 29 to the financial statements. The Company completed the acquisition of various businesses during the year ended December 31,
2024, which were accounted for under IFRS 3 &#8220;Business Combination&#8221;. The transactions resulted in the recognition of goodwill
and intangible assets with carrying value totalling $13.8 million and $13.2 million, respectively, as at December 31, 2024. The determination
of the fair value of the identifiable assets acquired, liabilities assumed, and the resulting goodwill required management to make significant
estimates and assumptions, particularly related to the projected future cash flows, discount rates, and the allocation of the purchase
price to the net assets acquired.</span></span></div>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
principal considerations for our determination that performing procedures relating to the business combination and valuation of goodwill
is a critical audit matter are the significant judgment and estimation required by management in determining the fair values, especially
those related to projected revenue growth rates, profit margins, terminal values, and discount rates used in the discounted cash flow
models. These elements involved a high degree of complexity and subjectivity due to the sensitivity of the valuation to changes in assumptions,
as well as the magnitude of the amounts involved.</span></span></div>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">How
the critical audit matter was addressed in the audit</span></span></div>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our
audit procedures related to the assumptions, as described above, used by management to estimate the value of acquired assets and liabilities
and the determination of goodwill included the following, among others:</span></span></div>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        evaluated the design effectiveness of certain internal controls related to the Company's business combination process, including controls
        over the development and selection of significant assumptions used in the valuation of acquired intangible assets.</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        reviewed the purchase price allocation and the identification and measurement of the fair value of acquired assets and assumed liabilities,
        including intangible assets, to evaluate compliance with relevant accounting standards.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        evaluated the reasonableness of the significant assumptions used by management by comparing the information underlying the significant
        assumptions to recent industry and/or market data.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        involved our valuation specialists to review the appropriateness of the discount rate and methodology used by the management&#8217;s specialist
        in their report to value the intangible assets.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        evaluated the competence, capabilities, and objectivity of the external valuer involved in the valuation process, including review of
        their qualifications, independence, and terms of engagement.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        assessed the valuation of goodwill and other acquired assets for impairment at the acquisition date (&#8220;Day 1&#8221; review) and inspected
        subsequent adjustments recognized within the measurement period for appropriateness and adequacy of disclosure.</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        performed sensitivity analyses around significant assumptions used within each model, specifically on revenue and expense drivers, to
        account for uncertainties around assumptions in the valuation model.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        assessed the adequacy of the Company&#8217;s disclosure related to business combination, including the description of key assumptions
        and sensitivities as required under relevant accounting standards.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Going
Concern</span></span></div>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Refer
to Note 1(iii) to the financial statements. Management assessed that it is appropriate to prepare the consolidated financial statements
on a going concern basis. In making this assessment, in particular the directors have considered the significant progress on their multi-year
transformation plan which will be largely completed by mid-2025 and which is expected to deliver significant annualized cost savings.
The directors also considered the launching of their strategic realignment review of the Company&#8217;s businesses which would generate
material capital proceeds to reduce maturing obligations and support current projects. Lastly, the directors considered the continuing
support obtained from the Company&#8217;s principal lender and largest investor. The amended agreement with the lender deferred the date
of the maturity of the senior secured term loan amounting to $72.4 million from January 2026 to July 2026 which provides the Company flexibility
to preserve liquidity to continue to execute its updated strategy, including the Company&#8217;s comprehensive transition plan. The Company
has suffered recurring losses from operations, net cash outflows from operating activities, and has a significant accumulated deficit.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">112</span></span></span></div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
</div> </div>

<div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
principal considerations for our determination that the&#160;going&#160;concern&#160;is a critical audit matter&#160;are the uncertainties
surrounding the achievability of management&#8217;s forecast, the success of the Company&#8217;s multi-year transformation plan and strategic
realignment review of the Company&#8217;s businesses, and the support obtained from the Company&#8217;s principal lender. These considerations
require significant auditor judgment in assessing the uncertainties surrounding the management&#8217;s assumptions on their ability to
continue as going concern.</span></span></div>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">How
the critical audit matter was addressed in the audit</span></span></div>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our
audit procedures related to going concern included the following, among others:</span></span></div>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        obtained an understanding, evaluated the design effectiveness of controls over management&#8217;s going concern assessment process.</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        evaluated management&#8217;s assessment on going concern and performed an independent assessment of the inputs and assumptions used by
        management in preparing their cash flow forecast by comparing the assumptions and estimates used elsewhere in the preparation of the financial
        statements.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        assessed management communication and revised agreements with the lender to extend the maturity of the senior secured term loan to July
        2026. We also discussed with management the options being considered in relation to repayment plan of the senior secured term loan.</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        evaluated the credit agreement and inspected management's assessment on the Company&#8217;s compliance with debt covenants, including
        inspection of any related waivers obtained for breaches.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        considered subsequent events up to the date of the auditor&#8217;s report that may affect the going concern conclusion.</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:17.85pt">&#160;</td>
    <td style="width:17.85pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman',Times,serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
        evaluated the adequacy of the Company&#8217;s disclosure in the financial statements, including the description of substantial doubt and
        management plans as required by relevant accounting standards.</span></span></div> </td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">/s/ <ix:nonNumeric id="Fxbrl_20220327041219624" name="dei:AuditorName" contextRef="C_20240101to20241231">GRANT
THORNTON</ix:nonNumeric></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220327041225533" name="dei:AuditorLocation" contextRef="C_20240101to20241231">Dublin,
Ireland</ix:nonNumeric></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We have served as the
Company&#8217;s auditor since 2008.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25">

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15 May 2025</span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:0pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">113</span></span></span></div>
</div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:3pt;margin-bottom:10pt"/>
</div>

<div style="line-height:1.25;font-weight:bold;margin-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED
STATEMENT OF OPERATIONS</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December 31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114121347800_27" name="ifrs-full:Revenue" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,555</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114121347800_211" name="ifrs-full:Revenue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,832</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114121347800_215" name="ifrs-full:Revenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,521</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost
        of sales</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_37" name="ifrs-full:CostOfSales" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,114</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_311" name="ifrs-full:CostOfSales" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37,382</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_315" name="ifrs-full:CostOfSales" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,253</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross
        profit</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114121347800_57" name="ifrs-full:GrossProfit" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,441</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114121347800_511" name="ifrs-full:GrossProfit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,450</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114121347800_515" name="ifrs-full:GrossProfit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,268</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        operating (expense)/income</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_67" name="ifrs-full:OtherOperatingIncomeExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,787</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114121347800_611" name="ifrs-full:OtherOperatingIncomeExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">141</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114121347800_615" name="ifrs-full:OtherOperatingIncomeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">343</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research
        and development expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_77" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,543</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_711" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,379</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_715" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,138</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling,
        general and administrative expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_87" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,815</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_811" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,152</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_815" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,983</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling,
        general and administrative expenses &#8211; Restructuring costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512160338671" name="trib:SellingGeneralAndAdministrativeExpensesRestructuringCosts" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,181</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512160348513" name="trib:SellingGeneralAndAdministrativeExpensesRestructuringCosts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512160351673" name="trib:SellingGeneralAndAdministrativeExpensesRestructuringCosts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Once
        off items</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512160446176_xbrl_20250512160338671" name="trib:OnceOffExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,872</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512160446176_xbrl_20250512160348513" name="trib:OnceOffExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512160446176_xbrl_20250512160351673" name="trib:OnceOffExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        charges</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_127" name="ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,408</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_1211" name="ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,105</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_1215" name="ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,839</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413004631278" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">21,165</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_1411" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">27,045</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_1415" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,349</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        income</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114121347800_157" name="ifrs-full:FinanceIncome" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114121347800_1511" name="ifrs-full:FinanceIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,171</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114121347800_1515" name="ifrs-full:FinanceIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">303</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_167" name="ifrs-full:FinanceCosts" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,565</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_1611" name="ifrs-full:FinanceCosts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,053</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_1615" name="ifrs-full:FinanceCosts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,734</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        financing expense</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_187" name="trib:NetFinancingExpenseIncome" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9,565</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_1811" name="trib:NetFinancingExpenseIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9,882</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_1815" name="trib:NetFinancingExpenseIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,431</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,
        9</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413005149122" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">30,730</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_207" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">36,927</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_2015" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">43,780</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        income tax (expense)/credit</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,
        7</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_217" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">486</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114121347800_2111" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">59</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114121347800_2115" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">194</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year on continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,
        10</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230412225228865" name="ifrs-full:ProfitLoss" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,216</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_237" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">36,868</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_2315" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">43,586</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Loss)/profit
        for the year on discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_257" name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">573</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326234440814" name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,850</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230412225307585" name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,577</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year (all attributable to owners of the parent)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,
        10</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230412225131064" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,789</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_277" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,018</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_2715" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">41,009</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per ADS (US Dollars) &#8211; continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414172355559" name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">1.74</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_297" name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">4.81</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_2915" name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">6.46</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
        loss per ADS (US Dollars) &#8211; continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414172514392" name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">1.74</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_2911" name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">4.81</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_3015" name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">6.46</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per &#8216;A&#8217; ordinary share (US Dollars) &#8211; continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414172630589" name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.09</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_327" name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.24</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_3215" name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.32</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
        loss per &#8216;A&#8217; ordinary share (US Dollars) &#8211; continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414172712450" name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.09</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_3211" name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.24</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_3315" name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.32</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:52.53%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per ADS (US Dollars) &#8211; group</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414172801585" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">1.77</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_357" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">3.14</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_3515" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">6.08</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
        loss per ADS (US Dollars) &#8211; group</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414172843253" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">1.77</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_3511" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">3.14</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_3615" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">6.08</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per &#8216;A&#8217; ordinary share (US Dollars) &#8211; group</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414173012858" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.09</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_3811" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.16</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_3815" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.30</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
        loss per &#8216;A&#8217; ordinary share (US Dollars) &#8211; group</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414173056858" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.09</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_3911" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.16</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114121347800_3915" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.30</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:3pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">114</span></span></span></div>
</div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
</div>

<div style="line-height:1.25;font-weight:bold;margin-top:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED
STATEMENT OF COMPREHENSIVE INCOME</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December 31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230412230627043" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,789</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114125028095_210" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,018</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114125028095_214" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">41,009</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        comprehensive profit/(loss)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Items
        that will be reclassified subsequently to profit or loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign
        exchange translation differences</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114125028095_56" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">245</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114125028095_510" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114125028095_514" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">396</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        comprehensive profit/(loss)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114125028095_76" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">245</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114125028095_710" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114125028095_714" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">396</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        Comprehensive Loss (all attributable to owners of the parent)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230412230557342" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,544</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114125028095_910" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">23,949</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114125028095_914" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">41,405</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:3pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">115</span></span></span></div>
</div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
</div>

<div style="line-height:1.25;font-weight:bold;margin-top:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">CONSOLIDATED
STATEMENT OF FINANCIAL POSITION</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">At
        December 31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Notes</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">ASSETS</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Non-current
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Property,
        plant and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">11</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_47" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,621</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_411" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,892</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Goodwill
        and intangible assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">12</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_57" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51,343</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_511" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,270</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Financial
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20250512171126584" name="ifrs-full:NoncurrentFinancialAssets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,455</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20250512171144361" name="ifrs-full:NoncurrentFinancialAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Deferred
        tax assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">14</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_67" name="ifrs-full:DeferredTaxAssets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,553</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_611" name="ifrs-full:DeferredTaxAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,975</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Derivative
        financial instruments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_77" name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">166</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_711" name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Other assets</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">15</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_87" name="ifrs-full:OtherNoncurrentFinancialAssets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_811" name="ifrs-full:OtherNoncurrentFinancialAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">79</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Total
        non-current assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_107" name="ifrs-full:NoncurrentAssets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,166</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_1011" name="ifrs-full:NoncurrentAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,394</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Current
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Inventories</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">16</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_137" name="ifrs-full:Inventories" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,374</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_1311" name="ifrs-full:Inventories" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,933</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Trade
        and other receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">17</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_147" name="ifrs-full:TradeAndOtherCurrentReceivables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,065</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_1411" name="ifrs-full:TradeAndOtherCurrentReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,901</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Income
        tax receivable</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_157" name="ifrs-full:CurrentTaxAssetsCurrent" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">518</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_1511" name="ifrs-full:CurrentTaxAssetsCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,516</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Cash
        and cash equivalents</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">18</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_167" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,167</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_1611" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Total
        current assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_197" name="ifrs-full:CurrentAssets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,124</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_1911" name="ifrs-full:CurrentAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,041</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">TOTAL
        ASSETS</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_217" name="ifrs-full:Assets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103,290</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_2111" name="ifrs-full:Assets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59,435</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">EQUITY
        AND LIABILITIES</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Equity
        attributable to the equity holders of the parent</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Share
        capital</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">19</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_257" name="ifrs-full:IssuedCapital" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,190</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_2511" name="ifrs-full:IssuedCapital" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,972</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Share
        premium</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_267" name="ifrs-full:SharePremium" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,397</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_2611" name="ifrs-full:SharePremium" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,619</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Treasury
        shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">19</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(<ix:nonFraction id="Fxbrl_20220114130013533_277" name="ifrs-full:TreasuryShares" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,922</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(<ix:nonFraction id="Fxbrl_20220114130013533_2711" name="ifrs-full:TreasuryShares" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,922</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Accumulated
        deficit</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(<ix:nonFraction id="Fxbrl_20240412211846794" name="ifrs-full:RetainedEarnings" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">79,117</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(<ix:nonFraction id="Fxbrl_20240412211850539" name="ifrs-full:RetainedEarnings" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">48,644</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Translation
        reserve</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">19</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(<ix:nonFraction id="Fxbrl_20220114130013533_297" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,461</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(<ix:nonFraction id="Fxbrl_20220114130013533_2911" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,706</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Equity
        component of convertible note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">19,
        23</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230413015603125" name="trib:EquityComponentOfConvertibleNote" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,709</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230413015823026" name="trib:EquityComponentOfConvertibleNote" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,709</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Other
        reserves</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">19</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_307" name="ifrs-full:OtherReserves" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_3011" name="ifrs-full:OtherReserves" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Total
        deficit</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(<ix:nonFraction id="Fxbrl_20220114130013533_327" name="ifrs-full:Equity" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">35,181</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(<ix:nonFraction id="Fxbrl_20220326225326285" name="ifrs-full:Equity" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">23,949</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Income
        tax payable</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_357" name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">364</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_3511" name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">279</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">21</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_367" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,782</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_3611" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,802</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Provisions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_377" name="ifrs-full:CurrentProvisions" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,454</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_3711" name="ifrs-full:CurrentProvisions" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Exchangeable
        notes and other borrowings</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220422112458271" name="trib:ExchangeableNotesAndOtherBorrowingsCurrent" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220422112507789" name="trib:ExchangeableNotesAndOtherBorrowingsCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Lease
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_387" name="trib:CurrentFinanceLeaseLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,285</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_3811" name="trib:CurrentFinanceLeaseLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,694</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Total
        current liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_407" name="ifrs-full:CurrentLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,095</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_4011" name="ifrs-full:CurrentLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,035</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Non-current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Senior secured term loan</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_437" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_4311" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,109</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Derivative financial
        liability</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_447" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,658</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_4411" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">526</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230413013920928" name="trib:ConvertibleNote" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230413014002813" name="trib:ConvertibleNote" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,542</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Contingent
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20250512171243112" name="trib:ContingentConsiderationNonCurrent" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,813</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20250512171246652" name="trib:ContingentConsiderationNonCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Provisions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20250512171258546_xbrl_20250512171243112" name="ifrs-full:NoncurrentProvisions" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20250512171258546_xbrl_20250512171246652" name="ifrs-full:NoncurrentProvisions" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Lease liabilities</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_457" name="trib:NoncurrentFinanceLeaseLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,477</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_4511" name="trib:NoncurrentFinanceLeaseLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,872</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Deferred
        tax liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">14</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_467" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,561</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_4611" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,300</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Total
        non-current liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_487" name="ifrs-full:NoncurrentLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106,376</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_4811" name="ifrs-full:NoncurrentLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,349</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">TOTAL
        LIABILITIES</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_507" name="ifrs-full:Liabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">138,471</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_5011" name="ifrs-full:Liabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83,384</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">TOTAL
        EQUITY AND LIABILITIES</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_527" name="ifrs-full:EquityAndLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103,290</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220114130013533_5211" name="ifrs-full:EquityAndLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59,435</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:3pt">

<div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:normal;font-style:normal">116</span></span></span></div>
</div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
</div>

<div style="line-height:1.25;font-weight:bold;margin-top:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED
STATEMENT OF CHANGES IN EQUITY</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="text-align:right;line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><em style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Share
        capital</span></span></span></span></span></em></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#8216;<span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">A&#8217;&#160;ordinary</span></span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">shares</span></span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">US<span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">$</span>&#8217;000</span></span></span></span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">Share</span></span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;<span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">premium</span></span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">US<span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">$</span>&#8217;000</span></span></span></span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">Treasury</span></span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">Shares</span></span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">US<span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">$</span>&#8217;000</span></span></span></span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">Translation</span></span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">reserve</span></span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">US<span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">$</span>&#8217;000</span></span></span></span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Equity
        Component of</span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">convertible
        Note</span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">US<span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">$</span>&#8217;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">Other</span></span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">reserves</span></span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">US<span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">$</span>&#8217;000</span></span></span></span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">Accumulated</span></span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">(deficit)/surplus</span></span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">US<span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">$</span>&#8217;000</span></span></span></span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">Total</span></span></span></span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">US<span style="font-style:italic;margin-top:0pt;margin-bottom:0pt">$</span>&#8217;000</span></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326221702067" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,213</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326221930805" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,187</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326221959372" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,922</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326222018252" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,379</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181249289" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326222039827" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326222113535" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,559</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326222130941" name="ifrs-full:Equity" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">319</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181401830" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181344387" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181404761" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181408897" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181411617" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181418109" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114131757597_1323" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">41,009</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114131757597_1327" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">41,009</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        comprehensive loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181441354" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181508195" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181511409" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114131757597_1415" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">396</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181536174" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181542714" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181546407" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114131757597_1427" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">396</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        comprehensive loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181927844" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181932710" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181935111" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114131757597_1615" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">396</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181937549" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181942061" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114131757597_1623" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">41,009</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114131757597_1627" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">41,405</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shares
        issued in the year (Note 19)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412213820561" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">750</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412213824956" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,271</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181953294" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182004001" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182006553" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182015898" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182012736" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412214409737" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,021</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shares
        to be issued</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182024092" name="trib:SharesToBeIssued" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182026212" name="trib:SharesToBeIssued" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182029376" name="trib:SharesToBeIssued" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182031706" name="trib:SharesToBeIssued" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182035326" name="trib:SharesToBeIssued" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412214349239" name="trib:SharesToBeIssued" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182038306" name="trib:SharesToBeIssued" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412214354928" name="trib:SharesToBeIssued" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:20%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity
        component of convertible note (Note 19)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182044816" name="trib:IncreasedecreasethroughequityComponentOfConvertibleNote" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182050994" name="trib:IncreasedecreasethroughequityComponentOfConvertibleNote" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182054408" name="trib:IncreasedecreasethroughequityComponentOfConvertibleNote" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182101492" name="trib:IncreasedecreasethroughequityComponentOfConvertibleNote" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414180326524" name="trib:IncreasedecreasethroughequityComponentOfConvertibleNote" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,709</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182104424" name="trib:IncreasedecreasethroughequityComponentOfConvertibleNote" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182107792" name="trib:IncreasedecreasethroughequityComponentOfConvertibleNote" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413030530424" name="trib:IncreasedecreasethroughequityComponentOfConvertibleNote" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,709</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments (Note 20)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182131051" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182147534" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182152392" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182155864" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182159273" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182203863" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412213923866" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,755</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412213928533" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,755</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at December&#160;31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412213556559" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,963</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412213609835" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,458</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240412213634431" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,922</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240412213653897" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,775</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412213703415" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,709</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412213711097" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240412213832971" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">26,695</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240412213840106" name="ifrs-full:Equity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,176</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412213558644" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,963</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412213618341" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,458</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240412213637734" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,922</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240412213656034" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,775</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240421152903111" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,709</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412213712964" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240412213849515" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">26,695</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240412213851379" name="ifrs-full:Equity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,176</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182231555" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182235352" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182238263" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182248947" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182252075" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182254657" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240412214003549" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,018</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240412214021938" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,018</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        comprehensive income</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182711737" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182714474" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182716833" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412214031755" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182720119" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182727039" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182731910" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412214038654" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        comprehensive loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182746597" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182749154" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182752181" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413023537920" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182808027" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182810573" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413023551717" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,018</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413023545442" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">23,949</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shares
        issued in the year (Note 19)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413031911904" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413031907902" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">161</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182819271" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182822292" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182825282" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413031930594" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">63</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182833128" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413031847251" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">107</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments (Note 20)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182856083" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182859251" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182904206" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182907085" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182910615" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182913879" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413023630175" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,069</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413023637363" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,069</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:20%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413024018171" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,972</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413024041976" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,619</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413024050249" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,922</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413024056266" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,706</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413024101890" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,709</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413024108326" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413024114426" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">48,644</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413024121890" name="ifrs-full:Equity" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">23,949</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512173619169_xbrl_20230413024018171" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,972</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512173619169_xbrl_20230413024041976" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,619</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512173619169_xbrl_20230413024050249" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,922</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512173619169_xbrl_20230413024056266" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,706</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512173619169_xbrl_20230413024101890" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,709</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512173619169_xbrl_20230413024108326" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512173619169_xbrl_20230413024114426" name="ifrs-full:Equity" contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">48,644</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512173619169_xbrl_20230413024121890" name="ifrs-full:Equity" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">23,949</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182333871" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182340673" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182343267" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182345524" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182347874" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182350044" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512174025927" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,789</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512174028039" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,789</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        comprehensive income</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182611518" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182615310" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182623842" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512174057910" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">245</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182628407" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182631214" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182634117" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512174100591" name="ifrs-full:OtherComprehensiveIncome" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">245</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:20%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        comprehensive loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182924505" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182927011" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182929560" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512174120783" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">245</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182932703" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512182949260" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512174125772" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,789</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512174131621" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,544</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shares
        issued in the year (Note 19)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512175943012" name="ifrs-full:IssueOfEquity" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,218</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512175948019" name="ifrs-full:IssueOfEquity" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,778</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512183019517" name="ifrs-full:IssueOfEquity" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512183022918" name="ifrs-full:IssueOfEquity" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512183026068" name="ifrs-full:IssueOfEquity" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512183029004" name="ifrs-full:IssueOfEquity" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512183032894" name="ifrs-full:IssueOfEquity" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180001700" name="ifrs-full:IssueOfEquity" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,996</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:20%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments (Note 20)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512183044208" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512183046611" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512183049772" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512183053868" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512183056172" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512183058870" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180012711" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180017636" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:20%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180029954_xbrl_20230413024018171" name="ifrs-full:Equity" contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,190</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180029954_xbrl_20230413024041976" name="ifrs-full:Equity" contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,397</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512180029954_xbrl_20230413024050249" name="ifrs-full:Equity" contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,922</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512180029954_xbrl_20230413024056266" name="ifrs-full:Equity" contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,461</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180029954_xbrl_20230413024101890" name="ifrs-full:Equity" contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,709</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180029954_xbrl_20230413024108326" name="ifrs-full:Equity" contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512180029954_xbrl_20230413024114426" name="ifrs-full:Equity" contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">79,117</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512180029954_xbrl_20230413024121890" name="ifrs-full:Equity" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">35,181</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table>

<div>&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:3pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">117</span></span></span></div>
</div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
</div>

<div>

<div>

<div>

<div>

<div style="line-height:1.25;font-weight:bold;margin-top:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED
STATEMENT OF CASH FLOWS</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December 31,</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Notes</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        flows from operating activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413051933911" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,789</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_310" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,018</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_314" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">41,009</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments
        to reconcile net loss to cash provided by operating activities:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;text-align:center;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,
        11</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_56" name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">675</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_510" name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">831</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_514" name="ifrs-full:AdjustmentsForDepreciationExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,410</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortisation</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,12</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_66" name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,190</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_610" name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">946</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_614" name="ifrs-full:AdjustmentsForAmortisationExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">923</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax expense/(credit)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_76" name="ifrs-full:AdjustmentsForIncomeTaxExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">486</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_710" name="ifrs-full:AdjustmentsForIncomeTaxExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">59</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_714" name="ifrs-full:AdjustmentsForIncomeTaxExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">192</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        income</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_86" name="ifrs-full:AdjustmentsForFinanceIncome" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_810" name="ifrs-full:AdjustmentsForFinanceIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,171</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_814" name="ifrs-full:AdjustmentsForFinanceIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">303</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        expense</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_96" name="ifrs-full:AdjustmentsForFinanceCosts" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,565</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_910" name="ifrs-full:AdjustmentsForFinanceCosts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,053</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_914" name="ifrs-full:AdjustmentsForFinanceCosts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,745</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments (net of capitalized amounts)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_106" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_1010" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,069</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_1014" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,755</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign
        exchange gains on operating cash flows</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_116" name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,010</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_1110" name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">238</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326224904128" name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">76</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        on disposal or retirement of property, plant and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413033537164" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413051440145" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_1214" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Movement
        in inventory provision</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_136" name="ifrs-full:AdjustmentsForProvisions" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,113</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_1310" name="ifrs-full:AdjustmentsForProvisions" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,291</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_1314" name="ifrs-full:AdjustmentsForProvisions" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory
        write off</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513024511057_xbrl_20220114135841083_136" name="trib:AdjustmentsForInventoryWriteOff" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,884</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513024511057_xbrl_20220114135841083_1310" name="trib:AdjustmentsForInventoryWriteOff" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513024511057_xbrl_20220114135841083_1314" name="trib:AdjustmentsForInventoryWriteOff" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        of prepayments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,
        17</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_146" name="ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_1410" name="ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_1414" name="ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">482</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-align:justify;text-indent:-7.1pt;margin-left:7.5pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        of property, plant and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,
        11</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_156" name="ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">612</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_1510" name="ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,772</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_1514" name="ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">733</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        of intangible assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,
        12</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_166" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,596</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_1610" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,833</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_1614" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,624</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities
        related to financial assets (reversal)/written off</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,
        13</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413012243239" name="ifrs-full:ImpairmentLossOnFinancialAssets" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">800</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413012249788" name="ifrs-full:ImpairmentLossOnFinancialAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413012258145" name="ifrs-full:ImpairmentLossOnFinancialAssets" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gain
        on sale of business</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413012305863" name="trib:AdjustmentsForGainLossOnSaleOfBusiness" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413012331457" name="trib:AdjustmentsForGainLossOnSaleOfBusiness" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,718</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413012336820" name="trib:AdjustmentsForGainLossOnSaleOfBusiness" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restructuring
        provision</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513024601380_xbrl_20240413012305863" name="trib:AdjustmentForRestructuringProvision" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">361</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513024601380_xbrl_20240413012331457" name="trib:AdjustmentForRestructuringProvision" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513024601380_xbrl_20240413012336820" name="trib:AdjustmentForRestructuringProvision" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        non-cash items</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_176" name="ifrs-full:OtherAdjustmentsForNoncashItems" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,505</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326225125856" name="ifrs-full:OtherAdjustmentsForNoncashItems" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">257</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413051605313" name="ifrs-full:OtherAdjustmentsForNoncashItems" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">269</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        cash flows before changes in working capital</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_196" name="ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9,276</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_1910" name="ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9,176</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_1914" name="ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">754</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Increase)/decrease
        in trade and other receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413052316452" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,368</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326225259098" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,047</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413052619964" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">966</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase&#160;in
        inventories</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_216" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,742</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_2110" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">971</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326225419561" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">877</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase/(decrease)
        in trade and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220430125903838" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,185</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413052518333" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,769</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_2214" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">181</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        used in operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413052046301" name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,201</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_2410" name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,869</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_2414" name="ifrs-full:CashFlowsFromUsedInOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">908</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest
        received</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_266" name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_2610" name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_2614" name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        taxes received/(paid)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413052656031" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,010</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_2710" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">312</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326225614743" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash used in operating activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413052708840" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,191</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_2910" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,557</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">(<ix:nonFraction id="Fxbrl_20220114135841083_2914" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">921</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        flows from investing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Payments
        to acquire intangible assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_336" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,659</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_3310" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,901</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_3314" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,876</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition
        of property, plant and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_346" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">405</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_3410" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">803</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_3414" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,101</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Payments
        to acquire financial asset</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413012434744" name="trib:PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413012439007" name="trib:PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">700</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413012441535" name="trib:PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds
        from sale of business (net of transaction costs)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413012513093" name="ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413012519077" name="ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,160</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413012522250" name="ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Payments
        to acquire trades or businesses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250513024632161_xbrl_20240413012513093" name="trib:PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,904</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513024632161_xbrl_20240413012519077" name="trib:PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513024632161_xbrl_20240413012522250" name="trib:PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash (used in)/generated by investing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_376" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,968</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_3710" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,756</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_3714" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,977</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        flows from financing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issue
        of ordinary share capital including share premium (net of issuance costs)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413045351224" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413045401765" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413045413687" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,336</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds
        from shares to be issued</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413045430592" name="trib:ProceedsFromSharesToBeIssued" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413045503424" name="trib:ProceedsFromSharesToBeIssued" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413045515704" name="trib:ProceedsFromSharesToBeIssued" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        proceeds from senior secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413045755722" name="ifrs-full:ProceedsFromNoncurrentBorrowings" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,176</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413045817526" name="ifrs-full:ProceedsFromNoncurrentBorrowings" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413045830198" name="ifrs-full:ProceedsFromNoncurrentBorrowings" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">80,015</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds
        from convertible note issued</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413045846074" name="trib:ProceedsForConvertibleNoteIssued" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413045916233" name="trib:ProceedsForConvertibleNoteIssued" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413045936069" name="trib:ProceedsForConvertibleNoteIssued" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expenses
        paid in connection with debt financing</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413050229227" name="ifrs-full:PaymentsForShareIssueCosts" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413050248083" name="ifrs-full:PaymentsForShareIssueCosts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">147</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413050257775" name="ifrs-full:PaymentsForShareIssueCosts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,356</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase
        of exchangeable notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413050318613" name="ifrs-full:RepaymentsOfBondsNotesAndDebentures" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413050343629" name="ifrs-full:RepaymentsOfBondsNotesAndDebentures" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413050355775" name="ifrs-full:RepaymentsOfBondsNotesAndDebentures" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86,730</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repayment
        of senior secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413050411567" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413050440431" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,050</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413050449332" name="ifrs-full:RepaymentsOfNoncurrentBorrowings" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Penalty
        for early settlement of term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413050501374" name="trib:PenaltyForEarlySettlementOfTermLoan" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413050534267" name="trib:PenaltyForEarlySettlementOfTermLoan" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">905</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413050547979" name="trib:PenaltyForEarlySettlementOfTermLoan" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,450</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Repayment
        of other loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413050602612" name="trib:RepaymentOfOtherLoan" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413050619968" name="trib:RepaymentOfOtherLoan" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413050632525" name="trib:RepaymentOfOtherLoan" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest
        paid on senior secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413050644860" name="trib:InterestPaidOnSeniorSecuredTermLoan" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,946</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413050727552" name="trib:InterestPaidOnSeniorSecuredTermLoan" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,314</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413050740305" name="trib:InterestPaidOnSeniorSecuredTermLoan" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,424</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest
        paid on convertible note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413050752339" name="trib:InterestPaidOnConvertibleNote" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">300</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413051230516" name="trib:InterestPaidOnConvertibleNote" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">300</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413051244252" name="trib:InterestPaidOnConvertibleNote" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">199</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest
        paid on exchangeable notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_426" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_4210" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_4214" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,293</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Payment
        of lease liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_456" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,503</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_4510" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,318</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_4514" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,761</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash generated by/(used in) financing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114135841083_476" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,810</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_4710" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">16,042</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_4714" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,322</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase/(decrease)
        in cash and cash equivalents and short-term investments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220426045940794" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,651</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413051314337" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,843</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_4914" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,220</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effects of exchange rate
        movements on cash held</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414191203012" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">175</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_5010" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">44</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114135841083_5014" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">112</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents and short-term investments at beginning of year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114145212118_xbrl_20220114135841083_506" name="trib:CashAndCashEquivalentsAndShortTermInvestments" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114145212118_xbrl_20220114135841083_5010" name="trib:CashAndCashEquivalentsAndShortTermInvestments" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,578</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114145212118_xbrl_20220114135841083_5014" name="trib:CashAndCashEquivalentsAndShortTermInvestments" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,910</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52.53%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52.53%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents and short-term investments at end of year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114145451063_xbrl_20220114145212118_xbrl_20220114135841083_506" name="trib:CashAndCashEquivalentsAndShortTermInvestments" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,167</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114145451063_xbrl_20220114145212118_xbrl_20220114135841083_5010" name="trib:CashAndCashEquivalentsAndShortTermInvestments" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114145451063_xbrl_20220114145212118_xbrl_20220114135841083_5014" name="trib:CashAndCashEquivalentsAndShortTermInvestments" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,578</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>

<div>&#160;</div> </div> </div> </div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="color:#000000;font-family:Times New Roman, Times, serif"><span style="font-size:13.3333px">118</span></span></div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
</div> </div>

<div style="text-indent:30.95pt;line-height:1.25;margin-top:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></div>

<div style="text-indent:30.95pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">DECEMBER
31, 2024</span></span></div> </div>

<p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>

<div> <ix:nonNumeric id="Fxbrl_20250512131539410" name="trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>1.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>BASIS OF PREPARATION AND SIGNIFICANT
        ACCOUNTING POLICIES</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
principal accounting policies adopted by Trinity Biotech plc (&#8220;the Company&#8221;) and its subsidiaries (together the &#8220;the
Group&#8221;) are set out below.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413041607737" name="trib:DescriptionOfAccountingPolicyForGeneralInformationExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>i)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">General
        information</span></span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trinity
Biotech is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable
biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation,
for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and
to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood and the Company intends to develop
a range of biosensor devices and related services, starting with a continuous glucose monitoring product.</span></span></span></span></span></div>
</div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20240413041828192" name="trib:DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>ii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Statement
        of compliance</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (&#8220;IFRS&#8221;)
both as issued by the International Accounting Standards Board (&#8220;IASB&#8221;) and as subsequently adopted by the European Union
(&#8220;EU&#8221;) (together &#8220;IFRS&#8221;).&#160;The IFRS applied are those effective for accounting periods beginning January&#160;1,
2024. Consolidated financial statements are required by Irish law to comply with IFRS as adopted by the EU which differ in certain respects
from IFRS as issued by the IASB.&#160;These differences predominantly relate to the timing of adoption of new standards by the EU.&#160;However,
in relation to the 2024 consolidated financial statements there are no differences regarding the effective date of new IFRS relevant to
Trinity Biotech as issued by the IASB and as adopted by the EU. In relation to prior periods presented, none of the differences are relevant
in the context of Trinity Biotech and the consolidated financial statements comply with IFRS both as issued by the IASB and as adopted
by the EU.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413041857113" name="ifrs-full:DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>iii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Basis of preparation and going concern</p>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
consolidated financial statements have been prepared in United States Dollars (US$), rounded to the nearest thousand, under the historical
cost basis of accounting, except for derivative financial instruments, certain balances arising on acquisition of subsidiary entities
and share-based payments which are initially recorded at fair value. Derivative financial instruments are also subsequently revalued and
carried at fair value.</span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
preparation of financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect
the application of policies and amounts reported in the financial statements and accompanying notes. The estimates and associated assumptions
are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of
which form the basis of making the judgements about the carrying value of assets and liabilities that are not readily apparent from other
sources. Actual results may differ from these estimates.</span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period
in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision
affects both current and future periods. Judgements made by management that have a significant effect on the financial statements and
estimates with a significant risk of material adjustment in the next year are discussed in Note 31.</span></span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates
the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future.</span></span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>As
reflected in the accompanying consolidated financial statements, for the years ended December 31, 2024 and 2023, the Group recorded a
loss of US$<ix:nonFraction id="Fxbrl_20250514153747421" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal" sign="-">31.8</ix:nonFraction>
million and a loss of US$<ix:nonFraction id="Fxbrl_20250514153755721" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal" sign="-">24.0</ix:nonFraction>
million, respectively. For the year ended December 31, 2024 we reported cash inflows of US<ix:nonFraction id="Fxbrl_20250514153806005" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.7</ix:nonFraction>
million compared to cash outflows of US$<ix:nonFraction id="Fxbrl_20250514153819750" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20230101to20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal" sign="-">2.8</ix:nonFraction>
million for 2023. As of December 31, 2024, we had net current assets of US$<ix:nonFraction id="Fxbrl_20250514153833638" name="ifrs-full:CurrentAssetsLiabilities" contextRef="C_20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.0</ix:nonFraction>
million but had an accumulated deficit in equity attributable to the equity holders of the Company of US$<ix:nonFraction id="Fxbrl_20250514153944560" name="trib:AccumulatedDeficitInEquityAttributableToEquityHolders" contextRef="C_20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal" sign="-">79.1</ix:nonFraction>
million.</span></span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>We
have made significant progress on a multi-year transformation plan aimed at improving profitability and simplifying our operating model.
Key actions implemented include the consolidation and outsourcing of global manufacturing, closure of underutilized facilities, relocation
of certain business support functions to lower-cost jurisdictions, and a reduction in overall headcount. These restructuring measures,
largely completed by mid-2025, are expected to deliver significant annualized cost savings. Additionally, the Group retains further levers
to manage liquidity if required, including deferring projected research and development spend.</span></span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>A
temporary decline in revenue occurred during the first four months of 2025, primarily due to transitional impacts associated with the
Group&#8217;s restructuring initiatives, including the consolidation of manufacturing operations and the transfer of Point-of-Care/HIV
products to a third-party contract manufacturing partner. These initiatives have since progressed materially. Sales were also affected
by reduced HIV test volumes resulting from uncertainty surrounding potential changes to U.S. foreign aid policy following a presidential
executive order. In light of these temporary factors, the Group sought and received a formal waiver from Perceptive in respect of the
Q1 2025 minimum revenue covenant, to ensure that no breach occurred under the Perceptive credit facility. In May 2025, the Group signed
a buy-sell agreement with a contract manufacturing partner. We also have obtained World Health Organisation (&#8220;WHO&#8221;) approval
to commence assembly at the new site. It is expected that WHO approval for full production of our Trinscreen product to be received in
July 2025, with approval for full production of our UniGold product expected in August 2025. The directors have alternative options and
have prepared financial forecasts to address a scenario whereby WHO approval for production with our contract manufacturing partner takes
longer than expected to achieve and the facility takes longer than expected to get up to full operational capacity. In such a scenario,
management remain confident that all revenue covenants will be met through to 31 December 2025. In addition, the minimum revenue covenant
thresholds for Q2, Q3 and Q4 2025 have been renegotiated to align with the Group&#8217;s updated forecasts. Accordingly, management is
confident in the Group&#8217;s ability to maintain compliance with its debt covenants for the remainder of the going concern review period.
Furthermore, Perceptive have a track record of supporting the Company and, when required, have provided covenant waivers and amendment
of terms which indicates an appreciation of the Company&#8217;s circumstances in terms of our transformational plan for the business and
temporary declines in revenue. If a similar need were to recur in the foreseeable future, management are confident of their continued
support.</span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>We
have also launched a strategic realignment review of our businesses in partnership with Barclays Bank. This process, is expected to make
significant progress by the end of 2025 and may generate material capital proceeds that can be potentially used to reduce debt and support
investment, including CGM investment.</span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="text-indent:0pt;line-height:1.25;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">119</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.95pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">1.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">BASIS
        OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td style="width:30.95pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt">&#160;</td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">&#160;</td> </tr>
  <tr>
    <td style="width:30.95pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><em>iii)</em></span></span></span></p>
        </td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><em>Basis
        of preparation (continued)</em></span></span></span></p> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In
addition, the Group has continued to benefit from strong support from Perceptive, its principal lender and largest investor. On December
23, 2024, we entered into the third amendment and restatement of the credit agreement governing the Term Loan. As part of this agreement,
an additional US$<ix:nonFraction id="Fxbrl_20250514154729835" name="ifrs-full:NotionalAmount" contextRef="C_20241223_tribCreditAgreementAxis_tribAmendedCreditAgreementMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction>
million of funding was made available to us. We also agreed that certain <ix:nonNumeric id="Fxbrl_20250514154755374" name="ifrs-full:BorrowingsInterestRateBasis" contextRef="C_20241223to20241223_tribCreditAgreementAxis_tribAmendedCreditAgreementMember">interest
payments payable in 2024 and 2025 would be paid-in-kind</ix:nonNumeric> on the applicable payment date by increasing the outstanding principal
amount of the Term Loan. In February 2025, we entered into a fourth amendment to the credit agreement, which provided for an additional
US$<ix:nonFraction id="Fxbrl_20250514154840817" name="ifrs-full:NotionalAmount" contextRef="C_20250228_ifrsfullBorrowingsByNameAxis_tribFourthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction>
million in term loan funding. On May 14, 2025, we entered into a fifth amendment to the credit agreement, which provided for a further
US$<ix:nonFraction id="Fxbrl_20250514154958198" name="ifrs-full:NotionalAmount" contextRef="C_20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction>
million in funding, extended the maturity date of the Term Loan by six months from <ix:nonNumeric id="Fxbrl_20250515125018868" name="ifrs-full:BorrowingsMaturity" contextRef="C_20250514to20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">January
2026 to July 27, 2026</ix:nonNumeric>, and confirmed that <ix:nonNumeric id="Fxbrl_20250514155053886" name="ifrs-full:BorrowingsInterestRateBasis" contextRef="C_20250514to20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">interest
payments for the months of April, May, and June 2025 would be paid-in-kind</ix:nonNumeric>. There are no material debt maturities until
July 2026. These successive amendments demonstrate Perceptive&#8217;s continued support and demonstrate their willingness to flex terms
to preserve liquidity while the Company continues to execute its updated strategy, including its comprehensive transformation plan.</span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under
the fifth amendment to the credit agreement, the minimum liquidity covenant was reduced to US$<ix:nonFraction id="Fxbrl_20250515103710859" name="trib:MinimumLiquidityCovenant" contextRef="C_20251031_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">1</ix:nonFraction>
million through to October 31, 2025, after which it reverts to US$<ix:nonFraction id="Fxbrl_20250515111954660" name="trib:RevertsMinimumLiquidityCovenant" contextRef="C_20251031_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">3</ix:nonFraction>
million. While management is confident in the Group&#8217;s ability to maintain compliance with this covenant, it is noted that the Group
has planned significant R&amp;D expenditure related to its CGM development program in the second half of 2025. However, the Group retains
full discretion over the timing and phasing of these activities, which enables management to align expenditure with available funding
and preserve liquidity if required.</span></span></p> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In
addition to lender support, our going concern forecasts include expected equity raises. These funds are expected to support ongoing CGM
development activities. The Group has a strong track record of capital raising, including over US$<ix:nonFraction id="Fxbrl_20250514160248880" name="ifrs-full:CapitalReserve" contextRef="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribContinuousGlucoseMonitoringTechnologyMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">7</ix:nonFraction>
million secured in 2024, and maintains active engagement with existing and potential investors. Management believes that the equity raise
is achievable based on the Group&#8217;s strategic focus and transformation progress to date.</span></span></span></span></p>

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
directors have considered the Group&#8217;s current financial position and cash flow projections, taking into account all known events
and developments including the amendment and restatement of the term loan with Perceptive, The directors believe that, based on currently
available information and reasonable assumptions, the Group will be able to continue its operations for at least the next 12 months from
the year-end date, and that it is appropriate to continue to prepare the consolidated financial statements on a going concern basis.</span></span></span></span></p>

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
accounting policies set out below have been applied consistently to all periods presented in these consolidated financial statements.
The accounting policies have been applied consistently by all Group entities. The comparative information agrees with the amounts and
other disclosures presented in the prior period consolidated financial statements or, when appropriate, have been restated.</span></span></span></span></span></span></span></div>
</div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413041952130" name="ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>iv)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Basis
        of consolidation</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Subsidiaries</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Subsidiaries
are all entities over which the Group has control. The Group controls an entity when the Group is exposed to, or has rights to, variable
returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries
are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control
ceases. A change in the ownership interest of a subsidiary without a change in control is accounted for as an equity transaction. The
Group currently holds a majority of voting rights in all entities in the Group and as a result there are no non-controlling interests
reflected in the consolidated financial statements.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Transactions
eliminated on consolidation</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Intra-group
balances and any unrealised gains or losses or income and expenses arising from intra-group transactions are eliminated in preparing the
consolidated financial statements.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413042030690" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>v)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Property,
        plant and equipment</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Owned
assets</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Items
of property, plant and equipment are stated at cost less any accumulated depreciation and any impairment losses (see Note 1(viii)). The
cost of self-constructed assets includes the cost of materials, direct labour and attributable overheads. It is not Group policy to revalue
any items of property, plant and equipment.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Depreciation
is charged to the statement of operations on a straight-line basis to write-off the cost of the assets over their expected useful lives
as follows:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512110457883" name="trib:DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Leasehold improvements</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonNumeric id="Fxbrl_20250513122634045" name="ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">5-15&#160;years</ix:nonNumeric></span></span></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Buildings</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonNumeric id="Fxbrl_20250513122642841" name="ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">50
        years</ix:nonNumeric></span></span></span></span></span></div> </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Office equipment and fittings</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonNumeric id="Fxbrl_20250513122650716" name="ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">10
        years</ix:nonNumeric></span></span></span></span></span></div> </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Computer equipment</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonNumeric id="Fxbrl_20250513122712628" name="ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">3-5
        years</ix:nonNumeric></span></span></span></span></span></div> </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Plant and equipment</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonNumeric id="Fxbrl_20250513122805181" name="ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribPropertyAndEquipmentMember">5-15
        years</ix:nonNumeric></span></span></span></span></span></div> </td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Land
is not depreciated. The residual values, if not insignificant, useful lives and depreciation methods of property, plant and equipment
are reviewed and adjusted if appropriate on a prospective basis, at each balance sheet date. There were no changes to useful lives in
the year.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group considers whether a contract is or contains a lease. A lease is defined as &#8216;a contract, or part of a contract, that conveys
the right to use an asset (the underlying asset) for a period of time in exchange for consideration&#8217;. To apply this definition the
Group assesses whether the contract meets three key evaluations which are whether:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>the contract contains an identified
        asset, which is either explicitly identified in the contract or implicitly specified by being identified at the time the asset is made
        available to the Group</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>the Group has the right to obtain
        substantially all of the economic benefits from use of the identified asset throughout the period of use, considering its rights within
        the defined scope of the contract</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>the Group has the right to direct
        the use of the identified asset throughout the period of use. The Group assess whether it has the right to direct &#8216;how and for what
        purpose&#8217; the asset is used throughout the period of use.</span></span></span></span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">120</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.95pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">1.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">BASIS
        OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></span></span></span></span></span></span></div> </td> </tr>
  <tr>
    <td style="width:30.95pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt">&#160;</td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">&#160;</td> </tr>
  <tr>
    <td style="width:30.95pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><em>v)</em></span></span></span></p>
        </td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><em>Property,
        plant and equipment (continued)</em></span></span></span></p> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
lease commencement date, the Group recognises a right-of-use asset and a lease liability on the balance sheet. The right-of-use asset
is measured at cost, which is made up of the initial measurement of the lease liability, any initial direct costs incurred by the Group,
an estimate of any costs to dismantle and remove the asset at the end of the lease, and any lease payments made in advance of the lease
commencement date (net of any incentives received).</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group depreciates the right-of-use assets on a straight-line basis from the lease commencement date to the earlier of the end of the useful
life of the right-of-use asset or the end of the lease term. The Group also assesses the right-of-use asset for impairment when such indicators
exist.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
the commencement date, the Group measures the lease liability at the present value of the lease payments unpaid at that date, discounted
using the interest rate implicit in the lease if that rate is readily available or the Group&#8217;s incremental borrowing rate. Lease
payments included in the measurement of the lease liability are made up of fixed payments (including in substance fixed), variable payments
based on an index or rate, amounts expected to be payable under a residual value guarantee and payments arising from options reasonably
certain to be exercised. Subsequent to initial measurement, the liability will be reduced for payments made and increased for interest.
It is remeasured to reflect any reassessment or modification, or if there are changes in in-substance fixed payments. When the lease liability
is remeasured, the corresponding adjustment is reflected in the right-of-use asset, or profit and loss if the right-of-use asset is already
reduced to zero.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group has elected to account for short-term leases and leases of low-value assets using the practical expedients. Instead of recognising
a right-of-use asset and lease liability, the payments in relation to these are recognised as an expense in profit or loss on a straight-line
basis over the lease term. On the statement of financial position, right-of-use assets have been included in property, plant and equipment
and lease liabilities have been included in separate lines within the current liabilities and non-current liabilities sections.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.9pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Leased
assets - as lessor</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group&#8217;s accounting policy under IFRS 16 has not changed from the comparative period. As a lessor, the Group classifies its leases
as either operating or finance leases. A lease is classified as a finance lease if it transfers substantially all the risks and rewards
incidental to ownership of the underlying asset, and classified as an operating lease if it does not.</span></span></span></span></span></div>
</div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413042107413" name="ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>vi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Business
        combinations &amp; goodwill</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
the time of each transaction, the Group evaluates whether the acquisition constitutes a business combination in accordance with the definition
in IFRS 3 Business Combinations. A business is defined as an integrated set of activities and assets that is capable of being conducted
and managed for the purpose of providing a return. The assessment considers whether the acquired set includes inputs and substantive processes
that together significantly contribute to the ability to create outputs. Where such criteria are not met, the transaction is accounted
for as an asset acquisition. Transactions assessed as asset acquisitions do not give rise to goodwill.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In
respect of business combinations that have occurred since January 1, 2004 (being the transition date to IFRS), goodwill represents the
difference between the cost of the acquisition and the fair value of the net identifiable assets acquired. In respect of acquisitions
prior to this date, goodwill is included on the basis of its deemed cost, which represents the amount recorded under Irish GAAP.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>To
the extent that the Group&#8217;s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities acquired
exceeds the cost of a business combination, the identification and measurement of the related assets, liabilities and contingent liabilities
are revisited accompanied by a reassessment of the cost of the transaction, and any remaining balance is immediately recognised in the
statement of operations.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">121</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>1.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>BASIS OF PREPARATION AND SIGNIFICANT
        ACCOUNTING POLICIES (CONTINUED)</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td style="width:30.95pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  <tr>
    <td style="width:30.95pt;vertical-align:top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><em>vi)</em></span></span></span></p>
        </td>
    <td style="width:auto;vertical-align:top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><em><span>Business
        combinations &amp; goodwill (continued)</span></em></span></span></span></p> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
the acquisition date, any goodwill is allocated to each of the Group&#8217;s cash-generating units expected to benefit from the combination&#8217;s
synergies. Following initial recognition, goodwill is stated at cost less any accumulated impairment losses and is not amortised but is
tested annually for impairment.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>This
policy has been applied to acquisitions completed during the year, including the acquisition of the CGM assets of Waveform Technologies,
Inc. in January 2024, and the acquisitions of EpiCapture Limited and Metabolomics Diagnostics Limited, further details of which are disclosed
in Note 29 to the consolidated financial statements losses.</span></span></span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413042359787" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>vii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Intangibles,
        including research and development (other than goodwill)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>An
intangible asset, which is an identifiable non-monetary asset without physical substance, is recognised to the extent that it is probable
that the expected future economic benefits attributable to the asset will flow to the Group and that its cost can be measured reliably.
The asset is deemed to be identifiable when it is separable (that is, capable of being divided from the entity and sold, transferred,
licenced, rented or exchanged, either individually or together with a related contract, asset or liability) or when it arises from contractual
or other legal rights, regardless of whether those rights are transferable or separable from the Group or from other rights and obligations.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Intangible
assets acquired as part of a business combination are capitalised separately from goodwill if the intangible asset meets the definition
of an asset and the fair value can be reliably measured on initial recognition. In the case of recent acquisitions, the Group has recognised
technology-based intangible assets, comprising know-how, trade secrets and similar intellectual property. These assets are classified
as finite-lived and are initially recognised at fair value as determined by independent valuation.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent
to initial recognition, these intangible assets are carried at cost less any accumulated amortisation and any accumulated impairment losses
(Note 1(viii)). Intangible assets with definite useful lives are reviewed for indicators of impairment annually while intangible assets
with indefinite useful lives and those not yet brought into use are tested for impairment at least annually, either individually or at
the cash-generating unit level.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Expenditure
on development activities, whereby research findings are applied to a plan or design for the production of new or substantially improved
products and processes, is capitalised if the product or process is technically and commercially feasible and the Group has sufficient
resources to complete the development. The expenditure capitalised includes the cost of materials, direct labour and attributable overheads
and third party costs. Subsequent expenditure on capitalised intangible assets is capitalised only when it increases the future economic
benefits embodied in the specific asset to which it relates.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
technical feasibility of a new product is determined by a specific feasibility study undertaken at the first stage of any development
project. The majority of our new product developments involve the transfer of existing product know-how to a new application. Since the
technology is already proven in an existing product which is being used by customers, this facilitates the proving of the technical feasibility
of that same technology in a new product.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
results of the feasibility study are reviewed by a design review committee comprising senior managers. The feasibility study occurs in
the initial research phase of a project and costs in this phase are not capitalised.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
commercial feasibility of a new product is determined by preparing a discounted cash flow projection. This projection compares the discounted
sales revenues for future periods with the relevant costs. As part of preparing the cash flow projection, the size of the relevant market
is determined, feedback is sought from customers and the strength of the proposed new product is assessed against competitors&#8217; offerings.
Once the technical and commercial feasibility has been established and the project has been approved for commencement, the project moves
into the development phase.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>All
other development expenditure is expensed as incurred. Subsequent to initial recognition, the capitalised development expenditure is carried
at cost less any accumulated amortisation and any accumulated impairment losses.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Expenditure
on research activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognised
in the statement of operations as an expense as incurred.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Expenditure
on internally generated goodwill and brands is recognised in the statement of operations as an expense as incurred.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Amortisation</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Amortisation
is charged to the statement of operations on a straight-line basis over the estimated useful lives of intangible assets, unless such lives
are indefinite. Intangible assets are amortised from the date they are available for use in its intended market. The estimated useful
lives are as follows:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512110519733" name="trib:DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:bottom">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Capitalised development costs</span></span></span></span></span></div> </td>
    <td style="width:15.77%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonNumeric id="Fxbrl_20220424133907146" name="ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCapitalisedDevelopmentExpenditureMember">15&#160;years</ix:nonNumeric></span></span></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:middle">&#160;</td>
    <td style="width:15.77%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:bottom">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Patents and licences</span></span></span></span></span></div> </td>
    <td style="width:15.77%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonNumeric id="Fxbrl_20250513122821525" name="ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">6-15&#160;years</ix:nonNumeric></span></span></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:middle">&#160;</td>
    <td style="width:15.77%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:bottom">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Other (including acquired customer and supplier lists)</span></span></span></span></span></div> </td>
    <td style="width:15.77%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonNumeric id="Fxbrl_20250513122831377" name="ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullOtherIntangibleAssetsMember">6-15
        years</ix:nonNumeric></span></span></span></span></span></div> </td> </tr>
  </table> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> </div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">122</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>1.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>BASIS OF PREPARATION AND SIGNIFICANT
        ACCOUNTING POLICIES (CONTINUED)</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td style="width:30.95pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  <tr>
    <td style="width:30.95pt;vertical-align:top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><em><span>vii)</span></em></span></span></p>
        </td>
    <td style="width:auto;vertical-align:top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><em>Intangibles,
        including research and development (other than goodwill) (continued)</em></span></span></p> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group uses a useful economic life of <ix:nonNumeric id="Fxbrl_20220327174731265" name="ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCapitalisedDevelopmentExpenditureMember">15
years</ix:nonNumeric> for capitalised development costs. This is a conservative estimate of the likely life of the products. The Group
is confident that products have a minimum of 15 years life given the inertia that characterizes the medical diagnostics industry and the
barriers to enter into the industry. The following factors have been considered in estimating the useful life of developed products:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>(a)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>once a diagnostic test becomes
        established, customers are reluctant to change to new technology until it is fully proven, thus resulting in relatively long product life
        cycles. There is also reluctance in customers to change to a new product as it can be costly both in terms of the initial changeover cost
        and as new technology is typically more expensive.</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>(b)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>demand for the diagnostic tests
        is enduring and robust within a wide geographic base. The diseases that the products diagnose are widely prevalent (HIV, Diabetes and
        Chlamydia being just three examples) in many countries. There is a general consensus that these diseases will continue to be widely prevalent
        in the future. Demand for biosensors is showing high growth in recent years due to the ease of use and the appeal of real time information.</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>(c)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>there are significant barriers
        to new entrants in this industry. Patents and/or licences are in place for several of our products, though this is not the only barrier
        to entry. There is a significant cost and time to develop new products, it is necessary to obtain regulatory approval and tests are protected
        by proprietary know-how, manufacturing techniques and trade secrets.</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>During
the year ended December 31, 2024, the Group capitalised US$<ix:nonFraction id="Fxbrl_20250513124243560" name="ifrs-full:IntangibleAssetsUnderDevelopment" contextRef="C_20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCapitalisedDevelopmentExpenditureMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.0</ix:nonFraction>
million in development costs related to newly acquired intangible assets. As the underlying intellectual property remains at a pre-commercialisation
stage and is not yet available for use, amortisation has not commenced. Amortisation will begin when the assets are brought into use,
in accordance with the Group&#8217;s stated policy.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Technology-based
intangible assets acquired as part of business combinations are assigned finite useful lives in line with the Group&#8217;s amortisation
policies, based on independent valuation reports. Amortisation of these assets will commence when they are available for use, i.e., when
they are in the location and condition necessary for them to be capable of operating in the manner intended by management. For technology-based
intangible assets acquired in 2024, amortisation has not commenced as the technologies have not yet been commercialised.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Certain
trade names acquired are deemed to have an indefinite useful life as there is no foreseeable limit to the period over which these assets
are expected to generate cash inflows for the Group.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
amortisation is charged on assets with finite lives, this expense is taken to the statement of operations through the &#8216;selling,
general and administrative expenses&#8217; line.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Useful
lives are examined on an annual basis and adjustments, where applicable, are made on a prospective basis.</span></span></span></span></span></div>
</div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413042429756" name="ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>viii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Impairment</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
carrying amount of the Group&#8217;s assets, other than inventories, accounts receivable, cash and cash equivalents, short-term investments
and deferred tax assets, are reviewed at each balance sheet date to determine whether there is any indication of impairment. If any such
indication exists, the asset&#8217;s recoverable amount (being the greater of fair value less costs to sell and value in use) is assessed
at each balance sheet date.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Fair
value less costs to sell is defined as the amount obtainable from the sale of an asset or cash-generating unit in an arm&#8217;s length
transaction between knowledgeable and willing parties, less the costs that would be incurred on disposal. Value in use is defined as the
present value of the future cash flows expected to be derived through the continued use of an asset or cash-generating unit. In assessing
value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current
market assessments of the time value of money and the risks specific to the asset for which the future cash flow estimates have not yet
been adjusted. The estimates of future cash flows exclude cash inflows or outflows attributable to financing activities. For an asset
that does not generate largely independent cash flows, the recoverable amount is determined by reference to the cash-generating unit to
which the asset belongs.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>For
goodwill, assets that have an indefinite useful life and intangible assets that are not yet available for use, the recoverable amount
is estimated at each balance sheet date at the cash-generating unit level. The goodwill and indefinite-lived assets were reviewed for
impairment at June 30, 2023, December&#160;31, 2023, June 30, 2024 and December&#160;31, 2024. See Note 12.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In-process
research and development (IPR&amp;D) is tested for impairment on a bi-annual basis, and always at year end, or more frequently if impairment
indicators are present, using projected discounted cash flow models. If IPR&amp;D becomes impaired or is abandoned, the carrying value
of the IPR&amp;D is written down to its revised fair value with the related impairment charge recognised in the period in which the impairment
occurs. If the fair value of the asset becomes impaired as the result of unfavorable data from any ongoing or future clinical trial, changes
in assumptions that negatively impact projected cash flows, or because of any other information regarding the prospects of successfully
developing or commercializing our programs, we could incur significant charges in the period in which the impairment occurs. The valuation
techniques utilized in performing impairment tests incorporate significant assumptions and judgments to estimate the fair value, as described
above. The use of different valuation techniques or different assumptions could result in materially different fair value estimates.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>1.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>BASIS OF PREPARATION AND SIGNIFICANT
        ACCOUNTING POLICIES (CONTINUED)</span></span></span></span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>viii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Impairment
        (continued)</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  </table> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>An
impairment loss is recognised whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount. Impairment
losses are recognised in the statement of operations.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Impairment
losses recognised in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash-generating
units and then to reduce the carrying amount of other assets in the cash-generating units on a pro-rata basis.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>An
impairment loss is reversed only to the extent that the asset&#8217;s carrying amount does not exceed the carrying amount that would have
been determined, net of depreciation or amortisation, if no impairment loss had been recognised.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>An
impairment loss in respect of goodwill is not reversed.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Following
recognition of any impairment loss (and on recognition of an impairment loss reversal), the depreciation or amortisation charge applicable
to the asset or cash-generating unit is adjusted prospectively with the objective of systematically allocating the revised carrying amount,
net of any residual value, over the remaining useful life.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20240413042527576" name="trib:FinancialAssetsPolicyTextBlock" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">ix)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Financial
        Assets</span></span></span></span></span></span></div> </div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>On
initial recognition, a financial asset is classified as measured at amortised cost and subsequently measured using the effective interest
rate (EIR) method and subject to impairment. Financial assets may also be initially measured at fair value with any movement being reflected
through other comprehensive income or the Consolidated Statement of Operations.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>On
initial recognition of an equity investment that is not held for trading, the Group may irrevocably elect to present subsequent changes
in the investment&#8217;s fair value in other comprehensive income. This election is made on an investment-by investment&#160;basis.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
such an election is not made, and the investment is not held for trading, the equity instrument is classified as measured at fair value
through profit or loss (FVTPL). Subsequent changes in fair value are recognised in the Consolidated Statement of Operations. During 2024,
the Group acquired a strategic equity interest in an unlisted entity accounted for under this classification. Refer to Note 13.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Financial
assets are written off when there is no reasonable expectation of recovery, such as when the debtor has entered bankruptcy, when collection
efforts have been exhausted, or when the asset has been significantly past due (typically over 365 days) without any recent payments or
active correspondence. The Group considers both quantitative factors (such as aging) and qualitative indicators (e.g., legal or insolvency
proceedings) in making this assessment. Where receivables are written off but remain subject to enforcement activity, such as legal action
or engagement with collection agencies, these efforts are continued until formally closed.</span></span></span></span></span></div> </div>
</ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413044050928" name="ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">x)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Inventories</span></span></span></span></span></span></div>
        </div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Inventories
are stated at the lower of cost and net realisable value. Cost is based on the first-in, first-out principle and includes all expenditure
which has been incurred in bringing the products to their present location and condition and includes an appropriate allocation of manufacturing
overhead based on the normal level of operating capacity. Net realisable value is the estimated selling price of inventory on hand in
the ordinary course of business less all further costs to completion and costs expected to be incurred in selling these products.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group provides for inventory, based on estimates of the expected realisability. The estimated realisability is evaluated on a case-by-case
basis and any inventory that is approaching its &#8220;use-by&#8221; date and for which no further re-processing can be performed is written
off. Any reversal of an inventory provision is recognised in the statement of operations in the year in which the reversal occurs.</span></span></span></span></span></div>
</div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div>

<div> <ix:nonNumeric id="Fxbrl_20250514160753391" name="ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trade
        and other receivables</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trade
receivables are amounts due from customers for products sold or services provided in the ordinary course of business. Trade and other
receivables are stated at their amortised cost less impairment losses incurred. Cost approximates fair value given the short-term nature
of these assets. The Group records the loss allowance as lifetime expected credit losses.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>These
are the expected shortfalls in contractual cash flows, considering the potential for default at any point during the life of the financial
instrument. Expected credit losses are recorded on all of trade receivables based on an assessment of the probability of default or delinquency
in payments and the probability that debtor will enter into financial difficulties or bankruptcy.</span></span></span></span></span></div>
</div> </ix:nonNumeric>

<p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">124</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">1.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">BASIS
        OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></span></span></span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div> </div> <ix:nonNumeric id="Fxbrl_20240413044137702" name="ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trade
        and other payables</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trade
payables are obligations to pay for goods or services that have been acquired in the ordinary course of business. Trade and other payables
are stated at cost. Cost approximates fair value given the short term nature of these liabilities.</span></span></span></span></span></div>
</div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413044202548" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xiii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Cash
        and cash equivalents</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="text-align:justify;text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Cash
and cash equivalents comprise cash balances and short-term deposits which are readily available at year-end. Deposits with maturities
less than six months as at the year-end date are recognised as cash and cash equivalents and are carried at fair value when there is no
expected loss in value on early termination. The Group has no short-term bank overdraft facilities. Where restrictions are imposed by
third parties, such as lending institutions, on cash balances held by the Group these are treated as financial assets in the financial
statements.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413044227700" name="ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xiv)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Share-based
        payments</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>For
equity-settled share-based payments (share options), the Group measures the services received and the corresponding increase in equity
at fair value at the measurement date (which is the grant date) using a trinomial model. Given that the share options granted do not vest
until the completion of a specified period of service, the fair value, which is assessed at the grant date, is recognised on the basis
that the services to be rendered by employees as consideration for the granting of share options will be received over the vesting period.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Certain
share options have been granted for which there is a condition that the options only become exercisable into ADSs when the market price
of an ADS reaches a certain level. This is deemed to be a non-vesting condition. The term &#8216;non-vesting condition&#8217; is not explicitly
defined in IFRS 2, Share based Payment, but is inferred to be any condition that does not meet the definition of a vesting condition.
The only condition for these options to vest is that the option holder continues service and there were no other conditions which would
be considered non-vesting conditions. Non-vesting conditions are reflected in measuring the grant-date fair value of the share-based payment
and there is no true-up in the measurement of the share-based payment for differences between the expected and the actual outcome of non-vesting
conditions. If all service conditions are met, then the share-based payment cost will be recognized even if the option holder does not
receive the share-based payment due to a failure to meet the non-vesting condition.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
expense in the consolidated statement of operations in relation to share options represents the product of the total number of options
anticipated to vest and the fair value of those options; this amount is allocated to accounting periods on a straight-line basis over
the vesting period.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Share
based payments, to the extent they relate to direct labour involved in development activities, are capitalised.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when
the options are exercised. The Group does not operate any cash-settled share-based payment schemes or share-based payment transactions
with cash alternatives as defined in IFRS 2.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">125</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">1.</span></span></span></span></span></td>
    <td style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">BASIS
        OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></span></span></span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div> <ix:nonNumeric id="Fxbrl_20250514161603452" name="ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xv)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Government
        grants</span>&#160;<span style="font-style:italic">and financial support</span></span></span></span></span></span></div> </td> </tr>
  </table>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
Group received government-backed Covid-19 financial supports in the form of forgivable loans. Under IAS 20, Accounting for Government
Grants, a forgivable loan from government is treated as a government grant when there is reasonable assurance that the terms for forgiveness
of the loan will be met. Where a loan was received in the financial year but not yet forgiven within the financial year, the loan is treated
as a current liability. The Group has opted to present government grant income for loans that have been forgiven as Other operating income
in the consolidated statement of operations.</span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>If
it is no longer reasonably assured that the terms of forgiveness will be met, any income previously recognised in respect of such a loan
is reversed in the period in which the change in assessment occurs. Grants that compensate the Group for expenses incurred such as research
and development, employment and training are recognised as income in the statement of operations on a systematic basis in the same periods
in which the expenses are incurred. Grants that compensate the Group for the cost of an asset are recognised in the statement of operations
on a systematic basis over the useful life of the asset. R&amp;D tax credits claimed from tax authorities are credited to the taxation
line in the consolidated statement of operations.</span></span></span></span></span></span></span></div> </div> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413044323744" name="ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xvi)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div>
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Revenue
        recognition</span></span></span></span></span></span></div> </div> </td> </tr>
  </table> </div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Goods
sold and services rendered</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group recognises revenue when it transfers control over a good or service to a customer. Revenue is recognised to the extent that it is
probable that economic benefit will flow to the Group and the revenue can be measured. No revenue is recognised if there is uncertainty
regarding recovery of the consideration due at the outset of the transaction. Revenue, including any amounts invoiced for shipping and
handling costs, represents the value of goods and services supplied to external customers, net of discounts and rebates and excluding
sales taxes.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Revenue
from products is generally recorded as of the date of shipment, consistent with typical ex-works shipment terms. Where the shipment terms
do not permit revenue to be recognised as of the date of shipment, revenue is recognised when the Group has satisfied all of its performance
obligations to the customer in accordance with the shipping terms.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Some
contracts oblige the Group to ship product to the customer ahead of the agreed payment schedule. For these shipments, a contract asset
is recognised when control over the goods has transferred to the customer. The financing component is insignificant as invoicing for these
shipments occurs within a short period of time after shipment has occurred and standard 30 day credit terms typically apply.<span style="font-style:italic">&#160;</span>Some
contracts could be regarded as offering the customer a right of return. Due to the uncertainty of the magnitude and likelihood of product
returns, there is a level of estimation involved in assessing the amount of revenue to be recognized for these types of contracts. In
accordance with IFRS 15, when estimating the effect of an uncertainty on an amount of variable consideration to which the Group will be
entitled, all information that is reasonably available, including historical, current and forecast, is considered.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Revenue
is recognised on bill-and-hold transactions when all of the criteria in IFRS 15 are met, including: (i) the arrangement is at the customer&#8217;s
request and has a substantive business reason; (ii) the products are separately identified as belonging to the customer; (iii) the products
are ready for physical transfer to the customer; and (iv) the Group has no ability to use the products or redirect them to another customer.
The Group assesses each bill-and-hold arrangement individually for compliance with these criteria. When all criteria are satisfied, control
is deemed to have transferred and revenue is recognised.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group operates a licenced referenced laboratory in the US, which provides testing services to institutional customers and insurance companies.
In the US, there are rules requiring all insurance companies to be billed the same amount per test. However, the amount that each insurance
company pays for a particular test varies according to their own internal policies and this can typically be considerably less than the
amount invoiced. We recognise lab services revenue for insurance companies by taking the invoiced amount and reducing it by an estimated
percentage based on historical payment data. We review the percentage reduction annually based on the latest data. As a practical expedient,
and in accordance with IFRS, we apply a portfolio approach to the insurance companies as they have similar characteristics. We judge that
the effect on the financial statements of using a portfolio approach for the insurance companies will not differ materially from applying
IFRS 15 to the individual contracts within that portfolio.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Revenue
from services rendered is recognised in the statement of operations in proportion to the stage of completion of the transaction at the
balance sheet date.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group leases instruments to customers typically as part of a bundled package. Where a contract has multiple performance obligations and
its duration is greater than one year, the transaction price is allocated to the performance obligations in the contract by reference
to their relative standalone selling prices. For contracts where control of the instrument is transferred to the customer, the fair value
of the instrument is recognised as revenue at the commencement of the lease and is matched by the related cost of sale. Fair value is
determined on the basis of standalone selling price. In the case where control of the instrument does not transfer to the customer, revenue
is recognised on the basis of customer usage of the instrument. See also Note 1 (v).</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">126</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">1.</span></span></span></span></span></td>
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:auto">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">BASIS
        OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30pt">&#160;</td>
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:auto">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><em>xvi)</em></span></span></p>
        </td>
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:auto">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><em>Revenue
        recognition (continued)</em></span></span></p> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In
obtaining these contracts, the Group incurs a number of incremental costs, such as sales bonus paid to sales staff commissions paid to
distributors and royalty payments. As the amortisation period of these costs, if capitalised, would be less than one year, the Group makes
use of the practical expedient in IFRS 15.94 and recognised them as expense as they are incurred.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>A
receivable is recognised when the goods are delivered as this is the point in time that the consideration is unconditional because only
the passage of time is required before the payment is due.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group&#8217;s obligation to provide a refund for faulty products under the standard warranty terms is recognised as a provision, see Note
22 for details.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20250512130823706" name="trib:DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xvi)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Other
        operating income</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Other
operating income primarily includes items of income that arise outside the normal course of business, including government grant income
from forgiven loans, insurance proceeds, sublease income, and other non-recurring items. Income is recognised when it is probable that
the economic benefits associated with the transaction will flow to the Group and the amount can be measured reliably.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>During
the year ended December 31, 2024, other operating income included the reversal of $<ix:nonFraction id="Fxbrl_20250512131432226" name="ifrs-full:OtherOperatingIncomeExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal" sign="-">1.8</ix:nonFraction>
million previously recognised in relation to the forgiveness of Paycheck Protection Program (PPP) loans. This reversal was recognised
following the commencement of a U.S. Department of Justice investigation regarding the eligibility of certain U.S. subsidiaries for loan
forgiveness.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413044355542" name="ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xvii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Employee
        benefits</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Defined
contribution plans</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group operates defined contribution schemes in various locations where its subsidiaries are based. Contributions to the defined contribution
schemes are recognised in the statement of operations in the period in which the related service is received from the employee.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Other
long-term benefits</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
employees participate in the Group&#8217;s other long-term benefit schemes (such as permanent health insurance schemes under which the
scheme insures the employees), or where the Group contributes to insurance schemes for employees, the Group pays an annual fee to a service
provider, and accordingly the Group expenses such payments as incurred.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Termination
benefits</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Termination
benefits are recognised as an expense when the Group is demonstrably committed, without realistic possibility of withdrawal, to a formal
detailed plan to either terminate employment before normal retirement date, or to provide termination benefits as a result of an offer
made to encourage voluntary redundancy.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413044428933" name="ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xviii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Foreign
        currency</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>A
majority of the revenue of the Group is generated in US Dollars. The Group&#8217;s management has determined that the US&#160;Dollar is
the primary currency of the economic environment in which the Company and its subsidiaries (with the exception of the Group&#8217;s subsidiaries
in Brazil, Canada and Sweden) principally operate. Thus, the functional currency of the Company and its subsidiaries (other than the Brazilian,
Canadian and Swedish subsidiaries) is the US&#160;Dollar. The functional currency of the Brazilian entity is the Brazilian Real and the
functional currency of the Canadian subsidiary is the Canadian Dollar.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
presentation currency of the Company and Group is the US&#160;Dollar. Monetary assets and liabilities denominated in foreign currencies
are translated at the rates of exchange ruling at the balance sheet date. The resulting gains and losses are included in the consolidated
statement of operations. Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated
using the exchange rate at the date of the transaction.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">127</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.95pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">1.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">BASIS
        OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td style="width:30.95pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt">&#160;</td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">&#160;</td> </tr>
  <tr>
    <td style="width:30.95pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><em>xviii)</em></span></span></p>
        </td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><em>Foreign
        currency (continued)</em></span></span></p> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Results
and cash flows of subsidiary undertakings, which have a functional currency other than the US&#160;Dollar, are translated into US Dollars
at average exchange rates for the year, and the related balance sheets have been translated at the rates of exchange ruling on the balance
sheet date. Any exchange differences arising from the translations are recognised in the currency translation reserve via the statement
of changes in equity.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
Euro, Brazilian Real, or Canadian Dollar amounts have been referenced in this document, their corresponding US&#160;Dollar equivalent
has also been included and these equivalents have been calculated with reference to the foreign exchange rates prevailing at December&#160;31,
2024.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20240413044449403" name="ifrs-full:DescriptionOfAccountingPolicyForHedgingExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xix)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Hedging</span></span></span></span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
activities of the Group expose it primarily to changes in foreign exchange rates and interest rates. The Group uses derivative financial
instruments, from time to time, such as forward foreign exchange contracts to hedge these exposures.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group enters into forward contracts to sell US Dollars forward for Euro. The principal exchange risk identified by the Group is with respect
to fluctuations in the Euro as a substantial portion of its expenses are denominated in Euro but its revenues are primarily denominated
in US Dollars. Trinity Biotech monitors its exposure to foreign currency movements and may use these forward contracts as cash flow hedging
instruments whose objective is to cover a portion of this Euro expense.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
the inception of a hedging transaction entailing the use of derivatives, the Group documents the relationship between the hedged item
and the hedging instrument together with its risk management objective and the strategy underlying the proposed transaction. The Group
also documents its quarterly assessment of the effectiveness of the hedge in offsetting movements in the cash flows of the hedged items.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Derivative
financial instruments are recognised at fair value. Where derivatives do not fulfil the criteria for hedge accounting, they are classified
as held-for-trading and changes in fair values are reported in the statement of operations. The fair value of forward exchange contracts
is calculated by reference to current forward exchange rates for contracts with similar maturity profiles and equates to the current market
price at the balance sheet date.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
portion of the gain or loss on a hedging instrument that is deemed to be an effective cash flow hedge is recognised directly in the hedging
reserve in equity and the ineffective portion is recognised in the statement of operations. As the forward contracts are exercised the
net cumulative gain or loss recognised in the hedging reserve is transferred to the statement of operations and reflected in the same
line as the hedged item.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413044514301" name="ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xx)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Exchangeable
        notes and derivative financial instruments</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Company&#8217;s exchangeable notes are treated as a host debt instrument with embedded derivatives attached. On initial recognition, the
host debt instrument is recognised at the residual value of the total net proceeds of the bond issue less fair value of the embedded derivatives.
Subsequently, the host debt instrument is measured at amortised cost using the effective interest rate method.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
embedded derivatives are initially recognised at fair value and are restated at their fair value at each reporting date. The fair value
changes of the embedded derivatives are recognised in the consolidated statement of operations, except for changes in fair value related
to the Group&#8217;s own credit risk, which are recorded in the statement of comprehensive income.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
the exchangeable notes are redeemed early or repurchased in a way that does not alter the original conversion privileges, the consideration
paid is allocated to the respective components and the amount of any gain or loss is recognised in the consolidated statement of operations.</span></span></span></span></span></div>
</div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413044539535" name="trib:DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Senior
        secured term loan</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
senior secured term loan is initially recorded at the fair value of the consideration received net of:&#160; a) directly attributable
transaction costs, b) the fair value at the date of issue of the warrants issued to the lender (see Note 1xxii) and c) the fair value
of the option to prepay the loan at the date of issue (see Note 1xxii).</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Subsequent
to initial recognition, the term loan is measured at amortised cost employing the effective interest methodology. Borrowing costs, including
any penalties for early settlement of the loan, are recognised as an expense in the period in which they are incurred.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">128</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>1.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>BASIS OF PREPARATION AND SIGNIFICANT
        ACCOUNTING POLICIES (CONTINUED)</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td style="width:30.95pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  <tr>
    <td style="width:30.95pt;vertical-align:top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><em>xxi)</em></span></span></p>
        </td>
    <td style="width:auto;vertical-align:top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><em>Senior
        secured term loan (continued)</em></span></span></p> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In
accordance with IFRS 9, the Group assesses any changes to the contractual terms of its borrowings to determine whether such changes result
in a substantial modification. A modification is considered substantial if the revised cash flows differ significantly from those of the
original arrangement, in which case the original liability is derecognised and a new financial liability is recognised. If a modification
is not substantial, the loan is remeasured using the original EIR, with any resulting gain or loss recognised in profit or loss.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>During
2024, the Group amended the terms of its senior secured term loan; however, this was assessed under IFRS 9 and determined not to constitute
a substantial modification. Refer to Note 23 for further details.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413044712918" name="trib:DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Warrants
        and loan prepayment option</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Company has issued warrants to third parties. A warrant contract might be accounted for as an equity instrument or a financial liability
under IFRS depending on the terms of a warrant. A warrant contract that will or might be settled by an entity by delivering a fixed number
of its own equity instruments, in exchange for a fixed amount of cash or another financial asset, is an equity instrument.&#160;As Perceptive
has the option to choose a cashless exercise option, the Company will have to deliver a variable number of ADS, since the number of shares
will vary depending on the ADS traded price. Even though the cashless exercise option is economically comparable to the cash exercise
option, the fact that the Company will issue a variable number of shares under the cashless exercise option results in one settlement
alternative violating the &#8216;fixed for fixed&#8217; requirement.&#160; The warrant contract therefore meets the definition of a financial
liability and given the value of the warrant changes in response to the price of the Company&#8217;s ADS, with no initial investment and
settlement occurring in the future it meets the definition of a derivative liability under IFRS 9. The warrant is issued in a separate
contract, is transferable independently of the term loan and can be exercised while the term loan remains outstanding. Therefore, the
warrant is a separate instrument to the term loan.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
warrant contracts are initially recognised as a derivative liability at fair value and subsequently measured at fair value at each reporting
period with any changes recognised in the consolidated statement of operations.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Company has the option to prepay the senior secured term loan in whole or in part for an amount equal to the principal, accrued interest
and prepayment premium. In accordance with IFRS 9, this option is separated from the term loan and is initially recognised as a derivative
asset at fair value and subsequently measured at fair value at each reporting period with any changes recognised in the consolidated statement
of operations.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413044733862" name="ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xxiii)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Convertible
        Note</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
convertible note is accounted for as a compound financial instrument containing both an equity and liability element. The convertible
note has a contractual obligation to deliver cash on redemption equal to the principal amount plus accrued interest and therefore has
a liability component in line with the definition of a financial liability in IAS 32. The convertible loan note also has a conversion
feature where it mandatorily converts into ADS if the volume weighted average price of the Company&#8217;s ADSs is at a certain price
for any five consecutive NASDAQ trading days or any other time at the discretion of the Noteholder. Where a derivative that will or may
be settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity's own equity
instruments, the conversion feature represents an equity component of the convertible note.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
equity component is measured as the residual amount that results from deducting the fair value of the liability component from the initial
carrying amount of the instrument as a whole. There is no remeasurement of the equity element following initial recognition. The debt
component is accounted for at amortised cost employing the effective interest methodology.</span></span></span></span></span></div> </div>
</ix:nonNumeric>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20240413044824505" name="ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xxiv)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Segment
        reporting</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Operating
segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating
decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as
the Board of Directors.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">129</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>1.</span></span></span></span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>BASIS OF PREPARATION AND SIGNIFICANT
        ACCOUNTING POLICIES (CONTINUED)</span></span></span></span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div> <ix:nonNumeric id="Fxbrl_20240413044907100" name="ifrs-full:DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;font-style:italic;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxv)</span></span></span></span></span></td>
    <td style="vertical-align:top;width:auto">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Tax
        (current and deferred)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Income
tax on the profit or loss for the year comprises current and deferred tax. Income tax is recognised in the consolidated statement of operations
except to the extent that it relates to items recognised directly in equity, in which case it is recognised in equity.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Current
tax represents the expected tax payable or recoverable on the taxable profit for the year using tax rates enacted or substantively enacted
at the balance sheet date in the countries where the company and its subsidiaries operate and generate income and taking into account
any adjustments stemming from prior years.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Deferred
tax is provided on the basis of the balance sheet liability method on all temporary differences at the balance sheet date which is defined
as the difference between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred tax
assets and liabilities are not subject to discounting and are measured at the tax rates that are anticipated to apply in the period in
which the asset is realised or the liability is settled based on tax rates and tax laws that have been enacted or substantively enacted
at the balance sheet date. Deferred tax assets are recognised when it is probable that future taxable profits will be available to utilize
the associated losses or temporary differences. The amount of deferred tax provided is based on the expected manner of realisation or
settlement of the carrying amount of assets and liabilities.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Deferred
tax assets and liabilities are recognised for all temporary differences (that is, differences between the carrying amount of the asset
or liability and its tax base) with the exception of the following:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>i.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where the deferred tax liability
        arises from goodwill not deductible for tax purposes or the initial recognition of an asset or a liability in a transaction that is not
        a business combination and affects neither the accounting profit nor the taxable profit or loss at the time of the transaction; and</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>ii.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where, in respect of temporary
        differences associated with investments in subsidiary undertakings, the timing of the reversal of the temporary difference is subject
        to control and it is probable that the temporary difference will not reverse in the foreseeable future.</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
goodwill is tax deductible, a deferred tax liability is not recognised on initial recognition of goodwill. It is recognised subsequently
for the taxable temporary difference which arises when the goodwill is amortised for tax with no corresponding adjustment to the carrying
value of the goodwill.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
carrying amounts of deferred tax assets are subject to review at each balance sheet date and are derecognised to the extent that future
taxable profits are considered to be inadequate to allow all or part of any deferred tax asset to be utilised.</span></span></span></span></span></div>
</div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413044936805" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxvi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Provisions</span>&#160;<span style="font-style:italic">and
        contingent liabilities</span></span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>A
provision is recognised in the balance sheet when the Group has a present legal or constructive obligation because of a past event, and
it is probable that an outflow of economic benefits will be required to settle the obligation. The status of any significant claim and
legal proceeding in which the Group is involved is reviewed by management on a periodic basis and the Group&#8217;s potential financial
exposure is assessed. If the potential loss from any claim or legal proceeding is considered probable, and the amount can be reliably
estimated, a liability is recognised for the estimated loss.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Due
to the uncertainties inherent in such matters, the related provisions are based on the best information available at the time. As additional
information becomes available on pending claims, the potential liability is reassessed and revisions are made to the amounts accrued as
appropriate. Such revisions in the judgments and estimates of the potential liabilities could have an impact on the results of operations
and financial position of the Group in future accounting periods.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Provisions
for restructuring costs are recognised only when the Group has approved a detailed formal plan and has either commenced implementation
or raised a valid expectation among those affected that the restructuring will be carried out. Under IAS 37, restructuring provisions
must only include direct expenditures that are necessarily incurred by the restructuring and not associated with the ongoing activities
of the business.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">130</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>1.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>BASIS OF PREPARATION AND SIGNIFICANT
        ACCOUNTING POLICIES (CONTINUED)</span></span></span></span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div> <ix:nonNumeric id="Fxbrl_20240413045027626" name="ifrs-full:DescriptionOfAccountingPolicyForFinanceCostsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xxvii)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Cost
        of sales</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Cost
of sales comprises product cost including manufacturing and payroll costs, quality control, shipping, handling, and packaging costs and
the cost of services provided.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413045101541" name="ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxviii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Finance
        income and costs</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Financing
expenses comprise interest costs payable on senior secured term loan, convertible note, leases and exchangeable notes along with non-recurring
financing expenses such as penalty for early settlement of term loan and loss on disposal of exchangeable notes. Interest payable on finance
leases is allocated to each period during the lease term so as to produce a constant periodic rate of interest on the remaining balance
of the liability. Financing expenses also includes the financing element of long term liabilities which have been discounted. Finance
income includes interest income on deposits and is recognised in the consolidated statement of operations as it accrues, using the effective
interest method. Finance income also includes fair value adjustments for derivative assets and liabilities related to the senior secured
term loan and to embedded derivatives associated with exchangeable notes.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413045136113" name="ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxix)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Treasury
        shares</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>When
the Group purchases its<span style="font-style:italic">&#160;</span>own equity instruments (treasury shares), the costs, including any
directly attributable incremental costs, are deducted from equity. No gain or loss is recognised in the consolidated statement of operations
on the purchase, sale, issue or cancellation of the Group&#8217;s own equity instruments. Any difference between the carrying amount and
the consideration, if reissued, is recognised in share premium. Voting rights related to treasury shares are nullified for the Group and
no dividends are allocated to them.</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413045238925" name="ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxx)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Equity</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Share
capital represents the nominal (par) value of shares that have been issued. Share premium includes any premiums received on issue of share
capital. Any transaction costs associated with the issuing of shares are deducted from share premium, net of any related income tax benefits.</span></span></span></span></span></div>
</div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413045320705" name="ifrs-full:DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxxi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Profit
        or loss from discontinued operations</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>A
discontinued operation is a component of the Group that either has been disposed of or is classified as held for sale. Profit or loss
from discontinued operations comprises the post-tax profit or loss of discontinued operations and the post-tax gain or loss resulting
from the measurement and disposal of assets classified as held for sale and any gain or loss on disposal.</span></span></span></span></span></div>
</div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413045438839" name="ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxxii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Fair
        values</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>For
financial reporting purposes, fair value measurements are categorized into Level&#160;1, 2 or 3 based on the degree to which inputs to
the fair value measurements are observable and the significance of the inputs to the fair value measurement in its entirety, which are
described as follows:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Level&#160;1:
quoted prices (unadjusted) in active markets for identical assets or liabilities</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Level&#160;2:
valuation techniques for which the lowest level of inputs which have a significant effect on the recorded fair value are observable, either
directly or indirectly</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Level&#160;3:
valuation techniques for which the lowest level of inputs that have a significant effect on the recorded fair value are not based on observable
market data</span></span></span></span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">131</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">1.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">BASIS
        OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></span></span></span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div> <ix:nonNumeric id="Fxbrl_20240413045531222" name="trib:DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxxiii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>New
        IFRS Standards</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
following new accounting standards and interpretations became effective for annual periods beginning on or after 1 January 2024. The adoption
of these standards did not have a material impact on the Group&#8217;s consolidated financial statements:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Classification of Liabilities
        as Current or Non-current (Amendments to IAS 1)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Lease Liability in a Sale and
        Leaseback (Amendments to IFRS 16)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Supplier Finance Arrangements
        (Amendments to IAS 7 and IFRS 7)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Company is currently assessing the impact of the new standards and amendments on the Company&#8217;s accounting policy disclosure.</span></span></span></span></span></div>
</div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413045624646" name="ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxxiv)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Standards,
        amendments and interpretations to existing IFRS Standards that are not yet effective</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
standards and amendments that have been issued but are not yet effective as at the date of issuance of the financial statements, and which
may have an impact on the Group's financial statements in future periods, are listed below. The Group intends to adopt these standards,
if applicable, when they become effective:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Lack of Exchangeability (Amendments
        to IAS 21), effective from 1 January 2025</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Amendments to the Classification
        and Measurement of Financial Instruments (Amendments to IFRS 9 and 7), effective from 1 January 2026</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Annual Improvements to IFRS
        Accounting Standards, effective from 1 January 2026</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>IFRS 18 &#8216;Presentation
        and Disclosure in Financial Statements&#8217;, effective from 1 January 2027</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>IFRS 19 &#8216;Subsidiaries
        without Public Accountability: Disclosures&#8217;, effective from 1 January 2027</span></span></span></span></span></div> </td> </tr>
  </table> </div> </ix:nonNumeric> </div> </div> </ix:nonNumeric> </div>

<p style="margin:0pt">&#160;</p>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">132</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <ix:nonNumeric id="Fxbrl_20230420120204238" name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SEGMENT INFORMATION</span></span></div> </td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating
decision-maker, who is responsible for allocating resources and assessing the performance of the operating segments, has been identified
as the Board of Directors. Management has determined the operating segments based on the reports reviewed by the Board of Directors, which
are used to make strategic decisions. The Board considers the business from a geographic perspective based on the Group&#8217;s management
and internal reporting structure. Sales of product between companies in the Group are made on commercial terms which reflect the nature
of the relationship between the relevant companies. Segment results, assets and liabilities include items directly attributable to a segment
as well as those that can be allocated on a reasonable basis. Unallocated items comprise interest-bearing loans, borrowings and expenses
and corporate expenses. Segment capital expenditure is the total cost during the year to acquire segment plant, property and equipment
and intangible assets that are expected to be used for more than one period, whether acquired on acquisition of a business combination
or through acquisitions as part of the current operations.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group comprises two main geographical segments (i)&#160;the Americas and (ii)&#160;Rest of World - Ireland. The Group&#8217;s geographical
segments are determined by the location of the Group&#8217;s assets and operations. The Group has also presented a geographical analysis
of the segmental data for Ireland as is consistent with the information used by the Board of Directors.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
reportable operating segments derive their revenue primarily from one source (i.e., the market for diagnostic tests for a range of diseases
and other medical conditions). In determining the nature of its segmentation, the Group has considered the nature of the products, their
risks and rewards, the nature of the production base, the customer base and the nature of the regulatory environment. The Group acquires,
manufactures and markets a range of diagnostic products. The Group&#8217;s products are sold to a similar customer base and the Group&#8217;s
products must comply with various regulators worldwide in the markets that we serve.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following presents revenue and profit information and certain asset and liability information regarding the Group&#8217;s geographical
segments.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of revenue by geographical area
        based on location of assets was as follows:</span></span></div> </td> </tr>
  </table>

<div>&#160;</div> <ix:nonNumeric id="Fxbrl_20250512141235479" name="ifrs-full:DisclosureOfGeographicalAreasExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminations</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
        from external customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118215805905_33" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,792</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118215805905_37" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,763</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118215805905_315" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118215805905_319" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,555</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inter-segment
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118215805905_43" name="ifrs-full:OtherRevenue" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,815</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118215805905_47" name="ifrs-full:OtherRevenue" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">702</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118215805905_415" name="ifrs-full:OtherRevenue" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">20,517</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118215805905_419" name="ifrs-full:OtherRevenue" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118215805905_63" name="ifrs-full:Revenue" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,607</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118215805905_67" name="ifrs-full:Revenue" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,465</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240415003318431" name="ifrs-full:Revenue" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">20,517</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118215805905_619" name="ifrs-full:Revenue" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,555</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminations</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
        from external customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220231323_xbrl_20220118215805905_33" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,984</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220231323_xbrl_20220118215805905_37" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,848</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220231323_xbrl_20220118215805905_315" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220231323_xbrl_20220118215805905_319" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,832</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inter-segment
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220231350_xbrl_20220118215805905_43" name="ifrs-full:OtherRevenue" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,867</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220231350_xbrl_20220118215805905_47" name="ifrs-full:OtherRevenue" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">872</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118220231350_xbrl_20220118215805905_415" name="ifrs-full:OtherRevenue" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,739</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220231350_xbrl_20220118215805905_419" name="ifrs-full:OtherRevenue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220231382_xbrl_20220118215805905_63" name="ifrs-full:Revenue" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,851</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220231382_xbrl_20220118215805905_67" name="ifrs-full:Revenue" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,720</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118220231382_xbrl_20220118215805905_615" name="ifrs-full:Revenue" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,739</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220231382_xbrl_20220118215805905_619" name="ifrs-full:Revenue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,832</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">133</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">2.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">SEGMENT
        INFORMATION (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminations</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
        from external customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220403210_xbrl_20220118215805905_33" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,508</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220403210_xbrl_20220118215805905_37" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,013</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220403210_xbrl_20220118215805905_315" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220403210_xbrl_20220118215805905_319" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,521</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inter-segment
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220403239_xbrl_20220118215805905_43" name="ifrs-full:OtherRevenue" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,110</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220403239_xbrl_20220118215805905_47" name="ifrs-full:OtherRevenue" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">828</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118220403239_xbrl_20220118215805905_415" name="ifrs-full:OtherRevenue" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">26,938</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220403239_xbrl_20220118215805905_419" name="ifrs-full:OtherRevenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220403270_xbrl_20220118215805905_63" name="ifrs-full:Revenue" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,618</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220403270_xbrl_20220118215805905_67" name="ifrs-full:Revenue" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,841</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118220403270_xbrl_20220118215805905_615" name="ifrs-full:Revenue" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">26,938</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220403270_xbrl_20220118215805905_619" name="ifrs-full:Revenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,521</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ii)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of revenue by customers&#8217;
        geographical area was as follows:</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20250512141325139" name="ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220551225_13" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,917</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220551225_17" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,282</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220551225_111" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,557</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia
        / Africa</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220551225_23" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,775</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220551225_27" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,909</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220551225_211" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe
        (including Ireland) *</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220551225_33" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribEuropeIncludingIrelandMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,863</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220551225_37" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribEuropeIncludingIrelandMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,641</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220551225_311" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribEuropeIncludingIrelandMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,563</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220551225_53" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,555</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220551225_57" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,832</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118220551225_511" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,521</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:12.25pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue from customers in Ireland is not disclosed
        separately due to the immateriality of these revenues.</span></span></div> </td> </tr>
  </table> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iii)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of revenue by major product group
        was as follows:</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20250512141356454" name="ifrs-full:DisclosureOfProductsAndServicesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Clinical
        laboratory goods</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231209911_xbrl_20220118221140215_13" name="ifrs-full:Revenue" contextRef="C_20240101to20241231_ifrsfullProductsAndServicesAxis_tribClinicalLaboratoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,372</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231209911_xbrl_20220118221140215_17" name="ifrs-full:Revenue" contextRef="C_20230101to20231231_ifrsfullProductsAndServicesAxis_tribClinicalLaboratoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,288</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231209911_xbrl_20220118221140215_111" name="ifrs-full:Revenue" contextRef="C_20220101to20221231_ifrsfullProductsAndServicesAxis_tribClinicalLaboratoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,036</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Clinical
        laboratory services</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231209918_xbrl_20220118221140215_23" name="ifrs-full:Revenue" contextRef="C_20240101to20241231_ifrsfullProductsAndServicesAxis_tribLaboratoryServicesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,750</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231209918_xbrl_20220118221140215_27" name="ifrs-full:Revenue" contextRef="C_20230101to20231231_ifrsfullProductsAndServicesAxis_tribLaboratoryServicesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,453</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231209918_xbrl_20220118221140215_211" name="ifrs-full:Revenue" contextRef="C_20220101to20221231_ifrsfullProductsAndServicesAxis_tribLaboratoryServicesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,272</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Point-of-care</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231209922_xbrl_20220118221140215_33" name="ifrs-full:Revenue" contextRef="C_20240101to20241231_ifrsfullProductsAndServicesAxis_tribPointOfCareMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,433</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231209922_xbrl_20220118221140215_37" name="ifrs-full:Revenue" contextRef="C_20230101to20231231_ifrsfullProductsAndServicesAxis_tribPointOfCareMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,091</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231209922_xbrl_20220118221140215_311" name="ifrs-full:Revenue" contextRef="C_20220101to20221231_ifrsfullProductsAndServicesAxis_tribPointOfCareMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,213</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231209926_xbrl_20220118221140215_53" name="ifrs-full:Revenue" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,555</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231209926_xbrl_20220118221140215_57" name="ifrs-full:Revenue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,832</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231209926_xbrl_20220118221140215_511" name="ifrs-full:Revenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,521</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iv)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The group has recognised the following amounts
        relating to revenue in the consolidated statement of operations:</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20250512141421351" name="trib:DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
        from contracts with customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231547271_xbrl_20220118221511000_13" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,555</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231547271_xbrl_20220118221511000_17" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,832</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231547271_xbrl_20220118221511000_111" name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,521</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231601331_xbrl_20220118221511000_43" name="ifrs-full:Revenue" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,555</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231601331_xbrl_20220118221511000_47" name="ifrs-full:Revenue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,832</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220421231601331_xbrl_20220118221511000_411" name="ifrs-full:Revenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,521</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </ix:nonNumeric>

<div>&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">134</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">2.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">SEGMENT
        INFORMATION (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(v)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disaggregation of revenue from contracts with
        customers:</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group derives revenue from the transfer of goods and services over time and at a point in time in the following geographical areas:</span></span></div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20250512141501989" name="trib:DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory" contextRef="C_20240101to20241231" continuedAt="F20250512142559644" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222328207_23" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,536</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222328207_27" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,763</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222328207_215" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,299</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222328207_33" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">256</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222328207_37" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222328207_315" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">256</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222328207_53" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,792</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222328207_57" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,763</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222328207_515" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,555</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222926176_xbrl_20220118222328207_23" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,692</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222926176_xbrl_20220118222328207_27" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,848</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222926176_xbrl_20220118222328207_215" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,540</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222926198_xbrl_20220118222328207_33" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">292</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222926198_xbrl_20220118222328207_37" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222926198_xbrl_20220118222328207_315" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">292</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222926225_xbrl_20220118222328207_53" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,984</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222926225_xbrl_20220118222328207_57" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,848</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118222926225_xbrl_20220118222328207_515" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,832</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223104983_xbrl_20220118222328207_23" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,174</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223104983_xbrl_20220118222328207_27" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,013</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223104983_xbrl_20220118222328207_215" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,187</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223105003_xbrl_20220118222328207_33" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">334</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223105003_xbrl_20220118222328207_37" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223105003_xbrl_20220118222328207_315" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">334</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223105027_xbrl_20220118222328207_53" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,508</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223105027_xbrl_20220118222328207_57" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,013</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223105027_xbrl_20220118222328207_515" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,521</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(vi)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group derives revenue from the transfer of
        goods and services over time and at a point in time based on customers&#8217; geographical area as follows:</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div> <ix:continuation id="F20250512142559644">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia
        / Africa</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223732981_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_23" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,661</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223732981_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_27" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,775</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223732981_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_211" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,863</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223732981_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_215" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,299</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223732986_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_33" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">256</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223732986_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_37" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223732986_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_311" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223732986_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_315" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20241231_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">256</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223732990_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_53" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,917</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223732990_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_57" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,775</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223732990_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_511" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,863</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223732990_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_515" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20241231_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,555</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia
        / Africa</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223746781_xbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_23" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,990</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223746781_xbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_27" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,909</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223746781_xbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_211" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,641</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223746781_xbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_215" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,540</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223746785_xbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_33" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">292</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223746785_xbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_37" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223746785_xbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_311" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223746785_xbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_315" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20231231_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">292</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223746789_xbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_53" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,282</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223746789_xbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_57" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,909</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223746789_xbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_511" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,641</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420223746789_xbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_515" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20231231_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,832</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">135</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">2.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">SEGMENT
        INFORMATION (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia
        / Africa</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_23" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,223</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_27" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_211" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,563</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_215" name="ifrs-full:CurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,187</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_33" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">334</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_37" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_311" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_315" name="ifrs-full:NoncurrentReceivablesFromContractsWithCustomers" contextRef="C_20221231_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">334</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_53" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,557</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_57" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_511" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20221231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,563</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_515" name="ifrs-full:ReceivablesFromContractsWithCustomers" contextRef="C_20221231_srtMajorCustomersAxis_tribCustomerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,521</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </ix:continuation> </div>

<div style="line-height:1.25">

<div>&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(vii)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of segment results by geographical
        area was as follows:</span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div> <ix:nonNumeric id="Fxbrl_20250512142457949" name="ifrs-full:DisclosureOfOperatingSegmentsExplanatory" contextRef="C_20240101to20241231" continuedAt="F20250512142537349" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        before restructuring costs, impairment and unallocated expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135542008_xbrl_20230413111549043" name="trib:ResultBeforeExceptionalExpenses" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,503</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135542008_xbrl_20230413111633962" name="trib:ResultBeforeExceptionalExpenses" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,386</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135542008_xbrl_20220118224340376_311" name="trib:ResultBeforeExceptionalExpenses" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">315</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135542008_xbrl_20230413111705971" name="trib:ResultBeforeExceptionalExpenses" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,204</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restructuring
        costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512144347433_xbrl_20240414135542008_xbrl_20230413111633962" name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,025</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512144347433_xbrl_20240414135542008_xbrl_20220118224340376_311" name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,156</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512144347433_xbrl_20240414135542008_xbrl_20230413111705971" name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,181</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        charges</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135536780_xbrl_20230413111611411" name="ifrs-full:ImpairmentLoss" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">612</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135536780_xbrl_20220118224340376_47" name="ifrs-full:ImpairmentLoss" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">796</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414135536780_xbrl_20220118224340376_411" name="ifrs-full:ImpairmentLoss" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135536780_xbrl_20220118224340376_415" name="ifrs-full:ImpairmentLoss" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,408</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        after impairment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135445480_xbrl_20230413111622875" name="trib:ResultAfterExceptionalExpenses" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,140</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135445480_xbrl_20230413111649747" name="trib:ResultAfterExceptionalExpenses" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,338</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135445480_xbrl_20220118224340376_611" name="trib:ResultAfterExceptionalExpenses" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">315</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135445480_xbrl_20240414135432768" name="trib:ResultAfterExceptionalExpenses" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,793</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        expenses *</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413195541011" name="trib:UnallocatedExpenses" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,372</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135409100" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">21,165</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        financing expense (Note 6)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135358250" name="trib:FinancingIncomeBySegment" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9,565</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135340664" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">30,730</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax credit (Note 7)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118224340376_1315" name="ifrs-full:IncomeTaxesPaidRefund" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">486</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year on continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135329561" name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,216</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year on discontinued operations (Note 8)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118224340376_1615" name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">573</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414135247056" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,789</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        before restructuring costs, impairment and unallocated expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413111549043" name="trib:ResultBeforeExceptionalExpenses" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,365</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413111633962" name="trib:ResultBeforeExceptionalExpenses" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,886</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118224340376_311" name="trib:ResultBeforeExceptionalExpenses" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">104</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413111705971" name="trib:ResultBeforeExceptionalExpenses" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,355</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        charges</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413111611411" name="ifrs-full:ImpairmentLoss" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,105</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118224340376_47" name="ifrs-full:ImpairmentLoss" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118224340376_411" name="ifrs-full:ImpairmentLoss" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118224340376_415" name="ifrs-full:ImpairmentLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,105</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        after impairment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413111622875" name="trib:ResultAfterExceptionalExpenses" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,470</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413111649747" name="trib:ResultAfterExceptionalExpenses" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,886</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118224340376_611" name="trib:ResultAfterExceptionalExpenses" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">104</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240415001914388" name="trib:ResultAfterExceptionalExpenses" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,460</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        expenses *</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413195556956" name="trib:UnallocatedExpenses" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,585</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240415001925332" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">27,045</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        financing expense (Note 6)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240415001938076" name="trib:FinancingIncomeBySegment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9,882</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240415001952988" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">36,927</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax charge (Note 7)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240415002015799" name="ifrs-full:IncomeTaxesPaidRefund" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year on continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240415002035071" name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">36,868</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        for the year on discontinued operations (Note 8)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118230546103_xbrl_20220118224340376_1815" name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,850</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240415002113635" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,018</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">136</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">2.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">SEGMENT
        INFORMATION (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div> <ix:continuation id="F20250512142537349">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        before restructuring costs, impairment and unallocated expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426150951731_xbrl_20220118230545996_xbrl_20220118224340376_33" name="trib:ResultBeforeExceptionalExpenses" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,892</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426150951731_xbrl_20220118230545996_xbrl_20220118224340376_37" name="trib:ResultBeforeExceptionalExpenses" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,112</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426150951731_xbrl_20220118230545996_xbrl_20220118224340376_311" name="trib:ResultBeforeExceptionalExpenses" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426150951731_xbrl_20220118230545996_xbrl_20220118224340376_315" name="trib:ResultBeforeExceptionalExpenses" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,037</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426151001436_xbrl_20220118230546016_xbrl_20220118224340376_43" name="ifrs-full:ImpairmentLoss" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,331</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426151001436_xbrl_20230413112701323" name="ifrs-full:ImpairmentLoss" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,508</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230426151001436_xbrl_20220118230546016_xbrl_20220118224340376_411" name="ifrs-full:ImpairmentLoss" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426151001436_xbrl_20220118230546016_xbrl_20220118224340376_415" name="ifrs-full:ImpairmentLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,839</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        after impairment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426151012994_xbrl_20220118230546041_xbrl_20220118224340376_63" name="trib:ResultAfterExceptionalExpenses" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,223</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426151012994_xbrl_20220118230546041_xbrl_20220118224340376_67" name="trib:ResultAfterExceptionalExpenses" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,620</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426151012994_xbrl_20220118230546041_xbrl_20220118224340376_611" name="trib:ResultAfterExceptionalExpenses" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426151012994_xbrl_20220118230546041_xbrl_20220118224340376_615" name="trib:ResultAfterExceptionalExpenses" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,876</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        expenses *</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426151110276_xbrl_20220118230546067_xbrl_20220118224340376_715" name="trib:UnallocatedExpenses" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,473</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426151117428_xbrl_20220118233909154" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,349</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        financing expense (Note 6)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426151126699_xbrl_20220118230546074_xbrl_20220118224340376_1015" name="trib:FinancingIncomeBySegment" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,431</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426151133868_xbrl_20220118230546081_xbrl_20220118224340376_1215" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">43,780</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax credit (Note 7)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230426151146427_xbrl_20220118230546087_xbrl_20220118224340376_1315" name="ifrs-full:IncomeTaxesPaidRefund" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">194</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year on continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426151157267_xbrl_20220118230546095_xbrl_20220118224340376_1515" name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">43,586</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        for the year on discontinued operations (Note 8)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230426151208799_xbrl_20220327021944791" name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,577</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230426151216119_xbrl_20220118230546103_xbrl_20220118224340376_1815" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">41,009</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated expenses represent head office general
        and administration costs of the Group, which cannot be allocated to the results of any specific geographical area.</span></span></div>
        </td> </tr>
  </table> </div> </ix:continuation> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">viii)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of segment assets and segment
        liabilities by geographical area was as follows:</span></span></div> </td> </tr>
  </table>

<div>&#160;</div> </div> <ix:nonNumeric id="Fxbrl_20250512141741987" name="trib:DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Assets
        and liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118235330519_43" name="trib:SegmentAssets" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,798</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118235330519_47" name="trib:SegmentAssets" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,254</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118235330519_411" name="trib:SegmentAssets" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118235330519_415" name="trib:SegmentAssets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94,052</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        assets:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax assets (current and deferred)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118235330519_615" name="trib:IncomeTaxAssetsCurrentAndDeferred" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,071</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents and short-term investments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118235330519_715" name="trib:CashAndCashEquivalentsAndShortTermInvestments" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,167</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        assets as reported in the Group balance sheet</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118235330519_915" name="ifrs-full:NetDeferredTaxAssets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103,290</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118235330519_113" name="trib:SegmentLiabilities" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84,863</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118235330519_117" name="trib:SegmentLiabilities" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,621</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118235330519_1111" name="trib:SegmentLiabilities" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118235330519_1115" name="trib:SegmentLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">133,546</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        liabilities:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax liabilities (current and deferred)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118235330519_1315" name="trib:IncomeTaxLiabilitiesCurrentAndDeferred" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,925</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        liabilities as reported in the Group balance sheet</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118235330519_1515" name="ifrs-full:NetDeferredTaxLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">138,471</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div> </div>

<div><ix:exclude>

<div>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">137</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SEGMENT INFORMATION (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Assets
        and liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004658693_xbrl_20220118235330519_43" name="trib:SegmentAssets" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,230</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004658693_xbrl_20220118235330519_47" name="trib:SegmentAssets" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,023</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004658693_xbrl_20220118235330519_411" name="trib:SegmentAssets" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004658693_xbrl_20220118235330519_415" name="trib:SegmentAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,253</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        assets:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax assets (current and deferred)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004658715_xbrl_20220118235330519_615" name="trib:IncomeTaxAssetsCurrentAndDeferred" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,491</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents and short-term investments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004658722_xbrl_20220118235330519_715" name="trib:CashAndCashEquivalentsAndShortTermInvestments" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        assets as reported in the Group balance sheet</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004658729_xbrl_20220118235330519_915" name="ifrs-full:NetDeferredTaxAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59,435</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004756266_xbrl_20220118235330519_113" name="trib:SegmentLiabilities" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49,398</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004756266_xbrl_20220118235330519_117" name="trib:SegmentLiabilities" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,387</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004756266_xbrl_20220118235330519_1111" name="trib:SegmentLiabilities" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004756266_xbrl_20220118235330519_1115" name="trib:SegmentLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">80,805</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        liabilities:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax liabilities (current and deferred)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004658737_xbrl_20220118235330519_1315" name="trib:IncomeTaxLiabilitiesCurrentAndDeferred" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,579</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        liabilities as reported in the Group balance sheet</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004658745_xbrl_20220118235330519_1515" name="ifrs-full:NetDeferredTaxLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83,384</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </ix:nonNumeric>

<div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ix)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of long-lived assets, which are
        property, plant and equipment, goodwill and intangible assets and other non-current assets (excluding deferred tax assets and derivative
        financial instruments), by geographical area was as follows:</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512142048020" name="trib:DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004904694_13" name="trib:LongLivedAsstesBySegment" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,504</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004904694_17" name="trib:LongLivedAsstesBySegment" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,448</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004904694_23" name="trib:LongLivedAsstesBySegment" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,943</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004904694_27" name="trib:LongLivedAsstesBySegment" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,793</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004904694_43" name="trib:LongLivedAsstesBySegment" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58,447</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119004904694_47" name="trib:LongLivedAsstesBySegment" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,241</ix:nonFraction></span></span></div>
        </td> </tr>
  </table> </div> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">x)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of depreciation and amortisation
        by geographical area was as follows:</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20250512142007573" name="trib:DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation:</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_23" name="ifrs-full:DepreciationExpense" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">160</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_27" name="ifrs-full:DepreciationExpense" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">162</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_211" name="ifrs-full:DepreciationExpense" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">123</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_33" name="ifrs-full:DepreciationExpense" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">515</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_37" name="ifrs-full:DepreciationExpense" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">668</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_311" name="ifrs-full:DepreciationExpense" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,282</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_53" name="ifrs-full:DepreciationExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">675</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_57" name="ifrs-full:DepreciationExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">830</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_511" name="ifrs-full:DepreciationExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,405</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortisation:</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_73" name="ifrs-full:AmortisationExpense" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">770</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_77" name="ifrs-full:AmortisationExpense" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">458</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_711" name="ifrs-full:AmortisationExpense" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_83" name="ifrs-full:AmortisationExpense" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">420</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_87" name="ifrs-full:AmortisationExpense" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">487</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_811" name="ifrs-full:AmortisationExpense" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">800</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_103" name="ifrs-full:AmortisationExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,190</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_107" name="ifrs-full:AmortisationExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">945</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005128190_1011" name="ifrs-full:AmortisationExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">889</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">xi)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of share-based payment expense
        by geographical area was as follows:</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512141923531" name="trib:ScheduleOfShareBasedPaymentExpenseByGeographicalArea" contextRef="C_20240101to20241231" escape="true">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023<br/>US$&#8216;000</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022<br/>US$&#8216;000</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005502995_13" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">843</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005502995_17" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,650</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005502995_111" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">632</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005502995_23" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">473</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005502995_27" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">419</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005502995_211" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,123</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005502995_43" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005502995_47" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,069</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119005502995_411" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,755</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">See
Note 20 for further information on share-based payments.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">138</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<div style="text-indent:30.6pt;line-height:1.25;font-family:Times New Roman, serif;font-size:1pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">2.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">SEGMENT
        INFORMATION (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">xii)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of taxation (expense)/credit
        by geographical area was as follows:</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20250512141852492" name="trib:DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250514163005408" name="trib:IncomeTaxExpense" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">)</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119012342054_17" name="trib:IncomeTaxExpense" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">385</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119012342054_111" name="trib:IncomeTaxExpense" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">286</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Other</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240427023227523" name="trib:IncomeTaxExpense" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326204428595_xbrl_20220119012342054_27" name="trib:IncomeTaxExpense" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">235</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413120038463" name="trib:IncomeTaxExpense" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119012342054_33" name="trib:IncomeTaxExpense" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">490</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413120021632" name="trib:IncomeTaxExpense" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">679</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119012342054_311" name="trib:IncomeTaxExpense" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">88</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119012342054_53" name="trib:IncomeTaxExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">486</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119012342054_57" name="trib:IncomeTaxExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119012342054_511" name="trib:IncomeTaxExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">194</ix:nonFraction></span></span></div>
        </td> </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">xiii)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2024, 2023 and 2022 there were no customers
        generating 10% or more of total revenues.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">xiv)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of capital expenditure by geographical
        area was as follows:</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512141826219" name="trib:DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="width:7px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;width:73px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119012714732_13" name="ifrs-full:PaymentsForDevelopmentProjectExpenditure" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37,929</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119012714732_17" name="ifrs-full:PaymentsForDevelopmentProjectExpenditure" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">251</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="width:7px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;width:73px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119012714732_33" name="ifrs-full:PaymentsForDevelopmentProjectExpenditure" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,753</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119012714732_37" name="ifrs-full:PaymentsForDevelopmentProjectExpenditure" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,547</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="width:7px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;width:73px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="width:7px;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;width:73px;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119012714732_53" name="ifrs-full:PaymentsForDevelopmentProjectExpenditure" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,682</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119012714732_57" name="ifrs-full:PaymentsForDevelopmentProjectExpenditure" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,798</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital
expenditure for the year ended December 31, 2024 includes significant additions arising from the acquisitions of Waveform assets, EpiCapture
Limited, and Metabolomics Diagnostic Limited (see Note 29). In addition, capitalised development costs increased from US$<ix:nonFraction id="Fxbrl_20250512145309994" name="trib:CapitalisedDevelopmentCost" contextRef="C_20230101to20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.8</ix:nonFraction>
million in 2023 to US$<ix:nonFraction id="Fxbrl_20250512145321997" name="trib:CapitalisedDevelopmentCost" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.6</ix:nonFraction>
million in 2024, reflecting investment in development of newly acquired intangible assets.</span></span></div> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20240412203235960" name="ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EMPLOYMENT</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
average number of persons employed by the Group in continuing operations is as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240412194520992" name="ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research
        and development</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114161829123_13" name="ifrs-full:AverageNumberOfEmployees" contextRef="C_20240101to20241231_ifrsfullDefinedBenefitPlansAxis_tribResearchAndDevelopmentMember" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">33</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114161829123_17" name="ifrs-full:AverageNumberOfEmployees" contextRef="C_20230101to20231231_ifrsfullDefinedBenefitPlansAxis_tribResearchAndDevelopmentMember" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114161829123_111" name="ifrs-full:AverageNumberOfEmployees" contextRef="C_20220101to20221231_ifrsfullDefinedBenefitPlansAxis_tribResearchAndDevelopmentMember" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">26</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Administration
        and sales</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114161829123_23" name="ifrs-full:AverageNumberOfEmployees" contextRef="C_20240101to20241231_ifrsfullDefinedBenefitPlansAxis_tribAdministrationAndSalesMember" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">82</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114161829123_27" name="ifrs-full:AverageNumberOfEmployees" contextRef="C_20230101to20231231_ifrsfullDefinedBenefitPlansAxis_tribAdministrationAndSalesMember" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">99</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114161829123_211" name="ifrs-full:AverageNumberOfEmployees" contextRef="C_20220101to20221231_ifrsfullDefinedBenefitPlansAxis_tribAdministrationAndSalesMember" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">105</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacturing
        and quality</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114161829123_33" name="ifrs-full:AverageNumberOfEmployees" contextRef="C_20240101to20241231_ifrsfullDefinedBenefitPlansAxis_tribManufacturingAndQualityMember" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">286</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114161829123_37" name="ifrs-full:AverageNumberOfEmployees" contextRef="C_20230101to20231231_ifrsfullDefinedBenefitPlansAxis_tribManufacturingAndQualityMember" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">258</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114161829123_311" name="ifrs-full:AverageNumberOfEmployees" contextRef="C_20220101to20221231_ifrsfullDefinedBenefitPlansAxis_tribManufacturingAndQualityMember" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">253</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114161829123_53" name="ifrs-full:AverageNumberOfEmployees" contextRef="C_20240101to20241231" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114161829123_57" name="ifrs-full:AverageNumberOfEmployees" contextRef="C_20230101to20231231" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">380</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114161829123_511" name="ifrs-full:AverageNumberOfEmployees" contextRef="C_20220101to20221231" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">384</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:-30.6pt;margin-left:61.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
average number of employees, including discontinued operations, was <ix:nonFraction id="Fxbrl_20240412202305296" name="trib:AverageNumberOfEmployeesIncludingDiscontinuedOperations" contextRef="C_20240101to20241231" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">401</ix:nonFraction>
(2023: <ix:nonFraction id="Fxbrl_20240412202320746" name="trib:AverageNumberOfEmployeesIncludingDiscontinuedOperations" contextRef="C_20230101to20231231" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">383</ix:nonFraction>;
2022: <ix:nonFraction id="Fxbrl_20240412202342512" name="trib:AverageNumberOfEmployeesIncludingDiscontinuedOperations" contextRef="C_20220101to20221231" unitRef="Employee" scale="0" decimals="0" format="ixt:num-dot-decimal">398</ix:nonFraction>).</span></span></div>

<div style="text-indent:-30.6pt;margin-left:61.2pt;line-height:1.25">&#160;</div>

<div style="text-indent:-30.6pt;margin-left:61.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employment
costs charged in the consolidated statement of operations for continuing operations are analysed as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240412194638273" name="ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wages
        and salaries</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_13" name="ifrs-full:WagesAndSalaries" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,570</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_17" name="ifrs-full:WagesAndSalaries" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,718</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_111" name="ifrs-full:WagesAndSalaries" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,364</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Social
        welfare costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_23" name="ifrs-full:SocialSecurityContributions" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,219</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_27" name="ifrs-full:SocialSecurityContributions" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,061</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_211" name="ifrs-full:SocialSecurityContributions" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,965</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pension
        costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_33" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">451</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_37" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">508</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_311" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">347</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_43" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_47" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,069</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_411" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,755</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restructuring
        cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_53" name="trib:ExpenseOfRestructuringCost" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">596</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_57" name="trib:ExpenseOfRestructuringCost" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">485</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_511" name="trib:ExpenseOfRestructuringCost" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">274</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_73" name="ifrs-full:EmployeeBenefitsExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,152</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_77" name="ifrs-full:EmployeeBenefitsExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,841</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412201956808_711" name="ifrs-full:EmployeeBenefitsExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,705</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">139</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">3.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">EMPLOYMENT
        (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employment
costs are shown net of capitalisations and Irish government wage subsidies. There were no Irish government wage subsidies netted against
employment costs in the year ended December 31, 2024.&#160; Total employment costs, inclusive of amounts capitalised for wages and salaries,
social welfare costs and pension costs, for the year ended December&#160;31, 2024, amounted to US$<ix:nonFraction id="Fxbrl_20250513134643533" name="ifrs-full:ShorttermEmployeeBenefitsExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,584</ix:nonFraction>,000
(2023: US$<ix:nonFraction id="Fxbrl_20250513134703328" name="ifrs-full:ShorttermEmployeeBenefitsExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,975</ix:nonFraction>,000)
(2022: US$<ix:nonFraction id="Fxbrl_20250513134713474" name="ifrs-full:ShorttermEmployeeBenefitsExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,528</ix:nonFraction>,000).
Total share-based payments in the balance sheet amounted to US$<ix:nonFraction id="Fxbrl_20250513134747596" name="trib:IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction>,000
for the year ended December&#160;31, 2024 (2023: US$<ix:nonFraction id="Fxbrl_20250513134757648" name="trib:IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,069</ix:nonFraction>,000)
(2022: US$<ix:nonFraction id="Fxbrl_20250513134809707" name="trib:IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,755</ix:nonFraction>,000).
See Note 20 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employment
costs including discontinued operations, are analysed as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240412204106528" name="ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory" contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wages
        and salaries</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203641928_xbrl_20240412201956808_13" name="ifrs-full:WagesAndSalaries" contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,570</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203641928_xbrl_20240412201956808_17" name="ifrs-full:WagesAndSalaries" contextRef="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,343</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203641928_xbrl_20240412201956808_111" name="ifrs-full:WagesAndSalaries" contextRef="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,608</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Social
        welfare costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203710128_xbrl_20240412201956808_23" name="ifrs-full:SocialSecurityContributions" contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,219</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203710128_xbrl_20240412201956808_27" name="ifrs-full:SocialSecurityContributions" contextRef="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,097</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203710128_xbrl_20240412201956808_211" name="ifrs-full:SocialSecurityContributions" contextRef="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,036</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pension
        costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203749720_xbrl_20240412201956808_33" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">451</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203749720_xbrl_20240412201956808_37" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" contextRef="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">510</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203749720_xbrl_20240412201956808_311" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" contextRef="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">352</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203756038_xbrl_20240412201956808_43" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203756038_xbrl_20240412201956808_47" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,069</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203756038_xbrl_20240412201956808_411" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,755</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restructuring
        cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203803151_xbrl_20240412201956808_53" name="trib:ExpenseOfRestructuringCost" contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">596</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203803151_xbrl_20240412201956808_57" name="trib:ExpenseOfRestructuringCost" contextRef="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">485</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203803151_xbrl_20240412201956808_511" name="trib:ExpenseOfRestructuringCost" contextRef="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">274</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203809191_xbrl_20240412201956808_73" name="ifrs-full:EmployeeBenefitsExpense" contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,152</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203809191_xbrl_20240412201956808_77" name="ifrs-full:EmployeeBenefitsExpense" contextRef="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,504</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412203809191_xbrl_20240412201956808_711" name="ifrs-full:EmployeeBenefitsExpense" contextRef="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,025</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group operates defined contribution pension schemes for certain of its full-time employees. The benefits under these schemes are financed
by both Group and employee contributions. Total contributions made by the Group in the financial year and charged against income in respect
of continuing operations amounted to US$<ix:nonFraction id="Fxbrl_20250513134904818" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">451</ix:nonFraction>,000
(2023: US$<ix:nonFraction id="Fxbrl_20250513134912549" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">508</ix:nonFraction>,000)
(2022: US$<ix:nonFraction id="Fxbrl_20250513134921859" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">347</ix:nonFraction>,000).
The pension accrual for the Group at December&#160;31, 2024 was US$<ix:nonFraction id="Fxbrl_20220326133106202" name="trib:ActuarialAssumptionOfExpectedPensionIncreases" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">nil</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20250513134932045" name="trib:ActuarialAssumptionOfExpectedPensionIncreases" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction>,000)
(2022: US$<ix:nonFraction id="Fxbrl_20250513134940611" name="trib:ActuarialAssumptionOfExpectedPensionIncreases" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44</ix:nonFraction>,000).</span></span></div>
</div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20220114163453082" name="ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OTHER OPERATING (EXPENSE) / INCOME</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20220114163521142" name="ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        income</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114164626134_23" name="ifrs-full:OtherIncome" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114164626134_27" name="ifrs-full:OtherIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">138</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114164626134_211" name="ifrs-full:OtherIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental
        income from premises</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114164626134_33" name="trib:RentalIncomeFromPremises" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114164626134_37" name="trib:RentalIncomeFromPremises" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114164626134_311" name="trib:RentalIncomeFromPremises" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government
        supports</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114164626134_13" name="trib:GovernmentSupportsCovid19" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,827</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114164626134_17" name="trib:GovernmentSupportsCovid19" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114164626134_111" name="trib:GovernmentSupportsCovid19" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government
        grants</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413124458163" name="ifrs-full:RevenueFromGovernmentGrants" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413124512509" name="ifrs-full:RevenueFromGovernmentGrants" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413124938769" name="ifrs-full:RevenueFromGovernmentGrants" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">333</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114164626134_53" name="ifrs-full:OtherOperatingIncomeExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,787</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114164626134_57" name="ifrs-full:OtherOperatingIncomeExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">141</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114164626134_511" name="ifrs-full:OtherOperatingIncomeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">343</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
other income for year ended December 31, 2024 relates to income from a transition services agreement with the acquirers of Fitzgerald
Industries for the provision of bookkeeping and I.T. services.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
October 2024, the Company was notified that it is the subject of a U.S. Department of Justice (DOJ) investigation relating to second-round
Paycheck Protection Program (PPP) loans received by certain U.S. subsidiaries. At year-end, a payable of US$<ix:nonFraction id="Fxbrl_20250512163402997" name="trib:LoanIncome" contextRef="C_20241031_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribPaycheckProtectionProgramLoanMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">2,165,000</ix:nonFraction>
was recognised, covering the US$<ix:nonFraction id="Fxbrl_20250512163419692" name="ifrs-full:LoansPayableInDefault" contextRef="C_20241031_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribPaycheckProtectionProgramLoanMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">1,827,000</ix:nonFraction>
in loans and estimated interest of US$<ix:nonFraction id="Fxbrl_20250512163446548" name="ifrs-full:InterestPayable" contextRef="C_20241031_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribPaycheckProtectionProgramLoanMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">338,000</ix:nonFraction>.
As the original loan income was recognised in other operating income, the reversal to the extent of the loan to be repaid has been recorded
as a corresponding charge to other operating (expense)/income, noted as &#8220;Government supports&#8221;. The interest costs incidental
to the loan repayment has been charged to finance costs.</span></span></div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">140</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <ix:nonNumeric id="Fxbrl_20240412205107919" name="ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Impairment
charges</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
accordance with IAS 36, <span style="font-style:italic">Impairment of Assets</span>, the Company&#160;carries out periodic impairment
reviews of the asset valuations. A number of factors impacted this calculation including the Company&#8217;s market capitalization during
the year ended December 31 2024, the cost of capital, cash flow projections and net asset values across each of the Company&#8217;s cash-generating
units.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
impact of the above items on the consolidated statement of operations for the year ended December 31, 2024, 2023, and 2022 are as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240412205129312" name="trib:DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling,
        general&#160;&amp; administration expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        of PP&amp;E (Note 11)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174152778_43" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">612</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174152778_47" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,772</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174152778_411" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">733</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        of goodwill and other intangible&#160;assets (Note 12)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412205232256" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,596</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174152778_57" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,833</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174152778_511" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,624</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        of prepayments (Note 17)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174152778_63" name="trib:ImpairmentOfPrepayments" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174152778_67" name="trib:ImpairmentOfPrepayments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174152778_611" name="trib:ImpairmentOfPrepayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">482</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Reversal)/Impairment
        of financial assets (Note 13)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240412205448487_xbrl_20240412205232256" name="ifrs-full:ImpairmentLossOnFinancialAssets" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">800</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412205448487_xbrl_20220114174152778_57" name="ifrs-full:ImpairmentLossOnFinancialAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412205448487_xbrl_20220114174152778_511" name="ifrs-full:ImpairmentLossOnFinancialAssets" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        impairment loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174152778_83" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,408</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174152778_87" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,105</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174152778_811" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,839</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Restructuring
costs</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year ended December 31, 2024, the Group undertook a comprehensive business transformation program aimed at improving long-term operational
efficiency and aligning the organization with its strategic priorities. These changes were previously communicated to the market and include
operationally profitability measures, organizational realignment, and changes to business unit structures.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
a result, the Group recognized restructuring costs of US$<ix:nonFraction id="Fxbrl_20250512221619462" name="trib:RestructuringActivitiesExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.2</ix:nonFraction>
million (2023: US$<ix:nonFraction id="Fxbrl_20250512221627665" name="trib:RestructuringActivitiesExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">nil</ix:nonFraction>)
(2022: US$<ix:nonFraction id="Fxbrl_20250512221650787" name="trib:RestructuringActivitiesExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">nil</ix:nonFraction>)
which are presented separately in the consolidated statement of operations within &#8216;Selling, general and administrative expenses
&#8211; Restructuring costs&#8217;.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
restructuring costs incurred during the year comprised the following:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512201859513" name="ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>December&#160;31,</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Nature
        of cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Personnel
        related costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512201922084_43" name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribPersonnelRelatedCostsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,216</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outsourcing
        costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512201922084_53" name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribOutsourcingCostsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">754</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Site
        transfer costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512201922084_63" name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,281</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory
        related costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512201922084_73" name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribInventoryRelatedCostsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">772</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        restructuring costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512201922084_83" name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribOtherRestructuringCostsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">158</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        restructuring costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512201922084_103" name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,181</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Included
within Site transfer costs above is US$<ix:nonFraction id="Fxbrl_20250513162352083" name="trib:RestructuringActivitiesExpense" contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">356</ix:nonFraction>,000
related to the impairment of plant &amp; equipment arising as part of the restructuring program. Refer to Note 11. We have provided for
additional restructuring costs of US$<ix:nonFraction id="Fxbrl_20250513153245351" name="trib:AdditionalRestructuringCosts" contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.6</ix:nonFraction>
million as at December 31, 2024 (see Note 22).</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div> </div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="text-align:left;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">141</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<div style="margin-top:0pt;margin-bottom:0pt">

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">5.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">IMPAIRMENT,
        RESTRUCTURING AND ONCE OFF COSTS (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Once
off costs</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year ended 31 December 2024, the Company&#160;incurred exceptional, non-trading costs totaling US$<ix:nonFraction id="Fxbrl_20250513153550995" name="trib:NonRadingCosts" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.9</ix:nonFraction>
million, which is made up as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
October 2024, the Company issued <ix:nonFraction id="Fxbrl_20250513162424475" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20241031_ifrsfullUnderlyingEquityInstrumentAndDepositaryReceiptsAxis_tribAmericanDepositarySharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">650,000</ix:nonFraction>
American Depositary Shares (&#8220;ADSs&#8221;) to a corporate finance advisor as a non-refundable retainer fee in respect of advisory
services provided in connection with a planned future equity raise. The fair value of the ADSs issued, amounting to US$<ix:nonFraction id="Fxbrl_20250512222356490" name="trib:FairValueOfSharesIssued" contextRef="C_20241001to20241031_ifrsfullUnderlyingEquityInstrumentAndDepositaryReceiptsAxis_tribAmericanDepositarySharesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.1</ix:nonFraction>
million, was recognized directly in equity, with a corresponding charge recorded within the consolidated statement of operations as an
exceptional cost.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year, the Company&#160;recognized a provision of US$<ix:nonFraction id="Fxbrl_20250512221823047" name="ifrs-full:LegalProceedingsProvision" contextRef="C_20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction>
million in respect of a legacy matter currently subject to resolution. Owing to the sensitive nature of ongoing discussions, further disclosure
has been withheld in accordance with IAS 37.92, as the Directors believe such disclosure could seriously prejudice the Company&#8217;s
position.</span></span></div> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div>

<div> <ix:nonNumeric id="Fxbrl_20250512154159461" name="ifrs-full:DisclosureOfFinanceIncomeExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">FINANCIAL INCOME AND EXPENSES</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<div> <ix:nonNumeric id="Fxbrl_20250512154426399" name="trib:DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        income:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        financial income</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174919548_23" name="ifrs-full:InterestIncomeOnOtherFinancialAssets" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174919548_27" name="ifrs-full:InterestIncomeOnOtherFinancialAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,171</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174919548_211" name="ifrs-full:InterestIncomeOnOtherFinancialAssets" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">303</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        expense:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest
        on leases (Note 24)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114174919548_83" name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">592</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114174919548_87" name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">624</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114174919548_811" name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">647</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        on disposal of exchangeable notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413155242980" name="trib:LossOnDisposalOfExchangeableNotes" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413155258304" name="trib:LossOnDisposalOfExchangeableNotes" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413155310528" name="trib:LossOnDisposalOfExchangeableNotes" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,678</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Penalty
        for early partial settlement of senior secured term loan (Note 23,28)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413155445294" name="trib:PenaltyForEarlySettlementOfTermLoan" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">905</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413155514442" name="trib:PenaltyForEarlySettlementOfTermLoan" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,450</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        interest payable on senior secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413155548222" name="trib:CashInterestPayableOnSeniorSecureTermLoan" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,293</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413155600261" name="trib:CashInterestPayableOnSeniorSecureTermLoan" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,289</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413155614258" name="trib:CashInterestPayableOnSeniorSecureTermLoan" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,039</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        interest payable on convertible note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413155718296" name="trib:InterestPaidOnConvertibleNote" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">300</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413155748449" name="trib:InterestPaidOnConvertibleNote" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">300</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413155801400" name="trib:InterestPaidOnConvertibleNote" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">199</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        interest on exchangeable notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114174919548_103" name="ifrs-full:InterestExpenseOnDebtInstrumentsIssued" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114174919548_107" name="ifrs-full:InterestExpenseOnDebtInstrumentsIssued" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114174919548_1011" name="ifrs-full:InterestExpenseOnDebtInstrumentsIssued" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">296</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        interest payable on PPP loans (Note 4)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512160311398_xbrl_20220114174919548_103" name="trib:CashInterestPayableOnPppLoans" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">338</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512160311398_xbrl_20220114174919548_107" name="trib:CashInterestPayableOnPppLoans" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512160311398_xbrl_20220114174919548_1011" name="trib:CashInterestPayableOnPppLoans" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        interest on exchangeable notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174919548_113" name="ifrs-full:InterestExpenseOnOtherFinancialLiabilities" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114174919548_117" name="ifrs-full:InterestExpenseOnOtherFinancialLiabilities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114174919548_1111" name="ifrs-full:InterestExpenseOnOtherFinancialLiabilities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        interest on senior secured term loan (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413155934594" name="trib:NoncashInterestOnSeniorSecuredTermLoan" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,355</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413155951220" name="trib:NoncashInterestOnSeniorSecuredTermLoan" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,131</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413160004667" name="trib:NoncashInterestOnSeniorSecuredTermLoan" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,772</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        interest on convertible note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413160047288" name="trib:NoncashInterestOnConvertibleNote" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">859</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413160112347" name="trib:NoncashInterestOnConvertibleNote" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">796</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413160214875" name="trib:NoncashInterestOnConvertibleNote" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">495</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        financial expense</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413134114407" name="ifrs-full:FinanceIncomeCost" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,172</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413134122278" name="ifrs-full:FinanceIncomeCost" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413134134062" name="ifrs-full:FinanceIncomeCost" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unwinding
        of discount on deferred contingent consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512160313565_xbrl_20220114174919548_103" name="trib:UnwindingOfDiscountOnDeferredContingentConsideration" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">53</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalisation
        of borrowing costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512160315700_xbrl_20220114174919548_103" name="ifrs-full:BorrowingCostsCapitalised" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,085</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512160315700_xbrl_20220114174919548_107" name="ifrs-full:BorrowingCostsCapitalised" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512160315700_xbrl_20220114174919548_1011" name="ifrs-full:BorrowingCostsCapitalised" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        loan modification gain (Note 23,28)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250514011300218_xbrl_20250512160315700_xbrl_20220114174919548_103" name="trib:NoncashLoanModificationGain" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,567</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250514011300218_xbrl_20250512160315700_xbrl_20220114174919548_107" name="trib:NoncashLoanModificationGain" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250514011300218_xbrl_20250512160315700_xbrl_20220114174919548_1011" name="trib:NoncashLoanModificationGain" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalisation
        of unpaid interest on term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512160322988_xbrl_20220114174919548_103" name="trib:CapitalisationOfUnpaidInterestOnTermLoan" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,247</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512160322988_xbrl_20220114174919548_107" name="trib:CapitalisationOfUnpaidInterestOnTermLoan" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512160322988_xbrl_20220114174919548_1011" name="trib:CapitalisationOfUnpaidInterestOnTermLoan" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114174919548_143" name="ifrs-full:FinanceCosts" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,565</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114174919548_147" name="ifrs-full:FinanceCosts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,053</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114174919548_1411" name="ifrs-full:FinanceCosts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,734</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        financing expense</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114174919548_153" name="trib:FinanceIncomeExpenseNet" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9,565</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114174919548_157" name="trib:FinanceIncomeExpenseNet" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9,882</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114174919548_1511" name="trib:FinanceIncomeExpenseNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,431</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </ix:nonNumeric> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For
more information on the senior secured term loan, convertible note and exchangeable notes, refer to Note 23 Interest-Bearing Loans and
Borrowings.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
financial expense relates to the fair value loss on warrant liabilities during the year. Refer to Note 23 for further details.</span></span></div>
</div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">142</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div> <ix:nonNumeric id="Fxbrl_20230420131708998" name="ifrs-full:DisclosureOfIncomeTaxExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INCOME TAX (EXPENSE)/CREDIT</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20250512162046179" name="trib:DisclosureOfDetailedInformationAboutChargeForTaxExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current
        tax expense/(credit)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Irish
        Corporation tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_23" name="ifrs-full:CurrentTaxExpenseIncome" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_27" name="ifrs-full:CurrentTaxExpenseIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118014436239_211" name="ifrs-full:CurrentTaxExpenseIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">336</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign
        taxes (a)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_33" name="trib:CurrentTaxForeignExpenseIncome" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">254</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_37" name="trib:CurrentTaxForeignExpenseIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">462</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118014436239_311" name="trib:CurrentTaxForeignExpenseIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustment
        in respect of prior years</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_43" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118014436239_47" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">198</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_411" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        current tax expense/(credit)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_63" name="ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">285</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_67" name="ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">264</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118014436239_611" name="ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">280</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">Deferred
        tax credit </span>(b)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Origination
        and reversal of temporary differences (see Note 14)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118014436239_93" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">41</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118014436239_97" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">547</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220118014436239_911" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">324</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Origination
        and reversal of net operating losses (see Note 14)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220118014436239_103" name="trib:ReversalOfNetOperatingLoss" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">242</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220118014436239_107" name="trib:ReversalOfNetOperatingLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">224</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326145341160" name="trib:ReversalOfNetOperatingLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">238</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        deferred tax charge/(credit)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_123" name="ifrs-full:DeferredTaxExpenseIncome" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">201</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118014436239_127" name="ifrs-full:DeferredTaxExpenseIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">323</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_1211" name="ifrs-full:DeferredTaxExpenseIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        income tax charge/(credit) on continuing operations in statement of operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_143" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">486</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118014436239_147" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">59</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118014436239_1411" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">194</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax
        charge on discontinued operations (see Note 8)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_163" name="ifrs-full:TaxExpenseRelatingToGainLossOnDiscontinuance" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_167" name="ifrs-full:TaxExpenseRelatingToGainLossOnDiscontinuance" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_1611" name="ifrs-full:TaxExpenseRelatingToGainLossOnDiscontinuance" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        tax charge/(credit)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118014436239_183" name="trib:IncomeTaxExpenseBenefits" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">486</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118014436239_187" name="trib:IncomeTaxExpenseBenefits" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">59</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118014436239_1811" name="trib:IncomeTaxExpenseBenefits" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">192</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(a)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2024, the foreign taxes relate primarily to
        Luxembourg and Canada.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(b)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2024, there was
        a deferred tax credit of US$<ix:nonFraction id="Fxbrl_20250513122731696" name="ifrs-full:DeferredTaxExpenseIncome" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">43,000</ix:nonFraction>
        (2023: charge of US$<ix:nonFraction id="Fxbrl_20220502173641752" name="ifrs-full:DeferredTaxExpenseIncome" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">174,000</ix:nonFraction>)
        (2022: charge of US$<ix:nonFraction id="Fxbrl_20230413095340209" name="ifrs-full:DeferredTaxExpenseIncome" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">109,000</ix:nonFraction>)
        recognised in respect of Ireland and a deferred tax charge of US$<ix:nonFraction id="Fxbrl_20230413095510361" name="ifrs-full:DeferredTaxExpenseIncome" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">244,000</ix:nonFraction>
        (2023: credit of US$<ix:nonFraction id="Fxbrl_20230413095449295" name="ifrs-full:DeferredTaxExpenseIncome" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">497,000</ix:nonFraction>)
        (2022: credit of US$<ix:nonFraction id="Fxbrl_20220502173723393" name="ifrs-full:DeferredTaxExpenseIncome" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">26,000</ix:nonFraction>)
        recognised in respect of overseas tax jurisdictions.</span></span></div> </td> </tr>
  </table> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240413145551985" name="trib:DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective
        tax rate</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before taxation &#8211; continuing operations (US$&#8216;000)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413095832952" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">30,730</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015402375_17" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">36,927</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015402375_111" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">43,780</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        a percentage of loss before&#160;tax:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current
        tax %</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240427031027657" name="trib:TaxRateEffectOfCurrentTaxOfPriorPeriods" contextRef="C_20240101to20241231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">0.93</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015402375_37" name="trib:TaxRateEffectOfCurrentTaxOfPriorPeriods" contextRef="C_20230101to20231231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">0.72</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015402375_311" name="trib:TaxRateEffectOfCurrentTaxOfPriorPeriods" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">0.64</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        (current and deferred) %</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513155056256" name="ifrs-full:AverageEffectiveTaxRate" contextRef="C_20240101to20241231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">1.58</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015402375_47" name="ifrs-full:AverageEffectiveTaxRate" contextRef="C_20230101to20231231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">0.16</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015402375_411" name="ifrs-full:AverageEffectiveTaxRate" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">0.44</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">143</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INCOME TAX (EXPENSE)/CREDIT (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following table reconciles the applicable Republic of Ireland statutory tax rate to the effective total tax rate for the Group:</span></span></div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20250513155626181" name="trib:DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25;margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Irish
        corporation tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413100444958" name="ifrs-full:ApplicableTaxRate" contextRef="C_20240101to20241231" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">12.5</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015958552_17" name="ifrs-full:ApplicableTaxRate" contextRef="C_20230101to20231231" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">12.5</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015958552_111" name="ifrs-full:ApplicableTaxRate" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">12.5</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect
        of current year net operating losses and temporary differences for which no deferred tax asset was recognised (a)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414175446320" name="ifrs-full:TaxRateEffectOfTaxLosses" contextRef="C_20240101to20241231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">15.89</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118015958552_27" name="ifrs-full:TaxRateEffectOfTaxLosses" contextRef="C_20230101to20231231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">17.19</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118015958552_211" name="ifrs-full:TaxRateEffectOfTaxLosses" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">10.97</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect
        of tax rates on overseas earnings</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414175454620" name="ifrs-full:TaxRateEffectOfForeignTaxRates" contextRef="C_20240101to20241231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">6.63</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015958552_37" name="ifrs-full:TaxRateEffectOfForeignTaxRates" contextRef="C_20230101to20231231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">7.82</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015958552_311" name="ifrs-full:TaxRateEffectOfForeignTaxRates" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">7.30</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect
        of Irish income taxable at higher tax rate</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250514170043260" name="trib:EffectOfIrishIncomeTaxableAtHigherTaxRate" contextRef="C_20240101to20241231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">4.09</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118015958552_47" name="trib:EffectOfIrishIncomeTaxableAtHigherTaxRate" contextRef="C_20230101to20231231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.62</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118015958552_411" name="trib:EffectOfIrishIncomeTaxableAtHigherTaxRate" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.93</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments
        in respect of prior years</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414175510061" name="ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" contextRef="C_20240101to20241231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.04</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015958552_57" name="ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" contextRef="C_20230101to20231231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">0.53</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326161835864" name="ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.14</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">R&amp;D
        tax credits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414175616007" name="trib:TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods" contextRef="C_20240101to20241231" unitRef="Pure" scale="-2" decimals="2" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118015958552_67" name="trib:TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods" contextRef="C_20230101to20231231" unitRef="Pure" scale="-2" decimals="2" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015958552_611" name="trib:TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">0.75</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        items (b)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414175634088" name="ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" contextRef="C_20240101to20241231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">7.55</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413100256416" name="ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" contextRef="C_20230101to20231231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.88</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118015958552_711" name="ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">5.07</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective
        tax rate</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250516020212628" name="ifrs-full:AverageEffectiveTaxRate" contextRef="C_20240101to20241231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">1.58</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015958552_97" name="ifrs-full:AverageEffectiveTaxRate" contextRef="C_20230101to20231231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">0.16</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118015958552_911" name="ifrs-full:AverageEffectiveTaxRate" contextRef="C_20220101to20221231" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">0.44</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(a)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No deferred tax asset was recognised because there
        was no reversing deferred tax liability in the same jurisdiction reversing in the same period and insufficient future projected taxable
        income in the same jurisdiction.</span></span></div> </td> </tr>
  <tr>
    <td style="width:28.35pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td> </tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(b)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other items comprise items not chargeable to tax
        and expenses not deductible for tax purposes. In 2022, other items mainly related to the loss on disposal of the exchangeable notes which
        was non-recurring.</span></span></div> </td> </tr>
  </table> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> </div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
distribution of loss before taxes by geographical area was as follows:</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20250512162302133" name="ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413100948940" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17,296</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118035012541" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,922</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118035254632" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,354</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Other</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413101032816" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">315</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118035030790" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">104</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118035036165" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">33</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118034929542" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,119</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118035304150" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">23,901</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118035818764" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">21,393</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413101113616" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">30,730</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118035731555" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">36,927</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118035802269" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">43,780</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
December&#160;31, 2024, the Group had unutilised net operating losses for continuing operations as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512162343604" name="trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414175945265" name="trib:UnutilisedNetOperatingLosses" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">107,093</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118040639298_17" name="trib:UnutilisedNetOperatingLosses" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,851</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118040639298_111" name="trib:UnutilisedNetOperatingLosses" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,731</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Other</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414175959407" name="trib:UnutilisedNetOperatingLosses" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,852</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118040639298_27" name="trib:UnutilisedNetOperatingLosses" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,511</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118040639298_211" name="trib:UnutilisedNetOperatingLosses" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">448</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414180017744" name="trib:UnutilisedNetOperatingLosses" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,866</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118040639298_37" name="trib:UnutilisedNetOperatingLosses" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,840</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240415102747414" name="trib:UnutilisedNetOperatingLosses" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,778</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414180101422" name="trib:UnutilisedNetOperatingLosses" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">182,811</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118040639298_77" name="trib:UnutilisedNetOperatingLosses" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">136,202</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118040639298_711" name="trib:UnutilisedNetOperatingLosses" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75,957</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">144</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">7.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">INCOME
        TAX (EXPENSE)/CREDIT (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
December&#160;31, 2024, the Group had unrecognised deferred tax assets in respect of unused tax losses and unused tax credits as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512162401988" name="trib:DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland &#8211; unused tax losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230414180115238" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,275</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220118043641143_17" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,464</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220118043641143_111" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,489</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Other &#8211; unused tax losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230414180459950" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,777</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220118043641143_27" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,701</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220118043641143_211" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">124</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas
        &#8211; unused tax losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414180514946" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,149</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118043641143_37" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,395</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118043641143_311" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,163</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas
        &#8211; unused tax credits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414180528804" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribUS1Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,702</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118043641143_47" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribUS1Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,806</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118043641143_411" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribUS1Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,658</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unrecognised
        deferred tax asset</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414180538554" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,903</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118043641143_87" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,366</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118043641143_811" name="ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,434</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
accounting policy for deferred tax is to calculate the deferred tax asset that is deemed recoverable, considering all sources for future
taxable profits. The deferred tax assets in the above table have not been recognised due to uncertainty regarding the full utilization
of these losses in the related tax jurisdiction in future periods. Only when it is probable that future profits will be available to utilize
the forward losses or temporary differences is a deferred tax asset recognised. When there is a reversing deferred tax liability in that
jurisdiction that reverses in the same period, the deferred tax asset is restricted so that it equals the reversing deferred tax liability.</span></span></div>
</div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="F20220421211806147_0" name="ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span>8<span style="font-weight:bold">.</span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS</span></span></div> </td> </tr>
  </table> </div> </div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
April 2023, the Company announced the sale of its Fitzgerald Industries life sciences supply business, consisting of Benen Trading Ltd
and Fitzgerald Industries International, Inc, to Biosynth for cash proceeds of approximately US$<ix:nonFraction id="Fxbrl_20240415105217717" name="trib:CashProceedsFromDiscontinuedOperations" contextRef="C_20230401to20230430_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">30</ix:nonFraction>
million subject to customary adjustments. The results of Fitzgerald Industries were presented as discontinued operations in the 2023 financial
statements.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
2024, the Company recognised additional costs related to the 2023 disposal of Fitzgerald Industries, following a settlement agreement
with Biosynth that was finalised prior to year-end and formally signed in January 2025. A provision of US$<ix:nonFraction id="Fxbrl_20250512214626001" name="ifrs-full:CurrentProvisions" contextRef="C_20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150</ix:nonFraction>,000
was recorded in respect of the full and final settlement of all post-completion claims. In addition, outstanding receivables of US$<ix:nonFraction id="Fxbrl_20250512214644990" name="trib:ReceivablesOutstanding" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">423</ix:nonFraction>,000
from Biosynth relating to completion account adjustments were written off as unrecoverable under the terms of the settlement.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
operating profit for the discontinued operations are summarised as follows:&#160;</span></span>

<p style="margin:0pt">&#160;</p> </div> <ix:nonNumeric id="Fxbrl_20250512214959586" name="trib:DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,&#160;</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414182726687" name="ifrs-full:Revenue" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414182734205" name="ifrs-full:Revenue" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,784</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414182747069" name="ifrs-full:Revenue" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,258</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414182803280_xbrl_20240414182726687" name="ifrs-full:OperatingExpense" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414182803280_xbrl_20240414182734205" name="ifrs-full:OperatingExpense" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,652</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414182803280_xbrl_20240414182747069" name="ifrs-full:OperatingExpense" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,679</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax
        expense (Note 7)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414182810237_xbrl_20240414182726687" name="ifrs-full:TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414182810237_xbrl_20240414182734205" name="ifrs-full:TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414182810237_xbrl_20240414182747069" name="ifrs-full:TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        from operating activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414182812845_xbrl_20240414182726687" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414182812845_xbrl_20240414182734205" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">132</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414182812845_xbrl_20240414182747069" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,577</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Loss)/Gain
        on sale of discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414182814395_xbrl_20240414182726687" name="ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">573</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414182814395_xbrl_20240414182734205" name="ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,718</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414182814395_xbrl_20240414182747069" name="ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Loss)/Profit
        for the year from discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414182816049_xbrl_20240414182726687" name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">573</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414182816049_xbrl_20240414182734205" name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,850</ix:nonFraction></span></span></strong></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414182816049_xbrl_20240414182747069" name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,577</ix:nonFraction></span></span></strong></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">145</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">8.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">(LOSS)/PROFIT
        FOR THE YEAR ON DISCONTINUED OPERATIONS (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
net cashflows generated from discontinued operations are as follows:</span></span>

<p style="margin:0pt">&#160;</p> </div> <ix:nonNumeric id="Fxbrl_20250512215026803" name="trib:DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:middle;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash received from sale
        of the discontinued operations net of transaction costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414183735555" name="trib:CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512215746218" name="trib:CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,935</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash sold as a part of
        discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414183903131" name="trib:CashSoldAsAPartOfDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512215828697" name="trib:CashSoldAsAPartOfDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">775</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash inflow on date of disposal</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414183926320" name="ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512215901146" name="ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,160</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25">

<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The
following amounts relating to the Biosynth transaction were recognised in 2024 as post-disposal adjustments, reflecting the write-off
of receivables and provision for settlement costs:</span></span></p>

<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> <ix:nonNumeric id="Fxbrl_20250512215041070" name="trib:DisclosureOfAssetsAndLiabilitiesDisposedExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets disposed in 2023</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Post
        disposal adjustment</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets disposed/adjusted</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property plant &amp;
        equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414184656191_13" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512220849491" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512221739583" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill and intangible
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414184656191_23" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,123</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512220927596" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512221754859" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,123</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414184656191_33" name="ifrs-full:Inventories" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,160</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512221036946" name="ifrs-full:Inventories" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512221823708" name="ifrs-full:Inventories" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,160</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414184656191_43" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">775</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512221109699" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512221837512" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">775</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other receivables</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414184656191_53" name="ifrs-full:TradeAndOtherCurrentReceivables" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,309</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512221131556" name="ifrs-full:TradeAndOtherCurrentReceivables" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">423</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512221849411" name="ifrs-full:TradeAndOtherCurrentReceivables" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">886</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other payables</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414184656191_63" name="ifrs-full:TradeAndOtherCurrentPayables" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">864</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512221153469" name="ifrs-full:TradeAndOtherCurrentPayables" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512221915402" name="ifrs-full:TradeAndOtherCurrentPayables" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,014</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liabilities</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414184656191_73" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512221212407" name="ifrs-full:LeaseLiabilities" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512221940627" name="ifrs-full:LeaseLiabilities" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current corporation tax</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414184656191_83" name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512221237382" name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512221953708" name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liability</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414184656191_93" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">195</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512221320412" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512222012223" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">195</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Total net assets
        disposed</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414184656191_103" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,303</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512221337583" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">573</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512221410127" name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,730</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
consideration from the sale of Fitzgerald Industries which was receivable as at December 31, 2024 was US$<ix:nonFraction id="Fxbrl_20240422153341118" name="ifrs-full:ConsiderationPaidReceived" contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">Nil</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20250513191550398" name="ifrs-full:ConsiderationPaidReceived" contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">373</ix:nonFraction>,000)
(refer to Note 17).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
(loss)/earnings per ordinary share &#8211; discontinued operations</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
(loss)/earnings per ordinary share for discontinued operations is computed by dividing the profit/ (loss) after taxation on discontinued
operations of US$(<ix:nonFraction id="Fxbrl_20240422153355871" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">573</ix:nonFraction>,000),
(2023: US$<ix:nonFraction id="Fxbrl_20240422153416974" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,850</ix:nonFraction>,000)
(2022: US$<ix:nonFraction id="Fxbrl_20240422153426950" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,577</ix:nonFraction>,000)
for the financial year by the weighted average number of &#8216;A&#8217; ordinary shares in issue as at December&#160;31, 2024, this amounted
to <ix:nonFraction id="Fxbrl_20230413134240945" name="trib:WeightedAverageSharesDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">359,193,482</ix:nonFraction>
shares (2023: <ix:nonFraction id="Fxbrl_20230413134249849" name="trib:WeightedAverageSharesDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">153,099,405</ix:nonFraction>
shares) (2022: <ix:nonFraction id="Fxbrl_20230413134259942" name="trib:WeightedAverageSharesDiscontinuedOperations" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">134,939,327</ix:nonFraction>
shares), see Note 10 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
(loss)/earnings/ per ordinary share &#8211; discontinued operations</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
(loss)/earnings per ordinary share for discontinued operations is computed by dividing the profit/ (loss) after taxation on discontinued
operations of US$(<ix:nonFraction id="Fxbrl_20240422153457086" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">573</ix:nonFraction>,000),
(2023: US$<ix:nonFraction id="Fxbrl_20240422153511309" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,850</ix:nonFraction>,000)
(2022: US$<ix:nonFraction id="Fxbrl_20240422153535549" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,577</ix:nonFraction>,000)
for the financial year by the diluted weighted average number of ordinary shares in issue of <ix:nonFraction id="Fxbrl_20230413134432273" name="trib:AdjustedWeightedAverageSharesDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">404,096,277</ix:nonFraction>
shares (2023: <ix:nonFraction id="Fxbrl_20230413134441089" name="trib:AdjustedWeightedAverageSharesDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">178,016,062</ix:nonFraction>
shares) (2022: <ix:nonFraction id="Fxbrl_20230413134452455" name="trib:AdjustedWeightedAverageSharesDiscontinuedOperations" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">155,498,651</ix:nonFraction>&#160;shares),
see Note 10 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">146</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">8.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">(LOSS)/PROFIT
        FOR THE YEAR ON DISCONTINUED OPERATION (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div> <ix:nonNumeric id="Fxbrl_20250512215111717" name="trib:DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory" contextRef="C_20240101to20241231" continuedAt="F20250512215129366" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        (loss)/earnings per &#8216;A&#8217; share (US Dollars) &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240421193754154_xbrl_20230420133057815" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.00</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240421193754154_20220421211806169_58" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.08</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240421193754154_xbrl_20230413135313895" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.02</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
        (loss)/earnings per &#8216;A&#8217; share (US Dollars) &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240421193804801_xbrl_20220118201529352_20220421211806151_7" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.00</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240421193804801_20220421211806169_59" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.07</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240421193804801_xbrl_20230413135322718" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.02</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">Basic
(loss)/earnings per ADS</span>&#160;<span style="font-style:italic">&#8211; discontinued operations</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
February 2024, the Company changed the ratio of the ADSs representing its &#8216;A&#8217; ordinary shares from one (1) ADS representing
four (4) &#8216;A&#8217; ordinary shares to one (1) ADS representing twenty (20) &#8216;A&#8217; ordinary shares.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
earnings per ADS for discontinued operations is computed by dividing the profit/(loss) after taxation on discontinued operations of US$(<ix:nonFraction id="Fxbrl_20240422153558765" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">573</ix:nonFraction>,000),
(2023: US$<ix:nonFraction id="Fxbrl_20240422153609395" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">12,850</ix:nonFraction>,000)
(2022: US$<ix:nonFraction id="Fxbrl_20240422153620458" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">2,577</ix:nonFraction>,000)
for the financial year by the weighted average number of ADS in issue of <ix:nonFraction id="Fxbrl_20230413134712792" name="trib:WeightedAverageSharesDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">17,959,674</ix:nonFraction>
(2023: <ix:nonFraction id="Fxbrl_20230413134733871" name="trib:WeightedAverageSharesDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">7,654,970</ix:nonFraction>)
(2022: <ix:nonFraction id="Fxbrl_20230413134744343" name="trib:WeightedAverageSharesDiscontinuedOperations" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">6,746,966</ix:nonFraction>),
see Note 10 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
(loss)/earnings per ADS &#8211; discontinued operations</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
earnings per ADS for discontinued operations is computed by dividing the profit/ (loss) after taxation on discontinued operations of US$(<ix:nonFraction id="Fxbrl_20240422153634875" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">573</ix:nonFraction>,000),
(2023: US$<ix:nonFraction id="Fxbrl_20240422153645714" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,850</ix:nonFraction>,000)
(2022: US$<ix:nonFraction id="Fxbrl_20240422153702878" name="ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,577</ix:nonFraction>,000)
for the financial year, by the diluted weighted average number of ADS in issue of <ix:nonFraction id="Fxbrl_20230413134920810" name="trib:AdjustedWeightedAverageSharesDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">20,204,814</ix:nonFraction>
(2023: <ix:nonFraction id="Fxbrl_20230413134930384" name="trib:AdjustedWeightedAverageSharesDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">8,900,803</ix:nonFraction>)
(2022: <ix:nonFraction id="Fxbrl_20230413134939403" name="trib:AdjustedWeightedAverageSharesDiscontinuedOperations" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">7,774,933</ix:nonFraction>),
see Note 10 for further details.</span></span>

<p style="margin:0pt">&#160;</p> </div> <ix:continuation id="F20250512215129366">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        (loss)/earnings per ADS (US Dollars) &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420133057815" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.03</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20220421211806169_58" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.68</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413135313895" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.38</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
        (loss)/earnings per ADS (US Dollars) &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118201529352_20220421211806151_7" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.03</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20220421211806169_59" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.44</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413135322718" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.33</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </ix:continuation>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
flows</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
cash flows attributable to discontinued operations are as follows:</span></span>

<p style="margin:0pt">&#160;</p> </div> <ix:nonNumeric id="Fxbrl_20250512215144835" name="trib:DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        (outflow)/inflow from operating activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20220421211806150_4" name="ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" contextRef="C_20240101to20241231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="F20220421211806151_5" name="ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" contextRef="C_20230101to20231231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">177</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20220421211806170_60" name="ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" contextRef="C_20220101to20221231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,798</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        inflow from investing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240427031301090_20220421211806150_4" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" contextRef="C_20240101to20241231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240427031301090_20220421211806151_5" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" contextRef="C_20230101to20231231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,160</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240427031301090_20220421211806170_60" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" contextRef="C_20220101to20221231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        outflow&#160;from financing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240427031302968_20220421211806150_4" name="ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" contextRef="C_20240101to20241231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240427031302968_20220421211806151_5" name="ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" contextRef="C_20230101to20231231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240427031302968_20220421211806170_60" name="ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" contextRef="C_20220101to20221231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">10,800</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">There
were no cash inflows from discontinued operations during the year ended December 31, 2024.</span></span></div> </div> </div> </div> </div>
</ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">147</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<div>

<div>

<div>

<div>

<div>

<div>

<div> <ix:nonNumeric id="Fxbrl_20220426134520145" name="trib:DisclosureOfLossProfitBeforeTaxExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span><span><span>9.</span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span><span><span>LOSS BEFORE TAX</span></span></span></span></div> </td> </tr>
  </table> </div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:30.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
following amounts were charged / (credited) to the statement of operations:</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20250512160626422" name="trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,
        2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,
        2023</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,
        2022</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Directors&#8217;
        emoluments (including non- executive directors):</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Remuneration</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_23" name="ifrs-full:DirectorsRemunerationExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,454</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_27" name="ifrs-full:DirectorsRemunerationExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,058</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_211" name="ifrs-full:DirectorsRemunerationExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,639</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Pension</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_33" name="trib:DirectorPensionExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_37" name="trib:DirectorPensionExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_311" name="trib:DirectorPensionExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share
        based payments (Note 26)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_43" name="trib:ShareBasedPayments" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">931</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_47" name="trib:ShareBasedPayments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,601</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_411" name="trib:ShareBasedPayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,707</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Auditor&#8217;s
        remuneration</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Audit
        fees</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230426162817545_xbrl_20220114180710749_73" name="ifrs-full:AuditorsRemunerationForTaxServices" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,082</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230426162817545_xbrl_20220114180710749_77" name="ifrs-full:AuditorsRemunerationForTaxServices" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">861</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230426162817545_xbrl_20220114180710749_711" name="ifrs-full:AuditorsRemunerationForTaxServices" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">888</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Tax
        fees</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_73" name="trib:TaxFees" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">175</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_77" name="trib:TaxFees" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">407</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_711" name="trib:TaxFees" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation
        (Note 11) <sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_93" name="trib:DepreciationOnIntangibleAssets" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">675</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_97" name="trib:DepreciationOnIntangibleAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">830</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_911" name="trib:DepreciationOnIntangibleAssets" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,405</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortisation
        (Note 12)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_103" name="trib:AmortisationOnIntangibleAssets" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,190</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_107" name="trib:AmortisationOnIntangibleAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">945</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_1011" name="trib:AmortisationOnIntangibleAssets" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">889</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Loss&#160;on
        the disposal of property, plant and equipment</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220501154520791" name="ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230413095514174" name="ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_1111" name="ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net
        foreign exchange differences</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220114180710749_123" name="trib:NetForeignExchangeGainLoss" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">376</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230413095554140" name="trib:NetForeignExchangeGainLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">336</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220326164438880" name="trib:NetForeignExchangeGainLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,210</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup>
In 2024, US$<ix:nonFraction id="Fxbrl_20250513182751038" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">204</ix:nonFraction>,000
was capitalised to research and development projects (2023: US$<ix:nonFraction id="Fxbrl_20240415110630841" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">Nil</ix:nonFraction>)
(2022: US$<ix:nonFraction id="Fxbrl_20240415110644557" name="ifrs-full:DepreciationAndAmortisationExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">Nil</ix:nonFraction>).</span></span></span></span></div>
</div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation
for discontinued operations for the year ended December 31, 2024 is US$<ix:nonFraction id="Fxbrl_20240412211603984" name="trib:DeprecationForDiscontinuedOperations" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">Nil
</ix:nonFraction>(2023: US$<ix:nonFraction id="Fxbrl_20250513183543859" name="trib:DeprecationForDiscontinuedOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction>,000)
(2022:US$<ix:nonFraction id="Fxbrl_20250513183557442" name="trib:DeprecationForDiscontinuedOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction>,000)</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortisation
for discontinued operations for the year ended December 31, 2024 is US$<ix:nonFraction id="Fxbrl_20240412211915818" name="trib:AmortisationForDiscontinuedOperations" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">Nil
</ix:nonFraction>(2023: US$<ix:nonFraction id="Fxbrl_20250513183627911" name="trib:AmortisationForDiscontinuedOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction>,000)
(2022:US$<ix:nonFraction id="Fxbrl_20250513183636356" name="trib:AmortisationForDiscontinuedOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34</ix:nonFraction>,000).</span></span></span></span></div>
</div> </div> </div> </div> </div> </ix:nonNumeric> </div> </div> </div> </div> </div> </div> </div>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20250512170129689" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <p style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">10.</span></span></p>
        </td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">LOSS PER SHARE</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
loss per ordinary share</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
loss per ordinary share is calculated by dividing the net loss attributable to owners of the parent of US$<ix:nonFraction id="Fxbrl_20250513133527396" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,789</ix:nonFraction>,000
(2023: loss of US$<ix:nonFraction id="Fxbrl_20250513133544787" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,018</ix:nonFraction>,000)
(2022: loss of US$<ix:nonFraction id="Fxbrl_20250513133558307" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,009</ix:nonFraction>,000)
by the weighted average number of &#8216;A&#8217; ordinary shares in issue, net of any Treasury Shares, during the year. Basic loss per
ordinary share from continuing operations is calculated by dividing the loss from continuing operations attributable to owners of the
parent of US$<ix:nonFraction id="Fxbrl_20250513171236813" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,216</ix:nonFraction>,000
(2023: loss of US$<ix:nonFraction id="Fxbrl_20250513171245625" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,868</ix:nonFraction>,000)
(2022: loss of US$<ix:nonFraction id="Fxbrl_20250513171254630" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,586</ix:nonFraction>,000)
by the weighted average number of &#8216;A&#8217; ordinary shares in issue, net of any Treasury Shares, during the year.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
at December&#160;31, 2024, the number of &#8216;A&#8217; ordinary shares for the purposes of the calculation of basic loss per share are
<ix:nonFraction id="Fxbrl_20230414094216646" name="ifrs-full:WeightedAverageShares" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">359,193,482
</ix:nonFraction>shares (2023: <ix:nonFraction id="Fxbrl_20230414094225157" name="ifrs-full:WeightedAverageShares" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">153,099,405
</ix:nonFraction>shares) (2022: <ix:nonFraction id="Fxbrl_20230414094233872" name="ifrs-full:WeightedAverageShares" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">134,939,327
</ix:nonFraction>shares).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">148</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">10.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">LOSS
        PER SHARE (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div> <ix:nonNumeric id="Fxbrl_20250512170805250" name="trib:DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;A&#8217;
        ordinary shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_13" name="ifrs-full:WeightedAverageShares" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">359,193,482</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_17" name="ifrs-full:WeightedAverageShares" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">153,099,405</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_111" name="ifrs-full:WeightedAverageShares" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">134,939,327</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per share denominator</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_33" name="ifrs-full:WeightedAverageShares" contextRef="C_20240101to20241231" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">359,193,482</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_37" name="ifrs-full:WeightedAverageShares" contextRef="C_20230101to20231231" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">153,099,405</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_311" name="ifrs-full:WeightedAverageShares" contextRef="C_20220101to20221231" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">134,939,327</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation
        to weighted average loss per share denominator:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number
        of &#8216;A&#8217; ordinary shares at January&#160;1 (Note 19)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_63" name="trib:NumberOfAOrdinaryWeightedAverageShares" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">165,865,882</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_67" name="trib:NumberOfAOrdinaryWeightedAverageShares" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">164,985,882</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230421011529433" name="trib:NumberOfAOrdinaryWeightedAverageShares" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">96,162,410</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted
        average number of &#8216;A&#8217; ordinary shares issued during the year*</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_73" name="trib:WeightedAverageNumberOfSharesIssued" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">205,883,200</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_77" name="trib:WeightedAverageNumberOfSharesIssued" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">669,123</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_711" name="trib:WeightedAverageNumberOfSharesIssued" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">51,332,517</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted
        average number of treasury shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220115161837833_83" name="trib:WeightedAverageNumberOfTreasuryShares" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal" sign="-">12,555,600</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220115161837833_87" name="trib:WeightedAverageNumberOfTreasuryShares" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal" sign="-">12,555,600</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220115161837833_811" name="trib:WeightedAverageNumberOfTreasuryShares" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal" sign="-">12,555,600</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per share denominator</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_103" name="ifrs-full:WeightedAverageShares" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">359,193,482</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_107" name="ifrs-full:WeightedAverageShares" contextRef="C_20230101to20231231" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">153,099,405</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115161837833_1011" name="ifrs-full:WeightedAverageShares" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">134,939,327</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*The
weighted average number of shares issued during the year is calculated by taking the number of shares issued multiplied by the number
of days in the year each share is in issue, divided by 365 days.</span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
loss per ordinary share</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
loss per ordinary share is calculated by dividing the net loss attributable to owners of the parent by the weighted average number of
&#8216;A&#8217; ordinary shares in issue, net of any Treasury Shares, during the year, plus the weighted average number of &#8216;A&#8217;
ordinary shares that would be issued on the conversion of all the dilutive potential &#8216;A&#8217; ordinary shares into &#8216;A&#8217;
ordinary shares. As the potentially dilutive instruments were anti-dilutive in all periods presented, basic loss per &#8216;A&#8217; ordinary
share and diluted loss per &#8216;A&#8217; ordinary share are equivalent.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following potential &#8216;A&#8217; ordinary shares are anti-dilutive and are therefore excluded from the weighted average number of &#8216;A&#8217;
ordinary shares for the purposes of calculating diluted loss per &#8216;A&#8217; ordinary share.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512170828433" name="trib:DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Potentially
        Dilutive Instruments:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on exercise of options (Note 20)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414113950072" name="trib:IssuableOnExerciseOfOptions" contextRef="C_20240101to20241231" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114222974" name="trib:IssuableOnExerciseOfOptions" contextRef="C_20230101to20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">186,908</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114233156" name="trib:IssuableOnExerciseOfOptions" contextRef="C_20220101to20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">2,752,153</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on exercise of warrants to Perceptive (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114005111" name="trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" contextRef="C_20240101to20241231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">20,173,151</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114253565" name="trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" contextRef="C_20230101to20231231" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114303733" name="trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" contextRef="C_20220101to20221231" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on conversion of Exchangeable notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114019788" name="trib:SharesIssuableOnConversionOfExchangeableNotes" contextRef="C_20240101to20241231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">38,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114322076" name="trib:SharesIssuableOnConversionOfExchangeableNotes" contextRef="C_20230101to20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">38,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114334333" name="trib:SharesIssuableOnConversionOfExchangeableNotes" contextRef="C_20220101to20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,436,463</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on conversion of Convertible notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114052546" name="trib:IssuableOnConversionOfConvertibleNotes" contextRef="C_20240101to20241231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">24,691,358</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114352156" name="trib:IssuableOnConversionOfConvertibleNotes" contextRef="C_20230101to20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">24,691,358</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114402452" name="trib:IssuableOnConversionOfConvertibleNotes" contextRef="C_20220101to20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">16,370,709</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        number of potentially dilutive instruments excluded from the weighted average number of &#8216;A&#8217; ordinary shares in calculating
        dilutive loss per &#8216;A&#8217; ordinary share</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114209545" name="ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented" contextRef="C_20240101to20241231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">44,902,900</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114435165" name="ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented" contextRef="C_20230101to20231231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">24,916,657</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114454084" name="ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented" contextRef="C_20220101to20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">20,559,325</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Of
the &#8216;A&#8217; ordinary shares issuable on exercise of options, <span style="-sec-ix-hidden:Fxbrl_20230414123050603">NIL</span> are
contingently issuable as their issue is contingent upon satisfaction of specified performance conditions in addition to the passage of
time. The conditions governing their exercisability have not been satisfied as at the end of the reporting period.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div> </div>

<div><ix:exclude>

<div>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">149</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">LOSS PER SHARE (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">Loss
per ADS</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
February 2024, the Company changed the ratio of the ADSs representing its &#8216;A&#8217; ordinary shares from one (1) ADS representing
four (4) &#8216;A&#8217; ordinary shares to one (1) ADS representing twenty (20) &#8216;A&#8217; ordinary shares.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
loss per ADS is calculated by dividing the loss attributable to owners of the parent of US$<ix:nonFraction id="Fxbrl_20250513133627779" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,789</ix:nonFraction>,000
(2023: loss of US$<ix:nonFraction id="Fxbrl_20250513133638067" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,018</ix:nonFraction>,000)
(2022: loss of US$<ix:nonFraction id="Fxbrl_20250513133648978" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,009</ix:nonFraction>,000)
by the weighted average number of ADS in issue, net of any Treasury Shares, during the year. Basic loss per ADS from continuing operations
is calculated by dividing the loss of US$<ix:nonFraction id="Fxbrl_20250513171357898" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,216</ix:nonFraction>,000
(2023: loss of US$<ix:nonFraction id="Fxbrl_20250513171408707" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,868</ix:nonFraction>,000)
(2022: loss of US$<ix:nonFraction id="Fxbrl_20250513171417568" name="ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,586</ix:nonFraction>,000)
by the weighted average number of ADS in issue, net of any Treasury Shares, during the year.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
at December&#160;31, 2024, the number of ADS for the purposes of the calculation of basic loss per ADS were <ix:nonFraction id="Fxbrl_20230414105404398" name="ifrs-full:WeightedAverageShares" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">17,959,674
</ix:nonFraction>ADS (2023: <ix:nonFraction id="Fxbrl_20230414105424003" name="ifrs-full:WeightedAverageShares" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">7,654,970
</ix:nonFraction>ADS) (2022: <ix:nonFraction id="Fxbrl_20230414105434386" name="ifrs-full:WeightedAverageShares" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">6,746,966
</ix:nonFraction>ADS).</span></span></div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20250512171149745" name="trib:DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ADS</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115165133370" name="trib:AmericanDepositoryShares" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">17,959,674</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115165144381" name="trib:AmericanDepositoryShares" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">7,654,970</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115165148677" name="trib:AmericanDepositoryShares" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">6,746,966</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per ADS denominator</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115163702535_33" name="ifrs-full:WeightedAverageShares" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">17,959,674</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115163702535_37" name="ifrs-full:WeightedAverageShares" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">7,654,970</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115163702535_311" name="ifrs-full:WeightedAverageShares" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">6,746,966</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation
        to weighted average loss per ADS denominator:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number
        of ADS at January&#160;1 (Note 19)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115165218333" name="trib:NumberOfAmericanDepositorySharesWeightedAverageShares" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">8,293,294</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115165227073" name="trib:NumberOfAmericanDepositorySharesWeightedAverageShares" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">8,249,294</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115165248565" name="trib:NumberOfAmericanDepositorySharesWeightedAverageShares" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">4,808,120</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted
        average number of shares issued during the year*</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115163702535_73" name="trib:WeightedAverageNumberOfSharesIssued" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">10,294,160</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115163702535_77" name="trib:WeightedAverageNumberOfSharesIssued" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">33,456</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115163702535_711" name="trib:WeightedAverageNumberOfSharesIssued" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">2,566,626</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted
        average number of treasury shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220115163702535_83" name="trib:WeightedAverageNumberOfTreasuryShares" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal" sign="-">627,780</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220115163702535_87" name="trib:WeightedAverageNumberOfTreasuryShares" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal" sign="-">627,780</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220115163702535_811" name="trib:WeightedAverageNumberOfTreasuryShares" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal" sign="-">627,780</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per ADS denominator</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115163702535_103" name="ifrs-full:WeightedAverageShares" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">17,959,674</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115163702535_107" name="ifrs-full:WeightedAverageShares" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">7,654,970</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115163702535_1011" name="ifrs-full:WeightedAverageShares" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="0" decimals="0" format="ixt:num-dot-decimal">6,746,966</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*The
weighted average number of ADSs issued during the year is calculated by taking the number of ADSs issued multiplied by the number of days
in the year each share is in issue, divided by 365 days.</span></span></div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
loss per ADS</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
loss per ADS is calculated by dividing the net loss attributable to owners of the parent by the weighted average number of ADS in issue,
net of any Treasury Shares, during the year, plus the weighted average number of ADS that would be issued on the conversion of all the
dilutive potential ADS into ADS. As the potentially dilutive instruments were anti-dilutive in all periods presented, basic loss per ADS
and diluted earnings per ADS are equivalent.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following potential ADS are anti-dilutive and are therefore excluded from the weighted average number of ADS for the purposes of calculating
dilutive (loss)/earnings per ADS.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">10.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">LOSS
        PER SHARE (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div> <ix:nonNumeric id="Fxbrl_20250512171250243" name="trib:DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Potentially
        Dilutive Instruments:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on exercise of options (Note 20)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115639354_xbrl_20230414113950072" name="trib:IssuableOnExerciseOfOptions" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115639354_xbrl_20230414114222974" name="trib:IssuableOnExerciseOfOptions" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">9,345</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115639354_xbrl_20230414114233156" name="trib:IssuableOnExerciseOfOptions" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">137,608</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on exercise of warrants to Perceptive (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115651914_xbrl_20230414114005111" name="trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,008,658</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115651914_xbrl_20230414114253565" name="trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115651914_xbrl_20230414114303733" name="trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on conversion of Exchangeable notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115705531_xbrl_20230414114019788" name="trib:SharesIssuableOnConversionOfExchangeableNotes" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,920</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115705531_xbrl_20230414114322076" name="trib:SharesIssuableOnConversionOfExchangeableNotes" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,920</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115705531_xbrl_20230414114334333" name="trib:SharesIssuableOnConversionOfExchangeableNotes" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">71,823</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on conversion of Convertible notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115717187_xbrl_20230414114052546" name="trib:IssuableOnConversionOfConvertibleNotes" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,234,568</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115717187_xbrl_20230414114352156" name="trib:IssuableOnConversionOfConvertibleNotes" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,234,568</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115717187_xbrl_20230414114402452" name="trib:IssuableOnConversionOfConvertibleNotes" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">818,535</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        number of potentially dilutive instruments excluded from the weighted average number of ADS in calculating dilutive loss per ADS</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115726330_xbrl_20230414114209545" name="ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">2,245,146</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115726330_xbrl_20230414114435165" name="ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,245,833</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414115726330_xbrl_20230414114454084" name="ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,027,966</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Of
the ADS issuable on exercise of options, <span style="-sec-ix-hidden:Fxbrl_20250512171325106">NIL</span> are contingently issuable as
their issue is contingent upon satisfaction of specified performance conditions in addition to the passage of time. The conditions governing
their exercisability have not been satisfied as at the end of the reporting period.</span></span></div> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">151</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <ix:nonNumeric id="Fxbrl_20250512180233902" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PROPERTY, PLANT AND EQUIPMENT</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:27pt"> <ix:nonNumeric id="Fxbrl_20250512180513767" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="text-align:right;line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Land
        &amp; Buildings</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold
        Improvements</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer
        &amp; Office Equipment</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Plant
        &amp; Equipment,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vehicles</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_23" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,682</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_27" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,701</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_211" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,540</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_215" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,683</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_219" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,606</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_43" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_47" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">87</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_411" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">173</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_415" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">596</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_419" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">911</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_53" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">480</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_57" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_511" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">115</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_515" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">220</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_519" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">855</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reallocations/
        reclassifications</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413111252947_xbrl_20230413101850876_xbrl_20220118111332977_53" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413111252947_xbrl_20230413101850876_xbrl_20220118111332977_57" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413111252947_xbrl_20230413101850876_xbrl_20220118111332977_511" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413111252947_xbrl_20230413101850876_xbrl_20220118111332977_515" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413111252947_xbrl_20230413101850876_xbrl_20220118111332977_519" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange
        adjustments</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_63" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326233740292" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326233958110" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_615" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">370</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_619" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">407</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_83" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,268</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_87" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,760</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_811" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,612</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_815" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,429</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_819" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,069</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_103" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,268</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_107" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,760</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_1011" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,612</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_1015" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,429</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_1019" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,069</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions<sup style="vertical-align:text-top;line-height:1;font-size:smaller">#</sup></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_113" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">752</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_117" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_1111" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_1115" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">478</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_1119" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,380</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions
        through acquisition (Note 29)</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220327204415354" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_127" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_1211" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">582</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_1215" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">740</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_1219" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,373</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181607742_xbrl_20220118111332977_53" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181607742_xbrl_20220118111332977_57" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512181607742_xbrl_20220118111332977_511" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512181607742_xbrl_20220118111332977_515" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512181607742_xbrl_20220118111332977_519" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Remeasurement
        of ROU assets</span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515104758943_xbrl_20250512181607742_xbrl_20220118111332977_53" name="ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,764</ix:nonFraction></span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515104758943_xbrl_20250512181607742_xbrl_20220118111332977_57" name="ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515104758943_xbrl_20250512181607742_xbrl_20220118111332977_511" name="ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515104758943_xbrl_20250512181607742_xbrl_20220118111332977_515" name="ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515104758943_xbrl_20250512181607742_xbrl_20220118111332977_519" name="ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,764</ix:nonFraction></span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reallocations/
        reclassifications</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413101850876_xbrl_20220118111332977_53" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413101850876_xbrl_20220118111332977_57" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413101850876_xbrl_20220118111332977_511" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413101850876_xbrl_20220118111332977_515" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413101850876_xbrl_20220118111332977_519" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_153" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,784</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_157" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,811</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_1511" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,344</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_1515" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,686</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_1519" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">70,625</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Accumulated
        depreciation and Impairment losses</span></span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_183" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">21,885</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_187" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,284</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_1811" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,178</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_1815" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,577</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_1819" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">59,924</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
        for the year (Note 9)</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_193" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">272</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_197" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_1911" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_1915" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">317</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_1919" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">831</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_223" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">385</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_227" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">38</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_2211" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">115</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_2215" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">213</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_2219" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">751</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        losses</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_213" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,246</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_217" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">339</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2111" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2115" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,086</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2119" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,772</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange
        adjustments</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_243" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413102634836" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">20</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413102737381" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2415" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">370</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2419" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_263" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,022</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_267" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,669</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2611" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,349</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2615" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">33,137</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2619" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">64,177</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_283" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,022</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_287" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,669</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2811" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,349</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2815" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">33,137</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2819" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">64,177</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
        for the year (Note 9)</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_293" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">325</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_297" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2911" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">283</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2915" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_2919" name="ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">675</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_313" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_317" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_3111" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_3115" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_3119" name="trib:DisposalsOrRetirementsPropertyAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        losses*</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326182655798_xbrl_20220118111332977_213" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">410</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326182655798_xbrl_20220118111332977_217" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326182655798_xbrl_20220118111332977_2111" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326182655798_xbrl_20220118111332977_2115" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">477</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326182655798_xbrl_20220118111332977_2119" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">968</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reallocations/
        reclassifications</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180732415_xbrl_20230413101850876_xbrl_20220118111332977_53" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180732415_xbrl_20230413101850876_xbrl_20220118111332977_57" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180732415_xbrl_20230413101850876_xbrl_20220118111332977_511" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512180732415_xbrl_20230413101850876_xbrl_20220118111332977_515" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">179</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512180732415_xbrl_20230413101850876_xbrl_20220118111332977_519" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">179</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_343" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,757</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_347" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,728</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_3411" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,717</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_3415" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">33,802</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118111332977_3419" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">66,004</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        amounts</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_373" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,027</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_377" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_3711" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">627</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_3715" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,884</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_3719" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,621</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_393" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">246</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_397" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">91</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_3911" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">263</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_3915" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,292</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118111332977_3919" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,892</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table> </div> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
assets of the Group are pledged as security for the senior secured term loan from Perceptive Advisors.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><sup style="font-weight:bold;vertical-align:text-top;line-height:1;font-size:smaller">#&#160;
</sup>Additions include US$<ix:nonFraction id="Fxbrl_20250512190321774" name="ifrs-full:AdditionsToRightofuseAssets" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.9</ix:nonFraction>
million additions in ROU assets.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">*&#160;&#160;</span>The
total impairment charge recognised against Property, Plant &amp; Equipment during the year was US$<ix:nonFraction id="Fxbrl_20250512190303975" name="trib:ImpairmentChargePropertyPlantEquipment" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.0</ix:nonFraction>
million. Of this, US$<ix:nonFraction id="Fxbrl_20250512190357910" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction>
million, corresponding to the impairment loss allocated to property, plant and equipment as described above, is presented within &#8216;Impairment
Charges&#8217; in the Consolidated Statement of Operations. The remaining US$<ix:nonFraction id="Fxbrl_20250512190422567" name="trib:RestructuringCost" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction>
million is included within &#8216;Restructuring Costs&#8217; (see Note 5).</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Remeasurement
of ROU assets during the year includes adjustments arising from rent reviews on leased properties in Bray, Ireland. These relate to leases
with a related party, Mr. O&#8217;Caoimh, and reflect revised future lease payments following independent valuations. Further details
are provided in Note 26 &#8211; Related Party Transactions</span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">152</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PROPERTY, PLANT AND EQUIPMENT (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-use
assets</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additional
information on the right-of-use assets by class of assets is as follows:</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20250512181900446" name="trib:ScheduleOfAdditionalInformationOnRightOfUseAssets" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><em><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Carrying
        amount At December 31, 2024</span></em></p> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation
        Charge Year ended December 31, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        Charge Year ended December 31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101120273_33" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,126</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118101120273_37" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">325</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118101120273_311" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">356</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101120273_43" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118101120273_47" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">56</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118101120273_411" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">43</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:64%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101120273_73" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,198</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118101120273_77" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">381</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118101120273_711" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">399</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        amount At December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation
        Charge Year ended December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        Charge Year ended December 31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101611093_xbrl_20220118101120273_33" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">229</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118101611093_xbrl_20220118101120273_37" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">196</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118101611093_xbrl_20220118101120273_311" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,930</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101648913_xbrl_20220118101120273_43" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">166</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118101648913_xbrl_20220118101120273_47" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">51</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101648913_xbrl_20220118101120273_411" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Plant and Equipment,
        vehicles</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326185023005_xbrl_20220118101120273_53" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326185023005_xbrl_20220118101120273_57" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">26</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326185023005_xbrl_20220118101120273_511" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">86</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101741171_xbrl_20220118101120273_73" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">395</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118101741171_xbrl_20220118101120273_77" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">273</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118101741171_xbrl_20220118101120273_711" name="trib:RightOfUseAssetsIncludingDepreciationAndImpairment" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,016</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
from sub-letting right-of-use buildings amounted to US$<ix:nonFraction id="Fxbrl_20240413112539513" name="ifrs-full:IncomeFromSubleasingRightofuseAssets" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="USD" scale="0" decimals="0" format="ixt-sec:numwordsen">nil</ix:nonFraction>
in the year ended December 31, 2024 (2023: US$<ix:nonFraction id="Fxbrl_20240413112550927" name="ifrs-full:IncomeFromSubleasingRightofuseAssets" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">3,000</ix:nonFraction>).</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20250512181933789" name="trib:ScheduleOfIncomeFromSubLettingRightOfUseBuildings" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-Use
        assets at 31 December 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Right-of-Use leased assets</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range
        of remaining term in years</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average
        remaining lease term (years)</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Leases with extension options</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Leases with options to purchase</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of leases with variable payments linked to index</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of leases with termination options</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Building</span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101933618_13" name="trib:NumberOfRightOfUseLeasedAssets" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="Pure" scale="0" decimals="0" format="ixt:num-dot-decimal">10</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20250513174813942" name="trib:RemainingTermInYears" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" format="ixt-sec:duryear">0</ix:nonNumeric>
        to <ix:nonNumeric id="Fxbrl_20250513174826581" name="trib:RemainingTermInYears" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" format="ixt-sec:duryear">9</ix:nonNumeric></span></span></p>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230420114918775" name="trib:AverageRemainingLeaseTermYears" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" format="ixt-sec:duryear">3</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101933618_112" name="trib:NumberOfLeasesWithExtensionOptions" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="Pure" scale="0" decimals="0" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101933618_116" name="trib:NumberOfLeasesWithOptionsToPurchase" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101933618_120" name="trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101933618_124" name="trib:NumberOfLeasesWithTerminationOptions" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vehicle</span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101933618_23" name="trib:NumberOfRightOfUseLeasedAssets" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember" unitRef="Pure" scale="0" decimals="0" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230420114807706" name="trib:RemainingTermInYears" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" format="ixt-sec:duryear">0</ix:nonNumeric>
        to <ix:nonNumeric id="Fxbrl_20230420114815219" name="trib:RemainingTermInYears" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" format="ixt-sec:duryear">2</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230420114935547" name="trib:AverageRemainingLeaseTermYears" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember" format="ixt-sec:duryear">1</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101933618_212" name="trib:NumberOfLeasesWithExtensionOptions" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101933618_216" name="trib:NumberOfLeasesWithOptionsToPurchase" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember" unitRef="Pure" scale="0" decimals="0" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101933618_220" name="trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101933618_224" name="trib:NumberOfLeasesWithTerminationOptions" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember" unitRef="Pure" scale="0" decimals="0" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">I.T. and office equipment</span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101933618_33" name="trib:NumberOfRightOfUseLeasedAssets" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember" unitRef="Pure" scale="0" decimals="0" format="ixt:num-dot-decimal">6</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230420114833243" name="trib:RemainingTermInYears" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" format="ixt-sec:duryear">2</ix:nonNumeric>
        to <ix:nonNumeric id="Fxbrl_20250513181642958" name="trib:RemainingTermInYears" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230420114947533" name="trib:AverageRemainingLeaseTermYears" contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember" format="ixt-sec:duryear">3</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101933618_312" name="trib:NumberOfLeasesWithExtensionOptions" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220422052805353" name="trib:NumberOfLeasesWithOptionsToPurchase" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220422052817057" name="trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118101933618_324" name="trib:NumberOfLeasesWithTerminationOptions" contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-Use
        assets at 31 December 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Right-of-Use leased assets</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range
        of remaining term in years</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average
        remaining lease term (years)</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Leases with extension options</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Leases with options to purchase</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of leases with variable payments linked to index</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of leases with termination options</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Building</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118102816393_xbrl_20220118101933618_13" name="trib:NumberOfRightOfUseLeasedAssets" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="Pure" scale="0" decimals="0" format="ixt:num-dot-decimal">7</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220118103055176" name="trib:RemainingTermInYears" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" format="ixt-sec:duryear">1</ix:nonNumeric>
        to <ix:nonNumeric id="Fxbrl_20220118103110614" name="trib:RemainingTermInYears" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" format="ixt-sec:duryear">10</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220118102816393_xbrl_20220118101933618_18" name="trib:AverageRemainingLeaseTermYears" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118102816393_xbrl_20220118101933618_112" name="trib:NumberOfLeasesWithExtensionOptions" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="Pure" scale="0" decimals="0" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118102816393_xbrl_20220118101933618_116" name="trib:NumberOfLeasesWithOptionsToPurchase" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118102816393_xbrl_20220118101933618_120" name="trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118102816393_xbrl_20220118101933618_124" name="trib:NumberOfLeasesWithTerminationOptions" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vehicle</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118102816423_xbrl_20220118101933618_23" name="trib:NumberOfRightOfUseLeasedAssets" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember" unitRef="Pure" scale="0" decimals="0" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220118103121160" name="trib:RemainingTermInYears" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" format="ixt-sec:duryear">1</ix:nonNumeric>
        to <ix:nonNumeric id="Fxbrl_20220118103130952" name="trib:RemainingTermInYears" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" format="ixt-sec:duryear">3</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220118102816423_xbrl_20220118101933618_28" name="trib:AverageRemainingLeaseTermYears" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember" format="ixt-sec:duryear">2</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118102816423_xbrl_20220118101933618_212" name="trib:NumberOfLeasesWithExtensionOptions" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118102816423_xbrl_20220118101933618_216" name="trib:NumberOfLeasesWithOptionsToPurchase" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember" unitRef="Pure" scale="0" decimals="0" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118102816423_xbrl_20220118101933618_220" name="trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118102816423_xbrl_20220118101933618_224" name="trib:NumberOfLeasesWithTerminationOptions" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember" unitRef="Pure" scale="0" decimals="0" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="margin-right:29.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">I.T.
        and office equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413113153304_xbrl_20220118101933618_33" name="trib:NumberOfRightOfUseLeasedAssets" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember" unitRef="Pure" scale="0" decimals="0" format="ixt:num-dot-decimal">5</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413113153304_xbrl_20230420114833243" name="trib:RemainingTermInYears" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember" format="ixt-sec:duryear">3</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413113153304_xbrl_20230420114947533" name="trib:AverageRemainingLeaseTermYears" contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember" format="ixt-sec:duryear">3</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413113153304_xbrl_20220118101933618_312" name="trib:NumberOfLeasesWithExtensionOptions" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413113153304_xbrl_20220422052805353" name="trib:NumberOfLeasesWithOptionsToPurchase" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413113153304_xbrl_20220422052817057" name="trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413113153304_xbrl_20220118101933618_324" name="trib:NumberOfLeasesWithTerminationOptions" contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember" unitRef="Pure" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </ix:nonNumeric>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<div style="text-align:justify;margin-left:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
details of the impairment review are described in Note 12. When an impairment loss is identified in a cash-generating unit, it must be
first allocated to reduce the carrying amount of any goodwill allocated to the cash-generating unit and then to the other assets of the
unit pro rata on the basis of the carrying amount of each asset in the unit. In this manner, an impairment loss of US$<ix:nonFraction id="Fxbrl_20220426150404839" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction>
million was allocated to property, plant and equipment as at December 31, 2024 (2023: US$<ix:nonFraction id="Fxbrl_20220426150413141" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" contextRef="C_20230101to20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.8</ix:nonFraction>
million). The recoverable amount of property, plant and equipment was determined to be the value in use of each cash-generating unit.</span></span></div>
</div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">153</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div>

<div>

<div>

<div>

<div>

<div> <ix:nonNumeric id="Fxbrl_20220422105749322" name="ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GOODWILL
        AND INTANGIBLE ASSETS</span></span></div> </td> </tr>
  </table>

<div>&#160;</div>

<div>

<div>

<div> <ix:nonNumeric id="Fxbrl_20240414170427820" name="ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Development</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">costs</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Patents
        and</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">licenses</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Technology</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">based
        intangibles</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_23" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">79,182</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_27" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">125,584</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_211" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,729</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515110659974" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_215" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,580</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_219" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">247,075</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513093549850" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_37" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,758</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_311" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111236292" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_315" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">110</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_319" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,887</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250513093615241_xbrl_20250513093549850" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,591</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513093615241_xbrl_20220118142015527_37" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513093615241_xbrl_20220118142015527_311" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111307276" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250513093615241_xbrl_20220118142015527_315" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,488</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250513093615241_xbrl_20220118142015527_319" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,079</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reclassifications</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513093755281_xbrl_20250513093615241_xbrl_20250513093549850" name="trib:ReclassificationGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">54</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513093755281_xbrl_20250513093615241_xbrl_20220118142015527_37" name="trib:ReclassificationGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250513093755281_xbrl_20250513093615241_xbrl_20220118142015527_311" name="trib:ReclassificationGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">54</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111320991" name="trib:ReclassificationGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513093755281_xbrl_20250513093615241_xbrl_20220118142015527_315" name="trib:ReclassificationGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513093755281_xbrl_20250513093615241_xbrl_20220118142015527_319" name="trib:ReclassificationGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange
        adjustments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_53" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_57" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_511" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111341051" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_515" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_519" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_73" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,645</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_77" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">127,365</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_711" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,694</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111358707" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_715" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,202</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_719" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">221,906</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_93" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,645</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_97" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">127,365</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_911" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,694</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111524394" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_915" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,202</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_919" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">221,906</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230426172539603" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_107" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,582</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_1011" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111536651" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_1015" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,280</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_1019" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,863</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions
        through acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513094253273_xbrl_20230426172539603" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,839</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513094253273_xbrl_20220118142015527_107" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">122</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513094253273_xbrl_20220118142015527_1011" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111600355" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,105</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513094253273_xbrl_20220118142015527_1015" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513094253273_xbrl_20220118142015527_1019" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,066</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326184407079_xbrl_20220118142015527_33" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326184407079_xbrl_20220118142015527_37" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">70</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326184407079_xbrl_20220118142015527_311" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111617442" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220326184407079_xbrl_20220118142015527_315" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326184407079_xbrl_20220118142015527_319" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">70</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_153" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">80,484</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_157" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">135,999</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_1511" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,695</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111634739" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,105</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_1515" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,482</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_1519" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">259,765</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Accumulated
        amortisation and Impairment losses</span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_263" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">66,645</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_267" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">108,576</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_2611" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,570</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111709362" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_2615" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">28,015</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_2619" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">211,806</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
        for the year (Note 9)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513094412364" name="ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_197" name="ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">753</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_1911" name="ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111727627" name="ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_1915" name="ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">223</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_1919" name="ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">946</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513094455125_xbrl_20230414114552500" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513094455125_xbrl_20220118142015527_217" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513094455125_xbrl_20230414115055092" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111751962" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513094455125_xbrl_20220118142015527_2115" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,956</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513094455125_xbrl_20220118142015527_2119" name="trib:DisposalsGoodwillAndIntangibleAssets" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,956</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        losses (Note 5)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414114552500" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_217" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,926</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414115055092" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111807897" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_2115" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,898</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_2119" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,833</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange
        adjustments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_223" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_227" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_2211" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111824170" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_2215" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_2219" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_243" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">66,645</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_247" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">112,262</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_2411" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,549</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111839898" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_2415" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">18,180</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_2419" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">205,636</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220327201323223" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">66,645</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_187" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">112,262</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_1811" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,549</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111855324" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_1815" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">18,180</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_1819" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">205,636</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
        for the year (Note 9)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240415091749623" name="ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240415091725440" name="ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,190</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_2711" name="ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111919586" name="ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_2715" name="ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_2719" name="ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,190</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        losses (Note 5)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_293" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_297" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,596</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_2911" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515111951090" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_2915" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_2919" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,596</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_323" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">66,645</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_327" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">115,048</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_3211" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,549</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515112015539" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_3215" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">18,180</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118142015527_3219" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">208,422</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        amounts</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_353" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,839</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_357" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,951</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_3511" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">146</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515112034802" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,105</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_3515" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,302</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_3519" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51,343</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_373" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_377" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,103</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_3711" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">145</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515112100698" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_3715" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,022</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118142015527_3719" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,270</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div> </ix:nonNumeric> </div> </div> </div>

<div style="line-height:1.25;clear:both;margin-top:0pt;margin-bottom:0pt">&#160;</div> </div> </div>

<div>

<div>

<div style="text-align:justify;line-height:1.25;font-family:Times New Roman, serif">

<div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
assets of the Group are pledged as security for the senior secured term loan from Perceptive Advisors.</span></span></span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Included
within development costs are projects with a carrying value of US$<ix:nonFraction id="Fxbrl_20220426151023923" name="ifrs-full:PropertyDevelopmentAndProjectManagementExpense" contextRef="C_20240101to20241231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">7,040,000</ix:nonFraction>
which were not amortised in 2024 (2023: US$<ix:nonFraction id="Fxbrl_20220426151031300" name="ifrs-full:PropertyDevelopmentAndProjectManagementExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">1,596,000</ix:nonFraction>)
(2022: US$<ix:nonFraction id="Fxbrl_20230413111818317" name="ifrs-full:PropertyDevelopmentAndProjectManagementExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">6,982,000</ix:nonFraction>).
These development costs are not being amortised as the projects to which the costs relate were not fully complete at the end of the financial
year. As at December&#160;31, 2024 these projects are expected to be completed during the period from <ix:nonNumeric id="Fxbrl_20220426151049084" name="ifrs-full:ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets" contextRef="C_20240101to20241231">January&#160;1,
2025 to December&#160;31, 2026</ix:nonNumeric> at an expected further cost of approximately US$<ix:nonFraction id="Fxbrl_20220426151059438" name="trib:AdditionalProjectCost" contextRef="C_20240101to20241231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">20</ix:nonFraction>
million to US$<ix:nonFraction id="Fxbrl_20250515141249680" name="trib:AdditionalProjectCost" contextRef="C_20240101to20241231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">25</ix:nonFraction>
million.</span></span></span></span></span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Included
within technology-based intangibles in 2024 is an amount of US$<ix:nonFraction id="Fxbrl_20250515113511004" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.1</ix:nonFraction>
million related to the recognition of acquired technology-based intangible assets from the Waveform, Metabolomics, and Epicapture acquisitions.
These assets were recognised at fair value in accordance with IFRS 3. Further details of these acquisitions are provided in Note 29. As
the acquired technologies were not yet available for use at year-end, no amortisation has been recorded in 2024. Amortisation will commence
when the technologies are brought into commercial use.</span></span></span></span></span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify">&#160;</div> </div> </div>

<div style="line-height:1.25;clear:both">

<div><ix:exclude>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">154</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">12.</span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="font-family:Times New Roman, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">GOODWILL
        AND INTANGIBLE ASSETS&#160;</span><span style="margin-top:0pt;margin-bottom:0pt">(CONTINUED)</span></span></span></div>
        <div style="font-family:Times New Roman, serif;margin-top:0pt;margin-bottom:0pt">&#160;</div> </td> </tr>
  </table> </ix:exclude></div> </div> </div> </div>

<div style="margin-left:30pt;line-height:1.25;font-family:Times New Roman, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following represents the costs incurred during each period presented for each of the principal development projects:</span></span></div>
</div> </div>

<div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240414154518767" name="ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="width:76%;padding-bottom:0px;vertical-align:bottom;white-space:nowrap;border-bottom:2px solid black">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product
        Name</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-style:italic;vertical-align:bottom">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2024</span><br/><span style="font-weight:bold">US</span></span></span><strong>$</strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">&#8217;000</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-style:italic;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;padding-bottom:2px;font-style:italic;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-style:italic;vertical-align:bottom">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2023</span><br/><span style="font-weight:bold">US</span></span></span><strong>$</strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">&#8217;000</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Continuous
        glucose monitoring testing</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513103609678_xbrl_20220117161844810_23" name="trib:PrincipalDevelopmentProjectsCapitalizedCosts" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribContinuousGlucoseMonitoringTestingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,040</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513103609678_xbrl_20220117161844810_27" name="trib:PrincipalDevelopmentProjectsCapitalizedCosts" contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribContinuousGlucoseMonitoringTestingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Premier
        Instruments for A1c and haemoglobinopathies testing</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117161844810_23" name="trib:PrincipalDevelopmentProjectsCapitalizedCosts" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPremierInstrumentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,542</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117161844810_27" name="trib:PrincipalDevelopmentProjectsCapitalizedCosts" contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPremierInstrumentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,669</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Mid-tier
        haemoglobins instrument</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117161844810_73" name="trib:PrincipalDevelopmentProjectsCapitalizedCosts" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribMidTierHaemoglobinsInstrumentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117161844810_77" name="trib:PrincipalDevelopmentProjectsCapitalizedCosts" contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribMidTierHaemoglobinsInstrumentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">HIV
        screening rapid test</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117161844810_13" name="trib:PrincipalDevelopmentProjectsCapitalizedCosts" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribHivOneByTwoRapidTestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117161844810_17" name="trib:PrincipalDevelopmentProjectsCapitalizedCosts" contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribHivOneByTwoRapidTestMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        projects</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117161844810_143" name="trib:PrincipalDevelopmentProjectsCapitalizedCosts" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribOtherProjectsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117161844810_147" name="trib:PrincipalDevelopmentProjectsCapitalizedCosts" contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribOtherProjectsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        capitalised development costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117161844810_153" name="trib:PrincipalDevelopmentProjectsCapitalizedCosts" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,582</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117161844810_157" name="trib:PrincipalDevelopmentProjectsCapitalizedCosts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,758</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </ix:nonNumeric> </div>

<div>

<div>

<div>

<div style="text-indent:30.6pt;line-height:1.25;font-weight:bold;margin-top:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
intangible assets</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
intangible assets consist primarily of software assets, acquired customer and supplier lists, trade names and websites.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year ended December 31, 2024, additions of US$<ix:nonFraction id="Fxbrl_20250513104556987" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.2</ix:nonFraction>
million were recorded in respect of intangible assets acquired through business combinations. These relate to the fair value of identifiable
intangible assets recognised as part of the acquisitions of Waveform, EpiCapture and Metabolomics. The acquired intangible assets comprise
the following:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer relationships</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade names and brand assets</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proprietary technology and software</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Supplier agreements</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Website and digital assets</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair values of these assets were determined as part of the purchase price allocation process in accordance with IFRS 3 Business Combinations.
Refer to Note 29 for further detail on the business combinations.&#160;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortisation</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortisation
is charged to the consolidated statement of operations through the selling, general and administrative expenses line.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
testing for intangibles including goodwill and indefinite lived assets</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill
and other intangibles are subject to impairment testing on a periodic basis and whenever there are indicators of impairment. Specific
assets are assessed for impairment when there are indicators of impairment. If any such indication exists, the Company estimates the recoverable
amount of the asset.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
recoverable amount of seven CGUs is determined based on a value-in-use computation at June 30 and December 31. The value-in-use calculations
use cash flow projections based on the 2025 and 2026 projections for each CGU and a further three years projections using estimated revenue
and cost average growth rates of between <ix:nonFraction id="Fxbrl_20220118123108420" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" contextRef="C_20241231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">2</ix:nonFraction>%
and <ix:nonFraction id="Fxbrl_20220118123116328" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" contextRef="C_20241231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">3</ix:nonFraction>%.
At the end of the five-year forecast period, terminal values for each CGU, based on a long-term growth rate of <ix:nonFraction id="Fxbrl_20220118123249765" name="trib:LongTermGrowthRate" contextRef="C_20240101to20241231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">2</ix:nonFraction>%,
are used in the value-in-use calculations. The value-in-use represents the present value of the future cash flows, including the terminal
value, discounted at a rate appropriate to each CGU. The pre-tax discount rates used range from <ix:nonFraction id="Fxbrl_20220118123424599" name="trib:PreTaxDiscountRates" contextRef="C_20240101to20241231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">17</ix:nonFraction>%
to <ix:nonFraction id="Fxbrl_20220118123433440" name="trib:PreTaxDiscountRates" contextRef="C_20240101to20241231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">28</ix:nonFraction>%
(2023: <ix:nonFraction id="Fxbrl_20220118123516169" name="trib:PreTaxDiscountRates" contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction>%
to <ix:nonFraction id="Fxbrl_20220118123539052" name="trib:PreTaxDiscountRates" contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">22</ix:nonFraction>%).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sources
of estimation uncertainty</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
cash flows have been arrived at taking into account the Group&#8217;s financial position, its recent financial results and cash flow generation
and the nature of the medical diagnostic industry, where product obsolescence can be a feature. However, expected future cash flows are
inherently uncertain and are therefore liable to material change over time. The key assumptions employed in arriving at the estimates
of future cash flows factored into impairment testing are subjective and include projected EBITDA margins, net cash flows, discount rates
used and the duration of the discounted cash flow model. Significant under-performance in any of the Group&#8217;s major CGUs may give
rise to a material impairment which would have a substantial impact on the Group&#8217;s income and equity.</span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">155</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GOODWILL
        AND INTANGIBLE ASSETS (CONTINUED)</span></span></div> </td> </tr>
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  </table> </ix:exclude></div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
tests of cash-generating units</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
impairment tests performed at June 30, 2024 and at December&#160;31, 2024 resulted in an impairment loss being recorded in four CGUs,
Immco Diagnostics Inc, Trinity Biotech Do Brasil, Clark Laboratories and Biopool Inc</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
table below sets forth the impairment loss recorded for each of the CGU&#8217;s, comprising both the specific asset impairment charges
recorded in year ended December 31, 2024 as per the below table and the impairments arising from the CGU impairment tests:&#160;</span></span></div>
</div> </div> </div>

<div>

<div>

<div style="line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240414163646251" name="trib:DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Immco
        Diagnostics Inc.</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414151534979_xbrl_20220117163126674_53" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribImmcoDiagnosticsIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414151534979_xbrl_20220117163126674_57" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribImmcoDiagnosticsIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,331</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Manufacturing Limited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220117163126674_53" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechManufacturingLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">120</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117163126674_57" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechManufacturingLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Do Brasil</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117163126674_33" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechDoBrasilMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">162</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117163126674_37" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechDoBrasilMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">274</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus
        Corp</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414151426852" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribPrimusCorpMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">916</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414151452299" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribPrimusCorpMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Clark
        Laboratories Inc.</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414151021080" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribClarkLaboratoriesIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">130</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413132759618_xbrl_20220117163126674_33" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribClarkLaboratoriesIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Biopool
        US Inc.</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117163126674_43" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribBiopoolUsIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">219</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117163126674_47" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribBiopoolUsIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        impairment loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117163126674_103" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,408</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117163126674_107" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,105</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </ix:nonNumeric> </div>

<div style="margin-left:30pt;line-height:1.25;font-family:Times New Roman, serif;margin-top:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
table below sets forth the breakdown of the impairment loss for each class of asset:</span></span></div>

<div style="line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240414163731177" name="ifrs-full:DisclosureOfIntangibleAssetsMaterialToEntityExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill
        and other intangible assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117163542610_23" name="ifrs-full:RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,596</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117163542610_27" name="ifrs-full:RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,833</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property,
        plant and equipment (see Note 11)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117163542610_33" name="ifrs-full:ChangesInPropertyPlantAndEquipment" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">612</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117163542610_37" name="ifrs-full:ChangesInPropertyPlantAndEquipment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,772</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        assets (see Note 13)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414151934337" name="ifrs-full:ImpairmentLossOnFinancialAssets" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">800</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240430163328793" name="ifrs-full:ImpairmentLossOnFinancialAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        impairment loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117163542610_63" name="ifrs-full:DecreaseThroughImpairmentContractAssets" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,408</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117163542610_67" name="ifrs-full:DecreaseThroughImpairmentContractAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,105</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </ix:nonNumeric> </div>

<div style="line-height:1.25;font-family:'Times New Roman',serif;clear:both">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
impairment tests performed at June 30, 2024 and at December&#160;31, 2024 resulted in an impairment loss being recorded in four CGUs,
Immco Diagnostics Inc, Trinity Biotech Do Brasil, Clark Laboratories Inc, and Biopool Inc.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management
is seeking to implement profit improvement initiatives across these entities, however the values in use of these CGUs at June 30, 2024
and December 31, 2024, defined as the present value of the future projected cash flows, were below the value of the carrying amount of
their assets, other than inventories, accounts receivable, cash and cash equivalents and deferred tax assets.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Included
within the impairment for Trinity Biotech Manufacturing Limited was the reversal of a previously recognised financial asset impairment
of US$<ix:nonFraction id="Fxbrl_20240414165633029" name="ifrs-full:ImpairmentLossOnFinancialAssets" contextRef="C_20230601to20230630" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction>
million, refer to Note 13 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Specific
asset impairment charges in year ended December 31, 2024</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
the year ended December 31, 2024, two internally developed intangible assets were fully impaired, and certain plant items in our Bray
production facility and the right-of-use asset associated with the Kansas production facility were both fully impaired as a result of
restructuring activities. These impairments are shown in the table below. There were no specific asset impairment charges in the year
ended December 31, 2023.</span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25;font-family:'Times New Roman', serif">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">156</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GOODWILL
        AND INTANGIBLE ASSETS (CONTINUED)</span></span></div> </td> </tr>
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  </table> </ix:exclude></div>

<div> <ix:nonNumeric id="Fxbrl_20240414164635863" name="trib:DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;width:43%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asset
        name</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Entity</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">T10 HPLC Analyzer</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity Biotech Manufacturing
        Ltd</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513113538757" name="ifrs-full:IntangibleAssetsUnderDevelopment" contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribT10HplcAnalyzerMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">916</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Syphilis Point-of-Care</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity Biotech Manufacturing
        Ltd</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513113542874" name="ifrs-full:IntangibleAssetsUnderDevelopment" contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribSyphilisPointOfCareMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">680</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinscreen plant &amp;
        equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity Biotech Manufacturing
        Ltd</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513113545569" name="ifrs-full:IntangibleAssetsUnderDevelopment" contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribTrinscreenPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">223</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Kansas right-of-use asset</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus Corp.</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513113549298" name="ifrs-full:IntangibleAssetsUnderDevelopment" contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribKansasRightOfUseAssetMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">133</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413155949179" name="ifrs-full:IntangibleAssetsUnderDevelopment" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,952</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </ix:nonNumeric> </div>

<div style="line-height:1.25;clear:both;margin-top:0pt;margin-bottom:0pt">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
T10 HPLC Analyzer project was an internally developed HPLC analyser designed for mid-volume haemoglobin testing laboratories, with the
Chinese market identified as a key commercial opportunity. Although the project achieved technical feasibility and early market validation,
recent developments in global trade relations, particularly increasing tensions between the United States and China, have created significant
uncertainty around market access and the ability to generate sufficient future sales. While the Company continues to pursue a licensing
arrangement with a local Chinese partner, this is not expected to generate adequate economic returns to support the carrying value of
the asset. As a result, the Company has fully impaired the related intangible asset and recognised an impairment charge of US$<ix:nonFraction id="Fxbrl_20230413163947199" name="trib:IntangibleAssetsUnderDevelopmentImpairmentCharge" contextRef="C_20240101to20241231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">916,000</ix:nonFraction>.
This was recorded in the Primus Corp. entity.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Syphilis Point of Care project is an internally developed lateral flow assay intended for the global syphilis and HIV/syphilis dual testing
markets. Although the project demonstrated technical feasibility prior to 2020, the suspension of development activities during the COVID-19
pandemic and subsequent changes in manufacturing strategy have introduced additional uncertainty around technical completion, regulatory
approval timelines, and cost to completion. As a result of this reassessment, and in light of the need for further development work before
the product can be commercialised, the Group have fully impaired the project and recorded an impairment charge of US$<ix:nonFraction id="Fxbrl_20250513190748534" name="trib:IntangibleAssetsUnderDevelopmentImpairmentCharge" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribSyphilisPointOfCareMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">680,000</ix:nonFraction>.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinscreen,
one of the Group&#8217;s HIV screening products, was manufactured at Trinity Biotech Manufacturing Ltd in 2024. In line with the planned
transfer of Point-of-Care/HIV product manufacturing to a contract manufacturing partner by Q2 2025, certain plant and equipment at Trinity
Biotech Manufacturing Limited were assessed as having limited future utility. An impairment charge of US$<ix:nonFraction id="Fxbrl_20250513114251185" name="trib:IntangibleAssetsUnderDevelopmentImpairmentCharge" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribTrinscreenPlantAndEquipmentMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">223,000</ix:nonFraction>
was recognised to reflect the revised recoverable amount. This has been included within &#8216;Selling, general and administrative expenses
&#8211; Restructuring costs&#8217;. See also Note 11.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Kansas City facility, operated by Primus Corporation, previously supported the manufacture and R&amp;D of the Group&#8217;s haemoglobin
product range. At year-end, the Group assessed that the associated right-of-use asset no longer has future economic benefit, and a full
impairment charge of US$<ix:nonFraction id="Fxbrl_20250513114305786" name="trib:IntangibleAssetsUnderDevelopmentImpairmentCharge" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribKansasRightOfUseAssetMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">133,000</ix:nonFraction>
was recognized within &#8216;Selling, general and administrative expenses &#8211; Restructuring costs&#8217;. See also Note 11.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
value-in-use calculations for CGUs are subject to significant estimation, uncertainty and accounting judgements and the following sensitivity
analysis has been performed:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the event that there was a reduction of <ix:nonFraction id="Fxbrl_20220426152527780" name="ifrs-full:ActuarialAssumptionOfDiscountRates" contextRef="C_20241231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction>%
        in the assumed level of future growth in revenue growth rate, which would represent a reasonably likely range of outcomes, there would
        be no additional impairment loss recorded at December&#160;31, 2024.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the event there was a <ix:nonFraction id="Fxbrl_20230413151815632" name="trib:ActuarialAssumptionOfDiscountRatePercentage" contextRef="C_20240101to20241231" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction>%
        increase in the discount rate used to calculate the potential impairment of the carrying values, which would represent a reasonably likely
        range of outcomes, there would be no additional impairment loss recorded at December&#160;31, 2024.</span></span></div> </td> </tr>
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td> </tr>
  </table> </div> </div>

<div style="line-height:1.25;clear:both">

<div><ix:exclude>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">157</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">12.</span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:Times New Roman, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">GOODWILL AND INTANGIBLE
        ASSETS (CONTINUED)</span></div> </td> </tr>
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  </table> </ix:exclude></div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Significant
Goodwill and Intangible Assets with Indefinite Useful Lives</span></span></div>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Following
the disposal of Fitzgerald Industries during 2023, the carrying value of goodwill was US$nil as at December 31, 2023. During 2024, goodwill
was recognised in connection with the acquisitions of Waveform Technologies' CGM assets, EpiCapture, and Metabolomics. The carrying value
of goodwill as at December 31, 2024 was US$<ix:nonFraction id="Fxbrl_20250513133740924" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribWaveformTechnologiesIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,829</ix:nonFraction>,000.
The CGUs for which goodwill is considered significant from a Group perspective, and the additional disclosures required for these CGUs,
are set out below.</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify">&#160;</div> </div> <ix:nonNumeric id="Fxbrl_20250513143021538" name="ifrs-full:DisclosureOfGoodwillExplanatory" contextRef="C_20240101to20241231" continuedAt="F20250513143201093" escape="true">

<div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Goodwill
arising from the purchase of CGM assets from Waveform Technologies</span></span></span></div> </div>

<div style="line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying amount of goodwill
        (US$&#8217;000)</span></span></div> </td>
    <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220422105350049_13" name="trib:CarryingAmountOfGoodwill" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribWaveformTechnologiesIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,403</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discount rate applied
        (real pre-tax)</span></span></div> </td>
    <td style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220422105350049_23" name="ifrs-full:TaxRateEffectOfImpairmentOfGoodwill" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribWaveformTechnologiesIncMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">18.6</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap">%</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">% EBITDA would need to
        decrease for an impairment to arise</span></span></div> </td>
    <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220422105350049_43" name="trib:EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribWaveformTechnologiesIncMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">56.51</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term growth rate</span></span></div>
        </td>
    <td style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220426183912017" name="trib:LongTermGrowthRate" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribWaveformTechnologiesIncMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  </table> </div> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Waveform CGM CGU includes proprietary continuous glucose monitoring (CGM) technology and related assets acquired from Waveform Technologies
in January 2024. The value-in-use was determined using a discounted cash flow model based on seven years of forecast cash flows, reflecting
the expected development and commercialisation trajectory of the technology, followed by a terminal value using a <ix:nonFraction id="Fxbrl_20250513144045624" name="trib:LongTermGrowthRate" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribWaveformTechnologiesIncMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">2</ix:nonFraction>%
long-term growth rate. The pre-tax discount rate of <ix:nonFraction id="Fxbrl_20250513144056867" name="trib:PreTaxDiscountRates" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribWaveformTechnologiesIncMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">26</ix:nonFraction>%
reflects the high-risk, early-stage nature of the opportunity and incorporates market-based risk adjustments.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
assumptions and estimates used are specific to this CGU and were derived from a combination of internal forecasts, external market data,
and management&#8217;s expectations regarding development timelines, regulatory approvals, and commercial potential.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No
impairment loss was recognised for this CGU in 2024. Management concluded that no reasonably possible change in key assumptions would
lead to the carrying amount exceeding the recoverable amount.</span></span></div>

<div style="line-height:1.25">&#160;</div> <ix:continuation id="F20250513143201093">

<div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Goodwill
arising from the acquisition of EpiCapture Limited</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying amount of goodwill
        (US$&#8217;000)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513142734860" name="trib:CarryingAmountOfGoodwill" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,420</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discount rate applied
        (real pre-tax)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513142801220" name="ifrs-full:TaxRateEffectOfImpairmentOfGoodwill" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribEpiCaptureLimitedMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">21.9</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">% EBITDA would need to
        decrease for an impairment to arise</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513142814660" name="trib:EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribEpiCaptureLimitedMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">84.35</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term growth rate</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513142838588" name="trib:LongTermGrowthRate" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribEpiCaptureLimitedMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  </table> </div> </div> </ix:continuation>

<div style="margin-left:36pt">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
EpiCapture CGU includes oncology diagnostics technology and associated intellectual property acquired in 2024. The value-in-use was determined
using a discounted cash flow model incorporating probability-weighted scenarios reflecting the early-stage nature of the development pipeline,
projected regulatory milestones, and anticipated commercialisation timelines. The model included ten years of forecast cash flows followed
by a terminal value using a <ix:nonFraction id="Fxbrl_20250513120239237" name="trib:LongTermGrowthRate" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribEpiCaptureLimitedMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.0</ix:nonFraction>%
long-term growth rate. The pre-tax discount rate of <ix:nonFraction id="Fxbrl_20250513120049866" name="trib:PreTaxDiscountRates" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribEpiCaptureLimitedMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">29.4</ix:nonFraction>%
reflects the significant risk and uncertainty associated with product development, clinical validation, and future market access.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
assumptions and estimates used are specific to this CGU and were developed based on internal forecasts, external market data, and management&#8217;s
expectations regarding product viability and commercial uptake.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No
impairment loss was recognised for this CGU in 2024. Management concluded that no reasonably possible change in key assumptions would
lead to the carrying amount exceeding the recoverable amount.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div> </div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">158</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top">12.</td>
    <td style="width:auto;vertical-align:top">
        <div>GOODWILL AND INTANGIBLE ASSETS (CONTINUED)</div> </td> </tr>
  <tr>
    <td style="width:30.6pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  </table> </ix:exclude></div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Goodwill
arising from the acquisition of Metabolomic Diagnostics Limited</span></span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill
of US$<ix:nonFraction id="Fxbrl_20250513120943404" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribMetabolomicDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,000</ix:nonFraction>
was also recognised in connection with the acquisition of Metabolomics. This amount is not considered individually material to the Group,
and therefore no further disclosures have been provided in accordance with IAS 36.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240414164402454" name="trib:DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        Assets with Indefinite Useful lives</span></span></div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(included
        in other intangibles)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus
        Corporation CGU</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus
        trade name</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220422105506152_53" name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPrimusCorporationCguTradeNameMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">365</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220422105506152_57" name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="C_20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPrimusCorporationCguTradeNameMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">365</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220422105506152_83" name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">365</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"><ix:nonFraction id="Fxbrl_20220422105506152_87" name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">365</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </ix:nonNumeric> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman', serif">&#160;</div>
        <div style="font-family:'Times New Roman',serif">
        <div>
        <div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        2023, an impairment loss of US$<ix:nonFraction id="Fxbrl_20220423023246421" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribImmcoDiagnosticsIncMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">2,069,000</ix:nonFraction>
        was allocated against the Immco Diagnostic trade name as the carrying value of the CGU&#8217;s net assets exceeded its discounted future
        cashflows. In 2023, the Group sold the Fitzgerald Industries business and the Fitzgerald trade name and RDI trade name were disposed of
        as part of that divestment.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
        trade name assets purchased as part of the acquisition of Fitzgerald in 2004, Primus and RDI in 2005 and Immco Diagnostics in 2013 were
        valued using the relief from royalty method and based on factors such as (1)&#160;the market and competitive trends and (2)&#160;the expected
        usage of the name. It was considered that these trade names will generate net cash inflows for the Group for an indefinite period.</span></span></div>
        </div> </div> </td> </tr>
  </table> </div> </div> </div> </div> </div> </div> </ix:nonNumeric> </div> </div> </div> </div> </div>

<p style="margin:0pt">&#160;</p>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">159</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <ix:nonNumeric id="Fxbrl_20250513115430502" name="ifrs-full:DisclosureOfFinancialAssetsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">FINANCIAL ASSETS</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240414155237946" name="trib:DisclosureOfDetailedInformationAboutFinancialAssets" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January 1, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414155852862" name="ifrs-full:FinancialAssets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions
        in year</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414160006415" name="trib:FinancialAssetsAdditions" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414155904544" name="ifrs-full:FinancialAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January 1, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513115143672_xbrl_20240414155904544" name="ifrs-full:FinancialAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions
        in year</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513115152342_xbrl_20240414160006415" name="trib:FinancialAssetsAdditions" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,562</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Write
        off in the year</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250513115154383_xbrl_20240414160006415" name="trib:FinancialAssetsWriteOff" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">800</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair
        value remeasured through profit &amp; loss</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250513115156679_xbrl_20240414160006415" name="trib:FairValueRemeasuredThroughProfitLossOfFinancialAssets" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">107</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513115146127_xbrl_20240414155904544" name="ifrs-full:FinancialAssets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,155</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provision
        for impairment</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January 1, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414155912198" name="trib:ProvisionForImpairment" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        in the current year</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414155944093" name="ifrs-full:ImpairmentLossOnFinancialAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240414155924121" name="trib:ProvisionForImpairment" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January 1, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250513115209199_xbrl_20240414155912198" name="trib:ProvisionForImpairment" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reversal
        of impairment in the current year (Note 5)</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513132549653" name="trib:ReversalOfImpairmentLossOnFinancialAssets" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">800</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250513115207335_xbrl_20240414155912198" name="trib:ProvisionForImpairment" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">700</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        amounts</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414160017762" name="ifrs-full:FinancialAssetsAtFairValue" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,455</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513115230159_xbrl_20240414160017762" name="ifrs-full:FinancialAssetsAtFairValue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
January 2023, the Company entered into a strategic partnership with imaware Inc. (&#8220;imaware&#8221;), combining imaware&#8217;s digital
health platform with the Company&#8217;s reference laboratory capabilities to support the delivery of at-home and remote testing programs.
As part of the partnership, the Company agreed to invest US$<ix:nonFraction id="Fxbrl_20240414155314658" name="trib:ConvertibleNoteInvestment" contextRef="C_20230131_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction>&#160;million
in imaware through a convertible note arrangement. In addition, a <ix:nonNumeric id="Fxbrl_20240414155423326" name="trib:AgreementTerm" contextRef="C_20230101to20230131_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember">five-year</ix:nonNumeric>
agreement was signed appointing the Company as imaware&#8217;s laboratory testing partner. As at December 31, 2023, the Company had paid
US$<ix:nonFraction id="Fxbrl_20240414155343034" name="ifrs-full:IssueOfConvertibleInstruments" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction>&#160;million
of the committed US$<ix:nonFraction id="Fxbrl_20240414155414203" name="trib:ConvertibleNoteInvestment" contextRef="C_20230131_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction>&#160;million
investment. The remaining US$<ix:nonFraction id="Fxbrl_20240414155509311" name="trib:AccruedLiability" contextRef="C_20241231_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction>&#160;million,
which had not yet been funded, was recognised as an accrued liability. The partnership did not generate any income in 2023. Due to continued
uncertainty over imaware&#8217;s financial performance and the recoverability of the investment, the Company recognised a full impairment
loss of US$<ix:nonFraction id="Fxbrl_20240414155631223" name="ifrs-full:ImpairmentLossOnFinancialAssets" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal" sign="-">1.5</ix:nonFraction>&#160;million
in the year ended December 31, 2023. In 2024, following the acquisition of Imaware by SuperTruth, and subsequent engagement with the acquirer,
it was confirmed that the Company is not liable to settle the outstanding US$<ix:nonFraction id="Fxbrl_20250513105232015" name="ifrs-full:DecreaseThroughWriteoffFinancialAssets" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction>
million and it was written off against the corresponding impairment previously recognised. No further amounts are expected to be paid
under the original convertible note agreement.</span></span></div> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
2024, the Company purchased a strategic investment in Novus Diagnostics Limited, a company pioneering a rapid sepsis testing platform,
acquiring a <ix:nonFraction id="Fxbrl_20250513105047478" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="C_20241231_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">12.5</ix:nonFraction>%
stake at that time. This investment will accelerate the development and commercialization of Novus&#8217; groundbreaking point-of-care
diagnostic solutions, including its 15-minute bloodstream infection test. The investment was valued at approximately US$<ix:nonFraction id="Fxbrl_20250513105107198" name="ifrs-full:InvestmentAccountedForUsingEquityMethod" contextRef="C_20241231_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,562,000</ix:nonFraction>
and was made through issuance of approximately <ix:nonFraction id="Fxbrl_20250513105111119" name="trib:AmericanDepositorySharesIssued" contextRef="C_20240101to20241231_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,399,985</ix:nonFraction>
ADSs in the Company. The ADS issuance was recognised directly in equity. The investment does not meet the criteria for classification
at amortised cost, as it is not held to collect contractual cash flows. Nor did the Company make the irrevocable election to measure it
at fair value through other comprehensive income (FVOCI). Accordingly, the investment is measured at fair value through profit or loss
(FVTPL) in accordance with IFRS 9. As at December 31, 2024, the investment is classified within Level 3 of the fair value hierarchy under
IFRS 13, as it is not quoted in an active market and the fair value was determined using unobservable inputs. A remeasurement loss of
US$<ix:nonFraction id="Fxbrl_20250513152551496" name="trib:RemeasurementLossRecognizedInProfitLoss" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal" sign="-">0.1</ix:nonFraction>&#160;million
was recognised in profit or loss for the year ended December 31, 2024.</span></span></div> </div> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">160</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <ix:nonNumeric id="Fxbrl_20240414130211974" name="ifrs-full:DisclosureOfDeferredTaxesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">DEFERRED TAX ASSETS AND LIABILITIES</span></span></div>
        </td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognised
deferred tax assets and liabilities</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
tax assets and liabilities of the Group are attributable to the following:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20230420125531839" name="trib:DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black">
        <div style="text-align:center;line-height:1.25;font-style:italic">Assets</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black">
        <div style="text-align:center;line-height:1.25;font-style:italic">Liabilities</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black">
        <div style="text-align:center;line-height:1.25;font-style:italic">Net</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2024<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2023<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2024<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2023<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2024<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2023<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Property, plant and equipment</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_23" name="ifrs-full:DeferredTaxAssets" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">224</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_27" name="ifrs-full:DeferredTaxAssets" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">168</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_211" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_215" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_219" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">224</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_223" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">168</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Intangible assets</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_33" name="ifrs-full:DeferredTaxAssets" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_37" name="ifrs-full:DeferredTaxAssets" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220115184224890_311" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,001</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220115184224890_315" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">931</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220115184224890_319" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,001</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220115184224890_323" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">931</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Inventories</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_43" name="ifrs-full:DeferredTaxAssets" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">776</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_47" name="ifrs-full:DeferredTaxAssets" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">105</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_411" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_415" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_419" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">776</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_423" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">105</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Provisions</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_53" name="ifrs-full:DeferredTaxAssets" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,414</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_57" name="ifrs-full:DeferredTaxAssets" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">558</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_511" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_515" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_519" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,414</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_523" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">558</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Tax value of loss carry-forwards</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250514171930374" name="ifrs-full:DeferredTaxAssets" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,026</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_67" name="ifrs-full:DeferredTaxAssets" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,030</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_611" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_615" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230413160020714" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,026</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_623" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,030</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Other items</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_73" name="ifrs-full:DeferredTaxAssets" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">113</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_77" name="ifrs-full:DeferredTaxAssets" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">114</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220115184224890_711" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,560</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220115184224890_715" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,369</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20250514181028851" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,447</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">)</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220115184224890_723" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,255</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Deferred tax assets/(liabilities)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_93" name="ifrs-full:DeferredTaxAssets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,553</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115184224890_97" name="ifrs-full:DeferredTaxAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,975</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220115184224890_911" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,561</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220115184224890_915" name="ifrs-full:DeferredTaxLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,300</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220115184224890_919" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,008</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220115184224890_923" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">325</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  </table> </div> </div> </ix:nonNumeric> </div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
deferred tax asset at December 31, 2024 is mainly due to deductible temporary differences relating to provisions and loss carry-forwards
In 2024, the deferred tax asset increased by US$<ix:nonFraction id="Fxbrl_20240414131710358" name="trib:DeferredTaxAssetIncreaseDueToIncreaseInProvision" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.6</ix:nonFraction>
million mainly due to an increase in deductible temporary differences principally attributable to imputed interest provisions.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
deferred tax liability is caused by the net book value of non-current assets being greater than the tax written down value of non-current
assets, temporary differences due to the acceleration of the recognition of certain charges in calculating taxable income permitted in
Ireland and the US. The deferred tax liability increased by US$<ix:nonFraction id="Fxbrl_20240414131734731" name="trib:DeferredTaxLiabilityIncreased" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.3</ix:nonFraction>
million in 2024, principally because of temporary differences in relation to acquired intangible assets.</span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
tax assets and liabilities are only offset when the entity has a legally enforceable right to set off current tax assets against current
tax liabilities and where the intention is to settle current tax liabilities and assets on a net basis or to realise the assets and settle
the liabilities simultaneously. At December 31, 2024 and at December 31, 2023 no deferred tax assets and liabilities are offset as it
is not certain as to whether there is a legally enforceable right to set off current tax assets against current tax liabilities and it
is also uncertain as to what current tax assets may be set off against current tax liabilities and in what periods.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Movement
in temporary differences during the year</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold">&#160;</div> <ix:nonNumeric id="Fxbrl_20250512171321562" name="trib:DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<div>

<div style="line-height:1.25">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center">Balance</div>
        <div style="line-height:1.25;font-style:italic;text-align:center">January 1,<br/>2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center">Recognised<br/>in income</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="line-height:1.25;text-align:center"><em>Recognised<br/>in discontinued operations</em></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center">Balance</div>
        <div style="line-height:1.25;font-style:italic;text-align:center">December&#160;31,<br/>2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Property, plant and equipment</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220117164906025_23" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">168</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220117164906025_27" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240414131103187" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220117164906025_211" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">224</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Intangible assets</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220117164906025_33" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">931</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220117164906025_37" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,070</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240414131122455" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220117164906025_311" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,001</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Inventories</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220422095512288" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">105</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220117164906025_47" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">671</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240414131126430" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220117164906025_411" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">776</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Provisions</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220117164906025_53" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">558</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220117164906025_57" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">856</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240414131133003" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220117164906025_511" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,414</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Tax value of loss carry-forwards</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220117164906025_63" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,030</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220117164906025_67" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240414131147291" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230413163118649" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,026</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Other items</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220117164906025_73" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,255</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220117164906025_77" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">192</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240414131157003" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20230428002253052" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,447</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220117164906025_83" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">325</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220117164906025_87" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">683</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240414131213435" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20220117164906025_811" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,008</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  </table> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">161</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:28.35pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">14.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">DEFERRED
        TAX ASSETS AND LIABILITIES (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><em><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance</span></span></em></div>
        <div style="line-height:1.25;font-style:italic"><em><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January
        1,<br/>2023</span></span></em></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><em><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognised<br/>in
        income</span></span></em></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25"><em><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognised<br/>in
        discontinued operations</span></span></em></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property,
        plant and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165513195_xbrl_20220117164906025_23" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">224</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220117165513195_xbrl_20220117164906025_27" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">56</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414131402992_xbrl_20240414131103187" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165513195_xbrl_20220117164906025_211" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">168</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220117165513208_xbrl_20220117164906025_33" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,950</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165513208_xbrl_20220117164906025_37" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,827</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414131402993_xbrl_20240414131122455" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">192</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220117165513208_xbrl_20220117164906025_311" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">931</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165513223_xbrl_20220117164906025_43" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">423</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414122127884" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">318</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414131402994_xbrl_20240414131126430" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165513223_xbrl_20220117164906025_411" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">105</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165513238_xbrl_20220117164906025_53" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,194</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220117165513238_xbrl_20220117164906025_57" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,636</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414131402995_xbrl_20240414131133003" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165513238_xbrl_20220117164906025_511" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">558</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax
        value of loss carry-forwards</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165513252_xbrl_20220117164906025_63" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,254</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220117165513252_xbrl_20220117164906025_67" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">224</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414131402997_xbrl_20240414131147291" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165513252_xbrl_20220117164906025_611" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,030</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        items</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220117165513263_xbrl_20220117164906025_73" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">985</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220117165513263_xbrl_20220117164906025_77" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">270</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414131402998_xbrl_20240414131157003" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220117165513263_xbrl_20220117164906025_711" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,255</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512171348973" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">840</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413163837410" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">323</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414131426540" name="trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">192</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220117165635376_xbrl_20220117164906025_811" name="ifrs-full:DeferredTaxLiabilityAsset" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">325</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unrecognised
deferred tax assets</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
tax assets have not been recognised by the Group in respect of the following items, which have not been tax effected:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20230420125833020" name="trib:DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital
        losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165725471_23" name="trib:DeferredTaxAssetsCapitalLossCarryforward" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,293</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165725471_27" name="trib:DeferredTaxAssetsCapitalLossCarryforward" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,293</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        operating losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165725471_33" name="trib:DeferredTaxAssetsOperatingLossDomestic" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">180,810</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165725471_37" name="trib:DeferredTaxAssetsOperatingLossDomestic" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">136,202</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US
        alternative minimum tax credits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20250513161404099" name="trib:DeferredTaxAssetsUsAlternativeMinimumTaxCredits" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,791</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165725471_47" name="trib:DeferredTaxAssetsUsAlternativeMinimumTaxCredits" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,790</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        temporary timing differences</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165725471_53" name="trib:DeferredTaxAssetsOtherTemporaryTimingDifferences" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,246</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165725471_57" name="trib:DeferredTaxAssetsOtherTemporaryTimingDifferences" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">57,986</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US
        state credit carry-forwards</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230421022610748" name="trib:DeferredTaxAssetsOperatingLossCarryforwardsState" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165725471_67" name="trib:DeferredTaxAssetsOperatingLossCarryforwardsState" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,015</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165725471_83" name="trib:DeferredTaxAssetsOperatingLossCarryforward" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210,140</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117165725471_87" name="trib:DeferredTaxAssetsOperatingLossCarryforward" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">208,286</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </ix:nonNumeric> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20220115170221607" name="ifrs-full:DisclosureOfOtherAssetsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OTHER NON-CURRENT ASSETS</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240412213107455" name="trib:DisclosureOfDetailedInformationAboutOtherAssetsExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance
        lease receivables (see Note 17)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114182948302_13" name="ifrs-full:NoncurrentFinanceLeaseReceivables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114182948302_17" name="ifrs-full:NoncurrentFinanceLeaseReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240412212938544" name="trib:OtherAssetNoncurrent" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114182948302_27" name="trib:OtherAssetNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114182948302_43" name="ifrs-full:OtherNoncurrentAssets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114182948302_47" name="ifrs-full:OtherNoncurrentAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">79</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group leases instruments as part of its business. For details of future minimum finance lease receivables with non-cancellable terms,
please refer to Note 17.</span></span></div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">162</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <ix:nonNumeric id="Fxbrl_20220422102056077" name="ifrs-full:DisclosureOfInventoriesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INVENTORIES</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240413083359963" name="trib:DisclosureOfDetailedInformationAboutInventoriesExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw
        materials and consumables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114183920220_13" name="ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,032</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114183920220_17" name="ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,053</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Work-in-progress</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114183920220_23" name="ifrs-full:WorkInProgress" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,989</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114183920220_27" name="ifrs-full:WorkInProgress" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,498</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished
        goods</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114183920220_33" name="ifrs-full:FinishedGoods" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,353</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114183920220_37" name="ifrs-full:FinishedGoods" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,382</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114183920220_53" name="ifrs-full:Inventories" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,374</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114183920220_57" name="ifrs-full:Inventories" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,933</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
assets of the Group, including inventories have been pledged as security for the term loan from Perceptive Advisors.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">All
inventories are stated at the lower of cost or net realisable value. Total inventories for the Group are shown net of provisions of US$<ix:nonFraction id="Fxbrl_20220114185015437" name="ifrs-full:InventoriesAtNetRealisableValue" contextRef="C_20241231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">7,648,000</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20220426173801289" name="ifrs-full:InventoriesAtNetRealisableValue" contextRef="C_20231231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">11,344,000</ix:nonFraction>)
(2022: US$<ix:nonFraction id="Fxbrl_20220114185057452" name="ifrs-full:InventoriesAtNetRealisableValue" contextRef="C_20221231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">16,274,000</ix:nonFraction>).
Cost of sales in 2024 includes inventories expensed of US$<ix:nonFraction id="Fxbrl_20220114185129584" name="ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod" contextRef="C_20240101to20241231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">38,001,000</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20220114185158228" name="ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod" contextRef="C_20230101to20231231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">35,091,000</ix:nonFraction>)
(2022: US$<ix:nonFraction id="Fxbrl_20220114185303700" name="ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod" contextRef="C_20220101to20221231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">45,340,000</ix:nonFraction>).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement on the inventory provision for the three-year period to December&#160;31, 2024 is as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240413083419823" name="trib:DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Opening
        provision at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114184650874" name="ifrs-full:OtherProvisions" contextRef="C_20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,344</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114184702438" name="ifrs-full:OtherProvisions" contextRef="C_20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,274</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114184705586" name="ifrs-full:OtherProvisions" contextRef="C_20211231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,063</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charged
        during the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114184146045_23" name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,113</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114184146045_27" name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="C_20230101to20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,291</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114184146045_211" name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="C_20220101to20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Utilised
        during the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114184146045_33" name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,809</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114184146045_37" name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="C_20230101to20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,456</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220114184146045_311" name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="C_20220101to20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,180</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminated
        on disposal of business</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413084538336" name="trib:EliminatedOnDisposalOfBusiness" contextRef="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240430163145534" name="trib:EliminatedOnDisposalOfBusiness" contextRef="C_20230101to20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,765</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240430163149402" name="trib:EliminatedOnDisposalOfBusiness" contextRef="C_20220101to20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Closing
        provision at December&#160;31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114184823076_xbrl_20220114184650874" name="ifrs-full:OtherProvisions" contextRef="C_20241231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,648</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114184823076_xbrl_20220114184702438" name="ifrs-full:OtherProvisions" contextRef="C_20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,344</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114184823076_xbrl_20220114184705586" name="ifrs-full:OtherProvisions" contextRef="C_20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,274</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </ix:nonNumeric> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div>

<div> <ix:nonNumeric id="Fxbrl_20240413091539442" name="ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>17.</span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>TRADE AND OTHER RECEIVABLES</span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512142116200" name="trib:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trade
        receivables, net of impairment losses</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115142942808_13" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,416</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115142942808_17" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,698</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Prepayments</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115142942808_23" name="ifrs-full:CurrentPrepayments" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,979</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115142942808_27" name="ifrs-full:CurrentPrepayments" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,036</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Contract
        assets</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115142942808_33" name="ifrs-full:CurrentContractAssets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">460</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115142942808_37" name="ifrs-full:CurrentContractAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">525</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Value
        added tax</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115142942808_43" name="ifrs-full:CurrentValueAddedTaxReceivables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115142942808_47" name="ifrs-full:CurrentValueAddedTaxReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Finance
        lease receivables</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115142942808_53" name="ifrs-full:CurrentReceivablesFromRentalOfProperties" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115142942808_57" name="ifrs-full:CurrentReceivablesFromRentalOfProperties" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Consideration
        due from sale of business (Note 8)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240413095227955_xbrl_20220115142942808_53" name="trib:ReceivablesFromConsiderationDueSaleOfBusiness" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240413095227955_xbrl_20220115142942808_57" name="trib:ReceivablesFromConsiderationDueSaleOfBusiness" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">373</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other
        receivables</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240413095230165_xbrl_20220115142942808_53" name="ifrs-full:OtherReceivables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">168</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240413095230165_xbrl_20220115142942808_57" name="ifrs-full:OtherReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">107</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240413095332685_xbrl_20230413173736667" name="ifrs-full:TradeAndOtherCurrentReceivables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,065</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240413095332685_xbrl_20230413173747389" name="ifrs-full:TradeAndOtherCurrentReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,901</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trade
receivables are shown net of an impairment losses provision of US$<ix:nonFraction id="Fxbrl_20250512142454034" name="ifrs-full:TradeReceivables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,286,000</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20250512142500697" name="ifrs-full:TradeReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,324,000</ix:nonFraction>)
(2022: US$<ix:nonFraction id="Fxbrl_20250512142511779" name="ifrs-full:TradeReceivables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,691,000</ix:nonFraction>)
(see Note 27). Prepayments are shown after impairment charges of US$<ix:nonFraction id="Fxbrl_20250512142537589" name="ifrs-full:Prepayments" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">Nil</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20250512142545716" name="ifrs-full:Prepayments" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">Nil</ix:nonFraction>)
(2022: US$<ix:nonFraction id="Fxbrl_20250512142556264" name="ifrs-full:Prepayments" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">482,000</ix:nonFraction>)
(see Note 5).</span></span></span></span>

<p style="margin:0pt">&#160;</p> </div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">163</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>17.</span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>TRADE AND OTHER RECEIVABLES (CONTINUED)</span></span></span></span></div>
        </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Long-term
contract receivable</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-style:italic;margin-left:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(i)
Finance lease commitments &#8211; Group as lessor</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
Group leases instruments as part of its business. Future minimum receivables with non-cancellable terms are as follows:</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20250512142405559" name="ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December
        31, 2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Gross<br/>investment</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Unearned<br/>income</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Minimum<br/>payments<br/>receivable</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less
        than one year</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143430581_23" name="trib:GrossInvestmentInFinanceLease" contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143430581_27" name="trib:UnearnedFinanceIncomeOnFinanceLease" contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143430581_211" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Between
        one and five years (Note 15)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143430581_33" name="trib:GrossInvestmentInFinanceLease" contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143430581_37" name="trib:UnearnedFinanceIncomeOnFinanceLease" contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143430581_311" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143430581_53" name="trib:GrossInvestmentInFinanceLease" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143430581_57" name="trib:UnearnedFinanceIncomeOnFinanceLease" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143430581_511" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div>&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December
        31, 2023</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Gross<br/>investment</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Unearned<br/>income</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Minimum<br/>payments<br/>receivable</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less
        than one year</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143718292_xbrl_20220115143430581_23" name="trib:GrossInvestmentInFinanceLease" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">170</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143718292_xbrl_20220115143430581_27" name="trib:UnearnedFinanceIncomeOnFinanceLease" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143718292_xbrl_20220115143430581_211" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Between
        one and five years (Note 15)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143718299_xbrl_20220115143430581_33" name="trib:GrossInvestmentInFinanceLease" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">54</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143718299_xbrl_20220115143430581_37" name="trib:UnearnedFinanceIncomeOnFinanceLease" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143718299_xbrl_20220115143430581_311" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143806876_xbrl_20220115143430581_53" name="trib:GrossInvestmentInFinanceLease" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">224</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143806876_xbrl_20220115143430581_57" name="trib:UnearnedFinanceIncomeOnFinanceLease" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220115143806876_xbrl_20220115143430581_511" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">155</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </ix:nonNumeric>

<div>&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
Group classified future minimum lease receivables between one and five years of US$<ix:nonFraction id="Fxbrl_20240413094004582" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">Nil</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20250513132821452" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36</ix:nonFraction>,000)
as Other Assets, see Note 15. Under the terms of the lease arrangements, no contingent rents are receivable.</span></span></span></span></div>

<div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(ii)
Operating lease commitments &#8211; Group as lessor</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
Group leases instruments under operating leases as part of its business.</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Future
minimum rentals receivable under non-cancellable operating leases are as follows:</span></span></span></span></div>

<div>&#160;</div> </div> <ix:nonNumeric id="Fxbrl_20250512142427208" name="ifrs-full:DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December
        31, 2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Instruments</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less
        than one year</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230426182306523_xbrl_20230420100522121" name="ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived" contextRef="C_20241231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,461</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230426182306523_xbrl_20230420100528944" name="ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived" contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,461</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230426182314389_xbrl_20230420100822516" name="ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived" contextRef="C_20241231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,461</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230426182314389_xbrl_20230420100852441" name="ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,461</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">164</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:28.35pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">17.</span></span></span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">TRADE
        AND OTHER RECEIVABLES (CONTINUED)</span></span></span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(ii)
Operating lease commitments &#8211; Group as lessor</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December
        31, 2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Instruments</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less
        than one year</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230420100522121" name="ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,995</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230420100528944" name="ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived" contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,995</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230420100822516" name="ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,995</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230420100852441" name="ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,995</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div> </ix:nonNumeric> </div> </div> </div> </div> </div> </div> </div> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25;clear:both">&#160;</div> </div> </div>

<div> <ix:nonNumeric id="Fxbrl_20250512142719766" name="ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH AND CASH EQUIVALENTS</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512142733996" name="trib:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        at bank and in hand</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114233029161_13" name="ifrs-full:Cash" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,167</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114233029161_17" name="ifrs-full:Cash" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="text-align:right;line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114233029161_43" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,167</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220114233029161_47" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </ix:nonNumeric> </div> </div> </ix:nonNumeric> </div>

<p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>

<div style="line-height:1.25;clear:both">

<div>

<div>

<div>

<div> <ix:nonNumeric id="Fxbrl_20230420104649169" name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAPITAL AND RESERVES</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share
capital</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
February 2024, the Company adjusted its ADS ratio from 1 ADS: 4 ordinary share to 1 ADS: 20 ordinary shares. The 2024 and 2023 ADS amounts
in the below tables reflect this change.</span></span></div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20250512164828821" name="ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Ordinary shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Ordinary shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        thousands of shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        issue at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115000936793_23" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">165,866</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115000936793_27" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">164,986</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued
        for a cash consideration (a)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413172244170" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">81,628</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413172229470" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">880</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued
        for non-cash consideration (b)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180527944_xbrl_20230413172244170" name="trib:IssuedForNoncashConsideration" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">124,255</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180527944_xbrl_20230413172229470" name="trib:IssuedForNoncashConsideration" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        period end</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115000936793_53" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">371,749</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115000936793_57" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">165,866</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ADS</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ADS</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        thousands of ADSs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115001534477_xbrl_20220115000936793_23" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,293</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115001534477_xbrl_20220115000936793_27" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,249</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued
        for a cash consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413174835986" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,081</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413174847700" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">44</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued
        for non-cash consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180549394_xbrl_20230413174835986" name="trib:IssuedForNoncashConsideration" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,213</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512180549394_xbrl_20230413174847700" name="trib:IssuedForNoncashConsideration" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        period end</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115001556277_xbrl_20220115000936793_53" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,587</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115001556277_xbrl_20220115000936793_57" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,293</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">165</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAPITAL AND RESERVES (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="text-indent:30.6pt;line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
amounts in the tables above are inclusive of Treasury Shares. The number of Treasury Shares is as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Treasury shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Treasury shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        thousands of shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115004136546_xbrl_20220115001534477_xbrl_20220115000936793_23" name="ifrs-full:TreasuryShares" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,556</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115004136546_xbrl_20220115001534477_xbrl_20220115000936793_27" name="ifrs-full:TreasuryShares" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,556</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchased
        during period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115004229488_xbrl_20220115001545580_xbrl_20220115000936793_33" name="ifrs-full:PurchaseOfTreasuryShares" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115004229488_xbrl_20220115001545580_xbrl_20220115000936793_37" name="ifrs-full:PurchaseOfTreasuryShares" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        period end</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115004136554_xbrl_20220115001556277_xbrl_20220115000936793_53" name="ifrs-full:TreasuryShares" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,556</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115004136554_xbrl_20220115001556277_xbrl_20220115000936793_57" name="ifrs-full:TreasuryShares" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,556</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div>&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Treasury shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Treasury shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        thousands of ADSs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115004359377_xbrl_20220115004136546_xbrl_20220115001534477_xbrl_20220115000936793_23" name="ifrs-full:TreasuryShares" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">628</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115004359377_xbrl_20220115004136546_xbrl_20220115001534477_xbrl_20220115000936793_27" name="ifrs-full:TreasuryShares" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">628</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchased
        during period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115004359393_xbrl_20220115004229488_xbrl_20220115001545580_xbrl_20220115000936793_33" name="ifrs-full:PurchaseOfTreasuryShares" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115004359393_xbrl_20220115004229488_xbrl_20220115001545580_xbrl_20220115000936793_37" name="ifrs-full:PurchaseOfTreasuryShares" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        period end</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115004359404_xbrl_20220115004136554_xbrl_20220115001556277_xbrl_20220115000936793_53" name="ifrs-full:TreasuryShares" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">628</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115004359404_xbrl_20220115004136554_xbrl_20220115001556277_xbrl_20220115000936793_57" name="ifrs-full:TreasuryShares" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">628</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </ix:nonNumeric>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:9pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(a)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the year ended December 31, 2024, the Company
        issued <ix:nonFraction id="Fxbrl_20250513150355973" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">81,628</ix:nonFraction>,000
        &#8216;A&#8217; Ordinary shares for a consideration of US$<ix:nonFraction id="Fxbrl_20230413202751678" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.4</ix:nonFraction>
        million settled in cash. The Company incurred expenses of US$<ix:nonFraction id="Fxbrl_20230413202756252" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction>
        million in connection with the issuances. No employee share options were exercised during the year.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:9pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(b)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the year ended December 31, 2024, the Company
        issued following shares for a consideration other than cash:</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:27pt">&#160;</td>
    <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 31, 2024, the Company issued <ix:nonFraction id="Fxbrl_20250512164918210" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20240101to20240131_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">36,000,000</ix:nonFraction>
        &#8216;A&#8217; Ordinary shares (<ix:nonFraction id="Fxbrl_20250512164925713" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20240101to20240131_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,800,000</ix:nonFraction>
        ADS) as a part of the purchase consideration to acquire Waveform Technologies Inc., as a wholly owned subsidiary.</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:27pt">&#160;</td>
    <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ii)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 24, 2024, the Company issued <ix:nonFraction id="Fxbrl_20250512165014645" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20240901to20240924_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicDiagnosticsLimitedMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">5,406,000</ix:nonFraction>
        &#8216;A&#8217; Ordinary shares (<ix:nonFraction id="Fxbrl_20250512165328850" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20240901to20240924_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicDiagnosticsLimitedMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">270,000</ix:nonFraction>
        ADS) as a part of the purchase consideration to acquire Metabolomic Diagnostics Limited, as a wholly owned subsidiary.</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:27pt">&#160;</td>
    <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iii)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 10, 2024, the Company issued <ix:nonFraction id="Fxbrl_20250512165018859" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribCraigHallumMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">13,000,000</ix:nonFraction>
        &#8216;A&#8217; Ordinary shares (<ix:nonFraction id="Fxbrl_20250512165332647" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribCraigHallumMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">650,000</ix:nonFraction>
        ADS) to Craig-Hallum pursuant to the Advisory Agreement.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:27pt">&#160;</td>
    <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iv)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 10, 2024, the Company issued <ix:nonFraction id="Fxbrl_20250512165023646" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNativeDesignLimitedMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">7,237,000</ix:nonFraction>
        &#8216;A&#8217; Ordinary shares (<ix:nonFraction id="Fxbrl_20250512165336769" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNativeDesignLimitedMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">362,000</ix:nonFraction>
        ADS) to Native Design Limited pursuant to a design services agreement.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:27pt">&#160;</td>
    <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">v)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 25, 2024, the Company issued <ix:nonFraction id="Fxbrl_20250512165028494" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">34,612,000</ix:nonFraction>
        &#8216;A&#8217; Ordinary shares (<ix:nonFraction id="Fxbrl_20250512165345654" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,731,000</ix:nonFraction>
        ADS) as a purchase consideration to acquire EpiCapture Limited, as a wholly owned subsidiary.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:27pt">&#160;</td>
    <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">vi)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 25, 2024, the Company issued <ix:nonFraction id="Fxbrl_20250512165312406" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovusDiagnosticsLimitedMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">28,000,000</ix:nonFraction>
        &#8216;A&#8217; Ordinary shares (<ix:nonFraction id="Fxbrl_20250512165349502" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" contextRef="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovusDiagnosticsLimitedMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,400,000</ix:nonFraction>
        ADS) as a purchase consideration to acquire <ix:nonFraction id="Fxbrl_20250512181713449" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="C_20241025_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovusDiagnosticsLimitedMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">12.5</ix:nonFraction>%
        equity stake in Novus Diagnostics.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAPITAL AND RESERVES (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Translation
reserve</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign currency
denominated operations of the Group since January&#160;1, 2004.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
reserves</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
reserves comprise the hedging reserve of US$<ix:nonFraction id="Fxbrl_20230413210434825" name="ifrs-full:ReserveOfCashFlowHedges" contextRef="C_20241231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">23,000</ix:nonFraction>.
The hedging reserve comprises the effective portion of the cumulative net change in the fair value of cash flow hedging instruments related
to hedged transactions entered into but not yet crystallised. The hedging reserve is shown within Other Reserves in the Consolidated Statement
of Financial Position.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity
component of Convertible Note</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
May 2022, the Company completed a US$<ix:nonFraction id="Fxbrl_20230413210557724" name="ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments" contextRef="C_20220501to20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">45.2</ix:nonFraction>
million investment from MiCo IVD Holdings, LLC&#160;(&#8220;MiCo&#8221;). The investment consisted of an equity investment of US$<ix:nonFraction id="Fxbrl_20230413210837416" name="ifrs-full:InvestmentAccountedForUsingEquityMethod" contextRef="C_20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">25.2</ix:nonFraction>
million and a <ix:nonNumeric id="Fxbrl_20230413211657270" name="ifrs-full:BorrowingsMaturity" contextRef="C_20220501to20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember">seven-year</ix:nonNumeric>,
unsecured junior convertible note of US$<ix:nonFraction id="Fxbrl_20230413210832777" name="ifrs-full:Borrowings" contextRef="C_20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.0</ix:nonFraction>
million. The convertible note mandatorily converts into ADSs if the volume weighted average price of the Company&#8217;s ADSs is at or
above US$<ix:nonFraction id="Fxbrl_20230413210840939" name="trib:MaximumWeightedAveragePriceOfAmericanDepositoryShares" contextRef="C_20220501to20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">16.20</ix:nonFraction>
for any five consecutive NASDAQ trading days. The convertible loan is accounted for as a compound financial instrument containing both
an equity and liability element. The equity component of the convertible note is US$<ix:nonFraction id="Fxbrl_20230426184739838" name="ifrs-full:ReserveOfEquityComponentOfConvertibleInstruments" contextRef="C_20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.7</ix:nonFraction>
million. There is no remeasurement of the equity element following initial recognition.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury
shares</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
2024, the Group did not purchase any &#8216;A&#8217; Ordinary shares (2023: <ix:nonFraction id="Fxbrl_20230414133842617" name="trib:PurchaseOfTreasuryShare" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt-sec:numwordsen">nil</ix:nonFraction>)
(2022: <ix:nonFraction id="Fxbrl_20230414133903303" name="trib:PurchaseOfTreasuryShare" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt-sec:numwordsen">nil</ix:nonFraction>)
&#8216;Treasury shares&#8217;.</span></span></div> </div> </div> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> </div> </div> </div> </div>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">167</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> <ix:nonNumeric id="F20240413052446065_0" name="trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SHARE OPTIONS</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under
the terms of the Company&#8217;s Employee Share Option Plans, options to purchase <ix:nonFraction id="F20240413052446439_217" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">40,506,672</ix:nonFraction>&#8216;A&#8217;
Ordinary Shares (<ix:nonFraction id="F20240413052446533_275" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">2,025,334</ix:nonFraction>
ADS&#8217;s) were outstanding at December&#160;31, 2024. Under these Plans, options are granted to officers and employees of the Group
at the discretion of the Compensation Committee (designated by the Board of Directors), under the terms outlined below.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share
options are sometimes granted to consultants of the Group and the fair value of the services provided by these consultants is measured
by reference to the fair value of the equity instruments granted. This approach is adopted as it is impractical for the Group to reliably
estimate the fair value of such services. There are <ix:nonFraction id="Fxbrl_20250513034239149" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20241231" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">2,000,000</ix:nonFraction>
outstanding options for consultants at December 31, 2024.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
terms and conditions of the grants are as follows, whereby all options are settled by physical delivery of shares:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vesting
conditions</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
options vest following a period of service by the officer or employee. The required period of service is determined by the Board or any
other relevant delegated committee at the date of grant of the options (usually the date of approval by the Compensation Committee) and
it is generally over a two to four-year period.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-vesting
conditions</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Since
2022, share options were granted to directors and certain employees for which there is a condition that the options only become exercisable
into ADSs when the market price of an ADS reaches a certain level. This is deemed to be a non-vesting condition. The term &#8216;non-vesting
condition&#8217; is not explicitly defined in IFRS 2, Share based payments, but is inferred to be any condition that does not meet the
definition of a vesting condition. The only condition for these particular options to vest is that the director or employee continues
service and there were no other conditions which would be considered non-vesting conditions. Non-vesting conditions are reflected in measuring
the grant-date fair value of the share-based payment and there is no true-up in the measurement of the share-based payment for differences
between the expected and the actual outcome of non-vesting conditions. If all service conditions are met, then the share-based payment
cost will be recognized even if the director or employee does not receive the share-based payment due to a failure to meet the non-vesting
condition.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractual
life</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
term of an option is determined by the Board of Directors, typically through its Remuneration Committee and Employee Compensation Committee,
provided that the term may not exceed ten years from the date of grant. All options will terminate 90 days after termination of the option
holder&#8217;s employment, service or consultancy with the Group (or one year after such termination because of death or disability) except
where a longer period is approved by the Board of Directors. Under certain circumstances involving a change in control of the Group, the
Board may accelerate the exercisability and termination of options.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">168</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SHARE OPTIONS (CONTINUED)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30pt">&#160;</td>
    <td style="vertical-align:top;width:auto">&#160;</td> </tr>
  </table> </ix:exclude></div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
number and weighted average exercise price of share options per ordinary share is as follows:</span></span></div> </div> </div> </div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="F20240413052446074_3" name="trib:DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">Share Options &#8216;A&#8217; Ordinary Shares</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">Weighted- average exercise price US$ Per</div>
        <div style="text-align:center;line-height:1.25">&#8216;A&#8217; Ordinary Share</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">Range US$ Per &#8216;A&#8217; Ordinary Share</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding January&#160;1, 2022</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446076_4" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">18,727,990</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513024535497" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.78</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513120539072" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.19</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513120556071" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">4.36</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Granted</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513024511889" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">29,400,000</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513024525968" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.27</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513120605679" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.27</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513120609063" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.29</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercised</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="F20240413052446083_8" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">2,733,328</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446118_25" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.19</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513120623351" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.19</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513120626640" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.19</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Expired / Forfeited</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="F20240413052446087_9" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">579,990</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446117_24" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.87</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513120634520" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.69</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513120637223" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">4.36</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding December 31, 2022</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240413111003291" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">44,814,672</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240413111016987" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.47</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513120646567" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.19</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513120652968" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.43</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercisable December 31, 2022</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446079_6" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">14,138,004</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446104_18" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.89</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513120701719" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.19</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513120705071" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.43</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding January&#160;1, 2023</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446093_12" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">44,814,672</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446108_20" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.47</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513120718800" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.19</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513120721584" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.43</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Granted</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446094_13" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">19,600,000</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446120_26" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.14</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513120728800" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.12</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513120734904" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.25</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercised</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="F20240413052446099_15" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">880,000</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446125_28" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.19</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513120744167" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.19</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513120750559" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.19</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Expired / Forfeited</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="F20240413052446489_249" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">16,620,000</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446546_283" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.33</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513120759920" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.27</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513120805159" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.43</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding December 31, 2023</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446493_252" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">46,914,672</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446552_286" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.39</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513120814391" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.12</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513120817719" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.34</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercisable December 31, 2023</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446495_253" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">19,764,672</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446549_284" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.67</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513120834487" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.19</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513120841479" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.34</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding January&#160;1, 2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446498_254" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">46,914,672</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446550_285" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.39</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513121026184" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.12</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121032728" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.34</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Granted</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446096_14" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">12,100,000</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446123_27" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.14</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513121038287" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.14</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121041223" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.14</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Expired / Forfeited</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="F20240413052446101_16" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">18,508,000</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446128_30" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.50</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513121047567" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.12</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121050904" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.34</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding December 31, 2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446091_11" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">40,506,672</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446111_21" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.26</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513121057044" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.12</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121100368" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.29</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercisable December 31, 2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446089_10" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">17,275,422</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="F20240413052446113_22" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.41</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250513121106103" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.12</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121109279" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.29</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div> </div> </div> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25;clear:both">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">169</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">
  <tr>
    <td style="width:30.6pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><span>20.</span></span></span></span></span></span></span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><span>SHARE
        OPTIONS (CONTINUED)</span></span></span></span></span></span></span></span></span></span></span></span></div> </div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div>

<div>

<div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>In
February 2024, the Company adjusted its ADS ratio from 1 ADS: 4 ordinary shares to 1 ADS: 20 ordinary shares.</span> The 2024 and 2023
ADS amounts in the below tables reflect this change.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
number and weighted average exercise price of share options per ADS is as follows:</span></span></div> </div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share
        Options &#8216;ADS&#8217; Equivalent</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-
        average exercise price US$ Per &#8216;ADS&#8217;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range
        US$ Per &#8216;ADS&#8217;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        January&#160;1, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446133_37" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">936,400</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446133_36" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">15.60</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121322663" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.80</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121326864" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">87.20</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513031126944_xbrl_20220119161141174_20240413052446094_13" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">1,470,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513031126944_xbrl_20220119161141174_20240413052446120_26" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">5.40</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121333728" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">5.40</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121337151" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">5.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250513031136569_20240413052446148_49" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">136,666</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513031136569_20240413052446150_50" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121343072" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.80</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121346072" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / Forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="F20240413052446138_41" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">29,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446138_40" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">37.40</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121354519" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.80</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121357264" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">87.20</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        December 31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119161141144_20240413052446078_5" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">2,240,734</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119161141144_20240413052446106_19" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.40</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121402840" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.80</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121408369" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">48.60</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable
        December 31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119161141152_20240413052446079_6" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">706,900</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119161141152_20240413052446104_18" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">17.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121414992" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.80</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121419064" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">48.60</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446152_51" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">2,240,734</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446154_52" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.40</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121427937" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.80</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121430768" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">48.60</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119161141174_20240413052446094_13" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">980,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119161141174_20240413052446120_26" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121436914" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.40</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121439840" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">5.00</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="F20240413052446148_49" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">44,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446150_50" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121445399" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.80</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121451976" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / Forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119161141238_20240413052446101_16" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">831,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446501_256" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">6.60</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121458072" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">5.40</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121501179" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">48.60</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446140_42" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">2,345,734</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446502_257" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">7.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121509200" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.40</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121516912" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">26.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513031233216" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">988,234</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446504_258" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.40</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121524624" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.80</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121528400" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">26.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119161141213_20240413052446093_12" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">2,345,734</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119161141213_20240413052446108_20" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">7.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121534176" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.40</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121536952" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">26.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446480_244" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">605,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446482_245" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121544735" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.80</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121547952" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / Forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220327031543955_xbrl_20220119161141238_20240413052446101_16" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">925,400</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220327031543955_xbrl_20220119161141238_20240413052446128_30" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">10.00</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121555672" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.40</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121558904" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">26.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220327031003039_20240413052446140_42" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">2,025,334</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446467_233" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">5.20</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121606808" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.40</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121610456" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">25.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220327031018180_20240413052446141_43" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">863,771</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446470_235" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">8.20</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513121618568" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.40</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20250513121621800" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">25.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div> </div> </div> </div> </ix:nonNumeric>

<div>

<div>

<div>

<div>

<div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman', serif">

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
opening share price per &#8216;A&#8217; Ordinary share at the start of the financial year was US$<ix:nonFraction id="Fxbrl_20240421222606767" name="trib:OpeningSharePrice" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.10</ix:nonFraction>
or US$<ix:nonFraction id="Fxbrl_20240421222613546" name="trib:OpeningSharePrice" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.00</ix:nonFraction>
per ADS (2023: US$<ix:nonFraction id="Fxbrl_20240421222619777" name="trib:OpeningSharePrice" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.24</ix:nonFraction>
per &#8216;A&#8217; ordinary share or US$<ix:nonFraction id="Fxbrl_20240421222625560" name="trib:OpeningSharePrice" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="1" format="ixt:num-dot-decimal">4.8</ix:nonFraction>
per ADS) (2022: US$<ix:nonFraction id="Fxbrl_20240421222632305" name="trib:OpeningSharePrice" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.36</ix:nonFraction>
per &#8216;A&#8217; ordinary share or US$<ix:nonFraction id="Fxbrl_20240421222639361" name="trib:OpeningSharePrice" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">7.35</ix:nonFraction>
per ADS) and the closing share price at December&#160;31, 2024 was US$<ix:nonFraction id="Fxbrl_20240421222653544" name="trib:ClosingExercisePriceOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.04</ix:nonFraction>
per &#8216;A&#8217; ordinary share or US$<ix:nonFraction id="Fxbrl_20240421222702731" name="trib:ClosingExercisePriceOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.88</ix:nonFraction>
per ADS (2023: US$<ix:nonFraction id="Fxbrl_20240421222709321" name="trib:ClosingExercisePriceOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.11</ix:nonFraction>
per &#8216;A&#8217; ordinary share or US$<ix:nonFraction id="Fxbrl_20240421222717178" name="trib:ClosingExercisePriceOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.15</ix:nonFraction>
per ADS) (2022: US$<ix:nonFraction id="Fxbrl_20240421222724552" name="trib:ClosingExercisePriceOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.25</ix:nonFraction>
per &#8216;A&#8217; ordinary share or US$<ix:nonFraction id="Fxbrl_20240421222731490" name="trib:ClosingExercisePriceOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">4.95</ix:nonFraction>
per ADS). The average share price for the year ended December&#160;31, 2024 was US$<ix:nonFraction id="Fxbrl_20240421222740017" name="ifrs-full:WeightedAverageSharePrice2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.10</ix:nonFraction>
per &#8216;A&#8217; Ordinary share or US$<ix:nonFraction id="Fxbrl_20240421222745858" name="ifrs-full:WeightedAverageSharePrice2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.96</ix:nonFraction>
per ADS.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">170</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SHARE OPTIONS (CONTINUED)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30pt">&#160;</td>
    <td style="vertical-align:top;width:auto">&#160;</td> </tr>
  </table> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A
summary of the range of prices for the Company&#8217;s share options for the year ended December&#160;31, 2024 follows:</span></span></div>
</div> </div> </div> </div> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman', Times, serif">&#160;</div> </div> </div>
<ix:nonNumeric id="F20240413052446637_336" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" contextRef="C_20240101to20241231" continuedAt="F20240413130849550" escape="true">

<div>

<div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Exercise
        price range</span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of<br/>options<br/>&#8216;A&#8217; ordinary<br/>shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of<br/>options<br/>&#8216;A&#8217; ordinary<br/>shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$0.12-US$0.99</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446249_102" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">40,356,672</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446252_103" name="trib:WeightedAverageExercisePriceOutstanding" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">0.25</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446253_104" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">5.00</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446255_105" name="trib:NumberOfShareOptionsExercisableShareBasedPayment" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">17,125,422</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446257_106" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.40</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446258_107" name="trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">4.78</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$1.00-US$1.29</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446260_108" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">150,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446266_111" name="trib:WeightedAverageExercisePriceOutstanding" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">1.14</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446270_113" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">2.38</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446274_115" name="trib:NumberOfShareOptionsExercisableShareBasedPayment" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">150,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446278_117" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.76</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446281_119" name="trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">2.36</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446265_110" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">40,506,672</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446569_296" name="trib:NumberOfShareOptionsExercisableShareBasedPayment" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">17,275,422</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Exercise
        price range</span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;ADS<br/>equivalent&#8217;</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;ADS<br/>equivalent&#8217;</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$2.40-US$19.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446316_148" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">2,017,834</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446336_159" name="trib:WeightedAverageExercisePriceOutstanding" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">5.00</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446349_166" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">5.00</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446322_151" name="trib:NumberOfShareOptionsExercisableShareBasedPayment" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">856,271</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446362_173" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">8.00</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446375_180" name="trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">4.78</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$20.00-US$25.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446317_149" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">7,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446338_160" name="trib:WeightedAverageExercisePriceOutstanding" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">22.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446351_167" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">2.38</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446323_152" name="trib:NumberOfShareOptionsExercisableShareBasedPayment" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">7,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446364_174" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">22.80</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446378_181" name="trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">3.38</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446643_339" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">2,025,334</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446644_340" name="trib:NumberOfShareOptionsExercisableShareBasedPayment" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">863,771</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </div> </div> </div> </div> </ix:nonNumeric>

<div>

<div>

<div>

<div style="line-height:1.25">&#160;</div>

<div>

<div>

<div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
weighted-average remaining contractual life of options outstanding at December&#160;31, 2024 was <ix:nonNumeric id="F20240413052446634_334" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20240101to20241231" format="ixt-sec:duryear">4.98</ix:nonNumeric>
years (2023: <ix:nonNumeric id="F20240413052446635_335" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20230101to20231231" format="ixt-sec:duryear">5.03</ix:nonNumeric>
years).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A
summary of the range of prices for the Company&#8217;s share options for the year ended December&#160;31, 2023 follows:</span></span></div>
</div> </div> </div>

<div style="line-height:1.25">&#160;</div> </div> </div> </div>

<div>

<div>

<div>

<div> <ix:continuation id="F20240413130849550">

<div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Exercise price
        range</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;A&#8217;
        ordinary<br/>shares</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;A&#8217;
        ordinary<br/>shares</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$0.12-US$0.99</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446300_139" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">42,266,672</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446301_140" name="trib:WeightedAverageExercisePriceOutstanding" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">0.28</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446303_141" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">5.50</ix:nonNumeric></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446449_223" name="trib:NumberOfShareOptionsExercisableShareBasedPayment" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">15,116,672</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446451_224" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.47</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446453_225" name="trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">4.16</ix:nonNumeric></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$1.00-US$1.74</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119170955938_20240413052446260_108" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">4,648,000</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119170955938_20240413052446266_111" name="trib:WeightedAverageExercisePriceOutstanding" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">1.33</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220119170955938_20240413052446270_113" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">0.79</ix:nonNumeric></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119170955938_20240413052446274_115" name="trib:NumberOfShareOptionsExercisableShareBasedPayment" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">4,648,000</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119170955938_20240413052446278_117" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.33</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220119170955938_20240413052446281_119" name="trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">0.79</ix:nonNumeric></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446305_142" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">46,914,672</ix:nonFraction></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446570_297" name="trib:NumberOfShareOptionsExercisableShareBasedPayment" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">19,764,672</ix:nonFraction></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap">
        <div style="margin-right:62.3pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Exercise
        price range </span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;ADS<br/>equivalent&#8217;</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;ADS<br/>equivalent&#8217;</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$2.40-US$19.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446306_143" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">2,113,334</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446341_162" name="trib:WeightedAverageExercisePriceOutstanding" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">5.64</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446355_169" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">5.50</ix:nonNumeric></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446328_155" name="trib:NumberOfShareOptionsExercisableShareBasedPayment" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">755,834</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446368_176" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.32</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446381_183" name="trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">4.16</ix:nonNumeric></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$20.00-US$34.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446308_144" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">232,400</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446344_163" name="trib:WeightedAverageExercisePriceOutstanding" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">26.54</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446357_170" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">0.79</ix:nonNumeric></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446327_154" name="trib:NumberOfShareOptionsExercisableShareBasedPayment" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">232,400</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446370_177" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">26.54</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20240413052446382_184" name="trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember" format="ixt-sec:duryear">0.79</ix:nonNumeric></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446314_147" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Share" scale="0" decimals="0" format="ixt:num-dot-decimal">2,345,734</ix:nonFraction></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446334_158" name="trib:NumberOfShareOptionsExercisableShareBasedPayment" contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">988,234</ix:nonFraction></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div> </div> </ix:continuation> </div> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">171</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SHARE OPTIONS (CONTINUED)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30pt">&#160;</td>
    <td style="vertical-align:top;width:auto">&#160;</td> </tr>
  </table> </ix:exclude></div>

<div>

<div>

<div>

<div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
for the year under IFRS 2</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
charge for the year is calculated based on the fair value of the options granted which have not yet vested.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25">

<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The
fair value of the options is expensed over the vesting period of the option. In 2024, US$<ix:nonFraction id="F20240413052446645_341" name="trib:ShareBasedPaymentsContinuingOperations" contextRef="C_20240101to20241231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">1,316,000</ix:nonFraction>
(2023: US$<ix:nonFraction id="F20240413052446647_342" name="trib:ShareBasedPaymentsContinuingOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">2,069,000</ix:nonFraction>)
(2022: US$<ix:nonFraction id="F20240413052446649_343" name="trib:ShareBasedPaymentsContinuingOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">1,755,000</ix:nonFraction>)
was charged to the statement of operations split as follows:</span></span></p>

<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </div> </div> </div> </div> </div> <ix:nonNumeric id="F20240413052446069_2" name="ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments &#8211; cost of sales</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446221_87" name="trib:ShareBasedPaymentsCostOfSales" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446223_88" name="trib:ShareBasedPaymentsCostOfSales" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446224_89" name="trib:ShareBasedPaymentsCostOfSales" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments &#8211; selling, general and administrative</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446226_90" name="trib:ShareBasedPaymentsSellingGeneralAndAdministrative" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446229_91" name="trib:ShareBasedPaymentsSellingGeneralAndAdministrative" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,069</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446231_92" name="trib:ShareBasedPaymentsSellingGeneralAndAdministrative" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,755</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        &#8211; continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446232_93" name="trib:ShareBasedPaymentsContinuingOperations" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446234_94" name="trib:ShareBasedPaymentsContinuingOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,069</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446236_95" name="trib:ShareBasedPaymentsContinuingOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,755</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446237_96" name="trib:ShareBasedPaymentsDiscontinuedOperations" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446240_97" name="trib:ShareBasedPaymentsDiscontinuedOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446242_98" name="trib:ShareBasedPaymentsDiscontinuedOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446244_99" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446245_100" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,069</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446247_101" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,755</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </ix:nonNumeric>

<div>

<div>

<div>

<div>

<div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No
share-based payment expense was capitalised in intangible development project assets during the years ended December 31, 2022, 2023 or
2024.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair value of services received in return for share options granted are measured by reference to the fair value of share options granted.
The estimate of the fair value of services received is measured based on a Black-Scholes model. The following are the input assumptions
used in determining the fair value of share options granted in 2024, 2023 and 2022:</span></span></div> </div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25;font-family:Times New Roman, serif;margin-bottom:0pt">

<p style="margin:0pt">&#160;</p> </div> </div> </div> </div> </div> </div> </div> <ix:nonNumeric id="F20240413052446067_1" name="ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Key</span><br/><span style="font-weight:bold">management</span><br/><span style="font-weight:bold">personnel</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Key</span><br/><span style="font-weight:bold">management</span><br/><span style="font-weight:bold">personnel</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Key</span><br/><span style="font-weight:bold">management</span><br/><span style="font-weight:bold">personnel</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">2023</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">2022</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        fair value at measurement date per &#8216;A&#8217; share / (per ADS)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$<ix:nonFraction id="F20240413052446505_259" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" contextRef="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">0.10</ix:nonFraction>
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$<ix:nonFraction id="F20240413052446508_260" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" contextRef="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">2.08</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US<ix:nonFraction id="F20240413052446388_187" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">0.50</ix:nonFraction>
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$<ix:nonFraction id="F20240413052446395_191" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">10.04</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US<ix:nonFraction id="F20240413052446455_226" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">0.19</ix:nonFraction>
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$<ix:nonFraction id="F20240413052446457_227" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">3.80</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Total &#8216;A&#8217;
        share options granted / (ADS&#8217;s equivalent)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446512_263" name="trib:TotalShareOptionsGrantedAdsEquivalent" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">12,100,000
        </ix:nonFraction>/ (<ix:nonFraction id="Fxbrl_20240427021952282" name="trib:TotalShareOptionsGrantedAdsEquivalent" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">605,000</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446390_188" name="trib:TotalShareOptionsGrantedAdsEquivalent" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">19,600,000</ix:nonFraction>
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="F20240413052446396_192" name="trib:TotalShareOptionsGrantedAdsEquivalent" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">980,000</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446458_228" name="trib:TotalShareOptionsGrantedAdsEquivalent" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">29,400,000</ix:nonFraction>
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="F20240413052446460_229" name="trib:TotalShareOptionsGrantedAdsEquivalent" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,470,000</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        share price per &#8216;A&#8217; share / (per ADS)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US<ix:nonFraction id="F20240413052446520_267" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.14</ix:nonFraction>/</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$<ix:nonFraction id="F20240413052446521_268" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.80</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US<ix:nonFraction id="F20240413052446392_189" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.14</ix:nonFraction>
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$<ix:nonFraction id="F20240413052446399_193" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.80</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US<ix:nonFraction id="F20240413052446461_230" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.27</ix:nonFraction>
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$<ix:nonFraction id="F20240413052446463_231" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">5.40</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        exercise price per &#8216;A&#8217; share / (per ADS)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US<ix:nonFraction id="F20240413052446579_302" name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.14</ix:nonFraction>
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$<ix:nonFraction id="F20240413052446576_301" name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.80</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US<ix:nonFraction id="F20240413052446572_298" name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.14</ix:nonFraction>
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$<ix:nonFraction id="F20240413052446575_300" name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.80</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US<ix:nonFraction id="F20240413052446466_232" name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.27</ix:nonFraction>
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$<ix:nonFraction id="F20240413052446573_299" name="ifrs-full:ExercisePriceShareOptionsGranted2019" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">5.40</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        expected volatility</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446565_294" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">74.40</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446530_273" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">40.21</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220120115232807_20240413052446413_201" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">76.79</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        expected life</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446393_190" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" unitRef="Years" scale="0" decimals="0" format="ixt:num-dot-decimal">7</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446407_198" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" unitRef="Years" scale="0" decimals="0" format="ixt:num-dot-decimal">7</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220120115232839_20240413052446411_200" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" unitRef="Years" scale="0" decimals="2" format="ixt:num-dot-decimal">6.82</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        risk-free interest rate</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446526_271" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.06</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20240413052446400_194" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.13</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220120115232851_20240413052446404_196" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.59</ix:nonFraction></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td> </tr>
  </table> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">172</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><span>20.</span></span></span></span></span></span></span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span><span>SHARE
        OPTIONS (CONTINUED)</span></span></span></span></span></span></span></span></span></span></span></span></div> </td> </tr>
  <tr>
    <td style="width:30.6pt;vertical-align:top;align:right">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  </table> </ix:exclude></div>

<div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The
expected life of the options is based on historical data and is not necessarily indicative of exercise patterns that may occur. The expected
volatility is based on the historic volatility (calculated based on the expected life of the options). The Group has considered how future
experience may affect historical volatility. The profile and activities of the Group are not expected to change in the immediate future
and therefore Trinity Biotech would expect estimated volatility to be consistent with historical volatility.</span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
model assumed an expected dividend yield of 0%, consistent with the Group&#8217;s current dividend policy.</span></span></p> </div> </div>
</div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20240412232912612" name="ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TRADE AND OTHER PAYABLES</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240412232944780" name="trib:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">December&#160;31,</div>
        <div style="text-align:center;line-height:1.25;font-style:italic">2024</div>
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">December&#160;31,</div>
        <div style="text-align:center;line-height:1.25;font-style:italic">2023</div>
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Trade payables</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115011253185_13" name="ifrs-full:TradeAndOtherCurrentPayables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,833</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115011253185_17" name="ifrs-full:TradeAndOtherCurrentPayables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,885</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Accruals and other liabilities</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230413093602863_xbrl_20220115011253185_43" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,597</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230413093602863_xbrl_20220115011253185_47" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,552</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Amounts payable for financial assets (Note 13)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240413014847971" name="ifrs-full:AmountsPayableToTransfereeInRespectOfTransferredAssets" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240413014852495" name="ifrs-full:AmountsPayableToTransfereeInRespectOfTransferredAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">800</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Payroll taxes</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115011253185_23" name="ifrs-full:CurrentValueAddedTaxPayables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">659</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115011253185_27" name="ifrs-full:CurrentValueAddedTaxPayables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">405</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Employee related social insurance</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115011253185_33" name="trib:EmployeeRelatedSocialInsurance" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">112</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115011253185_37" name="trib:EmployeeRelatedSocialInsurance" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">110</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Contingent consideration</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512172409226_xbrl_20220115011253185_33" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,384</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512172409226_xbrl_20220115011253185_37" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Deferred income</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115011253185_53" name="ifrs-full:DeferredIncomeIncludingContractLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">197</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115011253185_57" name="ifrs-full:DeferredIncomeIncludingContractLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115011253185_83" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,782</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20220115011253185_87" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,802</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Included
in trade and other payables at December 31, 2024 was US$<ix:nonFraction id="Fxbrl_20250513195400990" name="trib:AccruedLiabilitiesToContractedLicencePayments" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">185</ix:nonFraction>,000
(2023: US$<ix:nonFraction id="Fxbrl_20250513195410484" name="trib:AccruedLiabilitiesToContractedLicencePayments" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">144</ix:nonFraction>,000)
relating to contracted licence payments.</span></span></div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20250513014611489" name="ifrs-full:DisclosureOfProvisionsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PROVISIONS</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250513014636905" name="ifrs-full:DisclosureOfOtherProvisionsExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product
        warranty provision</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115013615767_13" name="ifrs-full:WarrantyProvision" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115013615767_17" name="ifrs-full:WarrantyProvision" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Legal &amp; regulatory
        provision</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513015802818_xbrl_20220115013615767_13" name="ifrs-full:LegalProceedingsProvision" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">735</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513015802818_xbrl_20220115013615767_17" name="ifrs-full:LegalProceedingsProvision" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposal-related warranty
        settlement provision</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513015804482_xbrl_20220115013615767_13" name="ifrs-full:OtherProvisions" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513015804482_xbrl_20220115013615767_17" name="ifrs-full:OtherProvisions" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restructuring provision</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513015805985_xbrl_20220115013615767_13" name="ifrs-full:RestructuringProvision" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,594</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513015805985_xbrl_20220115013615767_17" name="ifrs-full:RestructuringProvision" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115013615767_33" name="ifrs-full:Provisions" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,529</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115013615767_37" name="ifrs-full:Provisions" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513015808146_xbrl_20220115013615767_13" name="ifrs-full:CurrentProvisions" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,454</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513015808146_xbrl_20220115013615767_17" name="ifrs-full:CurrentProvisions" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513015809825_xbrl_20220115013615767_13" name="ifrs-full:NoncurrentProvisions" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513015809825_xbrl_20220115013615767_17" name="ifrs-full:NoncurrentProvisions" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
2024 and 2023 the Group experienced no significant product warranty claims. However, the Group believes that it is appropriate to retain
a product warranty provision to cover any future claims. The provision at December&#160;31, 2024 represents the estimated cost of product
warranties, the exact amount which cannot be determined. US$<ix:nonFraction id="Fxbrl_20220115013748990" name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" contextRef="C_20240101to20241231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">50,000</ix:nonFraction>
represents management&#8217;s best estimate of these obligations at December&#160;31, 2024.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year ended December 31, 2024, the Group recognised a provision of US$<ix:nonFraction id="Fxbrl_20250513022002176" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_ifrsfullRestructuringProvisionMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">150,000</ix:nonFraction>
in respect of a post-completion settlement related to the sale of Fitzgerald Industries. The settlement agreement was finalised prior
to year-end and signed in January 2025. The provision is payable in two instalments: US$<ix:nonFraction id="Fxbrl_20250513022039625" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_ifrsfullRestructuringProvisionMember_tribInstalmentsAxis_tribWithinOneYearMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">75,000</ix:nonFraction>
within one year and US$<ix:nonFraction id="Fxbrl_20250513022051867" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_ifrsfullRestructuringProvisionMember_tribInstalmentsAxis_tribMoreThanOneYearMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">75,000</ix:nonFraction>
after more than one year. Refer to note 25 for further details.</span></span></div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25">

<div><ix:exclude>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">173</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PROVISIONS (CONTINUED)</span></span></div> </td>
        </tr>
  <tr>
    <td style="width:28.35pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  </table> </ix:exclude></div>

<div style="margin-left:41px;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25">During
the year, the Group recognised a provision of US$<ix:nonFraction id="Fxbrl_20250514170850817" name="ifrs-full:LegalProceedingsProvision" contextRef="C_20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction>
million in respect of a legacy matter currently subject to resolution. Owing to the sensitive nature of ongoing discussions, further disclosure
has been withheld in accordance with&#160;<span style="font-style:italic">IAS 37.92:&#160;seriously prejudicial exemption for non-disclosure
of certain information on&#160;provision</span>, as the Directors believe such disclosure could seriously prejudice the Group&#8217;s
position.</span></span></span></div>

<div style="text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25">&#160;</span></span></span></div>

<div style="margin-left:41px;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25">At
31 December 2024, the Company recognised a provision of US$<ix:nonFraction id="Fxbrl_20250514170453148" name="trib:AdditionalRestructuringCosts" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.9</ix:nonFraction>
million (2023: US$<ix:nonFraction id="Fxbrl_20250514170504937" name="trib:AdditionalRestructuringCosts" contextRef="C_20230101to20231231" unitRef="USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">nil</ix:nonFraction>)
in respect of restructuring activities undertaken as part of the Group&#8217;s business transformation programme (refer to Note 5). The
restructuring provision is expected to be fully utilised during the next 12 months. No further restructuring provisions are anticipated
at the reporting date.</span></span></span></div> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20250513100914500" name="ifrs-full:DisclosureOfBorrowingsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INTEREST-BEARING LOANS AND BORROWINGS</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
carrying value of interest-bearing loans, borrowings and related balances is as follows:</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20250513101130981" name="ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        senior notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181301339" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181318945" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181322303" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181325775" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181349926_xbrl_20230414181301339" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181349926_xbrl_20230414181318945" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,109</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        financial liability</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181352315_xbrl_20230414181301339" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,658</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181352315_xbrl_20230414181318945" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">526</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingent
        liability (Note 29)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513185256289_xbrl_20230414181352315_xbrl_20230414181301339" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribContingentLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,813</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513185256289_xbrl_20230414181352315_xbrl_20230414181318945" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribContingentLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181354329_xbrl_20230414181301339" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181354329_xbrl_20230414181318945" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,542</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        non-current liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181356281_xbrl_20230414181301339" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">91,263</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181356281_xbrl_20230414181318945" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55,177</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Current
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        financial asset</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181358957_xbrl_20230414181301339" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember_ifrsfullClassesOfFinancialAssetsAxis_tribDerivativeFinancialAssetMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">166</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181358957_xbrl_20230414181318945" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember_ifrsfullClassesOfFinancialAssetsAxis_tribDerivativeFinancialAssetMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        non-current assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181401574_xbrl_20230414181301339" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">166</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414181401574_xbrl_20230414181318945" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
senior notes</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
January 2022, the Company retired approximately US$<ix:nonFraction id="Fxbrl_20240430031135602" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">99.7</ix:nonFraction>
million of the Exchangeable Notes as part of a debt re-financing. This represented approximately <ix:nonFraction id="Fxbrl_20240430031451722" name="trib:TotalExchangeableNotesPercentage" contextRef="C_20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">99.7</ix:nonFraction>%
of the total Exchangeable Notes. Consideration was in cash and an issue of &#8216;A&#8217; Ordinary shares. The cash paid was US$<ix:nonFraction id="Fxbrl_20240430031520538" name="trib:CashPaidToEachHolder" contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember" unitRef="USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">86.73</ix:nonFraction>
million with each holder that was party to the agreement receiving US$<ix:nonFraction id="Fxbrl_20240430031730882" name="trib:CashReceivedPerNominalValue" contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember" unitRef="USD" scale="0" decimals="2" format="ixt:num-dot-decimal">0.87</ix:nonFraction>
of cash per US$<ix:nonFraction id="Fxbrl_20240430031804826" name="trib:NominalAmountOfDebt" contextRef="C_20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">1</ix:nonFraction>
nominal value of the Exchangeable Notes. The shares consideration was <ix:nonFraction id="Fxbrl_20240430031930690" name="trib:SharesConsideration" contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,066,600</ix:nonFraction>
ADSs (<ix:nonFraction id="Fxbrl_20240430032040986" name="trib:SharesConsideration" contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">21,332,000</ix:nonFraction>
&#8216;A&#8217; Ordinary shares) representing the equivalent of US$<ix:nonFraction id="Fxbrl_20240430032116498" name="trib:SharesRepresentationRateComparedToADS" contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.40</ix:nonFraction>
of the Company&#8217;s ADS (based upon the 5-day trailing VWAP of the ADSs on NASDAQ on December 10, 2021, discounted by <ix:nonFraction id="Fxbrl_20240430032538018" name="trib:ExchangeableNotesDiscountRate" contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">13</ix:nonFraction>%)
per US$<ix:nonFraction id="Fxbrl_20240430032551721" name="trib:CashReceivedPerNominalValue" contextRef="C_20211201to20211210_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">1</ix:nonFraction>
nominal value of the Exchangeable Notes, as partial consideration for the exchange of the Exchangeable Notes. The shares consideration
is valued at US$<ix:nonFraction id="Fxbrl_20240430032613737" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20211201to20211210_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.1</ix:nonFraction>
million based on market price on the date of issue.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div> </div>

<div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">174</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INTEREST-BEARING LOANS AND BORROWINGS (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
senior notes (continued)</span></span></div>

<div style="line-height:1.25">&#160;</div> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Exchangeable Notes were treated as a host debt instrument under IFRS with embedded derivatives attached. The embedded derivatives related
to a number of put and call options which were measured at fair value in the consolidated statement of operations. On initial recognition
in 2015, the host debt instrument was recognised at the residual value of the total net proceeds of the note issue less fair value of
the embedded derivatives. Subsequently, the host debt instrument was measured at amortised cost using the effective interest rate method.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
date of disposal, the carrying value of the extinguished Exchangeable Notes was US$<ix:nonFraction id="Fxbrl_20230414184822058" name="trib:ExtinguishmentOfDebtAmounts" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">83.2</ix:nonFraction>
million. As the IFRS measure of consideration was higher by US$<ix:nonFraction id="Fxbrl_20230414184921630" name="trib:LossOnDisposalOnBorrowings" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.7</ix:nonFraction>
million, the resulting loss on disposal was recorded as a financial expense in the year ended December 31, 2022. The remaining nominal
value of the Exchangeable Notes at December 31, 2024 is US$<ix:nonFraction id="Fxbrl_20230414184953504" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">210,000</ix:nonFraction>
and this is shown within Current Liabilities.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement in the exchangeable notes balance was as follows:</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240422141924647" name="trib:DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422141856422_xbrl_20240413151643948" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422141856422_xbrl_20240413153445408" name="ifrs-full:Borrowings" contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liability</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422141856445_xbrl_20240413153357597" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422141856445_xbrl_20240413153547159" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
secured term loan</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Company and its subsidiaries entered into a US$<ix:nonFraction id="Fxbrl_20240422151759693" name="ifrs-full:NotionalAmount" contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">81.3</ix:nonFraction>
million senior secured term loan credit facility in December 2021 with Perceptive, an investment manager with an expertise in healthcare.
The Term Loan was drawn down in January 2022. <ix:nonNumeric id="Fxbrl_20240422151834381" name="ifrs-full:BorrowingsInterestRateBasis" contextRef="C_20220101to20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember">The
Term Loan is secured by a charge over the Group&#8217;s assets. The 48-month Term Loan was originally due to expire in January 2026, however
this has since been amended to a maturity date of July 2026. The loan accrues interest at an annual rate equal to 11.25% plus the greater
of (a) one-month LIBOR (later changed to the Term SOFR Reference Rate effective from October 28, 2022) and (b) one percent per annum,
and interest is payable monthly in arrears in cash.</ix:nonNumeric> In connection with the initial draw down of the Term Loan the Company
agreed to issue warrants to Perceptive for <ix:nonFraction id="Fxbrl_20240422151846999" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">500,000</ix:nonFraction>
of the Company&#8217;s ADSs.&#160; The per ADS exercise price of the Warrants was US$<ix:nonFraction id="Fxbrl_20240422151859615" name="trib:ExercisePriceOfWarrantsOrRights" contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">6.50</ix:nonFraction>.</span></span></div>
</div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Term Loan can be repaid, in part or in full, at a premium before the end of the four-year term at the discretion of the Company.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
accordance with IFRS accounting standards, the Term Loan is represented by three separate balances in the statement of financial position,
US$<ix:nonFraction id="Fxbrl_20240422154334927" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">72.4</ix:nonFraction>
million (2023: US$<ix:nonFraction id="Fxbrl_20240422154342702" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">40.1</ix:nonFraction>
million) is shown as a non-current liability balance representing the carrying value of the loan, a derivative financial asset estimated
at US$<ix:nonFraction id="Fxbrl_20240422154409268" name="ifrs-full:DerivativeFinancialAssets" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction>
million (2023: US$<ix:nonFraction id="Fxbrl_20240422154352520" name="ifrs-full:DerivativeFinancialAssets" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction>
million) representing the value to the Company of being able to repay the Term Loan early and potentially refinance at a lower interest
rate and a derivative financial liability estimated at US$<ix:nonFraction id="Fxbrl_20240422154412711" name="ifrs-full:DerivativeFinancialLiabilities" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.7</ix:nonFraction>
million (2023: US$<ix:nonFraction id="Fxbrl_20240422154356864" name="ifrs-full:DerivativeFinancialLiabilities" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction>
million) representing the fair value of the warrants issued to Perceptive.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
May 2022, the Company repaid US$<ix:nonFraction id="Fxbrl_20240422155223637" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="C_20220501to20220522_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">34.5</ix:nonFraction>
million of the term loan principal and incurred an early payment penalty of approximately US$<ix:nonFraction id="Fxbrl_20240422155226871" name="trib:PaymentOfPenalty" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.5</ix:nonFraction>
million, which has been recorded as a financial expense in the year ended December 31, 2022.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
February 2023, the Company announced that it had entered into an amended and restated senior secured Term Loan credit facility to allow
for an immediate US$<ix:nonFraction id="Fxbrl_20240422152511388" name="ifrs-full:NotionalAmount" contextRef="C_20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">5</ix:nonFraction>
million increase to the outstanding Term Loan and provide for a US$<ix:nonFraction id="Fxbrl_20240422152535967" name="ifrs-full:GrossLoanCommitments" contextRef="C_20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">20</ix:nonFraction>
million facility to fund potential acquisitions. In connection with the increased loan facility, <ix:nonFraction id="Fxbrl_20240422152643439" name="trib:NumberOfWarrantsRepriced" contextRef="C_20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">500,000</ix:nonFraction>
warrants originally issued under the Term Loan were repriced, with the Warrants having a per ADS exercise price of US$<ix:nonFraction id="Fxbrl_20240422152656951" name="trib:ExercisePriceOfWarrantsOrRights" contextRef="C_20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">5.36</ix:nonFraction>
compared to their initial per ADS exercise price of US$<ix:nonFraction id="Fxbrl_20240422152711508" name="trib:InitialExercisePriceOfWarrantsOrRights" contextRef="C_20230201to20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">6.50</ix:nonFraction>.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On
April 27, 2023, the Company announced that it had closed the sale of our Fitzgerald Industries life sciences supply business, the Company
used approximately US$<ix:nonFraction id="Fxbrl_20240422152750626" name="trib:ProceedsFromSaleOfBusiness" contextRef="C_20230401to20230427_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSaleOfFitzgeraldIndustriesMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">11</ix:nonFraction>
million of the proceeds of this sale to repay approximately US$<ix:nonFraction id="Fxbrl_20240422152802294" name="ifrs-full:NotionalAmount" contextRef="C_20230427_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSaleOfFitzgeraldIndustriesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.1</ix:nonFraction>
million of its senior secured debt held by Perceptive plus an approximately US$<ix:nonFraction id="Fxbrl_20240422152844976" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="C_20230401to20230427_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSaleOfFitzgeraldIndustriesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.9</ix:nonFraction>
million early repayment penalty, which has been recorded as a financial expense in the year ended December 31, 2023. In connection with
this transaction, the Company entered an amendment to its senior secured Term Loan credit facility with Perceptive Advisors, which significantly
reduced the Company&#8217;s minimum revenue covenants under that loan.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">175</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INTEREST-BEARING LOANS AND BORROWINGS (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
January 2024, as part of the agreement to purchase the Waveform assets, we entered into an amended credit agreement with Perceptive. Under
this agreement, an additional US$<ix:nonFraction id="Fxbrl_20240422163310593" name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="C_20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">22</ix:nonFraction>
million of funding has been made available to us, with US$<ix:nonFraction id="Fxbrl_20240422163339660" name="trib:AmountUsedToAcquireTheCGMAssets" contextRef="C_20240101to20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.5</ix:nonFraction>
million being used to acquire the Waveform assets. The remaining US$<ix:nonFraction id="Fxbrl_20240422163411995" name="trib:AmountAvailableForDevelopmentOfTheCGM" contextRef="C_20240101to20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.5</ix:nonFraction>
million was made available for general corporate purposes including for the further development of the CGM and biosensor technologies.
The Amended Term Loan also provides for additional liquidity of up to US$<ix:nonFraction id="Fxbrl_20240422163436676" name="trib:AdditionalLiquidityRecognizedAsOfAcquisitionDate" contextRef="C_20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.5</ix:nonFraction>
million, that may be drawn down between April and December 2024 and can be used for general corporate purposes. In April 2024, the Company
drew down the additional funding of US$<ix:nonFraction id="Fxbrl_20240422163508403" name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="C_20240430_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.5</ix:nonFraction>
million as prescribed in the Amended Term Loan agreement. This funding will be used for general corporate purposes, including the further
development of our CGM offering.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">I</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt">n
December 2024, the Company entered into a further amendment to the credit agreement with Perceptive. As part of this amendment, the Company
drew down an additional US$2 million for general corporate purposes. We also agreed that certain interest payments payable in 2024 and
2025 would be paid-in-kind on the applicable payment date by increasing the outstanding principal amount of the Term Loan. This included
the interest payments due for the period from September through December 2024, which were settled through PIK. Additionally, as part of
this amendment the Company granted Perceptive new warrants to purchase an additional </span><ix:nonFraction id="Fxbrl_20250513164652156" name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">1,500,000</ix:nonFraction><span style="font-family:Times New Roman, Times, serif;font-size:10pt">
ADSs at an exercise price of US$</span><ix:nonFraction id="Fxbrl_20250513164704394" name="trib:ExercisePriceOfWarrantsOrRights" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.80</ix:nonFraction><span style="font-family:Times New Roman, Times, serif;font-size:10pt">
per ADS, and the exercise price of its existing ADS warrants was also reset to US$</span><ix:nonFraction id="Fxbrl_20250513164739760" name="trib:ExercisePriceOfWarrantsOrRights" contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.80</ix:nonFraction><span style="font-family:Times New Roman, Times, serif;font-size:10pt">
per ADS.</span>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
issuance of additional warrants and repricing of existing warrants was not considered a modification of the original financial liability
under IFRS. All warrants are classified as financial liabilities and are measured at fair value through profit or loss. For the year ended
December 31, 2024, a non-cash fair value loss of US$<ix:nonFraction id="Fxbrl_20250513164756763" name="trib:NonCashFairValueGainLoss" contextRef="C_20240101to20241231_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.1</ix:nonFraction>
million was recognized in finance expense, reflecting the initial recognition of the newly issued warrants, the repricing of existing
warrants, and subsequent remeasurement of all warrant liabilities.</span></span></p> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year ended December 31, 2024 accretion interest of US$<ix:nonFraction id="Fxbrl_20240422151328218" name="trib:AccretionInterestAccrued" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.4</ix:nonFraction>
million (2023: US$<ix:nonFraction id="Fxbrl_20240422151340317" name="trib:AccretionInterestAccrued" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.1</ix:nonFraction>
million) was accrued to leave a closing carrying value of US$<ix:nonFraction id="Fxbrl_20240422151354398" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">72.4</ix:nonFraction>
million at year end (2023: US$<ix:nonFraction id="Fxbrl_20240422151409223" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">40.1</ix:nonFraction>
million).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
secured term loan</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement in the Term Loan was as follows:</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240422142510583" name="trib:ScheduleOfMovementInTermLoanExplanatoryTableTextBlock" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142449825_xbrl_20240413154956640" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,109</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142449825_xbrl_20240413155602222" name="ifrs-full:Borrowings" contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,301</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal amount loaned</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142449828_xbrl_20240413155037289" name="trib:PrincipalAmountLoaned" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,500</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142449828_xbrl_20240413155624030" name="trib:PrincipalAmountLoaned" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loan drawdown costs</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142449833_xbrl_20240413155138259" name="trib:LoanOriginationCosts" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">325</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142449833_xbrl_20240413155633061" name="trib:LoanOriginationCosts" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">194</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative financial
        liability at date of drawdown</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142449837_xbrl_20240413155227609" name="trib:DerivativeFinancialLiabilityAtDateOfIssue" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142449837_xbrl_20240413155647846" name="trib:DerivativeFinancialLiabilityAtDateOfIssue" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">90</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative financial
        asset at date of drawdown</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142449841_xbrl_20240413155250033" name="trib:DerivativeFinancialAssetAtDateOfIssue" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">28</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142449841_xbrl_20240413155659638" name="trib:DerivativeFinancialAssetAtDateOfIssue" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accretion interest (Note
        6)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142449845_xbrl_20240413155330514" name="trib:AccretionInterestOnBorrowings" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,355</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142449845_xbrl_20240413155716819" name="trib:AccretionInterestOnBorrowings" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,131</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash repayment of principal</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142449850_xbrl_20240413155359262" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142449850_xbrl_20240413155723772" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,050</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Payment-in-kind (PIK)
        Interest</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250513190135118_xbrl_20240422142449850_xbrl_20240413155359262" name="trib:PaymentInKindInterest" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,291</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513190135118_xbrl_20240422142449850_xbrl_20240413155723772" name="trib:PaymentInKindInterest" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash Loan Modification
        Gain</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513190136889_xbrl_20240422142449850_xbrl_20240413155359262" name="trib:NoncashLoanModificationGain" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,567</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513190136889_xbrl_20240422142449850_xbrl_20240413155723772" name="trib:NoncashLoanModificationGain" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December&#160;31</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142449852_xbrl_20240413155420671" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142449852_xbrl_20240413155732445" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,109</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair value of the derivative financial asset is estimated at US$<ix:nonFraction id="Fxbrl_20240422150337522" name="trib:FairValueOfDerivativeFinancialAsset" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction>
million at December 31, 2024 (2023: US$<ix:nonFraction id="Fxbrl_20240422150351309" name="trib:FairValueOfDerivativeFinancialAsset" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction>
million). The fair value of the derivative financial liability is estimated at US$<ix:nonFraction id="Fxbrl_20240422150405751" name="trib:FairValueOfDerivativeFinancialLiability" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.7</ix:nonFraction>
million at December 31, 2023 (2023: $<ix:nonFraction id="Fxbrl_20240422150416786" name="trib:FairValueOfDerivativeFinancialLiability" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction>
million) The fair value remeasurement for these two derivative financial balances at December 31, 2024, resulted in the recognition of
net financial income of US$<ix:nonFraction id="Fxbrl_20240422150436535" name="ifrs-full:Borrowings" contextRef="C_20240131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">26,000</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20240422150500521" name="ifrs-full:DerivativeFinancialLiabilities" contextRef="C_20240131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.2</ix:nonFraction>
million) in the consolidated statement of operations.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">176</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INTEREST-BEARING LOANS AND BORROWINGS (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
Q1 2024, <ix:nonNumeric id="Fxbrl_20250513103151445" name="ifrs-full:BorrowingsInterestRateBasis" contextRef="C_20240101to20240331_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember">the
Company negotiated a 2.5% reduction in the base interest rate on its term loan facility, lowering the rate from 11.25% to 8.75%.</ix:nonNumeric>
In accordance with IFRS 9, this amendment was treated as a non-substantial modification of the financial liability. As a result, the carrying
amount of the loan was remeasured using the original effective interest rate (EIR), and a non-cash gain of $<ix:nonFraction id="Fxbrl_20250513103447376" name="trib:NonCashFairValueGainLoss" contextRef="C_20240101to20240331_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.6</ix:nonFraction>
million was recognised in finance income. This gain reflects the difference between the previous carrying amount of the loan and the present
value of the modified cash flows, discounted at the original EIR, and is presented in the consolidated statement of operations as a &#8220;Non-cash
loan modification gain.&#8221;.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingent
liability</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
part of the consideration for the acquisition of the CGM assets from Waveform Technologies, Inc., the Group recognised a contingent liability
of US$<ix:nonFraction id="Fxbrl_20250513104051435" name="ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20240331_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.8</ix:nonFraction>
million at the acquisition date. This relates to potential additional consideration payable upon entering into certain commercial partnering
agreements with designated glucose pump manufacturers within 24 months of the acquisition. As the payment is subject to the occurrence
of uncertain future events, it is disclosed as a contingent liability rather than a recognised financial liability. Refer to Note 29.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement in the derivative financial asset in the year was as follows:</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240422142914653" name="trib:DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142841318_xbrl_20230414183713981_xbrl_20230414183539889" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142841318_xbrl_20240413144931606" name="ifrs-full:Borrowings" contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">128</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative financial
        asset at date of drawdown</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142841321_xbrl_20230414183720925_xbrl_20230414183608068" name="trib:DerivativeFinancialAssetAtDateOfDrawdown" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142841321_xbrl_20240413144951574" name="trib:DerivativeFinancialAssetAtDateOfDrawdown" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustments
        in the period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142841325_xbrl_20230414183726350_xbrl_20230414183623509" name="ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">40</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142841325_xbrl_20240413145004422" name="ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current asset at
        December 31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142841329_xbrl_20230414183733827_xbrl_20230414183647256" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">166</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142841329_xbrl_20240413145026249" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement in the derivative financial liability in the year was as follows:</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240422142901408" name="trib:DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142825814_xbrl_20230414183539889" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">526</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142825814_xbrl_20240413144812614" name="ifrs-full:Borrowings" contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,569</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative financial
        liability at date of drawdown</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142825817_xbrl_20230414183608068" name="trib:DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,066</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142825817_xbrl_20240413144820918" name="trib:DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">90</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustments
        in the period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142825821_xbrl_20230414183623509" name="ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">66</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240422142825821_xbrl_20240413144828509" name="ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,133</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liability
        at December 31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142825825_xbrl_20230414183647256" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,658</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422142825825_xbrl_20240413144847981" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">526</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7-year
convertible note</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
May 2022, the Company completed a US$<ix:nonFraction id="Fxbrl_20240422140239092" name="ifrs-full:NotionalAmount" contextRef="C_20220531_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">45.2</ix:nonFraction>
million investment from MiCo IVD Holdings, LLC. Based on public filings, we understand that on December 17, 2024, MiCo was acquired by
Dayli Trinity Holdings Limited as a result of a share purchase agreement with Mainstream Holdings Limited. The investment consists of
an equity investment of US$<ix:nonFraction id="Fxbrl_20240422140247127" name="trib:EquityComponentOfConvertibleNote" contextRef="C_20220531_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">25.2</ix:nonFraction>
million and a seven-year, unsecured junior convertible note of US$<ix:nonFraction id="Fxbrl_20240422140255374" name="trib:PrincipalAmountLoaned" contextRef="C_20220501to20220531_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.0</ix:nonFraction>
million. <ix:nonNumeric id="Fxbrl_20240422140308845" name="ifrs-full:DescriptionOfConversionOfDebtToEquity" contextRef="C_20220501to20220531_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember">The
convertible note has an interest rate of 1.5%. The convertible note mandatorily converts into ADSs if the volume weighted average price
of the Company&#8217;s ADSs is at or above US$16.20 for any five consecutive NASDAQ trading days.</ix:nonNumeric> For further details
on the convertible note, refer to the Company&#8217;s Form 6-K filings with the SEC on April 11, 2022.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div> </div>

<div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">177</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INTEREST-BEARING LOANS AND BORROWINGS (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
convertible loan note is accounted for as a compound financial instrument containing both an equity and liability element. The debt component
is accounted for at amortised cost in accordance with IFRS 9. At December 31, 2024, the carrying value of the convertible note&#8217;s
debt component was US$<ix:nonFraction id="Fxbrl_20240413170903945" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.4</ix:nonFraction>
million (2023: US$<ix:nonFraction id="Fxbrl_20230414192959649" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">14.5</ix:nonFraction>
million) and accretion interest of US$<ix:nonFraction id="Fxbrl_20230414193014660" name="trib:AccretionInterestOnBorrowings" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.9</ix:nonFraction>
million (2023: US$<ix:nonFraction id="Fxbrl_20240413170922106" name="trib:AccretionInterestOnBorrowings" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction>
million) has been recognised as a financial expense in the year. The equity component of the convertible note is US$<ix:nonFraction id="Fxbrl_20230414193035798" name="trib:EquityComponentAtDateOfIssue" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.7</ix:nonFraction>
million and has been recorded in the equity section of the statement of financial position as Equity component of convertible note. There
is no remeasurement of the equity element following initial recognition.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement in the 7-year convertible note in the year was as follows:</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240413144009342" name="trib:DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413145732182" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,542</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413150212608" name="ifrs-full:Borrowings" contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,746</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accretion interest</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413150022221" name="trib:AccretionInterestOnBorrowings" contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">859</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413150334085" name="trib:AccretionInterestOnBorrowings" contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">796</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liability
        at December 31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413150049140" name="ifrs-full:Borrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413150341084" name="ifrs-full:Borrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,542</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </ix:nonNumeric> </div> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <ix:nonNumeric id="Fxbrl_20220115030203125" name="ifrs-full:DisclosureOfLeasesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">LEASE LIABILITIES</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group has leases for some of its manufacturing plants, all warehouses, offices, motor vehicles and some IT equipment. With the exception
of short-term leases and leases of low-value underlying assets, each lease is reflected on the balance sheet as a right-of-use asset (net
of any depreciation and/or impairment) and a lease liability. Variable lease payments which do not depend on an index or a rate (such
as lease payments based on a percentage of Group sales) are excluded from the initial measurement of the lease liability and asset. The
Group classifies its right-of-use assets in a consistent manner to its property, plant and equipment (see Note 11).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Each
lease generally imposes a restriction that, unless there is a contractual right for the Group to sublet the asset to another party, the
right-of-use asset can only be used by the Group. Leases are either non-cancellable or may only be cancelled by incurring a substantive
termination fee. Some leases contain an option to purchase the underlying leased asset outright at the end of the lease, or to extend
the lease for a further term. The Group is prohibited from selling or pledging the underlying leased assets as security. For leases over
office buildings and factory premises the Group must keep those properties in a good state of repair and return the properties in their
original condition at the end of the lease. Further, the Group must insure items of property, plant and equipment and incur maintenance
fees on such items in accordance with the lease contracts.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
liabilities</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
liabilities are payable as follows:</span></span></div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;</span></span></div>

<div style="line-height:1.25;margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240422124037901" name="trib:DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities related to Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115030252898_23" name="trib:LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,285</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115030252898_27" name="trib:LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,694</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115030252898_53" name="trib:CurrentFinanceLeaseLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,285</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115030252898_57" name="trib:CurrentFinanceLeaseLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,694</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities related to Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115030252898_83" name="trib:LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,477</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220115030252898_87" name="trib:LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,872</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240413021521911" name="trib:DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory" contextRef="C_20240101to20241231" continuedAt="F20250515104351838" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities related to</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right
        of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Minimum</span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">lease</span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">payments</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less
        than one year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413015910226" name="trib:MinimumFinanceLeasePaymentsPayable" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,862</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413015918007" name="trib:InterestExpenseOnLeaseLiabilities1" contextRef="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">577</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413015947753" name="trib:MinimumFinanceLeasePaymentsPayableAtPresentValue" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,285</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        more than one year, but not more than two</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413020019672_xbrl_20240413015910226" name="trib:MinimumFinanceLeasePaymentsPayable" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,214</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413020019672_xbrl_20240413015918007" name="trib:InterestExpenseOnLeaseLiabilities1" contextRef="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">472</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413020019672_xbrl_20240413015947753" name="trib:MinimumFinanceLeasePaymentsPayableAtPresentValue" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,742</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        more than two years but not more than five</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413020021692_xbrl_20240413015910226" name="trib:MinimumFinanceLeasePaymentsPayable" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,487</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413020021692_xbrl_20240413015918007" name="trib:InterestExpenseOnLeaseLiabilities1" contextRef="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">955</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413020021692_xbrl_20240413015947753" name="trib:MinimumFinanceLeasePaymentsPayableAtPresentValue" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,532</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">More
        than five years</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413020023537_xbrl_20240413015910226" name="trib:MinimumFinanceLeasePaymentsPayable" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,652</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413020023537_xbrl_20240413015918007" name="trib:InterestExpenseOnLeaseLiabilities1" contextRef="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">449</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413020023537_xbrl_20240413015947753" name="trib:MinimumFinanceLeasePaymentsPayableAtPresentValue" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,203</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413020025218_xbrl_20240413015910226" name="trib:MinimumFinanceLeasePaymentsPayable" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,215</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413020025218_xbrl_20240413015918007" name="trib:InterestExpenseOnLeaseLiabilities1" contextRef="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,453</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413020025218_xbrl_20240413015947753" name="trib:MinimumFinanceLeasePaymentsPayableAtPresentValue" contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,762</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </ix:nonNumeric> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">179</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top">24.</td>
    <td style="width:auto;vertical-align:top">
        <div>LEASE LIABILITIES (CONTINUED)</div> </td> </tr>
  </table>

<div style="margin-left:36pt">&#160;</div> </ix:exclude></div> <ix:continuation id="F20250515104351838">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities related to</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right
        of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Minimum</span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">lease</span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">payments</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less
        than one year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165533728_xbrl_20240413015910226" name="trib:MinimumFinanceLeasePaymentsPayable" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,221</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165533728_xbrl_20240413015918007" name="trib:InterestExpenseOnLeaseLiabilities1" contextRef="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">577</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165533728_xbrl_20240413015947753" name="trib:MinimumFinanceLeasePaymentsPayableAtPresentValue" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,644</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        more than one year, but not more than two</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165533731_xbrl_20240413020019672_xbrl_20240413015910226" name="trib:MinimumFinanceLeasePaymentsPayable" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,243</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165533731_xbrl_20240413020019672_xbrl_20240413015918007" name="trib:InterestExpenseOnLeaseLiabilities1" contextRef="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">498</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165533731_xbrl_20240413020019672_xbrl_20240413015947753" name="trib:MinimumFinanceLeasePaymentsPayableAtPresentValue" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,745</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        more than two years but not more than five</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165533734_xbrl_20240413020021692_xbrl_20240413015910226" name="trib:MinimumFinanceLeasePaymentsPayable" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,442</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165533734_xbrl_20240413020021692_xbrl_20240413015918007" name="trib:InterestExpenseOnLeaseLiabilities1" contextRef="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,017</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165533734_xbrl_20240413020021692_xbrl_20240413015947753" name="trib:MinimumFinanceLeasePaymentsPayableAtPresentValue" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,425</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">more
        than five years</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165533739_xbrl_20240413020023537_xbrl_20240413015910226" name="trib:MinimumFinanceLeasePaymentsPayable" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,400</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165533739_xbrl_20240413020023537_xbrl_20240413015918007" name="trib:InterestExpenseOnLeaseLiabilities1" contextRef="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">648</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165533739_xbrl_20240413020023537_xbrl_20240413015947753" name="trib:MinimumFinanceLeasePaymentsPayableAtPresentValue" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,752</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165718363_xbrl_20240413020025218_xbrl_20240413015910226" name="trib:MinimumFinanceLeasePaymentsPayable" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,306</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165718363_xbrl_20240413020025218_xbrl_20240413015918007" name="trib:InterestExpenseOnLeaseLiabilities1" contextRef="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,740</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512165718363_xbrl_20240413020025218_xbrl_20240413015947753" name="trib:MinimumFinanceLeasePaymentsPayableAtPresentValue" contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,566</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </ix:continuation>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-weight:bold;margin-left:30.6pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
payments not recognised as a liability</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No
short-term lease expenses were incurred for the year ended December 31, 2024. Payments made under such leases are expensed on a straight-line
basis. In addition, certain variable lease payments are not permitted to be recognised as lease liabilities and are expensed as incurred.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25">

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The total paid in respect
of lease liabilities in the year ended December 31, 2024, was US$<ix:nonFraction id="Fxbrl_20220422115212946" name="trib:AmountPaidInRespectOfLeaseLiabilities" contextRef="C_20240101to20241231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">2,503,000</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20220115042811316" name="trib:AmountPaidInRespectOfLeaseLiabilities" contextRef="C_20230101to20231231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">2,318,000</ix:nonFraction>).</span></span></div>
</div> </div> </div> </ix:nonNumeric>

<p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>

<div>

<div>

<div>

<div> <ix:nonNumeric id="Fxbrl_20230420113024134" name="ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">COMMITMENTS AND CONTINGENCIES</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(a)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital
        Commitments</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group has capital commitments authorised and contracted for of US$<ix:nonFraction id="Fxbrl_20220115150301789" name="ifrs-full:CapitalCommitments" contextRef="C_20241231" unitRef="USD" scale="0" decimals="0" format="ixt-sec:numwordsen">nil</ix:nonFraction>
as at December&#160;31, 2024 (2023: US$<ix:nonFraction id="Fxbrl_20220115150311881" name="ifrs-full:CapitalCommitments" contextRef="C_20231231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">39,900</ix:nonFraction>).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(b)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold;font-style:italic">Leasing
        Commitments</span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:0pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group&#8217;s leasing commitments are shown in Note 24.</span></span></div>

<div style="text-indent:0pt;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">180</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:28.35pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">25.</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">COMMITMENTS
        AND CONTINGENCIES (CONTINUED)</span></span></td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">
  <tr style="vertical-align:top">
    <td style="text-align:right;vertical-align:top;width:28.35pt">
        <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(c)</span></span></div>
        </td>
    <td style="text-align:left;vertical-align:top;width:auto">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold;font-style:italic">Bank
        Security</span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Credit Agreement for the senior secured term loan is secured by substantially all of our property and assets, including our equity interests
in our subsidiaries, refer to Note 23.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
2023, the sale and leaseback liability matured as the lease came to an end and was not renewed, as a result, the bank charge against the
equipment for which the borrowings pertained did not exist as at December 31, 2023.</span></span></div>

<div style="line-height:1.25">&#160;</div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(d)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Group
        Company Guarantees</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant
to the provisions of Section&#160;357, Companies Act, 2014, the Company has guaranteed the liabilities of Trinity Biotech Manufacturing
Limited, Trinity Research Limited and Trinity Biotech Financial Services Limited subsidiary undertakings in the Republic of Ireland, for
the financial year to December&#160;31, 2024 and, as a result, these subsidiary undertakings have been exempted from the filing provisions
of Section&#160;357, Companies Act, 2014. Where the Company enters into these guarantees of the indebtedness of other companies within
its Group, the Company considers these to be insurance arrangements and accounts for them as such.&#160;The Company treats the guarantee
contract as a contingent liability until such time as it becomes probable that the Company will be required to make a payment under the
guarantee.&#160;The Company does not enter into financial guarantees with third parties.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(e)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government
        Grant Contingencies</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group has received training and employment grant income from Irish development agencies. Subject to existence of certain conditions specified
in the grant agreements, this income may become repayable. No such conditions existed as at December&#160;31, 2024. However, if the income
were to become repayable, the maximum amounts repayable as at December&#160;31, 2024 would amount to US$<ix:nonFraction id="Fxbrl_20220115150814507" name="trib:GrantContingenciesMaximumAmountPayable" contextRef="C_20240101to20241231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">3,313,000</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20220115150825428" name="trib:GrantContingenciesMaximumAmountPayable" contextRef="C_20230101to20231231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">3,410,000</ix:nonFraction>).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(f)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingency
        relating to the sale of Fitzgerald Industries</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On
April 27, 2023 the Company announced it had closed the sale of Fitzgerald Industries (&#8220;Fitzgerald&#8221;) to Biosynth for cash proceeds
of approximately US$<ix:nonFraction id="Fxbrl_20240422130046439" name="trib:ProceedsFromSaleOfBusiness" contextRef="C_20230401to20230427_ifrsfullBusinessCombinationsAxis_tribBiosynthMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">30</ix:nonFraction>
million subject to customary adjustments. In a telephone call conducted in March 2024, a representative of Biosynth alleged a breach of
certain of the warranties set out in the Share Purchase Agreement for the sale of Fitzgerald. Following negotiations, a settlement agreement
was finalised prior to December 31, 2024 and subsequently signed in January 2025. Under the terms of the settlement, the Company agreed
to pay Biosynth US$<ix:nonFraction id="Fxbrl_20250512204032555" name="trib:AgreementPayments" contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribBiosynthMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">150,000</ix:nonFraction>
in full and final settlement of all post-completion claims. Accordingly, a provision of US$<ix:nonFraction id="Fxbrl_20250513142611057" name="ifrs-full:OtherProvisions" contextRef="C_20241231_ifrsfullBusinessCombinationsAxis_tribBiosynthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150</ix:nonFraction>,000
has been recorded in the consolidated financial statements as at December 31, 2024, see Note 22. In addition, outstanding receivables
of US$<ix:nonFraction id="Fxbrl_20250512213736245" name="trib:ReceivablesOutstanding" contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribBiosynthMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">423,000</ix:nonFraction>
from Biosynth relating to completion account adjustments were written off as unrecoverable under the terms of the settlement. The settlement
fully resolves all disputes related to the sale of Fitzgerald Industries, and no further liabilities are expected to arise.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(g)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold;font-style:italic">Contingent
        considerations relating to business combinations</span></span></span></td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
part of the acquisition of the CGM assets of Waveform Technologies, Inc., the Company may pay up to US$<ix:nonFraction id="Fxbrl_20250512203112162" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">20</ix:nonFraction>
million in contingent consideration based on share price, trading volume, and commercial milestones. The fair value of this contingent
consideration is US$<ix:nonFraction id="Fxbrl_20250512194624072" name="trib:FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.8</ix:nonFraction>
million as of December 31, 2024. Refer to Note 29 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
part of the acquisition of EpiCapture Limited (see Note 29), contingent consideration of up to US$<ix:nonFraction id="Fxbrl_20250512203656693" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction>
million may become payable based on cumulative revenue targets. The fair value of this contingent consideration is US$<ix:nonFraction id="Fxbrl_20250512194611356" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction>
million as of December 31, 2024. Refer to Note 29 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top">
        <div style="line-height:1.25">(h)</div> </td>
    <td style="width:auto;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold;font-style:italic">Other
        Contingencies</span></span></span></td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Company has other contingencies primarily relating to claims and legal proceedings, onerous contracts, product warranties and employee
related provisions. The status of each significant claim and legal proceeding in which the Company is involved is reviewed by management
on a periodic basis and the Group&#8217;s potential financial exposure is assessed. If the potential loss from any claim or legal proceeding
is considered probable, and the amount can be reliably estimated, a liability is recognised for the estimated loss. Because of the uncertainties
inherent in such matters, the related provisions are based on the best information available at the time; the issues taken into account
by management and factored into the assessment of legal contingencies include, as applicable, the status of settlement negotiations, interpretations
of contractual obligations, prior experience with similar contingencies/claims, and advice obtained from legal counsel and other third
parties. The Group expects the majority of these provisions will be utilised within one to three years of the balance sheet date; however
due to the nature of the legal provisions there is a level of uncertainty in the timing of settlement as the Group generally cannot determine
the extent and duration of the legal process.</span></span></div> </div> </div> </div> </div> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> </div> </div> </div> </div>

<div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">181</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> <ix:nonNumeric id="Fxbrl_20240413053357384" name="ifrs-full:DisclosureOfRelatedPartyExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RELATED PARTY TRANSACTIONS</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group has related party relationships with its subsidiaries, and with its directors and executive officers.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasing
arrangements with related parties</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group has entered into various arrangements with JRJ Investments (&#8220;JRJ&#8221;), a partnership owned by Mr O&#8217;Caoimh and Dr
Walsh, directors of Trinity Biotech, and directly with Mr O&#8217;Caoimh, to provide premises at IDA Business Park, Bray, County Wicklow,
Ireland.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group entered into an agreement with JRJ for a <ix:nonNumeric id="Fxbrl_20230428183528217" name="trib:TermOfLease" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribJrjMember">25-year</ix:nonNumeric>
lease commencing in December 2003 for offices that were adjacent to its then premises at IDA Business Park, Bray, County Wicklow, Ireland
with an annual rent of &#8364;<ix:nonFraction id="Fxbrl_20230428182906230" name="trib:AnnualRentPayable" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribJrjMember" unitRef="EUR" scale="0" decimals="0" format="ixt:num-dot-decimal">381,000</ix:nonFraction>
(US$<ix:nonFraction id="Fxbrl_20250513104142166" name="trib:AnnualRentPayable" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribJrjMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">421,000</ix:nonFraction>).
Upward-only rent reviews are carried out every five years and there have been no increases arising from these rent reviews.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
2007 we entered into a <ix:nonNumeric id="Fxbrl_20250513104408144" name="trib:TermOfLease" contextRef="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_tribJrjMember">25-year</ix:nonNumeric>
lease agreement with JRJ for a <ix:nonFraction id="Fxbrl_20230515110735061" name="trib:RateOfRentPerSqureFoot" contextRef="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhAndDrWalshMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">43,860</ix:nonFraction>
square foot manufacturing facility in Bray, Ireland with an annual rent of &#8364;<ix:nonFraction id="Fxbrl_20230515110806999" name="trib:AnnualRentPayable" contextRef="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhAndDrWalshMember" unitRef="EUR" scale="0" decimals="0" format="ixt:num-dot-decimal">787,000</ix:nonFraction>
(US$<ix:nonFraction id="Fxbrl_20230515110812742" name="trib:AnnualRentPayable" contextRef="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhAndDrWalshMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">834,000</ix:nonFraction>).
Subsequent to the signing of this lease, the ownership of the building transferred from JRJ to Mr O&#8217;Caoimh solely. A rent review
for this property became effective 1 July 2022 and, following an independent valuation, the annual rent increased to &#8364;<ix:nonFraction id="Fxbrl_20250512191408999" name="trib:IncreaseInAnnualRent" contextRef="C_20220701to20220701" unitRef="EUR" scale="0" decimals="0" format="ixt:num-dot-decimal">1,050,000</ix:nonFraction>,
with backdated rent accruing from that date. Included within overhead costs in cost of sales is an amount of $<ix:nonFraction id="Fxbrl_20250513105608436" name="trib:OverheadCosts" contextRef="C_20220701to20220701" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">686,000</ix:nonFraction>
in respect of backdated rent. In 2016, we entered into a <ix:nonNumeric id="Fxbrl_20250513105705235" name="trib:TermOfLease" contextRef="C_20161201to20161231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhAndDrWalshMember">10-year</ix:nonNumeric>
lease with Mr. O&#8217;Caoimh for a warehouse adjacent to our leased manufacturing facility in Bray, Ireland. The warehouse is <ix:nonFraction id="Fxbrl_20230515110918578" name="trib:RateOfRentPerSqureFoot" contextRef="C_20161201to20161231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">16,000</ix:nonFraction>
square feet with an annual rent of &#8364;<ix:nonFraction id="Fxbrl_20230515110905839" name="trib:AnnualRentPayableForWareHouse" contextRef="C_20161201to20161231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhMember" unitRef="EUR" scale="0" decimals="0" format="ixt:num-dot-decimal">144,000</ix:nonFraction>
(US$<ix:nonFraction id="Fxbrl_20230515110912227" name="trib:AnnualRentPayableForWareHouse" contextRef="C_20161201to20161231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">159,000</ix:nonFraction>).
A rent review for this property became effective on 1 July 2021 and, following an independent valuation, the annual rent increased to
&#8364;<ix:nonFraction id="Fxbrl_20250513105822577" name="trib:IncreaseInAnnualRent" contextRef="C_20210701to20210701" unitRef="EUR" scale="0" decimals="0" format="ixt:num-dot-decimal">170,560</ix:nonFraction>,
with backdated rent accruing from that date. Included within overhead costs in cost of sales is an amount of $<ix:nonFraction id="Fxbrl_20250513105829777" name="trib:OverheadCosts" contextRef="C_20210701to20210701" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">97,000</ix:nonFraction>
in respect of backdated rent. Independent valuers advised the Group that the rent in respect of each of the leases represented a fair
market rent.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
late 2020, the Group occupied some additional space adjoining the warehouse owned by Mr O&#8217;Caoimh. This was a short-term arrangement,
and no payments were made for the additional space during 2020 and 2021. The Company vacated this space in 2021. In 2022, the rent payable
to Mr O&#8217;Caoimh of US$<ix:nonFraction id="Fxbrl_20230414165644800" name="trib:AnnualRentPayable" contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhMember_ifrsfullClassesOfFinancialInstrumentsAxis_tribAdditionalSpaceMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">90,000</ix:nonFraction>
was settled.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
the time that the arrangements were entered into, Trinity Biotech and its directors (excepting Mr O&#8217;Caoimh and Dr Walsh who expressed
no opinion on this point) believed they represented a fair and reasonable basis on which the Group could meet its ongoing requirements
for premises. Dr Walsh has no ownership interest in the additional space adjoining the warehouse owned by Mr O&#8217;Caoimh and was therefore
entitled to express an opinion on this arrangement.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
September 2024, the Company completed the acquisition of Metabolomics Diagnostics Ltd ("Metabolomics") for consideration of approximately
US$<ix:nonFraction id="Fxbrl_20250513120550803" name="trib:AcquisitionConsideration" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.9</ix:nonFraction>
million, satisfied through the issuance of approximately <ix:nonFraction id="Fxbrl_20250513120601118" name="trib:AcquisitionConsideration" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">0.27</ix:nonFraction>
million ADSs and the extinguishment of amounts owed to the Company totaling US$<ix:nonFraction id="Fxbrl_20250513120620440" name="trib:ExtinguishmentOfAmountOwed" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">0.41</ix:nonFraction>
million. At the time of the acquisition, Dr. Jim Walsh, a director of the Company, held a <ix:nonFraction id="Fxbrl_20250513120644347" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullCategoriesOfRelatedPartiesAxis_tribDrJimWalshMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">6</ix:nonFraction>%
minority shareholding in Metabolomics. Based on the net assets acquired and goodwill recognised, the value attributable to Dr. Walsh&#8217;s
interest was estimated at approximately $<ix:nonFraction id="Fxbrl_20250513120723049" name="ifrs-full:InterestExpense" contextRef="C_20240901to20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullCategoriesOfRelatedPartiesAxis_tribDrJimWalshMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">55,000</ix:nonFraction>.
Dr. Walsh fully disclosed his interest, and the acquisition was approved unanimously by the board, with appropriate procedures followed
to manage the potential conflict of interest, including the passing of a resolution under the Company's Constitution to authorise Dr.
Walsh&#8217;s involvement in the decision-making process. The transaction was conducted at arm&#8217;s length, and the board determined
that it was in the best interests of the Company.</span></span><br/>&#160;</div> </div>

<div><ix:exclude>

<div style="margin-top:0pt;margin-bottom:0pt">

<div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">182</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<div style="margin-top:0pt;margin-bottom:0pt">

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">26.</span></span></td>
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:auto">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">RELATED
        PARTY TRANSACTIONS (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div>

<div style="text-align:justify;line-height:1.25;font-style:italic;font-weight:bold;margin-left:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Compensation
of key management personnel of the Group</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25;margin-left:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the years ended December 31, 2024 and 2023, the Group&#8217;s key management personnel comprised directors Mr. Ronan O&#8217;Caoimh, Dr.
Jim Walsh, and Mr. John Gillard. The Group does not engage a separate management entity, as all key management personnel are employed
directly by the Group. Compensation for the year for these personnel is detailed below:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512183852382" name="trib:DisclosureOfDetailedInformationAboutCompensationExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term
        employee benefits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117233701828_23" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">843</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117233701828_27" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,774</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Performance
        related bonus</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220117233701828_33" name="trib:KeyManagementPersonnelCompensationPerformanceRelatedBonus" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">260</ix:nonFraction></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117233701828_37" name="trib:KeyManagementPersonnelCompensationPerformanceRelatedBonus" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">211</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Post-employment
        benefits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117233701828_43" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117233701828_47" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        compensation benefits as calculated under IFRS 2</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117233701828_53" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">931</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117233701828_57" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,601</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117233701828_73" name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,073</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117233701828_77" name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,612</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
amounts disclosed in respect of directors&#8217; emoluments in Note 9 includes independent directors&#8217; fees and non-executive director
fees of US$<ix:nonFraction id="Fxbrl_20240430024420074" name="ifrs-full:DirectorsRemunerationExpense" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">114,000</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20240430024511282" name="ifrs-full:DirectorsRemunerationExpense" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">73,000</ix:nonFraction>)
and share-based compensation benefits of US$<ix:nonFraction id="Fxbrl_20240430024519562" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsMember" unitRef="USD" scale="0" decimals="0" format="ixt-sec:numwordsen">Nil</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20240430024524834" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsMember" unitRef="USD" scale="0" decimals="0" format="ixt-sec:numwordsen">Nil</ix:nonFraction>).
Total directors&#8217; remuneration is also included in &#8220;employment&#8221; (Note 3) and &#8220;(Loss)/profit before tax&#8221; (Note
9).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Directors&#8217;
interests in the Company&#8217;s shares and share option plan</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250513103944095" name="trib:DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;A&#8217;
        Ordinary Shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share
        options</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117234712986" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">11,117,777</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117234958300" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">30,387,336</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shares
        purchased during the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117235203837" name="trib:SharesPurchasedDuringYear" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">200,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413171437292" name="trib:SharesPurchasedDuringYear" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117235210157" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117235519141" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">5,600,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117235217132" name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220117235650310" name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">2,994,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117235028141" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">11,317,777</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220117235036627" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">32,993,336</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;A&#8217;
        Ordinary Shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share
        options</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118000810356_xbrl_20220117234712986" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">11,117,777</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118000810356_xbrl_20220117234958300" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">40,547,336</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options
        of retired director</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118000835467_xbrl_20220117235136070" name="trib:NumberOfRetiredDirectorOptions" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413171839105" name="trib:NumberOfRetiredDirectorOptions" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal" sign="-">20,000,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118000921243_xbrl_20220117235210157" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118000921243_xbrl_20220117235519141" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">14,000,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118000929252_xbrl_20220117235217132" name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220118000929252_xbrl_20220117235650310" name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">4,160,000</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118000936603_xbrl_20220117235028141" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">11,117,777</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220118000936603_xbrl_20220117235036627" name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">30,387,336</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </ix:nonNumeric> </div> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">183</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div>

<div>

<div style="margin-top:0px"> <ix:nonNumeric id="Fxbrl_20240415102829322" name="ifrs-full:DisclosureOfFinancialInstrumentsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAPITAL AND FINANCIAL RISK MANAGEMENT</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-weight:bold;margin-left:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital
Management</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group&#8217;s policy is to maintain a strong capital base to maintain investor, creditor and market confidence and to sustain future development
of the business. The Board of Directors monitors (loss)/earnings per share as a measure of performance, which the Group defines as (loss)/profit
after tax divided by the weighted average number of shares in issue.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair
Values</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
table below sets out the Group&#8217;s classification of each class of financial assets/liabilities, their fair values and under which
valuation method they are valued:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240413100740332" name="ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory" contextRef="C_20240101to20241231" continuedAt="F20250513104823205" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        2</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        3</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">carrying</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">amount</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Value</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loans
        and receivables at amortised cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119025807475" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,416</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119025823748" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105208983" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119025932818" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,416</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030018593" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,416</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030101541_xbrl_20220119025807475" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,167</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030101541_xbrl_20220119025823748" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105242084" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030101541_xbrl_20220119025932818" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,167</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030101541_xbrl_20220119030018593" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,167</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030106788_xbrl_20220119025807475" name="ifrs-full:MaximumExposureToCreditRisk" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,583</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030106788_xbrl_20220119025823748" name="ifrs-full:MaximumExposureToCreditRisk" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"><ix:nonFraction id="Fxbrl_20250514155605134" name="ifrs-full:MaximumExposureToCreditRisk" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030106788_xbrl_20220119025932818" name="ifrs-full:MaximumExposureToCreditRisk" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,583</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030106788_xbrl_20220119030018593" name="ifrs-full:MaximumExposureToCreditRisk" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,583</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities
        at amortised cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025807475" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025823748" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105309989" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025932818" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119030018593" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025807475" name="trib:ConvertibleNote" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025823748" name="trib:ConvertibleNote" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105336756" name="trib:ConvertibleNote" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025932818" name="trib:ConvertibleNote" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119030018593" name="trib:ConvertibleNote" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030109342_xbrl_20220119025807475" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030109342_xbrl_20220119025823748" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105359717" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030109342_xbrl_20220119025932818" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030109342_xbrl_20220119030018593" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414133805048_xbrl_20220119030114460_xbrl_20220119025807475" name="ifrs-full:LeaseLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,762</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230414133805048_xbrl_20220119030114460_xbrl_20220119025823748" name="ifrs-full:LeaseLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105502116" name="ifrs-full:LeaseLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414133805048_xbrl_20220119030114460_xbrl_20220119025932818" name="ifrs-full:LeaseLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,762</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230414133805048_xbrl_20220119030114460_xbrl_20220119030018593" name="ifrs-full:LeaseLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,762</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables (excluding deferred income)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030114460_xbrl_20220119025807475" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,585</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030114460_xbrl_20220119025823748" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105514614" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030114460_xbrl_20220119025932818" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,585</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030114460_xbrl_20220119030018593" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,585</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030120188_xbrl_20220119025807475" name="ifrs-full:Provisions" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,529</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030120188_xbrl_20220119025823748" name="ifrs-full:Provisions" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105532628" name="ifrs-full:Provisions" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030120188_xbrl_20220119025932818" name="ifrs-full:Provisions" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,529</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030120188_xbrl_20220119030018593" name="ifrs-full:Provisions" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,529</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030122116_xbrl_20220119025807475" name="ifrs-full:FinancialLiabilitiesAtAmortisedCost" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,876</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030122116_xbrl_20220119025823748" name="ifrs-full:FinancialLiabilitiesAtAmortisedCost" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">88,002</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105551364" name="ifrs-full:FinancialLiabilitiesAtAmortisedCost" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030122116_xbrl_20220119025932818" name="ifrs-full:FinancialLiabilitiesAtAmortisedCost" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">129,878</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030122116_xbrl_20220119030018593" name="ifrs-full:FinancialLiabilitiesAtAmortisedCost" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">129,878</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair
        value through profit and loss (FVPL)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        liability - warrants</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030124916_xbrl_20220119025807475" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030124916_xbrl_20220119025823748" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,658</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105610996" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030124916_xbrl_20220119025932818" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,658</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030124916_xbrl_20220119030018593" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,658</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        asset &#8211; prepayment option</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030127597_xbrl_20220119025807475" name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030127597_xbrl_20220119025823748" name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">166</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105627844" name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030127597_xbrl_20220119025932818" name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">166</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030127597_xbrl_20220119030018593" name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">166</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity
        investments in Novus</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513120708889_xbrl_20220119030127597_xbrl_20220119025807475" name="ifrs-full:NoncontrollingInterests" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513120708889_xbrl_20220119030127597_xbrl_20220119025823748" name="ifrs-full:NoncontrollingInterests" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513120708889_xbrl_20250513105627844" name="ifrs-full:NoncontrollingInterests" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,455</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513120708889_xbrl_20220119030127597_xbrl_20220119025932818" name="ifrs-full:NoncontrollingInterests" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,455</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513120708889_xbrl_20220119030127597_xbrl_20220119030018593" name="ifrs-full:NoncontrollingInterests" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,455</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030129707_xbrl_20220119025807475" name="trib:FairValueThroughProfitAndLoss" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030129707_xbrl_20220119025823748" name="trib:FairValueThroughProfitAndLoss" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,492</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105653453" name="trib:FairValueThroughProfitAndLoss" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,455</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030129707_xbrl_20220119025932818" name="trib:FairValueThroughProfitAndLoss" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">963</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119030129707_xbrl_20220119030018593" name="trib:FairValueThroughProfitAndLoss" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">963</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030132996_xbrl_20220119025807475" name="trib:FairValueOfFinancialAssetsLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">23,293</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030132996_xbrl_20220119025823748" name="trib:FairValueOfFinancialAssetsLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">89,494</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105715948" name="trib:FairValueOfFinancialAssetsLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,455</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030132996_xbrl_20220119025932818" name="trib:FairValueOfFinancialAssetsLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">110,332</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119030132996_xbrl_20220119030018593" name="trib:FairValueOfFinancialAssetsLiabilities" contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">110,332</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:28.35pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For
financial reporting purposes, fair value measurements are categorized into Level&#160;1, 2 or 3 based on the degree to which inputs to
the fair value measurements are observable and the significance of the inputs to the fair value measurement in its entirety, which are
described as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level&#160;1:
quoted prices (unadjusted) in active markets for identical assets or liabilities</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level&#160;2:
valuation techniques for which the lowest level of inputs which have a significant effect on the recorded fair value are observable, either
directly or indirectly</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level&#160;3:
valuation techniques for which the lowest level of inputs that have a significant effect on the recorded fair value are not based on observable
market data.</span></span></div>

<div style="margin-left:28.35pt;line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">184</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">27.</span></span></td>
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:auto">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">CAPITAL
        AND FINANCIAL RISK MANAGEMENT (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div> <ix:continuation id="F20250513104823205">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        2</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        3</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">carrying</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">amount</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Value</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loans
        and receivables at amortised cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031634202_xbrl_20220119025807475" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,698</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031634202_xbrl_20220119025823748" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513183823266" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031634202_xbrl_20220119025932818" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,698</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031634202_xbrl_20220119030018593" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,698</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031835442_xbrl_20220119031634202_xbrl_20220119025807475" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031835442_xbrl_20220119031634202_xbrl_20220119025823748" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513183836905" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031835442_xbrl_20220119031634202_xbrl_20220119025932818" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031835442_xbrl_20220119031634202_xbrl_20220119030018593" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance
        lease receivable</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,
        17</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031839618_xbrl_20220119031634202_xbrl_20220119025807475" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">155</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031839618_xbrl_20220119031634202_xbrl_20220119025823748" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513183851986" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031839618_xbrl_20220119031634202_xbrl_20220119025932818" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">155</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031839618_xbrl_20220119031634202_xbrl_20220119030018593" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">155</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031842018_xbrl_20220119031634202_xbrl_20220119025807475" name="ifrs-full:MaximumExposureToCreditRisk" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,544</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031842018_xbrl_20220119031634202_xbrl_20220119025823748" name="ifrs-full:MaximumExposureToCreditRisk" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513184121417" name="ifrs-full:MaximumExposureToCreditRisk" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031842018_xbrl_20220119031634202_xbrl_20220119025932818" name="ifrs-full:MaximumExposureToCreditRisk" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,544</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031842018_xbrl_20220119031634202_xbrl_20220119030018593" name="ifrs-full:MaximumExposureToCreditRisk" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,544</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities
        at amortised cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413102621081_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025807475" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413102621081_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025823748" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,109</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513184136977" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413102621081_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025932818" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,109</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413102621081_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119030018593" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,109</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413102632426_xbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025807475" name="trib:ConvertibleNote" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413102632426_xbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025823748" name="trib:ConvertibleNote" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,542</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513184148657" name="trib:ConvertibleNote" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413102632426_xbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025932818" name="trib:ConvertibleNote" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,542</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413102632426_xbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119030018593" name="trib:ConvertibleNote" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,542</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        note&#185;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413102647457_xbrl_20220119030109342_xbrl_20220119025807475" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422102853731" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513184205194" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413102647457_xbrl_20220119030109342_xbrl_20220119025932818" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413102647457_xbrl_20220119030109342_xbrl_20220119030018593" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031846937_xbrl_20220119031634202_xbrl_20220119025807475" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,566</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031846937_xbrl_20220119031634202_xbrl_20220119025823748" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105945317" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031846937_xbrl_20220119031634202_xbrl_20220119025932818" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,566</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031846937_xbrl_20220119031634202_xbrl_20220119030018593" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,566</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables (excluding deferred income)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031851810_xbrl_20220119031634202_xbrl_20220119025807475" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,752</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031851810_xbrl_20220119031634202_xbrl_20220119025823748" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105929628" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031851810_xbrl_20220119031634202_xbrl_20220119025932818" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,752</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031851810_xbrl_20220119031634202_xbrl_20220119030018593" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,752</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031849186_xbrl_20220119031634202_xbrl_20220119025807475" name="ifrs-full:Provisions" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031849186_xbrl_20220119031634202_xbrl_20220119025823748" name="ifrs-full:Provisions" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105907716" name="ifrs-full:Provisions" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031849186_xbrl_20220119031634202_xbrl_20220119025932818" name="ifrs-full:Provisions" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031849186_xbrl_20220119031634202_xbrl_20220119030018593" name="ifrs-full:Provisions" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031856170_xbrl_20220119031634202_xbrl_20220119025807475" name="ifrs-full:FinancialLiabilitiesAtAmortisedCost" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,368</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031856170_xbrl_20220119031634202_xbrl_20220119025823748" name="ifrs-full:FinancialLiabilitiesAtAmortisedCost" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">54,861</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105856276" name="ifrs-full:FinancialLiabilitiesAtAmortisedCost" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031856170_xbrl_20220119031634202_xbrl_20220119025932818" name="ifrs-full:FinancialLiabilitiesAtAmortisedCost" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">80,229</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031856170_xbrl_20220119031634202_xbrl_20220119030018593" name="ifrs-full:FinancialLiabilitiesAtAmortisedCost" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">80,229</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair
        value through profit and loss (FVPL)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        liability - warrants</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413102658793_xbrl_20220119030124916_xbrl_20220119025807475" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413102658793_xbrl_20220119030124916_xbrl_20220119025823748" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">526</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105836484" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413102658793_xbrl_20220119030124916_xbrl_20220119025932818" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">526</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413102658793_xbrl_20220119030124916_xbrl_20220119030018593" name="ifrs-full:NoncurrentDerivativeFinancialLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">526</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        asset &#8211; prepayment option</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413102711803_xbrl_20220119030127597_xbrl_20220119025807475" name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413102711803_xbrl_20220119030127597_xbrl_20220119025823748" name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105816668" name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413102711803_xbrl_20220119030127597_xbrl_20220119025932818" name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413102711803_xbrl_20220119030127597_xbrl_20220119030018593" name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119031902274_xbrl_20220119031634202_xbrl_20220119025807475" name="trib:FairValueThroughProfitAndLoss" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326220806474" name="trib:FairValueThroughProfitAndLoss" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">348</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105800076" name="trib:FairValueThroughProfitAndLoss" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326221008680" name="trib:FairValueThroughProfitAndLoss" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">348</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220326221127599" name="trib:FairValueThroughProfitAndLoss" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">348</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031904537_xbrl_20220119031634202_xbrl_20220119025807475" name="trib:FairValueOfFinancialAssetsLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">10,824</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031904537_xbrl_20220119031634202_xbrl_20220119025823748" name="trib:FairValueOfFinancialAssetsLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">55,209</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513105744501" name="trib:FairValueOfFinancialAssetsLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031904537_xbrl_20220119031634202_xbrl_20220119025932818" name="trib:FairValueOfFinancialAssetsLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">66,033</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119031904537_xbrl_20220119031634202_xbrl_20220119030018593" name="trib:FairValueOfFinancialAssetsLiabilities" contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">66,033</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> </ix:continuation>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
valuation techniques used for instruments categorised as level 2 are described below:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair values of the options associated with the exchangeable notes are calculated in consultation with third-party valuation specialists
due to the complexity of their nature. There are a number of inputs utilised in the valuation of the options, including share price, historical
share price volatility, risk-free rate and the expected borrowing cost spread over the risk-free rate.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
Risk Management</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group uses a range of financial instruments (including cash, finance leases, receivables, payables and derivatives) to fund its operations.
These instruments are used to manage the liquidity of the Group. Working capital management is a key additional element in the effective
management of overall liquidity. The Group does not trade in financial instruments or derivatives. The main risks arising from the utilization
of these financial instruments are interest rate risk, liquidity risk and credit risk.</span></span>

<p style="margin:0pt">&#160;</p> </div>

<div><ix:exclude>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">185</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAPITAL AND FINANCIAL RISK MANAGEMENT (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;<span style="font-weight:bold;font-style:italic">Interest
rate risk</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
of December 31, 2024, all of the Group&#8217;s financial instruments referencing interest rates are based on SOFR, a post-reform benchmark
rate. The Group no longer has exposure to interest rate benchmarks subject to IBOR reform; therefore, the disclosure requirements related
to benchmark interest rate reform are not applicable.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective
and repricing analysis</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following tables sets out all interest-earning financial assets and interest-bearing financial liabilities held by the Group at December&#160;31,
2024 and 2023, indicating their effective interest rates and the period in which they re-price:</span></span></div>

<div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413100910916" name="ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As&#160;at&#160;December&#160;31,&#160;2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">interest<br/>rate</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths or less</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        &#8211;12 mths</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&gt;
        5 years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash&#160;and&#160;cash&#160;equivalents</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119111701722_xbrl_20220119103015701_17" name="trib:EffectiveInterestRate" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.00</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119111701722_xbrl_20220119103015701_111" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,167</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119111701722_xbrl_20220119103015701_115" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,167</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119111701722_xbrl_20220119103015701_119" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119111701722_xbrl_20220119103015701_123" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119111701722_xbrl_20220119103015701_127" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119111701722_xbrl_20220119103015701_131" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        note<sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup></span></span></div> </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17" name="trib:EffectiveInterestRate" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan<sup style="vertical-align:text-top;line-height:1;font-size:smaller">2</sup></span></span></div> </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17" name="trib:EffectiveInterestRate" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">16.3</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note<sup style="vertical-align:text-top;line-height:1;font-size:smaller">3</sup></span></span></div> </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17" name="trib:EffectiveInterestRate" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:20.21%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-9pt;margin-left:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;&#160;Lease
        payable on Right of Use assets</span></span></div> </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_17" name="trib:EffectiveInterestRate" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_111" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,762</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_115" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,150</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_119" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,135</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_123" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,742</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_127" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,532</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_131" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,203</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:20.21%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119111702063_xbrl_20220119104922500_xbrl_20220119103015701_111" name="trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">95,597</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119111702063_xbrl_20220119104922500_xbrl_20220119103015701_115" name="trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,017</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119111702063_xbrl_20220119104922500_xbrl_20220119103015701_119" name="trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,135</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119111702063_xbrl_20220119104922500_xbrl_20220119103015701_123" name="trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities" contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,133</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119111702063_xbrl_20220119104922500_xbrl_20220119103015701_127" name="trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities" contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,933</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119111702063_xbrl_20220119104922500_xbrl_20220119103015701_131" name="trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities" contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,413</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As&#160;at&#160;December&#160;31,&#160;2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">interest<br/>rate</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths or less</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        &#8211;12 mths</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&gt;
        5 years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash&#160;and&#160;cash&#160;equivalents</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119103015701_17" name="trib:EffectiveInterestRate" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember" unitRef="Pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.00</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119103015701_111" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119103015701_115" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119103015701_119" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119103015701_123" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119103015701_127" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119103015701_131" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:middle;width:20.21%;vertical-align:bottom">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease&#160;receivable</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,17</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104859173_xbrl_20220119103015701_17" name="trib:EffectiveInterestRate" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104859173_xbrl_20220119103015701_111" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">155</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104859173_xbrl_20220119103015701_115" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104859173_xbrl_20220119103015701_119" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104859173_xbrl_20220119103015701_123" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104859173_xbrl_20220119103015701_127" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104859173_xbrl_20220119103015701_131" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        note<sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104905700_xbrl_20220119103015701_17" name="trib:EffectiveInterestRate" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.8</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119104905700_xbrl_20220119103015701_111" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104905700_xbrl_20220119103015701_115" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104905700_xbrl_20220119103015701_119" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104905700_xbrl_20220119103015701_123" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104905700_xbrl_20220119103015701_127" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119104905700_xbrl_20220119103015701_131" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20.21%;vertical-align:bottom">
        <div style="text-indent:-2.6pt;margin-left:9.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan<sup style="vertical-align:text-top;line-height:1;font-size:smaller">2</sup></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413104647018" name="trib:EffectiveInterestRate" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">16.3</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_115" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,109</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_119" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_123" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_127" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_131" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,109</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250513120950208" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-1.9pt;margin-left:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note<sup style="vertical-align:text-top;line-height:1;font-size:smaller">3</sup></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_17" name="trib:EffectiveInterestRate" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_111" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,542</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_115" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_119" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_123" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_127" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_131" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,542</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20.21%;padding-bottom:2px;vertical-align:bottom">
        <div style="margin-left:7.1pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        payable on Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104914171_xbrl_20220119103015701_17" name="trib:EffectiveInterestRate" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119104914171_xbrl_20220119103015701_111" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,566</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119104914171_xbrl_20220119103015701_115" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">812</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119104914171_xbrl_20220119103015701_119" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">832</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119104914171_xbrl_20220119103015701_123" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,745</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119104914171_xbrl_20220119103015701_127" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,425</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220430202446013" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,752</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:20.21%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119104922500_xbrl_20220119103015701_111" name="trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,581</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119104922500_xbrl_20220119103015701_115" name="trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,941</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119104922500_xbrl_20220119103015701_119" name="trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">793</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119104922500_xbrl_20220119103015701_123" name="trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,696</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119104922500_xbrl_20220119103015701_127" name="trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,529</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119104922500_xbrl_20220119103015701_131" name="trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,504</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup>
The maturity of the exchangeable notes is based on the contractual maturity date of April 1, 2045.</span></span></div>

<div style="margin-left:31.2pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><sup style="vertical-align:text-top;line-height:1;font-size:smaller">2</sup>
The senior secured term loan is a variable instrument. In January 2024, <ix:nonNumeric id="Fxbrl_20240413122609456" name="trib:TermLoanAgreementDescription" contextRef="C_20240101to20241231">the
amended term loan agreement reduced the annual rate of interest on the loan by 2.5% to 8.75% plus the greater of (a) Term Secured Overnight
Financing Rate or (b) 4.0% per annum, and allows for a further 2.5% reduction in the base rate to 6.25% once the outstanding principal
under the term loan falls below US$35 million.&#160; The loan matures in July 2026.</ix:nonNumeric></span></span></div>

<div style="margin-left:31.2pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><sup style="vertical-align:text-top;line-height:1;font-size:smaller">3</sup>
The 7-year convertible note was issued in May 2022 and is a fixed rate instrument which bears a fixed rate of interest of <ix:nonFraction id="Fxbrl_20230427044257579" name="trib:SeniorSecuredTermLoanFixedRate" contextRef="C_20240101to20241231" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">1.5</ix:nonFraction>%
per annum.</span></span></div> </div> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>In
broad terms, a one-percentage point increase in interest rates would increase interest income by US$<ix:nonFraction id="Fxbrl_20250513185509177" name="trib:GrossIncreaseInterestIncome" contextRef="C_20240101to20241231" unitRef="USD" scale="0" decimals="0" format="ixt-sec:numwordsen">Nil</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20230420182535305" name="trib:GrossIncreaseInterestIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="0" decimals="0" format="ixt-sec:numwordsen">Nil</ix:nonFraction>)
as at December 31, 2024 the Company holds no funds in interest-bearing accounts; while the annual impact on the interest expense would
be an increase of US$<ix:nonFraction id="Fxbrl_20230420182605915" name="trib:NetInterestIncome" contextRef="C_20240101to20241231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">755,000</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20230420182610651" name="trib:NetInterestIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">417,000</ix:nonFraction>)
on the costs of servicing the senior secured term loan. </span>&#160;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">186</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">27.</span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">CAPITAL AND FINANCIAL RISK MANAGEMENT (CONTINUED)</span></div>
        </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest
rate profile of financial assets / liabilities</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
interest rate profile of financial assets/liabilities of the Group was as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240413101047221" name="trib:DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Variable
        rate instruments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        at bank and in hand</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420154242645_xbrl_20220119112358490_33" name="ifrs-full:Cash" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,167</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420154242645_xbrl_20220119112358490_37" name="ifrs-full:Cash" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Variable
        rate financial liabilities (senior secured term loan)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420154244413_xbrl_20220119112358490_33" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420154244413_xbrl_20220119112358490_37" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,109</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420154246893_xbrl_20220119112358490_33" name="trib:VariableRateInstruments" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">67,224</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420154246893_xbrl_20220119112358490_37" name="trib:VariableRateInstruments" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">36,418</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fixed
        rate instruments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fixed
        rate financial liabilities (exchangeable note)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119112358490_33" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119112358490_37" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fixed
        rate financial liabilities (convertible note)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420154159505_xbrl_20220119112358490_33" name="trib:ConvertibleNote" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420154159505_xbrl_20220119112358490_37" name="trib:ConvertibleNote" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,542</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fixed
        rate financial liabilities (lease payables)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119112358490_53" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,762</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119112358490_57" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,566</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        assets (lease receivables)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119112358490_73" name="trib:FinancialAssetsLeaseReceivables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119112358490_77" name="trib:FinancialAssetsLeaseReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">155</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119112358490_93" name="trib:FixedRateInstruments" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,373</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119112358490_97" name="trib:FixedRateInstruments" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,163</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold;font-style:italic">&#160;Fair
value sensitivity analysis for fixed rate instruments</span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group does not account for any fixed rate financial liabilities at fair value through profit and loss. Therefore, a change in interest
rates at December&#160;31, 2024 or December 31, 2023 would not affect profit or loss. There was no significant difference between the
fair value and carrying value of the Group&#8217;s trade receivables and trade and other payables at December&#160;31, 2024 and December
31, 2023 as all fell due within 6 months.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic;font-weight:bold">Liquidity
risk</span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following are the contractual maturities of financial liabilities, including estimated interest payments:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240413101250158" name="trib:DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory" contextRef="C_20240101to20241231" continuedAt="F20250513104859165" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2024</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying<br/>amount</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractual<br/>cash
        flows</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths or<br/>less</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths &#8211;</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12
        mths</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&gt;5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:16%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables (excluding deferred income)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119114428934_23" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,286</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119114428934_27" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,286</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119114428934_211" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,286</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119114428934_215" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119114428934_219" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119114428934_223" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119114428934_227" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        payable on Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115850913_xbrl_20220119114428934_23" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,762</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115850913_xbrl_20220119114428934_27" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,214</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115850913_xbrl_20220119114428934_211" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,454</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115850913_xbrl_20220119114428934_215" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,408</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115850913_xbrl_20220119114428934_219" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,213</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115850913_xbrl_20220119114428934_223" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,487</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115850913_xbrl_20220119114428934_227" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,652</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan&#185;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_23" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,391</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_27" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81,438</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_211" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,703</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_215" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,319</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_219" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,416</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_223" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_227" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_23" name="trib:ConvertibleNote" contextRef="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,401</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_27" name="trib:ConvertibleNote" contextRef="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,350</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_211" name="trib:ConvertibleNote" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_215" name="trib:ConvertibleNote" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_219" name="trib:ConvertibleNote" contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">300</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_223" name="trib:ConvertibleNote" contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">900</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_227" name="trib:ConvertibleNote" contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,850</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:16%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115857970_xbrl_20220119114428934_23" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115857970_xbrl_20220119114428934_27" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">380</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115857970_xbrl_20220119114428934_211" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115857970_xbrl_20220119114428934_215" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115857970_xbrl_20220119114428934_219" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115857970_xbrl_20220119114428934_223" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115857970_xbrl_20220119114428934_227" name="ifrs-full:LongtermBorrowings" contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">340</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:16%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115902530_xbrl_20220119114428934_23" name="ifrs-full:FinancialLiabilities" contextRef="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">126,050</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115902530_xbrl_20220119114428934_27" name="ifrs-full:FinancialLiabilities" contextRef="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143,668</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115902530_xbrl_20220119114428934_211" name="ifrs-full:FinancialLiabilities" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,597</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115902530_xbrl_20220119114428934_215" name="ifrs-full:FinancialLiabilities" contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,881</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115902530_xbrl_20220119114428934_219" name="ifrs-full:FinancialLiabilities" contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78,937</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115902530_xbrl_20220119114428934_223" name="ifrs-full:FinancialLiabilities" contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,411</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119115902530_xbrl_20220119114428934_227" name="ifrs-full:FinancialLiabilities" contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,842</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </ix:nonNumeric> </div>

<div>&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#185;
The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December
31, 2024</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">187</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">27.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">CAPITAL
        AND FINANCIAL RISK MANAGEMENT (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div> <ix:continuation id="F20250513104859165">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2023</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying<br/>amount</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractual<br/>cash
        flows</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths or<br/>less</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths &#8211;</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12
        mths</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&gt;5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:16%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables (excluding deferred income)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500878_xbrl_20220119114428934_23" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,752</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500878_xbrl_20220119114428934_27" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,752</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500878_xbrl_20220119114428934_211" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,752</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500878_xbrl_20220119114428934_215" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500878_xbrl_20220119114428934_219" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500878_xbrl_20220119114428934_223" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500878_xbrl_20220119114428934_227" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        payable on Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_23" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,566</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_27" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,306</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_211" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,107</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_215" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,114</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_219" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,243</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_223" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,442</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_227" name="trib:LeasePayableOnRightOfUseAssets" contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,400</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan&#185;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_23" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,109</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_27" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,121</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_211" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,461</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_215" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,461</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_219" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,922</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_223" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,277</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_227" name="ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings" contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_23" name="trib:ConvertibleNote" contextRef="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,542</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_27" name="trib:ConvertibleNote" contextRef="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,650</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_211" name="trib:ConvertibleNote" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_215" name="trib:ConvertibleNote" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_219" name="trib:ConvertibleNote" contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">300</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_223" name="trib:ConvertibleNote" contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">900</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_227" name="trib:ConvertibleNote" contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,150</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:16%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_23" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_27" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">389</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_211" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_215" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_219" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_223" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_227" name="ifrs-full:LongtermBorrowings" contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">349</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:16%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_23" name="ifrs-full:FinancialLiabilities" contextRef="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">80,179</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_27" name="ifrs-full:FinancialLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106,218</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_211" name="ifrs-full:FinancialLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,474</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_215" name="ifrs-full:FinancialLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,729</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_219" name="ifrs-full:FinancialLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,473</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_223" name="ifrs-full:FinancialLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,643</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_227" name="ifrs-full:FinancialLiabilities" contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,899</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#185;
The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December
31, 2023.</span></span></div> </div> </ix:continuation>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign
exchange risk</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
majority of the Group&#8217;s activities are conducted in US Dollars. Foreign exchange risk arises from the fluctuating value of the Group&#8217;s
Euro denominated expenses as a result of the movement in the exchange rate between the US&#160;Dollar and the Euro. There were no forward
contracts in place as at December 31, 2024 or December&#160;31, 2023.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign
currency financial assets and liabilities which expose the Group to currency risk are disclosed below. The amounts shown are those reported
to key management translated into US Dollars at the closing rate:</span></span></div>

<div>&#160;</div> <ix:nonNumeric id="Fxbrl_20240413101341323" name="trib:DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td rowspan="1" style="vertical-align:bottom;vertical-align:bottom"/>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EUR</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GBP</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SEK</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAD</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BRL</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120834197_23" name="ifrs-full:Cash" contextRef="C_20241231_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">116</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120834197_27" name="ifrs-full:Cash" contextRef="C_20241231_srtCurrencyAxis_currencyGBP" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120834197_211" name="ifrs-full:Cash" contextRef="C_20241231_srtCurrencyAxis_currencySEK" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120834197_215" name="ifrs-full:Cash" contextRef="C_20241231_srtCurrencyAxis_currencyCAD" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">293</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120834197_219" name="ifrs-full:Cash" contextRef="C_20241231_srtCurrencyAxis_currencyBRL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">373</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119120834197_223" name="ifrs-full:Cash" contextRef="C_20241231_srtCurrencyAxis_currencyXXX" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other receivable</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121051965_xbrl_20220119120834197_23" name="ifrs-full:TradeAndOtherReceivables" contextRef="C_20241231_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,009</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121051965_xbrl_20220119120834197_27" name="ifrs-full:TradeAndOtherReceivables" contextRef="C_20241231_srtCurrencyAxis_currencyGBP" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121051965_xbrl_20220119120834197_211" name="ifrs-full:TradeAndOtherReceivables" contextRef="C_20241231_srtCurrencyAxis_currencySEK" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121051965_xbrl_20220119120834197_215" name="ifrs-full:TradeAndOtherReceivables" contextRef="C_20241231_srtCurrencyAxis_currencyCAD" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">294</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121051965_xbrl_20220119120834197_219" name="ifrs-full:TradeAndOtherReceivables" contextRef="C_20241231_srtCurrencyAxis_currencyBRL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,019</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121051965_xbrl_20220119120834197_223" name="ifrs-full:TradeAndOtherReceivables" contextRef="C_20241231_srtCurrencyAxis_currencyXXX" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121054174_xbrl_20220119120834197_23" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,098</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121054174_xbrl_20220119120834197_27" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_srtCurrencyAxis_currencyGBP" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">453</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121054174_xbrl_20220119120834197_211" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_srtCurrencyAxis_currencySEK" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121054174_xbrl_20220119120834197_215" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_srtCurrencyAxis_currencyCAD" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">114</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121054174_xbrl_20220119120834197_219" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_srtCurrencyAxis_currencyBRL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">135</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422121518838" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20241231_srtCurrencyAxis_currencyXXX" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420161312737_xbrl_20220119121054174_xbrl_20220119120834197_23" name="ifrs-full:LeaseLiabilities" contextRef="C_20241231_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,867</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420161312737_xbrl_20220119121054174_xbrl_20220119120834197_27" name="ifrs-full:LeaseLiabilities" contextRef="C_20241231_srtCurrencyAxis_currencyGBP" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420161312737_xbrl_20220119121054174_xbrl_20220119120834197_211" name="ifrs-full:LeaseLiabilities" contextRef="C_20241231_srtCurrencyAxis_currencySEK" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420161312737_xbrl_20220119121054174_xbrl_20220119120834197_215" name="ifrs-full:LeaseLiabilities" contextRef="C_20241231_srtCurrencyAxis_currencyCAD" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420161312737_xbrl_20220119121054174_xbrl_20220119120834197_219" name="ifrs-full:LeaseLiabilities" contextRef="C_20241231_srtCurrencyAxis_currencyBRL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">171</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420161312737_xbrl_20220119121054174_xbrl_20220119120834197_223" name="ifrs-full:LeaseLiabilities" contextRef="C_20241231_srtCurrencyAxis_currencyXXX" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        exposure</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121056325_xbrl_20220119120834197_23" name="trib:TotalExposureFinancialInstruments" contextRef="C_20241231_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,840</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121056325_xbrl_20220119120834197_27" name="trib:TotalExposureFinancialInstruments" contextRef="C_20241231_srtCurrencyAxis_currencyGBP" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">329</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121056325_xbrl_20220119120834197_211" name="trib:TotalExposureFinancialInstruments" contextRef="C_20241231_srtCurrencyAxis_currencySEK" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121056325_xbrl_20220119120834197_215" name="trib:TotalExposureFinancialInstruments" contextRef="C_20241231_srtCurrencyAxis_currencyCAD" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">473</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121056325_xbrl_20220119120834197_219" name="trib:TotalExposureFinancialInstruments" contextRef="C_20241231_srtCurrencyAxis_currencyBRL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,086</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422121449118" name="trib:TotalExposureFinancialInstruments" contextRef="C_20241231_srtCurrencyAxis_currencyXXX" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td rowspan="1" style="vertical-align:bottom;vertical-align:bottom"/>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EUR</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GBP</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SEK</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAD</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BRL</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232679_xbrl_20220119120834197_23" name="ifrs-full:Cash" contextRef="C_20231231_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">219</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232679_xbrl_20220119120834197_27" name="ifrs-full:Cash" contextRef="C_20231231_srtCurrencyAxis_currencyGBP" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232679_xbrl_20220119120834197_211" name="ifrs-full:Cash" contextRef="C_20231231_srtCurrencyAxis_currencySEK" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232679_xbrl_20220119120834197_215" name="ifrs-full:Cash" contextRef="C_20231231_srtCurrencyAxis_currencyCAD" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">191</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232679_xbrl_20220119120834197_219" name="ifrs-full:Cash" contextRef="C_20231231_srtCurrencyAxis_currencyBRL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">854</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232679_xbrl_20220119120834197_223" name="ifrs-full:Cash" contextRef="C_20231231_srtCurrencyAxis_currencyXXX" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other receivable</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232726_xbrl_20220119121051965_xbrl_20220119120834197_23" name="ifrs-full:TradeAndOtherReceivables" contextRef="C_20231231_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">856</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232726_xbrl_20220119121051965_xbrl_20220119120834197_27" name="ifrs-full:TradeAndOtherReceivables" contextRef="C_20231231_srtCurrencyAxis_currencyGBP" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232726_xbrl_20220119121051965_xbrl_20220119120834197_211" name="ifrs-full:TradeAndOtherReceivables" contextRef="C_20231231_srtCurrencyAxis_currencySEK" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232726_xbrl_20220119121051965_xbrl_20220119120834197_215" name="ifrs-full:TradeAndOtherReceivables" contextRef="C_20231231_srtCurrencyAxis_currencyCAD" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">533</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232726_xbrl_20220119121051965_xbrl_20220119120834197_219" name="ifrs-full:TradeAndOtherReceivables" contextRef="C_20231231_srtCurrencyAxis_currencyBRL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,533</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232726_xbrl_20220119121051965_xbrl_20220119120834197_223" name="ifrs-full:TradeAndOtherReceivables" contextRef="C_20231231_srtCurrencyAxis_currencyXXX" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_23" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,766</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_27" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_srtCurrencyAxis_currencyGBP" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_211" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_srtCurrencyAxis_currencySEK" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_215" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_srtCurrencyAxis_currencyCAD" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">220</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_219" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_srtCurrencyAxis_currencyBRL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">704</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_223" name="ifrs-full:TradeAndOtherPayables" contextRef="C_20231231_srtCurrencyAxis_currencyXXX" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420161702836_xbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_23" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,349</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420161702836_xbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_27" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_srtCurrencyAxis_currencyGBP" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420161702836_xbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_211" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_srtCurrencyAxis_currencySEK" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420161702836_xbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_215" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_srtCurrencyAxis_currencyCAD" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230420161702836_xbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_219" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_srtCurrencyAxis_currencyBRL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">241</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420161702836_xbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_223" name="ifrs-full:LeaseLiabilities" contextRef="C_20231231_srtCurrencyAxis_currencyXXX" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        exposure</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121232843_xbrl_20220119121056325_xbrl_20220119120834197_23" name="trib:TotalExposureFinancialInstruments" contextRef="C_20231231_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,040</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232843_xbrl_20220119121056325_xbrl_20220119120834197_27" name="trib:TotalExposureFinancialInstruments" contextRef="C_20231231_srtCurrencyAxis_currencyGBP" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240422121605984" name="trib:TotalExposureFinancialInstruments" contextRef="C_20231231_srtCurrencyAxis_currencySEK" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232843_xbrl_20220119121056325_xbrl_20220119120834197_215" name="trib:TotalExposureFinancialInstruments" contextRef="C_20231231_srtCurrencyAxis_currencyCAD" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">504</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121232843_xbrl_20220119121056325_xbrl_20220119120834197_219" name="trib:TotalExposureFinancialInstruments" contextRef="C_20231231_srtCurrencyAxis_currencyBRL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,442</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121232843_xbrl_20220119121056325_xbrl_20220119120834197_223" name="trib:TotalExposureFinancialInstruments" contextRef="C_20231231_srtCurrencyAxis_currencyXXX" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> </div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">188</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<div style="margin-top:0pt;margin-bottom:0pt">

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">27.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">CAPITAL
        AND FINANCIAL RISK MANAGEMENT (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sensitivity
analysis</span></span></div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20240413101524956" name="ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A 10%
strengthening of the US&#160;Dollar against the Euro at December&#160;31, 2024 would have increased profit and other equity by the amounts
shown below. This analysis assumes that all other variables, in particular interest rates, remain constant.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        or Loss</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td colspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td colspan="1" style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121630891_23" name="ifrs-full:ProfitLoss" contextRef="C_20240101to20241231_ifrsfullTypesOfRisksAxis_tribTenPercentStrengtheningUSDollarMember_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,167</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td colspan="1" style="vertical-align:middle;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td colspan="1" style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td colspan="1" style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119121630891_53" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20231231_ifrsfullTypesOfRisksAxis_tribTenPercentStrengtheningUSDollarMember_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,004</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>&#160;

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A
10% weakening of the US&#160;Dollar against the Euro at December&#160;31, 2024 would have decreased profit and other equity by the amounts
shown below. This analysis assumes that all other variables, in particular interest rates, remain constant.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        or Loss</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121818191_23" name="ifrs-full:ProfitLoss" contextRef="C_20240101to20241231_ifrsfullTypesOfRisksAxis_tribTenPercentWeakeningUSDollarMember_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,427</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119121818191_53" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20231231_ifrsfullTypesOfRisksAxis_tribTenPercentWeakeningUSDollarMember_srtCurrencyAxis_currencyEUR" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,227</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
sensitivity analysis is based on the Group&#8217;s foreign currency exposures at the reporting date and assumes a 10% movement in the
US Dollar against the Euro. The analysis includes monetary assets and liabilities denominated in Euro at the reporting date and assumes
that exchange rate changes occur at the period-end and are applied to the net exposure. Non-monetary items and future forecast transactions
are excluded. The analysis assumes that all other variables, including interest rates, remain constant. The analysis does not incorporate
interdependencies between variables, such as interest rate effects on exchange rates, and is not based on a value-at-risk model.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
objective of this analysis is to assess the potential impact of reasonably possible changes in exchange rates on the Group&#8217;s profit
or loss and equity, based on exposures at the reporting date. The analysis reflects only monetary assets and liabilities denominated in
foreign currencies and does not include future transactions or embedded derivatives. The analysis has inherent limitations, as it is based
on a hypothetical movement in a single variable (foreign exchange rate) and assumes all other variables remain constant. It does not consider
the potential interdependence between risk factors (such as changes in interest rates or inflation), nor does it reflect management&#8217;s
dynamic hedging activities or the potential impact on fair value from market volatility occurring after the reporting date.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Credit
Risk</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group has no significant concentrations of credit risk. Exposure to credit risk is monitored on an ongoing basis. For trade receivables,
the Group applies the simplified approach to measuring expected credit losses and recognizes a lifetime expected credit loss allowance.
A receivable is considered credit-impaired when it is more than 120 days past due or when there is evidence of significant financial difficulty.
The Group maintains specific provisions for potential credit losses. To date such losses have been within management&#8217;s expectations.
Due to the large number of customers and the geographical dispersion of these customers, the Group has no significant concentrations of
accounts receivable.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">189</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">27.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">CAPITAL
        AND FINANCIAL RISK MANAGEMENT (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">With
respect to credit risk arising from the other financial assets of the Group, which comprise cash and cash equivalents, the Group&#8217;s
exposure to credit risk arises from default of the counterparty, with a maximum exposure equal to the carrying amount of these instruments.
The Group&#8217;s management considers that all of the above financial assets that are not impaired or past due for each of the 31&#160;December
reporting dates under review are of good credit quality.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group maintains cash and cash equivalents with various financial institutions. The Group performs regular and detailed evaluations of
these financial institutions to assess their relative credit standing. The carrying amount reported in the balance sheet for cash and
cash equivalents approximate their fair value.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exposure
to credit risk</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
carrying amount of financial assets represents the maximum credit exposure. The maximum exposure to credit risk is as follows:</span></span></div>

<div>&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240413101833924" name="ifrs-full:DisclosureOfCreditRiskExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Third
        party trade receivables (Note 17)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420162205892" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,416</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122448537_17" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,698</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance
        lease income receivable (Note 17)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420162212669" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122448537_27" name="trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">155</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash&#160;and
        cash equivalents (Note 18)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420162225100" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,167</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122448537_37" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420162231253" name="ifrs-full:MaximumExposureToCreditRisk" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,583</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122448537_67" name="ifrs-full:MaximumExposureToCreditRisk" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,544</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
maximum exposure to credit risk for trade receivables and finance lease income receivable by geographic location is as follows:</span></span></div>

<div>&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240413102053189" name="trib:DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United
        States</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122643528_13" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,185</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122643528_17" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,041</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro-zone
        countries</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122643528_23" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribEuroZoneCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">742</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122643528_27" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribEuroZoneCountriesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">851</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United
        Kingdom</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122643528_33" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryGB" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">741</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122643528_37" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryGB" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">126</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        regions</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122643528_53" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,748</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122643528_57" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,835</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420162359949" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,416</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122643528_77" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,853</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </ix:nonNumeric> </div>&#160;

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
maximum exposure to credit risk for trade receivables and finance lease income receivable by type of customer is as follows: &#160;</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240413102123268" name="trib:DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">End-user
        customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122855472_13" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20241231_ifrsfullTypesOfCustomersAxis_tribEndUserCustomersMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,828</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122855472_17" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20231231_ifrsfullTypesOfCustomersAxis_tribEndUserCustomersMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,029</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Distributors</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122855472_23" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20241231_ifrsfullTypesOfCustomersAxis_tribDistributorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,236</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122855472_27" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20231231_ifrsfullTypesOfCustomersAxis_tribDistributorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,399</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-governmental
        organisations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122855472_33" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20241231_ifrsfullTypesOfCustomersAxis_ifrsfullNongovernmentCustomersMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,352</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122855472_37" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20231231_ifrsfullTypesOfCustomersAxis_ifrsfullNongovernmentCustomersMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">425</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420162449037" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,416</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119122855472_57" name="ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,853</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Due
to the large number of customers and the geographical dispersion of these customers, the Group has no significant concentrations of accounts
receivable.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">190</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
  <tr style="margin-top:0pt;margin-bottom:0pt">
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">27.</span></span></td>
    <td style="width:auto;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">CAPITAL
        AND FINANCIAL RISK MANAGEMENT (CONTINUED)</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
Losses</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
ageing of trade receivables at December&#160;31, 2024 is as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240413102145899" name="trib:DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected
        Credit Loss Rate</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected
        Credit Loss Rate</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Not
        past due</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_33" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,363</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_37" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_311" name="ifrs-full:ExpectedCreditLossRate" contextRef="C_20241231_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_315" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,031</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_319" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_323" name="ifrs-full:ExpectedCreditLossRate" contextRef="C_20231231_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Past
        due 0-30 days</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_43" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,455</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_47" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_411" name="ifrs-full:ExpectedCreditLossRate" contextRef="C_20241231_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_415" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,534</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_419" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_423" name="ifrs-full:ExpectedCreditLossRate" contextRef="C_20231231_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Past
        due 31-120 days</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_53" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,753</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_57" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_511" name="ifrs-full:ExpectedCreditLossRate" contextRef="C_20241231_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">1.8</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_515" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">856</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_519" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_523" name="ifrs-full:ExpectedCreditLossRate" contextRef="C_20231231_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.6</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Greater
        than 120 days</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_63" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,131</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_67" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,255</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_611" name="ifrs-full:ExpectedCreditLossRate" contextRef="C_20241231_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">72.0</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_615" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,601</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_619" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,302</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413121411538" name="ifrs-full:ExpectedCreditLossRate" contextRef="C_20231231_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">88.5</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420162704565" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,702</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420162743757" name="ifrs-full:TradeReceivables" contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,286</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420162805813" name="ifrs-full:ExpectedCreditLossRate" contextRef="C_20241231" unitRef="Pure" scale="-2" decimals="2" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_83" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,022</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119123450796_87" name="ifrs-full:TradeReceivables" contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,324</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230420162819174" name="ifrs-full:ExpectedCreditLossRate" contextRef="C_20231231" unitRef="Pure" scale="-2" decimals="2" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </ix:nonNumeric> </div>&#160;

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group considers that the credit risk of a financial asset may have increased since initial recognition when it is more than 30 days past
due, unless there is evidence to the contrary. As at December 31, 2024, all trade receivables past due more than 30 days were assessed
for changes in credit risk since initial recognition. Based on this assessment:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Receivables past due
        between 31 and 120 days are not automatically considered to have an increased credit risk unless other qualitative indicators are present
        (e.g., known financial difficulty, adverse changes in circumstances, etc.).</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Receivables past due more than 120 days are generally
        considered to have a higher credit risk and are assessed for lifetime expected credit losses.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group applies a simplified approach in measuring expected credit losses which uses a provision matrix based on historical credit loss
experience, adjusted for forward-looking factors specific to the debtors and the economic environment.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement in the allowance for impairment in respect of trade receivables during the year was as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20240413102210635" name="trib:DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory" contextRef="C_20240101to20241231" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119124612102_23" name="trib:AllowanceForImpairmentOfReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,324</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119124612102_27" name="trib:AllowanceForImpairmentOfReceivables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,691</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charged
        to costs and expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119124612102_33" name="ifrs-full:IncreaseThroughOriginationOrPurchaseFinancialAssets" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">225</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119124612102_37" name="ifrs-full:IncreaseThroughOriginationOrPurchaseFinancialAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">715</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amounts
        written off during the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119124612102_43" name="ifrs-full:DecreaseThroughWriteoffFinancialAssets" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">263</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220119124612102_47" name="ifrs-full:DecreaseThroughWriteoffFinancialAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">977</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminated
        on disposal of business</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413122053217" name="trib:EliminatedOnDisposalsOfBusiness" contextRef="C_20240101to20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240413122104395" name="trib:EliminatedOnDisposalsOfBusiness" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">105</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at December&#160;31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119124612102_63" name="trib:AllowanceForImpairmentOfReceivables" contextRef="C_20241231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,286</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220119124612102_67" name="trib:AllowanceForImpairmentOfReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,324</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
allowance for impairment in respect of trade receivables is used to record impairment losses unless the Group is satisfied that no recovery
of the account owing is possible. At this point the amount is considered irrecoverable and is written off against the financial asset
directly.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group does not provide financing to customers as a main business activity and therefore is not required to present credit risk exposure
disclosures by credit risk grade.</span></span></div> </div> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> </div> </div>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">191</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div>

<div>

<div> <ix:nonNumeric id="Fxbrl_20220117145818621" name="ifrs-full:DisclosureOfCashFlowStatementExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span><span><span>28.</span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div>
        <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span>RECONCILIATION OF LIABILITIES ARISING FROM
        FINANCING ACTIVITIES</span></span></p> </div> </td> </tr>
  </table> </div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The
changes in the Group&#8217;s liabilities arising from financing activities can be classified as follows:</span></span></span></span></span></span>

<p style="margin:0pt">&#160;</p> </div> <ix:nonNumeric id="Fxbrl_20250512224504358" name="ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" contextRef="C_20240101to20241231" continuedAt="F20250512224528974" escape="true">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:85%">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Note</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Borrowings
        &amp; derivative</span></span></span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>financial
        instruments<br/>US$&#8217;000</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Lease
        liabilities<br/>US$&#8217;000</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Balance
        at January 1, 2024</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>23,24</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133537494_xbrl_20220117153657356_27" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55,387</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133537494_xbrl_20220117153657356_211" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,566</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash-flows:</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Principal
        amount loaned &#8211; term loan</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133544310_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,500</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133544310_xbrl_20240413133138207" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Loan
        origination costs paid</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240413133553242_xbrl_20230414075105281_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67" name="trib:PrincipalAmountLoaned" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">324</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133553242_xbrl_20230414075105281_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611" name="trib:PrincipalAmountLoaned" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Interest
        paid for senior secured term loan</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240413133602470_xbrl_20230420112110106" name="trib:InterestPaidOnSeniorSecuredTermLoan" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,253</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133602470_xbrl_20230420112138686" name="trib:InterestPaidOnSeniorSecuredTermLoan" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Interest
        paid for convertible note</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240413133615821_xbrl_20230420112238075_xbrl_20230420112138686" name="trib:InterestPaidOnConvertibleNote" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">300</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133615821_xbrl_20240413133308772" name="trib:InterestPaidOnConvertibleNote" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Interest
        paid for exchangeable notes</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240413133626501_xbrl_20230420112239729_xbrl_20230420112138686" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133626501_xbrl_20240413133332978" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Repayment
        of leases</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133809268_xbrl_20230420112414641_xbrl_20220117153657356_97" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240413133809268_xbrl_20230420112414641_xbrl_20220117153657356_911" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,503</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Non-cash:</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Interest
        charged</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133831248_xbrl_20230421023512172" name="trib:IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,561</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133831248_xbrl_20230421025317005" name="trib:IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Derivative
        financial asset at date of issue</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133851425_xbrl_20230414075122996_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67" name="trib:DerivativeFinancialAssetAtDateOfIssue" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133851425_xbrl_20230414075122996_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611" name="trib:DerivativeFinancialAssetAtDateOfIssue" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Remeasurement
        of ROU assets</span></span></p> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515105125930_xbrl_20240413133851425_xbrl_20230414075122996_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67" name="trib:RemeasurementOfRightOfUseAssets" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250515105125930_xbrl_20240413133851425_xbrl_20230414075122996_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611" name="trib:RemeasurementOfRightOfUseAssets" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,764</ix:nonFraction></span></span></td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Additions
        (related to Right of Use assets)</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133910392_xbrl_20230421023957817_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67" name="trib:AdditionsRelatedToRightOfUseAssets" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133910392_xbrl_20230421023957817_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611" name="trib:AdditionsRelatedToRightOfUseAssets" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">855</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Exchange
        adjustment</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133919737_xbrl_20230421024838106" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240413133919737_xbrl_20230421023050399" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">512</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Accretion
        interest</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133930855_xbrl_20230421024003622_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67" name="trib:IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,214</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133930855_xbrl_20230421024003622_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611" name="trib:IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">592</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Fair
        value of derivative liability - warrants</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133939669_xbrl_20230414071356785_xbrl_20220327190830086" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133939669_xbrl_20230414071356785_xbrl_20220117153657356_1411" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Fair
        value of additional derivative liability - warrants</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20250513000757642" name="trib:IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,066</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20250513000812364" name="trib:IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Payment-in-kind
        (PIK) Interest</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20250513000839337" name="trib:IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,291</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20250513000905420" name="trib:IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></p>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Contingent
        liability</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20250513000845086" name="trib:IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,813</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20250513000908445" name="trib:IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Non-cash
        loan modification gain</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20250513000849128" name="trib:NoncashLoanModificationGain" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,567</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20250513000920202" name="trib:NoncashLoanModificationGain" contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Balance
        at December 31, 2024</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>23,24</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133947363_xbrl_20230421024150500_xbrl_20230421023618201_xbrl_20220117153657356_47" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">91,474</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240413133947363_xbrl_20230421024150500_xbrl_20230421023618201_xbrl_20220117153657356_411" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,762</ix:nonFraction></span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
  </table> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">192</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>28.</span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>RECONCILIATION OF LIABILITIES ARISING
        FROM FINANCING ACTIVITIES (CONTINUED)</span></span></span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div> <ix:continuation id="F20250512224528974">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Borrowings
        &amp; derivative</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>financial
        instruments<br/>US$&#8217;000</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease
        liabilities<br/>US$&#8217;000</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance
        at January 1, 2023</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>23,24</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220117153657356_27" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59,826</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220117153657356_211" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,943</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash-flows:</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Principal
        amount loaned &#8211; term loan</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,000</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240413133138207" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Loan
        origination costs paid</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20230414075105281_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67" name="trib:PrincipalAmountLoaned" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">194</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230414075105281_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611" name="trib:PrincipalAmountLoaned" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest
        paid for senior secured term loan</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20250513001140156" name="trib:InterestPaidOnSeniorSecuredTermLoan" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,314</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest
        paid for convertible note</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20230420112238075_xbrl_20230420112138686" name="trib:InterestPaidOnConvertibleNote" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">300</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240413133308772" name="trib:InterestPaidOnConvertibleNote" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest
        paid for exchangeable notes</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20230420112239729_xbrl_20230420112138686" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240413133332978" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Repayment
        of term loan</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20240413133414191" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,050</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Repayment
        of leases</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20250513001212487" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20250513001227792" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,318</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Penalty
        paid for early settlement of term loan</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20230420112457803_xbrl_20220117153657356_97" name="trib:PenaltyPaidForEarlySettlement" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">905</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230420112457803_xbrl_20220117153657356_911" name="trib:PenaltyPaidForEarlySettlement" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Non-cash:</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8212;</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest
        charged</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230421023512172" name="trib:IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,622</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230421025317005" name="trib:IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Penalty
        for early settlement charged</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230414075114554_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67" name="trib:PenaltyForEarlySettlementCharged" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">905</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230414075114554_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611" name="trib:PenaltyForEarlySettlementCharged" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derivative
        financial asset at date of issue</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>23</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230414075122996_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67" name="trib:DerivativeFinancialAssetAtDateOfIssue" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230414075122996_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611" name="trib:DerivativeFinancialAssetAtDateOfIssue" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Disposals
        (related to Right of Use assets)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20250513001245005" name="trib:DisposalsRelatedToRightOfUseAssets" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20250513001302002" name="trib:DisposalsRelatedToRightOfUseAssets" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">106</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions
        (related to Right of Use assets)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20250513001334884" name="trib:AdditionsRelatedToRightOfUseAssets" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230421023957817_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611" name="trib:AdditionsRelatedToRightOfUseAssets" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">112</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exchange
        adjustment</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230421024838106" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230421023050399" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">311</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Accretion
        interest</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230421024003622_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67" name="trib:IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,927</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230421024003622_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611" name="trib:IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">624</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair
        value of derivative liability - warrants</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20230414071356785_xbrl_20220327190830086" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,133</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230414071356785_xbrl_20220117153657356_1411" name="ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance at
        December 31, 2023</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>23,24</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230421024150500_xbrl_20230421023618201_xbrl_20220117153657356_47" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55,387</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230421024150500_xbrl_20230421023618201_xbrl_20220117153657356_411" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,566</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </ix:continuation> </div> </div> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> </div> </div>

<div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">193</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> <ix:nonNumeric id="Fxbrl_20250512154900931" name="ifrs-full:DisclosureOfBusinessCombinationsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BUSINESS COMBINATIONS</span></span></div> </td>
        </tr>
  </table> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Acquisition
of the CGM assets of Waveform Technologies, Inc.</span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On
January 30, 2024, the Company purchased the biosensor and continuous glucose monitoring (&#8220;CGM&#8221;)&#160; assets of privately
held Waveform Technologies, Inc. (&#8220;Waveform&#8221;) for the initial consideration of US$<ix:nonFraction id="Fxbrl_20250512173130947" name="ifrs-full:CashTransferred" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.5</ix:nonFraction>
million in cash and <ix:nonFraction id="Fxbrl_20250512175227543" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">36</ix:nonFraction>
million &#8216;A&#8217; Ordinary shares (represented by <ix:nonFraction id="Fxbrl_20250512175211650" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.8</ix:nonFraction>
million ADSs) of the Company, which had a fair value of US$<ix:nonFraction id="Fxbrl_20250513130555942" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,960</ix:nonFraction>,000
on the date of acquisition. In addition contingent consideration of a maximum of US$<ix:nonFraction id="Fxbrl_20250512175642139" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">20</ix:nonFraction>
million. We intend to update the Waveform CGM device, which is not being marketed, and optimize it for broad adoption and then evolve
this platform technology to measure and analyze other valuable biomarkers and related datapoints. Our vision is to develop a portfolio
of technologies that can offer users and clinicians valuable actionable health and wellness insights. Control was obtained through the
acquisition of substantially all of Waveform&#8217;s operational assets and intellectual property, representing an integrated set of activities
and assets capable of being conducted and managed to provide a return in the form of outputs. The integrated set of activities and assets
purchased will significantly contribute to achieving our vision and its associated outputs.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">This
transaction has been accounted for as a business combination under IFRS 3. The determination was based on the acquisition of an integrated
set of activities and assets, including intellectual property, technical processes, and a skilled workforce, that together constitute
a business capable of being conducted and managed to provide returns</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair value of non-cash consideration in the form of ADSs issued in connection with the acquisition was determined using the volume-weighted
average price (VWAP) of the Company&#8217;s ADSs on the acquisition date.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingent
consideration of up to US$<ix:nonFraction id="Fxbrl_20250512175930343" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">20</ix:nonFraction>
million may be payable upon the occurrence of certain events, including;</span></span></div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20250512180255087" name="ifrs-full:DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" contextRef="C_20240130to20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.05pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$5.0 million payment
        if, within the next 12 months after closing, (i) the closing price of the Company&#8217;s ADSs does not exceed US$7.50 per ADS for at
        a least 20 consecutive trading days and (ii) the average daily trading volume of the Company&#8217;s ADSs does not equal or exceed 20,000
        ADSs for 20 consecutive trading days, and</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.05pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50% of the proceeds
        received by the Company (up to a maximum payment of additional consideration of US$15.0 million) on our entering into certain commercial
        partnering agreements with certain glucose pump manufacturers in the 24 months from date of acquisition. The fair value assigned to this
        element of the contingent consideration was US$1.8 million at the acquisition date. This is disclosed as a contingent liability in Note
        23.</span></span></div> </td> </tr>
  </table> </div> </ix:nonNumeric>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair value of the contingent consideration at date of acquisition was US$<ix:nonFraction id="Fxbrl_20250512182124569" name="trib:FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.8</ix:nonFraction>
million. Of this, US$<ix:nonFraction id="Fxbrl_20250512182248061" name="trib:ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction>
million is classified as a current liability </span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Note
21)</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">, while the US$<ix:nonFraction id="Fxbrl_20250512182301892" name="trib:ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.8</ix:nonFraction>
million is disclosed as a contingent liability (see Note 23). As of December 31, 2024, there have been no changes to the amount recognized
or to the assumptions used in its initial measurement.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition-related
costs amounting to US$<ix:nonFraction id="Fxbrl_20250512182312631" name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20240130to20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction>
million in respect of the Waveform transaction are not included as part of consideration transferred and have been recognised as an expense
in the condensed consolidated statement of operations, within &#8216;Selling, general and administrative expenses&#8217;.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
initial assignment of fair values to identifiable net assets acquired has been performed on a provisional basis in respect of the above
acquisitions. Any amendments to these acquisition fair values within the 12-month timeframe from the date of acquisition will be disclosed
in the relevant Annual Report as stipulated by IFRS 3 Business Combinations.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">194</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BUSINESS COMBINATIONS (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512155003854" name="ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisional
        value</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Measurement
        period adjustment</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjusted
        values</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property,
        plant and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512163217141" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,569</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512163258763" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">206</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512163302909" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,363</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        assets &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_3_2" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9,360</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_7_2" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_11_2" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9,360</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_3_3" name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_7_3" name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_11_3" name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_3_4" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,296</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20250512163328997_7_4" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,296</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_11_4" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_3_5" name="trib:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">135</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_7_5" name="trib:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_11_5" name="trib:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">135</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20250512163328997_3_6" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">50</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_7_6" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20250512163328997_11_6" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">50</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        tax liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20250512163328997_3_7" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,170</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_7_7" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,170</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_11_7" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets acquired</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20250512163328997_3_8" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,149</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">(<ix:nonFraction id="Fxbrl_20250512163328997_7_8" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">332</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20250512163328997_11_8" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">10,817</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_3_9" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,071</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_7_9" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">332</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_11_9" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,403</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consideration</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20250512163328997_3_10" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,220</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20250512163328997_7_10" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20250512163328997_11_10" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,220</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Satisfied
        by:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_3_13" name="ifrs-full:CashTransferred" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,500</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_7_13" name="ifrs-full:CashTransferred" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_11_13" name="ifrs-full:CashTransferred" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,500</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_3_14" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,960</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_7_14" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_11_14" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,960</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        contingent consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_3_15" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,760</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_7_15" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_11_15" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,760</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20250512163328997_3_16" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,220</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20250512163328997_7_16" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20250512163328997_11_16" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,220</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_3_19" name="ifrs-full:CashTransferred" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,500</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_7_19" name="ifrs-full:CashTransferred" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20250512163328997_11_19" name="ifrs-full:CashTransferred" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,500</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20250512163328997_3_20" name="trib:NetCashOutFlowOnBusinessCombination" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,500</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20250512163328997_7_20" name="trib:NetCashOutFlowOnBusinessCombination" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><ix:nonFraction id="Fxbrl_20250512163328997_11_20" name="trib:NetCashOutFlowOnBusinessCombination" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,500</ix:nonFraction></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </ix:nonNumeric> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
accordance with IFRS 3 Business Combinations, the Group finalised the fair value assessments relating to the acquisition of the Waveform
CGM assets during the year. As part of this process, the Group reassessed the fair value of several acquired balances based on new information
obtained during the measurement period.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair value of intellectual property related to the acquired technology at the Closing Date was derived using the multi-period excess earnings
method. Significant assumptions used in the valuation including CGM cash flow projections which were based on estimates used to price
the Waveform acquisition, and the discount rate applied was benchmarked with reference to the implied rate of return to the Company&#8217;s
pricing model and the weighted-average cost of capital. The intangible asset for acquired technology will be amortized over the respective
estimated periods for which the intangible assets will provide economic benefit to the Company, which is 15 years.</span></span></p> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Following
further evaluation, the deferred tax liability of US$<ix:nonFraction id="Fxbrl_20250512182723983" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.2</ix:nonFraction>
million initially recognised on acquisition was reversed. This adjustment was based on a more detailed analysis of the tax base of the
acquired intangible assets, which concluded that a deferred tax liability was not required.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
addition, the fair value of inventory was reduced by US$<ix:nonFraction id="Fxbrl_20250512182733294" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.3</ix:nonFraction>
million. This reduction reflects a revised assessment of net realisable value. Although initial discussions with management and potential
buyers such as Bayer India suggested a potential market in emerging economies, further exploration indicated that the additional expenditure
required to bring the acquired raw materials, finished goods and work-in-progress to market would render the inventory commercially unviable.
As a result, the inventory was deemed to have no recoverable value.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
value of property, plant and equipment was also reduced by US$<ix:nonFraction id="Fxbrl_20250512182957042" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction>
million. These assets were found to be specific to the legacy CGM product and, following further technical review, were determined to
have no future economic value. Accordingly, their fair value was adjusted to nil.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These
adjustments have been accounted for retrospectively as measurement period adjustments in accordance with IFRS 3. These measurement period
adjustments resulted in a corresponding increase in goodwill of US$<ix:nonFraction id="Fxbrl_20250512183106157" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal" sign="-">0.3</ix:nonFraction>
million. Comparative figures have not been restated as the acquisition occurred during the current financial year.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">195</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BUSINESS COMBINATIONS (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
goodwill recognised from the acquisition of the Waveform CGM assets primarily reflects expected synergies from integrating Waveform&#8217;s
European-approved CGM technology with Trinity Biotech&#8217;s global manufacturing and diabetes expertise. The platform is expected to
accelerate the development of a next-generation, affordable, and user-friendly CGM device, and supports the Group&#8217;s strategy to
expand into adjacent biosensor markets. None of the goodwill is expected to be deductible for tax purposes.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Waveform
was acquired on January 30, 2024. As of December 31, 2024, the acquiree had not generated any revenue since the acquisition date, and
therefore no revenue has been included in the Group&#8217;s consolidated statement of comprehensive income for the reporting period. In
addition, the acquired business incurred a net loss of US$<ix:nonFraction id="Fxbrl_20250512183502513" name="ifrs-full:GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination" contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal" sign="-">1.3</ix:nonFraction>
million, which has been included in the Group&#8217;s consolidated results. The reported loss excludes interest on intercompany funding
arrangements in order to reflect the underlying performance of the acquired business. Waveform Technologies, Inc. was a privately held
company in the late stages of product development and commercial readiness. Although the company was not generating revenue, it had developed
a CE-marked CGM device. It did not maintain financial information in accordance with IFRS, and as such, the Group is unable to reliably
reconstruct the required historical information for pro forma disclosure without incurring undue cost or effort.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Acquisition
of Metabolomics Diagnostics Limited</span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
September 2024, the Company completed the acquisition of <ix:nonFraction id="Fxbrl_20250512184019569" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%
of Metabolomics Diagnostics Ltd (&#8220;Metabolomics&#8221;), a privately-owned Irish deep-tech company, specializing in the development
of novel biomarker-based diagnostic solutions for complex diseases, with the initial focus being screening for preeclampsia risk using
the company&#8217;s PrePsia test. Control was obtained through the execution of a share purchase agreement, resulting in the acquisition
of <ix:nonFraction id="Fxbrl_20250512184102617" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%
of the voting interests. The primary reason for the acquisition was to enter a new area of medical diagnostics with significant long-term
growth potential. The acquisition aligns with the Group&#8217;s strategy of combining its established capabilities with innovative technologies
to unlock new revenue opportunities. The Group intends to leverage this platform to commercialise the PrePsia test in the U.S. through
its Immco laboratory and to explore opportunities in international markets.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Company acquired Metabolomics for consideration of approximately US$<ix:nonFraction id="Fxbrl_20250515012312741" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.9</ix:nonFraction>
million paid through the issuance of approximately <ix:nonFraction id="Fxbrl_20250515012336609" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">0.27</ix:nonFraction>
million ADSs of the Company alongside the extinguishment of monies owed to the Company totalling US$<ix:nonFraction id="Fxbrl_20250515012351853" name="trib:ExtinguishmentOfAmountOwed" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction>
million. The fair value of non-cash consideration in the form of ADSs issued in connection with the acquisition was determined using the
volume-weighted average price (VWAP) of the Company&#8217;s ADSs on the acquisition date.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512155117536" name="ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Metabolomics</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisional
        value</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property,
        plant and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512170458829_xbrl_20250512163302909" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">10</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        assets &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512170458830_xbrl_20250512163328997_11_2" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,200</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512170458831_xbrl_20250512163328997_11_4" name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">144</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512170458833_xbrl_20250512163328997_11_5" name="trib:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">181</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512170458834_xbrl_20250512163328997_11_6" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">494</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        tax liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512170458835_xbrl_20250512163328997_11_7" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">150</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        acquired</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512170625411_73" name="trib:CashAcquiredAsOfAcquisitionDate" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets acquired</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512170458836_xbrl_20250512163328997_11_8" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">900</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512170458837_xbrl_20250512163328997_11_9" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consideration</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512170458838_xbrl_20250512163328997_11_10" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">906</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Satisfied
        by:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512170458838_xbrl_20250512163328997_11_13" name="ifrs-full:CashTransferred" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">412</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512170458839_xbrl_20250512163328997_11_14" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">494</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512170458839_xbrl_20250512163328997_11_16" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">906</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512170458840_xbrl_20250512163328997_11_19" name="ifrs-full:CashTransferred" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">412</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less:
        Cash and cash equivalents</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512170625411_193" name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512170458840_xbrl_20250512163328997_11_20" name="trib:NetCashOutFlowOnBusinessCombination" contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">404</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> </div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">196</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BUSINESS COMBINATIONS (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transaction
costs associated with the acquisition of Metabolomics amounted to US$<ix:nonFraction id="Fxbrl_20250512184840078" name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20240930to20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction>
million, relating to the disbursement of agreed fees and closing bonuses. These costs have been expensed as incurred in accordance with
IFRS 3 and have been recognised in the condensed consolidated statement of operations, within &#8216;Selling, general and administrative
expenses&#8217;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
goodwill recognised in respect of the Metabolomics acquisition is attributable to expected synergies arising from the combination of operations,
as well as the assembled workforce of the acquired business. None of the goodwill recognised is expected to be deductible for tax purposes.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Metabolomics
was acquired in September 2024. As of December 31, 2024, the acquiree had not generated any revenue since the acquisition date, and therefore
no revenue has been included in the Group&#8217;s consolidated statement of comprehensive income for the reporting period. The acquired
business incurred a net loss of US$<ix:nonFraction id="Fxbrl_20250512184956108" name="ifrs-full:GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination" contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal" sign="-">0.3</ix:nonFraction>
million, primarily relating to ongoing development and administrative costs, which has been included in the Group&#8217;s consolidated
results. Metabolomics was a privately held, early-stage Irish entity focused on biomarker-based diagnostics. The company did not prepare
its financial information in accordance with IFRS, and the Group is therefore unable to reliably reconstruct the necessary historical
financial information to provide pro forma consolidated revenue and profit or loss data without incurring undue cost or effort.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Acquisition
of EpiCapture Limited</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
October 2024, the Company completed the acquisition of <ix:nonFraction id="Fxbrl_20250512185037002" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%
of EpiCapture Limited (&#8220;EpiCapture&#8221;), a company developing a non-invasive test for monitoring the risk of aggressive prostate
cancer. Control was obtained through the execution of a share purchase agreement, resulting in the acquisition of <ix:nonFraction id="Fxbrl_20250512185111174" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%
of the voting interests. The primary reason for the acquisition was to strengthen the Group&#8217;s oncology diagnostics pipeline by acquiring
a novel, epigenetics-based prostate cancer test aligned with our strategy of combining Trinity&#8217;s established capabilities with cutting-edge
technologies to address large-scale, urgent, and important clinical issues.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Company acquired EpiCapture for an initial consideration of approximately US$<ix:nonFraction id="Fxbrl_20250515013059389" name="ifrs-full:CashTransferred" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.0</ix:nonFraction>
million, with an additional consideration of US$<ix:nonFraction id="Fxbrl_20250515013120835" name="trib:AdditionalConsiderationContingentOnAchievementOfFutureMilestone" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction>
million contingent (Note 21) on the achievement of future milestones. The initial consideration was paid through the issuance of approximately
<ix:nonFraction id="Fxbrl_20250515013135745" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.7</ix:nonFraction>
million ADS in Trinity Biotech. The fair value of non-cash consideration in the form of Company ADSs issued in connection with the acquisition
was determined using the volume-weighted average price (VWAP) of the Company&#8217;s ADSs on the acquisition date.</span></span></div>

<div>&#160;</div>

<div style="margin-left:36pt"> <ix:nonNumeric id="Fxbrl_20250512155132986" name="ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" escape="true">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EpiCapture</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisional
        value</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        assets &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512171445560_xbrl_20250512170458830_xbrl_20250512163328997_11_2" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,668</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512171445561_xbrl_20250512170458834_xbrl_20250512163328997_11_6" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">406</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        tax liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20250512171445563_xbrl_20250512170458835_xbrl_20250512163328997_11_7" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">333</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets acquired</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512171445563_xbrl_20250512170458836_xbrl_20250512163328997_11_8" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,929</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512171445564_xbrl_20250512170458837_xbrl_20250512163328997_11_9" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,420</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consideration</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512171445564_xbrl_20250512170458838_xbrl_20250512163328997_11_10" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,349</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Satisfied
        by:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512171445565_xbrl_20250512170458839_xbrl_20250512163328997_11_14" name="ifrs-full:EquityInterestsOfAcquirer" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,965</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        contingent consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512171557048" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">384</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512171445566_xbrl_20250512170458839_xbrl_20250512163328997_11_16" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,349</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512171445567_xbrl_20250512170458840_xbrl_20250512163328997_11_20" name="trib:NetCashOutFlowOnBusinessCombination" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">&#160;</div> </td> </tr>
  </table> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> </div>

<div><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">197</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BUSINESS COMBINATIONS (CONTINUED)</span></span></div>
        </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
contingent consideration related to the acquisition of EpiCapture Limited comprises deferred consideration with a fair value of US$<ix:nonFraction id="Fxbrl_20250512185620603" name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction>
million. <ix:nonNumeric id="Fxbrl_20250512185858023" name="trib:DescriptionOfCumulativeRevenuesPayable" contextRef="C_20241031to20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember">An
amount of US$0.5 million will become payable if cumulative revenues from EpiCapture&#8217;s operations reach US$1.0 million within a period
of three years</ix:nonNumeric>, commencing from the date on which the Company obtains validation of the EpiCapture prostate test under
the New York State Department of Health&#8217;s Clinical Laboratory Evaluation Programme. As of December 31, 2024, there have been no
changes to the amount recognized or to the assumptions used in its initial measurement.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transaction
costs associated with the acquisition of EpiCapture amounted to US$<ix:nonFraction id="Fxbrl_20250512185951572" name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="C_20241031to20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,000</ix:nonFraction>,
have been expensed as incurred in accordance with IFRS 3 and have been recognised in the condensed consolidated statement of profit or
loss, within &#8216;Selling, general and administrative expenses&#8217;.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
goodwill recognised in respect of the EpiCapture acquisition is attributable to expected synergies arising from the combination of operations.
None of the goodwill recognised is expected to be deductible for tax purposes.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EpiCapture
was acquired in October 2024. As of December 31, 2024, the acquiree had not generated any revenue since the acquisition date, and therefore
no revenue has been included in the Group&#8217;s consolidated statement of comprehensive income for the reporting period. The acquired
business incurred a net loss of US$<ix:nonFraction id="Fxbrl_20250512190118327" name="ifrs-full:GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination" contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">20,000</ix:nonFraction>,
mainly comprising transaction-related expenses, which has been included in the Group&#8217;s consolidated results. EpiCapture Limited
was a privately held, early-stage Irish company developing a novel epigenetics-based diagnostic test. As the entity did not prepare its
financial information in accordance with IFRS, it is not practicable for the Group to reconstruct the required historical financial information
to present pro forma consolidated results for the year ended December 31, 2024, without undue cost or effort</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
initial assignment of fair values to the identifiable net assets acquired in respect of the Metabolomics and EpiCapture acquisitions has
been performed on a provisional basis. Any amendments to these acquisition fair values within the 12-month timeframe from the respective
dates of acquisition will be disclosed in future financial statements in accordance with IFRS 3 Business Combinations.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">It
is impracticable for the Group to disclose the pro forma consolidated revenue and profit or loss for the year ended December 31, 2024,
as if the acquisitions of Waveform, Metabolomics, and EpiCapture had occurred on January 1, 2024. All three entities were privately held,
early-stage businesses that did not maintain financial information in accordance with IFRS. As a result, the Group is unable to reliably
reconstruct the required historical financial information without incurring undue cost or effort.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">There
were no individually immaterial business combinations that are collectively material during the year. All business combinations completed
during the year have been assessed as individually material and have been disclosed separately in the notes to the consolidated financial
statements.</span></span></div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> <ix:nonNumeric id="Fxbrl_20250512143804581" name="ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">POST BALANCE SHEET EVENTS</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendment
and Restatement of Term Loan</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
2025, the Company entered into further amendments to its senior secured term loan credit agreement with its principal lender, Perceptive,
to access additional funding and enhance its financial position.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On
February 27, 2025, the Company entered into a fourth amendment to the credit agreement, pursuant to which Perceptive provided an additional
US$<ix:nonFraction id="Fxbrl_20250512145552888" name="ifrs-full:NotionalAmount" contextRef="C_20250227_ifrsfullBorrowingsByNameAxis_tribFourthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction>
million in term loan funding. This funding will be used for general corporate purposes, including the further development of our CGM offering.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On
May 14, 2025, the Company entered into a fifth amendment to the credit agreement, which provided for a further US$<ix:nonFraction id="Fxbrl_20250512145704200" name="ifrs-full:NotionalAmount" contextRef="C_20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction>
million in term loan funding, extended the maturity date of the Term Loan from <ix:nonNumeric id="Fxbrl_20250515124951112" name="ifrs-full:BorrowingsMaturity" contextRef="C_20250514to20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">January
2026 to July 27, 2026</ix:nonNumeric>, and confirmed that <ix:nonNumeric id="Fxbrl_20250512145808323" name="ifrs-full:BorrowingsInterestRateBasis" contextRef="C_20250514to20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">interest
payments for the months of April, May, and June 2025 would be paid-in-kind</ix:nonNumeric>. This funding is also intended to support general
corporate purposes and continued investment in the Company&#8217;s CGM and biosensor development programs.</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>These
2025 amendments reflect the ongoing support of Perceptive and have further strengthened the Company&#8217;s liquidity position, while
providing greater operational and financial flexibility to support the execution of its strategic and commercial objectives.</span></span></span></span></div>
</div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">198</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <ix:nonNumeric id="Fxbrl_20250512133133514" name="ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <p style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">31.</span></span></p>
        </td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ACCOUNTING ESTIMATES AND JUDGEMENTS</span></span></div>
        </td> </tr>
  </table> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
preparation of these financial statements requires the Group to make estimates and judgements that affect the reported amount of assets,
liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On
an on-going basis, the Group evaluates these estimates, including those related to intangible assets, contingencies and litigation. The
estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances,
the results of which form the basis for making judgements about the carrying values of assets and liabilities that are not readily apparent
from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Key
sources of estimation uncertainty</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note
12 contains information about the assumptions and the risk factors relating to the impairment of goodwill, other intangible assets, property,
plant and equipment and financial asset. Note 20 outlines information regarding the valuation of share options. Note 23 outlines the valuation
techniques used by the Company in determining the fair value of the Group&#8217;s interest-bearing loans and borrowings. In Note 27, detailed
analysis is given about the interest rate risk, credit risk, liquidity risk and foreign exchange risk of the Group.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Critical
accounting judgements in applying the Group&#8217;s accounting policies</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certain
critical accounting judgements in applying the Group&#8217;s accounting policies are described below:</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-indent:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
Recognition</span></span></div>

<div style="text-indent:30.6pt;line-height:1.25;font-style:italic">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No
revenue is recognised if there is uncertainty regarding recovery of the consideration due at the outset of the transaction. We make a
judgement as to the collectability of invoiced sales based on an assessment of the individual debtor taking into account past payment
history, the probability of default or delinquency in payments and the probability that debtor will enter into financial difficulties
or bankruptcy.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Some
customer contracts could be regarded as offering the customer a right of return. Due to the uncertainty of the magnitude and likelihood
of product returns, there is a level of estimation involved in assessing the amount of revenue to be recognized for these types of contracts.
In accordance with IFRS 15, when estimating the effect of an uncertainty on an amount of variable consideration to which the Group will
be entitled, all information that is reasonably available, including historical, current and forecast, is considered.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
operate a licenced reference laboratory in New York, USA that specializes in diagnostics for autoimmune diseases. The laboratory provides
testing services to two types of customers. Firstly, institutional customers, such as hospitals and commercial diagnostic testing providers,
and secondly insurance companies on behalf of their policyholders. The revenue recognition for services provided to insurance companies
requires some judgement. In the US, there are rules requiring all insurance companies to be billed the same amount per test. However,
the amount that each insurance company pays for a particular test varies according to their own internal policies and this can typically
be considerably less than the amount invoiced. We recognise lab services revenue for insurance companies by taking the invoiced amount
and reducing it by an estimated percentage based on historical payment data. We review the percentage reduction annually based on the
latest data. As a practical expedient, and in accordance with IFRS, we apply a portfolio approach to the insurance companies as they have
similar characteristics. We judge that the effect on the financial statements of using a portfolio approach for the insurance companies
will not differ materially from applying IFRS 15 to the individual contracts within that portfolio.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
December 31, 2024 US$<ix:nonFraction id="Fxbrl_20230413152043027" name="ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities" contextRef="C_20241231" unitRef="USD" scale="0" decimals="0" format="ixt-sec:numwordsen">nil</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20230413152052490" name="ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities" contextRef="C_20231231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">50,000</ix:nonFraction>)
(2022: US$<ix:nonFraction id="Fxbrl_20230413152057124" name="ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities" contextRef="C_20221231" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">114,000</ix:nonFraction>)
of revenue was deferred in accordance with IFRS15.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research
and development expenditure &#8211; capitalized development costs</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under
IFRS as issued by IASB, the Group writes off research and development expenditure as incurred, with the exception of expenditure on projects
whose outcome has been assessed with reasonable certainty as to technical feasibility, commercial viability and recovery of costs through
future revenues. <ix:nonNumeric id="Fxbrl_20220422034250338" name="ifrs-full:DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill" contextRef="C_20240101to20241231">Such
expenditure is capitalised at cost within intangible assets and amortised over its expected useful life of 15 years</ix:nonNumeric>, which
commences when commercial production starts. For further information, refer to Note 12.</span></span>

<p style="margin:0pt">&#160;</p> </div>

<div style="margin-bottom:0px"><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">199</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div>

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">31.</span></td>
    <td style="width:auto;vertical-align:top">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt">ACCOUNTING
        ESTIMATES AND JUDGEMENTS&#160;</span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(CONTINUED)</span></p> </td>
        </tr>
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  </table> </div> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquired
in-process research and development (IPR&amp;D) is valued at its fair value at acquisition date in accordance with IFRS 3. The Company
determines this fair value by adopting the income approach valuation technique. Once the fair value has been determined, the Company will
recognise the IPR&amp;D as an intangible asset when it: (a)&#160;meets the definition of an asset and (b)&#160;is identifiable (i.e.,
is separable or arises from contractual or other legal rights).</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Factors
which impact our judgement to capitalise certain research and development expenditure include the degree of regulatory approval for products
and the results of any market research to determine the likely future commercial success of products being developed. We review these
factors each year to determine whether our previous estimates as to feasibility, viability and recovery should be changed.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
December 31, 2024 the carrying value of capitalised development costs was US$<ix:nonFraction id="Fxbrl_20230428014644369" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">20,951,000</ix:nonFraction>
(2023: US$<ix:nonFraction id="Fxbrl_20230428014653478" name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="C_20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">15,103,000</ix:nonFraction>)
(see&#160; Note 12 to the consolidated financial statements). The increase in 2024 was mainly as a result of additions of US$<ix:nonFraction id="Fxbrl_20230428014754909" name="ifrs-full:AmortisationExpense" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">8,582,000</ix:nonFraction>,
partially offset by impairment losses of US$<ix:nonFraction id="Fxbrl_20230428014743440" name="ifrs-full:ImpairmentLoss" contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">1,596,000</ix:nonFraction>
recognised during the year.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">Impairment
of intangible assets and goodwill</span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Definite
lived intangible assets are reviewed for indicators of impairment periodically while goodwill and indefinite lived assets are tested for
impairment at least annually, individually or at the cash-generating unit level.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Factors
considered important, as part of an impairment review, include the following:</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Significant underperformance relative to expected
        historical or projected future operating results;</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Significant changes in the manner of our use of
        the acquired assets or the strategy for our overall business;</span></span></div> </td> </tr>
  </table> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Obsolescence of products;</span></span></div>
        </td> </tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Significant decline in our stock price for a sustained
        period; and</span></span></div> </td> </tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our market capitalisation relative to net book
        value.</span></span></div> </td> </tr>
  </table>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">When
we determine that the carrying value of intangibles and non-current assets may not be recoverable based upon the existence of one or more
of the above indicators of impairment, any impairment is measured based on our estimates of projected net discounted cash flows expected
to result from that asset, including eventual disposition. Our estimated impairment could prove insufficient if our analysis overestimated
the cash flows or conditions change in the future.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
impairment testing performed during the year ended December 31, 2024 resulted in impairment losses being recorded&#160; in four cash generating
units, namely Immco Diagnostics Inc, Trinity Biotech Do Brasil, Biopool US Inc and Clark Laboratories Inc totalling US$<ix:nonFraction id="Fxbrl_20230413154626958" name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncome" contextRef="C_20240101to20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.4</ix:nonFraction>
million. For further information, refer to Note 12.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allowance
for slow-moving and obsolete inventory</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
evaluate the realisability of our inventory on a case-by-case basis and make adjustments to our inventory provision based on our estimates
of expected losses. We write off inventory that is approaching its &#8220;use-by&#8221; date and for which no further re-processing can
be performed. We also consider recent trends in revenues for various inventory items and instances where the realisable value of inventory
is likely to be less than its carrying value. Given the allowance is calculated on the basis of the actual inventory on hand at the particular
balance sheet date, there were no material changes in estimates made during 2024, 2023 or 2022 which would have an impact on the carrying
values of inventory during those periods, except as discussed below. At December&#160;31, 2024 our allowance for slow moving and obsolete
inventory was US$<ix:nonFraction id="Fxbrl_20230413155326235" name="ifrs-full:InventoriesAtNetRealisableValue" contextRef="C_20241231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.6</ix:nonFraction>
million which represents approximately <ix:nonFraction id="Fxbrl_20230413155338972" name="trib:PercentageOfGrossInventory1" contextRef="C_20241231" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">28.3</ix:nonFraction>%
of gross inventory value. At December 31, 2023 our allowance for slow moving and obsolete inventory was US$<ix:nonFraction id="Fxbrl_20230413155355020" name="ifrs-full:InventoriesAtNetRealisableValue" contextRef="C_20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">11.3</ix:nonFraction>
million which represented approximately <ix:nonFraction id="Fxbrl_20230413155447530" name="trib:PercentageOfGrossInventory1" contextRef="C_20231231" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">36.3</ix:nonFraction>%
of gross inventory value and at December 31, 2022 the provision was US$<ix:nonFraction id="Fxbrl_20230413155439173" name="ifrs-full:InventoriesAtNetRealisableValue" contextRef="C_20221231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">16.3</ix:nonFraction>
million, or approximately <ix:nonFraction id="Fxbrl_20230413155502588" name="trib:PercentageOfGrossInventory1" contextRef="C_20221231" unitRef="Pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">42.0</ix:nonFraction>%
of gross inventory value. The estimated allowance for slow moving and obsolete inventory as a percentage of gross inventory has decreased
between 2023 and 2024 due to the physical scrapping of obsolete inventory and better inventory management.</span></span>

<p style="margin:0pt">&#160;</p> </div>

<div style="margin-bottom:0px"><ix:exclude>

<div style="line-height:1.25">

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">200</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div>

<div style="line-height:1.25;font-family:'Times New Roman', serif">

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0);border:0px">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">31.</span></td>
    <td style="width:auto;vertical-align:top">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt">ACCOUNTING
        ESTIMATES AND JUDGEMENTS</span><span style="font-size:10pt">&#160;</span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(CONTINUED)</span></p>
        </td> </tr>
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif">&#160;</td>
    <td style="width:auto;vertical-align:top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><em>Allowance for slow-moving and
        obsolete inventory (continued)</em></p> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </ix:exclude></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management
is satisfied that the assumptions made with respect to future sales and production levels of these products are reasonable to ensure the
adequacy of this provision. In the event that the estimate of the provision required for slow moving and obsolete inventory was to increase
or decrease by 2% of gross inventory, which would represent a reasonably likely range of outcomes, then a change in allowance of US$<ix:nonFraction id="Fxbrl_20230413163110854" name="trib:ChangeInAllowance" contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTwoPercentageOfGrossInventoryMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction>
million at December&#160;31, 2024 (2023: US$<ix:nonFraction id="Fxbrl_20230413163134671" name="trib:ChangeInAllowance" contextRef="C_20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTwoPercentageOfGrossInventoryMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction>
million) (2022: US$<ix:nonFraction id="Fxbrl_20230413163144885" name="trib:ChangeInAllowance" contextRef="C_20221231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTwoPercentageOfGrossInventoryMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction>
million) would result. For further information, refer to Note 16.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Business
Combinations</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group completed three business combinations during the year: the acquisitions of Waveform Technologies, Metabolomics Health, and EpiCapture.
Significant judgement was required in determining whether each transaction met the definition of a business under IFRS 3 Business Combinations,
based on the acquisition of an integrated set of activities and assets capable of generating outputs.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
accounting for these transactions, management was required to make key estimates in the determination of the fair value of the identifiable
assets acquired and liabilities assumed, including the recognition and measurement of separately identifiable intangible assets and contingent
consideration. The valuations involved the use of discounted cash flow models and required management to estimate future cash flows, apply
appropriate discount rates reflecting the Group&#8217;s weighted average cost of capital, and assess the probability of meeting contingent
consideration milestones. The Group engaged an independent third-party valuation specialist to assist with the purchase price allocation
for all three acquisitions. These estimates had a material impact on the allocation of consideration between identifiable intangible assets
and goodwill.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investment
in Novus Diagnostics</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year, the Group acquired a minority equity interest in a privately held company that is not quoted in an active market. The investment
is classified as a financial asset at fair value through profit or loss (FVTPL) in accordance with IFRS 9. The fair value of the investment
was initially based on the transaction price. As the investment is classified within Level 3 of the fair value hierarchy under IFRS 13,
subsequent remeasurement requires the use of unobservable inputs and significant management judgement. This includes consideration of
investee-specific developments, commercial progress, and market conditions.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Going
Concern</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates
the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future.</span></span></div>

<div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management&#8217;s
assessment of the Group&#8217;s ability to continue as a going concern involves significant judgement. For details of the assumptions
and considerations underpinning this assessment, refer to the &#8220;Going concern&#8221; section of Note 1, which outlines the basis
of preparation..</span></span></div> </div> </div> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">201</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div>

<div>

<div>

<div> <ix:nonNumeric id="Fxbrl_20240415111120043" name="trib:DisclosureOfGroupUndertakingsExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<div>

<div>

<div>

<div>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"><span id="GROUPUNDERTAKINGS"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32</span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GROUP
        UNDERTAKINGS</span></span></div> </td> </tr>
  </table> </div> </div> </div>

<div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
consolidated financial statements include the financial statements of Trinity Biotech plc and the following principal subsidiary undertakings:</span></span></span></span></div>

<div style="line-height:1.25;font-family:'Times New Roman', serif">&#160;</div> <ix:nonNumeric id="Fxbrl_20240414195344650" name="ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" contextRef="C_20240101to20241231" continuedAt="F20240414200059329" escape="true">

<div style="margin-left:36pt">

<table cellpadding="0" cellspacing="0" style="width:85%">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name
        and registered office</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal
        activity</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal&#160;Country&#160;of<br/>incorporation
        and<br/>operation</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Group&#160;%&#160;holding</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413054331240" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember">Trinity
        Biotech Manufacturing Limited</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055623654" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">County
        Wicklow, Ireland</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413054345280" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember">Manufacture
        and sale<br/>of diagnostic test kits</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240413054415131" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember">Ireland</ix:nonNumeric></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240413054432534" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055638453" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityResearchLimitedMember">Trinity
        Research Limited</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055604876" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityResearchLimitedMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">County
        Wicklow, Ireland</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055952931" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityResearchLimitedMember">Research
        and<br/>development</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240414185436058" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityResearchLimitedMember"><span>Ireland</span></ix:nonNumeric>&#160;</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185833821" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityResearchLimitedMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055642839" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingServicesLimitedMember">Trinity
        Biotech Manufacturing Services Limited</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055549092" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingServicesLimitedMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">County
        Wicklow, Ireland</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055956180" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingServicesLimitedMember">Dormant</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414185448044" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingServicesLimitedMember">Ireland</ix:nonNumeric></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185845450" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingServicesLimitedMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle">&#160;</td>
    <td colspan="1" style="vertical-align:middle">&#160;</td>
    <td style="vertical-align:middle;text-align:center">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center">&#160;</td>
    <td style="vertical-align:middle;text-align:center">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055648179" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechLuxembourgSarlMember">Trinity
        Biotech Luxembourg Sarl</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055541878" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechLuxembourgSarlMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,
        rue Bender,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">L-1229
        Luxembourg</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413060001755" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechLuxembourgSarlMember">Investment
        and<br/>provision of financial<br/>services</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414185511164" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechLuxembourgSarlMember">Luxembourg</ix:nonNumeric></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185848995" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechLuxembourgSarlMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055656812" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechIncMember">Trinity
        Biotech Inc</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055534644" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechIncMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Girts
        Road,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Jamestown,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NY
        14702, USA</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413060005354" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechIncMember">Holding
        Company</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414185513708" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechIncMember">U.S.A.</ix:nonNumeric></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185903964" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechIncMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055703356" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribClarkLaboratoriesIncMember">Clark
        Laboratories Inc</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055524941" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribClarkLaboratoriesIncMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trading
        as Trinity Biotech (USA)</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Girts
        Road, Jamestown</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NY14702,
        USA</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413060009964" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribClarkLaboratoriesIncMember">Manufacture
        and sale<br/>of diagnostic test kits</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414185517037" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribClarkLaboratoriesIncMember">U.S.A</ix:nonNumeric>.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185908588" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribClarkLaboratoriesIncMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055707381" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMardxDiagnosticsIncMember">Mardx
        Diagnostics Inc</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055519966" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMardxDiagnosticsIncMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5919
        Farnsworth Court</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carlsbad</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CA
        92008, USA</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413060023046" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMardxDiagnosticsIncMember">Dormant</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414185523684" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMardxDiagnosticsIncMember">U.S.A.</ix:nonNumeric></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185913556" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMardxDiagnosticsIncMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055712596" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiopoolUsIncMember">Biopool
        US Inc (trading as Trinity Biotech Distribution)</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055515369" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiopoolUsIncMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Girts
        Road, Jamestown</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NY14702,
        USA</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413060105029" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiopoolUsIncMember">Sale
        of diagnostic test<br/>kits</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414185553274" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiopoolUsIncMember">U.S.A.</ix:nonNumeric></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185918108" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiopoolUsIncMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055720564" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPrimusCorporationMember">Primus
        Corporation</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055508746" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPrimusCorporationMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4231
        E 75<sup style="vertical-align:text-top;line-height:1;font-size:smaller">th</sup> Terrace</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Kansas
        City,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MO
        64132, USA</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413060119716" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPrimusCorporationMember">Manufacture
        and sale<br/>of diagnostic test kits<br/>and instrumentation</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414185530212" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPrimusCorporationMember">U.S.A</ix:nonNumeric>.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185921805" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPrimusCorporationMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  </table> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> </div> </div> </div>

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">202</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GROUP
        UNDERTAKINGS (CONTINUED)</span></span></div> </td> </tr>
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  </table> </ix:exclude></div> <ix:continuation id="F20240414200059329" continuedAt="F20240414200115730">

<div>

<div style="margin-left:36pt">

<table cellpadding="0" cellspacing="0" style="width:85%">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name
        and registered office</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal&#160;activity</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><em><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Principal
        Country of<br/>incorporation and<br/>operation</span></em></p> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Group&#160;%&#160;holding</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055726421" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPhoenixBioTechCorpMember">Phoenix
        Bio-tech Corp.</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055449541" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPhoenixBioTechCorpMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1166
        South Service Road West</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Oakville,
        ON L6L 5T7</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada.</span></span></div>
        </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413060124589" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPhoenixBioTechCorpMember">Dormant</ix:nonNumeric></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414185534482" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPhoenixBioTechCorpMember">Canada</ix:nonNumeric></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185925940" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPhoenixBioTechCorpMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055731220" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsHoldingAbMember">Fiomi
        Diagnostics Holding AB</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055445525" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsHoldingAbMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dag
        Hammarskj&#246;ldsv 52A</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SE-752
        37 Uppsala</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sweden</span></span></div>
        </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413060128077" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsHoldingAbMember">Holding
        Company</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414185608243" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsHoldingAbMember">Sweden</ix:nonNumeric></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185930202" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsHoldingAbMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055735565" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsAbMember">Fiomi
        Diagnostics AB</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055434731" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsAbMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dag
        Hammarskj&#246;ldsv 52A</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SE-752
        37 Uppsala</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sweden</span></span></div>
        </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20250513172709355" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsAbMember">Discontinued
        operation</ix:nonNumeric></span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(in
        liquidation)</span></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414185642588" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsAbMember">Sweden</ix:nonNumeric></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185933764" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsAbMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055740974" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechDoBrasilMember">Trinity
        Biotech Do Brasil</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055430860" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechDoBrasilMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Comercio
        e Importacao Ltda</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rua
        Silva Bueno</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.660
        &#8211; Cj. 101/102</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ipiranga</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sao
        Paulo</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Brazil</span></span></div>
        </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413060137979" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechDoBrasilMember">Sale
        of diagnostic test<br/>kits</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414185645277" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechDoBrasilMember">Brazil</ix:nonNumeric></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185937668" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechDoBrasilMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055745042" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechUkLtdMember">Trinity
        Biotech (UK) Ltd</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055426365" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechUkLtdMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Mills
        and Reeve LLP</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Botanic
        House</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100
        Hills Road</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cambridge,
        CB2 1PH</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United
        Kingdom</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413060141957" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechUkLtdMember">Sales
        &amp; marketing<br/>activities</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414185650501" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechUkLtdMember">UK</ix:nonNumeric></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185941125" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechUkLtdMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055748980" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribImmcoDiagnosticsIncMember">Immco
        Diagnostics Inc</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055421301" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribImmcoDiagnosticsIncMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">60
        Pineview Drive</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buffalo</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NY
        14228, USA</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413060146523" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribImmcoDiagnosticsIncMember">Manufacture
        and sale of<br/>autoimmune products<br/>and laboratory services</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414190012981" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribImmcoDiagnosticsIncMember">U.S.A.</ix:nonNumeric></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185944868" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribImmcoDiagnosticsIncMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055808709" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovaCenturyScientificIncMember">Nova
        Century Scientific Inc</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055415477" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovaCenturyScientificIncMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5022
        South Service Road</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Burlington</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ontario</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada</span></span></div>
        </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413155759904" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovaCenturyScientificIncMember">Manufacture
        and sale of<br/>autoimmune products and infectious diseases</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20240414190015957" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovaCenturyScientificIncMember">Canada</ix:nonNumeric></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414191145340" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovaCenturyScientificIncMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055853845" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechInvestmentLtdMember">Trinity
        Biotech Investment Ltd</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055408067" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechInvestmentLtdMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PO
        Box 309</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ugland
        House</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grand
        Cayman</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">KY1-1104</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cayman
        Islands</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413060155920" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechInvestmentLtdMember">Investment
        and<br/>provision of financial<br/>services</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240414190019164" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechInvestmentLtdMember">Cayman
        Islands</ix:nonNumeric></span></span></div>
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185949035" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechInvestmentLtdMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  </table> </div> </div> </ix:continuation> </div> </div>&#160;

<div><ix:exclude>

<div style="clear:both;margin-top:0pt;margin-bottom:0pt">

<div>

<div style="margin-top:10pt;margin-bottom:0pt">

<div>

<p style="text-align:center;margin-top:pt;margin-bottom:3pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">203</span></span></p><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;page-break-after:always;background-color:#000000;margin-top:0pt;margin-bottom:0pt"/></div></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt">

<p style="margin-top:10pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-bottom:0pt">NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS</p></div>

<div style="line-height:1.25;font-weight:bold;margin-left:30.95pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">DECEMBER
31, 2024</span>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p></div> </div> </div>

<div style="line-height:1.25;font-family:'Times New Roman', serif">

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GROUP
        UNDERTAKINGS (CONTINUED)</span></span></div> </td> </tr>
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  </table> </div> </ix:exclude></div> <ix:continuation id="F20240414200115730">

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:85%">
  <tr>
    <td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name
        and registered office</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;width:1%">&#160;</td>
    <td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal
        activity</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal
        Country of<br/>incorporation and<br/>operation</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Group
        % holding</span></span></div> </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240413055902128" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTribBiosensorsIncMember">Trib
        Biosensors Inc.</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055402307" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTribBiosensorsIncMember">
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27700
        S.W. 95<sup style="vertical-align:text-top;line-height:1;font-size:smaller">th</sup> Avenue,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wilsonville,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Oregon
        97070, USA</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240422095311803" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTribBiosensorsIncMember">Manufacturing,
        development, and sale of biosensors</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)"><ix:nonNumeric id="Fxbrl_20240422095343935" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTribBiosensorsIncMember">USA</ix:nonNumeric></span><br/><span style="color:rgb(0, 0, 0)">&#160;</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414185952151" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTribBiosensorsIncMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;color:rgb(0, 0, 0);width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="Fxbrl_20240413055919916" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribKonamiteLimitedMember">Konamite
        Limited</ix:nonNumeric></span></span></div> <ix:nonNumeric id="Fxbrl_20240413055358131" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribKonamiteLimitedMember">
        <div style="margin-top:0pt;margin-bottom:0pt">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">County
        Wicklow, Ireland</span></span></div> </div> </ix:nonNumeric> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240422095258002" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribKonamiteLimitedMember">Sales
        &amp; marketing<br/>activities</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)"><ix:nonNumeric id="Fxbrl_20240414190027997" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribKonamiteLimitedMember">Ireland</ix:nonNumeric></span><br/><span style="color:rgb(0, 0, 0)">&#160;</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240414190002067" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribKonamiteLimitedMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:top;width:30%">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td rowspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:1%">&#160;</td>
    <td rowspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td rowspan="1" style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="Fxbrl_20250512110841485" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechJointVentureLimitedMember">Trinity
        Biotech Joint Venture Limited</ix:nonNumeric></span></span></div>
        <div style="margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt"> <ix:nonNumeric id="Fxbrl_20250512111021048" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechJointVentureLimitedMember">
        <div style="margin-top:0pt;margin-bottom:0pt">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">County
        Wicklow, Ireland</span></span></div> </div> </ix:nonNumeric> </div> </div> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20250512111043390" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechJointVentureLimitedMember">Holding
        Company</ix:nonNumeric></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)"><ix:nonNumeric id="Fxbrl_20250512111105369" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechJointVentureLimitedMember">Ireland</ix:nonNumeric></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20250512111124188" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechJointVentureLimitedMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><ix:nonNumeric id="Fxbrl_20250512110852121" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember">EpiCapture
        Limited</ix:nonNumeric></span></div>
        <div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"><ix:nonNumeric id="Fxbrl_20250512110945576" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember">19
        Mather Road, Mount Merrion, Dublin, Ireland</ix:nonNumeric></div> </div> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><ix:nonNumeric id="Fxbrl_20250512111050706" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember">Research
        and development</ix:nonNumeric></span></p> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"><ix:nonNumeric id="Fxbrl_20250512111109162" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember">Ireland</ix:nonNumeric></span></p>
        </td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><ix:nonFraction id="Fxbrl_20250512111131816" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></p>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><ix:nonNumeric id="Fxbrl_20250512110858493" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicsDiagnosticsLimitedMember">Metabolomics
        Diagnostics Limited</ix:nonNumeric></span></div>
        <div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"><ix:nonNumeric id="Fxbrl_20250512111004536" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicsDiagnosticsLimitedMember">Hoffman
        Park, Inchera, Little Island, Co. Cork, Ireland</ix:nonNumeric></div> </div> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><ix:nonNumeric id="Fxbrl_20250512111054618" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicsDiagnosticsLimitedMember">Research
        and development</ix:nonNumeric></span></p> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"><ix:nonNumeric id="Fxbrl_20250512111114136" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicsDiagnosticsLimitedMember">Ireland</ix:nonNumeric></span></p>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><ix:nonFraction id="Fxbrl_20250512111135385" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicsDiagnosticsLimitedMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></p>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><ix:nonNumeric id="Fxbrl_20250512110903322" name="ifrs-full:NameOfSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncorporationMember">Waveform
        Technologies Inc.</ix:nonNumeric></span></div>
        <div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"><ix:nonNumeric id="Fxbrl_20250512111010860" name="ifrs-full:AddressOfRegisteredOfficeOfEntity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncorporationMember">Obrtna
        cesta 18, 8310 Sentjernej, Slovenia</ix:nonNumeric></div> </div> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><ix:nonNumeric id="Fxbrl_20250512111059352" name="trib:PrincipalActivity" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncorporationMember">Manufacturing,
        development, and sale of biosensors</ix:nonNumeric></span></p> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"><ix:nonNumeric id="Fxbrl_20250512111118414" name="ifrs-full:PrincipalPlaceOfBusiness" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncorporationMember">Slovenia</ix:nonNumeric></span></p>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><ix:nonFraction id="Fxbrl_20250512111139078" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncorporationMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</span></p>
        </td> </tr>
  </table> </div> </div> </div> </div> </ix:continuation> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p> </div> </div> </div> <ix:nonNumeric id="Fxbrl_20220115144118972" name="trib:DisclosureOfAuthorisationForIssueExplanatory" contextRef="C_20240101to20241231" escape="true">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AUTHORISATION FOR ISSUE</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These
Group consolidated financial statements were authorised for issue by the Board of Directors on May 15, 2025.</span></span></div> </div>
</ix:nonNumeric>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">204</span></span></span></div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
</div> </div>

<div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Signatures</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Registrant hereby
certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorised the undersigned to
sign this Annual Report on its behalf.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td colspan="1" style="width:50%;vertical-align:top">&#160;</td>
    <td colspan="2" style="vertical-align:top">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TRINITY BIOTECH PLC</span></span></div></td></tr>
  <tr>
    <td colspan="1" style="width:50%;vertical-align:middle">&#160;</td>
    <td style="width:3%;vertical-align:middle">&#160;</td>
    <td style="width:47%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td colspan="1" style="width:50%;vertical-align:top;padding-bottom:2px">&#160;</td>
    <td style="width:3%;vertical-align:top;padding-bottom:2px">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">By</span></span></div></td>
    <td style="width:47%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">/s/ John Gillard</span></span></div></td></tr>
  <tr>
    <td colspan="1" style="width:50%;vertical-align:top">&#160;</td>
    <td style="width:3%;vertical-align:top">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:47%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Mr John Gillard</span></span></div></td></tr>
  <tr>
    <td colspan="1" style="width:50%;vertical-align:top">&#160;</td>
    <td style="width:3%;vertical-align:top">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:47%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Director/</span></span></div></td></tr>
  <tr>
    <td colspan="1" style="width:50%;vertical-align:top">&#160;</td>
    <td style="width:3%;vertical-align:top">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:47%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chief Executive Officer</span></span></div></td></tr>
  <tr>
    <td colspan="1" style="width:50%;vertical-align:middle">&#160;</td>
    <td style="width:3%;vertical-align:middle">&#160;</td>
    <td style="width:47%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td colspan="1" style="width:50%;vertical-align:top">&#160;</td>
    <td style="width:3%;vertical-align:top">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:47%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Date: May 15, 2025</span></span></div></td></tr>
  <tr>
    <td colspan="1" style="width:50%;vertical-align:middle">&#160;</td>
    <td style="width:3%;vertical-align:middle">&#160;</td>
    <td style="width:47%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td colspan="1" style="width:50%;vertical-align:top;padding-bottom:2px">&#160;</td>
    <td style="width:3%;vertical-align:top;padding-bottom:2px">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">By:</span></span></div></td>
    <td style="width:47%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">/s/ Susan O&#8217;Connor</span></span></div></td></tr>
  <tr>
    <td colspan="1" style="width:50%;vertical-align:top">&#160;</td>
    <td style="width:3%;vertical-align:top">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:47%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Susan O&#8217;Connor</span></span></div></td></tr>
  <tr>
    <td colspan="1" style="width:50%;vertical-align:top">&#160;</td>
    <td style="width:3%;vertical-align:top">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:47%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interim Chief Financial
        Officer</span></span></div></td></tr>
  <tr>
    <td colspan="1" style="width:50%;vertical-align:middle">&#160;</td>
    <td style="width:3%;vertical-align:middle">&#160;</td>
    <td style="width:47%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td colspan="1" style="width:50%;vertical-align:top">&#160;</td>
    <td style="width:3%;vertical-align:top">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:47%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Date: May 15, 2025</span></span></div></td></tr>
  </table>

<div>&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">205</span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/></div></div>

<table id="e19" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:48.95pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Item&#160;19</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exhibits</span></span></div></td></tr>
  </table>

<div>&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:9.28%;vertical-align:bottom">
        <div style="margin-right:10.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exhibit&#160;No.</span></span></div></td>
    <td style="width:90.72%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Description
        of Exhibit</span></span></div></td></tr>
  </table>

<div>&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891323001916/exhibit_1-1.htm">1.1</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891323001916/exhibit_1-1.htm">Memorandum
        and Articles of Association of Trinity Biotech plc (as altered by Special Resolution dated September 30, 2022) (included as Exhibit 1.1
        to our Annual Report on Form 20-F filed on May 16, 2023 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">&#160;</td>
    <td style="width:90.72%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000101915504000015/trinityda.htm">2.0</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000101915504000015/trinityda.htm">Form
        of Deposit Agreement dated as of October&#160;21, 1992, as amended and restated, among Trinity Biotech plc, The Bank of New York as Depositary,
        and all Owners and holders from time to time of American Depositary Receipts issued thereunder (included as Exhibit 1 to our Form F-6
        filed on January&#160;15, 2004 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891323001916/exhibit_2-1.htm"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.1</span></span></a></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891323001916/exhibit_2-1.htm"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Description
        of Rights of Securities Registered under Section 12 of the Securities and Exchange Act of 1934 (included as Exhibit 2.1 to our Annual
        Report on Form 20-F filed on May 16, 2023 and incorporated herein by reference)</span></span></a></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891321000514/exhibit_4-4.htm">4.1</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891321000514/exhibit_4-4.htm">Trinity
        Biotech plc Share Option Plan 2020 (included as Exhibit 4.4 to our Registration Statement on Form S-8, filed on February&#160;12, 2021
        and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891321000514/exhibit_4-3.htm">4.2</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891321000514/exhibit_4-3.htm">Trinity
        Biotech plc Employee Share Option Plan 2017 (included as Exhibits 4.3 to our Registration Statement on Form S-8, filed on February 12,
        2021 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">&#160;</td>
    <td style="width:90.72%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000119312514140772/d708450dex41.htm">4.3</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000119312514140772/d708450dex41.htm">Trinity
        Biotech plc Employee Share Option Plan 2013 (included as Exhibit 4.1 to our Registration Statement on Form S-8 filed on April&#160;11,
        2014 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">&#160;</td>
    <td style="width:90.72%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000119380512001073/e609793_ex4.htm">4.4</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000119380512001073/e609793_ex4.htm">Trinity
        Biotech plc Employee Share Option Plan 2011 (included as Exhibit 4 to our Registration Statement on Form S-8 filed on June&#160;22, 2012
        and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">&#160;</td>
    <td style="width:90.72%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000112528206002027/b412502_ex4b-1.txt">4.5</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000112528206002027/b412502_ex4b-1.txt">Lease
        agreement dated as of October&#160;18, 2004 between Ronan O&#8217;Caoimh and Jim Walsh with Trinity Biotech Manufacturing Limited in respect
        of office premises in Bray, County Wicklow, Ireland (included as Exhibit 4b.1 to our Annual Report on Form 20-F filed on March&#160;31,
        2006 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">&#160;</td>
    <td style="width:90.72%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000112528206002027/b412502_ex4b-2.txt">4.6</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000112528206002027/b412502_ex4b-2.txt">Lease
        agreement dated as of November&#160;26, 2004 between Ronan O&#8217;Caoimh, Jonathon O&#8217;Connell and Jim Walsh with Trinity Biotech
        plc in respect of warehouse premises in Bray, County Wicklow, Ireland (included as Exhibit 4b.2 to our Annual Report on Form 20-F filed
        March 31 2006 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">&#160;</td>
    <td style="width:90.72%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000119312515104123/d870315dex413.htm">4.7</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000119312515104123/d870315dex413.htm">Lease
        agreement dated as of December&#160;20, 2007 between Ronan O&#8217;Caoimh and Jim Walsh with Trinity Biotech Manufacturing Limited in
        respect of warehouse premises in Bray, County Wicklow, Ireland (included as Exhibit 4.13 to our Annual Report on Form 20-F filed on March&#160;25,
        2015 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">&#160;</td>
    <td style="width:90.72%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000119312515104123/d870315dex419.htm">4.8</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000119312515104123/d870315dex419.htm">CDC
        Non-Exclusive Patent Licence Agreement dated as of May&#160;22, 2012 (included as Exhibit 4.19 to our Annual Report on Form 20-F filed
        on March&#160;25, 2015 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">&#160;</td>
    <td style="width:90.72%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000119312515104123/d870315dex421.htm">4.9</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000119312515104123/d870315dex421.htm">Inverness
        Medical Innovations, Inc. Patent Licence Agreement renewal dated as of August&#160;3, 2006 (included as Exhibit 4.21 to our Annual Report
        on Form 20-F filed on March&#160;25, 2015 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000119312515104123/d870315dex422.htm">4.10</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000119312515104123/d870315dex422.htm">National
        Institute of Health Non-Exclusive Patent Licence Agreement dated as of December&#160;17, 1999 (included as Exhibit 4.22 to our Report
        on Form 6-K filed on March&#160;25, 2015 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324001486/exhibit_4-11.htm"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.11</span></span></a></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324001486/exhibit_4-11.htm"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrant
        to purchase American Depositary Shares of Trinity Biotech plc, dated January 27, 2022 (included as Exhibit 4.11 to our Annual Report on
        Form 20-F filed on April 30, 2024 and incorporated herein by reference).</span></span></a></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891323000704/exhibit4_12-1.htm">4.12</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891323000704/exhibit4_12-1.htm">First
        Amendment to Warrant Certificate to purchase American Depositary Shares of Trinity Biotech plc dated February 21, 2023 (included as Exhibit
        4.12.1 to our Report on Form 6-K filed on February 22, 2023 and incorporated herein by reference).</a></span></span></div></td></tr>
  </table></div>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_4-13.htm">4.13</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_4-13.htm">Second
        Amendment to Warrant to purchase American Depositary Shares of Trinity Biotech plc dated January 30, 2024.</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_4-14.htm">4.14</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_4-14.htm">Third
        Amendment to Warrant to purchase American Depositary Shares of Trinity Biotech plc dated December 23, 2024</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891322001470/exhibit_99-2.htm">4.15</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891322001470/exhibit_99-2.htm">Securities
        Purchase Agreement between Trinity Biotech Plc and MiCo IVD Holdings, LLC dated April 11, 2022 (included as Exhibit 99.2 to our Report
        on Form 6-K filed on April 11, 2022 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891322001470/exhibit_99-3.htm">4.16</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891322001470/exhibit_99-3.htm">Convertible
        Loan Note (included as Exhibit 99.3 to our Report on Form 6-K filed on April 11, 2022 and incorporated herein by reference).</a></span></span></div></td></tr>
  </table>

<div>&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">206</span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/></div></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td rowspan="1" style="width:9.28%;vertical-align:middle">
        <div style="margin-right:10.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exhibit&#160;No.</span></span></div></td>
    <td rowspan="1" style="width:90.72%;vertical-align:middle">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Description
        of Exhibit</span></span></div></td></tr>
  <tr>
    <td rowspan="1" style="width:9.28%;vertical-align:middle">&#160;</td>
    <td rowspan="1" style="width:90.72%;vertical-align:middle">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324001486/exhibit_4-15.htm">4.17</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:middle">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324001486/exhibit_4-15.htm">Investor
        Subordination Agreement dated May 3, 2022 (included as Exhibit 4.15 to our Annual Report on Form 20-F filed on April 30, 2024 and incorporated
        herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891323001506/exhibit_4-15.htm">4.18*</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891323001506/exhibit_4-15.htm">Share
        Purchase Agreement in respect of Benen Trading Limited and Fitzgerald Industries International Inc., dated as of April 20, 2023 (included
        as Exhibit 4.15 to our Report on Form 6-K filed on April 24, 2023 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324001486/exhibit_4-17.htm">4.19
        &#8224;</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324001486/exhibit_4-17.htm">Transition
        Agreement, dated as of December 20, 2023, among Bayer Healthcare LLC, Waveform Technologies, Inc. and TRIB Biosensors Inc. (included as
        Exhibit 4.17 to our Annual Report on Form 20-F filed on April 30, 2024 and incorporated herein by reference)</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324000345/exhibit_4-20.htm">4.20*&#8224;</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324000345/exhibit_4-20.htm">Asset
        and Share Purchase Agreement dated as of January 30, 2024 (included as Exhibit 4.20 to our Report on Form 6-K filed on February 1, 2024
        and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891325001821/0001178913-25-001821-index.htm">4.21*</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891325001821/0001178913-25-001821-index.htm">Fifth Amended and Restated Credit Agreement and Guaranty, dated as of May 14, 2025 (included as Exhibit 99.1 to our Report on Form 6-K filed on May 15, 2025 and incorporated herein by reference).</a></span></span></div></div></td></tr>
  <tr>
    <td rowspan="1" style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td rowspan="1" style="width:90.72%;vertical-align:top">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324001486/exhibit_4-20.htm">4.22</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324001486/exhibit_4-20.htm">Warrant
        to purchase American Depositary Shares of Trinity Biotech plc, dated January 30, 2024 (included as Exhibit 4.20 to our Annual Report on
        Form 20-F filed on April 30, 2024 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_4-23.htm">4.23</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_4-23.htm">First
        Amendment to Warrant to purchase American Depositary Shares of Trinity Biotech plc dated December 23, 2024.</a></span></span></div></td></tr>
  <tr>
    <td rowspan="1" style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td rowspan="1" style="width:90.72%;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td></tr>
  <tr>
    <td rowspan="1" style="width:9.28%;vertical-align:top;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_4-24.htm">4.24</a></span></span></td>
    <td rowspan="1" style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_4-24.htm">Warrant
        to purchase to purchase American Depositary Shares of Trinity Biotech plc, dated December 23, 2024 (of Perceptive Credit Holdings III,
        LP)</a></span></span></div></div></td></tr>
  <tr>
    <td rowspan="1" style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td rowspan="1" style="width:90.72%;vertical-align:top;font-family:'Times New Roman',Times,serif">&#160;</td></tr>
  <tr>
    <td rowspan="1" style="width:9.28%;vertical-align:top;white-space:nowrap"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_4-25.htm">4.25</a></span></span></td>
    <td rowspan="1" style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_4-25.htm">Warrant
        to purchase to purchase American Depositary Shares of Trinity Biotech plc, dated December 23, 2024 (of Perceptive Credit Holdings II,
        LP)</a></span></span></div></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#GROUPUNDERTAKINGS">8.1</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#GROUPUNDERTAKINGS">List
        of significant subsidiaries of Trinity Biotech plc (included as Item 18, note 32 to the consolidated financial statements in this Annual
        Report).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">&#160;</td>
    <td style="width:90.72%;vertical-align:middle;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324001486/exhibit_4-21.htm">11.1</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324001486/exhibit_4-21.htm">Insider
        trading policy (included as Exhibit 4.21 to our Annual Report on Form 20-F filed on April 30, 2024 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_12-1.htm">12.1</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_12-1.htm">Certification
        by Chief Executive Officer Pursuant to Section&#160;302 of the Sarbanes- Oxley Act of 2002.</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">&#160;</td>
    <td style="width:90.72%;vertical-align:middle;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_12-2.htm">12.2</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_12-2.htm">Certification
        by Chief Financial Officer Pursuant to Section&#160;302 of the Sarbanes- Oxley Act of 2002.</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">&#160;</td>
    <td style="width:90.72%;vertical-align:middle;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_13-1.htm">13.1</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_13-1.htm">Certification
        by Chief Executive Officer Pursuant to 18 U.S.C. Section&#160;1350, As Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act
        of 2002.</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">&#160;</td>
    <td style="width:90.72%;vertical-align:middle;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_13-2.htm">13.2</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_13-2.htm">Certification
        by Chief Financial Officer Pursuant to 18 U.S.C. Section&#160;1350, As Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act
        of 2002.</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:middle">&#160;</td>
    <td style="width:90.72%;vertical-align:middle;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324001483/exhibit_99-1.htm">15.1</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/888721/000117891324001483/exhibit_99-1.htm">Statement
        of Assets Acquired and Liabilities Assumed as of January 30, 2024 (on Form 6-K filed on April 30, 2024 and incorporated herein by reference).</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_15-2.htm">15.2</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_15-2.htm">Consent
        of Independent Registered Public Accounting Firm</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_97-1.htm">97.1</a></span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="exhibit_97-1.htm">Clawback
        Policy.</a></span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">&#160;</td>
    <td style="width:90.72%;vertical-align:top;text-align:justify">&#160;</td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">101.INS</span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">XBRL
        Instance Document (The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline
        XBRL document).</span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">101.SCH</span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inline
        XBRL Taxonomy Extension Schema Document.</span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">101.PRE</span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inline
        XBRL Taxonomy Presentation Linkbase Document.</span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">101.CAL</span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inline
        XBRL Taxonomy Calculation Linkbase Document.</span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">101.LAB</span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inline
        XBRL Taxonomy Label Linkbase Document.</span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">101.DEF</span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inline
        XBRL Taxonomy Extension Definition Linkbase Document.</span></span></div></td></tr>
  <tr>
    <td style="width:9.28%;vertical-align:top;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">104</span></span></div></td>
    <td style="width:90.72%;vertical-align:top">
        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cover
        Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></span></div></td></tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">*
Certain schedules to this exhibit have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Registrant hereby agrees to furnish
a copy of any omitted schedules to the Commission upon request.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8224; Portions of this
exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">207</span></span></span></div>

<div style="text-align:center"><hr style="border:none;border-bottom:4px solid #000000;border-top:1px solid #000000;height:10px;width:100%;color:#000000;text-align:center;text-align:center"/></div></div></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.13
<SEQUENCE>2
<FILENAME>exhibit_4-13.htm
<DESCRIPTION>EXHIBIT 4.13
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
      <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 4.13</font></u><br>
      </div>
      <div> <br>
      </div>
      <div>
        <div style="text-align: right; margin-right: 5.8pt; line-height: 1.25; font-variant: small-caps;">Execution Version</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-right: 65pt; margin-left: 65pt; line-height: 1.25; font-variant: small-caps;">Second Amendment to Warrant Certificate</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 6pt; line-height: 1.25;">This Second Amendment to Warrant Certificate, dated as of January 30, 2024 (this <font style="font-style: italic;">&#8220;Amendment&#8221;</font>),
          is entered into by and among TRINITY BIOTECH PLC, a public limited company organized and existing under the laws of Ireland (the &#8220;<font style="font-style: italic;">Company</font>&#8221;) and PERCEPTIVE CREDIT HOLDINGS III, LP, a Delaware limited
          partnership (the &#8220;<font style="font-style: italic;">Holder</font>&#8221;).</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-right: 65pt; margin-left: 65pt; line-height: 1.25; font-variant: small-caps;">Recitals</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 5.75pt; margin-left: 5.95pt; line-height: 1.25;">WHEREAS, the Company issued to the Holder that certain Warrant To Purchase American Depositary Shares represented by American
          Depositary Receipts, dated as of January 27, 2022, as amended by that certain First Amendment to Warrant Certificate, dated February 21, 2023, by and among the Company and the Holder and this Amendment, (the <font style="font-style: italic;">&#8220;Warrant&#8221;</font>).






          Capitalized terms used herein but not otherwise defined herein shall have the meanings ascribed thereto in the Warrant.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; text-indent: 35.95pt; margin-right: 5.8pt; margin-left: 5.95pt; line-height: 1.25;">WHEREAS, in connection with that certain Second Amended and Restated Credit Agreement and Guaranty, dated as of January 30, 2024
          (the <font style="font-style: italic;">&#8220;Credit Agreement&#8221;</font>), by and among TRINITY BIOTECH, INC., a Delaware corporation (&#8220;<font style="font-style: italic;">U.S. Holdings</font>&#8221;) and the other borrowers party thereto, the Guarantors party
          thereto, the Lenders party thereto, and PERCEPTIVE CREDIT HOLDINGS III, LP as administrative agent for the Lenders (in such capacity, the <font style="font-style: italic;">&#8220;Administrative Agent&#8221;</font>), the Company and the Holder have agreed to
          amend certain provisions of the Warrant.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 6pt; margin-left: 5.95pt; line-height: 1.25;">WHEREAS, the Company and the Holder are willing to make such amendments to the Warrant as are further described herein, in accordance
          with and subject to the terms and conditions of this Amendment.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; text-indent: 35.95pt; margin-right: 5.9pt; margin-left: 5.95pt; line-height: 1.25;">NOW, THEREFORE, in consideration of the premises and the mutual covenants and the agreements herein set forth, and other good and
          valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:</div>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z95f2258c2f3449dda1bba660a1d4a4d3">

            <tr>
              <td style="width: 5.95pt;"><br>
              </td>
              <td style="width: 21.6pt; vertical-align: top;">1</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Amendment to Warrant</font>. Concurrently with the effectiveness of the Credit Agreement (the &#8220;<font style="font-style: italic;">Effective Date</font>&#8221;):</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f67a96df1b14d4284999644489ee065">

            <tr>
              <td style="width: 55.45pt;"><br>
              </td>
              <td style="width: 31.5pt; vertical-align: top;">1.1</td>
              <td style="width: auto; vertical-align: top;">
                <div>Section 2(b) of the Warrant is hereby amended to state in its entirety to read as follows:</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <div style="margin-left: 87pt; line-height: 1.25;">&#8220;<u>Exercise Price</u>.&#160; The exercise price per ADS under this Warrant shall be $0.4399, subject to adjustment hereun<u>der (the &#8220;Exer</u>cise Price&#8221;).&#8221;</div>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8e074edd661242f6ab09546b468b5f8d">

            <tr>
              <td style="width: 5.95pt;"><br>
              </td>
              <td style="width: 21.6pt; vertical-align: top;">2</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Covenants</font>. If the Company determines that the terms of this Amendment require an amendment to the currently-effective Resale Registration Statement governing the Registrable Securities issuable
                  upon exercise of the Warrant to reflect the revised Exercise Price set forth in this Amendment (such amendment, an &#8220;<font style="font-style: italic;">F-3 Amendment</font>&#8221;), then no later than April 30, 2024, the Company shall prepare and
                  file or shall cause to be prepared and filed with the Commission such F-3 Amendment. The F-3 Amendment (if any) shall be in form and substance reasonably acceptable to the Holder, and the Company shall use its reasonable best efforts to
                  cause such F-3 Amendment to be declared effective as soon as possible after filing. For the avoidance of doubt, the provisions of Section 13.03(b) of the Credit Agreement shall apply to any Claims or Losses suffered by an Indemnified
                  Party (each as defined in the Credit Agreement) arising from or relating to any misstatement or omission contained in the Resale Registration Statement, the F-3 Amendment, and any prospectus contained in such Resale Registration
                  Statement, any further amendment or supplement thereto, or any violation by the Company of the Securities Act or any rule or regulation promulgated thereunder applicable to the Company or any state securities (or Blue Sky) law, rule or
                  regulation and relating to action or inaction required of the Company in connection with any such registration.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%2%%%-->
        <div style="text-align: justify; margin-right: 5.75pt; margin-left: 27.6pt; line-height: 1.25;"><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6928dffdddcc4173a4e03a56b5469c98">

            <tr>
              <td style="width: 6pt;"><br>
              </td>
              <td style="width: 21.6pt; vertical-align: top;">3</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Effect of Amendment. </font>On and after the date hereof, each reference in the Warrant to &#8220;this Warrant&#8221;, &#8220;hereunder&#8221;, &#8220;hereof&#8221;, &#8220;herein&#8221; or words of like import referring to the Warrant, shall mean
                  and be a reference to the Warrant after giving effect to this Amendment. Except as specifically set forth in this Amendment, the Warrant remains in full force and effect and is hereby ratified and confirmed.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z132418a3fad040428189b1e487544dc4">

            <tr>
              <td style="width: 6pt;"><br>
              </td>
              <td style="width: 21.6pt; vertical-align: top;">4</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Governing Law. </font>This Amendment, and all questions concerning the construction, validity, enforcement and interpretation of the Amendment, shall be governed by and construed and enforced in
                  accordance with the internal laws of the State of New York.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z178e3a445fd042f5ad25472097de6c78">

            <tr>
              <td style="width: 6pt;"><br>
              </td>
              <td style="width: 21.6pt; vertical-align: top;">5</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Counterparts. </font>This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, shall be deemed to be an
                  original, and all of which, when taken together, shall constitute but one and the same Amendment. Delivery of an executed counterpart of this Amendment by facsimile, DocuSign or a scanned copy by electronic mail shall be equally as
                  effective as delivery of an original executed counterpart of this Amendment.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0a799c0d96f243e498fbdc5f98efe2a9">

            <tr>
              <td style="width: 6pt;"><br>
              </td>
              <td style="width: 21.6pt; vertical-align: top;">6</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Binding Effect. </font>This Amendment will be binding upon and inure to the benefit of and is enforceable by the respective successors and permitted assigns of the parties hereto.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7a36d8db2ab047ffac9c7616e68dc2b8">

            <tr>
              <td style="width: 6pt;"><br>
              </td>
              <td style="width: 21.6pt; vertical-align: top;">7</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div><font style="font-weight: bold;">Incorporation By Reference</font>. The provisions set forth in Sections 6(h) (Submission to Jurisdiction), 6(i) (Waiver of Venue, Etc.), and 6(j) (Waiver of Jury Trial) of the Warrant shall apply to
                  this Amendment in all respects.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; margin-right: 65pt; margin-left: 68.05pt; line-height: 1.25; font-style: italic;">[Remainder of page intentionally left blank; signatures on following pages]</div>
        <div style="text-align: center; line-height: 1.25;"><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="line-height: 1.25;">
          <div><br>
          </div>
          <div style="text-indent: 33.45pt; margin-left: 8.25pt; margin-top: 0.05pt;">IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by its officer thereunto duly authorized as a Deed on the date first above indicated.</div>
          <div><br>
          </div>
          <div><img src="image00008.jpg"></div>
          <div><br>
          </div>
          <div style="font-family: 'Times New Roman',Times,serif;">Address for Notices:</div>
          <div style="margin-top: 1.1pt;"><br>
          </div>
          <div style="font-family: 'Times New Roman',Times,serif;">Trinity Biotech plc</div>
          <div style="font-family: 'Times New Roman',Times,serif;"> IDA Business Park,</div>
          <div style="font-family: 'Times New Roman',Times,serif;">Bray, Co. Wicklow, Ireland </div>
          <div style="font-family: 'Times New Roman',Times,serif;">A98 H5C8</div>
          <div style="font-family: 'Times New Roman',Times,serif;">Attention: John Gillard, CEO </div>
          <div style="font-family: 'Times New Roman',Times,serif;">Telephone: +353 l 276 9800</div>
          <div style="font-family: 'Times New Roman',Times,serif;">Email: Lennotice@trinitybiotech.com</div>
          <div style="margin-top: 1.25pt;"><br>
          </div>
          <div style="font-family: 'Times New Roman',Times,serif;">With a copy to (which shall not constitute notice): </div>
          <div style="font-family: 'Times New Roman',Times,serif;">Carter Ledyard &amp; Milburn LLP</div>
          <div style="margin-top: 0.4pt; font-family: 'Times New Roman',Times,serif;">2 Wall Street, New York, NY 10005 </div>
          <div style="margin-top: 0.4pt; font-family: 'Times New Roman',Times,serif;">Attention: Steven J. Glusband, Esq.</div>
          <div style="margin-top: 0.15pt; font-family: 'Times New Roman',Times,serif;">Email: glusband@clm.com</div>
          <div style="text-align: center;"> <br>
          </div>
          <div style="text-align: center;">[Signature Page to Warrant Amendment] </div>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">
          <table cellspacing="0" cellpadding="0" border="0" id="z55a8081f1ac0400da6b5ebb60fbade38" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 5%;"><br>
                </td>
                <td colspan="2">
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Accepted and Agreed,</div>
                  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                  </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Perceptive Credit Holdings III, LP</div>
                </td>
                <td style="width: 50%;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%;"><br>
                </td>
                <td colspan="2" rowspan="1"><br>
                </td>
                <td rowspan="1" style="width: 50%;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%;"><br>
                </td>
                <td rowspan="1" style="width: 3%;">By:</td>
                <td rowspan="1" style="width: 42%;">Perceptive Credit Opportunities GP, LLC, its general partner</td>
                <td rowspan="1" style="width: 50%;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%;">&#160;</td>
                <td rowspan="1" style="width: 3%;"><br>
                </td>
                <td rowspan="1" style="width: 42%;"><br>
                </td>
                <td rowspan="1" style="width: 50%;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; padding-bottom: 2px;">&#160;</td>
                <td rowspan="1" style="width: 3%; text-align: left; vertical-align: bottom; padding-bottom: 2px;">By:</td>
                <td rowspan="1" style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; line-height: 1.25;"><img width="106" height="46" src="image1.jpg"></div>
                </td>
                <td rowspan="1" style="width: 50%; padding-bottom: 2px;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%;">&#160;</td>
                <td rowspan="1" style="width: 3%;"><br>
                </td>
                <td rowspan="1" style="width: 42%;">Name: Sandeep Dixit</td>
                <td rowspan="1" style="width: 50%;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%;">&#160;</td>
                <td rowspan="1" style="width: 3%;"><br>
                </td>
                <td rowspan="1" style="width: 42%;">Title: Chief Credit Officer</td>
                <td rowspan="1" style="width: 50%;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%;">&#160;</td>
                <td rowspan="1" style="width: 3%;"><br>
                </td>
                <td rowspan="1" style="width: 42%;"><br>
                </td>
                <td rowspan="1" style="width: 50%;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; padding-bottom: 2px;">&#160;</td>
                <td rowspan="1" style="width: 3%; padding-bottom: 2px; text-align: left; vertical-align: bottom;">By:</td>
                <td rowspan="1" style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: left; line-height: 1.25;"><img width="104" height="46" src="image2.jpg"></div>
                </td>
                <td rowspan="1" style="width: 50%; padding-bottom: 2px;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%;"><br>
                </td>
                <td rowspan="1" style="width: 3%;"><br>
                </td>
                <td rowspan="1" style="width: 42%;">Name: Sam Chawla</td>
                <td rowspan="1" style="width: 50%;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%;"><br>
                </td>
                <td rowspan="1" style="width: 3%;"><br>
                </td>
                <td rowspan="1" style="width: 42%;">Title: Portfolio Manager</td>
                <td rowspan="1" style="width: 50%;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%;"><br>
                </td>
                <td colspan="2" rowspan="1"><br>
                </td>
                <td rowspan="1" style="width: 50%;"><br>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%;"><br>
                </td>
                <td colspan="3" rowspan="1">
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Address for Notices:</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
                  </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">c/o Perceptive Advisors LLC </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">51 Astor Place, 10th Floor </div>
                  <div style="line-height: 1.25;">New York, NY 10003 <br>
                  </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Attn: Sandeep Dixit</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Email: Sandeep@perceptivelife.com&#160;</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>PCOFReporting@perceptivelife.com</u></div>
                  <div style="line-height: 1.25;">&#160; <br>
                  </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">with a copy to (which shall not constitute notice):</div>
                  <div style="line-height: 1.25;">&#160;</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Chapman and Cutler LLP </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">1270 Avenue of the Americas </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">30th Floor</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">New York, New York 10020-1708 </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Attention: Nicholas Whitney</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">E-mail: Whitney@chapman.com</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
        </div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">[Signature Page to Warrant Amendment]</div>
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
        </div>
      </div>
    </div>
    <div style="text-align: center;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.14
<SEQUENCE>3
<FILENAME>exhibit_4-14.htm
<DESCRIPTION>EXHIBIT 4.14
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div>
      <div>
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
        <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 4.14</font></u><br>
        </div>
        <div> <br>
        </div>
        <div>
          <div style="text-align: right; margin-right: 5.8pt; line-height: 1.25; font-variant: small-caps;">Execution Version</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: center; margin-right: 65pt; margin-left: 64.099pt; line-height: 1.25; font-variant: small-caps;">Third Amendment to Warrant Certificate</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 5pt; line-height: 1.25;">This Third Amendment to Warrant Certificate, dated as of December 23, 2024 (this <font style="font-style: italic;">&#8220;Amendment&#8221;</font>),






            is entered into by and among TRINITY BIOTECH PLC, a public limited company organized and existing under the laws of Ireland (the &#8220;<font style="font-style: italic;">Company</font>&#8221;) and PERCEPTIVE CREDIT HOLDINGS III, LP, a Delaware limited
            partnership (the &#8220;<font style="font-style: italic;">Holder</font>&#8221;).</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: center; margin-right: 65pt; margin-left: 64.099pt; line-height: 1.25; font-variant: small-caps;">Recitals</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-right: 5.8pt; margin-left: 5pt; line-height: 1.25;">WHEREAS, the Company issued to the Holder that certain Warrant To Purchase American Depositary Shares represented by American
            Depositary Receipts, dated as of January 27, 2022, as amended by that certain First Amendment to Warrant Certificate, dated February 21, 2023, and that certain Second Amendment to Warrant Certificate, dated January 30, 2024, by and among the
            Company and the Holder and this Amendment, (the <font style="font-style: italic;">&#8220;Warrant&#8221;</font>). Capitalized terms used herein but not otherwise defined herein shall have the meanings ascribed thereto in the Warrant.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 5pt; line-height: 1.25;">WHEREAS, in connection with that certain Third Amended and Restated Credit Agreement and Guaranty, dated as of December 23, 2024 (the
            <font style="font-style: italic;">&#8220;Credit Agreement&#8221;</font>), by and among TRINITY BIOTECH, INC., a Delaware corporation (&#8220;<font style="font-style: italic;">U.S. Holdings</font>&#8221;) and the other borrowers party thereto, the Guarantors party
            thereto, the Lenders party thereto, and PERCEPTIVE CREDIT HOLDINGS III, LP as administrative agent for the Lenders (in such capacity, the <font style="font-style: italic;">&#8220;Administrative Agent&#8221;</font>), the Company and the Holder have agreed
            to amend certain provisions of the Warrant.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 5pt; line-height: 1.25;">WHEREAS, the Company and the Holder are willing to make such amendments to the Warrant as are further described herein, in accordance
            with and subject to the terms and conditions of this Amendment.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">NOW, THEREFORE, in consideration of the premises and the mutual covenants and the agreements herein set forth, and other good and
            valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:</div>
          <div style="line-height: 1.25">&#160;</div>
          <table cellspacing="0" cellpadding="0" id="z38f5bcf3de3f4432a8c0b992feea13e7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 5pt;"><br>
                </td>
                <td style="width: 21.6pt; vertical-align: top;">1</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div><font style="font-weight: bold;">Amendment to Warrant</font>. Concurrently with the effectiveness of the Credit Agreement (the &#8220;<font style="font-style: italic;">Third Amendment Restatement Date</font>&#8221;):</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
          <table cellspacing="0" cellpadding="0" id="z6b71d1bc3bc149b199aeb1ad62ae9b51" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 54.5pt;"><br>
                </td>
                <td style="width: 31.45pt; vertical-align: top;">1.1</td>
                <td style="width: auto; vertical-align: top;">
                  <div>Section 2(b) of the Warrant is hereby amended to state in its entirety to read as follows:</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
          <div style="margin-left: 86pt; line-height: 1.25;">&#8220;<u>Exercise Price</u>. The exercise price per ADS under this Warrant shall be $0.8000, subject to adjustment hereunder (the &#8220;<u>Exercise Price</u>&#8221;).&#8221;</div>
          <div style="line-height: 1.25">&#160;</div>
          <table cellspacing="0" cellpadding="0" id="za0a5deede9634288be1226297162baae" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 5pt;"><br>
                </td>
                <td style="width: 21.6pt; vertical-align: top;">2</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div><font style="font-weight: bold;">Covenants</font>. If the Company determines that the terms of this Amendment require an amendment to the currently-effective Resale Registration Statement governing the Registrable Securities issuable
                    upon exercise of the Warrant to reflect the revised Exercise Price set forth in this Amendment (such amendment, an &#8220;<font style="font-style: italic;">F-3 Amendment</font>&#8221;), then no later than April 30, 2025, the Company shall prepare
                    and file or shall cause to be prepared and filed with the Commission such F-3 Amendment. The F-3 Amendment (if any) shall be in form and substance reasonably acceptable to the Holder, and the Company shall use its reasonable best
                    efforts to cause such F-3 Amendment to be declared effective as soon as possible after filing. For the avoidance of doubt, the provisions of Section 13.03(b) of the Credit Agreement shall apply to any Claims or Losses suffered by an
                    Indemnified Party (each as defined in the Credit Agreement) arising from or relating to any misstatement or omission contained in the Resale Registration Statement, the F-3 Amendment, and any prospectus contained in such Resale
                    Registration Statement, any further amendment or supplement thereto, or any violation by the Company of the Securities Act or any rule or regulation promulgated thereunder applicable to the Company or any state securities (or Blue Sky)
                    law, rule or regulation and relating to action or inaction required of the Company in connection with any such registration.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <!--PROfilePageNumberReset%Num%2%%%-->
          <div style="line-height: 1.25">&#160;</div>
          <table cellspacing="0" cellpadding="0" id="zb6e17a5697e04b62a2e91c7f39108249" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 5pt;"><br>
                </td>
                <td style="width: 21.6pt; vertical-align: top;">3</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div><font style="font-weight: bold;">Effect of Amendment. </font>On and after the date hereof, each reference in the Warrant to &#8220;this Warrant&#8221;, &#8220;hereunder&#8221;, &#8220;hereof&#8221;, &#8220;herein&#8221; or words of like import referring to the Warrant, shall mean
                    and be a reference to the Warrant after giving effect to this Amendment. Except as specifically set forth in this Amendment, the Warrant remains in full force and effect and is hereby ratified and confirmed.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
          <table cellspacing="0" cellpadding="0" id="z800384f3afcc4ddda8025e4e52c04fa1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 5pt;"><br>
                </td>
                <td style="width: 21.6pt; vertical-align: top;">4</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div><font style="font-weight: bold;">Governing Law. </font>This Amendment, and all questions concerning the construction, validity, enforcement and interpretation of the Amendment, shall be governed by and construed and enforced in
                    accordance with the internal laws of the State of New York.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
          <table cellspacing="0" cellpadding="0" id="zf2591de046f940d081f64cb0270a49a6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 5pt;"><br>
                </td>
                <td style="width: 21.6pt; vertical-align: top;">5</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div><font style="font-weight: bold;">Counterparts. </font>This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, shall be deemed to be
                    an original, and all of which, when taken together, shall constitute but one and the same Amendment. Delivery of an executed counterpart of this Amendment by facsimile, DocuSign or a scanned copy by electronic mail shall be equally as
                    effective as delivery of an original executed counterpart of this Amendment.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
          <table cellspacing="0" cellpadding="0" id="z4f3c39a6b2ed439b8abb537f54de6248" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 5pt;"><br>
                </td>
                <td style="width: 21.6pt; vertical-align: top;">6</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div><font style="font-weight: bold;">Binding Effect. </font>This Amendment will be binding upon and inure to the benefit of and is enforceable by the respective successors and permitted assigns of the parties hereto.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
          <table cellspacing="0" cellpadding="0" id="zca9f1d99ece748e2adcefae7f622f9c6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 5pt;"><br>
                </td>
                <td style="width: 21.6pt; vertical-align: top;">7</td>
                <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div><font style="font-weight: bold;">Incorporation By Reference</font>. The provisions set forth in Sections 6(h) (Submission to Jurisdiction), 6(i) (Waiver of Venue, Etc.), and 6(j) (Waiver of Jury Trial) of the Warrant shall apply to
                    this Amendment in all respects.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: center; margin-right: 65pt; margin-left: 67.05pt; line-height: 1.25; font-style: italic;">[Remainder of page intentionally left blank; signatures on following pages]</div>
          <div style="text-align: center; margin-right: 0.95pt; line-height: 1.25;"><br>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="text-indent: 32.95pt; margin-left: 7.1pt; line-height: 1.25;">
            <div style="text-indent: 32.95pt; margin-right: 0.1pt; margin-left: 7.1pt;">IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by its officer thereunto duly authorized as a Deed on the date first above indicated.</div>
          </div>
          <div><br>
          </div>
          <div>
            <div><img src="image00007.jpg"></div>
            <div><br>
            </div>
          </div>
          <div style="line-height: 1.25;">
            <div style="font-family: 'Times New Roman',Times,serif;">Address for Notices:</div>
            <div style="font-family: 'Times New Roman',Times,serif;"> <br>
            </div>
            <div style="font-family: 'Times New Roman',Times,serif;">Trinity Biotech plc</div>
            <div style="font-family: 'Times New Roman',Times,serif;"> IDA Business Park,</div>
            <div style="font-family: 'Times New Roman',Times,serif;">Bray, Co. Wicklow, Ireland </div>
            <div style="font-family: 'Times New Roman',Times,serif;">A98 H5C8</div>
            <div style="font-family: 'Times New Roman',Times,serif;">Attention: John Gillard, CEO </div>
            <div style="font-family: 'Times New Roman',Times,serif;">Telephone: +353 l 276 9800</div>
            <div style="font-family: 'Times New Roman',Times,serif;">Email: Lennotice@trinitybiotech.com</div>
            <div style="margin-top: 1.25pt;"><br>
            </div>
            <div style="font-family: 'Times New Roman',Times,serif;">With a copy to (which shall not constitute notice): </div>
            <div style="font-family: 'Times New Roman',Times,serif;">Carter Ledyard &amp; Milburn LLP</div>
            <div style="margin-top: 0.4pt; font-family: 'Times New Roman',Times,serif;">2 Wall Street, New York, NY 10005 </div>
            <div style="margin-top: 0.4pt; font-family: 'Times New Roman',Times,serif;">Attention: Steven J. Glusband, Esq.</div>
            <div style="margin-top: 0.15pt; font-family: 'Times New Roman',Times,serif;">Email: glusband@clm.com</div>
          </div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="line-height: 1.25; text-align: center;">[Signature Page to Warrant Amendment] </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="line-height: 1.25">&#160;</div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="a43d8cf646b0441faa6821b5c990d9e21">

              <tr>
                <td style="width: 5%;">&#160;</td>
                <td colspan="2">
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Accepted and Agreed,</div>
                  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                  </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Perceptive Credit Holdings III, LP</div>
                </td>
                <td style="width: 50%;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 5%;" rowspan="1"><br>
                </td>
                <td rowspan="1" colspan="2"><br>
                </td>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%;" rowspan="1"><br>
                </td>
                <td style="width: 3%;" rowspan="1">By:</td>
                <td style="width: 42%;" rowspan="1">Perceptive Credit Opportunities GP, LLC, its general partner</td>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%;" rowspan="1"><br>
                </td>
                <td style="width: 3%;" rowspan="1"><br>
                </td>
                <td style="width: 42%;" rowspan="1"><br>
                </td>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; padding-bottom: 2px;" rowspan="1"><br>
                </td>
                <td style="width: 3%; text-align: left; vertical-align: bottom; padding-bottom: 2px;" rowspan="1">By:</td>
                <td style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
                  <div style="text-align: left; line-height: 1.25;"><img width="106" height="46" src="image1.jpg"></div>
                </td>
                <td style="width: 50%; padding-bottom: 2px;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%;" rowspan="1"><br>
                </td>
                <td style="width: 3%;" rowspan="1"><br>
                </td>
                <td style="width: 42%;" rowspan="1">Name: Sandeep Dixit</td>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%;" rowspan="1"><br>
                </td>
                <td style="width: 3%;" rowspan="1"><br>
                </td>
                <td style="width: 42%;" rowspan="1">Title: Chief Credit Officer</td>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%;" rowspan="1"><br>
                </td>
                <td style="width: 3%;" rowspan="1"><br>
                </td>
                <td style="width: 42%;" rowspan="1"><br>
                </td>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; padding-bottom: 2px;" rowspan="1"><br>
                </td>
                <td style="width: 3%; padding-bottom: 2px; text-align: left; vertical-align: bottom;" rowspan="1">By:</td>
                <td style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
                  <div style="text-align: left; line-height: 1.25;"><img width="104" height="46" src="image6.jpg"></div>
                </td>
                <td style="width: 50%; padding-bottom: 2px;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%;" rowspan="1"><br>
                </td>
                <td style="width: 3%;" rowspan="1"><br>
                </td>
                <td style="width: 42%;" rowspan="1">Name: Sam Chawla</td>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%;" rowspan="1"><br>
                </td>
                <td style="width: 3%;" rowspan="1"><br>
                </td>
                <td style="width: 42%;" rowspan="1">Title: Portfolio Manager</td>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%;" rowspan="1"><br>
                </td>
                <td rowspan="1" colspan="2"><br>
                </td>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 5%;" rowspan="1"><br>
                </td>
                <td rowspan="1" colspan="3">
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Address for Notices:</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
                  </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">c/o Perceptive Advisors LLC </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">51 Astor Place, 10th Floor </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">New York, NY 10003</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Attn: Sandeep Dixit</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Email: Sandeep@perceptivelife.com <br>
                    <u>PCOFReporting@perceptivelife.com</u></div>
                  <div style="line-height: 1.25;">&#160;</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">with a copy to (which shall not constitute notice):</div>
                  <div style="line-height: 1.25;">&#160;</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Chapman and Cutler LLP </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">1270 Avenue of the Americas </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">30th Floor</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">New York, New York 10020-1708 </div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Attention: Nicholas Whitney</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">E-mail: Whitney@chapman.com</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">[Signature Page to Warrant Amendment]</div>
          <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: center;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.23
<SEQUENCE>4
<FILENAME>exhibit_4-23.htm
<DESCRIPTION>EXHIBIT 4.23
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div>
      <div>
        <div>
          <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
          <div style="text-align: right;"><u><font style="font-weight: bold;"> Exhibit 4.23</font></u><br>
          </div>
          <div> <br>
          </div>
          <div>
            <div style="text-align: right; margin-right: 5.8pt; line-height: 1.25; font-variant: small-caps;">Execution Version</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 66.05pt; margin-left: 65.15pt; line-height: 1.25; font-variant: small-caps;">First Amendment to Warrant Certificate</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 5pt; line-height: 1.25;">This First Amendment to Warrant Certificate, dated as of December 23, 2024 (this <font style="font-style: italic;">&#8220;Amendment&#8221;</font>),









              is entered into by and among TRINITY BIOTECH PLC, a public limited company organized and existing under the laws of Ireland (the &#8220;<font style="font-style: italic;">Company</font>&#8221;) and PERCEPTIVE CREDIT HOLDINGS III, LP, a Delaware limited
              partnership (the &#8220;<font style="font-style: italic;">Holder</font>&#8221;).</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 66.05pt; margin-left: 65.15pt; line-height: 1.25; font-variant: small-caps;">Recitals</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 5.8pt; margin-left: 5pt; line-height: 1.25;">WHEREAS, the Company issued to the Holder that certain Warrant To Purchase American Depositary Shares represented by American
              Depositary Receipts, dated as of January 30, 2024, as amended by this Amendment, (the <font style="font-style: italic;">&#8220;Warrant&#8221;</font>). Capitalized terms used herein but not otherwise defined herein shall have the meanings ascribed
              thereto in the Warrant.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 5pt; line-height: 1.25;">WHEREAS, in connection with that certain Third Amended and Restated Credit Agreement and Guaranty, dated as of December 23, 2024
              (the <font style="font-style: italic;">&#8220;Credit Agreement&#8221;</font>), by and among TRINITY BIOTECH, INC., a Delaware corporation (&#8220;<font style="font-style: italic;">U.S. Holdings</font>&#8221;) and the other borrowers party thereto, the Guarantors
              party thereto, the Lenders party thereto, and PERCEPTIVE CREDIT HOLDINGS III, LP as administrative agent for the Lenders (in such capacity, the <font style="font-style: italic;">&#8220;Administrative Agent&#8221;</font>), the Company and the Holder have
              agreed to amend certain provisions of the Warrant.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 5pt; line-height: 1.25;">WHEREAS, the Company and the Holder are willing to make such amendments to the Warrant as are further described herein, in
              accordance with and subject to the terms and conditions of this Amendment.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">NOW, THEREFORE, in consideration of the premises and the mutual covenants and the agreements herein set forth, and other good and
              valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" id="za0dcca70eb8e4b24badd2a26253b59ea" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 5pt;"><br>
                  </td>
                  <td style="width: 21.6pt; vertical-align: top;">1</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div><font style="font-weight: bold;">Amendment to Warrant</font>. Concurrently with the effectiveness of the Credit Agreement (the &#8220;<font style="font-style: italic;">Third Amendment Restatement Date</font>&#8221;):</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" id="z5838e4121b3c43e99ddd5242d97d2603" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 54.5pt;"><br>
                  </td>
                  <td style="width: 31.45pt; vertical-align: top;">1.1</td>
                  <td style="width: auto; vertical-align: top;">
                    <div>Section 2(b) of the Warrant is hereby amended to state in its entirety to read as follows:</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="margin-left: 86pt; line-height: 1.25;">&#8220;<u>Exercise Price</u>. The exercise price per ADS under this Warrant shall be $0.8000, subject to adjustment hereunder (the &#8220;<u>Exercise Price</u>&#8221;).&#8221;</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" id="z2b2b24d88d5845f6b21109cfd00821ea" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 5pt;"><br>
                  </td>
                  <td style="width: 21.6pt; vertical-align: top;">2</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div><font style="font-weight: bold;">Covenants</font>. If the Company determines that the terms of this Amendment require an amendment to the currently-effective Resale Registration Statement governing the Registrable Securities
                      issuable upon exercise of the Warrant to reflect the revised Exercise Price set forth in this Amendment (such amendment, an &#8220;<font style="font-style: italic;">F-3 Amendment</font>&#8221;), then no later than April 30, 2025, the Company
                      shall prepare and file or shall cause to be prepared and filed with the Commission such F-3 Amendment. The F-3 Amendment (if any) shall be in form and substance reasonably acceptable to the Holder, and the Company shall use its
                      reasonable best efforts to cause such F-3 Amendment to be declared effective as soon as possible after filing. For the avoidance of doubt, the provisions of Section 13.03(b) of the Credit Agreement shall apply to any Claims or Losses
                      suffered by an Indemnified Party (each as defined in the Credit Agreement) arising from or relating to any misstatement or omission contained in the Resale Registration Statement, the F-3 Amendment, and any prospectus contained in
                      such Resale Registration Statement, any further amendment or supplement thereto, or any violation by the Company of the Securities Act or any rule or regulation promulgated thereunder applicable to the Company or any state securities
                      (or Blue Sky) law, rule or regulation and relating to action or inaction required of the Company in connection with any such registration.</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <!--PROfilePageNumberReset%Num%2%%%-->
            <div style="text-align: justify; margin-right: 5.9pt; margin-left: 26.6pt; line-height: 1.25;"><br>
            </div>
            <table cellspacing="0" cellpadding="0" id="ze7c7041116c04b13a6f11f78b2d8a2dd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 5pt;"><br>
                  </td>
                  <td style="width: 21.6pt; vertical-align: top;">3</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div><font style="font-weight: bold;">Effect of Amendment. </font>On and after the date hereof, each reference in the Warrant to &#8220;this Warrant&#8221;, &#8220;hereunder&#8221;, &#8220;hereof&#8221;, &#8220;herein&#8221; or words of like import referring to the Warrant, shall
                      mean and be a reference to the Warrant after giving effect to this Amendment. Except as specifically set forth in this Amendment, the Warrant remains in full force and effect and is hereby ratified and confirmed.</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" id="z5030c09481f647a7a96f632f1ca9ec36" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 5pt;"><br>
                  </td>
                  <td style="width: 21.6pt; vertical-align: top;">4</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div><font style="font-weight: bold;">Governing Law. </font>This Amendment, and all questions concerning the construction, validity, enforcement and interpretation of the Amendment, shall be governed by and construed and enforced in
                      accordance with the internal laws of the State of New York.</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" id="z98a3eff619b4401fb45998002e4d9cdf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 5pt;"><br>
                  </td>
                  <td style="width: 21.6pt; vertical-align: top;">5</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div><font style="font-weight: bold;">Counterparts. </font>This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, shall be deemed to
                      be an original, and all of which, when taken together, shall constitute but one and the same Amendment. Delivery of an executed counterpart of this Amendment by facsimile, DocuSign or a scanned copy by electronic mail shall be equally
                      as effective as delivery of an original executed counterpart of this Amendment.</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" id="z8075e86913aa4c338508f8e2b2ae680c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 5pt;"><br>
                  </td>
                  <td style="width: 21.6pt; vertical-align: top;">6</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div><font style="font-weight: bold;">Binding Effect. </font>This Amendment will be binding upon and inure to the benefit of and is enforceable by the respective successors and permitted assigns of the parties hereto.</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" id="z6a8ab47398bb4a40a67a0a8704e7adb0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 5pt;"><br>
                  </td>
                  <td style="width: 21.6pt; vertical-align: top;">7</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div><font style="font-weight: bold;">Incorporation By Reference</font>. The provisions set forth in Sections 6(h) (Submission to Jurisdiction), 6(i) (Waiver of Venue, Etc.), and 6(j) (Waiver of Jury Trial) of the Warrant shall apply to
                      this Amendment in all respects.</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 66.05pt; margin-left: 68pt; line-height: 1.25;">[Remainder of page intentionally left blank; signatures on following pages]</div>
            <div style="text-align: center; margin-right: 0.8pt; line-height: 1.25;"><br>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <br>
            <div style="text-indent: 33.2pt; margin-right: 0.85pt; margin-left: 6.45pt; margin-top: 0.05pt;">IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by its officer thereunto duly authorized as a Deed on the date first above
              indicated.</div>
            <div style="text-align: center; margin-right: 143.5pt; margin-left: 150.4pt; line-height: 1.25;"> <br>
            </div>
            <div style="line-height: 1.25;">
              <div><img src="image00009.jpg"></div>
              <div><br>
              </div>
              <div>
                <div style="font-family: 'Times New Roman',Times,serif;">Address for Notices:</div>
                <div style="margin-top: 1.1pt;"><br>
                </div>
                <div style="font-family: 'Times New Roman',Times,serif;">Trinity Biotech plc</div>
                <div style="font-family: 'Times New Roman',Times,serif;"> IDA Business Park,</div>
                <div style="font-family: 'Times New Roman',Times,serif;">Bray, Co. Wicklow, Ireland </div>
                <div style="font-family: 'Times New Roman',Times,serif;">A98 H5C8</div>
                <div style="font-family: 'Times New Roman',Times,serif;">Attention: John Gillard, CEO </div>
                <div style="font-family: 'Times New Roman',Times,serif;">Telephone: +353 l 276 9800</div>
                <div style="font-family: 'Times New Roman',Times,serif;">Email: Lennotice@trinitybiotech.com</div>
                <div style="margin-top: 1.25pt;"><br>
                </div>
                <div style="font-family: 'Times New Roman',Times,serif;">With a copy to (which shall not constitute notice): </div>
                <div style="font-family: 'Times New Roman',Times,serif;">Carter Ledyard &amp; Milburn LLP</div>
                <div style="margin-top: 0.4pt; font-family: 'Times New Roman',Times,serif;">2 Wall Street, New York, NY 10005 </div>
                <div style="margin-top: 0.4pt; font-family: 'Times New Roman',Times,serif;">Attention: Steven J. Glusband, Esq.</div>
                <div style="margin-top: 0.15pt; font-family: 'Times New Roman',Times,serif;">Email: glusband@clm.com</div>
              </div>
              <div>
                <div style="text-align: center; font-family: 'Times New Roman',Times,serif;"> <br>
                </div>
                <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">[Signature Page to Warrant Amendment]</div>
              </div>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="margin-left: 5pt; line-height: 1.25;"> <br>
            </div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="cb7f594f2f5841f59822f5550cc4b84a">

                <tr>
                  <td style="width: 5%;"><br>
                  </td>
                  <td colspan="2">
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Accepted and Agreed,</div>
                    <div style="line-height: 1.25;">&#160;</div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Perceptive Credit Holdings III, LP</div>
                  </td>
                  <td style="width: 50%;"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 5%;" rowspan="1"><br>
                  </td>
                  <td rowspan="1" colspan="2"><br>
                  </td>
                  <td style="width: 50%;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 5%;" rowspan="1"><br>
                  </td>
                  <td style="width: 3%;" rowspan="1">By:</td>
                  <td style="width: 42%;" rowspan="1">Perceptive Credit Opportunities GP, LLC, its general partner</td>
                  <td style="width: 50%;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 5%;" rowspan="1"><br>
                  </td>
                  <td style="width: 3%;" rowspan="1"><br>
                  </td>
                  <td style="width: 42%;" rowspan="1"><br>
                  </td>
                  <td style="width: 50%;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 5%; padding-bottom: 2px;" rowspan="1"><br>
                  </td>
                  <td style="width: 3%; text-align: left; vertical-align: bottom; padding-bottom: 2px;" rowspan="1">By:</td>
                  <td style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
                    <div style="text-align: left; line-height: 1.25;"><img width="106" height="46" src="image1.jpg"></div>
                  </td>
                  <td style="width: 50%; padding-bottom: 2px;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 5%;" rowspan="1"><br>
                  </td>
                  <td style="width: 3%;" rowspan="1"><br>
                  </td>
                  <td style="width: 42%;" rowspan="1">Name: Sandeep Dixit</td>
                  <td style="width: 50%;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 5%;" rowspan="1"><br>
                  </td>
                  <td style="width: 3%;" rowspan="1"><br>
                  </td>
                  <td style="width: 42%;" rowspan="1">Title: Chief Credit Officer</td>
                  <td style="width: 50%;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 5%;" rowspan="1"><br>
                  </td>
                  <td style="width: 3%;" rowspan="1"><br>
                  </td>
                  <td style="width: 42%;" rowspan="1"><br>
                  </td>
                  <td style="width: 50%;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 5%; padding-bottom: 2px;" rowspan="1"><br>
                  </td>
                  <td style="width: 3%; padding-bottom: 2px; text-align: left; vertical-align: bottom;" rowspan="1">By:</td>
                  <td style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
                    <div style="text-align: left; line-height: 1.25;"><img width="104" height="46" src="image6.jpg"></div>
                  </td>
                  <td style="width: 50%; padding-bottom: 2px;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 5%;" rowspan="1"><br>
                  </td>
                  <td style="width: 3%;" rowspan="1"><br>
                  </td>
                  <td style="width: 42%;" rowspan="1">Name: Sam Chawla</td>
                  <td style="width: 50%;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 5%;" rowspan="1"><br>
                  </td>
                  <td style="width: 3%;" rowspan="1"><br>
                  </td>
                  <td style="width: 42%;" rowspan="1">Title: Portfolio Manager</td>
                  <td style="width: 50%;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 5%;" rowspan="1"><br>
                  </td>
                  <td rowspan="1" colspan="2"><br>
                  </td>
                  <td style="width: 50%;" rowspan="1"><br>
                  </td>
                </tr>
                <tr>
                  <td style="width: 5%;" rowspan="1"><br>
                  </td>
                  <td rowspan="1" colspan="3">
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Address for Notices:</div>
                    <div style="line-height: 1.25;">&#160;</div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">c/o Perceptive Advisors LLC </div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">51 Astor Place, 10th Floor New York, NY 10003</div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Attn: Sandeep Dixit</div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Email: Sandeep@perceptivelife.com&#160;</div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>PCOFReporting@perceptivelife.com</u></div>
                    <div style="line-height: 1.25;">&#160;</div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">with a copy to (which shall not constitute notice):</div>
                    <div style="line-height: 1.25;">&#160;</div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Chapman and Cutler LLP </div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">1270 Avenue of the Americas </div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">30th Floor</div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">New York, New York 10020-1708 </div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Attention: Nicholas Whitney</div>
                    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">E-mail: Whitney@chapman.com</div>
                  </td>
                </tr>

            </table>
            <br>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">[Signature Page to Warrant Amendment]</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
            </div>
          </div>
        </div>
      </div>
    </div>
    <div style="text-align: center;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.24
<SEQUENCE>5
<FILENAME>exhibit_4-24.htm
<DESCRIPTION>EXHIBIT 4.24
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div>
      <div>
        <div>
          <div>
            <div>
              <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
              <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 4.24</font></u><br>
              </div>
              <div> <br>
              </div>
              <div>
                <div style="text-align: right; margin-right: 5.8pt; line-height: 1.25; font-variant: small-caps;">Execution Version</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-right: 5.85pt; margin-left: 5pt; line-height: 1.25;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
                  THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;<u>SECURITIES ACT</u>&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD IN THE UNITED
                  STATES EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
                  WITH APPLICABLE STATE SECURITIES LAWS AS MAY BE REQUIRED TO BE EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE
                  SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &#8220;ACCREDITED INVESTOR&#8221; AS DEFINED IN RULE
                  501(a) UNDER THE SECURITIES ACT.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: center; margin-right: 62.05pt; margin-left: 61.15pt; line-height: 1.25; font-weight: bold;">WARRANT TO PURCHASE AMERICAN DEPOSITARY SHARES </div>
                <div style="text-align: center; margin-right: 62.05pt; margin-left: 61.15pt; line-height: 1.25; font-weight: bold;">REPRESENTED BY AMERICAN DEPOSITARY RECEIPTS</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: center; margin-right: 62pt; margin-left: 61.15pt; line-height: 1.25; font-weight: bold;">TRINITY BIOTECH PLC</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="line-height: 1.25;">
                  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                      <tr>
                        <td style="text-align: justify; margin-left: 5pt; line-height: 1.25;">
                          <div style="margin: 0px 0px 0px 5pt;">Warrant ADSs: 1,000,000</div>
                        </td>
                        <td style="width: 50%; text-align: right; vertical-align: bottom;"><font style="font-family: 'Times New Roman',Times,serif;">Issue Date: December 23, 2024</font></td>
                      </tr>

                  </table>
                </div>
                <br>
                <div style="text-align: justify; margin-left: 5pt; line-height: 1.25;">Warrant No. 3</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-right: 5.85pt; margin-left: 5pt; line-height: 1.25;"><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;&#160;&#160;&#160;</font>THIS&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;WARRANT&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;TO&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PURCHASE&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;AMERICAN&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;DEPOSITARY&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SHARES



                  REPRESENTED BY AMERICAN DEPOSITARY RECEIPTS (this &#8220;<u>Warrant</u>&#8221; or &#8220;<u>Warrant Certificate</u>&#8221;) certifies that, for value received, Perceptive Credit Holdings III, LP or its assigns (the &#8220;<u>Holder</u>&#8221;) is entitled, upon the terms
                  and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof, and on or prior to the close of business on December 23, 2031 (the &#8220;<u>Expiration Date</u>&#8221;), but not
                  thereafter, to purchase from Trinity Biotech PLC, a public limited company organized and existing under the laws of Ireland (the &#8220;<u>Company</u>&#8221;), and the Company shall be obliged to cause the issuance, of up to one million (1,000,000)
                  American Depositary Shares of the Company (&#8220;<u>ADSs</u>&#8221;), with each ADS being represented by one American Depositary Receipt issued by the Depositary (&#8220;<u>ADR</u>&#8221;), each of which in turn represents four &#8220;A&#8221; Ordinary Shares of the
                  Company (the &#8220;<u>ADS Ratio</u>&#8221;) (as subject to adjustment hereunder the &#8220;Warrants ADSs&#8221;). The purchase price of one ADS, represented by one ADR, issuable under this Warrant shall be equal to the Exercise Price, as defined in <u>Section
                    2(b)</u>.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-right: 5.95pt; margin-left: 5pt; line-height: 1.25;">This Warrant is issued pursuant to that certain Third Amended and Restated Credit Agreement and Guaranty dated as of December 23, 2024 (the &#8220;<u>Credit







                    Agreement</u>&#8221;) by and among Trinity Biotech, Inc., a Delaware corporation (&#8220;<u>U.S. Holdings</u>&#8221;), Fitzgerald Industries International, Inc., a Delaware corporation (&#8220;<u>U.S. Fitzgerald</u>&#8221;), Clark Laboratories, Inc. (d/b/a as
                  Trinity Biotech (USA)), a New York corporation (&#8220;<u>U.S. Clark</u>&#8221;), MarDx Diagnostics, Inc., a California corporation (&#8220;<u>U.S. MarD</u><font style="font-style: italic;">x</font>&#8221;), Biopool U.S., Inc., a Delaware corporation (d/b/a
                  Trinity Biotech Distribution) (&#8220;<u>U.S. Biopool</u>&#8221;), Primus Corporation, a Missouri corporation (&#8220;<u>U.S. Primus</u>&#8221;), IMMCO Diagnostics, Inc., a Delaware corporation (&#8220;<u>U.S. Immco</u>&#8221;), TRIB Biosensors Inc., a Delaware corporation
                  (&#8220;<u>U.S. TRIB</u>&#8221; and together with U.S. Holdings, U.S. Fitzgerald, U.S. Clark, U.S. Mardx, U.S. Biopool, U.S. Primus and U.S. Immco, each a &#8220;<u>Borrower</u>&#8221; and collectively, the <font style="font-style: italic;">&#8220;</font><u>Borrowers</u><font style="font-style: italic;">&#8221;</font>), certain guarantors party thereto from time to time, the lenders from time to time party thereto, and Perceptive Credit Holdings III, LP, as administrative agent (in such capacity, together with its
                  successors and assigns, <font style="font-style: italic;">&#8220;</font><u>Administrative Agent</u><font style="font-style: italic;">&#8221;</font>).</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: justify; margin-right: 5.85pt; margin-left: 5pt; line-height: 1.25;"><br>
                </div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;"><u>Section 1.</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Definitions</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; For the purposes hereof, in addition to the terms defined elsewhere in
                  this Warrant, (a) capitalized terms used and not otherwise defined herein shall have the meanings set forth in the Credit Agreement, and (b) the following terms shall have the following meanings:</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Affiliate</u>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by
                  or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="margin-left: 41pt; line-height: 1.25;">&#8220;<u>Commission</u>&#8221; means the United States Securities and Exchange Commission.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Companies Act</u>&#8221; means the Companies Act of 2014 of Ireland (as amended). &#8220;<u>Convertible Securities</u>&#8221; means any debt,
                  equity or other securities that are, directly or indirectly, convertible into or exchangeable for Ordinary Shares or ADSs or ADRs.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Depositary</u>&#8221; means The Bank of New York Mellon, a New York banking corporation, as depositary for the ADSs and the issuer
                  of the ADRs.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Excluded Issuance</u>&#8221; means the issuance of (a) Ordinary Shares or ADSs (or options with respect thereto) issued or issuable
                  to employees or directors of, or consultants to, the Company or any of its subsidiaries pursuant to a plan, agreement or arrangement approved by the Board of Directors of the Company, (b) warrants issued pursuant to the Credit Agreement
                  and/or other securities exercisable or exchangeable for or convertible into Ordinary Shares or ADSs issued and outstanding on the date of this Warrant, <font style="font-style: italic;">provided </font>that such securities have not been
                  amended since the date of this Warrant to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (for purposes of clarity, any decrease in the exercise price,
                  exchange price or conversion price of such securities shall not be deemed an amendment thereto, if such decrease is as a result of any price-based anti-dilution provision contained in such securities prior to the date hereof), and (c)
                  other securities issued to financial institutions, institutional investors or lessors in connection with credit arrangements, equipment financings or similar transactions (and not for the purpose of raising capital) approved by a majority
                  of disinterested directors of the Company. In addition, for the avoidance of doubt, &#8220;Excluded Issuances&#8221; also include the filing of any registration statement of the Company with the Commission registering securities of the Company, or
                  the filing of any amendments or supplements thereto, provided that the determination of whether sales under any such registration statement is an Excluded Issuance will be determined based on the preceding clauses (a) to (c) hereof.</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Fundamental Transaction</u>&#8221; means (a) the Company, directly or indirectly, in one or more related transactions effects any
                  merger or consolidation of the Company with or into another Person, (b) the Company, directly or indirectly, effects any sale, lease, exclusive license, assignment, transfer, conveyance or other disposition of all or substantially all of
                  its assets in one or a series of related transactions, (c) any, direct or indirect, purchase offer, scheme of arrangement, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of
                  Ordinary Shares, ADRs or ADSs are permitted to sell, tender, agree to cancel or exchange their shares for other securities, cash or property and has been accepted by the holders of fifty percent (50%) or more of the outstanding security
                  holders of the Company (or, in the case of a scheme of arrangement, the requisite majority to approve such scheme), (d) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
                  or recapitalization of the Ordinary Shares or ADSs (but, for the avoidance of doubt, excluding any transaction, event or occurrence covered by <u>Section 3(a)</u>) or any compulsory share exchange pursuant to which the Ordinary Shares or
                  ADSs are effectively converted into or exchanged for other securities, cash or property, (e) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
                  combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than fifty percent (50%) of the outstanding voting shares of
                  the Company (not including any shares held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
                  combination).</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Marketable Securities</u>&#8221; means securities that (a) are tradable on an established national U.S. stock exchange or reported
                  through an established over-the-counter trading system and (b) are not subject to restrictions on transfer under the Securities Act, the Companies Act or contractual restrictions on transfer.</div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;"><br>
                </div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Options</u>&#8221; means any warrants or other rights or options to subscribe for or purchase Ordinary Shares or Convertible
                  Securities.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Ordinary Shares</u>&#8221; means the &#8220;A&#8221; ordinary shares of the Company, par value USD $0.0109 per share, and any other class of
                  securities into which such securities may hereafter be reclassified or changed.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Person</u>&#8221; means any individual, sole proprietorship, partnership, limited liability company, corporation, joint venture,
                  trust, incorporated organization or government or department or agency thereof.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Prospectus</u>&#8221; means the prospectus or prospectuses included in any Registration Statement, as amended or supplemented by
                  any prospectus supplement with respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement and by all other amendments and supplements to the prospectus, including
                  post-effective amendments and all material incorporated by reference in such prospectus or prospectuses.</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="line-height: 1.25">&#160;
                  <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Registrable Securities</u>&#8221; means (a) any ADSs (represented by ADRs), or Ordinary Shares held by Holder or issuable upon
                    conversion, exercise or exchange of any securities owned by Holder at any time (including Warrant ADSs exercisable upon exercise of this Warrant), and (b) any ADSs (represented by ADRs) or Ordinary Shares issued or issuable with respect
                    to any shares described in subsection (a) above by way of a stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization (it being understood that for
                    purposes of this Warrant, Holder shall be deemed to be a holder of Registrable Securities whenever Holder has the right to then acquire or obtain from the Company any Registrable Securities, whether or not such acquisition has actually
                    been effected). As to any particular Registrable Securities, such securities shall cease to be Registrable Securities when (i) a Registration Statement covering such securities has been declared effective by the SEC and such securities
                    have been disposed of pursuant to such effective Registration Statement, (ii) such securities are sold under circumstances in which all of the applicable conditions of Rule 144 (or any similar provisions then in force) under the
                    Securities Act are met, (iii) such securities are otherwise transferred and such securities may be resold without subsequent registration under the Securities Act, or (iv) such securities shall have ceased to be outstanding.</div>
                </div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Registration Statement</u>&#8221; means any registration statement of the Company which covers any of the Registrable Securities
                  pursuant to the provisions of this Warrant, including the Prospectus, amendments and supplements to or replacements of such Registration Statement, including post-effective amendments, all exhibits and all materials incorporated by
                  reference in such Registration Statement.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Rule 144</u>&#8221; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from
                  time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Share Equivalents</u>&#8221; means any securities of the Company or its wholly owned subsidiaries which would entitle the holder
                  thereof to acquire at any time Ordinary Shares or ADSs, including, without limitation, any debt, preferred stock, right, option, warrant, ADR or other instrument that is at any time convertible into or exercisable or exchangeable for, or
                  otherwise entitles the holder thereof to receive, Ordinary Shares or ADSs.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Stock Deemed Outstanding</u>&#8221; means, at any given time, the sum of (i) the number of Ordinary Shares and ADSs actually
                  outstanding at such time, plus (ii) the number of Ordinary Shares issuable upon exercise of Options actually outstanding at such time, plus (iii) the number of Ordinary Shares issuable upon conversion or exchange of Convertible Securities
                  (including ADSs) actually outstanding at such time (treating as actually outstanding any Convertible Securities issuable upon exercise of Options actually outstanding at such time), in each case, regardless of whether the Options or
                  Convertible Securities are actually exercisable at such time; <font style="font-style: italic;">provided </font>that Stock Deemed Outstanding at any given time shall not include shares owned or held by or for the account of the Company
                  or any of its wholly owned subsidiaries.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Trading Day</u>&#8221; means a day on which the principal Trading Market is open for trading. &#8220;<u>Trading Market</u>&#8221; means the
                  Nasdaq Global Market (or any successor to the Nasdaq Global Market), or any national securities exchange registered with the Commission on which the ADSs are listed and which is then the primary trading market for the ADSs.</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Transfer Agent</u>&#8221; means Computershare Investor Services (Ireland) Limited, the current transfer agent of the Company, and
                  any successor transfer agent of the Company.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>VWAP</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the ADSs are
                  then listed or quoted on the Trading Market, the daily volume weighted average price of the ADSs for such date on the Trading Market on which the ADSs are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from
                  9:30 a.m. (New York City time) to 4:00 p.m. (New York City time)), (b) if the ADSs are not then listed or quoted for trading on the Trading Market and if prices for the ADSs are then reported on the &#8220;Pink Market&#8221; of the OTC Markets Group,
                  Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per ADS as reported, or (c) in all other cases, the fair market value of one ADS as determined by the Company and the
                  Holder, provided that if the Company and the Holder cannot agree on the fair market value of one ADS, such value shall be determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the
                  Company, the reasonable, actual and documented fees and reasonable, actual and documented out-of-pocket expenses of which shall be paid by the Company.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="margin-left: 41pt; line-height: 1.25;"><u>Section 2.</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise</u>.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 41pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise of Warrant</u>. Exercise of the purchase rights represented by this Warrant may be made, in whole or
                  in part, at any time or times before the Expiration Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on
                  the books of the Company) of a duly executed electronic copy of the Notice of Exercise in the form annexed hereto (the &#8220;<u>Notice of Exercise</u>&#8221;) and within one (1) Trading Day of the date said Notice of Exercise is delivered to the
                  Company, the Company shall have received payment of the aggregate Exercise Price of the Warrant ADSs thereby purchased by wire transfer or cashier&#8217;s check drawn on a United States bank or pursuant to the cashless exercise procedure
                  specified in <u>Section 2(c)</u> below. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding
                  anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant ADSs available hereunder and this Warrant has been exercised in full,
                  in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in
                  purchases of a portion of the total number of Warrant ADSs available hereunder shall have the effect of lowering the outstanding number of Warrant ADSs purchasable hereunder in an amount equal to the applicable number of Warrant ADSs
                  purchased. The Holder and the Company shall maintain records showing the number of Warrant ADSs purchased and the date of such purchases. <font style="font-weight: bold;">The Holder and any assignee, by acceptance of this Warrant,
                    acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant ADSs hereunder, the number of Warrant ADSs available for purchase hereunder at any given time may be different
                    than the amount stated on the face hereof. For the avoidance of doubt, the Holder may request a new Warrant upon the partial exercise of this Warrant.</font></div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 41pt; line-height: 1.25;"><font style="font-weight: bold;"> <br>
                  </font></div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;">In the event that immediately prior to the close of business on the Expiration Date, the VWAP of one ADS is greater than the then applicable
                  Exercise Price, this Warrant shall be deemed to be automatically exercised as a &#8220;cashless exercise&#8221; pursuant to <u>Section 2(c)</u> below, and the Company or the Depositary, as applicable, shall deliver the applicable number of ADSs
                  (represented by ADRs) to the Holder pursuant to the provisions of <u>Section 2(d) </u>below.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div>
                  <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Exercise Price</u>. The exercise price per ADS under this Warrant shall be $0.8000, subject to adjustment hereunder (the &#8220;<u>Exercise







                      Price</u>&#8221;).</div>
                </div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Cashless Exercise</u>. This Warrant may be exercised, in whole or in part, at any time by means of a &#8220;cashless exercise&#8221; in which the
                  Holder shall be entitled to receive a number of Warrant ADSs (represented by ADRs) equal to the quotient obtained by dividing [(A-B) (X)] by (A) (a &#8220;<u>Cashless Exercise</u>&#8221;), where:</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 113pt; line-height: 1.25;">(A) = the VWAP on the Trading Day immediately preceding the date on which Holder elects to exercise this Warrant by means of a &#8220;cashless
                  exercise,&#8221; as set forth in the applicable Notice of Exercise;</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 113pt; line-height: 1.25;">(B) = the Exercise Price, as adjusted hereunder; and</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 113pt; line-height: 1.25;">(X) = the number of Warrant ADSs (represented by ADRs) that would be issuable upon exercise of this Warrant in accordance with the terms of this
                  Warrant if such exercise were by means of a cash exercise rather than a cashless exercise or, if only a portion of this Warrant is being exercised, the portion of this Warrant being cancelled.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">Notwithstanding any other provision of this Warrant, the issue of any Warrant ADSs (represented by ADRs) (or shares underlying
                  such Warrant ADSs) pursuant to any exercise or redemption of this Warrant (including any exercise or redemption made on a cashless basis pursuant to this Section 2(c) or otherwise) shall be conditional on the payment to the Company by the
                  Holder, whether by payment of the Exercise Price in cash or otherwise, of an amount in cash at least equal to the product of the nominal value of the &#8220;A&#8221; Ordinary Shares of the Company underlying the Warrant ADSs, the number of Warrant
                  ADSs (represented by ADRs) to be issued and the ADS Ratio.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">If Warrant ADSs (represented by ADRs) are issued in such a cashless exercise, the parties acknowledge and agree that, in
                  accordance with Section 3(a)(9) of the Securities Act, the Warrant ADSs (represented by ADRs) shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant ADSs (represented by ADRs) being issued
                  may be tacked on to the holding period of this Warrant commencing as of the Issue Date. The Company agrees not to take any position contrary to this <u>Section 2(c)</u>.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                    <tr>
                      <td style="width: 77pt;"><br>
                      </td>
                      <td style="width: 35.95pt; vertical-align: top;">(d)</td>
                      <td style="width: auto; vertical-align: top;">
                        <div><u>Mechanics of Exercise</u>.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of Warrant ADSs Upon Exercise</u>. Warrant ADSs (represented by ADRs) purchased hereunder shall be transmitted by the
                  Depositary to the Holder by crediting the account of the Holder&#8217;s prime broker with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) and the Warrant ADSs (represented by ADRs) are eligible
                  for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 or an available Registration Statement, and otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise by the
                  date that is two (2) Trading Days after the delivery to the Company, by 11 a.m. (local time in New York City, New York) on a Trading Day, of the Notice of Exercise and payment of the aggregate Exercise Price as set forth above (including
                  by Cashless Exercise) (such date, the &#8220;<u>Warrant ADS Delivery Date</u>&#8221;). The Warrant ADSs (represented by ADRs) shall be deemed to have been issued, and the Holder or any other person so designated to be named therein shall be deemed to
                  have become a holder of record of such Warrant ADSs (represented by ADRs) for all purposes, as of the date this Warrant has been exercised, with payment to the Company of the Exercise Price (or by Cashless Exercise) and all taxes required
                  to be paid by the Holder, if any, pursuant to <u>Section 2(d)(v)</u> prior to the issuance of such Warrant ADSs (represented by ADRs), having been paid. If the Company fails for any reason to deliver to the Holder the Warrant ADSs
                  (represented by ADRs) subject to a Notice of Exercise by the Warrant ADS Delivery Date, other than a failure to deliver caused by the Holder&#8217;s failure to pay the applicable Exercise Price for such Warrant ADSs or to timely take such
                  actions as are necessary to post such Warrant ADSs (represented by ADRs) in DWAC, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant ADSs (represented by ADRs) subject to
                  such exercise (based on the VWAP on the date of the applicable Notice of Exercise) $0.8000 per Trading Day for each Trading Day after such Warrant ADS Delivery Date until such Warrant ADSs (represented by ADRs) are delivered or Holder
                  rescinds such exercise. The Company agrees to maintain a registrar (which may be the Depositary) that is a participant in the &#8220;FAST&#8221; program for so long as this Warrant remains outstanding and exercisable.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of New Warrants Upon Exercise</u>. If this Warrant shall have been exercised in part, the Company shall, at the request of
                  a Holder and upon surrender of this Warrant certificate, at or promptly after the time of delivery of the Warrant ADSs (represented by ADRs), deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the
                  unpurchased Warrant ADSs called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rescission Rights</u>. If the Company fails to cause the Depositary to transmit to the Holder the Warrant ADSs (represented by
                  ADRs) pursuant to <u>Section 2(d)(i)</u> by the Warrant ADS Delivery Date, other than a failure to deliver caused by the Holder&#8217;s failure to pay the applicable Exercise Price for such Warrant ADSs or to timely take such actions as are
                  necessary to post such Warrant ADSs (represented by ADRs) in DWAC, then the Holder will have the right to rescind such exercise and have its Exercise Price, if any, refunded by the Company.</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;"><br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 77pt; line-height: 1.25;"><br>
                </div>
                <div style="line-height: 1.25">
                  <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compensation for Buy-In on Failure to Timely Deliver Warrant</u>&#160;<u>ADSs Upon Exercise</u>. In addition to any other rights
                    available to the Holder, if the Company fails to cause the Depositary to transmit to the Holder the Warrant ADSs (represented by ADRs) pursuant to an exercise on or before the Warrant ADS Delivery Date and such failure is not caused by
                    any act or omission of the Holder, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) ADSs (represented by ADRs) to deliver in satisfaction of a sale by the Holder of the
                    Warrant ADS (represented by ADRs) which the Holder anticipated receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price
                    (including brokerage commissions, if any) for the ADSs (represented by ADRs) so purchased (<font style="font-style: italic;">provided</font>, Holder exercises reasonable efforts to minimize the amount of such purchase price) exceeds (y)
                    the amount obtained by multiplying (1) the number of Warrant ADSs (represented by ADRs) that the Company was required to deliver to the Holder in connection with the exercise at issue by (2) the actual sale price at which the sell order
                    giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant ADSs for which such exercise was not honored (in which case such
                    exercise shall be deemed rescinded) or deliver to the Holder the number of ADSs (represented by ADRs) that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
                    Holder purchases ADSs (represented by ADRs) having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise to acquire Warrant ADSs (represented by ADRs) with an aggregate sale price giving rise to such
                    purchase obligation of</div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <div style="text-align: justify; margin-right: 5.95pt; margin-left: 77pt; line-height: 1.25;">$10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide
                  the Company written notice indicating the amounts payable to the Holder in respect of the Buy- In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&#8217;s right to pursue any other
                  remedies available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#8217;s failure to timely deliver Warrant ADSs (represented by ADRs)
                  upon exercise of the Warrant as required pursuant to the terms hereof.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Fractional ADSs or Scrip</u>. No fractional ADSs (represented by ADRs) or scrip representing fractional ADSs (represented by ADRs)
                  shall be issued upon the exercise of this Warrant. As to any fraction of an ADS which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall round up to the next whole ADS (represented by and ADR).</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Charges, Taxes and Expenses</u>. Subject to applicable law or regulation, the issuance of this Warrant and the Warrant ADSs
                  (represented by ADRs) shall be made without charge to the Holder for any stamp duty, issue or transfer tax or other incidental expense in respect of the issuance of this Warrant and Warrant ADSs (represented by ADRs) (but not any
                  subsequent transfer of this Warrant or any Warrant ADSs (represented by ADRs) so issued), all of which taxes and expenses shall be paid by the Company, and such Warrant ADSs (represented by ADRs) shall be issued in the name of the Holder
                  or in such name or names as may be directed by the Holder; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that in the event that Warrant ADSs (represented by ADRs) are to be issued
                  in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by a completed Assignment Form in the form attached hereto duly executed by the Holder and the Company may require, as a
                  condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all fees of the Depositary required for same-day processing of any Notice of Exercise and all fees to the
                  Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant ADSs (represented by ADRs).</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Closing of Books</u>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
                  of this Warrant, pursuant to the terms hereof.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 41pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Holder&#8217;s Exercise Limitations</u>. The Company shall not effect any exercise of this Warrant, and a Holder
                  shall not have the right to exercise any portion of this Warrant, pursuant to this <u>Section 2</u> or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise,
                  the Holder (together with the Holder&#8217;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation (as defined
                  below). For purposes of the foregoing sentence, the number of Ordinary Shares beneficially owned by the Holder and its Affiliates shall include the number of Ordinary Shares underlying the Warrant ADSs with respect to which such
                  determination is being made, but shall exclude the number of Ordinary Shares underlying the Warrant ADSs which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or
                  any of its Affiliates, and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Share Equivalents) subject to a limitation on conversion or
                  exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this <u>Section 2(f)</u>, beneficial ownership shall be
                  calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in
                  compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this <u>Section 2(f)</u> applies, the
                  determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and
                  the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this
                  Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as
                  contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this <u>Section 2(f)</u>, in determining the number of outstanding Ordinary
                  Shares, a Holder may rely on the number of outstanding shares of Ordinary Shares as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement
                  by the Company, or (C) a more recent written notice from the Company or the Transfer Agent or the Depositary setting forth the number of Ordinary Shares outstanding. Upon the written request of a Holder, the Company shall within one (1)
                  Trading Day confirm orally and in writing to the Holder the number of Ordinary Shares then outstanding. In any case, the number of outstanding Ordinary Shares shall be determined after giving effect to the conversion or exercise of
                  securities of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding Ordinary Shares was reported. The &#8220;<u>Beneficial Ownership</u>&#160;<u>Limitation</u>&#8221; shall be 9.99% of
                  the number of Ordinary Shares outstanding immediately after giving effect to the applicable issuance of the Warrant ADSs (represented by ADRs)issuable upon exercise of this Warrant, <font style="font-style: italic;">provided </font>that
                  the Holder may decrease such Beneficial Ownership Limitation upon written notice to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this <u>Section
                    2(f)</u> to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
                  give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Violation</u>. The Company shall take all such actions as may be necessary to ensure that all such Warrant ADSs (represented by
                  ADRs) are issued without any rights of pre-emption in favor of any other person and without violation by the Company of any applicable law or governmental regulation or of any requirements of any domestic securities exchange upon which
                  Ordinary Shares, ADSs (represented by ADRs), or other securities constituting Warrant ADSs (represented by ADRs) or into which such Warrant ADSs (represented by ADRs) may be converted or exchanged may be listed at the time of such
                  exercise (except for official notice of issuance which shall be immediately delivered by the Company upon each such issuance).</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 41pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Listing</u>. Promptly following the date of this Warrant Certificate the Company shall cause the Warrant ADSs
                  (represented by ADRs) to be listed on the Trading Market, and shall maintain such listing through the time of such exercise and the holding of the Warrant ADSs by the Holder, and shall assure that it and the Depositary shall, at all times
                  maintain, for the benefit of the Holder, (i) that number of ADSs underlying the Warrant ADSs available for issuance in connection with the exercise of this Warrant Certificate under a registration statement on Form F-3 in accordance with
                  Section 4, and</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;">(ii) that number of ADRs available for issuance in connection with the exercise of this Warrant Certificate under a registration statement on Form
                  F-6.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;"><u>Section 3.</u>&#160; <u>Certain Adjustments</u>. In order to prevent dilution of the purchase rights granted under this Warrant
                  Certificate, the Exercise Price and the number of Warrant ADSs (represented by ADRs) issuable upon exercise of this Warrant Certificate shall be subject to adjustment from time to time as provided in this <u>Section 3</u>.</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;"> <br>
                </div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 41pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price Upon Issuance of Ordinary Shares or ADSs</u>. Subject to <u>Section 3(c)</u>, if
                  the Company shall, at any time after the date hereof (the &#8220;<u>Issue</u>&#160;<u>Date</u>&#8221;), issue or sell any Ordinary Shares, whether directly or indirectly by way of Options or Convertible Securities (including through the issuance of ADSs
                  (represented by ADRs)(other than in an Excluded Issuance or any event described in <u>Section 3(d)</u> or <u>(e)</u>), without consideration or for consideration per share less than the Exercise Price in effect immediately prior to such
                  issuance or sale, then immediately upon such issuance or sale, the Exercise Price in effect immediately prior to such issuance or sale shall be reduced (and in no event increased) to an Exercise Price equal to the quotient obtained by
                  dividing:</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the sum of (A) the product obtained by multiplying the Stock Deemed Outstanding immediately prior to such issuance or sale (or deemed
                  issuance or sale) by the Exercise Price then in effect plus (B) the aggregate consideration, if any, received by the Company upon such issuance or sale (or deemed issuance or sale); by</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the sum of (A) the Stock Deemed Outstanding immediately prior to such issuance or sale (or deemed issuance or sale) plus (B) the
                  aggregate number of Ordinary Shares issued or sold (or deemed issued or sold) by the Company in such issuance or sale (or deemed issuance or sale);</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;"><font style="font-style: italic;">provided</font>, for the avoidance of doubt, the number of Warrant ADSs (represented by ADRs)
                  issued pursuant to this Warrant Certificate will not be adjusted in the event that the Exercise Price is adjusted under <u>Section 3(a)</u>.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 41pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Effect of Certain Events on Adjustment to Exercise Price</u>. For purposes of determining the adjusted Exercise
                  Price under <u>Section 3(a)</u>, the following shall be applicable:</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Issuance of Options</u>. If the Company shall, at any time or from time to time after the date hereof, in any manner grant or sell
                  (whether directly or by assumption in a merger or otherwise) any Options, whether or not such Options or the right to convert or exchange any Convertible Securities issuable upon the exercise of such Options are immediately exercisable,
                  and the price per share (determined as provided in this <u>Section 3(b)(i)</u> and in <u>Section 3(b)(v)</u>) for which Ordinary Shares (or equivalent securities) are issuable upon the exercise of such Options or upon the conversion or
                  exchange of Convertible Securities issuable upon the exercise of such Options is less than the Exercise Price in effect immediately prior to the time of the granting or sale of such Options, then the total maximum number of Ordinary
                  Shares (or equivalent securities) issuable upon the exercise of such Options or upon conversion or exchange of the total maximum amount of Convertible Securities issuable upon the exercise of such Options shall be deemed to have been
                  issued as of the date of granting or sale of such Options (and thereafter shall be deemed to be outstanding for purposes of adjusting the Exercise Price under <u>Section 3(a)</u>), at a price per share equal to the quotient obtained by <u>dividing</u>:</div>
                <div style="line-height: 1.25">&#160;</div>
                <div>
                  <div style="text-align: justify; text-indent: 36pt; margin-left: 113pt; line-height: 1.25;">(A) the&#160; sum&#160; (which&#160; sum&#160; shall&#160; constitute&#160; the&#160; applicable consideration received for purposes of <u>Section 3(a)</u>) of (1) the total
                    amount, if any, received or receivable by the Company as consideration for the granting or sale of all such Options, <u>plus</u> (2) the minimum aggregate amount of additional consideration payable to the Company upon the exercise of
                    all such Options, <u>plus</u> (3), in the case of such Options which relate to Convertible Securities, the minimum aggregate amount of additional consideration, if any, payable to the Company upon the issuance or sale of all such
                    Convertible Securities and the conversion or exchange of all such Convertible Securities, <u>by</u></div>
                  <div style="text-align: justify; text-indent: 36pt; margin-left: 113pt; line-height: 1.25;"><u> <br>
                    </u></div>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 113pt; line-height: 1.25;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the total maximum number of Ordinary Shares issuable upon the exercise of all such Options or upon the conversion or exchange of all
                  Convertible Securities issuable upon the exercise of all such Options.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 77pt; line-height: 1.25;">Except as otherwise provided in <u>Section 3(b)(iii)</u>, no further adjustment of the Exercise Price shall be made upon the actual issuance of
                  Ordinary Shares (or equivalents) or of Convertible Securities upon exercise of such Options or upon the actual issuance of Ordinary Shares (or equivalents) upon conversion or exchange of Convertible Securities issuable upon exercise of
                  such Options.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Issuance of Convertible Securities</u>. If the Company shall, at any time or from time to time after the Issue Date, in any manner
                  grant or sell (whether directly or by assumption in a merger or otherwise) any Convertible Securities, whether or not the right to convert or exchange any such Convertible Securities is immediately exercisable, and the price per share
                  (determined as provided in this <u>Section 3(b)(ii)</u> and in <u>Section 3(b)(v)</u>) for which Ordinary Shares (or equivalent securities) are issuable upon the conversion or exchange of such Convertible Securities is less than the
                  Exercise Price in effect immediately prior to the time of the granting or sale of such Convertible Securities, then the total maximum number of Ordinary Shares issuable upon conversion or exchange of the total maximum amount of such
                  Convertible Securities shall be deemed to have been issued as of the date of granting or sale of such Convertible Securities (and thereafter shall be deemed to be outstanding for purposes of adjusting the Exercise Price pursuant to
                  Section 3(a)), at a price per share equal to the quotient obtained by <u>dividing</u>:</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 113pt; line-height: 1.25;">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the sum (which sum shall constitute the applicable consideration received for purposes of <u>Section 3(a)</u>) of (1) the total
                  amount, if any, received or receivable by the Company as consideration for the granting or sale of such Convertible Securities, <u>plus</u> (2) the minimum aggregate amount of additional consideration, if any, payable to the Company upon
                  the conversion or exchange of all such Convertible Securities, <u>by</u></div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 113pt; line-height: 1.25;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the total maximum number of Ordinary Shares (or equivalent securities) issuable upon the conversion or exchange of all such Convertible
                  Securities.</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 113pt; line-height: 1.25;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 77pt; line-height: 1.25;">Except as otherwise provided in <u>Section 3(b)(iii)</u>, (A) no further adjustment of the Exercise Price shall be made upon the actual issuance
                  of Ordinary Shares (or equivalents) upon conversion or exchange of such Convertible Securities and (B) no further adjustment of the Exercise Price shall be made by reason of the issue or sale of Convertible Securities upon exercise of any
                  Options to purchase any such Convertible Securities for which adjustments of the Exercise Price have been made pursuant to the other provisions of this <u>Section 3(b)</u>.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 77pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Change in Terms of Options or Convertible Securities</u>. Upon any change in any of (A) the total amount
                  received or receivable by the Company as consideration for the granting or sale of any Options or Convertible Securities referred to in <u>Section 3(b)(i)</u> or <u>(ii)</u>, (B) the minimum aggregate amount of additional consideration,
                  if any, payable to the Company upon the exercise of any Options or upon the issuance, conversion or exchange of any Convertible Securities referred to in <u>Section 3(b)(i)</u> or <u>(ii)</u>, (C) the rate at which Convertible
                  Securities referred to in <u>Section 3(b)(i)</u> or <u>(ii)</u> are convertible into or exchangeable for Ordinary Shares (or equivalent securities), or (D) the maximum number of Ordinary Shares (or equivalent securities) issuable in
                  connection with any Options referred to in <u>Section 3(b)(i)</u> or any Convertible Securities referred to in <u>Section 3(b)(ii)</u> (in each case, other than in connection with an Excluded Issuance), then (whether or not the original
                  issuance or sale of such Options or Convertible Securities resulted in an adjustment to the Exercise Price pursuant to this <u>Section 3</u>) the Exercise Price in effect at the time of such change shall be adjusted or readjusted, as
                  applicable, to the Exercise Price which would have been in effect at such time pursuant to the provisions of this <u>Section 3</u> had such Options or Convertible Securities still outstanding provided for such changed consideration,
                  conversion rate or maximum number of shares, as the case may be, at the time initially granted, issued or sold, but only if as a result of such adjustment or readjustment the Exercise Price then in effect is reduced.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 77pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Treatment of Expired or Terminated Options or Convertible</u>&#160;<u>Securities</u>. Upon the expiration or
                  termination of any unexercised Option (or portion thereof) or any unconverted or unexchanged Convertible Security (or portion thereof) for which any adjustment (either upon its original issuance or upon a revision of its terms) was made
                  pursuant to this <u>Section 3</u> (including without limitation upon the redemption or purchase for consideration of all or any portion of such Option or Convertible Security by the Company), the Exercise Price then in effect hereunder
                  automatically shall be changed to the Exercise Price which would have been in effect at the time of such expiration or termination had such unexercised Option (or portion thereof) or unconverted or unexchanged Convertible Security (or
                  portion thereof), to the extent outstanding immediately prior to such expiration or termination, never been issued.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Calculation of Consideration Received</u>. If the Company shall, at any time or from time to time after the Issue Date, issue or
                  sell, or pursuant to <u>Section 3(b)</u> be deemed to have issued or sold, any Ordinary Shares, Options or Convertible Securities: (A) for cash, the consideration received therefor shall be deemed to be the net amount received by the
                  Company therefor; (B) for Marketable Securities, the amount of consideration received therefor shall be deemed to be the market price (as reflected on any securities exchange, quotation system or association or similar pricing system
                  covering such security) for such securities as of the end of business on the date of receipt of such securities; (C) for consideration other than cash or Marketable Securities, the amount of consideration received therefor shall be deemed
                  to be the fair value of such consideration; (D) for no specifically allocated consideration in connection with an issuance or sale of other securities of the Company, together comprising one integrated transaction, the amount of
                  consideration received therefor shall be deemed to be to be the fair value of such portion of the aggregate consideration received by the Company in such transaction as is attributable to such Ordinary Shares, Options or Convertible
                  Securities, as the case may be, issued in such transaction; or (E) to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving corporation, the amount of consideration received therefor
                  shall be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such Ordinary Shares, Options or Convertible Securities, as the case may be, issued to such owners. The
                  net amount of any cash consideration and the fair value of any consideration other than cash or Marketable Securities shall be determined in accordance with Section 1028 of the Companies Act and, to the extent necessary or required, in
                  good faith jointly by the Board of Directors of the Company and the Holder.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Record Date</u>. For purposes of any adjustment to the Exercise Price or the number of Warrant ADSs in accordance with this <u>Section







                    3</u>, or any adjustment to the number of Warrant ADSs pursuant to <u>Section 3(c</u>) or <u>3(d</u>), in case the Company shall take a record of the holders of its Ordinary Shares (or equivalent securities) for the purpose of
                  entitling them (A) to receive a dividend or other distribution payable in Ordinary Shares, Options or Convertible Securities or (B) to subscribe for or purchase Ordinary Shares, Options or Convertible Securities, then such record date
                  shall be deemed to be the date of the issue or sale of the Ordinary Shares deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such right of
                  subscription or purchase, as the case may be.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Treasury Shares</u>. The number of Ordinary Shares (or equivalent securities) outstanding at any given time shall not include
                  shares owned or held by or for the account of the Company or any of its wholly-owned subsidiaries, and the disposition of any such shares (other than the cancellation or retirement thereof or the transfer of such shares among the Company
                  and its wholly-owned subsidiaries) shall be considered an issue or sale of Ordinary Shares for the purpose of this <u>Section 3</u>.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price and Warrant ADSs Upon Dividend,</u>&#160;<u>Subdivision or Combination of Ordinary Shares</u>. If the Company
                  shall, at any time or from time to time after the Issue Date, (i) pay a dividend or make any other distribution upon the Ordinary Shares or any other capital stock of the Company payable in Ordinary Shares or in Options or Convertible
                  Securities, or (ii) subdivide (by any stock split, recapitalization or otherwise) its outstanding Ordinary Shares (or equivalent securities) into a greater number of shares, the Exercise Price in effect immediately prior to any such
                  dividend, distribution or subdivision shall be proportionately reduced and the number of Warrant ADSs (represented by ADRs) issuable upon exercise of this Warrant Certificate shall be proportionately increased. If the Company at any time
                  combines (by combination, reverse stock split or otherwise) its outstanding Ordinary Shares (or equivalent securities) into a smaller number of shares, the Exercise Price in effect immediately prior to such combination shall be
                  proportionately increased and the number of Warrant ADSs (represented by ADRs) issuable upon exercise of this Warrant Certificate shall be proportionately decreased. Any adjustment under this <u>Section 3(c)</u> shall become effective at
                  the close of business on the date the dividend, subdivision or combination becomes effective.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price and Warrant ADSs Upon Reorganization,</u>&#160;<u>Reclassification, Consolidation or Merger</u>. Unless the
                  Holder otherwise consents (in its sole discretion), in the event of any (A) capital reorganization of the Company,</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;">(B) reclassification of the stock of the Company (other than a change in par value or from par value to no par value or from no par value to par
                  value or as a result of a stock dividend or subdivision, split-up or combination of shares), (C) Fundamental Transaction or</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;">(D) other similar transaction (other than any such transaction covered by <u>Section 3(c)</u>), in each case which entitles the holders of
                  Ordinary Shares (or equivalent securities) to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect to or in exchange for Ordinary Shares (or equivalent securities):</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;this Warrant Certificate shall, immediately after such transaction, remain outstanding and shall thereafter, in lieu of or in addition
                  to (as the case may be) the number of Warrant ADSs (represented by ADRs) then exercisable under this Warrant Certificate, be exercisable for the kind and number of shares of stock or other securities or assets of the Company or of the
                  successor Person resulting from such transaction to which the Holder would have been entitled upon such transaction if the Holder had exercised this Warrant Certificate in full immediately prior to the time of such transaction and
                  acquired the applicable number of Warrant ADSs (represented by ADRs) then issuable hereunder as a result of such exercise (without taking into account any limitations or restrictions on the exercisability of this Warrant Certificate); and</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;appropriate adjustment (in form and substance satisfactory to the Holder) shall be made with respect to the Holder&#8217;s rights under this
                  Warrant Certificate to insure that the provisions of this <u>Section 3</u> shall thereafter be applicable, as nearly as possible, to this Warrant Certificate in relation to any shares of stock, securities or assets thereafter acquirable
                  upon exercise of this Warrant Certificate (including, in the case of any transaction in which the successor or purchasing Person is other than the Company, an immediate adjustment in the Exercise Price to the value per share for the
                  Ordinary Shares (or equivalent securities) reflected by the terms of such transaction, and a corresponding adjustment immediately shall be made to the number of Warrant ADSs acquirable upon exercise of this Warrant Certificate, without
                  regard to any limitations or restrictions on exercise, if the value so reflected is less than the Exercise Price in effect immediately prior to such transaction).</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 77pt; line-height: 1.25;"><br>
                </div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;">The provisions of this <u>Section 3(d)</u> shall similarly apply to successive reorganizations, reclassifications, Fundamental Transactions or
                  similar transactions.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;">Notwithstanding anything to the contrary contained herein, with respect to any corporate event or other transaction contemplated by this <u>Section

                    3(d)</u>, the Holder shall have the right to elect, prior to the consummation of such event or transaction, to exercise this Warrant instead of giving effect to <u>Section 3(d)</u>.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Other Dividends and Distributions</u>. If the Company shall, at any time or from time to time after the Issue Date, make or declare,
                  or fix a record date for the determination of holders of Ordinary Shares (or equivalent securities) entitled to receive, a dividend or any other distribution payable in cash, securities of the Company (other than a dividend or
                  distribution of shares of Ordinary Shares, Options or Convertible Securities in respect of outstanding Ordinary Shares (or equivalent securities)) or other property, then, and in each such event, the Company shall ensure that provisions
                  are made so that the Holder shall receive upon exercise of this Warrant Certificate, in addition to the number of Warrant ADSs (represented by ADRs) receivable thereupon, the kind and amount of cash, securities of the Company or other
                  property which the Holder would have been entitled to receive had this Warrant Certificate been exercised in full into Warrant ADSs (represented by ADRs) on the date of such event and had the Holder thereafter, during the period from the
                  date of such event to and including the date of exercise, retained such cash, securities or other property receivable by them as aforesaid during such period, giving application to all adjustments called for during such period under this
                  <u>Section 3</u> with respect to the rights of the Holder; <font style="font-style: italic;">provided </font>that no such provision shall be made if the Holder receives, simultaneously with the distribution to the holders of Ordinary
                  Shares (or equivalent securities), a dividend or other distribution of such securities, cash or other property in an amount equal to the amount of such securities, cash or other property as the Holder would have received if this Warrant
                  Certificate had been exercised in full into Warrant ADSs (represented by ADRs) on the date of such event.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Certain Events</u>. If any event of the type contemplated by the provisions of this <u>Section 3</u> but not expressly provided for
                  by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features in each case, other than with respect to any Excluded Issuance) occurs, then the Board
                  of Directors of the Company shall make an appropriate adjustment in the Exercise Price of this Warrant Certificate so as to protect the rights of the Holder in a manner consistent with the provisions of this <u>Section 3</u>; <font style="font-style: italic;">provided </font>that (i) no such adjustment pursuant to this <u>Section 3(f)</u> shall increase the Exercise Price or decrease the number of Warrant ADSs (represented by ADRs) issuable as otherwise
                  determined pursuant to this <u>Section 3</u> and (ii) for the avoidance of doubt, no adjustment pursuant to this <u>Section 3(f)</u> shall be made in connection with an Excluded Issuance.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25;">
                  <div>
                    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;"> (g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Certificate as to Adjustment</u>. As promptly as reasonably practicable following any adjustment of the Exercise Price, but in
                      any event not later than three business days thereafter, the Company shall furnish to the Holder a certificate of an executive officer setting forth in reasonable detail such adjustment and the facts upon which it is based and
                      certifying the calculation thereof. As promptly as reasonably practicable following the receipt by the Company of a written request by the Holder, but in any event not later than three business days thereafter, the Company shall
                      furnish to the Holder a certificate of an executive officer certifying the Exercise Price then in effect and the number of Warrant ADSs or the amount, if any, of other shares of stock, securities or assets then issuable upon exercise
                      of this Warrant Certificate. Upon request of the Holder, the Company shall issue a replacement Warrant Certificate reflecting the as-adjusted number of Warrant ADSs and the then-applicable Exercise Price, as set forth in Section
                      5(b)(iii).</div>
                  </div>
                </div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Change in ADS Ratio</u>. If, after the Issue Date, the ADS Ratio is increased or reduced, then the number of Warrant ADSs
                  (represented by ADRs) to be issued on exercise of this Warrant Certificate will be reduced or increased (respectively) in inverse proportion to the change in the ADS Ratio, and the Exercise Price per Warrant ADS will be increased or
                  reduced (respectively) in proportion to the change in the number Ordinary Shares issuable per ADS, so that the aggregate Exercise Price remains unchanged.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding, the Company effects a Fundamental Transaction, then,
                  upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant ADS (represented by an ADR) that would have been issuable upon such exercise immediately prior to the occurrence of such
                  Fundamental Transaction, at the option of the Holder (without regard to any limitation in <u>Section 2(e)</u> on the exercise of this Warrant), the number of Ordinary Shares (or other securities) of the successor or acquiring corporation
                  or of the Company, if it is the surviving corporation, and any additional consideration (the &#8220;<u>Alternate</u>&#160;<u>Consideration</u>&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of Ordinary Shares (or
                  equivalent securities) for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in <u>Section 2(e)</u> on the exercise of this Warrant). For purposes of any such exercise,
                  the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one (1) Ordinary Share in such Fundamental Transaction,
                  and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Ordinary Shares (or
                  equivalent securities) are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise
                  of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;<u>Successor Entity</u>&#8221;) to assume in writing all of the
                  obligations of the Company under this Warrant pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and
                  shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
                  for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Ordinary Shares (or equivalent securities) acquirable and receivable upon exercise of this Warrant (without regard to
                  any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the Exercise Price hereunder to such shares of capital stock (but taking into account the relative value of
                  the Ordinary Shares (or equivalent securities) pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such Exercise Price being for the purpose of protecting the
                  economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the
                  Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &#8220;Company&#8221; shall refer instead to the Successor Entity), and may
                  exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;"><br>
                </div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Calculations</u>. All calculations under this <u>Section 3</u> shall be made to the nearest cent or the nearest 1/100th of a share,
                  as the case may be. For purposes of this <u>Section 3</u>, the number of Ordinary Shares (or equivalent securities) deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (or equivalent
                  securities) (excluding treasury shares, if any) issued and outstanding.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 41pt; line-height: 1.25;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution
                  in whatever form) on its Ordinary Shares (or equivalent securities), (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of its Ordinary Shares (or equivalent securities), (C) the Company shall authorize
                  the granting to all holders of its Ordinary Shares (or equivalent securities) rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company
                  shall be required in connection with any reclassification of its Ordinary Shares (or equivalent securities), any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of
                  the Company, or any compulsory share exchange whereby its Ordinary Shares (or equivalent securities) are converted into other securities, cash or property, (E) the Company shall authorize the voluntary or involuntary dissolution,
                  liquidation or winding up of the affairs of the Company, or (F) the Company seeks to engage in a Fundamental Transaction, then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon
                  the Warrant Register (as defined below) of the Company, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
                  purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of its Ordinary Shares of record to be entitled to such dividend, distributions, redemption,
                  rights or warrants are to be determined or (y) the date on which such Fundamental Transaction, reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it
                  is expected that holders of its Ordinary Shares (or equivalent securities) of record shall be entitled to exchange their Ordinary Shares (or equivalent securities) for securities, cash or other property deliverable upon such Fundamental
                  Transaction, reclassification, consolidation, merger, sale, transfer or share exchange; <font style="font-style: italic;">provided </font>that the failure to mail such notice or any defect therein or in the mailing thereof shall not
                  affect the validity of the corporate action required to be specified in such notice. To the extent that any notice required to be provided hereunder may contain information that constitutes material, non-public information regarding the
                  Company or any of its subsidiaries, the Company shall obtain the Holder&#8217;s prior consent to receipt of such notice. If the Holder declines to receive any such notice pursuant to the immediately preceding sentence, the Company shall not be
                  deemed to have breached its obligation to deliver such notice hereunder. The Holder shall remain entitled to exercise this Warrant during the 20-day period commencing on the date of such notice through the effective date of the event
                  triggering such notice except as may otherwise be expressly set forth herein.</div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;"><br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;"><br>
                </div>
                <div style="text-align: justify; margin-left: 41pt; line-height: 1.25;"><u>Section 4.</u>&#160;&#160; <u>Registration Rights</u>.</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                    <tr>
                      <td style="width: 77pt;"><br>
                      </td>
                      <td style="width: 35.95pt; vertical-align: top;">(a)</td>
                      <td style="width: auto; vertical-align: top;">
                        <div><u>Registration</u>.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall prepare and file or cause to be prepared and filed with the Commission, no later than April 30, 2025 (the &#8220;<u>Filing
                    Deadline</u>&#8221;), a registration statement for an offering to be made on a continuous basis pursuant to Rule 415 of the Securities Act registering the resale from time to time by the Holder of all Registrable Securities held by the Holder
                  (the &#8220;<u>Resale Registration</u>&#160;<u>Statement</u>&#8221;). The Resale Registration Statement shall be on Form F-3 or, if the use of Form F-3 is not then available to the Company, on Form F-1 or such other appropriate form permitting
                  registration of such Registrable Securities for resale by the Holder. The Company shall use reasonable best efforts to cause the Resale Registration Statement to be declared effective as soon as possible after filing, but in no event
                  shall the Resale Registration Statement be declared effective later than the earlier of (i) sixty (60) days following the Filing Deadline or (ii) ten (10) Business Days after the Commission notifies the Company that it will not review the
                  Resale Shelf Registration Statement, if applicable (the &#8220;<u>Effectiveness</u>&#160;<u>Deadline</u>&#8221;); provided, that the Effectiveness Deadline shall be extended by no more than ninety (90) days after the Filing Deadline if the Registration
                  Statement is reviewed by, and receives comments from, the Commission. Once effective, the Company shall keep the Resale Registration Statement continuously effective and supplemented and amended to the extent necessary to ensure that such
                  Registration Statement is available or, if not available, to ensure that another registration statement is available, under the Securities Act at all times until such date as all Registrable Securities covered by the Resale Registration
                  Statement have been disposed of in accordance with the intended method(s) of distribution set forth in such Registration Statement or such securities have been withdrawn (the &#8220;<u>Effectiveness Period</u>&#8221;). The Resale Registration
                  Statement shall contain a prospectus in such form as to permit the Holder to sell such Registrable Securities pursuant to Rule 415 under the Securities Act (or any successor or similar provision adopted by the Commission then in effect)
                  at any time beginning on the effective date for such Registration Statement, and shall provide that such Registrable Securities may be sold pursuant to any method or combination of methods legally available to, and requested by, the
                  Holder.</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">18</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall notify the Holder in writing of the effectiveness of the Resale Registration Statement as soon as practicable, and in
                  any event within one (1) Business Day after the Resale Registration Statement becomes effective, and shall furnish to Holder, without charge, such number of copies of the Resale Registration Statement (including any amendments,
                  supplements and exhibits), the prospectus contained therein (including each preliminary prospectus and all related amendments and supplements) and any documents incorporated by reference in the Resale Shelf Registration Statement or such
                  other documents as the Holder may reasonably request in order to facilitate the sale of the Registrable Securities in the manner described in the Resale Registration Statement.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 77pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the provisions of <u>Section 4(a)(i)</u> above, the Company shall promptly prepare and file with the
                  Commission from time to time such amendments and supplements to (or replacements of) the Resale Registration Statement and prospectus used in connection therewith as may be necessary to keep the Resale Registration Statement (or
                  replacements thereof) effective and to comply with the provisions of the Securities Act with respect to the disposition of all the Registrable Securities during the Effectiveness Period. If any Resale Registration Statement filed pursuant
                  to <u>Section 4(a)(i)</u> is filed on Form F-3 and thereafter the Company becomes ineligible to use such registration statement for secondary sales, the Company shall promptly notify the Holder of such ineligibility and shall file a
                  shelf registration on Form F-1 or other appropriate form as promptly as practicable (but no later than 14 calendar days after becoming ineligible to use Form F-3) to replace the Resale Registration Statement and use its best efforts to
                  have the such replacement Resale Registration Statement declared effective as promptly as practicable and shall cause such replacement Resale Registration Statement to remain effective, and to be supplemented and amended to the extent
                  necessary to ensure that such Resale Shelf Registration Statement is available or, if not available, that another Resale Registration Statement is available, for the resale of all the Registrable Securities held by the Holder until all
                  such Registrable Securities have been sold; provided, however, that at any time the Company once again becomes eligible to use Form F-3, the Company shall cause such replacement Resale Registration Statement to be amended, or shall file a
                  new replacement Resale Registration Statement, such that the Resale Registration Statement is once again on Form F-3.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company represents and warrants that there are sufficient ADRs registered on a registration statement on Form F-6 and available for
                  issuance in respect of all Warrant ADSs issuable hereunder, and the Company covenants that it will cause a sufficient number of ADRs to remain registered on a registration statement on Form F-6 and available for issuance to satisfy the
                  Company&#8217;s obligations hereunder at all times that this Warrant is outstanding.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">19</font></div>
                  <div class="BRPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div>
                  <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Rule 144 Reporting.</u> With a view to making available to the Holder the benefits of Rule 144 and any other rule or regulation of
                    the Commission that may at any time permit the Holder to sell securities of the Company to the public without registration or pursuant to a registration on a Shelf Form, the Company shall make and keep available adequate current public
                    information, as those terms are understood and defined in Rule 144.</div>
                </div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 41pt; line-height: 1.25;"><u>Section 5.</u>&#160;&#160; <u>Transfer of Warrant</u>.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transferability</u>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including,
                  without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant
                  substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment,
                  the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor
                  a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
                  the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within two (2) Trading Days of the date the Holder delivers to the Company a completed Assignment Form
                  in the form attached hereto duly executed by the Holder assigning all or any portion of this Warrant. This Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant ADSs
                  (represented by ADRs) without having a new Warrant issued.</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                    <tr>
                      <td style="width: 77pt;"><br>
                      </td>
                      <td style="width: 35.95pt; vertical-align: top;">(b)</td>
                      <td style="width: auto; vertical-align: top;">
                        <div><u>Replacement Warrants</u>.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
                  with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with <u>Section 5(a)</u>, as to any transfer which may be involved
                  in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or
                  exchanges shall be dated as of the Issue Date and shall be identical with this Warrant except as to the number of Warrant ADSs (represented by ADRs) issuable pursuant thereto.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and upon
                  delivery of an indemnity reasonably satisfactory to it (it being understood that a written indemnification agreement or affidavit of loss of the Holder shall be a sufficient indemnity) and, in case of mutilation, upon surrender of such
                  Warrant for cancellation to the Company, the Company at its own expense shall execute and deliver to the Holder, in lieu hereof, a new Warrant of like tenor and exercisable for an equivalent number of Warrant ADSs (represented by ADRs) as
                  this Warrant so lost, stolen, mutilated or destroyed; <font style="font-style: italic;">provided that</font>, in the case of mutilation, no indemnity shall be required if this Warrant in identifiable form is surrendered to the Company
                  for cancellation.</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">20</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon request by the Holder and surrender of this Warrant Certificate to the Company for replacement, the Company, at its own expense,
                  shall execute and deliver to the Holder in replacement of this Warrant Certificate a new Warrant Certificate of like tenor and exercisable for such number of Warrant ADSs (represented by ADRs) and at such Exercise Price as this Warrant
                  shall be exercisable for immediately prior to such request, after taking into account any adjustments to the number of Warrant ADSs and the Exercise Price has may have been made pursuant to the terms hereof.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transferee Representations</u>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the
                  transfer of this Warrant shall not be eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer,
                  that the Holder or transferee of this Warrant, as the case may be, deliver a written statement from the transferee to the Company certifying that the transferee is an &#8220;accredited investor&#8221; as defined in Rule 501(a) under the Securities
                  Act, making the representations and certifications set forth in <u>Section 5(e)</u> of this Warrant and making such additional representations as the Company may, after consultation with its counsel, require in order to confirm
                  compliance with applicable securities laws.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;<u>Warrant








                    Register</u>&#8221;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to
                  the Holder, and for all other purposes, absent actual notice to the contrary.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Representation by the Holder</u>. The Holder, by the acceptance hereof, represents and warrants that (i) it is an &#8220;accredited
                  investor&#8221; as defined in Rule 501(a) under the Securities Act and (ii) it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant ADSs (represented by ADRs) issuable upon such exercise, for its own account and not
                  with a view to or for distributing or reselling such Warrant ADSs (represented by ADRs) or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under
                  the Securities Act.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="margin-left: 41pt; line-height: 1.25;"><u>Section 6.</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Miscellaneous</u>.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Rights as Stockholder Until Exercise; No Settlement in Cash</u>. This Warrant does not entitle the Holder to any voting rights,
                  dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth herein. Without limiting the rights of a Holder to receive Warrant ADSs (represented by ADRs) on a &#8220;cashless exercise,&#8221; in no event will
                  the Company be required to net cash settle an exercise of this Warrant.</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">21</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;"><br>
                </div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Removal of Restrictive Legends</u>. Neither this Warrant nor any certificates or ADRs evidencing Warrant ADSs shall contain any
                  legend restricting the transfer thereof in any of the following circumstances: (A) following any sale of this Warrant or such Warrant ADSs (represented by ADRs) issued or delivered to the Holder under or in connection herewith pursuant to
                  Rule 144, (B) if this Warrant or such Warrant ADSs (represented by ADRs) are eligible for sale under Rule 144(b)(1), or (C) if such legend is not required under applicable requirements of the Securities Act (including judicial
                  interpretations and pronouncements issued by the staff of the Commission and including due to such securities being covered by a valid registration statement) (collectively, the &#8220;<u>Unrestricted Conditions</u>&#8221;). In such circumstances,
                  the Company shall seek to cause its counsel to issue a legal opinion to the Transfer Agent or Depositary, as applicable, if required by such Transfer Agent or Depositary to effect the issuance of Warrant ADSs (represented by ADRs),
                  without a restrictive legend or removal of the legend hereunder. If the Unrestricted Conditions are met at the time of issuance of this Warrant, the Warrant ADSs or such other securities of the Company issuable in connection with this
                  Warrant, then this Warrant, Warrant ADSs or other securities, as the case may be, shall be issued free of all legends.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Replacement Warrant</u>. The Company agrees that at such time as the Unrestricted Conditions have been satisfied it shall promptly
                  (but in any event within ten (10) business days) following written request from the Holder issue a replacement Warrant or replacement Warrant ADSs (represented by ADRs), or replacement shares in respect of such other securities, as the
                  case may be, free of all restrictive legends (&#8220;<u>Unlegended Shares</u>&#8221;).</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Authorized Shares</u>. The Company covenants that, during the period this Warrant is outstanding, it will reserve from its authorized
                  and unissued Ordinary Shares a sufficient number of Ordinary Shares to provide for the issuance of the Ordinary Shares and ADSs underlying this Warrant upon the exercise of any purchase rights under this Warrant. The Company further
                  covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Ordinary Shares and ADSs upon the exercise of the purchase rights under this Warrant. The
                  Company will take all such action as may be necessary, including giving directions to the Depositary, to assure that the Warrant ADSs (represented by ADRs) and the underlying Ordinary Shares may be issued as provided herein without
                  violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the ADSs (represented by ADRs) are then listed. The Company covenants that all Warrant ADSs (represented by ADRs) and all Ordinary
                  Shares underlying the Warrant ADSs will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant ADSs in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free
                  from all taxes, rights of pre-emption, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">22</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Impairment</u>. Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including,
                  without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the
                  observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights
                  of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) take all such action as may be necessary or appropriate in order that the Company may validly and legally
                  issue unrestricted, fully paid and nonassessable Warrant ADSs (represented by ADRs) upon the exercise of this Warrant, and (ii) use best efforts to obtain all such authorizations, exemptions or consents from any public regulatory body
                  having jurisdiction thereof, as may be necessary to enable the Company to perform its obligations under this Warrant. Before taking any action which would result in an adjustment in the number of Warrant ADSs for which this Warrant is
                  exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rule 144 Compliance</u>. With a view to making available to the Holder the benefits of Rule 144 under the Securities Act and any
                  other rule or regulation of the SEC that may at any time permit a holder to sell securities of the Company to the public without registration or pursuant to a Registration Statement, the Company shall:</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;make and keep public information available, as those terms are understood and defined in Rule 144 under the Securities Act;</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;use reasonable best efforts to file with the SEC in a timely manner all reports and other documents required of the Company under the
                  Securities Act and the Exchange Act; and</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;furnish to the Holder, promptly upon request, a written statement by the Company as to its compliance with the reporting requirements
                  of Rule 144 under the Securities Act and of the Securities Act and the Exchange Act, a copy of the most recent annual or quarterly report of the Company, and such other reports and documents so filed or furnished by the Company as such
                  holder may reasonably request in connection with the sale of Warrant ADSs (represented by ADRs) without registration.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Governing Law</u>. This Warrant and the rights and obligations of the parties hereunder shall be governed by, and construed in
                  accordance with, the law of the State of New York, without regard to principles of conflicts of laws that would result in the application of the laws of any other jurisdiction.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 41pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Submission to Jurisdiction</u>. The Company agrees that any suit, action or proceeding with respect to this
                  Warrant or any judgment entered by any court in respect thereof may be brought initially in the federal or state courts in New York, New York or in the courts of its own corporate domicile and irrevocably submits to the exclusive
                  jurisdiction of each such court for the purpose of any such suit, action, proceeding or judgment. This Section is for the benefit of the Holder only and, as a result, the Holder shall not be prevented from taking proceedings in any other
                  courts with jurisdiction. To the extent allowed by any applicable law, the Holder may take concurrent proceedings in any number of jurisdictions.</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 41pt; line-height: 1.25;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">23</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Waiver of Venue, Etc</u>. The Company irrevocably waives to the fullest extent permitted by law any objection that it may now or
                  hereafter have to the laying of the venue of any suit, action or proceeding arising out of or relating to this Warrant and hereby further irrevocably waives to the fullest extent permitted by law any claim that any such suit, action or
                  proceeding brought in any such court has been brought in an inconvenient forum. A final judgment (in respect of which time for all appeals has elapsed) in any such suit, action or proceeding shall be conclusive and may be enforced in any
                  court to the jurisdiction of which the Company is or may be subject, by suit upon judgment.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 41pt; line-height: 1.25;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Waiver of Jury Trial</u>. THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED
                  BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS WARRANT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Waiver</u>. No failure on the part of the Holder to exercise and no delay in exercising, and no course of dealing with respect to,
                  any right, power or privilege under this Warrant shall operate as a waiver thereof, nor shall any single or partial exercise of any right, power or privilege under this Warrant preclude any other or further exercise thereof or the
                  exercise of any other right, power or privilege. The remedies provided herein are cumulative and not exclusive of any remedies provided by law.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Expenses</u>. If the Company fails to comply with any provision of this Warrant, which results in any material damages to the Holder,
                  the Company shall pay to the Holder such amounts as shall be sufficient to cover any actual, reasonable and documented attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due
                  pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>. All notices, requests, instructions, directions and other communications provided for herein (including any
                  modifications of, or waivers, requests or consents under, this Warrant) shall be given or made in writing (including by telecopy or email) delivered, if to the Company or the Holder, to its address specified on the signature pages hereto,
                  or at such other address as shall be designated by such party in a written notice to the other party. Except as otherwise provided in this Warrant, all such communications shall be deemed to have been duly given upon receipt of a legible
                  copy thereof, in each case given or addressed as aforesaid. All such communications provided for herein by telecopy shall be confirmed in writing promptly after the delivery of such communication (it being understood that non-receipt of
                  written confirmation of such communication shall not invalidate such communication).</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">24</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Limitation of Liability</u>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to
                  purchase Warrant ADSs (represented by ADRs), and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any ADSs (represented by ADRs) or any Ordinary
                  Shares or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Remedies</u>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be
                  entitled to seek specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and
                  hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successors and Assigns</u>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
                  be binding upon and inure to the benefit of the successors and permitted assigns of the Company and the successors and permitted assigns of the Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from
                  time to time of this Warrant and shall be enforceable by the Holder or any holder of Warrant ADSs (represented by ADRs).</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendments, Etc</u>. Except as otherwise expressly provided in this Warrant, any provision of this Warrant may be modified or
                  supplemented only by an instrument in writing signed by the Company and the Holder.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Severability</u>. If any provision hereof is found by a court to be invalid or unenforceable, to the fullest extent permitted by any
                  applicable law the parties agree that such invalidity or unenforceability shall not impair the validity or enforceability of any other provision hereof.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Currency</u>. Unless otherwise indicated, all dollar amounts referred to in this Warrant are in United States Dollars (&#8220;<u>US Dollars</u>&#8221;).









                  All amounts owing under this Warrant shall be paid in US Dollars. All amounts denominated in other currencies shall be converted in the US Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. &#8220;<u>Exchange







                    Rate</u>&#8221; means, in relation to any amount of currency to be converted into US Dollars pursuant to this Warrant, the US Dollar exchange rate as published in the Wall Street Journal (NY edition) on the relevant date of calculation.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Captions</u>. The captions and section headings appearing herein are included solely for convenience of reference and are not
                  intended to affect the interpretation of any provision of this Warrant.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Counterparts</u>. This Warrant may be executed in any number of counterparts, all of which taken together shall constitute one and
                  the same instrument and any of the parties hereto may execute this Warrant by signing any such counterpart.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: center; margin-right: 62.05pt; margin-left: 61.15pt; line-height: 1.25;">(Signature Page Follows)</div>
                <div style="text-align: center; margin-right: 62.05pt; margin-left: 61.15pt; line-height: 1.25;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">25</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <br>
                <div style="text-indent: 33.5pt; margin-left: 5.05pt; margin-top: 0.05pt;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as a Deed on the date first above indicated.</div>
                <br>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td style="width: 50.00%;">
                        <div>&#160;</div>
                      </td>
                      <td style="width: 50%;">
                        <div><font style="font-weight: bold;">GIVEN <font style="font-family: 'Times New Roman',Times,serif;">UNDER THE COMMON SEAL </font></font>
                          <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-weight: bold;">OF TRINITY BIOTECH PLC</div>
                          <div style="margin-top: 0.8pt;">
                            <div><img width="302" border="0" height="68" src="image00004.jpg"></div>
                            <div><br>
                            </div>
                            <div>
                              <div style="text-align: left; margin-top: 0.05pt; font-family: 'Times New Roman',Times,serif;">Address for Notices:</div>
                              <div style="margin-top: 1.05pt;"><br>
                              </div>
                              <div style="font-family: 'Times New Roman',Times,serif;">Trinity Biotech plc</div>
                              <div style="font-family: 'Times New Roman',Times,serif;"> IDA Business Park,</div>
                              <div style="font-family: 'Times New Roman',Times,serif;">Bray, Co. Wicklow, Ireland </div>
                              <div style="font-family: 'Times New Roman',Times,serif;">A98 H5C8</div>
                              <div style="font-family: 'Times New Roman',Times,serif;">Attention: John Gillard, CEO </div>
                              <div style="font-family: 'Times New Roman',Times,serif;">Telephone: +353 l 276 9800</div>
                              <div style="font-family: 'Times New Roman',Times,serif;">Email: Lennotice@trinitybiotech.com</div>
                              <div style="margin-top: 1.25pt;"><br>
                              </div>
                              <div style="font-family: 'Times New Roman',Times,serif;">With a copy to (which shall not constitute notice): </div>
                              <div style="font-family: 'Times New Roman',Times,serif;">Carter Ledyard &amp; Milburn LLP</div>
                              <div style="margin-top: 0.4pt; font-family: 'Times New Roman',Times,serif;">2 Wall Street, New York, NY 10005 </div>
                              <div style="margin-top: 0.4pt; font-family: 'Times New Roman',Times,serif;">Attention: Steven J. Glusband, Esq.</div>
                              <div style="margin-top: 0.15pt; font-family: 'Times New Roman',Times,serif;">Email: glusband@clm.com</div>
                            </div>
                          </div>
                        </div>
                      </td>
                    </tr>

                </table>
                <div style="margin-top: 0.8pt;"><br>
                </div>
                <div style="margin-top: 0.8pt;">
                  <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">[Signature Page to Warrant 3]</div>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="margin-left: 5pt; line-height: 1.25;">Docusign Envelope ID: 7485231E-3091-4EB2-8AFC-54D7011410FE</div>
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td style="width: 5%;"><br>
                      </td>
                      <td colspan="2">
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Accepted and Agreed,</div>
                        <div style="line-height: 1.25;">&#160;</div>
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Perceptive Credit Holdings III, LP</div>
                      </td>
                      <td style="width: 50%;"><br>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 5%;"><br>
                      </td>
                      <td colspan="2" rowspan="1"><br>
                      </td>
                      <td rowspan="1" style="width: 50%;"><br>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 5%;"><br>
                      </td>
                      <td rowspan="1" style="width: 3%;">By:</td>
                      <td rowspan="1" style="width: 42%;">Perceptive Credit Opportunities GP, LLC, its general partner</td>
                      <td rowspan="1" style="width: 50%;"><br>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 5%;"><br>
                      </td>
                      <td rowspan="1" style="width: 3%;"><br>
                      </td>
                      <td rowspan="1" style="width: 42%;"><br>
                      </td>
                      <td rowspan="1" style="width: 50%;"><br>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 5%; padding-bottom: 2px;"><br>
                      </td>
                      <td rowspan="1" style="width: 3%; text-align: left; vertical-align: bottom; padding-bottom: 2px;">By:</td>
                      <td rowspan="1" style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);">
                        <div style="text-align: left; line-height: 1.25;"><img width="106" height="46" src="image1.jpg"></div>
                      </td>
                      <td rowspan="1" style="width: 50%; padding-bottom: 2px;"><br>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 5%;"><br>
                      </td>
                      <td rowspan="1" style="width: 3%;"><br>
                      </td>
                      <td rowspan="1" style="width: 42%;">Name: Sandeep Dixit</td>
                      <td rowspan="1" style="width: 50%;"><br>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 5%;"><br>
                      </td>
                      <td rowspan="1" style="width: 3%;"><br>
                      </td>
                      <td rowspan="1" style="width: 42%;">Title: Chief Credit Officer</td>
                      <td rowspan="1" style="width: 50%;"><br>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 5%;"><br>
                      </td>
                      <td rowspan="1" style="width: 3%;"><br>
                      </td>
                      <td rowspan="1" style="width: 42%;"><br>
                      </td>
                      <td rowspan="1" style="width: 50%;"><br>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 5%; padding-bottom: 2px;"><br>
                      </td>
                      <td rowspan="1" style="width: 3%; padding-bottom: 2px; text-align: left; vertical-align: bottom;">By:</td>
                      <td rowspan="1" style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);">
                        <div style="text-align: left; line-height: 1.25;"><img width="104" height="46" src="image6.jpg"></div>
                      </td>
                      <td rowspan="1" style="width: 50%; padding-bottom: 2px;"><br>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 5%;"><br>
                      </td>
                      <td rowspan="1" style="width: 3%;"><br>
                      </td>
                      <td rowspan="1" style="width: 42%;">Name: Sam Chawla</td>
                      <td rowspan="1" style="width: 50%;"><br>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 5%;"><br>
                      </td>
                      <td rowspan="1" style="width: 3%;"><br>
                      </td>
                      <td rowspan="1" style="width: 42%;">Title: Portfolio Manager</td>
                      <td rowspan="1" style="width: 50%;"><br>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 5%;"><br>
                      </td>
                      <td colspan="2" rowspan="1"><br>
                      </td>
                      <td rowspan="1" style="width: 50%;"><br>
                      </td>
                    </tr>
                    <tr>
                      <td rowspan="1" style="width: 5%;"><br>
                      </td>
                      <td colspan="3" rowspan="1">
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Address for Notices:</div>
                        <div style="line-height: 1.25;">&#160;</div>
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">c/o Perceptive Advisors LLC </div>
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">51 Astor Place, 10th Floor </div>
                        <div style="line-height: 1.25;">New York, NY 10003 <br>
                        </div>
                        <div style="line-height: 1.25;">Attn: Sandeep Dixit <br>
                        </div>
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Email: Sandeep@perceptivelife.com&#160;</div>
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>PCOFReporting@perceptivelife.com</u></div>
                        <div style="line-height: 1.25;">&#160;</div>
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">with a copy to (which shall not constitute notice):</div>
                        <div style="line-height: 1.25;">&#160;</div>
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Chapman and Cutler LLP </div>
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">1270 Avenue of the Americas </div>
                        <div style="line-height: 1.25;">30th Floor <br>
                        </div>
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">New York, New York 10020-1708 </div>
                        <div style="line-height: 1.25;">Attention: Nicholas Whitney <br>
                        </div>
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">E-mail: Whitney@chapman.com</div>
                      </td>
                    </tr>

                </table>
                &#160;&#160; <br>
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">[Signature Page to Warrant 3]</div>
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">NOTICE OF EXERCISE</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="margin-left: 60pt; line-height: 1.25;">TO:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;TRINITY BIOTECH PLC</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-indent: 36pt; margin-right: 68.7pt; margin-left: 60pt; line-height: 1.25;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned hereby elects to purchase&#160;<u>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160;&#160; &#160;</u> American Depositary Receipts pursuant to the terms of the attached
                  Warrant and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div>
                  <div style="text-indent: 36pt; margin-right: 68.7pt; margin-left: 60pt; line-height: 1.25;">(2) Payment shall take the form of (check applicable box): </div>
                  <div style="text-indent: 36pt; margin-right: 68.7pt; margin-left: 60pt; line-height: 1.25;"> <br>
                  </div>
                  <div style="text-indent: 72pt; margin-right: 37.8pt; margin-left: 60pt; line-height: 1.25;">&#9744; in lawful money of the United States; or</div>
                </div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-indent: 72pt; margin-right: 37.8pt; margin-left: 60pt; line-height: 1.25;">&#9744; the cancellation of such number of Warrant ADSs as is necessary, in accordance with the formula set forth in <u>subsection 2(c)</u>, to exercise
                  this Warrant with respect to the maximum number of Warrant ADSs purchasable pursuant to the cashless exercise procedure set forth in <u>subsection 2(c)</u>.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-indent: 36pt; margin-right: 78pt; margin-left: 60pt; line-height: 1.25;">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Please issue said Warrant ADSs (represented by ADRs) in the name of the undersigned or in such other name as is specified below:</div>
                <div style="text-indent: 36pt; margin-right: 78pt; margin-left: 60pt; line-height: 1.25;"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td style="width: 168pt; padding-bottom: 1px;">&#160;</td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 220pt;">&#160;</td>
                      <td style="width: auto; padding-bottom: 1px;" colspan="1">&#160;</td>
                    </tr>

                </table>
                <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                </div>
                <div style="margin-left: 60pt; line-height: 1.25;">Check applicable box and fill in information:</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-indent: 36pt; margin-right: 37.8pt; margin-left: 60pt; line-height: 1.25;">&#9744; The Warrant ADSs (represented by ADRs) shall be delivered to the following DWAC Account Number:</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td style="width: 255pt; padding-bottom: 2px;">
                        <div style="margin: 0px 0px 0px 168pt;">DTC Participant #:</div>
                      </td>
                      <td style="border-bottom: 1px solid #000000; width: auto;">&#160;</td>
                    </tr>

                </table>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td style="width: 280pt; padding-bottom: 2px;">
                        <div style="margin: 0px 0px 0px 168pt;">Undersigned&#8217;s Account #</div>
                      </td>
                      <td style="border-bottom: 1px solid #000000; width: auto;">&#160;</td>
                    </tr>

                </table>
                <div><br>
                </div>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td style="width: 168pt; padding-bottom: 1px;">&#160;</td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 220pt;">&#160;</td>
                      <td style="width: auto; padding-bottom: 1px;" colspan="1">&#160;</td>
                    </tr>

                </table>
                <br>
                <div style="text-indent: 36pt; margin-right: 37.8pt; margin-left: 60pt; line-height: 1.25;">&#9744; The Warrant ADSs (represented by ADRs) shall be delivered by physical delivery of ADRs to:</div>
                <div><br>
                </div>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td style="width: 168pt; padding-bottom: 1px;">&#160;</td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 220pt;">&#160;</td>
                      <td style="width: auto; padding-bottom: 1px;" colspan="1">&#160;</td>
                    </tr>

                </table>
                <div><br>
                </div>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td style="width: 168pt; padding-bottom: 1px;">&#160;</td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 220pt;">&#160;</td>
                      <td style="width: auto; padding-bottom: 1px;" colspan="1">&#160;</td>
                    </tr>

                </table>
                <br>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td style="width: 168pt; padding-bottom: 1px;">&#160;</td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 220pt;">&#160;</td>
                      <td style="width: auto; padding-bottom: 1px;" colspan="1">&#160;</td>
                    </tr>

                </table>
                <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                </div>
                <div style="text-align: justify; margin-left: 60pt; line-height: 1.25;">[SIGNATURE OF HOLDER]</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="line-height: 1.25">
                  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                      <tr>
                        <td style="width: 180pt; padding-bottom: 2px;">
                          <div>
                            <div>
                              <div>
                                <div>
                                  <div>
                                    <div style="margin: 0px 0px 0px 60pt;"><font style="font-family: 'Times New Roman',Times,serif;">Name of Investing Entity:</font></div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </td>
                        <td style="border-bottom: 1px solid #000000; width: auto;"><br>
                        </td>
                      </tr>

                  </table>
                  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                      <tr>
                        <td rowspan="1" style="width: 290pt; padding-bottom: 2px;">
                          <div style="margin: 0px 0px 0px 60pt;"><font style="font-style: italic;">Signature of Authorized Signatory of Investing Entity</font>:</div>
                        </td>
                        <td rowspan="1" style="border-bottom: 1px solid #000000; width: auto;">&#160;</td>
                      </tr>

                  </table>
                  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                      <tr>
                        <td rowspan="1" style="width: 200pt; padding-bottom: 2px;">
                          <div style="margin: 0px 0px 0px 60pt;">Name of Authorized Signatory:</div>
                        </td>
                        <td rowspan="1" style="border-bottom: 1px solid #000000; width: auto;">&#160;</td>
                      </tr>

                  </table>
                  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                      <tr>
                        <td rowspan="1" style="width: 200pt; padding-bottom: 2px;">
                          <div style="margin: 0px 0px 0px 60pt;">Title of Authorized Signatory:</div>
                        </td>
                        <td rowspan="1" style="border-bottom: 1px solid #000000; width: auto;">&#160;</td>
                      </tr>

                  </table>
                  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                      <tr>
                        <td rowspan="1" style="width: 90pt; padding-bottom: 2px;">
                          <div style="margin: 0px 0px 0px 60pt;">Date:</div>
                        </td>
                        <td rowspan="1" style="border-bottom: 1px solid #000000; width: auto;">&#160;</td>
                      </tr>

                  </table>
                  <div><br>
                  </div>
                </div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                </div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">ASSIGNMENT FORM</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-indent: 10.5pt; margin-right: 37.8pt; margin-left: 60pt; line-height: 1.25; font-style: italic;">(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-indent: 10.5pt; margin-right: 37.8pt; margin-left: 60pt; line-height: 1.25;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
                <div style="line-height: 1.25;"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
                        <div style="margin: 0px 0px 0px 60pt;">Name of Person to Whom Warrant is being Transferred:</div>
                      </td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
                        <div style="margin: 0px 0px 0px 60pt;">Address of Person to Whom Warrant is being Transferred:</div>
                      </td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
                        <div style="margin: 0px 0px 0px 60pt;">Number of Shares Subject to Warrant being Transferred:</div>
                      </td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 50%;" rowspan="1">&#160;</td>
                      <td style="width: 50%;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 50%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 50%;" rowspan="1">&#160;</td>
                      <td style="width: 50%;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
                        <div style="margin: 0px 0px 0px 60pt;">Number of Shares Subject to Warrant being Transferred:</div>
                      </td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                      <td style="width: 50%;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
                        <div style="margin: 0px 0px 0px 60pt;">Dated:&#160;<u>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; </u>&#160; <u>&#160; &#160;&#160; ,</u>&#160;&#160;<u>&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160; </u><br>
                        </div>
                      </td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
                        <div style="margin: 0px 0px 0px 60pt;">Holder&#8217;s Name: <br>
                        </div>
                      </td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
                        <div style="margin: 0px 0px 0px 60pt;">Holder&#8217;s Signature:</div>
                      </td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
                        <div style="margin: 0px 0px 0px 60pt;">Name of Authorized Signatory:<br>
                        </div>
                      </td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
                        <div style="margin: 0px 0px 0px 60pt;">Title of Authorized Signatory:<br>
                        </div>
                      </td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                      <td style="width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
                        <div style="margin: 0px 0px 0px 60pt;">Holder&#8217;s Address:</div>
                      </td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 50%;" rowspan="1">&#160;</td>
                      <td style="width: 50%;" rowspan="1">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width: 50%; padding-bottom: 2px;" rowspan="1">&#160;</td>
                      <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1">&#160;</td>
                    </tr>

                </table>
                <div style="line-height: 1.25;"> <br>
                </div>
                <div>
                  <div>
                    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.25
<SEQUENCE>6
<FILENAME>exhibit_4-25.htm
<DESCRIPTION>EXHIBIT 4.25
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; margin-right: 5.8pt; line-height: 1.25; font-variant: small-caps;"><u><font style="font-variant: normal; font-weight: bold;"> </font></u>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u><font style="font-variant: normal; font-weight: bold;">Exhibit 4.25</font></u><br>
    </div>
    <div style="text-align: right; margin-right: 5.8pt; line-height: 1.25; font-variant: small-caps;"> <br>
    </div>
    <div style="text-align: right; margin-right: 5.8pt; line-height: 1.25; font-variant: small-caps;">Execution Version</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 5.85pt; margin-left: 5pt; line-height: 1.25;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
      SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;<u>SECURITIES ACT</u>&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES EXCEPT
      PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
      SECURITIES LAWS AS MAY BE REQUIRED TO BE EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS
      SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &#8220;ACCREDITED INVESTOR&#8221; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; margin-right: 62.05pt; margin-left: 61.15pt; line-height: 1.25; font-weight: bold;">WARRANT TO PURCHASE AMERICAN DEPOSITARY SHARES </div>
    <div style="text-align: center; margin-right: 62.05pt; margin-left: 61.15pt; line-height: 1.25; font-weight: bold;">REPRESENTED BY AMERICAN DEPOSITARY RECEIPTS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; margin-right: 62pt; margin-left: 61.15pt; line-height: 1.25; font-weight: bold;">TRINITY BIOTECH PLC</div>
    <div style="line-height: 1.25"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="text-align: justify; margin-left: 5pt; line-height: 1.25;">
            <div style="margin: 0px 0px 0px 5pt;">Warrant ADSs: 500,000</div>
          </td>
          <td style="width: 50%; text-align: right; vertical-align: bottom;">Issue Date: December 23, 2024</td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 5pt; line-height: 1.25;">Warrant No. 4</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 5.95pt; margin-left: 5pt; line-height: 1.25;"><font style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;&#160;&#160;&#160;</font>THIS&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;WARRANT&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;TO&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PURCHASE&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;AMERICAN&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;DEPOSITARY&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SHARES




      REPRESENTED BY AMERICAN DEPOSITARY RECEIPTS (this &#8220;<u>Warrant</u>&#8221; or &#8220;<u>Warrant Certificate</u>&#8221;) certifies that, for value received, Perceptive Credit Holdings II, LP or its assigns (the &#8220;<u>Holder</u>&#8221;) is entitled, upon the terms and subject to
      the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof, and on or prior to the close of business on December 23, 2031 (the &#8220;<u>Expiration Date</u>&#8221;), but not thereafter, to purchase from Trinity
      Biotech PLC, a public limited company organized and existing under the laws of Ireland (the &#8220;<u>Company</u>&#8221;), and the Company shall be obliged to cause the issuance, of up to five hundred thousand (500,000) American Depositary Shares of the Company
      (&#8220;<u>ADSs</u>&#8221;), with each ADS being represented by one American Depositary Receipt issued by the Depositary (&#8220;<u>ADR</u>&#8221;), each of which in turn represents twenty (20) &#8220;A&#8221; Ordinary Shares of the Company (the &#8220;<u>ADS Ratio</u>&#8221;) (as subject to
      adjustment hereunder the &#8220;<u>Warrants ADSs</u>&#8221;). The purchase price of one ADS, represented by one ADR, issuable under this Warrant shall be equal to the Exercise Price, as defined in <u>Section 2(b)</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">This Warrant is issued pursuant to that certain Side Letter, dated as of the date hereof, by and between the Company and the Holder.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;"><u>Section 1.</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Definitions</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;For the purposes hereof, in addition to the terms defined elsewhere in this Warrant, the following terms
      shall have the following meanings:</div>
    <div style="margin-left: 5pt; line-height: 1.25;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Affiliate</u>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under
      common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Business Day</u>&#8221; means any day, except a Saturday, Sunday or legal holiday, on which banking institutions in the city of New York, New
      York are authorized or obligated by law or executive order to close.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;">&#8220;<u>Commission</u>&#8221; means the United States Securities and Exchange Commission. &#8220;<u>Companies Act</u>&#8221; means the Companies Act of 2014 of Ireland (as amended). &#8220;<u>Convertible
        Securities</u>&#8221; means any debt, equity or other securities that are, directly or indirectly, convertible into or exchangeable for Ordinary Shares or ADSs or ADRs.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Depositary</u>&#8221; means The Bank of New York Mellon, a New York banking corporation, as depositary for the ADSs and the issuer of the ADRs.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Excluded Issuance</u>&#8221; means the issuance of (a) Ordinary Shares or ADSs (or options with respect thereto) issued or issuable to
      employees or directors of, or consultants to, the Company or any of its subsidiaries pursuant to a plan, agreement or arrangement approved by the Board of Directors of the Company, (b) other securities exercisable or exchangeable for or convertible
      into Ordinary Shares or ADSs issued and outstanding on the date of this Warrant, <font style="font-style: italic;">provided </font>that such securities have not been amended since the date of this Warrant to increase the number of such securities
      or to decrease the exercise price, exchange price or conversion price of such securities (for purposes of clarity, any decrease in the exercise price, exchange price or conversion price of such securities shall not be deemed an amendment thereto, if
      such decrease is as a result of any price-based anti-dilution provision contained in such securities prior to the date hereof), and (c) other securities issued to financial institutions, institutional investors or lessors in connection with credit
      arrangements, equipment financings or similar transactions (and not for the purpose of raising capital) approved by a majority of disinterested directors of the Company. In addition, for the avoidance of doubt, &#8220;Excluded Issuances&#8221; also include the
      filing of any registration statement of the Company with the Commission registering securities of the Company, or the filing of any amendments or supplements thereto, provided that the determination of whether sales under any such registration
      statement is an Excluded Issuance will be determined based on the preceding clauses (a) to (c) hereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Fundamental Transaction</u>&#8221; means (a) the Company, directly or indirectly, in one or more related transactions effects any merger or
      consolidation of the Company with or into another Person, (b) the Company, directly or indirectly, effects any sale, lease, exclusive license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a
      series of related transactions, (c) any, direct or indirect, purchase offer, scheme of arrangement, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Ordinary Shares, ADRs or ADSs are
      permitted to sell, tender, agree to cancel or exchange their shares for other securities, cash or property and has been accepted by the holders of fifty percent (50%) or more of the outstanding security holders of the Company (or, in the case of a
      scheme of arrangement, the requisite majority to approve such scheme), (d) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Ordinary Shares or ADSs (but,
      for the avoidance of doubt, excluding any transaction, event or occurrence covered by <u>Section 3(a)</u>) or any compulsory share exchange pursuant to which the Ordinary Shares or ADSs are effectively converted into or exchanged for other
      securities, cash or property, (e) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
      recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than fifty percent (50%) of the outstanding voting shares of the Company (not including any shares held by the other Person or other
      Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination).</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Marketable Securities</u>&#8221; means securities that (a) are tradable on an established national U.S. stock exchange or reported through an
      established over-the-counter trading system and (b) are not subject to restrictions on transfer under the Securities Act, the Companies Act or contractual restrictions on transfer.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Options</u>&#8221; means any warrants or other rights or options to subscribe for or purchase Ordinary Shares or Convertible Securities.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Ordinary Shares</u>&#8221; means the &#8220;A&#8221; ordinary shares of the Company, par value USD $0.0109 per share, and any other class of securities
      into which such securities may hereafter be reclassified or changed.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Person</u>&#8221; means any individual, sole proprietorship, partnership, limited liability company, corporation, joint venture, trust,
      incorporated organization or government or department or agency thereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Prospectus</u>&#8221; means the prospectus or prospectuses included in any Registration Statement, as amended or supplemented by any prospectus
      supplement with respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement and by all other amendments and supplements to the prospectus, including post-effective amendments and all
      material incorporated by reference in such prospectus or prospectuses.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Registrable Securities</u>&#8221; means (a) any ADSs (represented by ADRs), or Ordinary Shares held by Holder or issuable upon conversion,
      exercise or exchange of any securities owned by Holder at any time (including Warrant ADSs exercisable upon exercise of this Warrant), and (b) any ADSs (represented by ADRs) or Ordinary Shares issued or issuable with respect to any shares described
      in subsection (a) above by way of a stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization (it being understood that for purposes of this Warrant, Holder shall be
      deemed to be a holder of Registrable Securities whenever Holder has the right to then acquire or obtain from the Company any Registrable Securities, whether or not such acquisition has actually been effected). As to any particular Registrable
      Securities, such securities shall cease to be Registrable Securities when (i) a Registration Statement covering such securities has been declared effective by the Commission and such securities have been disposed of pursuant to such effective
      Registration Statement, (ii) such securities are sold under circumstances in which all of the applicable conditions of Rule 144 (or any similar provisions then in force) under the Securities Act are met, (iii) such securities are otherwise
      transferred and such securities may be resold without subsequent registration under the Securities Act, or (iv) such securities shall have ceased to be outstanding.</div>
    <div style="text-align: justify; margin-right: 5.95pt; margin-left: 5pt; line-height: 1.25;"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Registration Statement</u>&#8221; means any registration statement of the Company which covers any of the Registrable Securities pursuant to
      the provisions of this Warrant, including the Prospectus, amendments and supplements to or replacements of such Registration Statement, including post-effective amendments, all exhibits and all materials incorporated by reference in such Registration
      Statement.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Rule 144</u>&#8221; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time,
      or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Share Equivalents</u>&#8221; means any securities of the Company or its wholly owned subsidiaries which would entitle the holder thereof to
      acquire at any time Ordinary Shares or ADSs, including, without limitation, any debt, preferred stock, right, option, warrant, ADR or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the
      holder thereof to receive, Ordinary Shares or ADSs.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Stock Deemed Outstanding</u>&#8221; means, at any given time, the sum of (i) the number of Ordinary Shares and ADSs actually outstanding at
      such time, plus (ii) the number of Ordinary Shares issuable upon exercise of Options actually outstanding at such time, plus (iii) the number of Ordinary Shares issuable upon conversion or exchange of Convertible Securities (including ADSs) actually
      outstanding at such time (treating as actually outstanding any Convertible Securities issuable upon exercise of Options actually outstanding at such time), in each case, regardless of whether the Options or Convertible Securities are actually
      exercisable at such time; <font style="font-style: italic;">provided </font>that Stock Deemed Outstanding at any given time shall not include shares owned or held by or for the account of the Company or any of its wholly owned subsidiaries.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;">&#8220;<u>Trading Day</u>&#8221; means a day on which the principal Trading Market is open for trading. &#8220;<u>Trading Market</u>&#8221; means the Nasdaq Global Market (or any
      successor to the Nasdaq Global</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">Market), or any national securities exchange registered with the Commission on which the ADSs are listed and which is then the primary trading market for the
      ADSs.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>Transfer Agent</u>&#8221; means Computershare Investor Services (Ireland) Limited, the current transfer agent of the Company, and any successor
      transfer agent of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">&#8220;<u>VWAP</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the ADSs are then listed
      or quoted on the Trading Market, the daily volume weighted average price of the ADSs for such date on the Trading Market on which the ADSs are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City
      time) to 4:00 p.m. (New York City time)), (b) if the ADSs are not then listed or quoted for trading on the Trading Market and if prices for the ADSs are then reported on the &#8220;Pink Market&#8221; of the OTC Markets Group, Inc. (or a similar organization or
      agency succeeding to its functions of reporting prices), the most recent bid price per ADS as reported, or (c) in all other cases, the fair market value of one ADS as determined by the Company and the Holder, provided that if the Company and the
      Holder cannot agree on the fair market value of one ADS, such value shall be determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the reasonable, actual and documented fees and
      reasonable, actual and documented out-of-pocket expenses of which shall be paid by the Company.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;"><br>
    </div>
    <div style="text-align: justify; margin-left: 41pt; line-height: 1.25;"><u>Section 2.</u>&#160;&#160; <u>Exercise</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 41pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise of Warrant</u>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at
      any time or times before the Expiration Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the
      Company) of a duly executed electronic copy of the Notice of Exercise in the form annexed hereto (the &#8220;<u>Notice of Exercise</u>&#8221;) and within one (1) Trading Day of the date said Notice of Exercise is delivered to the Company, the Company shall have
      received payment of the aggregate Exercise Price of the Warrant ADSs thereby purchased by wire transfer or cashier&#8217;s check drawn on a United States bank or pursuant to the cashless exercise procedure specified in <u>Section 2(c)</u> below. No
      ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything herein to the contrary, the Holder shall not be
      required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant ADSs available hereunder and this Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company
      for cancellation within three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant ADSs available hereunder shall
      have the effect of lowering the outstanding number of Warrant ADSs purchasable hereunder in an amount equal to the applicable number of Warrant ADSs purchased. The Holder and the Company shall maintain records showing the number of Warrant ADSs
      purchased and the date of such purchases. <font style="font-weight: bold;">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of
        the Warrant ADSs hereunder, the number of Warrant ADSs available for purchase hereunder at any given time may be different than the amount stated on the face hereof. For the avoidance of doubt, the Holder may request a new Warrant upon the partial
        exercise of this Warrant.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;">In the event that immediately prior to the close of business on the Expiration Date, the VWAP of one (1) ADS is greater than the then applicable Exercise
      Price, this Warrant shall be deemed to be automatically exercised as a &#8220;cashless exercise&#8221; pursuant to <u>Section 2(c)</u> below, and the Company or the Depositary, as applicable, shall deliver the applicable number of ADSs (represented by ADRs) to
      the Holder pursuant to the provisions of <u>Section 2(d) </u>below.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise Price</u>. The exercise price per ADS under this Warrant shall initially be $0.8000 (the &#8220;<u>Initial Exercise Price</u>&#8221;); <font style="font-style: italic;">provided </font>that if the Company issues or causes the Depositary (as defined below) to issue any ADSs in the twelve (12) months following the Issue Date at a price per ADS less than the Initial Exercise Price, then
      (i) the Initial Exercise Price will be automatically, without further action required from any party, reduced to match the lowest price per ADS at which the Company issued or caused the Depositary to issue any ADSs during such twelve (12) month
      period and (ii) the Company shall provide written notice to the Holder within three (3) Business Days from the date of any such issuance and shall simultaneously issue the Holder a new Warrant Certificate reflecting the reduced Exercise Price within
      the same three (3) Business Days. The Initial Exercise Price, as may be adjusted pursuant to this Warrant, is referred to herein as the &#8220;Exercise Price&#8221;.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Cashless Exercise. This Warrant may be exercised, in whole or in part, at any time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be
      entitled to receive a number of Warrant ADSs (represented by ADRs) equal to the quotient obtained by dividing [(A-B) (X)] by (A) (a &#8220;<u>Cashless Exercise</u>&#8221;), where:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 113pt; line-height: 1.25;">(A) = the VWAP on the Trading Day immediately preceding the date on which Holder elects to exercise this Warrant by means of a &#8220;cashless exercise,&#8221; as set
      forth in the applicable Notice of Exercise;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 113pt; line-height: 1.25;">(B) = the Exercise Price, as adjusted hereunder; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 113pt; line-height: 1.25;">(X) = the number of Warrant ADSs (represented by ADRs) that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if
      such exercise were by means of a cash exercise rather than a cashless exercise or, if only a portion of this Warrant is being exercised, the portion of this Warrant being cancelled.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">Notwithstanding any other provision of this Warrant, the issue of any Warrant ADSs (represented by ADRs) (or shares underlying such Warrant
      ADSs) pursuant to any exercise or redemption of this Warrant (including any exercise or redemption made on a cashless basis pursuant to this Section 2(c) or otherwise) shall be conditional on the payment to the Company by the Holder, whether by
      payment of the Exercise Price in cash or otherwise, of an amount in cash at least equal to the product of the nominal value of the &#8220;A&#8221; Ordinary Shares of the Company underlying the Warrant ADSs, the number of Warrant ADSs (represented by ADRs) to be
      issued and the ADS Ratio.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;">If Warrant ADSs (represented by ADRs) are issued in such a cashless exercise, the parties acknowledge and agree that, in accordance with
      Section 3(a)(9) of the Securities Act, the Warrant ADSs (represented by ADRs) shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant ADSs (represented by ADRs) being issued may be tacked on to the
      holding period of this Warrant commencing as of the Issue Date. The Company agrees not to take any position contrary to this <u>Section 2(c)</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 77pt;"><br>
          </td>
          <td style="width: 35.95pt; vertical-align: top;">(d)</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Mechanics of Exercise</u>.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of Warrant ADSs Upon Exercise</u>. Warrant ADSs (represented by ADRs) purchased hereunder shall be transmitted by the Depositary to the
      Holder by crediting the account of the Holder&#8217;s prime broker with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) and the Warrant ADSs (represented by ADRs) are eligible for resale by the Holder
      without volume or manner-of-sale limitations pursuant to Rule 144 or an available Registration Statement, and otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise by the date that is two (2) Trading Days
      after the delivery to the Company, by 11 a.m. (local time in New York City, New York) on a Trading Day, of the Notice of Exercise and payment of the aggregate Exercise Price as set forth above (including by Cashless Exercise) (such date, the &#8220;<u>Warrant

        ADS Delivery Date</u>&#8221;). The Warrant ADSs (represented by ADRs) shall be deemed to have been issued, and the Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such Warrant ADSs
      (represented by ADRs) for all purposes, as of the date this Warrant has been exercised, with payment to the Company of the Exercise Price (or by Cashless Exercise) and all taxes required to be paid by the Holder, if any, pursuant to <u>Section
        2(d)(v)</u> prior to the issuance of such Warrant ADSs (represented by ADRs), having been paid. If the Company fails for any reason to deliver to the Holder the Warrant ADSs (represented by ADRs) subject to a Notice of Exercise by the Warrant ADS
      Delivery Date, other than a failure to deliver caused by the Holder&#8217;s failure to pay the applicable Exercise Price for such Warrant ADSs or to timely take such actions as are necessary to post such Warrant ADSs (represented by ADRs) in DWAC, the
      Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant ADSs (represented by ADRs) subject to such exercise (based on the VWAP on the date of the applicable Notice of Exercise) $0.8000 per
      Trading Day for each Trading Day after such Warrant ADS Delivery Date until such Warrant ADSs (represented by ADRs) are delivered or Holder rescinds such exercise. The Company agrees to maintain a registrar (which may be the Depositary) that is a
      participant in the &#8220;FAST&#8221; program for so long as this Warrant remains outstanding and exercisable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of New Warrants Upon Exercise</u>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
      upon surrender of this Warrant, at or promptly after the time of delivery of the Warrant ADSs (represented by ADRs), deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant ADSs called for by this
      Warrant, which new Warrant shall in all other respects be identical with this Warrant.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rescission Rights</u>. If the Company fails to cause the Depositary to transmit to the Holder the Warrant ADSs (represented by ADRs) pursuant
      to <u>Section 2(d)(i)</u> by the Warrant ADS Delivery Date, other than a failure to deliver caused by the Holder&#8217;s failure to pay the applicable Exercise Price for such Warrant ADSs or to timely take such actions as are necessary to post such
      Warrant ADSs (represented by ADRs) in DWAC, then the Holder will have the right to rescind such exercise and have its Exercise Price, if any, refunded by the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compensation for Buy-In on Failure to Timely Deliver Warrant</u>&#160;<u>ADSs Upon Exercise</u>. In addition to any other rights available to the
      Holder, if the Company fails to cause the Depositary to transmit to the Holder the Warrant ADSs (represented by ADRs) pursuant to an exercise on or before the Warrant ADS Delivery Date and such failure is not caused by any act or omission of the
      Holder, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) ADSs (represented by ADRs) to deliver in satisfaction of a sale by the Holder of the Warrant ADS (represented by ADRs) which
      the Holder anticipated receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the ADSs
      (represented by ADRs) so purchased (<font style="font-style: italic;">provided</font>, Holder exercises reasonable efforts to minimize the amount of such purchase price) exceeds (y) the amount obtained by multiplying (1) the number of Warrant ADSs
      (represented by ADRs) that the Company was required to deliver to the Holder in connection with the exercise at issue by (2) the actual sale price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of
      the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant ADSs for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of ADSs (represented by
      ADRs) that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases ADSs (represented by ADRs) having a total purchase price of $11,000 to cover a Buy-In with
      respect to an attempted exercise to acquire Warrant ADSs (represented by ADRs) with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to
      pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy- In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a
      Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#8217;s failure to timely deliver Warrant ADSs
      (represented by ADRs) upon exercise of the Warrant as required pursuant to the terms hereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Fractional ADSs or Scrip</u>. No fractional ADSs (represented by ADRs) or scrip representing fractional ADSs (represented by ADRs) shall be
      issued upon the exercise of this Warrant. As to any fraction of an ADS which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall round up to the next whole ADS (represented by and ADR).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Charges, Taxes and Expenses</u>. Subject to applicable law or regulation, the issuance of this Warrant and the Warrant ADSs (represented by
      ADRs) shall be made without charge to the Holder for any stamp duty, issue or transfer tax or other incidental expense in respect of the issuance of this Warrant and Warrant ADSs (represented by ADRs) (but not any subsequent transfer of this Warrant
      or any Warrant ADSs (represented by ADRs) so issued), all of which taxes and expenses shall be paid by the Company, and such Warrant ADSs (represented by ADRs) shall be issued in the name of the Holder or in such name or names as may be directed by
      the Holder; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that in the event that Warrant ADSs (represented by ADRs) are to be issued in a name other than the name of the Holder, this Warrant
      when surrendered for exercise shall be accompanied by a completed Assignment Form in the form attached hereto (the &#8220;<u>Assignment Form</u>&#8221;) duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum
      sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all fees of the Depositary required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established
      clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant ADSs (represented by ADRs).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Closing of Books</u>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this
      Warrant, pursuant to the terms hereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 41pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Holder&#8217;s Exercise Limitations</u>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have
      the right to exercise any portion of this Warrant, pursuant to this <u>Section 2</u> or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with
      the Holder&#8217;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing
      sentence, the number of Ordinary Shares beneficially owned by the Holder and its Affiliates shall include the number of Ordinary Shares underlying the Warrant ADSs with respect to which such determination is being made, but shall exclude the number
      of Ordinary Shares underlying the Warrant ADSs which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates, and (ii) exercise or conversion of the
      unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Share Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned
      by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this <u>Section 2(e)</u>, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and
      regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any
      schedules required to be filed in accordance therewith. To the extent that the limitation contained in this <u>Section 2(e)</u> applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder
      together with any Affiliates) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is
      exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation
      to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
      thereunder. For purposes of this <u>Section 2(e)</u>, in determining the number of outstanding Ordinary Shares, a Holder may rely on the number of outstanding shares of Ordinary Shares as reflected in (A) the Company&#8217;s most recent periodic or annual
      report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company, or (C) a more recent written notice from the Company or the Transfer Agent or the Depositary setting forth the number of Ordinary Shares
      outstanding. Upon the written request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of Ordinary Shares then outstanding. In any case, the number of outstanding Ordinary Shares shall
      be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding Ordinary Shares was reported. The &#8220;<u>Beneficial



        Ownership</u>&#160;<u>Limitation</u>&#8221; shall be 9.99% of the number of Ordinary Shares outstanding immediately after giving effect to the applicable issuance of the Warrant ADSs (represented by ADRs)issuable upon exercise of this Warrant, <font style="font-style: italic;">provided </font>that the Holder may decrease such Beneficial Ownership Limitation upon written notice to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
      strict conformity with the terms of this <u>Section 2(e)</u> to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or
      supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Violation</u>. The Company shall take all such actions as may be necessary to ensure that all such Warrant ADSs (represented by ADRs) are
      issued without any rights of pre-emption in favor of any other person and without violation by the Company of any applicable law or governmental regulation or of any requirements of any domestic securities exchange upon which Ordinary Shares, ADSs
      (represented by ADRs), or other securities constituting Warrant ADSs (represented by ADRs) or into which such Warrant ADSs (represented by ADRs) may be converted or exchanged may be listed at the time of such exercise (except for official notice of
      issuance which shall be immediately delivered by the Company upon each such issuance).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 41pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Listing</u>. Promptly following the date of this Warrant Certificate the Company shall cause the Warrant ADSs (represented
      by ADRs) to be listed on the Trading Market, and shall maintain such listing through the time of such exercise and the holding of the Warrant ADSs by the Holder, and shall assure that it and the Depositary shall, at all times maintain, for the
      benefit of the Holder, (i) that number of ADSs underlying the Warrant ADSs available for issuance in connection with the exercise of this Warrant Certificate under a registration statement on Form F-3 in accordance with Section 4, and (ii) that
      number of ADRs available for issuance in connection with the exercise of this Warrant Certificate under a registration statement on Form F-6.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 5pt; line-height: 1.25;"><u>Section 3.</u>&#160; <u>Certain Adjustments</u>. In addition to any adjustments to the Exercise Price pursuant to <u>Section 2(b)</u> and in
      order to prevent dilution of the purchase rights granted under this Warrant Certificate, the Exercise Price and the number of Warrant ADSs (represented by ADRs) issuable upon exercise of this Warrant Certificate shall be subject to adjustment from
      time to time as provided in this <u>Section 3</u>.</div>
    <div style="margin-left: 5pt; line-height: 1.25;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 41pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price Upon Issuance of Ordinary Shares or ADSs</u>. Subject to <u>Section 3(c)</u>, if the Company
      shall, at any time after the date hereof (the &#8220;<u>Issue</u>&#160;<u>Date</u>&#8221;), issue or sell any Ordinary Shares, whether directly or indirectly by way of Options or Convertible Securities (including through the issuance of ADSs (represented by ADRs)
      other than in an Excluded Issuance or any event described in <u>Section 3(d)</u> or <u>(e)</u>), without consideration or for consideration per share less than the Exercise Price in effect immediately prior to such issuance or sale, then
      immediately upon such issuance or sale, the Exercise Price in effect immediately prior to such issuance or sale shall be reduced (and in no event increased) to an Exercise Price equal to the quotient obtained by dividing:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the sum of (A) the product obtained by multiplying the Stock Deemed Outstanding immediately prior to such issuance or sale (or deemed issuance or
      sale) by the Exercise Price then in effect plus (B) the aggregate consideration, if any, received by the Company upon such issuance or sale (or deemed issuance or sale); by</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the sum of (A) the Stock Deemed Outstanding immediately prior to such issuance or sale (or deemed issuance or sale) plus (B) the aggregate number
      of Ordinary Shares issued or sold (or deemed issued or sold) by the Company in such issuance or sale (or deemed issuance or sale);</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;"><font style="font-style: italic;">provided</font>, for the avoidance of doubt, the number of Warrant ADSs (represented by ADRs) issued
      pursuant to this Warrant Certificate will not be adjusted in the event that the Exercise Price is adjusted under <u>Section 3(a)</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 41pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Effect of Certain Events on Adjustment to Exercise Price</u>. For purposes of determining the adjusted Exercise Price under
      <u>Section 3(a)</u>, the following shall be applicable:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Issuance of Options</u>. If the Company shall, at any time or from time to time after the date hereof, in any manner grant or sell (whether
      directly or by assumption in a merger or otherwise) any Options, whether or not such Options or the right to convert or exchange any Convertible Securities issuable upon the exercise of such Options are immediately exercisable, and the price per
      share (determined as provided in this <u>Section 3(b)(i)</u> and in <u>Section 3(b)(v)</u>) for which Ordinary Shares (or equivalent securities) are issuable upon the exercise of such Options or upon the conversion or exchange of Convertible
      Securities issuable upon the exercise of such Options is less than the Exercise Price in effect immediately prior to the time of the granting or sale of such Options, then the total maximum number of Ordinary Shares (or equivalent securities)
      issuable upon the exercise of such Options or upon conversion or exchange of the total maximum amount of Convertible Securities issuable upon the exercise of such Options shall be deemed to have been issued as of the date of granting or sale of such
      Options (and thereafter shall be deemed to be outstanding for purposes of adjusting the Exercise Price under <u>Section 3(a)</u>), at a price per share equal to the quotient obtained by <u>dividing</u>:</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 113pt; line-height: 1.25;">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the sum (which sum shall constitute the applicable consideration received for purposes of <u>Section 3(a)</u>) of (1) the total amount, if any,
      received or receivable by the Company as consideration for the granting or sale of all such Options, <u>plus</u> (2) the minimum aggregate amount of additional consideration payable to the Company upon the exercise of all such Options, <u>plus</u>
      (3), in the case of such Options which relate to Convertible Securities, the minimum aggregate amount of additional consideration, if any, payable to the Company upon the issuance or sale of all such Convertible Securities and the conversion or
      exchange of all such Convertible Securities, <u>by</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 113pt; line-height: 1.25;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the total maximum number of Ordinary Shares issuable upon the exercise of all such Options or upon the conversion or exchange of all Convertible
      Securities issuable upon the exercise of all such Options.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 77pt; line-height: 1.25;">Except as otherwise provided in <u>Section 3(b)(iii)</u>, no further adjustment of the Exercise Price shall be made upon the actual issuance of Ordinary
      Shares (or equivalents) or of Convertible Securities upon exercise of such Options or upon the actual issuance of Ordinary Shares (or equivalents) upon conversion or exchange of Convertible Securities issuable upon exercise of such Options.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Issuance of Convertible Securities</u>. If the Company shall, at any time or from time to time after the Issue Date, in any manner grant or sell
      (whether directly or by assumption in a merger or otherwise) any Convertible Securities, whether or not the right to convert or exchange any such Convertible Securities is immediately exercisable, and the price per share (determined as provided in
      this <u>Section 3(b)(ii)</u> and in <u>Section 3(b)(v)</u>) for which Ordinary Shares (or equivalent securities) are issuable upon the conversion or exchange of such Convertible Securities is less than the Exercise Price in effect immediately prior
      to the time of the granting or sale of such Convertible Securities, then the total maximum number of Ordinary Shares issuable upon conversion or exchange of the total maximum amount of such Convertible Securities shall be deemed to have been issued
      as of the date of granting or sale of such Convertible Securities (and thereafter shall be deemed to be outstanding for purposes of adjusting the Exercise Price pursuant to Section 3(a)), at a price per share equal to the quotient obtained by <u>dividing</u>:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 113pt; line-height: 1.25;">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the sum (which sum shall constitute the applicable consideration received for purposes of <u>Section 3(a)</u>) of (1) the total amount, if any,
      received or receivable by the Company as consideration for the granting or sale of such Convertible Securities, <u>plus</u> (2) the minimum aggregate amount of additional consideration, if any, payable to the Company upon the conversion or exchange
      of all such Convertible Securities, <u>by</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 113pt; line-height: 1.25;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the total maximum number of Ordinary Shares (or equivalent securities) issuable upon the conversion or exchange of all such Convertible Securities.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 77pt; line-height: 1.25;">Except as otherwise provided in <u>Section 3(b)(iii)</u>, (A) no further adjustment of the Exercise Price shall be made upon the actual issuance of Ordinary
      Shares (or equivalents) upon conversion or exchange of such Convertible Securities and (B) no further adjustment of the Exercise Price shall be made by reason of the issue or sale of Convertible Securities upon exercise of any Options to purchase any
      such Convertible Securities for which adjustments of the Exercise Price have been made pursuant to the other provisions of this <u>Section 3(b)</u>. </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 77pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Change in Terms of Options or Convertible Securities</u>. Upon any change in any of (A) the total amount received or
      receivable by the Company as consideration for the granting or sale of any Options or Convertible Securities referred to in <u>Section 3(b)(i)</u> or <u>(ii)</u>, (B) the minimum aggregate amount of additional consideration, if any, payable to the
      Company upon the exercise of any Options or upon the issuance, conversion or exchange of any Convertible Securities referred to in <u>Section 3(b)(i)</u> or <u>(ii)</u>, (C) the rate at which Convertible Securities referred to in <u>Section
        3(b)(i)</u> or <u>(ii)</u> are convertible into or exchangeable for Ordinary Shares (or equivalent securities), or (D) the maximum number of Ordinary Shares (or equivalent securities) issuable in connection with any Options referred to in <u>Section

        3(b)(i)</u> or any Convertible Securities referred to in <u>Section 3(b)(ii)</u> (in each case, other than in connection with an Excluded Issuance), then (whether or not the original issuance or sale of such Options or Convertible Securities
      resulted in an adjustment to the Exercise Price pursuant to this <u>Section 3</u>) the Exercise Price in effect at the time of such change shall be adjusted or readjusted, as applicable, to the Exercise Price which would have been in effect at such
      time pursuant to the provisions of this <u>Section 3</u> had such Options or Convertible Securities still outstanding provided for such changed consideration, conversion rate or maximum number of shares, as the case may be, at the time initially
      granted, issued or sold, but only if as a result of such adjustment or readjustment the Exercise Price then in effect is reduced.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 77pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Treatment of Expired or Terminated Options or Convertible</u>&#160;<u>Securities</u>. Upon the expiration or termination of any
      unexercised Option (or portion thereof) or any unconverted or unexchanged Convertible Security (or portion thereof) for which any adjustment (either upon its original issuance or upon a revision of its terms) was made pursuant to this <u>Section 3</u>
      (including without limitation upon the redemption or purchase for consideration of all or any portion of such Option or Convertible Security by the Company), the Exercise Price then in effect hereunder automatically shall be changed to the Exercise
      Price which would have been in effect at the time of such expiration or termination had such unexercised Option (or portion thereof) or unconverted or unexchanged Convertible Security (or portion thereof), to the extent outstanding immediately prior
      to such expiration or termination, never been issued.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Calculation of Consideration Received</u>. If the Company shall, at any time or from time to time after the Issue Date, issue or sell, or
      pursuant to <u>Section 3(b)</u> be deemed to have issued or sold, any Ordinary Shares, Options or Convertible Securities: (A) for cash, the consideration received therefor shall be deemed to be the net amount received by the Company therefor; (B)
      for Marketable Securities, the amount of consideration received therefor shall be deemed to be the market price (as reflected on any securities exchange, quotation system or association or similar pricing system covering such security) for such
      securities as of the end of business on the date of receipt of such securities; (C) for consideration other than cash or Marketable Securities, the amount of consideration received therefor shall be deemed to be the fair value of such consideration;
      (D) for no specifically allocated consideration in connection with an issuance or sale of other securities of the Company, together comprising one integrated transaction, the amount of consideration received therefor shall be deemed to be to be the
      fair value of such portion of the aggregate consideration received by the Company in such transaction as is attributable to such Ordinary Shares, Options or Convertible Securities, as the case may be, issued in such transaction; or (E) to the owners
      of the non-surviving entity in connection with any merger in which the Company is the surviving corporation, the amount of consideration received therefor shall be deemed to be the fair value of such portion of the net assets and business of the
      non-surviving entity as is attributable to such Ordinary Shares, Options or Convertible Securities, as the case may be, issued to such owners. The net amount of any cash consideration and the fair value of any consideration other than cash or
      Marketable Securities shall be determined in accordance with Section 1028 of the Companies Act and, to the extent necessary or required, in good faith jointly by the Board of Directors of the Company and the Holder.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; margin-right: 5.85pt; margin-left: 77pt; line-height: 1.25;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Record Date</u>. For purposes of any adjustment to the Exercise Price or the number of Warrant ADSs in accordance with this <u>Section 3</u>,
      or any adjustment to the number of Warrant ADSs pursuant to <u>Section 3(c</u>) or <u>3(d</u>), in case the Company shall take a record of the holders of its Ordinary Shares (or equivalent securities) for the purpose of entitling them (A) to
      receive a dividend or other distribution payable in Ordinary Shares, Options or Convertible Securities or (B) to subscribe for or purchase Ordinary Shares, Options or Convertible Securities, then such record date shall be deemed to be the date of the
      issue or sale of the Ordinary Shares deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase, as the case may be.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Treasury Shares</u>. The number of Ordinary Shares (or equivalent securities) outstanding at any given time shall not include shares owned or
      held by or for the account of the Company or any of its wholly-owned subsidiaries, and the disposition of any such shares (other than the cancellation or retirement thereof or the transfer of such shares among the Company and its wholly-owned
      subsidiaries) shall be considered an issue or sale of Ordinary Shares for the purpose of this <u>Section 3</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price and Warrant ADSs Upon Dividend,</u>&#160;<u>Subdivision or Combination of Ordinary Shares</u>. If the Company shall, at
      any time or from time to time after the Issue Date, (i) pay a dividend or make any other distribution upon the Ordinary Shares or any other capital stock of the Company payable in Ordinary Shares or in Options or Convertible Securities, or (ii)
      subdivide (by any stock split, recapitalization or otherwise) its outstanding Ordinary Shares (or equivalent securities) into a greater number of shares, the Exercise Price in effect immediately prior to any such dividend, distribution or subdivision
      shall be proportionately reduced and the number of Warrant ADSs (represented by ADRs) issuable upon exercise of this Warrant Certificate shall be proportionately increased. If the Company at any time combines (by combination, reverse stock split or
      otherwise) its outstanding Ordinary Shares (or equivalent securities) into a smaller number of shares, the Exercise Price in effect immediately prior to such combination shall be proportionately increased and the number of Warrant ADSs (represented
      by ADRs) issuable upon exercise of this Warrant Certificate shall be proportionately decreased. Any adjustment under this <u>Section 3(c)</u> shall become effective at the close of business on the date the dividend, subdivision or combination
      becomes effective.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price and Warrant ADSs Upon Reorganization,</u>&#160;<u>Reclassification, Consolidation or Merger</u>. Unless the Holder
      otherwise consents (in its sole discretion), in the event of any (A) capital reorganization of the Company,</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;">(B) reclassification of the stock of the Company (other than a change in par value or from par value to no par value or from no par value to par value or as a
      result of a stock dividend or subdivision, split-up or combination of shares), (C) Fundamental Transaction or</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;">(D) other similar transaction (other than any such transaction covered by <u>Section 3(c)</u>), in each case which entitles the holders of Ordinary Shares (or
      equivalent securities) to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect to or in exchange for Ordinary Shares (or equivalent securities):</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;this Warrant Certificate shall, immediately after such transaction, remain outstanding and shall thereafter, in lieu of or in addition to (as the
      case may be) the number of Warrant ADSs (represented by ADRs) then exercisable under this Warrant Certificate, be exercisable for the kind and number of shares of stock or other securities or assets of the Company or of the successor Person resulting
      from such transaction to which the Holder would have been entitled upon such transaction if the Holder had exercised this Warrant Certificate in full immediately prior to the time of such transaction and acquired the applicable number of Warrant ADSs
      (represented by ADRs) then issuable hereunder as a result of such exercise (without taking into account any limitations or restrictions on the exercisability of this Warrant Certificate); and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;appropriate adjustment (in form and substance satisfactory to the Holder) shall be made with respect to the Holder&#8217;s rights under this Warrant
      Certificate to insure that the provisions of this <u>Section 3</u> shall thereafter be applicable, as nearly as possible, to this Warrant Certificate in relation to any shares of stock, securities or assets thereafter acquirable upon exercise of
      this Warrant Certificate (including, in the case of any transaction in which the successor or purchasing Person is other than the Company, an immediate adjustment in the Exercise Price to the value per share for the Ordinary Shares (or equivalent
      securities) reflected by the terms of such transaction, and a corresponding adjustment immediately shall be made to the number of Warrant ADSs acquirable upon exercise of this Warrant Certificate, without regard to any limitations or restrictions on
      exercise, if the value so reflected is less than the Exercise Price in effect immediately prior to such transaction).</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;">The provisions of this <u>Section 3(d)</u> shall similarly apply to successive reorganizations, reclassifications, Fundamental Transactions or similar
      transactions.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;">Notwithstanding anything to the contrary contained herein, with respect to any corporate event or other transaction contemplated by this <u>Section 3(d)</u>,
      the Holder shall have the right to elect, prior to the consummation of such event or transaction, to exercise this Warrant instead of giving effect to <u>Section 3(d)</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Other Dividends and Distributions</u>. If the Company shall, at any time or from time to time after the Issue Date, make or declare, or fix a
      record date for the determination of holders of Ordinary Shares (or equivalent securities) entitled to receive, a dividend or any other distribution payable in cash, securities of the Company (other than a dividend or distribution of shares of
      Ordinary Shares, Options or Convertible Securities in respect of outstanding Ordinary Shares (or equivalent securities)) or other property, then, and in each such event, the Company shall ensure that provisions are made so that the Holder shall
      receive upon exercise of this Warrant Certificate, in addition to the number of Warrant ADSs (represented by ADRs) receivable thereupon, the kind and amount of cash, securities of the Company or other property which the Holder would have been
      entitled to receive had this Warrant Certificate been exercised in full into Warrant ADSs (represented by ADRs) on the date of such event and had the Holder thereafter, during the period from the date of such event to and including the date of
      exercise, retained such cash, securities or other property receivable by them as aforesaid during such period, giving application to all adjustments called for during such period under this <u>Section 3</u> with respect to the rights of the Holder;
      <font style="font-style: italic;">provided </font>that no such provision shall be made if the Holder receives, simultaneously with the distribution to the holders of Ordinary Shares (or equivalent securities), a dividend or other distribution of
      such securities, cash or other property in an amount equal to the amount of such securities, cash or other property as the Holder would have received if this Warrant Certificate had been exercised in full into Warrant ADSs (represented by ADRs) on
      the date of such event.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Certain Events</u>. If any event of the type contemplated by the provisions of this <u>Section 3</u> but not expressly provided for by such
      provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features in each case, other than with respect to any Excluded Issuance) occurs, then the Board of Directors of the
      Company shall make an appropriate adjustment in the Exercise Price of this Warrant Certificate so as to protect the rights of the Holder in a manner consistent with the provisions of this <u>Section 3</u>; <font style="font-style: italic;">provided
      </font>that (i) no such adjustment pursuant to this <u>Section 3(f)</u> shall increase the Exercise Price or decrease the number of Warrant ADSs (represented by ADRs) issuable as otherwise determined pursuant to this <u>Section 3</u> and (ii) for
      the avoidance of doubt, no adjustment pursuant to this <u>Section 3(f)</u> shall be made in connection with an Excluded Issuance.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;"> (g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Certificate as to Adjustment</u>. As promptly as reasonably practicable following any adjustment of the Exercise Price, but in any event not
      later than three business days thereafter, the Company shall furnish to the Holder a certificate of an executive officer setting forth in reasonable detail such adjustment and the facts upon which it is based and certifying the calculation thereof.
      As promptly as reasonably practicable following the receipt by the Company of a written request by the Holder, but in any event not later than three business days thereafter, the Company shall furnish to the Holder a certificate of an executive
      officer certifying the Exercise Price then in effect and the number of Warrant ADSs or the amount, if any, of other shares of stock, securities or assets then issuable upon exercise of this Warrant Certificate. Upon request of the Holder, the Company
      shall issue a replacement Warrant Certificate reflecting the as-adjusted number of Warrant ADSs and the then-applicable Exercise Price, as set forth in Section 5(b)(iii).</div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Change in ADS Ratio</u>. If, after the Issue Date, the ADS Ratio is increased or reduced, then the number of Warrant ADSs (represented by ADRs)
      to be issued on exercise of this Warrant Certificate will be reduced or increased (respectively) in inverse proportion to the change in the ADS Ratio, and the Exercise Price per Warrant ADS will be increased or reduced (respectively) in proportion to
      the change in the number Ordinary Shares issuable per ADS, so that the aggregate Exercise Price remains unchanged.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding, the Company effects a Fundamental Transaction, then, upon any
      subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant ADS (represented by an ADR) that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the
      option of the Holder (without regard to any limitation in <u>Section 2(e)</u> on the exercise of this Warrant), the number of Ordinary Shares (or other securities) of the successor or acquiring corporation or of the Company, if it is the surviving
      corporation, and any additional consideration (the &#8220;<u>Alternate</u>&#160;<u>Consideration</u>&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of Ordinary Shares (or equivalent securities) for which this Warrant is
      exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in <u>Section 2(e)</u> on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
      appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one (1) Ordinary Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the
      Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Ordinary Shares (or equivalent securities) are given any choice as to the securities, cash or
      property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any
      successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;<u>Successor Entity</u>&#8221;) to assume in writing all of the obligations of the Company under this Warrant pursuant to written agreements in form and substance
      reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor
      Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Ordinary
      Shares (or equivalent securities) acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the Exercise
      Price hereunder to such shares of capital stock (but taking into account the relative value of the Ordinary Shares (or equivalent securities) pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of
      shares of capital stock and such Exercise Price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance
      to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the
      &#8220;Company&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as
      the Company herein.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Calculations</u>. All calculations under this <u>Section 3</u> shall be made to the nearest cent or the nearest 1/100th of a share, as the case
      may be. For purposes of this <u>Section 3</u>, the number of Ordinary Shares (or equivalent securities) deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (or equivalent securities) (excluding
      treasury shares, if any) issued and outstanding.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 41pt; line-height: 1.25;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution in whatever
      form) on its Ordinary Shares (or equivalent securities), (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of its Ordinary Shares (or equivalent securities), (C) the Company shall authorize the granting to all
      holders of its Ordinary Shares (or equivalent securities) rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection
      with any reclassification of its Ordinary Shares (or equivalent securities), any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange
      whereby its Ordinary Shares (or equivalent securities) are converted into other securities, cash or property, (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, or (F)
      the Company seeks to engage in a Fundamental Transaction, then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the Warrant Register (as defined below) of the Company, at least twenty (20)
      calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not
      to be taken, the date as of which the holders of its Ordinary Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such Fundamental Transaction,
      reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of its Ordinary Shares (or equivalent securities) of record shall be entitled to
      exchange their Ordinary Shares (or equivalent securities) for securities, cash or other property deliverable upon such Fundamental Transaction, reclassification, consolidation, merger, sale, transfer or share exchange; <font style="font-style: italic;">provided </font>that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice required to
      be provided hereunder may contain information that constitutes material, non-public information regarding the Company or any of its subsidiaries, the Company shall obtain the Holder&#8217;s prior consent to receipt of such notice. If the Holder declines to
      receive any such notice pursuant to the immediately preceding sentence, the Company shall not be deemed to have breached its obligation to deliver such notice hereunder. The Holder shall remain entitled to exercise this Warrant during the 20-day
      period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;"><br>
    </div>
    <div style="text-align: justify; margin-left: 41pt; line-height: 1.25;"><u>Section 4.</u>&#160;&#160; <u>Registration Rights</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 77pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><u>Registration</u>.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall prepare and file or cause to be prepared and filed with the Commission, no later than April 30, 2025 (the &#8220;<u>Filing

        Deadline</u>&#8221;), a registration statement for an offering to be made on a continuous basis pursuant to Rule 415 of the Securities Act registering the resale from time to time by the Holder of all Registrable Securities held by the Holder (the &#8220;<u>Resale

        Registration</u>&#160;<u>Statement</u>&#8221;). The Resale Registration Statement shall be on Form F-3 or, if the use of Form F-3 is not then available to the Company, on Form F-1 or such other appropriate form permitting registration of such Registrable
      Securities for resale by the Holder. The Company shall use reasonable best efforts to cause the Resale Registration Statement to be declared effective as soon as possible after filing, but in no event shall the Resale Registration Statement be
      declared effective later than the earlier of (i) sixty (60) days following the Filing Deadline or (ii) ten (10) Business Days after the Commission notifies the Company that it will not review the Resale Registration Statement, if applicable (the &#8220;<u>Effectiveness

        Deadline</u>&#8221;); provided, that the Effectiveness Deadline shall be extended by no more than ninety (90) days after the Filing Deadline if the Registration Statement is reviewed by, and receives comments from, the Commission. Once effective, the
      Company shall keep the Resale Registration Statement continuously effective and supplemented and amended to the extent necessary to ensure that such Registration Statement is available or, if not available, to ensure that another registration
      statement is available, under the Securities Act at all times until such date as all Registrable Securities covered by the Resale Registration Statement have been disposed of in accordance with the intended method(s) of distribution set forth in such
      Registration Statement or such securities have been withdrawn (the &#8220;<u>Effectiveness</u>&#160;<u>Period</u>&#8221;). The Resale Registration Statement shall contain a prospectus in such form as to permit the Holder to sell such Registrable Securities pursuant
      to Rule 415 under the Securities Act (or any successor or similar provision adopted by the Commission then in effect) at any time beginning on the effective date for such Registration Statement, and shall provide that such Registrable Securities may
      be sold pursuant to any method or combination of methods legally available to, and requested by, the Holder.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">18</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall notify the Holder in writing of the effectiveness of the Resale Registration Statement as soon as practicable, and in any event
      within one (1) Business Day after the Resale Registration Statement becomes effective, and shall furnish to Holder, without charge, such number of copies of the Resale Registration Statement (including any amendments, supplements and exhibits), the
      prospectus contained therein (including each preliminary prospectus and all related amendments and supplements) and any documents incorporated by reference in the Resale Registration Statement or such other documents as the Holder may reasonably
      request in order to facilitate the sale of the Registrable Securities in the manner described in the Resale Registration Statement.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the provisions of <u>Section 4(a)(i)</u> above, the Company shall promptly prepare and file with the Commission from time to time such
      amendments and supplements to (or replacements of) the Resale Registration Statement and prospectus used in connection therewith as may be necessary to keep the Resale Registration Statement (or replacements thereof) effective and to comply with the
      provisions of the Securities Act with respect to the disposition of all the Registrable Securities during the Effectiveness Period. If any Resale Registration Statement filed pursuant to <u>Section 4(a)(i)</u> is filed on Form F-3 and thereafter the
      Company becomes ineligible to use such registration statement for secondary sales, the Company shall promptly notify the Holder of such ineligibility and shall file a shelf registration on Form F-1 or other appropriate form as promptly as practicable
      (but no later than 14 calendar days after becoming ineligible to use Form F-3) to replace the Resale Registration Statement and use its best efforts to have the such replacement Resale Registration Statement declared effective as promptly as
      practicable and shall cause such replacement Resale Registration Statement to remain effective, and to be supplemented and amended to the extent necessary to ensure that such Resale Registration Statement is available or, if not available, that
      another Resale Registration Statement is available, for the resale of all the Registrable Securities held by the Holder until all such Registrable Securities have been sold; provided, however, that at any time the Company once again becomes eligible
      to use Form F-3, the Company shall cause such replacement Resale Registration Statement to be amended, or shall file a new replacement Resale Registration Statement, such that the Resale Registration Statement is once again on Form F-3.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company represents and warrants that there are sufficient ADRs registered on a registration statement on Form F-6 and available for issuance in
      respect of all Warrant ADSs issuable hereunder, and the Company covenants that it will cause a sufficient number of ADRs to remain registered on a registration statement on Form F-6 and available for issuance to satisfy the Company&#8217;s obligations
      hereunder at all times that this Warrant is outstanding.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(b) <u>Rule 144 Reporting.</u> With a view to making available to the Holder the benefits of Rule 144 and any other rule or regulation of the Commission that
        may at any time permit the Holder to sell securities of the Company to the public without registration or pursuant to a registration on a Resale Registration Statement, the Company shall make and keep available adequate current public information,
        as those terms are understood and defined in Rule 144.</div>
      <div> <br>
      </div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">19</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 41pt; line-height: 1.25;"><br>
    </div>
    <div style="text-align: justify; margin-left: 41pt; line-height: 1.25;"><u>Section 5.</u>&#160;&#160; <u>Transfer of Warrant</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transferability</u>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without
      limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form
      attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a
      new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant
      not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
      in which case, the Holder shall surrender this Warrant to the Company within two (2) Trading Days of the date the Holder delivers to the Company a completed Assignment Form in the form attached hereto duly executed by the Holder assigning all or any
      portion of this Warrant. This Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant ADSs (represented by ADRs) without having a new Warrant issued.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 77pt;"><br>
          </td>
          <td style="width: 35.95pt; vertical-align: top;">(b)</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Replacement Warrants</u>.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written
      notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with <u>Section 5(a)</u>, as to any transfer which may be involved in such division or
      combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated as of the
      Issue Date and shall be identical with this Warrant except as to the number of Warrant ADSs (represented by ADRs) issuable pursuant thereto.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and upon delivery of
      an indemnity reasonably satisfactory to it (it being understood that a written indemnification agreement or affidavit of loss of the Holder shall be a sufficient indemnity) and, in case of mutilation, upon surrender of such Warrant for cancellation
      to the Company, the Company at its own expense shall execute and deliver to the Holder, in lieu hereof, a new Warrant of like tenor and exercisable for an equivalent number of Warrant ADSs (represented by ADRs) as this Warrant so lost, stolen,
      mutilated or destroyed; <font style="font-style: italic;">provided that</font>, in the case of mutilation, no indemnity shall be required if this Warrant in identifiable form is surrendered to the Company for cancellation.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">20</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; margin-right: 5.9pt; margin-left: 77pt; line-height: 1.25;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon request by the Holder and surrender of this Warrant Certificate to the Company for replacement, the Company, at its own expense, shall
      execute and deliver to the Holder in replacement of this Warrant Certificate a new Warrant Certificate of like tenor and exercisable for such number of Warrant ADSs (represented by ADRs) and at such Exercise Price as this Warrant shall be exercisable
      for immediately prior to such request, after taking into account any adjustments to the number of Warrant ADSs and the Exercise Price has may have been made pursuant to the terms hereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transferee Representations</u>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of
      this Warrant shall not be eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
      transferee of this Warrant, as the case may be, deliver a written statement from the transferee to the Company certifying that the transferee is an &#8220;accredited investor&#8221; as defined in Rule 501(a) under the Securities Act, making the representations
      and certifications set forth in <u>Section 5(e)</u> of this Warrant and making such additional representations as the Company may, after consultation with its counsel, require in order to confirm compliance with applicable securities laws.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;<u>Warrant
        Register</u>&#8221;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
      and for all other purposes, absent actual notice to the contrary.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Representation by the Holder</u>. The Holder, by the acceptance hereof, represents and warrants that (i) it is an &#8220;accredited investor&#8221; as
      defined in Rule 501(a) under the Securities Act and (ii) it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant ADSs (represented by ADRs) issuable upon such exercise, for its own account and not with a view to or for
      distributing or reselling such Warrant ADSs (represented by ADRs) or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 41pt; line-height: 1.25;"><u>Section 6.</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Miscellaneous</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Rights as Stockholder Until Exercise; No Settlement in Cash</u>. This Warrant does not entitle the Holder to any voting rights, dividends or
      other rights as a stockholder of the Company prior to the exercise hereof as set forth herein. Without limiting the rights of a Holder to receive Warrant ADSs (represented by ADRs) on a &#8220;cashless exercise,&#8221; in no event will the Company be required to
      net cash settle an exercise of this Warrant.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">21</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 41pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Removal of Restrictive Legends</u>. Neither this Warrant nor any certificates or ADRs evidencing Warrant ADSs shall contain
      any legend restricting the transfer thereof in any of the following circumstances: (A) following any sale of this Warrant or such Warrant ADSs (represented by ADRs) issued or delivered to the Holder under or in connection herewith pursuant to Rule
      144, (B) if this Warrant or such Warrant ADSs (represented by ADRs) are eligible for sale under Rule 144(b)(1), or (C) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and
      pronouncements issued by the staff of the Commission and including due to such securities being covered by a valid registration statement) (collectively, the &#8220;<u>Unrestricted Conditions</u>&#8221;). In such circumstances, the Company shall seek to cause
      its counsel to issue a legal opinion to the Transfer Agent or Depositary, as applicable, if required by such Transfer Agent or Depositary to effect the issuance of Warrant ADSs (represented by ADRs), without a restrictive legend or removal of the
      legend hereunder. If the Unrestricted Conditions are met at the time of issuance of this Warrant, the Warrant ADSs or such other securities of the Company issuable in connection with this Warrant, then this Warrant, Warrant ADSs or other securities,
      as the case may be, shall be issued free of all legends.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Replacement Warrant</u>. The Company agrees that at such time as the Unrestricted Conditions have been satisfied it shall promptly (but in any
      event within ten (10) business days) following written request from the Holder issue a replacement Warrant or replacement Warrant ADSs (represented by ADRs), or replacement shares in respect of such other securities, as the case may be, free of all
      restrictive legends.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Authorized Shares</u>. The Company covenants that, during the period this Warrant is outstanding, it will reserve from its authorized and
      unissued Ordinary Shares a sufficient number of Ordinary Shares to provide for the issuance of the Ordinary Shares and ADSs underlying this Warrant upon the exercise of any purchase rights under this Warrant. The Company further covenants that its
      issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Ordinary Shares and ADSs upon the exercise of the purchase rights under this Warrant. The Company will take all such
      action as may be necessary, including giving directions to the Depositary, to assure that the Warrant ADSs (represented by ADRs) and the underlying Ordinary Shares may be issued as provided herein without violation of any applicable law or
      regulation, or of any requirements of the Trading Market upon which the ADSs (represented by ADRs) are then listed. The Company covenants that all Warrant ADSs (represented by ADRs) and all Ordinary Shares underlying the Warrant ADSs will, upon
      exercise of the purchase rights represented by this Warrant and payment for such Warrant ADSs in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, rights of pre-emption, liens and charges
      created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">22</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Impairment</u>. Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without
      limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or
      performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in
      this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue unrestricted, fully paid and
      nonassessable Warrant ADSs (represented by ADRs) upon the exercise of this Warrant, and (ii) use best efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be necessary
      to enable the Company to perform its obligations under this Warrant. Before taking any action which would result in an adjustment in the number of Warrant ADSs for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain
      all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rule 144 Compliance</u>. With a view to making available to the Holder the benefits of Rule 144 under the Securities Act and any other rule or
      regulation of the Commission that may at any time permit a holder to sell securities of the Company to the public without registration or pursuant to a Registration Statement, the Company shall:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;make and keep public information available, as those terms are understood and defined in Rule 144 under the Securities Act;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; use reasonable best efforts to file with the Commission in a timely manner all reports and other documents required of the Company under the
      Securities Act and the Exchange Act; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 77pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; furnish to the Holder, promptly upon request, a written statement by the Company as to its compliance with the reporting requirements of Rule 144
      under the Securities Act and of the Securities Act and the Exchange Act, a copy of the most recent annual or quarterly report of the Company, and such other reports and documents so filed or furnished by the Company as such holder may reasonably
      request in connection with the sale of Warrant ADSs (represented by ADRs) without registration.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Governing Law</u>. This Warrant and the rights and obligations of the parties hereunder shall be governed by, and construed in accordance with,
      the law of the State of New York, without regard to principles of conflicts of laws that would result in the application of the laws of any other jurisdiction.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.95pt; margin-left: 41pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Submission to Jurisdiction</u>. The Company agrees that any suit, action or proceeding with respect to this Warrant or any
      judgment entered by any court in respect thereof may be brought initially in the federal or state courts in New York, New York or in the courts of its own corporate domicile and irrevocably submits to the exclusive jurisdiction of each such court for
      the purpose of any such suit, action, proceeding or judgment. This Section is for the benefit of the Holder only and, as a result, the Holder shall not be prevented from taking proceedings in any other courts with jurisdiction. To the extent allowed
      by any applicable law, the Holder may take concurrent proceedings in any number of jurisdictions.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">23</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Waiver of Venue, Etc</u>. The Company irrevocably waives to the fullest extent permitted by law any objection that it may now or hereafter have
      to the laying of the venue of any suit, action or proceeding arising out of or relating to this Warrant and hereby further irrevocably waives to the fullest extent permitted by law any claim that any such suit, action or proceeding brought in any
      such court has been brought in an inconvenient forum. A final judgment (in respect of which time for all appeals has elapsed) in any such suit, action or proceeding shall be conclusive and may be enforced in any court to the jurisdiction of which the
      Company is or may be subject, by suit upon judgment.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.85pt; margin-left: 41pt; line-height: 1.25;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Waiver of Jury Trial</u>. THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY
      APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS WARRANT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Waiver</u>. No failure on the part of the Holder to exercise and no delay in exercising, and no course of dealing with respect to, any right,
      power or privilege under this Warrant shall operate as a waiver thereof, nor shall any single or partial exercise of any right, power or privilege under this Warrant preclude any other or further exercise thereof or the exercise of any other right,
      power or privilege. The remedies provided herein are cumulative and not exclusive of any remedies provided by law.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Expenses</u>. If the Company fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company
      shall pay to the Holder such amounts as shall be sufficient to cover any actual, reasonable and documented attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise
      enforcing any of its rights, powers or remedies hereunder.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>. All notices, requests, instructions, directions and other communications provided for herein (including any modifications of, or
      waivers, requests or consents under, this Warrant) shall be given or made in writing (including by telecopy or email) delivered, if to the Company or the Holder, to its address specified on the signature pages hereto, or at such other address as
      shall be designated by such party in a written notice to the other party. Except as otherwise provided in this Warrant, all such communications shall be deemed to have been duly given upon receipt of a legible copy thereof, in each case given or
      addressed as aforesaid. All such communications provided for herein by telecopy shall be confirmed in writing promptly after the delivery of such communication (it being understood that non-receipt of written confirmation of such communication shall
      not invalidate such communication).</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">24</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Limitation of Liability</u>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
      Warrant ADSs (represented by ADRs), and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any ADSs (represented by ADRs) or any Ordinary Shares or as a
      stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Remedies</u>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to
      seek specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and
      not to assert the defense in any action for specific performance that a remedy at law would be adequate.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successors and Assigns</u>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall be binding
      upon and inure to the benefit of the successors and permitted assigns of the Company and the successors and permitted assigns of the Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this
      Warrant and shall be enforceable by the Holder or any holder of Warrant ADSs (represented by ADRs).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendments, Etc</u>. Except as otherwise expressly provided in this Warrant, any provision of this Warrant may be modified or supplemented only
      by an instrument in writing signed by the Company and the Holder.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Severability</u>. If any provision hereof is found by a court to be invalid or unenforceable, to the fullest extent permitted by any applicable
      law the parties agree that such invalidity or unenforceability shall not impair the validity or enforceability of any other provision hereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Currency</u>. Unless otherwise indicated, all dollar amounts referred to in this Warrant are in United States Dollars (&#8220;<u>US Dollars</u>&#8221;). All
      amounts owing under this Warrant shall be paid in US Dollars. All amounts denominated in other currencies shall be converted in the US Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. &#8220;<u>Exchange Rate</u>&#8221;
      means, in relation to any amount of currency to be converted into US Dollars pursuant to this Warrant, the US Dollar exchange rate as published in the Wall Street Journal (NY edition) on the relevant date of calculation.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Captions</u>. The captions and section headings appearing herein are included solely for convenience of reference and are not intended to affect
      the interpretation of any provision of this Warrant.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 41pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Counterparts</u>. This Warrant may be executed in any number of counterparts, all of which taken together shall constitute one and the same
      instrument and any of the parties hereto may execute this Warrant by signing any such counterpart.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; margin-right: 62.05pt; margin-left: 61.15pt; line-height: 1.25;">(Signature Page Follows)</div>
    <div style="text-align: center; margin-right: 62.05pt; margin-left: 61.15pt; line-height: 1.25;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">25</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <br>
    <div style="text-indent: 33.5pt; margin-left: 5.15pt; margin-top: 0.05pt;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as a Deed on the date first above indicated.</div>
    <div style="margin-top: 8.9pt;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%;">
              <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: bold;"><font style="font-size: 10pt;">GIVEN UNDER THE COMMON SEAL OF</font></div>
              <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: bold;"><font style="font-size: 10pt;">TRINITY BIOTECH PLC </font></div>
              <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: bold;"><font style="font-size: 10pt;"> <br>
                </font></div>
              <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: bold;"><font style="font-size: 10pt; font-weight: normal;"> <br>
                </font></div>
              <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: bold;"><img width="285" border="0" height="62" src="image00005.jpg">
                <div style="margin-top: 0.65pt; font-weight: normal;"><br>
                </div>
                <div style="font-size: 10pt; font-weight: normal;">Address for Notices:</div>
                <div style="font-weight: normal;"><br>
                </div>
                <div style="font-weight: normal; font-size: 10pt;">Trinity Biotech plc</div>
                <div style="font-weight: normal; font-size: 10pt;"> IDA Business Park,</div>
                <div style="font-weight: normal; font-size: 10pt;">Bray, Co. Wicklow, Ireland </div>
                <div style="font-weight: normal; font-size: 10pt;">A98 H5C8</div>
                <div style="font-weight: normal; font-size: 10pt;">Attention: John Gillard, CEO </div>
                <div style="font-weight: normal; font-size: 10pt;">Telephone: +353 l 276 9800</div>
                <div style="font-weight: normal; font-size: 10pt;">Email: Lennotice@trinitybiotech.com</div>
                <font style="font-weight: normal; font-size: 10pt;">&#160;</font>
                <div style="font-weight: normal; font-size: 10pt;">With a copy to (which shall not constitute notice): </div>
                <div style="font-weight: normal; font-size: 10pt;"> <br>
                </div>
                <div style="font-weight: normal; font-size: 10pt;">Carter Ledyard &amp; Milburn LLP</div>
                <div style="margin-top: 0.4pt; font-weight: normal; font-size: 10pt;">2 Wall Street, New York, NY 10005 </div>
                <div style="margin-top: 0.4pt; font-weight: normal; font-size: 10pt;">Attention: Steven J. Glusband, Esq.</div>
                <div style="margin-top: 0.15pt; font-weight: normal; font-size: 10pt;">Email: glusband@clm.com</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="margin-left: 192.85pt; font-size: 8pt; font-weight: bold;"><br>
    </div>
    <div style="text-align: center; margin-right: 34.1pt; margin-left: 38.75pt; font-family: 'Times New Roman',Times,serif;">[Signature Page to Warrant 500k ADS]</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 5%;"><br>
          </td>
          <td colspan="2">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Accepted and Agreed,</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Perceptive Credit Holdings II, LP</div>
          </td>
          <td style="width: 50%;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 5%;" rowspan="1"><br>
          </td>
          <td rowspan="1" colspan="2"><br>
          </td>
          <td style="width: 50%;" rowspan="1"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 5%;" rowspan="1"><br>
          </td>
          <td style="width: 3%;" rowspan="1"><br>
          </td>
          <td style="width: 42%;" rowspan="1">Perceptive Credit Opportunities GP, LLC, its general partner</td>
          <td style="width: 50%;" rowspan="1"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 5%;" rowspan="1"><br>
          </td>
          <td style="width: 3%;" rowspan="1"><br>
          </td>
          <td style="width: 42%;" rowspan="1"><br>
          </td>
          <td style="width: 50%;" rowspan="1"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; padding-bottom: 2px;" rowspan="1"><br>
          </td>
          <td style="width: 3%; text-align: left; vertical-align: bottom; padding-bottom: 2px;" rowspan="1">By:</td>
          <td style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
            <div style="text-align: left; line-height: 1.25;"><img width="106" height="46" src="image1.jpg"></div>
          </td>
          <td style="width: 50%; padding-bottom: 2px;" rowspan="1"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 5%;" rowspan="1"><br>
          </td>
          <td style="width: 3%;" rowspan="1"><br>
          </td>
          <td style="width: 42%;" rowspan="1">Name: Sandeep Dixit</td>
          <td style="width: 50%;" rowspan="1"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 5%;" rowspan="1"><br>
          </td>
          <td style="width: 3%;" rowspan="1"><br>
          </td>
          <td style="width: 42%;" rowspan="1">Title: Chief Credit Officer</td>
          <td style="width: 50%;" rowspan="1"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 5%;" rowspan="1"><br>
          </td>
          <td style="width: 3%;" rowspan="1"><br>
          </td>
          <td style="width: 42%;" rowspan="1"><br>
          </td>
          <td style="width: 50%;" rowspan="1"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; padding-bottom: 2px;" rowspan="1"><br>
          </td>
          <td style="width: 3%; padding-bottom: 2px; text-align: left; vertical-align: bottom;" rowspan="1">By:</td>
          <td style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
            <div style="text-align: left; line-height: 1.25;"><img width="104" height="46" src="image6.jpg"></div>
          </td>
          <td style="width: 50%; padding-bottom: 2px;" rowspan="1"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 5%;" rowspan="1"><br>
          </td>
          <td style="width: 3%;" rowspan="1"><br>
          </td>
          <td style="width: 42%;" rowspan="1">Name: Sam Chawla</td>
          <td style="width: 50%;" rowspan="1"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 5%;" rowspan="1"><br>
          </td>
          <td style="width: 3%;" rowspan="1"><br>
          </td>
          <td style="width: 42%;" rowspan="1">Title: Portfolio Manager</td>
          <td style="width: 50%;" rowspan="1"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 5%;" rowspan="1"><br>
          </td>
          <td rowspan="1" colspan="2"><br>
          </td>
          <td style="width: 50%;" rowspan="1"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 5%;" rowspan="1"><br>
          </td>
          <td rowspan="1" colspan="3">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Address for Notices:</div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">c/o Perceptive Advisors LLC </div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">51 Astor Place, 10th Floor </div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">New York, NY 10003</div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Attn: Sandeep Dixit</div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Email: Sandeep@perceptivelife.com&#160;</div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>PCOFReporting@perceptivelife.com</u></div>
            <div style="line-height: 1.25;">&#160; <br>
            </div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">with a copy to (which shall not constitute notice):</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Chapman and Cutler LLP </div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">1270 Avenue of the Americas </div>
            <div style="line-height: 1.25;">30th Floor <br>
            </div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">New York, New York 10020-1708 </div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Attention: Nicholas Whitney</div>
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">E-mail: Whitney@chapman.com</div>
          </td>
        </tr>

    </table>
    <br>
    <div style="text-align: center; margin-right: 203.2pt; margin-left: 223.15pt; line-height: 1.25;">[Signature Page to Warrant 500k ADS]</div>
    <div style="text-align: center; margin-right: 203.2pt; margin-left: 223.15pt; line-height: 1.25;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">NOTICE OF EXERCISE</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 60pt; line-height: 1.25;">TO:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;TRINITY BIOTECH PLC</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-right: 68.7pt; margin-left: 60pt; line-height: 1.25;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned hereby elects to purchase&#160;<u>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160;&#160; &#160;</u> American Depositary Receipts pursuant to the terms of the attached Warrant and
      tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <div style="text-indent: 36pt; margin-right: 68.7pt; margin-left: 60pt; line-height: 1.25;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Payment shall take the form of (check applicable box): </div>
      <div style="text-indent: 36pt; margin-right: 68.7pt; margin-left: 60pt; line-height: 1.25;"> <br>
      </div>
      <div style="text-indent: 72pt; margin-right: 37.8pt; margin-left: 60pt; line-height: 1.25;">&#9744; in lawful money of the United States; or</div>
      <div style="text-indent: 36pt; margin-right: 68.7pt; margin-left: 60pt; line-height: 1.25;"> <br>
      </div>
    </div>
    <div style="text-indent: 72pt; margin-right: 37.8pt; margin-left: 60pt; line-height: 1.25;">&#9744; the cancellation of such number of Warrant ADSs as is necessary, in accordance with the formula set forth in <u>subsection 2(c)</u>, to exercise this Warrant
      with respect to the maximum number of Warrant ADSs purchasable pursuant to the cashless exercise procedure set forth in <u>subsection 2(c)</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-right: 78pt; margin-left: 60pt; line-height: 1.25;">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Please issue said Warrant ADSs (represented by ADRs) in the name of the undersigned or in such other name as is specified below:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 168pt; padding-bottom: 1px;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 220pt;">&#160;</td>
          <td style="width: auto; padding-bottom: 1px;" colspan="1">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="margin-left: 60pt; line-height: 1.25;">Check applicable box and fill in information:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-right: 37.8pt; margin-left: 60pt; line-height: 1.25;">&#9744; The Warrant ADSs (represented by ADRs) shall be delivered to the following DWAC Account Number:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 255pt; padding-bottom: 2px;">
            <div style="margin: 0px 0px 0px 168pt;">DTC Participant #:</div>
          </td>
          <td style="border-bottom: 1px solid #000000; width: auto;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 280pt; padding-bottom: 2px;">
            <div style="margin: 0px 0px 0px 168pt;">Undersigned&#8217;s Account #</div>
          </td>
          <td style="border-bottom: 1px solid #000000; width: auto;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 168pt; padding-bottom: 1px;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 220pt;">&#160;</td>
          <td style="width: auto; padding-bottom: 1px;" colspan="1">&#160;</td>
        </tr>

    </table>
    <br>
    <div style="text-indent: 36pt; margin-right: 37.8pt; margin-left: 60pt; line-height: 1.25;">&#9744; The Warrant ADSs (represented by ADRs) shall be delivered by physical delivery of ADRs to:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 168pt; padding-bottom: 1px;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 220pt;">&#160;</td>
          <td style="width: auto; padding-bottom: 1px;" colspan="1">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 168pt; padding-bottom: 1px;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 220pt;">&#160;</td>
          <td style="width: auto; padding-bottom: 1px;" colspan="1">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

        <tr>
          <td style="width: 168pt; padding-bottom: 1px;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 220pt;">&#160;</td>
          <td style="width: auto; padding-bottom: 1px;" colspan="1">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 60pt; line-height: 1.25;">[SIGNATURE OF HOLDER]</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 180pt; padding-bottom: 2px;">
                <div>
                  <div>
                    <div>
                      <div>
                        <div>
                          <div style="margin: 0px 0px 0px 60pt;">Name of Investing Entity:</div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </td>
              <td style="border-bottom: 1px solid #000000; width: auto;"><br>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td rowspan="1" style="width: 290pt; padding-bottom: 2px;">
                <div style="margin: 0px 0px 0px 60pt;"><font style="font-style: italic;">Signature of Authorized Signatory of Investing Entity</font>:</div>
              </td>
              <td rowspan="1" style="border-bottom: 1px solid #000000; width: auto;">&#160;</td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td rowspan="1" style="width: 200pt; padding-bottom: 2px;">
                <div style="margin: 0px 0px 0px 60pt;">Name of Authorized Signatory:</div>
              </td>
              <td rowspan="1" style="border-bottom: 1px solid #000000; width: auto;">&#160;</td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td rowspan="1" style="width: 200pt; padding-bottom: 2px;">
                <div style="margin: 0px 0px 0px 60pt;">Title of Authorized Signatory:</div>
              </td>
              <td rowspan="1" style="border-bottom: 1px solid #000000; width: auto;">&#160;</td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td rowspan="1" style="width: 90pt; padding-bottom: 2px;">
                <div style="margin: 0px 0px 0px 60pt;">Date:</div>
              </td>
              <td rowspan="1" style="border-bottom: 1px solid #000000; width: auto;">&#160;</td>
            </tr>

        </table>
        <br>
      </div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">ASSIGNMENT FORM</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 10.5pt; margin-right: 37.8pt; margin-left: 60pt; line-height: 1.25; font-style: italic;">(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 10.5pt; margin-right: 37.8pt; margin-left: 60pt; line-height: 1.25;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
              <div style="margin: 0px 0px 0px 60pt;">Name of Person to Whom Warrant is being Transferred:</div>
            </td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
              <div style="margin: 0px 0px 0px 60pt;">Address of Person to Whom Warrant is being Transferred:</div>
            </td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
              <div style="margin: 0px 0px 0px 60pt;">Number of Shares Subject to Warrant being Transferred:</div>
            </td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" rowspan="1">&#160;</td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;" rowspan="1">&#160;</td>
            <td style="width: 50%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" rowspan="1">&#160;</td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;" rowspan="1">&#160;</td>
            <td style="width: 50%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
              <div style="margin: 0px 0px 0px 60pt;">Number of Shares Subject to Warrant being Transferred:</div>
            </td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;" rowspan="1">&#160;</td>
            <td style="width: 50%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
              <div style="margin: 0px 0px 0px 60pt;">Dated:&#160;<u>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; </u>&#160; <u>&#160; &#160;&#160; ,</u>&#160;&#160;<u>&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160; </u><br>
              </div>
            </td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
              <div style="margin: 0px 0px 0px 60pt;">Holder&#8217;s Name: <br>
              </div>
            </td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
              <div style="margin: 0px 0px 0px 60pt;">Holder&#8217;s Signature:</div>
            </td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
              <div style="margin: 0px 0px 0px 60pt;">Name of Authorized Signatory:<br>
              </div>
            </td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
              <div style="margin: 0px 0px 0px 60pt;">Title of Authorized Signatory:<br>
              </div>
            </td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" rowspan="1">
              <div style="margin: 0px 0px 0px 60pt;">Holder&#8217;s Address:</div>
            </td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%;" rowspan="1">&#160;</td>
            <td style="width: 50%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" rowspan="1">&#160;</td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); width: 50%;" rowspan="1">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;">&#160;<br>
      </div>
    </div>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>7
<FILENAME>exhibit_12-1.htm
<DESCRIPTION>EXHIBIT 12.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div>
        <div>
          <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 12.1</u></div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div style="line-height: 1.25;">I, John Gillard, certify that:</div>
          <div style="line-height: 1.25;">&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z717e4d4f3324486a9a429442bed3e1c2" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="line-height: 1.25; text-align: left;">1.</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="line-height: 1.25;">I have reviewed this annual report on Form 20-F of Trinity Biotech plc;</div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zdc04aa374d2044d99d201e702b1bc94d" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="line-height: 1.25; text-align: left;">2.</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="line-height: 1.25;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under
                      which such statements were made, not misleading with respect to the period covered by this report;</div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="za23b3bbc4a49410390a800cff41975a6" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="line-height: 1.25; text-align: left;">3.</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="line-height: 1.25;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash
                      flows of the registrant as of, and for, the periods presented in this report;</div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z4b4a11f57c5e4b6596857f81309eb009" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="line-height: 1.25; text-align: left;">4.</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="line-height: 1.25;">The company&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
                      control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the company and have:</div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z237afc421de3486f9d8b21f76423bcc6" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">&#160;</td>
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="line-height: 1.25; text-align: left;">a)</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="line-height: 1.25;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company,
                      including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zcb1294590324490191f3fcec7ebc64b5" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">&#160;</td>
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="line-height: 1.25; text-align: left;">b)</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="line-height: 1.25;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the
                      reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z8820d107285142efaca47eeb941f0a4a" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">&#160;</td>
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="line-height: 1.25; text-align: left;">c)</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="line-height: 1.25;">Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the
                      end of the period covered by this report based on such evaluation; and</div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zb8cd2f01c4be49b0ba0b38827dfe546a" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">&#160;</td>
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="line-height: 1.25; text-align: left;">d)</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="line-height: 1.25;">Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably
                      likely to materially affect, the company&#8217;s internal control over financial reporting; and</div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z7e84c106820e45aeb821015d367d39e9" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="line-height: 1.25; text-align: left;">5.</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="line-height: 1.25;">The company&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the company&#8217;s auditors and the audit committee of the
                      company&#8217;s board of directors:</div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf2ea639715f145758ac7f96c6d2cef2b" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">&#160;</td>
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="line-height: 1.25; text-align: left;">a)</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="line-height: 1.25;">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to
                      record, process, summarize and report financial information; and</div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25;">&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zb660551c82a842d8965ec55893e6d2de" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

                <tr style="vertical-align: top;">
                  <td style="width: 18pt;">&#160;</td>
                  <td style="text-align: right; vertical-align: top; width: 18pt;">
                    <div style="line-height: 1.25; text-align: left;">b)</div>
                  </td>
                  <td style="text-align: left; vertical-align: top; width: auto;">
                    <div style="line-height: 1.25;">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="line-height: 1.25;">DATE: May 15, 2025</div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="line-height: 1.25;">/s/ John Gillard</div>
                </td>
                <td style="width: 25%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="width: 100%; vertical-align: top;">
                  <div style="line-height: 1.25;">John Gillard</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" style="width: 100%; vertical-align: top;">
                  <div style="line-height: 1.25;">Chief Executive Officer</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;</div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 12.25pt; vertical-align: top;">*</td>
                <td style="width: auto; vertical-align: top;">
                  <div>The originally executed copy of this Certification will be maintained at the Company&#8217;s offices and will be made available for inspection upon request.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25;">&#160;
            <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>8
<FILENAME>exhibit_12-2.htm
<DESCRIPTION>EXHIBIT 12.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 1pt;">&#160;</div>
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 12.2</u></div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">I, Susan O&#8217;Connor, certify that:</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="line-height: 1.25; text-align: left;">1.</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="line-height: 1.25;">I have reviewed this annual report on Form 20-F of Trinity Biotech plc;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="line-height: 1.25; text-align: left;">2.</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="line-height: 1.25;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which
                  such statements were made, not misleading with respect to the period covered by this report;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="line-height: 1.25; text-align: left;">3.</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="line-height: 1.25;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows
                  of the registrant as of, and for, the periods presented in this report;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="line-height: 1.25; text-align: left;">4.</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="line-height: 1.25;">The company&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control
                  over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the company and have:</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 18pt; text-align: left;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="line-height: 1.25; text-align: left;">a)</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="line-height: 1.25;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including
                  its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 18pt; text-align: left;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="line-height: 1.25; text-align: left;">b)</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="line-height: 1.25;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the
                  reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 18pt; text-align: left;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="line-height: 1.25; text-align: left;">c)</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="line-height: 1.25;">Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
                  the period covered by this report based on such evaluation; and</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 18pt; text-align: left;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="line-height: 1.25; text-align: left;">d)</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="line-height: 1.25;">Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably
                  likely to materially affect, the company&#8217;s internal control over financial reporting; and</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="line-height: 1.25; text-align: left;">5.</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="line-height: 1.25;">The company&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the company&#8217;s auditors and the audit committee of the company&#8217;s
                  board of directors:</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 18pt; text-align: left;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="line-height: 1.25; text-align: left;">a)</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="line-height: 1.25;">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record,
                  process, summarize and report financial information; and</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 18pt; text-align: left;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="line-height: 1.25; text-align: left;">b)</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="line-height: 1.25;">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">DATE: May 15, 2025</div>
      <div style="line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">/s/ Susan O&#8217;Connor</div>
            </td>
            <td style="width: 25%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td colspan="3" style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25;">Susan O&#8217;Connor</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25;">Interim Chief Financial Officer</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 12.25pt; vertical-align: top;">*</td>
            <td style="width: auto; vertical-align: top;">
              <div>The originally executed copy of this Certification will be maintained at the Company&#8217;s offices and will be made available for inspection upon request.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">&#160;
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>9
<FILENAME>exhibit_13-1.htm
<DESCRIPTION>EXHIBIT 13.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 1pt;">&#160;</div>
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 13.1</u></div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">18 U.S.C. SECTION 1350</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">In connection with the Annual Report of Trinity Biotech plc (the &#8220;Company&#8221;) on Form 20-F for the period ended December&#160;31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I,
        John Gillard, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-indent: 24.5pt; line-height: 1.25;">(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-indent: 24.5pt; line-height: 1.25;">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">/s/ John Gillard</div>
            </td>
            <td style="width: 25%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td colspan="3" style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25;">John Gillard</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25;">Chief Executive Officer</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">DATE: May 15, 2025</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 12.25pt; vertical-align: top;">*</td>
            <td style="width: auto; vertical-align: top;">
              <div>The originally executed copy of this Certification will be maintained at the Company&#8217;s offices and will be made available for inspection upon request.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">This certification accompanies the Report pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by Trinity Biotech plc
        for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended.</div>
      <div style="line-height: 1.25;">&#160;
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>10
<FILENAME>exhibit_13-2.htm
<DESCRIPTION>EXHIBIT 13.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',serif; font-size: 1pt;">&#160;</div>
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 13.2</u></div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">18 U.S.C. SECTION 1350</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">In connection with the Annual Report of Trinity Biotech plc (the &#8220;Company&#8221;) on Form 20-F for the period ended December&#160;31, 2024
          as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Susan O&#8217;Connor, Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley
          Act of 2002, that:</div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-indent: 24.5pt; line-height: 1.25;">(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-indent: 24.5pt; line-height: 1.25;">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">/s/ Susan O&#8217;Connor</div>
            </td>
            <td style="width: 25%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td colspan="3" style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25;">Susan O&#8217;Connor</div>
            </td>
          </tr>
          <tr>
            <td colspan="3" style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25;">Interim Chief Financial Officer</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">Date: May 15, 2025</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 12.25pt; vertical-align: top;">*</td>
            <td style="width: auto; vertical-align: top;">
              <div>The originally executed copy of this Certification will be maintained at the Company&#8217;s offices and will be made available for inspection upon request.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">This certification accompanies the Report pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by Trinity Biotech plc
        for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended. </div>
      <div style="line-height: 1.25;">&#160;
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.2
<SEQUENCE>11
<FILENAME>exhibit_15-2.htm
<DESCRIPTION>EXHIBIT 15.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 15.2</u></div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>Consent of Independent Registered Public Accounting Firm</u></div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We have issued our report dated May 15,
            2025, with respect to the consolidated financial statements included in the Annual Report of Trinity Biotech plc on Form 20-F for the year ended December&#160;31, 2024. We consent to the incorporation by reference of said report in the following
            Registration Statements of Trinity Biotech plc:</div>
        </div>
      </div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="line-height: 1.25; font-weight: bold;"><u>Form Type</u></div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>File Number</u></div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>Effective&#160;Date</u></div>
            </td>
            <td nowrap="nowrap" style="width: 40%; vertical-align: bottom;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25; font-weight: bold;">Form S-8</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">333-182279</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">6/22/2012</div>
            </td>
            <td nowrap="nowrap" style="width: 40%; vertical-align: bottom;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25; font-weight: bold;">Form S-8</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">333-195232</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">4/11/2014</div>
            </td>
            <td nowrap="nowrap" style="width: 40%; vertical-align: bottom;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25; font-weight: bold;">Form S-8</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">333-253070</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">2/12/2021</div>
            </td>
            <td nowrap="nowrap" style="width: 40%; vertical-align: bottom;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25; font-weight: bold;">Form F-3</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">333-267160</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">9/14/2022</div>
            </td>
            <td nowrap="nowrap" style="width: 40%; vertical-align: bottom;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25; font-weight: bold;">Form F-3</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">333-283091</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">7/28/2024</div>
            </td>
            <td nowrap="nowrap" style="width: 40%; vertical-align: bottom;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25; font-weight: bold;">Form F-3</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">333-283273</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">12/2/2024</div>
            </td>
            <td nowrap="nowrap" style="width: 40%; vertical-align: bottom;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-indent: -12pt; margin-left: 12pt; line-height: 1.25; font-weight: bold;">Form F-3</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">333-286020</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25;">3/28/2025</div>
            </td>
            <td nowrap="nowrap" style="width: 40%; vertical-align: bottom;" colspan="1">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25;">/s/ GRANT THORNTON</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25;">Dublin, Ireland</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: middle;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="line-height: 1.25;">DATE May 15, 2025</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>12
<FILENAME>exhibit_97-1.htm
<DESCRIPTION>EXHIBIT 97.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-family: 'Times New Roman',Times,serif;">
  </font>
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25; text-align: right;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><font style="font-family: 'Times New Roman',Times,serif;"><u><font style="font-weight: bold;">Exhibit 97.1</font></u><br style="line-height: 1.25;">
        </font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">TRINITY BIOTECH PLC</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">INCENTIVE-BASED COMPENSATION RECOVERY POLICY</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">ADOPTED 1 December, 2023</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z317d5b7ab4d14ac59afbd5dc0a33bd59" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Policy Purpose</u>. The purpose of this Incentive-Based Compensation Recovery Policy (the &#8220;<u>Policy</u>&#8221;) is to enable Trinity Biotech plc. (the &#8220;<u>Company</u>&#8221;) to recover Erroneously Awarded Compensation in the
                event that the Company is required to prepare an Accounting Restatement. This Policy is intended to comply with the requirements set forth in Listing Rule 5608 of the corporate governance rules of The NASDAQ Stock Market (the &#8220;<u>Listing
                  Rule</u>&#8221;) and shall be construed and interpreted in accordance with such intent. Unless otherwise defined in this Policy, capitalized terms shall have the meaning ascribed to such terms in Section 7 of the Policy.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z0ecca9874f574666bb605486d9cfc189" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Policy Administration</u>. This Policy shall be administered by the Compensation Committee of the Board (the &#8220;<u>Committee</u>&#8221;) unless the Board determines to administer this Policy itself. The Committee has full and
                final authority to make all determinations under this Policy, in each case to the extent permitted under the Listing Rule and in compliance with (or pursuant to an exemption from the application of) Section 409A of the Code. All
                determinations and decisions made by the Committee pursuant to the provisions of this Policy shall be final, conclusive and binding on all persons, including the Company, its affiliates, its stockholders and Executive Officers. Any action
                or inaction by the Committee with respect to an Executive Officer under this Policy in no way limits the Committee&#8217;s actions or decisions not to act with respect to any other Executive Officer under this Policy or under any similar policy,
                agreement or arrangement, nor shall any such action or inaction serve as a waiver of any rights the Company may have against any Executive Officer other than as set forth in this Policy.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zc3adb4b5b2b04af8a6e989feaa3c3c82" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Policy Application</u>. This Policy applies to all Incentive-Based Compensation received by a person: (a) after beginning service as an Executive Officer; (b) who served as an Executive Officer at any time during the
                performance period for such Incentive-Based Compensation; (c) while the Company had a class of securities listed on a national securities exchange or a national securities association; and (d) during the three completed fiscal years
                immediately preceding the Accounting Restatement Date. In addition to such last three completed fiscal years, the immediately preceding clause (d) includes any transition period that results from a change in the Company&#8217;s fiscal year within
                or immediately following such three completed fiscal years; <u>provided</u>, <u>however</u>, that a transition period between the last day of the Company&#8217;s previous fiscal year end and the first day of its new fiscal year that comprises a
                period of nine to twelve months shall be deemed a completed fiscal year. For purposes of this <u>Section 3</u>, Incentive-Based Compensation is deemed received in the Company&#8217;s fiscal period during which the Financial Reporting Measure
                specified in the Incentive-Based Compensation award is attained, even if the payment or grant of the Incentive-Based Compensation occurs after the end of that period. For the avoidance of doubt, Incentive-Based Compensation that is subject
                to both a Financial Reporting Measure vesting condition and a service-based vesting condition shall be considered received when the relevant Financial Reporting Measure is achieved, even if the Incentive-Based Compensation continues to be
                subject to the service-based vesting condition.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zc2212dd3df1b4a0aadf63b5cb08d313e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Policy Recovery Requirement</u>. In the event of an Accounting Restatement, the Company must recover, reasonably promptly, Erroneously Awarded Compensation, in amounts determined pursuant to this Policy. The Company&#8217;s obligation
                to recover Erroneously Awarded Compensation is not dependent on if or when the Company files restated financial statements. Recovery under this Policy with respect to an Executive Officer shall not require the finding of any misconduct by
                such Executive Officer or such Executive Officer being found responsible for the accounting error leading to an Accounting</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Restatement. In the event of an Accounting Restatement, the Company shall satisfy the Company&#8217;s obligations
      under this Policy to recover any amount owed from any applicable Executive Officer by exercising its sole and absolute discretion in how to accomplish such recovery, to the extent permitted under the Listing Rule and in compliance with (or pursuant
      to an exemption from the application of) Section 409A of the Code. The Company&#8217;s recovery obligation pursuant to this <u>Section 4</u> shall not apply to the extent that the Committee, or in the absence of the Committee, a majority of the
      independent directors serving on the Board, determines that such recovery would be impracticable and:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z2dc3d17f2206489c8fd64b6386628f32" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">a.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>The direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered. Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on
              expense of enforcement, the Company must make a reasonable attempt to recover such Erroneously Awarded Compensation, document such reasonable attempt(s) to recover, and provide such documentation to the Stock Exchange;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z6514f112d87c4491beae1b4ccb7f830a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">b.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Recovery would violate Irish law where that law was adopted prior to November 28, 2022. Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on violation of Irish law, the Company
              must obtain an opinion of Irish counsel, acceptable to the Stock Exchange, that recovery would result in such a violation, and must provide such opinion to the Stock Exchange; or</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z48a160c18aec4eacad89e2397d40ecf3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">c.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the registrant, to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Code.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z5bdf356f88d34db4995ef0aefb109612" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Policy Prohibition on Indemnification and Insurance Reimbursement</u>. The Company is prohibited from indemnifying any Executive Officer or former Executive Officer against the loss of Erroneously Awarded Compensation. Further,
                the Company is prohibited from paying or reimbursing an Executive Officer for the purchase of insurance to cover any such loss.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z0a9c4024ae02465f951859a92c24b0a3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Required Policy-Related Filings</u>. The Company shall file all disclosures with respect to this Policy in accordance with the requirements of the federal securities laws, including disclosures required under the federal securities
                laws.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="ze2ed5ffb658547e5a6f924f772945400" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">7.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Definitions</u>.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zf8c7ac83e47343f8a73b58634d27844e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">a.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>&#8220;<u>Accounting Restatement</u>&#8221; means an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct
              an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the
              current period.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z63473b4ad9784d7f9778223db67acb79" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">b.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>&#8220;<u>Accounting Restatement Date</u>&#8221; means the earlier to occur of: (i) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if the Board action is not required, concludes,
              or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement; and (ii) the date a court, regulator, or other legally authorized body directs the Company to prepare an Accounting Restatement.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="za156f84b50f24d8fa9c2195bbb049a16" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">c.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif;"><font style="font-family: 'Times New Roman',Times,serif;">&#8220;<u>Board</u>&#8221; means the board of directors of the Company.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z5e86c24667d7455abe5915cf81d2ab3e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">d.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>&#8220;<u>Code</u>&#8221; means the U.S. Internal Revenue Code of 1986, as amended. Any reference to a section of the Code or regulation thereunder includes such section or regulation, any valid regulation or other official guidance promulgated under
              such section, and any comparable provision of any future legislation or regulation amending, supplementing, or superseding such section or regulation.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zfcd1718ae7e241cd99862eed4da8ff80" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">e.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>&#8220;<u>Erroneously Awarded Compensation</u>&#8221; means, in the event of an Accounting Restatement, the amount of Incentive-Based Compensation previously received that exceeds the amount of Incentive-Based Compensation that otherwise would have
              been received had it been determined based on the restated amounts in such Accounting Restatement, and must be computed without regard to any taxes paid by the relevant Executive Officer; <u>provided</u>, <u>however</u>, that for
              Incentive-Based Compensation based on stock price or total stockholder<u>&#160;</u>return, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in an Accounting
              Restatement: (i) the amount of Erroneously Awarded Compensation must be based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or total stockholder return upon which the Incentive-Based Compensation was
              received; and (ii) the Company must maintain documentation of the determination of that reasonable estimate and provide such documentation to the Stock Exchange.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zca3ac895005d44b695780e314528b07b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">f.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>&#8220;<u>Executive Officer</u>&#8221; means the Company&#8217;s president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal
              business unit, division, or function (such as sales, administration, or finance), any other officer who performs a policy-making function, or any other person who performs similar policy-making functions for the Company. An executive officer
              of the Company&#8217;s parent or subsidiary is deemed an &#8220;Executive Officer&#8221; if the executive officer performs such policy making functions for the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z7f5e28d45646456fbbb742d8e47e9e15" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">g.</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>&#8220;<u>Financial Reporting Measure</u>&#8221; means any measure that is determined and presented in accordance with the accounting principles used in preparing the Company&#8217;s financial statements, and any measure that is derived wholly or in part
              from such measure; <u>provided</u>, <u>however</u>, that a Financial Reporting Measure is not required to be presented within the<u>&#160;</u>Company&#8217;s financial statements or included in a filing with the U.S. Securities and Exchange Commission
              to qualify as a &#8220;Financial Reporting Measure.&#8221; For purposes of this Policy, &#8220;Financial Reporting Measure&#8221; includes, but is not limited to, stock price and total stockholder return.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z7ae477913d694ed6b1834598cbff90b7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">h.</td>
          <td style="width: auto; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div>&#8220;<u>Incentive-Based Compensation</u>&#8221; means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="za2c37b2c464c4d5a90488725c5719df0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">i.</td>
          <td style="width: auto; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div>&#8220;<u>Stock Exchange</u>&#8221; means the U.S. national stock exchange on which the Company&#8217;s ADSs or ordinary shares are listed (e.g., Nasdaq).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z64974b60c86e4976b7e8371960463853" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">8.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Acknowledgement</u>. Each Executive Officer shall sign and return to the Company, within 30 calendar days following the later of (i) the effective date of this Policy first set forth above or (ii) the date the
                individual becomes an Executive Officer, the Acknowledgement Form attached hereto as <u>Exhibit A</u>, pursuant to which the Executive Officer agrees to be bound by, and to comply with, the terms and conditions of this Policy.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z1dea29f3338c482d99d1e47fdb437142" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">9.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Severability</u>. The provisions in this Policy are intended to be applied to the fullest extent of the law. To the extent that any provision of this Policy is found to be unenforceable or invalid under any
                applicable law, such provision shall be applied to the maximum extent permitted, and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under
                applicable law.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z24a6b8fd2a0445d2a3c7fd87464a2ca8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">10.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Amendment; Termination</u>. The Board may amend this Policy from time to time in its sole and absolute discretion and shall amend this Policy as it deems necessary to reflect the Listing Rule, to comply with (or maintain an
                exemption from the application of) Section 409A of the Code. The Board may terminate this Policy at any time.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z9401d290c17e43ef87d96cdb10d97240" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">11.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Other Recovery Obligations; General Rights</u>. To the extent that the application of this Policy would provide for recovery of Incentive-Based Compensation that the Company recovers pursuant to Section 304 of the
                Sarbanes-Oxley Act or other recovery obligations (including under Irish law), the amount the relevant Executive Officer has already reimbursed the Company will be credited to the required recovery under this Policy. This Policy shall not
                limit the rights of the Company to take any other actions or pursue other remedies that the Company may deem appropriate under the circumstances and under applicable law, in each case to the extent permitted under the Listing Rule and in
                compliance with (or pursuant to an exemption from the application of) Section 409A of the Code. Nothing contained in this Policy shall limit the Company&#8217;s ability to seek recoupment, in appropriate circumstances (including circumstances
                beyond the scope of this Policy) and as permitted by applicable law, of any amounts from any individual, in each case to the extent permitted under the Listing Rule and in compliance with (or pursuant to an exemption from the application
                of) Section 409A of the Code.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z7588eda7b307495a9dac420ed9c90f2f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">12.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Successors</u>. This Policy is binding and enforceable against all Executive Officers and their beneficiaries, heirs, executors, administrators or other legal representatives.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z2ca031d356bc4b4b80468783e3502c4c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">13.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>Effective Date</u>. This policy shall come into effect on, and shall apply to an Incentive-Base Compensation received on or after, the day on which the Listing Rule becomes effective.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>EXHIBIT A</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">TRINITY BIOTECH PLC.</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">INCENTIVE-BASED COMPENSATION RECOVERY POLICY</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">ACKNOWLEDGEMENT FORM</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">By signing below, the undersigned acknowledges and confirms that the undersigned has received and reviewed a copy of the
      Incentive-Based Compensation Recovery Policy (the &#8220;<u>Policy</u>&#8221;) of Trinity Biotech plc (the &#8220;<u>Company</u>&#8221;).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">By signing this Acknowledgement Form, the undersigned acknowledges and agrees that the undersigned is and will continue to be
      subject to the Policy and that the Policy will apply both during and after the undersigned&#8217;s employment with the Company. Further, by signing below, the undersigned agrees to abide by the terms of the Policy, including, without limitation, by
      returning any Erroneously Awarded Compensation (as defined in the Policy) to the Company to the extent required by, and in a manner consistent with, the Policy.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z308dc42b460c4cec957f9778499bb320">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%;">
              <div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">EXECUTIVE OFFICER</div>
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
                </div>
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">____________________________________________<br style="line-height: 1.25;">
                </div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Signature</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
                </div>
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">____________________________________________</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Print Name</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
                </div>
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">____________________________________________</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Date</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
  </div>
  <font style="font-family: 'Times New Roman',Times,serif;">
  </font>
  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>trib-20241231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#DocumentAndEntityInformation" roleURI="http://trinitybiotech.com/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ConsolidatedStatementOfOperations" roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ConsolidatedStatementOfComprehensiveIncome" roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ConsolidatedStatementOfFinancialPosition" roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ConsolidatedStatementOfChangesInEquity" roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ConsolidatedStatementOfCashFlows" roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#Employment" roleURI="http://trinitybiotech.com/role/Employment"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#OtherOperatingIncome" roleURI="http://trinitybiotech.com/role/OtherOperatingIncome"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ImpairmentCharges" roleURI="http://trinitybiotech.com/role/ImpairmentCharges"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#FinancialIncomeAndExpenses" roleURI="http://trinitybiotech.com/role/FinancialIncomeAndExpenses"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IncomeTaxCredit" roleURI="http://trinitybiotech.com/role/IncomeTaxCredit"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossBeforeTax" roleURI="http://trinitybiotech.com/role/LossBeforeTax"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossPerShare" roleURI="http://trinitybiotech.com/role/LossPerShare"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PropertyPlantAndEquipment" roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipment"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#DeferredTaxAssetsAndLiabilities" roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#OtherNon-currentAssets" roleURI="http://trinitybiotech.com/role/OtherNon-currentAssets"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#Inventories" roleURI="http://trinitybiotech.com/role/Inventories"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#TradeAndOtherReceivables" roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CashAndCashEquivalents" roleURI="http://trinitybiotech.com/role/CashAndCashEquivalents"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndReserves" roleURI="http://trinitybiotech.com/role/CapitalAndReserves"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ShareOptions" roleURI="http://trinitybiotech.com/role/ShareOptions"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#TradeAndOtherPayables" roleURI="http://trinitybiotech.com/role/TradeAndOtherPayables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#Provisions" roleURI="http://trinitybiotech.com/role/Provisions"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LeaseLiabilities" roleURI="http://trinitybiotech.com/role/LeaseLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CommitmentsAndContingencies" roleURI="http://trinitybiotech.com/role/CommitmentsAndContingencies"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#RelatedPartyTransactions" roleURI="http://trinitybiotech.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagement" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagement"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ReconciliationOfLiabilitiesArisingFromFinancingActivities" roleURI="http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivities"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#AccountingEstimatesAndJudgements" roleURI="http://trinitybiotech.com/role/AccountingEstimatesAndJudgements"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#AuthorisationForIssue" roleURI="http://trinitybiotech.com/role/AuthorisationForIssue"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BasisOfPreparationAndSignificantAccountingPoliciesPolicies" roleURI="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BasisOfPreparationAndSignificantAccountingPoliciesTables" roleURI="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationTables" roleURI="http://trinitybiotech.com/role/SegmentInformationTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#EmploymentTables" roleURI="http://trinitybiotech.com/role/EmploymentTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#OtherOperatingIncomeTables" roleURI="http://trinitybiotech.com/role/OtherOperatingIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ImpairmentChargesTables" roleURI="http://trinitybiotech.com/role/ImpairmentChargesTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#FinancialIncomeAndExpensesTables" roleURI="http://trinitybiotech.com/role/FinancialIncomeAndExpensesTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IncomeTaxCreditTables" roleURI="http://trinitybiotech.com/role/IncomeTaxCreditTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossBeforeTaxTables" roleURI="http://trinitybiotech.com/role/LossBeforeTaxTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossPerShareTables" roleURI="http://trinitybiotech.com/role/LossPerShareTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PropertyPlantAndEquipmentTables" roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsTables" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#DeferredTaxAssetsAndLiabilitiesTables" roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#OtherNon-currentAssetsTables" roleURI="http://trinitybiotech.com/role/OtherNon-currentAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#InventoriesTables" roleURI="http://trinitybiotech.com/role/InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#TradeAndOtherReceivablesTables" roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CashAndCashEquivalentsTables" roleURI="http://trinitybiotech.com/role/CashAndCashEquivalentsTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndReservesTables" roleURI="http://trinitybiotech.com/role/CapitalAndReservesTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ShareOptionsTables" roleURI="http://trinitybiotech.com/role/ShareOptionsTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#TradeAndOtherPayablesTables" roleURI="http://trinitybiotech.com/role/TradeAndOtherPayablesTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ProvisionsTables" roleURI="http://trinitybiotech.com/role/ProvisionsTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LeaseLiabilitiesTables" roleURI="http://trinitybiotech.com/role/LeaseLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#RelatedPartyTransactionsTables" roleURI="http://trinitybiotech.com/role/RelatedPartyTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementTables" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTables" roleURI="http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails" roleURI="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails" roleURI="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfRevenueByMajorProductGroupDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfAmountRelatingFromRevenueDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfAmountRelatingFromRevenueDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfLongLivedAssetsDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#EmploymentNarrativeDetails" roleURI="http://trinitybiotech.com/role/EmploymentNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails" roleURI="http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#EmploymentScheduleOfEmploymentCostsDetails" roleURI="http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#OtherOperatingIncomeDetails" roleURI="http://trinitybiotech.com/role/OtherOperatingIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails" roleURI="http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ImpairmentChargesScheduleOfStatementOfOperationDetails" roleURI="http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails" roleURI="http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IncomeTaxCreditNarrativeDetails" roleURI="http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IncomeTaxCreditScheduleOfChargeForTaxDetails" roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IncomeTaxCreditScheduleOfOverseasTaxJurisdictionsDetails" roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfOverseasTaxJurisdictionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IncomeTaxCreditScheduleOfStatutoryTaxRateDetails" roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfStatutoryTaxRateDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails" roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IncomeTaxCreditScheduleOfNetOperatingLossesDetails" roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails" roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossBeforeTaxNarrativeDetails" roleURI="http://trinitybiotech.com/role/LossBeforeTaxNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails" roleURI="http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossPerShareNarrativeDetails" roleURI="http://trinitybiotech.com/role/LossPerShareNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails" roleURI="http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossPerShareScheduleOfDilutedEarningsPerOrdinaryShareDetails" roleURI="http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerOrdinaryShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossPerShareScheduleOfEarningsPerAdsDetails" roleURI="http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails" roleURI="http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PropertyPlantAndEquipmentNarrativeDetails" roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails" roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails" roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails" roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsNarrativeDetails" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsScheduleOfBreakdownOfImpairmentLossDetailsUsd" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfBreakdownOfImpairmentLossDetailsUsd"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#DeferredTaxAssetsAndLiabilitiesNarrativeDetails" roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails" roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails" roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#OtherNon-currentAssetsDetails" roleURI="http://trinitybiotech.com/role/OtherNon-currentAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#InventoriesNarrativeDetails" roleURI="http://trinitybiotech.com/role/InventoriesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#InventoriesScheduleOfInventoriesDetails" roleURI="http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#InventoriesScheduleOfMovementOnInventoryProvisionDetails" roleURI="http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#TradeAndOtherReceivablesNarrativeDetails" roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails" roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails" roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails" roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails" roleURI="http://trinitybiotech.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndReservesNarrativeDetails" roleURI="http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndReservesScheduleOfShareCapitalDetails" roleURI="http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ShareOptionsNarrativeDetails" roleURI="http://trinitybiotech.com/role/ShareOptionsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails" roleURI="http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails" roleURI="http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails" roleURI="http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails" roleURI="http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails" roleURI="http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ProvisionsNarrativeDetails" roleURI="http://trinitybiotech.com/role/ProvisionsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ProvisionsScheduleOfProvisionsDetails" roleURI="http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails" roleURI="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails" roleURI="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails" roleURI="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CommitmentsAndContingenciesNarrativeDetails" roleURI="http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#RelatedPartyTransactionsNarrativeDetails" roleURI="http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#RelatedPartyTransactionsScheduleOfCompensationDetails" roleURI="http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails" roleURI="http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementNarrativeDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfMaximumCreditExposureOfFinancialAssetsDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMaximumCreditExposureOfFinancialAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfMovementInAllowanceForImpairmentOfTradeReceivablesDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMovementInAllowanceForImpairmentOfTradeReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails" roleURI="http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GROUPUNDERTAKINGS" roleURI="http://trinitybiotech.com/role/GROUPUNDERTAKINGS"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GROUPUNDERTAKINGSTables" roleURI="http://trinitybiotech.com/role/GROUPUNDERTAKINGSTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GROUPUNDERTAKINGSDetails" roleURI="http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GOODWILLANDINTANGIBLEASSETSDetails" roleURI="http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GOODWILLANDINTANGIBLEASSETS" roleURI="http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETS"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSDetails" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGS" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGS"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSTables" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSDetails1" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSDetails2" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSDetails3" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSDetails4" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#FINANCIALASSETS" roleURI="http://trinitybiotech.com/role/FINANCIALASSETS"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#FINANCIALASSETSDetails" roleURI="http://trinitybiotech.com/role/FINANCIALASSETSDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#FINANCIALASSETSTables" roleURI="http://trinitybiotech.com/role/FINANCIALASSETSTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#FINANCIALASSETSNarrativeDetails" roleURI="http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONS" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONS"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#POSTBALANCESHEETEVENTS" roleURI="http://trinitybiotech.com/role/POSTBALANCESHEETEVENTS"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#AccountingEstimatesAndJudgementsNarrativeDetails" roleURI="http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PostBalanceSheetEventsDetails" roleURI="http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SEGMENTINFORMATIONNarrativeDetails" roleURI="http://trinitybiotech.com/role/SEGMENTINFORMATIONNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BasisOfPreparationAndSignificantAccountingPolicies" roleURI="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformation" roleURI="http://trinitybiotech.com/role/SegmentInformation"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BUSINESSCOMBINATIONS" roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONS"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BUSINESSCOMBINATIONSDetails" roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BUSINESSCOMBINATIONSTables" roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BUSINESSCOMBINATIONSNarrativeDetails" roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear" roleURI="http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails" roleURI="http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BUSINESSCOMBINATIONSDetails__1" roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails__1"/>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_dei_EntityAddressesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_dei_EntityAddressesLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelFaxNumber" xlink:label="loc_dei_ContactPersonnelFaxNumber_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_44"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_1" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_1" xlink:to="loc_dei_BusinessContactMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_1" xlink:to="loc_dei_EntityAddressesLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityRegistrantName_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityCentralIndexKey_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentType_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentPeriodEndDate_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_CurrentFiscalYearEndDate_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_AmendmentFlag_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentFiscalYearFocus_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentRegistrationStatement_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentAnnualReport_13" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentTransitionReport_14" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentShellCompanyReport_15" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityEmergingGrowthCompany_16" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityFileNumber_17" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_18" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityVoluntaryFilers_19" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_20" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_21" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityCurrentReportingStatus_22" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityInteractiveDataCurrent_23" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityFilerCategory_24" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_ContactPersonnelName_25" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_CityAreaCode_26" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_LocalPhoneNumber_27" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_ContactPersonnelFaxNumber_28" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressAddressLine1_29" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressAddressLine2_30" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressCityOrTown_31" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressStateOrProvince_32" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressCountry_33" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressPostalZipCode_34" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_Security12bTitle_35" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_TradingSymbol_36" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_SecurityExchangeName_37" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_IcfrAuditorAttestationFlag_38" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentAccountingStandard_39" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityShellCompany_40" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_AuditorName_41" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_AuditorLocation_42" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_AuditorFirmId_43" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_44" order="400" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ConsolidatedStatementOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OnceOffExpense" xlink:label="loc_trib_OnceOffExpense_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetFinancingExpenseIncome" xlink:label="loc_trib_NetFinancingExpenseIncome_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_26"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_Revenue_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_CostOfSales_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_GrossProfit_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_11" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_trib_OnceOffExpense_12" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_13" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_14" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_FinanceIncome_15" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_FinanceCosts_16" order="110" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_trib_NetFinancingExpenseIncome_17" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_18" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_19" order="140" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_ProfitLoss_20" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_21" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_22" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_23" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_24" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_25" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_26" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConsolidatedStatementOfComprehensiveIncomeAbstract" xlink:label="loc_trib_ConsolidatedStatementOfComprehensiveIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_ConsolidatedStatementOfComprehensiveIncomeAbstract_0" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_ConsolidatedStatementOfComprehensiveIncomeAbstract_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeAbstract_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_2" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_2" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_2" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_3" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_2" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_2" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialAssets_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxAssetsCurrent" xlink:label="loc_ifrs-full_CurrentTaxAssetsCurrent_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-full_TreasuryShares_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNote" xlink:label="loc_trib_EquityComponentOfConvertibleNote_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReserves" xlink:label="loc_ifrs-full_OtherReserves_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisions" xlink:label="loc_ifrs-full_CurrentProvisions_28"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentFinanceLeaseLiabilities" xlink:label="loc_trib_CurrentFinanceLeaseLiabilities_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_34"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNote" xlink:label="loc_trib_ConvertibleNote_35"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationNonCurrent" xlink:label="loc_trib_ContingentConsiderationNonCurrent_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisions" xlink:label="loc_ifrs-full_NoncurrentProvisions_37"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncurrentFinanceLeaseLiabilities" xlink:label="loc_trib_NoncurrentFinanceLeaseLiabilities_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_43"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_AssetsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_NoncurrentFinancialAssets_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_DeferredTaxAssets_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_OtherNoncurrentFinancialAssets_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_NoncurrentAssets_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_9" xlink:to="loc_ifrs-full_Inventories_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_9" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_9" xlink:to="loc_ifrs-full_CurrentTaxAssetsCurrent_11" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_9" xlink:to="loc_ifrs-full_CashAndCashEquivalents_12" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_9" xlink:to="loc_ifrs-full_CurrentAssets_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_1" xlink:to="loc_ifrs-full_Assets_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_17" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_17" xlink:to="loc_ifrs-full_EquityAbstract_17" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_17" xlink:to="loc_ifrs-full_IssuedCapital_17" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_17" xlink:to="loc_ifrs-full_SharePremium_18" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_17" xlink:to="loc_ifrs-full_TreasuryShares_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_17" xlink:to="loc_ifrs-full_RetainedEarnings_20" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_17" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_21" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_17" xlink:to="loc_trib_EquityComponentOfConvertibleNote_22" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_17" xlink:to="loc_ifrs-full_OtherReserves_23" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_17" xlink:to="loc_ifrs-full_Equity_24" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_17" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_26" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_26" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_26" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_27" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_26" xlink:to="loc_ifrs-full_CurrentProvisions_28" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_26" xlink:to="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_29" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_26" xlink:to="loc_trib_CurrentFinanceLeaseLiabilities_30" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_26" xlink:to="loc_ifrs-full_CurrentLiabilities_31" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_17" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_33" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_33" xlink:to="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_33" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_33" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_34" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_33" xlink:to="loc_trib_ConvertibleNote_35" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_33" xlink:to="loc_trib_ContingentConsiderationNonCurrent_36" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_33" xlink:to="loc_ifrs-full_NoncurrentProvisions_37" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_33" xlink:to="loc_trib_NoncurrentFinanceLeaseLiabilities_38" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_33" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_39" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_33" xlink:to="loc_ifrs-full_NoncurrentLiabilities_40" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_17" xlink:to="loc_ifrs-full_Liabilities_42" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_17" xlink:to="loc_ifrs-full_EquityAndLiabilities_43" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-full_TreasurySharesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNoteMember" xlink:label="loc_trib_EquityComponentOfConvertibleNoteMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReservesMember" xlink:label="loc_ifrs-full_OtherReservesMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfCashFlowHedgesMember" xlink:label="loc_ifrs-full_ReserveOfCashFlowHedgesMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesToBeIssued" xlink:label="loc_trib_SharesToBeIssued_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreasedecreasethroughequityComponentOfConvertibleNote" xlink:label="loc_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_20"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_IssuedCapitalMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_SharePremiumMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_TreasurySharesMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_trib_EquityComponentOfConvertibleNoteMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_OtherReservesMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_RetainedEarningsMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_ReserveOfCashFlowHedgesMember_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_Equity_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_IssueOfEquity_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_16" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_trib_SharesToBeIssued_17" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_18" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_19" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_11" xlink:to="loc_ifrs-full_Equity_20" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForAmortisationExpense_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForIncomeTaxExpense_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForFinanceIncome" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncome_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForFinanceCosts" xlink:label="loc_ifrs-full_AdjustmentsForFinanceCosts_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="loc_ifrs-full_AdjustmentsForProvisions_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForInventoryWriteOff" xlink:label="loc_trib_AdjustmentsForInventoryWriteOff_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForGainLossOnSaleOfBusiness" xlink:label="loc_trib_AdjustmentsForGainLossOnSaleOfBusiness_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentForRestructuringProvision" xlink:label="loc_trib_AdjustmentForRestructuringProvision_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="loc_ifrs-full_OtherAdjustmentsForNoncashItems_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_30"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities" xlink:label="loc_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_32"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities" xlink:label="loc_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_36"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromSharesToBeIssued" xlink:label="loc_trib_ProceedsFromSharesToBeIssued_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_38"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsForConvertibleNoteIssued" xlink:label="loc_trib_ProceedsForConvertibleNoteIssued_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_42"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlySettlementOfTermLoan" xlink:label="loc_trib_PenaltyForEarlySettlementOfTermLoan_43"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RepaymentOfOtherLoan" xlink:label="loc_trib_RepaymentOfOtherLoan_44"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnSeniorSecuredTermLoan" xlink:label="loc_trib_InterestPaidOnSeniorSecuredTermLoan_45"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnConvertibleNote" xlink:label="loc_trib_InterestPaidOnConvertibleNote_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_51"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_52"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentsAndShortTermInvestments" xlink:label="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_53"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentsAndShortTermInvestments" xlink:label="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_54"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationExpense_2" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForAmortisationExpense_3" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForIncomeTaxExpense_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForFinanceIncome_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForFinanceCosts_6" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_7" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForProvisions_10" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_trib_AdjustmentsForInventoryWriteOff_11" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables_12" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_13" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_14" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_ImpairmentLossOnFinancialAssets_15" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_trib_AdjustmentsForGainLossOnSaleOfBusiness_16" order="140" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_trib_AdjustmentForRestructuringProvision_17" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_OtherAdjustmentsForNoncashItems_18" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_19" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_22" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_23" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperations_24" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_25" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_26" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_27" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_29" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_29" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_29" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_29" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_30" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_29" xlink:to="loc_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_31" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_29" xlink:to="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_32" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_29" xlink:to="loc_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_33" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_29" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_34" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_36" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_trib_ProceedsFromSharesToBeIssued_37" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_38" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_trib_ProceedsForConvertibleNoteIssued_39" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_40" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_41" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_42" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_trib_PenaltyForEarlySettlementOfTermLoan_43" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_trib_RepaymentOfOtherLoan_44" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_trib_InterestPaidOnSeniorSecuredTermLoan_45" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_trib_InterestPaidOnConvertibleNote_46" order="100" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_47" order="110" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_48" order="120" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_36" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_49" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_51" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_52" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_53" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_54" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/Employment">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/OtherOperatingIncome">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherOperatingIncomeAbstract" xlink:label="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ImpairmentCharges">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract" xlink:label="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/FinancialIncomeAndExpenses">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialIncomeAndExpensesAbstract" xlink:label="loc_trib_FinancialIncomeAndExpensesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinancingIncomeExpensesNetAbstract" xlink:label="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancialIncomeAndExpensesAbstract_0" xlink:to="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_1" xlink:to="loc_ifrs-full_DisclosureOfFinanceIncomeExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IncomeTaxCredit">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfIncomeTaxCreditAbstract" xlink:label="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossBeforeTax">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossProfitBeforeTaxAbstract" xlink:label="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossProfitBeforeTaxExplanatory" xlink:label="loc_trib_DisclosureOfLossProfitBeforeTaxExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xlink:to="loc_trib_DisclosureOfLossProfitBeforeTaxExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossPerShare">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PropertyPlantAndEquipment">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilities">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_1" xlink:to="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/OtherNon-currentAssets">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherNonCurrentAssets" xlink:label="loc_trib_OtherNonCurrentAssets_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherAssetsAbstract" xlink:label="loc_trib_DisclosureOfOtherAssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OtherNonCurrentAssets_0" xlink:to="loc_trib_DisclosureOfOtherAssetsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfOtherAssetsAbstract_1" xlink:to="loc_ifrs-full_DisclosureOfOtherAssetsExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/Inventories">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInventoriesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/TradeAndOtherReceivables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CashAndCashEquivalents">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndReserves">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ShareOptions">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShareOptionsAndShareWarrantsAbstract" xlink:label="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory" xlink:label="loc_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/TradeAndOtherPayables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/Provisions">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionsAbstract" xlink:label="loc_ifrs-full_ProvisionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProvisionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfProvisionsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProvisionsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfProvisionsExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LeaseLiabilities">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinanceLeaseLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfLeasesExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CommitmentsAndContingencies">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract" xlink:label="loc_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/RelatedPartyTransactions">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagement">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivities">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCashFlowStatementExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfCashFlowStatementExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/AccountingEstimatesAndJudgements">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAccountingEstimatesAndJudgementsAbstract" xlink:label="loc_trib_DisclosureOfAccountingEstimatesAndJudgementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAccountingEstimatesAndJudgementsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/AuthorisationForIssue">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAuthorisationForIssueAbstract" xlink:label="loc_trib_DisclosureOfAuthorisationForIssueAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAuthorisationForIssueExplanatory" xlink:label="loc_trib_DisclosureOfAuthorisationForIssueExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAuthorisationForIssueAbstract_0" xlink:to="loc_trib_DisclosureOfAuthorisationForIssueExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract" xlink:label="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsPolicyTextBlock" xlink:label="loc_trib_FinancialAssetsPolicyTextBlock_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinanceCostsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinanceCostsExplanatory_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_35"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_37"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_trib_FinancialAssetsPolicyTextBlock_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_16" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_17" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_18" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_19" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_20" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_21" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory_22" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_23" order="220" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_24" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_25" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_26" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_27" order="260" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory_28" order="270" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_29" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinanceCostsExplanatory_30" order="290" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_31" order="300" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_32" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_33" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_34" order="330" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_35" order="340" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_36" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_37" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract" xlink:label="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfProductsAndServicesExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea" xlink:label="loc_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfProductsAndServicesExplanatory_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_10" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/EmploymentTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="loc_ifrs-full_ContinuingOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_ContinuingOperationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContinuingOperationsMember_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4" xlink:to="loc_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_5" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/OtherOperatingIncomeTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherOperatingIncomeAbstract" xlink:label="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ImpairmentChargesTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract" xlink:label="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/FinancialIncomeAndExpensesTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinancingIncomeExpensesNetAbstract" xlink:label="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IncomeTaxCreditTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfIncomeTaxCreditAbstract" xlink:label="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossBeforeTaxTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossProfitBeforeTaxAbstract" xlink:label="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossPerShareTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory" xlink:label="loc_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfAdditionalInformationOnRightOfUseAssets" xlink:label="loc_trib_ScheduleOfAdditionalInformationOnRightOfUseAssets_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings" xlink:label="loc_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xlink:to="loc_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xlink:to="loc_trib_ScheduleOfAdditionalInformationOnRightOfUseAssets_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xlink:to="loc_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" xlink:label="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGoodwillExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGoodwillExplanatory_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityExplanatory_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGoodwillExplanatory_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/OtherNon-currentAssetsTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherAssetsAbstract" xlink:label="loc_trib_DisclosureOfOtherAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfOtherAssetsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/InventoriesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/TradeAndOtherReceivablesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory_3" order="20" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CashAndCashEquivalentsTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndReservesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ShareOptionsTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShareOptionsAndShareWarrantsAbstract" xlink:label="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_4" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/TradeAndOtherPayablesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ProvisionsTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionsAbstract" xlink:label="loc_ifrs-full_ProvisionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProvisionsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LeaseLiabilitiesTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinanceLeaseLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory" xlink:label="loc_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0" xlink:to="loc_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/RelatedPartyTransactionsTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCompensationExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:label="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExplanatory_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExplanatory_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract" xlink:label="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PropertyAndEquipmentMember" xlink:label="loc_trib_PropertyAndEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_OfficeEquipmentMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ComputerEquipmentMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_trib_PropertyAndEquipmentMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_8" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract" xlink:label="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:label="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1" xlink:to="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1" xlink:to="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_6" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="loc_country_US_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EliminationOfIntersegmentAmountsMember" xlink:label="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_US_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_7" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_7" xlink:to="loc_ifrs-full_OtherRevenue_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_7" xlink:to="loc_ifrs-full_Revenue_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AsiaOrAfricaMember" xlink:label="loc_trib_AsiaOrAfricaMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EuropeIncludingIrelandMember" xlink:label="loc_trib_EuropeIncludingIrelandMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AsiaOrAfricaMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_EuropeIncludingIrelandMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_6" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesTable" xlink:label="loc_ifrs-full_DisclosureOfProductsAndServicesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClinicalLaboratoryMember" xlink:label="loc_trib_ClinicalLaboratoryMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaboratoryServicesMember" xlink:label="loc_trib_LaboratoryServicesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PointOfCareMember" xlink:label="loc_trib_PointOfCareMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:label="loc_ifrs-full_DisclosureOfProductsAndServicesLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfProductsAndServicesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesTable_1" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_1" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_1" xlink:to="loc_trib_ClinicalLaboratoryMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_1" xlink:to="loc_trib_LaboratoryServicesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_1" xlink:to="loc_trib_PointOfCareMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesTable_1" xlink:to="loc_ifrs-full_DisclosureOfProductsAndServicesLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesLineItems_6" xlink:to="loc_ifrs-full_Revenue_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfAmountRelatingFromRevenueDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_Revenue_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CustomerMember" xlink:label="loc_trib_CustomerMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AsiaOrAfricaMember" xlink:label="loc_trib_AsiaOrAfricaMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentReceivablesFromContractsWithCustomers" xlink:label="loc_ifrs-full_CurrentReceivablesFromContractsWithCustomers_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentReceivablesFromContractsWithCustomers" xlink:label="loc_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomers" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomers_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1" xlink:to="loc_srt_MajorCustomersAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_1" xlink:to="loc_srt_NameOfMajorCustomerDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1" xlink:to="loc_trib_CustomerMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_4" xlink:to="loc_ifrs-full_GeographicalAreasDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_4" xlink:to="loc_trib_AmericaMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_4" xlink:to="loc_country_IE_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_4" xlink:to="loc_trib_OtherCountriesMember_6" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_4" xlink:to="loc_trib_AsiaOrAfricaMember_7" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_4" xlink:to="loc_srt_EuropeMember_8" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_11" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_11" xlink:to="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_11" xlink:to="loc_ifrs-full_CurrentReceivablesFromContractsWithCustomers_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_11" xlink:to="loc_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_11" xlink:to="loc_ifrs-full_ReceivablesFromContractsWithCustomers_13" order="20" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResultBeforeExceptionalExpenses" xlink:label="loc_trib_ResultBeforeExceptionalExpenses_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLoss" xlink:label="loc_ifrs-full_ImpairmentLoss_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResultAfterExceptionalExpenses" xlink:label="loc_trib_ResultAfterExceptionalExpenses_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnallocatedExpenses" xlink:label="loc_trib_UnallocatedExpenses_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingIncomeBySegment" xlink:label="loc_trib_FinancingIncomeBySegment_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefund" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefund_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_trib_ResultBeforeExceptionalExpenses_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_ImpairmentLoss_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_trib_ResultAfterExceptionalExpenses_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_trib_UnallocatedExpenses_10" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_11" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_trib_FinancingIncomeBySegment_12" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_13" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefund_14" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations_15" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_16" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_17" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AssetsAndLiabilitiesBySegmentAbstract" xlink:label="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SegmentAssets" xlink:label="loc_trib_SegmentAssets_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnallocatedAssetsBySegmentAbstract" xlink:label="loc_trib_UnallocatedAssetsBySegmentAbstract_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxAssetsCurrentAndDeferred" xlink:label="loc_trib_IncomeTaxAssetsCurrentAndDeferred_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentsAndShortTermInvestments" xlink:label="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SegmentLiabilities" xlink:label="loc_trib_SegmentLiabilities_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnallocatedLiabilitiesBySegmentAbstract" xlink:label="loc_trib_UnallocatedLiabilitiesBySegmentAbstract_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxLiabilitiesCurrentAndDeferred" xlink:label="loc_trib_IncomeTaxLiabilitiesCurrentAndDeferred_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities" xlink:label="loc_ifrs-full_NetDeferredTaxLiabilities_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_6" xlink:to="loc_trib_SegmentAssets_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_6" xlink:to="loc_trib_UnallocatedAssetsBySegmentAbstract_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_UnallocatedAssetsBySegmentAbstract_7" xlink:to="loc_trib_IncomeTaxAssetsCurrentAndDeferred_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_UnallocatedAssetsBySegmentAbstract_7" xlink:to="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_6" xlink:to="loc_ifrs-full_NetDeferredTaxAssets_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_6" xlink:to="loc_trib_SegmentLiabilities_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_6" xlink:to="loc_trib_UnallocatedLiabilitiesBySegmentAbstract_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_UnallocatedLiabilitiesBySegmentAbstract_12" xlink:to="loc_trib_IncomeTaxLiabilitiesCurrentAndDeferred_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_6" xlink:to="loc_ifrs-full_NetDeferredTaxLiabilities_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongLivedAsstesBySegment" xlink:label="loc_trib_LongLivedAsstesBySegment_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_trib_LongLivedAsstesBySegment_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-full_DepreciationExpense_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationExpense" xlink:label="loc_ifrs-full_AmortisationExpense_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_DepreciationExpense_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_AmortisationExpense_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxExpense" xlink:label="loc_trib_IncomeTaxExpense_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_trib_IncomeTaxExpense_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForDevelopmentProjectExpenditure" xlink:label="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure_6" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/EmploymentNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations" xlink:label="loc_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WagesSubsidiesReceived" xlink:label="loc_trib_WagesSubsidiesReceived_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised" xlink:label="loc_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ActuarialAssumptionOfExpectedPensionIncreases" xlink:label="loc_trib_ActuarialAssumptionOfExpectedPensionIncreases_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WagesAndSalariesNetOfCredit" xlink:label="loc_trib_WagesAndSalariesNetOfCredit_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0" xlink:to="loc_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0" xlink:to="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0" xlink:to="loc_trib_WagesSubsidiesReceived_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0" xlink:to="loc_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0" xlink:to="loc_trib_ActuarialAssumptionOfExpectedPensionIncreases_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0" xlink:to="loc_trib_WagesAndSalariesNetOfCredit_7" order="60" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResearchAndDevelopmentMember" xlink:label="loc_trib_ResearchAndDevelopmentMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdministrationAndSalesMember" xlink:label="loc_trib_AdministrationAndSalesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ManufacturingAndQualityMember" xlink:label="loc_trib_ManufacturingAndQualityMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageNumberOfEmployees" xlink:label="loc_ifrs-full_AverageNumberOfEmployees_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_1" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_1" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_1" xlink:to="loc_trib_ResearchAndDevelopmentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_1" xlink:to="loc_trib_AdministrationAndSalesMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_1" xlink:to="loc_trib_ManufacturingAndQualityMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_1" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_6" xlink:to="loc_ifrs-full_AverageNumberOfEmployees_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="loc_ifrs-full_ContinuingOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SocialSecurityContributions" xlink:label="loc_ifrs-full_SocialSecurityContributions_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes" xlink:label="loc_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExpenseOfRestructuringCost" xlink:label="loc_trib_ExpenseOfRestructuringCost_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RecognitionOfContingentAsset" xlink:label="loc_trib_RecognitionOfContingentAsset_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_ContinuingOperationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContinuingOperationsMember_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4" xlink:to="loc_ifrs-full_WagesAndSalaries_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4" xlink:to="loc_ifrs-full_SocialSecurityContributions_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_6" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4" xlink:to="loc_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4" xlink:to="loc_trib_ExpenseOfRestructuringCost_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4" xlink:to="loc_trib_RecognitionOfContingentAsset_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_4" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/OtherOperatingIncomeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherOperatingIncomeAbstract" xlink:label="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherOperatingIncomeTable" xlink:label="loc_trib_OtherOperatingIncomeTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaycheckProtectionProgramLoanMember" xlink:label="loc_trib_PaycheckProtectionProgramLoanMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherOperatingIncomeLineItems" xlink:label="loc_trib_OtherOperatingIncomeLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LoansPayableInDefault" xlink:label="loc_ifrs-full_LoansPayableInDefault_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanIncome" xlink:label="loc_trib_LoanIncome_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPayable" xlink:label="loc_ifrs-full_InterestPayable_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_0" xlink:to="loc_trib_OtherOperatingIncomeTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OtherOperatingIncomeTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1" xlink:to="loc_trib_PaycheckProtectionProgramLoanMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OtherOperatingIncomeTable_1" xlink:to="loc_trib_OtherOperatingIncomeLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OtherOperatingIncomeLineItems_4" xlink:to="loc_ifrs-full_LoansPayableInDefault_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OtherOperatingIncomeLineItems_4" xlink:to="loc_trib_LoanIncome_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OtherOperatingIncomeLineItems_4" xlink:to="loc_ifrs-full_InterestPayable_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherOperatingIncomeAbstract" xlink:label="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RentalIncomeFromPremises" xlink:label="loc_trib_RentalIncomeFromPremises_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GovernmentSupportsCovid19" xlink:label="loc_trib_GovernmentSupportsCovid19_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_0" xlink:to="loc_ifrs-full_OtherIncome_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_0" xlink:to="loc_trib_RentalIncomeFromPremises_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_0" xlink:to="loc_trib_GovernmentSupportsCovid19_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_0" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_0" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract" xlink:label="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAdministrationExpensesAbstract" xlink:label="loc_trib_SellingGeneralAdministrationExpensesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentOfPrepayments" xlink:label="loc_trib_ImpairmentOfPrepayments_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxImpactOfImpairmentLoss" xlink:label="loc_trib_IncomeTaxImpactOfImpairmentLoss_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0" xlink:to="loc_trib_SellingGeneralAdministrationExpensesAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_SellingGeneralAdministrationExpensesAbstract_1" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_SellingGeneralAdministrationExpensesAbstract_1" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_SellingGeneralAdministrationExpensesAbstract_1" xlink:to="loc_trib_ImpairmentOfPrepayments_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_SellingGeneralAdministrationExpensesAbstract_1" xlink:to="loc_ifrs-full_ImpairmentLossOnFinancialAssets_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0" xlink:to="loc_trib_IncomeTaxImpactOfImpairmentLoss_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0" xlink:to="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinancingIncomeExpensesNetAbstract" xlink:label="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingIncomeAbstract" xlink:label="loc_trib_FinancingIncomeAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestIncomeOnOtherFinancialAssets" xlink:label="loc_ifrs-full_InterestIncomeOnOtherFinancialAssets_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingExpensesAbstract" xlink:label="loc_trib_FinancingExpensesAbstract_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOfExchangeableNotes" xlink:label="loc_trib_LossOnDisposalOfExchangeableNotes_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlySettlementOfTermLoan" xlink:label="loc_trib_PenaltyForEarlySettlementOfTermLoan_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashInterestPayableOnSeniorSecureTermLoan" xlink:label="loc_trib_CashInterestPayableOnSeniorSecureTermLoan_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnConvertibleNote" xlink:label="loc_trib_InterestPaidOnConvertibleNote_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnDebtInstrumentsIssued" xlink:label="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashInterestPayableOnPppLoans" xlink:label="loc_trib_CashInterestPayableOnPppLoans_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnOtherFinancialLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashInterestOnSeniorSecuredTermLoan" xlink:label="loc_trib_NoncashInterestOnSeniorSecuredTermLoan_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashInterestOnConvertibleNote" xlink:label="loc_trib_NoncashInterestOnConvertibleNote_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnwindingOfDiscountOnDeferredContingentConsideration" xlink:label="loc_trib_UnwindingOfDiscountOnDeferredContingentConsideration_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingCostsCapitalised" xlink:label="loc_ifrs-full_BorrowingCostsCapitalised_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashLoanModificationGain" xlink:label="loc_trib_NoncashLoanModificationGain_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CapitalisationOfUnpaidInterestOnTermLoan" xlink:label="loc_trib_CapitalisationOfUnpaidInterestOnTermLoan_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceIncomeExpenseNet" xlink:label="loc_trib_FinanceIncomeExpenseNet_20"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_0" xlink:to="loc_trib_FinancingIncomeAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingIncomeAbstract_1" xlink:to="loc_ifrs-full_InterestIncomeOnOtherFinancialAssets_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_0" xlink:to="loc_trib_FinancingExpensesAbstract_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_trib_LossOnDisposalOfExchangeableNotes_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_trib_PenaltyForEarlySettlementOfTermLoan_5" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_trib_CashInterestPayableOnSeniorSecureTermLoan_6" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_trib_InterestPaidOnConvertibleNote_7" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_8" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_trib_CashInterestPayableOnPppLoans_9" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_10" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_trib_NoncashInterestOnSeniorSecuredTermLoan_11" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_trib_NoncashInterestOnConvertibleNote_12" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_ifrs-full_FinanceIncomeCost_13" order="100" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_trib_UnwindingOfDiscountOnDeferredContingentConsideration_14" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_ifrs-full_BorrowingCostsCapitalised_15" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_trib_NoncashLoanModificationGain_16" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancingExpensesAbstract_3" xlink:to="loc_trib_CapitalisationOfUnpaidInterestOnTermLoan_17" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_0" xlink:to="loc_ifrs-full_FinanceCosts_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_0" xlink:to="loc_trib_FinanceIncomeExpenseNet_20" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfIncomeTaxCreditAbstract" xlink:label="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="loc_country_US_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeFromPaycheckProtectionProgramLoans" xlink:label="loc_trib_IncomeFromPaycheckProtectionProgramLoans_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetOperatingLossCarryforwards" xlink:label="loc_trib_NetOperatingLossCarryforwards_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetOperatingLossPeriod" xlink:label="loc_trib_NetOperatingLossPeriod_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OnceOffTaxCredit" xlink:label="loc_trib_OnceOffTaxCredit_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_US_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_trib_IncomeFromPaycheckProtectionProgramLoans_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_trib_NetOperatingLossCarryforwards_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_trib_NetOperatingLossPeriod_9" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_trib_OnceOffTaxCredit_10" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_ApplicableTaxRate_11" order="50" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfIncomeTaxCreditAbstract" xlink:label="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentTaxForeignExpenseIncome" xlink:label="loc_trib_CurrentTaxForeignExpenseIncome_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeAbstract_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReversalOfNetOperatingLoss" xlink:label="loc_trib_ReversalOfNetOperatingLoss_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance" xlink:label="loc_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxExpenseBenefits" xlink:label="loc_trib_IncomeTaxExpenseBenefits_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_1" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncome_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_1" xlink:to="loc_trib_CurrentTaxForeignExpenseIncome_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_1" xlink:to="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeAbstract_6" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeAbstract_6" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeAbstract_6" xlink:to="loc_trib_ReversalOfNetOperatingLoss_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_11" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_trib_IncomeTaxExpenseBenefits_12" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfOverseasTaxJurisdictionsDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfIncomeTaxCreditAbstract" xlink:label="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract" xlink:label="loc_trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract" xlink:label="loc_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxRateEffectOfCurrentTaxOfPriorPeriods" xlink:label="loc_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageEffectiveTaxRate" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract_1" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_3" xlink:to="loc_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_AverageEffectiveTaxRate_5" order="20" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfStatutoryTaxRateDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfIncomeTaxCreditAbstract" xlink:label="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxRateEffectOfTaxLosses" xlink:label="loc_ifrs-full_TaxRateEffectOfTaxLosses_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectOfIrishIncomeTaxableAtHigherTaxRate" xlink:label="loc_trib_EffectOfIrishIncomeTaxableAtHigherTaxRate_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="loc_ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods" xlink:label="loc_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageEffectiveTaxRate" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_ApplicableTaxRate_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_TaxRateEffectOfTaxLosses_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_trib_EffectOfIrishIncomeTaxableAtHigherTaxRate_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_AverageEffectiveTaxRate_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfIncomeTaxCreditAbstract" xlink:label="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRegionsMember" xlink:label="loc_trib_OtherRegionsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherRegionsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfIncomeTaxCreditAbstract" xlink:label="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRegionsMember" xlink:label="loc_trib_OtherRegionsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnutilisedNetOperatingLosses" xlink:label="loc_trib_UnutilisedNetOperatingLosses_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherRegionsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_6" xlink:to="loc_trib_UnutilisedNetOperatingLosses_6" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfIncomeTaxCreditAbstract" xlink:label="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRegionsMember" xlink:label="loc_trib_OtherRegionsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_US1Member" xlink:label="loc_trib_US1Member_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherRegionsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_US1Member_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset_7" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossBeforeTaxNarrativeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossProfitBeforeTaxAbstract" xlink:label="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeprecationForDiscontinuedOperations" xlink:label="loc_trib_DeprecationForDiscontinuedOperations_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmortisationForDiscontinuedOperations" xlink:label="loc_trib_AmortisationForDiscontinuedOperations_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesClosureCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xlink:to="loc_ifrs-full_DepreciationAndAmortisationExpense_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xlink:to="loc_trib_DeprecationForDiscontinuedOperations_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xlink:to="loc_trib_AmortisationForDiscontinuedOperations_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xlink:to="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossProfitBeforeTaxAbstract" xlink:label="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract" xlink:label="loc_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorPensionExpense" xlink:label="loc_trib_DirectorPensionExpense_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPayments" xlink:label="loc_trib_ShareBasedPayments_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationAbstract" xlink:label="loc_ifrs-full_AuditorsRemunerationAbstract_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForTaxServices" xlink:label="loc_ifrs-full_AuditorsRemunerationForTaxServices_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxFees" xlink:label="loc_trib_TaxFees_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForOtherServices" xlink:label="loc_ifrs-full_AuditorsRemunerationForOtherServices_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DepreciationOnIntangibleAssets" xlink:label="loc_trib_DepreciationOnIntangibleAssets_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmortisationOnIntangibleAssets" xlink:label="loc_trib_AmortisationOnIntangibleAssets_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesClosureCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetForeignExchangeGainLoss" xlink:label="loc_trib_NetForeignExchangeGainLoss_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xlink:to="loc_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract_1" xlink:to="loc_ifrs-full_DirectorsRemunerationExpense_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract_1" xlink:to="loc_trib_DirectorPensionExpense_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract_1" xlink:to="loc_trib_ShareBasedPayments_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xlink:to="loc_ifrs-full_AuditorsRemunerationAbstract_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AuditorsRemunerationAbstract_5" xlink:to="loc_ifrs-full_AuditorsRemunerationForTaxServices_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AuditorsRemunerationAbstract_5" xlink:to="loc_trib_TaxFees_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AuditorsRemunerationAbstract_5" xlink:to="loc_ifrs-full_AuditorsRemunerationForOtherServices_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xlink:to="loc_trib_DepreciationOnIntangibleAssets_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xlink:to="loc_trib_AmortisationOnIntangibleAssets_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xlink:to="loc_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xlink:to="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xlink:to="loc_trib_NetForeignExchangeGainLoss_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossPerShareNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedProfitAfterTax" xlink:label="loc_trib_AdjustedProfitAfterTax_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions" xlink:label="loc_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsGranted" xlink:label="loc_trib_NumberOfOptionsGranted_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsIssuable" xlink:label="loc_trib_NumberOfOptionsIssuable_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsLapsedUnexercised" xlink:label="loc_trib_NumberOfOptionsLapsedUnexercised_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuedOnExerciseOfOptions" xlink:label="loc_trib_NumberOfSharesIssuedOnExerciseOfOptions_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare" xlink:label="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive" xlink:label="loc_trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive_20"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MaximumMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_5" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_5" xlink:to="loc_trib_ClassAOrdinarySharesMember_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_5" xlink:to="loc_trib_AmericanDepositaryShareMember_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_10" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_11" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_ifrs-full_WeightedAverageShares_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_AdjustedProfitAfterTax_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_NumberOfOptionsGranted_15" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_NumberOfOptionsIssuable_16" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_NumberOfOptionsLapsedUnexercised_17" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_NumberOfSharesIssuedOnExerciseOfOptions_18" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_19" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive_20" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract" xlink:label="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAOrdinaryWeightedAverageShares" xlink:label="loc_trib_NumberOfAOrdinaryWeightedAverageShares_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfSharesIssued" xlink:label="loc_trib_WeightedAverageNumberOfSharesIssued_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfTreasuryShares" xlink:label="loc_trib_WeightedAverageNumberOfTreasuryShares_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageShares_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4" xlink:to="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_5" xlink:to="loc_trib_NumberOfAOrdinaryWeightedAverageShares_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_5" xlink:to="loc_trib_WeightedAverageNumberOfSharesIssued_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_5" xlink:to="loc_trib_WeightedAverageNumberOfTreasuryShares_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_5" xlink:to="loc_ifrs-full_WeightedAverageShares_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerOrdinaryShareDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PotentiallyDilutiveInstrumentsAbstract" xlink:label="loc_trib_PotentiallyDilutiveInstrumentsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnExerciseOfOptions" xlink:label="loc_trib_IssuableOnExerciseOfOptions_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" xlink:label="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuableOnConversionOfExchangeableNotes" xlink:label="loc_trib_SharesIssuableOnConversionOfExchangeableNotes_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnConversionOfConvertibleNotes" xlink:label="loc_trib_IssuableOnConversionOfConvertibleNotes_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented" xlink:label="loc_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_trib_PotentiallyDilutiveInstrumentsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_1" xlink:to="loc_trib_IssuableOnExerciseOfOptions_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_1" xlink:to="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_1" xlink:to="loc_trib_SharesIssuableOnConversionOfExchangeableNotes_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_1" xlink:to="loc_trib_IssuableOnConversionOfConvertibleNotes_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_1" xlink:to="loc_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositoryShares" xlink:label="loc_trib_AmericanDepositoryShares_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract" xlink:label="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAmericanDepositorySharesWeightedAverageShares" xlink:label="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfSharesIssued" xlink:label="loc_trib_WeightedAverageNumberOfSharesIssued_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfTreasuryShares" xlink:label="loc_trib_WeightedAverageNumberOfTreasuryShares_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4" xlink:to="loc_trib_AmericanDepositoryShares_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/measurementGuidance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4" xlink:to="loc_ifrs-full_WeightedAverageShares_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4" xlink:to="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_6" xlink:to="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_6" xlink:to="loc_trib_WeightedAverageNumberOfSharesIssued_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_6" xlink:to="loc_trib_WeightedAverageNumberOfTreasuryShares_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_6" xlink:to="loc_ifrs-full_WeightedAverageShares_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PotentiallyDilutiveInstrumentsAbstract" xlink:label="loc_trib_PotentiallyDilutiveInstrumentsAbstract_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnExerciseOfOptions" xlink:label="loc_trib_IssuableOnExerciseOfOptions_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" xlink:label="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuableOnConversionOfExchangeableNotes" xlink:label="loc_trib_SharesIssuableOnConversionOfExchangeableNotes_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnConversionOfConvertibleNotes" xlink:label="loc_trib_IssuableOnConversionOfConvertibleNotes_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented" xlink:label="loc_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_4" xlink:to="loc_trib_PotentiallyDilutiveInstrumentsAbstract_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_4" xlink:to="loc_trib_IssuableOnExerciseOfOptions_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_4" xlink:to="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_4" xlink:to="loc_trib_SharesIssuableOnConversionOfExchangeableNotes_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_4" xlink:to="loc_trib_IssuableOnConversionOfConvertibleNotes_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_4" xlink:to="loc_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringCost" xlink:label="loc_trib_RestructuringCost_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsImpairmentAdjustmentOnTransition" xlink:label="loc_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentChargePropertyPlantEquipment" xlink:label="loc_trib_ImpairmentChargePropertyPlantEquipment_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossInvestmentProperty" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossInvestmentProperty_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeRelatingToVariableLeasePaymentsForOperatingLeasesThatDoNotDependOnIndexOrRate" xlink:label="loc_ifrs-full_IncomeRelatingToVariableLeasePaymentsForOperatingLeasesThatDoNotDependOnIndexOrRate_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentExpendituresRecognisedForConstructions" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentExpendituresRecognisedForConstructions_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeFromSubleasingRightofuseAssets" xlink:label="loc_ifrs-full_IncomeFromSubleasingRightofuseAssets_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_4" xlink:to="loc_ifrs-full_RightofuseAssets_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_4" xlink:to="loc_ifrs-full_AdditionsToRightofuseAssets_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_4" xlink:to="loc_trib_RestructuringCost_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_4" xlink:to="loc_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_4" xlink:to="loc_trib_ImpairmentChargePropertyPlantEquipment_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_4" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_4" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossInvestmentProperty_10" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_4" xlink:to="loc_ifrs-full_IncomeRelatingToVariableLeasePaymentsForOperatingLeasesThatDoNotDependOnIndexOrRate_11" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_4" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_12" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_4" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentExpendituresRecognisedForConstructions_13" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_4" xlink:to="loc_ifrs-full_IncomeFromSubleasingRightofuseAssets_14" order="100" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCarryingAmountMember" xlink:label="loc_trib_NetCarryingAmountMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LandAndBuildingsMember" xlink:label="loc_ifrs-full_LandAndBuildingsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment" xlink:label="loc_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment" xlink:label="loc_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsOrRetirementsPropertyAndEquipment" xlink:label="loc_trib_DisposalsOrRetirementsPropertyAndEquipment_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:label="loc_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated_24"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_trib_NetCarryingAmountMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_6" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_6" xlink:to="loc_ifrs-full_LandAndBuildingsMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_6" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_6" xlink:to="loc_ifrs-full_ComputerEquipmentMember_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_6" xlink:to="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/measurementGuidance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_14" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_trib_DisposalsOrRetirementsPropertyAndEquipment_18" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_19" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets_20" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_21" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_22" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_23" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_12" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated_24" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ComputerEquipmentsMember" xlink:label="loc_trib_ComputerEquipmentsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DepreciationMember" xlink:label="loc_trib_DepreciationMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsIncludingDepreciationAndImpairment" xlink:label="loc_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_trib_ComputerEquipmentsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_6" xlink:to="loc_ifrs-full_CarryingAmountMember_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_6" xlink:to="loc_trib_DepreciationMember_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_6" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_10" xlink:to="loc_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-full_VehiclesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ITAndOfficeEquipmentMember" xlink:label="loc_trib_ITAndOfficeEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRightOfUseLeasedAssets" xlink:label="loc_trib_NumberOfRightOfUseLeasedAssets_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemainingTermInYears" xlink:label="loc_trib_RemainingTermInYears_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AverageRemainingLeaseTermYears" xlink:label="loc_trib_AverageRemainingLeaseTermYears_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithExtensionOptions" xlink:label="loc_trib_NumberOfLeasesWithExtensionOptions_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithOptionsToPurchase" xlink:label="loc_trib_NumberOfLeasesWithOptionsToPurchase_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex" xlink:label="loc_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithTerminationOptions" xlink:label="loc_trib_NumberOfLeasesWithTerminationOptions_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_VehiclesMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_trib_ITAndOfficeEquipmentMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_RangeAxis_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_6" xlink:to="loc_ifrs-full_RangeDomain_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_6" xlink:to="loc_ifrs-full_BottomOfRangeMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_6" xlink:to="loc_ifrs-full_TopOfRangeMember_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_10" xlink:to="loc_trib_NumberOfRightOfUseLeasedAssets_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_10" xlink:to="loc_trib_RemainingTermInYears_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_10" xlink:to="loc_trib_AverageRemainingLeaseTermYears_12" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_10" xlink:to="loc_trib_NumberOfLeasesWithExtensionOptions_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_10" xlink:to="loc_trib_NumberOfLeasesWithOptionsToPurchase_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_10" xlink:to="loc_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_15" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_10" xlink:to="loc_trib_NumberOfLeasesWithTerminationOptions_16" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" xlink:label="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-full_BrandNamesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticsIncMember" xlink:label="loc_trib_ImmcoDiagnosticsIncMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingLimitedMember" xlink:label="loc_trib_TrinityBiotechManufacturingLimitedMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicDiagnosticsLimitedMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncMember" xlink:label="loc_trib_WaveformTechnologiesIncMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-full_TechnologybasedIntangibleAssetsMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_T10HplcAnalyzerMember" xlink:label="loc_trib_T10HplcAnalyzerMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SyphilisPointOfCareMember" xlink:label="loc_trib_SyphilisPointOfCareMember_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinscreenPlantAndEquipmentMember" xlink:label="loc_trib_TrinscreenPlantAndEquipmentMember_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KansasRightOfUseAssetMember" xlink:label="loc_trib_KansasRightOfUseAssetMember_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TristatMember" xlink:label="loc_trib_TristatMember_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyDevelopmentAndProjectManagementExpense" xlink:label="loc_ifrs-full_PropertyDevelopmentAndProjectManagementExpense_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets" xlink:label="loc_ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets_22"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalProjectCost" xlink:label="loc_trib_AdditionalProjectCost_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_25"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GoodwillWriteOff" xlink:label="loc_trib_GoodwillWriteOff_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IntangibleAssetsUnderDevelopmentWrittenDown" xlink:label="loc_trib_IntangibleAssetsUnderDevelopmentWrittenDown_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IntangibleAssetsUnderDevelopmentImpairmentCharge" xlink:label="loc_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_28"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AssetsUnderDevelopmentCarryingValue" xlink:label="loc_trib_AssetsUnderDevelopmentCarryingValue_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashImpairmentCharge" xlink:label="loc_trib_NonCashImpairmentCharge_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_32"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentLossForInvestment" xlink:label="loc_trib_ImpairmentLossForInvestment_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:label="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_35"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongTermGrowthRate" xlink:label="loc_trib_LongTermGrowthRate_36"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PreTaxDiscountRates" xlink:label="loc_trib_PreTaxDiscountRates_37"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalImpairmentLossDueToGrowthInRevenues" xlink:label="loc_trib_AdditionalImpairmentLossDueToGrowthInRevenues_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_39"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ActuarialAssumptionOfDiscountRatePercentage" xlink:label="loc_trib_ActuarialAssumptionOfDiscountRatePercentage_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_41"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalImpairmentLoss" xlink:label="loc_trib_AdditionalImpairmentLoss_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssets" xlink:label="loc_ifrs-full_OtherIntangibleAssets_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_46"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_BrandNamesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_ImmcoDiagnosticsIncMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_TrinityBiotechManufacturingLimitedMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_MetabolomicDiagnosticsLimitedMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_WaveformTechnologiesIncMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_EpiCaptureLimitedMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_TechnologybasedIntangibleAssetsMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_RangeAxis_10" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_10" xlink:to="loc_ifrs-full_RangeDomain_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_10" xlink:to="loc_ifrs-full_BottomOfRangeMember_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_10" xlink:to="loc_ifrs-full_TopOfRangeMember_11" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_14" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_14" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_14" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_14" xlink:to="loc_trib_T10HplcAnalyzerMember_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_14" xlink:to="loc_trib_SyphilisPointOfCareMember_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_14" xlink:to="loc_trib_TrinscreenPlantAndEquipmentMember_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_14" xlink:to="loc_trib_KansasRightOfUseAssetMember_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_14" xlink:to="loc_trib_TristatMember_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_PropertyDevelopmentAndProjectManagementExpense_21" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets_22" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_trib_AdditionalProjectCost_23" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_25" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_trib_GoodwillWriteOff_26" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_trib_IntangibleAssetsUnderDevelopmentWrittenDown_27" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_28" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_trib_AssetsUnderDevelopmentCarryingValue_29" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_trib_NonCashImpairmentCharge_30" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_31" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_ImpairmentLossOnFinancialAssets_32" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_trib_ImpairmentLossForInvestment_33" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_34" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_35" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_trib_LongTermGrowthRate_36" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_trib_PreTaxDiscountRates_37" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_trib_AdditionalImpairmentLossDueToGrowthInRevenues_38" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_39" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_trib_ActuarialAssumptionOfDiscountRatePercentage_40" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_41" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_trib_AdditionalImpairmentLoss_42" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_43" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_OtherIntangibleAssets_44" order="230" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_45" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_21" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_46" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" xlink:label="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-full_GoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DevelopmentCostMember" xlink:label="loc_trib_DevelopmentCostMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-full_TechnologybasedIntangibleAssetsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCarryingAmountMember" xlink:label="loc_trib_NetCarryingAmountMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsGoodwillAndIntangibleAssets" xlink:label="loc_trib_DisposalsGoodwillAndIntangibleAssets_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReclassificationGoodwillAndIntangibleAssets" xlink:label="loc_trib_ReclassificationGoodwillAndIntangibleAssets_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_21"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_ifrs-full_GoodwillMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_DevelopmentCostMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_ifrs-full_TechnologybasedIntangibleAssetsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_8" xlink:to="loc_ifrs-full_CarryingAmountMember_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_8" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_8" xlink:to="loc_trib_NetCarryingAmountMember_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_8" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_13" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_13" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_13" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_13" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_13" xlink:to="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_13" xlink:to="loc_trib_DisposalsGoodwillAndIntangibleAssets_17" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_13" xlink:to="loc_trib_ReclassificationGoodwillAndIntangibleAssets_18" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_13" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_19" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_13" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_20" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_13" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_21" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" xlink:label="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContinuousGlucoseMonitoringTestingMember" xlink:label="loc_trib_ContinuousGlucoseMonitoringTestingMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PremierInstrumentMember" xlink:label="loc_trib_PremierInstrumentMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CovidTestMember" xlink:label="loc_trib_CovidTestMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AutoimmuneSmartReaderMember" xlink:label="loc_trib_AutoimmuneSmartReaderMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MidTierHaemoglobinsInstrumentMember" xlink:label="loc_trib_MidTierHaemoglobinsInstrumentMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_HivOneByTwoRapidTestMember" xlink:label="loc_trib_HivOneByTwoRapidTestMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldRawMaterialStabilisationMember" xlink:label="loc_trib_UniGoldRawMaterialStabilisationMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TriStatPointOfCareInstrumentMember" xlink:label="loc_trib_TriStatPointOfCareInstrumentMember_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SjogrensTestsMember" xlink:label="loc_trib_SjogrensTestsMember_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldAntigenImprovementMember" xlink:label="loc_trib_UniGoldAntigenImprovementMember_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SyphilisPointOfCareTestMember" xlink:label="loc_trib_SyphilisPointOfCareTestMember_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ColumnEnhancementMember" xlink:label="loc_trib_ColumnEnhancementMember_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UltraGenesysMember" xlink:label="loc_trib_UltraGenesysMember_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherProjectsMember" xlink:label="loc_trib_OtherProjectsMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_G6PDHTestMember" xlink:label="loc_trib_G6PDHTestMember_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldTestMember" xlink:label="loc_trib_UniGoldTestMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalDevelopmentProjectsCapitalizedCosts" xlink:label="loc_trib_PrincipalDevelopmentProjectsCapitalizedCosts_19"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_ContinuousGlucoseMonitoringTestingMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_PremierInstrumentMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_CovidTestMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_AutoimmuneSmartReaderMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_MidTierHaemoglobinsInstrumentMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_HivOneByTwoRapidTestMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_UniGoldRawMaterialStabilisationMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_TriStatPointOfCareInstrumentMember_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_SjogrensTestsMember_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_UniGoldAntigenImprovementMember_10" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_SyphilisPointOfCareTestMember_11" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_ColumnEnhancementMember_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_UltraGenesysMember_13" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_OtherProjectsMember_14" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_G6PDHTestMember_15" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_UniGoldTestMember_16" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_19" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_19" xlink:to="loc_trib_PrincipalDevelopmentProjectsCapitalizedCosts_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" xlink:label="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticsIncMember" xlink:label="loc_trib_ImmcoDiagnosticsIncMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingLimitedMember" xlink:label="loc_trib_TrinityBiotechManufacturingLimitedMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechDoBrasilMember" xlink:label="loc_trib_TrinityBiotechDoBrasilMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrimusCorpMember" xlink:label="loc_trib_PrimusCorpMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClarkLaboratoriesIncMember" xlink:label="loc_trib_ClarkLaboratoriesIncMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiopoolUsIncMember" xlink:label="loc_trib_BiopoolUsIncMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MardxDiagnosticsIncMember" xlink:label="loc_trib_MardxDiagnosticsIncMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_ImmcoDiagnosticsIncMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_TrinityBiotechManufacturingLimitedMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_TrinityBiotechDoBrasilMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_PrimusCorpMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_ClarkLaboratoriesIncMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_BiopoolUsIncMember_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_MardxDiagnosticsIncMember_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_10" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_10" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_10" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfBreakdownOfImpairmentLossDetailsUsd">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" xlink:label="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ChangesInPropertyPlantAndEquipment_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Prepayments" xlink:label="loc_ifrs-full_Prepayments_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DecreaseThroughImpairmentContractAssets" xlink:label="loc_ifrs-full_DecreaseThroughImpairmentContractAssets_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_ChangesInPropertyPlantAndEquipment_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_ImpairmentLossOnFinancialAssets_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_Prepayments_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DecreaseThroughImpairmentContractAssets_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" xlink:label="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncMember" xlink:label="loc_trib_WaveformTechnologiesIncMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalCguTradeNameMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CarryingAmountOfGoodwill" xlink:label="loc_trib_CarryingAmountOfGoodwill_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxRateEffectOfImpairmentOfGoodwill" xlink:label="loc_ifrs-full_TaxRateEffectOfImpairmentOfGoodwill_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExcessValueOfGoodwillInUseOverCarryingAmount" xlink:label="loc_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment" xlink:label="loc_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongTermGrowthRate" xlink:label="loc_trib_LongTermGrowthRate_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_WaveformTechnologiesIncMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_EpiCaptureLimitedMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_6" xlink:to="loc_trib_CarryingAmountOfGoodwill_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_6" xlink:to="loc_ifrs-full_TaxRateEffectOfImpairmentOfGoodwill_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_6" xlink:to="loc_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_6" xlink:to="loc_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_6" xlink:to="loc_trib_LongTermGrowthRate_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" xlink:label="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticCGUMember" xlink:label="loc_trib_ImmcoDiagnosticCGUMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalCguTradeNameMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrimusCorporationCguTradeNameMember" xlink:label="loc_trib_PrimusCorporationCguTradeNameMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_ImmcoDiagnosticCGUMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_PrimusCorporationCguTradeNameMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_7" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_7" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision" xlink:label="loc_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision" xlink:label="loc_trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxLiabilityDecreased" xlink:label="loc_trib_DeferredTaxLiabilityDecreased_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxLiabilityIncreased" xlink:label="loc_trib_DeferredTaxLiabilityIncreased_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreasedInUnrecognisedDeferredTaxAssets" xlink:label="loc_trib_IncreasedInUnrecognisedDeferredTaxAssets_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuenceOfExchangeableNote" xlink:label="loc_trib_IssuenceOfExchangeableNote_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnrecognizedDeferredTaxAsset" xlink:label="loc_trib_UnrecognizedDeferredTaxAsset_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DeferredTaxLiabilityDecreased_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DeferredTaxLiabilityIncreased_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_IncreasedInUnrecognisedDeferredTaxAssets_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_IssuenceOfExchangeableNote_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_UnrecognizedDeferredTaxAsset_7" order="60" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryMember" xlink:label="loc_trib_InventoryMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember" xlink:label="loc_ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxValueOfLossCarryForwardsMember" xlink:label="loc_trib_TaxValueOfLossCarryForwardsMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherItemsMember" xlink:label="loc_trib_OtherItemsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_trib_InventoryMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_trib_TaxValueOfLossCarryForwardsMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_trib_OtherItemsMember_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9" xlink:to="loc_ifrs-full_DeferredTaxAssets_9" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_11" order="20" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryMember" xlink:label="loc_trib_InventoryMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember" xlink:label="loc_ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxValueOfLossCarryForwardsMember" xlink:label="loc_trib_TaxValueOfLossCarryForwardsMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherItemsMember" xlink:label="loc_trib_OtherItemsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" xlink:label="loc_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_trib_InventoryMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_trib_TaxValueOfLossCarryForwardsMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_trib_OtherItemsMember_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9" xlink:to="loc_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_9" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsCapitalLossCarryforward" xlink:label="loc_trib_DeferredTaxAssetsCapitalLossCarryforward_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossDomestic" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossDomestic_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits" xlink:label="loc_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOtherTemporaryTimingDifferences" xlink:label="loc_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossCarryforwardsState" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossCarryforward" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DeferredTaxAssetsCapitalLossCarryforward_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DeferredTaxAssetsOperatingLossDomestic_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xlink:to="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/OtherNon-currentAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousNoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinanceLeaseReceivables" xlink:label="loc_ifrs-full_NoncurrentFinanceLeaseReceivables_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherAssetNoncurrent" xlink:label="loc_trib_OtherAssetNoncurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_0" xlink:to="loc_ifrs-full_NoncurrentFinanceLeaseReceivables_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_0" xlink:to="loc_trib_OtherAssetNoncurrent_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_0" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/InventoriesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoriesAtNetRealisableValue" xlink:label="loc_ifrs-full_InventoriesAtNetRealisableValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NewProvisionsOtherProvisions" xlink:label="loc_ifrs-full_NewProvisionsOtherProvisions_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_InventoriesAtNetRealisableValue_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_NewProvisionsOtherProvisions_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies" xlink:label="loc_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WorkInProgress" xlink:label="loc_ifrs-full_WorkInProgress_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_WorkInProgress_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_FinishedGoods_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_Inventories_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForInventoriesMember" xlink:label="loc_trib_ProvisionForInventoriesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-full_OtherProvisions_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="loc_ifrs-full_AdditionalProvisionsOtherProvisions_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="loc_ifrs-full_ProvisionUsedOtherProvisions_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NewProvisionsOtherProvisions" xlink:label="loc_ifrs-full_NewProvisionsOtherProvisions_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EliminatedOnDisposalOfBusiness" xlink:label="loc_trib_EliminatedOnDisposalOfBusiness_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-full_OtherProvisions_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_1" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_1" xlink:to="loc_trib_ProvisionForInventoriesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_4" xlink:to="loc_ifrs-full_OtherProvisions_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_4" xlink:to="loc_ifrs-full_AdditionalProvisionsOtherProvisions_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_4" xlink:to="loc_ifrs-full_ProvisionUsedOtherProvisions_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_4" xlink:to="loc_ifrs-full_NewProvisionsOtherProvisions_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_4" xlink:to="loc_trib_EliminatedOnDisposalOfBusiness_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_4" xlink:to="loc_ifrs-full_OtherProvisions_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Prepayments" xlink:label="loc_ifrs-full_Prepayments_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_4" xlink:to="loc_ifrs-full_TradeReceivables_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_4" xlink:to="loc_ifrs-full_Prepayments_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_4" xlink:to="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPrepayments" xlink:label="loc_ifrs-full_CurrentPrepayments_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentContractAssets" xlink:label="loc_ifrs-full_CurrentContractAssets_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentReceivablesFromRentalOfProperties" xlink:label="loc_ifrs-full_CurrentReceivablesFromRentalOfProperties_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReceivablesFromConsiderationDueSaleOfBusiness" xlink:label="loc_trib_ReceivablesFromConsiderationDueSaleOfBusiness_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrantReceivable" xlink:label="loc_trib_GrantReceivable_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_CurrentTradeReceivables_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_CurrentPrepayments_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_CurrentContractAssets_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_CurrentValueAddedTaxReceivables_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_CurrentReceivablesFromRentalOfProperties_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_trib_ReceivablesFromConsiderationDueSaleOfBusiness_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_OtherReceivables_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_trib_GrantReceivable_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrossInvestmentInFinanceLease" xlink:label="loc_trib_GrossInvestmentInFinanceLease_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnearnedFinanceIncomeOnFinanceLease" xlink:label="loc_trib_UnearnedFinanceIncomeOnFinanceLease_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_5" xlink:to="loc_trib_GrossInvestmentInFinanceLease_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_5" xlink:to="loc_trib_UnearnedFinanceIncomeOnFinanceLease_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_5" xlink:to="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_7" order="20" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InstrumentsMember" xlink:label="loc_trib_InstrumentsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived" xlink:label="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_5" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_5" xlink:to="loc_trib_InstrumentsMember_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_8" xlink:to="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_8" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_0" xlink:to="loc_ifrs-full_Cash_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_0" xlink:to="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareTreasurySharesMember" xlink:label="loc_trib_AmericanDepositaryShareTreasurySharesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteMember" xlink:label="loc_trib_ConvertibleNoteMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MicoLtdMember" xlink:label="loc_trib_MicoLtdMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncMember" xlink:label="loc_trib_WaveformTechnologiesIncMember_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicDiagnosticsLimitedMember_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CraigHallumMember" xlink:label="loc_trib_CraigHallumMember_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NativeDesignLimitedMember" xlink:label="loc_trib_NativeDesignLimitedMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NovusDiagnosticsLimitedMember" xlink:label="loc_trib_NovusDiagnosticsLimitedMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-full_NumberOfSharesAuthorised_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConsiderationFromEmployeeOptionsSettledInCash" xlink:label="loc_trib_ConsiderationFromEmployeeOptionsSettledInCash_25"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CostIncurredIssueOfShares" xlink:label="loc_trib_CostIncurredIssueOfShares_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareRepurchasedUnderBuybackProgram" xlink:label="loc_trib_ShareRepurchasedUnderBuybackProgram_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PurchaseOfTreasuryShare" xlink:label="loc_trib_PurchaseOfTreasuryShare_28"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase" xlink:label="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue" xlink:label="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_30"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareIssueCostForExchangeableNotesPurchase" xlink:label="loc_trib_ShareIssueCostForExchangeableNotesPurchase_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfCashFlowHedges" xlink:label="loc_ifrs-full_ReserveOfCashFlowHedges_33"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesToBeIssuedForHedgingReservesValue" xlink:label="loc_trib_SharesToBeIssuedForHedgingReservesValue_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_38"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares" xlink:label="loc_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments" xlink:label="loc_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments_40"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareTreasurySharesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_5" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5" xlink:to="loc_trib_ConvertibleNoteMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_8" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_8" xlink:to="loc_trib_MicoLtdMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_11" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_11" xlink:to="loc_trib_WaveformTechnologiesIncMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_11" xlink:to="loc_trib_MetabolomicDiagnosticsLimitedMember_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_11" xlink:to="loc_trib_CraigHallumMember_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_11" xlink:to="loc_trib_NativeDesignLimitedMember_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_11" xlink:to="loc_trib_EpiCaptureLimitedMember_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_11" xlink:to="loc_trib_NovusDiagnosticsLimitedMember_16" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_22" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_ifrs-full_NumberOfSharesAuthorised_23" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_ifrs-full_ParValuePerShare_24" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_trib_ConsiderationFromEmployeeOptionsSettledInCash_25" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_trib_CostIncurredIssueOfShares_26" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_trib_ShareRepurchasedUnderBuybackProgram_27" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_trib_PurchaseOfTreasuryShare_28" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_29" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_30" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_trib_ShareIssueCostForExchangeableNotesPurchase_31" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_32" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_ifrs-full_ReserveOfCashFlowHedges_33" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_trib_SharesToBeIssuedForHedgingReservesValue_34" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_35" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_36" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_ifrs-full_BorrowingsMaturity_37" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_ifrs-full_Borrowings_38" order="190" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_39" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_19" xlink:to="loc_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments_40" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassATreasurySharesMember" xlink:label="loc_trib_ClassATreasurySharesMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareTreasurySharesMember" xlink:label="loc_trib_AmericanDepositaryShareTreasurySharesMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuedForNoncashConsideration" xlink:label="loc_trib_IssuedForNoncashConsideration_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-full_TreasuryShares_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-full_TreasuryShares_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassATreasurySharesMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareTreasurySharesMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_NumberOfSharesIssued_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_trib_IssuedForNoncashConsideration_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_NumberOfSharesIssued_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_12" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_TreasuryShares_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_PurchaseOfTreasuryShares_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_7" xlink:to="loc_ifrs-full_TreasuryShares_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ShareOptionsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShareOptionsAndShareWarrantsAbstract" xlink:label="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfShareAdjustedRatio" xlink:label="loc_trib_DescriptionOfShareAdjustedRatio_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AverageSharePriceShareOptionsExercised" xlink:label="loc_trib_AverageSharePriceShareOptionsExercised_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OpeningSharePrice" xlink:label="loc_trib_OpeningSharePrice_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosingExercisePriceOfOutstandingShareOptions" xlink:label="loc_trib_ClosingExercisePriceOfOutstandingShareOptions_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsContinuingOperations" xlink:label="loc_trib_ShareBasedPaymentsContinuingOperations_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets" xlink:label="loc_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_21"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_RangeAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_5" xlink:to="loc_ifrs-full_RangeDomain_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_5" xlink:to="loc_ifrs-full_BottomOfRangeMember_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_5" xlink:to="loc_ifrs-full_TopOfRangeMember_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_10" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_DescriptionOfShareAdjustedRatio_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_AverageSharePriceShareOptionsExercised_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_OpeningSharePrice_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_ClosingExercisePriceOfOutstandingShareOptions_15" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_ifrs-full_WeightedAverageSharePrice2019_16" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_17" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_ShareBasedPaymentsContinuingOperations_18" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_19" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_20" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_21" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShareOptionsAndShareWarrantsAbstract" xlink:label="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OptionsAndWarrantsAbstract" xlink:label="loc_trib_OptionsAndWarrantsAbstract_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageExercisePriceAbstract" xlink:label="loc_trib_WeightedAverageExercisePriceAbstract_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_21"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_RangeAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_5" xlink:to="loc_ifrs-full_RangeDomain_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_5" xlink:to="loc_ifrs-full_BottomOfRangeMember_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_5" xlink:to="loc_ifrs-full_TopOfRangeMember_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_OptionsAndWarrantsAbstract_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OptionsAndWarrantsAbstract_9" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OptionsAndWarrantsAbstract_9" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_10" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OptionsAndWarrantsAbstract_9" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OptionsAndWarrantsAbstract_9" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OptionsAndWarrantsAbstract_9" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OptionsAndWarrantsAbstract_9" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_9" xlink:to="loc_trib_WeightedAverageExercisePriceAbstract_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_WeightedAverageExercisePriceAbstract_16" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_WeightedAverageExercisePriceAbstract_16" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_17" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_WeightedAverageExercisePriceAbstract_16" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_WeightedAverageExercisePriceAbstract_16" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_19" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_WeightedAverageExercisePriceAbstract_16" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_20" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_WeightedAverageExercisePriceAbstract_16" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_21" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShareOptionsAndShareWarrantsAbstract" xlink:label="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember" xlink:label="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_22"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutstandingAbstract" xlink:label="loc_trib_OutstandingAbstract_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_22"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageExercisePriceOutstanding" xlink:label="loc_trib_WeightedAverageExercisePriceOutstanding_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExercisableAbstract" xlink:label="loc_trib_ExercisableAbstract_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfShareOptionsExercisableShareBasedPayment" xlink:label="loc_trib_NumberOfShareOptionsExercisableShareBasedPayment_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" xlink:label="loc_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_28"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_5" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_11" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_12" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_13" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember_14" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember_15" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember_16" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember_17" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember_18" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_5" xlink:to="loc_trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember_19" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_22" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_22" xlink:to="loc_trib_OutstandingAbstract_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OutstandingAbstract_22" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OutstandingAbstract_22" xlink:to="loc_trib_WeightedAverageExercisePriceOutstanding_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_OutstandingAbstract_22" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_24" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_22" xlink:to="loc_trib_ExercisableAbstract_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_ExercisableAbstract_26" xlink:to="loc_trib_NumberOfShareOptionsExercisableShareBasedPayment_26" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_ExercisableAbstract_26" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_27" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_ExercisableAbstract_26" xlink:to="loc_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_28" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShareOptionsAndShareWarrantsAbstract" xlink:label="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsCostOfSales" xlink:label="loc_trib_ShareBasedPaymentsCostOfSales_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsSellingGeneralAndAdministrative" xlink:label="loc_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsContinuingOperations" xlink:label="loc_trib_ShareBasedPaymentsContinuingOperations_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsDiscontinuedOperations" xlink:label="loc_trib_ShareBasedPaymentsDiscontinuedOperations_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_trib_ShareBasedPaymentsCostOfSales_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_trib_ShareBasedPaymentsContinuingOperations_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_trib_ShareBasedPaymentsDiscontinuedOperations_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShareOptionsAndShareWarrantsAbstract" xlink:label="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherEmployeesMember" xlink:label="loc_trib_OtherEmployeesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalShareOptionsGrantedAdsEquivalent" xlink:label="loc_trib_TotalShareOptionsGrantedAdsEquivalent_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_OtherEmployeesMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangeAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_5" xlink:to="loc_ifrs-full_RangeDomain_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_5" xlink:to="loc_ifrs-full_BottomOfRangeMember_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_5" xlink:to="loc_ifrs-full_TopOfRangeMember_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_9" xlink:to="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_9" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_9" xlink:to="loc_trib_TotalShareOptionsGrantedAdsEquivalent_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_9" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_11" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_9" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_12" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_9" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_13" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_9" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_14" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_9" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_15" order="60" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets" xlink:label="loc_ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentValueAddedTaxPayables" xlink:label="loc_ifrs-full_CurrentValueAddedTaxPayables_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EmployeeRelatedSocialInsurance" xlink:label="loc_trib_EmployeeRelatedSocialInsurance_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredIncomeIncludingContractLiabilities" xlink:label="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedLiabilitiesToContractedLicencePayments" xlink:label="loc_trib_AccruedLiabilitiesToContractedLicencePayments_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_CurrentValueAddedTaxPayables_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_trib_EmployeeRelatedSocialInsurance_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xlink:to="loc_trib_AccruedLiabilitiesToContractedLicencePayments_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ProvisionsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionsAbstract" xlink:label="loc_ifrs-full_ProvisionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestructuringProvisionMember" xlink:label="loc_ifrs-full_RestructuringProvisionMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InstalmentsAxis" xlink:label="loc_trib_InstalmentsAxis_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InstalmentsDomain" xlink:label="loc_trib_InstalmentsDomain_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WithinOneYearMember" xlink:label="loc_trib_WithinOneYearMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MoreThanOneYearMember" xlink:label="loc_trib_MoreThanOneYearMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember" xlink:label="loc_trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EstimatedObligations" xlink:label="loc_trib_EstimatedObligations_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="loc_ifrs-full_LegalProceedingsProvision_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalRestructuringCosts" xlink:label="loc_trib_AdditionalRestructuringCosts_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProvisionsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_1" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_1" xlink:to="loc_ifrs-full_RestructuringProvisionMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" xlink:to="loc_trib_InstalmentsAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_InstalmentsAxis_4" xlink:to="loc_trib_InstalmentsDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_InstalmentsDomain_4" xlink:to="loc_trib_WithinOneYearMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_InstalmentsDomain_4" xlink:to="loc_trib_MoreThanOneYearMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_8" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_8" xlink:to="loc_trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_11" xlink:to="loc_trib_EstimatedObligations_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_11" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_11" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_11" xlink:to="loc_ifrs-full_LegalProceedingsProvision_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_11" xlink:to="loc_trib_AdditionalRestructuringCosts_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionsAbstract" xlink:label="loc_ifrs-full_ProvisionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WarrantyProvision" xlink:label="loc_ifrs-full_WarrantyProvision_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="loc_ifrs-full_LegalProceedingsProvision_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-full_OtherProvisions_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestructuringProvision" xlink:label="loc_ifrs-full_RestructuringProvision_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-full_Provisions_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisions" xlink:label="loc_ifrs-full_CurrentProvisions_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisions" xlink:label="loc_ifrs-full_NoncurrentProvisions_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProvisionsAbstract_0" xlink:to="loc_ifrs-full_WarrantyProvision_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProvisionsAbstract_0" xlink:to="loc_ifrs-full_LegalProceedingsProvision_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProvisionsAbstract_0" xlink:to="loc_ifrs-full_OtherProvisions_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProvisionsAbstract_0" xlink:to="loc_ifrs-full_RestructuringProvision_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProvisionsAbstract_0" xlink:to="loc_ifrs-full_Provisions_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProvisionsAbstract_0" xlink:to="loc_ifrs-full_CurrentProvisions_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProvisionsAbstract_0" xlink:to="loc_ifrs-full_NoncurrentProvisions_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinanceLeaseLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentLeaseLiabilitiesAbstract" xlink:label="loc_trib_CurrentLeaseLiabilitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleAndLeasebackLiabilitiesCurrent" xlink:label="loc_trib_SaleAndLeasebackLiabilitiesCurrent_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentFinanceLeaseLiabilities" xlink:label="loc_trib_CurrentFinanceLeaseLiabilities_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLeaseLiabilitiesAbstract" xlink:label="loc_trib_NonCurrentLeaseLiabilitiesAbstract_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0" xlink:to="loc_trib_CurrentLeaseLiabilitiesAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_CurrentLeaseLiabilitiesAbstract_1" xlink:to="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_CurrentLeaseLiabilitiesAbstract_1" xlink:to="loc_trib_SaleAndLeasebackLiabilitiesCurrent_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_CurrentLeaseLiabilitiesAbstract_1" xlink:to="loc_trib_CurrentFinanceLeaseLiabilities_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0" xlink:to="loc_trib_NonCurrentLeaseLiabilitiesAbstract_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCurrentLeaseLiabilitiesAbstract_5" xlink:to="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinanceLeaseLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember" xlink:label="loc_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleAndLeasebackLiabilitiesMember" xlink:label="loc_trib_SaleAndLeasebackLiabilitiesMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayable" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayable_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpenseOnLeaseLiabilities1" xlink:label="loc_trib_InterestExpenseOnLeaseLiabilities1_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesAxis_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_7" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_7" xlink:to="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_7" xlink:to="loc_trib_SaleAndLeasebackLiabilitiesMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_11" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_11" xlink:to="loc_trib_MinimumFinanceLeasePaymentsPayable_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_11" xlink:to="loc_trib_InterestExpenseOnLeaseLiabilities1_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_11" xlink:to="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_13" order="20" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinanceLeaseLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseLiabilitiesMember" xlink:label="loc_trib_FinanceLeaseLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseLiabilitiesTwoMember" xlink:label="loc_trib_FinanceLeaseLiabilitiesTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsOriginalCurrency" xlink:label="loc_ifrs-full_BorrowingsOriginalCurrency_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountPaidInRespectOfLeaseLiabilities" xlink:label="loc_trib_AmountPaidInRespectOfLeaseLiabilities_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain_1" xlink:to="loc_trib_FinanceLeaseLiabilitiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain_1" xlink:to="loc_trib_FinanceLeaseLiabilitiesTwoMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_1" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_5" xlink:to="loc_ifrs-full_BorrowingsOriginalCurrency_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_5" xlink:to="loc_ifrs-full_BorrowingsInterestRate_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_5" xlink:to="loc_ifrs-full_BorrowingsMaturity_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_5" xlink:to="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_5" xlink:to="loc_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_5" xlink:to="loc_trib_AmountPaidInRespectOfLeaseLiabilities_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract" xlink:label="loc_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DarnickCompanyMember" xlink:label="loc_trib_DarnickCompanyMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaycheckProtectionProgramLoanMember" xlink:label="loc_trib_PaycheckProtectionProgramLoanMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiosynthMember" xlink:label="loc_trib_BiosynthMember_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalCommitments" xlink:label="loc_ifrs-full_CapitalCommitments_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContributionForTaxAuditSettlement" xlink:label="loc_trib_ContributionForTaxAuditSettlement_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrantContingenciesMaximumAmountPayable" xlink:label="loc_trib_GrantContingenciesMaximumAmountPayable_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GovernmentGrantReceived" xlink:label="loc_trib_GovernmentGrantReceived_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ForgivenessOfBorrowings" xlink:label="loc_trib_ForgivenessOfBorrowings_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_22"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnforgivenLoansAmount" xlink:label="loc_trib_UnforgivenLoansAmount_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfCurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfCurrentBorrowings_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AgreementPayments" xlink:label="loc_trib_AgreementPayments_25"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentAssets" xlink:label="loc_trib_ContingentAssets_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromSaleOfBusiness" xlink:label="loc_trib_ProceedsFromSaleOfBusiness_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisions" xlink:label="loc_ifrs-full_CurrentProvisions_28"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReceivablesOutstanding" xlink:label="loc_trib_ReceivablesOutstanding_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-full_OtherProvisions_31"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_DarnickCompanyMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_4" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_4" xlink:to="loc_trib_PaycheckProtectionProgramLoanMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_RangeAxis_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_7" xlink:to="loc_ifrs-full_RangeDomain_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_7" xlink:to="loc_ifrs-full_TopOfRangeMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_10" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_10" xlink:to="loc_trib_BiosynthMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_10" xlink:to="loc_trib_WaveformTechnologiesIncorporationMember_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_10" xlink:to="loc_trib_MetabolomicsDiagnosticsLimitedMember_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_10" xlink:to="loc_trib_EpiCaptureLimitedMember_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_ifrs-full_CapitalCommitments_16" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_trib_ContributionForTaxAuditSettlement_17" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_trib_GrantContingenciesMaximumAmountPayable_18" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_trib_GovernmentGrantReceived_19" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_trib_ForgivenessOfBorrowings_20" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_21" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_22" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_trib_UnforgivenLoansAmount_23" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_ifrs-full_RepaymentsOfCurrentBorrowings_24" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_trib_AgreementPayments_25" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_trib_ContingentAssets_26" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_trib_ProceedsFromSaleOfBusiness_27" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_ifrs-full_CurrentProvisions_28" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_trib_ReceivablesOutstanding_29" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_30" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_16" xlink:to="loc_ifrs-full_OtherProvisions_31" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MrOCaoimhMember" xlink:label="loc_trib_MrOCaoimhMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_JrjMember" xlink:label="loc_trib_JrjMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MrOCaoimhAndDrWalshMember" xlink:label="loc_trib_MrOCaoimhAndDrWalshMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DarnickCompanyMember" xlink:label="loc_trib_DarnickCompanyMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsMember" xlink:label="loc_trib_DirectorsMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RayvilleLimitedMember" xlink:label="loc_trib_RayvilleLimitedMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DrJimWalshMember" xlink:label="loc_trib_DrJimWalshMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR" xlink:label="loc_currency_EUR_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DarnickCompanyMember" xlink:label="loc_trib_DarnickCompanyMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalSpaceMember" xlink:label="loc_trib_AdditionalSpaceMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_22"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AcquisitionConsideration" xlink:label="loc_trib_AcquisitionConsideration_25"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermOfLease" xlink:label="loc_trib_TermOfLease_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MaturityDateForLease" xlink:label="loc_trib_MaturityDateForLease_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AnnualRentPayable" xlink:label="loc_trib_AnnualRentPayable_28"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AnnualRentPayableForWareHouse" xlink:label="loc_trib_AnnualRentPayableForWareHouse_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContributionForTaxAuditSettlement" xlink:label="loc_trib_ContributionForTaxAuditSettlement_30"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RateOfRentPerSqureFoot" xlink:label="loc_trib_RateOfRentPerSqureFoot_31"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseInAnnualRent" xlink:label="loc_trib_IncreaseInAnnualRent_32"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OverheadCosts" xlink:label="loc_trib_OverheadCosts_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_35"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExerciseOfShareOptionsReceivable" xlink:label="loc_trib_ExerciseOfShareOptionsReceivable_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_DividendsPaidClassifiedAsFinancingActivities_37"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsForCEOServices" xlink:label="loc_trib_PaymentsForCEOServices_38"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltiesPayments" xlink:label="loc_trib_PenaltiesPayments_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfCurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfCurrentBorrowings_41"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PatentDividendSchemeAmount" xlink:label="loc_trib_PatentDividendSchemeAmount_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-full_ServicesExpense_43"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedBonus" xlink:label="loc_trib_AccruedBonus_44"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseInSettlementAmountDueToDepreciation" xlink:label="loc_trib_IncreaseInSettlementAmountDueToDepreciation_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_46"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExtinguishmentOfAmountOwed" xlink:label="loc_trib_ExtinguishmentOfAmountOwed_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpense" xlink:label="loc_ifrs-full_InterestExpense_49"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_MrOCaoimhMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_JrjMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_MrOCaoimhAndDrWalshMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_DarnickCompanyMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_DirectorsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_RayvilleLimitedMember_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_DrJimWalshMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_srt_CurrencyAxis_10" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_10" xlink:to="loc_currency_AllCurrenciesDomain_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_10" xlink:to="loc_currency_EUR_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_srt_CounterpartyNameAxis_13" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_13" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_13" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_13" xlink:to="loc_trib_DarnickCompanyMember_13" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_16" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_16" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_16" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_16" xlink:to="loc_trib_AdditionalSpaceMember_16" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_19" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_19" xlink:to="loc_trib_MetabolomicsDiagnosticsLimitedMember_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_22" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_22" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_22" xlink:to="loc_trib_AmericanDepositaryShareMember_22" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_AcquisitionConsideration_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_TermOfLease_26" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_MaturityDateForLease_27" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_AnnualRentPayable_28" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_AnnualRentPayableForWareHouse_29" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_ContributionForTaxAuditSettlement_30" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_RateOfRentPerSqureFoot_31" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_IncreaseInAnnualRent_32" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_OverheadCosts_33" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_ifrs-full_DirectorsRemunerationExpense_34" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_35" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_ExerciseOfShareOptionsReceivable_36" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_ifrs-full_DividendsPaidClassifiedAsFinancingActivities_37" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_PaymentsForCEOServices_38" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_PenaltiesPayments_39" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_40" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_ifrs-full_RepaymentsOfCurrentBorrowings_41" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_PatentDividendSchemeAmount_42" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_ifrs-full_ServicesExpense_43" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_AccruedBonus_44" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_IncreaseInSettlementAmountDueToDepreciation_45" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_46" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_trib_ExtinguishmentOfAmountOwed_47" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_48" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_25" xlink:to="loc_ifrs-full_InterestExpense_49" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus" xlink:label="loc_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensation_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareOptionMember" xlink:label="loc_trib_ShareOptionMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsAndCompanySecretaryMember" xlink:label="loc_trib_DirectorsAndCompanySecretaryMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRetiredDirectorShares" xlink:label="loc_trib_NumberOfRetiredDirectorShares_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRetiredDirectorOptions" xlink:label="loc_trib_NumberOfRetiredDirectorOptions_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesPurchasedDuringYear" xlink:label="loc_trib_SharesPurchasedDuringYear_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesSoldDuringYear" xlink:label="loc_trib_SharesSoldDuringYear_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ShareOptionMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_5" xlink:to="loc_trib_DirectorsAndCompanySecretaryMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_trib_NumberOfRetiredDirectorShares_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_trib_NumberOfRetiredDirectorOptions_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_trib_SharesPurchasedDuringYear_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_trib_SharesSoldDuringYear_12" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_13" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_14" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_8" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_15" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanAnnualRate" xlink:label="loc_trib_SeniorSecuredTermLoanAnnualRate_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanFixedRate" xlink:label="loc_trib_SeniorSecuredTermLoanFixedRate_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrossIncreaseInterestIncome" xlink:label="loc_trib_GrossIncreaseInterestIncome_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpenses" xlink:label="loc_trib_InterestExpenses_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetInterestIncome" xlink:label="loc_trib_NetInterestIncome_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndDebenturesIssued" xlink:label="loc_ifrs-full_NotesAndDebenturesIssued_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotesAndDebenturesPurchased" xlink:label="loc_trib_NotesAndDebenturesPurchased_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermOfExchangeableSeniorNotes" xlink:label="loc_trib_TermOfExchangeableSeniorNotes_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MaturityDateOfExchangeableSeniorNotes" xlink:label="loc_trib_MaturityDateOfExchangeableSeniorNotes_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositoryShares" xlink:label="loc_trib_AmericanDepositoryShares_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotesAndDebenturesRetired" xlink:label="loc_trib_NotesAndDebenturesRetired_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentInvestments" xlink:label="loc_ifrs-full_CurrentInvestments_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InvestmentInUnsecuredJuniorConvertibleNote" xlink:label="loc_trib_InvestmentInUnsecuredJuniorConvertibleNote_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermLoanAgreementDescription" xlink:label="loc_trib_TermLoanAgreementDescription_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_SeniorSecuredTermLoanAnnualRate_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_SeniorSecuredTermLoanFixedRate_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_GrossIncreaseInterestIncome_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_InterestExpenses_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_NetInterestIncome_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_NotesAndDebenturesIssued_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_NotesAndDebenturesPurchased_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_TermOfExchangeableSeniorNotes_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_MaturityDateOfExchangeableSeniorNotes_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_AmericanDepositoryShares_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_NotesAndDebenturesRetired_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_CurrentInvestments_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_InvestmentInUnsecuredJuniorConvertibleNote_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_TermLoanAgreementDescription_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueMember" xlink:label="loc_trib_FairValueMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NovusDiagnosticsLimitedMember" xlink:label="loc_trib_NovusDiagnosticsLimitedMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoansAndReceivablesAbstract" xlink:label="loc_trib_LoansAndReceivablesAbstract_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaximumExposureToCreditRisk" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LiabilitiesAtAmortisedCostAbstract" xlink:label="loc_trib_LiabilitiesAtAmortisedCostAbstract_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNote" xlink:label="loc_trib_ConvertibleNote_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredConsideration" xlink:label="loc_trib_DeferredConsideration_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-full_TradeAndOtherPayables_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-full_Provisions_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredConsiderationPayable" xlink:label="loc_trib_DeferredConsiderationPayable_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicenceFee" xlink:label="loc_trib_LicenceFee_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCost" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCost_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAtFairValueThroughProfitOrLossAbstract" xlink:label="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests_30"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteEquityConversionOption" xlink:label="loc_trib_ExchangeableNoteEquityConversionOption_31"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueThroughProfitAndLoss" xlink:label="loc_trib_FairValueThroughProfitAndLoss_32"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfFinancialAssetsLiabilities" xlink:label="loc_trib_FairValueOfFinancialAssetsLiabilities_34"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1" xlink:to="loc_ifrs-full_Level2OfFairValueHierarchyMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1" xlink:to="loc_ifrs-full_CarryingAmountMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1" xlink:to="loc_trib_FairValueMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_1" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_8" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_8" xlink:to="loc_trib_NovusDiagnosticsLimitedMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_11" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_11" xlink:to="loc_trib_LoansAndReceivablesAbstract_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LoansAndReceivablesAbstract_11" xlink:to="loc_ifrs-full_TradeReceivables_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LoansAndReceivablesAbstract_11" xlink:to="loc_ifrs-full_CashAndCashEquivalents_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LoansAndReceivablesAbstract_11" xlink:to="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LoansAndReceivablesAbstract_11" xlink:to="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LoansAndReceivablesAbstract_11" xlink:to="loc_ifrs-full_MaximumExposureToCreditRisk_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_11" xlink:to="loc_trib_LiabilitiesAtAmortisedCostAbstract_17" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_17" xlink:to="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_17" xlink:to="loc_trib_ConvertibleNote_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_17" xlink:to="loc_ifrs-full_LongtermBorrowings_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_17" xlink:to="loc_ifrs-full_LeaseLiabilities_20" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_17" xlink:to="loc_trib_DeferredConsideration_21" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_17" xlink:to="loc_ifrs-full_TradeAndOtherPayables_22" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_17" xlink:to="loc_ifrs-full_Provisions_23" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_17" xlink:to="loc_trib_DeferredConsiderationPayable_24" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_17" xlink:to="loc_trib_LicenceFee_25" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_17" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCost_26" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_11" xlink:to="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_28" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_28" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_28" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_28" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_29" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_28" xlink:to="loc_ifrs-full_NoncontrollingInterests_30" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_28" xlink:to="loc_trib_ExchangeableNoteEquityConversionOption_31" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_28" xlink:to="loc_trib_FairValueThroughProfitAndLoss_32" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_11" xlink:to="loc_trib_FairValueOfFinancialAssetsLiabilities_34" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthOrLessMember" xlink:label="loc_trib_SixMonthOrLessMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthToTwelveMonthMember" xlink:label="loc_trib_SixMonthToTwelveMonthMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OneYearToTwoYearsMember" xlink:label="loc_trib_OneYearToTwoYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TwoYearToFiveYearsMember" xlink:label="loc_trib_TwoYearToFiveYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GreaterThanFiveYearsMember" xlink:label="loc_trib_GreaterThanFiveYearsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentMember" xlink:label="loc_trib_CashAndCashEquivalentMember_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseReceivableMember" xlink:label="loc_trib_FinanceLeaseReceivableMember_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicencePaymentsMember" xlink:label="loc_trib_LicencePaymentsMember_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteMember" xlink:label="loc_trib_ExchangeableNoteMember_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanMember" xlink:label="loc_trib_SeniorSecuredTermLoanMember_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteMember" xlink:label="loc_trib_ConvertibleNoteMember_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherBorrowingsMember" xlink:label="loc_trib_OtherBorrowingsMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnRightOfUseAssetsMember" xlink:label="loc_trib_LeasePayableOnRightOfUseAssetsMember_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnSaleLeasebackTransactionsMember" xlink:label="loc_trib_LeasePayableOnSaleLeasebackTransactionsMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectiveInterestRate" xlink:label="loc_trib_EffectiveInterestRate_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicenceFeePayments" xlink:label="loc_trib_LicenceFeePayments_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCurrentBorrowings" xlink:label="loc_trib_OtherCurrentBorrowings_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnRightOfUseAssets" xlink:label="loc_trib_LeasePayableOnRightOfUseAssets_25"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnSaleAndLeasebackTransactions" xlink:label="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities" xlink:label="loc_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_27"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_SixMonthOrLessMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_SixMonthToTwelveMonthMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_OneYearToTwoYearsMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_TwoYearToFiveYearsMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_GreaterThanFiveYearsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_8" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_8" xlink:to="loc_trib_CashAndCashEquivalentMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_8" xlink:to="loc_trib_FinanceLeaseReceivableMember_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_8" xlink:to="loc_trib_LicencePaymentsMember_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_8" xlink:to="loc_trib_ExchangeableNoteMember_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_8" xlink:to="loc_trib_SeniorSecuredTermLoanMember_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_8" xlink:to="loc_trib_ConvertibleNoteMember_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_8" xlink:to="loc_trib_OtherBorrowingsMember_14" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_8" xlink:to="loc_trib_LeasePayableOnRightOfUseAssetsMember_15" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_8" xlink:to="loc_trib_LeasePayableOnSaleLeasebackTransactionsMember_16" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_19" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_19" xlink:to="loc_trib_EffectiveInterestRate_19" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_19" xlink:to="loc_ifrs-full_CashAndCashEquivalents_20" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_19" xlink:to="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_19" xlink:to="loc_trib_LicenceFeePayments_22" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_19" xlink:to="loc_ifrs-full_LongtermBorrowings_23" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_19" xlink:to="loc_trib_OtherCurrentBorrowings_24" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_19" xlink:to="loc_trib_LeasePayableOnRightOfUseAssets_25" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_19" xlink:to="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_26" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_19" xlink:to="loc_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_27" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_VariableRateInstrumentsAbstract" xlink:label="loc_trib_VariableRateInstrumentsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_VariableRateInstruments" xlink:label="loc_trib_VariableRateInstruments_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FixedRateInstrumentsAbstract" xlink:label="loc_trib_FixedRateInstrumentsAbstract_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNote" xlink:label="loc_trib_ConvertibleNote_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FixedRateFinancialLiabilitiesBorrowings" xlink:label="loc_trib_FixedRateFinancialLiabilitiesBorrowings_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShortTermDepositsAndShortTermInvestments" xlink:label="loc_trib_ShortTermDepositsAndShortTermInvestments_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsLeaseReceivables" xlink:label="loc_trib_FinancialAssetsLeaseReceivables_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FixedRateInstruments" xlink:label="loc_trib_FixedRateInstruments_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_VariableRateInstrumentsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_VariableRateInstrumentsAbstract_1" xlink:to="loc_ifrs-full_Cash_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_VariableRateInstrumentsAbstract_1" xlink:to="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_VariableRateInstrumentsAbstract_1" xlink:to="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_VariableRateInstrumentsAbstract_1" xlink:to="loc_trib_VariableRateInstruments_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_FixedRateInstrumentsAbstract_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FixedRateInstrumentsAbstract_6" xlink:to="loc_ifrs-full_LongtermBorrowings_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FixedRateInstrumentsAbstract_6" xlink:to="loc_trib_ConvertibleNote_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FixedRateInstrumentsAbstract_6" xlink:to="loc_trib_FixedRateFinancialLiabilitiesBorrowings_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FixedRateInstrumentsAbstract_6" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FixedRateInstrumentsAbstract_6" xlink:to="loc_trib_ShortTermDepositsAndShortTermInvestments_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_FixedRateInstrumentsAbstract_6" xlink:to="loc_trib_FinancialAssetsLeaseReceivables_11" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_FixedRateInstruments_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContractualCashFlowsMember" xlink:label="loc_trib_ContractualCashFlowsMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthOrLessMember" xlink:label="loc_trib_SixMonthOrLessMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthToTwelveMonthMember" xlink:label="loc_trib_SixMonthToTwelveMonthMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OneYearToTwoYearsMember" xlink:label="loc_trib_OneYearToTwoYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TwoYearToFiveYearsMember" xlink:label="loc_trib_TwoYearToFiveYearsMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GreaterThanFiveYearsMember" xlink:label="loc_trib_GreaterThanFiveYearsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-full_TypesOfRisksDomain_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-full_LiquidityRiskMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-full_TradeAndOtherPayables_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnRightOfUseAssets" xlink:label="loc_trib_LeasePayableOnRightOfUseAssets_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnSaleAndLeasebackTransactions" xlink:label="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNote" xlink:label="loc_trib_ConvertibleNote_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherBorrowings" xlink:label="loc_ifrs-full_OtherBorrowings_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteInterest" xlink:label="loc_trib_ExchangeableNoteInterest_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-full_FinancialLiabilities_20"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_ContractualCashFlowsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_SixMonthOrLessMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_SixMonthToTwelveMonthMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_OneYearToTwoYearsMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_TwoYearToFiveYearsMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_GreaterThanFiveYearsMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksAxis_9" xlink:to="loc_ifrs-full_TypesOfRisksDomain_9" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksDomain_9" xlink:to="loc_ifrs-full_LiquidityRiskMember_9" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_12" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_12" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_12" xlink:to="loc_ifrs-full_TradeAndOtherPayables_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_12" xlink:to="loc_trib_LeasePayableOnRightOfUseAssets_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_12" xlink:to="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_14" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_12" xlink:to="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_12" xlink:to="loc_trib_ConvertibleNote_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_12" xlink:to="loc_ifrs-full_OtherBorrowings_17" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_12" xlink:to="loc_ifrs-full_LongtermBorrowings_18" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_12" xlink:to="loc_trib_ExchangeableNoteInterest_19" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_12" xlink:to="loc_ifrs-full_FinancialLiabilities_20" order="80" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR" xlink:label="loc_currency_EUR_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_GBP" xlink:label="loc_currency_GBP_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_SEK" xlink:label="loc_currency_SEK_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_CAD" xlink:label="loc_currency_CAD_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_BRL" xlink:label="loc_currency_BRL_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_XXX" xlink:label="loc_currency_XXX_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-full_TradeAndOtherPayables_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalExposureFinancialInstruments" xlink:label="loc_trib_TotalExposureFinancialInstruments_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_srt_CurrencyAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_EUR_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_GBP_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_SEK_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_CAD_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_BRL_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_XXX_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_9" xlink:to="loc_ifrs-full_Cash_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_9" xlink:to="loc_ifrs-full_TradeAndOtherReceivables_10" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_9" xlink:to="loc_ifrs-full_TradeAndOtherPayables_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_9" xlink:to="loc_ifrs-full_LeaseLiabilities_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_9" xlink:to="loc_trib_TotalExposureFinancialInstruments_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR" xlink:label="loc_currency_EUR_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-full_TypesOfRisksDomain_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TenPercentStrengtheningUSDollarMember" xlink:label="loc_trib_TenPercentStrengtheningUSDollarMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TenPercentWeakeningUSDollarMember" xlink:label="loc_trib_TenPercentWeakeningUSDollarMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable_1" xlink:to="loc_srt_CurrencyAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_EUR_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksAxis_4" xlink:to="loc_ifrs-full_TypesOfRisksDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksDomain_4" xlink:to="loc_trib_TenPercentStrengtheningUSDollarMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfRisksDomain_4" xlink:to="loc_trib_TenPercentWeakeningUSDollarMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable_1" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems_8" xlink:to="loc_ifrs-full_ProfitLoss_8" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMaximumCreditExposureOfFinancialAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaximumExposureToCreditRisk" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_CurrentTradeReceivables_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_MaximumExposureToCreditRisk_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="loc_country_US_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EuroZoneCountriesMember" xlink:label="loc_trib_EuroZoneCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB" xlink:label="loc_country_GB_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherEuropeanCountriesMember" xlink:label="loc_trib_OtherEuropeanCountriesMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRegionsMember" xlink:label="loc_trib_OtherRegionsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables" xlink:label="loc_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_US_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_EuroZoneCountriesMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_GB_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherEuropeanCountriesMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherRegionsMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_8" xlink:to="loc_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables_8" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfCustomersAxis" xlink:label="loc_ifrs-full_TypesOfCustomersAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfCustomersDomain" xlink:label="loc_ifrs-full_TypesOfCustomersDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EndUserCustomersMember" xlink:label="loc_trib_EndUserCustomersMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DistributorsMember" xlink:label="loc_trib_DistributorsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NongovernmentCustomersMember" xlink:label="loc_ifrs-full_NongovernmentCustomersMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables" xlink:label="loc_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1" xlink:to="loc_ifrs-full_TypesOfCustomersAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfCustomersAxis_1" xlink:to="loc_ifrs-full_TypesOfCustomersDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfCustomersDomain_1" xlink:to="loc_trib_EndUserCustomersMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfCustomersDomain_1" xlink:to="loc_trib_DistributorsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfCustomersDomain_1" xlink:to="loc_ifrs-full_NongovernmentCustomersMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_6" xlink:to="loc_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables_6" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusAxis" xlink:label="loc_ifrs-full_PastDueStatusAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusDomain" xlink:label="loc_ifrs-full_PastDueStatusDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentMember" xlink:label="loc_ifrs-full_CurrentMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember" xlink:label="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember" xlink:label="loc_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GreaterThanFourMonthsMember" xlink:label="loc_trib_GreaterThanFourMonthsMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpectedCreditLossRate" xlink:label="loc_ifrs-full_ExpectedCreditLossRate_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_PastDueStatusAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PastDueStatusAxis_5" xlink:to="loc_ifrs-full_PastDueStatusDomain_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PastDueStatusDomain_5" xlink:to="loc_ifrs-full_CurrentMember_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PastDueStatusDomain_5" xlink:to="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PastDueStatusDomain_5" xlink:to="loc_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PastDueStatusDomain_5" xlink:to="loc_trib_GreaterThanFourMonthsMember_8" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_11" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_11" xlink:to="loc_ifrs-full_TradeReceivables_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_11" xlink:to="loc_ifrs-full_ExpectedCreditLossRate_12" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMovementInAllowanceForImpairmentOfTradeReceivablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AllowanceForImpairmentOfReceivables" xlink:label="loc_trib_AllowanceForImpairmentOfReceivables_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseThroughOriginationOrPurchaseFinancialAssets" xlink:label="loc_ifrs-full_IncreaseThroughOriginationOrPurchaseFinancialAssets_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DecreaseThroughWriteoffFinancialAssets" xlink:label="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EliminatedOnDisposalsOfBusiness" xlink:label="loc_trib_EliminatedOnDisposalsOfBusiness_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AllowanceForImpairmentOfReceivables" xlink:label="loc_trib_AllowanceForImpairmentOfReceivables_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_AllowanceForImpairmentOfReceivables_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_IncreaseThroughOriginationOrPurchaseFinancialAssets_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_EliminatedOnDisposalsOfBusiness_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xlink:to="loc_trib_AllowanceForImpairmentOfReceivables_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowingsMember" xlink:label="loc_ifrs-full_LongtermBorrowingsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsForConvertibleNoteIssued" xlink:label="loc_trib_ProceedsForConvertibleNoteIssued_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnSeniorSecuredTermLoan" xlink:label="loc_trib_InterestPaidOnSeniorSecuredTermLoan_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnConvertibleNote" xlink:label="loc_trib_InterestPaidOnConvertibleNote_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyPaidForEarlySettlement" xlink:label="loc_trib_PenaltyPaidForEarlySettlement_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashActivityForFinancingActivityAbstract" xlink:label="loc_trib_NonCashActivityForFinancingActivityAbstract_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlySettlementCharged" xlink:label="loc_trib_PenaltyForEarlySettlementCharged_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MovementInInterestAccrual" xlink:label="loc_trib_MovementInInterestAccrual_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes" xlink:label="loc_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNoteAtDateOfIssue" xlink:label="loc_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_22"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfIssue_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemeasurementOfRightOfUseAssets" xlink:label="loc_trib_RemeasurementOfRightOfUseAssets_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOfExchangeableNotes" xlink:label="loc_trib_LossOnDisposalOfExchangeableNotes_25"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdoptionOfIfrs16" xlink:label="loc_trib_AdoptionOfIfrs16_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsRelatedToRightOfUseAssets" xlink:label="loc_trib_DisposalsRelatedToRightOfUseAssets_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionsRelatedToRightOfUseAssets" xlink:label="loc_trib_AdditionsRelatedToRightOfUseAssets_28"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_31"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_32"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_34"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_35"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_36"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_37"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashLoanModificationGain" xlink:label="loc_trib_NoncashLoanModificationGain_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_40"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_1" xlink:to="loc_ifrs-full_LongtermBorrowingsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_1" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_5" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_5" xlink:to="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_6" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_6" xlink:to="loc_trib_ProceedsForConvertibleNoteIssued_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_6" xlink:to="loc_trib_PrincipalAmountLoaned_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_6" xlink:to="loc_trib_InterestPaidOnSeniorSecuredTermLoan_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_6" xlink:to="loc_trib_InterestPaidOnConvertibleNote_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_6" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_11" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_6" xlink:to="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_12" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_6" xlink:to="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_13" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_6" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_14" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_6" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_15" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_6" xlink:to="loc_trib_PenaltyPaidForEarlySettlement_16" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_5" xlink:to="loc_trib_NonCashActivityForFinancingActivityAbstract_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_PenaltyForEarlySettlementCharged_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_MovementInInterestAccrual_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_21" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_22" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_DerivativeFinancialAssetAtDateOfIssue_23" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_RemeasurementOfRightOfUseAssets_24" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_LossOnDisposalOfExchangeableNotes_25" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_AdoptionOfIfrs16_26" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_DisposalsRelatedToRightOfUseAssets_27" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_AdditionsRelatedToRightOfUseAssets_28" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_29" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_30" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_31" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_32" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_33" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_34" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_35" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_36" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_37" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_18" xlink:to="loc_trib_NoncashLoanModificationGain_38" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_5" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_40" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GROUPUNDERTAKINGS">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGroupUndertakingsAbstract" xlink:label="loc_trib_DisclosureOfGroupUndertakingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGroupUndertakingsExplanatory" xlink:label="loc_trib_DisclosureOfGroupUndertakingsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGroupUndertakingsAbstract_0" xlink:to="loc_trib_DisclosureOfGroupUndertakingsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GROUPUNDERTAKINGSTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGroupUndertakingsAbstract" xlink:label="loc_trib_DisclosureOfGroupUndertakingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGroupUndertakingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGroupUndertakingsAbstract" xlink:label="loc_trib_DisclosureOfGroupUndertakingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfCompositionOfGroupTable" xlink:label="loc_trib_DisclosureOfCompositionOfGroupTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingLimitedMember" xlink:label="loc_trib_TrinityBiotechManufacturingLimitedMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityResearchLimitedMember" xlink:label="loc_trib_TrinityResearchLimitedMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BenenTradingLimitedMember" xlink:label="loc_trib_BenenTradingLimitedMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingServicesLimitedMember" xlink:label="loc_trib_TrinityBiotechManufacturingServicesLimitedMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechLuxembourgSarlMember" xlink:label="loc_trib_TrinityBiotechLuxembourgSarlMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechIncMember" xlink:label="loc_trib_TrinityBiotechIncMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClarkLaboratoriesIncMember" xlink:label="loc_trib_ClarkLaboratoriesIncMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MardxDiagnosticsIncMember" xlink:label="loc_trib_MardxDiagnosticsIncMember_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalIncMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalIncMember_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiopoolUsIncMember" xlink:label="loc_trib_BiopoolUsIncMember_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrimusCorporationMember" xlink:label="loc_trib_PrimusCorporationMember_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PhoenixBioTechCorpMember" xlink:label="loc_trib_PhoenixBioTechCorpMember_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsHoldingAbMember" xlink:label="loc_trib_FiomiDiagnosticsHoldingAbMember_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsAbMember" xlink:label="loc_trib_FiomiDiagnosticsAbMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechDoBrasilMember" xlink:label="loc_trib_TrinityBiotechDoBrasilMember_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechUkLtdMember" xlink:label="loc_trib_TrinityBiotechUkLtdMember_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticsIncMember" xlink:label="loc_trib_ImmcoDiagnosticsIncMember_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NovaCenturyScientificIncMember" xlink:label="loc_trib_NovaCenturyScientificIncMember_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechInvestmentLtdMember" xlink:label="loc_trib_TrinityBiotechInvestmentLtdMember_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TribBiosensorsIncMember" xlink:label="loc_trib_TribBiosensorsIncMember_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KonamiteLimitedMember" xlink:label="loc_trib_KonamiteLimitedMember_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechJointVentureLimitedMember" xlink:label="loc_trib_TrinityBiotechJointVentureLimitedMember_22"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_25"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfCompositionOfGroupLineItems" xlink:label="loc_trib_DisclosureOfCompositionOfGroupLineItems_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NameOfSubsidiary" xlink:label="loc_ifrs-full_NameOfSubsidiary_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AddressOfRegisteredOfficeOfEntity" xlink:label="loc_ifrs-full_AddressOfRegisteredOfficeOfEntity_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalActivity" xlink:label="loc_trib_PrincipalActivity_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PrincipalPlaceOfBusiness" xlink:label="loc_ifrs-full_PrincipalPlaceOfBusiness_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_32"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGroupUndertakingsAbstract_0" xlink:to="loc_trib_DisclosureOfCompositionOfGroupTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfCompositionOfGroupTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechManufacturingLimitedMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityResearchLimitedMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_BenenTradingLimitedMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechManufacturingServicesLimitedMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechLuxembourgSarlMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechIncMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_ClarkLaboratoriesIncMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_MardxDiagnosticsIncMember_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_FitzgeraldIndustriesInternationalIncMember_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_BiopoolUsIncMember_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_PrimusCorporationMember_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_PhoenixBioTechCorpMember_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_FiomiDiagnosticsHoldingAbMember_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_FiomiDiagnosticsAbMember_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechDoBrasilMember_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechUkLtdMember_16" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_ImmcoDiagnosticsIncMember_17" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_NovaCenturyScientificIncMember_18" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechInvestmentLtdMember_19" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TribBiosensorsIncMember_20" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_KonamiteLimitedMember_21" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechJointVentureLimitedMember_22" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_EpiCaptureLimitedMember_23" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_MetabolomicsDiagnosticsLimitedMember_24" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_WaveformTechnologiesIncorporationMember_25" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfCompositionOfGroupTable_1" xlink:to="loc_trib_DisclosureOfCompositionOfGroupLineItems_28" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfCompositionOfGroupLineItems_28" xlink:to="loc_ifrs-full_NameOfSubsidiary_28" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfCompositionOfGroupLineItems_28" xlink:to="loc_ifrs-full_AddressOfRegisteredOfficeOfEntity_29" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfCompositionOfGroupLineItems_28" xlink:to="loc_trib_PrincipalActivity_30" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfCompositionOfGroupLineItems_28" xlink:to="loc_ifrs-full_PrincipalPlaceOfBusiness_31" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfCompositionOfGroupLineItems_28" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_32" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" xlink:label="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_T10HplcAnalyzerMember" xlink:label="loc_trib_T10HplcAnalyzerMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SyphilisPointOfCareMember" xlink:label="loc_trib_SyphilisPointOfCareMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinscreenPlantAndEquipmentMember" xlink:label="loc_trib_TrinscreenPlantAndEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KansasRightOfUseAssetMember" xlink:label="loc_trib_KansasRightOfUseAssetMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsUnderDevelopment" xlink:label="loc_ifrs-full_IntangibleAssetsUnderDevelopment_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_T10HplcAnalyzerMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_SyphilisPointOfCareMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_TrinscreenPlantAndEquipmentMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_KansasRightOfUseAssetMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_7" xlink:to="loc_ifrs-full_IntangibleAssetsUnderDevelopment_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETS">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" xlink:label="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract" xlink:label="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentLiabilitiesMember" xlink:label="loc_trib_CurrentLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLiabilitiesMember" xlink:label="loc_trib_NonCurrentLiabilitiesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentAssetsMember" xlink:label="loc_trib_NonCurrentAssetsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableSeniorNotesMember" xlink:label="loc_trib_ExchangeableSeniorNotesMember_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanMember" xlink:label="loc_trib_SeniorSecuredTermLoanMember_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityMember" xlink:label="loc_trib_DerivativeFinancialLiabilityMember_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentLiabilityMember" xlink:label="loc_trib_ContingentLiabilityMember_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteMember" xlink:label="loc_trib_ConvertibleNoteMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetMember" xlink:label="loc_trib_DerivativeFinancialAssetMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_18"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" xlink:to="loc_trib_CurrentLiabilitiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" xlink:to="loc_trib_NonCurrentLiabilitiesMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_5" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_5" xlink:to="loc_trib_NonCurrentAssetsMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_8" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_8" xlink:to="loc_trib_ExchangeableSeniorNotesMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_8" xlink:to="loc_trib_SeniorSecuredTermLoanMember_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_8" xlink:to="loc_trib_DerivativeFinancialLiabilityMember_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_8" xlink:to="loc_trib_ContingentLiabilityMember_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_8" xlink:to="loc_trib_ConvertibleNoteMember_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_15" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_15" xlink:to="loc_trib_DerivativeFinancialAssetMember_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_18" xlink:to="loc_ifrs-full_Borrowings_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGS">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract" xlink:label="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract" xlink:label="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock" xlink:label="loc_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract" xlink:label="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentLiabilitiesMember" xlink:label="loc_trib_CurrentLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableSeniorNotesMember" xlink:label="loc_trib_ExchangeableSeniorNotesMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestOnBorrowings" xlink:label="loc_trib_AccretionInterestOnBorrowings_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings" xlink:label="loc_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOnBorrowings" xlink:label="loc_trib_LossOnDisposalOnBorrowings_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" xlink:to="loc_trib_CurrentLiabilitiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4" xlink:to="loc_trib_ExchangeableSeniorNotesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_Borrowings_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_AccretionInterestOnBorrowings_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_LossOnDisposalOnBorrowings_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_Borrowings_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract" xlink:label="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLiabilitiesMember" xlink:label="loc_trib_NonCurrentLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SevenYearConvertibleNoteMember" xlink:label="loc_trib_SevenYearConvertibleNoteMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanOriginationCosts" xlink:label="loc_trib_LoanOriginationCosts_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentAtDateOfIssue" xlink:label="loc_trib_EquityComponentAtDateOfIssue_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestOnBorrowings" xlink:label="loc_trib_AccretionInterestOnBorrowings_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" xlink:to="loc_trib_NonCurrentLiabilitiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4" xlink:to="loc_trib_SevenYearConvertibleNoteMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_Borrowings_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_PrincipalAmountLoaned_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_LoanOriginationCosts_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_EquityComponentAtDateOfIssue_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_AccretionInterestOnBorrowings_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_Borrowings_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract" xlink:label="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLiabilitiesMember" xlink:label="loc_trib_NonCurrentLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityMember" xlink:label="loc_trib_DerivativeFinancialLiabilityMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan" xlink:label="loc_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" xlink:to="loc_trib_NonCurrentLiabilitiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4" xlink:to="loc_trib_DerivativeFinancialLiabilityMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_Borrowings_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_Borrowings_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract" xlink:label="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentAssetsMember" xlink:label="loc_trib_NonCurrentAssetsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetMember" xlink:label="loc_trib_DerivativeFinancialAssetMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfDrawdown" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfDrawdown_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" xlink:to="loc_trib_NonCurrentAssetsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_4" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_4" xlink:to="loc_trib_DerivativeFinancialAssetMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_Borrowings_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_DerivativeFinancialAssetAtDateOfDrawdown_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_Borrowings_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract" xlink:label="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableSeniorNotesMember" xlink:label="loc_trib_ExchangeableSeniorNotesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanMember" xlink:label="loc_trib_SeniorSecuredTermLoanMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SevenYearConvertibleNoteMember" xlink:label="loc_trib_SevenYearConvertibleNoteMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteMember" xlink:label="loc_trib_ConvertibleNoteMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanCreditFacilityOneMember" xlink:label="loc_trib_SeniorSecuredTermLoanCreditFacilityOneMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleOfFitzgeraldIndustriesMember" xlink:label="loc_trib_SaleOfFitzgeraldIndustriesMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentMember" xlink:label="loc_trib_CashAndCashEquivalentMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentLiabilitiesMember" xlink:label="loc_trib_CurrentLiabilitiesMember_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLiabilitiesMember" xlink:label="loc_trib_NonCurrentLiabilitiesMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PerceptiveCreditHoldingsIiiLpMember" xlink:label="loc_trib_PerceptiveCreditHoldingsIiiLpMember_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MicoLtdMember" xlink:label="loc_trib_MicoLtdMember_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WarrantReserveMember" xlink:label="loc_ifrs-full_WarrantReserveMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmendmentAndRestatementOfTermLoanMember" xlink:label="loc_trib_AmendmentAndRestatementOfTermLoanMember_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_30"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_33"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalExchangeableNotesPercentage" xlink:label="loc_trib_TotalExchangeableNotesPercentage_34"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashPaidToEachHolder" xlink:label="loc_trib_CashPaidToEachHolder_35"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashReceivedPerNominalValue" xlink:label="loc_trib_CashReceivedPerNominalValue_36"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NominalValuePerShareOfExchangeableNotes" xlink:label="loc_trib_NominalValuePerShareOfExchangeableNotes_37"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NominalAmountOfDebt" xlink:label="loc_trib_NominalAmountOfDebt_38"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfBorrowingsPaid" xlink:label="loc_trib_DescriptionOfBorrowingsPaid_39"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesDiscountRate" xlink:label="loc_trib_ExchangeableNotesDiscountRate_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_41"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesConsideration" xlink:label="loc_trib_SharesConsideration_42"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesRepresentationRateComparedToADS" xlink:label="loc_trib_SharesRepresentationRateComparedToADS_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossLoanCommitments" xlink:label="loc_ifrs-full_GrossLoanCommitments_44"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExtinguishmentOfDebtAmounts" xlink:label="loc_trib_ExtinguishmentOfDebtAmounts_45"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOnBorrowings" xlink:label="loc_trib_LossOnDisposalOnBorrowings_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_51"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfWarrantsRepriced" xlink:label="loc_trib_NumberOfWarrantsRepriced_52"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExercisePriceOfWarrantsOrRights" xlink:label="loc_trib_ExercisePriceOfWarrantsOrRights_53"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentOfPenalty" xlink:label="loc_trib_PaymentOfPenalty_54"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_55"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanOriginationCosts" xlink:label="loc_trib_LoanOriginationCosts_56"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InitialExercisePriceOfWarrantsOrRights" xlink:label="loc_trib_InitialExercisePriceOfWarrantsOrRights_57"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_58"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_59"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromSaleOfBusiness" xlink:label="loc_trib_ProceedsFromSaleOfBusiness_60"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestOnBorrowings" xlink:label="loc_trib_AccretionInterestOnBorrowings_61"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestAccrued" xlink:label="loc_trib_AccretionInterestAccrued_62"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestAdjustment" xlink:label="loc_trib_AccretionInterestAdjustment_63"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfDerivativeFinancialAsset" xlink:label="loc_trib_FairValueOfDerivativeFinancialAsset_64"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfDerivativeFinancialLiability" xlink:label="loc_trib_FairValueOfDerivativeFinancialLiability_65"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueRemeasurementForDerivativeFinancialBalances" xlink:label="loc_trib_FairValueRemeasurementForDerivativeFinancialBalances_66"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue" xlink:label="loc_ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue_67"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_68"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNote" xlink:label="loc_trib_EquityComponentOfConvertibleNote_69"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfConversionOfDebtToEquity" xlink:label="loc_ifrs-full_DescriptionOfConversionOfDebtToEquity_70"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentAtDateOfIssue" xlink:label="loc_trib_EquityComponentAtDateOfIssue_71"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_72"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountAvailableForDevelopmentOfTheCGM" xlink:label="loc_trib_AmountAvailableForDevelopmentOfTheCGM_73"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate" xlink:label="loc_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_74"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountUsedToAcquireTheCGMAssets" xlink:label="loc_trib_AmountUsedToAcquireTheCGMAssets_75"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashFairValueGainLoss" xlink:label="loc_trib_NonCashFairValueGainLoss_76"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_77"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_ExchangeableSeniorNotesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_SeniorSecuredTermLoanMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_SevenYearConvertibleNoteMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_ConvertibleNoteMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_SeniorSecuredTermLoanCreditFacilityOneMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_SaleOfFitzgeraldIndustriesMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_9" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_9" xlink:to="loc_trib_CashAndCashEquivalentMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_12" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_12" xlink:to="loc_trib_CurrentLiabilitiesMember_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_12" xlink:to="loc_trib_NonCurrentLiabilitiesMember_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_16" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_16" xlink:to="loc_trib_PerceptiveCreditHoldingsIiiLpMember_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_16" xlink:to="loc_trib_MicoLtdMember_17" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_20" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_20" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_20" xlink:to="loc_ifrs-full_WarrantReserveMember_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_23" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_23" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_23" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_23" xlink:to="loc_trib_AmericanDepositaryShareMember_23" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_23" xlink:to="loc_trib_ClassAOrdinarySharesMember_24" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_27" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_27" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_27" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_27" xlink:to="loc_trib_AmendmentAndRestatementOfTermLoanMember_27" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_30" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_30" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_30" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_30" xlink:to="loc_trib_WaveformTechnologiesIncorporationMember_30" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_33" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/disclosureGuidance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_TotalExchangeableNotesPercentage_34" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_CashPaidToEachHolder_35" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_CashReceivedPerNominalValue_36" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_NominalValuePerShareOfExchangeableNotes_37" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_NominalAmountOfDebt_38" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_DescriptionOfBorrowingsPaid_39" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_ExchangeableNotesDiscountRate_40" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_41" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_SharesConsideration_42" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_SharesRepresentationRateComparedToADS_43" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_GrossLoanCommitments_44" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_ExtinguishmentOfDebtAmounts_45" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_LossOnDisposalOnBorrowings_46" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_Borrowings_47" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_NotionalAmount_48" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_BorrowingsMaturity_49" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_BorrowingsInterestRateBasis_50" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_NumberOfSharesIssued_51" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_NumberOfWarrantsRepriced_52" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_ExercisePriceOfWarrantsOrRights_53" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_PaymentOfPenalty_54" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_PrincipalAmountLoaned_55" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_LoanOriginationCosts_56" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_InitialExercisePriceOfWarrantsOrRights_57" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_58" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_59" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_ProceedsFromSaleOfBusiness_60" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_AccretionInterestOnBorrowings_61" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_AccretionInterestAccrued_62" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_AccretionInterestAdjustment_63" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_FairValueOfDerivativeFinancialAsset_64" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_FairValueOfDerivativeFinancialLiability_65" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_FairValueRemeasurementForDerivativeFinancialBalances_66" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue_67" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_BorrowingsInterestRate_68" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_EquityComponentOfConvertibleNote_69" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_DescriptionOfConversionOfDebtToEquity_70" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_EquityComponentAtDateOfIssue_71" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_72" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_AmountAvailableForDevelopmentOfTheCGM_73" order="400" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_74" order="410" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_AmountUsedToAcquireTheCGMAssets_75" order="420" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_trib_NonCashFairValueGainLoss_76" order="430" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_33" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_77" order="440" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract" xlink:label="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermLoanMember" xlink:label="loc_trib_TermLoanMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLiabilitiesMember" xlink:label="loc_trib_NonCurrentLiabilitiesMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanOriginationCosts" xlink:label="loc_trib_LoanOriginationCosts_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialLiabilityAtDateOfIssue_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfIssue_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestOnBorrowings" xlink:label="loc_trib_AccretionInterestOnBorrowings_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentInKindInterest" xlink:label="loc_trib_PaymentInKindInterest_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashLoanModificationGain" xlink:label="loc_trib_NoncashLoanModificationGain_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_TermLoanMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_4" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_4" xlink:to="loc_trib_NonCurrentLiabilitiesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_Borrowings_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_PrincipalAmountLoaned_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_LoanOriginationCosts_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/disclosureGuidance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_DerivativeFinancialLiabilityAtDateOfIssue_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_DerivativeFinancialAssetAtDateOfIssue_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/disclosureGuidance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_AccretionInterestOnBorrowings_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_PaymentInKindInterest_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_trib_NoncashLoanModificationGain_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_7" xlink:to="loc_ifrs-full_Borrowings_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/FINANCIALASSETS">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/FINANCIALASSETSDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsAdditions" xlink:label="loc_trib_FinancialAssetsAdditions_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsWriteOff" xlink:label="loc_trib_FinancialAssetsWriteOff_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets" xlink:label="loc_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForImpairment" xlink:label="loc_trib_ProvisionForImpairment_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReversalOfImpairmentLossOnFinancialAssets" xlink:label="loc_trib_ReversalOfImpairmentLossOnFinancialAssets_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForImpairment" xlink:label="loc_trib_ProvisionForImpairment_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xlink:to="loc_ifrs-full_FinancialAssets_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xlink:to="loc_trib_FinancialAssetsAdditions_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xlink:to="loc_trib_FinancialAssetsWriteOff_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xlink:to="loc_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xlink:to="loc_ifrs-full_FinancialAssets_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xlink:to="loc_trib_ProvisionForImpairment_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xlink:to="loc_ifrs-full_ImpairmentLossOnFinancialAssets_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xlink:to="loc_trib_ReversalOfImpairmentLossOnFinancialAssets_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xlink:to="loc_trib_ProvisionForImpairment_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValue_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/FINANCIALASSETSTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFinancialAssets" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFinancialAssets_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutFinancialAssets_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_StrategicPartnershipWithImawareIncMember" xlink:label="loc_trib_StrategicPartnershipWithImawareIncMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NovusDiagnosticsLimitedMember" xlink:label="loc_trib_NovusDiagnosticsLimitedMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteInvestment" xlink:label="loc_trib_ConvertibleNoteInvestment_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AgreementTerm" xlink:label="loc_trib_AgreementTerm_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfConvertibleInstruments" xlink:label="loc_ifrs-full_IssueOfConvertibleInstruments_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedLiability" xlink:label="loc_trib_AccruedLiability_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DecreaseThroughWriteoffFinancialAssets" xlink:label="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositorySharesIssued" xlink:label="loc_trib_AmericanDepositorySharesIssued_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemeasurementLossRecognizedInProfitLoss" xlink:label="loc_trib_RemeasurementLossRecognizedInProfitLoss_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_1" xlink:to="loc_trib_StrategicPartnershipWithImawareIncMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_4" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_4" xlink:to="loc_trib_NovusDiagnosticsLimitedMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_7" xlink:to="loc_trib_ConvertibleNoteInvestment_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_7" xlink:to="loc_trib_AgreementTerm_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_7" xlink:to="loc_ifrs-full_IssueOfConvertibleInstruments_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_7" xlink:to="loc_trib_AccruedLiability_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_7" xlink:to="loc_ifrs-full_ImpairmentLossOnFinancialAssets_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_7" xlink:to="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_7" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_7" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_7" xlink:to="loc_trib_AmericanDepositorySharesIssued_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_7" xlink:to="loc_trib_RemeasurementLossRecognizedInProfitLoss_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsAxis" xlink:label="loc_trib_DiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsMember" xlink:label="loc_trib_FiomiDiagnosticsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SE" xlink:label="loc_country_SE_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts" xlink:label="loc_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashSoldAsAPartOfDiscontinuedOperations" xlink:label="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0" xlink:to="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_trib_DiscontinuedOperationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DiscontinuedOperationsAxis_1" xlink:to="loc_trib_DiscontinuedOperationsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DiscontinuedOperationsDomain_1" xlink:to="loc_trib_FiomiDiagnosticsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_4" xlink:to="loc_ifrs-full_GeographicalAreasDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_4" xlink:to="loc_country_SE_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7" xlink:to="loc_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7" xlink:to="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7" xlink:to="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsAxis" xlink:label="loc_trib_DiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsMember" xlink:label="loc_trib_FiomiDiagnosticsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SE" xlink:label="loc_country_SE_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosureProvision" xlink:label="loc_trib_ClosureProvision_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations" xlink:label="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation" xlink:label="loc_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0" xlink:to="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_trib_DiscontinuedOperationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DiscontinuedOperationsAxis_1" xlink:to="loc_trib_DiscontinuedOperationsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DiscontinuedOperationsDomain_1" xlink:to="loc_trib_FiomiDiagnosticsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_4" xlink:to="loc_ifrs-full_GeographicalAreasDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_4" xlink:to="loc_country_SE_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7" xlink:to="loc_ifrs-full_Revenue_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7" xlink:to="loc_ifrs-full_OperatingExpense_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7" xlink:to="loc_trib_ClosureProvision_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7" xlink:to="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7" xlink:to="loc_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_7" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/disclosureGuidance"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsAxis" xlink:label="loc_trib_DiscontinuedOperationsAxis_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsMember" xlink:label="loc_trib_FiomiDiagnosticsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SE" xlink:label="loc_country_SE_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_1" xlink:to="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_2" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_2" xlink:to="loc_trib_DiscontinuedOperationsAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DiscontinuedOperationsAxis_2" xlink:to="loc_trib_DiscontinuedOperationsDomain_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DiscontinuedOperationsDomain_2" xlink:to="loc_trib_FiomiDiagnosticsMember_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_2" xlink:to="loc_ifrs-full_GeographicalAreasAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5" xlink:to="loc_ifrs-full_GeographicalAreasDomain_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_5" xlink:to="loc_country_SE_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_2" xlink:to="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_8" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_8" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_8" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock" xlink:label="loc_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory" xlink:label="loc_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory" xlink:label="loc_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0" xlink:to="loc_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0" xlink:to="loc_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0" xlink:to="loc_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0" xlink:to="loc_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONS">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_5" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SE" xlink:label="loc_country_SE_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsAxis" xlink:label="loc_trib_DiscontinuedOperationsAxis_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsMember" xlink:label="loc_trib_FiomiDiagnosticsMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiosynthMember" xlink:label="loc_trib_BiosynthMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdministrativeExpense" xlink:label="loc_ifrs-full_AdministrativeExpense_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageSharesDiscontinuedOperations" xlink:label="loc_trib_WeightedAverageSharesDiscontinuedOperations_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedWeightedAverageSharesDiscontinuedOperations" xlink:label="loc_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestructuringProvision" xlink:label="loc_ifrs-full_RestructuringProvision_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance" xlink:label="loc_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosureProvision" xlink:label="loc_trib_ClosureProvision_22"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForIncomeTaxExpenseCredit" xlink:label="loc_trib_AdjustmentsForIncomeTaxExpenseCredit_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-full_ConsiderationPaidReceived_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashProceedsFromDiscontinuedOperations" xlink:label="loc_trib_CashProceedsFromDiscontinuedOperations_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisions" xlink:label="loc_ifrs-full_CurrentProvisions_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReceivablesOutstanding" xlink:label="loc_trib_ReceivablesOutstanding_28"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5" xlink:to="loc_ifrs-full_GeographicalAreasDomain_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_5" xlink:to="loc_country_SE_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_trib_DiscontinuedOperationsAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DiscontinuedOperationsAxis_8" xlink:to="loc_trib_DiscontinuedOperationsDomain_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DiscontinuedOperationsDomain_8" xlink:to="loc_trib_FiomiDiagnosticsMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_11" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_11" xlink:to="loc_trib_BiosynthMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_ifrs-full_AdministrativeExpense_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_trib_WeightedAverageSharesDiscontinuedOperations_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_ifrs-full_RestructuringProvision_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_19" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_20" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_21" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_trib_ClosureProvision_22" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_trib_AdjustmentsForIncomeTaxExpenseCredit_23" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_ifrs-full_ConsiderationPaidReceived_24" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_trib_CashProceedsFromDiscontinuedOperations_25" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_26" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_ifrs-full_CurrentProvisions_27" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_14" xlink:to="loc_trib_ReceivablesOutstanding_28" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsAxis" xlink:label="loc_trib_DiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsMember" xlink:label="loc_trib_FiomiDiagnosticsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SE" xlink:label="loc_country_SE_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PostDisposalAdjustmentMember" xlink:label="loc_trib_PostDisposalAdjustmentMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsHeldForSaleMember" xlink:label="loc_ifrs-full_NoncurrentAssetsHeldForSaleMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiosynthMember" xlink:label="loc_trib_BiosynthMember_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_24"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0" xlink:to="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_trib_DiscontinuedOperationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DiscontinuedOperationsAxis_1" xlink:to="loc_trib_DiscontinuedOperationsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DiscontinuedOperationsDomain_1" xlink:to="loc_trib_FiomiDiagnosticsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_4" xlink:to="loc_ifrs-full_GeographicalAreasDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_4" xlink:to="loc_country_SE_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_7" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_7" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_7" xlink:to="loc_trib_PostDisposalAdjustmentMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_7" xlink:to="loc_ifrs-full_NoncurrentAssetsHeldForSaleMember_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_12" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_12" xlink:to="loc_trib_BiosynthMember_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_15" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_15" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_15" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_15" xlink:to="loc_ifrs-full_Inventories_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_15" xlink:to="loc_ifrs-full_CashAndCashEquivalents_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveVerboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_15" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_15" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_20" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_15" xlink:to="loc_ifrs-full_LeaseLiabilities_21" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_15" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_22" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_15" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_23" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_15" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_24" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/POSTBALANCESHEETEVENTS">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccountingEstimatesAndJudgementsAbstract" xlink:label="loc_trib_AccountingEstimatesAndJudgementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:label="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TwoPercentageOfGrossInventoryMember" xlink:label="loc_trib_TwoPercentageOfGrossInventoryMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PointFivePercentageOfGrossInventoryMember" xlink:label="loc_trib_PointFivePercentageOfGrossInventoryMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities" xlink:label="loc_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationExpense" xlink:label="loc_ifrs-full_AmortisationExpense_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLoss" xlink:label="loc_ifrs-full_ImpairmentLoss_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoriesAtNetRealisableValue" xlink:label="loc_ifrs-full_InventoriesAtNetRealisableValue_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PercentageOfGrossInventory1" xlink:label="loc_trib_PercentageOfGrossInventory1_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ChangeInAllowance" xlink:label="loc_trib_ChangeInAllowance_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_AccountingEstimatesAndJudgementsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_TwoPercentageOfGrossInventoryMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_PointFivePercentageOfGrossInventoryMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_1" xlink:to="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_6" xlink:to="loc_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_6" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_6" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_6" xlink:to="loc_ifrs-full_AmortisationExpense_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_6" xlink:to="loc_ifrs-full_ImpairmentLoss_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_6" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome_11" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_6" xlink:to="loc_ifrs-full_InventoriesAtNetRealisableValue_12" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_6" xlink:to="loc_trib_PercentageOfGrossInventory1_13" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_6" xlink:to="loc_trib_ChangeInAllowance_14" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PostBalanceSheetEventsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EventsAfterReportingPeriodMember" xlink:label="loc_trib_EventsAfterReportingPeriodMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FourthAmendmentToCreditAgreementMember" xlink:label="loc_trib_FourthAmendmentToCreditAgreementMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FifthAmendmentToCreditAgreementMember" xlink:label="loc_trib_FifthAmendmentToCreditAgreementMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1" xlink:to="loc_trib_EventsAfterReportingPeriodMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_4" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_4" xlink:to="loc_trib_FourthAmendmentToCreditAgreementMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_4" xlink:to="loc_trib_FifthAmendmentToCreditAgreementMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_8" xlink:to="loc_ifrs-full_NotionalAmount_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_8" xlink:to="loc_ifrs-full_BorrowingsMaturity_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_8" xlink:to="loc_ifrs-full_BorrowingsInterestRateBasis_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract" xlink:label="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:label="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CreditAgreementAxis" xlink:label="loc_trib_CreditAgreementAxis_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CreditAgreementDomain" xlink:label="loc_trib_CreditAgreementDomain_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmendedCreditAgreementMember" xlink:label="loc_trib_AmendedCreditAgreementMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsMember" xlink:label="loc_trib_DirectorsMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EventsAfterReportingPeriodMember" xlink:label="loc_trib_EventsAfterReportingPeriodMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FourthAmendmentToCreditAgreementMember" xlink:label="loc_trib_FourthAmendmentToCreditAgreementMember_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FifthAmendmentToCreditAgreementMember" xlink:label="loc_trib_FifthAmendmentToCreditAgreementMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LenderMember" xlink:label="loc_trib_LenderMember_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContinuousGlucoseMonitoringTechnologyMember" xlink:label="loc_trib_ContinuousGlucoseMonitoringTechnologyMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsLiabilities" xlink:label="loc_ifrs-full_CurrentAssetsLiabilities_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccumulatedDeficitInEquityAttributableToEquityHolders" xlink:label="loc_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsUnderDevelopment" xlink:label="loc_ifrs-full_IntangibleAssetsUnderDevelopment_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumLiquidityCovenant" xlink:label="loc_trib_MinimumLiquidityCovenant_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RevertsMinimumLiquidityCovenant" xlink:label="loc_trib_RevertsMinimumLiquidityCovenant_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalReserve" xlink:label="loc_ifrs-full_CapitalReserve_32"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1" xlink:to="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_trib_CreditAgreementAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_CreditAgreementAxis_4" xlink:to="loc_trib_CreditAgreementDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_CreditAgreementDomain_4" xlink:to="loc_trib_AmendedCreditAgreementMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_7" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_7" xlink:to="loc_trib_DirectorsMember_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_7" xlink:to="loc_trib_EventsAfterReportingPeriodMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_11" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_11" xlink:to="loc_trib_FourthAmendmentToCreditAgreementMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_11" xlink:to="loc_trib_FifthAmendmentToCreditAgreementMember_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_15" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_15" xlink:to="loc_trib_LenderMember_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_15" xlink:to="loc_trib_ContinuousGlucoseMonitoringTechnologyMember_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_ifrs-full_CurrentAssetsLiabilities_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_22" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_23" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_24" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_ifrs-full_IntangibleAssetsUnderDevelopment_25" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_ifrs-full_NotionalAmount_26" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_trib_MinimumLiquidityCovenant_27" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_trib_RevertsMinimumLiquidityCovenant_28" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_ifrs-full_BorrowingsInterestRateBasis_29" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_ifrs-full_BorrowingsMaturity_30" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_ifrs-full_Equity_31" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_19" xlink:to="loc_ifrs-full_CapitalReserve_32" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SEGMENTINFORMATIONNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CapitalisedDevelopmentCost" xlink:label="loc_trib_CapitalisedDevelopmentCost_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_trib_CapitalisedDevelopmentCost_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract" xlink:label="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory" xlink:label="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xlink:to="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BUSINESSCOMBINATIONS">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:label="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:label="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionalValueMember" xlink:label="loc_trib_ProvisionalValueMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MeasurementPeriodAdjustmentMember" xlink:label="loc_trib_MeasurementPeriodAdjustmentMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAcquiredAsOfAcquisitionDate" xlink:label="loc_trib_CashAcquiredAsOfAcquisitionDate_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SatisfiedByAbstract" xlink:label="loc_trib_SatisfiedByAbstract_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCashOutflowArisingOnAcquisitionAbstract" xlink:label="loc_trib_NetCashOutflowArisingOnAcquisitionAbstract_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCashOutFlowOnBusinessCombination" xlink:label="loc_trib_NetCashOutFlowOnBusinessCombination_28"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_WaveformTechnologiesIncorporationMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_MetabolomicsDiagnosticsLimitedMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_EpiCaptureLimitedMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_6" xlink:to="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_6" xlink:to="loc_trib_ProvisionalValueMember_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_6" xlink:to="loc_trib_MeasurementPeriodAdjustmentMember_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" xlink:to="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" xlink:to="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" xlink:to="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" xlink:to="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_15" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_16" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" xlink:to="loc_trib_CashAcquiredAsOfAcquisitionDate_17" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_18" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_19" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_20" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" xlink:to="loc_trib_SatisfiedByAbstract_21" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_SatisfiedByAbstract_21" xlink:to="loc_ifrs-full_CashTransferred_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_SatisfiedByAbstract_21" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_SatisfiedByAbstract_21" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_SatisfiedByAbstract_21" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_10" xlink:to="loc_trib_NetCashOutflowArisingOnAcquisitionAbstract_26" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NetCashOutflowArisingOnAcquisitionAbstract_26" xlink:to="loc_ifrs-full_CashTransferred_26" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NetCashOutflowArisingOnAcquisitionAbstract_26" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_27" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_NetCashOutflowArisingOnAcquisitionAbstract_26" xlink:to="loc_trib_NetCashOutFlowOnBusinessCombination_28" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_WaveformTechnologiesIncorporationMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_MetabolomicsDiagnosticsLimitedMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_EpiCaptureLimitedMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_6" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:label="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:label="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MeasurementPeriodAdjustmentMember" xlink:label="loc_trib_MeasurementPeriodAdjustmentMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:label="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" xlink:label="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination" xlink:label="loc_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_31"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExtinguishmentOfAmountOwed" xlink:label="loc_trib_ExtinguishmentOfAmountOwed_32"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone" xlink:label="loc_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_33"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfCumulativeRevenuesPayable" xlink:label="loc_trib_DescriptionOfCumulativeRevenuesPayable_34"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_WaveformTechnologiesIncorporationMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_MetabolomicsDiagnosticsLimitedMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_EpiCaptureLimitedMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_6" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_6" xlink:to="loc_trib_ClassAOrdinarySharesMember_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_6" xlink:to="loc_trib_AmericanDepositaryShareMember_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_RangeAxis_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_10" xlink:to="loc_ifrs-full_RangeDomain_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_10" xlink:to="loc_ifrs-full_TopOfRangeMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_13" xlink:to="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_13" xlink:to="loc_trib_MeasurementPeriodAdjustmentMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_ifrs-full_CashTransferred_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_17" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_19" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_20" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_21" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_22" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_23" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_24" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_25" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_26" order="100" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_27" order="110" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_28" order="120" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination_29" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_30" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_31" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_trib_ExtinguishmentOfAmountOwed_32" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_33" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_16" xlink:to="loc_trib_DescriptionOfCumulativeRevenuesPayable_34" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract" xlink:label="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PersonnelRelatedCostsMember" xlink:label="loc_trib_PersonnelRelatedCostsMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutsourcingCostsMember" xlink:label="loc_trib_OutsourcingCostsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SiteTransferCostsMember" xlink:label="loc_trib_SiteTransferCostsMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryRelatedCostsMember" xlink:label="loc_trib_InventoryRelatedCostsMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRestructuringCostsMember" xlink:label="loc_trib_OtherRestructuringCostsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" xlink:to="loc_trib_PersonnelRelatedCostsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" xlink:to="loc_trib_OutsourcingCostsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" xlink:to="loc_trib_SiteTransferCostsMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" xlink:to="loc_trib_InventoryRelatedCostsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" xlink:to="loc_trib_OtherRestructuringCostsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_8" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract" xlink:label="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember" xlink:label="loc_trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis" xlink:label="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain" xlink:label="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositarySharesMember" xlink:label="loc_trib_AmericanDepositarySharesMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringActivitiesExpense" xlink:label="loc_trib_RestructuringActivitiesExpense_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonTradingCosts" xlink:label="loc_trib_NonTradingCosts_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfSharesIssued" xlink:label="loc_trib_FairValueOfSharesIssued_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="loc_ifrs-full_LegalProceedingsProvision_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalRestructuringCosts" xlink:label="loc_trib_AdditionalRestructuringCosts_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonRadingCosts" xlink:label="loc_trib_NonRadingCosts_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" xlink:to="loc_trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1" xlink:to="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis_4" xlink:to="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_4" xlink:to="loc_trib_AmericanDepositarySharesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7" xlink:to="loc_trib_RestructuringActivitiesExpense_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7" xlink:to="loc_trib_NonTradingCosts_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7" xlink:to="loc_ifrs-full_NumberOfSharesIssued_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7" xlink:to="loc_trib_FairValueOfSharesIssued_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7" xlink:to="loc_ifrs-full_LegalProceedingsProvision_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7" xlink:to="loc_trib_AdditionalRestructuringCosts_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_7" xlink:to="loc_trib_NonRadingCosts_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails__1">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>trib-20241231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB" xlink:label="loc_country_GB_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB" xlink:label="loc_country_GB_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SE" xlink:label="loc_country_SE_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="loc_country_US_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="loc_country_US_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="loc_country_US_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_BRL" xlink:label="loc_currency_BRL_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_CAD" xlink:label="loc_currency_CAD_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR" xlink:label="loc_currency_EUR_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_GBP" xlink:label="loc_currency_GBP_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_SEK" xlink:label="loc_currency_SEK_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_XXX" xlink:label="loc_currency_XXX_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelFaxNumber" xlink:label="loc_dei_ContactPersonnelFaxNumber_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_dei_EntityAddressesLineItems_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_dei_EntityAddressesTable_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_51"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_53"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_54"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_55"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_56"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_57"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_58"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_59"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_61"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_62"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_63"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_64"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_65"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_66"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_67"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_68"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_69"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_70"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_71"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_72"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_73"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_74"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_75"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_76"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="loc_ifrs-full_AdditionalProvisionsOtherProvisions_77"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_78"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_79"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets_81"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets_82"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AddressOfRegisteredOfficeOfEntity" xlink:label="loc_ifrs-full_AddressOfRegisteredOfficeOfEntity_83"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_84"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_85"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_86"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForAmortisationExpense_87"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForAmortisationExpense_88"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_89"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_90"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_91"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_92"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_93"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_94"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_95"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense_96"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForFinanceCosts" xlink:label="loc_ifrs-full_AdjustmentsForFinanceCosts_97"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForFinanceIncome" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncome_98"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForFinanceIncome" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncome_99"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_101"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_102"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_103"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_104"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_105"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_106"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_107"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables_108"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForIncomeTaxExpense_109"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForIncomeTaxExpense_110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForIncomeTaxExpense_111"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_112"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_113"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="loc_ifrs-full_AdjustmentsForProvisions_114"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_115"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_116"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_117"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_118"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_119"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_121"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_122"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdministrativeExpense" xlink:label="loc_ifrs-full_AdministrativeExpense_123"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdministrativeExpense" xlink:label="loc_ifrs-full_AdministrativeExpense_124"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdministrativeExpense" xlink:label="loc_ifrs-full_AdministrativeExpense_125"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationExpense" xlink:label="loc_ifrs-full_AmortisationExpense_126"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationExpense" xlink:label="loc_ifrs-full_AmortisationExpense_127"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationExpense" xlink:label="loc_ifrs-full_AmortisationExpense_128"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_129"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets" xlink:label="loc_ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets_130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets" xlink:label="loc_ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets_131"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract" xlink:label="loc_ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract_132"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract" xlink:label="loc_ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract_133"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_134"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_135"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_136"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_137"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_138"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_139"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_141"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_142"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis_143"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_144"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_145"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_146"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_147"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_148"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationAbstract" xlink:label="loc_ifrs-full_AuditorsRemunerationAbstract_149"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForOtherServices" xlink:label="loc_ifrs-full_AuditorsRemunerationForOtherServices_150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AuditorsRemunerationForTaxServices" xlink:label="loc_ifrs-full_AuditorsRemunerationForTaxServices_151"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageEffectiveTaxRate" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate_152"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageEffectiveTaxRate" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate_153"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageNumberOfEmployees" xlink:label="loc_ifrs-full_AverageNumberOfEmployees_154"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_155"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_156"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_157"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_158"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_159"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_160"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingCostsCapitalised" xlink:label="loc_ifrs-full_BorrowingCostsCapitalised_161"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingCostsCapitalised" xlink:label="loc_ifrs-full_BorrowingCostsCapitalised_162"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingCostsRecognisedAsExpense" xlink:label="loc_ifrs-full_BorrowingCostsRecognisedAsExpense_163"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingCostsRecognisedAsExpense" xlink:label="loc_ifrs-full_BorrowingCostsRecognisedAsExpense_164"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingCostsRecognisedAsExpense" xlink:label="loc_ifrs-full_BorrowingCostsRecognisedAsExpense_165"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_166"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_167"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_168"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_169"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_170"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_171"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_172"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_173"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_174"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_175"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsAbstract" xlink:label="loc_ifrs-full_BorrowingsAbstract_176"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_177"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_178"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_179"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_181"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_182"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_183"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_184"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_185"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_186"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_187"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_188"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsOriginalCurrency" xlink:label="loc_ifrs-full_BorrowingsOriginalCurrency_189"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_190"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_191"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_192"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_193"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-full_BrandNamesMember_194"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_195"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_196"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_197"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalCommitments" xlink:label="loc_ifrs-full_CapitalCommitments_198"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:label="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_199"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:label="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalReserve" xlink:label="loc_ifrs-full_CapitalReserve_201"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_202"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_203"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_204"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_205"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_206"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_207"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_208"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAdvancesAndLoansFromRelatedParties" xlink:label="loc_ifrs-full_CashAdvancesAndLoansFromRelatedParties_209"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAdvancesAndLoansFromRelatedParties" xlink:label="loc_ifrs-full_CashAdvancesAndLoansFromRelatedParties_210"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_211"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_212"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_213"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_214"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_215"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_216"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_217"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_218"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_219"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_220"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_221"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_222"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_223"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_224"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_225"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_226"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_227"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_228"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_229"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_230"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_231"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_232"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_233"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_234"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_235"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_236"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations_237"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations_238"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_239"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" xlink:label="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_241"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" xlink:label="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_242"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_243"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_244"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_245"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_246"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_247"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_248"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill_249"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill_250"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_251"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ChangesInPropertyPlantAndEquipment_252"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ChangesInPropertyPlantAndEquipment_253"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_254"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_255"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_256"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_257"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_258"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_259"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_261"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_262"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_263"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_264"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_265"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_266"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_267"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_268"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_269"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_271"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_272"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_273"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_274"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_275"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_276"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_277"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_278"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_279"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_280"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_281"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_282"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_283"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-full_ConsiderationPaidReceived_284"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_285"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_286"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_287"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_288"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_289"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_290"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="loc_ifrs-full_ContinuingOperationsMember_291"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_292"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_293"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_294"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_295"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_296"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_297"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_298"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_299"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_300"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_301"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsLiabilities" xlink:label="loc_ifrs-full_CurrentAssetsLiabilities_302"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsLiabilities" xlink:label="loc_ifrs-full_CurrentAssetsLiabilities_303"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_304"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_305"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentContractAssets" xlink:label="loc_ifrs-full_CurrentContractAssets_306"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities" xlink:label="loc_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_307"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentInvestments" xlink:label="loc_ifrs-full_CurrentInvestments_308"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentInvestments" xlink:label="loc_ifrs-full_CurrentInvestments_309"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_310"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_311"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_312"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_313"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_314"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_315"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentMember" xlink:label="loc_ifrs-full_CurrentMember_316"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPrepayments" xlink:label="loc_ifrs-full_CurrentPrepayments_317"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisions" xlink:label="loc_ifrs-full_CurrentProvisions_318"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisions" xlink:label="loc_ifrs-full_CurrentProvisions_319"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisions" xlink:label="loc_ifrs-full_CurrentProvisions_320"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies" xlink:label="loc_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_321"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentReceivablesFromContractsWithCustomers" xlink:label="loc_ifrs-full_CurrentReceivablesFromContractsWithCustomers_322"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentReceivablesFromRentalOfProperties" xlink:label="loc_ifrs-full_CurrentReceivablesFromRentalOfProperties_323"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentReceivablesFromRentalOfProperties" xlink:label="loc_ifrs-full_CurrentReceivablesFromRentalOfProperties_324"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxAssetsCurrent" xlink:label="loc_ifrs-full_CurrentTaxAssetsCurrent_325"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_326"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_327"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_328"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_329"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_330"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_331"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_332"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_333"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_334"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_335"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentValueAddedTaxPayables" xlink:label="loc_ifrs-full_CurrentValueAddedTaxPayables_336"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables_337"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DecreaseThroughImpairmentContractAssets" xlink:label="loc_ifrs-full_DecreaseThroughImpairmentContractAssets_338"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DecreaseThroughImpairmentContractAssets" xlink:label="loc_ifrs-full_DecreaseThroughImpairmentContractAssets_339"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DecreaseThroughWriteoffFinancialAssets" xlink:label="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_340"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DecreaseThroughWriteoffFinancialAssets" xlink:label="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_341"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DecreaseThroughWriteoffFinancialAssets" xlink:label="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_342"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredIncomeIncludingContractLiabilities" xlink:label="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_343"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredIncomeIncludingContractLiabilities" xlink:label="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_344"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredIncomeIncludingContractLiabilities" xlink:label="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_345"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredIncomeIncludingContractLiabilities" xlink:label="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_346"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredIncomeIncludingContractLiabilities" xlink:label="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_347"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_348"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_349"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_350"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_351"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeAbstract" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeAbstract_352"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_353"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_354"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_355"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_356"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_357"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_358"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_359"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_360"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_361"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_362"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_363"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_364"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_365"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_366"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_367"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_368"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_DepreciationAndAmortisationExpense_369"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-full_DepreciationExpense_370"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-full_DepreciationExpense_371"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-full_DepreciationExpense_372"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_373"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_374"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_375"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_376"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_377"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_378"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_379"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_380"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_381"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_382"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_383"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_384"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_385"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinanceCostsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinanceCostsExplanatory_386"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_387"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_388"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_389"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_390"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory_391"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_392"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_393"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_394"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_395"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_396"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_397"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_398"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_399"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_400"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_401"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_402"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_403"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_404"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_405"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_406"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_407"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory_408"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_409"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_410"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_411"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_412"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_413"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_414"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_415"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_416"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:label="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_417"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:label="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_418"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfConversionOfDebtToEquity" xlink:label="loc_ifrs-full_DescriptionOfConversionOfDebtToEquity_419"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfConversionOfDebtToEquity" xlink:label="loc_ifrs-full_DescriptionOfConversionOfDebtToEquity_420"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:label="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_421"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_422"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_423"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_424"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_425"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_426"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_427"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_428"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_429"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue" xlink:label="loc_ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue_430"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue" xlink:label="loc_ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue_431"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_432"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_433"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_434"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_435"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_436"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_437"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_438"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_439"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_440"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_441"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory_442"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory_443"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory_444"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_445"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_446"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_447"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory_448"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory_449"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_450"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_451"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_452"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_453"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_454"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_455"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_456"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_457"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_458"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_459"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_460"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCashFlowStatementExplanatory_461"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_462"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_463"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_464"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_465"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_466"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_467"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_468"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfComparativeInformationPreparedUnderPreviousGAAPLineItems" xlink:label="loc_ifrs-full_DisclosureOfComparativeInformationPreparedUnderPreviousGAAPLineItems_469"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfComparativeInformationPreparedUnderPreviousGAAPTable" xlink:label="loc_ifrs-full_DisclosureOfComparativeInformationPreparedUnderPreviousGAAPTable_470"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExplanatory_471"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_472"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_473"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_474"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_475"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_476"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_477"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_478"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_479"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_480"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_481"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_482"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_483"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_484"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_485"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_486"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_487"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_488"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_489"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_490"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_491"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_492"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_493"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_494"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_495"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_496"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_497"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExplanatory_498"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_499"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory_500"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory_501"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_502"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsTable_503"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_504"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_505"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_506"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_507"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_508"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_509"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_510"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_511"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_512"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_513"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfGoodwillExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGoodwillExplanatory_514"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory_515"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory_516"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_517"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_518"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_519"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems_520"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable_521"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory_522"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_523"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_524"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_525"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_526"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityExplanatory_527"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_528"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_529"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_530"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_531"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_532"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory_533"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_534"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_535"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_536"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_537"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_538"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_539"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_540"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_541"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_542"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_543"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_544"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_545"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_546"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_547"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_548"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_549"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_550"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_551"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_552"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_553"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherAssetsExplanatory_554"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_555"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_556"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsExplanatory_557"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_558"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsTable_559"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfProductsAndServicesExplanatory_560"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:label="loc_ifrs-full_DisclosureOfProductsAndServicesLineItems_561"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesTable" xlink:label="loc_ifrs-full_DisclosureOfProductsAndServicesTable_562"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_563"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_564"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_565"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_566"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_567"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_568"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProvisionsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfProvisionsExplanatory_569"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_570"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_571"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_572"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_573"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_574"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_575"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_576"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_577"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract_578"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_579"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_580"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_581"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_582"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_583"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_584"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_585"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_586"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_587"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_588"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_589"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_590"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_591"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_592"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_593"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_594"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_595"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_596"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_597"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_598"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_599"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_DividendsPaidClassifiedAsFinancingActivities_600"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_601"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_602"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EffectOfTransitionToIFRSsMember" xlink:label="loc_ifrs-full_EffectOfTransitionToIFRSsMember_603"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EliminationOfIntersegmentAmountsMember" xlink:label="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_604"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EliminationOfIntersegmentAmountsMember" xlink:label="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_605"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_606"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_607"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_608"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_609"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_610"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_611"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_612"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_613"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_614"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_615"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_616"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_617"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_618"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpectedCreditLossRate" xlink:label="loc_ifrs-full_ExpectedCreditLossRate_619"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_620"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_621"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_622"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_623"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_624"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_625"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:label="loc_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities_626"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExplanationOfNotAppliedNewStandardsOrInterpretations" xlink:label="loc_ifrs-full_ExplanationOfNotAppliedNewStandardsOrInterpretations_627"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExplanationOfNotAppliedNewStandardsOrInterpretations" xlink:label="loc_ifrs-full_ExplanationOfNotAppliedNewStandardsOrInterpretations_628"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets" xlink:label="loc_ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets_629"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_630"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_631"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_632"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_633"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_634"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss" xlink:label="loc_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_635"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_636"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_637"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_638"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_639"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_640"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_641"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost_642"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost_643"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost_644"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets_645"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets_646"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets_647"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-full_FinancialAssets_648"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue_649"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue_650"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_651"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_652"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_653"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_654"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialEffectOfTransitionFromPreviousGAAPToIFRSsAxis" xlink:label="loc_ifrs-full_FinancialEffectOfTransitionFromPreviousGAAPToIFRSsAxis_655"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-full_FinancialLiabilities_656"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCost" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCost_657"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCost" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCost_658"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCost" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCost_659"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCost" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCost_660"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_661"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation" xlink:label="loc_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation_662"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation" xlink:label="loc_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation_663"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination" xlink:label="loc_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination_664"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination" xlink:label="loc_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination_665"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainRecognisedInBargainPurchaseTransaction" xlink:label="loc_ifrs-full_GainRecognisedInBargainPurchaseTransaction_666"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_667"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_668"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_669"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-full_GoodwillMember_670"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_671"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_672"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_673"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_674"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_675"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_676"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_677"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossLoanCommitments" xlink:label="loc_ifrs-full_GrossLoanCommitments_678"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossLoanCommitments" xlink:label="loc_ifrs-full_GrossLoanCommitments_679"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_680"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_681"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_682"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_683"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_684"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_685"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_686"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_687"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLoss" xlink:label="loc_ifrs-full_ImpairmentLoss_688"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLoss" xlink:label="loc_ifrs-full_ImpairmentLoss_689"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_690"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_691"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_692"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_693"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_694"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_695"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_696"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_697"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_698"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome_699"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_700"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_701"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_702"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_703"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_704"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_705"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossInvestmentProperty" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossInvestmentProperty_706"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_707"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_708"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_709"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_710"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_711"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_712"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_713"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_714"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_715"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_716"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeFromFinesAndPenalties" xlink:label="loc_ifrs-full_IncomeFromFinesAndPenalties_717"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeFromSubleasingRightofuseAssets" xlink:label="loc_ifrs-full_IncomeFromSubleasingRightofuseAssets_718"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeRelatingToVariableLeasePaymentsForOperatingLeasesThatDoNotDependOnIndexOrRate" xlink:label="loc_ifrs-full_IncomeRelatingToVariableLeasePaymentsForOperatingLeasesThatDoNotDependOnIndexOrRate_719"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_720"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefund" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefund_721"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefund" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefund_722"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_723"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_724"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_725"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_726"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome" xlink:label="loc_ifrs-full_IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome_727"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_728"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_729"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_730"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_731"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCreditDerivativeNominalAmount" xlink:label="loc_ifrs-full_IncreaseDecreaseInCreditDerivativeNominalAmount_732"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset_733"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_734"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_735"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_736"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_737"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_738"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_739"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_740"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_741"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_742"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_743"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_744"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_745"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_746"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_747"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_748"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_749"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_750"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_751"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_752"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_753"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_754"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_755"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseThroughOriginationOrPurchaseFinancialAssets" xlink:label="loc_ifrs-full_IncreaseThroughOriginationOrPurchaseFinancialAssets_756"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_757"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_758"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_759"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_760"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_761"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_762"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_763"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsUnderDevelopment" xlink:label="loc_ifrs-full_IntangibleAssetsUnderDevelopment_764"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsUnderDevelopment" xlink:label="loc_ifrs-full_IntangibleAssetsUnderDevelopment_765"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsUnderDevelopment" xlink:label="loc_ifrs-full_IntangibleAssetsUnderDevelopment_766"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_767"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_768"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_769"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_770"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpense" xlink:label="loc_ifrs-full_InterestExpense_771"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpense" xlink:label="loc_ifrs-full_InterestExpense_772"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpense" xlink:label="loc_ifrs-full_InterestExpense_773"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnDebtInstrumentsIssued" xlink:label="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_774"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnDebtInstrumentsIssued" xlink:label="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_775"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnDebtInstrumentsIssued" xlink:label="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_776"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_777"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_778"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnOtherFinancialLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_779"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnOtherFinancialLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_780"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnOtherFinancialLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_781"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpenseOnOtherFinancialLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_782"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestIncomeOnOtherFinancialAssets" xlink:label="loc_ifrs-full_InterestIncomeOnOtherFinancialAssets_783"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestIncomeOnOtherFinancialAssets" xlink:label="loc_ifrs-full_InterestIncomeOnOtherFinancialAssets_784"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestIncomeOnOtherFinancialAssets" xlink:label="loc_ifrs-full_InterestIncomeOnOtherFinancialAssets_785"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_786"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_787"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_788"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPayable" xlink:label="loc_ifrs-full_InterestPayable_789"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_790"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_791"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_792"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_793"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_794"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoriesAtNetRealisableValue" xlink:label="loc_ifrs-full_InventoriesAtNetRealisableValue_795"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_796"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_797"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_798"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_799"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_800"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_801"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_802"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfConvertibleInstruments" xlink:label="loc_ifrs-full_IssueOfConvertibleInstruments_803"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_804"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_805"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_806"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_807"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_808"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_809"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_810"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_811"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_812"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_813"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LandAndBuildingsMember" xlink:label="loc_ifrs-full_LandAndBuildingsMember_814"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LandAndBuildingsMember" xlink:label="loc_ifrs-full_LandAndBuildingsMember_815"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_816"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_817"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember" xlink:label="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember_818"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_819"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_820"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseCommitmentsForShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-full_LeaseCommitmentsForShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_821"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_822"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_823"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_824"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_825"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_826"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_827"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="loc_ifrs-full_LegalProceedingsProvision_828"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="loc_ifrs-full_LegalProceedingsProvision_829"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="loc_ifrs-full_LegalProceedingsProvision_830"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_831"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_832"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_833"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_834"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_835"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_836"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_837"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_838"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_839"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_840"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_841"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_842"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_843"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_844"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-full_LiquidityRiskMember_845"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LoansPayableInDefault" xlink:label="loc_ifrs-full_LoansPayableInDefault_846"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_847"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_848"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_849"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_850"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_851"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_852"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_853"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowingsMember" xlink:label="loc_ifrs-full_LongtermBorrowingsMember_854"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_855"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_856"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_857"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_858"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MajorCustomersDomain" xlink:label="loc_ifrs-full_MajorCustomersDomain_859"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_860"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_861"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_862"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaximumExposureToCreditRisk" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk_863"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaximumExposureToCreditRisk" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk_864"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaximumExposureToCreditRisk" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk_865"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables" xlink:label="loc_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables_866"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MiscellaneousNoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_867"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NameOfSubsidiary" xlink:label="loc_ifrs-full_NameOfSubsidiary_868"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="loc_ifrs-full_NetAssetsLiabilities_869"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="loc_ifrs-full_NetAssetsLiabilities_870"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_871"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_872"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_873"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities" xlink:label="loc_ifrs-full_NetDeferredTaxLiabilities_874"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities" xlink:label="loc_ifrs-full_NetDeferredTaxLiabilities_875"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities" xlink:label="loc_ifrs-full_NetDeferredTaxLiabilities_876"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NewProvisionsOtherProvisions" xlink:label="loc_ifrs-full_NewProvisionsOtherProvisions_877"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NewProvisionsOtherProvisions" xlink:label="loc_ifrs-full_NewProvisionsOtherProvisions_878"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NewProvisionsOtherProvisions" xlink:label="loc_ifrs-full_NewProvisionsOtherProvisions_879"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_880"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_881"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_882"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_883"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests_884"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests_885"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_886"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_887"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_888"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsHeldForSaleMember" xlink:label="loc_ifrs-full_NoncurrentAssetsHeldForSaleMember_889"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_890"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_891"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_NoncurrentAssetsRecognisedAsOfAcquisitionDate_892"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_NoncurrentAssetsRecognisedAsOfAcquisitionDate_893"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_894"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_895"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_896"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_897"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_898"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_899"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_900"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_901"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinanceLeaseReceivables" xlink:label="loc_ifrs-full_NoncurrentFinanceLeaseReceivables_902"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinanceLeaseReceivables" xlink:label="loc_ifrs-full_NoncurrentFinanceLeaseReceivables_903"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_904"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_905"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_906"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_907"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_908"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesRecognisedAsOfAcquisitionDate_909"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesRecognisedAsOfAcquisitionDate_910"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_911"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_912"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_913"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_914"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_915"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisions" xlink:label="loc_ifrs-full_NoncurrentProvisions_916"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisions" xlink:label="loc_ifrs-full_NoncurrentProvisions_917"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentReceivablesFromContractsWithCustomers" xlink:label="loc_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers_918"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NongovernmentCustomersMember" xlink:label="loc_ifrs-full_NongovernmentCustomersMember_919"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NongovernmentCustomersMember" xlink:label="loc_ifrs-full_NongovernmentCustomersMember_920"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotesAndDebenturesIssued" xlink:label="loc_ifrs-full_NotesAndDebenturesIssued_921"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_922"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_923"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_924"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_925"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_926"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_927"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_928"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented" xlink:label="loc_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_929"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented" xlink:label="loc_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_930"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented" xlink:label="loc_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_931"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_932"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_933"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_934"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_935"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_936"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_937"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_938"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_939"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_940"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_941"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_942"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_943"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-full_NumberOfSharesAuthorised_944"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_945"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_946"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_947"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_948"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_949"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_950"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_951"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_952"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_953"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_954"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_955"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_956"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="loc_ifrs-full_OtherAdjustmentsForNoncashItems_957"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherBorrowings" xlink:label="loc_ifrs-full_OtherBorrowings_958"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherBorrowings" xlink:label="loc_ifrs-full_OtherBorrowings_959"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_960"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_961"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_962"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_963"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_964"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_965"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_966"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_967"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_968"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssets" xlink:label="loc_ifrs-full_OtherIntangibleAssets_969"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_970"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_971"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_972"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_973"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_974"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialAssets_975"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_976"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_977"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_978"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_979"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_980"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_981"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_982"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-full_OtherProvisions_983"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-full_OtherProvisions_984"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-full_OtherProvisions_985"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-full_OtherProvisions_986"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_987"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_988"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReserves" xlink:label="loc_ifrs-full_OtherReserves_989"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReservesMember" xlink:label="loc_ifrs-full_OtherReservesMember_990"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue_991"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue_992"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_993"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_994"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusAxis" xlink:label="loc_ifrs-full_PastDueStatusAxis_995"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusAxis" xlink:label="loc_ifrs-full_PastDueStatusAxis_996"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForDevelopmentProjectExpenditure" xlink:label="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure_997"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_998"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_999"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_1000"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1001"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1002"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1003"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1004"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1005"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1006"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_1007"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_1008"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Prepayments" xlink:label="loc_ifrs-full_Prepayments_1009"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Prepayments" xlink:label="loc_ifrs-full_Prepayments_1010"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PreviousGAAPMember" xlink:label="loc_ifrs-full_PreviousGAAPMember_1011"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PrincipalPlaceOfBusiness" xlink:label="loc_ifrs-full_PrincipalPlaceOfBusiness_1012"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PrincipalPlaceOfBusiness" xlink:label="loc_ifrs-full_PrincipalPlaceOfBusiness_1013"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1014"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1015"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1016"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1017"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_1018"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_1019"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_1020"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_1021"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_1022"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_1023"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_1024"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_1025"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_1026"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_1027"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_1028"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_1029"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_1030"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_1031"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_1032"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_1033"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:label="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_1034"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1035"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1036"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1037"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1038"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1039"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_1040"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_1041"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_1042"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_1043"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_1044"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_1045"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_1046"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_1047"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_1048"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_1049"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_1050"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_1051"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_1052"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_1053"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_1054"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_1055"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_1056"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_1057"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_1058"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_1059"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_1060"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_1061"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_1062"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_1063"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyDevelopmentAndProjectManagementExpense" xlink:label="loc_ifrs-full_PropertyDevelopmentAndProjectManagementExpense_1064"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_1065"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_1066"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_1067"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_1068"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_1069"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_1070"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentExpendituresRecognisedForConstructions" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentExpendituresRecognisedForConstructions_1071"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated_1072"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated_1073"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1074"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_1075"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_1076"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_1077"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1078"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1079"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember" xlink:label="loc_ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember_1080"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-full_Provisions_1081"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-full_Provisions_1082"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-full_Provisions_1083"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionsAbstract" xlink:label="loc_ifrs-full_ProvisionsAbstract_1084"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="loc_ifrs-full_ProvisionUsedOtherProvisions_1085"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="loc_ifrs-full_ProvisionUsedOtherProvisions_1086"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1087"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1088"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1089"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1090"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares_1091"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares_1092"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares_1093"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_1094"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_1095"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1096"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1097"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomers" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomers_1098"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_1099"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" xlink:label="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_1100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" xlink:label="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_1101"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_1102"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_1103"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_1104"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_1105"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1106"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1107"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1108"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1109"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1111"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1112"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1113"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfCurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfCurrentBorrowings_1114"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_1115"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_1116"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_1117"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_1118"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_1119"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_1120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfCashFlowHedges" xlink:label="loc_ifrs-full_ReserveOfCashFlowHedges_1121"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfCashFlowHedgesMember" xlink:label="loc_ifrs-full_ReserveOfCashFlowHedgesMember_1122"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments" xlink:label="loc_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments_1123"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments" xlink:label="loc_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments_1124"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_1125"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_1126"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestructuringProvision" xlink:label="loc_ifrs-full_RestructuringProvision_1127"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestructuringProvision" xlink:label="loc_ifrs-full_RestructuringProvision_1128"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestructuringProvision" xlink:label="loc_ifrs-full_RestructuringProvision_1129"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestructuringProvisionMember" xlink:label="loc_ifrs-full_RestructuringProvisionMember_1130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestructuringProvisionMember" xlink:label="loc_ifrs-full_RestructuringProvisionMember_1131"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_1132"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_1133"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_1134"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_1135"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_1136"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill_1137"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill_1138"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:label="loc_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets_1139"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:label="loc_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets_1140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_1141"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_1142"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_1143"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_1144"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_1145"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_1146"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_1147"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_1148"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="loc_ifrs-full_RevenueFromInterest_1149"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="loc_ifrs-full_RevenueFromInterest_1150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="loc_ifrs-full_RevenueFromInterest_1151"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_1152"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_1153"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" xlink:label="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_1154"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssetsRevaluedAssetsAtCost" xlink:label="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_1155"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_1156"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_1157"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_1158"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk" xlink:label="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_1159"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-full_ServicesExpense_1160"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-full_ServicesExpense_1161"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_1162"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_1163"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_1164"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_1165"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_1166"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_1167"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:label="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_1168"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_1169"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_1170"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_1171"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1172"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1173"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SocialSecurityContributions" xlink:label="loc_ifrs-full_SocialSecurityContributions_1174"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_1175"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_1176"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_1177"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1178"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_1179"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense" xlink:label="loc_ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense_1180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance" xlink:label="loc_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_1181"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance" xlink:label="loc_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_1182"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance" xlink:label="loc_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_1183"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations" xlink:label="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1184"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations" xlink:label="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1185"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations" xlink:label="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1186"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations" xlink:label="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1187"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations" xlink:label="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1188"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations" xlink:label="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1189"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="loc_ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods_1190"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_1191"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxRateEffectOfImpairmentOfGoodwill" xlink:label="loc_ifrs-full_TaxRateEffectOfImpairmentOfGoodwill_1192"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxRateEffectOfTaxLosses" xlink:label="loc_ifrs-full_TaxRateEffectOfTaxLosses_1193"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-full_TechnologybasedIntangibleAssetsMember_1194"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-full_TechnologybasedIntangibleAssetsMember_1195"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1196"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1197"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_1198"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_1199"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_1200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_1201"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_1202"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_1203"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_1204"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1205"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1206"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1207"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_1208"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_1209"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_1210"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_1211"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_1212"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_1213"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-full_TradeAndOtherPayables_1214"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-full_TradeAndOtherPayables_1215"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-full_TradeAndOtherPayables_1216"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-full_TradeAndOtherPayables_1217"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1218"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1219"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1220"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_1221"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_1222"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_1223"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_1224"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_1225"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_1226"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:label="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_1227"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:label="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_1228"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-full_TreasuryShares_1229"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-full_TreasuryShares_1230"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-full_TreasuryShares_1231"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-full_TreasuryShares_1232"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-full_TreasurySharesMember_1233"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfCustomersAxis" xlink:label="loc_ifrs-full_TypesOfCustomersAxis_1234"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfCustomersAxis" xlink:label="loc_ifrs-full_TypesOfCustomersAxis_1235"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfCustomersDomain" xlink:label="loc_ifrs-full_TypesOfCustomersDomain_1236"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_1237"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_1238"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_1239"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_1240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis" xlink:label="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis_1241"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain" xlink:label="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_1242"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived" xlink:label="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_1243"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-full_VehiclesMember_1244"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_1245"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WarrantReserveMember" xlink:label="loc_ifrs-full_WarrantReserveMember_1246"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WarrantyProvision" xlink:label="loc_ifrs-full_WarrantyProvision_1247"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1248"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1249"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1250"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1251"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1252"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1253"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1254"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1255"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_1256"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1257"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1258"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1259"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_1260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_1261"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1262"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1263"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_1264"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1265"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_1266"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_1267"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_1268"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WorkInProgress" xlink:label="loc_ifrs-full_WorkInProgress_1269"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_1270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_1271"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_1272"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_1273"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_1274"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_1275"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_1276"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1277"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1278"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1279"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1280"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1281"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccountingEstimatesAndJudgementsAbstract" xlink:label="loc_trib_AccountingEstimatesAndJudgementsAbstract_1282"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestAccrued" xlink:label="loc_trib_AccretionInterestAccrued_1283"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestAccrued" xlink:label="loc_trib_AccretionInterestAccrued_1284"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestAccrued" xlink:label="loc_trib_AccretionInterestAccrued_1285"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestAdjustment" xlink:label="loc_trib_AccretionInterestAdjustment_1286"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestAdjustment" xlink:label="loc_trib_AccretionInterestAdjustment_1287"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestAdjustment" xlink:label="loc_trib_AccretionInterestAdjustment_1288"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestOnBorrowings" xlink:label="loc_trib_AccretionInterestOnBorrowings_1289"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestOnBorrowings" xlink:label="loc_trib_AccretionInterestOnBorrowings_1290"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestOnBorrowings" xlink:label="loc_trib_AccretionInterestOnBorrowings_1291"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestOnBorrowings" xlink:label="loc_trib_AccretionInterestOnBorrowings_1292"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestOnBorrowings" xlink:label="loc_trib_AccretionInterestOnBorrowings_1293"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedBonus" xlink:label="loc_trib_AccruedBonus_1294"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedBonus" xlink:label="loc_trib_AccruedBonus_1295"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedInterestOnNotes" xlink:label="loc_trib_AccruedInterestOnNotes_1296"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedInterestOnNotes" xlink:label="loc_trib_AccruedInterestOnNotes_1297"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedLiabilitiesToContractedLicencePayments" xlink:label="loc_trib_AccruedLiabilitiesToContractedLicencePayments_1298"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedLiabilitiesToContractedLicencePayments" xlink:label="loc_trib_AccruedLiabilitiesToContractedLicencePayments_1299"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedLiabilitiesToContractedLicencePayments" xlink:label="loc_trib_AccruedLiabilitiesToContractedLicencePayments_1300"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedLiabilitiesToContractedLicencePayments" xlink:label="loc_trib_AccruedLiabilitiesToContractedLicencePayments_1301"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedLiabilitiesToContractedLicencePayments" xlink:label="loc_trib_AccruedLiabilitiesToContractedLicencePayments_1302"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedLiability" xlink:label="loc_trib_AccruedLiability_1303"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedLiability" xlink:label="loc_trib_AccruedLiability_1304"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccumulatedDeficitInEquityAttributableToEquityHolders" xlink:label="loc_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_1305"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccumulatedDeficitInEquityAttributableToEquityHolders" xlink:label="loc_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_1306"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccumulatedDeficitInEquityAttributableToEquityHolders" xlink:label="loc_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_1307"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AcquisitionConsideration" xlink:label="loc_trib_AcquisitionConsideration_1308"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AcquisitionConsideration" xlink:label="loc_trib_AcquisitionConsideration_1309"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ActuarialAssumptionOfDiscountRatePercentage" xlink:label="loc_trib_ActuarialAssumptionOfDiscountRatePercentage_1310"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ActuarialAssumptionOfDiscountRatePercentage" xlink:label="loc_trib_ActuarialAssumptionOfDiscountRatePercentage_1311"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ActuarialAssumptionOfDiscountRatePercentage" xlink:label="loc_trib_ActuarialAssumptionOfDiscountRatePercentage_1312"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ActuarialAssumptionOfExpectedPensionIncreases" xlink:label="loc_trib_ActuarialAssumptionOfExpectedPensionIncreases_1313"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ActuarialAssumptionOfExpectedPensionIncreases" xlink:label="loc_trib_ActuarialAssumptionOfExpectedPensionIncreases_1314"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ActuarialAssumptionOfExpectedPensionIncreases" xlink:label="loc_trib_ActuarialAssumptionOfExpectedPensionIncreases_1315"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone" xlink:label="loc_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_1316"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone" xlink:label="loc_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_1317"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone" xlink:label="loc_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_1318"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalFunding" xlink:label="loc_trib_AdditionalFunding_1319"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalFunding" xlink:label="loc_trib_AdditionalFunding_1320"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalImpairmentLoss" xlink:label="loc_trib_AdditionalImpairmentLoss_1321"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalImpairmentLoss" xlink:label="loc_trib_AdditionalImpairmentLoss_1322"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalImpairmentLossDueToGrowthInRevenues" xlink:label="loc_trib_AdditionalImpairmentLossDueToGrowthInRevenues_1323"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalImpairmentLossDueToGrowthInRevenues" xlink:label="loc_trib_AdditionalImpairmentLossDueToGrowthInRevenues_1324"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs" xlink:label="loc_trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs_1325"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs" xlink:label="loc_trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs_1326"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs" xlink:label="loc_trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs_1327"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalLiquidity" xlink:label="loc_trib_AdditionalLiquidity_1328"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalLiquidity" xlink:label="loc_trib_AdditionalLiquidity_1329"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate" xlink:label="loc_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_1330"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate" xlink:label="loc_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_1331"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate" xlink:label="loc_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_1332"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalProjectCost" xlink:label="loc_trib_AdditionalProjectCost_1333"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalProjectCost" xlink:label="loc_trib_AdditionalProjectCost_1334"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalRestructuringCosts" xlink:label="loc_trib_AdditionalRestructuringCosts_1335"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalRestructuringCosts" xlink:label="loc_trib_AdditionalRestructuringCosts_1336"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalRestructuringCosts" xlink:label="loc_trib_AdditionalRestructuringCosts_1337"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalSpaceMember" xlink:label="loc_trib_AdditionalSpaceMember_1338"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalSpaceMember" xlink:label="loc_trib_AdditionalSpaceMember_1339"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionsRelatedToRightOfUseAssets" xlink:label="loc_trib_AdditionsRelatedToRightOfUseAssets_1340"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionsRelatedToRightOfUseAssets" xlink:label="loc_trib_AdditionsRelatedToRightOfUseAssets_1341"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedLossProfitAfterTax" xlink:label="loc_trib_AdjustedLossProfitAfterTax_1342"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedLossProfitAfterTax" xlink:label="loc_trib_AdjustedLossProfitAfterTax_1343"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedLossProfitAfterTax" xlink:label="loc_trib_AdjustedLossProfitAfterTax_1344"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedLossProfitAfterTax" xlink:label="loc_trib_AdjustedLossProfitAfterTax_1345"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedProfitAfterTax" xlink:label="loc_trib_AdjustedProfitAfterTax_1346"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedProfitAfterTax" xlink:label="loc_trib_AdjustedProfitAfterTax_1347"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedProfitAfterTax" xlink:label="loc_trib_AdjustedProfitAfterTax_1348"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedWeightedAverageSharesDiscontinuedOperations" xlink:label="loc_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_1349"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedWeightedAverageSharesDiscontinuedOperations" xlink:label="loc_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_1350"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedWeightedAverageSharesDiscontinuedOperations" xlink:label="loc_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_1351"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentForRestructuringProvision" xlink:label="loc_trib_AdjustmentForRestructuringProvision_1352"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentForRestructuringProvision" xlink:label="loc_trib_AdjustmentForRestructuringProvision_1353"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentForRestructuringProvision" xlink:label="loc_trib_AdjustmentForRestructuringProvision_1354"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIFRS16" xlink:label="loc_trib_AdjustmentOnTransitionToIFRS16_1355"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIFRS16" xlink:label="loc_trib_AdjustmentOnTransitionToIFRS16_1356"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIFRS16" xlink:label="loc_trib_AdjustmentOnTransitionToIFRS16_1357"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIFRS16" xlink:label="loc_trib_AdjustmentOnTransitionToIFRS16_1358"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment" xlink:label="loc_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_1359"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment" xlink:label="loc_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_1360"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment" xlink:label="loc_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_1361"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment" xlink:label="loc_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_1362"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment" xlink:label="loc_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_1363"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment" xlink:label="loc_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_1364"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForGainLossOnSaleOfBusiness" xlink:label="loc_trib_AdjustmentsForGainLossOnSaleOfBusiness_1365"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForGainLossOnSaleOfBusiness" xlink:label="loc_trib_AdjustmentsForGainLossOnSaleOfBusiness_1366"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForGainLossOnSaleOfBusiness" xlink:label="loc_trib_AdjustmentsForGainLossOnSaleOfBusiness_1367"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForGainLossOnSaleOfBusiness" xlink:label="loc_trib_AdjustmentsForGainLossOnSaleOfBusiness_1368"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForIncomeTaxExpenseCredit" xlink:label="loc_trib_AdjustmentsForIncomeTaxExpenseCredit_1369"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForIncomeTaxExpenseCredit" xlink:label="loc_trib_AdjustmentsForIncomeTaxExpenseCredit_1370"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForIncomeTaxExpenseCredit" xlink:label="loc_trib_AdjustmentsForIncomeTaxExpenseCredit_1371"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForIncomeTaxExpenseCredit" xlink:label="loc_trib_AdjustmentsForIncomeTaxExpenseCredit_1372"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForInventoryWriteOff" xlink:label="loc_trib_AdjustmentsForInventoryWriteOff_1373"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForInventoryWriteOff" xlink:label="loc_trib_AdjustmentsForInventoryWriteOff_1374"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForInventoryWriteOff" xlink:label="loc_trib_AdjustmentsForInventoryWriteOff_1375"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdministrationAndSalesMember" xlink:label="loc_trib_AdministrationAndSalesMember_1376"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdministrationAndSalesMember" xlink:label="loc_trib_AdministrationAndSalesMember_1377"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdoptionOfIfrs16" xlink:label="loc_trib_AdoptionOfIfrs16_1378"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdoptionOfIfrs16" xlink:label="loc_trib_AdoptionOfIfrs16_1379"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdoptionOfIfrs16" xlink:label="loc_trib_AdoptionOfIfrs16_1380"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdsRatioChangeMember" xlink:label="loc_trib_AdsRatioChangeMember_1381"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdsRatioChangeMember" xlink:label="loc_trib_AdsRatioChangeMember_1382"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdsRatioChangeMember" xlink:label="loc_trib_AdsRatioChangeMember_1383"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AgreementPayments" xlink:label="loc_trib_AgreementPayments_1384"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AgreementPayments" xlink:label="loc_trib_AgreementPayments_1385"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AgreementTerm" xlink:label="loc_trib_AgreementTerm_1386"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AgreementTerm" xlink:label="loc_trib_AgreementTerm_1387"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AgreementTerm" xlink:label="loc_trib_AgreementTerm_1388"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AllowanceForImpairmentOfReceivables" xlink:label="loc_trib_AllowanceForImpairmentOfReceivables_1389"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AllowanceForImpairmentOfReceivables" xlink:label="loc_trib_AllowanceForImpairmentOfReceivables_1390"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AllowanceForImpairmentOfReceivables" xlink:label="loc_trib_AllowanceForImpairmentOfReceivables_1391"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AllowanceForImpairmentOfReceivables" xlink:label="loc_trib_AllowanceForImpairmentOfReceivables_1392"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AllowanceForImpairmentOfReceivables" xlink:label="loc_trib_AllowanceForImpairmentOfReceivables_1393"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AllowanceForImpairmentOfReceivables" xlink:label="loc_trib_AllowanceForImpairmentOfReceivables_1394"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AllowanceRepresentsGroupRevenues" xlink:label="loc_trib_AllowanceRepresentsGroupRevenues_1395"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AllowanceRepresentsGroupRevenues" xlink:label="loc_trib_AllowanceRepresentsGroupRevenues_1396"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AllowanceRepresentsGroupRevenues" xlink:label="loc_trib_AllowanceRepresentsGroupRevenues_1397"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AlternativeMinimumTaxCreditMember" xlink:label="loc_trib_AlternativeMinimumTaxCreditMember_1398"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmendedCreditAgreementMember" xlink:label="loc_trib_AmendedCreditAgreementMember_1399"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmendedCreditAgreementMember" xlink:label="loc_trib_AmendedCreditAgreementMember_1400"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmendmentAndRestatementOfTermLoanMember" xlink:label="loc_trib_AmendmentAndRestatementOfTermLoanMember_1401"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmendmentAndRestatementOfTermLoanMember" xlink:label="loc_trib_AmendmentAndRestatementOfTermLoanMember_1402"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmendmentAndRestatementOfTermLoanMember" xlink:label="loc_trib_AmendmentAndRestatementOfTermLoanMember_1403"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_1404"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_1405"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_1406"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_1407"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_1408"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_1409"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositarySharesMember" xlink:label="loc_trib_AmericanDepositarySharesMember_1410"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareTreasurySharesMember" xlink:label="loc_trib_AmericanDepositaryShareTreasurySharesMember_1411"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareTreasurySharesMember" xlink:label="loc_trib_AmericanDepositaryShareTreasurySharesMember_1412"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareTreasurySharesMember" xlink:label="loc_trib_AmericanDepositaryShareTreasurySharesMember_1413"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositoryShares" xlink:label="loc_trib_AmericanDepositoryShares_1414"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositoryShares" xlink:label="loc_trib_AmericanDepositoryShares_1415"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositoryShares" xlink:label="loc_trib_AmericanDepositoryShares_1416"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositoryShares" xlink:label="loc_trib_AmericanDepositoryShares_1417"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositoryShares" xlink:label="loc_trib_AmericanDepositoryShares_1418"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositoryShares" xlink:label="loc_trib_AmericanDepositoryShares_1419"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositoryShares" xlink:label="loc_trib_AmericanDepositoryShares_1420"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositoryShares" xlink:label="loc_trib_AmericanDepositoryShares_1421"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositorySharesIssued" xlink:label="loc_trib_AmericanDepositorySharesIssued_1422"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositorySharesIssued" xlink:label="loc_trib_AmericanDepositorySharesIssued_1423"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositorySharesIssued" xlink:label="loc_trib_AmericanDepositorySharesIssued_1424"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmortisationForDiscontinuedOperations" xlink:label="loc_trib_AmortisationForDiscontinuedOperations_1425"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmortisationForDiscontinuedOperations" xlink:label="loc_trib_AmortisationForDiscontinuedOperations_1426"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmortisationForDiscontinuedOperations" xlink:label="loc_trib_AmortisationForDiscontinuedOperations_1427"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmortisationForDiscontinuedOperations" xlink:label="loc_trib_AmortisationForDiscontinuedOperations_1428"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmortisationOnIntangibleAssets" xlink:label="loc_trib_AmortisationOnIntangibleAssets_1429"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmortisationOnIntangibleAssets" xlink:label="loc_trib_AmortisationOnIntangibleAssets_1430"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmortisationOnIntangibleAssets" xlink:label="loc_trib_AmortisationOnIntangibleAssets_1431"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountAvailableForDevelopmentOfTheCGM" xlink:label="loc_trib_AmountAvailableForDevelopmentOfTheCGM_1432"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountAvailableForDevelopmentOfTheCGM" xlink:label="loc_trib_AmountAvailableForDevelopmentOfTheCGM_1433"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountAvailableForDevelopmentOfTheCGM" xlink:label="loc_trib_AmountAvailableForDevelopmentOfTheCGM_1434"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountPaidInRespectOfLeaseLiabilities" xlink:label="loc_trib_AmountPaidInRespectOfLeaseLiabilities_1435"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountPaidInRespectOfLeaseLiabilities" xlink:label="loc_trib_AmountPaidInRespectOfLeaseLiabilities_1436"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountPaidInRespectOfLeaseLiabilities" xlink:label="loc_trib_AmountPaidInRespectOfLeaseLiabilities_1437"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountReceivedFromProviderReliefFund" xlink:label="loc_trib_AmountReceivedFromProviderReliefFund_1438"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountReceivedFromProviderReliefFund" xlink:label="loc_trib_AmountReceivedFromProviderReliefFund_1439"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountUsedToAcquireTheCGMAssets" xlink:label="loc_trib_AmountUsedToAcquireTheCGMAssets_1440"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountUsedToAcquireTheCGMAssets" xlink:label="loc_trib_AmountUsedToAcquireTheCGMAssets_1441"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountUsedToAcquireTheCGMAssets" xlink:label="loc_trib_AmountUsedToAcquireTheCGMAssets_1442"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AnnualBorrowingBaseRate" xlink:label="loc_trib_AnnualBorrowingBaseRate_1443"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AnnualBorrowingBaseRate" xlink:label="loc_trib_AnnualBorrowingBaseRate_1444"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AnnualBorrowingBaseRate" xlink:label="loc_trib_AnnualBorrowingBaseRate_1445"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AnnualRentIncreased" xlink:label="loc_trib_AnnualRentIncreased_1446"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AnnualRentIncreased" xlink:label="loc_trib_AnnualRentIncreased_1447"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AnnualRentPayable" xlink:label="loc_trib_AnnualRentPayable_1448"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AnnualRentPayable" xlink:label="loc_trib_AnnualRentPayable_1449"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AnnualRentPayableForWareHouse" xlink:label="loc_trib_AnnualRentPayableForWareHouse_1450"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AnnualRentPayableForWareHouse" xlink:label="loc_trib_AnnualRentPayableForWareHouse_1451"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AntigenProjectsMember" xlink:label="loc_trib_AntigenProjectsMember_1452"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AsiaOrAfricaMember" xlink:label="loc_trib_AsiaOrAfricaMember_1453"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AsiaOrAfricaMember" xlink:label="loc_trib_AsiaOrAfricaMember_1454"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AsiaOrAfricaMember" xlink:label="loc_trib_AsiaOrAfricaMember_1455"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AssetsAndLiabilitiesBySegmentAbstract" xlink:label="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_1456"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AssetsAndLiabilitiesBySegmentAbstract" xlink:label="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_1457"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AssetsUnderDevelopmentCarryingValue" xlink:label="loc_trib_AssetsUnderDevelopmentCarryingValue_1458"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AssetsUnderDevelopmentCarryingValue" xlink:label="loc_trib_AssetsUnderDevelopmentCarryingValue_1459"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AssetsUnderDevelopmentCarryingValue" xlink:label="loc_trib_AssetsUnderDevelopmentCarryingValue_1460"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AutoimmuneFdaRegistrationsMember" xlink:label="loc_trib_AutoimmuneFdaRegistrationsMember_1461"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AutoimmuneSmartReaderMember" xlink:label="loc_trib_AutoimmuneSmartReaderMember_1462"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AutoimmuneSmartReaderMember" xlink:label="loc_trib_AutoimmuneSmartReaderMember_1463"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AutoimmuneSmartReaderMember" xlink:label="loc_trib_AutoimmuneSmartReaderMember_1464"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations" xlink:label="loc_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_1465"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations" xlink:label="loc_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_1466"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations" xlink:label="loc_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_1467"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AverageRemainingLeaseTermYears" xlink:label="loc_trib_AverageRemainingLeaseTermYears_1468"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AverageRemainingLeaseTermYears" xlink:label="loc_trib_AverageRemainingLeaseTermYears_1469"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AverageSharePriceShareOptionsExercised" xlink:label="loc_trib_AverageSharePriceShareOptionsExercised_1470"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AverageSharePriceShareOptionsExercised" xlink:label="loc_trib_AverageSharePriceShareOptionsExercised_1471"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AverageSharePriceShareOptionsExercised" xlink:label="loc_trib_AverageSharePriceShareOptionsExercised_1472"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BasisOfPreparationAndSignificantAccountingPoliciesLineItems" xlink:label="loc_trib_BasisOfPreparationAndSignificantAccountingPoliciesLineItems_1473"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BasisOfPreparationAndSignificantAccountingPoliciesLineItems" xlink:label="loc_trib_BasisOfPreparationAndSignificantAccountingPoliciesLineItems_1474"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BasisOfPreparationAndSignificantAccountingPoliciesTable" xlink:label="loc_trib_BasisOfPreparationAndSignificantAccountingPoliciesTable_1475"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BasisOfPreparationAndSignificantAccountingPoliciesTable" xlink:label="loc_trib_BasisOfPreparationAndSignificantAccountingPoliciesTable_1476"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BenenTradingLimitedMember" xlink:label="loc_trib_BenenTradingLimitedMember_1477"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BenenTradingLimitedMember" xlink:label="loc_trib_BenenTradingLimitedMember_1478"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiopoolUsIncMember" xlink:label="loc_trib_BiopoolUsIncMember_1479"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiopoolUsIncMember" xlink:label="loc_trib_BiopoolUsIncMember_1480"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiosynthMember" xlink:label="loc_trib_BiosynthMember_1481"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiosynthMember" xlink:label="loc_trib_BiosynthMember_1482"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiosynthMember" xlink:label="loc_trib_BiosynthMember_1483"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BloodBankScreeningBusinessMember" xlink:label="loc_trib_BloodBankScreeningBusinessMember_1484"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BorrowingsAndDerivativeFinancialInstrumentsMember" xlink:label="loc_trib_BorrowingsAndDerivativeFinancialInstrumentsMember_1485"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BrainNatriureticPeptideMember" xlink:label="loc_trib_BrainNatriureticPeptideMember_1486"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BrazilMember" xlink:label="loc_trib_BrazilMember_1487"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BusinessacquisitionAxis" xlink:label="loc_trib_BusinessacquisitionAxis_1488"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BusinessacquisitionAxis" xlink:label="loc_trib_BusinessacquisitionAxis_1489"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BusinessacquisitionDomain" xlink:label="loc_trib_BusinessacquisitionDomain_1490"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BusinessacquisitionDomain" xlink:label="loc_trib_BusinessacquisitionDomain_1491"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CapitalisationOfUnpaidInterestOnTermLoan" xlink:label="loc_trib_CapitalisationOfUnpaidInterestOnTermLoan_1492"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CapitalisationOfUnpaidInterestOnTermLoan" xlink:label="loc_trib_CapitalisationOfUnpaidInterestOnTermLoan_1493"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CapitalisationOfUnpaidInterestOnTermLoan" xlink:label="loc_trib_CapitalisationOfUnpaidInterestOnTermLoan_1494"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CapitalisedDevelopmentCost" xlink:label="loc_trib_CapitalisedDevelopmentCost_1495"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CapitalisedDevelopmentCost" xlink:label="loc_trib_CapitalisedDevelopmentCost_1496"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CapitalisedDevelopmentCost" xlink:label="loc_trib_CapitalisedDevelopmentCost_1497"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CardiacAnalyserMember" xlink:label="loc_trib_CardiacAnalyserMember_1498"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CarryingAmountOfGoodwill" xlink:label="loc_trib_CarryingAmountOfGoodwill_1499"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CarryingAmountOfGoodwill" xlink:label="loc_trib_CarryingAmountOfGoodwill_1500"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAcquiredAsOfAcquisitionDate" xlink:label="loc_trib_CashAcquiredAsOfAcquisitionDate_1501"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAcquiredAsOfAcquisitionDate" xlink:label="loc_trib_CashAcquiredAsOfAcquisitionDate_1502"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAcquiredAsOfAcquisitionDate" xlink:label="loc_trib_CashAcquiredAsOfAcquisitionDate_1503"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAcquiredAsOfAcquisitionDate" xlink:label="loc_trib_CashAcquiredAsOfAcquisitionDate_1504"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAcquiredAsOfAcquisitionDate" xlink:label="loc_trib_CashAcquiredAsOfAcquisitionDate_1505"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentMember" xlink:label="loc_trib_CashAndCashEquivalentMember_1506"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentMember" xlink:label="loc_trib_CashAndCashEquivalentMember_1507"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentMember" xlink:label="loc_trib_CashAndCashEquivalentMember_1508"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentsAndShortTermInvestments" xlink:label="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1509"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentsAndShortTermInvestments" xlink:label="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1510"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentsAndShortTermInvestments" xlink:label="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1511"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentsAndShortTermInvestments" xlink:label="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1512"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentsAndShortTermInvestments" xlink:label="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1513"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentsAndShortTermInvestments" xlink:label="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1514"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentsAndShortTermInvestments" xlink:label="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1515"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashInterestPayableOnPppLoans" xlink:label="loc_trib_CashInterestPayableOnPppLoans_1516"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashInterestPayableOnPppLoans" xlink:label="loc_trib_CashInterestPayableOnPppLoans_1517"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashInterestPayableOnPppLoans" xlink:label="loc_trib_CashInterestPayableOnPppLoans_1518"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashInterestPayableOnSeniorSecureTermLoan" xlink:label="loc_trib_CashInterestPayableOnSeniorSecureTermLoan_1519"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashInterestPayableOnSeniorSecureTermLoan" xlink:label="loc_trib_CashInterestPayableOnSeniorSecureTermLoan_1520"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashInterestPayableOnSeniorSecureTermLoan" xlink:label="loc_trib_CashInterestPayableOnSeniorSecureTermLoan_1521"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashPaidForNominalValue" xlink:label="loc_trib_CashPaidForNominalValue_1522"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashPaidForNominalValue" xlink:label="loc_trib_CashPaidForNominalValue_1523"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashPaidForNominalValue" xlink:label="loc_trib_CashPaidForNominalValue_1524"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashPaidToEachHolder" xlink:label="loc_trib_CashPaidToEachHolder_1525"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashPaidToEachHolder" xlink:label="loc_trib_CashPaidToEachHolder_1526"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashPaidToEachHolder" xlink:label="loc_trib_CashPaidToEachHolder_1527"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashProceedsFromDiscontinuedOperations" xlink:label="loc_trib_CashProceedsFromDiscontinuedOperations_1528"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashProceedsFromDiscontinuedOperations" xlink:label="loc_trib_CashProceedsFromDiscontinuedOperations_1529"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashProceedsFromDiscontinuedOperations" xlink:label="loc_trib_CashProceedsFromDiscontinuedOperations_1530"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts" xlink:label="loc_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_1531"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts" xlink:label="loc_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_1532"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts" xlink:label="loc_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_1533"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashReceivedPerNominalValue" xlink:label="loc_trib_CashReceivedPerNominalValue_1534"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashReceivedPerNominalValue" xlink:label="loc_trib_CashReceivedPerNominalValue_1535"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashReceivedPerNominalValue" xlink:label="loc_trib_CashReceivedPerNominalValue_1536"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashSoldAsAPartOfDiscontinuedOperations" xlink:label="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_1537"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashSoldAsAPartOfDiscontinuedOperations" xlink:label="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_1538"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashSoldAsAPartOfDiscontinuedOperations" xlink:label="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_1539"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashSoldAsAPartOfDiscontinuedOperations" xlink:label="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_1540"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ChangeInAllowance" xlink:label="loc_trib_ChangeInAllowance_1541"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ChangeInAllowance" xlink:label="loc_trib_ChangeInAllowance_1542"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClarkLaboratoriesIncMember" xlink:label="loc_trib_ClarkLaboratoriesIncMember_1543"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClarkLaboratoriesIncMember" xlink:label="loc_trib_ClarkLaboratoriesIncMember_1544"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1545"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1546"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassATreasurySharesMember" xlink:label="loc_trib_ClassATreasurySharesMember_1547"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassATreasurySharesMember" xlink:label="loc_trib_ClassATreasurySharesMember_1548"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClinicalLaboratoryMember" xlink:label="loc_trib_ClinicalLaboratoryMember_1549"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClinicalLaboratoryMember" xlink:label="loc_trib_ClinicalLaboratoryMember_1550"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClinicalLaboratoryMember" xlink:label="loc_trib_ClinicalLaboratoryMember_1551"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosingExercisePriceOfOutstandingShareOptions" xlink:label="loc_trib_ClosingExercisePriceOfOutstandingShareOptions_1552"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosingExercisePriceOfOutstandingShareOptions" xlink:label="loc_trib_ClosingExercisePriceOfOutstandingShareOptions_1553"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosingExercisePriceOfOutstandingShareOptions" xlink:label="loc_trib_ClosingExercisePriceOfOutstandingShareOptions_1554"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosureCosts" xlink:label="loc_trib_ClosureCosts_1555"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosureCosts" xlink:label="loc_trib_ClosureCosts_1556"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosureCosts" xlink:label="loc_trib_ClosureCosts_1557"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosureCostsMember" xlink:label="loc_trib_ClosureCostsMember_1558"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosureProvision" xlink:label="loc_trib_ClosureProvision_1559"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosureProvision" xlink:label="loc_trib_ClosureProvision_1560"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosureProvision" xlink:label="loc_trib_ClosureProvision_1561"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosureProvision" xlink:label="loc_trib_ClosureProvision_1562"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosureProvision" xlink:label="loc_trib_ClosureProvision_1563"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ColumnEnhancementMember" xlink:label="loc_trib_ColumnEnhancementMember_1564"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ColumnEnhancementMember" xlink:label="loc_trib_ColumnEnhancementMember_1565"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ComputerEquipmentsMember" xlink:label="loc_trib_ComputerEquipmentsMember_1566"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ComputerEquipmentsMember" xlink:label="loc_trib_ComputerEquipmentsMember_1567"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ComputerEquipmentsMember" xlink:label="loc_trib_ComputerEquipmentsMember_1568"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConsiderationFromEmployeeOptionsSettledInCash" xlink:label="loc_trib_ConsiderationFromEmployeeOptionsSettledInCash_1569"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConsiderationFromEmployeeOptionsSettledInCash" xlink:label="loc_trib_ConsiderationFromEmployeeOptionsSettledInCash_1570"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConsolidatedStatementOfComprehensiveIncomeAbstract" xlink:label="loc_trib_ConsolidatedStatementOfComprehensiveIncomeAbstract_1571"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConsolidatedStatementOfComprehensiveIncomeAbstract" xlink:label="loc_trib_ConsolidatedStatementOfComprehensiveIncomeAbstract_1572"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentAssets" xlink:label="loc_trib_ContingentAssets_1573"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentAssets" xlink:label="loc_trib_ContingentAssets_1574"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentAssets" xlink:label="loc_trib_ContingentAssets_1575"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_1576"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_1577"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_1578"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_1579"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_1580"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_1581"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationNonCurrent" xlink:label="loc_trib_ContingentConsiderationNonCurrent_1582"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationNonCurrent" xlink:label="loc_trib_ContingentConsiderationNonCurrent_1583"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationNonCurrent" xlink:label="loc_trib_ContingentConsiderationNonCurrent_1584"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentLiabilityMember" xlink:label="loc_trib_ContingentLiabilityMember_1585"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentLiabilityMember" xlink:label="loc_trib_ContingentLiabilityMember_1586"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentLiabilityMember" xlink:label="loc_trib_ContingentLiabilityMember_1587"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContinuousGlucoseMonitoringTechnologyMember" xlink:label="loc_trib_ContinuousGlucoseMonitoringTechnologyMember_1588"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContinuousGlucoseMonitoringTechnologyMember" xlink:label="loc_trib_ContinuousGlucoseMonitoringTechnologyMember_1589"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContinuousGlucoseMonitoringTestingMember" xlink:label="loc_trib_ContinuousGlucoseMonitoringTestingMember_1590"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContinuousGlucoseMonitoringTestingMember" xlink:label="loc_trib_ContinuousGlucoseMonitoringTestingMember_1591"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContinuousGlucoseMonitoringTestingMember" xlink:label="loc_trib_ContinuousGlucoseMonitoringTestingMember_1592"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContractualCashFlowsMember" xlink:label="loc_trib_ContractualCashFlowsMember_1593"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContractualCashFlowsMember" xlink:label="loc_trib_ContractualCashFlowsMember_1594"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContributionAmountInSettlement" xlink:label="loc_trib_ContributionAmountInSettlement_1595"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContributionAmountInSettlement" xlink:label="loc_trib_ContributionAmountInSettlement_1596"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContributionForTaxAuditSettlement" xlink:label="loc_trib_ContributionForTaxAuditSettlement_1597"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContributionForTaxAuditSettlement" xlink:label="loc_trib_ContributionForTaxAuditSettlement_1598"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConversionPricePerAds" xlink:label="loc_trib_ConversionPricePerAds_1599"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConversionPricePerAds" xlink:label="loc_trib_ConversionPricePerAds_1600"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConversionPricePerAds" xlink:label="loc_trib_ConversionPricePerAds_1601"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConversionRatePerAds" xlink:label="loc_trib_ConversionRatePerAds_1602"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConversionRatePerAds" xlink:label="loc_trib_ConversionRatePerAds_1603"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNote" xlink:label="loc_trib_ConvertibleNote_1604"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNote" xlink:label="loc_trib_ConvertibleNote_1605"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNote" xlink:label="loc_trib_ConvertibleNote_1606"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNote" xlink:label="loc_trib_ConvertibleNote_1607"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNote" xlink:label="loc_trib_ConvertibleNote_1608"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteInvestment" xlink:label="loc_trib_ConvertibleNoteInvestment_1609"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteInvestment" xlink:label="loc_trib_ConvertibleNoteInvestment_1610"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteMember" xlink:label="loc_trib_ConvertibleNoteMember_1611"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteMember" xlink:label="loc_trib_ConvertibleNoteMember_1612"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteMember" xlink:label="loc_trib_ConvertibleNoteMember_1613"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CostIncurredIssueOfShares" xlink:label="loc_trib_CostIncurredIssueOfShares_1614"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CostIncurredIssueOfShares" xlink:label="loc_trib_CostIncurredIssueOfShares_1615"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_Covid19ElisaTestMember" xlink:label="loc_trib_Covid19ElisaTestMember_1616"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_Covid19ElisaTestMember" xlink:label="loc_trib_Covid19ElisaTestMember_1617"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_Covid19ElisaTestMember" xlink:label="loc_trib_Covid19ElisaTestMember_1618"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CovidPointOfCareRapidTestAndElisaTestMember" xlink:label="loc_trib_CovidPointOfCareRapidTestAndElisaTestMember_1619"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CovidTestMember" xlink:label="loc_trib_CovidTestMember_1620"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CovidTestMember" xlink:label="loc_trib_CovidTestMember_1621"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CovidTestMember" xlink:label="loc_trib_CovidTestMember_1622"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CraigHallumMember" xlink:label="loc_trib_CraigHallumMember_1623"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CreditAgreementAxis" xlink:label="loc_trib_CreditAgreementAxis_1624"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CreditAgreementAxis" xlink:label="loc_trib_CreditAgreementAxis_1625"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CreditAgreementDomain" xlink:label="loc_trib_CreditAgreementDomain_1626"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CreditAgreementDomain" xlink:label="loc_trib_CreditAgreementDomain_1627"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentDerivativeLiabilities" xlink:label="loc_trib_CurrentDerivativeLiabilities_1628"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentDerivativeLiabilities" xlink:label="loc_trib_CurrentDerivativeLiabilities_1629"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentDerivativeLiabilities" xlink:label="loc_trib_CurrentDerivativeLiabilities_1630"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentDerivativeLiabilities" xlink:label="loc_trib_CurrentDerivativeLiabilities_1631"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentFinanceLeaseLiabilities" xlink:label="loc_trib_CurrentFinanceLeaseLiabilities_1632"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentFinanceLeaseLiabilities" xlink:label="loc_trib_CurrentFinanceLeaseLiabilities_1633"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentFinanceLeaseLiabilities" xlink:label="loc_trib_CurrentFinanceLeaseLiabilities_1634"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentFinanceLeaseLiabilities" xlink:label="loc_trib_CurrentFinanceLeaseLiabilities_1635"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentGovernmentLoans" xlink:label="loc_trib_CurrentGovernmentLoans_1636"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentGovernmentLoans" xlink:label="loc_trib_CurrentGovernmentLoans_1637"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentGovernmentLoans" xlink:label="loc_trib_CurrentGovernmentLoans_1638"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentLeaseLiabilitiesAbstract" xlink:label="loc_trib_CurrentLeaseLiabilitiesAbstract_1639"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentLiabilitiesMember" xlink:label="loc_trib_CurrentLiabilitiesMember_1640"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentLiabilitiesMember" xlink:label="loc_trib_CurrentLiabilitiesMember_1641"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentTaxForeignExpenseIncome" xlink:label="loc_trib_CurrentTaxForeignExpenseIncome_1642"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentTaxForeignExpenseIncome" xlink:label="loc_trib_CurrentTaxForeignExpenseIncome_1643"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentTaxForeignExpenseIncome" xlink:label="loc_trib_CurrentTaxForeignExpenseIncome_1644"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CustomerMember" xlink:label="loc_trib_CustomerMember_1645"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CustomerMember" xlink:label="loc_trib_CustomerMember_1646"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DarnickCompanyMember" xlink:label="loc_trib_DarnickCompanyMember_1647"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DarnickCompanyMember" xlink:label="loc_trib_DarnickCompanyMember_1648"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DDimerDevelopmentMember" xlink:label="loc_trib_DDimerDevelopmentMember_1649"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DebtRefinancingMember" xlink:label="loc_trib_DebtRefinancingMember_1650"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DebtRefinancingMember" xlink:label="loc_trib_DebtRefinancingMember_1651"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredConsideration" xlink:label="loc_trib_DeferredConsideration_1652"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredConsideration" xlink:label="loc_trib_DeferredConsideration_1653"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredConsideration" xlink:label="loc_trib_DeferredConsideration_1654"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredConsiderationPayable" xlink:label="loc_trib_DeferredConsiderationPayable_1655"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredConsiderationPayable" xlink:label="loc_trib_DeferredConsiderationPayable_1656"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredConsiderationPayable" xlink:label="loc_trib_DeferredConsiderationPayable_1657"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision" xlink:label="loc_trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision_1658"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision" xlink:label="loc_trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision_1659"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision" xlink:label="loc_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_1660"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision" xlink:label="loc_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_1661"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision" xlink:label="loc_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_1662"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsCapitalLossCarryforward" xlink:label="loc_trib_DeferredTaxAssetsCapitalLossCarryforward_1663"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsCapitalLossCarryforward" xlink:label="loc_trib_DeferredTaxAssetsCapitalLossCarryforward_1664"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsCapitalLossCarryforward" xlink:label="loc_trib_DeferredTaxAssetsCapitalLossCarryforward_1665"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossCarryforward" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_1666"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossCarryforward" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_1667"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossCarryforward" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_1668"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossCarryforwardsState" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_1669"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossCarryforwardsState" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_1670"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossCarryforwardsState" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_1671"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossDomestic" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossDomestic_1672"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossDomestic" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossDomestic_1673"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossDomestic" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossDomestic_1674"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOtherTemporaryTimingDifferences" xlink:label="loc_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_1675"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOtherTemporaryTimingDifferences" xlink:label="loc_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_1676"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOtherTemporaryTimingDifferences" xlink:label="loc_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_1677"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits" xlink:label="loc_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_1678"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits" xlink:label="loc_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_1679"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits" xlink:label="loc_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_1680"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" xlink:label="loc_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_1681"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" xlink:label="loc_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_1682"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" xlink:label="loc_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_1683"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxLiabilityDecreased" xlink:label="loc_trib_DeferredTaxLiabilityDecreased_1684"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxLiabilityDecreased" xlink:label="loc_trib_DeferredTaxLiabilityDecreased_1685"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxLiabilityIncreased" xlink:label="loc_trib_DeferredTaxLiabilityIncreased_1686"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxLiabilityIncreased" xlink:label="loc_trib_DeferredTaxLiabilityIncreased_1687"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxLiabilityIncreased" xlink:label="loc_trib_DeferredTaxLiabilityIncreased_1688"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeprecationForDiscontinuedOperations" xlink:label="loc_trib_DeprecationForDiscontinuedOperations_1689"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeprecationForDiscontinuedOperations" xlink:label="loc_trib_DeprecationForDiscontinuedOperations_1690"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeprecationForDiscontinuedOperations" xlink:label="loc_trib_DeprecationForDiscontinuedOperations_1691"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeprecationForDiscontinuedOperations" xlink:label="loc_trib_DeprecationForDiscontinuedOperations_1692"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DepreciationMember" xlink:label="loc_trib_DepreciationMember_1693"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DepreciationMember" xlink:label="loc_trib_DepreciationMember_1694"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DepreciationMember" xlink:label="loc_trib_DepreciationMember_1695"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DepreciationOnIntangibleAssets" xlink:label="loc_trib_DepreciationOnIntangibleAssets_1696"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DepreciationOnIntangibleAssets" xlink:label="loc_trib_DepreciationOnIntangibleAssets_1697"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DepreciationOnIntangibleAssets" xlink:label="loc_trib_DepreciationOnIntangibleAssets_1698"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfDrawdown" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfDrawdown_1699"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfDrawdown" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfDrawdown_1700"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfDrawdown" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfDrawdown_1701"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfIssue_1702"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfIssue_1703"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfIssue_1704"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfIssue_1705"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfIssue_1706"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetMember" xlink:label="loc_trib_DerivativeFinancialAssetMember_1707"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetMember" xlink:label="loc_trib_DerivativeFinancialAssetMember_1708"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityAtDateOfDrawdown" xlink:label="loc_trib_DerivativeFinancialLiabilityAtDateOfDrawdown_1709"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityAtDateOfDrawdown" xlink:label="loc_trib_DerivativeFinancialLiabilityAtDateOfDrawdown_1710"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialLiabilityAtDateOfIssue_1711"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialLiabilityAtDateOfIssue_1712"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialLiabilityAtDateOfIssue_1713"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialLiabilityAtDateOfIssue_1714"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan" xlink:label="loc_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_1715"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan" xlink:label="loc_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_1716"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan" xlink:label="loc_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_1717"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityMember" xlink:label="loc_trib_DerivativeFinancialLiabilityMember_1718"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityMember" xlink:label="loc_trib_DerivativeFinancialLiabilityMember_1719"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityMember" xlink:label="loc_trib_DerivativeFinancialLiabilityMember_1720"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_1721"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_1722"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_1723"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_1724"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_1725"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_1726"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_1727"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_1728"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_1729"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_1730"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_1731"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_1732"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_1733"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_1734"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_1735"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_1736"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_1737"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_1738"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_1739"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_1740"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_1741"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_1742"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_1743"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_1744"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_1745"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory" xlink:label="loc_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_1746"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfBorrowingsPaid" xlink:label="loc_trib_DescriptionOfBorrowingsPaid_1747"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfBorrowingsPaid" xlink:label="loc_trib_DescriptionOfBorrowingsPaid_1748"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfBorrowingsPaid" xlink:label="loc_trib_DescriptionOfBorrowingsPaid_1749"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfCumulativeRevenuesPayable" xlink:label="loc_trib_DescriptionOfCumulativeRevenuesPayable_1750"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfCumulativeRevenuesPayable" xlink:label="loc_trib_DescriptionOfCumulativeRevenuesPayable_1751"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfCumulativeRevenuesPayable" xlink:label="loc_trib_DescriptionOfCumulativeRevenuesPayable_1752"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfShareAdjustedRatio" xlink:label="loc_trib_DescriptionOfShareAdjustedRatio_1753"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfShareAdjustedRatio" xlink:label="loc_trib_DescriptionOfShareAdjustedRatio_1754"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfShareAdjustedRatio" xlink:label="loc_trib_DescriptionOfShareAdjustedRatio_1755"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DevelopmentCostMember" xlink:label="loc_trib_DevelopmentCostMember_1756"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DevelopmentCostMember" xlink:label="loc_trib_DevelopmentCostMember_1757"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DevelopmentCostsMember" xlink:label="loc_trib_DevelopmentCostsMember_1758"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DevelopmentCostsMember" xlink:label="loc_trib_DevelopmentCostsMember_1759"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorPensionExpense" xlink:label="loc_trib_DirectorPensionExpense_1760"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorPensionExpense" xlink:label="loc_trib_DirectorPensionExpense_1761"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorPensionExpense" xlink:label="loc_trib_DirectorPensionExpense_1762"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsAndCompanySecretaryMember" xlink:label="loc_trib_DirectorsAndCompanySecretaryMember_1763"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsAndCompanySecretaryMember" xlink:label="loc_trib_DirectorsAndCompanySecretaryMember_1764"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsAndCompanySecretaryMember" xlink:label="loc_trib_DirectorsAndCompanySecretaryMember_1765"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract" xlink:label="loc_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract_1766"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract" xlink:label="loc_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract_1767"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsMember" xlink:label="loc_trib_DirectorsMember_1768"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsMember" xlink:label="loc_trib_DirectorsMember_1769"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsMember" xlink:label="loc_trib_DirectorsMember_1770"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAccountingEstimatesAndJudgementsAbstract" xlink:label="loc_trib_DisclosureOfAccountingEstimatesAndJudgementsAbstract_1771"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_1772"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_1773"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1774"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1775"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory" xlink:label="loc_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_1776"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory" xlink:label="loc_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_1777"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory" xlink:label="loc_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_1778"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAuthorisationForIssueAbstract" xlink:label="loc_trib_DisclosureOfAuthorisationForIssueAbstract_1779"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAuthorisationForIssueExplanatory" xlink:label="loc_trib_DisclosureOfAuthorisationForIssueExplanatory_1780"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAuthorisationForIssueExplanatory" xlink:label="loc_trib_DisclosureOfAuthorisationForIssueExplanatory_1781"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAuthorisationForIssueExplanatory" xlink:label="loc_trib_DisclosureOfAuthorisationForIssueExplanatory_1782"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract" xlink:label="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_1783"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract" xlink:label="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_1784"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory" xlink:label="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_1785"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory" xlink:label="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_1786"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory" xlink:label="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_1787"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract" xlink:label="loc_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_1788"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract" xlink:label="loc_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_1789"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract" xlink:label="loc_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_1790"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfCompositionOfGroupLineItems" xlink:label="loc_trib_DisclosureOfCompositionOfGroupLineItems_1791"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfCompositionOfGroupLineItems" xlink:label="loc_trib_DisclosureOfCompositionOfGroupLineItems_1792"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfCompositionOfGroupTable" xlink:label="loc_trib_DisclosureOfCompositionOfGroupTable_1793"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfCompositionOfGroupTable" xlink:label="loc_trib_DisclosureOfCompositionOfGroupTable_1794"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_1795"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_1796"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_1797"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_1798"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_1799"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_1800"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_1801"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_1802"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_1803"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_1804"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_1805"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_1806"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_1807"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_1808"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_1809"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_1810"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_1811"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_1812"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory_1813"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory_1814"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory_1815"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_1816"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_1817"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_1818"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1819"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1820"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1821"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_1822"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_1823"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_1824"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_1825"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_1826"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_1827"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCompensationExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_1828"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCompensationExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_1829"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutCompensationExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_1830"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1831"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1832"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1833"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_1834"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_1835"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_1836"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_1837"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_1838"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_1839"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_1840"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_1841"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_1842"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_1843"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_1844"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_1845"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_1846"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_1847"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_1848"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_1849"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_1850"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_1851"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_1852"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_1853"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_1854"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory_1855"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory_1856"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory_1857"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_1858"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_1859"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_1860"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_1861"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_1862"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_1863"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_1864"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_1865"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_1866"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFinancialAssets" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFinancialAssets_1867"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFinancialAssets" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFinancialAssets_1868"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFinancialAssets" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFinancialAssets_1869"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_1870"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_1871"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_1872"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_1873"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_1874"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_1875"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory_1876"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory_1877"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory_1878"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_1879"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_1880"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_1881"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory_1882"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory_1883"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory_1884"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_1885"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_1886"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_1887"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_1888"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_1889"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_1890"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_1891"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_1892"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_1893"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_1894"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_1895"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_1896"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_1897"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_1898"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_1899"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1900"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1901"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1902"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_1903"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_1904"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_1905"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_1906"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_1907"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_1908"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory_1909"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory_1910"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory_1911"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_1912"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_1913"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_1914"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_1915"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_1916"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_1917"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_1918"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_1919"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_1920"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_1921"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_1922"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_1923"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_1924"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_1925"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_1926"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_1927"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_1928"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_1929"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_1930"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_1931"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_1932"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_1933"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_1934"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_1935"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_1936"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_1937"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_1938"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_1939"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory_1940"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory_1941"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory_1942"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_1943"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_1944"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_1945"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_1946"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_1947"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_1948"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_1949"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_1950"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_1951"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_1952"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_1953"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_1954"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_1955"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_1956"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_1957"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_1958"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_1959"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_1960"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1961"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1962"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1963"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_1964"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_1965"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_1966"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_1967"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_1968"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_1969"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_1970"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_1971"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_1972"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_1973"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_1974"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_1975"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_1976"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_1977"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_1978"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_1979"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_1980"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_1981"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_1982"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_1983"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_1984"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_1985"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_1986"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_1987"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1988"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1989"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1990"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_1991"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_1992"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_1993"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_1994"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_1995"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory" xlink:label="loc_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_1996"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDividendPaidAbstract" xlink:label="loc_trib_DisclosureOfDividendPaidAbstract_1997"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDividendPaidAbstract" xlink:label="loc_trib_DisclosureOfDividendPaidAbstract_1998"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDividendsPaidExplanatory" xlink:label="loc_trib_DisclosureOfDividendsPaidExplanatory_1999"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDividendsPaidExplanatory" xlink:label="loc_trib_DisclosureOfDividendsPaidExplanatory_2000"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfDividendsPaidExplanatory" xlink:label="loc_trib_DisclosureOfDividendsPaidExplanatory_2001"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock" xlink:label="loc_trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock_2002"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock" xlink:label="loc_trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock_2003"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock" xlink:label="loc_trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock_2004"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinanceLeaseLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_2005"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinanceLeaseLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_2006"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinanceLeaseLiabilitiesAbstract" xlink:label="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_2007"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinancingIncomeExpensesNetAbstract" xlink:label="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_2008"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinancingIncomeExpensesNetAbstract" xlink:label="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_2009"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfFinancingIncomeExpensesNetAbstract" xlink:label="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_2010"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" xlink:label="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_2011"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" xlink:label="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_2012"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" xlink:label="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_2013"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGroupUndertakingsAbstract" xlink:label="loc_trib_DisclosureOfGroupUndertakingsAbstract_2014"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGroupUndertakingsExplanatory" xlink:label="loc_trib_DisclosureOfGroupUndertakingsExplanatory_2015"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGroupUndertakingsExplanatory" xlink:label="loc_trib_DisclosureOfGroupUndertakingsExplanatory_2016"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfGroupUndertakingsExplanatory" xlink:label="loc_trib_DisclosureOfGroupUndertakingsExplanatory_2017"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract" xlink:label="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_2018"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract" xlink:label="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_2019"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract" xlink:label="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_2020"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfIncomeTaxCreditAbstract" xlink:label="loc_trib_DisclosureOfIncomeTaxCreditAbstract_2021"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfIncomeTaxCreditAbstract" xlink:label="loc_trib_DisclosureOfIncomeTaxCreditAbstract_2022"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfIncomeTaxCreditAbstract" xlink:label="loc_trib_DisclosureOfIncomeTaxCreditAbstract_2023"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract" xlink:label="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_2024"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory" xlink:label="loc_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_2025"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory" xlink:label="loc_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_2026"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory" xlink:label="loc_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_2027"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_2028"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_2029"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_2030"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossProfitBeforeTaxAbstract" xlink:label="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_2031"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossProfitBeforeTaxAbstract" xlink:label="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_2032"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossProfitBeforeTaxAbstract" xlink:label="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_2033"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossProfitBeforeTaxExplanatory" xlink:label="loc_trib_DisclosureOfLossProfitBeforeTaxExplanatory_2034"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossProfitBeforeTaxExplanatory" xlink:label="loc_trib_DisclosureOfLossProfitBeforeTaxExplanatory_2035"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfLossProfitBeforeTaxExplanatory" xlink:label="loc_trib_DisclosureOfLossProfitBeforeTaxExplanatory_2036"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory" xlink:label="loc_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_2037"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory" xlink:label="loc_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_2038"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory" xlink:label="loc_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_2039"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock" xlink:label="loc_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_2040"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock" xlink:label="loc_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_2041"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock" xlink:label="loc_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_2042"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherAssetsAbstract" xlink:label="loc_trib_DisclosureOfOtherAssetsAbstract_2043"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherAssetsAbstract" xlink:label="loc_trib_DisclosureOfOtherAssetsAbstract_2044"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherOperatingIncomeAbstract" xlink:label="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_2045"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherOperatingIncomeAbstract" xlink:label="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_2046"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherOperatingIncomeAbstract" xlink:label="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_2047"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherPayablesDueAfterOneYearAbstract" xlink:label="loc_trib_DisclosureOfOtherPayablesDueAfterOneYearAbstract_2048"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherPayablesDueAfterOneYearAbstract" xlink:label="loc_trib_DisclosureOfOtherPayablesDueAfterOneYearAbstract_2049"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory" xlink:label="loc_trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory_2050"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory" xlink:label="loc_trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory_2051"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory" xlink:label="loc_trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory_2052"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfPensionSchemesAbstract" xlink:label="loc_trib_DisclosureOfPensionSchemesAbstract_2053"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfPostBalanceSheetEventsAbstract" xlink:label="loc_trib_DisclosureOfPostBalanceSheetEventsAbstract_2054"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory" xlink:label="loc_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_2055"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory" xlink:label="loc_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_2056"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory" xlink:label="loc_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_2057"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory_2058"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory_2059"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory" xlink:label="loc_trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory_2060"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShareOptionsAndShareWarrantsAbstract" xlink:label="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_2061"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShareOptionsAndShareWarrantsAbstract" xlink:label="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_2062"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory" xlink:label="loc_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_2063"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory" xlink:label="loc_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_2064"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory" xlink:label="loc_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_2065"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShortTermInvestmentsAbstract" xlink:label="loc_trib_DisclosureOfShortTermInvestmentsAbstract_2066"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShortTermInvestmentsAbstract" xlink:label="loc_trib_DisclosureOfShortTermInvestmentsAbstract_2067"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfShortTermInvestmentsAbstract" xlink:label="loc_trib_DisclosureOfShortTermInvestmentsAbstract_2068"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsAxis" xlink:label="loc_trib_DiscontinuedOperationsAxis_2069"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_2070"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_2071"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscountingLeaseLiability" xlink:label="loc_trib_DiscountingLeaseLiability_2072"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscountingLeaseLiability" xlink:label="loc_trib_DiscountingLeaseLiability_2073"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscountingLeaseLiability" xlink:label="loc_trib_DiscountingLeaseLiability_2074"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsGoodwillAndIntangibleAssets" xlink:label="loc_trib_DisposalsGoodwillAndIntangibleAssets_2075"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsGoodwillAndIntangibleAssets" xlink:label="loc_trib_DisposalsGoodwillAndIntangibleAssets_2076"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsGoodwillAndIntangibleAssets" xlink:label="loc_trib_DisposalsGoodwillAndIntangibleAssets_2077"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsGoodwillAndIntangibleAssets" xlink:label="loc_trib_DisposalsGoodwillAndIntangibleAssets_2078"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsOrRetirementsPropertyAndEquipment" xlink:label="loc_trib_DisposalsOrRetirementsPropertyAndEquipment_2079"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsOrRetirementsPropertyAndEquipment" xlink:label="loc_trib_DisposalsOrRetirementsPropertyAndEquipment_2080"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsOrRetirementsPropertyAndEquipment" xlink:label="loc_trib_DisposalsOrRetirementsPropertyAndEquipment_2081"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsRelatedToRightOfUseAssets" xlink:label="loc_trib_DisposalsRelatedToRightOfUseAssets_2082"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsRelatedToRightOfUseAssets" xlink:label="loc_trib_DisposalsRelatedToRightOfUseAssets_2083"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsRelatedToRightOfUseAssets" xlink:label="loc_trib_DisposalsRelatedToRightOfUseAssets_2084"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DistributorsMember" xlink:label="loc_trib_DistributorsMember_2085"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DistributorsMember" xlink:label="loc_trib_DistributorsMember_2086"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DivestitureOfFitzgeraldLifeSciencesBusinessMember" xlink:label="loc_trib_DivestitureOfFitzgeraldLifeSciencesBusinessMember_2087"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DivestitureOfFitzgeraldLifeSciencesBusinessMember" xlink:label="loc_trib_DivestitureOfFitzgeraldLifeSciencesBusinessMember_2088"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DrJimWalshMember" xlink:label="loc_trib_DrJimWalshMember_2089"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EarlyRepaymentPenaltyDescription" xlink:label="loc_trib_EarlyRepaymentPenaltyDescription_2090"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EarlyRepaymentPenaltyDescription" xlink:label="loc_trib_EarlyRepaymentPenaltyDescription_2091"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EarlyRepaymentPenaltyDescription" xlink:label="loc_trib_EarlyRepaymentPenaltyDescription_2092"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment" xlink:label="loc_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_2093"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment" xlink:label="loc_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_2094"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment" xlink:label="loc_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_2095"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract" xlink:label="loc_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_2096"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract" xlink:label="loc_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_2097"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract" xlink:label="loc_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_2098"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectiveInterestRate" xlink:label="loc_trib_EffectiveInterestRate_2099"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectiveInterestRate" xlink:label="loc_trib_EffectiveInterestRate_2100"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16" xlink:label="loc_trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16_2101"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16" xlink:label="loc_trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16_2102"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16" xlink:label="loc_trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16_2103"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectOfIrishIncomeTaxableAtHigherTaxRate" xlink:label="loc_trib_EffectOfIrishIncomeTaxableAtHigherTaxRate_2104"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectOfIrishIncomeTaxableAtHigherTaxRate" xlink:label="loc_trib_EffectOfIrishIncomeTaxableAtHigherTaxRate_2105"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EliminatedOnDisposalOfBusiness" xlink:label="loc_trib_EliminatedOnDisposalOfBusiness_2106"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EliminatedOnDisposalOfBusiness" xlink:label="loc_trib_EliminatedOnDisposalOfBusiness_2107"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EliminatedOnDisposalOfBusiness" xlink:label="loc_trib_EliminatedOnDisposalOfBusiness_2108"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EliminatedOnDisposalOfBusiness" xlink:label="loc_trib_EliminatedOnDisposalOfBusiness_2109"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EliminatedOnDisposalsOfBusiness" xlink:label="loc_trib_EliminatedOnDisposalsOfBusiness_2110"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EliminatedOnDisposalsOfBusiness" xlink:label="loc_trib_EliminatedOnDisposalsOfBusiness_2111"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EliminatedOnDisposalsOfBusiness" xlink:label="loc_trib_EliminatedOnDisposalsOfBusiness_2112"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EmployeeRelatedSocialInsurance" xlink:label="loc_trib_EmployeeRelatedSocialInsurance_2113"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EmployeeRelatedSocialInsurance" xlink:label="loc_trib_EmployeeRelatedSocialInsurance_2114"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EndUserCustomersMember" xlink:label="loc_trib_EndUserCustomersMember_2115"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EndUserCustomersMember" xlink:label="loc_trib_EndUserCustomersMember_2116"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EnhancedTphaByCmvMember" xlink:label="loc_trib_EnhancedTphaByCmvMember_2117"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_2118"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_2119"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_2120"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentAtDateOfIssue" xlink:label="loc_trib_EquityComponentAtDateOfIssue_2121"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentAtDateOfIssue" xlink:label="loc_trib_EquityComponentAtDateOfIssue_2122"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentAtDateOfIssue" xlink:label="loc_trib_EquityComponentAtDateOfIssue_2123"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentAtDateOfIssue" xlink:label="loc_trib_EquityComponentAtDateOfIssue_2124"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNote" xlink:label="loc_trib_EquityComponentOfConvertibleNote_2125"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNote" xlink:label="loc_trib_EquityComponentOfConvertibleNote_2126"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNote" xlink:label="loc_trib_EquityComponentOfConvertibleNote_2127"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNote" xlink:label="loc_trib_EquityComponentOfConvertibleNote_2128"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNoteAtDateOfIssue" xlink:label="loc_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_2129"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNoteAtDateOfIssue" xlink:label="loc_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_2130"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNoteAtDateOfIssue" xlink:label="loc_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_2131"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNoteMember" xlink:label="loc_trib_EquityComponentOfConvertibleNoteMember_2132"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNoteMember" xlink:label="loc_trib_EquityComponentOfConvertibleNoteMember_2133"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNoteMember" xlink:label="loc_trib_EquityComponentOfConvertibleNoteMember_2134"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EstimatedObligations" xlink:label="loc_trib_EstimatedObligations_2135"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EstimatedObligations" xlink:label="loc_trib_EstimatedObligations_2136"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EuropeIncludingIrelandMember" xlink:label="loc_trib_EuropeIncludingIrelandMember_2137"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EuropeIncludingIrelandMember" xlink:label="loc_trib_EuropeIncludingIrelandMember_2138"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EuropeIncludingIrelandMember" xlink:label="loc_trib_EuropeIncludingIrelandMember_2139"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EuroZoneCountriesMember" xlink:label="loc_trib_EuroZoneCountriesMember_2140"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EuroZoneCountriesMember" xlink:label="loc_trib_EuroZoneCountriesMember_2141"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EventsAfterReportingPeriodMember" xlink:label="loc_trib_EventsAfterReportingPeriodMember_2142"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EventsAfterReportingPeriodMember" xlink:label="loc_trib_EventsAfterReportingPeriodMember_2143"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExcessValueOfGoodwillInUseOverCarryingAmount" xlink:label="loc_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_2144"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExcessValueOfGoodwillInUseOverCarryingAmount" xlink:label="loc_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_2145"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExcessValueOfGoodwillInUseOverCarryingAmount" xlink:label="loc_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_2146"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteBondPutOption" xlink:label="loc_trib_ExchangeableNoteBondPutOption_2147"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteBondPutOption" xlink:label="loc_trib_ExchangeableNoteBondPutOption_2148"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteEquityConversionOption" xlink:label="loc_trib_ExchangeableNoteEquityConversionOption_2149"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteEquityConversionOption" xlink:label="loc_trib_ExchangeableNoteEquityConversionOption_2150"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteEquityConversionOption" xlink:label="loc_trib_ExchangeableNoteEquityConversionOption_2151"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteInterest" xlink:label="loc_trib_ExchangeableNoteInterest_2152"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteInterest" xlink:label="loc_trib_ExchangeableNoteInterest_2153"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteMember" xlink:label="loc_trib_ExchangeableNoteMember_2154"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteMember" xlink:label="loc_trib_ExchangeableNoteMember_2155"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowings" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowings_2156"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowings" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowings_2157"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowings" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowings_2158"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_2159"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_2160"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_2161"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_2162"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_2163"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsNonCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2164"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsNonCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2165"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsNonCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2166"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsNonCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2167"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsNonCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2168"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsNonCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2169"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsNonCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2170"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsNonCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2171"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsNonCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2172"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesDiscountRate" xlink:label="loc_trib_ExchangeableNotesDiscountRate_2173"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesDiscountRate" xlink:label="loc_trib_ExchangeableNotesDiscountRate_2174"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesDiscountRate" xlink:label="loc_trib_ExchangeableNotesDiscountRate_2175"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableSeniorNotesMember" xlink:label="loc_trib_ExchangeableSeniorNotesMember_2176"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableSeniorNotesMember" xlink:label="loc_trib_ExchangeableSeniorNotesMember_2177"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeRatePricePerAds" xlink:label="loc_trib_ExchangeRatePricePerAds_2178"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeRatePricePerAds" xlink:label="loc_trib_ExchangeRatePricePerAds_2179"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExercisableAbstract" xlink:label="loc_trib_ExercisableAbstract_2180"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExercisableAbstract" xlink:label="loc_trib_ExercisableAbstract_2181"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExerciseOfShareOptionsReceivable" xlink:label="loc_trib_ExerciseOfShareOptionsReceivable_2182"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExerciseOfShareOptionsReceivable" xlink:label="loc_trib_ExerciseOfShareOptionsReceivable_2183"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExercisePriceOfWarrantsOrRights" xlink:label="loc_trib_ExercisePriceOfWarrantsOrRights_2184"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExercisePriceOfWarrantsOrRights" xlink:label="loc_trib_ExercisePriceOfWarrantsOrRights_2185"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExercisePriceOfWarrantsOrRights" xlink:label="loc_trib_ExercisePriceOfWarrantsOrRights_2186"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExercisePricePerADS" xlink:label="loc_trib_ExercisePricePerADS_2187"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExercisePricePerADS" xlink:label="loc_trib_ExercisePricePerADS_2188"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExercisePricePerADS" xlink:label="loc_trib_ExercisePricePerADS_2189"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExpenseOfRestructuringCost" xlink:label="loc_trib_ExpenseOfRestructuringCost_2190"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExpenseOfRestructuringCost" xlink:label="loc_trib_ExpenseOfRestructuringCost_2191"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExpenseOfRestructuringCost" xlink:label="loc_trib_ExpenseOfRestructuringCost_2192"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExtinguishmentOfAmountOwed" xlink:label="loc_trib_ExtinguishmentOfAmountOwed_2193"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExtinguishmentOfAmountOwed" xlink:label="loc_trib_ExtinguishmentOfAmountOwed_2194"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExtinguishmentOfAmountOwed" xlink:label="loc_trib_ExtinguishmentOfAmountOwed_2195"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExtinguishmentOfDebtAmounts" xlink:label="loc_trib_ExtinguishmentOfDebtAmounts_2196"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExtinguishmentOfDebtAmounts" xlink:label="loc_trib_ExtinguishmentOfDebtAmounts_2197"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExtinguishmentOfDebtAmounts" xlink:label="loc_trib_ExtinguishmentOfDebtAmounts_2198"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueMember" xlink:label="loc_trib_FairValueMember_2199"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueMember" xlink:label="loc_trib_FairValueMember_2200"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_2201"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_2202"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_2203"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfDerivativeFinancialAsset" xlink:label="loc_trib_FairValueOfDerivativeFinancialAsset_2204"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfDerivativeFinancialAsset" xlink:label="loc_trib_FairValueOfDerivativeFinancialAsset_2205"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfDerivativeFinancialAsset" xlink:label="loc_trib_FairValueOfDerivativeFinancialAsset_2206"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfDerivativeFinancialLiability" xlink:label="loc_trib_FairValueOfDerivativeFinancialLiability_2207"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfDerivativeFinancialLiability" xlink:label="loc_trib_FairValueOfDerivativeFinancialLiability_2208"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfDerivativeFinancialLiability" xlink:label="loc_trib_FairValueOfDerivativeFinancialLiability_2209"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfFinancialAssetsLiabilities" xlink:label="loc_trib_FairValueOfFinancialAssetsLiabilities_2210"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfFinancialAssetsLiabilities" xlink:label="loc_trib_FairValueOfFinancialAssetsLiabilities_2211"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfFinancialAssetsLiabilities" xlink:label="loc_trib_FairValueOfFinancialAssetsLiabilities_2212"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfFinancialAssetsLiabilities" xlink:label="loc_trib_FairValueOfFinancialAssetsLiabilities_2213"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfSharesIssued" xlink:label="loc_trib_FairValueOfSharesIssued_2214"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfSharesIssued" xlink:label="loc_trib_FairValueOfSharesIssued_2215"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfSharesIssued" xlink:label="loc_trib_FairValueOfSharesIssued_2216"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets" xlink:label="loc_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_2217"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets" xlink:label="loc_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_2218"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets" xlink:label="loc_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_2219"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueRemeasurementForDerivativeFinancialBalances" xlink:label="loc_trib_FairValueRemeasurementForDerivativeFinancialBalances_2220"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueRemeasurementForDerivativeFinancialBalances" xlink:label="loc_trib_FairValueRemeasurementForDerivativeFinancialBalances_2221"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueRemeasurementForDerivativeFinancialBalances" xlink:label="loc_trib_FairValueRemeasurementForDerivativeFinancialBalances_2222"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueThroughProfitAndLoss" xlink:label="loc_trib_FairValueThroughProfitAndLoss_2223"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueThroughProfitAndLoss" xlink:label="loc_trib_FairValueThroughProfitAndLoss_2224"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueThroughProfitAndLoss" xlink:label="loc_trib_FairValueThroughProfitAndLoss_2225"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueThroughProfitAndLoss" xlink:label="loc_trib_FairValueThroughProfitAndLoss_2226"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FederalCorporationTaxRateMember" xlink:label="loc_trib_FederalCorporationTaxRateMember_2227"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FifthAmendmentToCreditAgreementMember" xlink:label="loc_trib_FifthAmendmentToCreditAgreementMember_2228"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FifthAmendmentToCreditAgreementMember" xlink:label="loc_trib_FifthAmendmentToCreditAgreementMember_2229"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceIncomeExpenseNet" xlink:label="loc_trib_FinanceIncomeExpenseNet_2230"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceIncomeExpenseNet" xlink:label="loc_trib_FinanceIncomeExpenseNet_2231"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceIncomeExpenseNet" xlink:label="loc_trib_FinanceIncomeExpenseNet_2232"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseLiabilitiesMember" xlink:label="loc_trib_FinanceLeaseLiabilitiesMember_2233"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseLiabilitiesMember" xlink:label="loc_trib_FinanceLeaseLiabilitiesMember_2234"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseLiabilitiesMember" xlink:label="loc_trib_FinanceLeaseLiabilitiesMember_2235"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseLiabilitiesTwoMember" xlink:label="loc_trib_FinanceLeaseLiabilitiesTwoMember_2236"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseLiabilitiesTwoMember" xlink:label="loc_trib_FinanceLeaseLiabilitiesTwoMember_2237"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseLiabilitiesTwoMember" xlink:label="loc_trib_FinanceLeaseLiabilitiesTwoMember_2238"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeasePayableMember" xlink:label="loc_trib_FinanceLeasePayableMember_2239"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseReceivableMember" xlink:label="loc_trib_FinanceLeaseReceivableMember_2240"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseReceivableMember" xlink:label="loc_trib_FinanceLeaseReceivableMember_2241"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseReceivableMember" xlink:label="loc_trib_FinanceLeaseReceivableMember_2242"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsAdditions" xlink:label="loc_trib_FinancialAssetsAdditions_2243"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsAdditions" xlink:label="loc_trib_FinancialAssetsAdditions_2244"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsAdditions" xlink:label="loc_trib_FinancialAssetsAdditions_2245"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsLeaseReceivables" xlink:label="loc_trib_FinancialAssetsLeaseReceivables_2246"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsLeaseReceivables" xlink:label="loc_trib_FinancialAssetsLeaseReceivables_2247"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsLeaseReceivables" xlink:label="loc_trib_FinancialAssetsLeaseReceivables_2248"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsLeaseReceivables" xlink:label="loc_trib_FinancialAssetsLeaseReceivables_2249"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsLeaseReceivables" xlink:label="loc_trib_FinancialAssetsLeaseReceivables_2250"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsLeaseReceivables" xlink:label="loc_trib_FinancialAssetsLeaseReceivables_2251"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsPolicyTextBlock" xlink:label="loc_trib_FinancialAssetsPolicyTextBlock_2252"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsPolicyTextBlock" xlink:label="loc_trib_FinancialAssetsPolicyTextBlock_2253"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsPolicyTextBlock" xlink:label="loc_trib_FinancialAssetsPolicyTextBlock_2254"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsWriteOff" xlink:label="loc_trib_FinancialAssetsWriteOff_2255"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsWriteOff" xlink:label="loc_trib_FinancialAssetsWriteOff_2256"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAssetsWriteOff" xlink:label="loc_trib_FinancialAssetsWriteOff_2257"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAtFairValueThroughProfitOrLossAbstract" xlink:label="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_2258"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAtFairValueThroughProfitOrLossAbstract" xlink:label="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_2259"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialIncomeAndExpensesAbstract" xlink:label="loc_trib_FinancialIncomeAndExpensesAbstract_2260"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialIncomeAndExpensesAbstract" xlink:label="loc_trib_FinancialIncomeAndExpensesAbstract_2261"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialIncomeAndExpensesLineItems" xlink:label="loc_trib_FinancialIncomeAndExpensesLineItems_2262"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialIncomeAndExpensesLineItems" xlink:label="loc_trib_FinancialIncomeAndExpensesLineItems_2263"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialIncomeAndExpensesTable" xlink:label="loc_trib_FinancialIncomeAndExpensesTable_2264"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialIncomeAndExpensesTable" xlink:label="loc_trib_FinancialIncomeAndExpensesTable_2265"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue" xlink:label="loc_trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue_2266"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue" xlink:label="loc_trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue_2267"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue" xlink:label="loc_trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue_2268"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingExpensesAbstract" xlink:label="loc_trib_FinancingExpensesAbstract_2269"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingExpensesAbstract" xlink:label="loc_trib_FinancingExpensesAbstract_2270"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingExpensesOther" xlink:label="loc_trib_FinancingExpensesOther_2271"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingExpensesOther" xlink:label="loc_trib_FinancingExpensesOther_2272"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingExpensesOther" xlink:label="loc_trib_FinancingExpensesOther_2273"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingExpensesOther" xlink:label="loc_trib_FinancingExpensesOther_2274"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingIncomeAbstract" xlink:label="loc_trib_FinancingIncomeAbstract_2275"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingIncomeAbstract" xlink:label="loc_trib_FinancingIncomeAbstract_2276"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingIncomeBySegment" xlink:label="loc_trib_FinancingIncomeBySegment_2277"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingIncomeBySegment" xlink:label="loc_trib_FinancingIncomeBySegment_2278"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingIncomeBySegment" xlink:label="loc_trib_FinancingIncomeBySegment_2279"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsAbMember" xlink:label="loc_trib_FiomiDiagnosticsAbMember_2280"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsAbMember" xlink:label="loc_trib_FiomiDiagnosticsAbMember_2281"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsHoldingAbMember" xlink:label="loc_trib_FiomiDiagnosticsHoldingAbMember_2282"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsHoldingAbMember" xlink:label="loc_trib_FiomiDiagnosticsHoldingAbMember_2283"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsMember" xlink:label="loc_trib_FiomiDiagnosticsMember_2284"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsMember" xlink:label="loc_trib_FiomiDiagnosticsMember_2285"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsMember" xlink:label="loc_trib_FiomiDiagnosticsMember_2286"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiMember" xlink:label="loc_trib_FiomiMember_2287"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember_2288"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember_2289"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalCguTradeNameMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_2290"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalCguTradeNameMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_2291"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalIncMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalIncMember_2292"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalIncMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalIncMember_2293"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FixedRateFinancialLiabilitiesBorrowings" xlink:label="loc_trib_FixedRateFinancialLiabilitiesBorrowings_2294"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FixedRateFinancialLiabilitiesBorrowings" xlink:label="loc_trib_FixedRateFinancialLiabilitiesBorrowings_2295"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FixedRateFinancialLiabilitiesBorrowings" xlink:label="loc_trib_FixedRateFinancialLiabilitiesBorrowings_2296"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FixedRateInstruments" xlink:label="loc_trib_FixedRateInstruments_2297"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FixedRateInstruments" xlink:label="loc_trib_FixedRateInstruments_2298"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FixedRateInstruments" xlink:label="loc_trib_FixedRateInstruments_2299"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FixedRateInstruments" xlink:label="loc_trib_FixedRateInstruments_2300"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FixedRateInstrumentsAbstract" xlink:label="loc_trib_FixedRateInstrumentsAbstract_2301"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FixedRateInstrumentsAbstract" xlink:label="loc_trib_FixedRateInstrumentsAbstract_2302"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ForeignExchangeDifferencesMember" xlink:label="loc_trib_ForeignExchangeDifferencesMember_2303"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ForgivenessOfBorrowings" xlink:label="loc_trib_ForgivenessOfBorrowings_2304"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ForgivenessOfBorrowings" xlink:label="loc_trib_ForgivenessOfBorrowings_2305"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ForgivenessOfBorrowings" xlink:label="loc_trib_ForgivenessOfBorrowings_2306"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FourthAmendmentToCreditAgreementMember" xlink:label="loc_trib_FourthAmendmentToCreditAgreementMember_2307"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FourthAmendmentToCreditAgreementMember" xlink:label="loc_trib_FourthAmendmentToCreditAgreementMember_2308"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FutureFinanceChargeOnFinanceLeases" xlink:label="loc_trib_FutureFinanceChargeOnFinanceLeases_2309"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FutureFinanceChargeOnFinanceLeases" xlink:label="loc_trib_FutureFinanceChargeOnFinanceLeases_2310"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FutureFinanceChargeOnFinanceLeases" xlink:label="loc_trib_FutureFinanceChargeOnFinanceLeases_2311"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_G6PDHTestMember" xlink:label="loc_trib_G6PDHTestMember_2312"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_G6PDHTestMember" xlink:label="loc_trib_G6PDHTestMember_2313"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_G6PDHTestMember" xlink:label="loc_trib_G6PDHTestMember_2314"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GenesysOrResolutionColumnEnhancementMember" xlink:label="loc_trib_GenesysOrResolutionColumnEnhancementMember_2315"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GoodwillWriteOff" xlink:label="loc_trib_GoodwillWriteOff_2316"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GoodwillWriteOff" xlink:label="loc_trib_GoodwillWriteOff_2317"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GovernmentGrantReceived" xlink:label="loc_trib_GovernmentGrantReceived_2318"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GovernmentGrantReceived" xlink:label="loc_trib_GovernmentGrantReceived_2319"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GovernmentLoansForgivenAmount" xlink:label="loc_trib_GovernmentLoansForgivenAmount_2320"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GovernmentLoansForgivenAmount" xlink:label="loc_trib_GovernmentLoansForgivenAmount_2321"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GovernmentSupportsCovid19" xlink:label="loc_trib_GovernmentSupportsCovid19_2322"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GovernmentSupportsCovid19" xlink:label="loc_trib_GovernmentSupportsCovid19_2323"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrantContingenciesMaximumAmountPayable" xlink:label="loc_trib_GrantContingenciesMaximumAmountPayable_2324"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrantContingenciesMaximumAmountPayable" xlink:label="loc_trib_GrantContingenciesMaximumAmountPayable_2325"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrantReceivable" xlink:label="loc_trib_GrantReceivable_2326"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrantReceivable" xlink:label="loc_trib_GrantReceivable_2327"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrantReceivable" xlink:label="loc_trib_GrantReceivable_2328"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GreaterThanFiveYearsMember" xlink:label="loc_trib_GreaterThanFiveYearsMember_2329"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GreaterThanFiveYearsMember" xlink:label="loc_trib_GreaterThanFiveYearsMember_2330"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GreaterThanFiveYearsMember" xlink:label="loc_trib_GreaterThanFiveYearsMember_2331"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GreaterThanFourMonthsMember" xlink:label="loc_trib_GreaterThanFourMonthsMember_2332"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GreaterThanFourMonthsMember" xlink:label="loc_trib_GreaterThanFourMonthsMember_2333"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GreaterThanFourMonthsMember" xlink:label="loc_trib_GreaterThanFourMonthsMember_2334"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrossIncreaseInterestIncome" xlink:label="loc_trib_GrossIncreaseInterestIncome_2335"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrossIncreaseInterestIncome" xlink:label="loc_trib_GrossIncreaseInterestIncome_2336"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrossInvestmentInFinanceLease" xlink:label="loc_trib_GrossInvestmentInFinanceLease_2337"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrossInvestmentInFinanceLease" xlink:label="loc_trib_GrossInvestmentInFinanceLease_2338"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrossInvestmentInFinanceLease" xlink:label="loc_trib_GrossInvestmentInFinanceLease_2339"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GroupLeaseExpense" xlink:label="loc_trib_GroupLeaseExpense_2340"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GroupLeaseExpense" xlink:label="loc_trib_GroupLeaseExpense_2341"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_HivIncidenceAssayMember" xlink:label="loc_trib_HivIncidenceAssayMember_2342"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_HivOneByTwoRapidTestMember" xlink:label="loc_trib_HivOneByTwoRapidTestMember_2343"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_HivOneByTwoRapidTestMember" xlink:label="loc_trib_HivOneByTwoRapidTestMember_2344"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_HivOneByTwoRapidTestMember" xlink:label="loc_trib_HivOneByTwoRapidTestMember_2345"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_HivScreeningAfricaMember" xlink:label="loc_trib_HivScreeningAfricaMember_2346"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IgmCaptiaMember" xlink:label="loc_trib_IgmCaptiaMember_2347"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticCGUMember" xlink:label="loc_trib_ImmcoDiagnosticCGUMember_2348"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticCGUMember" xlink:label="loc_trib_ImmcoDiagnosticCGUMember_2349"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticsIncMember" xlink:label="loc_trib_ImmcoDiagnosticsIncMember_2350"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticsIncMember" xlink:label="loc_trib_ImmcoDiagnosticsIncMember_2351"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticsIncMember" xlink:label="loc_trib_ImmcoDiagnosticsIncMember_2352"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticsMember" xlink:label="loc_trib_ImmcoDiagnosticsMember_2353"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticTradeNameMember" xlink:label="loc_trib_ImmcoDiagnosticTradeNameMember_2354"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentChargePropertyPlantEquipment" xlink:label="loc_trib_ImpairmentChargePropertyPlantEquipment_2355"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentChargePropertyPlantEquipment" xlink:label="loc_trib_ImpairmentChargePropertyPlantEquipment_2356"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentChargesMember" xlink:label="loc_trib_ImpairmentChargesMember_2357"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentLossForInvestment" xlink:label="loc_trib_ImpairmentLossForInvestment_2358"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentLossForInvestment" xlink:label="loc_trib_ImpairmentLossForInvestment_2359"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentOfPrepayments" xlink:label="loc_trib_ImpairmentOfPrepayments_2360"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentOfPrepayments" xlink:label="loc_trib_ImpairmentOfPrepayments_2361"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentOfPrepayments" xlink:label="loc_trib_ImpairmentOfPrepayments_2362"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentOfPrepayments" xlink:label="loc_trib_ImpairmentOfPrepayments_2363"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeFromPaycheckProtectionProgramLoans" xlink:label="loc_trib_IncomeFromPaycheckProtectionProgramLoans_2364"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeFromPaycheckProtectionProgramLoans" xlink:label="loc_trib_IncomeFromPaycheckProtectionProgramLoans_2365"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeFromPaycheckProtectionProgramLoans" xlink:label="loc_trib_IncomeFromPaycheckProtectionProgramLoans_2366"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeLoss" xlink:label="loc_trib_IncomeLoss_2367"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeLoss" xlink:label="loc_trib_IncomeLoss_2368"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeLoss" xlink:label="loc_trib_IncomeLoss_2369"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeLoss" xlink:label="loc_trib_IncomeLoss_2370"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxAssetsCurrentAndDeferred" xlink:label="loc_trib_IncomeTaxAssetsCurrentAndDeferred_2371"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxAssetsCurrentAndDeferred" xlink:label="loc_trib_IncomeTaxAssetsCurrentAndDeferred_2372"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxExpense" xlink:label="loc_trib_IncomeTaxExpense_2373"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxExpense" xlink:label="loc_trib_IncomeTaxExpense_2374"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxExpense" xlink:label="loc_trib_IncomeTaxExpense_2375"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract" xlink:label="loc_trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract_2376"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract" xlink:label="loc_trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract_2377"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxExpenseBenefits" xlink:label="loc_trib_IncomeTaxExpenseBenefits_2378"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxExpenseBenefits" xlink:label="loc_trib_IncomeTaxExpenseBenefits_2379"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxExpenseBenefits" xlink:label="loc_trib_IncomeTaxExpenseBenefits_2380"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxImpactOfImpairmentLoss" xlink:label="loc_trib_IncomeTaxImpactOfImpairmentLoss_2381"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxImpactOfImpairmentLoss" xlink:label="loc_trib_IncomeTaxImpactOfImpairmentLoss_2382"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxLiabilitiesCurrentAndDeferred" xlink:label="loc_trib_IncomeTaxLiabilitiesCurrentAndDeferred_2383"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxLiabilitiesCurrentAndDeferred" xlink:label="loc_trib_IncomeTaxLiabilitiesCurrentAndDeferred_2384"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_2385"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_2386"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_2387"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_2388"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_2389"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_2390"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_2391"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_2392"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_2393"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_2394"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_2395"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_2396"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_2397"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_2398"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_2399"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_2400"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_2401"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_2402"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreasedecreasethroughequityComponentOfConvertibleNote" xlink:label="loc_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_2403"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreasedecreasethroughequityComponentOfConvertibleNote" xlink:label="loc_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_2404"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreasedecreasethroughequityComponentOfConvertibleNote" xlink:label="loc_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_2405"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_2406"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_2407"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_2408"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised" xlink:label="loc_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_2409"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised" xlink:label="loc_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_2410"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised" xlink:label="loc_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_2411"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised" xlink:label="loc_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_2412"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreasedInUnrecognisedDeferredTaxAssets" xlink:label="loc_trib_IncreasedInUnrecognisedDeferredTaxAssets_2413"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreasedInUnrecognisedDeferredTaxAssets" xlink:label="loc_trib_IncreasedInUnrecognisedDeferredTaxAssets_2414"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseInAnnualRent" xlink:label="loc_trib_IncreaseInAnnualRent_2415"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseInAnnualRent" xlink:label="loc_trib_IncreaseInAnnualRent_2416"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseInAnnualRent" xlink:label="loc_trib_IncreaseInAnnualRent_2417"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseInSettlementAmountDueToDepreciation" xlink:label="loc_trib_IncreaseInSettlementAmountDueToDepreciation_2418"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseInSettlementAmountDueToDepreciation" xlink:label="loc_trib_IncreaseInSettlementAmountDueToDepreciation_2419"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseTermLoan" xlink:label="loc_trib_IncreaseTermLoan_2420"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseTermLoan" xlink:label="loc_trib_IncreaseTermLoan_2421"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseTermLoan" xlink:label="loc_trib_IncreaseTermLoan_2422"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InitialExercisePriceOfWarrantsOrRights" xlink:label="loc_trib_InitialExercisePriceOfWarrantsOrRights_2423"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InitialExercisePriceOfWarrantsOrRights" xlink:label="loc_trib_InitialExercisePriceOfWarrantsOrRights_2424"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InitialExercisePriceOfWarrantsOrRights" xlink:label="loc_trib_InitialExercisePriceOfWarrantsOrRights_2425"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InstalmentsAxis" xlink:label="loc_trib_InstalmentsAxis_2426"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InstalmentsDomain" xlink:label="loc_trib_InstalmentsDomain_2427"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InstrumentsMember" xlink:label="loc_trib_InstrumentsMember_2428"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InstrumentsMember" xlink:label="loc_trib_InstrumentsMember_2429"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IntangibleAssetsUnderDevelopmentImpairmentCharge" xlink:label="loc_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_2430"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IntangibleAssetsUnderDevelopmentImpairmentCharge" xlink:label="loc_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_2431"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IntangibleAssetsUnderDevelopmentImpairmentCharge" xlink:label="loc_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_2432"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IntangibleAssetsUnderDevelopmentWrittenDown" xlink:label="loc_trib_IntangibleAssetsUnderDevelopmentWrittenDown_2433"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IntangibleAssetsUnderDevelopmentWrittenDown" xlink:label="loc_trib_IntangibleAssetsUnderDevelopmentWrittenDown_2434"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IntangibleAssetsUnderDevelopmentWrittenDown" xlink:label="loc_trib_IntangibleAssetsUnderDevelopmentWrittenDown_2435"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities" xlink:label="loc_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_2436"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities" xlink:label="loc_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_2437"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities" xlink:label="loc_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_2438"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities" xlink:label="loc_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_2439"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpenseOnLeaseLiabilities1" xlink:label="loc_trib_InterestExpenseOnLeaseLiabilities1_2440"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpenseOnLeaseLiabilities1" xlink:label="loc_trib_InterestExpenseOnLeaseLiabilities1_2441"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpenseOnLeaseLiabilities1" xlink:label="loc_trib_InterestExpenseOnLeaseLiabilities1_2442"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpenseOnTaxAuditSettlement" xlink:label="loc_trib_InterestExpenseOnTaxAuditSettlement_2443"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpenseOnTaxAuditSettlement" xlink:label="loc_trib_InterestExpenseOnTaxAuditSettlement_2444"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpenseOnTaxAuditSettlement" xlink:label="loc_trib_InterestExpenseOnTaxAuditSettlement_2445"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpenses" xlink:label="loc_trib_InterestExpenses_2446"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpenses" xlink:label="loc_trib_InterestExpenses_2447"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpenses" xlink:label="loc_trib_InterestExpenses_2448"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpensesAbstract" xlink:label="loc_trib_InterestExpensesAbstract_2449"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpensesAbstract" xlink:label="loc_trib_InterestExpensesAbstract_2450"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestIncomeAbstract" xlink:label="loc_trib_InterestIncomeAbstract_2451"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestIncomeAbstract" xlink:label="loc_trib_InterestIncomeAbstract_2452"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestIncomeCredit" xlink:label="loc_trib_InterestIncomeCredit_2453"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestIncomeCredit" xlink:label="loc_trib_InterestIncomeCredit_2454"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestIncomeCredit" xlink:label="loc_trib_InterestIncomeCredit_2455"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestIncomeEarned" xlink:label="loc_trib_InterestIncomeEarned_2456"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestIncomeEarned" xlink:label="loc_trib_InterestIncomeEarned_2457"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestIncomeEarned" xlink:label="loc_trib_InterestIncomeEarned_2458"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestOnDeferredConsiderationAndLicenceFee" xlink:label="loc_trib_InterestOnDeferredConsiderationAndLicenceFee_2459"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestOnDeferredConsiderationAndLicenceFee" xlink:label="loc_trib_InterestOnDeferredConsiderationAndLicenceFee_2460"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestOnDeferredConsiderationAndLicenceFee" xlink:label="loc_trib_InterestOnDeferredConsiderationAndLicenceFee_2461"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnConvertibleNote" xlink:label="loc_trib_InterestPaidOnConvertibleNote_2462"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnConvertibleNote" xlink:label="loc_trib_InterestPaidOnConvertibleNote_2463"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnConvertibleNote" xlink:label="loc_trib_InterestPaidOnConvertibleNote_2464"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnConvertibleNote" xlink:label="loc_trib_InterestPaidOnConvertibleNote_2465"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnConvertibleNote" xlink:label="loc_trib_InterestPaidOnConvertibleNote_2466"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnSeniorSecuredTermLoan" xlink:label="loc_trib_InterestPaidOnSeniorSecuredTermLoan_2467"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnSeniorSecuredTermLoan" xlink:label="loc_trib_InterestPaidOnSeniorSecuredTermLoan_2468"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnSeniorSecuredTermLoan" xlink:label="loc_trib_InterestPaidOnSeniorSecuredTermLoan_2469"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnSeniorSecuredTermLoan" xlink:label="loc_trib_InterestPaidOnSeniorSecuredTermLoan_2470"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnSeniorSecuredTermLoan" xlink:label="loc_trib_InterestPaidOnSeniorSecuredTermLoan_2471"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterSegmentInterestExpense" xlink:label="loc_trib_InterSegmentInterestExpense_2472"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterSegmentInterestExpense" xlink:label="loc_trib_InterSegmentInterestExpense_2473"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterSegmentInterestIncome" xlink:label="loc_trib_InterSegmentInterestIncome_2474"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterSegmentInterestIncome" xlink:label="loc_trib_InterSegmentInterestIncome_2475"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryMember" xlink:label="loc_trib_InventoryMember_2476"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryMember" xlink:label="loc_trib_InventoryMember_2477"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryMember" xlink:label="loc_trib_InventoryMember_2478"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryRelatedCostsMember" xlink:label="loc_trib_InventoryRelatedCostsMember_2479"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryRelatedCostsMember" xlink:label="loc_trib_InventoryRelatedCostsMember_2480"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryRelatedCostsMember" xlink:label="loc_trib_InventoryRelatedCostsMember_2481"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryWrittenDown" xlink:label="loc_trib_InventoryWrittenDown_2482"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryWrittenDown" xlink:label="loc_trib_InventoryWrittenDown_2483"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryWrittenDown" xlink:label="loc_trib_InventoryWrittenDown_2484"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InvestmentInUnsecuredJuniorConvertibleNote" xlink:label="loc_trib_InvestmentInUnsecuredJuniorConvertibleNote_2485"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InvestmentInUnsecuredJuniorConvertibleNote" xlink:label="loc_trib_InvestmentInUnsecuredJuniorConvertibleNote_2486"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InvestmentInUnsecuredJuniorConvertibleNote" xlink:label="loc_trib_InvestmentInUnsecuredJuniorConvertibleNote_2487"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnConversionOfConvertibleNotes" xlink:label="loc_trib_IssuableOnConversionOfConvertibleNotes_2488"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnConversionOfConvertibleNotes" xlink:label="loc_trib_IssuableOnConversionOfConvertibleNotes_2489"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnConversionOfConvertibleNotes" xlink:label="loc_trib_IssuableOnConversionOfConvertibleNotes_2490"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnConversionOfExchangeableNotes" xlink:label="loc_trib_IssuableOnConversionOfExchangeableNotes_2491"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnConversionOfExchangeableNotes" xlink:label="loc_trib_IssuableOnConversionOfExchangeableNotes_2492"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnConversionOfExchangeableNotes" xlink:label="loc_trib_IssuableOnConversionOfExchangeableNotes_2493"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnExerciseOfOptions" xlink:label="loc_trib_IssuableOnExerciseOfOptions_2494"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnExerciseOfOptions" xlink:label="loc_trib_IssuableOnExerciseOfOptions_2495"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnExerciseOfOptions" xlink:label="loc_trib_IssuableOnExerciseOfOptions_2496"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnExerciseOfOptionsAndWarrants" xlink:label="loc_trib_IssuableOnExerciseOfOptionsAndWarrants_2497"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnExerciseOfOptionsAndWarrants" xlink:label="loc_trib_IssuableOnExerciseOfOptionsAndWarrants_2498"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuedAmericanDepositoryShares" xlink:label="loc_trib_IssuedAmericanDepositoryShares_2499"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuedAmericanDepositoryShares" xlink:label="loc_trib_IssuedAmericanDepositoryShares_2500"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuedAmericanDepositoryShares" xlink:label="loc_trib_IssuedAmericanDepositoryShares_2501"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuedForNoncashConsideration" xlink:label="loc_trib_IssuedForNoncashConsideration_2502"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuedForNoncashConsideration" xlink:label="loc_trib_IssuedForNoncashConsideration_2503"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuedForNoncashConsideration" xlink:label="loc_trib_IssuedForNoncashConsideration_2504"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuedForNoncashConsideration" xlink:label="loc_trib_IssuedForNoncashConsideration_2505"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuenceOfExchangeableNote" xlink:label="loc_trib_IssuenceOfExchangeableNote_2506"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuenceOfExchangeableNote" xlink:label="loc_trib_IssuenceOfExchangeableNote_2507"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ITAndOfficeEquipmentMember" xlink:label="loc_trib_ITAndOfficeEquipmentMember_2508"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ITAndOfficeEquipmentMember" xlink:label="loc_trib_ITAndOfficeEquipmentMember_2509"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_JrjMember" xlink:label="loc_trib_JrjMember_2510"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_JrjMember" xlink:label="loc_trib_JrjMember_2511"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_JrjMember" xlink:label="loc_trib_JrjMember_2512"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KansasRightOfUseAssetMember" xlink:label="loc_trib_KansasRightOfUseAssetMember_2513"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KansasRightOfUseAssetMember" xlink:label="loc_trib_KansasRightOfUseAssetMember_2514"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KansasRightOfUseAssetMember" xlink:label="loc_trib_KansasRightOfUseAssetMember_2515"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus" xlink:label="loc_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_2516"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus" xlink:label="loc_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_2517"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus" xlink:label="loc_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_2518"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes" xlink:label="loc_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_2519"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes" xlink:label="loc_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_2520"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes" xlink:label="loc_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_2521"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KonamiteLimitedMember" xlink:label="loc_trib_KonamiteLimitedMember_2522"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KonamiteLimitedMember" xlink:label="loc_trib_KonamiteLimitedMember_2523"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaboratoryEquipmentMember" xlink:label="loc_trib_LaboratoryEquipmentMember_2524"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaboratoryServicesMember" xlink:label="loc_trib_LaboratoryServicesMember_2525"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaboratoryServicesMember" xlink:label="loc_trib_LaboratoryServicesMember_2526"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaboratoryServicesMember" xlink:label="loc_trib_LaboratoryServicesMember_2527"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember" xlink:label="loc_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_2528"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember" xlink:label="loc_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_2529"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember" xlink:label="loc_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_2530"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember" xlink:label="loc_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_2531"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember" xlink:label="loc_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_2532"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember" xlink:label="loc_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_2533"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseCosts" xlink:label="loc_trib_LeaseCosts_2534"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseCosts" xlink:label="loc_trib_LeaseCosts_2535"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed_2536"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed_2537"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed_2538"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_2539"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_2540"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_2541"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_2542"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_2543"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_2544"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_2545"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_2546"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_2547"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnRightOfUseAssets" xlink:label="loc_trib_LeasePayableOnRightOfUseAssets_2548"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnRightOfUseAssets" xlink:label="loc_trib_LeasePayableOnRightOfUseAssets_2549"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnRightOfUseAssetsMember" xlink:label="loc_trib_LeasePayableOnRightOfUseAssetsMember_2550"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnRightOfUseAssetsMember" xlink:label="loc_trib_LeasePayableOnRightOfUseAssetsMember_2551"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnSaleAndLeasebackTransactions" xlink:label="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_2552"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnSaleAndLeasebackTransactions" xlink:label="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_2553"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnSaleAndLeasebackTransactions" xlink:label="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_2554"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnSaleLeasebackTransactionsMember" xlink:label="loc_trib_LeasePayableOnSaleLeasebackTransactionsMember_2555"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnSaleLeasebackTransactionsMember" xlink:label="loc_trib_LeasePayableOnSaleLeasebackTransactionsMember_2556"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseTerm" xlink:label="loc_trib_LeaseTerm_2557"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseTerm" xlink:label="loc_trib_LeaseTerm_2558"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LenderMember" xlink:label="loc_trib_LenderMember_2559"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LenderMember" xlink:label="loc_trib_LenderMember_2560"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LiabilitiesAssumedAsOfAcquisitionDateAbstract" xlink:label="loc_trib_LiabilitiesAssumedAsOfAcquisitionDateAbstract_2561"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LiabilitiesAssumedAsOfAcquisitionDateAbstract" xlink:label="loc_trib_LiabilitiesAssumedAsOfAcquisitionDateAbstract_2562"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LiabilitiesAtAmortisedCostAbstract" xlink:label="loc_trib_LiabilitiesAtAmortisedCostAbstract_2563"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LiabilitiesAtAmortisedCostAbstract" xlink:label="loc_trib_LiabilitiesAtAmortisedCostAbstract_2564"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicenceFee" xlink:label="loc_trib_LicenceFee_2565"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicenceFee" xlink:label="loc_trib_LicenceFee_2566"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicenceFee" xlink:label="loc_trib_LicenceFee_2567"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicenceFeePayments" xlink:label="loc_trib_LicenceFeePayments_2568"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicenceFeePayments" xlink:label="loc_trib_LicenceFeePayments_2569"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicenceFeePayments" xlink:label="loc_trib_LicenceFeePayments_2570"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicenceFeePayments" xlink:label="loc_trib_LicenceFeePayments_2571"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicenceFeePayments" xlink:label="loc_trib_LicenceFeePayments_2572"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicencePaymentsMember" xlink:label="loc_trib_LicencePaymentsMember_2573"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicencePaymentsMember" xlink:label="loc_trib_LicencePaymentsMember_2574"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LineImmunoassayPanelsMember" xlink:label="loc_trib_LineImmunoassayPanelsMember_2575"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanIncome" xlink:label="loc_trib_LoanIncome_2576"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanIncome" xlink:label="loc_trib_LoanIncome_2577"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanOriginationCosts" xlink:label="loc_trib_LoanOriginationCosts_2578"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanOriginationCosts" xlink:label="loc_trib_LoanOriginationCosts_2579"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanOriginationCosts" xlink:label="loc_trib_LoanOriginationCosts_2580"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanOriginationCosts" xlink:label="loc_trib_LoanOriginationCosts_2581"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanOriginationCosts" xlink:label="loc_trib_LoanOriginationCosts_2582"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanOriginationCosts" xlink:label="loc_trib_LoanOriginationCosts_2583"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanOriginationCosts" xlink:label="loc_trib_LoanOriginationCosts_2584"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoansAndReceivablesAbstract" xlink:label="loc_trib_LoansAndReceivablesAbstract_2585"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoansAndReceivablesAbstract" xlink:label="loc_trib_LoansAndReceivablesAbstract_2586"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongLivedAsstesBySegment" xlink:label="loc_trib_LongLivedAsstesBySegment_2587"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongLivedAsstesBySegment" xlink:label="loc_trib_LongLivedAsstesBySegment_2588"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongLivedAsstesBySegment" xlink:label="loc_trib_LongLivedAsstesBySegment_2589"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongTermGrowthRate" xlink:label="loc_trib_LongTermGrowthRate_2590"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongTermGrowthRate" xlink:label="loc_trib_LongTermGrowthRate_2591"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongTermGrowthRate" xlink:label="loc_trib_LongTermGrowthRate_2592"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongTermGrowthRate" xlink:label="loc_trib_LongTermGrowthRate_2593"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongTermLeaseLiabilitiesMember" xlink:label="loc_trib_LongTermLeaseLiabilitiesMember_2594"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_LossOnDiscontinuedOperationsAbstract_2595"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_LossOnDiscontinuedOperationsAbstract_2596"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDiscontinuedOperationsAbstract" xlink:label="loc_trib_LossOnDiscontinuedOperationsAbstract_2597"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOfExchangeableNotes" xlink:label="loc_trib_LossOnDisposalOfExchangeableNotes_2598"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOfExchangeableNotes" xlink:label="loc_trib_LossOnDisposalOfExchangeableNotes_2599"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOfExchangeableNotes" xlink:label="loc_trib_LossOnDisposalOfExchangeableNotes_2600"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOfExchangeableNotes" xlink:label="loc_trib_LossOnDisposalOfExchangeableNotes_2601"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOnBorrowings" xlink:label="loc_trib_LossOnDisposalOnBorrowings_2602"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOnBorrowings" xlink:label="loc_trib_LossOnDisposalOnBorrowings_2603"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOnBorrowings" xlink:label="loc_trib_LossOnDisposalOnBorrowings_2604"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MalariaPointOfCareTestMember" xlink:label="loc_trib_MalariaPointOfCareTestMember_2605"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ManufacturingAndQualityMember" xlink:label="loc_trib_ManufacturingAndQualityMember_2606"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ManufacturingAndQualityMember" xlink:label="loc_trib_ManufacturingAndQualityMember_2607"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MardxDiagnosticIncMember" xlink:label="loc_trib_MardxDiagnosticIncMember_2608"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MardxDiagnosticsIncMember" xlink:label="loc_trib_MardxDiagnosticsIncMember_2609"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MardxDiagnosticsIncMember" xlink:label="loc_trib_MardxDiagnosticsIncMember_2610"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MatrixProjectMember" xlink:label="loc_trib_MatrixProjectMember_2611"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MaturityDateForLease" xlink:label="loc_trib_MaturityDateForLease_2612"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MaturityDateForLease" xlink:label="loc_trib_MaturityDateForLease_2613"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MaturityDateForLease" xlink:label="loc_trib_MaturityDateForLease_2614"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MaturityDateOfExchangeableSeniorNotes" xlink:label="loc_trib_MaturityDateOfExchangeableSeniorNotes_2615"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MaturityDateOfExchangeableSeniorNotes" xlink:label="loc_trib_MaturityDateOfExchangeableSeniorNotes_2616"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares" xlink:label="loc_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_2617"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares" xlink:label="loc_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_2618"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares" xlink:label="loc_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_2619"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MeasurementPeriodAdjustmentMember" xlink:label="loc_trib_MeasurementPeriodAdjustmentMember_2620"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MeasurementPeriodAdjustmentMember" xlink:label="loc_trib_MeasurementPeriodAdjustmentMember_2621"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicDiagnosticsLimitedMember_2622"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicDiagnosticsLimitedMember_2623"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicDiagnosticsLimitedMember_2624"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_2625"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_2626"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_2627"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MicoLtdMember" xlink:label="loc_trib_MicoLtdMember_2628"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MicoLtdMember" xlink:label="loc_trib_MicoLtdMember_2629"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MicoLtdMember" xlink:label="loc_trib_MicoLtdMember_2630"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MicropillarTechnologyMember" xlink:label="loc_trib_MicropillarTechnologyMember_2631"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MidTierHaemoglobinsInstrumentMember" xlink:label="loc_trib_MidTierHaemoglobinsInstrumentMember_2632"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MidTierHaemoglobinsInstrumentMember" xlink:label="loc_trib_MidTierHaemoglobinsInstrumentMember_2633"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayable" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayable_2634"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayable" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayable_2635"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayable" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayable_2636"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_2637"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_2638"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_2639"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_2640"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_2641"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_2642"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_2643"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_2644"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2645"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2646"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2647"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2648"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2649"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2650"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumLiquidityCovenant" xlink:label="loc_trib_MinimumLiquidityCovenant_2651"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumLiquidityCovenant" xlink:label="loc_trib_MinimumLiquidityCovenant_2652"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumLiquidityCovenant" xlink:label="loc_trib_MinimumLiquidityCovenant_2653"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MoreThanOneYearMember" xlink:label="loc_trib_MoreThanOneYearMember_2654"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MoreThanOneYearMember" xlink:label="loc_trib_MoreThanOneYearMember_2655"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MovementInInterestAccrual" xlink:label="loc_trib_MovementInInterestAccrual_2656"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MovementInInterestAccrual" xlink:label="loc_trib_MovementInInterestAccrual_2657"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MovementInInterestAccrual" xlink:label="loc_trib_MovementInInterestAccrual_2658"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MrOCaoimhAndDrWalshMember" xlink:label="loc_trib_MrOCaoimhAndDrWalshMember_2659"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MrOCaoimhAndDrWalshMember" xlink:label="loc_trib_MrOCaoimhAndDrWalshMember_2660"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MrOCaoimhAndDrWalshMember" xlink:label="loc_trib_MrOCaoimhAndDrWalshMember_2661"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MrOCaoimhMember" xlink:label="loc_trib_MrOCaoimhMember_2662"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MrOCaoimhMember" xlink:label="loc_trib_MrOCaoimhMember_2663"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MrOCaoimhMember" xlink:label="loc_trib_MrOCaoimhMember_2664"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NativeDesignLimitedMember" xlink:label="loc_trib_NativeDesignLimitedMember_2665"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NativeDesignLimitedMember" xlink:label="loc_trib_NativeDesignLimitedMember_2666"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCarryingAmountMember" xlink:label="loc_trib_NetCarryingAmountMember_2667"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCarryingAmountMember" xlink:label="loc_trib_NetCarryingAmountMember_2668"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCarryingAmountMember" xlink:label="loc_trib_NetCarryingAmountMember_2669"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCashOutflowArisingOnAcquisitionAbstract" xlink:label="loc_trib_NetCashOutflowArisingOnAcquisitionAbstract_2670"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCashOutflowArisingOnAcquisitionAbstract" xlink:label="loc_trib_NetCashOutflowArisingOnAcquisitionAbstract_2671"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCashOutFlowOnBusinessCombination" xlink:label="loc_trib_NetCashOutFlowOnBusinessCombination_2672"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCashOutFlowOnBusinessCombination" xlink:label="loc_trib_NetCashOutFlowOnBusinessCombination_2673"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCashOutFlowOnBusinessCombination" xlink:label="loc_trib_NetCashOutFlowOnBusinessCombination_2674"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCashOutFlowOnBusinessCombination" xlink:label="loc_trib_NetCashOutFlowOnBusinessCombination_2675"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetFinancingExpenseIncome" xlink:label="loc_trib_NetFinancingExpenseIncome_2676"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetFinancingExpenseIncome" xlink:label="loc_trib_NetFinancingExpenseIncome_2677"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetFinancingExpenseIncome" xlink:label="loc_trib_NetFinancingExpenseIncome_2678"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetForeignExchangeGainLoss" xlink:label="loc_trib_NetForeignExchangeGainLoss_2679"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetForeignExchangeGainLoss" xlink:label="loc_trib_NetForeignExchangeGainLoss_2680"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetForeignExchangeGainLoss" xlink:label="loc_trib_NetForeignExchangeGainLoss_2681"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetInterestIncome" xlink:label="loc_trib_NetInterestIncome_2682"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetInterestIncome" xlink:label="loc_trib_NetInterestIncome_2683"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetInterestIncome" xlink:label="loc_trib_NetInterestIncome_2684"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetOperatingLossCarryforwards" xlink:label="loc_trib_NetOperatingLossCarryforwards_2685"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetOperatingLossCarryforwards" xlink:label="loc_trib_NetOperatingLossCarryforwards_2686"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetOperatingLossPeriod" xlink:label="loc_trib_NetOperatingLossPeriod_2687"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetOperatingLossPeriod" xlink:label="loc_trib_NetOperatingLossPeriod_2688"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NominalAmountOfDebt" xlink:label="loc_trib_NominalAmountOfDebt_2689"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NominalAmountOfDebt" xlink:label="loc_trib_NominalAmountOfDebt_2690"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NominalAmountOfDebt" xlink:label="loc_trib_NominalAmountOfDebt_2691"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NominalValue" xlink:label="loc_trib_NominalValue_2692"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NominalValue" xlink:label="loc_trib_NominalValue_2693"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NominalValue" xlink:label="loc_trib_NominalValue_2694"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NominalValuePerShareOfExchangeableNotes" xlink:label="loc_trib_NominalValuePerShareOfExchangeableNotes_2695"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NominalValuePerShareOfExchangeableNotes" xlink:label="loc_trib_NominalValuePerShareOfExchangeableNotes_2696"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NominalValuePerShareOfExchangeableNotes" xlink:label="loc_trib_NominalValuePerShareOfExchangeableNotes_2697"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashActivityForFinancingActivityAbstract" xlink:label="loc_trib_NonCashActivityForFinancingActivityAbstract_2698"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashActivityForFinancingActivityAbstract" xlink:label="loc_trib_NonCashActivityForFinancingActivityAbstract_2699"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashActivityForFinancingActivityAbstract" xlink:label="loc_trib_NonCashActivityForFinancingActivityAbstract_2700"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashActivityForFinancingActivityAbstract" xlink:label="loc_trib_NonCashActivityForFinancingActivityAbstract_2701"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashFairValueGainLoss" xlink:label="loc_trib_NonCashFairValueGainLoss_2702"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashFairValueGainLoss" xlink:label="loc_trib_NonCashFairValueGainLoss_2703"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashFairValueGainLoss" xlink:label="loc_trib_NonCashFairValueGainLoss_2704"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashFairValueLoss" xlink:label="loc_trib_NoncashFairValueLoss_2705"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashFairValueLoss" xlink:label="loc_trib_NoncashFairValueLoss_2706"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashFairValueLoss" xlink:label="loc_trib_NoncashFairValueLoss_2707"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashImpairmentCharge" xlink:label="loc_trib_NonCashImpairmentCharge_2708"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashImpairmentCharge" xlink:label="loc_trib_NonCashImpairmentCharge_2709"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashInterestOnConvertibleNote" xlink:label="loc_trib_NoncashInterestOnConvertibleNote_2710"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashInterestOnConvertibleNote" xlink:label="loc_trib_NoncashInterestOnConvertibleNote_2711"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashInterestOnConvertibleNote" xlink:label="loc_trib_NoncashInterestOnConvertibleNote_2712"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashInterestOnSeniorSecuredTermLoan" xlink:label="loc_trib_NoncashInterestOnSeniorSecuredTermLoan_2713"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashInterestOnSeniorSecuredTermLoan" xlink:label="loc_trib_NoncashInterestOnSeniorSecuredTermLoan_2714"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashInterestOnSeniorSecuredTermLoan" xlink:label="loc_trib_NoncashInterestOnSeniorSecuredTermLoan_2715"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashInterestOnSeniorSecuredTermLoan" xlink:label="loc_trib_NoncashInterestOnSeniorSecuredTermLoan_2716"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashLoanModificationGain" xlink:label="loc_trib_NoncashLoanModificationGain_2717"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashLoanModificationGain" xlink:label="loc_trib_NoncashLoanModificationGain_2718"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashLoanModificationGain" xlink:label="loc_trib_NoncashLoanModificationGain_2719"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentAssetsMember" xlink:label="loc_trib_NonCurrentAssetsMember_2720"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentAssetsMember" xlink:label="loc_trib_NonCurrentAssetsMember_2721"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncurrentDerivativeLiabilities" xlink:label="loc_trib_NoncurrentDerivativeLiabilities_2722"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncurrentDerivativeLiabilities" xlink:label="loc_trib_NoncurrentDerivativeLiabilities_2723"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncurrentDerivativeLiabilities" xlink:label="loc_trib_NoncurrentDerivativeLiabilities_2724"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncurrentDerivativeLiabilities" xlink:label="loc_trib_NoncurrentDerivativeLiabilities_2725"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncurrentFinanceLeaseLiabilities" xlink:label="loc_trib_NoncurrentFinanceLeaseLiabilities_2726"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncurrentFinanceLeaseLiabilities" xlink:label="loc_trib_NoncurrentFinanceLeaseLiabilities_2727"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncurrentFinanceLeaseLiabilities" xlink:label="loc_trib_NoncurrentFinanceLeaseLiabilities_2728"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncurrentFinanceLeaseLiabilities" xlink:label="loc_trib_NoncurrentFinanceLeaseLiabilities_2729"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLeaseLiabilitiesAbstract" xlink:label="loc_trib_NonCurrentLeaseLiabilitiesAbstract_2730"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLeaseLiabilitiesAbstract" xlink:label="loc_trib_NonCurrentLeaseLiabilitiesAbstract_2731"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLiabilitiesMember" xlink:label="loc_trib_NonCurrentLiabilitiesMember_2732"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLiabilitiesMember" xlink:label="loc_trib_NonCurrentLiabilitiesMember_2733"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLiabilitiesMember" xlink:label="loc_trib_NonCurrentLiabilitiesMember_2734"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonRadingCosts" xlink:label="loc_trib_NonRadingCosts_2735"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonRadingCosts" xlink:label="loc_trib_NonRadingCosts_2736"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonRadingCosts" xlink:label="loc_trib_NonRadingCosts_2737"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonTradingCosts" xlink:label="loc_trib_NonTradingCosts_2738"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonTradingCosts" xlink:label="loc_trib_NonTradingCosts_2739"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonTradingCosts" xlink:label="loc_trib_NonTradingCosts_2740"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotesAndDebenturesPurchased" xlink:label="loc_trib_NotesAndDebenturesPurchased_2741"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotesAndDebenturesPurchased" xlink:label="loc_trib_NotesAndDebenturesPurchased_2742"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotesAndDebenturesPurchased" xlink:label="loc_trib_NotesAndDebenturesPurchased_2743"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotesAndDebenturesRetired" xlink:label="loc_trib_NotesAndDebenturesRetired_2744"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotesAndDebenturesRetired" xlink:label="loc_trib_NotesAndDebenturesRetired_2745"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotesAndDebenturesRetired" xlink:label="loc_trib_NotesAndDebenturesRetired_2746"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotLaterThan10YearMember" xlink:label="loc_trib_NotLaterThan10YearMember_2747"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotLaterThan1YearMember" xlink:label="loc_trib_NotLaterThan1YearMember_2748"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotLaterThan2YearMember" xlink:label="loc_trib_NotLaterThan2YearMember_2749"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotLaterThan3YearMember" xlink:label="loc_trib_NotLaterThan3YearMember_2750"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotLaterThan4YearMember" xlink:label="loc_trib_NotLaterThan4YearMember_2751"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotLaterThan5YearMember" xlink:label="loc_trib_NotLaterThan5YearMember_2752"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotLaterThan6YearMember" xlink:label="loc_trib_NotLaterThan6YearMember_2753"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotLaterThan7YearMember" xlink:label="loc_trib_NotLaterThan7YearMember_2754"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotLaterThan8YearMember" xlink:label="loc_trib_NotLaterThan8YearMember_2755"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NotLaterThan9YearMember" xlink:label="loc_trib_NotLaterThan9YearMember_2756"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NovaCenturyScientificIncMember" xlink:label="loc_trib_NovaCenturyScientificIncMember_2757"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NovaCenturyScientificIncMember" xlink:label="loc_trib_NovaCenturyScientificIncMember_2758"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NovusDiagnosticsLimitedMember" xlink:label="loc_trib_NovusDiagnosticsLimitedMember_2759"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NovusDiagnosticsLimitedMember" xlink:label="loc_trib_NovusDiagnosticsLimitedMember_2760"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NovusDiagnosticsLimitedMember" xlink:label="loc_trib_NovusDiagnosticsLimitedMember_2761"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAmericanDepositorySharesWeightedAverageShares" xlink:label="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2762"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAmericanDepositorySharesWeightedAverageShares" xlink:label="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2763"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAmericanDepositorySharesWeightedAverageShares" xlink:label="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2764"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAmericanDepositorySharesWeightedAverageShares" xlink:label="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2765"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAmericanDepositorySharesWeightedAverageShares" xlink:label="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2766"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAmericanDepositorySharesWeightedAverageShares" xlink:label="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2767"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAmericanDepositorySharesWeightedAverageShares" xlink:label="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2768"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAOrdinaryWeightedAverageShares" xlink:label="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2769"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAOrdinaryWeightedAverageShares" xlink:label="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2770"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAOrdinaryWeightedAverageShares" xlink:label="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2771"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAOrdinaryWeightedAverageShares" xlink:label="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2772"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAOrdinaryWeightedAverageShares" xlink:label="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2773"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAOrdinaryWeightedAverageShares" xlink:label="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2774"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAOrdinaryWeightedAverageShares" xlink:label="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2775"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithExtensionOptions" xlink:label="loc_trib_NumberOfLeasesWithExtensionOptions_2776"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithExtensionOptions" xlink:label="loc_trib_NumberOfLeasesWithExtensionOptions_2777"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithExtensionOptions" xlink:label="loc_trib_NumberOfLeasesWithExtensionOptions_2778"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithOptionsToPurchase" xlink:label="loc_trib_NumberOfLeasesWithOptionsToPurchase_2779"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithOptionsToPurchase" xlink:label="loc_trib_NumberOfLeasesWithOptionsToPurchase_2780"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithOptionsToPurchase" xlink:label="loc_trib_NumberOfLeasesWithOptionsToPurchase_2781"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithTerminationOptions" xlink:label="loc_trib_NumberOfLeasesWithTerminationOptions_2782"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithTerminationOptions" xlink:label="loc_trib_NumberOfLeasesWithTerminationOptions_2783"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithTerminationOptions" xlink:label="loc_trib_NumberOfLeasesWithTerminationOptions_2784"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex" xlink:label="loc_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_2785"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex" xlink:label="loc_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_2786"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex" xlink:label="loc_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_2787"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsGranted" xlink:label="loc_trib_NumberOfOptionsGranted_2788"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsGranted" xlink:label="loc_trib_NumberOfOptionsGranted_2789"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsGranted" xlink:label="loc_trib_NumberOfOptionsGranted_2790"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsIssuable" xlink:label="loc_trib_NumberOfOptionsIssuable_2791"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsIssuable" xlink:label="loc_trib_NumberOfOptionsIssuable_2792"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsIssuable" xlink:label="loc_trib_NumberOfOptionsIssuable_2793"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsLapsedUnexercised" xlink:label="loc_trib_NumberOfOptionsLapsedUnexercised_2794"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsLapsedUnexercised" xlink:label="loc_trib_NumberOfOptionsLapsedUnexercised_2795"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsLapsedUnexercised" xlink:label="loc_trib_NumberOfOptionsLapsedUnexercised_2796"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions" xlink:label="loc_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_2797"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions" xlink:label="loc_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_2798"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions" xlink:label="loc_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_2799"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRetiredDirectorOptions" xlink:label="loc_trib_NumberOfRetiredDirectorOptions_2800"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRetiredDirectorOptions" xlink:label="loc_trib_NumberOfRetiredDirectorOptions_2801"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRetiredDirectorOptions" xlink:label="loc_trib_NumberOfRetiredDirectorOptions_2802"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRetiredDirectorShares" xlink:label="loc_trib_NumberOfRetiredDirectorShares_2803"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRetiredDirectorShares" xlink:label="loc_trib_NumberOfRetiredDirectorShares_2804"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRetiredDirectorShares" xlink:label="loc_trib_NumberOfRetiredDirectorShares_2805"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRightOfUseLeasedAssets" xlink:label="loc_trib_NumberOfRightOfUseLeasedAssets_2806"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRightOfUseLeasedAssets" xlink:label="loc_trib_NumberOfRightOfUseLeasedAssets_2807"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRightOfUseLeasedAssets" xlink:label="loc_trib_NumberOfRightOfUseLeasedAssets_2808"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfShareOptionsExercisableShareBasedPayment" xlink:label="loc_trib_NumberOfShareOptionsExercisableShareBasedPayment_2809"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfShareOptionsExercisableShareBasedPayment" xlink:label="loc_trib_NumberOfShareOptionsExercisableShareBasedPayment_2810"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfShareOptionsExercisableShareBasedPayment" xlink:label="loc_trib_NumberOfShareOptionsExercisableShareBasedPayment_2811"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive" xlink:label="loc_trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive_2812"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive" xlink:label="loc_trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive_2813"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" xlink:label="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_2814"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" xlink:label="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_2815"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" xlink:label="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_2816"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare" xlink:label="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_2817"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare" xlink:label="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_2818"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare" xlink:label="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_2819"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuedOnExerciseOfOptions" xlink:label="loc_trib_NumberOfSharesIssuedOnExerciseOfOptions_2820"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuedOnExerciseOfOptions" xlink:label="loc_trib_NumberOfSharesIssuedOnExerciseOfOptions_2821"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuedOnExerciseOfOptions" xlink:label="loc_trib_NumberOfSharesIssuedOnExerciseOfOptions_2822"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfStockOptionsToPurchaseOrdinaryShares" xlink:label="loc_trib_NumberOfStockOptionsToPurchaseOrdinaryShares_2823"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfStockOptionsToPurchaseOrdinaryShares" xlink:label="loc_trib_NumberOfStockOptionsToPurchaseOrdinaryShares_2824"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfStockOptionsToPurchaseOrdinaryShares" xlink:label="loc_trib_NumberOfStockOptionsToPurchaseOrdinaryShares_2825"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfWarrantsRepriced" xlink:label="loc_trib_NumberOfWarrantsRepriced_2826"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfWarrantsRepriced" xlink:label="loc_trib_NumberOfWarrantsRepriced_2827"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfWarrantsRepriced" xlink:label="loc_trib_NumberOfWarrantsRepriced_2828"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OnceOffExpense" xlink:label="loc_trib_OnceOffExpense_2829"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OnceOffExpense" xlink:label="loc_trib_OnceOffExpense_2830"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OnceOffExpense" xlink:label="loc_trib_OnceOffExpense_2831"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OnceOffTaxCredit" xlink:label="loc_trib_OnceOffTaxCredit_2832"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OnceOffTaxCredit" xlink:label="loc_trib_OnceOffTaxCredit_2833"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OneYearToTwoYearsMember" xlink:label="loc_trib_OneYearToTwoYearsMember_2834"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OneYearToTwoYearsMember" xlink:label="loc_trib_OneYearToTwoYearsMember_2835"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OneYearToTwoYearsMember" xlink:label="loc_trib_OneYearToTwoYearsMember_2836"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OpeningSharePrice" xlink:label="loc_trib_OpeningSharePrice_2837"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OpeningSharePrice" xlink:label="loc_trib_OpeningSharePrice_2838"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OpeningSharePrice" xlink:label="loc_trib_OpeningSharePrice_2839"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OperatingLeasesMember" xlink:label="loc_trib_OperatingLeasesMember_2840"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OperatingLossesBrazilMember" xlink:label="loc_trib_OperatingLossesBrazilMember_2841"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OperatingLossesIrelandMember" xlink:label="loc_trib_OperatingLossesIrelandMember_2842"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OperatingLossesStateMember" xlink:label="loc_trib_OperatingLossesStateMember_2843"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OptionsAndWarrantsAbstract" xlink:label="loc_trib_OptionsAndWarrantsAbstract_2844"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OptionsAndWarrantsAbstract" xlink:label="loc_trib_OptionsAndWarrantsAbstract_2845"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherAssetNoncurrent" xlink:label="loc_trib_OtherAssetNoncurrent_2846"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherAssetNoncurrent" xlink:label="loc_trib_OtherAssetNoncurrent_2847"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherAssetNoncurrent" xlink:label="loc_trib_OtherAssetNoncurrent_2848"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherBorrowingsMember" xlink:label="loc_trib_OtherBorrowingsMember_2849"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherBorrowingsMember" xlink:label="loc_trib_OtherBorrowingsMember_2850"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_2851"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_2852"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_2853"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCurrentBorrowings" xlink:label="loc_trib_OtherCurrentBorrowings_2854"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCurrentBorrowings" xlink:label="loc_trib_OtherCurrentBorrowings_2855"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCurrentBorrowings" xlink:label="loc_trib_OtherCurrentBorrowings_2856"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCurrentBorrowings" xlink:label="loc_trib_OtherCurrentBorrowings_2857"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherDeferredTaxAssetsInIrelandMember" xlink:label="loc_trib_OtherDeferredTaxAssetsInIrelandMember_2858"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherDeferredTaxAssetsInUsMember" xlink:label="loc_trib_OtherDeferredTaxAssetsInUsMember_2859"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherEmployeesMember" xlink:label="loc_trib_OtherEmployeesMember_2860"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherEmployeesMember" xlink:label="loc_trib_OtherEmployeesMember_2861"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherEuropeanCountriesMember" xlink:label="loc_trib_OtherEuropeanCountriesMember_2862"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherEuropeanCountriesMember" xlink:label="loc_trib_OtherEuropeanCountriesMember_2863"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherItemsMember" xlink:label="loc_trib_OtherItemsMember_2864"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherItemsMember" xlink:label="loc_trib_OtherItemsMember_2865"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherLeases" xlink:label="loc_trib_OtherLeases_2866"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherLeases" xlink:label="loc_trib_OtherLeases_2867"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherLeases" xlink:label="loc_trib_OtherLeases_2868"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherNonCurrentAssets" xlink:label="loc_trib_OtherNonCurrentAssets_2869"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherOperatingIncomeLineItems" xlink:label="loc_trib_OtherOperatingIncomeLineItems_2870"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherOperatingIncomeLineItems" xlink:label="loc_trib_OtherOperatingIncomeLineItems_2871"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherOperatingIncomeTable" xlink:label="loc_trib_OtherOperatingIncomeTable_2872"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherOperatingIncomeTable" xlink:label="loc_trib_OtherOperatingIncomeTable_2873"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherProjectsMember" xlink:label="loc_trib_OtherProjectsMember_2874"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherProjectsMember" xlink:label="loc_trib_OtherProjectsMember_2875"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherReceivablesAsOfAcquisitionDate" xlink:label="loc_trib_OtherReceivablesAsOfAcquisitionDate_2876"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherReceivablesAsOfAcquisitionDate" xlink:label="loc_trib_OtherReceivablesAsOfAcquisitionDate_2877"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherReceivablesAsOfAcquisitionDate" xlink:label="loc_trib_OtherReceivablesAsOfAcquisitionDate_2878"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRegionsMember" xlink:label="loc_trib_OtherRegionsMember_2879"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRegionsMember" xlink:label="loc_trib_OtherRegionsMember_2880"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRegionsMember" xlink:label="loc_trib_OtherRegionsMember_2881"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRestructuringCostsMember" xlink:label="loc_trib_OtherRestructuringCostsMember_2882"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRestructuringCostsMember" xlink:label="loc_trib_OtherRestructuringCostsMember_2883"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRestructuringCostsMember" xlink:label="loc_trib_OtherRestructuringCostsMember_2884"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutsourcingCostsMember" xlink:label="loc_trib_OutsourcingCostsMember_2885"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutsourcingCostsMember" xlink:label="loc_trib_OutsourcingCostsMember_2886"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutsourcingCostsMember" xlink:label="loc_trib_OutsourcingCostsMember_2887"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutstandingAbstract" xlink:label="loc_trib_OutstandingAbstract_2888"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutstandingAbstract" xlink:label="loc_trib_OutstandingAbstract_2889"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutstandingPrincipal" xlink:label="loc_trib_OutstandingPrincipal_2890"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutstandingPrincipal" xlink:label="loc_trib_OutstandingPrincipal_2891"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutstandingTermLoan" xlink:label="loc_trib_OutstandingTermLoan_2892"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutstandingTermLoan" xlink:label="loc_trib_OutstandingTermLoan_2893"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutstandingTermLoan" xlink:label="loc_trib_OutstandingTermLoan_2894"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OverheadCosts" xlink:label="loc_trib_OverheadCosts_2895"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OverheadCosts" xlink:label="loc_trib_OverheadCosts_2896"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OverheadCosts" xlink:label="loc_trib_OverheadCosts_2897"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PartnershipTriggerEventsDescription" xlink:label="loc_trib_PartnershipTriggerEventsDescription_2898"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PartnershipTriggerEventsDescription" xlink:label="loc_trib_PartnershipTriggerEventsDescription_2899"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PartnershipTriggerEventsDescription" xlink:label="loc_trib_PartnershipTriggerEventsDescription_2900"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PatentDividendSchemeAmount" xlink:label="loc_trib_PatentDividendSchemeAmount_2901"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PatentDividendSchemeAmount" xlink:label="loc_trib_PatentDividendSchemeAmount_2902"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PatentsAndLicencesMember" xlink:label="loc_trib_PatentsAndLicencesMember_2903"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PatentsAndLicencesMember" xlink:label="loc_trib_PatentsAndLicencesMember_2904"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaycheckProtectionProgramLoanMember" xlink:label="loc_trib_PaycheckProtectionProgramLoanMember_2905"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaycheckProtectionProgramLoanMember" xlink:label="loc_trib_PaycheckProtectionProgramLoanMember_2906"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentInKindInterest" xlink:label="loc_trib_PaymentInKindInterest_2907"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentInKindInterest" xlink:label="loc_trib_PaymentInKindInterest_2908"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentInKindInterest" xlink:label="loc_trib_PaymentInKindInterest_2909"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentOfPenalty" xlink:label="loc_trib_PaymentOfPenalty_2910"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentOfPenalty" xlink:label="loc_trib_PaymentOfPenalty_2911"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentOfPenalty" xlink:label="loc_trib_PaymentOfPenalty_2912"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsForCEOServices" xlink:label="loc_trib_PaymentsForCEOServices_2913"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsForCEOServices" xlink:label="loc_trib_PaymentsForCEOServices_2914"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsForCEOServices" xlink:label="loc_trib_PaymentsForCEOServices_2915"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities" xlink:label="loc_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_2916"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities" xlink:label="loc_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_2917"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities" xlink:label="loc_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_2918"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities" xlink:label="loc_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_2919"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities" xlink:label="loc_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_2920"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities" xlink:label="loc_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_2921"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentToRetireExchangeableNotes" xlink:label="loc_trib_PaymentToRetireExchangeableNotes_2922"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentToRetireExchangeableNotes" xlink:label="loc_trib_PaymentToRetireExchangeableNotes_2923"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentToRetireExchangeableNotes" xlink:label="loc_trib_PaymentToRetireExchangeableNotes_2924"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltiesPayments" xlink:label="loc_trib_PenaltiesPayments_2925"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltiesPayments" xlink:label="loc_trib_PenaltiesPayments_2926"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan" xlink:label="loc_trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan_2927"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan" xlink:label="loc_trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan_2928"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan" xlink:label="loc_trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan_2929"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlySettlementCharged" xlink:label="loc_trib_PenaltyForEarlySettlementCharged_2930"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlySettlementCharged" xlink:label="loc_trib_PenaltyForEarlySettlementCharged_2931"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlySettlementCharged" xlink:label="loc_trib_PenaltyForEarlySettlementCharged_2932"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlySettlementOfTermLoan" xlink:label="loc_trib_PenaltyForEarlySettlementOfTermLoan_2933"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlySettlementOfTermLoan" xlink:label="loc_trib_PenaltyForEarlySettlementOfTermLoan_2934"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlySettlementOfTermLoan" xlink:label="loc_trib_PenaltyForEarlySettlementOfTermLoan_2935"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyPaidForEarlySettlement" xlink:label="loc_trib_PenaltyPaidForEarlySettlement_2936"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyPaidForEarlySettlement" xlink:label="loc_trib_PenaltyPaidForEarlySettlement_2937"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyPaidForEarlySettlement" xlink:label="loc_trib_PenaltyPaidForEarlySettlement_2938"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PercentageOfForgivenLoan" xlink:label="loc_trib_PercentageOfForgivenLoan_2939"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PercentageOfForgivenLoan" xlink:label="loc_trib_PercentageOfForgivenLoan_2940"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PercentageOfForgivenLoan" xlink:label="loc_trib_PercentageOfForgivenLoan_2941"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PercentageOfGrossInventory1" xlink:label="loc_trib_PercentageOfGrossInventory1_2942"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PercentageOfGrossInventory1" xlink:label="loc_trib_PercentageOfGrossInventory1_2943"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PercentageOfGrossInventory1" xlink:label="loc_trib_PercentageOfGrossInventory1_2944"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PercentageOfGroupRevenues" xlink:label="loc_trib_PercentageOfGroupRevenues_2945"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PercentageOfGroupRevenues" xlink:label="loc_trib_PercentageOfGroupRevenues_2946"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PerceptiveAdvisorsMember" xlink:label="loc_trib_PerceptiveAdvisorsMember_2947"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PerceptiveAdvisorsMember" xlink:label="loc_trib_PerceptiveAdvisorsMember_2948"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PerceptiveCreditHoldingsIiiLpMember" xlink:label="loc_trib_PerceptiveCreditHoldingsIiiLpMember_2949"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PerceptiveCreditHoldingsIiiLpMember" xlink:label="loc_trib_PerceptiveCreditHoldingsIiiLpMember_2950"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PerceptiveMember" xlink:label="loc_trib_PerceptiveMember_2951"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PerceptiveMember" xlink:label="loc_trib_PerceptiveMember_2952"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PersonnelRelatedCostsMember" xlink:label="loc_trib_PersonnelRelatedCostsMember_2953"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PersonnelRelatedCostsMember" xlink:label="loc_trib_PersonnelRelatedCostsMember_2954"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PhoenixBioTechCorpMember" xlink:label="loc_trib_PhoenixBioTechCorpMember_2955"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PhoenixBioTechCorpMember" xlink:label="loc_trib_PhoenixBioTechCorpMember_2956"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PhoenixBiotechMember" xlink:label="loc_trib_PhoenixBiotechMember_2957"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PointFivePercentageOfGrossInventoryMember" xlink:label="loc_trib_PointFivePercentageOfGrossInventoryMember_2958"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PointFivePercentageOfGrossInventoryMember" xlink:label="loc_trib_PointFivePercentageOfGrossInventoryMember_2959"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PointFivePercentageOfGrossInventoryMember" xlink:label="loc_trib_PointFivePercentageOfGrossInventoryMember_2960"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PointOfCareMember" xlink:label="loc_trib_PointOfCareMember_2961"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PointOfCareMember" xlink:label="loc_trib_PointOfCareMember_2962"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PostBsEventsMember" xlink:label="loc_trib_PostBsEventsMember_2963"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PostDisposalAdjustmentMember" xlink:label="loc_trib_PostDisposalAdjustmentMember_2964"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PostDisposalAdjustmentMember" xlink:label="loc_trib_PostDisposalAdjustmentMember_2965"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PotentiallyDilutiveInstrumentsAbstract" xlink:label="loc_trib_PotentiallyDilutiveInstrumentsAbstract_2966"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PotentiallyDilutiveInstrumentsAbstract" xlink:label="loc_trib_PotentiallyDilutiveInstrumentsAbstract_2967"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PremierInstrumentMember" xlink:label="loc_trib_PremierInstrumentMember_2968"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PremierInstrumentMember" xlink:label="loc_trib_PremierInstrumentMember_2969"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PremierInstrumentMember" xlink:label="loc_trib_PremierInstrumentMember_2970"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PremierLabAutomationMember" xlink:label="loc_trib_PremierLabAutomationMember_2971"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PremierResolutionMember" xlink:label="loc_trib_PremierResolutionMember_2972"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PremierTTenInstrumentMember" xlink:label="loc_trib_PremierTTenInstrumentMember_2973"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PreTaxDiscountRates" xlink:label="loc_trib_PreTaxDiscountRates_2974"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PreTaxDiscountRates" xlink:label="loc_trib_PreTaxDiscountRates_2975"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrimusCorpMember" xlink:label="loc_trib_PrimusCorpMember_2976"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrimusCorpMember" xlink:label="loc_trib_PrimusCorpMember_2977"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrimusCorporationCguTradeNameMember" xlink:label="loc_trib_PrimusCorporationCguTradeNameMember_2978"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrimusCorporationCguTradeNameMember" xlink:label="loc_trib_PrimusCorporationCguTradeNameMember_2979"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrimusCorporationIncMember" xlink:label="loc_trib_PrimusCorporationIncMember_2980"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrimusCorporationMember" xlink:label="loc_trib_PrimusCorporationMember_2981"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrimusCorporationMember" xlink:label="loc_trib_PrimusCorporationMember_2982"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalActivity" xlink:label="loc_trib_PrincipalActivity_2983"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalActivity" xlink:label="loc_trib_PrincipalActivity_2984"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalActivity" xlink:label="loc_trib_PrincipalActivity_2985"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_2986"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_2987"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_2988"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_2989"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_2990"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_2991"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalDevelopmentProjectsCapitalizedCosts" xlink:label="loc_trib_PrincipalDevelopmentProjectsCapitalizedCosts_2992"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalDevelopmentProjectsCapitalizedCosts" xlink:label="loc_trib_PrincipalDevelopmentProjectsCapitalizedCosts_2993"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalDevelopmentProjectsCapitalizedCosts" xlink:label="loc_trib_PrincipalDevelopmentProjectsCapitalizedCosts_2994"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsForConvertibleNoteIssued" xlink:label="loc_trib_ProceedsForConvertibleNoteIssued_2995"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsForConvertibleNoteIssued" xlink:label="loc_trib_ProceedsForConvertibleNoteIssued_2996"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsForConvertibleNoteIssued" xlink:label="loc_trib_ProceedsForConvertibleNoteIssued_2997"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsForConvertibleNoteIssued" xlink:label="loc_trib_ProceedsForConvertibleNoteIssued_2998"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromCash" xlink:label="loc_trib_ProceedsFromCash_2999"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromCash" xlink:label="loc_trib_ProceedsFromCash_3000"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromCash" xlink:label="loc_trib_ProceedsFromCash_3001"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromNewFinanceLeases" xlink:label="loc_trib_ProceedsFromNewFinanceLeases_3002"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromNewFinanceLeases" xlink:label="loc_trib_ProceedsFromNewFinanceLeases_3003"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromNewFinanceLeases" xlink:label="loc_trib_ProceedsFromNewFinanceLeases_3004"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromSaleOfBusiness" xlink:label="loc_trib_ProceedsFromSaleOfBusiness_3005"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromSaleOfBusiness" xlink:label="loc_trib_ProceedsFromSaleOfBusiness_3006"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromSaleOfBusiness" xlink:label="loc_trib_ProceedsFromSaleOfBusiness_3007"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromSaleOfBusiness" xlink:label="loc_trib_ProceedsFromSaleOfBusiness_3008"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromSharesToBeIssued" xlink:label="loc_trib_ProceedsFromSharesToBeIssued_3009"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromSharesToBeIssued" xlink:label="loc_trib_ProceedsFromSharesToBeIssued_3010"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromSharesToBeIssued" xlink:label="loc_trib_ProceedsFromSharesToBeIssued_3011"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProductCullMember" xlink:label="loc_trib_ProductCullMember_3012"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PropertyAndEquipmentMember" xlink:label="loc_trib_PropertyAndEquipmentMember_3013"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PropertyAndEquipmentMember" xlink:label="loc_trib_PropertyAndEquipmentMember_3014"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PropertyAndEquipmentMember" xlink:label="loc_trib_PropertyAndEquipmentMember_3015"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionalValueMember" xlink:label="loc_trib_ProvisionalValueMember_3016"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionalValueMember" xlink:label="loc_trib_ProvisionalValueMember_3017"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForImpairment" xlink:label="loc_trib_ProvisionForImpairment_3018"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForImpairment" xlink:label="loc_trib_ProvisionForImpairment_3019"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForImpairment" xlink:label="loc_trib_ProvisionForImpairment_3020"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForImpairment" xlink:label="loc_trib_ProvisionForImpairment_3021"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForImpairment" xlink:label="loc_trib_ProvisionForImpairment_3022"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForInventoriesMember" xlink:label="loc_trib_ProvisionForInventoriesMember_3023"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForInventoriesMember" xlink:label="loc_trib_ProvisionForInventoriesMember_3024"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForInventory" xlink:label="loc_trib_ProvisionForInventory_3025"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForInventory" xlink:label="loc_trib_ProvisionForInventory_3026"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForInventory" xlink:label="loc_trib_ProvisionForInventory_3027"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionOfCanteenServicesToThirdParties" xlink:label="loc_trib_ProvisionOfCanteenServicesToThirdParties_3028"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionOfCanteenServicesToThirdParties" xlink:label="loc_trib_ProvisionOfCanteenServicesToThirdParties_3029"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionOfCanteenServicesToThirdParties" xlink:label="loc_trib_ProvisionOfCanteenServicesToThirdParties_3030"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionOnExpenses" xlink:label="loc_trib_ProvisionOnExpenses_3031"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionOnExpenses" xlink:label="loc_trib_ProvisionOnExpenses_3032"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionOnExpenses" xlink:label="loc_trib_ProvisionOnExpenses_3033"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PurchaseOfTreasuryShare" xlink:label="loc_trib_PurchaseOfTreasuryShare_3034"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PurchaseOfTreasuryShare" xlink:label="loc_trib_PurchaseOfTreasuryShare_3035"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PurchaseOfTreasuryShare" xlink:label="loc_trib_PurchaseOfTreasuryShare_3036"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_Ranges10OfExercisePricesForOutstandingShareOptionOneMember" xlink:label="loc_trib_Ranges10OfExercisePricesForOutstandingShareOptionOneMember_3037"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_Ranges10OfExercisePricesForOutstandingShareOptionOneMember" xlink:label="loc_trib_Ranges10OfExercisePricesForOutstandingShareOptionOneMember_3038"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_3039"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_3040"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_3041"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_3042"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_3043"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_3044"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_3045"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_3046"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_3047"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_3048"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember_3049"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember_3050"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember_3051"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember_3052"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_3053"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_3054"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_3055"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember" xlink:label="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_3056"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember" xlink:label="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_3057"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember" xlink:label="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_3058"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember_3059"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember_3060"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember_3061"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember_3062"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember_3063"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember_3064"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember_3065"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember_3066"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_3067"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_3068"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_3069"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_3070"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_3071"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_3072"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_3073"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_3074"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_3075"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_3076"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_3077"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_3078"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_3079"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RapidCovid19AntigenTestMember" xlink:label="loc_trib_RapidCovid19AntigenTestMember_3080"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RapidCovid19AntigenTestMember" xlink:label="loc_trib_RapidCovid19AntigenTestMember_3081"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RapidCovid19AntigenTestMember" xlink:label="loc_trib_RapidCovid19AntigenTestMember_3082"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RateOfRentPerSqureFoot" xlink:label="loc_trib_RateOfRentPerSqureFoot_3083"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RateOfRentPerSqureFoot" xlink:label="loc_trib_RateOfRentPerSqureFoot_3084"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown" xlink:label="loc_trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown_3085"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown" xlink:label="loc_trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown_3086"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown" xlink:label="loc_trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown_3087"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RayvilleLimitedMember" xlink:label="loc_trib_RayvilleLimitedMember_3088"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RayvilleLimitedMember" xlink:label="loc_trib_RayvilleLimitedMember_3089"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReceivablesFromConsiderationDueSaleOfBusiness" xlink:label="loc_trib_ReceivablesFromConsiderationDueSaleOfBusiness_3090"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReceivablesFromConsiderationDueSaleOfBusiness" xlink:label="loc_trib_ReceivablesFromConsiderationDueSaleOfBusiness_3091"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReceivablesFromConsiderationDueSaleOfBusiness" xlink:label="loc_trib_ReceivablesFromConsiderationDueSaleOfBusiness_3092"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReceivablesOutstanding" xlink:label="loc_trib_ReceivablesOutstanding_3093"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReceivablesOutstanding" xlink:label="loc_trib_ReceivablesOutstanding_3094"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReceivablesOutstanding" xlink:label="loc_trib_ReceivablesOutstanding_3095"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReclassificationGoodwillAndIntangibleAssets" xlink:label="loc_trib_ReclassificationGoodwillAndIntangibleAssets_3096"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReclassificationGoodwillAndIntangibleAssets" xlink:label="loc_trib_ReclassificationGoodwillAndIntangibleAssets_3097"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReclassificationGoodwillAndIntangibleAssets" xlink:label="loc_trib_ReclassificationGoodwillAndIntangibleAssets_3098"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReclassificationMember" xlink:label="loc_trib_ReclassificationMember_3099"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RecognitionOfContingentAsset" xlink:label="loc_trib_RecognitionOfContingentAsset_3100"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RecognitionOfContingentAsset" xlink:label="loc_trib_RecognitionOfContingentAsset_3101"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RecognitionOfContingentAsset" xlink:label="loc_trib_RecognitionOfContingentAsset_3102"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract" xlink:label="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_3103"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract" xlink:label="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_3104"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract" xlink:label="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_3105"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReducedGrossDebt" xlink:label="loc_trib_ReducedGrossDebt_3106"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReducedGrossDebt" xlink:label="loc_trib_ReducedGrossDebt_3107"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReducedGrossDebt" xlink:label="loc_trib_ReducedGrossDebt_3108"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReductionOfGrossDebt" xlink:label="loc_trib_ReductionOfGrossDebt_3109"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReductionOfGrossDebt" xlink:label="loc_trib_ReductionOfGrossDebt_3110"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReductionOfGrossDebt" xlink:label="loc_trib_ReductionOfGrossDebt_3111"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReductionPercentageInBaseRate" xlink:label="loc_trib_ReductionPercentageInBaseRate_3112"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReductionPercentageInBaseRate" xlink:label="loc_trib_ReductionPercentageInBaseRate_3113"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReductionPercentageInBaseRate" xlink:label="loc_trib_ReductionPercentageInBaseRate_3114"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RefinancingCostsClassifiedAsFinancingActivities" xlink:label="loc_trib_RefinancingCostsClassifiedAsFinancingActivities_3115"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RefinancingCostsClassifiedAsFinancingActivities" xlink:label="loc_trib_RefinancingCostsClassifiedAsFinancingActivities_3116"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RefinancingCostsClassifiedAsFinancingActivities" xlink:label="loc_trib_RefinancingCostsClassifiedAsFinancingActivities_3117"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReliefOptionForLowValueAssets" xlink:label="loc_trib_ReliefOptionForLowValueAssets_3118"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReliefOptionForLowValueAssets" xlink:label="loc_trib_ReliefOptionForLowValueAssets_3119"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReliefOptionForShortTermLeases" xlink:label="loc_trib_ReliefOptionForShortTermLeases_3120"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReliefOptionForShortTermLeases" xlink:label="loc_trib_ReliefOptionForShortTermLeases_3121"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemainingFundsForCorporatePurposes" xlink:label="loc_trib_RemainingFundsForCorporatePurposes_3122"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemainingFundsForCorporatePurposes" xlink:label="loc_trib_RemainingFundsForCorporatePurposes_3123"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemainingTermInYears" xlink:label="loc_trib_RemainingTermInYears_3124"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemainingTermInYears" xlink:label="loc_trib_RemainingTermInYears_3125"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemainingTermInYears" xlink:label="loc_trib_RemainingTermInYears_3126"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemeasurementLossRecognizedInProfitLoss" xlink:label="loc_trib_RemeasurementLossRecognizedInProfitLoss_3127"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemeasurementLossRecognizedInProfitLoss" xlink:label="loc_trib_RemeasurementLossRecognizedInProfitLoss_3128"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemeasurementLossRecognizedInProfitLoss" xlink:label="loc_trib_RemeasurementLossRecognizedInProfitLoss_3129"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemeasurementMember" xlink:label="loc_trib_RemeasurementMember_3130"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemeasurementMember" xlink:label="loc_trib_RemeasurementMember_3131"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemeasurementOfRightOfUseAssets" xlink:label="loc_trib_RemeasurementOfRightOfUseAssets_3132"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemeasurementOfRightOfUseAssets" xlink:label="loc_trib_RemeasurementOfRightOfUseAssets_3133"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemeasurementOfRightOfUseAssets" xlink:label="loc_trib_RemeasurementOfRightOfUseAssets_3134"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RentalIncomeFromPremises" xlink:label="loc_trib_RentalIncomeFromPremises_3135"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RentalIncomeFromPremises" xlink:label="loc_trib_RentalIncomeFromPremises_3136"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RepaymentOfOtherLoan" xlink:label="loc_trib_RepaymentOfOtherLoan_3137"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RepaymentOfOtherLoan" xlink:label="loc_trib_RepaymentOfOtherLoan_3138"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RepaymentOfOtherLoan" xlink:label="loc_trib_RepaymentOfOtherLoan_3139"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RepaymentOfSecuredDebt" xlink:label="loc_trib_RepaymentOfSecuredDebt_3140"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RepaymentOfSecuredDebt" xlink:label="loc_trib_RepaymentOfSecuredDebt_3141"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RepaymentOfSecuredDebt" xlink:label="loc_trib_RepaymentOfSecuredDebt_3142"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResearchAndDevelopmentMember" xlink:label="loc_trib_ResearchAndDevelopmentMember_3143"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResearchAndDevelopmentMember" xlink:label="loc_trib_ResearchAndDevelopmentMember_3144"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResearchAndDevelopmentTaxCredits" xlink:label="loc_trib_ResearchAndDevelopmentTaxCredits_3145"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResearchAndDevelopmentTaxCredits" xlink:label="loc_trib_ResearchAndDevelopmentTaxCredits_3146"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestOfWorldOtherMember" xlink:label="loc_trib_RestOfWorldOtherMember_3147"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestOfWorldOtherMember" xlink:label="loc_trib_RestOfWorldOtherMember_3148"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringAccrual" xlink:label="loc_trib_RestructuringAccrual_3149"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringAccrual" xlink:label="loc_trib_RestructuringAccrual_3150"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringActivitiesExpense" xlink:label="loc_trib_RestructuringActivitiesExpense_3151"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringActivitiesExpense" xlink:label="loc_trib_RestructuringActivitiesExpense_3152"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringActivitiesExpense" xlink:label="loc_trib_RestructuringActivitiesExpense_3153"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringActivitiesExpense" xlink:label="loc_trib_RestructuringActivitiesExpense_3154"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringActivitiesExpense" xlink:label="loc_trib_RestructuringActivitiesExpense_3155"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringCost" xlink:label="loc_trib_RestructuringCost_3156"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringCost" xlink:label="loc_trib_RestructuringCost_3157"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringCost" xlink:label="loc_trib_RestructuringCost_3158"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringCost" xlink:label="loc_trib_RestructuringCost_3159"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringCost" xlink:label="loc_trib_RestructuringCost_3160"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResultAfterExceptionalExpenses" xlink:label="loc_trib_ResultAfterExceptionalExpenses_3161"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResultAfterExceptionalExpenses" xlink:label="loc_trib_ResultAfterExceptionalExpenses_3162"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResultAfterExceptionalExpenses" xlink:label="loc_trib_ResultAfterExceptionalExpenses_3163"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResultBeforeExceptionalExpenses" xlink:label="loc_trib_ResultBeforeExceptionalExpenses_3164"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResultBeforeExceptionalExpenses" xlink:label="loc_trib_ResultBeforeExceptionalExpenses_3165"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResultBeforeExceptionalExpenses" xlink:label="loc_trib_ResultBeforeExceptionalExpenses_3166"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReversalOfImpairmentLossOnFinancialAssets" xlink:label="loc_trib_ReversalOfImpairmentLossOnFinancialAssets_3167"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReversalOfImpairmentLossOnFinancialAssets" xlink:label="loc_trib_ReversalOfImpairmentLossOnFinancialAssets_3168"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReversalOfImpairmentLossOnFinancialAssets" xlink:label="loc_trib_ReversalOfImpairmentLossOnFinancialAssets_3169"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReversalOfNetOperatingLoss" xlink:label="loc_trib_ReversalOfNetOperatingLoss_3170"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReversalOfNetOperatingLoss" xlink:label="loc_trib_ReversalOfNetOperatingLoss_3171"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReversalOfNetOperatingLoss" xlink:label="loc_trib_ReversalOfNetOperatingLoss_3172"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RevertsMinimumLiquidityCovenant" xlink:label="loc_trib_RevertsMinimumLiquidityCovenant_3173"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RevertsMinimumLiquidityCovenant" xlink:label="loc_trib_RevertsMinimumLiquidityCovenant_3174"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsCostAtTransitionBeforeImpairment" xlink:label="loc_trib_RightOfUseAssetsCostAtTransitionBeforeImpairment_3175"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsCostAtTransitionBeforeImpairment" xlink:label="loc_trib_RightOfUseAssetsCostAtTransitionBeforeImpairment_3176"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsCostAtTransitionBeforeImpairment" xlink:label="loc_trib_RightOfUseAssetsCostAtTransitionBeforeImpairment_3177"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsImpairmentAdjustmentOnTransition" xlink:label="loc_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_3178"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsImpairmentAdjustmentOnTransition" xlink:label="loc_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_3179"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsImpairmentAdjustmentOnTransition" xlink:label="loc_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_3180"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsImpairmentAdjustmentOnTransition" xlink:label="loc_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_3181"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsIncludingDepreciationAndImpairment" xlink:label="loc_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_3182"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsIncludingDepreciationAndImpairment" xlink:label="loc_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_3183"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsIncludingDepreciationAndImpairment" xlink:label="loc_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_3184"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RonanOCaoimhMember" xlink:label="loc_trib_RonanOCaoimhMember_3185"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RonanOCaoimhMember" xlink:label="loc_trib_RonanOCaoimhMember_3186"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RonanOCaoimhMember" xlink:label="loc_trib_RonanOCaoimhMember_3187"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RubellaAssayEnhancementMember" xlink:label="loc_trib_RubellaAssayEnhancementMember_3188"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleAndLeasebackLiabilitiesCurrent" xlink:label="loc_trib_SaleAndLeasebackLiabilitiesCurrent_3189"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleAndLeasebackLiabilitiesCurrent" xlink:label="loc_trib_SaleAndLeasebackLiabilitiesCurrent_3190"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleAndLeasebackLiabilitiesCurrent" xlink:label="loc_trib_SaleAndLeasebackLiabilitiesCurrent_3191"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleAndLeasebackLiabilitiesMember" xlink:label="loc_trib_SaleAndLeasebackLiabilitiesMember_3192"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleAndLeasebackLiabilitiesMember" xlink:label="loc_trib_SaleAndLeasebackLiabilitiesMember_3193"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleAndLeasebackLiabilitiesMember" xlink:label="loc_trib_SaleAndLeasebackLiabilitiesMember_3194"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleAndLeasebackLiabilitiesNonCurrent" xlink:label="loc_trib_SaleAndLeasebackLiabilitiesNonCurrent_3195"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleAndLeasebackLiabilitiesNonCurrent" xlink:label="loc_trib_SaleAndLeasebackLiabilitiesNonCurrent_3196"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleAndLeasebackLiabilitiesNonCurrent" xlink:label="loc_trib_SaleAndLeasebackLiabilitiesNonCurrent_3197"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleOfFitzgeraldIndustriesMember" xlink:label="loc_trib_SaleOfFitzgeraldIndustriesMember_3198"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleOfFitzgeraldIndustriesMember" xlink:label="loc_trib_SaleOfFitzgeraldIndustriesMember_3199"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleOfFitzgeraldIndustriesMember" xlink:label="loc_trib_SaleOfFitzgeraldIndustriesMember_3200"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SatisfiedByAbstract" xlink:label="loc_trib_SatisfiedByAbstract_3201"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SatisfiedByAbstract" xlink:label="loc_trib_SatisfiedByAbstract_3202"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfAdditionalInformationOnRightOfUseAssets" xlink:label="loc_trib_ScheduleOfAdditionalInformationOnRightOfUseAssets_3203"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfAdditionalInformationOnRightOfUseAssets" xlink:label="loc_trib_ScheduleOfAdditionalInformationOnRightOfUseAssets_3204"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings" xlink:label="loc_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_3205"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings" xlink:label="loc_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_3206"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings" xlink:label="loc_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_3207"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock" xlink:label="loc_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_3208"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock" xlink:label="loc_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_3209"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock" xlink:label="loc_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_3210"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea" xlink:label="loc_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_3211"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea" xlink:label="loc_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_3212"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea" xlink:label="loc_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_3213"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SecuredOvernightFinancingRate" xlink:label="loc_trib_SecuredOvernightFinancingRate_3214"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SecuredOvernightFinancingRate" xlink:label="loc_trib_SecuredOvernightFinancingRate_3215"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SecuredOvernightFinancingRate" xlink:label="loc_trib_SecuredOvernightFinancingRate_3216"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SegmentAssets" xlink:label="loc_trib_SegmentAssets_3217"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SegmentAssets" xlink:label="loc_trib_SegmentAssets_3218"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SegmentLiabilities" xlink:label="loc_trib_SegmentLiabilities_3219"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SegmentLiabilities" xlink:label="loc_trib_SegmentLiabilities_3220"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAdministrationExpensesAbstract" xlink:label="loc_trib_SellingGeneralAdministrationExpensesAbstract_3221"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAdministrationExpensesAbstract" xlink:label="loc_trib_SellingGeneralAdministrationExpensesAbstract_3222"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesClosureCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_3223"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesClosureCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_3224"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesClosureCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_3225"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesClosureCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_3226"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesClosureCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_3227"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesRecognitionOfContingentAsset" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesRecognitionOfContingentAsset_3228"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesRecognitionOfContingentAsset" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesRecognitionOfContingentAsset_3229"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_3230"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_3231"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_3232"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense_3233"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense_3234"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense_3235"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement_3236"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement_3237"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement_3238"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlementGross" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlementGross_3239"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlementGross" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlementGross_3240"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorNoteMember" xlink:label="loc_trib_SeniorNoteMember_3241"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorNoteMember" xlink:label="loc_trib_SeniorNoteMember_3242"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorNoteMember" xlink:label="loc_trib_SeniorNoteMember_3243"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanAnnualRate" xlink:label="loc_trib_SeniorSecuredTermLoanAnnualRate_3244"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanAnnualRate" xlink:label="loc_trib_SeniorSecuredTermLoanAnnualRate_3245"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanAnnualRate" xlink:label="loc_trib_SeniorSecuredTermLoanAnnualRate_3246"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanCreditFacilityMember" xlink:label="loc_trib_SeniorSecuredTermLoanCreditFacilityMember_3247"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanCreditFacilityMember" xlink:label="loc_trib_SeniorSecuredTermLoanCreditFacilityMember_3248"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanCreditFacilityMember" xlink:label="loc_trib_SeniorSecuredTermLoanCreditFacilityMember_3249"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanCreditFacilityOneMember" xlink:label="loc_trib_SeniorSecuredTermLoanCreditFacilityOneMember_3250"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanCreditFacilityOneMember" xlink:label="loc_trib_SeniorSecuredTermLoanCreditFacilityOneMember_3251"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanCreditFacilityOneMember" xlink:label="loc_trib_SeniorSecuredTermLoanCreditFacilityOneMember_3252"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanFixedRate" xlink:label="loc_trib_SeniorSecuredTermLoanFixedRate_3253"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanFixedRate" xlink:label="loc_trib_SeniorSecuredTermLoanFixedRate_3254"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanFixedRate" xlink:label="loc_trib_SeniorSecuredTermLoanFixedRate_3255"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanMember" xlink:label="loc_trib_SeniorSecuredTermLoanMember_3256"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanMember" xlink:label="loc_trib_SeniorSecuredTermLoanMember_3257"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanMember" xlink:label="loc_trib_SeniorSecuredTermLoanMember_3258"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SevenYearConvertibleNoteMember" xlink:label="loc_trib_SevenYearConvertibleNoteMember_3259"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SevenYearConvertibleNoteMember" xlink:label="loc_trib_SevenYearConvertibleNoteMember_3260"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SevenYearConvertibleNoteMember" xlink:label="loc_trib_SevenYearConvertibleNoteMember_3261"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPayments" xlink:label="loc_trib_ShareBasedPayments_3262"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPayments" xlink:label="loc_trib_ShareBasedPayments_3263"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets" xlink:label="loc_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_3264"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets" xlink:label="loc_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_3265"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets" xlink:label="loc_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_3266"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsContinuingOperations" xlink:label="loc_trib_ShareBasedPaymentsContinuingOperations_3267"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsContinuingOperations" xlink:label="loc_trib_ShareBasedPaymentsContinuingOperations_3268"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsContinuingOperations" xlink:label="loc_trib_ShareBasedPaymentsContinuingOperations_3269"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsContinuingOperations" xlink:label="loc_trib_ShareBasedPaymentsContinuingOperations_3270"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsContinuingOperations" xlink:label="loc_trib_ShareBasedPaymentsContinuingOperations_3271"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsCostOfSales" xlink:label="loc_trib_ShareBasedPaymentsCostOfSales_3272"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsCostOfSales" xlink:label="loc_trib_ShareBasedPaymentsCostOfSales_3273"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsCostOfSales" xlink:label="loc_trib_ShareBasedPaymentsCostOfSales_3274"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsDiscontinuedOperations" xlink:label="loc_trib_ShareBasedPaymentsDiscontinuedOperations_3275"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsDiscontinuedOperations" xlink:label="loc_trib_ShareBasedPaymentsDiscontinuedOperations_3276"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsDiscontinuedOperations" xlink:label="loc_trib_ShareBasedPaymentsDiscontinuedOperations_3277"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsSellingGeneralAndAdministrative" xlink:label="loc_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_3278"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsSellingGeneralAndAdministrative" xlink:label="loc_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_3279"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsSellingGeneralAndAdministrative" xlink:label="loc_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_3280"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareIssueCostForExchangeableNotesPurchase" xlink:label="loc_trib_ShareIssueCostForExchangeableNotesPurchase_3281"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareIssueCostForExchangeableNotesPurchase" xlink:label="loc_trib_ShareIssueCostForExchangeableNotesPurchase_3282"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareOptionMember" xlink:label="loc_trib_ShareOptionMember_3283"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareOptionMember" xlink:label="loc_trib_ShareOptionMember_3284"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharePricePerAds" xlink:label="loc_trib_SharePricePerAds_3285"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharePricePerAds" xlink:label="loc_trib_SharePricePerAds_3286"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharePricePerAds" xlink:label="loc_trib_SharePricePerAds_3287"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareRepurchasedUnderBuybackProgram" xlink:label="loc_trib_ShareRepurchasedUnderBuybackProgram_3288"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareRepurchasedUnderBuybackProgram" xlink:label="loc_trib_ShareRepurchasedUnderBuybackProgram_3289"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesConsideration" xlink:label="loc_trib_SharesConsideration_3290"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesConsideration" xlink:label="loc_trib_SharesConsideration_3291"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesConsideration" xlink:label="loc_trib_SharesConsideration_3292"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuableOnConversionOfExchangeableNotes" xlink:label="loc_trib_SharesIssuableOnConversionOfExchangeableNotes_3293"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuableOnConversionOfExchangeableNotes" xlink:label="loc_trib_SharesIssuableOnConversionOfExchangeableNotes_3294"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuableOnConversionOfExchangeableNotes" xlink:label="loc_trib_SharesIssuableOnConversionOfExchangeableNotes_3295"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase" xlink:label="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_3296"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase" xlink:label="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_3297"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase" xlink:label="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_3298"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase" xlink:label="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_3299"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue" xlink:label="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_3300"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue" xlink:label="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_3301"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue" xlink:label="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_3302"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes" xlink:label="loc_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_3303"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes" xlink:label="loc_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_3304"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes" xlink:label="loc_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_3305"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings" xlink:label="loc_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_3306"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings" xlink:label="loc_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_3307"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings" xlink:label="loc_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_3308"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesPurchasedDuringYear" xlink:label="loc_trib_SharesPurchasedDuringYear_3309"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesPurchasedDuringYear" xlink:label="loc_trib_SharesPurchasedDuringYear_3310"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesRepresentationRateComparedToADS" xlink:label="loc_trib_SharesRepresentationRateComparedToADS_3311"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesRepresentationRateComparedToADS" xlink:label="loc_trib_SharesRepresentationRateComparedToADS_3312"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesRepresentationRateComparedToADS" xlink:label="loc_trib_SharesRepresentationRateComparedToADS_3313"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesSoldDuringYear" xlink:label="loc_trib_SharesSoldDuringYear_3314"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesSoldDuringYear" xlink:label="loc_trib_SharesSoldDuringYear_3315"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesToBeIssued" xlink:label="loc_trib_SharesToBeIssued_3316"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesToBeIssued" xlink:label="loc_trib_SharesToBeIssued_3317"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesToBeIssued" xlink:label="loc_trib_SharesToBeIssued_3318"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesToBeIssuedForHedgingReservesValue" xlink:label="loc_trib_SharesToBeIssuedForHedgingReservesValue_3319"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesToBeIssuedForHedgingReservesValue" xlink:label="loc_trib_SharesToBeIssuedForHedgingReservesValue_3320"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesToBeIssuedForHedgingReservesValue" xlink:label="loc_trib_SharesToBeIssuedForHedgingReservesValue_3321"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShortTermDepositsAndShortTermInvestments" xlink:label="loc_trib_ShortTermDepositsAndShortTermInvestments_3322"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShortTermDepositsAndShortTermInvestments" xlink:label="loc_trib_ShortTermDepositsAndShortTermInvestments_3323"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShortTermDepositsAndShortTermInvestments" xlink:label="loc_trib_ShortTermDepositsAndShortTermInvestments_3324"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShortTermLeaseLiabilitiesMember" xlink:label="loc_trib_ShortTermLeaseLiabilitiesMember_3325"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SiteTransferCostsMember" xlink:label="loc_trib_SiteTransferCostsMember_3326"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SiteTransferCostsMember" xlink:label="loc_trib_SiteTransferCostsMember_3327"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SiteTransferCostsMember" xlink:label="loc_trib_SiteTransferCostsMember_3328"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember" xlink:label="loc_trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember_3329"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthOrLessMember" xlink:label="loc_trib_SixMonthOrLessMember_3330"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthOrLessMember" xlink:label="loc_trib_SixMonthOrLessMember_3331"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthOrLessMember" xlink:label="loc_trib_SixMonthOrLessMember_3332"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthToTwelveMonthMember" xlink:label="loc_trib_SixMonthToTwelveMonthMember_3333"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthToTwelveMonthMember" xlink:label="loc_trib_SixMonthToTwelveMonthMember_3334"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthToTwelveMonthMember" xlink:label="loc_trib_SixMonthToTwelveMonthMember_3335"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SjogrensCytokineMember" xlink:label="loc_trib_SjogrensCytokineMember_3336"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SjogrensMonoclonalAntibodiesMember" xlink:label="loc_trib_SjogrensMonoclonalAntibodiesMember_3337"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SjogrensMonoclonalAntibodiesTwoMember" xlink:label="loc_trib_SjogrensMonoclonalAntibodiesTwoMember_3338"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SjogrensTestsMember" xlink:label="loc_trib_SjogrensTestsMember_3339"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SjogrensTestsMember" xlink:label="loc_trib_SjogrensTestsMember_3340"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_StateCreditCarryforwardsMember" xlink:label="loc_trib_StateCreditCarryforwardsMember_3341"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_StrategicInvestmentAndPartnershipWithMICOMember" xlink:label="loc_trib_StrategicInvestmentAndPartnershipWithMICOMember_3342"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_StrategicInvestmentAndPartnershipWithMICOMember" xlink:label="loc_trib_StrategicInvestmentAndPartnershipWithMICOMember_3343"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_StrategicInvestmentAndPartnershipWithMICOMember" xlink:label="loc_trib_StrategicInvestmentAndPartnershipWithMICOMember_3344"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_StrategicPartnershipWithImawareIncMember" xlink:label="loc_trib_StrategicPartnershipWithImawareIncMember_3345"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_StrategicPartnershipWithImawareIncMember" xlink:label="loc_trib_StrategicPartnershipWithImawareIncMember_3346"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_StrategicPartnershipWithImawareIncMember" xlink:label="loc_trib_StrategicPartnershipWithImawareIncMember_3347"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SyphilisPointOfCareMember" xlink:label="loc_trib_SyphilisPointOfCareMember_3348"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SyphilisPointOfCareMember" xlink:label="loc_trib_SyphilisPointOfCareMember_3349"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SyphilisPointOfCareMember" xlink:label="loc_trib_SyphilisPointOfCareMember_3350"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SyphilisPointOfCareTestMember" xlink:label="loc_trib_SyphilisPointOfCareTestMember_3351"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SyphilisPointOfCareTestMember" xlink:label="loc_trib_SyphilisPointOfCareTestMember_3352"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SyphilisRapidPointCareMember" xlink:label="loc_trib_SyphilisRapidPointCareMember_3353"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_T10HplcAnalyzerMember" xlink:label="loc_trib_T10HplcAnalyzerMember_3354"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_T10HplcAnalyzerMember" xlink:label="loc_trib_T10HplcAnalyzerMember_3355"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_T10HplcAnalyzerMember" xlink:label="loc_trib_T10HplcAnalyzerMember_3356"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxFees" xlink:label="loc_trib_TaxFees_3357"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxFees" xlink:label="loc_trib_TaxFees_3358"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxRateEffectOfCurrentTaxOfPriorPeriods" xlink:label="loc_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_3359"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxRateEffectOfCurrentTaxOfPriorPeriods" xlink:label="loc_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_3360"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxRateEffectOfCurrentTaxOfPriorPeriods" xlink:label="loc_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_3361"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods" xlink:label="loc_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_3362"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods" xlink:label="loc_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_3363"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods" xlink:label="loc_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_3364"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxValueLossCarryforwardsRecognisedMember" xlink:label="loc_trib_TaxValueLossCarryforwardsRecognisedMember_3365"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxValueOfLossCarryForwardsMember" xlink:label="loc_trib_TaxValueOfLossCarryForwardsMember_3366"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxValueOfLossCarryForwardsMember" xlink:label="loc_trib_TaxValueOfLossCarryForwardsMember_3367"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TenPercentStrengtheningUSDollarMember" xlink:label="loc_trib_TenPercentStrengtheningUSDollarMember_3368"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TenPercentStrengtheningUSDollarMember" xlink:label="loc_trib_TenPercentStrengtheningUSDollarMember_3369"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TenPercentStrengtheningUSDollarMember" xlink:label="loc_trib_TenPercentStrengtheningUSDollarMember_3370"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TenPercentWeakeningUSDollarMember" xlink:label="loc_trib_TenPercentWeakeningUSDollarMember_3371"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TenPercentWeakeningUSDollarMember" xlink:label="loc_trib_TenPercentWeakeningUSDollarMember_3372"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TenPercentWeakeningUSDollarMember" xlink:label="loc_trib_TenPercentWeakeningUSDollarMember_3373"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermLoanAgreementDescription" xlink:label="loc_trib_TermLoanAgreementDescription_3374"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermLoanAgreementDescription" xlink:label="loc_trib_TermLoanAgreementDescription_3375"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermLoanAgreementDescription" xlink:label="loc_trib_TermLoanAgreementDescription_3376"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermLoanFacility" xlink:label="loc_trib_TermLoanFacility_3377"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermLoanFacility" xlink:label="loc_trib_TermLoanFacility_3378"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermLoanFacility" xlink:label="loc_trib_TermLoanFacility_3379"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermLoanMember" xlink:label="loc_trib_TermLoanMember_3380"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermLoanMember" xlink:label="loc_trib_TermLoanMember_3381"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermOfExchangeableSeniorNotes" xlink:label="loc_trib_TermOfExchangeableSeniorNotes_3382"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermOfExchangeableSeniorNotes" xlink:label="loc_trib_TermOfExchangeableSeniorNotes_3383"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermOfLease" xlink:label="loc_trib_TermOfLease_3384"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermOfLease" xlink:label="loc_trib_TermOfLease_3385"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ThirtyFirstDecemberTwoThousandThirtyFiveMember" xlink:label="loc_trib_ThirtyFirstDecemberTwoThousandThirtyFiveMember_3386"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ThirtyFirstDecemberTwoThousandThirtyFourMember" xlink:label="loc_trib_ThirtyFirstDecemberTwoThousandThirtyFourMember_3387"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ThirtyFirstDecemberTwoThousandThirtySevenMember" xlink:label="loc_trib_ThirtyFirstDecemberTwoThousandThirtySevenMember_3388"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ThirtyFirstDecemberTwoThousandThirtySixMember" xlink:label="loc_trib_ThirtyFirstDecemberTwoThousandThirtySixMember_3389"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ThirtyFirstDecemberTwoThousandThirtyThreeMember" xlink:label="loc_trib_ThirtyFirstDecemberTwoThousandThirtyThreeMember_3390"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ThirtyFirstDecemberTwoThousandThirtyTwoMember" xlink:label="loc_trib_ThirtyFirstDecemberTwoThousandThirtyTwoMember_3391"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ThreeLoanMember" xlink:label="loc_trib_ThreeLoanMember_3392"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ThreeLoanMember" xlink:label="loc_trib_ThreeLoanMember_3393"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ThresholdWeightedAveragePriceOfAds" xlink:label="loc_trib_ThresholdWeightedAveragePriceOfAds_3394"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ThresholdWeightedAveragePriceOfAds" xlink:label="loc_trib_ThresholdWeightedAveragePriceOfAds_3395"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ThresholdWeightedAveragePriceOfAds" xlink:label="loc_trib_ThresholdWeightedAveragePriceOfAds_3396"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalAssetsAcquiredAsOfAcquisitionDate" xlink:label="loc_trib_TotalAssetsAcquiredAsOfAcquisitionDate_3397"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalAssetsAcquiredAsOfAcquisitionDate" xlink:label="loc_trib_TotalAssetsAcquiredAsOfAcquisitionDate_3398"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalAssetsAcquiredAsOfAcquisitionDate" xlink:label="loc_trib_TotalAssetsAcquiredAsOfAcquisitionDate_3399"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalExchangeableNotesPercentage" xlink:label="loc_trib_TotalExchangeableNotesPercentage_3400"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalExchangeableNotesPercentage" xlink:label="loc_trib_TotalExchangeableNotesPercentage_3401"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalExchangeableNotesPercentage" xlink:label="loc_trib_TotalExchangeableNotesPercentage_3402"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalExposureFinancialInstruments" xlink:label="loc_trib_TotalExposureFinancialInstruments_3403"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalExposureFinancialInstruments" xlink:label="loc_trib_TotalExposureFinancialInstruments_3404"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalExposureFinancialInstruments" xlink:label="loc_trib_TotalExposureFinancialInstruments_3405"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalLiabilitiesAssumedAsOfAcquisitionDate" xlink:label="loc_trib_TotalLiabilitiesAssumedAsOfAcquisitionDate_3406"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalLiabilitiesAssumedAsOfAcquisitionDate" xlink:label="loc_trib_TotalLiabilitiesAssumedAsOfAcquisitionDate_3407"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalLiabilitiesAssumedAsOfAcquisitionDate" xlink:label="loc_trib_TotalLiabilitiesAssumedAsOfAcquisitionDate_3408"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalShareOptionsGrantedAdsEquivalent" xlink:label="loc_trib_TotalShareOptionsGrantedAdsEquivalent_3409"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalShareOptionsGrantedAdsEquivalent" xlink:label="loc_trib_TotalShareOptionsGrantedAdsEquivalent_3410"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalShareOptionsGrantedAdsEquivalent" xlink:label="loc_trib_TotalShareOptionsGrantedAdsEquivalent_3411"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalShareOptionsGrantedAdsEquivalent" xlink:label="loc_trib_TotalShareOptionsGrantedAdsEquivalent_3412"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_3413"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_3414"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_3415"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_3416"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradeReceivablesAllowanceForImpairment" xlink:label="loc_trib_TradeReceivablesAllowanceForImpairment_3417"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradeReceivablesAllowanceForImpairment" xlink:label="loc_trib_TradeReceivablesAllowanceForImpairment_3418"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradingTriggerEventsDescription" xlink:label="loc_trib_TradingTriggerEventsDescription_3419"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradingTriggerEventsDescription" xlink:label="loc_trib_TradingTriggerEventsDescription_3420"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradingTriggerEventsDescription" xlink:label="loc_trib_TradingTriggerEventsDescription_3421"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradingTriggerPayment" xlink:label="loc_trib_TradingTriggerPayment_3422"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradingTriggerPayment" xlink:label="loc_trib_TradingTriggerPayment_3423"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradingTriggerPayment" xlink:label="loc_trib_TradingTriggerPayment_3424"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TribBiosensorsIncMember" xlink:label="loc_trib_TribBiosensorsIncMember_3425"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TribBiosensorsIncMember" xlink:label="loc_trib_TribBiosensorsIncMember_3426"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechDoBrasilMember" xlink:label="loc_trib_TrinityBiotechDoBrasilMember_3427"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechDoBrasilMember" xlink:label="loc_trib_TrinityBiotechDoBrasilMember_3428"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechIncMember" xlink:label="loc_trib_TrinityBiotechIncMember_3429"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechIncMember" xlink:label="loc_trib_TrinityBiotechIncMember_3430"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechInvestmentLtdMember" xlink:label="loc_trib_TrinityBiotechInvestmentLtdMember_3431"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechInvestmentLtdMember" xlink:label="loc_trib_TrinityBiotechInvestmentLtdMember_3432"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechInvestmentsLtdMember" xlink:label="loc_trib_TrinityBiotechInvestmentsLtdMember_3433"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechJointVentureLimitedMember" xlink:label="loc_trib_TrinityBiotechJointVentureLimitedMember_3434"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechJointVentureLimitedMember" xlink:label="loc_trib_TrinityBiotechJointVentureLimitedMember_3435"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechLuxembourgSarlMember" xlink:label="loc_trib_TrinityBiotechLuxembourgSarlMember_3436"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechLuxembourgSarlMember" xlink:label="loc_trib_TrinityBiotechLuxembourgSarlMember_3437"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingLimitedMember" xlink:label="loc_trib_TrinityBiotechManufacturingLimitedMember_3438"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingLimitedMember" xlink:label="loc_trib_TrinityBiotechManufacturingLimitedMember_3439"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingLtdMember" xlink:label="loc_trib_TrinityBiotechManufacturingLtdMember_3440"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingLtdTwoMember" xlink:label="loc_trib_TrinityBiotechManufacturingLtdTwoMember_3441"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingServicesLimitedMember" xlink:label="loc_trib_TrinityBiotechManufacturingServicesLimitedMember_3442"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingServicesLimitedMember" xlink:label="loc_trib_TrinityBiotechManufacturingServicesLimitedMember_3443"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechPlcMember" xlink:label="loc_trib_TrinityBiotechPlcMember_3444"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechUkLtdMember" xlink:label="loc_trib_TrinityBiotechUkLtdMember_3445"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechUkLtdMember" xlink:label="loc_trib_TrinityBiotechUkLtdMember_3446"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityResearchLimitedMember" xlink:label="loc_trib_TrinityResearchLimitedMember_3447"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityResearchLimitedMember" xlink:label="loc_trib_TrinityResearchLimitedMember_3448"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinscreenPlantAndEquipmentMember" xlink:label="loc_trib_TrinscreenPlantAndEquipmentMember_3449"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinscreenPlantAndEquipmentMember" xlink:label="loc_trib_TrinscreenPlantAndEquipmentMember_3450"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinscreenPlantAndEquipmentMember" xlink:label="loc_trib_TrinscreenPlantAndEquipmentMember_3451"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TriStatInstrumentMember" xlink:label="loc_trib_TriStatInstrumentMember_3452"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TriStatInstrumentMember" xlink:label="loc_trib_TriStatInstrumentMember_3453"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TriStatInstrumentMember" xlink:label="loc_trib_TriStatInstrumentMember_3454"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TristatMember" xlink:label="loc_trib_TristatMember_3455"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TristatMember" xlink:label="loc_trib_TristatMember_3456"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TriStatPointOfCareInstrumentMember" xlink:label="loc_trib_TriStatPointOfCareInstrumentMember_3457"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TriStatPointOfCareInstrumentMember" xlink:label="loc_trib_TriStatPointOfCareInstrumentMember_3458"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TriStatPointOfCareInstrumentMember" xlink:label="loc_trib_TriStatPointOfCareInstrumentMember_3459"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TroponinIassayAndReaderMember" xlink:label="loc_trib_TroponinIassayAndReaderMember_3460"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TroponinIassayBrainNatriureticPeptideDdimerMember" xlink:label="loc_trib_TroponinIassayBrainNatriureticPeptideDdimerMember_3461"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TwoPercentageOfGrossInventoryMember" xlink:label="loc_trib_TwoPercentageOfGrossInventoryMember_3462"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TwoPercentageOfGrossInventoryMember" xlink:label="loc_trib_TwoPercentageOfGrossInventoryMember_3463"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TwoPercentageOfGrossInventoryMember" xlink:label="loc_trib_TwoPercentageOfGrossInventoryMember_3464"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TwoYearToFiveYearsMember" xlink:label="loc_trib_TwoYearToFiveYearsMember_3465"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TwoYearToFiveYearsMember" xlink:label="loc_trib_TwoYearToFiveYearsMember_3466"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TwoYearToFiveYearsMember" xlink:label="loc_trib_TwoYearToFiveYearsMember_3467"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UltraGenesysMember" xlink:label="loc_trib_UltraGenesysMember_3468"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UltraGenesysMember" xlink:label="loc_trib_UltraGenesysMember_3469"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnallocatedAssetsBySegmentAbstract" xlink:label="loc_trib_UnallocatedAssetsBySegmentAbstract_3470"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnallocatedAssetsBySegmentAbstract" xlink:label="loc_trib_UnallocatedAssetsBySegmentAbstract_3471"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnallocatedExpenses" xlink:label="loc_trib_UnallocatedExpenses_3472"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnallocatedExpenses" xlink:label="loc_trib_UnallocatedExpenses_3473"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnallocatedLiabilitiesBySegmentAbstract" xlink:label="loc_trib_UnallocatedLiabilitiesBySegmentAbstract_3474"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnallocatedLiabilitiesBySegmentAbstract" xlink:label="loc_trib_UnallocatedLiabilitiesBySegmentAbstract_3475"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnearnedFinanceIncomeOnFinanceLease" xlink:label="loc_trib_UnearnedFinanceIncomeOnFinanceLease_3476"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnearnedFinanceIncomeOnFinanceLease" xlink:label="loc_trib_UnearnedFinanceIncomeOnFinanceLease_3477"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnearnedFinanceIncomeOnFinanceLease" xlink:label="loc_trib_UnearnedFinanceIncomeOnFinanceLease_3478"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnforgivenLoansAmount" xlink:label="loc_trib_UnforgivenLoansAmount_3479"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnforgivenLoansAmount" xlink:label="loc_trib_UnforgivenLoansAmount_3480"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnforgivenLoansAmount" xlink:label="loc_trib_UnforgivenLoansAmount_3481"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldAntigenImprovementMember" xlink:label="loc_trib_UniGoldAntigenImprovementMember_3482"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldAntigenImprovementMember" xlink:label="loc_trib_UniGoldAntigenImprovementMember_3483"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldRawMaterialStabilisationMember" xlink:label="loc_trib_UniGoldRawMaterialStabilisationMember_3484"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldRawMaterialStabilisationMember" xlink:label="loc_trib_UniGoldRawMaterialStabilisationMember_3485"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldRawMaterialStabilisationMember" xlink:label="loc_trib_UniGoldRawMaterialStabilisationMember_3486"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldTestEnhancementMember" xlink:label="loc_trib_UniGoldTestEnhancementMember_3487"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldTestMember" xlink:label="loc_trib_UniGoldTestMember_3488"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldTestMember" xlink:label="loc_trib_UniGoldTestMember_3489"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnitedKingdomMember" xlink:label="loc_trib_UnitedKingdomMember_3490"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnitedKingdomMember" xlink:label="loc_trib_UnitedKingdomMember_3491"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnrecognizedDeferredTaxAsset" xlink:label="loc_trib_UnrecognizedDeferredTaxAsset_3492"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnrecognizedDeferredTaxAsset" xlink:label="loc_trib_UnrecognizedDeferredTaxAsset_3493"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnsecuredJuniorConvertibleNoteMember" xlink:label="loc_trib_UnsecuredJuniorConvertibleNoteMember_3494"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnsecuredJuniorConvertibleNoteMember" xlink:label="loc_trib_UnsecuredJuniorConvertibleNoteMember_3495"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnsecuredJuniorConvertibleNoteMember" xlink:label="loc_trib_UnsecuredJuniorConvertibleNoteMember_3496"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnutilisedNetOperatingLosses" xlink:label="loc_trib_UnutilisedNetOperatingLosses_3497"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnutilisedNetOperatingLosses" xlink:label="loc_trib_UnutilisedNetOperatingLosses_3498"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnwindingOfDiscountOnDeferredContingentConsideration" xlink:label="loc_trib_UnwindingOfDiscountOnDeferredContingentConsideration_3499"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnwindingOfDiscountOnDeferredContingentConsideration" xlink:label="loc_trib_UnwindingOfDiscountOnDeferredContingentConsideration_3500"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_US1Member" xlink:label="loc_trib_US1Member_3501"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_US1Member" xlink:label="loc_trib_US1Member_3502"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_US1Member" xlink:label="loc_trib_US1Member_3503"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_US1Member" xlink:label="loc_trib_US1Member_3504"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UsStripedLymeMember" xlink:label="loc_trib_UsStripedLymeMember_3505"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ValueOfEmbeddedDerivativesNetLiability" xlink:label="loc_trib_ValueOfEmbeddedDerivativesNetLiability_3506"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ValueOfEmbeddedDerivativesNetLiability" xlink:label="loc_trib_ValueOfEmbeddedDerivativesNetLiability_3507"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ValueOfEmbeddedDerivativesNetLiability" xlink:label="loc_trib_ValueOfEmbeddedDerivativesNetLiability_3508"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_VariableRateInstruments" xlink:label="loc_trib_VariableRateInstruments_3509"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_VariableRateInstruments" xlink:label="loc_trib_VariableRateInstruments_3510"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_VariableRateInstruments" xlink:label="loc_trib_VariableRateInstruments_3511"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_VariableRateInstrumentsAbstract" xlink:label="loc_trib_VariableRateInstrumentsAbstract_3512"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WagesAndSalariesNetOfCredit" xlink:label="loc_trib_WagesAndSalariesNetOfCredit_3513"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WagesAndSalariesNetOfCredit" xlink:label="loc_trib_WagesAndSalariesNetOfCredit_3514"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WagesSubsidiesReceived" xlink:label="loc_trib_WagesSubsidiesReceived_3515"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WagesSubsidiesReceived" xlink:label="loc_trib_WagesSubsidiesReceived_3516"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WagesSubsidiesReceived" xlink:label="loc_trib_WagesSubsidiesReceived_3517"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WarrantsIssuedShares" xlink:label="loc_trib_WarrantsIssuedShares_3518"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WarrantsIssuedShares" xlink:label="loc_trib_WarrantsIssuedShares_3519"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WarrantsIssuedShares" xlink:label="loc_trib_WarrantsIssuedShares_3520"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WarrantsPerAdsPrice" xlink:label="loc_trib_WarrantsPerAdsPrice_3521"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WarrantsPerAdsPrice" xlink:label="loc_trib_WarrantsPerAdsPrice_3522"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WarrantsPerAdsPrice" xlink:label="loc_trib_WarrantsPerAdsPrice_3523"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WarrantsToPurchaseADS" xlink:label="loc_trib_WarrantsToPurchaseADS_3524"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WarrantsToPurchaseADS" xlink:label="loc_trib_WarrantsToPurchaseADS_3525"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WarrantsToPurchaseADS" xlink:label="loc_trib_WarrantsToPurchaseADS_3526"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformAcquisitionMember" xlink:label="loc_trib_WaveformAcquisitionMember_3527"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformAcquisitionMember" xlink:label="loc_trib_WaveformAcquisitionMember_3528"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncMember" xlink:label="loc_trib_WaveformTechnologiesIncMember_3529"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncMember" xlink:label="loc_trib_WaveformTechnologiesIncMember_3530"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncMember" xlink:label="loc_trib_WaveformTechnologiesIncMember_3531"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_3532"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_3533"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_3534"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageExercisePriceAbstract" xlink:label="loc_trib_WeightedAverageExercisePriceAbstract_3535"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageExercisePriceAbstract" xlink:label="loc_trib_WeightedAverageExercisePriceAbstract_3536"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageExercisePriceOutstanding" xlink:label="loc_trib_WeightedAverageExercisePriceOutstanding_3537"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageExercisePriceOutstanding" xlink:label="loc_trib_WeightedAverageExercisePriceOutstanding_3538"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageExercisePriceOutstanding" xlink:label="loc_trib_WeightedAverageExercisePriceOutstanding_3539"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfSharesIssued" xlink:label="loc_trib_WeightedAverageNumberOfSharesIssued_3540"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfSharesIssued" xlink:label="loc_trib_WeightedAverageNumberOfSharesIssued_3541"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfSharesIssued" xlink:label="loc_trib_WeightedAverageNumberOfSharesIssued_3542"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfSharesIssued" xlink:label="loc_trib_WeightedAverageNumberOfSharesIssued_3543"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfTreasuryShares" xlink:label="loc_trib_WeightedAverageNumberOfTreasuryShares_3544"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfTreasuryShares" xlink:label="loc_trib_WeightedAverageNumberOfTreasuryShares_3545"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" xlink:label="loc_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_3546"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" xlink:label="loc_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_3547"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" xlink:label="loc_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_3548"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageSharesDiscontinuedOperations" xlink:label="loc_trib_WeightedAverageSharesDiscontinuedOperations_3549"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageSharesDiscontinuedOperations" xlink:label="loc_trib_WeightedAverageSharesDiscontinuedOperations_3550"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageSharesDiscontinuedOperations" xlink:label="loc_trib_WeightedAverageSharesDiscontinuedOperations_3551"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageSharesDiscontinuedOperations" xlink:label="loc_trib_WeightedAverageSharesDiscontinuedOperations_3552"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WithinOneYearMember" xlink:label="loc_trib_WithinOneYearMember_3553"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WithinOneYearMember" xlink:label="loc_trib_WithinOneYearMember_3554"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_GB_0" xml:lang="en-US">UNITED KINGDOM</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_GB_1" xml:lang="en-US">United Kingdom [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_IE_0" xml:lang="en-US">Ireland [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_country_IE_1" xml:lang="en-US">Ireland [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_SE_0" xml:lang="en-US">Sweden [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_US_0" xml:lang="en-US">USA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_US_1" xml:lang="en-US">United States [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_country_US_2" xml:lang="en-US">Americas [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_BRL_0" xml:lang="en-US">BRL [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_CAD_0" xml:lang="en-US">CAD [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_EUR_0" xml:lang="en-US">Euro [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_GBP_0" xml:lang="en-US">GBP [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_SEK_0" xml:lang="en-US">SEK [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_XXX_0" xml:lang="en-US">Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AddressTypeDomain_0" xml:lang="en-US">Address Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorFirmId_0" xml:lang="en-US">Auditor Firm ID</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorLocation_0" xml:lang="en-US">Auditor Location</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorName_0" xml:lang="en-US">Auditor Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_BusinessContactMember_0" xml:lang="en-US">Business Contact [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode_0" xml:lang="en-US">City Area Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelFaxNumber_0" xml:lang="en-US">Contact Personnel Fax Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelName_0" xml:lang="en-US">Contact Personnel Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CoverAbstract_0" xml:lang="en-US">Cover [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentAccountingStandard_0" xml:lang="en-US">Document Accounting Standard</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentAnnualReport_0" xml:lang="en-US">Document Annual Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag_0" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentRegistrationStatement_0" xml:lang="en-US">Document Registration Statement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentShellCompanyReport_0" xml:lang="en-US">Document Shell Company Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentTransitionReport_0" xml:lang="en-US">Document Transition Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1_0" xml:lang="en-US">Entity Address, Address Line One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine2_0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown_0" xml:lang="en-US">Entity Address, City or Town</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCountry_0" xml:lang="en-US">Entity Address, Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesAddressTypeAxis_0" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesLineItems_0" xml:lang="en-US">Entity Addresses [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesTable_0" xml:lang="en-US">Entity Addresses [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode_0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressStateOrProvince_0" xml:lang="en-US">Entity Address, State or Province</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus_0" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain_0" xml:lang="en-US">Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany_0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFileNumber_0" xml:lang="en-US">Entity File Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory_0" xml:lang="en-US">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode_0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent_0" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityShellCompany_0" xml:lang="en-US">Entity Shell Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityVoluntaryFilers_0" xml:lang="en-US">Entity Voluntary Filers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_IcfrAuditorAttestationFlag_0" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber_0" xml:lang="en-US">Local Phone Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_Security12bTitle_0" xml:lang="en-US">Title of 12(b) Security</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_SecurityExchangeName_0" xml:lang="en-US">Security Exchange Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol_0" xml:lang="en-US">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_0" xml:lang="en-US">Accumulated depreciation and impairment losses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccumulatedImpairmentMember_0" xml:lang="en-US">Accumulated impairment Charge [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0" xml:lang="en-US">Consideration transferred, acquisition-date fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1" xml:lang="en-US">Consideration transferred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_2" xml:lang="en-US">Total consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_0" xml:lang="en-US">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1" xml:lang="en-US">Acquisition-related costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Acquisitions through business combinations, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Intangible assets acquired through business combinations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Additions through acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_0" xml:lang="en-US">Acquisitions through business combinations, other provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_0" xml:lang="en-US">Acquisitions through business combinations, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_1" xml:lang="en-US">Additions through acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_0" xml:lang="en-US">Variation in discount rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionalProvisionsOtherProvisions_0" xml:lang="en-US">Charged during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_0" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsToRightofuseAssets_0" xml:lang="en-US">Additions to right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdditionsToRightofuseAssets_1" xml:lang="en-US">Additional right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AddressOfRegisteredOfficeOfEntity_0" xml:lang="en-US">Address of entity's registered office</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_0" xml:lang="en-US">Diluted weighted average number of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_1" xml:lang="en-US">Total number of potentially dilutive instruments excluded from the weighted average number of &#8216;A&#8217; ordinary shares in calculating dilutive (loss)/earnings per &#8216;A&#8217; ordinary share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_2" xml:lang="en-US">Diluted earnings per share denominator</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForAmortisationExpense_0" xml:lang="en-US">Amortisation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForAmortisationExpense_1" xml:lang="en-US">Amortisation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_0" xml:lang="en-US">Adjustment in respect of prior years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0" xml:lang="en-US">Increase) / decrease in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1" xml:lang="en-US">Increase in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_2" xml:lang="en-US">(Increase) / decrease in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_0" xml:lang="en-US">Increase (Decrease) in net operating losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_0" xml:lang="en-US">(Increase) / decrease in trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1" xml:lang="en-US">(Increase)/decrease in trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationExpense_0" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForFinanceCosts_0" xml:lang="en-US">Financial expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncome_0" xml:lang="en-US">Financial income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncome_1" xml:lang="en-US">Adjustments for finance income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_0" xml:lang="en-US">Loss on disposal or retirement of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_1" xml:lang="en-US">Adjustments for gain (loss) on disposals, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_0" xml:lang="en-US">Adjustments for gains (losses) on change in fair value of derivatives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_1" xml:lang="en-US">Fair value adjustments in the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0" xml:lang="en-US">Impairment through use or sale of the assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1" xml:lang="en-US">Impairment loss charge</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_0" xml:lang="en-US">Impairment of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1" xml:lang="en-US">Impairment of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables_0" xml:lang="en-US">Impairment of prepayments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncomeTaxExpense_0" xml:lang="en-US">Adjustments for income tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncomeTaxExpense_1" xml:lang="en-US">Income tax expense/(credit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncomeTaxExpense_2" xml:lang="en-US">Tax (expense)/credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_0" xml:lang="en-US">Increase / (decrease) in trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1" xml:lang="en-US">Increase/(decrease) in trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForProvisions_0" xml:lang="en-US">Movement in inventory provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0" xml:lang="en-US">Adjustments to reconcile net loss to cash provided by operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_1" xml:lang="en-US">Adjustments to reconcile net profit/(loss) to cash provided by operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_0" xml:lang="en-US">Share-based payments (net of capitalized amounts)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_1" xml:lang="en-US">Share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_2" xml:lang="en-US">Total share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_3" xml:lang="en-US">Total Share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_0" xml:lang="en-US">Foreign exchange (gains)/losses on operating cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_1" xml:lang="en-US">Foreign exchange gains on operating cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdministrativeExpense_0" xml:lang="en-US">Administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdministrativeExpense_1" xml:lang="en-US">Administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdministrativeExpense_2" xml:lang="en-US">Administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmortisationExpense_0" xml:lang="en-US">Amortisation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AmortisationExpense_1" xml:lang="en-US">Amortisation for discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AmortisationExpense_2" xml:lang="en-US">Amortisation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Amortisation method, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets_0" xml:lang="en-US">Other amounts payable to transferee in respect of transferred assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets_1" xml:lang="en-US">Amounts payable for financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract_0" xml:lang="en-US">Amounts recognised as of acquisition date for each major class of assets acquired and liabilities assumed [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract_1" xml:lang="en-US">ASSETS ACQUIRED</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_0" xml:lang="en-US">Analysis of income and expense [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_1" xml:lang="en-US">Selling General And Administrative Expenses - Tax Audit Settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_2" xml:lang="en-US">Loss/profit For Year On Discontinued Operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ApplicableTaxRate_0" xml:lang="en-US">Irish corporation tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ApplicableTaxRate_1" xml:lang="en-US">Corporation tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Assets_0" xml:lang="en-US">Assets [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Assets_1" xml:lang="en-US">TOTAL ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAbstract_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AssetsAbstract_1" xml:lang="en-US">ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesAxis_0" xml:lang="en-US">Assets and liabilities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_0" xml:lang="en-US">Assets and liabilities classified as held for sale [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_0" xml:lang="en-US">Assets and liabilities classified as held for sale [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_0" xml:lang="en-US">Assets and liabilities not classified as held for sale [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_0" xml:lang="en-US">Attribution of expenses by nature to their function [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_0" xml:lang="en-US">Attribution of expenses by nature to their function [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AuditorsRemunerationAbstract_0" xml:lang="en-US">Auditor's remuneration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AuditorsRemunerationForOtherServices_0" xml:lang="en-US">Other non-audit fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AuditorsRemunerationForTaxServices_0" xml:lang="en-US">Audit fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AverageEffectiveTaxRate_0" xml:lang="en-US">Total (current and deferred) %</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AverageEffectiveTaxRate_1" xml:lang="en-US">Effective tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AverageNumberOfEmployees_0" xml:lang="en-US">Average number of employees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_0" xml:lang="en-US">Basic loss per ADS (US Dollars) - group</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_1" xml:lang="en-US">Basic loss per ADS (US Dollars) &#8211; group</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_0" xml:lang="en-US">Basic loss per ADS (US Dollars) - continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_1" xml:lang="en-US">Basic loss per ADS (US Dollars) &#8211; continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_0" xml:lang="en-US">Basic earnings/(loss) per ADS (US Dollars) - discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_1" xml:lang="en-US">Basic (loss)/earnings per &#8216;A&#8217; share (US Dollars) &#8211; discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingCostsCapitalised_0" xml:lang="en-US">Borrowing costs capitalised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BorrowingCostsCapitalised_1" xml:lang="en-US">Capitalisation of borrowing costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_BorrowingCostsRecognisedAsExpense_0" xml:lang="en-US">Less: purchased during the year at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingCostsRecognisedAsExpense_1" xml:lang="en-US">Borrowing costs recognised as expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BorrowingCostsRecognisedAsExpense_2" xml:lang="en-US">Loan origination costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="lab_ifrs-full_Borrowings_0" xml:lang="en-US">Balance at end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="lab_ifrs-full_Borrowings_1" xml:lang="en-US">Balance at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_Borrowings_2" xml:lang="en-US">Unsecured junior convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_Borrowings_3" xml:lang="en-US">Balance at end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_Borrowings_4" xml:lang="en-US">Balance at beginning of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_Borrowings_5" xml:lang="en-US">Outstanding amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_Borrowings_6" xml:lang="en-US">Convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Borrowings_7" xml:lang="en-US">Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Borrowings_8" xml:lang="en-US">Remaining amount of loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Borrowings_9" xml:lang="en-US">Principal amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsAbstract_0" xml:lang="en-US">Borrowings [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsByNameAxis_0" xml:lang="en-US">Borrowings by name [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BorrowingsByNameAxis_1" xml:lang="en-US">Borrowings by name [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsByNameDomain_0" xml:lang="en-US">Borrowings by name [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_BorrowingsInterestRate_0" xml:lang="en-US">Annual rate of interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsInterestRate_1" xml:lang="en-US">Borrowings, interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BorrowingsInterestRate_2" xml:lang="en-US">Interest rate of note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BorrowingsInterestRate_3" xml:lang="en-US">Nominal interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsInterestRateBasis_0" xml:lang="en-US">Borrowings, interest rate basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BorrowingsInterestRateBasis_1" xml:lang="en-US">Loan, interest rate basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsMaturity_0" xml:lang="en-US">Borrowings, maturity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BorrowingsMaturity_1" xml:lang="en-US">Maturity of unsecured junior convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BorrowingsMaturity_2" xml:lang="en-US">Loan maturity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsOriginalCurrency_0" xml:lang="en-US">Currency</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Borrowings recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Funding amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BottomOfRangeMember_0" xml:lang="en-US">Bottom of range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BottomOfRangeMember_1" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BrandNamesMember_0" xml:lang="en-US">Primus trade name [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BuildingsMember_0" xml:lang="en-US">Buildings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BusinessCombinationsAxis_0" xml:lang="en-US">Business combinations [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BusinessCombinationsDomain_0" xml:lang="en-US">Business combinations [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CapitalCommitments_0" xml:lang="en-US">Capital Commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CapitalisedDevelopmentExpenditureMember_0" xml:lang="en-US">Capitalised development expenditure [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CapitalisedDevelopmentExpenditureMember_1" xml:lang="en-US">Capitalised development costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CapitalReserve_0" xml:lang="en-US">Capital reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_0" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountMember_0" xml:lang="en-US">Carrying Amount [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_Cash_0" xml:lang="en-US">Cash at bank and in hand</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Cash_1" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Cash_2" xml:lang="en-US">Cash at bank and in hand</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Cash_3" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAdvancesAndLoansFromRelatedParties_0" xml:lang="en-US">Cash advances and loans from related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashAdvancesAndLoansFromRelatedParties_1" xml:lang="en-US">Principal amount loaned</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_0" xml:lang="en-US">Cash at bank and in hand</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_1" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalents_2" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_3" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_4" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_5" xml:lang="en-US">Cash and cash equivalents and short-term investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalentsAbstract_0" xml:lang="en-US">Cash and cash equivalents [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalentsAbstract_1" xml:lang="en-US">Cash and cash equivalents [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Less: Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Cash and cash equivalents recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Less: Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0" xml:lang="en-US">Cash flows from (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" xml:lang="en-US">Net cash generated by/(used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">Cash flows from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_0" xml:lang="en-US">Cash flows from (used in) financing activities, discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_1" xml:lang="en-US">Cash outflow from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_0" xml:lang="en-US">Cash flows from (used in) investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_1" xml:lang="en-US">Net cash (used in)/generated by investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">Cash flows from investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_0" xml:lang="en-US">Cash flows from (used in) investing activities, discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_1" xml:lang="en-US">Cash inflow from investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0" xml:lang="en-US">Cash flows from (used in) operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Cash flows from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_0" xml:lang="en-US">Cash flows from (used in) operating activities, discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_1" xml:lang="en-US">Cash (outflow)/inflow from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperations_0" xml:lang="en-US">Cash flows from (used in) operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperations_1" xml:lang="en-US">Cash used in operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0" xml:lang="en-US">Cash flows from (used in) operations before changes in working capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_1" xml:lang="en-US">Operating cash flows before changes in working capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_0" xml:lang="en-US">Cash repayments of advances and loans from related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_1" xml:lang="en-US">Loan origination costs paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashTransferred_0" xml:lang="en-US">Cash transferred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashTransferred_1" xml:lang="en-US">Cash consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_0" xml:lang="en-US">Financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0" xml:lang="en-US">Categories of related parties [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xml:lang="en-US">Categories of related parties [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesDomain_0" xml:lang="en-US">Categories of related parties [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Increase (decrease) in intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Charge for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_0" xml:lang="en-US">Cash-flows:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ChangesInPropertyPlantAndEquipment_0" xml:lang="en-US">Property, plant and equipment (see Note 13)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ChangesInPropertyPlantAndEquipment_1" xml:lang="en-US">Property, plant and equipment (see Note 11)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis_0" xml:lang="en-US">Classes of assets [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis_1" xml:lang="en-US">Classes of assets [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfAssetsDomain_0" xml:lang="en-US">Classes of assets [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsAxis_0" xml:lang="en-US">Classes of financial assets [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsDomain_0" xml:lang="en-US">Classes of financial assets [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_0" xml:lang="en-US">Classes of financial instruments [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialLiabilitiesAxis_0" xml:lang="en-US">Classes of financial liabilities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialLiabilitiesDomain_0" xml:lang="en-US">Classes of financial liabilities [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_0" xml:lang="en-US">Classes of intangible assets and goodwill [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xml:lang="en-US">Classes of intangible assets and goodwill [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_0" xml:lang="en-US">Classes of intangible assets other than goodwill [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfInventoriesAbstract_0" xml:lang="en-US">Classes of current inventories [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesAxis_0" xml:lang="en-US">Classes of liabilities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesDomain_0" xml:lang="en-US">Classes of liabilities [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfOtherProvisionsDomain_0" xml:lang="en-US">Classes of other provisions [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_0" xml:lang="en-US">Classes of property, plant and equipment [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xml:lang="en-US">Classes of property, plant and equipment [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfProvisionsAxis_0" xml:lang="en-US">Classes of other provisions [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ClassesOfProvisionsAxis_1" xml:lang="en-US">Classes of other provisions [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis_0" xml:lang="en-US">Classes of share capital [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfShareCapitalDomain_0" xml:lang="en-US">Classes of share capital [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis_0" xml:lang="en-US">Components of equity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis_1" xml:lang="en-US">Components of equity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfEquityDomain_0" xml:lang="en-US">Components of equity [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_0" xml:lang="en-US">Total comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_1" xml:lang="en-US">Total comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_2" xml:lang="en-US">Total Comprehensive Loss (all attributable to owners of the parent)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComputerEquipmentMember_0" xml:lang="en-US">Computer equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComputerEquipmentMember_1" xml:lang="en-US">Computer &amp; Office Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ConsiderationPaidReceived_0" xml:lang="en-US">Consideration paid (received)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Contingent consideration recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Deferred contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Contingent liabilities recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Contingent liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_0" xml:lang="en-US">Continuing and discontinued operations [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContinuingOperationsMember_0" xml:lang="en-US">Continuing operations [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_0" xml:lang="en-US">Patents and licences [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_0" xml:lang="en-US">Cost of inventories recognised as expense during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_1" xml:lang="en-US">Cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CostOfSales_0" xml:lang="en-US">Cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfSales_1" xml:lang="en-US">Cost of sales [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CounterpartiesAxis_0" xml:lang="en-US">Counterparties [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_0" xml:lang="en-US">Accruals and other liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssets_0" xml:lang="en-US">Current assets [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentAssets_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssetsAbstract_0" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssetsLiabilities_0" xml:lang="en-US">Current assets (liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentAssetsLiabilities_1" xml:lang="en-US">Net current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Current assets recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentContractAssets_0" xml:lang="en-US">Contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_0" xml:lang="en-US">Current deferred income other than current contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentInvestments_0" xml:lang="en-US">Current investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentInvestments_1" xml:lang="en-US">Strategic investment and partnership with MiCo</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilities_0" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentLiabilities_1" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_0" xml:lang="en-US">Current liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_1" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Current liabilities recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentMember_0" xml:lang="en-US">Not past due [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentPrepayments_0" xml:lang="en-US">Prepayments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentProvisions_0" xml:lang="en-US">Current provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentProvisions_1" xml:lang="en-US">Provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentProvisions_2" xml:lang="en-US">Provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_0" xml:lang="en-US">Raw materials and consumables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentReceivablesFromContractsWithCustomers_0" xml:lang="en-US">At a point in time</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentReceivablesFromRentalOfProperties_0" xml:lang="en-US">Finance lease receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentReceivablesFromRentalOfProperties_1" xml:lang="en-US">Finance lease receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTaxAssetsCurrent_0" xml:lang="en-US">Income tax receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome_0" xml:lang="en-US">Irish Corporation tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_0" xml:lang="en-US">Total current tax credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_1" xml:lang="en-US">Total current tax expense/(credit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_2" xml:lang="en-US">Total current tax credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_0" xml:lang="en-US">Current tax (credit)/ expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CurrentTaxLiabilitiesCurrent_0" xml:lang="en-US">Current corporation tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTaxLiabilitiesCurrent_1" xml:lang="en-US">Current tax liabilities, current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentTaxLiabilitiesCurrent_2" xml:lang="en-US">Income tax payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTradeReceivables_0" xml:lang="en-US">Trade receivables, net of impairment losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentTradeReceivables_1" xml:lang="en-US">Third party trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentValueAddedTaxPayables_0" xml:lang="en-US">Payroll taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentValueAddedTaxReceivables_0" xml:lang="en-US">Value added tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DecreaseThroughImpairmentContractAssets_0" xml:lang="en-US">Decrease through impairment, contract assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DecreaseThroughImpairmentContractAssets_1" xml:lang="en-US">Total impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DecreaseThroughWriteoffFinancialAssets_0" xml:lang="en-US">Amounts written off during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DecreaseThroughWriteoffFinancialAssets_1" xml:lang="en-US">Decrease through write-off, financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DecreaseThroughWriteoffFinancialAssets_2" xml:lang="en-US">Unpaid investment amount written off</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DeferredIncomeIncludingContractLiabilities_0" xml:lang="en-US">Deferred tax liabilities recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredIncomeIncludingContractLiabilities_1" xml:lang="en-US">Deferred income including contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DeferredIncomeIncludingContractLiabilities_2" xml:lang="en-US">Deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DeferredIncomeIncludingContractLiabilities_3" xml:lang="en-US">Total deferred income including contract liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredIncomeIncludingContractLiabilities_4" xml:lang="en-US">Deferred income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxAssets_0" xml:lang="en-US">Deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_0" xml:lang="en-US">Deferred tax assets and liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome_0" xml:lang="en-US">Total deferred tax (credit)/expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome_1" xml:lang="en-US">Total deferred tax charge/(credit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeAbstract_0" xml:lang="en-US">Deferred tax credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_0" xml:lang="en-US">Increase in net operating losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_1" xml:lang="en-US">Recognised in income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_0" xml:lang="en-US">Origination and reversal of temporary differences (see Note 15)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_1" xml:lang="en-US">Origination and reversal of temporary differences (see Note 14)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_0" xml:lang="en-US">Deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_1" xml:lang="en-US">Deferred tax liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_2" xml:lang="en-US">Deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilities_3" xml:lang="en-US">Deferred tax liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Deferred tax liabilities recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Deferred tax liabilities recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_0" xml:lang="en-US">Balance at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_1" xml:lang="en-US">Balance at beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset_2" xml:lang="en-US">Net deferred tax assets/(liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DefinedBenefitPlansAxis_0" xml:lang="en-US">Defined benefit plans [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DefinedBenefitPlansAxis_1" xml:lang="en-US">Defined benefit plans [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationAndAmortisationExpense_0" xml:lang="en-US">Depreciation on capitalised Intangible projects</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationExpense_0" xml:lang="en-US">Depreciation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DepreciationExpense_1" xml:lang="en-US">Deprecation for discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DepreciationExpense_2" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_0" xml:lang="en-US">Reduces assets property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_0" xml:lang="en-US">Depreciation charged on assets under operating lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DerivativeFinancialAssets_0" xml:lang="en-US">Derivative financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilities_0" xml:lang="en-US">Derivative financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_0" xml:lang="en-US">Description of accounting policy for borrowings [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_1" xml:lang="en-US">Convertible Note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_0" xml:lang="en-US">Description of accounting policy for business combinations and goodwill [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_1" xml:lang="en-US">Business combinations &amp; goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_0" xml:lang="en-US">Basis of consolidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_0" xml:lang="en-US">Exchangeable notes and derivative financial instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_0" xml:lang="en-US">Profit or loss from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_0" xml:lang="en-US">Employee benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_0" xml:lang="en-US">Fair values</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinanceCostsExplanatory_0" xml:lang="en-US">Cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_0" xml:lang="en-US">Finance income and costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_0" xml:lang="en-US">Foreign currency</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_0" xml:lang="en-US">Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_0" xml:lang="en-US">Government grants and financial support</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory_0" xml:lang="en-US">Hedging</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_0" xml:lang="en-US">Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0" xml:lang="en-US">Intangibles, including research and development (other than goodwill)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_0" xml:lang="en-US">Equity at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_1" xml:lang="en-US">Equity at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_2" xml:lang="en-US">Description of accounting policy for issued capital [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_3" xml:lang="en-US">Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0" xml:lang="en-US">Description of accounting policy for measuring inventories [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_0" xml:lang="en-US">Description of accounting policy for provisions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_1" xml:lang="en-US">Provisions and contingent liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_2" xml:lang="en-US">Provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0" xml:lang="en-US">Revenue recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_0" xml:lang="en-US">Segment reporting</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0" xml:lang="en-US">Share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory_0" xml:lang="en-US">Tax (current and deferred)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_0" xml:lang="en-US">Description of accounting policy for trade and other payables [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_1" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_0" xml:lang="en-US">Description of accounting policy for trade and other receivables [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_1" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_0" xml:lang="en-US">Description Of Accounting Policy For Treasury Shares Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_1" xml:lang="en-US">Treasury shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_0" xml:lang="en-US">Description of arrangement for contingent consideration arrangements and indemnification assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_1" xml:lang="en-US">Description of arrangement for contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfConversionOfDebtToEquity_0" xml:lang="en-US">Description of conversion of debt to equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfConversionOfDebtToEquity_1" xml:lang="en-US">Description of conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_0" xml:lang="en-US">Cash flow projections</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_0" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_1" xml:lang="en-US">Standards, amendments and interpretations to existing IFRS Standards that are not yet effective</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_0" xml:lang="en-US">Weighted average expected volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_0" xml:lang="en-US">Weighted average expected life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_0" xml:lang="en-US">Weighted average risk free interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Description of useful life, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_0" xml:lang="en-US">Description of useful life, property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_1" xml:lang="en-US">Estimated useful lives of intangible assets (In years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue_0" xml:lang="en-US">Description of whether investment in associate is measured using equity method or at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue_1" xml:lang="en-US">Description of whether investment in associate is measured using equity method or at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_0" xml:lang="en-US">Diluted loss per ADS (US Dollars) - group</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_1" xml:lang="en-US">Diluted loss per ADS (US Dollars) &#8211; group</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_0" xml:lang="en-US">Diluted loss per ADS (US Dollars) - continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_1" xml:lang="en-US">Diluted loss per ADS (US Dollars) &#8211; continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_0" xml:lang="en-US">Diluted earnings/(loss per ADS (US Dollars) - discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_1" xml:lang="en-US">Diluted earnings/(loss) per ADS (US Dollars) - discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_2" xml:lang="en-US">Diluted (loss)/earnings per &#8216;A&#8217; share (US Dollars) &#8211; discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DirectorsRemunerationExpense_0" xml:lang="en-US">Remuneration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DirectorsRemunerationExpense_1" xml:lang="en-US">Non executive directors fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_0" xml:lang="en-US">ACCOUNTING ESTIMATES AND JUDGEMENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory_0" xml:lang="en-US">Schedule of Persons Employed by the Group in the Financial Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory_0" xml:lang="en-US">Basis of preparation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory_1" xml:lang="en-US">Basis of preparation and going concern</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0" xml:lang="en-US">Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0" xml:lang="en-US">Disclosure of analysis of single amount of discontinued operations [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_0" xml:lang="en-US">Disclosure of analysis of single amount of discontinued operations [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory_0" xml:lang="en-US">Disclosure of attribution of expenses by nature to their function [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory_1" xml:lang="en-US">Schedule of Restructuring Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0" xml:lang="en-US">Disclosure of attribution of expenses by nature to their function [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_0" xml:lang="en-US">Disclosure of attribution of expenses by nature to their function [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_0" xml:lang="en-US">Disclosure of borrowings [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_1" xml:lang="en-US">INTEREST-BEARING LOANS AND BORROWINGS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0" xml:lang="en-US">Disclosure of detailed information about business combination [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_0" xml:lang="en-US">Disclosure of business combinations [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1" xml:lang="en-US">BUSINESS COMBINATIONS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_0" xml:lang="en-US">Disclosure of detailed information about business combination [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_0" xml:lang="en-US">Disclosure of cash and cash equivalents [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_1" xml:lang="en-US">CASH AND CASH EQUIVALENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCashFlowStatementExplanatory_0" xml:lang="en-US">RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_0" xml:lang="en-US">Disclosure of changes in accounting estimates [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_0" xml:lang="en-US">Disclosure of changes in accounting estimates [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0" xml:lang="en-US">Disclosure of classes of share capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_0" xml:lang="en-US">Schedule of Share Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xml:lang="en-US">Disclosure of classes of share capital [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0" xml:lang="en-US">Disclosure of classes of share capital [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_0" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfComparativeInformationPreparedUnderPreviousGAAPLineItems_0" xml:lang="en-US">Disclosure of comparative information prepared under previous GAAP [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfComparativeInformationPreparedUnderPreviousGAAPTable_0" xml:lang="en-US">Disclosure of comparative information prepared under previous GAAP [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExplanatory_0" xml:lang="en-US">Schedule of Maximum Credit Exposure of Financial Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExposureLineItems_0" xml:lang="en-US">Disclosure of credit risk exposure [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCreditRiskExposureTable_0" xml:lang="en-US">Disclosure of credit risk exposure [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_0" xml:lang="en-US">DEFERRED TAX ASSETS AND LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_0" xml:lang="en-US">Schedule of Employment Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_0" xml:lang="en-US">Disclosure of defined benefit plans [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable_0" xml:lang="en-US">Disclosure of defined benefit plans [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about borrowings [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1" xml:lang="en-US">Schedule of Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0" xml:lang="en-US">Disclosure of detailed information about borrowings [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_0" xml:lang="en-US">Disclosure of detailed information about borrowings [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_0" xml:lang="en-US">Disclosure of detailed information about business combination [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_1" xml:lang="en-US">Schedule of Assets Acquired and Liabilities, Fair Values at Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_0" xml:lang="en-US">Schedule of Principal Development Projects</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Schedule of Property, Plant and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_0" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_0" xml:lang="en-US">(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATION</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_1" xml:lang="en-US">(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_0" xml:lang="en-US">LOSS PER SHARE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1" xml:lang="en-US">LOSS PER SHARE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_0" xml:lang="en-US">SEGMENT INFORMATION</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_0" xml:lang="en-US">Schedule of Fair Values of Financial Assets/Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_0" xml:lang="en-US">Disclosure of fair value measurement of assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_0" xml:lang="en-US">Disclosure of fair value measurement of assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xml:lang="en-US">Disclosure of fair value measurement of liabilities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_0" xml:lang="en-US">Disclosure of fair value measurement of liabilities [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinanceIncomeExplanatory_0" xml:lang="en-US">FINANCIAL INCOME AND EXPENSES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsAbstract_0" xml:lang="en-US">Disclosure of financial assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsExplanatory_0" xml:lang="en-US">Disclosure of financial assets [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsExplanatory_1" xml:lang="en-US">FINANCIAL ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xml:lang="en-US">Disclosure of financial assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsTable_0" xml:lang="en-US">Disclosure of financial assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_1" xml:lang="en-US">Disclosure of detailed information about financial instruments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_0" xml:lang="en-US">Disclosure of financial instruments [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1" xml:lang="en-US">CAPITAL AND FINANCIAL RISK MANAGEMENT</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_0" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_0" xml:lang="en-US">Disclosure of financial liabilities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialLiabilitiesTable_0" xml:lang="en-US">Disclosure of financial liabilities [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_0" xml:lang="en-US">SELLING, GENERAL AND ADMINISTRATIVE EXPENSES - CLOSURE COSTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_0" xml:lang="en-US">Schedule of Revenue by Geographical Area Based on Location of Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGoodwillExplanatory_0" xml:lang="en-US">Schedule of Significant Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory_0" xml:lang="en-US">IMPAIRMENT CHARGES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory_1" xml:lang="en-US">IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_0" xml:lang="en-US">INCOME TAX (EXPENSE)/CREDIT</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_0" xml:lang="en-US">Schedule of Assumption Determining Fair Value of Share Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_0" xml:lang="en-US">Schedule of Fair Value of the Options Vesting Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems_0" xml:lang="en-US">Disclosure of information about amounts that affected statement of comprehensive income as result of hedge accounting [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable_0" xml:lang="en-US">Disclosure of information about amounts that affected statement of comprehensive income as result of hedge accounting [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory_0" xml:lang="en-US">PENSION SCHEMES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_0" xml:lang="en-US">EMPLOYMENT</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_0" xml:lang="en-US">Disclosure of intangible assets and goodwill [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_1" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityExplanatory_0" xml:lang="en-US">Schedule of Impairment Loss for Each Class of Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_0" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xml:lang="en-US">Disclosure of intangible assets with indefinite useful life [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_0" xml:lang="en-US">Disclosure of intangible assets with indefinite useful life [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory_0" xml:lang="en-US">INVENTORIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory_0" xml:lang="en-US">LEASE LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory_0" xml:lang="en-US">Schedule of Future Minimum Rentals Receivable Under Non-Cancellable Operating Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_0" xml:lang="en-US">Disclosure of maturity analysis of finance lease payments receivable [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_0" xml:lang="en-US">Disclosure of maturity analysis of finance lease payments receivable [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_0" xml:lang="en-US">Schedule of Future Minimum Finance Lease Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_0" xml:lang="en-US">Disclosure of maturity analysis of operating lease payments [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_0" xml:lang="en-US">Schedule of Interest Rate Risk Effective and Repricing Analysis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1" xml:lang="en-US">POST BALANCE SHEET EVENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_0" xml:lang="en-US">Summary of Range of Prices of Stock Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1" xml:lang="en-US">Schedule of Range of Prices of Stock Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_0" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0" xml:lang="en-US">Disclosure of operating segments [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_1" xml:lang="en-US">Disclosure of operating segments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_0" xml:lang="en-US">Schedule of Segment Results by Geographical Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems_0" xml:lang="en-US">Disclosure of operating segments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsTable_0" xml:lang="en-US">Disclosure of operating segments [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOtherAssetsExplanatory_0" xml:lang="en-US">OTHER NON-CURRENT ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_0" xml:lang="en-US">Schedule of Other Operating Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_0" xml:lang="en-US">OTHER OPERATING (EXPENSE) / INCOME</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsExplanatory_0" xml:lang="en-US">Schedule of Provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsLineItems_0" xml:lang="en-US">Disclosure of other provisions [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOtherProvisionsTable_0" xml:lang="en-US">Disclosure of other provisions [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfProductsAndServicesExplanatory_0" xml:lang="en-US">Schedule of Revenue by Major Product Group</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfProductsAndServicesLineItems_0" xml:lang="en-US">Disclosure of products and services [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfProductsAndServicesTable_0" xml:lang="en-US">Disclosure of products and services [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_1" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfProvisionsExplanatory_0" xml:lang="en-US">PROVISIONS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_0" xml:lang="en-US">Schedule of Right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_0" xml:lang="en-US">Schedule of Goodwill and Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_0" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xml:lang="en-US">Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_0" xml:lang="en-US">Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract_0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_0" xml:lang="en-US">Schedule of Liabilities Arising from Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_0" xml:lang="en-US">RELATED PARTY TRANSACTIONS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_0" xml:lang="en-US">Schedule of Revenue by Customers' Geographical Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_0" xml:lang="en-US">CAPITAL AND RESERVES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_0" xml:lang="en-US">Disclosure of subsidiaries [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1" xml:lang="en-US">Schedule of Subsidiary Undertakings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_0" xml:lang="en-US">Schedule of Unrecognised Deferred Tax Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_0" xml:lang="en-US">Disclosure of trade and other payables [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_1" xml:lang="en-US">TRADE AND OTHER PAYABLES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_0" xml:lang="en-US">Disclosure of trade and other receivables [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1" xml:lang="en-US">TRADE AND OTHER RECEIVABLES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0" xml:lang="en-US">Disclosure of transactions between related parties [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xml:lang="en-US">Disclosure of transactions between related parties [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_0" xml:lang="en-US">Disclosure of transactions between related parties [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DiscontinuedOperationsMember_0" xml:lang="en-US">Discontinued operations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DividendsPaidClassifiedAsFinancingActivities_0" xml:lang="en-US">Payment of dividend</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareAbstract_0" xml:lang="en-US">Earnings per share [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_0" xml:lang="en-US">Effects of exchange rate movements on cash held</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EffectOfTransitionToIFRSsMember_0" xml:lang="en-US">Impairment adjustment on transition [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EliminationOfIntersegmentAmountsMember_0" xml:lang="en-US">Eliminations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EliminationOfIntersegmentAmountsMember_1" xml:lang="en-US">Eliminations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EmployeeBenefitsExpense_0" xml:lang="en-US">Employee benefits expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EmployeeBenefitsExpense_1" xml:lang="en-US">Employment Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_Equity_0" xml:lang="en-US">Equity at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_Equity_1" xml:lang="en-US">Equity at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Equity_2" xml:lang="en-US">Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Equity_3" xml:lang="en-US">Total equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAbstract_0" xml:lang="en-US">Equity attributable to the equity holders of the parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilities_0" xml:lang="en-US">Equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EquityAndLiabilities_1" xml:lang="en-US">TOTAL EQUITY AND LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract_0" xml:lang="en-US">EQUITY AND LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_0" xml:lang="en-US">Equity interests of acquirer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer_1" xml:lang="en-US">Non-cash consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_0" xml:lang="en-US">Weighted average exercise price per 'A' share / (per ADS)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpectedCreditLossRate_0" xml:lang="en-US">Expected credit loss rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ExpenseOfRestructuringActivities_0" xml:lang="en-US">Total restructuring costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseOfRestructuringActivities_1" xml:lang="en-US">Expense of restructuring activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseOfRestructuringActivities_2" xml:lang="en-US">Total restructuring costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExpenseOfRestructuringActivities_3" xml:lang="en-US">Restructuring cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_0" xml:lang="en-US">Leases of low value assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_0" xml:lang="en-US">Short term leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities_0" xml:lang="en-US">Variable lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExplanationOfNotAppliedNewStandardsOrInterpretations_0" xml:lang="en-US">Explanation of new standards or interpretations not applied</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExplanationOfNotAppliedNewStandardsOrInterpretations_1" xml:lang="en-US">Standards, amendments and interpretations to existing IFRS Standards that are not yet effective</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets_0" xml:lang="en-US">Description of project completion period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_0" xml:lang="en-US">Non-cash financial (income)/expense (Note 8)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_1" xml:lang="en-US">Financial expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_2" xml:lang="en-US">Financial expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_3" xml:lang="en-US">Fee income (expense) arising from financial assets or financial liabilities not at fair value through profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_4" xml:lang="en-US">Non-cash financial expense/(income) (Note 8)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_5" xml:lang="en-US">Financial income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FinanceCosts_0" xml:lang="en-US">Financial expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_ifrs-full_FinanceCosts_1" xml:lang="en-US">Financial expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceCosts_2" xml:lang="en-US">Finance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinanceCosts_3" xml:lang="en-US">Financial expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceIncome_0" xml:lang="en-US">Financial income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_FinanceIncome_1" xml:lang="en-US">Financial income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FinanceIncomeCost_0" xml:lang="en-US">Non-cash financial expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceIncomeCost_1" xml:lang="en-US">Finance income (cost)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinanceIncomeCost_2" xml:lang="en-US">Non-cash financial expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_FinancialAssets_0" xml:lang="en-US">Cost At December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_FinancialAssets_1" xml:lang="en-US">Cost At January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssets_2" xml:lang="en-US">Financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinancialAssets_3" xml:lang="en-US">Financial assets (see Note 13)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValue_0" xml:lang="en-US">Financial assets, at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValue_1" xml:lang="en-US">Carrying amount At December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Financial assets recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_3" xml:lang="en-US">Financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialEffectOfTransitionFromPreviousGAAPToIFRSsAxis_0" xml:lang="en-US">Financial effect of transition from previous GAAP to IFRSs [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialLiabilities_0" xml:lang="en-US">Total maturities of financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCost_0" xml:lang="en-US">Total Liabilities at amortised cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCost_1" xml:lang="en-US">Total Liabilities at amortised cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCost_2" xml:lang="en-US">Financial liabilities at amortised cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCost_3" xml:lang="en-US">Total Liabilities at amortised cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinishedGoods_0" xml:lang="en-US">Finished goods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation_0" xml:lang="en-US">(Loss)/Gain on sale of discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation_1" xml:lang="en-US">Gain (loss) recognised on measurement to fair value less costs to sell or on disposal of assets or disposal groups constituting discontinued operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination_0" xml:lang="en-US">Gain (loss) that relates to identifiable assets acquired or liabilities assumed in business combination and is of such size, nature or incidence that disclosure is relevant to understanding combined entity's financial statements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination_1" xml:lang="en-US">Acquired business incurred net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainRecognisedInBargainPurchaseTransaction_0" xml:lang="en-US">Gain on purchase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeographicalAreasAxis_0" xml:lang="en-US">Geographical areas [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GeographicalAreasAxis_1" xml:lang="en-US">Geographical areas [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeographicalAreasDomain_0" xml:lang="en-US">Geographical areas [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GoodwillMember_0" xml:lang="en-US">Goodwill [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Goodwill recognised in connection with acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Goodwill recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_3" xml:lang="en-US">Goodwill and Intangible assets acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_4" xml:lang="en-US">Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossCarryingAmountMember_0" xml:lang="en-US">Cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossLeaseLiabilities_0" xml:lang="en-US">Gross lease liabilities at January 1, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossLoanCommitments_0" xml:lang="en-US">Gross loan commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GrossLoanCommitments_1" xml:lang="en-US">Outstanding principal term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossProfit_0" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GrossProfit_1" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0" xml:lang="en-US">Net assets acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_1" xml:lang="en-US">Identifiable assets acquired (liabilities assumed)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Intangible assets - arising on acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Identifiable intangible assets recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Intangible assets - arising on acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_3" xml:lang="en-US">Other intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ImpairmentLoss_0" xml:lang="en-US">Impairment charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLoss_1" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/commentaryGuidance" xlink:label="lab_ifrs-full_ImpairmentLossOnFinancialAssets_0" xml:lang="en-US">This element should be used to tag non-restated comparative information only.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ImpairmentLossOnFinancialAssets_1" xml:lang="en-US">Impairment in the current year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_ImpairmentLossOnFinancialAssets_2" xml:lang="en-US">Financial assets at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_ImpairmentLossOnFinancialAssets_3" xml:lang="en-US">Financial assets at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_ImpairmentLossOnFinancialAssets_4" xml:lang="en-US">Financial assets (see Note 13)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossOnFinancialAssets_5" xml:lang="en-US">Impairment loss on financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ImpairmentLossOnFinancialAssets_6" xml:lang="en-US">Impairment of financial assets (Note 13)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ImpairmentLossOnFinancialAssets_7" xml:lang="en-US">Total financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ImpairmentLossOnFinancialAssets_8" xml:lang="en-US">Liabilities related to financial assets (reversal)/written off</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome_0" xml:lang="en-US">Impairment loss recognised in other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_0" xml:lang="en-US">Total impairment loss allocated to goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_0" xml:lang="en-US">Impairment of goodwill and other intangible assets (Note 12)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Impairment of intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Impairment losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_2" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossInvestmentProperty_0" xml:lang="en-US">Remaining impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_0" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1" xml:lang="en-US">Impairment of PP&amp;E (Note 11)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_2" xml:lang="en-US">Impairment of PP&amp;E (Note 13)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_3" xml:lang="en-US">Impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_0" xml:lang="en-US">Impairment loss recognised in profit or loss, trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_1" xml:lang="en-US">Total impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0" xml:lang="en-US">Impairment charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1" xml:lang="en-US">Impairment loss (reversal of impairment loss) recognised in profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_0" xml:lang="en-US">Impairment loss (reversal of impairment loss) recognised in profit or loss, trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_1" xml:lang="en-US">Total impairment loss after tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeFromFinesAndPenalties_0" xml:lang="en-US">Penalties income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeFromSubleasingRightofuseAssets_0" xml:lang="en-US">Income from sub-letting right-of-use</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeRelatingToVariableLeasePaymentsForOperatingLeasesThatDoNotDependOnIndexOrRate_0" xml:lang="en-US">Net book value of assets held under operating lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeStatementAbstract_0" xml:lang="en-US">Profit or loss [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefund_0" xml:lang="en-US">Income tax credit (Note 9)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefund_1" xml:lang="en-US">Income tax credit (Note 7)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_0" xml:lang="en-US">Income taxes received/(paid)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_1" xml:lang="en-US">Income taxes (paid) / received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xml:lang="en-US">Total income tax (expense)/credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_1" xml:lang="en-US">Total income tax charge/(credit) on continuing operations in statement of operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome_0" xml:lang="en-US">Foreign currency translation reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xml:lang="en-US">Increase (decrease) in cash and cash equivalents after effect of exchange rate changes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1" xml:lang="en-US">Cash outflows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2" xml:lang="en-US">Increase/(decrease) in cash and cash equivalents and short-term investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_0" xml:lang="en-US">Contingent liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInCreditDerivativeNominalAmount_0" xml:lang="en-US">Derivatives balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset_0" xml:lang="en-US">Unrecognised deferred tax asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_0" xml:lang="en-US">Increase (decrease) in number of ordinary shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_1" xml:lang="en-US">Ordinary shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_2" xml:lang="en-US">Issued for a cash consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_0" xml:lang="en-US">Purchased during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Fair value of derivative liability - warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_0" xml:lang="en-US">Increase (decrease) through conversion of convertible instruments, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_1" xml:lang="en-US">Amount of investment from MiCo</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Exchange adjustment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0" xml:lang="en-US">Options or warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_0" xml:lang="en-US">Increase (decrease) through net exchange differences, intangible assets and goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_1" xml:lang="en-US">Exchange adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_0" xml:lang="en-US">Exchange adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Reduction in accrued interest payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_0" xml:lang="en-US">Charge for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_1" xml:lang="en-US">Charge for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0" xml:lang="en-US">Share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_1" xml:lang="en-US">Share based payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_2" xml:lang="en-US">Share based payments charge</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_3" xml:lang="en-US">Total share based payments, inclusive of amounts capitalised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_0" xml:lang="en-US">Provision for reduced warranty claims</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_0" xml:lang="en-US">Reallocations / reclassifications</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseThroughOriginationOrPurchaseFinancialAssets_0" xml:lang="en-US">Charged to costs and expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill_0" xml:lang="en-US">Balance at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill_1" xml:lang="en-US">Balance at beginning year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill_2" xml:lang="en-US">Goodwill and intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill_3" xml:lang="en-US">Intangible assets and goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill_4" xml:lang="en-US">Goodwill and intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill_5" xml:lang="en-US">Carrying amounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_0" xml:lang="en-US">Intangible assets other than goodwill [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsUnderDevelopment_0" xml:lang="en-US">Intangible assets under development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsUnderDevelopment_1" xml:lang="en-US">Internally developed intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsUnderDevelopment_2" xml:lang="en-US">Development costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_0" xml:lang="en-US">Intangible assets with indefinite useful lives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_0" xml:lang="en-US">Intangible assets with indefinite useful life [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1" xml:lang="en-US">Intangible assets with indefinite useful life [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_0" xml:lang="en-US">Intangible assets with indefinite useful life [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpense_0" xml:lang="en-US">Interest expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InterestExpense_1" xml:lang="en-US">Value attributable to interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_InterestExpense_2" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_0" xml:lang="en-US">Cash interest on exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_1" xml:lang="en-US">Cash interest on exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_2" xml:lang="en-US">Cash interest expense (Note 8)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_0" xml:lang="en-US">Interest on leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_1" xml:lang="en-US">Interest on finance leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_0" xml:lang="en-US">Non-cash interest on exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_1" xml:lang="en-US">Interest Expense On Other Financial Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_2" xml:lang="en-US">Accretion interest (Note 8)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_3" xml:lang="en-US">Non-cash interest on exchangeable notes (Note 8)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_InterestIncomeOnOtherFinancialAssets_0" xml:lang="en-US">Non-cash financial expense/(income) (Note 8)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestIncomeOnOtherFinancialAssets_1" xml:lang="en-US">Non-cash financial income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InterestIncomeOnOtherFinancialAssets_2" xml:lang="en-US">Financial income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_0" xml:lang="en-US">Interest paid on exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_1" xml:lang="en-US">Interest paid for term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_2" xml:lang="en-US">Interest paid, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestPayable_0" xml:lang="en-US">Interest payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_0" xml:lang="en-US">Interest received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Inventories_0" xml:lang="en-US">Current inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Inventories_1" xml:lang="en-US">Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Inventories_2" xml:lang="en-US">Total inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Inventories_3" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InventoriesAtNetRealisableValue_0" xml:lang="en-US">Inventories, at net realisable value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Inventory recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_0" xml:lang="en-US">Investments accounted for using equity method</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_1" xml:lang="en-US">Equity investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapital_0" xml:lang="en-US">Share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapitalMember_0" xml:lang="en-US">Share Capital 'A' Ordinary shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssueOfConvertibleInstruments_0" xml:lang="en-US">Issue of convertible instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssueOfEquity_0" xml:lang="en-US">Issue of equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssueOfEquity_1" xml:lang="en-US">Shares issued in the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation_0" xml:lang="en-US">Key management personnel compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation_1" xml:lang="en-US">Total compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_0" xml:lang="en-US">Post-employment benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_0" xml:lang="en-US">Share-based compensation benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_1" xml:lang="en-US">Share-based compensation benefits as calculated under IFRS 2</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_0" xml:lang="en-US">Short-term employee benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_0" xml:lang="en-US">Compensation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_0" xml:lang="en-US">Key management personnel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LandAndBuildingsMember_0" xml:lang="en-US">Land and buildings [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LandAndBuildingsMember_1" xml:lang="en-US">Land &amp; Buildings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember_0" xml:lang="en-US">More than five years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember_1" xml:lang="en-US">Later than five years [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember_0" xml:lang="en-US">Past due 0-30 days [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_0" xml:lang="en-US">Between one and five years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0" xml:lang="en-US">In more than one year, but not more than two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseCommitmentsForShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_0" xml:lang="en-US">Outstanding commitments on lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseholdImprovementsMember_0" xml:lang="en-US">Leasehold improvements [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LeaseholdImprovementsMember_1" xml:lang="en-US">Leasehold improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_0" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_LeaseLiabilities_1" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilities_2" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilitiesMember_0" xml:lang="en-US">Lease liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LegalProceedingsProvision_0" xml:lang="en-US">Legal proceedings provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LegalProceedingsProvision_1" xml:lang="en-US">Provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LegalProceedingsProvision_2" xml:lang="en-US">Legal &amp; regulatory provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Level1OfFairValueHierarchyMember_0" xml:lang="en-US">Level 1 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Level2OfFairValueHierarchyMember_0" xml:lang="en-US">Level 2 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember_0" xml:lang="en-US">Level 3 of fair value hierarchy [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember_1" xml:lang="en-US">Level 3 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_0" xml:lang="en-US">Levels of fair value hierarchy [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_1" xml:lang="en-US">Levels of fair value hierarchy [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Liabilities_1" xml:lang="en-US">TOTAL LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">Fixed rate financial liabilities (lease payables)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Balance at December 31, 2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_2" xml:lang="en-US">Balance at January 1, 2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_3" xml:lang="en-US">Liabilities arising from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_4" xml:lang="en-US">Fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_0" xml:lang="en-US">Liabilities arising from financing activities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiquidityRiskMember_0" xml:lang="en-US">Liquidity risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LoansPayableInDefault_0" xml:lang="en-US">Loans payable in default</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_LongtermBorrowings_0" xml:lang="en-US">Exchangeable note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_LongtermBorrowings_1" xml:lang="en-US">Fixed rate financial liabilities (exchangeable note)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_LongtermBorrowings_2" xml:lang="en-US">Balance at 31 December</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_LongtermBorrowings_3" xml:lang="en-US">Balance at 1 January</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LongtermBorrowings_4" xml:lang="en-US">Exchangeable notes and other borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LongtermBorrowings_5" xml:lang="en-US">Exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LongtermBorrowings_6" xml:lang="en-US">Exchangeable senior notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LongtermBorrowingsMember_0" xml:lang="en-US">Borrowings &amp; derivative financial instruments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_0" xml:lang="en-US">Loss on the disposal of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_1" xml:lang="en-US">(Profit)/Loss on the disposal of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_2" xml:lang="en-US">(Gain)/Loss on the disposal of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_3" xml:lang="en-US">(Profit)/Loss on the disposal of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MajorCustomersDomain_0" xml:lang="en-US">End-user customers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaturityAxis_0" xml:lang="en-US">Maturity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_MaturityAxis_1" xml:lang="en-US">Maturity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaturityDomain_0" xml:lang="en-US">Maturity [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_ifrs-full_MaximumExposureToCreditRisk_0" xml:lang="en-US">Total maximum credit exposure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaximumExposureToCreditRisk_1" xml:lang="en-US">Maximum exposure to credit risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MaximumExposureToCreditRisk_2" xml:lang="en-US">Total maximum credit exposure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables_0" xml:lang="en-US">Maximum Exposure to credit risk for trade receivables and finance lease income receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_0" xml:lang="en-US">Miscellaneous non-current assets [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NameOfSubsidiary_0" xml:lang="en-US">Name of subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NetAssetsLiabilities_0" xml:lang="en-US">Assets (liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NetAssetsLiabilities_1" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NetDeferredTaxAssets_0" xml:lang="en-US">Net deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NetDeferredTaxAssets_1" xml:lang="en-US">Total assets as reported in the Group balance sheet</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NetDeferredTaxAssets_2" xml:lang="en-US">Total assets as reported in the Group balance sheet</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NetDeferredTaxLiabilities_0" xml:lang="en-US">Net deferred tax liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NetDeferredTaxLiabilities_1" xml:lang="en-US">Total liabilities as reported in the Group balance sheet</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NetDeferredTaxLiabilities_2" xml:lang="en-US">Total liabilities as reported in the Group balance sheet</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NewProvisionsOtherProvisions_0" xml:lang="en-US">Released during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NewProvisionsOtherProvisions_1" xml:lang="en-US">New provisions, other provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NewProvisionsOtherProvisions_2" xml:lang="en-US">Inventory provision released during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0" xml:lang="en-US">Nonadjusting Events After Reporting Period Axis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_2" xml:lang="en-US">Non-adjusting events after reporting period [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0" xml:lang="en-US">Non-adjusting events after reporting period [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncontrollingInterests_0" xml:lang="en-US">Non-controlling interests</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncontrollingInterests_1" xml:lang="en-US">Equity investments in Novus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssets_0" xml:lang="en-US">Non-current assets [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentAssets_1" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract_0" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsHeldForSaleMember_0" xml:lang="en-US">Non-current assets held for sale [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0" xml:lang="en-US">Non-current assets or disposal groups classified as held for sale or as held for distribution to owners</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_1" xml:lang="en-US">Total net assets disposed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Non-current assets recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentAssetsRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_0" xml:lang="en-US">Derivative asset &#8211; prepayment option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_1" xml:lang="en-US">Non-current derivative financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_2" xml:lang="en-US">Derivative financial instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_3" xml:lang="en-US">Exchangeable note bond call option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities_0" xml:lang="en-US">Derivative liability - warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities_1" xml:lang="en-US">Non-current derivative financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities_2" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities_3" xml:lang="en-US">Derivative financial liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentFinanceLeaseReceivables_0" xml:lang="en-US">non current Finance lease receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentFinanceLeaseReceivables_1" xml:lang="en-US">Finance lease receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentFinancialAssets_0" xml:lang="en-US">Non-current financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentFinancialAssets_1" xml:lang="en-US">Financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilities_0" xml:lang="en-US">Non-current liabilities [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilities_1" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract_0" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Non-current liabilities recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_0" xml:lang="en-US">Senior secured term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_1" xml:lang="en-US">Variable rate financial liabilities (senior secured term loan)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_2" xml:lang="en-US">Non-current portion of other non-current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_3" xml:lang="en-US">Senior secured term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_4" xml:lang="en-US">Variable rate financial liabilities (senior secured term loan)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentProvisions_0" xml:lang="en-US">Non-current provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentProvisions_1" xml:lang="en-US">Provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers_0" xml:lang="en-US">Over time</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NongovernmentCustomersMember_0" xml:lang="en-US">Non-government customers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NongovernmentCustomersMember_1" xml:lang="en-US">Non-governmental organisations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotesAndDebenturesIssued_0" xml:lang="en-US">Issuance of exchangeable senior notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotionalAmount_0" xml:lang="en-US">Notional amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NotionalAmount_1" xml:lang="en-US">Face amount of loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember_0" xml:lang="en-US">Less than one year [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_0" xml:lang="en-US">Outstanding at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_1" xml:lang="en-US">Outstanding Beginning Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_2" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions_3" xml:lang="en-US">Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_0" xml:lang="en-US">Number of potential ordinary shares that are antidilutive in period presented</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_1" xml:lang="en-US">Total number of potentially dilutive instruments excluded from the weighted average number of &#8216;A&#8217; ordinary shares in calculating dilutive (loss)/earnings per &#8216;A&#8217; ordinary share/earnings per ADS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_2" xml:lang="en-US">Diluted earnings per share denominator</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_0" xml:lang="en-US">Exercisable at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2" xml:lang="en-US">Number of Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_0" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2" xml:lang="en-US">Ordinary shares issued from exercise of employee share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3" xml:lang="en-US">Number of share options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_0" xml:lang="en-US">Expired / forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options expired in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_0" xml:lang="en-US">Expired/ Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesAuthorised_0" xml:lang="en-US">Authorised share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_0" xml:lang="en-US">At period end</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_1" xml:lang="en-US">Number of shares at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_2" xml:lang="en-US">Number of ADS at January 1 (Note 18)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesIssued_3" xml:lang="en-US">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued_4" xml:lang="en-US">Number of ADSs issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_0" xml:lang="en-US">At period end</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_1" xml:lang="en-US">Balance at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_2" xml:lang="en-US">Number of shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OfficeEquipmentMember_0" xml:lang="en-US">Office equipment and fittings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_OperatingExpense_0" xml:lang="en-US">Operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OperatingExpense_1" xml:lang="en-US">Operating expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OperatingExpense_2" xml:lang="en-US">Operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherAdjustmentsForNoncashItems_0" xml:lang="en-US">Other non-cash items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_OtherBorrowings_0" xml:lang="en-US">Other borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherBorrowings_1" xml:lang="en-US">Other borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncome_0" xml:lang="en-US">Other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncome_1" xml:lang="en-US">Other comprehensive profit/(loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncome_2" xml:lang="en-US">Other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract_0" xml:lang="en-US">Other comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract_1" xml:lang="en-US">Other comprehensive profit/(loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_0" xml:lang="en-US">Foreign exchange translation differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_0" xml:lang="en-US">Items that will be reclassified subsequently to profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherIncome_0" xml:lang="en-US">Other income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherIncome_1" xml:lang="en-US">Government grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherIntangibleAssets_0" xml:lang="en-US">Other intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherIntangibleAssetsMember_0" xml:lang="en-US">Intangible assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherIntangibleAssetsMember_1" xml:lang="en-US">Other (including acquired customer and supplier lists) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherIntangibleAssetsMember_2" xml:lang="en-US">Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherNoncurrentAssets_0" xml:lang="en-US">Other non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherNoncurrentAssets_1" xml:lang="en-US">Total other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherNoncurrentFinancialAssets_0" xml:lang="en-US">Other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense_0" xml:lang="en-US">Other operating income (expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense_1" xml:lang="en-US">Other operating (expense)/income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense_2" xml:lang="en-US">Other operating income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense_3" xml:lang="en-US">Other operating income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/measurementGuidance" xlink:label="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember_0" xml:lang="en-US">Plant &amp; Equipment, Vehicles [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember_1" xml:lang="en-US">Other property, plant and equipment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember_2" xml:lang="en-US">Plant and Equipment, vehicles [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_OtherProvisions_0" xml:lang="en-US">Closing provision at December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_OtherProvisions_1" xml:lang="en-US">Opening provision at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherProvisions_2" xml:lang="en-US">Other provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherProvisions_3" xml:lang="en-US">Disposal-related warranty settlement provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherReceivables_0" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherReceivables_1" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherReserves_0" xml:lang="en-US">Other reserves</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherReservesMember_0" xml:lang="en-US">Other reserves [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherRevenue_0" xml:lang="en-US">Inter-segment revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherRevenue_1" xml:lang="en-US">Revenue from other sources</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_0" xml:lang="en-US">Other items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ParValuePerShare_0" xml:lang="en-US">Par value of share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PastDueStatusAxis_0" xml:lang="en-US">Past due status [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PastDueStatusAxis_1" xml:lang="en-US">Past due status [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsForDevelopmentProjectExpenditure_0" xml:lang="en-US">Capital expenditure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_0" xml:lang="en-US">Expenses paid in connection with debt financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_1" xml:lang="en-US">Payments for share issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PaymentsForShareIssueCosts_2" xml:lang="en-US">Expenses paid in connection with debt financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0" xml:lang="en-US">Payment of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1" xml:lang="en-US">Repayment of leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_0" xml:lang="en-US">Percentage of voting equity interests acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1" xml:lang="en-US">Percentage of minority shareholding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_2" xml:lang="en-US">Percentage of equity acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_0" xml:lang="en-US">Pension costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_0" xml:lang="en-US">Employees contribution</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Prepayments_0" xml:lang="en-US">Prepayments (see Note 18)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Prepayments_1" xml:lang="en-US">Prepayments of impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PreviousGAAPMember_0" xml:lang="en-US">Right-of-use assets cost at transition before impairment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PrincipalPlaceOfBusiness_0" xml:lang="en-US">Principal place of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PrincipalPlaceOfBusiness_1" xml:lang="en-US">Principal Country of incorporation and operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_0" xml:lang="en-US">Proceeds from Paycheck Protection loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1" xml:lang="en-US">Proceeds from borrowings, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_2" xml:lang="en-US">Proceeds from borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_3" xml:lang="en-US">Principal amount loaned &#8211; term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_0" xml:lang="en-US">Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_1" xml:lang="en-US">Proceeds from sale of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_2" xml:lang="en-US">Net cash inflow on date of disposal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_3" xml:lang="en-US">Proceeds from sale of business (net of transaction costs)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_0" xml:lang="en-US">Proceeds from government Covid-19 loan (Note 25)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_1" xml:lang="en-US">Proceeds from government Covid-19 loan (Note 24)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares_0" xml:lang="en-US">Proceeds from issue of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_0" xml:lang="en-US">Proceeds from issuing shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_1" xml:lang="en-US">Issue of ordinary share capital including share premium (net of issuance costs)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_2" xml:lang="en-US">Shares consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromNoncurrentBorrowings_0" xml:lang="en-US">Proceeds from non-current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromNoncurrentBorrowings_1" xml:lang="en-US">Net proceeds from senior secured term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProductsAndServicesAxis_0" xml:lang="en-US">Products and services [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProductsAndServicesAxis_1" xml:lang="en-US">Products and services [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLoss_0" xml:lang="en-US">Profit or loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLoss_1" xml:lang="en-US">Loss for the year on continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_0" xml:lang="en-US">Profit (loss), attributable to ordinary equity holders of parent entity including dilutive effects</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_0" xml:lang="en-US">Profit/(Loss) after tax for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_1" xml:lang="en-US">Loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_2" xml:lang="en-US">Profit (loss), attributable to owners of parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_3" xml:lang="en-US">Loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_4" xml:lang="en-US">Loss for the year (all attributable to owners of the parent)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_0" xml:lang="en-US">Loss before taxation &#8211; continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_1" xml:lang="en-US">Loss before tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_2" xml:lang="en-US">Profit/Loss before taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_3" xml:lang="en-US">Loss before tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_4" xml:lang="en-US">Profit/(Loss) before taxation - continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_0" xml:lang="en-US">Loss for the year on continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations_1" xml:lang="en-US">Profit/Loss for the year on continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_0" xml:lang="en-US">Basic earnings per ordinary share for continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_0" xml:lang="en-US">Diluted earnings per ordinary share for continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/disclosureGuidance" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_0" xml:lang="en-US">(Loss)/Profit for the year from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_1" xml:lang="en-US">(Loss)/profit for the year on discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_2" xml:lang="en-US">Profit (loss) from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_3" xml:lang="en-US">Loss for the year from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_4" xml:lang="en-US">Profit for the year from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_5" xml:lang="en-US">Profit/loss for the year on discontinued operations (Note 8)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_0" xml:lang="en-US">Profit (loss) from discontinued operations attributable to ordinary equity holders of parent entity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_1" xml:lang="en-US">Basic (loss)/earnings per ordinary share for discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_0" xml:lang="en-US">Profit (loss) from discontinued operations attributable to ordinary equity holders of parent entity including dilutive effects</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_1" xml:lang="en-US">Diluted (loss)/earnings per ordinary share for discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_0" xml:lang="en-US">Profit from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_1" xml:lang="en-US">Profit (loss) from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_2" xml:lang="en-US">Operating loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_3" xml:lang="en-US">Operating loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_4" xml:lang="en-US">Profit from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyDevelopmentAndProjectManagementExpense_0" xml:lang="en-US">Development costs not amortised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_0" xml:lang="en-US">Balance at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_1" xml:lang="en-US">Balance at beginning year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_2" xml:lang="en-US">Property plant &amp; equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_3" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_4" xml:lang="en-US">Property, plant &amp; equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_0" xml:lang="en-US">Property, plant and equipment by operating lease status [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentExpendituresRecognisedForConstructions_0" xml:lang="en-US">Property, plant and equipment under construction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated_0" xml:lang="en-US">Depreciated cost at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated_1" xml:lang="en-US">Property, plant and equipment, gross carrying amount of fully depreciated assets still in use</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentMember_0" xml:lang="en-US">Property, plant and equipment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Property, plant and equipment recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_0" xml:lang="en-US">Proportion of ownership interest in subsidiary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1" xml:lang="en-US">Group % holding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember_0" xml:lang="en-US">Provision for taxes other than income tax [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_Provisions_0" xml:lang="en-US">Provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Provisions_1" xml:lang="en-US">Provisions [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Provisions_2" xml:lang="en-US">Provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProvisionsAbstract_0" xml:lang="en-US">Provisions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ProvisionUsedOtherProvisions_0" xml:lang="en-US">Utilised during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProvisionUsedOtherProvisions_1" xml:lang="en-US">Provision used, other provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_0" xml:lang="en-US">Payments to acquire intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0" xml:lang="en-US">Acquisition of property, plant and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfTreasuryShares_0" xml:lang="en-US">Shares purchased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfTreasuryShares_1" xml:lang="en-US">Purchase of treasury shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PurchaseOfTreasuryShares_2" xml:lang="en-US">Purchased during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangeAxis_0" xml:lang="en-US">Range [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangeDomain_0" xml:lang="en-US">Range [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_0" xml:lang="en-US">Ranges of exercise prices for outstanding share options [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1" xml:lang="en-US">Ranges of exercise prices for outstanding share options [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReceivablesFromContractsWithCustomers_0" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_0" xml:lang="en-US">Timing of revenue recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_0" xml:lang="en-US">Remaining amortisation period of intangible assets material to entity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_1" xml:lang="en-US">Intangible asset amortization period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_0" xml:lang="en-US">Purchase of exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_1" xml:lang="en-US">Repayment of exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_2" xml:lang="en-US">Repayments of bonds, notes and debentures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_3" xml:lang="en-US">Purchase of exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/disclosureGuidance" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_0" xml:lang="en-US">Debt issued/repaid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1" xml:lang="en-US">Repayment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_2" xml:lang="en-US">Repayment of term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_3" xml:lang="en-US">Cash repayment of principal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_4" xml:lang="en-US">Debt retired / repaid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_5" xml:lang="en-US">Repayments of borrowings, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_6" xml:lang="en-US">Repayment of term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_7" xml:lang="en-US">Repaid to Note holders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RepaymentsOfCurrentBorrowings_0" xml:lang="en-US">Repayments of borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_0" xml:lang="en-US">Repayment of senior secured term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_1" xml:lang="en-US">Repayments of borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_2" xml:lang="en-US">Repayments of non-current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_3" xml:lang="en-US">Repayment of term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_1" xml:lang="en-US">Research and development expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfCashFlowHedges_0" xml:lang="en-US">Reserve of cash flow hedges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfCashFlowHedgesMember_0" xml:lang="en-US">Hedging reserves [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments_0" xml:lang="en-US">Reserve of equity component of convertible instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments_1" xml:lang="en-US">Equity component of the convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_0" xml:lang="en-US">Translation reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_0" xml:lang="en-US">Translation reserve [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RestructuringProvision_0" xml:lang="en-US">Restructuring provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RestructuringProvision_1" xml:lang="en-US">Closure provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RestructuringProvision_2" xml:lang="en-US">Provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RestructuringProvisionMember_0" xml:lang="en-US">Restructuring provision [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RestructuringProvisionMember_1" xml:lang="en-US">Fitzgerald Industries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_RetainedEarnings_0" xml:lang="en-US">Retaining earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarnings_1" xml:lang="en-US">Accumulated surplus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarnings_2" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarningsMember_0" xml:lang="en-US">Accumulated surplus [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarningsMember_1" xml:lang="en-US">Accumulated (deficit)/surplus [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Goodwill and other intangible assets (see Note 14)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Goodwill and other intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets_0" xml:lang="en-US">Revaluation increase (decrease), property, plant and equipment including right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets_1" xml:lang="en-US">Remeasurement of ROU assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Revenue_0" xml:lang="en-US">Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Revenue_1" xml:lang="en-US">Total revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Revenue_2" xml:lang="en-US">Total revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Revenue_3" xml:lang="en-US">Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromContractsWithCustomers_0" xml:lang="en-US">Revenue from external customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RevenueFromContractsWithCustomers_1" xml:lang="en-US">Revenue from contracts with customers (a)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromGovernmentGrants_0" xml:lang="en-US">Income from government grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RevenueFromGovernmentGrants_1" xml:lang="en-US">Government grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromInterest_0" xml:lang="en-US">Interest income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RevenueFromInterest_1" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_RevenueFromInterest_2" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssets_0" xml:lang="en-US">Right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RightofuseAssets_1" xml:lang="en-US">Right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_0" xml:lang="en-US">Right-of-use assets, revalued assets, at cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_1" xml:lang="en-US">Right-of-use assets value at transition after impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xml:lang="en-US">Selling, general and administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_1" xml:lang="en-US">Selling, general and administrative expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0" xml:lang="en-US">Selling, general and administrative expense [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_0" xml:lang="en-US">Schedule of Sensitivity Analysis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ServicesExpense_0" xml:lang="en-US">Services Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ServicesExpense_1" xml:lang="en-US">Payments for CEO Services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_0" xml:lang="en-US">Share issue related cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharePremium_0" xml:lang="en-US">Share premium</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharePremiumMember_0" xml:lang="en-US">Share premium [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_0" xml:lang="en-US">Short-term deposits, classified as cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_1" xml:lang="en-US">Short-term deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2" xml:lang="en-US">Financial assets (short-term deposits and short-term investments)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShorttermEmployeeBenefitsExpense_0" xml:lang="en-US">Total personnel expenses, inclusive of amounts capitalised for wages and salaries, social welfare costs and pension costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_0" xml:lang="en-US">Short term investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_1" xml:lang="en-US">Short term investments (Note 20)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_2" xml:lang="en-US">Investments (deposits)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_0" xml:lang="en-US">Subsidiaries [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0" xml:lang="en-US">Subsidiaries [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SocialSecurityContributions_0" xml:lang="en-US">Social welfare costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of cash flows [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract_0" xml:lang="en-US">Statement of changes in equity [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems_0" xml:lang="en-US">Statement of changes in equity [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable_0" xml:lang="en-US">Statement of changes in equity [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of financial position [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense_0" xml:lang="en-US">Temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_0" xml:lang="en-US">Tax charge on discontinued operations (see Note 10)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_1" xml:lang="en-US">Tax charge on discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_2" xml:lang="en-US">Tax credit recovered</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_0" xml:lang="en-US">Total income tax credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:label="lab_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1" xml:lang="en-US">Tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_2" xml:lang="en-US">Tax income (expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_3" xml:lang="en-US">Tax expense (income) relating to profit (loss) from ordinary activities of discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_4" xml:lang="en-US">Total tax expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_5" xml:lang="en-US">Tax (expense)/credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods_0" xml:lang="en-US">Adjustments in respect of prior years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxRateEffectOfForeignTaxRates_0" xml:lang="en-US">Effect of tax rates on overseas earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxRateEffectOfImpairmentOfGoodwill_0" xml:lang="en-US">Discount rate applied (real pre-tax)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxRateEffectOfTaxLosses_0" xml:lang="en-US">Effect of current year net operating losses and temporary differences for which no deferred tax asset was recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TechnologybasedIntangibleAssetsMember_0" xml:lang="en-US">Technology-based intangible assets [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TechnologybasedIntangibleAssetsMember_1" xml:lang="en-US">Technology based intangibles [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_0" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TopOfRangeMember_0" xml:lang="en-US">Top of range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TopOfRangeMember_1" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables_0" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables_1" xml:lang="en-US">Trade and other current payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayables_2" xml:lang="en-US">Trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0" xml:lang="en-US">Trade and other current payables [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract_1" xml:lang="en-US">Trade and other current payables [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_0" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1" xml:lang="en-US">Total trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_2" xml:lang="en-US">Total trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_0" xml:lang="en-US">Trade and other current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_1" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_2" xml:lang="en-US">Total and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables_3" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0" xml:lang="en-US">Trade and other current receivables [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_1" xml:lang="en-US">Trade and other current receivables [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayables_0" xml:lang="en-US">Trade and other payables (excluding deferred income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayables_1" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherPayables_2" xml:lang="en-US">Trade &amp; other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayables_3" xml:lang="en-US">Trade and other payables (excluding deferred income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Trade and other payables recognised as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Trade and other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherReceivables_0" xml:lang="en-US">Trade and other receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherReceivablesAbstract_0" xml:lang="en-US">Trade and other receivables [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_TradeReceivables_0" xml:lang="en-US">Balance at December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_TradeReceivables_1" xml:lang="en-US">Balance at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeReceivables_2" xml:lang="en-US">Trade receivables, net impairment losses provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TradeReceivables_3" xml:lang="en-US">Trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_0" xml:lang="en-US">Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_0" xml:lang="en-US">Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_TreasuryShares_0" xml:lang="en-US">Treasury shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_TreasuryShares_1" xml:lang="en-US">At period end</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_TreasuryShares_2" xml:lang="en-US">Balance at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TreasuryShares_3" xml:lang="en-US">Treasury shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TreasurySharesMember_0" xml:lang="en-US">Treasury Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfCustomersAxis_0" xml:lang="en-US">Types of customers [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TypesOfCustomersAxis_1" xml:lang="en-US">Types of customers [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfCustomersDomain_0" xml:lang="en-US">Types of customers [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfRisksAxis_0" xml:lang="en-US">Types of risks [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TypesOfRisksAxis_1" xml:lang="en-US">Types of risks [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UnconsolidatedStructuredEntitiesAxis_0" xml:lang="en-US">Unconsolidated structured entities [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UnconsolidatedStructuredEntitiesDomain_0" xml:lang="en-US">Unconsolidated structured entities [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis_0" xml:lang="en-US">Underlying equity instrument and depositary receipts [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_0" xml:lang="en-US">Underlying equity instrument and depositary receipts [domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_0" xml:lang="en-US">Future minimum rentals receivable under non-cancellable operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_VehiclesMember_0" xml:lang="en-US">Vehicles [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WagesAndSalaries_0" xml:lang="en-US">Wages and salaries</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WarrantReserveMember_0" xml:lang="en-US">Warrant reserve [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WarrantyProvision_0" xml:lang="en-US">Product warranty provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Exercisable at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Weighted average exercise price of share options exercisable in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_2" xml:lang="en-US">Weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Expired/ Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Weighted average exercise price of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_0" xml:lang="en-US">Weighted average share price date of exercise for options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0" xml:lang="en-US">Outstanding at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1" xml:lang="en-US">Outstanding Beginning Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_0" xml:lang="en-US">Weighted average fair value at measurement date per 'A' share / (per ADS)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_0" xml:lang="en-US">Weighted average discount rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_0" xml:lang="en-US">Weighted-average remaining contractual life of options outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1" xml:lang="en-US">Weighted average contractual life remaining (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageSharePrice2019_0" xml:lang="en-US">Average share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_0" xml:lang="en-US">Weighted average share price per 'A' share / (per ADS)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageShares_0" xml:lang="en-US">Basic (loss)/earnings per ADS denominator</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageShares_1" xml:lang="en-US">Weighted average number of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageShares_2" xml:lang="en-US">Basic (loss)/earnings per share denominator</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WorkInProgress_0" xml:lang="en-US">Work-in-progress</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_0" xml:lang="en-US">Capitalised development cost write off</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_CounterpartyNameAxis_0" xml:lang="en-US">Counterparty Name [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_CurrencyAxis_0" xml:lang="en-US">Foreign Currency Axis [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_CurrencyAxis_1" xml:lang="en-US">Currency [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_EuropeMember_0" xml:lang="en-US">Europe [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MajorCustomersAxis_0" xml:lang="en-US">Major Customers [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_MajorCustomersAxis_1" xml:lang="en-US">Customer [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember_0" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember_0" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis_0" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeMember_0" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain_0" xml:lang="en-US">Counterparty Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AccountingEstimatesAndJudgementsAbstract_0" xml:lang="en-US">Accounting Estimates And Judgements [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AccretionInterestAccrued_0" xml:lang="en-US">Accretion interest accrued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AccretionInterestAccrued_1" xml:lang="en-US">Accretion Interest Accrued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AccretionInterestAccrued_2" xml:lang="en-US">Accretion interest accrued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AccretionInterestAdjustment_0" xml:lang="en-US">The amount of accretion interest adjustment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AccretionInterestAdjustment_1" xml:lang="en-US">Accretion Interest Adjustment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AccretionInterestAdjustment_2" xml:lang="en-US">Accretion interest adjustment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AccretionInterestOnBorrowings_0" xml:lang="en-US">The amount of accretion interest on borrowings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_trib_AccretionInterestOnBorrowings_1" xml:lang="en-US">Accretion interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AccretionInterestOnBorrowings_2" xml:lang="en-US">Accretion Interest On Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AccretionInterestOnBorrowings_3" xml:lang="en-US">Accretion interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_AccretionInterestOnBorrowings_4" xml:lang="en-US">Accretion interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AccruedBonus_0" xml:lang="en-US">Accrued Bonus.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AccruedBonus_1" xml:lang="en-US">Accrued Bonus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AccruedInterestOnNotes_0" xml:lang="en-US">Accrued interest on notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AccruedInterestOnNotes_1" xml:lang="en-US">Accrued interest on notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AccruedLiabilitiesToContractedLicencePayments_0" xml:lang="en-US">Accrued liabilities to contracted licence payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_AccruedLiabilitiesToContractedLicencePayments_1" xml:lang="en-US">Licence payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_trib_AccruedLiabilitiesToContractedLicencePayments_2" xml:lang="en-US">Fixed rate financial liabilities (licence fees)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AccruedLiabilitiesToContractedLicencePayments_3" xml:lang="en-US">Accrued Liabilities To Contracted Licence Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AccruedLiabilitiesToContractedLicencePayments_4" xml:lang="en-US">Accrued liabilities to contracted licence payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AccruedLiability_0" xml:lang="en-US">Amount of accrued liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AccruedLiability_1" xml:lang="en-US">Accrued Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_0" xml:lang="en-US">accumulated deficit in equity attributable to equity holders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_1" xml:lang="en-US">Accumulated Deficit In Equity Attributable To Equity Holders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_2" xml:lang="en-US">Accumulated deficit in equity attributable to equity holders</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AcquisitionConsideration_0" xml:lang="en-US">Acquisition Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AcquisitionConsideration_1" xml:lang="en-US">Acquisition Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ActuarialAssumptionOfDiscountRatePercentage_0" xml:lang="en-US">Actuarial assumption of discount rate percentage.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ActuarialAssumptionOfDiscountRatePercentage_1" xml:lang="en-US">Actuarial Assumption Of Discount Rate Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ActuarialAssumptionOfDiscountRatePercentage_2" xml:lang="en-US">Actuarial assumption of discount rate percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ActuarialAssumptionOfExpectedPensionIncreases_0" xml:lang="en-US">Amount of pension accrual.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ActuarialAssumptionOfExpectedPensionIncreases_1" xml:lang="en-US">Actuarial Assumption Of Expected Pension Increases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ActuarialAssumptionOfExpectedPensionIncreases_2" xml:lang="en-US">Pension accrual</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_0" xml:lang="en-US">The fair value of additional consideration contingent on the achievement of future milestone.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_1" xml:lang="en-US">Additional Consideration Contingent On Achievement Of Future Milestone</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_2" xml:lang="en-US">Additional consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdditionalFunding_0" xml:lang="en-US">Additional Funding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdditionalFunding_1" xml:lang="en-US">Additional Funding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdditionalImpairmentLoss_0" xml:lang="en-US">Amount of additional impairment loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdditionalImpairmentLoss_1" xml:lang="en-US">Additional impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdditionalImpairmentLossDueToGrowthInRevenues_0" xml:lang="en-US">Additional impairment loss due to growth in revenues.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdditionalImpairmentLossDueToGrowthInRevenues_1" xml:lang="en-US">Additional impairment loss due to growth in revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs_0" xml:lang="en-US">Additional Lease liabilities as a result of the initial application of IFRS 16.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs_1" xml:lang="en-US">Additional Lease Liabilities As Result Of Initial Application Of Ifrs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs_2" xml:lang="en-US">Additional Lease liabilities as a result of the initial application of IFRS 16 at January 1, 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdditionalLiquidity_0" xml:lang="en-US">Additional Liquidity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdditionalLiquidity_1" xml:lang="en-US">Additional Liquidity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_0" xml:lang="en-US">Amount of additional liquidity recognized as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_1" xml:lang="en-US">Additional Liquidity Recognized As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_2" xml:lang="en-US">Additional liquidity recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdditionalProjectCost_0" xml:lang="en-US">Amount of additional project cost.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdditionalProjectCost_1" xml:lang="en-US">Additional project cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdditionalRestructuringCosts_0" xml:lang="en-US">The amount of expense relating to additional restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdditionalRestructuringCosts_1" xml:lang="en-US">Additional Restructuring Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AdditionalRestructuringCosts_2" xml:lang="en-US">Additional restructuring costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdditionalSpaceMember_0" xml:lang="en-US">Additional Space [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdditionalSpaceMember_1" xml:lang="en-US">Additional Space [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdditionsRelatedToRightOfUseAssets_0" xml:lang="en-US">Amount of additions related to right of use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdditionsRelatedToRightOfUseAssets_1" xml:lang="en-US">Additions (related to Right of Use assets)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdjustedLossProfitAfterTax_0" xml:lang="en-US">Amount of adjusted loss profit after tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_AdjustedLossProfitAfterTax_1" xml:lang="en-US">Adjusted profit/(loss) after tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdjustedLossProfitAfterTax_2" xml:lang="en-US">Adjusted (loss)/profit after tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AdjustedLossProfitAfterTax_3" xml:lang="en-US">Adjusted loss after tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdjustedProfitAfterTax_0" xml:lang="en-US">Adjusted profit after tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdjustedProfitAfterTax_1" xml:lang="en-US">Adjusted Profit After Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AdjustedProfitAfterTax_2" xml:lang="en-US">Adjusted profit after tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_0" xml:lang="en-US">The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_1" xml:lang="en-US">Adjusted Weighted Average Shares Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_2" xml:lang="en-US">Diluted earnings per share denominator</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdjustmentForRestructuringProvision_0" xml:lang="en-US">Represents the amount of provision for restructuring.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdjustmentForRestructuringProvision_1" xml:lang="en-US">Adjustment For Restructuring Provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_AdjustmentForRestructuringProvision_2" xml:lang="en-US">Restructuring provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdjustmentOnTransitionToIFRS16_0" xml:lang="en-US">Adjustment on transition to IFRS 16.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_AdjustmentOnTransitionToIFRS16_1" xml:lang="en-US">Adjustment on transition to IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdjustmentOnTransitionToIFRS16_2" xml:lang="en-US">Adjustment On Transition To I F R S 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AdjustmentOnTransitionToIFRS16_3" xml:lang="en-US">Adjustment on transition to IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_0" xml:lang="en-US">Adjustment on transition to IFRS 16 in property, plant and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_1" xml:lang="en-US">Adjustment On Transition To Ifrs 16 Property Plant And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_2" xml:lang="en-US">Adjustment on transition to IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_0" xml:lang="en-US">Adjustment on transition to IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_1" xml:lang="en-US">Adjustment on transition to IFRS 16 to depreciation and impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_2" xml:lang="en-US">Adjustment On Transition To Ifrs 16 To Depreciation And Impairment Property Plant And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdjustmentsForGainLossOnSaleOfBusiness_0" xml:lang="en-US">The amount represents gain on sale of business.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_AdjustmentsForGainLossOnSaleOfBusiness_1" xml:lang="en-US">Gain on sale of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdjustmentsForGainLossOnSaleOfBusiness_2" xml:lang="en-US">Adjustments For Gain Loss On Sale Of Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AdjustmentsForGainLossOnSaleOfBusiness_3" xml:lang="en-US">Gain on sale of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdjustmentsForIncomeTaxExpenseCredit_0" xml:lang="en-US">Represent the adjustments for income tax expense credit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdjustmentsForIncomeTaxExpenseCredit_1" xml:lang="en-US">Adjustments For Income Tax Expense Credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AdjustmentsForIncomeTaxExpenseCredit_2" xml:lang="en-US">Income tax credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_AdjustmentsForIncomeTaxExpenseCredit_3" xml:lang="en-US">Tax expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdjustmentsForInventoryWriteOff_0" xml:lang="en-US">Represents the amount of adjustments for inventory write off.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_AdjustmentsForInventoryWriteOff_1" xml:lang="en-US">Inventory write off</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdjustmentsForInventoryWriteOff_2" xml:lang="en-US">Adjustments For Inventory Write Off</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdministrationAndSalesMember_0" xml:lang="en-US">Administration and sales [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdministrationAndSalesMember_1" xml:lang="en-US">Administration and sales [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdoptionOfIfrs16_0" xml:lang="en-US">Amount of adoption of IFRS 16.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdoptionOfIfrs16_1" xml:lang="en-US">Adoption Of Ifrs 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AdoptionOfIfrs16_2" xml:lang="en-US">Adoption of IFRS 16 (Note 13)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AdsRatioChangeMember_0" xml:lang="en-US">This member represent about ADS Ratio change.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AdsRatioChangeMember_1" xml:lang="en-US">Ads Ratio Change [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AdsRatioChangeMember_2" xml:lang="en-US">ADS Ratio change [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AgreementPayments_0" xml:lang="en-US">The amount represents agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AgreementPayments_1" xml:lang="en-US">Agreement Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AgreementTerm_0" xml:lang="en-US">Agreement Term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AgreementTerm_1" xml:lang="en-US">Agreement Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AgreementTerm_2" xml:lang="en-US">Agreement Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AllowanceForImpairmentOfReceivables_0" xml:lang="en-US">Allowance for impairment of receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_trib_AllowanceForImpairmentOfReceivables_1" xml:lang="en-US">Balance at December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_trib_AllowanceForImpairmentOfReceivables_2" xml:lang="en-US">Balance at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AllowanceForImpairmentOfReceivables_3" xml:lang="en-US">Allowance For Impairment Of Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AllowanceForImpairmentOfReceivables_4" xml:lang="en-US">Allowance for impairment of receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_AllowanceForImpairmentOfReceivables_5" xml:lang="en-US">Trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AllowanceRepresentsGroupRevenues_0" xml:lang="en-US">Represent the amount of allowance represents group revenues.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AllowanceRepresentsGroupRevenues_1" xml:lang="en-US">Allowance Represents Group Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AllowanceRepresentsGroupRevenues_2" xml:lang="en-US">Allowance represents group revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AlternativeMinimumTaxCreditMember_0" xml:lang="en-US">Alternative minimum tax credit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AmendedCreditAgreementMember_0" xml:lang="en-US">This member stand for Amended Credit Agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmendedCreditAgreementMember_1" xml:lang="en-US">Amended Credit Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AmendmentAndRestatementOfTermLoanMember_0" xml:lang="en-US">Amendment and restatement of Term Loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmendmentAndRestatementOfTermLoanMember_1" xml:lang="en-US">Amendment And Restatement Of Term Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AmendmentAndRestatementOfTermLoanMember_2" xml:lang="en-US">Amendment and Restatement of Term Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AmericaMember_0" xml:lang="en-US">Americas [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmericaMember_1" xml:lang="en-US">America [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AmericaMember_2" xml:lang="en-US">Americas &#8211; unused tax losses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_AmericaMember_3" xml:lang="en-US">Americas [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AmericanDepositaryShareMember_0" xml:lang="en-US">American depositary share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmericanDepositaryShareMember_1" xml:lang="en-US">American depositary share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmericanDepositarySharesMember_0" xml:lang="en-US">American Depositary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AmericanDepositaryShareTreasurySharesMember_0" xml:lang="en-US">ADS Treasury shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmericanDepositaryShareTreasurySharesMember_1" xml:lang="en-US">American Depositary Share Treasury Shares Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AmericanDepositaryShareTreasurySharesMember_2" xml:lang="en-US">ADS Treasury shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AmericanDepositoryShares_0" xml:lang="en-US">Number Of American Depository Shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/measurementGuidance" xlink:label="lab_trib_AmericanDepositoryShares_1" xml:lang="en-US">ADS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_trib_AmericanDepositoryShares_2" xml:lang="en-US">In issue at December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_trib_AmericanDepositoryShares_3" xml:lang="en-US">In issue at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmericanDepositoryShares_4" xml:lang="en-US">American Depository Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AmericanDepositoryShares_5" xml:lang="en-US">Ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_AmericanDepositoryShares_6" xml:lang="en-US">Total number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_AmericanDepositoryShares_7" xml:lang="en-US">Number of American Depository Shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AmericanDepositorySharesIssued_0" xml:lang="en-US">American depository shares issued share value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmericanDepositorySharesIssued_1" xml:lang="en-US">American Depository Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AmericanDepositorySharesIssued_2" xml:lang="en-US">ADS issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AmortisationForDiscontinuedOperations_0" xml:lang="en-US">Represent the amortizations for discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmortisationForDiscontinuedOperations_1" xml:lang="en-US">Amortisation For Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AmortisationForDiscontinuedOperations_2" xml:lang="en-US">Amortisation for discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_AmortisationForDiscontinuedOperations_3" xml:lang="en-US">Amortisation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AmortisationOnIntangibleAssets_0" xml:lang="en-US">Amortisation on intangible assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmortisationOnIntangibleAssets_1" xml:lang="en-US">Amortisation On Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_AmortisationOnIntangibleAssets_2" xml:lang="en-US">Amortisation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AmountAvailableForDevelopmentOfTheCGM_0" xml:lang="en-US">Amount available for development of the CGM.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmountAvailableForDevelopmentOfTheCGM_1" xml:lang="en-US">Amount Available For Development Of The C G M</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AmountAvailableForDevelopmentOfTheCGM_2" xml:lang="en-US">Amount available for development of the CGM</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AmountPaidInRespectOfLeaseLiabilities_0" xml:lang="en-US">Total amount paid in respect of lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmountPaidInRespectOfLeaseLiabilities_1" xml:lang="en-US">Amount Paid In Respect Of Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AmountPaidInRespectOfLeaseLiabilities_2" xml:lang="en-US">Total amount paid in respect of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AmountReceivedFromProviderReliefFund_0" xml:lang="en-US">Amount received from Provider Relief Fund.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmountReceivedFromProviderReliefFund_1" xml:lang="en-US">Amount received from Provider Relief Fund</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AmountUsedToAcquireTheCGMAssets_0" xml:lang="en-US">Amount used to acquire the CGM assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AmountUsedToAcquireTheCGMAssets_1" xml:lang="en-US">Amount Used To Acquire The C G M Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AmountUsedToAcquireTheCGMAssets_2" xml:lang="en-US">Amount used to acquire the CGM assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AnnualBorrowingBaseRate_0" xml:lang="en-US">Annual borrowing base rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AnnualBorrowingBaseRate_1" xml:lang="en-US">Annual Borrowing Base Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AnnualBorrowingBaseRate_2" xml:lang="en-US">Annual borrowing base rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AnnualRentIncreased_0" xml:lang="en-US">The amount represents annual rent increased.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AnnualRentIncreased_1" xml:lang="en-US">Annual Rent Increased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AnnualRentPayable_0" xml:lang="en-US">Annual rent payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AnnualRentPayable_1" xml:lang="en-US">Annual rent payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AnnualRentPayableForWareHouse_0" xml:lang="en-US">Annual rent payable for ware house.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AnnualRentPayableForWareHouse_1" xml:lang="en-US">Annual rent payable for ware house</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AntigenProjectsMember_0" xml:lang="en-US">Antigen Projects [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AsiaOrAfricaMember_0" xml:lang="en-US">Asia / Africa [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AsiaOrAfricaMember_1" xml:lang="en-US">Asia Or Africa Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AsiaOrAfricaMember_2" xml:lang="en-US">Asia / Africa [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AssetsAndLiabilitiesBySegmentAbstract_0" xml:lang="en-US">Assets And Liabilities By Segment Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AssetsAndLiabilitiesBySegmentAbstract_1" xml:lang="en-US">Assets and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AssetsUnderDevelopmentCarryingValue_0" xml:lang="en-US">Assets under development carrying value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AssetsUnderDevelopmentCarryingValue_1" xml:lang="en-US">Assets Under Development Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AssetsUnderDevelopmentCarryingValue_2" xml:lang="en-US">Assets under development carrying value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AutoimmuneFdaRegistrationsMember_0" xml:lang="en-US">Autoimmune FDA Registrations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AutoimmuneSmartReaderMember_0" xml:lang="en-US">Autoimmune Smart Reader [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AutoimmuneSmartReaderMember_1" xml:lang="en-US">Autoimmune Smart Reader [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AutoimmuneSmartReaderMember_2" xml:lang="en-US">Autoimmune smart reader [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_0" xml:lang="en-US">Represent the average number of employees, including discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_1" xml:lang="en-US">Average Number Of Employees, Including Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_2" xml:lang="en-US">Average number of employees, including discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AverageRemainingLeaseTermYears_0" xml:lang="en-US">Average remaining lease term in years.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AverageRemainingLeaseTermYears_1" xml:lang="en-US">Average remaining lease term (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_AverageSharePriceShareOptionsExercised_0" xml:lang="en-US">Average share price, share options exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_AverageSharePriceShareOptionsExercised_1" xml:lang="en-US">Average Share Price Share Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_AverageSharePriceShareOptionsExercised_2" xml:lang="en-US">Average share price, share options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_BasisOfPreparationAndSignificantAccountingPoliciesLineItems_0" xml:lang="en-US">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_BasisOfPreparationAndSignificantAccountingPoliciesLineItems_1" xml:lang="en-US">Basis Of Preparation And Significant Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_BasisOfPreparationAndSignificantAccountingPoliciesTable_0" xml:lang="en-US">Table of basis of preparation and significant accounting policies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_BasisOfPreparationAndSignificantAccountingPoliciesTable_1" xml:lang="en-US">Basis Of Preparation And Significant Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_BenenTradingLimitedMember_0" xml:lang="en-US">This member stands for Benen Trading Limited.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_BenenTradingLimitedMember_1" xml:lang="en-US">Benen Trading Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_BiopoolUsIncMember_0" xml:lang="en-US">Biopool US Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_BiopoolUsIncMember_1" xml:lang="en-US">Biopool US Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_BiosynthMember_0" xml:lang="en-US">This member stands for Biosynth.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_BiosynthMember_1" xml:lang="en-US">Biosynth [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_BiosynthMember_2" xml:lang="en-US">Biosynth [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_BloodBankScreeningBusinessMember_0" xml:lang="en-US">Blood Bank Screening Business [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_BorrowingsAndDerivativeFinancialInstrumentsMember_0" xml:lang="en-US">Borrowings &amp;amp; derivative financial instruments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_BrainNatriureticPeptideMember_0" xml:lang="en-US">Brain Natriuretic Peptide [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_BrazilMember_0" xml:lang="en-US">Brazil [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_BusinessacquisitionAxis_0" xml:lang="en-US">The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_BusinessacquisitionAxis_1" xml:lang="en-US">Businessacquisition [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_BusinessacquisitionDomain_0" xml:lang="en-US">BusinessAcquisition [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_BusinessacquisitionDomain_1" xml:lang="en-US">Businessacquisition [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CapitalisationOfUnpaidInterestOnTermLoan_0" xml:lang="en-US">Amount of capitalisation of unpaid interest on term loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CapitalisationOfUnpaidInterestOnTermLoan_1" xml:lang="en-US">Capitalisation Of Unpaid Interest On Term Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_CapitalisationOfUnpaidInterestOnTermLoan_2" xml:lang="en-US">Capitalisation of unpaid interest on term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CapitalisedDevelopmentCost_0" xml:lang="en-US">Represent the amount of capitalized development cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CapitalisedDevelopmentCost_1" xml:lang="en-US">Capitalised Development Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_CapitalisedDevelopmentCost_2" xml:lang="en-US">Capitalised development costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CardiacAnalyserMember_0" xml:lang="en-US">Cardiac Analyser [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CarryingAmountOfGoodwill_0" xml:lang="en-US">Carrying amount of goodwill.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CarryingAmountOfGoodwill_1" xml:lang="en-US">Carrying amount of goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CashAcquiredAsOfAcquisitionDate_0" xml:lang="en-US">The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Total for all business combinations [member]]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_CashAcquiredAsOfAcquisitionDate_1" xml:lang="en-US">Cash acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CashAcquiredAsOfAcquisitionDate_2" xml:lang="en-US">Cash Acquired As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_CashAcquiredAsOfAcquisitionDate_3" xml:lang="en-US">Cash acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_CashAcquiredAsOfAcquisitionDate_4" xml:lang="en-US">Less: Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CashAndCashEquivalentMember_0" xml:lang="en-US">Cash and cash equivalents [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CashAndCashEquivalentMember_1" xml:lang="en-US">Cash And Cash Equivalent [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_CashAndCashEquivalentMember_2" xml:lang="en-US">Cash and cash equivalents [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_0" xml:lang="en-US">Cash, cash equivalents, and short term investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_1" xml:lang="en-US">Cash and cash equivalents and short-term investments at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_2" xml:lang="en-US">Cash and cash equivalents and short-term investments at beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_3" xml:lang="en-US">Cash And Cash Equivalents And Short Term Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_4" xml:lang="en-US">Cash and cash equivalents (Note 19)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_5" xml:lang="en-US">Total cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_6" xml:lang="en-US">Cash and cash equivalents and short-term investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CashInterestPayableOnPppLoans_0" xml:lang="en-US">Represents the amount of cash interest payable on PPP loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CashInterestPayableOnPppLoans_1" xml:lang="en-US">Cash Interest Payable On Ppp Loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_CashInterestPayableOnPppLoans_2" xml:lang="en-US">Cash interest payable on PPP loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CashInterestPayableOnSeniorSecureTermLoan_0" xml:lang="en-US">Represents the amount of cash interest payable on senior secure term loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CashInterestPayableOnSeniorSecureTermLoan_1" xml:lang="en-US">Cash Interest Payable On Senior Secure Term Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_CashInterestPayableOnSeniorSecureTermLoan_2" xml:lang="en-US">Cash interest payable on senior secured term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CashPaidForNominalValue_0" xml:lang="en-US">Represents the cash paid for nominal value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CashPaidForNominalValue_1" xml:lang="en-US">Cash Paid For Nominal Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_CashPaidForNominalValue_2" xml:lang="en-US">Cash per $1 nominal value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CashPaidToEachHolder_0" xml:lang="en-US">Cash paid to each holder.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CashPaidToEachHolder_1" xml:lang="en-US">Cash Paid To Each Holder</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_CashPaidToEachHolder_2" xml:lang="en-US">Cash paid to each holder</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CashProceedsFromDiscontinuedOperations_0" xml:lang="en-US">The amount of cash proceeds from discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CashProceedsFromDiscontinuedOperations_1" xml:lang="en-US">Cash Proceeds From Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_CashProceedsFromDiscontinuedOperations_2" xml:lang="en-US">Cash proceeds from discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_0" xml:lang="en-US">Amount of Cash received from sale of the discontinued operations net of transaction costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_1" xml:lang="en-US">Cash Received From Sale Of The Discontinued Operations Net Of Transaction Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_2" xml:lang="en-US">Cash received from sale of the discontinued operations net of transaction costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CashReceivedPerNominalValue_0" xml:lang="en-US">Cash received per nominal value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CashReceivedPerNominalValue_1" xml:lang="en-US">Cash Received Per Nominal Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_CashReceivedPerNominalValue_2" xml:lang="en-US">Cash received per nominal value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CashSoldAsAPartOfDiscontinuedOperations_0" xml:lang="en-US">Amount of cash sold as a part of discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_CashSoldAsAPartOfDiscontinuedOperations_1" xml:lang="en-US">Cash sold as a part of discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CashSoldAsAPartOfDiscontinuedOperations_2" xml:lang="en-US">Cash Sold As A Part Of Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_CashSoldAsAPartOfDiscontinuedOperations_3" xml:lang="en-US">Cash sold as a part of discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ChangeInAllowance_0" xml:lang="en-US">Change in allowance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ChangeInAllowance_1" xml:lang="en-US">Change in allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ClarkLaboratoriesIncMember_0" xml:lang="en-US">Clark Laboratories Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ClarkLaboratoriesIncMember_1" xml:lang="en-US">Clark Laboratories Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ClassAOrdinarySharesMember_0" xml:lang="en-US">Class A Ordinary shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ClassAOrdinarySharesMember_1" xml:lang="en-US">Class A Ordinary shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ClassATreasurySharesMember_0" xml:lang="en-US">Class A Treasury shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ClassATreasurySharesMember_1" xml:lang="en-US">Class A Treasury shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ClinicalLaboratoryMember_0" xml:lang="en-US">Clinical laboratory [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ClinicalLaboratoryMember_1" xml:lang="en-US">Clinical Laboratory Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ClinicalLaboratoryMember_2" xml:lang="en-US">Clinical laboratory goods [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ClosingExercisePriceOfOutstandingShareOptions_0" xml:lang="en-US">exercise price of outstanding share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ClosingExercisePriceOfOutstandingShareOptions_1" xml:lang="en-US">Closing Exercise Price Of Outstanding Share Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ClosingExercisePriceOfOutstandingShareOptions_2" xml:lang="en-US">Closing share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ClosureCosts_0" xml:lang="en-US">Amount of closure cost.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ClosureCosts_1" xml:lang="en-US">Closure Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ClosureCosts_2" xml:lang="en-US">Closure costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ClosureCostsMember_0" xml:lang="en-US">Closure costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ClosureProvision_0" xml:lang="en-US">Closure provision.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_ClosureProvision_1" xml:lang="en-US">Closure provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ClosureProvision_2" xml:lang="en-US">Closure provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ClosureProvision_3" xml:lang="en-US">Closure costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ClosureProvision_4" xml:lang="en-US">Closure provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ColumnEnhancementMember_0" xml:lang="en-US">Column Enhancement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ColumnEnhancementMember_1" xml:lang="en-US">Column Enhancement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ComputerEquipmentsMember_0" xml:lang="en-US">Computer equipment [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ComputerEquipmentsMember_1" xml:lang="en-US">Computer Equipments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ComputerEquipmentsMember_2" xml:lang="en-US">Computer equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ConsiderationFromEmployeeOptionsSettledInCash_0" xml:lang="en-US">Consideration from employee options settled in cash.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ConsiderationFromEmployeeOptionsSettledInCash_1" xml:lang="en-US">Consideration from employee options settled in cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ConsolidatedStatementOfComprehensiveIncomeAbstract_0" xml:lang="en-US">Consolidated Statement Of Comprehensive Income Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ConsolidatedStatementOfComprehensiveIncomeAbstract_1" xml:lang="en-US">Consolidated Statement Of Comprehensive Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ContingentAssets_0" xml:lang="en-US">Represents the amount of contingent assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ContingentAssets_1" xml:lang="en-US">Contingent Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ContingentAssets_2" xml:lang="en-US">Contingent assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">The amount, at acquisition date, of fair value of contingent consideration arrangements classified as a current liability recognised as consideration transferred in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Contingent Consideration Classified As A Current Liability Recognised As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Contingent consideration classified as a current liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">The amount, at acquisition date, of fair value of contingent consideration arrangements classified as Contingent liability recognised as consideration transferred in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Contingent Consideration Classified As Contingent Liability Recognised As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Contingent consideration classified as contingent liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ContingentConsiderationNonCurrent_0" xml:lang="en-US">It represents the amount of contingent consideration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ContingentConsiderationNonCurrent_1" xml:lang="en-US">Contingent Consideration Non Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ContingentConsiderationNonCurrent_2" xml:lang="en-US">Contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ContingentLiabilityMember_0" xml:lang="en-US">This member stands for Contingent liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ContingentLiabilityMember_1" xml:lang="en-US">Contingent Liability [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ContingentLiabilityMember_2" xml:lang="en-US">Contingent liability [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ContinuousGlucoseMonitoringTechnologyMember_0" xml:lang="en-US">This member stand for continuous glucose monitoring (CGM) technology.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ContinuousGlucoseMonitoringTechnologyMember_1" xml:lang="en-US">Continuous Glucose Monitoring Technology [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ContinuousGlucoseMonitoringTestingMember_0" xml:lang="en-US">Continuous glucose monitoring testing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ContinuousGlucoseMonitoringTestingMember_1" xml:lang="en-US">Continuous Glucose Monitoring Testing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ContinuousGlucoseMonitoringTestingMember_2" xml:lang="en-US">Continuous glucose monitoring testing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ContractualCashFlowsMember_0" xml:lang="en-US">Carrying amount [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ContractualCashFlowsMember_1" xml:lang="en-US">Contractual cash flows [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ContributionAmountInSettlement_0" xml:lang="en-US">Contribution amount in settlement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ContributionAmountInSettlement_1" xml:lang="en-US">Contribution amount in settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ContributionForTaxAuditSettlement_0" xml:lang="en-US">Contribution for tax audit settlement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ContributionForTaxAuditSettlement_1" xml:lang="en-US">Contribution for tax audit settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ConversionPricePerAds_0" xml:lang="en-US">Conversion price per ADS.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ConversionPricePerAds_1" xml:lang="en-US">Conversion Price Per Ads</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ConversionPricePerAds_2" xml:lang="en-US">Conversion price per ADS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ConversionRatePerAds_0" xml:lang="en-US">Conversion rate per ADS.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ConversionRatePerAds_1" xml:lang="en-US">Conversion rate per ADS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ConvertibleNote_0" xml:lang="en-US">The amout represents convertiable note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_ConvertibleNote_1" xml:lang="en-US">Convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_trib_ConvertibleNote_2" xml:lang="en-US">Fixed rate financial liabilities (convertible note)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ConvertibleNote_3" xml:lang="en-US">Convertible Note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ConvertibleNote_4" xml:lang="en-US">Convertible Note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ConvertibleNoteInvestment_0" xml:lang="en-US">Amount of convertible note investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ConvertibleNoteInvestment_1" xml:lang="en-US">Convertible Note Investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ConvertibleNoteMember_0" xml:lang="en-US">Convertible Note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ConvertibleNoteMember_1" xml:lang="en-US">Convertible Note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ConvertibleNoteMember_2" xml:lang="en-US">Convertible note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CostIncurredIssueOfShares_0" xml:lang="en-US">Cost incurred issue of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CostIncurredIssueOfShares_1" xml:lang="en-US">Cost incurred issue of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_Covid19ElisaTestMember_0" xml:lang="en-US">COVID-19 ELISA test member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_Covid19ElisaTestMember_1" xml:lang="en-US">Covid 19 Elisa Test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_Covid19ElisaTestMember_2" xml:lang="en-US">COVID-19 ELISA test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CovidPointOfCareRapidTestAndElisaTestMember_0" xml:lang="en-US">COVID point-of-care rapid test &amp; Elisa test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CovidTestMember_0" xml:lang="en-US">COVID test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CovidTestMember_1" xml:lang="en-US">COVID Test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_CovidTestMember_2" xml:lang="en-US">COVID-19 tests [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CraigHallumMember_0" xml:lang="en-US">Craig Hallum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CreditAgreementAxis_0" xml:lang="en-US">The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CreditAgreementAxis_1" xml:lang="en-US">Credit Agreement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CreditAgreementDomain_0" xml:lang="en-US">Credit Agreement [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CreditAgreementDomain_1" xml:lang="en-US">Credit Agreement [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CurrentDerivativeLiabilities_0" xml:lang="en-US">Current derivative liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_CurrentDerivativeLiabilities_1" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CurrentDerivativeLiabilities_2" xml:lang="en-US">Current Derivative Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_CurrentDerivativeLiabilities_3" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CurrentFinanceLeaseLiabilities_0" xml:lang="en-US">Current finance lease liabilities as of balance sheet date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CurrentFinanceLeaseLiabilities_1" xml:lang="en-US">Current Finance Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_CurrentFinanceLeaseLiabilities_2" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_CurrentFinanceLeaseLiabilities_3" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CurrentGovernmentLoans_0" xml:lang="en-US">Government COVID-19 loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CurrentGovernmentLoans_1" xml:lang="en-US">Current Government Loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_CurrentGovernmentLoans_2" xml:lang="en-US">Government COVID-19 loans (Note 4)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_CurrentLeaseLiabilitiesAbstract_0" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CurrentLiabilitiesMember_0" xml:lang="en-US">Represent information about the current liabilities member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CurrentLiabilitiesMember_1" xml:lang="en-US">Current Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CurrentTaxForeignExpenseIncome_0" xml:lang="en-US">Current Foreign taxes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CurrentTaxForeignExpenseIncome_1" xml:lang="en-US">Current Tax Foreign Expense Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_CurrentTaxForeignExpenseIncome_2" xml:lang="en-US">Foreign taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_CustomerMember_0" xml:lang="en-US">Customer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_CustomerMember_1" xml:lang="en-US">Customer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DarnickCompanyMember_0" xml:lang="en-US">Darnick Company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DarnickCompanyMember_1" xml:lang="en-US">Darnick Company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DDimerDevelopmentMember_0" xml:lang="en-US">D-Dimer development [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DebtRefinancingMember_0" xml:lang="en-US">Debt refinancing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DebtRefinancingMember_1" xml:lang="en-US">Debt Refinancing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeferredConsideration_0" xml:lang="en-US">Deferred consideration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeferredConsideration_1" xml:lang="en-US">Deferred Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DeferredConsideration_2" xml:lang="en-US">Deferred Consideration (Phoenix Bio-tech)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeferredConsiderationPayable_0" xml:lang="en-US">Deferred consideration payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeferredConsiderationPayable_1" xml:lang="en-US">Deferred Consideration Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DeferredConsiderationPayable_2" xml:lang="en-US">Net Deferred Consideration Payable ('Fiomi')</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision_0" xml:lang="en-US">Deferred tax asset decrease due to decrease in provision.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision_1" xml:lang="en-US">Deferred tax asset decrease due to decrease in provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_0" xml:lang="en-US">Represents the amount of increase in deferred tax asset due to increase in provision.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_1" xml:lang="en-US">Deferred Tax Asset Increase Due To Increase In Provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_2" xml:lang="en-US">Deferred tax asset increase due to increase in provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeferredTaxAssetsCapitalLossCarryforward_0" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforward.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeferredTaxAssetsCapitalLossCarryforward_1" xml:lang="en-US">Deferred Tax Assets Capital Loss Carryforward</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DeferredTaxAssetsCapitalLossCarryforward_2" xml:lang="en-US">Capital losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeferredTaxAssetsOperatingLossCarryforward_0" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforward.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeferredTaxAssetsOperatingLossCarryforward_1" xml:lang="en-US">Deferred Tax Assets Operating Loss Carryforward</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_DeferredTaxAssetsOperatingLossCarryforward_2" xml:lang="en-US">Unrecognised deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_0" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state operating loss carryforwards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_1" xml:lang="en-US">Deferred Tax Assets Operating Loss Carryforwards State</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_2" xml:lang="en-US">US state credit carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeferredTaxAssetsOperatingLossDomestic_0" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeferredTaxAssetsOperatingLossDomestic_1" xml:lang="en-US">Deferred Tax Assets Operating Loss Domestic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DeferredTaxAssetsOperatingLossDomestic_2" xml:lang="en-US">Net operating losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_0" xml:lang="en-US">Other temporary timing differences.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_1" xml:lang="en-US">Deferred Tax Assets Other Temporary Timing Differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_2" xml:lang="en-US">Other temporary timing differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_0" xml:lang="en-US">US alternative minimum tax credits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_1" xml:lang="en-US">Deferred Tax Assets Us Alternative Minimum Tax Credits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_2" xml:lang="en-US">US alternative minimum tax credits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_0" xml:lang="en-US">The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_1" xml:lang="en-US">Deferred Tax Expense (Income) Recognised Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_2" xml:lang="en-US">Recognised in discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeferredTaxLiabilityDecreased_0" xml:lang="en-US">Deferred tax liability decreased.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeferredTaxLiabilityDecreased_1" xml:lang="en-US">Deferred tax liability decreased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeferredTaxLiabilityIncreased_0" xml:lang="en-US">Represents the amount of increase in deferred tax liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeferredTaxLiabilityIncreased_1" xml:lang="en-US">Deferred Tax Liability Increased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DeferredTaxLiabilityIncreased_2" xml:lang="en-US">Deferred tax liability increased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DeprecationForDiscontinuedOperations_0" xml:lang="en-US">Represent the deprecation for discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DeprecationForDiscontinuedOperations_1" xml:lang="en-US">Deprecation For Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DeprecationForDiscontinuedOperations_2" xml:lang="en-US">Deprecation for discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DeprecationForDiscontinuedOperations_3" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DepreciationMember_0" xml:lang="en-US">Depreciation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DepreciationMember_1" xml:lang="en-US">Depreciation Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DepreciationMember_2" xml:lang="en-US">Depreciation Charge [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DepreciationOnIntangibleAssets_0" xml:lang="en-US">Depreciation on intangible assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DepreciationOnIntangibleAssets_1" xml:lang="en-US">Depreciation On Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DepreciationOnIntangibleAssets_2" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DerivativeFinancialAssetAtDateOfDrawdown_0" xml:lang="en-US">Derivative financial liability at date of drawdown.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DerivativeFinancialAssetAtDateOfDrawdown_1" xml:lang="en-US">Derivative Financial Asset At Date Of Drawdown</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DerivativeFinancialAssetAtDateOfDrawdown_2" xml:lang="en-US">Derivative financial asset at date of drawdown</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/disclosureGuidance" xlink:label="lab_trib_DerivativeFinancialAssetAtDateOfIssue_0" xml:lang="en-US">Derivative financial asset at date of drawdown</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DerivativeFinancialAssetAtDateOfIssue_1" xml:lang="en-US">Derivative financial asset at date of issue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DerivativeFinancialAssetAtDateOfIssue_2" xml:lang="en-US">Derivative Financial Asset At Date Of Issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DerivativeFinancialAssetAtDateOfIssue_3" xml:lang="en-US">Derivative financial asset at date of issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DerivativeFinancialAssetAtDateOfIssue_4" xml:lang="en-US">Derivative financial asset at date of issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DerivativeFinancialAssetMember_0" xml:lang="en-US">Represent information about the derivative financial asset member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DerivativeFinancialAssetMember_1" xml:lang="en-US">Derivative Financial Asset [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DerivativeFinancialLiabilityAtDateOfDrawdown_0" xml:lang="en-US">Derivative financial liability at date of drawdown.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DerivativeFinancialLiabilityAtDateOfDrawdown_1" xml:lang="en-US">Derivative Financial Liability At Date Of Drawdown</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DerivativeFinancialLiabilityAtDateOfIssue_0" xml:lang="en-US">The amount of derivative financial liability at date of issue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DerivativeFinancialLiabilityAtDateOfIssue_1" xml:lang="en-US">Derivative Financial Liability At Date Of Issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DerivativeFinancialLiabilityAtDateOfIssue_2" xml:lang="en-US">Derivative financial liability at date of issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DerivativeFinancialLiabilityAtDateOfIssue_3" xml:lang="en-US">Derivative financial liability at date of drawdown</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_0" xml:lang="en-US">The amount of derivative financial liability at date of issue of term loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_1" xml:lang="en-US">Derivative Financial Liability At Date Of Issue Of Term Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_2" xml:lang="en-US">Derivative financial liability at date of drawdown</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DerivativeFinancialLiabilityMember_0" xml:lang="en-US">Represent information about the derivative financial liability member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DerivativeFinancialLiabilityMember_1" xml:lang="en-US">Derivative Financial Liability [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DerivativeFinancialLiabilityMember_2" xml:lang="en-US">Derivative financial liability [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for expected credit losses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Expected Credit Losses Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_2" xml:lang="en-US">Expected credit losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for general information.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For General Information Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_2" xml:lang="en-US">General information</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for new standards and interpretations not yet adopted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For New Standards And Interpretations Not Yet Adopted Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_2" xml:lang="en-US">New IFRS Standards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_3" xml:lang="en-US">New IFRS Standards adopted as of January 1, 2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_0" xml:lang="en-US">The description of the entity's material accounting policy information for Other Operating Income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Other Operating Income Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_2" xml:lang="en-US">Other Operating Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_3" xml:lang="en-US">Other operating income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_0" xml:lang="en-US">The description of the entity's material accounting policy information for senior secured term loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Senior Secured Term Loan Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_2" xml:lang="en-US">Senior secured term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for short-term investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Short Term Investments Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_2" xml:lang="en-US">Short-term investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for statements of compliance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Statement Of Compliance Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_2" xml:lang="en-US">Statement of compliance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for warrants and loan prepayment option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Warrants And Loan Prepayment Option Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_2" xml:lang="en-US">Warrants and loan prepayment option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DescriptionOfBorrowingsPaid_0" xml:lang="en-US">Represent information about the description of borrowings paid.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DescriptionOfBorrowingsPaid_1" xml:lang="en-US">Description Of Borrowings Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DescriptionOfBorrowingsPaid_2" xml:lang="en-US">Description of borrowings paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DescriptionOfCumulativeRevenuesPayable_0" xml:lang="en-US">Description of cumulative revenues payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DescriptionOfCumulativeRevenuesPayable_1" xml:lang="en-US">Description Of Cumulative Revenues Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DescriptionOfCumulativeRevenuesPayable_2" xml:lang="en-US">Description of cumulative revenues payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DescriptionOfShareAdjustedRatio_0" xml:lang="en-US">Represent the description of share-adjusted ratio.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DescriptionOfShareAdjustedRatio_1" xml:lang="en-US">Description Of Share Adjusted Ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DescriptionOfShareAdjustedRatio_2" xml:lang="en-US">Description of share-adjusted ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DevelopmentCostMember_0" xml:lang="en-US">Development cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DevelopmentCostMember_1" xml:lang="en-US">Development cost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DevelopmentCostsMember_0" xml:lang="en-US">It represents Developmentcosts member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DevelopmentCostsMember_1" xml:lang="en-US">Development Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DirectorPensionExpense_0" xml:lang="en-US">Amount of director pension expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DirectorPensionExpense_1" xml:lang="en-US">Director Pension Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DirectorPensionExpense_2" xml:lang="en-US">Pension</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DirectorsAndCompanySecretaryMember_0" xml:lang="en-US">Directors' and Company Secretary's [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DirectorsAndCompanySecretaryMember_1" xml:lang="en-US">Directors And Company Secretary [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DirectorsAndCompanySecretaryMember_2" xml:lang="en-US">Directors and company secretary [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract_0" xml:lang="en-US">Directors Emoluments Including Non Executive Directors Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract_1" xml:lang="en-US">Directors' emoluments (including non- executive directors):</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DirectorsMember_0" xml:lang="en-US">Director [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DirectorsMember_1" xml:lang="en-US">Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DirectorsMember_2" xml:lang="en-US">Director [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfAccountingEstimatesAndJudgementsAbstract_0" xml:lang="en-US">Disclosure of accounting estimates and judgements [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xml:lang="en-US">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_1" xml:lang="en-US">Disclosure Of Analysis Of Discontinued Operations [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_0" xml:lang="en-US">Schedule disclosing information related to the analysis of discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xml:lang="en-US">Disclosure Of Analysis Of Discontinued Operations [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_0" xml:lang="en-US">The entire disclosure for assets and liabilities disposed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_1" xml:lang="en-US">Disclosure Of Assets And Liabilities Disposed Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_2" xml:lang="en-US">Schedule of Assets and Liabilities Disposed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfAuthorisationForIssueAbstract_0" xml:lang="en-US">Disclosure of authorisation for issue [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfAuthorisationForIssueExplanatory_0" xml:lang="en-US">The entire disclosure for authorisation for issue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfAuthorisationForIssueExplanatory_1" xml:lang="en-US">Disclosure Of Authorisation For Issue Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfAuthorisationForIssueExplanatory_2" xml:lang="en-US">AUTHORISATION FOR ISSUE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0" xml:lang="en-US">Disclosure of basis of preparation and significant accounting policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_1" xml:lang="en-US">Basis Of Preparation And Significant Accounting Policies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_0" xml:lang="en-US">The entire disclosure for basis of preparation and significant accounting policies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_1" xml:lang="en-US">Disclosure Of Basis Of Preparation And Significant Accounting Policies Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_2" xml:lang="en-US">BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_0" xml:lang="en-US">Disclosure Of Commitments And Contingent Liability Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_1" xml:lang="en-US">Disclosure of commitments and contingencies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_2" xml:lang="en-US">Commitments And Contingencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfCompositionOfGroupLineItems_0" xml:lang="en-US">Disclosure of composition of group.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfCompositionOfGroupLineItems_1" xml:lang="en-US">Disclosure Of Composition Of Group [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfCompositionOfGroupTable_0" xml:lang="en-US">Disclosure of composition of group.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfCompositionOfGroupTable_1" xml:lang="en-US">Disclosure Of Composition Of Group [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0" xml:lang="en-US">Disclosure Of Deferred Tax Assets And Liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_1" xml:lang="en-US">Disclosure of deferred tax assets and liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_2" xml:lang="en-US">Deferred Tax Assets And Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about Ageing of trade receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Ageing Of Trade Receivables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_2" xml:lang="en-US">Schedule of Ageing of Trade Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_0" xml:lang="en-US">The disclosure of detailed information about amount relating from revenue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Amount Relating From Revenue Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_2" xml:lang="en-US">Schedule of Amount Relating From Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about basic earning per ADS.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Basic Earning Per Ads Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_2" xml:lang="en-US">Schedule of Basic Earning Per ADS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_0" xml:lang="en-US">The disclosure of detailed information about basic earning per shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Basic Earnings Per Ordinary Share Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_2" xml:lang="en-US">Schedule of Basic Earnings Per Ordinary Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_0" xml:lang="en-US">The disclosure of detailed information about capital expanditure by geographical area.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Capital Expenditure Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_2" xml:lang="en-US">Schedule of Capital Expenditure by Geographical Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about carrying value of exchangeable senior notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Carrying Value Of Exchangeable Senior Notes Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory_2" xml:lang="en-US">Schedule of Carrying Value of Exchangeable Senior Notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about carrying values of finance lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Carrying Values Of Finance Lease Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_2" xml:lang="en-US">Schedule of Carrying Values of Finance Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about cash and cash equivalents.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Cash And Cash Equivalents Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_2" xml:lang="en-US">Schedule of Cash and Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about cash flows attributable to discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Cash Flows Attributable To Discontinued Operations Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_2" xml:lang="en-US">Schedule of Cash Flows Attributable to Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_0" xml:lang="en-US">The disclosure of detailed information about charges for tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Charge For Tax Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_2" xml:lang="en-US">Schedule of Charge for Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_0" xml:lang="en-US">The disclosure of detailed information about compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Compensation Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_2" xml:lang="en-US">Schedule of Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about deferred tax assets and liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Deferred Tax Assets And Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_2" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_0" xml:lang="en-US">The disclosure of detailed information about deferred tax assets not recognised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Deferred Tax Assets Not Recognised Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_2" xml:lang="en-US">Schedule of Deferred Tax Assets Not Recognised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_0" xml:lang="en-US">The disclosure of detailed information about depreciation and amortisation by geographical area.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Depreciation And Amortisation Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_2" xml:lang="en-US">Schedule of Depreciation and Amortisation by Geographical Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about diluted earning per ADS.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Diluted Earning Per Ads Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_2" xml:lang="en-US">Schedule of Diluted Earning Per ADS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_0" xml:lang="en-US">The disclosure of detailed information about diluted earning per shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Diluted Earnings Per Ordinary Share Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_2" xml:lang="en-US">Schedule of Diluted Earnings Per Ordinary Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about earning per ADS for discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Earnings Per Ads For Discontinued Operations Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_2" xml:lang="en-US">Schedule of Earnings Per ADS for Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about estimated useful lives of intangible assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Estimated Useful Lives Of Intangible Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_2" xml:lang="en-US">Schedule of Estimated Useful Lives of Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about estimated useful lives of owned assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Estimated Useful Lives Of Owned Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_2" xml:lang="en-US">Schedule of Estimated Useful Lives of Owned Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about exchangeable notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Exchangeable Notes Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory_2" xml:lang="en-US">Schedule of Exchangeable Notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_0" xml:lang="en-US">The disclosure of detailed information about exposure of trade receivables by customer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Exposure Of Trade Receivables By Customer Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_2" xml:lang="en-US">Schedule of Exposure of Trade Receivables by Customer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_0" xml:lang="en-US">The disclosure of detailed information about exposure of trade receivables by geographic location.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Exposure Of Trade Receivables By Geographic Location Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_2" xml:lang="en-US">Schedule of Exposure of Trade Receivables by Geographic Location</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_0" xml:lang="en-US">The disclosure of detailed information about finance lease liabilities payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Finance Lease Liabilities Payable Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_2" xml:lang="en-US">Schedule of Finance Lease Liabilities Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutFinancialAssets_0" xml:lang="en-US">The disclosure of detailed information about financial assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutFinancialAssets_1" xml:lang="en-US">Disclosure Of Detailed Information About Financial Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutFinancialAssets_2" xml:lang="en-US">Schedule of Financial Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about financial income and expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Financial Income And Expenses Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_2" xml:lang="en-US">Schedule of Financial Income and Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about foreign currency risk short term financial assets and liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Foreign Currency Risk Short Term Financial Assets And Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_2" xml:lang="en-US">Schedule of Foreign Currency Risk Short Term Financial Assets and Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory_0" xml:lang="en-US">The disclosure of detailed information about future minimum operating lease commitments with non-cancellable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Future Minimum Operating Lease Commitments With Non Cancellable Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory_2" xml:lang="en-US">Schedule of Future Minimum Operating Lease Commitments with Non-Cancellable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_0" xml:lang="en-US">The disclosure of detailed information about impairment charges and inventory provisioning.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Impairment Charges And Inventory Provisioning Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_2" xml:lang="en-US">Schedule of Impairment Charges and Inventory Provisioning</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about impairment loss of intangible assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Impairment Loss Of Intangible Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory_2" xml:lang="en-US">Schedule of Impairment Loss of Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about impairment loss recorded on discontinued assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Impairment Loss Recorded On Discontinued Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_2" xml:lang="en-US">Schedule of Impairment Loss Recorded on Discontinued Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_0" xml:lang="en-US">The disclosure of detailed information about interest income and interest expense by geographical area.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Interest Income And Interest Expense Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_2" xml:lang="en-US">Schedule of Interest Income and Interest Expense by Geographical Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about interest rate profile of financial assets/liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Interest Rate Profile Of Financial Assets Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_2" xml:lang="en-US">Schedule of Interest Rate Profile of Financial Assets/Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_0" xml:lang="en-US">The disclosure of detailed information about interest rates used for determining fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Interest Rates Used For Determining Fair Value Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_2" xml:lang="en-US">Schedule of Interest Rates Used for Determining Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about internal and external fectors based on historical experience.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Internal And External Factors Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_2" xml:lang="en-US">Schedule of Internal and External Factors Based on Historical Experience</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about inventory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Inventories Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_2" xml:lang="en-US">Schedule of Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about liquidity risk estimated interest payments of maturities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Liquidity Risk Estimated Interest Payments Of Maturities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_2" xml:lang="en-US">Schedule of Liquidity Risk Estimated Interest Payments of Maturities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about long lived assets by geographical area.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Long Lived Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_2" xml:lang="en-US">Schedule of Long-Lived Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about loss on remeasurement of its assets and liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Loss On Remeasurement Of Assets And Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory_2" xml:lang="en-US">Schedule of Loss on Remeasurement of Assets and Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about loss profit before tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Loss Profit Before Taxes Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_2" xml:lang="en-US">Schedule of (Loss)/Profit Before Taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_0" xml:lang="en-US">The disclosure of detailed information about loss profit before tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Loss Profit Before Tax Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_2" xml:lang="en-US">Schedule of Loss Before Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about movement in the allowance for impairment of trade receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Movement In Allowance For Impairment Of Trade Receivables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_2" xml:lang="en-US">Schedule of Movement in Allowance for Impairment of Trade Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_0" xml:lang="en-US">The disclosure of detailed information about movement in derivative financial asset explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Movement In Derivative Financial Asset Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_2" xml:lang="en-US">Schedule of Derivative Financial Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_0" xml:lang="en-US">The disclosure of detailed information about movement in derivative financial liability explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Movement In Derivative Financial Liability Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_2" xml:lang="en-US">Schedule of Derivative Financial Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_0" xml:lang="en-US">The disclosure of detailed information about movement in exchangeable notes balance explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Movement In Exchangeable Notes Balance Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_2" xml:lang="en-US">Schedule of Exchangeable Notes Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about movement in term loan and the 7-year convertible notes explanatory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Movement In Term Loan And The 7-Year Convertible Notes Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_2" xml:lang="en-US">Schedule of Term Loan And The 7-Year Convertible Notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_3" xml:lang="en-US">Schedule of Term Loan And The 7-Year Convertible Notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_0" xml:lang="en-US">The disclosure of detailed information about movement on inventory provision.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Movement On Inventory Provision Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_2" xml:lang="en-US">Schedule of Movement on Inventory Provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about other assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Other Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_2" xml:lang="en-US">Schedule of Other Non-Current Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory_0" xml:lang="en-US">The disclosure of detailed information about other payables due after one year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Other Payables Due After One Year Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory_2" xml:lang="en-US">Schedule of Other Payables Due After One Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about outstanding interest bearing loans and borrowings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Outstanding Interest Bearing Loans And Borrowings Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_2" xml:lang="en-US">Schedule of Outstanding Interest Bearing Loans and Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about overseas tax jurisdictions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Overseas Tax Jurisdictions Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_2" xml:lang="en-US">Schedule of Overseas Tax Jurisdictions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_0" xml:lang="en-US">The disclosure of detailed information about profit after tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Profit After Tax Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_2" xml:lang="en-US">Schedule of Profit After Tax Diluted Earnings Per Ordinary Share Calculation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about reconciliation of operating lease commitments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Reconciliation Of Operating Lease Commitments Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_2" xml:lang="en-US">Schedule of Reconciliation of Operating Lease Commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about revenues derives from goods and services.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Revenue Derives From Transfer Of Goods And Services Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_2" xml:lang="en-US">Schedule of Revenue Derives From Transfer of Goods and Services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_0" xml:lang="en-US">The disclosure of detailed information about segment assets and segment liabilities by geographical area.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Segment Assets And Segment Liabilities By Geographical Area Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_2" xml:lang="en-US">Schedule of Segment Assets and Segment Liabilities by Geographical Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about share option and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Share Options And Warrants Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_2" xml:lang="en-US">Schedule of Grants of Share Options and Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_0" xml:lang="en-US">The disclosure of detailed information about shares and share option plan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Shares And Share Option Plan Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_2" xml:lang="en-US">Schedule of Company's Shares and Share Option Plan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_0" xml:lang="en-US">The disclosure of detailed information about specific asset impairment charges.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_1" xml:lang="en-US">Disclosure Of Detailed Information About Specific Asset Impairment Charges Explanatory [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_2" xml:lang="en-US">Schedule of Specific Asset Impairment Charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_0" xml:lang="en-US">The disclosure of detailed information about statutory tax rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Statutory Tax Rate Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_2" xml:lang="en-US">Schedule of Statutory Tax Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_0" xml:lang="en-US">The disclosure of detailed information about tax expense by geographical area.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Taxation Expense Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_2" xml:lang="en-US">Schedule of Taxation Expense by Geographical Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about trade and other payables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Trade And Other Payables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_2" xml:lang="en-US">Schedule of Trade and Other Payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about trade and other receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Trade And Other Receivables Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_2" xml:lang="en-US">Schedule of Trade and Other Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about unrecognised deferred tax assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Unrecognised Deferred Tax Assets Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_2" xml:lang="en-US">Schedule of Unrecognised Deferred Tax Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about unrecognised tax liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Unrecognised Deferred Tax Liabilities Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_2" xml:lang="en-US">Schedule of Unrecognised Deferred Tax Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_0" xml:lang="en-US">The disclosure of detailed information about unused tax losses and unused tax credits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Unused Tax Losses And Unused Tax Credits Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_2" xml:lang="en-US">Schedule of Unused Tax Losses and Unused Tax Credits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_0" xml:lang="en-US">The disclosure of detailed information about unutilised net operating losses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Unutilised Net Operating Losses Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_2" xml:lang="en-US">Schedule of Unutilised Net Operating Losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_0" xml:lang="en-US">The disclosure of detailed information about weighted average interest rate and weighted average period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Weighted Average Interest Rate And Weighted Average Period Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_2" xml:lang="en-US">Schedule of Weighted Average Interest Rate and Weighted Average Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDividendPaidAbstract_0" xml:lang="en-US">Disclosure of dividend paid [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDividendPaidAbstract_1" xml:lang="en-US">Disclosure of dividends paid [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfDividendsPaidExplanatory_0" xml:lang="en-US">The entire disclosure for dividends paid.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfDividendsPaidExplanatory_1" xml:lang="en-US">Disclosure Of Dividends Paid Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfDividendsPaidExplanatory_2" xml:lang="en-US">DIVIDENDS PAID</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock_0" xml:lang="en-US">Disclosure of fair value of total net assets acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock_1" xml:lang="en-US">Disclosure Of Fair Value Of Total Net Assets Acquired [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock_2" xml:lang="en-US">Schedule of fair value of total net assets acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0" xml:lang="en-US">Disclosure of finance lease liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_1" xml:lang="en-US">Lease Liabilities Schedule Of Carrying Values Of Finance Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_2" xml:lang="en-US">Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_0" xml:lang="en-US">Disclosure Of Financing Income Expenses Net [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_1" xml:lang="en-US">Financial Income And Expenses Schedule Of Financial Income Expenses Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_2" xml:lang="en-US">Financial Income And Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0" xml:lang="en-US">Disclosure Of Goodwill And Intangible Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_1" xml:lang="en-US">Goodwill And Intangible Assets Schedule Of Breakdown Of Impairment Loss Details</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_2" xml:lang="en-US">Goodwill And Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfGroupUndertakingsAbstract_0" xml:lang="en-US">Disclosure of group undertakings [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfGroupUndertakingsExplanatory_0" xml:lang="en-US">The entire disclosure for group undertakings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfGroupUndertakingsExplanatory_1" xml:lang="en-US">Disclosure Of Group Undertakings Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfGroupUndertakingsExplanatory_2" xml:lang="en-US">GROUP UNDERTAKINGS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0" xml:lang="en-US">Disclosure of impairment charges and inventory provisioning [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_1" xml:lang="en-US">Impairment Charges Schedule Of Statement Of Operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_2" xml:lang="en-US">Impairment Charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfIncomeTaxCreditAbstract_0" xml:lang="en-US">Disclosure of income tax credit [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfIncomeTaxCreditAbstract_1" xml:lang="en-US">Income Tax Credit Schedule Of Charge For Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfIncomeTaxCreditAbstract_2" xml:lang="en-US">Income Tax Credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0" xml:lang="en-US">Disclosure Of Interest-bearing Loans And Borrowings [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_0" xml:lang="en-US">The disclosure of lease payments not recognised as liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_1" xml:lang="en-US">Disclosure Of Lease Payments Not Recognised As Liability Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_2" xml:lang="en-US">Schedule of Lease Payments Not Recognised as Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0" xml:lang="en-US">Disclosure of loss on discontinued operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_1" xml:lang="en-US">Lossprofit For Year On Discontinued Operation Schedule Of Cash Flows Attributable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_2" xml:lang="en-US">Lossprofit For Year On Discontinued Operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfLossProfitBeforeTaxAbstract_0" xml:lang="en-US">Disclosure of loss profit before tax [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfLossProfitBeforeTaxAbstract_1" xml:lang="en-US">Loss Before Tax Narrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfLossProfitBeforeTaxAbstract_2" xml:lang="en-US">Loss Before Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfLossProfitBeforeTaxExplanatory_0" xml:lang="en-US">The entire disclosure for loss profit before tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfLossProfitBeforeTaxExplanatory_1" xml:lang="en-US">Disclosure Of Loss Profit Before Tax Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfLossProfitBeforeTaxExplanatory_2" xml:lang="en-US">LOSS BEFORE TAX</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_0" xml:lang="en-US">The entire disclosure for net cashflows generated from discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_1" xml:lang="en-US">Disclosure Of Net Cashflows Generated Discontinued Operations Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_2" xml:lang="en-US">Schedule of Net Cashflows Generated From Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_0" xml:lang="en-US">The entire disclosure for operating profit for the discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_1" xml:lang="en-US">Disclosure Of Operating Profit For The Discontinued Operations [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_2" xml:lang="en-US">Schedule of Operating Profit For The Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfOtherAssetsAbstract_0" xml:lang="en-US">Disclosure Of Other Assets Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfOtherAssetsAbstract_1" xml:lang="en-US">Other Non-current Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfOtherOperatingIncomeAbstract_0" xml:lang="en-US">Disclosure of other operating income [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfOtherOperatingIncomeAbstract_1" xml:lang="en-US">Other Operating Income Schedule Of Other Operating Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfOtherOperatingIncomeAbstract_2" xml:lang="en-US">Other Operating Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfOtherPayablesDueAfterOneYearAbstract_0" xml:lang="en-US">Disclosure of other payables due after one year [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfOtherPayablesDueAfterOneYearAbstract_1" xml:lang="en-US">Other Payables Due After One Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory_0" xml:lang="en-US">The entire disclosure for other payables due after one year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory_1" xml:lang="en-US">Disclosure Of Other Payables Due After One Year Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory_2" xml:lang="en-US">OTHER PAYABLES DUE AFTER ONE YEAR</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfPensionSchemesAbstract_0" xml:lang="en-US">Disclosure of pension schemes [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfPostBalanceSheetEventsAbstract_0" xml:lang="en-US">Disclosure of post balance sheet events [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_0" xml:lang="en-US">The disclosure of reconciliation from IAS 17 to IFRS 16 effect.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_1" xml:lang="en-US">Disclosure Of Reconciliation From Ias 17 To Ifrs 16 Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_2" xml:lang="en-US">Schedule of Reconciliation from IAS 17 to IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory_0" xml:lang="en-US">The disclosure of selling, general and administrative expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory_1" xml:lang="en-US">Disclosure Of Selling General And Administrative Expense Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory_2" xml:lang="en-US">SELLING, GENERAL AND ADMINISTRATIVE EXPENSES - TAX AUDIT SETTLEMENT</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0" xml:lang="en-US">Disclosure Of Share Options And Share Warrants [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_1" xml:lang="en-US">Share Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_0" xml:lang="en-US">The entire disclosure for share oprtions and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_1" xml:lang="en-US">Disclosure Of Share Options And Share Warrants Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_2" xml:lang="en-US">SHARE OPTIONS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisclosureOfShortTermInvestmentsAbstract_0" xml:lang="en-US">Disclosure of short-term investments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisclosureOfShortTermInvestmentsAbstract_1" xml:lang="en-US">Short-term Investments Schedule Of Short-term Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisclosureOfShortTermInvestmentsAbstract_2" xml:lang="en-US">Short-term Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DiscontinuedOperationsAxis_0" xml:lang="en-US">Discontinued Operations [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DiscontinuedOperationsDomain_0" xml:lang="en-US">DISCONTINUED OPERATIONS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DiscontinuedOperationsDomain_1" xml:lang="en-US">Discontinued Operations [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DiscountingLeaseLiability_0" xml:lang="en-US">Discounting lease liability as of balance sheet date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DiscountingLeaseLiability_1" xml:lang="en-US">Discounting Lease Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DiscountingLeaseLiability_2" xml:lang="en-US">Discounting</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisposalsGoodwillAndIntangibleAssets_0" xml:lang="en-US">Disposals of goodwill and intangible assets for the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_DisposalsGoodwillAndIntangibleAssets_1" xml:lang="en-US">Disposals or retirements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisposalsGoodwillAndIntangibleAssets_2" xml:lang="en-US">Disposals Goodwill And Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_DisposalsGoodwillAndIntangibleAssets_3" xml:lang="en-US">Disposals or retirements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisposalsOrRetirementsPropertyAndEquipment_0" xml:lang="en-US">Disposals or retirements of property, plant and equipment during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_DisposalsOrRetirementsPropertyAndEquipment_1" xml:lang="en-US">Disposals or retirements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisposalsOrRetirementsPropertyAndEquipment_2" xml:lang="en-US">Disposals Or Retirements Property And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DisposalsRelatedToRightOfUseAssets_0" xml:lang="en-US">Represent the amount of Disposals Related To Right Of Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DisposalsRelatedToRightOfUseAssets_1" xml:lang="en-US">Disposals Related To Right Of Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_DisposalsRelatedToRightOfUseAssets_2" xml:lang="en-US">Disposals (related to Right of Use assets)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DistributorsMember_0" xml:lang="en-US">Distributors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DistributorsMember_1" xml:lang="en-US">Distributors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_DivestitureOfFitzgeraldLifeSciencesBusinessMember_0" xml:lang="en-US">This member is stand for Divestiture of Fitzgerald Life Sciences business.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DivestitureOfFitzgeraldLifeSciencesBusinessMember_1" xml:lang="en-US">Divestiture Of Fitzgerald Life Sciences Business [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_DrJimWalshMember_0" xml:lang="en-US">Dr. Jim Walsh [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EarlyRepaymentPenaltyDescription_0" xml:lang="en-US">Early repayment penalty description.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EarlyRepaymentPenaltyDescription_1" xml:lang="en-US">Early Repayment Penalty Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_EarlyRepaymentPenaltyDescription_2" xml:lang="en-US">Early repayment penalty description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_0" xml:lang="en-US">Earnings before interest, tax, depreciation and amortization decrease for impairment loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_1" xml:lang="en-US">Earnings Before Interest Tax Depreciation And Amortization Decrease For Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_2" xml:lang="en-US">EBITDA would need to decrease for an impairment to arise</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_0" xml:lang="en-US">Effective Income Tax Rate Continuing Operations Tax Rate Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_1" xml:lang="en-US">As a percentage of loss before tax:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_2" xml:lang="en-US">As a percentage of loss before tax:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EffectiveInterestRate_0" xml:lang="en-US">Effective interest rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EffectiveInterestRate_1" xml:lang="en-US">Effective interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16_0" xml:lang="en-US">Effect of assumed probable lease extension in adoption of IFRS 16.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16_1" xml:lang="en-US">Effect Of Assumed Probable Lease Extension In Adoption Of I F R S 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16_2" xml:lang="en-US">Effect of assumed probable lease extension in adoption of IFRS 16</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EffectOfIrishIncomeTaxableAtHigherTaxRate_0" xml:lang="en-US">Effect of Irish income taxable at higher tax rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EffectOfIrishIncomeTaxableAtHigherTaxRate_1" xml:lang="en-US">Effect of Irish income taxable at higher tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EliminatedOnDisposalOfBusiness_0" xml:lang="en-US">Represent the amount Eliminated on disposal of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_EliminatedOnDisposalOfBusiness_1" xml:lang="en-US">Eliminated on disposal of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EliminatedOnDisposalOfBusiness_2" xml:lang="en-US">Eliminated On Disposal Of Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_EliminatedOnDisposalOfBusiness_3" xml:lang="en-US">Eliminated on disposal of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EliminatedOnDisposalsOfBusiness_0" xml:lang="en-US">Amount of eliminated on disposal of business.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_EliminatedOnDisposalsOfBusiness_1" xml:lang="en-US">Eliminated on disposal of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EliminatedOnDisposalsOfBusiness_2" xml:lang="en-US">Eliminated On Disposals Of Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EmployeeRelatedSocialInsurance_0" xml:lang="en-US">Employee related social insurance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EmployeeRelatedSocialInsurance_1" xml:lang="en-US">Employee related social insurance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EndUserCustomersMember_0" xml:lang="en-US">This member stands for End-user customers.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EndUserCustomersMember_1" xml:lang="en-US">End User Customers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EnhancedTphaByCmvMember_0" xml:lang="en-US">Enhanced TPHA/CMV [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EpiCaptureLimitedMember_0" xml:lang="en-US">This member stands for Epi Capture Limited.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EpiCaptureLimitedMember_1" xml:lang="en-US">Epi Capture Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_EpiCaptureLimitedMember_2" xml:lang="en-US">Epi Capture Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EquityComponentAtDateOfIssue_0" xml:lang="en-US">The amount of equity component at date of issue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EquityComponentAtDateOfIssue_1" xml:lang="en-US">Equity Component At Date Of Issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_EquityComponentAtDateOfIssue_2" xml:lang="en-US">Equity component at date of issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_EquityComponentAtDateOfIssue_3" xml:lang="en-US">Equity component at date of issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EquityComponentOfConvertibleNote_0" xml:lang="en-US">The amount represents equity component of convertible note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EquityComponentOfConvertibleNote_1" xml:lang="en-US">Equity Component Of Convertible Note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_EquityComponentOfConvertibleNote_2" xml:lang="en-US">Equity component of convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_EquityComponentOfConvertibleNote_3" xml:lang="en-US">Equity investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_0" xml:lang="en-US">Equity component of convertible note at date of issue.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_1" xml:lang="en-US">Equity component of convertible note at date of issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_2" xml:lang="en-US">Equity Component Of Convertible Note At Date Of Issue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EquityComponentOfConvertibleNoteMember_0" xml:lang="en-US">Equity Component of Convertible Note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EquityComponentOfConvertibleNoteMember_1" xml:lang="en-US">Equity Component Of Convertible Note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_EquityComponentOfConvertibleNoteMember_2" xml:lang="en-US">Equity Component of convertible Note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EstimatedObligations_0" xml:lang="en-US">Estimated obligations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EstimatedObligations_1" xml:lang="en-US">Estimated obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EuropeIncludingIrelandMember_0" xml:lang="en-US">Europe (including Ireland) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EuropeIncludingIrelandMember_1" xml:lang="en-US">Europe Including Ireland Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_EuropeIncludingIrelandMember_2" xml:lang="en-US">Europe (including Ireland) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EuroZoneCountriesMember_0" xml:lang="en-US">Euro-zone countries [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EuroZoneCountriesMember_1" xml:lang="en-US">Euro-zone countries [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_EventsAfterReportingPeriodMember_0" xml:lang="en-US">This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_EventsAfterReportingPeriodMember_1" xml:lang="en-US">Events After Reporting Period [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_0" xml:lang="en-US">Excess value-in-use over carrying amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_1" xml:lang="en-US">Excess Value Of Goodwill In Use Over Carrying Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_2" xml:lang="en-US">Excess value-in-use over carrying amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExchangeableNoteBondPutOption_0" xml:lang="en-US">Exchangeable note bond put option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExchangeableNoteBondPutOption_1" xml:lang="en-US">Exchangeable note bond put option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExchangeableNoteEquityConversionOption_0" xml:lang="en-US">Exchangeable note equity conversion option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_ExchangeableNoteEquityConversionOption_1" xml:lang="en-US">Exchangeable note equity conversion option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExchangeableNoteEquityConversionOption_2" xml:lang="en-US">Exchangeable note equity conversion option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExchangeableNoteInterest_0" xml:lang="en-US">Exchangeable note interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExchangeableNoteInterest_1" xml:lang="en-US">Exchangeable note interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExchangeableNoteMember_0" xml:lang="en-US">Exchangeable note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExchangeableNoteMember_1" xml:lang="en-US">Exchangeable note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowings_0" xml:lang="en-US">Information about exchangeable notes and other borrowings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowings_1" xml:lang="en-US">Exchangeable Notes And Other Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowings_2" xml:lang="en-US">Exchangeable notes and other borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsCurrent_0" xml:lang="en-US">Information about Exchangeable notes and other borrowings classified as current liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsCurrent_1" xml:lang="en-US">Exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsCurrent_2" xml:lang="en-US">Exchangeable Notes And Other Borrowings Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsCurrent_3" xml:lang="en-US">Exchangeable notes and other borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsCurrent_4" xml:lang="en-US">Exchangeable senior notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_0" xml:lang="en-US">Information about Exchangeable notes and other borrowings classified as non-current liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_1" xml:lang="en-US">Exchangeable note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2" xml:lang="en-US">Fixed rate financial liabilities (exchangeable note)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_3" xml:lang="en-US">Balance at 31 December</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_4" xml:lang="en-US">Balance at 1 January</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_5" xml:lang="en-US">Exchangeable Notes And Other Borrowings Non Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_6" xml:lang="en-US">Exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_7" xml:lang="en-US">Total non-current portion of non-current borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_8" xml:lang="en-US">Exchangeable senior notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExchangeableNotesDiscountRate_0" xml:lang="en-US">Represents the percentage of discount rate for exchangeable notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExchangeableNotesDiscountRate_1" xml:lang="en-US">Exchangeable Notes Discount Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ExchangeableNotesDiscountRate_2" xml:lang="en-US">Exchangeable notes discount rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExchangeableSeniorNotesMember_0" xml:lang="en-US">Represent information about the exchangeable senior notes member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExchangeableSeniorNotesMember_1" xml:lang="en-US">Exchangeable Senior Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExchangeRatePricePerAds_0" xml:lang="en-US">Exchange rate price per ADS.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExchangeRatePricePerAds_1" xml:lang="en-US">Exchange rate price per ADS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExercisableAbstract_0" xml:lang="en-US">Exercisable Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ExercisableAbstract_1" xml:lang="en-US">Exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExerciseOfShareOptionsReceivable_0" xml:lang="en-US">Exercise of share options receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExerciseOfShareOptionsReceivable_1" xml:lang="en-US">Exercise of share options receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExercisePriceOfWarrantsOrRights_0" xml:lang="en-US">Exercise price per share or per unit of warrants or rights outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExercisePriceOfWarrantsOrRights_1" xml:lang="en-US">Exercise Price Of Warrants Or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ExercisePriceOfWarrantsOrRights_2" xml:lang="en-US">Exercise price of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExercisePricePerADS_0" xml:lang="en-US">Exercise price per ADS .</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExercisePricePerADS_1" xml:lang="en-US">Exercise Price Per A D S</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ExercisePricePerADS_2" xml:lang="en-US">Exercise price per ADS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExpenseOfRestructuringCost_0" xml:lang="en-US">The amount of expense relating to restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExpenseOfRestructuringCost_1" xml:lang="en-US">Expense Of Restructuring Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ExpenseOfRestructuringCost_2" xml:lang="en-US">Restructuring cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExtinguishmentOfAmountOwed_0" xml:lang="en-US">The fair value, at acquisition date, of the consideration transferred in a business combination extinguishment of amount owed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExtinguishmentOfAmountOwed_1" xml:lang="en-US">Extinguishment Of Amount Owed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ExtinguishmentOfAmountOwed_2" xml:lang="en-US">Extinguishment of monies owed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ExtinguishmentOfDebtAmounts_0" xml:lang="en-US">Gross amount of debt extinguished.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ExtinguishmentOfDebtAmounts_1" xml:lang="en-US">Extinguishment Of Debt, Amounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ExtinguishmentOfDebtAmounts_2" xml:lang="en-US">Extinguishment of debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FairValueMember_0" xml:lang="en-US">Fair Value [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FairValueMember_1" xml:lang="en-US">Fair Value [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">The amount, at acquisition date, of fair value of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Fair Value Of Contingent Consideration Recognised As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Fair value of contingent consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FairValueOfDerivativeFinancialAsset_0" xml:lang="en-US">Fair value of derivative financial asset.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FairValueOfDerivativeFinancialAsset_1" xml:lang="en-US">Fair Value Of Derivative Financial Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FairValueOfDerivativeFinancialAsset_2" xml:lang="en-US">Fair value of derivative financial asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FairValueOfDerivativeFinancialLiability_0" xml:lang="en-US">Fair value of derivative financial liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FairValueOfDerivativeFinancialLiability_1" xml:lang="en-US">Fair Value Of Derivative Financial Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FairValueOfDerivativeFinancialLiability_2" xml:lang="en-US">Fair value of derivative financial liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FairValueOfFinancialAssetsLiabilities_0" xml:lang="en-US">Total fair value of financial assets liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_trib_FairValueOfFinancialAssetsLiabilities_1" xml:lang="en-US">Total fair value of financial assets liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FairValueOfFinancialAssetsLiabilities_2" xml:lang="en-US">Fair Value Of Financial Assets Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_FairValueOfFinancialAssetsLiabilities_3" xml:lang="en-US">Total fair value of financial assets liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FairValueOfSharesIssued_0" xml:lang="en-US">Represents amount of fair value of shares issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FairValueOfSharesIssued_1" xml:lang="en-US">Fair Value Of Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FairValueOfSharesIssued_2" xml:lang="en-US">Fair value of ADSs issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_0" xml:lang="en-US">Represents the amount of fair value remeasured through profit &amp; loss for financial assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_1" xml:lang="en-US">Fair Value Remeasured Through Profit &amp; Loss Of Financial Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_2" xml:lang="en-US">Fair value remeasured through profit &amp; loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FairValueRemeasurementForDerivativeFinancialBalances_0" xml:lang="en-US">Fair value remeasurement for derivative financial balances.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FairValueRemeasurementForDerivativeFinancialBalances_1" xml:lang="en-US">Fair Value Remeasurement For Derivative Financial Balances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FairValueRemeasurementForDerivativeFinancialBalances_2" xml:lang="en-US">Fair value remeasurement for derivative financial balances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FairValueThroughProfitAndLoss_0" xml:lang="en-US">Ffair value through profit and loss (FVPL).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_trib_FairValueThroughProfitAndLoss_1" xml:lang="en-US">Total fair value through profit and loss (FVPL)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FairValueThroughProfitAndLoss_2" xml:lang="en-US">Fair Value Through Profit And Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FairValueThroughProfitAndLoss_3" xml:lang="en-US">Total fair value through profit and loss (FVPL)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FederalCorporationTaxRateMember_0" xml:lang="en-US">Federal corporation tax rate [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FifthAmendmentToCreditAgreementMember_0" xml:lang="en-US">Fifth Amendment To Credit Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FifthAmendmentToCreditAgreementMember_1" xml:lang="en-US">Fifth Amendment To Credit Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinanceIncomeExpenseNet_0" xml:lang="en-US">Financing expenses, net.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinanceIncomeExpenseNet_1" xml:lang="en-US">Finance Income Expense Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FinanceIncomeExpenseNet_2" xml:lang="en-US">Net financing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinanceLeaseLiabilitiesMember_0" xml:lang="en-US">Finance lease liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinanceLeaseLiabilitiesMember_1" xml:lang="en-US">Finance Lease Liabilities Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FinanceLeaseLiabilitiesMember_2" xml:lang="en-US">Sale and leaseback liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinanceLeaseLiabilitiesTwoMember_0" xml:lang="en-US">Finance lease liabilities Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinanceLeaseLiabilitiesTwoMember_1" xml:lang="en-US">Finance Lease Liabilities Two Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FinanceLeaseLiabilitiesTwoMember_2" xml:lang="en-US">Sale and leaseback liabilities Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinanceLeasePayableMember_0" xml:lang="en-US">Finance lease payable [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinanceLeaseReceivableMember_0" xml:lang="en-US">Finance lease receivable [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinanceLeaseReceivableMember_1" xml:lang="en-US">Finance Lease Receivable Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FinanceLeaseReceivableMember_2" xml:lang="en-US">Lease receivable [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinancialAssetsAdditions_0" xml:lang="en-US">Amount of financial assets additions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinancialAssetsAdditions_1" xml:lang="en-US">Financial Assets Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_FinancialAssetsAdditions_2" xml:lang="en-US">Additions in year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinancialAssetsLeaseReceivables_0" xml:lang="en-US">Financial assets lease receivables.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_trib_FinancialAssetsLeaseReceivables_1" xml:lang="en-US">Finance lease receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_trib_FinancialAssetsLeaseReceivables_2" xml:lang="en-US">Finance lease income receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinancialAssetsLeaseReceivables_3" xml:lang="en-US">Financial Assets Lease Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FinancialAssetsLeaseReceivables_4" xml:lang="en-US">Financial assets (lease receivables)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_FinancialAssetsLeaseReceivables_5" xml:lang="en-US">Lease receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinancialAssetsPolicyTextBlock_0" xml:lang="en-US">Disclosure of accounting policy for financial assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinancialAssetsPolicyTextBlock_1" xml:lang="en-US">Financial Assets [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FinancialAssetsPolicyTextBlock_2" xml:lang="en-US">Financial Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinancialAssetsWriteOff_0" xml:lang="en-US">Represents the amount of financial assets written off.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinancialAssetsWriteOff_1" xml:lang="en-US">Financial Assets Write Off</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FinancialAssetsWriteOff_2" xml:lang="en-US">Write off in the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinancialAtFairValueThroughProfitOrLossAbstract_0" xml:lang="en-US">Financial At Fair Value Through Profit Or Loss Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FinancialAtFairValueThroughProfitOrLossAbstract_1" xml:lang="en-US">Fair value through profit and loss (FVPL)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinancialIncomeAndExpensesAbstract_0" xml:lang="en-US">Financial Income And Expenses Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_FinancialIncomeAndExpensesAbstract_1" xml:lang="en-US">Financial Income And Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinancialIncomeAndExpensesLineItems_0" xml:lang="en-US">Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinancialIncomeAndExpensesLineItems_1" xml:lang="en-US">Financial Income And Expenses [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinancialIncomeAndExpensesTable_0" xml:lang="en-US">Schedule disclosing information related to financial income and expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinancialIncomeAndExpensesTable_1" xml:lang="en-US">Financial Income And Expenses [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue_0" xml:lang="en-US">Financial income from revaluation of embedded derivatives at fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue_1" xml:lang="en-US">Financial Income From Revaluation Of Embedded Derivatives At Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue_2" xml:lang="en-US">Financial income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinancingExpensesAbstract_0" xml:lang="en-US">Financing Expenses Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FinancingExpensesAbstract_1" xml:lang="en-US">Financial expense:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinancingExpensesOther_0" xml:lang="en-US">Represents the amount of financing expenses other.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_FinancingExpensesOther_1" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinancingExpensesOther_2" xml:lang="en-US">Financing Expenses Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FinancingExpensesOther_3" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinancingIncomeAbstract_0" xml:lang="en-US">Financing Income Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FinancingIncomeAbstract_1" xml:lang="en-US">Financial income:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FinancingIncomeBySegment_0" xml:lang="en-US">Amount of financing income by operating segment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FinancingIncomeBySegment_1" xml:lang="en-US">Financing Income By Segment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FinancingIncomeBySegment_2" xml:lang="en-US">Net financing expense (Note 6)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FiomiDiagnosticsAbMember_0" xml:lang="en-US">Fiomi Diagnostics AB [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FiomiDiagnosticsAbMember_1" xml:lang="en-US">Fiomi Diagnostics Ab [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FiomiDiagnosticsHoldingAbMember_0" xml:lang="en-US">This member stands for Fiomi Diagnostics Holding AB.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FiomiDiagnosticsHoldingAbMember_1" xml:lang="en-US">Fiomi Diagnostics Holding Ab [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FiomiDiagnosticsMember_0" xml:lang="en-US">This member stands for Fiomi Diagnostics.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FiomiDiagnosticsMember_1" xml:lang="en-US">Fiomi Diagnostics [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_FiomiDiagnosticsMember_2" xml:lang="en-US">Fiomi Diagnostics (&#8220;Fiomi&#8221;) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FiomiMember_0" xml:lang="en-US">Fiomi [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember_0" xml:lang="en-US">Fitzgerald Industries International CGU RDI Trade Name [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember_1" xml:lang="en-US">Fitzgerald Industries International CGU RDI Trade Name [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_0" xml:lang="en-US">Fitzgerald Industries International CGU Trade Name [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_1" xml:lang="en-US">Fitzgerald Industries International CGU Trade Name [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FitzgeraldIndustriesInternationalIncMember_0" xml:lang="en-US">This member stands for Fitzgerald Industries International, Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FitzgeraldIndustriesInternationalIncMember_1" xml:lang="en-US">Fitzgerald Industries International, Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FixedRateFinancialLiabilitiesBorrowings_0" xml:lang="en-US">Fixed rate financial liabilities of borrowings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_FixedRateFinancialLiabilitiesBorrowings_1" xml:lang="en-US">Fixed rate financial liabilities (borrowings)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FixedRateFinancialLiabilitiesBorrowings_2" xml:lang="en-US">Fixed Rate Financial Liabilities Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FixedRateInstruments_0" xml:lang="en-US">The amount of total fixed rate instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_FixedRateInstruments_1" xml:lang="en-US">Fixed rate instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_trib_FixedRateInstruments_2" xml:lang="en-US">Fixed rate instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FixedRateInstruments_3" xml:lang="en-US">Fixed Rate Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FixedRateInstrumentsAbstract_0" xml:lang="en-US">Fixed Rate Instruments Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FixedRateInstrumentsAbstract_1" xml:lang="en-US">Fixed rate instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ForeignExchangeDifferencesMember_0" xml:lang="en-US">Foreign Exchange Differences [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ForgivenessOfBorrowings_0" xml:lang="en-US">Forgiveness amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ForgivenessOfBorrowings_1" xml:lang="en-US">Forgiveness Of Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ForgivenessOfBorrowings_2" xml:lang="en-US">Forgiveness amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FourthAmendmentToCreditAgreementMember_0" xml:lang="en-US">Fourth Amendment To Credit Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FourthAmendmentToCreditAgreementMember_1" xml:lang="en-US">Fourth Amendment To Credit Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_FutureFinanceChargeOnFinanceLeases_0" xml:lang="en-US">The amount representing the difference between the future minimum finance lease payments and their present value. Minimum lease payments are payments over the lease term that the lessee is or can be required to make, excluding contingent rent, costs for services and taxes to be paid by, and reimbursed to, the lessor, together with: (a) for a lessee, any amounts guaranteed by the lessee or by a party related to the lessee; or (b) for a lessor, any residual value guaranteed to the lessor by: (i) the lessee; (ii) a party related to the lessee; or (iii) a third party unrelated to the lessor that is financially capable of discharging the obligations under the guarantee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_FutureFinanceChargeOnFinanceLeases_1" xml:lang="en-US">Future Finance Charge On Finance Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_FutureFinanceChargeOnFinanceLeases_2" xml:lang="en-US">Operating Lease commitments at December, 31, 2018 (Note 27)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_G6PDHTestMember_0" xml:lang="en-US">G-6-PDH test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_G6PDHTestMember_1" xml:lang="en-US">G 6 P D H Test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_G6PDHTestMember_2" xml:lang="en-US">G-6-PDH Test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_GenesysOrResolutionColumnEnhancementMember_0" xml:lang="en-US">Genesys/Resolution Column Enhancement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_GoodwillWriteOff_0" xml:lang="en-US">Amount of goodwill write off.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_GoodwillWriteOff_1" xml:lang="en-US">Goodwill write off</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_GovernmentGrantReceived_0" xml:lang="en-US">The amount of government grant received.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_GovernmentGrantReceived_1" xml:lang="en-US">Government Grant Received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_GovernmentLoansForgivenAmount_0" xml:lang="en-US">Government loans forgiven amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_GovernmentLoansForgivenAmount_1" xml:lang="en-US">Government loans forgiven amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_GovernmentSupportsCovid19_0" xml:lang="en-US">Government supports - COVID-19.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_GovernmentSupportsCovid19_1" xml:lang="en-US">Government supports</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_GrantContingenciesMaximumAmountPayable_0" xml:lang="en-US">Grant contingencies maximum amount payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_GrantContingenciesMaximumAmountPayable_1" xml:lang="en-US">Grant contingencies maximum amount payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_GrantReceivable_0" xml:lang="en-US">Grant receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_GrantReceivable_1" xml:lang="en-US">Grant Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_GrantReceivable_2" xml:lang="en-US">Grant receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_GreaterThanFiveYearsMember_0" xml:lang="en-US">5 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_GreaterThanFiveYearsMember_1" xml:lang="en-US">Greater Than Five Years Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_GreaterThanFiveYearsMember_2" xml:lang="en-US">&gt;5 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_GreaterThanFourMonthsMember_0" xml:lang="en-US">Greater than 120 days [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_GreaterThanFourMonthsMember_1" xml:lang="en-US">Greater Than Four Months Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_GreaterThanFourMonthsMember_2" xml:lang="en-US">Greater than 120 days [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_GrossIncreaseInterestIncome_0" xml:lang="en-US">Represent the gross Increase interest income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_GrossIncreaseInterestIncome_1" xml:lang="en-US">Gross Increase Interest Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_GrossInvestmentInFinanceLease_0" xml:lang="en-US">The aggregate of: (a) the minimum lease payments receivable by the lessor under a finance lease; and (b) any unguaranteed residual value accruing to the lessor. Minimum lease payments are payments over the lease term that the lessee is or can be required to make, excluding contingent rent, costs for services and taxes to be paid by, and reimbursed to, the lessor, together with: (a) for a lessee, any amounts guaranteed by the lessee or by a party related to the lessee; or (b) for a lessor, any residual value guaranteed to the lessor by: (i) the lessee; (ii) a party related to the lessee; or (iii) a third party unrelated to the lessor that is financially capable of discharging the obligations under the guarantee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_GrossInvestmentInFinanceLease_1" xml:lang="en-US">Gross Investment In Finance Lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_GrossInvestmentInFinanceLease_2" xml:lang="en-US">Gross investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_GroupLeaseExpense_0" xml:lang="en-US">Group lease expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_GroupLeaseExpense_1" xml:lang="en-US">Group lease expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_HivIncidenceAssayMember_0" xml:lang="en-US">HIV Incidence Assay [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_HivOneByTwoRapidTestMember_0" xml:lang="en-US">HIV 1/2 Rapid Test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_HivOneByTwoRapidTestMember_1" xml:lang="en-US">Hiv One By Two Rapid Test Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_HivOneByTwoRapidTestMember_2" xml:lang="en-US">HIV Screening Rapid Test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_HivScreeningAfricaMember_0" xml:lang="en-US">HIV screening Africa [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IgmCaptiaMember_0" xml:lang="en-US">IgM Captia [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ImmcoDiagnosticCGUMember_0" xml:lang="en-US">Immco Diagnostic CGU Trade Name [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ImmcoDiagnosticCGUMember_1" xml:lang="en-US">Immco Diagnostic C G U Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ImmcoDiagnosticsIncMember_0" xml:lang="en-US">Immco Diagnostics Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ImmcoDiagnosticsIncMember_1" xml:lang="en-US">Immco Diagnostics Inc Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ImmcoDiagnosticsIncMember_2" xml:lang="en-US">Immco Diagnostics Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ImmcoDiagnosticsMember_0" xml:lang="en-US">Immco Diagnostics [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ImmcoDiagnosticTradeNameMember_0" xml:lang="en-US">Immco Diagnostic trade name [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ImpairmentChargePropertyPlantEquipment_0" xml:lang="en-US">Represent the amount of Impairment Charge Property, Plant &amp; Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ImpairmentChargePropertyPlantEquipment_1" xml:lang="en-US">Impairment Charge Property, Plant &amp; Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ImpairmentChargesMember_0" xml:lang="en-US">Impairment Charges [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ImpairmentLossForInvestment_0" xml:lang="en-US">Represents the amount of impairment loss for the investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ImpairmentLossForInvestment_1" xml:lang="en-US">Impairment Loss For Investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ImpairmentOfPrepayments_0" xml:lang="en-US">Impairment of prepayments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ImpairmentOfPrepayments_1" xml:lang="en-US">Impairment Of Prepayments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ImpairmentOfPrepayments_2" xml:lang="en-US">Impairment of prepayments (Note 18)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ImpairmentOfPrepayments_3" xml:lang="en-US">Impairment of prepayments (Note 17)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncomeFromPaycheckProtectionProgramLoans_0" xml:lang="en-US">Represents amount of income from the Paycheck Protection Program loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncomeFromPaycheckProtectionProgramLoans_1" xml:lang="en-US">Income From Paycheck Protection Program Loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_IncomeFromPaycheckProtectionProgramLoans_2" xml:lang="en-US">Income from the Paycheck Protection Program loans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncomeLoss_0" xml:lang="en-US">Amount of net income loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncomeLoss_1" xml:lang="en-US">Income Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IncomeLoss_2" xml:lang="en-US">Total loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_IncomeLoss_3" xml:lang="en-US">Total loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncomeTaxAssetsCurrentAndDeferred_0" xml:lang="en-US">Amount of income tax assets current and deferred.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncomeTaxAssetsCurrentAndDeferred_1" xml:lang="en-US">Income tax assets (current and deferred)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncomeTaxExpense_0" xml:lang="en-US">Income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncomeTaxExpense_1" xml:lang="en-US">Income Tax Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IncomeTaxExpense_2" xml:lang="en-US">Taxation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract_0" xml:lang="en-US">Income Tax Expense Benefit Continuing Operations Income Tax Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract_1" xml:lang="en-US">Effective tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncomeTaxExpenseBenefits_0" xml:lang="en-US">The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncomeTaxExpenseBenefits_1" xml:lang="en-US">Income Tax Expense Benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IncomeTaxExpenseBenefits_2" xml:lang="en-US">Total tax charge/(credit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncomeTaxImpactOfImpairmentLoss_0" xml:lang="en-US">Income tax, impact of impairment loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncomeTaxImpactOfImpairmentLoss_1" xml:lang="en-US">Income tax impact of impairment loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncomeTaxLiabilitiesCurrentAndDeferred_0" xml:lang="en-US">Amount of income tax liabilities current and deferred.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncomeTaxLiabilitiesCurrentAndDeferred_1" xml:lang="en-US">Income tax liabilities (current and deferred)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">The increase (decrease) in liabilities arising from financing activities resulting from changes in accretion interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Increase Decrease Through Changes In Accretion Interest Liabilities Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_2" xml:lang="en-US">Accretion interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_0" xml:lang="en-US">Represents the amount of increase decrease through changes in additional fair value liabilities warrants arising from financing activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_1" xml:lang="en-US">Increase Decrease Through Changes In Additional Fair Value Liabilities Warrants Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_2" xml:lang="en-US">Fair value of additional derivative liability - warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">The increase (decrease) in liabilities arising from financing activities resulting from changes in contingent liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Increase Decrease Through Changes In Contingent Liabilities Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_2" xml:lang="en-US">Contingent liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">The increase (decrease) in liabilities arising from financing activities resulting from changes in interest charged.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Increase Decrease Through Changes In Interest Charged Liabilities Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_2" xml:lang="en-US">Interest charged</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_0" xml:lang="en-US">The increase (decrease) in liabilities arising from financing activities resulting from changes in payment in kind interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_1" xml:lang="en-US">Increase Decrease Through Changes In Payment In Kind Interest Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_2" xml:lang="en-US">Payment-in-kind (PIK) Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_0" xml:lang="en-US">The increase (decrease) in liabilities arising from financing activities resulting from disposals.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_1" xml:lang="en-US">Increase Decrease Through Disposals Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_2" xml:lang="en-US">Disposals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_0" xml:lang="en-US">The amount represents equity component of convertible note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_1" xml:lang="en-US">Increasedecreasethroughequity Component Of Convertible Note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_2" xml:lang="en-US">Equity component of convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_0" xml:lang="en-US">The increase (decrease) in liabilities arising from financing activities resulting from loan forgiven.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_1" xml:lang="en-US">Increase Decrease Through Loan Forgiven Liabilities Arising From Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_2" xml:lang="en-US">Loan forgiven</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_0" xml:lang="en-US">The increase (decrease) in equity resulting from share-based payment transactions inclusive of amounts capitalised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_1" xml:lang="en-US">Increase Decrease Through Sharebased Payment Transactions Inclusive Of Amounts Capitalised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_2" xml:lang="en-US">Share based payments charge</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_3" xml:lang="en-US">Total share based payments, inclusive of amounts capitalised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncreasedInUnrecognisedDeferredTaxAssets_0" xml:lang="en-US">Increased in unrecognised deferred tax assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncreasedInUnrecognisedDeferredTaxAssets_1" xml:lang="en-US">Increased in unrecognised deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncreaseInAnnualRent_0" xml:lang="en-US">The amount represents increase in annual rent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncreaseInAnnualRent_1" xml:lang="en-US">Increase In Annual Rent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IncreaseInAnnualRent_2" xml:lang="en-US">Increase In annual rent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncreaseInSettlementAmountDueToDepreciation_0" xml:lang="en-US">Increase in settlement amount due to depreciation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncreaseInSettlementAmountDueToDepreciation_1" xml:lang="en-US">Increase in settlement amount due to depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IncreaseTermLoan_0" xml:lang="en-US">Represents the amount of increase term loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IncreaseTermLoan_1" xml:lang="en-US">Increase Term Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IncreaseTermLoan_2" xml:lang="en-US">Increase term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InitialExercisePriceOfWarrantsOrRights_0" xml:lang="en-US">Initial Exercise Price Of Warrants Or Rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InitialExercisePriceOfWarrantsOrRights_1" xml:lang="en-US">Initial Exercise Price Of Warrants Or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_InitialExercisePriceOfWarrantsOrRights_2" xml:lang="en-US">Initial exercise price of warrants or rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InstalmentsAxis_0" xml:lang="en-US">Instalments [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InstalmentsDomain_0" xml:lang="en-US">Instalments [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InstrumentsMember_0" xml:lang="en-US">This member stands for Instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InstrumentsMember_1" xml:lang="en-US">Instruments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_0" xml:lang="en-US">Intangible Assets Under Development Impairment Charge.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_1" xml:lang="en-US">Intangible Assets Under Development Impairment Charge</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_2" xml:lang="en-US">Intangible assets under development impairment charge</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IntangibleAssetsUnderDevelopmentWrittenDown_0" xml:lang="en-US">Intangible assets under development written down.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IntangibleAssetsUnderDevelopmentWrittenDown_1" xml:lang="en-US">Intangible Assets Under Development Written Down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IntangibleAssetsUnderDevelopmentWrittenDown_2" xml:lang="en-US">Intangible assets under development written down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_0" xml:lang="en-US">Total interest earning financial and interest bearing financial liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_1" xml:lang="en-US">Total interest earning financial and interest bearing financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_2" xml:lang="en-US">Total interest earning financial and interest bearing financial liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_3" xml:lang="en-US">Interest Earning Financial And Interest Bearing Financial Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InterestExpenseOnLeaseLiabilities1_0" xml:lang="en-US">The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InterestExpenseOnLeaseLiabilities1_1" xml:lang="en-US">Interest Expense On Lease Liabilities 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_InterestExpenseOnLeaseLiabilities1_2" xml:lang="en-US">Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InterestExpenseOnTaxAuditSettlement_0" xml:lang="en-US">Interest on tax audit settlement (Note 6).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_InterestExpenseOnTaxAuditSettlement_1" xml:lang="en-US">Interest on tax audit settlement (Note 6)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InterestExpenseOnTaxAuditSettlement_2" xml:lang="en-US">Interest Expense On Tax Audit Settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InterestExpenses_0" xml:lang="en-US">Represent the interest expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InterestExpenses_1" xml:lang="en-US">Interest Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_InterestExpenses_2" xml:lang="en-US">Interest expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InterestExpensesAbstract_0" xml:lang="en-US">Interest Expenses Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_InterestExpensesAbstract_1" xml:lang="en-US">Interest expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InterestIncomeAbstract_0" xml:lang="en-US">Interest Income Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_InterestIncomeAbstract_1" xml:lang="en-US">Interest Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InterestIncomeCredit_0" xml:lang="en-US">Interest income credits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InterestIncomeCredit_1" xml:lang="en-US">Interest Income Credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_InterestIncomeCredit_2" xml:lang="en-US">Interest credits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InterestIncomeEarned_0" xml:lang="en-US">Amount of interest income earned.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InterestIncomeEarned_1" xml:lang="en-US">Interest income earned</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_InterestIncomeEarned_2" xml:lang="en-US">Interest income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InterestOnDeferredConsiderationAndLicenceFee_0" xml:lang="en-US">Amount of interest on deferred consideration and licence fee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_InterestOnDeferredConsiderationAndLicenceFee_1" xml:lang="en-US">Interest on deferred consideration and licence fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InterestOnDeferredConsiderationAndLicenceFee_2" xml:lang="en-US">Interest On Deferred Consideration And Licence Fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InterestPaidOnConvertibleNote_0" xml:lang="en-US">The amount represents interest paid on convertible note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_InterestPaidOnConvertibleNote_1" xml:lang="en-US">Interest paid on convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_trib_InterestPaidOnConvertibleNote_2" xml:lang="en-US">Cash interest payable on convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InterestPaidOnConvertibleNote_3" xml:lang="en-US">Interest Paid On Convertible Note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_InterestPaidOnConvertibleNote_4" xml:lang="en-US">Interest paid for convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InterestPaidOnSeniorSecuredTermLoan_0" xml:lang="en-US">The amount represents interest paid on senior secured term loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_InterestPaidOnSeniorSecuredTermLoan_1" xml:lang="en-US">Interest paid on senior secured term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_trib_InterestPaidOnSeniorSecuredTermLoan_2" xml:lang="en-US">Interest paid for senior secured term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InterestPaidOnSeniorSecuredTermLoan_3" xml:lang="en-US">Interest Paid On Senior Secured Term Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_InterestPaidOnSeniorSecuredTermLoan_4" xml:lang="en-US">Interest paid on senior secured term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InterSegmentInterestExpense_0" xml:lang="en-US">Amount of inter segment interest expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InterSegmentInterestExpense_1" xml:lang="en-US">Inter Segment Interest Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InterSegmentInterestIncome_0" xml:lang="en-US">Amount of inter segment interest income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InterSegmentInterestIncome_1" xml:lang="en-US">Inter-segment interest income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InventoryMember_0" xml:lang="en-US">Inventory [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InventoryMember_1" xml:lang="en-US">Inventory Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_InventoryMember_2" xml:lang="en-US">Inventories [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InventoryRelatedCostsMember_0" xml:lang="en-US">Inventory Related Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InventoryRelatedCostsMember_1" xml:lang="en-US">Inventory Related Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_InventoryRelatedCostsMember_2" xml:lang="en-US">Inventory related costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InventoryWrittenDown_0" xml:lang="en-US">It represents inventory written down.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InventoryWrittenDown_1" xml:lang="en-US">Inventory Written Down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_InventoryWrittenDown_2" xml:lang="en-US">Inventory written down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_InvestmentInUnsecuredJuniorConvertibleNote_0" xml:lang="en-US">Represents the amount of investment in unsecured junior convertible notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_InvestmentInUnsecuredJuniorConvertibleNote_1" xml:lang="en-US">Investment In Unsecured Junior Convertible Note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_InvestmentInUnsecuredJuniorConvertibleNote_2" xml:lang="en-US">Investment in unsecured junior convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IssuableOnConversionOfConvertibleNotes_0" xml:lang="en-US">Shares issuable on conversion of convertible notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IssuableOnConversionOfConvertibleNotes_1" xml:lang="en-US">Issuable On Conversion Of Convertible Notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IssuableOnConversionOfConvertibleNotes_2" xml:lang="en-US">Issuable on conversion of Convertible notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IssuableOnConversionOfExchangeableNotes_0" xml:lang="en-US">Number of issuable on conversion of exchangeable notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IssuableOnConversionOfExchangeableNotes_1" xml:lang="en-US">Issuable on conversion of exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IssuableOnConversionOfExchangeableNotes_2" xml:lang="en-US">Issuable on conversion of Exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IssuableOnExerciseOfOptions_0" xml:lang="en-US">Number of issuable on exercise of options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IssuableOnExerciseOfOptions_1" xml:lang="en-US">Issuable On Exercise Of Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IssuableOnExerciseOfOptions_2" xml:lang="en-US">Issuable on exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IssuableOnExerciseOfOptionsAndWarrants_0" xml:lang="en-US">Number of issuable on exercise of options and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IssuableOnExerciseOfOptionsAndWarrants_1" xml:lang="en-US">Issuable on exercise of options and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IssuedAmericanDepositoryShares_0" xml:lang="en-US">The amount of American depository shares issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IssuedAmericanDepositoryShares_1" xml:lang="en-US">Issued American Depository Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_IssuedAmericanDepositoryShares_2" xml:lang="en-US">American Depository Shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IssuedForNoncashConsideration_0" xml:lang="en-US">Represents the number of Issued for non-cash consideration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IssuedForNoncashConsideration_1" xml:lang="en-US">Issued For Non-cash Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_IssuedForNoncashConsideration_2" xml:lang="en-US">Issued for non-cash consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_IssuedForNoncashConsideration_3" xml:lang="en-US">Shares issued as consideration for Exchangeable Notes purchase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_IssuenceOfExchangeableNote_0" xml:lang="en-US">Issuence of exchangeable note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_IssuenceOfExchangeableNote_1" xml:lang="en-US">Issuence of exchangeable note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ITAndOfficeEquipmentMember_0" xml:lang="en-US">I.T. and office equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ITAndOfficeEquipmentMember_1" xml:lang="en-US">I.T. and office equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_JrjMember_0" xml:lang="en-US">JRJ [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_JrjMember_1" xml:lang="en-US">JRJ [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_JrjMember_2" xml:lang="en-US">JRJ Investments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_KansasRightOfUseAssetMember_0" xml:lang="en-US">This member stands for Kansas right-of-use asset.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_KansasRightOfUseAssetMember_1" xml:lang="en-US">Kansas Right Of Use Asset [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_KansasRightOfUseAssetMember_2" xml:lang="en-US">Kansas right-of-use asset [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_0" xml:lang="en-US">Performance related bonus.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_1" xml:lang="en-US">Key Management Personnel Compensation Performance Related Bonus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_2" xml:lang="en-US">Performance related bonus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_0" xml:lang="en-US">The amount of compensation to key management personnel in the form of settlement related to payroll taxes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_1" xml:lang="en-US">Key Management Personnel Compensation Settlement Related To Payroll Taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_2" xml:lang="en-US">Tax settlement (Note 6)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_KonamiteLimitedMember_0" xml:lang="en-US">Represent the member of Konamite Limited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_KonamiteLimitedMember_1" xml:lang="en-US">Konamite Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LaboratoryEquipmentMember_0" xml:lang="en-US">Laboratory equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LaboratoryServicesMember_0" xml:lang="en-US">Laboratory services [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LaboratoryServicesMember_1" xml:lang="en-US">Laboratory Services Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LaboratoryServicesMember_2" xml:lang="en-US">Clinical laboratory services [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_0" xml:lang="en-US">Past due 31-120 days [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_1" xml:lang="en-US">Later Than One Months And Not Later Than Four Months Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_2" xml:lang="en-US">Past due 31-120 days [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_0" xml:lang="en-US">In more than two years but not more than five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_1" xml:lang="en-US">Later Than Two Year And Not Later Than Five Years Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_2" xml:lang="en-US">In more than two years but not more than five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LeaseCosts_0" xml:lang="en-US">The amount of expense recognised on Lease costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LeaseCosts_1" xml:lang="en-US">Lease costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed_0" xml:lang="en-US">Lease payments not recognised as a liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed_1" xml:lang="en-US">Lease Expenses For Short Term Leases For Which Recognition Exemption Has Been Used</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed_2" xml:lang="en-US">Lease payments not recognised as a liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_0" xml:lang="en-US">Lease liabilities related to right of use assets current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_1" xml:lang="en-US">Lease Liabilities Related To Right Of Use Assets Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_2" xml:lang="en-US">Lease liabilities related to Right of Use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_0" xml:lang="en-US">Lease liabilities related Right of Use assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_1" xml:lang="en-US">Lease Liabilities Related To Right Of Use Assets Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_2" xml:lang="en-US">Lease liabilities related Right of Use assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_0" xml:lang="en-US">Lease liabilities related to right of use assets non-current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_1" xml:lang="en-US">Lease Liabilities Related To Right Of Use Assets Non Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_2" xml:lang="en-US">Lease liabilities related to Right of Use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LeasePayableOnRightOfUseAssets_0" xml:lang="en-US">Amount of lease payable on right of use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LeasePayableOnRightOfUseAssets_1" xml:lang="en-US">Lease payable on Right of Use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LeasePayableOnRightOfUseAssetsMember_0" xml:lang="en-US">Lease payable on Right of Use assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LeasePayableOnRightOfUseAssetsMember_1" xml:lang="en-US">Lease payable on Right of Use assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LeasePayableOnSaleAndLeasebackTransactions_0" xml:lang="en-US">Amount of lease payable on sale and leaseback transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LeasePayableOnSaleAndLeasebackTransactions_1" xml:lang="en-US">Lease Payable On Sale And Leaseback Transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LeasePayableOnSaleAndLeasebackTransactions_2" xml:lang="en-US">Lease payable on sale &amp; leaseback transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LeasePayableOnSaleLeasebackTransactionsMember_0" xml:lang="en-US">Lease payable on sale &amp; leaseback transactions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LeasePayableOnSaleLeasebackTransactionsMember_1" xml:lang="en-US">Lease payable on sale &amp; leaseback transactions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LeaseTerm_0" xml:lang="en-US">Lease term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LeaseTerm_1" xml:lang="en-US">Lease Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LenderMember_0" xml:lang="en-US">This member stand for lender.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LenderMember_1" xml:lang="en-US">Lender [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LiabilitiesAssumedAsOfAcquisitionDateAbstract_0" xml:lang="en-US">Liabilities Assumed As Of Acquisition Date [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LiabilitiesAssumedAsOfAcquisitionDateAbstract_1" xml:lang="en-US">LIABILITIES ASSUMED</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LiabilitiesAtAmortisedCostAbstract_0" xml:lang="en-US">Liabilities At Amortised Cost Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LiabilitiesAtAmortisedCostAbstract_1" xml:lang="en-US">Liabilities at amortised cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LicenceFee_0" xml:lang="en-US">Licence fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LicenceFee_1" xml:lang="en-US">Licence Fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LicenceFee_2" xml:lang="en-US">Licence fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LicenceFeePayments_0" xml:lang="en-US">Accrued liabilities to contracted licence payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_LicenceFeePayments_1" xml:lang="en-US">Licence payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_trib_LicenceFeePayments_2" xml:lang="en-US">Fixed rate financial liabilities (licence fees)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LicenceFeePayments_3" xml:lang="en-US">Licence Fee Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_LicenceFeePayments_4" xml:lang="en-US">Accrued liabilities to contracted licence payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LicencePaymentsMember_0" xml:lang="en-US">Licence payments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LicencePaymentsMember_1" xml:lang="en-US">Licence payments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LineImmunoassayPanelsMember_0" xml:lang="en-US">Line Immunoassay Panels [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LoanIncome_0" xml:lang="en-US">Represent the amount of orginal loan income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LoanIncome_1" xml:lang="en-US">Loan Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/disclosureGuidance" xlink:label="lab_trib_LoanOriginationCosts_0" xml:lang="en-US">Loan drawdown costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LoanOriginationCosts_1" xml:lang="en-US">Represents the amount of loan origination costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_LoanOriginationCosts_2" xml:lang="en-US">Loan origination costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_trib_LoanOriginationCosts_3" xml:lang="en-US">Loan origination costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LoanOriginationCosts_4" xml:lang="en-US">Loan Origination Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LoanOriginationCosts_5" xml:lang="en-US">Loan origination costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_LoanOriginationCosts_6" xml:lang="en-US">Loan origination costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LoansAndReceivablesAbstract_0" xml:lang="en-US">Loans And Receivables Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LoansAndReceivablesAbstract_1" xml:lang="en-US">Loans and receivables at amortised cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LongLivedAsstesBySegment_0" xml:lang="en-US">Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LongLivedAsstesBySegment_1" xml:lang="en-US">Long Lived Asstes By Segment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LongLivedAsstesBySegment_2" xml:lang="en-US">Long lived asstes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LongTermGrowthRate_0" xml:lang="en-US">Long-term growth rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LongTermGrowthRate_1" xml:lang="en-US">Long Term Growth Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LongTermGrowthRate_2" xml:lang="en-US">Long term growth rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_LongTermGrowthRate_3" xml:lang="en-US">Long-term growth rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LongTermLeaseLiabilitiesMember_0" xml:lang="en-US">Long-term lease liabilities [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LossOnDiscontinuedOperationsAbstract_0" xml:lang="en-US">Loss On Discontinued Operations Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LossOnDiscontinuedOperationsAbstract_1" xml:lang="en-US">Selling General And Administrative Expenses - Tax Audit Settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_LossOnDiscontinuedOperationsAbstract_2" xml:lang="en-US">Loss/profit For Year On Discontinued Operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LossOnDisposalOfExchangeableNotes_0" xml:lang="en-US">Represents the amount of loss on disposal of exchangeable notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_LossOnDisposalOfExchangeableNotes_1" xml:lang="en-US">Loss on disposal of exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LossOnDisposalOfExchangeableNotes_2" xml:lang="en-US">Loss On Disposal Of Exchangeable Notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LossOnDisposalOfExchangeableNotes_3" xml:lang="en-US">Loss on disposal of Exchangeable Notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_LossOnDisposalOnBorrowings_0" xml:lang="en-US">The amount of loss on disposal on borrowings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_LossOnDisposalOnBorrowings_1" xml:lang="en-US">Loss On Disposal On Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_LossOnDisposalOnBorrowings_2" xml:lang="en-US">Loss on disposal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MalariaPointOfCareTestMember_0" xml:lang="en-US">Malaria Point-of-Care Test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ManufacturingAndQualityMember_0" xml:lang="en-US">Manufacturing and quality [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ManufacturingAndQualityMember_1" xml:lang="en-US">Manufacturing and quality [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MardxDiagnosticIncMember_0" xml:lang="en-US">Mardx Diagnostic Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MardxDiagnosticsIncMember_0" xml:lang="en-US">Mardx Diagnostics Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MardxDiagnosticsIncMember_1" xml:lang="en-US">Mardx Diagnostics Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MatrixProjectMember_0" xml:lang="en-US">Matrix Project [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MaturityDateForLease_0" xml:lang="en-US">Maturity date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MaturityDateForLease_1" xml:lang="en-US">Maturity Date For Lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_MaturityDateForLease_2" xml:lang="en-US">Maturity date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MaturityDateOfExchangeableSeniorNotes_0" xml:lang="en-US">Maturity date of exchangeable senior notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MaturityDateOfExchangeableSeniorNotes_1" xml:lang="en-US">Maturity date of exchangeable senior notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_0" xml:lang="en-US">Maximum weighted average price of American Depository Shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_1" xml:lang="en-US">Maximum Weighted Average Price Of American Depository Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_2" xml:lang="en-US">Maximum weighted average price of ADS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MeasurementPeriodAdjustmentMember_0" xml:lang="en-US">Measurement Period Adjustment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MeasurementPeriodAdjustmentMember_1" xml:lang="en-US">Measurement Period Adjustment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MetabolomicDiagnosticsLimitedMember_0" xml:lang="en-US">This member is stand for Metabolomic Diagnostics Limited.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MetabolomicDiagnosticsLimitedMember_1" xml:lang="en-US">Metabolomic Diagnostics Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_MetabolomicDiagnosticsLimitedMember_2" xml:lang="en-US">Metabolomic Diagnostics Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MetabolomicsDiagnosticsLimitedMember_0" xml:lang="en-US">Metabolomics Diagnostics Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MetabolomicsDiagnosticsLimitedMember_1" xml:lang="en-US">Metabolomics Diagnostics Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_MetabolomicsDiagnosticsLimitedMember_2" xml:lang="en-US">Metabolomics [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MicoLtdMember_0" xml:lang="en-US">MiCO LTD.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MicoLtdMember_1" xml:lang="en-US">Mico Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_MicoLtdMember_2" xml:lang="en-US">MiCo Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MicropillarTechnologyMember_0" xml:lang="en-US">Micropillar Technology [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MidTierHaemoglobinsInstrumentMember_0" xml:lang="en-US">Mid-tier haemoglobins instrument [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MidTierHaemoglobinsInstrumentMember_1" xml:lang="en-US">Mid-tier haemoglobins instrument [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MinimumFinanceLeasePaymentsPayable_0" xml:lang="en-US">The amount of payments over the finance lease term that the lessee is or can be required to make, excluding contingent rent, costs for services and taxes to be paid by, and reimbursed to, the lessor, together with any amounts guaranteed by the lessee or by a party related to the lessee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MinimumFinanceLeasePaymentsPayable_1" xml:lang="en-US">Minimum Finance Lease Payments Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_MinimumFinanceLeasePaymentsPayable_2" xml:lang="en-US">Minimum lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_0" xml:lang="en-US">The Carrying value of minimum finance lease payments payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_1" xml:lang="en-US">Minimum Finance Lease Payments Payable At Carrying Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_2" xml:lang="en-US">Carrying value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_0" xml:lang="en-US">The present value of minimum finance lease payments payable. [Refer: Minimum finance lease payments payable]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_1" xml:lang="en-US">Fixed rate financial liabilities (lease payables)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_2" xml:lang="en-US">Minimum Finance Lease Payments Payable At Present Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_3" xml:lang="en-US">Principal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_4" xml:lang="en-US">Fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_0" xml:lang="en-US">Finance lease receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_1" xml:lang="en-US">Finance lease receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2" xml:lang="en-US">Finance lease income receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_3" xml:lang="en-US">Minimum Finance Lease Payments Receivable At Present Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_4" xml:lang="en-US">Financial assets (lease receivables)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_5" xml:lang="en-US">Lease receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MinimumLiquidityCovenant_0" xml:lang="en-US">Represent the amount of minimum liquidity covenant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MinimumLiquidityCovenant_1" xml:lang="en-US">Minimum Liquidity Covenant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_MinimumLiquidityCovenant_2" xml:lang="en-US">Minimum Liquidity Covenant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MoreThanOneYearMember_0" xml:lang="en-US">More Than One Year [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MoreThanOneYearMember_1" xml:lang="en-US">More Than One Year [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MovementInInterestAccrual_0" xml:lang="en-US">Movement in interest accrual.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MovementInInterestAccrual_1" xml:lang="en-US">Movement In Interest Accrual</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_MovementInInterestAccrual_2" xml:lang="en-US">Movement in interest accrual</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MrOCaoimhAndDrWalshMember_0" xml:lang="en-US">Mr. O'Caoimh and Dr Walsh [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MrOCaoimhAndDrWalshMember_1" xml:lang="en-US">Mr O Caoimh And Dr Walsh Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_MrOCaoimhAndDrWalshMember_2" xml:lang="en-US">Mr. O'Caoimh and Dr Walsh [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_MrOCaoimhMember_0" xml:lang="en-US">Mr. O'Caoimh [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_MrOCaoimhMember_1" xml:lang="en-US">Mr O Caoimh Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_MrOCaoimhMember_2" xml:lang="en-US">Mr. O'Caoimh [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NativeDesignLimitedMember_0" xml:lang="en-US">This member is stand for Native Design Limited.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NativeDesignLimitedMember_1" xml:lang="en-US">Native Design Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NetCarryingAmountMember_0" xml:lang="en-US">Carrying amounts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NetCarryingAmountMember_1" xml:lang="en-US">Net Carrying Amount Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NetCarryingAmountMember_2" xml:lang="en-US">Carrying amounts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NetCashOutflowArisingOnAcquisitionAbstract_0" xml:lang="en-US">Net Cash Outflow Arising On Acquisition [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NetCashOutflowArisingOnAcquisitionAbstract_1" xml:lang="en-US">Net cash outflow &#8211; arising on acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NetCashOutFlowOnBusinessCombination_0" xml:lang="en-US">The amount of cash outflow, net of cash acquired on business combination, recognised at acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NetCashOutFlowOnBusinessCombination_1" xml:lang="en-US">Net Cash Out Flow On Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_NetCashOutFlowOnBusinessCombination_2" xml:lang="en-US">Net cash outflow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_NetCashOutFlowOnBusinessCombination_3" xml:lang="en-US">Net cash outflow</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NetFinancingExpenseIncome_0" xml:lang="en-US">Net financing (expense)/income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NetFinancingExpenseIncome_1" xml:lang="en-US">Net Financing Expense Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_NetFinancingExpenseIncome_2" xml:lang="en-US">Net financing expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NetForeignExchangeGainLoss_0" xml:lang="en-US">Net foreign exchange gain (loss).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NetForeignExchangeGainLoss_1" xml:lang="en-US">Net Foreign Exchange Gain Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NetForeignExchangeGainLoss_2" xml:lang="en-US">Net foreign exchange differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NetInterestIncome_0" xml:lang="en-US">Represent the net interest income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NetInterestIncome_1" xml:lang="en-US">Net Interest Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NetInterestIncome_2" xml:lang="en-US">Net interest income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NetOperatingLossCarryforwards_0" xml:lang="en-US">Net operating loss carryforwards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NetOperatingLossCarryforwards_1" xml:lang="en-US">Net operating loss carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NetOperatingLossPeriod_0" xml:lang="en-US">Description net operating loss period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NetOperatingLossPeriod_1" xml:lang="en-US">Net operating loss period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NominalAmountOfDebt_0" xml:lang="en-US">Nominal amount of debt.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NominalAmountOfDebt_1" xml:lang="en-US">Nominal Amount Of Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NominalAmountOfDebt_2" xml:lang="en-US">Nominal amount of debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NominalValue_0" xml:lang="en-US">Represents the nominal value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NominalValue_1" xml:lang="en-US">Nominal Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NominalValue_2" xml:lang="en-US">Nominal value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NominalValuePerShareOfExchangeableNotes_0" xml:lang="en-US">Nominal value per share of the Exchangeable Notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NominalValuePerShareOfExchangeableNotes_1" xml:lang="en-US">Nominal Value Per Share Of Exchangeable Notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NominalValuePerShareOfExchangeableNotes_2" xml:lang="en-US">Nominal value per share of the Exchangeable Notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NonCashActivityForFinancingActivityAbstract_0" xml:lang="en-US">Non cash activity for financing activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NonCashActivityForFinancingActivityAbstract_1" xml:lang="en-US">Non Cash Activity For Financing Activity Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NonCashActivityForFinancingActivityAbstract_2" xml:lang="en-US">Non-cash:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_NonCashActivityForFinancingActivityAbstract_3" xml:lang="en-US">Non-cash:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NonCashFairValueGainLoss_0" xml:lang="en-US">The amount of non-cash fair value gain (loss).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NonCashFairValueGainLoss_1" xml:lang="en-US">Non Cash Fair Value Gain Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NonCashFairValueGainLoss_2" xml:lang="en-US">Non-cash fair value gain (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NoncashFairValueLoss_0" xml:lang="en-US">The amount of non-cash fair value loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NoncashFairValueLoss_1" xml:lang="en-US">Non-cash Fair Value Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NoncashFairValueLoss_2" xml:lang="en-US">Non-cash fair value loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NonCashImpairmentCharge_0" xml:lang="en-US">Amount of non cash impairment charge.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NonCashImpairmentCharge_1" xml:lang="en-US">Non-cash impairment charge</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NoncashInterestOnConvertibleNote_0" xml:lang="en-US">Represents the amount of non-cash interest on convertible note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_NoncashInterestOnConvertibleNote_1" xml:lang="en-US">Non-cash interest on convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NoncashInterestOnConvertibleNote_2" xml:lang="en-US">Noncash Interest On Convertible Note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NoncashInterestOnSeniorSecuredTermLoan_0" xml:lang="en-US">Represents the amount of non-cash interest on senior secured term loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_trib_NoncashInterestOnSeniorSecuredTermLoan_1" xml:lang="en-US">Non-cash interest on senior secured term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NoncashInterestOnSeniorSecuredTermLoan_2" xml:lang="en-US">Noncash Interest On Senior Secured Term Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NoncashInterestOnSeniorSecuredTermLoan_3" xml:lang="en-US">Non-cash interest on senior secured term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NoncashLoanModificationGain_0" xml:lang="en-US">Represents the amount of non-cash loan modification gain.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NoncashLoanModificationGain_1" xml:lang="en-US">Non-cash Loan Modification Gain</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NoncashLoanModificationGain_2" xml:lang="en-US">Non cash loan modification gain</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NonCurrentAssetsMember_0" xml:lang="en-US">Represent information about the non-current assets member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NonCurrentAssetsMember_1" xml:lang="en-US">Non Current Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NoncurrentDerivativeLiabilities_0" xml:lang="en-US">Non-current liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NoncurrentDerivativeLiabilities_1" xml:lang="en-US">Noncurrent Derivative Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NoncurrentDerivativeLiabilities_2" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_NoncurrentDerivativeLiabilities_3" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NoncurrentFinanceLeaseLiabilities_0" xml:lang="en-US">Finance lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NoncurrentFinanceLeaseLiabilities_1" xml:lang="en-US">Noncurrent Finance Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_NoncurrentFinanceLeaseLiabilities_2" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_NoncurrentFinanceLeaseLiabilities_3" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NonCurrentLeaseLiabilitiesAbstract_0" xml:lang="en-US">Non Current Lease Liabilities Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NonCurrentLeaseLiabilitiesAbstract_1" xml:lang="en-US">Non-Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NonCurrentLiabilitiesMember_0" xml:lang="en-US">Represent information about the non-current liabilities member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NonCurrentLiabilitiesMember_1" xml:lang="en-US">Non Current Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NonCurrentLiabilitiesMember_2" xml:lang="en-US">Non-current liability [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NonRadingCosts_0" xml:lang="en-US">The amount of non-trading costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NonRadingCosts_1" xml:lang="en-US">Non Rading Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NonRadingCosts_2" xml:lang="en-US">Non-trading costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NonTradingCosts_0" xml:lang="en-US">Represents amount of non-trading costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NonTradingCosts_1" xml:lang="en-US">Non Trading Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NonTradingCosts_2" xml:lang="en-US">Non-trading costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NotesAndDebenturesPurchased_0" xml:lang="en-US">Repurchased of exchangeable senior notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NotesAndDebenturesPurchased_1" xml:lang="en-US">Notes And Debentures Purchased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NotesAndDebenturesPurchased_2" xml:lang="en-US">Repurchased of exchangeable senior notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NotesAndDebenturesRetired_0" xml:lang="en-US">Represents notes and debenture retired amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NotesAndDebenturesRetired_1" xml:lang="en-US">Notes And Debentures Retired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_NotesAndDebenturesRetired_2" xml:lang="en-US">Notes and debenture retired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NotLaterThan10YearMember_0" xml:lang="en-US">2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NotLaterThan1YearMember_0" xml:lang="en-US">2016 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NotLaterThan2YearMember_0" xml:lang="en-US">2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NotLaterThan3YearMember_0" xml:lang="en-US">2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NotLaterThan4YearMember_0" xml:lang="en-US">2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NotLaterThan5YearMember_0" xml:lang="en-US">2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NotLaterThan6YearMember_0" xml:lang="en-US">2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NotLaterThan7YearMember_0" xml:lang="en-US">2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NotLaterThan8YearMember_0" xml:lang="en-US">Later years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NotLaterThan9YearMember_0" xml:lang="en-US">2023 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NovaCenturyScientificIncMember_0" xml:lang="en-US">This member stands for Nova Century Scientific Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NovaCenturyScientificIncMember_1" xml:lang="en-US">Nova Century Scientific Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NovusDiagnosticsLimitedMember_0" xml:lang="en-US">This member stands for Novus Diagnostics Limited.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NovusDiagnosticsLimitedMember_1" xml:lang="en-US">Novus Diagnostics Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_NovusDiagnosticsLimitedMember_2" xml:lang="en-US">Novus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_0" xml:lang="en-US">Number of American Depository Shares, weighted average shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_1" xml:lang="en-US">At period end</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2" xml:lang="en-US">Number of shares at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_3" xml:lang="en-US">Number of ADS at January 1 (Note 18)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_4" xml:lang="en-US">Number Of American Depository Shares Weighted Average Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_5" xml:lang="en-US">Number of warrant issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_6" xml:lang="en-US">Total number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfAOrdinaryWeightedAverageShares_0" xml:lang="en-US">Number of A ordinary weighted average shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_trib_NumberOfAOrdinaryWeightedAverageShares_1" xml:lang="en-US">At period end</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_trib_NumberOfAOrdinaryWeightedAverageShares_2" xml:lang="en-US">Number of &#8216;A&#8217; ordinary shares at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_trib_NumberOfAOrdinaryWeightedAverageShares_3" xml:lang="en-US">Number of &#8216;A&#8217; ordinary shares at January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfAOrdinaryWeightedAverageShares_4" xml:lang="en-US">Number Of A Ordinary Weighted Average Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfAOrdinaryWeightedAverageShares_5" xml:lang="en-US">Number of warrant issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_NumberOfAOrdinaryWeightedAverageShares_6" xml:lang="en-US">Total number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfLeasesWithExtensionOptions_0" xml:lang="en-US">Number of leases with extension options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfLeasesWithExtensionOptions_1" xml:lang="en-US">Number Of Leases With Extension Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfLeasesWithExtensionOptions_2" xml:lang="en-US">No. of Leases with extension options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfLeasesWithOptionsToPurchase_0" xml:lang="en-US">Number of leases with options to purchase.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfLeasesWithOptionsToPurchase_1" xml:lang="en-US">Number Of Leases With Options To Purchase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfLeasesWithOptionsToPurchase_2" xml:lang="en-US">No. of Leases with options to purchase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfLeasesWithTerminationOptions_0" xml:lang="en-US">Number of leases with termination options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfLeasesWithTerminationOptions_1" xml:lang="en-US">Number Of Leases With Termination Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfLeasesWithTerminationOptions_2" xml:lang="en-US">No. of leases with termination options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_0" xml:lang="en-US">Number of leases with variable payments linked to index.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_1" xml:lang="en-US">Number Of Leases With Variable Payments Linked To Index</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_2" xml:lang="en-US">No. of leases with variable payments linked to index</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfOptionsGranted_0" xml:lang="en-US">Number of options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfOptionsGranted_1" xml:lang="en-US">Number Of Options Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfOptionsGranted_2" xml:lang="en-US">Number of options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfOptionsIssuable_0" xml:lang="en-US">Number of options issuable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfOptionsIssuable_1" xml:lang="en-US">Number Of Options Issuable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfOptionsIssuable_2" xml:lang="en-US">Number of options issuable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfOptionsLapsedUnexercised_0" xml:lang="en-US">Number of options lapsed unexercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfOptionsLapsedUnexercised_1" xml:lang="en-US">Number Of Options Lapsed Unexercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfOptionsLapsedUnexercised_2" xml:lang="en-US">Number of options lapsed unexercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_0" xml:lang="en-US">Number of ordinary shares issuable on exercise of options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_1" xml:lang="en-US">Number Of Ordinary Shares Issuable On Exercise Of Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_2" xml:lang="en-US">Number of ordinary shares issuable on exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfRetiredDirectorOptions_0" xml:lang="en-US">Number of options of retired director in share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfRetiredDirectorOptions_1" xml:lang="en-US">Number Of Retired Director Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfRetiredDirectorOptions_2" xml:lang="en-US">Options of retired director</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfRetiredDirectorShares_0" xml:lang="en-US">Number of shares of retired director in share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfRetiredDirectorShares_1" xml:lang="en-US">Number Of Retired Director Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfRetiredDirectorShares_2" xml:lang="en-US">Shares of retired director</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfRightOfUseLeasedAssets_0" xml:lang="en-US">Number of Right-of-Use leased assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfRightOfUseLeasedAssets_1" xml:lang="en-US">Number Of Right Of Use Leased Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfRightOfUseLeasedAssets_2" xml:lang="en-US">No. of Right-of-Use leased assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfShareOptionsExercisableShareBasedPayment_0" xml:lang="en-US">The number of share options exercisable in a share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfShareOptionsExercisableShareBasedPayment_1" xml:lang="en-US">Number Of Share Options Exercisable Share Based Payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfShareOptionsExercisableShareBasedPayment_2" xml:lang="en-US">Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive_0" xml:lang="en-US">Number of shares issuable on exercise of warrants to perceptive.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive_1" xml:lang="en-US">Number Of Shares Issuable Exercise Of Warrants To Perceptive</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_0" xml:lang="en-US">Number of shares issuable on exercise of warrants to perceptive.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_1" xml:lang="en-US">Number Of Shares Issuable On Exercise Of Warrants To Perceptive</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_2" xml:lang="en-US">Issuable on exercise of warrants to Perceptive</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_0" xml:lang="en-US">Number of shares issuable on exercise of warrants to perceptive exercise price per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_1" xml:lang="en-US">Number Of Shares Issuable On Exercise Of Warrants To Perceptive Exercise Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_2" xml:lang="en-US">Number of shares issuable on exercise of warrants to perceptive exercise price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfSharesIssuedOnExerciseOfOptions_0" xml:lang="en-US">Number of shares issued on the exercise of options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfSharesIssuedOnExerciseOfOptions_1" xml:lang="en-US">Number Of Shares Issued On Exercise Of Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfSharesIssuedOnExerciseOfOptions_2" xml:lang="en-US">Number of shares issued on the exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfStockOptionsToPurchaseOrdinaryShares_0" xml:lang="en-US">Represents number of stock option to purchase ordinary share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfStockOptionsToPurchaseOrdinaryShares_1" xml:lang="en-US">Number Of Stock Options To Purchase Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_NumberOfStockOptionsToPurchaseOrdinaryShares_2" xml:lang="en-US">Number of options to purchase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_NumberOfWarrantsRepriced_0" xml:lang="en-US">The number of warrants repriced.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_NumberOfWarrantsRepriced_1" xml:lang="en-US">Number Of Warrants Repriced</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_NumberOfWarrantsRepriced_2" xml:lang="en-US">Number of warrants repriced</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OnceOffExpense_0" xml:lang="en-US">It represents the amount of once off items.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_OnceOffExpense_1" xml:lang="en-US">Once off items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OnceOffExpense_2" xml:lang="en-US">Once Off Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OnceOffTaxCredit_0" xml:lang="en-US">Once-off tax credit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OnceOffTaxCredit_1" xml:lang="en-US">Once Off Tax Credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OneYearToTwoYearsMember_0" xml:lang="en-US">1-2 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OneYearToTwoYearsMember_1" xml:lang="en-US">One Year To Two Years Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_OneYearToTwoYearsMember_2" xml:lang="en-US">1-2 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OpeningSharePrice_0" xml:lang="en-US">Represent the opening share price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OpeningSharePrice_1" xml:lang="en-US">Opening Share Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_OpeningSharePrice_2" xml:lang="en-US">Opening share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OperatingLeasesMember_0" xml:lang="en-US">Operating Leases [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OperatingLossesBrazilMember_0" xml:lang="en-US">Operating Losses Brazil [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OperatingLossesIrelandMember_0" xml:lang="en-US">Operating Losses Ireland [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OperatingLossesStateMember_0" xml:lang="en-US">Operating Losses US [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OptionsAndWarrantsAbstract_0" xml:lang="en-US">Options And Warrants Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_OptionsAndWarrantsAbstract_1" xml:lang="en-US">Options and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherAssetNoncurrent_0" xml:lang="en-US">Other remaining assets non current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherAssetNoncurrent_1" xml:lang="en-US">Other Asset Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_OtherAssetNoncurrent_2" xml:lang="en-US">Other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherBorrowingsMember_0" xml:lang="en-US">Other borrowings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherBorrowingsMember_1" xml:lang="en-US">Other borrowings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherCountriesMember_0" xml:lang="en-US">Other Countries [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherCountriesMember_1" xml:lang="en-US">Other Countries [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_OtherCountriesMember_2" xml:lang="en-US">Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherCurrentBorrowings_0" xml:lang="en-US">The amount of current payables that the entity does not separately disclose in the same statement or note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_OtherCurrentBorrowings_1" xml:lang="en-US">Other borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherCurrentBorrowings_2" xml:lang="en-US">Other Current Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_OtherCurrentBorrowings_3" xml:lang="en-US">Other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherDeferredTaxAssetsInIrelandMember_0" xml:lang="en-US">Other deferred tax assets in Ireland [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherDeferredTaxAssetsInUsMember_0" xml:lang="en-US">Other deferred tax assets inUS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherEmployeesMember_0" xml:lang="en-US">Other employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherEmployeesMember_1" xml:lang="en-US">Other employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherEuropeanCountriesMember_0" xml:lang="en-US">Other European countries [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherEuropeanCountriesMember_1" xml:lang="en-US">Other European countries [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherItemsMember_0" xml:lang="en-US">Other item [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherItemsMember_1" xml:lang="en-US">Other items [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherLeases_0" xml:lang="en-US">Amount of other leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherLeases_1" xml:lang="en-US">Other Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_OtherLeases_2" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherNonCurrentAssets_0" xml:lang="en-US">Other Non Current Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherOperatingIncomeLineItems_0" xml:lang="en-US">Line item for Other Operating Income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherOperatingIncomeLineItems_1" xml:lang="en-US">Other Operating Income [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherOperatingIncomeTable_0" xml:lang="en-US">Table of Other Operating Income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherOperatingIncomeTable_1" xml:lang="en-US">Other Operating Income [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherProjectsMember_0" xml:lang="en-US">Other Projects with Spend less than US$100,000 in 2016 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherProjectsMember_1" xml:lang="en-US">Other Projects [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherReceivablesAsOfAcquisitionDate_0" xml:lang="en-US">Other receivables as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherReceivablesAsOfAcquisitionDate_1" xml:lang="en-US">Other Receivables As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_OtherReceivablesAsOfAcquisitionDate_2" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherRegionsMember_0" xml:lang="en-US">Other regions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherRegionsMember_1" xml:lang="en-US">Other regions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_OtherRegionsMember_2" xml:lang="en-US">Other regions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OtherRestructuringCostsMember_0" xml:lang="en-US">Other Restructuring Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OtherRestructuringCostsMember_1" xml:lang="en-US">Other Restructuring Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_OtherRestructuringCostsMember_2" xml:lang="en-US">Other restructuring costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OutsourcingCostsMember_0" xml:lang="en-US">Outsourcing Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OutsourcingCostsMember_1" xml:lang="en-US">Outsourcing Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_OutsourcingCostsMember_2" xml:lang="en-US">Outsourcing costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OutstandingAbstract_0" xml:lang="en-US">Outstanding Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_OutstandingAbstract_1" xml:lang="en-US">Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OutstandingPrincipal_0" xml:lang="en-US">outstanding principal.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OutstandingPrincipal_1" xml:lang="en-US">Outstanding Principal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OutstandingTermLoan_0" xml:lang="en-US">Represents the amount of outstanding term loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OutstandingTermLoan_1" xml:lang="en-US">Outstanding Term Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_OutstandingTermLoan_2" xml:lang="en-US">Outstanding term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_OverheadCosts_0" xml:lang="en-US">Represents amount of overhead costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_OverheadCosts_1" xml:lang="en-US">Overhead Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_OverheadCosts_2" xml:lang="en-US">Overhead costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PartnershipTriggerEventsDescription_0" xml:lang="en-US">Partnership trigger events description.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PartnershipTriggerEventsDescription_1" xml:lang="en-US">Partnership Trigger Events Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PartnershipTriggerEventsDescription_2" xml:lang="en-US">Partnership trigger events description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PatentDividendSchemeAmount_0" xml:lang="en-US">Patent dividend scheme amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PatentDividendSchemeAmount_1" xml:lang="en-US">Patent dividend scheme amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PatentsAndLicencesMember_0" xml:lang="en-US">This member stands for Patents andlicences.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PatentsAndLicencesMember_1" xml:lang="en-US">Patents And Licences [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PaycheckProtectionProgramLoanMember_0" xml:lang="en-US">Paycheck Protection Program Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PaycheckProtectionProgramLoanMember_1" xml:lang="en-US">Paycheck Protection Program Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PaymentInKindInterest_0" xml:lang="en-US">It represets payment in kind Interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_PaymentInKindInterest_1" xml:lang="en-US">Payment-in-kind (PIK) Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PaymentInKindInterest_2" xml:lang="en-US">Payment In Kind Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PaymentOfPenalty_0" xml:lang="en-US">The amount of payment penalty.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PaymentOfPenalty_1" xml:lang="en-US">Payment Of Penalty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PaymentOfPenalty_2" xml:lang="en-US">Payment of penalty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PaymentsForCEOServices_0" xml:lang="en-US">Payments for CEO Services.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PaymentsForCEOServices_1" xml:lang="en-US">Payments For C E O Services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_PaymentsForCEOServices_2" xml:lang="en-US">Payments for CEO Services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_0" xml:lang="en-US">The amount represents payments to acquire financial asset classified as investing activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_1" xml:lang="en-US">Payments to acquire financial asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_2" xml:lang="en-US">Payments To Acquire Financial Asset Classified As Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_0" xml:lang="en-US">The amount represents payments to acquire trades or businesses classified as investing activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_1" xml:lang="en-US">Payments to acquire trades or businesses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_2" xml:lang="en-US">Payments To Acquire Trades Or Businesses Classified As Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PaymentToRetireExchangeableNotes_0" xml:lang="en-US">Represents the payment to retire exchangeable notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PaymentToRetireExchangeableNotes_1" xml:lang="en-US">Payment To Retire Exchangeable Notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PaymentToRetireExchangeableNotes_2" xml:lang="en-US">Payment to retire exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PenaltiesPayments_0" xml:lang="en-US">Penalties payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PenaltiesPayments_1" xml:lang="en-US">Penalties payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan_0" xml:lang="en-US">Represents the amount of penalty for early partial settlement of senior secured term loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan_1" xml:lang="en-US">Penalty For Early Partial Settlement Of Senior Secured Term Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan_2" xml:lang="en-US">Early repayment penalty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PenaltyForEarlySettlementCharged_0" xml:lang="en-US">Penalty for early settlement charged.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PenaltyForEarlySettlementCharged_1" xml:lang="en-US">Penalty For Early Settlement Charged</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PenaltyForEarlySettlementCharged_2" xml:lang="en-US">Penalty for early settlement charged</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PenaltyForEarlySettlementOfTermLoan_0" xml:lang="en-US">The amount represents penalty for early settlement of term loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PenaltyForEarlySettlementOfTermLoan_1" xml:lang="en-US">Penalty For Early Settlement Of Term Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_PenaltyForEarlySettlementOfTermLoan_2" xml:lang="en-US">Penalty for early partial settlement of senior secured term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PenaltyPaidForEarlySettlement_0" xml:lang="en-US">Represent the Penalty Paid For Early Settlement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PenaltyPaidForEarlySettlement_1" xml:lang="en-US">Penalty Paid For Early Settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PenaltyPaidForEarlySettlement_2" xml:lang="en-US">Penalty paid for early settlement of term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PercentageOfForgivenLoan_0" xml:lang="en-US">Represents the amount of percentage of forgiven loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PercentageOfForgivenLoan_1" xml:lang="en-US">Percentage Of Forgiven Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_PercentageOfForgivenLoan_2" xml:lang="en-US">Percentage of forgiveness loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PercentageOfGrossInventory1_0" xml:lang="en-US">Percentage of gross inventory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PercentageOfGrossInventory1_1" xml:lang="en-US">Percentage Of Gross Inventory 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PercentageOfGrossInventory1_2" xml:lang="en-US">Percentage of gross inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PercentageOfGroupRevenues_0" xml:lang="en-US">Percentage of group revenues.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PercentageOfGroupRevenues_1" xml:lang="en-US">Percentage of group revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PerceptiveAdvisorsMember_0" xml:lang="en-US">This member stands for perceptive advisors.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PerceptiveAdvisorsMember_1" xml:lang="en-US">Perceptive Advisors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PerceptiveCreditHoldingsIiiLpMember_0" xml:lang="en-US">Represent information about the Perceptive Credit Holdings III, LP.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PerceptiveCreditHoldingsIiiLpMember_1" xml:lang="en-US">Perceptive Credit Holdings Iii, Lp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PerceptiveMember_0" xml:lang="en-US">Represent information about the Perceptive member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PerceptiveMember_1" xml:lang="en-US">Perceptive [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PersonnelRelatedCostsMember_0" xml:lang="en-US">Personnel Related Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PersonnelRelatedCostsMember_1" xml:lang="en-US">Personnel related costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PhoenixBioTechCorpMember_0" xml:lang="en-US">Phoenix Bio Tech Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PhoenixBioTechCorpMember_1" xml:lang="en-US">Phoenix Bio Tech Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PhoenixBiotechMember_0" xml:lang="en-US">Phoenix Biotech [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PointFivePercentageOfGrossInventoryMember_0" xml:lang="en-US">0.5% of gross inventory [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PointFivePercentageOfGrossInventoryMember_1" xml:lang="en-US">Point Five Percentage Of Gross Inventory Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PointFivePercentageOfGrossInventoryMember_2" xml:lang="en-US">0.5% of gross inventory [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PointOfCareMember_0" xml:lang="en-US">Point-of-Care [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PointOfCareMember_1" xml:lang="en-US">Point-of-Care [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PostBsEventsMember_0" xml:lang="en-US">Post BS Events [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PostDisposalAdjustmentMember_0" xml:lang="en-US">This member stands for post disposal adjustment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PostDisposalAdjustmentMember_1" xml:lang="en-US">Post Disposal Adjustment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PotentiallyDilutiveInstrumentsAbstract_0" xml:lang="en-US">Potentially Dilutive Instruments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PotentiallyDilutiveInstrumentsAbstract_1" xml:lang="en-US">Potentially Dilutive Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PremierInstrumentMember_0" xml:lang="en-US">Premier Instrument for Haemoglobin A1c Testing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PremierInstrumentMember_1" xml:lang="en-US">Premier Instrument Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PremierInstrumentMember_2" xml:lang="en-US">Premier Instruments for A1c and haemoglobinopathies testing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PremierLabAutomationMember_0" xml:lang="en-US">Premier Total Lab Automation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PremierResolutionMember_0" xml:lang="en-US">Premier Resolution [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PremierTTenInstrumentMember_0" xml:lang="en-US">Premier T-10 instrument [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PreTaxDiscountRates_0" xml:lang="en-US">Percentage of pre tax discount rates.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PreTaxDiscountRates_1" xml:lang="en-US">Pre tax discount rates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PrimusCorpMember_0" xml:lang="en-US">Primus Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PrimusCorpMember_1" xml:lang="en-US">Primus Corp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PrimusCorporationCguTradeNameMember_0" xml:lang="en-US">Primus Corporation CGU Trade Name [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PrimusCorporationCguTradeNameMember_1" xml:lang="en-US">Primus Corporation CGU Trade Name [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PrimusCorporationIncMember_0" xml:lang="en-US">Primus Corporation Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PrimusCorporationMember_0" xml:lang="en-US">This member stands for Primus Corporation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PrimusCorporationMember_1" xml:lang="en-US">Primus Corporation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PrincipalActivity_0" xml:lang="en-US">Principal activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PrincipalActivity_1" xml:lang="en-US">Principal Activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PrincipalActivity_2" xml:lang="en-US">Principal activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PrincipalAmountLoaned_0" xml:lang="en-US">Principal amount loaned.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_PrincipalAmountLoaned_1" xml:lang="en-US">Principal amount loaned</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_trib_PrincipalAmountLoaned_2" xml:lang="en-US">Principal amount loaned</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PrincipalAmountLoaned_3" xml:lang="en-US">Principal Amount Loaned</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PrincipalAmountLoaned_4" xml:lang="en-US">Loan origination costs paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_PrincipalAmountLoaned_5" xml:lang="en-US">Principal amount loaned</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PrincipalDevelopmentProjectsCapitalizedCosts_0" xml:lang="en-US">Amount of principal development projects.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PrincipalDevelopmentProjectsCapitalizedCosts_1" xml:lang="en-US">Principal Development Projects Capitalized Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PrincipalDevelopmentProjectsCapitalizedCosts_2" xml:lang="en-US">Capitalised development costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ProceedsForConvertibleNoteIssued_0" xml:lang="en-US">The amount represents of proceeds for convertible note issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ProceedsForConvertibleNoteIssued_1" xml:lang="en-US">Proceeds For Convertible Note Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ProceedsForConvertibleNoteIssued_2" xml:lang="en-US">Proceeds from convertible note issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ProceedsForConvertibleNoteIssued_3" xml:lang="en-US">Principal amount loaned &#8211; convertible note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ProceedsFromCash_0" xml:lang="en-US">Represents the amount of cash proceeds.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ProceedsFromCash_1" xml:lang="en-US">Proceeds From Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ProceedsFromCash_2" xml:lang="en-US">Proceeds from cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ProceedsFromNewFinanceLeases_0" xml:lang="en-US">The cash inflow from the new finance leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ProceedsFromNewFinanceLeases_1" xml:lang="en-US">Proceeds From New Finance Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ProceedsFromNewFinanceLeases_2" xml:lang="en-US">Proceeds from sale &amp; leaseback transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ProceedsFromSaleOfBusiness_0" xml:lang="en-US">The cash inflow from sales of business.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ProceedsFromSaleOfBusiness_1" xml:lang="en-US">Proceeds From Sale Of Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ProceedsFromSaleOfBusiness_2" xml:lang="en-US">Proceeds from sale of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ProceedsFromSaleOfBusiness_3" xml:lang="en-US">Proceeds from sale of business (net of transaction costs)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ProceedsFromSharesToBeIssued_0" xml:lang="en-US">The amount represent of proceeds from shares to be issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ProceedsFromSharesToBeIssued_1" xml:lang="en-US">Proceeds From Shares To Be Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ProceedsFromSharesToBeIssued_2" xml:lang="en-US">Proceeds from shares to be issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ProductCullMember_0" xml:lang="en-US">Product Cull [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PropertyAndEquipmentMember_0" xml:lang="en-US">Plant and equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PropertyAndEquipmentMember_1" xml:lang="en-US">Property And Equipment Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PropertyAndEquipmentMember_2" xml:lang="en-US">Plant and equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ProvisionalValueMember_0" xml:lang="en-US">Provisional value [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ProvisionalValueMember_1" xml:lang="en-US">Provisional Value [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ProvisionForImpairment_0" xml:lang="en-US">Amount of Provision for impairment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_trib_ProvisionForImpairment_1" xml:lang="en-US">Provision for impairment At December 31</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_trib_ProvisionForImpairment_2" xml:lang="en-US">Provision for impairment At January 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ProvisionForImpairment_3" xml:lang="en-US">Provision For Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ProvisionForImpairment_4" xml:lang="en-US">Provision for impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ProvisionForInventoriesMember_0" xml:lang="en-US">Provision for inventories [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ProvisionForInventoriesMember_1" xml:lang="en-US">Provision for inventories [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ProvisionForInventory_0" xml:lang="en-US">It represents provision for inventory.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ProvisionForInventory_1" xml:lang="en-US">Provision For Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ProvisionForInventory_2" xml:lang="en-US">Provision for inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ProvisionOfCanteenServicesToThirdParties_0" xml:lang="en-US">Represents the amount of provision for canteen services to third parties.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ProvisionOfCanteenServicesToThirdParties_1" xml:lang="en-US">Provision Of Canteen Services To Third Parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ProvisionOfCanteenServicesToThirdParties_2" xml:lang="en-US">Provision of canteen services to third parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ProvisionOnExpenses_0" xml:lang="en-US">Provision on expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ProvisionOnExpenses_1" xml:lang="en-US">Provision On Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ProvisionOnExpenses_2" xml:lang="en-US">Provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_PurchaseOfTreasuryShare_0" xml:lang="en-US">Treasury shares purchased.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_PurchaseOfTreasuryShare_1" xml:lang="en-US">Purchase Of Treasury Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_PurchaseOfTreasuryShare_2" xml:lang="en-US">Treasury shares purchased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_Ranges10OfExercisePricesForOutstandingShareOptionOneMember_0" xml:lang="en-US">Ranges 10 Of Exercise Prices For Outstanding Share Option One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_Ranges10OfExercisePricesForOutstandingShareOptionOneMember_1" xml:lang="en-US">US$0.77-US$3.96 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">US$12.00 -US$17.88 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">Ranges Eight Of Exercise Prices For Outstanding Share Options Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_2" xml:lang="en-US">US$12.00 -US$17.45 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">US$2.63-US$3.96 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">Ranges Five Of Exercise Prices For Outstanding Share Options Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_2" xml:lang="en-US">US$1.00-US$1.74 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">US$3.00 -US$4.47 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">Ranges Four Of Exercise Prices For Outstanding Share Options Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_2" xml:lang="en-US">US$3.00 -US$4.36 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_3" xml:lang="en-US">US$20.00-US$25.80 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">Ranges Nine Of Exercise Prices For Outstanding Share Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">US$1.00-US$2.05 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">Ranges One Four Of Exercise Prices For Outstanding Share Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">US$12.00 -US$17.45 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">Ranges One Of Exercise Prices For Outstanding Share Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">US$0.12-US$0.99 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_2" xml:lang="en-US">US$0.19 - $0.99 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_0" xml:lang="en-US">US$0.19-US$0.99 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_1" xml:lang="en-US">Ranges One Of Exercise Prices For Outstanding Share Options Nine To Nineteen Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_2" xml:lang="en-US">US$0.19-US$0.99 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">Ranges One One Of Exercise Prices For Outstanding Share Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">US$3.00 -US$4.36 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">Ranges One Three Of Exercise Prices For Outstanding Share Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">US$8.24- US$11.96 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">Ranges One Two Of Exercise Prices For Outstanding Share Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">US$4.00-US$8.20 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">Ranges One Zero Of Exercise Prices For Outstanding Share Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">US$2.06- US$2.99 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">US$8.24- US$11.96 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">Ranges Seven Of Exercise Prices For Outstanding Share Options Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_2" xml:lang="en-US">US$35.00- US$48.60 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">US$4.00-US$8.20 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">Ranges Six Of Exercise Prices For Outstanding Share Options Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_2" xml:lang="en-US">US$20.00-US$34.80 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">US$2.06- US$2.99 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">Ranges Three Of Exercise Prices For Outstanding Share Options Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_2" xml:lang="en-US">US$1.75- US$2.43 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_3" xml:lang="en-US">US$2.40-US$19.80 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_0" xml:lang="en-US">US$1.00-US$2.05 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_1" xml:lang="en-US">Ranges Two Of Exercise Prices For Outstanding Share Options Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_2" xml:lang="en-US">US$1.00-US$1.29 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RapidCovid19AntigenTestMember_0" xml:lang="en-US">Rapid COVID-19 antigen test.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RapidCovid19AntigenTestMember_1" xml:lang="en-US">Rapid Covid 19 Antigen Test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RapidCovid19AntigenTestMember_2" xml:lang="en-US">Rapid COVID-19 antigen test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RateOfRentPerSqureFoot_0" xml:lang="en-US">Rate of rent per squre foot.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RateOfRentPerSqureFoot_1" xml:lang="en-US">Rate of rent per squre foot</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown_0" xml:lang="en-US">It represents raw materials and work in progress of inventory written down.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown_1" xml:lang="en-US">Raw Materials And Work In Progress Of Inventory Written Down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown_2" xml:lang="en-US">Raw materials and work in progress of inventory written down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RayvilleLimitedMember_0" xml:lang="en-US">Rayville Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RayvilleLimitedMember_1" xml:lang="en-US">Rayville Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ReceivablesFromConsiderationDueSaleOfBusiness_0" xml:lang="en-US">Represent the amount of Consideration due from sale of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ReceivablesFromConsiderationDueSaleOfBusiness_1" xml:lang="en-US">Receivables From Consideration Due Sale Of Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ReceivablesFromConsiderationDueSaleOfBusiness_2" xml:lang="en-US">Consideration due from sale of business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ReceivablesOutstanding_0" xml:lang="en-US">The amounts represents receivables outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ReceivablesOutstanding_1" xml:lang="en-US">Receivables Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ReceivablesOutstanding_2" xml:lang="en-US">Outstanding receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ReclassificationGoodwillAndIntangibleAssets_0" xml:lang="en-US">Reclassification.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ReclassificationGoodwillAndIntangibleAssets_1" xml:lang="en-US">Reclassification Goodwill And Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ReclassificationGoodwillAndIntangibleAssets_2" xml:lang="en-US">Reclassification</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ReclassificationMember_0" xml:lang="en-US">Reclassification [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RecognitionOfContingentAsset_0" xml:lang="en-US">Recognition of contingent asset.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_RecognitionOfContingentAsset_1" xml:lang="en-US">Recognition of contingent asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RecognitionOfContingentAsset_2" xml:lang="en-US">Recognition of contingent asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_0" xml:lang="en-US">Reconciliation To Weighted Average Earnings Per Share Denominator Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_1" xml:lang="en-US">Reconciliation to weighted average (loss)/earnings per share denominator:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_2" xml:lang="en-US">Reconciliation to weighted average (loss)/earnings per ADS denominator:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ReducedGrossDebt_0" xml:lang="en-US">Reducing gross debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ReducedGrossDebt_1" xml:lang="en-US">Reduced Gross Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ReducedGrossDebt_2" xml:lang="en-US">Reducing gross debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ReductionOfGrossDebt_0" xml:lang="en-US">The amount of reduction in gross debt.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ReductionOfGrossDebt_1" xml:lang="en-US">Reduction Of Gross Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ReductionOfGrossDebt_2" xml:lang="en-US">Reduction of gross debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ReductionPercentageInBaseRate_0" xml:lang="en-US">Reduction percentage in the Base Rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ReductionPercentageInBaseRate_1" xml:lang="en-US">Reduction Percentage In Base Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ReductionPercentageInBaseRate_2" xml:lang="en-US">Reduction percentage in the base rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RefinancingCostsClassifiedAsFinancingActivities_0" xml:lang="en-US">The cash outflow for refinancing costs, classified as financing activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_RefinancingCostsClassifiedAsFinancingActivities_1" xml:lang="en-US">Loan Origination Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RefinancingCostsClassifiedAsFinancingActivities_2" xml:lang="en-US">Refinancing Costs Classified As Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ReliefOptionForLowValueAssets_0" xml:lang="en-US">Relief option for low value assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ReliefOptionForLowValueAssets_1" xml:lang="en-US">Relief option for low value assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ReliefOptionForShortTermLeases_0" xml:lang="en-US">Relief option for short term leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ReliefOptionForShortTermLeases_1" xml:lang="en-US">Relief option for short term leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RemainingFundsForCorporatePurposes_0" xml:lang="en-US">Remaining Funds for Corporate Purposes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RemainingFundsForCorporatePurposes_1" xml:lang="en-US">Remaining Funds For Corporate Purposes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RemainingTermInYears_0" xml:lang="en-US">Remaining term of right of use assets in years.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RemainingTermInYears_1" xml:lang="en-US">Remaining Term In Years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RemainingTermInYears_2" xml:lang="en-US">Range of remaining term in years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RemeasurementLossRecognizedInProfitLoss_0" xml:lang="en-US">It represents remeasurement loss recognized in profit loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RemeasurementLossRecognizedInProfitLoss_1" xml:lang="en-US">Remeasurement Loss Recognized In Profit Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_RemeasurementLossRecognizedInProfitLoss_2" xml:lang="en-US">Remeasurement loss recognized in profit loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RemeasurementMember_0" xml:lang="en-US">Remeasurement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RemeasurementMember_1" xml:lang="en-US">Remeasurement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RemeasurementOfRightOfUseAssets_0" xml:lang="en-US">The amount of remeasurement of ROU assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RemeasurementOfRightOfUseAssets_1" xml:lang="en-US">Remeasurement Of Right Of Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RemeasurementOfRightOfUseAssets_2" xml:lang="en-US">Remeasurement of ROU assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RentalIncomeFromPremises_0" xml:lang="en-US">Amount of rental income from premises.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RentalIncomeFromPremises_1" xml:lang="en-US">Rental income from premises</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RepaymentOfOtherLoan_0" xml:lang="en-US">The amount represents repayment of other loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_RepaymentOfOtherLoan_1" xml:lang="en-US">Repayment of other loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RepaymentOfOtherLoan_2" xml:lang="en-US">Repayment Of Other Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RepaymentOfSecuredDebt_0" xml:lang="en-US">Represents the amount of repayment of secured debt.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RepaymentOfSecuredDebt_1" xml:lang="en-US">Repayment Of Secured Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RepaymentOfSecuredDebt_2" xml:lang="en-US">Repayment of secured debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ResearchAndDevelopmentMember_0" xml:lang="en-US">Research and development [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ResearchAndDevelopmentMember_1" xml:lang="en-US">Research and development [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ResearchAndDevelopmentTaxCredits_0" xml:lang="en-US">Research and developmen tax credits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ResearchAndDevelopmentTaxCredits_1" xml:lang="en-US">Research And Development Tax Credits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RestOfWorldOtherMember_0" xml:lang="en-US">Rest of world Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RestOfWorldOtherMember_1" xml:lang="en-US">Rest of world Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RestructuringAccrual_0" xml:lang="en-US">Restructuring accrual.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RestructuringAccrual_1" xml:lang="en-US">Restructuring accrual</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RestructuringActivitiesExpense_0" xml:lang="en-US">Restructuring Activities Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_RestructuringActivitiesExpense_1" xml:lang="en-US">Total restructuring costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RestructuringActivitiesExpense_2" xml:lang="en-US">Restructuring Activities Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RestructuringActivitiesExpense_3" xml:lang="en-US">Total restructuring costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_RestructuringActivitiesExpense_4" xml:lang="en-US">Restructuring cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RestructuringCost_0" xml:lang="en-US">Represent the amount of restructuring costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_RestructuringCost_1" xml:lang="en-US">Selling, general and administrative expenses &#8211; Restructuring costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RestructuringCost_2" xml:lang="en-US">Restructuring Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RestructuringCost_3" xml:lang="en-US">Restructuring Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_RestructuringCost_4" xml:lang="en-US">Restructuring Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ResultAfterExceptionalExpenses_0" xml:lang="en-US">Amount of after exceptional expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_ResultAfterExceptionalExpenses_1" xml:lang="en-US">Result after impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ResultAfterExceptionalExpenses_2" xml:lang="en-US">Result After Exceptional Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ResultBeforeExceptionalExpenses_0" xml:lang="en-US">Amount of before exceptional expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_ResultBeforeExceptionalExpenses_1" xml:lang="en-US">Result before impairment and unallocated expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ResultBeforeExceptionalExpenses_2" xml:lang="en-US">Result Before Exceptional Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ReversalOfImpairmentLossOnFinancialAssets_0" xml:lang="en-US">Represents the amount of reversal of impairment loss on financial assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ReversalOfImpairmentLossOnFinancialAssets_1" xml:lang="en-US">Reversal Of Impairment Loss On Financial Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ReversalOfImpairmentLossOnFinancialAssets_2" xml:lang="en-US">Reversal of impairment in the current year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ReversalOfNetOperatingLoss_0" xml:lang="en-US">Origination and reversal of net operating losses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ReversalOfNetOperatingLoss_1" xml:lang="en-US">Reversal Of Net Operating Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ReversalOfNetOperatingLoss_2" xml:lang="en-US">Origination and reversal of net operating losses (see Note 14)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RevertsMinimumLiquidityCovenant_0" xml:lang="en-US">Represent the amount of reverts minimum liquidity covenant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RevertsMinimumLiquidityCovenant_1" xml:lang="en-US">Reverts Minimum Liquidity Covenant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RightOfUseAssetsCostAtTransitionBeforeImpairment_0" xml:lang="en-US">Right-of-use assets cost at transition before impairment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RightOfUseAssetsCostAtTransitionBeforeImpairment_1" xml:lang="en-US">Right Of Use Assets Cost At Transition Before Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RightOfUseAssetsCostAtTransitionBeforeImpairment_2" xml:lang="en-US">Right-of-use assets cost at transition before impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_0" xml:lang="en-US">Right-of-use assets, Impairment adjustment on transition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_1" xml:lang="en-US">Impairment adjustment on transition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_2" xml:lang="en-US">Right Of Use Assets Impairment Adjustment On Transition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_3" xml:lang="en-US">Right-of-use assets, Impairment adjustment on transition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_0" xml:lang="en-US">Right-of-use assets including depreciation and impairment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_1" xml:lang="en-US">Right Of Use Assets Including Depreciation And Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_2" xml:lang="en-US">Right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RonanOCaoimhMember_0" xml:lang="en-US">Ronan O'Caoimh [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_RonanOCaoimhMember_1" xml:lang="en-US">Ronan O Caoimh Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_RonanOCaoimhMember_2" xml:lang="en-US">Ronan O'Caoimh [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_RubellaAssayEnhancementMember_0" xml:lang="en-US">Rubella assay enhancement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SaleAndLeasebackLiabilitiesCurrent_0" xml:lang="en-US">Sale and leaseback liabilities current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SaleAndLeasebackLiabilitiesCurrent_1" xml:lang="en-US">Sale And Leaseback Liabilities Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SaleAndLeasebackLiabilitiesCurrent_2" xml:lang="en-US">Sale and leaseback liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SaleAndLeasebackLiabilitiesMember_0" xml:lang="en-US">Sale and leaseback liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SaleAndLeasebackLiabilitiesMember_1" xml:lang="en-US">Sale And Leaseback Liabilities Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_SaleAndLeasebackLiabilitiesMember_2" xml:lang="en-US">Sale and leaseback liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SaleAndLeasebackLiabilitiesNonCurrent_0" xml:lang="en-US">Sale and leaseback liabilities non-current.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SaleAndLeasebackLiabilitiesNonCurrent_1" xml:lang="en-US">Sale And Leaseback Liabilities Non Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_SaleAndLeasebackLiabilitiesNonCurrent_2" xml:lang="en-US">Sale and leaseback liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SaleOfFitzgeraldIndustriesMember_0" xml:lang="en-US">Sale Of Fitzgerald Industries [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SaleOfFitzgeraldIndustriesMember_1" xml:lang="en-US">Sale Of Fitzgerald Industries [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SaleOfFitzgeraldIndustriesMember_2" xml:lang="en-US">Sale of Fitzgerald Industries [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SatisfiedByAbstract_0" xml:lang="en-US">Satisfied By [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SatisfiedByAbstract_1" xml:lang="en-US">Satisfied by:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ScheduleOfAdditionalInformationOnRightOfUseAssets_0" xml:lang="en-US">The tabular disclosure of additional information on the right-of-use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ScheduleOfAdditionalInformationOnRightOfUseAssets_1" xml:lang="en-US">Schedule Of Additional Information On Right Of Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_0" xml:lang="en-US">The tabular disclosure of income from sub-letting right-of-use buildings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_1" xml:lang="en-US">Schedule Of Income From Sub Letting Right Of Use Buildings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_2" xml:lang="en-US">Schedule of Income From Sub-Letting Right-of-Use Buildings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_0" xml:lang="en-US">The disclosure of detailed information about movement in the term loan.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_1" xml:lang="en-US">Schedule Of Movement In Term Loan Explanatory [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_2" xml:lang="en-US">Schedule Of Movement In Term Loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_0" xml:lang="en-US">The disclosure of detailed information about share based payment expenses by geographical area.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_1" xml:lang="en-US">Schedule Of Share Based Payment Expense By Geographical Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_2" xml:lang="en-US">Schedule Of Share Based Payment Expense By Geographical Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SecuredOvernightFinancingRate_0" xml:lang="en-US">Secured Overnight Financing Rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SecuredOvernightFinancingRate_1" xml:lang="en-US">Secured Overnight Financing Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SecuredOvernightFinancingRate_2" xml:lang="en-US">Secured overnight financing rate (SOFR)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SegmentAssets_0" xml:lang="en-US">Amount of segment assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SegmentAssets_1" xml:lang="en-US">Segment assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SegmentLiabilities_0" xml:lang="en-US">Amount of segment liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SegmentLiabilities_1" xml:lang="en-US">Segment liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SellingGeneralAdministrationExpensesAbstract_0" xml:lang="en-US">Selling General Administration Expenses Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SellingGeneralAdministrationExpensesAbstract_1" xml:lang="en-US">Selling, general &amp; administration expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_0" xml:lang="en-US">Selling, general and administrative expenses - closure costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_1" xml:lang="en-US">Selling, general and administrative expenses - closure costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_2" xml:lang="en-US">Amount of charge for closing facility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_3" xml:lang="en-US">Selling General And Administrative Expenses Closure Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_4" xml:lang="en-US">Selling, General and Administrative Expenses &#8211; Closure Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesRecognitionOfContingentAsset_0" xml:lang="en-US">Selling, general and administrative expenses - recognition of contingent asset.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesRecognitionOfContingentAsset_1" xml:lang="en-US">Selling, general and administrative expenses - recognition of contingent asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_0" xml:lang="en-US">It Represents the selling, general and administrative expenses - restructuring costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_1" xml:lang="en-US">Selling, general and administrative expenses &#8211; Restructuring costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_2" xml:lang="en-US">Selling, General And Administrative Expenses &#8211; Restructuring Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense_0" xml:lang="en-US">Represents the amount of selling, general and administrative expenses - restructuring expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense_1" xml:lang="en-US">Selling, general and administrative expenses - restructuring expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense_2" xml:lang="en-US">Selling General And Administrative Expenses Restructuring Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement_0" xml:lang="en-US">Selling, general and administrative expenses, tax audit settlement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement_1" xml:lang="en-US">Selling, general and administrative expenses - tax audit settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement_2" xml:lang="en-US">Selling, general and administrative expenses - tax audit settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlementGross_0" xml:lang="en-US">Selling, general and administrative expenses, tax audit settlement gross amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlementGross_1" xml:lang="en-US">Selling, general and administrative expenses - tax audit settlement gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SeniorNoteMember_0" xml:lang="en-US">Senior Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SeniorNoteMember_1" xml:lang="en-US">Senior Note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SeniorNoteMember_2" xml:lang="en-US">Senior Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SeniorSecuredTermLoanAnnualRate_0" xml:lang="en-US">Represents about senior secured term loan annual rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SeniorSecuredTermLoanAnnualRate_1" xml:lang="en-US">Senior Secured Term Loan Annual Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SeniorSecuredTermLoanAnnualRate_2" xml:lang="en-US">Senior secured term loan annual rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SeniorSecuredTermLoanCreditFacilityMember_0" xml:lang="en-US">Senior secured term loan credit facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SeniorSecuredTermLoanCreditFacilityMember_1" xml:lang="en-US">Senior Secured Term Loan Credit Facility [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SeniorSecuredTermLoanCreditFacilityMember_2" xml:lang="en-US">Senior secured term loan credit facility [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SeniorSecuredTermLoanCreditFacilityOneMember_0" xml:lang="en-US">senior secured term loan credit facility one [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SeniorSecuredTermLoanCreditFacilityOneMember_1" xml:lang="en-US">Senior Secured Term Loan Credit Facility One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SeniorSecuredTermLoanCreditFacilityOneMember_2" xml:lang="en-US">Amended and restated senior secured term loan credit facility [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SeniorSecuredTermLoanFixedRate_0" xml:lang="en-US">Represents about senior secured term loan fixed rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SeniorSecuredTermLoanFixedRate_1" xml:lang="en-US">Senior Secured Term Loan Fixed Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SeniorSecuredTermLoanFixedRate_2" xml:lang="en-US">Senior secured term loan fixed rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SeniorSecuredTermLoanMember_0" xml:lang="en-US">Represent information about the senior secured term loan member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SeniorSecuredTermLoanMember_1" xml:lang="en-US">Senior Secured Term Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SeniorSecuredTermLoanMember_2" xml:lang="en-US">Senior secured term loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SevenYearConvertibleNoteMember_0" xml:lang="en-US">Represent information about the 7-year convertible note member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SevenYearConvertibleNoteMember_1" xml:lang="en-US">Seven Year Convertible Note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SevenYearConvertibleNoteMember_2" xml:lang="en-US">7-year Convertible Note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ShareBasedPayments_0" xml:lang="en-US">Share based payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ShareBasedPayments_1" xml:lang="en-US">Share based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_0" xml:lang="en-US">Represents share based payments capitalised in intangible development project assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_1" xml:lang="en-US">Share Based Payments Capitalised Intangible Development Project Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_2" xml:lang="en-US">Share based payments capitalised in intangible development project assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ShareBasedPaymentsContinuingOperations_0" xml:lang="en-US">Share based payments continuing operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_trib_ShareBasedPaymentsContinuingOperations_1" xml:lang="en-US">Share based payments continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ShareBasedPaymentsContinuingOperations_2" xml:lang="en-US">Share Based Payments Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_ShareBasedPaymentsContinuingOperations_3" xml:lang="en-US">Total - continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ShareBasedPaymentsContinuingOperations_4" xml:lang="en-US">Continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ShareBasedPaymentsCostOfSales_0" xml:lang="en-US">Share-based payments cost of sales.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ShareBasedPaymentsCostOfSales_1" xml:lang="en-US">Share Based Payments Cost Of Sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ShareBasedPaymentsCostOfSales_2" xml:lang="en-US">Share-based payments - cost of sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ShareBasedPaymentsDiscontinuedOperations_0" xml:lang="en-US">Share based payment discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ShareBasedPaymentsDiscontinuedOperations_1" xml:lang="en-US">Share Based Payments Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ShareBasedPaymentsDiscontinuedOperations_2" xml:lang="en-US">Share-based payments - discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_0" xml:lang="en-US">Share-based payments selling, general and administrative.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_1" xml:lang="en-US">Share Based Payments Selling General And Administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_2" xml:lang="en-US">Share-based payments - selling, general and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ShareIssueCostForExchangeableNotesPurchase_0" xml:lang="en-US">Share issue cost for Exchangeable Notes purchase.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ShareIssueCostForExchangeableNotesPurchase_1" xml:lang="en-US">Share Issue Cost For Exchangeable Notes Purchase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ShareOptionMember_0" xml:lang="en-US">Share Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ShareOptionMember_1" xml:lang="en-US">Share Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SharePricePerAds_0" xml:lang="en-US">Share price per ADS.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SharePricePerAds_1" xml:lang="en-US">Share Price Per Ads</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SharePricePerAds_2" xml:lang="en-US">Share price per ADS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ShareRepurchasedUnderBuybackProgram_0" xml:lang="en-US">Share repurchased under buyback program.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ShareRepurchasedUnderBuybackProgram_1" xml:lang="en-US">Share repurchased under buyback program</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SharesConsideration_0" xml:lang="en-US">Represents the amount of shares consideration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SharesConsideration_1" xml:lang="en-US">Shares Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SharesConsideration_2" xml:lang="en-US">Shares consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SharesIssuableOnConversionOfExchangeableNotes_0" xml:lang="en-US">Shares issuable on conversion of exchangeable notes .</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SharesIssuableOnConversionOfExchangeableNotes_1" xml:lang="en-US">Shares Issuable On Conversion Of Exchangeable Notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SharesIssuableOnConversionOfExchangeableNotes_2" xml:lang="en-US">Issuable on conversion of Exchangeable notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_0" xml:lang="en-US">Shares issued as consideration for Exchangeable Notes purchase.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_1" xml:lang="en-US">Shares Issued As Consideration For Exchangeable Notes Purchase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_2" xml:lang="en-US">Issued as consideration for Exchangeable Notes purchase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_3" xml:lang="en-US">Shares issued as consideration for Exchangeable Notes purchase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_0" xml:lang="en-US">Value of shares issued as consideration for Exchangeable Notes purchase.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_1" xml:lang="en-US">Shares Issued As Consideration For Exchangeable Notes Purchase Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_2" xml:lang="en-US">Shares issued as consideration for Exchangeable Notes purchase, value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_0" xml:lang="en-US">Shares issued as consideration for purchase of Exchangeable Notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_1" xml:lang="en-US">Shares issued as consideration for purchase of Exchangeable Notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_2" xml:lang="en-US">Shares Issued As Consideration For Purchase Of Exchangeable Notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_0" xml:lang="en-US">The amount of shares issued to note holders as consideration, borrowings.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_1" xml:lang="en-US">Shares Issued To Note Holders As Consideration, Borrowings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_2" xml:lang="en-US">Shares issued to Note holders as consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SharesPurchasedDuringYear_0" xml:lang="en-US">Shares purchased during the year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SharesPurchasedDuringYear_1" xml:lang="en-US">Shares Purchased During Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SharesRepresentationRateComparedToADS_0" xml:lang="en-US">Represents the representation rate of shares compared to companies ADS.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SharesRepresentationRateComparedToADS_1" xml:lang="en-US">Shares Representation Rate Compared To A D S</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SharesRepresentationRateComparedToADS_2" xml:lang="en-US">Shares amount representing companies ADS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SharesSoldDuringYear_0" xml:lang="en-US">Shares sold during the year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SharesSoldDuringYear_1" xml:lang="en-US">Shares sold during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SharesToBeIssued_0" xml:lang="en-US">The amount represents shares to be issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SharesToBeIssued_1" xml:lang="en-US">Shares To Be Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SharesToBeIssued_2" xml:lang="en-US">Shares to be issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SharesToBeIssuedForHedgingReservesValue_0" xml:lang="en-US">Value of shares to be issued for hedging reserves.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SharesToBeIssuedForHedgingReservesValue_1" xml:lang="en-US">Shares To Be Issued For Hedging Reserves Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SharesToBeIssuedForHedgingReservesValue_2" xml:lang="en-US">Value of shares to be issued for hedging reserves</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ShortTermDepositsAndShortTermInvestments_0" xml:lang="en-US">The amount of short term deposits and investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ShortTermDepositsAndShortTermInvestments_1" xml:lang="en-US">Short Term Deposits And Short Term Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_ShortTermDepositsAndShortTermInvestments_2" xml:lang="en-US">Financial assets (short-term deposits and short-term investments)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ShortTermLeaseLiabilitiesMember_0" xml:lang="en-US">Short-term lease liabilities [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SiteTransferCostsMember_0" xml:lang="en-US">Site Transfer Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SiteTransferCostsMember_1" xml:lang="en-US">Site Transfer Costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SiteTransferCostsMember_2" xml:lang="en-US">Site transfer costs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember_0" xml:lang="en-US">Site Transfer Costs Related To The Impairment Of Plant &amp; Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SixMonthOrLessMember_0" xml:lang="en-US">6 mths or less [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SixMonthOrLessMember_1" xml:lang="en-US">Six Month Or Less Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SixMonthOrLessMember_2" xml:lang="en-US">6 mths or less [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SixMonthToTwelveMonthMember_0" xml:lang="en-US">6 mths - 12 mths [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SixMonthToTwelveMonthMember_1" xml:lang="en-US">Six Month To Twelve Month Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_SixMonthToTwelveMonthMember_2" xml:lang="en-US">6 mths - 12 mths [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SjogrensCytokineMember_0" xml:lang="en-US">Sjogrens Cytokine [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SjogrensMonoclonalAntibodiesMember_0" xml:lang="en-US">Sjogrens monoclonal antibodies [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SjogrensMonoclonalAntibodiesTwoMember_0" xml:lang="en-US">Sjogrens monoclonal antibodies [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SjogrensTestsMember_0" xml:lang="en-US">Sjogrens tests [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SjogrensTestsMember_1" xml:lang="en-US">Sjogrens Tests [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_StateCreditCarryforwardsMember_0" xml:lang="en-US">State Credit Carryforwards [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_StrategicInvestmentAndPartnershipWithMICOMember_0" xml:lang="en-US">Strategic Investment and Partnership with The MiCo; KOSDAQ-listed and Korea-based company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_StrategicInvestmentAndPartnershipWithMICOMember_1" xml:lang="en-US">Strategic Investment And Partnership With M I C O [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_StrategicInvestmentAndPartnershipWithMICOMember_2" xml:lang="en-US">Strategic Investment and Partnership with MiCo [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_StrategicPartnershipWithImawareIncMember_0" xml:lang="en-US">strategic partnership with imaware, Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_StrategicPartnershipWithImawareIncMember_1" xml:lang="en-US">Strategic Partnership With Imaware Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_StrategicPartnershipWithImawareIncMember_2" xml:lang="en-US">Strategic partnership with imaware, Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SyphilisPointOfCareMember_0" xml:lang="en-US">This member stands for Syphilis Point-of-Care.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SyphilisPointOfCareMember_1" xml:lang="en-US">Syphilis Point Of Care [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_SyphilisPointOfCareMember_2" xml:lang="en-US">Syphilis Point-of-Care [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SyphilisPointOfCareTestMember_0" xml:lang="en-US">Syphilis point-of-care test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_SyphilisPointOfCareTestMember_1" xml:lang="en-US">Syphilis Point-of-Care Test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_SyphilisRapidPointCareMember_0" xml:lang="en-US">Syphilis Rapid Point-of-Care [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_T10HplcAnalyzerMember_0" xml:lang="en-US">This member stands for T10 HPLC Analyzer.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_T10HplcAnalyzerMember_1" xml:lang="en-US">T10 Hplc Analyzer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_T10HplcAnalyzerMember_2" xml:lang="en-US">T10 HPLC Analyzer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TaxFees_0" xml:lang="en-US">Tax fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TaxFees_1" xml:lang="en-US">Tax fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_0" xml:lang="en-US">Current tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_1" xml:lang="en-US">Tax Rate Effect Of Current Tax Of Prior Periods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_2" xml:lang="en-US">Current tax %</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_0" xml:lang="en-US">R and D tax credits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_1" xml:lang="en-US">Tax Rate Effect Of Research And Development Tax Of Prior Periods</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_2" xml:lang="en-US">R&amp;D tax credits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TaxValueLossCarryforwardsRecognisedMember_0" xml:lang="en-US">Tax Value Loss Carryforwards Recognised [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TaxValueOfLossCarryForwardsMember_0" xml:lang="en-US">Tax value of loss carry-forwards [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TaxValueOfLossCarryForwardsMember_1" xml:lang="en-US">Tax value of loss carry-forwards [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TenPercentStrengtheningUSDollarMember_0" xml:lang="en-US">10% Strengthening US Dollar [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TenPercentStrengtheningUSDollarMember_1" xml:lang="en-US">Ten Percent Strengthening U S Dollar Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TenPercentStrengtheningUSDollarMember_2" xml:lang="en-US">10% strengthening US Dollar [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TenPercentWeakeningUSDollarMember_0" xml:lang="en-US">10% Weakening US Dollar [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TenPercentWeakeningUSDollarMember_1" xml:lang="en-US">Ten Percent Weakening U S Dollar Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TenPercentWeakeningUSDollarMember_2" xml:lang="en-US">10% Weakening US Dollar [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TermLoanAgreementDescription_0" xml:lang="en-US">Represents about term loan agreement description.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TermLoanAgreementDescription_1" xml:lang="en-US">Term Loan Agreement Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TermLoanAgreementDescription_2" xml:lang="en-US">Term loan agreement description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TermLoanFacility_0" xml:lang="en-US">Amount of term loan facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TermLoanFacility_1" xml:lang="en-US">Term Loan Facility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TermLoanFacility_2" xml:lang="en-US">Toan credit facility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TermLoanMember_0" xml:lang="en-US">Term Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TermLoanMember_1" xml:lang="en-US">Term Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TermOfExchangeableSeniorNotes_0" xml:lang="en-US">Term of exchangeable senior notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TermOfExchangeableSeniorNotes_1" xml:lang="en-US">Term of exchangeable senior notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TermOfLease_0" xml:lang="en-US">Term of lease.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TermOfLease_1" xml:lang="en-US">Term of lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ThirtyFirstDecemberTwoThousandThirtyFiveMember_0" xml:lang="en-US">December 31, 2035 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ThirtyFirstDecemberTwoThousandThirtyFourMember_0" xml:lang="en-US">December 31, 2034 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ThirtyFirstDecemberTwoThousandThirtySevenMember_0" xml:lang="en-US">December 31, 2037 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ThirtyFirstDecemberTwoThousandThirtySixMember_0" xml:lang="en-US">December 31, 2036 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ThirtyFirstDecemberTwoThousandThirtyThreeMember_0" xml:lang="en-US">December 31, 2033 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ThirtyFirstDecemberTwoThousandThirtyTwoMember_0" xml:lang="en-US">December 31, 2032 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ThreeLoanMember_0" xml:lang="en-US">Three Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ThreeLoanMember_1" xml:lang="en-US">Three Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ThresholdWeightedAveragePriceOfAds_0" xml:lang="en-US">Threshold weighted average price of the Company&#8217;s ADSs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ThresholdWeightedAveragePriceOfAds_1" xml:lang="en-US">Threshold Weighted Average Price Of Ads</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_ThresholdWeightedAveragePriceOfAds_2" xml:lang="en-US">Threshold weighted average price of ADSs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TotalAssetsAcquiredAsOfAcquisitionDate_0" xml:lang="en-US">Total assets acquired as of acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TotalAssetsAcquiredAsOfAcquisitionDate_1" xml:lang="en-US">Total Assets Acquired As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_TotalAssetsAcquiredAsOfAcquisitionDate_2" xml:lang="en-US">Total assets acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TotalExchangeableNotesPercentage_0" xml:lang="en-US">Represented total exchangeable notes percentage.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TotalExchangeableNotesPercentage_1" xml:lang="en-US">Total Exchangeable Notes Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TotalExchangeableNotesPercentage_2" xml:lang="en-US">Total exchangeable notes percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TotalExposureFinancialInstruments_0" xml:lang="en-US">The total credit exposure associated with derivative financial assets and liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TotalExposureFinancialInstruments_1" xml:lang="en-US">Total Exposure Financial Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TotalExposureFinancialInstruments_2" xml:lang="en-US">Total exposure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TotalLiabilitiesAssumedAsOfAcquisitionDate_0" xml:lang="en-US">Total liabilities assumed as of acquisition date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TotalLiabilitiesAssumedAsOfAcquisitionDate_1" xml:lang="en-US">Total Liabilities Assumed As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_TotalLiabilitiesAssumedAsOfAcquisitionDate_2" xml:lang="en-US">Total liabilities assumed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TotalShareOptionsGrantedAdsEquivalent_0" xml:lang="en-US">Total number of shares granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_TotalShareOptionsGrantedAdsEquivalent_1" xml:lang="en-US">Total 'A' share options granted / (ADS's equivalent)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TotalShareOptionsGrantedAdsEquivalent_2" xml:lang="en-US">Total Share Options Granted Ads Equivalent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TotalShareOptionsGrantedAdsEquivalent_3" xml:lang="en-US">Total 'A' share options granted / (ADS's equivalent)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_0" xml:lang="en-US">The amount recognised as of the acquisition date for trade and other receivables assumed in a business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_1" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_2" xml:lang="en-US">Trade And Other Receivables Recognised As Of Acquisition Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_3" xml:lang="en-US">Trade and other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TradeReceivablesAllowanceForImpairment_0" xml:lang="en-US">Trade receivables, allowance for impairment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TradeReceivablesAllowanceForImpairment_1" xml:lang="en-US">Trade Receivables Allowance For Impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TradingTriggerEventsDescription_0" xml:lang="en-US">Trading trigger events description.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TradingTriggerEventsDescription_1" xml:lang="en-US">Trading Trigger Events Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TradingTriggerEventsDescription_2" xml:lang="en-US">Trading trigger events description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TradingTriggerPayment_0" xml:lang="en-US">Amount of trading trigger payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TradingTriggerPayment_1" xml:lang="en-US">Trading Trigger Payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TradingTriggerPayment_2" xml:lang="en-US">Trading trigger payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TribBiosensorsIncMember_0" xml:lang="en-US">Represent the Trib Biosensors Inc member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TribBiosensorsIncMember_1" xml:lang="en-US">Trib Biosensors Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinityBiotechDoBrasilMember_0" xml:lang="en-US">Trinity Biotech Do Brasil [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TrinityBiotechDoBrasilMember_1" xml:lang="en-US">Trinity Biotech Do Brasil [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinityBiotechIncMember_0" xml:lang="en-US">This member stands for Trinity Biotech Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TrinityBiotechIncMember_1" xml:lang="en-US">Trinity Biotech Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinityBiotechInvestmentLtdMember_0" xml:lang="en-US">This member stands for Trinity Biotech Investment Ltd.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TrinityBiotechInvestmentLtdMember_1" xml:lang="en-US">Trinity Biotech Investment Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinityBiotechInvestmentsLtdMember_0" xml:lang="en-US">Trinity Biotech Investments Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinityBiotechJointVentureLimitedMember_0" xml:lang="en-US">Represent member of Trinity Biotech Joint Venture Limited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TrinityBiotechJointVentureLimitedMember_1" xml:lang="en-US">Trinity Biotech Joint Venture Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinityBiotechLuxembourgSarlMember_0" xml:lang="en-US">This member stands for Trinity Biotech Luxembourg Sarl.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TrinityBiotechLuxembourgSarlMember_1" xml:lang="en-US">Trinity Biotech Luxembourg Sarl [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinityBiotechManufacturingLimitedMember_0" xml:lang="en-US">Trinity Biotech Manufacturing Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TrinityBiotechManufacturingLimitedMember_1" xml:lang="en-US">Trinity Biotech Manufacturing Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinityBiotechManufacturingLtdMember_0" xml:lang="en-US">Trinity Biotech Manufacturing Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinityBiotechManufacturingLtdTwoMember_0" xml:lang="en-US">TBML Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinityBiotechManufacturingServicesLimitedMember_0" xml:lang="en-US">This member stands for Trinity Biotech Manufacturing Services Limited.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TrinityBiotechManufacturingServicesLimitedMember_1" xml:lang="en-US">Trinity Biotech Manufacturing Services Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinityBiotechPlcMember_0" xml:lang="en-US">Trinity Biotech Plc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinityBiotechUkLtdMember_0" xml:lang="en-US">This member stands for Trinity Biotech (UK) Ltd.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TrinityBiotechUkLtdMember_1" xml:lang="en-US">Trinity Biotech (Uk) Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinityResearchLimitedMember_0" xml:lang="en-US">This member stands for Trinity Research Limited.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TrinityResearchLimitedMember_1" xml:lang="en-US">Trinity Research Limited [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TrinscreenPlantAndEquipmentMember_0" xml:lang="en-US">This member stands for Trinscreen plant &amp; equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TrinscreenPlantAndEquipmentMember_1" xml:lang="en-US">Trinscreen Plant And Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_TrinscreenPlantAndEquipmentMember_2" xml:lang="en-US">Trinscreen plant &amp; equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TriStatInstrumentMember_0" xml:lang="en-US">Tri-stat instrument member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TriStatInstrumentMember_1" xml:lang="en-US">Tri Stat Instrument [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TriStatInstrumentMember_2" xml:lang="en-US">Tri-stat instrument [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TristatMember_0" xml:lang="en-US">Tri-stat member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TristatMember_1" xml:lang="en-US">Tristat [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TriStatPointOfCareInstrumentMember_0" xml:lang="en-US">Tristat Point-of-Care Instrument [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TriStatPointOfCareInstrumentMember_1" xml:lang="en-US">Tri Stat Point Of Care Instrument [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TriStatPointOfCareInstrumentMember_2" xml:lang="en-US">Tri-stat point-of-care instrument [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TroponinIassayAndReaderMember_0" xml:lang="en-US">Troponin I Assay and Reader [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TroponinIassayBrainNatriureticPeptideDdimerMember_0" xml:lang="en-US">Troponin I, BNP assay, D-dimer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TwoPercentageOfGrossInventoryMember_0" xml:lang="en-US">2% of gross inventory [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TwoPercentageOfGrossInventoryMember_1" xml:lang="en-US">Two Percentage Of Gross Inventory Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TwoPercentageOfGrossInventoryMember_2" xml:lang="en-US">2% of gross inventory [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_TwoYearToFiveYearsMember_0" xml:lang="en-US">2-5 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_TwoYearToFiveYearsMember_1" xml:lang="en-US">Two Year To Five Years Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_TwoYearToFiveYearsMember_2" xml:lang="en-US">2-5 years [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UltraGenesysMember_0" xml:lang="en-US">Ultra Genesys [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UltraGenesysMember_1" xml:lang="en-US">Ultra Genesys [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UnallocatedAssetsBySegmentAbstract_0" xml:lang="en-US">Unallocated Assets By Segment Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_UnallocatedAssetsBySegmentAbstract_1" xml:lang="en-US">Unallocated assets:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UnallocatedExpenses_0" xml:lang="en-US">Amount of unallocated expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UnallocatedExpenses_1" xml:lang="en-US">Unallocated expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UnallocatedLiabilitiesBySegmentAbstract_0" xml:lang="en-US">Unallocated Liabilities By Segment Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_UnallocatedLiabilitiesBySegmentAbstract_1" xml:lang="en-US">Unallocated liabilities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UnearnedFinanceIncomeOnFinanceLease_0" xml:lang="en-US">Unearned income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UnearnedFinanceIncomeOnFinanceLease_1" xml:lang="en-US">Unearned Finance Income On Finance Lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_UnearnedFinanceIncomeOnFinanceLease_2" xml:lang="en-US">Unearned income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UnforgivenLoansAmount_0" xml:lang="en-US">Unforgiven loans amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UnforgivenLoansAmount_1" xml:lang="en-US">Unforgiven loans amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_UnforgivenLoansAmount_2" xml:lang="en-US">Unforgiven Loans amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UniGoldAntigenImprovementMember_0" xml:lang="en-US">Uni-Gold Antigen Improvement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UniGoldAntigenImprovementMember_1" xml:lang="en-US">Uni-Gold Antigen Improvement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UniGoldRawMaterialStabilisationMember_0" xml:lang="en-US">Uni-gold raw material stabilisation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UniGoldRawMaterialStabilisationMember_1" xml:lang="en-US">Uni Gold Raw Material Stabilisation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_UniGoldRawMaterialStabilisationMember_2" xml:lang="en-US">Uni-Gold Raw Material Stabilisation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UniGoldTestEnhancementMember_0" xml:lang="en-US">Uni-Gold Test Enhancement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UniGoldTestMember_0" xml:lang="en-US">Uni-Gold Test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UniGoldTestMember_1" xml:lang="en-US">Uni-Gold Test [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UnitedKingdomMember_0" xml:lang="en-US">United Kingdom [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UnitedKingdomMember_1" xml:lang="en-US">United Kingdom [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UnrecognizedDeferredTaxAsset_0" xml:lang="en-US">Unrecognized deferred tax asset.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UnrecognizedDeferredTaxAsset_1" xml:lang="en-US">Unrecognized deferred tax asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UnsecuredJuniorConvertibleNoteMember_0" xml:lang="en-US">Unsecured junior convertible note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UnsecuredJuniorConvertibleNoteMember_1" xml:lang="en-US">Unsecured Junior Convertible Note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_UnsecuredJuniorConvertibleNoteMember_2" xml:lang="en-US">Unsecured junior convertible note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UnutilisedNetOperatingLosses_0" xml:lang="en-US">Unutilised net operating losses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UnutilisedNetOperatingLosses_1" xml:lang="en-US">Unutilised net operating losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UnwindingOfDiscountOnDeferredContingentConsideration_0" xml:lang="en-US">Amount of unwinding of discount on deferred contingent consideration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_UnwindingOfDiscountOnDeferredContingentConsideration_1" xml:lang="en-US">Unwinding Of Discount On Deferred Contingent Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_US1Member_0" xml:lang="en-US">USA Tax Credits [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_US1Member_1" xml:lang="en-US">U S 1 Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_US1Member_2" xml:lang="en-US">USA Tax Credits [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_US1Member_3" xml:lang="en-US">Americas &#8211; unused tax credits [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_UsStripedLymeMember_0" xml:lang="en-US">US Striped Lyme [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_ValueOfEmbeddedDerivativesNetLiability_0" xml:lang="en-US">Total value of embedded derivatives - net liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_ValueOfEmbeddedDerivativesNetLiability_1" xml:lang="en-US">Value Of Embedded Derivatives Net Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_trib_ValueOfEmbeddedDerivativesNetLiability_2" xml:lang="en-US">Total value of embedded derivatives - net liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_VariableRateInstruments_0" xml:lang="en-US">Represents the amount of variable rate instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_VariableRateInstruments_1" xml:lang="en-US">Variable Rate Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_VariableRateInstruments_2" xml:lang="en-US">Variable rate instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_VariableRateInstrumentsAbstract_0" xml:lang="en-US">Variable Rate Instruments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WagesAndSalariesNetOfCredit_0" xml:lang="en-US">Wages and salaries net of credit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WagesAndSalariesNetOfCredit_1" xml:lang="en-US">Wages and salaries net of credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WagesSubsidiesReceived_0" xml:lang="en-US">Amount of wage subsidies received.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WagesSubsidiesReceived_1" xml:lang="en-US">Wages Subsidies Received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_WagesSubsidiesReceived_2" xml:lang="en-US">Wage subsidies received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WarrantsIssuedShares_0" xml:lang="en-US">Warrants issued shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WarrantsIssuedShares_1" xml:lang="en-US">Warrants Issued Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_WarrantsIssuedShares_2" xml:lang="en-US">Warrants issued shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WarrantsPerAdsPrice_0" xml:lang="en-US">Warrants per ADS price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WarrantsPerAdsPrice_1" xml:lang="en-US">Warrants Per Ads Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_WarrantsPerAdsPrice_2" xml:lang="en-US">Warrants per ADS price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WarrantsToPurchaseADS_0" xml:lang="en-US">Warrants to purchase an additional ADSs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WarrantsToPurchaseADS_1" xml:lang="en-US">Warrants To Purchase A D S</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_WarrantsToPurchaseADS_2" xml:lang="en-US">Warrants to purchase an additional ADSs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WaveformAcquisitionMember_0" xml:lang="en-US">This member stand for Waveform acquisition.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WaveformAcquisitionMember_1" xml:lang="en-US">Waveform Acquisition [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WaveformTechnologiesIncMember_0" xml:lang="en-US">This member is stand for Waveform Technologies Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WaveformTechnologiesIncMember_1" xml:lang="en-US">Waveform Technologies Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_WaveformTechnologiesIncMember_2" xml:lang="en-US">Waveform Technologies Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WaveformTechnologiesIncorporationMember_0" xml:lang="en-US">Waveform Technologies Incorporation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WaveformTechnologiesIncorporationMember_1" xml:lang="en-US">Waveform Technologies Incorporation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_WaveformTechnologiesIncorporationMember_2" xml:lang="en-US">Waveform Technologies Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WeightedAverageExercisePriceAbstract_0" xml:lang="en-US">Weighted Average Exercise Price Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_WeightedAverageExercisePriceAbstract_1" xml:lang="en-US">Weighted Average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WeightedAverageExercisePriceOutstanding_0" xml:lang="en-US">Weighted average exercise price outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WeightedAverageExercisePriceOutstanding_1" xml:lang="en-US">Weighted Average Exercise Price Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_WeightedAverageExercisePriceOutstanding_2" xml:lang="en-US">Weighted average exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WeightedAverageNumberOfSharesIssued_0" xml:lang="en-US">Weighted average number of shares issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WeightedAverageNumberOfSharesIssued_1" xml:lang="en-US">Weighted Average Number Of Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_WeightedAverageNumberOfSharesIssued_2" xml:lang="en-US">Weighted average number of shares issued during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_WeightedAverageNumberOfSharesIssued_3" xml:lang="en-US">Weighted average number of &#8216;A&#8217; ordinary shares issued during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WeightedAverageNumberOfTreasuryShares_0" xml:lang="en-US">Weighted average number of treasury shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WeightedAverageNumberOfTreasuryShares_1" xml:lang="en-US">Weighted average number of treasury shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_0" xml:lang="en-US">The weighted average remaining contractual life of exercisable share options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_1" xml:lang="en-US">Weighted Average Remaining Contractual Life Of Exercisable Share Options 2019</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_2" xml:lang="en-US">Weighted average contractual life remaining (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WeightedAverageSharesDiscontinuedOperations_0" xml:lang="en-US">Weighted average shares discontinued operations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WeightedAverageSharesDiscontinuedOperations_1" xml:lang="en-US">Weighted Average Shares Discontinued Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_trib_WeightedAverageSharesDiscontinuedOperations_2" xml:lang="en-US">Weighted average number of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_trib_WeightedAverageSharesDiscontinuedOperations_3" xml:lang="en-US">Basic earnings per ordinary share - discontinued operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_trib_WithinOneYearMember_0" xml:lang="en-US">Within One Year [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_trib_WithinOneYearMember_1" xml:lang="en-US">Within One Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB_1" xlink:to="lab_country_GB_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB_2" xlink:to="lab_country_GB_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE_3" xlink:to="lab_country_IE_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE_4" xlink:to="lab_country_IE_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_SE_5" xlink:to="lab_country_SE_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_6" xlink:to="lab_country_US_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_7" xlink:to="lab_country_US_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_8" xlink:to="lab_country_US_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_BRL_9" xlink:to="lab_currency_BRL_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CAD_10" xlink:to="lab_currency_CAD_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR_11" xlink:to="lab_currency_EUR_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP_12" xlink:to="lab_currency_GBP_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_SEK_13" xlink:to="lab_currency_SEK_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_XXX_14" xlink:to="lab_currency_XXX_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain_15" xlink:to="lab_dei_AddressTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_16" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId_17" xlink:to="lab_dei_AuditorFirmId_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation_18" xlink:to="lab_dei_AuditorLocation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName_19" xlink:to="lab_dei_AuditorName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember_20" xlink:to="lab_dei_BusinessContactMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_21" xlink:to="lab_dei_CityAreaCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelFaxNumber_22" xlink:to="lab_dei_ContactPersonnelFaxNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName_23" xlink:to="lab_dei_ContactPersonnelName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_24" xlink:to="lab_dei_CoverAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_25" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard_26" xlink:to="lab_dei_DocumentAccountingStandard_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport_27" xlink:to="lab_dei_DocumentAnnualReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag_28" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_29" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_30" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_31" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement_32" xlink:to="lab_dei_DocumentRegistrationStatement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport_33" xlink:to="lab_dei_DocumentShellCompanyReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_34" xlink:to="lab_dei_DocumentTransitionReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_35" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_36" xlink:to="lab_dei_EntityAddressAddressLine1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2_37" xlink:to="lab_dei_EntityAddressAddressLine2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_38" xlink:to="lab_dei_EntityAddressCityOrTown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry_39" xlink:to="lab_dei_EntityAddressCountry_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_40" xlink:to="lab_dei_EntityAddressesAddressTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesLineItems_41" xlink:to="lab_dei_EntityAddressesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesTable_42" xlink:to="lab_dei_EntityAddressesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_43" xlink:to="lab_dei_EntityAddressPostalZipCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_44" xlink:to="lab_dei_EntityAddressStateOrProvince_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_45" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_46" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_47" xlink:to="lab_dei_EntityCurrentReportingStatus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain_48" xlink:to="lab_dei_EntityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_49" xlink:to="lab_dei_EntityEmergingGrowthCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_50" xlink:to="lab_dei_EntityFileNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_51" xlink:to="lab_dei_EntityFilerCategory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_52" xlink:to="lab_dei_EntityIncorporationStateCountryCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_53" xlink:to="lab_dei_EntityInteractiveDataCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_54" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_55" xlink:to="lab_dei_EntityShellCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers_56" xlink:to="lab_dei_EntityVoluntaryFilers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer_57" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag_58" xlink:to="lab_dei_IcfrAuditorAttestationFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_59" xlink:to="lab_dei_LocalPhoneNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_60" xlink:to="lab_dei_Security12bTitle_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_61" xlink:to="lab_dei_SecurityExchangeName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_62" xlink:to="lab_dei_TradingSymbol_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_63" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedImpairmentMember_64" xlink:to="lab_ifrs-full_AccumulatedImpairmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_65" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_66" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_67" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_68" xlink:to="lab_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_69" xlink:to="lab_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_70" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_71" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_72" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_73" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_74" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_75" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_76" xlink:to="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionalProvisionsOtherProvisions_77" xlink:to="lab_ifrs-full_AdditionalProvisionsOtherProvisions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_78" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_79" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_80" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsToRightofuseAssets_81" xlink:to="lab_ifrs-full_AdditionsToRightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsToRightofuseAssets_82" xlink:to="lab_ifrs-full_AdditionsToRightofuseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AddressOfRegisteredOfficeOfEntity_83" xlink:to="lab_ifrs-full_AddressOfRegisteredOfficeOfEntity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_84" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_85" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_86" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForAmortisationExpense_87" xlink:to="lab_ifrs-full_AdjustmentsForAmortisationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForAmortisationExpense_88" xlink:to="lab_ifrs-full_AdjustmentsForAmortisationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_89" xlink:to="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_90" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_91" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_92" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_93" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_94" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_95" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationExpense_96" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceCosts_97" xlink:to="lab_ifrs-full_AdjustmentsForFinanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceIncome_98" xlink:to="lab_ifrs-full_AdjustmentsForFinanceIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceIncome_99" xlink:to="lab_ifrs-full_AdjustmentsForFinanceIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_100" xlink:to="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_101" xlink:to="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_102" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_103" xlink:to="lab_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_104" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_105" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_106" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_107" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables_108" xlink:to="lab_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncomeTaxExpense_109" xlink:to="lab_ifrs-full_AdjustmentsForIncomeTaxExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncomeTaxExpense_110" xlink:to="lab_ifrs-full_AdjustmentsForIncomeTaxExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncomeTaxExpense_111" xlink:to="lab_ifrs-full_AdjustmentsForIncomeTaxExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_112" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_113" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForProvisions_114" xlink:to="lab_ifrs-full_AdjustmentsForProvisions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_115" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_116" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_117" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_118" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_119" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_120" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_121" xlink:to="lab_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_122" xlink:to="lab_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdministrativeExpense_123" xlink:to="lab_ifrs-full_AdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdministrativeExpense_124" xlink:to="lab_ifrs-full_AdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdministrativeExpense_125" xlink:to="lab_ifrs-full_AdministrativeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationExpense_126" xlink:to="lab_ifrs-full_AmortisationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationExpense_127" xlink:to="lab_ifrs-full_AmortisationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationExpense_128" xlink:to="lab_ifrs-full_AmortisationExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_129" xlink:to="lab_ifrs-full_AmortisationMethodIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets_130" xlink:to="lab_ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets_131" xlink:to="lab_ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract_132" xlink:to="lab_ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract_133" xlink:to="lab_ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_134" xlink:to="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_135" xlink:to="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_136" xlink:to="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate_137" xlink:to="lab_ifrs-full_ApplicableTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate_138" xlink:to="lab_ifrs-full_ApplicableTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_139" xlink:to="lab_ifrs-full_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_140" xlink:to="lab_ifrs-full_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract_141" xlink:to="lab_ifrs-full_AssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract_142" xlink:to="lab_ifrs-full_AssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_143" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_144" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_145" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_146" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_147" xlink:to="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_148" xlink:to="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuditorsRemunerationAbstract_149" xlink:to="lab_ifrs-full_AuditorsRemunerationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuditorsRemunerationForOtherServices_150" xlink:to="lab_ifrs-full_AuditorsRemunerationForOtherServices_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AuditorsRemunerationForTaxServices_151" xlink:to="lab_ifrs-full_AuditorsRemunerationForTaxServices_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_152" xlink:to="lab_ifrs-full_AverageEffectiveTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate_153" xlink:to="lab_ifrs-full_AverageEffectiveTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AverageNumberOfEmployees_154" xlink:to="lab_ifrs-full_AverageNumberOfEmployees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_155" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_156" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_157" xlink:to="lab_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_158" xlink:to="lab_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_159" xlink:to="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_160" xlink:to="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingCostsCapitalised_161" xlink:to="lab_ifrs-full_BorrowingCostsCapitalised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingCostsCapitalised_162" xlink:to="lab_ifrs-full_BorrowingCostsCapitalised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingCostsRecognisedAsExpense_163" xlink:to="lab_ifrs-full_BorrowingCostsRecognisedAsExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingCostsRecognisedAsExpense_164" xlink:to="lab_ifrs-full_BorrowingCostsRecognisedAsExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingCostsRecognisedAsExpense_165" xlink:to="lab_ifrs-full_BorrowingCostsRecognisedAsExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_166" xlink:to="lab_ifrs-full_Borrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_167" xlink:to="lab_ifrs-full_Borrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_168" xlink:to="lab_ifrs-full_Borrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_169" xlink:to="lab_ifrs-full_Borrowings_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_170" xlink:to="lab_ifrs-full_Borrowings_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_171" xlink:to="lab_ifrs-full_Borrowings_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_172" xlink:to="lab_ifrs-full_Borrowings_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_173" xlink:to="lab_ifrs-full_Borrowings_7"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_174" xlink:to="lab_ifrs-full_Borrowings_8"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings_175" xlink:to="lab_ifrs-full_Borrowings_9"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsAbstract_176" xlink:to="lab_ifrs-full_BorrowingsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_177" xlink:to="lab_ifrs-full_BorrowingsByNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_178" xlink:to="lab_ifrs-full_BorrowingsByNameAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_179" xlink:to="lab_ifrs-full_BorrowingsByNameDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate_180" xlink:to="lab_ifrs-full_BorrowingsInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate_181" xlink:to="lab_ifrs-full_BorrowingsInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate_182" xlink:to="lab_ifrs-full_BorrowingsInterestRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate_183" xlink:to="lab_ifrs-full_BorrowingsInterestRate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRateBasis_184" xlink:to="lab_ifrs-full_BorrowingsInterestRateBasis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRateBasis_185" xlink:to="lab_ifrs-full_BorrowingsInterestRateBasis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsMaturity_186" xlink:to="lab_ifrs-full_BorrowingsMaturity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsMaturity_187" xlink:to="lab_ifrs-full_BorrowingsMaturity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsMaturity_188" xlink:to="lab_ifrs-full_BorrowingsMaturity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsOriginalCurrency_189" xlink:to="lab_ifrs-full_BorrowingsOriginalCurrency_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_190" xlink:to="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_191" xlink:to="lab_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember_192" xlink:to="lab_ifrs-full_BottomOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember_193" xlink:to="lab_ifrs-full_BottomOfRangeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BrandNamesMember_194" xlink:to="lab_ifrs-full_BrandNamesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BuildingsMember_195" xlink:to="lab_ifrs-full_BuildingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_196" xlink:to="lab_ifrs-full_BusinessCombinationsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_197" xlink:to="lab_ifrs-full_BusinessCombinationsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CapitalCommitments_198" xlink:to="lab_ifrs-full_CapitalCommitments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_199" xlink:to="lab_ifrs-full_CapitalisedDevelopmentExpenditureMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_200" xlink:to="lab_ifrs-full_CapitalisedDevelopmentExpenditureMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CapitalReserve_201" xlink:to="lab_ifrs-full_CapitalReserve_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_202" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_203" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountMember_204" xlink:to="lab_ifrs-full_CarryingAmountMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_205" xlink:to="lab_ifrs-full_Cash_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_206" xlink:to="lab_ifrs-full_Cash_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_207" xlink:to="lab_ifrs-full_Cash_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash_208" xlink:to="lab_ifrs-full_Cash_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAdvancesAndLoansFromRelatedParties_209" xlink:to="lab_ifrs-full_CashAdvancesAndLoansFromRelatedParties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAdvancesAndLoansFromRelatedParties_210" xlink:to="lab_ifrs-full_CashAdvancesAndLoansFromRelatedParties_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_211" xlink:to="lab_ifrs-full_CashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_212" xlink:to="lab_ifrs-full_CashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_213" xlink:to="lab_ifrs-full_CashAndCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_214" xlink:to="lab_ifrs-full_CashAndCashEquivalents_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_215" xlink:to="lab_ifrs-full_CashAndCashEquivalents_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_216" xlink:to="lab_ifrs-full_CashAndCashEquivalents_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_217" xlink:to="lab_ifrs-full_CashAndCashEquivalentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_218" xlink:to="lab_ifrs-full_CashAndCashEquivalentsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_219" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_220" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_221" xlink:to="lab_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_222" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_223" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_224" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_225" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_226" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_227" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_228" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_229" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_230" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_231" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_232" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_233" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_234" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_235" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_236" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_237" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_238" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_239" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_240" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_241" xlink:to="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_242" xlink:to="lab_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashTransferred_243" xlink:to="lab_ifrs-full_CashTransferred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashTransferred_244" xlink:to="lab_ifrs-full_CashTransferred_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_245" xlink:to="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_246" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_247" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_248" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill_249" xlink:to="lab_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill_250" xlink:to="lab_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_251" xlink:to="lab_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInPropertyPlantAndEquipment_252" xlink:to="lab_ifrs-full_ChangesInPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInPropertyPlantAndEquipment_253" xlink:to="lab_ifrs-full_ChangesInPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_254" xlink:to="lab_ifrs-full_ClassesOfAssetsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_255" xlink:to="lab_ifrs-full_ClassesOfAssetsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_256" xlink:to="lab_ifrs-full_ClassesOfAssetsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_257" xlink:to="lab_ifrs-full_ClassesOfFinancialAssetsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_258" xlink:to="lab_ifrs-full_ClassesOfFinancialAssetsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_259" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_260" xlink:to="lab_ifrs-full_ClassesOfFinancialLiabilitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_261" xlink:to="lab_ifrs-full_ClassesOfFinancialLiabilitiesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_262" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_263" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_264" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_265" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_266" xlink:to="lab_ifrs-full_ClassesOfInventoriesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_267" xlink:to="lab_ifrs-full_ClassesOfLiabilitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_268" xlink:to="lab_ifrs-full_ClassesOfLiabilitiesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_269" xlink:to="lab_ifrs-full_ClassesOfOtherProvisionsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_270" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_271" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_272" xlink:to="lab_ifrs-full_ClassesOfProvisionsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_273" xlink:to="lab_ifrs-full_ClassesOfProvisionsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_274" xlink:to="lab_ifrs-full_ClassesOfShareCapitalAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_275" xlink:to="lab_ifrs-full_ClassesOfShareCapitalDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_276" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_277" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_278" xlink:to="lab_ifrs-full_ComponentsOfEquityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_279" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_280" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_281" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember_282" xlink:to="lab_ifrs-full_ComputerEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember_283" xlink:to="lab_ifrs-full_ComputerEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConsiderationPaidReceived_284" xlink:to="lab_ifrs-full_ConsiderationPaidReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_285" xlink:to="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_286" xlink:to="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_287" xlink:to="lab_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_288" xlink:to="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_289" xlink:to="lab_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_290" xlink:to="lab_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContinuingOperationsMember_291" xlink:to="lab_ifrs-full_ContinuingOperationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_292" xlink:to="lab_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_293" xlink:to="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_294" xlink:to="lab_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_295" xlink:to="lab_ifrs-full_CostOfSales_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_296" xlink:to="lab_ifrs-full_CostOfSales_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesAxis_297" xlink:to="lab_ifrs-full_CounterpartiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_298" xlink:to="lab_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_299" xlink:to="lab_ifrs-full_CurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_300" xlink:to="lab_ifrs-full_CurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_301" xlink:to="lab_ifrs-full_CurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsLiabilities_302" xlink:to="lab_ifrs-full_CurrentAssetsLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsLiabilities_303" xlink:to="lab_ifrs-full_CurrentAssetsLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_304" xlink:to="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_305" xlink:to="lab_ifrs-full_CurrentAssetsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentContractAssets_306" xlink:to="lab_ifrs-full_CurrentContractAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_307" xlink:to="lab_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentInvestments_308" xlink:to="lab_ifrs-full_CurrentInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentInvestments_309" xlink:to="lab_ifrs-full_CurrentInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_310" xlink:to="lab_ifrs-full_CurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_311" xlink:to="lab_ifrs-full_CurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_312" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_313" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_314" xlink:to="lab_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_315" xlink:to="lab_ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentMember_316" xlink:to="lab_ifrs-full_CurrentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepayments_317" xlink:to="lab_ifrs-full_CurrentPrepayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentProvisions_318" xlink:to="lab_ifrs-full_CurrentProvisions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentProvisions_319" xlink:to="lab_ifrs-full_CurrentProvisions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentProvisions_320" xlink:to="lab_ifrs-full_CurrentProvisions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_321" xlink:to="lab_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentReceivablesFromContractsWithCustomers_322" xlink:to="lab_ifrs-full_CurrentReceivablesFromContractsWithCustomers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentReceivablesFromRentalOfProperties_323" xlink:to="lab_ifrs-full_CurrentReceivablesFromRentalOfProperties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentReceivablesFromRentalOfProperties_324" xlink:to="lab_ifrs-full_CurrentReceivablesFromRentalOfProperties_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxAssetsCurrent_325" xlink:to="lab_ifrs-full_CurrentTaxAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncome_326" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_327" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_328" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_329" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_330" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_331" xlink:to="lab_ifrs-full_CurrentTaxLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_332" xlink:to="lab_ifrs-full_CurrentTaxLiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_333" xlink:to="lab_ifrs-full_CurrentTaxLiabilitiesCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables_334" xlink:to="lab_ifrs-full_CurrentTradeReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables_335" xlink:to="lab_ifrs-full_CurrentTradeReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentValueAddedTaxPayables_336" xlink:to="lab_ifrs-full_CurrentValueAddedTaxPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentValueAddedTaxReceivables_337" xlink:to="lab_ifrs-full_CurrentValueAddedTaxReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseThroughImpairmentContractAssets_338" xlink:to="lab_ifrs-full_DecreaseThroughImpairmentContractAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseThroughImpairmentContractAssets_339" xlink:to="lab_ifrs-full_DecreaseThroughImpairmentContractAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_340" xlink:to="lab_ifrs-full_DecreaseThroughWriteoffFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_341" xlink:to="lab_ifrs-full_DecreaseThroughWriteoffFinancialAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_342" xlink:to="lab_ifrs-full_DecreaseThroughWriteoffFinancialAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_343" xlink:to="lab_ifrs-full_DeferredIncomeIncludingContractLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_344" xlink:to="lab_ifrs-full_DeferredIncomeIncludingContractLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_345" xlink:to="lab_ifrs-full_DeferredIncomeIncludingContractLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_346" xlink:to="lab_ifrs-full_DeferredIncomeIncludingContractLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredIncomeIncludingContractLiabilities_347" xlink:to="lab_ifrs-full_DeferredIncomeIncludingContractLiabilities_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets_348" xlink:to="lab_ifrs-full_DeferredTaxAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_349" xlink:to="lab_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_350" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_351" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeAbstract_352" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_353" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_354" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_355" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_356" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_357" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_358" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_359" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities_360" xlink:to="lab_ifrs-full_DeferredTaxLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_361" xlink:to="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_362" xlink:to="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_363" xlink:to="lab_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_364" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_365" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset_366" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_367" xlink:to="lab_ifrs-full_DefinedBenefitPlansAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_368" xlink:to="lab_ifrs-full_DefinedBenefitPlansAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationAndAmortisationExpense_369" xlink:to="lab_ifrs-full_DepreciationAndAmortisationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationExpense_370" xlink:to="lab_ifrs-full_DepreciationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationExpense_371" xlink:to="lab_ifrs-full_DepreciationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationExpense_372" xlink:to="lab_ifrs-full_DepreciationExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationPropertyPlantAndEquipment_373" xlink:to="lab_ifrs-full_DepreciationPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_374" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialAssets_375" xlink:to="lab_ifrs-full_DerivativeFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialLiabilities_376" xlink:to="lab_ifrs-full_DerivativeFinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_377" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_378" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_379" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_380" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_381" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_382" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_383" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_384" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_385" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinanceCostsExplanatory_386" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinanceCostsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_387" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_388" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_389" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_390" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory_391" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_392" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_393" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_394" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_395" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_396" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_397" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_398" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_399" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_400" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_401" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_402" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_403" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_404" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_405" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_406" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_407" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory_408" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_409" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_410" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_411" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_412" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_413" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_414" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_415" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_416" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_417" xlink:to="lab_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_418" xlink:to="lab_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfConversionOfDebtToEquity_419" xlink:to="lab_ifrs-full_DescriptionOfConversionOfDebtToEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfConversionOfDebtToEquity_420" xlink:to="lab_ifrs-full_DescriptionOfConversionOfDebtToEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_421" xlink:to="lab_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_422" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_423" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_424" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_425" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_426" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_427" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_428" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_429" xlink:to="lab_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue_430" xlink:to="lab_ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue_431" xlink:to="lab_ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_432" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_433" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_434" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_435" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_436" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_437" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_438" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DirectorsRemunerationExpense_439" xlink:to="lab_ifrs-full_DirectorsRemunerationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DirectorsRemunerationExpense_440" xlink:to="lab_ifrs-full_DirectorsRemunerationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_441" xlink:to="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory_442" xlink:to="lab_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory_443" xlink:to="lab_ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory_444" xlink:to="lab_ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_445" xlink:to="lab_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_446" xlink:to="lab_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_447" xlink:to="lab_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory_448" xlink:to="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory_449" xlink:to="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_450" xlink:to="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_451" xlink:to="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_452" xlink:to="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_453" xlink:to="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_454" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_455" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_456" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_457" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_458" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_459" xlink:to="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_460" xlink:to="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCashFlowStatementExplanatory_461" xlink:to="lab_ifrs-full_DisclosureOfCashFlowStatementExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_462" xlink:to="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_463" xlink:to="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_464" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_465" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_466" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_467" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_468" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfComparativeInformationPreparedUnderPreviousGAAPLineItems_469" xlink:to="lab_ifrs-full_DisclosureOfComparativeInformationPreparedUnderPreviousGAAPLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfComparativeInformationPreparedUnderPreviousGAAPTable_470" xlink:to="lab_ifrs-full_DisclosureOfComparativeInformationPreparedUnderPreviousGAAPTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExplanatory_471" xlink:to="lab_ifrs-full_DisclosureOfCreditRiskExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_472" xlink:to="lab_ifrs-full_DisclosureOfCreditRiskExposureLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_473" xlink:to="lab_ifrs-full_DisclosureOfCreditRiskExposureTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDeferredTaxesExplanatory_474" xlink:to="lab_ifrs-full_DisclosureOfDeferredTaxesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_475" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_476" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_477" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_478" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_479" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_480" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_481" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_482" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_483" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_484" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_485" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_486" xlink:to="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_487" xlink:to="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_488" xlink:to="lab_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_489" xlink:to="lab_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_490" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_491" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_492" xlink:to="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_493" xlink:to="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_494" xlink:to="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_495" xlink:to="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_496" xlink:to="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_497" xlink:to="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinanceIncomeExplanatory_498" xlink:to="lab_ifrs-full_DisclosureOfFinanceIncomeExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsAbstract_499" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory_500" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsExplanatory_501" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_502" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_503" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_504" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_505" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_506" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_507" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_508" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_509" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_510" xlink:to="lab_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_511" xlink:to="lab_ifrs-full_DisclosureOfFinancialLiabilitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_512" xlink:to="lab_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_513" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGoodwillExplanatory_514" xlink:to="lab_ifrs-full_DisclosureOfGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory_515" xlink:to="lab_ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory_516" xlink:to="lab_ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_517" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_518" xlink:to="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_519" xlink:to="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems_520" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable_521" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory_522" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutEmployeesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_523" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_524" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_525" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_526" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityExplanatory_527" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_528" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_529" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_530" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInventoriesExplanatory_531" xlink:to="lab_ifrs-full_DisclosureOfInventoriesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLeasesExplanatory_532" xlink:to="lab_ifrs-full_DisclosureOfLeasesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory_533" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_534" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_535" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_536" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_537" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_538" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_539" xlink:to="lab_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_540" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_541" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_542" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_543" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_544" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_545" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_546" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_547" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_548" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_549" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_550" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_551" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_552" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_553" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherAssetsExplanatory_554" xlink:to="lab_ifrs-full_DisclosureOfOtherAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_555" xlink:to="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_556" xlink:to="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsExplanatory_557" xlink:to="lab_ifrs-full_DisclosureOfOtherProvisionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_558" xlink:to="lab_ifrs-full_DisclosureOfOtherProvisionsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_559" xlink:to="lab_ifrs-full_DisclosureOfOtherProvisionsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesExplanatory_560" xlink:to="lab_ifrs-full_DisclosureOfProductsAndServicesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesLineItems_561" xlink:to="lab_ifrs-full_DisclosureOfProductsAndServicesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesTable_562" xlink:to="lab_ifrs-full_DisclosureOfProductsAndServicesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_563" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_564" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_565" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_566" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_567" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_568" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfProvisionsExplanatory_569" xlink:to="lab_ifrs-full_DisclosureOfProvisionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_570" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_571" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_572" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_573" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_574" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_575" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_576" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_577" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract_578" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_579" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_580" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_581" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_582" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_583" xlink:to="lab_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_584" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_585" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_586" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_587" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_588" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_589" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_590" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_591" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_592" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_593" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_594" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_595" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_596" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_597" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_598" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DiscontinuedOperationsMember_599" xlink:to="lab_ifrs-full_DiscontinuedOperationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsPaidClassifiedAsFinancingActivities_600" xlink:to="lab_ifrs-full_DividendsPaidClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_601" xlink:to="lab_ifrs-full_EarningsPerShareAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_602" xlink:to="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfTransitionToIFRSsMember_603" xlink:to="lab_ifrs-full_EffectOfTransitionToIFRSsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_604" xlink:to="lab_ifrs-full_EliminationOfIntersegmentAmountsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_605" xlink:to="lab_ifrs-full_EliminationOfIntersegmentAmountsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_606" xlink:to="lab_ifrs-full_EmployeeBenefitsExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_607" xlink:to="lab_ifrs-full_EmployeeBenefitsExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_608" xlink:to="lab_ifrs-full_Equity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_609" xlink:to="lab_ifrs-full_Equity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_610" xlink:to="lab_ifrs-full_Equity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_611" xlink:to="lab_ifrs-full_Equity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract_612" xlink:to="lab_ifrs-full_EquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_613" xlink:to="lab_ifrs-full_EquityAndLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_614" xlink:to="lab_ifrs-full_EquityAndLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_615" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_616" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer_617" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_618" xlink:to="lab_ifrs-full_ExercisePriceShareOptionsGranted2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedCreditLossRate_619" xlink:to="lab_ifrs-full_ExpectedCreditLossRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities_620" xlink:to="lab_ifrs-full_ExpenseOfRestructuringActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities_621" xlink:to="lab_ifrs-full_ExpenseOfRestructuringActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities_622" xlink:to="lab_ifrs-full_ExpenseOfRestructuringActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities_623" xlink:to="lab_ifrs-full_ExpenseOfRestructuringActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_624" xlink:to="lab_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_625" xlink:to="lab_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities_626" xlink:to="lab_ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfNotAppliedNewStandardsOrInterpretations_627" xlink:to="lab_ifrs-full_ExplanationOfNotAppliedNewStandardsOrInterpretations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfNotAppliedNewStandardsOrInterpretations_628" xlink:to="lab_ifrs-full_ExplanationOfNotAppliedNewStandardsOrInterpretations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets_629" xlink:to="lab_ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_630" xlink:to="lab_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_631" xlink:to="lab_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_632" xlink:to="lab_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_633" xlink:to="lab_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_634" xlink:to="lab_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_635" xlink:to="lab_ifrs-full_FeeIncomeExpenseArisingFromFinancialAssetsOrFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_636" xlink:to="lab_ifrs-full_FinanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_637" xlink:to="lab_ifrs-full_FinanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_638" xlink:to="lab_ifrs-full_FinanceCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_639" xlink:to="lab_ifrs-full_FinanceCosts_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome_640" xlink:to="lab_ifrs-full_FinanceIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome_641" xlink:to="lab_ifrs-full_FinanceIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncomeCost_642" xlink:to="lab_ifrs-full_FinanceIncomeCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncomeCost_643" xlink:to="lab_ifrs-full_FinanceIncomeCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncomeCost_644" xlink:to="lab_ifrs-full_FinanceIncomeCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssets_645" xlink:to="lab_ifrs-full_FinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssets_646" xlink:to="lab_ifrs-full_FinancialAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssets_647" xlink:to="lab_ifrs-full_FinancialAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssets_648" xlink:to="lab_ifrs-full_FinancialAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValue_649" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValue_650" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_651" xlink:to="lab_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_652" xlink:to="lab_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_653" xlink:to="lab_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_654" xlink:to="lab_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialEffectOfTransitionFromPreviousGAAPToIFRSsAxis_655" xlink:to="lab_ifrs-full_FinancialEffectOfTransitionFromPreviousGAAPToIFRSsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilities_656" xlink:to="lab_ifrs-full_FinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCost_657" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCost_658" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCost_659" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCost_660" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCost_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinishedGoods_661" xlink:to="lab_ifrs-full_FinishedGoods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation_662" xlink:to="lab_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation_663" xlink:to="lab_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination_664" xlink:to="lab_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination_665" xlink:to="lab_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainRecognisedInBargainPurchaseTransaction_666" xlink:to="lab_ifrs-full_GainRecognisedInBargainPurchaseTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasAxis_667" xlink:to="lab_ifrs-full_GeographicalAreasAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasAxis_668" xlink:to="lab_ifrs-full_GeographicalAreasAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasDomain_669" xlink:to="lab_ifrs-full_GeographicalAreasDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GoodwillMember_670" xlink:to="lab_ifrs-full_GoodwillMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_671" xlink:to="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_672" xlink:to="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_673" xlink:to="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_674" xlink:to="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_675" xlink:to="lab_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember_676" xlink:to="lab_ifrs-full_GrossCarryingAmountMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLeaseLiabilities_677" xlink:to="lab_ifrs-full_GrossLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLoanCommitments_678" xlink:to="lab_ifrs-full_GrossLoanCommitments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLoanCommitments_679" xlink:to="lab_ifrs-full_GrossLoanCommitments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_680" xlink:to="lab_ifrs-full_GrossProfit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_681" xlink:to="lab_ifrs-full_GrossProfit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_682" xlink:to="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_683" xlink:to="lab_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_684" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_685" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_686" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_687" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLoss_688" xlink:to="lab_ifrs-full_ImpairmentLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLoss_689" xlink:to="lab_ifrs-full_ImpairmentLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossOnFinancialAssets_690" xlink:to="lab_ifrs-full_ImpairmentLossOnFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossOnFinancialAssets_691" xlink:to="lab_ifrs-full_ImpairmentLossOnFinancialAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossOnFinancialAssets_692" xlink:to="lab_ifrs-full_ImpairmentLossOnFinancialAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossOnFinancialAssets_693" xlink:to="lab_ifrs-full_ImpairmentLossOnFinancialAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossOnFinancialAssets_694" xlink:to="lab_ifrs-full_ImpairmentLossOnFinancialAssets_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossOnFinancialAssets_695" xlink:to="lab_ifrs-full_ImpairmentLossOnFinancialAssets_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossOnFinancialAssets_696" xlink:to="lab_ifrs-full_ImpairmentLossOnFinancialAssets_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossOnFinancialAssets_697" xlink:to="lab_ifrs-full_ImpairmentLossOnFinancialAssets_7"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossOnFinancialAssets_698" xlink:to="lab_ifrs-full_ImpairmentLossOnFinancialAssets_8"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome_699" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_700" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_701" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_702" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_703" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_704" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_705" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossInvestmentProperty_706" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossInvestmentProperty_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_707" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_708" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_709" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_710" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_711" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_712" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_713" xlink:to="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_714" xlink:to="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_715" xlink:to="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_716" xlink:to="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeFromFinesAndPenalties_717" xlink:to="lab_ifrs-full_IncomeFromFinesAndPenalties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeFromSubleasingRightofuseAssets_718" xlink:to="lab_ifrs-full_IncomeFromSubleasingRightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeRelatingToVariableLeasePaymentsForOperatingLeasesThatDoNotDependOnIndexOrRate_719" xlink:to="lab_ifrs-full_IncomeRelatingToVariableLeasePaymentsForOperatingLeasesThatDoNotDependOnIndexOrRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeStatementAbstract_720" xlink:to="lab_ifrs-full_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefund_721" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefund_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefund_722" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefund_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_723" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_724" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_725" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_726" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome_727" xlink:to="lab_ifrs-full_IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_728" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_729" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_730" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_731" xlink:to="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCreditDerivativeNominalAmount_732" xlink:to="lab_ifrs-full_IncreaseDecreaseInCreditDerivativeNominalAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset_733" xlink:to="lab_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_734" xlink:to="lab_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_735" xlink:to="lab_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_736" xlink:to="lab_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_737" xlink:to="lab_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_738" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_739" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_740" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_741" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_742" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_743" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_744" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_745" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_746" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_747" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_748" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_749" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_750" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_751" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_752" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_753" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_754" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_755" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseThroughOriginationOrPurchaseFinancialAssets_756" xlink:to="lab_ifrs-full_IncreaseThroughOriginationOrPurchaseFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwill_757" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwill_758" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwill_759" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwill_760" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwill_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwill_761" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwill_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwill_762" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwill_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_763" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsUnderDevelopment_764" xlink:to="lab_ifrs-full_IntangibleAssetsUnderDevelopment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsUnderDevelopment_765" xlink:to="lab_ifrs-full_IntangibleAssetsUnderDevelopment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsUnderDevelopment_766" xlink:to="lab_ifrs-full_IntangibleAssetsUnderDevelopment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_767" xlink:to="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_768" xlink:to="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_769" xlink:to="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_770" xlink:to="lab_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpense_771" xlink:to="lab_ifrs-full_InterestExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpense_772" xlink:to="lab_ifrs-full_InterestExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpense_773" xlink:to="lab_ifrs-full_InterestExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_774" xlink:to="lab_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_775" xlink:to="lab_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_776" xlink:to="lab_ifrs-full_InterestExpenseOnDebtInstrumentsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_777" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_778" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_779" xlink:to="lab_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_780" xlink:to="lab_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_781" xlink:to="lab_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_782" xlink:to="lab_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestIncomeOnOtherFinancialAssets_783" xlink:to="lab_ifrs-full_InterestIncomeOnOtherFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestIncomeOnOtherFinancialAssets_784" xlink:to="lab_ifrs-full_InterestIncomeOnOtherFinancialAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestIncomeOnOtherFinancialAssets_785" xlink:to="lab_ifrs-full_InterestIncomeOnOtherFinancialAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_786" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_787" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_788" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPayable_789" xlink:to="lab_ifrs-full_InterestPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_790" xlink:to="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_791" xlink:to="lab_ifrs-full_Inventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_792" xlink:to="lab_ifrs-full_Inventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_793" xlink:to="lab_ifrs-full_Inventories_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_794" xlink:to="lab_ifrs-full_Inventories_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoriesAtNetRealisableValue_795" xlink:to="lab_ifrs-full_InventoriesAtNetRealisableValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_796" xlink:to="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_797" xlink:to="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_798" xlink:to="lab_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_799" xlink:to="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_800" xlink:to="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_801" xlink:to="lab_ifrs-full_IssuedCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember_802" xlink:to="lab_ifrs-full_IssuedCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfConvertibleInstruments_803" xlink:to="lab_ifrs-full_IssueOfConvertibleInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_804" xlink:to="lab_ifrs-full_IssueOfEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_805" xlink:to="lab_ifrs-full_IssueOfEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_806" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_807" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_808" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_809" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_810" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_811" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_812" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_813" xlink:to="lab_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LandAndBuildingsMember_814" xlink:to="lab_ifrs-full_LandAndBuildingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LandAndBuildingsMember_815" xlink:to="lab_ifrs-full_LandAndBuildingsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember_816" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember_817" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember_818" xlink:to="lab_ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_819" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_820" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseCommitmentsForShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_821" xlink:to="lab_ifrs-full_LeaseCommitmentsForShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseholdImprovementsMember_822" xlink:to="lab_ifrs-full_LeaseholdImprovementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseholdImprovementsMember_823" xlink:to="lab_ifrs-full_LeaseholdImprovementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_824" xlink:to="lab_ifrs-full_LeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_825" xlink:to="lab_ifrs-full_LeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_826" xlink:to="lab_ifrs-full_LeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilitiesMember_827" xlink:to="lab_ifrs-full_LeaseLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LegalProceedingsProvision_828" xlink:to="lab_ifrs-full_LegalProceedingsProvision_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LegalProceedingsProvision_829" xlink:to="lab_ifrs-full_LegalProceedingsProvision_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LegalProceedingsProvision_830" xlink:to="lab_ifrs-full_LegalProceedingsProvision_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level1OfFairValueHierarchyMember_831" xlink:to="lab_ifrs-full_Level1OfFairValueHierarchyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level2OfFairValueHierarchyMember_832" xlink:to="lab_ifrs-full_Level2OfFairValueHierarchyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level3OfFairValueHierarchyMember_833" xlink:to="lab_ifrs-full_Level3OfFairValueHierarchyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level3OfFairValueHierarchyMember_834" xlink:to="lab_ifrs-full_Level3OfFairValueHierarchyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_835" xlink:to="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_836" xlink:to="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_837" xlink:to="lab_ifrs-full_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_838" xlink:to="lab_ifrs-full_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_839" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_840" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_841" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_842" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_843" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivities_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_844" xlink:to="lab_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiquidityRiskMember_845" xlink:to="lab_ifrs-full_LiquidityRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LoansPayableInDefault_846" xlink:to="lab_ifrs-full_LoansPayableInDefault_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings_847" xlink:to="lab_ifrs-full_LongtermBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings_848" xlink:to="lab_ifrs-full_LongtermBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings_849" xlink:to="lab_ifrs-full_LongtermBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings_850" xlink:to="lab_ifrs-full_LongtermBorrowings_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings_851" xlink:to="lab_ifrs-full_LongtermBorrowings_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings_852" xlink:to="lab_ifrs-full_LongtermBorrowings_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings_853" xlink:to="lab_ifrs-full_LongtermBorrowings_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowingsMember_854" xlink:to="lab_ifrs-full_LongtermBorrowingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_855" xlink:to="lab_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_856" xlink:to="lab_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_857" xlink:to="lab_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_858" xlink:to="lab_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorCustomersDomain_859" xlink:to="lab_ifrs-full_MajorCustomersDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAxis_860" xlink:to="lab_ifrs-full_MaturityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAxis_861" xlink:to="lab_ifrs-full_MaturityAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityDomain_862" xlink:to="lab_ifrs-full_MaturityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaximumExposureToCreditRisk_863" xlink:to="lab_ifrs-full_MaximumExposureToCreditRisk_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaximumExposureToCreditRisk_864" xlink:to="lab_ifrs-full_MaximumExposureToCreditRisk_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaximumExposureToCreditRisk_865" xlink:to="lab_ifrs-full_MaximumExposureToCreditRisk_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables_866" xlink:to="lab_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_867" xlink:to="lab_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NameOfSubsidiary_868" xlink:to="lab_ifrs-full_NameOfSubsidiary_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetAssetsLiabilities_869" xlink:to="lab_ifrs-full_NetAssetsLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetAssetsLiabilities_870" xlink:to="lab_ifrs-full_NetAssetsLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_871" xlink:to="lab_ifrs-full_NetDeferredTaxAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_872" xlink:to="lab_ifrs-full_NetDeferredTaxAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxAssets_873" xlink:to="lab_ifrs-full_NetDeferredTaxAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxLiabilities_874" xlink:to="lab_ifrs-full_NetDeferredTaxLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxLiabilities_875" xlink:to="lab_ifrs-full_NetDeferredTaxLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxLiabilities_876" xlink:to="lab_ifrs-full_NetDeferredTaxLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NewProvisionsOtherProvisions_877" xlink:to="lab_ifrs-full_NewProvisionsOtherProvisions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NewProvisionsOtherProvisions_878" xlink:to="lab_ifrs-full_NewProvisionsOtherProvisions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NewProvisionsOtherProvisions_879" xlink:to="lab_ifrs-full_NewProvisionsOtherProvisions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_880" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_881" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_882" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_883" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterests_884" xlink:to="lab_ifrs-full_NoncontrollingInterests_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterests_885" xlink:to="lab_ifrs-full_NoncontrollingInterests_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_886" xlink:to="lab_ifrs-full_NoncurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_887" xlink:to="lab_ifrs-full_NoncurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_888" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsHeldForSaleMember_889" xlink:to="lab_ifrs-full_NoncurrentAssetsHeldForSaleMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_890" xlink:to="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_891" xlink:to="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsRecognisedAsOfAcquisitionDate_892" xlink:to="lab_ifrs-full_NoncurrentAssetsRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsRecognisedAsOfAcquisitionDate_893" xlink:to="lab_ifrs-full_NoncurrentAssetsRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_894" xlink:to="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_895" xlink:to="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_896" xlink:to="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_897" xlink:to="lab_ifrs-full_NoncurrentDerivativeFinancialAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_898" xlink:to="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_899" xlink:to="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_900" xlink:to="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_901" xlink:to="lab_ifrs-full_NoncurrentDerivativeFinancialLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentFinanceLeaseReceivables_902" xlink:to="lab_ifrs-full_NoncurrentFinanceLeaseReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentFinanceLeaseReceivables_903" xlink:to="lab_ifrs-full_NoncurrentFinanceLeaseReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentFinancialAssets_904" xlink:to="lab_ifrs-full_NoncurrentFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentFinancialAssets_905" xlink:to="lab_ifrs-full_NoncurrentFinancialAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_906" xlink:to="lab_ifrs-full_NoncurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_907" xlink:to="lab_ifrs-full_NoncurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_908" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesRecognisedAsOfAcquisitionDate_909" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesRecognisedAsOfAcquisitionDate_910" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_911" xlink:to="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_912" xlink:to="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_913" xlink:to="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_914" xlink:to="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_915" xlink:to="lab_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentProvisions_916" xlink:to="lab_ifrs-full_NoncurrentProvisions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentProvisions_917" xlink:to="lab_ifrs-full_NoncurrentProvisions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers_918" xlink:to="lab_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NongovernmentCustomersMember_919" xlink:to="lab_ifrs-full_NongovernmentCustomersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NongovernmentCustomersMember_920" xlink:to="lab_ifrs-full_NongovernmentCustomersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotesAndDebenturesIssued_921" xlink:to="lab_ifrs-full_NotesAndDebenturesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotionalAmount_922" xlink:to="lab_ifrs-full_NotionalAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotionalAmount_923" xlink:to="lab_ifrs-full_NotionalAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember_924" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_925" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_926" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_927" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions_928" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_929" xlink:to="lab_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_930" xlink:to="lab_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_931" xlink:to="lab_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_932" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_933" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_934" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_935" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_936" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_937" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_938" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_939" xlink:to="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_940" xlink:to="lab_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_941" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_942" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_943" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesAuthorised_944" xlink:to="lab_ifrs-full_NumberOfSharesAuthorised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_945" xlink:to="lab_ifrs-full_NumberOfSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_946" xlink:to="lab_ifrs-full_NumberOfSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_947" xlink:to="lab_ifrs-full_NumberOfSharesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_948" xlink:to="lab_ifrs-full_NumberOfSharesIssued_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_949" xlink:to="lab_ifrs-full_NumberOfSharesIssued_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_950" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_951" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_952" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OfficeEquipmentMember_953" xlink:to="lab_ifrs-full_OfficeEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense_954" xlink:to="lab_ifrs-full_OperatingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense_955" xlink:to="lab_ifrs-full_OperatingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense_956" xlink:to="lab_ifrs-full_OperatingExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAdjustmentsForNoncashItems_957" xlink:to="lab_ifrs-full_OtherAdjustmentsForNoncashItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherBorrowings_958" xlink:to="lab_ifrs-full_OtherBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherBorrowings_959" xlink:to="lab_ifrs-full_OtherBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_960" xlink:to="lab_ifrs-full_OtherComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_961" xlink:to="lab_ifrs-full_OtherComprehensiveIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_962" xlink:to="lab_ifrs-full_OtherComprehensiveIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_963" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_964" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_965" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_966" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_967" xlink:to="lab_ifrs-full_OtherIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIncome_968" xlink:to="lab_ifrs-full_OtherIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIntangibleAssets_969" xlink:to="lab_ifrs-full_OtherIntangibleAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIntangibleAssetsMember_970" xlink:to="lab_ifrs-full_OtherIntangibleAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIntangibleAssetsMember_971" xlink:to="lab_ifrs-full_OtherIntangibleAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIntangibleAssetsMember_972" xlink:to="lab_ifrs-full_OtherIntangibleAssetsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentAssets_973" xlink:to="lab_ifrs-full_OtherNoncurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentAssets_974" xlink:to="lab_ifrs-full_OtherNoncurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentFinancialAssets_975" xlink:to="lab_ifrs-full_OtherNoncurrentFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_976" xlink:to="lab_ifrs-full_OtherOperatingIncomeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_977" xlink:to="lab_ifrs-full_OtherOperatingIncomeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_978" xlink:to="lab_ifrs-full_OtherOperatingIncomeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_979" xlink:to="lab_ifrs-full_OtherOperatingIncomeExpense_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_980" xlink:to="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_981" xlink:to="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_982" xlink:to="lab_ifrs-full_OtherPropertyPlantAndEquipmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherProvisions_983" xlink:to="lab_ifrs-full_OtherProvisions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherProvisions_984" xlink:to="lab_ifrs-full_OtherProvisions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherProvisions_985" xlink:to="lab_ifrs-full_OtherProvisions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherProvisions_986" xlink:to="lab_ifrs-full_OtherProvisions_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReceivables_987" xlink:to="lab_ifrs-full_OtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReceivables_988" xlink:to="lab_ifrs-full_OtherReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReserves_989" xlink:to="lab_ifrs-full_OtherReserves_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReservesMember_990" xlink:to="lab_ifrs-full_OtherReservesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherRevenue_991" xlink:to="lab_ifrs-full_OtherRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherRevenue_992" xlink:to="lab_ifrs-full_OtherRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_993" xlink:to="lab_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParValuePerShare_994" xlink:to="lab_ifrs-full_ParValuePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PastDueStatusAxis_995" xlink:to="lab_ifrs-full_PastDueStatusAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PastDueStatusAxis_996" xlink:to="lab_ifrs-full_PastDueStatusAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure_997" xlink:to="lab_ifrs-full_PaymentsForDevelopmentProjectExpenditure_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_998" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_999" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsForShareIssueCosts_1000" xlink:to="lab_ifrs-full_PaymentsForShareIssueCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1001" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1002" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1003" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1004" xlink:to="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1005" xlink:to="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_1006" xlink:to="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_1007" xlink:to="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_1008" xlink:to="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Prepayments_1009" xlink:to="lab_ifrs-full_Prepayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Prepayments_1010" xlink:to="lab_ifrs-full_Prepayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PreviousGAAPMember_1011" xlink:to="lab_ifrs-full_PreviousGAAPMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PrincipalPlaceOfBusiness_1012" xlink:to="lab_ifrs-full_PrincipalPlaceOfBusiness_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PrincipalPlaceOfBusiness_1013" xlink:to="lab_ifrs-full_PrincipalPlaceOfBusiness_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1014" xlink:to="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1015" xlink:to="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1016" xlink:to="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_1017" xlink:to="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_1018" xlink:to="lab_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_1019" xlink:to="lab_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_1020" xlink:to="lab_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_1021" xlink:to="lab_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_1022" xlink:to="lab_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_1023" xlink:to="lab_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_1024" xlink:to="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_1025" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_1026" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_1027" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_1028" xlink:to="lab_ifrs-full_ProceedsFromNoncurrentBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_1029" xlink:to="lab_ifrs-full_ProceedsFromNoncurrentBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_1030" xlink:to="lab_ifrs-full_ProductsAndServicesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_1031" xlink:to="lab_ifrs-full_ProductsAndServicesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_1032" xlink:to="lab_ifrs-full_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_1033" xlink:to="lab_ifrs-full_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_1034" xlink:to="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1035" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1036" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1037" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1038" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1039" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1040" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1041" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1042" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1043" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1044" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_1045" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations_1046" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_1047" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_1048" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_1049" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_1050" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_1051" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_1052" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_1053" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_1054" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_1055" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_1056" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_1057" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_1058" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1059" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1060" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1061" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1062" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1063" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyDevelopmentAndProjectManagementExpense_1064" xlink:to="lab_ifrs-full_PropertyDevelopmentAndProjectManagementExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_1065" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_1066" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_1067" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_1068" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_1069" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_1070" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentExpendituresRecognisedForConstructions_1071" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentExpendituresRecognisedForConstructions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated_1072" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated_1073" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1074" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_1075" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_1076" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_1077" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1078" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1079" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember_1080" xlink:to="lab_ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Provisions_1081" xlink:to="lab_ifrs-full_Provisions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Provisions_1082" xlink:to="lab_ifrs-full_Provisions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Provisions_1083" xlink:to="lab_ifrs-full_Provisions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProvisionsAbstract_1084" xlink:to="lab_ifrs-full_ProvisionsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProvisionUsedOtherProvisions_1085" xlink:to="lab_ifrs-full_ProvisionUsedOtherProvisions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProvisionUsedOtherProvisions_1086" xlink:to="lab_ifrs-full_ProvisionUsedOtherProvisions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1087" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1088" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1089" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1090" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfTreasuryShares_1091" xlink:to="lab_ifrs-full_PurchaseOfTreasuryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfTreasuryShares_1092" xlink:to="lab_ifrs-full_PurchaseOfTreasuryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfTreasuryShares_1093" xlink:to="lab_ifrs-full_PurchaseOfTreasuryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis_1094" xlink:to="lab_ifrs-full_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeDomain_1095" xlink:to="lab_ifrs-full_RangeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1096" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1097" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomers_1098" xlink:to="lab_ifrs-full_ReceivablesFromContractsWithCustomers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_1099" xlink:to="lab_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_1100" xlink:to="lab_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_1101" xlink:to="lab_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_1102" xlink:to="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_1103" xlink:to="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_1104" xlink:to="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_1105" xlink:to="lab_ifrs-full_RepaymentsOfBondsNotesAndDebentures_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1106" xlink:to="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1107" xlink:to="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1108" xlink:to="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1109" xlink:to="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1110" xlink:to="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1111" xlink:to="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1112" xlink:to="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_1113" xlink:to="lab_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_7"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfCurrentBorrowings_1114" xlink:to="lab_ifrs-full_RepaymentsOfCurrentBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_1115" xlink:to="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_1116" xlink:to="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_1117" xlink:to="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_1118" xlink:to="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_1119" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_1120" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfCashFlowHedges_1121" xlink:to="lab_ifrs-full_ReserveOfCashFlowHedges_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfCashFlowHedgesMember_1122" xlink:to="lab_ifrs-full_ReserveOfCashFlowHedgesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments_1123" xlink:to="lab_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments_1124" xlink:to="lab_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_1125" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_1126" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestructuringProvision_1127" xlink:to="lab_ifrs-full_RestructuringProvision_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestructuringProvision_1128" xlink:to="lab_ifrs-full_RestructuringProvision_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestructuringProvision_1129" xlink:to="lab_ifrs-full_RestructuringProvision_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestructuringProvisionMember_1130" xlink:to="lab_ifrs-full_RestructuringProvisionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestructuringProvisionMember_1131" xlink:to="lab_ifrs-full_RestructuringProvisionMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_1132" xlink:to="lab_ifrs-full_RetainedEarnings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_1133" xlink:to="lab_ifrs-full_RetainedEarnings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_1134" xlink:to="lab_ifrs-full_RetainedEarnings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember_1135" xlink:to="lab_ifrs-full_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember_1136" xlink:to="lab_ifrs-full_RetainedEarningsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill_1137" xlink:to="lab_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill_1138" xlink:to="lab_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets_1139" xlink:to="lab_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets_1140" xlink:to="lab_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_1141" xlink:to="lab_ifrs-full_Revenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_1142" xlink:to="lab_ifrs-full_Revenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_1143" xlink:to="lab_ifrs-full_Revenue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_1144" xlink:to="lab_ifrs-full_Revenue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromContractsWithCustomers_1145" xlink:to="lab_ifrs-full_RevenueFromContractsWithCustomers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromContractsWithCustomers_1146" xlink:to="lab_ifrs-full_RevenueFromContractsWithCustomers_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromGovernmentGrants_1147" xlink:to="lab_ifrs-full_RevenueFromGovernmentGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromGovernmentGrants_1148" xlink:to="lab_ifrs-full_RevenueFromGovernmentGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromInterest_1149" xlink:to="lab_ifrs-full_RevenueFromInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromInterest_1150" xlink:to="lab_ifrs-full_RevenueFromInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromInterest_1151" xlink:to="lab_ifrs-full_RevenueFromInterest_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_1152" xlink:to="lab_ifrs-full_RightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_1153" xlink:to="lab_ifrs-full_RightofuseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_1154" xlink:to="lab_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_1155" xlink:to="lab_ifrs-full_RightofuseAssetsRevaluedAssetsAtCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_1156" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_1157" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_1158" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_1159" xlink:to="lab_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ServicesExpense_1160" xlink:to="lab_ifrs-full_ServicesExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ServicesExpense_1161" xlink:to="lab_ifrs-full_ServicesExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_1162" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremium_1163" xlink:to="lab_ifrs-full_SharePremium_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremiumMember_1164" xlink:to="lab_ifrs-full_SharePremiumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_1165" xlink:to="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_1166" xlink:to="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_1167" xlink:to="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermEmployeeBenefitsExpense_1168" xlink:to="lab_ifrs-full_ShorttermEmployeeBenefitsExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_1169" xlink:to="lab_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_1170" xlink:to="lab_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_1171" xlink:to="lab_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1172" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1173" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SocialSecurityContributions_1174" xlink:to="lab_ifrs-full_SocialSecurityContributions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_1175" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_1176" xlink:to="lab_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_1177" xlink:to="lab_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1178" xlink:to="lab_ifrs-full_StatementOfChangesInEquityTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_1179" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense_1180" xlink:to="lab_ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_1181" xlink:to="lab_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_1182" xlink:to="lab_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_1183" xlink:to="lab_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1184" xlink:to="lab_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1185" xlink:to="lab_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1186" xlink:to="lab_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1187" xlink:to="lab_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1188" xlink:to="lab_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_1189" xlink:to="lab_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods_1190" xlink:to="lab_ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_1191" xlink:to="lab_ifrs-full_TaxRateEffectOfForeignTaxRates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxRateEffectOfImpairmentOfGoodwill_1192" xlink:to="lab_ifrs-full_TaxRateEffectOfImpairmentOfGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxRateEffectOfTaxLosses_1193" xlink:to="lab_ifrs-full_TaxRateEffectOfTaxLosses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TechnologybasedIntangibleAssetsMember_1194" xlink:to="lab_ifrs-full_TechnologybasedIntangibleAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TechnologybasedIntangibleAssetsMember_1195" xlink:to="lab_ifrs-full_TechnologybasedIntangibleAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1196" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1197" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember_1198" xlink:to="lab_ifrs-full_TopOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember_1199" xlink:to="lab_ifrs-full_TopOfRangeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_1200" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_1201" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayables_1202" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_1203" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesAbstract_1204" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1205" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1206" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_1207" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_1208" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_1209" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_1210" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_1211" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_1212" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_1213" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivablesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayables_1214" xlink:to="lab_ifrs-full_TradeAndOtherPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayables_1215" xlink:to="lab_ifrs-full_TradeAndOtherPayables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayables_1216" xlink:to="lab_ifrs-full_TradeAndOtherPayables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayables_1217" xlink:to="lab_ifrs-full_TradeAndOtherPayables_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1218" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1219" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_1220" xlink:to="lab_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivables_1221" xlink:to="lab_ifrs-full_TradeAndOtherReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_1222" xlink:to="lab_ifrs-full_TradeAndOtherReceivablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeReceivables_1223" xlink:to="lab_ifrs-full_TradeReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeReceivables_1224" xlink:to="lab_ifrs-full_TradeReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeReceivables_1225" xlink:to="lab_ifrs-full_TradeReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeReceivables_1226" xlink:to="lab_ifrs-full_TradeReceivables_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_1227" xlink:to="lab_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_1228" xlink:to="lab_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasuryShares_1229" xlink:to="lab_ifrs-full_TreasuryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasuryShares_1230" xlink:to="lab_ifrs-full_TreasuryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasuryShares_1231" xlink:to="lab_ifrs-full_TreasuryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasuryShares_1232" xlink:to="lab_ifrs-full_TreasuryShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasurySharesMember_1233" xlink:to="lab_ifrs-full_TreasurySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfCustomersAxis_1234" xlink:to="lab_ifrs-full_TypesOfCustomersAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfCustomersAxis_1235" xlink:to="lab_ifrs-full_TypesOfCustomersAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfCustomersDomain_1236" xlink:to="lab_ifrs-full_TypesOfCustomersDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksAxis_1237" xlink:to="lab_ifrs-full_TypesOfRisksAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfRisksAxis_1238" xlink:to="lab_ifrs-full_TypesOfRisksAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_1239" xlink:to="lab_ifrs-full_UnconsolidatedStructuredEntitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_1240" xlink:to="lab_ifrs-full_UnconsolidatedStructuredEntitiesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis_1241" xlink:to="lab_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_1242" xlink:to="lab_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_1243" xlink:to="lab_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_VehiclesMember_1244" xlink:to="lab_ifrs-full_VehiclesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WagesAndSalaries_1245" xlink:to="lab_ifrs-full_WagesAndSalaries_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WarrantReserveMember_1246" xlink:to="lab_ifrs-full_WarrantReserveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WarrantyProvision_1247" xlink:to="lab_ifrs-full_WarrantyProvision_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1248" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1249" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1250" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1251" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_1252" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_1253" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1254" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1255" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_1256" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1257" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1258" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_1259" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_1260" xlink:to="lab_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_1261" xlink:to="lab_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1262" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1263" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePrice2019_1264" xlink:to="lab_ifrs-full_WeightedAverageSharePrice2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_1265" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_1266" xlink:to="lab_ifrs-full_WeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_1267" xlink:to="lab_ifrs-full_WeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_1268" xlink:to="lab_ifrs-full_WeightedAverageShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WorkInProgress_1269" xlink:to="lab_ifrs-full_WorkInProgress_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_1270" xlink:to="lab_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis_1271" xlink:to="lab_srt_CounterpartyNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis_1272" xlink:to="lab_srt_CurrencyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis_1273" xlink:to="lab_srt_CurrencyAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember_1274" xlink:to="lab_srt_EuropeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis_1275" xlink:to="lab_srt_MajorCustomersAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis_1276" xlink:to="lab_srt_MajorCustomersAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_1277" xlink:to="lab_srt_MaximumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_1278" xlink:to="lab_srt_MinimumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_1279" xlink:to="lab_srt_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_1280" xlink:to="lab_srt_RangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1281" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccountingEstimatesAndJudgementsAbstract_1282" xlink:to="lab_trib_AccountingEstimatesAndJudgementsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccretionInterestAccrued_1283" xlink:to="lab_trib_AccretionInterestAccrued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccretionInterestAccrued_1284" xlink:to="lab_trib_AccretionInterestAccrued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccretionInterestAccrued_1285" xlink:to="lab_trib_AccretionInterestAccrued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccretionInterestAdjustment_1286" xlink:to="lab_trib_AccretionInterestAdjustment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccretionInterestAdjustment_1287" xlink:to="lab_trib_AccretionInterestAdjustment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccretionInterestAdjustment_1288" xlink:to="lab_trib_AccretionInterestAdjustment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccretionInterestOnBorrowings_1289" xlink:to="lab_trib_AccretionInterestOnBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccretionInterestOnBorrowings_1290" xlink:to="lab_trib_AccretionInterestOnBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccretionInterestOnBorrowings_1291" xlink:to="lab_trib_AccretionInterestOnBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccretionInterestOnBorrowings_1292" xlink:to="lab_trib_AccretionInterestOnBorrowings_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccretionInterestOnBorrowings_1293" xlink:to="lab_trib_AccretionInterestOnBorrowings_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccruedBonus_1294" xlink:to="lab_trib_AccruedBonus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccruedBonus_1295" xlink:to="lab_trib_AccruedBonus_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccruedInterestOnNotes_1296" xlink:to="lab_trib_AccruedInterestOnNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccruedInterestOnNotes_1297" xlink:to="lab_trib_AccruedInterestOnNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccruedLiabilitiesToContractedLicencePayments_1298" xlink:to="lab_trib_AccruedLiabilitiesToContractedLicencePayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccruedLiabilitiesToContractedLicencePayments_1299" xlink:to="lab_trib_AccruedLiabilitiesToContractedLicencePayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccruedLiabilitiesToContractedLicencePayments_1300" xlink:to="lab_trib_AccruedLiabilitiesToContractedLicencePayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccruedLiabilitiesToContractedLicencePayments_1301" xlink:to="lab_trib_AccruedLiabilitiesToContractedLicencePayments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccruedLiabilitiesToContractedLicencePayments_1302" xlink:to="lab_trib_AccruedLiabilitiesToContractedLicencePayments_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccruedLiability_1303" xlink:to="lab_trib_AccruedLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccruedLiability_1304" xlink:to="lab_trib_AccruedLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_1305" xlink:to="lab_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_1306" xlink:to="lab_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_1307" xlink:to="lab_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AcquisitionConsideration_1308" xlink:to="lab_trib_AcquisitionConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AcquisitionConsideration_1309" xlink:to="lab_trib_AcquisitionConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ActuarialAssumptionOfDiscountRatePercentage_1310" xlink:to="lab_trib_ActuarialAssumptionOfDiscountRatePercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ActuarialAssumptionOfDiscountRatePercentage_1311" xlink:to="lab_trib_ActuarialAssumptionOfDiscountRatePercentage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ActuarialAssumptionOfDiscountRatePercentage_1312" xlink:to="lab_trib_ActuarialAssumptionOfDiscountRatePercentage_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ActuarialAssumptionOfExpectedPensionIncreases_1313" xlink:to="lab_trib_ActuarialAssumptionOfExpectedPensionIncreases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ActuarialAssumptionOfExpectedPensionIncreases_1314" xlink:to="lab_trib_ActuarialAssumptionOfExpectedPensionIncreases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ActuarialAssumptionOfExpectedPensionIncreases_1315" xlink:to="lab_trib_ActuarialAssumptionOfExpectedPensionIncreases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_1316" xlink:to="lab_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_1317" xlink:to="lab_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_1318" xlink:to="lab_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalFunding_1319" xlink:to="lab_trib_AdditionalFunding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalFunding_1320" xlink:to="lab_trib_AdditionalFunding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalImpairmentLoss_1321" xlink:to="lab_trib_AdditionalImpairmentLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalImpairmentLoss_1322" xlink:to="lab_trib_AdditionalImpairmentLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalImpairmentLossDueToGrowthInRevenues_1323" xlink:to="lab_trib_AdditionalImpairmentLossDueToGrowthInRevenues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalImpairmentLossDueToGrowthInRevenues_1324" xlink:to="lab_trib_AdditionalImpairmentLossDueToGrowthInRevenues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs_1325" xlink:to="lab_trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs_1326" xlink:to="lab_trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs_1327" xlink:to="lab_trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalLiquidity_1328" xlink:to="lab_trib_AdditionalLiquidity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalLiquidity_1329" xlink:to="lab_trib_AdditionalLiquidity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_1330" xlink:to="lab_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_1331" xlink:to="lab_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_1332" xlink:to="lab_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalProjectCost_1333" xlink:to="lab_trib_AdditionalProjectCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalProjectCost_1334" xlink:to="lab_trib_AdditionalProjectCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalRestructuringCosts_1335" xlink:to="lab_trib_AdditionalRestructuringCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalRestructuringCosts_1336" xlink:to="lab_trib_AdditionalRestructuringCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalRestructuringCosts_1337" xlink:to="lab_trib_AdditionalRestructuringCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalSpaceMember_1338" xlink:to="lab_trib_AdditionalSpaceMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionalSpaceMember_1339" xlink:to="lab_trib_AdditionalSpaceMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionsRelatedToRightOfUseAssets_1340" xlink:to="lab_trib_AdditionsRelatedToRightOfUseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdditionsRelatedToRightOfUseAssets_1341" xlink:to="lab_trib_AdditionsRelatedToRightOfUseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustedLossProfitAfterTax_1342" xlink:to="lab_trib_AdjustedLossProfitAfterTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustedLossProfitAfterTax_1343" xlink:to="lab_trib_AdjustedLossProfitAfterTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustedLossProfitAfterTax_1344" xlink:to="lab_trib_AdjustedLossProfitAfterTax_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustedLossProfitAfterTax_1345" xlink:to="lab_trib_AdjustedLossProfitAfterTax_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustedProfitAfterTax_1346" xlink:to="lab_trib_AdjustedProfitAfterTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustedProfitAfterTax_1347" xlink:to="lab_trib_AdjustedProfitAfterTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustedProfitAfterTax_1348" xlink:to="lab_trib_AdjustedProfitAfterTax_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_1349" xlink:to="lab_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_1350" xlink:to="lab_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_1351" xlink:to="lab_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentForRestructuringProvision_1352" xlink:to="lab_trib_AdjustmentForRestructuringProvision_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentForRestructuringProvision_1353" xlink:to="lab_trib_AdjustmentForRestructuringProvision_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentForRestructuringProvision_1354" xlink:to="lab_trib_AdjustmentForRestructuringProvision_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentOnTransitionToIFRS16_1355" xlink:to="lab_trib_AdjustmentOnTransitionToIFRS16_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentOnTransitionToIFRS16_1356" xlink:to="lab_trib_AdjustmentOnTransitionToIFRS16_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentOnTransitionToIFRS16_1357" xlink:to="lab_trib_AdjustmentOnTransitionToIFRS16_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentOnTransitionToIFRS16_1358" xlink:to="lab_trib_AdjustmentOnTransitionToIFRS16_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_1359" xlink:to="lab_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_1360" xlink:to="lab_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_1361" xlink:to="lab_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_1362" xlink:to="lab_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_1363" xlink:to="lab_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_1364" xlink:to="lab_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentsForGainLossOnSaleOfBusiness_1365" xlink:to="lab_trib_AdjustmentsForGainLossOnSaleOfBusiness_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentsForGainLossOnSaleOfBusiness_1366" xlink:to="lab_trib_AdjustmentsForGainLossOnSaleOfBusiness_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentsForGainLossOnSaleOfBusiness_1367" xlink:to="lab_trib_AdjustmentsForGainLossOnSaleOfBusiness_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentsForGainLossOnSaleOfBusiness_1368" xlink:to="lab_trib_AdjustmentsForGainLossOnSaleOfBusiness_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentsForIncomeTaxExpenseCredit_1369" xlink:to="lab_trib_AdjustmentsForIncomeTaxExpenseCredit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentsForIncomeTaxExpenseCredit_1370" xlink:to="lab_trib_AdjustmentsForIncomeTaxExpenseCredit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentsForIncomeTaxExpenseCredit_1371" xlink:to="lab_trib_AdjustmentsForIncomeTaxExpenseCredit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentsForIncomeTaxExpenseCredit_1372" xlink:to="lab_trib_AdjustmentsForIncomeTaxExpenseCredit_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentsForInventoryWriteOff_1373" xlink:to="lab_trib_AdjustmentsForInventoryWriteOff_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentsForInventoryWriteOff_1374" xlink:to="lab_trib_AdjustmentsForInventoryWriteOff_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdjustmentsForInventoryWriteOff_1375" xlink:to="lab_trib_AdjustmentsForInventoryWriteOff_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdministrationAndSalesMember_1376" xlink:to="lab_trib_AdministrationAndSalesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdministrationAndSalesMember_1377" xlink:to="lab_trib_AdministrationAndSalesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdoptionOfIfrs16_1378" xlink:to="lab_trib_AdoptionOfIfrs16_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdoptionOfIfrs16_1379" xlink:to="lab_trib_AdoptionOfIfrs16_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdoptionOfIfrs16_1380" xlink:to="lab_trib_AdoptionOfIfrs16_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdsRatioChangeMember_1381" xlink:to="lab_trib_AdsRatioChangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdsRatioChangeMember_1382" xlink:to="lab_trib_AdsRatioChangeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AdsRatioChangeMember_1383" xlink:to="lab_trib_AdsRatioChangeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AgreementPayments_1384" xlink:to="lab_trib_AgreementPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AgreementPayments_1385" xlink:to="lab_trib_AgreementPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AgreementTerm_1386" xlink:to="lab_trib_AgreementTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AgreementTerm_1387" xlink:to="lab_trib_AgreementTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AgreementTerm_1388" xlink:to="lab_trib_AgreementTerm_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AllowanceForImpairmentOfReceivables_1389" xlink:to="lab_trib_AllowanceForImpairmentOfReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AllowanceForImpairmentOfReceivables_1390" xlink:to="lab_trib_AllowanceForImpairmentOfReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AllowanceForImpairmentOfReceivables_1391" xlink:to="lab_trib_AllowanceForImpairmentOfReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AllowanceForImpairmentOfReceivables_1392" xlink:to="lab_trib_AllowanceForImpairmentOfReceivables_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AllowanceForImpairmentOfReceivables_1393" xlink:to="lab_trib_AllowanceForImpairmentOfReceivables_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AllowanceForImpairmentOfReceivables_1394" xlink:to="lab_trib_AllowanceForImpairmentOfReceivables_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AllowanceRepresentsGroupRevenues_1395" xlink:to="lab_trib_AllowanceRepresentsGroupRevenues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AllowanceRepresentsGroupRevenues_1396" xlink:to="lab_trib_AllowanceRepresentsGroupRevenues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AllowanceRepresentsGroupRevenues_1397" xlink:to="lab_trib_AllowanceRepresentsGroupRevenues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AlternativeMinimumTaxCreditMember_1398" xlink:to="lab_trib_AlternativeMinimumTaxCreditMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmendedCreditAgreementMember_1399" xlink:to="lab_trib_AmendedCreditAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmendedCreditAgreementMember_1400" xlink:to="lab_trib_AmendedCreditAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmendmentAndRestatementOfTermLoanMember_1401" xlink:to="lab_trib_AmendmentAndRestatementOfTermLoanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmendmentAndRestatementOfTermLoanMember_1402" xlink:to="lab_trib_AmendmentAndRestatementOfTermLoanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmendmentAndRestatementOfTermLoanMember_1403" xlink:to="lab_trib_AmendmentAndRestatementOfTermLoanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericaMember_1404" xlink:to="lab_trib_AmericaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericaMember_1405" xlink:to="lab_trib_AmericaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericaMember_1406" xlink:to="lab_trib_AmericaMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericaMember_1407" xlink:to="lab_trib_AmericaMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositaryShareMember_1408" xlink:to="lab_trib_AmericanDepositaryShareMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositaryShareMember_1409" xlink:to="lab_trib_AmericanDepositaryShareMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositarySharesMember_1410" xlink:to="lab_trib_AmericanDepositarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositaryShareTreasurySharesMember_1411" xlink:to="lab_trib_AmericanDepositaryShareTreasurySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositaryShareTreasurySharesMember_1412" xlink:to="lab_trib_AmericanDepositaryShareTreasurySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositaryShareTreasurySharesMember_1413" xlink:to="lab_trib_AmericanDepositaryShareTreasurySharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositoryShares_1414" xlink:to="lab_trib_AmericanDepositoryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositoryShares_1415" xlink:to="lab_trib_AmericanDepositoryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositoryShares_1416" xlink:to="lab_trib_AmericanDepositoryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositoryShares_1417" xlink:to="lab_trib_AmericanDepositoryShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositoryShares_1418" xlink:to="lab_trib_AmericanDepositoryShares_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositoryShares_1419" xlink:to="lab_trib_AmericanDepositoryShares_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositoryShares_1420" xlink:to="lab_trib_AmericanDepositoryShares_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositoryShares_1421" xlink:to="lab_trib_AmericanDepositoryShares_7"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositorySharesIssued_1422" xlink:to="lab_trib_AmericanDepositorySharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositorySharesIssued_1423" xlink:to="lab_trib_AmericanDepositorySharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmericanDepositorySharesIssued_1424" xlink:to="lab_trib_AmericanDepositorySharesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmortisationForDiscontinuedOperations_1425" xlink:to="lab_trib_AmortisationForDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmortisationForDiscontinuedOperations_1426" xlink:to="lab_trib_AmortisationForDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmortisationForDiscontinuedOperations_1427" xlink:to="lab_trib_AmortisationForDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmortisationForDiscontinuedOperations_1428" xlink:to="lab_trib_AmortisationForDiscontinuedOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmortisationOnIntangibleAssets_1429" xlink:to="lab_trib_AmortisationOnIntangibleAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmortisationOnIntangibleAssets_1430" xlink:to="lab_trib_AmortisationOnIntangibleAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmortisationOnIntangibleAssets_1431" xlink:to="lab_trib_AmortisationOnIntangibleAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmountAvailableForDevelopmentOfTheCGM_1432" xlink:to="lab_trib_AmountAvailableForDevelopmentOfTheCGM_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmountAvailableForDevelopmentOfTheCGM_1433" xlink:to="lab_trib_AmountAvailableForDevelopmentOfTheCGM_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmountAvailableForDevelopmentOfTheCGM_1434" xlink:to="lab_trib_AmountAvailableForDevelopmentOfTheCGM_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmountPaidInRespectOfLeaseLiabilities_1435" xlink:to="lab_trib_AmountPaidInRespectOfLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmountPaidInRespectOfLeaseLiabilities_1436" xlink:to="lab_trib_AmountPaidInRespectOfLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmountPaidInRespectOfLeaseLiabilities_1437" xlink:to="lab_trib_AmountPaidInRespectOfLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmountReceivedFromProviderReliefFund_1438" xlink:to="lab_trib_AmountReceivedFromProviderReliefFund_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmountReceivedFromProviderReliefFund_1439" xlink:to="lab_trib_AmountReceivedFromProviderReliefFund_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmountUsedToAcquireTheCGMAssets_1440" xlink:to="lab_trib_AmountUsedToAcquireTheCGMAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmountUsedToAcquireTheCGMAssets_1441" xlink:to="lab_trib_AmountUsedToAcquireTheCGMAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AmountUsedToAcquireTheCGMAssets_1442" xlink:to="lab_trib_AmountUsedToAcquireTheCGMAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AnnualBorrowingBaseRate_1443" xlink:to="lab_trib_AnnualBorrowingBaseRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AnnualBorrowingBaseRate_1444" xlink:to="lab_trib_AnnualBorrowingBaseRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AnnualBorrowingBaseRate_1445" xlink:to="lab_trib_AnnualBorrowingBaseRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AnnualRentIncreased_1446" xlink:to="lab_trib_AnnualRentIncreased_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AnnualRentIncreased_1447" xlink:to="lab_trib_AnnualRentIncreased_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AnnualRentPayable_1448" xlink:to="lab_trib_AnnualRentPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AnnualRentPayable_1449" xlink:to="lab_trib_AnnualRentPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AnnualRentPayableForWareHouse_1450" xlink:to="lab_trib_AnnualRentPayableForWareHouse_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AnnualRentPayableForWareHouse_1451" xlink:to="lab_trib_AnnualRentPayableForWareHouse_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AntigenProjectsMember_1452" xlink:to="lab_trib_AntigenProjectsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AsiaOrAfricaMember_1453" xlink:to="lab_trib_AsiaOrAfricaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AsiaOrAfricaMember_1454" xlink:to="lab_trib_AsiaOrAfricaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AsiaOrAfricaMember_1455" xlink:to="lab_trib_AsiaOrAfricaMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_1456" xlink:to="lab_trib_AssetsAndLiabilitiesBySegmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_1457" xlink:to="lab_trib_AssetsAndLiabilitiesBySegmentAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AssetsUnderDevelopmentCarryingValue_1458" xlink:to="lab_trib_AssetsUnderDevelopmentCarryingValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AssetsUnderDevelopmentCarryingValue_1459" xlink:to="lab_trib_AssetsUnderDevelopmentCarryingValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AssetsUnderDevelopmentCarryingValue_1460" xlink:to="lab_trib_AssetsUnderDevelopmentCarryingValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AutoimmuneFdaRegistrationsMember_1461" xlink:to="lab_trib_AutoimmuneFdaRegistrationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AutoimmuneSmartReaderMember_1462" xlink:to="lab_trib_AutoimmuneSmartReaderMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AutoimmuneSmartReaderMember_1463" xlink:to="lab_trib_AutoimmuneSmartReaderMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AutoimmuneSmartReaderMember_1464" xlink:to="lab_trib_AutoimmuneSmartReaderMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_1465" xlink:to="lab_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_1466" xlink:to="lab_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_1467" xlink:to="lab_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AverageRemainingLeaseTermYears_1468" xlink:to="lab_trib_AverageRemainingLeaseTermYears_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AverageRemainingLeaseTermYears_1469" xlink:to="lab_trib_AverageRemainingLeaseTermYears_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AverageSharePriceShareOptionsExercised_1470" xlink:to="lab_trib_AverageSharePriceShareOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AverageSharePriceShareOptionsExercised_1471" xlink:to="lab_trib_AverageSharePriceShareOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_AverageSharePriceShareOptionsExercised_1472" xlink:to="lab_trib_AverageSharePriceShareOptionsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BasisOfPreparationAndSignificantAccountingPoliciesLineItems_1473" xlink:to="lab_trib_BasisOfPreparationAndSignificantAccountingPoliciesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BasisOfPreparationAndSignificantAccountingPoliciesLineItems_1474" xlink:to="lab_trib_BasisOfPreparationAndSignificantAccountingPoliciesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BasisOfPreparationAndSignificantAccountingPoliciesTable_1475" xlink:to="lab_trib_BasisOfPreparationAndSignificantAccountingPoliciesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BasisOfPreparationAndSignificantAccountingPoliciesTable_1476" xlink:to="lab_trib_BasisOfPreparationAndSignificantAccountingPoliciesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BenenTradingLimitedMember_1477" xlink:to="lab_trib_BenenTradingLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BenenTradingLimitedMember_1478" xlink:to="lab_trib_BenenTradingLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BiopoolUsIncMember_1479" xlink:to="lab_trib_BiopoolUsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BiopoolUsIncMember_1480" xlink:to="lab_trib_BiopoolUsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BiosynthMember_1481" xlink:to="lab_trib_BiosynthMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BiosynthMember_1482" xlink:to="lab_trib_BiosynthMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BiosynthMember_1483" xlink:to="lab_trib_BiosynthMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BloodBankScreeningBusinessMember_1484" xlink:to="lab_trib_BloodBankScreeningBusinessMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BorrowingsAndDerivativeFinancialInstrumentsMember_1485" xlink:to="lab_trib_BorrowingsAndDerivativeFinancialInstrumentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BrainNatriureticPeptideMember_1486" xlink:to="lab_trib_BrainNatriureticPeptideMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BrazilMember_1487" xlink:to="lab_trib_BrazilMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BusinessacquisitionAxis_1488" xlink:to="lab_trib_BusinessacquisitionAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BusinessacquisitionAxis_1489" xlink:to="lab_trib_BusinessacquisitionAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BusinessacquisitionDomain_1490" xlink:to="lab_trib_BusinessacquisitionDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_BusinessacquisitionDomain_1491" xlink:to="lab_trib_BusinessacquisitionDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CapitalisationOfUnpaidInterestOnTermLoan_1492" xlink:to="lab_trib_CapitalisationOfUnpaidInterestOnTermLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CapitalisationOfUnpaidInterestOnTermLoan_1493" xlink:to="lab_trib_CapitalisationOfUnpaidInterestOnTermLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CapitalisationOfUnpaidInterestOnTermLoan_1494" xlink:to="lab_trib_CapitalisationOfUnpaidInterestOnTermLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CapitalisedDevelopmentCost_1495" xlink:to="lab_trib_CapitalisedDevelopmentCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CapitalisedDevelopmentCost_1496" xlink:to="lab_trib_CapitalisedDevelopmentCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CapitalisedDevelopmentCost_1497" xlink:to="lab_trib_CapitalisedDevelopmentCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CardiacAnalyserMember_1498" xlink:to="lab_trib_CardiacAnalyserMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CarryingAmountOfGoodwill_1499" xlink:to="lab_trib_CarryingAmountOfGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CarryingAmountOfGoodwill_1500" xlink:to="lab_trib_CarryingAmountOfGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAcquiredAsOfAcquisitionDate_1501" xlink:to="lab_trib_CashAcquiredAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAcquiredAsOfAcquisitionDate_1502" xlink:to="lab_trib_CashAcquiredAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAcquiredAsOfAcquisitionDate_1503" xlink:to="lab_trib_CashAcquiredAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAcquiredAsOfAcquisitionDate_1504" xlink:to="lab_trib_CashAcquiredAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAcquiredAsOfAcquisitionDate_1505" xlink:to="lab_trib_CashAcquiredAsOfAcquisitionDate_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAndCashEquivalentMember_1506" xlink:to="lab_trib_CashAndCashEquivalentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAndCashEquivalentMember_1507" xlink:to="lab_trib_CashAndCashEquivalentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAndCashEquivalentMember_1508" xlink:to="lab_trib_CashAndCashEquivalentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1509" xlink:to="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1510" xlink:to="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1511" xlink:to="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1512" xlink:to="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1513" xlink:to="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1514" xlink:to="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_1515" xlink:to="lab_trib_CashAndCashEquivalentsAndShortTermInvestments_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashInterestPayableOnPppLoans_1516" xlink:to="lab_trib_CashInterestPayableOnPppLoans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashInterestPayableOnPppLoans_1517" xlink:to="lab_trib_CashInterestPayableOnPppLoans_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashInterestPayableOnPppLoans_1518" xlink:to="lab_trib_CashInterestPayableOnPppLoans_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashInterestPayableOnSeniorSecureTermLoan_1519" xlink:to="lab_trib_CashInterestPayableOnSeniorSecureTermLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashInterestPayableOnSeniorSecureTermLoan_1520" xlink:to="lab_trib_CashInterestPayableOnSeniorSecureTermLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashInterestPayableOnSeniorSecureTermLoan_1521" xlink:to="lab_trib_CashInterestPayableOnSeniorSecureTermLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashPaidForNominalValue_1522" xlink:to="lab_trib_CashPaidForNominalValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashPaidForNominalValue_1523" xlink:to="lab_trib_CashPaidForNominalValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashPaidForNominalValue_1524" xlink:to="lab_trib_CashPaidForNominalValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashPaidToEachHolder_1525" xlink:to="lab_trib_CashPaidToEachHolder_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashPaidToEachHolder_1526" xlink:to="lab_trib_CashPaidToEachHolder_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashPaidToEachHolder_1527" xlink:to="lab_trib_CashPaidToEachHolder_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashProceedsFromDiscontinuedOperations_1528" xlink:to="lab_trib_CashProceedsFromDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashProceedsFromDiscontinuedOperations_1529" xlink:to="lab_trib_CashProceedsFromDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashProceedsFromDiscontinuedOperations_1530" xlink:to="lab_trib_CashProceedsFromDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_1531" xlink:to="lab_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_1532" xlink:to="lab_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_1533" xlink:to="lab_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashReceivedPerNominalValue_1534" xlink:to="lab_trib_CashReceivedPerNominalValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashReceivedPerNominalValue_1535" xlink:to="lab_trib_CashReceivedPerNominalValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashReceivedPerNominalValue_1536" xlink:to="lab_trib_CashReceivedPerNominalValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_1537" xlink:to="lab_trib_CashSoldAsAPartOfDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_1538" xlink:to="lab_trib_CashSoldAsAPartOfDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_1539" xlink:to="lab_trib_CashSoldAsAPartOfDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_1540" xlink:to="lab_trib_CashSoldAsAPartOfDiscontinuedOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ChangeInAllowance_1541" xlink:to="lab_trib_ChangeInAllowance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ChangeInAllowance_1542" xlink:to="lab_trib_ChangeInAllowance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClarkLaboratoriesIncMember_1543" xlink:to="lab_trib_ClarkLaboratoriesIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClarkLaboratoriesIncMember_1544" xlink:to="lab_trib_ClarkLaboratoriesIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClassAOrdinarySharesMember_1545" xlink:to="lab_trib_ClassAOrdinarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClassAOrdinarySharesMember_1546" xlink:to="lab_trib_ClassAOrdinarySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClassATreasurySharesMember_1547" xlink:to="lab_trib_ClassATreasurySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClassATreasurySharesMember_1548" xlink:to="lab_trib_ClassATreasurySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClinicalLaboratoryMember_1549" xlink:to="lab_trib_ClinicalLaboratoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClinicalLaboratoryMember_1550" xlink:to="lab_trib_ClinicalLaboratoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClinicalLaboratoryMember_1551" xlink:to="lab_trib_ClinicalLaboratoryMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClosingExercisePriceOfOutstandingShareOptions_1552" xlink:to="lab_trib_ClosingExercisePriceOfOutstandingShareOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClosingExercisePriceOfOutstandingShareOptions_1553" xlink:to="lab_trib_ClosingExercisePriceOfOutstandingShareOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClosingExercisePriceOfOutstandingShareOptions_1554" xlink:to="lab_trib_ClosingExercisePriceOfOutstandingShareOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClosureCosts_1555" xlink:to="lab_trib_ClosureCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClosureCosts_1556" xlink:to="lab_trib_ClosureCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClosureCosts_1557" xlink:to="lab_trib_ClosureCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClosureCostsMember_1558" xlink:to="lab_trib_ClosureCostsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClosureProvision_1559" xlink:to="lab_trib_ClosureProvision_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClosureProvision_1560" xlink:to="lab_trib_ClosureProvision_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClosureProvision_1561" xlink:to="lab_trib_ClosureProvision_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClosureProvision_1562" xlink:to="lab_trib_ClosureProvision_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ClosureProvision_1563" xlink:to="lab_trib_ClosureProvision_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ColumnEnhancementMember_1564" xlink:to="lab_trib_ColumnEnhancementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ColumnEnhancementMember_1565" xlink:to="lab_trib_ColumnEnhancementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ComputerEquipmentsMember_1566" xlink:to="lab_trib_ComputerEquipmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ComputerEquipmentsMember_1567" xlink:to="lab_trib_ComputerEquipmentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ComputerEquipmentsMember_1568" xlink:to="lab_trib_ComputerEquipmentsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConsiderationFromEmployeeOptionsSettledInCash_1569" xlink:to="lab_trib_ConsiderationFromEmployeeOptionsSettledInCash_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConsiderationFromEmployeeOptionsSettledInCash_1570" xlink:to="lab_trib_ConsiderationFromEmployeeOptionsSettledInCash_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConsolidatedStatementOfComprehensiveIncomeAbstract_1571" xlink:to="lab_trib_ConsolidatedStatementOfComprehensiveIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConsolidatedStatementOfComprehensiveIncomeAbstract_1572" xlink:to="lab_trib_ConsolidatedStatementOfComprehensiveIncomeAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentAssets_1573" xlink:to="lab_trib_ContingentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentAssets_1574" xlink:to="lab_trib_ContingentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentAssets_1575" xlink:to="lab_trib_ContingentAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_1576" xlink:to="lab_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_1577" xlink:to="lab_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_1578" xlink:to="lab_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_1579" xlink:to="lab_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_1580" xlink:to="lab_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_1581" xlink:to="lab_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentConsiderationNonCurrent_1582" xlink:to="lab_trib_ContingentConsiderationNonCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentConsiderationNonCurrent_1583" xlink:to="lab_trib_ContingentConsiderationNonCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentConsiderationNonCurrent_1584" xlink:to="lab_trib_ContingentConsiderationNonCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentLiabilityMember_1585" xlink:to="lab_trib_ContingentLiabilityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentLiabilityMember_1586" xlink:to="lab_trib_ContingentLiabilityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContingentLiabilityMember_1587" xlink:to="lab_trib_ContingentLiabilityMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContinuousGlucoseMonitoringTechnologyMember_1588" xlink:to="lab_trib_ContinuousGlucoseMonitoringTechnologyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContinuousGlucoseMonitoringTechnologyMember_1589" xlink:to="lab_trib_ContinuousGlucoseMonitoringTechnologyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContinuousGlucoseMonitoringTestingMember_1590" xlink:to="lab_trib_ContinuousGlucoseMonitoringTestingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContinuousGlucoseMonitoringTestingMember_1591" xlink:to="lab_trib_ContinuousGlucoseMonitoringTestingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContinuousGlucoseMonitoringTestingMember_1592" xlink:to="lab_trib_ContinuousGlucoseMonitoringTestingMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContractualCashFlowsMember_1593" xlink:to="lab_trib_ContractualCashFlowsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContractualCashFlowsMember_1594" xlink:to="lab_trib_ContractualCashFlowsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContributionAmountInSettlement_1595" xlink:to="lab_trib_ContributionAmountInSettlement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContributionAmountInSettlement_1596" xlink:to="lab_trib_ContributionAmountInSettlement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContributionForTaxAuditSettlement_1597" xlink:to="lab_trib_ContributionForTaxAuditSettlement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ContributionForTaxAuditSettlement_1598" xlink:to="lab_trib_ContributionForTaxAuditSettlement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConversionPricePerAds_1599" xlink:to="lab_trib_ConversionPricePerAds_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConversionPricePerAds_1600" xlink:to="lab_trib_ConversionPricePerAds_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConversionPricePerAds_1601" xlink:to="lab_trib_ConversionPricePerAds_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConversionRatePerAds_1602" xlink:to="lab_trib_ConversionRatePerAds_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConversionRatePerAds_1603" xlink:to="lab_trib_ConversionRatePerAds_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConvertibleNote_1604" xlink:to="lab_trib_ConvertibleNote_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConvertibleNote_1605" xlink:to="lab_trib_ConvertibleNote_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConvertibleNote_1606" xlink:to="lab_trib_ConvertibleNote_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConvertibleNote_1607" xlink:to="lab_trib_ConvertibleNote_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConvertibleNote_1608" xlink:to="lab_trib_ConvertibleNote_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConvertibleNoteInvestment_1609" xlink:to="lab_trib_ConvertibleNoteInvestment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConvertibleNoteInvestment_1610" xlink:to="lab_trib_ConvertibleNoteInvestment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConvertibleNoteMember_1611" xlink:to="lab_trib_ConvertibleNoteMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConvertibleNoteMember_1612" xlink:to="lab_trib_ConvertibleNoteMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ConvertibleNoteMember_1613" xlink:to="lab_trib_ConvertibleNoteMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CostIncurredIssueOfShares_1614" xlink:to="lab_trib_CostIncurredIssueOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CostIncurredIssueOfShares_1615" xlink:to="lab_trib_CostIncurredIssueOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_Covid19ElisaTestMember_1616" xlink:to="lab_trib_Covid19ElisaTestMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_Covid19ElisaTestMember_1617" xlink:to="lab_trib_Covid19ElisaTestMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_Covid19ElisaTestMember_1618" xlink:to="lab_trib_Covid19ElisaTestMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CovidPointOfCareRapidTestAndElisaTestMember_1619" xlink:to="lab_trib_CovidPointOfCareRapidTestAndElisaTestMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CovidTestMember_1620" xlink:to="lab_trib_CovidTestMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CovidTestMember_1621" xlink:to="lab_trib_CovidTestMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CovidTestMember_1622" xlink:to="lab_trib_CovidTestMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CraigHallumMember_1623" xlink:to="lab_trib_CraigHallumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CreditAgreementAxis_1624" xlink:to="lab_trib_CreditAgreementAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CreditAgreementAxis_1625" xlink:to="lab_trib_CreditAgreementAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CreditAgreementDomain_1626" xlink:to="lab_trib_CreditAgreementDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CreditAgreementDomain_1627" xlink:to="lab_trib_CreditAgreementDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentDerivativeLiabilities_1628" xlink:to="lab_trib_CurrentDerivativeLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentDerivativeLiabilities_1629" xlink:to="lab_trib_CurrentDerivativeLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentDerivativeLiabilities_1630" xlink:to="lab_trib_CurrentDerivativeLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentDerivativeLiabilities_1631" xlink:to="lab_trib_CurrentDerivativeLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentFinanceLeaseLiabilities_1632" xlink:to="lab_trib_CurrentFinanceLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentFinanceLeaseLiabilities_1633" xlink:to="lab_trib_CurrentFinanceLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentFinanceLeaseLiabilities_1634" xlink:to="lab_trib_CurrentFinanceLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentFinanceLeaseLiabilities_1635" xlink:to="lab_trib_CurrentFinanceLeaseLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentGovernmentLoans_1636" xlink:to="lab_trib_CurrentGovernmentLoans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentGovernmentLoans_1637" xlink:to="lab_trib_CurrentGovernmentLoans_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentGovernmentLoans_1638" xlink:to="lab_trib_CurrentGovernmentLoans_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentLeaseLiabilitiesAbstract_1639" xlink:to="lab_trib_CurrentLeaseLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentLiabilitiesMember_1640" xlink:to="lab_trib_CurrentLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentLiabilitiesMember_1641" xlink:to="lab_trib_CurrentLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentTaxForeignExpenseIncome_1642" xlink:to="lab_trib_CurrentTaxForeignExpenseIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentTaxForeignExpenseIncome_1643" xlink:to="lab_trib_CurrentTaxForeignExpenseIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CurrentTaxForeignExpenseIncome_1644" xlink:to="lab_trib_CurrentTaxForeignExpenseIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CustomerMember_1645" xlink:to="lab_trib_CustomerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_CustomerMember_1646" xlink:to="lab_trib_CustomerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DarnickCompanyMember_1647" xlink:to="lab_trib_DarnickCompanyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DarnickCompanyMember_1648" xlink:to="lab_trib_DarnickCompanyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DDimerDevelopmentMember_1649" xlink:to="lab_trib_DDimerDevelopmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DebtRefinancingMember_1650" xlink:to="lab_trib_DebtRefinancingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DebtRefinancingMember_1651" xlink:to="lab_trib_DebtRefinancingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredConsideration_1652" xlink:to="lab_trib_DeferredConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredConsideration_1653" xlink:to="lab_trib_DeferredConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredConsideration_1654" xlink:to="lab_trib_DeferredConsideration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredConsiderationPayable_1655" xlink:to="lab_trib_DeferredConsiderationPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredConsiderationPayable_1656" xlink:to="lab_trib_DeferredConsiderationPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredConsiderationPayable_1657" xlink:to="lab_trib_DeferredConsiderationPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision_1658" xlink:to="lab_trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision_1659" xlink:to="lab_trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_1660" xlink:to="lab_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_1661" xlink:to="lab_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_1662" xlink:to="lab_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsCapitalLossCarryforward_1663" xlink:to="lab_trib_DeferredTaxAssetsCapitalLossCarryforward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsCapitalLossCarryforward_1664" xlink:to="lab_trib_DeferredTaxAssetsCapitalLossCarryforward_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsCapitalLossCarryforward_1665" xlink:to="lab_trib_DeferredTaxAssetsCapitalLossCarryforward_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_1666" xlink:to="lab_trib_DeferredTaxAssetsOperatingLossCarryforward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_1667" xlink:to="lab_trib_DeferredTaxAssetsOperatingLossCarryforward_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_1668" xlink:to="lab_trib_DeferredTaxAssetsOperatingLossCarryforward_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_1669" xlink:to="lab_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_1670" xlink:to="lab_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_1671" xlink:to="lab_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossDomestic_1672" xlink:to="lab_trib_DeferredTaxAssetsOperatingLossDomestic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossDomestic_1673" xlink:to="lab_trib_DeferredTaxAssetsOperatingLossDomestic_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossDomestic_1674" xlink:to="lab_trib_DeferredTaxAssetsOperatingLossDomestic_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_1675" xlink:to="lab_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_1676" xlink:to="lab_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_1677" xlink:to="lab_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_1678" xlink:to="lab_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_1679" xlink:to="lab_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_1680" xlink:to="lab_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_1681" xlink:to="lab_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_1682" xlink:to="lab_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_1683" xlink:to="lab_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxLiabilityDecreased_1684" xlink:to="lab_trib_DeferredTaxLiabilityDecreased_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxLiabilityDecreased_1685" xlink:to="lab_trib_DeferredTaxLiabilityDecreased_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxLiabilityIncreased_1686" xlink:to="lab_trib_DeferredTaxLiabilityIncreased_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxLiabilityIncreased_1687" xlink:to="lab_trib_DeferredTaxLiabilityIncreased_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeferredTaxLiabilityIncreased_1688" xlink:to="lab_trib_DeferredTaxLiabilityIncreased_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeprecationForDiscontinuedOperations_1689" xlink:to="lab_trib_DeprecationForDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeprecationForDiscontinuedOperations_1690" xlink:to="lab_trib_DeprecationForDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeprecationForDiscontinuedOperations_1691" xlink:to="lab_trib_DeprecationForDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DeprecationForDiscontinuedOperations_1692" xlink:to="lab_trib_DeprecationForDiscontinuedOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DepreciationMember_1693" xlink:to="lab_trib_DepreciationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DepreciationMember_1694" xlink:to="lab_trib_DepreciationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DepreciationMember_1695" xlink:to="lab_trib_DepreciationMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DepreciationOnIntangibleAssets_1696" xlink:to="lab_trib_DepreciationOnIntangibleAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DepreciationOnIntangibleAssets_1697" xlink:to="lab_trib_DepreciationOnIntangibleAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DepreciationOnIntangibleAssets_1698" xlink:to="lab_trib_DepreciationOnIntangibleAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialAssetAtDateOfDrawdown_1699" xlink:to="lab_trib_DerivativeFinancialAssetAtDateOfDrawdown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialAssetAtDateOfDrawdown_1700" xlink:to="lab_trib_DerivativeFinancialAssetAtDateOfDrawdown_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialAssetAtDateOfDrawdown_1701" xlink:to="lab_trib_DerivativeFinancialAssetAtDateOfDrawdown_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialAssetAtDateOfIssue_1702" xlink:to="lab_trib_DerivativeFinancialAssetAtDateOfIssue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialAssetAtDateOfIssue_1703" xlink:to="lab_trib_DerivativeFinancialAssetAtDateOfIssue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialAssetAtDateOfIssue_1704" xlink:to="lab_trib_DerivativeFinancialAssetAtDateOfIssue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialAssetAtDateOfIssue_1705" xlink:to="lab_trib_DerivativeFinancialAssetAtDateOfIssue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialAssetAtDateOfIssue_1706" xlink:to="lab_trib_DerivativeFinancialAssetAtDateOfIssue_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialAssetMember_1707" xlink:to="lab_trib_DerivativeFinancialAssetMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialAssetMember_1708" xlink:to="lab_trib_DerivativeFinancialAssetMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialLiabilityAtDateOfDrawdown_1709" xlink:to="lab_trib_DerivativeFinancialLiabilityAtDateOfDrawdown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialLiabilityAtDateOfDrawdown_1710" xlink:to="lab_trib_DerivativeFinancialLiabilityAtDateOfDrawdown_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialLiabilityAtDateOfIssue_1711" xlink:to="lab_trib_DerivativeFinancialLiabilityAtDateOfIssue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialLiabilityAtDateOfIssue_1712" xlink:to="lab_trib_DerivativeFinancialLiabilityAtDateOfIssue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialLiabilityAtDateOfIssue_1713" xlink:to="lab_trib_DerivativeFinancialLiabilityAtDateOfIssue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialLiabilityAtDateOfIssue_1714" xlink:to="lab_trib_DerivativeFinancialLiabilityAtDateOfIssue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_1715" xlink:to="lab_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_1716" xlink:to="lab_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_1717" xlink:to="lab_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialLiabilityMember_1718" xlink:to="lab_trib_DerivativeFinancialLiabilityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialLiabilityMember_1719" xlink:to="lab_trib_DerivativeFinancialLiabilityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DerivativeFinancialLiabilityMember_1720" xlink:to="lab_trib_DerivativeFinancialLiabilityMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_1721" xlink:to="lab_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_1722" xlink:to="lab_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_1723" xlink:to="lab_trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_1724" xlink:to="lab_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_1725" xlink:to="lab_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_1726" xlink:to="lab_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_1727" xlink:to="lab_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_1728" xlink:to="lab_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_1729" xlink:to="lab_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_1730" xlink:to="lab_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_1731" xlink:to="lab_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_1732" xlink:to="lab_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_1733" xlink:to="lab_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_1734" xlink:to="lab_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_1735" xlink:to="lab_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_1736" xlink:to="lab_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_1737" xlink:to="lab_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_1738" xlink:to="lab_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_1739" xlink:to="lab_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_1740" xlink:to="lab_trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_1741" xlink:to="lab_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_1742" xlink:to="lab_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_1743" xlink:to="lab_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_1744" xlink:to="lab_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_1745" xlink:to="lab_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_1746" xlink:to="lab_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfBorrowingsPaid_1747" xlink:to="lab_trib_DescriptionOfBorrowingsPaid_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfBorrowingsPaid_1748" xlink:to="lab_trib_DescriptionOfBorrowingsPaid_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfBorrowingsPaid_1749" xlink:to="lab_trib_DescriptionOfBorrowingsPaid_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfCumulativeRevenuesPayable_1750" xlink:to="lab_trib_DescriptionOfCumulativeRevenuesPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfCumulativeRevenuesPayable_1751" xlink:to="lab_trib_DescriptionOfCumulativeRevenuesPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfCumulativeRevenuesPayable_1752" xlink:to="lab_trib_DescriptionOfCumulativeRevenuesPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfShareAdjustedRatio_1753" xlink:to="lab_trib_DescriptionOfShareAdjustedRatio_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfShareAdjustedRatio_1754" xlink:to="lab_trib_DescriptionOfShareAdjustedRatio_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DescriptionOfShareAdjustedRatio_1755" xlink:to="lab_trib_DescriptionOfShareAdjustedRatio_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DevelopmentCostMember_1756" xlink:to="lab_trib_DevelopmentCostMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DevelopmentCostMember_1757" xlink:to="lab_trib_DevelopmentCostMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DevelopmentCostsMember_1758" xlink:to="lab_trib_DevelopmentCostsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DevelopmentCostsMember_1759" xlink:to="lab_trib_DevelopmentCostsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DirectorPensionExpense_1760" xlink:to="lab_trib_DirectorPensionExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DirectorPensionExpense_1761" xlink:to="lab_trib_DirectorPensionExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DirectorPensionExpense_1762" xlink:to="lab_trib_DirectorPensionExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DirectorsAndCompanySecretaryMember_1763" xlink:to="lab_trib_DirectorsAndCompanySecretaryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DirectorsAndCompanySecretaryMember_1764" xlink:to="lab_trib_DirectorsAndCompanySecretaryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DirectorsAndCompanySecretaryMember_1765" xlink:to="lab_trib_DirectorsAndCompanySecretaryMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract_1766" xlink:to="lab_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract_1767" xlink:to="lab_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DirectorsMember_1768" xlink:to="lab_trib_DirectorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DirectorsMember_1769" xlink:to="lab_trib_DirectorsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DirectorsMember_1770" xlink:to="lab_trib_DirectorsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfAccountingEstimatesAndJudgementsAbstract_1771" xlink:to="lab_trib_DisclosureOfAccountingEstimatesAndJudgementsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_1772" xlink:to="lab_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_1773" xlink:to="lab_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1774" xlink:to="lab_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1775" xlink:to="lab_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_1776" xlink:to="lab_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_1777" xlink:to="lab_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_1778" xlink:to="lab_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfAuthorisationForIssueAbstract_1779" xlink:to="lab_trib_DisclosureOfAuthorisationForIssueAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfAuthorisationForIssueExplanatory_1780" xlink:to="lab_trib_DisclosureOfAuthorisationForIssueExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfAuthorisationForIssueExplanatory_1781" xlink:to="lab_trib_DisclosureOfAuthorisationForIssueExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfAuthorisationForIssueExplanatory_1782" xlink:to="lab_trib_DisclosureOfAuthorisationForIssueExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_1783" xlink:to="lab_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_1784" xlink:to="lab_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_1785" xlink:to="lab_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_1786" xlink:to="lab_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_1787" xlink:to="lab_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_1788" xlink:to="lab_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_1789" xlink:to="lab_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_1790" xlink:to="lab_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfCompositionOfGroupLineItems_1791" xlink:to="lab_trib_DisclosureOfCompositionOfGroupLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfCompositionOfGroupLineItems_1792" xlink:to="lab_trib_DisclosureOfCompositionOfGroupLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfCompositionOfGroupTable_1793" xlink:to="lab_trib_DisclosureOfCompositionOfGroupTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfCompositionOfGroupTable_1794" xlink:to="lab_trib_DisclosureOfCompositionOfGroupTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_1795" xlink:to="lab_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_1796" xlink:to="lab_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_1797" xlink:to="lab_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_1798" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_1799" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_1800" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_1801" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_1802" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_1803" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_1804" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_1805" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_1806" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_1807" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_1808" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_1809" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_1810" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_1811" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_1812" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory_1813" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory_1814" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory_1815" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_1816" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_1817" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_1818" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1819" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1820" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_1821" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_1822" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_1823" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_1824" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_1825" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_1826" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_1827" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_1828" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_1829" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_1830" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1831" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1832" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_1833" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_1834" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_1835" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_1836" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_1837" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_1838" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_1839" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_1840" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_1841" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_1842" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_1843" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_1844" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_1845" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_1846" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_1847" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_1848" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_1849" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_1850" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_1851" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_1852" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_1853" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_1854" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory_1855" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory_1856" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory_1857" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_1858" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_1859" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_1860" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_1861" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_1862" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_1863" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_1864" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_1865" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_1866" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutFinancialAssets_1867" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutFinancialAssets_1868" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutFinancialAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutFinancialAssets_1869" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutFinancialAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_1870" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_1871" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_1872" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_1873" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_1874" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_1875" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory_1876" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory_1877" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory_1878" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_1879" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_1880" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_1881" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory_1882" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory_1883" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory_1884" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_1885" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_1886" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_1887" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_1888" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_1889" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_1890" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_1891" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_1892" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_1893" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_1894" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_1895" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_1896" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_1897" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_1898" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_1899" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1900" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1901" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_1902" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_1903" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_1904" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_1905" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_1906" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_1907" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_1908" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory_1909" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory_1910" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory_1911" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_1912" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_1913" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_1914" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_1915" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_1916" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_1917" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_1918" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_1919" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_1920" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_1921" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_1922" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_1923" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_1924" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_1925" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_1926" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_1927" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_1928" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_1929" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_1930" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_1931" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_1932" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_1933" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_1934" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_1935" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_1936" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_1937" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_1938" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_1939" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory_1940" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory_1941" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory_1942" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_1943" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_1944" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_1945" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_1946" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_1947" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_1948" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_1949" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_1950" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_1951" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_1952" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_1953" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_1954" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_1955" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_1956" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_1957" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_1958" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_1959" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_1960" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1961" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1962" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_1963" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_1964" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_1965" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_1966" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_1967" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_1968" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_1969" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_1970" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_1971" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_1972" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_1973" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_1974" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_1975" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_1976" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_1977" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_1978" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_1979" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_1980" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_1981" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_1982" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_1983" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_1984" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_1985" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_1986" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_1987" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1988" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1989" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_1990" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_1991" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_1992" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_1993" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_1994" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_1995" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_1996" xlink:to="lab_trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDividendPaidAbstract_1997" xlink:to="lab_trib_DisclosureOfDividendPaidAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDividendPaidAbstract_1998" xlink:to="lab_trib_DisclosureOfDividendPaidAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDividendsPaidExplanatory_1999" xlink:to="lab_trib_DisclosureOfDividendsPaidExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDividendsPaidExplanatory_2000" xlink:to="lab_trib_DisclosureOfDividendsPaidExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfDividendsPaidExplanatory_2001" xlink:to="lab_trib_DisclosureOfDividendsPaidExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock_2002" xlink:to="lab_trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock_2003" xlink:to="lab_trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock_2004" xlink:to="lab_trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_2005" xlink:to="lab_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_2006" xlink:to="lab_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_2007" xlink:to="lab_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_2008" xlink:to="lab_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_2009" xlink:to="lab_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_2010" xlink:to="lab_trib_DisclosureOfFinancingIncomeExpensesNetAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_2011" xlink:to="lab_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_2012" xlink:to="lab_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_2013" xlink:to="lab_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfGroupUndertakingsAbstract_2014" xlink:to="lab_trib_DisclosureOfGroupUndertakingsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfGroupUndertakingsExplanatory_2015" xlink:to="lab_trib_DisclosureOfGroupUndertakingsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfGroupUndertakingsExplanatory_2016" xlink:to="lab_trib_DisclosureOfGroupUndertakingsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfGroupUndertakingsExplanatory_2017" xlink:to="lab_trib_DisclosureOfGroupUndertakingsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_2018" xlink:to="lab_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_2019" xlink:to="lab_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_2020" xlink:to="lab_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_2021" xlink:to="lab_trib_DisclosureOfIncomeTaxCreditAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_2022" xlink:to="lab_trib_DisclosureOfIncomeTaxCreditAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfIncomeTaxCreditAbstract_2023" xlink:to="lab_trib_DisclosureOfIncomeTaxCreditAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_2024" xlink:to="lab_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_2025" xlink:to="lab_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_2026" xlink:to="lab_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_2027" xlink:to="lab_trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_2028" xlink:to="lab_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_2029" xlink:to="lab_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_2030" xlink:to="lab_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_2031" xlink:to="lab_trib_DisclosureOfLossProfitBeforeTaxAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_2032" xlink:to="lab_trib_DisclosureOfLossProfitBeforeTaxAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxAbstract_2033" xlink:to="lab_trib_DisclosureOfLossProfitBeforeTaxAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxExplanatory_2034" xlink:to="lab_trib_DisclosureOfLossProfitBeforeTaxExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxExplanatory_2035" xlink:to="lab_trib_DisclosureOfLossProfitBeforeTaxExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfLossProfitBeforeTaxExplanatory_2036" xlink:to="lab_trib_DisclosureOfLossProfitBeforeTaxExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_2037" xlink:to="lab_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_2038" xlink:to="lab_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_2039" xlink:to="lab_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_2040" xlink:to="lab_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_2041" xlink:to="lab_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_2042" xlink:to="lab_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfOtherAssetsAbstract_2043" xlink:to="lab_trib_DisclosureOfOtherAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfOtherAssetsAbstract_2044" xlink:to="lab_trib_DisclosureOfOtherAssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_2045" xlink:to="lab_trib_DisclosureOfOtherOperatingIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_2046" xlink:to="lab_trib_DisclosureOfOtherOperatingIncomeAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfOtherOperatingIncomeAbstract_2047" xlink:to="lab_trib_DisclosureOfOtherOperatingIncomeAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfOtherPayablesDueAfterOneYearAbstract_2048" xlink:to="lab_trib_DisclosureOfOtherPayablesDueAfterOneYearAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfOtherPayablesDueAfterOneYearAbstract_2049" xlink:to="lab_trib_DisclosureOfOtherPayablesDueAfterOneYearAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory_2050" xlink:to="lab_trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory_2051" xlink:to="lab_trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory_2052" xlink:to="lab_trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfPensionSchemesAbstract_2053" xlink:to="lab_trib_DisclosureOfPensionSchemesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfPostBalanceSheetEventsAbstract_2054" xlink:to="lab_trib_DisclosureOfPostBalanceSheetEventsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_2055" xlink:to="lab_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_2056" xlink:to="lab_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_2057" xlink:to="lab_trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory_2058" xlink:to="lab_trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory_2059" xlink:to="lab_trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory_2060" xlink:to="lab_trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_2061" xlink:to="lab_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_2062" xlink:to="lab_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_2063" xlink:to="lab_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_2064" xlink:to="lab_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_2065" xlink:to="lab_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfShortTermInvestmentsAbstract_2066" xlink:to="lab_trib_DisclosureOfShortTermInvestmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfShortTermInvestmentsAbstract_2067" xlink:to="lab_trib_DisclosureOfShortTermInvestmentsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisclosureOfShortTermInvestmentsAbstract_2068" xlink:to="lab_trib_DisclosureOfShortTermInvestmentsAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DiscontinuedOperationsAxis_2069" xlink:to="lab_trib_DiscontinuedOperationsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DiscontinuedOperationsDomain_2070" xlink:to="lab_trib_DiscontinuedOperationsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DiscontinuedOperationsDomain_2071" xlink:to="lab_trib_DiscontinuedOperationsDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DiscountingLeaseLiability_2072" xlink:to="lab_trib_DiscountingLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DiscountingLeaseLiability_2073" xlink:to="lab_trib_DiscountingLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DiscountingLeaseLiability_2074" xlink:to="lab_trib_DiscountingLeaseLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisposalsGoodwillAndIntangibleAssets_2075" xlink:to="lab_trib_DisposalsGoodwillAndIntangibleAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisposalsGoodwillAndIntangibleAssets_2076" xlink:to="lab_trib_DisposalsGoodwillAndIntangibleAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisposalsGoodwillAndIntangibleAssets_2077" xlink:to="lab_trib_DisposalsGoodwillAndIntangibleAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisposalsGoodwillAndIntangibleAssets_2078" xlink:to="lab_trib_DisposalsGoodwillAndIntangibleAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisposalsOrRetirementsPropertyAndEquipment_2079" xlink:to="lab_trib_DisposalsOrRetirementsPropertyAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisposalsOrRetirementsPropertyAndEquipment_2080" xlink:to="lab_trib_DisposalsOrRetirementsPropertyAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisposalsOrRetirementsPropertyAndEquipment_2081" xlink:to="lab_trib_DisposalsOrRetirementsPropertyAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisposalsRelatedToRightOfUseAssets_2082" xlink:to="lab_trib_DisposalsRelatedToRightOfUseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisposalsRelatedToRightOfUseAssets_2083" xlink:to="lab_trib_DisposalsRelatedToRightOfUseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DisposalsRelatedToRightOfUseAssets_2084" xlink:to="lab_trib_DisposalsRelatedToRightOfUseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DistributorsMember_2085" xlink:to="lab_trib_DistributorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DistributorsMember_2086" xlink:to="lab_trib_DistributorsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DivestitureOfFitzgeraldLifeSciencesBusinessMember_2087" xlink:to="lab_trib_DivestitureOfFitzgeraldLifeSciencesBusinessMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DivestitureOfFitzgeraldLifeSciencesBusinessMember_2088" xlink:to="lab_trib_DivestitureOfFitzgeraldLifeSciencesBusinessMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_DrJimWalshMember_2089" xlink:to="lab_trib_DrJimWalshMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EarlyRepaymentPenaltyDescription_2090" xlink:to="lab_trib_EarlyRepaymentPenaltyDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EarlyRepaymentPenaltyDescription_2091" xlink:to="lab_trib_EarlyRepaymentPenaltyDescription_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EarlyRepaymentPenaltyDescription_2092" xlink:to="lab_trib_EarlyRepaymentPenaltyDescription_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_2093" xlink:to="lab_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_2094" xlink:to="lab_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_2095" xlink:to="lab_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_2096" xlink:to="lab_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_2097" xlink:to="lab_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_2098" xlink:to="lab_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EffectiveInterestRate_2099" xlink:to="lab_trib_EffectiveInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EffectiveInterestRate_2100" xlink:to="lab_trib_EffectiveInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16_2101" xlink:to="lab_trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16_2102" xlink:to="lab_trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16_2103" xlink:to="lab_trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EffectOfIrishIncomeTaxableAtHigherTaxRate_2104" xlink:to="lab_trib_EffectOfIrishIncomeTaxableAtHigherTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EffectOfIrishIncomeTaxableAtHigherTaxRate_2105" xlink:to="lab_trib_EffectOfIrishIncomeTaxableAtHigherTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EliminatedOnDisposalOfBusiness_2106" xlink:to="lab_trib_EliminatedOnDisposalOfBusiness_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EliminatedOnDisposalOfBusiness_2107" xlink:to="lab_trib_EliminatedOnDisposalOfBusiness_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EliminatedOnDisposalOfBusiness_2108" xlink:to="lab_trib_EliminatedOnDisposalOfBusiness_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EliminatedOnDisposalOfBusiness_2109" xlink:to="lab_trib_EliminatedOnDisposalOfBusiness_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EliminatedOnDisposalsOfBusiness_2110" xlink:to="lab_trib_EliminatedOnDisposalsOfBusiness_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EliminatedOnDisposalsOfBusiness_2111" xlink:to="lab_trib_EliminatedOnDisposalsOfBusiness_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EliminatedOnDisposalsOfBusiness_2112" xlink:to="lab_trib_EliminatedOnDisposalsOfBusiness_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EmployeeRelatedSocialInsurance_2113" xlink:to="lab_trib_EmployeeRelatedSocialInsurance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EmployeeRelatedSocialInsurance_2114" xlink:to="lab_trib_EmployeeRelatedSocialInsurance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EndUserCustomersMember_2115" xlink:to="lab_trib_EndUserCustomersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EndUserCustomersMember_2116" xlink:to="lab_trib_EndUserCustomersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EnhancedTphaByCmvMember_2117" xlink:to="lab_trib_EnhancedTphaByCmvMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EpiCaptureLimitedMember_2118" xlink:to="lab_trib_EpiCaptureLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EpiCaptureLimitedMember_2119" xlink:to="lab_trib_EpiCaptureLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EpiCaptureLimitedMember_2120" xlink:to="lab_trib_EpiCaptureLimitedMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentAtDateOfIssue_2121" xlink:to="lab_trib_EquityComponentAtDateOfIssue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentAtDateOfIssue_2122" xlink:to="lab_trib_EquityComponentAtDateOfIssue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentAtDateOfIssue_2123" xlink:to="lab_trib_EquityComponentAtDateOfIssue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentAtDateOfIssue_2124" xlink:to="lab_trib_EquityComponentAtDateOfIssue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentOfConvertibleNote_2125" xlink:to="lab_trib_EquityComponentOfConvertibleNote_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentOfConvertibleNote_2126" xlink:to="lab_trib_EquityComponentOfConvertibleNote_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentOfConvertibleNote_2127" xlink:to="lab_trib_EquityComponentOfConvertibleNote_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentOfConvertibleNote_2128" xlink:to="lab_trib_EquityComponentOfConvertibleNote_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_2129" xlink:to="lab_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_2130" xlink:to="lab_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_2131" xlink:to="lab_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentOfConvertibleNoteMember_2132" xlink:to="lab_trib_EquityComponentOfConvertibleNoteMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentOfConvertibleNoteMember_2133" xlink:to="lab_trib_EquityComponentOfConvertibleNoteMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EquityComponentOfConvertibleNoteMember_2134" xlink:to="lab_trib_EquityComponentOfConvertibleNoteMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EstimatedObligations_2135" xlink:to="lab_trib_EstimatedObligations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EstimatedObligations_2136" xlink:to="lab_trib_EstimatedObligations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EuropeIncludingIrelandMember_2137" xlink:to="lab_trib_EuropeIncludingIrelandMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EuropeIncludingIrelandMember_2138" xlink:to="lab_trib_EuropeIncludingIrelandMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EuropeIncludingIrelandMember_2139" xlink:to="lab_trib_EuropeIncludingIrelandMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EuroZoneCountriesMember_2140" xlink:to="lab_trib_EuroZoneCountriesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EuroZoneCountriesMember_2141" xlink:to="lab_trib_EuroZoneCountriesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EventsAfterReportingPeriodMember_2142" xlink:to="lab_trib_EventsAfterReportingPeriodMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_EventsAfterReportingPeriodMember_2143" xlink:to="lab_trib_EventsAfterReportingPeriodMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_2144" xlink:to="lab_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_2145" xlink:to="lab_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_2146" xlink:to="lab_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNoteBondPutOption_2147" xlink:to="lab_trib_ExchangeableNoteBondPutOption_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNoteBondPutOption_2148" xlink:to="lab_trib_ExchangeableNoteBondPutOption_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNoteEquityConversionOption_2149" xlink:to="lab_trib_ExchangeableNoteEquityConversionOption_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNoteEquityConversionOption_2150" xlink:to="lab_trib_ExchangeableNoteEquityConversionOption_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNoteEquityConversionOption_2151" xlink:to="lab_trib_ExchangeableNoteEquityConversionOption_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNoteInterest_2152" xlink:to="lab_trib_ExchangeableNoteInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNoteInterest_2153" xlink:to="lab_trib_ExchangeableNoteInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNoteMember_2154" xlink:to="lab_trib_ExchangeableNoteMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNoteMember_2155" xlink:to="lab_trib_ExchangeableNoteMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowings_2156" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowings_2157" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowings_2158" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_2159" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_2160" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_2161" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_2162" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsCurrent_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_2163" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsCurrent_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2164" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2165" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2166" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2167" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2168" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2169" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2170" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2171" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_7"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_2172" xlink:to="lab_trib_ExchangeableNotesAndOtherBorrowingsNonCurrent_8"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesDiscountRate_2173" xlink:to="lab_trib_ExchangeableNotesDiscountRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesDiscountRate_2174" xlink:to="lab_trib_ExchangeableNotesDiscountRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableNotesDiscountRate_2175" xlink:to="lab_trib_ExchangeableNotesDiscountRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableSeniorNotesMember_2176" xlink:to="lab_trib_ExchangeableSeniorNotesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeableSeniorNotesMember_2177" xlink:to="lab_trib_ExchangeableSeniorNotesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeRatePricePerAds_2178" xlink:to="lab_trib_ExchangeRatePricePerAds_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExchangeRatePricePerAds_2179" xlink:to="lab_trib_ExchangeRatePricePerAds_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExercisableAbstract_2180" xlink:to="lab_trib_ExercisableAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExercisableAbstract_2181" xlink:to="lab_trib_ExercisableAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExerciseOfShareOptionsReceivable_2182" xlink:to="lab_trib_ExerciseOfShareOptionsReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExerciseOfShareOptionsReceivable_2183" xlink:to="lab_trib_ExerciseOfShareOptionsReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExercisePriceOfWarrantsOrRights_2184" xlink:to="lab_trib_ExercisePriceOfWarrantsOrRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExercisePriceOfWarrantsOrRights_2185" xlink:to="lab_trib_ExercisePriceOfWarrantsOrRights_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExercisePriceOfWarrantsOrRights_2186" xlink:to="lab_trib_ExercisePriceOfWarrantsOrRights_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExercisePricePerADS_2187" xlink:to="lab_trib_ExercisePricePerADS_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExercisePricePerADS_2188" xlink:to="lab_trib_ExercisePricePerADS_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExercisePricePerADS_2189" xlink:to="lab_trib_ExercisePricePerADS_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExpenseOfRestructuringCost_2190" xlink:to="lab_trib_ExpenseOfRestructuringCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExpenseOfRestructuringCost_2191" xlink:to="lab_trib_ExpenseOfRestructuringCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExpenseOfRestructuringCost_2192" xlink:to="lab_trib_ExpenseOfRestructuringCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExtinguishmentOfAmountOwed_2193" xlink:to="lab_trib_ExtinguishmentOfAmountOwed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExtinguishmentOfAmountOwed_2194" xlink:to="lab_trib_ExtinguishmentOfAmountOwed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExtinguishmentOfAmountOwed_2195" xlink:to="lab_trib_ExtinguishmentOfAmountOwed_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExtinguishmentOfDebtAmounts_2196" xlink:to="lab_trib_ExtinguishmentOfDebtAmounts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExtinguishmentOfDebtAmounts_2197" xlink:to="lab_trib_ExtinguishmentOfDebtAmounts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ExtinguishmentOfDebtAmounts_2198" xlink:to="lab_trib_ExtinguishmentOfDebtAmounts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueMember_2199" xlink:to="lab_trib_FairValueMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueMember_2200" xlink:to="lab_trib_FairValueMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_2201" xlink:to="lab_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_2202" xlink:to="lab_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_2203" xlink:to="lab_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfDerivativeFinancialAsset_2204" xlink:to="lab_trib_FairValueOfDerivativeFinancialAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfDerivativeFinancialAsset_2205" xlink:to="lab_trib_FairValueOfDerivativeFinancialAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfDerivativeFinancialAsset_2206" xlink:to="lab_trib_FairValueOfDerivativeFinancialAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfDerivativeFinancialLiability_2207" xlink:to="lab_trib_FairValueOfDerivativeFinancialLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfDerivativeFinancialLiability_2208" xlink:to="lab_trib_FairValueOfDerivativeFinancialLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfDerivativeFinancialLiability_2209" xlink:to="lab_trib_FairValueOfDerivativeFinancialLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfFinancialAssetsLiabilities_2210" xlink:to="lab_trib_FairValueOfFinancialAssetsLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfFinancialAssetsLiabilities_2211" xlink:to="lab_trib_FairValueOfFinancialAssetsLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfFinancialAssetsLiabilities_2212" xlink:to="lab_trib_FairValueOfFinancialAssetsLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfFinancialAssetsLiabilities_2213" xlink:to="lab_trib_FairValueOfFinancialAssetsLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfSharesIssued_2214" xlink:to="lab_trib_FairValueOfSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfSharesIssued_2215" xlink:to="lab_trib_FairValueOfSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueOfSharesIssued_2216" xlink:to="lab_trib_FairValueOfSharesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_2217" xlink:to="lab_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_2218" xlink:to="lab_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_2219" xlink:to="lab_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueRemeasurementForDerivativeFinancialBalances_2220" xlink:to="lab_trib_FairValueRemeasurementForDerivativeFinancialBalances_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueRemeasurementForDerivativeFinancialBalances_2221" xlink:to="lab_trib_FairValueRemeasurementForDerivativeFinancialBalances_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueRemeasurementForDerivativeFinancialBalances_2222" xlink:to="lab_trib_FairValueRemeasurementForDerivativeFinancialBalances_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueThroughProfitAndLoss_2223" xlink:to="lab_trib_FairValueThroughProfitAndLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueThroughProfitAndLoss_2224" xlink:to="lab_trib_FairValueThroughProfitAndLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueThroughProfitAndLoss_2225" xlink:to="lab_trib_FairValueThroughProfitAndLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FairValueThroughProfitAndLoss_2226" xlink:to="lab_trib_FairValueThroughProfitAndLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FederalCorporationTaxRateMember_2227" xlink:to="lab_trib_FederalCorporationTaxRateMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FifthAmendmentToCreditAgreementMember_2228" xlink:to="lab_trib_FifthAmendmentToCreditAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FifthAmendmentToCreditAgreementMember_2229" xlink:to="lab_trib_FifthAmendmentToCreditAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinanceIncomeExpenseNet_2230" xlink:to="lab_trib_FinanceIncomeExpenseNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinanceIncomeExpenseNet_2231" xlink:to="lab_trib_FinanceIncomeExpenseNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinanceIncomeExpenseNet_2232" xlink:to="lab_trib_FinanceIncomeExpenseNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinanceLeaseLiabilitiesMember_2233" xlink:to="lab_trib_FinanceLeaseLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinanceLeaseLiabilitiesMember_2234" xlink:to="lab_trib_FinanceLeaseLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinanceLeaseLiabilitiesMember_2235" xlink:to="lab_trib_FinanceLeaseLiabilitiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinanceLeaseLiabilitiesTwoMember_2236" xlink:to="lab_trib_FinanceLeaseLiabilitiesTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinanceLeaseLiabilitiesTwoMember_2237" xlink:to="lab_trib_FinanceLeaseLiabilitiesTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinanceLeaseLiabilitiesTwoMember_2238" xlink:to="lab_trib_FinanceLeaseLiabilitiesTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinanceLeasePayableMember_2239" xlink:to="lab_trib_FinanceLeasePayableMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinanceLeaseReceivableMember_2240" xlink:to="lab_trib_FinanceLeaseReceivableMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinanceLeaseReceivableMember_2241" xlink:to="lab_trib_FinanceLeaseReceivableMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinanceLeaseReceivableMember_2242" xlink:to="lab_trib_FinanceLeaseReceivableMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsAdditions_2243" xlink:to="lab_trib_FinancialAssetsAdditions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsAdditions_2244" xlink:to="lab_trib_FinancialAssetsAdditions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsAdditions_2245" xlink:to="lab_trib_FinancialAssetsAdditions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsLeaseReceivables_2246" xlink:to="lab_trib_FinancialAssetsLeaseReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsLeaseReceivables_2247" xlink:to="lab_trib_FinancialAssetsLeaseReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsLeaseReceivables_2248" xlink:to="lab_trib_FinancialAssetsLeaseReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsLeaseReceivables_2249" xlink:to="lab_trib_FinancialAssetsLeaseReceivables_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsLeaseReceivables_2250" xlink:to="lab_trib_FinancialAssetsLeaseReceivables_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsLeaseReceivables_2251" xlink:to="lab_trib_FinancialAssetsLeaseReceivables_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsPolicyTextBlock_2252" xlink:to="lab_trib_FinancialAssetsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsPolicyTextBlock_2253" xlink:to="lab_trib_FinancialAssetsPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsPolicyTextBlock_2254" xlink:to="lab_trib_FinancialAssetsPolicyTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsWriteOff_2255" xlink:to="lab_trib_FinancialAssetsWriteOff_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsWriteOff_2256" xlink:to="lab_trib_FinancialAssetsWriteOff_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAssetsWriteOff_2257" xlink:to="lab_trib_FinancialAssetsWriteOff_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_2258" xlink:to="lab_trib_FinancialAtFairValueThroughProfitOrLossAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_2259" xlink:to="lab_trib_FinancialAtFairValueThroughProfitOrLossAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialIncomeAndExpensesAbstract_2260" xlink:to="lab_trib_FinancialIncomeAndExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialIncomeAndExpensesAbstract_2261" xlink:to="lab_trib_FinancialIncomeAndExpensesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialIncomeAndExpensesLineItems_2262" xlink:to="lab_trib_FinancialIncomeAndExpensesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialIncomeAndExpensesLineItems_2263" xlink:to="lab_trib_FinancialIncomeAndExpensesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialIncomeAndExpensesTable_2264" xlink:to="lab_trib_FinancialIncomeAndExpensesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialIncomeAndExpensesTable_2265" xlink:to="lab_trib_FinancialIncomeAndExpensesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue_2266" xlink:to="lab_trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue_2267" xlink:to="lab_trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue_2268" xlink:to="lab_trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancingExpensesAbstract_2269" xlink:to="lab_trib_FinancingExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancingExpensesAbstract_2270" xlink:to="lab_trib_FinancingExpensesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancingExpensesOther_2271" xlink:to="lab_trib_FinancingExpensesOther_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancingExpensesOther_2272" xlink:to="lab_trib_FinancingExpensesOther_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancingExpensesOther_2273" xlink:to="lab_trib_FinancingExpensesOther_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancingExpensesOther_2274" xlink:to="lab_trib_FinancingExpensesOther_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancingIncomeAbstract_2275" xlink:to="lab_trib_FinancingIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancingIncomeAbstract_2276" xlink:to="lab_trib_FinancingIncomeAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancingIncomeBySegment_2277" xlink:to="lab_trib_FinancingIncomeBySegment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancingIncomeBySegment_2278" xlink:to="lab_trib_FinancingIncomeBySegment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FinancingIncomeBySegment_2279" xlink:to="lab_trib_FinancingIncomeBySegment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FiomiDiagnosticsAbMember_2280" xlink:to="lab_trib_FiomiDiagnosticsAbMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FiomiDiagnosticsAbMember_2281" xlink:to="lab_trib_FiomiDiagnosticsAbMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FiomiDiagnosticsHoldingAbMember_2282" xlink:to="lab_trib_FiomiDiagnosticsHoldingAbMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FiomiDiagnosticsHoldingAbMember_2283" xlink:to="lab_trib_FiomiDiagnosticsHoldingAbMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FiomiDiagnosticsMember_2284" xlink:to="lab_trib_FiomiDiagnosticsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FiomiDiagnosticsMember_2285" xlink:to="lab_trib_FiomiDiagnosticsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FiomiDiagnosticsMember_2286" xlink:to="lab_trib_FiomiDiagnosticsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FiomiMember_2287" xlink:to="lab_trib_FiomiMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember_2288" xlink:to="lab_trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember_2289" xlink:to="lab_trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_2290" xlink:to="lab_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_2291" xlink:to="lab_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FitzgeraldIndustriesInternationalIncMember_2292" xlink:to="lab_trib_FitzgeraldIndustriesInternationalIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FitzgeraldIndustriesInternationalIncMember_2293" xlink:to="lab_trib_FitzgeraldIndustriesInternationalIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FixedRateFinancialLiabilitiesBorrowings_2294" xlink:to="lab_trib_FixedRateFinancialLiabilitiesBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FixedRateFinancialLiabilitiesBorrowings_2295" xlink:to="lab_trib_FixedRateFinancialLiabilitiesBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FixedRateFinancialLiabilitiesBorrowings_2296" xlink:to="lab_trib_FixedRateFinancialLiabilitiesBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FixedRateInstruments_2297" xlink:to="lab_trib_FixedRateInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FixedRateInstruments_2298" xlink:to="lab_trib_FixedRateInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FixedRateInstruments_2299" xlink:to="lab_trib_FixedRateInstruments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FixedRateInstruments_2300" xlink:to="lab_trib_FixedRateInstruments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FixedRateInstrumentsAbstract_2301" xlink:to="lab_trib_FixedRateInstrumentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FixedRateInstrumentsAbstract_2302" xlink:to="lab_trib_FixedRateInstrumentsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ForeignExchangeDifferencesMember_2303" xlink:to="lab_trib_ForeignExchangeDifferencesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ForgivenessOfBorrowings_2304" xlink:to="lab_trib_ForgivenessOfBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ForgivenessOfBorrowings_2305" xlink:to="lab_trib_ForgivenessOfBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ForgivenessOfBorrowings_2306" xlink:to="lab_trib_ForgivenessOfBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FourthAmendmentToCreditAgreementMember_2307" xlink:to="lab_trib_FourthAmendmentToCreditAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FourthAmendmentToCreditAgreementMember_2308" xlink:to="lab_trib_FourthAmendmentToCreditAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FutureFinanceChargeOnFinanceLeases_2309" xlink:to="lab_trib_FutureFinanceChargeOnFinanceLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FutureFinanceChargeOnFinanceLeases_2310" xlink:to="lab_trib_FutureFinanceChargeOnFinanceLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_FutureFinanceChargeOnFinanceLeases_2311" xlink:to="lab_trib_FutureFinanceChargeOnFinanceLeases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_G6PDHTestMember_2312" xlink:to="lab_trib_G6PDHTestMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_G6PDHTestMember_2313" xlink:to="lab_trib_G6PDHTestMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_G6PDHTestMember_2314" xlink:to="lab_trib_G6PDHTestMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GenesysOrResolutionColumnEnhancementMember_2315" xlink:to="lab_trib_GenesysOrResolutionColumnEnhancementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GoodwillWriteOff_2316" xlink:to="lab_trib_GoodwillWriteOff_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GoodwillWriteOff_2317" xlink:to="lab_trib_GoodwillWriteOff_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GovernmentGrantReceived_2318" xlink:to="lab_trib_GovernmentGrantReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GovernmentGrantReceived_2319" xlink:to="lab_trib_GovernmentGrantReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GovernmentLoansForgivenAmount_2320" xlink:to="lab_trib_GovernmentLoansForgivenAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GovernmentLoansForgivenAmount_2321" xlink:to="lab_trib_GovernmentLoansForgivenAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GovernmentSupportsCovid19_2322" xlink:to="lab_trib_GovernmentSupportsCovid19_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GovernmentSupportsCovid19_2323" xlink:to="lab_trib_GovernmentSupportsCovid19_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GrantContingenciesMaximumAmountPayable_2324" xlink:to="lab_trib_GrantContingenciesMaximumAmountPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GrantContingenciesMaximumAmountPayable_2325" xlink:to="lab_trib_GrantContingenciesMaximumAmountPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GrantReceivable_2326" xlink:to="lab_trib_GrantReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GrantReceivable_2327" xlink:to="lab_trib_GrantReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GrantReceivable_2328" xlink:to="lab_trib_GrantReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GreaterThanFiveYearsMember_2329" xlink:to="lab_trib_GreaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GreaterThanFiveYearsMember_2330" xlink:to="lab_trib_GreaterThanFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GreaterThanFiveYearsMember_2331" xlink:to="lab_trib_GreaterThanFiveYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GreaterThanFourMonthsMember_2332" xlink:to="lab_trib_GreaterThanFourMonthsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GreaterThanFourMonthsMember_2333" xlink:to="lab_trib_GreaterThanFourMonthsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GreaterThanFourMonthsMember_2334" xlink:to="lab_trib_GreaterThanFourMonthsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GrossIncreaseInterestIncome_2335" xlink:to="lab_trib_GrossIncreaseInterestIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GrossIncreaseInterestIncome_2336" xlink:to="lab_trib_GrossIncreaseInterestIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GrossInvestmentInFinanceLease_2337" xlink:to="lab_trib_GrossInvestmentInFinanceLease_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GrossInvestmentInFinanceLease_2338" xlink:to="lab_trib_GrossInvestmentInFinanceLease_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GrossInvestmentInFinanceLease_2339" xlink:to="lab_trib_GrossInvestmentInFinanceLease_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GroupLeaseExpense_2340" xlink:to="lab_trib_GroupLeaseExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_GroupLeaseExpense_2341" xlink:to="lab_trib_GroupLeaseExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_HivIncidenceAssayMember_2342" xlink:to="lab_trib_HivIncidenceAssayMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_HivOneByTwoRapidTestMember_2343" xlink:to="lab_trib_HivOneByTwoRapidTestMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_HivOneByTwoRapidTestMember_2344" xlink:to="lab_trib_HivOneByTwoRapidTestMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_HivOneByTwoRapidTestMember_2345" xlink:to="lab_trib_HivOneByTwoRapidTestMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_HivScreeningAfricaMember_2346" xlink:to="lab_trib_HivScreeningAfricaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IgmCaptiaMember_2347" xlink:to="lab_trib_IgmCaptiaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImmcoDiagnosticCGUMember_2348" xlink:to="lab_trib_ImmcoDiagnosticCGUMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImmcoDiagnosticCGUMember_2349" xlink:to="lab_trib_ImmcoDiagnosticCGUMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImmcoDiagnosticsIncMember_2350" xlink:to="lab_trib_ImmcoDiagnosticsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImmcoDiagnosticsIncMember_2351" xlink:to="lab_trib_ImmcoDiagnosticsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImmcoDiagnosticsIncMember_2352" xlink:to="lab_trib_ImmcoDiagnosticsIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImmcoDiagnosticsMember_2353" xlink:to="lab_trib_ImmcoDiagnosticsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImmcoDiagnosticTradeNameMember_2354" xlink:to="lab_trib_ImmcoDiagnosticTradeNameMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImpairmentChargePropertyPlantEquipment_2355" xlink:to="lab_trib_ImpairmentChargePropertyPlantEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImpairmentChargePropertyPlantEquipment_2356" xlink:to="lab_trib_ImpairmentChargePropertyPlantEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImpairmentChargesMember_2357" xlink:to="lab_trib_ImpairmentChargesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImpairmentLossForInvestment_2358" xlink:to="lab_trib_ImpairmentLossForInvestment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImpairmentLossForInvestment_2359" xlink:to="lab_trib_ImpairmentLossForInvestment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImpairmentOfPrepayments_2360" xlink:to="lab_trib_ImpairmentOfPrepayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImpairmentOfPrepayments_2361" xlink:to="lab_trib_ImpairmentOfPrepayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImpairmentOfPrepayments_2362" xlink:to="lab_trib_ImpairmentOfPrepayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ImpairmentOfPrepayments_2363" xlink:to="lab_trib_ImpairmentOfPrepayments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeFromPaycheckProtectionProgramLoans_2364" xlink:to="lab_trib_IncomeFromPaycheckProtectionProgramLoans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeFromPaycheckProtectionProgramLoans_2365" xlink:to="lab_trib_IncomeFromPaycheckProtectionProgramLoans_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeFromPaycheckProtectionProgramLoans_2366" xlink:to="lab_trib_IncomeFromPaycheckProtectionProgramLoans_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeLoss_2367" xlink:to="lab_trib_IncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeLoss_2368" xlink:to="lab_trib_IncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeLoss_2369" xlink:to="lab_trib_IncomeLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeLoss_2370" xlink:to="lab_trib_IncomeLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxAssetsCurrentAndDeferred_2371" xlink:to="lab_trib_IncomeTaxAssetsCurrentAndDeferred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxAssetsCurrentAndDeferred_2372" xlink:to="lab_trib_IncomeTaxAssetsCurrentAndDeferred_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxExpense_2373" xlink:to="lab_trib_IncomeTaxExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxExpense_2374" xlink:to="lab_trib_IncomeTaxExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxExpense_2375" xlink:to="lab_trib_IncomeTaxExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract_2376" xlink:to="lab_trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract_2377" xlink:to="lab_trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxExpenseBenefits_2378" xlink:to="lab_trib_IncomeTaxExpenseBenefits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxExpenseBenefits_2379" xlink:to="lab_trib_IncomeTaxExpenseBenefits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxExpenseBenefits_2380" xlink:to="lab_trib_IncomeTaxExpenseBenefits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxImpactOfImpairmentLoss_2381" xlink:to="lab_trib_IncomeTaxImpactOfImpairmentLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxImpactOfImpairmentLoss_2382" xlink:to="lab_trib_IncomeTaxImpactOfImpairmentLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxLiabilitiesCurrentAndDeferred_2383" xlink:to="lab_trib_IncomeTaxLiabilitiesCurrentAndDeferred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncomeTaxLiabilitiesCurrentAndDeferred_2384" xlink:to="lab_trib_IncomeTaxLiabilitiesCurrentAndDeferred_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_2385" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_2386" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_2387" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_2388" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_2389" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_2390" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_2391" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_2392" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_2393" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_2394" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_2395" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_2396" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_2397" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_2398" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_2399" xlink:to="lab_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_2400" xlink:to="lab_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_2401" xlink:to="lab_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_2402" xlink:to="lab_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_2403" xlink:to="lab_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_2404" xlink:to="lab_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_2405" xlink:to="lab_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_2406" xlink:to="lab_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_2407" xlink:to="lab_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_2408" xlink:to="lab_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_2409" xlink:to="lab_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_2410" xlink:to="lab_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_2411" xlink:to="lab_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_2412" xlink:to="lab_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreasedInUnrecognisedDeferredTaxAssets_2413" xlink:to="lab_trib_IncreasedInUnrecognisedDeferredTaxAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreasedInUnrecognisedDeferredTaxAssets_2414" xlink:to="lab_trib_IncreasedInUnrecognisedDeferredTaxAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseInAnnualRent_2415" xlink:to="lab_trib_IncreaseInAnnualRent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseInAnnualRent_2416" xlink:to="lab_trib_IncreaseInAnnualRent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseInAnnualRent_2417" xlink:to="lab_trib_IncreaseInAnnualRent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseInSettlementAmountDueToDepreciation_2418" xlink:to="lab_trib_IncreaseInSettlementAmountDueToDepreciation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseInSettlementAmountDueToDepreciation_2419" xlink:to="lab_trib_IncreaseInSettlementAmountDueToDepreciation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseTermLoan_2420" xlink:to="lab_trib_IncreaseTermLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseTermLoan_2421" xlink:to="lab_trib_IncreaseTermLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IncreaseTermLoan_2422" xlink:to="lab_trib_IncreaseTermLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InitialExercisePriceOfWarrantsOrRights_2423" xlink:to="lab_trib_InitialExercisePriceOfWarrantsOrRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InitialExercisePriceOfWarrantsOrRights_2424" xlink:to="lab_trib_InitialExercisePriceOfWarrantsOrRights_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InitialExercisePriceOfWarrantsOrRights_2425" xlink:to="lab_trib_InitialExercisePriceOfWarrantsOrRights_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InstalmentsAxis_2426" xlink:to="lab_trib_InstalmentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InstalmentsDomain_2427" xlink:to="lab_trib_InstalmentsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InstrumentsMember_2428" xlink:to="lab_trib_InstrumentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InstrumentsMember_2429" xlink:to="lab_trib_InstrumentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_2430" xlink:to="lab_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_2431" xlink:to="lab_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_2432" xlink:to="lab_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IntangibleAssetsUnderDevelopmentWrittenDown_2433" xlink:to="lab_trib_IntangibleAssetsUnderDevelopmentWrittenDown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IntangibleAssetsUnderDevelopmentWrittenDown_2434" xlink:to="lab_trib_IntangibleAssetsUnderDevelopmentWrittenDown_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IntangibleAssetsUnderDevelopmentWrittenDown_2435" xlink:to="lab_trib_IntangibleAssetsUnderDevelopmentWrittenDown_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_2436" xlink:to="lab_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_2437" xlink:to="lab_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_2438" xlink:to="lab_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_2439" xlink:to="lab_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestExpenseOnLeaseLiabilities1_2440" xlink:to="lab_trib_InterestExpenseOnLeaseLiabilities1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestExpenseOnLeaseLiabilities1_2441" xlink:to="lab_trib_InterestExpenseOnLeaseLiabilities1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestExpenseOnLeaseLiabilities1_2442" xlink:to="lab_trib_InterestExpenseOnLeaseLiabilities1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestExpenseOnTaxAuditSettlement_2443" xlink:to="lab_trib_InterestExpenseOnTaxAuditSettlement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestExpenseOnTaxAuditSettlement_2444" xlink:to="lab_trib_InterestExpenseOnTaxAuditSettlement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestExpenseOnTaxAuditSettlement_2445" xlink:to="lab_trib_InterestExpenseOnTaxAuditSettlement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestExpenses_2446" xlink:to="lab_trib_InterestExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestExpenses_2447" xlink:to="lab_trib_InterestExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestExpenses_2448" xlink:to="lab_trib_InterestExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestExpensesAbstract_2449" xlink:to="lab_trib_InterestExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestExpensesAbstract_2450" xlink:to="lab_trib_InterestExpensesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestIncomeAbstract_2451" xlink:to="lab_trib_InterestIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestIncomeAbstract_2452" xlink:to="lab_trib_InterestIncomeAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestIncomeCredit_2453" xlink:to="lab_trib_InterestIncomeCredit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestIncomeCredit_2454" xlink:to="lab_trib_InterestIncomeCredit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestIncomeCredit_2455" xlink:to="lab_trib_InterestIncomeCredit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestIncomeEarned_2456" xlink:to="lab_trib_InterestIncomeEarned_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestIncomeEarned_2457" xlink:to="lab_trib_InterestIncomeEarned_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestIncomeEarned_2458" xlink:to="lab_trib_InterestIncomeEarned_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestOnDeferredConsiderationAndLicenceFee_2459" xlink:to="lab_trib_InterestOnDeferredConsiderationAndLicenceFee_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestOnDeferredConsiderationAndLicenceFee_2460" xlink:to="lab_trib_InterestOnDeferredConsiderationAndLicenceFee_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestOnDeferredConsiderationAndLicenceFee_2461" xlink:to="lab_trib_InterestOnDeferredConsiderationAndLicenceFee_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestPaidOnConvertibleNote_2462" xlink:to="lab_trib_InterestPaidOnConvertibleNote_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestPaidOnConvertibleNote_2463" xlink:to="lab_trib_InterestPaidOnConvertibleNote_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestPaidOnConvertibleNote_2464" xlink:to="lab_trib_InterestPaidOnConvertibleNote_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestPaidOnConvertibleNote_2465" xlink:to="lab_trib_InterestPaidOnConvertibleNote_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestPaidOnConvertibleNote_2466" xlink:to="lab_trib_InterestPaidOnConvertibleNote_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestPaidOnSeniorSecuredTermLoan_2467" xlink:to="lab_trib_InterestPaidOnSeniorSecuredTermLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestPaidOnSeniorSecuredTermLoan_2468" xlink:to="lab_trib_InterestPaidOnSeniorSecuredTermLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestPaidOnSeniorSecuredTermLoan_2469" xlink:to="lab_trib_InterestPaidOnSeniorSecuredTermLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestPaidOnSeniorSecuredTermLoan_2470" xlink:to="lab_trib_InterestPaidOnSeniorSecuredTermLoan_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterestPaidOnSeniorSecuredTermLoan_2471" xlink:to="lab_trib_InterestPaidOnSeniorSecuredTermLoan_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterSegmentInterestExpense_2472" xlink:to="lab_trib_InterSegmentInterestExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterSegmentInterestExpense_2473" xlink:to="lab_trib_InterSegmentInterestExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterSegmentInterestIncome_2474" xlink:to="lab_trib_InterSegmentInterestIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InterSegmentInterestIncome_2475" xlink:to="lab_trib_InterSegmentInterestIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InventoryMember_2476" xlink:to="lab_trib_InventoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InventoryMember_2477" xlink:to="lab_trib_InventoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InventoryMember_2478" xlink:to="lab_trib_InventoryMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InventoryRelatedCostsMember_2479" xlink:to="lab_trib_InventoryRelatedCostsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InventoryRelatedCostsMember_2480" xlink:to="lab_trib_InventoryRelatedCostsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InventoryRelatedCostsMember_2481" xlink:to="lab_trib_InventoryRelatedCostsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InventoryWrittenDown_2482" xlink:to="lab_trib_InventoryWrittenDown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InventoryWrittenDown_2483" xlink:to="lab_trib_InventoryWrittenDown_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InventoryWrittenDown_2484" xlink:to="lab_trib_InventoryWrittenDown_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InvestmentInUnsecuredJuniorConvertibleNote_2485" xlink:to="lab_trib_InvestmentInUnsecuredJuniorConvertibleNote_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InvestmentInUnsecuredJuniorConvertibleNote_2486" xlink:to="lab_trib_InvestmentInUnsecuredJuniorConvertibleNote_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_InvestmentInUnsecuredJuniorConvertibleNote_2487" xlink:to="lab_trib_InvestmentInUnsecuredJuniorConvertibleNote_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuableOnConversionOfConvertibleNotes_2488" xlink:to="lab_trib_IssuableOnConversionOfConvertibleNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuableOnConversionOfConvertibleNotes_2489" xlink:to="lab_trib_IssuableOnConversionOfConvertibleNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuableOnConversionOfConvertibleNotes_2490" xlink:to="lab_trib_IssuableOnConversionOfConvertibleNotes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuableOnConversionOfExchangeableNotes_2491" xlink:to="lab_trib_IssuableOnConversionOfExchangeableNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuableOnConversionOfExchangeableNotes_2492" xlink:to="lab_trib_IssuableOnConversionOfExchangeableNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuableOnConversionOfExchangeableNotes_2493" xlink:to="lab_trib_IssuableOnConversionOfExchangeableNotes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuableOnExerciseOfOptions_2494" xlink:to="lab_trib_IssuableOnExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuableOnExerciseOfOptions_2495" xlink:to="lab_trib_IssuableOnExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuableOnExerciseOfOptions_2496" xlink:to="lab_trib_IssuableOnExerciseOfOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuableOnExerciseOfOptionsAndWarrants_2497" xlink:to="lab_trib_IssuableOnExerciseOfOptionsAndWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuableOnExerciseOfOptionsAndWarrants_2498" xlink:to="lab_trib_IssuableOnExerciseOfOptionsAndWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuedAmericanDepositoryShares_2499" xlink:to="lab_trib_IssuedAmericanDepositoryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuedAmericanDepositoryShares_2500" xlink:to="lab_trib_IssuedAmericanDepositoryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuedAmericanDepositoryShares_2501" xlink:to="lab_trib_IssuedAmericanDepositoryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuedForNoncashConsideration_2502" xlink:to="lab_trib_IssuedForNoncashConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuedForNoncashConsideration_2503" xlink:to="lab_trib_IssuedForNoncashConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuedForNoncashConsideration_2504" xlink:to="lab_trib_IssuedForNoncashConsideration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuedForNoncashConsideration_2505" xlink:to="lab_trib_IssuedForNoncashConsideration_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuenceOfExchangeableNote_2506" xlink:to="lab_trib_IssuenceOfExchangeableNote_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_IssuenceOfExchangeableNote_2507" xlink:to="lab_trib_IssuenceOfExchangeableNote_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ITAndOfficeEquipmentMember_2508" xlink:to="lab_trib_ITAndOfficeEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ITAndOfficeEquipmentMember_2509" xlink:to="lab_trib_ITAndOfficeEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_JrjMember_2510" xlink:to="lab_trib_JrjMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_JrjMember_2511" xlink:to="lab_trib_JrjMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_JrjMember_2512" xlink:to="lab_trib_JrjMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_KansasRightOfUseAssetMember_2513" xlink:to="lab_trib_KansasRightOfUseAssetMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_KansasRightOfUseAssetMember_2514" xlink:to="lab_trib_KansasRightOfUseAssetMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_KansasRightOfUseAssetMember_2515" xlink:to="lab_trib_KansasRightOfUseAssetMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_2516" xlink:to="lab_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_2517" xlink:to="lab_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_2518" xlink:to="lab_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_2519" xlink:to="lab_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_2520" xlink:to="lab_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_2521" xlink:to="lab_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_KonamiteLimitedMember_2522" xlink:to="lab_trib_KonamiteLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_KonamiteLimitedMember_2523" xlink:to="lab_trib_KonamiteLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LaboratoryEquipmentMember_2524" xlink:to="lab_trib_LaboratoryEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LaboratoryServicesMember_2525" xlink:to="lab_trib_LaboratoryServicesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LaboratoryServicesMember_2526" xlink:to="lab_trib_LaboratoryServicesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LaboratoryServicesMember_2527" xlink:to="lab_trib_LaboratoryServicesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_2528" xlink:to="lab_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_2529" xlink:to="lab_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_2530" xlink:to="lab_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_2531" xlink:to="lab_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_2532" xlink:to="lab_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_2533" xlink:to="lab_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseCosts_2534" xlink:to="lab_trib_LeaseCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseCosts_2535" xlink:to="lab_trib_LeaseCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed_2536" xlink:to="lab_trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed_2537" xlink:to="lab_trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed_2538" xlink:to="lab_trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_2539" xlink:to="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_2540" xlink:to="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_2541" xlink:to="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_2542" xlink:to="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_2543" xlink:to="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_2544" xlink:to="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_2545" xlink:to="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_2546" xlink:to="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_2547" xlink:to="lab_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeasePayableOnRightOfUseAssets_2548" xlink:to="lab_trib_LeasePayableOnRightOfUseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeasePayableOnRightOfUseAssets_2549" xlink:to="lab_trib_LeasePayableOnRightOfUseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeasePayableOnRightOfUseAssetsMember_2550" xlink:to="lab_trib_LeasePayableOnRightOfUseAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeasePayableOnRightOfUseAssetsMember_2551" xlink:to="lab_trib_LeasePayableOnRightOfUseAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_2552" xlink:to="lab_trib_LeasePayableOnSaleAndLeasebackTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_2553" xlink:to="lab_trib_LeasePayableOnSaleAndLeasebackTransactions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_2554" xlink:to="lab_trib_LeasePayableOnSaleAndLeasebackTransactions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeasePayableOnSaleLeasebackTransactionsMember_2555" xlink:to="lab_trib_LeasePayableOnSaleLeasebackTransactionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeasePayableOnSaleLeasebackTransactionsMember_2556" xlink:to="lab_trib_LeasePayableOnSaleLeasebackTransactionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseTerm_2557" xlink:to="lab_trib_LeaseTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LeaseTerm_2558" xlink:to="lab_trib_LeaseTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LenderMember_2559" xlink:to="lab_trib_LenderMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LenderMember_2560" xlink:to="lab_trib_LenderMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LiabilitiesAssumedAsOfAcquisitionDateAbstract_2561" xlink:to="lab_trib_LiabilitiesAssumedAsOfAcquisitionDateAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LiabilitiesAssumedAsOfAcquisitionDateAbstract_2562" xlink:to="lab_trib_LiabilitiesAssumedAsOfAcquisitionDateAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_2563" xlink:to="lab_trib_LiabilitiesAtAmortisedCostAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_2564" xlink:to="lab_trib_LiabilitiesAtAmortisedCostAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LicenceFee_2565" xlink:to="lab_trib_LicenceFee_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LicenceFee_2566" xlink:to="lab_trib_LicenceFee_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LicenceFee_2567" xlink:to="lab_trib_LicenceFee_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LicenceFeePayments_2568" xlink:to="lab_trib_LicenceFeePayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LicenceFeePayments_2569" xlink:to="lab_trib_LicenceFeePayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LicenceFeePayments_2570" xlink:to="lab_trib_LicenceFeePayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LicenceFeePayments_2571" xlink:to="lab_trib_LicenceFeePayments_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LicenceFeePayments_2572" xlink:to="lab_trib_LicenceFeePayments_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LicencePaymentsMember_2573" xlink:to="lab_trib_LicencePaymentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LicencePaymentsMember_2574" xlink:to="lab_trib_LicencePaymentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LineImmunoassayPanelsMember_2575" xlink:to="lab_trib_LineImmunoassayPanelsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LoanIncome_2576" xlink:to="lab_trib_LoanIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LoanIncome_2577" xlink:to="lab_trib_LoanIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LoanOriginationCosts_2578" xlink:to="lab_trib_LoanOriginationCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LoanOriginationCosts_2579" xlink:to="lab_trib_LoanOriginationCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LoanOriginationCosts_2580" xlink:to="lab_trib_LoanOriginationCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LoanOriginationCosts_2581" xlink:to="lab_trib_LoanOriginationCosts_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LoanOriginationCosts_2582" xlink:to="lab_trib_LoanOriginationCosts_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LoanOriginationCosts_2583" xlink:to="lab_trib_LoanOriginationCosts_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LoanOriginationCosts_2584" xlink:to="lab_trib_LoanOriginationCosts_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LoansAndReceivablesAbstract_2585" xlink:to="lab_trib_LoansAndReceivablesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LoansAndReceivablesAbstract_2586" xlink:to="lab_trib_LoansAndReceivablesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LongLivedAsstesBySegment_2587" xlink:to="lab_trib_LongLivedAsstesBySegment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LongLivedAsstesBySegment_2588" xlink:to="lab_trib_LongLivedAsstesBySegment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LongLivedAsstesBySegment_2589" xlink:to="lab_trib_LongLivedAsstesBySegment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LongTermGrowthRate_2590" xlink:to="lab_trib_LongTermGrowthRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LongTermGrowthRate_2591" xlink:to="lab_trib_LongTermGrowthRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LongTermGrowthRate_2592" xlink:to="lab_trib_LongTermGrowthRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LongTermGrowthRate_2593" xlink:to="lab_trib_LongTermGrowthRate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LongTermLeaseLiabilitiesMember_2594" xlink:to="lab_trib_LongTermLeaseLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LossOnDiscontinuedOperationsAbstract_2595" xlink:to="lab_trib_LossOnDiscontinuedOperationsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LossOnDiscontinuedOperationsAbstract_2596" xlink:to="lab_trib_LossOnDiscontinuedOperationsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LossOnDiscontinuedOperationsAbstract_2597" xlink:to="lab_trib_LossOnDiscontinuedOperationsAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LossOnDisposalOfExchangeableNotes_2598" xlink:to="lab_trib_LossOnDisposalOfExchangeableNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LossOnDisposalOfExchangeableNotes_2599" xlink:to="lab_trib_LossOnDisposalOfExchangeableNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LossOnDisposalOfExchangeableNotes_2600" xlink:to="lab_trib_LossOnDisposalOfExchangeableNotes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LossOnDisposalOfExchangeableNotes_2601" xlink:to="lab_trib_LossOnDisposalOfExchangeableNotes_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LossOnDisposalOnBorrowings_2602" xlink:to="lab_trib_LossOnDisposalOnBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LossOnDisposalOnBorrowings_2603" xlink:to="lab_trib_LossOnDisposalOnBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_LossOnDisposalOnBorrowings_2604" xlink:to="lab_trib_LossOnDisposalOnBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MalariaPointOfCareTestMember_2605" xlink:to="lab_trib_MalariaPointOfCareTestMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ManufacturingAndQualityMember_2606" xlink:to="lab_trib_ManufacturingAndQualityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ManufacturingAndQualityMember_2607" xlink:to="lab_trib_ManufacturingAndQualityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MardxDiagnosticIncMember_2608" xlink:to="lab_trib_MardxDiagnosticIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MardxDiagnosticsIncMember_2609" xlink:to="lab_trib_MardxDiagnosticsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MardxDiagnosticsIncMember_2610" xlink:to="lab_trib_MardxDiagnosticsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MatrixProjectMember_2611" xlink:to="lab_trib_MatrixProjectMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MaturityDateForLease_2612" xlink:to="lab_trib_MaturityDateForLease_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MaturityDateForLease_2613" xlink:to="lab_trib_MaturityDateForLease_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MaturityDateForLease_2614" xlink:to="lab_trib_MaturityDateForLease_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MaturityDateOfExchangeableSeniorNotes_2615" xlink:to="lab_trib_MaturityDateOfExchangeableSeniorNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MaturityDateOfExchangeableSeniorNotes_2616" xlink:to="lab_trib_MaturityDateOfExchangeableSeniorNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_2617" xlink:to="lab_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_2618" xlink:to="lab_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_2619" xlink:to="lab_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MeasurementPeriodAdjustmentMember_2620" xlink:to="lab_trib_MeasurementPeriodAdjustmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MeasurementPeriodAdjustmentMember_2621" xlink:to="lab_trib_MeasurementPeriodAdjustmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MetabolomicDiagnosticsLimitedMember_2622" xlink:to="lab_trib_MetabolomicDiagnosticsLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MetabolomicDiagnosticsLimitedMember_2623" xlink:to="lab_trib_MetabolomicDiagnosticsLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MetabolomicDiagnosticsLimitedMember_2624" xlink:to="lab_trib_MetabolomicDiagnosticsLimitedMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MetabolomicsDiagnosticsLimitedMember_2625" xlink:to="lab_trib_MetabolomicsDiagnosticsLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MetabolomicsDiagnosticsLimitedMember_2626" xlink:to="lab_trib_MetabolomicsDiagnosticsLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MetabolomicsDiagnosticsLimitedMember_2627" xlink:to="lab_trib_MetabolomicsDiagnosticsLimitedMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MicoLtdMember_2628" xlink:to="lab_trib_MicoLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MicoLtdMember_2629" xlink:to="lab_trib_MicoLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MicoLtdMember_2630" xlink:to="lab_trib_MicoLtdMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MicropillarTechnologyMember_2631" xlink:to="lab_trib_MicropillarTechnologyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MidTierHaemoglobinsInstrumentMember_2632" xlink:to="lab_trib_MidTierHaemoglobinsInstrumentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MidTierHaemoglobinsInstrumentMember_2633" xlink:to="lab_trib_MidTierHaemoglobinsInstrumentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsPayable_2634" xlink:to="lab_trib_MinimumFinanceLeasePaymentsPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsPayable_2635" xlink:to="lab_trib_MinimumFinanceLeasePaymentsPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsPayable_2636" xlink:to="lab_trib_MinimumFinanceLeasePaymentsPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_2637" xlink:to="lab_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_2638" xlink:to="lab_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_2639" xlink:to="lab_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_2640" xlink:to="lab_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_2641" xlink:to="lab_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_2642" xlink:to="lab_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_2643" xlink:to="lab_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_2644" xlink:to="lab_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2645" xlink:to="lab_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2646" xlink:to="lab_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2647" xlink:to="lab_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2648" xlink:to="lab_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2649" xlink:to="lab_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_2650" xlink:to="lab_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumLiquidityCovenant_2651" xlink:to="lab_trib_MinimumLiquidityCovenant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumLiquidityCovenant_2652" xlink:to="lab_trib_MinimumLiquidityCovenant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MinimumLiquidityCovenant_2653" xlink:to="lab_trib_MinimumLiquidityCovenant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MoreThanOneYearMember_2654" xlink:to="lab_trib_MoreThanOneYearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MoreThanOneYearMember_2655" xlink:to="lab_trib_MoreThanOneYearMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MovementInInterestAccrual_2656" xlink:to="lab_trib_MovementInInterestAccrual_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MovementInInterestAccrual_2657" xlink:to="lab_trib_MovementInInterestAccrual_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MovementInInterestAccrual_2658" xlink:to="lab_trib_MovementInInterestAccrual_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MrOCaoimhAndDrWalshMember_2659" xlink:to="lab_trib_MrOCaoimhAndDrWalshMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MrOCaoimhAndDrWalshMember_2660" xlink:to="lab_trib_MrOCaoimhAndDrWalshMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MrOCaoimhAndDrWalshMember_2661" xlink:to="lab_trib_MrOCaoimhAndDrWalshMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MrOCaoimhMember_2662" xlink:to="lab_trib_MrOCaoimhMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MrOCaoimhMember_2663" xlink:to="lab_trib_MrOCaoimhMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_MrOCaoimhMember_2664" xlink:to="lab_trib_MrOCaoimhMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NativeDesignLimitedMember_2665" xlink:to="lab_trib_NativeDesignLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NativeDesignLimitedMember_2666" xlink:to="lab_trib_NativeDesignLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetCarryingAmountMember_2667" xlink:to="lab_trib_NetCarryingAmountMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetCarryingAmountMember_2668" xlink:to="lab_trib_NetCarryingAmountMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetCarryingAmountMember_2669" xlink:to="lab_trib_NetCarryingAmountMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetCashOutflowArisingOnAcquisitionAbstract_2670" xlink:to="lab_trib_NetCashOutflowArisingOnAcquisitionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetCashOutflowArisingOnAcquisitionAbstract_2671" xlink:to="lab_trib_NetCashOutflowArisingOnAcquisitionAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetCashOutFlowOnBusinessCombination_2672" xlink:to="lab_trib_NetCashOutFlowOnBusinessCombination_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetCashOutFlowOnBusinessCombination_2673" xlink:to="lab_trib_NetCashOutFlowOnBusinessCombination_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetCashOutFlowOnBusinessCombination_2674" xlink:to="lab_trib_NetCashOutFlowOnBusinessCombination_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetCashOutFlowOnBusinessCombination_2675" xlink:to="lab_trib_NetCashOutFlowOnBusinessCombination_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetFinancingExpenseIncome_2676" xlink:to="lab_trib_NetFinancingExpenseIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetFinancingExpenseIncome_2677" xlink:to="lab_trib_NetFinancingExpenseIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetFinancingExpenseIncome_2678" xlink:to="lab_trib_NetFinancingExpenseIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetForeignExchangeGainLoss_2679" xlink:to="lab_trib_NetForeignExchangeGainLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetForeignExchangeGainLoss_2680" xlink:to="lab_trib_NetForeignExchangeGainLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetForeignExchangeGainLoss_2681" xlink:to="lab_trib_NetForeignExchangeGainLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetInterestIncome_2682" xlink:to="lab_trib_NetInterestIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetInterestIncome_2683" xlink:to="lab_trib_NetInterestIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetInterestIncome_2684" xlink:to="lab_trib_NetInterestIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetOperatingLossCarryforwards_2685" xlink:to="lab_trib_NetOperatingLossCarryforwards_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetOperatingLossCarryforwards_2686" xlink:to="lab_trib_NetOperatingLossCarryforwards_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetOperatingLossPeriod_2687" xlink:to="lab_trib_NetOperatingLossPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NetOperatingLossPeriod_2688" xlink:to="lab_trib_NetOperatingLossPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NominalAmountOfDebt_2689" xlink:to="lab_trib_NominalAmountOfDebt_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NominalAmountOfDebt_2690" xlink:to="lab_trib_NominalAmountOfDebt_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NominalAmountOfDebt_2691" xlink:to="lab_trib_NominalAmountOfDebt_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NominalValue_2692" xlink:to="lab_trib_NominalValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NominalValue_2693" xlink:to="lab_trib_NominalValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NominalValue_2694" xlink:to="lab_trib_NominalValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NominalValuePerShareOfExchangeableNotes_2695" xlink:to="lab_trib_NominalValuePerShareOfExchangeableNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NominalValuePerShareOfExchangeableNotes_2696" xlink:to="lab_trib_NominalValuePerShareOfExchangeableNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NominalValuePerShareOfExchangeableNotes_2697" xlink:to="lab_trib_NominalValuePerShareOfExchangeableNotes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_2698" xlink:to="lab_trib_NonCashActivityForFinancingActivityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_2699" xlink:to="lab_trib_NonCashActivityForFinancingActivityAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_2700" xlink:to="lab_trib_NonCashActivityForFinancingActivityAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_2701" xlink:to="lab_trib_NonCashActivityForFinancingActivityAbstract_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCashFairValueGainLoss_2702" xlink:to="lab_trib_NonCashFairValueGainLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCashFairValueGainLoss_2703" xlink:to="lab_trib_NonCashFairValueGainLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCashFairValueGainLoss_2704" xlink:to="lab_trib_NonCashFairValueGainLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncashFairValueLoss_2705" xlink:to="lab_trib_NoncashFairValueLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncashFairValueLoss_2706" xlink:to="lab_trib_NoncashFairValueLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncashFairValueLoss_2707" xlink:to="lab_trib_NoncashFairValueLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCashImpairmentCharge_2708" xlink:to="lab_trib_NonCashImpairmentCharge_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCashImpairmentCharge_2709" xlink:to="lab_trib_NonCashImpairmentCharge_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncashInterestOnConvertibleNote_2710" xlink:to="lab_trib_NoncashInterestOnConvertibleNote_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncashInterestOnConvertibleNote_2711" xlink:to="lab_trib_NoncashInterestOnConvertibleNote_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncashInterestOnConvertibleNote_2712" xlink:to="lab_trib_NoncashInterestOnConvertibleNote_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncashInterestOnSeniorSecuredTermLoan_2713" xlink:to="lab_trib_NoncashInterestOnSeniorSecuredTermLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncashInterestOnSeniorSecuredTermLoan_2714" xlink:to="lab_trib_NoncashInterestOnSeniorSecuredTermLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncashInterestOnSeniorSecuredTermLoan_2715" xlink:to="lab_trib_NoncashInterestOnSeniorSecuredTermLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncashInterestOnSeniorSecuredTermLoan_2716" xlink:to="lab_trib_NoncashInterestOnSeniorSecuredTermLoan_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncashLoanModificationGain_2717" xlink:to="lab_trib_NoncashLoanModificationGain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncashLoanModificationGain_2718" xlink:to="lab_trib_NoncashLoanModificationGain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncashLoanModificationGain_2719" xlink:to="lab_trib_NoncashLoanModificationGain_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCurrentAssetsMember_2720" xlink:to="lab_trib_NonCurrentAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCurrentAssetsMember_2721" xlink:to="lab_trib_NonCurrentAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncurrentDerivativeLiabilities_2722" xlink:to="lab_trib_NoncurrentDerivativeLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncurrentDerivativeLiabilities_2723" xlink:to="lab_trib_NoncurrentDerivativeLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncurrentDerivativeLiabilities_2724" xlink:to="lab_trib_NoncurrentDerivativeLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncurrentDerivativeLiabilities_2725" xlink:to="lab_trib_NoncurrentDerivativeLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncurrentFinanceLeaseLiabilities_2726" xlink:to="lab_trib_NoncurrentFinanceLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncurrentFinanceLeaseLiabilities_2727" xlink:to="lab_trib_NoncurrentFinanceLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncurrentFinanceLeaseLiabilities_2728" xlink:to="lab_trib_NoncurrentFinanceLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NoncurrentFinanceLeaseLiabilities_2729" xlink:to="lab_trib_NoncurrentFinanceLeaseLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCurrentLeaseLiabilitiesAbstract_2730" xlink:to="lab_trib_NonCurrentLeaseLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCurrentLeaseLiabilitiesAbstract_2731" xlink:to="lab_trib_NonCurrentLeaseLiabilitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCurrentLiabilitiesMember_2732" xlink:to="lab_trib_NonCurrentLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCurrentLiabilitiesMember_2733" xlink:to="lab_trib_NonCurrentLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonCurrentLiabilitiesMember_2734" xlink:to="lab_trib_NonCurrentLiabilitiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonRadingCosts_2735" xlink:to="lab_trib_NonRadingCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonRadingCosts_2736" xlink:to="lab_trib_NonRadingCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonRadingCosts_2737" xlink:to="lab_trib_NonRadingCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonTradingCosts_2738" xlink:to="lab_trib_NonTradingCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonTradingCosts_2739" xlink:to="lab_trib_NonTradingCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NonTradingCosts_2740" xlink:to="lab_trib_NonTradingCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotesAndDebenturesPurchased_2741" xlink:to="lab_trib_NotesAndDebenturesPurchased_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotesAndDebenturesPurchased_2742" xlink:to="lab_trib_NotesAndDebenturesPurchased_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotesAndDebenturesPurchased_2743" xlink:to="lab_trib_NotesAndDebenturesPurchased_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotesAndDebenturesRetired_2744" xlink:to="lab_trib_NotesAndDebenturesRetired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotesAndDebenturesRetired_2745" xlink:to="lab_trib_NotesAndDebenturesRetired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotesAndDebenturesRetired_2746" xlink:to="lab_trib_NotesAndDebenturesRetired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotLaterThan10YearMember_2747" xlink:to="lab_trib_NotLaterThan10YearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotLaterThan1YearMember_2748" xlink:to="lab_trib_NotLaterThan1YearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotLaterThan2YearMember_2749" xlink:to="lab_trib_NotLaterThan2YearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotLaterThan3YearMember_2750" xlink:to="lab_trib_NotLaterThan3YearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotLaterThan4YearMember_2751" xlink:to="lab_trib_NotLaterThan4YearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotLaterThan5YearMember_2752" xlink:to="lab_trib_NotLaterThan5YearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotLaterThan6YearMember_2753" xlink:to="lab_trib_NotLaterThan6YearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotLaterThan7YearMember_2754" xlink:to="lab_trib_NotLaterThan7YearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotLaterThan8YearMember_2755" xlink:to="lab_trib_NotLaterThan8YearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NotLaterThan9YearMember_2756" xlink:to="lab_trib_NotLaterThan9YearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NovaCenturyScientificIncMember_2757" xlink:to="lab_trib_NovaCenturyScientificIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NovaCenturyScientificIncMember_2758" xlink:to="lab_trib_NovaCenturyScientificIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NovusDiagnosticsLimitedMember_2759" xlink:to="lab_trib_NovusDiagnosticsLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NovusDiagnosticsLimitedMember_2760" xlink:to="lab_trib_NovusDiagnosticsLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NovusDiagnosticsLimitedMember_2761" xlink:to="lab_trib_NovusDiagnosticsLimitedMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2762" xlink:to="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2763" xlink:to="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2764" xlink:to="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2765" xlink:to="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2766" xlink:to="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2767" xlink:to="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_2768" xlink:to="lab_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2769" xlink:to="lab_trib_NumberOfAOrdinaryWeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2770" xlink:to="lab_trib_NumberOfAOrdinaryWeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2771" xlink:to="lab_trib_NumberOfAOrdinaryWeightedAverageShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2772" xlink:to="lab_trib_NumberOfAOrdinaryWeightedAverageShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2773" xlink:to="lab_trib_NumberOfAOrdinaryWeightedAverageShares_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2774" xlink:to="lab_trib_NumberOfAOrdinaryWeightedAverageShares_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfAOrdinaryWeightedAverageShares_2775" xlink:to="lab_trib_NumberOfAOrdinaryWeightedAverageShares_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfLeasesWithExtensionOptions_2776" xlink:to="lab_trib_NumberOfLeasesWithExtensionOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfLeasesWithExtensionOptions_2777" xlink:to="lab_trib_NumberOfLeasesWithExtensionOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfLeasesWithExtensionOptions_2778" xlink:to="lab_trib_NumberOfLeasesWithExtensionOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfLeasesWithOptionsToPurchase_2779" xlink:to="lab_trib_NumberOfLeasesWithOptionsToPurchase_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfLeasesWithOptionsToPurchase_2780" xlink:to="lab_trib_NumberOfLeasesWithOptionsToPurchase_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfLeasesWithOptionsToPurchase_2781" xlink:to="lab_trib_NumberOfLeasesWithOptionsToPurchase_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfLeasesWithTerminationOptions_2782" xlink:to="lab_trib_NumberOfLeasesWithTerminationOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfLeasesWithTerminationOptions_2783" xlink:to="lab_trib_NumberOfLeasesWithTerminationOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfLeasesWithTerminationOptions_2784" xlink:to="lab_trib_NumberOfLeasesWithTerminationOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_2785" xlink:to="lab_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_2786" xlink:to="lab_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_2787" xlink:to="lab_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfOptionsGranted_2788" xlink:to="lab_trib_NumberOfOptionsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfOptionsGranted_2789" xlink:to="lab_trib_NumberOfOptionsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfOptionsGranted_2790" xlink:to="lab_trib_NumberOfOptionsGranted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfOptionsIssuable_2791" xlink:to="lab_trib_NumberOfOptionsIssuable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfOptionsIssuable_2792" xlink:to="lab_trib_NumberOfOptionsIssuable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfOptionsIssuable_2793" xlink:to="lab_trib_NumberOfOptionsIssuable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfOptionsLapsedUnexercised_2794" xlink:to="lab_trib_NumberOfOptionsLapsedUnexercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfOptionsLapsedUnexercised_2795" xlink:to="lab_trib_NumberOfOptionsLapsedUnexercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfOptionsLapsedUnexercised_2796" xlink:to="lab_trib_NumberOfOptionsLapsedUnexercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_2797" xlink:to="lab_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_2798" xlink:to="lab_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_2799" xlink:to="lab_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfRetiredDirectorOptions_2800" xlink:to="lab_trib_NumberOfRetiredDirectorOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfRetiredDirectorOptions_2801" xlink:to="lab_trib_NumberOfRetiredDirectorOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfRetiredDirectorOptions_2802" xlink:to="lab_trib_NumberOfRetiredDirectorOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfRetiredDirectorShares_2803" xlink:to="lab_trib_NumberOfRetiredDirectorShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfRetiredDirectorShares_2804" xlink:to="lab_trib_NumberOfRetiredDirectorShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfRetiredDirectorShares_2805" xlink:to="lab_trib_NumberOfRetiredDirectorShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfRightOfUseLeasedAssets_2806" xlink:to="lab_trib_NumberOfRightOfUseLeasedAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfRightOfUseLeasedAssets_2807" xlink:to="lab_trib_NumberOfRightOfUseLeasedAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfRightOfUseLeasedAssets_2808" xlink:to="lab_trib_NumberOfRightOfUseLeasedAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfShareOptionsExercisableShareBasedPayment_2809" xlink:to="lab_trib_NumberOfShareOptionsExercisableShareBasedPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfShareOptionsExercisableShareBasedPayment_2810" xlink:to="lab_trib_NumberOfShareOptionsExercisableShareBasedPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfShareOptionsExercisableShareBasedPayment_2811" xlink:to="lab_trib_NumberOfShareOptionsExercisableShareBasedPayment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive_2812" xlink:to="lab_trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive_2813" xlink:to="lab_trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_2814" xlink:to="lab_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_2815" xlink:to="lab_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_2816" xlink:to="lab_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_2817" xlink:to="lab_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_2818" xlink:to="lab_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_2819" xlink:to="lab_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfSharesIssuedOnExerciseOfOptions_2820" xlink:to="lab_trib_NumberOfSharesIssuedOnExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfSharesIssuedOnExerciseOfOptions_2821" xlink:to="lab_trib_NumberOfSharesIssuedOnExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfSharesIssuedOnExerciseOfOptions_2822" xlink:to="lab_trib_NumberOfSharesIssuedOnExerciseOfOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfStockOptionsToPurchaseOrdinaryShares_2823" xlink:to="lab_trib_NumberOfStockOptionsToPurchaseOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfStockOptionsToPurchaseOrdinaryShares_2824" xlink:to="lab_trib_NumberOfStockOptionsToPurchaseOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfStockOptionsToPurchaseOrdinaryShares_2825" xlink:to="lab_trib_NumberOfStockOptionsToPurchaseOrdinaryShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfWarrantsRepriced_2826" xlink:to="lab_trib_NumberOfWarrantsRepriced_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfWarrantsRepriced_2827" xlink:to="lab_trib_NumberOfWarrantsRepriced_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_NumberOfWarrantsRepriced_2828" xlink:to="lab_trib_NumberOfWarrantsRepriced_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OnceOffExpense_2829" xlink:to="lab_trib_OnceOffExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OnceOffExpense_2830" xlink:to="lab_trib_OnceOffExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OnceOffExpense_2831" xlink:to="lab_trib_OnceOffExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OnceOffTaxCredit_2832" xlink:to="lab_trib_OnceOffTaxCredit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OnceOffTaxCredit_2833" xlink:to="lab_trib_OnceOffTaxCredit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OneYearToTwoYearsMember_2834" xlink:to="lab_trib_OneYearToTwoYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OneYearToTwoYearsMember_2835" xlink:to="lab_trib_OneYearToTwoYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OneYearToTwoYearsMember_2836" xlink:to="lab_trib_OneYearToTwoYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OpeningSharePrice_2837" xlink:to="lab_trib_OpeningSharePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OpeningSharePrice_2838" xlink:to="lab_trib_OpeningSharePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OpeningSharePrice_2839" xlink:to="lab_trib_OpeningSharePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OperatingLeasesMember_2840" xlink:to="lab_trib_OperatingLeasesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OperatingLossesBrazilMember_2841" xlink:to="lab_trib_OperatingLossesBrazilMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OperatingLossesIrelandMember_2842" xlink:to="lab_trib_OperatingLossesIrelandMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OperatingLossesStateMember_2843" xlink:to="lab_trib_OperatingLossesStateMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OptionsAndWarrantsAbstract_2844" xlink:to="lab_trib_OptionsAndWarrantsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OptionsAndWarrantsAbstract_2845" xlink:to="lab_trib_OptionsAndWarrantsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherAssetNoncurrent_2846" xlink:to="lab_trib_OtherAssetNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherAssetNoncurrent_2847" xlink:to="lab_trib_OtherAssetNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherAssetNoncurrent_2848" xlink:to="lab_trib_OtherAssetNoncurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherBorrowingsMember_2849" xlink:to="lab_trib_OtherBorrowingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherBorrowingsMember_2850" xlink:to="lab_trib_OtherBorrowingsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherCountriesMember_2851" xlink:to="lab_trib_OtherCountriesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherCountriesMember_2852" xlink:to="lab_trib_OtherCountriesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherCountriesMember_2853" xlink:to="lab_trib_OtherCountriesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherCurrentBorrowings_2854" xlink:to="lab_trib_OtherCurrentBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherCurrentBorrowings_2855" xlink:to="lab_trib_OtherCurrentBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherCurrentBorrowings_2856" xlink:to="lab_trib_OtherCurrentBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherCurrentBorrowings_2857" xlink:to="lab_trib_OtherCurrentBorrowings_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherDeferredTaxAssetsInIrelandMember_2858" xlink:to="lab_trib_OtherDeferredTaxAssetsInIrelandMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherDeferredTaxAssetsInUsMember_2859" xlink:to="lab_trib_OtherDeferredTaxAssetsInUsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherEmployeesMember_2860" xlink:to="lab_trib_OtherEmployeesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherEmployeesMember_2861" xlink:to="lab_trib_OtherEmployeesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherEuropeanCountriesMember_2862" xlink:to="lab_trib_OtherEuropeanCountriesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherEuropeanCountriesMember_2863" xlink:to="lab_trib_OtherEuropeanCountriesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherItemsMember_2864" xlink:to="lab_trib_OtherItemsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherItemsMember_2865" xlink:to="lab_trib_OtherItemsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherLeases_2866" xlink:to="lab_trib_OtherLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherLeases_2867" xlink:to="lab_trib_OtherLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherLeases_2868" xlink:to="lab_trib_OtherLeases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherNonCurrentAssets_2869" xlink:to="lab_trib_OtherNonCurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherOperatingIncomeLineItems_2870" xlink:to="lab_trib_OtherOperatingIncomeLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherOperatingIncomeLineItems_2871" xlink:to="lab_trib_OtherOperatingIncomeLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherOperatingIncomeTable_2872" xlink:to="lab_trib_OtherOperatingIncomeTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherOperatingIncomeTable_2873" xlink:to="lab_trib_OtherOperatingIncomeTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherProjectsMember_2874" xlink:to="lab_trib_OtherProjectsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherProjectsMember_2875" xlink:to="lab_trib_OtherProjectsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherReceivablesAsOfAcquisitionDate_2876" xlink:to="lab_trib_OtherReceivablesAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherReceivablesAsOfAcquisitionDate_2877" xlink:to="lab_trib_OtherReceivablesAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherReceivablesAsOfAcquisitionDate_2878" xlink:to="lab_trib_OtherReceivablesAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherRegionsMember_2879" xlink:to="lab_trib_OtherRegionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherRegionsMember_2880" xlink:to="lab_trib_OtherRegionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherRegionsMember_2881" xlink:to="lab_trib_OtherRegionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherRestructuringCostsMember_2882" xlink:to="lab_trib_OtherRestructuringCostsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherRestructuringCostsMember_2883" xlink:to="lab_trib_OtherRestructuringCostsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OtherRestructuringCostsMember_2884" xlink:to="lab_trib_OtherRestructuringCostsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OutsourcingCostsMember_2885" xlink:to="lab_trib_OutsourcingCostsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OutsourcingCostsMember_2886" xlink:to="lab_trib_OutsourcingCostsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OutsourcingCostsMember_2887" xlink:to="lab_trib_OutsourcingCostsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OutstandingAbstract_2888" xlink:to="lab_trib_OutstandingAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OutstandingAbstract_2889" xlink:to="lab_trib_OutstandingAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OutstandingPrincipal_2890" xlink:to="lab_trib_OutstandingPrincipal_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OutstandingPrincipal_2891" xlink:to="lab_trib_OutstandingPrincipal_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OutstandingTermLoan_2892" xlink:to="lab_trib_OutstandingTermLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OutstandingTermLoan_2893" xlink:to="lab_trib_OutstandingTermLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OutstandingTermLoan_2894" xlink:to="lab_trib_OutstandingTermLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OverheadCosts_2895" xlink:to="lab_trib_OverheadCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OverheadCosts_2896" xlink:to="lab_trib_OverheadCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_OverheadCosts_2897" xlink:to="lab_trib_OverheadCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PartnershipTriggerEventsDescription_2898" xlink:to="lab_trib_PartnershipTriggerEventsDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PartnershipTriggerEventsDescription_2899" xlink:to="lab_trib_PartnershipTriggerEventsDescription_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PartnershipTriggerEventsDescription_2900" xlink:to="lab_trib_PartnershipTriggerEventsDescription_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PatentDividendSchemeAmount_2901" xlink:to="lab_trib_PatentDividendSchemeAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PatentDividendSchemeAmount_2902" xlink:to="lab_trib_PatentDividendSchemeAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PatentsAndLicencesMember_2903" xlink:to="lab_trib_PatentsAndLicencesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PatentsAndLicencesMember_2904" xlink:to="lab_trib_PatentsAndLicencesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaycheckProtectionProgramLoanMember_2905" xlink:to="lab_trib_PaycheckProtectionProgramLoanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaycheckProtectionProgramLoanMember_2906" xlink:to="lab_trib_PaycheckProtectionProgramLoanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentInKindInterest_2907" xlink:to="lab_trib_PaymentInKindInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentInKindInterest_2908" xlink:to="lab_trib_PaymentInKindInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentInKindInterest_2909" xlink:to="lab_trib_PaymentInKindInterest_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentOfPenalty_2910" xlink:to="lab_trib_PaymentOfPenalty_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentOfPenalty_2911" xlink:to="lab_trib_PaymentOfPenalty_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentOfPenalty_2912" xlink:to="lab_trib_PaymentOfPenalty_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentsForCEOServices_2913" xlink:to="lab_trib_PaymentsForCEOServices_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentsForCEOServices_2914" xlink:to="lab_trib_PaymentsForCEOServices_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentsForCEOServices_2915" xlink:to="lab_trib_PaymentsForCEOServices_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_2916" xlink:to="lab_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_2917" xlink:to="lab_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_2918" xlink:to="lab_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_2919" xlink:to="lab_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_2920" xlink:to="lab_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_2921" xlink:to="lab_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentToRetireExchangeableNotes_2922" xlink:to="lab_trib_PaymentToRetireExchangeableNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentToRetireExchangeableNotes_2923" xlink:to="lab_trib_PaymentToRetireExchangeableNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PaymentToRetireExchangeableNotes_2924" xlink:to="lab_trib_PaymentToRetireExchangeableNotes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltiesPayments_2925" xlink:to="lab_trib_PenaltiesPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltiesPayments_2926" xlink:to="lab_trib_PenaltiesPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan_2927" xlink:to="lab_trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan_2928" xlink:to="lab_trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan_2929" xlink:to="lab_trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltyForEarlySettlementCharged_2930" xlink:to="lab_trib_PenaltyForEarlySettlementCharged_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltyForEarlySettlementCharged_2931" xlink:to="lab_trib_PenaltyForEarlySettlementCharged_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltyForEarlySettlementCharged_2932" xlink:to="lab_trib_PenaltyForEarlySettlementCharged_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltyForEarlySettlementOfTermLoan_2933" xlink:to="lab_trib_PenaltyForEarlySettlementOfTermLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltyForEarlySettlementOfTermLoan_2934" xlink:to="lab_trib_PenaltyForEarlySettlementOfTermLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltyForEarlySettlementOfTermLoan_2935" xlink:to="lab_trib_PenaltyForEarlySettlementOfTermLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltyPaidForEarlySettlement_2936" xlink:to="lab_trib_PenaltyPaidForEarlySettlement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltyPaidForEarlySettlement_2937" xlink:to="lab_trib_PenaltyPaidForEarlySettlement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PenaltyPaidForEarlySettlement_2938" xlink:to="lab_trib_PenaltyPaidForEarlySettlement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PercentageOfForgivenLoan_2939" xlink:to="lab_trib_PercentageOfForgivenLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PercentageOfForgivenLoan_2940" xlink:to="lab_trib_PercentageOfForgivenLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PercentageOfForgivenLoan_2941" xlink:to="lab_trib_PercentageOfForgivenLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PercentageOfGrossInventory1_2942" xlink:to="lab_trib_PercentageOfGrossInventory1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PercentageOfGrossInventory1_2943" xlink:to="lab_trib_PercentageOfGrossInventory1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PercentageOfGrossInventory1_2944" xlink:to="lab_trib_PercentageOfGrossInventory1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PercentageOfGroupRevenues_2945" xlink:to="lab_trib_PercentageOfGroupRevenues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PercentageOfGroupRevenues_2946" xlink:to="lab_trib_PercentageOfGroupRevenues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PerceptiveAdvisorsMember_2947" xlink:to="lab_trib_PerceptiveAdvisorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PerceptiveAdvisorsMember_2948" xlink:to="lab_trib_PerceptiveAdvisorsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PerceptiveCreditHoldingsIiiLpMember_2949" xlink:to="lab_trib_PerceptiveCreditHoldingsIiiLpMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PerceptiveCreditHoldingsIiiLpMember_2950" xlink:to="lab_trib_PerceptiveCreditHoldingsIiiLpMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PerceptiveMember_2951" xlink:to="lab_trib_PerceptiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PerceptiveMember_2952" xlink:to="lab_trib_PerceptiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PersonnelRelatedCostsMember_2953" xlink:to="lab_trib_PersonnelRelatedCostsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PersonnelRelatedCostsMember_2954" xlink:to="lab_trib_PersonnelRelatedCostsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PhoenixBioTechCorpMember_2955" xlink:to="lab_trib_PhoenixBioTechCorpMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PhoenixBioTechCorpMember_2956" xlink:to="lab_trib_PhoenixBioTechCorpMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PhoenixBiotechMember_2957" xlink:to="lab_trib_PhoenixBiotechMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PointFivePercentageOfGrossInventoryMember_2958" xlink:to="lab_trib_PointFivePercentageOfGrossInventoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PointFivePercentageOfGrossInventoryMember_2959" xlink:to="lab_trib_PointFivePercentageOfGrossInventoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PointFivePercentageOfGrossInventoryMember_2960" xlink:to="lab_trib_PointFivePercentageOfGrossInventoryMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PointOfCareMember_2961" xlink:to="lab_trib_PointOfCareMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PointOfCareMember_2962" xlink:to="lab_trib_PointOfCareMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PostBsEventsMember_2963" xlink:to="lab_trib_PostBsEventsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PostDisposalAdjustmentMember_2964" xlink:to="lab_trib_PostDisposalAdjustmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PostDisposalAdjustmentMember_2965" xlink:to="lab_trib_PostDisposalAdjustmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_2966" xlink:to="lab_trib_PotentiallyDilutiveInstrumentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_2967" xlink:to="lab_trib_PotentiallyDilutiveInstrumentsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PremierInstrumentMember_2968" xlink:to="lab_trib_PremierInstrumentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PremierInstrumentMember_2969" xlink:to="lab_trib_PremierInstrumentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PremierInstrumentMember_2970" xlink:to="lab_trib_PremierInstrumentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PremierLabAutomationMember_2971" xlink:to="lab_trib_PremierLabAutomationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PremierResolutionMember_2972" xlink:to="lab_trib_PremierResolutionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PremierTTenInstrumentMember_2973" xlink:to="lab_trib_PremierTTenInstrumentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PreTaxDiscountRates_2974" xlink:to="lab_trib_PreTaxDiscountRates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PreTaxDiscountRates_2975" xlink:to="lab_trib_PreTaxDiscountRates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrimusCorpMember_2976" xlink:to="lab_trib_PrimusCorpMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrimusCorpMember_2977" xlink:to="lab_trib_PrimusCorpMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrimusCorporationCguTradeNameMember_2978" xlink:to="lab_trib_PrimusCorporationCguTradeNameMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrimusCorporationCguTradeNameMember_2979" xlink:to="lab_trib_PrimusCorporationCguTradeNameMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrimusCorporationIncMember_2980" xlink:to="lab_trib_PrimusCorporationIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrimusCorporationMember_2981" xlink:to="lab_trib_PrimusCorporationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrimusCorporationMember_2982" xlink:to="lab_trib_PrimusCorporationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrincipalActivity_2983" xlink:to="lab_trib_PrincipalActivity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrincipalActivity_2984" xlink:to="lab_trib_PrincipalActivity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrincipalActivity_2985" xlink:to="lab_trib_PrincipalActivity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrincipalAmountLoaned_2986" xlink:to="lab_trib_PrincipalAmountLoaned_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrincipalAmountLoaned_2987" xlink:to="lab_trib_PrincipalAmountLoaned_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrincipalAmountLoaned_2988" xlink:to="lab_trib_PrincipalAmountLoaned_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrincipalAmountLoaned_2989" xlink:to="lab_trib_PrincipalAmountLoaned_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrincipalAmountLoaned_2990" xlink:to="lab_trib_PrincipalAmountLoaned_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrincipalAmountLoaned_2991" xlink:to="lab_trib_PrincipalAmountLoaned_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrincipalDevelopmentProjectsCapitalizedCosts_2992" xlink:to="lab_trib_PrincipalDevelopmentProjectsCapitalizedCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrincipalDevelopmentProjectsCapitalizedCosts_2993" xlink:to="lab_trib_PrincipalDevelopmentProjectsCapitalizedCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PrincipalDevelopmentProjectsCapitalizedCosts_2994" xlink:to="lab_trib_PrincipalDevelopmentProjectsCapitalizedCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsForConvertibleNoteIssued_2995" xlink:to="lab_trib_ProceedsForConvertibleNoteIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsForConvertibleNoteIssued_2996" xlink:to="lab_trib_ProceedsForConvertibleNoteIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsForConvertibleNoteIssued_2997" xlink:to="lab_trib_ProceedsForConvertibleNoteIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsForConvertibleNoteIssued_2998" xlink:to="lab_trib_ProceedsForConvertibleNoteIssued_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsFromCash_2999" xlink:to="lab_trib_ProceedsFromCash_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsFromCash_3000" xlink:to="lab_trib_ProceedsFromCash_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsFromCash_3001" xlink:to="lab_trib_ProceedsFromCash_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsFromNewFinanceLeases_3002" xlink:to="lab_trib_ProceedsFromNewFinanceLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsFromNewFinanceLeases_3003" xlink:to="lab_trib_ProceedsFromNewFinanceLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsFromNewFinanceLeases_3004" xlink:to="lab_trib_ProceedsFromNewFinanceLeases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsFromSaleOfBusiness_3005" xlink:to="lab_trib_ProceedsFromSaleOfBusiness_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsFromSaleOfBusiness_3006" xlink:to="lab_trib_ProceedsFromSaleOfBusiness_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsFromSaleOfBusiness_3007" xlink:to="lab_trib_ProceedsFromSaleOfBusiness_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsFromSaleOfBusiness_3008" xlink:to="lab_trib_ProceedsFromSaleOfBusiness_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsFromSharesToBeIssued_3009" xlink:to="lab_trib_ProceedsFromSharesToBeIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsFromSharesToBeIssued_3010" xlink:to="lab_trib_ProceedsFromSharesToBeIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProceedsFromSharesToBeIssued_3011" xlink:to="lab_trib_ProceedsFromSharesToBeIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProductCullMember_3012" xlink:to="lab_trib_ProductCullMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PropertyAndEquipmentMember_3013" xlink:to="lab_trib_PropertyAndEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PropertyAndEquipmentMember_3014" xlink:to="lab_trib_PropertyAndEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PropertyAndEquipmentMember_3015" xlink:to="lab_trib_PropertyAndEquipmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionalValueMember_3016" xlink:to="lab_trib_ProvisionalValueMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionalValueMember_3017" xlink:to="lab_trib_ProvisionalValueMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionForImpairment_3018" xlink:to="lab_trib_ProvisionForImpairment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionForImpairment_3019" xlink:to="lab_trib_ProvisionForImpairment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionForImpairment_3020" xlink:to="lab_trib_ProvisionForImpairment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionForImpairment_3021" xlink:to="lab_trib_ProvisionForImpairment_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionForImpairment_3022" xlink:to="lab_trib_ProvisionForImpairment_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionForInventoriesMember_3023" xlink:to="lab_trib_ProvisionForInventoriesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionForInventoriesMember_3024" xlink:to="lab_trib_ProvisionForInventoriesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionForInventory_3025" xlink:to="lab_trib_ProvisionForInventory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionForInventory_3026" xlink:to="lab_trib_ProvisionForInventory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionForInventory_3027" xlink:to="lab_trib_ProvisionForInventory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionOfCanteenServicesToThirdParties_3028" xlink:to="lab_trib_ProvisionOfCanteenServicesToThirdParties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionOfCanteenServicesToThirdParties_3029" xlink:to="lab_trib_ProvisionOfCanteenServicesToThirdParties_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionOfCanteenServicesToThirdParties_3030" xlink:to="lab_trib_ProvisionOfCanteenServicesToThirdParties_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionOnExpenses_3031" xlink:to="lab_trib_ProvisionOnExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionOnExpenses_3032" xlink:to="lab_trib_ProvisionOnExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ProvisionOnExpenses_3033" xlink:to="lab_trib_ProvisionOnExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PurchaseOfTreasuryShare_3034" xlink:to="lab_trib_PurchaseOfTreasuryShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PurchaseOfTreasuryShare_3035" xlink:to="lab_trib_PurchaseOfTreasuryShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_PurchaseOfTreasuryShare_3036" xlink:to="lab_trib_PurchaseOfTreasuryShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_Ranges10OfExercisePricesForOutstandingShareOptionOneMember_3037" xlink:to="lab_trib_Ranges10OfExercisePricesForOutstandingShareOptionOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_Ranges10OfExercisePricesForOutstandingShareOptionOneMember_3038" xlink:to="lab_trib_Ranges10OfExercisePricesForOutstandingShareOptionOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_3039" xlink:to="lab_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_3040" xlink:to="lab_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_3041" xlink:to="lab_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_3042" xlink:to="lab_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_3043" xlink:to="lab_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_3044" xlink:to="lab_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_3045" xlink:to="lab_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_3046" xlink:to="lab_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_3047" xlink:to="lab_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_3048" xlink:to="lab_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember_3049" xlink:to="lab_trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember_3050" xlink:to="lab_trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember_3051" xlink:to="lab_trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember_3052" xlink:to="lab_trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_3053" xlink:to="lab_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_3054" xlink:to="lab_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_3055" xlink:to="lab_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_3056" xlink:to="lab_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_3057" xlink:to="lab_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_3058" xlink:to="lab_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember_3059" xlink:to="lab_trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember_3060" xlink:to="lab_trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember_3061" xlink:to="lab_trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember_3062" xlink:to="lab_trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember_3063" xlink:to="lab_trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember_3064" xlink:to="lab_trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember_3065" xlink:to="lab_trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember_3066" xlink:to="lab_trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_3067" xlink:to="lab_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_3068" xlink:to="lab_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_3069" xlink:to="lab_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_3070" xlink:to="lab_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_3071" xlink:to="lab_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_3072" xlink:to="lab_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_3073" xlink:to="lab_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_3074" xlink:to="lab_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_3075" xlink:to="lab_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_3076" xlink:to="lab_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_3077" xlink:to="lab_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_3078" xlink:to="lab_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_3079" xlink:to="lab_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RapidCovid19AntigenTestMember_3080" xlink:to="lab_trib_RapidCovid19AntigenTestMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RapidCovid19AntigenTestMember_3081" xlink:to="lab_trib_RapidCovid19AntigenTestMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RapidCovid19AntigenTestMember_3082" xlink:to="lab_trib_RapidCovid19AntigenTestMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RateOfRentPerSqureFoot_3083" xlink:to="lab_trib_RateOfRentPerSqureFoot_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RateOfRentPerSqureFoot_3084" xlink:to="lab_trib_RateOfRentPerSqureFoot_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown_3085" xlink:to="lab_trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown_3086" xlink:to="lab_trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown_3087" xlink:to="lab_trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RayvilleLimitedMember_3088" xlink:to="lab_trib_RayvilleLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RayvilleLimitedMember_3089" xlink:to="lab_trib_RayvilleLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReceivablesFromConsiderationDueSaleOfBusiness_3090" xlink:to="lab_trib_ReceivablesFromConsiderationDueSaleOfBusiness_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReceivablesFromConsiderationDueSaleOfBusiness_3091" xlink:to="lab_trib_ReceivablesFromConsiderationDueSaleOfBusiness_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReceivablesFromConsiderationDueSaleOfBusiness_3092" xlink:to="lab_trib_ReceivablesFromConsiderationDueSaleOfBusiness_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReceivablesOutstanding_3093" xlink:to="lab_trib_ReceivablesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReceivablesOutstanding_3094" xlink:to="lab_trib_ReceivablesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReceivablesOutstanding_3095" xlink:to="lab_trib_ReceivablesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReclassificationGoodwillAndIntangibleAssets_3096" xlink:to="lab_trib_ReclassificationGoodwillAndIntangibleAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReclassificationGoodwillAndIntangibleAssets_3097" xlink:to="lab_trib_ReclassificationGoodwillAndIntangibleAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReclassificationGoodwillAndIntangibleAssets_3098" xlink:to="lab_trib_ReclassificationGoodwillAndIntangibleAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReclassificationMember_3099" xlink:to="lab_trib_ReclassificationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RecognitionOfContingentAsset_3100" xlink:to="lab_trib_RecognitionOfContingentAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RecognitionOfContingentAsset_3101" xlink:to="lab_trib_RecognitionOfContingentAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RecognitionOfContingentAsset_3102" xlink:to="lab_trib_RecognitionOfContingentAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_3103" xlink:to="lab_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_3104" xlink:to="lab_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_3105" xlink:to="lab_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReducedGrossDebt_3106" xlink:to="lab_trib_ReducedGrossDebt_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReducedGrossDebt_3107" xlink:to="lab_trib_ReducedGrossDebt_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReducedGrossDebt_3108" xlink:to="lab_trib_ReducedGrossDebt_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReductionOfGrossDebt_3109" xlink:to="lab_trib_ReductionOfGrossDebt_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReductionOfGrossDebt_3110" xlink:to="lab_trib_ReductionOfGrossDebt_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReductionOfGrossDebt_3111" xlink:to="lab_trib_ReductionOfGrossDebt_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReductionPercentageInBaseRate_3112" xlink:to="lab_trib_ReductionPercentageInBaseRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReductionPercentageInBaseRate_3113" xlink:to="lab_trib_ReductionPercentageInBaseRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReductionPercentageInBaseRate_3114" xlink:to="lab_trib_ReductionPercentageInBaseRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RefinancingCostsClassifiedAsFinancingActivities_3115" xlink:to="lab_trib_RefinancingCostsClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RefinancingCostsClassifiedAsFinancingActivities_3116" xlink:to="lab_trib_RefinancingCostsClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RefinancingCostsClassifiedAsFinancingActivities_3117" xlink:to="lab_trib_RefinancingCostsClassifiedAsFinancingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReliefOptionForLowValueAssets_3118" xlink:to="lab_trib_ReliefOptionForLowValueAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReliefOptionForLowValueAssets_3119" xlink:to="lab_trib_ReliefOptionForLowValueAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReliefOptionForShortTermLeases_3120" xlink:to="lab_trib_ReliefOptionForShortTermLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReliefOptionForShortTermLeases_3121" xlink:to="lab_trib_ReliefOptionForShortTermLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RemainingFundsForCorporatePurposes_3122" xlink:to="lab_trib_RemainingFundsForCorporatePurposes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RemainingFundsForCorporatePurposes_3123" xlink:to="lab_trib_RemainingFundsForCorporatePurposes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RemainingTermInYears_3124" xlink:to="lab_trib_RemainingTermInYears_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RemainingTermInYears_3125" xlink:to="lab_trib_RemainingTermInYears_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RemainingTermInYears_3126" xlink:to="lab_trib_RemainingTermInYears_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RemeasurementLossRecognizedInProfitLoss_3127" xlink:to="lab_trib_RemeasurementLossRecognizedInProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RemeasurementLossRecognizedInProfitLoss_3128" xlink:to="lab_trib_RemeasurementLossRecognizedInProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RemeasurementLossRecognizedInProfitLoss_3129" xlink:to="lab_trib_RemeasurementLossRecognizedInProfitLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RemeasurementMember_3130" xlink:to="lab_trib_RemeasurementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RemeasurementMember_3131" xlink:to="lab_trib_RemeasurementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RemeasurementOfRightOfUseAssets_3132" xlink:to="lab_trib_RemeasurementOfRightOfUseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RemeasurementOfRightOfUseAssets_3133" xlink:to="lab_trib_RemeasurementOfRightOfUseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RemeasurementOfRightOfUseAssets_3134" xlink:to="lab_trib_RemeasurementOfRightOfUseAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RentalIncomeFromPremises_3135" xlink:to="lab_trib_RentalIncomeFromPremises_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RentalIncomeFromPremises_3136" xlink:to="lab_trib_RentalIncomeFromPremises_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RepaymentOfOtherLoan_3137" xlink:to="lab_trib_RepaymentOfOtherLoan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RepaymentOfOtherLoan_3138" xlink:to="lab_trib_RepaymentOfOtherLoan_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RepaymentOfOtherLoan_3139" xlink:to="lab_trib_RepaymentOfOtherLoan_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RepaymentOfSecuredDebt_3140" xlink:to="lab_trib_RepaymentOfSecuredDebt_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RepaymentOfSecuredDebt_3141" xlink:to="lab_trib_RepaymentOfSecuredDebt_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RepaymentOfSecuredDebt_3142" xlink:to="lab_trib_RepaymentOfSecuredDebt_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ResearchAndDevelopmentMember_3143" xlink:to="lab_trib_ResearchAndDevelopmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ResearchAndDevelopmentMember_3144" xlink:to="lab_trib_ResearchAndDevelopmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ResearchAndDevelopmentTaxCredits_3145" xlink:to="lab_trib_ResearchAndDevelopmentTaxCredits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ResearchAndDevelopmentTaxCredits_3146" xlink:to="lab_trib_ResearchAndDevelopmentTaxCredits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestOfWorldOtherMember_3147" xlink:to="lab_trib_RestOfWorldOtherMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestOfWorldOtherMember_3148" xlink:to="lab_trib_RestOfWorldOtherMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestructuringAccrual_3149" xlink:to="lab_trib_RestructuringAccrual_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestructuringAccrual_3150" xlink:to="lab_trib_RestructuringAccrual_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestructuringActivitiesExpense_3151" xlink:to="lab_trib_RestructuringActivitiesExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestructuringActivitiesExpense_3152" xlink:to="lab_trib_RestructuringActivitiesExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestructuringActivitiesExpense_3153" xlink:to="lab_trib_RestructuringActivitiesExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestructuringActivitiesExpense_3154" xlink:to="lab_trib_RestructuringActivitiesExpense_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestructuringActivitiesExpense_3155" xlink:to="lab_trib_RestructuringActivitiesExpense_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestructuringCost_3156" xlink:to="lab_trib_RestructuringCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestructuringCost_3157" xlink:to="lab_trib_RestructuringCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestructuringCost_3158" xlink:to="lab_trib_RestructuringCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestructuringCost_3159" xlink:to="lab_trib_RestructuringCost_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RestructuringCost_3160" xlink:to="lab_trib_RestructuringCost_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ResultAfterExceptionalExpenses_3161" xlink:to="lab_trib_ResultAfterExceptionalExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ResultAfterExceptionalExpenses_3162" xlink:to="lab_trib_ResultAfterExceptionalExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ResultAfterExceptionalExpenses_3163" xlink:to="lab_trib_ResultAfterExceptionalExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ResultBeforeExceptionalExpenses_3164" xlink:to="lab_trib_ResultBeforeExceptionalExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ResultBeforeExceptionalExpenses_3165" xlink:to="lab_trib_ResultBeforeExceptionalExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ResultBeforeExceptionalExpenses_3166" xlink:to="lab_trib_ResultBeforeExceptionalExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReversalOfImpairmentLossOnFinancialAssets_3167" xlink:to="lab_trib_ReversalOfImpairmentLossOnFinancialAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReversalOfImpairmentLossOnFinancialAssets_3168" xlink:to="lab_trib_ReversalOfImpairmentLossOnFinancialAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReversalOfImpairmentLossOnFinancialAssets_3169" xlink:to="lab_trib_ReversalOfImpairmentLossOnFinancialAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReversalOfNetOperatingLoss_3170" xlink:to="lab_trib_ReversalOfNetOperatingLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReversalOfNetOperatingLoss_3171" xlink:to="lab_trib_ReversalOfNetOperatingLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ReversalOfNetOperatingLoss_3172" xlink:to="lab_trib_ReversalOfNetOperatingLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RevertsMinimumLiquidityCovenant_3173" xlink:to="lab_trib_RevertsMinimumLiquidityCovenant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RevertsMinimumLiquidityCovenant_3174" xlink:to="lab_trib_RevertsMinimumLiquidityCovenant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RightOfUseAssetsCostAtTransitionBeforeImpairment_3175" xlink:to="lab_trib_RightOfUseAssetsCostAtTransitionBeforeImpairment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RightOfUseAssetsCostAtTransitionBeforeImpairment_3176" xlink:to="lab_trib_RightOfUseAssetsCostAtTransitionBeforeImpairment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RightOfUseAssetsCostAtTransitionBeforeImpairment_3177" xlink:to="lab_trib_RightOfUseAssetsCostAtTransitionBeforeImpairment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_3178" xlink:to="lab_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_3179" xlink:to="lab_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_3180" xlink:to="lab_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_3181" xlink:to="lab_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_3182" xlink:to="lab_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_3183" xlink:to="lab_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_3184" xlink:to="lab_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RonanOCaoimhMember_3185" xlink:to="lab_trib_RonanOCaoimhMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RonanOCaoimhMember_3186" xlink:to="lab_trib_RonanOCaoimhMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RonanOCaoimhMember_3187" xlink:to="lab_trib_RonanOCaoimhMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_RubellaAssayEnhancementMember_3188" xlink:to="lab_trib_RubellaAssayEnhancementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SaleAndLeasebackLiabilitiesCurrent_3189" xlink:to="lab_trib_SaleAndLeasebackLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SaleAndLeasebackLiabilitiesCurrent_3190" xlink:to="lab_trib_SaleAndLeasebackLiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SaleAndLeasebackLiabilitiesCurrent_3191" xlink:to="lab_trib_SaleAndLeasebackLiabilitiesCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SaleAndLeasebackLiabilitiesMember_3192" xlink:to="lab_trib_SaleAndLeasebackLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SaleAndLeasebackLiabilitiesMember_3193" xlink:to="lab_trib_SaleAndLeasebackLiabilitiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SaleAndLeasebackLiabilitiesMember_3194" xlink:to="lab_trib_SaleAndLeasebackLiabilitiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SaleAndLeasebackLiabilitiesNonCurrent_3195" xlink:to="lab_trib_SaleAndLeasebackLiabilitiesNonCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SaleAndLeasebackLiabilitiesNonCurrent_3196" xlink:to="lab_trib_SaleAndLeasebackLiabilitiesNonCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SaleAndLeasebackLiabilitiesNonCurrent_3197" xlink:to="lab_trib_SaleAndLeasebackLiabilitiesNonCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SaleOfFitzgeraldIndustriesMember_3198" xlink:to="lab_trib_SaleOfFitzgeraldIndustriesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SaleOfFitzgeraldIndustriesMember_3199" xlink:to="lab_trib_SaleOfFitzgeraldIndustriesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SaleOfFitzgeraldIndustriesMember_3200" xlink:to="lab_trib_SaleOfFitzgeraldIndustriesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SatisfiedByAbstract_3201" xlink:to="lab_trib_SatisfiedByAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SatisfiedByAbstract_3202" xlink:to="lab_trib_SatisfiedByAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ScheduleOfAdditionalInformationOnRightOfUseAssets_3203" xlink:to="lab_trib_ScheduleOfAdditionalInformationOnRightOfUseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ScheduleOfAdditionalInformationOnRightOfUseAssets_3204" xlink:to="lab_trib_ScheduleOfAdditionalInformationOnRightOfUseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_3205" xlink:to="lab_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_3206" xlink:to="lab_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_3207" xlink:to="lab_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_3208" xlink:to="lab_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_3209" xlink:to="lab_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_3210" xlink:to="lab_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_3211" xlink:to="lab_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_3212" xlink:to="lab_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_3213" xlink:to="lab_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SecuredOvernightFinancingRate_3214" xlink:to="lab_trib_SecuredOvernightFinancingRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SecuredOvernightFinancingRate_3215" xlink:to="lab_trib_SecuredOvernightFinancingRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SecuredOvernightFinancingRate_3216" xlink:to="lab_trib_SecuredOvernightFinancingRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SegmentAssets_3217" xlink:to="lab_trib_SegmentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SegmentAssets_3218" xlink:to="lab_trib_SegmentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SegmentLiabilities_3219" xlink:to="lab_trib_SegmentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SegmentLiabilities_3220" xlink:to="lab_trib_SegmentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAdministrationExpensesAbstract_3221" xlink:to="lab_trib_SellingGeneralAdministrationExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAdministrationExpensesAbstract_3222" xlink:to="lab_trib_SellingGeneralAdministrationExpensesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_3223" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_3224" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_3225" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_3226" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_3227" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesRecognitionOfContingentAsset_3228" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesRecognitionOfContingentAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesRecognitionOfContingentAsset_3229" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesRecognitionOfContingentAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_3230" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_3231" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_3232" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense_3233" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense_3234" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense_3235" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement_3236" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement_3237" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement_3238" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlementGross_3239" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlementGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlementGross_3240" xlink:to="lab_trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlementGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorNoteMember_3241" xlink:to="lab_trib_SeniorNoteMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorNoteMember_3242" xlink:to="lab_trib_SeniorNoteMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorNoteMember_3243" xlink:to="lab_trib_SeniorNoteMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanAnnualRate_3244" xlink:to="lab_trib_SeniorSecuredTermLoanAnnualRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanAnnualRate_3245" xlink:to="lab_trib_SeniorSecuredTermLoanAnnualRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanAnnualRate_3246" xlink:to="lab_trib_SeniorSecuredTermLoanAnnualRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanCreditFacilityMember_3247" xlink:to="lab_trib_SeniorSecuredTermLoanCreditFacilityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanCreditFacilityMember_3248" xlink:to="lab_trib_SeniorSecuredTermLoanCreditFacilityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanCreditFacilityMember_3249" xlink:to="lab_trib_SeniorSecuredTermLoanCreditFacilityMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanCreditFacilityOneMember_3250" xlink:to="lab_trib_SeniorSecuredTermLoanCreditFacilityOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanCreditFacilityOneMember_3251" xlink:to="lab_trib_SeniorSecuredTermLoanCreditFacilityOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanCreditFacilityOneMember_3252" xlink:to="lab_trib_SeniorSecuredTermLoanCreditFacilityOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanFixedRate_3253" xlink:to="lab_trib_SeniorSecuredTermLoanFixedRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanFixedRate_3254" xlink:to="lab_trib_SeniorSecuredTermLoanFixedRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanFixedRate_3255" xlink:to="lab_trib_SeniorSecuredTermLoanFixedRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanMember_3256" xlink:to="lab_trib_SeniorSecuredTermLoanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanMember_3257" xlink:to="lab_trib_SeniorSecuredTermLoanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SeniorSecuredTermLoanMember_3258" xlink:to="lab_trib_SeniorSecuredTermLoanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SevenYearConvertibleNoteMember_3259" xlink:to="lab_trib_SevenYearConvertibleNoteMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SevenYearConvertibleNoteMember_3260" xlink:to="lab_trib_SevenYearConvertibleNoteMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SevenYearConvertibleNoteMember_3261" xlink:to="lab_trib_SevenYearConvertibleNoteMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPayments_3262" xlink:to="lab_trib_ShareBasedPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPayments_3263" xlink:to="lab_trib_ShareBasedPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_3264" xlink:to="lab_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_3265" xlink:to="lab_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_3266" xlink:to="lab_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsContinuingOperations_3267" xlink:to="lab_trib_ShareBasedPaymentsContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsContinuingOperations_3268" xlink:to="lab_trib_ShareBasedPaymentsContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsContinuingOperations_3269" xlink:to="lab_trib_ShareBasedPaymentsContinuingOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsContinuingOperations_3270" xlink:to="lab_trib_ShareBasedPaymentsContinuingOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsContinuingOperations_3271" xlink:to="lab_trib_ShareBasedPaymentsContinuingOperations_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsCostOfSales_3272" xlink:to="lab_trib_ShareBasedPaymentsCostOfSales_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsCostOfSales_3273" xlink:to="lab_trib_ShareBasedPaymentsCostOfSales_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsCostOfSales_3274" xlink:to="lab_trib_ShareBasedPaymentsCostOfSales_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsDiscontinuedOperations_3275" xlink:to="lab_trib_ShareBasedPaymentsDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsDiscontinuedOperations_3276" xlink:to="lab_trib_ShareBasedPaymentsDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsDiscontinuedOperations_3277" xlink:to="lab_trib_ShareBasedPaymentsDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_3278" xlink:to="lab_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_3279" xlink:to="lab_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_3280" xlink:to="lab_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareIssueCostForExchangeableNotesPurchase_3281" xlink:to="lab_trib_ShareIssueCostForExchangeableNotesPurchase_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareIssueCostForExchangeableNotesPurchase_3282" xlink:to="lab_trib_ShareIssueCostForExchangeableNotesPurchase_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareOptionMember_3283" xlink:to="lab_trib_ShareOptionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareOptionMember_3284" xlink:to="lab_trib_ShareOptionMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharePricePerAds_3285" xlink:to="lab_trib_SharePricePerAds_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharePricePerAds_3286" xlink:to="lab_trib_SharePricePerAds_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharePricePerAds_3287" xlink:to="lab_trib_SharePricePerAds_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareRepurchasedUnderBuybackProgram_3288" xlink:to="lab_trib_ShareRepurchasedUnderBuybackProgram_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShareRepurchasedUnderBuybackProgram_3289" xlink:to="lab_trib_ShareRepurchasedUnderBuybackProgram_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesConsideration_3290" xlink:to="lab_trib_SharesConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesConsideration_3291" xlink:to="lab_trib_SharesConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesConsideration_3292" xlink:to="lab_trib_SharesConsideration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuableOnConversionOfExchangeableNotes_3293" xlink:to="lab_trib_SharesIssuableOnConversionOfExchangeableNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuableOnConversionOfExchangeableNotes_3294" xlink:to="lab_trib_SharesIssuableOnConversionOfExchangeableNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuableOnConversionOfExchangeableNotes_3295" xlink:to="lab_trib_SharesIssuableOnConversionOfExchangeableNotes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_3296" xlink:to="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_3297" xlink:to="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_3298" xlink:to="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_3299" xlink:to="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_3300" xlink:to="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_3301" xlink:to="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_3302" xlink:to="lab_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_3303" xlink:to="lab_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_3304" xlink:to="lab_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_3305" xlink:to="lab_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_3306" xlink:to="lab_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_3307" xlink:to="lab_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_3308" xlink:to="lab_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesPurchasedDuringYear_3309" xlink:to="lab_trib_SharesPurchasedDuringYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesPurchasedDuringYear_3310" xlink:to="lab_trib_SharesPurchasedDuringYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesRepresentationRateComparedToADS_3311" xlink:to="lab_trib_SharesRepresentationRateComparedToADS_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesRepresentationRateComparedToADS_3312" xlink:to="lab_trib_SharesRepresentationRateComparedToADS_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesRepresentationRateComparedToADS_3313" xlink:to="lab_trib_SharesRepresentationRateComparedToADS_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesSoldDuringYear_3314" xlink:to="lab_trib_SharesSoldDuringYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesSoldDuringYear_3315" xlink:to="lab_trib_SharesSoldDuringYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesToBeIssued_3316" xlink:to="lab_trib_SharesToBeIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesToBeIssued_3317" xlink:to="lab_trib_SharesToBeIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesToBeIssued_3318" xlink:to="lab_trib_SharesToBeIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesToBeIssuedForHedgingReservesValue_3319" xlink:to="lab_trib_SharesToBeIssuedForHedgingReservesValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesToBeIssuedForHedgingReservesValue_3320" xlink:to="lab_trib_SharesToBeIssuedForHedgingReservesValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SharesToBeIssuedForHedgingReservesValue_3321" xlink:to="lab_trib_SharesToBeIssuedForHedgingReservesValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShortTermDepositsAndShortTermInvestments_3322" xlink:to="lab_trib_ShortTermDepositsAndShortTermInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShortTermDepositsAndShortTermInvestments_3323" xlink:to="lab_trib_ShortTermDepositsAndShortTermInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShortTermDepositsAndShortTermInvestments_3324" xlink:to="lab_trib_ShortTermDepositsAndShortTermInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ShortTermLeaseLiabilitiesMember_3325" xlink:to="lab_trib_ShortTermLeaseLiabilitiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SiteTransferCostsMember_3326" xlink:to="lab_trib_SiteTransferCostsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SiteTransferCostsMember_3327" xlink:to="lab_trib_SiteTransferCostsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SiteTransferCostsMember_3328" xlink:to="lab_trib_SiteTransferCostsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember_3329" xlink:to="lab_trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SixMonthOrLessMember_3330" xlink:to="lab_trib_SixMonthOrLessMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SixMonthOrLessMember_3331" xlink:to="lab_trib_SixMonthOrLessMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SixMonthOrLessMember_3332" xlink:to="lab_trib_SixMonthOrLessMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SixMonthToTwelveMonthMember_3333" xlink:to="lab_trib_SixMonthToTwelveMonthMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SixMonthToTwelveMonthMember_3334" xlink:to="lab_trib_SixMonthToTwelveMonthMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SixMonthToTwelveMonthMember_3335" xlink:to="lab_trib_SixMonthToTwelveMonthMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SjogrensCytokineMember_3336" xlink:to="lab_trib_SjogrensCytokineMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SjogrensMonoclonalAntibodiesMember_3337" xlink:to="lab_trib_SjogrensMonoclonalAntibodiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SjogrensMonoclonalAntibodiesTwoMember_3338" xlink:to="lab_trib_SjogrensMonoclonalAntibodiesTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SjogrensTestsMember_3339" xlink:to="lab_trib_SjogrensTestsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SjogrensTestsMember_3340" xlink:to="lab_trib_SjogrensTestsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_StateCreditCarryforwardsMember_3341" xlink:to="lab_trib_StateCreditCarryforwardsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_StrategicInvestmentAndPartnershipWithMICOMember_3342" xlink:to="lab_trib_StrategicInvestmentAndPartnershipWithMICOMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_StrategicInvestmentAndPartnershipWithMICOMember_3343" xlink:to="lab_trib_StrategicInvestmentAndPartnershipWithMICOMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_StrategicInvestmentAndPartnershipWithMICOMember_3344" xlink:to="lab_trib_StrategicInvestmentAndPartnershipWithMICOMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_StrategicPartnershipWithImawareIncMember_3345" xlink:to="lab_trib_StrategicPartnershipWithImawareIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_StrategicPartnershipWithImawareIncMember_3346" xlink:to="lab_trib_StrategicPartnershipWithImawareIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_StrategicPartnershipWithImawareIncMember_3347" xlink:to="lab_trib_StrategicPartnershipWithImawareIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SyphilisPointOfCareMember_3348" xlink:to="lab_trib_SyphilisPointOfCareMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SyphilisPointOfCareMember_3349" xlink:to="lab_trib_SyphilisPointOfCareMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SyphilisPointOfCareMember_3350" xlink:to="lab_trib_SyphilisPointOfCareMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SyphilisPointOfCareTestMember_3351" xlink:to="lab_trib_SyphilisPointOfCareTestMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SyphilisPointOfCareTestMember_3352" xlink:to="lab_trib_SyphilisPointOfCareTestMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_SyphilisRapidPointCareMember_3353" xlink:to="lab_trib_SyphilisRapidPointCareMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_T10HplcAnalyzerMember_3354" xlink:to="lab_trib_T10HplcAnalyzerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_T10HplcAnalyzerMember_3355" xlink:to="lab_trib_T10HplcAnalyzerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_T10HplcAnalyzerMember_3356" xlink:to="lab_trib_T10HplcAnalyzerMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TaxFees_3357" xlink:to="lab_trib_TaxFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TaxFees_3358" xlink:to="lab_trib_TaxFees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_3359" xlink:to="lab_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_3360" xlink:to="lab_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_3361" xlink:to="lab_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_3362" xlink:to="lab_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_3363" xlink:to="lab_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_3364" xlink:to="lab_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TaxValueLossCarryforwardsRecognisedMember_3365" xlink:to="lab_trib_TaxValueLossCarryforwardsRecognisedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TaxValueOfLossCarryForwardsMember_3366" xlink:to="lab_trib_TaxValueOfLossCarryForwardsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TaxValueOfLossCarryForwardsMember_3367" xlink:to="lab_trib_TaxValueOfLossCarryForwardsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TenPercentStrengtheningUSDollarMember_3368" xlink:to="lab_trib_TenPercentStrengtheningUSDollarMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TenPercentStrengtheningUSDollarMember_3369" xlink:to="lab_trib_TenPercentStrengtheningUSDollarMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TenPercentStrengtheningUSDollarMember_3370" xlink:to="lab_trib_TenPercentStrengtheningUSDollarMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TenPercentWeakeningUSDollarMember_3371" xlink:to="lab_trib_TenPercentWeakeningUSDollarMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TenPercentWeakeningUSDollarMember_3372" xlink:to="lab_trib_TenPercentWeakeningUSDollarMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TenPercentWeakeningUSDollarMember_3373" xlink:to="lab_trib_TenPercentWeakeningUSDollarMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TermLoanAgreementDescription_3374" xlink:to="lab_trib_TermLoanAgreementDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TermLoanAgreementDescription_3375" xlink:to="lab_trib_TermLoanAgreementDescription_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TermLoanAgreementDescription_3376" xlink:to="lab_trib_TermLoanAgreementDescription_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TermLoanFacility_3377" xlink:to="lab_trib_TermLoanFacility_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TermLoanFacility_3378" xlink:to="lab_trib_TermLoanFacility_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TermLoanFacility_3379" xlink:to="lab_trib_TermLoanFacility_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TermLoanMember_3380" xlink:to="lab_trib_TermLoanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TermLoanMember_3381" xlink:to="lab_trib_TermLoanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TermOfExchangeableSeniorNotes_3382" xlink:to="lab_trib_TermOfExchangeableSeniorNotes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TermOfExchangeableSeniorNotes_3383" xlink:to="lab_trib_TermOfExchangeableSeniorNotes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TermOfLease_3384" xlink:to="lab_trib_TermOfLease_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TermOfLease_3385" xlink:to="lab_trib_TermOfLease_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ThirtyFirstDecemberTwoThousandThirtyFiveMember_3386" xlink:to="lab_trib_ThirtyFirstDecemberTwoThousandThirtyFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ThirtyFirstDecemberTwoThousandThirtyFourMember_3387" xlink:to="lab_trib_ThirtyFirstDecemberTwoThousandThirtyFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ThirtyFirstDecemberTwoThousandThirtySevenMember_3388" xlink:to="lab_trib_ThirtyFirstDecemberTwoThousandThirtySevenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ThirtyFirstDecemberTwoThousandThirtySixMember_3389" xlink:to="lab_trib_ThirtyFirstDecemberTwoThousandThirtySixMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ThirtyFirstDecemberTwoThousandThirtyThreeMember_3390" xlink:to="lab_trib_ThirtyFirstDecemberTwoThousandThirtyThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ThirtyFirstDecemberTwoThousandThirtyTwoMember_3391" xlink:to="lab_trib_ThirtyFirstDecemberTwoThousandThirtyTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ThreeLoanMember_3392" xlink:to="lab_trib_ThreeLoanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ThreeLoanMember_3393" xlink:to="lab_trib_ThreeLoanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ThresholdWeightedAveragePriceOfAds_3394" xlink:to="lab_trib_ThresholdWeightedAveragePriceOfAds_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ThresholdWeightedAveragePriceOfAds_3395" xlink:to="lab_trib_ThresholdWeightedAveragePriceOfAds_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ThresholdWeightedAveragePriceOfAds_3396" xlink:to="lab_trib_ThresholdWeightedAveragePriceOfAds_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalAssetsAcquiredAsOfAcquisitionDate_3397" xlink:to="lab_trib_TotalAssetsAcquiredAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalAssetsAcquiredAsOfAcquisitionDate_3398" xlink:to="lab_trib_TotalAssetsAcquiredAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalAssetsAcquiredAsOfAcquisitionDate_3399" xlink:to="lab_trib_TotalAssetsAcquiredAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalExchangeableNotesPercentage_3400" xlink:to="lab_trib_TotalExchangeableNotesPercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalExchangeableNotesPercentage_3401" xlink:to="lab_trib_TotalExchangeableNotesPercentage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalExchangeableNotesPercentage_3402" xlink:to="lab_trib_TotalExchangeableNotesPercentage_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalExposureFinancialInstruments_3403" xlink:to="lab_trib_TotalExposureFinancialInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalExposureFinancialInstruments_3404" xlink:to="lab_trib_TotalExposureFinancialInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalExposureFinancialInstruments_3405" xlink:to="lab_trib_TotalExposureFinancialInstruments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalLiabilitiesAssumedAsOfAcquisitionDate_3406" xlink:to="lab_trib_TotalLiabilitiesAssumedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalLiabilitiesAssumedAsOfAcquisitionDate_3407" xlink:to="lab_trib_TotalLiabilitiesAssumedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalLiabilitiesAssumedAsOfAcquisitionDate_3408" xlink:to="lab_trib_TotalLiabilitiesAssumedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalShareOptionsGrantedAdsEquivalent_3409" xlink:to="lab_trib_TotalShareOptionsGrantedAdsEquivalent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalShareOptionsGrantedAdsEquivalent_3410" xlink:to="lab_trib_TotalShareOptionsGrantedAdsEquivalent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalShareOptionsGrantedAdsEquivalent_3411" xlink:to="lab_trib_TotalShareOptionsGrantedAdsEquivalent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TotalShareOptionsGrantedAdsEquivalent_3412" xlink:to="lab_trib_TotalShareOptionsGrantedAdsEquivalent_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_3413" xlink:to="lab_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_3414" xlink:to="lab_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_3415" xlink:to="lab_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_3416" xlink:to="lab_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TradeReceivablesAllowanceForImpairment_3417" xlink:to="lab_trib_TradeReceivablesAllowanceForImpairment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TradeReceivablesAllowanceForImpairment_3418" xlink:to="lab_trib_TradeReceivablesAllowanceForImpairment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TradingTriggerEventsDescription_3419" xlink:to="lab_trib_TradingTriggerEventsDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TradingTriggerEventsDescription_3420" xlink:to="lab_trib_TradingTriggerEventsDescription_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TradingTriggerEventsDescription_3421" xlink:to="lab_trib_TradingTriggerEventsDescription_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TradingTriggerPayment_3422" xlink:to="lab_trib_TradingTriggerPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TradingTriggerPayment_3423" xlink:to="lab_trib_TradingTriggerPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TradingTriggerPayment_3424" xlink:to="lab_trib_TradingTriggerPayment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TribBiosensorsIncMember_3425" xlink:to="lab_trib_TribBiosensorsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TribBiosensorsIncMember_3426" xlink:to="lab_trib_TribBiosensorsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechDoBrasilMember_3427" xlink:to="lab_trib_TrinityBiotechDoBrasilMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechDoBrasilMember_3428" xlink:to="lab_trib_TrinityBiotechDoBrasilMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechIncMember_3429" xlink:to="lab_trib_TrinityBiotechIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechIncMember_3430" xlink:to="lab_trib_TrinityBiotechIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechInvestmentLtdMember_3431" xlink:to="lab_trib_TrinityBiotechInvestmentLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechInvestmentLtdMember_3432" xlink:to="lab_trib_TrinityBiotechInvestmentLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechInvestmentsLtdMember_3433" xlink:to="lab_trib_TrinityBiotechInvestmentsLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechJointVentureLimitedMember_3434" xlink:to="lab_trib_TrinityBiotechJointVentureLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechJointVentureLimitedMember_3435" xlink:to="lab_trib_TrinityBiotechJointVentureLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechLuxembourgSarlMember_3436" xlink:to="lab_trib_TrinityBiotechLuxembourgSarlMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechLuxembourgSarlMember_3437" xlink:to="lab_trib_TrinityBiotechLuxembourgSarlMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechManufacturingLimitedMember_3438" xlink:to="lab_trib_TrinityBiotechManufacturingLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechManufacturingLimitedMember_3439" xlink:to="lab_trib_TrinityBiotechManufacturingLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechManufacturingLtdMember_3440" xlink:to="lab_trib_TrinityBiotechManufacturingLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechManufacturingLtdTwoMember_3441" xlink:to="lab_trib_TrinityBiotechManufacturingLtdTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechManufacturingServicesLimitedMember_3442" xlink:to="lab_trib_TrinityBiotechManufacturingServicesLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechManufacturingServicesLimitedMember_3443" xlink:to="lab_trib_TrinityBiotechManufacturingServicesLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechPlcMember_3444" xlink:to="lab_trib_TrinityBiotechPlcMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechUkLtdMember_3445" xlink:to="lab_trib_TrinityBiotechUkLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityBiotechUkLtdMember_3446" xlink:to="lab_trib_TrinityBiotechUkLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityResearchLimitedMember_3447" xlink:to="lab_trib_TrinityResearchLimitedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinityResearchLimitedMember_3448" xlink:to="lab_trib_TrinityResearchLimitedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinscreenPlantAndEquipmentMember_3449" xlink:to="lab_trib_TrinscreenPlantAndEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinscreenPlantAndEquipmentMember_3450" xlink:to="lab_trib_TrinscreenPlantAndEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TrinscreenPlantAndEquipmentMember_3451" xlink:to="lab_trib_TrinscreenPlantAndEquipmentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TriStatInstrumentMember_3452" xlink:to="lab_trib_TriStatInstrumentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TriStatInstrumentMember_3453" xlink:to="lab_trib_TriStatInstrumentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TriStatInstrumentMember_3454" xlink:to="lab_trib_TriStatInstrumentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TristatMember_3455" xlink:to="lab_trib_TristatMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TristatMember_3456" xlink:to="lab_trib_TristatMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TriStatPointOfCareInstrumentMember_3457" xlink:to="lab_trib_TriStatPointOfCareInstrumentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TriStatPointOfCareInstrumentMember_3458" xlink:to="lab_trib_TriStatPointOfCareInstrumentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TriStatPointOfCareInstrumentMember_3459" xlink:to="lab_trib_TriStatPointOfCareInstrumentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TroponinIassayAndReaderMember_3460" xlink:to="lab_trib_TroponinIassayAndReaderMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TroponinIassayBrainNatriureticPeptideDdimerMember_3461" xlink:to="lab_trib_TroponinIassayBrainNatriureticPeptideDdimerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TwoPercentageOfGrossInventoryMember_3462" xlink:to="lab_trib_TwoPercentageOfGrossInventoryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TwoPercentageOfGrossInventoryMember_3463" xlink:to="lab_trib_TwoPercentageOfGrossInventoryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TwoPercentageOfGrossInventoryMember_3464" xlink:to="lab_trib_TwoPercentageOfGrossInventoryMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TwoYearToFiveYearsMember_3465" xlink:to="lab_trib_TwoYearToFiveYearsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TwoYearToFiveYearsMember_3466" xlink:to="lab_trib_TwoYearToFiveYearsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_TwoYearToFiveYearsMember_3467" xlink:to="lab_trib_TwoYearToFiveYearsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UltraGenesysMember_3468" xlink:to="lab_trib_UltraGenesysMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UltraGenesysMember_3469" xlink:to="lab_trib_UltraGenesysMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnallocatedAssetsBySegmentAbstract_3470" xlink:to="lab_trib_UnallocatedAssetsBySegmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnallocatedAssetsBySegmentAbstract_3471" xlink:to="lab_trib_UnallocatedAssetsBySegmentAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnallocatedExpenses_3472" xlink:to="lab_trib_UnallocatedExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnallocatedExpenses_3473" xlink:to="lab_trib_UnallocatedExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnallocatedLiabilitiesBySegmentAbstract_3474" xlink:to="lab_trib_UnallocatedLiabilitiesBySegmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnallocatedLiabilitiesBySegmentAbstract_3475" xlink:to="lab_trib_UnallocatedLiabilitiesBySegmentAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnearnedFinanceIncomeOnFinanceLease_3476" xlink:to="lab_trib_UnearnedFinanceIncomeOnFinanceLease_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnearnedFinanceIncomeOnFinanceLease_3477" xlink:to="lab_trib_UnearnedFinanceIncomeOnFinanceLease_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnearnedFinanceIncomeOnFinanceLease_3478" xlink:to="lab_trib_UnearnedFinanceIncomeOnFinanceLease_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnforgivenLoansAmount_3479" xlink:to="lab_trib_UnforgivenLoansAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnforgivenLoansAmount_3480" xlink:to="lab_trib_UnforgivenLoansAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnforgivenLoansAmount_3481" xlink:to="lab_trib_UnforgivenLoansAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UniGoldAntigenImprovementMember_3482" xlink:to="lab_trib_UniGoldAntigenImprovementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UniGoldAntigenImprovementMember_3483" xlink:to="lab_trib_UniGoldAntigenImprovementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UniGoldRawMaterialStabilisationMember_3484" xlink:to="lab_trib_UniGoldRawMaterialStabilisationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UniGoldRawMaterialStabilisationMember_3485" xlink:to="lab_trib_UniGoldRawMaterialStabilisationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UniGoldRawMaterialStabilisationMember_3486" xlink:to="lab_trib_UniGoldRawMaterialStabilisationMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UniGoldTestEnhancementMember_3487" xlink:to="lab_trib_UniGoldTestEnhancementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UniGoldTestMember_3488" xlink:to="lab_trib_UniGoldTestMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UniGoldTestMember_3489" xlink:to="lab_trib_UniGoldTestMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnitedKingdomMember_3490" xlink:to="lab_trib_UnitedKingdomMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnitedKingdomMember_3491" xlink:to="lab_trib_UnitedKingdomMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnrecognizedDeferredTaxAsset_3492" xlink:to="lab_trib_UnrecognizedDeferredTaxAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnrecognizedDeferredTaxAsset_3493" xlink:to="lab_trib_UnrecognizedDeferredTaxAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnsecuredJuniorConvertibleNoteMember_3494" xlink:to="lab_trib_UnsecuredJuniorConvertibleNoteMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnsecuredJuniorConvertibleNoteMember_3495" xlink:to="lab_trib_UnsecuredJuniorConvertibleNoteMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnsecuredJuniorConvertibleNoteMember_3496" xlink:to="lab_trib_UnsecuredJuniorConvertibleNoteMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnutilisedNetOperatingLosses_3497" xlink:to="lab_trib_UnutilisedNetOperatingLosses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnutilisedNetOperatingLosses_3498" xlink:to="lab_trib_UnutilisedNetOperatingLosses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnwindingOfDiscountOnDeferredContingentConsideration_3499" xlink:to="lab_trib_UnwindingOfDiscountOnDeferredContingentConsideration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UnwindingOfDiscountOnDeferredContingentConsideration_3500" xlink:to="lab_trib_UnwindingOfDiscountOnDeferredContingentConsideration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_US1Member_3501" xlink:to="lab_trib_US1Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_US1Member_3502" xlink:to="lab_trib_US1Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_US1Member_3503" xlink:to="lab_trib_US1Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_US1Member_3504" xlink:to="lab_trib_US1Member_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_UsStripedLymeMember_3505" xlink:to="lab_trib_UsStripedLymeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ValueOfEmbeddedDerivativesNetLiability_3506" xlink:to="lab_trib_ValueOfEmbeddedDerivativesNetLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ValueOfEmbeddedDerivativesNetLiability_3507" xlink:to="lab_trib_ValueOfEmbeddedDerivativesNetLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_ValueOfEmbeddedDerivativesNetLiability_3508" xlink:to="lab_trib_ValueOfEmbeddedDerivativesNetLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_VariableRateInstruments_3509" xlink:to="lab_trib_VariableRateInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_VariableRateInstruments_3510" xlink:to="lab_trib_VariableRateInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_VariableRateInstruments_3511" xlink:to="lab_trib_VariableRateInstruments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_VariableRateInstrumentsAbstract_3512" xlink:to="lab_trib_VariableRateInstrumentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WagesAndSalariesNetOfCredit_3513" xlink:to="lab_trib_WagesAndSalariesNetOfCredit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WagesAndSalariesNetOfCredit_3514" xlink:to="lab_trib_WagesAndSalariesNetOfCredit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WagesSubsidiesReceived_3515" xlink:to="lab_trib_WagesSubsidiesReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WagesSubsidiesReceived_3516" xlink:to="lab_trib_WagesSubsidiesReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WagesSubsidiesReceived_3517" xlink:to="lab_trib_WagesSubsidiesReceived_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WarrantsIssuedShares_3518" xlink:to="lab_trib_WarrantsIssuedShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WarrantsIssuedShares_3519" xlink:to="lab_trib_WarrantsIssuedShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WarrantsIssuedShares_3520" xlink:to="lab_trib_WarrantsIssuedShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WarrantsPerAdsPrice_3521" xlink:to="lab_trib_WarrantsPerAdsPrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WarrantsPerAdsPrice_3522" xlink:to="lab_trib_WarrantsPerAdsPrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WarrantsPerAdsPrice_3523" xlink:to="lab_trib_WarrantsPerAdsPrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WarrantsToPurchaseADS_3524" xlink:to="lab_trib_WarrantsToPurchaseADS_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WarrantsToPurchaseADS_3525" xlink:to="lab_trib_WarrantsToPurchaseADS_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WarrantsToPurchaseADS_3526" xlink:to="lab_trib_WarrantsToPurchaseADS_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WaveformAcquisitionMember_3527" xlink:to="lab_trib_WaveformAcquisitionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WaveformAcquisitionMember_3528" xlink:to="lab_trib_WaveformAcquisitionMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WaveformTechnologiesIncMember_3529" xlink:to="lab_trib_WaveformTechnologiesIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WaveformTechnologiesIncMember_3530" xlink:to="lab_trib_WaveformTechnologiesIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WaveformTechnologiesIncMember_3531" xlink:to="lab_trib_WaveformTechnologiesIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WaveformTechnologiesIncorporationMember_3532" xlink:to="lab_trib_WaveformTechnologiesIncorporationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WaveformTechnologiesIncorporationMember_3533" xlink:to="lab_trib_WaveformTechnologiesIncorporationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WaveformTechnologiesIncorporationMember_3534" xlink:to="lab_trib_WaveformTechnologiesIncorporationMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageExercisePriceAbstract_3535" xlink:to="lab_trib_WeightedAverageExercisePriceAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageExercisePriceAbstract_3536" xlink:to="lab_trib_WeightedAverageExercisePriceAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageExercisePriceOutstanding_3537" xlink:to="lab_trib_WeightedAverageExercisePriceOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageExercisePriceOutstanding_3538" xlink:to="lab_trib_WeightedAverageExercisePriceOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageExercisePriceOutstanding_3539" xlink:to="lab_trib_WeightedAverageExercisePriceOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageNumberOfSharesIssued_3540" xlink:to="lab_trib_WeightedAverageNumberOfSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageNumberOfSharesIssued_3541" xlink:to="lab_trib_WeightedAverageNumberOfSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageNumberOfSharesIssued_3542" xlink:to="lab_trib_WeightedAverageNumberOfSharesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageNumberOfSharesIssued_3543" xlink:to="lab_trib_WeightedAverageNumberOfSharesIssued_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageNumberOfTreasuryShares_3544" xlink:to="lab_trib_WeightedAverageNumberOfTreasuryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageNumberOfTreasuryShares_3545" xlink:to="lab_trib_WeightedAverageNumberOfTreasuryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_3546" xlink:to="lab_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_3547" xlink:to="lab_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_3548" xlink:to="lab_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageSharesDiscontinuedOperations_3549" xlink:to="lab_trib_WeightedAverageSharesDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageSharesDiscontinuedOperations_3550" xlink:to="lab_trib_WeightedAverageSharesDiscontinuedOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageSharesDiscontinuedOperations_3551" xlink:to="lab_trib_WeightedAverageSharesDiscontinuedOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WeightedAverageSharesDiscontinuedOperations_3552" xlink:to="lab_trib_WeightedAverageSharesDiscontinuedOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WithinOneYearMember_3553" xlink:to="lab_trib_WithinOneYearMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_trib_WithinOneYearMember_3554" xlink:to="lab_trib_WithinOneYearMember_1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>15
<FILENAME>trib-20241231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#DocumentAndEntityInformation" roleURI="http://trinitybiotech.com/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ConsolidatedStatementOfOperations" roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ConsolidatedStatementOfChangesInEquity" roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#EmploymentTables" roleURI="http://trinitybiotech.com/role/EmploymentTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails" roleURI="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails" roleURI="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfRevenueByMajorProductGroupDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfLongLivedAssetsDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails" roleURI="http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#EmploymentScheduleOfEmploymentCostsDetails" roleURI="http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#OtherOperatingIncomeDetails" roleURI="http://trinitybiotech.com/role/OtherOperatingIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IncomeTaxCreditNarrativeDetails" roleURI="http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails" roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IncomeTaxCreditScheduleOfNetOperatingLossesDetails" roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails" roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossPerShareNarrativeDetails" roleURI="http://trinitybiotech.com/role/LossPerShareNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails" roleURI="http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossPerShareScheduleOfEarningsPerAdsDetails" roleURI="http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails" roleURI="http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PropertyPlantAndEquipmentNarrativeDetails" roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails" roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails" roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails" roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsNarrativeDetails" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails" roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails" roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#InventoriesScheduleOfMovementOnInventoryProvisionDetails" roleURI="http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#TradeAndOtherReceivablesNarrativeDetails" roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails" roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails" roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndReservesNarrativeDetails" roleURI="http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndReservesScheduleOfShareCapitalDetails" roleURI="http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ShareOptionsNarrativeDetails" roleURI="http://trinitybiotech.com/role/ShareOptionsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails" roleURI="http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails" roleURI="http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails" roleURI="http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ProvisionsNarrativeDetails" roleURI="http://trinitybiotech.com/role/ProvisionsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails" roleURI="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails" roleURI="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CommitmentsAndContingenciesNarrativeDetails" roleURI="http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#RelatedPartyTransactionsNarrativeDetails" roleURI="http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails" roleURI="http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails" roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails" roleURI="http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GROUPUNDERTAKINGSDetails" roleURI="http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#GOODWILLANDINTANGIBLEASSETSDetails" roleURI="http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSDetails" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSDetails1" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSDetails2" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSDetails3" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSDetails4" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan" roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#FINANCIALASSETSNarrativeDetails" roleURI="http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#AccountingEstimatesAndJudgementsNarrativeDetails" roleURI="http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PostBalanceSheetEventsDetails" roleURI="http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BUSINESSCOMBINATIONSDetails" roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BUSINESSCOMBINATIONSTables" roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BUSINESSCOMBINATIONSNarrativeDetails" roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear" roleURI="http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails" roleURI="http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_dei_EntityAddressesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_dei_EntityAddressesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelFaxNumber" xlink:label="loc_dei_ContactPersonnelFaxNumber_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_46"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntityAddressesTable_1" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_1" xlink:to="loc_dei_BusinessContactMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityRegistrantName_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityCentralIndexKey_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentType_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentPeriodEndDate_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_AmendmentFlag_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentFiscalYearFocus_13" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentRegistrationStatement_14" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentAnnualReport_15" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentTransitionReport_16" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentShellCompanyReport_17" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityEmergingGrowthCompany_18" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityFileNumber_19" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_20" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityVoluntaryFilers_21" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_22" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_23" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityCurrentReportingStatus_24" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityInteractiveDataCurrent_25" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityFilerCategory_26" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_ContactPersonnelName_27" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_CityAreaCode_28" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_LocalPhoneNumber_29" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_ContactPersonnelFaxNumber_30" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine1_31" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine2_32" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressCityOrTown_33" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressStateOrProvince_34" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressCountry_35" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressPostalZipCode_36" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_Security12bTitle_37" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_TradingSymbol_38" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_SecurityExchangeName_39" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_IcfrAuditorAttestationFlag_40" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentAccountingStandard_41" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityShellCompany_42" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_AuditorName_43" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_AuditorLocation_44" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_AuditorFirmId_45" order="400" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_46" order="410" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ConsolidatedStatementOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OnceOffExpense" xlink:label="loc_trib_OnceOffExpense_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetFinancingExpenseIncome" xlink:label="loc_trib_NetFinancingExpenseIncome_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_28"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_Revenue_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_CostOfSales_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_GrossProfit_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_12" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_13" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_OnceOffExpense_14" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_15" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_16" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_FinanceIncome_17" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_FinanceCosts_18" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_NetFinancingExpenseIncome_19" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_20" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_21" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProfitLoss_22" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_23" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_24" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_25" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_26" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_27" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_28" order="220" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-full_TreasurySharesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNoteMember" xlink:label="loc_trib_EquityComponentOfConvertibleNoteMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReservesMember" xlink:label="loc_ifrs-full_OtherReservesMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfCashFlowHedgesMember" xlink:label="loc_ifrs-full_ReserveOfCashFlowHedgesMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesToBeIssued" xlink:label="loc_trib_SharesToBeIssued_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreasedecreasethroughequityComponentOfConvertibleNote" xlink:label="loc_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_21"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_1" xlink:to="loc_ifrs-full_IssuedCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_1" xlink:to="loc_ifrs-full_SharePremiumMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_1" xlink:to="loc_ifrs-full_TreasurySharesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_1" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_1" xlink:to="loc_trib_EquityComponentOfConvertibleNoteMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_1" xlink:to="loc_ifrs-full_OtherReservesMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_1" xlink:to="loc_ifrs-full_RetainedEarningsMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_1" xlink:to="loc_ifrs-full_ReserveOfCashFlowHedgesMember_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_Equity_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_16" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IssueOfEquity_17" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_18" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_trib_SharesToBeIssued_19" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_trib_IncreasedecreasethroughequityComponentOfConvertibleNote_20" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_21" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/EmploymentTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="loc_ifrs-full_ContinuingOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="loc_ifrs-full_ContinuingOperationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_ContinuingOperationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ContinuingOperationsMember_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_ContinuingOperationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_7" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OfficeEquipmentMember" xlink:label="loc_ifrs-full_OfficeEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PropertyAndEquipmentMember" xlink:label="loc_trib_PropertyAndEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_OfficeEquipmentMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_ComputerEquipmentMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_trib_PropertyAndEquipmentMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_10" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:label="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1" xlink:to="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1" xlink:to="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="loc_country_US_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EliminationOfIntersegmentAmountsMember" xlink:label="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_US_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_ifrs-full_EliminationOfIntersegmentAmountsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_OtherRevenue_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_Revenue_11" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AsiaOrAfricaMember" xlink:label="loc_trib_AsiaOrAfricaMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EuropeIncludingIrelandMember" xlink:label="loc_trib_EuropeIncludingIrelandMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AsiaOrAfricaMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_EuropeIncludingIrelandMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:label="loc_ifrs-full_DisclosureOfProductsAndServicesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesTable" xlink:label="loc_ifrs-full_DisclosureOfProductsAndServicesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClinicalLaboratoryMember" xlink:label="loc_trib_ClinicalLaboratoryMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaboratoryServicesMember" xlink:label="loc_trib_LaboratoryServicesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PointOfCareMember" xlink:label="loc_trib_PointOfCareMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfProductsAndServicesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesTable_1" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_1" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_1" xlink:to="loc_trib_ClinicalLaboratoryMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_1" xlink:to="loc_trib_LaboratoryServicesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_1" xlink:to="loc_trib_PointOfCareMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_1" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfProductsAndServicesLineItems_0" xlink:to="loc_ifrs-full_Revenue_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CustomerMember" xlink:label="loc_trib_CustomerMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AsiaOrAfricaMember" xlink:label="loc_trib_AsiaOrAfricaMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentReceivablesFromContractsWithCustomers" xlink:label="loc_ifrs-full_CurrentReceivablesFromContractsWithCustomers_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentReceivablesFromContractsWithCustomers" xlink:label="loc_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomers" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomers_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1" xlink:to="loc_srt_MajorCustomersAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_1" xlink:to="loc_srt_NameOfMajorCustomerDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1" xlink:to="loc_trib_CustomerMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_1" xlink:to="loc_srt_NameOfMajorCustomerDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5" xlink:to="loc_ifrs-full_GeographicalAreasDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_5" xlink:to="loc_trib_AmericaMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_5" xlink:to="loc_country_IE_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_5" xlink:to="loc_trib_OtherCountriesMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_5" xlink:to="loc_trib_AsiaOrAfricaMember_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_5" xlink:to="loc_srt_EuropeMember_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_0" xlink:to="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_14" xlink:to="loc_ifrs-full_CurrentReceivablesFromContractsWithCustomers_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_14" xlink:to="loc_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_14" xlink:to="loc_ifrs-full_ReceivablesFromContractsWithCustomers_16" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResultBeforeExceptionalExpenses" xlink:label="loc_trib_ResultBeforeExceptionalExpenses_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLoss" xlink:label="loc_ifrs-full_ImpairmentLoss_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResultAfterExceptionalExpenses" xlink:label="loc_trib_ResultAfterExceptionalExpenses_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnallocatedExpenses" xlink:label="loc_trib_UnallocatedExpenses_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancingIncomeBySegment" xlink:label="loc_trib_FinancingIncomeBySegment_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefund" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefund_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_trib_ResultBeforeExceptionalExpenses_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLoss_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_trib_ResultAfterExceptionalExpenses_11" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_trib_UnallocatedExpenses_12" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_13" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_trib_FinancingIncomeBySegment_14" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_15" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefund_16" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations_17" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_18" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_19" order="120" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AssetsAndLiabilitiesBySegmentAbstract" xlink:label="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SegmentAssets" xlink:label="loc_trib_SegmentAssets_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnallocatedAssetsBySegmentAbstract" xlink:label="loc_trib_UnallocatedAssetsBySegmentAbstract_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxAssetsCurrentAndDeferred" xlink:label="loc_trib_IncomeTaxAssetsCurrentAndDeferred_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentsAndShortTermInvestments" xlink:label="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDeferredTaxAssets" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SegmentLiabilities" xlink:label="loc_trib_SegmentLiabilities_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnallocatedLiabilitiesBySegmentAbstract" xlink:label="loc_trib_UnallocatedLiabilitiesBySegmentAbstract_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxLiabilitiesCurrentAndDeferred" xlink:label="loc_trib_IncomeTaxLiabilitiesCurrentAndDeferred_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities" xlink:label="loc_ifrs-full_NetDeferredTaxLiabilities_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_8" xlink:to="loc_trib_SegmentAssets_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_8" xlink:to="loc_trib_UnallocatedAssetsBySegmentAbstract_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_UnallocatedAssetsBySegmentAbstract_9" xlink:to="loc_trib_IncomeTaxAssetsCurrentAndDeferred_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_UnallocatedAssetsBySegmentAbstract_9" xlink:to="loc_trib_CashAndCashEquivalentsAndShortTermInvestments_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_8" xlink:to="loc_ifrs-full_NetDeferredTaxAssets_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_8" xlink:to="loc_trib_SegmentLiabilities_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_8" xlink:to="loc_trib_UnallocatedLiabilitiesBySegmentAbstract_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_UnallocatedLiabilitiesBySegmentAbstract_14" xlink:to="loc_trib_IncomeTaxLiabilitiesCurrentAndDeferred_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_AssetsAndLiabilitiesBySegmentAbstract_8" xlink:to="loc_ifrs-full_NetDeferredTaxLiabilities_16" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongLivedAsstesBySegment" xlink:label="loc_trib_LongLivedAsstesBySegment_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_trib_LongLivedAsstesBySegment_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-full_DepreciationExpense_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationExpense" xlink:label="loc_ifrs-full_AmortisationExpense_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DepreciationExpense_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_AmortisationExpense_9" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxExpense" xlink:label="loc_trib_IncomeTaxExpense_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_trib_IncomeTaxExpense_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForDevelopmentProjectExpenditure" xlink:label="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_PaymentsForDevelopmentProjectExpenditure_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ResearchAndDevelopmentMember" xlink:label="loc_trib_ResearchAndDevelopmentMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdministrationAndSalesMember" xlink:label="loc_trib_AdministrationAndSalesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ManufacturingAndQualityMember" xlink:label="loc_trib_ManufacturingAndQualityMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AverageNumberOfEmployees" xlink:label="loc_ifrs-full_AverageNumberOfEmployees_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_1" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_1" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_1" xlink:to="loc_trib_ResearchAndDevelopmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_1" xlink:to="loc_trib_AdministrationAndSalesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_1" xlink:to="loc_trib_ManufacturingAndQualityMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_1" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_0" xlink:to="loc_ifrs-full_AverageNumberOfEmployees_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="loc_ifrs-full_ContinuingOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="loc_ifrs-full_DiscontinuedOperationsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="loc_ifrs-full_ContinuingOperationsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SocialSecurityContributions" xlink:label="loc_ifrs-full_SocialSecurityContributions_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes" xlink:label="loc_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExpenseOfRestructuringCost" xlink:label="loc_trib_ExpenseOfRestructuringCost_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RecognitionOfContingentAsset" xlink:label="loc_trib_RecognitionOfContingentAsset_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_ContinuingOperationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ContinuingOperationsMember_1" xlink:to="loc_ifrs-full_DiscontinuedOperationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ContinuingAndDiscontinuedOperationsAxis_1" xlink:to="loc_ifrs-full_ContinuingOperationsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_WagesAndSalaries_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_SocialSecurityContributions_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0" xlink:to="loc_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0" xlink:to="loc_trib_ExpenseOfRestructuringCost_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0" xlink:to="loc_trib_RecognitionOfContingentAsset_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_EmployeeBenefitsExpense_13" order="80" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/OtherOperatingIncomeDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherOperatingIncomeLineItems" xlink:label="loc_trib_OtherOperatingIncomeLineItems_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherOperatingIncomeTable" xlink:label="loc_trib_OtherOperatingIncomeTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaycheckProtectionProgramLoanMember" xlink:label="loc_trib_PaycheckProtectionProgramLoanMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LoansPayableInDefault" xlink:label="loc_ifrs-full_LoansPayableInDefault_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanIncome" xlink:label="loc_trib_LoanIncome_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPayable" xlink:label="loc_ifrs-full_InterestPayable_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_trib_OtherOperatingIncomeLineItems_0" xlink:to="loc_trib_OtherOperatingIncomeTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_trib_OtherOperatingIncomeTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1" xlink:to="loc_trib_PaycheckProtectionProgramLoanMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_OtherOperatingIncomeLineItems_0" xlink:to="loc_ifrs-full_LoansPayableInDefault_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_OtherOperatingIncomeLineItems_0" xlink:to="loc_trib_LoanIncome_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_OtherOperatingIncomeLineItems_0" xlink:to="loc_ifrs-full_InterestPayable_8" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="loc_country_US_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCountriesMember" xlink:label="loc_trib_OtherCountriesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeFromPaycheckProtectionProgramLoans" xlink:label="loc_trib_IncomeFromPaycheckProtectionProgramLoans_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetOperatingLossCarryforwards" xlink:label="loc_trib_NetOperatingLossCarryforwards_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetOperatingLossPeriod" xlink:label="loc_trib_NetOperatingLossPeriod_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OnceOffTaxCredit" xlink:label="loc_trib_OnceOffTaxCredit_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_US_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherCountriesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_trib_IncomeFromPaycheckProtectionProgramLoans_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_trib_NetOperatingLossCarryforwards_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_trib_NetOperatingLossPeriod_11" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_trib_OnceOffTaxCredit_12" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_ApplicableTaxRate_13" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRegionsMember" xlink:label="loc_trib_OtherRegionsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherRegionsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRegionsMember" xlink:label="loc_trib_OtherRegionsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnutilisedNetOperatingLosses" xlink:label="loc_trib_UnutilisedNetOperatingLosses_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherRegionsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_trib_UnutilisedNetOperatingLosses_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE" xlink:label="loc_country_IE_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRegionsMember" xlink:label="loc_trib_OtherRegionsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericaMember" xlink:label="loc_trib_AmericaMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_US1Member" xlink:label="loc_trib_US1Member_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_IE_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherRegionsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_AmericaMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_US1Member_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset_9" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossPerShareNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedProfitAfterTax" xlink:label="loc_trib_AdjustedProfitAfterTax_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions" xlink:label="loc_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsGranted" xlink:label="loc_trib_NumberOfOptionsGranted_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsIssuable" xlink:label="loc_trib_NumberOfOptionsIssuable_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfOptionsLapsedUnexercised" xlink:label="loc_trib_NumberOfOptionsLapsedUnexercised_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuedOnExerciseOfOptions" xlink:label="loc_trib_NumberOfSharesIssuedOnExerciseOfOptions_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare" xlink:label="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_22"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive" xlink:label="loc_trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive_23"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MaximumMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_6" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_6" xlink:to="loc_trib_ClassAOrdinarySharesMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_6" xlink:to="loc_trib_AmericanDepositaryShareMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_6" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageShares_15" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_AdjustedProfitAfterTax_16" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions_17" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_NumberOfOptionsGranted_18" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_NumberOfOptionsIssuable_19" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_NumberOfOptionsLapsedUnexercised_20" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_NumberOfSharesIssuedOnExerciseOfOptions_21" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare_22" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive_23" order="120" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract" xlink:label="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAOrdinaryWeightedAverageShares" xlink:label="loc_trib_NumberOfAOrdinaryWeightedAverageShares_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfSharesIssued" xlink:label="loc_trib_WeightedAverageNumberOfSharesIssued_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfTreasuryShares" xlink:label="loc_trib_WeightedAverageNumberOfTreasuryShares_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageShares_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_7" xlink:to="loc_trib_NumberOfAOrdinaryWeightedAverageShares_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_7" xlink:to="loc_trib_WeightedAverageNumberOfSharesIssued_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_7" xlink:to="loc_trib_WeightedAverageNumberOfTreasuryShares_9" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositoryShares" xlink:label="loc_trib_AmericanDepositoryShares_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract" xlink:label="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfAmericanDepositorySharesWeightedAverageShares" xlink:label="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfSharesIssued" xlink:label="loc_trib_WeightedAverageNumberOfSharesIssued_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageNumberOfTreasuryShares" xlink:label="loc_trib_WeightedAverageNumberOfTreasuryShares_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_AmericanDepositoryShares_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageShares_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_8" xlink:to="loc_trib_NumberOfAmericanDepositorySharesWeightedAverageShares_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_8" xlink:to="loc_trib_WeightedAverageNumberOfSharesIssued_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract_8" xlink:to="loc_trib_WeightedAverageNumberOfTreasuryShares_10" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PotentiallyDilutiveInstrumentsAbstract" xlink:label="loc_trib_PotentiallyDilutiveInstrumentsAbstract_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnExerciseOfOptions" xlink:label="loc_trib_IssuableOnExerciseOfOptions_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" xlink:label="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuableOnConversionOfExchangeableNotes" xlink:label="loc_trib_SharesIssuableOnConversionOfExchangeableNotes_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuableOnConversionOfConvertibleNotes" xlink:label="loc_trib_IssuableOnConversionOfConvertibleNotes_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented" xlink:label="loc_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_PotentiallyDilutiveInstrumentsAbstract_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_6" xlink:to="loc_trib_IssuableOnExerciseOfOptions_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_6" xlink:to="loc_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_6" xlink:to="loc_trib_SharesIssuableOnConversionOfExchangeableNotes_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_6" xlink:to="loc_trib_IssuableOnConversionOfConvertibleNotes_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_PotentiallyDilutiveInstrumentsAbstract_6" xlink:to="loc_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented_10" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringCost" xlink:label="loc_trib_RestructuringCost_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsImpairmentAdjustmentOnTransition" xlink:label="loc_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentChargePropertyPlantEquipment" xlink:label="loc_trib_ImpairmentChargePropertyPlantEquipment_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossInvestmentProperty" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossInvestmentProperty_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeRelatingToVariableLeasePaymentsForOperatingLeasesThatDoNotDependOnIndexOrRate" xlink:label="loc_ifrs-full_IncomeRelatingToVariableLeasePaymentsForOperatingLeasesThatDoNotDependOnIndexOrRate_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentExpendituresRecognisedForConstructions" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentExpendituresRecognisedForConstructions_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeFromSubleasingRightofuseAssets" xlink:label="loc_ifrs-full_IncomeFromSubleasingRightofuseAssets_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_RightofuseAssets_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_AdditionsToRightofuseAssets_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_trib_RestructuringCost_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_trib_RightOfUseAssetsImpairmentAdjustmentOnTransition_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_trib_ImpairmentChargePropertyPlantEquipment_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossInvestmentProperty_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_IncomeRelatingToVariableLeasePaymentsForOperatingLeasesThatDoNotDependOnIndexOrRate_13" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_14" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentExpendituresRecognisedForConstructions_15" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_IncomeFromSubleasingRightofuseAssets_16" order="110" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCarryingAmountMember" xlink:label="loc_trib_NetCarryingAmountMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LandAndBuildingsMember" xlink:label="loc_ifrs-full_LandAndBuildingsMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="loc_ifrs-full_ComputerEquipmentMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment" xlink:label="loc_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment" xlink:label="loc_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsOrRetirementsPropertyAndEquipment" xlink:label="loc_trib_DisposalsOrRetirementsPropertyAndEquipment_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets" xlink:label="loc_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated_26"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_trib_NetCarryingAmountMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_7" xlink:to="loc_ifrs-full_LandAndBuildingsMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_7" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_7" xlink:to="loc_ifrs-full_ComputerEquipmentMember_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_7" xlink:to="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_7" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_17" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_18" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment_19" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment_20" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_trib_DisposalsOrRetirementsPropertyAndEquipment_21" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_22" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets_23" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_24" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_25" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated_26" order="120" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ComputerEquipmentsMember" xlink:label="loc_trib_ComputerEquipmentsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DepreciationMember" xlink:label="loc_trib_DepreciationMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RightOfUseAssetsIncludingDepreciationAndImpairment" xlink:label="loc_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_trib_ComputerEquipmentsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7" xlink:to="loc_ifrs-full_CarryingAmountMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_7" xlink:to="loc_trib_DepreciationMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_7" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_7" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xlink:to="loc_trib_RightOfUseAssetsIncludingDepreciationAndImpairment_13" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-full_BuildingsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-full_VehiclesMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ITAndOfficeEquipmentMember" xlink:label="loc_trib_ITAndOfficeEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRightOfUseLeasedAssets" xlink:label="loc_trib_NumberOfRightOfUseLeasedAssets_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemainingTermInYears" xlink:label="loc_trib_RemainingTermInYears_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AverageRemainingLeaseTermYears" xlink:label="loc_trib_AverageRemainingLeaseTermYears_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithExtensionOptions" xlink:label="loc_trib_NumberOfLeasesWithExtensionOptions_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithOptionsToPurchase" xlink:label="loc_trib_NumberOfLeasesWithOptionsToPurchase_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex" xlink:label="loc_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfLeasesWithTerminationOptions" xlink:label="loc_trib_NumberOfLeasesWithTerminationOptions_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_BuildingsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_ifrs-full_VehiclesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentMember_1" xlink:to="loc_trib_ITAndOfficeEquipmentMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable_1" xlink:to="loc_ifrs-full_RangeAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_7" xlink:to="loc_ifrs-full_RangeDomain_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_7" xlink:to="loc_ifrs-full_BottomOfRangeMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_7" xlink:to="loc_ifrs-full_TopOfRangeMember_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_7" xlink:to="loc_ifrs-full_RangeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_trib_NumberOfRightOfUseLeasedAssets_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_trib_RemainingTermInYears_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_trib_AverageRemainingLeaseTermYears_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_trib_NumberOfLeasesWithExtensionOptions_16" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_trib_NumberOfLeasesWithOptionsToPurchase_17" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex_18" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems_0" xlink:to="loc_trib_NumberOfLeasesWithTerminationOptions_19" order="70" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-full_BrandNamesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticsIncMember" xlink:label="loc_trib_ImmcoDiagnosticsIncMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingLimitedMember" xlink:label="loc_trib_TrinityBiotechManufacturingLimitedMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicDiagnosticsLimitedMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncMember" xlink:label="loc_trib_WaveformTechnologiesIncMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-full_TechnologybasedIntangibleAssetsMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_T10HplcAnalyzerMember" xlink:label="loc_trib_T10HplcAnalyzerMember_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SyphilisPointOfCareMember" xlink:label="loc_trib_SyphilisPointOfCareMember_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinscreenPlantAndEquipmentMember" xlink:label="loc_trib_TrinscreenPlantAndEquipmentMember_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KansasRightOfUseAssetMember" xlink:label="loc_trib_KansasRightOfUseAssetMember_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TristatMember" xlink:label="loc_trib_TristatMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyDevelopmentAndProjectManagementExpense" xlink:label="loc_ifrs-full_PropertyDevelopmentAndProjectManagementExpense_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets" xlink:label="loc_ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalProjectCost" xlink:label="loc_trib_AdditionalProjectCost_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GoodwillWriteOff" xlink:label="loc_trib_GoodwillWriteOff_30"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IntangibleAssetsUnderDevelopmentWrittenDown" xlink:label="loc_trib_IntangibleAssetsUnderDevelopmentWrittenDown_31"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IntangibleAssetsUnderDevelopmentImpairmentCharge" xlink:label="loc_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_32"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AssetsUnderDevelopmentCarryingValue" xlink:label="loc_trib_AssetsUnderDevelopmentCarryingValue_33"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashImpairmentCharge" xlink:label="loc_trib_NonCashImpairmentCharge_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_36"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentLossForInvestment" xlink:label="loc_trib_ImpairmentLossForInvestment_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:label="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_39"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongTermGrowthRate" xlink:label="loc_trib_LongTermGrowthRate_40"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PreTaxDiscountRates" xlink:label="loc_trib_PreTaxDiscountRates_41"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalImpairmentLossDueToGrowthInRevenues" xlink:label="loc_trib_AdditionalImpairmentLossDueToGrowthInRevenues_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_43"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ActuarialAssumptionOfDiscountRatePercentage" xlink:label="loc_trib_ActuarialAssumptionOfDiscountRatePercentage_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_45"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalImpairmentLoss" xlink:label="loc_trib_AdditionalImpairmentLoss_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssets" xlink:label="loc_ifrs-full_OtherIntangibleAssets_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_50"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_BrandNamesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_ImmcoDiagnosticsIncMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_TrinityBiotechManufacturingLimitedMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_MetabolomicDiagnosticsLimitedMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_WaveformTechnologiesIncMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_EpiCaptureLimitedMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_TechnologybasedIntangibleAssetsMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_RangeAxis_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_11" xlink:to="loc_ifrs-full_RangeDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_11" xlink:to="loc_ifrs-full_BottomOfRangeMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_11" xlink:to="loc_ifrs-full_TopOfRangeMember_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_11" xlink:to="loc_ifrs-full_RangeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_16" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_16" xlink:to="loc_trib_T10HplcAnalyzerMember_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_16" xlink:to="loc_trib_SyphilisPointOfCareMember_17" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_16" xlink:to="loc_trib_TrinscreenPlantAndEquipmentMember_18" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_16" xlink:to="loc_trib_KansasRightOfUseAssetMember_19" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_16" xlink:to="loc_trib_TristatMember_20" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_16" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_PropertyDevelopmentAndProjectManagementExpense_25" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets_26" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_AdditionalProjectCost_27" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_28" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment_29" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_GoodwillWriteOff_30" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_IntangibleAssetsUnderDevelopmentWrittenDown_31" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge_32" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_AssetsUnderDevelopmentCarryingValue_33" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_NonCashImpairmentCharge_34" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_35" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossOnFinancialAssets_36" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_ImpairmentLossForInvestment_37" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_38" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_39" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_LongTermGrowthRate_40" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_PreTaxDiscountRates_41" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_AdditionalImpairmentLossDueToGrowthInRevenues_42" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_43" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_ActuarialAssumptionOfDiscountRatePercentage_44" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_45" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_AdditionalImpairmentLoss_46" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_47" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_OtherIntangibleAssets_48" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_49" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_50" order="260" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-full_GoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DevelopmentCostMember" xlink:label="loc_trib_DevelopmentCostMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:label="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-full_TechnologybasedIntangibleAssetsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCarryingAmountMember" xlink:label="loc_trib_NetCarryingAmountMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsGoodwillAndIntangibleAssets" xlink:label="loc_trib_DisposalsGoodwillAndIntangibleAssets_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReclassificationGoodwillAndIntangibleAssets" xlink:label="loc_trib_ReclassificationGoodwillAndIntangibleAssets_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_23"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_ifrs-full_GoodwillMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_DevelopmentCostMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_ifrs-full_TechnologybasedIntangibleAssetsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9" xlink:to="loc_ifrs-full_CarryingAmountMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_9" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_9" xlink:to="loc_trib_NetCarryingAmountMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_9" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_9" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill_19" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_trib_DisposalsGoodwillAndIntangibleAssets_20" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_trib_ReclassificationGoodwillAndIntangibleAssets_21" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_22" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_23" order="80" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContinuousGlucoseMonitoringTestingMember" xlink:label="loc_trib_ContinuousGlucoseMonitoringTestingMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PremierInstrumentMember" xlink:label="loc_trib_PremierInstrumentMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CovidTestMember" xlink:label="loc_trib_CovidTestMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AutoimmuneSmartReaderMember" xlink:label="loc_trib_AutoimmuneSmartReaderMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MidTierHaemoglobinsInstrumentMember" xlink:label="loc_trib_MidTierHaemoglobinsInstrumentMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_HivOneByTwoRapidTestMember" xlink:label="loc_trib_HivOneByTwoRapidTestMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldRawMaterialStabilisationMember" xlink:label="loc_trib_UniGoldRawMaterialStabilisationMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TriStatPointOfCareInstrumentMember" xlink:label="loc_trib_TriStatPointOfCareInstrumentMember_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SjogrensTestsMember" xlink:label="loc_trib_SjogrensTestsMember_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldAntigenImprovementMember" xlink:label="loc_trib_UniGoldAntigenImprovementMember_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SyphilisPointOfCareTestMember" xlink:label="loc_trib_SyphilisPointOfCareTestMember_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ColumnEnhancementMember" xlink:label="loc_trib_ColumnEnhancementMember_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UltraGenesysMember" xlink:label="loc_trib_UltraGenesysMember_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherProjectsMember" xlink:label="loc_trib_OtherProjectsMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_G6PDHTestMember" xlink:label="loc_trib_G6PDHTestMember_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UniGoldTestMember" xlink:label="loc_trib_UniGoldTestMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalDevelopmentProjectsCapitalizedCosts" xlink:label="loc_trib_PrincipalDevelopmentProjectsCapitalizedCosts_21"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_ContinuousGlucoseMonitoringTestingMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_PremierInstrumentMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_CovidTestMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_AutoimmuneSmartReaderMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_MidTierHaemoglobinsInstrumentMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_HivOneByTwoRapidTestMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_UniGoldRawMaterialStabilisationMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_TriStatPointOfCareInstrumentMember_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_SjogrensTestsMember_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_UniGoldAntigenImprovementMember_10" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_SyphilisPointOfCareTestMember_11" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_ColumnEnhancementMember_12" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_UltraGenesysMember_13" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_OtherProjectsMember_14" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_G6PDHTestMember_15" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_UniGoldTestMember_16" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_trib_PrincipalDevelopmentProjectsCapitalizedCosts_21" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticsIncMember" xlink:label="loc_trib_ImmcoDiagnosticsIncMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingLimitedMember" xlink:label="loc_trib_TrinityBiotechManufacturingLimitedMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechDoBrasilMember" xlink:label="loc_trib_TrinityBiotechDoBrasilMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrimusCorpMember" xlink:label="loc_trib_PrimusCorpMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClarkLaboratoriesIncMember" xlink:label="loc_trib_ClarkLaboratoriesIncMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiopoolUsIncMember" xlink:label="loc_trib_BiopoolUsIncMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MardxDiagnosticsIncMember" xlink:label="loc_trib_MardxDiagnosticsIncMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_ImmcoDiagnosticsIncMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_TrinityBiotechManufacturingLimitedMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_TrinityBiotechDoBrasilMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_PrimusCorpMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_ClarkLaboratoriesIncMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_BiopoolUsIncMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_MardxDiagnosticsIncMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_12" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncMember" xlink:label="loc_trib_WaveformTechnologiesIncMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalCguTradeNameMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CarryingAmountOfGoodwill" xlink:label="loc_trib_CarryingAmountOfGoodwill_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxRateEffectOfImpairmentOfGoodwill" xlink:label="loc_ifrs-full_TaxRateEffectOfImpairmentOfGoodwill_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExcessValueOfGoodwillInUseOverCarryingAmount" xlink:label="loc_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment" xlink:label="loc_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LongTermGrowthRate" xlink:label="loc_trib_LongTermGrowthRate_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_WaveformTechnologiesIncMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_EpiCaptureLimitedMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_CarryingAmountOfGoodwill_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_TaxRateEffectOfImpairmentOfGoodwill_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_ExcessValueOfGoodwillInUseOverCarryingAmount_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment_11" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_trib_LongTermGrowthRate_12" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticCGUMember" xlink:label="loc_trib_ImmcoDiagnosticCGUMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalCguTradeNameMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrimusCorporationCguTradeNameMember" xlink:label="loc_trib_PrimusCorporationCguTradeNameMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_ImmcoDiagnosticCGUMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_FitzgeraldIndustriesInternationalCguTradeNameMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_PrimusCorporationCguTradeNameMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems_0" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_9" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryMember" xlink:label="loc_trib_InventoryMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember" xlink:label="loc_ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxValueOfLossCarryForwardsMember" xlink:label="loc_trib_TaxValueOfLossCarryForwardsMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherItemsMember" xlink:label="loc_trib_OtherItemsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_trib_InventoryMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_trib_TaxValueOfLossCarryForwardsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_trib_OtherItemsMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxAssets_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_13" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryMember" xlink:label="loc_trib_InventoryMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember" xlink:label="loc_ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TaxValueOfLossCarryForwardsMember" xlink:label="loc_trib_TaxValueOfLossCarryForwardsMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherItemsMember" xlink:label="loc_trib_OtherItemsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" xlink:label="loc_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_ifrs-full_OtherPropertyPlantAndEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_trib_InventoryMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_trib_TaxValueOfLossCarryForwardsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_1" xlink:to="loc_trib_OtherItemsMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_1" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_0" xlink:to="loc_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations_13" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionForInventoriesMember" xlink:label="loc_trib_ProvisionForInventoriesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-full_OtherProvisions_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="loc_ifrs-full_AdditionalProvisionsOtherProvisions_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="loc_ifrs-full_ProvisionUsedOtherProvisions_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NewProvisionsOtherProvisions" xlink:label="loc_ifrs-full_NewProvisionsOtherProvisions_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EliminatedOnDisposalOfBusiness" xlink:label="loc_trib_EliminatedOnDisposalOfBusiness_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_1" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_1" xlink:to="loc_trib_ProvisionForInventoriesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_1" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0" xlink:to="loc_ifrs-full_OtherProvisions_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0" xlink:to="loc_ifrs-full_AdditionalProvisionsOtherProvisions_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0" xlink:to="loc_ifrs-full_ProvisionUsedOtherProvisions_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0" xlink:to="loc_ifrs-full_NewProvisionsOtherProvisions_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0" xlink:to="loc_trib_EliminatedOnDisposalOfBusiness_10" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Prepayments" xlink:label="loc_ifrs-full_Prepayments_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_TradeReceivables_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_Prepayments_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_8" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrossInvestmentInFinanceLease" xlink:label="loc_trib_GrossInvestmentInFinanceLease_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnearnedFinanceIncomeOnFinanceLease" xlink:label="loc_trib_UnearnedFinanceIncomeOnFinanceLease_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_GrossInvestmentInFinanceLease_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_UnearnedFinanceIncomeOnFinanceLease_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_9" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InstrumentsMember" xlink:label="loc_trib_InstrumentsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived" xlink:label="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_6" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_6" xlink:to="loc_trib_InstrumentsMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_6" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived_11" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareTreasurySharesMember" xlink:label="loc_trib_AmericanDepositaryShareTreasurySharesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteMember" xlink:label="loc_trib_ConvertibleNoteMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MicoLtdMember" xlink:label="loc_trib_MicoLtdMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncMember" xlink:label="loc_trib_WaveformTechnologiesIncMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicDiagnosticsLimitedMember_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CraigHallumMember" xlink:label="loc_trib_CraigHallumMember_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NativeDesignLimitedMember" xlink:label="loc_trib_NativeDesignLimitedMember_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NovusDiagnosticsLimitedMember" xlink:label="loc_trib_NovusDiagnosticsLimitedMember_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-full_NumberOfSharesAuthorised_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConsiderationFromEmployeeOptionsSettledInCash" xlink:label="loc_trib_ConsiderationFromEmployeeOptionsSettledInCash_30"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CostIncurredIssueOfShares" xlink:label="loc_trib_CostIncurredIssueOfShares_31"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareRepurchasedUnderBuybackProgram" xlink:label="loc_trib_ShareRepurchasedUnderBuybackProgram_32"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PurchaseOfTreasuryShare" xlink:label="loc_trib_PurchaseOfTreasuryShare_33"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase" xlink:label="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_34"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue" xlink:label="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_35"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareIssueCostForExchangeableNotesPurchase" xlink:label="loc_trib_ShareIssueCostForExchangeableNotesPurchase_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfCashFlowHedges" xlink:label="loc_ifrs-full_ReserveOfCashFlowHedges_38"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesToBeIssuedForHedgingReservesValue" xlink:label="loc_trib_SharesToBeIssuedForHedgingReservesValue_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_43"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares" xlink:label="loc_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments" xlink:label="loc_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments_45"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareTreasurySharesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_6" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_6" xlink:to="loc_trib_ConvertibleNoteMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_6" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_10" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_10" xlink:to="loc_trib_MicoLtdMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_10" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_14" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_14" xlink:to="loc_trib_WaveformTechnologiesIncMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_14" xlink:to="loc_trib_MetabolomicDiagnosticsLimitedMember_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_14" xlink:to="loc_trib_CraigHallumMember_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_14" xlink:to="loc_trib_NativeDesignLimitedMember_17" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_14" xlink:to="loc_trib_EpiCaptureLimitedMember_18" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_14" xlink:to="loc_trib_NovusDiagnosticsLimitedMember_19" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_14" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_24" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_25" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_26" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_27" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesAuthorised_28" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ParValuePerShare_29" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_ConsiderationFromEmployeeOptionsSettledInCash_30" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_CostIncurredIssueOfShares_31" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_ShareRepurchasedUnderBuybackProgram_32" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_PurchaseOfTreasuryShare_33" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase_34" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue_35" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_ShareIssueCostForExchangeableNotesPurchase_36" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_37" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ReserveOfCashFlowHedges_38" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_SharesToBeIssuedForHedgingReservesValue_39" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_40" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_41" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_BorrowingsMaturity_42" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_Borrowings_43" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares_44" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments_45" order="220" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassATreasurySharesMember" xlink:label="loc_trib_ClassATreasurySharesMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareTreasurySharesMember" xlink:label="loc_trib_AmericanDepositaryShareTreasurySharesMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IssuedForNoncashConsideration" xlink:label="loc_trib_IssuedForNoncashConsideration_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:label="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-full_TreasuryShares_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares_15"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassATreasurySharesMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareTreasurySharesMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_IssuedForNoncashConsideration_11" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_12" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding_13" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_TreasuryShares_14" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_PurchaseOfTreasuryShares_15" order="70" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ShareOptionsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfShareAdjustedRatio" xlink:label="loc_trib_DescriptionOfShareAdjustedRatio_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AverageSharePriceShareOptionsExercised" xlink:label="loc_trib_AverageSharePriceShareOptionsExercised_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OpeningSharePrice" xlink:label="loc_trib_OpeningSharePrice_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosingExercisePriceOfOutstandingShareOptions" xlink:label="loc_trib_ClosingExercisePriceOfOutstandingShareOptions_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageSharePrice2019" xlink:label="loc_ifrs-full_WeightedAverageSharePrice2019_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsContinuingOperations" xlink:label="loc_trib_ShareBasedPaymentsContinuingOperations_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets" xlink:label="loc_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_24"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_RangeAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_6" xlink:to="loc_ifrs-full_RangeDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_6" xlink:to="loc_ifrs-full_BottomOfRangeMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_6" xlink:to="loc_ifrs-full_TopOfRangeMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_6" xlink:to="loc_ifrs-full_RangeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_DescriptionOfShareAdjustedRatio_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_15" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_AverageSharePriceShareOptionsExercised_16" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_OpeningSharePrice_17" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_ClosingExercisePriceOfOutstandingShareOptions_18" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageSharePrice2019_19" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_20" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_ShareBasedPaymentsContinuingOperations_21" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets_22" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_23" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_24" order="130" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OptionsAndWarrantsAbstract" xlink:label="loc_trib_OptionsAndWarrantsAbstract_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageExercisePriceAbstract" xlink:label="loc_trib_WeightedAverageExercisePriceAbstract_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_22"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_RangeAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_6" xlink:to="loc_ifrs-full_RangeDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_6" xlink:to="loc_ifrs-full_BottomOfRangeMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_6" xlink:to="loc_ifrs-full_TopOfRangeMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_6" xlink:to="loc_ifrs-full_RangeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_OptionsAndWarrantsAbstract_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_OptionsAndWarrantsAbstract_12" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_OptionsAndWarrantsAbstract_12" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_OptionsAndWarrantsAbstract_12" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_OptionsAndWarrantsAbstract_12" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_OptionsAndWarrantsAbstract_12" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_16" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_WeightedAverageExercisePriceAbstract_18" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_WeightedAverageExercisePriceAbstract_18" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_WeightedAverageExercisePriceAbstract_18" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_19" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_WeightedAverageExercisePriceAbstract_18" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_20" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_WeightedAverageExercisePriceAbstract_18" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_21" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_WeightedAverageExercisePriceAbstract_18" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_22" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember" xlink:label="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember" xlink:label="loc_trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutstandingAbstract" xlink:label="loc_trib_OutstandingAbstract_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_25"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageExercisePriceOutstanding" xlink:label="loc_trib_WeightedAverageExercisePriceOutstanding_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExercisableAbstract" xlink:label="loc_trib_ExercisableAbstract_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfShareOptionsExercisableShareBasedPayment" xlink:label="loc_trib_NumberOfShareOptionsExercisableShareBasedPayment_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_30"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" xlink:label="loc_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_31"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable_1" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_6" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember_12" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember_13" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember_14" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember_15" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember_16" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember_17" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember_18" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember_19" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_6" xlink:to="loc_trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember_20" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_6" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xlink:to="loc_trib_OutstandingAbstract_25" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_OutstandingAbstract_25" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_OutstandingAbstract_25" xlink:to="loc_trib_WeightedAverageExercisePriceOutstanding_26" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_OutstandingAbstract_25" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_27" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_0" xlink:to="loc_trib_ExercisableAbstract_29" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_ExercisableAbstract_29" xlink:to="loc_trib_NumberOfShareOptionsExercisableShareBasedPayment_29" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_ExercisableAbstract_29" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_30" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_ExercisableAbstract_29" xlink:to="loc_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_31" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherEmployeesMember" xlink:label="loc_trib_OtherEmployeesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalShareOptionsGrantedAdsEquivalent" xlink:label="loc_trib_TotalShareOptionsGrantedAdsEquivalent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:label="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_OtherEmployeesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_RangeAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_6" xlink:to="loc_ifrs-full_RangeDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_6" xlink:to="loc_ifrs-full_BottomOfRangeMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_6" xlink:to="loc_ifrs-full_TopOfRangeMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_6" xlink:to="loc_ifrs-full_RangeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_trib_TotalShareOptionsGrantedAdsEquivalent_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_ExercisePriceShareOptionsGranted2019_15" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_16" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_17" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_18" order="70" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ProvisionsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestructuringProvisionMember" xlink:label="loc_ifrs-full_RestructuringProvisionMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InstalmentsAxis" xlink:label="loc_trib_InstalmentsAxis_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InstalmentsDomain" xlink:label="loc_trib_InstalmentsDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WithinOneYearMember" xlink:label="loc_trib_WithinOneYearMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MoreThanOneYearMember" xlink:label="loc_trib_MoreThanOneYearMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InstalmentsDomain" xlink:label="loc_trib_InstalmentsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember" xlink:label="loc_trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EstimatedObligations" xlink:label="loc_trib_EstimatedObligations_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="loc_ifrs-full_LegalProceedingsProvision_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalRestructuringCosts" xlink:label="loc_trib_AdditionalRestructuringCosts_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_1" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_1" xlink:to="loc_ifrs-full_RestructuringProvisionMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_1" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" xlink:to="loc_trib_InstalmentsAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_trib_InstalmentsAxis_5" xlink:to="loc_trib_InstalmentsDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_InstalmentsDomain_5" xlink:to="loc_trib_WithinOneYearMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_InstalmentsDomain_5" xlink:to="loc_trib_MoreThanOneYearMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_trib_InstalmentsAxis_5" xlink:to="loc_trib_InstalmentsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsTable_1" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_10" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_10" xlink:to="loc_trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_10" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0" xlink:to="loc_trib_EstimatedObligations_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_17" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0" xlink:to="loc_ifrs-full_LegalProceedingsProvision_18" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOtherProvisionsLineItems_0" xlink:to="loc_trib_AdditionalRestructuringCosts_19" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember" xlink:label="loc_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleAndLeasebackLiabilitiesMember" xlink:label="loc_trib_SaleAndLeasebackLiabilitiesMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayable" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayable_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestExpenseOnLeaseLiabilities1" xlink:label="loc_trib_InterestExpenseOnLeaseLiabilities1_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesAxis_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_8" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_8" xlink:to="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_8" xlink:to="loc_trib_SaleAndLeasebackLiabilitiesMember_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_8" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_MinimumFinanceLeasePaymentsPayable_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_InterestExpenseOnLeaseLiabilities1_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_16" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseLiabilitiesMember" xlink:label="loc_trib_FinanceLeaseLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseLiabilitiesTwoMember" xlink:label="loc_trib_FinanceLeaseLiabilitiesTwoMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsOriginalCurrency" xlink:label="loc_ifrs-full_BorrowingsOriginalCurrency_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount" xlink:label="loc_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountPaidInRespectOfLeaseLiabilities" xlink:label="loc_trib_AmountPaidInRespectOfLeaseLiabilities_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain_1" xlink:to="loc_trib_FinanceLeaseLiabilitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain_1" xlink:to="loc_trib_FinanceLeaseLiabilitiesTwoMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_0" xlink:to="loc_ifrs-full_BorrowingsOriginalCurrency_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRate_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_0" xlink:to="loc_ifrs-full_BorrowingsMaturity_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_0" xlink:to="loc_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_0" xlink:to="loc_trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems_0" xlink:to="loc_trib_AmountPaidInRespectOfLeaseLiabilities_12" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DarnickCompanyMember" xlink:label="loc_trib_DarnickCompanyMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaycheckProtectionProgramLoanMember" xlink:label="loc_trib_PaycheckProtectionProgramLoanMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiosynthMember" xlink:label="loc_trib_BiosynthMember_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalCommitments" xlink:label="loc_ifrs-full_CapitalCommitments_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContributionForTaxAuditSettlement" xlink:label="loc_trib_ContributionForTaxAuditSettlement_22"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrantContingenciesMaximumAmountPayable" xlink:label="loc_trib_GrantContingenciesMaximumAmountPayable_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GovernmentGrantReceived" xlink:label="loc_trib_GovernmentGrantReceived_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ForgivenessOfBorrowings" xlink:label="loc_trib_ForgivenessOfBorrowings_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_UnforgivenLoansAmount" xlink:label="loc_trib_UnforgivenLoansAmount_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfCurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfCurrentBorrowings_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AgreementPayments" xlink:label="loc_trib_AgreementPayments_30"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentAssets" xlink:label="loc_trib_ContingentAssets_31"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromSaleOfBusiness" xlink:label="loc_trib_ProceedsFromSaleOfBusiness_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisions" xlink:label="loc_ifrs-full_CurrentProvisions_33"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReceivablesOutstanding" xlink:label="loc_trib_ReceivablesOutstanding_34"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-full_OtherProvisions_36"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_DarnickCompanyMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_5" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_5" xlink:to="loc_trib_PaycheckProtectionProgramLoanMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_5" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_RangeAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_9" xlink:to="loc_ifrs-full_RangeDomain_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_9" xlink:to="loc_ifrs-full_TopOfRangeMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_9" xlink:to="loc_ifrs-full_RangeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_13" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_13" xlink:to="loc_trib_BiosynthMember_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_13" xlink:to="loc_trib_WaveformTechnologiesIncorporationMember_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_13" xlink:to="loc_trib_MetabolomicsDiagnosticsLimitedMember_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_13" xlink:to="loc_trib_EpiCaptureLimitedMember_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_13" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_CapitalCommitments_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_ContributionForTaxAuditSettlement_22" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_GrantContingenciesMaximumAmountPayable_23" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_GovernmentGrantReceived_24" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_ForgivenessOfBorrowings_25" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_26" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_27" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_UnforgivenLoansAmount_28" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_RepaymentsOfCurrentBorrowings_29" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_AgreementPayments_30" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_ContingentAssets_31" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_ProceedsFromSaleOfBusiness_32" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_CurrentProvisions_33" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_ReceivablesOutstanding_34" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_35" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems_0" xlink:to="loc_ifrs-full_OtherProvisions_36" order="160" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MrOCaoimhMember" xlink:label="loc_trib_MrOCaoimhMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_JrjMember" xlink:label="loc_trib_JrjMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MrOCaoimhAndDrWalshMember" xlink:label="loc_trib_MrOCaoimhAndDrWalshMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DarnickCompanyMember" xlink:label="loc_trib_DarnickCompanyMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsMember" xlink:label="loc_trib_DirectorsMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RayvilleLimitedMember" xlink:label="loc_trib_RayvilleLimitedMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DrJimWalshMember" xlink:label="loc_trib_DrJimWalshMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR" xlink:label="loc_currency_EUR_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DarnickCompanyMember" xlink:label="loc_trib_DarnickCompanyMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalSpaceMember" xlink:label="loc_trib_AdditionalSpaceMember_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AcquisitionConsideration" xlink:label="loc_trib_AcquisitionConsideration_32"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermOfLease" xlink:label="loc_trib_TermOfLease_33"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MaturityDateForLease" xlink:label="loc_trib_MaturityDateForLease_34"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AnnualRentPayable" xlink:label="loc_trib_AnnualRentPayable_35"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AnnualRentPayableForWareHouse" xlink:label="loc_trib_AnnualRentPayableForWareHouse_36"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContributionForTaxAuditSettlement" xlink:label="loc_trib_ContributionForTaxAuditSettlement_37"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RateOfRentPerSqureFoot" xlink:label="loc_trib_RateOfRentPerSqureFoot_38"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseInAnnualRent" xlink:label="loc_trib_IncreaseInAnnualRent_39"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OverheadCosts" xlink:label="loc_trib_OverheadCosts_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DirectorsRemunerationExpense" xlink:label="loc_ifrs-full_DirectorsRemunerationExpense_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_42"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExerciseOfShareOptionsReceivable" xlink:label="loc_trib_ExerciseOfShareOptionsReceivable_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_DividendsPaidClassifiedAsFinancingActivities_44"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsForCEOServices" xlink:label="loc_trib_PaymentsForCEOServices_45"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltiesPayments" xlink:label="loc_trib_PenaltiesPayments_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfCurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfCurrentBorrowings_48"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PatentDividendSchemeAmount" xlink:label="loc_trib_PatentDividendSchemeAmount_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-full_ServicesExpense_50"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedBonus" xlink:label="loc_trib_AccruedBonus_51"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseInSettlementAmountDueToDepreciation" xlink:label="loc_trib_IncreaseInSettlementAmountDueToDepreciation_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_53"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExtinguishmentOfAmountOwed" xlink:label="loc_trib_ExtinguishmentOfAmountOwed_54"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_55"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestExpense" xlink:label="loc_ifrs-full_InterestExpense_56"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_MrOCaoimhMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_JrjMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_MrOCaoimhAndDrWalshMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_DarnickCompanyMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_DirectorsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_RayvilleLimitedMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_1" xlink:to="loc_trib_DrJimWalshMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_srt_CurrencyAxis_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_11" xlink:to="loc_currency_AllCurrenciesDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_11" xlink:to="loc_currency_EUR_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_11" xlink:to="loc_currency_AllCurrenciesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_srt_CounterpartyNameAxis_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_15" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_15" xlink:to="loc_trib_DarnickCompanyMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_15" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_19" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_19" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_19" xlink:to="loc_trib_AdditionalSpaceMember_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_19" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_23" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_23" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_23" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_23" xlink:to="loc_trib_MetabolomicsDiagnosticsLimitedMember_23" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_23" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_27" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_27" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_27" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_27" xlink:to="loc_trib_AmericanDepositaryShareMember_27" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_27" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_AcquisitionConsideration_32" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_TermOfLease_33" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_MaturityDateForLease_34" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_AnnualRentPayable_35" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_AnnualRentPayableForWareHouse_36" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_ContributionForTaxAuditSettlement_37" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_RateOfRentPerSqureFoot_38" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_IncreaseInAnnualRent_39" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_OverheadCosts_40" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DirectorsRemunerationExpense_41" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_42" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_ExerciseOfShareOptionsReceivable_43" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_DividendsPaidClassifiedAsFinancingActivities_44" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_PaymentsForCEOServices_45" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_PenaltiesPayments_46" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits_47" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_RepaymentsOfCurrentBorrowings_48" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_PatentDividendSchemeAmount_49" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_ServicesExpense_50" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_AccruedBonus_51" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_IncreaseInSettlementAmountDueToDepreciation_52" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_53" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_trib_ExtinguishmentOfAmountOwed_54" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_55" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_0" xlink:to="loc_ifrs-full_InterestExpense_56" order="250" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareOptionMember" xlink:label="loc_trib_ShareOptionMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsAndCompanySecretaryMember" xlink:label="loc_trib_DirectorsAndCompanySecretaryMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRetiredDirectorShares" xlink:label="loc_trib_NumberOfRetiredDirectorShares_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfRetiredDirectorOptions" xlink:label="loc_trib_NumberOfRetiredDirectorOptions_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesPurchasedDuringYear" xlink:label="loc_trib_SharesPurchasedDuringYear_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesSoldDuringYear" xlink:label="loc_trib_SharesSoldDuringYear_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ShareOptionMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_6" xlink:to="loc_trib_DirectorsAndCompanySecretaryMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_6" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_trib_NumberOfRetiredDirectorShares_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_trib_NumberOfRetiredDirectorOptions_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_trib_SharesPurchasedDuringYear_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_trib_SharesSoldDuringYear_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_16" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_17" order="70" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueMember" xlink:label="loc_trib_FairValueMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NovusDiagnosticsLimitedMember" xlink:label="loc_trib_NovusDiagnosticsLimitedMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoansAndReceivablesAbstract" xlink:label="loc_trib_LoansAndReceivablesAbstract_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaximumExposureToCreditRisk" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LiabilitiesAtAmortisedCostAbstract" xlink:label="loc_trib_LiabilitiesAtAmortisedCostAbstract_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNote" xlink:label="loc_trib_ConvertibleNote_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredConsideration" xlink:label="loc_trib_DeferredConsideration_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-full_TradeAndOtherPayables_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-full_Provisions_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredConsiderationPayable" xlink:label="loc_trib_DeferredConsiderationPayable_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicenceFee" xlink:label="loc_trib_LicenceFee_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCost" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCost_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinancialAtFairValueThroughProfitOrLossAbstract" xlink:label="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests_33"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteEquityConversionOption" xlink:label="loc_trib_ExchangeableNoteEquityConversionOption_34"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueThroughProfitAndLoss" xlink:label="loc_trib_FairValueThroughProfitAndLoss_35"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfFinancialAssetsLiabilities" xlink:label="loc_trib_FairValueOfFinancialAssetsLiabilities_37"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1" xlink:to="loc_ifrs-full_Level2OfFairValueHierarchyMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1" xlink:to="loc_ifrs-full_CarryingAmountMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_1" xlink:to="loc_trib_FairValueMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_1" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_1" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_9" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_9" xlink:to="loc_trib_NovusDiagnosticsLimitedMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_9" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_0" xlink:to="loc_trib_LoansAndReceivablesAbstract_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LoansAndReceivablesAbstract_14" xlink:to="loc_ifrs-full_TradeReceivables_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LoansAndReceivablesAbstract_14" xlink:to="loc_ifrs-full_CashAndCashEquivalents_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LoansAndReceivablesAbstract_14" xlink:to="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LoansAndReceivablesAbstract_14" xlink:to="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_17" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LoansAndReceivablesAbstract_14" xlink:to="loc_ifrs-full_MaximumExposureToCreditRisk_18" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_0" xlink:to="loc_trib_LiabilitiesAtAmortisedCostAbstract_20" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_20" xlink:to="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_20" xlink:to="loc_trib_ConvertibleNote_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_20" xlink:to="loc_ifrs-full_LongtermBorrowings_22" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_20" xlink:to="loc_ifrs-full_LeaseLiabilities_23" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_20" xlink:to="loc_trib_DeferredConsideration_24" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_20" xlink:to="loc_ifrs-full_TradeAndOtherPayables_25" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_20" xlink:to="loc_ifrs-full_Provisions_26" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_20" xlink:to="loc_trib_DeferredConsiderationPayable_27" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_20" xlink:to="loc_trib_LicenceFee_28" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_LiabilitiesAtAmortisedCostAbstract_20" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCost_29" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_0" xlink:to="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_31" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_31" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_31" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_31" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_32" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_31" xlink:to="loc_ifrs-full_NoncontrollingInterests_33" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_31" xlink:to="loc_trib_ExchangeableNoteEquityConversionOption_34" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_FinancialAtFairValueThroughProfitOrLossAbstract_31" xlink:to="loc_trib_FairValueThroughProfitAndLoss_35" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_0" xlink:to="loc_trib_FairValueOfFinancialAssetsLiabilities_37" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthOrLessMember" xlink:label="loc_trib_SixMonthOrLessMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthToTwelveMonthMember" xlink:label="loc_trib_SixMonthToTwelveMonthMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OneYearToTwoYearsMember" xlink:label="loc_trib_OneYearToTwoYearsMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TwoYearToFiveYearsMember" xlink:label="loc_trib_TwoYearToFiveYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GreaterThanFiveYearsMember" xlink:label="loc_trib_GreaterThanFiveYearsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentMember" xlink:label="loc_trib_CashAndCashEquivalentMember_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FinanceLeaseReceivableMember" xlink:label="loc_trib_FinanceLeaseReceivableMember_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicencePaymentsMember" xlink:label="loc_trib_LicencePaymentsMember_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteMember" xlink:label="loc_trib_ExchangeableNoteMember_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanMember" xlink:label="loc_trib_SeniorSecuredTermLoanMember_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteMember" xlink:label="loc_trib_ConvertibleNoteMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherBorrowingsMember" xlink:label="loc_trib_OtherBorrowingsMember_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnRightOfUseAssetsMember" xlink:label="loc_trib_LeasePayableOnRightOfUseAssetsMember_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnSaleLeasebackTransactionsMember" xlink:label="loc_trib_LeasePayableOnSaleLeasebackTransactionsMember_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EffectiveInterestRate" xlink:label="loc_trib_EffectiveInterestRate_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" xlink:label="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LicenceFeePayments" xlink:label="loc_trib_LicenceFeePayments_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherCurrentBorrowings" xlink:label="loc_trib_OtherCurrentBorrowings_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnRightOfUseAssets" xlink:label="loc_trib_LeasePayableOnRightOfUseAssets_28"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnSaleAndLeasebackTransactions" xlink:label="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities" xlink:label="loc_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_30"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_SixMonthOrLessMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_SixMonthToTwelveMonthMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_OneYearToTwoYearsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_TwoYearToFiveYearsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_GreaterThanFiveYearsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_9" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_9" xlink:to="loc_trib_CashAndCashEquivalentMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_9" xlink:to="loc_trib_FinanceLeaseReceivableMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_9" xlink:to="loc_trib_LicencePaymentsMember_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_9" xlink:to="loc_trib_ExchangeableNoteMember_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_9" xlink:to="loc_trib_SeniorSecuredTermLoanMember_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_9" xlink:to="loc_trib_ConvertibleNoteMember_14" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_9" xlink:to="loc_trib_OtherBorrowingsMember_15" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_9" xlink:to="loc_trib_LeasePayableOnRightOfUseAssetsMember_16" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_9" xlink:to="loc_trib_LeasePayableOnSaleLeasebackTransactionsMember_17" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_9" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xlink:to="loc_trib_EffectiveInterestRate_22" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_23" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xlink:to="loc_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue_24" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xlink:to="loc_trib_LicenceFeePayments_25" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_LongtermBorrowings_26" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xlink:to="loc_trib_OtherCurrentBorrowings_27" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xlink:to="loc_trib_LeasePayableOnRightOfUseAssets_28" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xlink:to="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_29" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xlink:to="loc_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities_30" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContractualCashFlowsMember" xlink:label="loc_trib_ContractualCashFlowsMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthOrLessMember" xlink:label="loc_trib_SixMonthOrLessMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SixMonthToTwelveMonthMember" xlink:label="loc_trib_SixMonthToTwelveMonthMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OneYearToTwoYearsMember" xlink:label="loc_trib_OneYearToTwoYearsMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TwoYearToFiveYearsMember" xlink:label="loc_trib_TwoYearToFiveYearsMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GreaterThanFiveYearsMember" xlink:label="loc_trib_GreaterThanFiveYearsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-full_TypesOfRisksDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-full_LiquidityRiskMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-full_TypesOfRisksDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAbstract" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-full_TradeAndOtherPayables_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnRightOfUseAssets" xlink:label="loc_trib_LeasePayableOnRightOfUseAssets_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeasePayableOnSaleAndLeasebackTransactions" xlink:label="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNote" xlink:label="loc_trib_ConvertibleNote_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherBorrowings" xlink:label="loc_ifrs-full_OtherBorrowings_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNoteInterest" xlink:label="loc_trib_ExchangeableNoteInterest_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-full_FinancialLiabilities_23"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_1" xlink:to="loc_ifrs-full_MaturityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_ContractualCashFlowsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_SixMonthOrLessMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_SixMonthToTwelveMonthMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_OneYearToTwoYearsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_TwoYearToFiveYearsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_1" xlink:to="loc_trib_GreaterThanFiveYearsMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_1" xlink:to="loc_ifrs-full_MaturityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_10" xlink:to="loc_ifrs-full_TypesOfRisksDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_10" xlink:to="loc_ifrs-full_LiquidityRiskMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_10" xlink:to="loc_ifrs-full_TypesOfRisksDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_15" xlink:to="loc_ifrs-full_TradeAndOtherPayables_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_15" xlink:to="loc_trib_LeasePayableOnRightOfUseAssets_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_15" xlink:to="loc_trib_LeasePayableOnSaleAndLeasebackTransactions_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_15" xlink:to="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_15" xlink:to="loc_trib_ConvertibleNote_19" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_15" xlink:to="loc_ifrs-full_OtherBorrowings_20" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_15" xlink:to="loc_ifrs-full_LongtermBorrowings_21" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_15" xlink:to="loc_trib_ExchangeableNoteInterest_22" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract_15" xlink:to="loc_ifrs-full_FinancialLiabilities_23" order="80" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR" xlink:label="loc_currency_EUR_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_GBP" xlink:label="loc_currency_GBP_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_SEK" xlink:label="loc_currency_SEK_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_CAD" xlink:label="loc_currency_CAD_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_BRL" xlink:label="loc_currency_BRL_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_XXX" xlink:label="loc_currency_XXX_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherReceivables" xlink:label="loc_ifrs-full_TradeAndOtherReceivables_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayables" xlink:label="loc_ifrs-full_TradeAndOtherPayables_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalExposureFinancialInstruments" xlink:label="loc_trib_TotalExposureFinancialInstruments_15"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_1" xlink:to="loc_srt_CurrencyAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_EUR_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_GBP_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_SEK_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_CAD_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_BRL_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_XXX_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_Cash_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_TradeAndOtherReceivables_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_TradeAndOtherPayables_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_LeaseLiabilities_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_0" xlink:to="loc_trib_TotalExposureFinancialInstruments_15" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_EUR" xlink:label="loc_currency_EUR_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2024/currency-2024.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-full_TypesOfRisksAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-full_TypesOfRisksDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TenPercentStrengtheningUSDollarMember" xlink:label="loc_trib_TenPercentStrengtheningUSDollarMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TenPercentWeakeningUSDollarMember" xlink:label="loc_trib_TenPercentWeakeningUSDollarMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfRisksDomain" xlink:label="loc_ifrs-full_TypesOfRisksDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable_1" xlink:to="loc_srt_CurrencyAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_1" xlink:to="loc_currency_EUR_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_1" xlink:to="loc_currency_AllCurrenciesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable_1" xlink:to="loc_ifrs-full_TypesOfRisksAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfRisksAxis_5" xlink:to="loc_ifrs-full_TypesOfRisksDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_5" xlink:to="loc_trib_TenPercentStrengtheningUSDollarMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfRisksDomain_5" xlink:to="loc_trib_TenPercentWeakeningUSDollarMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfRisksAxis_5" xlink:to="loc_ifrs-full_TypesOfRisksDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems_0" xlink:to="loc_ifrs-full_ProfitLoss_11" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US" xlink:label="loc_country_US_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EuroZoneCountriesMember" xlink:label="loc_trib_EuroZoneCountriesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB" xlink:label="loc_country_GB_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherEuropeanCountriesMember" xlink:label="loc_trib_OtherEuropeanCountriesMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRegionsMember" xlink:label="loc_trib_OtherRegionsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables" xlink:label="loc_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_US_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_EuroZoneCountriesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_country_GB_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherEuropeanCountriesMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_1" xlink:to="loc_trib_OtherRegionsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_1" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_0" xlink:to="loc_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables_10" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureLineItems" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfCreditRiskExposureTable" xlink:label="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfCustomersAxis" xlink:label="loc_ifrs-full_TypesOfCustomersAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfCustomersDomain" xlink:label="loc_ifrs-full_TypesOfCustomersDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EndUserCustomersMember" xlink:label="loc_trib_EndUserCustomersMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DistributorsMember" xlink:label="loc_trib_DistributorsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NongovernmentCustomersMember" xlink:label="loc_ifrs-full_NongovernmentCustomersMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TypesOfCustomersDomain" xlink:label="loc_ifrs-full_TypesOfCustomersDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables" xlink:label="loc_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureTable_1" xlink:to="loc_ifrs-full_TypesOfCustomersAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfCustomersAxis_1" xlink:to="loc_ifrs-full_TypesOfCustomersDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfCustomersDomain_1" xlink:to="loc_trib_EndUserCustomersMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfCustomersDomain_1" xlink:to="loc_trib_DistributorsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfCustomersDomain_1" xlink:to="loc_ifrs-full_NongovernmentCustomersMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfCustomersAxis_1" xlink:to="loc_ifrs-full_TypesOfCustomersDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfCreditRiskExposureLineItems_0" xlink:to="loc_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AccumulatedImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusAxis" xlink:label="loc_ifrs-full_PastDueStatusAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusDomain" xlink:label="loc_ifrs-full_PastDueStatusDomain_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentMember" xlink:label="loc_ifrs-full_CurrentMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember" xlink:label="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember" xlink:label="loc_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GreaterThanFourMonthsMember" xlink:label="loc_trib_GreaterThanFourMonthsMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PastDueStatusDomain" xlink:label="loc_ifrs-full_PastDueStatusDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-full_TradeReceivables_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpectedCreditLossRate" xlink:label="loc_ifrs-full_ExpectedCreditLossRate_15"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_1" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_1" xlink:to="loc_ifrs-full_CarryingAmountMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_1" xlink:to="loc_ifrs-full_PastDueStatusAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_PastDueStatusAxis_6" xlink:to="loc_ifrs-full_PastDueStatusDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PastDueStatusDomain_6" xlink:to="loc_ifrs-full_CurrentMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PastDueStatusDomain_6" xlink:to="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PastDueStatusDomain_6" xlink:to="loc_trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_PastDueStatusDomain_6" xlink:to="loc_trib_GreaterThanFourMonthsMember_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_PastDueStatusAxis_6" xlink:to="loc_ifrs-full_PastDueStatusDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_TradeReceivables_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_0" xlink:to="loc_ifrs-full_ExpectedCreditLossRate_15" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LongtermBorrowingsMember" xlink:label="loc_ifrs-full_LongtermBorrowingsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsForConvertibleNoteIssued" xlink:label="loc_trib_ProceedsForConvertibleNoteIssued_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnSeniorSecuredTermLoan" xlink:label="loc_trib_InterestPaidOnSeniorSecuredTermLoan_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnConvertibleNote" xlink:label="loc_trib_InterestPaidOnConvertibleNote_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyPaidForEarlySettlement" xlink:label="loc_trib_PenaltyPaidForEarlySettlement_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashActivityForFinancingActivityAbstract" xlink:label="loc_trib_NonCashActivityForFinancingActivityAbstract_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlySettlementCharged" xlink:label="loc_trib_PenaltyForEarlySettlementCharged_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MovementInInterestAccrual" xlink:label="loc_trib_MovementInInterestAccrual_22"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes" xlink:label="loc_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNoteAtDateOfIssue" xlink:label="loc_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfIssue_25"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemeasurementOfRightOfUseAssets" xlink:label="loc_trib_RemeasurementOfRightOfUseAssets_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOfExchangeableNotes" xlink:label="loc_trib_LossOnDisposalOfExchangeableNotes_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdoptionOfIfrs16" xlink:label="loc_trib_AdoptionOfIfrs16_28"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisposalsRelatedToRightOfUseAssets" xlink:label="loc_trib_DisposalsRelatedToRightOfUseAssets_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionsRelatedToRightOfUseAssets" xlink:label="loc_trib_AdditionsRelatedToRightOfUseAssets_30"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_33"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_34"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_36"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_37"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_38"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities" xlink:label="loc_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_39"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashLoanModificationGain" xlink:label="loc_trib_NoncashLoanModificationGain_40"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_1" xlink:to="loc_ifrs-full_LongtermBorrowingsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_1" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_1" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_LiabilitiesArisingFromFinancingActivities_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_8" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_8" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_8" xlink:to="loc_trib_ProceedsForConvertibleNoteIssued_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_8" xlink:to="loc_trib_PrincipalAmountLoaned_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_8" xlink:to="loc_trib_InterestPaidOnSeniorSecuredTermLoan_11" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_8" xlink:to="loc_trib_InterestPaidOnConvertibleNote_12" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_8" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_13" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_8" xlink:to="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_14" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_8" xlink:to="loc_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_15" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_8" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_16" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_8" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_17" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_8" xlink:to="loc_trib_PenaltyPaidForEarlySettlement_18" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems_0" xlink:to="loc_trib_NonCashActivityForFinancingActivityAbstract_20" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_PenaltyForEarlySettlementCharged_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_MovementInInterestAccrual_22" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes_23" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_EquityComponentOfConvertibleNoteAtDateOfIssue_24" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_DerivativeFinancialAssetAtDateOfIssue_25" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_RemeasurementOfRightOfUseAssets_26" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_LossOnDisposalOfExchangeableNotes_27" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_AdoptionOfIfrs16_28" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_DisposalsRelatedToRightOfUseAssets_29" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_AdditionsRelatedToRightOfUseAssets_30" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities_31" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_32" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_33" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities_34" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities_35" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities_36" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities_37" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities_38" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities_39" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NonCashActivityForFinancingActivityAbstract_20" xlink:to="loc_trib_NoncashLoanModificationGain_40" order="200" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfCompositionOfGroupLineItems" xlink:label="loc_trib_DisclosureOfCompositionOfGroupLineItems_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfCompositionOfGroupTable" xlink:label="loc_trib_DisclosureOfCompositionOfGroupTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingLimitedMember" xlink:label="loc_trib_TrinityBiotechManufacturingLimitedMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityResearchLimitedMember" xlink:label="loc_trib_TrinityResearchLimitedMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BenenTradingLimitedMember" xlink:label="loc_trib_BenenTradingLimitedMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechManufacturingServicesLimitedMember" xlink:label="loc_trib_TrinityBiotechManufacturingServicesLimitedMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechLuxembourgSarlMember" xlink:label="loc_trib_TrinityBiotechLuxembourgSarlMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechIncMember" xlink:label="loc_trib_TrinityBiotechIncMember_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClarkLaboratoriesIncMember" xlink:label="loc_trib_ClarkLaboratoriesIncMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MardxDiagnosticsIncMember" xlink:label="loc_trib_MardxDiagnosticsIncMember_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FitzgeraldIndustriesInternationalIncMember" xlink:label="loc_trib_FitzgeraldIndustriesInternationalIncMember_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiopoolUsIncMember" xlink:label="loc_trib_BiopoolUsIncMember_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrimusCorporationMember" xlink:label="loc_trib_PrimusCorporationMember_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PhoenixBioTechCorpMember" xlink:label="loc_trib_PhoenixBioTechCorpMember_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsHoldingAbMember" xlink:label="loc_trib_FiomiDiagnosticsHoldingAbMember_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsAbMember" xlink:label="loc_trib_FiomiDiagnosticsAbMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechDoBrasilMember" xlink:label="loc_trib_TrinityBiotechDoBrasilMember_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechUkLtdMember" xlink:label="loc_trib_TrinityBiotechUkLtdMember_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImmcoDiagnosticsIncMember" xlink:label="loc_trib_ImmcoDiagnosticsIncMember_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NovaCenturyScientificIncMember" xlink:label="loc_trib_NovaCenturyScientificIncMember_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechInvestmentLtdMember" xlink:label="loc_trib_TrinityBiotechInvestmentLtdMember_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TribBiosensorsIncMember" xlink:label="loc_trib_TribBiosensorsIncMember_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KonamiteLimitedMember" xlink:label="loc_trib_KonamiteLimitedMember_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinityBiotechJointVentureLimitedMember" xlink:label="loc_trib_TrinityBiotechJointVentureLimitedMember_22"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NameOfSubsidiary" xlink:label="loc_ifrs-full_NameOfSubsidiary_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AddressOfRegisteredOfficeOfEntity" xlink:label="loc_ifrs-full_AddressOfRegisteredOfficeOfEntity_31"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalActivity" xlink:label="loc_trib_PrincipalActivity_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PrincipalPlaceOfBusiness" xlink:label="loc_ifrs-full_PrincipalPlaceOfBusiness_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_34"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_trib_DisclosureOfCompositionOfGroupLineItems_0" xlink:to="loc_trib_DisclosureOfCompositionOfGroupTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_trib_DisclosureOfCompositionOfGroupTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechManufacturingLimitedMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityResearchLimitedMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_BenenTradingLimitedMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechManufacturingServicesLimitedMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechLuxembourgSarlMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechIncMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_ClarkLaboratoriesIncMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_MardxDiagnosticsIncMember_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_FitzgeraldIndustriesInternationalIncMember_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_BiopoolUsIncMember_10" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_PrimusCorporationMember_11" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_PhoenixBioTechCorpMember_12" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_FiomiDiagnosticsHoldingAbMember_13" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_FiomiDiagnosticsAbMember_14" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechDoBrasilMember_15" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechUkLtdMember_16" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_ImmcoDiagnosticsIncMember_17" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_NovaCenturyScientificIncMember_18" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechInvestmentLtdMember_19" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TribBiosensorsIncMember_20" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_KonamiteLimitedMember_21" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_TrinityBiotechJointVentureLimitedMember_22" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_EpiCaptureLimitedMember_23" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_MetabolomicsDiagnosticsLimitedMember_24" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_1" xlink:to="loc_trib_WaveformTechnologiesIncorporationMember_25" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfCompositionOfGroupLineItems_0" xlink:to="loc_ifrs-full_NameOfSubsidiary_30" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfCompositionOfGroupLineItems_0" xlink:to="loc_ifrs-full_AddressOfRegisteredOfficeOfEntity_31" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfCompositionOfGroupLineItems_0" xlink:to="loc_trib_PrincipalActivity_32" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfCompositionOfGroupLineItems_0" xlink:to="loc_ifrs-full_PrincipalPlaceOfBusiness_33" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfCompositionOfGroupLineItems_0" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_34" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_T10HplcAnalyzerMember" xlink:label="loc_trib_T10HplcAnalyzerMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SyphilisPointOfCareMember" xlink:label="loc_trib_SyphilisPointOfCareMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TrinscreenPlantAndEquipmentMember" xlink:label="loc_trib_TrinscreenPlantAndEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KansasRightOfUseAssetMember" xlink:label="loc_trib_KansasRightOfUseAssetMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsUnderDevelopment" xlink:label="loc_ifrs-full_IntangibleAssetsUnderDevelopment_9"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_T10HplcAnalyzerMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_SyphilisPointOfCareMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_TrinscreenPlantAndEquipmentMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_1" xlink:to="loc_trib_KansasRightOfUseAssetMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_0" xlink:to="loc_ifrs-full_IntangibleAssetsUnderDevelopment_9" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentLiabilitiesMember" xlink:label="loc_trib_CurrentLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLiabilitiesMember" xlink:label="loc_trib_NonCurrentLiabilitiesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentAssetsMember" xlink:label="loc_trib_NonCurrentAssetsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableSeniorNotesMember" xlink:label="loc_trib_ExchangeableSeniorNotesMember_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanMember" xlink:label="loc_trib_SeniorSecuredTermLoanMember_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityMember" xlink:label="loc_trib_DerivativeFinancialLiabilityMember_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentLiabilityMember" xlink:label="loc_trib_ContingentLiabilityMember_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteMember" xlink:label="loc_trib_ConvertibleNoteMember_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetMember" xlink:label="loc_trib_DerivativeFinancialAssetMember_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_23"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" xlink:to="loc_trib_CurrentLiabilitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" xlink:to="loc_trib_NonCurrentLiabilitiesMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_6" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_6" xlink:to="loc_trib_NonCurrentAssetsMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_6" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_10" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_10" xlink:to="loc_trib_ExchangeableSeniorNotesMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_10" xlink:to="loc_trib_SeniorSecuredTermLoanMember_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_10" xlink:to="loc_trib_DerivativeFinancialLiabilityMember_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_10" xlink:to="loc_trib_ContingentLiabilityMember_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_10" xlink:to="loc_trib_ConvertibleNoteMember_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_10" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_18" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_18" xlink:to="loc_trib_DerivativeFinancialAssetMember_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_18" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_Borrowings_23" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentLiabilitiesMember" xlink:label="loc_trib_CurrentLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableSeniorNotesMember" xlink:label="loc_trib_ExchangeableSeniorNotesMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestOnBorrowings" xlink:label="loc_trib_AccretionInterestOnBorrowings_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings" xlink:label="loc_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOnBorrowings" xlink:label="loc_trib_LossOnDisposalOnBorrowings_14"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" xlink:to="loc_trib_CurrentLiabilitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5" xlink:to="loc_trib_ExchangeableSeniorNotesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_Borrowings_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_AccretionInterestOnBorrowings_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_LossOnDisposalOnBorrowings_14" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLiabilitiesMember" xlink:label="loc_trib_NonCurrentLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SevenYearConvertibleNoteMember" xlink:label="loc_trib_SevenYearConvertibleNoteMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanOriginationCosts" xlink:label="loc_trib_LoanOriginationCosts_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentAtDateOfIssue" xlink:label="loc_trib_EquityComponentAtDateOfIssue_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestOnBorrowings" xlink:label="loc_trib_AccretionInterestOnBorrowings_14"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" xlink:to="loc_trib_NonCurrentLiabilitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5" xlink:to="loc_trib_SevenYearConvertibleNoteMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_Borrowings_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_PrincipalAmountLoaned_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_LoanOriginationCosts_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_EquityComponentAtDateOfIssue_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_AccretionInterestOnBorrowings_14" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLiabilitiesMember" xlink:label="loc_trib_NonCurrentLiabilitiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityMember" xlink:label="loc_trib_DerivativeFinancialLiabilityMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan" xlink:label="loc_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" xlink:to="loc_trib_NonCurrentLiabilitiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5" xlink:to="loc_trib_DerivativeFinancialLiabilityMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_Borrowings_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_12" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentAssetsMember" xlink:label="loc_trib_NonCurrentAssetsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetMember" xlink:label="loc_trib_DerivativeFinancialAssetMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfDrawdown" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfDrawdown_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives" xlink:label="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_1" xlink:to="loc_trib_NonCurrentAssetsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_5" xlink:to="loc_trib_DerivativeFinancialAssetMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_5" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_Borrowings_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_DerivativeFinancialAssetAtDateOfDrawdown_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives_12" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableSeniorNotesMember" xlink:label="loc_trib_ExchangeableSeniorNotesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanMember" xlink:label="loc_trib_SeniorSecuredTermLoanMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SevenYearConvertibleNoteMember" xlink:label="loc_trib_SevenYearConvertibleNoteMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteMember" xlink:label="loc_trib_ConvertibleNoteMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SeniorSecuredTermLoanCreditFacilityOneMember" xlink:label="loc_trib_SeniorSecuredTermLoanCreditFacilityOneMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleOfFitzgeraldIndustriesMember" xlink:label="loc_trib_SaleOfFitzgeraldIndustriesMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAndCashEquivalentMember" xlink:label="loc_trib_CashAndCashEquivalentMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentLiabilitiesMember" xlink:label="loc_trib_CurrentLiabilitiesMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLiabilitiesMember" xlink:label="loc_trib_NonCurrentLiabilitiesMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PerceptiveCreditHoldingsIiiLpMember" xlink:label="loc_trib_PerceptiveCreditHoldingsIiiLpMember_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MicoLtdMember" xlink:label="loc_trib_MicoLtdMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WarrantReserveMember" xlink:label="loc_ifrs-full_WarrantReserveMember_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_28"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_28"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_33"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmendmentAndRestatementOfTermLoanMember" xlink:label="loc_trib_AmendmentAndRestatementOfTermLoanMember_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_37"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_42"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TotalExchangeableNotesPercentage" xlink:label="loc_trib_TotalExchangeableNotesPercentage_43"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashPaidToEachHolder" xlink:label="loc_trib_CashPaidToEachHolder_44"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashReceivedPerNominalValue" xlink:label="loc_trib_CashReceivedPerNominalValue_45"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NominalValuePerShareOfExchangeableNotes" xlink:label="loc_trib_NominalValuePerShareOfExchangeableNotes_46"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NominalAmountOfDebt" xlink:label="loc_trib_NominalAmountOfDebt_47"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfBorrowingsPaid" xlink:label="loc_trib_DescriptionOfBorrowingsPaid_48"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesDiscountRate" xlink:label="loc_trib_ExchangeableNotesDiscountRate_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_50"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesConsideration" xlink:label="loc_trib_SharesConsideration_51"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SharesRepresentationRateComparedToADS" xlink:label="loc_trib_SharesRepresentationRateComparedToADS_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossLoanCommitments" xlink:label="loc_ifrs-full_GrossLoanCommitments_53"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExtinguishmentOfDebtAmounts" xlink:label="loc_trib_ExtinguishmentOfDebtAmounts_54"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LossOnDisposalOnBorrowings" xlink:label="loc_trib_LossOnDisposalOnBorrowings_55"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_56"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_57"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_58"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_59"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_60"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NumberOfWarrantsRepriced" xlink:label="loc_trib_NumberOfWarrantsRepriced_61"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExercisePriceOfWarrantsOrRights" xlink:label="loc_trib_ExercisePriceOfWarrantsOrRights_62"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentOfPenalty" xlink:label="loc_trib_PaymentOfPenalty_63"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_64"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanOriginationCosts" xlink:label="loc_trib_LoanOriginationCosts_65"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InitialExercisePriceOfWarrantsOrRights" xlink:label="loc_trib_InitialExercisePriceOfWarrantsOrRights_66"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_67"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_68"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromSaleOfBusiness" xlink:label="loc_trib_ProceedsFromSaleOfBusiness_69"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestOnBorrowings" xlink:label="loc_trib_AccretionInterestOnBorrowings_70"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestAccrued" xlink:label="loc_trib_AccretionInterestAccrued_71"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestAdjustment" xlink:label="loc_trib_AccretionInterestAdjustment_72"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfDerivativeFinancialAsset" xlink:label="loc_trib_FairValueOfDerivativeFinancialAsset_73"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfDerivativeFinancialLiability" xlink:label="loc_trib_FairValueOfDerivativeFinancialLiability_74"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueRemeasurementForDerivativeFinancialBalances" xlink:label="loc_trib_FairValueRemeasurementForDerivativeFinancialBalances_75"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue" xlink:label="loc_ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue_76"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="loc_ifrs-full_BorrowingsInterestRate_77"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNote" xlink:label="loc_trib_EquityComponentOfConvertibleNote_78"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfConversionOfDebtToEquity" xlink:label="loc_ifrs-full_DescriptionOfConversionOfDebtToEquity_79"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentAtDateOfIssue" xlink:label="loc_trib_EquityComponentAtDateOfIssue_80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_81"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountAvailableForDevelopmentOfTheCGM" xlink:label="loc_trib_AmountAvailableForDevelopmentOfTheCGM_82"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate" xlink:label="loc_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_83"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmountUsedToAcquireTheCGMAssets" xlink:label="loc_trib_AmountUsedToAcquireTheCGMAssets_84"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCashFairValueGainLoss" xlink:label="loc_trib_NonCashFairValueGainLoss_85"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_86"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_ExchangeableSeniorNotesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_SeniorSecuredTermLoanMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_SevenYearConvertibleNoteMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_ConvertibleNoteMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_SeniorSecuredTermLoanCreditFacilityOneMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_SaleOfFitzgeraldIndustriesMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_10" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_10" xlink:to="loc_trib_CashAndCashEquivalentMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_10" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_14" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_14" xlink:to="loc_trib_CurrentLiabilitiesMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_14" xlink:to="loc_trib_NonCurrentLiabilitiesMember_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_14" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_19" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_19" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_19" xlink:to="loc_trib_PerceptiveCreditHoldingsIiiLpMember_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_19" xlink:to="loc_trib_MicoLtdMember_20" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_19" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_24" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_24" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_24" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_24" xlink:to="loc_ifrs-full_WarrantReserveMember_24" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_24" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_28" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_28" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_28" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_28" xlink:to="loc_trib_AmericanDepositaryShareMember_28" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_28" xlink:to="loc_trib_ClassAOrdinarySharesMember_29" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_28" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_33" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_33" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_33" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_33" xlink:to="loc_trib_AmendmentAndRestatementOfTermLoanMember_33" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_33" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_37" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_37" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_37" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_37" xlink:to="loc_trib_WaveformTechnologiesIncorporationMember_37" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_37" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_42" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_TotalExchangeableNotesPercentage_43" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_CashPaidToEachHolder_44" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_CashReceivedPerNominalValue_45" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_NominalValuePerShareOfExchangeableNotes_46" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_NominalAmountOfDebt_47" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_DescriptionOfBorrowingsPaid_48" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_ExchangeableNotesDiscountRate_49" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_50" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_SharesConsideration_51" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_SharesRepresentationRateComparedToADS_52" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_GrossLoanCommitments_53" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_ExtinguishmentOfDebtAmounts_54" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_LossOnDisposalOnBorrowings_55" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_Borrowings_56" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_NotionalAmount_57" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_BorrowingsMaturity_58" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRateBasis_59" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_60" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_NumberOfWarrantsRepriced_61" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_ExercisePriceOfWarrantsOrRights_62" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_PaymentOfPenalty_63" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_PrincipalAmountLoaned_64" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_LoanOriginationCosts_65" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_InitialExercisePriceOfWarrantsOrRights_66" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_67" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_68" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_ProceedsFromSaleOfBusiness_69" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_AccretionInterestOnBorrowings_70" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_AccretionInterestAccrued_71" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_AccretionInterestAdjustment_72" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_FairValueOfDerivativeFinancialAsset_73" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_FairValueOfDerivativeFinancialLiability_74" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_FairValueRemeasurementForDerivativeFinancialBalances_75" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue_76" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRate_77" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_EquityComponentOfConvertibleNote_78" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfConversionOfDebtToEquity_79" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_EquityComponentAtDateOfIssue_80" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_81" order="400" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_AmountAvailableForDevelopmentOfTheCGM_82" order="410" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate_83" order="420" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_AmountUsedToAcquireTheCGMAssets_84" order="430" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_NonCashFairValueGainLoss_85" order="440" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate_86" order="450" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TermLoanMember" xlink:label="loc_trib_TermLoanMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonCurrentLiabilitiesMember" xlink:label="loc_trib_NonCurrentLiabilitiesMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PrincipalAmountLoaned" xlink:label="loc_trib_PrincipalAmountLoaned_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LoanOriginationCosts" xlink:label="loc_trib_LoanOriginationCosts_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialLiabilityAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialLiabilityAtDateOfIssue_13"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DerivativeFinancialAssetAtDateOfIssue" xlink:label="loc_trib_DerivativeFinancialAssetAtDateOfIssue_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccretionInterestOnBorrowings" xlink:label="loc_trib_AccretionInterestOnBorrowings_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentInKindInterest" xlink:label="loc_trib_PaymentInKindInterest_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncashLoanModificationGain" xlink:label="loc_trib_NoncashLoanModificationGain_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_1" xlink:to="loc_trib_TermLoanMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialLiabilitiesAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable_1" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_5" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_5" xlink:to="loc_trib_NonCurrentLiabilitiesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_5" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_Borrowings_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_PrincipalAmountLoaned_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_LoanOriginationCosts_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_DerivativeFinancialLiabilityAtDateOfIssue_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_DerivativeFinancialAssetAtDateOfIssue_14" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_AccretionInterestOnBorrowings_15" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_16" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_PaymentInKindInterest_17" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems_0" xlink:to="loc_trib_NoncashLoanModificationGain_18" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_StrategicPartnershipWithImawareIncMember" xlink:label="loc_trib_StrategicPartnershipWithImawareIncMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesAxis" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NovusDiagnosticsLimitedMember" xlink:label="loc_trib_NovusDiagnosticsLimitedMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnconsolidatedStructuredEntitiesDomain" xlink:label="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNoteInvestment" xlink:label="loc_trib_ConvertibleNoteInvestment_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AgreementTerm" xlink:label="loc_trib_AgreementTerm_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssueOfConvertibleInstruments" xlink:label="loc_ifrs-full_IssueOfConvertibleInstruments_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccruedLiability" xlink:label="loc_trib_AccruedLiability_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DecreaseThroughWriteoffFinancialAssets" xlink:label="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositorySharesIssued" xlink:label="loc_trib_AmericanDepositorySharesIssued_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RemeasurementLossRecognizedInProfitLoss" xlink:label="loc_trib_RemeasurementLossRecognizedInProfitLoss_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_1" xlink:to="loc_trib_StrategicPartnershipWithImawareIncMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_1" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsTable_1" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_5" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_5" xlink:to="loc_trib_NovusDiagnosticsLimitedMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnconsolidatedStructuredEntitiesAxis_5" xlink:to="loc_ifrs-full_UnconsolidatedStructuredEntitiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_trib_ConvertibleNoteInvestment_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_trib_AgreementTerm_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_ifrs-full_IssueOfConvertibleInstruments_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_trib_AccruedLiability_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossOnFinancialAssets_14" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_15" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_16" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_17" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_trib_AmericanDepositorySharesIssued_18" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsLineItems_0" xlink:to="loc_trib_RemeasurementLossRecognizedInProfitLoss_19" order="100" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsAxis" xlink:label="loc_trib_DiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsMember" xlink:label="loc_trib_FiomiDiagnosticsMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SE" xlink:label="loc_country_SE_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts" xlink:label="loc_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashSoldAsAPartOfDiscontinuedOperations" xlink:label="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_trib_DiscontinuedOperationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_trib_DiscontinuedOperationsAxis_1" xlink:to="loc_trib_DiscontinuedOperationsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DiscontinuedOperationsDomain_1" xlink:to="loc_trib_FiomiDiagnosticsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_trib_DiscontinuedOperationsAxis_1" xlink:to="loc_trib_DiscontinuedOperationsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5" xlink:to="loc_ifrs-full_GeographicalAreasDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_5" xlink:to="loc_country_SE_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_12" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsAxis" xlink:label="loc_trib_DiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsMember" xlink:label="loc_trib_FiomiDiagnosticsMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SE" xlink:label="loc_country_SE_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosureProvision" xlink:label="loc_trib_ClosureProvision_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations" xlink:label="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation" xlink:label="loc_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_trib_DiscontinuedOperationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_trib_DiscontinuedOperationsAxis_1" xlink:to="loc_trib_DiscontinuedOperationsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DiscontinuedOperationsDomain_1" xlink:to="loc_trib_FiomiDiagnosticsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_trib_DiscontinuedOperationsAxis_1" xlink:to="loc_trib_DiscontinuedOperationsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5" xlink:to="loc_ifrs-full_GeographicalAreasDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_5" xlink:to="loc_country_SE_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_Revenue_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_OperatingExpense_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_trib_ClosureProvision_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_14" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation_15" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_16" order="70" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_8" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SE" xlink:label="loc_country_SE_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsAxis" xlink:label="loc_trib_DiscontinuedOperationsAxis_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsMember" xlink:label="loc_trib_FiomiDiagnosticsMember_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiosynthMember" xlink:label="loc_trib_BiosynthMember_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdministrativeExpense" xlink:label="loc_ifrs-full_AdministrativeExpense_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_20"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WeightedAverageSharesDiscontinuedOperations" xlink:label="loc_trib_WeightedAverageSharesDiscontinuedOperations_21"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustedWeightedAverageSharesDiscontinuedOperations" xlink:label="loc_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestructuringProvision" xlink:label="loc_ifrs-full_RestructuringProvision_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance" xlink:label="loc_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClosureProvision" xlink:label="loc_trib_ClosureProvision_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForIncomeTaxExpenseCredit" xlink:label="loc_trib_AdjustmentsForIncomeTaxExpenseCredit_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="loc_ifrs-full_ConsiderationPaidReceived_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashProceedsFromDiscontinuedOperations" xlink:label="loc_trib_CashProceedsFromDiscontinuedOperations_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisions" xlink:label="loc_ifrs-full_CurrentProvisions_32"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReceivablesOutstanding" xlink:label="loc_trib_ReceivablesOutstanding_33"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_ClassAOrdinarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_1" xlink:to="loc_trib_AmericanDepositaryShareMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_6" xlink:to="loc_ifrs-full_GeographicalAreasDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_6" xlink:to="loc_country_SE_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_6" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_trib_DiscontinuedOperationsAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_trib_DiscontinuedOperationsAxis_10" xlink:to="loc_trib_DiscontinuedOperationsDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DiscontinuedOperationsDomain_10" xlink:to="loc_trib_FiomiDiagnosticsMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_trib_DiscontinuedOperationsAxis_10" xlink:to="loc_trib_DiscontinuedOperationsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_14" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_14" xlink:to="loc_trib_BiosynthMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_14" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_AdministrativeExpense_19" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_20" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_WeightedAverageSharesDiscontinuedOperations_21" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_AdjustedWeightedAverageSharesDiscontinuedOperations_22" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_RestructuringProvision_23" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance_24" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity_25" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_26" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_ClosureProvision_27" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_AdjustmentsForIncomeTaxExpenseCredit_28" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ConsiderationPaidReceived_29" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_CashProceedsFromDiscontinuedOperations_30" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_31" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_CurrentProvisions_32" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_trib_ReceivablesOutstanding_33" order="150" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable" xlink:label="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsAxis" xlink:label="loc_trib_DiscontinuedOperationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FiomiDiagnosticsMember" xlink:label="loc_trib_FiomiDiagnosticsMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DiscontinuedOperationsDomain" xlink:label="loc_trib_DiscontinuedOperationsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SE" xlink:label="loc_country_SE_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PostDisposalAdjustmentMember" xlink:label="loc_trib_PostDisposalAdjustmentMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsHeldForSaleMember" xlink:label="loc_ifrs-full_NoncurrentAssetsHeldForSaleMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_BiosynthMember" xlink:label="loc_trib_BiosynthMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_29"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_trib_DiscontinuedOperationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_trib_DiscontinuedOperationsAxis_1" xlink:to="loc_trib_DiscontinuedOperationsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DiscontinuedOperationsDomain_1" xlink:to="loc_trib_FiomiDiagnosticsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_trib_DiscontinuedOperationsAxis_1" xlink:to="loc_trib_DiscontinuedOperationsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_GeographicalAreasAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5" xlink:to="loc_ifrs-full_GeographicalAreasDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_5" xlink:to="loc_country_SE_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_5" xlink:to="loc_ifrs-full_GeographicalAreasDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_9" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_9" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_9" xlink:to="loc_trib_PostDisposalAdjustmentMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_9" xlink:to="loc_ifrs-full_NoncurrentAssetsHeldForSaleMember_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_9" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable_1" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_15" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_15" xlink:to="loc_trib_BiosynthMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_15" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_20" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_21" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_Inventories_22" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_23" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_24" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_25" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_LeaseLiabilities_26" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_27" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_28" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems_0" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_29" order="100" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:label="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TwoPercentageOfGrossInventoryMember" xlink:label="loc_trib_TwoPercentageOfGrossInventoryMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PointFivePercentageOfGrossInventoryMember" xlink:label="loc_trib_PointFivePercentageOfGrossInventoryMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities" xlink:label="loc_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AmortisationExpense" xlink:label="loc_ifrs-full_AmortisationExpense_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLoss" xlink:label="loc_ifrs-full_ImpairmentLoss_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoriesAtNetRealisableValue" xlink:label="loc_ifrs-full_InventoriesAtNetRealisableValue_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PercentageOfGrossInventory1" xlink:label="loc_trib_PercentageOfGrossInventory1_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ChangeInAllowance" xlink:label="loc_trib_ChangeInAllowance_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_1" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_TwoPercentageOfGrossInventoryMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_1" xlink:to="loc_trib_PointFivePercentageOfGrossInventoryMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_0" xlink:to="loc_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_0" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_0" xlink:to="loc_ifrs-full_AmortisationExpense_11" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLoss_12" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome_13" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_0" xlink:to="loc_ifrs-full_InventoriesAtNetRealisableValue_14" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_0" xlink:to="loc_trib_PercentageOfGrossInventory1_15" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_0" xlink:to="loc_trib_ChangeInAllowance_16" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PostBalanceSheetEventsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EventsAfterReportingPeriodMember" xlink:label="loc_trib_EventsAfterReportingPeriodMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FourthAmendmentToCreditAgreementMember" xlink:label="loc_trib_FourthAmendmentToCreditAgreementMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FifthAmendmentToCreditAgreementMember" xlink:label="loc_trib_FifthAmendmentToCreditAgreementMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_1" xlink:to="loc_trib_EventsAfterReportingPeriodMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_5" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5" xlink:to="loc_trib_FourthAmendmentToCreditAgreementMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_5" xlink:to="loc_trib_FifthAmendmentToCreditAgreementMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_5" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_NotionalAmount_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_BorrowingsMaturity_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRateBasis_13" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:label="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain" xlink:label="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CreditAgreementAxis" xlink:label="loc_trib_CreditAgreementAxis_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CreditAgreementDomain" xlink:label="loc_trib_CreditAgreementDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmendedCreditAgreementMember" xlink:label="loc_trib_AmendedCreditAgreementMember_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CreditAgreementDomain" xlink:label="loc_trib_CreditAgreementDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DirectorsMember" xlink:label="loc_trib_DirectorsMember_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EventsAfterReportingPeriodMember" xlink:label="loc_trib_EventsAfterReportingPeriodMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FourthAmendmentToCreditAgreementMember" xlink:label="loc_trib_FourthAmendmentToCreditAgreementMember_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FifthAmendmentToCreditAgreementMember" xlink:label="loc_trib_FifthAmendmentToCreditAgreementMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LenderMember" xlink:label="loc_trib_LenderMember_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContinuousGlucoseMonitoringTechnologyMember" xlink:label="loc_trib_ContinuousGlucoseMonitoringTechnologyMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssetsLiabilities" xlink:label="loc_ifrs-full_CurrentAssetsLiabilities_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AccumulatedDeficitInEquityAttributableToEquityHolders" xlink:label="loc_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment" xlink:label="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsUnderDevelopment" xlink:label="loc_ifrs-full_IntangibleAssetsUnderDevelopment_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_32"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MinimumLiquidityCovenant" xlink:label="loc_trib_MinimumLiquidityCovenant_33"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RevertsMinimumLiquidityCovenant" xlink:label="loc_trib_RevertsMinimumLiquidityCovenant_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-full_BorrowingsInterestRateBasis_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-full_BorrowingsMaturity_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CapitalReserve" xlink:label="loc_ifrs-full_CapitalReserve_38"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_1" xlink:to="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis_1" xlink:to="loc_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_trib_CreditAgreementAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_trib_CreditAgreementAxis_5" xlink:to="loc_trib_CreditAgreementDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_CreditAgreementDomain_5" xlink:to="loc_trib_AmendedCreditAgreementMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_trib_CreditAgreementAxis_5" xlink:to="loc_trib_CreditAgreementDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_9" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_9" xlink:to="loc_trib_DirectorsMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_9" xlink:to="loc_trib_EventsAfterReportingPeriodMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_9" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_14" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_14" xlink:to="loc_trib_FourthAmendmentToCreditAgreementMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_14" xlink:to="loc_trib_FifthAmendmentToCreditAgreementMember_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_14" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_19" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_19" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_19" xlink:to="loc_trib_LenderMember_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_19" xlink:to="loc_trib_ContinuousGlucoseMonitoringTechnologyMember_20" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_19" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_25" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_26" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_CurrentAssetsLiabilities_27" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_trib_AccumulatedDeficitInEquityAttributableToEquityHolders_28" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_29" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment_30" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_IntangibleAssetsUnderDevelopment_31" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_NotionalAmount_32" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_trib_MinimumLiquidityCovenant_33" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_trib_RevertsMinimumLiquidityCovenant_34" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_BorrowingsInterestRateBasis_35" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_BorrowingsMaturity_36" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_Equity_37" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_0" xlink:to="loc_ifrs-full_CapitalReserve_38" order="140" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:label="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:label="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProvisionalValueMember" xlink:label="loc_trib_ProvisionalValueMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MeasurementPeriodAdjustmentMember" xlink:label="loc_trib_MeasurementPeriodAdjustmentMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:label="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_19"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAcquiredAsOfAcquisitionDate" xlink:label="loc_trib_CashAcquiredAsOfAcquisitionDate_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_23"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SatisfiedByAbstract" xlink:label="loc_trib_SatisfiedByAbstract_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCashOutflowArisingOnAcquisitionAbstract" xlink:label="loc_trib_NetCashOutflowArisingOnAcquisitionAbstract_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_28"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCashOutFlowOnBusinessCombination" xlink:label="loc_trib_NetCashOutFlowOnBusinessCombination_29"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_WaveformTechnologiesIncorporationMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_MetabolomicsDiagnosticsLimitedMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_EpiCaptureLimitedMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_7" xlink:to="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_7" xlink:to="loc_trib_ProvisionalValueMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_7" xlink:to="loc_trib_MeasurementPeriodAdjustmentMember_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_7" xlink:to="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_16" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_17" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_18" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_19" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_trib_CashAcquiredAsOfAcquisitionDate_20" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_21" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_22" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_23" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_trib_SatisfiedByAbstract_24" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_SatisfiedByAbstract_24" xlink:to="loc_ifrs-full_CashTransferred_24" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_SatisfiedByAbstract_24" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_25" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_SatisfiedByAbstract_24" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_26" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_trib_NetCashOutflowArisingOnAcquisitionAbstract_28" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NetCashOutflowArisingOnAcquisitionAbstract_28" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_28" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_trib_NetCashOutflowArisingOnAcquisitionAbstract_28" xlink:to="loc_trib_NetCashOutFlowOnBusinessCombination_29" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_WaveformTechnologiesIncorporationMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_MetabolomicsDiagnosticsLimitedMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_EpiCaptureLimitedMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_8" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_WaveformTechnologiesIncorporationMember" xlink:label="loc_trib_WaveformTechnologiesIncorporationMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MetabolomicsDiagnosticsLimitedMember" xlink:label="loc_trib_MetabolomicsDiagnosticsLimitedMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EpiCaptureLimitedMember" xlink:label="loc_trib_EpiCaptureLimitedMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ClassAOrdinarySharesMember" xlink:label="loc_trib_ClassAOrdinarySharesMember_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositaryShareMember" xlink:label="loc_trib_AmericanDepositaryShareMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:label="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:label="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_MeasurementPeriodAdjustmentMember" xlink:label="loc_trib_MeasurementPeriodAdjustmentMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:label="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:label="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_25"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_26"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019" xlink:label="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination" xlink:label="loc_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_36"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExtinguishmentOfAmountOwed" xlink:label="loc_trib_ExtinguishmentOfAmountOwed_37"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone" xlink:label="loc_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_38"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DescriptionOfCumulativeRevenuesPayable" xlink:label="loc_trib_DescriptionOfCumulativeRevenuesPayable_39"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_WaveformTechnologiesIncorporationMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_MetabolomicsDiagnosticsLimitedMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_1" xlink:to="loc_trib_EpiCaptureLimitedMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_1" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_7" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_7" xlink:to="loc_trib_ClassAOrdinarySharesMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_7" xlink:to="loc_trib_AmericanDepositaryShareMember_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_7" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_RangeAxis_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_12" xlink:to="loc_ifrs-full_RangeDomain_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_12" xlink:to="loc_ifrs-full_TopOfRangeMember_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_12" xlink:to="loc_ifrs-full_RangeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_1" xlink:to="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_16" xlink:to="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_16" xlink:to="loc_trib_MeasurementPeriodAdjustmentMember_16" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_16" xlink:to="loc_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_CashTransferred_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_22" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_23" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets_24" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate_25" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate_26" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate_27" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019_28" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_29" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_30" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_31" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_32" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_33" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination_34" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_35" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_36" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_trib_ExtinguishmentOfAmountOwed_37" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone_38" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_0" xlink:to="loc_trib_DescriptionOfCumulativeRevenuesPayable_39" order="190" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PersonnelRelatedCostsMember" xlink:label="loc_trib_PersonnelRelatedCostsMember_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OutsourcingCostsMember" xlink:label="loc_trib_OutsourcingCostsMember_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SiteTransferCostsMember" xlink:label="loc_trib_SiteTransferCostsMember_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InventoryRelatedCostsMember" xlink:label="loc_trib_InventoryRelatedCostsMember_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherRestructuringCostsMember" xlink:label="loc_trib_OtherRestructuringCostsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" xlink:to="loc_trib_PersonnelRelatedCostsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" xlink:to="loc_trib_OutsourcingCostsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" xlink:to="loc_trib_SiteTransferCostsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" xlink:to="loc_trib_InventoryRelatedCostsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" xlink:to="loc_trib_OtherRestructuringCostsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_10" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember" xlink:label="loc_trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis" xlink:label="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain" xlink:label="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AmericanDepositarySharesMember" xlink:label="loc_trib_AmericanDepositarySharesMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain" xlink:label="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RestructuringActivitiesExpense" xlink:label="loc_trib_RestructuringActivitiesExpense_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonTradingCosts" xlink:label="loc_trib_NonTradingCosts_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_12"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_FairValueOfSharesIssued" xlink:label="loc_trib_FairValueOfSharesIssued_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="loc_ifrs-full_LegalProceedingsProvision_14"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdditionalRestructuringCosts" xlink:label="loc_trib_AdditionalRestructuringCosts_15"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NonRadingCosts" xlink:label="loc_trib_NonRadingCosts_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_1" xlink:to="loc_trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_1" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_1" xlink:to="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis_5" xlink:to="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_5" xlink:to="loc_trib_AmericanDepositarySharesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis_5" xlink:to="loc_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0" xlink:to="loc_trib_RestructuringActivitiesExpense_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0" xlink:to="loc_trib_NonTradingCosts_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0" xlink:to="loc_trib_FairValueOfSharesIssued_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0" xlink:to="loc_ifrs-full_LegalProceedingsProvision_14" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0" xlink:to="loc_trib_AdditionalRestructuringCosts_15" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_0" xlink:to="loc_trib_NonRadingCosts_16" order="70" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>trib-20241231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ConsolidatedStatementOfOperations" roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ConsolidatedStatementOfComprehensiveIncome" roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ConsolidatedStatementOfFinancialPosition" roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ConsolidatedStatementOfCashFlows" roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails" roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#EmploymentScheduleOfEmploymentCostsDetails" roleURI="http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails" roleURI="http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ImpairmentChargesScheduleOfStatementOfOperationDetails" roleURI="http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails" roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#OtherNon-currentAssetsDetails" roleURI="http://trinitybiotech.com/role/OtherNon-currentAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#InventoriesScheduleOfInventoriesDetails" roleURI="http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails" roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails" roleURI="http://trinitybiotech.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails" roleURI="http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#ProvisionsScheduleOfProvisionsDetails" roleURI="http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails" roleURI="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#RelatedPartyTransactionsScheduleOfCompensationDetails" roleURI="http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5" roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BUSINESSCOMBINATIONSDetails" roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"/>
  <roleRef xlink:type="simple" xlink:href="trib-20241231.xsd#BUSINESSCOMBINATIONSDetails__1" roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails__1"/>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ConsolidatedStatementOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_6"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OnceOffExpense" xlink:label="loc_trib_OnceOffExpense_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SellingGeneralAndAdministrativeExpensesClosureCosts" xlink:label="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_10"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetFinancingExpenseIncome" xlink:label="loc_trib_NetFinancingExpenseIncome_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_18"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_0" xlink:to="loc_ifrs-full_ProfitLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_1" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1" xlink:to="loc_ifrs-full_GrossProfit_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_1" xlink:to="loc_ifrs-full_Revenue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_1" xlink:to="loc_ifrs-full_CostOfSales_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_4" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_5" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_6" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1" xlink:to="loc_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts_7" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1" xlink:to="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_8" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1" xlink:to="loc_trib_OnceOffExpense_9" order="60" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1" xlink:to="loc_trib_SellingGeneralAndAdministrativeExpensesClosureCosts_10" order="70" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1" xlink:to="loc_trib_NetFinancingExpenseIncome_12" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_trib_NetFinancingExpenseIncome_12" xlink:to="loc_ifrs-full_FinanceIncome_12" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_trib_NetFinancingExpenseIncome_12" xlink:to="loc_ifrs-full_FinanceCosts_13" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_1" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_16" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_0" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_18" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_3"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_0" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_2" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_2" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_3" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets" xlink:label="loc_ifrs-full_OtherNoncurrentFinancialAssets_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentFinancialAssets_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxAssetsCurrent" xlink:label="loc_ifrs-full_CurrentTaxAssetsCurrent_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-full_TreasuryShares_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_18"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_EquityComponentOfConvertibleNote" xlink:label="loc_trib_EquityComponentOfConvertibleNote_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReserves" xlink:label="loc_ifrs-full_OtherReserves_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings" xlink:label="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_22"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NoncurrentFinanceLeaseLiabilities" xlink:label="loc_trib_NoncurrentFinanceLeaseLiabilities_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_24"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ConvertibleNote" xlink:label="loc_trib_ConvertibleNote_25"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ContingentConsiderationNonCurrent" xlink:label="loc_trib_ContingentConsiderationNonCurrent_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentProvisions" xlink:label="loc_ifrs-full_NoncurrentProvisions_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_30"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentFinanceLeaseLiabilities" xlink:label="loc_trib_CurrentFinanceLeaseLiabilities_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentProvisions" xlink:label="loc_ifrs-full_CurrentProvisions_32"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExchangeableNotesAndOtherBorrowingsCurrent" xlink:label="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_34"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_NoncurrentAssets_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_1" xlink:to="loc_ifrs-full_OtherNoncurrentFinancialAssets_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_1" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_1" xlink:to="loc_ifrs-full_NoncurrentFinancialAssets_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_1" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_1" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_1" xlink:to="loc_ifrs-full_DeferredTaxAssets_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_CurrentAssets_8" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_8" xlink:to="loc_ifrs-full_Inventories_8" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_8" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_9" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_8" xlink:to="loc_ifrs-full_CashAndCashEquivalents_10" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_8" xlink:to="loc_ifrs-full_CurrentTaxAssetsCurrent_11" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_13" xlink:to="loc_ifrs-full_Equity_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_14" xlink:to="loc_ifrs-full_IssuedCapital_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_14" xlink:to="loc_ifrs-full_SharePremium_15" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_14" xlink:to="loc_ifrs-full_RetainedEarnings_16" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_14" xlink:to="loc_ifrs-full_TreasuryShares_17" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_14" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_18" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_14" xlink:to="loc_trib_EquityComponentOfConvertibleNote_19" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_14" xlink:to="loc_ifrs-full_OtherReserves_20" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_13" xlink:to="loc_ifrs-full_Liabilities_22" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_22" xlink:to="loc_ifrs-full_NoncurrentLiabilities_22" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_22" xlink:to="loc_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings_22" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_22" xlink:to="loc_trib_NoncurrentFinanceLeaseLiabilities_23" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_22" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_24" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_22" xlink:to="loc_trib_ConvertibleNote_25" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_22" xlink:to="loc_trib_ContingentConsiderationNonCurrent_26" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_22" xlink:to="loc_ifrs-full_NoncurrentProvisions_27" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_22" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialLiabilities_28" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_22" xlink:to="loc_ifrs-full_CurrentLiabilities_30" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_30" xlink:to="loc_trib_CurrentFinanceLeaseLiabilities_30" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_30" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_31" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_30" xlink:to="loc_ifrs-full_CurrentProvisions_32" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_30" xlink:to="loc_trib_ExchangeableNotesAndOtherBorrowingsCurrent_33" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_30" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_34" order="40" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="loc_ifrs-full_OtherAdjustmentsForNoncashItems_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForIncomeTaxExpense_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForAmortisationExpense_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForFinanceIncome" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncome_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForFinanceCosts" xlink:label="loc_ifrs-full_AdjustmentsForFinanceCosts_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="loc_ifrs-full_AdjustmentsForProvisions_11"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForInventoryWriteOff" xlink:label="loc_trib_AdjustmentsForInventoryWriteOff_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_16"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentsForGainLossOnSaleOfBusiness" xlink:label="loc_trib_AdjustmentsForGainLossOnSaleOfBusiness_17"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_AdjustmentForRestructuringProvision" xlink:label="loc_trib_AdjustmentForRestructuringProvision_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_27"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsFromSharesToBeIssued" xlink:label="loc_trib_ProceedsFromSharesToBeIssued_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_29"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ProceedsForConvertibleNoteIssued" xlink:label="loc_trib_ProceedsForConvertibleNoteIssued_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-full_PaymentsForShareIssueCosts_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_34"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PenaltyForEarlySettlementOfTermLoan" xlink:label="loc_trib_PenaltyForEarlySettlementOfTermLoan_35"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RepaymentOfOtherLoan" xlink:label="loc_trib_RepaymentOfOtherLoan_36"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnSeniorSecuredTermLoan" xlink:label="loc_trib_InterestPaidOnSeniorSecuredTermLoan_37"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_InterestPaidOnConvertibleNote" xlink:label="loc_trib_InterestPaidOnConvertibleNote_38"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RefinancingCostsClassifiedAsFinancingActivities" xlink:label="loc_trib_RefinancingCostsClassifiedAsFinancingActivities_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_43"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities" xlink:label="loc_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_45"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities" xlink:label="loc_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_46"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperations_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_3" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_OtherAdjustmentsForNoncashItems_3" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_AdjustmentsForIncomeTaxExpense_4" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables_5" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_6" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_AdjustmentsForAmortisationExpense_7" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_AdjustmentsForFinanceIncome_8" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_9" order="60" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_AdjustmentsForFinanceCosts_10" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_AdjustmentsForProvisions_11" order="80" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_trib_AdjustmentsForInventoryWriteOff_12" order="90" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_13" order="100" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_14" order="110" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_15" order="120" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_ImpairmentLossOnFinancialAssets_16" order="130" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_trib_AdjustmentsForGainLossOnSaleOfBusiness_17" order="140" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_trib_AdjustmentForRestructuringProvision_18" order="150" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationExpense_19" order="160" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_3" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_20" order="170" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_3" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_22" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_3" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_23" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_3" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_24" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_27" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_trib_ProceedsFromSharesToBeIssued_28" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_29" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_trib_ProceedsForConvertibleNoteIssued_30" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_ifrs-full_PaymentsForShareIssueCosts_31" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_32" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_33" order="60" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_34" order="70" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_trib_PenaltyForEarlySettlementOfTermLoan_35" order="80" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_trib_RepaymentOfOtherLoan_36" order="90" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_trib_InterestPaidOnSeniorSecuredTermLoan_37" order="100" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_trib_InterestPaidOnConvertibleNote_38" order="110" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_trib_RefinancingCostsClassifiedAsFinancingActivities_39" order="120" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_27" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_40" order="130" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_42" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_42" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_42" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_42" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_43" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_42" xlink:to="loc_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities_44" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_42" xlink:to="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_45" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_42" xlink:to="loc_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities_46" order="40" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Revenue_0" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Revenue_0" xlink:to="loc_ifrs-full_OtherRevenue_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="loc_ifrs-full_EmployeeBenefitsExpense_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RecognitionOfContingentAsset" xlink:label="loc_trib_RecognitionOfContingentAsset_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes" xlink:label="loc_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ExpenseOfRestructuringCost" xlink:label="loc_trib_ExpenseOfRestructuringCost_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_SocialSecurityContributions" xlink:label="loc_ifrs-full_SocialSecurityContributions_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WagesAndSalaries" xlink:label="loc_ifrs-full_WagesAndSalaries_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_7"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_0" xlink:to="loc_trib_RecognitionOfContingentAsset_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_0" xlink:to="loc_trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_0" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_0" xlink:to="loc_trib_ExpenseOfRestructuringCost_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_0" xlink:to="loc_ifrs-full_SocialSecurityContributions_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_0" xlink:to="loc_ifrs-full_WagesAndSalaries_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EmployeeBenefitsExpense_0" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_7" order="60" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-full_OtherIncome_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_RentalIncomeFromPremises" xlink:label="loc_trib_RentalIncomeFromPremises_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GovernmentSupportsCovid19" xlink:label="loc_trib_GovernmentSupportsCovid19_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants" xlink:label="loc_ifrs-full_RevenueFromGovernmentGrants_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_0" xlink:to="loc_ifrs-full_OtherIncome_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_0" xlink:to="loc_trib_RentalIncomeFromPremises_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_0" xlink:to="loc_trib_GovernmentSupportsCovid19_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense_0" xlink:to="loc_ifrs-full_RevenueFromGovernmentGrants_4" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ImpairmentOfPrepayments" xlink:label="loc_trib_ImpairmentOfPrepayments_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ImpairmentLossOnFinancialAssets" xlink:label="loc_ifrs-full_ImpairmentLossOnFinancialAssets_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_IncomeTaxImpactOfImpairmentLoss" xlink:label="loc_trib_IncomeTaxImpactOfImpairmentLoss_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_0" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_1" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_1" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_1" xlink:to="loc_trib_ImpairmentOfPrepayments_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_1" xlink:to="loc_ifrs-full_ImpairmentLossOnFinancialAssets_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_0" xlink:to="loc_trib_IncomeTaxImpactOfImpairmentLoss_6" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossCarryforward" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsCapitalLossCarryforward" xlink:label="loc_trib_DeferredTaxAssetsCapitalLossCarryforward_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossDomestic" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossDomestic_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits" xlink:label="loc_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_3"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOtherTemporaryTimingDifferences" xlink:label="loc_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_4"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_DeferredTaxAssetsOperatingLossCarryforwardsState" xlink:label="loc_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_5"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_0" xlink:to="loc_trib_DeferredTaxAssetsCapitalLossCarryforward_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_0" xlink:to="loc_trib_DeferredTaxAssetsOperatingLossDomestic_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_0" xlink:to="loc_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_0" xlink:to="loc_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_trib_DeferredTaxAssetsOperatingLossCarryforward_0" xlink:to="loc_trib_DeferredTaxAssetsOperatingLossCarryforwardsState_5" order="40" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/OtherNon-currentAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentFinanceLeaseReceivables" xlink:label="loc_ifrs-full_NoncurrentFinanceLeaseReceivables_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_OtherAssetNoncurrent" xlink:label="loc_trib_OtherAssetNoncurrent_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets_0" xlink:to="loc_ifrs-full_NoncurrentFinanceLeaseReceivables_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets_0" xlink:to="loc_trib_OtherAssetNoncurrent_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies" xlink:label="loc_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WorkInProgress" xlink:label="loc_ifrs-full_WorkInProgress_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinishedGoods" xlink:label="loc_ifrs-full_FinishedGoods_3"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_0" xlink:to="loc_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_0" xlink:to="loc_ifrs-full_WorkInProgress_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_0" xlink:to="loc_ifrs-full_FinishedGoods_3" order="20" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentPrepayments" xlink:label="loc_ifrs-full_CurrentPrepayments_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentReceivablesFromRentalOfProperties" xlink:label="loc_ifrs-full_CurrentReceivablesFromRentalOfProperties_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentContractAssets" xlink:label="loc_ifrs-full_CurrentContractAssets_5"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ReceivablesFromConsiderationDueSaleOfBusiness" xlink:label="loc_trib_ReceivablesFromConsiderationDueSaleOfBusiness_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-full_OtherReceivables_7"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_GrantReceivable" xlink:label="loc_trib_GrantReceivable_8"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_0" xlink:to="loc_ifrs-full_CurrentTradeReceivables_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_0" xlink:to="loc_ifrs-full_CurrentPrepayments_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_0" xlink:to="loc_ifrs-full_CurrentValueAddedTaxReceivables_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_0" xlink:to="loc_ifrs-full_CurrentReceivablesFromRentalOfProperties_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_0" xlink:to="loc_ifrs-full_CurrentContractAssets_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_0" xlink:to="loc_trib_ReceivablesFromConsiderationDueSaleOfBusiness_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_0" xlink:to="loc_ifrs-full_OtherReceivables_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables_0" xlink:to="loc_trib_GrantReceivable_8" order="70" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-full_Cash_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalents_0" xlink:to="loc_ifrs-full_Cash_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalents_0" xlink:to="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsContinuingOperations" xlink:label="loc_trib_ShareBasedPaymentsContinuingOperations_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsCostOfSales" xlink:label="loc_trib_ShareBasedPaymentsCostOfSales_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsSellingGeneralAndAdministrative" xlink:label="loc_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_ShareBasedPaymentsDiscontinuedOperations" xlink:label="loc_trib_ShareBasedPaymentsDiscontinuedOperations_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_0" xlink:to="loc_trib_ShareBasedPaymentsContinuingOperations_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_trib_ShareBasedPaymentsContinuingOperations_1" xlink:to="loc_trib_ShareBasedPaymentsCostOfSales_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_trib_ShareBasedPaymentsContinuingOperations_1" xlink:to="loc_trib_ShareBasedPaymentsSellingGeneralAndAdministrative_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_0" xlink:to="loc_trib_ShareBasedPaymentsDiscontinuedOperations_4" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-full_Provisions_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-full_OtherProvisions_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="loc_ifrs-full_LegalProceedingsProvision_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_RestructuringProvision" xlink:label="loc_ifrs-full_RestructuringProvision_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_WarrantyProvision" xlink:label="loc_ifrs-full_WarrantyProvision_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Provisions_0" xlink:to="loc_ifrs-full_OtherProvisions_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Provisions_0" xlink:to="loc_ifrs-full_LegalProceedingsProvision_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Provisions_0" xlink:to="loc_ifrs-full_RestructuringProvision_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Provisions_0" xlink:to="loc_ifrs-full_WarrantyProvision_4" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CurrentFinanceLeaseLiabilities" xlink:label="loc_trib_CurrentFinanceLeaseLiabilities_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent" xlink:label="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_SaleAndLeasebackLiabilitiesCurrent" xlink:label="loc_trib_SaleAndLeasebackLiabilitiesCurrent_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_trib_CurrentFinanceLeaseLiabilities_0" xlink:to="loc_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_trib_CurrentFinanceLeaseLiabilities_0" xlink:to="loc_trib_SaleAndLeasebackLiabilitiesCurrent_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus" xlink:label="loc_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0" xlink:to="loc_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_0" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_4" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_0"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashSoldAsAPartOfDiscontinuedOperations" xlink:label="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_1"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts" xlink:label="loc_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_0" xlink:to="loc_trib_CashSoldAsAPartOfDiscontinuedOperations_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations_0" xlink:to="loc_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_9"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_3" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_6" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_7" order="60" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0" xlink:to="loc_ifrs-full_LeaseLiabilities_8" order="70" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_0" xlink:to="loc_ifrs-full_Inventories_9" order="80" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" xlink:label="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_8"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_CashAcquiredAsOfAcquisitionDate" xlink:label="loc_trib_CashAcquiredAsOfAcquisitionDate_9"/>
    <loc xlink:type="locator" xlink:href="trib-20241231.xsd#trib_NetCashOutFlowOnBusinessCombination" xlink:label="loc_trib_NetCashOutFlowOnBusinessCombination_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_13"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0" xlink:to="loc_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0" xlink:to="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2" xlink:to="loc_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2" xlink:to="loc_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate_3" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2" xlink:to="loc_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_4" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2" xlink:to="loc_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_5" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_6" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2" xlink:to="loc_ifrs-full_InventoryRecognisedAsOfAcquisitionDate_7" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2" xlink:to="loc_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_8" order="60" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_2" xlink:to="loc_trib_CashAcquiredAsOfAcquisitionDate_9" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_trib_NetCashOutFlowOnBusinessCombination_11" xlink:to="loc_ifrs-full_CashTransferred_12" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_trib_NetCashOutFlowOnBusinessCombination_11" xlink:to="loc_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_13" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails__1">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-full_CashTransferred_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_3"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0" xlink:to="loc_ifrs-full_CashTransferred_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_0" xlink:to="loc_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_3" order="20" use="optional" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>17
<FILENAME>trib-20241231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:trib="http://trinitybiotech.com/20241231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:cyd-af-sub="http://xbrl.sec.gov/cyd-af-sub/2024" xmlns:cyd-af="http://xbrl.sec.gov/cyd-af/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" targetNamespace="http://trinitybiotech.com/20241231" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
  <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd"/>
  <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd"/>
  <import namespace="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full" schemaLocation="https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd"/>
  <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/cyd-af-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/cyd-af/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd"/>
  <import namespace="http://xbrl.sec.gov/cyd/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://trinitybiotech.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>0001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfOperations" id="ConsolidatedStatementOfOperations">
        <link:definition>0002 - Statement - CONSOLIDATED STATEMENT OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome" id="ConsolidatedStatementOfComprehensiveIncome">
        <link:definition>0003 - Statement - CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition" id="ConsolidatedStatementOfFinancialPosition">
        <link:definition>0004 - Statement - CONSOLIDATED STATEMENT OF FINANCIAL POSITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity" id="ConsolidatedStatementOfChangesInEquity">
        <link:definition>0005 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows" id="ConsolidatedStatementOfCashFlows">
        <link:definition>0006 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPolicies" id="BasisOfPreparationAndSignificantAccountingPolicies">
        <link:definition>0007 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformation" id="SegmentInformation">
        <link:definition>0008 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/Employment" id="Employment">
        <link:definition>0009 - Disclosure - EMPLOYMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/OtherOperatingIncome" id="OtherOperatingIncome">
        <link:definition>0010 - Disclosure - OTHER OPERATING (EXPENSE) / INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ImpairmentCharges" id="ImpairmentCharges">
        <link:definition>0011 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/FinancialIncomeAndExpenses" id="FinancialIncomeAndExpenses">
        <link:definition>0012 - Disclosure - FINANCIAL INCOME AND EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/IncomeTaxCredit" id="IncomeTaxCredit">
        <link:definition>0013 - Disclosure - INCOME TAX (EXPENSE)/CREDIT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONS" id="PROFITFORTHEYEARONDISCONTINUEDOPERATIONS">
        <link:definition>0014 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LossBeforeTax" id="LossBeforeTax">
        <link:definition>0015 - Disclosure - LOSS BEFORE TAX</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LossPerShare" id="LossPerShare">
        <link:definition>0016 - Disclosure - LOSS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipment" id="PropertyPlantAndEquipment">
        <link:definition>0017 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETS" id="GOODWILLANDINTANGIBLEASSETS">
        <link:definition>0018 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/FINANCIALASSETS" id="FINANCIALASSETS">
        <link:definition>0019 - Disclosure - FINANCIAL ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilities" id="DeferredTaxAssetsAndLiabilities">
        <link:definition>0020 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/OtherNon-currentAssets" id="OtherNon-currentAssets">
        <link:definition>0021 - Disclosure - OTHER NON-CURRENT ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/Inventories" id="Inventories">
        <link:definition>0022 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivables" id="TradeAndOtherReceivables">
        <link:definition>0023 - Disclosure - TRADE AND OTHER RECEIVABLES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CashAndCashEquivalents" id="CashAndCashEquivalents">
        <link:definition>0024 - Disclosure - CASH AND CASH EQUIVALENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndReserves" id="CapitalAndReserves">
        <link:definition>0025 - Disclosure - CAPITAL AND RESERVES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ShareOptions" id="ShareOptions">
        <link:definition>0026 - Disclosure - SHARE OPTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/TradeAndOtherPayables" id="TradeAndOtherPayables">
        <link:definition>0027 - Disclosure - TRADE AND OTHER PAYABLES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/Provisions" id="Provisions">
        <link:definition>0028 - Disclosure - PROVISIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGS" id="INTERESTBEARINGLOANSANDBORROWINGS">
        <link:definition>0029 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LeaseLiabilities" id="LeaseLiabilities">
        <link:definition>0030 - Disclosure - LEASE LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>0031 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>0032 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagement" id="CapitalAndFinancialRiskManagement">
        <link:definition>0033 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivities" id="ReconciliationOfLiabilitiesArisingFromFinancingActivities">
        <link:definition>0034 - Disclosure - RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONS" id="BUSINESSCOMBINATIONS">
        <link:definition>0035 - Disclosure - BUSINESS COMBINATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/POSTBALANCESHEETEVENTS" id="POSTBALANCESHEETEVENTS">
        <link:definition>0036 - Disclosure - POST BALANCE SHEET EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/AccountingEstimatesAndJudgements" id="AccountingEstimatesAndJudgements">
        <link:definition>0037 - Disclosure - ACCOUNTING ESTIMATES AND JUDGEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/GROUPUNDERTAKINGS" id="GROUPUNDERTAKINGS">
        <link:definition>0038 - Disclosure - GROUP UNDERTAKINGS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/AuthorisationForIssue" id="AuthorisationForIssue">
        <link:definition>0039 - Disclosure - AUTHORISATION FOR ISSUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies" id="BasisOfPreparationAndSignificantAccountingPoliciesPolicies">
        <link:definition>9960701 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesTables" id="BasisOfPreparationAndSignificantAccountingPoliciesTables">
        <link:definition>9960702 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformationTables" id="SegmentInformationTables">
        <link:definition>9960703 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/EmploymentTables" id="EmploymentTables">
        <link:definition>9960704 - Disclosure - EMPLOYMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/OtherOperatingIncomeTables" id="OtherOperatingIncomeTables">
        <link:definition>9960705 - Disclosure - OTHER OPERATING (EXPENSE) / INCOME (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ImpairmentChargesTables" id="ImpairmentChargesTables">
        <link:definition>9960706 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/FinancialIncomeAndExpensesTables" id="FinancialIncomeAndExpensesTables">
        <link:definition>9960707 - Disclosure - FINANCIAL INCOME AND EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/IncomeTaxCreditTables" id="IncomeTaxCreditTables">
        <link:definition>9960708 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables" id="PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables">
        <link:definition>9960709 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LossBeforeTaxTables" id="LossBeforeTaxTables">
        <link:definition>9960710 - Disclosure - LOSS BEFORE TAX (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LossPerShareTables" id="LossPerShareTables">
        <link:definition>9960711 - Disclosure - LOSS PER SHARE  (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables" id="PropertyPlantAndEquipmentTables">
        <link:definition>9960712 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables" id="GoodwillAndIntangibleAssetsTables">
        <link:definition>9960713 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/FINANCIALASSETSTables" id="FINANCIALASSETSTables">
        <link:definition>9960714 - Disclosure - FINANCIAL ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesTables" id="DeferredTaxAssetsAndLiabilitiesTables">
        <link:definition>9960715 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/OtherNon-currentAssetsTables" id="OtherNon-currentAssetsTables">
        <link:definition>9960716 - Disclosure - OTHER NON-CURRENT ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/InventoriesTables" id="InventoriesTables">
        <link:definition>9960717 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesTables" id="TradeAndOtherReceivablesTables">
        <link:definition>9960718 - Disclosure - TRADE AND OTHER RECEIVABLES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CashAndCashEquivalentsTables" id="CashAndCashEquivalentsTables">
        <link:definition>9960719 - Disclosure - CASH AND CASH EQUIVALENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndReservesTables" id="CapitalAndReservesTables">
        <link:definition>9960720 - Disclosure - CAPITAL AND RESERVES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ShareOptionsTables" id="ShareOptionsTables">
        <link:definition>9960721 - Disclosure - SHARE OPTIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/TradeAndOtherPayablesTables" id="TradeAndOtherPayablesTables">
        <link:definition>9960722 - Disclosure - TRADE AND OTHER PAYABLES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ProvisionsTables" id="ProvisionsTables">
        <link:definition>9960723 - Disclosure - PROVISIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables" id="INTERESTBEARINGLOANSANDBORROWINGSTables">
        <link:definition>9960724 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LeaseLiabilitiesTables" id="LeaseLiabilitiesTables">
        <link:definition>9960725 - Disclosure - LEASE LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/RelatedPartyTransactionsTables" id="RelatedPartyTransactionsTables">
        <link:definition>9960726 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables" id="CapitalAndFinancialRiskManagementTables">
        <link:definition>9960727 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT  (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTables" id="ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTables">
        <link:definition>9960728 - Disclosure - RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables" id="BUSINESSCOMBINATIONSTables">
        <link:definition>9960729 - Disclosure - BUSINESS COMBINATIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/GROUPUNDERTAKINGSTables" id="GROUPUNDERTAKINGSTables">
        <link:definition>9960730 - Disclosure - GROUP UNDERTAKINGS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" id="BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
        <link:definition>9960731 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails" id="BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails">
        <link:definition>9960732 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Schedule of owned assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails" id="BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails">
        <link:definition>9960733 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Schedule of amortisation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SEGMENTINFORMATIONNarrativeDetails" id="SEGMENTINFORMATIONNarrativeDetails">
        <link:definition>9960734 - Disclosure - SEGMENT INFORMATION (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails" id="SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails">
        <link:definition>9960735 - Disclosure - SEGMENT INFORMATION (Schedule of Revenue by Geographical Area Based on Location of Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails" id="SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails">
        <link:definition>9960736 - Disclosure - SEGMENT INFORMATION (Schedule of Revenue by Customers Geographical Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails" id="SegmentInformationScheduleOfRevenueByMajorProductGroupDetails">
        <link:definition>9960737 - Disclosure - SEGMENT INFORMATION (Schedule of Revenue by Major Product Group) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfAmountRelatingFromRevenueDetails" id="SegmentInformationScheduleOfAmountRelatingFromRevenueDetails">
        <link:definition>9960738 - Disclosure - SEGMENT INFORMATION (Schedule of Amount Relating From Revenue) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails" id="SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails">
        <link:definition>9960739 - Disclosure - SEGMENT INFORMATION (Schedule of Revenue Derives From Transfer of Goods and Services) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails" id="SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails">
        <link:definition>9960740 - Disclosure - SEGMENT INFORMATION (Schedule of Segment Results by Geographical Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails" id="SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails">
        <link:definition>9960741 - Disclosure - SEGMENT INFORMATION (Schedule of Segment Assets and Segment Liabilities by Geographical Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails" id="SegmentInformationScheduleOfLongLivedAssetsDetails">
        <link:definition>9960742 - Disclosure - SEGMENT INFORMATION (Schedule of Long Lived Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails" id="SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails">
        <link:definition>9960743 - Disclosure - SEGMENT INFORMATION (Schedule of Depreciation and Amortisation by Geographical Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails" id="SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails">
        <link:definition>9960744 - Disclosure - SEGMENT INFORMATION (Schedule of Share Based Payment Expense by Geographical Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails" id="SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails">
        <link:definition>9960745 - Disclosure - SEGMENT INFORMATION (Schedule of Taxation Expense by Geographical Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails" id="SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails">
        <link:definition>9960746 - Disclosure - SEGMENT INFORMATION (Schedule of Capital Expenditure by Geographical Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/EmploymentNarrativeDetails" id="EmploymentNarrativeDetails">
        <link:definition>9960747 - Disclosure - EMPLOYMENT (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails" id="EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails">
        <link:definition>9960748 - Disclosure - EMPLOYMENT (Schedule of Average Number of Persons Employed) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails" id="EmploymentScheduleOfEmploymentCostsDetails">
        <link:definition>9960749 - Disclosure - EMPLOYMENT (Schedule of Employment Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/OtherOperatingIncomeDetails" id="OtherOperatingIncomeDetails">
        <link:definition>9960750 - Disclosure - OTHER OPERATING (EXPENSE) / INCOME (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails" id="OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails">
        <link:definition>9960751 - Disclosure - OTHER OPERATING (EXPENSE) / INCOME (Schedule of Other Operating Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails" id="IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails">
        <link:definition>9960752 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails" id="ImpairmentChargesScheduleOfStatementOfOperationDetails">
        <link:definition>9960753 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Schedule of Statement of Operation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear" id="IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear">
        <link:definition>9960754 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Schedule of restructuring costs incurred during the year) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails" id="FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails">
        <link:definition>9960755 - Disclosure - FINANCIAL INCOME AND EXPENSES (Schedule of Financial Income (Expenses), Net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails" id="IncomeTaxCreditNarrativeDetails">
        <link:definition>9960756 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails" id="IncomeTaxCreditScheduleOfChargeForTaxDetails">
        <link:definition>9960757 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Charge for Tax) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfOverseasTaxJurisdictionsDetails" id="IncomeTaxCreditScheduleOfOverseasTaxJurisdictionsDetails">
        <link:definition>9960758 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Overseas Tax Jurisdictions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfStatutoryTaxRateDetails" id="IncomeTaxCreditScheduleOfStatutoryTaxRateDetails">
        <link:definition>9960759 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Statutory Tax Rate) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails" id="IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails">
        <link:definition>9960760 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Loss Profit Before Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails" id="IncomeTaxCreditScheduleOfNetOperatingLossesDetails">
        <link:definition>9960761 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Net Operating Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails" id="IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails">
        <link:definition>9960762 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Unrecognised Deferred Tax Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails" id="PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails">
        <link:definition>9960763 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails" id="PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails">
        <link:definition>9960764 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of operating profit for the discontinued operations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1" id="PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1">
        <link:definition>9960765 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of net cashflows generated from discontinued operations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5" id="PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5">
        <link:definition>9960766 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of assets and liabilities disposed) (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2" id="PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2">
        <link:definition>9960767 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of Earnings Per ADS for Discontinued Operations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3" id="PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3">
        <link:definition>9960768 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of Cash Flows Attributable to Discontinued Operations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LossBeforeTaxNarrativeDetails" id="LossBeforeTaxNarrativeDetails">
        <link:definition>9960769 - Disclosure - LOSS BEFORE TAX (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails" id="LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails">
        <link:definition>9960770 - Disclosure - LOSS BEFORE TAX (Schedule of Amount Charged to Statement of Operation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LossPerShareNarrativeDetails" id="LossPerShareNarrativeDetails">
        <link:definition>9960771 - Disclosure - LOSS PER SHARE  (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails" id="LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails">
        <link:definition>9960772 - Disclosure - LOSS PER SHARE (Schedule of Basic Earnings Per Ordinary Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerOrdinaryShareDetails" id="LossPerShareScheduleOfDilutedEarningsPerOrdinaryShareDetails">
        <link:definition>9960773 - Disclosure - LOSS PER SHARE  (Schedule of Diluted Earnings Per Ordinary Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails" id="LossPerShareScheduleOfEarningsPerAdsDetails">
        <link:definition>9960774 - Disclosure - LOSS PER SHARE  (Schedule of Earnings Per ADS) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails" id="LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails">
        <link:definition>9960775 - Disclosure - LOSS PER SHARE (Schedule of Diluted Earnings Per ADS Share Calculation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails" id="PropertyPlantAndEquipmentNarrativeDetails">
        <link:definition>9960776 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails" id="PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails">
        <link:definition>9960777 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Schedule of Composition of Property and Equipment Related to Accumulated Depreciation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails" id="PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails">
        <link:definition>9960778 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Schedule of Additional Information on Right-of-use Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails" id="PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails">
        <link:definition>9960779 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Schedule of Income from Sub-letting Right-of-use Buildings) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails" id="GoodwillAndIntangibleAssetsNarrativeDetails">
        <link:definition>9960780 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails" id="GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails">
        <link:definition>9960781 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Goodwill and Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails" id="GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails">
        <link:definition>9960782 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Principal Development Projects) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails" id="GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails">
        <link:definition>9960783 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Impairment Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfBreakdownOfImpairmentLossDetailsUsd" id="GoodwillAndIntangibleAssetsScheduleOfBreakdownOfImpairmentLossDetailsUsd">
        <link:definition>9960784 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Breakdown of Impairment Loss) (Details) (USD $)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails" id="GOODWILLANDINTANGIBLEASSETSDetails">
        <link:definition>9960785 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Specific asset impairment charges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails" id="GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails">
        <link:definition>9960786 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Significant Goodwill and Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails" id="GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails">
        <link:definition>9960787 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Intangible Assets with Indefinite Useful lives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails" id="FINANCIALASSETSNarrativeDetails">
        <link:definition>9960788 - Disclosure - FINANCIAL ASSETS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/FINANCIALASSETSDetails" id="FINANCIALASSETSDetails">
        <link:definition>9960789 - Disclosure - FINANCIAL ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesNarrativeDetails" id="DeferredTaxAssetsAndLiabilitiesNarrativeDetails">
        <link:definition>9960790 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails" id="DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>9960791 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Recognised Deferred Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails" id="DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails">
        <link:definition>9960792 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Unrecognised Deferred Tax Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails" id="DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails">
        <link:definition>9960793 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Unrecognised Deferred Tax Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/OtherNon-currentAssetsDetails" id="OtherNon-currentAssetsDetails">
        <link:definition>9960794 - Disclosure - OTHER NON-CURRENT ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/InventoriesNarrativeDetails" id="InventoriesNarrativeDetails">
        <link:definition>9960795 - Disclosure - INVENTORIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails" id="InventoriesScheduleOfInventoriesDetails">
        <link:definition>9960796 - Disclosure - INVENTORIES (Schedule of inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails" id="InventoriesScheduleOfMovementOnInventoryProvisionDetails">
        <link:definition>9960797 - Disclosure - INVENTORIES (Schedule of Movement on the Inventory Provision) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails" id="TradeAndOtherReceivablesNarrativeDetails">
        <link:definition>9960798 - Disclosure - TRADE AND OTHER RECEIVABLES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails" id="TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails">
        <link:definition>9960799 - Disclosure - TRADE AND OTHER RECEIVABLES (Schedule of Trade and Other Receivables) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails" id="TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails">
        <link:definition>9960800 - Disclosure - TRADE AND OTHER RECEIVABLES (Schedule of Future Minimum Finance Lease Receivables) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails" id="TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails">
        <link:definition>9960801 - Disclosure - TRADE AND OTHER RECEIVABLES (Schedule of Future Minimum Rentals Receivable Under Non-Cancellable Operating Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails" id="CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails">
        <link:definition>9960802 - Disclosure - CASH AND CASH EQUIVALENTS (Schedule of Cash and Cash Equivalents) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails" id="CapitalAndReservesNarrativeDetails">
        <link:definition>9960803 - Disclosure - CAPITAL AND RESERVES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails" id="CapitalAndReservesScheduleOfShareCapitalDetails">
        <link:definition>9960804 - Disclosure - CAPITAL AND RESERVES (Schedule of Share Capital) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ShareOptionsNarrativeDetails" id="ShareOptionsNarrativeDetails">
        <link:definition>9960805 - Disclosure - SHARE OPTIONS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails" id="ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails">
        <link:definition>9960806 - Disclosure - SHARE OPTIONS (Schedule of Grants of Share Options and Warrants) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails" id="ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails">
        <link:definition>9960807 - Disclosure - SHARE OPTIONS (Summary of Range of Prices of Stock Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails" id="ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails">
        <link:definition>9960808 - Disclosure - SHARE OPTIONS (Schedule of Fair Value of the Options Vesting Period) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails" id="ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails">
        <link:definition>9960809 - Disclosure - SHARE OPTIONS (Schedule of Assumption Determining Fair Value of Share Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails" id="TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails">
        <link:definition>9960810 - Disclosure - TRADE AND OTHER PAYABLES (Schedule of Trade and Other Payables) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ProvisionsNarrativeDetails" id="ProvisionsNarrativeDetails">
        <link:definition>9960811 - Disclosure - PROVISIONS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails" id="ProvisionsScheduleOfProvisionsDetails">
        <link:definition>9960812 - Disclosure - PROVISIONS (Schedule of Provisions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails" id="INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails">
        <link:definition>9960813 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails" id="INTERESTBEARINGLOANSANDBORROWINGSDetails">
        <link:definition>9960814 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of carrying value of interest-bearing loans, borrowings and related balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1" id="INTERESTBEARINGLOANSANDBORROWINGSDetails1">
        <link:definition>9960815 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the Exchangeable Notes balance) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan" id="INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan">
        <link:definition>9960816 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in term loan) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4" id="INTERESTBEARINGLOANSANDBORROWINGSDetails4">
        <link:definition>9960817 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the derivative financial asset) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3" id="INTERESTBEARINGLOANSANDBORROWINGSDetails3">
        <link:definition>9960818 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the derivative financial liability) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2" id="INTERESTBEARINGLOANSANDBORROWINGSDetails2">
        <link:definition>9960819 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the Term Loan and the 7-year convertible notes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails" id="LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails">
        <link:definition>9960820 - Disclosure - LEASE LIABILITIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails" id="LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails">
        <link:definition>9960821 - Disclosure - LEASE LIABILITIES (Schedule of Carrying Values of Finance Lease Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails" id="LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails">
        <link:definition>9960822 - Disclosure - LEASE LIABILITIES (Schedule of Finance Lease Liabilities Payable) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails" id="CommitmentsAndContingenciesNarrativeDetails">
        <link:definition>9960823 - Disclosure - COMMITMENTS AND CONTINGENCIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails" id="RelatedPartyTransactionsNarrativeDetails">
        <link:definition>9960824 - Disclosure - RELATED PARTY TRANSACTIONS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails" id="RelatedPartyTransactionsScheduleOfCompensationDetails">
        <link:definition>9960825 - Disclosure - RELATED PARTY TRANSACTIONS (Schedule of Compensation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails" id="RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails">
        <link:definition>9960826 - Disclosure - RELATED PARTY TRANSACTIONS (Schedule of Company's Shares and Share Option Plan) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails" id="CapitalAndFinancialRiskManagementNarrativeDetails">
        <link:definition>9960827 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails" id="CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails">
        <link:definition>9960828 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Fair Values of Financial Assets/Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails" id="CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails">
        <link:definition>9960829 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Interest Rate Risk Effective and Repricing Analysis) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails" id="CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails">
        <link:definition>9960830 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of  interest Rate Profile of Financial Assets/Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails" id="CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails">
        <link:definition>9960831 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Liquidity Risk Estimated Interest Payments of Maturities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails" id="CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails">
        <link:definition>9960832 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Foreign Currency Risk Short Term Financial Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails" id="CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails">
        <link:definition>9960833 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Sensitivity Analysis) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMaximumCreditExposureOfFinancialAssetsDetails" id="CapitalAndFinancialRiskManagementScheduleOfMaximumCreditExposureOfFinancialAssetsDetails">
        <link:definition>9960834 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Maximum Credit Exposure of Financial Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails" id="CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails">
        <link:definition>9960835 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Exposure of Trade Receivables by Geographic Location) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails" id="CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails">
        <link:definition>9960836 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Exposure of Trade Receivables by Customer) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails" id="CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails">
        <link:definition>9960837 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Ageing of Trade Receivables) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMovementInAllowanceForImpairmentOfTradeReceivablesDetails" id="CapitalAndFinancialRiskManagementScheduleOfMovementInAllowanceForImpairmentOfTradeReceivablesDetails">
        <link:definition>9960838 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Movement in the Allowance for Impairment of Trade Receivables) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails" id="ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails">
        <link:definition>9960839 - Disclosure - RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Schedule of Liabilities Arising from Financing) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails" id="BUSINESSCOMBINATIONSNarrativeDetails">
        <link:definition>9960840 - Disclosure - BUSINESS COMBINATIONS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails" id="BUSINESSCOMBINATIONSDetails">
        <link:definition>9960841 - Disclosure - BUSINESS COMBINATIONS (Schedule of acquisition of the CGM assets of Waveform Technologies, Inc) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/PostBalanceSheetEventsDetails" id="PostBalanceSheetEventsDetails">
        <link:definition>9960842 - Disclosure - POST BALANCE SHEET EVENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails" id="AccountingEstimatesAndJudgementsNarrativeDetails">
        <link:definition>9960843 - Disclosure - ACCOUNTING ESTIMATES AND JUDGEMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails" id="GROUPUNDERTAKINGSDetails">
        <link:definition>9960844 - Disclosure - GROUP UNDERTAKINGS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails__1" id="BUSINESSCOMBINATIONSDetails__1">
        <link:definition>9960845 - Statement - BUSINESS COMBINATIONS (Schedule of acquisition of the CGM assets of Waveform Technologies, Inc) (Details) 1</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="trib-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="trib-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="trib-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="trib-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AccountingEstimatesAndJudgementsAbstract" id="trib_AccountingEstimatesAndJudgementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AccretionInterestAccrued" id="trib_AccretionInterestAccrued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AccretionInterestAdjustment" id="trib_AccretionInterestAdjustment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AccretionInterestOnBorrowings" id="trib_AccretionInterestOnBorrowings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AccruedBonus" id="trib_AccruedBonus" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AccruedInterestOnNotes" id="trib_AccruedInterestOnNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AccruedLiabilitiesToContractedLicencePayments" id="trib_AccruedLiabilitiesToContractedLicencePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AccruedLiability" id="trib_AccruedLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AccumulatedDeficitInEquityAttributableToEquityHolders" id="trib_AccumulatedDeficitInEquityAttributableToEquityHolders" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AcquisitionConsideration" id="trib_AcquisitionConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ActuarialAssumptionOfDiscountRatePercentage" id="trib_ActuarialAssumptionOfDiscountRatePercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ActuarialAssumptionOfExpectedPensionIncreases" id="trib_ActuarialAssumptionOfExpectedPensionIncreases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionalConsiderationContingentOnAchievementOfFutureMilestone" id="trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdditionalFunding" id="trib_AdditionalFunding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionalImpairmentLoss" id="trib_AdditionalImpairmentLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionalImpairmentLossDueToGrowthInRevenues" id="trib_AdditionalImpairmentLossDueToGrowthInRevenues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs" id="trib_AdditionalLeaseLiabilitiesAsResultOfInitialApplicationOfIfrs" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdditionalLiquidity" id="trib_AdditionalLiquidity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionalLiquidityRecognizedAsOfAcquisitionDate" id="trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdditionalProjectCost" id="trib_AdditionalProjectCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionalRestructuringCosts" id="trib_AdditionalRestructuringCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdditionalSpaceMember" id="trib_AdditionalSpaceMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdditionsRelatedToRightOfUseAssets" id="trib_AdditionsRelatedToRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustedLossProfitAfterTax" id="trib_AdjustedLossProfitAfterTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustedProfitAfterTax" id="trib_AdjustedProfitAfterTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustedWeightedAverageSharesDiscontinuedOperations" id="trib_AdjustedWeightedAverageSharesDiscontinuedOperations" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdjustmentForRestructuringProvision" id="trib_AdjustmentForRestructuringProvision" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentOnTransitionToIFRS16" id="trib_AdjustmentOnTransitionToIFRS16" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment" id="trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment" id="trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentsForGainLossOnSaleOfBusiness" id="trib_AdjustmentsForGainLossOnSaleOfBusiness" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdjustmentsForIncomeTaxExpenseCredit" id="trib_AdjustmentsForIncomeTaxExpenseCredit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForInventoryWriteOff" id="trib_AdjustmentsForInventoryWriteOff" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdministrationAndSalesMember" id="trib_AdministrationAndSalesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdoptionOfIfrs16" id="trib_AdoptionOfIfrs16" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdsRatioChangeMember" id="trib_AdsRatioChangeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AgreementPayments" id="trib_AgreementPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AgreementTerm" id="trib_AgreementTerm" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AllowanceForImpairmentOfReceivables" id="trib_AllowanceForImpairmentOfReceivables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AllowanceRepresentsGroupRevenues" id="trib_AllowanceRepresentsGroupRevenues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AlternativeMinimumTaxCreditMember" id="trib_AlternativeMinimumTaxCreditMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmendedCreditAgreementMember" id="trib_AmendedCreditAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmendmentAndRestatementOfTermLoanMember" id="trib_AmendmentAndRestatementOfTermLoanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmericaMember" id="trib_AmericaMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmericanDepositaryShareMember" id="trib_AmericanDepositaryShareMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmericanDepositarySharesMember" id="trib_AmericanDepositarySharesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmericanDepositaryShareTreasurySharesMember" id="trib_AmericanDepositaryShareTreasurySharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmericanDepositoryShares" id="trib_AmericanDepositoryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmericanDepositorySharesIssued" id="trib_AmericanDepositorySharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmortisationForDiscontinuedOperations" id="trib_AmortisationForDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmortisationOnIntangibleAssets" id="trib_AmortisationOnIntangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountAvailableForDevelopmentOfTheCGM" id="trib_AmountAvailableForDevelopmentOfTheCGM" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountPaidInRespectOfLeaseLiabilities" id="trib_AmountPaidInRespectOfLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountReceivedFromProviderReliefFund" id="trib_AmountReceivedFromProviderReliefFund" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountUsedToAcquireTheCGMAssets" id="trib_AmountUsedToAcquireTheCGMAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AnnualBorrowingBaseRate" id="trib_AnnualBorrowingBaseRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AnnualRentIncreased" id="trib_AnnualRentIncreased" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AnnualRentPayable" id="trib_AnnualRentPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AnnualRentPayableForWareHouse" id="trib_AnnualRentPayableForWareHouse" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AntigenProjectsMember" id="trib_AntigenProjectsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AsiaOrAfricaMember" id="trib_AsiaOrAfricaMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AssetsAndLiabilitiesBySegmentAbstract" id="trib_AssetsAndLiabilitiesBySegmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AssetsUnderDevelopmentCarryingValue" id="trib_AssetsUnderDevelopmentCarryingValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AutoimmuneFdaRegistrationsMember" id="trib_AutoimmuneFdaRegistrationsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AutoimmuneSmartReaderMember" id="trib_AutoimmuneSmartReaderMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AverageNumberOfEmployeesIncludingDiscontinuedOperations" id="trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AverageRemainingLeaseTermYears" id="trib_AverageRemainingLeaseTermYears" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AverageSharePriceShareOptionsExercised" id="trib_AverageSharePriceShareOptionsExercised" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BasisOfPreparationAndSignificantAccountingPoliciesLineItems" id="trib_BasisOfPreparationAndSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BasisOfPreparationAndSignificantAccountingPoliciesTable" id="trib_BasisOfPreparationAndSignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="BenenTradingLimitedMember" id="trib_BenenTradingLimitedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BiopoolUsIncMember" id="trib_BiopoolUsIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BiosynthMember" id="trib_BiosynthMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BloodBankScreeningBusinessMember" id="trib_BloodBankScreeningBusinessMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BorrowingsAndDerivativeFinancialInstrumentsMember" id="trib_BorrowingsAndDerivativeFinancialInstrumentsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BrainNatriureticPeptideMember" id="trib_BrainNatriureticPeptideMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BrazilMember" id="trib_BrazilMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BusinessacquisitionAxis" id="trib_BusinessacquisitionAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="BusinessacquisitionDomain" id="trib_BusinessacquisitionDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CapitalisationOfUnpaidInterestOnTermLoan" id="trib_CapitalisationOfUnpaidInterestOnTermLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CapitalisedDevelopmentCost" id="trib_CapitalisedDevelopmentCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CardiacAnalyserMember" id="trib_CardiacAnalyserMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CarryingAmountOfGoodwill" id="trib_CarryingAmountOfGoodwill" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashAcquiredAsOfAcquisitionDate" id="trib_CashAcquiredAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashAndCashEquivalentMember" id="trib_CashAndCashEquivalentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CashAndCashEquivalentsAndShortTermInvestments" id="trib_CashAndCashEquivalentsAndShortTermInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashInterestPayableOnPppLoans" id="trib_CashInterestPayableOnPppLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashInterestPayableOnSeniorSecureTermLoan" id="trib_CashInterestPayableOnSeniorSecureTermLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashPaidForNominalValue" id="trib_CashPaidForNominalValue" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CashPaidToEachHolder" id="trib_CashPaidToEachHolder" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashProceedsFromDiscontinuedOperations" id="trib_CashProceedsFromDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts" id="trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashReceivedPerNominalValue" id="trib_CashReceivedPerNominalValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CashSoldAsAPartOfDiscontinuedOperations" id="trib_CashSoldAsAPartOfDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ChangeInAllowance" id="trib_ChangeInAllowance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ClarkLaboratoriesIncMember" id="trib_ClarkLaboratoriesIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassAOrdinarySharesMember" id="trib_ClassAOrdinarySharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassATreasurySharesMember" id="trib_ClassATreasurySharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClinicalLaboratoryMember" id="trib_ClinicalLaboratoryMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClosingExercisePriceOfOutstandingShareOptions" id="trib_ClosingExercisePriceOfOutstandingShareOptions" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClosureCosts" id="trib_ClosureCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ClosureCostsMember" id="trib_ClosureCostsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClosureProvision" id="trib_ClosureProvision" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ColumnEnhancementMember" id="trib_ColumnEnhancementMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ComputerEquipmentsMember" id="trib_ComputerEquipmentsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConsiderationFromEmployeeOptionsSettledInCash" id="trib_ConsiderationFromEmployeeOptionsSettledInCash" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ConsolidatedStatementOfComprehensiveIncomeAbstract" id="trib_ConsolidatedStatementOfComprehensiveIncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContingentAssets" id="trib_ContingentAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate" id="trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate" id="trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ContingentConsiderationNonCurrent" id="trib_ContingentConsiderationNonCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ContingentLiabilityMember" id="trib_ContingentLiabilityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContinuousGlucoseMonitoringTechnologyMember" id="trib_ContinuousGlucoseMonitoringTechnologyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContinuousGlucoseMonitoringTestingMember" id="trib_ContinuousGlucoseMonitoringTestingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContractualCashFlowsMember" id="trib_ContractualCashFlowsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContributionAmountInSettlement" id="trib_ContributionAmountInSettlement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ContributionForTaxAuditSettlement" id="trib_ContributionForTaxAuditSettlement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ConversionPricePerAds" id="trib_ConversionPricePerAds" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConversionRatePerAds" id="trib_ConversionRatePerAds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ConvertibleNote" id="trib_ConvertibleNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ConvertibleNoteInvestment" id="trib_ConvertibleNoteInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ConvertibleNoteMember" id="trib_ConvertibleNoteMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CostIncurredIssueOfShares" id="trib_CostIncurredIssueOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="Covid19ElisaTestMember" id="trib_Covid19ElisaTestMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CovidPointOfCareRapidTestAndElisaTestMember" id="trib_CovidPointOfCareRapidTestAndElisaTestMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CovidTestMember" id="trib_CovidTestMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CraigHallumMember" id="trib_CraigHallumMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CreditAgreementAxis" id="trib_CreditAgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="CreditAgreementDomain" id="trib_CreditAgreementDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CurrentDerivativeLiabilities" id="trib_CurrentDerivativeLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CurrentFinanceLeaseLiabilities" id="trib_CurrentFinanceLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CurrentGovernmentLoans" id="trib_CurrentGovernmentLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CurrentLeaseLiabilitiesAbstract" id="trib_CurrentLeaseLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CurrentLiabilitiesMember" id="trib_CurrentLiabilitiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CurrentTaxForeignExpenseIncome" id="trib_CurrentTaxForeignExpenseIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CustomerMember" id="trib_CustomerMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DarnickCompanyMember" id="trib_DarnickCompanyMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DDimerDevelopmentMember" id="trib_DDimerDevelopmentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DebtRefinancingMember" id="trib_DebtRefinancingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeferredConsideration" id="trib_DeferredConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeferredConsiderationPayable" id="trib_DeferredConsiderationPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeferredTaxAssetDecreaseDueToDecreaseInProvision" id="trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxAssetIncreaseDueToIncreaseInProvision" id="trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeferredTaxAssetsCapitalLossCarryforward" id="trib_DeferredTaxAssetsCapitalLossCarryforward" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxAssetsOperatingLossCarryforward" id="trib_DeferredTaxAssetsOperatingLossCarryforward" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxAssetsOperatingLossCarryforwardsState" id="trib_DeferredTaxAssetsOperatingLossCarryforwardsState" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxAssetsOperatingLossDomestic" id="trib_DeferredTaxAssetsOperatingLossDomestic" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxAssetsOtherTemporaryTimingDifferences" id="trib_DeferredTaxAssetsOtherTemporaryTimingDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxAssetsUsAlternativeMinimumTaxCredits" id="trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" id="trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeferredTaxLiabilityDecreased" id="trib_DeferredTaxLiabilityDecreased" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxLiabilityIncreased" id="trib_DeferredTaxLiabilityIncreased" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeprecationForDiscontinuedOperations" id="trib_DeprecationForDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DepreciationMember" id="trib_DepreciationMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DepreciationOnIntangibleAssets" id="trib_DepreciationOnIntangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DerivativeFinancialAssetAtDateOfDrawdown" id="trib_DerivativeFinancialAssetAtDateOfDrawdown" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DerivativeFinancialAssetAtDateOfIssue" id="trib_DerivativeFinancialAssetAtDateOfIssue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DerivativeFinancialAssetMember" id="trib_DerivativeFinancialAssetMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DerivativeFinancialLiabilityAtDateOfDrawdown" id="trib_DerivativeFinancialLiabilityAtDateOfDrawdown" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DerivativeFinancialLiabilityAtDateOfIssue" id="trib_DerivativeFinancialLiabilityAtDateOfIssue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan" id="trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DerivativeFinancialLiabilityMember" id="trib_DerivativeFinancialLiabilityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory" id="trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForGeneralInformationExplanatory" id="trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory" id="trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory" id="trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory" id="trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory" id="trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory" id="trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory" id="trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfBorrowingsPaid" id="trib_DescriptionOfBorrowingsPaid" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfCumulativeRevenuesPayable" id="trib_DescriptionOfCumulativeRevenuesPayable" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfShareAdjustedRatio" id="trib_DescriptionOfShareAdjustedRatio" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DevelopmentCostMember" id="trib_DevelopmentCostMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DevelopmentCostsMember" id="trib_DevelopmentCostsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DirectorPensionExpense" id="trib_DirectorPensionExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DirectorsAndCompanySecretaryMember" id="trib_DirectorsAndCompanySecretaryMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract" id="trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DirectorsMember" id="trib_DirectorsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfAccountingEstimatesAndJudgementsAbstract" id="trib_DisclosureOfAccountingEstimatesAndJudgementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfAnalysisOfDiscontinuedOperationsLineItems" id="trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfAnalysisOfDiscontinuedOperationsTable" id="trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DisclosureOfAssetsAndLiabilitiesDisposedExplanatory" id="trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfAuthorisationForIssueAbstract" id="trib_DisclosureOfAuthorisationForIssueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfAuthorisationForIssueExplanatory" id="trib_DisclosureOfAuthorisationForIssueExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract" id="trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory" id="trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCommitmentsAndContingentLiabilityAbstract" id="trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCompositionOfGroupLineItems" id="trib_DisclosureOfCompositionOfGroupLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfCompositionOfGroupTable" id="trib_DisclosureOfCompositionOfGroupTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" id="trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory" id="trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory" id="trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory" id="trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory" id="trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory" id="trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory" id="trib_DisclosureOfDetailedInformationAboutCarryingValueOfExchangeableSeniorNotesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory" id="trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" id="trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory" id="trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutChargeForTaxExplanatory" id="trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutCompensationExplanatory" id="trib_DisclosureOfDetailedInformationAboutCompensationExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" id="trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory" id="trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory" id="trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory" id="trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory" id="trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory" id="trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory" id="trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory" id="trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory" id="trib_DisclosureOfDetailedInformationAboutExchangeableNotesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory" id="trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory" id="trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory" id="trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutFinancialAssets" id="trib_DisclosureOfDetailedInformationAboutFinancialAssets" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory" id="trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory" id="trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory" id="trib_DisclosureOfDetailedInformationAboutFutureMinimumOperatingLeaseCommitmentsWithNonCancellableExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory" id="trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory" id="trib_DisclosureOfDetailedInformationAboutImpairmentLossOfIntangibleAssetsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory" id="trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory" id="trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory" id="trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory" id="trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory" id="trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutInventoriesExplanatory" id="trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory" id="trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory" id="trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory" id="trib_DisclosureOfDetailedInformationAboutLossOnRemeasurementOfAssetsAndLiabilitiesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory" id="trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory" id="trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory" id="trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory" id="trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory" id="trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory" id="trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory" id="trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory" id="trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutOtherAssetsExplanatory" id="trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory" id="trib_DisclosureOfDetailedInformationAboutOtherPayablesDueAfterOneYearExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory" id="trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory" id="trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory" id="trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory" id="trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory" id="trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory" id="trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" id="trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory" id="trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock" id="trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory" id="trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory" id="trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory" id="trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory" id="trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory" id="trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory" id="trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory" id="trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory" id="trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory" id="trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDividendPaidAbstract" id="trib_DisclosureOfDividendPaidAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDividendsPaidExplanatory" id="trib_DisclosureOfDividendsPaidExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock" id="trib_DisclosureOfFairValueOfTotalNetAssetsAcquiredTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfFinanceLeaseLiabilitiesAbstract" id="trib_DisclosureOfFinanceLeaseLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfFinancingIncomeExpensesNetAbstract" id="trib_DisclosureOfFinancingIncomeExpensesNetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfGoodwillAndIntangibleAssetsAbstract" id="trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfGroupUndertakingsAbstract" id="trib_DisclosureOfGroupUndertakingsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfGroupUndertakingsExplanatory" id="trib_DisclosureOfGroupUndertakingsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract" id="trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfIncomeTaxCreditAbstract" id="trib_DisclosureOfIncomeTaxCreditAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfInterestbearingLoansAndBorrowingsAbstract" id="trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory" id="trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfLossOnDiscontinuedOperationsAbstract" id="trib_DisclosureOfLossOnDiscontinuedOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfLossProfitBeforeTaxAbstract" id="trib_DisclosureOfLossProfitBeforeTaxAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfLossProfitBeforeTaxExplanatory" id="trib_DisclosureOfLossProfitBeforeTaxExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory" id="trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock" id="trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOtherAssetsAbstract" id="trib_DisclosureOfOtherAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOtherOperatingIncomeAbstract" id="trib_DisclosureOfOtherOperatingIncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOtherPayablesDueAfterOneYearAbstract" id="trib_DisclosureOfOtherPayablesDueAfterOneYearAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfOtherPayablesDueAfterOneYearExplanatory" id="trib_DisclosureOfOtherPayablesDueAfterOneYearExplanatory" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfPensionSchemesAbstract" id="trib_DisclosureOfPensionSchemesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfPostBalanceSheetEventsAbstract" id="trib_DisclosureOfPostBalanceSheetEventsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfReconciliationFromIas17ToIfrs16Explanatory" id="trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory" id="trib_DisclosureOfSellingGeneralAndAdministrativeExpenseExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfShareOptionsAndShareWarrantsAbstract" id="trib_DisclosureOfShareOptionsAndShareWarrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfShareOptionsAndShareWarrantsExplanatory" id="trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfShortTermInvestmentsAbstract" id="trib_DisclosureOfShortTermInvestmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DiscontinuedOperationsAxis" id="trib_DiscontinuedOperationsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="DiscontinuedOperationsDomain" id="trib_DiscontinuedOperationsDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DiscountingLeaseLiability" id="trib_DiscountingLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DisposalsGoodwillAndIntangibleAssets" id="trib_DisposalsGoodwillAndIntangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DisposalsOrRetirementsPropertyAndEquipment" id="trib_DisposalsOrRetirementsPropertyAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DisposalsRelatedToRightOfUseAssets" id="trib_DisposalsRelatedToRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DistributorsMember" id="trib_DistributorsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DivestitureOfFitzgeraldLifeSciencesBusinessMember" id="trib_DivestitureOfFitzgeraldLifeSciencesBusinessMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DrJimWalshMember" id="trib_DrJimWalshMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EarlyRepaymentPenaltyDescription" id="trib_EarlyRepaymentPenaltyDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment" id="trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract" id="trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EffectiveInterestRate" id="trib_EffectiveInterestRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16" id="trib_EffectOfAssumedProbableLeaseExtensionInAdoptionOfIFRS16" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EffectOfIrishIncomeTaxableAtHigherTaxRate" id="trib_EffectOfIrishIncomeTaxableAtHigherTaxRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EliminatedOnDisposalOfBusiness" id="trib_EliminatedOnDisposalOfBusiness" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EliminatedOnDisposalsOfBusiness" id="trib_EliminatedOnDisposalsOfBusiness" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EmployeeRelatedSocialInsurance" id="trib_EmployeeRelatedSocialInsurance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EndUserCustomersMember" id="trib_EndUserCustomersMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EnhancedTphaByCmvMember" id="trib_EnhancedTphaByCmvMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EpiCaptureLimitedMember" id="trib_EpiCaptureLimitedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquityComponentAtDateOfIssue" id="trib_EquityComponentAtDateOfIssue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EquityComponentOfConvertibleNote" id="trib_EquityComponentOfConvertibleNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EquityComponentOfConvertibleNoteAtDateOfIssue" id="trib_EquityComponentOfConvertibleNoteAtDateOfIssue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EquityComponentOfConvertibleNoteMember" id="trib_EquityComponentOfConvertibleNoteMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EstimatedObligations" id="trib_EstimatedObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EuropeIncludingIrelandMember" id="trib_EuropeIncludingIrelandMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EuroZoneCountriesMember" id="trib_EuroZoneCountriesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EventsAfterReportingPeriodMember" id="trib_EventsAfterReportingPeriodMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExcessValueOfGoodwillInUseOverCarryingAmount" id="trib_ExcessValueOfGoodwillInUseOverCarryingAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExchangeableNoteBondPutOption" id="trib_ExchangeableNoteBondPutOption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ExchangeableNoteEquityConversionOption" id="trib_ExchangeableNoteEquityConversionOption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ExchangeableNoteInterest" id="trib_ExchangeableNoteInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExchangeableNoteMember" id="trib_ExchangeableNoteMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExchangeableNotesAndOtherBorrowings" id="trib_ExchangeableNotesAndOtherBorrowings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ExchangeableNotesAndOtherBorrowingsCurrent" id="trib_ExchangeableNotesAndOtherBorrowingsCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ExchangeableNotesAndOtherBorrowingsNonCurrent" id="trib_ExchangeableNotesAndOtherBorrowingsNonCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ExchangeableNotesDiscountRate" id="trib_ExchangeableNotesDiscountRate" type="xbrli:pureItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExchangeableSeniorNotesMember" id="trib_ExchangeableSeniorNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExchangeRatePricePerAds" id="trib_ExchangeRatePricePerAds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExercisableAbstract" id="trib_ExercisableAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExerciseOfShareOptionsReceivable" id="trib_ExerciseOfShareOptionsReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExercisePriceOfWarrantsOrRights" id="trib_ExercisePriceOfWarrantsOrRights" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePricePerADS" id="trib_ExercisePricePerADS" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpenseOfRestructuringCost" id="trib_ExpenseOfRestructuringCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExtinguishmentOfAmountOwed" id="trib_ExtinguishmentOfAmountOwed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ExtinguishmentOfDebtAmounts" id="trib_ExtinguishmentOfDebtAmounts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueMember" id="trib_FairValueMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate" id="trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueOfDerivativeFinancialAsset" id="trib_FairValueOfDerivativeFinancialAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueOfDerivativeFinancialLiability" id="trib_FairValueOfDerivativeFinancialLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueOfFinancialAssetsLiabilities" id="trib_FairValueOfFinancialAssetsLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueOfSharesIssued" id="trib_FairValueOfSharesIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueRemeasuredThroughProfitLossOfFinancialAssets" id="trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FairValueRemeasurementForDerivativeFinancialBalances" id="trib_FairValueRemeasurementForDerivativeFinancialBalances" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueThroughProfitAndLoss" id="trib_FairValueThroughProfitAndLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FederalCorporationTaxRateMember" id="trib_FederalCorporationTaxRateMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FifthAmendmentToCreditAgreementMember" id="trib_FifthAmendmentToCreditAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinanceIncomeExpenseNet" id="trib_FinanceIncomeExpenseNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FinanceLeaseLiabilitiesMember" id="trib_FinanceLeaseLiabilitiesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinanceLeaseLiabilitiesTwoMember" id="trib_FinanceLeaseLiabilitiesTwoMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinanceLeasePayableMember" id="trib_FinanceLeasePayableMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinanceLeaseReceivableMember" id="trib_FinanceLeaseReceivableMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinancialAssetsAdditions" id="trib_FinancialAssetsAdditions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FinancialAssetsLeaseReceivables" id="trib_FinancialAssetsLeaseReceivables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FinancialAssetsPolicyTextBlock" id="trib_FinancialAssetsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinancialAssetsWriteOff" id="trib_FinancialAssetsWriteOff" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FinancialAtFairValueThroughProfitOrLossAbstract" id="trib_FinancialAtFairValueThroughProfitOrLossAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinancialIncomeAndExpensesAbstract" id="trib_FinancialIncomeAndExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinancialIncomeAndExpensesLineItems" id="trib_FinancialIncomeAndExpensesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinancialIncomeAndExpensesTable" id="trib_FinancialIncomeAndExpensesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue" id="trib_FinancialIncomeFromRevaluationOfEmbeddedDerivativesAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FinancingExpensesAbstract" id="trib_FinancingExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinancingExpensesOther" id="trib_FinancingExpensesOther" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FinancingIncomeAbstract" id="trib_FinancingIncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinancingIncomeBySegment" id="trib_FinancingIncomeBySegment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FiomiDiagnosticsAbMember" id="trib_FiomiDiagnosticsAbMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FiomiDiagnosticsHoldingAbMember" id="trib_FiomiDiagnosticsHoldingAbMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FiomiDiagnosticsMember" id="trib_FiomiDiagnosticsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FiomiMember" id="trib_FiomiMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FitzgeraldIndustriesInternationalCguRdiTradeNameMember" id="trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FitzgeraldIndustriesInternationalCguTradeNameMember" id="trib_FitzgeraldIndustriesInternationalCguTradeNameMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FitzgeraldIndustriesInternationalIncMember" id="trib_FitzgeraldIndustriesInternationalIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FixedRateFinancialLiabilitiesBorrowings" id="trib_FixedRateFinancialLiabilitiesBorrowings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FixedRateInstruments" id="trib_FixedRateInstruments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FixedRateInstrumentsAbstract" id="trib_FixedRateInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForeignExchangeDifferencesMember" id="trib_ForeignExchangeDifferencesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForgivenessOfBorrowings" id="trib_ForgivenessOfBorrowings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FourthAmendmentToCreditAgreementMember" id="trib_FourthAmendmentToCreditAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FutureFinanceChargeOnFinanceLeases" id="trib_FutureFinanceChargeOnFinanceLeases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="G6PDHTestMember" id="trib_G6PDHTestMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GenesysOrResolutionColumnEnhancementMember" id="trib_GenesysOrResolutionColumnEnhancementMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GoodwillWriteOff" id="trib_GoodwillWriteOff" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GovernmentGrantReceived" id="trib_GovernmentGrantReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GovernmentLoansForgivenAmount" id="trib_GovernmentLoansForgivenAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GovernmentSupportsCovid19" id="trib_GovernmentSupportsCovid19" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GrantContingenciesMaximumAmountPayable" id="trib_GrantContingenciesMaximumAmountPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GrantReceivable" id="trib_GrantReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GreaterThanFiveYearsMember" id="trib_GreaterThanFiveYearsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GreaterThanFourMonthsMember" id="trib_GreaterThanFourMonthsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrossIncreaseInterestIncome" id="trib_GrossIncreaseInterestIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GrossInvestmentInFinanceLease" id="trib_GrossInvestmentInFinanceLease" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GroupLeaseExpense" id="trib_GroupLeaseExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="HivIncidenceAssayMember" id="trib_HivIncidenceAssayMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HivOneByTwoRapidTestMember" id="trib_HivOneByTwoRapidTestMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HivScreeningAfricaMember" id="trib_HivScreeningAfricaMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IgmCaptiaMember" id="trib_IgmCaptiaMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ImmcoDiagnosticCGUMember" id="trib_ImmcoDiagnosticCGUMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ImmcoDiagnosticsIncMember" id="trib_ImmcoDiagnosticsIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ImmcoDiagnosticsMember" id="trib_ImmcoDiagnosticsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ImmcoDiagnosticTradeNameMember" id="trib_ImmcoDiagnosticTradeNameMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ImpairmentChargePropertyPlantEquipment" id="trib_ImpairmentChargePropertyPlantEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ImpairmentChargesMember" id="trib_ImpairmentChargesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ImpairmentLossForInvestment" id="trib_ImpairmentLossForInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ImpairmentOfPrepayments" id="trib_ImpairmentOfPrepayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeFromPaycheckProtectionProgramLoans" id="trib_IncomeFromPaycheckProtectionProgramLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncomeLoss" id="trib_IncomeLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncomeTaxAssetsCurrentAndDeferred" id="trib_IncomeTaxAssetsCurrentAndDeferred" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeTaxExpense" id="trib_IncomeTaxExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract" id="trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncomeTaxExpenseBenefits" id="trib_IncomeTaxExpenseBenefits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeTaxImpactOfImpairmentLoss" id="trib_IncomeTaxImpactOfImpairmentLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeTaxLiabilitiesCurrentAndDeferred" id="trib_IncomeTaxLiabilitiesCurrentAndDeferred" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities" id="trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities" id="trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities" id="trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities" id="trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities" id="trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities" id="trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreasedecreasethroughequityComponentOfConvertibleNote" id="trib_IncreasedecreasethroughequityComponentOfConvertibleNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities" id="trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised" id="trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreasedInUnrecognisedDeferredTaxAssets" id="trib_IncreasedInUnrecognisedDeferredTaxAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseInAnnualRent" id="trib_IncreaseInAnnualRent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseInSettlementAmountDueToDepreciation" id="trib_IncreaseInSettlementAmountDueToDepreciation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseTermLoan" id="trib_IncreaseTermLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InitialExercisePriceOfWarrantsOrRights" id="trib_InitialExercisePriceOfWarrantsOrRights" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InstalmentsAxis" id="trib_InstalmentsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="InstalmentsDomain" id="trib_InstalmentsDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InstrumentsMember" id="trib_InstrumentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IntangibleAssetsUnderDevelopmentImpairmentCharge" id="trib_IntangibleAssetsUnderDevelopmentImpairmentCharge" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IntangibleAssetsUnderDevelopmentWrittenDown" id="trib_IntangibleAssetsUnderDevelopmentWrittenDown" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InterestEarningFinancialAndInterestBearingFinancialLiabilities" id="trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="InterestExpenseOnLeaseLiabilities1" id="trib_InterestExpenseOnLeaseLiabilities1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InterestExpenseOnTaxAuditSettlement" id="trib_InterestExpenseOnTaxAuditSettlement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InterestExpenses" id="trib_InterestExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InterestExpensesAbstract" id="trib_InterestExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InterestIncomeAbstract" id="trib_InterestIncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InterestIncomeCredit" id="trib_InterestIncomeCredit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="InterestIncomeEarned" id="trib_InterestIncomeEarned" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="InterestOnDeferredConsiderationAndLicenceFee" id="trib_InterestOnDeferredConsiderationAndLicenceFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InterestPaidOnConvertibleNote" id="trib_InterestPaidOnConvertibleNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="InterestPaidOnSeniorSecuredTermLoan" id="trib_InterestPaidOnSeniorSecuredTermLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InterSegmentInterestExpense" id="trib_InterSegmentInterestExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InterSegmentInterestIncome" id="trib_InterSegmentInterestIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="InventoryMember" id="trib_InventoryMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InventoryRelatedCostsMember" id="trib_InventoryRelatedCostsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InventoryWrittenDown" id="trib_InventoryWrittenDown" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InvestmentInUnsecuredJuniorConvertibleNote" id="trib_InvestmentInUnsecuredJuniorConvertibleNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IssuableOnConversionOfConvertibleNotes" id="trib_IssuableOnConversionOfConvertibleNotes" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuableOnConversionOfExchangeableNotes" id="trib_IssuableOnConversionOfExchangeableNotes" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuableOnExerciseOfOptions" id="trib_IssuableOnExerciseOfOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuableOnExerciseOfOptionsAndWarrants" id="trib_IssuableOnExerciseOfOptionsAndWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuedAmericanDepositoryShares" id="trib_IssuedAmericanDepositoryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IssuedForNoncashConsideration" id="trib_IssuedForNoncashConsideration" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuenceOfExchangeableNote" id="trib_IssuenceOfExchangeableNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ITAndOfficeEquipmentMember" id="trib_ITAndOfficeEquipmentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="JrjMember" id="trib_JrjMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="KansasRightOfUseAssetMember" id="trib_KansasRightOfUseAssetMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="KeyManagementPersonnelCompensationPerformanceRelatedBonus" id="trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes" id="trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="KonamiteLimitedMember" id="trib_KonamiteLimitedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LaboratoryEquipmentMember" id="trib_LaboratoryEquipmentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LaboratoryServicesMember" id="trib_LaboratoryServicesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LaterThanOneMonthsAndNotLaterThanFourMonthsMember" id="trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LaterThanTwoYearAndNotLaterThanFiveYearsMember" id="trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeaseCosts" id="trib_LeaseCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed" id="trib_LeaseExpensesForShortTermLeasesForWhichRecognitionExemptionHasBeenUsed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent" id="trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LeaseLiabilitiesRelatedToRightOfUseAssetsMember" id="trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent" id="trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LeasePayableOnRightOfUseAssets" id="trib_LeasePayableOnRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LeasePayableOnRightOfUseAssetsMember" id="trib_LeasePayableOnRightOfUseAssetsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeasePayableOnSaleAndLeasebackTransactions" id="trib_LeasePayableOnSaleAndLeasebackTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LeasePayableOnSaleLeasebackTransactionsMember" id="trib_LeasePayableOnSaleLeasebackTransactionsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeaseTerm" id="trib_LeaseTerm" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LenderMember" id="trib_LenderMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LiabilitiesAssumedAsOfAcquisitionDateAbstract" id="trib_LiabilitiesAssumedAsOfAcquisitionDateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LiabilitiesAtAmortisedCostAbstract" id="trib_LiabilitiesAtAmortisedCostAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LicenceFee" id="trib_LicenceFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LicenceFeePayments" id="trib_LicenceFeePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LicencePaymentsMember" id="trib_LicencePaymentsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LineImmunoassayPanelsMember" id="trib_LineImmunoassayPanelsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LoanIncome" id="trib_LoanIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LoanOriginationCosts" id="trib_LoanOriginationCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LoansAndReceivablesAbstract" id="trib_LoansAndReceivablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LongLivedAsstesBySegment" id="trib_LongLivedAsstesBySegment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LongTermGrowthRate" id="trib_LongTermGrowthRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LongTermLeaseLiabilitiesMember" id="trib_LongTermLeaseLiabilitiesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LossOnDiscontinuedOperationsAbstract" id="trib_LossOnDiscontinuedOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LossOnDisposalOfExchangeableNotes" id="trib_LossOnDisposalOfExchangeableNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LossOnDisposalOnBorrowings" id="trib_LossOnDisposalOnBorrowings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MalariaPointOfCareTestMember" id="trib_MalariaPointOfCareTestMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ManufacturingAndQualityMember" id="trib_ManufacturingAndQualityMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MardxDiagnosticIncMember" id="trib_MardxDiagnosticIncMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MardxDiagnosticsIncMember" id="trib_MardxDiagnosticsIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MatrixProjectMember" id="trib_MatrixProjectMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MaturityDateForLease" id="trib_MaturityDateForLease" type="xbrli:gYearItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MaturityDateOfExchangeableSeniorNotes" id="trib_MaturityDateOfExchangeableSeniorNotes" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MaximumWeightedAveragePriceOfAmericanDepositoryShares" id="trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MeasurementPeriodAdjustmentMember" id="trib_MeasurementPeriodAdjustmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MetabolomicDiagnosticsLimitedMember" id="trib_MetabolomicDiagnosticsLimitedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MetabolomicsDiagnosticsLimitedMember" id="trib_MetabolomicsDiagnosticsLimitedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MicoLtdMember" id="trib_MicoLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MicropillarTechnologyMember" id="trib_MicropillarTechnologyMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MidTierHaemoglobinsInstrumentMember" id="trib_MidTierHaemoglobinsInstrumentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MinimumFinanceLeasePaymentsPayable" id="trib_MinimumFinanceLeasePaymentsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="MinimumFinanceLeasePaymentsPayableAtCarryingAmount" id="trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="MinimumFinanceLeasePaymentsPayableAtPresentValue" id="trib_MinimumFinanceLeasePaymentsPayableAtPresentValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="MinimumFinanceLeasePaymentsReceivableAtPresentValue" id="trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MinimumLiquidityCovenant" id="trib_MinimumLiquidityCovenant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MoreThanOneYearMember" id="trib_MoreThanOneYearMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MovementInInterestAccrual" id="trib_MovementInInterestAccrual" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MrOCaoimhAndDrWalshMember" id="trib_MrOCaoimhAndDrWalshMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MrOCaoimhMember" id="trib_MrOCaoimhMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NativeDesignLimitedMember" id="trib_NativeDesignLimitedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NetCarryingAmountMember" id="trib_NetCarryingAmountMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NetCashOutflowArisingOnAcquisitionAbstract" id="trib_NetCashOutflowArisingOnAcquisitionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NetCashOutFlowOnBusinessCombination" id="trib_NetCashOutFlowOnBusinessCombination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NetFinancingExpenseIncome" id="trib_NetFinancingExpenseIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NetForeignExchangeGainLoss" id="trib_NetForeignExchangeGainLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NetInterestIncome" id="trib_NetInterestIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NetOperatingLossCarryforwards" id="trib_NetOperatingLossCarryforwards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NetOperatingLossPeriod" id="trib_NetOperatingLossPeriod" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NominalAmountOfDebt" id="trib_NominalAmountOfDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NominalValue" id="trib_NominalValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NominalValuePerShareOfExchangeableNotes" id="trib_NominalValuePerShareOfExchangeableNotes" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonCashActivityForFinancingActivityAbstract" id="trib_NonCashActivityForFinancingActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonCashFairValueGainLoss" id="trib_NonCashFairValueGainLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NoncashFairValueLoss" id="trib_NoncashFairValueLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonCashImpairmentCharge" id="trib_NonCashImpairmentCharge" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NoncashInterestOnConvertibleNote" id="trib_NoncashInterestOnConvertibleNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NoncashInterestOnSeniorSecuredTermLoan" id="trib_NoncashInterestOnSeniorSecuredTermLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NoncashLoanModificationGain" id="trib_NoncashLoanModificationGain" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NonCurrentAssetsMember" id="trib_NonCurrentAssetsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NoncurrentDerivativeLiabilities" id="trib_NoncurrentDerivativeLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NoncurrentFinanceLeaseLiabilities" id="trib_NoncurrentFinanceLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NonCurrentLeaseLiabilitiesAbstract" id="trib_NonCurrentLeaseLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonCurrentLiabilitiesMember" id="trib_NonCurrentLiabilitiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonRadingCosts" id="trib_NonRadingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NonTradingCosts" id="trib_NonTradingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NotesAndDebenturesPurchased" id="trib_NotesAndDebenturesPurchased" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NotesAndDebenturesRetired" id="trib_NotesAndDebenturesRetired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NotLaterThan10YearMember" id="trib_NotLaterThan10YearMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NotLaterThan1YearMember" id="trib_NotLaterThan1YearMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NotLaterThan2YearMember" id="trib_NotLaterThan2YearMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NotLaterThan3YearMember" id="trib_NotLaterThan3YearMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NotLaterThan4YearMember" id="trib_NotLaterThan4YearMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NotLaterThan5YearMember" id="trib_NotLaterThan5YearMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NotLaterThan6YearMember" id="trib_NotLaterThan6YearMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NotLaterThan7YearMember" id="trib_NotLaterThan7YearMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NotLaterThan8YearMember" id="trib_NotLaterThan8YearMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NotLaterThan9YearMember" id="trib_NotLaterThan9YearMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NovaCenturyScientificIncMember" id="trib_NovaCenturyScientificIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NovusDiagnosticsLimitedMember" id="trib_NovusDiagnosticsLimitedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfAmericanDepositorySharesWeightedAverageShares" id="trib_NumberOfAmericanDepositorySharesWeightedAverageShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfAOrdinaryWeightedAverageShares" id="trib_NumberOfAOrdinaryWeightedAverageShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfLeasesWithExtensionOptions" id="trib_NumberOfLeasesWithExtensionOptions" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfLeasesWithOptionsToPurchase" id="trib_NumberOfLeasesWithOptionsToPurchase" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfLeasesWithTerminationOptions" id="trib_NumberOfLeasesWithTerminationOptions" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfLeasesWithVariablePaymentsLinkedToIndex" id="trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOptionsGranted" id="trib_NumberOfOptionsGranted" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOptionsIssuable" id="trib_NumberOfOptionsIssuable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOptionsLapsedUnexercised" id="trib_NumberOfOptionsLapsedUnexercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOrdinarySharesIssuableOnExerciseOfOptions" id="trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfRetiredDirectorOptions" id="trib_NumberOfRetiredDirectorOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfRetiredDirectorShares" id="trib_NumberOfRetiredDirectorShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfRightOfUseLeasedAssets" id="trib_NumberOfRightOfUseLeasedAssets" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfShareOptionsExercisableShareBasedPayment" id="trib_NumberOfShareOptionsExercisableShareBasedPayment" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuableExerciseOfWarrantsToPerceptive" id="trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" id="trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare" id="trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesIssuedOnExerciseOfOptions" id="trib_NumberOfSharesIssuedOnExerciseOfOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfStockOptionsToPurchaseOrdinaryShares" id="trib_NumberOfStockOptionsToPurchaseOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsRepriced" id="trib_NumberOfWarrantsRepriced" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OnceOffExpense" id="trib_OnceOffExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OnceOffTaxCredit" id="trib_OnceOffTaxCredit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OneYearToTwoYearsMember" id="trib_OneYearToTwoYearsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OpeningSharePrice" id="trib_OpeningSharePrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OperatingLeasesMember" id="trib_OperatingLeasesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OperatingLossesBrazilMember" id="trib_OperatingLossesBrazilMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OperatingLossesIrelandMember" id="trib_OperatingLossesIrelandMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OperatingLossesStateMember" id="trib_OperatingLossesStateMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OptionsAndWarrantsAbstract" id="trib_OptionsAndWarrantsAbstract" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherAssetNoncurrent" id="trib_OtherAssetNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherBorrowingsMember" id="trib_OtherBorrowingsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherCountriesMember" id="trib_OtherCountriesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherCurrentBorrowings" id="trib_OtherCurrentBorrowings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OtherDeferredTaxAssetsInIrelandMember" id="trib_OtherDeferredTaxAssetsInIrelandMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherDeferredTaxAssetsInUsMember" id="trib_OtherDeferredTaxAssetsInUsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherEmployeesMember" id="trib_OtherEmployeesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherEuropeanCountriesMember" id="trib_OtherEuropeanCountriesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherItemsMember" id="trib_OtherItemsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherLeases" id="trib_OtherLeases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OtherNonCurrentAssets" id="trib_OtherNonCurrentAssets" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherOperatingIncomeLineItems" id="trib_OtherOperatingIncomeLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherOperatingIncomeTable" id="trib_OtherOperatingIncomeTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="OtherProjectsMember" id="trib_OtherProjectsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherReceivablesAsOfAcquisitionDate" id="trib_OtherReceivablesAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OtherRegionsMember" id="trib_OtherRegionsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherRestructuringCostsMember" id="trib_OtherRestructuringCostsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OutsourcingCostsMember" id="trib_OutsourcingCostsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OutstandingAbstract" id="trib_OutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OutstandingPrincipal" id="trib_OutstandingPrincipal" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OutstandingTermLoan" id="trib_OutstandingTermLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OverheadCosts" id="trib_OverheadCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PartnershipTriggerEventsDescription" id="trib_PartnershipTriggerEventsDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PatentDividendSchemeAmount" id="trib_PatentDividendSchemeAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PatentsAndLicencesMember" id="trib_PatentsAndLicencesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PaycheckProtectionProgramLoanMember" id="trib_PaycheckProtectionProgramLoanMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PaymentInKindInterest" id="trib_PaymentInKindInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PaymentOfPenalty" id="trib_PaymentOfPenalty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PaymentsForCEOServices" id="trib_PaymentsForCEOServices" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities" id="trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities" id="trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PaymentToRetireExchangeableNotes" id="trib_PaymentToRetireExchangeableNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PenaltiesPayments" id="trib_PenaltiesPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan" id="trib_PenaltyForEarlyPartialSettlementOfSeniorSecuredTermLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PenaltyForEarlySettlementCharged" id="trib_PenaltyForEarlySettlementCharged" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PenaltyForEarlySettlementOfTermLoan" id="trib_PenaltyForEarlySettlementOfTermLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PenaltyPaidForEarlySettlement" id="trib_PenaltyPaidForEarlySettlement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PercentageOfForgivenLoan" id="trib_PercentageOfForgivenLoan" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfGrossInventory1" id="trib_PercentageOfGrossInventory1" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfGroupRevenues" id="trib_PercentageOfGroupRevenues" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PerceptiveAdvisorsMember" id="trib_PerceptiveAdvisorsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PerceptiveCreditHoldingsIiiLpMember" id="trib_PerceptiveCreditHoldingsIiiLpMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PerceptiveMember" id="trib_PerceptiveMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PersonnelRelatedCostsMember" id="trib_PersonnelRelatedCostsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PhoenixBioTechCorpMember" id="trib_PhoenixBioTechCorpMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PhoenixBiotechMember" id="trib_PhoenixBiotechMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PointFivePercentageOfGrossInventoryMember" id="trib_PointFivePercentageOfGrossInventoryMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PointOfCareMember" id="trib_PointOfCareMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PostBsEventsMember" id="trib_PostBsEventsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PostDisposalAdjustmentMember" id="trib_PostDisposalAdjustmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PotentiallyDilutiveInstrumentsAbstract" id="trib_PotentiallyDilutiveInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PremierInstrumentMember" id="trib_PremierInstrumentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PremierLabAutomationMember" id="trib_PremierLabAutomationMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PremierResolutionMember" id="trib_PremierResolutionMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PremierTTenInstrumentMember" id="trib_PremierTTenInstrumentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreTaxDiscountRates" id="trib_PreTaxDiscountRates" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrimusCorpMember" id="trib_PrimusCorpMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrimusCorporationCguTradeNameMember" id="trib_PrimusCorporationCguTradeNameMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrimusCorporationIncMember" id="trib_PrimusCorporationIncMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrimusCorporationMember" id="trib_PrimusCorporationMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrincipalActivity" id="trib_PrincipalActivity" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrincipalAmountLoaned" id="trib_PrincipalAmountLoaned" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PrincipalDevelopmentProjectsCapitalizedCosts" id="trib_PrincipalDevelopmentProjectsCapitalizedCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsForConvertibleNoteIssued" id="trib_ProceedsForConvertibleNoteIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromCash" id="trib_ProceedsFromCash" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromNewFinanceLeases" id="trib_ProceedsFromNewFinanceLeases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromSaleOfBusiness" id="trib_ProceedsFromSaleOfBusiness" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromSharesToBeIssued" id="trib_ProceedsFromSharesToBeIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProductCullMember" id="trib_ProductCullMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PropertyAndEquipmentMember" id="trib_PropertyAndEquipmentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProvisionalValueMember" id="trib_ProvisionalValueMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProvisionForImpairment" id="trib_ProvisionForImpairment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProvisionForInventoriesMember" id="trib_ProvisionForInventoriesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProvisionForInventory" id="trib_ProvisionForInventory" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProvisionOfCanteenServicesToThirdParties" id="trib_ProvisionOfCanteenServicesToThirdParties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProvisionOnExpenses" id="trib_ProvisionOnExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PurchaseOfTreasuryShare" id="trib_PurchaseOfTreasuryShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Ranges10OfExercisePricesForOutstandingShareOptionOneMember" id="trib_Ranges10OfExercisePricesForOutstandingShareOptionOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesEightOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesFiveOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesFourOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesNineOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOneFourOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOneOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember" id="trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOneOneOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesSevenOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesSixOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesThreeOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RangesTwoOfExercisePricesForOutstandingShareOptionsMember" id="trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RapidCovid19AntigenTestMember" id="trib_RapidCovid19AntigenTestMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RateOfRentPerSqureFoot" id="trib_RateOfRentPerSqureFoot" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RawMaterialsAndWorkInProgressOfInventoryWrittenDown" id="trib_RawMaterialsAndWorkInProgressOfInventoryWrittenDown" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RayvilleLimitedMember" id="trib_RayvilleLimitedMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReceivablesFromConsiderationDueSaleOfBusiness" id="trib_ReceivablesFromConsiderationDueSaleOfBusiness" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReceivablesOutstanding" id="trib_ReceivablesOutstanding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReclassificationGoodwillAndIntangibleAssets" id="trib_ReclassificationGoodwillAndIntangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ReclassificationMember" id="trib_ReclassificationMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RecognitionOfContingentAsset" id="trib_RecognitionOfContingentAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract" id="trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReducedGrossDebt" id="trib_ReducedGrossDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ReductionOfGrossDebt" id="trib_ReductionOfGrossDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ReductionPercentageInBaseRate" id="trib_ReductionPercentageInBaseRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RefinancingCostsClassifiedAsFinancingActivities" id="trib_RefinancingCostsClassifiedAsFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ReliefOptionForLowValueAssets" id="trib_ReliefOptionForLowValueAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ReliefOptionForShortTermLeases" id="trib_ReliefOptionForShortTermLeases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RemainingFundsForCorporatePurposes" id="trib_RemainingFundsForCorporatePurposes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RemainingTermInYears" id="trib_RemainingTermInYears" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RemeasurementLossRecognizedInProfitLoss" id="trib_RemeasurementLossRecognizedInProfitLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RemeasurementMember" id="trib_RemeasurementMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RemeasurementOfRightOfUseAssets" id="trib_RemeasurementOfRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RentalIncomeFromPremises" id="trib_RentalIncomeFromPremises" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RepaymentOfOtherLoan" id="trib_RepaymentOfOtherLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RepaymentOfSecuredDebt" id="trib_RepaymentOfSecuredDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ResearchAndDevelopmentMember" id="trib_ResearchAndDevelopmentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ResearchAndDevelopmentTaxCredits" id="trib_ResearchAndDevelopmentTaxCredits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RestOfWorldOtherMember" id="trib_RestOfWorldOtherMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RestructuringAccrual" id="trib_RestructuringAccrual" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RestructuringActivitiesExpense" id="trib_RestructuringActivitiesExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RestructuringCost" id="trib_RestructuringCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ResultAfterExceptionalExpenses" id="trib_ResultAfterExceptionalExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ResultBeforeExceptionalExpenses" id="trib_ResultBeforeExceptionalExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ReversalOfImpairmentLossOnFinancialAssets" id="trib_ReversalOfImpairmentLossOnFinancialAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ReversalOfNetOperatingLoss" id="trib_ReversalOfNetOperatingLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RevertsMinimumLiquidityCovenant" id="trib_RevertsMinimumLiquidityCovenant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RightOfUseAssetsCostAtTransitionBeforeImpairment" id="trib_RightOfUseAssetsCostAtTransitionBeforeImpairment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RightOfUseAssetsImpairmentAdjustmentOnTransition" id="trib_RightOfUseAssetsImpairmentAdjustmentOnTransition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RightOfUseAssetsIncludingDepreciationAndImpairment" id="trib_RightOfUseAssetsIncludingDepreciationAndImpairment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RonanOCaoimhMember" id="trib_RonanOCaoimhMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RubellaAssayEnhancementMember" id="trib_RubellaAssayEnhancementMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SaleAndLeasebackLiabilitiesCurrent" id="trib_SaleAndLeasebackLiabilitiesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SaleAndLeasebackLiabilitiesMember" id="trib_SaleAndLeasebackLiabilitiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SaleAndLeasebackLiabilitiesNonCurrent" id="trib_SaleAndLeasebackLiabilitiesNonCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SaleOfFitzgeraldIndustriesMember" id="trib_SaleOfFitzgeraldIndustriesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SatisfiedByAbstract" id="trib_SatisfiedByAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfAdditionalInformationOnRightOfUseAssets" id="trib_ScheduleOfAdditionalInformationOnRightOfUseAssets" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfIncomeFromSubLettingRightOfUseBuildings" id="trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfMovementInTermLoanExplanatoryTableTextBlock" id="trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfShareBasedPaymentExpenseByGeographicalArea" id="trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecuredOvernightFinancingRate" id="trib_SecuredOvernightFinancingRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SegmentAssets" id="trib_SegmentAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SegmentLiabilities" id="trib_SegmentLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SellingGeneralAdministrationExpensesAbstract" id="trib_SellingGeneralAdministrationExpensesAbstract" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SellingGeneralAndAdministrativeExpensesClosureCosts" id="trib_SellingGeneralAndAdministrativeExpensesClosureCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SellingGeneralAndAdministrativeExpensesRecognitionOfContingentAsset" id="trib_SellingGeneralAndAdministrativeExpensesRecognitionOfContingentAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SellingGeneralAndAdministrativeExpensesRestructuringCosts" id="trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SellingGeneralAndAdministrativeExpensesRestructuringExpense" id="trib_SellingGeneralAndAdministrativeExpensesRestructuringExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SellingGeneralAndAdministrativeExpensesTaxAuditSettlement" id="trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SellingGeneralAndAdministrativeExpensesTaxAuditSettlementGross" id="trib_SellingGeneralAndAdministrativeExpensesTaxAuditSettlementGross" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SeniorNoteMember" id="trib_SeniorNoteMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeniorSecuredTermLoanAnnualRate" id="trib_SeniorSecuredTermLoanAnnualRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeniorSecuredTermLoanCreditFacilityMember" id="trib_SeniorSecuredTermLoanCreditFacilityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeniorSecuredTermLoanCreditFacilityOneMember" id="trib_SeniorSecuredTermLoanCreditFacilityOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeniorSecuredTermLoanFixedRate" id="trib_SeniorSecuredTermLoanFixedRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeniorSecuredTermLoanMember" id="trib_SeniorSecuredTermLoanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SevenYearConvertibleNoteMember" id="trib_SevenYearConvertibleNoteMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedPayments" id="trib_ShareBasedPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets" id="trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareBasedPaymentsContinuingOperations" id="trib_ShareBasedPaymentsContinuingOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareBasedPaymentsCostOfSales" id="trib_ShareBasedPaymentsCostOfSales" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareBasedPaymentsDiscontinuedOperations" id="trib_ShareBasedPaymentsDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareBasedPaymentsSellingGeneralAndAdministrative" id="trib_ShareBasedPaymentsSellingGeneralAndAdministrative" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareIssueCostForExchangeableNotesPurchase" id="trib_ShareIssueCostForExchangeableNotesPurchase" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareOptionMember" id="trib_ShareOptionMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharePricePerAds" id="trib_SharePricePerAds" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareRepurchasedUnderBuybackProgram" id="trib_ShareRepurchasedUnderBuybackProgram" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesConsideration" id="trib_SharesConsideration" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesIssuableOnConversionOfExchangeableNotes" id="trib_SharesIssuableOnConversionOfExchangeableNotes" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesIssuedAsConsiderationForExchangeableNotesPurchase" id="trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue" id="trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes" id="trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SharesIssuedToNoteHoldersAsConsiderationBorrowings" id="trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SharesPurchasedDuringYear" id="trib_SharesPurchasedDuringYear" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesRepresentationRateComparedToADS" id="trib_SharesRepresentationRateComparedToADS" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesSoldDuringYear" id="trib_SharesSoldDuringYear" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesToBeIssued" id="trib_SharesToBeIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SharesToBeIssuedForHedgingReservesValue" id="trib_SharesToBeIssuedForHedgingReservesValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ShortTermDepositsAndShortTermInvestments" id="trib_ShortTermDepositsAndShortTermInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShortTermLeaseLiabilitiesMember" id="trib_ShortTermLeaseLiabilitiesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SiteTransferCostsMember" id="trib_SiteTransferCostsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember" id="trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SixMonthOrLessMember" id="trib_SixMonthOrLessMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SixMonthToTwelveMonthMember" id="trib_SixMonthToTwelveMonthMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SjogrensCytokineMember" id="trib_SjogrensCytokineMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SjogrensMonoclonalAntibodiesMember" id="trib_SjogrensMonoclonalAntibodiesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SjogrensMonoclonalAntibodiesTwoMember" id="trib_SjogrensMonoclonalAntibodiesTwoMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SjogrensTestsMember" id="trib_SjogrensTestsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StateCreditCarryforwardsMember" id="trib_StateCreditCarryforwardsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StrategicInvestmentAndPartnershipWithMICOMember" id="trib_StrategicInvestmentAndPartnershipWithMICOMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StrategicPartnershipWithImawareIncMember" id="trib_StrategicPartnershipWithImawareIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SyphilisPointOfCareMember" id="trib_SyphilisPointOfCareMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SyphilisPointOfCareTestMember" id="trib_SyphilisPointOfCareTestMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SyphilisRapidPointCareMember" id="trib_SyphilisRapidPointCareMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="T10HplcAnalyzerMember" id="trib_T10HplcAnalyzerMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TaxFees" id="trib_TaxFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TaxRateEffectOfCurrentTaxOfPriorPeriods" id="trib_TaxRateEffectOfCurrentTaxOfPriorPeriods" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods" id="trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TaxValueLossCarryforwardsRecognisedMember" id="trib_TaxValueLossCarryforwardsRecognisedMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TaxValueOfLossCarryForwardsMember" id="trib_TaxValueOfLossCarryForwardsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TenPercentStrengtheningUSDollarMember" id="trib_TenPercentStrengtheningUSDollarMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TenPercentWeakeningUSDollarMember" id="trib_TenPercentWeakeningUSDollarMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TermLoanAgreementDescription" id="trib_TermLoanAgreementDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TermLoanFacility" id="trib_TermLoanFacility" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TermLoanMember" id="trib_TermLoanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TermOfExchangeableSeniorNotes" id="trib_TermOfExchangeableSeniorNotes" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TermOfLease" id="trib_TermOfLease" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThirtyFirstDecemberTwoThousandThirtyFiveMember" id="trib_ThirtyFirstDecemberTwoThousandThirtyFiveMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThirtyFirstDecemberTwoThousandThirtyFourMember" id="trib_ThirtyFirstDecemberTwoThousandThirtyFourMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThirtyFirstDecemberTwoThousandThirtySevenMember" id="trib_ThirtyFirstDecemberTwoThousandThirtySevenMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThirtyFirstDecemberTwoThousandThirtySixMember" id="trib_ThirtyFirstDecemberTwoThousandThirtySixMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThirtyFirstDecemberTwoThousandThirtyThreeMember" id="trib_ThirtyFirstDecemberTwoThousandThirtyThreeMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThirtyFirstDecemberTwoThousandThirtyTwoMember" id="trib_ThirtyFirstDecemberTwoThousandThirtyTwoMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThreeLoanMember" id="trib_ThreeLoanMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThresholdWeightedAveragePriceOfAds" id="trib_ThresholdWeightedAveragePriceOfAds" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TotalAssetsAcquiredAsOfAcquisitionDate" id="trib_TotalAssetsAcquiredAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TotalExchangeableNotesPercentage" id="trib_TotalExchangeableNotesPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TotalExposureFinancialInstruments" id="trib_TotalExposureFinancialInstruments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="TotalLiabilitiesAssumedAsOfAcquisitionDate" id="trib_TotalLiabilitiesAssumedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="TotalShareOptionsGrantedAdsEquivalent" id="trib_TotalShareOptionsGrantedAdsEquivalent" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" id="trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TradeReceivablesAllowanceForImpairment" id="trib_TradeReceivablesAllowanceForImpairment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="TradingTriggerEventsDescription" id="trib_TradingTriggerEventsDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TradingTriggerPayment" id="trib_TradingTriggerPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TribBiosensorsIncMember" id="trib_TribBiosensorsIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinityBiotechDoBrasilMember" id="trib_TrinityBiotechDoBrasilMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinityBiotechIncMember" id="trib_TrinityBiotechIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinityBiotechInvestmentLtdMember" id="trib_TrinityBiotechInvestmentLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinityBiotechInvestmentsLtdMember" id="trib_TrinityBiotechInvestmentsLtdMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinityBiotechJointVentureLimitedMember" id="trib_TrinityBiotechJointVentureLimitedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinityBiotechLuxembourgSarlMember" id="trib_TrinityBiotechLuxembourgSarlMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinityBiotechManufacturingLimitedMember" id="trib_TrinityBiotechManufacturingLimitedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinityBiotechManufacturingLtdMember" id="trib_TrinityBiotechManufacturingLtdMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinityBiotechManufacturingLtdTwoMember" id="trib_TrinityBiotechManufacturingLtdTwoMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinityBiotechManufacturingServicesLimitedMember" id="trib_TrinityBiotechManufacturingServicesLimitedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinityBiotechPlcMember" id="trib_TrinityBiotechPlcMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinityBiotechUkLtdMember" id="trib_TrinityBiotechUkLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinityResearchLimitedMember" id="trib_TrinityResearchLimitedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrinscreenPlantAndEquipmentMember" id="trib_TrinscreenPlantAndEquipmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TriStatInstrumentMember" id="trib_TriStatInstrumentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TristatMember" id="trib_TristatMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TriStatPointOfCareInstrumentMember" id="trib_TriStatPointOfCareInstrumentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TroponinIassayAndReaderMember" id="trib_TroponinIassayAndReaderMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TroponinIassayBrainNatriureticPeptideDdimerMember" id="trib_TroponinIassayBrainNatriureticPeptideDdimerMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TwoPercentageOfGrossInventoryMember" id="trib_TwoPercentageOfGrossInventoryMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TwoYearToFiveYearsMember" id="trib_TwoYearToFiveYearsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UltraGenesysMember" id="trib_UltraGenesysMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnallocatedAssetsBySegmentAbstract" id="trib_UnallocatedAssetsBySegmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnallocatedExpenses" id="trib_UnallocatedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="UnallocatedLiabilitiesBySegmentAbstract" id="trib_UnallocatedLiabilitiesBySegmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnearnedFinanceIncomeOnFinanceLease" id="trib_UnearnedFinanceIncomeOnFinanceLease" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="UnforgivenLoansAmount" id="trib_UnforgivenLoansAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="UniGoldAntigenImprovementMember" id="trib_UniGoldAntigenImprovementMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UniGoldRawMaterialStabilisationMember" id="trib_UniGoldRawMaterialStabilisationMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UniGoldTestEnhancementMember" id="trib_UniGoldTestEnhancementMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UniGoldTestMember" id="trib_UniGoldTestMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnitedKingdomMember" id="trib_UnitedKingdomMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnrecognizedDeferredTaxAsset" id="trib_UnrecognizedDeferredTaxAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="UnsecuredJuniorConvertibleNoteMember" id="trib_UnsecuredJuniorConvertibleNoteMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnutilisedNetOperatingLosses" id="trib_UnutilisedNetOperatingLosses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="UnwindingOfDiscountOnDeferredContingentConsideration" id="trib_UnwindingOfDiscountOnDeferredContingentConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="US1Member" id="trib_US1Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UsStripedLymeMember" id="trib_UsStripedLymeMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ValueOfEmbeddedDerivativesNetLiability" id="trib_ValueOfEmbeddedDerivativesNetLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="VariableRateInstruments" id="trib_VariableRateInstruments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="VariableRateInstrumentsAbstract" id="trib_VariableRateInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WagesAndSalariesNetOfCredit" id="trib_WagesAndSalariesNetOfCredit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="WagesSubsidiesReceived" id="trib_WagesSubsidiesReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="WarrantsIssuedShares" id="trib_WarrantsIssuedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsPerAdsPrice" id="trib_WarrantsPerAdsPrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseADS" id="trib_WarrantsToPurchaseADS" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WaveformAcquisitionMember" id="trib_WaveformAcquisitionMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WaveformTechnologiesIncMember" id="trib_WaveformTechnologiesIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WaveformTechnologiesIncorporationMember" id="trib_WaveformTechnologiesIncorporationMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePriceAbstract" id="trib_WeightedAverageExercisePriceAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageExercisePriceOutstanding" id="trib_WeightedAverageExercisePriceOutstanding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="WeightedAverageNumberOfSharesIssued" id="trib_WeightedAverageNumberOfSharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageNumberOfTreasuryShares" id="trib_WeightedAverageNumberOfTreasuryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" id="trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WeightedAverageSharesDiscontinuedOperations" id="trib_WeightedAverageSharesDiscontinuedOperations" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WithinOneYearMember" id="trib_WithinOneYearMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #J @D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBOQ0_X+S?\%5M4_X)+_L3'XS^!/">E>-/
MC9\3_'>G_"#X,Z7XEAO9O!^C^*-3T+7O$FI>,_%\%A/97.H:+X7T'P[?SP:'
M:ZC8W6N:[=Z-8-<VVFOJ=[:<F.QE+ 8:>)JQG-*="C3I4E#VM?$XNO2PF$PU
M)U)TZ4:F)Q5:CAZ<Z]6C0A.HIUZU&C&=6/3A,-4QE>-"FXQ;A5JSJ3YO9T:&
M'HU,1B:]3V<:E1TZ&'I5:TXTJ=2M*,'&E2J5'&$OVOHK_-^_9C_8G_X.FO\
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MA/+XP\033:UXF\ 7>CZ7XAU+PF-9N9KGPG+X9M]$T-%\/ZS:Z?H?S5_P2/\
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MMGXJ\7S>-OB%<>(=*MLW_@^$5?\ A>G[ #"6-G/PG^.*M #-YT:KXP\!%)I
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M)?#NU@TR+3] OK59]-UR6[-S>(DMC-;L[Q?U^5\S?!/]M3]C?]I7Q!JGA/\
M9R_:T_9F^/WBG1-).O:SX:^"?QX^%GQ5\0:1H8NH+$ZSJFC>!?%6O:C8:2+V
MZM;,ZC=VT5F+JY@MS-YTT:-],UKB,1B*U' 4ZT;4\)A9X?"/V?)S8>6.QF*E
M)R_Y>OZUB<3'VFME%4O^7=ECAL/AZ-;,*E"7-5Q>,AB,8N>,N3$1P&!PL8M1
MUIMX3#86?).\FIJHO<G%(HHHKD.L**** "BBB@ HHHH **** "BBB@ HHHH
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M4U6JT^%^%$J^;1I5%#ZYC8<L<0I*[M:>(AEV&E*'/3G0S.I1GRN=OTF_8_\
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MXG_M>_&'XH_M<>$?B1\6YO"ESXJT'X5^/_@]HO@5+GPEX,\.^!K.?3-.\7?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXT\4W%QI=[H/B6WL&L]'MO#_ (YTC2/#0M6TK-I<TES03C'6TFI232=I<O\
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MUK^LWBVT-Q=RPZ?IEE<W!M[.VN;RY*"WL[:XN9(H7_RGHOAWXE_X+R?M5_\
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M<7@\)+GY++EO-SBI-7J<G,Y284445_/!^[A1110 4444 ?Q$?\'D_P#P4?\
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MXG\1:OHOAC0=:UFP\@_X)@_\%6OV7O\ @K1\'O&?QC_9FM_B-X>L_AYXZD\
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MV-/C#XJ_>R^6X^V?$;X)^"/]&3[%=>?-_P 5CAHO/TW%N9Y_MLGD_P!G7_\
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M:AOLIN(_$_Q1^)O@%='FB68/<+"/#W@CQG#/+9I&ZO<6\4UU'#,UK>_U4_\
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MWT<5]I<RYDWHFX2C[UO>CJ7:TTMJ^9:Z.*TYH\T5--NRDZ<HM3:]Z&O\,O\
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M!JFGW<$]O<1>,O@/\3]"\-:7I][9R6_GVMY;:3\:?&Q?[4ULML]M/:RHUU/
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MRCR1NKU%9KGJ<S4G&+32C:I[WN<RC.2O4<FN7VLE3<F_=AI4C!^XZD*BC/\
MDV_X-Q]8M]#_ ."V'[ M[=&Y$<_Q)\:Z.OV7[$)?M'B'X-_$G0+0-]OEA@^S
M&[U.$7@C<WILS.--BFU'[+#)_LAU_B[_ /!*Z'Q3^RG_ ,%L_P!B_P &^-@F
MC^+OAG^WM\/O@5XY6UO EKINK:A\5HO@MXQC:]N?L0.EVLNK:HEY/,L'F::D
M[/#EC"?]H*XN(+2WGNKJ>&VM;:&6XN;FXD2&WM[>%&DFGGFD98XH8HU:2661
ME2-%9F8*":+^2MOS)IMW_16NG=IW=K6=U?RC;?G33<K]-/LJUXN[3YI6ZW_S
M8/\ @]K^+ US]MC]D/X)QL)(_AK^S%J_Q(E9/+9(;[XP?%'Q)X>FM))$OI76
M[2R^#6FW<EM+IUFT=K?6-RMU?I>+'8?V:_\ !!GX86'PA_X(Z_\ !/+PIIUF
M]C;ZM^SCX3^*$D,@<,]_\;[G4OC1JEX-]K9G9J&I^/[R_C(B=#'<J8[J^C*W
MMQ_F]_\ !S'^UO\ !W]L[_@J5XU^*?P ^)_A?XO_  BT#X4?#/X:^$O&_@_4
M-6U#1+V7PC%K;>*K:U?5%BC6&T\:ZGXD6RN=%MXO#VO:6UAXHT:;5+375UK4
MO]3+_@GEH>F^&?V OV&_#>C6KV6D>'OV/?V9]#TJSDFNKA[33=)^"W@JPL;9
MY[Y([V=X+6WBB::\C2ZD*%[A%F9U"UO9R;UDG=+1J5N5VM\'P+K9:Z@Y7E:[
MT3BTTUK!Q@T[MM.+NK;;Z)62_CV_X/9OVOM5TCP1^R9^PGHEK<6^G^,]:U3]
MI[Q_K"RWMLMW;>#XO$'PV^'GAJ+RE2SU*PGU#Q#XXU_7+*YDF^RZCH7@V^6W
M2403C\ ?^#67]EWQC^T7_P %>_@CXO\ #]]8:7X:_9<T7Q7^T+\0+V[2TN;B
M;1-)T\>!=$T;2["YGB>YO]:\9>.O#EG)=0K(VCZ9_:.L(&N;*UAG_1'_ (*B
M7.G?\%>_^#I/X/\ [*WA^UL/%7PP^"/C?X4?LP^+9;*SN]<L-1\%? [6/$GQ
ME_:<BUNQLHYDAN="U_7?BQ\/-0DN3'9Q/X;LAJES:VZR_9_C?_@W9^(<W["_
M_!P%H/P.UV^O-'T?QAXO_:)_8J\6/=Z@IG>]@O=8?P;I>I-_9.G+JTVI?%OX
M8> M,:,6&AYU"YAU);: V@TJ=IZ)RTT;CRN,KQ6L9:2>]TY72:NXJ\HRC$4M
M$Y-)V<HJ,HRO"[<)*TGH[Q<[I<KDXQ3E&48?ZI/Q,^(O@_X/_#?X@_%KXA:S
M;>'? 'PN\$>*_B+XX\07CK'9Z%X/\$Z#?^)?$VLW4CLB);:9HNF7M[.[NJK%
M Q9E )'^7E_P0I\%^-/^"M__  <*:I^V'\5=.2]TCP+\0OB;^W;X^M95O9=,
MT#4-'\10VGP)\&^'[K4YM;-K'X'^(WBCX:'PMI%[J5[?Q^"_A[J,=C?/+I#Z
ME;_U"?\ !W;^WPO[,G_!/"Q_9<\':K80_%/]MSQ,_@C4+=FD;5-&^ W@9[#Q
M+\4]<L?)F\N"XU_67\"_#8QZG:S6NH^&O&?C.73VBU71X+FUX7_@SK_84D^
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M8@F867PPET_XEZBS@2P_Z(FG^$KI]0.]MM@MRQBN /(D_G'_ .#'[XE66H?
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M ,$4/^"=G["__!)U_P!OS]LKX#?#?]I_XPZS^RI?_MA?$&Z^.W@[2OB%X/\
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MZ5X2\?>&-*F.N6YTKPYXJT?1=9@O?'&HZ)R'[&?_  :Z_MD_MB>/O '[2?\
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M;KQ!?:#!KMQXK\5Z+:6=];7/BO6OA]IMI,/$GA/6M.M?Z ?^"_W_  06T?\
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MX^$?P@\(>*/!UYXGO;]K5+'1+:^^)GQ-U.UU"9SHT$)U5UU W5OJ]MI_R/\
ML+:]:_\ !>+_ (.8_B)^VT8KG7OV2OV =$TK5_@O/J=AY^F7UI\-=9O_  [^
MSK' EXMKJ&BWWC7XL:O\0/VI="BO+!KG2I/#NH:'>&UO5MG/YD_L@?\ !NU_
MP7AO_'/[1O['&G7.L?LA_LZ^-O$7A+P[^TO\4-:^)%SI'P6^-OA_P4^L3>%%
M\*Z=X)EN?%_QZT63P_X[\4:SH.@1:3I_@3^UKE_#?Q4UOP'XJLX;33/[X_\
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MZS49V@:6^'WF[WE=)1:^.FU&,XSDE.G9<SC?WIJ-7EI_S+?\'EO_  3S\2^
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M)65[*]E=VO;:[LK*^@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ%J5Q#%)-?W,4.G6=[=V_P Z_P#!)7XU?$O]HO\ X)H?L0_&SXQW][K'Q/\
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M_C%\"/#%U);A,6"^/OCG\./AUX#CU>]>2.#2=$F\2QZQK=VZV>CV-]=$0U^
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M0=:DL5#,*F71]I&G4IR]G.O3M)QGSTHR<N2I*'LY?T;U\-?MJ?\ !2O]A?\
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M_&U_K_B[6OR3_P""4>A6W_!);_@OM^UA_P $C/A[XK\7W_[(G[0/PSB_:'^
M?@GQ)JTFL+X#\=_\(GX?\736_P!NO+*6\N7@\*:;XV\"#69-2^W^(M&\(> W
M\4W>M>)+,3Q>@J6'IYE+(JU5U<=.CF<\#F>%:GE>/Q628'$YCF.!CAW%XFA[
M?+\#C\PRO&QKXJ.(I8*K1Q6$P2DL4O-GBIULOAG>%H^SRY3R^6*P>*G+Z_@\
M#G&/P>79?CGB%2I4*TZ.-Q^!PV8X*6'PTJ/UOV^'Q&(CAJM.?]IA( ))  !)
M)X  Y))/  '4U^,7QP_X.&_^",?[/'CJ?X<_$;]O/X8WOBBUL(;^\'PG\,?%
M;]H'PY9"6[OK%M.OO&_P#^'_ ,2_!-CX@L[K3KF/5/"]WXAA\2:0OV:75-*L
MX;ZQDN/QI_X.,?VE/V@/VM_VR?V2?^""/[*/C6X^'U[^U -$\7?M.^-;%KT$
M^ =9NM?N;#P?JO\ 9\MM?3^$O#/@OP7XO^*OQ \/V\J?\)?9P^#-%:]M[#^V
MK+4?VK_9>_X(%_\ !)3]ECX5Z9\,-$_8D^ _QGG@-K>Z_P#$K]ISX9^!?VA/
MB?XMUZ+2-,TB]UR_\2?$KPYKEOX;BU1=+AU"?PA\/-+\&?#VQU6YU+4-$\(:
M7<ZIJ#W/FX-UL;A)YG&5&E@%F68Y5AH2C.IB\;B<IJQPV8U5%2A3PF$P^*DZ
M%.K4]M4Q52G/V5&-+FK4_2Q2HX2O2P$N>MF$\!@LSQ,8S5.CE^%S!5JF7QJ-
MTZGUS$8ZA25>-.A.E3PE)M8FK]92PK^P?V._^"@_[%O[?_@^[\;_ +'W[1?P
M[^-^EZ7&LWB#1M O;[1?B!X0@FU75]&L+CQU\*_%]AX=^)W@.WUJ^T'5CX=N
M/&7A'0X?$MC9MJV@/J6E2P7LOV17\=?_  4?_P""%'QA_9<_:C_9Y_X*0?\
M!!#X/:=X%^/GA+XE?9_C=^S#X+\;>"?A?\)?''@S5AJFKZUKVDV'Q)\=>#?
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M:SCOVBFFL;ZWF1K:&\>*1AY45PZA'_)[_@H/_P $//V"?CY^Q1^TO\*/@/\
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M]F+=2:?!:WEK/=_N?^TC_P '9?\ P2 ^&GP7\=^+O@9\;O$W[2?Q:L=$O8?
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MM"MQ:_MO>/I)K;S +R%9_@E\ XT:XMMHDBC>2UGC@FD)\Z2"YB 7[*V?3O\
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MCV^N1Z7XB2PL?'5K%XIAM=8\/:7J=G!\18X=0C@N8GL;/^V8D $D@  DD\
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MIZFVLV7A>U\:Z-\4(;/P;JLFG^&O"X^(7A33/#>J>(--UWQ_I]UJ/VO\3O\
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M5?#S]IAZR6RJT)^_1J+WZ4_>@XO4^ /^'3O_  2R_P"D:?[ '_B&_P"SK_\
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M[RHU)5:2EJJ56</93J4T[J%2=/\ =RG&TI0]QMQT/%/@]^S7^SG^SS+XPG^
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M2C[1Q2BZJDJKBK>T4Z?L9JI;XU.C^ZDI7YJ?N.\=!J*L:JB*J(BA$1%"JBJ
M%55  55        &*=114W!)))))))))*R26B22T22V0A (((!!!!!&00>""
M#P01U%>,?!;]F_\ 9W_9NTK7="_9V^ OP7^ FA^*=8'B'Q-HWP6^%O@?X6Z5
MXCU\6T=F-<UW3O VA:%::OK M(HK4:GJ$-Q>BVCC@\_RD51[1133<7-QO%U(
M*G-K1SIJ<:BIS:^*"J1C-1=XJ<8RMS),IMN*B[N*FJBB_A52,*E.-1+;GC"K
M5@I?$H5*D4[3DFC*KJR.H9&!5E8!E96&&5E.0002"",$<&OC;P)_P3G_ .">
M_P +?'&A_$[X9?L(_L:_#GXD^&-2;6?#7Q"\"?LP?!+PAXX\/:PZ31-JVA^+
M/#_@?3]>TG4FCN+B-KZPO[>Z*3S(92LKAOLJBIBE"I[:*4:R44JL5:HE"3E!
M<ZM*T)2E**O:,FVK-L4O?I3H3]^C5_B49>]2J>[*'OTW>$_<G./O)^[.4=I-
M,KXE\9?\$T?^"<7Q%\6>(_'OQ!_X)_?L2^._'/C'6=0\1^+O&?C+]E/X$^)_
M%GBGQ#J]S)>ZMKWB/Q%K?@.^UC7-9U.\FEN]0U34[RZOKVYEDGN9Y979S]M4
M4N6+DIN,7.,91C*RYHQFXN45+=1DX0<DG:3A%N_*K6JDU"5)3FJ<YPG.FI24
M)3IJ<:<Y0ORRG"-6K&$FFXJI-1:4Y7^ /^'3O_!++_I&G^P!_P"(;_LZ_P#S
MN:]I^"7[%_['?[,^O:OXI_9P_9._9I_9_P#$^OZ1_P (_KWB/X)? GX7?"G7
MM;T'[9;:C_8FKZOX$\+:#J&I:1_:%G:7W]FWEQ-9_;+6VNO)\^")U^EJ*TA.
M=-N4)2A)QG!N$G%N%2$J=2#::?+4IRE"<=I0E*,DXMHRE&,U:48R2E&24DI)
M2A)3A*SO[T)QC*+WC**DK-)GAMY^S#^S5J/QLTW]I;4/V>?@;??M':-9'3-(
M_: O/A+X!N?C9I6FG1;WPV=/TWXJS: _CNQLCX=U+4= -I:Z]% =%O[W2O+^
MPW4\$COC=^S)^S;^TQI^@:3^T?\ L]_ _P#:!TKPG?W6J^%M,^-WPG\!?%;3
M_#6J7L$=M>ZEH%EX[T#7K;1K^[MH8K>ZO-.CMKBX@BCBED>-%4>X45*5E3BE
M:-&HJU%)65*LL0\6JM-;0J+%R>*4XVE]8;K7]HW(U]I4YW4YY^TE25"53FES
MNBJ3PZHN5^9TE0;HJFWR*DW32Y'8XOQ_\-_AY\5_!.O?#3XI> O!?Q*^'/BK
M3QI/BCP!X_\ "VA^,?!/B32EEAG73->\*^(K'4="UC3UGM[>86>H6%Q;"6"&
M01[XD*T_A=\)OA7\#O VB?##X*_#/X?_  ?^&GAK^T3X<^'GPN\&>'/A_P"!
MM _M?5+W7-6_L3PEX3TW2= TK^T]:U+4=8U'[#I\'VW5+^]U"Y\V[NIYI/0*
M*%HYM:.K[-56M'4]BZKI<[^W[)UZSI\U^1UJKC;VD[Q=\E.G_P NZ4I3I4_L
D4Y3C"$Y4X_#"4X4X0DXI.480BVU%)%%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image00005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !9 9@# 2(  A$! Q$!_\0
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ME;6V)QRB'[S\?ZQLGKC:"16;XB^)GAO1KIK&"XFUG6!P-,T>+[7<Y]U7A?\
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M.I  RD"X09QSD$^]=GI6DZ=I$!ATG3[2QA/6.VA6)?R4"KM% !1110 4444
M%%%% !1110 4444 %%%)O7.-PSG&,]\9Q^5 "T5%)<01J6DFC0#.2S 8QUJ
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M<_\ 'E'_ (5NT4 8?_"(>&O^A>T?_P  HO\ XFC_ (1#PU_T+VC_ /@%%_\
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)44 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image00004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !B ; # 2(  A$! Q$!_\0
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MM-I4\,Z?/JBH0OVLL(;0D],2MRZ^\:O0!TU<_P"(O&7A_P .SQV^KZI!#=R
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M9&P5964@@^E<QHNH:GXN;5-1AU6XT31+2ZFL[4VR0L]QY3%))G:5' 7>K!0
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M,(>?7IWP3WW:* ,+[;XB)PNBV X/+:DPYQ[1'J::U]XDV@IH>GD]PVIL,?\
MD$UOT4 <^U]XG!^70]+(_P"PH_'_ ) I1>^)RF?[$TH''W?[5?/_ *(K?HH
MP!>^)S)M.B:4!_>.JOC_ -$9IWVKQ+G']D:/]?[4D_\ D>MVB@#"%UXE)/\
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M#[?CSXOL]Q$K[-A;>?.!(_O#K@[AZO110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
=BB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #J @D# 2(  A$! Q$!_\0
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M%%% !1110 445_'3_P '(W_!=C]J/]B/XS?"']@;]@%++P[^T?\ $OP_X/\
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MDF1A_P % /VZ'0&]MXBOE^'_ (^O;H9W$\+&!%139*R32^7]@@>.Z:-1SO\
MP=A_"U_#'_!:OPSXT^-5OXRT[X%?&'X8_ +4_P#A)M $[W[> ?#-RW@KXFV?
M@JZU:RU;1XO$V@?V7J>H)ID-C?6=I?ZSI.I7^E2_VTT=T8C%2S/*_!^KC73G
M#/*BPF<OV\,$L;AZ&!SC-*5+%UY4:DL(O:JFO;5*,J5'!8+#X>=.KAU+#/MK
M86GD.>^)V&R]55_8>"JXS*_:X26.K87&SSO^QZF*C@J5:G.M7GA*%U0H>SJ/
M,*E3%82K2S"<<51]M_:0_P"#5C]L?_@G?^R;XC_X*"?"7]O(7W[2O[.?@>?X
MS>.O!OPE\(^.OA?KG@K3]%T"^U#XIZK\)_VB='^)3^+?$&J^$M)?4[BUN[OX
M<?#R?Q3H,6L3S2Z)<F'2-0_IR_X-L/\ @K1\1/\ @H_^P[X\O?VE]5L=1^.G
M[*?B2T\$_$3Q]%!!8M\0_ EYX9&O^#OB/K]C:1P6EGXIG@T[Q+HGBH:=;1V%
M_=^'(?$,<=M/KT^GV7Y*?%#_ (-G_P#@WL^#/[+=I^VK\1_^"@7[76A?LMZG
MH6C>(M"^,5K\9OV??$?A[Q1I_B)"^A6_@ZR\+_LE:UX@\9:[JVV9+#POX6T?
M5_$US-:WL$>D-/8WD<'ZX?\ !$W_ ()\_P#!,'X _L]?M3^+/^"57[7GCG]J
M+PY^U/X#\&:'XRU?QK\2_A?XVU?X=ZMHOA+X@S>!=+U;PEX*^&7P?\6?"[Q7
M=6WQ+U&]U[P?\4M,TWQ/ +33XY-.T"6UOC<=-?$XG X'CFERSK5\'E:J9=D4
M<+4G+)>(*.)A.G2J1C*6+I?7<)A\1A*5'&1GB7*->"JU^>E3PWFPHT,7B>%<
M3/$J*Q>.C'%9Q6Q"_P"%S)L2H1Q5:E."AA:E;"SE+,I8K#T:]!^S]G##45.I
M5G_'=XO\9_MV?\'4_P#P5%\5_!3PE\8+WX>_LM^%/$.M^-/!GAG6[GQ*WP=^
M ?P!\$ZW+X4TGXE3_#/3=3>P\;_M >*M#\3?O;N\OM-U7Q;XM\37/A=/%_@'
MX5:7;#P=M_\ !:G_ ()<?M]_\$<OV-? 7P!F_;(U3]K#_@G'\7OB7H<PT+4O
M!-WX"@^#'[17AX^-?%>C66A^!M5\:_$Q_!^B^-/#M]XOUB/4O!?CJ#P]XWUZ
M/Q0_Q!\"V/B+PU\._$^K]S_P:5?''X>_L>_\%2?CC\ OVCM:TCX3^/\ XL_#
MC6OV?/"L7C2[L=%B;XW^%/BOX:!^%;:I?7,-O;^*?$=_I>J:-H&CDE_$7B2P
MLM!T^276[S2=.U+]SO\ @\W_ &K?@[X8_8>^%O[(0\8:%J/Q[^*'QN\&?$U/
MAY9:C:W?B/PY\*O VC>-(KWQSXATZWDDO-"TK6?%-]I'ASPO+JL=I%XHN8?%
M!T3^T/\ A$==;3>+-L-A\LX9X1>4U7F$<V>45<?6J5(8C^V*T.)94)UL5-1=
M'$XC!99@\'Q+"KAX4Z\,32HXZ=3ZLHP7HY97Q6:\2<4T\RH?57D\LVA@,/3=
M3#?V7AH\+*M3IT))^UIT)X[%8W)G3J2E2Q5"5;+Y)SJUG+[G_P"#3)U;_@BI
M\"E4L3'\4?V@TD#3"4*Y^+/B.0!(Q<SFV78Z,8&BLBSEKC[,PN!>7?\ 2?7\
MV7_!IFTA_P""*?P'#_=3XG_M"+%T_P!6?BYXE8]+JX/^M:3[T5DW_3JZ[;V[
M_I-KZ+._]\H_]BCA_JW_ ,R'+>K_ !7V?A6B/G<ENL'6NFO^%;/]X*&^>YDT
M^5:--:J>]16J2UDS_)O_ ."EVH?M+:1_P<[?' ?L<J+#]J36/VH? /A;X&7F
MIZ9HNL1:1\0?'7PH\#^$]$\2R6OB+3]4\/0VNBOK[^([?5-=TV^TC0K:SAUK
M4[:>TT^=6^YO^"CW_!L?^W7^R=\!_&/_  4TL/\ @H7XE_:B_:F^#Q\-?'3X
MS7DNC>./!7Q/\-CP5I4&K^*?B;\./VB?$/Q@\3^-/'?B7X2ZAH^EZCX=NM5\
M.?#KQ)J7A+1+C7M#;2/$VD:+X&U7Y;_;+_:)\%_LD_\ !V/XQ_:&^(6J6]A\
M._AG^VE\*]5\?:[]EO;^#P_X,U?X>>!?#WB_6Y;..QU34;D^&-$UO4M2N8-,
ML+N^>3394T.$W'V$#^\[_@L=^V'^SM\)?^"1?[5GQ=U_XJ> M1\$_'G]EWXB
M?#_X&:II7BS2-2L/C1XE^.WPQUK0?AS8?#.ZTR]N!XWBUZUU^+Q0ESX8>_AA
M\%V&L>+I[BV\.Z3J.K6GQ^#4\#X6\-YU@93AF>%P+CA<3&=7%2IU:&2\.XK
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M:O!P?O4W'V<[SC)A1117(=84444 %%%% !1110 4444 %%%% !1110 4444
M?*O[;'[5O@O]BC]F3XI_M&^-UAO;7P-HT,7AOP[)>)8S^,O'OB&]MO#_ (%\
M'6LY666(Z_XGU'3;2_O+>VO)=(T?^T]<DM)[72[A:_SJ?A#\+OVKO^"W'[==
M[)K.L7VO^)_B5JO_  F/Q0\>2VUU%X.^$/P<MH5T&TN[33B8X=-TFRT.]L]/
M\":!#>)J.JW&IWGAR6\CUS3!KEA^NW_!T?\ M7:YXK^/?P=_8Y\.ZZ]MX/\
MA=X7TSXJ>-K&SNM2M8-1^)GQ$C\3:/HMIK<:ZC;Z7>3^#/ MII5UIDC06MWI
MMA\7]6%AJ4FNZIH4-I^W?_!OW^Q/I'[*?["GA#XE:IIZ)\5OVLK/0_C;XNO9
M+?R+S3/ 6KV,MW\%O S >61%X=\":K!K%W%<0)>V7B'Q7KVCM-+IFE:/#:?T
MSPS.AX4>&/\ KHJ5.KQ=QA.6"R64X1?U+ U:3J4YR4TIRIQI4GCL1&,:F'Q,
MJ^!PM1QY)M_SSQ"J_B7XB_ZI*M5I<,<)J.(S:-*HH?7,;!QCB$[-V]ZO#+\-
M)Q56E/#YG.E+E<[?I/\ L?\ [&_P*_8@^#^D?!WX%>$K+0],MUCO?%7B:2TM
M/^$L^(?BAU9M1\7>--6@@AEU76+^XEN)8XVVV.E6\PT[2+6RT^&*W7ZHHHK^
M;\9C<7F.+Q&.QV(K8O&8NK.OB<37G*I6K5:CYISJ3DVY2;^25DDDDC]^PN%P
MV!P]'"8.A2PN%P].-*AAZ%.-*E2IQVA"$$HQ2\EJ[MZML****YCH"BBB@ HH
MHH **** "OQF_P""V7_!(P?\%BOV>_A9\"?^&@C^SJWPS^,MK\6QXJ_X5-%\
M71K2V_@CQAX.;P]_8K?$3X93Z89#XJ74AJD>OW<7_$O-I-H]P]Q;WNG_ +,T
M5C7P]+$PC3K1<X1K8;$12G.%JV$Q%+%8>5Z<HR:A7HTYN#;A4473J1G3E*$M
M:5:I0FYTI<LI4JU%OEC*]/$4:F'K1M)->_2JSAS)<T>;F@XS49+^ /\ X@8_
M^LHO_FDW_P"5Q7WI^PM_P9Q?L3_LY>/=(^)?[57QI\:?MKZQX5\36VO>%_ -
MWX$TKX+?!"\M[*VADL;/XC^ H/%7Q/\ %/Q >SUN+^U?LA^)/A[P9K-FJ>'O
M%O@GQ)HTNHV^H_V$45V4,15PU15:$E"JK<E3DA*=.2E&<:E&4XRE1K0E%2A6
MI.%6FU[DXW=^6M1A7A[.HI.%[N,:E2FI*S3C/V<HN<&FU*G*\)+XHL@M;:VL
MK:WL[.W@M+.T@BM;2TM88X+:UMH(UB@M[>")4BA@AB18XHHU6..-51%"@ ?R
MO?\ !2W_ (-.?V)_VZ?B9XQ^/?P6^)/C#]C7XV?$+7+;7O''_")^$M#^)'P.
M\2ZQ<W>IWOBSQ7/\(+K5/ NMZ-XY\73WEG)J6I^%?BEX?\(FZL+C6;KP'J'B
M+7-;UJ]_JHHKCK8>C7KTL55AS8FC[14\0I2C7C"M.C5KTO;0E&I*CB*F'H3Q
M%"4G1Q$J%&5:$W2AR]-*M4HTIT*;4:-114J3A"5/]VI1ISC"491A4I1G4C2J
MP4:M*-2I&G.,:DU+^/#]A/\ X,X?V,OV</B1IOQ/_:K^.'BW]M>\\*^(--UW
MP=\.Y_AWIWP3^#<SZ?')*D/Q,\'P^-?BEXD^(\<.K+8ZE:Z6GCSPMX1OH+6?
M0_&/A3QCHFHW=DW]?VI:1I.LZ3?Z#K&EZ=JNA:KIUUI&J:+J5E;7VDZEI-];
M265[I=_IUU%+9WFG7EG++:75E<0R6UQ;22031/$[(=&BNO$5JF*P\<)7Y:F%
MA&I%89TZ:P[]K3ITJTIT8PC3J5*]*E2IUZM2,JM>%.G&K.:A&W-1HPP]65>E
M[2->4N?VLJM6I4BU-U(QI3J3E*C"$Y.5.E2<*=-_!&*2M_%C^V!_P9;?LL?&
M7XK:E\0/V5/VI?&G[)7A/Q%>:KJVN?"77_A/9?'[PAHFI7]U'-;V?PSOV^)G
MPC\1^$_"MG'YX&@^*-5^(EX)YP-/UW3-,MK;28OT8_X)&_\ !M7^Q]_P2U\9
M:=\>-6\8^)OVI/VJ=+L=2T_0_BUXV\/Z=X*\$_#R+49]?L[F_P#A-\)M.U/Q
M,WACQ!K'A35K#P[XC\1^+_'GQ%UACIMY<^#+KP+IOB37M"O/Z-J*RP%\LI1H
MX*=2C"%.5&$G4J5JT*4U*,H0Q%>53$0BX3E2M&JOW+]C_"M O&1CCYN>*2J-
MU85I*/[F$ZD&G%U*=#V=.I%R2G*$XRA.:YYQE/WC\Q_^"J7_  2F_9Q_X*T_
M &Q^"GQZN?%7A36O!NLW?B[X1_%7P+=6D/BOX<>,;G3GTZ6[6PU2WO-&\3>%
M]:M_(LO%WA/5+>)=9TZ")])U?PUXCLM%\3:1_-U^S5_P9+?LY_#_ .*.E>+/
MVH/VSO'W[1_PVT?['?CX4> _@[:?L\CQ+J]AKFCWXT[QGXX/Q9^+^NW/@75M
M&M=:T#Q!H?@JV\!>-)AJ]MJ?A[XE>&;O2MM__;[1486G3P>)KXO#P4*^)J1K
M5Y27M83JPP\,+"K[&M[2C"I&A2I04X4XR_=4IWYZ<)1VK5:F(HT:%6<I4\/"
M5.BHOV<Z=.=:>(E!5:?)5<'6J5*G*YM)U*EDE.2?\SW_  2 _P"#=*R_X)._
MMD?%O]J_3/VL;/XQZ;\3?A7X[^%VG_"JP_9Y_P"%4V/@ZR\8_$?P)X^M+JQ\
M3GXW?$8WUGX?M_!">'[?2/\ A'-/%W#?1WQO[4V L[K[^_X*B?\ !&']BS_@
MK5X<\'6O[2>B^,_#7Q#^',-]8_#_ .-?PDU[3O#'Q+\.Z+JEY:ZAJGA:YEUW
M0O%7A/Q1X5U"^LXK@Z5XK\+:Q/HDL^JW/@_4/#&H:[K-[??K'13Q$%BL'EF!
MQ#G4P^38>&%RQ.I45;"4:>(Q6*C&&*C)8J4W7QN+E4K5*TZU6&(K4:M2=&;I
MA1JRP^(Q>*H<E&KCJE2IBE2ITZ=&HZM&GAYP6&C!8:G1]C2IPC0I4H4*:A%T
MZ<6DS^ 5_P#@QC4LQ3_@J&RH6)17_8H#LJY.T,X_:UC#L!@%@B!CDA%!P/Z2
M/^"4_P#P06_8C_X),7&L^-_A##XT^+'Q\\5Z%:Z#XB^.WQ?NM!U'Q+IFE26.
MEKK_ (9^&NB>'M"T/1/A_P"#=<UNPFUJ>R$?B#QE<1W46C>(?'OB72]+TN*U
M_;*BNFAB:^&C5C0G[-UJ<J4YQC'VWLJE.=*K3A7<76IPKT:E2CB(4YPCB*,Y
M4JRJ4Y.)RU\/1Q$X3KP53V<U4A!N7L?:1JTZU.I+#IJA.I1K4:=7#SG3E+#5
M(*=!TY7;_GF_X+C_ /!!@?\ !9SQ'^SEXA_X:J/[-S? #1/B;HQM/^%%Q?&
M>+5^(M]X(OEN/M2_%OX63Z$=&/@YHS!(=>BOO[2$D(TM[:X_M'VW_@H'X^_9
M,_X)O?\ !(O0OAQ^W7\/OB;^U3^S#X7^%GP<_9'^*.F?#'PEHD7B7QGI[>&-
M-\":?XNN]'UGXJ>!D\%VMYJ?A^SU&"_T'XAIK?A'7[S1G\,7OVZUL;N#]K*\
MY^+OPB^&7Q[^&?C7X-_&;P/X=^)/PN^(N@WGAGQKX(\5Z?'J6A>(-&O0IDMK
MNVDPT<T$T<-[IVH6LEOJ.DZE;6>J:7=V>HV=K=0^9B*5>&38W*<!]76'QF-I
MYAB,)C(NMAL;56)Q=?$X:O6G&MB,/0Q]+,<RP<YT?:0PD,:JU/"5_JF'H+NH
MRH3S;!9IC?;_ %C!X66!H8S"R]GBL'0E2P=.G5H0C.C2JU,-/+LOQ$83G2G7
MEA%2>*H.O5KG^9E\*?\ @C'_ ,$"/VE?B!J/Q#^$'_!P!X&^&W[/&E>-O#D6
MJ_!K]H_P%X/^!GQ\@\-O9Z3J/B7PSHWQ/^/?C[X):3XAU2ZA?5+/2/B5X<_9
MX\4>#?#5[<6EGJ.D>+[O1KY-7^8;SX.?LF>/?^#B+]DW]G3_ ()J66A>./V:
M_A5^T'^R;X#\,>+O#$+^/['XEK\$O^$/\4_';XLZWK%OIK:?\04N]7\/^/\
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M#F\/?V*WQ$^&4^F&0^*EU(:I'K]W%_Q+S:3:/</<6][I_P!:_P#!-G]C%_\
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MRMM2L;S3KR/S;._M;BRNHMS)YMM=0O!/'N0JZ[XI&7<K!ESE2" :_E=^$O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAO6_B/IGB73/W>_X/._^"B/C'P+X8^!__!.'X8^*/[&T[XM^';CXX?M*6MB
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M1M?#NL:YID<FLZ5I^HW5K97.H:7:ZHEVFE7\]I;RWFF_9;F2-6E-?6U?%_\
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M^"_!$CAY+^'2/B'\0]#UK4M:FM4L'N[/X9?\(_)>7VB:_P"(M+F]&_X-I_\
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M:5H'AKPWH=G+?ZMK&K:A<LD-M:6=I#)+(Q)=R!'$DDKHC ':5_C1_M+:X?\
M@I+_ ,%Z?'MO;7'_  DV@?M-?\%'-)^$WA>[AN;+4(K[X77OQITCX1>!9S>V
M]SK>D26=O\---T-Y[RVNM1T*"S@DGMYIM)BC8_ZC'C'_ (*C?LI?$G_@GA^U
MY^V_^RK\;_"_QD\!?L^?"CXXW]UX@\(C5;:YT_XC_#SX?W^OZ;X5N=)UZW\-
M:U8:QJE_<^'CH9O8],M-7M=:TG5--U-M+O;?4C_F:_\ !LM\'Q\8O^"U7[&]
MK=Z>E_HGPYU3XD?&'6FDM9+J.P/PZ^%7C/6?"NH,JKY<+P_$'_A#HK>ZGDA2
MVNIX)8VEN5M[:<M=_%;=-<UFG>UVK.S332=F[\R2NK"M=_'R[Q=I6<7>UVK.
MSBTU%\K=^9)-II_[!U%%% PHHHH **** "BBB@ HHHH **** "BBB@#_ #(/
MV =S_P#!9GX'%)W?[/\ MDW67E>.Y-U)<_$.Y&IS(ZSL5:\\G1M866#^T(YI
MM1UO4;F:YM->T'7Y_P#3?K_,@_8"EC/_  65^ 0N7N9M_P"V;=W<<DSK;O<+
M>^+G%C*LK&:5VUFYBF\0741FN+>\OM)URR?^T+ZTM/$=M_IOU_1'TB+K-^$$
ME:F^%J52"MRWOBZ].4VHWI\U3V*E.S]HI7C44^6.(Q'X3X"7_L#B&ZT_UEQ#
M6B22^I8-.*O:;;DG4<G'E?M%R2FEH4445_.Y^[!1110 4444 ?QB_P#!Y9^P
M7JGQH_9)^#_[<7@/2[_4?%/[)GB;4?!_Q1L].LXIOM'P/^+=UI<">*]1EWO?
M.OPZ^)&D>&K.UM+&V,$6D_$SQ;KNK3Q6>A(Z:O\ P9X_\%&]-^.?[(WBG_@G
M_P".]?A?XM?LE3:GXL^&EG?WYFU?Q3^SMXW\3RW\TMI'<-)>7D/PJ^(WB.?P
MUJ,WF_8M$\.>-/AEH-E#!;P11+_7+\5_A;X#^.'PP^(?P:^*7AVT\6_#;XJ^
M"_$WP]\>>&+\S)::]X2\7Z/=Z#K^ERRV\D-U;_;-,OKF%+NTF@O+21DN;2>"
MYBBE3_( ^)_@W]IS_@W._P""P=NWAV^U'4M<_9X^(UEXR^'^LW 71=&_:._9
MC\7W-U##8ZL\VF:I86VG?%#X>2:QX$\<G2[36&\ ^/;;Q+;^&]3D\2>"]-UJ
M%6ZWN[NRU;22BN79))VT]]N]WRVBN96WE>[NVEJVDHQ7+\*C&+:5OWC;E=N"
M45S?[']%?+_[&7[7?P;_ &[?V9_A-^U3\!]:?5_AU\6?#-OK5I:W@ACUWPIK
MMN[Z?XJ\">*[2WEN(;'Q9X)\16NI>&O$%O;7%W8/J&G2W>D7^IZ/=:?J5W]0
M533B[-6:_KYI[IK1K5%23BW&2LU_7HTUJFM&M5H%%%%(0445_GJ_\'+7_!PO
M^TG\/_VE?B/_ ,$]_P!AWXF'X3^#?A=I&E>&?CK\:/ 4T]C\5=9^*.K:;=WO
MBOP'X*\>:=K4O_")>'/!VCZSHF@ZW>Z'INB^/+'XCZ=XIL(]=L;;1;07(FN:
M*;LGJVM6HK=J-US=$E=+FE%2<4W)"<>:,9/E3NVTKM17Q-1NN9ZI)72YI14I
M1BW)?V>?$O\ X*@_\$Z/@U\8+GX _%?]MS]F/X>?&+3YK6UUCP%XN^,7@K1-
M8\.ZA>R0)::1XI:^U:*Q\*Z[<I=6EU#H/B.\TO6'T^[M=36Q.G7,%U)]QZ?J
M%AJUA8ZKI5[::GI>IVEMJ&FZEI]S#>V&H6%["ES9WUC>6SR6]W:7=O)'/;7,
M$DD,\,B2Q.R,K'_ ;O+R\U&\NM0U"ZN;Z_OKF>\OKZ\GENKR\O+J5I[FZNKF
M=GFN+FXF=YIYYG>665VDD9G8D_ZI_P#P9Y:E?WW_  1_BM;S4+R\M]&_:B^-
MNFZ5;7-Y-=0Z382Z?X#U>33]/@EO;I-.M)-4U74M5>SMH--A>_U.^U!K*2XO
MY]1OU?2-][6E;5.6KO'9I):6=VWK=)\J5](77O-6E;5.6LKQT345%6L[MOWK
MI/E7]4%<IX-\>>!OB+I$NO\ P^\9^%/'>@P:IJFASZWX-\1:1XGTB'6]#O)-
M.UO1Y=2T2\OK./5-'U"&:QU33WF%WI]Y%):W<,,\;(/F+_@HII^EZK_P3^_;
MCT_6_$NM>#-'N?V0OVD4U/Q?X=OI=-UWPM8K\'?&,ESXBTF]BO-/\J^T6)&U
M&W6:\M[29[807K_9)9U/\$'_  9._&+XJ:=^VW^U)\ -/U2YF^"_B[]F"]^+
M_BC0;F:\.GV/Q%^'OQ2^&'@WPAKNF*(Y[&VU2]T#XE^+-,U.W L9M:L+>QN9
M[R<>%K*RD=GH[:.Z^:Y7TN]$]4XQ3YDU/W9(=I:.WNNZOYKE=U;F>BNFG&*;
MDI*I[DXO_0-_:B_;+_9:_8I\(>'_ ![^U9\<? 7P,\(^*_$T7@[PWK7CK5'L
M8=;\23:?>ZK_ &9IUO;P7=Y</#IVGW=Y>7"6QL[&"-6O;B#SH/-]F^'/Q'\!
M?%_P)X2^*'PM\8>'?B#\.O'FA:?XG\&^-?"6K6>N>&_$N@:K MSI^K:/JUA+
M-:7MI<PN"LD4A*.'BD"2QNB_YK?_  >4_MBW7QH_;N^%7[&_A2_FO_"_[(GP
MND\2>,=-L1<G9\7?C5IND^-M<&HP11"&^A\._"+1?AKJ-A>N]RNC#Q%XJA1K
M+S]4$WZL_P#!E9^V5JGCS]GO]IC]B'Q;KCW4WP"\5^'_ (O_  CTZ[EB:6'X
M?_%NXUNU\?Z-I$$-C&\>E^&/B'HEIXBOI;V^N)9M4^*Y2TBCA@F"J[:32T>M
M[QMRV;4E9M2YO=:2::4M4FFA7NHM*ZEK?FBURM-J4>5R4E)<C2332E[R332_
MM_HKXQ_;X_;W_9S_ .";?[-_BC]J#]IWQ+?Z+X$T&_L/#VAZ!X=M;'5?'OQ)
M\<ZS#?7.@_#OX<>']1U31;77_&.LVNEZMJ,-I=:MI6EZ7H>C:[XG\1:OHOAC
M0=:UFP\@_P""8/\ P5:_9>_X*T?![QG\8_V9K?XC>'K/X>>.I/ 'C3P+\7M%
M\+^'/B'X?U*32+'6](U:\TGPAXS\>Z*_ASQ)87DW]@:M:^(K@7EUI&N6,T%M
M>:3=P)5M+Z:>:OTZ;]5ZZVV=JL[7T^]7TMTO?[2MIKK;9V_2VBBBD(**** "
MOY#O^#R_]I-OA=_P38^&W[/FEZM-9ZW^U'^T!X=M-9TN*26*/6/AG\&M/N/B
M%XA%P$C:.XBT_P"(Y^#URMM+)'F=H;I-[6F!_7C7^9K_ ,'JOQYO?&?[>_[-
MW[/D$R2^'O@7^S8?&;(+JZ>2V\;_ !O\<ZW_ ,)%;M9F]ET^W0^$?AC\-[F.
MXAL;/4KMKF2/4);NRL]'^SEF^C:6KLKV6R;NFDN9I7T=VK-2LPLWM%M+632O
MRK9-W327,XJ^FK5FI6/ZC/\ @U1_9DM?V=_^"._P8\43VDUKXL_:?\:?$3]H
MOQ6ES#(DB1ZWK$?P\\");2S.TDFFWGPQ^''@OQ!;)'';6B7>O:A+!!*UQ-J%
M_P#T?5\D_L"?",_ +]AK]CGX(R,\MS\*/V8/@3X U&>07*O=:MX6^&7AG2-8
MO7CO(X+F%[W5+6\NVMY+>V^SF8P+:VJ1K;Q_6U'W:ZZ:K7L^J\^H)W5U:SUT
MU6NNCZKL^H5QWQ$\5Q^!/A_XZ\<3*CQ>#?!WB?Q7*L@5HVC\.Z)?:NZR*US9
MJR,MF0P:[M5*D@W, _>KV-? '_!5WQA>> O^"8/_  4.\6Z;YRZIH_[%/[3D
MFD306NG7QM-8NO@WXQL=)OIK/5S_ &==6FGZC=6U[?6]U%=)-96]Q&MCJ$C)
M97!OIM?2]TK?-Z+U>BW8/72]KZ7;4;>?,[J-N[5EN]#_ #$_^#8CPKJ/Q._X
M+F?LBZOK,UQK3>'[CX]_$KQ+J.I7#7VHW=[IWP"^*DECJMS<WT5[)>7\WC+4
M]$N+JZN76Z=I)[N.\COEAEK_ %ZZ_P M#_@S2\*_\)#_ ,%:?&FKXA_XH7]C
M3XP^*OWLOEN/MGQ&^"?@C_1D^Q77GS?\5CAHO/TW%N9Y_MLGD_V=?_ZE]'6]
MM7UZM*^^KMJWO9];6:;.K;6KZZ7:5]]6]V]U%^5K2D45_GJ_\'N7[2>N?\+&
M_8J_9+T+Q7KNF:-9?#KXC_'/XB^$=/UB>UT+Q2OC'Q=H?@WX9ZAXBT:WU#R]
M4F\-7GPN^(;:!-J6F+#8S:QJ<FGW5Q</=)8_U!_\&[.@^/O#O_!%O]@JU^)6
MO:OXD\3ZI\-/%WBZ'5=<U6\UG46\(^._BY\1/&WPZT]K^_N[ZY-IHGP]\0>%
M]%TRS,XATS3-/L],M;>SM;.&S@//1KK9IZ]M&^SOUB_=DD]!VZZ-:7::=F[V
M6C>NCNMXM.,DI)H_:>BBB@05XC\?OVE?V?\ ]E;P!>?%+]I#XR?#KX)?#ZRF
M2U?Q3\2/%6D^%M-N;Z7 @TO2SJ5S#/K.L7)(%KH^D0WNJ71XM[24\5\$_P#!
M:?\ X*86'_!*G]A3QW^TGIVG>&?$GQ;U36M$^&OP$\$^+H[^Y\.^*OBGXG^U
MW=J/$-CH^M>'M:N_#/AGPSI'B3Q?X@M]*UK2;V]L=".DVNJ:=>ZG:74?^15^
MVA^WI^UC_P %!?BK<_&#]K'XQ^*?BGXE2;5!X9TC4+M[3P1\/-*U:YAN;GPY
M\-_!-FT7AWP7H1-K9+/;:-907.JR65M?:[>:KJHEOY2Z[W?5+IZOI)Z-1LWR
M^]+E3ASB<>]W?WDOLZ?:>MI.Z:C9OE]Z7*I4^?\ VJ_V=?VP?V5?VN=!N_$O
M[,'[1/P:^/>DZ8EJVMO\*_B'X8\97_AM[Z/S;2V\5Z-HVI7.L^%+^>,B1-.\
M1V&EWY0AC; $$_1U?X\7_!L_K.KZ1_P6X_8=CTK6-8TB/6?$?Q6T;5UTBXN8
M?[6TBX^!'Q0N9M'U.*V#K>:1=75G9R7MO<QO;(+>.]<P26D5U!_L.TWW6WSZ
M6OK9)_+5;-;.3?=7L^Z>ZM?6W*][Z:J]FDK2E\E_MV_M<>!OV$/V0?C_ /M<
M?$5/M/AKX(_#^_\ $T6DB46\GB;Q5?75GX<\ >#+>X;"6]YXV\>ZWX:\(V=Q
M(1%;W>M0S2D1HQ'\Q?\ P:G?\%"_V[/^"B7Q)_X*-_$W]K'XM^*_B+X.TG5/
M@??^!O#UQ966G_#;X=^(_&VH_&34-;\+?#/31;&XT;2]/T/1M!M9-&M-3O3;
MZ=#HMYXDFO=5OK+4KMW_  >E_M$7?P^_8(_9]_9VTK5(;*]_:+_: DUW7;#S
M(Q=:SX$^!_AMM9U.U2 W4<SVEIX[\9_#34;J9+.YAAN+6PCFGM)+BW2Z];_X
M,W_@0WPT_P""5OB;XNWT%BVI_M(?M*?$?Q?IM_;JGVP^"OA[I?AGX3:1I.H,
MLDCE[#QEX0^(FHVRR+ 5M]<5EAVN)[B79-.SYG=)Z62>KNGT]UJZO*[5K6;$
M[+E=GS.Z3TLD]7I+I[K5TN:[5K).1_5CXD\2>'?!OAW7_%_B_7]%\*>$O"FB
MZKXD\4>*/$FJ6.A^'?#?AW0[&?5-;U_7];U2>UTS1]%T?3;6YU'5=5U&YM['
M3[&WGN[N>&WADD7XQ_9&_P""F'["'[>.L^+O#G[(_P"TO\/_ (V^(O >FVVL
M^+/#_AP:]INN:1HUY?/IEOK+Z1XGT;0M0N](;4%2S?5+"WNK&&XN+*.>XC:_
MLOM'QI_P<7?'!O@+_P $8_VY_$EK=>1JOCCX::7\#]+@6::";4%^.OC3PU\*
M?$-K"T,L#/Y/@SQ7XEU*Z@>3R9["PNX9HKJ-VM)_\\G_ (-</B]K_P *?^"U
M?[*MAI6H&RT3XO:=\8/A%XUM2_E)K.@:Y\)O%_B71].DD\J8CR/B#X1\$:S$
M@0?:+C28;9I8%F:>.E;K=_$FEO?E]SN]W=KEU6B:O=-<OF[<R<8[WY4X6MS.
M_,[N/+>2LHM-W7^O37\K/_!WW^U))\#O^"54GP6T>]^S^)/VN/C%X'^&4T<%
MW]DU&+P#X%NC\7/&5_;>5<PW<EI-JG@WP;X3UA(XI[6XTSQA<:??@07X27^J
M:O\ ,;_X.^_VBM:_:>_X*?\ P3_8K^&T-YXGO?V;OA_X9\%6OANT9C/>?'7]
MI>]\-^+;[2--6X\BR:;5/!:_!*R$J3LG]H>?:74\4EF\4 M-?.RW2YM6M8R@
M[I)RBDVFX^]&4.9 K;RYEJN5Q:C[^LHKF>MO=<G&*<I1C)64>:<?I']B_P#9
M&^-7A_\ X,^/VUO%OP_U'PY::E^TKXT^(7[2>M+XFU2]TYM)^ WP(\9^!O#/
MCNTT2U@\,:G]I\7^*-/_ &=_%D&D:?J,]MIFHZ+XDLM0MM?TJ[^RJWSU_P &
M5?PEN?$__!0[]HKXPRK"VD?"C]E'5?#:AOLIN(_$_P 4?B;X!71YHEF#W"PC
MP]X(\9PSRV:1NKW%O%-=1PS-:WO]5/\ P5U^'?A[]@[_ (-M/CS\"M!>WDT7
MX-_LD?!?]G*VO8X=1NHM4O/$'BWX6_!>ZUDK#=Z;>FXUW6/$EQJTEU<2?9X+
MN^:\U+3KZQCN=+N/QA_X,=OAI+9^ O\ @H=\8[F&&2#Q'XO_ &>/AIH]PUL@
MN+27P7HWQ7\4^)88KSSFD:'4$\?>%'N+;[/"B/IEM+YUP7V6LM/^5+X;Z\RN
MG=ZQE>ZZ.R@Y6:YKR1#3_DBOANM)1NI.4M8RO=;J34:;ERN/,W-+^\VBBBF4
M%<7\1/B1\/?A%X,\0?$;XJ^.?"'PU^'_ (3TZXU?Q1XW\>>(](\)>$_#VEVL
M;2W&H:UXAUZ\L-*TRTAC5FDGO+N&-0/O9XKQ;]L[]J_X9?L.?LN?&W]J[XO7
M/E^!?@IX&U7Q;>Z;#?Z9INI^*M8C"67A7P+X>N-8NK/3F\4^//%-YH_@_P ,
M6US<1I=Z[K5A;Y_>8K_'7_X**?\ !7?]NG_@J#XM_MG]J#XL33>!=/U==:\(
M? ;X?QZCX2^!7@2^2S>QAN_#_@B35=6N-4U>"WN+Z*#Q5XXUOQ?XSBM]2U"Q
M3Q&-.N#9JVFE?J]DW;RYMGHG?MS-<J:UE$::5]+OX4W;2[7/LVXQ:>FG.XN"
ME'WIP_V /V;O^"A7[#7[8%W<:9^S'^UC\!OC5K]IYS7?A+P/\2/#>I>-[6""
M.69[VY\#/?0>+[?36BM[F6'4YM%33[F.TNWM[F5;2X,7V+7^%9^PWJ6IZ1^V
MG^R+J.C7U_IFIVO[37P*:SOM,GN+:_@D?XG^&(B;::U@NKA7>-WB*Q6EVTB.
MT9M;D.8)/]U.AVO=)J/1-W?2]VE%=>W_  6[7O%-1Z)RYI>=VHQ7IIY6TNRB
MBBD(**** "BBB@ HHHH _P R/_@G\S2_\%EO@=+"LTYOOVTKZ-]B3$C;XSN_
M%"7+L+B07#26-]=W=U%-)<7EMYEU?VXO+<^,=>U+_3<K_,@_8"#2?\%F?@=_
MI#R/;_MD3Y:<QSM<^?\ $2X_M"X0_:?DFOGT_2M6F*MJ'EW%UJ%U/<WL>I^'
M=8U'_3?K^A_I$)K..$OM1?#%'EJ74INV(J)4ZCB^53A25*2I<LI4:=6%.5:J
MX^Y^$> EO[!XCLU?_66OSJSNI?4,$T[M)-.FZ:2C%).,KRE)MA1117\\'[N%
M%%% !1110 5^;7_!43_@EU^S?_P58_9RU+X&?';24TGQ1HJ:MK/P3^-.D:=#
M=>.?@GX]OK%+5/$&A%KFP;6_#.JM;:?;^//A]?:C:Z'XWTNQLEGGTGQ'HOA3
MQ3X;_26BC^NJ_%!Y:ZZ:73U\UJOD?Y47[,W[9?\ P4;_ .#5O]LCQW^RK\<_
MA_IOC_X#^,O$=GXW\:?#0W1C\'?%_P +.+CPUH?Q^_9V^(\FG_:]#U?4]-TB
M/3[I-2TV2WNSH;^!_B3X1TCQ9X;L[CPE_I&_L'_M^?LQ_P#!1SX"Z%^T#^R]
M\0M.\9>&;TQZ;XL\.R,UCXU^&?C".$/J?@GX@^&+M8-5\/:[8ONDLY+JU73/
M$FD-9^)O"]]K/AK5-,U:[\G_ ."H_P#P2X_9Q_X*M_LXZC\"_CIIW]B>*=$_
MM+6_@G\;-$TVUN_'?P5\=W=K%"-<T,S2VG]M^%M;^R6%E\0/A_>W]IH_C;1[
M2T!N]$\4Z)X1\7>&/\O3X5?%S_@H;_P;7?\ !1SQ'H&I:/>:!XK\+WEIIOQ'
M^&VL7-\/@]^U+\#[C5+PZ#XATF_A22WU3P[K]O;W^H^ /'NFP2>(OA]XHCU;
M1=4LK/6M+\=>")4]%HE>[;BKIM7OI=VOK>_VG?FLFFI?NKW5&[E)N*O&ZNV[
M7;CS:WO]J5^;E34H_P"QG17QU^P5^W!\$O\ @HE^RY\-/VJ_@)JDUUX.\?:<
M8M7\/:DT2^)?AYXXTQ8H/%WPZ\7VT):.V\1^%-3=K2XE@,FG:Q8/IWB+0[F_
M\/ZSI6H7?V+3Z)]&E):/6,DI1?HXM-/JFF4M4GK:48R5TU>,HJ49*_246I)]
M4TSX,_X*=?ML^'?^"=_["G[1?[6^N?V==:G\,? MROP\T'4Q<26OBSXM^*;F
MW\)_"OPO<6]DRZA-INJ^.M9T-?$,M@&FTKPO%KFNS&&RTJ[N8?\ ./\ ^#;[
M_@EQX _X+%?MB_M)?&_]M'4==^)?PQ^"/]@_$GXJ>&SXBOM"UCXT?&;X]>)?
M&NI:"OC#6M%EL/$"^%[IO!OQ%\3^*F\.:CHNJ7VMP^'[$ZE#I=]J5I=_J;_P
M>P_MIR76O?LJ_P#!/[PMK"&TTFPU']J/XPV%N[2^9J>I2:U\.?@MIUQ-!,L5
MM<:;I]K\6M9U/1[V.:XFMM?\':NL=I!]CFU#^AO_ (-O_P!@GP9^P;_P2X^"
MGB&\TFWTSXO_ +4/@[P]^TS\=/$^HQ2Z?J#?\)SHW_"1?#CPIJ,>I$7.AV'P
MT^&.JZ'HM[HT\D=M:>+Y?&^O?9[&Y\07UM&7DM-+:O9;.*O[T5+WE?2,I1<+
M2<4I*7,7DKJZY=7>RMK%7M."E[Z;LHSG!P<9N"C.,N;^&7_@ZI\)_LL?!K_@
MHQX5_9F_9,^!OP.^!?A#X#_L^> [3XA:%\'/ASX1\"W6I?%/XBZGXA^(=S=>
M-;SPSI>G7GB"_B^&NN?#!](/B"74+W3K*\F>VNEM=26"+^LS_@S2\1V6M_\
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MW_B+::E=P>"/V#?^"H_[7_BJ'4I;_6--TC4O&7[/7Q2^'/PK\!0ZZXACMO\
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MF@N]/M[[P_XD\(>-H$>6VU,M)^ZG[?G_  2)_P"";?\ P1R_X(8?M1>*+/\
M9Y^&/QJ_:2O/A!HGPQD_:!^,G@_P]\3_ (C7?QE^-&M:!\+[CQE\+KGQA826
M/PE3P2WBK5/%/@O_ (5[9>&M8\/:9X6L]7N;WQ!XS@N]8U?\ _\ @UF_8NMO
M^"@O_!43QK^T]^T+ /B1X=_9DM+O]HGQ7_PD7V>\A\;?M$?$/Q1?)\-K_P 3
M6+Z?)%J$5CKZ>-?BFODW&G#_ (2WP3X>6YCO]'GU/2[G]S?^#T'X^:GK'PI_
M8A_8$^'<.M>(OB5\=?C7=?%RZ\'>&DN)]4U6S\'Z;<?##X;^'I]/ML7&KOXZ
M\;?$_5_^$=TJ%;N*?6O K3W$,-[:Z-)(*W-)03DN>T%-<T[.7/;XDKM22]V*
ME&TE%R4G%D8M-)6J>]>-U&4M:CDUR>UDJ;EM&#M5C#X74A42G_)M_P &X^L6
M^A_\%L/V!;VZ-R(Y_B3XUT=?LOV(2_:/$/P;^).@6@;[?+#!]F-WJ<(O!&YO
M39F<:;%-J/V6&3_9#K_%W_X)70^*?V4_^"V?[%_@WQL$T?Q=\,_V]OA]\"O'
M*VMX$M=-U;4/BM%\%O&,;7MS]B!TNUEU;5$O)YE@\S34G9X<L83_ +05Q<06
MEO/=74\-M:VT,MQ<W-Q(D-O;V\*-)-//-(RQQ0Q1JTDLLC*D:*S,P4$T7\E;
M?F33;O\ HK73NT[NUK.Y?RC;?G33<K]-/LJUXN[3YI6ZW_S8?^#VOXKKKG[:
M_P"R%\$XW\Q/AM^S%K'Q'F*")HX;WXO_ !0\1^'Y+1Y4OY9%O$LO@UI]W+:S
M:;9F*TO;"Y2\U!+T1:?_ &:?\$&?AA8?"'_@CK_P3R\*:=9O8V^K?LX^$_BA
M)#('#/?_ !ON=2^-&J7@WVMF=FH:GX_O+^,B)T,=RICNKZ,K>W'^;W_P<Q_M
M;_!W]L[_ (*E>-?BG\ /B?X7^+_PBT#X4?#/X:^$O&_@_4-6U#1+V7PC%K;>
M*K:U?5%BC6&T\:ZGXD6RN=%MXO#VO:6UAXHT:;5+375UK4O]3+_@GEH>F^&?
MV OV&_#>C6KV6D>'OV/?V9]#TJSDFNKA[33=)^"W@JPL;9Y[Y([V=X+6WBB:
M:\C2ZD*%[A%F9U VV[7>ETUYQ:B[W;=XM-6VWT6B0Y-RM=Z*2::MK!Q@T[MM
M.+O%=-]%HE_'M_P>S?M?:KI'@C]DS]A/1+6XM]/\9ZUJG[3WC_6%EO;9;NV\
M'Q>(/AM\//#47E*EGJ5A/J'B'QQK^N65S)-]EU'0O!M\MNDH@G'X _\ !K+^
MR[XQ_:+_ ."O?P1\7^'[ZPTOPU^RYHOBO]H7X@7MVEI<W$VB:3IX\"Z)HVEV
M%S/$]S?ZUXR\=>'+.2ZA61M'TS^T=80-<V5K#/\ HC_P5$N=._X*]_\ !TG\
M'_V5O#]K8>*OAA\$?&_PH_9A\6RV5G=ZY8:CX*^!VL>)/C+^TY%K=C91S)#<
MZ%K^N_%CX>:A)<F.SB?PW9#5+FUMUE^S_&__  ;L_$.;]A?_ (. M!^!VNWU
MYH^C^,/%_P"T3^Q5XL>[U!3.][!>ZP_@W2]2;^R=.75IM2^+?PP\!:8T8L-#
MSJ%S#J2VT!M!I4XGHG+31N/*XRO%:QEI)[W3E=)J[BKRC*,12T3DTG9RBHRC
M*\+MPDK2>CO%SNERN3C%.491A_JD_$SXB^#_ (/_  W^(/Q:^(6LVWAWP!\+
MO!'BOXB^./$%XZQV>A>#_!.@W_B7Q-K-U([(B6VF:+IE[>SN[JJQ0,690"1_
MEY?\$*?!?C3_ (*W_P#!PIJG[8?Q5TY+W2/ OQ"^)O[=OCZUE6]ETS0-0T?Q
M%#:? GP;X?NM3FULVL?@?XC>*/AH?"VD7NI7M_'X+^'NHQV-\\ND/J5O_4)_
MP=V_M\+^S)_P3PL?V7/!VJV$/Q3_ &W/$S^"-0MV:1M4T;X#>!GL/$OQ3URQ
M\F;RX+C7]9?P+\-C'J=K-:ZCX:\9^,Y=/:+5='@N;7A?^#.O]A23X!?L'>.?
MVP?%^D/9^/?VT?&,4GA8WL#1WEA\#/@]?^(?"WA*2."[@CO-,?Q=XZO_ (B>
M(9F@9;/Q)X7A^'VLH;JVBTZ<&J?9V36CB^]T[;6:=UI=)<R;T'=.ST;2:5G&
M2_O*5KVM*,KK31+F3:M]^?\ !T=_R@H_;F_[MF_];#_9]K\QO^#)FT@3_@G]
M^U5?K96<=U<_MBW]I-J*(@U"ZM[+X*?"::VLKF00+(]G82:A=3V*-<RI'-J6
MHM'!;M+))<_N5_P7C\#7OQ#_ .".W_!0[0+!;QY]/_9N\8>.7%B"9A9?#"73
M_B7J+.!+#_HB:?X2NGU [VVV"W+&*X \B3^<?_@Q^^)5EJ'P._;W^#YNL:CX
M2^*_P:^)2V3D+OLOB)X0\8>%VNK920TWES_"](KXQAA;>;IXF*F[@#E]6NR3
MZ]7;35)O3;WN]EHT)ZR6UDGU5[RM;=)O3;W^_*K*2_NEHHKB_'OQ'^'_ ,+=
M!?Q1\2?&OA;P'X=69K5=8\6ZYIN@V$]ZMG>:B-/M)]2N+=;W4I+'3[^Z@TZT
M\Z^N(;.Y>"WD$,FT_P"'^[5_<@_X?[M7]R/X*/\ @]%_X*#W,U_\"O\ @FQ\
M/?$B)96B6O[1'[1=GI=[>)<7%_*E]HWP5\#:X;1X+5["VM9?%/Q"U;PYJ3:@
MEU>7'PQ\2_9-/GT?2;N\^U_^"7__  10_P""=G["_P#P2=?]OS]LKX#?#?\
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M\RWO^EU>[L7NKIW7EK'7JIIM/FZ=+*Z;N[;5%?.GPG_:Y_9F^.GQ5^.GP/\
MA!\;?A_\0?BY^S1XIL_!GQS\ >'-;AN_$?P]\0WND:;J\=KJ=DRQ_;[2W_M,
M:%J>LZ(^J:+H_C;2O%/P]U;4++QWX-\6^'-%^BZ+[^3L_)]GYA??R=GY/L_,
M**** "BBB@ HHHH _P Q_P#8!DC/_!9;X I<R73%_P!L^_NXC,RQ22F\\5 P
MNI)N99&U>\M[O7+ZW:>:VFU6P\3MMU.[TNU\46/^G!7^9'_P3^+R?\%EO@<]
MNLUQ]O\ VT+I60)*C",>-+KQ/;RX>XN(9EAL;G5+RXCEGO+NVQ+/:OJ,@\2>
M*K__ $W*_H?Z1/\ R.N$WO+_ %7I)S5N1VQ=>\8JFHT?<FYI.--5'2=).=;#
MK"U)?A'@);^P>(E9JW$E>R;U<7@\)+GY++EO-SBI-7J<G,Y284445_/!^[A1
M110 4444 %<YXJ\8^$? NCR^(?&_BGPYX.T"":"WGUSQ5K>F>'M'AN+J016T
M$NIZO=6=E'-<2D1P1/.'FD(2-68XJI\0/'W@[X5> O&_Q0^(OB'3O"/P^^&_
MA'Q+X]\=>+-8E:#2/#'@WP?HU[XA\3^(=4F1)&AT[1=$TZ^U*^E6-VCMK:5P
MC$ '_,O\'?$K]H;_ (.PO^"N.F_"KXC>.?&/PH_84^$J>)/BS8?"31;M;23X
M<_ ;PGJFB>&#+:)9:?K7AO4?V@_BGJ'B+0]+U?QQXH?5[7PVWB'7(_#;W_A3
MPIHO@R_:MHY72OT3=]5=72=M'O9M;\LDF-6T<KJ-^B>MFKI-)I:-7=I-73Y9
M),_T^+>X@N[>"ZM9X;FUN88KBVN;>1)K>XMYD62&>":-FCEAEC99(I8V9)$9
M65BI!K^?#_@Y8_X)_P#P0_;%_P""9WQZ^+'C73+/1?C+^R!\,_&_QZ^#WQ/L
MM&M;WQ%IT7@G1Y?$?C+X;WUQY]A>77@OXE:%I4^DW]@=0%IH_B2/PSXV%AJM
MUX7CTC4OW[\-^'=&\(>'= \)^'+%-,\/>%]%TKP[H.FQR3S1Z?HVB6,&FZ78
MQS74L]S*EI8VT%NLEQ/-/(L8::620LY_DS_X.S?^"GOPD^ ?[#_CC]@KPAXW
MTW5/VG?VHHO"6EZ_X0T2XAOM7^&WP1L_$FF>*O%'B?Q>J+<6^A_\)[;Z!!X#
M\.Z3J8AU77-)\1^(->T>-8- :_C(MI_$X[)M1<M+K1Q6DDW:\9>X_MM1NT)N
M/VI1V3DHN756O!74HN5KQG^[:TJ-0YFOS5_X,=/%GB5];_X**^!9/$&MR>#K
M72_V;O%EEX4DGGG\.6?B6^N_C'H^I^(;2UD22VTS6]2TO3M)TW49[.6SGUVQ
MTK2X]2348_#NE-I?^@A7\/O_  90_LH?$'P!^S[^UG^U]XLL[O2O!?[1/B_X
M>?#7X3V]U:R6Q\0Z7\#)/B WC?QG9RRH4U'0KCQ7X\7P9IMW:2)'!K_@?QI8
MW(FE@B^S?W!4M>UONZZWT2[]6WYVLDMM+6^[KK?1+J^K;\[62_R+?^#A'Q!;
M_';_ (.!?VA_"?Q0\63>"? -K\5_V>O@O<^(?$%W'I^F_#OX=6'PY^%>AZ]X
MACN'_MR#3="@FU'Q+X^DNFMKI<ZM>:G/I,,EQ+I<7]V7_!QU_P %"?!W_!.7
M_@F3XY^'?@?7].\-?'+]I/PCJ?[.O[/OA33KXVVNZ7X9O])L_#WQ-\>:1##)
M_:5CIOPT^'>J/;6'B" A=)\<>(? -L]Q'/J4#5^-G_!T!_P;_P#QL_:-^+(_
MX*&_L,_#[5/BKX]\76/A_P -?M+_  0\++%/XUU>_P##NDZ=X7\'?%WX?:&P
MB?Q,[>'].TOPG\0/#>ES-KEM_97AWQ7I.CZQ;7GCC4=#Y#]C/_@UU_;)_;$\
M?> /VD_^"WW[3'CW64\,^'_"FD>'?V?=*^($7Q&^)I\,>%+73U\/^"/&_P 1
M-03Q#X#\ >$T6T>'Q'X4^'%OXIU3Q"FH:I?OXQ\*^*[^^U9AM-ZVE9*\='-1
MDG%:N2?+&48VNK-0DM+II2:;^S*R5X:.HH33BM923Y5*,=XV:A):.2<?H[]C
M_P#X(8ZSXV_X-@O%O[-B:)#I_P"U/^UQX<L_VW=&CEU%HI$^)D4_A_QM^S[X
M#N;C5H]*BT$Z_P#"+PMX/\"^+=,UJ$V?@WQ5X]\=76]KNRCU,?S\?\&RG_!5
M'X)?\$FOVFOVJOAU^VOJ7B;X._"OXU>"-!TGQ/KUUX \8>(];\#?&GX"^(?%
M$?AOPOXL\%>&?#&M>/\ 3$O]-\=_$G0+]K/2Y7T;Q5!HEEXBTF.PGN]<\-?Z
MJ5G9VFG6=KI^GVEM8V%C;06=C8V<$5K9V=G:Q+!;6MK;0*D-O;6\*)#!!"B1
M11(L<:JB@#^>3]OG_@V)_P"";'_!0C]HWQ!^U%\0;SX^_!KXD>-K:Q?XBVG[
M/7C'X=>$O"7Q#\261>*7QUXET+QO\)?B.UOXRU>P6SL?$&H^&+[P[9Z])8)K
MNJZ==>+-0UWQ!JU:-J[;2:^*Z32<;<WL[36B]])R36D4O>Y]/=;5Y-I27QW2
M<8N/+S.ERU%9+WXIRC):1C'WO:?R7>,;+]IS_@[5_P""K=[=^"M+\7_"W]@W
M]G:&XT#2O$FJ1+'9_"7X+2ZI<W<6I:O+Y>I>'$_:,_:/U+24N(=!T^'Q)+X>
ML;.QM;@^-/!/P<U#7[S^<K]DC]AGXV?M<?MM?#+]A7PIH=_H/Q7\:_%J7X8^
M+C=6$>I_\*OL_#6IW<7Q5\8^([&'4+..[TOX6>'M&\2^)]>L[74H[C4+;0+C
M3=)EN-2O+&&?_:H_9>_97^ /[&/P6\(_L^?LT?#3P_\ "KX4>"[8Q:5X<T&*
M5YKV_F2)=0\1>)-9O9;K6O%7BO6G@CGUSQ1XAO\ 4M<U>=$DOKZ;RX@G@7P6
M_P""7W[$?[/?[8/QS_;M^$OP6TWPK^TI^T1::A;_ !(\90ZOKEWITUUXBUJ+
MQ)XZUKP]X8O-0GT#PSKOQ'U^TTS6?'FJ:/86UQKNIZ<;[-M<ZSXFDUR->NEU
MWO9V227NJ_=MZMWO)Z6SU:=_=;7>]K)1BDN5)]9-R]YNZ<I>[;Z1^&/[//PM
M^$/[/'@O]ESP-H)TKX/^ _A1I7P9T+0X9([:Y'@O2O#,?A0+=7FG0V/F:QJ&
MG))<ZIJT,-O<WNK75WJ;[;F=VK_'N^#/_!%7]M'XS_\ !2C7_P#@FII?@'Q'
MH'Q \"_$#6]&^)GQ&UOPIJD/@GP#\)?#WB*ZTJ^^/.K3F5+*?P+J^EVJZEX&
M:WUL0^/=6U+0O"OAK5+S5]:LMW^S_13^23[J*75:.R3:M?E5[1;;2U:;Z;).
M^ZBEU5TVDFU:_*KVBVVEK)2^;OV0_P!E;X1?L2_LW?"+]ESX&Z%#H7PX^$'A
M'3O#.EG[-9P:GXAU*-#<^(_&OB:2QM[6WO\ Q?XW\0SZGXK\5ZFD$0O]>U:_
MN4BAB>.&/_,M_9%\)7O[+W_!V?9>"-9CA\-1Z3_P4<_: \.Z&DR%H9_"GQ=N
M?B?8_#XPQ1+K+0_\)3X2\=^'6L(Y9'ELVU>W2\OK&2&:^MO]6.OX-_\ @YR_
MX(I?M9^._P!JKPG_ ,%1_P#@G[X"\=?%#QY=6G@:7XU^"_A;;7&M_%SPK\1O
M@[8Z/I?PP^,/P_\ "]CYVO>+H9?#'ASPMX:U#0O"6G:EXAT'6/!VC:W;:7JM
MCX@U:X\.JRM:VC]U)*5[O1)<LDDGU]URO;EE%<W,FM.6RL_=LE*]WHE[LHI)
MW=_=<K\O+*"YN;^\BBOD;]@GXG?M$_&7]C7]G'XG?M:?!_4?@/\ M(^+OA=X
M?U#XP_##56TR.^T;QC#')87FLR:3IE[J \)0^.(+2V\=VG@#5KD^*_AU9^)H
M/ GC2&U\7>'=;M8?KFG\K>7_  VGW#UZJS[?\-=?<V@HHHH *_R&?VTEL/V2
M?^#F[QYXT\0R6UEH_@'_ (*L?#?]H_5I[S^T&LX-'\6_'/P5^T+=7-T)8X;T
MVPT_Q,T\XME,7E;AIDLUI]EFD_UYJ_RRO^#Q7]G"\^%'_!5#2OCG:Z/-!X;_
M &J?@+\/O%LVO^<9+74_B!\*X)?@_P")M)2*2=Y8+O1/!/A7X67=RL5O!8R6
M^OV$D+SWS:EY1U5U)K:R^6[YERJR:32D^9Q5DFVA6YDVI-;67FT_>?,N5632
MDHSES.*22<F?ZFM%?)/[!'Q^MOVJ/V)?V3OVBH-235;GXQ?L^_"CQSKMTH*O
M%XMUCP;I$OC33;E#-<[+[1O%RZUI&H1K=7<<=]8W"1W=U&JW$GUM0G=)]_7]
M;/[TF"=TG9J_=-/YII-/R:3[H*_SV/\ @ZS_ ."@?C[]K[]I'X0_\$8/V/(=
M4^(VL:3\0O!^H_&?0/!$C37OC[]H#Q!#]D^&/P92_@U"VTV]TOP%IOB$^*/&
MUGJCR:!IWC;4M!EUNXTC7/A=?-8_T#_\%_?^"X_@+_@E/\#;KX>?##6M"\4?
MMS_&#P[>1_"+P)_H>K#X6>'[]+[36^/'Q$TN>"\L8-"T2^MYX/ OAS6X<_$3
MQ99R6=O8:AX7\.^.+S1_RZ_X-8O^",WB[X;V]W_P5A_;1TO6-7_:#^-5GJVL
M_LXZ+\0%U/4/&W@_PIX\356\:_'SQI?^(7GU:Z^(WQML=7G@\,W=R%U&P^'F
MI:WKVH:GK5Q\4OLGA9-[V46]DI)VNE>ZDK\K5DKN$U=Z<LTFI<M^7E;U24U*
MS:5[J4;\K32C=TZD;RM[LTFOYT_V'/#^O_\ ! #_ (.&_A3\)_VE?'FFP>#?
M WBFR^$_Q6^)%G=?\(=\.]?^&?[2/PD@M?#WQ!U#4]=-Q!;?#KP1XG\;>$/'
M7B.ZOKB#[ _P^U*WU271[_3;^"P_5C_@[O\ ^"H]M\:O&WPX_P""4_[-6K7W
MC-?#'BOP[XZ_:,;P; =<C\6_$O5[*P;X,?!GP]+HTUS=>(+[08-=N/%?BO1;
M2SOK:Y\5ZU\/M-M)AXD\)ZUIUK_0#_P7^_X(+:/_ ,%>?!G@/XD_"+Q;X1^%
M7[8WP>T[_A$_!_B_QU'J%O\ #WXC?#'4=<;5KWX>?$O5_#?AWQ+XPTB'PGJ6
MHZYXL^'FO:)H^OPZ3JNM^+M$U#PU=P>-?^$A\*?F-_P1._X-3/'_ .Q/^UKI
M_P"U7^WOXZ^ 'Q;N_@U_8GB3]G/X?_!?5_'WB_0K?XLPWMS<P?$SQ_>?$7X9
M_#/[%>?#/['IFJ?#C2=(TWQ";OQCJ,'BZZU7PU>> -(M/$]*RMINUS-<KD]%
M%MII1;22<6DFFDN9V25145:ZWDG-QY7*6B@W*Z46U%*4;*+BTDI244E^27_!
M=C_@BEK/[$G_  28_P""7_Q=L?#T+_$?]GKPCJ7P._:ZOM)5M<:'7?CKXJ\0
M_'/0;VZUZWMK%$\)?#[XO>*?B?\ #W3K^[M7BNI/'G@W3X+B.4*VI?TG_P#!
MI_\ \%$--_:X_P""<WA_]F_QCXG.H_'7]B+['\*-4L-2NK3^U]8^!D\EY/\
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MT63P_P"._%&LZ#H$6DZ?X$_M:Y?PW\5-;\!^*K.&TTS^^/\ X)$_\$B?@/\
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MY')-_P *Z^#'C3POKNIZFMY#+I&K:K!X7\#?VH7\5V>IC[<_X.'?^"06H_\
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MO'2+LMW\3UL[MWE]M;7C?E45I>SO'W8NR=V_C>MI.4I<WYX_\&J/_!'#XE_
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MVNMOFV<UQ 5D/\A__!QK^UM\7OV_?B%\7?\ @E!^Q?K,O_"L_P!E+X(_$_\
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MV:?V:/V?_P!G@^-?[('C(_ SX-?#KX2_\);_ ,(__:7]@_\ "3?\(#X<\/\
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M+&M0P.&IRJS=;$/#T*<E*M3@NL_X+0_\%O=2^!/B1/\ @FY_P3>T;5/VA_\
M@J-\;Y8? >@:%\/[.U\0Z9^SB?$5E)--XF\5W$A?2)_B=::&;C7- \)ZC+#H
M7@+2(;CXJ?&#4="\(:+I.@>/_K'_ ((7?\$FA_P2P_9AU_3?B/XGC^)'[6?[
M1?B*R^*G[4/Q):=M4-QXM:SF.E_#[1_$5VAUGQ'X<\"SZMXAN?\ A(M;N+C4
M/%'C'Q/XS\5[=.L=<L=$TK^?[_@C=^V[_P &V?\ P2L^'ESXNO/VZH_C!^VI
M\5]"MV_:#_:2\1?LT?MEZOK-_J.I7*:]K_@;X;7.K?L]'4/#GP['B)A>:I<D
M0^)OB9JVFZ5XF\?75U)I/A30O"7]1_[$G_!7W_@G=_P49\;^,/AS^QI^T&_Q
MC\9> ?"L?C;Q;I(^$7QU^'T>D>&9M7LM"BU%M5^*?PR\$:->/+JNH6MM'I^G
MZA=ZFZO)<K9FUMKF>'CPV$J8+Z[AJ$HYEFV,PCHYMC\'3E5P\<#@9+,\3@,J
MBE*<<JP]?"1QN+QT[U,8L#1Q$I4,+1E&KT5\;'&0P=6O#^S<IPE>-3+<%C%2
MI8RMF&.]G@J>89K-U*BCCZRJ0P.7970K.A@U7G>-?,,7+ZO][?$7XB^ _A%X
M$\6?$_XH^,/#OP_^'?@30M0\3^,O&OB[5K/0O#7AGP_I4#7.H:MK.K:A+!:6
M5G:PH6>6:5<MMC0-(Z(W\._QX^*/Q^_X.LOVJ-*_9K_9>7XA_!;_ ((U?LV^
M/;'4?CK^T+J>ER^'=:^/WC72XVN[>/0-&U>!-^KS:=<+'\+OA_JEM?S>!=+U
MF#XS_&71['7M4\#_  ST7X3_ ."H/_!5/X"?\%2_^"GNM?L@?M??M8^(/V/?
M^"2G[*_C[Q3IGB+_ (0[P=\3?&7BW]I'X@_##6QX;U2^;3_A=X(^(]RNI>)O
M$:ZM#\.-7\4Z(GA'P'\.M,OO%)M)OB'K4.A:E_2)^SY_P<$_\&X'[*OP;\!?
ML_\ [/?[47A[X6?"'X9Z)#H'@[P7X:_9=_;'BLK"U622XO+Z^N[GX!7.IZ]X
MAUS49[O6_%'BG7K[4_$GBKQ%J&I^(O$>JZIK>I7U_<>9EGL,;1P.>XQ83%8.
MK4I8_(,IYJ6,IXB&'K2G@\]SV'[RC"G4KTZ6)R?(:L'B%3I4\TS1495\OP]+
MT\PEB<OKXS)L&JE'&1I2P6<9M*"C'"2K7CC,JR1N7-7Q-.BOJN8YLZ7U%O%5
M\)EU3%0P^)JXG^B3PCX5^'GP,^%WAOP5X6L-!^'OPI^$/@32?#6@:;&]OI'A
MGP5X \!Z!!INFV@FG>*UT[1?#WA_2X8VFGD2&ULK0RS2*B,]?YY/_!.;_@KM
M_P $[-1_X+2?\% ?^"IG[>/[1?\ PJJ75$N/A%^QMX9/P[^._P 2X)?AG/<C
MPH?%L:?#?X4>,H]!N+/X<^!O#=HEGJU]H1GU#XD>,IH]#NW"WEC_ $(_\%T/
M^"L?PB\.?\$//%_[1G[+GQ%MO%5C^W#I@^ ?[/?BJXT;QSX+U36],\?7.OZ#
M\2?%&D>&O$ND^$O'&E7?AWP!X<\?2Z1?ZQI6DVUKKQ\.WLRWUG?V%EJ_HO\
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MK2?!W[,G[,/_  M7PYI^F6]QJLWPWO/'>K:IK.H6EA/X(\)ZUXXM= C3@/\
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M/\)4VIXRI'C#B/%1QV)KQ>(S7-,;D.!_M>MC^2C)8.2I2EF'UFC1<,5B*O\
M9]&C0HQCR?5G_!X/^VU9_!7]A?P!^QYX>\3:=H_CG]L?Q_8V_BHF_P!12_T#
MX(?#'4M*\1>*-9O+'1K2]U Z5K?C"3P=H$D;PL=8TE/%-GIUEJLUG>0VR_#C
M_@L?_P &Y'@;_@G)H/\ P3=N/VVEU?X1VG[,ES^SCK\U]^S)^V'=7&N6VN>#
M+KP[XK\67#1?L\Z;_P 3K6]<U+5?%K7-G'I;6^LW?VG3TTUHK=8/E7P)X/\
M"G_!;?\ X.;_ (Z>)OB3X,\#_&?]B;_@F7\/-6^%$/A;Q7IVG>,_AEXU\8Z8
M=;\&VFG>)O"OB:+5=#\52ZU\8=>^)WBRVDM-(C\.7^@_"?PVE]/?B*UFU[^I
MO_AT[_P2R_Z1I_L ?^(;_LZ__.YKP\'@_K/#&(>+C"6$X^G4SRK2C[55GDU&
MECN',BA[:3A6PBKY92Q>92P=.,)T<3FU:M4K2J3AA\%Z.*Q$<-Q!A_J<IPQO
M!U*GEBK<U*5.&<8J6!SW-I*BHRA4J8?$O+\!]8FZE+$4<LH.BI4+5:_\R_\
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M,>+<T5*IR^]B:;AAI2K3K*G".*DJTJM#ZQ!SBU05)23I.G3^W/\ @F!\-/\
M@IC\+/@3XN\/_P#!4_\ :$^#O[2?Q[N_BIK&K^#O'/P4T?2]"\,Z7\*)_"O@
M^TT?PMJ%CH_P,^ 5JVMV/BRQ\9:K-=/X3U2>6RUFQB?7YX[>*PT_WG]N']J'
MPU^Q7^R)^T-^U1XL6*;2O@C\+O$_C6VT^8,5USQ%:6;6OA'PVH26!C+XE\5W
M>BZ#"!/!^]U%"T\*@RI\_P#[$G_!7W_@G=_P49\;^,/AS^QI^T&_QC\9> ?"
ML?C;Q;I(^$7QU^'T>D>&9M7LM"BU%M5^*?PR\$:->/+JNH6MM'I^GZA=ZFZO
M)<K9FUMKF>'\:/\ @\0^+VK>#/\ @E[X,^#V@,\VJ_M(_M._#/P%-IEG?&/4
M]2T?PKIWB3XC/#;Z3%:W-UK%JWB3POX5M[B.%[5;>\NM,+S2O-#97:XE>95<
MOIPPN'GA<9G*RC)LLJX6@L.^?,<=A>&*.9X6-Z4<57H8J53$594YJ>,S##XB
MGSK$SDEAD4<#+'2CB,13Q&&RZ>.Q^94Z^)C=4\'A*N>ULOJU%=X9UL'R4<-&
MHDZ5"OAIV=-QE*Y_P:C?LB^+_!?[)WQ<_P""A?QU%YK?[1/_  45^)^N?$_4
M_%^OG[5XBO\ X9:9K^NS:/J$]V^I7\D;>/?'6L>./'-\[6^FW>K6-[X8FOX[
MR'3])GC_ &?_ ."I_P#P42^&G_!,']C/XG?M1>/FT_5=?TJT_P"$8^#WP_N[
MU;6Z^)_Q?UZVND\&^$+95FBO'TY9H+CQ!XNN[#S+K2/!>B>(=8ABEELHX9?I
M7]E#X(Z'^S7^S%^S[^S]X;TRRT?1_@S\&_AS\-[:PT_S6MDE\)>$]*T:^N!-
M.D=S=3WU_:W5_>7UV@O;^\N9[V]S=3S,?D'_ (*D_P#!)O\ 9S_X*W_"OX<?
M"+]I#QG\;?!7ASX7_$";XC^'[[X(^*?!WAG6+O6Y_#FJ>&9+36O^$Y^'WQ'T
M6]TT6.JSS1>3HMIJEM=1I]FU2*TGO[2\]#BB$I3K9=D4J5#!8">!R/+'1DJ<
M,/D.7U\/E\J^%Y5*C3Q;RNE6QM-TJ4<-/,JCJPP\*53V2\_AFLIT\/FN<QJ5
ML9F2Q&?9G#%4FIXC-\=1J8]83%PIU/:K"QQDJ&6NG]8G7P^64J>'CBY2H0K'
MY\?\$!/^"?\ \5OAOX%^*O\ P4Z_;<N;KQ9_P4'_ ."B4,/Q&\9:EXBT[R-6
M^#_P7UM+/6_ OPHTRTNPVH>&7U2PMO#NM>)O"L,NG67AG1]"^&WPU&B:=+\,
MGGOOAC_@S"E63]DC]N0"6:9_^&T+Z5I)I@7D27X9^#]DKVOVR<PS2%)#+,8$
M$Y"QB\O3;,EGU<W_  96_P#!+**&67_A?O[?P\N.23+?%/\ 9UVC8I;+?\8K
M#CCGD<=Q7X\?\&L?_!'G]F7]K6\\2_MQ?$/QS\<M'^*O[%_[9OAV'X5Z!X/U
MSP!9?#WQ!%X%T?PGX]T=OB%H7B?X2^*]3U22YU:[>#4!X8\<Z%<"P")%!H]R
MEGJU_P!&7SP-7.,?AJ$5EN68?A;*LHI8*A%U:60<.X;B/+(8:M1I4U1CC:M.
M<%&O3C#"5,QQ57$9A6K2Q$JES$1QM#('.<EF.-K\783,\1C,14I4*^;9Y/AC
MC50HU%9^PIXBC5Q+CBX0Q#R[#X+"X"%*6'K<U/\ :7_@Y _:5M?CW\4?V<O^
M"*'P5_9#^#/[6_[4O[4\$'Q%LM5^-UQXFT_P[^SKH"2^)K31?B%X0U[P#XE\
M&>-/#7CJSL/"'CGQ9XA\1V/C#3]-T3X;^%M0T3Q-X-^*/AOXC7OA=/B/XR_\
M&M'_  4M/[+'AWP-;_\ !6GQE^V!IWPPT?X;ZKH/[ /QSO/VA_"/[)GBA?AT
M-)D7X3:/XGT[]IK59?#WA_2M)LKWPS\/-1TCX<_#B=D72K:'7/@_#=R>(O#7
MO/\ P7<T?XX?\$V_^"LO['/_  70\&?"SQ=\9OV<O!'@"T^!/[3>D^%+,7<W
M@+3+JX\7>$H-3U74]3;6;+PO:^-=&^*$-GX-U633_#7A<?$+PIIGAO5/$&FZ
M[X_T^ZU'[7^)W_!VW_P1U\(_ S5/B9\/OBO\1OBQ\4T\,:?JFA?LY:9\%OBO
MX1\>7GB358[94\+:YXV\7^#=,^#FC#P_=71/B[6]-^(?B2QM]/T_5+GP<GCB
M]72=+UCP,,L-'(<9BU4OF<^(<RJYM3A2>+QE&ME&/J+AYQR.M1JX:O2GD<<M
MK4L6\#5Q&(E*4E6A1>$Q&)]+%SQ4LYPF$C3C#+(9%@(Y;.,_987%5<?0C//I
M8G-?:4JF&Q-+,9U<-+!K%T*-+#QC43JU)5J. ^@?^#>+_@H#\-/VU/V(U^'/
MAG]G[P;^R9\2/V.?$$7P"^*O[.GP_M+_ $WP3X2U33K(7EKXI\':3K,U[XCT
MK0_&.JCQ*VH:7XMU?Q%XRT_QGI'BR'Q/XH\67SKXLU[^5G]DCX2_\%=/BS_P
M65_X+?6?_!)?]J7X&?LS^(](_:F^)-W\:]6^.'A_0-;T[Q=HMW\=_BS'X.L/
M#UKK/[/G[1)AN=*U./Q)/<W%KIWAS?:W5O\ :;Z[:2&T@_?+_@UV_8^_:)^&
M'PN_;(_;M_:C\!W?PC^)_P#P4;^.S?%O3OA5J/AS5?"FI:%X(TC6_'_B2Q\1
MW/AW6KQM5\/:9XK\5_%#QB_@_0=3TNQU)?!FE:'XD>_UK2O%.BO8_D%_P38_
MX*7?L3_\$X/^"TG_  7?\1_MH?&H?!;1OBG^TYX[T/P+/'\./C%\0X_$.J^%
MOC[\8KS7D-M\*_!WCR72GLK?5;"<RZ[8VL4[7[Q:5>1K#>6LON8N-9\999/-
M:OU?,JO!&>8C/?98BM3C#B;$Y+P]B,VPE2=;$.M[:IGD\5A,1AIJ7[Z>(P3C
M2BUAY\6&G27!>=PRJA'$Y;0X\X:PN2<^%Y)3X=P^8<1X;!8JG1C#V#H8?+(0
MKX;&1A3^L8>AA<RHTZ"JRA3_ $B_X8V_X/)/^DL7[ '_ (;GP-_]+3K]V_\
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MY0H3A7G&DY.-&<:C2A)2?T%1112*"BBB@ HHHH **** "BBB@ HHHH ****
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J2E*=*G]BG*<80G*G'X82G"G"$G%)RC"$6VHI(HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image00007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M\1R^*+FW_MTZC)>I##LCLY/(1/L#[WS(?WB?)G>B 'T*VHPJ^UI8]^5^7/\
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M=/NKVUOK*\MI-0=YXXY+>,H\<D._]X!T#T ?3E%?E)\&_P#@N9\3M+_X)\?
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M+6&;]MGQ%,[*;F+P1IB1J7;[CW^H[_D_X E>M4 %%%% !1110 4444 %%%%
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MIO7M_BUJD,EW-_STD*^%_G?_ &CS0!\Z_M=?!'5O!?QDC_9OA\8>*/'7@O\
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MZS/F[T]IS.D,]M>Z?=6TVR1G="Z?(9'KVS3I?VB[6PABDM?@[=-&FUIIM0U
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ME\<:QX3T3POJ_P#:UU86FG6UU_:%PFQ[2=/.#I'/;3)O1Y(YHP7=O+\Q()H
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MSY_N4 >R45XU_P -Y?!__HH7A_&[/^L?^_L_S_WUTJ'_ (>*_!;_ *'[2O\
MOS/_ /$4 >UT5XI_P\5^"W_0_:5_WYG_ /B*]1\$>.-+^(_@_3==T2]M]2T?
M5H$NK.[A.8YX7&4=: -JO/OVE'\OX=Z;C=_R-7AW^'=_S&K&O0:\]_:,TY=5
M\ :?'Y7F;?%'A^;9_N:U9/N_#9F@#T*BBB@ HHHH \]_9,_Y-9^&W_8JZ9_Z
M21UY_JO_  44^'>A:W<6UT?$MO:6/C=/A[J.J2Z--'8Z9J\BVIACFD<?)'))
M>01I)C87?^Y^\KT#]DS_ )-9^&W_ &*NF?\ I)'7Q_X1^%VN?M>)^TI\-]/N
M/"$7AVX^,D$^KWYU=Y-4L$M4T>Z>-;,0E-[FV=$D>=,?W/DY /<O^'GGPI6/
MQI<37FO6>E_#_4]3T+7-1N-)GCM;+4K*YT^U^Q;^]S/)J5KY$?WY]YV=*33_
M /@II\/M2U5/#Z6?B1?'4GBS_A#QX4V6LFI_VA_9_P#:FS?'.]KL^P_OM_GX
M_P"6?^N_=UYI\2?^";GC/XD?LU?$WPBWB#PSH/B36?BJ_P 4?"5\D3ZK:)/#
MJ,.HVT%]"\*?(9(0C[-XP^?GP4?>\8_L>^.?C!X:L[/QIX)^!=]I<MZET^BZ
M9+=:=_8L\".8-3L-2CM?/2^WR8W^6FQ(_D.7>@#I_BE_P4V^&WP4\+6.N:Q'
MKT>FR>&;'QEJ,RPPQRZ)I-X)S%//#),DDAQ:W)>*U2>1?(=BF.:L^-/^"E/@
M/P/XS\5:?=:5XXFT_P #ZKI6E:YK4.D,^E6+ZFEJ;6;SMX\Z'_2X=[0(^S+N
M1L1WKR_PW^PK\8OAIXHT'7(=;^%?Q$UK6/ .@^%_&6H^,M-GGNH]6TR)XWU2
MS=$_?I/Y\SO!/LR\:8F3>^)OBO\ L ?$?Q=X ^.&AV>K>%;Y_B1JGAJZT>YO
M[V>&2VATN'3D?[5Y=M_K))+)W_=_\]_]B@#V7Q1^W!X5\.?$6;0VT[Q1=V-E
MXGT_P=?>(+:T1]*L=9O5A,%D_P"\$SY^TVT;21PO$CW"(\B.DFS+\!?\%'_A
MO\2?CY8?#ZQO+B+5M<O-2T[1KF2>V,&K76GI(US&B1S/.G[N.:1#-"B2) [H
M7 %9/PR_9L^+'P;^-'C(:'XH\(P_#?QQXKA\9S)<V]U<:UH\S^2^HZ?#\_D/
M!.\/R2'8\?VN;Y'V)63^SC^S/XZ_9"CTO0[S6OA_)\,_!.IZG?:;+::3-_PD
M%_93FZ>#3Y!G8)(/.B_?Q[WG^SHGEIO=Z /5_CE^U=IOP6\:Z?X7M?#?BWQM
MXLO]/N=:71?#D,$]W#80.BO<OY\T*!-[JBIO\R1SL1'.<?)'Q3_:AC^+/QA_
M9K\)^'_%?C3QIX+_ &@M,\0>(_\ A+=(U&UT>XCT^ST])(4M=CP?97A>_CDD
MDV)=?N-A=T\R"OH_Q5\"_'=G^U!I?Q>\*GPS)JNI^&/^$3\2>']7O9[>%K5+
MN2ZLIX+F-)MDT#S7*.@AV3B<9=/)3/E/PW_X)E:K\&/'_P"RO+H^HZ#K6G_L
M\Z%K&DZB]X7M+C5?[7ACCNI(88T=(41X Z1G?O#[-\>S>X!]$_LJ7NN?\*>L
M=#\23^+-6\0>#?\ BG=3US7M.2QG\37-K'&DFHPQI\A@GDWNCC%>HUR/PQL/
M%M@FN?\ "5WFBWGF:S<R:2-/B>/R--)'D1S%_O3CG>PXYKKJ "BBB@ HHHH
M**YOXGC5!\.]<_L.Y&GZP;";[%<;(V$$VP['_>?)\AY^?Y?7BN=T3]GOPO%8
M1->-JGB2Z:*-&OM8U.:^GGV;#N^=MB9D17*1HD>_G8* /1J*X7_A0OA4NC0Z
M7)9SQR_:%EL[R:UD1\.@;?&Z/G8[)U^Y\O3BN;^'M[K'PM^,\W@O4O$&I>)=
M.US2[KQ!I-QJFQ]0L!!/!#/:L\:(DD*?:;;RW?\ >?ZS>\WWT /7J*** "BB
MB@ HHHH **\Q\&?'-?&7[17C7P#;Z1=0KX'L-,O;C4GG01SR7OGLL:1?ZS")
M!G?]PF38,E'QZ=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!XG:_\I%M0_[)S:_^G.>J_P"UYX?^"O@WPY_PG?Q8\%>%?$$D%Q9:-937
MGAB'6-1OKFZN5@M;*V3R7FDDDGF1$1,\OG^\:T(=':/]N^;4-OR3^ X8-Y;^
MYJ$C_<[??Z]_^ UA_MM_"'PC^UWH"_ OQ)=Z[IFH>,-)NO$VD:QI-U]FO-#N
M-(N].\F]A</O$\-U>6LB<%#L</V#@'GZZ-^SGI"^+K?7_P!GOP_X7U;P'X:?
MQ7K6G7?P_P!/N[BWTW]]LDB>S2>"Y>3[-/LA@D>3]U\Z(2@?C_B%HOPO^,VK
M:IX+_9]^ OPB\8>*M/S::KXGU;PA9V_AGP;.Z'BY?R1)>749^_96N71X]D[V
MV<UX[\;OVD_&GQU_81U;POJE]<>$/C=#\6;+X)ZGXWT>_;0X-<ATRZ%WJ&KH
MZ.C_ &+^RVU-WAR_D2?:MG^K\RMCQ-XY\;?'CXH?%[X<_ :P\2:-8>&]%TF'
MX8WWAG4?^$<\,^%K.>%$34)+9'C2ZWW37[^3/"Z/:6EC-:QSQW+R4 >M>$?V
M!/A3^SY=_P!@P^"?!7Q6^.'B)&U4W>J^%[*.PT=7S#]J%M''Y.F67#HD:?OY
MQ&Z;YW21T]T\'_L)_"CP_HD,=]\.? 6M:E(F+S4KOPQI_GWCNFUW(2$(F=S#
M8@V!3CH:^+_VCW\5> OBY^TMJ7A[Q=X]_P"$3^&/PSLM%N;F+Q5=6^K:]XLO
M=]U#"B1[($G>W.C0_:ALFA1]B?Z]Y(^@N_VH=6^"7PC\7:Q\7/'VJW/A?]E/
MPEIGA_5?[-U:;3]2^)OB_P#L*UU.YNGFA<3O!Y$T'DQ_<=[J[FFWI#&8P#ZP
M\6?LO? /PH]FVN?#3X2V7]N7\&GVGVGPU8+]LNGSY,*_N_F?[V/QK4_X83^"
M/_1'?A5_X2>G_P#QFOCK]F[X=>(O'W[1'[/O@;QYXI\3ZUX^^#OPL;QMXKUF
MZUZZD=/$VLN\-J$A+B/S(TAUP#>A_P!&(A\OR)"E87[-OQI\0?&NV^!/A?1?
MB%XK9?B%\1M9^+&KW']NW4EQI?A.VDFO=.TMYG?YTG2YT5YX=^SR+I_D\N>#
M> ?<7_#"?P1_Z([\*O\ PD]/_P#C-'_#"?P1_P"B._"K_P )/3__ (S7P7\!
M_$7C_P  _P#!.[Q!^U'K7B[QU(_]N^*?'7@+P]KWBF^OK 6&K.]CHO\ :32.
M=^GP6KVTZ)\Z1I(\_P!]_P!W]7?L=_"OQ!X-^-?B2[UGXC?\) VE>'=.T.;0
M(?%5UKWF7'G74SZU>-,L:075UG9Y$$")&D'WW3RT@ /1O^&$_@C_ -$=^%7_
M (2>G_\ QFN%_:%^"'[-_P"S#\(]6\:>*OA-\,(M+TTQQI%#X1T]Y[ZYFD2&
M"UAC\O\ >33S.D:)W=Q7&_%/XZ0>+_VL?BY'X^UP^#_@E^SCX8T_5]4*WDUJ
M^MZA>P3W,EU<O"_F/:VMK"B1P;#YD\\C_.\$&SPW1_@OJ7[7WAW]B?P)\7)/
M&-UXHM8+_P")>NVL_B'4+>ZCTS3X'CT[[9Y<R?Z<EWJ>DOYS_O\ S+2?Y_\
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M=[5\??0N/D?W%>1ZW\/?AI\>_A/X7\4:9<:%:?#VQU+_ (39I;>SAM+._?\
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M9_PRM\-?,W;O^$8T[_OC[,FW]*]*H ***Q?%OB2/PCX6O-2N%,BVL3R%,/\
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M7[/-?I/&9O,>*?[;/YR._P#?23>GX5V'Q-^)MO\ #32T(CDU36[Y772M'MY
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M10 5R/QC_P"11L_^P[I'_ITM:ZZN1^,?_(HV?_8=TC_TZ6M '74444 %%%%
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MMRP_97U[2?#L.DVOQF^)-OI=O;"TALH=)\,+!'"J[!&B?V3L";?X,8Q7M5%
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M.EO^TW\"?#?Q"L=+U71]*\86W]I:7;ZE'Y=S+9.[_99W3^#SH/+FV?P"3!H
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MM,B0P?O/D?8F^O7_ !-\4-*\$_#F;Q-KL_\ 8FG6UG]LG^WNL+V_R;]CC/\
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M?^#'F3(/WG&]X\?/LJ;]I#7=4?P%)X9\/F<>)/&1_LFTFA;RY-,ADVQSW_\
MV[I)O]W\M.] '$^"OVNM0\4>+M*U2+P])'\.?$WB6Y\+:;J\QDCGEN(XW\N]
MV\I]BN)X)8(7^7>[P-TF%>^7MW#IUL\TTD<,,";G=FV*BUY+K7[(OAVZ^ MU
MX$TF\UC0;"328-+LI[:5)I-*>&,)!<PPR(\$<\;HDF](Q\Z;ZX3XQ_&'Q/\
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M 4444 %%%1LY Y'&['3/% $E%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'E'BM_\ C-?X?K\NV3P1XG;[OI?>'J]7KROQ5N_X;-\
M?N?E_P"$+\3;I<?<_P!.T#"?C_[)7JE !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7E_[6]@
MU_\ LY>*$*J_^BQR$.^S.R9'_OIZ>O\ P!_]6?4*\[_:AMKB[_9_\6+:R&.;
M^SG9BTCI\BD,X^3OLW=?D_O_ "9H ]$HHHH **** .2^#(SX2O/^P[J__ISN
MJZO9]?SKE?@Q_P BG>_]AS6/_3G=5UE #6B5NWK^M.HHH :(U7^$4[&#110
M4444 %%%% #1&H/W1W[>O6G444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!'!;BW^ZS$8Q@G/K^/?_)S4E%(1D@\\?K0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZVZ^:RN^WYG5=N:L4 %%%% !1110 456DB:2=7\V1(X_O+\NU_ZU9H ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
2HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image00008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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MDZ?QBOC7_A+?&7Q"^('['^M7FJZ;JOB?7-;\1S?;+FU\N.-$@=/G1/\ <K]
M/A1\$O#OP:CU;^Q89XYM<NOMVH7-S<O/<7DW]]W>N#T#]@GX>^%_$'A74K6#
M7/M/@NZNK[10^IS.FGO=?ZX)S]P_W*@1Y7#^W!X]\7?#3P3;Z#X=CU7QMXDL
M[V[NOL4&^"V2UFDC3Y'?_EHZ5]$?L]>-?$WQ ^$FBZEXRT%?#/BBX@WZAIJ/
MYD=I-W&^N)U#]@OP'?>&-!TRV?Q'IK^%YYI],O[#5I(;^U\Y]\B";KY;G'R5
MZUX)\%6?P_\ "]KI6G^>;:S38GG2EY'_ -YJ#0?X9^_?_P#7Z]:]9'AB+RC?
M?]?LE:] !1110 4444 %%9?B?Q7IO@S2)M0U2^M-/L[=-\DUQ+Y:(OK7CT_[
M6>J_%,M:_"OP?>^*DD'_ "'K_?IN@Q_]MG3S)O\ MA&] 'N,DRP_>9$KQ3XP
M?MY> _A5XBAT&WFU7QIXJN/N:#X8L7U6_P#^!HGR1_\ ;1TK#\-_L@^(/B='
M]M^,7CG5O%5S(_F)HNBSSZ-HEG_L;(72>?\ [;O_ , KVGP#\,?#GPLT---\
M-:%I6@:?']R"PM4@C_)* /+[?XP?&;QW KZ#\*-+\,V[#._QAXC2"?\ [\V4
M=U_X^Z5F_!']I;QGK'[3FM_"WQMI/AK^TM,T6/7H-1\/SS26_DO)Y8AF29=Z
M/WKTCXY?''1_@3X374M4<W%Q>2?9M.L(1ONM4N?X((4[N:Q/V:_A)<^";'5/
M$GB"(?\ ";>-+C[;J[^9O^S_ //&U3_8C3]=] 'J]%%% !1110 5%/+Y4>YJ
M\^^-_P"T[X/_ &?=.AD\0:D?MEZ_EV6FV:?:K^_?^Y# GSN:\EL_!?Q&_;(U
MN2\\5S:W\._ALT&RUT&VG^SZOJI_OWCI]Q/]A* +GC7]MUOB)XUU3P)\']-/
MBSQ=I[^1=:DYV:3H_P#MO-_RT_W$KI/@-^RI/X-\8R>,/&6O7'B[QE<1[%G?
MY+73_P"^D$?\%>D?#/X2^'_A!X7M](\.Z7:Z786Z;$CACV;_ />KJ* "BBB@
M HHHH **** "BBB@ INRG44 -V4;*=10 W961X[_ '7A.\_W*V:Q?'?_ "*]
MU0!M44V/[@HH 'Z5E6'_ "-&H_[D-:K]*RM*_P"1CU/ZP_\ H% 'SM^T-XKT
MB#]KW1='^(L=]'X#D\-FZT1S#,]A<ZM]JD2Z2?R_^6B0?9C!O_YZ3[*^<OA/
MXCL/^&=_@?X2\1:WKGA'P?J'A?4T^WOIT_\ R$TG@V)-O3Y'2-W='_ZZ5^D-
M_I5OJ@3[1#'-Y;[TWITJ&Y\/:?=6<<,EK!)#']Q'3>@H ^ =<UVUU74U\$^)
MOB]XJTJPL_"%FOA?Q-JEB\=_JLF^=)+U/D_X^O,1/DV?<V?)\]5OVA_B-IOQ
M ^&'QOL_%7B/6/\ A+/#\UE9:1IMR[VGF:?LM9$NH8?X_/\ G=_^^/X*_0'4
M_#&EZR\/VJPL[K[/_J/.A1_+_P!RF:AX(T76;[[5=:5IMU=;-GG36R2/0!)X
M0NX;_P ,Z?-;R>9#) FQ_P#@%?'?QO\ BMJGB3X__';0M8\3ZOX5N? _ABVU
M#P/%!)Y-O<[[)YGO4_Y[R?:@\&S^Y'_MU]D0ZA8VM\--CFM4N+>%9/LZ.-\:
M= VS^[\M5M;\):3K]];S:AIVG7LEO_J7N($D=/\ <H ^7?".EKX\_;?\ ZEK
MLUU:>(KCX:IJ-S;)=;/+G^U0;TV5]=>7\E9@\(:7)K:ZF;"Q;4HD\M+G[.GG
MQI_<WU?NKN'3;=IIY8X88_ON[[$2@#X)_P""AIL=!_X*:_L1Z;:):VMII^K^
M(\PHFR.W3^SDV?[E<3_P79M+?1?BQ^R99:6MM8W%_P#%>UN1M3]WYWG0?.Z5
M^B6K_#?P_P"*=6AU#4M#T?4-0MA^YNKFRCFFB_W'=<U'XE^%/AGQU?VMUKGA
MW1-7N+'_ (]);VRCN)+;_<WI\GX5=S/D/RO_ &:?$:^*/BI^V[K7Q(A?P_\
M'C_A&[W3K[1X?DTR32X-.=+6>V_O_P"V_P#\74G[#?@/1_BU_P $:_V7_!_B
M.SM;[1_%'C5].U2SF_U=PFS5'_\ 1B)7ZBZY\'O">O:J]_J/AOP_?7TL'V9[
MJYTV"2=X?^>9=T^Y_L=*KQ? GP3;VEE"OA'PK'#I=U]MLHETJ#9:3_\ /9/D
M^23_ &Q3YP]F? 7_  3V?XD?LR_\% 9/V;_&UG?:MX0\$:#JVK^!O%5S)\]Y
MI+SV*1VO^V\'W/\ 8KH?^"(NB:7XI7]I*ZNK&WFCMOC;K5S:B5-_D.B1IO\
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MLX+34KCXA7L$Z[_,DMT1(_W&_P#N)7W=^T_86VJ?L[^.(;R&.>'^P;URC_\
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MA^]1XGTN#5;9+>,/_<?9YP3K\GF;,?P;.*N7]PFE[OQ'JV@?\@.R_P"N*?\
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M\*62?^TZ]RHH \C^&W["OP;^#'C6W\2>$?A?X&\-Z]9HZ0W^G:/!:SQA_O\
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M_P# \G^YKUK_ /%U,/VD?A[+]WQSX._\'5K_ /%UT$?AJPOH(7FTVTW??V/
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M7C7.CZ=</J&S[5YENC^?L^YO]<43^ -$N5O$?2=/?^T$\FZ_<I_I";-FQO\
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M_>_S['_VWKYZTV?]H#XD^,[G5O#OP-@TG1[A(?[+MO%6J0VD>C;/]3_HR?\
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MI]UXFUB/YA?Z]>OJ-QGZR4&9XQ\:-?\ &7[5OQ1T2^^&_A^R\0>$?"4-UO\
M^$DWVNF:AJ#^7Y%S!_'-Y<?G??\ D_>5T/PX_8T\?>)?%:^)_B5X_DO-8&?L
ML.CIY$>EHZ;"D/\ SS_WTKZ@@M8[.%8XU2../[BJO2IJ .!\%?LW^$? ]ZMY
M#I2WVI?\_E^_VNX_[[>N\V4ZB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHIK]* ,WPI_R+]GM_N5J5F^%?^1?L]O_ #P2M*@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB;[?;)LC\L[/[CR/LV??K,#V+_A%/BH/N^)O#+_[^GO3SX?^*P'R^(O"K?\
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M]T+48_LNIVZ/]Q_(?G8?[WM0!Z1IUL++3X81OQ&FW+??JU110 4444 %%%%
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M21//3?\ <1T3?_P.KGP=^+]C\9O!>F:W;V]QIK:DDTB6-X EPB)(4W.GY?\
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MAAH-UXV\1^)K&XT^WTR;4-7T2:%$@T_8GF?Z-,B;W_N?O* /._BGXZA^./\
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M_P#X6MXN\[^__9>D?_(59/BO]F76/'E@MMK?Q"US6+:/YTAO-$TB2/\ ]):
M.\\)?$S0/'=[?0Z'JEKJDFGOY=R]LWF1QO\ W-_W-]?(_C7QE\1OVSOBIK7@
M^'P?J6E>"='O7M'_ +5ADAL-4V?\MYON23)_<A3Y/[]?0_AW]G_Q#X-TO['I
M?Q"U6QM8_N0PZ)ID:?\ HBKO_"J_&T/W?B7J7_ ]'LO_ (B@#A_VCO .H^%_
MV6KRS^TWFH+;R6?VJ&RM=D:6T;Q[TAA3^"O'/VHOC!JW[6/CGP%\*_".EWNG
M>&?$&H?:KW6-1L7@CN(;+]X42%_GV9V?? KZ9G^&WC__ **1/M_[ MK_ /$5
M\^_ ;P5\0?CM^TSXQ\>W/BZW&C>%]_A3PW=?V7 _G['_ -*GV?[;_)0!RO[/
M?@#P_+X)U/3_ !]XR^(\'B34-7N9]7T6V^U6MO+/Y_\ !L38Z/'L_CIGQA_9
M-\9?%CXCZEK&A>'];\/^&/AWI]K!X0L+;4?LDFH2??F=$_U:2?[<E?67_"!_
M$+^'QM8O_OZ0E/\ ^$3^(D<?R>+=*_X'I= <YP_P:T&Q\.? C6/$VB^']<T?
MQ;_9$D-U_;?SZE+-!"^Q'?\ C^>OF7X;_%#4K_3_ (4>#-#T&[@\,:QXEM9_
M%'B&Y1X)-4U!]\\\"?\ ;3[[U]F2>#OB4?\ F:/#\G^_I=<_XS^"OCCQ_#8I
MJFJ^%;K^R[U-1M#]B='@G3[CT 2:;I<VN?MKW]_=?\>^B>&D@T_Y/^>TV]W_
M /9*YW6O"\?[17[9=Y'JSS3>'OA1#;36UIG_ $>?4YT\SS'_ .N:5W7_  CO
MQ1$F_P#MCPD[_P#7K)7DMY^QM\5-:^*VN:FOQ4C\,^'O%#I/J=GHFG_Z7),D
M>SY)W^Y0!W_QX^*DZ:ZOAGP+#:ZEX]U1?LK7*C>FAVN?GGG?^X.R?WZX7_@E
MOX+3P?X ^(HFN)[[5)/'&H)>W4W_ !\3NFS[]>Y_"CX*^'_@MX<.GZ#9+!YG
MSW-RW[RXO7_OS/\ ?=Z\YU#]GKQ1\/OC3K'C+X>Z]IMK;^)BD^M:!JL#_9+N
M=.!.DR?/&Y_C^1Z />**R] FU";2XVU2WM;>^V9E2VG>:)3_ ++NB?RK4H *
M*** "BBB@ HHHH **** "BBB@ HHHH *IZM_R#IO^N;U<JGJW_(.F_ZYO0!3
M@N9K+PO"UO#]JFCM4\N+?L\SY*\>_9I^"^M:1\2_B=XL\8:/#::IXRU>":UQ
M/'/Y=E!!L@3Y/XT=YO\ OY7MVC?\@NV_ZXI_*K= '@^H_ K6O'?[;UGXTUNV
MM8_"O@O07LO#W[[?)/>W3_OYI$_V(TV)_P!=*YCX@?"'Q]J?C3XS:YI>DVOV
MS7M"M?#WAAFOD^YB3SG/]SYY/_'*^GZ* /@W4/V(O''PT\>6?_"*Z/)J.B?"
M_P"&S^&O!J3:A"G]IZG=)LNKI][[]_EIL_>?\]*^G/V8_AHWP%_9H\+^$;;2
MX[2X\-Z1':FV21&,\J)\[N_W-\CY=_\ ?KU:B@#X?\/_ +)'C;PEX0\&Z:=!
MFU#5/$GC*;QMXNOWOH/+T^:"9[JRMOO[W3S$A3]WO_CK#?\ 9@\;?$#X'^"_
M >M?"VZ@L]4\:IXA\?7%YJ&GO_:;I=/=;TV3R/)#YB0P_/\ /Y>S]W7WY16G
MM".0^&?B5^R=X[^)$WBN*Z\/723?%_QQ;)K=X-0A*>'_  Y9;-G\?[R2?8_^
MK_Y[IO\ N5@2_!;XI7VN^(?%]YX0UZWAUCQ_9(^E:4]E]NM]"TM'&G/"DS^0
M_P#I#O,_F?P25^@M%9EGE_[-WPXA^&?A+5&73]5L]2\0:@^J:C-JETEU?WES
M(B1F2=X_W>_"(FR/Y$2-*^;;3X-^+/&_P+^(/P]NO#VHQ^//B1XBO?\ A(=;
MF@\NTL]/>;RX9TF_Y;>7:)#L2/\ C_N5]Q5SOC[X?6/Q'T-;"^:^6&.>.Z5K
M6Z>UD#QOO3YT^<<^E 'BGP#TB'XG?MC_ !.\>+Y<UAX;M;7P5IS_ '\R)_I5
MZWXR/;?]\5Q'QDUGQ%HW[3/Q#UZ?P+XJ\37WA_PLEKX.AA3S--?>CO=-OW_Z
M]Y$A3[F_9_OU]0^ _A]HWPPT"/2]!L+?3[&W=Y!#"G5W.]W/^T^<UT= 'P#^
MR9^SIJ7P?\<?!709?#.L1Z;\/_!NI^(;V::%/+N-=U!_WZ?^1KI/^VB4>#/
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M:;9'I_A73M\&^;_?WVS_ /?==%\"_C)X^T_3_ACJWBK7M<VR:)JWBC4=-?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KF=7_ .2D:5_UZS_^R5TU<S?_ #_$O3?^O*?_ -DH Z:BBB@"
MGKG_ "![K_KB_P#*JW@V+9X2TQ?^G:/_ -!%6=>_Y E]_P!<7_\ 0#3?#48C
MT*S _P">"?RH N!<#[Q^M+M__72T4 -V#'XYIU%% !1110 4444 %%%% !11
M10 4444 '2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "F3VZW,+1N-RL,$9Q3Z* &I$L:*J_=4
M #GTIU%% ";!Z=\TM%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %<U>1?\7,LW_ZATW_ *&E=+7-
M7/\ R5"V_O\ ]G/_ .AT =+1110!0\12>7X>OV_Z=I#_ ..4_0UVZ5;?]<4_
ME4/B7_D5]2_Z]I/_ $"KED +:, 8&T8'H.U $U%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #=_P ^
M*=110 4444 %<[_S5!?^P=_[/715S,?_ "5&;_L'_P#L] '34444 9?BW_D4
M=2_Z]G_] K0@C\J)5R6VC&3UK.\:_P#(H:M_U[2?^@UH0K@_>SR3TSCV!H E
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *HZ
M[>26>G-)&VU@Z@' /5L&KU9OB;_D#/\ ]=8?_1B4 :*'*BEHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'GPLL=*LYO.G;1TNO/O-G\'[Y_D2O8[;]I[X>RQ_+XPT#]W_ '[M$IUO\2?
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M_OB@#?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LGQ9_R#HO\
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MC_YA>I?^0_\ XN@#4HK)?Q')_P! O4O^^$_^+H_X2B3_ *!NI?\ ?"?_ !=
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M]%&?^ 4W^RK?_GC#_P!\444 1OH5G)]ZU@/_  "FGPW8R?>L[8_\ HHH /\
MA'+'_GSMO^^!4;^$M-E^]8VI_P" 444 #^$M-E^]8VI_X!3?^$1TO_GQM?\
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?DT?1UT=[C]X\SW#^<[/Z[$3_ -D%%% &A1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image00009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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MYF^M/HH **** "BBB@ HHHH **** "BBB@ HHHH **** "N;^*_BA_!/PO\
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MO#:S?;?+B)0##^7GK_L;/0/'?_!.76]>_P""C&E_M):'X^TO2_$>C>#_ /A
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M#1=0\&:]X)3QGXHFETF=YK!;KRTT^VCG$Z1PSR2)>[X629T2Q??Y>^,O]/4
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MAXE\;>.O%>I^.M=Q-):::=3OF3=#"_ENZP1QQ0IOV;G\LOY:%]@POV.OV_\
MQY\6?VR_'GP6^*7P_L/!OB[0]&M?%-E!H.JQZ[::/I\BVL'V74+Q"F+R>Z^U
M3P)Y,9>U3<Z)L_>>W)^U1X1NOVJ7^#=F^H:IXUM=#_X275$L[5Y+71+-W\N$
MW4W^KCDG</Y<.3(XC=]@3YZ /'/^"0'[''Q _P""=W_!-[P?\'_%'_"':UXC
M\%'4/(NM*U6Y^P:A]IU"ZO?F>2U1X=OVC9]Q_N5\[?\ !-K_ ().?'+_ ()\
M_L9VW@6VA^$NH?$33]+\0Z9I?C&V\4:C!_9":N]K,^R'^S-\FR>QM7_UB?<K
M]"?A5\:O"OQJ3Q!)X3UZQ\10>%]8FT'4IK(^;';7L*1O-!O^Z[IYB[_+R ^4
M/SHX&5)^U=\-H?VA%^%I\<:#_P +$:+SAH N0]V1Y'G[-@_Y:>0IFV??\OY\
M;.: / O!'["OC;]E+]N_XN?%KX5_\(IXA\._'4:?>>)?#OB#6KO29-)U.R29
M!>6TZ6UUYD<_G?O(71-GWT<A$CJ+_@IM^Q?\6?\ @HQ_P3J\>?"*>X^'GAO7
M/'&HV7DRI>WLUIH=E;7EK=#=+Y.^]G>2V8_ZNV1!.H^?R?,F^S:* /BC]H+]
MBGXI?&[XQ?LK^,K6W^'FER_ .]FU#5-.&NWSQ7[SV?V1X[:3[%]R-!O1W3+_
M '/W?WZ^UZ^:?VR?VB=8M_BY\//@?\/+TVGQ(^)4S:K>WL:K)_PC'ARRFB?4
M+V9/OJ9]Z64'W#YUV'5QY#U[!\&='T?P)X TOP;IGB&[\1-X-L+72)KC4-4_
MM#4Y/)C\M)+R;[[SOY9+N_WWW^] 'SWJW[$WCBY_X+$Z=^T;"_@RX\+Q_"]/
MAO/IES>SKJ47_$TDU'[;'^X:,L/D39O'&_YZYG_@IG_P3I\?_M??MB?LR_%#
MP?J7@^TM_P!GW6KW6KBQUJ]N;>36WN9+$^2CPP2>2 +,C>=_,GW/DY^@?CA^
MUCX;^"WQ0\">");'5_$7BSQ]?B&QTC1_(DNK>R$B1W.IS)-+'_H5N9HS,R;Y
M-KED1]C[.ILOC9X8U?XTZCX"M=2CNO%&AZ7#K&H6,44DGV.VGE:.!Y7 V([O
M#)L5R'<1N4R$? !\M_MG_P#!.KQI_P %+OAMX]\,_$[5M,\":=J6E:9!X2C\
M+ZU=:M_8NJVUY/=2:I,9K:UW/_Q[0HB)E(_M'S_O!L]T\ 3?&^?2/#MEXML_
MAC:W4%Q#_;.K:9J-[=?;(D^_Y%G);1^2\V"OSW#B/?G]YPE=YKWQ6\+^%?B-
MX?\ ".H:YI=AXF\61WD^C:9+,$N-32U$;W+PI_'Y?G1E\?WQ6J^L6L>M0V'V
MBU6^GBDN(8#)^^=(S&CNJ==J><@..GF)_>H U:^,O&7[ 'C;7O#7[07@FWO?
M#$G@_P#:"\8?\)!>:JUY-;ZEH-M-9:=8W4"6WDO'-)Y>G[XY#/'\]Q\Z?)\_
MU&OQ1\-"WF?_ (2'166'4(=*G=;^+$5Y,Z)';/\ /Q,[O&B(?GRZ#O6;X$^/
MW@_XD?$CQ!X5T'Q'IVL:WX9AAN]2M+8[_LT<T]S!&WF?<?\ ?6=U&=A.R2"1
M'PXQ0!\Q^#M)\%?MB_\ !1B;QCX!\03:QX9\%VTFD_$:UMK::&QG\2Z1>_\
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M0S>=ODS)LG?^"1Z_8"B@#\J?@"O@!O&/[&GB#4D\/ZHVFIXU\%>&+^YD>?\
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MVN-8NK9)=WDOLWGRW2V^?^ QQGLE?H/10!1TS4%O].AN(Q<*LR;U$T3QN/\
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M >!;+X7V/C:X\;>$[?P;JD<,UGKTFKP)IMXDW^K>.Y\SRV5_X,-S7Q'^T!\
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MGAK5+G3[:XO9H[?48Y"UM!($FN$/\<*2.J.Z91'PA.>*^-_CE\*OB7\8+/\
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MP?I>M/IUW>ZM/I]K/:ZQ-;(Z&ZA>^NMO[_S+5+6P=]G[R=* /1OVEO ?P*^
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M[0/AE6FQ=?\ "/:ML3=]]/M.E[_E]OD_[[KN*XG6KOROV@/#,/S;I/#VKO\
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MP_K< NK*^MCF.X0]"*I_'N/S/@;XSC5VC_XD5[\Z_P '[AZ .PHHHH ****
M"BBB@#SG]D>ZCN?V6?AJ\;(Z_P#"+Z8OR_\ 7K'73Z?X%T72]?CU:WTC2X=3
MCM?L*7<5K&DZ6V_?Y._&_P O?\^SIOYKFOV4XEB_9C^'<.^&4V_AC38G:*17
MCW):QY^9>/Z5Z)0!Y#\;/V;8?BGJ7A?4-&U*'P[J7A#7I?$$"2:<EUINH3S0
M36\WVJV^3SLQSR$.'21'YW]:K_LJ?LDZ%^RSH'B"TTRWTIKSQ/XAF\4:B=.T
M>#2]/2^DM8;5WMK:'Y(-Z0(7.6>2229V)\RO9JJWET+.,-M9OG5?E7=]YL4
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M'XB^&\GQ,CT&^\1ZD==FDNH-,@@DC@A@D@MI4F\RXG<C?O\ W,=K,[(Y\M'
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M;6_V:?$>B?M ?!G1?[*F\2:%_P )3KOQ/\;^)XH(;6%M6CMOLNGVPCWY1/\
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MD1D#;OF5F4OT&"[#GK6M10 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 <#XB3/[3/A-]R_+X9UM=I_BS=:17
M?5Y_XEG9?VG/"<*W,<>[PQK;>1Y&YI/]+TCY_,_AV9QL_CWY_@KT"@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KA_VD-+&N_L[^/+/S&A-YX<U"#>O_ "SWVT@S7<5Q/[0R
M*_P#\<*V[8?#]^'VKO\ ^79_X?Z4 =M1110 4444 %%%% 'DW[$8GC_9F\)Q
MW'F(T-H\$<+/O^SQI-(B1YWR8V($39O;9L S7K->4_L1M#)^RWX+DM!,MC)I
MJM:K-]^.'<WEH?G;[JX'7TKU:@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH \U\4V1E_:X\%7&Y]L7A'Q!'MS\K;[W1/_B/U
MKTJO._$^HI#^U1X-M_[/1VF\*Z\_V_\ BM]EUH_[C_MIOW_]L*]$H **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *\]_:GBU*Z_9B^)$6BQM)K$GAC4TT]$ZO/]ED\O_Q_%>A5
MQ?[1%K]L_9_\<PMN99/#U^GR_?YMI* .THHHH **** "BBB@#QG]@&&2T_9)
M\#0236L[0Z;M9K8CR_OMW'#=_G_CZY?[Y]FKRG]B;S/^&:O#GG6\EG-_I.^W
MD^];_P"E3?*?I7JU !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2\'>);?QIX;M=4M?M$,=VAQ'/'Y4\#@['21#]R1'!1T[.AH WJ*** "BBB@
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M_+,[OLW\[,5T'AGP?I7@G25LM)TVRTNSC8MY-M L,8;NV!6O0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 >7^*=/FE_:_\ !-PJQ_9HO"'B*.23*^8CO>Z&4Q['8_\
MWPM>H5Y;XNE7_AL_P"OS;SX+\3;?E_Z?M KU*@ HHHH **** "BBB@ HHHH
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MZOM\OF73]N><_/S]S]W3?^%5?$[_ **PGW?^A7M?_BZM?LM?$V\^,?P$\/\
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MUN_AK45FF;?B-/LKY;Y&1^G]QP??T /1**** "BBB@ HHHH Y'X.?\BC>?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW-A#?+^^AAF_A^=-] %JBBH+>!+6!88E6-(UVHJ_P4 3T45'-$MPC*RJZ/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
5110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #J A4# 2(  A$! Q$!_\0
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M%%% !1110 445_'3_P '(W_!=C]J/]B/XS?"']@;]@%++P[^T?\ $OP_X/\
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MCCOIHH;6.QQXLF65%E?58(KXO<)>R:18_8;2_DU"T@US^[G_ (8Q_8]V[?\
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M:_H&LW6F:9X<@\5Z1XHM-8\9V4M]X<T.;1?U,_X.I/\ @K]^U#\%/BU\&O\
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M_L0ZY^S5^T)XN^%/C3QUJ?QS\<?$VWU;X.ZYXI\0>$H- \3>'_!6DV&G&_\
M&7P\^'&O?VG#=>&[^YNX)=)O+2,7D1M+X[I88_V]KR;X-?'SX%_M&>$Y?'O[
M/?QI^$WQV\#0:M=:#/XS^#7Q&\'_ !/\)PZY816T]]HTOB+P1K.N:/'JUG!>
M6DUUISW@O+>*ZMI)H42>(MZS7?C,1B,36A4Q,>6I'"X##Q2I^S_V?"8'#X7"
M2Y=+N6%HT9.I_P O6_:Z\]S@P.'P^&HSIX67/2EC,PQ$FIQG;$8O'XG%8R-X
MV2<,76KP<'[U-Q]G.\XR84445R'6%%%% !1110 4444 %%%% !1110 4444
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MLA^)/A[P9K-FJ>'O%O@GQ)HTNHV^H_IY_P %D?V]O^"A/_!-3X67/[47P/\
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MLO\ @D[^V1\6_P!J_3/VL;/XQZ;\3?A7X[^%VG_"JP_9Y_X538^#K+QC\1_
MGCZTNK'Q.?C=\1C?6?A^W\$)X?M](_X1S3Q=PWT=\;^U-@+.Z^_O^"HG_!&'
M]BS_ (*U>'/!UK^TGHOC/PU\0_AS#?6/P_\ C7\)->T[PQ\2_#NBZI>6NH:I
MX6N9==T+Q5X3\4>%=0OK.*X.E>*_"VL3Z)+/JMSX/U#PQJ&NZS>WWZQT4\1!
M8K!Y9@<0YU,/DV'AA<L3J5%6PE&GB,5BHQABHR6*E-U\;BY5*U2M.M5AB*U&
MK4G1FZ84:LL/B,7BJ')1JXZI4J8I4J=.G1J.K1IX><%AHP6&IT?8TJ<(T*5*
M%"FH1=.G%I,_@%?_ (,8U+,4_P""H;*A8E%?]B@.RKD[0SC]K6,.P& 6"(&.
M2$4' _I(_P""4_\ P06_8C_X),7&L^-_A##XT^+'Q\\5Z%:Z#XB^.WQ?NM!U
M'Q+IFE26.EKK_AGX:Z)X>T+0]$^'_@W7-;L)M:GLA'X@\97$=U%HWB'Q[XET
MO2]+BM?T8_:9_;/_ &3_ -C3PO#XQ_:G_:&^$OP(T.]2=M'_ .%B^,]'T+6?
M$KVI7[3;>#_"\MRWB?QE?VZN)9].\*Z/K%_% LEQ);+!%+(GXKZU_P '47_!
M+*_UN_\ #GP$B_:Q_:[UJRLK2\ATO]F_]ESX@ZOJ6I-="0M:66F?$\?"S4HK
MBU,;)/+J=GIUA(P/V*]NU5V7IHXFOAH550FZ?M:4Z<YTX*5=TITZE*M3IU5&
M5>$*U&I4HXBG1G%8BC.=*LJE-N)S5L-2Q,Z<JU/VGLYJI"#<E1]I"K3JTZCH
M)JA.="M1IU:%2=.4L+4A[2C*E)-G4_\ !<?_ ((,#_@LYXC_ &<O$/\ PU4?
MV;F^ &B?$W1C:?\ "BXOC /%J_$6^\$7RW'VI?BW\+)]".C'P<T9@D.O17W]
MI"2$:6]M<?VC[;_P4#\??LF?\$WO^"1>A?#C]NOX??$W]JG]F'PO\+/@Y^R/
M\4=,^&/A+1(O$OC/3V\,:;X$T_Q==Z/K/Q4\#)X+M;S4_#]GJ,%_H/Q#36_"
M.OWFC/X8O?MUK8W<'Q_K/_!PO^T)>7]S<_#3_@@?_P %A/%_@V73K'5-!\1>
M)/V<?%W@^_UFTN9T>6<:1I'A7QUI:PG2Y8;_ $QM+\4:W)JLS_9UAMK9?[1/
MIW@?_@M]_P $NOVY9?$O["_[:GP\^)_[)7Q#^*VB6/@SQ/\ LM?\%%/@[>_!
M]/'2>(YIM.DTK3->OKK5/",#Q^(K..T\*W7B;7? ?C&_UY-,O?"6D1Z_I]Q'
MH_F8BCB(9/C<HP"H+#XS'PQV)PF-ISK8;&UXXC%XG%8/$5YQK8C#4\=0S+,L
M+-T>=82GC5B*>#K_ %3#T%W4949YO@LSQJQ/UG!X>>74,7A+T\3@Z;H8-0E1
MA"5&E4KX5Y?EV*C2J3HU:_U2--XJA[>K7/Y"OA3_ ,$8_P#@@1^TK\0-1^(?
MP@_X. / WPV_9XTKQMX<BU7X-?M'^ O!_P #/CY!X;>STG4?$OAG1OB?\>_'
MWP2TGQ#JEU"^J6>D?$KPY^SQXH\&^&KVXM+/4=(\7W>C7R:O\PWGP<_9,\>_
M\'$7[)O[.G_!-2RT+QQ^S7\*OV@_V3? ?ACQ=X8A?Q_8_$M?@E_PA_BGX[?%
MG6]8M]-;3_B"EWJ_A_Q_KNO^-[2$> M?T;27U_1;[3OAVVFSV7]=?Q'_ .#-
M3_@DIXX\;:_XJ\,^,/VR/@[H6L7,$^G?#3X<?&+X>:IX)\*116=M:R66@7_Q
M=^"OQ3^(US;7,\$NHSOXI\?^);Q;R]N4MKNWT]+.PM/U!_X)J?\ !"[_ ()]
M?\$K[V_\7?L[> _%?BWXS:KIFI:#J7Q^^-?B6U\;_%63PUJ5^]\_AW23HVB>
M$? '@[3E4Q6%W/X%\!>&-6\0Z?:V5OXLU/Q UI!*GLY3B:>%S+),QJ1J4<+D
MF)HYQ3RRJJ>(Q&*S+#T:=/#4,1C;U9U*$.?%4JM.O7Q5"-+$5,2I8W&8>B\3
MYN:4JF)P.=8:$,)7QV<83$93_:+I*CA\%@<9BJ>(Q>(PV A3IT8U6\-AI4Z=
M*AAH552^I.G@L-B)5,'E_P#!;+_@D8/^"Q7[/?PL^!/_  T$?V=6^&?QEM?B
MV/%7_"IHOBZ-:6W\$>,/!S>'O[%;XB?#*?3#(?%2ZD-4CU^[B_XEYM)M'N'N
M+>]T_P"M?^";/[&+_P#!/;]B;X$_L=/\37^,7_"D]$\0Z,OQ&D\'_P#" MXD
M37O&OB7Q@L@\(+XH\9QZ(EA_PD7]EQP1^(]2^T1V2WLTINKF?/W)17'0;PU+
M'4*/N4LRQF&Q^-B_?]MB\'A'@</54I\TJ*IX5NFZ5!TZ,V_:U*<ZOOF]:$<1
M5P5>M%3JY?AL1A,'/X71P^+K_6<13M'E53VE=*;E54YQLHPE&"43^7GX'_\
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M\96GTW6?#>L+:>/?#.NP?# 2Z3JNF:99QVCFT&HO\$/_ ,&/7P2/Q=76H_\
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MF:;I^BZ;I^CZ39V^GZ5I-C::9IEA:1K#:V.GV%O':V=G;1+A8K>VMHHX88U
M5(T51P*_S(_V%K9M9_X+)? Q-7N[Z[N+K]M[2=4O+^XU")M0U2\T_P")^M^)
M(=1FOFC:UUB^UGQ!HZ7FH36NGQ6^IVFF^*O$FFR:*WB^U-S_ *=5?T5]("3P
MLN!,FHO_ &'+^&X2PZC?D3G3P>&Y/CDVZ-+!T8TXSYJE*A*G3E4LE1H_@_@<
MOK-/CC.*EWBLSXFE]8J>TYHU%3ISQ=/W-)1G&>95^:4X1<U*+BHTU"G HHHK
M^=3]X"BBB@ J.66*"*2>>2.&&&-Y9II76.***-2\DDDCD(D:("SNQ"JH+,0
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M<+J7-8_L#HHHH **** "BBB@ K^:W]IC7+3Q-_P=%?\ !-KP+>:0EY)\*_\
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MQ3M%3G&$+OFDU)U%S3A3]HX6Y(WC><FZD%3535K^QNOX9?\ @S(\0/I>O?\
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MKE7LUJUKRW23^/W-4[:)RN[2AHM9*/,?T24444 %%%% !1110 4444 %%%%
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M_P""-7QY?4+[2O@)XO\ V?=?U(R-+KO[/OQ.\2>%DMGDM]4BWZ?X.\8GQ_\
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MIEM<2&+^W5L%N;_X'_ O3BDMO$?$OQ,\2>+[:!;N&:*Z\-ZH]H\7Z"_\$/\
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MQZ;XL^*FO^$UF0^$7M;?^HROY3O^"]^DZE^PM^VE_P $U?\ @MQX*L?L^@?
MOXEP?LL?ME7%K9W>I7&H?LW_ !;N-2M--UJ72K"":2X/A.S\1_%BQM;A;;4-
M0G\7^*?AO':6^=(A1OZIM/U"PU:PL=5TJ]M-3TO4[2VU#3=2T^YAO;#4+"]A
M2YL[ZQO+9Y+>[M+NWDCGMKF"22&>&1)8G9&5BN:[M[ONI15N5.T8Q23C"T8V
M32BE&*Y.2]Y7DTI-Z-Q]VT$ER)J,(Q24H0M&-DURJ,(KV;A=.7,W;HHHIC"B
MBB@ HHHH **** "BBB@#_,C_ ."?S-)_P66^!SPK/*;[]M.^1TV3,Z%/&<_B
M07#;[BX$P>SEN[F\AGN+R_M;LZCJ,+ZFMMXF\5ZG_IN5_F0?L [I/^"S'P.V
M3O)]G_;(F!,KQRBZ-Q\0II+^2/;</'&\\MOIVLAK:34H0]YJ%RUS?6VN^&->
MN?\ 3?K^A_I$_P#(ZX4;:E)\,45.4=8<ZQ-7]W&<.6C)4X<EHPIQG3A*$'.M
M16'JR_"/ /\ Y$/$=FO^2EK\RUNI?4,"TVW;1TO9))*R:E>4IN3"BBBOYX/W
M<**** "OC?\ ;V_;F^!O_!.G]F+X@_M2_'_5;FU\'^"K5;;1_#NDFS;Q5\0O
M&FH17!\-?#_P;:7]S9VMWXD\1W-M+';_ &FZM[&PLH+[6-3N;;3-.O+F+ZQ\
M0>(-#\)Z#K?BGQ1K&F>'?#7AK2-2U_Q%X@UN^MM,T;0M"T:SFU'5M8U?4KV2
M&ST_3-,L+:XO;^^NYHK:TM8);B>1(HV8?Y=W[:GQ]_:&_P"#H3_@KMX)_9:_
M9QU"_P!#_98^&>K^(=)^&K7TMRGAKPG\(O#>JP0_%3]J?QG8!-K^)?&MM_9M
MOX9TN>.*6.WN?AW\/86M]8U'6-5U,4HIIMK1P;C)2::<DN5\KBUSV<4U+FO\
M*E9V<?BC?DMS4T^>45!N4THPG>K3G%5$I152-XP:]YIN*EUOP=^&O_!1#_@[
M4_;=N_B#\:?$6N_!3]@SX)^([Z*]N?#EMJDWPW^$NAW#V-U#\+/A-9:LTVB^
M.OVD?&>@3:+-XR\9ZHC0:%I3Q>,/$&FV>@I\/_AGXA_O:_8J_P""1O\ P3Q_
MX)^:=I*_LS_LR_#_ ,->,M.TW2[&Z^+OB73QXZ^,6LW6G6;VL^KW?Q$\5?VG
MKFDWFL2S7-]JNG^$Y/#?AMKJY:.PT*PL+>QLK7Z4_9,_92^"/[$O[/OPV_9G
M_9Z\(VO@_P"&'PPT"TT;2K=8K+^V-?U!8D.L^,O&&HV-EI\>O>-O%VI"?7/%
M>OR6D$FJ:Q>7,ZP6UOY%K!]&TK-Z3<9VTB^5:+1NSY8NTI+FLHPC?:">KB*O
M&+E!<[5Y-QI\SD^5.\H0CTA!2BFX\T;QLK)%%%%,H_./]OO_ (*Q?L*?\$RU
M^'L?[8/QAF^'VJ_%/^W)? _AW1?!7C7QYX@UBP\.0Q-K&KOI?@O0=;ET[2+6
M[N].TH7^IM9PSZEJ5M!;F6.&_FLOQF^*7_!X-_P2_P##MRFA?!#P5^U+^TQX
MNOTMTT+2O /PGMO"VG:I?SAF;3C<_$#Q%X>\3I<6ZJ3,;#P9JJ.,FV-P Q']
M'?QM_98_9G_:5?PC)^T1^S[\%_CH_@'4;K5O!3?%SX9^#OB)_P (MJ%_;BUO
MY]#'BS1]5&G?VA L4>H0VX2"^%O:M=13-:VS17_A?^S7^SG\$)[FZ^"WP!^"
MGPAN;R."*[N/A?\ "OP+X GNHK6&>WMH[F;PIH.DR3QV]O<W,$"2LRQ0W$\4
M85)9%9II23<4XK=:IR]V+:EK_/SQ3BXVARMIRNDTTIQ;BG"+NU=IS7)!M2L_
M^?G/&+@X6I\LFI2NE_&_X^_X*M?\',W[>MQ+X<_8,_X)C>(/V._AYXDM[R#1
M_BE\7_!DR^,H=-U#6KS3].\06GCG]H"+P!\,+=[;3X8EN[32_AKXGNK2X^TZ
MQ;WKV4VG&V] _8\_X-1-4^)/Q,N?VG?^"U'[2WBS]L3XRZU<6>JWGPW\+?$?
MQS?^$KF1;B6Z72/B!\4_$-EHGQ!\2:78I+]GM?#/@7_A M!TAVFL-/U+4]%A
MA2Z_M+HI+2^KO)+F=VKM6=TDU&*O=I122O9WLK2E9/5MR24G=J[5G=*+48*Z
M;48I)7>^EO*_@S\#?@U^SIX T?X5_ 7X6^ O@]\.-!11I?@OX<^%M'\(^'K>
M46]M:R7TFG:+:6D-WJEW#:6PU#5[P7&J:E)"L^H7=S/F0^J444?\-]VB^Y#O
M^B^25DODM%Y!1110!^<G_!47_@I;\#_^"6'[+NM_M&?&5I]9OKO4H_"'PN^'
M&DW-K%XD^)7Q!O[&]OM/T'2X[B6,PZ?9VMC<ZGXBU@H]MHVEV[RS'S[BSAG_
M )8_A-\*_P#@XE_X+XV-E\6/BY^T-+_P3'_8,\=ZC'JWACPC\,?^$D\(>//&
MWP\O!%<Z6?#N@:!J6E>/O'FCWVEW1$_B'XH^/_!_A;Q%>2_VSHWA;4](@TW3
M-.ZG_@H?X$D_X*_?\'-G[/7[ 7BD3>(?V6_^"?GPST3XO_'7P>S7=]X=UJ2Y
MTSPE\6O&5GJUA(+C29].^(M]XO\ @!\$_%<L*6%W:Z/=ZQ:1ZK%K,%M;0_W$
M6]O!:6\%K:P0VUK;0Q6]M;6\20V]O;PHL<,$$,:K'%#%&JQQ11JJ1HJJJA0!
M2NI6U>C=U:UKN+=I1WY^31\W/3@VX*FZK;2:>S>KBY1<4G%0E=<DXM\KJ6DF
MXS514^65H.4)+\4/V#?^#?3_ ()F?L%VFE:YX;^!^E_'?XU6KF^U+X^?M'6F
ME?%'Q]<:Y/&OVS5/#NFZMIP\%^ Y&G:Z-K<>$?#6FZ\MK=S6VJ^(-9D>6YE_
M:^WMX+2W@M;6"&VM;:&*WMK:WB2&WM[>%%CA@@AC58XH8HU6.**-52-%554*
M *FHI_GWW?W[]%]R[!:WJ]V]6]MV]7HDO1);)!117\O?[?O_  6B^)W[0'Q*
MUG_@FU_P1 T:U_:4_;!\3Q7&@_%#]IGPY<V^J_ #]D/PG?7UCX>UOX@7_CJR
MCU3P]K'B/P]<:G+ NJ@WWA[PKK<%O#;6'CWQ:]GX%NFDW:RWE&-^B<Y<L;OI
MKZNR;2=BE&3M9;SA"[ORJ522C!-V=KM]F[)M)V/FS_@LSJFG_P#!97]O?X-_
M\$5OV;O#7A/7M*^%>OZ+\7O^"@?[5=IX?\'^(M3_ &?/ /AN_$A^&'@3QG=Z
M9K=_X>^)#+J%SINHZ79F)+GQIXN\,^#=:CCT:T^*1T.Y=?\ !.+_ (*?_P#!
M"OQCJOQ5_P""2'BKQ7^W)^P[J>J7'B/XF?\ !.GXP^(+:X\=Z#)=M-;WVJ_!
MKQ)%90RRZG8::FEP:??>$-.B\6ZHFGV5KXP\%_%0:38RU^VO_!)3_@E9\*_^
M"6'P U#P'H/B#4OBI\=_BMJ\/C[]IG]H'Q*UU/XF^+GQ+GCGDNKE'U"XO+_3
MO".BW-_J<?AG2+F\N[UFO]3U_7;W4O$NO:UJ-U^JU3H[MJ]TTI/FC/D?LY)2
M4963@X1BFFVXQ3;5U"$64N9N+O).*FW*%3V;=*2C)0ERIP=.,(M7DX1CS-:0
MA^5G_!-__@L+^R#_ ,%,=+U71?A/K7B#X<_'_P $VUS_ ,+7_9>^+^E_\(C\
M:?AU?:7)9V6MO<:'-(]OXB\/6&J7D=BGB+0I[A(G:.WUZP\/:Q]IT>U_5.OP
M^_X*F?\ !$KX.?MZZAI7[1WP5\0O^R=_P43^%EQI?B7X+?M;?#R.]T;5IO$O
MA=X;GP_H_P 6+30)[*7Q=HK_ &6#2;/Q4\=WXS\&6?D-I$^L>'[;4/!&O_+7
M_!/G_@M?\0O 'Q=L?^";_P#P6C\,6?[*O[<V@_V3X?\ AS\8O$ MM(^!G[8=
MC+=RZ!I/C+PAXJLM,TSP7X?\2>+=3LI5L(;66Q\&>*=7D?1M!/AWQ@3\.[2M
MU*5XQ46]-4W'W+2C'FJ.WO/VCE)<C6G-%W5[J<FX146]-8N4?<49PCS57;WG
M[5SG'D<;QYH.\?Z9J***0@K^7/\ X._9HXO^".OB!'EN(VN/VCO@;#"D$RQ1
M3R+<^);@Q7D9N[8W-N(H)9U@6'4&6[AM;G[(BV[7]E_497\M?_!X$^IQ_P#!
M'^]EL)?+@B_:=^!TFJQL%>&YL$C\9&&"X@DD6&ZA&K_V7.UO<07D+- C/;90
M7$ W;K;M>3A=O2*YE*/Q.T;7?-?EY*E^20W9-WMT7O."<GI&+DI0=I2:BU>7
M,GR^SJW]G/\ I@^&_A)? 'P[\!>!$F^TIX*\%^%O"27'[D^>OAO0['1EFS;V
M>G6Y\T60?]QI]C#\W[JSM4VP)VE>)_LU?%FS^/?[.7P ^.FG2M/I_P :/@G\
M*OBS8SO:7.GO-9_$;P+H/C"UE:PO+33[NR:2#6$=K2ZL+*XMB3#/:6TJ-"GM
ME-IIM/=-IZ6U6^EE;TLK=D-IIM.]TVG=-.Z>MTTK._2RMV0456O+RTTZSNM0
MU"ZMK&PL;:>\OKZ\GBM;.SL[6)I[FZNKF=DAM[:WA1YIYYG2**)&DD944D?A
MA^T3_P ')_\ P1R_9L\4:GX)\2?M9Z7\1?%>B7]SINLZ9\#O!_C'XM:=IUY:
MB=9(6\9>%]&N/ -\XN+>6RE32?%6H26ET%COTM$=)"6>FCU;2T>ME=_<M9?R
MQU=EJ%GIH]6TK)N[2YI;?RQ]Z72,;RE:*;/W8HK\C_V*/^"YW_!,3]O[Q8GP
M[_9Z_:5T6;XGW-^;#2?AC\1M"\0_"_QOXD?[,UTDWA+2_&FG:5;>+4=(YD:#
MPY?:G?VLL0COK.U-S9?:OUPI?Y)^:YDFKK=.SV=FMFDQ7_*+MU2DE)76Z=GJ
MG9IZ-)IH**** "OFO]L+]J#X<?L8?LR_&G]IWXK:K;:7X-^#W@+Q!XNN4FEM
M$NM<U/3["9]!\+:+;WE_ID>I>(/%&L_8="T/28[ZVGU+4KZWM898WD#K]*5_
MF0_\'7O_  5AU[]K+XW:E^Q%\#=0U&\_9@_9-\?VVC?&7Q7H@O)/#OCC]IN2
MW\3V*>&]7U:PN;C1;K3OA_8:#XLTWPQI]V]O=ZCXHL/B#>)93IX6M;R!I7=N
MR<FKVDXII2Y='JK[V=OB:LF-6;LWT<FKVDXII2Y='JN9:V?+\35DS[]_X(&?
M\$N_B-_P4A_:L^(/_!=#_@H[X5DUO3OB'\3M?^(_[-_PU\6VEO>:+XT\41WO
MV'0OB+=Z+JEM</<?"SX0V%E:>$O@UI=W;V0O=4\*Z/XBMA+H7AK26UW^^&OS
M2_X(T^$]=\$?\$H?^">/ASQ)!]FUBV_9&^"%_/ +Z'4?)M]>\#Z3K^G1_:K<
M>22NFZG: P1-(EF?]#6>X$'GR?I;4I);)+2*TBXZ15EHVVNKY;V3;LDM%*2C
MLDM$E:,H*T596C)MQ[\M[1;=DME^:7[57_!77]@W]BG]IOX-_LC_ +27Q@F^
M'7QB^.>A:#XE\%6UWX3\2W_A6VT/Q3XK\0>!_#6I^*?%^G:=<Z)X8L]:\5^%
M]<T>VN=5N88+:2QDN]2DL=._TROTMK_-5_X/;/!^DV7[<?[(?C^&YW:[XF_9
M1O/!^I6?VJV<P:1X&^+WCK6M$N?L273WEO\ :KSXAZ_$+J>QM[:\^QF*TNKR
M6QO8;'^YK_@DS^U6G[:W_!.#]CO]H^Y\00^)_%7CCX(^$-/^)NK1/<,\_P 8
M/ ]E_P ('\71<)=L]Y#,?B-X:\2RJEU)/(]O+!.EW?6\T-]</:RWU;OKU4;1
MV2TM)ZOF=WK)*Z>BTW;;=]>L8^XO=4;1:D]7S-R=G**O']$**** "OXHOB_X
ME/\ P6X_X./OAA^SYI D\4_L/_\ !()]1^(OQ,:.)-1\%>-OCYX9U[2'U33]
M7\V2;1-62]^+.G^#OAL?#>J6UVVJ^$_A=\6)[""XT?5M6EB_3_\ X."_^"NE
MS_P3Z^ NG?L[_LZM?^+/^"@O[7=@?A[^SQX*\*6=YKGBWP/8>,]0F\%O\8+?
M1=*D&HS^(+?59KCP]\&=,2*\?Q'\5182_P!C>(="\+>*M*D]F_X(/?\ !*?2
M_P#@EK^QU9Z%XSBAUC]K#X_3:3\3OVK?&[7L>K7-WXR\G49O#?PYLM9$?GW_
M (=^%FGZ]JFG17$]WJ2ZOXUUOQ]XNL[N*R\4V^G6 [66J?,Y*R<6URI-W34E
MUC&<7::A5@TK5%.([6CK%\SDFE*+DDDF[IQFK.\8U(2Y9JG5@XIQJJ</VXHH
MHH **** /G']KW]F#X;_ +:/[,GQL_98^+=J]QX!^-O@+5_!>KSP*S7NB7ER
ML=[X<\5Z6HF@5M:\&^)[+1O%FB":06YU?1;(722V_FQ/^-/_  01_:6^+/AG
MPO\ %S_@DC^V'(FG_M@_\$VKBR\"Z-=7=Q=R7'QJ_9.D-G!\$_C'H+7!G@N]
M%L="U'0?"9%E?WEQIOA^7P _B%;+Q%K-_9Q?T25^&O\ P5U_8+^+_P 0-?\
MA#_P4@_8)T[3;'_@H]^Q>9+OP=ITUW)I>G?M,_ AQJ\WC[]F7QI+#)!#J/\
M;5GK.MW_ ,.WU29;*R\0:EJ^BM/I0\5GQ%H)=^;6ON^[JVK+WIM1@KVE.6[4
M4FTM0NTNK23]WW5S2:M%<\VHTX\W+*<]&XP46U&[/W*HKX=_X)Y?MZ?!_P#X
M*,?LS>#OVB?A+)=Z5<7F_P -?%'X;ZY#<V7C#X/?%K0X8(?''PS\6Z?>VUG=
MQZCX;U9Y8+343:Q6>NZ6;+6;#-O>*D?W%0]VM[-J^O3UL_O2?<;T;5[V;5U?
MH[=4G\FDUU284444""BBB@ HHHH **** /\ ,?\ V I8S_P65^ (N'N9 W[9
MU]>1O.RP/,NH^+1+93(X^TB5];O'N-;U"(/+9W&K:5X@MX8KVZTZW\4Z5_IP
M5_F1_P#!/UF?_@LM\#I;=9I_M_[:=^KA5F9QCQG=^)(Y6D:><3@:7>W5W<).
M]U?HTU]J$8O&_P"$K\67O^FY7]#_ $B+?VSPE:\?^,6H6@VG+D>)K2A.3M"5
MWS.'OTES*DJM.I/#U*,:7X1X"6_L'B)6::XDK[NUT\'A'S<B244YNI%2M>HH
M\TI2:NRBBBOYX/W<**** /Y7/^#JVS_X*5?$;]E?X)_LV?L$_!3XP?%3P!\?
M?&/C#1?VI-2^!_AC7_%/C&P\/:&G@E?AUX!UR#PU]HU/2?AO\1=2U[Q7?>.M
M9FLXM#6T\!V.C>)M:T[P[K6IV&M?8O\ P0,_X(\>&O\ @D[^RA;V7C.PT76/
MVNOC;;:1XI_:+\:V307RZ+/##)<>'?@SX8U*">ZMIO"GPW2^N[>]U/3YFA\7
M^,+O7O$AF?1Y/#6FZ)^[U%'WOU;:LK-))[6DG+32[O:]VSON[]VVK*S22>R4
MKRLK+F?-;FNV4444 %%%% !1110 4444 %%%% !1110!_'M_P2KTZP\(?\'/
MW_!<'PGX[MOM/Q9UGX=>'/&_@O5!<7GB/['\)-;UGX,^)+G3?^$E-RUII1NM
M*\;?!ACX4GA>:P.D_P!CV#6EMX2NX)?[":_E"_X+@_LI_M._LO\ [:?[-G_!
M=K]A+P)J_P 4O''[/VD6WPT_;"^!'@[2]0N]?^*GP"2'7X-6\6/IVD6M[+K\
M5AX)UK6?"7B6^N-/U:_\%#2OA=\0M-TNYM?A]J-YI/1:/_P7_P#VN/VW["P\
M(_\ !)C_ ().?M+_ !"\;:K%);ZK\8_VR],T7X)_LV?#.]CBN+:]N]9\0Z'X
MUO=/\=#0M7@NHKSPI8?$;P-XMUJ#2=4MO#MG>ZL(;*FVWO*4HQ2MS2YY0BY-
M>\^:4Y>^[N;C'FE4BK.<O>;;=[RE*,$K<\O:3A!R=^=\TZD_?;<JCA'GG5A%
M*52:YOZFZ^*_VT?^"B/[&?\ P3Y\"R>/?VM?CUX(^%-K-8SWOA[PG>W_ /:W
MQ*\;^2SPBW\"?#?15O\ QGXJ=KI1:3WFEZ/-I.ER.)];U+3+))KN+\@=+_X)
M@?\ !9G]K">'7/\ @H%_P6+\9? GPUJ#R2ZA^S]_P3&\+Q_!:UT:VGUF'48]
M.TS]HS6+/2_']W'!IJ2:3/;>)/!?B\OYJ1S:[JUA;WR>(/LC]C'_ ((0?\$W
M?V)?&MC\7_!OPBU?XT?M"V$VCWL7[1O[3WBN^^-_Q>@UG0K:TM],\2:+>>((
M;?P9X+\4V[6OG)XE\ >#/"FMQ^<;&*^CTFUTW3K%)Q]WXK--MI)6NO=MS/FO
MK[RE"+33CUNDG%\O\2TDW)J,5:\;PMS2Y[W:YXSIQ<6G&VO,O@#6?!'_  4M
M_P""[;(/'0^*7_!*K_@E-J6I03)\.;FW/AG_ (*#_M<^&+>:"YBN/&DD,^I:
M-\!/AIXB@)$&AB?5[J[$,[W^F_%+PKK>A:[I'[O?L>_L2?LN_L%?"'2O@A^R
MG\'_  I\)_!%BEM-JTFBV$4GBGQQK=O;BV?Q7\1O&%RLGB/QYXKN(0('UWQ+
MJ&H7=M8QVVD::;'1;#3]-M/JNBCS;;^;LO2-[+\VVVW>4FUUNVWY7?*K:+EC
M=I65U=:N\FVY2DV4444#"OB;]O+_ ()Y_LI_\%)?@G?? K]JWX<6_C/PZKW6
MH>$/%6F7 T3XB_##Q-<6PMX_%WPW\80PS7GA_6H=ENUU:3PZCX:\106T6D^+
M_#_B+07N-*G^V:*.VB=FGJDU=--:--.S2>J#M=)V:DE**DKQ:DFU)-.S2>J>
MQ_%SI?[1G_!3?_@VXU_2/A_^V1;^,O\ @H=_P2.GU32M!\#?M2^%M-\[XU?L
MPZ9?ZM_9&CZ!X\M+FZGD>U-Q?Z7IUOH/CG7)/#&NW5[HUE\,OB=H^JQZA\-I
M?ZP_V7_VJ?V?OVS?@WX9^/O[,WQ0\,_%GX6>*T9+'Q%X;N_,DT[5((;>;4/#
M7B;29UAU;PMXLT=;NV76?#'B"RT_6],:> W=E''<6\DON6L:/I/B'2-4T#7]
M+T[7-"US3K[1];T36+&VU/2-8TC4[:6RU+2]4TV]BGL]0T[4+.>:TOK&[AFM
MKNVFE@GBDBD=#_&Y^U]_P32_:S_X(K?M-ZM_P4E_X(C_  UU3X@_ ?QXFG6?
M[7?_  3L\,6NHZMI5YH>B6UW<1^)?AWI7VG7?%6I^'WU.\U+5+'0O!VE:AXN
M^$NO:OJ<G@VRO_A7KNK^$O" Y7?O-N3<(Q>D4E:S<[]=%RI-<S?)&+FX1F.3
M;]]W<I4X0>D8I6LW.ZM=)+D46N=M4X0=1PC/^S2OYL_^#F3XB_LY?%/_ ((V
M?MG^!H/C5\$]0^('A5_A%XD\.:"OQ!\(ZKXHL?%?A#X_?"V34=-T[0+'69=8
M3Q!?Z'=ZOX7\D6AEM1XA874:12,:^:_#G_!WA_P2S^*/@77O!'QM\-?M?_LS
M>,M:TC7O!'C?29?A_9:IJO@O5;W3&TG6KCPOXP\">*=3UV&[T:[O+VWTC5[[
MPGX<\1V6JZ3)=W7AG36CM!<_P+O^PIX#_::_:H\"_LQ_\$J/'_QW_;8UKQU<
M7LD^H>._V<=/^ 5GX+TMM5L;:VU?5=1M_C%\4&G\'>';'4$D\=_$7QAHWPLT
M31KA+;['I=XFIPQV[LT[:<UTE?:[V3LUNVD]8]D[WL[-.WVN912>S;Z.S3WL
MGK'>R=[\O^ES_P &X7QWM9?^"&/['WC7XS^)[3P7HW@+2/BGX!'C;XD7NB>"
MM N?"G@7XP_$+1_"US::M?PZ%HC:#H?ABQL?"MIJ9GN);K_A&+N?5=1N]835
M)1Z1^VG_ ,'%7_!*3]BWPYKMSJ?[3/@W]H#XAZ6]S8V/PC_9DUK0OC!XJOM;
MMUNDDTO4]>\/ZJ_P_P#![V=W;-::N?%OB[2;O3I2T*V%W>JMD_\ '%KO_!E'
M_P %+[?5;J'PQ^T=^POJ^AIY'V'4==\<?'[PYJMQNMH6N?M6C:?^SKXIM+/R
MKQKB"#R==OOM%M%#=2?999WL[?["_9L_X,A_&,^KZ+JG[8'[;WAG2]!MGTV;
MQ%X'_9L\ :IKNKZU'+9WO]KZ?HOQ4^)[^'++PP]AJ']G'3=9OO@WXN75[,WJ
MW6A:),L#,M4GI%M:63DUHK.SE4E)O323J2ULY.2T:U2=U%R5E:+DXZ;VYZDY
MR;L[2E5DE)IR<EH_%/B-_P %+O\ @L5_P<R>+O$/['O[#OPGM/V8_P!E4ZS8
M0?&CQ+H_BS68++2_ ^M37]KI\7[0?QJ2TTV>_P!#U+3X;^[F^%'PY\+KJ/C0
M6-W:/H'BZPTR:2'^DW]A_P#X-<O^"6W[+GPH\+:%\9O@MX?_ &N_C7%8PR^/
M?B[\75\0RZ/KNN/%?)<Q>%OA8GB6Y\$^%/#-G_:4]OI5C+9:UKTD5MIUYKOB
M+6-5L+.\MOV;_8Z_8N_9L_8)^!_AS]GK]EKX9:+\,_ASH#/?745BAN_$7C'Q
M+=06\&J>-?'WB>ZWZQXQ\8ZO':6L-YKFM7-Q-!I]EINA:6FG>'M'T;2-/^I:
M5N^[YN9J]I<RM)-)13CNDN2*47RJ*2224>^_O<S3?O\ .K24K*"E'XE%.$4H
MOE45%1C'_-^_X.)O^#<CPO\ L8^$=:_X*&?\$\;'5_"?P6\%:CX?U/XS_ O3
MM6UB_P!0^"LUUK%AI=A\7/A;XDUCQ!?^++SPB?$U_I'_  D7A2-K[4/AS-<R
M>+-%OX?A_::A8^!/Z3_^#:#_ (*E^)O^"DW["T^C?&;Q$/$/[3'[+VNZ=\,/
MBGK-S_9\.J>./"NI:=)J'PN^)=_:6"01K>:[I5EJ_A;6;IK:*34_$G@G6=8F
MW2:IN/\ 0?XQ\(>&/B#X1\4^ O&VAZ=XG\&>-_#FM^$/%WAK6+=;O2/$/ACQ
M+IEUHVOZ'JEI)\EUIVK:5>W=A?6[_)-;7$L;<,:_@]^-G_!#/_@I;_P1._:+
M\0_MT?\ !#[QA>?'3X;:E%K5EXS_ &7O$6EGQ#X]T[P!J6H_VJGP_P!3\+76
ML6Y_:#\%Z3/:63:/JWAG4_#OQLTF\33AI6D:Q=0:SXNN*OI9R:T5KQNER*,=
M6FFY3CS<TI=4YRE4FXP=7TLYNUE:\>9)P48ZM-.4IPYN:<]I)U)SJS<:<O[Y
M:*_B%\$_\'GO@;P)J%AX*_;1_P""=G[07P7^(&G6!;QCIW@GQ#H^J:A;7LKJ
M^G3V'@3XK:9\)];L+#4K%A=F/5->DEM'VPP7&JPO]L7](/@9_P '9O\ P1Q^
M+_V*U\5_%;XH_L^ZO?&Q6/3OC)\(?%!M$FO!,TL-SXC^&2_$CPS8G3$C0:E<
MZEJUC8>=,L>F7FJ*#+2^]_$U9-M\J3>EKW=_<6\WI!2::%\F_BLDFV^2S?NI
M7N[KD5KU'I!2::/M;_@N=^W]?_\ !//_ ()[_%+XC> ;F:7]HCXKS6/P#_9C
MT'3(YKSQ'J?QC^)B7&E:?K/A[2[/S+_4=1\!Z NN^.K&VM[:Y2]U?0-)T66-
MGUB!)/\ +U_X*1>&M+_9S\._"W]@SPZ+CQ3\1_@%)JOQ<_;T^)T5S+K[Z]^V
MO\:[+0AXH^'.H>(U-XMUHG[.'A31]!^$MD]QJ+17/Q:NOCEK$$*77B2[>?\
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MO3J*225[)+F=Y65KON[;OU$DH\W*DN9WE96YFMG*V[\V%%%%,84444 %%%%
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MM1%S]BO;6>:VN=-UG39TM]7T#58)K>5)M*URPT_48PH=[41NC-^<<:^'O$?
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M$<2I<0YMF> I1JQY(TZ>#R3+\XHN5/DYH5_9XC$0KQE4DD_8I1@XR=7]!_\
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M1ETBQ$$,%]?V]S?6$-U[C\#OC;\+OVD?A#\._CS\$_%EOXZ^$WQ7\+:7XT\
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MCXQUBS\<>./#^K:YX9TB?4K6>;P]X=\'W'A[P[X<1C=:)I=EJ=WJ%_>?@_\
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M?&_PP\>?MH?V%XY^''B_Q+X#\9Z'_P ,Z?M8ZI_8WBOPAK-[X>\1:5_:6C?
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MX3!X.7L8XO'4<)+'8RU>JL6L'ALOPSHU:]6M"K/$*I[/!4Z]55(TOWY^%_\
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M5,QK>T57&5<3C*LZ$?W]:O4BJ<*M+#P52O4TII\RC:,?XP/C'H]S_P %B/\
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M[Z_N)([6UL+2SBENKF\GE2W@MXWFDD6-68?YS?\ P3F_X*[?\$[-1_X+2?\
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MVJ:SJ%I83^"/">M>.+70(TX#_@V#_P""RW_!-G_@G?\ L(_%KX-?MB?M(O\
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M-!U&]\)^ =0\/_#+P'X_L/BAK>B>+O#&A?$/P_XALO'TFAP:[X*75^K^+?\
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MQ_LFI4YU\#BH9'D.#QT)-J/U><L\S3"I4W*IB/JU>%:C+ 2A7_,;_@XZ\/\
MB3Q+_P $4OV]-/\ "LES%J-I\.O!OB"\:VGO(';PWX5^+OP\\3>+XY#8I)-)
M;R^%=)UF.Y@D3['- \D=^\-B;B>*K_P;=ZIX<U3_ ((I_L*GPU=6%S#I_@3Q
MMI>L"P%@!;>([+XM>/UURUO%TY5A%_%>LYNO/!OW9UDU%FOGN&/ZZ?&SX/>
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J^Q3E.,(3E3C\,)3A3A"3BDY1A"+;44D4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Trinity
Biotech plc<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000888721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">359,193,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">IDA
Business Park<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bray,
County Wicklow<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">A98
H5C8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American
        Depositary Shares (each representing 20&#8216;A&#8217;
        Ordinary Shares, par value US$0.0109)
        &#160; <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TRIB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">GRANT
THORNTON<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Dublin,
Ireland<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Susan
O&#8217;Connor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">1276
9800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelFaxNumber', window );">Contact Personnel Fax Number</a></td>
<td class="text">1276
9888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">IDA
Business Park<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bray,
County Wicklow<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">A98
H5C8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelFaxNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fax Number of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelFaxNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="nump">$ 61,555<span></span>
</td>
<td class="nump">$ 56,832<span></span>
</td>
<td class="nump">$ 62,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(40,114)<span></span>
</td>
<td class="num">(37,382)<span></span>
</td>
<td class="num">(45,253)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">21,441<span></span>
</td>
<td class="nump">19,450<span></span>
</td>
<td class="nump">17,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other operating (expense)/income</a></td>
<td class="num">(1,787)<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(4,543)<span></span>
</td>
<td class="num">(4,379)<span></span>
</td>
<td class="num">(4,138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="num">(28,815)<span></span>
</td>
<td class="num">(31,152)<span></span>
</td>
<td class="num">(26,983)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts', window );">Selling, general and administrative expenses &#8211; Restructuring costs</a></td>
<td class="num">(4,181)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OnceOffExpense', window );">Once off items</a></td>
<td class="num">(1,872)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment charges</a></td>
<td class="num">(1,408)<span></span>
</td>
<td class="num">(11,105)<span></span>
</td>
<td class="num">(5,839)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss</a></td>
<td class="num">(21,165)<span></span>
</td>
<td class="num">(27,045)<span></span>
</td>
<td class="num">(19,349)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,171<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expenses</a></td>
<td class="num">(9,565)<span></span>
</td>
<td class="num">(11,053)<span></span>
</td>
<td class="num">(24,734)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NetFinancingExpenseIncome', window );">Net financing expense</a></td>
<td class="num">(9,565)<span></span>
</td>
<td class="num">(9,882)<span></span>
</td>
<td class="num">(24,431)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before tax</a></td>
<td class="num">(30,730)<span></span>
</td>
<td class="num">(36,927)<span></span>
</td>
<td class="num">(43,780)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Total income tax (expense)/credit</a></td>
<td class="num">(486)<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year on continuing operations</a></td>
<td class="num">(31,216)<span></span>
</td>
<td class="num">(36,868)<span></span>
</td>
<td class="num">(43,586)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">(Loss)/profit for the year on discontinued operations</a></td>
<td class="num">(573)<span></span>
</td>
<td class="nump">12,850<span></span>
</td>
<td class="nump">2,577<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss for the year (all attributable to owners of the parent)</a></td>
<td class="num">(31,789)<span></span>
</td>
<td class="num">(24,018)<span></span>
</td>
<td class="num">(41,009)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss for the year (all attributable to owners of the parent)</a></td>
<td class="nump">$ 31,789<span></span>
</td>
<td class="nump">$ 24,018<span></span>
</td>
<td class="nump">$ 41,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations', window );">Basic loss per ADS (US Dollars) &#8211; continuing operations</a></td>
<td class="num">$ (1.74)<span></span>
</td>
<td class="num">$ (4.81)<span></span>
</td>
<td class="num">$ (6.46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations', window );">Diluted loss per ADS (US Dollars) &#8211; continuing operations</a></td>
<td class="num">(1.74)<span></span>
</td>
<td class="num">(4.81)<span></span>
</td>
<td class="num">(6.46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic loss per ADS (US Dollars) &#8211; group</a></td>
<td class="num">(1.77)<span></span>
</td>
<td class="num">(3.14)<span></span>
</td>
<td class="num">(6.08)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per ADS (US Dollars) &#8211; group</a></td>
<td class="num">$ (1.77)<span></span>
</td>
<td class="num">$ (3.14)<span></span>
</td>
<td class="num">$ (6.08)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss for the year (all attributable to owners of the parent)</a></td>
<td class="nump">$ 31,789<span></span>
</td>
<td class="nump">$ 24,018<span></span>
</td>
<td class="nump">$ 41,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations', window );">Basic loss per ADS (US Dollars) &#8211; continuing operations</a></td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.24)<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations', window );">Diluted loss per ADS (US Dollars) &#8211; continuing operations</a></td>
<td class="num">(0.09)<span></span>
</td>
<td class="num">(0.24)<span></span>
</td>
<td class="num">(0.32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic loss per ADS (US Dollars) &#8211; group</a></td>
<td class="num">(0.09)<span></span>
</td>
<td class="num">(0.16)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per ADS (US Dollars) &#8211; group</a></td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.16)<span></span>
</td>
<td class="num">$ (0.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basic earnings (loss) per share from continuing operations. [Refer: Basic earnings (loss) per share; Continuing operations, unless line item indicates otherwise [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShareFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Diluted earnings (loss) per share from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Diluted earnings (loss) per share]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss or reversal of impairment loss recognised in profit or loss. [Refer: Impairment loss recognised in profit or loss; Reversal of impairment loss recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2024-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NetFinancingExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net financing (expense)/income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NetFinancingExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_OnceOffExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents the amount of once off items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_OnceOffExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It Represents the selling, general and administrative expenses - restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConsolidatedStatementOfComprehensiveIncomeAbstract', window );"><strong>Consolidated Statement Of Comprehensive Income Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss for the year</a></td>
<td class="num">$ (31,789)<span></span>
</td>
<td class="num">$ (24,018)<span></span>
</td>
<td class="num">$ (41,009)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeAbstract', window );"><strong>Other comprehensive profit/(loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Foreign exchange translation differences</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="num">(396)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive profit/(loss)</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="num">(396)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Total Comprehensive Loss (all attributable to owners of the parent)</a></td>
<td class="num">$ (31,544)<span></span>
</td>
<td class="num">$ (23,949)<span></span>
</td>
<td class="num">$ (41,405)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81B_b_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ConsolidatedStatementOfComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ConsolidatedStatementOfComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF FINANCIAL POSITION - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">$ 4,621<span></span>
</td>
<td class="nump">$ 1,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Goodwill and intangible assets</a></td>
<td class="nump">51,343<span></span>
</td>
<td class="nump">16,270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Financial assets</a></td>
<td class="nump">2,455<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">3,553<span></span>
</td>
<td class="nump">1,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Derivative financial instruments</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Other assets</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">62,166<span></span>
</td>
<td class="nump">20,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">19,374<span></span>
</td>
<td class="nump">19,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade and other receivables</a></td>
<td class="nump">16,065<span></span>
</td>
<td class="nump">13,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxAssetsCurrent', window );">Income tax receivable</a></td>
<td class="nump">518<span></span>
</td>
<td class="nump">1,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">5,167<span></span>
</td>
<td class="nump">3,691<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">41,124<span></span>
</td>
<td class="nump">39,041<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">103,290<span></span>
</td>
<td class="nump">59,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity attributable to the equity holders of the parent</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">4,190<span></span>
</td>
<td class="nump">1,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium</a></td>
<td class="nump">63,397<span></span>
</td>
<td class="nump">46,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Treasury shares</a></td>
<td class="num">(24,922)<span></span>
</td>
<td class="num">(24,922)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="num">(79,117)<span></span>
</td>
<td class="num">(48,644)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Translation reserve</a></td>
<td class="num">(5,461)<span></span>
</td>
<td class="num">(5,706)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EquityComponentOfConvertibleNote', window );">Equity component of convertible note</a></td>
<td class="nump">6,709<span></span>
</td>
<td class="nump">6,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherReserves', window );">Other reserves</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="num">(35,181)<span></span>
</td>
<td class="num">(23,949)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Income tax payable</a></td>
<td class="nump">364<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Trade and other payables</a></td>
<td class="nump">26,782<span></span>
</td>
<td class="nump">12,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentProvisions', window );">Provisions</a></td>
<td class="nump">2,454<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExchangeableNotesAndOtherBorrowingsCurrent', window );">Exchangeable notes and other borrowings</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CurrentFinanceLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">2,285<span></span>
</td>
<td class="nump">1,694<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">32,095<span></span>
</td>
<td class="nump">15,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="nump">72,391<span></span>
</td>
<td class="nump">40,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Derivative financial liability</a></td>
<td class="nump">1,658<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible Note</a></td>
<td class="nump">15,401<span></span>
</td>
<td class="nump">14,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ContingentConsiderationNonCurrent', window );">Contingent consideration</a></td>
<td class="nump">1,813<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Provisions</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NoncurrentFinanceLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">10,477<span></span>
</td>
<td class="nump">10,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">4,561<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">106,376<span></span>
</td>
<td class="nump">68,349<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">138,471<span></span>
</td>
<td class="nump">83,384<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">TOTAL EQUITY AND LIABILITIES</a></td>
<td class="nump">$ 103,290<span></span>
</td>
<td class="nump">$ 59,435<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax assets. [Refer: Current tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentDerivativeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current derivative financial assets. [Refer: Derivative financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentDerivativeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current other borrowings. [Refer: Other borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2024-01-01<br> -Paragraph 52<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_52_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An entity&#8217;s own equity instruments, held by the entity or other members of the consolidated group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ContingentConsiderationNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents the amount of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ContingentConsiderationNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amout represents convertiable note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CurrentFinanceLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current finance lease liabilities as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CurrentFinanceLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_EquityComponentOfConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents equity component of convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_EquityComponentOfConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ExchangeableNotesAndOtherBorrowingsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Information about Exchangeable notes and other borrowings classified as current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ExchangeableNotesAndOtherBorrowingsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NoncurrentFinanceLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NoncurrentFinanceLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Share Capital 'A' Ordinary shares [Member]</div></th>
<th class="th"><div>Share premium [Member]</div></th>
<th class="th"><div>Treasury Shares [Member]</div></th>
<th class="th"><div>Translation reserve [Member]</div></th>
<th class="th"><div>Equity Component of convertible Note [Member]</div></th>
<th class="th"><div>Other reserves [member]</div></th>
<th class="th"><div>Accumulated (deficit)/surplus [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 1,213<span></span>
</td>
<td class="nump">$ 16,187<span></span>
</td>
<td class="num">$ (24,922)<span></span>
</td>
<td class="num">$ (5,379)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 12,559<span></span>
</td>
<td class="num">$ (319)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss for the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(41,009)<span></span>
</td>
<td class="num">(41,009)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(396)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(396)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Total comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(396)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(41,009)<span></span>
</td>
<td class="num">(41,405)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued in the year</a></td>
<td class="nump">750<span></span>
</td>
<td class="nump">30,271<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">31,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SharesToBeIssued', window );">Shares to be issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncreasedecreasethroughequityComponentOfConvertibleNote', window );">Equity component of convertible note</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,709<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,709<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at end of period at Dec. 31, 2022</a></td>
<td class="nump">1,963<span></span>
</td>
<td class="nump">46,458<span></span>
</td>
<td class="num">(24,922)<span></span>
</td>
<td class="num">(5,775)<span></span>
</td>
<td class="nump">6,709<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="num">(26,695)<span></span>
</td>
<td class="num">(2,176)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss for the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(24,018)<span></span>
</td>
<td class="num">(24,018)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Total comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(24,018)<span></span>
</td>
<td class="num">(23,949)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued in the year</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,069<span></span>
</td>
<td class="nump">2,069<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at end of period at Dec. 31, 2023</a></td>
<td class="nump">1,972<span></span>
</td>
<td class="nump">46,619<span></span>
</td>
<td class="num">(24,922)<span></span>
</td>
<td class="num">(5,706)<span></span>
</td>
<td class="nump">6,709<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="num">(48,644)<span></span>
</td>
<td class="num">(23,949)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss for the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(31,789)<span></span>
</td>
<td class="num">(31,789)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Total comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(31,789)<span></span>
</td>
<td class="num">(31,544)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Shares issued in the year</a></td>
<td class="nump">2,218<span></span>
</td>
<td class="nump">16,778<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at end of period at Dec. 31, 2024</a></td>
<td class="nump">$ 4,190<span></span>
</td>
<td class="nump">$ 63,397<span></span>
</td>
<td class="num">$ (24,922)<span></span>
</td>
<td class="num">$ (5,461)<span></span>
</td>
<td class="nump">$ 6,709<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="num">$ (79,117)<span></span>
</td>
<td class="num">$ (35,181)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81B_b_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IncreasedecreasethroughequityComponentOfConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents equity component of convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IncreasedecreasethroughequityComponentOfConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_SharesToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_SharesToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss for the year</a></td>
<td class="num">$ (31,789)<span></span>
</td>
<td class="num">$ (24,018)<span></span>
</td>
<td class="num">$ (41,009)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments to reconcile net profit/(loss) to cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationExpense', window );">Depreciation</a></td>
<td class="nump">675<span></span>
</td>
<td class="nump">831<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForAmortisationExpense', window );">Amortisation</a></td>
<td class="nump">1,190<span></span>
</td>
<td class="nump">946<span></span>
</td>
<td class="nump">923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncomeTaxExpense', window );">Income tax expense/(credit)</a></td>
<td class="nump">486<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="num">(192)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFinanceIncome', window );">Financial income</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,171)<span></span>
</td>
<td class="num">(303)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFinanceCosts', window );">Financial expense</a></td>
<td class="nump">9,565<span></span>
</td>
<td class="nump">11,053<span></span>
</td>
<td class="nump">24,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based payments (net of capitalized amounts)</a></td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">2,069<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains', window );">Foreign exchange gains on operating cash flows</a></td>
<td class="nump">1,010<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment', window );">Loss on disposal or retirement of property, plant and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForProvisions', window );">Movement in inventory provision</a></td>
<td class="nump">2,113<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
<td class="nump">7,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdjustmentsForInventoryWriteOff', window );">Inventory write off</a></td>
<td class="nump">1,884<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables', window );">Impairment of prepayments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment of property, plant and equipment</a></td>
<td class="nump">612<span></span>
</td>
<td class="nump">3,772<span></span>
</td>
<td class="nump">733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">1,596<span></span>
</td>
<td class="nump">5,833<span></span>
</td>
<td class="nump">4,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossOnFinancialAssets', window );">Liabilities related to financial assets (reversal)/written off</a></td>
<td class="num">(800)<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdjustmentsForGainLossOnSaleOfBusiness', window );">Gain on sale of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,718)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdjustmentForRestructuringProvision', window );">Restructuring provision</a></td>
<td class="nump">361<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsForNoncashItems', window );">Other non-cash items</a></td>
<td class="nump">2,505<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="nump">269<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital', window );">Operating cash flows before changes in working capital</a></td>
<td class="num">(9,276)<span></span>
</td>
<td class="num">(9,176)<span></span>
</td>
<td class="nump">754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables', window );">(Increase)/decrease in trade and other receivables</a></td>
<td class="num">(2,368)<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
<td class="num">(966)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(1,742)<span></span>
</td>
<td class="num">(971)<span></span>
</td>
<td class="num">(877)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">Increase/(decrease) in trade and other payables</a></td>
<td class="nump">8,185<span></span>
</td>
<td class="num">(2,769)<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperations', window );">Cash used in operations</a></td>
<td class="num">(5,201)<span></span>
</td>
<td class="num">(11,869)<span></span>
</td>
<td class="num">(908)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities', window );">Interest received</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities', window );">Income taxes received/(paid)</a></td>
<td class="nump">1,010<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(4,191)<span></span>
</td>
<td class="num">(11,557)<span></span>
</td>
<td class="num">(921)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Payments to acquire intangible assets</a></td>
<td class="num">(9,659)<span></span>
</td>
<td class="num">(1,901)<span></span>
</td>
<td class="num">(4,876)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Acquisition of property, plant and equipment</a></td>
<td class="num">(405)<span></span>
</td>
<td class="num">(803)<span></span>
</td>
<td class="num">(1,101)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities', window );">Payments to acquire financial asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(700)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations', window );">Proceeds from sale of business (net of transaction costs)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,160<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities', window );">Payments to acquire trades or businesses</a></td>
<td class="num">(12,904)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash (used in)/generated by investing activities</a></td>
<td class="num">(22,968)<span></span>
</td>
<td class="nump">24,756<span></span>
</td>
<td class="num">(5,977)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Issue of ordinary share capital including share premium (net of issuance costs)</a></td>
<td class="nump">7,391<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ProceedsFromSharesToBeIssued', window );">Proceeds from shares to be issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromNoncurrentBorrowings', window );">Net proceeds from senior secured term loan</a></td>
<td class="nump">30,176<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">80,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ProceedsForConvertibleNoteIssued', window );">Proceeds from convertible note issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Expenses paid in connection with debt financing</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="num">(2,356)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBondsNotesAndDebentures', window );">Purchase of exchangeable notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(86,730)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfNoncurrentBorrowings', window );">Repayment of senior secured term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,050)<span></span>
</td>
<td class="num">(34,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PenaltyForEarlySettlementOfTermLoan', window );">Penalty for early partial settlement of senior secured term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(905)<span></span>
</td>
<td class="num">(3,450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RepaymentOfOtherLoan', window );">Repayment of other loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestPaidOnSeniorSecuredTermLoan', window );">Interest paid on senior secured term loan</a></td>
<td class="num">(5,946)<span></span>
</td>
<td class="num">(7,314)<span></span>
</td>
<td class="num">(6,424)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestPaidOnConvertibleNote', window );">Interest paid on convertible note</a></td>
<td class="num">(300)<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="num">(199)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest paid on exchangeable notes</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(1,293)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payment of lease liabilities</a></td>
<td class="num">(2,503)<span></span>
</td>
<td class="num">(2,318)<span></span>
</td>
<td class="num">(2,761)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash generated by/(used in) financing activities</a></td>
<td class="nump">28,810<span></span>
</td>
<td class="num">(16,042)<span></span>
</td>
<td class="num">(12,322)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Increase/(decrease) in cash and cash equivalents and short-term investments</a></td>
<td class="nump">1,651<span></span>
</td>
<td class="num">(2,843)<span></span>
</td>
<td class="num">(19,220)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effects of exchange rate movements on cash held</a></td>
<td class="num">(175)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CashAndCashEquivalentsAndShortTermInvestments', window );">Cash and cash equivalents and short-term investments at beginning of year</a></td>
<td class="nump">3,691<span></span>
</td>
<td class="nump">6,578<span></span>
</td>
<td class="nump">25,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CashAndCashEquivalentsAndShortTermInvestments', window );">Cash and cash equivalents and short-term investments at end of year</a></td>
<td class="nump">$ 5,167<span></span>
</td>
<td class="nump">$ 3,691<span></span>
</td>
<td class="nump">$ 6,578<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for finance costs to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance costs; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for finance income to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for impairment loss (reversal of impairment loss) on property, plant and equipment recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for impairment loss (reversal of impairment loss) on trade and other receivables recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Impairment loss; Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss; Impairment loss (reversal of impairment loss) recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities, from continuing and discontinued operations. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash from (used in) the entity's operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) from the entity's operations before changes in working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossOnFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_20_e&amp;doctype=Standard&amp;book=b<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossOnFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 14<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_14_f&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAdjustmentsForNoncashItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAdjustmentsForNoncashItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for share issue costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the disposal of non-current assets or disposal groups classified as held for sale and discontinued operations. [Refer: Discontinued operations [member]; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from non-current borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBondsNotesAndDebentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for repayments of bonds, notes and debentures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBondsNotesAndDebentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AdjustmentForRestructuringProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of provision for restructuring.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AdjustmentForRestructuringProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AdjustmentsForGainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents gain on sale of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AdjustmentsForGainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AdjustmentsForInventoryWriteOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of adjustments for inventory write off.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AdjustmentsForInventoryWriteOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CashAndCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, cash equivalents, and short term investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CashAndCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_InterestPaidOnConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents interest paid on convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_InterestPaidOnConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_InterestPaidOnSeniorSecuredTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents interest paid on senior secured term loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_InterestPaidOnSeniorSecuredTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents payments to acquire financial asset classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents payments to acquire trades or businesses classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PenaltyForEarlySettlementOfTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents penalty for early settlement of term loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PenaltyForEarlySettlementOfTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ProceedsForConvertibleNoteIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents of proceeds for convertible note issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ProceedsForConvertibleNoteIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ProceedsFromSharesToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represent of proceeds from shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ProceedsFromSharesToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_RepaymentOfOtherLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents repayment of other loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_RepaymentOfOtherLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure of basis of preparation and significant accounting policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory', window );">BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>1.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>BASIS OF PREPARATION AND SIGNIFICANT
        ACCOUNTING POLICIES</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
principal accounting policies adopted by Trinity Biotech plc (&#8220;the Company&#8221;) and its subsidiaries (together the &#8220;the
Group&#8221;) are set out below.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>i)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">General
        information</span></span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trinity
Biotech is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable
biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation,
for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and
to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood and the Company intends to develop
a range of biosensor devices and related services, starting with a continuous glucose monitoring product.</span></span></span></span></span></div>
</div>

<p style="margin:0pt">&#160;</p>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>ii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Statement
        of compliance</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (&#8220;IFRS&#8221;)
both as issued by the International Accounting Standards Board (&#8220;IASB&#8221;) and as subsequently adopted by the European Union
(&#8220;EU&#8221;) (together &#8220;IFRS&#8221;).&#160;The IFRS applied are those effective for accounting periods beginning January&#160;1,
2024. Consolidated financial statements are required by Irish law to comply with IFRS as adopted by the EU which differ in certain respects
from IFRS as issued by the IASB.&#160;These differences predominantly relate to the timing of adoption of new standards by the EU.&#160;However,
in relation to the 2024 consolidated financial statements there are no differences regarding the effective date of new IFRS relevant to
Trinity Biotech as issued by the IASB and as adopted by the EU. In relation to prior periods presented, none of the differences are relevant
in the context of Trinity Biotech and the consolidated financial statements comply with IFRS both as issued by the IASB and as adopted
by the EU.</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>iii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Basis of preparation and going concern</p>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
consolidated financial statements have been prepared in United States Dollars (US$), rounded to the nearest thousand, under the historical
cost basis of accounting, except for derivative financial instruments, certain balances arising on acquisition of subsidiary entities
and share-based payments which are initially recorded at fair value. Derivative financial instruments are also subsequently revalued and
carried at fair value.</span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
preparation of financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect
the application of policies and amounts reported in the financial statements and accompanying notes. The estimates and associated assumptions
are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of
which form the basis of making the judgements about the carrying value of assets and liabilities that are not readily apparent from other
sources. Actual results may differ from these estimates.</span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period
in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision
affects both current and future periods. Judgements made by management that have a significant effect on the financial statements and
estimates with a significant risk of material adjustment in the next year are discussed in Note 31.</span></span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates
the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future.</span></span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>As
reflected in the accompanying consolidated financial statements, for the years ended December 31, 2024 and 2023, the Group recorded a
loss of US$31.8
million and a loss of US$24.0
million, respectively. For the year ended December 31, 2024 we reported cash inflows of US1.7
million compared to cash outflows of US$2.8
million for 2023. As of December 31, 2024, we had net current assets of US$9.0
million but had an accumulated deficit in equity attributable to the equity holders of the Company of US$79.1
million.</span></span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>We
have made significant progress on a multi-year transformation plan aimed at improving profitability and simplifying our operating model.
Key actions implemented include the consolidation and outsourcing of global manufacturing, closure of underutilized facilities, relocation
of certain business support functions to lower-cost jurisdictions, and a reduction in overall headcount. These restructuring measures,
largely completed by mid-2025, are expected to deliver significant annualized cost savings. Additionally, the Group retains further levers
to manage liquidity if required, including deferring projected research and development spend.</span></span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>A
temporary decline in revenue occurred during the first four months of 2025, primarily due to transitional impacts associated with the
Group&#8217;s restructuring initiatives, including the consolidation of manufacturing operations and the transfer of Point-of-Care/HIV
products to a third-party contract manufacturing partner. These initiatives have since progressed materially. Sales were also affected
by reduced HIV test volumes resulting from uncertainty surrounding potential changes to U.S. foreign aid policy following a presidential
executive order. In light of these temporary factors, the Group sought and received a formal waiver from Perceptive in respect of the
Q1 2025 minimum revenue covenant, to ensure that no breach occurred under the Perceptive credit facility. In May 2025, the Group signed
a buy-sell agreement with a contract manufacturing partner. We also have obtained World Health Organisation (&#8220;WHO&#8221;) approval
to commence assembly at the new site. It is expected that WHO approval for full production of our Trinscreen product to be received in
July 2025, with approval for full production of our UniGold product expected in August 2025. The directors have alternative options and
have prepared financial forecasts to address a scenario whereby WHO approval for production with our contract manufacturing partner takes
longer than expected to achieve and the facility takes longer than expected to get up to full operational capacity. In such a scenario,
management remain confident that all revenue covenants will be met through to 31 December 2025. In addition, the minimum revenue covenant
thresholds for Q2, Q3 and Q4 2025 have been renegotiated to align with the Group&#8217;s updated forecasts. Accordingly, management is
confident in the Group&#8217;s ability to maintain compliance with its debt covenants for the remainder of the going concern review period.
Furthermore, Perceptive have a track record of supporting the Company and, when required, have provided covenant waivers and amendment
of terms which indicates an appreciation of the Company&#8217;s circumstances in terms of our transformational plan for the business and
temporary declines in revenue. If a similar need were to recur in the foreseeable future, management are confident of their continued
support.</span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>We
have also launched a strategic realignment review of our businesses in partnership with Barclays Bank. This process, is expected to make
significant progress by the end of 2025 and may generate material capital proceeds that can be potentially used to reduce debt and support
investment, including CGM investment.</span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In
addition, the Group has continued to benefit from strong support from Perceptive, its principal lender and largest investor. On December
23, 2024, we entered into the third amendment and restatement of the credit agreement governing the Term Loan. As part of this agreement,
an additional US$2.0
million of funding was made available to us. We also agreed that certain interest
payments payable in 2024 and 2025 would be paid-in-kind on the applicable payment date by increasing the outstanding principal
amount of the Term Loan. In February 2025, we entered into a fourth amendment to the credit agreement, which provided for an additional
US$4.0
million in term loan funding. On May 14, 2025, we entered into a fifth amendment to the credit agreement, which provided for a further
US$2.0
million in funding, extended the maturity date of the Term Loan by six months from January
2026 to July 27, 2026, and confirmed that interest
payments for the months of April, May, and June 2025 would be paid-in-kind. There are no material debt maturities until
July 2026. These successive amendments demonstrate Perceptive&#8217;s continued support and demonstrate their willingness to flex terms
to preserve liquidity while the Company continues to execute its updated strategy, including its comprehensive transformation plan.</span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under
the fifth amendment to the credit agreement, the minimum liquidity covenant was reduced to US$1
million through to October 31, 2025, after which it reverts to US$3
million. While management is confident in the Group&#8217;s ability to maintain compliance with this covenant, it is noted that the Group
has planned significant R&amp;D expenditure related to its CGM development program in the second half of 2025. However, the Group retains
full discretion over the timing and phasing of these activities, which enables management to align expenditure with available funding
and preserve liquidity if required.</span></span></p> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In
addition to lender support, our going concern forecasts include expected equity raises. These funds are expected to support ongoing CGM
development activities. The Group has a strong track record of capital raising, including over US$7
million secured in 2024, and maintains active engagement with existing and potential investors. Management believes that the equity raise
is achievable based on the Group&#8217;s strategic focus and transformation progress to date.</span></span></span></span></p>

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
directors have considered the Group&#8217;s current financial position and cash flow projections, taking into account all known events
and developments including the amendment and restatement of the term loan with Perceptive, The directors believe that, based on currently
available information and reasonable assumptions, the Group will be able to continue its operations for at least the next 12 months from
the year-end date, and that it is appropriate to continue to prepare the consolidated financial statements on a going concern basis.</span></span></span></span></p>

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
accounting policies set out below have been applied consistently to all periods presented in these consolidated financial statements.
The accounting policies have been applied consistently by all Group entities. The comparative information agrees with the amounts and
other disclosures presented in the prior period consolidated financial statements or, when appropriate, have been restated.</span></span></span></span></span></span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>iv)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Basis
        of consolidation</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Subsidiaries</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Subsidiaries
are all entities over which the Group has control. The Group controls an entity when the Group is exposed to, or has rights to, variable
returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries
are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control
ceases. A change in the ownership interest of a subsidiary without a change in control is accounted for as an equity transaction. The
Group currently holds a majority of voting rights in all entities in the Group and as a result there are no non-controlling interests
reflected in the consolidated financial statements.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Transactions
eliminated on consolidation</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Intra-group
balances and any unrealised gains or losses or income and expenses arising from intra-group transactions are eliminated in preparing the
consolidated financial statements.</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>v)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Property,
        plant and equipment</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Owned
assets</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Items
of property, plant and equipment are stated at cost less any accumulated depreciation and any impairment losses (see Note 1(viii)). The
cost of self-constructed assets includes the cost of materials, direct labour and attributable overheads. It is not Group policy to revalue
any items of property, plant and equipment.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Depreciation
is charged to the statement of operations on a straight-line basis to write-off the cost of the assets over their expected useful lives
as follows:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Leasehold improvements</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>5-15&#160;years</span></span></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Buildings</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>50
        years</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Office equipment and fittings</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>10
        years</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Computer equipment</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>3-5
        years</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Plant and equipment</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>5-15
        years</span></span></span></span></span></div> </td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Land
is not depreciated. The residual values, if not insignificant, useful lives and depreciation methods of property, plant and equipment
are reviewed and adjusted if appropriate on a prospective basis, at each balance sheet date. There were no changes to useful lives in
the year.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group considers whether a contract is or contains a lease. A lease is defined as &#8216;a contract, or part of a contract, that conveys
the right to use an asset (the underlying asset) for a period of time in exchange for consideration&#8217;. To apply this definition the
Group assesses whether the contract meets three key evaluations which are whether:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>the contract contains an identified
        asset, which is either explicitly identified in the contract or implicitly specified by being identified at the time the asset is made
        available to the Group</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>the Group has the right to obtain
        substantially all of the economic benefits from use of the identified asset throughout the period of use, considering its rights within
        the defined scope of the contract</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>the Group has the right to direct
        the use of the identified asset throughout the period of use. The Group assess whether it has the right to direct &#8216;how and for what
        purpose&#8217; the asset is used throughout the period of use.</span></span></span></span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
lease commencement date, the Group recognises a right-of-use asset and a lease liability on the balance sheet. The right-of-use asset
is measured at cost, which is made up of the initial measurement of the lease liability, any initial direct costs incurred by the Group,
an estimate of any costs to dismantle and remove the asset at the end of the lease, and any lease payments made in advance of the lease
commencement date (net of any incentives received).</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group depreciates the right-of-use assets on a straight-line basis from the lease commencement date to the earlier of the end of the useful
life of the right-of-use asset or the end of the lease term. The Group also assesses the right-of-use asset for impairment when such indicators
exist.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
the commencement date, the Group measures the lease liability at the present value of the lease payments unpaid at that date, discounted
using the interest rate implicit in the lease if that rate is readily available or the Group&#8217;s incremental borrowing rate. Lease
payments included in the measurement of the lease liability are made up of fixed payments (including in substance fixed), variable payments
based on an index or rate, amounts expected to be payable under a residual value guarantee and payments arising from options reasonably
certain to be exercised. Subsequent to initial measurement, the liability will be reduced for payments made and increased for interest.
It is remeasured to reflect any reassessment or modification, or if there are changes in in-substance fixed payments. When the lease liability
is remeasured, the corresponding adjustment is reflected in the right-of-use asset, or profit and loss if the right-of-use asset is already
reduced to zero.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group has elected to account for short-term leases and leases of low-value assets using the practical expedients. Instead of recognising
a right-of-use asset and lease liability, the payments in relation to these are recognised as an expense in profit or loss on a straight-line
basis over the lease term. On the statement of financial position, right-of-use assets have been included in property, plant and equipment
and lease liabilities have been included in separate lines within the current liabilities and non-current liabilities sections.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.9pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Leased
assets - as lessor</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group&#8217;s accounting policy under IFRS 16 has not changed from the comparative period. As a lessor, the Group classifies its leases
as either operating or finance leases. A lease is classified as a finance lease if it transfers substantially all the risks and rewards
incidental to ownership of the underlying asset, and classified as an operating lease if it does not.</span></span></span></span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>vi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Business
        combinations &amp; goodwill</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
the time of each transaction, the Group evaluates whether the acquisition constitutes a business combination in accordance with the definition
in IFRS 3 Business Combinations. A business is defined as an integrated set of activities and assets that is capable of being conducted
and managed for the purpose of providing a return. The assessment considers whether the acquired set includes inputs and substantive processes
that together significantly contribute to the ability to create outputs. Where such criteria are not met, the transaction is accounted
for as an asset acquisition. Transactions assessed as asset acquisitions do not give rise to goodwill.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In
respect of business combinations that have occurred since January 1, 2004 (being the transition date to IFRS), goodwill represents the
difference between the cost of the acquisition and the fair value of the net identifiable assets acquired. In respect of acquisitions
prior to this date, goodwill is included on the basis of its deemed cost, which represents the amount recorded under Irish GAAP.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>To
the extent that the Group&#8217;s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities acquired
exceeds the cost of a business combination, the identification and measurement of the related assets, liabilities and contingent liabilities
are revisited accompanied by a reassessment of the cost of the transaction, and any remaining balance is immediately recognised in the
statement of operations.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
the acquisition date, any goodwill is allocated to each of the Group&#8217;s cash-generating units expected to benefit from the combination&#8217;s
synergies. Following initial recognition, goodwill is stated at cost less any accumulated impairment losses and is not amortised but is
tested annually for impairment.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>This
policy has been applied to acquisitions completed during the year, including the acquisition of the CGM assets of Waveform Technologies,
Inc. in January 2024, and the acquisitions of EpiCapture Limited and Metabolomics Diagnostics Limited, further details of which are disclosed
in Note 29 to the consolidated financial statements losses.</span></span></span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>vii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Intangibles,
        including research and development (other than goodwill)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>An
intangible asset, which is an identifiable non-monetary asset without physical substance, is recognised to the extent that it is probable
that the expected future economic benefits attributable to the asset will flow to the Group and that its cost can be measured reliably.
The asset is deemed to be identifiable when it is separable (that is, capable of being divided from the entity and sold, transferred,
licenced, rented or exchanged, either individually or together with a related contract, asset or liability) or when it arises from contractual
or other legal rights, regardless of whether those rights are transferable or separable from the Group or from other rights and obligations.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Intangible
assets acquired as part of a business combination are capitalised separately from goodwill if the intangible asset meets the definition
of an asset and the fair value can be reliably measured on initial recognition. In the case of recent acquisitions, the Group has recognised
technology-based intangible assets, comprising know-how, trade secrets and similar intellectual property. These assets are classified
as finite-lived and are initially recognised at fair value as determined by independent valuation.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent
to initial recognition, these intangible assets are carried at cost less any accumulated amortisation and any accumulated impairment losses
(Note 1(viii)). Intangible assets with definite useful lives are reviewed for indicators of impairment annually while intangible assets
with indefinite useful lives and those not yet brought into use are tested for impairment at least annually, either individually or at
the cash-generating unit level.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Expenditure
on development activities, whereby research findings are applied to a plan or design for the production of new or substantially improved
products and processes, is capitalised if the product or process is technically and commercially feasible and the Group has sufficient
resources to complete the development. The expenditure capitalised includes the cost of materials, direct labour and attributable overheads
and third party costs. Subsequent expenditure on capitalised intangible assets is capitalised only when it increases the future economic
benefits embodied in the specific asset to which it relates.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
technical feasibility of a new product is determined by a specific feasibility study undertaken at the first stage of any development
project. The majority of our new product developments involve the transfer of existing product know-how to a new application. Since the
technology is already proven in an existing product which is being used by customers, this facilitates the proving of the technical feasibility
of that same technology in a new product.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
results of the feasibility study are reviewed by a design review committee comprising senior managers. The feasibility study occurs in
the initial research phase of a project and costs in this phase are not capitalised.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
commercial feasibility of a new product is determined by preparing a discounted cash flow projection. This projection compares the discounted
sales revenues for future periods with the relevant costs. As part of preparing the cash flow projection, the size of the relevant market
is determined, feedback is sought from customers and the strength of the proposed new product is assessed against competitors&#8217; offerings.
Once the technical and commercial feasibility has been established and the project has been approved for commencement, the project moves
into the development phase.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>All
other development expenditure is expensed as incurred. Subsequent to initial recognition, the capitalised development expenditure is carried
at cost less any accumulated amortisation and any accumulated impairment losses.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Expenditure
on research activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognised
in the statement of operations as an expense as incurred.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Expenditure
on internally generated goodwill and brands is recognised in the statement of operations as an expense as incurred.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Amortisation</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Amortisation
is charged to the statement of operations on a straight-line basis over the estimated useful lives of intangible assets, unless such lives
are indefinite. Intangible assets are amortised from the date they are available for use in its intended market. The estimated useful
lives are as follows:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:bottom">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Capitalised development costs</span></span></span></span></span></div> </td>
    <td style="width:15.77%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>15&#160;years</span></span></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:middle">&#160;</td>
    <td style="width:15.77%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:bottom">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Patents and licences</span></span></span></span></span></div> </td>
    <td style="width:15.77%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>6-15&#160;years</span></span></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:middle">&#160;</td>
    <td style="width:15.77%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:bottom">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Other (including acquired customer and supplier lists)</span></span></span></span></span></div> </td>
    <td style="width:15.77%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>6-15
        years</span></span></span></span></span></div> </td> </tr>
  </table> </div>

<p style="margin:0pt">&#160;</p> </div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group uses a useful economic life of 15
years for capitalised development costs. This is a conservative estimate of the likely life of the products. The Group
is confident that products have a minimum of 15 years life given the inertia that characterizes the medical diagnostics industry and the
barriers to enter into the industry. The following factors have been considered in estimating the useful life of developed products:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>(a)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>once a diagnostic test becomes
        established, customers are reluctant to change to new technology until it is fully proven, thus resulting in relatively long product life
        cycles. There is also reluctance in customers to change to a new product as it can be costly both in terms of the initial changeover cost
        and as new technology is typically more expensive.</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>(b)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>demand for the diagnostic tests
        is enduring and robust within a wide geographic base. The diseases that the products diagnose are widely prevalent (HIV, Diabetes and
        Chlamydia being just three examples) in many countries. There is a general consensus that these diseases will continue to be widely prevalent
        in the future. Demand for biosensors is showing high growth in recent years due to the ease of use and the appeal of real time information.</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>(c)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>there are significant barriers
        to new entrants in this industry. Patents and/or licences are in place for several of our products, though this is not the only barrier
        to entry. There is a significant cost and time to develop new products, it is necessary to obtain regulatory approval and tests are protected
        by proprietary know-how, manufacturing techniques and trade secrets.</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>During
the year ended December 31, 2024, the Group capitalised US$7.0
million in development costs related to newly acquired intangible assets. As the underlying intellectual property remains at a pre-commercialisation
stage and is not yet available for use, amortisation has not commenced. Amortisation will begin when the assets are brought into use,
in accordance with the Group&#8217;s stated policy.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Technology-based
intangible assets acquired as part of business combinations are assigned finite useful lives in line with the Group&#8217;s amortisation
policies, based on independent valuation reports. Amortisation of these assets will commence when they are available for use, i.e., when
they are in the location and condition necessary for them to be capable of operating in the manner intended by management. For technology-based
intangible assets acquired in 2024, amortisation has not commenced as the technologies have not yet been commercialised.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Certain
trade names acquired are deemed to have an indefinite useful life as there is no foreseeable limit to the period over which these assets
are expected to generate cash inflows for the Group.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
amortisation is charged on assets with finite lives, this expense is taken to the statement of operations through the &#8216;selling,
general and administrative expenses&#8217; line.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Useful
lives are examined on an annual basis and adjustments, where applicable, are made on a prospective basis.</span></span></span></span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>viii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Impairment</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
carrying amount of the Group&#8217;s assets, other than inventories, accounts receivable, cash and cash equivalents, short-term investments
and deferred tax assets, are reviewed at each balance sheet date to determine whether there is any indication of impairment. If any such
indication exists, the asset&#8217;s recoverable amount (being the greater of fair value less costs to sell and value in use) is assessed
at each balance sheet date.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Fair
value less costs to sell is defined as the amount obtainable from the sale of an asset or cash-generating unit in an arm&#8217;s length
transaction between knowledgeable and willing parties, less the costs that would be incurred on disposal. Value in use is defined as the
present value of the future cash flows expected to be derived through the continued use of an asset or cash-generating unit. In assessing
value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current
market assessments of the time value of money and the risks specific to the asset for which the future cash flow estimates have not yet
been adjusted. The estimates of future cash flows exclude cash inflows or outflows attributable to financing activities. For an asset
that does not generate largely independent cash flows, the recoverable amount is determined by reference to the cash-generating unit to
which the asset belongs.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>For
goodwill, assets that have an indefinite useful life and intangible assets that are not yet available for use, the recoverable amount
is estimated at each balance sheet date at the cash-generating unit level. The goodwill and indefinite-lived assets were reviewed for
impairment at June 30, 2023, December&#160;31, 2023, June 30, 2024 and December&#160;31, 2024. See Note 12.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In-process
research and development (IPR&amp;D) is tested for impairment on a bi-annual basis, and always at year end, or more frequently if impairment
indicators are present, using projected discounted cash flow models. If IPR&amp;D becomes impaired or is abandoned, the carrying value
of the IPR&amp;D is written down to its revised fair value with the related impairment charge recognised in the period in which the impairment
occurs. If the fair value of the asset becomes impaired as the result of unfavorable data from any ongoing or future clinical trial, changes
in assumptions that negatively impact projected cash flows, or because of any other information regarding the prospects of successfully
developing or commercializing our programs, we could incur significant charges in the period in which the impairment occurs. The valuation
techniques utilized in performing impairment tests incorporate significant assumptions and judgments to estimate the fair value, as described
above. The use of different valuation techniques or different assumptions could result in materially different fair value estimates.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>An
impairment loss is recognised whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount. Impairment
losses are recognised in the statement of operations.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Impairment
losses recognised in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash-generating
units and then to reduce the carrying amount of other assets in the cash-generating units on a pro-rata basis.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>An
impairment loss is reversed only to the extent that the asset&#8217;s carrying amount does not exceed the carrying amount that would have
been determined, net of depreciation or amortisation, if no impairment loss had been recognised.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>An
impairment loss in respect of goodwill is not reversed.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Following
recognition of any impairment loss (and on recognition of an impairment loss reversal), the depreciation or amortisation charge applicable
to the asset or cash-generating unit is adjusted prospectively with the objective of systematically allocating the revised carrying amount,
net of any residual value, over the remaining useful life.</span></span></span></span></span></div> </div>

<p style="margin:0pt">&#160;</p>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">ix)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Financial
        Assets</span></span></span></span></span></span></div> </div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>On
initial recognition, a financial asset is classified as measured at amortised cost and subsequently measured using the effective interest
rate (EIR) method and subject to impairment. Financial assets may also be initially measured at fair value with any movement being reflected
through other comprehensive income or the Consolidated Statement of Operations.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>On
initial recognition of an equity investment that is not held for trading, the Group may irrevocably elect to present subsequent changes
in the investment&#8217;s fair value in other comprehensive income. This election is made on an investment-by investment&#160;basis.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
such an election is not made, and the investment is not held for trading, the equity instrument is classified as measured at fair value
through profit or loss (FVTPL). Subsequent changes in fair value are recognised in the Consolidated Statement of Operations. During 2024,
the Group acquired a strategic equity interest in an unlisted entity accounted for under this classification. Refer to Note 13.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Financial
assets are written off when there is no reasonable expectation of recovery, such as when the debtor has entered bankruptcy, when collection
efforts have been exhausted, or when the asset has been significantly past due (typically over 365 days) without any recent payments or
active correspondence. The Group considers both quantitative factors (such as aging) and qualitative indicators (e.g., legal or insolvency
proceedings) in making this assessment. Where receivables are written off but remain subject to enforcement activity, such as legal action
or engagement with collection agencies, these efforts are continued until formally closed.</span></span></span></span></span></div> </div>


<div style="line-height:1.25">&#160;</div>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">x)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Inventories</span></span></span></span></span></span></div>
        </div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Inventories
are stated at the lower of cost and net realisable value. Cost is based on the first-in, first-out principle and includes all expenditure
which has been incurred in bringing the products to their present location and condition and includes an appropriate allocation of manufacturing
overhead based on the normal level of operating capacity. Net realisable value is the estimated selling price of inventory on hand in
the ordinary course of business less all further costs to completion and costs expected to be incurred in selling these products.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group provides for inventory, based on estimates of the expected realisability. The estimated realisability is evaluated on a case-by-case
basis and any inventory that is approaching its &#8220;use-by&#8221; date and for which no further re-processing can be performed is written
off. Any reversal of an inventory provision is recognised in the statement of operations in the year in which the reversal occurs.</span></span></span></span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trade
        and other receivables</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trade
receivables are amounts due from customers for products sold or services provided in the ordinary course of business. Trade and other
receivables are stated at their amortised cost less impairment losses incurred. Cost approximates fair value given the short-term nature
of these assets. The Group records the loss allowance as lifetime expected credit losses.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>These
are the expected shortfalls in contractual cash flows, considering the potential for default at any point during the life of the financial
instrument. Expected credit losses are recorded on all of trade receivables based on an assessment of the probability of default or delinquency
in payments and the probability that debtor will enter into financial difficulties or bankruptcy.</span></span></span></span></span></div>
</div>

<p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left">&#160;</p>

<div></div> </div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trade
        and other payables</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trade
payables are obligations to pay for goods or services that have been acquired in the ordinary course of business. Trade and other payables
are stated at cost. Cost approximates fair value given the short term nature of these liabilities.</span></span></span></span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xiii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Cash
        and cash equivalents</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="text-align:justify;text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Cash
and cash equivalents comprise cash balances and short-term deposits which are readily available at year-end. Deposits with maturities
less than six months as at the year-end date are recognised as cash and cash equivalents and are carried at fair value when there is no
expected loss in value on early termination. The Group has no short-term bank overdraft facilities. Where restrictions are imposed by
third parties, such as lending institutions, on cash balances held by the Group these are treated as financial assets in the financial
statements.</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xiv)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Share-based
        payments</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>For
equity-settled share-based payments (share options), the Group measures the services received and the corresponding increase in equity
at fair value at the measurement date (which is the grant date) using a trinomial model. Given that the share options granted do not vest
until the completion of a specified period of service, the fair value, which is assessed at the grant date, is recognised on the basis
that the services to be rendered by employees as consideration for the granting of share options will be received over the vesting period.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Certain
share options have been granted for which there is a condition that the options only become exercisable into ADSs when the market price
of an ADS reaches a certain level. This is deemed to be a non-vesting condition. The term &#8216;non-vesting condition&#8217; is not explicitly
defined in IFRS 2, Share based Payment, but is inferred to be any condition that does not meet the definition of a vesting condition.
The only condition for these options to vest is that the option holder continues service and there were no other conditions which would
be considered non-vesting conditions. Non-vesting conditions are reflected in measuring the grant-date fair value of the share-based payment
and there is no true-up in the measurement of the share-based payment for differences between the expected and the actual outcome of non-vesting
conditions. If all service conditions are met, then the share-based payment cost will be recognized even if the option holder does not
receive the share-based payment due to a failure to meet the non-vesting condition.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
expense in the consolidated statement of operations in relation to share options represents the product of the total number of options
anticipated to vest and the fair value of those options; this amount is allocated to accounting periods on a straight-line basis over
the vesting period.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Share
based payments, to the extent they relate to direct labour involved in development activities, are capitalised.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when
the options are exercised. The Group does not operate any cash-settled share-based payment schemes or share-based payment transactions
with cash alternatives as defined in IFRS 2.</span></span></span></span></span></div> </div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xv)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Government
        grants</span>&#160;<span style="font-style:italic">and financial support</span></span></span></span></span></span></div> </td> </tr>
  </table>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
Group received government-backed Covid-19 financial supports in the form of forgivable loans. Under IAS 20, Accounting for Government
Grants, a forgivable loan from government is treated as a government grant when there is reasonable assurance that the terms for forgiveness
of the loan will be met. Where a loan was received in the financial year but not yet forgiven within the financial year, the loan is treated
as a current liability. The Group has opted to present government grant income for loans that have been forgiven as Other operating income
in the consolidated statement of operations.</span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>If
it is no longer reasonably assured that the terms of forgiveness will be met, any income previously recognised in respect of such a loan
is reversed in the period in which the change in assessment occurs. Grants that compensate the Group for expenses incurred such as research
and development, employment and training are recognised as income in the statement of operations on a systematic basis in the same periods
in which the expenses are incurred. Grants that compensate the Group for the cost of an asset are recognised in the statement of operations
on a systematic basis over the useful life of the asset. R&amp;D tax credits claimed from tax authorities are credited to the taxation
line in the consolidated statement of operations.</span></span></span></span></span></span></span></div> </div>  </div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xvi)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div>
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Revenue
        recognition</span></span></span></span></span></span></div> </div> </td> </tr>
  </table> </div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Goods
sold and services rendered</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group recognises revenue when it transfers control over a good or service to a customer. Revenue is recognised to the extent that it is
probable that economic benefit will flow to the Group and the revenue can be measured. No revenue is recognised if there is uncertainty
regarding recovery of the consideration due at the outset of the transaction. Revenue, including any amounts invoiced for shipping and
handling costs, represents the value of goods and services supplied to external customers, net of discounts and rebates and excluding
sales taxes.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Revenue
from products is generally recorded as of the date of shipment, consistent with typical ex-works shipment terms. Where the shipment terms
do not permit revenue to be recognised as of the date of shipment, revenue is recognised when the Group has satisfied all of its performance
obligations to the customer in accordance with the shipping terms.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Some
contracts oblige the Group to ship product to the customer ahead of the agreed payment schedule. For these shipments, a contract asset
is recognised when control over the goods has transferred to the customer. The financing component is insignificant as invoicing for these
shipments occurs within a short period of time after shipment has occurred and standard 30 day credit terms typically apply.<span style="font-style:italic">&#160;</span>Some
contracts could be regarded as offering the customer a right of return. Due to the uncertainty of the magnitude and likelihood of product
returns, there is a level of estimation involved in assessing the amount of revenue to be recognized for these types of contracts. In
accordance with IFRS 15, when estimating the effect of an uncertainty on an amount of variable consideration to which the Group will be
entitled, all information that is reasonably available, including historical, current and forecast, is considered.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Revenue
is recognised on bill-and-hold transactions when all of the criteria in IFRS 15 are met, including: (i) the arrangement is at the customer&#8217;s
request and has a substantive business reason; (ii) the products are separately identified as belonging to the customer; (iii) the products
are ready for physical transfer to the customer; and (iv) the Group has no ability to use the products or redirect them to another customer.
The Group assesses each bill-and-hold arrangement individually for compliance with these criteria. When all criteria are satisfied, control
is deemed to have transferred and revenue is recognised.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group operates a licenced referenced laboratory in the US, which provides testing services to institutional customers and insurance companies.
In the US, there are rules requiring all insurance companies to be billed the same amount per test. However, the amount that each insurance
company pays for a particular test varies according to their own internal policies and this can typically be considerably less than the
amount invoiced. We recognise lab services revenue for insurance companies by taking the invoiced amount and reducing it by an estimated
percentage based on historical payment data. We review the percentage reduction annually based on the latest data. As a practical expedient,
and in accordance with IFRS, we apply a portfolio approach to the insurance companies as they have similar characteristics. We judge that
the effect on the financial statements of using a portfolio approach for the insurance companies will not differ materially from applying
IFRS 15 to the individual contracts within that portfolio.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Revenue
from services rendered is recognised in the statement of operations in proportion to the stage of completion of the transaction at the
balance sheet date.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group leases instruments to customers typically as part of a bundled package. Where a contract has multiple performance obligations and
its duration is greater than one year, the transaction price is allocated to the performance obligations in the contract by reference
to their relative standalone selling prices. For contracts where control of the instrument is transferred to the customer, the fair value
of the instrument is recognised as revenue at the commencement of the lease and is matched by the related cost of sale. Fair value is
determined on the basis of standalone selling price. In the case where control of the instrument does not transfer to the customer, revenue
is recognised on the basis of customer usage of the instrument. See also Note 1 (v).</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In
obtaining these contracts, the Group incurs a number of incremental costs, such as sales bonus paid to sales staff commissions paid to
distributors and royalty payments. As the amortisation period of these costs, if capitalised, would be less than one year, the Group makes
use of the practical expedient in IFRS 15.94 and recognised them as expense as they are incurred.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>A
receivable is recognised when the goods are delivered as this is the point in time that the consideration is unconditional because only
the passage of time is required before the payment is due.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group&#8217;s obligation to provide a refund for faulty products under the standard warranty terms is recognised as a provision, see Note
22 for details.</span></span></span></span></span></div> </div>

<p style="margin:0pt">&#160;</p>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xvi)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Other
        operating income</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Other
operating income primarily includes items of income that arise outside the normal course of business, including government grant income
from forgiven loans, insurance proceeds, sublease income, and other non-recurring items. Income is recognised when it is probable that
the economic benefits associated with the transaction will flow to the Group and the amount can be measured reliably.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>During
the year ended December 31, 2024, other operating income included the reversal of $1.8
million previously recognised in relation to the forgiveness of Paycheck Protection Program (PPP) loans. This reversal was recognised
following the commencement of a U.S. Department of Justice investigation regarding the eligibility of certain U.S. subsidiaries for loan
forgiveness.</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xvii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Employee
        benefits</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Defined
contribution plans</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group operates defined contribution schemes in various locations where its subsidiaries are based. Contributions to the defined contribution
schemes are recognised in the statement of operations in the period in which the related service is received from the employee.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Other
long-term benefits</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
employees participate in the Group&#8217;s other long-term benefit schemes (such as permanent health insurance schemes under which the
scheme insures the employees), or where the Group contributes to insurance schemes for employees, the Group pays an annual fee to a service
provider, and accordingly the Group expenses such payments as incurred.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Termination
benefits</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Termination
benefits are recognised as an expense when the Group is demonstrably committed, without realistic possibility of withdrawal, to a formal
detailed plan to either terminate employment before normal retirement date, or to provide termination benefits as a result of an offer
made to encourage voluntary redundancy.</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xviii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Foreign
        currency</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>A
majority of the revenue of the Group is generated in US Dollars. The Group&#8217;s management has determined that the US&#160;Dollar is
the primary currency of the economic environment in which the Company and its subsidiaries (with the exception of the Group&#8217;s subsidiaries
in Brazil, Canada and Sweden) principally operate. Thus, the functional currency of the Company and its subsidiaries (other than the Brazilian,
Canadian and Swedish subsidiaries) is the US&#160;Dollar. The functional currency of the Brazilian entity is the Brazilian Real and the
functional currency of the Canadian subsidiary is the Canadian Dollar.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
presentation currency of the Company and Group is the US&#160;Dollar. Monetary assets and liabilities denominated in foreign currencies
are translated at the rates of exchange ruling at the balance sheet date. The resulting gains and losses are included in the consolidated
statement of operations. Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated
using the exchange rate at the date of the transaction.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Results
and cash flows of subsidiary undertakings, which have a functional currency other than the US&#160;Dollar, are translated into US Dollars
at average exchange rates for the year, and the related balance sheets have been translated at the rates of exchange ruling on the balance
sheet date. Any exchange differences arising from the translations are recognised in the currency translation reserve via the statement
of changes in equity.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
Euro, Brazilian Real, or Canadian Dollar amounts have been referenced in this document, their corresponding US&#160;Dollar equivalent
has also been included and these equivalents have been calculated with reference to the foreign exchange rates prevailing at December&#160;31,
2024.</span></span></span></span></span></div> </div>

<p style="margin:0pt">&#160;</p>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xix)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Hedging</span></span></span></span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
activities of the Group expose it primarily to changes in foreign exchange rates and interest rates. The Group uses derivative financial
instruments, from time to time, such as forward foreign exchange contracts to hedge these exposures.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group enters into forward contracts to sell US Dollars forward for Euro. The principal exchange risk identified by the Group is with respect
to fluctuations in the Euro as a substantial portion of its expenses are denominated in Euro but its revenues are primarily denominated
in US Dollars. Trinity Biotech monitors its exposure to foreign currency movements and may use these forward contracts as cash flow hedging
instruments whose objective is to cover a portion of this Euro expense.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
the inception of a hedging transaction entailing the use of derivatives, the Group documents the relationship between the hedged item
and the hedging instrument together with its risk management objective and the strategy underlying the proposed transaction. The Group
also documents its quarterly assessment of the effectiveness of the hedge in offsetting movements in the cash flows of the hedged items.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Derivative
financial instruments are recognised at fair value. Where derivatives do not fulfil the criteria for hedge accounting, they are classified
as held-for-trading and changes in fair values are reported in the statement of operations. The fair value of forward exchange contracts
is calculated by reference to current forward exchange rates for contracts with similar maturity profiles and equates to the current market
price at the balance sheet date.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
portion of the gain or loss on a hedging instrument that is deemed to be an effective cash flow hedge is recognised directly in the hedging
reserve in equity and the ineffective portion is recognised in the statement of operations. As the forward contracts are exercised the
net cumulative gain or loss recognised in the hedging reserve is transferred to the statement of operations and reflected in the same
line as the hedged item.</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xx)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Exchangeable
        notes and derivative financial instruments</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Company&#8217;s exchangeable notes are treated as a host debt instrument with embedded derivatives attached. On initial recognition, the
host debt instrument is recognised at the residual value of the total net proceeds of the bond issue less fair value of the embedded derivatives.
Subsequently, the host debt instrument is measured at amortised cost using the effective interest rate method.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
embedded derivatives are initially recognised at fair value and are restated at their fair value at each reporting date. The fair value
changes of the embedded derivatives are recognised in the consolidated statement of operations, except for changes in fair value related
to the Group&#8217;s own credit risk, which are recorded in the statement of comprehensive income.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
the exchangeable notes are redeemed early or repurchased in a way that does not alter the original conversion privileges, the consideration
paid is allocated to the respective components and the amount of any gain or loss is recognised in the consolidated statement of operations.</span></span></span></span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Senior
        secured term loan</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
senior secured term loan is initially recorded at the fair value of the consideration received net of:&#160; a) directly attributable
transaction costs, b) the fair value at the date of issue of the warrants issued to the lender (see Note 1xxii) and c) the fair value
of the option to prepay the loan at the date of issue (see Note 1xxii).</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Subsequent
to initial recognition, the term loan is measured at amortised cost employing the effective interest methodology. Borrowing costs, including
any penalties for early settlement of the loan, are recognised as an expense in the period in which they are incurred.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In
accordance with IFRS 9, the Group assesses any changes to the contractual terms of its borrowings to determine whether such changes result
in a substantial modification. A modification is considered substantial if the revised cash flows differ significantly from those of the
original arrangement, in which case the original liability is derecognised and a new financial liability is recognised. If a modification
is not substantial, the loan is remeasured using the original EIR, with any resulting gain or loss recognised in profit or loss.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>During
2024, the Group amended the terms of its senior secured term loan; however, this was assessed under IFRS 9 and determined not to constitute
a substantial modification. Refer to Note 23 for further details.</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Warrants
        and loan prepayment option</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Company has issued warrants to third parties. A warrant contract might be accounted for as an equity instrument or a financial liability
under IFRS depending on the terms of a warrant. A warrant contract that will or might be settled by an entity by delivering a fixed number
of its own equity instruments, in exchange for a fixed amount of cash or another financial asset, is an equity instrument.&#160;As Perceptive
has the option to choose a cashless exercise option, the Company will have to deliver a variable number of ADS, since the number of shares
will vary depending on the ADS traded price. Even though the cashless exercise option is economically comparable to the cash exercise
option, the fact that the Company will issue a variable number of shares under the cashless exercise option results in one settlement
alternative violating the &#8216;fixed for fixed&#8217; requirement.&#160; The warrant contract therefore meets the definition of a financial
liability and given the value of the warrant changes in response to the price of the Company&#8217;s ADS, with no initial investment and
settlement occurring in the future it meets the definition of a derivative liability under IFRS 9. The warrant is issued in a separate
contract, is transferable independently of the term loan and can be exercised while the term loan remains outstanding. Therefore, the
warrant is a separate instrument to the term loan.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
warrant contracts are initially recognised as a derivative liability at fair value and subsequently measured at fair value at each reporting
period with any changes recognised in the consolidated statement of operations.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Company has the option to prepay the senior secured term loan in whole or in part for an amount equal to the principal, accrued interest
and prepayment premium. In accordance with IFRS 9, this option is separated from the term loan and is initially recognised as a derivative
asset at fair value and subsequently measured at fair value at each reporting period with any changes recognised in the consolidated statement
of operations.</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xxiii)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Convertible
        Note</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
convertible note is accounted for as a compound financial instrument containing both an equity and liability element. The convertible
note has a contractual obligation to deliver cash on redemption equal to the principal amount plus accrued interest and therefore has
a liability component in line with the definition of a financial liability in IAS 32. The convertible loan note also has a conversion
feature where it mandatorily converts into ADS if the volume weighted average price of the Company&#8217;s ADSs is at a certain price
for any five consecutive NASDAQ trading days or any other time at the discretion of the Noteholder. Where a derivative that will or may
be settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity's own equity
instruments, the conversion feature represents an equity component of the convertible note.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
equity component is measured as the residual amount that results from deducting the fair value of the liability component from the initial
carrying amount of the instrument as a whole. There is no remeasurement of the equity element following initial recognition. The debt
component is accounted for at amortised cost employing the effective interest methodology.</span></span></span></span></span></div> </div>


<p style="margin:0pt">&#160;</p>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xxiv)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Segment
        reporting</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Operating
segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating
decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as
the Board of Directors.</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;font-style:italic;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxv)</span></span></span></span></span></td>
    <td style="vertical-align:top;width:auto">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Tax
        (current and deferred)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Income
tax on the profit or loss for the year comprises current and deferred tax. Income tax is recognised in the consolidated statement of operations
except to the extent that it relates to items recognised directly in equity, in which case it is recognised in equity.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Current
tax represents the expected tax payable or recoverable on the taxable profit for the year using tax rates enacted or substantively enacted
at the balance sheet date in the countries where the company and its subsidiaries operate and generate income and taking into account
any adjustments stemming from prior years.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Deferred
tax is provided on the basis of the balance sheet liability method on all temporary differences at the balance sheet date which is defined
as the difference between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred tax
assets and liabilities are not subject to discounting and are measured at the tax rates that are anticipated to apply in the period in
which the asset is realised or the liability is settled based on tax rates and tax laws that have been enacted or substantively enacted
at the balance sheet date. Deferred tax assets are recognised when it is probable that future taxable profits will be available to utilize
the associated losses or temporary differences. The amount of deferred tax provided is based on the expected manner of realisation or
settlement of the carrying amount of assets and liabilities.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Deferred
tax assets and liabilities are recognised for all temporary differences (that is, differences between the carrying amount of the asset
or liability and its tax base) with the exception of the following:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>i.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where the deferred tax liability
        arises from goodwill not deductible for tax purposes or the initial recognition of an asset or a liability in a transaction that is not
        a business combination and affects neither the accounting profit nor the taxable profit or loss at the time of the transaction; and</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>ii.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where, in respect of temporary
        differences associated with investments in subsidiary undertakings, the timing of the reversal of the temporary difference is subject
        to control and it is probable that the temporary difference will not reverse in the foreseeable future.</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
goodwill is tax deductible, a deferred tax liability is not recognised on initial recognition of goodwill. It is recognised subsequently
for the taxable temporary difference which arises when the goodwill is amortised for tax with no corresponding adjustment to the carrying
value of the goodwill.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
carrying amounts of deferred tax assets are subject to review at each balance sheet date and are derecognised to the extent that future
taxable profits are considered to be inadequate to allow all or part of any deferred tax asset to be utilised.</span></span></span></span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxvi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Provisions</span>&#160;<span style="font-style:italic">and
        contingent liabilities</span></span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>A
provision is recognised in the balance sheet when the Group has a present legal or constructive obligation because of a past event, and
it is probable that an outflow of economic benefits will be required to settle the obligation. The status of any significant claim and
legal proceeding in which the Group is involved is reviewed by management on a periodic basis and the Group&#8217;s potential financial
exposure is assessed. If the potential loss from any claim or legal proceeding is considered probable, and the amount can be reliably
estimated, a liability is recognised for the estimated loss.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Due
to the uncertainties inherent in such matters, the related provisions are based on the best information available at the time. As additional
information becomes available on pending claims, the potential liability is reassessed and revisions are made to the amounts accrued as
appropriate. Such revisions in the judgments and estimates of the potential liabilities could have an impact on the results of operations
and financial position of the Group in future accounting periods.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Provisions
for restructuring costs are recognised only when the Group has approved a detailed formal plan and has either commenced implementation
or raised a valid expectation among those affected that the restructuring will be carried out. Under IAS 37, restructuring provisions
must only include direct expenditures that are necessarily incurred by the restructuring and not associated with the ongoing activities
of the business.</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xxvii)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Cost
        of sales</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Cost
of sales comprises product cost including manufacturing and payroll costs, quality control, shipping, handling, and packaging costs and
the cost of services provided.</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxviii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Finance
        income and costs</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Financing
expenses comprise interest costs payable on senior secured term loan, convertible note, leases and exchangeable notes along with non-recurring
financing expenses such as penalty for early settlement of term loan and loss on disposal of exchangeable notes. Interest payable on finance
leases is allocated to each period during the lease term so as to produce a constant periodic rate of interest on the remaining balance
of the liability. Financing expenses also includes the financing element of long term liabilities which have been discounted. Finance
income includes interest income on deposits and is recognised in the consolidated statement of operations as it accrues, using the effective
interest method. Finance income also includes fair value adjustments for derivative assets and liabilities related to the senior secured
term loan and to embedded derivatives associated with exchangeable notes.</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxix)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Treasury
        shares</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>When
the Group purchases its<span style="font-style:italic">&#160;</span>own equity instruments (treasury shares), the costs, including any
directly attributable incremental costs, are deducted from equity. No gain or loss is recognised in the consolidated statement of operations
on the purchase, sale, issue or cancellation of the Group&#8217;s own equity instruments. Any difference between the carrying amount and
the consideration, if reissued, is recognised in share premium. Voting rights related to treasury shares are nullified for the Group and
no dividends are allocated to them.</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxx)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Equity</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Share
capital represents the nominal (par) value of shares that have been issued. Share premium includes any premiums received on issue of share
capital. Any transaction costs associated with the issuing of shares are deducted from share premium, net of any related income tax benefits.</span></span></span></span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxxi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Profit
        or loss from discontinued operations</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>A
discontinued operation is a component of the Group that either has been disposed of or is classified as held for sale. Profit or loss
from discontinued operations comprises the post-tax profit or loss of discontinued operations and the post-tax gain or loss resulting
from the measurement and disposal of assets classified as held for sale and any gain or loss on disposal.</span></span></span></span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxxii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Fair
        values</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>For
financial reporting purposes, fair value measurements are categorized into Level&#160;1, 2 or 3 based on the degree to which inputs to
the fair value measurements are observable and the significance of the inputs to the fair value measurement in its entirety, which are
described as follows:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Level&#160;1:
quoted prices (unadjusted) in active markets for identical assets or liabilities</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Level&#160;2:
valuation techniques for which the lowest level of inputs which have a significant effect on the recorded fair value are observable, either
directly or indirectly</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Level&#160;3:
valuation techniques for which the lowest level of inputs that have a significant effect on the recorded fair value are not based on observable
market data</span></span></span></span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxxiii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>New
        IFRS Standards</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
following new accounting standards and interpretations became effective for annual periods beginning on or after 1 January 2024. The adoption
of these standards did not have a material impact on the Group&#8217;s consolidated financial statements:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Classification of Liabilities
        as Current or Non-current (Amendments to IAS 1)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Lease Liability in a Sale and
        Leaseback (Amendments to IFRS 16)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Supplier Finance Arrangements
        (Amendments to IAS 7 and IFRS 7)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Company is currently assessing the impact of the new standards and amendments on the Company&#8217;s accounting policy disclosure.</span></span></span></span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxxiv)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Standards,
        amendments and interpretations to existing IFRS Standards that are not yet effective</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
standards and amendments that have been issued but are not yet effective as at the date of issuance of the financial statements, and which
may have an impact on the Group's financial statements in future periods, are listed below. The Group intends to adopt these standards,
if applicable, when they become effective:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Lack of Exchangeability (Amendments
        to IAS 21), effective from 1 January 2025</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Amendments to the Classification
        and Measurement of Financial Instruments (Amendments to IFRS 9 and 7), effective from 1 January 2026</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Annual Improvements to IFRS
        Accounting Standards, effective from 1 January 2026</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>IFRS 18 &#8216;Presentation
        and Disclosure in Financial Statements&#8217;, effective from 1 January 2027</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>IFRS 19 &#8216;Subsidiaries
        without Public Accountability: Disclosures&#8217;, effective from 1 January 2027</span></span></span></span></span></div> </td> </tr>
  </table> </div>  </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for basis of preparation and significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">SEGMENT INFORMATION</a></td>
<td class="text">

<div>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SEGMENT INFORMATION</span></span></div> </td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating
decision-maker, who is responsible for allocating resources and assessing the performance of the operating segments, has been identified
as the Board of Directors. Management has determined the operating segments based on the reports reviewed by the Board of Directors, which
are used to make strategic decisions. The Board considers the business from a geographic perspective based on the Group&#8217;s management
and internal reporting structure. Sales of product between companies in the Group are made on commercial terms which reflect the nature
of the relationship between the relevant companies. Segment results, assets and liabilities include items directly attributable to a segment
as well as those that can be allocated on a reasonable basis. Unallocated items comprise interest-bearing loans, borrowings and expenses
and corporate expenses. Segment capital expenditure is the total cost during the year to acquire segment plant, property and equipment
and intangible assets that are expected to be used for more than one period, whether acquired on acquisition of a business combination
or through acquisitions as part of the current operations.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group comprises two main geographical segments (i)&#160;the Americas and (ii)&#160;Rest of World - Ireland. The Group&#8217;s geographical
segments are determined by the location of the Group&#8217;s assets and operations. The Group has also presented a geographical analysis
of the segmental data for Ireland as is consistent with the information used by the Board of Directors.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
reportable operating segments derive their revenue primarily from one source (i.e., the market for diagnostic tests for a range of diseases
and other medical conditions). In determining the nature of its segmentation, the Group has considered the nature of the products, their
risks and rewards, the nature of the production base, the customer base and the nature of the regulatory environment. The Group acquires,
manufactures and markets a range of diagnostic products. The Group&#8217;s products are sold to a similar customer base and the Group&#8217;s
products must comply with various regulators worldwide in the markets that we serve.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following presents revenue and profit information and certain asset and liability information regarding the Group&#8217;s geographical
segments.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of revenue by geographical area
        based on location of assets was as follows:</span></span></div> </td> </tr>
  </table>

<div>&#160;</div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminations</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
        from external customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">41,792</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,763</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inter-segment
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,815</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">702</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(20,517</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,607</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,465</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(20,517</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminations</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
        from external customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44,984</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,848</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inter-segment
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,867</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">872</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,739</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,851</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,720</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,739</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminations</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
        from external customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,508</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,013</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inter-segment
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,110</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">828</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,938</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">76,618</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,841</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,938</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ii)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of revenue by customers&#8217;
        geographical area was as follows:</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29,917</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32,282</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35,557</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia
        / Africa</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,775</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,909</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe
        (including Ireland) *</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,863</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,641</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,563</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:12.25pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue from customers in Ireland is not disclosed
        separately due to the immateriality of these revenues.</span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iii)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of revenue by major product group
        was as follows:</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Clinical
        laboratory goods</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,372</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42,288</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,036</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Clinical
        laboratory services</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,750</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,453</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,272</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Point-of-care</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,433</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,091</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,213</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iv)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The group has recognised the following amounts
        relating to revenue in the consolidated statement of operations:</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
        from contracts with customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div>

<div>&#160;</div>

<div></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(v)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disaggregation of revenue from contracts with
        customers:</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group derives revenue from the transfer of goods and services over time and at a point in time in the following geographical areas:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">41,536</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,763</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,299</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">256</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">256</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">41,792</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,763</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44,692</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,848</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,540</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">292</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">292</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44,984</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,848</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,174</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,013</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,187</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,508</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,013</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(vi)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Group derives revenue from the transfer of
        goods and services over time and at a point in time based on customers&#8217; geographical area as follows:</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia
        / Africa</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29,661</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,775</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,863</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,299</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">256</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">256</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29,917</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,775</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,863</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia
        / Africa</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">31,990</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,909</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,641</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,540</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">292</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">292</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32,282</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,909</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,641</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia
        / Africa</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35,223</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,563</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,187</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35,557</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,563</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>  </div>

<div style="line-height:1.25">

<div>&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(vii)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of segment results by geographical
        area was as follows:</span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        before restructuring costs, impairment and unallocated expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,503</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,386</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(315</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,204</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restructuring
        costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,025</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,156</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,181</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        charges</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(612</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(796</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,408</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        after impairment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,140</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,338</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(315</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(17,793</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        expenses *</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,372</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21,165</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        financing expense (Note 6)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,565</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(30,730</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax credit (Note 7)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(486</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year on continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(31,216</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year on discontinued operations (Note 8)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(573</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(31,789</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        before restructuring costs, impairment and unallocated expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,365</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7,886</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(104</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,355</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        charges</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        after impairment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,470</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7,886</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(104</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(23,460</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        expenses *</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,585</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(27,045</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        financing expense (Note 6)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,882</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,927</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax charge (Note 7)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year on continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,868</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        for the year on discontinued operations (Note 8)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,850</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,018</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        before restructuring costs, impairment and unallocated expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,892</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,112</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(33</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,037</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,331</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,508</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,839</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        after impairment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,223</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,620</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(33</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(16,876</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        expenses *</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,473</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,349</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        financing expense (Note 6)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,431</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43,780</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax credit (Note 7)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">194</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year on continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43,586</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        for the year on discontinued operations (Note 8)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,577</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(41,009</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated expenses represent head office general
        and administration costs of the Group, which cannot be allocated to the results of any specific geographical area.</span></span></div>
        </td> </tr>
  </table> </div>  </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">viii)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of segment assets and segment
        liabilities by geographical area was as follows:</span></span></div> </td> </tr>
  </table>

<div>&#160;</div> </div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Assets
        and liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32,798</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,254</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94,052</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        assets:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax assets (current and deferred)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,071</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents and short-term investments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        assets as reported in the Group balance sheet</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">103,290</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">84,863</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">48,621</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">133,546</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        liabilities:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax liabilities (current and deferred)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,925</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        liabilities as reported in the Group balance sheet</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">138,471</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div> </div>

<div></div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Assets
        and liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,230</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,253</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        assets:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax assets (current and deferred)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,491</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents and short-term investments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        assets as reported in the Group balance sheet</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59,435</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,398</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">31,387</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">80,805</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        liabilities:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax liabilities (current and deferred)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,579</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        liabilities as reported in the Group balance sheet</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83,384</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div>

<div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ix)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of long-lived assets, which are
        property, plant and equipment, goodwill and intangible assets and other non-current assets (excluding deferred tax assets and derivative
        financial instruments), by geographical area was as follows:</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">43,504</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,448</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,943</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,793</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">58,447</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,241</span></span></div>
        </td> </tr>
  </table> </div>  </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">x)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of depreciation and amortisation
        by geographical area was as follows:</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation:</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">160</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">162</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">515</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">668</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,282</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">675</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">830</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,405</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortisation:</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">770</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">458</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">89</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">420</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">487</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">800</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,190</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">945</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">889</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">xi)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of share-based payment expense
        by geographical area was as follows:</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023<br/>US$&#8216;000</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022<br/>US$&#8216;000</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">843</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,650</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">632</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">473</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">419</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,123</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,316</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,069</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,755</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">See
Note 20 for further information on share-based payments.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">xii)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of taxation (expense)/credit
        by geographical area was as follows:</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">)</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(385</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Other</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(235</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(490</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">679</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(88</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(486</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">194</span></span></div>
        </td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">xiii)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2024, 2023 and 2022 there were no customers
        generating 10% or more of total revenues.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">xiv)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The distribution of capital expenditure by geographical
        area was as follows:</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="width:7px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;width:73px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37,929</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">251</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="width:7px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;width:73px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,753</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,547</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="width:7px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;width:73px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="width:7px;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;width:73px;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,682</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,798</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital
expenditure for the year ended December 31, 2024 includes significant additions arising from the acquisitions of Waveform assets, EpiCapture
Limited, and Metabolomics Diagnostic Limited (see Note 29). In addition, capitalised development costs increased from US$1.8
million in 2023 to US$8.6
million in 2024, reflecting investment in development of newly acquired intangible assets.</span></span></div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract', window );"><strong>Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory', window );">EMPLOYMENT</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EMPLOYMENT</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
average number of persons employed by the Group in continuing operations is as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research
        and development</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Administration
        and sales</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">82</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">99</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacturing
        and quality</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">258</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">253</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">380</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">384</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:-30.6pt;margin-left:61.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
average number of employees, including discontinued operations, was 401
(2023: 383;
2022: 398).</span></span></div>

<div style="text-indent:-30.6pt;margin-left:61.2pt;line-height:1.25">&#160;</div>

<div style="text-indent:-30.6pt;margin-left:61.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employment
costs charged in the consolidated statement of operations for continuing operations are analysed as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wages
        and salaries</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25,570</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23,718</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22,364</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Social
        welfare costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,219</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,061</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,965</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pension
        costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">451</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">508</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">347</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,316</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,069</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,755</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restructuring
        cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">596</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">485</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">274</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30,152</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,841</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,705</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employment
costs are shown net of capitalisations and Irish government wage subsidies. There were no Irish government wage subsidies netted against
employment costs in the year ended December 31, 2024.&#160; Total employment costs, inclusive of amounts capitalised for wages and salaries,
social welfare costs and pension costs, for the year ended December&#160;31, 2024, amounted to US$33,584,000
(2023: US$29,975,000)
(2022: US$27,528,000).
Total share-based payments in the balance sheet amounted to US$1,316,000
for the year ended December&#160;31, 2024 (2023: US$2,069,000)
(2022: US$1,755,000).
See Note 20 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employment
costs including discontinued operations, are analysed as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wages
        and salaries</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25,570</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,343</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23,608</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Social
        welfare costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,219</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,097</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,036</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pension
        costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">451</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">510</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">352</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,316</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,069</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,755</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restructuring
        cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">596</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">485</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">274</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30,152</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29,504</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,025</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group operates defined contribution pension schemes for certain of its full-time employees. The benefits under these schemes are financed
by both Group and employee contributions. Total contributions made by the Group in the financial year and charged against income in respect
of continuing operations amounted to US$451,000
(2023: US$508,000)
(2022: US$347,000).
The pension accrual for the Group at December&#160;31, 2024 was US$nil
(2023: US$56,000)
(2022: US$44,000).</span></span></div>
</div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER OPERATING (EXPENSE) / INCOME<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfOtherOperatingIncomeAbstract', window );"><strong>Disclosure of other operating income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory', window );">OTHER OPERATING (EXPENSE) / INCOME</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OTHER OPERATING (EXPENSE) / INCOME</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        income</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">138</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental
        income from premises</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government
        supports</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,827</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government
        grants</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">333</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,787</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">141</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">343</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
other income for year ended December 31, 2024 relates to income from a transition services agreement with the acquirers of Fitzgerald
Industries for the provision of bookkeeping and I.T. services.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
October 2024, the Company was notified that it is the subject of a U.S. Department of Justice (DOJ) investigation relating to second-round
Paycheck Protection Program (PPP) loans received by certain U.S. subsidiaries. At year-end, a payable of US$2,165,000
was recognised, covering the US$1,827,000
in loans and estimated interest of US$338,000.
As the original loan income was recognised in other operating income, the reversal to the extent of the loan to be repaid has been recorded
as a corresponding charge to other operating (expense)/income, noted as &#8220;Government supports&#8221;. The interest costs incidental
to the loan repayment has been charged to finance costs.</span></span></div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other operating income. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfOtherOperatingIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfOtherOperatingIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract', window );"><strong>Disclosure of impairment charges and inventory provisioning [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory', window );">IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS</a></td>
<td class="text">

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Impairment
charges</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
accordance with IAS 36, <span style="font-style:italic">Impairment of Assets</span>, the Company&#160;carries out periodic impairment
reviews of the asset valuations. A number of factors impacted this calculation including the Company&#8217;s market capitalization during
the year ended December 31 2024, the cost of capital, cash flow projections and net asset values across each of the Company&#8217;s cash-generating
units.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
impact of the above items on the consolidated statement of operations for the year ended December 31, 2024, 2023, and 2022 are as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling,
        general&#160;&amp; administration expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        of PP&amp;E (Note 11)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">612</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,772</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">733</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        of goodwill and other intangible&#160;assets (Note 12)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,596</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,833</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,624</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        of prepayments (Note 17)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">482</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Reversal)/Impairment
        of financial assets (Note 13)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(800</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        impairment loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,408</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,839</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Restructuring
costs</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year ended December 31, 2024, the Group undertook a comprehensive business transformation program aimed at improving long-term operational
efficiency and aligning the organization with its strategic priorities. These changes were previously communicated to the market and include
operationally profitability measures, organizational realignment, and changes to business unit structures.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
a result, the Group recognized restructuring costs of US$4.2
million (2023: US$nil)
(2022: US$nil)
which are presented separately in the consolidated statement of operations within &#8216;Selling, general and administrative expenses
&#8211; Restructuring costs&#8217;.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
restructuring costs incurred during the year comprised the following:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>December&#160;31,</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Nature
        of cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Personnel
        related costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,216</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outsourcing
        costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">754</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Site
        transfer costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,281</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory
        related costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">772</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        restructuring costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">158</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        restructuring costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,181</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Included
within Site transfer costs above is US$356,000
related to the impairment of plant &amp; equipment arising as part of the restructuring program. Refer to Note 11. We have provided for
additional restructuring costs of US$1.6
million as at December 31, 2024 (see Note 22).</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div> </div>

<div></div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Once
off costs</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year ended 31 December 2024, the Company&#160;incurred exceptional, non-trading costs totaling US$1.9
million, which is made up as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
October 2024, the Company issued 650,000
American Depositary Shares (&#8220;ADSs&#8221;) to a corporate finance advisor as a non-refundable retainer fee in respect of advisory
services provided in connection with a planned future equity raise. The fair value of the ADSs issued, amounting to US$1.1
million, was recognized directly in equity, with a corresponding charge recorded within the consolidated statement of operations as an
exceptional cost.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year, the Company&#160;recognized a provision of US$0.7
million in respect of a legacy matter currently subject to resolution. Owing to the sensitive nature of ongoing discussions, further disclosure
has been withheld in accordance with IAS 37.92, as the Directors believe such disclosure could seriously prejudice the Company&#8217;s
position.</span></span></div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the impairment of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS36_g126-137_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INCOME AND EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfFinancingIncomeExpensesNetAbstract', window );"><strong>Disclosure Of Financing Income Expenses Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExplanatory', window );">FINANCIAL INCOME AND EXPENSES</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">FINANCIAL INCOME AND EXPENSES</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        income:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        financial income</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,171</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">303</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        expense:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest
        on leases (Note 24)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(592</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(624</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(647</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        on disposal of exchangeable notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,678</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Penalty
        for early partial settlement of senior secured term loan (Note 23,28)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(905</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,450</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        interest payable on senior secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6,293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7,289</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7,039</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        interest payable on convertible note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(300</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(300</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(199</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        interest on exchangeable notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(296</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        interest payable on PPP loans (Note 4)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(338</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        interest on exchangeable notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(84</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        interest on senior secured term loan (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,355</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,131</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,772</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        interest on convertible note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(859</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(796</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(495</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        financial expense</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,172</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(74</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unwinding
        of discount on deferred contingent consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(53</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalisation
        of borrowing costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,085</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        loan modification gain (Note 23,28)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,567</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalisation
        of unpaid interest on term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,247</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,565</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,053</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,734</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        financing expense</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,565</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,882</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,431</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table>  </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For
more information on the senior secured term loan, convertible note and exchangeable notes, refer to Note 23 Interest-Bearing Loans and
Borrowings.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
financial expense relates to the fair value loss on warrant liabilities during the year. Refer to Note 23 for further details.</span></span></div>
</div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of finance income. [Refer: Finance income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfFinancingIncomeExpensesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfFinancingIncomeExpensesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (EXPENSE)/CREDIT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfIncomeTaxCreditAbstract', window );"><strong>Disclosure of income tax credit [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">INCOME TAX (EXPENSE)/CREDIT</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INCOME TAX (EXPENSE)/CREDIT</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current
        tax expense/(credit)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Irish
        Corporation tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(336</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign
        taxes (a)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">254</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">462</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustment
        in respect of prior years</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(198</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        current tax expense/(credit)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">285</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">264</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(280</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">Deferred
        tax credit </span>(b)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Origination
        and reversal of temporary differences (see Note 14)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(41</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(547</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">324</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Origination
        and reversal of net operating losses (see Note 14)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">242</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">224</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(238</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        deferred tax charge/(credit)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">201</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(323</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">86</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        income tax charge/(credit) on continuing operations in statement of operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">486</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(59</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(194</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax
        charge on discontinued operations (see Note 8)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        tax charge/(credit)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">486</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(59</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(192</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(a)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2024, the foreign taxes relate primarily to
        Luxembourg and Canada.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(b)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2024, there was
        a deferred tax credit of US$43,000
        (2023: charge of US$174,000)
        (2022: charge of US$109,000)
        recognised in respect of Ireland and a deferred tax charge of US$244,000
        (2023: credit of US$497,000)
        (2022: credit of US$26,000)
        recognised in respect of overseas tax jurisdictions.</span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective
        tax rate</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before taxation &#8211; continuing operations (US$&#8216;000)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(30,730</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,927</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43,780</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        a percentage of loss before&#160;tax:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current
        tax %</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.93</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.72</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.64</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        (current and deferred) %</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.58</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.16</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.44</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following table reconciles the applicable Republic of Ireland statutory tax rate to the effective total tax rate for the Group:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="line-height:1.25;margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Irish
        corporation tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12.5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12.5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12.5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect
        of current year net operating losses and temporary differences for which no deferred tax asset was recognised (a)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15.89</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17.19</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.97</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect
        of tax rates on overseas earnings</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.63</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7.82</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7.30</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect
        of Irish income taxable at higher tax rate</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4.09</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.62</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.93</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments
        in respect of prior years</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.04</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.53</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.14</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">R&amp;D
        tax credits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.75</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        items (b)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7.55</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.88</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.07</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective
        tax rate</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1.58</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.16</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.44</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(a)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No deferred tax asset was recognised because there
        was no reversing deferred tax liability in the same jurisdiction reversing in the same period and insufficient future projected taxable
        income in the same jurisdiction.</span></span></div> </td> </tr>
  <tr>
    <td style="width:28.35pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td> </tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(b)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other items comprise items not chargeable to tax
        and expenses not deductible for tax purposes. In 2022, other items mainly related to the loss on disposal of the exchangeable notes which
        was non-recurring.</span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div> </div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
distribution of loss before taxes by geographical area was as follows:</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(17,296</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,922</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,354</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Other</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(315</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(104</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(33</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13,119</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(23,901</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21,393</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(30,730</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,927</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43,780</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
December&#160;31, 2024, the Group had unutilised net operating losses for continuing operations as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">107,093</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">69,851</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,731</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Other</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,852</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,511</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">448</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22,866</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,840</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,778</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">182,811</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">136,202</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75,957</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>  </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
December&#160;31, 2024, the Group had unrecognised deferred tax assets in respect of unused tax losses and unused tax credits as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland &#8211; unused tax losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">13,275</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">8,464</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">7,489</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Other &#8211; unused tax losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">14,777</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">14,701</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">124</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas
        &#8211; unused tax losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,149</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,395</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,163</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas
        &#8211; unused tax credits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,702</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,806</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unrecognised
        deferred tax asset</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35,903</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32,366</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,434</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
accounting policy for deferred tax is to calculate the deferred tax asset that is deemed recoverable, considering all sources for future
taxable profits. The deferred tax assets in the above table have not been recognised due to uncertainty regarding the full utilization
of these losses in the related tax jurisdiction in future periods. Only when it is probable that future profits will be available to utilize
the forward losses or temporary differences is a deferred tax asset recognised. When there is a reversing deferred tax liability in that
jurisdiction that reverses in the same period, the deferred tax asset is restricted so that it equals the reversing deferred tax liability.</span></span></div>
</div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfIncomeTaxCreditAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfIncomeTaxCreditAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract', window );"><strong>Disclosure of loss on discontinued operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory', window );">(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS</a></td>
<td class="text">

<div>

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span>8<span style="font-weight:bold">.</span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS</span></span></div> </td> </tr>
  </table> </div> </div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
April 2023, the Company announced the sale of its Fitzgerald Industries life sciences supply business, consisting of Benen Trading Ltd
and Fitzgerald Industries International, Inc, to Biosynth for cash proceeds of approximately US$30
million subject to customary adjustments. The results of Fitzgerald Industries were presented as discontinued operations in the 2023 financial
statements.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
2024, the Company recognised additional costs related to the 2023 disposal of Fitzgerald Industries, following a settlement agreement
with Biosynth that was finalised prior to year-end and formally signed in January 2025. A provision of US$150,000
was recorded in respect of the full and final settlement of all post-completion claims. In addition, outstanding receivables of US$423,000
from Biosynth relating to completion account adjustments were written off as unrecoverable under the terms of the settlement.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
operating profit for the discontinued operations are summarised as follows:&#160;</span></span>

<p style="margin:0pt">&#160;</p> </div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,&#160;</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,784</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,258</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,652</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,679</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax
        expense (Note 7)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        from operating activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">132</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,577</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Loss)/Gain
        on sale of discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(573</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,718</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Loss)/Profit
        for the year from discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(573</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,850</span></span></strong></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,577</span></span></strong></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
net cashflows generated from discontinued operations are as follows:</span></span>

<p style="margin:0pt">&#160;</p> </div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:middle;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash received from sale
        of the discontinued operations net of transaction costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,935</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash sold as a part of
        discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(775</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash inflow on date of disposal</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,160</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25">

<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The
following amounts relating to the Biosynth transaction were recognised in 2024 as post-disposal adjustments, reflecting the write-off
of receivables and provision for settlement costs:</span></span></p>

<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets disposed in 2023</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Post
        disposal adjustment</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets disposed/adjusted</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property plant &amp;
        equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">103</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">103</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill and intangible
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,123</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,123</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,160</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,160</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">775</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">775</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other receivables</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,309</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(423</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">886</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other payables</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(864</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,014</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liabilities</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(106</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(106</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current corporation tax</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liability</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(195</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(195</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Total net assets
        disposed</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,303</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(573</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,730</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
consideration from the sale of Fitzgerald Industries which was receivable as at December 31, 2024 was US$Nil
(2023: US$373,000)
(refer to Note 17).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
(loss)/earnings per ordinary share &#8211; discontinued operations</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
(loss)/earnings per ordinary share for discontinued operations is computed by dividing the profit/ (loss) after taxation on discontinued
operations of US$(573,000),
(2023: US$12,850,000)
(2022: US$2,577,000)
for the financial year by the weighted average number of &#8216;A&#8217; ordinary shares in issue as at December&#160;31, 2024, this amounted
to 359,193,482
shares (2023: 153,099,405
shares) (2022: 134,939,327
shares), see Note 10 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
(loss)/earnings/ per ordinary share &#8211; discontinued operations</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
(loss)/earnings per ordinary share for discontinued operations is computed by dividing the profit/ (loss) after taxation on discontinued
operations of US$(573,000),
(2023: US$12,850,000)
(2022: US$2,577,000)
for the financial year by the diluted weighted average number of ordinary shares in issue of 404,096,277
shares (2023: 178,016,062
shares) (2022: 155,498,651&#160;shares),
see Note 10 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        (loss)/earnings per &#8216;A&#8217; share (US Dollars) &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.08</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.02</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
        (loss)/earnings per &#8216;A&#8217; share (US Dollars) &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.07</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.02</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">Basic
(loss)/earnings per ADS</span>&#160;<span style="font-style:italic">&#8211; discontinued operations</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
February 2024, the Company changed the ratio of the ADSs representing its &#8216;A&#8217; ordinary shares from one (1) ADS representing
four (4) &#8216;A&#8217; ordinary shares to one (1) ADS representing twenty (20) &#8216;A&#8217; ordinary shares.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
earnings per ADS for discontinued operations is computed by dividing the profit/(loss) after taxation on discontinued operations of US$(573,000),
(2023: US$12,850,000)
(2022: US$2,577,000)
for the financial year by the weighted average number of ADS in issue of 17,959,674
(2023: 7,654,970)
(2022: 6,746,966),
see Note 10 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
(loss)/earnings per ADS &#8211; discontinued operations</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
earnings per ADS for discontinued operations is computed by dividing the profit/ (loss) after taxation on discontinued operations of US$(573,000),
(2023: US$12,850,000)
(2022: US$2,577,000)
for the financial year, by the diluted weighted average number of ADS in issue of 20,204,814
(2023: 8,900,803)
(2022: 7,774,933),
see Note 10 for further details.</span></span>

<p style="margin:0pt">&#160;</p> </div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        (loss)/earnings per ADS (US Dollars) &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.03</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.68</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.38</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
        (loss)/earnings per ADS (US Dollars) &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.03</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.44</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.33</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
flows</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
cash flows attributable to discontinued operations are as follows:</span></span>

<p style="margin:0pt">&#160;</p> </div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        (outflow)/inflow from operating activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(177</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,798</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        inflow from investing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,160</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        outflow&#160;from financing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10,800</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">There
were no cash inflows from discontinued operations during the year ended December 31, 2024.</span></span></div> </div> </div> </div> </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of discontinued operations. [Refer: Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfLossOnDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS BEFORE TAX<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfLossProfitBeforeTaxAbstract', window );"><strong>Disclosure of loss profit before tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfLossProfitBeforeTaxExplanatory', window );">LOSS BEFORE TAX</a></td>
<td class="text">

<div>

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span><span><span>9.</span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span><span><span>LOSS BEFORE TAX</span></span></span></span></div> </td> </tr>
  </table> </div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:30.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
following amounts were charged / (credited) to the statement of operations:</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,
        2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,
        2023</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,
        2022</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Directors&#8217;
        emoluments (including non- executive directors):</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Remuneration</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,454</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,058</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,639</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Pension</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>39</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>26</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>24</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share
        based payments (Note 26)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>931</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,601</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,707</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Auditor&#8217;s
        remuneration</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Audit
        fees</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,082</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>861</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>888</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Tax
        fees</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>175</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>407</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>89</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation
        (Note 11) <sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>675</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>830</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,405</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortisation
        (Note 12)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,190</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>945</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>889</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Loss&#160;on
        the disposal of property, plant and equipment</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net
        foreign exchange differences</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>376</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>336</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1,210</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup>
In 2024, US$204,000
was capitalised to research and development projects (2023: US$Nil)
(2022: US$Nil).</span></span></span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation
for discontinued operations for the year ended December 31, 2024 is US$Nil
(2023: US$1,000)
(2022:US$5,000)</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortisation
for discontinued operations for the year ended December 31, 2024 is US$Nil
(2023: US$1,000)
(2022:US$34,000).</span></span></span></span></div>
</div> </div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfLossProfitBeforeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfLossProfitBeforeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfLossProfitBeforeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss profit before tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfLossProfitBeforeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">LOSS PER SHARE</a></td>
<td class="text">

<div>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <p style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">10.</span></span></p>
        </td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">LOSS PER SHARE</span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
loss per ordinary share</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
loss per ordinary share is calculated by dividing the net loss attributable to owners of the parent of US$31,789,000
(2023: loss of US$24,018,000)
(2022: loss of US$41,009,000)
by the weighted average number of &#8216;A&#8217; ordinary shares in issue, net of any Treasury Shares, during the year. Basic loss per
ordinary share from continuing operations is calculated by dividing the loss from continuing operations attributable to owners of the
parent of US$31,216,000
(2023: loss of US$36,868,000)
(2022: loss of US$43,586,000)
by the weighted average number of &#8216;A&#8217; ordinary shares in issue, net of any Treasury Shares, during the year.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
at December&#160;31, 2024, the number of &#8216;A&#8217; ordinary shares for the purposes of the calculation of basic loss per share are
359,193,482
shares (2023: 153,099,405
shares) (2022: 134,939,327
shares).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;A&#8217;
        ordinary shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">359,193,482</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">153,099,405</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">134,939,327</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per share denominator</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">359,193,482</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">153,099,405</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">134,939,327</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation
        to weighted average loss per share denominator:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number
        of &#8216;A&#8217; ordinary shares at January&#160;1 (Note 19)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">165,865,882</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">164,985,882</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">96,162,410</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted
        average number of &#8216;A&#8217; ordinary shares issued during the year*</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">205,883,200</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">669,123</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51,332,517</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted
        average number of treasury shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,555,600</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,555,600</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,555,600</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per share denominator</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">359,193,482</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">153,099,405</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">134,939,327</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*The
weighted average number of shares issued during the year is calculated by taking the number of shares issued multiplied by the number
of days in the year each share is in issue, divided by 365 days.</span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
loss per ordinary share</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
loss per ordinary share is calculated by dividing the net loss attributable to owners of the parent by the weighted average number of
&#8216;A&#8217; ordinary shares in issue, net of any Treasury Shares, during the year, plus the weighted average number of &#8216;A&#8217;
ordinary shares that would be issued on the conversion of all the dilutive potential &#8216;A&#8217; ordinary shares into &#8216;A&#8217;
ordinary shares. As the potentially dilutive instruments were anti-dilutive in all periods presented, basic loss per &#8216;A&#8217; ordinary
share and diluted loss per &#8216;A&#8217; ordinary share are equivalent.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following potential &#8216;A&#8217; ordinary shares are anti-dilutive and are therefore excluded from the weighted average number of &#8216;A&#8217;
ordinary shares for the purposes of calculating diluted loss per &#8216;A&#8217; ordinary share.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Potentially
        Dilutive Instruments:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on exercise of options (Note 20)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">186,908</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,752,153</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on exercise of warrants to Perceptive (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,173,151</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on conversion of Exchangeable notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,436,463</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on conversion of Convertible notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,691,358</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,691,358</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,370,709</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        number of potentially dilutive instruments excluded from the weighted average number of &#8216;A&#8217; ordinary shares in calculating
        dilutive loss per &#8216;A&#8217; ordinary share</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44,902,900</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,916,657</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,559,325</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Of
the &#8216;A&#8217; ordinary shares issuable on exercise of options, <span style="-sec-ix-hidden:Fxbrl_20230414123050603">NIL</span> are
contingently issuable as their issue is contingent upon satisfaction of specified performance conditions in addition to the passage of
time. The conditions governing their exercisability have not been satisfied as at the end of the reporting period.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div> </div>

<div></div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">Loss
per ADS</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
February 2024, the Company changed the ratio of the ADSs representing its &#8216;A&#8217; ordinary shares from one (1) ADS representing
four (4) &#8216;A&#8217; ordinary shares to one (1) ADS representing twenty (20) &#8216;A&#8217; ordinary shares.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
loss per ADS is calculated by dividing the loss attributable to owners of the parent of US$31,789,000
(2023: loss of US$24,018,000)
(2022: loss of US$41,009,000)
by the weighted average number of ADS in issue, net of any Treasury Shares, during the year. Basic loss per ADS from continuing operations
is calculated by dividing the loss of US$31,216,000
(2023: loss of US$36,868,000)
(2022: loss of US$43,586,000)
by the weighted average number of ADS in issue, net of any Treasury Shares, during the year.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
at December&#160;31, 2024, the number of ADS for the purposes of the calculation of basic loss per ADS were 17,959,674
ADS (2023: 7,654,970
ADS) (2022: 6,746,966
ADS).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ADS</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,959,674</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,654,970</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,746,966</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per ADS denominator</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,959,674</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,654,970</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,746,966</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation
        to weighted average loss per ADS denominator:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number
        of ADS at January&#160;1 (Note 19)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,293,294</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,249,294</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,808,120</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted
        average number of shares issued during the year*</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,294,160</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,456</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,566,626</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted
        average number of treasury shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(627,780</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(627,780</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(627,780</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per ADS denominator</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,959,674</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,654,970</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,746,966</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*The
weighted average number of ADSs issued during the year is calculated by taking the number of ADSs issued multiplied by the number of days
in the year each share is in issue, divided by 365 days.</span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
loss per ADS</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
loss per ADS is calculated by dividing the net loss attributable to owners of the parent by the weighted average number of ADS in issue,
net of any Treasury Shares, during the year, plus the weighted average number of ADS that would be issued on the conversion of all the
dilutive potential ADS into ADS. As the potentially dilutive instruments were anti-dilutive in all periods presented, basic loss per ADS
and diluted earnings per ADS are equivalent.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following potential ADS are anti-dilutive and are therefore excluded from the weighted average number of ADS for the purposes of calculating
dilutive (loss)/earnings per ADS.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Potentially
        Dilutive Instruments:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on exercise of options (Note 20)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,345</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">137,608</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on exercise of warrants to Perceptive (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,008,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on conversion of Exchangeable notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,920</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,920</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">71,823</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on conversion of Convertible notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,234,568</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,234,568</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">818,535</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        number of potentially dilutive instruments excluded from the weighted average number of ADS in calculating dilutive loss per ADS</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,245,146</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,245,833</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,027,966</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Of
the ADS issuable on exercise of options, <span style="-sec-ix-hidden:Fxbrl_20250512171325106">NIL</span> are contingently issuable as
their issue is contingent upon satisfaction of specified performance conditions in addition to the passage of time. The conditions governing
their exercisability have not been satisfied as at the end of the reporting period.</span></span></div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Disclosure of detailed information about property, plant and equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">PROPERTY, PLANT AND EQUIPMENT</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PROPERTY, PLANT AND EQUIPMENT</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:27pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="text-align:right;line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Land
        &amp; Buildings</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold
        Improvements</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer
        &amp; Office Equipment</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Plant
        &amp; Equipment,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vehicles</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,682</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,701</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,540</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,683</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">65,606</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">87</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">173</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">596</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">911</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(480</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(115</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(220</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(855</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reallocations/
        reclassifications</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange
        adjustments</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">370</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">407</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,268</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,760</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,612</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">34,429</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,069</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,268</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,760</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,612</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">34,429</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,069</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions<sup style="vertical-align:text-top;line-height:1;font-size:smaller">#</sup></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">752</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">478</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,380</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions
        through acquisition (Note 29)</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">582</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">740</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,373</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Remeasurement
        of ROU assets</span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,764</span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,764</span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reallocations/
        reclassifications</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">53</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">53</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,784</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,811</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,344</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35,686</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">70,625</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Accumulated
        depreciation and Impairment losses</span></span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21,885</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,284</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,178</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(31,577</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(59,924</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
        for the year (Note 9)</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(272</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(64</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(178</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(317</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(831</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">385</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">213</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">751</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        losses</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,246</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(339</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(101</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,086</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,772</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange
        adjustments</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(20</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(370</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(401</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,022</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,669</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,349</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(33,137</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(64,177</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,022</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,669</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,349</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(33,137</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(64,177</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
        for the year (Note 9)</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(325</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(58</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(283</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(675</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        losses*</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(410</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(80</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(477</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(968</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reallocations/
        reclassifications</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(179</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(179</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,757</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,728</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,717</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(33,802</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,004</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        amounts</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,027</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">627</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,884</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,621</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">246</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">91</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">263</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,292</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,892</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table> </div>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
assets of the Group are pledged as security for the senior secured term loan from Perceptive Advisors.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><sup style="font-weight:bold;vertical-align:text-top;line-height:1;font-size:smaller">#&#160;
</sup>Additions include US$0.9
million additions in ROU assets.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">*&#160;&#160;</span>The
total impairment charge recognised against Property, Plant &amp; Equipment during the year was US$1.0
million. Of this, US$0.6
million, corresponding to the impairment loss allocated to property, plant and equipment as described above, is presented within &#8216;Impairment
Charges&#8217; in the Consolidated Statement of Operations. The remaining US$0.4
million is included within &#8216;Restructuring Costs&#8217; (see Note 5).</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Remeasurement
of ROU assets during the year includes adjustments arising from rent reviews on leased properties in Bray, Ireland. These relate to leases
with a related party, Mr. O&#8217;Caoimh, and reflect revised future lease payments following independent valuations. Further details
are provided in Note 26 &#8211; Related Party Transactions</span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-use
assets</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additional
information on the right-of-use assets by class of assets is as follows:</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><em><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Carrying
        amount At December 31, 2024</span></em></p> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation
        Charge Year ended December 31, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        Charge Year ended December 31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,126</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(325</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(356</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">72</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(56</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:64%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,198</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(381</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(399</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        amount At December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation
        Charge Year ended December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        Charge Year ended December 31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">229</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(196</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,930</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(51</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Plant and Equipment,
        vehicles</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(86</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">395</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(273</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,016</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
from sub-letting right-of-use buildings amounted to US$nil
in the year ended December 31, 2024 (2023: US$3,000).</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-Use
        assets at 31 December 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Right-of-Use leased assets</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range
        of remaining term in years</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average
        remaining lease term (years)</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Leases with extension options</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Leases with options to purchase</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of leases with variable payments linked to index</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of leases with termination options</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Building</span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0
        to 9</span></span></p>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vehicle</span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0
        to 2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">I.T. and office equipment</span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2
        to 5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-Use
        assets at 31 December 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Right-of-Use leased assets</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range
        of remaining term in years</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average
        remaining lease term (years)</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Leases with extension options</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Leases with options to purchase</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of leases with variable payments linked to index</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of leases with termination options</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Building</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1
        to 10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vehicle</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1
        to 3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="margin-right:29.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">I.T.
        and office equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<div style="text-align:justify;margin-left:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
details of the impairment review are described in Note 12. When an impairment loss is identified in a cash-generating unit, it must be
first allocated to reduce the carrying amount of any goodwill allocated to the cash-generating unit and then to the other assets of the
unit pro rata on the basis of the carrying amount of each asset in the unit. In this manner, an impairment loss of US$0.6
million was allocated to property, plant and equipment as at December 31, 2024 (2023: US$3.8
million). The recoverable amount of property, plant and equipment was determined to be the value in use of each cash-generating unit.</span></span></div>
</div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract', window );"><strong>Disclosure Of Goodwill And Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">

<div>

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GOODWILL
        AND INTANGIBLE ASSETS</span></span></div> </td> </tr>
  </table>

<div>&#160;</div>

<div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Development</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">costs</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Patents
        and</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">licenses</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Technology</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">based
        intangibles</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">79,182</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">125,584</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,729</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,580</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">247,075</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,758</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">110</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,887</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,591</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,488</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(27,079</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reclassifications</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">54</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(54</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange
        adjustments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,645</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">127,365</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,694</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,202</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">221,906</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,645</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">127,365</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,694</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,202</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">221,906</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,582</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,280</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,863</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions
        through acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,839</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">122</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27,066</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(70</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(70</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">80,484</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">135,999</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,695</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,482</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">259,765</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Accumulated
        amortisation and Impairment losses</span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,645</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(108,576</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,570</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(28,015</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(211,806</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
        for the year (Note 9)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(753</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(223</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(946</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,956</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,956</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        losses (Note 5)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,926</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,898</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,833</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange
        adjustments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,645</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(112,262</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,549</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(18,180</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(205,636</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,645</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(112,262</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,549</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(18,180</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(205,636</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
        for the year (Note 9)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,190</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,190</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        losses (Note 5)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,596</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,596</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,645</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(115,048</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,549</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(18,180</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(208,422</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        amounts</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,839</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,951</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">146</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,302</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51,343</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,103</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">145</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,270</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div>  </div> </div> </div>

<div style="line-height:1.25;clear:both;margin-top:0pt;margin-bottom:0pt">&#160;</div> </div> </div>

<div>

<div>

<div style="text-align:justify;line-height:1.25;font-family:Times New Roman, serif">

<div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
assets of the Group are pledged as security for the senior secured term loan from Perceptive Advisors.</span></span></span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Included
within development costs are projects with a carrying value of US$7,040,000
which were not amortised in 2024 (2023: US$1,596,000)
(2022: US$6,982,000).
These development costs are not being amortised as the projects to which the costs relate were not fully complete at the end of the financial
year. As at December&#160;31, 2024 these projects are expected to be completed during the period from January&#160;1,
2025 to December&#160;31, 2026 at an expected further cost of approximately US$20
million to US$25
million.</span></span></span></span></span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Included
within technology-based intangibles in 2024 is an amount of US$13.1
million related to the recognition of acquired technology-based intangible assets from the Waveform, Metabolomics, and Epicapture acquisitions.
These assets were recognised at fair value in accordance with IFRS 3. Further details of these acquisitions are provided in Note 29. As
the acquired technologies were not yet available for use at year-end, no amortisation has been recorded in 2024. Amortisation will commence
when the technologies are brought into commercial use.</span></span></span></span></span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify">&#160;</div> </div> </div>

<div style="line-height:1.25;clear:both">

<div></div> </div> </div> </div>

<div style="margin-left:30pt;line-height:1.25;font-family:Times New Roman, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following represents the costs incurred during each period presented for each of the principal development projects:</span></span></div>
</div> </div>

<div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="width:76%;padding-bottom:0px;vertical-align:bottom;white-space:nowrap;border-bottom:2px solid black">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product
        Name</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-style:italic;vertical-align:bottom">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2024</span><br/><span style="font-weight:bold">US</span></span></span><strong>$</strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">&#8217;000</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-style:italic;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;padding-bottom:2px;font-style:italic;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-style:italic;vertical-align:bottom">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2023</span><br/><span style="font-weight:bold">US</span></span></span><strong>$</strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">&#8217;000</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Continuous
        glucose monitoring testing</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,040</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Premier
        Instruments for A1c and haemoglobinopathies testing</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,669</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Mid-tier
        haemoglobins instrument</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">HIV
        screening rapid test</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        projects</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        capitalised development costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,582</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,758</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>  </div>

<div>

<div>

<div>

<div style="text-indent:30.6pt;line-height:1.25;font-weight:bold;margin-top:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
intangible assets</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
intangible assets consist primarily of software assets, acquired customer and supplier lists, trade names and websites.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year ended December 31, 2024, additions of US$13.2
million were recorded in respect of intangible assets acquired through business combinations. These relate to the fair value of identifiable
intangible assets recognised as part of the acquisitions of Waveform, EpiCapture and Metabolomics. The acquired intangible assets comprise
the following:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer relationships</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade names and brand assets</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proprietary technology and software</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Supplier agreements</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Website and digital assets</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair values of these assets were determined as part of the purchase price allocation process in accordance with IFRS 3 Business Combinations.
Refer to Note 29 for further detail on the business combinations.&#160;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortisation</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortisation
is charged to the consolidated statement of operations through the selling, general and administrative expenses line.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
testing for intangibles including goodwill and indefinite lived assets</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill
and other intangibles are subject to impairment testing on a periodic basis and whenever there are indicators of impairment. Specific
assets are assessed for impairment when there are indicators of impairment. If any such indication exists, the Company estimates the recoverable
amount of the asset.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
recoverable amount of seven CGUs is determined based on a value-in-use computation at June 30 and December 31. The value-in-use calculations
use cash flow projections based on the 2025 and 2026 projections for each CGU and a further three years projections using estimated revenue
and cost average growth rates of between 2%
and 3%.
At the end of the five-year forecast period, terminal values for each CGU, based on a long-term growth rate of 2%,
are used in the value-in-use calculations. The value-in-use represents the present value of the future cash flows, including the terminal
value, discounted at a rate appropriate to each CGU. The pre-tax discount rates used range from 17%
to 28%
(2023: 15%
to 22%).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sources
of estimation uncertainty</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
cash flows have been arrived at taking into account the Group&#8217;s financial position, its recent financial results and cash flow generation
and the nature of the medical diagnostic industry, where product obsolescence can be a feature. However, expected future cash flows are
inherently uncertain and are therefore liable to material change over time. The key assumptions employed in arriving at the estimates
of future cash flows factored into impairment testing are subjective and include projected EBITDA margins, net cash flows, discount rates
used and the duration of the discounted cash flow model. Significant under-performance in any of the Group&#8217;s major CGUs may give
rise to a material impairment which would have a substantial impact on the Group&#8217;s income and equity.</span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
tests of cash-generating units</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
impairment tests performed at June 30, 2024 and at December&#160;31, 2024 resulted in an impairment loss being recorded in four CGUs,
Immco Diagnostics Inc, Trinity Biotech Do Brasil, Clark Laboratories and Biopool Inc</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
table below sets forth the impairment loss recorded for each of the CGU&#8217;s, comprising both the specific asset impairment charges
recorded in year ended December 31, 2024 as per the below table and the impairments arising from the CGU impairment tests:&#160;</span></span></div>
</div> </div> </div>

<div>

<div>

<div style="line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>

<div style="margin-left:36pt">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Immco
        Diagnostics Inc.</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">101</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,331</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Manufacturing Limited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(120</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Do Brasil</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">162</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">274</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus
        Corp</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">916</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Clark
        Laboratories Inc.</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">130</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Biopool
        US Inc.</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">219</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        impairment loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,408</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>  </div>

<div style="margin-left:30pt;line-height:1.25;font-family:Times New Roman, serif;margin-top:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
table below sets forth the breakdown of the impairment loss for each class of asset:</span></span></div>

<div style="line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>

<div style="margin-left:36pt">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill
        and other intangible assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,596</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,833</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property,
        plant and equipment (see Note 11)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">612</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,772</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        assets (see Note 13)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(800</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        impairment loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,408</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div>  </div>

<div style="line-height:1.25;font-family:'Times New Roman',serif;clear:both">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
impairment tests performed at June 30, 2024 and at December&#160;31, 2024 resulted in an impairment loss being recorded in four CGUs,
Immco Diagnostics Inc, Trinity Biotech Do Brasil, Clark Laboratories Inc, and Biopool Inc.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management
is seeking to implement profit improvement initiatives across these entities, however the values in use of these CGUs at June 30, 2024
and December 31, 2024, defined as the present value of the future projected cash flows, were below the value of the carrying amount of
their assets, other than inventories, accounts receivable, cash and cash equivalents and deferred tax assets.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Included
within the impairment for Trinity Biotech Manufacturing Limited was the reversal of a previously recognised financial asset impairment
of US$0.8
million, refer to Note 13 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Specific
asset impairment charges in year ended December 31, 2024</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
the year ended December 31, 2024, two internally developed intangible assets were fully impaired, and certain plant items in our Bray
production facility and the right-of-use asset associated with the Kansas production facility were both fully impaired as a result of
restructuring activities. These impairments are shown in the table below. There were no specific asset impairment charges in the year
ended December 31, 2023.</span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;width:43%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asset
        name</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Entity</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">T10 HPLC Analyzer</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity Biotech Manufacturing
        Ltd</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">916</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Syphilis Point-of-Care</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity Biotech Manufacturing
        Ltd</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">680</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinscreen plant &amp;
        equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity Biotech Manufacturing
        Ltd</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">223</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Kansas right-of-use asset</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus Corp.</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">133</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,952</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div>  </div>

<div style="line-height:1.25;clear:both;margin-top:0pt;margin-bottom:0pt">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
T10 HPLC Analyzer project was an internally developed HPLC analyser designed for mid-volume haemoglobin testing laboratories, with the
Chinese market identified as a key commercial opportunity. Although the project achieved technical feasibility and early market validation,
recent developments in global trade relations, particularly increasing tensions between the United States and China, have created significant
uncertainty around market access and the ability to generate sufficient future sales. While the Company continues to pursue a licensing
arrangement with a local Chinese partner, this is not expected to generate adequate economic returns to support the carrying value of
the asset. As a result, the Company has fully impaired the related intangible asset and recognised an impairment charge of US$916,000.
This was recorded in the Primus Corp. entity.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Syphilis Point of Care project is an internally developed lateral flow assay intended for the global syphilis and HIV/syphilis dual testing
markets. Although the project demonstrated technical feasibility prior to 2020, the suspension of development activities during the COVID-19
pandemic and subsequent changes in manufacturing strategy have introduced additional uncertainty around technical completion, regulatory
approval timelines, and cost to completion. As a result of this reassessment, and in light of the need for further development work before
the product can be commercialised, the Group have fully impaired the project and recorded an impairment charge of US$680,000.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinscreen,
one of the Group&#8217;s HIV screening products, was manufactured at Trinity Biotech Manufacturing Ltd in 2024. In line with the planned
transfer of Point-of-Care/HIV product manufacturing to a contract manufacturing partner by Q2 2025, certain plant and equipment at Trinity
Biotech Manufacturing Limited were assessed as having limited future utility. An impairment charge of US$223,000
was recognised to reflect the revised recoverable amount. This has been included within &#8216;Selling, general and administrative expenses
&#8211; Restructuring costs&#8217;. See also Note 11.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Kansas City facility, operated by Primus Corporation, previously supported the manufacture and R&amp;D of the Group&#8217;s haemoglobin
product range. At year-end, the Group assessed that the associated right-of-use asset no longer has future economic benefit, and a full
impairment charge of US$133,000
was recognized within &#8216;Selling, general and administrative expenses &#8211; Restructuring costs&#8217;. See also Note 11.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
value-in-use calculations for CGUs are subject to significant estimation, uncertainty and accounting judgements and the following sensitivity
analysis has been performed:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the event that there was a reduction of 10%
        in the assumed level of future growth in revenue growth rate, which would represent a reasonably likely range of outcomes, there would
        be no additional impairment loss recorded at December&#160;31, 2024.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the event there was a 10%
        increase in the discount rate used to calculate the potential impairment of the carrying values, which would represent a reasonably likely
        range of outcomes, there would be no additional impairment loss recorded at December&#160;31, 2024.</span></span></div> </td> </tr>
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td> </tr>
  </table> </div> </div>

<div style="line-height:1.25;clear:both">

<div></div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Significant
Goodwill and Intangible Assets with Indefinite Useful Lives</span></span></div>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Following
the disposal of Fitzgerald Industries during 2023, the carrying value of goodwill was US$nil as at December 31, 2023. During 2024, goodwill
was recognised in connection with the acquisitions of Waveform Technologies' CGM assets, EpiCapture, and Metabolomics. The carrying value
of goodwill as at December 31, 2024 was US$13,829,000.
The CGUs for which goodwill is considered significant from a Group perspective, and the additional disclosures required for these CGUs,
are set out below.</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify">&#160;</div> </div>

<div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Goodwill
arising from the purchase of CGM assets from Waveform Technologies</span></span></span></div> </div>

<div style="line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying amount of goodwill
        (US$&#8217;000)</span></span></div> </td>
    <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,403</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discount rate applied
        (real pre-tax)</span></span></div> </td>
    <td style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.6</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap">%</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">% EBITDA would need to
        decrease for an impairment to arise</span></span></div> </td>
    <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56.51</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term growth rate</span></span></div>
        </td>
    <td style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.0</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  </table> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Waveform CGM CGU includes proprietary continuous glucose monitoring (CGM) technology and related assets acquired from Waveform Technologies
in January 2024. The value-in-use was determined using a discounted cash flow model based on seven years of forecast cash flows, reflecting
the expected development and commercialisation trajectory of the technology, followed by a terminal value using a 2%
long-term growth rate. The pre-tax discount rate of 26%
reflects the high-risk, early-stage nature of the opportunity and incorporates market-based risk adjustments.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
assumptions and estimates used are specific to this CGU and were derived from a combination of internal forecasts, external market data,
and management&#8217;s expectations regarding development timelines, regulatory approvals, and commercial potential.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No
impairment loss was recognised for this CGU in 2024. Management concluded that no reasonably possible change in key assumptions would
lead to the carrying amount exceeding the recoverable amount.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Goodwill
arising from the acquisition of EpiCapture Limited</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying amount of goodwill
        (US$&#8217;000)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,420</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discount rate applied
        (real pre-tax)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21.9</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">% EBITDA would need to
        decrease for an impairment to arise</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">84.35</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term growth rate</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.0</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  </table> </div> </div>

<div style="margin-left:36pt">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
EpiCapture CGU includes oncology diagnostics technology and associated intellectual property acquired in 2024. The value-in-use was determined
using a discounted cash flow model incorporating probability-weighted scenarios reflecting the early-stage nature of the development pipeline,
projected regulatory milestones, and anticipated commercialisation timelines. The model included ten years of forecast cash flows followed
by a terminal value using a 2.0%
long-term growth rate. The pre-tax discount rate of 29.4%
reflects the significant risk and uncertainty associated with product development, clinical validation, and future market access.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
assumptions and estimates used are specific to this CGU and were developed based on internal forecasts, external market data, and management&#8217;s
expectations regarding product viability and commercial uptake.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No
impairment loss was recognised for this CGU in 2024. Management concluded that no reasonably possible change in key assumptions would
lead to the carrying amount exceeding the recoverable amount.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div> </div>

<div></div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Goodwill
arising from the acquisition of Metabolomic Diagnostics Limited</span></span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill
of US$6,000
was also recognised in connection with the acquisition of Metabolomics. This amount is not considered individually material to the Group,
and therefore no further disclosures have been provided in accordance with IAS 36.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        Assets with Indefinite Useful lives</span></span></div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(included
        in other intangibles)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus
        Corporation CGU</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus
        trade name</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">365</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">365</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">365</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">365</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div>  </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman', serif">&#160;</div>
        <div style="font-family:'Times New Roman',serif">
        <div>
        <div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        2023, an impairment loss of US$2,069,000
        was allocated against the Immco Diagnostic trade name as the carrying value of the CGU&#8217;s net assets exceeded its discounted future
        cashflows. In 2023, the Group sold the Fitzgerald Industries business and the Fitzgerald trade name and RDI trade name were disposed of
        as part of that divestment.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
        trade name assets purchased as part of the acquisition of Fitzgerald in 2004, Primus and RDI in 2005 and Immco Diagnostics in 2013 were
        valued using the relief from royalty method and based on factors such as (1)&#160;the market and competitive trends and (2)&#160;the expected
        usage of the name. It was considered that these trade names will generate net cash inflows for the Group for an indefinite period.</span></span></div>
        </div> </div> </td> </tr>
  </table> </div> </div> </div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of intangible assets and goodwill. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Disclosure of financial assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsExplanatory', window );">FINANCIAL ASSETS</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">FINANCIAL ASSETS</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January 1, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions
        in year</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January 1, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions
        in year</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,562</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Write
        off in the year</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(800</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair
        value remeasured through profit &amp; loss</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(107</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provision
        for impairment</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January 1, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        in the current year</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January 1, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reversal
        of impairment in the current year (Note 5)</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">800</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(700</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        amounts</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
January 2023, the Company entered into a strategic partnership with imaware Inc. (&#8220;imaware&#8221;), combining imaware&#8217;s digital
health platform with the Company&#8217;s reference laboratory capabilities to support the delivery of at-home and remote testing programs.
As part of the partnership, the Company agreed to invest US$1.5&#160;million
in imaware through a convertible note arrangement. In addition, a five-year
agreement was signed appointing the Company as imaware&#8217;s laboratory testing partner. As at December 31, 2023, the Company had paid
US$0.7&#160;million
of the committed US$1.5&#160;million
investment. The remaining US$0.8&#160;million,
which had not yet been funded, was recognised as an accrued liability. The partnership did not generate any income in 2023. Due to continued
uncertainty over imaware&#8217;s financial performance and the recoverability of the investment, the Company recognised a full impairment
loss of US$1.5&#160;million
in the year ended December 31, 2023. In 2024, following the acquisition of Imaware by SuperTruth, and subsequent engagement with the acquirer,
it was confirmed that the Company is not liable to settle the outstanding US$0.8
million and it was written off against the corresponding impairment previously recognised. No further amounts are expected to be paid
under the original convertible note agreement.</span></span></div> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
2024, the Company purchased a strategic investment in Novus Diagnostics Limited, a company pioneering a rapid sepsis testing platform,
acquiring a 12.5%
stake at that time. This investment will accelerate the development and commercialization of Novus&#8217; groundbreaking point-of-care
diagnostic solutions, including its 15-minute bloodstream infection test. The investment was valued at approximately US$2,562,000
and was made through issuance of approximately 1,399,985
ADSs in the Company. The ADS issuance was recognised directly in equity. The investment does not meet the criteria for classification
at amortised cost, as it is not held to collect contractual cash flows. Nor did the Company make the irrevocable election to measure it
at fair value through other comprehensive income (FVOCI). Accordingly, the investment is measured at fair value through profit or loss
(FVTPL) in accordance with IFRS 9. As at December 31, 2024, the investment is classified within Level 3 of the fair value hierarchy under
IFRS 13, as it is not quoted in an active market and the fair value was determined using unobservable inputs. A remeasurement loss of
US$0.1&#160;million
was recognised in profit or loss for the year ended December 31, 2024.</span></span></div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEFERRED TAX ASSETS AND LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Disclosure of deferred tax assets and liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory', window );">DEFERRED TAX ASSETS AND LIABILITIES</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">DEFERRED TAX ASSETS AND LIABILITIES</span></span></div>
        </td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognised
deferred tax assets and liabilities</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
tax assets and liabilities of the Group are attributable to the following:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<div style="line-height:1.25">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black">
        <div style="text-align:center;line-height:1.25;font-style:italic">Assets</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black">
        <div style="text-align:center;line-height:1.25;font-style:italic">Liabilities</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black">
        <div style="text-align:center;line-height:1.25;font-style:italic">Net</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2024<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2023<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2024<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2023<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2024<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2023<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Property, plant and equipment</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">224</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">168</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">224</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">168</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Intangible assets</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(3,001</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(931</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(3,001</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(931</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Inventories</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">776</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">105</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">776</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">105</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Provisions</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,414</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">558</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,414</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">558</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Tax value of loss carry-forwards</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,026</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,030</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,026</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,030</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Other items</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">113</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">114</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,560</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,369</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,447</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">)</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,255</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Deferred tax assets/(liabilities)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">3,553</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,975</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(4,561</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(2,300</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,008</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(325</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  </table> </div> </div>  </div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
deferred tax asset at December 31, 2024 is mainly due to deductible temporary differences relating to provisions and loss carry-forwards
In 2024, the deferred tax asset increased by US$1.6
million mainly due to an increase in deductible temporary differences principally attributable to imputed interest provisions.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
deferred tax liability is caused by the net book value of non-current assets being greater than the tax written down value of non-current
assets, temporary differences due to the acceleration of the recognition of certain charges in calculating taxable income permitted in
Ireland and the US. The deferred tax liability increased by US$2.3
million in 2024, principally because of temporary differences in relation to acquired intangible assets.</span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
tax assets and liabilities are only offset when the entity has a legally enforceable right to set off current tax assets against current
tax liabilities and where the intention is to settle current tax liabilities and assets on a net basis or to realise the assets and settle
the liabilities simultaneously. At December 31, 2024 and at December 31, 2023 no deferred tax assets and liabilities are offset as it
is not certain as to whether there is a legally enforceable right to set off current tax assets against current tax liabilities and it
is also uncertain as to what current tax assets may be set off against current tax liabilities and in what periods.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Movement
in temporary differences during the year</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold">&#160;</div>

<div>

<div style="margin-left:36pt">

<div>

<div style="line-height:1.25">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center">Balance</div>
        <div style="line-height:1.25;font-style:italic;text-align:center">January 1,<br/>2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center">Recognised<br/>in income</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="line-height:1.25;text-align:center"><em>Recognised<br/>in discontinued operations</em></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center">Balance</div>
        <div style="line-height:1.25;font-style:italic;text-align:center">December&#160;31,<br/>2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Property, plant and equipment</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">168</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">56</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">224</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Intangible assets</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(931</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(2,070</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(3,001</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Inventories</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">105</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">671</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">776</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Provisions</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">558</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">856</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,414</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Tax value of loss carry-forwards</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,030</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(4</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,026</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Other items</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,255</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(192</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,447</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(325</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(683</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,008</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  </table> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><em><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance</span></span></em></div>
        <div style="line-height:1.25;font-style:italic"><em><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January
        1,<br/>2023</span></span></em></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><em><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognised<br/>in
        income</span></span></em></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25"><em><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognised<br/>in
        discontinued operations</span></span></em></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property,
        plant and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">224</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(56</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">168</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,950</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,827</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">192</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(931</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">423</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(318</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,194</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,636</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">558</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax
        value of loss carry-forwards</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,254</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(224</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,030</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        items</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(985</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(270</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,255</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(840</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">323</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">192</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(325</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unrecognised
deferred tax assets</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
tax assets have not been recognised by the Group in respect of the following items, which have not been tax effected:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital
        losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        operating losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">180,810</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">136,202</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US
        alternative minimum tax credits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>1,791</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,790</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        temporary timing differences</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,246</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">57,986</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US
        state credit carry-forwards</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,015</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210,140</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">208,286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>  </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER NON-CURRENT ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfOtherAssetsAbstract', window );"><strong>Other Non-current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherAssetsExplanatory', window );">OTHER NON-CURRENT ASSETS</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OTHER NON-CURRENT ASSETS</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance
        lease receivables (see Note 17)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">43</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">79</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group leases instruments as part of its business. For details of future minimum finance lease receivables with non-cancellable terms,
please refer to Note 17.</span></span></div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other assets. [Refer: Other assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInventoriesExplanatory', window );">INVENTORIES</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INVENTORIES</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw
        materials and consumables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,032</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,053</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Work-in-progress</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,989</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,498</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished
        goods</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,353</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,382</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,374</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,933</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
assets of the Group, including inventories have been pledged as security for the term loan from Perceptive Advisors.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">All
inventories are stated at the lower of cost or net realisable value. Total inventories for the Group are shown net of provisions of US$7,648,000
(2023: US$11,344,000)
(2022: US$16,274,000).
Cost of sales in 2024 includes inventories expensed of US$38,001,000
(2023: US$35,091,000)
(2022: US$45,340,000).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement on the inventory provision for the three-year period to December&#160;31, 2024 is as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Opening
        provision at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,344</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,274</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,063</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charged
        during the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,113</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,291</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Utilised
        during the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,809</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,456</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,180</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminated
        on disposal of business</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,765</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Closing
        provision at December&#160;31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,648</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,344</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,274</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>  </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS02_g36-39_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TRADE AND OTHER RECEIVABLES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Trade and other current receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">TRADE AND OTHER RECEIVABLES</a></td>
<td class="text">

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>17.</span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>TRADE AND OTHER RECEIVABLES</span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trade
        receivables, net of impairment losses</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13,416</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,698</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Prepayments</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,979</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,036</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Contract
        assets</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>460</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>525</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Value
        added tax</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>42</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>43</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Finance
        lease receivables</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>119</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Consideration
        due from sale of business (Note 8)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>373</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other
        receivables</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>168</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>107</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>16,065</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13,901</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trade
receivables are shown net of an impairment losses provision of US$2,286,000
(2023: US$2,324,000)
(2022: US$2,691,000)
(see Note 27). Prepayments are shown after impairment charges of US$Nil
(2023: US$Nil)
(2022: US$482,000)
(see Note 5).</span></span></span></span>

<p style="margin:0pt">&#160;</p> </div>

<div></div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Long-term
contract receivable</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-style:italic;margin-left:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(i)
Finance lease commitments &#8211; Group as lessor</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
Group leases instruments as part of its business. Future minimum receivables with non-cancellable terms are as follows:</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December
        31, 2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Gross<br/>investment</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Unearned<br/>income</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Minimum<br/>payments<br/>receivable</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less
        than one year</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Between
        one and five years (Note 15)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div>&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December
        31, 2023</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Gross<br/>investment</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Unearned<br/>income</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Minimum<br/>payments<br/>receivable</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less
        than one year</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>170</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>119</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Between
        one and five years (Note 15)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>54</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>36</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>224</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>155</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>

<div>&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
Group classified future minimum lease receivables between one and five years of US$Nil
(2023: US$36,000)
as Other Assets, see Note 15. Under the terms of the lease arrangements, no contingent rents are receivable.</span></span></span></span></div>

<div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(ii)
Operating lease commitments &#8211; Group as lessor</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
Group leases instruments under operating leases as part of its business.</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Future
minimum rentals receivable under non-cancellable operating leases are as follows:</span></span></span></span></div>

<div>&#160;</div> </div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December
        31, 2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Instruments</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less
        than one year</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,461</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,461</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,461</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,461</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div></div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(ii)
Operating lease commitments &#8211; Group as lessor</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December
        31, 2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Instruments</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less
        than one year</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,995</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,995</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,995</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,995</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div>  </div> </div> </div> </div> </div> </div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CASH AND CASH EQUIVALENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory', window );">CASH AND CASH EQUIVALENTS</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH AND CASH EQUIVALENTS</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        at bank and in hand</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="text-align:right;line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>  </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL AND RESERVES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Disclosure of classes of share capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">CAPITAL AND RESERVES</a></td>
<td class="text">

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAPITAL AND RESERVES</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share
capital</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
February 2024, the Company adjusted its ADS ratio from 1 ADS: 4 ordinary share to 1 ADS: 20 ordinary shares. The 2024 and 2023 ADS amounts
in the below tables reflect this change.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Ordinary shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Ordinary shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        thousands of shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        issue at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">165,866</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">164,986</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued
        for a cash consideration (a)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">81,628</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">880</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued
        for non-cash consideration (b)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">124,255</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        period end</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">371,749</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">165,866</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ADS</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ADS</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        thousands of ADSs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,249</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued
        for a cash consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,081</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued
        for non-cash consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,213</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        period end</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,587</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div></div>

<div style="text-indent:30.6pt;line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
amounts in the tables above are inclusive of Treasury Shares. The number of Treasury Shares is as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Treasury shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Treasury shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        thousands of shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,556</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,556</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchased
        during period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        period end</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,556</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,556</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div>&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Treasury shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Treasury shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        thousands of ADSs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">628</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">628</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchased
        during period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        period end</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">628</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">628</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:9pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(a)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the year ended December 31, 2024, the Company
        issued 81,628,000
        &#8216;A&#8217; Ordinary shares for a consideration of US$7.4
        million settled in cash. The Company incurred expenses of US$0.7
        million in connection with the issuances. No employee share options were exercised during the year.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:9pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(b)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the year ended December 31, 2024, the Company
        issued following shares for a consideration other than cash:</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:27pt">&#160;</td>
    <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 31, 2024, the Company issued 36,000,000
        &#8216;A&#8217; Ordinary shares (1,800,000
        ADS) as a part of the purchase consideration to acquire Waveform Technologies Inc., as a wholly owned subsidiary.</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:27pt">&#160;</td>
    <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ii)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 24, 2024, the Company issued 5,406,000
        &#8216;A&#8217; Ordinary shares (270,000
        ADS) as a part of the purchase consideration to acquire Metabolomic Diagnostics Limited, as a wholly owned subsidiary.</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:27pt">&#160;</td>
    <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iii)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 10, 2024, the Company issued 13,000,000
        &#8216;A&#8217; Ordinary shares (650,000
        ADS) to Craig-Hallum pursuant to the Advisory Agreement.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:27pt">&#160;</td>
    <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iv)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 10, 2024, the Company issued 7,237,000
        &#8216;A&#8217; Ordinary shares (362,000
        ADS) to Native Design Limited pursuant to a design services agreement.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:27pt">&#160;</td>
    <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">v)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 25, 2024, the Company issued 34,612,000
        &#8216;A&#8217; Ordinary shares (1,731,000
        ADS) as a purchase consideration to acquire EpiCapture Limited, as a wholly owned subsidiary.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:27pt">&#160;</td>
    <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">vi)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On October 25, 2024, the Company issued 28,000,000
        &#8216;A&#8217; Ordinary shares (1,400,000
        ADS) as a purchase consideration to acquire 12.5%
        equity stake in Novus Diagnostics.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Translation
reserve</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign currency
denominated operations of the Group since January&#160;1, 2004.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
reserves</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
reserves comprise the hedging reserve of US$23,000.
The hedging reserve comprises the effective portion of the cumulative net change in the fair value of cash flow hedging instruments related
to hedged transactions entered into but not yet crystallised. The hedging reserve is shown within Other Reserves in the Consolidated Statement
of Financial Position.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity
component of Convertible Note</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
May 2022, the Company completed a US$45.2
million investment from MiCo IVD Holdings, LLC&#160;(&#8220;MiCo&#8221;). The investment consisted of an equity investment of US$25.2
million and a seven-year,
unsecured junior convertible note of US$20.0
million. The convertible note mandatorily converts into ADSs if the volume weighted average price of the Company&#8217;s ADSs is at or
above US$16.20
for any five consecutive NASDAQ trading days. The convertible loan is accounted for as a compound financial instrument containing both
an equity and liability element. The equity component of the convertible note is US$6.7
million. There is no remeasurement of the equity element following initial recognition.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury
shares</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
2024, the Group did not purchase any &#8216;A&#8217; Ordinary shares (2023: nil)
(2022: nil)
&#8216;Treasury shares&#8217;.</span></span></div> </div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE OPTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract', window );"><strong>Disclosure Of Share Options And Share Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory', window );">SHARE OPTIONS</a></td>
<td class="text">

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SHARE OPTIONS</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under
the terms of the Company&#8217;s Employee Share Option Plans, options to purchase 40,506,672&#8216;A&#8217;
Ordinary Shares (2,025,334
ADS&#8217;s) were outstanding at December&#160;31, 2024. Under these Plans, options are granted to officers and employees of the Group
at the discretion of the Compensation Committee (designated by the Board of Directors), under the terms outlined below.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share
options are sometimes granted to consultants of the Group and the fair value of the services provided by these consultants is measured
by reference to the fair value of the equity instruments granted. This approach is adopted as it is impractical for the Group to reliably
estimate the fair value of such services. There are 2,000,000
outstanding options for consultants at December 31, 2024.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
terms and conditions of the grants are as follows, whereby all options are settled by physical delivery of shares:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vesting
conditions</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
options vest following a period of service by the officer or employee. The required period of service is determined by the Board or any
other relevant delegated committee at the date of grant of the options (usually the date of approval by the Compensation Committee) and
it is generally over a two to four-year period.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-vesting
conditions</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Since
2022, share options were granted to directors and certain employees for which there is a condition that the options only become exercisable
into ADSs when the market price of an ADS reaches a certain level. This is deemed to be a non-vesting condition. The term &#8216;non-vesting
condition&#8217; is not explicitly defined in IFRS 2, Share based payments, but is inferred to be any condition that does not meet the
definition of a vesting condition. The only condition for these particular options to vest is that the director or employee continues
service and there were no other conditions which would be considered non-vesting conditions. Non-vesting conditions are reflected in measuring
the grant-date fair value of the share-based payment and there is no true-up in the measurement of the share-based payment for differences
between the expected and the actual outcome of non-vesting conditions. If all service conditions are met, then the share-based payment
cost will be recognized even if the director or employee does not receive the share-based payment due to a failure to meet the non-vesting
condition.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractual
life</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
term of an option is determined by the Board of Directors, typically through its Remuneration Committee and Employee Compensation Committee,
provided that the term may not exceed ten years from the date of grant. All options will terminate 90 days after termination of the option
holder&#8217;s employment, service or consultancy with the Group (or one year after such termination because of death or disability) except
where a longer period is approved by the Board of Directors. Under certain circumstances involving a change in control of the Group, the
Board may accelerate the exercisability and termination of options.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
number and weighted average exercise price of share options per ordinary share is as follows:</span></span></div> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">Share Options &#8216;A&#8217; Ordinary Shares</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">Weighted- average exercise price US$ Per</div>
        <div style="text-align:center;line-height:1.25">&#8216;A&#8217; Ordinary Share</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">Range US$ Per &#8216;A&#8217; Ordinary Share</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding January&#160;1, 2022</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">18,727,990</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.78</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-4.36</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Granted</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">29,400,000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.27</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.27-0.29</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercised</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(2,733,328</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-0.19</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Expired / Forfeited</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(579,990</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1.87</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.69-4.36</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding December 31, 2022</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">44,814,672</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.47</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-2.43</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercisable December 31, 2022</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">14,138,004</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.89</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-2.43</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding January&#160;1, 2023</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">44,814,672</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.47</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-2.43</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Granted</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">19,600,000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.14</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.12-0.25</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercised</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(880,000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-0.19</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Expired / Forfeited</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(16,620,000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.33</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.27-2.43</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding December 31, 2023</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">46,914,672</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.39</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.12-1.34</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercisable December 31, 2023</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">19,764,672</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.67</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-1.34</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding January&#160;1, 2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">46,914,672</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.39</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.12-1.34</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Granted</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">12,100,000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.14</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.14-0.14</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Expired / Forfeited</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(18,508,000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.50</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.12-1.34</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding December 31, 2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">40,506,672</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.26</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.12-1.29</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercisable December 31, 2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">17,275,422</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.41</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.12-1.29</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div> </div> </div> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<div>

<div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>In
February 2024, the Company adjusted its ADS ratio from 1 ADS: 4 ordinary shares to 1 ADS: 20 ordinary shares.</span> The 2024 and 2023
ADS amounts in the below tables reflect this change.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
number and weighted average exercise price of share options per ADS is as follows:</span></span></div> </div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share
        Options &#8216;ADS&#8217; Equivalent</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-
        average exercise price US$ Per &#8216;ADS&#8217;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range
        US$ Per &#8216;ADS&#8217;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        January&#160;1, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">936,400</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15.60</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-87.20</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,470,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.40-5.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(136,666</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-3.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / Forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(29,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37.40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.80-87.20</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        December 31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,240,734</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-48.60</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable
        December 31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">706,900</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-48.60</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,240,734</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-48.60</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">980,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.40-5.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(44,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-3.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / Forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(831,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.60</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.40-48.60</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,345,734</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.40-26.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">988,234</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-26.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,345,734</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.40-26.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">605,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.80-2.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / Forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(925,400</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.40-26.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,025,334</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.20</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.40-25.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">863,771</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.20</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.40-25.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div> </div> </div> </div>

<div>

<div>

<div>

<div>

<div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman', serif">

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
opening share price per &#8216;A&#8217; Ordinary share at the start of the financial year was US$0.10
or US$2.00
per ADS (2023: US$0.24
per &#8216;A&#8217; ordinary share or US$4.8
per ADS) (2022: US$0.36
per &#8216;A&#8217; ordinary share or US$7.35
per ADS) and the closing share price at December&#160;31, 2024 was US$0.04
per &#8216;A&#8217; ordinary share or US$0.88
per ADS (2023: US$0.11
per &#8216;A&#8217; ordinary share or US$2.15
per ADS) (2022: US$0.25
per &#8216;A&#8217; ordinary share or US$4.95
per ADS). The average share price for the year ended December&#160;31, 2024 was US$0.10
per &#8216;A&#8217; Ordinary share or US$1.96
per ADS.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A
summary of the range of prices for the Company&#8217;s share options for the year ended December&#160;31, 2024 follows:</span></span></div>
</div> </div> </div> </div> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman', Times, serif">&#160;</div> </div> </div>


<div>

<div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Exercise
        price range</span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of<br/>options<br/>&#8216;A&#8217; ordinary<br/>shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of<br/>options<br/>&#8216;A&#8217; ordinary<br/>shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$0.12-US$0.99</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,356,672</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.25</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,125,422</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.78</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$1.00-US$1.29</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.14</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.38</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.76</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.36</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,506,672</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,275,422</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Exercise
        price range</span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;ADS<br/>equivalent&#8217;</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;ADS<br/>equivalent&#8217;</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$2.40-US$19.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,017,834</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">856,271</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.78</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$20.00-US$25.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.38</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.38</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,025,334</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">863,771</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </div> </div> </div> </div>

<div>

<div>

<div>

<div style="line-height:1.25">&#160;</div>

<div>

<div>

<div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
weighted-average remaining contractual life of options outstanding at December&#160;31, 2024 was 4.98
years (2023: 5.03
years).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A
summary of the range of prices for the Company&#8217;s share options for the year ended December&#160;31, 2023 follows:</span></span></div>
</div> </div> </div>

<div style="line-height:1.25">&#160;</div> </div> </div> </div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Exercise price
        range</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;A&#8217;
        ordinary<br/>shares</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;A&#8217;
        ordinary<br/>shares</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$0.12-US$0.99</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">42,266,672</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">0.28</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">5.50</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">15,116,672</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">0.47</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">4.16</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$1.00-US$1.74</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">4,648,000</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">1.33</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">0.79</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">4,648,000</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">1.33</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">0.79</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">46,914,672</span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">19,764,672</span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap">
        <div style="margin-right:62.3pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Exercise
        price range </span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;ADS<br/>equivalent&#8217;</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;ADS<br/>equivalent&#8217;</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$2.40-US$19.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">2,113,334</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">5.64</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">5.50</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">755,834</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">9.32</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">4.16</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$20.00-US$34.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">232,400</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">26.54</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">0.79</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">232,400</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">26.54</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">0.79</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">2,345,734</span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">988,234</span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div> </div>  </div> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<div>

<div>

<div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
for the year under IFRS 2</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
charge for the year is calculated based on the fair value of the options granted which have not yet vested.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25">

<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The
fair value of the options is expensed over the vesting period of the option. In 2024, US$1,316,000
(2023: US$2,069,000)
(2022: US$1,755,000)
was charged to the statement of operations split as follows:</span></span></p>

<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt">&#160;</p> </div> </div> </div> </div> </div> </div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments &#8211; cost of sales</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments &#8211; selling, general and administrative</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,316</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,069</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,755</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        &#8211; continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,316</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,069</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,755</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,316</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,069</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,755</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div>

<div>

<div>

<div>

<div>

<div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No
share-based payment expense was capitalised in intangible development project assets during the years ended December 31, 2022, 2023 or
2024.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair value of services received in return for share options granted are measured by reference to the fair value of share options granted.
The estimate of the fair value of services received is measured based on a Black-Scholes model. The following are the input assumptions
used in determining the fair value of share options granted in 2024, 2023 and 2022:</span></span></div> </div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25;font-family:Times New Roman, serif;margin-bottom:0pt">

<p style="margin:0pt">&#160;</p> </div> </div> </div> </div> </div> </div> </div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Key</span><br/><span style="font-weight:bold">management</span><br/><span style="font-weight:bold">personnel</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Key</span><br/><span style="font-weight:bold">management</span><br/><span style="font-weight:bold">personnel</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Key</span><br/><span style="font-weight:bold">management</span><br/><span style="font-weight:bold">personnel</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">2023</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">2022</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        fair value at measurement date per &#8216;A&#8217; share / (per ADS)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$0.10
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$2.08</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.50
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$10.04</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.19
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$3.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Total &#8216;A&#8217;
        share options granted / (ADS&#8217;s equivalent)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">12,100,000
        / (605,000</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">19,600,000
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(980,000</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">29,400,000
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(1,470,000</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        share price per &#8216;A&#8217; share / (per ADS)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.14/</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$2.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.14
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$2.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.27
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$5.40</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        exercise price per &#8216;A&#8217; share / (per ADS)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.14
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$2.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.14
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$2.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.27
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$5.40</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        expected volatility</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">74.40</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">40.21</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">76.79</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        expected life</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">7</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">7</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">6.82</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        risk-free interest rate</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">4.06</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">4.13</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">3.59</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td> </tr>
  </table> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>

<p style="margin:0pt">&#160;</p>

<div></div>

<div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The
expected life of the options is based on historical data and is not necessarily indicative of exercise patterns that may occur. The expected
volatility is based on the historic volatility (calculated based on the expected life of the options). The Group has considered how future
experience may affect historical volatility. The profile and activities of the Group are not expected to change in the immediate future
and therefore Trinity Biotech would expect estimated volatility to be consistent with historical volatility.</span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
model assumed an expected dividend yield of 0%, consistent with the Group&#8217;s current dividend policy.</span></span></p> </div> </div>
</div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfShareOptionsAndShareWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share oprtions and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TRADE AND OTHER PAYABLES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory', window );">TRADE AND OTHER PAYABLES</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TRADE AND OTHER PAYABLES</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">December&#160;31,</div>
        <div style="text-align:center;line-height:1.25;font-style:italic">2024</div>
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">December&#160;31,</div>
        <div style="text-align:center;line-height:1.25;font-style:italic">2023</div>
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Trade payables</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">6,833</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">3,885</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Accruals and other liabilities</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">13,597</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">7,552</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Amounts payable for financial assets (Note 13)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">800</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Payroll taxes</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">659</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">405</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Employee related social insurance</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">112</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">110</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Contingent consideration</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">5,384</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Deferred income</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">197</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">50</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">26,782</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">12,802</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Included
in trade and other payables at December 31, 2024 was US$185,000
(2023: US$144,000)
relating to contracted licence payments.</span></span></div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other payables. [Refer: Trade and other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROVISIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionsAbstract', window );"><strong>Provisions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionsExplanatory', window );">PROVISIONS</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PROVISIONS</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product
        warranty provision</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Legal &amp; regulatory
        provision</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">735</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposal-related warranty
        settlement provision</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restructuring provision</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,594</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,529</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,454</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
2024 and 2023 the Group experienced no significant product warranty claims. However, the Group believes that it is appropriate to retain
a product warranty provision to cover any future claims. The provision at December&#160;31, 2024 represents the estimated cost of product
warranties, the exact amount which cannot be determined. US$50,000
represents management&#8217;s best estimate of these obligations at December&#160;31, 2024.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year ended December 31, 2024, the Group recognised a provision of US$150,000
in respect of a post-completion settlement related to the sale of Fitzgerald Industries. The settlement agreement was finalised prior
to year-end and signed in January 2025. The provision is payable in two instalments: US$75,000
within one year and US$75,000
after more than one year. Refer to note 25 for further details.</span></span></div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25">

<div></div>

<div style="margin-left:41px;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25">During
the year, the Group recognised a provision of US$0.7
million in respect of a legacy matter currently subject to resolution. Owing to the sensitive nature of ongoing discussions, further disclosure
has been withheld in accordance with&#160;<span style="font-style:italic">IAS 37.92:&#160;seriously prejudicial exemption for non-disclosure
of certain information on&#160;provision</span>, as the Directors believe such disclosure could seriously prejudice the Group&#8217;s
position.</span></span></span></div>

<div style="text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25">&#160;</span></span></span></div>

<div style="margin-left:41px;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25">At
31 December 2024, the Company recognised a provision of US$2.9
million (2023: US$nil)
in respect of restructuring activities undertaken as part of the Group&#8217;s business transformation programme (refer to Note 5). The
restructuring provision is expected to be fully utilised during the next 12 months. No further restructuring provisions are anticipated
at the reporting date.</span></span></span></div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProvisionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProvisionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTEREST-BEARING LOANS AND BORROWINGS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract', window );"><strong>Disclosure Of Interest-bearing Loans And Borrowings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBorrowingsExplanatory', window );">INTEREST-BEARING LOANS AND BORROWINGS</a></td>
<td class="text">

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INTEREST-BEARING LOANS AND BORROWINGS</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
carrying value of interest-bearing loans, borrowings and related balances is as follows:</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        senior notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        financial liability</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">526</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingent
        liability (Note 29)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,813</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        non-current liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">91,263</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55,177</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Current
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        financial asset</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        non-current assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
senior notes</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
January 2022, the Company retired approximately US$99.7
million of the Exchangeable Notes as part of a debt re-financing. This represented approximately 99.7%
of the total Exchangeable Notes. Consideration was in cash and an issue of &#8216;A&#8217; Ordinary shares. The cash paid was US$86.73
million with each holder that was party to the agreement receiving US$0.87
of cash per US$1
nominal value of the Exchangeable Notes. The shares consideration was 1,066,600
ADSs (21,332,000
&#8216;A&#8217; Ordinary shares) representing the equivalent of US$0.40
of the Company&#8217;s ADS (based upon the 5-day trailing VWAP of the ADSs on NASDAQ on December 10, 2021, discounted by 13%)
per US$1
nominal value of the Exchangeable Notes, as partial consideration for the exchange of the Exchangeable Notes. The shares consideration
is valued at US$6.1
million based on market price on the date of issue.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div> </div>

<div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Exchangeable Notes were treated as a host debt instrument under IFRS with embedded derivatives attached. The embedded derivatives related
to a number of put and call options which were measured at fair value in the consolidated statement of operations. On initial recognition
in 2015, the host debt instrument was recognised at the residual value of the total net proceeds of the note issue less fair value of
the embedded derivatives. Subsequently, the host debt instrument was measured at amortised cost using the effective interest rate method.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
date of disposal, the carrying value of the extinguished Exchangeable Notes was US$83.2
million. As the IFRS measure of consideration was higher by US$9.7
million, the resulting loss on disposal was recorded as a financial expense in the year ended December 31, 2022. The remaining nominal
value of the Exchangeable Notes at December 31, 2024 is US$210,000
and this is shown within Current Liabilities.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement in the exchangeable notes balance was as follows:</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liability</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
secured term loan</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Company and its subsidiaries entered into a US$81.3
million senior secured term loan credit facility in December 2021 with Perceptive, an investment manager with an expertise in healthcare.
The Term Loan was drawn down in January 2022. The
Term Loan is secured by a charge over the Group&#8217;s assets. The 48-month Term Loan was originally due to expire in January 2026, however
this has since been amended to a maturity date of July 2026. The loan accrues interest at an annual rate equal to 11.25% plus the greater
of (a) one-month LIBOR (later changed to the Term SOFR Reference Rate effective from October 28, 2022) and (b) one percent per annum,
and interest is payable monthly in arrears in cash. In connection with the initial draw down of the Term Loan the Company
agreed to issue warrants to Perceptive for 500,000
of the Company&#8217;s ADSs.&#160; The per ADS exercise price of the Warrants was US$6.50.</span></span></div>
</div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Term Loan can be repaid, in part or in full, at a premium before the end of the four-year term at the discretion of the Company.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
accordance with IFRS accounting standards, the Term Loan is represented by three separate balances in the statement of financial position,
US$72.4
million (2023: US$40.1
million) is shown as a non-current liability balance representing the carrying value of the loan, a derivative financial asset estimated
at US$0.2
million (2023: US$0.2
million) representing the value to the Company of being able to repay the Term Loan early and potentially refinance at a lower interest
rate and a derivative financial liability estimated at US$1.7
million (2023: US$0.5
million) representing the fair value of the warrants issued to Perceptive.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
May 2022, the Company repaid US$34.5
million of the term loan principal and incurred an early payment penalty of approximately US$3.5
million, which has been recorded as a financial expense in the year ended December 31, 2022.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
February 2023, the Company announced that it had entered into an amended and restated senior secured Term Loan credit facility to allow
for an immediate US$5
million increase to the outstanding Term Loan and provide for a US$20
million facility to fund potential acquisitions. In connection with the increased loan facility, 500,000
warrants originally issued under the Term Loan were repriced, with the Warrants having a per ADS exercise price of US$5.36
compared to their initial per ADS exercise price of US$6.50.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On
April 27, 2023, the Company announced that it had closed the sale of our Fitzgerald Industries life sciences supply business, the Company
used approximately US$11
million of the proceeds of this sale to repay approximately US$10.1
million of its senior secured debt held by Perceptive plus an approximately US$0.9
million early repayment penalty, which has been recorded as a financial expense in the year ended December 31, 2023. In connection with
this transaction, the Company entered an amendment to its senior secured Term Loan credit facility with Perceptive Advisors, which significantly
reduced the Company&#8217;s minimum revenue covenants under that loan.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
January 2024, as part of the agreement to purchase the Waveform assets, we entered into an amended credit agreement with Perceptive. Under
this agreement, an additional US$22
million of funding has been made available to us, with US$12.5
million being used to acquire the Waveform assets. The remaining US$9.5
million was made available for general corporate purposes including for the further development of the CGM and biosensor technologies.
The Amended Term Loan also provides for additional liquidity of up to US$6.5
million, that may be drawn down between April and December 2024 and can be used for general corporate purposes. In April 2024, the Company
drew down the additional funding of US$6.5
million as prescribed in the Amended Term Loan agreement. This funding will be used for general corporate purposes, including the further
development of our CGM offering.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">I</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt">n
December 2024, the Company entered into a further amendment to the credit agreement with Perceptive. As part of this amendment, the Company
drew down an additional US$2 million for general corporate purposes. We also agreed that certain interest payments payable in 2024 and
2025 would be paid-in-kind on the applicable payment date by increasing the outstanding principal amount of the Term Loan. This included
the interest payments due for the period from September through December 2024, which were settled through PIK. Additionally, as part of
this amendment the Company granted Perceptive new warrants to purchase an additional </span>1,500,000<span style="font-family:Times New Roman, Times, serif;font-size:10pt">
ADSs at an exercise price of US$</span>0.80<span style="font-family:Times New Roman, Times, serif;font-size:10pt">
per ADS, and the exercise price of its existing ADS warrants was also reset to US$</span>0.80<span style="font-family:Times New Roman, Times, serif;font-size:10pt">
per ADS.</span>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
issuance of additional warrants and repricing of existing warrants was not considered a modification of the original financial liability
under IFRS. All warrants are classified as financial liabilities and are measured at fair value through profit or loss. For the year ended
December 31, 2024, a non-cash fair value loss of US$2.1
million was recognized in finance expense, reflecting the initial recognition of the newly issued warrants, the repricing of existing
warrants, and subsequent remeasurement of all warrant liabilities.</span></span></p> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year ended December 31, 2024 accretion interest of US$2.4
million (2023: US$1.1
million) was accrued to leave a closing carrying value of US$72.4
million at year end (2023: US$40.1
million).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
secured term loan</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement in the Term Loan was as follows:</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(44,301</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal amount loaned</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(30,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loan drawdown costs</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">325</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">194</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative financial
        liability at date of drawdown</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">90</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative financial
        asset at date of drawdown</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(28</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accretion interest (Note
        6)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,355</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,131</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash repayment of principal</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,050</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Payment-in-kind (PIK)
        Interest</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,291</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash Loan Modification
        Gain</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,567</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December&#160;31</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table>  </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair value of the derivative financial asset is estimated at US$0.2
million at December 31, 2024 (2023: US$0.2
million). The fair value of the derivative financial liability is estimated at US$1.7
million at December 31, 2023 (2023: $0.5
million) The fair value remeasurement for these two derivative financial balances at December 31, 2024, resulted in the recognition of
net financial income of US$26,000
(2023: US$1.2
million) in the consolidated statement of operations.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
Q1 2024, the
Company negotiated a 2.5% reduction in the base interest rate on its term loan facility, lowering the rate from 11.25% to 8.75%.
In accordance with IFRS 9, this amendment was treated as a non-substantial modification of the financial liability. As a result, the carrying
amount of the loan was remeasured using the original effective interest rate (EIR), and a non-cash gain of $3.6
million was recognised in finance income. This gain reflects the difference between the previous carrying amount of the loan and the present
value of the modified cash flows, discounted at the original EIR, and is presented in the consolidated statement of operations as a &#8220;Non-cash
loan modification gain.&#8221;.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingent
liability</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
part of the consideration for the acquisition of the CGM assets from Waveform Technologies, Inc., the Group recognised a contingent liability
of US$1.8
million at the acquisition date. This relates to potential additional consideration payable upon entering into certain commercial partnering
agreements with designated glucose pump manufacturers within 24 months of the acquisition. As the payment is subject to the occurrence
of uncertain future events, it is disclosed as a contingent liability rather than a recognised financial liability. Refer to Note 29.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement in the derivative financial asset in the year was as follows:</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">128</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative financial
        asset at date of drawdown</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustments
        in the period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current asset at
        December 31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement in the derivative financial liability in the year was as follows:</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(526</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,569</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative financial
        liability at date of drawdown</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,066</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(90</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustments
        in the period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,133</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liability
        at December 31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(526</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7-year
convertible note</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
May 2022, the Company completed a US$45.2
million investment from MiCo IVD Holdings, LLC. Based on public filings, we understand that on December 17, 2024, MiCo was acquired by
Dayli Trinity Holdings Limited as a result of a share purchase agreement with Mainstream Holdings Limited. The investment consists of
an equity investment of US$25.2
million and a seven-year, unsecured junior convertible note of US$20.0
million. The
convertible note has an interest rate of 1.5%. The convertible note mandatorily converts into ADSs if the volume weighted average price
of the Company&#8217;s ADSs is at or above US$16.20 for any five consecutive NASDAQ trading days. For further details
on the convertible note, refer to the Company&#8217;s Form 6-K filings with the SEC on April 11, 2022.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div> </div>

<div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
convertible loan note is accounted for as a compound financial instrument containing both an equity and liability element. The debt component
is accounted for at amortised cost in accordance with IFRS 9. At December 31, 2024, the carrying value of the convertible note&#8217;s
debt component was US$15.4
million (2023: US$14.5
million) and accretion interest of US$0.9
million (2023: US$0.8
million) has been recognised as a financial expense in the year. The equity component of the convertible note is US$6.7
million and has been recorded in the equity section of the statement of financial position as Equity component of convertible note. There
is no remeasurement of the equity element following initial recognition.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement in the 7-year convertible note in the year was as follows:</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13,746</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accretion interest</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(859</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(796</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liability
        at December 31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table>  </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASE LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract', window );"><strong>Disclosure of finance lease liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">LEASE LIABILITIES</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">LEASE LIABILITIES</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group has leases for some of its manufacturing plants, all warehouses, offices, motor vehicles and some IT equipment. With the exception
of short-term leases and leases of low-value underlying assets, each lease is reflected on the balance sheet as a right-of-use asset (net
of any depreciation and/or impairment) and a lease liability. Variable lease payments which do not depend on an index or a rate (such
as lease payments based on a percentage of Group sales) are excluded from the initial measurement of the lease liability and asset. The
Group classifies its right-of-use assets in a consistent manner to its property, plant and equipment (see Note 11).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Each
lease generally imposes a restriction that, unless there is a contractual right for the Group to sublet the asset to another party, the
right-of-use asset can only be used by the Group. Leases are either non-cancellable or may only be cancelled by incurring a substantive
termination fee. Some leases contain an option to purchase the underlying leased asset outright at the end of the lease, or to extend
the lease for a further term. The Group is prohibited from selling or pledging the underlying leased assets as security. For leases over
office buildings and factory premises the Group must keep those properties in a good state of repair and return the properties in their
original condition at the end of the lease. Further, the Group must insure items of property, plant and equipment and incur maintenance
fees on such items in accordance with the lease contracts.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
liabilities</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
liabilities are payable as follows:</span></span></div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;</span></span></div>

<div style="line-height:1.25;margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities related to Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,285</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,694</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,285</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,694</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities related to Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,477</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,872</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities related to</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right
        of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Minimum</span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">lease</span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">payments</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less
        than one year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,862</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">577</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,285</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        more than one year, but not more than two</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,214</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">472</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,742</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        more than two years but not more than five</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,487</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">955</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,532</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">More
        than five years</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,652</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">449</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,203</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,215</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,453</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,762</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>  </div> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities related to</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right
        of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Minimum</span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">lease</span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">payments</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less
        than one year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,221</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">577</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,644</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        more than one year, but not more than two</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,243</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,745</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        more than two years but not more than five</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,442</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,017</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,425</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">more
        than five years</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,400</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">648</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,306</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,740</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-weight:bold;margin-left:30.6pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
payments not recognised as a liability</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No
short-term lease expenses were incurred for the year ended December 31, 2024. Payments made under such leases are expensed on a straight-line
basis. In addition, certain variable lease payments are not permitted to be recognised as lease liabilities and are expensed as incurred.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25">

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The total paid in respect
of lease liabilities in the year ended December 31, 2024, was US$2,503,000
(2023: US$2,318,000).</span></span></div>
</div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Section Presentation<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfFinanceLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract', window );"><strong>Disclosure Of Commitments And Contingent Liability Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">

<div>

<div>

<div>

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">COMMITMENTS AND CONTINGENCIES</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(a)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital
        Commitments</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group has capital commitments authorised and contracted for of US$nil
as at December&#160;31, 2024 (2023: US$39,900).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(b)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold;font-style:italic">Leasing
        Commitments</span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:0pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group&#8217;s leasing commitments are shown in Note 24.</span></span></div>

<div style="text-indent:0pt;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%">
  <tr style="vertical-align:top">
    <td style="text-align:right;vertical-align:top;width:28.35pt">
        <div style="line-height:1.25;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(c)</span></span></div>
        </td>
    <td style="text-align:left;vertical-align:top;width:auto">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold;font-style:italic">Bank
        Security</span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Credit Agreement for the senior secured term loan is secured by substantially all of our property and assets, including our equity interests
in our subsidiaries, refer to Note 23.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
2023, the sale and leaseback liability matured as the lease came to an end and was not renewed, as a result, the bank charge against the
equipment for which the borrowings pertained did not exist as at December 31, 2023.</span></span></div>

<div style="line-height:1.25">&#160;</div> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(d)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Group
        Company Guarantees</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant
to the provisions of Section&#160;357, Companies Act, 2014, the Company has guaranteed the liabilities of Trinity Biotech Manufacturing
Limited, Trinity Research Limited and Trinity Biotech Financial Services Limited subsidiary undertakings in the Republic of Ireland, for
the financial year to December&#160;31, 2024 and, as a result, these subsidiary undertakings have been exempted from the filing provisions
of Section&#160;357, Companies Act, 2014. Where the Company enters into these guarantees of the indebtedness of other companies within
its Group, the Company considers these to be insurance arrangements and accounts for them as such.&#160;The Company treats the guarantee
contract as a contingent liability until such time as it becomes probable that the Company will be required to make a payment under the
guarantee.&#160;The Company does not enter into financial guarantees with third parties.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(e)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government
        Grant Contingencies</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group has received training and employment grant income from Irish development agencies. Subject to existence of certain conditions specified
in the grant agreements, this income may become repayable. No such conditions existed as at December&#160;31, 2024. However, if the income
were to become repayable, the maximum amounts repayable as at December&#160;31, 2024 would amount to US$3,313,000
(2023: US$3,410,000).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(f)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingency
        relating to the sale of Fitzgerald Industries</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On
April 27, 2023 the Company announced it had closed the sale of Fitzgerald Industries (&#8220;Fitzgerald&#8221;) to Biosynth for cash proceeds
of approximately US$30
million subject to customary adjustments. In a telephone call conducted in March 2024, a representative of Biosynth alleged a breach of
certain of the warranties set out in the Share Purchase Agreement for the sale of Fitzgerald. Following negotiations, a settlement agreement
was finalised prior to December 31, 2024 and subsequently signed in January 2025. Under the terms of the settlement, the Company agreed
to pay Biosynth US$150,000
in full and final settlement of all post-completion claims. Accordingly, a provision of US$150,000
has been recorded in the consolidated financial statements as at December 31, 2024, see Note 22. In addition, outstanding receivables
of US$423,000
from Biosynth relating to completion account adjustments were written off as unrecoverable under the terms of the settlement. The settlement
fully resolves all disputes related to the sale of Fitzgerald Industries, and no further liabilities are expected to arise.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(g)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold;font-style:italic">Contingent
        considerations relating to business combinations</span></span></span></td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
part of the acquisition of the CGM assets of Waveform Technologies, Inc., the Company may pay up to US$20
million in contingent consideration based on share price, trading volume, and commercial milestones. The fair value of this contingent
consideration is US$6.8
million as of December 31, 2024. Refer to Note 29 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
part of the acquisition of EpiCapture Limited (see Note 29), contingent consideration of up to US$0.5
million may become payable based on cumulative revenue targets. The fair value of this contingent consideration is US$0.4
million as of December 31, 2024. Refer to Note 29 for further details.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top">
        <div style="line-height:1.25">(h)</div> </td>
    <td style="width:auto;vertical-align:top;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold;font-style:italic">Other
        Contingencies</span></span></span></td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Company has other contingencies primarily relating to claims and legal proceedings, onerous contracts, product warranties and employee
related provisions. The status of each significant claim and legal proceeding in which the Company is involved is reviewed by management
on a periodic basis and the Group&#8217;s potential financial exposure is assessed. If the potential loss from any claim or legal proceeding
is considered probable, and the amount can be reliably estimated, a liability is recognised for the estimated loss. Because of the uncertainties
inherent in such matters, the related provisions are based on the best information available at the time; the issues taken into account
by management and factored into the assessment of legal contingencies include, as applicable, the status of settlement negotiations, interpretations
of contractual obligations, prior experience with similar contingencies/claims, and advice obtained from legal counsel and other third
parties. The Group expects the majority of these provisions will be utilised within one to three years of the balance sheet date; however
due to the nature of the legal provisions there is a level of uncertainty in the timing of settlement as the Group generally cannot determine
the extent and duration of the legal process.</span></span></div> </div> </div> </div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments and contingent liabilities. [Refer: Classes of contingent liabilities [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text">

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.</span></span></td>
    <td style="vertical-align:top;width:auto">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RELATED PARTY TRANSACTIONS</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group has related party relationships with its subsidiaries, and with its directors and executive officers.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasing
arrangements with related parties</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group has entered into various arrangements with JRJ Investments (&#8220;JRJ&#8221;), a partnership owned by Mr O&#8217;Caoimh and Dr
Walsh, directors of Trinity Biotech, and directly with Mr O&#8217;Caoimh, to provide premises at IDA Business Park, Bray, County Wicklow,
Ireland.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group entered into an agreement with JRJ for a 25-year
lease commencing in December 2003 for offices that were adjacent to its then premises at IDA Business Park, Bray, County Wicklow, Ireland
with an annual rent of &#8364;381,000
(US$421,000).
Upward-only rent reviews are carried out every five years and there have been no increases arising from these rent reviews.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
2007 we entered into a 25-year
lease agreement with JRJ for a 43,860
square foot manufacturing facility in Bray, Ireland with an annual rent of &#8364;787,000
(US$834,000).
Subsequent to the signing of this lease, the ownership of the building transferred from JRJ to Mr O&#8217;Caoimh solely. A rent review
for this property became effective 1 July 2022 and, following an independent valuation, the annual rent increased to &#8364;1,050,000,
with backdated rent accruing from that date. Included within overhead costs in cost of sales is an amount of $686,000
in respect of backdated rent. In 2016, we entered into a 10-year
lease with Mr. O&#8217;Caoimh for a warehouse adjacent to our leased manufacturing facility in Bray, Ireland. The warehouse is 16,000
square feet with an annual rent of &#8364;144,000
(US$159,000).
A rent review for this property became effective on 1 July 2021 and, following an independent valuation, the annual rent increased to
&#8364;170,560,
with backdated rent accruing from that date. Included within overhead costs in cost of sales is an amount of $97,000
in respect of backdated rent. Independent valuers advised the Group that the rent in respect of each of the leases represented a fair
market rent.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
late 2020, the Group occupied some additional space adjoining the warehouse owned by Mr O&#8217;Caoimh. This was a short-term arrangement,
and no payments were made for the additional space during 2020 and 2021. The Company vacated this space in 2021. In 2022, the rent payable
to Mr O&#8217;Caoimh of US$90,000
was settled.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
the time that the arrangements were entered into, Trinity Biotech and its directors (excepting Mr O&#8217;Caoimh and Dr Walsh who expressed
no opinion on this point) believed they represented a fair and reasonable basis on which the Group could meet its ongoing requirements
for premises. Dr Walsh has no ownership interest in the additional space adjoining the warehouse owned by Mr O&#8217;Caoimh and was therefore
entitled to express an opinion on this arrangement.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
September 2024, the Company completed the acquisition of Metabolomics Diagnostics Ltd ("Metabolomics") for consideration of approximately
US$0.9
million, satisfied through the issuance of approximately 0.27
million ADSs and the extinguishment of amounts owed to the Company totaling US$0.41
million. At the time of the acquisition, Dr. Jim Walsh, a director of the Company, held a 6%
minority shareholding in Metabolomics. Based on the net assets acquired and goodwill recognised, the value attributable to Dr. Walsh&#8217;s
interest was estimated at approximately $55,000.
Dr. Walsh fully disclosed his interest, and the acquisition was approved unanimously by the board, with appropriate procedures followed
to manage the potential conflict of interest, including the passing of a resolution under the Company's Constitution to authorise Dr.
Walsh&#8217;s involvement in the decision-making process. The transaction was conducted at arm&#8217;s length, and the board determined
that it was in the best interests of the Company.</span></span><br/>&#160;</div> </div>

<div></div>

<div>

<div style="text-align:justify;line-height:1.25;font-style:italic;font-weight:bold;margin-left:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Compensation
of key management personnel of the Group</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25;margin-left:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the years ended December 31, 2024 and 2023, the Group&#8217;s key management personnel comprised directors Mr. Ronan O&#8217;Caoimh, Dr.
Jim Walsh, and Mr. John Gillard. The Group does not engage a separate management entity, as all key management personnel are employed
directly by the Group. Compensation for the year for these personnel is detailed below:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term
        employee benefits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">843</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,774</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Performance
        related bonus</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>260</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">211</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Post-employment
        benefits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        compensation benefits as calculated under IFRS 2</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">931</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,601</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,073</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,612</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
amounts disclosed in respect of directors&#8217; emoluments in Note 9 includes independent directors&#8217; fees and non-executive director
fees of US$114,000
(2023: US$73,000)
and share-based compensation benefits of US$Nil
(2023: US$Nil).
Total directors&#8217; remuneration is also included in &#8220;employment&#8221; (Note 3) and &#8220;(Loss)/profit before tax&#8221; (Note
9).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Directors&#8217;
interests in the Company&#8217;s shares and share option plan</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;A&#8217;
        Ordinary Shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share
        options</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,117,777</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30,387,336</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shares
        purchased during the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">200,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,600,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,994,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,317,777</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32,993,336</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;A&#8217;
        Ordinary Shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share
        options</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,117,777</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,547,336</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options
        of retired director</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(20,000,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,000,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,160,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,117,777</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30,387,336</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>  </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">CAPITAL AND FINANCIAL RISK MANAGEMENT</a></td>
<td class="text">

<div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAPITAL AND FINANCIAL RISK MANAGEMENT</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-weight:bold;margin-left:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital
Management</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group&#8217;s policy is to maintain a strong capital base to maintain investor, creditor and market confidence and to sustain future development
of the business. The Board of Directors monitors (loss)/earnings per share as a measure of performance, which the Group defines as (loss)/profit
after tax divided by the weighted average number of shares in issue.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair
Values</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
table below sets out the Group&#8217;s classification of each class of financial assets/liabilities, their fair values and under which
valuation method they are valued:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        2</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        3</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">carrying</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">amount</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Value</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loans
        and receivables at amortised cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,583</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">-</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,583</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,583</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities
        at amortised cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,762</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,762</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,762</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables (excluding deferred income)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,585</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,585</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,585</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,529</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,529</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,529</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(41,876</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(88,002</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(129,878</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(129,878</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair
        value through profit and loss (FVPL)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        liability - warrants</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        asset &#8211; prepayment option</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity
        investments in Novus</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,492</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">963</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">963</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(23,293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(89,494</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(110,332</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(110,332</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:28.35pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For
financial reporting purposes, fair value measurements are categorized into Level&#160;1, 2 or 3 based on the degree to which inputs to
the fair value measurements are observable and the significance of the inputs to the fair value measurement in its entirety, which are
described as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level&#160;1:
quoted prices (unadjusted) in active markets for identical assets or liabilities</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level&#160;2:
valuation techniques for which the lowest level of inputs which have a significant effect on the recorded fair value are observable, either
directly or indirectly</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level&#160;3:
valuation techniques for which the lowest level of inputs that have a significant effect on the recorded fair value are not based on observable
market data.</span></span></div>

<div style="margin-left:28.35pt;line-height:1.25">&#160;</div>

<div></div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        2</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        3</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">carrying</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">amount</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Value</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loans
        and receivables at amortised cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,698</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,698</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,698</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance
        lease receivable</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,
        17</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,544</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,544</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,544</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities
        at amortised cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        note&#185;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables (excluding deferred income)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(25,368</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(54,861</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(80,229</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(80,229</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair
        value through profit and loss (FVPL)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        liability - warrants</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(526</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(526</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(526</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        asset &#8211; prepayment option</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(348</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(348</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(348</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10,824</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(55,209</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,033</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,033</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
valuation techniques used for instruments categorised as level 2 are described below:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair values of the options associated with the exchangeable notes are calculated in consultation with third-party valuation specialists
due to the complexity of their nature. There are a number of inputs utilised in the valuation of the options, including share price, historical
share price volatility, risk-free rate and the expected borrowing cost spread over the risk-free rate.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
Risk Management</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group uses a range of financial instruments (including cash, finance leases, receivables, payables and derivatives) to fund its operations.
These instruments are used to manage the liquidity of the Group. Working capital management is a key additional element in the effective
management of overall liquidity. The Group does not trade in financial instruments or derivatives. The main risks arising from the utilization
of these financial instruments are interest rate risk, liquidity risk and credit risk.</span></span>

<p style="margin:0pt">&#160;</p> </div>

<div></div>

<div style="margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;<span style="font-weight:bold;font-style:italic">Interest
rate risk</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
of December 31, 2024, all of the Group&#8217;s financial instruments referencing interest rates are based on SOFR, a post-reform benchmark
rate. The Group no longer has exposure to interest rate benchmarks subject to IBOR reform; therefore, the disclosure requirements related
to benchmark interest rate reform are not applicable.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective
and repricing analysis</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following tables sets out all interest-earning financial assets and interest-bearing financial liabilities held by the Group at December&#160;31,
2024 and 2023, indicating their effective interest rates and the period in which they re-price:</span></span></div>

<div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As&#160;at&#160;December&#160;31,&#160;2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">interest<br/>rate</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths or less</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        &#8211;12 mths</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&gt;
        5 years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash&#160;and&#160;cash&#160;equivalents</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.00</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        note<sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup></span></span></div> </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.0</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan<sup style="vertical-align:text-top;line-height:1;font-size:smaller">2</sup></span></span></div> </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.3</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note<sup style="vertical-align:text-top;line-height:1;font-size:smaller">3</sup></span></span></div> </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.5</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:20.21%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-9pt;margin-left:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;&#160;Lease
        payable on Right of Use assets</span></span></div> </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.0</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,762</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,150</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,135</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,742</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,532</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,203</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:20.21%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(95,597</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,017</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,135</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(74,133</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,933</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,413</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As&#160;at&#160;December&#160;31,&#160;2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">interest<br/>rate</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths or less</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        &#8211;12 mths</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&gt;
        5 years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash&#160;and&#160;cash&#160;equivalents</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:middle;width:20.21%;vertical-align:bottom">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease&#160;receivable</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,17</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.0</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        note<sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20.21%;vertical-align:bottom">
        <div style="text-indent:-2.6pt;margin-left:9.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan<sup style="vertical-align:text-top;line-height:1;font-size:smaller">2</sup></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-1.9pt;margin-left:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note<sup style="vertical-align:text-top;line-height:1;font-size:smaller">3</sup></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20.21%;padding-bottom:2px;vertical-align:bottom">
        <div style="margin-left:7.1pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        payable on Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.0</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(812</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,745</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,425</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:20.21%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(63,581</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,941</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(793</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,696</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(44,529</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,504</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup>
The maturity of the exchangeable notes is based on the contractual maturity date of April 1, 2045.</span></span></div>

<div style="margin-left:31.2pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><sup style="vertical-align:text-top;line-height:1;font-size:smaller">2</sup>
The senior secured term loan is a variable instrument. In January 2024, the
amended term loan agreement reduced the annual rate of interest on the loan by 2.5% to 8.75% plus the greater of (a) Term Secured Overnight
Financing Rate or (b) 4.0% per annum, and allows for a further 2.5% reduction in the base rate to 6.25% once the outstanding principal
under the term loan falls below US$35 million.&#160; The loan matures in July 2026.</span></span></div>

<div style="margin-left:31.2pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><sup style="vertical-align:text-top;line-height:1;font-size:smaller">3</sup>
The 7-year convertible note was issued in May 2022 and is a fixed rate instrument which bears a fixed rate of interest of 1.5%
per annum.</span></span></div> </div>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>In
broad terms, a one-percentage point increase in interest rates would increase interest income by US$Nil
(2023: US$Nil)
as at December 31, 2024 the Company holds no funds in interest-bearing accounts; while the annual impact on the interest expense would
be an increase of US$755,000
(2023: US$417,000)
on the costs of servicing the senior secured term loan. </span>&#160;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest
rate profile of financial assets / liabilities</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
interest rate profile of financial assets/liabilities of the Group was as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Variable
        rate instruments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        at bank and in hand</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Variable
        rate financial liabilities (senior secured term loan)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(67,224</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,418</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fixed
        rate instruments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fixed
        rate financial liabilities (exchangeable note)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fixed
        rate financial liabilities (convertible note)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fixed
        rate financial liabilities (lease payables)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,762</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        assets (lease receivables)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(28,373</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(27,163</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold;font-style:italic">&#160;Fair
value sensitivity analysis for fixed rate instruments</span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group does not account for any fixed rate financial liabilities at fair value through profit and loss. Therefore, a change in interest
rates at December&#160;31, 2024 or December 31, 2023 would not affect profit or loss. There was no significant difference between the
fair value and carrying value of the Group&#8217;s trade receivables and trade and other payables at December&#160;31, 2024 and December
31, 2023 as all fell due within 6 months.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic;font-weight:bold">Liquidity
risk</span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
following are the contractual maturities of financial liabilities, including estimated interest payments:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2024</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying<br/>amount</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractual<br/>cash
        flows</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths or<br/>less</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths &#8211;</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12
        mths</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&gt;5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:16%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables (excluding deferred income)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25,286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25,286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25,286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        payable on Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,762</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,214</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,454</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,408</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,213</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,487</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,652</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan&#185;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">81,438</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,703</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,319</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">76,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,350</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">300</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">900</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,850</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:16%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">380</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">340</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:16%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">126,050</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">143,668</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,597</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,881</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">78,937</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,411</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,842</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>  </div>

<div>&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#185;
The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December
31, 2024</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2023</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying<br/>amount</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractual<br/>cash
        flows</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths or<br/>less</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths &#8211;</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12
        mths</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&gt;5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:16%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables (excluding deferred income)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        payable on Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,306</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,107</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,114</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,243</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,442</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,400</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan&#185;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,121</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,461</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,461</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,922</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42,277</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,650</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">300</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">900</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:16%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">389</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">349</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:16%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">80,179</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">106,218</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,474</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,729</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,473</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">48,643</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25,899</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#185;
The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December
31, 2023.</span></span></div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign
exchange risk</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
majority of the Group&#8217;s activities are conducted in US Dollars. Foreign exchange risk arises from the fluctuating value of the Group&#8217;s
Euro denominated expenses as a result of the movement in the exchange rate between the US&#160;Dollar and the Euro. There were no forward
contracts in place as at December 31, 2024 or December&#160;31, 2023.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign
currency financial assets and liabilities which expose the Group to currency risk are disclosed below. The amounts shown are those reported
to key management translated into US Dollars at the closing rate:</span></span></div>

<div>&#160;</div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td rowspan="1" style="vertical-align:bottom;vertical-align:bottom"></td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EUR</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GBP</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SEK</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAD</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BRL</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">116</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other receivable</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,009</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">294</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,019</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7,098</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(453</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(114</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(135</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6,867</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(171</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        exposure</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,840</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(329</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">473</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,086</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td rowspan="1" style="vertical-align:bottom;vertical-align:bottom"></td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EUR</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GBP</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SEK</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAD</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BRL</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">219</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">191</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">854</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other receivable</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">856</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">533</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,533</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,766</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(100</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(220</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(704</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,349</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(241</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        exposure</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,040</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">504</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,442</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div>

<p style="margin:0pt">&#160;</p> </div>

<div></div>

<div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sensitivity
analysis</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div>

<div style="margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A 10%
strengthening of the US&#160;Dollar against the Euro at December&#160;31, 2024 would have increased profit and other equity by the amounts
shown below. This analysis assumes that all other variables, in particular interest rates, remain constant.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        or Loss</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td colspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td colspan="1" style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td colspan="1" style="vertical-align:middle;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td colspan="1" style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td colspan="1" style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,004</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>&#160;

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A
10% weakening of the US&#160;Dollar against the Euro at December&#160;31, 2024 would have decreased profit and other equity by the amounts
shown below. This analysis assumes that all other variables, in particular interest rates, remain constant.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        or Loss</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,427</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,227</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
sensitivity analysis is based on the Group&#8217;s foreign currency exposures at the reporting date and assumes a 10% movement in the
US Dollar against the Euro. The analysis includes monetary assets and liabilities denominated in Euro at the reporting date and assumes
that exchange rate changes occur at the period-end and are applied to the net exposure. Non-monetary items and future forecast transactions
are excluded. The analysis assumes that all other variables, including interest rates, remain constant. The analysis does not incorporate
interdependencies between variables, such as interest rate effects on exchange rates, and is not based on a value-at-risk model.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
objective of this analysis is to assess the potential impact of reasonably possible changes in exchange rates on the Group&#8217;s profit
or loss and equity, based on exposures at the reporting date. The analysis reflects only monetary assets and liabilities denominated in
foreign currencies and does not include future transactions or embedded derivatives. The analysis has inherent limitations, as it is based
on a hypothetical movement in a single variable (foreign exchange rate) and assumes all other variables remain constant. It does not consider
the potential interdependence between risk factors (such as changes in interest rates or inflation), nor does it reflect management&#8217;s
dynamic hedging activities or the potential impact on fair value from market volatility occurring after the reporting date.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Credit
Risk</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group has no significant concentrations of credit risk. Exposure to credit risk is monitored on an ongoing basis. For trade receivables,
the Group applies the simplified approach to measuring expected credit losses and recognizes a lifetime expected credit loss allowance.
A receivable is considered credit-impaired when it is more than 120 days past due or when there is evidence of significant financial difficulty.
The Group maintains specific provisions for potential credit losses. To date such losses have been within management&#8217;s expectations.
Due to the large number of customers and the geographical dispersion of these customers, the Group has no significant concentrations of
accounts receivable.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">With
respect to credit risk arising from the other financial assets of the Group, which comprise cash and cash equivalents, the Group&#8217;s
exposure to credit risk arises from default of the counterparty, with a maximum exposure equal to the carrying amount of these instruments.
The Group&#8217;s management considers that all of the above financial assets that are not impaired or past due for each of the 31&#160;December
reporting dates under review are of good credit quality.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group maintains cash and cash equivalents with various financial institutions. The Group performs regular and detailed evaluations of
these financial institutions to assess their relative credit standing. The carrying amount reported in the balance sheet for cash and
cash equivalents approximate their fair value.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exposure
to credit risk</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
carrying amount of financial assets represents the maximum credit exposure. The maximum exposure to credit risk is as follows:</span></span></div>

<div>&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Third
        party trade receivables (Note 17)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,698</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance
        lease income receivable (Note 17)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash&#160;and
        cash equivalents (Note 18)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,583</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,544</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
maximum exposure to credit risk for trade receivables and finance lease income receivable by geographic location is as follows:</span></span></div>

<div>&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United
        States</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,185</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,041</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro-zone
        countries</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">742</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">851</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United
        Kingdom</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">741</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">126</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        regions</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,748</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,835</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,853</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>  </div>&#160;

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
maximum exposure to credit risk for trade receivables and finance lease income receivable by type of customer is as follows: &#160;</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">End-user
        customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,828</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,029</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Distributors</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,236</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,399</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-governmental
        organisations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,352</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">425</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,853</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Due
to the large number of customers and the geographical dispersion of these customers, the Group has no significant concentrations of accounts
receivable.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
Losses</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
ageing of trade receivables at December&#160;31, 2024 is as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected
        Credit Loss Rate</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected
        Credit Loss Rate</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Not
        past due</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,363</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,031</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Past
        due 0-30 days</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,534</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Past
        due 31-120 days</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,753</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">31</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">856</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.6</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Greater
        than 120 days</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,131</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,255</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">72.0</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,601</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,302</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">88.5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,702</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,324</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>  </div>&#160;

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group considers that the credit risk of a financial asset may have increased since initial recognition when it is more than 30 days past
due, unless there is evidence to the contrary. As at December 31, 2024, all trade receivables past due more than 30 days were assessed
for changes in credit risk since initial recognition. Based on this assessment:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Receivables past due
        between 31 and 120 days are not automatically considered to have an increased credit risk unless other qualitative indicators are present
        (e.g., known financial difficulty, adverse changes in circumstances, etc.).</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Receivables past due more than 120 days are generally
        considered to have a higher credit risk and are assessed for lifetime expected credit losses.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group applies a simplified approach in measuring expected credit losses which uses a provision matrix based on historical credit loss
experience, adjusted for forward-looking factors specific to the debtors and the economic environment.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
movement in the allowance for impairment in respect of trade receivables during the year was as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,324</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charged
        to costs and expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">225</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">715</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amounts
        written off during the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(263</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(977</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminated
        on disposal of business</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at December&#160;31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,324</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
allowance for impairment in respect of trade receivables is used to record impairment losses unless the Group is satisfied that no recovery
of the account owing is possible. At this point the amount is considered irrecoverable and is written off against the financial asset
directly.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group does not provide financing to customers as a main business activity and therefore is not required to present credit risk exposure
disclosures by credit risk grade.</span></span></div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section Scope<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashFlowStatementExplanatory', window );">RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES</a></td>
<td class="text">

<div>

<div>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span><span><span>28.</span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div>
        <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span>RECONCILIATION OF LIABILITIES ARISING FROM
        FINANCING ACTIVITIES</span></span></p> </div> </td> </tr>
  </table> </div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The
changes in the Group&#8217;s liabilities arising from financing activities can be classified as follows:</span></span></span></span></span></span>

<p style="margin:0pt">&#160;</p> </div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:85%">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Note</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Borrowings
        &amp; derivative</span></span></span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>financial
        instruments<br/>US$&#8217;000</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Lease
        liabilities<br/>US$&#8217;000</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Balance
        at January 1, 2024</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>23,24</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>55,387</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>12,566</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash-flows:</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Principal
        amount loaned &#8211; term loan</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>30,500</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Loan
        origination costs paid</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(324</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Interest
        paid for senior secured term loan</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(6,253</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Interest
        paid for convertible note</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(300</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Interest
        paid for exchangeable notes</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(8</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Repayment
        of leases</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(2,503</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Non-cash:</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Interest
        charged</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>6,561</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Derivative
        financial asset at date of issue</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>28</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Remeasurement
        of ROU assets</span></span></p> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,764</span></span></td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Additions
        (related to Right of Use assets)</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>855</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Exchange
        adjustment</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(512</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Accretion
        interest</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>3,214</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>592</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Fair
        value of derivative liability - warrants</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>66</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Fair
        value of additional derivative liability - warrants</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1,066</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Payment-in-kind
        (PIK) Interest</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>3,291</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>-</span></span></span></p>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Contingent
        liability</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1,813</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Non-cash
        loan modification gain</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(3,567</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Balance
        at December 31, 2024</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>23,24</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>91,474</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>12,762</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
  </table> </div> </div>

<p style="margin:0pt">&#160;</p>

<div></div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Borrowings
        &amp; derivative</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>financial
        instruments<br/>US$&#8217;000</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease
        liabilities<br/>US$&#8217;000</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance
        at January 1, 2023</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>23,24</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>59,826</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13,943</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash-flows:</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Principal
        amount loaned &#8211; term loan</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5,000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Loan
        origination costs paid</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(194</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest
        paid for senior secured term loan</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(7,314</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest
        paid for convertible note</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(300</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest
        paid for exchangeable notes</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(8</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Repayment
        of term loan</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(10,050</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Repayment
        of leases</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(2,318</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Penalty
        paid for early settlement of term loan</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(905</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Non-cash:</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8212;</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest
        charged</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,622</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Penalty
        for early settlement charged</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>905</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derivative
        financial asset at date of issue</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>23</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>11</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Disposals
        (related to Right of Use assets)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(106</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions
        (related to Right of Use assets)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>112</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exchange
        adjustment</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>311</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Accretion
        interest</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,927</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>624</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair
        value of derivative liability - warrants</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1,133</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance at
        December 31, 2023</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>23,24</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>55,387</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,566</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>  </div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashFlowStatementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section Presentation of a statement of cash flows<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IAS07_g10-17_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashFlowStatementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract', window );"><strong>Disclosure of detailed information about business combination [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory', window );">BUSINESS COMBINATIONS</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BUSINESS COMBINATIONS</span></span></div> </td>
        </tr>
  </table> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Acquisition
of the CGM assets of Waveform Technologies, Inc.</span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On
January 30, 2024, the Company purchased the biosensor and continuous glucose monitoring (&#8220;CGM&#8221;)&#160; assets of privately
held Waveform Technologies, Inc. (&#8220;Waveform&#8221;) for the initial consideration of US$12.5
million in cash and 36
million &#8216;A&#8217; Ordinary shares (represented by 1.8
million ADSs) of the Company, which had a fair value of US$3,960,000
on the date of acquisition. In addition contingent consideration of a maximum of US$20
million. We intend to update the Waveform CGM device, which is not being marketed, and optimize it for broad adoption and then evolve
this platform technology to measure and analyze other valuable biomarkers and related datapoints. Our vision is to develop a portfolio
of technologies that can offer users and clinicians valuable actionable health and wellness insights. Control was obtained through the
acquisition of substantially all of Waveform&#8217;s operational assets and intellectual property, representing an integrated set of activities
and assets capable of being conducted and managed to provide a return in the form of outputs. The integrated set of activities and assets
purchased will significantly contribute to achieving our vision and its associated outputs.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">This
transaction has been accounted for as a business combination under IFRS 3. The determination was based on the acquisition of an integrated
set of activities and assets, including intellectual property, technical processes, and a skilled workforce, that together constitute
a business capable of being conducted and managed to provide returns</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair value of non-cash consideration in the form of ADSs issued in connection with the acquisition was determined using the volume-weighted
average price (VWAP) of the Company&#8217;s ADSs on the acquisition date.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingent
consideration of up to US$20
million may be payable upon the occurrence of certain events, including;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.05pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$5.0 million payment
        if, within the next 12 months after closing, (i) the closing price of the Company&#8217;s ADSs does not exceed US$7.50 per ADS for at
        a least 20 consecutive trading days and (ii) the average daily trading volume of the Company&#8217;s ADSs does not equal or exceed 20,000
        ADSs for 20 consecutive trading days, and</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.05pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50% of the proceeds
        received by the Company (up to a maximum payment of additional consideration of US$15.0 million) on our entering into certain commercial
        partnering agreements with certain glucose pump manufacturers in the 24 months from date of acquisition. The fair value assigned to this
        element of the contingent consideration was US$1.8 million at the acquisition date. This is disclosed as a contingent liability in Note
        23.</span></span></div> </td> </tr>
  </table> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair value of the contingent consideration at date of acquisition was US$6.8
million. Of this, US$5.0
million is classified as a current liability </span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Note
21)</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">, while the US$1.8
million is disclosed as a contingent liability (see Note 23). As of December 31, 2024, there have been no changes to the amount recognized
or to the assumptions used in its initial measurement.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition-related
costs amounting to US$1.5
million in respect of the Waveform transaction are not included as part of consideration transferred and have been recognised as an expense
in the condensed consolidated statement of operations, within &#8216;Selling, general and administrative expenses&#8217;.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
initial assignment of fair values to identifiable net assets acquired has been performed on a provisional basis in respect of the above
acquisitions. Any amendments to these acquisition fair values within the 12-month timeframe from the date of acquisition will be disclosed
in the relevant Annual Report as stipulated by IFRS 3 Business Combinations.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisional
        value</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Measurement
        period adjustment</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjusted
        values</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property,
        plant and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,569</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(206</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,363</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        assets &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">9,360</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">9,360</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">9</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">9</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">1,296</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,296</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">135</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">135</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">(50</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(50</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        tax liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">(1,170</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,170</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets acquired</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold">11,149</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">(332</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">10,817</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">12,071</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">332</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">12,403</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consideration</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold">23,220</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">23,220</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Satisfied
        by:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">12,500</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">12,500</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">3,960</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">3,960</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        contingent consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">6,760</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">6,760</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold">23,220</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">23,220</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">12,500</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">12,500</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold">12,500</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">12,500</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
accordance with IFRS 3 Business Combinations, the Group finalised the fair value assessments relating to the acquisition of the Waveform
CGM assets during the year. As part of this process, the Group reassessed the fair value of several acquired balances based on new information
obtained during the measurement period.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
fair value of intellectual property related to the acquired technology at the Closing Date was derived using the multi-period excess earnings
method. Significant assumptions used in the valuation including CGM cash flow projections which were based on estimates used to price
the Waveform acquisition, and the discount rate applied was benchmarked with reference to the implied rate of return to the Company&#8217;s
pricing model and the weighted-average cost of capital. The intangible asset for acquired technology will be amortized over the respective
estimated periods for which the intangible assets will provide economic benefit to the Company, which is 15 years.</span></span></p> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Following
further evaluation, the deferred tax liability of US$1.2
million initially recognised on acquisition was reversed. This adjustment was based on a more detailed analysis of the tax base of the
acquired intangible assets, which concluded that a deferred tax liability was not required.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
addition, the fair value of inventory was reduced by US$1.3
million. This reduction reflects a revised assessment of net realisable value. Although initial discussions with management and potential
buyers such as Bayer India suggested a potential market in emerging economies, further exploration indicated that the additional expenditure
required to bring the acquired raw materials, finished goods and work-in-progress to market would render the inventory commercially unviable.
As a result, the inventory was deemed to have no recoverable value.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
value of property, plant and equipment was also reduced by US$0.2
million. These assets were found to be specific to the legacy CGM product and, following further technical review, were determined to
have no future economic value. Accordingly, their fair value was adjusted to nil.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These
adjustments have been accounted for retrospectively as measurement period adjustments in accordance with IFRS 3. These measurement period
adjustments resulted in a corresponding increase in goodwill of US$0.3
million. Comparative figures have not been restated as the acquisition occurred during the current financial year.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
goodwill recognised from the acquisition of the Waveform CGM assets primarily reflects expected synergies from integrating Waveform&#8217;s
European-approved CGM technology with Trinity Biotech&#8217;s global manufacturing and diabetes expertise. The platform is expected to
accelerate the development of a next-generation, affordable, and user-friendly CGM device, and supports the Group&#8217;s strategy to
expand into adjacent biosensor markets. None of the goodwill is expected to be deductible for tax purposes.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Waveform
was acquired on January 30, 2024. As of December 31, 2024, the acquiree had not generated any revenue since the acquisition date, and
therefore no revenue has been included in the Group&#8217;s consolidated statement of comprehensive income for the reporting period. In
addition, the acquired business incurred a net loss of US$1.3
million, which has been included in the Group&#8217;s consolidated results. The reported loss excludes interest on intercompany funding
arrangements in order to reflect the underlying performance of the acquired business. Waveform Technologies, Inc. was a privately held
company in the late stages of product development and commercial readiness. Although the company was not generating revenue, it had developed
a CE-marked CGM device. It did not maintain financial information in accordance with IFRS, and as such, the Group is unable to reliably
reconstruct the required historical information for pro forma disclosure without incurring undue cost or effort.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Acquisition
of Metabolomics Diagnostics Limited</span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
September 2024, the Company completed the acquisition of 100%
of Metabolomics Diagnostics Ltd (&#8220;Metabolomics&#8221;), a privately-owned Irish deep-tech company, specializing in the development
of novel biomarker-based diagnostic solutions for complex diseases, with the initial focus being screening for preeclampsia risk using
the company&#8217;s PrePsia test. Control was obtained through the execution of a share purchase agreement, resulting in the acquisition
of 100%
of the voting interests. The primary reason for the acquisition was to enter a new area of medical diagnostics with significant long-term
growth potential. The acquisition aligns with the Group&#8217;s strategy of combining its established capabilities with innovative technologies
to unlock new revenue opportunities. The Group intends to leverage this platform to commercialise the PrePsia test in the U.S. through
its Immco laboratory and to explore opportunities in international markets.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Company acquired Metabolomics for consideration of approximately US$0.9
million paid through the issuance of approximately 0.27
million ADSs of the Company alongside the extinguishment of monies owed to the Company totalling US$0.4
million. The fair value of non-cash consideration in the form of ADSs issued in connection with the acquisition was determined using the
volume-weighted average price (VWAP) of the Company&#8217;s ADSs on the acquisition date.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Metabolomics</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisional
        value</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property,
        plant and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        assets &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,200</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">144</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">181</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(494</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        tax liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        acquired</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets acquired</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">900</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consideration</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">906</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Satisfied
        by:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">412</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">494</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">906</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">412</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less:
        Cash and cash equivalents</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">404</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>

<p style="margin:0pt">&#160;</p> </div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transaction
costs associated with the acquisition of Metabolomics amounted to US$0.3
million, relating to the disbursement of agreed fees and closing bonuses. These costs have been expensed as incurred in accordance with
IFRS 3 and have been recognised in the condensed consolidated statement of operations, within &#8216;Selling, general and administrative
expenses&#8217;</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
goodwill recognised in respect of the Metabolomics acquisition is attributable to expected synergies arising from the combination of operations,
as well as the assembled workforce of the acquired business. None of the goodwill recognised is expected to be deductible for tax purposes.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Metabolomics
was acquired in September 2024. As of December 31, 2024, the acquiree had not generated any revenue since the acquisition date, and therefore
no revenue has been included in the Group&#8217;s consolidated statement of comprehensive income for the reporting period. The acquired
business incurred a net loss of US$0.3
million, primarily relating to ongoing development and administrative costs, which has been included in the Group&#8217;s consolidated
results. Metabolomics was a privately held, early-stage Irish entity focused on biomarker-based diagnostics. The company did not prepare
its financial information in accordance with IFRS, and the Group is therefore unable to reliably reconstruct the necessary historical
financial information to provide pro forma consolidated revenue and profit or loss data without incurring undue cost or effort.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Acquisition
of EpiCapture Limited</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
October 2024, the Company completed the acquisition of 100%
of EpiCapture Limited (&#8220;EpiCapture&#8221;), a company developing a non-invasive test for monitoring the risk of aggressive prostate
cancer. Control was obtained through the execution of a share purchase agreement, resulting in the acquisition of 100%
of the voting interests. The primary reason for the acquisition was to strengthen the Group&#8217;s oncology diagnostics pipeline by acquiring
a novel, epigenetics-based prostate cancer test aligned with our strategy of combining Trinity&#8217;s established capabilities with cutting-edge
technologies to address large-scale, urgent, and important clinical issues.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Company acquired EpiCapture for an initial consideration of approximately US$3.0
million, with an additional consideration of US$0.5
million contingent (Note 21) on the achievement of future milestones. The initial consideration was paid through the issuance of approximately
1.7
million ADS in Trinity Biotech. The fair value of non-cash consideration in the form of Company ADSs issued in connection with the acquisition
was determined using the volume-weighted average price (VWAP) of the Company&#8217;s ADSs on the acquisition date.</span></span></div>

<div>&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EpiCapture</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisional
        value</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        assets &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,668</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(406</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        tax liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(333</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets acquired</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,929</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,420</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consideration</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,349</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Satisfied
        by:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,965</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        contingent consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">384</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,349</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">&#160;</div> </td> </tr>
  </table>

<p style="margin:0pt">&#160;</p> </div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
contingent consideration related to the acquisition of EpiCapture Limited comprises deferred consideration with a fair value of US$0.4
million. An
amount of US$0.5 million will become payable if cumulative revenues from EpiCapture&#8217;s operations reach US$1.0 million within a period
of three years, commencing from the date on which the Company obtains validation of the EpiCapture prostate test under
the New York State Department of Health&#8217;s Clinical Laboratory Evaluation Programme. As of December 31, 2024, there have been no
changes to the amount recognized or to the assumptions used in its initial measurement.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transaction
costs associated with the acquisition of EpiCapture amounted to US$26,000,
have been expensed as incurred in accordance with IFRS 3 and have been recognised in the condensed consolidated statement of profit or
loss, within &#8216;Selling, general and administrative expenses&#8217;.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
goodwill recognised in respect of the EpiCapture acquisition is attributable to expected synergies arising from the combination of operations.
None of the goodwill recognised is expected to be deductible for tax purposes.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EpiCapture
was acquired in October 2024. As of December 31, 2024, the acquiree had not generated any revenue since the acquisition date, and therefore
no revenue has been included in the Group&#8217;s consolidated statement of comprehensive income for the reporting period. The acquired
business incurred a net loss of US$20,000,
mainly comprising transaction-related expenses, which has been included in the Group&#8217;s consolidated results. EpiCapture Limited
was a privately held, early-stage Irish company developing a novel epigenetics-based diagnostic test. As the entity did not prepare its
financial information in accordance with IFRS, it is not practicable for the Group to reconstruct the required historical financial information
to present pro forma consolidated results for the year ended December 31, 2024, without undue cost or effort</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
initial assignment of fair values to the identifiable net assets acquired in respect of the Metabolomics and EpiCapture acquisitions has
been performed on a provisional basis. Any amendments to these acquisition fair values within the 12-month timeframe from the respective
dates of acquisition will be disclosed in future financial statements in accordance with IFRS 3 Business Combinations.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">It
is impracticable for the Group to disclose the pro forma consolidated revenue and profit or loss for the year ended December 31, 2024,
as if the acquisitions of Waveform, Metabolomics, and EpiCapture had occurred on January 1, 2024. All three entities were privately held,
early-stage businesses that did not maintain financial information in accordance with IFRS. As a result, the Group is unable to reliably
reconstruct the required historical financial information without incurring undue cost or effort.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">There
were no individually immaterial business combinations that are collectively material during the year. All business combinations completed
during the year have been assessed as individually material and have been disclosed separately in the notes to the consolidated financial
statements.</span></span></div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS03_g59-63_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>POST BALANCE SHEET EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Disclosure of non-adjusting events after reporting period [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory', window );">POST BALANCE SHEET EVENTS</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">POST BALANCE SHEET EVENTS</span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendment
and Restatement of Term Loan</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
2025, the Company entered into further amendments to its senior secured term loan credit agreement with its principal lender, Perceptive,
to access additional funding and enhance its financial position.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On
February 27, 2025, the Company entered into a fourth amendment to the credit agreement, pursuant to which Perceptive provided an additional
US$4.0
million in term loan funding. This funding will be used for general corporate purposes, including the further development of our CGM offering.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On
May 14, 2025, the Company entered into a fifth amendment to the credit agreement, which provided for a further US$2.0
million in term loan funding, extended the maturity date of the Term Loan from January
2026 to July 27, 2026, and confirmed that interest
payments for the months of April, May, and June 2025 would be paid-in-kind. This funding is also intended to support general
corporate purposes and continued investment in the Company&#8217;s CGM and biosensor development programs.</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>These
2025 amendments reflect the ongoing support of Perceptive and have further strengthened the Company&#8217;s liquidity position, while
providing greater operational and financial flexibility to support the execution of its strategic and commercial objectives.</span></span></span></span></div>
</div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of non-adjusting events after the reporting period. [Refer: Non-adjusting events after reporting period [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2024-01-01<br> -Paragraph 21<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_21&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTING ESTIMATES AND JUDGEMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfAccountingEstimatesAndJudgementsAbstract', window );"><strong>Disclosure of accounting estimates and judgements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory', window );">ACCOUNTING ESTIMATES AND JUDGEMENTS</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
        <p style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">31.</span></span></p>
        </td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ACCOUNTING ESTIMATES AND JUDGEMENTS</span></span></div>
        </td> </tr>
  </table> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
preparation of these financial statements requires the Group to make estimates and judgements that affect the reported amount of assets,
liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On
an on-going basis, the Group evaluates these estimates, including those related to intangible assets, contingencies and litigation. The
estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances,
the results of which form the basis for making judgements about the carrying values of assets and liabilities that are not readily apparent
from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Key
sources of estimation uncertainty</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note
12 contains information about the assumptions and the risk factors relating to the impairment of goodwill, other intangible assets, property,
plant and equipment and financial asset. Note 20 outlines information regarding the valuation of share options. Note 23 outlines the valuation
techniques used by the Company in determining the fair value of the Group&#8217;s interest-bearing loans and borrowings. In Note 27, detailed
analysis is given about the interest rate risk, credit risk, liquidity risk and foreign exchange risk of the Group.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Critical
accounting judgements in applying the Group&#8217;s accounting policies</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;font-weight:bold">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certain
critical accounting judgements in applying the Group&#8217;s accounting policies are described below:</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-indent:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
Recognition</span></span></div>

<div style="text-indent:30.6pt;line-height:1.25;font-style:italic">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No
revenue is recognised if there is uncertainty regarding recovery of the consideration due at the outset of the transaction. We make a
judgement as to the collectability of invoiced sales based on an assessment of the individual debtor taking into account past payment
history, the probability of default or delinquency in payments and the probability that debtor will enter into financial difficulties
or bankruptcy.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Some
customer contracts could be regarded as offering the customer a right of return. Due to the uncertainty of the magnitude and likelihood
of product returns, there is a level of estimation involved in assessing the amount of revenue to be recognized for these types of contracts.
In accordance with IFRS 15, when estimating the effect of an uncertainty on an amount of variable consideration to which the Group will
be entitled, all information that is reasonably available, including historical, current and forecast, is considered.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
operate a licenced reference laboratory in New York, USA that specializes in diagnostics for autoimmune diseases. The laboratory provides
testing services to two types of customers. Firstly, institutional customers, such as hospitals and commercial diagnostic testing providers,
and secondly insurance companies on behalf of their policyholders. The revenue recognition for services provided to insurance companies
requires some judgement. In the US, there are rules requiring all insurance companies to be billed the same amount per test. However,
the amount that each insurance company pays for a particular test varies according to their own internal policies and this can typically
be considerably less than the amount invoiced. We recognise lab services revenue for insurance companies by taking the invoiced amount
and reducing it by an estimated percentage based on historical payment data. We review the percentage reduction annually based on the
latest data. As a practical expedient, and in accordance with IFRS, we apply a portfolio approach to the insurance companies as they have
similar characteristics. We judge that the effect on the financial statements of using a portfolio approach for the insurance companies
will not differ materially from applying IFRS 15 to the individual contracts within that portfolio.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
December 31, 2024 US$nil
(2023: US$50,000)
(2022: US$114,000)
of revenue was deferred in accordance with IFRS15.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research
and development expenditure &#8211; capitalized development costs</span></span></div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under
IFRS as issued by IASB, the Group writes off research and development expenditure as incurred, with the exception of expenditure on projects
whose outcome has been assessed with reasonable certainty as to technical feasibility, commercial viability and recovery of costs through
future revenues. Such
expenditure is capitalised at cost within intangible assets and amortised over its expected useful life of 15 years, which
commences when commercial production starts. For further information, refer to Note 12.</span></span>

<p style="margin:0pt">&#160;</p> </div>

<div style="margin-bottom:0px"></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquired
in-process research and development (IPR&amp;D) is valued at its fair value at acquisition date in accordance with IFRS 3. The Company
determines this fair value by adopting the income approach valuation technique. Once the fair value has been determined, the Company will
recognise the IPR&amp;D as an intangible asset when it: (a)&#160;meets the definition of an asset and (b)&#160;is identifiable (i.e.,
is separable or arises from contractual or other legal rights).</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Factors
which impact our judgement to capitalise certain research and development expenditure include the degree of regulatory approval for products
and the results of any market research to determine the likely future commercial success of products being developed. We review these
factors each year to determine whether our previous estimates as to feasibility, viability and recovery should be changed.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
December 31, 2024 the carrying value of capitalised development costs was US$20,951,000
(2023: US$15,103,000)
(see&#160; Note 12 to the consolidated financial statements). The increase in 2024 was mainly as a result of additions of US$8,582,000,
partially offset by impairment losses of US$1,596,000
recognised during the year.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">Impairment
of intangible assets and goodwill</span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Definite
lived intangible assets are reviewed for indicators of impairment periodically while goodwill and indefinite lived assets are tested for
impairment at least annually, individually or at the cash-generating unit level.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Factors
considered important, as part of an impairment review, include the following:</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Significant underperformance relative to expected
        historical or projected future operating results;</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Significant changes in the manner of our use of
        the acquired assets or the strategy for our overall business;</span></span></div> </td> </tr>
  </table> </div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Obsolescence of products;</span></span></div>
        </td> </tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Significant decline in our stock price for a sustained
        period; and</span></span></div> </td> </tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="width:36.7pt">&#160;</td>
    <td style="width:18.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our market capitalisation relative to net book
        value.</span></span></div> </td> </tr>
  </table>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">When
we determine that the carrying value of intangibles and non-current assets may not be recoverable based upon the existence of one or more
of the above indicators of impairment, any impairment is measured based on our estimates of projected net discounted cash flows expected
to result from that asset, including eventual disposition. Our estimated impairment could prove insufficient if our analysis overestimated
the cash flows or conditions change in the future.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
impairment testing performed during the year ended December 31, 2024 resulted in impairment losses being recorded&#160; in four cash generating
units, namely Immco Diagnostics Inc, Trinity Biotech Do Brasil, Biopool US Inc and Clark Laboratories Inc totalling US$1.4
million. For further information, refer to Note 12.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allowance
for slow-moving and obsolete inventory</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We
evaluate the realisability of our inventory on a case-by-case basis and make adjustments to our inventory provision based on our estimates
of expected losses. We write off inventory that is approaching its &#8220;use-by&#8221; date and for which no further re-processing can
be performed. We also consider recent trends in revenues for various inventory items and instances where the realisable value of inventory
is likely to be less than its carrying value. Given the allowance is calculated on the basis of the actual inventory on hand at the particular
balance sheet date, there were no material changes in estimates made during 2024, 2023 or 2022 which would have an impact on the carrying
values of inventory during those periods, except as discussed below. At December&#160;31, 2024 our allowance for slow moving and obsolete
inventory was US$7.6
million which represents approximately 28.3%
of gross inventory value. At December 31, 2023 our allowance for slow moving and obsolete inventory was US$11.3
million which represented approximately 36.3%
of gross inventory value and at December 31, 2022 the provision was US$16.3
million, or approximately 42.0%
of gross inventory value. The estimated allowance for slow moving and obsolete inventory as a percentage of gross inventory has decreased
between 2023 and 2024 due to the physical scrapping of obsolete inventory and better inventory management.</span></span>

<p style="margin:0pt">&#160;</p> </div>

<div style="margin-bottom:0px"></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management
is satisfied that the assumptions made with respect to future sales and production levels of these products are reasonable to ensure the
adequacy of this provision. In the event that the estimate of the provision required for slow moving and obsolete inventory was to increase
or decrease by 2% of gross inventory, which would represent a reasonably likely range of outcomes, then a change in allowance of US$0.5
million at December&#160;31, 2024 (2023: US$0.6
million) (2022: US$0.8
million) would result. For further information, refer to Note 16.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Business
Combinations</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
Group completed three business combinations during the year: the acquisitions of Waveform Technologies, Metabolomics Health, and EpiCapture.
Significant judgement was required in determining whether each transaction met the definition of a business under IFRS 3 Business Combinations,
based on the acquisition of an integrated set of activities and assets capable of generating outputs.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
accounting for these transactions, management was required to make key estimates in the determination of the fair value of the identifiable
assets acquired and liabilities assumed, including the recognition and measurement of separately identifiable intangible assets and contingent
consideration. The valuations involved the use of discounted cash flow models and required management to estimate future cash flows, apply
appropriate discount rates reflecting the Group&#8217;s weighted average cost of capital, and assess the probability of meeting contingent
consideration milestones. The Group engaged an independent third-party valuation specialist to assist with the purchase price allocation
for all three acquisitions. These estimates had a material impact on the allocation of consideration between identifiable intangible assets
and goodwill.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investment
in Novus Diagnostics</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During
the year, the Group acquired a minority equity interest in a privately held company that is not quoted in an active market. The investment
is classified as a financial asset at fair value through profit or loss (FVTPL) in accordance with IFRS 9. The fair value of the investment
was initially based on the transaction price. As the investment is classified within Level 3 of the fair value hierarchy under IFRS 13,
subsequent remeasurement requires the use of unobservable inputs and significant management judgement. This includes consideration of
investee-specific developments, commercial progress, and market conditions.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Going
Concern</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates
the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future.</span></span></div>

<div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Management&#8217;s
assessment of the Group&#8217;s ability to continue as a going concern involves significant judgement. For details of the assumptions
and considerations underpinning this assessment, refer to the &#8220;Going concern&#8221; section of Note 1, which outlines the basis
of preparation..</span></span></div> </div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfAccountingEstimatesAndJudgementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfAccountingEstimatesAndJudgementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GROUP UNDERTAKINGS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfGroupUndertakingsAbstract', window );"><strong>Disclosure of group undertakings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfGroupUndertakingsExplanatory', window );">GROUP UNDERTAKINGS</a></td>
<td class="text">

<div>

<div>

<div>

<div>

<div>

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"><span id="GROUPUNDERTAKINGS"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32</span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GROUP
        UNDERTAKINGS</span></span></div> </td> </tr>
  </table> </div> </div> </div>

<div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
consolidated financial statements include the financial statements of Trinity Biotech plc and the following principal subsidiary undertakings:</span></span></span></span></div>

<div style="line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>

<div style="margin-left:36pt">

<table cellpadding="0" cellspacing="0" style="width:85%">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name
        and registered office</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal
        activity</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal&#160;Country&#160;of<br/>incorporation
        and<br/>operation</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Group&#160;%&#160;holding</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Manufacturing Limited</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">County
        Wicklow, Ireland</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacture
        and sale<br/>of diagnostic test kits</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Ireland</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Research Limited</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">County
        Wicklow, Ireland</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research
        and<br/>development</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Ireland</span>&#160;</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Manufacturing Services Limited</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">County
        Wicklow, Ireland</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dormant</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Ireland</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle">&#160;</td>
    <td colspan="1" style="vertical-align:middle">&#160;</td>
    <td style="vertical-align:middle;text-align:center">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center">&#160;</td>
    <td style="vertical-align:middle;text-align:center">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Luxembourg Sarl</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,
        rue Bender,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">L-1229
        Luxembourg</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investment
        and<br/>provision of financial<br/>services</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Luxembourg</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Inc</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Girts
        Road,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Jamestown,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NY
        14702, USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Holding
        Company</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S.A.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Clark
        Laboratories Inc</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trading
        as Trinity Biotech (USA)</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Girts
        Road, Jamestown</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NY14702,
        USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacture
        and sale<br/>of diagnostic test kits</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S.A.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Mardx
        Diagnostics Inc</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5919
        Farnsworth Court</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carlsbad</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CA
        92008, USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dormant</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S.A.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Biopool
        US Inc (trading as Trinity Biotech Distribution)</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Girts
        Road, Jamestown</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NY14702,
        USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sale
        of diagnostic test<br/>kits</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S.A.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus
        Corporation</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4231
        E 75<sup style="vertical-align:text-top;line-height:1;font-size:smaller">th</sup> Terrace</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Kansas
        City,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MO
        64132, USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacture
        and sale<br/>of diagnostic test kits<br/>and instrumentation</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S.A.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  </table> </div>

<p style="margin:0pt">&#160;</p> </div> </div> </div>

<div></div>

<div>

<div style="margin-left:36pt">

<table cellpadding="0" cellspacing="0" style="width:85%">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name
        and registered office</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal&#160;activity</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><em><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Principal
        Country of<br/>incorporation and<br/>operation</span></em></p> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Group&#160;%&#160;holding</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Phoenix
        Bio-tech Corp.</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1166
        South Service Road West</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Oakville,
        ON L6L 5T7</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada.</span></span></div>
        </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dormant</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Canada</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fiomi
        Diagnostics Holding AB</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dag
        Hammarskj&#246;ldsv 52A</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SE-752
        37 Uppsala</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sweden</span></span></div>
        </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Holding
        Company</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Sweden</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fiomi
        Diagnostics AB</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dag
        Hammarskj&#246;ldsv 52A</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SE-752
        37 Uppsala</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sweden</span></span></div>
        </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discontinued
        operation</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(in
        liquidation)</span></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Sweden</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Do Brasil</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Comercio
        e Importacao Ltda</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rua
        Silva Bueno</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.660
        &#8211; Cj. 101/102</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ipiranga</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sao
        Paulo</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Brazil</span></span></div>
        </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sale
        of diagnostic test<br/>kits</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Brazil</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech (UK) Ltd</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Mills
        and Reeve LLP</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Botanic
        House</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100
        Hills Road</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cambridge,
        CB2 1PH</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United
        Kingdom</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sales
        &amp; marketing<br/>activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>UK</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Immco
        Diagnostics Inc</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">60
        Pineview Drive</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buffalo</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NY
        14228, USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacture
        and sale of<br/>autoimmune products<br/>and laboratory services</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S.A.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Nova
        Century Scientific Inc</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5022
        South Service Road</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Burlington</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ontario</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada</span></span></div>
        </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacture
        and sale of<br/>autoimmune products and infectious diseases</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Canada</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Investment Ltd</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PO
        Box 309</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ugland
        House</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grand
        Cayman</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">KY1-1104</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cayman
        Islands</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investment
        and<br/>provision of financial<br/>services</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cayman
        Islands</span></span></div>
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  </table> </div> </div>  </div> </div>&#160;

<div></div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:85%">
  <tr>
    <td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name
        and registered office</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;width:1%">&#160;</td>
    <td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal
        activity</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal
        Country of<br/>incorporation and<br/>operation</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Group
        % holding</span></span></div> </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trib
        Biosensors Inc.</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27700
        S.W. 95<sup style="vertical-align:text-top;line-height:1;font-size:smaller">th</sup> Avenue,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wilsonville,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Oregon
        97070, USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacturing,
        development, and sale of biosensors</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)">USA</span><br/><span style="color:rgb(0, 0, 0)">&#160;</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;color:rgb(0, 0, 0);width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Konamite
        Limited</span></span></div>
        <div style="margin-top:0pt;margin-bottom:0pt">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">County
        Wicklow, Ireland</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sales
        &amp; marketing<br/>activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)">Ireland</span><br/><span style="color:rgb(0, 0, 0)">&#160;</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:top;width:30%">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td rowspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:1%">&#160;</td>
    <td rowspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td rowspan="1" style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Trinity
        Biotech Joint Venture Limited</span></span></div>
        <div style="margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">County
        Wicklow, Ireland</span></span></div> </div>  </div> </div> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Holding
        Company</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)">Ireland</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">EpiCapture
        Limited</span></div>
        <div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)">19
        Mather Road, Mount Merrion, Dublin, Ireland</div> </div> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Research
        and development</span></p> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">Ireland</span></p>
        </td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">100%</span></p>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Metabolomics
        Diagnostics Limited</span></div>
        <div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)">Hoffman
        Park, Inchera, Little Island, Co. Cork, Ireland</div> </div> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Research
        and development</span></p> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">Ireland</span></p>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">100%</span></p>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Waveform
        Technologies Inc.</span></div>
        <div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)">Obrtna
        cesta 18, 8310 Sentjernej, Slovenia</div> </div> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Manufacturing,
        development, and sale of biosensors</span></p> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">Slovenia</span></p>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">100%</span></p>
        </td> </tr>
  </table> </div> </div> </div> </div>  </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfGroupUndertakingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfGroupUndertakingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfGroupUndertakingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for group undertakings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfGroupUndertakingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>AUTHORISATION FOR ISSUE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfAuthorisationForIssueAbstract', window );"><strong>Disclosure of authorisation for issue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfAuthorisationForIssueExplanatory', window );">AUTHORISATION FOR ISSUE</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33.</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AUTHORISATION FOR ISSUE</span></span></div> </td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These
Group consolidated financial statements were authorised for issue by the Board of Directors on May 15, 2025.</span></span></div> </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfAuthorisationForIssueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfAuthorisationForIssueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfAuthorisationForIssueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for authorisation for issue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfAuthorisationForIssueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text">

<div>

<div>

<div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Risk
management and strategy</span></span></span></span></div>

<div style="text-align:justify;line-height:1.25;font-style:italic">&#160;</div>

<div>

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
have not experienced any material cybersecurity incidents that have impacted our operations to date. However, like most
companies, we are subject to frequent and evolving cybersecurity threats and attempted attacks from a range of sources, including opportunistic
hackers, organised threat actors, and internal vulnerabilities.</span></span></span></span></div> </div>

<div style="text-align:justify;line-height:1.25">&#160;</div> </div>

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>To
identify, assess, and mitigate cybersecurity risks, we have implemented a cybersecurity program covering the full scope
of our information systems and data assets. This includes internally managed systems, cloud environments, third party-hosted infrastructure,
and sensitive data such as intellectual property, clinical research information, strategic documents, personal data of employees and trial
participants, and confidential commercial information, collectively referred to as our &#8220;Information Systems and Data.&#8221;</span></span></span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-size:10pt;font-family:Times New Roman">Our
cybersecurity program is led by our Chief
Information Officer (CIO), who has over 20 years of IT leadership experience, and is supported by an internal security
function that collaborates with our broader risk management team.</span> The CIO works across the organisation to ensure
that cybersecurity is embedded within our operations and treated as a core business risk.</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
use a variety of tools and practices to assess the cybersecurity threat landscape and evaluate our posture. These include internal and
external vulnerability scans, threat intelligence feeds, cyber risk assessments, penetration testing conducted by third-party firms, and
tabletop simulations to evaluate and improve our incident response readiness. We also monitor emerging regulatory developments and industry
standards to ensure our practices remain aligned with evolving expectations.</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>To
mitigate risks identified through these processes, we implement a combination of technical, administrative, and physical controls. These
include next-generation firewalls, endpoint protection and antivirus software, multi-factor authentication, access control protocols,
encryption of sensitive data, network segmentation, continuous system monitoring, secure configuration standards, data backup and recovery
protocols, and security awareness training for all staff, including phishing simulations. Our cybersecurity practices are regularly reviewed
and enhanced in response to changing threat dynamics.</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cybersecurity
risk management is also extended to our third-party
service providers, who perform a wide range of business-critical services including data hosting, software delivery, clinical
research, supply chain management, distribution, and contract manufacturing. We assess the cybersecurity posture of key vendors through
a combination of tools, such as security questionnaires, audits, analysis of certifications (e.g., ISO 27001, SOC 2), reviews of written
security policies, and assessment of penetration test results. Where necessary, we engage in direct discussions with vendors' security
teams to evaluate controls. We also impose contractual obligations related to cybersecurity and data protection, including confidentiality
and breach notification requirements. These measures are designed to reduce the risk of vulnerabilities introduced through our supply
chain or external partners.</span></span></span></span></div>

<div style="text-align:justify;line-height:1.25">&#160;</div> </div>

<div></div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Cybersecurity
risks are addressed through our overall approach to operational and strategic risk management. Key risks are discussed at senior management
level and prioritised based on their potential to affect our systems, data, or business continuity.</span></span></span></div> </div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>To
identify, assess, and mitigate cybersecurity risks, we have implemented a cybersecurity program covering the full scope
of our information systems and data assets. This includes internally managed systems, cloud environments, third party-hosted infrastructure,
and sensitive data such as intellectual property, clinical research information, strategic documents, personal data of employees and trial
participants, and confidential commercial information, collectively referred to as our &#8220;Information Systems and Data.&#8221;</span></span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</a></td>
<td class="text">

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
have not experienced any material cybersecurity incidents that have impacted our operations to date. However, like most
companies, we are subject to frequent and evolving cybersecurity threats and attempted attacks from a range of sources, including opportunistic
hackers, organised threat actors, and internal vulnerabilities.</span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<div>

<div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Governance</span></span></span></span></div>

<div style="text-align:justify;line-height:1.25;font-style:italic">&#160;</div>

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Oversight
of cybersecurity risk forms part of the Board of Directors&#8217; general risk oversight responsibilities. <span style="font-size:10pt;font-family:Times New Roman">Our
Chief Information Officer (CIO), who has over 20 years of experience in IT and security, is responsible for the day-to-day implementation
and ongoing development of our cybersecurity program.</span></span></span></span></span></div> </div>


<div style="line-height:1.25">&#160;</div> </div> </div>

<div>

<div style="line-height:1.25">

<div>

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
CIO is involved in reviewing security assessments, monitoring threat activity, approving key cybersecurity controls, and helping coordinate
incident preparedness across the organisation. In the event of a cybersecurity incident, our escalation procedures provide for involvement
of senior management, including the CIO and, where appropriate, other members of the executive team and relevant support functions.</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div> </div> </div> </div>

<div>

<div style="line-height:1.25">

<div>

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cybersecurity
matters are reported to senior management as needed, particularly in cases where a threat or incident may have a broader
business impact. Our governance structure is designed to support informed decision-making around risk prioritisation, incident response,
and investment in cybersecurity measures. As of the date of this filing, we are not aware of any cybersecurity threats, including past
incidents, that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or
financial condition.</span></span></span></span></div> </div> </div> </div> </div>  </div>  </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Oversight
of cybersecurity risk forms part of the Board of Directors&#8217; general risk oversight responsibilities. <span style="font-size:10pt;font-family:Times New Roman">Our
Chief Information Officer (CIO), who has over 20 years of experience in IT and security, is responsible for the day-to-day implementation
and ongoing development of our cybersecurity program.</span></span></span></span></span></div> </div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">Our
Chief Information Officer (CIO), who has over 20 years of experience in IT and security, is responsible for the day-to-day implementation
and ongoing development of our cybersecurity program.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<div>

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
CIO is involved in reviewing security assessments, monitoring threat activity, approving key cybersecurity controls, and helping coordinate
incident preparedness across the organisation. In the event of a cybersecurity incident, our escalation procedures provide for involvement
of senior management, including the CIO and, where appropriate, other members of the executive team and relevant support functions.</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div> </div> </div> </div>

<div>

<div style="line-height:1.25">

<div>

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cybersecurity
matters are reported to senior management as needed, particularly in cases where a threat or incident may have a broader
business impact. Our governance structure is designed to support informed decision-making around risk prioritisation, incident response,
and investment in cybersecurity measures. As of the date of this filing, we are not aware of any cybersecurity threats, including past
incidents, that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or
financial condition.</span></span></span></span></div> </div> </div> </div> </div>  </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">Our
cybersecurity program is led by our Chief
Information Officer (CIO), who has over 20 years of IT leadership experience, and is supported by an internal security
function that collaborates with our broader risk management team.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">Our
Chief Information Officer (CIO), who has over 20 years of experience in IT and security, is responsible for the day-to-day implementation
and ongoing development of our cybersecurity program.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<div>

<div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cybersecurity
matters are reported to senior management as needed, particularly in cases where a threat or incident may have a broader
business impact. Our governance structure is designed to support informed decision-making around risk prioritisation, incident response,
and investment in cybersecurity measures. As of the date of this filing, we are not aware of any cybersecurity threats, including past
incidents, that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or
financial condition.</span></span></span></span></div> </div> </div> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure of basis of preparation and significant accounting policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory', window );">General information</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>i)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">General
        information</span></span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trinity
Biotech is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable
biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation,
for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and
to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood and the Company intends to develop
a range of biosensor devices and related services, starting with a continuous glucose monitoring product.</span></span></span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory', window );">Statement of compliance</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>ii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Statement
        of compliance</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (&#8220;IFRS&#8221;)
both as issued by the International Accounting Standards Board (&#8220;IASB&#8221;) and as subsequently adopted by the European Union
(&#8220;EU&#8221;) (together &#8220;IFRS&#8221;).&#160;The IFRS applied are those effective for accounting periods beginning January&#160;1,
2024. Consolidated financial statements are required by Irish law to comply with IFRS as adopted by the EU which differ in certain respects
from IFRS as issued by the IASB.&#160;These differences predominantly relate to the timing of adoption of new standards by the EU.&#160;However,
in relation to the 2024 consolidated financial statements there are no differences regarding the effective date of new IFRS relevant to
Trinity Biotech as issued by the IASB and as adopted by the EU. In relation to prior periods presented, none of the differences are relevant
in the context of Trinity Biotech and the consolidated financial statements comply with IFRS both as issued by the IASB and as adopted
by the EU.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory', window );">Basis of preparation and going concern</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>iii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Basis of preparation and going concern</p>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
consolidated financial statements have been prepared in United States Dollars (US$), rounded to the nearest thousand, under the historical
cost basis of accounting, except for derivative financial instruments, certain balances arising on acquisition of subsidiary entities
and share-based payments which are initially recorded at fair value. Derivative financial instruments are also subsequently revalued and
carried at fair value.</span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
preparation of financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect
the application of policies and amounts reported in the financial statements and accompanying notes. The estimates and associated assumptions
are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of
which form the basis of making the judgements about the carrying value of assets and liabilities that are not readily apparent from other
sources. Actual results may differ from these estimates.</span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period
in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision
affects both current and future periods. Judgements made by management that have a significant effect on the financial statements and
estimates with a significant risk of material adjustment in the next year are discussed in Note 31.</span></span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates
the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future.</span></span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>As
reflected in the accompanying consolidated financial statements, for the years ended December 31, 2024 and 2023, the Group recorded a
loss of US$31.8
million and a loss of US$24.0
million, respectively. For the year ended December 31, 2024 we reported cash inflows of US1.7
million compared to cash outflows of US$2.8
million for 2023. As of December 31, 2024, we had net current assets of US$9.0
million but had an accumulated deficit in equity attributable to the equity holders of the Company of US$79.1
million.</span></span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>We
have made significant progress on a multi-year transformation plan aimed at improving profitability and simplifying our operating model.
Key actions implemented include the consolidation and outsourcing of global manufacturing, closure of underutilized facilities, relocation
of certain business support functions to lower-cost jurisdictions, and a reduction in overall headcount. These restructuring measures,
largely completed by mid-2025, are expected to deliver significant annualized cost savings. Additionally, the Group retains further levers
to manage liquidity if required, including deferring projected research and development spend.</span></span></span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>A
temporary decline in revenue occurred during the first four months of 2025, primarily due to transitional impacts associated with the
Group&#8217;s restructuring initiatives, including the consolidation of manufacturing operations and the transfer of Point-of-Care/HIV
products to a third-party contract manufacturing partner. These initiatives have since progressed materially. Sales were also affected
by reduced HIV test volumes resulting from uncertainty surrounding potential changes to U.S. foreign aid policy following a presidential
executive order. In light of these temporary factors, the Group sought and received a formal waiver from Perceptive in respect of the
Q1 2025 minimum revenue covenant, to ensure that no breach occurred under the Perceptive credit facility. In May 2025, the Group signed
a buy-sell agreement with a contract manufacturing partner. We also have obtained World Health Organisation (&#8220;WHO&#8221;) approval
to commence assembly at the new site. It is expected that WHO approval for full production of our Trinscreen product to be received in
July 2025, with approval for full production of our UniGold product expected in August 2025. The directors have alternative options and
have prepared financial forecasts to address a scenario whereby WHO approval for production with our contract manufacturing partner takes
longer than expected to achieve and the facility takes longer than expected to get up to full operational capacity. In such a scenario,
management remain confident that all revenue covenants will be met through to 31 December 2025. In addition, the minimum revenue covenant
thresholds for Q2, Q3 and Q4 2025 have been renegotiated to align with the Group&#8217;s updated forecasts. Accordingly, management is
confident in the Group&#8217;s ability to maintain compliance with its debt covenants for the remainder of the going concern review period.
Furthermore, Perceptive have a track record of supporting the Company and, when required, have provided covenant waivers and amendment
of terms which indicates an appreciation of the Company&#8217;s circumstances in terms of our transformational plan for the business and
temporary declines in revenue. If a similar need were to recur in the foreseeable future, management are confident of their continued
support.</span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>We
have also launched a strategic realignment review of our businesses in partnership with Barclays Bank. This process, is expected to make
significant progress by the end of 2025 and may generate material capital proceeds that can be potentially used to reduce debt and support
investment, including CGM investment.</span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In
addition, the Group has continued to benefit from strong support from Perceptive, its principal lender and largest investor. On December
23, 2024, we entered into the third amendment and restatement of the credit agreement governing the Term Loan. As part of this agreement,
an additional US$2.0
million of funding was made available to us. We also agreed that certain interest
payments payable in 2024 and 2025 would be paid-in-kind on the applicable payment date by increasing the outstanding principal
amount of the Term Loan. In February 2025, we entered into a fourth amendment to the credit agreement, which provided for an additional
US$4.0
million in term loan funding. On May 14, 2025, we entered into a fifth amendment to the credit agreement, which provided for a further
US$2.0
million in funding, extended the maturity date of the Term Loan by six months from January
2026 to July 27, 2026, and confirmed that interest
payments for the months of April, May, and June 2025 would be paid-in-kind. There are no material debt maturities until
July 2026. These successive amendments demonstrate Perceptive&#8217;s continued support and demonstrate their willingness to flex terms
to preserve liquidity while the Company continues to execute its updated strategy, including its comprehensive transformation plan.</span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under
the fifth amendment to the credit agreement, the minimum liquidity covenant was reduced to US$1
million through to October 31, 2025, after which it reverts to US$3
million. While management is confident in the Group&#8217;s ability to maintain compliance with this covenant, it is noted that the Group
has planned significant R&amp;D expenditure related to its CGM development program in the second half of 2025. However, the Group retains
full discretion over the timing and phasing of these activities, which enables management to align expenditure with available funding
and preserve liquidity if required.</span></span></p> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In
addition to lender support, our going concern forecasts include expected equity raises. These funds are expected to support ongoing CGM
development activities. The Group has a strong track record of capital raising, including over US$7
million secured in 2024, and maintains active engagement with existing and potential investors. Management believes that the equity raise
is achievable based on the Group&#8217;s strategic focus and transformation progress to date.</span></span></span></span></p>

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
directors have considered the Group&#8217;s current financial position and cash flow projections, taking into account all known events
and developments including the amendment and restatement of the term loan with Perceptive, The directors believe that, based on currently
available information and reasonable assumptions, the Group will be able to continue its operations for at least the next 12 months from
the year-end date, and that it is appropriate to continue to prepare the consolidated financial statements on a going concern basis.</span></span></span></span></p>

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
accounting policies set out below have been applied consistently to all periods presented in these consolidated financial statements.
The accounting policies have been applied consistently by all Group entities. The comparative information agrees with the amounts and
other disclosures presented in the prior period consolidated financial statements or, when appropriate, have been restated.</span></span></span></span></span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory', window );">Basis of consolidation</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>iv)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Basis
        of consolidation</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Subsidiaries</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Subsidiaries
are all entities over which the Group has control. The Group controls an entity when the Group is exposed to, or has rights to, variable
returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries
are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control
ceases. A change in the ownership interest of a subsidiary without a change in control is accounted for as an equity transaction. The
Group currently holds a majority of voting rights in all entities in the Group and as a result there are no non-controlling interests
reflected in the consolidated financial statements.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Transactions
eliminated on consolidation</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Intra-group
balances and any unrealised gains or losses or income and expenses arising from intra-group transactions are eliminated in preparing the
consolidated financial statements.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>v)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Property,
        plant and equipment</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Owned
assets</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Items
of property, plant and equipment are stated at cost less any accumulated depreciation and any impairment losses (see Note 1(viii)). The
cost of self-constructed assets includes the cost of materials, direct labour and attributable overheads. It is not Group policy to revalue
any items of property, plant and equipment.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Depreciation
is charged to the statement of operations on a straight-line basis to write-off the cost of the assets over their expected useful lives
as follows:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Leasehold improvements</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>5-15&#160;years</span></span></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Buildings</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>50
        years</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Office equipment and fittings</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>10
        years</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Computer equipment</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>3-5
        years</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Plant and equipment</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>5-15
        years</span></span></span></span></span></div> </td> </tr>
  </table>  </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Land
is not depreciated. The residual values, if not insignificant, useful lives and depreciation methods of property, plant and equipment
are reviewed and adjusted if appropriate on a prospective basis, at each balance sheet date. There were no changes to useful lives in
the year.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group considers whether a contract is or contains a lease. A lease is defined as &#8216;a contract, or part of a contract, that conveys
the right to use an asset (the underlying asset) for a period of time in exchange for consideration&#8217;. To apply this definition the
Group assesses whether the contract meets three key evaluations which are whether:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>the contract contains an identified
        asset, which is either explicitly identified in the contract or implicitly specified by being identified at the time the asset is made
        available to the Group</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>the Group has the right to obtain
        substantially all of the economic benefits from use of the identified asset throughout the period of use, considering its rights within
        the defined scope of the contract</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.95pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>the Group has the right to direct
        the use of the identified asset throughout the period of use. The Group assess whether it has the right to direct &#8216;how and for what
        purpose&#8217; the asset is used throughout the period of use.</span></span></span></span></span></div> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
lease commencement date, the Group recognises a right-of-use asset and a lease liability on the balance sheet. The right-of-use asset
is measured at cost, which is made up of the initial measurement of the lease liability, any initial direct costs incurred by the Group,
an estimate of any costs to dismantle and remove the asset at the end of the lease, and any lease payments made in advance of the lease
commencement date (net of any incentives received).</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group depreciates the right-of-use assets on a straight-line basis from the lease commencement date to the earlier of the end of the useful
life of the right-of-use asset or the end of the lease term. The Group also assesses the right-of-use asset for impairment when such indicators
exist.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
the commencement date, the Group measures the lease liability at the present value of the lease payments unpaid at that date, discounted
using the interest rate implicit in the lease if that rate is readily available or the Group&#8217;s incremental borrowing rate. Lease
payments included in the measurement of the lease liability are made up of fixed payments (including in substance fixed), variable payments
based on an index or rate, amounts expected to be payable under a residual value guarantee and payments arising from options reasonably
certain to be exercised. Subsequent to initial measurement, the liability will be reduced for payments made and increased for interest.
It is remeasured to reflect any reassessment or modification, or if there are changes in in-substance fixed payments. When the lease liability
is remeasured, the corresponding adjustment is reflected in the right-of-use asset, or profit and loss if the right-of-use asset is already
reduced to zero.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group has elected to account for short-term leases and leases of low-value assets using the practical expedients. Instead of recognising
a right-of-use asset and lease liability, the payments in relation to these are recognised as an expense in profit or loss on a straight-line
basis over the lease term. On the statement of financial position, right-of-use assets have been included in property, plant and equipment
and lease liabilities have been included in separate lines within the current liabilities and non-current liabilities sections.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.9pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Leased
assets - as lessor</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group&#8217;s accounting policy under IFRS 16 has not changed from the comparative period. As a lessor, the Group classifies its leases
as either operating or finance leases. A lease is classified as a finance lease if it transfers substantially all the risks and rewards
incidental to ownership of the underlying asset, and classified as an operating lease if it does not.</span></span></span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory', window );">Business combinations &amp; goodwill</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>vi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Business
        combinations &amp; goodwill</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
the time of each transaction, the Group evaluates whether the acquisition constitutes a business combination in accordance with the definition
in IFRS 3 Business Combinations. A business is defined as an integrated set of activities and assets that is capable of being conducted
and managed for the purpose of providing a return. The assessment considers whether the acquired set includes inputs and substantive processes
that together significantly contribute to the ability to create outputs. Where such criteria are not met, the transaction is accounted
for as an asset acquisition. Transactions assessed as asset acquisitions do not give rise to goodwill.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In
respect of business combinations that have occurred since January 1, 2004 (being the transition date to IFRS), goodwill represents the
difference between the cost of the acquisition and the fair value of the net identifiable assets acquired. In respect of acquisitions
prior to this date, goodwill is included on the basis of its deemed cost, which represents the amount recorded under Irish GAAP.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>To
the extent that the Group&#8217;s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities acquired
exceeds the cost of a business combination, the identification and measurement of the related assets, liabilities and contingent liabilities
are revisited accompanied by a reassessment of the cost of the transaction, and any remaining balance is immediately recognised in the
statement of operations.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
the acquisition date, any goodwill is allocated to each of the Group&#8217;s cash-generating units expected to benefit from the combination&#8217;s
synergies. Following initial recognition, goodwill is stated at cost less any accumulated impairment losses and is not amortised but is
tested annually for impairment.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>This
policy has been applied to acquisitions completed during the year, including the acquisition of the CGM assets of Waveform Technologies,
Inc. in January 2024, and the acquisitions of EpiCapture Limited and Metabolomics Diagnostics Limited, further details of which are disclosed
in Note 29 to the consolidated financial statements losses.</span></span></span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">Intangibles, including research and development (other than goodwill)</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>vii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Intangibles,
        including research and development (other than goodwill)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>An
intangible asset, which is an identifiable non-monetary asset without physical substance, is recognised to the extent that it is probable
that the expected future economic benefits attributable to the asset will flow to the Group and that its cost can be measured reliably.
The asset is deemed to be identifiable when it is separable (that is, capable of being divided from the entity and sold, transferred,
licenced, rented or exchanged, either individually or together with a related contract, asset or liability) or when it arises from contractual
or other legal rights, regardless of whether those rights are transferable or separable from the Group or from other rights and obligations.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Intangible
assets acquired as part of a business combination are capitalised separately from goodwill if the intangible asset meets the definition
of an asset and the fair value can be reliably measured on initial recognition. In the case of recent acquisitions, the Group has recognised
technology-based intangible assets, comprising know-how, trade secrets and similar intellectual property. These assets are classified
as finite-lived and are initially recognised at fair value as determined by independent valuation.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsequent
to initial recognition, these intangible assets are carried at cost less any accumulated amortisation and any accumulated impairment losses
(Note 1(viii)). Intangible assets with definite useful lives are reviewed for indicators of impairment annually while intangible assets
with indefinite useful lives and those not yet brought into use are tested for impairment at least annually, either individually or at
the cash-generating unit level.</span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Expenditure
on development activities, whereby research findings are applied to a plan or design for the production of new or substantially improved
products and processes, is capitalised if the product or process is technically and commercially feasible and the Group has sufficient
resources to complete the development. The expenditure capitalised includes the cost of materials, direct labour and attributable overheads
and third party costs. Subsequent expenditure on capitalised intangible assets is capitalised only when it increases the future economic
benefits embodied in the specific asset to which it relates.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
technical feasibility of a new product is determined by a specific feasibility study undertaken at the first stage of any development
project. The majority of our new product developments involve the transfer of existing product know-how to a new application. Since the
technology is already proven in an existing product which is being used by customers, this facilitates the proving of the technical feasibility
of that same technology in a new product.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
results of the feasibility study are reviewed by a design review committee comprising senior managers. The feasibility study occurs in
the initial research phase of a project and costs in this phase are not capitalised.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
commercial feasibility of a new product is determined by preparing a discounted cash flow projection. This projection compares the discounted
sales revenues for future periods with the relevant costs. As part of preparing the cash flow projection, the size of the relevant market
is determined, feedback is sought from customers and the strength of the proposed new product is assessed against competitors&#8217; offerings.
Once the technical and commercial feasibility has been established and the project has been approved for commencement, the project moves
into the development phase.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>All
other development expenditure is expensed as incurred. Subsequent to initial recognition, the capitalised development expenditure is carried
at cost less any accumulated amortisation and any accumulated impairment losses.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Expenditure
on research activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognised
in the statement of operations as an expense as incurred.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Expenditure
on internally generated goodwill and brands is recognised in the statement of operations as an expense as incurred.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Amortisation</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Amortisation
is charged to the statement of operations on a straight-line basis over the estimated useful lives of intangible assets, unless such lives
are indefinite. Intangible assets are amortised from the date they are available for use in its intended market. The estimated useful
lives are as follows:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:bottom">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Capitalised development costs</span></span></span></span></span></div> </td>
    <td style="width:15.77%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>15&#160;years</span></span></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:middle">&#160;</td>
    <td style="width:15.77%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:bottom">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Patents and licences</span></span></span></span></span></div> </td>
    <td style="width:15.77%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>6-15&#160;years</span></span></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:middle">&#160;</td>
    <td style="width:15.77%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:bottom">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Other (including acquired customer and supplier lists)</span></span></span></span></span></div> </td>
    <td style="width:15.77%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>6-15
        years</span></span></span></span></span></div> </td> </tr>
  </table> </div>

<p style="margin:0pt">&#160;</p> </div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group uses a useful economic life of 15
years for capitalised development costs. This is a conservative estimate of the likely life of the products. The Group
is confident that products have a minimum of 15 years life given the inertia that characterizes the medical diagnostics industry and the
barriers to enter into the industry. The following factors have been considered in estimating the useful life of developed products:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>(a)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>once a diagnostic test becomes
        established, customers are reluctant to change to new technology until it is fully proven, thus resulting in relatively long product life
        cycles. There is also reluctance in customers to change to a new product as it can be costly both in terms of the initial changeover cost
        and as new technology is typically more expensive.</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>(b)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>demand for the diagnostic tests
        is enduring and robust within a wide geographic base. The diseases that the products diagnose are widely prevalent (HIV, Diabetes and
        Chlamydia being just three examples) in many countries. There is a general consensus that these diseases will continue to be widely prevalent
        in the future. Demand for biosensors is showing high growth in recent years due to the ease of use and the appeal of real time information.</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>(c)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>there are significant barriers
        to new entrants in this industry. Patents and/or licences are in place for several of our products, though this is not the only barrier
        to entry. There is a significant cost and time to develop new products, it is necessary to obtain regulatory approval and tests are protected
        by proprietary know-how, manufacturing techniques and trade secrets.</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>During
the year ended December 31, 2024, the Group capitalised US$7.0
million in development costs related to newly acquired intangible assets. As the underlying intellectual property remains at a pre-commercialisation
stage and is not yet available for use, amortisation has not commenced. Amortisation will begin when the assets are brought into use,
in accordance with the Group&#8217;s stated policy.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Technology-based
intangible assets acquired as part of business combinations are assigned finite useful lives in line with the Group&#8217;s amortisation
policies, based on independent valuation reports. Amortisation of these assets will commence when they are available for use, i.e., when
they are in the location and condition necessary for them to be capable of operating in the manner intended by management. For technology-based
intangible assets acquired in 2024, amortisation has not commenced as the technologies have not yet been commercialised.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Certain
trade names acquired are deemed to have an indefinite useful life as there is no foreseeable limit to the period over which these assets
are expected to generate cash inflows for the Group.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
amortisation is charged on assets with finite lives, this expense is taken to the statement of operations through the &#8216;selling,
general and administrative expenses&#8217; line.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Useful
lives are examined on an annual basis and adjustments, where applicable, are made on a prospective basis.</span></span></span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory', window );">Impairment</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>viii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Impairment</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
carrying amount of the Group&#8217;s assets, other than inventories, accounts receivable, cash and cash equivalents, short-term investments
and deferred tax assets, are reviewed at each balance sheet date to determine whether there is any indication of impairment. If any such
indication exists, the asset&#8217;s recoverable amount (being the greater of fair value less costs to sell and value in use) is assessed
at each balance sheet date.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Fair
value less costs to sell is defined as the amount obtainable from the sale of an asset or cash-generating unit in an arm&#8217;s length
transaction between knowledgeable and willing parties, less the costs that would be incurred on disposal. Value in use is defined as the
present value of the future cash flows expected to be derived through the continued use of an asset or cash-generating unit. In assessing
value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current
market assessments of the time value of money and the risks specific to the asset for which the future cash flow estimates have not yet
been adjusted. The estimates of future cash flows exclude cash inflows or outflows attributable to financing activities. For an asset
that does not generate largely independent cash flows, the recoverable amount is determined by reference to the cash-generating unit to
which the asset belongs.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>For
goodwill, assets that have an indefinite useful life and intangible assets that are not yet available for use, the recoverable amount
is estimated at each balance sheet date at the cash-generating unit level. The goodwill and indefinite-lived assets were reviewed for
impairment at June 30, 2023, December&#160;31, 2023, June 30, 2024 and December&#160;31, 2024. See Note 12.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In-process
research and development (IPR&amp;D) is tested for impairment on a bi-annual basis, and always at year end, or more frequently if impairment
indicators are present, using projected discounted cash flow models. If IPR&amp;D becomes impaired or is abandoned, the carrying value
of the IPR&amp;D is written down to its revised fair value with the related impairment charge recognised in the period in which the impairment
occurs. If the fair value of the asset becomes impaired as the result of unfavorable data from any ongoing or future clinical trial, changes
in assumptions that negatively impact projected cash flows, or because of any other information regarding the prospects of successfully
developing or commercializing our programs, we could incur significant charges in the period in which the impairment occurs. The valuation
techniques utilized in performing impairment tests incorporate significant assumptions and judgments to estimate the fair value, as described
above. The use of different valuation techniques or different assumptions could result in materially different fair value estimates.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>An
impairment loss is recognised whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount. Impairment
losses are recognised in the statement of operations.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Impairment
losses recognised in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash-generating
units and then to reduce the carrying amount of other assets in the cash-generating units on a pro-rata basis.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>An
impairment loss is reversed only to the extent that the asset&#8217;s carrying amount does not exceed the carrying amount that would have
been determined, net of depreciation or amortisation, if no impairment loss had been recognised.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>An
impairment loss in respect of goodwill is not reversed.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Following
recognition of any impairment loss (and on recognition of an impairment loss reversal), the depreciation or amortisation charge applicable
to the asset or cash-generating unit is adjusted prospectively with the objective of systematically allocating the revised carrying amount,
net of any residual value, over the remaining useful life.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAssetsPolicyTextBlock', window );">Financial Assets</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">ix)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Financial
        Assets</span></span></span></span></span></span></div> </div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>On
initial recognition, a financial asset is classified as measured at amortised cost and subsequently measured using the effective interest
rate (EIR) method and subject to impairment. Financial assets may also be initially measured at fair value with any movement being reflected
through other comprehensive income or the Consolidated Statement of Operations.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>On
initial recognition of an equity investment that is not held for trading, the Group may irrevocably elect to present subsequent changes
in the investment&#8217;s fair value in other comprehensive income. This election is made on an investment-by investment&#160;basis.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
such an election is not made, and the investment is not held for trading, the equity instrument is classified as measured at fair value
through profit or loss (FVTPL). Subsequent changes in fair value are recognised in the Consolidated Statement of Operations. During 2024,
the Group acquired a strategic equity interest in an unlisted entity accounted for under this classification. Refer to Note 13.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Financial
assets are written off when there is no reasonable expectation of recovery, such as when the debtor has entered bankruptcy, when collection
efforts have been exhausted, or when the asset has been significantly past due (typically over 365 days) without any recent payments or
active correspondence. The Group considers both quantitative factors (such as aging) and qualitative indicators (e.g., legal or insolvency
proceedings) in making this assessment. Where receivables are written off but remain subject to enforcement activity, such as legal action
or engagement with collection agencies, these efforts are continued until formally closed.</span></span></span></span></span></div> </div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">Inventories</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">x)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Inventories</span></span></span></span></span></span></div>
        </div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Inventories
are stated at the lower of cost and net realisable value. Cost is based on the first-in, first-out principle and includes all expenditure
which has been incurred in bringing the products to their present location and condition and includes an appropriate allocation of manufacturing
overhead based on the normal level of operating capacity. Net realisable value is the estimated selling price of inventory on hand in
the ordinary course of business less all further costs to completion and costs expected to be incurred in selling these products.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group provides for inventory, based on estimates of the expected realisability. The estimated realisability is evaluated on a case-by-case
basis and any inventory that is approaching its &#8220;use-by&#8221; date and for which no further re-processing can be performed is written
off. Any reversal of an inventory provision is recognised in the statement of operations in the year in which the reversal occurs.</span></span></span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory', window );">Trade and other receivables</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trade
        and other receivables</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trade
receivables are amounts due from customers for products sold or services provided in the ordinary course of business. Trade and other
receivables are stated at their amortised cost less impairment losses incurred. Cost approximates fair value given the short-term nature
of these assets. The Group records the loss allowance as lifetime expected credit losses.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>These
are the expected shortfalls in contractual cash flows, considering the potential for default at any point during the life of the financial
instrument. Expected credit losses are recorded on all of trade receivables based on an assessment of the probability of default or delinquency
in payments and the probability that debtor will enter into financial difficulties or bankruptcy.</span></span></span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory', window );">Trade and other payables</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trade
        and other payables</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Trade
payables are obligations to pay for goods or services that have been acquired in the ordinary course of business. Trade and other payables
are stated at cost. Cost approximates fair value given the short term nature of these liabilities.</span></span></span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xiii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Cash
        and cash equivalents</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="text-align:justify;text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Cash
and cash equivalents comprise cash balances and short-term deposits which are readily available at year-end. Deposits with maturities
less than six months as at the year-end date are recognised as cash and cash equivalents and are carried at fair value when there is no
expected loss in value on early termination. The Group has no short-term bank overdraft facilities. Where restrictions are imposed by
third parties, such as lending institutions, on cash balances held by the Group these are treated as financial assets in the financial
statements.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based payments</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xiv)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Share-based
        payments</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>For
equity-settled share-based payments (share options), the Group measures the services received and the corresponding increase in equity
at fair value at the measurement date (which is the grant date) using a trinomial model. Given that the share options granted do not vest
until the completion of a specified period of service, the fair value, which is assessed at the grant date, is recognised on the basis
that the services to be rendered by employees as consideration for the granting of share options will be received over the vesting period.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Certain
share options have been granted for which there is a condition that the options only become exercisable into ADSs when the market price
of an ADS reaches a certain level. This is deemed to be a non-vesting condition. The term &#8216;non-vesting condition&#8217; is not explicitly
defined in IFRS 2, Share based Payment, but is inferred to be any condition that does not meet the definition of a vesting condition.
The only condition for these options to vest is that the option holder continues service and there were no other conditions which would
be considered non-vesting conditions. Non-vesting conditions are reflected in measuring the grant-date fair value of the share-based payment
and there is no true-up in the measurement of the share-based payment for differences between the expected and the actual outcome of non-vesting
conditions. If all service conditions are met, then the share-based payment cost will be recognized even if the option holder does not
receive the share-based payment due to a failure to meet the non-vesting condition.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
expense in the consolidated statement of operations in relation to share options represents the product of the total number of options
anticipated to vest and the fair value of those options; this amount is allocated to accounting periods on a straight-line basis over
the vesting period.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Share
based payments, to the extent they relate to direct labour involved in development activities, are capitalised.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when
the options are exercised. The Group does not operate any cash-settled share-based payment schemes or share-based payment transactions
with cash alternatives as defined in IFRS 2.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants', window );">Government grants and financial support</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xv)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Government
        grants</span>&#160;<span style="font-style:italic">and financial support</span></span></span></span></span></span></div> </td> </tr>
  </table>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
Group received government-backed Covid-19 financial supports in the form of forgivable loans. Under IAS 20, Accounting for Government
Grants, a forgivable loan from government is treated as a government grant when there is reasonable assurance that the terms for forgiveness
of the loan will be met. Where a loan was received in the financial year but not yet forgiven within the financial year, the loan is treated
as a current liability. The Group has opted to present government grant income for loans that have been forgiven as Other operating income
in the consolidated statement of operations.</span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>If
it is no longer reasonably assured that the terms of forgiveness will be met, any income previously recognised in respect of such a loan
is reversed in the period in which the change in assessment occurs. Grants that compensate the Group for expenses incurred such as research
and development, employment and training are recognised as income in the statement of operations on a systematic basis in the same periods
in which the expenses are incurred. Grants that compensate the Group for the cost of an asset are recognised in the statement of operations
on a systematic basis over the useful life of the asset. R&amp;D tax credits claimed from tax authorities are credited to the taxation
line in the consolidated statement of operations.</span></span></span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue recognition</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xvi)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div>
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Revenue
        recognition</span></span></span></span></span></span></div> </div> </td> </tr>
  </table> </div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Goods
sold and services rendered</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group recognises revenue when it transfers control over a good or service to a customer. Revenue is recognised to the extent that it is
probable that economic benefit will flow to the Group and the revenue can be measured. No revenue is recognised if there is uncertainty
regarding recovery of the consideration due at the outset of the transaction. Revenue, including any amounts invoiced for shipping and
handling costs, represents the value of goods and services supplied to external customers, net of discounts and rebates and excluding
sales taxes.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Revenue
from products is generally recorded as of the date of shipment, consistent with typical ex-works shipment terms. Where the shipment terms
do not permit revenue to be recognised as of the date of shipment, revenue is recognised when the Group has satisfied all of its performance
obligations to the customer in accordance with the shipping terms.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Some
contracts oblige the Group to ship product to the customer ahead of the agreed payment schedule. For these shipments, a contract asset
is recognised when control over the goods has transferred to the customer. The financing component is insignificant as invoicing for these
shipments occurs within a short period of time after shipment has occurred and standard 30 day credit terms typically apply.<span style="font-style:italic">&#160;</span>Some
contracts could be regarded as offering the customer a right of return. Due to the uncertainty of the magnitude and likelihood of product
returns, there is a level of estimation involved in assessing the amount of revenue to be recognized for these types of contracts. In
accordance with IFRS 15, when estimating the effect of an uncertainty on an amount of variable consideration to which the Group will be
entitled, all information that is reasonably available, including historical, current and forecast, is considered.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Revenue
is recognised on bill-and-hold transactions when all of the criteria in IFRS 15 are met, including: (i) the arrangement is at the customer&#8217;s
request and has a substantive business reason; (ii) the products are separately identified as belonging to the customer; (iii) the products
are ready for physical transfer to the customer; and (iv) the Group has no ability to use the products or redirect them to another customer.
The Group assesses each bill-and-hold arrangement individually for compliance with these criteria. When all criteria are satisfied, control
is deemed to have transferred and revenue is recognised.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group operates a licenced referenced laboratory in the US, which provides testing services to institutional customers and insurance companies.
In the US, there are rules requiring all insurance companies to be billed the same amount per test. However, the amount that each insurance
company pays for a particular test varies according to their own internal policies and this can typically be considerably less than the
amount invoiced. We recognise lab services revenue for insurance companies by taking the invoiced amount and reducing it by an estimated
percentage based on historical payment data. We review the percentage reduction annually based on the latest data. As a practical expedient,
and in accordance with IFRS, we apply a portfolio approach to the insurance companies as they have similar characteristics. We judge that
the effect on the financial statements of using a portfolio approach for the insurance companies will not differ materially from applying
IFRS 15 to the individual contracts within that portfolio.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Revenue
from services rendered is recognised in the statement of operations in proportion to the stage of completion of the transaction at the
balance sheet date.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group leases instruments to customers typically as part of a bundled package. Where a contract has multiple performance obligations and
its duration is greater than one year, the transaction price is allocated to the performance obligations in the contract by reference
to their relative standalone selling prices. For contracts where control of the instrument is transferred to the customer, the fair value
of the instrument is recognised as revenue at the commencement of the lease and is matched by the related cost of sale. Fair value is
determined on the basis of standalone selling price. In the case where control of the instrument does not transfer to the customer, revenue
is recognised on the basis of customer usage of the instrument. See also Note 1 (v).</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:28.35pt;line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In
obtaining these contracts, the Group incurs a number of incremental costs, such as sales bonus paid to sales staff commissions paid to
distributors and royalty payments. As the amortisation period of these costs, if capitalised, would be less than one year, the Group makes
use of the practical expedient in IFRS 15.94 and recognised them as expense as they are incurred.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>A
receivable is recognised when the goods are delivered as this is the point in time that the consideration is unconditional because only
the passage of time is required before the payment is due.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group&#8217;s obligation to provide a refund for faulty products under the standard warranty terms is recognised as a provision, see Note
22 for details.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory', window );">Other operating income</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xvi)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Other
        operating income</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Other
operating income primarily includes items of income that arise outside the normal course of business, including government grant income
from forgiven loans, insurance proceeds, sublease income, and other non-recurring items. Income is recognised when it is probable that
the economic benefits associated with the transaction will flow to the Group and the amount can be measured reliably.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>During
the year ended December 31, 2024, other operating income included the reversal of $1.8
million previously recognised in relation to the forgiveness of Paycheck Protection Program (PPP) loans. This reversal was recognised
following the commencement of a U.S. Department of Justice investigation regarding the eligibility of certain U.S. subsidiaries for loan
forgiveness.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory', window );">Employee benefits</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xvii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Employee
        benefits</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Defined
contribution plans</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group operates defined contribution schemes in various locations where its subsidiaries are based. Contributions to the defined contribution
schemes are recognised in the statement of operations in the period in which the related service is received from the employee.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Other
long-term benefits</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
employees participate in the Group&#8217;s other long-term benefit schemes (such as permanent health insurance schemes under which the
scheme insures the employees), or where the Group contributes to insurance schemes for employees, the Group pays an annual fee to a service
provider, and accordingly the Group expenses such payments as incurred.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Termination
benefits</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Termination
benefits are recognised as an expense when the Group is demonstrably committed, without realistic possibility of withdrawal, to a formal
detailed plan to either terminate employment before normal retirement date, or to provide termination benefits as a result of an offer
made to encourage voluntary redundancy.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory', window );">Foreign currency</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xviii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Foreign
        currency</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>A
majority of the revenue of the Group is generated in US Dollars. The Group&#8217;s management has determined that the US&#160;Dollar is
the primary currency of the economic environment in which the Company and its subsidiaries (with the exception of the Group&#8217;s subsidiaries
in Brazil, Canada and Sweden) principally operate. Thus, the functional currency of the Company and its subsidiaries (other than the Brazilian,
Canadian and Swedish subsidiaries) is the US&#160;Dollar. The functional currency of the Brazilian entity is the Brazilian Real and the
functional currency of the Canadian subsidiary is the Canadian Dollar.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
presentation currency of the Company and Group is the US&#160;Dollar. Monetary assets and liabilities denominated in foreign currencies
are translated at the rates of exchange ruling at the balance sheet date. The resulting gains and losses are included in the consolidated
statement of operations. Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated
using the exchange rate at the date of the transaction.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Results
and cash flows of subsidiary undertakings, which have a functional currency other than the US&#160;Dollar, are translated into US Dollars
at average exchange rates for the year, and the related balance sheets have been translated at the rates of exchange ruling on the balance
sheet date. Any exchange differences arising from the translations are recognised in the currency translation reserve via the statement
of changes in equity.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
Euro, Brazilian Real, or Canadian Dollar amounts have been referenced in this document, their corresponding US&#160;Dollar equivalent
has also been included and these equivalents have been calculated with reference to the foreign exchange rates prevailing at December&#160;31,
2024.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory', window );">Hedging</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xix)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Hedging</span></span></span></span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
activities of the Group expose it primarily to changes in foreign exchange rates and interest rates. The Group uses derivative financial
instruments, from time to time, such as forward foreign exchange contracts to hedge these exposures.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Group enters into forward contracts to sell US Dollars forward for Euro. The principal exchange risk identified by the Group is with respect
to fluctuations in the Euro as a substantial portion of its expenses are denominated in Euro but its revenues are primarily denominated
in US Dollars. Trinity Biotech monitors its exposure to foreign currency movements and may use these forward contracts as cash flow hedging
instruments whose objective is to cover a portion of this Euro expense.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>At
the inception of a hedging transaction entailing the use of derivatives, the Group documents the relationship between the hedged item
and the hedging instrument together with its risk management objective and the strategy underlying the proposed transaction. The Group
also documents its quarterly assessment of the effectiveness of the hedge in offsetting movements in the cash flows of the hedged items.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Derivative
financial instruments are recognised at fair value. Where derivatives do not fulfil the criteria for hedge accounting, they are classified
as held-for-trading and changes in fair values are reported in the statement of operations. The fair value of forward exchange contracts
is calculated by reference to current forward exchange rates for contracts with similar maturity profiles and equates to the current market
price at the balance sheet date.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
portion of the gain or loss on a hedging instrument that is deemed to be an effective cash flow hedge is recognised directly in the hedging
reserve in equity and the ineffective portion is recognised in the statement of operations. As the forward contracts are exercised the
net cumulative gain or loss recognised in the hedging reserve is transferred to the statement of operations and reflected in the same
line as the hedged item.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory', window );">Exchangeable notes and derivative financial instruments</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xx)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Exchangeable
        notes and derivative financial instruments</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Company&#8217;s exchangeable notes are treated as a host debt instrument with embedded derivatives attached. On initial recognition, the
host debt instrument is recognised at the residual value of the total net proceeds of the bond issue less fair value of the embedded derivatives.
Subsequently, the host debt instrument is measured at amortised cost using the effective interest rate method.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
embedded derivatives are initially recognised at fair value and are restated at their fair value at each reporting date. The fair value
changes of the embedded derivatives are recognised in the consolidated statement of operations, except for changes in fair value related
to the Group&#8217;s own credit risk, which are recorded in the statement of comprehensive income.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
the exchangeable notes are redeemed early or repurchased in a way that does not alter the original conversion privileges, the consideration
paid is allocated to the respective components and the amount of any gain or loss is recognised in the consolidated statement of operations.</span></span></span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory', window );">Senior secured term loan</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Senior
        secured term loan</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
senior secured term loan is initially recorded at the fair value of the consideration received net of:&#160; a) directly attributable
transaction costs, b) the fair value at the date of issue of the warrants issued to the lender (see Note 1xxii) and c) the fair value
of the option to prepay the loan at the date of issue (see Note 1xxii).</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Subsequent
to initial recognition, the term loan is measured at amortised cost employing the effective interest methodology. Borrowing costs, including
any penalties for early settlement of the loan, are recognised as an expense in the period in which they are incurred.</span></span></span></span></span></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25">&#160;</div>

<div></div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>In
accordance with IFRS 9, the Group assesses any changes to the contractual terms of its borrowings to determine whether such changes result
in a substantial modification. A modification is considered substantial if the revised cash flows differ significantly from those of the
original arrangement, in which case the original liability is derecognised and a new financial liability is recognised. If a modification
is not substantial, the loan is remeasured using the original EIR, with any resulting gain or loss recognised in profit or loss.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>During
2024, the Group amended the terms of its senior secured term loan; however, this was assessed under IFRS 9 and determined not to constitute
a substantial modification. Refer to Note 23 for further details.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory', window );">Warrants and loan prepayment option</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Warrants
        and loan prepayment option</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Company has issued warrants to third parties. A warrant contract might be accounted for as an equity instrument or a financial liability
under IFRS depending on the terms of a warrant. A warrant contract that will or might be settled by an entity by delivering a fixed number
of its own equity instruments, in exchange for a fixed amount of cash or another financial asset, is an equity instrument.&#160;As Perceptive
has the option to choose a cashless exercise option, the Company will have to deliver a variable number of ADS, since the number of shares
will vary depending on the ADS traded price. Even though the cashless exercise option is economically comparable to the cash exercise
option, the fact that the Company will issue a variable number of shares under the cashless exercise option results in one settlement
alternative violating the &#8216;fixed for fixed&#8217; requirement.&#160; The warrant contract therefore meets the definition of a financial
liability and given the value of the warrant changes in response to the price of the Company&#8217;s ADS, with no initial investment and
settlement occurring in the future it meets the definition of a derivative liability under IFRS 9. The warrant is issued in a separate
contract, is transferable independently of the term loan and can be exercised while the term loan remains outstanding. Therefore, the
warrant is a separate instrument to the term loan.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
warrant contracts are initially recognised as a derivative liability at fair value and subsequently measured at fair value at each reporting
period with any changes recognised in the consolidated statement of operations.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Company has the option to prepay the senior secured term loan in whole or in part for an amount equal to the principal, accrued interest
and prepayment premium. In accordance with IFRS 9, this option is separated from the term loan and is initially recognised as a derivative
asset at fair value and subsequently measured at fair value at each reporting period with any changes recognised in the consolidated statement
of operations.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory', window );">Convertible Note</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xxiii)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Convertible
        Note</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
convertible note is accounted for as a compound financial instrument containing both an equity and liability element. The convertible
note has a contractual obligation to deliver cash on redemption equal to the principal amount plus accrued interest and therefore has
a liability component in line with the definition of a financial liability in IAS 32. The convertible loan note also has a conversion
feature where it mandatorily converts into ADS if the volume weighted average price of the Company&#8217;s ADSs is at a certain price
for any five consecutive NASDAQ trading days or any other time at the discretion of the Noteholder. Where a derivative that will or may
be settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity's own equity
instruments, the conversion feature represents an equity component of the convertible note.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
equity component is measured as the residual amount that results from deducting the fair value of the liability component from the initial
carrying amount of the instrument as a whole. There is no remeasurement of the equity element following initial recognition. The debt
component is accounted for at amortised cost employing the effective interest methodology.</span></span></span></span></span></div> </div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory', window );">Segment reporting</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xxiv)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Segment
        reporting</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Operating
segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating
decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as
the Board of Directors.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory', window );">Tax (current and deferred)</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="vertical-align:top;font-style:italic;width:30pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxv)</span></span></span></span></span></td>
    <td style="vertical-align:top;width:auto">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Tax
        (current and deferred)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Income
tax on the profit or loss for the year comprises current and deferred tax. Income tax is recognised in the consolidated statement of operations
except to the extent that it relates to items recognised directly in equity, in which case it is recognised in equity.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Current
tax represents the expected tax payable or recoverable on the taxable profit for the year using tax rates enacted or substantively enacted
at the balance sheet date in the countries where the company and its subsidiaries operate and generate income and taking into account
any adjustments stemming from prior years.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Deferred
tax is provided on the basis of the balance sheet liability method on all temporary differences at the balance sheet date which is defined
as the difference between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred tax
assets and liabilities are not subject to discounting and are measured at the tax rates that are anticipated to apply in the period in
which the asset is realised or the liability is settled based on tax rates and tax laws that have been enacted or substantively enacted
at the balance sheet date. Deferred tax assets are recognised when it is probable that future taxable profits will be available to utilize
the associated losses or temporary differences. The amount of deferred tax provided is based on the expected manner of realisation or
settlement of the carrying amount of assets and liabilities.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Deferred
tax assets and liabilities are recognised for all temporary differences (that is, differences between the carrying amount of the asset
or liability and its tax base) with the exception of the following:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>i.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where the deferred tax liability
        arises from goodwill not deductible for tax purposes or the initial recognition of an asset or a liability in a transaction that is not
        a business combination and affects neither the accounting profit nor the taxable profit or loss at the time of the transaction; and</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:24.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>ii.</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where, in respect of temporary
        differences associated with investments in subsidiary undertakings, the timing of the reversal of the temporary difference is subject
        to control and it is probable that the temporary difference will not reverse in the foreseeable future.</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Where
goodwill is tax deductible, a deferred tax liability is not recognised on initial recognition of goodwill. It is recognised subsequently
for the taxable temporary difference which arises when the goodwill is amortised for tax with no corresponding adjustment to the carrying
value of the goodwill.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
carrying amounts of deferred tax assets are subject to review at each balance sheet date and are derecognised to the extent that future
taxable profits are considered to be inadequate to allow all or part of any deferred tax asset to be utilised.</span></span></span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Provisions and contingent liabilities</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxvi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Provisions</span>&#160;<span style="font-style:italic">and
        contingent liabilities</span></span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>A
provision is recognised in the balance sheet when the Group has a present legal or constructive obligation because of a past event, and
it is probable that an outflow of economic benefits will be required to settle the obligation. The status of any significant claim and
legal proceeding in which the Group is involved is reviewed by management on a periodic basis and the Group&#8217;s potential financial
exposure is assessed. If the potential loss from any claim or legal proceeding is considered probable, and the amount can be reliably
estimated, a liability is recognised for the estimated loss.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Due
to the uncertainties inherent in such matters, the related provisions are based on the best information available at the time. As additional
information becomes available on pending claims, the potential liability is reassessed and revisions are made to the amounts accrued as
appropriate. Such revisions in the judgments and estimates of the potential liabilities could have an impact on the results of operations
and financial position of the Group in future accounting periods.</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Provisions
for restructuring costs are recognised only when the Group has approved a detailed formal plan and has either commenced implementation
or raised a valid expectation among those affected that the restructuring will be carried out. Under IAS 37, restructuring provisions
must only include direct expenditures that are necessarily incurred by the restructuring and not associated with the ongoing activities
of the business.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinanceCostsExplanatory', window );">Cost of sales</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">xxvii)</span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span style="font-style:italic">Cost
        of sales</span></span></span></span></span></span></div> </td> </tr>
  </table> </div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Cost
of sales comprises product cost including manufacturing and payroll costs, quality control, shipping, handling, and packaging costs and
the cost of services provided.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory', window );">Finance income and costs</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxviii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Finance
        income and costs</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Financing
expenses comprise interest costs payable on senior secured term loan, convertible note, leases and exchangeable notes along with non-recurring
financing expenses such as penalty for early settlement of term loan and loss on disposal of exchangeable notes. Interest payable on finance
leases is allocated to each period during the lease term so as to produce a constant periodic rate of interest on the remaining balance
of the liability. Financing expenses also includes the financing element of long term liabilities which have been discounted. Finance
income includes interest income on deposits and is recognised in the consolidated statement of operations as it accrues, using the effective
interest method. Finance income also includes fair value adjustments for derivative assets and liabilities related to the senior secured
term loan and to embedded derivatives associated with exchangeable notes.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory', window );">Treasury shares</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxix)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Treasury
        shares</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>When
the Group purchases its<span style="font-style:italic">&#160;</span>own equity instruments (treasury shares), the costs, including any
directly attributable incremental costs, are deducted from equity. No gain or loss is recognised in the consolidated statement of operations
on the purchase, sale, issue or cancellation of the Group&#8217;s own equity instruments. Any difference between the carrying amount and
the consideration, if reissued, is recognised in share premium. Voting rights related to treasury shares are nullified for the Group and
no dividends are allocated to them.</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory', window );">Equity</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxx)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Equity</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Share
capital represents the nominal (par) value of shares that have been issued. Share premium includes any premiums received on issue of share
capital. Any transaction costs associated with the issuing of shares are deducted from share premium, net of any related income tax benefits.</span></span></span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory', window );">Profit or loss from discontinued operations</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxxi)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Profit
        or loss from discontinued operations</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>A
discontinued operation is a component of the Group that either has been disposed of or is classified as held for sale. Profit or loss
from discontinued operations comprises the post-tax profit or loss of discontinued operations and the post-tax gain or loss resulting
from the measurement and disposal of assets classified as held for sale and any gain or loss on disposal.</span></span></span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory', window );">Fair values</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxxii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Fair
        values</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>For
financial reporting purposes, fair value measurements are categorized into Level&#160;1, 2 or 3 based on the degree to which inputs to
the fair value measurements are observable and the significance of the inputs to the fair value measurement in its entirety, which are
described as follows:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Level&#160;1:
quoted prices (unadjusted) in active markets for identical assets or liabilities</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Level&#160;2:
valuation techniques for which the lowest level of inputs which have a significant effect on the recorded fair value are observable, either
directly or indirectly</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Level&#160;3:
valuation techniques for which the lowest level of inputs that have a significant effect on the recorded fair value are not based on observable
market data</span></span></span></span></span></div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory', window );">New IFRS Standards</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxxiii)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>New
        IFRS Standards</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
following new accounting standards and interpretations became effective for annual periods beginning on or after 1 January 2024. The adoption
of these standards did not have a material impact on the Group&#8217;s consolidated financial statements:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Classification of Liabilities
        as Current or Non-current (Amendments to IAS 1)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Lease Liability in a Sale and
        Leaseback (Amendments to IFRS 16)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Supplier Finance Arrangements
        (Amendments to IAS 7 and IFRS 7)</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
Company is currently assessing the impact of the new standards and amendments on the Company&#8217;s accounting policy disclosure.</span></span></span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations', window );">Standards, amendments and interpretations to existing IFRS Standards that are not yet effective</a></td>
<td class="text">

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>xxxiv)</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Standards,
        amendments and interpretations to existing IFRS Standards that are not yet effective</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
standards and amendments that have been issued but are not yet effective as at the date of issuance of the financial statements, and which
may have an impact on the Group's financial statements in future periods, are listed below. The Group intends to adopt these standards,
if applicable, when they become effective:</span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Lack of Exchangeability (Amendments
        to IAS 21), effective from 1 January 2025</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Amendments to the Classification
        and Measurement of Financial Instruments (Amendments to IFRS 9 and 7), effective from 1 January 2026</span></span></span></span></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Annual Improvements to IFRS
        Accounting Standards, effective from 1 January 2026</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>IFRS 18 &#8216;Presentation
        and Disclosure in Financial Statements&#8217;, effective from 1 January 2027</span></span></span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt">&#160;</td>
    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;</span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>IFRS 19 &#8216;Subsidiaries
        without Public Accountability: Disclosures&#8217;, effective from 1 January 2027</span></span></span></span></span></div> </td> </tr>
  </table> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for business combinations and goodwill. [Refer: Total for all business combinations [member]; Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for business combinations. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for derivative financial instruments and hedging. [Refer: Classes of financial instruments [domain]; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for discontinued operations. [Refer: Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinanceCostsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for finance costs. [Refer: Finance costs]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinanceCostsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for finance income and costs. [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2024-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for hedging.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for the impairment of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for issued capital. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Types of share-based payment arrangements [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for taxes other than income tax. [Refer: Tax expense other than income tax expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for trade and other payables. [Refer: Trade and other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 46<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 30<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_30_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of additional information that may be relevant to users of financial statements in understanding the financial position and liquidity of an entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 50<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_50&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for general information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for new standards and interpretations not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for Other Operating Income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for senior secured term loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for statements of compliance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for warrants and loan prepayment option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FinancialAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for financial assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FinancialAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure of basis of preparation and significant accounting policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory', window );">Schedule of Estimated Useful Lives of Owned Assets</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Leasehold improvements</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>5-15&#160;years</span></span></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Buildings</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>50
        years</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Office equipment and fittings</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>10
        years</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Computer equipment</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>3-5
        years</span></span></span></span></span></div> </td> </tr>
  <tr>
    <td colspan="2" style="width:81.03%;vertical-align:middle">&#160;</td>
    <td style="width:18.97%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align:bottom;width:81.03%">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Plant and equipment</span></span></span></span></span></div> </td>
    <td style="vertical-align:bottom;white-space:nowrap;width:18.97%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>5-15
        years</span></span></span></span></span></div> </td> </tr>
  </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory', window );">Schedule of Estimated Useful Lives of Intangible Assets</a></td>
<td class="text">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:bottom">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Capitalised development costs</span></span></span></span></span></div> </td>
    <td style="width:15.77%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>15&#160;years</span></span></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:middle">&#160;</td>
    <td style="width:15.77%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:bottom">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Patents and licences</span></span></span></span></span></div> </td>
    <td style="width:15.77%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>6-15&#160;years</span></span></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:middle">&#160;</td>
    <td style="width:15.77%;vertical-align:middle">&#160;</td> </tr>
  <tr>
    <td colspan="2" style="width:84.23%;vertical-align:bottom">
        <div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>&#8226;&#160;
        &#160; Other (including acquired customer and supplier lists)</span></span></span></span></span></div> </td>
    <td style="width:15.77%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>6-15
        years</span></span></span></span></span></div> </td> </tr>
  </table> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about estimated useful lives of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about estimated useful lives of owned assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory', window );">Schedule of Revenue by Geographical Area Based on Location of Assets</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminations</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
        from external customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">41,792</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,763</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inter-segment
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,815</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">702</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(20,517</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,607</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,465</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(20,517</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminations</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
        from external customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44,984</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,848</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inter-segment
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,867</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">872</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,739</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,851</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,720</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,739</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminations</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
        from external customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,508</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,013</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inter-segment
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,110</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">828</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,938</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        revenue</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">76,618</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,841</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,938</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory', window );">Schedule of Revenue by Customers' Geographical Area</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29,917</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32,282</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35,557</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia
        / Africa</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,775</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,909</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe
        (including Ireland) *</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,863</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,641</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,563</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.55pt">&#160;</td>
    <td style="width:12.25pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue from customers in Ireland is not disclosed
        separately due to the immateriality of these revenues.</span></span></div> </td> </tr>
  </table> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesExplanatory', window );">Schedule of Revenue by Major Product Group</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Clinical
        laboratory goods</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39,372</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42,288</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">46,036</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Clinical
        laboratory services</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,750</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,453</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,272</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Point-of-care</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,433</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,091</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,213</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory', window );">Schedule of Amount Relating From Revenue</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue
        from contracts with customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory', window );">Schedule of Revenue Derives From Transfer of Goods and Services</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">41,536</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,763</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,299</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">256</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">256</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">41,792</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,763</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44,692</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,848</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,540</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">292</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">292</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44,984</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,848</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,174</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,013</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,187</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,508</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,013</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia
        / Africa</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29,661</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,775</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,863</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,299</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">256</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">256</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29,917</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,775</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,863</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,555</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia
        / Africa</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">31,990</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,909</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,641</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,540</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">292</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">292</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32,282</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,909</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,641</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Timing
        of revenue recognition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia
        / Africa</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        a point in time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35,223</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,563</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,187</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over
        time</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">334</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35,557</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,563</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,521</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">Schedule of Segment Results by Geographical Area</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        before restructuring costs, impairment and unallocated expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,503</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,386</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(315</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,204</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restructuring
        costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,025</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,156</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,181</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        charges</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(612</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(796</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,408</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        after impairment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,140</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,338</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(315</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(17,793</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        expenses *</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,372</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21,165</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        financing expense (Note 6)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,565</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(30,730</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax credit (Note 7)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(486</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year on continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(31,216</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year on discontinued operations (Note 8)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(573</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(31,789</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        before restructuring costs, impairment and unallocated expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,365</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7,886</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(104</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,355</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        charges</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        after impairment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,470</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7,886</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(104</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(23,460</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        expenses *</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,585</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(27,045</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        financing expense (Note 6)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,882</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,927</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax charge (Note 7)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year on continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,868</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        for the year on discontinued operations (Note 8)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,850</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,018</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year
        ended December&#160;31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        before restructuring costs, impairment and unallocated expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,892</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,112</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(33</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,037</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,331</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,508</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,839</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Result
        after impairment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,223</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,620</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(33</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(16,876</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        expenses *</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,473</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,349</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        financing expense (Note 6)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,431</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43,780</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax credit (Note 7)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">194</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year on continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43,586</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        for the year on discontinued operations (Note 8)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,577</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        for the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(41,009</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:30.6pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated expenses represent head office general
        and administration costs of the Group, which cannot be allocated to the results of any specific geographical area.</span></span></div>
        </td> </tr>
  </table> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory', window );">Schedule of Segment Assets and Segment Liabilities by Geographical Area</a></td>
<td class="text">

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Assets
        and liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32,798</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61,254</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94,052</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        assets:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax assets (current and deferred)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,071</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents and short-term investments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        assets as reported in the Group balance sheet</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">103,290</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">84,863</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">48,621</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">133,546</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        liabilities:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax liabilities (current and deferred)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,925</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        liabilities as reported in the Group balance sheet</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">138,471</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div> </div>

<div></div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ireland</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Assets
        and liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,230</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,253</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        assets:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax assets (current and deferred)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,491</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents and short-term investments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        assets as reported in the Group balance sheet</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59,435</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Segment
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,398</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">31,387</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">80,805</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unallocated
        liabilities:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income
        tax liabilities (current and deferred)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,579</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        liabilities as reported in the Group balance sheet</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83,384</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory', window );">Schedule of Long-Lived Assets</a></td>
<td class="text">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">43,504</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,448</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,943</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,793</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">58,447</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,241</span></span></div>
        </td> </tr>
  </table> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory', window );">Schedule of Depreciation and Amortisation by Geographical Area</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation:</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">160</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">162</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">515</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">668</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,282</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">675</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">830</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,405</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amortisation:</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">770</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">458</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">89</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">420</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">487</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">800</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,190</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">945</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">889</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea', window );">Schedule Of Share Based Payment Expense By Geographical Area</a></td>
<td class="text">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023<br/>US$&#8216;000</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022<br/>US$&#8216;000</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">843</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,650</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">632</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">473</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">419</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,123</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,316</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,069</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,755</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory', window );">Schedule of Taxation Expense by Geographical Area</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">)</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(385</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Other</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(235</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(490</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">679</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(88</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(486</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">194</span></span></div>
        </td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory', window );">Schedule of Capital Expenditure by Geographical Area</a></td>
<td class="text">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="width:7px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;width:73px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37,929</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">251</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="width:7px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;width:73px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,753</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,547</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="width:7px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;width:73px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="width:7px;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;width:73px;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,682</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,798</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of geographical information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProductsAndServicesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the entity's products and services. [Refer: Products and services [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProductsAndServicesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of major customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about amount relating from revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about capital expanditure by geographical area.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about depreciation and amortisation by geographical area.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about long lived assets by geographical area.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about revenues derives from goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about segment assets and segment liabilities by geographical area.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about tax expense by geographical area.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about share based payment expenses by geographical area.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure of analysis of single amount of discontinued operations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory', window );">Schedule of Persons Employed by the Group in the Financial Year</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research
        and development</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Administration
        and sales</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">82</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">99</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacturing
        and quality</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">258</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">253</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">380</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">384</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory', window );">Schedule of Employment Costs</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wages
        and salaries</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25,570</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23,718</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22,364</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Social
        welfare costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,219</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,061</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,965</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pension
        costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">451</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">508</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">347</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,316</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,069</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,755</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restructuring
        cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">596</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">485</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">274</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30,152</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,841</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,705</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure of analysis of single amount of discontinued operations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory', window );">Schedule of Employment Costs</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wages
        and salaries</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25,570</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,343</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23,608</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Social
        welfare costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,219</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,097</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,036</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pension
        costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">451</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">510</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">352</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,316</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,069</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,755</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restructuring
        cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">596</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">485</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">274</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30,152</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29,504</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,025</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of additional information about defined benefit plans necessary to meet the objectives of IAS 19. [Refer: Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 137<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_137&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of defined benefit plans. [Refer: Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 138<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_138&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER OPERATING (EXPENSE) / INCOME (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfOtherOperatingIncomeAbstract', window );"><strong>Disclosure of other operating income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory', window );">Schedule of Other Operating Income</a></td>
<td class="text">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        income</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">138</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental
        income from premises</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government
        supports</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,827</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government
        grants</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">333</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,787</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">141</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">343</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other operating income or expense. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfOtherOperatingIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfOtherOperatingIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract', window );"><strong>Disclosure of impairment charges and inventory provisioning [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory', window );">Schedule of Impairment Charges and Inventory Provisioning</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling,
        general&#160;&amp; administration expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        of PP&amp;E (Note 11)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">612</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,772</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">733</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        of goodwill and other intangible&#160;assets (Note 12)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,596</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,833</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,624</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        of prepayments (Note 17)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">482</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Reversal)/Impairment
        of financial assets (Note 13)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(800</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        impairment loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,408</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,839</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory', window );">Schedule of Restructuring Costs</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>December&#160;31,</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Nature
        of cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Personnel
        related costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,216</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outsourcing
        costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">754</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Site
        transfer costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,281</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory
        related costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">772</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        restructuring costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">158</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        restructuring costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,181</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of attribution of expenses by nature to line items by function in the statement of profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 104<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about impairment charges and inventory provisioning.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INCOME AND EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfFinancingIncomeExpensesNetAbstract', window );"><strong>Disclosure Of Financing Income Expenses Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory', window );">Schedule of Financial Income and Expenses</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        income:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        financial income</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,171</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">303</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        expense:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest
        on leases (Note 24)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(592</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(624</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(647</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        on disposal of exchangeable notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,678</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Penalty
        for early partial settlement of senior secured term loan (Note 23,28)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(905</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,450</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        interest payable on senior secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6,293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7,289</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7,039</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        interest payable on convertible note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(300</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(300</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(199</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        interest on exchangeable notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(296</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        interest payable on PPP loans (Note 4)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(338</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        interest on exchangeable notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(84</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        interest on senior secured term loan (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,355</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,131</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,772</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        interest on convertible note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(859</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(796</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(495</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        financial expense</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,172</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(74</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unwinding
        of discount on deferred contingent consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(53</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalisation
        of borrowing costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,085</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        loan modification gain (Note 23,28)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,567</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capitalisation
        of unpaid interest on term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,247</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,565</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,053</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,734</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        financing expense</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,565</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,882</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,431</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about financial income and expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfFinancingIncomeExpensesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfFinancingIncomeExpensesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (EXPENSE)/CREDIT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfIncomeTaxCreditAbstract', window );"><strong>Disclosure of income tax credit [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory', window );">Schedule of Charge for Tax</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current
        tax expense/(credit)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Irish
        Corporation tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(336</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign
        taxes (a)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">254</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">462</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustment
        in respect of prior years</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(198</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        current tax expense/(credit)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">285</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">264</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(280</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-style:italic">Deferred
        tax credit </span>(b)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Origination
        and reversal of temporary differences (see Note 14)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(41</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(547</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">324</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Origination
        and reversal of net operating losses (see Note 14)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">242</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">224</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(238</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        deferred tax charge/(credit)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">201</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(323</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">86</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        income tax charge/(credit) on continuing operations in statement of operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">486</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(59</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(194</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax
        charge on discontinued operations (see Note 8)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        tax charge/(credit)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">486</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(59</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(192</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(a)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2024, the foreign taxes relate primarily to
        Luxembourg and Canada.</span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(b)</span></span></td>
    <td style="width:auto;vertical-align:top">
        <div style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2024, there was
        a deferred tax credit of US$43,000
        (2023: charge of US$174,000)
        (2022: charge of US$109,000)
        recognised in respect of Ireland and a deferred tax charge of US$244,000
        (2023: credit of US$497,000)
        (2022: credit of US$26,000)
        recognised in respect of overseas tax jurisdictions.</span></span></div> </td> </tr>
  </table> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory', window );">Schedule of Overseas Tax Jurisdictions</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective
        tax rate</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before taxation &#8211; continuing operations (US$&#8216;000)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(30,730</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,927</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43,780</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        a percentage of loss before&#160;tax:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current
        tax %</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.93</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.72</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.64</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        (current and deferred) %</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.58</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.16</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.44</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td> </tr>
  </table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory', window );">Schedule of Statutory Tax Rate</a></td>
<td class="text">

<div>

<div style="line-height:1.25;margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Irish
        corporation tax</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12.5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12.5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12.5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect
        of current year net operating losses and temporary differences for which no deferred tax asset was recognised (a)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15.89</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17.19</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.97</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect
        of tax rates on overseas earnings</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.63</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7.82</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7.30</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect
        of Irish income taxable at higher tax rate</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4.09</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.62</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.93</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments
        in respect of prior years</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.04</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.53</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.14</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">R&amp;D
        tax credits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.75</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        items (b)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7.55</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.88</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.07</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective
        tax rate</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1.58</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.16</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.44</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(a)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No deferred tax asset was recognised because there
        was no reversing deferred tax liability in the same jurisdiction reversing in the same period and insufficient future projected taxable
        income in the same jurisdiction.</span></span></div> </td> </tr>
  <tr>
    <td style="width:28.35pt;vertical-align:top">&#160;</td>
    <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td> </tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:28.35pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(b)</span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other items comprise items not chargeable to tax
        and expenses not deductible for tax purposes. In 2022, other items mainly related to the loss on disposal of the exchangeable notes which
        was non-recurring.</span></span></div> </td> </tr>
  </table> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory', window );">Schedule of Unrecognised Deferred Tax Assets</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(17,296</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,922</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,354</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Other</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(315</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(104</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(33</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13,119</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(23,901</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21,393</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(30,730</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,927</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43,780</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory', window );">Schedule of (Loss)/Profit Before Taxes</a></td>
<td class="text">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">107,093</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">69,851</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,731</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Other</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,852</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,511</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">448</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22,866</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,840</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,778</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">182,811</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">136,202</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75,957</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory', window );">Schedule of Unused Tax Losses and Unused Tax Credits</a></td>
<td class="text">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Ireland &#8211; unused tax losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">13,275</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">8,464</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">7,489</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest
        of World &#8211; Other &#8211; unused tax losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">14,777</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">14,701</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">124</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas
        &#8211; unused tax losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,149</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,395</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,163</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Americas
        &#8211; unused tax credits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,702</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,806</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unrecognised
        deferred tax asset</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35,903</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32,366</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,434</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about charges for tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about loss profit before tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about overseas tax jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about statutory tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about unused tax losses and unused tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfIncomeTaxCreditAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfIncomeTaxCreditAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract', window );"><strong>Disclosure of loss on discontinued operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock', window );">Schedule of Operating Profit For The Discontinued Operations</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,&#160;</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,784</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,258</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,652</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9,679</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax
        expense (Note 7)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        from operating activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">132</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,577</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Loss)/Gain
        on sale of discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(573</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,718</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Loss)/Profit
        for the year from discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(573</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,850</span></span></strong></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,577</span></span></strong></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory', window );">Schedule of Net Cashflows Generated From Discontinued Operations</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:middle;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash received from sale
        of the discontinued operations net of transaction costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,935</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash sold as a part of
        discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(775</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash inflow on date of disposal</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,160</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory', window );">Schedule of Assets and Liabilities Disposed</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets disposed in 2023</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Post
        disposal adjustment</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets disposed/adjusted</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property plant &amp;
        equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">103</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">103</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill and intangible
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,123</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,123</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,160</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,160</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">775</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">775</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other receivables</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,309</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(423</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">886</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade and other payables</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(864</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,014</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liabilities</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(106</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(106</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current corporation tax</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liability</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(195</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(195</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Total net assets
        disposed</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,303</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(573</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,730</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory', window );">Schedule of Earnings Per ADS for Discontinued Operations</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        (loss)/earnings per &#8216;A&#8217; share (US Dollars) &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.08</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.02</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
        (loss)/earnings per &#8216;A&#8217; share (US Dollars) &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.07</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.02</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        (loss)/earnings per ADS (US Dollars) &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.03</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.68</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.38</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted
        (loss)/earnings per ADS (US Dollars) &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.03</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.44</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.33</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory', window );">Schedule of Cash Flows Attributable to Discontinued Operations</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        (outflow)/inflow from operating activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(177</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,798</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        inflow from investing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,160</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        outflow&#160;from financing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10,800</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for assets and liabilities disposed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about cash flows attributable to discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about earning per ADS for discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfLossOnDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfLossOnDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for net cashflows generated from discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating profit for the discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS BEFORE TAX (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfLossProfitBeforeTaxAbstract', window );"><strong>Disclosure of loss profit before tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory', window );">Schedule of Loss Before Tax</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,
        2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,
        2023</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,
        2022</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Directors&#8217;
        emoluments (including non- executive directors):</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Remuneration</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,454</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,058</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,639</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Pension</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>39</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>26</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>24</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share
        based payments (Note 26)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>931</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,601</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,707</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Auditor&#8217;s
        remuneration</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Audit
        fees</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,082</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>861</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>888</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Tax
        fees</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>175</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>407</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>89</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Depreciation
        (Note 11) <sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>675</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>830</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,405</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortisation
        (Note 12)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,190</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>945</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>889</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Loss&#160;on
        the disposal of property, plant and equipment</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net
        foreign exchange differences</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>376</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>336</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1,210</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup>
In 2024, US$204,000
was capitalised to research and development projects (2023: US$Nil)
(2022: US$Nil).</span></span></span></span></div>
</div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about loss profit before tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfLossProfitBeforeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfLossProfitBeforeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE  (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory', window );">Schedule of Basic Earnings Per Ordinary Share</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;A&#8217;
        ordinary shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">359,193,482</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">153,099,405</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">134,939,327</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per share denominator</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">359,193,482</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">153,099,405</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">134,939,327</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation
        to weighted average loss per share denominator:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number
        of &#8216;A&#8217; ordinary shares at January&#160;1 (Note 19)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">165,865,882</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">164,985,882</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">96,162,410</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted
        average number of &#8216;A&#8217; ordinary shares issued during the year*</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">205,883,200</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">669,123</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51,332,517</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted
        average number of treasury shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,555,600</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,555,600</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,555,600</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per share denominator</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">359,193,482</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">153,099,405</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">134,939,327</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*The
weighted average number of shares issued during the year is calculated by taking the number of shares issued multiplied by the number
of days in the year each share is in issue, divided by 365 days.</span></span></div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory', window );">Schedule of Diluted Earnings Per Ordinary Share</a></td>
<td class="text">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Potentially
        Dilutive Instruments:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on exercise of options (Note 20)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">186,908</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,752,153</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on exercise of warrants to Perceptive (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,173,151</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on conversion of Exchangeable notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,436,463</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on conversion of Convertible notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,691,358</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,691,358</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,370,709</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        number of potentially dilutive instruments excluded from the weighted average number of &#8216;A&#8217; ordinary shares in calculating
        dilutive loss per &#8216;A&#8217; ordinary share</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44,902,900</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,916,657</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,559,325</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory', window );">Schedule of Basic Earning Per ADS</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ADS</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,959,674</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,654,970</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,746,966</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per ADS denominator</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,959,674</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,654,970</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,746,966</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation
        to weighted average loss per ADS denominator:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number
        of ADS at January&#160;1 (Note 19)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,293,294</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,249,294</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,808,120</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted
        average number of shares issued during the year*</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,294,160</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,456</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,566,626</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted
        average number of treasury shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(627,780</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(627,780</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(627,780</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic
        loss per ADS denominator</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,959,674</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,654,970</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,746,966</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*The
weighted average number of ADSs issued during the year is calculated by taking the number of ADSs issued multiplied by the number of days
in the year each share is in issue, divided by 365 days.</span></span></div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory', window );">Schedule of Diluted Earning Per ADS</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Potentially
        Dilutive Instruments:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on exercise of options (Note 20)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,345</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">137,608</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on exercise of warrants to Perceptive (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,008,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on conversion of Exchangeable notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,920</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,920</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">71,823</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuable
        on conversion of Convertible notes (Note 23)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,234,568</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,234,568</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">818,535</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        number of potentially dilutive instruments excluded from the weighted average number of ADS in calculating dilutive loss per ADS</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,245,146</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,245,833</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,027,966</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about basic earning per ADS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about basic earning per shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about diluted earning per ADS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about diluted earning per shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Disclosure of detailed information about property, plant and equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="text-align:right;line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Land
        &amp; Buildings</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold
        Improvements</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer
        &amp; Office Equipment</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Plant
        &amp; Equipment,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vehicles</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,682</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,701</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,540</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,683</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">65,606</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">87</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">173</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">596</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">911</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(480</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(115</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(220</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(855</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reallocations/
        reclassifications</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange
        adjustments</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">370</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">407</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,268</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,760</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,612</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">34,429</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,069</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,268</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,760</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,612</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">34,429</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,069</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions<sup style="vertical-align:text-top;line-height:1;font-size:smaller">#</sup></span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">752</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">478</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,380</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions
        through acquisition (Note 29)</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">582</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">740</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,373</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Remeasurement
        of ROU assets</span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,764</span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,764</span></span></td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reallocations/
        reclassifications</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">53</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">53</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26,784</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,811</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,344</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">35,686</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">70,625</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Accumulated
        depreciation and Impairment losses</span></span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21,885</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,284</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,178</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(31,577</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(59,924</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
        for the year (Note 9)</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(272</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(64</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(178</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(317</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(831</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">385</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">213</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">751</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        losses</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,246</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(339</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(101</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,086</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,772</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange
        adjustments</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(20</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(370</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(401</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,022</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,669</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,349</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(33,137</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(64,177</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,022</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,669</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,349</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(33,137</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(64,177</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
        for the year (Note 9)</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(325</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(58</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(283</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(675</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        losses*</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(410</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(80</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(477</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(968</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reallocations/
        reclassifications</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(179</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(179</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,757</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,728</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,717</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(33,802</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,004</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        amounts</span></span></div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,027</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">83</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">627</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,884</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,621</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:40%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">246</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">91</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">263</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,292</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,892</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ScheduleOfAdditionalInformationOnRightOfUseAssets', window );">Schedule Of Additional Information On Right Of Use Assets</a></td>
<td class="text">

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><em><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Carrying
        amount At December 31, 2024</span></em></p> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation
        Charge Year ended December 31, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        Charge Year ended December 31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,126</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(325</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(356</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">72</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(56</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:64%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,198</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(381</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(399</span></span></div>
        </td>
    <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        amount At December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation
        Charge Year ended December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        Charge Year ended December 31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buildings</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">229</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(196</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,930</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(51</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Plant and Equipment,
        vehicles</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(86</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">395</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(273</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,016</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings', window );">Schedule of Income From Sub-Letting Right-of-Use Buildings</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-Use
        assets at 31 December 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Right-of-Use leased assets</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range
        of remaining term in years</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average
        remaining lease term (years)</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Leases with extension options</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Leases with options to purchase</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of leases with variable payments linked to index</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of leases with termination options</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Building</span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0
        to 9</span></span></p>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vehicle</span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0
        to 2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">I.T. and office equipment</span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2
        to 5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-Use
        assets at 31 December 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Right-of-Use leased assets</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range
        of remaining term in years</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Average
        remaining lease term (years)</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Leases with extension options</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of Leases with options to purchase</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of leases with variable payments linked to index</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of leases with termination options</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Building</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1
        to 10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vehicle</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1
        to 3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="margin-right:29.8pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">I.T.
        and office equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ScheduleOfAdditionalInformationOnRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of additional information on the right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ScheduleOfAdditionalInformationOnRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of income from sub-letting right-of-use buildings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract', window );"><strong>Disclosure Of Goodwill And Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory', window );">Schedule of Goodwill and Intangible Assets</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Development</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">costs</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Patents
        and</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">licenses</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Technology</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">based
        intangibles</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">79,182</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">125,584</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,729</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,580</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">247,075</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,758</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">110</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,887</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,591</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,488</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(27,079</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reclassifications</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">54</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(54</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange
        adjustments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,645</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">127,365</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,694</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,202</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">221,906</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">66,645</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">127,365</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,694</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,202</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">221,906</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,582</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,280</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,863</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions
        through acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,839</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">122</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27,066</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(70</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(70</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">80,484</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">135,999</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,695</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,482</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">259,765</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Accumulated
        amortisation and Impairment losses</span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,645</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(108,576</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,570</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(28,015</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(211,806</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
        for the year (Note 9)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(753</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(223</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(946</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposals
        or retirements</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,956</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,956</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        losses (Note 5)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,926</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,898</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,833</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange
        adjustments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,645</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(112,262</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,549</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(18,180</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(205,636</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,645</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(112,262</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,549</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(18,180</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(205,636</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charge
        for the year (Note 9)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,190</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,190</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        losses (Note 5)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,596</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,596</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,645</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(115,048</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,549</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(18,180</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(208,422</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        amounts</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,839</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,951</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">146</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,302</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51,343</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,103</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">145</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,270</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Schedule of Principal Development Projects</a></td>
<td class="text">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="width:76%;padding-bottom:0px;vertical-align:bottom;white-space:nowrap;border-bottom:2px solid black">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product
        Name</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-style:italic;vertical-align:bottom">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2024</span><br/><span style="font-weight:bold">US</span></span></span><strong>$</strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">&#8217;000</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-style:italic;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;padding-bottom:2px;font-style:italic;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-style:italic;vertical-align:bottom">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2023</span><br/><span style="font-weight:bold">US</span></span></span><strong>$</strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">&#8217;000</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Continuous
        glucose monitoring testing</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,040</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Premier
        Instruments for A1c and haemoglobinopathies testing</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,669</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Mid-tier
        haemoglobins instrument</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">51</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">HIV
        screening rapid test</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        projects</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        capitalised development costs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,582</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,758</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory', window );">Schedule of Impairment Loss Recorded on Discontinued Assets</a></td>
<td class="text">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Immco
        Diagnostics Inc.</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">101</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,331</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Manufacturing Limited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(120</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Do Brasil</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">162</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">274</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus
        Corp</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">916</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Clark
        Laboratories Inc.</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">130</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Biopool
        US Inc.</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">219</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        impairment loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,408</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityExplanatory', window );">Schedule of Impairment Loss for Each Class of Asset</a></td>
<td class="text">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill
        and other intangible assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,596</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,833</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property,
        plant and equipment (see Note 11)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">612</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,772</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        assets (see Note 13)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(800</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        impairment loss</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,408</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock', window );">Schedule of Specific Asset Impairment Charges</a></td>
<td class="text">

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;width:43%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asset
        name</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Entity</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">T10 HPLC Analyzer</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity Biotech Manufacturing
        Ltd</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">916</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Syphilis Point-of-Care</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity Biotech Manufacturing
        Ltd</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">680</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinscreen plant &amp;
        equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity Biotech Manufacturing
        Ltd</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">223</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Kansas right-of-use asset</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus Corp.</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">133</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,952</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGoodwillExplanatory', window );">Schedule of Significant Goodwill</a></td>
<td class="text">

<div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Goodwill
arising from the purchase of CGM assets from Waveform Technologies</span></span></span></div> </div>

<div style="line-height:1.25;font-family:'Times New Roman', serif">&#160;</div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying amount of goodwill
        (US$&#8217;000)</span></span></div> </td>
    <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,403</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discount rate applied
        (real pre-tax)</span></span></div> </td>
    <td style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.6</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap">%</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">% EBITDA would need to
        decrease for an impairment to arise</span></span></div> </td>
    <td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56.51</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term growth rate</span></span></div>
        </td>
    <td style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.0</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  </table> </div> </div> </div>

<div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Goodwill
arising from the acquisition of EpiCapture Limited</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying amount of goodwill
        (US$&#8217;000)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,420</span></span></div>
        </td>
    <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discount rate applied
        (real pre-tax)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21.9</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">% EBITDA would need to
        decrease for an impairment to arise</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">84.35</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term growth rate</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.0</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory', window );">Schedule of Internal and External Factors Based on Historical Experience</a></td>
<td class="text">

<div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        Assets with Indefinite Useful lives</span></span></div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(included
        in other intangibles)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus
        Corporation CGU</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus
        trade name</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">365</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">365</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">365</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">365</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of intangible assets that are material to the entity. [Refer: Intangible assets material to entity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 122<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_122_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of changes in intangible assets and goodwill. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about impairment loss recorded on discontinued assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about internal and external fectors based on historical experience.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about specific asset impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Disclosure of financial assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutFinancialAssets', window );">Schedule of Financial Assets</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Cost</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January 1, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions
        in year</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January 1, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions
        in year</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,562</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Write
        off in the year</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(800</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair
        value remeasured through profit &amp; loss</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(107</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provision
        for impairment</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January 1, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment
        in the current year</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January 1, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reversal
        of impairment in the current year (Note 5)</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">800</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(700</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        amounts</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about financial assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEFERRED TAX ASSETS AND LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Disclosure Of Deferred Tax Assets And Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text">

<div>

<div style="line-height:1.25">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black">
        <div style="text-align:center;line-height:1.25;font-style:italic">Assets</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black">
        <div style="text-align:center;line-height:1.25;font-style:italic">Liabilities</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black">
        <div style="text-align:center;line-height:1.25;font-style:italic">Net</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2024<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2023<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2024<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2023<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2024<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center">2023<br/>US$&#8217;000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Property, plant and equipment</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">224</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">168</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">224</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">168</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Intangible assets</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(3,001</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(931</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(3,001</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(931</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Inventories</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">776</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">105</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">776</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">105</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Provisions</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,414</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">558</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,414</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">558</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Tax value of loss carry-forwards</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,026</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,030</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,026</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,030</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Other items</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">113</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">114</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,560</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,369</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,447</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">)</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,255</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Deferred tax assets/(liabilities)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">3,553</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,975</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(4,561</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(2,300</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,008</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(325</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory', window );">Schedule of Unrecognised Deferred Tax Liabilities</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<div>

<div style="line-height:1.25">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center">Balance</div>
        <div style="line-height:1.25;font-style:italic;text-align:center">January 1,<br/>2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center">Recognised<br/>in income</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="line-height:1.25;text-align:center"><em>Recognised<br/>in discontinued operations</em></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center">Balance</div>
        <div style="line-height:1.25;font-style:italic;text-align:center">December&#160;31,<br/>2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Property, plant and equipment</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">168</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">56</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">224</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Intangible assets</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(931</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(2,070</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(3,001</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Inventories</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">105</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">671</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">776</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Provisions</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">558</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">856</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,414</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Tax value of loss carry-forwards</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,030</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(4</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,026</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Other items</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,255</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(192</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,447</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(325</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(683</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,008</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td> </tr>
  </table> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div style="margin-left:36pt">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><em><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance</span></span></em></div>
        <div style="line-height:1.25;font-style:italic"><em><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January
        1,<br/>2023</span></span></em></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><em><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognised<br/>in
        income</span></span></em></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25"><em><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognised<br/>in
        discontinued operations</span></span></em></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property,
        plant and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">224</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(56</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">168</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,950</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,827</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">192</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(931</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">423</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(318</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,194</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,636</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">558</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax
        value of loss carry-forwards</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,254</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(224</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,030</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        items</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(985</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(270</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,255</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(840</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">323</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">192</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(325</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory', window );">Schedule of Deferred Tax Assets Not Recognised</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Capital
        losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        operating losses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">180,810</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">136,202</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US
        alternative minimum tax credits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>1,791</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,790</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        temporary timing differences</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,246</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">57,986</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US
        state credit carry-forwards</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,015</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210,140</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">208,286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about deferred tax assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about deferred tax assets not recognised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about unrecognised tax liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER NON-CURRENT ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfOtherAssetsAbstract', window );"><strong>Disclosure Of Other Assets Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory', window );">Schedule of Other Non-Current Assets</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance
        lease receivables (see Note 17)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">43</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">79</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory', window );">Schedule of Inventories</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw
        materials and consumables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,032</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,053</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Work-in-progress</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,989</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,498</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished
        goods</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,353</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,382</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,374</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,933</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory', window );">Schedule of Movement on Inventory Provision</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Opening
        provision at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,344</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,274</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,063</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charged
        during the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,113</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,291</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Utilised
        during the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,809</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,456</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,180</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminated
        on disposal of business</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,765</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Closing
        provision at December&#160;31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,648</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,344</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,274</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about movement on inventory provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TRADE AND OTHER RECEIVABLES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory', window );">Schedule of Trade and Other Receivables</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trade
        receivables, net of impairment losses</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13,416</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10,698</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Prepayments</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,979</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,036</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Contract
        assets</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>460</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>525</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Value
        added tax</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>42</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>43</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Finance
        lease receivables</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>119</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Consideration
        due from sale of business (Note 8)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>373</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other
        receivables</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>168</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>107</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>16,065</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13,901</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory', window );">Schedule of Future Minimum Finance Lease Receivables</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December
        31, 2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Gross<br/>investment</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Unearned<br/>income</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Minimum<br/>payments<br/>receivable</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less
        than one year</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Between
        one and five years (Note 15)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div>&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December
        31, 2023</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Gross<br/>investment</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Unearned<br/>income</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Minimum<br/>payments<br/>receivable</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less
        than one year</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>170</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>119</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Between
        one and five years (Note 15)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>54</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>36</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>224</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>155</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory', window );">Schedule of Future Minimum Rentals Receivable Under Non-Cancellable Operating Leases</a></td>
<td class="text">

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December
        31, 2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Instruments</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less
        than one year</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,461</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,461</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,461</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,461</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div></div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(ii)
Operating lease commitments &#8211; Group as lessor</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December
        31, 2024</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>US$&#8216;000</span></span></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Instruments</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Less
        than one year</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,995</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,995</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,995</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,995</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis of finance lease payments receivable. Finance lease is a lease that transfers substantially all the risks and rewards incidental to ownership of an underlying asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 94<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_94&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 97<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_97&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about trade and other receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CASH AND CASH EQUIVALENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        at bank and in hand</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="text-align:right;line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL AND RESERVES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract', window );"><strong>Disclosure of classes of share capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory', window );">Schedule of Share Capital</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Ordinary shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Ordinary shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        thousands of shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        issue at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">165,866</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">164,986</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued
        for a cash consideration (a)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">81,628</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">880</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued
        for non-cash consideration (b)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">124,255</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        period end</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">371,749</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">165,866</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ADS</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ADS</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        thousands of ADSs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,249</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued
        for a cash consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,081</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issued
        for non-cash consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,213</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        period end</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,587</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt">&#160;</p> </div>

<div></div>

<div style="text-indent:30.6pt;line-height:1.25;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
amounts in the tables above are inclusive of Treasury Shares. The number of Treasury Shares is as follows:</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Treasury shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Treasury shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        thousands of shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,556</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,556</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchased
        during period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        period end</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,556</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,556</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div>&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Treasury shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Class
        &#8216;A&#8217;<br/>Treasury shares</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;000s</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        thousands of ADSs</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">628</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">628</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchased
        during period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        period end</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">628</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">628</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of classes of share capital. [Refer: Classes of share capital [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE OPTIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract', window );"><strong>Disclosure Of Share Options And Share Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory', window );">Schedule of Grants of Share Options and Warrants</a></td>
<td class="text">

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">Share Options &#8216;A&#8217; Ordinary Shares</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">Weighted- average exercise price US$ Per</div>
        <div style="text-align:center;line-height:1.25">&#8216;A&#8217; Ordinary Share</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">Range US$ Per &#8216;A&#8217; Ordinary Share</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding January&#160;1, 2022</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">18,727,990</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.78</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-4.36</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Granted</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">29,400,000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.27</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.27-0.29</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercised</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(2,733,328</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-0.19</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Expired / Forfeited</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(579,990</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1.87</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.69-4.36</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding December 31, 2022</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">44,814,672</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.47</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-2.43</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercisable December 31, 2022</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">14,138,004</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.89</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-2.43</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding January&#160;1, 2023</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">44,814,672</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.47</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-2.43</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Granted</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">19,600,000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.14</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.12-0.25</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercised</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(880,000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-0.19</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Expired / Forfeited</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(16,620,000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.33</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.27-2.43</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding December 31, 2023</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">46,914,672</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.39</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.12-1.34</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercisable December 31, 2023</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">19,764,672</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.67</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.19-1.34</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding January&#160;1, 2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">46,914,672</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.39</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.12-1.34</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Granted</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">12,100,000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.14</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.14-0.14</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Expired / Forfeited</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(18,508,000</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.50</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.12-1.34</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Outstanding December 31, 2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">40,506,672</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.26</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.12-1.29</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Exercisable December 31, 2024</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">17,275,422</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.41</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">0.12-1.29</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div> </div> </div> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div></div>

<div>

<div>

<div>

<div>

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>In
February 2024, the Company adjusted its ADS ratio from 1 ADS: 4 ordinary shares to 1 ADS: 20 ordinary shares.</span> The 2024 and 2023
ADS amounts in the below tables reflect this change.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:30.6pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
number and weighted average exercise price of share options per ADS is as follows:</span></span></div> </div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share
        Options &#8216;ADS&#8217; Equivalent</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-
        average exercise price US$ Per &#8216;ADS&#8217;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range
        US$ Per &#8216;ADS&#8217;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        January&#160;1, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">936,400</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15.60</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-87.20</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,470,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.40-5.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(136,666</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-3.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / Forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(29,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37.40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.80-87.20</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        December 31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,240,734</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-48.60</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable
        December 31, 2022</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">706,900</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-48.60</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,240,734</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-48.60</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">980,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.40-5.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(44,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-3.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / Forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(831,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.60</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.40-48.60</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,345,734</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.40-26.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable
        December 31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">988,234</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.80-26.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,345,734</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.40-26.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">605,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.80-2.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / Forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(925,400</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.40-26.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,025,334</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.20</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.40-25.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable
        December 31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">863,771</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.20</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.40-25.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div> </div> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Schedule of Range of Prices of Stock Options</a></td>
<td class="text">

<div>

<div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Exercise
        price range</span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of<br/>options<br/>&#8216;A&#8217; ordinary<br/>shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No.
        of<br/>options<br/>&#8216;A&#8217; ordinary<br/>shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$0.12-US$0.99</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,356,672</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.25</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,125,422</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.78</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$1.00-US$1.29</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.14</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.38</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.76</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.36</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,506,672</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,275,422</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Exercise
        price range</span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;ADS<br/>equivalent&#8217;</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;ADS<br/>equivalent&#8217;</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$2.40-US$19.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,017,834</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">856,271</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.78</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$20.00-US$25.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.38</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22.80</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.38</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,025,334</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">863,771</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> </div> </div> </div> </div>

<div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Exercise price
        range</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;A&#8217;
        ordinary<br/>shares</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;A&#8217;
        ordinary<br/>shares</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$0.12-US$0.99</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">42,266,672</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">0.28</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">5.50</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">15,116,672</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">0.47</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">4.16</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$1.00-US$1.74</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">4,648,000</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">1.33</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">0.79</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">4,648,000</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">1.33</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">0.79</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">46,914,672</span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">19,764,672</span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap">
        <div style="margin-right:62.3pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Exercise
        price range </span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;ADS<br/>equivalent&#8217;</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">No. of<br/>options<br/>&#8216;ADS<br/>equivalent&#8217;</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted&#8211;<br/>average<br/>exercise<br/>price</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted-<br/>average<br/>contractual<br/>life<br/>remaining<br/>(years)</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$2.40-US$19.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">2,113,334</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">5.64</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">5.50</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">755,834</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">9.32</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">4.16</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$20.00-US$34.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">232,400</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">26.54</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">0.79</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">232,400</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">26.54</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">0.79</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">2,345,734</span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">988,234</span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> </div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Schedule of Fair Value of the Options Vesting Period</a></td>
<td class="text">

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments &#8211; cost of sales</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments &#8211; selling, general and administrative</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,316</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,069</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,755</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        &#8211; continuing operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,316</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,069</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,755</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        payments &#8211; discontinued operations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,316</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,069</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,755</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory', window );">Schedule of Assumption Determining Fair Value of Share Options</a></td>
<td class="text">

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Key</span><br/><span style="font-weight:bold">management</span><br/><span style="font-weight:bold">personnel</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Key</span><br/><span style="font-weight:bold">management</span><br/><span style="font-weight:bold">personnel</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Key</span><br/><span style="font-weight:bold">management</span><br/><span style="font-weight:bold">personnel</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">2023</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">2022</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        fair value at measurement date per &#8216;A&#8217; share / (per ADS)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US$0.10
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$2.08</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.50
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$10.04</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.19
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$3.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Total &#8216;A&#8217;
        share options granted / (ADS&#8217;s equivalent)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">12,100,000
        / (605,000</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">19,600,000
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(980,000</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">29,400,000
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(1,470,000</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        share price per &#8216;A&#8217; share / (per ADS)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.14/</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$2.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.14
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$2.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.27
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$5.40</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        exercise price per &#8216;A&#8217; share / (per ADS)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.14
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$2.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.14
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$2.80</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">$&#160;</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">US0.27
        /</span></div>
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">(US$5.40</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">)</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        expected volatility</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">74.40</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">40.21</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">76.79</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        expected life</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">7</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">7</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">6.82</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Weighted average
        risk-free interest rate</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">4.06</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">4.13</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">3.59</span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif">%</span></div> </td> </tr>
  </table> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's other equity instruments (ie other than share options).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about share option and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfShareOptionsAndShareWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TRADE AND OTHER PAYABLES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory', window );">Schedule of Trade and Other Payables</a></td>
<td class="text">

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">December&#160;31,</div>
        <div style="text-align:center;line-height:1.25;font-style:italic">2024</div>
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic">December&#160;31,</div>
        <div style="text-align:center;line-height:1.25;font-style:italic">2023</div>
        <div style="text-align:center;line-height:1.25;font-style:italic">US$&#8217;000</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Trade payables</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">6,833</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">3,885</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Accruals and other liabilities</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">13,597</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">7,552</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Amounts payable for financial assets (Note 13)</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">800</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Payroll taxes</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">659</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">405</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Employee related social insurance</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">112</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">110</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Contingent consideration</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">5,384</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25">Deferred income</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">197</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">50</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">26,782</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">12,802</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about trade and other payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROVISIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionsAbstract', window );"><strong>Provisions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsExplanatory', window );">Schedule of Provisions</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product
        warranty provision</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Legal &amp; regulatory
        provision</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">735</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disposal-related warranty
        settlement provision</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restructuring provision</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,594</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,529</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,454</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">75</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProvisionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProvisionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTEREST-BEARING LOANS AND BORROWINGS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract', window );"><strong>Disclosure Of Interest-bearing Loans And Borrowings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory', window );">Schedule of Borrowings</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        senior notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        financial liability</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">526</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingent
        liability (Note 29)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,813</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        non-current liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">91,263</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55,177</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,<br/>2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Current
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        financial asset</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        non-current assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory', window );">Schedule of Exchangeable Notes Balance</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liability</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock', window );">Schedule Of Movement In Term Loan</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(44,301</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal amount loaned</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(30,500</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loan drawdown costs</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">325</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">194</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative financial
        liability at date of drawdown</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">90</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative financial
        asset at date of drawdown</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(28</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accretion interest (Note
        6)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,355</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,131</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash repayment of principal</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,050</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Payment-in-kind (PIK)
        Interest</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,291</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash Loan Modification
        Gain</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,567</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December&#160;31</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory', window );">Schedule of Derivative Financial Asset</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">128</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative financial
        asset at date of drawdown</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustments
        in the period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current asset at
        December 31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory', window );">Schedule of Derivative Financial Liability</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(526</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,569</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative financial
        liability at date of drawdown</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,066</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(90</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value adjustments
        in the period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,133</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liability
        at December 31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(526</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory', window );">Schedule of Term Loan And The 7-Year Convertible Notes</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at January 1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13,746</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accretion interest</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(859</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(796</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liability
        at December 31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about movement in derivative financial asset explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about movement in derivative financial liability explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about movement in exchangeable notes balance explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about movement in term loan and the 7-year convertible notes explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about movement in the term loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASE LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract', window );"><strong>Disclosure of finance lease liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory', window );">Schedule of Carrying Values of Finance Lease Liabilities</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities related to Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,285</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,694</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,285</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,694</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-Current
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities related to Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,477</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,872</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory', window );">Schedule of Finance Lease Liabilities Payable</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities related to</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right
        of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Minimum</span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">lease</span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">payments</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less
        than one year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,862</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">577</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,285</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        more than one year, but not more than two</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,214</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">472</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,742</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        more than two years but not more than five</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,487</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">955</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,532</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">More
        than five years</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,652</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">449</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,203</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,215</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,453</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,762</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December
        31, 2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities related to</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right
        of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Minimum</span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">lease</span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">payments</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less
        than one year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,221</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">577</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,644</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        more than one year, but not more than two</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,243</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">498</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,745</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In
        more than two years but not more than five</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,442</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,017</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,425</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">more
        than five years</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,400</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">648</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,306</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,740</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about carrying values of finance lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about finance lease liabilities payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfFinanceLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfFinanceLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory', window );">Schedule of Compensation</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term
        employee benefits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">843</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,774</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Performance
        related bonus</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>260</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">211</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Post-employment
        benefits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        compensation benefits as calculated under IFRS 2</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">931</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,601</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,073</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,612</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory', window );">Schedule of Company's Shares and Share Option Plan</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;A&#8217;
        Ordinary Shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share
        options</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,117,777</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30,387,336</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shares
        purchased during the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">200,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,600,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,994,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,317,777</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">32,993,336</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8216;A&#8217;
        Ordinary Shares</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share
        options</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        January&#160;1, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,117,777</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,547,336</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options
        of retired director</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(20,000,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,000,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expired
        / forfeited</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,160,000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At
        December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,117,777</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">30,387,336</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutCompensationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutCompensationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about shares and share option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT  (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory', window );">Schedule of Fair Values of Financial Assets/Liabilities</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        2</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        3</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">carrying</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">amount</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Value</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loans
        and receivables at amortised cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,583</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25"></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">-</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,583</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,583</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities
        at amortised cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,762</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,762</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,762</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables (excluding deferred income)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,585</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,585</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,585</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,529</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,529</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,529</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(41,876</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(88,002</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(129,878</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(129,878</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair
        value through profit and loss (FVPL)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        liability - warrants</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,658</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        asset &#8211; prepayment option</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">166</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity
        investments in Novus</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,492</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">963</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">963</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(23,293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(89,494</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(110,332</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(110,332</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        2</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level
        3</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">carrying</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">amount</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Value</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loans
        and receivables at amortised cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,698</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,698</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,698</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        and cash equivalents</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance
        lease receivable</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,
        17</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,544</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,544</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,544</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities
        at amortised cost</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        note&#185;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables (excluding deferred income)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisions</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(25,368</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(54,861</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(80,229</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(80,229</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair
        value through profit and loss (FVPL)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        liability - warrants</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(526</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(526</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(526</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Derivative
        asset &#8211; prepayment option</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">178</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(348</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(348</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(348</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28.27%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10,824</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(55,209</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,033</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(66,033</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory', window );">Schedule of Interest Rate Risk Effective and Repricing Analysis</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As&#160;at&#160;December&#160;31,&#160;2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">interest<br/>rate</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths or less</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        &#8211;12 mths</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&gt;
        5 years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash&#160;and&#160;cash&#160;equivalents</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.00</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        note<sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup></span></span></div> </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.0</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan<sup style="vertical-align:text-top;line-height:1;font-size:smaller">2</sup></span></span></div> </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.3</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note<sup style="vertical-align:text-top;line-height:1;font-size:smaller">3</sup></span></span></div> </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.5</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:20.21%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-9pt;margin-left:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;&#160;&#160;&#160;Lease
        payable on Right of Use assets</span></span></div> </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.0</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,762</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,150</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,135</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,742</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,532</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,203</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:20.21%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(95,597</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,017</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,135</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(74,133</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,933</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,413</span></span></div>
        </td>
    <td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As&#160;at&#160;December&#160;31,&#160;2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effective</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">interest<br/>rate</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths or less</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        &#8211;12 mths</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&gt;
        5 years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash&#160;and&#160;cash&#160;equivalents</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.00</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:middle;width:20.21%;vertical-align:bottom">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease&#160;receivable</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,17</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.0</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">39</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        note<sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20.21%;vertical-align:bottom">
        <div style="text-indent:-2.6pt;margin-left:9.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan<sup style="vertical-align:text-top;line-height:1;font-size:smaller">2</sup></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.3</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-1.9pt;margin-left:9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note<sup style="vertical-align:text-top;line-height:1;font-size:smaller">3</sup></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:20.21%;padding-bottom:2px;vertical-align:bottom">
        <div style="margin-left:7.1pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        payable on Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.0</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(812</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(832</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,745</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,425</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:20.21%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(63,581</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,941</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(793</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,696</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(44,529</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,504</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><sup style="vertical-align:text-top;line-height:1;font-size:smaller">1</sup>
The maturity of the exchangeable notes is based on the contractual maturity date of April 1, 2045.</span></span></div>

<div style="margin-left:31.2pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><sup style="vertical-align:text-top;line-height:1;font-size:smaller">2</sup>
The senior secured term loan is a variable instrument. In January 2024, the
amended term loan agreement reduced the annual rate of interest on the loan by 2.5% to 8.75% plus the greater of (a) Term Secured Overnight
Financing Rate or (b) 4.0% per annum, and allows for a further 2.5% reduction in the base rate to 6.25% once the outstanding principal
under the term loan falls below US$35 million.&#160; The loan matures in July 2026.</span></span></div>

<div style="margin-left:31.2pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><sup style="vertical-align:text-top;line-height:1;font-size:smaller">3</sup>
The 7-year convertible note was issued in May 2022 and is a fixed rate instrument which bears a fixed rate of interest of 1.5%
per annum.</span></span></div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory', window );">Schedule of Interest Rate Profile of Financial Assets/Liabilities</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Variable
        rate instruments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        at bank and in hand</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Variable
        rate financial liabilities (senior secured term loan)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(67,224</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(36,418</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fixed
        rate instruments</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fixed
        rate financial liabilities (exchangeable note)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fixed
        rate financial liabilities (convertible note)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fixed
        rate financial liabilities (lease payables)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,762</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        assets (lease receivables)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(28,373</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(27,163</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory', window );">Schedule of Liquidity Risk Estimated Interest Payments of Maturities</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2024</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying<br/>amount</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractual<br/>cash
        flows</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths or<br/>less</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths &#8211;</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12
        mths</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&gt;5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:16%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables (excluding deferred income)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25,286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25,286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25,286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        payable on Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,762</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,214</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,454</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,408</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,213</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,487</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,652</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan&#185;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">72,391</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">81,438</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,703</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,319</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">76,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,401</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,350</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">300</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">900</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,850</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:16%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">380</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">340</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:16%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">126,050</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">143,668</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,597</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,881</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">78,937</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,411</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,842</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2023</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying<br/>amount</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractual<br/>cash
        flows</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths or<br/>less</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6
        mths &#8211;</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12
        mths</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1-2
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2-5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&gt;5
        years</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:16%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables (excluding deferred income)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,752</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        payable on Right of Use assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,566</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,306</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,107</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,114</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,243</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,442</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,400</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Senior
        secured term loan&#185;</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">40,109</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56,121</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,461</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,461</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,922</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42,277</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Convertible
        note</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,542</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,650</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">300</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">900</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20,150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:16%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchangeable
        notes</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">210</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">389</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">349</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:16%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">80,179</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">106,218</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">17,474</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,729</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,473</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">48,643</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25,899</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:31.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#185;
The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December
31, 2023.</span></span></div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory', window );">Schedule of Foreign Currency Risk Short Term Financial Assets and Liabilities</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td rowspan="1" style="vertical-align:bottom;vertical-align:bottom"></td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EUR</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GBP</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SEK</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAD</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BRL</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">116</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">293</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">373</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other receivable</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,009</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">74</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">294</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,019</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7,098</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(453</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(114</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(135</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6,867</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(171</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        exposure</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,840</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(329</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">473</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,086</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td rowspan="1" style="vertical-align:bottom;vertical-align:bottom"></td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EUR</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GBP</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SEK</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CAD</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BRL</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        at December&#160;31, 2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">219</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">191</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">854</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other receivable</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">856</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">533</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,533</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,766</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(100</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(220</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(704</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease
        liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8,349</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(241</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        exposure</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11,040</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">504</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,442</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk', window );">Schedule of Sensitivity Analysis</a></td>
<td class="text">

<div>

<div style="margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A 10%
strengthening of the US&#160;Dollar against the Euro at December&#160;31, 2024 would have increased profit and other equity by the amounts
shown below. This analysis assumes that all other variables, in particular interest rates, remain constant.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        or Loss</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td colspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td colspan="1" style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td colspan="1" style="vertical-align:middle;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td colspan="1" style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td colspan="1" style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,004</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> </div>&#160;

<div style="margin-left:30.6pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A
10% weakening of the US&#160;Dollar against the Euro at December&#160;31, 2024 would have decreased profit and other equity by the amounts
shown below. This analysis assumes that all other variables, in particular interest rates, remain constant.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit
        or Loss</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2024</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,427</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,
        2023</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,227</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExplanatory', window );">Schedule of Maximum Credit Exposure of Financial Assets</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Third
        party trade receivables (Note 17)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,698</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance
        lease income receivable (Note 17)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">155</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash&#160;and
        cash equivalents (Note 18)</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,167</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,583</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,544</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory', window );">Schedule of Exposure of Trade Receivables by Geographic Location</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United
        States</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,185</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,041</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Euro-zone
        countries</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">742</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">851</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United
        Kingdom</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">741</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">126</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other
        regions</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,748</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,835</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,853</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory', window );">Schedule of Exposure of Trade Receivables by Customer</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carrying
        Value<br/>December&#160;31, </span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023<br/>US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">End-user
        customers</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,828</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,029</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Distributors</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,236</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,399</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-governmental
        organisations</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,352</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">425</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,416</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,853</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory', window );">Schedule of Ageing of Trade Receivables</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected
        Credit Loss Rate</span></span></div> </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected
        Credit Loss Rate</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Not
        past due</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,363</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,031</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Past
        due 0-30 days</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,455</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,534</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Past
        due 31-120 days</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,753</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">31</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">856</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.6</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Greater
        than 120 days</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,131</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,255</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">72.0</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,601</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,302</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">88.5</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,702</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,022</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,324</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory', window );">Schedule of Movement in Allowance for Impairment of Trade Receivables</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8217;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at January&#160;1</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,324</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,691</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Charged
        to costs and expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">225</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">715</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amounts
        written off during the year</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(263</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(977</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Eliminated
        on disposal of business</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(105</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance
        at December&#160;31</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,286</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,324</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCreditRiskExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of credit risk. [Refer: Credit risk [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Section Credit risk<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g35A-38_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCreditRiskExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value measurement of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information that enables users of financial statements to evaluate the nature and extent of risks arising from financial instruments to which the entity is exposed. [Refer: Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the sensitivity analysis for types of market risk to which the entity is exposed, showing how profit or loss and equity would have been affected by changes in the relevant risk variable that were reasonably possible at that date. [Refer: Market risk [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 40<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_40_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about Ageing of trade receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about exposure of trade receivables by customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about exposure of trade receivables by geographic location.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about foreign currency risk short term financial assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about interest rate profile of financial assets/liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about liquidity risk estimated interest payments of maturities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about movement in the allowance for impairment of trade receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory', window );">Schedule of Liabilities Arising from Financing Activities</a></td>
<td class="text">

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:85%">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Note</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Borrowings
        &amp; derivative</span></span></span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>financial
        instruments<br/>US$&#8217;000</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Lease
        liabilities<br/>US$&#8217;000</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Balance
        at January 1, 2024</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>23,24</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>55,387</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>12,566</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash-flows:</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Principal
        amount loaned &#8211; term loan</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>30,500</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Loan
        origination costs paid</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(324</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Interest
        paid for senior secured term loan</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(6,253</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Interest
        paid for convertible note</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(300</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Interest
        paid for exchangeable notes</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(8</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Repayment
        of leases</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(2,503</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Non-cash:</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Interest
        charged</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>6,561</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Derivative
        financial asset at date of issue</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>28</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Remeasurement
        of ROU assets</span></span></p> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,764</span></span></td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Additions
        (related to Right of Use assets)</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>855</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Exchange
        adjustment</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(512</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Accretion
        interest</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>3,214</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>592</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Fair
        value of derivative liability - warrants</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>66</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Fair
        value of additional derivative liability - warrants</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1,066</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Payment-in-kind
        (PIK) Interest</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>3,291</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>-</span></span></span></p>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Contingent
        liability</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1,813</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Non-cash
        loan modification gain</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">&#160;</td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(3,567</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>-</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Balance
        at December 31, 2024</span></span></span></span></span></span></div> </td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>23,24</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>91,474</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>12,762</span></span></span></span></span></span></div>
        </td>
    <td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
  </table> </div> </div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Borrowings
        &amp; derivative</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>financial
        instruments<br/>US$&#8217;000</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Lease
        liabilities<br/>US$&#8217;000</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance
        at January 1, 2023</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>23,24</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>59,826</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>13,943</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash-flows:</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Principal
        amount loaned &#8211; term loan</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5,000</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Loan
        origination costs paid</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(194</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest
        paid for senior secured term loan</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(7,314</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest
        paid for convertible note</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(300</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest
        paid for exchangeable notes</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(8</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Repayment
        of term loan</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(10,050</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Repayment
        of leases</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(2,318</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Penalty
        paid for early settlement of term loan</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(905</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Non-cash:</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8212;</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Interest
        charged</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,622</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Penalty
        for early settlement charged</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>905</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Derivative
        financial asset at date of issue</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>23</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>11</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Disposals
        (related to Right of Use assets)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(106</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additions
        (related to Right of Use assets)</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>112</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exchange
        adjustment</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>311</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Accretion
        interest</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,927</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>624</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fair
        value of derivative liability - warrants</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1,133</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64.66%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance at
        December 31, 2023</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:4px;vertical-align:bottom">
        <div style="line-height:1.25;font-style:italic;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>23,24</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>55,387</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,566</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember', window );">Waveform Technologies Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory', window );">Schedule of Assets Acquired and Liabilities, Fair Values at Acquisition Date</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisional
        value</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Measurement
        period adjustment</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjusted
        values</span></span></div>
        <div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property,
        plant and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,569</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(206</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,363</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        assets &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">9,360</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">9,360</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        assets</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">9</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">9</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">1,296</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(1,296</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">135</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">135</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">(50</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">(50</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        tax liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">(1,170</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">1,170</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets acquired</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold">11,149</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">(332</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">10,817</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">12,071</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">332</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">12,403</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consideration</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold">23,220</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">23,220</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Satisfied
        by:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">12,500</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">12,500</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25">3,960</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">3,960</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        contingent consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25">6,760</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">6,760</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold">23,220</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">23,220</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25">12,500</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25">12,500</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold">12,500</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">-</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">12,500</div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember', window );">Metabolomics Diagnostics Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory', window );">Schedule of Assets Acquired and Liabilities, Fair Values at Acquisition Date</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Metabolomics</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisional
        value</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property,
        plant and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        assets &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,200</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventory</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">144</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other receivables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">181</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(494</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        tax liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(150</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        acquired</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets acquired</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">900</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consideration</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">906</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Satisfied
        by:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">412</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">494</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">906</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">412</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less:
        Cash and cash equivalents</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">404</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  </table> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember', window );">Epi Capture Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory', window );">Schedule of Assets Acquired and Liabilities, Fair Values at Acquisition Date</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EpiCapture</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provisional
        value</span></span></div>
        <div style="text-align:center;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US$&#8216;000</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible
        assets &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,668</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade
        and other payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(406</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        tax liabilities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(333</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        assets acquired</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,929</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,420</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consideration</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,349</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Satisfied
        by:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-cash
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,965</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred
        contingent consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">384</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        consideration</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,349</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow &#8211; arising on acquisition</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
        <div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash outflow</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
        <div style="line-height:1.25;font-weight:bold">&#160;</div> </td> </tr>
  </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about business combinations. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Section Disclosures application of paragraphs 59 and 61<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;doctype=Appendix&amp;subtype=B&amp;dita_xref=IFRS03_gB64-B67_TI<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GROUP UNDERTAKINGS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfGroupUndertakingsAbstract', window );"><strong>Disclosure of group undertakings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory', window );">Schedule of Subsidiary Undertakings</a></td>
<td class="text">

<div style="margin-left:36pt">

<table cellpadding="0" cellspacing="0" style="width:85%">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name
        and registered office</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal
        activity</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal&#160;Country&#160;of<br/>incorporation
        and<br/>operation</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Group&#160;%&#160;holding</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Manufacturing Limited</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">County
        Wicklow, Ireland</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacture
        and sale<br/>of diagnostic test kits</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Ireland</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Research Limited</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">County
        Wicklow, Ireland</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research
        and<br/>development</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Ireland</span>&#160;</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Manufacturing Services Limited</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">County
        Wicklow, Ireland</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dormant</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Ireland</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle">&#160;</td>
    <td colspan="1" style="vertical-align:middle">&#160;</td>
    <td style="vertical-align:middle;text-align:center">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center">&#160;</td>
    <td style="vertical-align:middle;text-align:center">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Luxembourg Sarl</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,
        rue Bender,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">L-1229
        Luxembourg</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investment
        and<br/>provision of financial<br/>services</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Luxembourg</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Inc</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Girts
        Road,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Jamestown,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NY
        14702, USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Holding
        Company</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S.A.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Clark
        Laboratories Inc</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trading
        as Trinity Biotech (USA)</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Girts
        Road, Jamestown</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NY14702,
        USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacture
        and sale<br/>of diagnostic test kits</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S.A.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Mardx
        Diagnostics Inc</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5919
        Farnsworth Court</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carlsbad</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CA
        92008, USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dormant</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S.A.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Biopool
        US Inc (trading as Trinity Biotech Distribution)</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Girts
        Road, Jamestown</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NY14702,
        USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sale
        of diagnostic test<br/>kits</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S.A.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Primus
        Corporation</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4231
        E 75<sup style="vertical-align:text-top;line-height:1;font-size:smaller">th</sup> Terrace</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Kansas
        City,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">MO
        64132, USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacture
        and sale<br/>of diagnostic test kits<br/>and instrumentation</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S.A.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  </table> </div>

<div>

<div style="margin-left:36pt">

<table cellpadding="0" cellspacing="0" style="width:85%">
  <tr>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name
        and registered office</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal&#160;activity</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><em><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Principal
        Country of<br/>incorporation and<br/>operation</span></em></p> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Group&#160;%&#160;holding</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Phoenix
        Bio-tech Corp.</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1166
        South Service Road West</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Oakville,
        ON L6L 5T7</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada.</span></span></div>
        </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dormant</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Canada</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fiomi
        Diagnostics Holding AB</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dag
        Hammarskj&#246;ldsv 52A</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SE-752
        37 Uppsala</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sweden</span></span></div>
        </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Holding
        Company</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Sweden</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fiomi
        Diagnostics AB</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dag
        Hammarskj&#246;ldsv 52A</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SE-752
        37 Uppsala</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sweden</span></span></div>
        </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Discontinued
        operation</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(in
        liquidation)</span></span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Sweden</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Do Brasil</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Comercio
        e Importacao Ltda</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rua
        Silva Bueno</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.660
        &#8211; Cj. 101/102</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ipiranga</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sao
        Paulo</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Brazil</span></span></div>
        </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sale
        of diagnostic test<br/>kits</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Brazil</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech (UK) Ltd</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Mills
        and Reeve LLP</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Botanic
        House</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100
        Hills Road</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cambridge,
        CB2 1PH</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United
        Kingdom</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sales
        &amp; marketing<br/>activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>UK</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Immco
        Diagnostics Inc</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">60
        Pineview Drive</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Buffalo</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NY
        14228, USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacture
        and sale of<br/>autoimmune products<br/>and laboratory services</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S.A.</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Nova
        Century Scientific Inc</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5022
        South Service Road</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Burlington</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ontario</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Canada</span></span></div>
        </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacture
        and sale of<br/>autoimmune products and infectious diseases</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Canada</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:middle;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;text-align:center;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:middle;width:1%">&#160;</td>
    <td style="vertical-align:middle;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trinity
        Biotech Investment Ltd</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">PO
        Box 309</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ugland
        House</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grand
        Cayman</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">KY1-1104</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cayman
        Islands</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investment
        and<br/>provision of financial<br/>services</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cayman
        Islands</span></span></div>
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  </table> </div> </div>

<div>

<div>

<div>

<div style="margin-left:36pt">

<table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:85%">
  <tr>
    <td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name
        and registered office</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;width:1%">&#160;</td>
    <td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal
        activity</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principal
        Country of<br/>incorporation and<br/>operation</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Group
        % holding</span></span></div> </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trib
        Biosensors Inc.</span></span></div>
        <div>
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27700
        S.W. 95<sup style="vertical-align:text-top;line-height:1;font-size:smaller">th</sup> Avenue,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Wilsonville,</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Oregon
        97070, USA</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Manufacturing,
        development, and sale of biosensors</span></span></div> </td>
    <td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)">USA</span><br/><span style="color:rgb(0, 0, 0)">&#160;</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;color:rgb(0, 0, 0);width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Konamite
        Limited</span></span></div>
        <div style="margin-top:0pt;margin-bottom:0pt">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">County
        Wicklow, Ireland</span></span></div> </div>  </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sales
        &amp; marketing<br/>activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)">Ireland</span><br/><span style="color:rgb(0, 0, 0)">&#160;</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:top;width:30%">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td rowspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:1%">&#160;</td>
    <td rowspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td rowspan="1" style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Trinity
        Biotech Joint Venture Limited</span></span></div>
        <div style="margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">IDA
        Business Park, Bray</span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">County
        Wicklow, Ireland</span></span></div> </div>  </div> </div> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Holding
        Company</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)">Ireland</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">100%</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">EpiCapture
        Limited</span></div>
        <div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)">19
        Mather Road, Mount Merrion, Dublin, Ireland</div> </div> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Research
        and development</span></p> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">Ireland</span></p>
        </td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">100%</span></p>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Metabolomics
        Diagnostics Limited</span></div>
        <div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)">Hoffman
        Park, Inchera, Little Island, Co. Cork, Ireland</div> </div> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Research
        and development</span></p> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">Ireland</span></p>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">100%</span></p>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">&#160;</td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">&#160;</td>
    <td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:30%">
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Waveform
        Technologies Inc.</span></div>
        <div>
        <div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)">Obrtna
        cesta 18, 8310 Sentjernej, Slovenia</div> </div> </td>
    <td colspan="1" style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Manufacturing,
        development, and sale of biosensors</span></p> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
    <td style="vertical-align:top;white-space:nowrap;width:23%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)">Slovenia</span></p>
        </td>
    <td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%">&#160;</td>
    <td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">100%</span></p>
        </td> </tr>
  </table> </div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of subsidiaries. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B4<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B4_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfGroupUndertakingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfGroupUndertakingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 14, 2025</div></th>
<th class="th"><div>Dec. 23, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2025</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 27, 2025</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Disclosure of intangible assets with indefinite useful life [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss for the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (31,789)<span></span>
</td>
<td class="num">$ (24,018)<span></span>
</td>
<td class="num">$ (41,009)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Cash outflows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
<td class="num">(2,843)<span></span>
</td>
<td class="num">(19,220)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsLiabilities', window );">Net current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AccumulatedDeficitInEquityAttributableToEquityHolders', window );">Accumulated deficit in equity attributable to equity holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,787)<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="nump">343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsUnderDevelopment', window );">Development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,181)<span></span>
</td>
<td class="num">$ (23,949)<span></span>
</td>
<td class="num">$ (2,176)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (319)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_ContinuousGlucoseMonitoringTechnologyMember', window );">Continuous Glucose Monitoring Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Disclosure of intangible assets with indefinite useful life [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalReserve', window );">Capital reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=trib_EventsAfterReportingPeriodMember', window );">Events After Reporting Period [Member] | Fourth Amendment To Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Disclosure of intangible assets with indefinite useful life [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Face amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=trib_EventsAfterReportingPeriodMember', window );">Events After Reporting Period [Member] | Fifth Amendment To Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Disclosure of intangible assets with indefinite useful life [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Face amount of loan</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumLiquidityCovenant', window );">Minimum Liquidity Covenant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RevertsMinimumLiquidityCovenant', window );">Reverts Minimum Liquidity Covenant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Loan, interest rate basis</a></td>
<td class="text">interest
payments for the months of April, May, and June 2025 would be paid-in-kind<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Loan maturity</a></td>
<td class="text">January
2026 to July 27, 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CreditAgreementAxis=trib_AmendedCreditAgreementMember', window );">Amended Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Disclosure of intangible assets with indefinite useful life [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Face amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Loan, interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">interest
payments payable in 2024 and 2025 would be paid-in-kind<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember', window );">Capitalised development costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Disclosure of intangible assets with indefinite useful life [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives of intangible assets (In years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15&#160;years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsUnderDevelopment', window );">Development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maturity of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CapitalReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the capital reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CapitalReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets less the amount of current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of useful life used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2024-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsUnderDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets representing such assets under development. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 119<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_119_g&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsUnderDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AccumulatedDeficitInEquityAttributableToEquityHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>accumulated deficit in equity attributable to equity holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AccumulatedDeficitInEquityAttributableToEquityHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_MinimumLiquidityCovenant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of minimum liquidity covenant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_MinimumLiquidityCovenant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_RevertsMinimumLiquidityCovenant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of reverts minimum liquidity covenant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_RevertsMinimumLiquidityCovenant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_ContinuousGlucoseMonitoringTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=trib_ContinuousGlucoseMonitoringTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=trib_EventsAfterReportingPeriodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=trib_EventsAfterReportingPeriodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=trib_FourthAmendmentToCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=trib_FourthAmendmentToCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=trib_FifthAmendmentToCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=trib_FifthAmendmentToCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CreditAgreementAxis=trib_AmendedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CreditAgreementAxis=trib_AmendedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Schedule of owned assets) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives of intangible assets (In years)</a></td>
<td class="text">5-15&#160;years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives of intangible assets (In years)</a></td>
<td class="text">50
        years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Office equipment and fittings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives of intangible assets (In years)</a></td>
<td class="text">10
        years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives of intangible assets (In years)</a></td>
<td class="text">3-5
        years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=trib_PropertyAndEquipmentMember', window );">Plant and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives of intangible assets (In years)</a></td>
<td class="text">5-15
        years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of useful life used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=trib_PropertyAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=trib_PropertyAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Schedule of amortisation) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember', window );">Capitalised development costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Disclosure of intangible assets with indefinite useful life [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives of intangible assets (In years)</a></td>
<td class="text">15&#160;years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember', window );">Patents and licences [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Disclosure of intangible assets with indefinite useful life [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives of intangible assets (In years)</a></td>
<td class="text">6-15&#160;years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other (including acquired customer and supplier lists) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Disclosure of intangible assets with indefinite useful life [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment', window );">Estimated useful lives of intangible assets (In years)</a></td>
<td class="text">6-15
        years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of useful life used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CapitalisedDevelopmentCost', window );">Capitalised development costs</a></td>
<td class="nump">$ 8.6<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CapitalisedDevelopmentCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of capitalized development cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CapitalisedDevelopmentCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Schedule of Revenue by Geographical Area Based on Location of Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from external customers</a></td>
<td class="nump">$ 61,555<span></span>
</td>
<td class="nump">$ 56,832<span></span>
</td>
<td class="nump">$ 62,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Inter-segment revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">61,555<span></span>
</td>
<td class="nump">56,832<span></span>
</td>
<td class="nump">62,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">Americas [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from external customers</a></td>
<td class="nump">41,792<span></span>
</td>
<td class="nump">44,984<span></span>
</td>
<td class="nump">50,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Inter-segment revenue</a></td>
<td class="nump">19,815<span></span>
</td>
<td class="nump">21,867<span></span>
</td>
<td class="nump">26,110<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">61,607<span></span>
</td>
<td class="nump">66,851<span></span>
</td>
<td class="nump">76,618<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from external customers</a></td>
<td class="nump">19,763<span></span>
</td>
<td class="nump">11,848<span></span>
</td>
<td class="nump">12,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Inter-segment revenue</a></td>
<td class="nump">702<span></span>
</td>
<td class="nump">872<span></span>
</td>
<td class="nump">828<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">20,465<span></span>
</td>
<td class="nump">12,720<span></span>
</td>
<td class="nump">12,841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=ifrs-full_EliminationOfIntersegmentAmountsMember', window );">Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from external customers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Inter-segment revenue</a></td>
<td class="num">(20,517)<span></span>
</td>
<td class="num">(22,739)<span></span>
</td>
<td class="num">(26,938)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="num">$ (20,517)<span></span>
</td>
<td class="num">$ (22,739)<span></span>
</td>
<td class="num">$ (26,938)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=ifrs-full_EliminationOfIntersegmentAmountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=ifrs-full_EliminationOfIntersegmentAmountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Schedule of Revenue by Customers Geographical Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from external customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 61,555<span></span>
</td>
<td class="nump">$ 56,832<span></span>
</td>
<td class="nump">$ 62,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember', window );">Americas [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from external customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">29,917<span></span>
</td>
<td class="nump">32,282<span></span>
</td>
<td class="nump">35,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_AsiaOrAfricaMember', window );">Asia / Africa [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from external customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,775<span></span>
</td>
<td class="nump">18,909<span></span>
</td>
<td class="nump">20,401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_EuropeIncludingIrelandMember', window );">Europe (including Ireland) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from external customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 6,863<span></span>
</td>
<td class="nump">$ 5,641<span></span>
</td>
<td class="nump">$ 6,563<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Revenue from customers in Ireland is not disclosed separately due to the immateriality of these revenues.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AsiaOrAfricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AsiaOrAfricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_EuropeIncludingIrelandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_EuropeIncludingIrelandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Schedule of Revenue by Major Product Group) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Disclosure of products and services [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">$ 61,555<span></span>
</td>
<td class="nump">$ 56,832<span></span>
</td>
<td class="nump">$ 62,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=trib_ClinicalLaboratoryMember', window );">Clinical Laboratory Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Disclosure of products and services [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">39,372<span></span>
</td>
<td class="nump">42,288<span></span>
</td>
<td class="nump">46,036<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=trib_LaboratoryServicesMember', window );">Clinical laboratory services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Disclosure of products and services [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">4,750<span></span>
</td>
<td class="nump">5,453<span></span>
</td>
<td class="nump">7,272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProductsAndServicesAxis=trib_PointOfCareMember', window );">Point-of-Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Disclosure of products and services [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">$ 17,433<span></span>
</td>
<td class="nump">$ 9,091<span></span>
</td>
<td class="nump">$ 9,213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProductsAndServicesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProductsAndServicesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=trib_ClinicalLaboratoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=trib_ClinicalLaboratoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=trib_LaboratoryServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=trib_LaboratoryServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=trib_PointOfCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=trib_PointOfCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Schedule of Amount Relating From Revenue) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers (a)</a></td>
<td class="nump">$ 61,555<span></span>
</td>
<td class="nump">$ 56,832<span></span>
</td>
<td class="nump">$ 62,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenue</a></td>
<td class="nump">$ 61,555<span></span>
</td>
<td class="nump">$ 56,832<span></span>
</td>
<td class="nump">$ 62,521<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Schedule of Revenue Derives From Transfer of Goods and Services) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomersAbstract', window );"><strong>Timing of revenue recognition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentReceivablesFromContractsWithCustomers', window );">At a point in time</a></td>
<td class="nump">$ 61,299<span></span>
</td>
<td class="nump">$ 56,540<span></span>
</td>
<td class="nump">$ 62,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers', window );">Over time</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Total</a></td>
<td class="nump">61,555<span></span>
</td>
<td class="nump">56,832<span></span>
</td>
<td class="nump">62,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember', window );">America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomersAbstract', window );"><strong>Timing of revenue recognition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentReceivablesFromContractsWithCustomers', window );">At a point in time</a></td>
<td class="nump">41,536<span></span>
</td>
<td class="nump">44,692<span></span>
</td>
<td class="nump">50,174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers', window );">Over time</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Total</a></td>
<td class="nump">41,792<span></span>
</td>
<td class="nump">44,984<span></span>
</td>
<td class="nump">50,508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomersAbstract', window );"><strong>Timing of revenue recognition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentReceivablesFromContractsWithCustomers', window );">At a point in time</a></td>
<td class="nump">19,763<span></span>
</td>
<td class="nump">11,848<span></span>
</td>
<td class="nump">12,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers', window );">Over time</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Total</a></td>
<td class="nump">19,763<span></span>
</td>
<td class="nump">11,848<span></span>
</td>
<td class="nump">12,013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=trib_CustomerMember', window );">Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomersAbstract', window );"><strong>Timing of revenue recognition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentReceivablesFromContractsWithCustomers', window );">At a point in time</a></td>
<td class="nump">61,299<span></span>
</td>
<td class="nump">56,540<span></span>
</td>
<td class="nump">62,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers', window );">Over time</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Total</a></td>
<td class="nump">61,555<span></span>
</td>
<td class="nump">56,832<span></span>
</td>
<td class="nump">62,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=trib_CustomerMember', window );">Customer [Member] | America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomersAbstract', window );"><strong>Timing of revenue recognition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentReceivablesFromContractsWithCustomers', window );">At a point in time</a></td>
<td class="nump">29,661<span></span>
</td>
<td class="nump">31,990<span></span>
</td>
<td class="nump">35,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers', window );">Over time</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Total</a></td>
<td class="nump">29,917<span></span>
</td>
<td class="nump">32,282<span></span>
</td>
<td class="nump">35,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=trib_CustomerMember', window );">Customer [Member] | Asia Or Africa Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomersAbstract', window );"><strong>Timing of revenue recognition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentReceivablesFromContractsWithCustomers', window );">At a point in time</a></td>
<td class="nump">24,775<span></span>
</td>
<td class="nump">18,909<span></span>
</td>
<td class="nump">20,401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers', window );">Over time</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Total</a></td>
<td class="nump">24,775<span></span>
</td>
<td class="nump">18,909<span></span>
</td>
<td class="nump">20,401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=trib_CustomerMember', window );">Customer [Member] | Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomersAbstract', window );"><strong>Timing of revenue recognition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentReceivablesFromContractsWithCustomers', window );">At a point in time</a></td>
<td class="nump">6,863<span></span>
</td>
<td class="nump">5,641<span></span>
</td>
<td class="nump">6,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers', window );">Over time</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomers', window );">Total</a></td>
<td class="nump">$ 6,863<span></span>
</td>
<td class="nump">$ 5,641<span></span>
</td>
<td class="nump">$ 6,563<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentReceivablesFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current receivables from contracts with customers. [Refer: Receivables from contracts with customers]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 105<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentReceivablesFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentReceivablesFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current receivables from contracts with customers. [Refer: Receivables from contracts with customers]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 105<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentReceivablesFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReceivablesFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an entity&#8217;s right to consideration in exchange for goods or services that the entity has transferred to a customer that is unconditional. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 105<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 116<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_116_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReceivablesFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReceivablesFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReceivablesFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=trib_CustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=trib_CustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AsiaOrAfricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AsiaOrAfricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Schedule of Segment Results by Geographical Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ResultBeforeExceptionalExpenses', window );">Result before impairment and unallocated expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (12,204)<span></span>
</td>
<td class="num">$ (12,355)<span></span>
</td>
<td class="num">$ (11,037)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Restructuring cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment charges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,408)<span></span>
</td>
<td class="num">(11,105)<span></span>
</td>
<td class="num">(5,839)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ResultAfterExceptionalExpenses', window );">Result after impairment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(17,793)<span></span>
</td>
<td class="num">(23,460)<span></span>
</td>
<td class="num">(16,876)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnallocatedExpenses', window );">Unallocated expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(3,372)<span></span>
</td>
<td class="num">(3,585)<span></span>
</td>
<td class="num">(2,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(21,165)<span></span>
</td>
<td class="num">(27,045)<span></span>
</td>
<td class="num">(19,349)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancingIncomeBySegment', window );">Net financing expense (Note 6)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9,565)<span></span>
</td>
<td class="num">(9,882)<span></span>
</td>
<td class="num">(24,431)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Profit/Loss before taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(30,730)<span></span>
</td>
<td class="num">(36,927)<span></span>
</td>
<td class="num">(43,780)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefund', window );">Income tax credit (Note 7)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">486<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromContinuingOperations', window );">Profit/Loss for the year on continuing operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(31,216)<span></span>
</td>
<td class="num">(36,868)<span></span>
</td>
<td class="num">(43,586)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Profit/loss for the year on discontinued operations (Note 8)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(573)<span></span>
</td>
<td class="nump">12,850<span></span>
</td>
<td class="nump">2,577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss for the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(31,789)<span></span>
</td>
<td class="num">(24,018)<span></span>
</td>
<td class="num">(41,009)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember', window );">America [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ResultBeforeExceptionalExpenses', window );">Result before impairment and unallocated expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,503)<span></span>
</td>
<td class="num">(4,365)<span></span>
</td>
<td class="num">(5,892)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Restructuring cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,025)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment charges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(612)<span></span>
</td>
<td class="num">(11,105)<span></span>
</td>
<td class="num">(2,331)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ResultAfterExceptionalExpenses', window );">Result after impairment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,140)<span></span>
</td>
<td class="num">(15,470)<span></span>
</td>
<td class="num">(8,223)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Profit/Loss before taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(13,119)<span></span>
</td>
<td class="num">(23,901)<span></span>
</td>
<td class="num">(21,393)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ResultBeforeExceptionalExpenses', window );">Result before impairment and unallocated expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9,386)<span></span>
</td>
<td class="num">(7,886)<span></span>
</td>
<td class="num">(5,112)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Restructuring cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,156)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment charges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(796)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,508)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ResultAfterExceptionalExpenses', window );">Result after impairment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12,338)<span></span>
</td>
<td class="num">(7,886)<span></span>
</td>
<td class="num">(8,620)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Profit/Loss before taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(17,296)<span></span>
</td>
<td class="num">(12,922)<span></span>
</td>
<td class="num">(22,354)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_OtherCountriesMember', window );">Other Countries [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ResultBeforeExceptionalExpenses', window );">Result before impairment and unallocated expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(315)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment charges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ResultAfterExceptionalExpenses', window );">Result after impairment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (315)<span></span>
</td>
<td class="num">$ (104)<span></span>
</td>
<td class="num">$ (33)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Unallocated expenses represent head office general and administration costs of the Group, which cannot be allocated to the results of any specific geographical area.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseOfRestructuringActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 98<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_98_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseOfRestructuringActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 130<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_130_d_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 130<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_130_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefund">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefund</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_vi&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2024-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FinancingIncomeBySegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of financing income by operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FinancingIncomeBySegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ResultAfterExceptionalExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of after exceptional expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ResultAfterExceptionalExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ResultBeforeExceptionalExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of before exceptional expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ResultBeforeExceptionalExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_UnallocatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unallocated expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_UnallocatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Schedule of Segment Assets and Segment Liabilities by Geographical Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AssetsAndLiabilitiesBySegmentAbstract', window );"><strong>Assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SegmentAssets', window );">Segment assets</a></td>
<td class="nump">$ 94,052<span></span>
</td>
<td class="nump">$ 52,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnallocatedAssetsBySegmentAbstract', window );"><strong>Unallocated assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncomeTaxAssetsCurrentAndDeferred', window );">Income tax assets (current and deferred)</a></td>
<td class="nump">4,071<span></span>
</td>
<td class="nump">3,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CashAndCashEquivalentsAndShortTermInvestments', window );">Cash and cash equivalents and short-term investments</a></td>
<td class="nump">5,167<span></span>
</td>
<td class="nump">3,691<span></span>
</td>
<td class="nump">$ 6,578<span></span>
</td>
<td class="nump">$ 25,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total assets as reported in the Group balance sheet</a></td>
<td class="nump">103,290<span></span>
</td>
<td class="nump">59,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SegmentLiabilities', window );">Segment liabilities</a></td>
<td class="nump">133,546<span></span>
</td>
<td class="nump">80,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnallocatedLiabilitiesBySegmentAbstract', window );"><strong>Unallocated liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncomeTaxLiabilitiesCurrentAndDeferred', window );">Income tax liabilities (current and deferred)</a></td>
<td class="nump">4,925<span></span>
</td>
<td class="nump">2,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Total liabilities as reported in the Group balance sheet</a></td>
<td class="nump">138,471<span></span>
</td>
<td class="nump">83,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember', window );">America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AssetsAndLiabilitiesBySegmentAbstract', window );"><strong>Assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SegmentAssets', window );">Segment assets</a></td>
<td class="nump">32,798<span></span>
</td>
<td class="nump">26,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnallocatedAssetsBySegmentAbstract', window );"><strong>Unallocated assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SegmentLiabilities', window );">Segment liabilities</a></td>
<td class="nump">84,863<span></span>
</td>
<td class="nump">49,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AssetsAndLiabilitiesBySegmentAbstract', window );"><strong>Assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SegmentAssets', window );">Segment assets</a></td>
<td class="nump">61,254<span></span>
</td>
<td class="nump">26,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnallocatedAssetsBySegmentAbstract', window );"><strong>Unallocated assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SegmentLiabilities', window );">Segment liabilities</a></td>
<td class="nump">48,621<span></span>
</td>
<td class="nump">31,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_OtherCountriesMember', window );">Other Countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AssetsAndLiabilitiesBySegmentAbstract', window );"><strong>Assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SegmentAssets', window );">Segment assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnallocatedAssetsBySegmentAbstract', window );"><strong>Unallocated assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SegmentLiabilities', window );">Segment liabilities</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AssetsAndLiabilitiesBySegmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AssetsAndLiabilitiesBySegmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CashAndCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, cash equivalents, and short term investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CashAndCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IncomeTaxAssetsCurrentAndDeferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax assets current and deferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IncomeTaxAssetsCurrentAndDeferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IncomeTaxLiabilitiesCurrentAndDeferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax liabilities current and deferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IncomeTaxLiabilitiesCurrentAndDeferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_SegmentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of segment assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_SegmentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_SegmentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of segment liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_SegmentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_UnallocatedAssetsBySegmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_UnallocatedAssetsBySegmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_UnallocatedLiabilitiesBySegmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_UnallocatedLiabilitiesBySegmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Schedule of Long Lived Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LongLivedAsstesBySegment', window );">Long lived asstes</a></td>
<td class="nump">$ 58,447<span></span>
</td>
<td class="nump">$ 18,241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LongLivedAsstesBySegment', window );">Long lived asstes</a></td>
<td class="nump">43,504<span></span>
</td>
<td class="nump">12,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember', window );">America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LongLivedAsstesBySegment', window );">Long lived asstes</a></td>
<td class="nump">$ 14,943<span></span>
</td>
<td class="nump">$ 5,793<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LongLivedAsstesBySegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LongLivedAsstesBySegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Schedule of Depreciation and Amortisation by Geographical Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="nump">$ 675<span></span>
</td>
<td class="nump">$ 830<span></span>
</td>
<td class="nump">$ 1,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortisation</a></td>
<td class="nump">1,190<span></span>
</td>
<td class="nump">945<span></span>
</td>
<td class="nump">889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortisation</a></td>
<td class="nump">770<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember', window );">America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="nump">515<span></span>
</td>
<td class="nump">668<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortisation</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 487<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Schedule of Share Based Payment Expense by Geographical Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Total Share-based payments</a></td>
<td class="nump">$ 1,316<span></span>
</td>
<td class="nump">$ 2,069<span></span>
</td>
<td class="nump">$ 1,755<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Total Share-based payments</a></td>
<td class="nump">843<span></span>
</td>
<td class="nump">1,650<span></span>
</td>
<td class="nump">632<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember', window );">America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Total Share-based payments</a></td>
<td class="nump">$ 473<span></span>
</td>
<td class="nump">$ 419<span></span>
</td>
<td class="nump">$ 1,123<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Schedule of Taxation Expense by Geographical Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncomeTaxExpense', window );">Taxation expense</a></td>
<td class="num">$ (486)<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncomeTaxExpense', window );">Taxation expense</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(385)<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_OtherCountriesMember', window );">Other Countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncomeTaxExpense', window );">Taxation expense</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(235)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember', window );">America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncomeTaxExpense', window );">Taxation expense</a></td>
<td class="num">$ (490)<span></span>
</td>
<td class="nump">$ 679<span></span>
</td>
<td class="num">$ (88)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Schedule of Capital Expenditure by Geographical Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForDevelopmentProjectExpenditure', window );">Capital expenditure</a></td>
<td class="nump">$ 40,682<span></span>
</td>
<td class="nump">$ 2,798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForDevelopmentProjectExpenditure', window );">Capital expenditure</a></td>
<td class="nump">37,929<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember', window );">America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForDevelopmentProjectExpenditure', window );">Capital expenditure</a></td>
<td class="nump">$ 2,753<span></span>
</td>
<td class="nump">$ 2,547<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForDevelopmentProjectExpenditure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for expenditure related to development projects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForDevelopmentProjectExpenditure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYMENT (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Employee</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Employee</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Employee</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract', window );"><strong>Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations', window );">Average number of employees, including discontinued operations | Employee</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsExpense', window );">Total personnel expenses, inclusive of amounts capitalised for wages and salaries, social welfare costs and pension costs</a></td>
<td class="nump">$ 33,584<span></span>
</td>
<td class="nump">$ 29,975<span></span>
</td>
<td class="nump">$ 27,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised', window );">Total share based payments, inclusive of amounts capitalised</a></td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">2,069<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans', window );">Employees contribution</a></td>
<td class="nump">451<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ActuarialAssumptionOfExpectedPensionIncreases', window );">Pension accrual</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of post-employment benefit expense relating to defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ActuarialAssumptionOfExpectedPensionIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of pension accrual.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ActuarialAssumptionOfExpectedPensionIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the average number of employees, including discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions inclusive of amounts capitalised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYMENT (Schedule of Average Number of Persons Employed) (Details) - Employee<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageNumberOfEmployees', window );">Average number of employees</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">380<span></span>
</td>
<td class="nump">384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=trib_ResearchAndDevelopmentMember', window );">Research and development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageNumberOfEmployees', window );">Average number of employees</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=trib_AdministrationAndSalesMember', window );">Administration and sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageNumberOfEmployees', window );">Average number of employees</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=trib_ManufacturingAndQualityMember', window );">Manufacturing and quality [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageNumberOfEmployees', window );">Average number of employees</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of personnel employed by the entity during a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=trib_ResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=trib_ResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=trib_AdministrationAndSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=trib_AdministrationAndSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=trib_ManufacturingAndQualityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=trib_ManufacturingAndQualityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYMENT (Schedule of Employment Costs) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure of analysis of single amount of discontinued operations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Wages and salaries</a></td>
<td class="nump">$ 25,570<span></span>
</td>
<td class="nump">$ 23,718<span></span>
</td>
<td class="nump">$ 22,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SocialSecurityContributions', window );">Social welfare costs</a></td>
<td class="nump">2,219<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
<td class="nump">1,965<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans', window );">Pension costs</a></td>
<td class="nump">451<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based payments</a></td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">2,069<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExpenseOfRestructuringCost', window );">Restructuring cost</a></td>
<td class="nump">596<span></span>
</td>
<td class="nump">485<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EmployeeBenefitsExpense', window );">Employment Costs</a></td>
<td class="nump">30,152<span></span>
</td>
<td class="nump">28,841<span></span>
</td>
<td class="nump">26,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure of analysis of single amount of discontinued operations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WagesAndSalaries', window );">Wages and salaries</a></td>
<td class="nump">25,570<span></span>
</td>
<td class="nump">24,343<span></span>
</td>
<td class="nump">23,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SocialSecurityContributions', window );">Social welfare costs</a></td>
<td class="nump">2,219<span></span>
</td>
<td class="nump">2,097<span></span>
</td>
<td class="nump">2,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans', window );">Pension costs</a></td>
<td class="nump">451<span></span>
</td>
<td class="nump">510<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based payments</a></td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">2,069<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExpenseOfRestructuringCost', window );">Restructuring cost</a></td>
<td class="nump">596<span></span>
</td>
<td class="nump">485<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EmployeeBenefitsExpense', window );">Employment Costs</a></td>
<td class="nump">$ 30,152<span></span>
</td>
<td class="nump">$ 29,504<span></span>
</td>
<td class="nump">$ 28,025<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 104<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [domain]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 5<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_5&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SocialSecurityContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents social security contributions. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 9<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SocialSecurityContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WagesAndSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 9<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WagesAndSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ExpenseOfRestructuringCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ExpenseOfRestructuringCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER OPERATING (EXPENSE) / INCOME (Narrative) (Details) - Paycheck Protection Program Loan [Member]<br></strong></div></th>
<th class="th">
<div>Oct. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OtherOperatingIncomeLineItems', window );"><strong>Other Operating Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LoansPayableInDefault', window );">Loans payable in default</a></td>
<td class="nump">$ 1,827,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LoanIncome', window );">Loan Income</a></td>
<td class="nump">2,165,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPayable', window );">Interest payable</a></td>
<td class="nump">$ 338,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest recognised as a liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LoansPayableInDefault">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loans payable in default.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LoansPayableInDefault</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LoanIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of orginal loan income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LoanIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_OtherOperatingIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line item for Other Operating Income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_OtherOperatingIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=trib_PaycheckProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=trib_PaycheckProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER OPERATING (EXPENSE) / INCOME (Schedule of Other Operating Income) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfOtherOperatingIncomeAbstract', window );"><strong>Disclosure of other operating income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 138<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RentalIncomeFromPremises', window );">Rental income from premises</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_GovernmentSupportsCovid19', window );">Government supports</a></td>
<td class="num">(1,827)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Government grants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other operating income</a></td>
<td class="num">$ (1,787)<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">$ 343<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income recognised in relation to government grants. [Refer: Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2024-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfOtherOperatingIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfOtherOperatingIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_GovernmentSupportsCovid19">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government supports - COVID-19.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_GovernmentSupportsCovid19</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_RentalIncomeFromPremises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of rental income from premises.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_RentalIncomeFromPremises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RestructuringActivitiesExpense', window );">Restructuring cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LegalProceedingsProvision', window );">Provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">735<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdditionalRestructuringCosts', window );">Additional restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NonRadingCosts', window );">Non-trading costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis=trib_AmericanDepositarySharesMember', window );">American Depositary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of ADSs issued</a></td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueOfSharesIssued', window );">Fair value of ADSs issued</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember', window );">Site Transfer Costs Related To The Impairment Of Plant &amp; Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RestructuringActivitiesExpense', window );">Restructuring cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LegalProceedingsProvision', window );">Provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdditionalRestructuringCosts', window );">Additional restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LegalProceedingsProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provision for legal proceedings. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Section Example 10 A court case<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS37_IE_C_ex10_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 87<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_87&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LegalProceedingsProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AdditionalRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to additional restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AdditionalRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FairValueOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amount of fair value of shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FairValueOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NonRadingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-trading costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NonRadingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_RestructuringActivitiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Activities Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_RestructuringActivitiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis=trib_AmericanDepositarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis=trib_AmericanDepositarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Schedule of Statement of Operation) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract', window );"><strong>Disclosure of impairment charges and inventory provisioning [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment of PP&amp;E (Note 11)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 612<span></span>
</td>
<td class="nump">$ 3,772<span></span>
</td>
<td class="nump">$ 733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment of goodwill and other intangible assets (Note 12)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,596<span></span>
</td>
<td class="nump">5,833<span></span>
</td>
<td class="nump">4,624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ImpairmentOfPrepayments', window );">Impairment of prepayments (Note 17)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossOnFinancialAssets', window );">Impairment of financial assets (Note 13)</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables', window );">Total impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,408<span></span>
</td>
<td class="nump">$ 11,105<span></span>
</td>
<td class="nump">$ 5,839<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossOnFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_20_e&amp;doctype=Standard&amp;book=b<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossOnFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets and goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e_v&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for trade receivables. [Refer: Impairment loss recognised in profit or loss; Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ImpairmentOfPrepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment of prepayments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ImpairmentOfPrepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Schedule of restructuring costs incurred during the year) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Total restructuring costs</a></td>
<td class="nump">$ 4,181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_PersonnelRelatedCostsMember', window );">Personnel related costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Total restructuring costs</a></td>
<td class="nump">1,216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_OutsourcingCostsMember', window );">Outsourcing costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Total restructuring costs</a></td>
<td class="nump">754<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_SiteTransferCostsMember', window );">Site transfer costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Total restructuring costs</a></td>
<td class="nump">1,281<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_InventoryRelatedCostsMember', window );">Inventory related costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Total restructuring costs</a></td>
<td class="nump">772<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_OtherRestructuringCostsMember', window );">Other restructuring costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure of attribution of expenses by nature to their function [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Total restructuring costs</a></td>
<td class="nump">$ 158<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseOfRestructuringActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 98<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_98_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseOfRestructuringActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_PersonnelRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_PersonnelRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_OutsourcingCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_OutsourcingCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_SiteTransferCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_SiteTransferCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_InventoryRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_InventoryRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_OtherRestructuringCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_OtherRestructuringCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INCOME AND EXPENSES (Schedule of Financial Income (Expenses), Net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancingIncomeAbstract', window );"><strong>Financial income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestIncomeOnOtherFinancialAssets', window );">Non-cash financial income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,171<span></span>
</td>
<td class="nump">$ 303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancingExpensesAbstract', window );"><strong>Financial expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest on leases</a></td>
<td class="num">(592)<span></span>
</td>
<td class="num">(624)<span></span>
</td>
<td class="num">(647)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LossOnDisposalOfExchangeableNotes', window );">Loss on disposal of exchangeable notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,678)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PenaltyForEarlySettlementOfTermLoan', window );">Penalty for early partial settlement of senior secured term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(905)<span></span>
</td>
<td class="num">(3,450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CashInterestPayableOnSeniorSecureTermLoan', window );">Cash interest payable on senior secured term loan</a></td>
<td class="num">(6,293)<span></span>
</td>
<td class="num">(7,289)<span></span>
</td>
<td class="num">(7,039)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestPaidOnConvertibleNote', window );">Cash interest payable on convertible note</a></td>
<td class="num">(300)<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="num">(199)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnDebtInstrumentsIssued', window );">Cash interest on exchangeable notes</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(296)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CashInterestPayableOnPppLoans', window );">Cash interest payable on PPP loans</a></td>
<td class="num">(338)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnOtherFinancialLiabilities', window );">Non-cash interest on exchangeable notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NoncashInterestOnSeniorSecuredTermLoan', window );">Non-cash interest on senior secured term loan</a></td>
<td class="num">(2,355)<span></span>
</td>
<td class="num">(1,131)<span></span>
</td>
<td class="num">(2,772)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NoncashInterestOnConvertibleNote', window );">Non-cash interest on convertible note</a></td>
<td class="num">(859)<span></span>
</td>
<td class="num">(796)<span></span>
</td>
<td class="num">(495)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Non-cash financial expense</a></td>
<td class="num">(1,172)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnwindingOfDiscountOnDeferredContingentConsideration', window );">Unwinding Of Discount On Deferred Contingent Consideration</a></td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingCostsCapitalised', window );">Capitalisation of borrowing costs</a></td>
<td class="nump">2,085<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NoncashLoanModificationGain', window );">Non-cash Loan Modification Gain</a></td>
<td class="nump">3,567<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CapitalisationOfUnpaidInterestOnTermLoan', window );">Capitalisation of unpaid interest on term loan</a></td>
<td class="num">(3,247)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expenses</a></td>
<td class="num">(9,565)<span></span>
</td>
<td class="num">(11,053)<span></span>
</td>
<td class="num">(24,734)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinanceIncomeExpenseNet', window );">Net financing expense</a></td>
<td class="num">$ (9,565)<span></span>
</td>
<td class="num">$ (9,882)<span></span>
</td>
<td class="num">$ (24,431)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingCostsCapitalised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest and other costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 23<br> -IssueDate 2024-01-01<br> -Paragraph 26<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=23&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_26_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingCostsCapitalised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnDebtInstrumentsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on debt instruments issued. [Refer: Interest expense; Debt instruments issued]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnDebtInstrumentsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnOtherFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on other financial liabilities. [Refer: Interest expense; Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnOtherFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestIncomeOnOtherFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income on other financial assets. [Refer: Interest income; Other financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestIncomeOnOtherFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CapitalisationOfUnpaidInterestOnTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of capitalisation of unpaid interest on term loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CapitalisationOfUnpaidInterestOnTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CashInterestPayableOnPppLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of cash interest payable on PPP loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CashInterestPayableOnPppLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CashInterestPayableOnSeniorSecureTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of cash interest payable on senior secure term loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CashInterestPayableOnSeniorSecureTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FinanceIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing expenses, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FinanceIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FinancingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FinancingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FinancingIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FinancingIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_InterestPaidOnConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents interest paid on convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_InterestPaidOnConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LossOnDisposalOfExchangeableNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of loss on disposal of exchangeable notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LossOnDisposalOfExchangeableNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NoncashInterestOnConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of non-cash interest on convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NoncashInterestOnConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NoncashInterestOnSeniorSecuredTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of non-cash interest on senior secured term loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NoncashInterestOnSeniorSecuredTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NoncashLoanModificationGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of non-cash loan modification gain.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NoncashLoanModificationGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PenaltyForEarlySettlementOfTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents penalty for early settlement of term loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PenaltyForEarlySettlementOfTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_UnwindingOfDiscountOnDeferredContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unwinding of discount on deferred contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_UnwindingOfDiscountOnDeferredContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (EXPENSE)/CREDIT (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Total deferred tax (credit)/expense</a></td>
<td class="nump">$ 201,000<span></span>
</td>
<td class="num">$ (323,000)<span></span>
</td>
<td class="nump">$ 86,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Corporation tax rate</a></td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Total deferred tax (credit)/expense</a></td>
<td class="nump">$ 43,000<span></span>
</td>
<td class="nump">$ 174,000<span></span>
</td>
<td class="nump">$ 109,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_OtherCountriesMember', window );">Other Countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Total deferred tax (credit)/expense</a></td>
<td class="nump">$ 244,000<span></span>
</td>
<td class="nump">$ 497,000<span></span>
</td>
<td class="nump">$ 26,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (EXPENSE)/CREDIT (Schedule of Charge for Tax) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract', window );"><strong>Current tax (credit)/ expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Irish Corporation tax</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (336)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CurrentTaxForeignExpenseIncome', window );">Foreign taxes</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">462<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod', window );">Adjustment in respect of prior years</a></td>
<td class="nump">10<span></span>
</td>
<td class="num">(198)<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods', window );">Total current tax expense/(credit)</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="num">(280)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeAbstract', window );"><strong>Deferred tax credit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences', window );">Origination and reversal of temporary differences (see Note 14)</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(547)<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReversalOfNetOperatingLoss', window );">Origination and reversal of net operating losses (see Note 14)</a></td>
<td class="nump">242<span></span>
</td>
<td class="nump">224<span></span>
</td>
<td class="num">(238)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Total deferred tax charge/(credit)</a></td>
<td class="nump">201<span></span>
</td>
<td class="num">(323)<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Total income tax charge/(credit) on continuing operations in statement of operations</a></td>
<td class="nump">486<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="num">(194)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance', window );">Tax charge on discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncomeTaxExpenseBenefits', window );">Total tax charge/(credit)</a></td>
<td class="nump">$ 486<span></span>
</td>
<td class="num">$ (59)<span></span>
</td>
<td class="num">$ (192)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments of tax expense (income) recognised in the period for current tax of prior periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 80<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_80_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current tax expense (income) and adjustments for the current tax of prior periods. [Refer: Current tax expense (income); Adjustments for current tax of prior periods]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 80<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_80&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax expense or income relating to the creation or reversal of temporary differences. [Refer: Temporary differences [member]; Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 80<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_80_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2024-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax expense (income) relating to the gain (loss) on discontinuance when operations are discontinued. [Refer: Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph h<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_h_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CurrentTaxForeignExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Foreign taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CurrentTaxForeignExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IncomeTaxExpenseBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IncomeTaxExpenseBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ReversalOfNetOperatingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Origination and reversal of net operating losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ReversalOfNetOperatingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (EXPENSE)/CREDIT (Schedule of Overseas Tax Jurisdictions) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract', window );"><strong>Effective tax rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before taxation &#8211; continuing operations</a></td>
<td class="num">$ (30,730)<span></span>
</td>
<td class="num">$ (36,927)<span></span>
</td>
<td class="num">$ (43,780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract', window );"><strong>As a percentage of loss before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods', window );">Current tax %</a></td>
<td class="num">(0.93%)<span></span>
</td>
<td class="num">(0.72%)<span></span>
</td>
<td class="num">(0.64%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageEffectiveTaxRate', window );">Total (current and deferred) %</a></td>
<td class="num">(1.58%)<span></span>
</td>
<td class="num">(0.16%)<span></span>
</td>
<td class="num">(0.44%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_TaxRateEffectOfCurrentTaxOfPriorPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_TaxRateEffectOfCurrentTaxOfPriorPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (EXPENSE)/CREDIT (Schedule of Statutory Tax Rate) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfIncomeTaxCreditAbstract', window );"><strong>Disclosure of income tax credit [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Irish corporation tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12.50%)<span></span>
</td>
<td class="num">(12.50%)<span></span>
</td>
<td class="num">(12.50%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxRateEffectOfTaxLosses', window );">Effect of current year net operating losses and temporary differences for which no deferred tax asset was recognised</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">15.89%<span></span>
</td>
<td class="nump">17.19%<span></span>
</td>
<td class="nump">10.97%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxRateEffectOfForeignTaxRates', window );">Effect of tax rates on overseas earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6.63%<span></span>
</td>
<td class="num">(7.82%)<span></span>
</td>
<td class="num">(7.30%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EffectOfIrishIncomeTaxableAtHigherTaxRate', window );">Effect of Irish income taxable at higher tax rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4.09%)<span></span>
</td>
<td class="nump">2.62%<span></span>
</td>
<td class="nump">3.93%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods', window );">Adjustments in respect of prior years</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.04%<span></span>
</td>
<td class="num">(0.53%)<span></span>
</td>
<td class="nump">0.14%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods', window );">R&amp;D tax credits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.75%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome', window );">Other items</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(7.55%)<span></span>
</td>
<td class="nump">0.88%<span></span>
</td>
<td class="nump">5.07%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageEffectiveTaxRate', window );">Effective tax rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1.58%)<span></span>
</td>
<td class="num">(0.16%)<span></span>
</td>
<td class="num">(0.44%)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">No deferred tax asset was recognised because there was no reversing deferred tax liability in the same jurisdiction reversing in the same period and insufficient future projected taxable income in the same jurisdiction.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Other items comprise items not chargeable to tax and expenses not deductible for tax purposes. In 2022, other items mainly related to the loss on disposal of the exchangeable notes which was non-recurring. In 2021 other items mainly related to the US$4.4 million income from the Paycheck Protection Program loans which was not chargeable for tax purposes. There was no Paycheck Protection Program income in 2023 or 2022.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax rate effects, in aggregate, on the reconciliation between the average effective tax rate and the applicable tax rate that the entity does not separately disclose in the reconciliation. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from adjustments for the current tax of prior periods. [Refer: Average effective tax rate; Applicable tax rate; Adjustments for current tax of prior periods]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectOfForeignTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the application of foreign tax rates. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectOfForeignTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectOfTaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from tax losses. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectOfTaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfIncomeTaxCreditAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfIncomeTaxCreditAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_EffectOfIrishIncomeTaxableAtHigherTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effect of Irish income taxable at higher tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_EffectOfIrishIncomeTaxableAtHigherTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>R and D tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (EXPENSE)/CREDIT (Schedule of Loss Profit Before Taxes) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Profit/Loss before taxes</a></td>
<td class="num">$ (30,730)<span></span>
</td>
<td class="num">$ (36,927)<span></span>
</td>
<td class="num">$ (43,780)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Profit/Loss before taxes</a></td>
<td class="num">(17,296)<span></span>
</td>
<td class="num">(12,922)<span></span>
</td>
<td class="num">(22,354)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_OtherRegionsMember', window );">Other regions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Profit/Loss before taxes</a></td>
<td class="num">(315)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember', window );">Americas [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Profit/Loss before taxes</a></td>
<td class="num">$ (13,119)<span></span>
</td>
<td class="num">$ (23,901)<span></span>
</td>
<td class="num">$ (21,393)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_OtherRegionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_OtherRegionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (EXPENSE)/CREDIT (Schedule of Net Operating Losses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnutilisedNetOperatingLosses', window );">Unutilised net operating losses</a></td>
<td class="nump">$ 182,811<span></span>
</td>
<td class="nump">$ 136,202<span></span>
</td>
<td class="nump">$ 75,957<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnutilisedNetOperatingLosses', window );">Unutilised net operating losses</a></td>
<td class="nump">107,093<span></span>
</td>
<td class="nump">69,851<span></span>
</td>
<td class="nump">62,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_OtherRegionsMember', window );">Other regions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnutilisedNetOperatingLosses', window );">Unutilised net operating losses</a></td>
<td class="nump">52,852<span></span>
</td>
<td class="nump">52,511<span></span>
</td>
<td class="nump">448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember', window );">Americas [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnutilisedNetOperatingLosses', window );">Unutilised net operating losses</a></td>
<td class="nump">$ 22,866<span></span>
</td>
<td class="nump">$ 13,840<span></span>
</td>
<td class="nump">$ 12,778<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_UnutilisedNetOperatingLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unutilised net operating losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_UnutilisedNetOperatingLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_OtherRegionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_OtherRegionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (EXPENSE)/CREDIT (Schedule of Unrecognised Deferred Tax Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset', window );">Unrecognised deferred tax asset</a></td>
<td class="nump">$ 35,903<span></span>
</td>
<td class="nump">$ 32,366<span></span>
</td>
<td class="nump">$ 15,434<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset', window );">Unrecognised deferred tax asset</a></td>
<td class="nump">13,275<span></span>
</td>
<td class="nump">8,464<span></span>
</td>
<td class="nump">7,489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_OtherRegionsMember', window );">Other regions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset', window );">Unrecognised deferred tax asset</a></td>
<td class="nump">14,777<span></span>
</td>
<td class="nump">14,701<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember', window );">Americas &#8211; unused tax losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset', window );">Unrecognised deferred tax asset</a></td>
<td class="nump">2,149<span></span>
</td>
<td class="nump">3,395<span></span>
</td>
<td class="nump">3,163<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_US1Member', window );">Americas &#8211; unused tax credits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset', window );">Unrecognised deferred tax asset</a></td>
<td class="nump">$ 5,702<span></span>
</td>
<td class="nump">$ 5,806<span></span>
</td>
<td class="nump">$ 4,658<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a deferred tax liability (asset). [Refer: Deferred tax liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_OtherRegionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_OtherRegionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_AmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_AmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_US1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_US1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Loss for the year from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (573,000)<span></span>
</td>
<td class="nump">$ 12,850,000<span></span>
</td>
<td class="nump">$ 2,577,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestructuringProvision', window );">Provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,594,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance', window );">Tax credit recovered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentProvisions', window );">Provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,454,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_BiosynthMember', window );">Biosynth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CashProceedsFromDiscontinuedOperations', window );">Cash proceeds from discontinued operations</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentProvisions', window );">Provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReceivablesOutstanding', window );">Outstanding receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">423,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DiscontinuedOperationsAxis=trib_FiomiDiagnosticsMember', window );">Fiomi Diagnostics (&#8220;Fiomi&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations', window );">Cash inflow from investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,160,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_SE', window );">Sweden [Member] | Fiomi Diagnostics (&#8220;Fiomi&#8221;) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Loss for the year from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(573,000)<span></span>
</td>
<td class="nump">12,850,000<span></span>
</td>
<td class="nump">$ 2,577,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Consideration paid (received)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 373,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageSharesDiscontinuedOperations', window );">Basic earnings per ordinary share - discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359,193,482<span></span>
</td>
<td class="nump">153,099,405<span></span>
</td>
<td class="nump">134,939,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdjustedWeightedAverageSharesDiscontinuedOperations', window );">Diluted earnings per share denominator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">404,096,277<span></span>
</td>
<td class="nump">178,016,062<span></span>
</td>
<td class="nump">155,498,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity', window );">Basic (loss)/earnings per ordinary share for discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (573,000)<span></span>
</td>
<td class="nump">$ 12,850,000<span></span>
</td>
<td class="nump">$ 2,577,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects', window );">Diluted (loss)/earnings per ordinary share for discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 573,000<span></span>
</td>
<td class="nump">$ 12,850,000<span></span>
</td>
<td class="nump">$ 2,577,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageSharesDiscontinuedOperations', window );">Basic earnings per ordinary share - discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,959,674<span></span>
</td>
<td class="nump">7,654,970<span></span>
</td>
<td class="nump">6,746,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdjustedWeightedAverageSharesDiscontinuedOperations', window );">Diluted earnings per share denominator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,204,814<span></span>
</td>
<td class="nump">8,900,803<span></span>
</td>
<td class="nump">7,774,933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity', window );">Basic (loss)/earnings per ordinary share for discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 573<span></span>
</td>
<td class="nump">$ 12,850<span></span>
</td>
<td class="nump">$ 2,577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects', window );">Diluted (loss)/earnings per ordinary share for discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 573,000<span></span>
</td>
<td class="nump">$ 12,850,000<span></span>
</td>
<td class="nump">$ 2,577,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's investing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) investing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsiderationPaidReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 40<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_40_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsiderationPaidReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss) from discontinued operations]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss) from discontinued operations]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestructuringProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provision for restructuring, such as the sale or termination of a line of business; closure of business locations in a country or region or relocation of activities from one country or region to another; changes in management structure; and fundamental reorganisations that have a material effect on the nature and focus of the entity's operations. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestructuringProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax expense (income) relating to the gain (loss) on discontinuance when operations are discontinued. [Refer: Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph h<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_h_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AdjustedWeightedAverageSharesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AdjustedWeightedAverageSharesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CashProceedsFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash proceeds from discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CashProceedsFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ReceivablesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts represents receivables outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ReceivablesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_WeightedAverageSharesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average shares discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_WeightedAverageSharesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_BiosynthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_BiosynthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DiscontinuedOperationsAxis=trib_FiomiDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DiscontinuedOperationsAxis=trib_FiomiDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_SE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_SE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of operating profit for the discontinued operations) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure Of Analysis Of Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">$ 61,555<span></span>
</td>
<td class="nump">$ 56,832<span></span>
</td>
<td class="nump">$ 62,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Profit from operating activities</a></td>
<td class="num">(21,165)<span></span>
</td>
<td class="num">(27,045)<span></span>
</td>
<td class="num">(19,349)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">(Loss)/Profit for the year from discontinued operations</a></td>
<td class="num">(573)<span></span>
</td>
<td class="nump">12,850<span></span>
</td>
<td class="nump">2,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DiscontinuedOperationsAxis=trib_FiomiDiagnosticsMember', window );">Fiomi Diagnostics (&#8220;Fiomi&#8221;) [Member] | Sweden [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure Of Analysis Of Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,784<span></span>
</td>
<td class="nump">12,258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Operating expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,652)<span></span>
</td>
<td class="num">(9,679)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations', window );">Tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Profit from operating activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">2,577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation', window );">(Loss)/Gain on sale of discontinued operations</a></td>
<td class="num">(573)<span></span>
</td>
<td class="nump">12,718<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">(Loss)/Profit for the year from discontinued operations</a></td>
<td class="num">$ (573)<span></span>
</td>
<td class="nump">$ 12,850<span></span>
</td>
<td class="nump">$ 2,577<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gain (loss) recognised on the measurement to fair value less costs to sell or on the disposal of the assets or disposal group(s) constituting the discontinued operation. [Refer: Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2024-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax expense (income) relating to the profit (loss) arising from ordinary activities of discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_b_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_h_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DiscontinuedOperationsAxis=trib_FiomiDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DiscontinuedOperationsAxis=trib_FiomiDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_SE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_SE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of net cashflows generated from discontinued operations) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure Of Analysis Of Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations', window );">Net cash inflow on date of disposal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 28,160<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DiscontinuedOperationsAxis=trib_FiomiDiagnosticsMember', window );">Fiomi Diagnostics (&#8220;Fiomi&#8221;) [Member] | Sweden [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure Of Analysis Of Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts', window );">Cash received from sale of the discontinued operations net of transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CashSoldAsAPartOfDiscontinuedOperations', window );">Cash sold as a part of discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(775)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations', window );">Net cash inflow on date of disposal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 28,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the disposal of non-current assets or disposal groups classified as held for sale and discontinued operations. [Refer: Discontinued operations [member]; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Cash received from sale of the discontinued operations net of transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CashSoldAsAPartOfDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash sold as a part of discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CashSoldAsAPartOfDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DiscontinuedOperationsAxis=trib_FiomiDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DiscontinuedOperationsAxis=trib_FiomiDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_SE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_SE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of assets and liabilities disposed) (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure Of Analysis Of Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property plant &amp; equipment</a></td>
<td class="nump">$ 4,621<span></span>
</td>
<td class="nump">$ 1,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Goodwill and intangible assets</a></td>
<td class="nump">51,343<span></span>
</td>
<td class="nump">16,270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">19,374<span></span>
</td>
<td class="nump">19,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash</a></td>
<td class="nump">5,167<span></span>
</td>
<td class="nump">3,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade and other receivables</a></td>
<td class="nump">16,065<span></span>
</td>
<td class="nump">13,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="num">(6,833)<span></span>
</td>
<td class="num">(3,885)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Current corporation tax</a></td>
<td class="num">(364)<span></span>
</td>
<td class="num">(279)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(4,561)<span></span>
</td>
<td class="num">(2,300)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_SE', window );">Sweden [Member] | Assets and liabilities classified as held for sale [Member] | Biosynth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure Of Analysis Of Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property plant &amp; equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Goodwill and intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade and other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(864)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(106)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Current corporation tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(195)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners', window );">Total net assets disposed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_SE', window );">Sweden [Member] | Post Disposal Adjustment [Member] | Biosynth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure Of Analysis Of Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property plant &amp; equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Goodwill and intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade and other receivables</a></td>
<td class="num">(423)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Current corporation tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners', window );">Total net assets disposed</a></td>
<td class="num">(573)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_SE', window );">Sweden [Member] | Non-current assets held for sale [Member] | Biosynth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure Of Analysis Of Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property plant &amp; equipment</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Goodwill and intangible assets</a></td>
<td class="nump">14,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash</a></td>
<td class="nump">775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade and other receivables</a></td>
<td class="nump">886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="num">(1,014)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(106)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Current corporation tax</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(195)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners', window );">Total net assets disposed</a></td>
<td class="nump">$ 15,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Non-current assets or disposal groups classified as held for distribution to owners; Non-current assets or disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_j&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_SE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_SE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_BiosynthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_BiosynthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=trib_PostDisposalAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=trib_PostDisposalAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_NoncurrentAssetsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_NoncurrentAssetsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of Earnings Per ADS for Discontinued Operations) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations', window );">Basic (loss)/earnings per &#8216;A&#8217; share (US Dollars) &#8211; discontinued operations</a></td>
<td class="nump">$ (0)<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations', window );">Diluted (loss)/earnings per &#8216;A&#8217; share (US Dollars) &#8211; discontinued operations</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">0.07<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations', window );">Basic (loss)/earnings per &#8216;A&#8217; share (US Dollars) &#8211; discontinued operations</a></td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">1.68<span></span>
</td>
<td class="nump">0.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations', window );">Diluted (loss)/earnings per &#8216;A&#8217; share (US Dollars) &#8211; discontinued operations</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="nump">$ 1.44<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Diluted earnings (loss) per share from discontinued operations. [Refer: Diluted earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of Cash Flows Attributable to Discontinued Operations) (Details) - Fiomi Diagnostics (&#8220;Fiomi&#8221;) [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure Of Analysis Of Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations', window );">Cash (outflow)/inflow from operating activities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (177)<span></span>
</td>
<td class="nump">$ 3,798<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations', window );">Cash inflow from investing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,160<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations', window );">Cash outflow from financing activities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (10,800)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's financing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's investing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) investing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's operating activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) operating activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2024-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DiscontinuedOperationsAxis=trib_FiomiDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DiscontinuedOperationsAxis=trib_FiomiDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS BEFORE TAX (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfLossProfitBeforeTaxAbstract', window );"><strong>Disclosure of loss profit before tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation on capitalised Intangible projects</a></td>
<td class="nump">$ 204<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeprecationForDiscontinuedOperations', window );">Deprecation for discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AmortisationForDiscontinuedOperations', window );">Amortisation for discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 104<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AmortisationForDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amortizations for discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AmortisationForDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DeprecationForDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the deprecation for discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DeprecationForDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfLossProfitBeforeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfLossProfitBeforeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>LOSS BEFORE TAX (Schedule of Amount Charged to Statement of Operation) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract', window );"><strong>Directors' emoluments (including non- executive directors):</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DirectorsRemunerationExpense', window );">Remuneration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,454<span></span>
</td>
<td class="nump">$ 2,058<span></span>
</td>
<td class="nump">$ 1,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DirectorPensionExpense', window );">Pension</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">39<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ShareBasedPayments', window );">Share based payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">931<span></span>
</td>
<td class="nump">1,601<span></span>
</td>
<td class="nump">1,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemunerationAbstract', window );"><strong>Auditor's remuneration</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AuditorsRemunerationForTaxServices', window );">Audit fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,082<span></span>
</td>
<td class="nump">861<span></span>
</td>
<td class="nump">888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TaxFees', window );">Tax fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">175<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DepreciationOnIntangibleAssets', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">675<span></span>
</td>
<td class="nump">830<span></span>
</td>
<td class="nump">1,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AmortisationOnIntangibleAssets', window );">Amortisation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,190<span></span>
</td>
<td class="nump">945<span></span>
</td>
<td class="nump">889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment', window );">Loss on the disposal of property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NetForeignExchangeGainLoss', window );">Net foreign exchange differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 376<span></span>
</td>
<td class="nump">$ 336<span></span>
</td>
<td class="num">$ (1,210)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">In 2024, US$204,000 was capitalised to research and development projects (2023: US$Nil) (2022: US$Nil).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AuditorsRemunerationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AuditorsRemunerationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AuditorsRemunerationForTaxServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable to the entity's auditors for tax services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AuditorsRemunerationForTaxServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DirectorsRemunerationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of remuneration paid or payable to the entity's directors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DirectorsRemunerationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The losses on the disposal of property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 98<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_98_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AmortisationOnIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortisation on intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AmortisationOnIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DepreciationOnIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation on intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DepreciationOnIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DirectorPensionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of director pension expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DirectorPensionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NetForeignExchangeGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net foreign exchange gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NetForeignExchangeGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ShareBasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ShareBasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_TaxFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_TaxFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE  (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss for the year</a></td>
<td class="num">$ (31,789)<span></span>
</td>
<td class="num">$ (24,018)<span></span>
</td>
<td class="num">$ (41,009)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average number of shares</a></td>
<td class="nump">359,193,482<span></span>
</td>
<td class="nump">153,099,405<span></span>
</td>
<td class="nump">134,939,327<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss for the year</a></td>
<td class="nump">$ 31,789<span></span>
</td>
<td class="nump">$ 24,018<span></span>
</td>
<td class="nump">$ 41,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity', window );">Basic earnings per ordinary share for continuing operations</a></td>
<td class="nump">$ 31,216<span></span>
</td>
<td class="nump">$ 36,868<span></span>
</td>
<td class="nump">$ 43,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average number of shares</a></td>
<td class="nump">359,193,482<span></span>
</td>
<td class="nump">153,099,405<span></span>
</td>
<td class="nump">134,939,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions', window );">Number of ordinary shares issuable on exercise of options</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Loss for the year</a></td>
<td class="nump">$ 31,789<span></span>
</td>
<td class="nump">$ 24,018<span></span>
</td>
<td class="nump">$ 41,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity', window );">Basic earnings per ordinary share for continuing operations</a></td>
<td class="nump">$ 31,216<span></span>
</td>
<td class="nump">$ 36,868<span></span>
</td>
<td class="nump">$ 43,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average number of shares</a></td>
<td class="nump">17,959,674<span></span>
</td>
<td class="nump">7,654,970<span></span>
</td>
<td class="nump">6,746,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions', window );">Number of ordinary shares issuable on exercise of options</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing operations attributable to ordinary equity holders of the parent entity. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss) from continuing operations]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of ordinary shares issuable on exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE (Schedule of Basic Earnings Per Ordinary Share) (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Basic (loss)/earnings per share denominator</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">359,193,482<span></span>
</td>
<td class="nump">153,099,405<span></span>
</td>
<td class="nump">134,939,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract', window );"><strong>Reconciliation to weighted average (loss)/earnings per share denominator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Basic (loss)/earnings per share denominator</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">359,193,482<span></span>
</td>
<td class="nump">153,099,405<span></span>
</td>
<td class="nump">134,939,327<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Basic (loss)/earnings per share denominator</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">359,193,482<span></span>
</td>
<td class="nump">153,099,405<span></span>
</td>
<td class="nump">134,939,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract', window );"><strong>Reconciliation to weighted average (loss)/earnings per share denominator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfAOrdinaryWeightedAverageShares', window );">Number of &#8216;A&#8217; ordinary shares at January 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">165,865,882<span></span>
</td>
<td class="nump">164,985,882<span></span>
</td>
<td class="nump">96,162,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageNumberOfSharesIssued', window );">Weighted average number of &#8216;A&#8217; ordinary shares issued during the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">205,883,200<span></span>
</td>
<td class="nump">669,123<span></span>
</td>
<td class="nump">51,332,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageNumberOfTreasuryShares', window );">Weighted average number of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12,555,600)<span></span>
</td>
<td class="num">(12,555,600)<span></span>
</td>
<td class="num">(12,555,600)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Basic (loss)/earnings per share denominator</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">359,193,482<span></span>
</td>
<td class="nump">153,099,405<span></span>
</td>
<td class="nump">134,939,327<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The weighted average number of shares issued during the year is calculated by taking the number of shares issued multiplied by the number of days in the year each share is in issue, divided by 365 days.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NumberOfAOrdinaryWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of A ordinary weighted average shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NumberOfAOrdinaryWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_WeightedAverageNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_WeightedAverageNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_WeightedAverageNumberOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_WeightedAverageNumberOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE  (Schedule of Diluted Earnings Per Ordinary Share) (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PotentiallyDilutiveInstrumentsAbstract', window );"><strong>Potentially Dilutive Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IssuableOnExerciseOfOptions', window );">Issuable on exercise of options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">186,908<span></span>
</td>
<td class="nump">2,752,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive', window );">Issuable on exercise of warrants to Perceptive</a></td>
<td class="nump">20,173,151<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SharesIssuableOnConversionOfExchangeableNotes', window );">Issuable on conversion of Exchangeable notes</a></td>
<td class="nump">38,391<span></span>
</td>
<td class="nump">38,391<span></span>
</td>
<td class="nump">1,436,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IssuableOnConversionOfConvertibleNotes', window );">Issuable on conversion of Convertible notes</a></td>
<td class="nump">24,691,358<span></span>
</td>
<td class="nump">24,691,358<span></span>
</td>
<td class="nump">16,370,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented', window );">Total number of potentially dilutive instruments excluded from the weighted average number of &#8216;A&#8217; ordinary shares in calculating dilutive (loss)/earnings per &#8216;A&#8217; ordinary share/earnings per ADS</a></td>
<td class="nump">44,902,900<span></span>
</td>
<td class="nump">24,916,657<span></span>
</td>
<td class="nump">20,559,325<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of potential ordinary shares that are antidilutive in the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IssuableOnConversionOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issuable on conversion of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IssuableOnConversionOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IssuableOnExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of issuable on exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IssuableOnExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issuable on exercise of warrants to perceptive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PotentiallyDilutiveInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PotentiallyDilutiveInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_SharesIssuableOnConversionOfExchangeableNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issuable on conversion of exchangeable notes .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_SharesIssuableOnConversionOfExchangeableNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE  (Schedule of Earnings Per ADS) (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Basic (loss)/earnings per ADS denominator</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">359,193,482<span></span>
</td>
<td class="nump">153,099,405<span></span>
</td>
<td class="nump">134,939,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract', window );"><strong>Reconciliation to weighted average (loss)/earnings per ADS denominator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Basic (loss)/earnings per share denominator</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">359,193,482<span></span>
</td>
<td class="nump">153,099,405<span></span>
</td>
<td class="nump">134,939,327<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AmericanDepositoryShares', window );">ADS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,959,674<span></span>
</td>
<td class="nump">7,654,970<span></span>
</td>
<td class="nump">6,746,966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Basic (loss)/earnings per ADS denominator</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,959,674<span></span>
</td>
<td class="nump">7,654,970<span></span>
</td>
<td class="nump">6,746,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract', window );"><strong>Reconciliation to weighted average (loss)/earnings per ADS denominator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfAmericanDepositorySharesWeightedAverageShares', window );">Number of ADS at January 1 (Note 18)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,293,294<span></span>
</td>
<td class="nump">8,249,294<span></span>
</td>
<td class="nump">4,808,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageNumberOfSharesIssued', window );">Weighted average number of shares issued during the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">10,294,160<span></span>
</td>
<td class="nump">33,456<span></span>
</td>
<td class="nump">2,566,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageNumberOfTreasuryShares', window );">Weighted average number of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(627,780)<span></span>
</td>
<td class="num">(627,780)<span></span>
</td>
<td class="num">(627,780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Basic (loss)/earnings per share denominator</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,959,674<span></span>
</td>
<td class="nump">7,654,970<span></span>
</td>
<td class="nump">6,746,966<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The weighted average number of ADSs issued during the year is calculated by taking the number of ADSs issued multiplied by the number of days in the year each share is in issue, divided by 365 days.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AmericanDepositoryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of American Depository Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AmericanDepositoryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NumberOfAmericanDepositorySharesWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of American Depository Shares, weighted average shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NumberOfAmericanDepositorySharesWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_WeightedAverageNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_WeightedAverageNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_WeightedAverageNumberOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_WeightedAverageNumberOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE (Schedule of Diluted Earnings Per ADS Share Calculation) (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PotentiallyDilutiveInstrumentsAbstract', window );"><strong>Potentially Dilutive Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IssuableOnExerciseOfOptions', window );">Issuable on exercise of options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">186,908<span></span>
</td>
<td class="nump">2,752,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive', window );">Issuable on exercise of warrants to Perceptive</a></td>
<td class="nump">20,173,151<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SharesIssuableOnConversionOfExchangeableNotes', window );">Issuable on conversion of Exchangeable notes</a></td>
<td class="nump">38,391<span></span>
</td>
<td class="nump">38,391<span></span>
</td>
<td class="nump">1,436,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IssuableOnConversionOfConvertibleNotes', window );">Issuable on conversion of Convertible notes</a></td>
<td class="nump">24,691,358<span></span>
</td>
<td class="nump">24,691,358<span></span>
</td>
<td class="nump">16,370,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented', window );">Total number of potentially dilutive instruments excluded from the weighted average number of &#8216;A&#8217; ordinary shares in calculating dilutive (loss)/earnings per &#8216;A&#8217; ordinary share/earnings per ADS</a></td>
<td class="nump">44,902,900<span></span>
</td>
<td class="nump">24,916,657<span></span>
</td>
<td class="nump">20,559,325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PotentiallyDilutiveInstrumentsAbstract', window );"><strong>Potentially Dilutive Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IssuableOnExerciseOfOptions', window );">Issuable on exercise of options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,345<span></span>
</td>
<td class="nump">137,608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive', window );">Issuable on exercise of warrants to Perceptive</a></td>
<td class="nump">1,008,658<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SharesIssuableOnConversionOfExchangeableNotes', window );">Issuable on conversion of Exchangeable notes</a></td>
<td class="nump">1,920<span></span>
</td>
<td class="nump">1,920<span></span>
</td>
<td class="nump">71,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IssuableOnConversionOfConvertibleNotes', window );">Issuable on conversion of Convertible notes</a></td>
<td class="nump">1,234,568<span></span>
</td>
<td class="nump">1,234,568<span></span>
</td>
<td class="nump">818,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented', window );">Total number of potentially dilutive instruments excluded from the weighted average number of &#8216;A&#8217; ordinary shares in calculating dilutive (loss)/earnings per &#8216;A&#8217; ordinary share/earnings per ADS</a></td>
<td class="nump">2,245,146<span></span>
</td>
<td class="nump">1,245,833<span></span>
</td>
<td class="nump">1,027,966<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of potential ordinary shares that are antidilutive in the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IssuableOnConversionOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issuable on conversion of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IssuableOnConversionOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IssuableOnExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of issuable on exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IssuableOnExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issuable on exercise of warrants to perceptive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PotentiallyDilutiveInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PotentiallyDilutiveInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_SharesIssuableOnConversionOfExchangeableNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issuable on conversion of exchangeable notes .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_SharesIssuableOnConversionOfExchangeableNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additional right-of-use assets</a></td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RestructuringCost', window );">Restructuring Costs</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ImpairmentChargePropertyPlantEquipment', window );">Impairment Charge Property, Plant &amp; Equipment</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment loss</a></td>
<td class="nump">612,000<span></span>
</td>
<td class="nump">$ 3,772,000<span></span>
</td>
<td class="nump">$ 733,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeFromSubleasingRightofuseAssets', window );">Income from sub-letting right-of-use</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e_v&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeFromSubleasingRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income from subleasing right-of-use assets. Sublease is a transaction for which an underlying asset is re-leased by a lessee (&#8216;intermediate lessor&#8217;) to a third party, and the lease (&#8216;head lease&#8217;) between the head lessor and lessee remains in effect. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 53<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_53_f&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeFromSubleasingRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ImpairmentChargePropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of Impairment Charge Property, Plant &amp; Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ImpairmentChargePropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_RestructuringCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_RestructuringCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Schedule of Composition of Property and Equipment Related to Accumulated Depreciation) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="nump">$ 1,892<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment loss</a></td>
<td class="num">(612)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (3,772)<span></span>
</td>
<td class="num">$ (733)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="nump">4,621<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="nump">66,069<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">65,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">1,380<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions through acquisition</a></td>
<td class="nump">1,373<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsOrRetirementsPropertyAndEquipment', window );">Disposals or retirements</a></td>
<td class="num">(14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(855)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Remeasurement of ROU assets</a></td>
<td class="nump">1,764<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reallocations / reclassifications</a></td>
<td class="nump">53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="nump">70,625<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">66,069<span></span>
</td>
<td class="nump">65,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Land &amp; Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="nump">24,268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions through acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsOrRetirementsPropertyAndEquipment', window );">Disposals or retirements</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(480)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Remeasurement of ROU assets</a></td>
<td class="nump">1,764<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reallocations / reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="nump">26,784<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24,268<span></span>
</td>
<td class="nump">24,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="nump">2,760<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions through acquisition</a></td>
<td class="nump">51<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsOrRetirementsPropertyAndEquipment', window );">Disposals or retirements</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Remeasurement of ROU assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reallocations / reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="nump">2,811<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,760<span></span>
</td>
<td class="nump">2,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Computer &amp; Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="nump">4,612<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions through acquisition</a></td>
<td class="nump">582<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsOrRetirementsPropertyAndEquipment', window );">Disposals or retirements</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Remeasurement of ROU assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reallocations / reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="nump">5,344<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,612<span></span>
</td>
<td class="nump">4,540<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Plant &amp; Equipment, Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="nump">34,429<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">33,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">478<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions through acquisition</a></td>
<td class="nump">740<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsOrRetirementsPropertyAndEquipment', window );">Disposals or retirements</a></td>
<td class="num">(14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(220)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets', window );">Remeasurement of ROU assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reallocations / reclassifications</a></td>
<td class="nump">53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="nump">35,686<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">34,429<span></span>
</td>
<td class="nump">33,683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and impairment losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="num">(64,177)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(59,924)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment', window );">Charge for the year</a></td>
<td class="num">(675)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(831)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsOrRetirementsPropertyAndEquipment', window );">Disposals or retirements</a></td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment loss</a></td>
<td class="num">(968)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(3,772)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reallocations / reclassifications</a></td>
<td class="num">(179)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="num">(66,004)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(64,177)<span></span>
</td>
<td class="num">(59,924)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and impairment losses [Member] | Land &amp; Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="num">(24,022)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21,885)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment', window );">Charge for the year</a></td>
<td class="num">(325)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(272)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsOrRetirementsPropertyAndEquipment', window );">Disposals or retirements</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment loss</a></td>
<td class="num">(410)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(2,246)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reallocations / reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="num">(24,757)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(24,022)<span></span>
</td>
<td class="num">(21,885)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and impairment losses [Member] | Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="num">(2,669)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,284)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment', window );">Charge for the year</a></td>
<td class="num">(58)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(64)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsOrRetirementsPropertyAndEquipment', window );">Disposals or retirements</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment loss</a></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(339)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reallocations / reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="num">(2,728)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,669)<span></span>
</td>
<td class="num">(2,284)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and impairment losses [Member] | Computer &amp; Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="num">(4,349)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment', window );">Charge for the year</a></td>
<td class="num">(283)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsOrRetirementsPropertyAndEquipment', window );">Disposals or retirements</a></td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment loss</a></td>
<td class="num">(80)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reallocations / reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="num">(4,717)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,349)<span></span>
</td>
<td class="num">(4,178)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and impairment losses [Member] | Plant &amp; Equipment, Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="num">(33,137)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(31,577)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment', window );">Charge for the year</a></td>
<td class="num">(9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(317)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsOrRetirementsPropertyAndEquipment', window );">Disposals or retirements</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment loss</a></td>
<td class="num">(477)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(1,086)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reallocations / reclassifications</a></td>
<td class="num">(179)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(370)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="num">(33,802)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(33,137)<span></span>
</td>
<td class="num">$ (31,577)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=trib_NetCarryingAmountMember', window );">Carrying amounts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="nump">1,892<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="nump">4,621<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=trib_NetCarryingAmountMember', window );">Carrying amounts [Member] | Land &amp; Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="nump">246<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="nump">2,027<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=trib_NetCarryingAmountMember', window );">Carrying amounts [Member] | Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="nump">91<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="nump">83<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=trib_NetCarryingAmountMember', window );">Carrying amounts [Member] | Computer &amp; Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="nump">263<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="nump">627<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=trib_NetCarryingAmountMember', window );">Carrying amounts [Member] | Plant &amp; Equipment, Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning year</a></td>
<td class="nump">1,292<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of year</a></td>
<td class="nump">$ 1,884<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Additions include US$0.9 million additions in ROU assets.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The total impairment charge recognised against Property, Plant &amp; Equipment during the year was US$1.0 million. Of this, US$0.6 million, corresponding to the impairment loss allocated to property, plant and equipment as described above, is presented within &#8216;Impairment Charges&#8217; in the Consolidated Statement of Operations. The remaining US$0.4 million is included within &#8216;Restructuring Costs&#8217; (see Note 5).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e_v&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e_viii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e_ix&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment including right-of-use assets resulting from revaluations to fair value. [Refer: Property, plant and equipment including right-of-use assets; Revaluation surplus]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisposalsOrRetirementsPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposals or retirements of property, plant and equipment during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisposalsOrRetirementsPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=trib_NetCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=trib_NetCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Schedule of Additional Information on Right-of-use Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RightOfUseAssetsIncludingDepreciationAndImpairment', window );">Right-of-use assets</a></td>
<td class="nump">$ 2,198<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=trib_DepreciationMember', window );">Depreciation Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RightOfUseAssetsIncludingDepreciationAndImpairment', window );">Right-of-use assets</a></td>
<td class="num">(381)<span></span>
</td>
<td class="num">(273)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember', window );">Accumulated impairment Charge [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RightOfUseAssetsIncludingDepreciationAndImpairment', window );">Right-of-use assets</a></td>
<td class="num">(399)<span></span>
</td>
<td class="num">(2,016)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RightOfUseAssetsIncludingDepreciationAndImpairment', window );">Right-of-use assets</a></td>
<td class="nump">2,126<span></span>
</td>
<td class="nump">229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [Member] | Depreciation Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RightOfUseAssetsIncludingDepreciationAndImpairment', window );">Right-of-use assets</a></td>
<td class="num">(325)<span></span>
</td>
<td class="num">(196)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [Member] | Accumulated impairment Charge [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RightOfUseAssetsIncludingDepreciationAndImpairment', window );">Right-of-use assets</a></td>
<td class="num">(356)<span></span>
</td>
<td class="num">(1,930)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=trib_ComputerEquipmentsMember', window );">Computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RightOfUseAssetsIncludingDepreciationAndImpairment', window );">Right-of-use assets</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=trib_ComputerEquipmentsMember', window );">Computer equipment [Member] | Depreciation Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RightOfUseAssetsIncludingDepreciationAndImpairment', window );">Right-of-use assets</a></td>
<td class="num">(56)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=trib_ComputerEquipmentsMember', window );">Computer equipment [Member] | Accumulated impairment Charge [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RightOfUseAssetsIncludingDepreciationAndImpairment', window );">Right-of-use assets</a></td>
<td class="num">$ (43)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember', window );">Plant and Equipment, vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RightOfUseAssetsIncludingDepreciationAndImpairment', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember', window );">Plant and Equipment, vehicles [Member] | Depreciation Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RightOfUseAssetsIncludingDepreciationAndImpairment', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember', window );">Plant and Equipment, vehicles [Member] | Accumulated impairment Charge [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RightOfUseAssetsIncludingDepreciationAndImpairment', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (86)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_RightOfUseAssetsIncludingDepreciationAndImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-use assets including depreciation and impairment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_RightOfUseAssetsIncludingDepreciationAndImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=trib_DepreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=trib_DepreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=trib_ComputerEquipmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=trib_ComputerEquipmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Schedule of Income from Sub-letting Right-of-use Buildings) (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfRightOfUseLeasedAssets', window );">Number Of Right Of Use Leased Assets</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AverageRemainingLeaseTermYears', window );">Average remaining lease term (years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfLeasesWithExtensionOptions', window );">No. of Leases with extension options</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfLeasesWithOptionsToPurchase', window );">No. of Leases with options to purchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex', window );">No. of leases with variable payments linked to index</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfLeasesWithTerminationOptions', window );">No. of leases with termination options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RemainingTermInYears', window );">Range of remaining term in years</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RemainingTermInYears', window );">Range of remaining term in years</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfRightOfUseLeasedAssets', window );">Number Of Right Of Use Leased Assets</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AverageRemainingLeaseTermYears', window );">Average remaining lease term (years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfLeasesWithExtensionOptions', window );">No. of Leases with extension options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfLeasesWithOptionsToPurchase', window );">No. of Leases with options to purchase</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex', window );">No. of leases with variable payments linked to index</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfLeasesWithTerminationOptions', window );">No. of leases with termination options</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RemainingTermInYears', window );">Range of remaining term in years</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RemainingTermInYears', window );">Range of remaining term in years</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=trib_ITAndOfficeEquipmentMember', window );">I.T. and office equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfRightOfUseLeasedAssets', window );">Number Of Right Of Use Leased Assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RemainingTermInYears', window );">Range of remaining term in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AverageRemainingLeaseTermYears', window );">Average remaining lease term (years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfLeasesWithExtensionOptions', window );">No. of Leases with extension options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfLeasesWithOptionsToPurchase', window );">No. of Leases with options to purchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex', window );">No. of leases with variable payments linked to index</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfLeasesWithTerminationOptions', window );">No. of leases with termination options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=trib_ITAndOfficeEquipmentMember', window );">I.T. and office equipment [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RemainingTermInYears', window );">Range of remaining term in years</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=trib_ITAndOfficeEquipmentMember', window );">I.T. and office equipment [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RemainingTermInYears', window );">Range of remaining term in years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AverageRemainingLeaseTermYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average remaining lease term in years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AverageRemainingLeaseTermYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NumberOfLeasesWithExtensionOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of leases with extension options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NumberOfLeasesWithExtensionOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NumberOfLeasesWithOptionsToPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of leases with options to purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NumberOfLeasesWithOptionsToPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NumberOfLeasesWithTerminationOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of leases with termination options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NumberOfLeasesWithTerminationOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of leases with variable payments linked to index.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NumberOfRightOfUseLeasedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Right-of-Use leased assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NumberOfRightOfUseLeasedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_RemainingTermInYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining term of right of use assets in years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_RemainingTermInYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=trib_ITAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=trib_ITAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyDevelopmentAndProjectManagementExpense', window );">Development costs not amortised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,040,000<span></span>
</td>
<td class="nump">$ 1,596,000<span></span>
</td>
<td class="nump">$ 6,982,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets', window );">Description of project completion period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">January&#160;1,
2025 to December&#160;31, 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Intangible assets acquired through business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge', window );">Intangible assets under development impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">916,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossOnFinancialAssets', window );">Impairment loss on financial assets</a></td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="num">$ (800,000)<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LongTermGrowthRate', window );">Long term growth rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Variation in discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ActuarialAssumptionOfDiscountRatePercentage', window );">Actuarial assumption of discount rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,343,000<span></span>
</td>
<td class="nump">16,270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,596,000<span></span>
</td>
<td class="nump">5,833,000<span></span>
</td>
<td class="nump">$ 4,624,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,408,000<span></span>
</td>
<td class="nump">$ 11,105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_SyphilisPointOfCareMember', window );">Syphilis Point-of-Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge', window );">Intangible assets under development impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">680,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_TrinscreenPlantAndEquipmentMember', window );">Trinscreen plant &amp; equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge', window );">Intangible assets under development impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_KansasRightOfUseAssetMember', window );">Kansas right-of-use asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge', window );">Intangible assets under development impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdditionalProjectCost', window );">Additional project cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections', window );">Cash flow projections</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PreTaxDiscountRates', window );">Pre tax discount rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdditionalProjectCost', window );">Additional project cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections', window );">Cash flow projections</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PreTaxDiscountRates', window );">Pre tax discount rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_ImmcoDiagnosticsIncMember', window );">Immco Diagnostics Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,069,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,000<span></span>
</td>
<td class="nump">9,331,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_TrinityBiotechManufacturingLimitedMember', window );">Trinity Biotech Manufacturing Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(120,000)<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_MetabolomicDiagnosticsLimitedMember', window );">Metabolomic Diagnostics Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill recognised in connection with acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_WaveformTechnologiesIncMember', window );">Waveform Technologies Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LongTermGrowthRate', window );">Long term growth rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PreTaxDiscountRates', window );">Pre tax discount rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,829,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_EpiCaptureLimitedMember', window );">Epi Capture Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LongTermGrowthRate', window );">Long term growth rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PreTaxDiscountRates', window );">Pre tax discount rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology based intangibles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2024-01-01<br> -Paragraph 144<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Total for all cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_d_v&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph e<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_e_v&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The explanation of restrictions on the distribution of the balance of the revaluation surplus for intangible assets to shareholders. [Refer: Revaluation surplus]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 124<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_124_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossOnFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_20_e&amp;doctype=Standard&amp;book=b<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossOnFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in other comprehensive income for intangible assets other than goodwill. [Refer: Impairment loss recognised in other comprehensive income; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyDevelopmentAndProjectManagementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from property development and project management.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyDevelopmentAndProjectManagementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ActuarialAssumptionOfDiscountRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial assumption of discount rate percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ActuarialAssumptionOfDiscountRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AdditionalProjectCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of additional project cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AdditionalProjectCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IntangibleAssetsUnderDevelopmentImpairmentCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets Under Development Impairment Charge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IntangibleAssetsUnderDevelopmentImpairmentCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LongTermGrowthRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term growth rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LongTermGrowthRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PreTaxDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of pre tax discount rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PreTaxDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_SyphilisPointOfCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_SyphilisPointOfCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_TrinscreenPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_TrinscreenPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_KansasRightOfUseAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_KansasRightOfUseAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_ImmcoDiagnosticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_ImmcoDiagnosticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_TrinityBiotechManufacturingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_TrinityBiotechManufacturingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_MetabolomicDiagnosticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_MetabolomicDiagnosticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_WaveformTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_WaveformTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_EpiCaptureLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_EpiCaptureLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Schedule of Goodwill and Intangible Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">$ 16,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions through acquisition</a></td>
<td class="nump">13,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment losses</a></td>
<td class="nump">1,596<span></span>
</td>
<td class="nump">$ 5,833<span></span>
</td>
<td class="nump">$ 4,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">51,343<span></span>
</td>
<td class="nump">16,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">221,906<span></span>
</td>
<td class="nump">247,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">10,863<span></span>
</td>
<td class="nump">1,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions through acquisition</a></td>
<td class="nump">27,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsGoodwillAndIntangibleAssets', window );">Disposals or retirements</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(27,079)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReclassificationGoodwillAndIntangibleAssets', window );">Reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">259,765<span></span>
</td>
<td class="nump">221,906<span></span>
</td>
<td class="nump">247,075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=trib_NetCarryingAmountMember', window );">Carrying amounts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">16,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">51,343<span></span>
</td>
<td class="nump">16,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and impairment losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="num">(205,636)<span></span>
</td>
<td class="num">(211,806)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill', window );">Charge for the year</a></td>
<td class="num">(1,190)<span></span>
</td>
<td class="num">(946)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsGoodwillAndIntangibleAssets', window );">Disposals or retirements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment losses</a></td>
<td class="num">(1,596)<span></span>
</td>
<td class="num">(5,833)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="num">(208,422)<span></span>
</td>
<td class="num">(205,636)<span></span>
</td>
<td class="num">(211,806)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">66,645<span></span>
</td>
<td class="nump">79,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions through acquisition</a></td>
<td class="nump">13,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsGoodwillAndIntangibleAssets', window );">Disposals or retirements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,591)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReclassificationGoodwillAndIntangibleAssets', window );">Reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">80,484<span></span>
</td>
<td class="nump">66,645<span></span>
</td>
<td class="nump">79,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member] | Carrying amounts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">13,839<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member] | Accumulated depreciation and impairment losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="num">(66,645)<span></span>
</td>
<td class="num">(66,645)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill', window );">Charge for the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsGoodwillAndIntangibleAssets', window );">Disposals or retirements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="num">(66,645)<span></span>
</td>
<td class="num">(66,645)<span></span>
</td>
<td class="num">(66,645)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_DevelopmentCostMember', window );">Development cost [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">127,365<span></span>
</td>
<td class="nump">125,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">8,582<span></span>
</td>
<td class="nump">1,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions through acquisition</a></td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsGoodwillAndIntangibleAssets', window );">Disposals or retirements</a></td>
<td class="num">(70)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReclassificationGoodwillAndIntangibleAssets', window );">Reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">135,999<span></span>
</td>
<td class="nump">127,365<span></span>
</td>
<td class="nump">125,584<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_DevelopmentCostMember', window );">Development cost [Member] | Carrying amounts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">15,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">20,951<span></span>
</td>
<td class="nump">15,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_DevelopmentCostMember', window );">Development cost [Member] | Accumulated depreciation and impairment losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="num">(112,262)<span></span>
</td>
<td class="num">(108,576)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill', window );">Charge for the year</a></td>
<td class="num">(1,190)<span></span>
</td>
<td class="num">(753)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsGoodwillAndIntangibleAssets', window );">Disposals or retirements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment losses</a></td>
<td class="num">(1,596)<span></span>
</td>
<td class="num">(2,926)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="num">(115,048)<span></span>
</td>
<td class="num">(112,262)<span></span>
</td>
<td class="num">(108,576)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember', window );">Patents and licences [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">8,694<span></span>
</td>
<td class="nump">8,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions through acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsGoodwillAndIntangibleAssets', window );">Disposals or retirements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReclassificationGoodwillAndIntangibleAssets', window );">Reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">8,695<span></span>
</td>
<td class="nump">8,694<span></span>
</td>
<td class="nump">8,729<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember', window );">Patents and licences [Member] | Carrying amounts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember', window );">Patents and licences [Member] | Accumulated depreciation and impairment losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="num">(8,549)<span></span>
</td>
<td class="num">(8,570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill', window );">Charge for the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsGoodwillAndIntangibleAssets', window );">Disposals or retirements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="num">(8,549)<span></span>
</td>
<td class="num">(8,549)<span></span>
</td>
<td class="num">(8,570)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology based intangibles [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions through acquisition</a></td>
<td class="nump">13,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsGoodwillAndIntangibleAssets', window );">Disposals or retirements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReclassificationGoodwillAndIntangibleAssets', window );">Reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">13,105<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology based intangibles [Member] | Carrying amounts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">13,105<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology based intangibles [Member] | Accumulated depreciation and impairment losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill', window );">Charge for the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsGoodwillAndIntangibleAssets', window );">Disposals or retirements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other [Member] | Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">19,202<span></span>
</td>
<td class="nump">33,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">2,280<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions through acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsGoodwillAndIntangibleAssets', window );">Disposals or retirements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(14,488)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReclassificationGoodwillAndIntangibleAssets', window );">Reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">21,482<span></span>
</td>
<td class="nump">19,202<span></span>
</td>
<td class="nump">33,580<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other [Member] | Carrying amounts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="nump">1,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="nump">3,302<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other [Member] | Accumulated depreciation and impairment losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at beginning year</a></td>
<td class="num">(18,180)<span></span>
</td>
<td class="num">(28,015)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill', window );">Charge for the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(223)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsGoodwillAndIntangibleAssets', window );">Disposals or retirements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,898)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Exchange adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Balance at end of year</a></td>
<td class="num">$ (18,180)<span></span>
</td>
<td class="num">$ (18,180)<span></span>
</td>
<td class="num">$ (28,015)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets and goodwill resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_vii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisposalsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposals of goodwill and intangible assets for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisposalsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ReclassificationGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ReclassificationGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=trib_NetCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=trib_NetCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_DevelopmentCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_DevelopmentCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Schedule of Principal Development Projects) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalDevelopmentProjectsCapitalizedCosts', window );">Capitalised development costs</a></td>
<td class="nump">$ 8,582<span></span>
</td>
<td class="nump">$ 1,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_ContinuousGlucoseMonitoringTestingMember', window );">Continuous glucose monitoring testing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalDevelopmentProjectsCapitalizedCosts', window );">Capitalised development costs</a></td>
<td class="nump">7,040<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_PremierInstrumentMember', window );">Premier Instruments for A1c and haemoglobinopathies testing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalDevelopmentProjectsCapitalizedCosts', window );">Capitalised development costs</a></td>
<td class="nump">1,542<span></span>
</td>
<td class="nump">1,669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_MidTierHaemoglobinsInstrumentMember', window );">Mid-tier haemoglobins instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalDevelopmentProjectsCapitalizedCosts', window );">Capitalised development costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_HivOneByTwoRapidTestMember', window );">HIV Screening Rapid Test [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalDevelopmentProjectsCapitalizedCosts', window );">Capitalised development costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_OtherProjectsMember', window );">Other Projects [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalDevelopmentProjectsCapitalizedCosts', window );">Capitalised development costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PrincipalDevelopmentProjectsCapitalizedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal development projects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PrincipalDevelopmentProjectsCapitalizedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_ContinuousGlucoseMonitoringTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_ContinuousGlucoseMonitoringTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_PremierInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_PremierInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_MidTierHaemoglobinsInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_MidTierHaemoglobinsInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_HivOneByTwoRapidTestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_HivOneByTwoRapidTestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_OtherProjectsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_OtherProjectsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Schedule of Impairment Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</a></td>
<td class="nump">$ 1,408<span></span>
</td>
<td class="nump">$ 11,105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_ImmcoDiagnosticsIncMember', window );">Immco Diagnostics Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">9,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_TrinityBiotechManufacturingLimitedMember', window );">Trinity Biotech Manufacturing Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</a></td>
<td class="num">(120)<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_TrinityBiotechDoBrasilMember', window );">Trinity Biotech Do Brasil [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_PrimusCorpMember', window );">Primus Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</a></td>
<td class="nump">916<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_ClarkLaboratoriesIncMember', window );">Clark Laboratories Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_BiopoolUsIncMember', window );">Biopool US Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</a></td>
<td class="nump">$ 219<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in other comprehensive income for intangible assets other than goodwill. [Refer: Impairment loss recognised in other comprehensive income; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_ImmcoDiagnosticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_ImmcoDiagnosticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_TrinityBiotechManufacturingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_TrinityBiotechManufacturingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_TrinityBiotechDoBrasilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_TrinityBiotechDoBrasilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_PrimusCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_PrimusCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_ClarkLaboratoriesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_ClarkLaboratoriesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_BiopoolUsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_BiopoolUsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Schedule of Breakdown of Impairment Loss) (Details) (USD $) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract', window );"><strong>Disclosure Of Goodwill And Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill', window );">Goodwill and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,596<span></span>
</td>
<td class="nump">$ 5,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipment', window );">Property, plant and equipment (see Note 11)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">612<span></span>
</td>
<td class="nump">3,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossOnFinancialAssets', window );">Financial assets (see Note 13)</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Prepayments', window );">Prepayments (see Note 18)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 482,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughImpairmentContractAssets', window );">Total impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,408<span></span>
</td>
<td class="nump">$ 11,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DecreaseThroughImpairmentContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in contract assets resulting from impairment. [Refer: Contract assets; Impairment loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DecreaseThroughImpairmentContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossOnFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_20_e&amp;doctype=Standard&amp;book=b<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossOnFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Prepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables that represent amounts paid for goods and services before they have been delivered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Prepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from revaluations to fair value. [Refer: Intangible assets other than goodwill; Revaluation surplus]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_e_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Schedule of Specific asset impairment charges) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsUnderDevelopment', window );">Internally developed intangible assets</a></td>
<td class="nump">$ 1,952<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_T10HplcAnalyzerMember', window );">T10 Hplc Analyzer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsUnderDevelopment', window );">Internally developed intangible assets</a></td>
<td class="nump">916<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_SyphilisPointOfCareMember', window );">Syphilis Point-of-Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsUnderDevelopment', window );">Internally developed intangible assets</a></td>
<td class="nump">680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_TrinscreenPlantAndEquipmentMember', window );">Trinscreen plant &amp; equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsUnderDevelopment', window );">Internally developed intangible assets</a></td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_KansasRightOfUseAssetMember', window );">Kansas right-of-use asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsUnderDevelopment', window );">Internally developed intangible assets</a></td>
<td class="nump">$ 133<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsUnderDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets representing such assets under development. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 119<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_119_g&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsUnderDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_T10HplcAnalyzerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_T10HplcAnalyzerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_SyphilisPointOfCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_SyphilisPointOfCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_TrinscreenPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_TrinscreenPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_KansasRightOfUseAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_KansasRightOfUseAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Schedule of Significant Goodwill and Intangible Assets) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LongTermGrowthRate', window );">Long-term growth rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_WaveformTechnologiesIncMember', window );">Waveform Technologies Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CarryingAmountOfGoodwill', window );">Carrying amount of goodwill</a></td>
<td class="nump">$ 12,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxRateEffectOfImpairmentOfGoodwill', window );">Discount rate applied (real pre-tax)</a></td>
<td class="nump">18.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment', window );">EBITDA would need to decrease for an impairment to arise</a></td>
<td class="nump">56.51%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LongTermGrowthRate', window );">Long-term growth rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_EpiCaptureLimitedMember', window );">Epi Capture Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CarryingAmountOfGoodwill', window );">Carrying amount of goodwill</a></td>
<td class="nump">$ 1,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxRateEffectOfImpairmentOfGoodwill', window );">Discount rate applied (real pre-tax)</a></td>
<td class="nump">21.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment', window );">EBITDA would need to decrease for an impairment to arise</a></td>
<td class="nump">84.35%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LongTermGrowthRate', window );">Long-term growth rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectOfImpairmentOfGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the impairment of goodwill. [Refer: Average effective tax rate; Applicable tax rate; Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectOfImpairmentOfGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CarryingAmountOfGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CarryingAmountOfGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings before interest, tax, depreciation and amortization decrease for impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LongTermGrowthRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term growth rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LongTermGrowthRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_WaveformTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_WaveformTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_EpiCaptureLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_EpiCaptureLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Schedule of Intangible Assets with Indefinite Useful lives) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Intangible assets with indefinite useful lives</a></td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_PrimusCorporationCguTradeNameMember', window );">Primus Corporation CGU Trade Name [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in intangible assets and goodwill [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Intangible assets with indefinite useful lives</a></td>
<td class="nump">$ 365<span></span>
</td>
<td class="nump">$ 365<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 134<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_134_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 122<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_122_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_PrimusCorporationCguTradeNameMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=trib_PrimusCorporationCguTradeNameMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL ASSETS (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossOnFinancialAssets', window );">Impairment loss on financial assets</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (800)<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughWriteoffFinancialAssets', window );">Unpaid investment amount written off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="nump">$ 977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RemeasurementLossRecognizedInProfitLoss', window );">Remeasurement loss recognized in profit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=trib_NovusDiagnosticsLimitedMember', window );">Novus Diagnostics Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of equity acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,562,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AmericanDepositorySharesIssued', window );">ADS issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,399,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=trib_StrategicPartnershipWithImawareIncMember', window );">Strategic partnership with imaware, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNoteInvestment', window );">Convertible Note Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AgreementTerm', window );">Agreement Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">five-year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfConvertibleInstruments', window );">Issue of convertible instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AccruedLiability', window );">Accrued Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossOnFinancialAssets', window );">Impairment loss on financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughWriteoffFinancialAssets', window );">Unpaid investment amount written off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DecreaseThroughWriteoffFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in financial assets resulting from write-off. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35I<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35I_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph IG20B<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IG20B&amp;doctype=Implementation%20Guidance<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DecreaseThroughWriteoffFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossOnFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_20_e&amp;doctype=Standard&amp;book=b<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossOnFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfConvertibleInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in equity resulting from the issuing of convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfConvertibleInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AccruedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AccruedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreement Term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AmericanDepositorySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>American depository shares issued share value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AmericanDepositorySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ConvertibleNoteInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of convertible note investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ConvertibleNoteInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_RemeasurementLossRecognizedInProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents remeasurement loss recognized in profit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_RemeasurementLossRecognizedInProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=trib_NovusDiagnosticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnconsolidatedStructuredEntitiesAxis=trib_NovusDiagnosticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=trib_StrategicPartnershipWithImawareIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=trib_StrategicPartnershipWithImawareIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R130.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL ASSETS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Disclosure of financial assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Cost At January 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAssetsAdditions', window );">Additions in year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,562<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAssetsWriteOff', window );">Write off in the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets', window );">Fair value remeasured through profit &amp; loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Cost At December 31</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,155<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ProvisionForImpairment', window );">Provision for impairment At January 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossOnFinancialAssets', window );">Impairment in the current year</a></td>
<td class="num">$ (800)<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReversalOfImpairmentLossOnFinancialAssets', window );">Reversal of impairment in the current year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ProvisionForImpairment', window );">Provision for impairment At December 31</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(700)<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Carrying amount At December 31</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,455<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial assets. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossOnFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_20_e&amp;doctype=Standard&amp;book=b<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossOnFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of fair value remeasured through profit &amp; loss for financial assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FinancialAssetsAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of financial assets additions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FinancialAssetsAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FinancialAssetsWriteOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of financial assets written off.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FinancialAssetsWriteOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ProvisionForImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Provision for impairment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ProvisionForImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ReversalOfImpairmentLossOnFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of reversal of impairment loss on financial assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ReversalOfImpairmentLossOnFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R131.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEFERRED TAX ASSETS AND LIABILITIES (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Disclosure Of Deferred Tax Assets And Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision', window );">Deferred tax asset increase due to increase in provision</a></td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxLiabilityIncreased', window );">Deferred tax liability increased</a></td>
<td class="nump">$ 2.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of increase in deferred tax asset due to increase in provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DeferredTaxLiabilityIncreased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of increase in deferred tax liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DeferredTaxLiabilityIncreased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R132.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Recognised Deferred Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">$ 3,553<span></span>
</td>
<td class="nump">$ 1,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(4,561)<span></span>
</td>
<td class="num">(2,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax assets/(liabilities)</a></td>
<td class="num">(1,008)<span></span>
</td>
<td class="num">(325)<span></span>
</td>
<td class="num">$ (840)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember', window );">Plant and Equipment, vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax assets/(liabilities)</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Intangible assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(3,001)<span></span>
</td>
<td class="num">(931)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax assets/(liabilities)</a></td>
<td class="num">(3,001)<span></span>
</td>
<td class="num">(931)<span></span>
</td>
<td class="num">(3,950)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_InventoryMember', window );">Inventory Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">776<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax assets/(liabilities)</a></td>
<td class="nump">776<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember', window );">Provision for taxes other than income tax [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax assets/(liabilities)</a></td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">558<span></span>
</td>
<td class="nump">2,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_TaxValueOfLossCarryForwardsMember', window );">Tax value of loss carry-forwards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">1,026<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax assets/(liabilities)</a></td>
<td class="nump">1,026<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
<td class="nump">1,254<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_OtherItemsMember', window );">Other items [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(1,560)<span></span>
</td>
<td class="num">(1,369)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax assets/(liabilities)</a></td>
<td class="num">$ (1,447)<span></span>
</td>
<td class="num">$ (1,255)<span></span>
</td>
<td class="num">$ (985)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_InventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_InventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_TaxValueOfLossCarryForwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_TaxValueOfLossCarryForwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_OtherItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_OtherItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R133.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Unrecognised Deferred Tax Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at beginning of year</a></td>
<td class="num">$ (325)<span></span>
</td>
<td class="num">$ (840)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognised in income</a></td>
<td class="num">(683)<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations', window );">Recognised in discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at end of year</a></td>
<td class="num">(1,008)<span></span>
</td>
<td class="num">(325)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember', window );">Plant and Equipment, vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at beginning of year</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognised in income</a></td>
<td class="nump">56<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations', window );">Recognised in discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at end of year</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Intangible assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at beginning of year</a></td>
<td class="num">(931)<span></span>
</td>
<td class="num">(3,950)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognised in income</a></td>
<td class="num">(2,070)<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations', window );">Recognised in discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at end of year</a></td>
<td class="num">(3,001)<span></span>
</td>
<td class="num">(931)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_InventoryMember', window );">Inventories [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at beginning of year</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognised in income</a></td>
<td class="nump">671<span></span>
</td>
<td class="num">(318)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations', window );">Recognised in discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at end of year</a></td>
<td class="nump">776<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember', window );">Provision for taxes other than income tax [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at beginning of year</a></td>
<td class="nump">558<span></span>
</td>
<td class="nump">2,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognised in income</a></td>
<td class="nump">856<span></span>
</td>
<td class="num">(1,636)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations', window );">Recognised in discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at end of year</a></td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_TaxValueOfLossCarryForwardsMember', window );">Tax value of loss carry-forwards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at beginning of year</a></td>
<td class="nump">1,030<span></span>
</td>
<td class="nump">1,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognised in income</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(224)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations', window );">Recognised in discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at end of year</a></td>
<td class="nump">1,026<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_OtherItemsMember', window );">Other items [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at beginning of year</a></td>
<td class="num">(1,255)<span></span>
</td>
<td class="num">(985)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognised in income</a></td>
<td class="num">(192)<span></span>
</td>
<td class="num">(270)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations', window );">Recognised in discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Balance at end of year</a></td>
<td class="num">$ (1,447)<span></span>
</td>
<td class="num">$ (1,255)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_InventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_InventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_TaxValueOfLossCarryForwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_TaxValueOfLossCarryForwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_OtherItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=trib_OtherItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R134.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Unrecognised Deferred Tax Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Disclosure Of Deferred Tax Assets And Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxAssetsCapitalLossCarryforward', window );">Capital losses</a></td>
<td class="nump">$ 8,293<span></span>
</td>
<td class="nump">$ 8,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxAssetsOperatingLossDomestic', window );">Net operating losses</a></td>
<td class="nump">180,810<span></span>
</td>
<td class="nump">136,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits', window );">US alternative minimum tax credits</a></td>
<td class="nump">1,791<span></span>
</td>
<td class="nump">1,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences', window );">Other temporary timing differences</a></td>
<td class="nump">19,246<span></span>
</td>
<td class="nump">57,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxAssetsOperatingLossCarryforwardsState', window );">US state credit carryforwards</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,015<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DeferredTaxAssetsOperatingLossCarryforward', window );">Unrecognised deferred tax assets</a></td>
<td class="nump">$ 210,140<span></span>
</td>
<td class="nump">$ 208,286<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DeferredTaxAssetsCapitalLossCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DeferredTaxAssetsCapitalLossCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DeferredTaxAssetsOperatingLossCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DeferredTaxAssetsOperatingLossCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DeferredTaxAssetsOperatingLossCarryforwardsState">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DeferredTaxAssetsOperatingLossCarryforwardsState</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DeferredTaxAssetsOperatingLossDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DeferredTaxAssetsOperatingLossDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DeferredTaxAssetsOtherTemporaryTimingDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other temporary timing differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DeferredTaxAssetsOtherTemporaryTimingDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>US alternative minimum tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R135.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER NON-CURRENT ASSETS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousNoncurrentAssetsAbstract', window );"><strong>Miscellaneous non-current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinanceLeaseReceivables', window );">Finance lease receivables</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OtherAssetNoncurrent', window );">Other assets</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Total other assets</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousNoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousNoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinanceLeaseReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current finance lease receivables. [Refer: Finance lease receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinanceLeaseReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_OtherAssetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other remaining assets non current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_OtherAssetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R136.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoriesAtNetRealisableValue', window );">Inventories, at net realisable value</a></td>
<td class="nump">$ 7,648,000<span></span>
</td>
<td class="nump">$ 11,344,000<span></span>
</td>
<td class="nump">$ 16,274,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod', window );">Cost of sales</a></td>
<td class="nump">$ 38,001,000<span></span>
</td>
<td class="nump">$ 35,091,000<span></span>
</td>
<td class="nump">$ 45,340,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventories recognised as an expense during the period. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 36<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_36_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoriesAtNetRealisableValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventories carried at net realisable value. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 36<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_36&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoriesAtNetRealisableValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R137.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Schedule of inventories) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies', window );">Raw materials and consumables</a></td>
<td class="nump">$ 10,032<span></span>
</td>
<td class="nump">$ 10,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Work-in-progress</a></td>
<td class="nump">4,989<span></span>
</td>
<td class="nump">4,498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Finished goods</a></td>
<td class="nump">4,353<span></span>
</td>
<td class="nump">5,382<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total inventories</a></td>
<td class="nump">$ 19,374<span></span>
</td>
<td class="nump">$ 19,933<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of current raw materials and current production supplies. [Refer: Current production supplies; Current raw materials]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WorkInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WorkInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R138.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Schedule of Movement on the Inventory Provision) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Opening provision at January 1</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Closing provision at December 31</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=trib_ProvisionForInventoriesMember', window );">Provision for inventories [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Opening provision at January 1</a></td>
<td class="nump">11,344<span></span>
</td>
<td class="nump">16,274<span></span>
</td>
<td class="nump">$ 12,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Charged during the year</a></td>
<td class="nump">2,113<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
<td class="nump">7,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Utilised during the year</a></td>
<td class="num">(5,809)<span></span>
</td>
<td class="num">(5,456)<span></span>
</td>
<td class="num">(3,180)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EliminatedOnDisposalOfBusiness', window );">Eliminated on disposal of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,765)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Closing provision at December 31</a></td>
<td class="nump">$ 7,648<span></span>
</td>
<td class="nump">$ 11,344<span></span>
</td>
<td class="nump">$ 16,274<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalProvisionsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additional other provisions made. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalProvisionsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherProvisionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherProvisionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provisions other than provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProvisionUsedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProvisionUsedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_EliminatedOnDisposalOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount Eliminated on disposal of business</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_EliminatedOnDisposalOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=trib_ProvisionForInventoriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=trib_ProvisionForInventoriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R139.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>TRADE AND OTHER RECEIVABLES (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables, net impairment losses provision</a></td>
<td class="nump">$ 2,286,000<span></span>
</td>
<td class="nump">$ 2,324,000<span></span>
</td>
<td class="nump">$ 2,691,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Prepayments', window );">Prepayments of impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 482,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Finance lease receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">Between one and five years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Finance lease receivable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Prepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables that represent amounts paid for goods and services before they have been delivered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Prepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R140.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>TRADE AND OTHER RECEIVABLES (Schedule of Trade and Other Receivables) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Trade and other current receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade receivables, net of impairment losses</a></td>
<td class="nump">$ 13,416<span></span>
</td>
<td class="nump">$ 10,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepayments', window );">Prepayments</a></td>
<td class="nump">1,979<span></span>
</td>
<td class="nump">2,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentContractAssets', window );">Contract assets</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentValueAddedTaxReceivables', window );">Value added tax</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentReceivablesFromRentalOfProperties', window );">Finance lease receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReceivablesFromConsiderationDueSaleOfBusiness', window );">Consideration due from sale of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherReceivables', window );">Other receivables</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Total and other receivables</a></td>
<td class="nump">$ 16,065<span></span>
</td>
<td class="nump">$ 13,901<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current contract assets. [Refer: Contract assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2024-01-01<br> -Paragraph 105<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current prepayments. [Refer: Prepayments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentReceivablesFromRentalOfProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current receivables from rental of properties. [Refer: Receivables from rental of properties]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentReceivablesFromRentalOfProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentValueAddedTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current value added tax receivables. [Refer: Value added tax receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentValueAddedTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount receivable by the entity that it does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ReceivablesFromConsiderationDueSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of Consideration due from sale of business</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ReceivablesFromConsiderationDueSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>R141.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>TRADE AND OTHER RECEIVABLES (Schedule of Future Minimum Finance Lease Receivables) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_GrossInvestmentInFinanceLease', window );">Gross investment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnearnedFinanceIncomeOnFinanceLease', window );">Unearned income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Minimum Finance Lease Payments Receivable At Present Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than one year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_GrossInvestmentInFinanceLease', window );">Gross investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnearnedFinanceIncomeOnFinanceLease', window );">Unearned income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Minimum Finance Lease Payments Receivable At Present Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">Between one and five years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_GrossInvestmentInFinanceLease', window );">Gross investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_UnearnedFinanceIncomeOnFinanceLease', window );">Unearned income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Minimum Finance Lease Payments Receivable At Present Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_GrossInvestmentInFinanceLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate of: (a) the minimum lease payments receivable by the lessor under a finance lease; and (b) any unguaranteed residual value accruing to the lessor. Minimum lease payments are payments over the lease term that the lessee is or can be required to make, excluding contingent rent, costs for services and taxes to be paid by, and reimbursed to, the lessor, together with: (a) for a lessee, any amounts guaranteed by the lessee or by a party related to the lessee; or (b) for a lessor, any residual value guaranteed to the lessor by: (i) the lessee; (ii) a party related to the lessee; or (iii) a third party unrelated to the lessor that is financially capable of discharging the obligations under the guarantee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_GrossInvestmentInFinanceLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_UnearnedFinanceIncomeOnFinanceLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unearned income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_UnearnedFinanceIncomeOnFinanceLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>168
<FILENAME>R142.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>TRADE AND OTHER RECEIVABLES (Schedule of Future Minimum Rentals Receivable Under Non-Cancellable Operating Leases) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived', window );">Future minimum rentals receivable under non-cancellable operating leases</a></td>
<td class="nump">$ 1,461<span></span>
</td>
<td class="nump">$ 1,995<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=trib_InstrumentsMember', window );">Instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived', window );">Future minimum rentals receivable under non-cancellable operating leases</a></td>
<td class="nump">1,461<span></span>
</td>
<td class="nump">1,995<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than one year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived', window );">Future minimum rentals receivable under non-cancellable operating leases</a></td>
<td class="nump">1,461<span></span>
</td>
<td class="nump">1,995<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than one year [Member] | Instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived', window );">Future minimum rentals receivable under non-cancellable operating leases</a></td>
<td class="nump">$ 1,461<span></span>
</td>
<td class="nump">$ 1,995<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of undiscounted operating lease payments to be received. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 97<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_97&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=trib_InstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=trib_InstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>169
<FILENAME>R143.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CASH AND CASH EQUIVALENTS (Schedule of Cash and Cash Equivalents) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash at bank and in hand</a></td>
<td class="nump">$ 5,167<span></span>
</td>
<td class="nump">$ 3,691<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 5,167<span></span>
</td>
<td class="nump">$ 3,691<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>R144.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL AND RESERVES (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 10, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 25, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 24, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Share </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Share </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfCashFlowHedges', window );">Reserve of cash flow hedges | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_NovusDiagnosticsLimitedMember', window );">Novus Diagnostics Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of equity acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=trib_MicoLtdMember', window );">MiCo Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments', window );">Amount of investment from MiCo | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Equity investment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity of unsecured junior convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">seven-year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Unsecured junior convertible note | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares', window );">Maximum weighted average price of ADS | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments', window );">Equity component of the convertible note | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,628,000<span></span>
</td>
<td class="nump">880,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from issue of ordinary shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issue related cost | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Ordinary shares issued from exercise of employee share options | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">880,000<span></span>
</td>
<td class="nump">2,733,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PurchaseOfTreasuryShare', window );">Treasury shares purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | Waveform Technologies Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | Metabolomic Diagnostics Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,406,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | Craig Hallum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | Native Design Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="nump">7,237,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | Epi Capture Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,612,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | Novus Diagnostics Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareTreasurySharesMember', window );">ADS Treasury shares [Member] | Waveform Technologies Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareTreasurySharesMember', window );">ADS Treasury shares [Member] | Metabolomic Diagnostics Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareTreasurySharesMember', window );">ADS Treasury shares [Member] | Craig Hallum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareTreasurySharesMember', window );">ADS Treasury shares [Member] | Native Design Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="nump">362,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareTreasurySharesMember', window );">ADS Treasury shares [Member] | Epi Capture Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,731,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareTreasurySharesMember', window );">ADS Treasury shares [Member] | Novus Diagnostics Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maturity of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the conversion of convertible instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfCashFlowHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the accumulated portion of gain (loss) on a hedging instrument that is determined to be an effective hedge for cash flow hedges. [Refer: Cash flow hedges [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 9<br> -IssueDate 2024-01-01<br> -Paragraph 6.5.11<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=9&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_6.5.11&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfCashFlowHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing components of convertible instruments classified as equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum weighted average price of American Depository Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PurchaseOfTreasuryShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury shares purchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PurchaseOfTreasuryShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_NovusDiagnosticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_NovusDiagnosticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=trib_MicoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnconsolidatedStructuredEntitiesAxis=trib_MicoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_WaveformTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_WaveformTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_MetabolomicDiagnosticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_MetabolomicDiagnosticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_CraigHallumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_CraigHallumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_NativeDesignLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_NativeDesignLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_EpiCaptureLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_EpiCaptureLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareTreasurySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareTreasurySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>171
<FILENAME>R145.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL AND RESERVES (Schedule of Share Capital) (Details) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Balance at January 1</a></td>
<td class="nump">$ 24,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">At period end</a></td>
<td class="nump">$ 24,922<span></span>
</td>
<td class="nump">$ 24,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares at January 1</a></td>
<td class="nump">165,866<span></span>
</td>
<td class="nump">164,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Issued for a cash consideration</a></td>
<td class="nump">81,628<span></span>
</td>
<td class="nump">880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IssuedForNoncashConsideration', window );">Issued for non-cash consideration</a></td>
<td class="nump">124,255<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">At period end</a></td>
<td class="nump">371,749<span></span>
</td>
<td class="nump">165,866<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares at January 1</a></td>
<td class="nump">8,293<span></span>
</td>
<td class="nump">8,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Issued for a cash consideration</a></td>
<td class="nump">4,081<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IssuedForNoncashConsideration', window );">Issued for non-cash consideration</a></td>
<td class="nump">6,213<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">At period end</a></td>
<td class="nump">18,587<span></span>
</td>
<td class="nump">8,293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassATreasurySharesMember', window );">Class A Treasury shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Balance at January 1</a></td>
<td class="nump">$ 12,556<span></span>
</td>
<td class="nump">$ 12,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfTreasuryShares', window );">Purchased during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">At period end</a></td>
<td class="nump">12,556<span></span>
</td>
<td class="nump">12,556<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareTreasurySharesMember', window );">ADS Treasury shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Balance at January 1</a></td>
<td class="nump">628<span></span>
</td>
<td class="nump">628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfTreasuryShares', window );">Purchased during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">At period end</a></td>
<td class="nump">$ 628<span></span>
</td>
<td class="nump">$ 628<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An entity&#8217;s own equity instruments, held by the entity or other members of the consolidated group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2024-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IssuedForNoncashConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of Issued for non-cash consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IssuedForNoncashConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassATreasurySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassATreasurySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareTreasurySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareTreasurySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>172
<FILENAME>R146.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE OPTIONS (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Share</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options | Share</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted-average remaining contractual life of options outstanding</a></td>
<td class="text">4 years 11 months 23 days<span></span>
</td>
<td class="text">5 years 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ShareBasedPaymentsContinuingOperations', window );">Share based payments continuing operations | $</a></td>
<td class="nump">$ 1,316,000<span></span>
</td>
<td class="nump">$ 2,069,000<span></span>
</td>
<td class="nump">$ 1,755,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share based payments charge | $</a></td>
<td class="nump">$ 1,316,000<span></span>
</td>
<td class="nump">$ 2,069,000<span></span>
</td>
<td class="nump">$ 1,755,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options | Share</a></td>
<td class="nump">40,506,672<span></span>
</td>
<td class="nump">46,914,672<span></span>
</td>
<td class="nump">44,814,672<span></span>
</td>
<td class="nump">18,727,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of share options exercised | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">880,000<span></span>
</td>
<td class="nump">2,733,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OpeningSharePrice', window );">Opening share price</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ClosingExercisePriceOfOutstandingShareOptions', window );">Closing share price</a></td>
<td class="nump">0.04<span></span>
</td>
<td class="nump">0.11<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Average share price</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options | Share</a></td>
<td class="nump">2,025,334<span></span>
</td>
<td class="nump">2,345,734<span></span>
</td>
<td class="nump">2,240,734<span></span>
</td>
<td class="nump">936,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of share options exercised | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="nump">136,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OpeningSharePrice', window );">Opening share price</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 7.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ClosingExercisePriceOfOutstandingShareOptions', window );">Closing share price</a></td>
<td class="nump">0.88<span></span>
</td>
<td class="nump">2.15<span></span>
</td>
<td class="nump">4.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePrice2019', window );">Average share price</a></td>
<td class="nump">$ 1.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePrice2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePrice2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ClosingExercisePriceOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>exercise price of outstanding share options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ClosingExercisePriceOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_OpeningSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the opening share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_OpeningSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ShareBasedPaymentsContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based payments continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ShareBasedPaymentsContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>173
<FILENAME>R147.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE OPTIONS (Schedule of Grants of Share Options and Warrants) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at end of year | Share</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Beginning Balance | Share</a></td>
<td class="nump">46,914,672<span></span>
</td>
<td class="nump">44,814,672<span></span>
</td>
<td class="nump">18,727,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted | Share</a></td>
<td class="nump">12,100,000<span></span>
</td>
<td class="nump">19,600,000<span></span>
</td>
<td class="nump">29,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(880,000)<span></span>
</td>
<td class="num">(2,733,328)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Expired/ Forfeited | Share</a></td>
<td class="num">(18,508,000)<span></span>
</td>
<td class="num">(16,620,000)<span></span>
</td>
<td class="num">(579,990)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at end of year | Share</a></td>
<td class="nump">40,506,672<span></span>
</td>
<td class="nump">46,914,672<span></span>
</td>
<td class="nump">44,814,672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable at end of year | Share</a></td>
<td class="nump">17,275,422<span></span>
</td>
<td class="nump">19,764,672<span></span>
</td>
<td class="nump">14,138,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding Beginning Balance</a></td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 0.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted</a></td>
<td class="nump">0.14<span></span>
</td>
<td class="nump">0.14<span></span>
</td>
<td class="nump">0.27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Expired/ Forfeited</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.33<span></span>
</td>
<td class="nump">1.87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at end of year</a></td>
<td class="nump">0.26<span></span>
</td>
<td class="nump">0.39<span></span>
</td>
<td class="nump">0.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercisable at end of year</a></td>
<td class="nump">0.41<span></span>
</td>
<td class="nump">0.67<span></span>
</td>
<td class="nump">0.89<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding Beginning Balance</a></td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted</a></td>
<td class="nump">0.14<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">0.27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Expired/ Forfeited</a></td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">0.27<span></span>
</td>
<td class="nump">0.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at end of year</a></td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercisable at end of year</a></td>
<td class="nump">0.12<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding Beginning Balance</a></td>
<td class="nump">1.34<span></span>
</td>
<td class="nump">2.43<span></span>
</td>
<td class="nump">4.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted</a></td>
<td class="nump">0.14<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="nump">0.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
<td class="nump">0.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Expired/ Forfeited</a></td>
<td class="nump">1.34<span></span>
</td>
<td class="nump">2.43<span></span>
</td>
<td class="nump">4.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at end of year</a></td>
<td class="nump">1.29<span></span>
</td>
<td class="nump">1.34<span></span>
</td>
<td class="nump">2.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercisable at end of year</a></td>
<td class="nump">$ 1.29<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="nump">$ 2.43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Beginning Balance | Share</a></td>
<td class="nump">2,345,734<span></span>
</td>
<td class="nump">2,240,734<span></span>
</td>
<td class="nump">936,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted | Share</a></td>
<td class="nump">605,000<span></span>
</td>
<td class="nump">980,000<span></span>
</td>
<td class="nump">1,470,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,000)<span></span>
</td>
<td class="num">(136,666)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Expired/ Forfeited | Share</a></td>
<td class="num">(925,400)<span></span>
</td>
<td class="num">(831,000)<span></span>
</td>
<td class="num">(29,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at end of year | Share</a></td>
<td class="nump">2,025,334<span></span>
</td>
<td class="nump">2,345,734<span></span>
</td>
<td class="nump">2,240,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable at end of year | Share</a></td>
<td class="nump">863,771<span></span>
</td>
<td class="nump">988,234<span></span>
</td>
<td class="nump">706,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding Beginning Balance</a></td>
<td class="nump">$ 7.8<span></span>
</td>
<td class="nump">$ 9.4<span></span>
</td>
<td class="nump">$ 15.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Expired/ Forfeited</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
<td class="nump">37.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at end of year</a></td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercisable at end of year</a></td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">13.4<span></span>
</td>
<td class="nump">17.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding Beginning Balance</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Expired/ Forfeited</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at end of year</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercisable at end of year</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding Beginning Balance</a></td>
<td class="nump">26.8<span></span>
</td>
<td class="nump">48.6<span></span>
</td>
<td class="nump">87.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Expired/ Forfeited</a></td>
<td class="nump">26.8<span></span>
</td>
<td class="nump">48.6<span></span>
</td>
<td class="nump">87.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at end of year</a></td>
<td class="nump">25.8<span></span>
</td>
<td class="nump">26.8<span></span>
</td>
<td class="nump">48.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercisable at end of year</a></td>
<td class="nump">$ 25.8<span></span>
</td>
<td class="nump">$ 26.8<span></span>
</td>
<td class="nump">$ 48.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_WeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_WeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>174
<FILENAME>R148.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE OPTIONS (Summary of Range of Prices of Stock Options) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Share </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Share </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Share</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OutstandingAbstract', window );"><strong>Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average contractual life remaining (years)</a></td>
<td class="text">4 years 11 months 23 days<span></span>
</td>
<td class="text">5 years 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OutstandingAbstract', window );"><strong>Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="nump">40,506,672<span></span>
</td>
<td class="nump">46,914,672<span></span>
</td>
<td class="nump">44,814,672<span></span>
</td>
<td class="nump">18,727,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExercisableAbstract', window );"><strong>Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfShareOptionsExercisableShareBasedPayment', window );">Number of options | shares</a></td>
<td class="nump">17,275,422<span></span>
</td>
<td class="nump">19,764,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | US$0.12-US$0.99 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OutstandingAbstract', window );"><strong>Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="nump">40,356,672<span></span>
</td>
<td class="nump">42,266,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageExercisePriceOutstanding', window );">Weighted average exercise price | $</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average contractual life remaining (years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExercisableAbstract', window );"><strong>Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfShareOptionsExercisableShareBasedPayment', window );">Number of options | shares</a></td>
<td class="nump">17,125,422<span></span>
</td>
<td class="nump">15,116,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019', window );">Weighted average contractual life remaining (years)</a></td>
<td class="text">4 years 9 months 10 days<span></span>
</td>
<td class="text">4 years 1 month 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | US$1.00-US$1.29 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OutstandingAbstract', window );"><strong>Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageExercisePriceOutstanding', window );">Weighted average exercise price | $</a></td>
<td class="nump">$ 1.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average contractual life remaining (years)</a></td>
<td class="text">2 years 4 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExercisableAbstract', window );"><strong>Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfShareOptionsExercisableShareBasedPayment', window );">Number of options | shares</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 3.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019', window );">Weighted average contractual life remaining (years)</a></td>
<td class="text">2 years 4 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | US$1.00-US$1.74 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OutstandingAbstract', window );"><strong>Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,648,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageExercisePriceOutstanding', window );">Weighted average exercise price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average contractual life remaining (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExercisableAbstract', window );"><strong>Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfShareOptionsExercisableShareBasedPayment', window );">Number of options | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,648,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019', window );">Weighted average contractual life remaining (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OutstandingAbstract', window );"><strong>Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="nump">2,025,334<span></span>
</td>
<td class="nump">2,345,734<span></span>
</td>
<td class="nump">2,240,734<span></span>
</td>
<td class="nump">936,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExercisableAbstract', window );"><strong>Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfShareOptionsExercisableShareBasedPayment', window );">Number of options | shares</a></td>
<td class="nump">863,771<span></span>
</td>
<td class="nump">988,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member] | US$2.40-US$19.80 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OutstandingAbstract', window );"><strong>Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="nump">2,017,834<span></span>
</td>
<td class="nump">2,113,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageExercisePriceOutstanding', window );">Weighted average exercise price | $</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 5.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average contractual life remaining (years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExercisableAbstract', window );"><strong>Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfShareOptionsExercisableShareBasedPayment', window );">Number of options | shares</a></td>
<td class="nump">856,271<span></span>
</td>
<td class="nump">755,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 9.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019', window );">Weighted average contractual life remaining (years)</a></td>
<td class="text">4 years 9 months 10 days<span></span>
</td>
<td class="text">4 years 1 month 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member] | US$20.00-US$25.80 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OutstandingAbstract', window );"><strong>Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageExercisePriceOutstanding', window );">Weighted average exercise price | $</a></td>
<td class="nump">$ 22.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average contractual life remaining (years)</a></td>
<td class="text">2 years 4 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExercisableAbstract', window );"><strong>Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfShareOptionsExercisableShareBasedPayment', window );">Number of options | shares</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 22.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019', window );">Weighted average contractual life remaining (years)</a></td>
<td class="text">3 years 4 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member] | US$20.00-US$34.80 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OutstandingAbstract', window );"><strong>Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageExercisePriceOutstanding', window );">Weighted average exercise price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average contractual life remaining (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExercisableAbstract', window );"><strong>Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfShareOptionsExercisableShareBasedPayment', window );">Number of options | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019', window );">Weighted average contractual life remaining (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ExercisableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ExercisableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NumberOfShareOptionsExercisableShareBasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NumberOfShareOptionsExercisableShareBasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_OutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_OutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_WeightedAverageExercisePriceOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_WeightedAverageExercisePriceOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of exercisable share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>175
<FILENAME>R149.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE OPTIONS (Schedule of Fair Value of the Options Vesting Period) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract', window );"><strong>Disclosure Of Share Options And Share Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ShareBasedPaymentsCostOfSales', window );">Share-based payments - cost of sales</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ShareBasedPaymentsSellingGeneralAndAdministrative', window );">Share-based payments - selling, general and administrative</a></td>
<td class="nump">1,316,000<span></span>
</td>
<td class="nump">2,069,000<span></span>
</td>
<td class="nump">1,755,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ShareBasedPaymentsContinuingOperations', window );">Total - continuing operations</a></td>
<td class="nump">1,316,000<span></span>
</td>
<td class="nump">2,069,000<span></span>
</td>
<td class="nump">1,755,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ShareBasedPaymentsDiscontinuedOperations', window );">Share-based payments - discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Total share-based payments</a></td>
<td class="nump">$ 1,316,000<span></span>
</td>
<td class="nump">$ 2,069,000<span></span>
</td>
<td class="nump">$ 1,755,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfShareOptionsAndShareWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfShareOptionsAndShareWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ShareBasedPaymentsContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based payments continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ShareBasedPaymentsContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ShareBasedPaymentsCostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based payments cost of sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ShareBasedPaymentsCostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ShareBasedPaymentsDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based payment discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ShareBasedPaymentsDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ShareBasedPaymentsSellingGeneralAndAdministrative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based payments selling, general and administrative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ShareBasedPaymentsSellingGeneralAndAdministrative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>176
<FILENAME>R150.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE OPTIONS (Schedule of Assumption Determining Fair Value of Share Options) (Details) - Key management personnel [Member]<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Years </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>Years </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Years </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Weighted average expected volatility</a></td>
<td class="nump">74.40%<span></span>
</td>
<td class="nump">40.21%<span></span>
</td>
<td class="nump">76.79%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Weighted average expected life | Years</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">6.82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Weighted average risk free interest rate</a></td>
<td class="nump">4.06%<span></span>
</td>
<td class="nump">4.13%<span></span>
</td>
<td class="nump">3.59%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember', window );">Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Weighted average fair value at measurement date per 'A' share / (per ADS) | $</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TotalShareOptionsGrantedAdsEquivalent', window );">Total 'A' share options granted / (ADS's equivalent) | shares</a></td>
<td class="nump">12,100,000<span></span>
</td>
<td class="nump">19,600,000<span></span>
</td>
<td class="nump">29,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average share price per 'A' share / (per ADS)</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Weighted average exercise price per 'A' share / (per ADS)</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember', window );">Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Weighted average fair value at measurement date per 'A' share / (per ADS) | $</a></td>
<td class="nump">$ 2.08<span></span>
</td>
<td class="nump">$ 10.04<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TotalShareOptionsGrantedAdsEquivalent', window );">Total 'A' share options granted / (ADS's equivalent) | shares</a></td>
<td class="nump">605,000<span></span>
</td>
<td class="nump">980,000<span></span>
</td>
<td class="nump">1,470,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average share price per 'A' share / (per ADS)</a></td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Weighted average exercise price per 'A' share / (per ADS)</a></td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_TotalShareOptionsGrantedAdsEquivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_TotalShareOptionsGrantedAdsEquivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>177
<FILENAME>R151.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>TRADE AND OTHER PAYABLES (Schedule of Trade and Other Payables) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract', window );"><strong>Trade and other current payables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade payables</a></td>
<td class="nump">$ 6,833<span></span>
</td>
<td class="nump">$ 3,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities', window );">Accruals and other liabilities</a></td>
<td class="nump">13,597<span></span>
</td>
<td class="nump">7,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets', window );">Amounts payable for financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentValueAddedTaxPayables', window );">Payroll taxes</a></td>
<td class="nump">659<span></span>
</td>
<td class="nump">405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EmployeeRelatedSocialInsurance', window );">Employee related social insurance</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration</a></td>
<td class="nump">5,384<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredIncomeIncludingContractLiabilities', window );">Deferred income</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Total trade and other payables</a></td>
<td class="nump">26,782<span></span>
</td>
<td class="nump">12,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AccruedLiabilitiesToContractedLicencePayments', window );">Accrued Liabilities To Contracted Licence Payments</a></td>
<td class="nump">$ 185<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts payable to the transferee in respect of transferred financial assets other than the undiscounted cash outflows that would or may be required to repurchase derecognised financial assets (for example, the strike price in an option agreement). [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 42E<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_42E_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentValueAddedTaxPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current value added tax payables. [Refer: Value added tax payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentValueAddedTaxPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredIncomeIncludingContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities representing income that has been received (or the amount is due) but is not yet earned, including contract liabilities. [Refer: Contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredIncomeIncludingContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AccruedLiabilitiesToContractedLicencePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued liabilities to contracted licence payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AccruedLiabilitiesToContractedLicencePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_EmployeeRelatedSocialInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee related social insurance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_EmployeeRelatedSocialInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>178
<FILENAME>R152.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROVISIONS (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Provision for reduced warranty claims</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LegalProceedingsProvision', window );">Legal proceedings provision</a></td>
<td class="nump">735,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdditionalRestructuringCosts', window );">Additional Restructuring Costs</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember', window );">Site Transfer Costs Related To The Impairment Of Plant &amp; Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LegalProceedingsProvision', window );">Legal proceedings provision</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdditionalRestructuringCosts', window );">Additional Restructuring Costs</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_RestructuringProvisionMember', window );">Fitzgerald Industries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Acquisitions through business combinations, other provisions</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_RestructuringProvisionMember', window );">Fitzgerald Industries | Within One Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Acquisitions through business combinations, other provisions</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_RestructuringProvisionMember', window );">Fitzgerald Industries | More Than One Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Acquisitions through business combinations, other provisions</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in other provisions resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherProvisionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherProvisionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LegalProceedingsProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provision for legal proceedings. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Section Example 10 A court case<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS37_IE_C_ex10_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 87<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_87&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LegalProceedingsProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AdditionalRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to additional restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AdditionalRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_RestructuringProvisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=ifrs-full_RestructuringProvisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_InstalmentsAxis=trib_WithinOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_InstalmentsAxis=trib_WithinOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_InstalmentsAxis=trib_MoreThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_InstalmentsAxis=trib_MoreThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>179
<FILENAME>R153.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROVISIONS (Schedule of Provisions) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionsAbstract', window );"><strong>Provisions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WarrantyProvision', window );">Product warranty provision</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LegalProceedingsProvision', window );">Legal &amp; regulatory provision</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Disposal-related warranty settlement provision</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestructuringProvision', window );">Restructuring provision</a></td>
<td class="nump">1,594<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Provisions</a></td>
<td class="nump">2,529<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentProvisions', window );">Current provisions</a></td>
<td class="nump">2,454<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Non-current provisions</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LegalProceedingsProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provision for legal proceedings. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Section Example 10 A court case<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS37_IE_C_ex10_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 87<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_87&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LegalProceedingsProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provisions other than provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Provisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities of uncertain timing or amount, including provisions for employee benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Provisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProvisionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProvisionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestructuringProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provision for restructuring, such as the sale or termination of a line of business; closure of business locations in a country or region or relocation of activities from one country or region to another; changes in management structure; and fundamental reorganisations that have a material effect on the nature and focus of the entity's operations. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestructuringProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WarrantyProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provision for estimated costs of making good under warranties for products sold. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Section Example 1 Warranties<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS37_IE_C_ex1_TI<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 87<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_87&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WarrantyProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>180
<FILENAME>R154.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTEREST-BEARING LOANS AND BORROWINGS (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 10, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 22, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Shares consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,391,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 25,336,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EquityComponentOfConvertibleNote', window );">Equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,709,000<span></span>
</td>
<td class="nump">$ 6,709,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember', window );">Waveform Technologies Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=trib_AmendmentAndRestatementOfTermLoanMember', window );">Amendment and Restatement of Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Funding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AmountAvailableForDevelopmentOfTheCGM', window );">Amount available for development of the CGM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate', window );">Additional liquidity recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AmountUsedToAcquireTheCGMAssets', window );">Amount used to acquire the CGM assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NonCashFairValueGainLoss', window );">Non-cash fair value gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,587,000<span></span>
</td>
<td class="nump">8,293,000<span></span>
</td>
<td class="nump">8,249,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExercisePriceOfWarrantsOrRights', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember', window );">American depositary share [Member] | Amendment and Restatement of Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExercisePriceOfWarrantsOrRights', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Funding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">371,749,000<span></span>
</td>
<td class="nump">165,866,000<span></span>
</td>
<td class="nump">164,986,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=trib_MicoLtdMember', window );">MiCo Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Remaining amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">seven-year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_CurrentLiabilitiesMember', window );">Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Remaining amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210,000<span></span>
</td>
<td class="nump">$ 210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember', window );">Non Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Remaining amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,263,000<span></span>
</td>
<td class="nump">55,177,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ExchangeableSeniorNotesMember', window );">Exchangeable Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Debt issued/repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TotalExchangeableNotesPercentage', window );">Total exchangeable notes percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CashPaidToEachHolder', window );">Cash paid to each holder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,730,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CashReceivedPerNominalValue', window );">Cash received per nominal value</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NominalAmountOfDebt', window );">Nominal amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExchangeableNotesDiscountRate', window );">Exchangeable notes discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Shares consideration</a></td>
<td class="nump">$ 6,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExtinguishmentOfDebtAmounts', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LossOnDisposalOnBorrowings', window );">Loss on disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ExchangeableSeniorNotesMember', window );">Exchangeable Senior Notes [Member] | American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SharesConsideration', window );">Shares consideration | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,066,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SharesRepresentationRateComparedToADS', window );">Shares amount representing companies ADS | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ExchangeableSeniorNotesMember', window );">Exchangeable Senior Notes [Member] | Class A Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SharesConsideration', window );">Shares consideration | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,332,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ExchangeableSeniorNotesMember', window );">Exchangeable Senior Notes [Member] | Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Remaining amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,000<span></span>
</td>
<td class="nump">210,000<span></span>
</td>
<td class="nump">$ 210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SeniorSecuredTermLoanMember', window );">Senior Secured Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Loan, interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the
Company negotiated a 2.5% reduction in the base interest rate on its term loan facility, lowering the rate from 11.25% to 8.75%.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SeniorSecuredTermLoanMember', window );">Senior Secured Term Loan [Member] | Perceptive Credit Holdings Iii, Lp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Face amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Loan, interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
Term Loan is secured by a charge over the Group&#8217;s assets. The 48-month Term Loan was originally due to expire in January 2026, however
this has since been amended to a maturity date of July 2026. The loan accrues interest at an annual rate equal to 11.25% plus the greater
of (a) one-month LIBOR (later changed to the Term SOFR Reference Rate effective from October 28, 2022) and (b) one percent per annum,
and interest is payable monthly in arrears in cash.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SeniorSecuredTermLoanMember', window );">Senior Secured Term Loan [Member] | Perceptive Credit Holdings Iii, Lp [Member] | Warrant reserve [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExercisePriceOfWarrantsOrRights', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SeniorSecuredTermLoanMember', window );">Senior Secured Term Loan [Member] | Non Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Remaining amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,391,000<span></span>
</td>
<td class="nump">40,109,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Derivative financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AccretionInterestAccrued', window );">Accretion interest accrued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueOfDerivativeFinancialAsset', window );">Fair value of derivative financial asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueOfDerivativeFinancialLiability', window );">Fair value of derivative financial liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SevenYearConvertibleNoteMember', window );">7-year Convertible Note [Member] | MiCo Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Face amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalAmountLoaned', window );">Principal amount loaned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EquityComponentOfConvertibleNote', window );">Equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfConversionOfDebtToEquity', window );">Description of conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
convertible note has an interest rate of 1.5%. The convertible note mandatorily converts into ADSs if the volume weighted average price
of the Company&#8217;s ADSs is at or above US$16.20 for any five consecutive NASDAQ trading days.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SevenYearConvertibleNoteMember', window );">7-year Convertible Note [Member] | Non Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Remaining amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,401,000<span></span>
</td>
<td class="nump">14,542,000<span></span>
</td>
<td class="nump">$ 13,746,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AccretionInterestOnBorrowings', window );">Accretion interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(859,000)<span></span>
</td>
<td class="num">(796,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ConvertibleNoteMember', window );">Convertible Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Remaining amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,400,000<span></span>
</td>
<td class="nump">14,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AccretionInterestOnBorrowings', window );">Accretion interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EquityComponentAtDateOfIssue', window );">Equity component at date of issue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ConvertibleNoteMember', window );">Convertible Note [Member] | Non Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Remaining amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,401,000<span></span>
</td>
<td class="nump">14,542,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SeniorSecuredTermLoanCreditFacilityOneMember', window );">Amended and restated senior secured term loan credit facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Debt issued/repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLoanCommitments', window );">Outstanding principal term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Face amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfWarrantsRepriced', window );">Number of warrants repriced | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExercisePriceOfWarrantsOrRights', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PaymentOfPenalty', window );">Payment of penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InitialExercisePriceOfWarrantsOrRights', window );">Initial exercise price of warrants or rights | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SeniorSecuredTermLoanCreditFacilityOneMember', window );">Amended and restated senior secured term loan credit facility [Member] | Non Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Remaining amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SaleOfFitzgeraldIndustriesMember', window );">Sale of Fitzgerald Industries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Debt issued/repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Face amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ProceedsFromSaleOfBusiness', window );">Proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maturity of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contingent liabilities recognised as of the acquisition date in a business combination. [Refer: Classes of contingent liabilities [domain]; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfConversionOfDebtToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the non-cash conversion of debt to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfConversionOfDebtToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossLoanCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows for gross commitments to receive a loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph B11D<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B11D_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossLoanCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AccretionInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion interest accrued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AccretionInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AccretionInterestOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accretion interest on borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AccretionInterestOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of additional liquidity recognized as of acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AmountAvailableForDevelopmentOfTheCGM">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount available for development of the CGM.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AmountAvailableForDevelopmentOfTheCGM</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AmountUsedToAcquireTheCGMAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount used to acquire the CGM assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AmountUsedToAcquireTheCGMAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CashPaidToEachHolder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid to each holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CashPaidToEachHolder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CashReceivedPerNominalValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received per nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CashReceivedPerNominalValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_EquityComponentAtDateOfIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity component at date of issue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_EquityComponentAtDateOfIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_EquityComponentOfConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents equity component of convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_EquityComponentOfConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ExchangeableNotesDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of discount rate for exchangeable notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ExchangeableNotesDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ExercisePriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ExercisePriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ExtinguishmentOfDebtAmounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ExtinguishmentOfDebtAmounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FairValueOfDerivativeFinancialAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of derivative financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FairValueOfDerivativeFinancialAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FairValueOfDerivativeFinancialLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of derivative financial liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FairValueOfDerivativeFinancialLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_InitialExercisePriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial Exercise Price Of Warrants Or Rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_InitialExercisePriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LossOnDisposalOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss on disposal on borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LossOnDisposalOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NominalAmountOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal amount of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NominalAmountOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NonCashFairValueGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-cash fair value gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NonCashFairValueGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NumberOfWarrantsRepriced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrants repriced.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NumberOfWarrantsRepriced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PaymentOfPenalty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payment penalty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PaymentOfPenalty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PrincipalAmountLoaned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount loaned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PrincipalAmountLoaned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ProceedsFromSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ProceedsFromSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_SharesConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of shares consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_SharesConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_SharesRepresentationRateComparedToADS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the representation rate of shares compared to companies ADS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_SharesRepresentationRateComparedToADS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_TotalExchangeableNotesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represented total exchangeable notes percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_TotalExchangeableNotesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=trib_AmendmentAndRestatementOfTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=trib_AmendmentAndRestatementOfTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=trib_MicoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnconsolidatedStructuredEntitiesAxis=trib_MicoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_CurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=trib_CurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ExchangeableSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ExchangeableSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SeniorSecuredTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SeniorSecuredTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=trib_PerceptiveCreditHoldingsIiiLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnconsolidatedStructuredEntitiesAxis=trib_PerceptiveCreditHoldingsIiiLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_WarrantReserveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_WarrantReserveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SevenYearConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SevenYearConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SeniorSecuredTermLoanCreditFacilityOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SeniorSecuredTermLoanCreditFacilityOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SaleOfFitzgeraldIndustriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SaleOfFitzgeraldIndustriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>181
<FILENAME>R155.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTEREST-BEARING LOANS AND BORROWINGS (Schedule of carrying value of interest-bearing loans, borrowings and related balances (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ConvertibleNoteMember', window );">Convertible note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">$ 15,400,000<span></span>
</td>
<td class="nump">$ 14,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=trib_NonCurrentAssetsMember', window );">Non Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">166,000<span></span>
</td>
<td class="nump">178,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=trib_NonCurrentAssetsMember', window );">Non Current Assets [Member] | Derivative Financial Asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">166,000<span></span>
</td>
<td class="nump">178,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_CurrentLiabilitiesMember', window );">Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">210,000<span></span>
</td>
<td class="nump">210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_CurrentLiabilitiesMember', window );">Current Liabilities [Member] | Exchangeable Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">210,000<span></span>
</td>
<td class="nump">210,000<span></span>
</td>
<td class="nump">$ 210,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember', window );">Non Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">91,263,000<span></span>
</td>
<td class="nump">55,177,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember', window );">Non Current Liabilities [Member] | Senior secured term loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">72,391,000<span></span>
</td>
<td class="nump">40,109,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember', window );">Non Current Liabilities [Member] | Derivative financial liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">1,658,000<span></span>
</td>
<td class="nump">526,000<span></span>
</td>
<td class="nump">$ 1,569,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember', window );">Non Current Liabilities [Member] | Contingent liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">1,813,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember', window );">Non Current Liabilities [Member] | Convertible note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">$ 15,401,000<span></span>
</td>
<td class="nump">$ 14,542,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=trib_NonCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=trib_NonCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=trib_DerivativeFinancialAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=trib_DerivativeFinancialAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_CurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=trib_CurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ExchangeableSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ExchangeableSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SeniorSecuredTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SeniorSecuredTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_DerivativeFinancialLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_DerivativeFinancialLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ContingentLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ContingentLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>182
<FILENAME>R156.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the Exchangeable Notes balance) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ExchangeableSeniorNotesMember', window );">Exchangeable Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Repaid to Note holders</a></td>
<td class="nump">$ 99,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LossOnDisposalOnBorrowings', window );">Loss on disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_CurrentLiabilitiesMember', window );">Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at January 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(210,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at end of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(210,000)<span></span>
</td>
<td class="num">$ (210,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_CurrentLiabilitiesMember', window );">Current Liabilities [Member] | Exchangeable Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at January 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(210,000)<span></span>
</td>
<td class="num">(210,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at end of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (210,000)<span></span>
</td>
<td class="num">$ (210,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LossOnDisposalOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss on disposal on borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LossOnDisposalOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ExchangeableSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_ExchangeableSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_CurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=trib_CurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>183
<FILENAME>R157.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in term loan) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NoncashLoanModificationGain', window );">Non cash loan modification gain</a></td>
<td class="nump">$ 3,567<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember', window );">Non-current liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at January 1</a></td>
<td class="num">(55,177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at end of the period</a></td>
<td class="num">(91,263)<span></span>
</td>
<td class="num">(55,177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_TermLoanMember', window );">Term Loan [Member] | Non-current liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at January 1</a></td>
<td class="num">(40,109)<span></span>
</td>
<td class="num">(44,301)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalAmountLoaned', window );">Principal amount loaned</a></td>
<td class="num">(30,500)<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LoanOriginationCosts', window );">Loan drawdown costs</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DerivativeFinancialLiabilityAtDateOfIssue', window );">Derivative financial liability at date of drawdown</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DerivativeFinancialAssetAtDateOfIssue', window );">Derivative financial asset at date of drawdown</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AccretionInterestOnBorrowings', window );">Accretion interest</a></td>
<td class="num">(2,355)<span></span>
</td>
<td class="num">(1,131)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Cash repayment of principal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PaymentInKindInterest', window );">Payment-in-kind (PIK) Interest</a></td>
<td class="num">(3,291)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NoncashLoanModificationGain', window );">Non cash loan modification gain</a></td>
<td class="nump">3,567<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at end of the period</a></td>
<td class="num">$ (72,391)<span></span>
</td>
<td class="num">$ (40,109)<span></span>
</td>
<td class="num">$ (44,301)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AccretionInterestOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accretion interest on borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AccretionInterestOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DerivativeFinancialAssetAtDateOfIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative financial asset at date of issue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DerivativeFinancialAssetAtDateOfIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DerivativeFinancialLiabilityAtDateOfIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of derivative financial liability at date of issue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DerivativeFinancialLiabilityAtDateOfIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LoanOriginationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of loan origination costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LoanOriginationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NoncashLoanModificationGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of non-cash loan modification gain.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NoncashLoanModificationGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PaymentInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represets payment in kind Interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PaymentInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PrincipalAmountLoaned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount loaned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PrincipalAmountLoaned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>184
<FILENAME>R158.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the derivative financial asset) (Details) - Non Current Assets [Member] - Derivative Financial Asset [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at beginning of the period</a></td>
<td class="nump">$ 178<span></span>
</td>
<td class="nump">$ 128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DerivativeFinancialAssetAtDateOfDrawdown', window );">Derivative financial asset at date of drawdown</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives', window );">Fair value adjustments in the period</a></td>
<td class="num">(40)<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at end of the period</a></td>
<td class="nump">$ 166<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) on changes in the fair value of derivatives to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: At fair value [member]; Derivatives [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DerivativeFinancialAssetAtDateOfDrawdown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative financial liability at date of drawdown.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DerivativeFinancialAssetAtDateOfDrawdown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_DerivativeFinancialAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_DerivativeFinancialAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>185
<FILENAME>R159.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the derivative financial liability) (Details) - Non-current liability [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at January 1</a></td>
<td class="num">$ (55,177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at end of the period</a></td>
<td class="num">(91,263)<span></span>
</td>
<td class="num">$ (55,177)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember', window );">Derivative Financial Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at January 1</a></td>
<td class="num">(526)<span></span>
</td>
<td class="num">(1,569)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan', window );">Derivative financial liability at date of drawdown</a></td>
<td class="num">(1,066)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives', window );">Fair value adjustments in the period</a></td>
<td class="num">(66)<span></span>
</td>
<td class="nump">1,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at end of the period</a></td>
<td class="num">$ (1,658)<span></span>
</td>
<td class="num">$ (526)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gains (losses) on changes in the fair value of derivatives to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: At fair value [member]; Derivatives [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of derivative financial liability at date of issue of term loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_DerivativeFinancialLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_DerivativeFinancialLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>186
<FILENAME>R160.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the Term Loan and the 7-year convertible notes) (Details) - Non-current liability [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at January 1</a></td>
<td class="num">$ (55,177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at end of the period</a></td>
<td class="num">(91,263)<span></span>
</td>
<td class="num">$ (55,177)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember', window );">7-year Convertible Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at January 1</a></td>
<td class="num">(14,542)<span></span>
</td>
<td class="num">(13,746)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AccretionInterestOnBorrowings', window );">Accretion interest</a></td>
<td class="num">(859)<span></span>
</td>
<td class="num">(796)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at end of the period</a></td>
<td class="num">$ (15,401)<span></span>
</td>
<td class="num">$ (14,542)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AccretionInterestOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accretion interest on borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AccretionInterestOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=trib_NonCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SevenYearConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=trib_SevenYearConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>187
<FILENAME>R161.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASE LIABILITIES (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems', window );"><strong>Disclosure of maturity analysis of finance lease payments receivable [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AmountPaidInRespectOfLeaseLiabilities', window );">Total amount paid in respect of lease liabilities</a></td>
<td class="nump">$ 2,503,000<span></span>
</td>
<td class="nump">$ 2,318,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AmountPaidInRespectOfLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount paid in respect of lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AmountPaidInRespectOfLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>188
<FILENAME>R162.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASE LIABILITIES (Schedule of Carrying Values of Finance Lease Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CurrentLeaseLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent', window );">Lease liabilities related to Right of Use assets</a></td>
<td class="nump">$ 2,285<span></span>
</td>
<td class="nump">$ 1,694<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CurrentFinanceLeaseLiabilities', window );">Current liabilities</a></td>
<td class="nump">2,285<span></span>
</td>
<td class="nump">1,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NonCurrentLeaseLiabilitiesAbstract', window );"><strong>Non-Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent', window );">Lease liabilities related to Right of Use assets</a></td>
<td class="nump">$ 10,477<span></span>
</td>
<td class="nump">$ 10,872<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CurrentFinanceLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current finance lease liabilities as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CurrentFinanceLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CurrentLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CurrentLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease liabilities related to right of use assets current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease liabilities related to right of use assets non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NonCurrentLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NonCurrentLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>189
<FILENAME>R163.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASE LIABILITIES (Schedule of Finance Lease Liabilities Payable) (Details) - Lease Liabilities Related To Right Of Use Assets Member - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsPayable', window );">Minimum Finance Lease Payments Payable</a></td>
<td class="nump">$ 15,215<span></span>
</td>
<td class="nump">$ 15,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestExpenseOnLeaseLiabilities1', window );">Interest Expense On Lease Liabilities 1</a></td>
<td class="nump">2,453<span></span>
</td>
<td class="nump">2,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue', window );">Minimum Finance Lease Payments Payable At Present Value</a></td>
<td class="nump">12,762<span></span>
</td>
<td class="nump">12,566<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Less than one year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsPayable', window );">Minimum Finance Lease Payments Payable</a></td>
<td class="nump">2,862<span></span>
</td>
<td class="nump">2,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestExpenseOnLeaseLiabilities1', window );">Interest Expense On Lease Liabilities 1</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue', window );">Minimum Finance Lease Payments Payable At Present Value</a></td>
<td class="nump">2,285<span></span>
</td>
<td class="nump">1,644<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">In more than one year, but not more than two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsPayable', window );">Minimum Finance Lease Payments Payable</a></td>
<td class="nump">2,214<span></span>
</td>
<td class="nump">2,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestExpenseOnLeaseLiabilities1', window );">Interest Expense On Lease Liabilities 1</a></td>
<td class="nump">472<span></span>
</td>
<td class="nump">498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue', window );">Minimum Finance Lease Payments Payable At Present Value</a></td>
<td class="nump">1,742<span></span>
</td>
<td class="nump">1,745<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember', window );">In more than two years but not more than five [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsPayable', window );">Minimum Finance Lease Payments Payable</a></td>
<td class="nump">5,487<span></span>
</td>
<td class="nump">5,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestExpenseOnLeaseLiabilities1', window );">Interest Expense On Lease Liabilities 1</a></td>
<td class="nump">955<span></span>
</td>
<td class="nump">1,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue', window );">Minimum Finance Lease Payments Payable At Present Value</a></td>
<td class="nump">4,532<span></span>
</td>
<td class="nump">4,425<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">More than five years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsPayable', window );">Minimum Finance Lease Payments Payable</a></td>
<td class="nump">4,652<span></span>
</td>
<td class="nump">5,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestExpenseOnLeaseLiabilities1', window );">Interest Expense On Lease Liabilities 1</a></td>
<td class="nump">449<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue', window );">Minimum Finance Lease Payments Payable At Present Value</a></td>
<td class="nump">$ 4,203<span></span>
</td>
<td class="nump">$ 4,752<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_InterestExpenseOnLeaseLiabilities1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_InterestExpenseOnLeaseLiabilities1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_MinimumFinanceLeasePaymentsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payments over the finance lease term that the lessee is or can be required to make, excluding contingent rent, costs for services and taxes to be paid by, and reimbursed to, the lessor, together with any amounts guaranteed by the lessee or by a party related to the lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_MinimumFinanceLeasePaymentsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_MinimumFinanceLeasePaymentsPayableAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The present value of minimum finance lease payments payable. [Refer: Minimum finance lease payments payable]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_MinimumFinanceLeasePaymentsPayableAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>190
<FILENAME>R164.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 27, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Jan. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalCommitments', window );">Capital Commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 39,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_GrantContingenciesMaximumAmountPayable', window );">Grant contingencies maximum amount payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,313,000<span></span>
</td>
<td class="nump">3,410,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,384,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentProvisions', window );">Current provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,454,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Disposal-related warranty settlement provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_BiosynthMember', window );">Biosynth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AgreementPayments', window );">Agreement Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ProceedsFromSaleOfBusiness', window );">Proceeds from sale of business</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ReceivablesOutstanding', window );">Receivables Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">423,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Disposal-related warranty settlement provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember', window );">Waveform Technologies Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,760,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember', window );">Epi Capture Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 384,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Maximum [Member] | Waveform Technologies Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Maximum [Member] | Epi Capture Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems', window );"><strong>Disclosure of maturity analysis of operating lease payments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CapitalCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of future capital expenditures that the entity is committed to make.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CapitalCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provisions other than provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2024-01-01<br> -Paragraph 84<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_84_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AgreementPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AgreementPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, at acquisition date, of fair value of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_GrantContingenciesMaximumAmountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grant contingencies maximum amount payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_GrantContingenciesMaximumAmountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ProceedsFromSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ProceedsFromSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ReceivablesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts represents receivables outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ReceivablesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_BiosynthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_BiosynthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>191
<FILENAME>R165.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jul. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2007 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2007 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncreaseInAnnualRent', window );">Increase In annual rent | &#8364;</a></td>
<td class="nump">&#8364; 1,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 170,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_OverheadCosts', window );">Overhead costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 686,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DirectorsRemunerationExpense', window );">Non executive directors fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,454,000<span></span>
</td>
<td class="nump">$ 2,058,000<span></span>
</td>
<td class="nump">$ 1,639,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based compensation benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 931,000<span></span>
</td>
<td class="nump">1,601,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember', window );">Metabolomics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AcquisitionConsideration', window );">Acquisition Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">906,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExtinguishmentOfAmountOwed', window );">Extinguishment of monies owed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of minority shareholding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember', window );">Metabolomics [Member] | American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AcquisitionConsideration', window );">Acquisition Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_MrOCaoimhMember', window );">Mr. O'Caoimh [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AnnualRentPayableForWareHouse', window );">Annual rent payable for ware house</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 144,000<span></span>
</td>
<td class="nump">$ 159,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RateOfRentPerSqureFoot', window );">Rate of rent per squre foot</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_MrOCaoimhMember', window );">Mr. O'Caoimh [Member] | Additional Space [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AnnualRentPayable', window );">Annual rent payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_JrjMember', window );">JRJ Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TermOfLease', window );">Term of lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25-year<span></span>
</td>
<td class="text">25-year<span></span>
</td>
<td class="text">25-year<span></span>
</td>
<td class="text">25-year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AnnualRentPayable', window );">Annual rent payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 381,000<span></span>
</td>
<td class="nump">$ 421,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_MrOCaoimhAndDrWalshMember', window );">Mr. O'Caoimh and Dr Walsh [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TermOfLease', window );">Term of lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10-year<span></span>
</td>
<td class="text">10-year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AnnualRentPayable', window );">Annual rent payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 787,000<span></span>
</td>
<td class="nump">$ 834,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RateOfRentPerSqureFoot', window );">Rate of rent per squre foot</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_DirectorsMember', window );">Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DirectorsRemunerationExpense', window );">Non executive directors fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,000<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based compensation benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_DrJimWalshMember', window );">Dr. Jim Walsh [Member] | Metabolomics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of minority shareholding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Value attributable to interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DirectorsRemunerationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of remuneration paid or payable to the entity's directors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DirectorsRemunerationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AcquisitionConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AcquisitionConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AnnualRentPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual rent payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AnnualRentPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AnnualRentPayableForWareHouse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual rent payable for ware house.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AnnualRentPayableForWareHouse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ExtinguishmentOfAmountOwed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination extinguishment of amount owed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ExtinguishmentOfAmountOwed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IncreaseInAnnualRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents increase in annual rent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IncreaseInAnnualRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_OverheadCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amount of overhead costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_OverheadCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_RateOfRentPerSqureFoot">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of rent per squre foot.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_RateOfRentPerSqureFoot</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_TermOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_TermOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_MrOCaoimhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=trib_MrOCaoimhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_AdditionalSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_AdditionalSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_JrjMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=trib_JrjMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_MrOCaoimhAndDrWalshMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=trib_MrOCaoimhAndDrWalshMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=trib_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_DrJimWalshMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=trib_DrJimWalshMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>192
<FILENAME>R166.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Schedule of Compensation) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Short-term employee benefits</a></td>
<td class="nump">$ 843<span></span>
</td>
<td class="nump">$ 1,774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus', window );">Performance related bonus</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits', window );">Post-employment benefits</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based compensation benefits as calculated under IFRS 2</a></td>
<td class="nump">931<span></span>
</td>
<td class="nump">1,601<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total compensation</a></td>
<td class="nump">$ 2,073<span></span>
</td>
<td class="nump">$ 3,612<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Performance related bonus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>193
<FILENAME>R167.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Schedule of Company's Shares and Share Option Plan) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>Share </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>Share </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Share </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at end of year | Share</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Beginning Balance | Share</a></td>
<td class="nump">46,914,672<span></span>
</td>
<td class="nump">44,814,672<span></span>
</td>
<td class="nump">18,727,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted | Share</a></td>
<td class="nump">12,100,000<span></span>
</td>
<td class="nump">19,600,000<span></span>
</td>
<td class="nump">29,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at end of year | Share</a></td>
<td class="nump">40,506,672<span></span>
</td>
<td class="nump">46,914,672<span></span>
</td>
<td class="nump">44,814,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember', window );">Class A Ordinary shares [Member] | Directors and company secretary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Beginning Balance</a></td>
<td class="nump">11,117,777<span></span>
</td>
<td class="nump">11,117,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfRetiredDirectorOptions', window );">Options of retired director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SharesPurchasedDuringYear', window );">Shares Purchased During Year</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement', window );">Expired / forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at end of year</a></td>
<td class="nump">11,317,777<span></span>
</td>
<td class="nump">11,117,777<span></span>
</td>
<td class="nump">11,117,777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ShareOptionMember', window );">Share Option [Member] | Directors and company secretary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding Beginning Balance</a></td>
<td class="nump">30,387,336<span></span>
</td>
<td class="nump">40,547,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NumberOfRetiredDirectorOptions', window );">Options of retired director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SharesPurchasedDuringYear', window );">Shares Purchased During Year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted</a></td>
<td class="nump">5,600,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement', window );">Expired / forfeited</a></td>
<td class="num">(2,994,000)<span></span>
</td>
<td class="num">(4,160,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at end of year</a></td>
<td class="nump">32,993,336<span></span>
</td>
<td class="nump">30,387,336<span></span>
</td>
<td class="nump">40,547,336<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NumberOfRetiredDirectorOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options of retired director in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NumberOfRetiredDirectorOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_SharesPurchasedDuringYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares purchased during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_SharesPurchasedDuringYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=trib_DirectorsAndCompanySecretaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=trib_DirectorsAndCompanySecretaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ShareOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ShareOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>194
<FILENAME>R168.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SeniorSecuredTermLoanFixedRate', window );">Senior secured term loan fixed rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_GrossIncreaseInterestIncome', window );">Gross Increase Interest Income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NetInterestIncome', window );">Net interest income</a></td>
<td class="nump">$ 755,000<span></span>
</td>
<td class="nump">$ 417,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TermLoanAgreementDescription', window );">Term loan agreement description</a></td>
<td class="text">the
amended term loan agreement reduced the annual rate of interest on the loan by 2.5% to 8.75% plus the greater of (a) Term Secured Overnight
Financing Rate or (b) 4.0% per annum, and allows for a further 2.5% reduction in the base rate to 6.25% once the outstanding principal
under the term loan falls below US$35 million.&#160; The loan matures in July 2026.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_GrossIncreaseInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the gross Increase interest income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_GrossIncreaseInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NetInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the net interest income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NetInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_SeniorSecuredTermLoanFixedRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents about senior secured term loan fixed rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_SeniorSecuredTermLoanFixedRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_TermLoanAgreementDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents about term loan agreement description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_TermLoanAgreementDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>195
<FILENAME>R169.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Fair Values of Financial Assets/Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LoansAndReceivablesAbstract', window );"><strong>Loans and receivables at amortised cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">$ 2,286,000<span></span>
</td>
<td class="nump">$ 2,324,000<span></span>
</td>
<td class="nump">$ 2,691,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">5,167<span></span>
</td>
<td class="nump">3,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Finance lease receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRisk', window );">Total maximum credit exposure</a></td>
<td class="nump">18,583<span></span>
</td>
<td class="nump">14,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LiabilitiesAtAmortisedCostAbstract', window );"><strong>Liabilities at amortised cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="num">(72,391)<span></span>
</td>
<td class="num">(40,109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible note</a></td>
<td class="num">(15,401)<span></span>
</td>
<td class="num">(14,542)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="num">(210)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Provisions</a></td>
<td class="num">(2,529)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAtFairValueThroughProfitOrLossAbstract', window );"><strong>Fair value through profit and loss (FVPL)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Derivative liability - warrants</a></td>
<td class="num">(1,658)<span></span>
</td>
<td class="num">(526)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Derivative asset &#8211; prepayment option</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LoansAndReceivablesAbstract', window );"><strong>Loans and receivables at amortised cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">13,416<span></span>
</td>
<td class="nump">10,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">5,167<span></span>
</td>
<td class="nump">3,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Finance lease receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRisk', window );">Total maximum credit exposure</a></td>
<td class="nump">18,583<span></span>
</td>
<td class="nump">14,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LiabilitiesAtAmortisedCostAbstract', window );"><strong>Liabilities at amortised cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible note</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(12,762)<span></span>
</td>
<td class="num">(12,566)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables (excluding deferred income)</a></td>
<td class="num">(26,585)<span></span>
</td>
<td class="num">(12,752)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Provisions</a></td>
<td class="num">(2,529)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtAmortisedCost', window );">Total Liabilities at amortised cost</a></td>
<td class="num">(41,876)<span></span>
</td>
<td class="num">(25,368)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAtFairValueThroughProfitOrLossAbstract', window );"><strong>Fair value through profit and loss (FVPL)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Derivative liability - warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Derivative asset &#8211; prepayment option</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueThroughProfitAndLoss', window );">Total fair value through profit and loss (FVPL)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueOfFinancialAssetsLiabilities', window );">Total fair value of financial assets liabilities</a></td>
<td class="num">(23,293)<span></span>
</td>
<td class="num">(10,824)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember', window );">Level 1 [Member] | Novus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAtFairValueThroughProfitOrLossAbstract', window );"><strong>Fair value through profit and loss (FVPL)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Equity investments in Novus</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LoansAndReceivablesAbstract', window );"><strong>Loans and receivables at amortised cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Finance lease receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRisk', window );">Total maximum credit exposure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LiabilitiesAtAmortisedCostAbstract', window );"><strong>Liabilities at amortised cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="num">(72,391)<span></span>
</td>
<td class="num">(40,109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible note</a></td>
<td class="num">(15,401)<span></span>
</td>
<td class="num">(14,542)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="num">(210)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables (excluding deferred income)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Provisions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtAmortisedCost', window );">Total Liabilities at amortised cost</a></td>
<td class="num">(88,002)<span></span>
</td>
<td class="num">(54,861)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAtFairValueThroughProfitOrLossAbstract', window );"><strong>Fair value through profit and loss (FVPL)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Derivative liability - warrants</a></td>
<td class="num">(1,658)<span></span>
</td>
<td class="num">(526)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Derivative asset &#8211; prepayment option</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueThroughProfitAndLoss', window );">Total fair value through profit and loss (FVPL)</a></td>
<td class="num">(1,492)<span></span>
</td>
<td class="num">(348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueOfFinancialAssetsLiabilities', window );">Total fair value of financial assets liabilities</a></td>
<td class="num">(89,494)<span></span>
</td>
<td class="num">(55,209)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level 2 [Member] | Novus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAtFairValueThroughProfitOrLossAbstract', window );"><strong>Fair value through profit and loss (FVPL)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Equity investments in Novus</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LoansAndReceivablesAbstract', window );"><strong>Loans and receivables at amortised cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Finance lease receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRisk', window );">Total maximum credit exposure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LiabilitiesAtAmortisedCostAbstract', window );"><strong>Liabilities at amortised cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible note</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables (excluding deferred income)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Provisions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtAmortisedCost', window );">Total Liabilities at amortised cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAtFairValueThroughProfitOrLossAbstract', window );"><strong>Fair value through profit and loss (FVPL)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Derivative liability - warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Derivative asset &#8211; prepayment option</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueThroughProfitAndLoss', window );">Total fair value through profit and loss (FVPL)</a></td>
<td class="nump">2,455<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueOfFinancialAssetsLiabilities', window );">Total fair value of financial assets liabilities</a></td>
<td class="nump">2,455<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level 3 [Member] | Novus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAtFairValueThroughProfitOrLossAbstract', window );"><strong>Fair value through profit and loss (FVPL)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Equity investments in Novus</a></td>
<td class="nump">2,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_CarryingAmountMember', window );">Carrying Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LoansAndReceivablesAbstract', window );"><strong>Loans and receivables at amortised cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">13,416<span></span>
</td>
<td class="nump">10,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">5,167<span></span>
</td>
<td class="nump">3,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Finance lease receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRisk', window );">Total maximum credit exposure</a></td>
<td class="nump">18,583<span></span>
</td>
<td class="nump">14,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LiabilitiesAtAmortisedCostAbstract', window );"><strong>Liabilities at amortised cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="num">(72,391)<span></span>
</td>
<td class="num">(40,109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible note</a></td>
<td class="num">(15,401)<span></span>
</td>
<td class="num">(14,542)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="num">(210)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(12,762)<span></span>
</td>
<td class="num">(12,566)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables (excluding deferred income)</a></td>
<td class="num">(26,585)<span></span>
</td>
<td class="num">(12,752)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Provisions</a></td>
<td class="num">(2,529)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtAmortisedCost', window );">Total Liabilities at amortised cost</a></td>
<td class="num">(129,878)<span></span>
</td>
<td class="num">(80,229)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAtFairValueThroughProfitOrLossAbstract', window );"><strong>Fair value through profit and loss (FVPL)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Derivative liability - warrants</a></td>
<td class="num">(1,658)<span></span>
</td>
<td class="num">(526)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Derivative asset &#8211; prepayment option</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueThroughProfitAndLoss', window );">Total fair value through profit and loss (FVPL)</a></td>
<td class="nump">963<span></span>
</td>
<td class="num">(348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueOfFinancialAssetsLiabilities', window );">Total fair value of financial assets liabilities</a></td>
<td class="num">(110,332)<span></span>
</td>
<td class="num">(66,033)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_CarryingAmountMember', window );">Carrying Amount [Member] | Novus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAtFairValueThroughProfitOrLossAbstract', window );"><strong>Fair value through profit and loss (FVPL)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Equity investments in Novus</a></td>
<td class="nump">2,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=trib_FairValueMember', window );">Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LoansAndReceivablesAbstract', window );"><strong>Loans and receivables at amortised cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">13,416<span></span>
</td>
<td class="nump">10,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">5,167<span></span>
</td>
<td class="nump">3,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Finance lease receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRisk', window );">Total maximum credit exposure</a></td>
<td class="nump">18,583<span></span>
</td>
<td class="nump">14,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LiabilitiesAtAmortisedCostAbstract', window );"><strong>Liabilities at amortised cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="num">(72,391)<span></span>
</td>
<td class="num">(40,109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible note</a></td>
<td class="num">(15,401)<span></span>
</td>
<td class="num">(14,542)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="num">(210)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(12,762)<span></span>
</td>
<td class="num">(12,566)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables (excluding deferred income)</a></td>
<td class="num">(26,585)<span></span>
</td>
<td class="num">(12,752)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Provisions</a></td>
<td class="num">(2,529)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtAmortisedCost', window );">Total Liabilities at amortised cost</a></td>
<td class="num">(129,878)<span></span>
</td>
<td class="num">(80,229)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAtFairValueThroughProfitOrLossAbstract', window );"><strong>Fair value through profit and loss (FVPL)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities', window );">Derivative liability - warrants</a></td>
<td class="num">(1,658)<span></span>
</td>
<td class="num">(526)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Derivative asset &#8211; prepayment option</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueThroughProfitAndLoss', window );">Total fair value through profit and loss (FVPL)</a></td>
<td class="nump">963<span></span>
</td>
<td class="num">(348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueOfFinancialAssetsLiabilities', window );">Total fair value of financial assets liabilities</a></td>
<td class="num">(110,332)<span></span>
</td>
<td class="num">$ (66,033)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=trib_FairValueMember', window );">Fair Value [Member] | Novus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAtFairValueThroughProfitOrLossAbstract', window );"><strong>Fair value through profit and loss (FVPL)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Equity investments in Novus</a></td>
<td class="nump">$ 2,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtAmortisedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities at amortised cost. The amortised cost is the amount at which financial liabilities are measured at initial recognition minus principal repayments, plus or minus the cumulative amortisation using the effective interest method of any difference between that initial amount and the maturity amount. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 8<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_8_g&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtAmortisedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaximumExposureToCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that best represents the maximum exposure to credit risk without taking into account any collateral held or other credit enhancements (for example, netting agreements that do not qualify for offset in accordance with IAS 32). [Refer: Credit risk [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35K<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35K_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaximumExposureToCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2024-01-01<br> -Paragraph 22<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentDerivativeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current derivative financial assets. [Refer: Derivative financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentDerivativeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current other borrowings. [Refer: Other borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Provisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities of uncertain timing or amount, including provisions for employee benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Provisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade payables and other payables. [Refer: Trade payables; Other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amout represents convertiable note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FairValueOfFinancialAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total fair value of financial assets liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FairValueOfFinancialAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FairValueThroughProfitAndLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ffair value through profit and loss (FVPL).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FairValueThroughProfitAndLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FinancialAtFairValueThroughProfitOrLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FinancialAtFairValueThroughProfitOrLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LiabilitiesAtAmortisedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LiabilitiesAtAmortisedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LoansAndReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LoansAndReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnconsolidatedStructuredEntitiesAxis=trib_NovusDiagnosticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnconsolidatedStructuredEntitiesAxis=trib_NovusDiagnosticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_CarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_CarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=trib_FairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=trib_FairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>196
<FILENAME>R170.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Interest Rate Risk Effective and Repricing Analysis) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,167<span></span>
</td>
<td class="nump">$ 3,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Lease receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(210)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities', window );">Total interest earning financial and interest bearing financial liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (95,597)<span></span>
</td>
<td class="num">$ (63,581)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_CashAndCashEquivalentMember', window );">Cash and cash equivalents [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EffectiveInterestRate', window );">Effective interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,167<span></span>
</td>
<td class="nump">$ 3,691<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_FinanceLeaseReceivableMember', window );">Finance Lease Receivable Member</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EffectiveInterestRate', window );">Effective interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Lease receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_ExchangeableNoteMember', window );">Exchangeable note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EffectiveInterestRate', window );">Effective interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (210)<span></span>
</td>
<td class="num">$ (210)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_SeniorSecuredTermLoanMember', window );">Senior Secured Term Loan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EffectiveInterestRate', window );">Effective interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">16.30%<span></span>
</td>
<td class="nump">16.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">$ (72,391)<span></span>
</td>
<td class="num">$ (40,109)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_ConvertibleNoteMember', window );">Convertible Note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EffectiveInterestRate', window );">Effective interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">$ (15,401)<span></span>
</td>
<td class="num">$ (14,542)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_LeasePayableOnRightOfUseAssetsMember', window );">Lease payable on Right of Use assets [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EffectiveInterestRate', window );">Effective interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeasePayableOnRightOfUseAssets', window );">Lease payable on Right of Use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (12,762)<span></span>
</td>
<td class="num">$ (12,566)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthOrLessMember', window );">Six Month Or Less Member</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities', window );">Total interest earning financial and interest bearing financial liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,017<span></span>
</td>
<td class="nump">2,941<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthOrLessMember', window );">Six Month Or Less Member | Cash and cash equivalents [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,167<span></span>
</td>
<td class="nump">3,691<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthOrLessMember', window );">Six Month Or Less Member | Finance Lease Receivable Member</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Lease receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthOrLessMember', window );">Six Month Or Less Member | Exchangeable note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthOrLessMember', window );">Six Month Or Less Member | Senior Secured Term Loan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthOrLessMember', window );">Six Month Or Less Member | Convertible Note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthOrLessMember', window );">Six Month Or Less Member | Lease payable on Right of Use assets [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeasePayableOnRightOfUseAssets', window );">Lease payable on Right of Use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,150)<span></span>
</td>
<td class="num">(812)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthToTwelveMonthMember', window );">Six Month To Twelve Month Member</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities', window );">Total interest earning financial and interest bearing financial liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,135)<span></span>
</td>
<td class="num">(793)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthToTwelveMonthMember', window );">Six Month To Twelve Month Member | Cash and cash equivalents [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthToTwelveMonthMember', window );">Six Month To Twelve Month Member | Finance Lease Receivable Member</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Lease receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthToTwelveMonthMember', window );">Six Month To Twelve Month Member | Exchangeable note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthToTwelveMonthMember', window );">Six Month To Twelve Month Member | Senior Secured Term Loan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthToTwelveMonthMember', window );">Six Month To Twelve Month Member | Convertible Note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthToTwelveMonthMember', window );">Six Month To Twelve Month Member | Lease payable on Right of Use assets [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeasePayableOnRightOfUseAssets', window );">Lease payable on Right of Use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,135)<span></span>
</td>
<td class="num">(832)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_OneYearToTwoYearsMember', window );">One Year To Two Years Member</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities', window );">Total interest earning financial and interest bearing financial liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(74,133)<span></span>
</td>
<td class="num">(1,696)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_OneYearToTwoYearsMember', window );">One Year To Two Years Member | Cash and cash equivalents [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_OneYearToTwoYearsMember', window );">One Year To Two Years Member | Finance Lease Receivable Member</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Lease receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_OneYearToTwoYearsMember', window );">One Year To Two Years Member | Exchangeable note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_OneYearToTwoYearsMember', window );">One Year To Two Years Member | Senior Secured Term Loan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(72,391)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_OneYearToTwoYearsMember', window );">One Year To Two Years Member | Convertible Note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_OneYearToTwoYearsMember', window );">One Year To Two Years Member | Lease payable on Right of Use assets [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeasePayableOnRightOfUseAssets', window );">Lease payable on Right of Use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,742)<span></span>
</td>
<td class="num">(1,745)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_TwoYearToFiveYearsMember', window );">Two Year To Five Years Member</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities', window );">Total interest earning financial and interest bearing financial liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(19,933)<span></span>
</td>
<td class="num">(44,529)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_TwoYearToFiveYearsMember', window );">Two Year To Five Years Member | Cash and cash equivalents [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_TwoYearToFiveYearsMember', window );">Two Year To Five Years Member | Finance Lease Receivable Member</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Lease receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_TwoYearToFiveYearsMember', window );">Two Year To Five Years Member | Exchangeable note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_TwoYearToFiveYearsMember', window );">Two Year To Five Years Member | Senior Secured Term Loan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(40,109)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_TwoYearToFiveYearsMember', window );">Two Year To Five Years Member | Convertible Note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(15,401)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_TwoYearToFiveYearsMember', window );">Two Year To Five Years Member | Lease payable on Right of Use assets [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeasePayableOnRightOfUseAssets', window );">Lease payable on Right of Use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,532)<span></span>
</td>
<td class="num">(4,425)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_GreaterThanFiveYearsMember', window );">Greater Than Five Years Member</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities', window );">Total interest earning financial and interest bearing financial liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,413)<span></span>
</td>
<td class="num">(19,504)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_GreaterThanFiveYearsMember', window );">Greater Than Five Years Member | Cash and cash equivalents [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_GreaterThanFiveYearsMember', window );">Greater Than Five Years Member | Finance Lease Receivable Member</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Lease receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_GreaterThanFiveYearsMember', window );">Greater Than Five Years Member | Exchangeable note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(210)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_GreaterThanFiveYearsMember', window );">Greater Than Five Years Member | Senior Secured Term Loan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_GreaterThanFiveYearsMember', window );">Greater Than Five Years Member | Convertible Note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable note</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(14,542)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_GreaterThanFiveYearsMember', window );">Greater Than Five Years Member | Lease payable on Right of Use assets [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeasePayableOnRightOfUseAssets', window );">Lease payable on Right of Use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (4,203)<span></span>
</td>
<td class="num">$ (4,752)<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The maturity of the exchangeable notes is based on the contractual maturity date of April 1, 2045.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The senior secured term loan is a variable instrument. In January 2024, the amended term loan agreement reduced the annual rate of interest on the loan by 2.5% to 8.75% plus the greater of (a) Term Secured Overnight Financing Rate or (b) 4.0% per annum, and allows for a further 2.5% reduction in the base rate to 6.25% once the outstanding principal under the term loan falls below US$35 million. The loan matures in July 2026.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The 7-year convertible note was issued in May 2022 and is a fixed rate instrument which bears a fixed rate of interest of 1.5% per annum.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_EffectiveInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_EffectiveInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total interest earning financial and interest bearing financial liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LeasePayableOnRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payable on right of use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LeasePayableOnRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_CashAndCashEquivalentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_CashAndCashEquivalentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_FinanceLeaseReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_FinanceLeaseReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_ExchangeableNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_ExchangeableNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_SeniorSecuredTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_SeniorSecuredTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_ConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_ConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_LeasePayableOnRightOfUseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=trib_LeasePayableOnRightOfUseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=trib_SixMonthOrLessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=trib_SixMonthOrLessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=trib_SixMonthToTwelveMonthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=trib_SixMonthToTwelveMonthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=trib_OneYearToTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=trib_OneYearToTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=trib_TwoYearToFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=trib_TwoYearToFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=trib_GreaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=trib_GreaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>197
<FILENAME>R171.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of  interest Rate Profile of Financial Assets/Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_VariableRateInstrumentsAbstract', window );"><strong>Variable Rate Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash at bank and in hand</a></td>
<td class="nump">$ 5,167<span></span>
</td>
<td class="nump">$ 3,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Variable rate financial liabilities (senior secured term loan)</a></td>
<td class="num">(72,391)<span></span>
</td>
<td class="num">(40,109)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_VariableRateInstruments', window );">Variable rate instruments</a></td>
<td class="num">(67,224)<span></span>
</td>
<td class="num">(36,418)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FixedRateInstrumentsAbstract', window );"><strong>Fixed rate instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Fixed rate financial liabilities (exchangeable note)</a></td>
<td class="num">(210)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Fixed rate financial liabilities (convertible note)</a></td>
<td class="num">(15,401)<span></span>
</td>
<td class="num">(14,542)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Fixed rate financial liabilities (lease payables)</a></td>
<td class="num">(12,762)<span></span>
</td>
<td class="num">(12,566)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FinancialAssetsLeaseReceivables', window );">Financial assets (lease receivables)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FixedRateInstruments', window );">Fixed rate instruments</a></td>
<td class="num">$ (28,373)<span></span>
</td>
<td class="num">$ (27,163)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current other borrowings. [Refer: Other borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amout represents convertiable note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FinancialAssetsLeaseReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial assets lease receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FinancialAssetsLeaseReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FixedRateInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of total fixed rate instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FixedRateInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FixedRateInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FixedRateInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_VariableRateInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of variable rate instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_VariableRateInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_VariableRateInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_VariableRateInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>198
<FILENAME>R172.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Liquidity Risk Estimated Interest Payments of Maturities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="nump">$ 72,391<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 40,109<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible Note</a></td>
<td class="nump">15,401<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,542<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable notes</a></td>
<td class="nump">210<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">210<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables (excluding deferred income)</a></td>
<td class="nump">25,286<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeasePayableOnRightOfUseAssets', window );">Lease payable on Right of Use assets</a></td>
<td class="nump">12,762<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,566<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="nump">72,391<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">40,109<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible Note</a></td>
<td class="nump">15,401<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,542<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable notes</a></td>
<td class="nump">210<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">210<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total maturities of financial liabilities</a></td>
<td class="nump">126,050<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">80,179<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_ContractualCashFlowsMember', window );">Contractual cash flows [Member] | Liquidity risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables (excluding deferred income)</a></td>
<td class="nump">25,286<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeasePayableOnRightOfUseAssets', window );">Lease payable on Right of Use assets</a></td>
<td class="nump">15,214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15,306<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="nump">81,438<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">56,121<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible Note</a></td>
<td class="nump">21,350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,650<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable notes</a></td>
<td class="nump">380<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total maturities of financial liabilities</a></td>
<td class="nump">143,668<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">106,218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthOrLessMember', window );">Six Month Or Less Member | Liquidity risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables (excluding deferred income)</a></td>
<td class="nump">25,286<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeasePayableOnRightOfUseAssets', window );">Lease payable on Right of Use assets</a></td>
<td class="nump">1,454<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,107<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,461<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible Note</a></td>
<td class="nump">150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable notes</a></td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total maturities of financial liabilities</a></td>
<td class="nump">28,597<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,474<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_SixMonthToTwelveMonthMember', window );">Six Month To Twelve Month Member | Liquidity risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables (excluding deferred income)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeasePayableOnRightOfUseAssets', window );">Lease payable on Right of Use assets</a></td>
<td class="nump">1,408<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,114<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="nump">3,319<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,461<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible Note</a></td>
<td class="nump">150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable notes</a></td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total maturities of financial liabilities</a></td>
<td class="nump">4,881<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,729<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_OneYearToTwoYearsMember', window );">One Year To Two Years Member | Liquidity risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables (excluding deferred income)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeasePayableOnRightOfUseAssets', window );">Lease payable on Right of Use assets</a></td>
<td class="nump">2,213<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,243<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="nump">76,416<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">6,922<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible Note</a></td>
<td class="nump">300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable notes</a></td>
<td class="nump">8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total maturities of financial liabilities</a></td>
<td class="nump">78,937<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,473<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_TwoYearToFiveYearsMember', window );">Two Year To Five Years Member | Liquidity risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables (excluding deferred income)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeasePayableOnRightOfUseAssets', window );">Lease payable on Right of Use assets</a></td>
<td class="nump">5,487<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,442<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">42,277<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible Note</a></td>
<td class="nump">900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable notes</a></td>
<td class="nump">24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total maturities of financial liabilities</a></td>
<td class="nump">6,411<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">48,643<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=trib_GreaterThanFiveYearsMember', window );">&gt;5 years [Member] | Liquidity risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract', window );"><strong>Financial liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables (excluding deferred income)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LeasePayableOnRightOfUseAssets', window );">Lease payable on Right of Use assets</a></td>
<td class="nump">4,652<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings', window );">Senior secured term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ConvertibleNote', window );">Convertible Note</a></td>
<td class="nump">19,850<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20,150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Exchangeable notes</a></td>
<td class="nump">340<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">349<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total maturities of financial liabilities</a></td>
<td class="nump">$ 24,842<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 25,899<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December 31, 2023</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December 31, 2022.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current other borrowings. [Refer: Other borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade payables and other payables. [Refer: Trade payables; Other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amout represents convertiable note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LeasePayableOnRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payable on right of use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LeasePayableOnRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=trib_ContractualCashFlowsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=trib_ContractualCashFlowsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=trib_SixMonthOrLessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=trib_SixMonthOrLessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=trib_SixMonthToTwelveMonthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=trib_SixMonthToTwelveMonthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=trib_OneYearToTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=trib_OneYearToTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=trib_TwoYearToFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=trib_TwoYearToFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=trib_GreaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=trib_GreaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>199
<FILENAME>R173.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Foreign Currency Risk Short Term Financial Assets and Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="nump">$ 5,167<span></span>
</td>
<td class="nump">$ 3,691<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivables', window );">Trade and other receivable</a></td>
<td class="nump">1,009<span></span>
</td>
<td class="nump">856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="num">(7,098)<span></span>
</td>
<td class="num">(3,766)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(6,867)<span></span>
</td>
<td class="num">(8,349)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TotalExposureFinancialInstruments', window );">Total exposure</a></td>
<td class="num">(12,840)<span></span>
</td>
<td class="num">(11,040)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_GBP', window );">GBP [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivables', window );">Trade and other receivable</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="num">(453)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TotalExposureFinancialInstruments', window );">Total exposure</a></td>
<td class="num">(329)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_SEK', window );">SEK [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivables', window );">Trade and other receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TotalExposureFinancialInstruments', window );">Total exposure</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CAD', window );">CAD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivables', window );">Trade and other receivable</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="num">(114)<span></span>
</td>
<td class="num">(220)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TotalExposureFinancialInstruments', window );">Total exposure</a></td>
<td class="nump">473<span></span>
</td>
<td class="nump">504<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_BRL', window );">BRL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">854<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivables', window );">Trade and other receivable</a></td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">1,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="num">(135)<span></span>
</td>
<td class="num">(704)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(171)<span></span>
</td>
<td class="num">(241)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TotalExposureFinancialInstruments', window );">Total exposure</a></td>
<td class="nump">1,086<span></span>
</td>
<td class="nump">1,442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_XXX', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivables', window );">Trade and other receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TotalExposureFinancialInstruments', window );">Total exposure</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2024-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade payables and other payables. [Refer: Trade payables; Other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_TotalExposureFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total credit exposure associated with derivative financial assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_TotalExposureFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_SEK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_SEK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_BRL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_BRL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_XXX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_XXX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>200
<FILENAME>R174.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Sensitivity Analysis) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems', window );"><strong>Disclosure of information about amounts that affected statement of comprehensive income as result of hedge accounting [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit or loss</a></td>
<td class="num">$ (31,216)<span></span>
</td>
<td class="num">$ (36,868)<span></span>
</td>
<td class="num">$ (43,586)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro [Member] | 10% strengthening US Dollar [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems', window );"><strong>Disclosure of information about amounts that affected statement of comprehensive income as result of hedge accounting [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit or loss</a></td>
<td class="nump">1,167<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro [Member] | 10% Weakening US Dollar [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems', window );"><strong>Disclosure of information about amounts that affected statement of comprehensive income as result of hedge accounting [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit or loss</a></td>
<td class="num">$ (1,427)<span></span>
</td>
<td class="num">$ (1,227)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2024-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2024-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=trib_TenPercentStrengtheningUSDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=trib_TenPercentStrengtheningUSDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=trib_TenPercentWeakeningUSDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=trib_TenPercentWeakeningUSDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>201
<FILENAME>R175.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Maximum Credit Exposure of Financial Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Third party trade receivables</a></td>
<td class="nump">$ 13,416<span></span>
</td>
<td class="nump">$ 10,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue', window );">Finance lease income receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">5,167<span></span>
</td>
<td class="nump">3,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRisk', window );">Total maximum credit exposure</a></td>
<td class="nump">$ 18,583<span></span>
</td>
<td class="nump">$ 14,544<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaximumExposureToCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that best represents the maximum exposure to credit risk without taking into account any collateral held or other credit enhancements (for example, netting agreements that do not qualify for offset in accordance with IAS 32). [Refer: Credit risk [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35K<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35K_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaximumExposureToCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>202
<FILENAME>R176.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Exposure of Trade Receivables by Geographic Location) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables', window );">Maximum Exposure to credit risk for trade receivables and finance lease income receivable</a></td>
<td class="nump">$ 13,416<span></span>
</td>
<td class="nump">$ 10,853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables', window );">Maximum Exposure to credit risk for trade receivables and finance lease income receivable</a></td>
<td class="nump">4,185<span></span>
</td>
<td class="nump">4,041<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_EuroZoneCountriesMember', window );">Euro-zone countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables', window );">Maximum Exposure to credit risk for trade receivables and finance lease income receivable</a></td>
<td class="nump">742<span></span>
</td>
<td class="nump">851<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">United Kingdom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables', window );">Maximum Exposure to credit risk for trade receivables and finance lease income receivable</a></td>
<td class="nump">741<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=trib_OtherRegionsMember', window );">Other regions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables', window );">Maximum Exposure to credit risk for trade receivables and finance lease income receivable</a></td>
<td class="nump">$ 7,748<span></span>
</td>
<td class="nump">$ 5,835<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCreditRiskExposureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum exposure to the credit risk of loans or receivables. [Refer: Loans and receivables; Credit risk [member]; Maximum exposure to credit risk]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 9<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_9_a&amp;doctype=Standard&amp;book=b<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_EuroZoneCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_EuroZoneCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=trib_OtherRegionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=trib_OtherRegionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>203
<FILENAME>R177.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Exposure of Trade Receivables by Customer) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables', window );">Maximum Exposure to credit risk for trade receivables and finance lease income receivable</a></td>
<td class="nump">$ 13,416<span></span>
</td>
<td class="nump">$ 10,853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfCustomersAxis=trib_EndUserCustomersMember', window );">End User Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables', window );">Maximum Exposure to credit risk for trade receivables and finance lease income receivable</a></td>
<td class="nump">3,828<span></span>
</td>
<td class="nump">5,029<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfCustomersAxis=trib_DistributorsMember', window );">Distributors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables', window );">Maximum Exposure to credit risk for trade receivables and finance lease income receivable</a></td>
<td class="nump">8,236<span></span>
</td>
<td class="nump">5,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfCustomersAxis=ifrs-full_NongovernmentCustomersMember', window );">Non-governmental organisations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems', window );"><strong>Disclosure of credit risk exposure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables', window );">Maximum Exposure to credit risk for trade receivables and finance lease income receivable</a></td>
<td class="nump">$ 1,352<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCreditRiskExposureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCreditRiskExposureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum exposure to the credit risk of loans or receivables. [Refer: Loans and receivables; Credit risk [member]; Maximum exposure to credit risk]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 9<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_9_a&amp;doctype=Standard&amp;book=b<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfCustomersAxis=trib_EndUserCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfCustomersAxis=trib_EndUserCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfCustomersAxis=trib_DistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfCustomersAxis=trib_DistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfCustomersAxis=ifrs-full_NongovernmentCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfCustomersAxis=ifrs-full_NongovernmentCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>204
<FILENAME>R178.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Ageing of Trade Receivables) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">$ 2,286,000<span></span>
</td>
<td class="nump">$ 2,324,000<span></span>
</td>
<td class="nump">$ 2,691,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedCreditLossRate', window );">Expected credit loss rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=ifrs-full_CurrentMember', window );">Not past due [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedCreditLossRate', window );">Expected credit loss rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember', window );">Past due 0-30 days [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedCreditLossRate', window );">Expected credit loss rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember', window );">Past due 31-120 days [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedCreditLossRate', window );">Expected credit loss rate</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=trib_GreaterThanFourMonthsMember', window );">Greater Than Four Months Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedCreditLossRate', window );">Expected credit loss rate</a></td>
<td class="nump">72.00%<span></span>
</td>
<td class="nump">88.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">$ 15,702<span></span>
</td>
<td class="nump">$ 13,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Not past due [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">9,363<span></span>
</td>
<td class="nump">8,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Past due 0-30 days [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">1,455<span></span>
</td>
<td class="nump">1,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Past due 31-120 days [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">1,753<span></span>
</td>
<td class="nump">856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Greater Than Four Months Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">3,131<span></span>
</td>
<td class="nump">2,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember', window );">Accumulated impairment Charge [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">2,286<span></span>
</td>
<td class="nump">2,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember', window );">Accumulated impairment Charge [Member] | Not past due [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember', window );">Accumulated impairment Charge [Member] | Past due 0-30 days [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember', window );">Accumulated impairment Charge [Member] | Past due 31-120 days [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember', window );">Accumulated impairment Charge [Member] | Greater Than Four Months Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">$ 2,255<span></span>
</td>
<td class="nump">$ 2,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedCreditLossRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate of expected credit losses, calculated as percentage of the gross carrying amount. Expected credit losses are the weighted average of credit losses with the respective risks of a default occurring as the weights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph IG20D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IG20D&amp;doctype=Implementation%20Guidance<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedCreditLossRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_CurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_CurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=trib_GreaterThanFourMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=trib_GreaterThanFourMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>205
<FILENAME>R179.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Movement in the Allowance for Impairment of Trade Receivables) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AllowanceForImpairmentOfReceivables', window );">Balance at January 1</a></td>
<td class="nump">$ 2,324<span></span>
</td>
<td class="nump">$ 2,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseThroughOriginationOrPurchaseFinancialAssets', window );">Charged to costs and expenses</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughWriteoffFinancialAssets', window );">Amounts written off during the year</a></td>
<td class="num">(263)<span></span>
</td>
<td class="num">(977)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_EliminatedOnDisposalsOfBusiness', window );">Eliminated on disposal of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AllowanceForImpairmentOfReceivables', window );">Balance at December 31</a></td>
<td class="nump">$ 2,286<span></span>
</td>
<td class="nump">$ 2,324<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DecreaseThroughWriteoffFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in financial assets resulting from write-off. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35I<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35I_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph IG20B<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IG20B&amp;doctype=Implementation%20Guidance<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DecreaseThroughWriteoffFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseThroughOriginationOrPurchaseFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in financial assets resulting from origination or purchase. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph IG20B<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IG20B&amp;doctype=Implementation%20Guidance<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 35I<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_35I_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseThroughOriginationOrPurchaseFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AllowanceForImpairmentOfReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance for impairment of receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AllowanceForImpairmentOfReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_EliminatedOnDisposalsOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of eliminated on disposal of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_EliminatedOnDisposalsOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>206
<FILENAME>R180.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Schedule of Liabilities Arising from Financing) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Balance at January 1, 2022</a></td>
<td class="nump">$ 12,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Cash-flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ProceedsForConvertibleNoteIssued', window );">Principal amount loaned &#8211; convertible note</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestPaidOnSeniorSecuredTermLoan', window );">Interest paid for senior secured term loan</a></td>
<td class="nump">5,946<span></span>
</td>
<td class="nump">7,314<span></span>
</td>
<td class="nump">6,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestPaidOnConvertibleNote', window );">Interest paid for convertible note</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest paid on exchangeable notes</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(1,293)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBondsNotesAndDebentures', window );">Repayment of exchangeable notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(86,730)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of leases</a></td>
<td class="num">(2,503)<span></span>
</td>
<td class="num">(2,318)<span></span>
</td>
<td class="num">(2,761)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NonCashActivityForFinancingActivityAbstract', window );"><strong>Non-cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_LossOnDisposalOfExchangeableNotes', window );">Loss on disposal of Exchangeable Notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NoncashLoanModificationGain', window );">Non cash loan modification gain</a></td>
<td class="nump">3,567<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Balance at December 31, 2022</a></td>
<td class="nump">12,762<span></span>
</td>
<td class="nump">12,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LongtermBorrowingsMember', window );">Borrowings &amp; derivative financial instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Balance at January 1, 2022</a></td>
<td class="nump">55,387<span></span>
</td>
<td class="nump">59,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Cash-flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Principal amount loaned &#8211; term loan</a></td>
<td class="nump">30,500<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalAmountLoaned', window );">Loan origination costs paid</a></td>
<td class="num">(324)<span></span>
</td>
<td class="num">(194)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestPaidOnSeniorSecuredTermLoan', window );">Interest paid for senior secured term loan</a></td>
<td class="num">(6,253)<span></span>
</td>
<td class="num">(7,314)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestPaidOnConvertibleNote', window );">Interest paid for convertible note</a></td>
<td class="num">(300)<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest paid on exchangeable notes</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Repayment of term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,050)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PenaltyPaidForEarlySettlement', window );">Penalty paid for early settlement of term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NonCashActivityForFinancingActivityAbstract', window );"><strong>Non-cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities', window );">Interest charged</a></td>
<td class="nump">6,561<span></span>
</td>
<td class="nump">7,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PenaltyForEarlySettlementCharged', window );">Penalty for early settlement charged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DerivativeFinancialAssetAtDateOfIssue', window );">Derivative financial asset at date of issue</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RemeasurementOfRightOfUseAssets', window );">Remeasurement of ROU assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsRelatedToRightOfUseAssets', window );">Disposals (related to Right of Use assets)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdditionsRelatedToRightOfUseAssets', window );">Additions (related to Right of Use assets)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Exchange adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities', window );">Accretion interest</a></td>
<td class="nump">3,214<span></span>
</td>
<td class="nump">1,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Fair value of derivative liability - warrants</a></td>
<td class="nump">66<span></span>
</td>
<td class="num">(1,133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities', window );">Fair value of additional derivative liability - warrants</a></td>
<td class="nump">1,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities', window );">Payment-in-kind (PIK) Interest</a></td>
<td class="nump">3,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities', window );">Contingent liability</a></td>
<td class="nump">1,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NoncashLoanModificationGain', window );">Non cash loan modification gain</a></td>
<td class="num">(3,567)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Balance at December 31, 2022</a></td>
<td class="nump">91,474<span></span>
</td>
<td class="nump">55,387<span></span>
</td>
<td class="nump">59,826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Disclosure of reconciliation of liabilities arising from financing activities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Balance at January 1, 2022</a></td>
<td class="nump">12,566<span></span>
</td>
<td class="nump">13,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract', window );"><strong>Cash-flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Principal amount loaned &#8211; term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalAmountLoaned', window );">Loan origination costs paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestPaidOnSeniorSecuredTermLoan', window );">Interest paid for senior secured term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_InterestPaidOnConvertibleNote', window );">Interest paid for convertible note</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest paid on exchangeable notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of leases</a></td>
<td class="num">(2,503)<span></span>
</td>
<td class="num">(2,318)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PenaltyPaidForEarlySettlement', window );">Penalty paid for early settlement of term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NonCashActivityForFinancingActivityAbstract', window );"><strong>Non-cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities', window );">Interest charged</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PenaltyForEarlySettlementCharged', window );">Penalty for early settlement charged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DerivativeFinancialAssetAtDateOfIssue', window );">Derivative financial asset at date of issue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_RemeasurementOfRightOfUseAssets', window );">Remeasurement of ROU assets</a></td>
<td class="nump">1,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisposalsRelatedToRightOfUseAssets', window );">Disposals (related to Right of Use assets)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdditionsRelatedToRightOfUseAssets', window );">Additions (related to Right of Use assets)</a></td>
<td class="nump">855<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Exchange adjustment</a></td>
<td class="num">(512)<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities', window );">Accretion interest</a></td>
<td class="nump">592<span></span>
</td>
<td class="nump">624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities', window );">Fair value of derivative liability - warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities', window );">Fair value of additional derivative liability - warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities', window );">Payment-in-kind (PIK) Interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities', window );">Contingent liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NoncashLoanModificationGain', window );">Non cash loan modification gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Balance at December 31, 2022</a></td>
<td class="nump">$ 12,762<span></span>
</td>
<td class="nump">$ 12,566<span></span>
</td>
<td class="nump">$ 13,943<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from changes in fair values. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44B<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44B_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from the effect of changes in foreign exchange rates. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44B_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 44D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBondsNotesAndDebentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for repayments of bonds, notes and debentures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBondsNotesAndDebentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AdditionsRelatedToRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of additions related to right of use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AdditionsRelatedToRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DerivativeFinancialAssetAtDateOfIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative financial asset at date of issue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DerivativeFinancialAssetAtDateOfIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisposalsRelatedToRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of Disposals Related To Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisposalsRelatedToRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from changes in accretion interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of increase decrease through changes in additional fair value liabilities warrants arising from financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from changes in contingent liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from changes in interest charged.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from changes in payment in kind interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_InterestPaidOnConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents interest paid on convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_InterestPaidOnConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_InterestPaidOnSeniorSecuredTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents interest paid on senior secured term loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_InterestPaidOnSeniorSecuredTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_LossOnDisposalOfExchangeableNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of loss on disposal of exchangeable notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_LossOnDisposalOfExchangeableNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NonCashActivityForFinancingActivityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash activity for financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NonCashActivityForFinancingActivityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NoncashLoanModificationGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of non-cash loan modification gain.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NoncashLoanModificationGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PenaltyForEarlySettlementCharged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Penalty for early settlement charged.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PenaltyForEarlySettlementCharged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PenaltyPaidForEarlySettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the Penalty Paid For Early Settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PenaltyPaidForEarlySettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PrincipalAmountLoaned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount loaned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PrincipalAmountLoaned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ProceedsForConvertibleNoteIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents of proceeds for convertible note issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ProceedsForConvertibleNoteIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_RemeasurementOfRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of remeasurement of ROU assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_RemeasurementOfRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LongtermBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LongtermBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>207
<FILENAME>R181.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jan. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,384,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember', window );">Waveform Technologies Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Non-cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,960,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,760,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets', window );">Description of arrangement for contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">





    &#160;
    &#8226;

        US$5.0 million payment
        if, within the next 12 months after closing, (i) the closing price of the Company&#8217;s ADSs does not exceed US$7.50 per ADS for at
        a least 20 consecutive trading days and (ii) the average daily trading volume of the Company&#8217;s ADSs does not equal or exceed 20,000
        ADSs for 20 consecutive trading days, and


&#160;



    &#160;
    &#8226;

        50% of the proceeds
        received by the Company (up to a maximum payment of additional consideration of US$15.0 million) on our entering into certain commercial
        partnering agreements with certain glucose pump manufacturers in the 24 months from date of acquisition. The fair value assigned to this
        element of the contingent consideration was US$1.8 million at the acquisition date. This is disclosed as a contingent liability in Note
        23.
    <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,800,000<span></span>
</td>
<td class="nump">6,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate', window );">Contingent consideration classified as a current liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate', window );">Contingent consideration classified as contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,363,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,403,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination', window );">Acquired business incurred net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember', window );">Waveform Technologies Inc. [Member] | Measurement Period Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Non-cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,296,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(206,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember', window );">Waveform Technologies Inc. [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember', window );">Waveform Technologies Inc. [Member] | Class A Ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Non-cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember', window );">Waveform Technologies Inc. [Member] | American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Non-cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember', window );">Metabolomics Diagnostics Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 412,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Non-cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">494,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination', window );">Acquired business incurred net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 906,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExtinguishmentOfAmountOwed', window );">Extinguishment of monies owed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember', window );">Metabolomics Diagnostics Limited [Member] | American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember', window );">Epi Capture Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Non-cash consideration</a></td>
<td class="nump">2,965,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration</a></td>
<td class="nump">384,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs</a></td>
<td class="nump">26,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="num">(333,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="nump">$ 1,420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination', window );">Acquired business incurred net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred</a></td>
<td class="nump">$ 3,349,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ExtinguishmentOfAmountOwed', window );">Extinguishment of monies owed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone', window );">Additional consideration</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DescriptionOfCumulativeRevenuesPayable', window );">Description of cumulative revenues payable</a></td>
<td class="text">An
amount of US$0.5 million will become payable if cumulative revenues from EpiCapture&#8217;s operations reach US$1.0 million within a period
of three years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember', window );">Epi Capture Limited [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember', window );">Epi Capture Limited [Member] | American depositary share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred</a></td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for deferred tax liabilities assumed in a business combination. [Refer: Deferred tax liabilities; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the contingent consideration arrangements and the arrangements for indemnification assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_g_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityInterestsOfAcquirer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityInterestsOfAcquirer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gain (loss) that both: (a) relates to identifiable assets acquired or liabilities assumed in a business combination; and (b) is of such size, nature or incidence that disclosure is relevant to understanding the combined entity's financial statements. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B67<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B67_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of additional consideration contingent on the achievement of future milestone.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, at acquisition date, of fair value of contingent consideration arrangements classified as a current liability recognised as consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, at acquisition date, of fair value of contingent consideration arrangements classified as Contingent liability recognised as consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DescriptionOfCumulativeRevenuesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of cumulative revenues payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DescriptionOfCumulativeRevenuesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ExtinguishmentOfAmountOwed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination extinguishment of amount owed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ExtinguishmentOfAmountOwed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, at acquisition date, of fair value of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=trib_MeasurementPeriodAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=trib_MeasurementPeriodAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=trib_AmericanDepositaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>208
<FILENAME>R182.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS (Schedule of acquisition of the CGM assets of Waveform Technologies, Inc) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jan. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SatisfiedByAbstract', window );"><strong>Satisfied by:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Deferred contingent consideration</a></td>
<td class="nump">$ 5,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember', window );">Waveform Technologies Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets - arising on acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate', window );">Trade and other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SatisfiedByAbstract', window );"><strong>Satisfied by:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Non-cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Deferred contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NetCashOutflowArisingOnAcquisitionAbstract', window );"><strong>Net cash outflow &#8211; arising on acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NetCashOutFlowOnBusinessCombination', window );">Net cash outflow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember', window );">Waveform Technologies Inc. [Member] | Provisional Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets - arising on acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate', window );">Trade and other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SatisfiedByAbstract', window );"><strong>Satisfied by:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Non-cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Deferred contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NetCashOutflowArisingOnAcquisitionAbstract', window );"><strong>Net cash outflow &#8211; arising on acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NetCashOutFlowOnBusinessCombination', window );">Net cash outflow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember', window );">Waveform Technologies Inc. [Member] | Measurement Period Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(206)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets - arising on acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,296)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate', window );">Trade and other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SatisfiedByAbstract', window );"><strong>Satisfied by:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Non-cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Deferred contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NetCashOutflowArisingOnAcquisitionAbstract', window );"><strong>Net cash outflow &#8211; arising on acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NetCashOutFlowOnBusinessCombination', window );">Net cash outflow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember', window );">Metabolomics Diagnostics Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets - arising on acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate', window );">Trade and other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(494)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_CashAcquiredAsOfAcquisitionDate', window );">Cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SatisfiedByAbstract', window );"><strong>Satisfied by:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Non-cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NetCashOutflowArisingOnAcquisitionAbstract', window );"><strong>Net cash outflow &#8211; arising on acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Less: Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NetCashOutFlowOnBusinessCombination', window );">Net cash outflow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember', window );">Epi Capture Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets - arising on acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(406)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(333)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,349<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_SatisfiedByAbstract', window );"><strong>Satisfied by:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Non-cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Deferred contingent consideration</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,349<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NetCashOutflowArisingOnAcquisitionAbstract', window );"><strong>Net cash outflow &#8211; arising on acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_NetCashOutFlowOnBusinessCombination', window );">Net cash outflow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for deferred tax liabilities assumed in a business combination. [Refer: Deferred tax liabilities; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityInterestsOfAcquirer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityInterestsOfAcquirer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial assets acquired in a business combination. [Refer: Financial assets; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2024-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_CashAcquiredAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_CashAcquiredAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NetCashOutFlowOnBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow, net of cash acquired on business combination, recognised at acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NetCashOutFlowOnBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_NetCashOutflowArisingOnAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_NetCashOutflowArisingOnAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_SatisfiedByAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_SatisfiedByAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for trade and other receivables assumed in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_WaveformTechnologiesIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=trib_ProvisionalValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=trib_ProvisionalValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=trib_MeasurementPeriodAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=trib_MeasurementPeriodAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_MetabolomicsDiagnosticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=trib_EpiCaptureLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>209
<FILENAME>R183.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>POST BALANCE SHEET EVENTS (Narrative) (Details) - Events After Reporting Period [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>May 14, 2025</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 27, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=trib_EventsAfterReportingPeriodMember', window );">Fourth Amendment To Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Face amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=trib_EventsAfterReportingPeriodMember', window );">Fifth Amendment To Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Face amount of loan</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Loan maturity</a></td>
<td class="text">January
2026 to July 27, 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Loan, interest rate basis</a></td>
<td class="text">interest
payments for the months of April, May, and June 2025 would be paid-in-kind<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maturity of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2024-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=trib_EventsAfterReportingPeriodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=trib_EventsAfterReportingPeriodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=trib_FourthAmendmentToCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=trib_FourthAmendmentToCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=trib_FifthAmendmentToCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=trib_FifthAmendmentToCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>210
<FILENAME>R184.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTING ESTIMATES AND JUDGEMENTS (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities', window );">Current deferred income other than current contract liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 114,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill', window );">Description of useful life, intangible assets other than goodwill</a></td>
<td class="text">Such
expenditure is capitalised at cost within intangible assets and amortised over its expected useful life of 15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Carrying amounts</a></td>
<td class="nump">$ 51,343,000<span></span>
</td>
<td class="nump">16,270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortisation for discontinued operations</a></td>
<td class="nump">1,190,000<span></span>
</td>
<td class="nump">945,000<span></span>
</td>
<td class="nump">889,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment loss</a></td>
<td class="nump">1,408,000<span></span>
</td>
<td class="nump">11,105,000<span></span>
</td>
<td class="nump">5,839,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome', window );">Impairment loss recognised in other comprehensive income</a></td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoriesAtNetRealisableValue', window );">Inventories, at net realisable value</a></td>
<td class="nump">$ 7,648,000<span></span>
</td>
<td class="nump">$ 11,344,000<span></span>
</td>
<td class="nump">$ 16,274,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PercentageOfGrossInventory1', window );">Percentage of gross inventory</a></td>
<td class="nump">28.30%<span></span>
</td>
<td class="nump">36.30%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember', window );">Capitalised development expenditure [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Carrying amounts</a></td>
<td class="nump">$ 20,951,000<span></span>
</td>
<td class="nump">$ 15,103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortisation for discontinued operations</a></td>
<td class="nump">8,582,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment loss</a></td>
<td class="nump">1,596,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_TwoPercentageOfGrossInventoryMember', window );">2% of gross inventory [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_ChangeInAllowance', window );">Change in allowance</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current deferred income other than current contract liabilities. [Refer: Deferred income other than contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of useful life used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2024-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 130<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_130_d_ii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 130<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_130_b&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in other comprehensive income. Impairment loss on a revalued asset is recognised in other comprehensive income to the extent that the impairment loss does not exceed the amount in the revaluation surplus for that same asset. [Refer: Impairment loss; Revaluation surplus; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 129<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_129_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2024-01-01<br> -Paragraph 126<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_126_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoriesAtNetRealisableValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventories carried at net realisable value. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2024-01-01<br> -Paragraph 36<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_36&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoriesAtNetRealisableValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_ChangeInAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_ChangeInAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PercentageOfGrossInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of gross inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PercentageOfGrossInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_TwoPercentageOfGrossInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=trib_TwoPercentageOfGrossInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>211
<FILENAME>R185.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GROUP UNDERTAKINGS (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechManufacturingLimitedMember', window );">Trinity Biotech Manufacturing Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Trinity
        Biotech Manufacturing Limited<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        IDA
        Business Park, Bray
        County
        Wicklow, Ireland  <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Manufacture
        and saleof diagnostic test kits<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Ireland<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityResearchLimitedMember', window );">Trinity Research Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Trinity
        Research Limited<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        IDA
        Business Park, Bray
        County
        Wicklow, Ireland  <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Research
        anddevelopment<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Ireland<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechManufacturingServicesLimitedMember', window );">Trinity Biotech Manufacturing Services Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Trinity
        Biotech Manufacturing Services Limited<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        IDA
        Business Park, Bray
        County
        Wicklow, Ireland  <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Dormant<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Ireland<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechLuxembourgSarlMember', window );">Trinity Biotech Luxembourg Sarl [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Trinity
        Biotech Luxembourg Sarl<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        1,
        rue Bender,
        L-1229
        Luxembourg  <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Investment
        andprovision of financialservices<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Luxembourg<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechIncMember', window );">Trinity Biotech Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Trinity
        Biotech Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        Girts
        Road,
        Jamestown,
        NY
        14702, USA  <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Holding
        Company<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">U.S.A.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_ClarkLaboratoriesIncMember', window );">Clark Laboratories Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Clark
        Laboratories Inc<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        Trading
        as Trinity Biotech (USA)
        Girts
        Road, Jamestown
        NY14702,
        USA  <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Manufacture
        and saleof diagnostic test kits<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">U.S.A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_MardxDiagnosticsIncMember', window );">Mardx Diagnostics Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Mardx
        Diagnostics Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        5919
        Farnsworth Court
        Carlsbad
        CA
        92008, USA  <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Dormant<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">U.S.A.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_BiopoolUsIncMember', window );">Biopool US Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Biopool
        US Inc (trading as Trinity Biotech Distribution)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        Girts
        Road, Jamestown
        NY14702,
        USA  <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Sale
        of diagnostic testkits<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">U.S.A.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_PrimusCorporationMember', window );">Primus Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Primus
        Corporation<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        4231
        E 75th Terrace
        Kansas
        City,
        MO
        64132, USA  <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Manufacture
        and saleof diagnostic test kitsand instrumentation<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">U.S.A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_PhoenixBioTechCorpMember', window );">Phoenix Bio Tech Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Phoenix
        Bio-tech Corp.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        1166
        South Service Road West
        Oakville,
        ON L6L 5T7
        Canada.
         <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Dormant<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Canada<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_FiomiDiagnosticsHoldingAbMember', window );">Fiomi Diagnostics Holding Ab [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Fiomi
        Diagnostics Holding AB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        Dag
        Hammarskj&#246;ldsv 52A
        SE-752
        37 Uppsala
        Sweden
         <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Holding
        Company<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Sweden<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_FiomiDiagnosticsAbMember', window );">Fiomi Diagnostics Ab [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Fiomi
        Diagnostics AB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        Dag
        Hammarskj&#246;ldsv 52A
        SE-752
        37 Uppsala
        Sweden
         <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Discontinued
        operation<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Sweden<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechDoBrasilMember', window );">Trinity Biotech Do Brasil [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Trinity
        Biotech Do Brasil<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        Comercio
        e Importacao Ltda
        Rua
        Silva Bueno
        1.660
        &#8211; Cj. 101/102
        Ipiranga
        Sao
        Paulo
        Brazil
         <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Sale
        of diagnostic testkits<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Brazil<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechUkLtdMember', window );">Trinity Biotech (Uk) Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Trinity
        Biotech (UK) Ltd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        Mills
        and Reeve LLP
        Botanic
        House
        100
        Hills Road
        Cambridge,
        CB2 1PH
        United
        Kingdom  <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Sales
        & marketingactivities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">UK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_ImmcoDiagnosticsIncMember', window );">Immco Diagnostics Inc Member</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Immco
        Diagnostics Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        60
        Pineview Drive
        Buffalo
        NY
        14228, USA  <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Manufacture
        and sale ofautoimmune productsand laboratory services<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">U.S.A.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_NovaCenturyScientificIncMember', window );">Nova Century Scientific Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Nova
        Century Scientific Inc<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        5022
        South Service Road
        Burlington
        Ontario
        Canada
         <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Manufacture
        and sale ofautoimmune products and infectious diseases<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Canada<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechInvestmentLtdMember', window );">Trinity Biotech Investment Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Trinity
        Biotech Investment Ltd<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        PO
        Box 309
        Ugland
        House
        Grand
        Cayman
        KY1-1104
        Cayman
        Islands  <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Investment
        andprovision of financialservices<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Cayman
        Islands<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TribBiosensorsIncMember', window );">Trib Biosensors Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Trib
        Biosensors Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        27700
        S.W. 95th Avenue,
        Wilsonville,
        Oregon
        97070, USA  <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Manufacturing,
        development, and sale of biosensors<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">USA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_KonamiteLimitedMember', window );">Konamite Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Konamite
        Limited<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        IDA
        Business Park, Bray
        County
        Wicklow, Ireland  <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Sales
        & marketingactivities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Ireland<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechJointVentureLimitedMember', window );">Trinity Biotech Joint Venture Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Trinity
        Biotech Joint Venture Limited<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">

        IDA
        Business Park, Bray
        County
        Wicklow, Ireland  <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Holding
        Company<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Ireland<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_EpiCaptureLimitedMember', window );">Epi Capture Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">EpiCapture
        Limited<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">19
        Mather Road, Mount Merrion, Dublin, Ireland<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Research
        and development<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Ireland<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_MetabolomicsDiagnosticsLimitedMember', window );">Metabolomics Diagnostics Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Metabolomics
        Diagnostics Limited<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">Hoffman
        Park, Inchera, Little Island, Co. Cork, Ireland<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Research
        and development<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Ireland<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_WaveformTechnologiesIncorporationMember', window );">Waveform Technologies Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_DisclosureOfCompositionOfGroupLineItems', window );"><strong>Disclosure Of Composition Of Group [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">Waveform
        Technologies Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AddressOfRegisteredOfficeOfEntity', window );">Address of entity's registered office</a></td>
<td class="text">Obrtna
        cesta 18, 8310 Sentjernej, Slovenia<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_trib_PrincipalActivity', window );">Principal activity</a></td>
<td class="text">Manufacturing,
        development, and sale of biosensors<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusiness', window );">Principal Country of incorporation and operation</a></td>
<td class="text">Slovenia<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Group % holding</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AddressOfRegisteredOfficeOfEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The address at which the entity's office is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 138<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_138_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AddressOfRegisteredOfficeOfEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NameOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The name of a subsidiary. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 12<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_12_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_b_i&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 19B<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_19B_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NameOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PrincipalPlaceOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The place where an entity principally conducts operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2024-01-01<br> -Paragraph 138<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_138_a&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PrincipalPlaceOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2024-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2024-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2024-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2024-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2024-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_DisclosureOfCompositionOfGroupLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of composition of group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_DisclosureOfCompositionOfGroupLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_trib_PrincipalActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">trib_PrincipalActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>trib_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechManufacturingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechManufacturingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityResearchLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityResearchLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechManufacturingServicesLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechManufacturingServicesLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechLuxembourgSarlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechLuxembourgSarlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_ClarkLaboratoriesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_ClarkLaboratoriesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_MardxDiagnosticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_MardxDiagnosticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_BiopoolUsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_BiopoolUsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_PrimusCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_PrimusCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_PhoenixBioTechCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_PhoenixBioTechCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_FiomiDiagnosticsHoldingAbMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_FiomiDiagnosticsHoldingAbMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_FiomiDiagnosticsAbMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_FiomiDiagnosticsAbMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechDoBrasilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechDoBrasilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechUkLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechUkLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_ImmcoDiagnosticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_ImmcoDiagnosticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_NovaCenturyScientificIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_NovaCenturyScientificIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechInvestmentLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechInvestmentLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TribBiosensorsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TribBiosensorsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_KonamiteLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_KonamiteLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechJointVentureLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_TrinityBiotechJointVentureLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_EpiCaptureLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_EpiCaptureLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_MetabolomicsDiagnosticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_MetabolomicsDiagnosticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_WaveformTechnologiesIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=trib_WaveformTechnologiesIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>212
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( "^-KUI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( "^-KUI-TMP"\@   "L"   1
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MNIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#
M"J5,7K5::0##.'W)$Q+#W(*+"$MX%,O67.!;&B\CUNJTV]U6A&ELH1A'9&!]
M7BQH0-!445IO7R"TY1\S^!7+5(UEHP$35T$FN8BT\OELQ?S:WCYES^DZ'3*!
M;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'T=)(@(+)?90%NDGVH],5"#(-.SJ=
M6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+<!P$X%&[GL*=]&R_I$$)M*-IT&38
M]MJND::JC5-/T_=]W^N;:)P*C5M/TVMWW=..B<:MT'@-OO%/A\.NB<:KT'3K
M:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8<';6S-(#EEXI^G64&MD=N]U!7/!8
M[CF)$?[&Q036:=(9EC1&<IV0!0X -\313%!\KT&VBN#"DM)<D-;/*;50&@B:
MR('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_::L!I^V[F\^3_'/HY)^GD]=-0LYP
MO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR
M([O=]EA]]D]';B/7J<"S(M>41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQ
MEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1
M]E6\W*.76!4!EQC?-*HU+,76>)7 \:V</!T3$LV4"P9!AI<D)A*I.7Y-2!/^
M*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S&L%&KQMUAVC2/'K^!?F<-0H<D1L=
M F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV&G*U%H&V<:F$8%H2QM%X3M*T$?Q9
MK#63/F#([,V1=<[6D0X1DEXW0CYBSHN0$;\>ACA*FNVB<5@$_9Y>PTG!Z(++
M9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'HYI9";V$5FJ?JH<T/J@>,@H%\;D>
M/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>
M1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@YG\#L_6@^GO'M^MDDA*^:62TC%I!+
M@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2GD(;;NE3]4J5U^6ON2BX/%ODZ:^A
M=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9=
M=N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8
MT='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7
M\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I
M=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*POFH]M!5.S_Y9K<B?#!%.%@L22&.4
M%Z9*HO,94[[G*TG$53B_13.V$I<8O./FQW%.4[@2=K8/ C*YNSFI>F4Q9Z;R
MWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z
M;I,[2$R<><41 71% B.5' 86%S+D4.Z2D 83 <V4R43P H)DIAR F/H+O?(,
MN2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7<N/O[Y-J=XS7^BR!;814,F35%\I#
MB<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@2\-Z;ITM)__;7M0]M!<]1O.CF> >
MLX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[
MM'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ
M#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1.
M"CS<_N\-L,+$CN'MB[\!4$L#!!0    ( "^-KUIR86F)Z08  -<?   8
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M@6DGB[?(Q8D2:_/F]DXH)1)SN.(LY%+? -_?"Z&J$_T#];O\X;]02P,$%
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M&Z"J@:G(5?47/=;:,!J@=*VT6#:%30N665'_9T]-1VP5P&%/ =(4('8!OZ<
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MOG:\YU*L5R!F!&+:-Y4@&1W:]P032!8.O9Z;,*1UB,3M$%\_OOV@,3B1.Z"
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MV[FPU:VN#>SO#\JFT>V'^D'R[A\'AO\#4$L#!!0    ( "^-KUI*W671@P8
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MB",1@,"Y#W+6T>[4O[EU:)#U\0;Y5;60KO: NB[7;7. HK;CR!TQ@,F!P)$
M1T(<B7 DAE8U<X?^X=</_:\^WO^>6A#I> .,(QZ.^#@2X$B((Q& 4(/:LNX(
MU9?]Z*[NJ;=U1PLB$PR%>CO3I*X2#96R#<-5;NF>>D\7NJEKRFU& (VJ%D0
MI=[9!09T7$H=.4#0S5V+SN2[ =.CIT^:!Z2^)-5#6M0D8_?"4/O@B!!7NV>.
M=@>\W+0/I-R5G)=Y^W'-DA6K&D#\?E^6_.6@><9E_^37Y6]02P,$%     @
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M.ZP J)0>H(Y9&66#@UNW"O([)L^BE%SY; $R8>Y4S++89N*B',^$(,<<C#[
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MVU'V!#9 S6 RB>Q"$H!SJ(4@Q]2,WJ%AO;/?CLZW^]'%^)'7>D?J#_).CM^
M>B%DXBAR $?BE-FY!V2.37PBEAHU1+-7;4_;13A,+RBR7KT]O:6U_*VL'0^I
M46AT0*&U[:9;^HV8J]$4+ZC5QQV[/%4?/U6;N1[B_KKJQ*K<K/8!HE3ME0]X
M*#JX2NRH$+P=U<'CK!R $$:I9P^+C:B+PZ+.BH6:9Q<L'GA'#Q;=\7"9:!B2
M Y#$4[6,C8J+PR6BK_TA_R$G7I<JUK5\MA&ZV,?%"E5- 5:-8J!J%#GUA2D
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M.C]J$R)VYQ*</%*<UXT$$0"MWH[^+.DPK/*@=1;FY*D1$/=[1 T.[L@2Q#W
MEV>*D&;'$&E5:66KR7:6Z:>=AQ>;TNLS1V(#Z[G"T4[.9;==3";0EPK*$5>Z
MX3 #"2";.D4Z>J+*-'-*<\2H5_3\S@N.X\IJ$(_P&GVSFVAT1Y<(!]5^ S7#
M4>V9]HIA9<*<;GB-RQ,D\LU%.+HRBPXE@D5JR#ZU7=8F(8Z V-RBKC:FF!/S
MNPD: &I*R9V34)KC#U($QXQIOATT&!Z=E*;%><<"$M,M(_C-(=',NYZ &>4V
M8[+$=HSMCU0W@QK6"J7 9L17FS$4G!X-2++F4A,U[98R70/X$\6U$GM"'=K%
MMKUE#EQQ&6=GA_CMS @P2HU(QB#G(-BQMN)%VP10-KI<G+;%VOQ%+6<6F]6)
M/BT62QA!GC)PR[)NQSX*U\ZO/ HY+=)9"I52$,QE0;"1#>SU3.F$ ,H&L9?+
MW491[=ZX$N!>J^G.)A4!UT=/9_%4]O&3A&Z>EI4@G,6.&9FFIT7+*S771VMT
M<N2JN>,YS*405%CW _'MHI.3IERH.&B\1ZW\)+(=:_=L#G=JI%+CW">PC_29
MFQ??IAI=!XQULL!U%D\:1ANWKCC6IVU[,F AYZ2X+1$\ON2'CDY2XI G=-$H
M J'5!*MTBEG*@]6?G*GW&[6'*@D[B2DQQ*4ZV2R',(OU07&P-3R$LL%9D$6=
MSC,F40X#"A,0UX,[)[UB8NLR+Z7Y.9FT%T]6ZCR:XE]4:^)DHCCQ8\>Y^<1@
M%HG.IX# QF@64QF84)+[PD2CJF%HF?0$![B( _QNT:ZRU+/FF)>6 6WS>OPZ
MM=")&Z.[H+E"V QPA>UF-55#97I"?F/HAY6&Y' 6M;'<C)SRE]Z6FC/+=LUI
MD;#L7EYPAGW(YS&I"^:JP>0"Z4'\6'5M=YE:%Y' >%E+*-HV=OI[HX;TW$QA
M;8[4>(D\-<>#1Y HX(:SO$0@:=#KY0 [LGAR1C>F *W#1BQ:/K$/?*@2,"J4
M.[U$)]>,]T?V,C5X$IH?[<M(H?(FJEK08X>0RJI'9B:SB>3D(W0@D2QK$WH\
M-H=08AU+,D"JH7!X0;;>*L)5#TCN5V@D%UDL*1,)*R6+75+_,V9-!7=EENP[
M6:2>CE'J%]9%1G%.2A4&;K>@YTJ#'E(?M6:*P<G8'E#U1':V;U0+>')&@FY"
M]:?/@@PRG'0[=:/UDN/E_6J!HP[ XV+'!,0:1T8]&WI"U)L^.NE ,UR_.Z%F
MBL1Q963/-/$]^H@&*W5H$>7BGB3NM8I3QM1CG3_:ON@0H[B9L&W8^M0>U7@E
M]YK9*FD544H9ST;7HQ0 H7)U?48G=;92)%775L&=_9BK;3U!VV@(T@H4[DHX
M3K'62*7?\PR%7NXOAEY'8"(YQ!F2R#1UY%:K;^,^/!I"XC80;(=9Y0-%Q+V%
M=JW]:N-3%S8[SCEQ?:T=Y5W%D^,TVHCFD\54TO(5Z,$.*:^2OX)Y+,@@K,+$
M]?[OGW^5;T#^QU]1&YJ*U+7495SVR6#WV&\9FEH:&M&>:GDH^Q0&<D^A;<:'
M,7PUK4G7RO7L8!AM]" 932G3UQ.F>9OEZ9Q= N^GRE5?WB$5K!K=4<WJF[+W
MUGI1 P'!/3VN;7W-HIQ5-T0_V-1>/'[.13(T@3Z<\TA:CYIRU8-45ND6Q)B+
ME<_$.U@%W;<<-2;:XKO!N3I)0.8E35*;\!Y>=UZ@8Z@[J[QQH_.1TCC0L+EV
M>[#CG#Q-[>C&HR)-TJ@73Q)?E7(_.)?T 6GN/]7"(3Z\Y.*L%-,CGAJXP[6J
M9;=@G=7).5:(8CH(;]<J3HAA6>MBF=+*V?FR*E9YF26,_"\44=+ZV.F%..JL
M/'<M]ZS).X!S=Z.%1[5^<)E)F>7V3\YSTC#2L]<.3] G*+H,:/$Y8XUMR4$1
M 8/0\$/>/2E6"=SP1K890,0:W/*PK!5SB]KG*BJ;Q%(.;L0)CJ8T!C?02C%F
M!R[#P::6O=O4,B.'8#(0JQA<[O1@QF2A\-$.>_70T$M$U2"M9^[.%N=NY7=6
MZ2A :$3Q -XDW2 1:TY7MPMTW]$"@1+OKB N]#@EN]\B@EE:[65LP![#GI&K
M]2F""3$";P#RR!S)_?[ZUQF"S]()'_7D+[=UN3O0;8K&4?I22#VP_U#"9PSG
MH-1."@D'I#W'VZ+VI!:!;<*0YA6RN8Z[1$I0=#I!,W?6K/&;1,+4=I]1VE9D
M9$N&H=AT[:ULIX:Z1(JM!1H7^@F4EFIL#=OO][ZL)4"&R@ INHX'V6@/E^=
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M*)-Z]%::X'C(XU_;9K?]\Y_R,,A^UX0")R\C%4]8'@SM%AU<[)Q_%A5, 3&
MAA(/H=CNBG2[:#9;42L,JM$F!G0;44K:&E,VLETHT":5:BL_)0"*Y&91+6@;
MYHS9RDI0A-=KM1TV<@/R4L! PZ[@S)J# (.X#>T25CH+FTJ)N:I49]E;5#LP
MI#H)%DICC>J&BZYKU7S7"<(@+"%Z^Q)4KI!;N(%,HS&Z%MA9U&"I1ZK5K<#F
M0C>UH0&-*[#U1[V?8K<DGENEG8])W9W-I6A)SU4C:C ^;UI$$CRPS,MKY&G
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M.<J_1#_1K]-/[!5YS(+ R^,<LB:IET?A$?V$F)5F+,](/Z&71<64?D A"5B
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M3BM1ZL42FS*<EEN?6JYZG=RA0-"FJ(?MIL8W7RRIX25_;-L)V&(KW6VIVZ"
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M!/!\H3!$[8(,[-Z9AO\"4$L#!!0    ( "^-KUH$[6Z+(0<  $40   9
M>&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;*586V_;.!9^YZ\@/(LB 5S;DB]Q
M<P/<))W-0Y,@3G<>%OM 2[3-J41J2,JNY]?O=RA9EKM)=@>+ +)(D>?ZG>^0
MN=P:^]VMI?3\1YYI=]59>U^<]_LN6<M<N)XII,:7I;&Y\!C:5=\55HHT;,JS
M?CP83/JY4+IS?1GFGNSUI2E]IK1\LMR5>2[L[K/,S/:J$W7V$\]JM?8TT;^^
M+,1*SJ7_5CQ9C/J-E%3E4CME-+=R>=691>>?1[0^+/B'DEO7>N?DR<*8[S2X
M3Z\Z S)(9C+Q)$'@9R-O9):1()CQ1RVSTZBDC>WWO?0OP7?XLA!.WICL-Y7Z
M]55GVN&I7(HR\\]F^W=9^S,F>8G)7'CR;;7V#!J3TGF3UYLQSI6N?L6/.@ZM
M#=/!&QOB>D,<[*X4!2MOA1?7E]9LN:75D$8OP=6P&\8I34F9>XNO"OO\]?W7
MI]G]\]>[AY<N?[Z;OSQ_NWGY]GS_\"N?/=SRQX>;._[XY0N_>9R_S"_['AII
M7S^II7^NI,=O2(]B_M5HOW;\3J<R/1;0AZF-O?'>WL_QNQ)O9=+CPZC+XT$\
M>D?>L/%_&.0-WY*G7)(95UK)S9*KO!#* G.>)VMA5])QH5.N] 93QNYX8<U&
M$2"57O%_SA;.6^#J7Z]%IM([>ETOU=JY*T0BKSHH)B?M1G:N/_P23087[W@U
M:KP:O2?]_\[J^]+'/?97%/#[)JIL']5[S422&)L*G4A WJ_Y_6S.AY-N:S5E
M9.:<](Z_K"6CY"1ATJ\E%PNSD5QYF3N.ZJ:IQ&AG,I4*+U/N/'[V4L!A5A +
M. X>"XMW4E@N"94<F)+Y0MH&5^$Y[(;<XRWF O 0M#<#B;ESUM[QSH!DT6-(
MCYA]F__MPR_3.#J[& P&[X[F8"D@K,M64L/RC'\0>7'!10H&4(2YP&CR!ZC9
M2<=: 8:S3T]A]1T_>3!>\B@Z99,H9L/NV5G,SH;#GY:OC$FW*LN"MP:AL<"[
M%WJE%AEY'>)?BXI/6=0=?YJP<7<*0:/N! X>BP.:"[&C4;/K[)1]Q-]H&K.3
M9[F1UHGLM'^\;:DTH*#@ZK'&X2D[F2(B03%^/[(7XT7&6I6*\G7X.AI,611U
MH\$X6/>)/TM$JDQ\:1%*EA@'J;?5X+\#@%;\:DU9\!)+K$=;X0((R^'?FGH2
MP+<H'2K#.8Z$:%<U2,H+2&)E1<X%NE?*A2=:(=X 961&KSYZ:?,#).&,7"Y5
MHJ1.=B$)(E.K0#!D!/JMT.K/2G(H% 4_ @;D2B50IHQ57DG7HRIQDIA+4XUM
M)5 +<S?*E"[;D?%YJ542RL.;(!V-^#LZ?T5R25:FDK4,RP+A+947"Y4IO^.Y
M%$25KGMD%I*&\P 93?FHRF9O!/0T88)RS_<Y(7MGC@EL=>B@[8A;F1@$X$^8
M:=LYY%4.@194RZ@7LQRPI;"<4(V=TZQ6&0!#U788;M<J68<2#DRK SL I!1!
M>*C^ GE0_+$^5.KD8E^E?%^E(7FM&@5&FAH->Z*+8U16'M6%'_+'7O,8J2FM
MA5UI-=O -^!1.<HGIBIZPH+S5VCHF& >!*6 "H\TL"?4I-%:9E"?A0@$Q:@J
M^,D>2^],:9.FC-C9>,3FX%Y6(5_:P_IIQ.[W[?(G:<0_CT0PKSG)HO&TKNW7
MOHZZT31"VP@835F="+*!']NP;PR.\C\<3[KD[MZ.&O7JJ,44F<!+Q;#RCU(5
MX8- 7$D]:!]0:=K.L6UUI?>053( XFO*[?'?)%^+C:Q.#$0RX <FTE0U%?,6
MLJ/>I$$VM(,__H.?^(F3LM(5QZ<]]H@NBF0N^7LL-XP.@@XD=P,(";T[8$S^
M2&11&=GEVNB/B&]ZL-%3BF@8+/VTM[3+JS)#W'.12HXR;C5,ZO>/B3=OJ':N
MA.+)>!"2-<NE!4MI6%L8!_+!N6N.<P/8Y(0@' \N9K?S4#5Q='%*42=FMH6A
MBJX["3I7BI,:FCV%,/B!XSZX7%!7L]+CO@)CE@BCHMN%*V1UMJBW[1B=R50"
MI4T&L3"A*DD.7"P">C2EMZ2*"@ "45J!J@P%S9> &M^(K)1[#)'UM=,@R]R4
MVH>J-E5,HU9,87R+#5.%@:\XJU+4W9L!_\D)HZM4A6-6V&K)\KI<_F>>HYAI
MUD)"2'[O9V =I[%EJ#@<E&M0#WIG#:A_"CC/Y$J@]:%[>JIB@J$F+UVY^)T6
M(3!8;[*2;.GQQVT=+5+NJ!<'IM6!TH(C>F5H28JS?>G("#2L96G#V29M#OQL
M#3<74E:I7,LL9/C58^E9[U/<I:B0RMN0!6-I<Z9PGH&A0/Y!,()59M1C;-UY
MT7=^+U. J1VOFHT="R GSUX[^/=;5SO4Q2I<8!UIT+ZZY36SS1UY5ET-#\NK
M"_978$(AN9E<8BL2,NYP6UU:JX$W1;@H+HS'M3.\KG'/EY86X/O2@'#J 2EH
M_G-P_6]02P,$%     @ +XVO6E>/OBMV!   D H  !D   !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&ULE59;;^(X%'[/K[ RJQ&54LB-6P>0H*5:I)9!K;J[
MTFH?3'( :QR;M4UI__T>.R%#IX5J7V(G]O>=[USLG,%>JA]Z V#(2\&%'OH;
M8[97K9;.-E!0W91;$+BRDJJ@!E_5NJ6W"FCN0 5OQ6'8:164"7\T<-\6:C20
M.\.9@(4B>E<45+U.@,O]T(_\PX<'MMX8^Z$U&FSI&A[!/&T7"M]:-4O."A":
M24$4K(;^.+J:I':_V_ '@[T^FA/KR5+*'_9EE@_]T H"#IFQ#!2'9[@&SBT1
MROBWXO1KDQ9X/#^PWSK?T9<EU7 M^9\L-YNAW_-)#BNZX^9![G^'RI^VY<LD
MU^Y)]N7>=MLGV4X;651@5% P48[TI8K#$: 7G@#$%2!VNDM#3N4--70T4')/
ME-V-;';B7'5H%,>$3<JC4;C*$&=&M[/Y>'X]&]^1V?SZ^_V4C.<W9/K78CI_
MG#X.6@9-V(VMK**;E'3Q";HH)O=2F(TF4Y%#_I:@A=IJ@?%!X"0^RW@#69,D
M44#B,$[/\"6UPXGC2T[Q,9UQJ7<*R/<5N66"BHR)-9F)3!9 IB]8[AHTF>.!
M^'N\U$9AX?SS421*.^G'=NQANM);FL'0Q].B03V#/_KZ)>J$W\YXD=9>I.?8
M_W_:SM-UFMY91@^S ,42E,V$9S-!GAY_^_JE%T>=;V$8OEM//EF/?UFO\D"Y
MQUP>KKRY%)<9U1MO=5@BY9)WZ45!U(V\)$R.<% F[LJ;"0,8<./AF>= ;2X;
M<VF Q.F%UVCW8P^'3IRZ(>WB<">UMKMSIK=2HR&Y(O"2;:A8 UUR( +A-4MR
M@0HNO48_Z'1[B%Z H-R\>GA!$J"*OY(M5<;JU6 ,![S!C&74(!ANT9!A[>4$
M11:$2RIJWB#N73CBL&VU)4':#G%R;8/ *J>0^]5)0KFG"-&M(.XGEJ.+G/UR
M$B;]<V29%,^ L@_NHOTP=#+*(>J_AR/L?9B\A@U*^8C[G7,V%XN%$WP(K<U/
MDEBD#7!= )_8<\GHV71^B/@T[%9GD+1=S+&PDL@I#[K=^!3E^UCUVF64G;^-
MM-\^AOXLX*I&G1U'C\J[5OF3V#.1XS7D8:%@&69R)YPI_+^ LKK1IL%U6TLX
MU2P'1>UO#2LZJ0)V3;?,4,YTN8!,2ZGP7K&W6R:UT5X<A+WVV^"Z4!0R9RN6
M.1Q9XY_\;4TF0;O3/6%B)[:4Y>0X/$>%B'AWPJH#T^Z448Z"T*ENQ&G035SJ
MP!SBA&KK.-60?M#KQ14BM2DB^$_V"HFW.!-E:V*U6^L;.)GSX%WJ"!7Y!T45
MV'X#;RLC214(<KA6+B=XR*W(.U>YB/<FAS#K)CF==:3DU-XC2&I%KBA3Y)GR
M': VK:WV/56*8H8YHTO&F6&X.]\Y:Q;QBI:;Y.%79?;B6>T4[E!8+X8RKIL?
M_6):1UU" 6KM>B%-7*V5#4/]M6ZWQF67\7-[V:O=4[5FZ#V'%4+#9A>[&U7V
M/^6+D5O7<RREP0[&33?8,H*R&W!])5%\]6(-U$WHZ#]02P,$%     @ +XVO
M6E$*#XES"   2!8  !D   !X;"]W;W)K<VAE971S+W-H965T,3,N>&ULS5A;
M;]LX%G[GKR \VT(!7%NB)%_2)$":9G<#3"](V^D BWV@)=I61Q8](M4D^^OG
M.Z1LRXGCZ2[V81X22R+/X;E\YSM'.KO3]6]FJ93E]ZNR,N>]I;7KT^'09$NU
MDF:@UZK"RES7*VEQ6R^&9ETKF3NA53D483@:KF11]2[.W+./]<69;FQ95.IC
MS4VS6LGZX8TJ]=UY+^IM'MP6BZ6E!\.+L[5<J$_*?EE_K'$WW&K)BY6J3*$K
M7JOY>>\R.GV3T'ZWX9="W9G.-2=/9EK_1C<W^7DO)(-4J3)+&B1^OJLK59:D
M"&;\WNKL;8\DP>[U1OO?G>_P92:-NM+EUR*WR_/>I,=S-9=-:6_UW3]5ZT]*
M^C)=&O>?W_F]2=SC66.L7K7"L&!55/Y7WK=QZ A,PF<$1"L@G-W^(&?E6VGE
MQ5FM[WA-NZ&-+IRK3AK&%14EY9.ML5I SE[<O+_Z\.Z:?[[\E0?7OWZ\?O_I
M^F1X=7O]]N;SV=#B -HVS%IE;[PR\8RR2/!WNK)+PZ^K7.7["H:P;&N>V)CW
M1AS5^%9E QY'?2Y"D1S1%V_=C9V^^#E]A<E*;9I:<3WG197IE>)6WO.L5GEA
M^;\N9\;6@,J_#WGO=2>'=5/YG)JUS-1Y#_5A5/U=]2Y>_A2-PM='+$^VEB?'
MM/^WB3JN;#Q@1_0Q1%VM9JJFR#.*//_RZ6\O?YJ(:/0Z#,,GZ_&?K(M'ZU=-
M7:O*,@J\N@>_&#4,? 9.V$U=F"6[TO5:U])5+K8Q$;%7+(CC$3MA*$<46T7B
MRO! GC"1)BP9"1:D6+[,OZ%N5G1 0<1AUF  2O>Z+G3-'Y2L#8M"%D33";:/
M(O996UFRS%O%#UHE)BD3HX0%8A)"Z*V:*^S.V0X[[$-=+(K*F<QDE>/D[ZHV
MLJ2CK5J1._4#SXLY1%65D>E&*?Y>6\6CY(0%203-09J,\1.+Y*C""GP-9J8(
M50L.2)LG^D0BF!!D<DQ^>B?SUG /^J6L%UTGPP@Q%C%V3T:M0+=&]K=SI"9#
MN1=50S:TUNC*H*ZXL1(^4SAA[&Z))5 <I%-R-)HF9!:2ZQ63OASUZ57"Q([&
MG6>3$P#A%1.M>8?<V#M#T \@<E,Y#NESNU1\[A'$/8)J5<)8@@?Z4E$^<*O9
MS\T](*R;>L$I]%>RDKD<L&"VKPD\<B<-DWP_KIY,X#EPG\1]PGQ =7+*-ZZZ
MI6B<T-J)6Q2/%\.I7ZQ5IA=58:!\'\\W9#B,<W_\0&9;32))]DS8LVXZWC>A
MNRA&?V*!)D J:=R9WQI4;EZX;FL&[!HX=RW7Y0B)5$]YY2F3/.4.]C/ S6:*
M<D;G>$YP;!*]?@: P1[?P+DX[(]C*MP@'O6G@BHL0&+&KI@O*8$0S@!7Z:-&
M!<5W9Y[N4=8+%H2#*:K$78Q%>P%VP(6'9; A$\K-)C,G),FC03II):)1>Y%X
MT:5B<UUB3B)WK)R5BE/HJZPH 5,"KERORR)S*[=JW<QPTT4"55UC-6AF$W-@
MV0FJ33;P  ;NUN&BV_"/6C?KT_\Q19ZSLT><'41B $(FKP]<>7PP6+^)%3'S
M86(CWPY3*)E_MRRR):_T?@E(2%JJ3MZ!+S%!E XF4_:"1>-!Y'Z1S#'K&K0)
MCB%*VF(<UE6PR;#18!1C?S >3(1W:CP@<.TYY4+2F3!<SJ3E2XR)"-VV)H)D
M$$XI^V* !O:"Q82L%YTF9HYTL7 0)LPA*(W=^< 4/;A]*5?KUV\[W<DXUB2X
M^NA_(/)B!8**:@&IP84T;55,)E"1#L)=4/:J.'B$8+Z%,%TAP.]_)!,SE<G&
M*$^BC!:10-_A*/%["LI"SHJRL ]$/P16(Q'4+M]T)+M;@*-">X(L*M/,YT56
M$-+FC:41<%WK;_#.GT()VG2[YX[Q#<#%COO883L2 C_\;:5MR[TNWU1\* 0Z
MOYTH_!8,QPT4TA97?_!QW:!XL#[@OK^(/M>=<^C]"IW)MZI\4]6.IGS;A' [
M:E"UW\.(JC4"!^)85R1MG*M72 2*#N$:<&(=R-NZF#4NE$_I#^*S![Y0>E'+
M-?3@((DW0)=2235(G&4.D,?_>6Z\5<;5UE==E_FV!;3D!UR.^V(Z<FU?@.1=
MYT<<XY3FC,.RO@R".$J=6)BX%D$#T.4*V,G0VX,H[D>1FR9$W)^&;D@343^F
M#G"\L_!+N^=39P)Q=,N7,N=-A;"7KB8.<A\!Y'"7^^N$/@HQ12 >HVE_DD9L
M)!"3Z&C(4X&=@G[2*&)),MD%'"F;C$8,89\D(4,JQ^,)BR9XBIT1H@SSV#CM
M3]/Q#P:X0SM/B<D\FFF0#[/AG5WWZ3QM"?6O$_[M_1/3*8@"C#_I)YA.QOT$
MC>](5HXI2I"&L?M!!428"[;Y>EY(]*-DRF*42HK_$;KF,:%-HTIQ!)#1GX0C
MEO1'Z#5?.AED3S/(8H AC/'.U(\).&D_B1/':S++=%.Y:EIKS$H/KIKV-!2&
MR!24EC7N+8"P<Z![V25Z-_;F"F\UN6MD:#C$KWVJ3E/DBNB4R[+D!J\-F]G$
M=QJV&0#0<>;PT;'N<UAT<]Y,TZCF9);RNR-Q$+*JNBTT;UR':3 (U1;]P5)_
M6,@Z=^,CO>8TL,:QRW_\6Z1O#T9MD-V>MNTJCZ9X6M^T2M=)8?@':D-W2UA2
MN(# HYGO=12A76,E-_E= 0-F<.>[+,I-1_0&(2;^1>P.!F_LH5YX<,S#0?)0
M6G;1&/"O9)1_)W/;?VR8D);MN>S<\**[ '6&B?YS""EHO*$VZ@8*HUO(6*Y^
M;V1IVD ?-VEPZ$/1L/-U#^6S<-\P:?( LOV'ONW3[6?22_]U<+?=?V-]A\D$
M@Q OU1RB- SV>.V_6_H;J]?N6^%,6ZM7[G*I)+!-&[ ^UQ@FVALZ8/OQ^.(/
M4$L#!!0    ( "^-KUH2Y$S\_P@  ,\:   9    >&PO=V]R:W-H965T<R]S
M:&5E=#$T+GAM;-U96V_CN!5^YZ\@O,7  918%]NR,TF W&8WB]DD2#(MBJ(/
MM$7;W)4E+TG%27]]OT/*CG*Q,SL[;8&^6*1(GOOYSJ%UL"SU;V8FI>4/\[PP
MAZV9M8O]3L>,9W(NS%ZYD 56)J6>"XNIGG;,0DN1N4/SO!.'8;\S%ZIH'1VX
M=]?ZZ*"L;*X*>:VYJ>9SH1]/9%XN#UM1:_7B1DUGEEYTC@X68BIOI?VRN-:8
M==94,C67A5%EP;6<'+:.H_V3+NUW&_ZJY-(TQIPT&97E;S2YR Y;(0DD<SFV
M1$'@<2]/99X3(8CQ>TVSM69)!YOC%?5/3G?H,A)&GI;YWU1F9X>M08MG<B*J
MW-Z4RY]DK4^/Z(W+W+A?OO1[>VF+CRMCRWE]&!+,5>&?XJ&V0^/ (-QP(*X/
MQ$YNS\A)>2:L.#K0Y9)KV@UJ-'"JNM,03A7DE%NKL:IPSAZU/U_=WNYTKF^N
M/EW<\4]7-_SNIW/^]_/C&WYUR<\N;D^O+N\N+K^<G_&KZ_.;X[N+J\O;@XX%
M:R+0&==L3CR;> .;*.:_E(6=&7Y>9#)[3J #F=>"QRO!3^*M%,_D>(\G4<#C
M,.YNH9>L#9$X>LDF>LJ,\])46O)RPC$R'$&3X2WD5D4E,XY,T()BR?!_'(^,
MU0BI?[YE"\^I^S8G2K-]LQ!C>=A"'AFI[V7KZ,,/43_\N$6/[EJ/[C;JW\^A
MV]D,^![[)E;LHF#'"ZUR<EP2<#N3_+2<+T3QR$51E%4QAJGIK1&Y\X6RAG]2
M]E]36#_/^$61(2VTDH;G:H)M8R5QQ@!7%HO\D8\J UF-"3@\9Y2!\Z9$YD06
MLN!W6F3TXK/-F"BR#80O"BMUX7PM\@#3,00M^8DJS2.BF ,,^5B8&5_H<BQE
M9HB!6&#VH( 4$F)\N?U+$K*YRG,"'U.-?@4.$1&?U ! +K)?,0;" 5;Y'31&
M- !,'+&WY5I*A*<+&@B8<6$V!J@JG W)QGRB"E&,E<B9L1"N9GA6:1B"4?H\
M]X*6XW):*$,,LDQY(\"8!I)IF0OB##W6Y"'"HH2S-HH=P%XYT)_L+KB1UN9.
M""ZF6KH16RI8=6U>.Q.6+Z$=29X[21 QL#G8/DJA=R4\1]YS12F'M8V:%M@%
MK7\6147&A6B]/7Y,'KI7KH1 /#@EZH5!&(:,R).F.O/G8-0%>0B[2+-)E>>>
M!8G0%)H\C36H;'?',%DN77D9YT+-8=:+8FVU@*,*PN2%BS@PD^I>C')I:E&Z
MB'\29:++^9/RSL1T@&+EB;X8CY$;MADT/AR66EDK2;T)!415D%;W\ $X899)
M[11"0,_-2KLG=5S@L3IPP!3FFBCK IPV;@HO <:^COLX,;6+S3X#,,OY"%Q7
MX$RJ?OAA$$?]CZ1M<YVY -J^'K]8OY'W$N*P718'Z:#+HCB(>P-VM5*!R0=T
M+$8:[&C'0;\7LQW6'@;]=(C!G7A8;>#MR])*GNY@(VW%ZK73WCODR2:N<X!'
M'<DHB<&XEZ: /Q2)G<Z/Z'P8I7@-5QM,QMJ]- $+B)M& V+HCZ]8U@:G\.:.
M__MT!KW0B^)\6*"#(TR:D!OX%&BG7:IN(^;\N,EY#AI>NXNMW)$Z=SR?G1(H
M^DA?L2:[L#KN-HE!LM,6+0HC?+OF\(:</ B&2<\3-F7N8DWPA=!T@FTR$LR;
MICV8Z5):YI!:%6085]-AEMI1#K<\$Y1?1F9L0-6<$LX\2TA2X@FF&N*Z5&P@
M)Q#%Q3ZD=4BQ!LE&_@;4U;KVE(C/?"K+720RV:N)%P1$3T!&L=( )&>I?:>I
M,'AO:LW64B3L&EO8&R*\=:CCEV7&GN?=MAF"&+:WCWR1"TCT0<P7'YG\O5(+
MQR4*$\H<_/Y8EME2U="J"F#C5$'#6@86=8,H=GO]X*) KMM2/[+(.6BW?E(T
M,'+PKONEHBX=R1)FU$W3X4 2#ED;6(MH& SZKS8OQ*/?V1[TNP05J!#N$801
MS3]+-/UH-<1(Y1X$VE'89X0:]>"TTMH[0B]*'X'< F<<I-3(<B8G$KLR6E@3
M>P2%8:\FY09WI86#*!UJBZR\PJ(^%$G6V=\+TB1T>>^ZG*R.?)]RS>YI0R,Q
M4^,9KVM@;2N769:_QF_:!G]?JARZ()SV77.3NN(%0VE2C9+#P6F4[NSQ$V'4
MF+5SAW! M (1CD3 -M1;%%349S,C['$Q%'W<" Q?38AR8F,O9%PAK0@-1X_8
M=J^R5<KY>M?AG@47$TNZB =OS1<W -8@ZDLXN<.9(6B8QD-S;1VJ8.ZM0VK_
M<@7VZ\;,PSYD<RC@;I)45:F*3R4O*N</<*Q3[KA&W!=&<%V?,J;:Z$IJ]& -
MCVS0!TY+>L,@&B9!=Q"SFDJM2=2#:L-AT U[]<H.K]6)DBY0>1@D<;I:"@!)
ML@Z!T+EC4FF78)FT0N74<:J<?/#2G9UO"8P-M/[/0R/S6F\+D8TA@;5NV(5'
M^T&<IB]]G0X =_T@[,>O?-WK!=WA (U4Q%>^9N_Y^GG;L'FR.;]?AKKW9?O+
M+3]#A18: KX3(ZP=[H4$Y7@,Z"=FVZ+F^S),'<,M^'5\=OMND..J_$F.].H^
M\^*>-IZA>M9W97=BU=V#-.%Z?4^D<*8K]'O8X9O> BI'.TZZ)@7$9:5YN[OS
M+AE RB8BW"XQ>*3 >I?.JH:\LMF?S.:O2F;^O\9Y4K29N%$:#'MTA>FNV*?(
M1V!P^L2Z'Z3=?C#L][\B/;?"Y]=$YNK\]W;/UX'M?]8_P1] VY>.BL,@!L@.
MHK6C<'T)PV 0)FL9TB!-J7PF_Q4<)0G_,(BY%G.O3ZB9#+:BYI\@W^T2^82[
M9M[?6ET_2[<U/Q46W>JHLJX[!;!\TRUV\P3!4%]E&@\G3;NL+(FPTZFOC=O^
M$6A'**<[+ G2X< ?;QY2N,*8UX?J&^>N/U"S\R?J:'QYPETW$$@H,&0G+9F[
M<Q8E;]QOS?;K?N;^\WOZHT'2G_&OV\2]M_Z'[C0^,LREGKI/*931:"7]]X;U
MV_77FF/_D>)IN__4\XO04P5Q<CG!T7 O[;6X]I]/_,26"_?)8E1:6\[=<"9Q
M;=.T >N3$CE33XC!^AO6T;\!4$L#!!0    ( "^-KUK'B>,CJ@,  /D'   9
M    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;+U5;6_;-A#^SE]Q4(<B!E+K
MU;;LV ;L-D4'M&D0I]N 81]HZ603E4B5I.KDW^\H*:[3)=D^#09DDG?WW,-[
MX_R@]%>S1[1P5Y72++R]M?7,]TVVQXJ;H:I1DJ10NN*6MGKGFUHCSUNCJO2C
M(!C[%1?26\[;LVN]G*O&ED+BM0;35!77]VLLU6'AA=[#P8W8[:T[\)?SFN]P
M@_9+?:UIYQ]1<E&A-$))T%@LO%4X6R=.OU7X3>#!G*S!W62KU%>W^35?>($C
MA"5FUB%P^ON.;[$L'1#1^-9C>D>7SO!T_8#^OKT[W67+#;Y5Y>\BM_N%EWJ0
M8\&;TMZHPP?L[S-R>)DJ3?N%0Z>;D'+6&*NJWI@85$)V__RNC\.)01H\8Q#U
M!E'+NW/4LGS'+5_.M3J =MJ$YA;M55MK(B>D2\K&:I(*LK/+CY\W&UA?OO]\
M<PFWJS_FOB50)_*S'F#= 43/ (01?%+2[@U<RASSQP ^L3E2BAXHK:,7$=]A
M-H0X/(<HB)(7\.+C%>,6+WX.3YBL5*;1"*H 6AFHM2J$A2U252-8?@=_KK;&
M:JJ1OYX*0><@>=J!ZYN9J7F&"X\:PZ#^CM[R]:MP'%R\0#\YTD]>0O\O&7H9
M8#ID/V&PVSVR0I74D4+N@%>JD=;  2D8V9[K'>;@PUFF,1<6\P%8!7:/8"RW
M2!UI72!I+FCN.LO,&*4,JRUJES;FT@9?-K^\?I5&X?@B"()_R.-_D4<_RX6F
M+E;:M&>3"X:5*AO'Q,"9D%G9Y.XB4LDW@'>8-:[5(7^P&LS8#5:-[ FS\#P9
M)2PZ#T8IK<?QE%UW8X;1,AJS*&$;"@,RU^\YU/R^=W6E+$(T'K!I'#K+P'TG
MP82MB !YZND9ID_=M4)6(!K2#M*(I>.0I6G*;OE=?SP9L81@TBF%@FHH$YUE
MYS ,!Q"R,>FD<>#(!R.VJI2VPCQ2BP8D#*<!FR:D2E@?7:V3W.4N%Z96AI<N
M=53^E#Q[?PYUR2F;7.: WQI1NVNR-_2+V!429>H.L9,44JH*N7,@14%%(C/B
M'$_&+(['["P\C\* $45XQ)V,G=.,AH.0#87Q1\& DSE2]\@UH)L;<%H";>>#
M,*X*KD3)SES)S-R.XA<$@_8@FM%^U.[A433^%\=QTAX,GVIP_V0<5TC=Y!X=
M YGKLFXR'T^/[]JJ&^<_U+M'\1,UHR#>)19D&@PG(P]T]]!T&ZOJ=KAOE:6G
MHEWNZ6U&[11(7B@JC7[C'!Q?^^7?4$L#!!0    ( "^-KUH(N1:73 <  .@<
M   9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;,U966_C-A!^YZ\@W*)(
M"JZM^\@F 9)-BFZQ1Y!LVX>B#[1%Q\+*HI>DXN3?=X:2;=GQE:/;/MBF2,['
MN3EC'4^E^JI'0AAZ/RY*?=(9&3,YZO7T8"3&7'?E1)2P,I1JS T\JMN>GBC!
M,TLT+GJ>XT2],<_+SNFQG;M2I\>R,D5>BBM%=34><_5P+@HY/>FXG=G$=7X[
M,CC1.SV>\%MQ(\SODRL%3[TY2I:/1:ES65(EAB>=,_?H/,#]=L,?N9CJUIBB
M)'TIO^+#^^RDXR!#HA #@P@<?N[$.U$4" 1L?&LP._,CD; ]GJ'_8F4'6?I<
MBW>R^#//S.BDDW1H)H:\*LRUG/XJ&GE"Q!O(0MMO.JWW^DZ'#BIMY+@A!@[&
M>5G_\OM&#RV"9!.!UQ!XEN_Z(,OE!3?\]%C)*56X&]!P8$6UU,!<7J)1;HR"
MU1SHS.F'SS<W].KRFM[\>G9]>=PS@(DKO4%#?U[3>QOH78]^E*49:7I99B);
M!N@!,W..O!E'Y]Y6Q LQZ%+?9=1SO& +GC^7T+=X_@:\2Z[*O+S5="+ &4=<
M"?K765\;!0[Q]SJ!:[A@/1P&R9&>\($XZ4 4:*'N1.?TIQ_<R'F[A=E@SFRP
M#7T/<VRG=YTN6<:@YUSG U)(76M JBPO(?P:56Q?S34=\&)0%=R(C/8?:);?
MY;#CEIJ1H"7D#$O)C5%YOS*\7PAJ))734BA-Y=!NFP!2:?#I]YL?P;!QDC+'
M<<@!&-@_JA'J12]@CIO@XJ%=]996 Q=6TGH56$'HJ0TZ8(W?"04YA);5N(]B
M#.E//R2>&[T]L[_QVQ7)-,U+D$Y7@EDQ@("7#_0+Y#5=P:8;NXG1K%(S:1\$
M5]U:7W2F+[*BKZ&28SJ >,C+"ND@=RJ.V4?O4*4%W$*]5<-D5<,@^ 8-^Q%+
MHLT:]EF81/^QAL\TX89"%A#VH%DF8+7+[7TZW%>U]U5J(K68>^/,"'@EP%1_
MR9Z-&>%#_#!E;NJS(/%( ]FHTPU]YJ0I"YRP63FDC2Y=/V"IGS+?BV=+7?)(
ME$<S_J,9CZS(M^)I>HF_-D=M%E:"NQ8N$Z6$BX0;J?8"N1;@DH.\R*W."#C?
M(Y_8?,(1^60M1O:P&%C]-UY6../2@T_2".JFA\2-0O!9^""/$?"5U.,T8F[D
ML<!UR)\-0^093HH>FJUZX<_$<_ 4GT%Q0Z((M 1&"EWF^QX+W7C;B6;FX8VA
M#EP@"4,6 =+AUJ?7,!?]^0LDA"U1NU7NQUG*\*_S=+\!8PP%4#XI\H9@OA-M
MGO$'FPCF!P@^&"TNET6*L-FP1O"CT-)UZ45>5*CD3=?3KO77O+YVYL/5B'V=
M?,CHI*CT$U/Q:K( <@BNJ:P*T(*8V4W69H'H!CS=Y$->%'8V0]5"O4PG$(=P
M(_%BCWP/NMO!":;W6JLSV.)A<59>0EE60<EO-$B+B1BVO&DM6_; T+G,P.!8
M?I6@$+::Q3=Q2IKT7F;UF:"$G32+*X&*;U5^QPLXLTLQRH:R@)X&K;6_DO@C
MJ9 ;G 6M0$,B\9S[05%A,-B"X(6F7W</SN] 8/V)BGCN=7:UL#>YF(G^?F'O
M(_(>O!(CD( CBGNA!KD6R*R<U"50?2-X4)J\(2Y4*:F3$(_%H<<@%6ZDGG*E
M./H3^.853(N)/;D!\P\AT3,W]@'#!=PW2SC+D7%Y/QCQ\E;8+%$"N6ZA^ GS
M4W?VX[( "JT@\K? O;-/)E^'!M5.E,)E$R;M(11U?NRPV$G)%VEX019.L#.:
M7N)2ZQ)9RX/(_, ]78@$<%LY'GP<%"\%N:(P1D.$(=YA(?T\),CB/G>WM<9Z
MCV'TT_L/Y ,P19"ILXL;<#CRB^@K6V,LBLIW<CS!7%S;-[-SMO">70% JJD2
M3<+!J,E!ISLK4%2U+,'9W$-[>AL!DD>EZ$%PN!,&+Z0-(-1,8?" U>=.G.YJ
MJX=@>S0E_\?>SK+^&OV;1=K<=I$]]/.=FZX7B+YG8V55\JSF"2GMM>W&+(50
MCN* X%RCD1C"',(]=G!RWC)%+ X@F4>1G7WN]0*TI'7JXJ@%_!KW;]?6.ZB?
MT@6M0+=[(%S:T.<DS(/2WDL#' 6I'04L<1+H/;:V.#LZ&==!*.B5'.)#ZQ!&
M<&N&$>1<+WI2&Q-Y,82W[5K6#E^DWYUMBTW!+VI:V@B;6A;:M"SD]5H6U,/:
MR>_:G"SG#?+J#0C"/[G)(&N:C)I/D!,&WZ=9P-31[@A$^_]B&Z][EOZSO:]:
MWF_*QFL+L ,4ZK"W*L'_HV:'TB[ ORH@^J%R?W:]CH5" @DD>4FY[K(4<FK]
M';LL\9Y;J<.U[P>03I/6*($R)_3#?[E(;P+Z42NW5(BC;WMPFX3,#2)D$4:)
M[Z,2(6]CWFU*[3HA[2ZGU[WBZ+7>/HV%NK7OV""YR:HT]8NH^>S\-=Y9_?9J
ML;U^!_B1JUO0""W$$$B=;AQVJ*K?J]4/1D[LNZR^-$:.[7 D>"84;H#UH00E
M-P]XP/SEYND_4$L#!!0    ( "^-KUHB/@P):@@  ,$5   9    >&PO=V]R
M:W-H965T<R]S:&5E=#$W+GAM;.U867/;.!)^QZ] *5LI>8J62/!.;%?9B6?6
M6SFTCC-34UO[ )&0A0U): #0CO_]=@/4X5C6.N];3H57=[./K[]N\>1>Z6]F
M*82EW]NF,Z>CI;6K-].IJ9:BY6:B5J*#)PNE6V[A4M].S4H+7CNEMIFR,,RF
M+9?=Z.S$W9OILQ/5VT9V8J:IZ=N6ZX<+T:C[TU$T6M^XEK=+BS>F9R<K?BN^
M"/MU-=-P-=U8J64K.B-51[58G([.HS<7"<H[@=^EN#<[YQ0CF2OU#2^NZM-1
MB Z)1E06+7 XW(EWHFG0$+CQUV!SM'DE*NZ>KZW_ZF*'6.;<B'>J^4/6=GDZ
M*D:T%@O>-_9:W?]=#/&D:*]2C7'_T_M!-AS1JC=6M8,R>-#*SA_Y]R$/+U%@
M@P)S?OL7.2_?<\O/3K2ZIQJEP1J>N%"=-C@G.RS*%ZOAJ00]>S:[_CR[O+[Y
M,Z"S#^>?;NCYI_?T\I]?KV8?+S_=G$PMO (%I]5@[L*;8\^8BQC]J#J[-/2R
MJT7]V, 4?-LXR-8.7K"#%M^+:D+C** L9,D!>_$FX-C9BY^S)TW5*--K0=4"
MZF>Y;$1-9><![I R!_32E0;D:_L0T%7#.TMY5U/Q5R]7 $E+_W4^-U8#IOZ]
M+TG>A62_"]AG;\R*5^)T!(UDA+X3H[/7KZ(L?'L@P&038'+(^L]7]+"Y*)J0
M@R;)!\@,><W;U5MZT<NFEMVMH5^__.WUJX)%V=LP#,D' 8VS5$U-KEK(ZYW
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ME9"6+,@+. 0%9#X-XB0A,6"DR$@>!AE+R7E5]6W?<"MJ4@OH]DH.' -L KW
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M%Y6TQHP380/BFSPE%CRCEUAR]!)S/XKXXC28SR*^."!>:/7(L6CQA:)SM%N
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MP.S:!%6DLMC,0!QE])0P<XD%4:59_T!9N6N99)1]:1^$)?D0N_0*S-?PLV3
MQ*W[M*@U BBO\-)&@GV<%Z:0-!S,7!TIH!$6+]$/1P<2?=U/,@^XCJ]ZC)O\
M&TI>U4-!Z*%*Q/8@RI;W#E9^6.ZF:6%.HQ)C!RZ0-.@"[FWX<&1V,*.=L$$L
MA5;@<YH1\YW?*FE:YJRXXTS%D(K_%LN4LS0NF]!C_Q7G.M;RT$I&'<GC=L]&
M"AY;M" ]Q*>JK)V8>0J(+<S5X+H>%+Y[3>!N5<AS!/Q\V?1QON[CW1HD"'%8
M$",DE?2VH,*8>$VVOS.NX6,XE#^^?WLE+R&@W1^J%$?55[RM$G:+M[OM&OS1
M\GT!21*#KR@!^/K+TYGQPJ9.;&7Z7;S9?B\:G_$-RU#+V@IM7\36B4MRXN2G
M1]:!A,%\$K&GV"/;81';)8/' 9WE-V)Z0[,I:43I-FS;I,G9?9'5B(:]$GF3
M7&0>P >-VHFK-=79%.43GTFVMA3KE(O2'Z]?46RW" \H>-X-Y&56K9OBF3L\
MPH%4W;M>#"=_R.%TNFB- DH"FNR&@#LJT1%L")MU>@5XUBPB!,N8ZG=3<PVX
M6IE268"60QY0TC[<@>!!.MT4-NA\GW+&O-N*4W(Z!E$>!R;?H'>Y3-@F/<+/
MN&/D''C%GAE(3J5)9^"QI0UX9S,,2N/NL$S*@&P\#0"6+/%7Z*SJU+J6IIVB
MN*.ZK4M=4_YCQH>X3UYR[< D2J9+3*783#K1$1]R2HWA#KC,14TOOSW:G H,
M_+VF#P#VG(KA-%U1ESEO3=T&"+?KY)SK$UZU[;)%G6[5CKIF/80R_L6T+/MX
MRPSTB_OY/K38-@7LG;K6U"L#?60@?OA#F_CV9D*+G:D+=F&"UKOR&N^VWWK0
MUNC45 ;FK!@GCG?\7.[R)-K6ZJ9VFQ!)/][\<MY<2&I27=O/,OJC'S&=!$:;
M<Z7Y4?-!^E6P8P5R#@WS=:VW=G(4M/G-J]8!^#WQJY]_N;D^0XH D6''=&E;
M30L-W;",SRVF;SIQ@SG::F=,!JQ@5T6"LTTE:FCN&TU+B>W1VQ!A106]HMP)
MKJG=$YO2C:*ZNNT]<]'2]$OM:QW=,P%92JI@2M-$=&"K)K ?ZK?:F"U75F1M
M#-*RB69I 154%A)6'%R0LC6H%OU(20-O:(39<$#?&RBTZLUJ>D2YX8]8N67K
ME )1Y.IP=07:)=L.ISTL(7JL/7F9?.,K<6#EM;5O<FYIM/$(N46X%@&AYYK"
M.9RFXVG/Z22.65U-X4(/X1K-D_;N6;22BYW\[X@KX$$OO.HF;RT9Q[-L$ZTT
M38J8ZZ+L^.Q]B\-UQ:8$57I<(G#M9MPF[G0?018BVXQ[+R9NYLO[G0="GE2W
M4P2VBF>B/=!IAS=O_T3#B3M^8?B]_- )\KA!;74#$;6B1IUV<;=I4[@@Y8H'
MFFQ,&=@F&'5"=CYX%J9"&/AY@/4,5KT])>,#?^#0Z?JPMGJ1B N232D<_/<'
M,+Q1+"=!9%"5:_*X:/E +(WXE/H*T"CC?OA<C7];@+/(2(.FAY)UDOB.U!&E
M]:7^Q]^2F?Q+,N/H\-'N!\.8R8:[K4 O=/'Z!D$7D>FL)@VE@_Q6)R:N:&.9
M=@Y%DU-A!P*$YH#3U^BFK-&VQ6^,(Z:N4]4(C[((FZ6XM ;,#H=/A/7;7%LG
M9TN(+-NZN>T0\1 "]['\GE'0J1@WW1_>)M9P1 MH;99^IBDMTWBAKF]=4:G8
M=!KI7/2R6'"&XWFP1TNCATHU@\>H;PDWM')PJERPTJG1F_X0^3DK9A,>;@N:
M)>\5ROLU"%,M^1/L$,?9(?\N.[RN03M$'Q_\P8$9&&C;X)^T@GD"SJE2],;I
MH;#\XH%@.O>;M/IC199':W(KR0MP*-$,#D>P;?N=Y )SS].,<YQ].D9NH,96
M$-R;?7\ :0)G<ONKF\9S/C:5(C]Z8V'_@A&_:VI&[;A*\,B\2I<>X=-SF(BQ
MHY-&::.Y"Y]M*8U0Q"A-LTQJAY42578S(5-ECRT^P_)Y* AB"MH4J%68I/G1
M"?'*#MG8<-D6\DRSE\ ;2FA+#E[-MU_;;R91*'9OF&;N'^1MM]I\M5>P:P5Z
MVJD[/Z6)\O%P1 /HGGW&/'Z3B%-84^::O'AV-IC*)^*)Z\@9 ^)0LRI$HJS)
M$^G=X(^B(YXOFDP'DU \$6\/]<5%-!CB'CF#ADBBGCL=)I[@:E$S1K1LQO+D
M@;&\4[S[M#]JY#*S_D37$=9"Y]TDK0D<]YKQI';>H(492XB/]!K;$0$SK6%&
M&\@5N$D#OS9K(S '#4V>V\E\.'MHXW;3](1[)F>)E,/A:,N.P'H^$P_%O9F&
MAHCHB3@XQ'"D_\_S#=,GPI[;E%S7B&/.H .? U,-.=,5369TF^=>L<7U@FV
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M8(62+AHO4=2+@N2'"'?L='KF8 )SM97K0K"*]D<D>94)TL08+#+>9E&(R2F
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M.HSEB&E___8O5M7NSKM6%C=H]XB6$:33!(RG"B2W+[1!_R/(Y=]02P,$%
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MNO_$@[_BYL9;1.G!85M[\Y2A3*^M[IW7Z[>"N]Y'KTXZTY;3+'3N+IV3'[\
ML;'C+5'"=TQ5,]#L-B](7 W.[_3J^7DB8D.91#FL-=1M][L8B6JD*T?QTH[1
MBBL]E-;,]"L(PB3H^)IS=73, <V[&OT"4$L#!!0    ( "^-KUIO& \Y_ <
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M3@+\'0,^@OPM#=R#8[<*F9T1E0YV'<#K%X,DMN3J(Q8"35)"10)Z!3-_E$K
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M]S*OD#(=*G7;:^K+'S?@EVXA,EUMB'>:P3;(3B&II8&\W%*BY:NTD%A=!J9
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M8G]*4J@Z'3$>66O[G-]@ :BU>?4A;5-./7NC7*%8-$VJ\X)>)\DPA]8)8G;
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MY^0@ENSE9%P#T4B$,0T=MRA@ -H&\-^*%^0' 5=[\ZR:FGP?]=LN3A:HJD=
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M7A\-A(M7^?$AV(JOS^<V8#C@C[F2X %:@.\7%F32/- !W?]3SOX+4$L#!!0
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MJ@^?)\='6RD,RQ$!R1-=8%&"4& G1XK*8BD-4G0\]>M#Q"QW&>S;0 ,7Z;]
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M^/95JB,>&B33[5HOES;L03QO^AJ9,,Y19(.GM7WK%J_UW[+!\EIE;9!&<Q3
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M'7@H#TM?YY,T\M?<^7KI,VY&Y+* 1292 \D+C=!XIJ!]!2-Y4]\)(Y>C//,
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MK' DTKJ)213[^)LD?MSMD##RDW:;C)A>-N:5#Q/%T4*))E@A5\+07#*!?KJ
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MG!_ /RLYQY>Y]BV</@+ <S8[<+IW^7T/C8FSNHC:2UE;>T"^44G-9<PG==L
ML$0EEJ=6=N)=@8@8JWN;>GU6G"4Y+3EB685:QVU!$?AV)$Q4UJ3-"$.QBRGV
MTJS0:H@U09)$+0R'=VX<R'Y-*=$RE9HQ94=35FW>Z#.7E C'PE!05('K1JQ
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M@$(4(VRHA:%0X=J%_Q!#@SQ4A+F@[D8UQ)/*F=@$^;2 S'"KZ8!,("]P<H[
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MI9@UQLJ=;HSW V@ ##EQUT3<\#4M61%2H!&:]0UJ[XQ;'(3D%K;V(V$)!>M
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MC)[^](RUR88'=3^TH.0LT-WA[8*[^'TX&V=CZD*R#PS)2-=XYVD7PR,TB$0
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M:8Z9"6D@YE,ZZE6:!R70Q:6W>+$JS2^:$V7IVIH_SCG2%.@VT/I44=RM7IR
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M+L5S58Y4W:E;.^.W:G5SXC=7)K,K H\9;+\5VL=2SI_5((<#SG8S'3V=:N+
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M4?G#*U5ADPSVD"FT!\V=/@'B.)->&WB2K_GZGV+G(T^F'M+EH+EI3*W*OE5
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ME$WP(*<$Q"(Q%]3D*NW2@4#W6ZF&#QB&K%F[[ADM,E."37EE5W!VO )9P6C
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MEB<C!1T)U$G?3\0'ESQP7HI[2);:;U?%*Y &9>=+2.SR)9Q*LF*=*62*I@U
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M=MM0]>]]!#BKAJIZ)2?*LT/7]AH;4>QR>P<_4.2!:(JO=8;&._1YPME(+M$
M5",QN$Y9G#VLQ^E>"6.]J\,*B7WQ;84V_2T6Q5'+*?TN[6?!6Y>S?(7Q84)
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M"8=>4&R8'HAOX+\4OT82$OFDWR6]QE,P,'Y*%-C$*$[#,0!-<H(G(8"7/*'
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MP B8-*;7^. P=L "4&D,N$5YS7D.S ,T#<(W7T4R2)2Q(-MOCJY2HU:/=7"
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M+_.>2KJ"_ZN?;Q^0G)'"';BL$7$<<<(1>)#'$\*M:U:T9<0;QEQA$:HU)3[
MO26)H7[)U"Q9UYRN^D]XXV"9"7. +Z>[1D&NT<6STX5G;JB998SK$QLUOX-T
M.3*60K[:G_-LQ>]MBUX[3(,Y9L E<I\^,IOG:3;,@E]OR">;C15<ETEWFSYL
M7.9,GVG=S%N'QT<+?&77'8\ZK>_*2$!XQ?$/?CKZX.?ZP2N/M:A H&]WUT
MVCU3CO,+-Y</_.@<@_J( F>O0)1_\]4F=C?Q9:SKGO.POGZ"'E?[*Z)T8"^[
M+UY<//D(WDR/?_/5MKR)/Y?=#=:BU'$-KSX]_Q3,J [3I_4_AG:+0V).^]!N
MZ)_8J"IV^ #\OFY!VY/_P ]0%S"<WC?_#U!+ P04    "  OC:]:*\D=]B(#
M   >!P  &0   'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6RM5=]/VS 0?N]?
M804),6F0-J5L@K926F"+Q-J*PO8P[<%-+HV%8V<^AV[__<Y.&]@&U1[VTOK'
MW7???;Z[##?:/& !8-F/4BH<!86UU7D88EI R?%$5Z#H)M>FY):V9AUB98!G
MWJF48=3MGH4E%RH8#_W9PHR'NK92*%@8AG59<O-S E)O1D$OV!W<BG5AW4$X
M'E9\#4NP]]7"T"YL43)1@D*A%3.0CX*X=SX9.'MO\%G !I^MF<MDI?6#VR39
M*.@Z0B AM0Z!T]\C3$%*!T0TOF\Q@S:D<WR^WJ%?^]PIEQ5'F&KY162V& 7O
M Y9!SFMI;_7F(VSS\013+='_LLW6MANPM$:KRZTS,2B%:O[YCZT._^(0;1TB
MS[L)Y%E><LO'0Z,WS#AK0G,+GZKW)G)"N4=96D.W@OSL>!(ODR6;7[/%[=4B
MOHWODOF,Q;-+MDP^S)+K9!K/[E@\G<[O9W?)[ -;S&^2:7*U9$=W?"4!WPQ#
M2S0<6)AN0TZ:D-$K(7L1^Z25+9!=J0RRWP%"XM\F$>V2F$1[$2\A/6']WEL6
M=:/3/7C]5I2^Q^N_AB<PE1IK TSG[M$%N@55?<4-;ZI)90S%6HE<I%Q9JJY4
MU\H*M6:5EB(5@.QKO$)KJ.Z^O2120^'T90JN%\^QXBF, @J+8!XA&!\>],ZZ
M%WL2/&T3/-V'/EY2;V>U].E=H154W9"Q>X2\ENR&VL3G.]\H.HT1P>)+&>R/
M<7CP/HK.+CHW0$U3:)DQ459&/P*UM,7.X+@W8#^!&^SL+">UD!DI2)?=SN]7
M\YQT!@;?:U$Y?Z]_+JSUYKT_S:>ZK&H+YLFATS\>_&&TD'P+]&3E6#5F>U0>
MM"H/_H/*B;)<K04UTQZI]P=JT^:5L%P*I# 9/-+$;<1*-9+B?^F](#[T%%X"
M*EE0*6#G[.]WF=N"I#P2*I6U>Q\J=A+,4)!F0-&E;X>ZJJ2@#1&P^,8CO:YE
M^&QF$<+:3V9DOHN:\=6>ML,_;F;>DWGSY?C$S5HH9!)R<NV>O".U3#.-FXW5
ME9^ *VV)KE\6] $#XPSH/M?:[C8N0/M)'/\"4$L#!!0    ( "^-KUI%K!'K
MMPH  !@I   9    >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;,5::V_;.A+]
MSE]!Y"[N.H52BY2H1YL$2-*T&Z!M@B3=B\5B/] V;6NO+/E*<A[_?@\I6582
M6;'SP'[Q0R*'G)DS,V<H[=^FV9_Y5*F"WLWB)#_8F1;%_%._GP^G:B;SC^E<
M);@S3K.9+/ WF_3S>:;DR$R:Q7UNVUY_)J-DYW#?7+O(#O?311%'B;K(:+Z8
MS61V?ZSB]/9@A^TL+UQ&DVFA+_0/]^=RHJY4\6M^D>%?OY8RBF8JR:,TH9D:
M'^P<L4_'3.@)9L0_(W6;-WY3K<H@3?_4?\Y&!SNVWI&*U;#0(B2^;M2)BF,M
M"?OXJQ*Z4Z^I)S9_+Z5_-<I#F8',U4D:_Q&-BNG!3K!#1VHL%W%QF=[^0U4*
MF0T.TS@WG_2V'.OS'3I<Y$4ZJR9C![,H*;_E766(QH3 7C.!5Q.XV7>YD-GE
M%UG(P_TLO:69'@UI^H=1U<S&YJ)$>^6JR' WPKSB\.KTVX_3G]?T[.?7\\L?
M1]=GYS]I[UH.8I7O[O<+K*#']8>5M.-2&E\CC7'Z(TV*:4Y/DY$:/130Q];J
M_?'E_HYYI\0O:OB1.LRBW.9NASRGUM<Q\IQU\J)\&*?Y(E,T'5. .Y-%E$QH
MKB; 6I'3?\M!7F0 RW_:U"^%N^W"=01]RN=RJ YV$"*YRF[4SN'OOS'/_MRQ
M=;?>NMLE_? *$3E:Q&;CE^I&)0M%!_?TFTHGF9Q/HZ&,Z1$BDQX#I2,*R']/
MA])@'S..\EP5>9M.G:NVZU0M3XYF*L.Z.;E4>4&PRA]I%H_H6:9BF8S(:1P!
MLF8+.;E."QF3?RF9$:7!0>%:-1NHK'8O^77UM]]_"SCS/MNVO>:?WW)ON9UQ
MELZHNBM4EL 69?2H+"<NL_R0$Q9:ON>0/>(Q2PA!SA*,W*L\3[)*"$8%3!#?
MYJ3';4LPG^QB3KG]Y2!(\&R?X+[KB<:X2O*[V,=Y/_NX5ABXA#$K< /H*CPK
M</@:^W",\GP2^-H^W/*=L,T^D" 88;C/[<:X2O*[V(=O9)^V?\_91\"]=J"U
ML9G!#[<$9^OLXUF,V23@ ?3VK- )6NSC>Y;'C,3 98UQI63:D2U$G2W$2[+%
MR5*IOS]-'&W)H7N1I>&:KB MH?SX_F,H/[[_V)4U3GAHA0@TAUL\X,01B#:?
M'.61)'UZ--9C"'<MWQ>$!59HAR9";49.%QER/>E%R3!>C'3"KS"V2S\08!)I
M05@>7.%9 K^K,*[06KG[PQ(GU."DA@>-DJ4T&N4T20LZ*JN,&I%<S25*C(KO
MZ0@SBY064T4C4"!@)Y)Q5-QK#^%BKFB%COQCA_^]VO_>2_S_0_XWS>A%EHX6
MPX)^R]+%O,WMG;*[:\)[8^$$N]&0);$<I#!MFMW329J.<N*$EH.LY&IP!,3U
M+-OQ6H?K'4=#A<1G^<*&YUWA$-_BF'R11DFQEX[WAC)#+? MUW%(:-DAPR=G
M[=#HBE>_]I>_L;^.9NDB*>"VN"0G7S7>*ONV>:M3\O_76P]2ZQ#<4%.K'"2W
MF#82;&N\;6OIH+9TL'5D?$$PWJB\M/1U)I-\#)TPX)M&%M6A?56!ILT!G0NV
M.^!:E[:)KGE5U.-[F$Z22%>[YPKC&W&I*KD61-*YQKW.9 5Z+DV8!&*G(DQP
M! ]#<GZC,F)N<^&AHNG/<B,/^57EM_=5<#,RM%Y!U_+TCDO& X@)UVXJB'M[
MYK-2\ %!JA#YO@INPV9:% 1E8;Z[I"P('A;X#04=QX6"^K/<R$.&4P7@A@H^
M++]5I7U3A#ZK+6B!Y[%EZ2_K^1K4-G%;L8G'T[9 [\MTWP:\S^H.F6%H+_E.
MR6+6 +H)Z8I"/9ZV!;!?IOO+67J;[L+BL&9%\BKNUH[U)MHKWOAXVC/U):SK
M2[AQ?;DJFP/4F7P1H^ZU]>MM!:5[A0<I9>6096XY!YO,WC,"2VW(0(W33(,C
M+S*PR46FN<HPS8O< L.=RR@SNNOBN4!#%>O3".Q#W<U5DH-]]6!RVT'7TP-Q
M"SS]PT'GC2_D(6Z[^'79E$V,;#W-YF88/"W,-!<N9_AQ5J]*AE.93?0B'N-Z
MB!]ZI@_K,3@]*$5K)>081+RQ7=(3%D/LE+MP3%=6;\M'G=,;_K52ARS502/1
M<PP!W27GRW,E@BY [YA9S-,B?JJ"C-'2)D-MJVHJ[?U,"T4]8PAAQGW7TRK[
M%O(.DFUTT'I79\D0G(G@(AUF:A05U6Q?F\$8T<S%3--IW,/_^BA(4Z\H6>A5
MJT,OW5-#,9#:M9-T&U/.T^=)];1JQ0 K"M]IFVP$^T%8>?#U6'UYQGPKK+J6
M8SS3\ZV@Q"HS"#4H$6(-^, 8F"T,\/8:_]9BCZ$7\>VV9;ACN9[=B3T1B#;L
M^9;M;H:](."MV/.LD/N/L&<T7&%/A-OA3A=;'5KH1,=1L3WR],D)6K<6Y*&:
MVRQX,^2]YE3I;9 GK" T*0R)J<QECDF:0)/M^ ^!U],IBYDQAM"9C <!3MB%
MNL!4T5W]P^-V8P5XR?<Z,,>!5J<%<^@$'#?< '-PEFOV^P1TKH,$\DS"8Z&[
M%>I<'2/>*U"'@N7[;:!#!V3;6N$/35O53H3W3><'/T^5A.SQ&*TDG:@$:\1$
M^UZ.0+HB_>C!G-@;@%0G0^4QC45OP1G0-<M$'S$-%%VM4QTK917+P#29W--\
MKH81%L(Z#<HA03FZ#IB8O7IT9&]-=,K'#%7#7%[Z'LE!%(,\JLWY3_?*ZXXT
M-H[WHYS(XBU;$J.U\6.\TI94%B"RO W*[8>!:4R$IJ0A,I7@#X*K'/FI"?KR
M$NT-%UFV3!0C-5;X-]HE$.$S<B+SJ5D="D^I^FL1W<C8/,[2%_-IFA5["/H9
MB/,-K&2>=('S,\^O#%(M(@U2,1J8TAQ[B3TZD+ A$&L>-!)F.^BM[%J_ILZ!
M:]HH5Z<2<&MT& ZBSO4>J-F8\$#7QO7U"H<@?^6NF\,WW;H3(&>Q;8I#.UA>
MT<-M!!;N61R$#U]ZK3TB0(F%\SJP@$*$+P2+8WF8^A*PB! I7K1BQ4690$#
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M[IM-UZY[Z-H5/3?4G86'ZM +S %/>7*")A8M19<C5D_?V>:/WT_D/$(-*OV
M!D:_?+2Q+SJ7>1;B;U\;'!\$+"1<L,93>0#8T>46!<&U+0]YR5#=5DSW&R^K
M0<#$O)*7H^%9)$7YWEI]M7[M[ZA\V6TUO'QG\(?,)A'ZLUB-,=7^Z,-86?D:
M7OFG2.?FU;=!6A3IS/S4_9?*] #<'Z=H[*H_>H'Z9<C#_P%02P,$%     @
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M;TNLB9^0V/*+T-/$"AZ,&C576S=0:; ;RJV?.H;386:[Z$>5/\7[@6_!U%9
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M;"]W;W)K<VAE971S+W-H965T-#<N>&ULC59;;^(Z$'[WK["R1U61V.;"=5M
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MO*1;RC=@:IYPA#<LT14JN'9:?:_3[2%Z 9SF^M7!0Y$ E?DK*:G41J\"K7/
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M"*29@.-K@0;6+R9 \V<U^A]02P,$%     @ +XVO6@?DY3. !P  ]!0  !D
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MD%*<('9G#&O? <@DAF;.$%H@G$$A<9M/+'7Z=.;1'IF^(XXWF4']FIN$M3?
M6W!C"\;9T1RB9H>9,4I2?Q*EK80?MS<AB@[D,NYR&;\YE[? #8V60(:8S!N(
M_Z$<#NO[WQ)F>TOVK+<X/IM X\ 8'+BS:"%@]RYRV$$.$S#&]##58R^^7Q?9
MFE9ROU0Y2&ID$=HK,V0L/YJD,_*.^,G$-U=(;4+Z!NW@JY ZNUH$ZRJP29%X
M$@>PWTDF*;-.)1.$VIY3)B2]20=G.\HU7</<"J'K*L0))]X,0<$FT&C?D0!Q
M]J[7;-5 M_4F7D@,GJ+ G \(PQ<W[_EF^_&BUT6587<$KXW^5R194D!0H7:
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M)'[-A?26\V[O5B_GJK65D'"KJ6GKFNN'-51JO_!"[W'C3NQ*ZS;\Y;SA.]B
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M)K7= ,^G"J+63JR"[E^1T;]02P,$%     @ +XVO6A34NSRE!@  (A(  !D
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MD!FBO@%_A"OSDL1+HAC,2[TPB<&\)$?6+/=@FP0!\W(_^=DOT4L)-_R2@<?
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M9&%@7"KVH7DQDGMAR,@UA(*T]^180OX72_H1JM(<YK_.A<B%K"5V#&CSF,*
M,LX?3TA.%#W6W,@*,@P:3AI!),D:8FZF=$MRE@!^LXKK[^2"WRC-,?S$2A%7
M^H%3JU0%NO=O S=^](#+Q[T)=(A\F$\85H)=&*=KC--?QABC_Y2#B3,<8/"$
M W<;MCN%_'^P70VH;M14;E!\&"0I=V%(^N+=]SFH(JW0]MXC;<7!1J03,*ST
M&30V0E#7!1A[0Q(60)U-TX"\EPV'"@=0]"PW#X98Z_V-T/A;D&5KR+(70W;5
MB@(GRQZ9303[UK@U$7>RWPZ68T\:K+^GD.D0_@ZQ:^;3#Y<7,_B<XM7]?Z!H
M#=E!MR84N;"ERXBK^W8IH8K12P68[:GY'O1$\0+B).L3L"^=M ?R-:_;=V0-
MY0O8X*SU3]X8;JC&#WK4H#-#U SY2S%_,47# 5<8BN-@%X#Y&L#\Y0#*1>,^
M#<".541OPVPWQX=<T#![0^6::U6[D:CM-,QVQLF:G7T<\J+?_\9_"+SQH>LO
M,BA,C[-P-:K0?E1!+HN5K/&C?'R#LV@$,X?K!G@62AUXM&TKB254"Y@1(*#V
M++^#L]E^0E^15_3T^/SZ9$IO55>5M!'00*PBI0!X46FL0+RA&QEE%44;!8F3
M?6BCK\B%:A9[5H 5"X#!+IU8$NS[L/>\6S:^4M"FTU;.>&OQDF!5\W_=#3#E
M^2_S0L#V<_*WO)!%^V&\VPL[ I;Y#_='_LO;1 ."(-]= 3V]&Q;O(<&4-O08
M/^EQ*O@@#;:Z O9.[Z#P2M$48NL-TT[1V^O1PZT'&:YN;B58?=Z48H[)+^A7
M(^9=12OY \=[&%*KKG1W#3_U"O/FI\X3_73K\:0S/;WU>.CXV.$QJF9G7U>O
MK>:EH*YXXM<V_NLKRK#:6E,F&[=]M8!2CG>:AKJ@ZB_^UF_7]Z;3_K;PX7A_
MZ?H1.@'.H)68 ZF_G\((KOM[S'YA5>ON#F^4M:IVCTL!.FL\ /MS!85T6*"
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M_+2#NFJAHE>@PHA^4=(6AGZ0&60O 7SDU9.+GLE=10<1WT-Z2L?AB$9!%!_
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M(C<0_NY?87'5B4B;L/:^L.0 "0*G4N5R44C:2E4_&#!@W>Z:LTU(_GW'WI=
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M,.W9<%%@I4VQ]60I &<VJ:!>Z/L]K\"$N?'0GKV(>,@K10F#%X%D5118?$Z
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M4'8 VF<2B[%MV E6=[3!_U!+ P04    "  OC:]:I.$Q&V0"  !:!0  &0
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M(X?X$_, X86XOATXA-N1,XU"FSF[*K*\T!21;WOF;^K#L/X*<T%)$ 10-ZC
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M@(EF:GOVQK HLEP;@Q-/*IK!$O1#-9<X<P9*6I3 52$XD;">VI?>^2PT\6W
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M*_"6,5ACJGL\CFPBNY>AFVA1M=VX$AI[NQWF^)B"- 'H7PNA-Q.SP/ \Q_\
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M-4A.):<2,UM2!KR_*^!]S0TUT'Y@>O@O4$L#!!0    ( "^-KUI?$/LZU00
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M#8;C-4%"_6Y+Y?BQ$#EJVAJF&"_(E'!(K"'Q TJ>$JL,.BU;1ZG&$^.&R'6
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MG5-&5M.JH'/V[.+V9CR$\77W_/:N==6[OAC!P1U.8FX^GU0M"7#;JN$*K%V
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M(4Q2$K&E(CM?A_T6$9LGNV_>2+XNGN%]SZ7D<?%RQ>B"B7P%]?LEY_+E33[
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M+<V<16D=S/U*"+TS;(!N<J=_ %!+ P04    "  OC:]:='VF2)T$   (&
M&0   'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6S-6%U/XS@4_2M6=K1BI(7$
MSF?9ME(AS"S2ED' [#ZL]B$D;AM-$G=MES+_?IV/)DWB!!!^X(7FX]R3>X]]
MKPZ>[@G]P388<_"<)AF;:1O.M^>ZSL(-3@-V1K8X$V]6A*8!%[=TK;,MQ4%4
M!*6)C@S#T=,@SK3YM'AV2^=3LN-)G.%;"M@N30/Z\P(G9#_3H'9X<!>O-SQ_
MH,^GVV"-[S'_OKVEXDZO6:(XQ1F+208H7LVT!3SW41%0(/Z*\9X=78.\E$="
M?N0WU]%,,_*,<()#GE,$XN<)7^(DR9E$'O]5I%K]S3SP^/K _J4H7A3S&#!\
M29*_XXAO9IJG@0BO@EW"[\C^#UP59.=\(4E8\1?L*ZRA@7#'.$FK8)%!&F?E
M;_!<"7$4 )V! %0%H&Z -1!@5@'F:P.L*L JE"E+*73P Q[,IY3L <W1@BV_
M*,0LHD7Y<9:O^SVGXFTLXOC\_NKK\NKF 5S??/EVMUP\7'^[ 2?W8G=%NP0#
ML@)W^ EG.PP>?X*OF*QIL-W$89" A=AEX$(H'@&Q?'^2,"C6440L&,.<?08G
M/N9!G(BK4_#]W@<GGSZ#3R#.P,.&[%B016RJ<U%"GH@>5NE>E.FB@70A DN2
M\0T#5UF$HS:!+FJO!4 ' 2[0**./PS-@PM\ ,I E2>CR]>&F)-Q_?3@:J<:L
ME],L^,PAOIB%"6$[6JQ=%+-@O:9X7:\-K59S14D*0J$D%8W'Q)[CFVJW8<K
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M7(ZDZUG93I<#0;.BP5Q3(=O5XG$') 2F N3[#:7B:: 6J/^IX?T/4$L#!!0
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MX#;8V_X=([& KKX!UF]QZM;3ZA;H<FO&5^,7U,Q?4"N :74+=+DULZP9#.J
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M!/SY!:7YZQUQP4EU1=+X/U!+ P04    "  OC:]:> EJ%3D'  "W)0  &0
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M<MW&.UD)M<3#Z_>=0ETG-)R"H2!N9G01F!?R" ]NL.<1')/%8J&E.DABC$R
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M19[C!5O2AZ]/]]?3;:5((XO7R.(9//\E/")BRD3)C08)$3A-.:386$^=<%A
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M9FK6!*X#U/,98_)IH\>99GJ-_@-02P,$%     @ ,(VO6CE!;76X P  &A
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MD-)R$"UO.-D5H]F&<%$@Q64DAG>@TD \WQ+"7V[D"^J_ ]S_ 5!+ P04
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M.OW^.^\J.3]:R0R[ #^E1_UWE.%7>V!(LG @LCWE+CKE+GX#_UT,J?V09.%
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M\POY5&#%AKXX$72;;W'75,A)EA_&@$-@RD!>WU JGD_4#:K/*M[_4$L#!!0
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M]B*J$\EVY=?Y,Y/J6[\\W!*<$*X!ZOZ:,?EVHA=H=H1FWP%02P,$%     @
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M9E_66V9(R=_L(,?SV@(-, B=MMDQLOD^.B"S-CRPUQ.899XT0CQ#UKV@K<Z
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M3; :RQJ@[B^Y>KF6)_H'JBWJR?]02P,$%     @ ,(VO6O?W,3-\ P  TPX
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M^>3HF!3]4>>1KY0>6>PTXV@ ]7W=?!SS:J.&)^X4U]NS\LY@Q?*89V#B1##
M,?9G+-_J:%9QY;G4E5PJBMFM*R"&??_*Z >O??,<6%_YH0WJ#T9--QA [NA4
M1N_;++>S_9@N:NZ:<L)DQ1I#_1-F?LN>YB7U<TAD@'@G*.U;'K>[YREC>VZB
MMGL60X ,C4T[0 :0.VJRL0_FEPS0.CT'2LRU;:[*7K_>+6?-6SUKZOFGL8\S
MZ$TQ>=E[->4 >X^D&69J"DM4Z5Q>H7=%.1.6"\4WQ93TPA7.7,7C&N=H$!J
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MT7YP[[IL.PWO>8-/X;M^ET4O D=!)S!]$1A'SX$'TD>M]-%)IH70M""]K'$
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MOC\8GT_<I_8^V->-_+UUL7V==SYJUNUP/&PX'I[(L68$. 7&(-SX$Q&2 #-
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MP:4$\B#*B)F$<BJ(KA.Z#.\(R"A>T(RJK4XH $ 20SK]5D)R36EU[7I%MI=
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M.TA4=_SJ1?'"7&(77,&5V#RN"4Z)T M@?LF!E?I%*VB^M$S_!U!+ P04
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MN!J(;:%ELZ^<<+(IVE_/A(NJ*X9KP"%0:2">KPCA^XE\0=URG?X'4$L#!!0
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ML=GMO#GA=%EMY[VCG-.L.EQ@E."B-!"_SRGE3R?E -L]YZ/_ 5!+ P04
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MGE9.I>.#(H7"BWZG2W,"S4FJ1!@@I\1S]^\$$ZSM-0\D3[SU1,25.B;T9:/
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MO]W*1C6RS]GL%<#P3X \1"S=SY[>'9>[=]4$%K.(BEE$63Q<%R\4LXB+=<+
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M5"U1.[W?AEP\Q')1'+-Z=FIJFE_:BE:>09U\X>_.OK#5]-M6M/+TZ 0,V\[
M[H"-[6-SL?1JL@S4N1JVG:S= 1N[LF1U E&=+YW6X2_D=7??QA8L *#:UCC0
M  "?1P#N;HW%FZS0[]=D-JA9 ;8*"^YHC2W9J,*KRX2:*F![6.$.U=B0A3\&
M._F_;$CS!W0#R$>FGMMW4Z/5B3-&8R<62(&>;W>"-*0@-Z0T0"EWI,9/A#:8
MJ7&C20:Y2>;IR.4.U-@,M)R<8<U:@':>Z9UY>73#)8U S.1CA>.QHF%UU.X#
M.S(?;WU<ES211@'D1@&3-:^XD"DF*6/*[&GP[UK(% L:$Z5[Y,83T%*T\CQI
MN$#D=]=S6H6/MJ*5IT<S"G(S2G.B1"9J>)7G*_>8S_6DJ06YJ:4Y3R*30 Q/
M+2%/V9.F&>2F&2=+(I,V#/DMX4U9O@87Y :7.I!$)E88REOBF+)R32C(32@-
M,1)9Z(*@:C''/>9SR[B:5;";59I@)+;@!>Q53Y)[P.<:TKB"W;CR)(S$)EL8
M-O91_< :4[ ;4QHP9![):68O[PIV7A:X >7I"(G-JH+A91\0@35$8'>%HA$_
M8K.<<-3K5Y< ]XC/=:3S/G;G?1,?+WE\-,LOP-SEKQ4FW0J:<E);T<KSI9D"
M^[\9(W&K-92VHI6G1^,)=N/),UX-6BHDGG&3[(-:L*86[*:6YB")39XIEQ)S
M7_M@&JR9!KN9Q@F3V"284BDQ=[ /@B&:8,A/JBTU/$E,6MDM)>8O<?<!*T3#
M"G'#2D.B)":V# 9^U=(^P(5H<"$_J:\T $IBDLL1]&#U5:)[Q.<ZTO1"W/3R
M)*(D)KB42HFYDWVP"]GY$L+-+@V@DEC(!57=[(-;B.86XN:6IU,E,>L4I5)B
M;F<?6$$T5A!WJ:(16.:Q2J5$!9;5I=D]9%-+W9T/TM*O 3_1Y"Y4>!.QN0KO
MO>JK"4RV']AM=R1?9=^HW7(I^3+;7#"U/"1I _7[G'/YN)-^]E9\YCCZ'U!+
M P04    "  PC:]:P1;.BK #  !F#@  &@   'AL+W=O<FMS:&5E=',O<VAE
M970Q,#@N>&ULS9=M;^(X$,>_RBA[6E'IECP6: M(0*@6Z5H0M'<ZK>Z%FQBP
MUHESME/VOOW93L@"#5Q/BE;;%XWMS/PS\[,]V/T=XU_%%F,)WQ*:BH&UE3*[
MM6T1;7&"1)ME.%5OUHPG2*HNW]@BXQC%QBFAMN<X'3M!)+6&?3.VX,,^RR4E
M*5YP$'F2(/[/&%.V&UBNM1]8DLU6Z@%[V,_0!J^P?,X67/7L2B4F"4X%82EP
MO!Y8(_<V=!WM8"Q^)W@G#MJ@4WEA[*ONS.*!Y>B(,,61U!)(/5[Q!%.JE50<
M?Y>B5O5-[7C8WJO?F^15,B](X FC?Y!8;@=6SX(8KU%.Y9+M/N,RH6NM%S$J
MS'_8E;:.!5$N)$M*9Q5!0M+BB;Z5( X<W,X9!Z]T\$X=@C,.?NG@O]<A*!T"
M0Z9(Q7 (D43#/F<[X-I:J>F&@6F\5?HDU?.^DER])<I/#EN_S5>K*WNQG-_/
MGN!^OH2GSU/X<SI:POP1PMEJ,G]\FCT^3T.8+Z;+T=-L_KB"UDJMOSBG&-@:
MIHBG)-T(6& .HW %:C5"2$3$4DG2',<PSS!'>IK%%;1"+!&AJO4)?@$;Q!9Q
M+/JV5,GHD.RH#'Q<!.Z="=SUX$%]8"M@FL8X/A:P%84*A;=',?8N*H8X:H/O
M_@J>XP4U 4W>[^[7N(?O=_<N9.-7$^L;O>",WH0B(6 $<QZ35.WH$C1\><#)
M"^9_U1&_J*@KT*W(4(0'EBHQ O-7; T_?G [SET=K2;%PH;$CD@&%<G J/OG
M9D8M9<I$SLUJCS17Q5$U#5&(4$8DHO!%^P&1.!&U<(,FX38I%C8D=@3WNH)[
M?7&9CI$@$;047W%EXWTE4?4"/G[H>6[G;F2>W;N2=NMY!2&C%'%50<PK]P[B
MPV+#JF)3-PM%-!T3C?Y-?!TZ??OU$&UAT3VT:#N]8Z.PULBKC(Y0="H4G8LH
M0D)SJ1+X<3"*>*XOP"@L>L=Y=IVC/_>$3:W/&3;=BDWW(IM1@CF)4*I^TC,F
MU'[;%[2+]>RBYO_=<DV*A0V)';'L52Q[/Z*>]9J$VZ18V)#8$=R;"N[-3U7/
M;MYLMD]JM_DGV_BME=ONG-:TMT9.V^_5[UO7^7Z^='ZRJE8&U/T/)C5F;CL(
M3J#46"DJ_@D5^^  KBK5QEQD!$0L3V5Q *U&B\O26%^6] '^9%Q=HD;FZF!_
MEREN8 ^(;T@J@.*UDG3:756V>7&I*3J29>:8_\*DNC28YE9=!#'7!NK]FC&Y
M[^@/5%?+X;]02P,$%     @ ,(VO6I]&P;]$ P  ^@@  !H   !X;"]W;W)K
M<VAE971S+W-H965T,3 Y+GAM;*U676_B.!3]*U>9T0BD;1,"I4P+2)2 !FG:
M(*"S6HWFP20W8$UBL[8#,_]^;2?-0LM''^8E\<<]QS[G.K[I[KCX*=>("GYE
M*9,]9ZW4YLYU9;3&C,AKOD&F9Q(N,J)T5ZQ<N1%(8@O*4M?WO+:;$<J<?M>.
M346_RW.54H93 3+/,B)^/V#*=SVGX;P,S.AJK<R V^]NR KGJ)XW4Z%[;L42
MTPR9I)R!P*3G#!IW0=O$VX!O%'=RKPU&R9+SGZ8SB7N.9S:$*4;*,!#]VN(0
MT]00Z6W\6W(ZU9(&N-]^81];[5K+DD@<\O1O&JMUS^DX$&-"\E3-^.X+EGIN
M#%_$4VF?L"MC/0>B7"J>E6"]@XRRXDU^E3[L 1KM$P"_!/BO :T3@&8):+X7
MT"H!+>M,(<7Z$!!%^EW!=R!,M&8S#6NF16OYE)FTSY70LU3C5+_V-9S/Z^YT
M%HXG"QB',UA\&<$_H\$,PB<()O-A^+28/#V/ @BGH]E@,0F?YE";Z^,7YRD"
M3V!(Y!K&^OQ(&"@EZ#)79*FG%(> RH@S15F.,80;%,0D6]:A%J B--6M*QA3
MGE$=2E:,2T4C";5/'SJ^[]W;&=MNW-?A^R-F2Q0_-.1Y'D#M8QT^ F6P6/-<
M$A;+KJNT(T:7&Y7J'PKU_@GU#1\>]?[6$D8LQOB0P-565G[Z+WX^^&<9 XRN
MH=GX"WS/;QW9T/#]\.81>/!^N']&3;,Z'4W+USS%I_.7<ID+A#"! 2/I;TFE
M:9_(+'S_JBE@HC"3/X[EHUBO=7P]<\?=R0V)L.?H2TRBV*+3__2AT?;NCWGY
M)\F"/T1VX'.K\KEUCKUO/Z&:OI43_1G57<K,&Q+!,^"%MVQ57)%443QZT(L%
MVG8!<]=O^U[7W>Z[]3;BJG%[>Q@4O UJWG[N5$$'ZFXJ=3>7U>UKHFR+\AV:
M"MJ;,YK>1O@=G9-7HL[Q'"AJ5XK:EQ65Z2HD)901%EV6U+Z8IHL1P=N(JX;7
M\5YK<O>J0H9B9:NKA(CG3!476C5:%/ '7<!MH7LUK@O[P-8S]W^:XJ_@D8@5
MU5]]BHFF]*YOM<>BJ+1%1_&-K3U+KG0EL\VU_CE!80+T?,*Y>NF8!:K?G?Y_
M4$L#!!0    ( #"-KUKC@;T:X@(  %4(   :    >&PO=V]R:W-H965T<R]S
M:&5E=#$Q,"YX;6RM5FUOTS 0_BM6F- FP9(F:4"CK=2734QB;%HW0$)\<)-K
M:Y;8P7;:\>\Y.VGH2UHJ-*EJ_'+/<_><G;MTED(^J3F )L]9RE77F6N=7[BN
MBN>0474N<N"X,Q4RHQJG<N:J7 )-+"A+7=_S(C>CC#N]CEV[D[V.*'3*.-Q)
MHHHLH_+W %*Q[#HM9[5PSV9S;1;<7B>G,QB#?LSO),[<FB5A&7#%!"<2IEVG
MW[H81<;>&GQAL%1K8V*43(1X,I/KI.MX)B!((=:&@>)C 4-(4T.$8?RJ.)W:
MI0&NCU?L5U8[:IE0!4.1?F6)GG>=]PY)8$J+5-^+Y4>H]+0-7RQ29?_)LK2-
M H?$A=(BJ\ 80<9X^:3/51[6 *UH#\"O /XV(-P#""I <"P@K "AS4PIQ>9A
M1#7M=:18$FFLD<T,;#(M&N4S;HY]K"7N,L3IWJ?;\9@,+J]N[R_)0_\;.?U,
MI:3F+,[(Z0@T9:DZ(V_)XWA$3D_.R EAG#S,1:$H3U3'U1B#87+CRM^@].?O
M\=?RR8W@>J[()4\@V21P,?A:@;]2,/ /,HX@/B=!ZPWQ/3]L"&AX/#QH@(^.
MA_L'U 3U>026+]C'QU2<"E5((&)*<*1(+L64:3(!?,F!:/I,OO<G2DM\97XT
M'4#I(&QV8,K(A<II#%T'ZX0"N0"G]_I5*_(^-"7O)<E&+T2VD=BP3FQXB!T/
M"DEC1FVUP5],<Z9IRA0DY)IKRF=LDH))]D\L28TWNW0060>FG"YZOH<W;K&>
MKUT;;]-B=,AB0UF[5M8^0EDI#*\(2? *X2O&>('2L#](N]6HJ"1N[X]VN&O1
MVM*S:]%NUA/5>J*#>OJ9D)JI_Q(4_2O]PUV+;4&[%D&XI<A=*[@9R)EM7(K$
MHN"ZK%SU:MD;!]@;;0_96L>>V;>MPOU+4S;<&RIGC"N2PA0IO?-WF&%9-K%R
MHD5NR_I$:&P2=CC'O@_2&.#^5 B]FA@']9=$[P]02P,$%     @ ,(VO6H\*
M;R=W!   CP\  !H   !X;"]W;W)K<VAE971S+W-H965T,3$Q+GAM;*U7;6^C
M.!#^*Q97W;926UY#2"Z)U"99[4J[VZKIWIUTN@\N.(%;L%G;-.V_OS%0FH!A
M^Z%?$@SSC)]GQB\SLSWC/T1,B$1/64K%W(BES*>F*<*89%A<LIQ0^+)E/,,2
MAGQGBIP3')6@+#4=R_+-#"?46,S*=[=\,6.%3!-*;CD2199A_GQ-4K:?&[;Q
M\N(NV<52O3 7LQSOR(;([_DMAY'9>(F2C%"1,(HXV<Z-*WNZMD<*4%K\F9"]
M.'A&2LH#8S_4X',T-RS%B*0DE,H%AK]'LB1IJCP!CY^U4Z.94P$/GU^\?RS%
M@Y@'+,B2I7\ED8SG1F"@B&QQD<H[MO]$:D$EP9"EHOQ%^]K6,E!8",FR&@P,
MLH16__BI#L0!P'9[ $X-<-H OP?@U@"W#?!Z %X-\-X*&-6 4KI9:2\#M\(2
M+V:<[1%7UN!-/931+]$0KX2JA;*1'+XF@).++S>;#;I>?[RY6Z/[J[_1Z0:6
M8E2D!+$MNLI8025:QICO2(0D0QN))8%U(M7GFYQPK-)]ADY71.(D%6?H GW?
MK-#IR1DZ00E%]S$K!*:1F)D2Z*I)S;"FMJRH.3W4; =]953& JUI1*)C!R;H
M;,0Z+V*7SJ#'%0DOD6N?(\=R/ VAU=OAK@:^?CO<&5#C-JES2W]NG[^$PVYC
M7'Q )&-IH=(BT&E"P[2($KI#E-$+1)Y(6*C-B*(7^[.I+AG59)Y^,G5>346.
M0S(WX$ 2A#\28_'[;[9O_:$+Y'LZ6[^3LZ,@>TV0O2'OBSN2%;1>YKJH56B_
M1*M#^7%A>R-86X^'T>@:.=8H.#9::SSY[J0Q.F(_:MB/!MG?5B>ZCG@%'!U,
M=S!91;MKXO@MTAH33T_9;RC[@Y0W<-B0\NR/4(Z?RT6MX^]W9IZX=DM UP96
M1<MHK3$:6V.]B'$C8CRX-:]@ \).^R#@+AU>/^/WW'7OZ6S]3LZ.XA<T\0L&
M%T$9/[0E1)OZH)LQ*W!:N>\:!7X[]1J;(-!G?M(PGPPRO\=/O;PGFI4V:M'N
MVG@'B[&BW;4)>LX)VWHM ZQ!WBL":0R3OG5Z_0OX/_:_V@O>ZE#U.Y(U1H%K
MM31KC&S/&O7(/JA^[.&%EC$N$]&[/6OXT;3VQ&HKZ%I-O%%;0=<HZ,V;\RK
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MHNR S->IJU;U*_0>"14H)5N@85V.(8:\ZOZJ@61YV=X\, G-4OD80\=,N#*
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ME^ -(!3\F;&-0#05$UNJ/6@F.VG6NZG7<\^L!UUPSZC,!+BC*4Z[!+;:?*O
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M')CU0F??]3C#&VC#^1('-4#/6:@)VN^A\*"Y@[TR/[:JV)&/$B$V:)DK3Z
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M4,]73"6_'N@7- =5L[\!4$L#!!0    ( #"-KUJ!!?P,D@,  .T-   :
M>&PO=V]R:W-H965T<R]S:&5E=#$Q-RYX;6S-EVUOXC@0Q[_**+=:M5+;/%%H
MNQ )"*NK=.UFZ?9.I]6],,D UB9QUG;*]MNOG8042AH5*2^.%Q [GK]G?LD,
MX^&&\1]BC2CA5Q*G8F2LI<QN3%.$:TR(N& 9INK.DO&$2#7D*U-D'$E4&"6Q
MZ5A6WTP(30UO6,P%W!NR7,8TQ8"#R).$\.<)QFPS,FQC.S&GJ[74$Z8WS,@*
M'U ^9@%7([-6B6B"J: L!8[+D3&V;WS;T@;%BK\I;L3.->A0%HS]T(/;:&18
MVB.,,91:@JB?)YQB'&LEY<?/2M2H]]2&N]=;]<]%\"J8!1$X9?$_-)+KD7%E
M0(1+DL=RSC9_8A70I=8+62R*;]A4:RT#PEQ(EE3&RH.$IN4O^56!V#&P^V\8
M.)6!\]J@]X:!6QFX[S7H50:]@DP92L'!)Y)X0\XVP/5JI:8O"IB%M0J?IOJY
M/TBN[E)E)[U@_B68S;_]>P;!7^/[;S"^]V'V]?$VN)NIT<D]X9SH)W,*)SY*
M0F-Q"N?P^.##R8?3H2F5"UK(#*OM)N5VSAO;V0[<L52N!<S2"*-] 5/Y7@?@
M; .8.*V*/H87X-IGX%A.K\&AZ?O-W09S__WF3DLT;OTXW$+/?4N/BC!F(N<(
M;*G>7TT<(Z!IF>%%IBQ4^D+&5>IS^7P&64Q2"22- '_F-%,Y*>&[U@4J,1'_
M-3VDTHE>LQ.ZU-R(C(0X,E0M$<B?T/ ^_F'WK4]-@+L4\SL2VX/?J^'WVM2]
M<111C9C$P'6Y.&?+\UP@$"%0BB:.I5Z_T-,5]LF[MO1G:#[M$FK=]EA"'8GM
M$;JL"5VV$IJCD#P/9<YINH(I$\U82I'+'2R])BRM>QV+I2.Q/2S]&DN_%<MM
MDA'*B\R;K@E?(01U>@9%>GXD2?8)9ML$;8+6/X!F6TW46ETYEEI'8GO4!C6U
MP7NIJ9+7^"(-#ICT;><0R> @#=W!X'"=?[ANX+J[R_;BN*KCN&J-8Y+3.%+Y
M(.#['28+Y(TEMU7CV)+;I9C?D=@>N^N:W?7_X?_NNDOX78KY'8GMP;>ME^;/
M:D_!-&0)PI*S1'7^B_,8I=25???OK[')LPXRZ75.-BQQ#S.RW;]CXS=W^N $
M51W6YPD!(<M367:4]6QY9IGH,XONHU_-J[/,N.C@S1>9\B!TI\H[307$N%22
MUL5 %2=>GBW*@619T6TOF%2]>W&Y5N<QY'J!NK]D3&X'>H/ZA.?]!E!+ P04
M    "  PC:]:6 B]MZ\/  #_C@  &@   'AL+W=O<FMS:&5E=',O<VAE970Q
M,3@N>&ULS9UM;]M&$L>_"N$610+$%KE\5.(82"065Z!I?$[2PR'H"UI:6[Q2
MHDI2<0/<A[\E)6NY#QIRZ2'.;Q)+&OYW9_;I1W+(O7S(BS_+%:65]?<ZVY1O
MSU95M7T]F92+%5TGY46^I1OVRUU>K).*?2SN)^6VH,FR.6B=38AM!Y-UDF[.
MKBZ;[ZZ+J\M\5V7IAEX75KE;KY/B^WN:Y0]OSYRSQR]NTOM557\QN;K<)O?T
M$ZV^;*\+]FER5%FF:[HITWQC%?3N[=D[YW7L$+<^HC'Y/:4/9>MOJ_;E-L__
MK#_\LGQ[9M=5HAE=5+5&PO[[1F<TRVHI5I&_#JIGQT+K ]M_/ZK_W'C/O+E-
M2CK+LW^ERVKU]BPZLY;T+MEEU4W^\ ]Z\,BO]19Y5C;_6@\'6_O,6NS**E\?
M#F8U6*>;_?_)WX=(M YP@A,'D,,!1#[ /7& >SC E0_P3AS@'0[P^A[@'PYH
M7)_L?6\"-T^JY.JRR!^LHK9F:O4?3?2;HUF\TDW=4SY5!?LU9<=55]<W'Z_C
MF\__?F5=__KNM\_6N]_F5OS/+[]<?XC9IQ>?6,]<[C)JY7?6+%]O\S)MVI=]
MO"Y8=RVJ[U:R65KQ7[MTRSI09=W0+*GHTJIRZ]UBL5OO]A_GE'7D19K41[^T
M7LQIE:19^=(ZM[Y\FELO?GQI_6BE&^OS*M^53+"\G%3,N[J.D\7!D_=[3\@)
M3QQB?<@WU:JTXLV2+D6!"0O+,3;D,3;O":@XIXL+RW5>6<0FGJ9"\_Z'NYK#
MX_Z'$\ ;]]C2;J/GGM)+RT66E[NB:<QETP"L8=+-?KII1NTMFTNL[:%A7UG;
M+&$M6K<O/;;OUUK72BNZ+O_0-=*^$IZ^$O6\][K<)@OZ]HSUAY(6W^C9U4\_
M.(']1A=@3+$824P(OG<,O@>I7[U/6"@7U$HJZY;>IYM-NKFWOM.DT(5P+Q4T
M4O5,_^W*B::L"WQKAP8LSS0T2&)":/QC:'PP-+^LMTE:-'V+=4_MP-\+^*V
MG >.'!!?B=JY&X:25:RQ"EWW:"1X$!P]"/HV+F5CA8VN4RT;*(YX 7$D1U0C
MM?ECL$8#6RP\^AN"_L[RDLT#'^CZEA;:.0 \W'0.P!2+D<2$L$7'L$7/80*.
M,(./*18CB0G!GQZ#/\6;@*?*" P".YA*XU1CY3,S::""U1KHM&-SNK-!M]\M
MEPVPZ7G*5F<:-[)%!V8=)7QU=+UPKM&>.M),%\/20X/30E^G7W"L:E7DN_L5
M.VUAPVR/N-J .9J A:[4+^!230<-EIH8(\)C1, 8L4F+07^2E59>L#/#*BUH
M/0OI^Q-1UVG'DZ.C,8I\7^X98*V&>LU1V0%A\.J&.9G4,W4SX[+9^N;C%RLI
M2WK"<5?M%V&@>(Y*LUAJ8H0XSSHPT-[0),OR1;(?/Q/6-189"U!ZEQZ^T\;)
M4^+D*Z-'M;'ESC$&KCJ<5QT86.._%ZMD<\_6DN5_V GZZ>$ RIBNQ(X*P9X=
MRI%!*E*,#.=@!PN$'15R0SL@OMP95#/-2ASKS(2E6/2'<ZYC +K6?ZU?:Q+[
M*5EOWUCO=VFV9 Q1@B ,ZQMW 504QE(38\MAV'D6-.R@XC"J6HRE)K8 )V('
M$8D=E7:)1X)('K ZLR"2SU[AF@WTG' J)D^@8J*2:^A+#LPZ"C@!Q1IIA7Q@
MY:&AX4Q,D)F8J$PLK==SN$C348.E)@:( S'! V*BLJX2&PT.>_(Y6 S7::C/
M'(<)*@Z37C@,EVG<*\; 8<)QF(R PZ03=>?=)C%<LZ&><QHF.#0,RY@NQ$2E
M8>7J E:)8F X#!,L&"8JOI(@C)0!HS%3E^!8:]9>@D5_. P30QAF4P)=Y1EC
MMC5CM&_[:1#$8;@$XSZ BL-8:F)T.0Z39X'#!!6'4=5B+#6Q!3@.$T0<)AK.
M#0-E]M99V<H\-08,NQR&W2? L*L2JWQ]N$/^! IKA"/Y:@:L/#0P'(5=9!1V
M513VY9M[<)G&M[3'8&&7L["+Q\)N-PMK3,X]&7?@*@UUN95$@8K"KHK"BM>X
M20YC<+#+.=@=@8/=;@[6F)S+X -7;:CK'(1='!"&98PS9%00)LJ0&0.$70["
M+A8(NQITC62NG^NLE+4WUEJUUE[1&4[!KAD%UTEQNXH6A\O"'^]83Z>M=#@(
MA^&BC'L"*@YCJ8EAYCCL/@L<=E%Q&%4MQE(36X#CL(N(PZX*NIZ:H:6S\M4%
M?@P<]C@.>T_ 84^3,>'+0-Q1P D@UDG+J04Q+#TT-IR(/60B]C1$+-\,F,.%
M&J<RCH'$'D=B#P^)O6XDUIB<.XY\SP"NTU"?.1-[J$SL=3,Q7*!QEQ@E\[>5
M^CL"$WO=3*PQD9$8KME0SSD2>SA(#,N8+L.>BL1R4AY6@6)<.!%[6$3LJ13K
MNYY\95ACI2Z_L<ZJO?R*SG B]LR(^+KAL#T.'SGXE?4[7:6+C,(7B.&BC#L"
M*A%CJ8EAYD3L/0LB]E")&%4MQE(36X 3L8=(Q)[*NFS<$CF'6&?F!I'"?6,P
ML<^9V'\"$_LJN'JAM!#-.@HXP<0::7\JS^6P]-#8<";VD9G85YDXE$^"YG"A
MI@,'2TT,$6=B'X^)_3XYQ#HCHESV@FLUU&M.Q3XJ%?O=5 P7:-PIQJ!BGU.Q
M/P(5^ST2B#4V2L\8 XO]U@-O.%@,RYBNQ;Z*Q6ZH1&8,,/8Y&/M88.RK,.OZ
M013(G4%CIB[#L<Y,6(9%?S@;^S ;MY^ 7K:>@&Z@+!4??.Q 8[@DX\Z BL98
M:F*4.1K[SP*-?50T1E6+L=3$%N!H[".BL:\R[WG@.6$HCUV-G3^=$D\>O&/
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M0X/$03J$ 7<0(X;=F1)PL<;O"1H#I$,.TB$,TGT!$98Q?M.2AL3EDVVL$L7
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M7<X"<OA0%_"0%W\V8;CZ'U!+ P04    "  PC:]:?PJ4VB4%  "N)0  &@
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MB$O+EX/*&TZ3XOV:)\HYC8K+#<$^2?,!XOLUI?SU)G]EIWY%:_8_4$L#!!0
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MN63283V('>5(M]P;$?QD??DGWLN_%<4<*5;F:*YKJ@722U;G(//"]!UD#5B
M-Z_CXPAOD0+9) $"LT@.1L8JC+PT_TG+=B6HEW]3O5(4*SW@WN+:#]:7[!9M
MB^U@BVS0-@D4FDWWAC,+O'1?IFI5,5[_@E?Y>H%B,5^M35+]NZ?NJ.IOHK<(
MP5XB0+9)H-!L$; 1 ?==:FRX'"?E7L#>E.-.\(V#, J[T;<M:87?,3YVQ%^H
M'MJ4&HL9>$W/]F3EY!#4';9H]L3D,!B)HV \";M<D[;@IBK1&$=O6I' 6+;
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M;./FZ8WU^7 G8N)"WU '@ "^!F/P^V_8L?X\Q4I-8"6.F@5'S2KTP9C$5)*
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M#FJ3#3IJU@&W8<-M:.3V@Q&A\L!*<1,QG&1GM+F4W;"%Y<.X->&ZK#'HR.R
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M J8"Y.\K2L5+05707*7Y_P-02P,$%     @ ,(VO6L<[C=2' @  C04  !H
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MPL!!KMMW0L*BSF2</KL7DS'?RX!%]%Z >!^&1/RXH0$_7G=@Y^G! ]ML9?+
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M6",PD!88R"XP?CJO9;BVO&8U*?+5J@#9]_>79S54W;T/!F4I;##*KXXB25V
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M3<!RWR+W$RWJILNLA#8]JQENS%\%2FM@WI="Z.>);5S=?TKZ'U!+ P04
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MQI7V3CLM=#L$80+T^9QSM5F8"]H&F_P'4$L#!!0    ( #"-KUJT1PYWI@(
M /\&   :    >&PO=V]R:W-H965T<R]S:&5E=#$S-RYX;6RM55U/VS 4_2M6
MAB:0!DGC-E#61H(6! ]CJ.7C8=J#F]RV%HZ=V4[#_OVNDQ(%"!4/>TG\<<_Q
M.=?V]:A4^LFL 2QYSH0T8V]M;7[J^R990\;,D<I!XLQ2Z8Q9[.J5;W(-+*U
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M'!VC/UV7V[IC55Y5K(6R6/^JYAI?*- N .>72MF7CBN"S9L7_P-02P,$%
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M8,C\D)4/M%AEYY2IT.;4DUTNS<$4I0TPS^="Z)>!/?J41]WP/U!+ P04
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MTIM*;&Y'FX[B<7K!F'"EKRMI<Z%OE"A,@/X^XUP]=<R=);^C^K\ 4$L#!!0
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M>8?B^X])DK]^44[PG*1_KA[.Z']02P,$%     @ ,(VO6J.>_&'&!   '!@
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M,E<L/XK.;P1=9Z>YSU0(&F>7*X*E&E,&\OL%I6)[HQ8H_R$P_@]02P,$%
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M6:!N#)3F0=':F6O<F(%?8XMJ@#HT4)H+2O.@:.U\-8[/4#N^$VJ6FC@Z-V1
MS1H2Y$'UJZWDP9=(U3<;!]6LP9?[U <;+3+LUTEAOT_Z$A[-:#R:8;Y*P8*\
M;WD%2G-!:1X4K9VOQE(:X/=4U<31N;'ZADE2L89$>5 ]*[74#IZ#X,7HOG@
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MU<TQ=\ SX,21,5,TA,.4RS^+:.6TF-MIS3MW9>;IX?<IB9CYB \ 3"@&E %
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M\JVH.X#\_+&JVJ\ON@I./_AP_3]02P,$%     @ ,(VO6EVD/01#"@  AVP
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MOJ^2#'*J3D0)!7Y9")E3C5.Y]%4I@:86E',_#(*!GU-6>-'8KLUD-!:5YJR
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M'0>V FOT^V_8=_XT^:=)LJ ALHKMO=+V7AW[Z+L^PJ1)R0J83"H$SYD\/.7
MBL9$1'$D7DS6S%EQ?@"H,K :.:VNYPWLU;:=C##/<7$5%YCI_&Z_Q%74=4IU
MG3>JBZ,9H'_SH#;IRWD[6_OI[DC[7T20(WI;"+_5<\V*_%*1?YHB%O$G-&,@
M0S^5J0-<($8$F#3Y)B,[GN/O*#N P^T=?69<NW/ :=U28K=6XC45LCZIE-?)
M77NPUS*=FM1-D@4-D54LV"LMV/L%#M1>D[9ODBQHB*QB^WYI^_YI"3I3G<U*
M=S9$H 2(\HLV<"CS5#4PZ'Q\GGM#%M<+-3 .)I?R=#HSF3U?'CN5K-LY3V^,
MH,Y._N:@;I7H0/)B9]/Z.;4&^$(%B;<DT;R+0W,96<HN4J*4=\X1_%Q&TB[2
M$DKKP6;ENEAO^Z3%+G;4WXYJ$[+O&Y"! >GVO2JRJG^K]<6G!4!NAHQ%TQIO
M&X5CDX-V2^Q1J,"(<KL'Q+H;L>ZI!1;8-.)OT^L>I?<85&!$'=2[Z51Q;3,F
M@SL[KC#5\YQZ.C;*%C3%5K7AIN/$WB]0G7!MWWNR YID"YIBJSI@TQ3C$[OB
MIDM4L?YV\KDMI[>;R/LHK/K,W4SN[->R=JMW(),W?32N;Z2;+U/^7DGQG8ZA
M2.WC^CU3B=K'8:];4Z$V_36N;[ ;K%#=?=^XK3U''X,*3*A.RSL@=M,*X]IN
MK^$*U3M*[S&HP(3:UVMO7<(EP.;Z,I/+LW*9BOP^JAS-+TROU86INL3;&1_C
MJ[&^/K0W-/DM["UA\TA&?@PS22E_=LN08_G%9OXB:*:O^A[U#S/]N  2 E,
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M/BY(&LI'MGZ/&T%MC>>Q4&3_89VO[78L\%(A6;0)5@PB&N>?Y/O&B)T YUB
MNPEP?P]H'0EH;@*:F="<62;KCD@R['.V!JY7*S1]D'F312LU--9?XTQR=9>J
M.#F</CY\FLPF#Q]F</&!<$ZTJY=P<8>2T%!<PE_P<78'%W]>]FVI]M-1MK?!
MOLVQW2/8C@OW+):!@+>QC_X^@*V(%FS=+=M;UXAXA]X5-)W7X#;<5@6A\?/#
MFP8ZS<*\9H;7/(9'A1<RD7($M@ F ^20<+:B.LD%?-'K@4J,Q+]5[N7@K6IP
M7;\W(B$>#BQ5H +Y"JWAJS^<3N--E?*:P/9\:!4^M$SHP^E6,ZCGBBIN/_70
MA[5.IUC^ "\D-!)5#N2PG0Q6/W!6PW9#_?7MU:XTX^8G2FL7TMI&:7_CDH3Z
M2_40?1HO1?D%5PG*P=H[@KK-]J&B]H'N<L4>S4Y!LV.D.?)]JA^+BNLC"LE3
M3Z9<T84Q$[+2^LX!4[?7J#"_\URJW8)JUTAUI@H"GE1FB(4JEXR?XAP2J5+F
MB<%3@#")$D*Y>EE(>%C -%19!*](E+R!M]]2FF0WOMQC-$=>65A& B\MK)K
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M9OU0S4 U@6HFJEFH9J.:@VHNJGFHYJ-:0&ER9]'& L?*1-*?N'I YJ4N4,U
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MU/)A=B2W:^VVJX91YOV^._'?3(@/GE"!,OB< D@T H56I;,L+_S.\44(6E^
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M:&6YCSPX;*6^93"EG=FUH#6L;&!M7->Q8&4'-P_KO;3M@K;=2'O.2.21& 4
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M&E^GD\Q<XC=L( 5F("1WN6E(!M+KATX_"'L!766)2C*T_[Z2;!P@AN8Z3+^
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MD?>8KPD5*(>5@G2N(Y5#7O5EU42RC6EMEDRJ1LD,,]7+ M<;U/J*J8I33W2
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M\RYZ.EFB?@OJCN*EO4YG7.G+V39S_7R", %Z?LZY>N^8&[I]D)._4$L#!!0
M   ( #"-KUIATZ\RS@0  %D9   :    >&PO=V]R:W-H965T<R]S:&5E=#$V
M,RYX;6S%66MOXC@4_2M6=K3J2+--;)( 74"BC]$B40TJ[>R'T7XP8,":Q&9C
MIY1_O\ZC>3J9K13:+R6/>X_O/;%/3YS1D0<_Q9X0"5Y\CXFQL9?R<&6:8KTG
M/A:7_$"8NK/E@8^E.@UVIC@$!&_B)-\SD66YIH\I,R:C^-HBF(QX*#W*R"(
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M/<$;$D0!ZOZ6<_EZ$@V0?4V9_ =02P,$%     @ ,(VO6CZV7U5#!@  [S(
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MP]"M,>6K(#,J%DDN]>2^U\C>P5@7)%&^75%N*+XJW@:XXTKQK/BX9%2/"M-
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M0*X#U/,%8_)MHC>H/T;"WU!+ P04    "  PC:]:_9=B+$8%  "G'@  &@
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M#-^@.0_;.7!Z3M!.EL90FU6D,=S/:B,^UZFUG/._^JJ,$\5,*F[*GMJ$4G6
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ME\C(-^#P*TSYC'E@>D6%&00N"3*B#QR +I\&Y<2JW'?7A;+4J_UP3:\IU.X
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MUHJI Y^V<!\0 >]!($IOG,I;5\O6YE8<QL<4[@.]A ON7H/LH.UK>&BVJ2N
M#O!Z[Y 2?@"5<8$M;* =L(<-#\DV9<6V@8%MAQ3S ZB6JVUB&V3%\7AL\U6P
M&IA@=4!)/]#KM%JR1A..1V*;J>+*P%#()2KD!WK%5A/#:,+Q8&W%4#@8X#B(
ME^\#,P>:33@>@NT&?<6!X9"E^]&?A"&P]31)7+>_? 79A4$2];=WX%':JJ#8
M,,27\,^J@82DL$CJC5-YZ^JJN#+$N=*B<!_JV CMW83,]+V;>'BVZ2O # =O
M7;6HWX=Z&5;?NPD9:7LW\3!M95!L&.)L2%###P$49$&JW6X ,S_0Y)B"%\/6
MEZ)P7J0HY8< )R9ID 9]00"[,/0TA,9#MI5$\62(\V2_&(B5\G%7HV^WI#55
M*F]=&16FAO@7L<[[&",MMI)ZXU3>NKHJ* YQ*!Y9R@_-[(N_X6AYIL#D4&%R
MB&/R_NKUT5(^[F+TV46ZNX'*6_=;HPK!(W>J4GY$A,U[54F]<2IO7545TD=X
MN7=0*3\R;Y$PFW \$MM,%61'.&2/*N5'YL*MV83C$=EFK+@ZPKEZ3"D?=S7Z
M$C'OLZ5ZPZXV"K:C(; ]YEOHYCVW9A..1V6;M6+J"-_$,+J $9%N7"#UQJF\
M=;5LM3' 87Q,*3\R[UHPFW \(-N$%39'>'5W2 $_,A=WS28<#\0V4<6QD8%C
MAY3M(S.]FDTX'HEMI@I)(Q.2#BC81^8"KMF$XY'8MMY0]!@;"KA$!?O8O,9O
M-N%XL+9B*.B+SVDV$)MISVS"\1!L4U2T%P]9JA_?<L7,?683CL=FF[OBOAA?
ML#^KOA&3@B"I-T[EK:NK8L889T:+,GULID:S"<?CLLU;46.,5V+/J\_'YI95
M9A..AV@K@8*]>$C3JK-J\[$.>%[0_XKR-6"E23%)$ZM6%RO#M_D)ZO*QSH"0
M%F92Q&.UU4*18HR38K^DAQ7D<5>C;ZRDE5$J;UT9%8;&$WXA+"8MF9)ZXU3>
MNHW2%/0FAB9:XPKRB0ZNP%6)O^=8A:B\=152))S@)'PM/[M_-.Q_M2ZV\F,,
MJ\WCKL:>:*3>.)6WKHR*MI/).KHFI"V]2+UQ*F]=517')P1M71-@9P/0-P<R
M _KFX!'99JP(.\$)>U2-/M'!&>B; U@!?7/PN&SS5H2=X(0]IE*/NQI]P>CH
MK??-H7K+KCH*OA/BCK')L):QD!G0-P>/SC9[Q=L)<=O8A'2' JDW3N6MJV6K
M=2QA[]BAS6.'=H^=@K$3Q=C)^0UDDX$=9$$[8/L]'I)ERJG"WY2@AVPZJ(?L
M("N.QV.;KX+9%(?90=7\%.@1"W74@>WTCCIX3+8Y*_),#75>HKI^"FR4A3KJ
M0'901QT\;%M9%#JF.#KB%?X4ZG"@=]2!S+2..G@@MHDJ8DR'K../_HQ,H8VR
M7IKT]P1?0X:)Z_6UXGB8MC(H@$PG[$Z0DA(EJ3=.Y:VKJT+/%$=/BY)_"O7<
MTG?F0V;ZSGP\/-OT%7NF>*WWO,I_"O1JU7;F0T;:SGP\3%L9%#:F0]IVG57]
M3W5*3*/^ PE@!.S+QX.U%:,UB,#PY7^"^G\* 21S?5^C$, PBJ1A7Y-IIA6T
MQQ68&@7 A41L1<#@<W0+7%)WG,Q=3]/62 1WPJ^;'9V3B4M:KR5SUQ/7:XF+
M@_/(M8&C.\/B@.%=Q\LTR5 %MS55P37LH3V-?L-[ZN-NQI]MI/LFR-SU9&Q-
M9W"#J18(CJ[)I*5TQ\G<]:1M37QP#=^3&]1=WP7JO%![?<@.ZJ^/!V6==FM2
M@XN3^;@6^ZY.VU"/?< ,:K*/AV:=?&N@@HMS^:@^^[BO\=</ .QZIWVJ-^U)
MU)K X YA]A&+!D>'IE4#T Y8-C $:"U!:QB#BV^K&%T5.3HD.U5(-U.0N>N-
MZ&I!OF$HV9CE P:-'8/6#T!#: '!$)UU_NT998;=$@/6$!@TA Q:1( -@54$
M0U36>;=8&9_=-7 8'8-*R/HTND%FW!"2==(M\C4,%!NTFL# &6+ <L)/#/7U
M!$-8UHFW6-4P2HQJ28$! \/ -070$%I4,$1NK4T+-@WSQ4QC"H$^"N"<0JC?
M@GX)3,*8[6E@^& LV\6%HUOSZ@)H"2TO&"*UUJ*%G&S"I@F,:A[743;230ED
M[GKBMF#5,"_,9G@C,! ,G-X(V0'C&Z>9'-8>'6:8'7;F!$=H )@^PA&RTF<X
M3C(GC+4&A;%!D\+.6G!@P%0P?<4!L@*6' SQ6BO20D]\HA;)JL/Q/<S+#D?+
M]G1[<-W!$+:U,"TV-8P" PJ4Z)H#U2"OHU#$,W0GH=[6G#'F3?C=.48U/.PH
M+FT5>)+19JPUVXR9AIN-7',XN&M?A=": ]4@LZ-,I) ]KY9"U#RKL\N+^^Q.
MO,W*NWPC[U7B5KIWGS5?;"OSN^7I15W<2U5GSI>BKHOU[L>ED$\D96,@__^V
MD ^@AQ=SZ?^Q*+_NWN/R_U!+ P04    "  PC:]:->"V%AX/  "*F0  &@
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M?H0A>9";),P4ZQC HZG;/(88C(U:-0IC&GD8SW9H<_P8?!P;M?(9AH8G8,A
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M6V$,41G7Z]CA:61X8,W%\T:IGH=KY?,P7"I.L42R*4_<@-LTYEECNI)"<=)
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MZ;K\<T5"NDBL ;V^3*DKJQ=L@,<T^U&:=?H_4$L#!!0    ( #"-KUJZ,$_
MAP,  ' +   :    >&PO=V]R:W-H965T<R]S:&5E=#$W,2YX;6RM5EUOXC@4
M_2M6=K1JI9WFBR30!:0,3'?13A$JG=F'U3Z8<"%6DYBQ#73^_5XG:1JHH5U-
M7Q([OO?DG/N1W/Z>BP>9 BCRF&>%'%BI4IMKVY9)"CF55WP#!9ZLN,BIPJU8
MVW(C@"Y+ISRS/<<)[9RRPAKVRV<S,>SSK<I8 3-!Y#;/J?CQ"3*^'UBN]?3@
MCJU3I1_8P_Z&KF$.ZNMF)G!G-RA+ED,A&2^(@-7 BMWKD5LZE!;?&.QE:TVT
ME 7G#WHS60XL1S."#!*E(2C>=C""+--(R.-[#6HU[]2.[?43^DTI'L4LJ(01
MS_YF2Y4.K*Y%EK"BVTS=\?V?4 L*-%[",UE>R;ZV=2R2;*7B>>V,#')65'?Z
M6 >BY>!V3CAXM8/W5@>_=O!+H16S4M:8*CKL"[XG0ELCFEZ4L2F]40TK=!KG
M2N I0S\U',6SR7W\A<33,;F93./I:(*[N\G\+W(;3^,_/M]^GMZ3BSF6SW*;
M >$K0EBA0(!4Y(XJ(#/!5ZPZN6$%+1)&,Q)+"4K:7QA=L(PI!O*27(Q!49;A
MZB/Y.A^3BP^7Y ."D?N4;R4MEK)O*Y2DB=E)3?]31=\[07\,R17QW=^(YW@=
M@_OH[>[^H;N-@6RBZ371]$H\_P3>-RI0,0:CC,RDD$ILL>:5)/_$"]Q@T?YK
M$EFA=LRHNI.OY88F,+"P526('5C#7W]Q0^=WD^1W CL(@-\$P#^'/AQ1F1*J
ML+.*!X(IU>E-\6X272&%)9+^VNR&@1M&?7O7%O/2R ][;F-T0++3D.R<)=ED
M2>@LK9JBS9ZKE5Q(*!C'[QTD6P%+@A6?DXS3XM(DI7I?T&+Y,?+\%L]*C,&L
MX[A.SRPG:.0$_T,.>RXZ$]/@)84P\G3O'# UF/EAQ^V:F88-T_!L>]RP1PSE
M6VB&[]D0[P1V(#EJ)$=GD].2?*+0X#'!#EE#F<*"*S!66/0R(9[K'&7M%:,#
M =U&0/<G!22\V(%0["S_[DMJ;H#%?Z3 9-8).IY90Z_1T/M)#1G@*$ V](?.
M@C0JZ!FH>5'H'2DPF@5A:%;@.L__:><5#4_$:?EO?>(L( &V.TV[AFT3.BX;
M@XD;!"<(MP8+]ZU!?Z79:Z#PH&Z[?N0?\S3916[H'U&U6^.0GD5OJ5@C!9+!
M"AV=JPB5BFJ\JS:*;\H):<$5SEOE,L61&(0VP/,5Q[*N-WKH:H;LX7]02P,$
M%     @ ,(VO6@CVZ?^("   UC8  !H   !X;"]W;W)K<VAE971S+W-H965T
M,3<R+GAM;,V;;6_CN!''OPKA'@Z[0+L6GV0YEQC(VMXVZ"87;+(MBL.]4&PF
M%E:6<A*=!Z ?OI2LB*9(C>Q$.?3-KF4/AS,,.;^_*.KX,<U^Y"LA)'I:QTE^
M,EA)>7\T'.:+E5B'^:?T7B3JE]LT6X=2769WP_P^$^&R;+2.A\3S_.$ZC)+!
MY+C\[C*;'*<;&4>)N,Q0OEFOP^SYLXC3QY,!'KQ\\2VZ6\GBB^'D^#Z\$U="
M?K^_S-35L/:RC-8BR:,T09FX/1F<XJ.Y3XL&I<6_(O&8[WQ&12HW:?JCN#A;
MG@R\(B(1BX4L7(3JOP<Q%7%<>%)Q_%$Y'=1]%@UW/[]X_U(FKY*Y"7,Q3>-_
M1TNY.AD$ [04M^$FEM_2QW^(*B%>^%ND<5[^BQXK6V^ %IM<INNJL8I@'27;
M_\.G:B!V&F#6TH!4#4BS 6UI0*L&=-\>6-6 [=L#KQJ4J0^WN9<#-PME.#G.
MTD>4%=;*6_&A'/VRM1JO*"DFRI7,U*^1:B<GT]/+L^O3K^CT8H:^G%V<7DS/
MU-6WLZM_HO/3B]._S\_G%]?HPY6:H,M-+%!ZB[Y&?VRB922?T;<H_X'FN8S4
M'TPLT5DB129RB2[#9S679%Y8GX=RDT4R$OE']&$F9!C%ZM/?T/>K&?KPTT?T
M$XH2=+U*-WF8+//CH51)%:$-%U4"G[<)D)8$9F+Q"5'\5T0\PAS-9_LWIV;S
MH1K*>CQ)/9ZD]$=;_'V)DC!91&&,XBB\B>(R<U=66S?,[:8H#T?Y?;@0)P.U
M_G.1/8C!Y.>_8-_[Q95C3\Z,C&F=,86\3ZY$$J6J](C%)E.30$V!-8K3,'$E
MO?7DEYZ*$O8P&1$ZQL?#A]UL;"OF86]<6QEALCI,!H8Y39,'D<GH1DWBBU0*
M5WA;#WRG8\Q5UXWP'%:,,^(.C]?A<3"\^=-B%29W(BSB2U1\SDG#K:X)]AKA
MP39&<'X=G \&IU=\5JSXW\[%^D9DO[LB!!T=.JU[<F;D/*IS'O6SD$=]9MR3
M,R/CH,XX /_*UUFX%$A5893*E<C0??A<S,8<?1!/BWBSC)*[ L$B*Y9YE"S2
MM?CH&I# GH"<!'YCFMI6F(QXRRH:URF,X8DJE&9X"1PI'5(*GP)#W]7W89X+
MZ?P;CEW!^*01LLN*^[X[9.QI GN]%=#*%8<KZ+2CQ]^P:^W.',[-PEN:S;N<
MD]^!R8AWA E^<\&N7'15;)=9>\G&FO48!.N>1;MR E?M#B,S0(UF#+/Y.I6J
M@*UK"5:LA-M]"UOEVYSOOL>MT&V[P,.C%EYC#6S<26R9J1N)C0IU$>8K=*ON
M:O*:/NB_Z  NP7T=6J;[\F:.C-8*F/?#)@R*CH.S[LF;F;46(1A6(7WQJ>JF
M"U .,X!06.L*#$+\U8RJW)JUCF#6#-ME1KTV2FEQ@&%U<!"E;+@'F-&@22FX
MQS9*V<ZYCPEN4JK#.4PI+3@PK#CVHI0M' BF=AUUF?F\!0)$ZPL" WD_2A$;
M_C1HAN@T:BGT1).>P*1_$Z6(B^W4]X-FZ X[SR<X:(E^YX8?%@%7T1,Z5ZA:
MH5\S]%7D.=IBZ# ^P9T<O!_P'AL"1,L.0GO:! 'ER\%9]^3-S%KK%0+KE;[X
M1.P-!A>?'&8 GX@6%P3>B7@MGXB]\5"([&;4#BOLC5J"UMJ P-K@$#H1!]A'
M'FW J:/#%C@Y?%/F-]G4Y1MD$]%*@\!*8Q\V$9=<L,H^;&2&IQ4%@1&\)Y=L
MW%MS"C(Q@]-<)S#7W\8D!\D#/AXUXW9L*(S8J"5VJH%/.S84:B)=I^CZ4<0/
MHKI^#9G@S@ZMT7UY,X=&2PV*^R$3!27+P5GWY,W,6DL4"DN4OLA$[4V*9JD
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M>H:QRGK4UX86134MET+C[*V6*?X=01H'W%\)H9\,,X#;_VWT#U!+ P04
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MG\=:!@2ID"S.DU4%,4T._^0N%Z*48'>>27#R!.>E"6Z>X&9$#Y5EM"9$$G_
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MJGXF&V[4G1"Y#E#O5XS)^XF^=12W3/\W4$L#!!0    ( #"-KUKNW) 8V 8
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MS%6%W/)-8@HWIZVY$EQ=&%S?G55TJQ_\JA:A<"O;>D'"J O?'3"94'2K;Q+
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M72WE L5[S.1QOV=FI[I>)$!I"926QL/Y1H>/+&M$!=:E5-Y-;/=N_OR-LSZ
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MC>N]0155,]NZ! VB]^:=2+N>C.YXNW4AJJR<6Z_G_[VKF]5/R(O50&4.E)9
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
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M A2:B1UV<'B:0,R<!2@T$SONX!#T96_.?"Y(P> #Q4X^P"<?Q%@/PP\4._T
M@XJQ'F8@*'8( @858SU,05#L& 0,*L9ZF(.@V$$(QX^]5/>3 (528H<BB(,O
MAWOR A1*B1V.($#-15VZ^:[_IP"%4F+'(QP%G6;?D[4HDL"P!,5.2X#GBL1V
MG8*Q"8J=FP!!Q8:=@L$)BIV< $'E<@E&)RAV=@(&%0J%X0F*G9X #I65MY8
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MO[Z(5XM9;I4?7AY$[)8/]MX_KU8C_9J_F63Q\O7O"K_^3>3/_P=02P,$%
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M>P'HO;C>"T#OQ?5> 'HOKO<"T'MQO1> WHOKO0#T7ESO!:#W$K$.0&^5S'4
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M__7R]XOYUGKE>OM^QNG3OU!+ P04    "  PC:]:Y\=OKU\#  "59@  $P
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M4$L! A0#%     @ +XVO6DW2W +R    *P(  !$              ( !PP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ +XVO6IE<G",0!@  G"<
M !,              ( !Y $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  OC:]:<F%IB>D&  #7'P  &               @($E"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ +XVO6F" 6 0-!P  FR,
M !@              ("!1 \  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+
M 0(4 Q0    ( "^-KUHBF/Y>70,  * *   8              " @8<6  !X
M;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    "  OC:]:,Q4@U@$'
M  !$(   &               @($:&@  >&PO=V]R:W-H965T<R]S:&5E=#0N
M>&UL4$L! A0#%     @ +XVO6DK=9=&#!@  !28  !@              ("!
M42$  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( "^-KUJ8
M4SO.Z H  -@T   8              " @0HH  !X;"]W;W)K<VAE971S+W-H
M965T-BYX;6Q02P$"% ,4    "  OC:]:%C^E2_@L  !;A@  &
M    @($H,P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M+XVO6C^QL2=<#P  N#(  !@              ("!5F   'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( "^-KUJ^/<D[A@4  +L-   8
M          " @>AO  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    "  OC:]:+OL%Y5\$   _"0  &0              @(&D=0  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( "^-KUH$[6Z+(0<  $40
M   9              " @3IZ  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ +XVO6E>/OBMV!   D H  !D              ("!DH$
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  OC:]:40H/
MB7,(  !(%@  &0              @($_A@  >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( "^-KUH2Y$S\_P@  ,\:   9
M  " @>F.  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M+XVO6L>)XR.J P  ^0<  !D              ("!'Y@  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    "  OC:]:"+D6ETP'  #H'   &0
M            @($ G   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( "^-KUHB/@P):@@  ,$5   9              " @8.C  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ +XVO6JZ?!U0L&
MDT4  !D              ("!)*P  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    "  OC:]:E"&S:7T'   0$0  &0              @(&'
MQ   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( "^-KUKL
M&$7<IP8  *D1   9              " @3O,  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ +XVO6BZ8=_"[ @  YP4  !D
M     ("!&=,  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "^-KUK5^Q>EB0X  '<K   9              "
M@=+I  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ +XVO
M6O2"HB0; P  C08  !D              ("!DO@  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    "  OC:]:-G.JN$<%  "K"P  &0
M        @('D^P  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( "^-KUJ;ZG9\ZA(  )PW   9              " @6(! 0!X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ +XVO6BY,@JW0!@  61
M !D              ("!@Q0! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    "  OC:]:B]O_:Z@*  !;&0  &0              @(&*&P$
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( "^-KUI?^(45
ML0H  %X:   9              " @6DF 0!X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ +XVO6@-T#8TN&   @DH  !D
M ("!43$! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    "  O
MC:]:?L=GB^P$  #>#   &0              @(&V20$ >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( "^-KUIX*;5@(A8  "='   9
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M970S.2YX;6Q02P$"% ,4    "  OC:]:/*4S.!$"  #=!   &0
M    @($:AP$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M "^-KUJLBZ-'R L  ",P   9              " @6*) 0!X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ +XVO6I.H0R/R40  Y!(! !D
M             ("!894! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    "  OC:]:*\D=]B(#   >!P  &0              @(&*YP$ >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( "^-KUI%K!'KMPH
M !@I   9              " @>/J 0!X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ +XVO6MM:%<ZO P  U0H  !D              ("!
MT?4! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    "  OC:]:
M&2K]4:D"  #$!0  &0              @(&W^0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    ( "^-KUH_%"N%G ,  #T(   9
M      " @9?\ 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ +XVO6CQE0<4/!   90D  !D              ("!:@ " 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  OC:]:!^3E,X '  #T%
M&0              @(&P! ( >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    ( "^-KUH)5L*I;P4  #H/   9              " @6<, @!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ +XVO6N/2[Y-&
M P  MP8  !D              ("!#1(" 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    "  OC:]:WN\+S$(%   A$0  &0
M@(&*%0( >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( "^-
MKUH4U+L\I08  "(2   9              " @0,; @!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ +XVO6@)L0A=:"   618  !D
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M=#4X+GAM;%!+ 0(4 Q0    ( "^-KUJ$+K&BP ,  *\)   9
M  " @9XX @!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
M+XVO6J3A,1MD @  6@4  !D              ("!E3P" 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    "  OC:]:,A-NX',#  #2"   &0
M            @($P/P( >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    ( "^-KUK_''];M <  +47   9              " @=I" @!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ +XVO6INU4)'N @
M%@8  !D              ("!Q4H" 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    "  OC:]:,C \>YL"  "J!0  &0              @('J
M30( >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( "^-KUHS
M;H "#04   H/   9              " @;Q0 @!X;"]W;W)K<VAE971S+W-H
M965T-C4N>&UL4$L! A0#%     @ +XVO6@3^1:>' P  .0D  !D
M     ("! %8" 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "^-KUI)=(./A08  /0/   9              "
M@;9T @!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ +XVO
M6FI*6_HA"0  :U\  !D              ("!<GL" 'AL+W=O<FMS:&5E=',O
M<VAE970W,BYX;6Q02P$"% ,4    "  OC:]:#C$I '4#   V#P  &0
M        @('*A ( >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0
M   ( "^-KUK</L22(@,  )<*   9              " @7:( @!X;"]W;W)K
M<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ +XVO6JK\ON)\ @  Q04
M !D              ("!SXL" 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q0
M2P$"% ,4    "  OC:]:='VF2)T$   (&   &0              @(&"C@(
M>&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( "^-KUH=O+ (
M*@0  "43   9              " @5:3 @!X;"]W;W)K<VAE971S+W-H965T
M-S<N>&UL4$L! A0#%     @ +XVO6O/3TXNJ P  X!   !D
M ("!MY<" 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4    "  O
MC:]:X%^1%LL"  "8!P  &0              @(&8FP( >&PO=V]R:W-H965T
M<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( "^-KUHT4W0:>@4  )TD   9
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M970X-"YX;6Q02P$"% ,4    "  PC:]:G7I00W0#   %#@  &0
M    @(&7N ( >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    (
M #"-KUJ0F]O%KP,  &(1   9              " @4*\ @!X;"]W;W)K<VAE
M971S+W-H965T.#8N>&UL4$L! A0#%     @ ,(VO6GNJ"2 P P  C L  !D
M             ("!*, " 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q02P$"
M% ,4    "  PC:]:EHR3G;H#  #P"@  &0              @(&/PP( >&PO
M=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( #"-KUH'S27!E0,
M !01   9              " @8#' @!X;"]W;W)K<VAE971S+W-H965T.#DN
M>&UL4$L! A0#%     @ ,(VO6CCSVQE&!   '1(  !D              ("!
M3,L" 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q02P$"% ,4    "  PC:]:
MK?RT#V8"  !/!0  &0              @(')SP( >&PO=V]R:W-H965T<R]S
M:&5E=#DQ+GAM;%!+ 0(4 Q0    ( #"-KUHWK N^*P,  ,0)   9
M      " @6;2 @!X;"]W;W)K<VAE971S+W-H965T.3(N>&UL4$L! A0#%
M  @ ,(VO6M1,@BV/!   \AD  !D              ("!R-4" 'AL+W=O<FMS
M:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4    "  PC:]:_R]'(+H#  "F#
M&0              @(&.V@( >&PO=V]R:W-H965T<R]S:&5E=#DT+GAM;%!+
M 0(4 Q0    ( #"-KUKWR#9DD@,  ) /   9              " @7_> @!X
M;"]W;W)K<VAE971S+W-H965T.34N>&UL4$L! A0#%     @ ,(VO6N:VG9Y0
M!0  KA8  !D              ("!2.(" 'AL+W=O<FMS:&5E=',O<VAE970Y
M-BYX;6Q02P$"% ,4    "  PC:]:]_<Q,WP#  #3#@  &0
M@('/YP( >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM;%!+ 0(4 Q0    ( #"-
MKUK^DS!F4@0  *4/   9              " @8+K @!X;"]W;W)K<VAE971S
M+W-H965T.3@N>&UL4$L! A0#%     @ ,(VO6G&DQA@O P  (PH  !D
M         ("!"_ " 'AL+W=O<FMS:&5E=',O<VAE970Y.2YX;6Q02P$"% ,4
M    "  PC:]:<8E!O$0%  !U$0  &@              @(%Q\P( >&PO=V]R
M:W-H965T<R]S:&5E=#$P,"YX;6Q02P$"% ,4    "  PC:]:/]*Z5, #  ":
M$0  &@              @('M^ ( >&PO=V]R:W-H965T<R]S:&5E=#$P,2YX
M;6Q02P$"% ,4    "  PC:]:LY5%4L@#  "N$0  &@              @('E
M_ ( >&PO=V]R:W-H965T<R]S:&5E=#$P,BYX;6Q02P$"% ,4    "  PC:]:
M!O_LS" $  !^%0  &@              @('E  , >&PO=V]R:W-H965T<R]S
M:&5E=#$P,RYX;6Q02P$"% ,4    "  PC:]:SS7-C,X&  !_+@  &@
M        @($]!0, >&PO=V]R:W-H965T<R]S:&5E=#$P-"YX;6Q02P$"% ,4
M    "  PC:]:OT%B[CH$  !Q$   &@              @(%## , >&PO=V]R
M:W-H965T<R]S:&5E=#$P-2YX;6Q02P$"% ,4    "  PC:]:_M@ADJT#   0
M#0  &@              @(&U$ , >&PO=V]R:W-H965T<R]S:&5E=#$P-BYX
M;6Q02P$"% ,4    "  PC:]:<",XQY4&  #R*   &@              @(&:
M% , >&PO=V]R:W-H965T<R]S:&5E=#$P-RYX;6Q02P$"% ,4    "  PC:]:
MP1;.BK #  !F#@  &@              @(%G&P, >&PO=V]R:W-H965T<R]S
M:&5E=#$P."YX;6Q02P$"% ,4    "  PC:]:GT;!OT0#  #Z"   &@
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M:&5E=#$Q,RYX;6Q02P$"% ,4    "  PC:]:LB'UF: #  #T"@  &@
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M:&5E=#$Q."YX;6Q02P$"% ,4    "  PC:]:?PJ4VB4%  "N)0  &@
M        @('T5 , >&PO=V]R:W-H965T<R]S:&5E=#$Q.2YX;6Q02P$"% ,4
M    "  PC:]:40[]DC@&  !.*P  &@              @(%16@, >&PO=V]R
M:W-H965T<R]S:&5E=#$R,"YX;6Q02P$"% ,4    "  PC:]:+9=RC;L)  "V
M5P  &@              @('!8 , >&PO=V]R:W-H965T<R]S:&5E=#$R,2YX
M;6Q02P$"% ,4    "  PC:]:);)';PP/  !KEP  &@              @(&T
M:@, >&PO=V]R:W-H965T<R]S:&5E=#$R,BYX;6Q02P$"% ,4    "  PC:]:
M&8UZABT$  !.%   &@              @('X>0, >&PO=V]R:W-H965T<R]S
M:&5E=#$R,RYX;6Q02P$"% ,4    "  PC:]:ZOX ZV\$  "N&   &@
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M:&5E=#$R."YX;6Q02P$"% ,4    "  PC:]:12)/0EP%  "Z(P  &@
M        @(%:D0, >&PO=V]R:W-H965T<R]S:&5E=#$R.2YX;6Q02P$"% ,4
M    "  PC:]:$<),SA\$  !6$P  &@              @('NE@, >&PO=V]R
M:W-H965T<R]S:&5E=#$S,"YX;6Q02P$"% ,4    "  PC:]:QSN-U(<"  "-
M!0  &@              @(%%FP, >&PO=V]R:W-H965T<R]S:&5E=#$S,2YX
M;6Q02P$"% ,4    "  PC:]:KVJ9,= %  #+*0  &@              @($$
MG@, >&PO=V]R:W-H965T<R]S:&5E=#$S,BYX;6Q02P$"% ,4    "  PC:]:
M,)1-$U0&  !I)0  &@              @($,I , >&PO=V]R:W-H965T<R]S
M:&5E=#$S,RYX;6Q02P$"% ,4    "  PC:]:$S<;3"L#  "S"   &@
M        @(&8J@, >&PO=V]R:W-H965T<R]S:&5E=#$S-"YX;6Q02P$"% ,4
M    "  PC:]:6.6=#70"  !!!@  &@              @('[K0, >&PO=V]R
M:W-H965T<R]S:&5E=#$S-2YX;6Q02P$"% ,4    "  PC:]: AG;*J\"  !L
M!P  &@              @(&GL , >&PO=V]R:W-H965T<R]S:&5E=#$S-BYX
M;6Q02P$"% ,4    "  PC:]:M$<.=Z8"  #_!@  &@              @(&.
MLP, >&PO=V]R:W-H965T<R]S:&5E=#$S-RYX;6Q02P$"% ,4    "  PC:]:
ME_%Y7,8#  #'#@  &@              @(%LM@, >&PO=V]R:W-H965T<R]S
M:&5E=#$S."YX;6Q02P$"% ,4    "  PC:]:+0O\U2H#  "G"P  &@
M        @(%JN@, >&PO=V]R:W-H965T<R]S:&5E=#$S.2YX;6Q02P$"% ,4
M    "  PC:]:B*S&13T#  # "0  &@              @(',O0, >&PO=V]R
M:W-H965T<R]S:&5E=#$T,"YX;6Q02P$"% ,4    "  PC:]:Y3ZCKXD#  #V
M#@  &@              @(%!P0, >&PO=V]R:W-H965T<R]S:&5E=#$T,2YX
M;6Q02P$"% ,4    "  PC:]:6A49'TX#  "O#@  &@              @($"
MQ0, >&PO=V]R:W-H965T<R]S:&5E=#$T,BYX;6Q02P$"% ,4    "  PC:]:
M]'L@"UD"  #=!0  &@              @(&(R , >&PO=V]R:W-H965T<R]S
M:&5E=#$T,RYX;6Q02P$"% ,4    "  PC:]:Y"[_].@+   "I   &@
M        @($9RP, >&PO=V]R:W-H965T<R]S:&5E=#$T-"YX;6Q02P$"% ,4
M    "  PC:]:HY[\8<8$   <&   &@              @($YUP, >&PO=V]R
M:W-H965T<R]S:&5E=#$T-2YX;6Q02P$"% ,4    "  PC:]:+U29TM,&   >
M-   &@              @($WW , >&PO=V]R:W-H965T<R]S:&5E=#$T-BYX
M;6Q02P$"% ,4    "  PC:]:_E9#1C$)  #\00  &@              @(%"
MXP, >&PO=V]R:W-H965T<R]S:&5E=#$T-RYX;6Q02P$"% ,4    "  PC:]:
M7:0]!$,*  "';   &@              @(&K[ , >&PO=V]R:W-H965T<R]S
M:&5E=#$T."YX;6Q02P$"% ,4    "  PC:]:D67V-SL#  !#"@  &@
M        @($F]P, >&PO=V]R:W-H965T<R]S:&5E=#$T.2YX;6Q02P$"% ,4
M    "  PC:]:+]]1$- $  !J%@  &@              @(&9^@, >&PO=V]R
M:W-H965T<R]S:&5E=#$U,"YX;6Q02P$"% ,4    "  PC:]:AH;U77D#  !]
M"@  &@              @(&A_P, >&PO=V]R:W-H965T<R]S:&5E=#$U,2YX
M;6Q02P$"% ,4    "  PC:]:M&ZJPB4$   T%   &@              @(%2
M P0 >&PO=V]R:W-H965T<R]S:&5E=#$U,BYX;6Q02P$"% ,4    "  PC:]:
M1G9TT=X"  #9"   &@              @(&O!P0 >&PO=V]R:W-H965T<R]S
M:&5E=#$U,RYX;6Q02P$"% ,4    "  PC:]:^>&9J\4<  #]P0$ &@
M        @('%"@0 >&PO=V]R:W-H965T<R]S:&5E=#$U-"YX;6Q02P$"% ,4
M    "  PC:]:9GC9XW4%   R*0  &@              @('")P0 >&PO=V]R
M:W-H965T<R]S:&5E=#$U-2YX;6Q02P$"% ,4    "  PC:]:VO!Y_>T#  !_
M$P  &@              @(%O+00 >&PO=V]R:W-H965T<R]S:&5E=#$U-BYX
M;6Q02P$"% ,4    "  PC:]:,_>HOOL$   E&   &@              @(&4
M,00 >&PO=V]R:W-H965T<R]S:&5E=#$U-RYX;6Q02P$"% ,4    "  PC:]:
M&WQ?U38#  !M"   &@              @(''-@0 >&PO=V]R:W-H965T<R]S
M:&5E=#$U."YX;6Q02P$"% ,4    "  PC:]:JQRD!)$#  #R"P  &@
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M:&5E=#$V,RYX;6Q02P$"% ,4    "  PC:]:/K9?54,&  #O,@  &@
M        @(%+3 0 >&PO=V]R:W-H965T<R]S:&5E=#$V-"YX;6Q02P$"% ,4
M    "  PC:]:X0A=+#@,   'KP  &@              @('&4@0 >&PO=V]R
M:W-H965T<R]S:&5E=#$V-2YX;6Q02P$"% ,4    "  PC:]:DQPA\"P#  "8
M"   &@              @($V7P0 >&PO=V]R:W-H965T<R]S:&5E=#$V-BYX
M;6Q02P$"% ,4    "  PC:]:_9=B+$8%  "G'@  &@              @(&:
M8@0 >&PO=V]R:W-H965T<R]S:&5E=#$V-RYX;6Q02P$"% ,4    "  PC:]:
MIJ&/XL4#  "K"0  &@              @($8: 0 >&PO=V]R:W-H965T<R]S
M:&5E=#$V."YX;6Q02P$"% ,4    "  PC:]:>O>HWF(.   ]B0  &@
M        @($5; 0 >&PO=V]R:W-H965T<R]S:&5E=#$V.2YX;6Q02P$"% ,4
M    "  PC:]:->"V%AX/  "*F0  &@              @(&O>@0 >&PO=V]R
M:W-H965T<R]S:&5E=#$W,"YX;6Q02P$"% ,4    "  PC:]:NC!/P(<#  !P
M"P  &@              @($%B@0 >&PO=V]R:W-H965T<R]S:&5E=#$W,2YX
M;6Q02P$"% ,4    "  PC:]:"/;I_X@(  #6-@  &@              @('$
MC00 >&PO=V]R:W-H965T<R]S:&5E=#$W,BYX;6Q02P$"% ,4    "  PC:]:
ML'WI; $&  "S)   &@              @(&$E@0 >&PO=V]R:W-H965T<R]S
M:&5E=#$W,RYX;6Q02P$"% ,4    "  PC:]:$[D:XYD#   '#P  &@
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M:&5E=#$W."YX;6Q02P$"% ,4    "  PC:]:EA%21F0#  #4"   &@
M        @(%+L@0 >&PO=V]R:W-H965T<R]S:&5E=#$W.2YX;6Q02P$"% ,4
M    "  PC:]:&RCN*EL*  !&2P  &@              @('GM00 >&PO=V]R
M:W-H965T<R]S:&5E=#$X,"YX;6Q02P$"% ,4    "  PC:]:*,:Q^"H.  !=
MC@  &@              @(%ZP 0 >&PO=V]R:W-H965T<R]S:&5E=#$X,2YX
M;6Q02P$"% ,4    "  PC:]:K9!1:^P-  ",L0  &@              @('<
MS@0 >&PO=V]R:W-H965T<R]S:&5E=#$X,BYX;6Q02P$"% ,4    "  PC:]:
M3B AC7\#  !&#@  &@              @($ W00 >&PO=V]R:W-H965T<R]S
M:&5E=#$X,RYX;6Q02P$"% ,4    "  PC:]:;,\&JD0%  #)%P  &@
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M! !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  PC:]:E=1F7\L$  ! ;
M&@              @ '0!04 >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    "  PC:]:Y\=OKU\#  "59@  $P              @ '3"@4
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     P0#! )0U  !C#@4    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>213
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>214
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>216
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>852</ContextCount>
  <ElementCount>752</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>222</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - CONSOLIDATED STATEMENT OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ConsolidatedStatementOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENT OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome</Role>
      <ShortName>CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - CONSOLIDATED STATEMENT OF FINANCIAL POSITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition</Role>
      <ShortName>CONSOLIDATED STATEMENT OF FINANCIAL POSITION</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity</Role>
      <ShortName>CONSOLIDATED STATEMENT OF CHANGES IN EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENT OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0007 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPolicies</Role>
      <ShortName>BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0008 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformation</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0009 - Disclosure - EMPLOYMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/Employment</Role>
      <ShortName>EMPLOYMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0010 - Disclosure - OTHER OPERATING (EXPENSE) / INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/OtherOperatingIncome</Role>
      <ShortName>OTHER OPERATING (EXPENSE) / INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0011 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ImpairmentCharges</Role>
      <ShortName>IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0012 - Disclosure - FINANCIAL INCOME AND EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/FinancialIncomeAndExpenses</Role>
      <ShortName>FINANCIAL INCOME AND EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0013 - Disclosure - INCOME TAX (EXPENSE)/CREDIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/IncomeTaxCredit</Role>
      <ShortName>INCOME TAX (EXPENSE)/CREDIT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0014 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONS</Role>
      <ShortName>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0015 - Disclosure - LOSS BEFORE TAX</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LossBeforeTax</Role>
      <ShortName>LOSS BEFORE TAX</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0016 - Disclosure - LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LossPerShare</Role>
      <ShortName>LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0017 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PropertyPlantAndEquipment</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0018 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0019 - Disclosure - FINANCIAL ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/FINANCIALASSETS</Role>
      <ShortName>FINANCIAL ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0020 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilities</Role>
      <ShortName>DEFERRED TAX ASSETS AND LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0021 - Disclosure - OTHER NON-CURRENT ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/OtherNon-currentAssets</Role>
      <ShortName>OTHER NON-CURRENT ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0022 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0023 - Disclosure - TRADE AND OTHER RECEIVABLES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/TradeAndOtherReceivables</Role>
      <ShortName>TRADE AND OTHER RECEIVABLES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0024 - Disclosure - CASH AND CASH EQUIVALENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CashAndCashEquivalents</Role>
      <ShortName>CASH AND CASH EQUIVALENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0025 - Disclosure - CAPITAL AND RESERVES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndReserves</Role>
      <ShortName>CAPITAL AND RESERVES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0026 - Disclosure - SHARE OPTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ShareOptions</Role>
      <ShortName>SHARE OPTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0027 - Disclosure - TRADE AND OTHER PAYABLES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/TradeAndOtherPayables</Role>
      <ShortName>TRADE AND OTHER PAYABLES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0028 - Disclosure - PROVISIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/Provisions</Role>
      <ShortName>PROVISIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0029 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGS</Role>
      <ShortName>INTEREST-BEARING LOANS AND BORROWINGS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0030 - Disclosure - LEASE LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LeaseLiabilities</Role>
      <ShortName>LEASE LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0031 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0032 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0033 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagement</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0034 - Disclosure - RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivities</Role>
      <ShortName>RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0035 - Disclosure - BUSINESS COMBINATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/BUSINESSCOMBINATIONS</Role>
      <ShortName>BUSINESS COMBINATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0036 - Disclosure - POST BALANCE SHEET EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/POSTBALANCESHEETEVENTS</Role>
      <ShortName>POST BALANCE SHEET EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0037 - Disclosure - ACCOUNTING ESTIMATES AND JUDGEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/AccountingEstimatesAndJudgements</Role>
      <ShortName>ACCOUNTING ESTIMATES AND JUDGEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0038 - Disclosure - GROUP UNDERTAKINGS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/GROUPUNDERTAKINGS</Role>
      <ShortName>GROUP UNDERTAKINGS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0039 - Disclosure - AUTHORISATION FOR ISSUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/AuthorisationForIssue</Role>
      <ShortName>AUTHORISATION FOR ISSUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9960701 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies</Role>
      <ShortName>BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9960702 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesTables</Role>
      <ShortName>BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPolicies</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9960703 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformationTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformation</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9960704 - Disclosure - EMPLOYMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/EmploymentTables</Role>
      <ShortName>EMPLOYMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/Employment</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9960705 - Disclosure - OTHER OPERATING (EXPENSE) / INCOME (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/OtherOperatingIncomeTables</Role>
      <ShortName>OTHER OPERATING (EXPENSE) / INCOME (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/OtherOperatingIncome</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9960706 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ImpairmentChargesTables</Role>
      <ShortName>IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ImpairmentCharges</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9960707 - Disclosure - FINANCIAL INCOME AND EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/FinancialIncomeAndExpensesTables</Role>
      <ShortName>FINANCIAL INCOME AND EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/FinancialIncomeAndExpenses</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9960708 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/IncomeTaxCreditTables</Role>
      <ShortName>INCOME TAX (EXPENSE)/CREDIT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/IncomeTaxCredit</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9960709 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables</Role>
      <ShortName>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONS</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9960710 - Disclosure - LOSS BEFORE TAX (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LossBeforeTaxTables</Role>
      <ShortName>LOSS BEFORE TAX (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/LossBeforeTax</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9960711 - Disclosure - LOSS PER SHARE  (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LossPerShareTables</Role>
      <ShortName>LOSS PER SHARE  (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/LossPerShare</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9960712 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/PropertyPlantAndEquipment</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9960713 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9960714 - Disclosure - FINANCIAL ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/FINANCIALASSETSTables</Role>
      <ShortName>FINANCIAL ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/FINANCIALASSETS</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9960715 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesTables</Role>
      <ShortName>DEFERRED TAX ASSETS AND LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilities</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9960716 - Disclosure - OTHER NON-CURRENT ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/OtherNon-currentAssetsTables</Role>
      <ShortName>OTHER NON-CURRENT ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/OtherNon-currentAssets</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9960717 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/Inventories</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9960718 - Disclosure - TRADE AND OTHER RECEIVABLES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/TradeAndOtherReceivablesTables</Role>
      <ShortName>TRADE AND OTHER RECEIVABLES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/TradeAndOtherReceivables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9960719 - Disclosure - CASH AND CASH EQUIVALENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CashAndCashEquivalentsTables</Role>
      <ShortName>CASH AND CASH EQUIVALENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CashAndCashEquivalents</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9960720 - Disclosure - CAPITAL AND RESERVES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndReservesTables</Role>
      <ShortName>CAPITAL AND RESERVES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndReserves</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9960721 - Disclosure - SHARE OPTIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ShareOptionsTables</Role>
      <ShortName>SHARE OPTIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ShareOptions</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9960722 - Disclosure - TRADE AND OTHER PAYABLES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/TradeAndOtherPayablesTables</Role>
      <ShortName>TRADE AND OTHER PAYABLES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/TradeAndOtherPayables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9960723 - Disclosure - PROVISIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ProvisionsTables</Role>
      <ShortName>PROVISIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/Provisions</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9960724 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables</Role>
      <ShortName>INTEREST-BEARING LOANS AND BORROWINGS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGS</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9960725 - Disclosure - LEASE LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LeaseLiabilitiesTables</Role>
      <ShortName>LEASE LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/LeaseLiabilities</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9960726 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/RelatedPartyTransactionsTables</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/RelatedPartyTransactions</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9960727 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT  (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT  (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagement</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9960728 - Disclosure - RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTables</Role>
      <ShortName>RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivities</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9960729 - Disclosure - BUSINESS COMBINATIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables</Role>
      <ShortName>BUSINESS COMBINATIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/BUSINESSCOMBINATIONS</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9960730 - Disclosure - GROUP UNDERTAKINGS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/GROUPUNDERTAKINGSTables</Role>
      <ShortName>GROUP UNDERTAKINGS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/GROUPUNDERTAKINGS</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9960731 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails</Role>
      <ShortName>BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9960732 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Schedule of owned assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails</Role>
      <ShortName>BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Schedule of owned assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9960733 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Schedule of amortisation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails</Role>
      <ShortName>BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Schedule of amortisation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9960734 - Disclosure - SEGMENT INFORMATION (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SEGMENTINFORMATIONNarrativeDetails</Role>
      <ShortName>SEGMENT INFORMATION (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformationTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9960735 - Disclosure - SEGMENT INFORMATION (Schedule of Revenue by Geographical Area Based on Location of Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails</Role>
      <ShortName>SEGMENT INFORMATION (Schedule of Revenue by Geographical Area Based on Location of Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformationTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9960736 - Disclosure - SEGMENT INFORMATION (Schedule of Revenue by Customers Geographical Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails</Role>
      <ShortName>SEGMENT INFORMATION (Schedule of Revenue by Customers Geographical Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformationTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9960737 - Disclosure - SEGMENT INFORMATION (Schedule of Revenue by Major Product Group) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails</Role>
      <ShortName>SEGMENT INFORMATION (Schedule of Revenue by Major Product Group) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformationTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9960738 - Disclosure - SEGMENT INFORMATION (Schedule of Amount Relating From Revenue) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformationScheduleOfAmountRelatingFromRevenueDetails</Role>
      <ShortName>SEGMENT INFORMATION (Schedule of Amount Relating From Revenue) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformationTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9960739 - Disclosure - SEGMENT INFORMATION (Schedule of Revenue Derives From Transfer of Goods and Services) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails</Role>
      <ShortName>SEGMENT INFORMATION (Schedule of Revenue Derives From Transfer of Goods and Services) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformationTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9960740 - Disclosure - SEGMENT INFORMATION (Schedule of Segment Results by Geographical Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails</Role>
      <ShortName>SEGMENT INFORMATION (Schedule of Segment Results by Geographical Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformationTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9960741 - Disclosure - SEGMENT INFORMATION (Schedule of Segment Assets and Segment Liabilities by Geographical Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails</Role>
      <ShortName>SEGMENT INFORMATION (Schedule of Segment Assets and Segment Liabilities by Geographical Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformationTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9960742 - Disclosure - SEGMENT INFORMATION (Schedule of Long Lived Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails</Role>
      <ShortName>SEGMENT INFORMATION (Schedule of Long Lived Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformationTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9960743 - Disclosure - SEGMENT INFORMATION (Schedule of Depreciation and Amortisation by Geographical Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails</Role>
      <ShortName>SEGMENT INFORMATION (Schedule of Depreciation and Amortisation by Geographical Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformationTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9960744 - Disclosure - SEGMENT INFORMATION (Schedule of Share Based Payment Expense by Geographical Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails</Role>
      <ShortName>SEGMENT INFORMATION (Schedule of Share Based Payment Expense by Geographical Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformationTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9960745 - Disclosure - SEGMENT INFORMATION (Schedule of Taxation Expense by Geographical Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails</Role>
      <ShortName>SEGMENT INFORMATION (Schedule of Taxation Expense by Geographical Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformationTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9960746 - Disclosure - SEGMENT INFORMATION (Schedule of Capital Expenditure by Geographical Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails</Role>
      <ShortName>SEGMENT INFORMATION (Schedule of Capital Expenditure by Geographical Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/SegmentInformationTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9960747 - Disclosure - EMPLOYMENT (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/EmploymentNarrativeDetails</Role>
      <ShortName>EMPLOYMENT (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/EmploymentTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9960748 - Disclosure - EMPLOYMENT (Schedule of Average Number of Persons Employed) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails</Role>
      <ShortName>EMPLOYMENT (Schedule of Average Number of Persons Employed) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/EmploymentTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>9960749 - Disclosure - EMPLOYMENT (Schedule of Employment Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails</Role>
      <ShortName>EMPLOYMENT (Schedule of Employment Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/EmploymentTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>9960750 - Disclosure - OTHER OPERATING (EXPENSE) / INCOME (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/OtherOperatingIncomeDetails</Role>
      <ShortName>OTHER OPERATING (EXPENSE) / INCOME (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/OtherOperatingIncomeTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>9960751 - Disclosure - OTHER OPERATING (EXPENSE) / INCOME (Schedule of Other Operating Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails</Role>
      <ShortName>OTHER OPERATING (EXPENSE) / INCOME (Schedule of Other Operating Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/OtherOperatingIncomeTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>9960752 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails</Role>
      <ShortName>IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ImpairmentChargesTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>9960753 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Schedule of Statement of Operation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails</Role>
      <ShortName>IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Schedule of Statement of Operation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ImpairmentChargesTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>9960754 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Schedule of restructuring costs incurred during the year) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear</Role>
      <ShortName>IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Schedule of restructuring costs incurred during the year) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ImpairmentChargesTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>9960755 - Disclosure - FINANCIAL INCOME AND EXPENSES (Schedule of Financial Income (Expenses), Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails</Role>
      <ShortName>FINANCIAL INCOME AND EXPENSES (Schedule of Financial Income (Expenses), Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/FinancialIncomeAndExpensesTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>9960756 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails</Role>
      <ShortName>INCOME TAX (EXPENSE)/CREDIT (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/IncomeTaxCreditTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>9960757 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Charge for Tax) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails</Role>
      <ShortName>INCOME TAX (EXPENSE)/CREDIT (Schedule of Charge for Tax) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/IncomeTaxCreditTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>9960758 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Overseas Tax Jurisdictions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfOverseasTaxJurisdictionsDetails</Role>
      <ShortName>INCOME TAX (EXPENSE)/CREDIT (Schedule of Overseas Tax Jurisdictions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/IncomeTaxCreditTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>9960759 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Statutory Tax Rate) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfStatutoryTaxRateDetails</Role>
      <ShortName>INCOME TAX (EXPENSE)/CREDIT (Schedule of Statutory Tax Rate) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/IncomeTaxCreditTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>9960760 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Loss Profit Before Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails</Role>
      <ShortName>INCOME TAX (EXPENSE)/CREDIT (Schedule of Loss Profit Before Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/IncomeTaxCreditTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>9960761 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Net Operating Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails</Role>
      <ShortName>INCOME TAX (EXPENSE)/CREDIT (Schedule of Net Operating Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/IncomeTaxCreditTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>9960762 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Unrecognised Deferred Tax Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails</Role>
      <ShortName>INCOME TAX (EXPENSE)/CREDIT (Schedule of Unrecognised Deferred Tax Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/IncomeTaxCreditTables</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>9960763 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails</Role>
      <ShortName>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>9960764 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of operating profit for the discontinued operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails</Role>
      <ShortName>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of operating profit for the discontinued operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>9960765 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of net cashflows generated from discontinued operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1</Role>
      <ShortName>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of net cashflows generated from discontinued operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>9960766 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of assets and liabilities disposed) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5</Role>
      <ShortName>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of assets and liabilities disposed) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>9960767 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of Earnings Per ADS for Discontinued Operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2</Role>
      <ShortName>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of Earnings Per ADS for Discontinued Operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>9960768 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of Cash Flows Attributable to Discontinued Operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3</Role>
      <ShortName>(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of Cash Flows Attributable to Discontinued Operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>9960769 - Disclosure - LOSS BEFORE TAX (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LossBeforeTaxNarrativeDetails</Role>
      <ShortName>LOSS BEFORE TAX (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/LossBeforeTaxTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>9960770 - Disclosure - LOSS BEFORE TAX (Schedule of Amount Charged to Statement of Operation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails</Role>
      <ShortName>LOSS BEFORE TAX (Schedule of Amount Charged to Statement of Operation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/LossBeforeTaxTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>9960771 - Disclosure - LOSS PER SHARE  (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LossPerShareNarrativeDetails</Role>
      <ShortName>LOSS PER SHARE  (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/LossPerShareTables</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>9960772 - Disclosure - LOSS PER SHARE (Schedule of Basic Earnings Per Ordinary Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails</Role>
      <ShortName>LOSS PER SHARE (Schedule of Basic Earnings Per Ordinary Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/LossPerShareTables</ParentRole>
      <Position>113</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>9960773 - Disclosure - LOSS PER SHARE  (Schedule of Diluted Earnings Per Ordinary Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerOrdinaryShareDetails</Role>
      <ShortName>LOSS PER SHARE  (Schedule of Diluted Earnings Per Ordinary Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/LossPerShareTables</ParentRole>
      <Position>114</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>9960774 - Disclosure - LOSS PER SHARE  (Schedule of Earnings Per ADS) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails</Role>
      <ShortName>LOSS PER SHARE  (Schedule of Earnings Per ADS) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/LossPerShareTables</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>9960775 - Disclosure - LOSS PER SHARE (Schedule of Diluted Earnings Per ADS Share Calculation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails</Role>
      <ShortName>LOSS PER SHARE (Schedule of Diluted Earnings Per ADS Share Calculation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/LossPerShareTables</ParentRole>
      <Position>116</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>9960776 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables</ParentRole>
      <Position>117</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>9960777 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Schedule of Composition of Property and Equipment Related to Accumulated Depreciation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Schedule of Composition of Property and Equipment Related to Accumulated Depreciation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables</ParentRole>
      <Position>118</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>9960778 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Schedule of Additional Information on Right-of-use Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Schedule of Additional Information on Right-of-use Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables</ParentRole>
      <Position>119</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>9960779 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Schedule of Income from Sub-letting Right-of-use Buildings) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Schedule of Income from Sub-letting Right-of-use Buildings) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables</ParentRole>
      <Position>120</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>9960780 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>121</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>9960781 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Goodwill and Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Schedule of Goodwill and Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>122</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>9960782 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Principal Development Projects) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Schedule of Principal Development Projects) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>123</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>9960783 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Impairment Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Schedule of Impairment Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>124</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>9960784 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Breakdown of Impairment Loss) (Details) (USD $)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfBreakdownOfImpairmentLossDetailsUsd</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Schedule of Breakdown of Impairment Loss) (Details) (USD $)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>125</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>9960785 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Specific asset impairment charges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Schedule of Specific asset impairment charges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>126</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>9960786 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Significant Goodwill and Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Schedule of Significant Goodwill and Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>127</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>9960787 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Intangible Assets with Indefinite Useful lives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Schedule of Intangible Assets with Indefinite Useful lives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>128</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>9960788 - Disclosure - FINANCIAL ASSETS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails</Role>
      <ShortName>FINANCIAL ASSETS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/FINANCIALASSETSTables</ParentRole>
      <Position>129</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R130.htm</HtmlFileName>
      <LongName>9960789 - Disclosure - FINANCIAL ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/FINANCIALASSETSDetails</Role>
      <ShortName>FINANCIAL ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/FINANCIALASSETSTables</ParentRole>
      <Position>130</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R131.htm</HtmlFileName>
      <LongName>9960790 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesNarrativeDetails</Role>
      <ShortName>DEFERRED TAX ASSETS AND LIABILITIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesTables</ParentRole>
      <Position>131</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R132.htm</HtmlFileName>
      <LongName>9960791 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Recognised Deferred Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Recognised Deferred Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesTables</ParentRole>
      <Position>132</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R133.htm</HtmlFileName>
      <LongName>9960792 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Unrecognised Deferred Tax Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails</Role>
      <ShortName>DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Unrecognised Deferred Tax Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesTables</ParentRole>
      <Position>133</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R134.htm</HtmlFileName>
      <LongName>9960793 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Unrecognised Deferred Tax Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails</Role>
      <ShortName>DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Unrecognised Deferred Tax Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesTables</ParentRole>
      <Position>134</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R135.htm</HtmlFileName>
      <LongName>9960794 - Disclosure - OTHER NON-CURRENT ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/OtherNon-currentAssetsDetails</Role>
      <ShortName>OTHER NON-CURRENT ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/OtherNon-currentAssetsTables</ParentRole>
      <Position>135</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R136.htm</HtmlFileName>
      <LongName>9960795 - Disclosure - INVENTORIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/InventoriesNarrativeDetails</Role>
      <ShortName>INVENTORIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/InventoriesTables</ParentRole>
      <Position>136</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R137.htm</HtmlFileName>
      <LongName>9960796 - Disclosure - INVENTORIES (Schedule of inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails</Role>
      <ShortName>INVENTORIES (Schedule of inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/InventoriesTables</ParentRole>
      <Position>137</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R138.htm</HtmlFileName>
      <LongName>9960797 - Disclosure - INVENTORIES (Schedule of Movement on the Inventory Provision) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails</Role>
      <ShortName>INVENTORIES (Schedule of Movement on the Inventory Provision) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/InventoriesTables</ParentRole>
      <Position>138</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R139.htm</HtmlFileName>
      <LongName>9960798 - Disclosure - TRADE AND OTHER RECEIVABLES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails</Role>
      <ShortName>TRADE AND OTHER RECEIVABLES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/TradeAndOtherReceivablesTables</ParentRole>
      <Position>139</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R140.htm</HtmlFileName>
      <LongName>9960799 - Disclosure - TRADE AND OTHER RECEIVABLES (Schedule of Trade and Other Receivables) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails</Role>
      <ShortName>TRADE AND OTHER RECEIVABLES (Schedule of Trade and Other Receivables) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/TradeAndOtherReceivablesTables</ParentRole>
      <Position>140</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R141.htm</HtmlFileName>
      <LongName>9960800 - Disclosure - TRADE AND OTHER RECEIVABLES (Schedule of Future Minimum Finance Lease Receivables) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails</Role>
      <ShortName>TRADE AND OTHER RECEIVABLES (Schedule of Future Minimum Finance Lease Receivables) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/TradeAndOtherReceivablesTables</ParentRole>
      <Position>141</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R142.htm</HtmlFileName>
      <LongName>9960801 - Disclosure - TRADE AND OTHER RECEIVABLES (Schedule of Future Minimum Rentals Receivable Under Non-Cancellable Operating Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails</Role>
      <ShortName>TRADE AND OTHER RECEIVABLES (Schedule of Future Minimum Rentals Receivable Under Non-Cancellable Operating Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/TradeAndOtherReceivablesTables</ParentRole>
      <Position>142</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R143.htm</HtmlFileName>
      <LongName>9960802 - Disclosure - CASH AND CASH EQUIVALENTS (Schedule of Cash and Cash Equivalents) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails</Role>
      <ShortName>CASH AND CASH EQUIVALENTS (Schedule of Cash and Cash Equivalents) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CashAndCashEquivalentsTables</ParentRole>
      <Position>143</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R144.htm</HtmlFileName>
      <LongName>9960803 - Disclosure - CAPITAL AND RESERVES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails</Role>
      <ShortName>CAPITAL AND RESERVES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndReservesTables</ParentRole>
      <Position>144</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R145.htm</HtmlFileName>
      <LongName>9960804 - Disclosure - CAPITAL AND RESERVES (Schedule of Share Capital) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails</Role>
      <ShortName>CAPITAL AND RESERVES (Schedule of Share Capital) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndReservesTables</ParentRole>
      <Position>145</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R146.htm</HtmlFileName>
      <LongName>9960805 - Disclosure - SHARE OPTIONS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ShareOptionsNarrativeDetails</Role>
      <ShortName>SHARE OPTIONS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ShareOptionsTables</ParentRole>
      <Position>146</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R147.htm</HtmlFileName>
      <LongName>9960806 - Disclosure - SHARE OPTIONS (Schedule of Grants of Share Options and Warrants) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails</Role>
      <ShortName>SHARE OPTIONS (Schedule of Grants of Share Options and Warrants) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ShareOptionsTables</ParentRole>
      <Position>147</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R148.htm</HtmlFileName>
      <LongName>9960807 - Disclosure - SHARE OPTIONS (Summary of Range of Prices of Stock Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails</Role>
      <ShortName>SHARE OPTIONS (Summary of Range of Prices of Stock Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ShareOptionsTables</ParentRole>
      <Position>148</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R149.htm</HtmlFileName>
      <LongName>9960808 - Disclosure - SHARE OPTIONS (Schedule of Fair Value of the Options Vesting Period) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails</Role>
      <ShortName>SHARE OPTIONS (Schedule of Fair Value of the Options Vesting Period) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ShareOptionsTables</ParentRole>
      <Position>149</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R150.htm</HtmlFileName>
      <LongName>9960809 - Disclosure - SHARE OPTIONS (Schedule of Assumption Determining Fair Value of Share Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails</Role>
      <ShortName>SHARE OPTIONS (Schedule of Assumption Determining Fair Value of Share Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ShareOptionsTables</ParentRole>
      <Position>150</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R151.htm</HtmlFileName>
      <LongName>9960810 - Disclosure - TRADE AND OTHER PAYABLES (Schedule of Trade and Other Payables) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails</Role>
      <ShortName>TRADE AND OTHER PAYABLES (Schedule of Trade and Other Payables) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/TradeAndOtherPayablesTables</ParentRole>
      <Position>151</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R152.htm</HtmlFileName>
      <LongName>9960811 - Disclosure - PROVISIONS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ProvisionsNarrativeDetails</Role>
      <ShortName>PROVISIONS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ProvisionsTables</ParentRole>
      <Position>152</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R153.htm</HtmlFileName>
      <LongName>9960812 - Disclosure - PROVISIONS (Schedule of Provisions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails</Role>
      <ShortName>PROVISIONS (Schedule of Provisions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ProvisionsTables</ParentRole>
      <Position>153</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R154.htm</HtmlFileName>
      <LongName>9960813 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails</Role>
      <ShortName>INTEREST-BEARING LOANS AND BORROWINGS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables</ParentRole>
      <Position>154</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R155.htm</HtmlFileName>
      <LongName>9960814 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of carrying value of interest-bearing loans, borrowings and related balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails</Role>
      <ShortName>INTEREST-BEARING LOANS AND BORROWINGS (Schedule of carrying value of interest-bearing loans, borrowings and related balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables</ParentRole>
      <Position>155</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R156.htm</HtmlFileName>
      <LongName>9960815 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the Exchangeable Notes balance) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1</Role>
      <ShortName>INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the Exchangeable Notes balance) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables</ParentRole>
      <Position>156</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R157.htm</HtmlFileName>
      <LongName>9960816 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in term loan) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan</Role>
      <ShortName>INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in term loan) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables</ParentRole>
      <Position>157</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R158.htm</HtmlFileName>
      <LongName>9960817 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the derivative financial asset) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4</Role>
      <ShortName>INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the derivative financial asset) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables</ParentRole>
      <Position>158</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R159.htm</HtmlFileName>
      <LongName>9960818 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the derivative financial liability) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3</Role>
      <ShortName>INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the derivative financial liability) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables</ParentRole>
      <Position>159</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R160.htm</HtmlFileName>
      <LongName>9960819 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the Term Loan and the 7-year convertible notes) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2</Role>
      <ShortName>INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the Term Loan and the 7-year convertible notes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables</ParentRole>
      <Position>160</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R161.htm</HtmlFileName>
      <LongName>9960820 - Disclosure - LEASE LIABILITIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails</Role>
      <ShortName>LEASE LIABILITIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/LeaseLiabilitiesTables</ParentRole>
      <Position>161</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R162.htm</HtmlFileName>
      <LongName>9960821 - Disclosure - LEASE LIABILITIES (Schedule of Carrying Values of Finance Lease Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails</Role>
      <ShortName>LEASE LIABILITIES (Schedule of Carrying Values of Finance Lease Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/LeaseLiabilitiesTables</ParentRole>
      <Position>162</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R163.htm</HtmlFileName>
      <LongName>9960822 - Disclosure - LEASE LIABILITIES (Schedule of Finance Lease Liabilities Payable) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails</Role>
      <ShortName>LEASE LIABILITIES (Schedule of Finance Lease Liabilities Payable) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/LeaseLiabilitiesTables</ParentRole>
      <Position>163</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R164.htm</HtmlFileName>
      <LongName>9960823 - Disclosure - COMMITMENTS AND CONTINGENCIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>164</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R165.htm</HtmlFileName>
      <LongName>9960824 - Disclosure - RELATED PARTY TRANSACTIONS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/RelatedPartyTransactionsTables</ParentRole>
      <Position>165</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R166.htm</HtmlFileName>
      <LongName>9960825 - Disclosure - RELATED PARTY TRANSACTIONS (Schedule of Compensation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Schedule of Compensation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/RelatedPartyTransactionsTables</ParentRole>
      <Position>166</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R167.htm</HtmlFileName>
      <LongName>9960826 - Disclosure - RELATED PARTY TRANSACTIONS (Schedule of Company's Shares and Share Option Plan) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Schedule of Company's Shares and Share Option Plan) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/RelatedPartyTransactionsTables</ParentRole>
      <Position>167</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R168.htm</HtmlFileName>
      <LongName>9960827 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables</ParentRole>
      <Position>168</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R169.htm</HtmlFileName>
      <LongName>9960828 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Fair Values of Financial Assets/Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Fair Values of Financial Assets/Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables</ParentRole>
      <Position>169</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R170.htm</HtmlFileName>
      <LongName>9960829 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Interest Rate Risk Effective and Repricing Analysis) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Interest Rate Risk Effective and Repricing Analysis) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables</ParentRole>
      <Position>170</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R171.htm</HtmlFileName>
      <LongName>9960830 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of  interest Rate Profile of Financial Assets/Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of  interest Rate Profile of Financial Assets/Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables</ParentRole>
      <Position>171</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R172.htm</HtmlFileName>
      <LongName>9960831 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Liquidity Risk Estimated Interest Payments of Maturities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Liquidity Risk Estimated Interest Payments of Maturities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables</ParentRole>
      <Position>172</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R173.htm</HtmlFileName>
      <LongName>9960832 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Foreign Currency Risk Short Term Financial Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Foreign Currency Risk Short Term Financial Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables</ParentRole>
      <Position>173</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R174.htm</HtmlFileName>
      <LongName>9960833 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Sensitivity Analysis) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Sensitivity Analysis) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables</ParentRole>
      <Position>174</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R175.htm</HtmlFileName>
      <LongName>9960834 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Maximum Credit Exposure of Financial Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMaximumCreditExposureOfFinancialAssetsDetails</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Maximum Credit Exposure of Financial Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables</ParentRole>
      <Position>175</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R176.htm</HtmlFileName>
      <LongName>9960835 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Exposure of Trade Receivables by Geographic Location) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Exposure of Trade Receivables by Geographic Location) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables</ParentRole>
      <Position>176</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R177.htm</HtmlFileName>
      <LongName>9960836 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Exposure of Trade Receivables by Customer) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Exposure of Trade Receivables by Customer) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables</ParentRole>
      <Position>177</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R178.htm</HtmlFileName>
      <LongName>9960837 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Ageing of Trade Receivables) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Ageing of Trade Receivables) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables</ParentRole>
      <Position>178</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R179.htm</HtmlFileName>
      <LongName>9960838 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Movement in the Allowance for Impairment of Trade Receivables) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMovementInAllowanceForImpairmentOfTradeReceivablesDetails</Role>
      <ShortName>CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Movement in the Allowance for Impairment of Trade Receivables) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables</ParentRole>
      <Position>179</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R180.htm</HtmlFileName>
      <LongName>9960839 - Disclosure - RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Schedule of Liabilities Arising from Financing) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails</Role>
      <ShortName>RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Schedule of Liabilities Arising from Financing) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTables</ParentRole>
      <Position>180</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R181.htm</HtmlFileName>
      <LongName>9960840 - Disclosure - BUSINESS COMBINATIONS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails</Role>
      <ShortName>BUSINESS COMBINATIONS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables</ParentRole>
      <Position>181</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R182.htm</HtmlFileName>
      <LongName>9960841 - Disclosure - BUSINESS COMBINATIONS (Schedule of acquisition of the CGM assets of Waveform Technologies, Inc) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails</Role>
      <ShortName>BUSINESS COMBINATIONS (Schedule of acquisition of the CGM assets of Waveform Technologies, Inc) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables</ParentRole>
      <Position>182</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R183.htm</HtmlFileName>
      <LongName>9960842 - Disclosure - POST BALANCE SHEET EVENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/PostBalanceSheetEventsDetails</Role>
      <ShortName>POST BALANCE SHEET EVENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/POSTBALANCESHEETEVENTS</ParentRole>
      <Position>183</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R184.htm</HtmlFileName>
      <LongName>9960843 - Disclosure - ACCOUNTING ESTIMATES AND JUDGEMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails</Role>
      <ShortName>ACCOUNTING ESTIMATES AND JUDGEMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/AccountingEstimatesAndJudgements</ParentRole>
      <Position>184</Position>
    </Report>
    <Report instance="zk2533151.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R185.htm</HtmlFileName>
      <LongName>9960844 - Disclosure - GROUP UNDERTAKINGS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails</Role>
      <ShortName>GROUP UNDERTAKINGS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trinitybiotech.com/role/GROUPUNDERTAKINGSTables</ParentRole>
      <Position>185</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>trib-20241231.xsd</File>
    <File>trib-20241231_cal.xml</File>
    <File>trib-20241231_def.xml</File>
    <File>trib-20241231_lab.xml</File>
    <File>trib-20241231_pre.xml</File>
    <File doctype="20-F" isDefinitelyFs="true" isIfrs="true" isUsgaap="true" original="zk2533151.htm">zk2533151.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="16">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="43">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="1">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
    <BaseTaxonomy items="2440">https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>219
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "zk2533151.htm": {
   "nsprefix": "trib",
   "nsuri": "http://trinitybiotech.com/20241231",
   "dts": {
    "schema": {
     "local": [
      "trib-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2024-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd",
      "https://xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "trib-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "trib-20241231_def.xml"
     ],
     "remote": [
      "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/dimensions/dim_full_ifrs_2024-03-27_role-995000.xml"
     ]
    },
    "labelLink": {
     "local": [
      "trib-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "trib-20241231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "zk2533151.htm"
     ]
    }
   },
   "keyStandard": 446,
   "keyCustom": 306,
   "axisStandard": 40,
   "axisCustom": 3,
   "memberStandard": 57,
   "memberCustom": 140,
   "hidden": {
    "total": 5,
    "http://trinitybiotech.com/20241231": 2,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 852,
   "entityCount": 1,
   "segmentCount": 222,
   "elementCount": 1499,
   "unitCount": 9,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full": 2440,
    "http://xbrl.sec.gov/dei/2024": 43,
    "http://xbrl.sec.gov/cyd/2024": 16,
    "http://xbrl.sec.gov/ecd/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://trinitybiotech.com/role/DocumentAndEntityInformation",
     "longName": "0001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
     "longName": "0002 - Statement - CONSOLIDATED STATEMENT OF OPERATIONS",
     "shortName": "CONSOLIDATED STATEMENT OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:Revenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:CostOfSales",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome",
     "longName": "0003 - Statement - CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME",
     "shortName": "CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ProfitLossAttributableToOwnersOfParent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
     "longName": "0004 - Statement - CONSOLIDATED STATEMENT OF FINANCIAL POSITION",
     "shortName": "CONSOLIDATED STATEMENT OF FINANCIAL POSITION",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:NoncurrentFinancialAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity",
     "longName": "0005 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN EQUITY",
     "shortName": "CONSOLIDATED STATEMENT OF CHANGES IN EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember",
      "name": "ifrs-full:Equity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember",
      "name": "ifrs-full:Equity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
     "longName": "0006 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENT OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ProfitLossAttributableToOwnersOfParent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:AdjustmentsForDepreciationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPolicies",
     "longName": "0007 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://trinitybiotech.com/role/SegmentInformation",
     "longName": "0008 - Disclosure - SEGMENT INFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://trinitybiotech.com/role/Employment",
     "longName": "0009 - Disclosure - EMPLOYMENT",
     "shortName": "EMPLOYMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://trinitybiotech.com/role/OtherOperatingIncome",
     "longName": "0010 - Disclosure - OTHER OPERATING (EXPENSE) / INCOME",
     "shortName": "OTHER OPERATING (EXPENSE) / INCOME",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://trinitybiotech.com/role/ImpairmentCharges",
     "longName": "0011 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS",
     "shortName": "IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://trinitybiotech.com/role/FinancialIncomeAndExpenses",
     "longName": "0012 - Disclosure - FINANCIAL INCOME AND EXPENSES",
     "shortName": "FINANCIAL INCOME AND EXPENSES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://trinitybiotech.com/role/IncomeTaxCredit",
     "longName": "0013 - Disclosure - INCOME TAX (EXPENSE)/CREDIT",
     "shortName": "INCOME TAX (EXPENSE)/CREDIT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONS",
     "longName": "0014 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS",
     "shortName": "(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://trinitybiotech.com/role/LossBeforeTax",
     "longName": "0015 - Disclosure - LOSS BEFORE TAX",
     "shortName": "LOSS BEFORE TAX",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfLossProfitBeforeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfLossProfitBeforeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://trinitybiotech.com/role/LossPerShare",
     "longName": "0016 - Disclosure - LOSS PER SHARE",
     "shortName": "LOSS PER SHARE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://trinitybiotech.com/role/PropertyPlantAndEquipment",
     "longName": "0017 - Disclosure - PROPERTY, PLANT AND EQUIPMENT",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETS",
     "longName": "0018 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://trinitybiotech.com/role/FINANCIALASSETS",
     "longName": "0019 - Disclosure - FINANCIAL ASSETS",
     "shortName": "FINANCIAL ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilities",
     "longName": "0020 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES",
     "shortName": "DEFERRED TAX ASSETS AND LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://trinitybiotech.com/role/OtherNon-currentAssets",
     "longName": "0021 - Disclosure - OTHER NON-CURRENT ASSETS",
     "shortName": "OTHER NON-CURRENT ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfOtherAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfOtherAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://trinitybiotech.com/role/Inventories",
     "longName": "0022 - Disclosure - INVENTORIES",
     "shortName": "INVENTORIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://trinitybiotech.com/role/TradeAndOtherReceivables",
     "longName": "0023 - Disclosure - TRADE AND OTHER RECEIVABLES",
     "shortName": "TRADE AND OTHER RECEIVABLES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://trinitybiotech.com/role/CashAndCashEquivalents",
     "longName": "0024 - Disclosure - CASH AND CASH EQUIVALENTS",
     "shortName": "CASH AND CASH EQUIVALENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://trinitybiotech.com/role/CapitalAndReserves",
     "longName": "0025 - Disclosure - CAPITAL AND RESERVES",
     "shortName": "CAPITAL AND RESERVES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://trinitybiotech.com/role/ShareOptions",
     "longName": "0026 - Disclosure - SHARE OPTIONS",
     "shortName": "SHARE OPTIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://trinitybiotech.com/role/TradeAndOtherPayables",
     "longName": "0027 - Disclosure - TRADE AND OTHER PAYABLES",
     "shortName": "TRADE AND OTHER PAYABLES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://trinitybiotech.com/role/Provisions",
     "longName": "0028 - Disclosure - PROVISIONS",
     "shortName": "PROVISIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfProvisionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfProvisionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGS",
     "longName": "0029 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS",
     "shortName": "INTEREST-BEARING LOANS AND BORROWINGS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfBorrowingsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfBorrowingsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://trinitybiotech.com/role/LeaseLiabilities",
     "longName": "0030 - Disclosure - LEASE LIABILITIES",
     "shortName": "LEASE LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://trinitybiotech.com/role/CommitmentsAndContingencies",
     "longName": "0031 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://trinitybiotech.com/role/RelatedPartyTransactions",
     "longName": "0032 - Disclosure - RELATED PARTY TRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagement",
     "longName": "0033 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivities",
     "longName": "0034 - Disclosure - RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES",
     "shortName": "RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://trinitybiotech.com/role/BUSINESSCOMBINATIONS",
     "longName": "0035 - Disclosure - BUSINESS COMBINATIONS",
     "shortName": "BUSINESS COMBINATIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://trinitybiotech.com/role/POSTBALANCESHEETEVENTS",
     "longName": "0036 - Disclosure - POST BALANCE SHEET EVENTS",
     "shortName": "POST BALANCE SHEET EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://trinitybiotech.com/role/AccountingEstimatesAndJudgements",
     "longName": "0037 - Disclosure - ACCOUNTING ESTIMATES AND JUDGEMENTS",
     "shortName": "ACCOUNTING ESTIMATES AND JUDGEMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://trinitybiotech.com/role/GROUPUNDERTAKINGS",
     "longName": "0038 - Disclosure - GROUP UNDERTAKINGS",
     "shortName": "GROUP UNDERTAKINGS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfGroupUndertakingsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfGroupUndertakingsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://trinitybiotech.com/role/AuthorisationForIssue",
     "longName": "0039 - Disclosure - AUTHORISATION FOR ISSUE",
     "shortName": "AUTHORISATION FOR ISSUE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfAuthorisationForIssueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfAuthorisationForIssueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies",
     "longName": "9960701 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DescriptionOfAccountingPolicyForGeneralInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DescriptionOfAccountingPolicyForGeneralInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesTables",
     "longName": "9960702 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "div",
       "trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "div",
       "trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://trinitybiotech.com/role/SegmentInformationTables",
     "longName": "9960703 - Disclosure - SEGMENT INFORMATION (Tables)",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://trinitybiotech.com/role/EmploymentTables",
     "longName": "9960704 - Disclosure - EMPLOYMENT (Tables)",
     "shortName": "EMPLOYMENT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://trinitybiotech.com/role/OtherOperatingIncomeTables",
     "longName": "9960705 - Disclosure - OTHER OPERATING (EXPENSE) / INCOME (Tables)",
     "shortName": "OTHER OPERATING (EXPENSE) / INCOME (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://trinitybiotech.com/role/ImpairmentChargesTables",
     "longName": "9960706 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Tables)",
     "shortName": "IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://trinitybiotech.com/role/FinancialIncomeAndExpensesTables",
     "longName": "9960707 - Disclosure - FINANCIAL INCOME AND EXPENSES (Tables)",
     "shortName": "FINANCIAL INCOME AND EXPENSES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinanceIncomeExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinanceIncomeExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://trinitybiotech.com/role/IncomeTaxCreditTables",
     "longName": "9960708 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Tables)",
     "shortName": "INCOME TAX (EXPENSE)/CREDIT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutChargeForTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutChargeForTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables",
     "longName": "9960709 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Tables)",
     "shortName": "(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://trinitybiotech.com/role/LossBeforeTaxTables",
     "longName": "9960710 - Disclosure - LOSS BEFORE TAX (Tables)",
     "shortName": "LOSS BEFORE TAX (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfLossProfitBeforeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfLossProfitBeforeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://trinitybiotech.com/role/LossPerShareTables",
     "longName": "9960711 - Disclosure - LOSS PER SHARE  (Tables)",
     "shortName": "LOSS PER SHARE  (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables",
     "longName": "9960712 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables",
     "longName": "9960713 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://trinitybiotech.com/role/FINANCIALASSETSTables",
     "longName": "9960714 - Disclosure - FINANCIAL ASSETS (Tables)",
     "shortName": "FINANCIAL ASSETS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutFinancialAssets",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutFinancialAssets",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesTables",
     "longName": "9960715 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Tables)",
     "shortName": "DEFERRED TAX ASSETS AND LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://trinitybiotech.com/role/OtherNon-currentAssetsTables",
     "longName": "9960716 - Disclosure - OTHER NON-CURRENT ASSETS (Tables)",
     "shortName": "OTHER NON-CURRENT ASSETS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutOtherAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfOtherAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutOtherAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfOtherAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://trinitybiotech.com/role/InventoriesTables",
     "longName": "9960717 - Disclosure - INVENTORIES (Tables)",
     "shortName": "INVENTORIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://trinitybiotech.com/role/TradeAndOtherReceivablesTables",
     "longName": "9960718 - Disclosure - TRADE AND OTHER RECEIVABLES (Tables)",
     "shortName": "TRADE AND OTHER RECEIVABLES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://trinitybiotech.com/role/CashAndCashEquivalentsTables",
     "longName": "9960719 - Disclosure - CASH AND CASH EQUIVALENTS (Tables)",
     "shortName": "CASH AND CASH EQUIVALENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://trinitybiotech.com/role/CapitalAndReservesTables",
     "longName": "9960720 - Disclosure - CAPITAL AND RESERVES (Tables)",
     "shortName": "CAPITAL AND RESERVES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://trinitybiotech.com/role/ShareOptionsTables",
     "longName": "9960721 - Disclosure - SHARE OPTIONS (Tables)",
     "shortName": "SHARE OPTIONS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://trinitybiotech.com/role/TradeAndOtherPayablesTables",
     "longName": "9960722 - Disclosure - TRADE AND OTHER PAYABLES (Tables)",
     "shortName": "TRADE AND OTHER PAYABLES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://trinitybiotech.com/role/ProvisionsTables",
     "longName": "9960723 - Disclosure - PROVISIONS (Tables)",
     "shortName": "PROVISIONS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfOtherProvisionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfOtherProvisionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables",
     "longName": "9960724 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Tables)",
     "shortName": "INTEREST-BEARING LOANS AND BORROWINGS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://trinitybiotech.com/role/LeaseLiabilitiesTables",
     "longName": "9960725 - Disclosure - LEASE LIABILITIES (Tables)",
     "shortName": "LEASE LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "66",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://trinitybiotech.com/role/RelatedPartyTransactionsTables",
     "longName": "9960726 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)",
     "shortName": "RELATED PARTY TRANSACTIONS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "67",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutCompensationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DisclosureOfDetailedInformationAboutCompensationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables",
     "longName": "9960727 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT  (Tables)",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT  (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "68",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTables",
     "longName": "9960728 - Disclosure - RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Tables)",
     "shortName": "RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "69",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables",
     "longName": "9960729 - Disclosure - BUSINESS COMBINATIONS (Tables)",
     "shortName": "BUSINESS COMBINATIONS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "70",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://trinitybiotech.com/role/GROUPUNDERTAKINGSTables",
     "longName": "9960730 - Disclosure - GROUP UNDERTAKINGS (Tables)",
     "shortName": "GROUP UNDERTAKINGS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "71",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfGroupUndertakingsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfGroupUndertakingsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
     "longName": "9960731 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "shortName": "BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ProfitLossAttributableToOwnersOfParent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CurrentAssetsLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory",
       "div",
       "trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails",
     "longName": "9960732 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Schedule of owned assets) (Details)",
     "shortName": "BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Schedule of owned assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember",
      "name": "ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory",
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "div",
       "trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember",
      "name": "ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory",
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "div",
       "trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails",
     "longName": "9960733 - Disclosure - BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Schedule of amortisation) (Details)",
     "shortName": "BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES (Schedule of amortisation) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCapitalisedDevelopmentExpenditureMember",
      "name": "ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
       "div",
       "trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember",
      "name": "ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory",
       "div",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
       "div",
       "trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://trinitybiotech.com/role/SEGMENTINFORMATIONNarrativeDetails",
     "longName": "9960734 - Disclosure - SEGMENT INFORMATION (Narrative) (Details)",
     "shortName": "SEGMENT INFORMATION (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:CapitalisedDevelopmentCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:CapitalisedDevelopmentCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails",
     "longName": "9960735 - Disclosure - SEGMENT INFORMATION (Schedule of Revenue by Geographical Area Based on Location of Assets) (Details)",
     "shortName": "SEGMENT INFORMATION (Schedule of Revenue by Geographical Area Based on Location of Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:OtherRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails",
     "longName": "9960736 - Disclosure - SEGMENT INFORMATION (Schedule of Revenue by Customers Geographical Area) (Details)",
     "shortName": "SEGMENT INFORMATION (Schedule of Revenue by Customers Geographical Area) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails",
     "longName": "9960737 - Disclosure - SEGMENT INFORMATION (Schedule of Revenue by Major Product Group) (Details)",
     "shortName": "SEGMENT INFORMATION (Schedule of Revenue by Major Product Group) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:Revenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullProductsAndServicesAxis_tribClinicalLaboratoryMember",
      "name": "ifrs-full:Revenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfProductsAndServicesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://trinitybiotech.com/role/SegmentInformationScheduleOfAmountRelatingFromRevenueDetails",
     "longName": "9960738 - Disclosure - SEGMENT INFORMATION (Schedule of Amount Relating From Revenue) (Details)",
     "shortName": "SEGMENT INFORMATION (Schedule of Amount Relating From Revenue) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R80": {
     "role": "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails",
     "longName": "9960739 - Disclosure - SEGMENT INFORMATION (Schedule of Revenue Derives From Transfer of Goods and Services) (Details)",
     "shortName": "SEGMENT INFORMATION (Schedule of Revenue Derives From Transfer of Goods and Services) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CurrentReceivablesFromContractsWithCustomers",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CurrentReceivablesFromContractsWithCustomers",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails",
     "longName": "9960740 - Disclosure - SEGMENT INFORMATION (Schedule of Segment Results by Geographical Area) (Details)",
     "shortName": "SEGMENT INFORMATION (Schedule of Segment Results by Geographical Area) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:ResultBeforeExceptionalExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:ResultBeforeExceptionalExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails",
     "longName": "9960741 - Disclosure - SEGMENT INFORMATION (Schedule of Segment Assets and Segment Liabilities by Geographical Area) (Details)",
     "shortName": "SEGMENT INFORMATION (Schedule of Segment Assets and Segment Liabilities by Geographical Area) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:SegmentAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:SegmentAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails",
     "longName": "9960742 - Disclosure - SEGMENT INFORMATION (Schedule of Long Lived Assets) (Details)",
     "shortName": "SEGMENT INFORMATION (Schedule of Long Lived Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:LongLivedAsstesBySegment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:LongLivedAsstesBySegment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails",
     "longName": "9960743 - Disclosure - SEGMENT INFORMATION (Schedule of Depreciation and Amortisation by Geographical Area) (Details)",
     "shortName": "SEGMENT INFORMATION (Schedule of Depreciation and Amortisation by Geographical Area) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DepreciationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DepreciationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails",
     "longName": "9960744 - Disclosure - SEGMENT INFORMATION (Schedule of Share Based Payment Expense by Geographical Area) (Details)",
     "shortName": "SEGMENT INFORMATION (Schedule of Share Based Payment Expense by Geographical Area) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:AdjustmentsForSharebasedPayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE",
      "name": "ifrs-full:AdjustmentsForSharebasedPayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:ScheduleOfShareBasedPaymentExpenseByGeographicalArea",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails",
     "longName": "9960745 - Disclosure - SEGMENT INFORMATION (Schedule of Taxation Expense by Geographical Area) (Details)",
     "shortName": "SEGMENT INFORMATION (Schedule of Taxation Expense by Geographical Area) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:IncomeTaxExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:IncomeTaxExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails",
     "longName": "9960746 - Disclosure - SEGMENT INFORMATION (Schedule of Capital Expenditure by Geographical Area) (Details)",
     "shortName": "SEGMENT INFORMATION (Schedule of Capital Expenditure by Geographical Area) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:PaymentsForDevelopmentProjectExpenditure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:PaymentsForDevelopmentProjectExpenditure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://trinitybiotech.com/role/EmploymentNarrativeDetails",
     "longName": "9960747 - Disclosure - EMPLOYMENT (Narrative) (Details)",
     "shortName": "EMPLOYMENT (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:AverageNumberOfEmployeesIncludingDiscontinuedOperations",
      "unitRef": "Employee",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:AverageNumberOfEmployeesIncludingDiscontinuedOperations",
      "unitRef": "Employee",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails",
     "longName": "9960748 - Disclosure - EMPLOYMENT (Schedule of Average Number of Persons Employed) (Details)",
     "shortName": "EMPLOYMENT (Schedule of Average Number of Persons Employed) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:AverageNumberOfEmployees",
      "unitRef": "Employee",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:AverageNumberOfEmployees",
      "unitRef": "Employee",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails",
     "longName": "9960749 - Disclosure - EMPLOYMENT (Schedule of Employment Costs) (Details)",
     "shortName": "EMPLOYMENT (Schedule of Employment Costs) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:WagesAndSalaries",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:WagesAndSalaries",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://trinitybiotech.com/role/OtherOperatingIncomeDetails",
     "longName": "9960750 - Disclosure - OTHER OPERATING (EXPENSE) / INCOME (Narrative) (Details)",
     "shortName": "OTHER OPERATING (EXPENSE) / INCOME (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "C_20241031_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribPaycheckProtectionProgramLoanMember",
      "name": "ifrs-full:LoansPayableInDefault",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241031_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribPaycheckProtectionProgramLoanMember",
      "name": "ifrs-full:LoansPayableInDefault",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails",
     "longName": "9960751 - Disclosure - OTHER OPERATING (EXPENSE) / INCOME (Schedule of Other Operating Income) (Details)",
     "shortName": "OTHER OPERATING (EXPENSE) / INCOME (Schedule of Other Operating Income) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:OtherIncome",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:OtherIncome",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails",
     "longName": "9960752 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Narrative) (Details)",
     "shortName": "IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:RestructuringActivitiesExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:RestructuringActivitiesExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R94": {
     "role": "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails",
     "longName": "9960753 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Schedule of Statement of Operation) (Details)",
     "shortName": "IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Schedule of Statement of Operation) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R95": {
     "role": "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear",
     "longName": "9960754 - Disclosure - IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Schedule of restructuring costs incurred during the year) (Details)",
     "shortName": "IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS (Schedule of restructuring costs incurred during the year) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ExpenseOfRestructuringActivities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribPersonnelRelatedCostsMember",
      "name": "ifrs-full:ExpenseOfRestructuringActivities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R96": {
     "role": "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails",
     "longName": "9960755 - Disclosure - FINANCIAL INCOME AND EXPENSES (Schedule of Financial Income (Expenses), Net) (Details)",
     "shortName": "FINANCIAL INCOME AND EXPENSES (Schedule of Financial Income (Expenses), Net) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:InterestIncomeOnOtherFinancialAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinanceIncomeExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:InterestIncomeOnOtherFinancialAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinanceIncomeExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails",
     "longName": "9960756 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Narrative) (Details)",
     "shortName": "INCOME TAX (EXPENSE)/CREDIT (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DeferredTaxExpenseIncome",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutChargeForTaxExplanatory",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE",
      "name": "ifrs-full:DeferredTaxExpenseIncome",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutChargeForTaxExplanatory",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R98": {
     "role": "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails",
     "longName": "9960757 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Charge for Tax) (Details)",
     "shortName": "INCOME TAX (EXPENSE)/CREDIT (Schedule of Charge for Tax) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutChargeForTaxExplanatory",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutChargeForTaxExplanatory",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfOverseasTaxJurisdictionsDetails",
     "longName": "9960758 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Overseas Tax Jurisdictions) (Details)",
     "shortName": "INCOME TAX (EXPENSE)/CREDIT (Schedule of Overseas Tax Jurisdictions) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ProfitLossBeforeTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:TaxRateEffectOfCurrentTaxOfPriorPeriods",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfStatutoryTaxRateDetails",
     "longName": "9960759 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Statutory Tax Rate) (Details)",
     "shortName": "INCOME TAX (EXPENSE)/CREDIT (Schedule of Statutory Tax Rate) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ApplicableTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:TaxRateEffectOfTaxLosses",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R101": {
     "role": "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails",
     "longName": "9960760 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Loss Profit Before Taxes) (Details)",
     "shortName": "INCOME TAX (EXPENSE)/CREDIT (Schedule of Loss Profit Before Taxes) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ProfitLossBeforeTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember",
      "name": "ifrs-full:ProfitLossBeforeTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R102": {
     "role": "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails",
     "longName": "9960761 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Net Operating Losses) (Details)",
     "shortName": "INCOME TAX (EXPENSE)/CREDIT (Schedule of Net Operating Losses) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:UnutilisedNetOperatingLosses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:UnutilisedNetOperatingLosses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R103": {
     "role": "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails",
     "longName": "9960762 - Disclosure - INCOME TAX (EXPENSE)/CREDIT (Schedule of Unrecognised Deferred Tax Assets) (Details)",
     "shortName": "INCOME TAX (EXPENSE)/CREDIT (Schedule of Unrecognised Deferred Tax Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R104": {
     "role": "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails",
     "longName": "9960763 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Narrative) (Details)",
     "shortName": "(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ProfitLossFromDiscontinuedOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230401to20230430_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember",
      "name": "trib:CashProceedsFromDiscontinuedOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R105": {
     "role": "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails",
     "longName": "9960764 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of operating profit for the discontinued operations) (Details)",
     "shortName": "(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of operating profit for the discontinued operations) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:Revenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember",
      "name": "ifrs-full:Revenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R106": {
     "role": "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1",
     "longName": "9960765 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of net cashflows generated from discontinued operations) (Details)",
     "shortName": "(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of net cashflows generated from discontinued operations) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember",
      "name": "trib:CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R107": {
     "role": "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
     "longName": "9960766 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of assets and liabilities disposed) (Detail)",
     "shortName": "(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of assets and liabilities disposed) (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfAssetsAndLiabilitiesDisposedExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R108": {
     "role": "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2",
     "longName": "9960767 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of Earnings Per ADS for Discontinued Operations) (Details)",
     "shortName": "(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of Earnings Per ADS for Discontinued Operations) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember",
      "name": "ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations",
      "unitRef": "USD_per_share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember",
      "name": "ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations",
      "unitRef": "USD_per_share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R109": {
     "role": "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3",
     "longName": "9960768 - Disclosure - (LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of Cash Flows Attributable to Discontinued Operations) (Details)",
     "shortName": "(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS (Schedule of Cash Flows Attributable to Discontinued Operations) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember",
      "name": "ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember",
      "name": "ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R110": {
     "role": "http://trinitybiotech.com/role/LossBeforeTaxNarrativeDetails",
     "longName": "9960769 - Disclosure - LOSS BEFORE TAX (Narrative) (Details)",
     "shortName": "LOSS BEFORE TAX (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DepreciationAndAmortisationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfLossProfitBeforeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DepreciationAndAmortisationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfLossProfitBeforeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R111": {
     "role": "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails",
     "longName": "9960770 - Disclosure - LOSS BEFORE TAX (Schedule of Amount Charged to Statement of Operation) (Details)",
     "shortName": "LOSS BEFORE TAX (Schedule of Amount Charged to Statement of Operation) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DirectorsRemunerationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfLossProfitBeforeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DirectorPensionExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfLossProfitBeforeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R112": {
     "role": "http://trinitybiotech.com/role/LossPerShareNarrativeDetails",
     "longName": "9960771 - Disclosure - LOSS PER SHARE  (Narrative) (Details)",
     "shortName": "LOSS PER SHARE  (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ProfitLossAttributableToOwnersOfParent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember",
      "name": "ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R113": {
     "role": "http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails",
     "longName": "9960772 - Disclosure - LOSS PER SHARE (Schedule of Basic Earnings Per Ordinary Share) (Details)",
     "shortName": "LOSS PER SHARE (Schedule of Basic Earnings Per Ordinary Share) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:WeightedAverageShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember",
      "name": "trib:NumberOfAOrdinaryWeightedAverageShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R114": {
     "role": "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerOrdinaryShareDetails",
     "longName": "9960773 - Disclosure - LOSS PER SHARE  (Schedule of Diluted Earnings Per Ordinary Share) (Details)",
     "shortName": "LOSS PER SHARE  (Schedule of Diluted Earnings Per Ordinary Share) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:IssuableOnExerciseOfOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R115": {
     "role": "http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails",
     "longName": "9960774 - Disclosure - LOSS PER SHARE  (Schedule of Earnings Per ADS) (Details)",
     "shortName": "LOSS PER SHARE  (Schedule of Earnings Per ADS) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "115",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:WeightedAverageShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember",
      "name": "trib:AmericanDepositoryShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R116": {
     "role": "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails",
     "longName": "9960775 - Disclosure - LOSS PER SHARE (Schedule of Diluted Earnings Per ADS Share Calculation) (Details)",
     "shortName": "LOSS PER SHARE (Schedule of Diluted Earnings Per ADS Share Calculation) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "116",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:IssuableOnExerciseOfOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember",
      "name": "trib:IssuableOnExerciseOfOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R117": {
     "role": "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails",
     "longName": "9960776 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Narrative) (Details)",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "117",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:AdditionsToRightofuseAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:AdditionsToRightofuseAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R118": {
     "role": "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails",
     "longName": "9960777 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Schedule of Composition of Property and Equipment Related to Accumulated Depreciation) (Details)",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Schedule of Composition of Property and Equipment Related to Accumulated Depreciation) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "118",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember",
      "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R119": {
     "role": "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails",
     "longName": "9960778 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Schedule of Additional Information on Right-of-use Assets) (Details)",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Schedule of Additional Information on Right-of-use Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "119",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:RightOfUseAssetsIncludingDepreciationAndImpairment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "trib:ScheduleOfAdditionalInformationOnRightOfUseAssets",
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:RightOfUseAssetsIncludingDepreciationAndImpairment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "trib:ScheduleOfAdditionalInformationOnRightOfUseAssets",
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R120": {
     "role": "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails",
     "longName": "9960779 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Schedule of Income from Sub-letting Right-of-use Buildings) (Details)",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Schedule of Income from Sub-letting Right-of-use Buildings) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "120",
     "firstAnchor": {
      "contextRef": "C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember",
      "name": "trib:NumberOfRightOfUseLeasedAssets",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:ScheduleOfIncomeFromSubLettingRightOfUseBuildings",
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember",
      "name": "trib:NumberOfRightOfUseLeasedAssets",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:ScheduleOfIncomeFromSubLettingRightOfUseBuildings",
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R121": {
     "role": "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
     "longName": "9960780 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Narrative) (Details)",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "121",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:PropertyDevelopmentAndProjectManagementExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:PropertyDevelopmentAndProjectManagementExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R122": {
     "role": "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails",
     "longName": "9960781 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Goodwill and Intangible Assets) (Details)",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Schedule of Goodwill and Intangible Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "122",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:IntangibleAssetsAndGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember",
      "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R123": {
     "role": "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails",
     "longName": "9960782 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Principal Development Projects) (Details)",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Schedule of Principal Development Projects) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "123",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:PrincipalDevelopmentProjectsCapitalizedCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:PrincipalDevelopmentProjectsCapitalizedCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R124": {
     "role": "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails",
     "longName": "9960783 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Impairment Loss) (Details)",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Schedule of Impairment Loss) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "124",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechDoBrasilMember",
      "name": "ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R125": {
     "role": "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfBreakdownOfImpairmentLossDetailsUsd",
     "longName": "9960784 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Breakdown of Impairment Loss) (Details) (USD $)",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Schedule of Breakdown of Impairment Loss) (Details) (USD $)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "125",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsMaterialToEntityExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsMaterialToEntityExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R126": {
     "role": "http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
     "longName": "9960785 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Specific asset impairment charges) (Details)",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Schedule of Specific asset impairment charges) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "126",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:IntangibleAssetsUnderDevelopment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribT10HplcAnalyzerMember",
      "name": "ifrs-full:IntangibleAssetsUnderDevelopment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R127": {
     "role": "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails",
     "longName": "9960786 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Significant Goodwill and Intangible Assets) (Details)",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Schedule of Significant Goodwill and Intangible Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "127",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:LongTermGrowthRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribWaveformTechnologiesIncMember",
      "name": "trib:CarryingAmountOfGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R128": {
     "role": "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails",
     "longName": "9960787 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedule of Intangible Assets with Indefinite Useful lives) (Details)",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Schedule of Intangible Assets with Indefinite Useful lives) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "128",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R129": {
     "role": "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails",
     "longName": "9960788 - Disclosure - FINANCIAL ASSETS (Narrative) (Details)",
     "shortName": "FINANCIAL ASSETS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "129",
     "firstAnchor": {
      "contextRef": "C_20230601to20230630",
      "name": "ifrs-full:ImpairmentLossOnFinancialAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:RemeasurementLossRecognizedInProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R130": {
     "role": "http://trinitybiotech.com/role/FINANCIALASSETSDetails",
     "longName": "9960789 - Disclosure - FINANCIAL ASSETS (Details)",
     "shortName": "FINANCIAL ASSETS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "130",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:FinancialAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutFinancialAssets",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:FinancialAssetsAdditions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutFinancialAssets",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R131": {
     "role": "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesNarrativeDetails",
     "longName": "9960790 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Narrative) (Details)",
     "shortName": "DEFERRED TAX ASSETS AND LIABILITIES (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "131",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DeferredTaxAssetIncreaseDueToIncreaseInProvision",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:DeferredTaxAssetIncreaseDueToIncreaseInProvision",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R132": {
     "role": "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails",
     "longName": "9960791 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Recognised Deferred Tax Assets and Liabilities) (Details)",
     "shortName": "DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Recognised Deferred Tax Assets and Liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "132",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:DeferredTaxAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember",
      "name": "ifrs-full:DeferredTaxAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R133": {
     "role": "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails",
     "longName": "9960792 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Unrecognised Deferred Tax Liabilities) (Details)",
     "shortName": "DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Unrecognised Deferred Tax Liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "133",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:DeferredTaxLiabilityAsset",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory",
       "div",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R134": {
     "role": "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails",
     "longName": "9960793 - Disclosure - DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Unrecognised Deferred Tax Assets) (Details)",
     "shortName": "DEFERRED TAX ASSETS AND LIABILITIES (Schedule of Unrecognised Deferred Tax Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "134",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:DeferredTaxAssetsCapitalLossCarryforward",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:DeferredTaxAssetsCapitalLossCarryforward",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R135": {
     "role": "http://trinitybiotech.com/role/OtherNon-currentAssetsDetails",
     "longName": "9960794 - Disclosure - OTHER NON-CURRENT ASSETS (Details)",
     "shortName": "OTHER NON-CURRENT ASSETS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "135",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:NoncurrentFinanceLeaseReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutOtherAssetsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfOtherAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:NoncurrentFinanceLeaseReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutOtherAssetsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfOtherAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R136": {
     "role": "http://trinitybiotech.com/role/InventoriesNarrativeDetails",
     "longName": "9960795 - Disclosure - INVENTORIES (Narrative) (Details)",
     "shortName": "INVENTORIES (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "136",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:InventoriesAtNetRealisableValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R137": {
     "role": "http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails",
     "longName": "9960796 - Disclosure - INVENTORIES (Schedule of inventories) (Details)",
     "shortName": "INVENTORIES (Schedule of inventories) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "137",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R138": {
     "role": "http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails",
     "longName": "9960797 - Disclosure - INVENTORIES (Schedule of Movement on the Inventory Provision) (Details)",
     "shortName": "INVENTORIES (Schedule of Movement on the Inventory Provision) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "138",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:OtherProvisions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOtherProvisionsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20211231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember",
      "name": "ifrs-full:OtherProvisions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R139": {
     "role": "http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails",
     "longName": "9960798 - Disclosure - TRADE AND OTHER RECEIVABLES (Narrative) (Details)",
     "shortName": "TRADE AND OTHER RECEIVABLES (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "139",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:TradeReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R140": {
     "role": "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails",
     "longName": "9960799 - Disclosure - TRADE AND OTHER RECEIVABLES (Schedule of Trade and Other Receivables) (Details)",
     "shortName": "TRADE AND OTHER RECEIVABLES (Schedule of Trade and Other Receivables) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "140",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CurrentTradeReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CurrentPrepayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R141": {
     "role": "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails",
     "longName": "9960800 - Disclosure - TRADE AND OTHER RECEIVABLES (Schedule of Future Minimum Finance Lease Receivables) (Details)",
     "shortName": "TRADE AND OTHER RECEIVABLES (Schedule of Future Minimum Finance Lease Receivables) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "141",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:GrossInvestmentInFinanceLease",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:GrossInvestmentInFinanceLease",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R142": {
     "role": "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails",
     "longName": "9960801 - Disclosure - TRADE AND OTHER RECEIVABLES (Schedule of Future Minimum Rentals Receivable Under Non-Cancellable Operating Leases) (Details)",
     "shortName": "TRADE AND OTHER RECEIVABLES (Schedule of Future Minimum Rentals Receivable Under Non-Cancellable Operating Leases) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "142",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R143": {
     "role": "http://trinitybiotech.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails",
     "longName": "9960802 - Disclosure - CASH AND CASH EQUIVALENTS (Schedule of Cash and Cash Equivalents) (Details)",
     "shortName": "CASH AND CASH EQUIVALENTS (Schedule of Cash and Cash Equivalents) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "143",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R144": {
     "role": "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
     "longName": "9960803 - Disclosure - CAPITAL AND RESERVES (Narrative) (Details)",
     "shortName": "CAPITAL AND RESERVES (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "144",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:ReserveOfCashFlowHedges",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:ReserveOfCashFlowHedges",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R145": {
     "role": "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails",
     "longName": "9960804 - Disclosure - CAPITAL AND RESERVES (Schedule of Share Capital) (Details)",
     "shortName": "CAPITAL AND RESERVES (Schedule of Share Capital) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "145",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:TreasuryShares",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember",
      "name": "trib:IssuedForNoncashConsideration",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R146": {
     "role": "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
     "longName": "9960805 - Disclosure - SHARE OPTIONS (Narrative) (Details)",
     "shortName": "SHARE OPTIONS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "146",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember",
      "name": "trib:OpeningSharePrice",
      "unitRef": "USD_per_share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R147": {
     "role": "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails",
     "longName": "9960806 - Disclosure - SHARE OPTIONS (Schedule of Grants of Share Options and Warrants) (Details)",
     "shortName": "SHARE OPTIONS (Schedule of Grants of Share Options and Warrants) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "147",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember",
      "name": "ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory",
       "div",
       "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R148": {
     "role": "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails",
     "longName": "9960807 - Disclosure - SHARE OPTIONS (Summary of Range of Prices of Stock Options) (Details)",
     "shortName": "SHARE OPTIONS (Summary of Range of Prices of Stock Options) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "148",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember",
      "name": "trib:NumberOfShareOptionsExercisableShareBasedPayment",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "div",
       "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R149": {
     "role": "http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails",
     "longName": "9960808 - Disclosure - SHARE OPTIONS (Schedule of Fair Value of the Options Vesting Period) (Details)",
     "shortName": "SHARE OPTIONS (Schedule of Fair Value of the Options Vesting Period) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "149",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:ShareBasedPaymentsCostOfSales",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "div",
       "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:ShareBasedPaymentsCostOfSales",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "div",
       "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R150": {
     "role": "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails",
     "longName": "9960809 - Disclosure - SHARE OPTIONS (Schedule of Assumption Determining Fair Value of Share Options) (Details)",
     "shortName": "SHARE OPTIONS (Schedule of Assumption Determining Fair Value of Share Options) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "150",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember",
      "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory",
       "div",
       "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember",
      "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory",
       "div",
       "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R151": {
     "role": "http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails",
     "longName": "9960810 - Disclosure - TRADE AND OTHER PAYABLES (Schedule of Trade and Other Payables) (Details)",
     "shortName": "TRADE AND OTHER PAYABLES (Schedule of Trade and Other Payables) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "151",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:TradeAndOtherCurrentPayables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R152": {
     "role": "http://trinitybiotech.com/role/ProvisionsNarrativeDetails",
     "longName": "9960811 - Disclosure - PROVISIONS (Narrative) (Details)",
     "shortName": "PROVISIONS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "152",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R153": {
     "role": "http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails",
     "longName": "9960812 - Disclosure - PROVISIONS (Schedule of Provisions) (Details)",
     "shortName": "PROVISIONS (Schedule of Provisions) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "153",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:WarrantyProvision",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOtherProvisionsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:WarrantyProvision",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOtherProvisionsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R154": {
     "role": "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
     "longName": "9960813 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Narrative) (Details)",
     "shortName": "INTEREST-BEARING LOANS AND BORROWINGS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "154",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ProceedsFromIssuingShares",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240331_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember",
      "name": "ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R155": {
     "role": "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
     "longName": "9960814 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of carrying value of interest-bearing loans, borrowings and related balances (Details)",
     "shortName": "INTEREST-BEARING LOANS AND BORROWINGS (Schedule of carrying value of interest-bearing loans, borrowings and related balances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "155",
     "firstAnchor": {
      "contextRef": "C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember",
      "name": "ifrs-full:Borrowings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember",
      "name": "ifrs-full:Borrowings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R156": {
     "role": "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1",
     "longName": "9960815 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the Exchangeable Notes balance) (Details)",
     "shortName": "INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the Exchangeable Notes balance) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "156",
     "firstAnchor": {
      "contextRef": "C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember",
      "name": "ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R157": {
     "role": "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan",
     "longName": "9960816 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in term loan) (Details)",
     "shortName": "INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in term loan) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "157",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:NoncashLoanModificationGain",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinanceIncomeExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember",
      "name": "trib:PrincipalAmountLoaned",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:ScheduleOfMovementInTermLoanExplanatoryTableTextBlock",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R158": {
     "role": "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4",
     "longName": "9960817 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the derivative financial asset) (Details)",
     "shortName": "INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the derivative financial asset) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "158",
     "firstAnchor": {
      "contextRef": "C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember",
      "name": "ifrs-full:Borrowings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember",
      "name": "ifrs-full:Borrowings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R159": {
     "role": "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3",
     "longName": "9960818 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the derivative financial liability) (Details)",
     "shortName": "INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the derivative financial liability) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "159",
     "firstAnchor": {
      "contextRef": "C_20231231_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember",
      "name": "ifrs-full:Borrowings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember",
      "name": "trib:DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R160": {
     "role": "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
     "longName": "9960819 - Disclosure - INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the Term Loan and the 7-year convertible notes) (Details)",
     "shortName": "INTEREST-BEARING LOANS AND BORROWINGS (Schedule of movement in the Term Loan and the 7-year convertible notes) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "160",
     "firstAnchor": {
      "contextRef": "C_20231231_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember",
      "name": "ifrs-full:Borrowings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R161": {
     "role": "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails",
     "longName": "9960820 - Disclosure - LEASE LIABILITIES (Narrative) (Details)",
     "shortName": "LEASE LIABILITIES (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "161",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:AmountPaidInRespectOfLeaseLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:AmountPaidInRespectOfLeaseLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R162": {
     "role": "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails",
     "longName": "9960821 - Disclosure - LEASE LIABILITIES (Schedule of Carrying Values of Finance Lease Liabilities) (Details)",
     "shortName": "LEASE LIABILITIES (Schedule of Carrying Values of Finance Lease Liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "162",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R163": {
     "role": "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails",
     "longName": "9960822 - Disclosure - LEASE LIABILITIES (Schedule of Finance Lease Liabilities Payable) (Details)",
     "shortName": "LEASE LIABILITIES (Schedule of Finance Lease Liabilities Payable) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "163",
     "firstAnchor": {
      "contextRef": "C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember",
      "name": "trib:MinimumFinanceLeasePaymentsPayable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember",
      "name": "trib:MinimumFinanceLeasePaymentsPayable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R164": {
     "role": "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
     "longName": "9960823 - Disclosure - COMMITMENTS AND CONTINGENCIES (Narrative) (Details)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "164",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CapitalCommitments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CapitalCommitments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R165": {
     "role": "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails",
     "longName": "9960824 - Disclosure - RELATED PARTY TRANSACTIONS (Narrative) (Details)",
     "shortName": "RELATED PARTY TRANSACTIONS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "165",
     "firstAnchor": {
      "contextRef": "C_20220701to20220701",
      "name": "trib:IncreaseInAnnualRent",
      "unitRef": "EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220701to20220701",
      "name": "trib:IncreaseInAnnualRent",
      "unitRef": "EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R166": {
     "role": "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails",
     "longName": "9960825 - Disclosure - RELATED PARTY TRANSACTIONS (Schedule of Compensation) (Details)",
     "shortName": "RELATED PARTY TRANSACTIONS (Schedule of Compensation) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "166",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutCompensationExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutCompensationExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R167": {
     "role": "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails",
     "longName": "9960826 - Disclosure - RELATED PARTY TRANSACTIONS (Schedule of Company's Shares and Share Option Plan) (Details)",
     "shortName": "RELATED PARTY TRANSACTIONS (Schedule of Company's Shares and Share Option Plan) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "167",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember",
      "name": "trib:NumberOfRetiredDirectorOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R168": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails",
     "longName": "9960827 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Narrative) (Details)",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "168",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:SeniorSecuredTermLoanFixedRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "trib:SeniorSecuredTermLoanFixedRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R169": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
     "longName": "9960828 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Fair Values of Financial Assets/Liabilities) (Details)",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Fair Values of Financial Assets/Liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "169",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:TradeReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember",
      "name": "ifrs-full:TradeReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R170": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
     "longName": "9960829 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Interest Rate Risk Effective and Repricing Analysis) (Details)",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Interest Rate Risk Effective and Repricing Analysis) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "170",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R171": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails",
     "longName": "9960830 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of  interest Rate Profile of Financial Assets/Liabilities) (Details)",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of  interest Rate Profile of Financial Assets/Liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "171",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "trib:VariableRateInstruments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R172": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails",
     "longName": "9960831 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Liquidity Risk Estimated Interest Payments of Maturities) (Details)",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Liquidity Risk Estimated Interest Payments of Maturities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "172",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember",
      "name": "ifrs-full:TradeAndOtherPayables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R173": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails",
     "longName": "9960832 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Foreign Currency Risk Short Term Financial Assets and Liabilities) (Details)",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Foreign Currency Risk Short Term Financial Assets and Liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "173",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_srtCurrencyAxis_currencyEUR",
      "name": "ifrs-full:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "trib:DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R174": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails",
     "longName": "9960833 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Sensitivity Analysis) (Details)",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Sensitivity Analysis) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "174",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullTypesOfRisksAxis_tribTenPercentStrengtheningUSDollarMember_srtCurrencyAxis_currencyEUR",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R175": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMaximumCreditExposureOfFinancialAssetsDetails",
     "longName": "9960834 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Maximum Credit Exposure of Financial Assets) (Details)",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Maximum Credit Exposure of Financial Assets) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "175",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CurrentTradeReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R176": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails",
     "longName": "9960835 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Exposure of Trade Receivables by Geographic Location) (Details)",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Exposure of Trade Receivables by Geographic Location) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "176",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_ifrsfullGeographicalAreasAxis_countryUS",
      "name": "ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R177": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails",
     "longName": "9960836 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Exposure of Trade Receivables by Customer) (Details)",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Exposure of Trade Receivables by Customer) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "177",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231_ifrsfullTypesOfCustomersAxis_tribEndUserCustomersMember",
      "name": "ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R178": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails",
     "longName": "9960837 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Ageing of Trade Receivables) (Details)",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Ageing of Trade Receivables) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "178",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:TradeReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:ExpectedCreditLossRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R179": {
     "role": "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMovementInAllowanceForImpairmentOfTradeReceivablesDetails",
     "longName": "9960838 - Disclosure - CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Movement in the Allowance for Impairment of Trade Receivables) (Details)",
     "shortName": "CAPITAL AND FINANCIAL RISK MANAGEMENT (Schedule of Movement in the Allowance for Impairment of Trade Receivables) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "179",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "trib:AllowanceForImpairmentOfReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231",
      "name": "trib:AllowanceForImpairmentOfReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R180": {
     "role": "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails",
     "longName": "9960839 - Disclosure - RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Schedule of Liabilities Arising from Financing) (Details)",
     "shortName": "RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Schedule of Liabilities Arising from Financing) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "180",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "trib:DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember",
      "name": "ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R181": {
     "role": "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
     "longName": "9960840 - Disclosure - BUSINESS COMBINATIONS (Narrative) (Details)",
     "shortName": "BUSINESS COMBINATIONS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "181",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240130to20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember",
      "name": "ifrs-full:DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R182": {
     "role": "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
     "longName": "9960841 - Disclosure - BUSINESS COMBINATIONS (Schedule of acquisition of the CGM assets of Waveform Technologies, Inc) (Details)",
     "shortName": "BUSINESS COMBINATIONS (Schedule of acquisition of the CGM assets of Waveform Technologies, Inc) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "182",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "trib:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember",
      "name": "ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
       "div",
       "div",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "unique": true
     }
    },
    "R183": {
     "role": "http://trinitybiotech.com/role/PostBalanceSheetEventsDetails",
     "longName": "9960842 - Disclosure - POST BALANCE SHEET EVENTS (Narrative) (Details)",
     "shortName": "POST BALANCE SHEET EVENTS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "183",
     "firstAnchor": {
      "contextRef": "C_20250228_ifrsfullBorrowingsByNameAxis_tribFourthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember",
      "name": "ifrs-full:NotionalAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory",
       "div",
       "trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R184": {
     "role": "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails",
     "longName": "9960843 - Disclosure - ACCOUNTING ESTIMATES AND JUDGEMENTS (Narrative) (Details)",
     "shortName": "ACCOUNTING ESTIMATES AND JUDGEMENTS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "184",
     "firstAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20241231",
      "name": "ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    },
    "R185": {
     "role": "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails",
     "longName": "9960844 - Disclosure - GROUP UNDERTAKINGS (Details)",
     "shortName": "GROUP UNDERTAKINGS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "185",
     "firstAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember",
      "name": "ifrs-full:NameOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfGroupUndertakingsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember",
      "name": "ifrs-full:NameOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "trib:DisclosureOfGroupUndertakingsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2533151.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "trib_AccountingEstimatesAndJudgementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AccountingEstimatesAndJudgementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Estimates And Judgements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AccretionInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AccretionInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion interest accrued.",
        "label": "Accretion Interest Accrued",
        "terseLabel": "Accretion interest accrued"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AccretionInterestAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AccretionInterestAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of accretion interest adjustment.",
        "label": "Accretion Interest Adjustment",
        "terseLabel": "Accretion interest adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AccretionInterestOnBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AccretionInterestOnBorrowings",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of accretion interest on borrowings.",
        "negatedTerseLabel": "Accretion interest",
        "label": "Accretion Interest On Borrowings",
        "terseLabel": "Accretion interest",
        "verboseLabel": "Accretion interest"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AccruedBonus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AccruedBonus",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Bonus.",
        "label": "Accrued Bonus"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AccruedLiabilitiesToContractedLicencePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AccruedLiabilitiesToContractedLicencePayments",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued liabilities to contracted licence payments.",
        "negatedLabel": "Licence payments",
        "negatedTerseLabel": "Fixed rate financial liabilities (licence fees)",
        "label": "Accrued Liabilities To Contracted Licence Payments",
        "terseLabel": "Accrued liabilities to contracted licence payments"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AccruedLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AccruedLiability",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued liability.",
        "label": "Accrued Liability"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AccumulatedDeficitInEquityAttributableToEquityHolders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AccumulatedDeficitInEquityAttributableToEquityHolders",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "accumulated deficit in equity attributable to equity holders.",
        "label": "Accumulated Deficit In Equity Attributable To Equity Holders",
        "verboseLabel": "Accumulated deficit in equity attributable to equity holders"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated depreciation and impairment losses [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r502",
      "r515",
      "r520",
      "r521"
     ]
    },
    "ifrs-full_AccumulatedImpairmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AccumulatedImpairmentMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated impairment Charge [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for accumulated impairment. [Refer: Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r241",
      "r263",
      "r360",
      "r502",
      "r515",
      "r520",
      "r521"
     ]
    },
    "trib_AcquisitionConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AcquisitionConsideration",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition Consideration",
        "label": "Acquisition Consideration"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails__1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration transferred, acquisition-date fair value",
        "terseLabel": "Consideration transferred",
        "totalLabel": "Total consideration"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r233"
     ]
    },
    "ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination",
        "terseLabel": "Acquisition-related costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r237"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions through business combinations, intangible assets other than goodwill",
        "terseLabel": "Intangible assets acquired through business combinations",
        "verboseLabel": "Additions through acquisition"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions through business combinations, other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in other provisions resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions through business combinations, property, plant and equipment",
        "verboseLabel": "Additions through acquisition"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "trib_ActuarialAssumptionOfDiscountRatePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ActuarialAssumptionOfDiscountRatePercentage",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Actuarial assumption of discount rate percentage.",
        "label": "Actuarial Assumption Of Discount Rate Percentage",
        "terseLabel": "Actuarial assumption of discount rate percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRates": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfDiscountRates",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variation in discount rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "trib_ActuarialAssumptionOfExpectedPensionIncreases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ActuarialAssumptionOfExpectedPensionIncreases",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of pension accrual.",
        "label": "Actuarial Assumption Of Expected Pension Increases",
        "verboseLabel": "Pension accrual"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "trib_AdditionalConsiderationContingentOnAchievementOfFutureMilestone": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdditionalConsiderationContingentOnAchievementOfFutureMilestone",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of additional consideration contingent on the achievement of future milestone.",
        "label": "Additional Consideration Contingent On Achievement Of Future Milestone",
        "terseLabel": "Additional consideration"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AdditionalImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdditionalImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additional impairment loss.",
        "label": "Additional impairment loss"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AdditionalImpairmentLossDueToGrowthInRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdditionalImpairmentLossDueToGrowthInRevenues",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional impairment loss due to growth in revenues.",
        "label": "Additional impairment loss due to growth in revenues"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AdditionalLiquidityRecognizedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdditionalLiquidityRecognizedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additional liquidity recognized as of acquisition date.",
        "label": "Additional Liquidity Recognized As Of Acquisition Date",
        "terseLabel": "Additional liquidity recognized"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AdditionalProjectCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdditionalProjectCost",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additional project cost.",
        "label": "Additional project cost"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionalProvisionsOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionalProvisionsOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Charged during the year"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additional other provisions made. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "trib_AdditionalRestructuringCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdditionalRestructuringCosts",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails",
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense relating to additional restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations.",
        "label": "Additional Restructuring Costs",
        "terseLabel": "Additional restructuring costs"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AdditionalSpaceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdditionalSpaceMember",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Space [Member]",
        "label": "Additional Space [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, intangible assets other than goodwill",
        "verboseLabel": "Additions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "trib_AdditionsRelatedToRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdditionsRelatedToRightOfUseAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additions related to right of use assets.",
        "label": "Additions (related to Right of Use assets)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdditionsToRightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions to right-of-use assets",
        "verboseLabel": "Additional right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r198"
     ]
    },
    "ifrs-full_AddressOfRegisteredOfficeOfEntity": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AddressOfRegisteredOfficeOfEntity",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address of entity's registered office"
       }
      },
      "en": {
       "role": {
        "documentation": "The address at which the entity's office is registered."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "trib_AdjustedProfitAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdjustedProfitAfterTax",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted profit after tax.",
        "label": "Adjusted Profit After Tax",
        "terseLabel": "Adjusted profit after tax"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AdjustedWeightedAverageSharesDiscontinuedOperations": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdjustedWeightedAverageSharesDiscontinuedOperations",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares.",
        "label": "Adjusted Weighted Average Shares Discontinued Operations",
        "verboseLabel": "Diluted earnings per share denominator"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AdjustmentForRestructuringProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdjustmentForRestructuringProvision",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 150.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of provision for restructuring.",
        "label": "Adjustment For Restructuring Provision",
        "verboseLabel": "Restructuring provision"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdjustmentOnTransitionToIfrs16PropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment on transition to IFRS 16 in property, plant and equipment.",
        "label": "Adjustment On Transition To Ifrs 16 Property Plant And Equipment",
        "terseLabel": "Adjustment on transition to IFRS 16"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdjustmentOnTransitionToIfrs16ToDepreciationAndImpairmentPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment on transition to IFRS 16",
        "negatedLabel": "Adjustment on transition to IFRS 16 to depreciation and impairment",
        "label": "Adjustment On Transition To Ifrs 16 To Depreciation And Impairment Property Plant And Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForAmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForAmortisationExpense",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortisation",
        "verboseLabel": "Amortisation"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]"
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForCurrentTaxOfPriorPeriod",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment in respect of prior years"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments of tax expense (income) recognised in the period for current tax of prior periods."
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase) / decrease in inventories",
        "terseLabel": "Increase in inventories",
        "verboseLabel": "(Increase) / decrease in inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Increase) / decrease in trade and other receivables",
        "verboseLabel": "(Increase)/decrease in trade and other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "ifrs-full_AdjustmentsForDepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForDepreciationExpense",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 160.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "ifrs-full_AdjustmentsForFinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForFinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial expense"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for finance costs to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance costs; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "ifrs-full_AdjustmentsForFinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForFinanceIncome",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": -1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financial income",
        "label": "Adjustments for finance income"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for finance income to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": -1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on disposal or retirement of property, plant and equipment",
        "label": "Adjustments for gain (loss) on disposals, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "trib_AdjustmentsForGainLossOnSaleOfBusiness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdjustmentsForGainLossOnSaleOfBusiness",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": -1.0,
       "order": 140.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents gain on sale of business.",
        "negatedLabel": "Gain on sale of business",
        "label": "Adjustments For Gain Loss On Sale Of Business",
        "terseLabel": "Gain on sale of business"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for gains (losses) on change in fair value of derivatives",
        "terseLabel": "Fair value adjustments in the period"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for gains (losses) on changes in the fair value of derivatives to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: At fair value [member]; Derivatives [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment through use or sale of the assets",
        "verboseLabel": "Impairment loss charge"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 110.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of property, plant and equipment",
        "terseLabel": "Impairment of property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for impairment loss (reversal of impairment loss) on property, plant and equipment recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of prepayments"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for impairment loss (reversal of impairment loss) on trade and other receivables recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Impairment loss; Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss; Impairment loss (reversal of impairment loss) recognised in profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "ifrs-full_AdjustmentsForIncomeTaxExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForIncomeTaxExpense",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for income tax expense",
        "terseLabel": "Income tax expense/(credit)",
        "verboseLabel": "Tax (expense)/credit"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "trib_AdjustmentsForIncomeTaxExpenseCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdjustmentsForIncomeTaxExpenseCredit",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the adjustments for income tax expense credit.",
        "label": "Adjustments For Income Tax Expense Credit",
        "terseLabel": "Income tax credit",
        "verboseLabel": "Tax expense"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase / (decrease) in trade and other payables",
        "verboseLabel": "Increase/(decrease) in trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "trib_AdjustmentsForInventoryWriteOff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdjustmentsForInventoryWriteOff",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": -1.0,
       "order": 90.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of adjustments for inventory write off.",
        "negatedLabel": "Inventory write off",
        "label": "Adjustments For Inventory Write Off"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForProvisions",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 80.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Movement in inventory provision"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to cash provided by operating activities:",
        "verboseLabel": "Adjustments to reconcile net profit/(loss) to cash provided by operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails": {
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0,
       "order": 20.0
      },
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 170.0
      },
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payments (net of capitalized amounts)",
        "terseLabel": "Share-based payments",
        "totalLabel": "Total share-based payments",
        "verboseLabel": "Total Share-based payments"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign exchange (gains)/losses on operating cash flows",
        "terseLabel": "Foreign exchange gains on operating cash flows"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r339",
      "r525"
     ]
    },
    "trib_AdministrationAndSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdministrationAndSalesMember",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Administration and sales [Member]",
        "label": "Administration and sales [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Administrative expenses",
        "label": "Administrative expenses",
        "terseLabel": "Administrative expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenses that the entity classifies as being administrative."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r92",
      "r302"
     ]
    },
    "trib_AdoptionOfIfrs16": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AdoptionOfIfrs16",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of adoption of IFRS 16.",
        "label": "Adoption Of Ifrs 16",
        "terseLabel": "Adoption of IFRS 16 (Note 13)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r394",
      "r405",
      "r415",
      "r448"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r397",
      "r408",
      "r418",
      "r451"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "trib_AgreementPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AgreementPayments",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents agreement.",
        "label": "Agreement Payments"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AgreementTerm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AgreementTerm",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement Term.",
        "label": "Agreement Term",
        "terseLabel": "Agreement Term"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "auth_ref": []
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r398",
      "r409",
      "r419",
      "r443",
      "r452",
      "r456",
      "r464"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "trib_AllowanceForImpairmentOfReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AllowanceForImpairmentOfReceivables",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMovementInAllowanceForImpairmentOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for impairment of receivables.",
        "periodEndLabel": "Balance at December 31",
        "periodStartLabel": "Balance at January 1",
        "label": "Allowance For Impairment Of Receivables",
        "terseLabel": "Allowance for impairment of receivables",
        "verboseLabel": "Trade receivables"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AmendedCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AmendedCreditAgreementMember",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stand for Amended Credit Agreement.",
        "label": "Amended Credit Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AmendmentAndRestatementOfTermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AmendmentAndRestatementOfTermLoanMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment and restatement of Term Loan.",
        "label": "Amendment And Restatement Of Term Loan [Member]",
        "terseLabel": "Amendment and Restatement of Term Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "trib_AmericaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AmericaMember",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Americas [Member]",
        "label": "America [Member]",
        "terseLabel": "Americas \u2013 unused tax losses [Member]",
        "verboseLabel": "Americas [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AmericanDepositaryShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AmericanDepositaryShareMember",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails",
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American depositary share [Member]",
        "label": "American depositary share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AmericanDepositaryShareTreasurySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AmericanDepositaryShareTreasurySharesMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ADS Treasury shares [Member]",
        "label": "American Depositary Share Treasury Shares Member",
        "terseLabel": "ADS Treasury shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AmericanDepositarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AmericanDepositarySharesMember",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "American Depositary Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AmericanDepositoryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AmericanDepositoryShares",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of American Depository Shares.",
        "measurementGuidance": "ADS",
        "periodEndLabel": "In issue at December 31",
        "periodStartLabel": "In issue at January 1",
        "label": "American Depository Shares",
        "terseLabel": "Ordinary shares",
        "totalLabel": "Total number of shares issued",
        "verboseLabel": "Number of American Depository Shares issued"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AmericanDepositorySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AmericanDepositorySharesIssued",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American depository shares issued share value.",
        "label": "American Depository Shares Issued",
        "terseLabel": "ADS issued"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AmortisationExpense",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortisation expense",
        "terseLabel": "Amortisation for discontinued operations",
        "verboseLabel": "Amortisation"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "trib_AmortisationForDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AmortisationForDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amortizations for discontinued operations.",
        "label": "Amortisation For Discontinued Operations",
        "terseLabel": "Amortisation for discontinued operations",
        "verboseLabel": "Amortisation"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AmortisationOnIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AmortisationOnIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortisation on intangible assets.",
        "label": "Amortisation On Intangible Assets",
        "verboseLabel": "Amortisation"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AmountAvailableForDevelopmentOfTheCGM": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AmountAvailableForDevelopmentOfTheCGM",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount available for development of the CGM.",
        "label": "Amount Available For Development Of The C G M",
        "terseLabel": "Amount available for development of the CGM"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AmountPaidInRespectOfLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AmountPaidInRespectOfLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amount paid in respect of lease liabilities.",
        "label": "Amount Paid In Respect Of Lease Liabilities",
        "terseLabel": "Total amount paid in respect of lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AmountUsedToAcquireTheCGMAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AmountUsedToAcquireTheCGMAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount used to acquire the CGM assets.",
        "label": "Amount Used To Acquire The C G M Assets",
        "terseLabel": "Amount used to acquire the CGM assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmountsPayableToTransfereeInRespectOfTransferredAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AmountsPayableToTransfereeInRespectOfTransferredAssets",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other amounts payable to transferee in respect of transferred assets",
        "terseLabel": "Amounts payable for financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts payable to the transferee in respect of transferred financial assets other than the undiscounted cash outflows that would or may be required to repurchase derecognised financial assets (for example, the strike price in an option agreement). [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "trib_AnnualRentPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AnnualRentPayable",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual rent payable.",
        "label": "Annual rent payable"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AnnualRentPayableForWareHouse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AnnualRentPayableForWareHouse",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual rent payable for ware house.",
        "label": "Annual rent payable for ware house"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ApplicableTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ApplicableTaxRate",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Irish corporation tax",
        "label": "Corporation tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "trib_AsiaOrAfricaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AsiaOrAfricaMember",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asia / Africa [Member]",
        "label": "Asia Or Africa Member",
        "terseLabel": "Asia / Africa [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Default Label]",
        "totalLabel": "TOTAL ASSETS"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r183",
      "r184",
      "r185",
      "r282",
      "r286"
     ]
    },
    "ifrs-full_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "terseLabel": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AssetsAndLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AssetsAndLiabilitiesAxis",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r297"
     ]
    },
    "trib_AssetsAndLiabilitiesBySegmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AssetsAndLiabilitiesBySegmentAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets And Liabilities By Segment Abstract",
        "terseLabel": "Assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and liabilities classified as held for sale [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AssetsAndLiabilitiesClassifiedAsHeldForSaleMember",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and liabilities classified as held for sale [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for assets and liabilities that are classified as held for sale. [Refer: Non-current assets held for sale [member]; Liabilities included in disposal groups classified as held for sale; Disposal groups classified as held for sale [member]]"
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "ifrs-full_AssetsAndLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AssetsAndLiabilitiesDomain",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for assets and liabilities. It also represents the standard value for the 'Assets and liabilities' axis if no other member is used. [Refer: Assets; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r297"
     ]
    },
    "ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and liabilities not classified as held for sale [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for assets and liabilities that are not classified as held for sale. It also represents the standard value for the 'Assets and liabilities classified as held for sale' axis if no other member is used. [Refer: Non-current assets held for sale [member]; Liabilities included in disposal groups classified as held for sale; Disposal groups classified as held for sale [member]]"
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "trib_AssetsUnderDevelopmentCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AssetsUnderDevelopmentCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets under development carrying value.",
        "label": "Assets Under Development Carrying Value",
        "terseLabel": "Assets under development carrying value"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails",
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear",
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Attribution of expenses by nature to their function [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r490"
     ]
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AttributionOfExpensesByNatureToTheirFunctionDomain",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails",
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear",
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Attribution of expenses by nature to their function [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value of the \u2018Attribution of expenses by nature to their function' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r490"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r377",
      "r378",
      "r401"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r377",
      "r378",
      "r401"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r377",
      "r378",
      "r401"
     ]
    },
    "ifrs-full_AuditorsRemunerationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AuditorsRemunerationAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor's remuneration"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AuditorsRemunerationForOtherServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AuditorsRemunerationForOtherServices",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other non-audit fees"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors for services that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "ifrs-full_AuditorsRemunerationForTaxServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AuditorsRemunerationForTaxServices",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit fees"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors for tax services."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "trib_AutoimmuneSmartReaderMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AutoimmuneSmartReaderMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Autoimmune Smart Reader [Member]",
        "label": "Autoimmune Smart Reader [Member]",
        "terseLabel": "Autoimmune smart reader [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AverageEffectiveTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AverageEffectiveTaxRate",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfOverseasTaxJurisdictionsDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total (current and deferred) %",
        "verboseLabel": "Effective tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "ifrs-full_AverageNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "AverageNumberOfEmployees",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average number of employees"
       }
      },
      "en": {
       "role": {
        "documentation": "The average number of personnel employed by the entity during a period."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "trib_AverageNumberOfEmployeesIncludingDiscontinuedOperations": {
     "xbrltype": "integerItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AverageNumberOfEmployeesIncludingDiscontinuedOperations",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the average number of employees, including discontinued operations.",
        "label": "Average Number Of Employees, Including Discontinued Operations",
        "terseLabel": "Average number of employees, including discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AverageRemainingLeaseTermYears": {
     "xbrltype": "durationItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AverageRemainingLeaseTermYears",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average remaining lease term in years.",
        "label": "Average remaining lease term (years)"
       }
      }
     },
     "auth_ref": []
    },
    "trib_AverageSharePriceShareOptionsExercised": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "AverageSharePriceShareOptionsExercised",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average share price, share options exercised.",
        "label": "Average Share Price Share Options Exercised",
        "terseLabel": "Average share price, share options exercised"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "currency_BRL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "BRL",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BRL [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BasicEarningsLossPerShare",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic loss per ADS (US Dollars) - group",
        "terseLabel": "Basic loss per ADS (US Dollars) \u2013 group"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102"
     ]
    },
    "ifrs-full_BasicEarningsLossPerShareFromContinuingOperations": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BasicEarningsLossPerShareFromContinuingOperations",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic loss per ADS (US Dollars) - continuing operations",
        "terseLabel": "Basic loss per ADS (US Dollars) \u2013 continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "Basic earnings (loss) per share from continuing operations. [Refer: Basic earnings (loss) per share; Continuing operations, unless line item indicates otherwise [member]]"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102"
     ]
    },
    "ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BasicEarningsLossPerShareFromDiscontinuedOperations",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings/(loss) per ADS (US Dollars) - discontinued operations",
        "terseLabel": "Basic (loss)/earnings per \u2018A\u2019 share (US Dollars) \u2013 discontinued operations"
       }
      },
      "en": {
       "role": {
        "documentation": "Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103"
     ]
    },
    "trib_BenenTradingLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "BenenTradingLimitedMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Benen Trading Limited.",
        "label": "Benen Trading Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_BiopoolUsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "BiopoolUsIncMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biopool US Inc [Member]",
        "label": "Biopool US Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_BiosynthMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "BiosynthMember",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Biosynth.",
        "label": "Biosynth [Member]",
        "verboseLabel": "Biosynth [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BorrowingCostsCapitalised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingCostsCapitalised",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowing costs capitalised",
        "terseLabel": "Capitalisation of borrowing costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest and other costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "ifrs-full_Borrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Borrowings",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodEndLabel": "Balance at end of the period",
        "negatedPeriodStartLabel": "Balance at January 1",
        "netLabel": "Unsecured junior convertible note",
        "periodEndLabel": "Balance at end of the period",
        "periodStartLabel": "Balance at beginning of the period",
        "positiveLabel": "Outstanding amount",
        "positiveTerseLabel": "Convertible note",
        "label": "Borrowings",
        "terseLabel": "Remaining amount of loan",
        "verboseLabel": "Principal amount"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of outstanding funds that the entity is obligated to repay."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsByNameAxis",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]",
        "verboseLabel": "Borrowings by name [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "ifrs-full_BorrowingsByNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsByNameDomain",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "ifrs-full_BorrowingsInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsInterestRate",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveLabel": "Annual rate of interest",
        "label": "Borrowings, interest rate",
        "terseLabel": "Interest rate of note",
        "verboseLabel": "Nominal interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "ifrs-full_BorrowingsInterestRateBasis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsInterestRateBasis",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings, interest rate basis",
        "terseLabel": "Loan, interest rate basis"
       }
      },
      "en": {
       "role": {
        "documentation": "The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "ifrs-full_BorrowingsMaturity": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsMaturity",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails",
      "http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings, maturity",
        "terseLabel": "Maturity of unsecured junior convertible note",
        "verboseLabel": "Loan maturity"
       }
      },
      "en": {
       "role": {
        "documentation": "The maturity of borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "ifrs-full_BorrowingsOriginalCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsOriginalCurrency",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency"
       }
      },
      "en": {
       "role": {
        "documentation": "The currency in which the borrowings are denominated. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BorrowingsRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings recognised as of acquisition date",
        "terseLabel": "Funding amount"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r529"
     ]
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails",
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bottom of range [Member]",
        "verboseLabel": "Minimum [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r187",
      "r209",
      "r225",
      "r343",
      "r345",
      "r531"
     ]
    },
    "ifrs-full_BrandNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BrandNamesMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primus trade name [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing rights to a group of complementary assets such as a trademark (or service mark) and its related trade name, formulas, recipes and technological expertise. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r325"
     ]
    },
    "ifrs-full_BuildingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BuildingsMember",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Buildings [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "ifrs-full_BusinessCombinationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BusinessCombinationsAxis",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combinations [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "ifrs-full_BusinessCombinationsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "BusinessCombinationsDomain",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combinations [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r243"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r378",
      "r401"
     ]
    },
    "currency_CAD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "CAD",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CAD [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CapitalCommitments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CapitalCommitments",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Commitments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of future capital expenditures that the entity is committed to make."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "ifrs-full_CapitalReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CapitalReserve",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital reserve"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the capital reserves."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "trib_CapitalisationOfUnpaidInterestOnTermLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CapitalisationOfUnpaidInterestOnTermLoan",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of capitalisation of unpaid interest on term loan.",
        "label": "Capitalisation Of Unpaid Interest On Term Loan",
        "terseLabel": "Capitalisation of unpaid interest on term loan"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CapitalisedDevelopmentCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CapitalisedDevelopmentCost",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/SEGMENTINFORMATIONNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of capitalized development cost",
        "label": "Capitalised Development Cost",
        "terseLabel": "Capitalised development costs"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CapitalisedDevelopmentExpenditureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CapitalisedDevelopmentExpenditureMember",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails",
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalised development expenditure [member]",
        "verboseLabel": "Capitalised development costs [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets arising from development expenditure capitalised before the start of commercial production or use. An intangible asset shall only be recognised if the entity can demonstrate all of the following: (a) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (b) its intention to complete the intangible asset and use or sell it; (c) its ability to use or sell the intangible asset; (d) how the intangible asset will generate probable future economic benefits. Among other things, the entity can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset; (e) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (f) its ability to measure reliably the expenditure attributable to the intangible asset during its development."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [Axis]",
        "verboseLabel": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r67",
      "r124",
      "r128",
      "r135",
      "r136",
      "r138",
      "r139",
      "r140",
      "r241",
      "r263",
      "r264"
     ]
    },
    "ifrs-full_CarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CarryingAmountMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying Amount [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r128",
      "r135",
      "r138",
      "r139",
      "r241",
      "r263",
      "r264"
     ]
    },
    "trib_CarryingAmountOfGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CarryingAmountOfGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of goodwill.",
        "label": "Carrying amount of goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails": {
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveLabel": "Cash at bank and in hand",
        "label": "Cash",
        "terseLabel": "Cash at bank and in hand",
        "verboseLabel": "Cash"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "trib_CashAcquiredAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CashAcquiredAsOfAcquisitionDate",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": 1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Total for all business combinations [member]]",
        "negatedLabel": "Cash acquired",
        "label": "Cash Acquired As Of Acquisition Date",
        "terseLabel": "Cash acquired",
        "verboseLabel": "Less: Cash and cash equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CashAndCashEquivalentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CashAndCashEquivalentMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalents [Member]",
        "label": "Cash And Cash Equivalent [Member]",
        "terseLabel": "Cash and cash equivalents [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 20.0
      },
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5": {
       "parentTag": "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0,
       "order": 30.0
      },
      "http://trinitybiotech.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMaximumCreditExposureOfFinancialAssetsDetails",
      "http://trinitybiotech.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveLabel": "Cash at bank and in hand",
        "positiveVerboseLabel": "Cash",
        "label": "Cash and cash equivalents",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents and short-term investments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r152",
      "r176"
     ]
    },
    "ifrs-full_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents [Abstract]",
        "verboseLabel": "Cash and cash equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CashAndCashEquivalentsAndShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CashAndCashEquivalentsAndShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, cash equivalents, and short term investments.",
        "periodEndLabel": "Cash and cash equivalents and short-term investments at end of year",
        "periodStartLabel": "Cash and cash equivalents and short-term investments at beginning of year",
        "label": "Cash And Cash Equivalents And Short Term Investments",
        "terseLabel": "Cash and cash equivalents (Note 19)",
        "totalLabel": "Total cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents and short-term investments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashAndCashEquivalentsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": "trib_NetCashOutFlowOnBusinessCombination",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Cash and cash equivalents",
        "label": "Cash and cash equivalents recognised as of acquisition date",
        "terseLabel": "Less: Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r529"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash generated by/(used in) financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r154"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities, discontinued operations",
        "verboseLabel": "Cash outflow from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) the entity's financing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) financing activities]"
       }
      }
     },
     "auth_ref": [
      "r252"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Net cash (used in)/generated by investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r154"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities, discontinued operations",
        "verboseLabel": "Cash inflow from investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) the entity's investing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) investing activities]"
       }
      }
     },
     "auth_ref": [
      "r252"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "totalLabel": "Net cash used in operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities, from continuing and discontinued operations. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r141",
      "r154"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities, discontinued operations",
        "verboseLabel": "Cash (outflow)/inflow from operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) the entity's operating activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) operating activities]"
       }
      }
     },
     "auth_ref": [
      "r252"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperations",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operations",
        "totalLabel": "Cash used in operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash from (used in) the entity's operations."
       }
      }
     },
     "auth_ref": [
      "r334",
      "r339"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operations before changes in working capital",
        "totalLabel": "Operating cash flows before changes in working capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow (outflow) from the entity's operations before changes in working capital."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r527"
     ]
    },
    "trib_CashInterestPayableOnPppLoans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CashInterestPayableOnPppLoans",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of cash interest payable on PPP loans.",
        "label": "Cash Interest Payable On Ppp Loans",
        "terseLabel": "Cash interest payable on PPP loans"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CashInterestPayableOnSeniorSecureTermLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CashInterestPayableOnSeniorSecureTermLoan",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of cash interest payable on senior secure term loan.",
        "label": "Cash Interest Payable On Senior Secure Term Loan",
        "terseLabel": "Cash interest payable on senior secured term loan"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CashPaidToEachHolder": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CashPaidToEachHolder",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid to each holder.",
        "label": "Cash Paid To Each Holder",
        "terseLabel": "Cash paid to each holder"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CashProceedsFromDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CashProceedsFromDiscontinuedOperations",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash proceeds from discontinued operations.",
        "label": "Cash Proceeds From Discontinued Operations",
        "verboseLabel": "Cash proceeds from discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1": {
       "parentTag": "ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Cash received from sale of the discontinued operations net of transaction costs.",
        "label": "Cash Received From Sale Of The Discontinued Operations Net Of Transaction Costs",
        "verboseLabel": "Cash received from sale of the discontinued operations net of transaction costs"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CashReceivedPerNominalValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CashReceivedPerNominalValue",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received per nominal value.",
        "label": "Cash Received Per Nominal Value",
        "terseLabel": "Cash received per nominal value"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CashSoldAsAPartOfDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CashSoldAsAPartOfDiscontinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1": {
       "parentTag": "ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash sold as a part of discontinued operations.",
        "negatedLabel": "Cash sold as a part of discontinued operations",
        "label": "Cash Sold As A Part Of Discontinued Operations",
        "verboseLabel": "Cash sold as a part of discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CashTransferred",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": "trib_NetCashOutFlowOnBusinessCombination",
       "weight": 1.0,
       "order": 0.0
      },
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails__1": {
       "parentTag": "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash transferred",
        "terseLabel": "Cash consideration"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "ifrs-full_CategoriesOfFinancialLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialLiabilitiesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesAxis",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]",
        "verboseLabel": "Categories of related parties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesDomain",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "trib_ChangeInAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ChangeInAllowance",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in allowance.",
        "label": "Change in allowance"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ifrs-full_ChangesInIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ChangesInIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in intangible assets other than goodwill",
        "verboseLabel": "Charge for the year"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash-flows:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ChangesInPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ChangesInPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfBreakdownOfImpairmentLossDetailsUsd"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment (see Note 13)",
        "verboseLabel": "Property, plant and equipment (see Note 11)"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ClarkLaboratoriesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ClarkLaboratoriesIncMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clark Laboratories Inc [Member]",
        "label": "Clark Laboratories Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ClassAOrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ClassAOrdinarySharesMember",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails",
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails",
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class A Ordinary shares [Member]",
        "label": "Class A Ordinary shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ClassATreasurySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ClassATreasurySharesMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class A Treasury shares [Member]",
        "label": "Class A Treasury shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfAssetsAxis",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]",
        "verboseLabel": "Classes of assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r111",
      "r186",
      "r200"
     ]
    },
    "ifrs-full_ClassesOfAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfAssetsDomain",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r186",
      "r200"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsAxis",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r272",
      "r273",
      "r295",
      "r296"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsDomain",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r215",
      "r272",
      "r273",
      "r295",
      "r296"
     ]
    },
    "ifrs-full_ClassesOfFinancialInstrumentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfFinancialInstrumentsAxis",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial instruments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r266",
      "r267",
      "r268"
     ]
    },
    "ifrs-full_ClassesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r263",
      "r266",
      "r267",
      "r268"
     ]
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfFinancialLiabilitiesAxis",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r273",
      "r295",
      "r296"
     ]
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfFinancialLiabilitiesDomain",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial liabilities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r272",
      "r273",
      "r295",
      "r296"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis",
     "presentation": [
      "http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets and goodwill [Axis]",
        "verboseLabel": "Classes of intangible assets and goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsAndGoodwillDomain",
     "presentation": [
      "http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [Axis]",
        "verboseLabel": "Classes of intangible assets other than goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ifrs-full_ClassesOfInventoriesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfInventoriesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of current inventories [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfLiabilitiesAxis",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "ifrs-full_ClassesOfLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfLiabilitiesDomain",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of liabilities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of liabilities' axis if no other member is used. [Refer: Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "ifrs-full_ClassesOfOtherProvisionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfOtherProvisionsDomain",
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails",
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of other provisions [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for provisions other than provisions for employee benefits. It also represents the standard value for the 'Classes of other provisions' axis if no other member is used. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [Axis]",
        "verboseLabel": "Classes of property, plant and equipment [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ifrs-full_ClassesOfProvisionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfProvisionsAxis",
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails",
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of other provisions [axis]",
        "verboseLabel": "Classes of other provisions [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalAxis",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails",
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails",
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalDomain",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails",
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails",
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "trib_ClinicalLaboratoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ClinicalLaboratoryMember",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical laboratory [Member]",
        "label": "Clinical Laboratory Member",
        "terseLabel": "Clinical laboratory goods [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ClosingExercisePriceOfOutstandingShareOptions": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ClosingExercisePriceOfOutstandingShareOptions",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "exercise price of outstanding share options",
        "label": "Closing Exercise Price Of Outstanding Share Options",
        "terseLabel": "Closing share price"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ClosureProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ClosureProvision",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closure provision.",
        "negatedLabel": "Closure provision",
        "label": "Closure provision",
        "terseLabel": "Closure costs",
        "verboseLabel": "Closure provision"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "trib_ColumnEnhancementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ColumnEnhancementMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Column Enhancement [Member]",
        "label": "Column Enhancement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [axis]",
        "verboseLabel": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ifrs-full_ComponentsOfEquityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComponentsOfEquityDomain",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total comprehensive loss",
        "terseLabel": "Total comprehensive loss",
        "totalLabel": "Total Comprehensive Loss (all attributable to owners of the parent)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r39"
     ]
    },
    "ifrs-full_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer equipment [Member]",
        "verboseLabel": "Computer &amp; Office Equipment [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "trib_ComputerEquipmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ComputerEquipmentsMember",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer equipment [member]",
        "label": "Computer Equipments [Member]",
        "terseLabel": "Computer equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ConsiderationFromEmployeeOptionsSettledInCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ConsiderationFromEmployeeOptionsSettledInCash",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consideration from employee options settled in cash.",
        "label": "Consideration from employee options settled in cash"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ConsiderationPaidReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ConsiderationPaidReceived",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration paid (received)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "trib_ConsolidatedStatementOfComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ConsolidatedStatementOfComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statement Of Comprehensive Income Abstract",
        "terseLabel": "Consolidated Statement Of Comprehensive Income"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ContingentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ContingentAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of contingent assets.",
        "label": "Contingent Assets",
        "verboseLabel": "Contingent assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount, at acquisition date, of fair value of contingent consideration arrangements classified as a current liability recognised as consideration transferred in a business combination.",
        "label": "Contingent Consideration Classified As A Current Liability Recognised As Of Acquisition Date",
        "terseLabel": "Contingent consideration classified as a current liability"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount, at acquisition date, of fair value of contingent consideration arrangements classified as Contingent liability recognised as consideration transferred in a business combination.",
        "label": "Contingent Consideration Classified As Contingent Liability Recognised As Of Acquisition Date",
        "terseLabel": "Contingent consideration classified as contingent liability"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ContingentConsiderationNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ContingentConsiderationNonCurrent",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents the amount of contingent consideration.",
        "label": "Contingent Consideration Non Current",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ContingentConsiderationRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails__1": {
       "parentTag": "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent consideration recognised as of acquisition date",
        "terseLabel": "Deferred contingent consideration",
        "verboseLabel": "Contingent consideration"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r234"
     ]
    },
    "ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ContingentLiabilitiesRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent liabilities recognised as of acquisition date",
        "terseLabel": "Contingent liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contingent liabilities recognised as of the acquisition date in a business combination. [Refer: Classes of contingent liabilities [domain]; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r353",
      "r355"
     ]
    },
    "trib_ContingentLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ContingentLiabilityMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Contingent liability.",
        "label": "Contingent Liability [Member]",
        "verboseLabel": "Contingent liability [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ContinuingAndDiscontinuedOperationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ContinuingAndDiscontinuedOperationsAxis",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails",
      "http://trinitybiotech.com/role/EmploymentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Continuing and discontinued operations [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "ifrs-full_ContinuingOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ContinuingOperationsMember",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails",
      "http://trinitybiotech.com/role/EmploymentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Continuing operations [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for components of the entity that are not discontinued operations. A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. This meaning may be overridden for line items which are either intrinsically related to discontinued operations (or disposal groups held for sale), or which are typically reported for the aggregate of continuing and discontinued. This member also represents the standard value for the 'Continuing and discontinued operations' axis if no other member is used. [Refer: Discontinued operations [member]; Aggregate continuing and discontinued operations [member]]"
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "trib_ContinuousGlucoseMonitoringTechnologyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ContinuousGlucoseMonitoringTechnologyMember",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stand for continuous glucose monitoring (CGM) technology.",
        "label": "Continuous Glucose Monitoring Technology [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ContinuousGlucoseMonitoringTestingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ContinuousGlucoseMonitoringTestingMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continuous glucose monitoring testing [Member]",
        "label": "Continuous Glucose Monitoring Testing [Member]",
        "verboseLabel": "Continuous glucose monitoring testing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ContractualCashFlowsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ContractualCashFlowsMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount [Member]",
        "label": "Contractual cash flows [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ContributionForTaxAuditSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ContributionForTaxAuditSettlement",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contribution for tax audit settlement.",
        "label": "Contribution for tax audit settlement"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ConvertibleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ConvertibleNote",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amout represents convertiable note.",
        "negatedLabel": "Convertible note",
        "negatedTerseLabel": "Fixed rate financial liabilities (convertible note)",
        "label": "Convertible Note",
        "terseLabel": "Convertible Note"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ConvertibleNoteInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ConvertibleNoteInvestment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of convertible note investment.",
        "label": "Convertible Note Investment"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ConvertibleNoteMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Note.",
        "label": "Convertible Note [Member]",
        "verboseLabel": "Convertible note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents and licences [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing copyrights, patents and other industrial property rights, service and operating rights. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "trib_CostIncurredIssueOfShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CostIncurredIssueOfShares",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost incurred issue of shares.",
        "label": "Cost incurred issue of shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CostOfInventoriesRecognisedAsExpenseDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of inventories recognised as expense during period",
        "verboseLabel": "Cost of sales"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of inventories recognised as an expense during the period. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ifrs-full_CostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of sales",
        "label": "Cost of sales [Default Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r49"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "trib_CovidTestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CovidTestMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID test [Member]",
        "label": "COVID Test [Member]",
        "terseLabel": "COVID-19 tests [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CraigHallumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CraigHallumMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Craig Hallum [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CreditAgreementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CreditAgreementAxis",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table.",
        "label": "Credit Agreement [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CreditAgreementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CreditAgreementDomain",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement [Domain]",
        "label": "Credit Agreement [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Axis [Axis]",
        "verboseLabel": "Currency [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accruals and other liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets [Default Label]",
        "totalLabel": "Total current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r168",
      "r341"
     ]
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentAssetsAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAssetsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentAssetsLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets (liabilities)",
        "terseLabel": "Net current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current assets less the amount of current liabilities."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ifrs-full_CurrentContractAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentContractAssets",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current contract assets. [Refer: Contract assets]"
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "ifrs-full_CurrentDeferredIncomeOtherThanCurrentContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentDeferredIncomeOtherThanCurrentContractLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current deferred income other than current contract liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current deferred income other than current contract liabilities. [Refer: Deferred income other than contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r492",
      "r495"
     ]
    },
    "trib_CurrentFinanceLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CurrentFinanceLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 0.0
      },
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current finance lease liabilities as of balance sheet date.",
        "label": "Current Finance Lease Liabilities",
        "totalLabel": "Current liabilities",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentInvestments",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current investments",
        "verboseLabel": "Strategic investment and partnership with MiCo"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current investments."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "trib_CurrentLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CurrentLeaseLiabilitiesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r170",
      "r341"
     ]
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentLiabilitiesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities [abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CurrentLiabilitiesMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent information about the current liabilities member.",
        "label": "Current Liabilities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Not past due [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a current time band."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r367"
     ]
    },
    "ifrs-full_CurrentPrepayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentPrepayments",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current prepayments. [Refer: Prepayments]"
       }
      }
     },
     "auth_ref": [
      "r306"
     ]
    },
    "ifrs-full_CurrentProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentProvisions",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current provisions",
        "terseLabel": "Provisions",
        "verboseLabel": "Provision"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "ifrs-full_CurrentRawMaterialsAndCurrentProductionSupplies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentRawMaterialsAndCurrentProductionSupplies",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails": {
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Raw materials and consumables"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of current raw materials and current production supplies. [Refer: Current production supplies; Current raw materials]"
       }
      }
     },
     "auth_ref": [
      "r509"
     ]
    },
    "ifrs-full_CurrentReceivablesFromContractsWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentReceivablesFromContractsWithCustomers",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At a point in time"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current receivables from contracts with customers. [Refer: Receivables from contracts with customers]"
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "ifrs-full_CurrentReceivablesFromRentalOfProperties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentReceivablesFromRentalOfProperties",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance lease receivables",
        "terseLabel": "Finance lease receivable"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current receivables from rental of properties. [Refer: Receivables from rental of properties]"
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "ifrs-full_CurrentTaxAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentTaxAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax receivable"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of current tax assets. [Refer: Current tax assets]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncome",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Irish Corporation tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      }
     },
     "auth_ref": [
      "r311"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total current tax credit",
        "terseLabel": "Total current tax expense/(credit)",
        "totalLabel": "Total current tax credit"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current tax expense (income) and adjustments for the current tax of prior periods. [Refer: Current tax expense (income); Adjustments for current tax of prior periods]"
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current tax (credit)/ expense"
       }
      }
     },
     "auth_ref": []
    },
    "trib_CurrentTaxForeignExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CurrentTaxForeignExpenseIncome",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Foreign taxes.",
        "label": "Current Tax Foreign Expense Income",
        "terseLabel": "Foreign taxes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentTaxLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentTaxLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 10.0
      },
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5": {
       "parentTag": "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": -1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Current corporation tax",
        "label": "Current tax liabilities, current",
        "terseLabel": "Income tax payable"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of current tax liabilities. [Refer: Current tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "ifrs-full_CurrentTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentTradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMaximumCreditExposureOfFinancialAssetsDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivables, net of impairment losses",
        "verboseLabel": "Third party trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r304",
      "r306"
     ]
    },
    "ifrs-full_CurrentValueAddedTaxPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentValueAddedTaxPayables",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payroll taxes"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current value added tax payables. [Refer: Value added tax payables]"
       }
      }
     },
     "auth_ref": [
      "r495"
     ]
    },
    "ifrs-full_CurrentValueAddedTaxReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "CurrentValueAddedTaxReceivables",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value added tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current value added tax receivables. [Refer: Value added tax receivables]"
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "trib_CustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "CustomerMember",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer [Member]",
        "label": "Customer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r386",
      "r475"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r386",
      "r475"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r388",
      "r477"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r388",
      "r477"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r390",
      "r479"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r388",
      "r477"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r381",
      "r470"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r382",
      "r471"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r382",
      "r471"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r380",
      "r469"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r380",
      "r469"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r380",
      "r469"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r383",
      "r472"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r385",
      "r474"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r385",
      "r474"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r386",
      "r475"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r389",
      "r478"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r387",
      "r476"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r384",
      "r473"
     ]
    },
    "trib_DarnickCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DarnickCompanyMember",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Darnick Company [Member]",
        "label": "Darnick Company [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DecreaseThroughImpairmentContractAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DecreaseThroughImpairmentContractAssets",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfBreakdownOfImpairmentLossDetailsUsd"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease through impairment, contract assets",
        "verboseLabel": "Total impairment loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in contract assets resulting from impairment. [Refer: Contract assets; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "ifrs-full_DecreaseThroughWriteoffFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DecreaseThroughWriteoffFinancialAssets",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMovementInAllowanceForImpairmentOfTradeReceivablesDetails",
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amounts written off during the year",
        "label": "Decrease through write-off, financial assets",
        "terseLabel": "Unpaid investment amount written off"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in financial assets resulting from write-off. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r357",
      "r359",
      "r366"
     ]
    },
    "trib_DeferredConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeferredConsideration",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred consideration.",
        "label": "Deferred Consideration",
        "terseLabel": "Deferred Consideration (Phoenix Bio-tech)"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DeferredConsiderationPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeferredConsiderationPayable",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred consideration payable.",
        "label": "Deferred Consideration Payable",
        "terseLabel": "Net Deferred Consideration Payable ('Fiomi')"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredIncomeIncludingContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredIncomeIncludingContractLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred tax liabilities recognised as of acquisition date",
        "label": "Deferred income including contract liabilities",
        "terseLabel": "Deferred tax liabilities",
        "totalLabel": "Total deferred income including contract liabilities",
        "verboseLabel": "Deferred income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities representing income that has been received (or the amount is due) but is not yet earned, including contract liabilities. [Refer: Contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r492",
      "r495"
     ]
    },
    "trib_DeferredTaxAssetDecreaseDueToDecreaseInProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeferredTaxAssetDecreaseDueToDecreaseInProvision",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax asset decrease due to decrease in provision.",
        "label": "Deferred tax asset decrease due to decrease in provision"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DeferredTaxAssetIncreaseDueToIncreaseInProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeferredTaxAssetIncreaseDueToIncreaseInProvision",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of increase in deferred tax asset due to increase in provision.",
        "label": "Deferred Tax Asset Increase Due To Increase In Provision",
        "terseLabel": "Deferred tax asset increase due to increase in provision"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r19",
      "r22",
      "r54"
     ]
    },
    "ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxAssetsAndLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets and liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DeferredTaxAssetsCapitalLossCarryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeferredTaxAssetsCapitalLossCarryforward",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails": {
       "parentTag": "trib_DeferredTaxAssetsOperatingLossCarryforward",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforward.",
        "label": "Deferred Tax Assets Capital Loss Carryforward",
        "terseLabel": "Capital losses"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DeferredTaxAssetsOperatingLossCarryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeferredTaxAssetsOperatingLossCarryforward",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforward.",
        "label": "Deferred Tax Assets Operating Loss Carryforward",
        "totalLabel": "Unrecognised deferred tax assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DeferredTaxAssetsOperatingLossCarryforwardsState": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsState",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails": {
       "parentTag": "trib_DeferredTaxAssetsOperatingLossCarryforward",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state operating loss carryforwards.",
        "label": "Deferred Tax Assets Operating Loss Carryforwards State",
        "terseLabel": "US state credit carryforwards"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DeferredTaxAssetsOperatingLossDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeferredTaxAssetsOperatingLossDomestic",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails": {
       "parentTag": "trib_DeferredTaxAssetsOperatingLossCarryforward",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards.",
        "label": "Deferred Tax Assets Operating Loss Domestic",
        "terseLabel": "Net operating losses"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DeferredTaxAssetsOtherTemporaryTimingDifferences": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeferredTaxAssetsOtherTemporaryTimingDifferences",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails": {
       "parentTag": "trib_DeferredTaxAssetsOperatingLossCarryforward",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other temporary timing differences.",
        "label": "Deferred Tax Assets Other Temporary Timing Differences",
        "terseLabel": "Other temporary timing differences"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DeferredTaxAssetsUsAlternativeMinimumTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeferredTaxAssetsUsAlternativeMinimumTaxCredits",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails": {
       "parentTag": "trib_DeferredTaxAssetsOperatingLossCarryforward",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US alternative minimum tax credits.",
        "label": "Deferred Tax Assets Us Alternative Minimum Tax Credits",
        "terseLabel": "US alternative minimum tax credits"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncome",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total deferred tax (credit)/expense",
        "verboseLabel": "Total deferred tax charge/(credit)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ifrs-full_DeferredTaxExpenseIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncomeAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax credit"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in discontinued operations.",
        "label": "Deferred Tax Expense (Income) Recognised Discontinued Operations",
        "verboseLabel": "Recognised in discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in net operating losses",
        "verboseLabel": "Recognised in income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Origination and reversal of temporary differences (see Note 15)",
        "verboseLabel": "Origination and reversal of temporary differences (see Note 14)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax expense or income relating to the creation or reversal of temporary differences. [Refer: Temporary differences [member]; Deferred tax expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r313"
     ]
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 20.0
      },
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5": {
       "parentTag": "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred tax liabilities",
        "negatedTerseLabel": "Deferred tax liability",
        "label": "Deferred tax liabilities",
        "verboseLabel": "Deferred tax liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r19",
      "r22",
      "r54"
     ]
    },
    "ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": -1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred tax liabilities recognised as of acquisition date",
        "label": "Deferred tax liabilities recognised as of acquisition date",
        "terseLabel": "Deferred tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for deferred tax liabilities assumed in a business combination. [Refer: Deferred tax liabilities; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r529"
     ]
    },
    "ifrs-full_DeferredTaxLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year",
        "label": "Net deferred tax assets/(liabilities)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "trib_DeferredTaxLiabilityDecreased": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeferredTaxLiabilityDecreased",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liability decreased.",
        "label": "Deferred tax liability decreased"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DeferredTaxLiabilityIncreased": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeferredTaxLiabilityIncreased",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of increase in deferred tax liability.",
        "label": "Deferred Tax Liability Increased",
        "terseLabel": "Deferred tax liability increased"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DefinedBenefitPlansAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DefinedBenefitPlansAxis",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined benefit plans [Axis]",
        "verboseLabel": "Defined benefit plans [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ifrs-full_DefinedBenefitPlansDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DefinedBenefitPlansDomain",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "trib_DeprecationForDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DeprecationForDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the deprecation for discontinued operations.",
        "label": "Deprecation For Discontinued Operations",
        "terseLabel": "Deprecation for discontinued operations",
        "verboseLabel": "Depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationAndAmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DepreciationAndAmortisationExpense",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation on capitalised Intangible projects"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r49",
      "r177",
      "r280",
      "r288",
      "r301"
     ]
    },
    "ifrs-full_DepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DepreciationExpense",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation expense",
        "terseLabel": "Deprecation for discontinued operations",
        "verboseLabel": "Depreciation"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "trib_DepreciationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DepreciationMember",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation [Member]",
        "label": "Depreciation Member",
        "terseLabel": "Depreciation Charge [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DepreciationOnIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DepreciationOnIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation on intangible assets.",
        "label": "Depreciation On Intangible Assets",
        "verboseLabel": "Depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DepreciationRightofuseAssets",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation charged on assets under operating lease"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "trib_DerivativeFinancialAssetAtDateOfDrawdown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DerivativeFinancialAssetAtDateOfDrawdown",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative financial liability at date of drawdown.",
        "label": "Derivative Financial Asset At Date Of Drawdown",
        "terseLabel": "Derivative financial asset at date of drawdown"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DerivativeFinancialAssetAtDateOfIssue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DerivativeFinancialAssetAtDateOfIssue",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan",
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "disclosureGuidance": "Derivative financial asset at date of drawdown",
        "documentation": "Derivative financial asset at date of issue.",
        "label": "Derivative Financial Asset At Date Of Issue",
        "terseLabel": "Derivative financial asset at date of issue",
        "verboseLabel": "Derivative financial asset at date of issue"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DerivativeFinancialAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DerivativeFinancialAssetMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent information about the derivative financial asset member.",
        "label": "Derivative Financial Asset [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DerivativeFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DerivativeFinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ifrs-full_DerivativeFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DerivativeFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "trib_DerivativeFinancialLiabilityAtDateOfIssue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DerivativeFinancialLiabilityAtDateOfIssue",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of derivative financial liability at date of issue.",
        "label": "Derivative Financial Liability At Date Of Issue",
        "terseLabel": "Derivative financial liability at date of issue",
        "verboseLabel": "Derivative financial liability at date of drawdown"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of derivative financial liability at date of issue of term loan.",
        "label": "Derivative Financial Liability At Date Of Issue Of Term Loan",
        "terseLabel": "Derivative financial liability at date of drawdown"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DerivativeFinancialLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DerivativeFinancialLiabilityMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent information about the derivative financial liability member.",
        "label": "Derivative Financial Liability [Member]",
        "verboseLabel": "Derivative financial liability [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForBorrowingsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for borrowings [text block]",
        "terseLabel": "Convertible Note"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for business combinations and goodwill [text block]",
        "verboseLabel": "Business combinations &amp; goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for business combinations and goodwill. [Refer: Total for all business combinations [member]; Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of consolidation"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for business combinations. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchangeable notes and derivative financial instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for derivative financial instruments and hedging. [Refer: Classes of financial instruments [domain]; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss from discontinued operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for discontinued operations. [Refer: Discontinued operations [member]]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "trib_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for expected credit losses.",
        "label": "Description Of Accounting Policy For Expected Credit Losses Explanatory",
        "terseLabel": "Expected credit losses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair values"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinanceCostsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinanceCostsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of sales"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for finance costs. [Refer: Finance costs]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance income and costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for finance income and costs. [Refer: Finance income (cost)]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign currency"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for foreign currency translation."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "trib_DescriptionOfAccountingPolicyForGeneralInformationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DescriptionOfAccountingPolicyForGeneralInformationExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for general information.",
        "label": "Description Of Accounting Policy For General Information Explanatory",
        "terseLabel": "General information"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForGovernmentGrants",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Government grants and financial support"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForHedgingExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForHedgingExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hedging"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for hedging."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for the impairment of assets."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangibles, including research and development (other than goodwill)"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIssuedCapitalExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Equity at end of period",
        "periodStartLabel": "Equity at beginning of period",
        "label": "Description of accounting policy for issued capital [text block]",
        "verboseLabel": "Equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for issued capital. [Refer: Issued capital]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for measuring inventories [text block]",
        "verboseLabel": "Inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "trib_DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for new standards and interpretations not yet adopted.",
        "label": "Description Of Accounting Policy For New Standards And Interpretations Not Yet Adopted Explanatory",
        "terseLabel": "New IFRS Standards",
        "verboseLabel": "New IFRS Standards adopted as of January 1, 2023"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for Other Operating Income.",
        "label": "Description Of Accounting Policy For Other Operating Income Explanatory",
        "terseLabel": "Other Operating Income",
        "verboseLabel": "Other operating income"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for property, plant and equipment [text block]",
        "verboseLabel": "Property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for provisions [text block]",
        "terseLabel": "Provisions and contingent liabilities",
        "verboseLabel": "Provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for provisions. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue recognition"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment reporting"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "trib_DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for senior secured term loan.",
        "label": "Description Of Accounting Policy For Senior Secured Term Loan Explanatory",
        "terseLabel": "Senior secured term loan"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payments"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Types of share-based payment arrangements [domain]]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "trib_DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DescriptionOfAccountingPolicyForShortTermInvestmentsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for short-term investments.",
        "label": "Description Of Accounting Policy For Short Term Investments Explanatory",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for statements of compliance.",
        "label": "Description Of Accounting Policy For Statement Of Compliance Explanatory",
        "terseLabel": "Statement of compliance"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax (current and deferred)"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for taxes other than income tax. [Refer: Tax expense other than income tax expense]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for trade and other payables [text block]",
        "verboseLabel": "Trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for trade and other payables. [Refer: Trade and other payables]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for trade and other receivables [text block]",
        "verboseLabel": "Trade and other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTreasurySharesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description Of Accounting Policy For Treasury Shares Explanatory",
        "terseLabel": "Treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for treasury shares. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "trib_DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for warrants and loan prepayment option.",
        "label": "Description Of Accounting Policy For Warrants And Loan Prepayment Option Explanatory",
        "terseLabel": "Warrants and loan prepayment option"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]",
        "terseLabel": "Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of arrangement for contingent consideration arrangements and indemnification assets",
        "terseLabel": "Description of arrangement for contingent consideration"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the contingent consideration arrangements and the arrangements for indemnification assets."
       }
      }
     },
     "auth_ref": [
      "r235"
     ]
    },
    "trib_DescriptionOfBorrowingsPaid": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DescriptionOfBorrowingsPaid",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent information about the description of borrowings paid.",
        "label": "Description Of Borrowings Paid",
        "terseLabel": "Description of borrowings paid"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfConversionOfDebtToEquity": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfConversionOfDebtToEquity",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of conversion of debt to equity",
        "verboseLabel": "Description of conversion"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the non-cash conversion of debt to equity."
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "trib_DescriptionOfCumulativeRevenuesPayable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DescriptionOfCumulativeRevenuesPayable",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of cumulative revenues payable.",
        "label": "Description Of Cumulative Revenues Payable",
        "terseLabel": "Description of cumulative revenues payable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfDiscountRatesAppliedToCashFlowProjections",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flow projections"
       }
      },
      "en": {
       "role": {
        "documentation": "The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Total for all cash-generating units [member]]"
       }
      }
     },
     "auth_ref": [
      "r114",
      "r116"
     ]
    },
    "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of expected impact of initial application of new standards or interpretations [text block]",
        "terseLabel": "Standards, amendments and interpretations to existing IFRS Standards that are not yet effective"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average expected volatility"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfOptionLifeShareOptionsGranted",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average expected life"
       }
      },
      "en": {
       "role": {
        "documentation": "The option life of share options granted."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average risk free interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "trib_DescriptionOfShareAdjustedRatio": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DescriptionOfShareAdjustedRatio",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the description of share-adjusted ratio.",
        "label": "Description Of Share Adjusted Ratio",
        "terseLabel": "Description of share-adjusted ratio"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of useful life, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "Description of useful life used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfUsefulLifePropertyPlantAndEquipment",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails",
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of useful life, property, plant and equipment",
        "verboseLabel": "Estimated useful lives of intangible assets (In years)"
       }
      },
      "en": {
       "role": {
        "documentation": "Description of useful life used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "ifrs-full_DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DescriptionOfWhetherInvestmentInAssociateIsMeasuredUsingEquityMethodOrAtFairValue",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of whether investment in associate is measured using equity method or at fair value",
        "terseLabel": "Description of whether investment in associate is measured using equity method or at fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of whether the investment in an associate is measured using the equity method or at fair value. [Refer: At fair value [member]; Total for all associates [member]]"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "trib_DevelopmentCostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DevelopmentCostMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development cost [Member]",
        "label": "Development cost [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DilutedEarningsLossPerShare",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted loss per ADS (US Dollars) - group",
        "terseLabel": "Diluted loss per ADS (US Dollars) \u2013 group"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102"
     ]
    },
    "ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DilutedEarningsLossPerShareFromContinuingOperations",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted loss per ADS (US Dollars) - continuing operations",
        "terseLabel": "Diluted loss per ADS (US Dollars) \u2013 continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "Diluted earnings (loss) per share from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Diluted earnings (loss) per share]"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102"
     ]
    },
    "ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DilutedEarningsLossPerShareFromDiscontinuedOperations",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted earnings/(loss per ADS (US Dollars) - discontinued operations",
        "terseLabel": "Diluted earnings/(loss) per ADS (US Dollars) - discontinued operations",
        "verboseLabel": "Diluted (loss)/earnings per \u2018A\u2019 share (US Dollars) \u2013 discontinued operations"
       }
      },
      "en": {
       "role": {
        "documentation": "Diluted earnings (loss) per share from discontinued operations. [Refer: Diluted earnings (loss) per share; Discontinued operations [member]]"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103"
     ]
    },
    "trib_DirectorPensionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DirectorPensionExpense",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of director pension expense.",
        "label": "Director Pension Expense",
        "terseLabel": "Pension"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DirectorsAndCompanySecretaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DirectorsAndCompanySecretaryMember",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors' and Company Secretary's [Member]",
        "label": "Directors And Company Secretary [Member]",
        "terseLabel": "Directors and company secretary [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DirectorsEmolumentsIncludingNonExecutiveDirectorsAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Directors Emoluments Including Non Executive Directors Abstract",
        "terseLabel": "Directors' emoluments (including non- executive directors):"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DirectorsMember",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Director [Member]",
        "label": "Directors [Member]",
        "terseLabel": "Director [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DirectorsRemunerationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DirectorsRemunerationExpense",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remuneration",
        "verboseLabel": "Non executive directors fees"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of remuneration paid or payable to the entity's directors."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "trib_DisclosureOfAccountingEstimatesAndJudgementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfAccountingEstimatesAndJudgementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of accounting estimates and judgements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTING ESTIMATES AND JUDGEMENTS"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Persons Employed by the Group in the Financial Year"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of additional information about defined benefit plans necessary to meet the objectives of IAS 19. [Refer: Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "ifrs-full_DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of preparation",
        "verboseLabel": "Basis of preparation and going concern"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of additional information that may be relevant to users of financial statements in understanding the financial position and liquidity of an entity."
       }
      }
     },
     "auth_ref": [
      "r338"
     ]
    },
    "ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfAnalysisOfDiscontinuedOperationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfAnalysisOfDiscontinuedOperationsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.",
        "label": "Disclosure Of Analysis Of Discontinued Operations [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfAnalysisOfDiscontinuedOperationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfAnalysisOfDiscontinuedOperationsTable",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to the analysis of discontinued operations.",
        "label": "Disclosure Of Analysis Of Discontinued Operations [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails",
      "http://trinitybiotech.com/role/EmploymentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of analysis of single amount of discontinued operations [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails",
      "http://trinitybiotech.com/role/EmploymentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of analysis of single amount of discontinued operations [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the analysis of the single amount of discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r251"
     ]
    },
    "trib_DisclosureOfAssetsAndLiabilitiesDisposedExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfAssetsAndLiabilitiesDisposedExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for assets and liabilities disposed.",
        "label": "Disclosure Of Assets And Liabilities Disposed Explanatory",
        "verboseLabel": "Schedule of Assets and Liabilities Disposed"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/ImpairmentChargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of attribution of expenses by nature to their function [text block]",
        "terseLabel": "Schedule of Restructuring Costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of attribution of expenses by nature to line items by function in the statement of profit or loss."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r490"
     ]
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails",
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of attribution of expenses by nature to their function [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails",
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of attribution of expenses by nature to their function [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to attribution of expenses by nature to analysis of expenses by function in the statement of profit or loss."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r490"
     ]
    },
    "trib_DisclosureOfAuthorisationForIssueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfAuthorisationForIssueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of authorisation for issue [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfAuthorisationForIssueExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfAuthorisationForIssueExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/AuthorisationForIssue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for authorisation for issue.",
        "label": "Disclosure Of Authorisation For Issue Explanatory",
        "terseLabel": "AUTHORISATION FOR ISSUE"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of basis of preparation and significant accounting policies [Abstract]",
        "verboseLabel": "Basis Of Preparation And Significant Accounting Policies"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for basis of preparation and significant accounting policies.",
        "label": "Disclosure Of Basis Of Preparation And Significant Accounting Policies Explanatory",
        "terseLabel": "BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfBorrowingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfBorrowingsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of borrowings [text block]",
        "terseLabel": "INTEREST-BEARING LOANS AND BORROWINGS"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "ifrs-full_DisclosureOfBusinessCombinationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of business combinations [text block]",
        "terseLabel": "BUSINESS COMBINATIONS"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for business combinations."
       }
      }
     },
     "auth_ref": [
      "r244"
     ]
    },
    "ifrs-full_DisclosureOfBusinessCombinationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfBusinessCombinationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsTable",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of business combinations."
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CashAndCashEquivalents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of cash and cash equivalents [text block]",
        "verboseLabel": "CASH AND CASH EQUIVALENTS"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "ifrs-full_DisclosureOfCashFlowStatementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfCashFlowStatementExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for a statement of cash flows."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfChangesInAccountingEstimatesLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of changes in accounting estimates [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfChangesInAccountingEstimatesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfChangesInAccountingEstimatesTable",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of changes in accounting estimates [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the changes in accounting estimates."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of classes of share capital. [Refer: Classes of share capital [domain]]"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalTable",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails2",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to classes of share capital."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Classes of contingent liabilities [domain]]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "trib_DisclosureOfCommitmentsAndContingentLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfCommitmentsAndContingentLiabilityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Commitments And Contingent Liability Abstract",
        "terseLabel": "Disclosure of commitments and contingencies [Abstract]",
        "verboseLabel": "Commitments And Contingencies"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfCompositionOfGroupLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfCompositionOfGroupLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of composition of group.",
        "label": "Disclosure Of Composition Of Group [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfCompositionOfGroupTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfCompositionOfGroupTable",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of composition of group.",
        "label": "Disclosure Of Composition Of Group [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCreditRiskExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfCreditRiskExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Maximum Credit Exposure of Financial Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of credit risk. [Refer: Credit risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r276",
      "r486"
     ]
    },
    "ifrs-full_DisclosureOfCreditRiskExposureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfCreditRiskExposureLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of credit risk exposure [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCreditRiskExposureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfCreditRiskExposureTable",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of credit risk exposure [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the credit risk exposure."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "trib_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Deferred Tax Assets And Liabilities [Abstract]",
        "terseLabel": "Disclosure of deferred tax assets and liabilities [Abstract]",
        "verboseLabel": "Deferred Tax Assets And Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDeferredTaxesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDeferredTaxesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DEFERRED TAX ASSETS AND LIABILITIES"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Employment Costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of defined benefit plans. [Refer: Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansTable",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to defined benefit plans."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "trib_DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about Ageing of trade receivables.",
        "label": "Disclosure Of Detailed Information About Ageing Of Trade Receivables Explanatory",
        "terseLabel": "Schedule of Ageing of Trade Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about amount relating from revenue.",
        "label": "Disclosure Of Detailed Information About Amount Relating From Revenue Explanatory",
        "terseLabel": "Schedule of Amount Relating From Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about basic earning per ADS.",
        "label": "Disclosure Of Detailed Information About Basic Earning Per Ads Explanatory",
        "terseLabel": "Schedule of Basic Earning Per ADS"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about basic earning per shares.",
        "label": "Disclosure Of Detailed Information About Basic Earnings Per Ordinary Share Explanatory",
        "terseLabel": "Schedule of Basic Earnings Per Ordinary Share"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [text block]",
        "terseLabel": "Schedule of Borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [text block]",
        "terseLabel": "Schedule of Assets Acquired and Liabilities, Fair Values at Acquisition Date"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about business combinations. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r245"
     ]
    },
    "trib_DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about capital expanditure by geographical area.",
        "label": "Disclosure Of Detailed Information About Capital Expenditure Explanatory",
        "terseLabel": "Schedule of Capital Expenditure by Geographical Area"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about carrying values of finance lease liabilities.",
        "label": "Disclosure Of Detailed Information About Carrying Values Of Finance Lease Liabilities Explanatory",
        "terseLabel": "Schedule of Carrying Values of Finance Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CashAndCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about cash and cash equivalents.",
        "label": "Disclosure Of Detailed Information About Cash And Cash Equivalents Explanatory",
        "terseLabel": "Schedule of Cash and Cash Equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about cash flows attributable to discontinued operations.",
        "label": "Disclosure Of Detailed Information About Cash Flows Attributable To Discontinued Operations Explanatory",
        "terseLabel": "Schedule of Cash Flows Attributable to Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutChargeForTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutChargeForTaxExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about charges for tax.",
        "label": "Disclosure Of Detailed Information About Charge For Tax Explanatory",
        "terseLabel": "Schedule of Charge for Tax"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutCompensationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutCompensationExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about compensation.",
        "label": "Disclosure Of Detailed Information About Compensation Explanatory",
        "terseLabel": "Schedule of Compensation"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about deferred tax assets and liabilities.",
        "label": "Disclosure Of Detailed Information About Deferred Tax Assets And Liabilities Explanatory",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about deferred tax assets not recognised.",
        "label": "Disclosure Of Detailed Information About Deferred Tax Assets Not Recognised Explanatory",
        "terseLabel": "Schedule of Deferred Tax Assets Not Recognised"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about depreciation and amortisation by geographical area.",
        "label": "Disclosure Of Detailed Information About Depreciation And Amortisation Explanatory",
        "terseLabel": "Schedule of Depreciation and Amortisation by Geographical Area"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about diluted earning per ADS.",
        "label": "Disclosure Of Detailed Information About Diluted Earning Per Ads Explanatory",
        "terseLabel": "Schedule of Diluted Earning Per ADS"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about diluted earning per shares.",
        "label": "Disclosure Of Detailed Information About Diluted Earnings Per Ordinary Share Explanatory",
        "terseLabel": "Schedule of Diluted Earnings Per Ordinary Share"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about earning per ADS for discontinued operations.",
        "label": "Disclosure Of Detailed Information About Earnings Per Ads For Discontinued Operations Explanatory",
        "terseLabel": "Schedule of Earnings Per ADS for Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about estimated useful lives of intangible assets.",
        "label": "Disclosure Of Detailed Information About Estimated Useful Lives Of Intangible Assets Explanatory",
        "terseLabel": "Schedule of Estimated Useful Lives of Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about estimated useful lives of owned assets.",
        "label": "Disclosure Of Detailed Information About Estimated Useful Lives Of Owned Assets Explanatory",
        "terseLabel": "Schedule of Estimated Useful Lives of Owned Assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about exposure of trade receivables by customer.",
        "label": "Disclosure Of Detailed Information About Exposure Of Trade Receivables By Customer Explanatory",
        "terseLabel": "Schedule of Exposure of Trade Receivables by Customer"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about exposure of trade receivables by geographic location.",
        "label": "Disclosure Of Detailed Information About Exposure Of Trade Receivables By Geographic Location Explanatory",
        "terseLabel": "Schedule of Exposure of Trade Receivables by Geographic Location"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about finance lease liabilities payable.",
        "label": "Disclosure Of Detailed Information About Finance Lease Liabilities Payable Explanatory",
        "terseLabel": "Schedule of Finance Lease Liabilities Payable"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutFinancialAssets": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutFinancialAssets",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about financial assets.",
        "label": "Disclosure Of Detailed Information About Financial Assets",
        "verboseLabel": "Schedule of Financial Assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about financial income and expenses.",
        "label": "Disclosure Of Detailed Information About Financial Income And Expenses Explanatory",
        "terseLabel": "Schedule of Financial Income and Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about foreign currency risk short term financial assets and liabilities.",
        "label": "Disclosure Of Detailed Information About Foreign Currency Risk Short Term Financial Assets And Liabilities Explanatory",
        "terseLabel": "Schedule of Foreign Currency Risk Short Term Financial Assets and Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/ImpairmentChargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about impairment charges and inventory provisioning.",
        "label": "Disclosure Of Detailed Information About Impairment Charges And Inventory Provisioning Explanatory",
        "terseLabel": "Schedule of Impairment Charges and Inventory Provisioning"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about impairment loss recorded on discontinued assets.",
        "label": "Disclosure Of Detailed Information About Impairment Loss Recorded On Discontinued Assets Explanatory",
        "terseLabel": "Schedule of Impairment Loss Recorded on Discontinued Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Principal Development Projects"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "trib_DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutInterestIncomeAndInterestExpenseExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about interest income and interest expense by geographical area.",
        "label": "Disclosure Of Detailed Information About Interest Income And Interest Expense Explanatory",
        "terseLabel": "Schedule of Interest Income and Interest Expense by Geographical Area"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about interest rate profile of financial assets/liabilities.",
        "label": "Disclosure Of Detailed Information About Interest Rate Profile Of Financial Assets Liabilities Explanatory",
        "verboseLabel": "Schedule of Interest Rate Profile of Financial Assets/Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutInterestRatesUsedForDeterminingFairValueExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about interest rates used for determining fair value.",
        "label": "Disclosure Of Detailed Information About Interest Rates Used For Determining Fair Value Explanatory",
        "terseLabel": "Schedule of Interest Rates Used for Determining Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about internal and external fectors based on historical experience.",
        "label": "Disclosure Of Detailed Information About Internal And External Factors Explanatory",
        "terseLabel": "Schedule of Internal and External Factors Based on Historical Experience"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutInventoriesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutInventoriesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about inventory.",
        "label": "Disclosure Of Detailed Information About Inventories Explanatory",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about liquidity risk estimated interest payments of maturities.",
        "label": "Disclosure Of Detailed Information About Liquidity Risk Estimated Interest Payments Of Maturities Explanatory",
        "terseLabel": "Schedule of Liquidity Risk Estimated Interest Payments of Maturities"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about long lived assets by geographical area.",
        "label": "Disclosure Of Detailed Information About Long Lived Assets Explanatory",
        "verboseLabel": "Schedule of Long-Lived Assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about loss profit before tax.",
        "label": "Disclosure Of Detailed Information About Loss Profit Before Tax Explanatory",
        "terseLabel": "Schedule of Loss Before Tax"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about loss profit before tax.",
        "label": "Disclosure Of Detailed Information About Loss Profit Before Taxes Explanatory",
        "terseLabel": "Schedule of (Loss)/Profit Before Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about movement in the allowance for impairment of trade receivables.",
        "label": "Disclosure Of Detailed Information About Movement In Allowance For Impairment Of Trade Receivables Explanatory",
        "terseLabel": "Schedule of Movement in Allowance for Impairment of Trade Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about movement in derivative financial asset explanatory.",
        "label": "Disclosure Of Detailed Information About Movement In Derivative Financial Asset Explanatory",
        "terseLabel": "Schedule of Derivative Financial Asset"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about movement in derivative financial liability explanatory.",
        "label": "Disclosure Of Detailed Information About Movement In Derivative Financial Liability Explanatory",
        "terseLabel": "Schedule of Derivative Financial Liability"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about movement in exchangeable notes balance explanatory.",
        "label": "Disclosure Of Detailed Information About Movement In Exchangeable Notes Balance Explanatory",
        "terseLabel": "Schedule of Exchangeable Notes Balance"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about movement in term loan and the 7-year convertible notes explanatory.",
        "label": "Disclosure Of Detailed Information About Movement In Term Loan And The 7-Year Convertible Notes Explanatory",
        "terseLabel": "Schedule of Term Loan And The 7-Year Convertible Notes",
        "verboseLabel": "Schedule of Term Loan And The 7-Year Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about movement on inventory provision.",
        "label": "Disclosure Of Detailed Information About Movement On Inventory Provision Explanatory",
        "terseLabel": "Schedule of Movement on Inventory Provision"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutOtherAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutOtherAssetsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/OtherNon-currentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about other assets.",
        "label": "Disclosure Of Detailed Information About Other Assets Explanatory",
        "terseLabel": "Schedule of Other Non-Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutOutstandingInterestBearingLoansAndBorrowingsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about outstanding interest bearing loans and borrowings.",
        "label": "Disclosure Of Detailed Information About Outstanding Interest Bearing Loans And Borrowings Explanatory",
        "terseLabel": "Schedule of Outstanding Interest Bearing Loans and Borrowings"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about overseas tax jurisdictions.",
        "label": "Disclosure Of Detailed Information About Overseas Tax Jurisdictions Explanatory",
        "terseLabel": "Schedule of Overseas Tax Jurisdictions"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutProfitAfterTaxExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about profit after tax.",
        "label": "Disclosure Of Detailed Information About Profit After Tax Explanatory",
        "terseLabel": "Schedule of Profit After Tax Diluted Earnings Per Ordinary Share Calculation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property, Plant and Equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "trib_DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutReconciliationOfOperatingLeaseCommitmentsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about reconciliation of operating lease commitments.",
        "label": "Disclosure Of Detailed Information About Reconciliation Of Operating Lease Commitments Explanatory",
        "verboseLabel": "Schedule of Reconciliation of Operating Lease Commitments"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about revenues derives from goods and services.",
        "label": "Disclosure Of Detailed Information About Revenue Derives From Transfer Of Goods And Services Explanatory",
        "terseLabel": "Schedule of Revenue Derives From Transfer of Goods and Services"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about segment assets and segment liabilities by geographical area.",
        "label": "Disclosure Of Detailed Information About Segment Assets And Segment Liabilities By Geographical Area Explanatory",
        "terseLabel": "Schedule of Segment Assets and Segment Liabilities by Geographical Area"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about share option and warrants.",
        "label": "Disclosure Of Detailed Information About Share Options And Warrants Explanatory",
        "terseLabel": "Schedule of Grants of Share Options and Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about shares and share option plan.",
        "label": "Disclosure Of Detailed Information About Shares And Share Option Plan Explanatory",
        "terseLabel": "Schedule of Company's Shares and Share Option Plan"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about specific asset impairment charges.",
        "label": "Disclosure Of Detailed Information About Specific Asset Impairment Charges Explanatory [Table Text Block]",
        "terseLabel": "Schedule of Specific Asset Impairment Charges"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about statutory tax rate.",
        "label": "Disclosure Of Detailed Information About Statutory Tax Rate Explanatory",
        "terseLabel": "Schedule of Statutory Tax Rate"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about tax expense by geographical area.",
        "label": "Disclosure Of Detailed Information About Taxation Expense Explanatory",
        "terseLabel": "Schedule of Taxation Expense by Geographical Area"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherPayablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about trade and other payables.",
        "label": "Disclosure Of Detailed Information About Trade And Other Payables Explanatory",
        "terseLabel": "Schedule of Trade and Other Payables"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about trade and other receivables.",
        "label": "Disclosure Of Detailed Information About Trade And Other Receivables Explanatory",
        "terseLabel": "Schedule of Trade and Other Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxAssetsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about unrecognised deferred tax assets.",
        "label": "Disclosure Of Detailed Information About Unrecognised Deferred Tax Assets Explanatory",
        "verboseLabel": "Schedule of Unrecognised Deferred Tax Assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about unrecognised tax liabilities.",
        "label": "Disclosure Of Detailed Information About Unrecognised Deferred Tax Liabilities Explanatory",
        "terseLabel": "Schedule of Unrecognised Deferred Tax Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about unused tax losses and unused tax credits.",
        "label": "Disclosure Of Detailed Information About Unused Tax Losses And Unused Tax Credits Explanatory",
        "terseLabel": "Schedule of Unused Tax Losses and Unused Tax Credits"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutUnutilisedNetOperatingLossesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about unutilised net operating losses.",
        "label": "Disclosure Of Detailed Information About Unutilised Net Operating Losses Explanatory",
        "terseLabel": "Schedule of Unutilised Net Operating Losses"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutWeightedAverageInterestRateAndWeightedAveragePeriodExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about weighted average interest rate and weighted average period.",
        "label": "Disclosure Of Detailed Information About Weighted Average Interest Rate And Weighted Average Period Explanatory",
        "terseLabel": "Schedule of Weighted Average Interest Rate and Weighted Average Period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfDiscontinuedOperationsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATION",
        "terseLabel": "(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of discontinued operations. [Refer: Discontinued operations [member]]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LOSS PER SHARE",
        "terseLabel": "LOSS PER SHARE"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENT INFORMATION"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Values of Financial Assets/Liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value measurement of assets."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsTable",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the fair value measurement of assets."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of liabilities [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesTable",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of liabilities [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the fair value measurement of liabilities."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "ifrs-full_DisclosureOfFinanceIncomeExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinanceIncomeExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCIAL INCOME AND EXPENSES"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of finance income. [Refer: Finance income]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "trib_DisclosureOfFinanceLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfFinanceLeaseLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of finance lease liabilities [Abstract]",
        "terseLabel": "Lease Liabilities Schedule Of Carrying Values Of Finance Lease Liabilities",
        "verboseLabel": "Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [text block]",
        "verboseLabel": "FINANCIAL ASSETS"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "ifrs-full_DisclosureOfFinancialAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsTable",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial assets."
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [abstract]",
        "terseLabel": "Disclosure of detailed information about financial instruments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments [text block]",
        "verboseLabel": "CAPITAL AND FINANCIAL RISK MANAGEMENT"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsTable",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r266",
      "r274"
     ]
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial liabilities [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesTable",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial liabilities [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial liabilities."
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "trib_DisclosureOfFinancingIncomeExpensesNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfFinancingIncomeExpensesNetAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Financing Income Expenses Net [Abstract]",
        "terseLabel": "Financial Income And Expenses Schedule Of Financial Income Expenses Net",
        "verboseLabel": "Financial Income And Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfGeographicalAreasExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfGeographicalAreasExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenue by Geographical Area Based on Location of Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of geographical information."
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "trib_DisclosureOfGoodwillAndIntangibleAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfGoodwillAndIntangibleAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Goodwill And Intangible Assets [Abstract]",
        "terseLabel": "Goodwill And Intangible Assets Schedule Of Breakdown Of Impairment Loss Details",
        "verboseLabel": "Goodwill And Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfGoodwillExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Significant Goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "trib_DisclosureOfGroupUndertakingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfGroupUndertakingsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of group undertakings [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfGroupUndertakingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfGroupUndertakingsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for group undertakings.",
        "label": "Disclosure Of Group Undertakings Explanatory",
        "verboseLabel": "GROUP UNDERTAKINGS"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfImpairmentChargesAndInventoryProvisioningAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of impairment charges and inventory provisioning [Abstract]",
        "terseLabel": "Impairment Charges Schedule Of Statement Of Operation",
        "verboseLabel": "Impairment Charges"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfImpairmentOfAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfImpairmentOfAssetsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/ImpairmentCharges"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IMPAIRMENT CHARGES",
        "terseLabel": "IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for the impairment of assets."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "trib_DisclosureOfIncomeTaxCreditAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfIncomeTaxCreditAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of income tax credit [Abstract]",
        "terseLabel": "Income Tax Credit Schedule Of Charge For Tax",
        "verboseLabel": "Income Tax Credit"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCredit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAX (EXPENSE)/CREDIT"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Assumption Determining Fair Value of Share Options"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's other equity instruments (ie other than share options)."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value of the Options Vesting Period"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options."
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of information about amounts that affected statement of comprehensive income as result of hedge accounting [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfInformationAboutAmountsThatAffectedStatementOfComprehensiveIncomeAsResultOfHedgeAccountingTable",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of information about amounts that affected statement of comprehensive income as result of hedge accounting [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to amounts that affected the statement of comprehensive income as a result of hedge accounting."
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/Employment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EMPLOYMENT"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets and goodwill [text block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsMaterialToEntityExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Impairment Loss for Each Class of Asset"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of intangible assets that are material to the entity. [Refer: Intangible assets material to entity]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsTable",
     "presentation": [
      "http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets with indefinite useful life [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets with indefinite useful life [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to intangible assets with an indefinite useful life."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "trib_DisclosureOfInterestbearingLoansAndBorrowingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfInterestbearingLoansAndBorrowingsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Interest-bearing Loans And Borrowings [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInventoriesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfInventoriesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVENTORIES"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for inventories."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "trib_DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfLeasePaymentsNotRecognisedAsLiabilityExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of lease payments not recognised as liability.",
        "label": "Disclosure Of Lease Payments Not Recognised As Liability Explanatory",
        "terseLabel": "Schedule of Lease Payments Not Recognised as Liability"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfLeasesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASE LIABILITIES"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for leases."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r206"
     ]
    },
    "trib_DisclosureOfLossOnDiscontinuedOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfLossOnDiscontinuedOperationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of loss on discontinued operations [Abstract]",
        "terseLabel": "Lossprofit For Year On Discontinued Operation Schedule Of Cash Flows Attributable",
        "verboseLabel": "Lossprofit For Year On Discontinued Operation"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfLossProfitBeforeTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfLossProfitBeforeTaxAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of loss profit before tax [Abstract]",
        "terseLabel": "Loss Before Tax Narrative",
        "verboseLabel": "Loss Before Tax"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfLossProfitBeforeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfLossProfitBeforeTaxExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss profit before tax.",
        "label": "Disclosure Of Loss Profit Before Tax Explanatory",
        "terseLabel": "LOSS BEFORE TAX"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Future Minimum Rentals Receivable Under Non-Cancellable Operating Leases"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis of finance lease payments receivable. Finance lease is a lease that transfers substantially all the risks and rewards incidental to ownership of an underlying asset."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of finance lease payments receivable [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableTable",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of finance lease payments receivable [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the maturity analysis of finance lease payments receivable."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Future Minimum Finance Lease Receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the maturity analysis of operating lease payments."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Interest Rate Risk Effective and Repricing Analysis"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information that enables users of financial statements to evaluate the nature and extent of risks arising from financial instruments to which the entity is exposed. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "trib_DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for net cashflows generated from discontinued operations.",
        "label": "Disclosure Of Net Cashflows Generated Discontinued Operations Explanatory",
        "verboseLabel": "Schedule of Net Cashflows Generated From Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/POSTBALANCESHEETEVENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [text block]",
        "terseLabel": "POST BALANCE SHEET EVENTS"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of non-adjusting events after the reporting period. [Refer: Non-adjusting events after reporting period [domain]]"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "presentation": [
      "http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Range of Prices of Stock Options",
        "terseLabel": "Schedule of Range of Prices of Stock Options"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the number and weighted average remaining contractual life of outstanding share options."
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "trib_DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating profit for the discontinued operations.",
        "label": "Disclosure Of Operating Profit For The Discontinued Operations [Table Text Block]",
        "verboseLabel": "Schedule of Operating Profit For The Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [abstract]",
        "terseLabel": "Disclosure of operating segments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Results by Geographical Area"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "ifrs-full_DisclosureOfOperatingSegmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsTable",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to operating segments."
       }
      }
     },
     "auth_ref": [
      "r282"
     ]
    },
    "trib_DisclosureOfOtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfOtherAssetsAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/OtherNon-currentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Other Assets Abstract",
        "verboseLabel": "Other Non-current Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOtherAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOtherAssetsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/OtherNon-currentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER NON-CURRENT ASSETS"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of other assets. [Refer: Other assets]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "trib_DisclosureOfOtherOperatingIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfOtherOperatingIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of other operating income [Abstract]",
        "terseLabel": "Other Operating Income Schedule Of Other Operating Income",
        "verboseLabel": "Other Operating Income"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOtherOperatingIncomeExpenseExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/OtherOperatingIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Operating Income"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of other operating income or expense. [Refer: Other operating income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOtherOperatingIncomeExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/OtherOperatingIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER OPERATING (EXPENSE) / INCOME"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of other operating income. [Refer: Other operating income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "ifrs-full_DisclosureOfOtherProvisionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOtherProvisionsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/ProvisionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of other provisions. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ifrs-full_DisclosureOfOtherProvisionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOtherProvisionsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails",
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of other provisions [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOtherProvisionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfOtherProvisionsTable",
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails",
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of other provisions [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to other provisions."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ifrs-full_DisclosureOfProductsAndServicesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfProductsAndServicesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenue by Major Product Group"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's products and services. [Refer: Products and services [domain]]"
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "ifrs-full_DisclosureOfProductsAndServicesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfProductsAndServicesLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of products and services [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfProductsAndServicesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfProductsAndServicesTable",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of products and services [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the entity's products and services."
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [Abstract]",
        "verboseLabel": "Disclosure of detailed information about property, plant and equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of property, plant and equipment [text block]",
        "verboseLabel": "PROPERTY, PLANT AND EQUIPMENT"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ifrs-full_DisclosureOfProvisionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfProvisionsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/Provisions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROVISIONS"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of provisions. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to right-of-use assets."
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "trib_DisclosureOfReconciliationFromIas17ToIfrs16Explanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfReconciliationFromIas17ToIfrs16Explanatory",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of reconciliation from IAS 17 to IFRS 16 effect.",
        "label": "Disclosure Of Reconciliation From Ias 17 To Ifrs 16 Explanatory",
        "terseLabel": "Schedule of Reconciliation from IAS 17 to IFRS 16"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Goodwill and Intangible Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of changes in intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of changes in intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of changes in the loss allowance and explanation of changes in the gross carrying amount for financial instruments."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r264"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Liabilities Arising from Financing Activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of liabilities arising from financing activities."
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfSegmentsMajorCustomersExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenue by Customers' Geographical Area"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of major customers."
       }
      }
     },
     "auth_ref": [
      "r292"
     ]
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReserves"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CAPITAL AND RESERVES"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "trib_DisclosureOfShareOptionsAndShareWarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfShareOptionsAndShareWarrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Share Options And Share Warrants [Abstract]",
        "verboseLabel": "Share Options"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisclosureOfShareOptionsAndShareWarrantsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisclosureOfShareOptionsAndShareWarrantsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share oprtions and warrants.",
        "label": "Disclosure Of Share Options And Share Warrants Explanatory",
        "terseLabel": "SHARE OPTIONS"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [text block]",
        "terseLabel": "Schedule of Subsidiary Undertakings"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of subsidiaries. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r99",
      "r181"
     ]
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unrecognised Deferred Tax Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r226"
     ]
    },
    "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherPayablesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherPayables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of trade and other payables [text block]",
        "verboseLabel": "TRADE AND OTHER PAYABLES"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of trade and other receivables [text block]",
        "verboseLabel": "TRADE AND OTHER RECEIVABLES"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to transactions between related parties."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "trib_DiscontinuedOperationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DiscontinuedOperationsAxis",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DiscontinuedOperationsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DiscontinuedOperationsDomain",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DISCONTINUED OPERATIONS",
        "label": "Discontinued Operations [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DiscontinuedOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DiscontinuedOperationsMember",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails",
      "http://trinitybiotech.com/role/EmploymentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued operations [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of an entity that either has been disposed of or is classified as held for sale, and that: (a) represents a separate major line of business or geographical area of operations; (b) is part of a single co-ordinated plan to dispose of a separate major line of business or geographical area of operations; or (c) is a subsidiary acquired exclusively with a view to resale. A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "trib_DisposalsGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisposalsGoodwillAndIntangibleAssets",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposals of goodwill and intangible assets for the period.",
        "negatedLabel": "Disposals or retirements",
        "label": "Disposals Goodwill And Intangible Assets",
        "verboseLabel": "Disposals or retirements"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisposalsOrRetirementsPropertyAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisposalsOrRetirementsPropertyAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposals or retirements of property, plant and equipment during the period.",
        "negatedLabel": "Disposals or retirements",
        "label": "Disposals Or Retirements Property And Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DisposalsRelatedToRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DisposalsRelatedToRightOfUseAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of Disposals Related To Right Of Use Assets",
        "label": "Disposals Related To Right Of Use Assets",
        "terseLabel": "Disposals (related to Right of Use assets)"
       }
      }
     },
     "auth_ref": []
    },
    "trib_DistributorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DistributorsMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distributors [Member]",
        "label": "Distributors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DividendsPaidClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "DividendsPaidClassifiedAsFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment of dividend"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for dividends paid by the entity, classified as financing activities."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r378",
      "r401"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r378",
      "r401",
      "r444"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "trib_DrJimWalshMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "DrJimWalshMember",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dr. Jim Walsh [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "currency_EUR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "EUR",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment": {
     "xbrltype": "percentItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings before interest, tax, depreciation and amortization decrease for impairment loss.",
        "label": "Earnings Before Interest Tax Depreciation And Amortization Decrease For Impairment",
        "terseLabel": "EBITDA would need to decrease for an impairment to arise"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of exchange rate movements on cash held"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r143",
      "r144"
     ]
    },
    "trib_EffectOfIrishIncomeTaxableAtHigherTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EffectOfIrishIncomeTaxableAtHigherTaxRate",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of Irish income taxable at higher tax rate.",
        "label": "Effect of Irish income taxable at higher tax rate"
       }
      }
     },
     "auth_ref": []
    },
    "trib_EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfOverseasTaxJurisdictionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Continuing Operations Tax Rate Abstract",
        "terseLabel": "As a percentage of loss before tax:",
        "verboseLabel": "As a percentage of loss before tax:"
       }
      }
     },
     "auth_ref": []
    },
    "trib_EffectiveInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EffectiveInterestRate",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate.",
        "label": "Effective interest rate"
       }
      }
     },
     "auth_ref": []
    },
    "trib_EliminatedOnDisposalOfBusiness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EliminatedOnDisposalOfBusiness",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount Eliminated on disposal of business",
        "negatedLabel": "Eliminated on disposal of business",
        "label": "Eliminated On Disposal Of Business",
        "verboseLabel": "Eliminated on disposal of business"
       }
      }
     },
     "auth_ref": []
    },
    "trib_EliminatedOnDisposalsOfBusiness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EliminatedOnDisposalsOfBusiness",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMovementInAllowanceForImpairmentOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of eliminated on disposal of business.",
        "negatedLabel": "Eliminated on disposal of business",
        "label": "Eliminated On Disposals Of Business"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EliminationOfIntersegmentAmountsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EliminationOfIntersegmentAmountsMember",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Eliminations [Member]",
        "verboseLabel": "Eliminations [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the elimination of intersegment amounts in the reconciliations of total segment amounts to amounts recognised in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r372"
     ]
    },
    "ifrs-full_EmployeeBenefitsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EmployeeBenefitsExpense",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee benefits expense",
        "totalLabel": "Employment Costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r49",
      "r301"
     ]
    },
    "trib_EmployeeRelatedSocialInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EmployeeRelatedSocialInsurance",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee related social insurance.",
        "label": "Employee related social insurance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "auth_ref": []
    },
    "trib_EndUserCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EndUserCustomersMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for End-user customers.",
        "label": "End User Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r485"
     ]
    },
    "trib_EpiCaptureLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EpiCaptureLimitedMember",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables",
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Epi Capture Limited.",
        "label": "Epi Capture Limited [Member]",
        "verboseLabel": "Epi Capture Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Equity at end of period",
        "periodStartLabel": "Equity at beginning of period",
        "label": "Equity",
        "totalLabel": "Total equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r30",
      "r158",
      "r160",
      "r183",
      "r184",
      "r185"
     ]
    },
    "ifrs-full_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EquityAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity attributable to the equity holders of the parent"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EquityAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "TOTAL EQUITY AND LIABILITIES"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "ifrs-full_EquityAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EquityAndLiabilitiesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EQUITY AND LIABILITIES"
       }
      }
     },
     "auth_ref": []
    },
    "trib_EquityComponentAtDateOfIssue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EquityComponentAtDateOfIssue",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of equity component at date of issue.",
        "label": "Equity Component At Date Of Issue",
        "terseLabel": "Equity component at date of issue",
        "verboseLabel": "Equity component at date of issue"
       }
      }
     },
     "auth_ref": []
    },
    "trib_EquityComponentOfConvertibleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EquityComponentOfConvertibleNote",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents equity component of convertible note.",
        "label": "Equity Component Of Convertible Note",
        "terseLabel": "Equity component of convertible note",
        "verboseLabel": "Equity investment"
       }
      }
     },
     "auth_ref": []
    },
    "trib_EquityComponentOfConvertibleNoteAtDateOfIssue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EquityComponentOfConvertibleNoteAtDateOfIssue",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity component of convertible note at date of issue.",
        "negatedLabel": "Equity component of convertible note at date of issue",
        "label": "Equity Component Of Convertible Note At Date Of Issue"
       }
      }
     },
     "auth_ref": []
    },
    "trib_EquityComponentOfConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EquityComponentOfConvertibleNoteMember",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Component of Convertible Note",
        "label": "Equity Component Of Convertible Note [Member]",
        "verboseLabel": "Equity Component of convertible Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityInterestsOfAcquirer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "EquityInterestsOfAcquirer",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails__1": {
       "parentTag": "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity interests of acquirer",
        "terseLabel": "Non-cash consideration"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r394",
      "r405",
      "r415",
      "r448"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r391",
      "r402",
      "r412",
      "r445"
     ]
    },
    "trib_EstimatedObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EstimatedObligations",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated obligations.",
        "label": "Estimated obligations"
       }
      }
     },
     "auth_ref": []
    },
    "trib_EuroZoneCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EuroZoneCountriesMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro-zone countries [Member]",
        "label": "Euro-zone countries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_EuropeIncludingIrelandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EuropeIncludingIrelandMember",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Europe (including Ireland) [Member]",
        "label": "Europe Including Ireland Member",
        "terseLabel": "Europe (including Ireland) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_EuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EuropeMember",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_EventsAfterReportingPeriodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "EventsAfterReportingPeriodMember",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used.",
        "label": "Events After Reporting Period [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ExcessValueOfGoodwillInUseOverCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ExcessValueOfGoodwillInUseOverCarryingAmount",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess value-in-use over carrying amount.",
        "label": "Excess Value Of Goodwill In Use Over Carrying Amount",
        "terseLabel": "Excess value-in-use over carrying amount"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ExchangeableNoteEquityConversionOption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ExchangeableNoteEquityConversionOption",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchangeable note equity conversion option.",
        "negatedLabel": "Exchangeable note equity conversion option",
        "label": "Exchangeable note equity conversion option"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ExchangeableNoteInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ExchangeableNoteInterest",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchangeable note interest.",
        "label": "Exchangeable note interest"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ExchangeableNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ExchangeableNoteMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchangeable note [Member]",
        "label": "Exchangeable note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ExchangeableNotesAndOtherBorrowingsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ExchangeableNotesAndOtherBorrowingsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about Exchangeable notes and other borrowings classified as current liabilities.",
        "positiveLabel": "Exchangeable notes",
        "label": "Exchangeable Notes And Other Borrowings Current",
        "terseLabel": "Exchangeable notes and other borrowings",
        "verboseLabel": "Exchangeable senior notes"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ExchangeableNotesDiscountRate": {
     "xbrltype": "pureItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ExchangeableNotesDiscountRate",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of discount rate for exchangeable notes.",
        "label": "Exchangeable Notes Discount Rate",
        "terseLabel": "Exchangeable notes discount rate"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ExchangeableSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ExchangeableSeniorNotesMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent information about the exchangeable senior notes member.",
        "label": "Exchangeable Senior Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "trib_ExercisableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ExercisableAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercisable Abstract",
        "terseLabel": "Exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ExerciseOfShareOptionsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ExerciseOfShareOptionsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of share options receivable.",
        "label": "Exercise of share options receivable"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ExercisePriceOfWarrantsOrRights": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ExercisePriceOfWarrantsOrRights",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Exercise Price Of Warrants Or Rights",
        "terseLabel": "Exercise price of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExercisePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExercisePriceShareOptionsGranted2019",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price per 'A' share / (per ADS)"
       }
      },
      "en": {
       "role": {
        "documentation": "The exercise price of share options granted."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "ifrs-full_ExpectedCreditLossRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpectedCreditLossRate",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected credit loss rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The rate of expected credit losses, calculated as percentage of the gross carrying amount. Expected credit losses are the weighted average of credit losses with the respective risks of a default occurring as the weights."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r367"
     ]
    },
    "ifrs-full_ExpenseOfRestructuringActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExpenseOfRestructuringActivities",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total restructuring costs",
        "label": "Expense of restructuring activities",
        "terseLabel": "Total restructuring costs",
        "verboseLabel": "Restructuring cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "trib_ExpenseOfRestructuringCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ExpenseOfRestructuringCost",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails": {
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense relating to restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations.",
        "label": "Expense Of Restructuring Cost",
        "verboseLabel": "Restructuring cost"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of project completion period"
       }
      },
      "en": {
       "role": {
        "documentation": "The explanation of restrictions on the distribution of the balance of the revaluation surplus for intangible assets to shareholders. [Refer: Revaluation surplus]"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "trib_ExtinguishmentOfAmountOwed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ExtinguishmentOfAmountOwed",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination extinguishment of amount owed.",
        "label": "Extinguishment Of Amount Owed",
        "terseLabel": "Extinguishment of monies owed"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ExtinguishmentOfDebtAmounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ExtinguishmentOfDebtAmounts",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment Of Debt, Amounts",
        "terseLabel": "Extinguishment of debt"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FairValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FairValueMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value [Member]",
        "label": "Fair Value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount, at acquisition date, of fair value of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Total for all business combinations [member]]",
        "label": "Fair Value Of Contingent Consideration Recognised As Of Acquisition Date",
        "terseLabel": "Fair value of contingent consideration"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FairValueOfDerivativeFinancialAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FairValueOfDerivativeFinancialAsset",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of derivative financial asset.",
        "label": "Fair Value Of Derivative Financial Asset",
        "terseLabel": "Fair value of derivative financial asset"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FairValueOfDerivativeFinancialLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FairValueOfDerivativeFinancialLiability",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of derivative financial liability.",
        "label": "Fair Value Of Derivative Financial Liability",
        "terseLabel": "Fair value of derivative financial liability"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FairValueOfFinancialAssetsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FairValueOfFinancialAssetsLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total fair value of financial assets liabilities.",
        "negatedTotalLabel": "Total fair value of financial assets liabilities",
        "label": "Fair Value Of Financial Assets Liabilities",
        "verboseLabel": "Total fair value of financial assets liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FairValueOfSharesIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FairValueOfSharesIssued",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of fair value of shares issued.",
        "label": "Fair Value Of Shares Issued",
        "terseLabel": "Fair value of ADSs issued"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FairValueRemeasuredThroughProfitLossOfFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FairValueRemeasuredThroughProfitLossOfFinancialAssets",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of fair value remeasured through profit &amp; loss for financial assets.",
        "label": "Fair Value Remeasured Through Profit &amp; Loss Of Financial Assets",
        "terseLabel": "Fair value remeasured through profit &amp; loss"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FairValueRemeasurementForDerivativeFinancialBalances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FairValueRemeasurementForDerivativeFinancialBalances",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value remeasurement for derivative financial balances.",
        "label": "Fair Value Remeasurement For Derivative Financial Balances",
        "terseLabel": "Fair value remeasurement for derivative financial balances"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FairValueThroughProfitAndLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FairValueThroughProfitAndLoss",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ffair value through profit and loss (FVPL).",
        "negatedTotalLabel": "Total fair value through profit and loss (FVPL)",
        "label": "Fair Value Through Profit And Loss",
        "terseLabel": "Total fair value through profit and loss (FVPL)"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FifthAmendmentToCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FifthAmendmentToCreditAgreementMember",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fifth Amendment To Credit Agreement [Member]",
        "label": "Fifth Amendment To Credit Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "trib_NetFinancingExpenseIncome",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financial expenses",
        "negatedTotalLabel": "Financial expense",
        "label": "Finance costs",
        "verboseLabel": "Financial expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ifrs-full_FinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinanceIncome",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "trib_NetFinancingExpenseIncome",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial income",
        "totalLabel": "Financial income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "ifrs-full_FinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinanceIncomeCost",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Non-cash financial expense",
        "label": "Finance income (cost)",
        "terseLabel": "Non-cash financial expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income or cost associated with interest and other financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "trib_FinanceIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FinanceIncomeExpenseNet",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing expenses, net.",
        "label": "Finance Income Expense Net",
        "terseLabel": "Net financing expense"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FinanceLeaseLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FinanceLeaseLiabilitiesMember",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liabilities [Member]",
        "label": "Finance Lease Liabilities Member",
        "terseLabel": "Sale and leaseback liabilities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FinanceLeaseLiabilitiesTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FinanceLeaseLiabilitiesTwoMember",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liabilities Two [Member]",
        "label": "Finance Lease Liabilities Two Member",
        "terseLabel": "Sale and leaseback liabilities Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FinanceLeaseReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FinanceLeaseReceivableMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease receivable [Member]",
        "label": "Finance Lease Receivable Member",
        "terseLabel": "Lease receivable [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cost At December 31",
        "periodStartLabel": "Cost At January 1",
        "label": "Financial assets",
        "verboseLabel": "Financial assets (see Note 13)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r259",
      "r263",
      "r264",
      "r267",
      "r360"
     ]
    },
    "trib_FinancialAssetsAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FinancialAssetsAdditions",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of financial assets additions.",
        "label": "Financial Assets Additions",
        "verboseLabel": "Additions in year"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssetsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialAssetsAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets, at fair value",
        "verboseLabel": "Carrying amount At December 31"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "trib_FinancialAssetsLeaseReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FinancialAssetsLeaseReceivables",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial assets lease receivables.",
        "positiveLabel": "Finance lease receivable",
        "positiveTerseLabel": "Finance lease income receivable",
        "label": "Financial Assets Lease Receivables",
        "terseLabel": "Financial assets (lease receivables)",
        "verboseLabel": "Lease receivable"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FinancialAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FinancialAssetsPolicyTextBlock",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for financial assets.",
        "label": "Financial Assets [Policy Text Block]",
        "terseLabel": "Financial Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialAssetsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financial assets",
        "label": "Financial assets recognised as of acquisition date",
        "terseLabel": "Financial assets",
        "verboseLabel": "Financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for financial assets acquired in a business combination. [Refer: Financial assets; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r353",
      "r355"
     ]
    },
    "trib_FinancialAssetsWriteOff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FinancialAssetsWriteOff",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of financial assets written off.",
        "label": "Financial Assets Write Off",
        "terseLabel": "Write off in the year"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FinancialAtFairValueThroughProfitOrLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FinancialAtFairValueThroughProfitOrLossAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial At Fair Value Through Profit Or Loss Abstract",
        "terseLabel": "Fair value through profit and loss (FVPL)"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FinancialIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FinancialIncomeAndExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Income And Expenses Abstract",
        "verboseLabel": "Financial Income And Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total maturities of financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtAmortisedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesAtAmortisedCost",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total Liabilities at amortised cost",
        "negatedTotalLabel": "Total Liabilities at amortised cost",
        "label": "Financial liabilities at amortised cost",
        "terseLabel": "Total Liabilities at amortised cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of financial liabilities at amortised cost. The amortised cost is the amount at which financial liabilities are measured at initial recognition minus principal repayments, plus or minus the cumulative amortisation using the effective interest method of any difference between that initial amount and the maturity amount. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "trib_FinancingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FinancingExpensesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Expenses Abstract",
        "terseLabel": "Financial expense:"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FinancingIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FinancingIncomeAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Income Abstract",
        "terseLabel": "Financial income:"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FinancingIncomeBySegment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FinancingIncomeBySegment",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of financing income by operating segment.",
        "label": "Financing Income By Segment",
        "terseLabel": "Net financing expense (Note 6)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "FinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails": {
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finished goods"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r307",
      "r509"
     ]
    },
    "trib_FiomiDiagnosticsAbMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FiomiDiagnosticsAbMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiomi Diagnostics AB [Member]",
        "label": "Fiomi Diagnostics Ab [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FiomiDiagnosticsHoldingAbMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FiomiDiagnosticsHoldingAbMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Fiomi Diagnostics Holding AB.",
        "label": "Fiomi Diagnostics Holding Ab [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FiomiDiagnosticsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FiomiDiagnosticsMember",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Fiomi Diagnostics.",
        "label": "Fiomi Diagnostics [Member]",
        "verboseLabel": "Fiomi Diagnostics (\u201cFiomi\u201d) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FitzgeraldIndustriesInternationalCguRdiTradeNameMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FitzgeraldIndustriesInternationalCguRdiTradeNameMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fitzgerald Industries International CGU RDI Trade Name [Member]",
        "label": "Fitzgerald Industries International CGU RDI Trade Name [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FitzgeraldIndustriesInternationalCguTradeNameMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FitzgeraldIndustriesInternationalCguTradeNameMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fitzgerald Industries International CGU Trade Name [Member]",
        "label": "Fitzgerald Industries International CGU Trade Name [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FitzgeraldIndustriesInternationalIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FitzgeraldIndustriesInternationalIncMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Fitzgerald Industries International, Inc.",
        "label": "Fitzgerald Industries International, Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FixedRateFinancialLiabilitiesBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FixedRateFinancialLiabilitiesBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate financial liabilities of borrowings.",
        "negatedLabel": "Fixed rate financial liabilities (borrowings)",
        "label": "Fixed Rate Financial Liabilities Borrowings"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FixedRateInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FixedRateInstruments",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of total fixed rate instruments.",
        "negatedLabel": "Fixed rate instruments",
        "negatedTotalLabel": "Fixed rate instruments",
        "label": "Fixed Rate Instruments"
       }
      }
     },
     "auth_ref": []
    },
    "trib_FixedRateInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FixedRateInstrumentsAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Rate Instruments Abstract",
        "terseLabel": "Fixed rate instruments"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ForgivenessOfBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ForgivenessOfBorrowings",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forgiveness amount.",
        "label": "Forgiveness Of Borrowings",
        "terseLabel": "Forgiveness amount"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r398",
      "r409",
      "r419",
      "r452"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r398",
      "r409",
      "r419",
      "r452"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r398",
      "r409",
      "r419",
      "r452"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r398",
      "r409",
      "r419",
      "r452"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r398",
      "r409",
      "r419",
      "r452"
     ]
    },
    "trib_FourthAmendmentToCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "FourthAmendmentToCreditAgreementMember",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fourth Amendment To Credit Agreement [Member]",
        "label": "Fourth Amendment To Credit Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "trib_G6PDHTestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "G6PDHTestMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "G-6-PDH test [Member]",
        "label": "G 6 P D H Test [Member]",
        "terseLabel": "G-6-PDH Test [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "country_GB": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "GB",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "United Kingdom [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "currency_GBP": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "GBP",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GBP [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveLabel": "(Loss)/Gain on sale of discontinued operations",
        "label": "Gain (loss) recognised on measurement to fair value less costs to sell or on disposal of assets or disposal groups constituting discontinued operation"
       }
      },
      "en": {
       "role": {
        "documentation": "The gain (loss) recognised on the measurement to fair value less costs to sell or on the disposal of the assets or disposal group(s) constituting the discontinued operation. [Refer: Discontinued operations [member]]"
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "ifrs-full_GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (loss) that relates to identifiable assets acquired or liabilities assumed in business combination and is of such size, nature or incidence that disclosure is relevant to understanding combined entity's financial statements",
        "terseLabel": "Acquired business incurred net loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The gain (loss) that both: (a) relates to identifiable assets acquired or liabilities assumed in a business combination; and (b) is of such size, nature or incidence that disclosure is relevant to understanding the combined entity's financial statements. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r242"
     ]
    },
    "ifrs-full_GeographicalAreasAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GeographicalAreasAxis",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [Axis]",
        "verboseLabel": "Geographical areas [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r317",
      "r348",
      "r352"
     ]
    },
    "ifrs-full_GeographicalAreasDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GeographicalAreasDomain",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r317",
      "r348",
      "r352"
     ]
    },
    "ifrs-full_GoodwillMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GoodwillMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "ifrs-full_GoodwillRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GoodwillRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Goodwill",
        "positiveTerseLabel": "Goodwill recognised in connection with acquisition",
        "label": "Goodwill recognised as of acquisition date",
        "terseLabel": "Goodwill and Intangible assets acquired",
        "verboseLabel": "Goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r354",
      "r355"
     ]
    },
    "trib_GoodwillWriteOff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "GoodwillWriteOff",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of goodwill write off.",
        "label": "Goodwill write off"
       }
      }
     },
     "auth_ref": []
    },
    "trib_GovernmentGrantReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "GovernmentGrantReceived",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of government grant received.",
        "label": "Government Grant Received"
       }
      }
     },
     "auth_ref": []
    },
    "trib_GovernmentSupportsCovid19": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "GovernmentSupportsCovid19",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails": {
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government supports - COVID-19.",
        "label": "Government supports"
       }
      }
     },
     "auth_ref": []
    },
    "trib_GrantContingenciesMaximumAmountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "GrantContingenciesMaximumAmountPayable",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant contingencies maximum amount payable.",
        "label": "Grant contingencies maximum amount payable"
       }
      }
     },
     "auth_ref": []
    },
    "trib_GrantReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "GrantReceivable",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant receivable.",
        "label": "Grant Receivable",
        "terseLabel": "Grant receivable"
       }
      }
     },
     "auth_ref": []
    },
    "trib_GreaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "GreaterThanFiveYearsMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5 years [Member]",
        "label": "Greater Than Five Years Member",
        "terseLabel": ">5 years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_GreaterThanFourMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "GreaterThanFourMonthsMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Greater than 120 days [Member]",
        "label": "Greater Than Four Months Member",
        "terseLabel": "Greater than 120 days [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GrossCarryingAmountMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r61",
      "r124",
      "r136",
      "r140",
      "r241",
      "r264",
      "r267",
      "r360"
     ]
    },
    "trib_GrossIncreaseInterestIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "GrossIncreaseInterestIncome",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the gross Increase interest income.",
        "label": "Gross Increase Interest Income"
       }
      }
     },
     "auth_ref": []
    },
    "trib_GrossInvestmentInFinanceLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "GrossInvestmentInFinanceLease",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate of: (a) the minimum lease payments receivable by the lessor under a finance lease; and (b) any unguaranteed residual value accruing to the lessor. Minimum lease payments are payments over the lease term that the lessee is or can be required to make, excluding contingent rent, costs for services and taxes to be paid by, and reimbursed to, the lessor, together with: (a) for a lessee, any amounts guaranteed by the lessee or by a party related to the lessee; or (b) for a lessor, any residual value guaranteed to the lessor by: (i) the lessee; (ii) a party related to the lessee; or (iii) a third party unrelated to the lessor that is financially capable of discharging the obligations under the guarantee.",
        "label": "Gross Investment In Finance Lease",
        "terseLabel": "Gross investment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GrossLoanCommitments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GrossLoanCommitments",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross loan commitments",
        "terseLabel": "Outstanding principal term loan"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows for gross commitments to receive a loan."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "ifrs-full_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross profit",
        "totalLabel": "Gross profit"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]"
       }
      }
     },
     "auth_ref": [
      "r302"
     ]
    },
    "trib_HivOneByTwoRapidTestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "HivOneByTwoRapidTestMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HIV 1/2 Rapid Test [Member]",
        "label": "Hiv One By Two Rapid Test Member",
        "verboseLabel": "HIV Screening Rapid Test [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "country_IE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "IE",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ireland [Member]",
        "verboseLabel": "Ireland [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ITAndOfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ITAndOfficeEquipmentMember",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "I.T. and office equipment [Member]",
        "label": "I.T. and office equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r377",
      "r378",
      "r401"
     ]
    },
    "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumed",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net assets acquired",
        "label": "Identifiable assets acquired (liabilities assumed)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r353",
      "r355"
     ]
    },
    "ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Intangible assets - arising on acquisition",
        "label": "Identifiable intangible assets recognised as of acquisition date",
        "terseLabel": "Intangible assets - arising on acquisition",
        "verboseLabel": "Other intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r353",
      "r355"
     ]
    },
    "trib_ImmcoDiagnosticCGUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ImmcoDiagnosticCGUMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Immco Diagnostic CGU Trade Name [Member]",
        "label": "Immco Diagnostic C G U Member"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ImmcoDiagnosticsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ImmcoDiagnosticsIncMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Immco Diagnostics Inc [Member]",
        "label": "Immco Diagnostics Inc Member",
        "verboseLabel": "Immco Diagnostics Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ImpairmentChargePropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ImpairmentChargePropertyPlantEquipment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of Impairment Charge Property, Plant &amp; Equipment",
        "label": "Impairment Charge Property, Plant &amp; Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Impairment charges",
        "label": "Impairment loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]"
       }
      }
     },
     "auth_ref": [
      "r110",
      "r111"
     ]
    },
    "trib_ImpairmentLossForInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ImpairmentLossForInvestment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of impairment loss for the investment.",
        "label": "Impairment Loss For Investment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ImpairmentLossOnFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossOnFinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails": {
       "parentTag": "ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables",
       "weight": 1.0,
       "order": 30.0
      },
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 130.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/FINANCIALASSETSDetails",
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfBreakdownOfImpairmentLossDetailsUsd",
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "commentaryGuidance": "This element should be used to tag non-restated comparative information only.",
        "negatedLabel": "Impairment in the current year",
        "periodEndLabel": "Financial assets at end of period",
        "periodStartLabel": "Financial assets at beginning of period",
        "positiveTerseLabel": "Financial assets (see Note 13)",
        "label": "Impairment loss on financial assets",
        "terseLabel": "Impairment of financial assets (Note 13)",
        "totalLabel": "Total financial assets",
        "verboseLabel": "Liabilities related to financial assets (reversal)/written off"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInOtherComprehensiveIncome",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in other comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in other comprehensive income. Impairment loss on a revalued asset is recognised in other comprehensive income to the extent that the impairment loss does not exceed the amount in the revaluation surplus for that same asset. [Refer: Impairment loss; Revaluation surplus; Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r107",
      "r109"
     ]
    },
    "ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in other comprehensive income, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in other comprehensive income for intangible assets other than goodwill. [Refer: Impairment loss recognised in other comprehensive income; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossGoodwill",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total impairment loss allocated to goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for goodwill. [Refer: Impairment loss recognised in profit or loss; Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r240"
     ]
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill",
     "calculation": {
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails": {
       "parentTag": "ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of goodwill and other intangible assets (Note 12)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for intangible assets and goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 100.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of intangible assets",
        "terseLabel": "Impairment losses",
        "verboseLabel": "Impairment loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossInvestmentProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossInvestmentProperty",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining impairment loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for investment property. [Refer: Impairment loss recognised in profit or loss; Investment property]"
       }
      }
     },
     "auth_ref": [
      "r134",
      "r137"
     ]
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment",
     "calculation": {
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails": {
       "parentTag": "ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Impairment loss",
        "positiveLabel": "Impairment of PP&amp;E (Note 11)",
        "label": "Impairment of PP&amp;E (Note 13)",
        "verboseLabel": "Impairment loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r65"
     ]
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossTradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails": {
       "parentTag": "ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in profit or loss, trade receivables",
        "totalLabel": "Total impairment loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for trade receivables. [Refer: Impairment loss recognised in profit or loss; Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Impairment charges",
        "label": "Impairment loss (reversal of impairment loss) recognised in profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss or reversal of impairment loss recognised in profit or loss. [Refer: Impairment loss recognised in profit or loss; Reversal of impairment loss recognised in profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment loss (reversal of impairment loss) recognised in profit or loss, trade receivables",
        "totalLabel": "Total impairment loss after tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss or reversal of impairment loss recognised in profit or loss for trade receivables. [Refer: Impairment loss recognised in profit or loss; Reversal of impairment loss recognised in profit or loss; Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "trib_ImpairmentOfPrepayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ImpairmentOfPrepayments",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails": {
       "parentTag": "ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment of prepayments.",
        "label": "Impairment Of Prepayments",
        "terseLabel": "Impairment of prepayments (Note 18)",
        "verboseLabel": "Impairment of prepayments (Note 17)"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IncomeFromPaycheckProtectionProgramLoans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncomeFromPaycheckProtectionProgramLoans",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of income from the Paycheck Protection Program loans.",
        "label": "Income From Paycheck Protection Program Loans",
        "verboseLabel": "Income from the Paycheck Protection Program loans"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeFromSubleasingRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeFromSubleasingRightofuseAssets",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income from sub-letting right-of-use"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income from subleasing right-of-use assets. Sublease is a transaction for which an underlying asset is re-leased by a lessee (\u2018intermediate lessor\u2019) to a third party, and the lease (\u2018head lease\u2019) between the head lessor and lessee remains in effect. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "ifrs-full_IncomeRelatingToVariableLeasePaymentsForOperatingLeasesThatDoNotDependOnIndexOrRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeRelatingToVariableLeasePaymentsForOperatingLeasesThatDoNotDependOnIndexOrRate",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net book value of assets held under operating lease"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income relating to variable lease payments for operating leases that do not depend on an index or a rate. Variable lease payments are the portion of payments made by a lessee to a lessor for the right to use an underlying asset during the lease term that varies because of changes in facts or circumstances occurring after the commencement date, other than the passage of time."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "ifrs-full_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IncomeTaxAssetsCurrentAndDeferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncomeTaxAssetsCurrentAndDeferred",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax assets current and deferred.",
        "label": "Income tax assets (current and deferred)"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IncomeTaxExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncomeTaxExpense",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities.",
        "label": "Income Tax Expense",
        "terseLabel": "Taxation expense"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfOverseasTaxJurisdictionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense Benefit Continuing Operations Income Tax Abstract",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IncomeTaxExpenseBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncomeTaxExpenseBenefits",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax.",
        "label": "Income Tax Expense Benefits",
        "terseLabel": "Total tax charge/(credit)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total income tax (expense)/credit",
        "label": "Total income tax charge/(credit) on continuing operations in statement of operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r42",
      "r51",
      "r52",
      "r53",
      "r93",
      "r179",
      "r281"
     ]
    },
    "trib_IncomeTaxImpactOfImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncomeTaxImpactOfImpairmentLoss",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails": {
       "parentTag": "ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax, impact of impairment loss.",
        "label": "Income tax impact of impairment loss"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IncomeTaxLiabilitiesCurrentAndDeferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncomeTaxLiabilitiesCurrentAndDeferred",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax liabilities current and deferred.",
        "label": "Income tax liabilities (current and deferred)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxesPaidRefund": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeTaxesPaidRefund",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax credit (Note 9)",
        "terseLabel": "Income tax credit (Note 7)"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income taxes received/(paid)",
        "label": "Income taxes (paid) / received"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]"
       }
      }
     },
     "auth_ref": [
      "r146",
      "r328"
     ]
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes",
        "terseLabel": "Cash outflows",
        "totalLabel": "Increase/(decrease) in cash and cash equivalents and short-term investments"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInContingentConsiderationAssetLiability",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a contingent consideration asset (liability) relating to a business combination."
       }
      }
     },
     "auth_ref": [
      "r239"
     ]
    },
    "ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInDeferredTaxLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognised deferred tax asset"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a deferred tax liability (asset). [Refer: Deferred tax liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInNumberOfOrdinarySharesIssued",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in number of ordinary shares issued",
        "terseLabel": "Ordinary shares issued",
        "verboseLabel": "Issued for a cash consideration"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]"
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInNumberOfSharesOutstanding",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchased during the year"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "trib_IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes in accretion interest.",
        "label": "Increase Decrease Through Changes In Accretion Interest Liabilities Arising From Financing Activities",
        "terseLabel": "Accretion interest"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of increase decrease through changes in additional fair value liabilities warrants arising from financing activities.",
        "label": "Increase Decrease Through Changes In Additional Fair Value Liabilities Warrants Arising From Financing Activities",
        "terseLabel": "Fair value of additional derivative liability - warrants"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes in contingent liability.",
        "label": "Increase Decrease Through Changes In Contingent Liabilities Arising From Financing Activities",
        "verboseLabel": "Contingent liability"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value",
        "terseLabel": "Fair value of derivative liability - warrants"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes in fair values. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "trib_IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes in interest charged.",
        "label": "Increase Decrease Through Changes In Interest Charged Liabilities Arising From Financing Activities",
        "terseLabel": "Interest charged"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes in payment in kind interest.",
        "label": "Increase Decrease Through Changes In Payment In Kind Interest Arising From Financing Activities",
        "verboseLabel": "Payment-in-kind (PIK) Interest"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughConversionOfConvertibleInstruments",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through conversion of convertible instruments, equity",
        "terseLabel": "Amount of investment from MiCo"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the conversion of convertible instruments."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "trib_IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncreaseDecreaseThroughDisposalsArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from disposals.",
        "label": "Increase Decrease Through Disposals Arising From Financing Activities",
        "terseLabel": "Disposals"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange adjustment"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from the effect of changes in foreign exchange rates. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options or warrants exercised"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of warrants."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "trib_IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncreaseDecreaseThroughLoanForgivenLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from loan forgiven.",
        "label": "Increase Decrease Through Loan Forgiven Liabilities Arising From Financing Activities",
        "terseLabel": "Loan forgiven"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, intangible assets and goodwill",
        "verboseLabel": "Exchange adjustments"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets and goodwill resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange adjustments"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reduction in accrued interest payable"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Charge for the year",
        "label": "Charge for the year"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity",
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveLabel": "Share-based payments",
        "label": "Share based payment",
        "terseLabel": "Share based payments charge",
        "verboseLabel": "Total share based payments, inclusive of amounts capitalised"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "trib_IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions inclusive of amounts capitalised.",
        "label": "Increase Decrease Through Sharebased Payment Transactions Inclusive Of Amounts Capitalised",
        "terseLabel": "Share based payments charge",
        "verboseLabel": "Total share based payments, inclusive of amounts capitalised"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for reduced warranty claims"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in other provisions resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reallocations / reclassifications"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r503"
     ]
    },
    "trib_IncreaseInAnnualRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncreaseInAnnualRent",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents increase in annual rent.",
        "label": "Increase In Annual Rent",
        "terseLabel": "Increase In annual rent"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IncreaseInSettlementAmountDueToDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncreaseInSettlementAmountDueToDepreciation",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in settlement amount due to depreciation.",
        "label": "Increase in settlement amount due to depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseThroughOriginationOrPurchaseFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IncreaseThroughOriginationOrPurchaseFinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMovementInAllowanceForImpairmentOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Charged to costs and expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in financial assets resulting from origination or purchase. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r357",
      "r358",
      "r366"
     ]
    },
    "trib_IncreasedInUnrecognisedDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncreasedInUnrecognisedDeferredTaxAssets",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increased in unrecognised deferred tax assets.",
        "label": "Increased in unrecognised deferred tax assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IncreasedecreasethroughequityComponentOfConvertibleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IncreasedecreasethroughequityComponentOfConvertibleNote",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents equity component of convertible note.",
        "label": "Increasedecreasethroughequity Component Of Convertible Note",
        "terseLabel": "Equity component of convertible note"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r398",
      "r409",
      "r419",
      "r443",
      "r452",
      "r456",
      "r464"
     ]
    },
    "trib_InitialExercisePriceOfWarrantsOrRights": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "InitialExercisePriceOfWarrantsOrRights",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Exercise Price Of Warrants Or Rights.",
        "label": "Initial Exercise Price Of Warrants Or Rights",
        "verboseLabel": "Initial exercise price of warrants or rights"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r379",
      "r468"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r379",
      "r468"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r379",
      "r468"
     ]
    },
    "trib_InstalmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "InstalmentsAxis",
     "presentation": [
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instalments [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_InstalmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "InstalmentsDomain",
     "presentation": [
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instalments [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_InstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "InstrumentsMember",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Instruments.",
        "label": "Instruments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsAndGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsAndGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5": {
       "parentTag": "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0,
       "order": 0.0
      },
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning year",
        "positiveLabel": "Goodwill and intangible assets",
        "label": "Intangible assets and goodwill",
        "terseLabel": "Goodwill and intangible assets",
        "verboseLabel": "Carrying amounts"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwillMember",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r320",
      "r350"
     ]
    },
    "ifrs-full_IntangibleAssetsUnderDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsUnderDevelopment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets under development",
        "terseLabel": "Internally developed intangible assets",
        "verboseLabel": "Development costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets representing such assets under development. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r327"
     ]
    },
    "trib_IntangibleAssetsUnderDevelopmentImpairmentCharge": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IntangibleAssetsUnderDevelopmentImpairmentCharge",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets Under Development Impairment Charge.",
        "label": "Intangible Assets Under Development Impairment Charge",
        "terseLabel": "Intangible assets under development impairment charge"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IntangibleAssetsUnderDevelopmentWrittenDown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IntangibleAssetsUnderDevelopmentWrittenDown",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets under development written down.",
        "label": "Intangible Assets Under Development Written Down",
        "terseLabel": "Intangible assets under development written down"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsWithIndefiniteUsefulLife",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets with indefinite useful lives"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r113",
      "r117",
      "r130"
     ]
    },
    "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsWithIndefiniteUsefulLifeAxis",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets with indefinite useful life [axis]",
        "verboseLabel": "Intangible assets with indefinite useful life [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IntangibleAssetsWithIndefiniteUsefulLifeDomain",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets with indefinite useful life [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets with an indefinite useful life. It also represents the standard value for the 'Intangible assets with indefinite useful life' axis if no other member is used. [Refer: Intangible assets with indefinite useful life]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "trib_InterestEarningFinancialAndInterestBearingFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "InterestEarningFinancialAndInterestBearingFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total interest earning financial and interest bearing financial liabilities.",
        "negatedLabel": "Total interest earning financial and interest bearing financial liabilities",
        "negatedTotalLabel": "Total interest earning financial and interest bearing financial liabilities",
        "label": "Interest Earning Financial And Interest Bearing Financial Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "terseLabel": "Value attributable to interest",
        "totalLabel": "Total"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from interest."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r279",
      "r288"
     ]
    },
    "ifrs-full_InterestExpenseOnDebtInstrumentsIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestExpenseOnDebtInstrumentsIssued",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash interest on exchangeable notes",
        "label": "Cash interest on exchangeable notes",
        "verboseLabel": "Cash interest expense (Note 8)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest expense on debt instruments issued. [Refer: Interest expense; Debt instruments issued]"
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestExpenseOnLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest on leases",
        "label": "Interest on finance leases"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "trib_InterestExpenseOnLeaseLiabilities1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "InterestExpenseOnLeaseLiabilities1",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]",
        "label": "Interest Expense On Lease Liabilities 1",
        "terseLabel": "Interest"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestExpenseOnOtherFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestExpenseOnOtherFinancialLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Non-cash interest on exchangeable notes",
        "label": "Interest Expense On Other Financial Liabilities",
        "terseLabel": "Accretion interest (Note 8)",
        "verboseLabel": "Non-cash interest on exchangeable notes (Note 8)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest expense on other financial liabilities. [Refer: Interest expense; Other financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "trib_InterestExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "InterestExpenses",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the interest expense.",
        "label": "Interest Expenses",
        "terseLabel": "Interest expense"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestIncomeOnOtherFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestIncomeOnOtherFinancialAssets",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Non-cash financial expense/(income) (Note 8)",
        "label": "Non-cash financial income",
        "verboseLabel": "Financial income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest income on other financial assets. [Refer: Interest income; Other financial assets]"
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "ifrs-full_InterestPaidClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestPaidClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 130.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest paid on exchangeable notes",
        "negatedTerseLabel": "Interest paid for term loan",
        "label": "Interest paid, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as financing activities."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "trib_InterestPaidOnConvertibleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "InterestPaidOnConvertibleNote",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 110.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails",
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents interest paid on convertible note.",
        "negatedLabel": "Interest paid on convertible note",
        "negatedTerseLabel": "Cash interest payable on convertible note",
        "label": "Interest Paid On Convertible Note",
        "terseLabel": "Interest paid for convertible note"
       }
      }
     },
     "auth_ref": []
    },
    "trib_InterestPaidOnSeniorSecuredTermLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "InterestPaidOnSeniorSecuredTermLoan",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 100.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents interest paid on senior secured term loan.",
        "negatedLabel": "Interest paid on senior secured term loan",
        "negatedTerseLabel": "Interest paid for senior secured term loan",
        "label": "Interest Paid On Senior Secured Term Loan",
        "terseLabel": "Interest paid on senior secured term loan"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestPayable",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/OtherOperatingIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest payable"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest recognised as a liability."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "ifrs-full_InterestReceivedClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InterestReceivedClassifiedAsOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest received"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from interest received, classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "ifrs-full_Inventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Inventories",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 0.0
      },
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5": {
       "parentTag": "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0,
       "order": 80.0
      },
      "http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
      "http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current inventories",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventories",
        "verboseLabel": "Inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r77",
      "r304"
     ]
    },
    "ifrs-full_InventoriesAtNetRealisableValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InventoriesAtNetRealisableValue",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails",
      "http://trinitybiotech.com/role/InventoriesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories, at net realisable value"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of inventories carried at net realisable value. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "trib_InventoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "InventoryMember",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory [Member]",
        "label": "Inventory Member",
        "terseLabel": "Inventories [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InventoryRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InventoryRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventory",
        "label": "Inventory recognised as of acquisition date",
        "terseLabel": "Inventory"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r353",
      "r355"
     ]
    },
    "trib_InventoryRelatedCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "InventoryRelatedCostsMember",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Related Costs [Member]",
        "label": "Inventory Related Costs [Member]",
        "terseLabel": "Inventory related costs [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InvestmentAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "InvestmentAccountedForUsingEquityMethod",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments accounted for using equity method",
        "verboseLabel": "Equity investment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r180",
      "r283"
     ]
    },
    "trib_InvestmentInUnsecuredJuniorConvertibleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "InvestmentInUnsecuredJuniorConvertibleNote",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of investment in unsecured junior convertible notes.",
        "label": "Investment In Unsecured Junior Convertible Note",
        "verboseLabel": "Investment in unsecured junior convertible note"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IssuableOnConversionOfConvertibleNotes": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IssuableOnConversionOfConvertibleNotes",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issuable on conversion of convertible notes.",
        "label": "Issuable On Conversion Of Convertible Notes",
        "terseLabel": "Issuable on conversion of Convertible notes"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IssuableOnExerciseOfOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IssuableOnExerciseOfOptions",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of issuable on exercise of options.",
        "label": "Issuable On Exercise Of Options",
        "terseLabel": "Issuable on exercise of options"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssueOfConvertibleInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IssueOfConvertibleInstruments",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue of convertible instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The change in equity resulting from the issuing of convertible instruments."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "ifrs-full_IssueOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IssueOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue of equity",
        "terseLabel": "Shares issued in the year"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital 'A' Ordinary shares [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "trib_IssuedForNoncashConsideration": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IssuedForNoncashConsideration",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of Issued for non-cash consideration.",
        "label": "Issued For Non-cash Consideration",
        "terseLabel": "Issued for non-cash consideration",
        "verboseLabel": "Shares issued as consideration for Exchangeable Notes purchase"
       }
      }
     },
     "auth_ref": []
    },
    "trib_IssuenceOfExchangeableNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "IssuenceOfExchangeableNote",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuence of exchangeable note.",
        "label": "Issuence of exchangeable note"
       }
      }
     },
     "auth_ref": []
    },
    "trib_JrjMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "JrjMember",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "JRJ [Member]",
        "label": "JRJ [Member]",
        "terseLabel": "JRJ Investments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_KansasRightOfUseAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "KansasRightOfUseAssetMember",
     "presentation": [
      "http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Kansas right-of-use asset.",
        "label": "Kansas Right Of Use Asset [Member]",
        "verboseLabel": "Kansas right-of-use asset [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensation",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Key management personnel compensation",
        "totalLabel": "Total compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "trib_KeyManagementPersonnelCompensationPerformanceRelatedBonus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "KeyManagementPersonnelCompensationPerformanceRelatedBonus",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance related bonus.",
        "label": "Key Management Personnel Compensation Performance Related Bonus",
        "terseLabel": "Performance related bonus"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-employment benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "trib_KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "KeyManagementPersonnelCompensationSettlementRelatedToPayrollTaxes",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails": {
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of settlement related to payroll taxes.",
        "label": "Key Management Personnel Compensation Settlement Related To Payroll Taxes",
        "terseLabel": "Tax settlement (Note 6)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation benefits",
        "terseLabel": "Share-based compensation benefits as calculated under IFRS 2"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationTerminationBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationTerminationBenefits",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of termination benefits. [Refer: Termination benefits expense; Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelOfEntityOrParentMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Key management personnel [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "trib_KonamiteLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "KonamiteLimitedMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the member of Konamite Limited",
        "label": "Konamite Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LaboratoryServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LaboratoryServicesMember",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory services [Member]",
        "label": "Laboratory Services Member",
        "terseLabel": "Clinical laboratory services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LandAndBuildingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LandAndBuildingsMember",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Land and buildings [member]",
        "verboseLabel": "Land &amp; Buildings [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing land and depreciable buildings and similar structures for use in operations. [Refer: Buildings; Land; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanFiveYearsMember",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "More than five years [Member]",
        "verboseLabel": "Later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r204",
      "r214",
      "r362",
      "r364",
      "r368"
     ]
    },
    "ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanOneMonthAndNotLaterThanTwoMonthsMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Past due 0-30 days [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one month and not later than two months."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r367",
      "r490"
     ]
    },
    "trib_LaterThanOneMonthsAndNotLaterThanFourMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LaterThanOneMonthsAndNotLaterThanFourMonthsMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Past due 31-120 days [Member]",
        "label": "Later Than One Months And Not Later Than Four Months Member",
        "terseLabel": "Past due 31-120 days [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanFiveYearsMember",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Between one and five years [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than five years."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r368"
     ]
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "In more than one year, but not more than two [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than two years."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r204",
      "r214",
      "r362",
      "r368",
      "r490"
     ]
    },
    "trib_LaterThanTwoYearAndNotLaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LaterThanTwoYearAndNotLaterThanFiveYearsMember",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In more than two years but not more than five [Member]",
        "label": "Later Than Two Year And Not Later Than Five Years Member",
        "terseLabel": "In more than two years but not more than five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5": {
       "parentTag": "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": -1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Lease liabilities",
        "positiveLabel": "Lease liabilities",
        "label": "Lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "ifrs-full_LeaseLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LeaseLiabilitiesMember",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r336",
      "r340"
     ]
    },
    "trib_LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails": {
       "parentTag": "trib_CurrentFinanceLeaseLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease liabilities related to right of use assets current.",
        "label": "Lease Liabilities Related To Right Of Use Assets Current",
        "terseLabel": "Lease liabilities related to Right of Use assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LeaseLiabilitiesRelatedToRightOfUseAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LeaseLiabilitiesRelatedToRightOfUseAssetsMember",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease liabilities related Right of Use assets [Member]",
        "label": "Lease Liabilities Related To Right Of Use Assets Member",
        "terseLabel": "Lease liabilities related Right of Use assets [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease liabilities related to right of use assets non-current.",
        "label": "Lease Liabilities Related To Right Of Use Assets Non Current",
        "verboseLabel": "Lease liabilities related to Right of Use assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LeasePayableOnRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LeasePayableOnRightOfUseAssets",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payable on right of use assets.",
        "label": "Lease payable on Right of Use assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LeasePayableOnRightOfUseAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LeasePayableOnRightOfUseAssetsMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease payable on Right of Use assets [Member]",
        "label": "Lease payable on Right of Use assets [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LeasePayableOnSaleAndLeasebackTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LeasePayableOnSaleAndLeasebackTransactions",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payable on sale and leaseback transactions.",
        "label": "Lease Payable On Sale And Leaseback Transactions",
        "terseLabel": "Lease payable on sale &amp; leaseback transactions"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LeasePayableOnSaleLeasebackTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LeasePayableOnSaleLeasebackTransactionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease payable on sale &amp; leaseback transactions [Member]",
        "label": "Lease payable on sale &amp; leaseback transactions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold improvements [member]",
        "terseLabel": "Leasehold improvements [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "ifrs-full_LegalProceedingsProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LegalProceedingsProvision",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails": {
       "parentTag": "ifrs-full_Provisions",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails",
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails",
      "http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal proceedings provision",
        "terseLabel": "Provision",
        "verboseLabel": "Legal &amp; regulatory provision"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of provision for legal proceedings. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r322",
      "r324"
     ]
    },
    "trib_LenderMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LenderMember",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stand for lender.",
        "label": "Lender [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Level1OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Level1OfFairValueHierarchyMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 1 [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r112",
      "r115",
      "r184"
     ]
    },
    "ifrs-full_Level2OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Level2OfFairValueHierarchyMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 2 [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r115",
      "r184"
     ]
    },
    "ifrs-full_Level3OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Level3OfFairValueHierarchyMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 3 of fair value hierarchy [member]",
        "terseLabel": "Level 3 [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r115",
      "r184"
     ]
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LevelsOfFairValueHierarchyAxis",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [Axis]",
        "verboseLabel": "Levels of fair value hierarchy [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r184"
     ]
    },
    "ifrs-full_LevelsOfFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LevelsOfFairValueHierarchyDomain",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r184"
     ]
    },
    "ifrs-full_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r183",
      "r184",
      "r185",
      "r282",
      "r287"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Fixed rate financial liabilities (lease payables)",
        "periodEndLabel": "Balance at December 31, 2022",
        "periodStartLabel": "Balance at January 1, 2022",
        "label": "Liabilities arising from financing activities",
        "verboseLabel": "Fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesAxis",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesDomain",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "trib_LiabilitiesAtAmortisedCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LiabilitiesAtAmortisedCostAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities At Amortised Cost Abstract",
        "terseLabel": "Liabilities at amortised cost"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LicenceFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LicenceFee",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licence fees.",
        "label": "Licence Fee",
        "terseLabel": "Licence fees"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LicenceFeePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LicenceFeePayments",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued liabilities to contracted licence payments.",
        "negatedLabel": "Licence payments",
        "negatedTerseLabel": "Fixed rate financial liabilities (licence fees)",
        "label": "Licence Fee Payments",
        "verboseLabel": "Accrued liabilities to contracted licence payments"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LicencePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LicencePaymentsMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licence payments [Member]",
        "label": "Licence payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LiquidityRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LiquidityRiskMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity risk [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r210",
      "r211",
      "r212",
      "r356"
     ]
    },
    "trib_LoanIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LoanIncome",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/OtherOperatingIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of orginal loan income.",
        "label": "Loan Income"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LoanOriginationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LoanOriginationCosts",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "disclosureGuidance": "Loan drawdown costs",
        "documentation": "Represents the amount of loan origination costs.",
        "negatedLabel": "Loan origination costs",
        "positiveLabel": "Loan origination costs",
        "label": "Loan Origination Costs",
        "terseLabel": "Loan origination costs",
        "verboseLabel": "Loan origination costs"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LoansAndReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LoansAndReceivablesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans And Receivables Abstract",
        "terseLabel": "Loans and receivables at amortised cost"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LoansPayableInDefault": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LoansPayableInDefault",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/OtherOperatingIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans payable in default"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of loans payable in default."
       }
      }
     },
     "auth_ref": [
      "r255"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "trib_LongLivedAsstesBySegment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LongLivedAsstesBySegment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long Lived Asstes By Segment",
        "terseLabel": "Long lived asstes"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LongTermGrowthRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LongTermGrowthRate",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term growth rate.",
        "label": "Long Term Growth Rate",
        "terseLabel": "Long term growth rate",
        "verboseLabel": "Long-term growth rate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LongtermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LongtermBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exchangeable note",
        "negatedTerseLabel": "Fixed rate financial liabilities (exchangeable note)",
        "periodEndLabel": "Balance at 31 December",
        "periodStartLabel": "Balance at 1 January",
        "label": "Exchangeable notes and other borrowings",
        "terseLabel": "Exchangeable notes",
        "verboseLabel": "Exchangeable senior notes"
       }
      },
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ifrs-full_LongtermBorrowingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LongtermBorrowingsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings &amp; derivative financial instruments [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for long-term borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r336",
      "r340"
     ]
    },
    "trib_LossOnDisposalOfExchangeableNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LossOnDisposalOfExchangeableNotes",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails",
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of loss on disposal of exchangeable notes.",
        "negatedLabel": "Loss on disposal of exchangeable notes",
        "label": "Loss On Disposal Of Exchangeable Notes",
        "terseLabel": "Loss on disposal of Exchangeable Notes"
       }
      }
     },
     "auth_ref": []
    },
    "trib_LossOnDisposalOnBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "LossOnDisposalOnBorrowings",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss on disposal on borrowings.",
        "label": "Loss On Disposal On Borrowings",
        "terseLabel": "Loss on disposal"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "LossesOnDisposalsOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveLabel": "Loss on the disposal of property, plant and equipment",
        "label": "(Profit)/Loss on the disposal of property, plant and equipment",
        "terseLabel": "(Gain)/Loss on the disposal of property, plant and equipment",
        "verboseLabel": "(Profit)/Loss on the disposal of property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The losses on the disposal of property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Major Customers [Axis]",
        "verboseLabel": "Customer [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ManufacturingAndQualityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ManufacturingAndQualityMember",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing and quality [Member]",
        "label": "Manufacturing and quality [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MardxDiagnosticsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MardxDiagnosticsIncMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mardx Diagnostics Inc. [Member]",
        "label": "Mardx Diagnostics Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MaturityAxis",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails",
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [Axis]",
        "verboseLabel": "Maturity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r192",
      "r202",
      "r204",
      "r207",
      "r208",
      "r209",
      "r214",
      "r257",
      "r271",
      "r318",
      "r362"
     ]
    },
    "trib_MaturityDateForLease": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MaturityDateForLease",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturity date",
        "label": "Maturity Date For Lease",
        "terseLabel": "Maturity date"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MaturityDateOfExchangeableSeniorNotes": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MaturityDateOfExchangeableSeniorNotes",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturity date of exchangeable senior notes.",
        "label": "Maturity date of exchangeable senior notes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MaturityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MaturityDomain",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails",
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r192",
      "r202",
      "r204",
      "r207",
      "r208",
      "r209",
      "r214",
      "r257",
      "r318",
      "r362",
      "r365"
     ]
    },
    "ifrs-full_MaximumExposureToCreditRisk": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MaximumExposureToCreditRisk",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMaximumCreditExposureOfFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total maximum credit exposure",
        "label": "Maximum exposure to credit risk",
        "terseLabel": "Total maximum credit exposure"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that best represents the maximum exposure to credit risk without taking into account any collateral held or other credit enhancements (for example, netting agreements that do not qualify for offset in accordance with IAS 32). [Refer: Credit risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r265"
     ]
    },
    "ifrs-full_MaximumExposureToCreditRiskOfLoansOrReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MaximumExposureToCreditRiskOfLoansOrReceivables",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Exposure to credit risk for trade receivables and finance lease income receivable"
       }
      },
      "en": {
       "role": {
        "documentation": "The maximum exposure to the credit risk of loans or receivables. [Refer: Loans and receivables; Credit risk [member]; Maximum exposure to credit risk]"
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MaximumWeightedAveragePriceOfAmericanDepositoryShares": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MaximumWeightedAveragePriceOfAmericanDepositoryShares",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum weighted average price of American Depository Shares.",
        "label": "Maximum Weighted Average Price Of American Depository Shares",
        "terseLabel": "Maximum weighted average price of ADS"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "trib_MeasurementPeriodAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MeasurementPeriodAdjustmentMember",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Period Adjustment [Member]",
        "label": "Measurement Period Adjustment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MetabolomicDiagnosticsLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MetabolomicDiagnosticsLimitedMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member is stand for Metabolomic Diagnostics Limited.",
        "label": "Metabolomic Diagnostics Limited [Member]",
        "verboseLabel": "Metabolomic Diagnostics Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MetabolomicsDiagnosticsLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MetabolomicsDiagnosticsLimitedMember",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Metabolomics Diagnostics Limited [Member]",
        "label": "Metabolomics Diagnostics Limited [Member]",
        "terseLabel": "Metabolomics [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MicoLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MicoLtdMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MiCO LTD.",
        "label": "Mico Ltd [Member]",
        "terseLabel": "MiCo Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MidTierHaemoglobinsInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MidTierHaemoglobinsInstrumentMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mid-tier haemoglobins instrument [Member]",
        "label": "Mid-tier haemoglobins instrument [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MinimumFinanceLeasePaymentsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MinimumFinanceLeasePaymentsPayable",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of payments over the finance lease term that the lessee is or can be required to make, excluding contingent rent, costs for services and taxes to be paid by, and reimbursed to, the lessor, together with any amounts guaranteed by the lessee or by a party related to the lessee.",
        "label": "Minimum Finance Lease Payments Payable",
        "terseLabel": "Minimum lease payments"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MinimumFinanceLeasePaymentsPayableAtCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MinimumFinanceLeasePaymentsPayableAtCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Carrying value of minimum finance lease payments payable.",
        "label": "Minimum Finance Lease Payments Payable At Carrying Amount",
        "terseLabel": "Carrying value"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MinimumFinanceLeasePaymentsPayableAtPresentValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MinimumFinanceLeasePaymentsPayableAtPresentValue",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails",
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The present value of minimum finance lease payments payable. [Refer: Minimum finance lease payments payable]",
        "negatedLabel": "Fixed rate financial liabilities (lease payables)",
        "label": "Minimum Finance Lease Payments Payable At Present Value",
        "terseLabel": "Principal",
        "verboseLabel": "Fair value"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MinimumFinanceLeasePaymentsReceivableAtPresentValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MinimumFinanceLeasePaymentsReceivableAtPresentValue",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfMaximumCreditExposureOfFinancialAssetsDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease receivable.",
        "positiveLabel": "Finance lease receivable",
        "positiveTerseLabel": "Finance lease income receivable",
        "label": "Minimum Finance Lease Payments Receivable At Present Value",
        "terseLabel": "Financial assets (lease receivables)",
        "verboseLabel": "Lease receivable"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MinimumLiquidityCovenant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MinimumLiquidityCovenant",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of minimum liquidity covenant",
        "label": "Minimum Liquidity Covenant",
        "verboseLabel": "Minimum Liquidity Covenant"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MiscellaneousNoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "MiscellaneousNoncurrentAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Miscellaneous non-current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "trib_MoreThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MoreThanOneYearMember",
     "presentation": [
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "More Than One Year [Member]",
        "label": "More Than One Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MovementInInterestAccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MovementInInterestAccrual",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Movement in interest accrual.",
        "label": "Movement In Interest Accrual",
        "terseLabel": "Movement in interest accrual"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MrOCaoimhAndDrWalshMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MrOCaoimhAndDrWalshMember",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mr. O'Caoimh and Dr Walsh [Member]",
        "label": "Mr O Caoimh And Dr Walsh Member",
        "terseLabel": "Mr. O'Caoimh and Dr Walsh [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_MrOCaoimhMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "MrOCaoimhMember",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mr. O'Caoimh [Member]",
        "label": "Mr O Caoimh Member",
        "terseLabel": "Mr. O'Caoimh [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails"
     ],
     "auth_ref": []
    },
    "ifrs-full_NameOfSubsidiary": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NameOfSubsidiary",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The name of a subsidiary. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r97",
      "r163",
      "r165"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "trib_NativeDesignLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NativeDesignLimitedMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member is stand for Native Design Limited.",
        "label": "Native Design Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NetCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NetCarryingAmountMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amounts [Member]",
        "label": "Net Carrying Amount Member",
        "terseLabel": "Carrying amounts [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NetCashOutFlowOnBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NetCashOutFlowOnBusinessCombination",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash outflow, net of cash acquired on business combination, recognised at acquisition date.",
        "label": "Net Cash Out Flow On Business Combination",
        "totalLabel": "Net cash outflow",
        "verboseLabel": "Net cash outflow"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NetCashOutflowArisingOnAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NetCashOutflowArisingOnAcquisitionAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Outflow Arising On Acquisition [Abstract]",
        "terseLabel": "Net cash outflow \u2013 arising on acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NetDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NetDeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net deferred tax assets",
        "terseLabel": "Total assets as reported in the Group balance sheet",
        "totalLabel": "Total assets as reported in the Group balance sheet"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "ifrs-full_NetDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NetDeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net deferred tax liabilities",
        "totalLabel": "Total liabilities as reported in the Group balance sheet",
        "verboseLabel": "Total liabilities as reported in the Group balance sheet"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "trib_NetFinancingExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NetFinancingExpenseIncome",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net financing (expense)/income.",
        "label": "Net Financing Expense Income",
        "totalLabel": "Net financing expense"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NetForeignExchangeGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NetForeignExchangeGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net foreign exchange gain (loss).",
        "label": "Net Foreign Exchange Gain Loss",
        "terseLabel": "Net foreign exchange differences"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NetInterestIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NetInterestIncome",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the net interest income.",
        "label": "Net Interest Income",
        "terseLabel": "Net interest income"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NetOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NetOperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carryforwards.",
        "label": "Net operating loss carryforwards"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NetOperatingLossPeriod": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NetOperatingLossPeriod",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description net operating loss period.",
        "label": "Net operating loss period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NewProvisionsOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NewProvisionsOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesNarrativeDetails",
      "http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Released during the year",
        "label": "New provisions, other provisions",
        "verboseLabel": "Inventory provision released during the year"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised for new other provisions. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r513"
     ]
    },
    "trib_NominalAmountOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NominalAmountOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal amount of debt.",
        "label": "Nominal Amount Of Debt",
        "terseLabel": "Nominal amount of debt"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NominalValuePerShareOfExchangeableNotes": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NominalValuePerShareOfExchangeableNotes",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal value per share of the Exchangeable Notes.",
        "label": "Nominal Value Per Share Of Exchangeable Notes",
        "terseLabel": "Nominal value per share of the Exchangeable Notes"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NonCashActivityForFinancingActivityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NonCashActivityForFinancingActivityAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non cash activity for financing activity.",
        "label": "Non Cash Activity For Financing Activity Abstract",
        "terseLabel": "Non-cash:",
        "verboseLabel": "Non-cash:"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NonCashFairValueGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NonCashFairValueGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of non-cash fair value gain (loss).",
        "label": "Non Cash Fair Value Gain Loss",
        "terseLabel": "Non-cash fair value gain (loss)"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NonCashImpairmentCharge": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NonCashImpairmentCharge",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of non cash impairment charge.",
        "label": "Non-cash impairment charge"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NonCurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NonCurrentAssetsMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent information about the non-current assets member.",
        "label": "Non Current Assets [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NonCurrentLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NonCurrentLeaseLiabilitiesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Current Lease Liabilities Abstract",
        "terseLabel": "Non-Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NonCurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NonCurrentLiabilitiesMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails3",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent information about the non-current liabilities member.",
        "label": "Non Current Liabilities [Member]",
        "terseLabel": "Non-current liability [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r398",
      "r409",
      "r419",
      "r443",
      "r452"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "trib_NonRadingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NonRadingCosts",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of non-trading costs.",
        "label": "Non Rading Costs",
        "terseLabel": "Non-trading costs"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "trib_NonTradingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NonTradingCosts",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of non-trading costs.",
        "label": "Non Trading Costs",
        "terseLabel": "Non-trading costs"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/OtherOperatingIncomeDetails",
      "http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonadjusting Events After Reporting Period Axis",
        "terseLabel": "Non-adjusting events after reporting period [axis]",
        "verboseLabel": "Non-adjusting events after reporting period [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodDomain",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/OtherOperatingIncomeDetails",
      "http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "trib_NoncashInterestOnConvertibleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NoncashInterestOnConvertibleNote",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of non-cash interest on convertible note.",
        "negatedLabel": "Non-cash interest on convertible note",
        "label": "Noncash Interest On Convertible Note"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NoncashInterestOnSeniorSecuredTermLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NoncashInterestOnSeniorSecuredTermLoan",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of non-cash interest on senior secured term loan.",
        "negatedTerseLabel": "Non-cash interest on senior secured term loan",
        "label": "Noncash Interest On Senior Secured Term Loan",
        "terseLabel": "Non-cash interest on senior secured term loan"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NoncashLoanModificationGain": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NoncashLoanModificationGain",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan",
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of non-cash loan modification gain.",
        "label": "Non-cash Loan Modification Gain",
        "terseLabel": "Non cash loan modification gain"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-controlling interests",
        "verboseLabel": "Equity investments in Novus"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r20",
      "r162",
      "r164"
     ]
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets [Default Label]",
        "totalLabel": "Total non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r169",
      "r341"
     ]
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentAssetsAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentAssetsHeldForSaleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentAssetsHeldForSaleMember",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets held for sale [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for non-current assets that are available for immediate sale in their present condition, subject only to terms that are usual and customary for sales of such assets, and for which sale is highly probable. [Refer: Non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r342",
      "r344",
      "r530"
     ]
    },
    "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets or disposal groups classified as held for sale or as held for distribution to owners",
        "totalLabel": "Total net assets disposed"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Non-current assets or disposal groups classified as held for distribution to owners; Non-current assets or disposal groups classified as held for sale]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "ifrs-full_NoncurrentDerivativeFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentDerivativeFinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveTerseLabel": "Derivative asset \u2013 prepayment option",
        "label": "Non-current derivative financial assets",
        "terseLabel": "Derivative financial instruments",
        "verboseLabel": "Exchangeable note bond call option"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current derivative financial assets. [Refer: Derivative financial assets]"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ifrs-full_NoncurrentDerivativeFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentDerivativeFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Derivative liability - warrants",
        "label": "Non-current derivative financial liabilities",
        "totalLabel": "Total non-current liabilities",
        "verboseLabel": "Derivative financial liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "trib_NoncurrentFinanceLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NoncurrentFinanceLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liabilities.",
        "label": "Noncurrent Finance Lease Liabilities",
        "totalLabel": "Non-current liabilities",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentFinanceLeaseReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentFinanceLeaseReceivables",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/OtherNon-currentAssetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/OtherNon-currentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "non current Finance lease receivables",
        "terseLabel": "Finance lease receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current finance lease receivables. [Refer: Finance lease receivables]"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ifrs-full_NoncurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentFinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current financial assets",
        "terseLabel": "Financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities [Default Label]",
        "totalLabel": "Total non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r26",
      "r171",
      "r341"
     ]
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentLiabilitiesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentPortionOfOtherNoncurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentPortionOfOtherNoncurrentBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Senior secured term loan",
        "negatedTerseLabel": "Variable rate financial liabilities (senior secured term loan)",
        "label": "Non-current portion of other non-current borrowings",
        "terseLabel": "Senior secured term loan",
        "verboseLabel": "Variable rate financial liabilities (senior secured term loan)"
       }
      },
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current other borrowings. [Refer: Other borrowings]"
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "ifrs-full_NoncurrentProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentProvisions",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
      "http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current provisions",
        "terseLabel": "Provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "ifrs-full_NoncurrentReceivablesFromContractsWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NoncurrentReceivablesFromContractsWithCustomers",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over time"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current receivables from contracts with customers. [Refer: Receivables from contracts with customers]"
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "ifrs-full_NongovernmentCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NongovernmentCustomersMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-government customers [Member]",
        "terseLabel": "Non-governmental organisations [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for non-government customers. [Refer: Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NotLaterThanOneYearMember",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less than one year [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r202",
      "r204",
      "r214",
      "r362",
      "r368"
     ]
    },
    "ifrs-full_NotesAndDebenturesIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NotesAndDebenturesIssued",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of exchangeable senior notes"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of notes and debentures issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "trib_NotesAndDebenturesPurchased": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NotesAndDebenturesPurchased",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchased of exchangeable senior notes.",
        "label": "Notes And Debentures Purchased",
        "terseLabel": "Repurchased of exchangeable senior notes"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NotesAndDebenturesRetired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NotesAndDebenturesRetired",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents notes and debenture retired amount.",
        "label": "Notes And Debentures Retired",
        "verboseLabel": "Notes and debenture retired"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NotionalAmount",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/PostBalanceSheetEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notional amount",
        "terseLabel": "Face amount of loan"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "trib_NovaCenturyScientificIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NovaCenturyScientificIncMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Nova Century Scientific Inc.",
        "label": "Nova Century Scientific Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NovusDiagnosticsLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NovusDiagnosticsLimitedMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Novus Diagnostics Limited.",
        "label": "Novus Diagnostics Limited [Member]",
        "verboseLabel": "Novus"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfAOrdinaryWeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfAOrdinaryWeightedAverageShares",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of A ordinary weighted average shares.",
        "periodEndLabel": "At period end",
        "periodStartLabel": "Number of \u2018A\u2019 ordinary shares at January 1",
        "positiveTerseLabel": "Number of \u2018A\u2019 ordinary shares at January 1",
        "label": "Number Of A Ordinary Weighted Average Shares",
        "terseLabel": "Number of warrant issued",
        "totalLabel": "Total number of shares issued"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfAmericanDepositorySharesWeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfAmericanDepositorySharesWeightedAverageShares",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of American Depository Shares, weighted average shares.",
        "periodEndLabel": "At period end",
        "periodStartLabel": "Number of shares at January 1",
        "positiveTerseLabel": "Number of ADS at January 1 (Note 18)",
        "label": "Number Of American Depository Shares Weighted Average Shares",
        "terseLabel": "Number of warrant issued",
        "totalLabel": "Total number of shares issued"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfLeasesWithExtensionOptions": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfLeasesWithExtensionOptions",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of leases with extension options.",
        "label": "Number Of Leases With Extension Options",
        "terseLabel": "No. of Leases with extension options"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfLeasesWithOptionsToPurchase": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfLeasesWithOptionsToPurchase",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of leases with options to purchase.",
        "label": "Number Of Leases With Options To Purchase",
        "terseLabel": "No. of Leases with options to purchase"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfLeasesWithTerminationOptions": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfLeasesWithTerminationOptions",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of leases with termination options.",
        "label": "Number Of Leases With Termination Options",
        "terseLabel": "No. of leases with termination options"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfLeasesWithVariablePaymentsLinkedToIndex": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfLeasesWithVariablePaymentsLinkedToIndex",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of leases with variable payments linked to index.",
        "label": "Number Of Leases With Variable Payments Linked To Index",
        "terseLabel": "No. of leases with variable payments linked to index"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfOptionsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfOptionsGranted",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options granted.",
        "label": "Number Of Options Granted",
        "terseLabel": "Number of options granted"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfOptionsIssuable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfOptionsIssuable",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options issuable.",
        "label": "Number Of Options Issuable",
        "terseLabel": "Number of options issuable"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfOptionsLapsedUnexercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfOptionsLapsedUnexercised",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options lapsed unexercised.",
        "label": "Number Of Options Lapsed Unexercised",
        "terseLabel": "Number of options lapsed unexercised"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfOrdinarySharesIssuableOnExerciseOfOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfOrdinarySharesIssuableOnExerciseOfOptions",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ordinary shares issuable on exercise of options.",
        "label": "Number Of Ordinary Shares Issuable On Exercise Of Options",
        "terseLabel": "Number of ordinary shares issuable on exercise of options"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfOutstandingShareOptions",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails",
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails",
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding at end of year",
        "periodStartLabel": "Outstanding Beginning Balance",
        "label": "Number of share options outstanding in share-based payment arrangement",
        "verboseLabel": "Number of options"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r221",
      "r225"
     ]
    },
    "ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of potential ordinary shares that are antidilutive in period presented",
        "terseLabel": "Total number of potentially dilutive instruments excluded from the weighted average number of \u2018A\u2019 ordinary shares in calculating dilutive (loss)/earnings per \u2018A\u2019 ordinary share/earnings per ADS",
        "verboseLabel": "Diluted earnings per share denominator"
       }
      },
      "en": {
       "role": {
        "documentation": "Number of potential ordinary shares that are antidilutive in the period presented."
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "trib_NumberOfRetiredDirectorOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfRetiredDirectorOptions",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options of retired director in share-based payment arrangement.",
        "label": "Number Of Retired Director Options",
        "terseLabel": "Options of retired director"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfRetiredDirectorShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfRetiredDirectorShares",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of retired director in share-based payment arrangement.",
        "label": "Number Of Retired Director Shares",
        "terseLabel": "Shares of retired director"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfRightOfUseLeasedAssets": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfRightOfUseLeasedAssets",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Right-of-Use leased assets.",
        "label": "Number Of Right Of Use Leased Assets",
        "terseLabel": "No. of Right-of-Use leased assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Exercisable at end of year",
        "label": "Number of share options exercisable in share-based payment arrangement",
        "verboseLabel": "Number of Options"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercisable in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "trib_NumberOfShareOptionsExercisableShareBasedPayment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfShareOptionsExercisableShareBasedPayment",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of share options exercisable in a share-based payment arrangement.",
        "label": "Number Of Share Options Exercisable Share Based Payment",
        "terseLabel": "Number of options"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exercised",
        "label": "Number of share options exercised in share-based payment arrangement",
        "terseLabel": "Ordinary shares issued from exercise of employee share options",
        "verboseLabel": "Number of share options exercised"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expired / forfeited",
        "label": "Number of share options expired in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options expired in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r220"
     ]
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expired/ Forfeited",
        "label": "Number of share options forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r217"
     ]
    },
    "ifrs-full_NumberOfSharesAuthorised": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfSharesAuthorised",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Authorised share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares authorised."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "trib_NumberOfSharesIssuableExerciseOfWarrantsToPerceptive": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfSharesIssuableExerciseOfWarrantsToPerceptive",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issuable on exercise of warrants to perceptive.",
        "label": "Number Of Shares Issuable Exercise Of Warrants To Perceptive"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issuable on exercise of warrants to perceptive.",
        "label": "Number Of Shares Issuable On Exercise Of Warrants To Perceptive",
        "terseLabel": "Issuable on exercise of warrants to Perceptive"
       }
      }
     },
     "auth_ref": []
    },
    "trib_NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptiveExercisePricePerShare",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issuable on exercise of warrants to perceptive exercise price per share.",
        "label": "Number Of Shares Issuable On Exercise Of Warrants To Perceptive Exercise Price Per Share",
        "terseLabel": "Number of shares issuable on exercise of warrants to perceptive exercise price per share"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails",
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "At period end",
        "periodStartLabel": "Number of shares at January 1",
        "positiveTerseLabel": "Number of ADS at January 1 (Note 18)",
        "label": "Number of shares issued",
        "terseLabel": "Number of ADSs issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "trib_NumberOfSharesIssuedOnExerciseOfOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfSharesIssuedOnExerciseOfOptions",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued on the exercise of options.",
        "label": "Number Of Shares Issued On Exercise Of Options",
        "terseLabel": "Number of shares issued on the exercise of options"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "NumberOfSharesOutstanding",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "At period end",
        "periodStartLabel": "Balance at January 1",
        "label": "Number of shares outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "trib_NumberOfWarrantsRepriced": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "NumberOfWarrantsRepriced",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of warrants repriced.",
        "label": "Number Of Warrants Repriced",
        "terseLabel": "Number of warrants repriced"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office equipment and fittings [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "trib_OnceOffExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OnceOffExpense",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents the amount of once off items.",
        "negatedLabel": "Once off items",
        "label": "Once Off Expense"
       }
      }
     },
     "auth_ref": []
    },
    "trib_OnceOffTaxCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OnceOffTaxCredit",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Once-off tax credit.",
        "label": "Once Off Tax Credit"
       }
      }
     },
     "auth_ref": []
    },
    "trib_OneYearToTwoYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OneYearToTwoYearsMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1-2 years [Member]",
        "label": "One Year To Two Years Member",
        "terseLabel": "1-2 years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_OpeningSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OpeningSharePrice",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the opening share price.",
        "label": "Opening Share Price",
        "terseLabel": "Opening share price"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OperatingExpense",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Operating expenses",
        "label": "Operating expense",
        "verboseLabel": "Operating expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of all operating expenses."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "trib_OptionsAndWarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OptionsAndWarrantsAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options And Warrants Abstract",
        "terseLabel": "Options and warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherAdjustmentsForNoncashItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherAdjustmentsForNoncashItems",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other non-cash items"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "trib_OtherAssetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OtherAssetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/OtherNon-currentAssetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/OtherNon-currentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other remaining assets non current.",
        "label": "Other Asset Noncurrent",
        "verboseLabel": "Other assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other borrowings",
        "label": "Other borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "trib_OtherBorrowingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OtherBorrowingsMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other borrowings [Member]",
        "label": "Other borrowings [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income",
        "totalLabel": "Other comprehensive profit/(loss)",
        "verboseLabel": "Other comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r37",
      "r44",
      "r175"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive loss",
        "terseLabel": "Other comprehensive profit/(loss)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome": {
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign exchange translation differences"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r27",
      "r44"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome": {
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Items that will be reclassified subsequently to profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r309",
      "r310"
     ]
    },
    "trib_OtherCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OtherCountriesMember",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfDepreciationAndAmortisationByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfLongLivedAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfShareBasedPaymentExpenseByGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfTaxationExpenseByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Countries [Member]",
        "label": "Other Countries [Member]",
        "verboseLabel": "Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_OtherCurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OtherCurrentBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note.",
        "negatedLabel": "Other borrowings",
        "label": "Other Current Borrowings",
        "terseLabel": "Other payables"
       }
      }
     },
     "auth_ref": []
    },
    "trib_OtherEmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OtherEmployeesMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other employees [Member]",
        "label": "Other employees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_OtherEuropeanCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OtherEuropeanCountriesMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other European countries [Member]",
        "label": "Other European countries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails": {
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income",
        "verboseLabel": "Government grants"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of operating income that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r301",
      "r302"
     ]
    },
    "ifrs-full_OtherIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "ifrs-full_OtherIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherIntangibleAssetsMember",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfAmortisationDetails",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets [Member]",
        "terseLabel": "Other (including acquired customer and supplier lists) [Member]",
        "verboseLabel": "Other [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "trib_OtherItemsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OtherItemsMember",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other item [Member]",
        "label": "Other items [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_OtherNonCurrentAssets": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OtherNonCurrentAssets",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Non Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/OtherNon-currentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/OtherNon-currentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other non-current assets",
        "totalLabel": "Total other assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ifrs-full_OtherNoncurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherNoncurrentFinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherOperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      },
      "http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other operating income (expense)",
        "terseLabel": "Other operating (expense)/income",
        "totalLabel": "Other operating income",
        "verboseLabel": "Other operating income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "trib_OtherOperatingIncomeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OtherOperatingIncomeLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/OtherOperatingIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line item for Other Operating Income.",
        "label": "Other Operating Income [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_OtherOperatingIncomeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OtherOperatingIncomeTable",
     "presentation": [
      "http://trinitybiotech.com/role/OtherOperatingIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of Other Operating Income.",
        "label": "Other Operating Income [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "trib_OtherProjectsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OtherProjectsMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Projects with Spend less than US$100,000 in 2016 [Member]",
        "label": "Other Projects [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherPropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherPropertyPlantAndEquipmentMember",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "measurementGuidance": "Plant &amp; Equipment, Vehicles [Member]",
        "label": "Other property, plant and equipment [member]",
        "verboseLabel": "Plant and Equipment, vehicles [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing property, plant and equipment that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "ifrs-full_OtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherProvisions",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails": {
       "parentTag": "ifrs-full_Provisions",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails",
      "http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Closing provision at December 31",
        "periodStartLabel": "Opening provision at January 1",
        "label": "Other provisions",
        "terseLabel": "Disposal-related warranty settlement provision"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of provisions other than provisions for employee benefits. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r29",
      "r119"
     ]
    },
    "ifrs-full_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other receivables",
        "terseLabel": "Other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r306"
     ]
    },
    "trib_OtherRegionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OtherRegionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other regions [Member]",
        "label": "Other regions [Member]",
        "verboseLabel": "Other regions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherReserves",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other reserves"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]"
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "ifrs-full_OtherReservesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherReservesMember",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other reserves [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "trib_OtherRestructuringCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OtherRestructuringCostsMember",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Restructuring Costs [Member]",
        "label": "Other Restructuring Costs [Member]",
        "terseLabel": "Other restructuring costs [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherRevenue",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inter-segment revenue",
        "verboseLabel": "Revenue from other sources"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other items"
       }
      },
      "en": {
       "role": {
        "documentation": "Tax rate effects, in aggregate, on the reconciliation between the average effective tax rate and the applicable tax rate that the entity does not separately disclose in the reconciliation. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "trib_OutsourcingCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OutsourcingCostsMember",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outsourcing Costs [Member]",
        "label": "Outsourcing Costs [Member]",
        "terseLabel": "Outsourcing costs [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_OutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OutstandingAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Abstract",
        "terseLabel": "Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r396",
      "r407",
      "r417",
      "r450"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r399",
      "r410",
      "r420",
      "r453"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r399",
      "r410",
      "r420",
      "r453"
     ]
    },
    "trib_OverheadCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "OverheadCosts",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of overhead costs.",
        "label": "Overhead Costs",
        "terseLabel": "Overhead costs"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ParValuePerShare",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Par value of share"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "ifrs-full_PastDueStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PastDueStatusAxis",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Past due status [Axis]",
        "verboseLabel": "Past due status [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "ifrs-full_PastDueStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PastDueStatusDomain",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all past-due statuses. It also represents the standard value for the 'Past due status' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "trib_PatentDividendSchemeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PatentDividendSchemeAmount",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent dividend scheme amount.",
        "label": "Patent dividend scheme amount"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "trib_PaycheckProtectionProgramLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PaycheckProtectionProgramLoanMember",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/OtherOperatingIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paycheck Protection Program Loan [Member]",
        "label": "Paycheck Protection Program Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PaymentInKindInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PaymentInKindInterest",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represets payment in kind Interest.",
        "negatedLabel": "Payment-in-kind (PIK) Interest",
        "label": "Payment In Kind Interest"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PaymentOfPenalty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PaymentOfPenalty",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of payment penalty.",
        "label": "Payment Of Penalty",
        "terseLabel": "Payment of penalty"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PaymentsForCEOServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PaymentsForCEOServices",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for CEO Services.",
        "label": "Payments For C E O Services",
        "verboseLabel": "Payments for CEO Services"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsForDevelopmentProjectExpenditure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PaymentsForDevelopmentProjectExpenditure",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfCapitalExpenditureByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital expenditure"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for expenditure related to development projects."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "ifrs-full_PaymentsForShareIssueCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PaymentsForShareIssueCosts",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expenses paid in connection with debt financing",
        "label": "Payments for share issue costs",
        "terseLabel": "Expenses paid in connection with debt financing"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for share issue costs."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of lease liabilities",
        "negatedTerseLabel": "Repayment of leases",
        "label": "Payments of lease liabilities, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "trib_PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents payments to acquire financial asset classified as investing activities.",
        "negatedLabel": "Payments to acquire financial asset",
        "label": "Payments To Acquire Financial Asset Classified As Investing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents payments to acquire trades or businesses classified as investing activities.",
        "negatedLabel": "Payments to acquire trades or businesses",
        "label": "Payments To Acquire Trades Or Businesses Classified As Investing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "trib_PenaltiesPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PenaltiesPayments",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Penalties payments.",
        "label": "Penalties payments"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PenaltyForEarlySettlementCharged": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PenaltyForEarlySettlementCharged",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Penalty for early settlement charged.",
        "label": "Penalty For Early Settlement Charged",
        "terseLabel": "Penalty for early settlement charged"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PenaltyForEarlySettlementOfTermLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PenaltyForEarlySettlementOfTermLoan",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 80.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents penalty for early settlement of term loan.",
        "label": "Penalty For Early Settlement Of Term Loan",
        "verboseLabel": "Penalty for early partial settlement of senior secured term loan"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PenaltyPaidForEarlySettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PenaltyPaidForEarlySettlement",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the Penalty Paid For Early Settlement.",
        "label": "Penalty Paid For Early Settlement",
        "terseLabel": "Penalty paid for early settlement of term loan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "trib_PercentageOfGrossInventory1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PercentageOfGrossInventory1",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of gross inventory.",
        "label": "Percentage Of Gross Inventory 1",
        "terseLabel": "Percentage of gross inventory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PercentageOfVotingEquityInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PercentageOfVotingEquityInterestsAcquired",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of voting equity interests acquired",
        "terseLabel": "Percentage of minority shareholding",
        "verboseLabel": "Percentage of equity acquired"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r230"
     ]
    },
    "trib_PerceptiveCreditHoldingsIiiLpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PerceptiveCreditHoldingsIiiLpMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent information about the Perceptive Credit Holdings III, LP.",
        "label": "Perceptive Credit Holdings Iii, Lp [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PersonnelRelatedCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PersonnelRelatedCostsMember",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Personnel Related Costs [Member]",
        "terseLabel": "Personnel related costs [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PhoenixBioTechCorpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PhoenixBioTechCorpMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phoenix Bio Tech Corp [Member]",
        "label": "Phoenix Bio Tech Corp [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "trib_PointFivePercentageOfGrossInventoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PointFivePercentageOfGrossInventoryMember",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.5% of gross inventory [Member]",
        "label": "Point Five Percentage Of Gross Inventory Member",
        "terseLabel": "0.5% of gross inventory [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PointOfCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PointOfCareMember",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Point-of-Care [Member]",
        "label": "Point-of-Care [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PostDisposalAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PostDisposalAdjustmentMember",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for post disposal adjustment.",
        "label": "Post Disposal Adjustment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PostemploymentBenefitExpenseDefinedBenefitPlans",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails": {
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [domain]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r504",
      "r506"
     ]
    },
    "ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PostemploymentBenefitExpenseDefinedContributionPlans",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees contribution"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of post-employment benefit expense relating to defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "trib_PotentiallyDilutiveInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PotentiallyDilutiveInstrumentsAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Potentially Dilutive Instruments [Abstract]",
        "terseLabel": "Potentially Dilutive Instruments"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PreTaxDiscountRates": {
     "xbrltype": "percentItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PreTaxDiscountRates",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of pre tax discount rates.",
        "label": "Pre tax discount rates"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PremierInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PremierInstrumentMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premier Instrument for Haemoglobin A1c Testing [Member]",
        "label": "Premier Instrument Member",
        "terseLabel": "Premier Instruments for A1c and haemoglobinopathies testing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Prepayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Prepayments",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfBreakdownOfImpairmentLossDetailsUsd",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayments (see Note 18)",
        "verboseLabel": "Prepayments of impairment"
       }
      },
      "en": {
       "role": {
        "documentation": "Receivables that represent amounts paid for goods and services before they have been delivered."
       }
      }
     },
     "auth_ref": [
      "r306"
     ]
    },
    "trib_PrimusCorpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PrimusCorpMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primus Corp [Member]",
        "label": "Primus Corp [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PrimusCorporationCguTradeNameMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PrimusCorporationCguTradeNameMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsWithIndefiniteUsefulLivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primus Corporation CGU Trade Name [Member]",
        "label": "Primus Corporation CGU Trade Name [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PrimusCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PrimusCorporationMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Primus Corporation.",
        "label": "Primus Corporation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PrincipalActivity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PrincipalActivity",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal activity.",
        "label": "Principal Activity",
        "terseLabel": "Principal activity"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PrincipalAmountLoaned": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PrincipalAmountLoaned",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan",
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount loaned.",
        "negatedLabel": "Principal amount loaned",
        "positiveLabel": "Principal amount loaned",
        "label": "Principal Amount Loaned",
        "terseLabel": "Loan origination costs paid",
        "verboseLabel": "Principal amount loaned"
       }
      }
     },
     "auth_ref": []
    },
    "trib_PrincipalDevelopmentProjectsCapitalizedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PrincipalDevelopmentProjectsCapitalizedCosts",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of principal development projects.",
        "label": "Principal Development Projects Capitalized Costs",
        "terseLabel": "Capitalised development costs"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PrincipalPlaceOfBusiness": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PrincipalPlaceOfBusiness",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal place of business",
        "terseLabel": "Principal Country of incorporation and operation"
       }
      },
      "en": {
       "role": {
        "documentation": "The place where an entity principally conducts operations."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "trib_ProceedsForConvertibleNoteIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ProceedsForConvertibleNoteIssued",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents of proceeds for convertible note issued.",
        "label": "Proceeds For Convertible Note Issued",
        "terseLabel": "Proceeds from convertible note issued",
        "verboseLabel": "Principal amount loaned \u2013 convertible note"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveLabel": "Proceeds from Paycheck Protection loans",
        "label": "Proceeds from borrowings, classified as financing activities",
        "terseLabel": "Proceeds from borrowings",
        "verboseLabel": "Principal amount loaned \u2013 term loan"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 30.0
      },
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations",
        "terseLabel": "Proceeds from sale of business",
        "totalLabel": "Net cash inflow on date of disposal",
        "verboseLabel": "Proceeds from sale of business (net of transaction costs)"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the disposal of non-current assets or disposal groups classified as held for sale and discontinued operations. [Refer: Discontinued operations [member]; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale]"
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from government Covid-19 loan (Note 25)",
        "terseLabel": "Proceeds from government Covid-19 loan (Note 24)"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from government grants, classified as financing activities. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r510"
     ]
    },
    "ifrs-full_ProceedsFromIssueOfOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromIssueOfOrdinaryShares",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issue of ordinary shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]"
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromIssuingShares",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuing shares",
        "terseLabel": "Issue of ordinary share capital including share premium (net of issuance costs)",
        "verboseLabel": "Shares consideration"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "ifrs-full_ProceedsFromNoncurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProceedsFromNoncurrentBorrowings",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from non-current borrowings",
        "terseLabel": "Net proceeds from senior secured term loan"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from non-current borrowings obtained. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "trib_ProceedsFromSaleOfBusiness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ProceedsFromSaleOfBusiness",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of business.",
        "label": "Proceeds From Sale Of Business",
        "terseLabel": "Proceeds from sale of business",
        "verboseLabel": "Proceeds from sale of business (net of transaction costs)"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ProceedsFromSharesToBeIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ProceedsFromSharesToBeIssued",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represent of proceeds from shares to be issued.",
        "label": "Proceeds From Shares To Be Issued",
        "verboseLabel": "Proceeds from shares to be issued"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProductsAndServicesAxis",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [Axis]",
        "verboseLabel": "Products and services [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r347"
     ]
    },
    "ifrs-full_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r347"
     ]
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLossAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss",
        "totalLabel": "Loss for the year on continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r36",
      "r142",
      "r159",
      "r161",
      "r282",
      "r285",
      "r341",
      "r351"
     ]
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 0.0
      },
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 120.0
      },
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfComprehensiveIncome",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Profit/(Loss) after tax for the year",
        "positiveLabel": "Loss for the period",
        "label": "Profit (loss), attributable to owners of parent",
        "terseLabel": "Loss for the year",
        "totalLabel": "Loss for the year (all attributable to owners of the parent)"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfLossProfitBeforeTaxesDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfOverseasTaxJurisdictionsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveLabel": "Loss before taxation \u2013 continuing operations",
        "label": "Loss before tax",
        "terseLabel": "Profit/Loss before taxes",
        "totalLabel": "Loss before tax",
        "verboseLabel": "Profit/(Loss) before taxation - continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r247",
      "r301",
      "r302",
      "r369",
      "r370"
     ]
    },
    "ifrs-full_ProfitLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossFromContinuingOperations",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss for the year on continuing operations",
        "terseLabel": "Profit/Loss for the year on continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r36",
      "r173",
      "r282",
      "r285"
     ]
    },
    "ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings per ordinary share for continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing operations attributable to ordinary equity holders of the parent entity. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss) from continuing operations]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ifrs-full_ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted earnings per ordinary share for continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing operations attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss) from continuing operations]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ifrs-full_ProfitLossFromDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossFromDiscontinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLossAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "disclosureGuidance": "(Loss)/Profit for the year from discontinued operations",
        "positiveLabel": "(Loss)/profit for the year on discontinued operations",
        "label": "Profit (loss) from discontinued operations",
        "terseLabel": "Loss for the year from discontinued operations",
        "totalLabel": "Profit for the year from discontinued operations",
        "verboseLabel": "Profit/loss for the year on discontinued operations (Note 8)"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r43",
      "r48",
      "r174",
      "r246"
     ]
    },
    "ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss) from discontinued operations attributable to ordinary equity holders of parent entity",
        "terseLabel": "Basic (loss)/earnings per ordinary share for discontinued operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from discontinued operations attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss) from discontinued operations]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ifrs-full_ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss) from discontinued operations attributable to ordinary equity holders of parent entity including dilutive effects",
        "terseLabel": "Diluted (loss)/earnings per ordinary share for discontinued operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from discontinued operations attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss) from discontinued operations]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProfitLossFromOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveLabel": "Profit from operating activities",
        "label": "Profit (loss) from operating activities",
        "terseLabel": "Operating loss",
        "totalLabel": "Operating loss",
        "verboseLabel": "Profit from operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r319",
      "r496"
     ]
    },
    "trib_PropertyAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PropertyAndEquipmentMember",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plant and equipment [Member]",
        "label": "Property And Equipment Member",
        "terseLabel": "Plant and equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyDevelopmentAndProjectManagementExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyDevelopmentAndProjectManagementExpense",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Development costs not amortised"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from property development and project management."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5": {
       "parentTag": "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0,
       "order": 10.0
      },
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning year",
        "positiveLabel": "Property plant &amp; equipment",
        "label": "Property, plant and equipment",
        "verboseLabel": "Property, plant &amp; equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r67"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentByOperatingLeaseStatusAxis",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment by operating lease status [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentByOperatingLeaseStatusDomain",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfOutstandingInterestBearingLoansAndBorrowingsDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all property, plant and equipment when disaggregated by the operating lease status by a lessor. It also represents the standard value for the 'Property, plant and equipment by operating lease status' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentExpendituresRecognisedForConstructions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentExpendituresRecognisedForConstructions",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment under construction"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenditures recognised in the carrying amount of an item of property, plant and equipment in the course of its construction. [Refer: Carrying amount [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Depreciated cost at end of year",
        "label": "Property, plant and equipment, gross carrying amount of fully depreciated assets still in use"
       }
      },
      "en": {
       "role": {
        "documentation": "The gross carrying amount of fully depreciated property, plant and equipment that is still in use. [Refer: Gross carrying amount [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r316"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://trinitybiotech.com/role/BasisOfPreparationAndSignificantAccountingPoliciesScheduleOfOwnedAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r68",
      "r320",
      "r350"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Property, plant and equipment",
        "label": "Property, plant and equipment recognised as of acquisition date",
        "terseLabel": "Property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r353",
      "r355"
     ]
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in subsidiary",
        "terseLabel": "Group % holding"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r95",
      "r98",
      "r166"
     ]
    },
    "trib_ProvisionForImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ProvisionForImpairment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Provision for impairment.",
        "periodEndLabel": "Provision for impairment At December 31",
        "periodStartLabel": "Provision for impairment At January 1",
        "label": "Provision For Impairment",
        "terseLabel": "Provision for impairment"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ProvisionForInventoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ProvisionForInventoriesMember",
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for inventories [Member]",
        "label": "Provision for inventories [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProvisionForTaxesOtherThanIncomeTaxMember",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for taxes other than income tax [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a provision for taxes other than income tax. Income taxes include all domestic and foreign taxes which are based on taxable profits. Income taxes also include taxes, such as withholding taxes, which are payable by a subsidiary, associate or joint arrangement on distributions to the reporting entity. [Refer: Classes of other provisions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "ifrs-full_ProvisionUsedOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProvisionUsedOtherProvisions",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesScheduleOfMovementOnInventoryProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Utilised during the year",
        "label": "Provision used, other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "trib_ProvisionalValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ProvisionalValueMember",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provisional value [Member]",
        "label": "Provisional Value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Provisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Provisions",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provisions",
        "label": "Provisions [Default Label]",
        "totalLabel": "Provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities of uncertain timing or amount, including provisions for employee benefits."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "ifrs-full_ProvisionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ProvisionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Provisions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments to acquire intangible assets",
        "label": "Purchase of intangible assets, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of property, plant and equipment",
        "label": "Purchase of property, plant and equipment, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "trib_PurchaseOfTreasuryShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "PurchaseOfTreasuryShare",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury shares purchased.",
        "label": "Purchase Of Treasury Share",
        "terseLabel": "Treasury shares purchased"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfTreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "PurchaseOfTreasuryShares",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares purchased",
        "label": "Purchase of treasury shares",
        "verboseLabel": "Purchased during period"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails",
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r187",
      "r209",
      "r225",
      "r343",
      "r345",
      "r531"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RangeDomain",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails",
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r187",
      "r209",
      "r225",
      "r343",
      "r345",
      "r531"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesEightOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesEightOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US$12.00 -US$17.88 [Member]",
        "label": "Ranges Eight Of Exercise Prices For Outstanding Share Options Member",
        "terseLabel": "US$12.00 -US$17.45 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesFiveOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesFiveOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US$2.63-US$3.96 [Member]",
        "label": "Ranges Five Of Exercise Prices For Outstanding Share Options Member",
        "terseLabel": "US$1.00-US$1.74 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesFourOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesFourOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US$3.00 -US$4.47 [Member]",
        "label": "Ranges Four Of Exercise Prices For Outstanding Share Options Member",
        "terseLabel": "US$3.00 -US$4.36 [Member]",
        "verboseLabel": "US$20.00-US$25.80 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesNineOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesNineOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges Nine Of Exercise Prices For Outstanding Share Options [Member]",
        "terseLabel": "US$1.00-US$2.05 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [Axis]",
        "verboseLabel": "Ranges of exercise prices for outstanding share options [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsDomain",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Range [domain]]"
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "trib_RangesOneFourOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesOneFourOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges One Four Of Exercise Prices For Outstanding Share Options [Member]",
        "terseLabel": "US$12.00 -US$17.45 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesOneOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesOneOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges One Of Exercise Prices For Outstanding Share Options [Member]",
        "terseLabel": "US$0.12-US$0.99 [Member]",
        "verboseLabel": "US$0.19 - $0.99 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesOneOfExercisePricesForOutstandingShareOptionsNineToNineteenMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US$0.19-US$0.99 [Member]",
        "label": "Ranges One Of Exercise Prices For Outstanding Share Options Nine To Nineteen Member",
        "terseLabel": "US$0.19-US$0.99 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesOneOneOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesOneOneOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges One One Of Exercise Prices For Outstanding Share Options [Member]",
        "verboseLabel": "US$3.00 -US$4.36 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesOneThreeOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges One Three Of Exercise Prices For Outstanding Share Options [Member]",
        "verboseLabel": "US$8.24- US$11.96 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesOneTwoOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges One Two Of Exercise Prices For Outstanding Share Options [Member]",
        "terseLabel": "US$4.00-US$8.20 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesOneZeroOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges One Zero Of Exercise Prices For Outstanding Share Options [Member]",
        "terseLabel": "US$2.06- US$2.99 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesSevenOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesSevenOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US$8.24- US$11.96 [Member]",
        "label": "Ranges Seven Of Exercise Prices For Outstanding Share Options Member",
        "terseLabel": "US$35.00- US$48.60 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesSixOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesSixOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US$4.00-US$8.20 [Member]",
        "label": "Ranges Six Of Exercise Prices For Outstanding Share Options Member",
        "terseLabel": "US$20.00-US$34.80 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesThreeOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesThreeOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US$2.06- US$2.99 [Member]",
        "label": "Ranges Three Of Exercise Prices For Outstanding Share Options Member",
        "terseLabel": "US$1.75- US$2.43 [Member]",
        "verboseLabel": "US$2.40-US$19.80 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RangesTwoOfExercisePricesForOutstandingShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RangesTwoOfExercisePricesForOutstandingShareOptionsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US$1.00-US$2.05 [Member]",
        "label": "Ranges Two Of Exercise Prices For Outstanding Share Options Member",
        "terseLabel": "US$1.00-US$1.29 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RateOfRentPerSqureFoot": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RateOfRentPerSqureFoot",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of rent per squre foot.",
        "label": "Rate of rent per squre foot"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RayvilleLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RayvilleLimitedMember",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rayville Limited [Member]",
        "label": "Rayville Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ReceivablesFromConsiderationDueSaleOfBusiness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ReceivablesFromConsiderationDueSaleOfBusiness",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of Consideration due from sale of business",
        "label": "Receivables From Consideration Due Sale Of Business",
        "terseLabel": "Consideration due from sale of business"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReceivablesFromContractsWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReceivablesFromContractsWithCustomers",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of an entity\u2019s right to consideration in exchange for goods or services that the entity has transferred to a customer that is unconditional. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r191"
     ]
    },
    "ifrs-full_ReceivablesFromContractsWithCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReceivablesFromContractsWithCustomersAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueDerivesFromTransferOfGoodsAndServicesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of revenue recognition"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ReceivablesOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ReceivablesOutstanding",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amounts represents receivables outstanding.",
        "label": "Receivables Outstanding",
        "terseLabel": "Outstanding receivables"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ReclassificationGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ReclassificationGoodwillAndIntangibleAssets",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification.",
        "label": "Reclassification Goodwill And Intangible Assets",
        "terseLabel": "Reclassification"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RecognitionOfContingentAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RecognitionOfContingentAsset",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails": {
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recognition of contingent asset.",
        "negatedLabel": "Recognition of contingent asset",
        "label": "Recognition of contingent asset"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ReconciliationToWeightedAverageEarningsPerShareDenominatorAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation To Weighted Average Earnings Per Share Denominator Abstract",
        "terseLabel": "Reconciliation to weighted average (loss)/earnings per share denominator:",
        "verboseLabel": "Reconciliation to weighted average (loss)/earnings per ADS denominator:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r391",
      "r402",
      "r412",
      "r445"
     ]
    },
    "trib_RefinancingCostsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RefinancingCostsClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 120.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for refinancing costs, classified as financing activities.",
        "negatedLabel": "Loan Origination Costs",
        "label": "Refinancing Costs Classified As Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining amortisation period of intangible assets material to entity",
        "terseLabel": "Intangible asset amortization period"
       }
      },
      "en": {
       "role": {
        "documentation": "The remaining amortisation period of individual intangible assets that are material to the entity\u2019s financial statements. [Refer: Depreciation and amortisation expense]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "trib_RemainingTermInYears": {
     "xbrltype": "durationItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RemainingTermInYears",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining term of right of use assets in years.",
        "label": "Remaining Term In Years",
        "terseLabel": "Range of remaining term in years"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RemeasurementLossRecognizedInProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RemeasurementLossRecognizedInProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents remeasurement loss recognized in profit loss.",
        "label": "Remeasurement Loss Recognized In Profit Loss",
        "verboseLabel": "Remeasurement loss recognized in profit loss"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RemeasurementOfRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RemeasurementOfRightOfUseAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of remeasurement of ROU assets.",
        "label": "Remeasurement Of Right Of Use Assets",
        "terseLabel": "Remeasurement of ROU assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RentalIncomeFromPremises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RentalIncomeFromPremises",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails": {
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rental income from premises.",
        "label": "Rental income from premises"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RepaymentOfOtherLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RepaymentOfOtherLoan",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 90.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents repayment of other loan.",
        "negatedLabel": "Repayment of other loan",
        "label": "Repayment Of Other Loan"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RepaymentsOfBondsNotesAndDebentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RepaymentsOfBondsNotesAndDebentures",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows",
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of exchangeable notes",
        "negatedTerseLabel": "Repayment of exchangeable notes",
        "label": "Repayments of bonds, notes and debentures",
        "verboseLabel": "Purchase of exchangeable notes"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for repayments of bonds, notes and debentures."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan",
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "disclosureGuidance": "Debt issued/repaid",
        "negatedLabel": "Repayment",
        "negatedTerseLabel": "Repayment of term loan",
        "positiveLabel": "Cash repayment of principal",
        "positiveTerseLabel": "Debt retired / repaid",
        "label": "Repayments of borrowings, classified as financing activities",
        "terseLabel": "Repayment of term loan",
        "verboseLabel": "Repaid to Note holders"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "ifrs-full_RepaymentsOfCurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RepaymentsOfCurrentBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for repayments of current borrowings. [Refer: Current borrowings]"
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "ifrs-full_RepaymentsOfNoncurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RepaymentsOfNoncurrentBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of senior secured term loan",
        "negatedTerseLabel": "Repayments of borrowings",
        "label": "Repayments of non-current borrowings",
        "terseLabel": "Repayment of term loan"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Research and development expenses",
        "label": "Research and development expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "trib_ResearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ResearchAndDevelopmentMember",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfAverageNumberOfPersonsEmployedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development [Member]",
        "label": "Research and development [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReserveOfCashFlowHedges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReserveOfCashFlowHedges",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve of cash flow hedges"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the accumulated portion of gain (loss) on a hedging instrument that is determined to be an effective hedge for cash flow hedges. [Refer: Cash flow hedges [member]]"
       }
      }
     },
     "auth_ref": [
      "r294",
      "r494"
     ]
    },
    "ifrs-full_ReserveOfCashFlowHedgesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReserveOfCashFlowHedgesMember",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hedging reserves [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing the accumulated portion of gain (loss) on a hedging instrument that is determined to be an effective hedge for cash flow hedges. [Refer: Cash flow hedges [member]]"
       }
      }
     },
     "auth_ref": [
      "r294",
      "r303"
     ]
    },
    "ifrs-full_ReserveOfEquityComponentOfConvertibleInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReserveOfEquityComponentOfConvertibleInstruments",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve of equity component of convertible instruments",
        "terseLabel": "Equity component of the convertible note"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing components of convertible instruments classified as equity."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Translation reserve"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslationMember",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Translation reserve [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r303"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r392",
      "r403",
      "r413",
      "r446"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r393",
      "r404",
      "r414",
      "r447"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r400",
      "r411",
      "r421",
      "r454"
     ]
    },
    "trib_RestructuringActivitiesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RestructuringActivitiesExpense",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Activities Expense",
        "negatedLabel": "Total restructuring costs",
        "label": "Restructuring Activities Expense",
        "terseLabel": "Total restructuring costs",
        "verboseLabel": "Restructuring cost"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RestructuringCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RestructuringCost",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of restructuring costs.",
        "negatedLabel": "Selling, general and administrative expenses \u2013 Restructuring costs",
        "label": "Restructuring Cost",
        "terseLabel": "Restructuring Costs",
        "verboseLabel": "Restructuring Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RestructuringProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RestructuringProvision",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails": {
       "parentTag": "ifrs-full_Provisions",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring provision",
        "terseLabel": "Closure provision",
        "verboseLabel": "Provision"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of provision for restructuring, such as the sale or termination of a line of business; closure of business locations in a country or region or relocation of activities from one country or region to another; changes in management structure; and fundamental reorganisations that have a material effect on the nature and focus of the entity's operations. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "ifrs-full_RestructuringProvisionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RestructuringProvisionMember",
     "presentation": [
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring provision [member]",
        "verboseLabel": "Fitzgerald Industries"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a provision for restructuring, such as the sale or termination of a line of business; closure of business locations in a country or region or relocation of activities from one country or region to another; changes in management structure; and fundamental reorganisations that have a material effect on the nature and focus of the entity's operations. [Refer: Classes of other provisions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "trib_ResultAfterExceptionalExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ResultAfterExceptionalExpenses",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of after exceptional expenses.",
        "negatedLabel": "Result after impairment",
        "label": "Result After Exceptional Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ResultBeforeExceptionalExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ResultBeforeExceptionalExpenses",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of before exceptional expenses.",
        "negatedLabel": "Result before impairment and unallocated expenses",
        "label": "Result Before Exceptional Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RetainedEarnings",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Retaining earnings",
        "label": "Accumulated surplus",
        "terseLabel": "Accumulated deficit"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r310"
     ]
    },
    "ifrs-full_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated surplus [Member]",
        "terseLabel": "Accumulated (deficit)/surplus [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r303"
     ]
    },
    "ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfBreakdownOfImpairmentLossDetailsUsd"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and other intangible assets (see Note 14)",
        "verboseLabel": "Goodwill and other intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from revaluations to fair value. [Refer: Intangible assets other than goodwill; Revaluation surplus]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfCompositionOfPropertyAndEquipmentRelatedToAccumulatedDepreciationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revaluation increase (decrease), property, plant and equipment including right-of-use assets",
        "verboseLabel": "Remeasurement of ROU assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment including right-of-use assets resulting from revaluations to fair value. [Refer: Property, plant and equipment including right-of-use assets; Revaluation surplus]"
       }
      }
     },
     "auth_ref": [
      "r503"
     ]
    },
    "ifrs-full_Revenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "Revenue",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0,
       "order": 0.0
      },
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfAmountRelatingFromRevenueDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByMajorProductGroupDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "terseLabel": "Total revenue",
        "totalLabel": "Total revenue",
        "verboseLabel": "Revenues"
       }
      },
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r172",
      "r247",
      "r278",
      "r284",
      "r289",
      "r290",
      "r292",
      "r301",
      "r302",
      "r341"
     ]
    },
    "ifrs-full_RevenueFromContractsWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RevenueFromContractsWithCustomers",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfAmountRelatingFromRevenueDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByCustomersGeographicalAreaDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from external customers",
        "verboseLabel": "Revenue from contracts with customers (a)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r190"
     ]
    },
    "ifrs-full_RevenueFromGovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RevenueFromGovernmentGrants",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails": {
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/OtherOperatingIncomeScheduleOfOtherOperatingIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income from government grants",
        "terseLabel": "Government grants"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income recognised in relation to government grants. [Refer: Government grants]"
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "trib_ReversalOfImpairmentLossOnFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ReversalOfImpairmentLossOnFinancialAssets",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of reversal of impairment loss on financial assets.",
        "label": "Reversal Of Impairment Loss On Financial Assets",
        "verboseLabel": "Reversal of impairment in the current year"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ReversalOfNetOperatingLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ReversalOfNetOperatingLoss",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Origination and reversal of net operating losses.",
        "label": "Reversal Of Net Operating Loss",
        "terseLabel": "Origination and reversal of net operating losses (see Note 14)"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RevertsMinimumLiquidityCovenant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RevertsMinimumLiquidityCovenant",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/BASISOFPREPARATIONANDSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of reverts minimum liquidity covenant",
        "label": "Reverts Minimum Liquidity Covenant"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RightOfUseAssetsImpairmentAdjustmentOnTransition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RightOfUseAssetsImpairmentAdjustmentOnTransition",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-use assets, Impairment adjustment on transition.",
        "negatedLabel": "Impairment adjustment on transition",
        "label": "Right Of Use Assets Impairment Adjustment On Transition",
        "terseLabel": "Right-of-use assets, Impairment adjustment on transition"
       }
      }
     },
     "auth_ref": []
    },
    "trib_RightOfUseAssetsIncludingDepreciationAndImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "RightOfUseAssetsIncludingDepreciationAndImpairment",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfAdditionalInformationOnRight-of-useAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-use assets including depreciation and impairment.",
        "label": "Right Of Use Assets Including Depreciation And Impairment",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "RightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "verboseLabel": "Right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r199"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "country_SE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "SE",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails1",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails3",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sweden [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "currency_SEK": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "SEK",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEK [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SaleAndLeasebackLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SaleAndLeasebackLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails": {
       "parentTag": "trib_CurrentFinanceLeaseLiabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfCarryingValuesOfFinanceLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale and leaseback liabilities current.",
        "label": "Sale And Leaseback Liabilities Current",
        "terseLabel": "Sale and leaseback liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SaleAndLeasebackLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SaleAndLeasebackLiabilitiesMember",
     "presentation": [
      "http://trinitybiotech.com/role/LeaseLiabilitiesScheduleOfFinanceLeaseLiabilitiesPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale and leaseback liabilities [Member]",
        "label": "Sale And Leaseback Liabilities Member",
        "verboseLabel": "Sale and leaseback liabilities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SaleOfFitzgeraldIndustriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SaleOfFitzgeraldIndustriesMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Fitzgerald Industries [Member]",
        "label": "Sale Of Fitzgerald Industries [Member]",
        "terseLabel": "Sale of Fitzgerald Industries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SatisfiedByAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SatisfiedByAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Satisfied By [Abstract]",
        "terseLabel": "Satisfied by:"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ScheduleOfAdditionalInformationOnRightOfUseAssets": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ScheduleOfAdditionalInformationOnRightOfUseAssets",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of additional information on the right-of-use assets.",
        "label": "Schedule Of Additional Information On Right Of Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ScheduleOfIncomeFromSubLettingRightOfUseBuildings": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ScheduleOfIncomeFromSubLettingRightOfUseBuildings",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of income from sub-letting right-of-use buildings.",
        "label": "Schedule Of Income From Sub Letting Right Of Use Buildings",
        "terseLabel": "Schedule of Income From Sub-Letting Right-of-Use Buildings"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ScheduleOfMovementInTermLoanExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ScheduleOfMovementInTermLoanExplanatoryTableTextBlock",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about movement in the term loan.",
        "label": "Schedule Of Movement In Term Loan Explanatory [Table Text Block]",
        "terseLabel": "Schedule Of Movement In Term Loan"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ScheduleOfShareBasedPaymentExpenseByGeographicalArea": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ScheduleOfShareBasedPaymentExpenseByGeographicalArea",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about share based payment expenses by geographical area.",
        "label": "Schedule Of Share Based Payment Expense By Geographical Area",
        "terseLabel": "Schedule Of Share Based Payment Expense By Geographical Area"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "trib_SegmentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SegmentAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of segment assets.",
        "label": "Segment assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SegmentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SegmentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of segment liabilities.",
        "label": "Segment liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SellingGeneralAdministrationExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SellingGeneralAdministrationExpensesAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ImpairmentChargesScheduleOfStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling General Administration Expenses Abstract",
        "terseLabel": "Selling, general &amp; administration expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Selling, general and administrative expenses",
        "label": "Selling, general and administrative expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to selling, general and administrative activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "trib_SellingGeneralAndAdministrativeExpensesClosureCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SellingGeneralAndAdministrativeExpensesClosureCosts",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxNarrativeDetails",
      "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selling, general and administrative expenses - closure costs.",
        "negatedLabel": "Selling, general and administrative expenses - closure costs",
        "negatedTerseLabel": "Amount of charge for closing facility",
        "label": "Selling General And Administrative Expenses Closure Costs",
        "terseLabel": "Selling, General and Administrative Expenses \u2013 Closure Costs"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SellingGeneralAndAdministrativeExpensesRestructuringCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SellingGeneralAndAdministrativeExpensesRestructuringCosts",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It Represents the selling, general and administrative expenses - restructuring costs.",
        "negatedLabel": "Selling, general and administrative expenses \u2013 Restructuring costs",
        "label": "Selling, General And Administrative Expenses \u2013 Restructuring Costs"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SeniorSecuredTermLoanAnnualRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SeniorSecuredTermLoanAnnualRate",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents about senior secured term loan annual rate.",
        "label": "Senior Secured Term Loan Annual Rate",
        "terseLabel": "Senior secured term loan annual rate"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SeniorSecuredTermLoanCreditFacilityOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SeniorSecuredTermLoanCreditFacilityOneMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "senior secured term loan credit facility one [Member]",
        "label": "Senior Secured Term Loan Credit Facility One [Member]",
        "terseLabel": "Amended and restated senior secured term loan credit facility [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SeniorSecuredTermLoanFixedRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SeniorSecuredTermLoanFixedRate",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents about senior secured term loan fixed rate.",
        "label": "Senior Secured Term Loan Fixed Rate",
        "terseLabel": "Senior secured term loan fixed rate"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SeniorSecuredTermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SeniorSecuredTermLoanMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent information about the senior secured term loan member.",
        "label": "Senior Secured Term Loan [Member]",
        "terseLabel": "Senior secured term loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SensitivityAnalysisForEachTypeOfMarketRisk",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Sensitivity Analysis"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the sensitivity analysis for types of market risk to which the entity is exposed, showing how profit or loss and equity would have been affected by changes in the relevant risk variable that were reasonably possible at that date. [Refer: Market risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "ifrs-full_ServicesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ServicesExpense",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Services Expense",
        "terseLabel": "Payments for CEO Services"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from services."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "trib_SevenYearConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SevenYearConvertibleNoteMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails2",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent information about the 7-year convertible note member.",
        "label": "Seven Year Convertible Note [Member]",
        "terseLabel": "7-year Convertible Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ShareBasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ShareBasedPayments",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based payments.",
        "label": "Share based payments"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ShareBasedPaymentsCapitalisedIntangibleDevelopmentProjectAssets",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents share based payments capitalised in intangible development project assets.",
        "label": "Share Based Payments Capitalised Intangible Development Project Assets",
        "verboseLabel": "Share based payments capitalised in intangible development project assets"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ShareBasedPaymentsContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ShareBasedPaymentsContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails": {
       "parentTag": "ifrs-full_AdjustmentsForSharebasedPayments",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based payments continuing operations.",
        "netLabel": "Share based payments continuing operations",
        "label": "Share Based Payments Continuing Operations",
        "totalLabel": "Total - continuing operations",
        "verboseLabel": "Continuing operations"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ShareBasedPaymentsCostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ShareBasedPaymentsCostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails": {
       "parentTag": "trib_ShareBasedPaymentsContinuingOperations",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payments cost of sales.",
        "label": "Share Based Payments Cost Of Sales",
        "verboseLabel": "Share-based payments - cost of sales"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ShareBasedPaymentsDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ShareBasedPaymentsDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails": {
       "parentTag": "ifrs-full_AdjustmentsForSharebasedPayments",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based payment discontinued operations.",
        "label": "Share Based Payments Discontinued Operations",
        "verboseLabel": "Share-based payments - discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ShareBasedPaymentsSellingGeneralAndAdministrative": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ShareBasedPaymentsSellingGeneralAndAdministrative",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails": {
       "parentTag": "trib_ShareBasedPaymentsContinuingOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfFairValueOfOptionsVestingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payments selling, general and administrative.",
        "label": "Share Based Payments Selling General And Administrative",
        "verboseLabel": "Share-based payments - selling, general and administrative"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ShareIssueCostForExchangeableNotesPurchase": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ShareIssueCostForExchangeableNotesPurchase",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share issue cost for Exchangeable Notes purchase.",
        "label": "Share Issue Cost For Exchangeable Notes Purchase"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareIssueRelatedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ShareIssueRelatedCost",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issue related cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cost related to the issuance of shares."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "trib_ShareOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ShareOptionMember",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Option [Member]",
        "label": "Share Option [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharePremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SharePremium",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share premium"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r308"
     ]
    },
    "ifrs-full_SharePremiumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SharePremiumMember",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share premium [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "trib_ShareRepurchasedUnderBuybackProgram": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ShareRepurchasedUnderBuybackProgram",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share repurchased under buyback program.",
        "label": "Share repurchased under buyback program"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SharesConsideration": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SharesConsideration",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of shares consideration.",
        "label": "Shares Consideration",
        "terseLabel": "Shares consideration"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SharesIssuableOnConversionOfExchangeableNotes": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SharesIssuableOnConversionOfExchangeableNotes",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerAdsShareCalculationDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfDilutedEarningsPerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issuable on conversion of exchangeable notes .",
        "label": "Shares Issuable On Conversion Of Exchangeable Notes",
        "terseLabel": "Issuable on conversion of Exchangeable notes"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SharesIssuedAsConsiderationForExchangeableNotesPurchase": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SharesIssuedAsConsiderationForExchangeableNotesPurchase",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issued as consideration for Exchangeable Notes purchase.",
        "label": "Shares Issued As Consideration For Exchangeable Notes Purchase",
        "terseLabel": "Issued as consideration for Exchangeable Notes purchase",
        "verboseLabel": "Shares issued as consideration for Exchangeable Notes purchase"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SharesIssuedAsConsiderationForExchangeableNotesPurchaseValue",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares issued as consideration for Exchangeable Notes purchase.",
        "label": "Shares Issued As Consideration For Exchangeable Notes Purchase Value",
        "terseLabel": "Shares issued as consideration for Exchangeable Notes purchase, value"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SharesIssuedAsConsiderationForPurchaseOfExchangeableNotes",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ReconciliationOfLiabilitiesArisingFromFinancingActivitiesScheduleOfLiabilitiesArisingFromFinancingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issued as consideration for purchase of Exchangeable Notes.",
        "negatedLabel": "Shares issued as consideration for purchase of Exchangeable Notes",
        "label": "Shares Issued As Consideration For Purchase Of Exchangeable Notes"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SharesIssuedToNoteHoldersAsConsiderationBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SharesIssuedToNoteHoldersAsConsiderationBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of shares issued to note holders as consideration, borrowings.",
        "label": "Shares Issued To Note Holders As Consideration, Borrowings",
        "terseLabel": "Shares issued to Note holders as consideration"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SharesPurchasedDuringYear": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SharesPurchasedDuringYear",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares purchased during the year.",
        "label": "Shares Purchased During Year"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SharesRepresentationRateComparedToADS": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SharesRepresentationRateComparedToADS",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the representation rate of shares compared to companies ADS.",
        "label": "Shares Representation Rate Compared To A D S",
        "terseLabel": "Shares amount representing companies ADS"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SharesSoldDuringYear": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SharesSoldDuringYear",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsScheduleOfCompanysSharesAndShareOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares sold during the year.",
        "label": "Shares sold during the year"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SharesToBeIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SharesToBeIssued",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents shares to be issued.",
        "label": "Shares To Be Issued",
        "terseLabel": "Shares to be issued"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SharesToBeIssuedForHedgingReservesValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SharesToBeIssuedForHedgingReservesValue",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares to be issued for hedging reserves.",
        "label": "Shares To Be Issued For Hedging Reserves Value",
        "terseLabel": "Value of shares to be issued for hedging reserves"
       }
      }
     },
     "auth_ref": []
    },
    "trib_ShortTermDepositsAndShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "ShortTermDepositsAndShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of short term deposits and investment.",
        "label": "Short Term Deposits And Short Term Investments",
        "verboseLabel": "Financial assets (short-term deposits and short-term investments)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ShorttermDepositsClassifiedAsCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails": {
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term deposits, classified as cash equivalents",
        "terseLabel": "Short-term deposits",
        "verboseLabel": "Financial assets (short-term deposits and short-term investments)"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "ifrs-full_ShorttermEmployeeBenefitsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ShorttermEmployeeBenefitsExpense",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total personnel expenses, inclusive of amounts capitalised for wages and salaries, social welfare costs and pension costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "ShorttermInvestmentsClassifiedAsCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short term investments",
        "terseLabel": "Short term investments (Note 20)",
        "verboseLabel": "Investments (deposits)"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of cash equivalents representing short-term investments. [Refer: Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r99",
      "r181"
     ]
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesDomain",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r99",
      "r181"
     ]
    },
    "trib_SiteTransferCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SiteTransferCostsMember",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSScheduleOfRestructuringCostsIncurredDuringTheYear"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Site Transfer Costs [Member]",
        "label": "Site Transfer Costs [Member]",
        "terseLabel": "Site transfer costs [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails",
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Site Transfer Costs Related To The Impairment Of Plant &amp; Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SixMonthOrLessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SixMonthOrLessMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6 mths or less [Member]",
        "label": "Six Month Or Less Member",
        "terseLabel": "6 mths or less [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SixMonthToTwelveMonthMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SixMonthToTwelveMonthMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6 mths - 12 mths [Member]",
        "label": "Six Month To Twelve Month Member",
        "terseLabel": "6 mths - 12 mths [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SjogrensTestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SjogrensTestsMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sjogrens tests [Member]",
        "label": "Sjogrens Tests [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SocialSecurityContributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "SocialSecurityContributions",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails": {
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Social welfare costs"
       }
      },
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents social security contributions. [Refer: Employee benefits expense]"
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityLineItems",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r395",
      "r406",
      "r416",
      "r449"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "auth_ref": []
    },
    "trib_StrategicPartnershipWithImawareIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "StrategicPartnershipWithImawareIncMember",
     "presentation": [
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "strategic partnership with imaware, Inc.",
        "label": "Strategic Partnership With Imaware Inc [Member]",
        "terseLabel": "Strategic partnership with imaware, Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SyphilisPointOfCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SyphilisPointOfCareMember",
     "presentation": [
      "http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Syphilis Point-of-Care.",
        "label": "Syphilis Point Of Care [Member]",
        "verboseLabel": "Syphilis Point-of-Care [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_SyphilisPointOfCareTestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "SyphilisPointOfCareTestMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Syphilis point-of-care test [Member]",
        "label": "Syphilis Point-of-Care Test [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_T10HplcAnalyzerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "T10HplcAnalyzerMember",
     "presentation": [
      "http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for T10 HPLC Analyzer.",
        "label": "T10 Hplc Analyzer [Member]",
        "verboseLabel": "T10 HPLC Analyzer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r442"
     ]
    },
    "ifrs-full_TaxExpenseRelatingToGainLossOnDiscontinuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TaxExpenseRelatingToGainLossOnDiscontinuance",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfChargeForTaxDetails",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax charge on discontinued operations (see Note 10)",
        "terseLabel": "Tax charge on discontinued operations",
        "verboseLabel": "Tax credit recovered"
       }
      },
      "en": {
       "role": {
        "documentation": "The tax expense (income) relating to the gain (loss) on discontinuance when operations are discontinued. [Refer: Discontinued operations [member]]"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r250"
     ]
    },
    "ifrs-full_TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total income tax credit",
        "negatedNetLabel": "Tax expense",
        "negatedTerseLabel": "Tax income (expense)",
        "label": "Tax expense (income) relating to profit (loss) from ordinary activities of discontinued operations",
        "totalLabel": "Total tax expense (income)",
        "verboseLabel": "Tax (expense)/credit"
       }
      },
      "en": {
       "role": {
        "documentation": "The tax expense (income) relating to the profit (loss) arising from ordinary activities of discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r58",
      "r248"
     ]
    },
    "trib_TaxFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TaxFees",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/LossBeforeTaxScheduleOfAmountChargedToStatementOfOperationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax fees.",
        "label": "Tax fees"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments in respect of prior years"
       }
      },
      "en": {
       "role": {
        "documentation": "Tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from adjustments for the current tax of prior periods. [Refer: Average effective tax rate; Applicable tax rate; Adjustments for current tax of prior periods]"
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "trib_TaxRateEffectOfCurrentTaxOfPriorPeriods": {
     "xbrltype": "percentItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TaxRateEffectOfCurrentTaxOfPriorPeriods",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfOverseasTaxJurisdictionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current tax.",
        "label": "Tax Rate Effect Of Current Tax Of Prior Periods",
        "terseLabel": "Current tax %"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxRateEffectOfForeignTaxRates": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TaxRateEffectOfForeignTaxRates",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of tax rates on overseas earnings"
       }
      },
      "en": {
       "role": {
        "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the application of foreign tax rates. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "ifrs-full_TaxRateEffectOfImpairmentOfGoodwill": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TaxRateEffectOfImpairmentOfGoodwill",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discount rate applied (real pre-tax)"
       }
      },
      "en": {
       "role": {
        "documentation": "Tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the impairment of goodwill. [Refer: Average effective tax rate; Applicable tax rate; Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "trib_TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods": {
     "xbrltype": "percentItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "R and D tax credits.",
        "label": "Tax Rate Effect Of Research And Development Tax Of Prior Periods",
        "verboseLabel": "R&amp;D tax credits"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxRateEffectOfTaxLosses": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TaxRateEffectOfTaxLosses",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of current year net operating losses and temporary differences for which no deferred tax asset was recognised"
       }
      },
      "en": {
       "role": {
        "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from tax losses. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "trib_TaxValueOfLossCarryForwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TaxValueOfLossCarryForwardsMember",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax value of loss carry-forwards [Member]",
        "label": "Tax value of loss carry-forwards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TechnologybasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TechnologybasedIntangibleAssetsMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Technology-based intangible assets [member]",
        "verboseLabel": "Technology based intangibles [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing assets based on technology. Such assets may include patented and unpatented technology, databases as well as trade secrets. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [Axis]",
        "verboseLabel": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfRecognisedDeferredTaxAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesScheduleOfUnrecognisedDeferredTaxLiabilitiesDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "trib_TenPercentStrengtheningUSDollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TenPercentStrengtheningUSDollarMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "10% Strengthening US Dollar [Member]",
        "label": "Ten Percent Strengthening U S Dollar Member",
        "terseLabel": "10% strengthening US Dollar [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TenPercentWeakeningUSDollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TenPercentWeakeningUSDollarMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "10% Weakening US Dollar [Member]",
        "label": "Ten Percent Weakening U S Dollar Member",
        "terseLabel": "10% Weakening US Dollar [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TermLoanAgreementDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TermLoanAgreementDescription",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents about term loan agreement description.",
        "label": "Term Loan Agreement Description",
        "terseLabel": "Term loan agreement description"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TermLoanMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSScheduleOfMovementInTermLoan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan [Member]",
        "label": "Term Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TermOfExchangeableSeniorNotes": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TermOfExchangeableSeniorNotes",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of exchangeable senior notes.",
        "label": "Term of exchangeable senior notes"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TermOfLease": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TermOfLease",
     "presentation": [
      "http://trinitybiotech.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lease.",
        "label": "Term of lease"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails",
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Top of range [Member]",
        "verboseLabel": "Maximum [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r187",
      "r209",
      "r225",
      "r343",
      "r345",
      "r531"
     ]
    },
    "trib_TotalExchangeableNotesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TotalExchangeableNotesPercentage",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represented total exchangeable notes percentage.",
        "label": "Total Exchangeable Notes Percentage",
        "terseLabel": "Total exchangeable notes percentage"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TotalExposureFinancialInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TotalExposureFinancialInstruments",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total credit exposure associated with derivative financial assets and liabilities.",
        "label": "Total Exposure Financial Instruments",
        "terseLabel": "Total exposure"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TotalShareOptionsGrantedAdsEquivalent": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TotalShareOptionsGrantedAdsEquivalent",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares granted.",
        "negatedLabel": "Total 'A' share options granted / (ADS's equivalent)",
        "label": "Total Share Options Granted Ads Equivalent",
        "terseLabel": "Total 'A' share options granted / (ADS's equivalent)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5": {
       "parentTag": "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": -1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Trade and other payables",
        "label": "Trade and other current payables",
        "verboseLabel": "Trade payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other current payables [Abstract]",
        "verboseLabel": "Trade and other current payables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
      "http://trinitybiotech.com/role/TradeAndOtherPayablesScheduleOfTradeAndOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other payables",
        "terseLabel": "Total trade and other payables",
        "totalLabel": "Total trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      }
     },
     "auth_ref": [
      "r305",
      "r495"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 10.0
      },
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5": {
       "parentTag": "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners",
       "weight": 1.0,
       "order": 40.0
      },
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition",
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONDetail5",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfTradeAndOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other current receivables",
        "terseLabel": "Trade and other receivables",
        "totalLabel": "Total and other receivables",
        "verboseLabel": "Trade and other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r28"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other current receivables [Abstract]",
        "verboseLabel": "Trade and other current receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherPayables",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Trade and other payables (excluding deferred income)",
        "negatedTerseLabel": "Trade and other payables",
        "label": "Trade &amp; other payables",
        "verboseLabel": "Trade and other payables (excluding deferred income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]"
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherPayablesRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Trade and other payables",
        "label": "Trade and other payables recognised as of acquisition date",
        "terseLabel": "Trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r529"
     ]
    },
    "ifrs-full_TradeAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherReceivables",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other receivable"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r28"
     ]
    },
    "ifrs-full_TradeAndOtherReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeAndOtherReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other receivables [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails": {
       "parentTag": "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for trade and other receivables assumed in a business combination.",
        "negatedLabel": "Trade and other receivables",
        "label": "Trade And Other Receivables Recognised As Of Acquisition Date",
        "terseLabel": "Trade and other receivables"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TradeReceivables",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfAgeingOfTradeReceivablesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance at December 31",
        "periodStartLabel": "Balance at January 1",
        "label": "Trade receivables, net impairment losses provision",
        "verboseLabel": "Trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount due from customers for goods and services sold."
       }
      }
     },
     "auth_ref": [
      "r306"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r464"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://trinitybiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for transactions that are recognised separately from the acquisition of assets and assumption of liabilities in business combinations. It also represents the standard value for the 'Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination' axis if no other member is used. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r464"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r464"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "ifrs-full_TreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TreasuryShares",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": -1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesScheduleOfShareCapitalDetails",
      "http://trinitybiotech.com/role/ConsolidatedStatementOfFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury shares",
        "periodEndLabel": "At period end",
        "periodStartLabel": "Balance at January 1",
        "label": "Treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r308"
     ]
    },
    "ifrs-full_TreasurySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TreasurySharesMember",
     "presentation": [
      "http://trinitybiotech.com/role/ConsolidatedStatementOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Shares [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "trib_TriStatPointOfCareInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TriStatPointOfCareInstrumentMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tristat Point-of-Care Instrument [Member]",
        "label": "Tri Stat Point Of Care Instrument [Member]",
        "terseLabel": "Tri-stat point-of-care instrument [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TribBiosensorsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TribBiosensorsIncMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the Trib Biosensors Inc member",
        "label": "Trib Biosensors Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TrinityBiotechDoBrasilMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TrinityBiotechDoBrasilMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trinity Biotech Do Brasil [Member]",
        "label": "Trinity Biotech Do Brasil [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TrinityBiotechIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TrinityBiotechIncMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Trinity Biotech Inc.",
        "label": "Trinity Biotech Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TrinityBiotechInvestmentLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TrinityBiotechInvestmentLtdMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Trinity Biotech Investment Ltd.",
        "label": "Trinity Biotech Investment Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TrinityBiotechJointVentureLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TrinityBiotechJointVentureLimitedMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent member of Trinity Biotech Joint Venture Limited",
        "label": "Trinity Biotech Joint Venture Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TrinityBiotechLuxembourgSarlMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TrinityBiotechLuxembourgSarlMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Trinity Biotech Luxembourg Sarl.",
        "label": "Trinity Biotech Luxembourg Sarl [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TrinityBiotechManufacturingLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TrinityBiotechManufacturingLimitedMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfImpairmentLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trinity Biotech Manufacturing Limited [Member]",
        "label": "Trinity Biotech Manufacturing Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TrinityBiotechManufacturingServicesLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TrinityBiotechManufacturingServicesLimitedMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Trinity Biotech Manufacturing Services Limited.",
        "label": "Trinity Biotech Manufacturing Services Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TrinityBiotechUkLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TrinityBiotechUkLtdMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Trinity Biotech (UK) Ltd.",
        "label": "Trinity Biotech (Uk) Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TrinityResearchLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TrinityResearchLimitedMember",
     "presentation": [
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Trinity Research Limited.",
        "label": "Trinity Research Limited [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TrinscreenPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TrinscreenPlantAndEquipmentMember",
     "presentation": [
      "http://trinitybiotech.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Trinscreen plant &amp; equipment.",
        "label": "Trinscreen Plant And Equipment [Member]",
        "verboseLabel": "Trinscreen plant &amp; equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TristatMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TristatMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tri-stat member.",
        "label": "Tristat [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TwoPercentageOfGrossInventoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TwoPercentageOfGrossInventoryMember",
     "presentation": [
      "http://trinitybiotech.com/role/AccountingEstimatesAndJudgementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2% of gross inventory [Member]",
        "label": "Two Percentage Of Gross Inventory Member",
        "terseLabel": "2% of gross inventory [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_TwoYearToFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "TwoYearToFiveYearsMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateRiskEffectiveAndRepricingAnalysisDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2-5 years [Member]",
        "label": "Two Year To Five Years Member",
        "terseLabel": "2-5 years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfCustomersAxis",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of customers [Axis]",
        "verboseLabel": "Types of customers [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_TypesOfCustomersDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfCustomersDomain",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of customers [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of customers. It also represents the standard value for the 'Types of customers' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_TypesOfRisksAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfRisksAxis",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of risks [Axis]",
        "verboseLabel": "Types of risks [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r211",
      "r212",
      "r213",
      "r256",
      "r261",
      "r262",
      "r298"
     ]
    },
    "ifrs-full_TypesOfRisksDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "TypesOfRisksDomain",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfLiquidityRiskEstimatedInterestPaymentsOfMaturitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfSensitivityAnalysisDetails"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r211",
      "r212",
      "r213",
      "r256",
      "r261",
      "r262",
      "r298"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "US",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfExposureOfTradeReceivablesByGeographicLocationDetails",
      "http://trinitybiotech.com/role/IncomeTaxCreditNarrativeDetails",
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfRevenueByGeographicalAreaBasedOnLocationOfAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "USA [Member]",
        "terseLabel": "United States [Member]",
        "verboseLabel": "Americas [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_US1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "US1Member",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfUnrecognisedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USA Tax Credits [Member]",
        "label": "U S 1 Member",
        "terseLabel": "USA Tax Credits [Member]",
        "verboseLabel": "Americas \u2013 unused tax credits [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_UltraGenesysMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "UltraGenesysMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ultra Genesys [Member]",
        "label": "Ultra Genesys [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_UnallocatedAssetsBySegmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "UnallocatedAssetsBySegmentAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unallocated Assets By Segment Abstract",
        "terseLabel": "Unallocated assets:"
       }
      }
     },
     "auth_ref": []
    },
    "trib_UnallocatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "UnallocatedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentResultsByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unallocated expenses.",
        "label": "Unallocated expenses"
       }
      }
     },
     "auth_ref": []
    },
    "trib_UnallocatedLiabilitiesBySegmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "UnallocatedLiabilitiesBySegmentAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/SegmentInformationScheduleOfSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unallocated Liabilities By Segment Abstract",
        "terseLabel": "Unallocated liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UnconsolidatedStructuredEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UnconsolidatedStructuredEntitiesAxis",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unconsolidated structured entities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "ifrs-full_UnconsolidatedStructuredEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UnconsolidatedStructuredEntitiesDomain",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfFairValuesOfFinancialAssetsliabilitiesDetails",
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/FINANCIALASSETSNarrativeDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unconsolidated structured entities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Unconsolidated structured entities' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UnderlyingEquityInstrumentAndDepositaryReceiptsAxis",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying equity instrument and depositary receipts [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UnderlyingEquityInstrumentAndDepositaryReceiptsDomain",
     "presentation": [
      "http://trinitybiotech.com/role/IMPAIRMENTRESTRUCTURINGANDONCEOFFCOSTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying equity instrument and depositary receipts [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the \u2018Underlying equity instrument and depositary receipts\u2019 axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "UndiscountedOperatingLeasePaymentsToBeReceived",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumRentalsReceivableUnderNon-cancellableOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Future minimum rentals receivable under non-cancellable operating leases"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of undiscounted operating lease payments to be received. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "trib_UnearnedFinanceIncomeOnFinanceLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "UnearnedFinanceIncomeOnFinanceLease",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/TradeAndOtherReceivablesScheduleOfFutureMinimumFinanceLeaseReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unearned income.",
        "label": "Unearned Finance Income On Finance Lease",
        "terseLabel": "Unearned income"
       }
      }
     },
     "auth_ref": []
    },
    "trib_UnforgivenLoansAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "UnforgivenLoansAmount",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unforgiven loans amount",
        "label": "Unforgiven loans amount",
        "verboseLabel": "Unforgiven Loans amount"
       }
      }
     },
     "auth_ref": []
    },
    "trib_UniGoldAntigenImprovementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "UniGoldAntigenImprovementMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uni-Gold Antigen Improvement [Member]",
        "label": "Uni-Gold Antigen Improvement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_UniGoldRawMaterialStabilisationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "UniGoldRawMaterialStabilisationMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uni-gold raw material stabilisation.",
        "label": "Uni Gold Raw Material Stabilisation [Member]",
        "terseLabel": "Uni-Gold Raw Material Stabilisation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_UniGoldTestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "UniGoldTestMember",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfPrincipalDevelopmentProjectsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uni-Gold Test [Member]",
        "label": "Uni-Gold Test [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_UnrecognizedDeferredTaxAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "UnrecognizedDeferredTaxAsset",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/DeferredTaxAssetsAndLiabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized deferred tax asset.",
        "label": "Unrecognized deferred tax asset"
       }
      }
     },
     "auth_ref": []
    },
    "trib_UnutilisedNetOperatingLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "UnutilisedNetOperatingLosses",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/IncomeTaxCreditScheduleOfNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unutilised net operating losses.",
        "label": "Unutilised net operating losses"
       }
      }
     },
     "auth_ref": []
    },
    "trib_UnwindingOfDiscountOnDeferredContingentConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "UnwindingOfDiscountOnDeferredContingentConsideration",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/FinancialIncomeAndExpensesScheduleOfFinancialIncomeExpensesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unwinding of discount on deferred contingent consideration.",
        "label": "Unwinding Of Discount On Deferred Contingent Consideration"
       }
      }
     },
     "auth_ref": []
    },
    "trib_VariableRateInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "VariableRateInstruments",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of variable rate instruments.",
        "label": "Variable Rate Instruments",
        "verboseLabel": "Variable rate instruments"
       }
      }
     },
     "auth_ref": []
    },
    "trib_VariableRateInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "VariableRateInstrumentsAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfInterestRateProfileOfFinancialAssetsliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate Instruments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "VehiclesMember",
     "presentation": [
      "http://trinitybiotech.com/role/PropertyPlantAndEquipmentScheduleOfIncomeFromSub-lettingRight-of-useBuildingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vehicles [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "ifrs-full_WagesAndSalaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WagesAndSalaries",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails": {
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentScheduleOfEmploymentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Wages and salaries"
       }
      },
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]"
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "trib_WagesAndSalariesNetOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "WagesAndSalariesNetOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Wages and salaries net of credit.",
        "label": "Wages and salaries net of credit"
       }
      }
     },
     "auth_ref": []
    },
    "trib_WagesSubsidiesReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "WagesSubsidiesReceived",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/EmploymentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of wage subsidies received.",
        "label": "Wages Subsidies Received",
        "terseLabel": "Wage subsidies received"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WarrantReserveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WarrantReserveMember",
     "presentation": [
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant reserve [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from issuing share purchase warrants, other than those resulting from share-based payment arrangements. [Refer: Reserve of share-based payments [member]]"
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "ifrs-full_WarrantyProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WarrantyProvision",
     "crdr": "credit",
     "calculation": {
      "http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails": {
       "parentTag": "ifrs-full_Provisions",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/ProvisionsScheduleOfProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product warranty provision"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of provision for estimated costs of making good under warranties for products sold. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r322",
      "r323"
     ]
    },
    "trib_WaveformTechnologiesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "WaveformTechnologiesIncMember",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndReservesNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails",
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsScheduleOfSignificantGoodwillAndIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member is stand for Waveform Technologies Inc.",
        "label": "Waveform Technologies Inc [Member]",
        "verboseLabel": "Waveform Technologies Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_WaveformTechnologiesIncorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "WaveformTechnologiesIncorporationMember",
     "presentation": [
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSNarrativeDetails",
      "http://trinitybiotech.com/role/BUSINESSCOMBINATIONSTables",
      "http://trinitybiotech.com/role/CommitmentsAndContingenciesNarrativeDetails",
      "http://trinitybiotech.com/role/GROUPUNDERTAKINGSDetails",
      "http://trinitybiotech.com/role/INTERESTBEARINGLOANSANDBORROWINGSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Waveform Technologies Incorporation [Member]",
        "label": "Waveform Technologies Incorporation [Member]",
        "terseLabel": "Waveform Technologies Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "trib_WeightedAverageExercisePriceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "WeightedAverageExercisePriceAbstract",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Abstract",
        "terseLabel": "Weighted Average exercise price"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Exercisable at end of year",
        "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails",
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options exercised in share-based payment arrangement",
        "terseLabel": "Exercised",
        "verboseLabel": "Weighted average exercise price"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expired/ Forfeited"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options granted in share-based payment arrangement",
        "verboseLabel": "Granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r217"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average share price date of exercise for options exercised"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price at the date of exercise for share options that are exercised in a share-based payment arrangement. [Refer: Types of share-based payment arrangements [domain]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r224"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfGrantsOfShareOptionsAndWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding at end of year",
        "periodStartLabel": "Outstanding Beginning Balance",
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r216",
      "r221"
     ]
    },
    "trib_WeightedAverageExercisePriceOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "WeightedAverageExercisePriceOutstanding",
     "crdr": "debit",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price outstanding.",
        "label": "Weighted Average Exercise Price Outstanding",
        "terseLabel": "Weighted average exercise price"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageFairValueAtMeasurementDateShareOptionsGranted",
     "crdr": "credit",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average fair value at measurement date per 'A' share / (per ADS)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r228"
     ]
    },
    "trib_WeightedAverageNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "WeightedAverageNumberOfSharesIssued",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average number of shares issued.",
        "label": "Weighted Average Number Of Shares Issued",
        "terseLabel": "Weighted average number of shares issued during the year",
        "verboseLabel": "Weighted average number of \u2018A\u2019 ordinary shares issued during the year"
       }
      }
     },
     "auth_ref": []
    },
    "trib_WeightedAverageNumberOfTreasuryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "WeightedAverageNumberOfTreasuryShares",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average number of treasury shares.",
        "label": "Weighted average number of treasury shares"
       }
      }
     },
     "auth_ref": []
    },
    "trib_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019": {
     "xbrltype": "durationItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average remaining contractual life of exercisable share options.",
        "label": "Weighted Average Remaining Contractual Life Of Exercisable Share Options 2019",
        "terseLabel": "Weighted average contractual life remaining (years)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails",
      "http://trinitybiotech.com/role/ShareOptionsSummaryOfRangeOfPricesOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-average remaining contractual life of options outstanding",
        "verboseLabel": "Weighted average contractual life remaining (years)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "ifrs-full_WeightedAverageSharePrice2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageSharePrice2019",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average share price"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r224"
     ]
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "presentation": [
      "http://trinitybiotech.com/role/ShareOptionsScheduleOfAssumptionDeterminingFairValueOfShareOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average share price per 'A' share / (per ADS)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "ifrs-full_WeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WeightedAverageShares",
     "presentation": [
      "http://trinitybiotech.com/role/LossPerShareNarrativeDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfBasicEarningsPerOrdinaryShareDetails",
      "http://trinitybiotech.com/role/LossPerShareScheduleOfEarningsPerAdsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic (loss)/earnings per ADS denominator",
        "terseLabel": "Weighted average number of shares",
        "verboseLabel": "Basic (loss)/earnings per share denominator"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "trib_WeightedAverageSharesDiscontinuedOperations": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "WeightedAverageSharesDiscontinuedOperations",
     "presentation": [
      "http://trinitybiotech.com/role/PROFITFORTHEYEARONDISCONTINUEDOPERATIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average shares discontinued operations.",
        "label": "Weighted Average Shares Discontinued Operations",
        "terseLabel": "Weighted average number of shares",
        "verboseLabel": "Basic earnings per ordinary share - discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "trib_WithinOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://trinitybiotech.com/20241231",
     "localname": "WithinOneYearMember",
     "presentation": [
      "http://trinitybiotech.com/role/ProvisionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Within One Year [Member]",
        "label": "Within One Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WorkInProgress": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WorkInProgress",
     "crdr": "debit",
     "calculation": {
      "http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails": {
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://trinitybiotech.com/role/InventoriesScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Work-in-progress"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]"
       }
      }
     },
     "auth_ref": [
      "r307",
      "r509"
     ]
    },
    "ifrs-full_WritedownsReversalsOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full",
     "localname": "WritedownsReversalsOfPropertyPlantAndEquipment",
     "presentation": [
      "http://trinitybiotech.com/role/GoodwillAndIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalised development cost write off"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised resulting from the write-down of property, plant and equipment to its recoverable amount or reversals of those write-downs. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "currency_XXX": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2024",
     "localname": "XXX",
     "presentation": [
      "http://trinitybiotech.com/role/CapitalAndFinancialRiskManagementScheduleOfForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_h&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_j&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "l",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_l&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "n",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_n&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_q&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_61_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81B_b_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82",
   "Subparagraph": "ea",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_ea&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "98",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_98_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "98",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_98_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "98",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_98_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "98",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_98_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2024-01-01",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2024-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "h",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_h_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "h",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_h_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2024-03-27"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_ix&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_v&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_viii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "74",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_74_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2024-03-27"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "137",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_137&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "138",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "142",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2024-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2024-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "36",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2024-en-r&anchor=para_36_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS02_g36-39_TI",
   "URIDate": "2024-03-27"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2024-01-01",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2024-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2024-01-01",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "23",
   "IssueDate": "2024-01-01",
   "Paragraph": "26",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=23&code=ifrs-tx-2024-en-r&anchor=para_26_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "19",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_19_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2024-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2024-03-27"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2024-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2024-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_vi&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2024-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2024-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2024-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2024-03-27"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "126",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_126_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "129",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_129_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "130",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_130_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "130",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "130",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_130_f_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "d",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_d_v&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "e",
   "Clause": "iiA",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_e_iiA&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "134",
   "Subparagraph": "e",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_e_v&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "135",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_135_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS36_g126-137_TI",
   "URIDate": "2024-03-27"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "84",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_84_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "84",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_84_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "84",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_84_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "84",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_122_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "122",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_122_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "124",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_124_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "76",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_76_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_d_v&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2024-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "40",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_40_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44B_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44B",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44B_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44B",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44B_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44H_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "Presentation of a statement of cash flows",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI",
   "URIDate": "2024-03-27"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "30",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2024-en-r&anchor=para_30_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "39",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2024-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "10",
   "IssueDate": "2024-01-01",
   "Paragraph": "22",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2024-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "12",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_12_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "19B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_19B_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "21",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_21_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_vi&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_vii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B16&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B4",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B4_e&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2024-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "105",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_105&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "113",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_113_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "114",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "116",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_116_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "120",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "90",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_90_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "95",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_95&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI",
   "URIDate": "2024-03-27"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI",
   "URIDate": "2024-03-27"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "C32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2024-03-27"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_v&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "g",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_g_ii&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "l",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_l&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "m",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_m&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B67",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B67_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B67_d_v&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B67",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B67_e&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B67&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS03_g59-63_TI",
   "URIDate": "2024-03-27"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Section": "Disclosures application of paragraphs 59 and 61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&doctype=Appendix&subtype=B&dita_xref=IFRS03_gB64-B67_TI",
   "URIDate": "2024-03-27"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_b_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_b_iii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_b_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2024-01-01",
   "Paragraph": "38",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_38&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2024-01-01",
   "Section": "Presentation and disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS05_g30-42_TI",
   "URIDate": "2024-03-27"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "21C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "24C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_24C&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35K",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35K_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35K",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "36",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "40",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_40_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "42E",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_42E_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "42I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "8",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_8_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "Credit risk",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS07_g35A-38_TI",
   "URIDate": "2024-03-27"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI",
   "URIDate": "2024-03-27"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI",
   "URIDate": "2024-03-27"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2024-01-01",
   "Paragraph": "6.5.11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2024-en-r&anchor=para_6.5.11&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2024-01-01",
   "Paragraph": "7.2.34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2024-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2024-01-01",
   "Paragraph": "7.2.42",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2024-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2025-01-01",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2024-01-01",
   "Paragraph": "A19",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_A19_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2025-01-01",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2024-01-01",
   "Paragraph": "A19",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_A19_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expired 2023-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_e&doctype=Standard&book=b",
   "URIDate": "2024-03-27"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expired 2023-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "9",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_9_a&doctype=Standard&book=b",
   "URIDate": "2024-03-27"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "82A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82A&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "80",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_80_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "80",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_80_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37_h&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_79_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2024-01-01",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2024-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2024-03-27"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2024-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "87",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_87&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Section": "Example 1 Warranties",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex1_TI",
   "URIDate": "2024-03-27"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Section": "Example 10 A court case",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex10_TI",
   "URIDate": "2024-03-27"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "119",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "119",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "119",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_g&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "14",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_14_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "44D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44D&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI",
   "URIDate": "2024-03-27"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI",
   "URIDate": "2024-03-27"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "IE60",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_IE60&doctype=Illustrative%20Examples",
   "URIDate": "2024-03-27"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2024-01-01",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2024-03-27"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2024-01-01",
   "Paragraph": "B89",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_B89_c&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2024-01-01",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "IE72",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_IE72&doctype=Illustrative%20Examples",
   "URIDate": "2024-03-27"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35I",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35I",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B11_d&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B11D",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B11D_e&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG20B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG20B&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG20D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG20D&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2024-01-01",
   "Paragraph": "IG4",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_IG4&doctype=Implementation%20Guidance",
   "URIDate": "2024-03-27"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r486": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r487": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r488": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r489": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r490": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r491": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r492": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r493": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r494": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r495": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r496": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2024-01-01",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r497": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "80",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_80&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r498": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r499": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r500": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2024-01-01",
   "Paragraph": "81",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r501": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r502": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r503": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2024-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r504": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "135",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_135_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r505": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "144",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_144&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r506": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "5",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_5&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r507": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2024-01-01",
   "Paragraph": "9",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_9&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r508": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "36",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2024-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r509": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2024-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2024-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r510": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2024-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2024-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r511": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2024-01-01",
   "Paragraph": "39",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2024-en-r&anchor=para_39_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r512": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2024-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r513": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "84",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_84_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r514": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2024-01-01",
   "Paragraph": "84",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2024-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r515": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r516": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_iv&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r517": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_vii&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r518": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r519": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2024-01-01",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r520": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2024-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r521": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2024-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r522": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r523": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r524": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r525": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r526": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20_c&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r527": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r528": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r529": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2024-01-01",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2024-03-27"
  },
  "r530": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2024-01-01",
   "Paragraph": "38",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_38&doctype=Standard",
   "URIDate": "2024-03-27"
  },
  "r531": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2024-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2024-03-27"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>220
<FILENAME>0001178913-25-001835-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-25-001835-xbrl.zip
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MS6-!KDM.SZQ8"FW')&6\',";*4MI#M=T#A.9$O&F!6:D!3E5+!Z"69VSO^D
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M54N7L+ZPYKY15E^MN6\4Y/^3FON:2Y;M16OD5/]^,(WF;QS_ %!+ P04
M"  PC:]:E&]?KF<2   J90  $    &5X:&EB:71?-"TQ,RYH=&WM7>MSXS:2
M_[Y5^S]@E9M=NT[24!3ULCVN^#EQSFN[;%^F<EO[ 21 "3%%,B!IC_+77S<
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M_U+^;RZG(QJK'M!Q@%I/$X!O<#@!GP1\NUD*>"4E$9 @'P3,"N,^3'O1()F
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M-H,Y)W^G4\#)_Q2!F\F0G)]?K2\LJ^V@@W_2Z#: 4N#S)I6<I\VBX M'/V/
MM'I?8/6YXY=4_R;E]SPD/[;)QR!+7(KO'9PDOZ[P_O4$='I/IL#HZ]B,^;T7
M3+^LH[5 BGQ%S%[LXU\W.6 EB'[*;V@6,???R^CBVU:*5X?H0!G6 WS/@HKK
MU4*TB-2A*D7T>G1H#3M^AWJ68UF,]MT>=]V^Y;L@]^YP4]6310F7YVU1 Y;K
M"LMEC-H=P.]6U#Q65#UT'T 9""S\T+#KR@^K#567?5:EJFM[/;5]TBP0J#U\
MK 8(;5S3RI)99[#-,W[%)7*.A4BS@S%_A39_4W4598_,Y8(^6$]4B*4:B>YW
ME?;)Z$%K3J>Q:4TL]_WTCAXA[(V)9'5_7>SO<+;S50\[]KM:%;R,<4-.%NKM
MFA^O0 WQ*THPCQWSD$L:Y-_L\1:EGY?MOE;:&YP]/0'_*8I-3(0ML!/BC>?*
MNV:-8;&0KH=;-?QSC&/QV[SLX@N[Y-C=LIH$_]]>%5*>&#@:NC"CA@=ZK'[#
M +</#0>.YP6;SJIBS3,59X4 OQEJ;J@7= I([@8P"N<Q.1:?1?KVK/05RO46
MOY5PAQQ-!/>+&*0+IM_DNP'Y?@LPCP68ND[7CSIO., XJP*,_2<),)O&X;];
MP)F";Z0/ 7U[)OL&A&RBSQ6D/#Z87D3^24,P@C<9>KXEVQL42;<JDA>HBJVU
M./K'T+)4RY]+\F4(\MY'I%2Z.&#W0FWB.S\_>C&:>AURD*0P6U<!]7B3=*QT
M0DZ#"*Y\?35S:0FJ^^KFXB!-PZ7$Z&5(,:M7AI;OXT)# N%S7,>JW[7U1Y&W
ME^U?'5V>7G.LL $4JB%0?6'V5VN+^=J7UZ8A#T]?4WZN#%Z*58!J\93JG<E'
M&6 +B:O6+R;YCCVPR,$];L\LO4B%WZN;O!A-W<(OOA0%):=JCM"UVE:K,["&
M+^E'\\7_"["/*( Y^C01:<AG+^9/6]JA&C*^][1VU^\(, 2M">K*9\N;;\EZ
M>\^>OV/U:?)8:S_"TU:PGP7$%GXNH716.?[2-HNB@Z_[F8NE7[(H_\S%TF]@
M?/7/7*S[DQ9SUO.CO??XXR+JP/Q"RO\#4$L#!!0    ( #"-KUH'W%?45Q(
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MT%<=R4K]4AWU[!5<TH&39$^)5-F;8)-4/P[<S%)_(BNER1(9X#2#LR_H?SZ
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M*^4Q/Z-66'BXI(5?6'24;'\N94\LDLHK2M7^#A=[&S_<M:I/KZK<183;E-)
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M6:,][ZJ$023D]XD?$ _D(<N*/CD")^6E5;UN(0==)@CEM2#[":F<&(?(Q=)
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MB% +B /;!1P54T-(6R'G02?-1?SI8[0U4*$Q"H5XM4X'>Z*J.#\-$X#29GA
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MJQ1!TO<%!U3#>_8BJ[#@X&X>CGZ,-^7Z5R78#K+I;Q!TSR +:)LG%VPQ1MA
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M\.&E1X2>NI'CDE33++9:("&Z"N8KPM/>]:F$UT=<[/3F!?-ZPAGVHHG;6T]
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MV_/N7?L?_[Q#Y'I)==HE4\5\&H,$"B1,J(39#._DEDZ+QD25S[:_ 38!&<8
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M<.HI\.=F<%)PU0$Q@)_?T2^)<>4<'3#5#L^#]?]N5GUZ=+#_TP&1<._D^/B
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MN88VIF1-^>&V8S697VZOIC/<D!.X@BG(%%(9Z?%N2@KT.1@9P$^*M9 9#SZ
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M=OEN)R*I?"#ZC_PRJW PM:&A#),E^&^UO,ITG\]F!6^.XUTK/4AL$$=E:"G
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M3:"(]$G1M>H(?&0(,,-3V#1\0]2@9IOYBJ+%(0<@?N%-'::55WA1HI8SCAA
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M(N%*0]\J?FVN)+.^TQY@+X$U^JUMCT;Q.ETZ_0H#)4)QQ?QFW;C;.H!&\\J
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MB,BV"G D"I=^0.O-Y 23(.S>]W7Z@,_L[[-LM@9G.:E8+#0K4WH&[ (]E1G
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MDU5^__=!.5K0/ZZ:20'_^']02P,$%     @ ,(VO6EN^$=U+&P  4*D  !
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M[]FO7+V'>CL\-+6O,X%1@RW>\A3F_IPG"0NP]30O5 F]P<?8-04<044<:.;
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M1Y4\E\D %5>Y+"REZ\ RL-LG+7;JW124"7I?OB91PQ<UW\(P2T$_>H$RN$$
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M_,EP.!&N&TS]R<P;RO'(G3A>,)P%SY+ZRTKJZ(E+ZJX(Z#<S>A(%8685%$6
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M3EU_Y@;38>A-)7R<!C/IC6$]3H?N=.Q-GH^K5</@;>9QM?WP?9K=)%)<-<[
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MUX/W3^@>>:#!JS2*+4ZE4'*0\&5JF7 [\]1%\F ]O)H\@FQP!1F&BVB_=P2
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MU^@R38=">G+S;O8P1"1Q<ED2'^/]%G88GV!1#B+;*5E&TE*U1+A-\G)VQ\(
M%^/E^E=<MV'>FPPFDVIG<(X$6'K1QWL[L+>D.'#0DZD%Q.VBR_N&PM>ZG*_^
M.;H?/XS?S88#",'0<2BPWO?81ZU-:?48AV!@!=O;D.XS 07;,0R=8VG%Z5Y=
M+5MN5[Z<P00X@64IC=JT;LO+U CLAA5:#K=+ZSX7/4;RP/#\95C(!#&ZC\"N
MV6H%B\P-<*L4F2 L4<N*V[_G;8S*C0P2J.YG++"@QW>@J+/5^]EL/4,';!X=
M(BY32X';U&,KHZR9$6MGE#8T2*(BB2*N?!;%WAY,!;3=?D[<=!'*)CHME5HZ
MW+:_%&8.6Y_Y/5@6J9WW\^,T7:@&.=6.RI?6X^+Q83I;KL?_++:C_,]J2?#'
MXMC J-S"P/CJ $GB'87%G'WSEH;S*$JR6!UQD5H W/Y__+A^;\$"GJ[L&+0V
M7ZT>A^B=2Z_57'J]ILDUFQ]__.';OW[+;5Z[WK09_2'_Z!\'\5\H_G7)4]VY
MME;TW"ZYN^C33PZ"U]VV*@M66JH5'+=[%ER^&F0BEDEQZZHL"^Y7K0RX76YQ
M*6M@O2+\J'8'JRP$1;E6'-Q&5G]9:Q"3Y"RI?CVK+"-9H59 W!ZWS26N0522
M2%?I;:VRS+146N%Q6V#EY:Y!6K*HO\J%KLJP$A9IY<)MB!67O@:I2+QY#>]S
ME<75LHY6CMR^NM-EL$'"D@/W\A6PLAA%!3I9\=?":Y?$!BG(I9#?#:L+H?:[
M5@:<TZ)Z>6PTR$ :B26^)U:9W#1$6NEP?@7EK;)!5A*?.:7NL^?C&?L<@ 9;
M3/B<WLHH2TM/II47YTY0WS8;!"8QQJLWS"H6N+!(*QC.QU"_A3:(0BP*S4VS
MLFB:D6I%Q?D?&MQ.&Z2G\!-Q5]$X3Y&,0BLKSA4AN[4V"$BVD3W?5JMN8NL_
M:T7!.19*M]D&[C>XU5"ZN%86A89&*Q?.L:"XY3;(219**;K25I:2DD(K(\YI
M(+W]-DA(%^R:7W>K2D=2JI,,?U5=="MN$(KDT+1T&:YR7,K_KA4$YR>HW)8;
M)-!@@<GOQDE7EQJ!5B:<=T!VBVX0C]2)DUV?JWEMJK]J!<%M^XO;=0/K)8:O
M[OY<Q1QN2*P5%.<&:'3K;I"AQ ]=NVA7\46+R[02XA/'U6_C#=*0W6$17_ J
M2T5#HY4.M]^7WP8;Q*2SE"7WO<2&LYI8*SC..]#HEMAP^G/M^V+5P7A9(UJA
M<ZZ'"Z^/#=H@B4H6W!:KQ!W+R[4RY%P3PFME@V0:WI:IG/=)"G4RX3,&\)=G
M!H%(A@K&Q5NWI:AX6(!*,?%%2'P>$?]@AQC%>B13$MN>GP^IR]O1BOF*]SG.
M'__CZ _9]P?-N/1JQ\K9$3?QB;6QG@/BIB=752VY;IM:C;GB-9"\(R.Z&5'L
MRLAF?1D4Z%,HT'A/PSB[P'<U#1(UJE4ASI5T'16R2WT95$CJ,$\O_Y3N_HA7
MGP9T6D%SKBCAS:-AX>AP-:P8@DMR)$%";D[O"-V&]F$'@]8?A\2&<8T]RA\9
MAL'*KQZ?HF&M6G#^+Z%:E(=VUI71TVE4[LP(>S-BW1G18)1W"&N,AY7D<HV:
M)%%,]R2,ZAK07H>T36FUAL]EV4)KSI_G]6?0D8MTY-[^#PT7(743)WX7TN30
M7C>D36AU@G/YM=$)]ME1]MT1^_"@"UUT 8Q L ^9WSUSZ&5<;JP*VA:TFM#D
MA<FJ)J3?'.4?'>%7<_48]."".6%*0C#F(N0G.W_9D-#:8. Y!LNN2'CT'-+:
M"FG5J%9;.(]CXWDCZT>J+7E/D(#U960'[BCOS:!$790H*UN2*/'CB#<^&RM.
MTX9TRO(]YPK5*DOVZ5'V;:'9.FC'!=IQCKW/_BX=*UVN,9T:UVH1'US65(O2
M_F132_I3J4N#<EU-N>YHL+V#V5WD9NU03ZL2G"M5JQ+XI1'[U+#!O4#04P+X
M'2_W=9:=F!=,'YU:U2I)L^P]924I]X/-&N6>#-/%]=8B##%FSJ>%S9(!97DR
M+EF!6C>IU9]F/MC*NH.=R+QJ63=&63\&[;F:]JSM%_;+Y4K3N"6MKK1WS.;?
M'A3DZ@J2Q<4QQKI># *Y0$?:-*95D_:>V.SSH]+W!TWIF(A.?%RG*-?*D_.B
MEI/3#:=S+613\F@>26AOR4.R?T)/U8*$$0VBE)*X$M&UK:Z5+.<5+4NVX@Q-
MOS=*/XB_9)\<Y=\<Q-]&_,5O$QK5MI(MZ+4"YAR9,@$7'QBQ+PSB;)-WLB(_
M%8%.8'_AG(E-,D\.<W GJ94"W;K(M%EUK<0EKQZK)5X>NNSKH_/G1^GW!U60
M7KL[IPJM) H=/TPQ3:AU>\N2A(K-J(YUM4K O\/<*I_I, &TST-;\JH ;G:3
M"$9R.HIJ$9 =ZVJESOGNVDF]XI3)^\%FA+PG@SI<-@F4CYFC.$P<V)G"%,LL
M))AF,5V0.V4_K7?D5V*';6:)]HUK%8J_V]M9H<)RGT8.=FKD9;T:N>FOL/",
M3M"Q0<W:IU0NI%^CR0D>2%R9A*[3E%:%.!^?)CES66?.G\]L$#!=LA[\\4\C
MZ,2@)PV3.4N,#PV15K9\UG15@N?!J&@KMI(_E=D)MS2$,I4,U36T A4D/%,(
MM.)Q99\;;6B(/OI!PJTE;!U)&!$[@J*?836,7"]-(]!,VKK:6LFWR]5>V2YF
MGT:YCRH?'[2@M1:@V9W$-#Q!V1(L\&;2E]722EWP8GI#J9\_R<2.'QVDW5K:
M++EX2#=>?,[S3AH.>&55G=Q_X+R"C>6.WQVE'QZE7QZQ3P_2;RU],&#/3C9D
M:U/1R^MIY<[Y!AO+'3Y:<@FFGQUDWEKFCT%('+H-O A/U6JYG9N)OU$36DW@
M'81--:'\_5'> ;8*#"&"UWG+1;Q;ZUQ;JPN<V[#C^R[#!N]J*M!)\HT%SKGU
M.@J\DE#AO#@<4NL MX+HT'/A0Q2O\R=X:S;W) _3Q+5TY$TG)7FCUQ+.<W<%
M+0G C'#L:+?QZ7,TVI( U0'T8H/7FP9-^32:DG+O+ZWT)*^CU1+.!W@%+;&+
M&RA^Z>8)Z,>!1J70H$$?+IHYWG::.=[J=8)S(UY!)V9V&,#J$F&@V&@\7;'U
M95J>,:QAQKBVAGS724.^TVL(YVZ\@H;@0P6C6[:PC&-@P%,28[ZX44P'/6FK
M)Y6W!\7[$36)5@,XUR/W4.&PG6@GIGIZ@_1(QEU3;3S*Y<WHQ/U7_;N4@EP)
MV:=Q! _Q*-W?LY2/7RF%5I[Z-RZ'X=M*2,6PP_QX3F[N0+$5NEY@AR=&)A5A
MR_I: 7,.PIJ *^.5?;)JHN5?3:_W#3K03@>FGI_ OO@"+6C8@E8/..<@-] K
M=X'3KPZJ<#U5*$EP[$8-)"^NH!4TYQ14"KJ^'1ND>ND !UDQFDG1PT[#7-&.
M5@?XET(4D[YPK././+W07?K^H!RMG[R6G $U)M>*FO/;:9[!'LRY[L(L1>71
M_8%&# QF0$[IRZ39:S)K.G:<9)^P/\H)-IJIPR?XH%:A.*>?1J$JKINBE^PN
M:-9/Y@$^]W24=16W@Z7.5O*/#,IY@7*.79<AP7#O\YU^*UAZVUW\BFY>0?<$
M@0J?HF&MLG'^PQ;*5O1F5.H.)O0M=VB(9KA<H=(8%DQ=N$J>7ODDQO/A,I-O
M$L]WT79HJU'M6]:J%.>0;*%2V?4$=HI9ZE!5H<Y=&G1*^K8,I>ZSY^/C7',
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M7).UTE.FP%Z.!)$J1.^25OK)%,U.KSN?VC3\E; .#('B#MT5.2=OMZ^,*^X
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M,QG EM7\,D EQ=DX:A'9U[X9LV>!-))=G!U)HQ+-JAJJ#7R =0.TTAJ] =E
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M4SB4RE#[&D^K6B;I@Q?OO, *V#$POP*)2K_H:O/WUY&S RW[K_\'4$L#!!0
M   ( #"-KUI !X"#?QD  -*. 0 5    =')I8BTR,#(T,3(S,5]C86PN>&UL
M[3W9<MM(DN_S%5KMLRQ3<H_M#KLG*%)2,U8F&"3=[GE"0&11PC8(< J@9.[7
M;Q5 G*P3!Y4E]<OTF*HC,U&5=V9]^=?/M7?RA'#H!O[7T]Z[]Z<GR%\$2]=_
M^'JZC59GGT[_]=L_OGBN_]>]$Z(3,MP/OYX^1M'FU_/SY^?G=S_OL?<NP _G
M%^_?7YZG T^3D;_^#-W2Z.?+=&SO_,]O=[/%(UH[9ZX?1HZ_R&?195CS>I\_
M?SZ/_TJ&ANZO83S_+E@X48R %*X3[@CZK[-TV!G]Z:QW<7;9>_<S7)[^]H^3
MDR__=79V,AK/KV]'?Y[<[TZN_^_LSZOIW<G96?Q7''AHBE8G,72_1KL-^GH:
MNNN-1[&*?WO$:/7U-,+N/5G^XD/O(EG\OP>!'P:>NW0BM)Q%Y'_7R(^LE;5!
M.$8K/#VABW^?CC($R2*^&^WNW2!"B\=WBV!]3H><RY<Z[P;80;#>8/2(_-!]
M0B-R@M:H,=2L-3L"_\;UR?ES'6\2A"XE5&/@#U?LBO).^'CC!<_-3TF^4E-0
M9^B!+CGR5P%>QP>/7O3EUD/6:HJ>D+]%5[M;%#Q@9_/H+AROCY%S1>[=TO+3
MRVRM^F&(HG"((L?U-+#K8O.F!+DF@X(=!2N')?]M$(0U\-18LRGX5O2(\)Z)
M^ _)5<PW9?U5&YOZ6S1%;K3>."Z.:?;HX <4YMNR6*@V9C77;XK6$*T0QF@Y
M=WXF9[GO+^]<Y][U"#LJ O'=QV@1//@NN0$'D[2Q;7?;5@[N./#/%ENROA_5
M1$J\3.,#Z!.F% 6X1)["C_HG3G'!IH#/L;-$Y/O&Y)FB!7*?G'NON"EOA#9*
MS;=J+'Z)="3+T_]<_V=+%O<(.0O[L_^NC6BS;1H+;L*AD+6)5<5\SQO"O_YP
MO"UEQ,G?_D A9<03A-U@J2^AF^S2%,4)#I[<L+QU_ILV+FK+-07Z#A']A,E&
M!P[&.T*DF')AJG>BZ@1MO%K;L2GJ4^11/77BX&A'[K@?.HO*P:%V C$2ZDGG
M>LLW/H13ZV8TO[&F\]^O_WW=GUKCX6@VL,;ST?C[]=":7$_[\Y$UGNWWZVF<
M1]V5CX1*LM\OK2.2KML4C:OOL]'X>D9V^'8U&I=HI ZS:)$. ;1MC0,B62<!
MDUA%BZT7'_D[ E0)7/0S0OX2+5. Z:HM.";HOF1G+UB4=O.H11;@,G7H9B'9
M+?;@N"L<QFZ<R/D9^,%Z=T[I=O;^\NSBX_EJZWDV'9'_O[-%@.U\2$S<^/=X
M!.'=*S>Z"\*P']&/L(VH%C$/K&<?8<+M"*,@D*?@>,X]\F(@;=TE[/<)K4'A
MK(A7>DY P7Z%B,&/B FAB$0V'B0V-SA89P9OG\BDIUBJ*N+&F0T(TUM,P$P
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MJ0TP9WY+GF4Q?8;D!(>1NZA'W71V2\K^P6;?P[X7(>R3#9_0-W*DU]LU^>.
MC''Y1H#F,BVE"QU2*F[OA]:; #MX-W?7A&A#=T5&(7_!]^SKKM.2UJ]^C<+8
M-=7\.B;K%'*'CBTN]-D'2PIH7&?(&FI'Q."Q"] *9T>TD+(AT'IG5P=$RMU
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M4)H.78_09(P?-HAEX9ND\F#<6B2N*37$B5_1#SGK!@DM&[T6N0&.1D;WS6[
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MW3TFG)[J0K8.6M:KPM0("[QSH[RA=F4FSGGPB*+\1:_==N?*4MRA7E&FIC;
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M48^2>':^^%5G0*.W(5*/QBY3?'ET*G0U].XFYTL+EAP39T>+)IF'G2'D_@X
M &AQ0("P $6RJT11H,7?E:G6"P.><U+KQ,8JSNJ%Q,9X&DLOV3:G[0 +>1ED
M3."ED2I6L,[!9H6BIL4!VT9G$<F)QBC9/&=TWA5X'[F0J]8-WKK!6S=XZ\Q[
MZQI(".VWV$T60#^2(Y9Y*'CM 65CFW(AFG%:@78AFDWRXJV-:AY%G<&:]=V9
M<C":26)KP<%X]=?!PSAX& </(R3+NHZ'4:8L#4Y&2/-;'_O*U]%ZR;1<D0/F
M.H3E6?T%&OS=(&,BSZJF@@GK.FA61FK:++##Y"PB.=6<X7I:D\07Y!XZ7'>'
MC>_$?B*RP0$+QI$Q.& '!^S@@ 4H=I,.V#D]NH/(LWW_(TM,G ;T)HJ94R&4
M^0#5>AM"0U8H@B5*/C-;KTLO\4/F?=0;S9"K^/BC8QQ098,9RK/EY-U9L\(7
M["^/=-*Y$M<:Q)#?M/QKZ;\C3T:Q6F]=[VF#1TJV2/+-=XC=6JSM:$30B/[)
MS?<D72P>=N?TSXA3C<WH^(,+=W#A#BY<8#;[X,(=7+B*;CUEO0Z8"#2)+^%<
MK#'"VM#UN:VL;_9NWG7U5F N?9,+7Z(&0_365^7<N-(KJ6C3BO=U3C#5^**/
MN4\W[BAP65&B+1-$%UX;XA*O[VB5#P74V<HE7,_A*AX&HH^,2[&Z!U8X!"">
MN71RW9[*?0%Q>1M[/JMYQD]_Y[8%Q$63<P4M ?Z)A1GQDMY=R9MYXEUWW!@0
M"G?DNLF52A57+98$_8PA<IEBXD0QO;Y78QP* +9'#0VY2Q.^9LN7C*_I9FM[
M)#DCDZIU[%^S8$'5_C 1!9<^S7$, 5#WGQE3U6R%#G98OKVXWEZEWD7_Y;E7
M\IYB%E9G (-5P,J*4?TS*2XX(TFXG7?."%=[S;&M*SB'M!HK4VK.I"LS8\J
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MLS=%)7<1K)C@2T#*HH)#,' (!@[!P"$8V#5/-!SI#,' (1@X! .'8.#%'<&
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MIAV-Z185+^ZR'M8U'%,K6V4)H;/$*QU.WA%QTK=#DE^_TO7H[ES;(T+L8)5
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MXT"3BY(C08ICZR_KBA YL'F%]250"L@#6RZO/K]"V!_8)SSK\RV %X)]P-/
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M@WWBI $A58[L@WW\Y-RJ$0\< /:UE 8$5A5L /:IE&86557D MS75!K:?-6
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M9A[0RO8I:0Y"+%TPS*D4\LWM9>JMB)&;^CQL_T 13XY/WB85]2F^\W V5([
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M+9ODT'-1>A,DF2Z9*U<,TZHXIG4-Y[SD$$S7$UX%7HC<$9W10FW$.QD4K\J
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M53&4)I=%W_54"0XGE\-%**9\#% NA\M03.O#BG*!78X&6X)*RJ5PSAH.!1S
M1_)2NYV$.#M1P*%([RV*OB$4',(:\ID1 L:J#0FT9(.4 ;U:#6K#=2*C?BC2
MH J4,I*D1F9C&WL;23[?43-#'_\O\D_Q9_,&AAY&SMD8!>X=^6K[H2K?QQUT
MGSMNJD:&&63SG4>00QM+ZID?-3-4MN#)_GCS?%\M^["TL:692L.3 ODO;Z.P
M*([; 2J;#;U0R=(.7Q-N0Q(EC/Z(_"AD/R7SD7!#?["RJH:<R^"XB795Y@.B
M0N3\987??G1V(Z:$93_M"<M^8XW\K.RB2+"BYBT3/'EY$A%(_]P]";:X&)G/
M$9$MT[T?[0VOY@:OJ7:>=B4BG] V)LZ:VCNY9^R8&*Z<M?J;2CNO7QZJ7V(%
MEV+NVV&(\DJ)GNU/@S B<5I'4*JDRWI;5W JH0B)5;DXY?VUV>4E7+JNESH?
MGK>VPZ] PV]\:8*'MJ_,EJS1+3S0J:H;AJHJ-%Z(I=>3 &W_Y'O^>6T3M(-L
MJ=]'Q[VTRPZTS9K.,7C:SU15A=$&$<^Q@SNTQ2$=GGPDWY+</Z).?1=\I7W#
MD_X^-G,0P>$*GM->N\  AYX%(IM=O6L>"84FIFH!Y$^IVQ&ZQT3X^;*VINH
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M94R9DI@*2!*8Z62*=2$,$YBM9(KG6D#.GAX:VK!08+:2*3DH@TV!64.F^%<
ML@*S>$QQK@21!6:_F.*]#(T+S 0QML&58+[ ; IS\ZR"'X9F132L&&N@CW/)
M]$<+; YIG NK/^KC&<##N11[IG":!AOG<NJ90MHL'#F76G_4V,8QQ[G,>J8
MMX5%SN77,R6Z(=!R+JZ>*>(-H9MS<?5,=9? I_>NNC-6[_S\-'N9OSS>39X6
MH]^GCY^?JQ3;Y"=V[I]M96ZJT$LMUL]TV6P?!!4P=;KK5K6L1"ROU*1J5T#E
M]9ZI;INL17:NO='S+ GC38/G^#7T7,\FGD+E2-5!.L:W0O4]]6%T>><LS$6Z
M<V_3G?O%#N(E/7-B^MO5@[?Q(N2*W]I2[6^6W"<4(GK<KG5(+.VC6\210]8M
M"E# ZE&KBHW;P3*3'2J8EF=$WCR'J;CUIK=T',M,DN?A9Q_B=SHXCLGJV2:^
M#L%E/2TS=2$./T1U%QVZ\N:Z;QURB!G[-OGSP7[%A'7QF+8DH8??P]##@U]L
MXK[?>?8JP&'D.7**N!T,%4V\]Z)_KQ"Q?:IJNS'5K1*FJ=*=%EAGA=,E%*J/
M8*B0(ETM6XS]%[GP3EN:*J$X)]XF#L>8;'$:$143PFENJE3B?(U1X+U3=A=T
M&['/2,CAM-<ND,A=5'CC%1;M;]AG1_KH5;:2A-VTZQ<J4J=+UIZ>)H[U.WQ+
M[-#3.M /^VA7]E.BZ^7/ATCK6BQTT"ZLQTLJWFP<K'-Z<CN8JF?WB-_L<0)S
M_7AV//H/IJ9*R1+W,E71[OARS11GS7DLZ6A=F3G)Z8=>Z5="%(28R&>3T]Q4
M[;C?Z67%E#8E%;"TL:DJ<8<3\%_8"Z(_4BQU!?64V]U4!;G)UAO;6V7J.,U-
M57_[@B*JO_GTR';"PLY7(DVEKZE:;U_M-[3$9,-NX(!^<Y5JFZH:A6)W[7IO
MO7(&0*O"_VAOT&R9$_HAY/.XL7;)L@89&;DN06'(,,HK+V0N>G>VI'/"T(#T
M-HO$G$E[:U<PXVOIN^RVG?=8H)\?-H14 BPG;N[;3$:W<>@%5'Y"&?,Z:1?:
M:K8J]I:]@,K<MK-O 2+AVMMF$9_"AA:O)N51BK6V6BB?HNE/+PMFJ#FY>U/F
M1(?G0VE5<I(#KEJBPT4=28"O5:+'1,D6TO#$]UT&/%<_L)0-@XR+X@G DC;:
M6?*\Z 2P;(W&A,&)? !+TFB,_6* !5ABAD&>A4$<8%D9!MD618J Y6,8Y%HK
M^@0L5\/D35<:Z0*6GF&07T% #5I:ADFN!7$[:#D71O>X-"X(+8FB0>Z+X4=H
M60^-:2ZG$4YHB0R-L7X41X66BF"0;V&T%EHZ@4&^Y>%@:+D #5HHI<%F:.!^
ML_SS@MK0,/H&N>:&SV4 _0[SK!&6SZ70/V5.$/[/N>Z?$J>*+,A%T#^%3@.Q
MD$NA-=U.IX!VR\$9H&6SZX4WQ3"'GK*JA'L %I<P$,4N!5< BSB8FF(1[ )8
ME,$<RQKX"TG4H9WTR]GL[NOTX6'T>#=]7(P>/T]O'R:CY^?)HE(B9H, F>+L
M4(G:P8K5&4LKT#P(4CDU1]#-YCP3Q[Q\4(W>@%(CDXJM*#PE=!2XGS%VOWF^
M+TT)51VD8WPKH$#5AS&58WGUU]^VOC.B9]7'OQ&1(+#+&ALBY/ECN_9\+YPS
M Y*>VC9!8F*X'0RE>3*[-G0(0@&]](*(3@"KDKAE&JT<IR[L:"CM\W<[".WP
MJ(27!-[/[Z*;S-FKO00-47U,\0O5!L@=>D,^3M:1D&]9YT*^XMF>VQ-=VER5
M3.4>[ UJ]/^U=ZW+B2-9^EWV :;'=I6K)F)B(V2,J]FUP0%45\POA4I*0+,@
M.23A*L_3;Z8$DH"\DX(C*?]T5U<KDW-.WL[U.XILLV2F\)0"3AQ5X>(<28!/
M'%5C@N:M93SAG668IR8 <\B87&8)'0282\8@]WPUY^(^&A4O[(5O.J!>6(-*
M@X0V)&#^(MZ;T7@^G YG\X>A,QV-OSU/G/',&3\^3*;3R0]=,*T+>31*0,"7
M.GAX#;=-W:DC/R50+X^0 36WC]QT$/TA=?@^:;_/T2#@?*G8HB?##+E/!MLD
M.01+%$ ",;XW1 Z!/%2DB#-$U:/3JO6'YGLH2=WI#-*'MOI>%>CJ<MRH+%5]
MA"'HKFJ/%Y/+GHCZUQT4+M@C4':!T7K%6*.5T;JNQ:K*@K+'FP(GJ[=D*?K9
MYHU9!+ LO$&F**-VUQ5$+]A#3,&G49H9[=?F@T^<>*0I2+53F&<!:<P!IF#4
MCCI?":DY_5@90*WEQQO^[:VJR5 &*J.778%!K?4\>(@-0;2QVJ@IWSIUQUTO
M%@#:6:K:%G.YJCZKXYU=+;JHY#V2"C=*^U\Z'G^4EX/0.7WJXVE# ))"M0JG
M[0DP4HFFQ%HXCJ3.\,AW35T\=J(53S*S<:\5+X)Q91UXN*ZX[/+7U2'%D@R6
M+B_P!_B87N[9/7*B7>^U43BUYZQ?O\\JS_EV\<P'G:/+94"+_<H=!_Y@"\BG
MG'.AHZ^#/ N<B&"3.LY@6<XU"3^U29USKN<36-V9*8;ISM6+5YQI/=V-W=_V
M7:?X9J^8U*?QI!_1KLITY:UMSZ-V0KG<Y7[D 6Z%TFYXF5N5HVG&]7KH3VY3
M?N:-3="T"9HV01,67WU.T&R5J*&%/YM.!(/3Q>@2B2)F^O<UD ;6KV6 =LC4
M<PP,I>TYOI\@HB+N85TF$9<6\2#EU+T&Q3I%;]Y'CK\U6504YALD7(0H<-+=
M'HF6.P0CO$6X*Z UHZE,P=G*P](>I>D6!?.8G%Z"EXR2U$D',;;1\!]SN#7Q
M"JK/9"JW\#E.TTF$U<:W./76,KN-/:*>96@3;6RBC4VTL8DVH+UB-@&EP:#V
MYW:DH_#H/R<D\AG^,>=3KQS0OCS'9H-@9RYXOWWBM6R&SC(N9VR!#?2;7W]M
MZPML;H#1K:)GU0$#KVU(-GPK$@)XK6QX[=:&UVQXS8;78/$%(;QF&'"DRP*'
MYO^W039X0;89>D?1OY"7*)7#\T?U;"&@';.KA=FJ1AF;>(LOV]B+*NWP> M1
M/S:%B$%FFR3A,BRZZ [B-.-$7DZ_-17+(EB<V4?>F"(BA4G9HY<1?$-BO# C
MV)PQIN)3301$;93*1JELE*HW42J^4MT*G[4-5-E E0U4R0>JA%I_*TZ]C539
M2-49+G:FW=+Y"!776NI'[$EDF_4CRB0T!-L4:+JS@28;:+*!)EA\V4!3JP0.
MS0-N TWP DV-@E3W:T&@';>K!9QX.^- -Y\L]J!).IN,,16D&C G^/<VS?*D
MP:<X^89W24IRP?!&B@9Y<O$H*A6>R:)BEK]BVK/6XV<V&F2C038:9*-!T/W"
M-AIDHT$V&B0?#9)2RUMQ\FU$R$:$SG"':YH.G8\7&;(C!)$E4,&$3S:88(,)
M-I@ BR]8P81Z<P)Q'.&@E4&7Q0S-IVE#"*T((=10@Q4\NW6LX7XM!+1C!BET
MD.^*O<+^F'B_@OB72KR .MX&"6R0P 8);)# !@DX:FTKO(0V/F#C S8^<%9\
MX%#O;L6IM[$!&QLP&QM@F@DV(-"A@,#82Y*<Y%UDP 8&;&"@58&!AOR>+>'4
MD+O-3/"@@4889@CCM"5ED<7K9&JH?T 3B$9F8%>4**(3\JFYA1O@/X?9D^?G
MF0N32"@Q^3E,@55Y:W*GAME_EBCQUL$H"K :D0CK<D3CW/M>W4K0@@"4)NAR
M/-;;+L)1)ZA-VE48JKKE&KETO'3E1 'Y%RE??L=G(1*$S#A#NBAHL.?!3'*&
MXI/1JK0!5>8:[]EGAA[3M:< @]R=S1SY'OEQE,;K,/ R%,RR9.MG1$4:1IG<
M29:9P+WY1VL8EEA>N2F4F6;A5*+$1V_$.5.HJP0_GK@E1V'X_,8_91)#35'Y
M$OKQ<Q;PZ3GX""]1#S<%M/-?HL/@VZK BQ&_W=0A[BV@E_N$0IE+FS$($F,_
MB)\VRJ8H1<D[V^+E#X#$D-F5 G>X]GI W@5DX+V%F;>6UXV/1[FW7V&SIJ(:
MG8Y39H\%%[Q!2>A[T2-ZBU,\??*1_Q;_:>(.,D59SKPS2? CO/\!D>K.'.'>
MPM&IFM@,T,XRMEB\/ Z(%:CA.[E\G$6&DBG>+PGY.ZQKA7$@/-SRT[AWBF[<
MJS,OL>(J$RD+@'T?1 $)93E1@!_"#.MG16!++@8@.=PN%[03^[!-PPBE*587
M?NX (,7F+&N0>_<%-&,2B\D>ILP<XZ3]\-[1(DXV<^2OHG@=+['=,\)V48*W
M2_Y[_),F.;S;2P'M%$'IU_[)3+QU'F,5HQYMSN/,N:,DRKPEL\^%:)S[R5#0
MU4M7KUX8S..AYZ^*7H&\P,?QM^XG0SYF//<4^2A\1P'F<AQO\)JL\^00'CF,
M(>XG,R'5^ISX)W*U$=N Q\O"]CI+#7<_*498^=06T,LD,>QG)J"L_JG[R<RE
M_(A2/PGSI+/Z>2,;AT4-9XC[R8PI=")TDH=$F)]B_4HF2^1DD/L)CD'TFL0^
M0D'ZE,0; J: I5?8;MR+D3G*_6PFN%K,=M!WE)F$</JI^]E0'DX^-7X%\#_)
MY4GF)@M(W#H>R<Z(G<<9GR[!8/>SXF/1X%;XEL1IFB>;Q)M-6&21<G<!;8#[
MV<SK,OQ-M/9MF*X*$X;<,\6=P[PS.4/<SV;>&G8?6!91G,ZQG^%$#]7+13_#
M2>W!]VN>IERLM<!*K'_J?@:DGI>B??&R;1)F'Y(KL?_<_0S'Y5I1MT>R)Q??
M@Y>*3%KV./<SG#=SO"7&W<X7N.N8S=]VE 'NO9F7<C_W+GZ2/SBAS^X/R/K>
MO3>55(LMC3!%KV36ZF<FR31<KGB7-W>8>V_&J'HM[+G)XA7A:X!ZR*C?N?=F
MGC4#K1SO33UE9[9RO#=C*(U(^0@Q6+6VC=QH]Q[.:\6J7!+4@K!&N?=PWC .
M8)O(T\(?ZMZ;,>7J9DN1N[QW;[&/(&N$>V\F':6!EJ%?S+PL)S]"_H+^U'&_
M=[^8>5E.YR^KW>1)*H>X7\R\*-1ZNL-#RJ).8JC[Q<R[P_^I$E91C])RN/O%
MS-M4_MP4;:KZKJ<XH?SX@[?&?V![TG3F<K_ ,<T./%P_5BA;H604O:-B%X\B
MO$UB3'N&1NFN%B[XGI(@6)YN\H*_CX-)XF2E' 3WL.%?<[_ >7KIYH6&1>)^
M,>/P/&I[-ED<U28QE67!./<+'%OP8$<5=*;YGXE[9AX7K,CO2=8,[A<SS['Q
MSN)?X>2.5IMYBOQX&6&%.7!(T8:/&4CS*NY'^0/!G</]:NC-SRT?Y]T+U\25
MGE_;[V@=O^T2&U9H\.V%G0\A,=C]:D8/<((@+)Q+SR$6!?Z/CYV$_B,K9:UY
MW*^F<D^(L+ZGN6.:_$2""@$QK1.98>Y7<X4;7KHJGQ4";4!<J^PH%?U[]RN<
MEQU?9<1A?5A9HG\RU:=SOU9OLP6*LT!Q&OA2[4",XY&OQ7M[,.3XU!\R?Q*Y
MIN$;=(]C/G0"6#RE<Q@68#* 14S2YYF%^@"VO[;A_<P&D #;6_L,"8AQ*02M
MM*&CY)WY</4;+?,0WJ(5 )E')$NR6 %>@'^U3PBFW>%\^(Q6X%Z>M9#]/K84
M (Z+*RI&\*H_J3%;07* /\5TJFE'F0/TT1TN!=@A5WQYSL'GUMN^O;R[9"%'
M+FZ%*-QCTCSH"J$"(8%Z\A4XH-P"DM@FW63^!$@%]*5WJ;W>R\N0C<9R<1>$
MBAK'IEJ>T0J?!>HIY]+,8I2%V0+:$C.XGOT\QCS0ERNZU>0-,BKA2NQ6,#!@
MS[. ;,I3+026Z1"O?+0:T#J*^6W<RVM,#=YF+YI[@/>:(B?G":0"O(%Z&RCS
M0;\*99%T(.LZU]@9O;Q,>%@\>T%\ 7AU<.E68;9"YX%Z+0BHIEP""B _D"\!
MTVO<PPYKVCA G9>1-.(0V)0BHY)@X1R!S3(RSCT'5@ELHI%1(2@@-UW<67)-
M@1P#1EW<HKI2GTHN/M7%=<.K"$$(AK47P]>NBJ&:D8N<M9?#/[HJ!QY@5Z4K
M]8!["5BP4AZ=51ZK&5E(8J4,NJTV"I#+2BET6WWD0Z650NBL^D@KLB4X:R7G
MG=43ZZ[&@K,*H*WDOK.*(FW=ZZANI00ZJR6*\!9*!+A2%#W0%%F@<:4,NJTE
M\G#J*F=2IT4@@8E72J*S2B(3CJ]DO=NZ(1,$L.2_ZUHA'7NP9+^S^J BP&$I
MD!ZHB5PXQ%(0/= 8Q;B)I30ZJSU* #660NBLWB@'"UG*H=NZ(P^)L@K%]4P$
M!\B7I12ZK3=*(FR6TNBV*JF XEE*I-O*I2XX:"F>SBJ?#/A%4Y"@I0![H*RR
M,41+*7164Y6&*RU%T5DU50/0M!1*M]56$7YJ*8;.:JU:^*I5/E57Q:*&XEK*
MH]LZK0Y ;"F:;BNX$F"TI22ZK=CR\&]+$?1 >=4#Q2TEQ-!.__E')2!,QO_E
M?W?X5P="0[\S% 55YXP#L>'UPL,^?H98$_)7?_/CS1^YU$;C^7 ZG,T?ALYT
M-/[V/''&,V?\^#"93B<_\%_,9OX*!5OBZGJ)WU&AC._KD_X+",:QWHKNR:/#
MP>MN$BBXS^JE1^;DL:]D@B(+(=(AEW49G,16<"K1B%L.#=,$UOIAC2.%*,I7
M/1,TM-;G++ N.4:/#PT@B'PFGI@R9[N5,]7=FPGLQCHO/"RX+@L<VE%1;W5[
M8Z:=FH'6CS=F+OBS6S_>F&F9P@M"2#7>D9[ O3'3)(451-*E]G0P@5<$VE;P
M!LXUI560RSWO>B6^-XK-S?A=:4?1_X91L)<]\VJ@?>S>F.E(AE\IWTM7N6(7
M!YAS/S_VW^@/@&B(>_.U(9>";3!C2I(PL,1L@YG>-)@Y,1PA@V?83@R-'OM3
MR[,5W1@H9*NP6IJBX \WE6A&N(%MW+;B@)M9TQZ"XQQ:RIUGG&^>]P/FAN44
MZ ?,C9+7H1^@-]*NC7Y W@C]*)T'OS'@6.D'-@[3F]-Y3!P9YY$ $.<B>1A/
MH[$S'HR<9V<V&\YG8U)Z1VZZ1Y1YX3H%F6EQ6!3WK)Y7P9@ :A;%(;F*.1.4
MP:##V54+.<4X=KWW''C^M"+UAUT$C7C$9QD^[F@9^J]>DD4H25?AVX\P6XTV
MWB\O0:/(Y\=]9<?W8DF@!8-E^OUP^95J& 0G;B;7GN@LC@WG6;QOT\?06T;8
MQ Q]_!!M0ORKHDP+SJ!>+H;6L6,LR5'M3E4)QEH.Y@!3B17.,D&YYDDB"\S0
M=OTCY42*!G=!;AH?E$2-HA0O9&XR<1>?.])4CL:N<KIT</!2!^K?*6=<-"GB
MS1NV4XA8"HBYH[>)+V3^6.5TC28U8N0GV Q#\U42;Y>K'PF^]>+%\4O,UXNE
MIH"4"5*AC$\6?\5967>Z-Z7371T(+=-*8Q;EC(\FMW5YD^+#1]S0*'B*DY/:
M6_[VEIO#5'K)48NI>-]ZJ4 W8]XMW%'U))-S:#LH 2>'O:JJ&D6O2;P(\[]E
M$2DYG'2/O'Y*#-N\9_KQ)$SFKJ>[,+B6#_\?&."MRFLYI%R5XQ9FLQP33O%=
M*ECVK8B FUWL-B:V*!YP2>,?<DJ++ NZ(@"?ZB+/ #5ZP?<T0#[V%UKY=B7$
M2.M%8L]&%QD^<:*T(]U%0]L5^E;:D>JBN+P4'TX[\E=T5ECLV&E'LHJ.+2?M
MYFE'HHJ&")0\/NU(1=$Y!/+NGW;DHRA>>$+'4CLZ,JEQK>"I$O5DND@"SNMT
M\C2:/TVF\S^'_QHZT\GX<30;3,;ST?C[\''R.IPZ\]%D/-LEY-PH9>2P"CUK
MXG4PNQ]IB"W=O&\9 93!NV/RMNM=Q4VOT9],-=7& ".LO!F]B0SE7]!_@1&8
M%XQHE"1FN%8XQA!93V&\"6O6*#]*3O\:JH2@)8Y\0_$R\=Y6^/58.T27$F:*
M4$< RD8XH4\B_8 QYBRN4N3_;1F__Y&K(TG!T_X_\IV6T[W["W<VI!!8_<^.
MRM=H/D>M:6\%GC]?(?IY'"."N9AX4>KY0O ($W.;RA(AM,SB=>"D#O'7LYXN
M'BL2PR%EEM1;(I1=]18DX[HHU2NTQ4FR_W_?L#'X=I"9_R=:$WN +)L3!=("
MNS0)]5R7"\14S]+I: JYCFK5F5BKO@08DF2J?N "KA(D2_,(-,0J13&%2:9V
M"B^DTL J@HZ=FCJP8M48<N"42;,TD^!#HQR*#YD\T+?A'= &%@UH5-.X9F)*
M@>^#G"2M V A4Y.BN(;>+XC#0G106_^T]4];_[3U3UO_M/5/=U.^T$[#%+VC
MB K,>_*-LKNY0;)WMTRT'/Y^PT8.G_[CCTV!10^*1Q5K=.]AW2%PXB _^DZY
M +%!0<Z]WSNI3-$Z%](\KA(=B)(Z28(P\I*/"H)&(4#0S ]!JJ \XF&_U22Q
ME86C(551[CLE54V")E$-W68>EY@WSRA-<PMW'L_0>CU))E%EZS L'+RN69AM
M"?O45>=?MU<E#535Y\&.T@M,"2>HUWK:L)(-*]FP$A@GM0TKV;"2#2O9L)(-
M*[4W1E SN'O!+\U [W PB.D4 %8YU\QBFW8$ "O#:RQJ*/83 "O*:T82U[?T
M@17^76+#L;T @OH_B$'F6XBXQ"5D2%YF-_#>PHQ@YZNB$_.G 8I13"5:#:F8
M/05$\-@ZD?)@Q<>CH'.F@HE[.LY0.#O_!6>O410UK/SH.GN$(9*.2FOW/\*G
MBCO(A1-/:F(G0(N9/GAIZ ^])"+M&L@3^8J2G&Q-C[O&?*XBZ&"C-_EZFZ'
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MUW)@LTI)#I5L7C=9RJ>& AE',_.[HU(_-D1(;GV@0"F0PAL#1S[P@AZ7SC.
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MGZ(5$!HFMX?(0=(*E S#-^B1GT8 ?'&:Y_#//\BT/[T4_??_ U!+ P04
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M1V#(**;OO;V.Q[.1#[_13>*EJA=P8Q37R;DQBNW%O%,E-93>_OSF8SU-"P/
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M]9<A#QL#$SX*Y$[D?K9]Q5;6 1CQ42!$C!AEAP: 5V(FX*$()MZK17ZTL@[
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M1>.9>9&\^[WES:DVAL #')636P]PU%-N/<!19;GU $<MYM8#'!6;[>F;D@[
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M''I)4_GQOL;!4XS43 49/ ;Q38;A!=ZAW2:^F:A[K68R&6LL1;(AW,E;;08
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ML9VMHG/X:".&SN$CNQ@ZAY&:$MH'&MY<C&=_4^9,Z#]2F:RW]>),0EG=<#7
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M..%5UQ)I[(/(J*(//3*J2*-6NW,;=:O0_7:(@"IZ=$= %14Z(VB;:*(20?R
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MRTC<)F)9^27N81)YT41)?KQHHFQ[$).Z_9&.YI /393EPX<FREZ(2&"*&8R
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MZ*BBU3#H!HM6VP53C]FTT@8B'RQJ#8V<Z.Z\S:AMGZ]R XAYL/@U(.;!XMB
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MSR)*1=R8S\6F-Z ER^OD!NT D7Q M -$99-R?Q3\D<:)"!YPB\H*YG$WQ#=
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M@]" ]+9H/S0]B@9>>4%P7I1P@/3RQ3A FCEK_$$L#\O9FVX-(&E9@03D[XQ
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M]2FVXE98ALR,-V[!0\3%;TJNW&NW0*B!7-<C:B +JA1:%9OHTX*$ <AVK3$
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MK$#.ZAPKB+VX:;.)9\_#+>,+L3$4/0BVS-T:-UEP;1HC64 L-PI90&PX"EE
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M$&=T6LEMH1.S-^:<.4@EVR-X1!KHU!7-*#MWB^WAAOUW1F/Q1S"^&=94\!Z
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MWG',WW-3+682S<E64Q9)UK1JPKMA-P^OI.-)N:<+\^?+0:7A87 +^V#<NDP
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MDF94,.(JXX(>B-#W>FA/J_.1_-"NV ;Y"$ M[G;H7VPH9U:3+9KY%$]):8?
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MW"/KR[4(#8@GY6RI'$IN3([U+4_I1;[*4!6BVH:MG@YB-@B:!Q;L0W@>Q?^
M&I<O4<I=K,7GN?5=EIN"<^DS%'!FH_R._/I(E[3X"[DVC?(3X1%.\"FH ZX;
MAEW ^"GYOT\KZCTJU72Q6R\V@%ET\B#A=HKU*R2C6'8B$[3_JJ?=&V^Q#%UH
M=-'HH_/?Q6[41;@N><YG)O\6E?&[YF0Q_,]M38YUPS(M'=ZLNS8(1AV&9P_\
MCZ:+9U\K&PRC8I]])H8+%=CXGM9Y@;4?H%*6J)QE%+/W!\C>\S<Z&$1ZGM3#
M>"RIT ^N>5O1;L@2\(=]P) YC+)?V48/7BL^,Y_U8T _8;8SX)FND@RMVB.R
MH?_J8\1NW-,TZQ%WW,=AN#E &2B@)<J(5;<-FN=9E.'Z\RC.5]VIV?I!TU9[
MP#.O\6CM];#B#$R7B&Z(;GK=>J292D2QS;*'[1:,51WNO/M5-A%N;;*2X6WL
MR/SP\("6*P_N('9XQJVEMBR*/F!A9+W0P.AQ+3$C,>X1UOD(2^J>:);DQ1-=
M[ IJM7OWE\ 2AV;_ V/[-82[ N\EFWP$PH?P;PMWQ=A+:EMS& =A#R_7D,[F
M+B_N\TV21:DY<&U/9%%0T<0/-I^,]_85NV;"891 S#$$::]$<Y\Q:B;BC:+%
MSNCD__G8YKEW$9KGM]%B_7.>QC8S @I,E1/*VI(U-O8G+2V2[:(RSPFT);RQ
M7SEID6T6DD-.^Y61(E]0&I>0?:E'Y-7\<'?<BI%X-J9@HJP<09KE3,*"SN<,
MH'*]4CB ,TNCRYQYE4\U.Q@4'<<D@WJ8]Q12$!;L]!DMX _P5&G-M,4D%[G0
MSB,&=<KEFXV!(R2C/&%A\S'^SNE'O(_FD5'XY<A<^&%LF832H B$?0";*)RY
M'NL%V%5#CN:/47].)SE!*-D#[3YOMG'#F2> 0Z8)0+=@LQZA'#9-(+JE[V 6
MO$K3$SO53,K)0U0P7>IQIIBTSQ,E&P:>SR-V9BKPSV<Y4_1\MG8!:Y1"9XA>
ME,H%FE$VH3.\<4\(](<M(<"CDPM"XSN!U\ES4\8U(YI.L[H<K7Y!QU;H9B+;
M>5C$#TC5*LTAJ?Z8FT;%;TS"<C;+>9'0C@ L;$[4]GX#L2SD:SE_?O)=9Z$L
M)[*D4&=M.FS.UJ2]&D1>I\%$OV$:SDY_CWEPKA$H<013)]!"OVT>@BN:=\W^
MFBSPA95KZIMU%GACDM:M?<Z @7(]_P7E36NO:0R-Q&O/1QJV@\=K$.*3ETFV
MDJDR,(?&;#G;51C1RGY1$VIH94HFR> I-.!4E#>]VPDU/(A8'W1ZN<,1ZCPG
M(@D*.]TJH[1SHO@2R#Y0]5+*H2H)4;R*Y:Z@+@:]!6^*1A4/QUB54),  7FC
MV<3<1*.FT33SDH4>+R\*F=8]3"$VC 5T!\F'\I>D9.VL-&]E*W\6C'UR;3);
MD^M+K1HR;6([*IG.ZM70JC4@C*UB3A:0?4JU;H+GX*J;:N7I;I/=9FNX]F\Z
M?..Q+5$:>SS8&NC6JMIYZ7;D^V:[8W(//HO;K@P0LC$Z)_( 0!E=Y('Q!L+U
MG!>$-ZU]1R&8R-<N?AJ^^Q><K(2"3+S499%O9(9/<>Q\HE65TGB:@3G5($W*
M"/R-3:;UK+/RE7P4, K"LX&',U\OF'K9ZPW3"\H\32!P$<(0*LHK_H'<%71-
M&8 7.LT6^89:\^"KPY!Z'+A M48B?"C/2?$'8#9-KSMFG^H*N>8@W[^Y1IG9
M0;;N[:U0V0$ PV1(.OV6;3V@5K^L[W$U .EHK59H"$V6"81?3JYW!=2?D24D
MWA[K,.C^,=3O(:9H/V3Z/4C:,DH*_LJ])W>+UC(:%04\%O&=?%&3R5_L%IS2
MNF+%VU[(=GLH=-98TL(>C>U1WD\U)1T*T]ZGFN_P=U[QJ;J^R1MI/A96M//)
M^=:ANFUIZI3%D'6\:1*\EBL3\#]=S7O/RA&*KC3[GZ#IO5EWA*XO-!(9FK+?
M,_;P!4FKNM-6&4CC$;#%A6!41L'62P'N00EXQZ#D6,'31RH#$+E:U_HGU-4M
MZSXE;!]*AV0U:Z;OG+MF"!W"E)X%0@^)VN6[\E.Z6S#$7_(L ?^D;#6GBW66
MI_FJEXSQI$SUJ&3%AR6;>ESR[OK3E^])50_O2_C<4)O%$?&) 4@S FF&"'Q^
M2Q!(JRW:-HT5[^_S7< 1VY I'!^;^Q+C -&\XOB</F<1!=/?+DK!P'N7YJ_6
M!Y*];'=>Q<] MTG@1'/NGK^$#H&P/WG>01ON!3+-N,5]8SK#JEWD-"29L+!#
M+S\KN@6%<4)L*(*8DKN\F$??)KLXJ?K,"NS"5?2-1- QF)G1@^F<'!,8GQ/$
M5F]XS$>_L =:3&)#\J^ZI?#G@TBCR<V3EWG0T&S@O:29>^=!B!=K[.WJIJ';
ML-]I>1V F#Q&E:.4%)#8-  A42CND!&58L^LKI+GE$+R+:O5M&6!68B.F,HD
M8UW]N9+M03"S'=L@L2/2.G?4S(9@G4[>)=]HS$6DJ5VBE#DG[Q9[D$9)FN8@
M] T.K;^90N7]J1G?<RUL*-7ZFYV!TB$JV:1FZW) WA,()1>;KP51!Z)+/3$'
M8-,^E&FP7_=;U'OGMOTVU>9T #=U#>GF8XHBWP%< 4MV7<)GU'A:ECLZ6_(
M+H.8E'!1XLU) NU!;7D EP^9,1&OEQL+\1XGX"6)/_[Y%NJ,@%W'IJ2SOTUO
M/GS\,[G]/'V:H!5'V%]]L%Y+MI[OK"D!LJ$QVM>\>X=JB==JK(;G 2@MH_\A
M3]"ACDGO8[1-8@ RR6)G02);&.!#OORP@""E L;@^+#\G)BM@  [@1J=WFZM
MZ%('I#,4+7 5?^"KSQ#C(DI6/T=INMO81 !:$=XL *%EVTQ2358%18O5_ZW/
MU\D=K;I@.U(W]%V8;X]N2U&^0\I]5>33T^S&;>^E^+B31E-6]7-C0="S7;@$
M*J53%:.#/Q./#8=V*O9<&Y-Q#JEVP;$1K=TO!-%-#_)Y7/H=<N+;0.@,/B(%
M_GGXWT<)>$5A^IE&I;,:<-,;TP'HU#*_\>I:SU&*OY=K2BMT(?6P%]CAV;1#
M]"'8*1A9,R&QJ<S(<N9DR+!3K].5S_MBY5M'/N4,:0:MS;42FC:D/N#ZJH2@
MI]HF\@KU/@L?Z G72;B1W:):RG^,8O?O(?#[DFZ/P@MO7U!(M]R.FLJO2;;,
MBXT( GB&5S',?G\(S)]YR03,IAA*ZP!N?YRH>?3M+B]HLLINOVUI5HJ81ZMD
MB0[@]^#%JFJGW#8#K$]-O>@U8F2F\R)E@J)]M529[U%ZRHI1:*VY*YIX-,JT
MB=0+QAF(=.+H351DR>(WB!J.,IM;LVA(1$M_[-52K&/R.2EVX_5-PN9<*7QM
M8_<';-PJ>^T? 'VN'JGP6K#Z24-+4C1-S[]<ZVG5R@G0JC0-@<\\9+ 5F6/@
MLP@N]!P=I:=8SVU!\?78\4/=^Z">:MWVIZ>:O'M8YS1+OI&K)/\ X1NC'-F'
MRXPH:-5#=&0-JT!$2 )PER19:"P@B9(@=((%M2WL0,B[[^Z2?)-\YU^VP%,9
M4D;<T 4DJ:4W.SK/Y3^FF3U#78T2_99A&+:Y\:XDWE$H8%3_.\G&2F371Q*=
MX5JELR?<8":9708:U/(?79-LS.629 W66,,:SA&U54 "T,D*JP# [0^'(;(K
M80-!G;'ZWU/P*_>:8K W9.LNV4QL/:.V&0Y&YLOK:)N ,3LO2XRJ6N;%:U3$
M-O_,9\H:4:P>L. +-Q-WR#(A#$FRJ@ ^*VA$/ZIX6 >N];@JQ+L%]X5;<&I(
MFD/""(4>_RIAY)2;*I1$]"<P %%'"$/^C?CTU4F:>?)H'3G ($J.9*M Y#F7
M] 0IT69NN<IT/<*9I+KSW:T'1IU<?\V4W#:'4WT)DEYB<CQ/\E["MVU2[\&,
MW9MU)Q#^DJ<H#&1E[P*LU80G,9D+[@G4FL1 U> FWT! ^\*3\,?B\Q<E_S7/
M!DJ][!^BJ-?83':(]D0%=9!AE\EB3C?;O(B*MWFR843>)$O6BH)P:B4<^Y!*
M=B(5]B)QTRT$X>L YBR&"+8>B/"1B#)4*!+9 5@GF]TS&8ZD?BTG*6-+AAYU
M7Y(LV>PV[$?N0*H75+:W1$T?LN&=<)'ENTT(@MJ!RU5.OY9$&8>(@;"%&"H0
M.>W :S@C=,QC"&+:>NIOTA(.KM,.\*CP:<@+L.] DFWNG \Y=7*RP J+Y8'E
MK^5TF6DO&._5Y)K0/Y0*\(,9VJDHTC_D'1_P>S4/9F#E3@<S0:<]CRX3'8("
MU9GMY$N WIIRHQ/UM]KF[]?@H<'0^8:AP1#4=$@CM7XZ^C],>,P$:8?7N80T
M^2#K3MYW50V.SA>$1N*2,7$X2AR3'WY%OLN+'KMEXUX*<A<WPV .IX V- =\
M>LEK$+&>Y]RC7 30 95>#IWFR=_.ZX!+%Y? .R9^<_:J1%A]R)IF'MT-#XDU
MJX$@UF?96 V]9@$7]%ZOHV(50-8-E:A9-F6MLQ78$BW%8UHXV/\E=2=O-6,Z
M4'1*SRPC32?/%64ZL'1)ED=)DE&-=S+'%I(\J2#A_FQY4T2O<?YJ\E2JHS0/
M,W2]07F)&-]UEB06P_@0,D> >G&K =:]A8O*I,+:"E!O00[A:QUS!*B70<T,
MRA>+@]D;14K9GLS+7'[:)3$\H0P%BAE\W.7TO"A/H8L<8(><6@!BRJ+P-)##
MZI!.B_IA_S!UCT/3GR^=9\S?EN8"3I='T#.XHY3MB #(V S;5QQD!\J>>UX
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M;Y<^L63^Q?<ZTQ".J4@'70D59PR>D-M;?FT#*-U4X"_^I9T3:-%,5=1'HWF
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MOD1%>E,694445V=)%NN"FSV9R5W3XBQ:I66T2 M'#DI+>U+=Z59#*>#[1\*
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M15&9$#71\&IW.?:W0O(B=(;7>DJ:G>>/MHZP'^VCU$$2KB0\$NL(=^6OTD%
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MNT57<%R3JRV3,2,WD\T^S3: "5":T?%RN<[RJ"BBS564T86[UC-*- $B)0(
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MOZ]X%Y;%W_=;?!R6Q3_T6"P*D@TO%,0V2F/XC_U5_3X$BQ^B,S$.;V[BE/\
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MK.<.N%G,'0C,_:9$ ,RIY@]XS.&##A,[]TU:?'.]0T$^?UA&J>A&U9,OXH5
M*88P3IF,-U:Y,%Z4)$U1K.4+H]G&(4N8C7Q"0AAQFC.6/W*_.\<J8>Y=712Q
M3S':;&?&@6SVK^\SF)<S]RL"TO2Z)')M;UMLK^S#6.S=$+<-MS?$0*@A.XR&
MW1Y/ %3/&*RB#>P\P>)/).<;D&BOW) DIR)%,RGH*N*Q 5WPWZ5%O.!5",>6
MH&@1+2EDLRO%.26B4E'C+169*\.GD2.UD(ZM=JI5KV><[M5FC]#&;+@I<8LT
MO&(8;ALYIS/*X&'(Z$F>2AQG'N&] ) H4;$<IH(<W@#""?4M^+[V#Q5F:'N.
M_?U!72Q7BWQ#/<8\6I5$'O.V+;;W/8>Q>$!=KUF^HE'F'V=4$B0.)."P0; [
MX< 0_+TQAIV,7@_ ?@=RG>N&VNM9;,P$4K5RU:SGF?M<F"UO[2/-8I6=]DJ5
M!1"C &6A-6;!J;?MIU\=[:?[]"LN->M5N'$6YTOZ.<VH:%_F3.O\K[('@$32
M$E"SC"<U(%'7BL-.YFW+R=\%/B&&W&%LH9E:LQQ,Y1F^6=#.F%J3'=@<(220
M?7#%\C]H['R=6II?%92I5FY6E$?H?/(AYK<9^7KS[\?OWKU]]^X=1/![?XFE
MWSE;N.QNJ7&%,8A>TYBF#V)>-RHFLU'\CW4*J4#S[)Q/TYW+Q;4@GW! 8XD:
M69)$+[U\X.V)'D1VSVB"?! 123PU1"",.$3WH+(O-VA^PF;:'/9&>AL^D^60
MVW/;6CMI#F&M]WIGVV@7)_9O]!!B%"5;Q^6:5>\P]G*D)2(?D$3GBP6$J[\Y
M+ COGL:"Q,4G'4F\=R1^W%J70K,/J9JBZ&0R6VUDT4&M]F"/V70C;333]T^7
MW@J'9WRX*>[#"4TY[#,)!HMM_%#E4!NALN&*=PYQNHH6QNK-M>I=5241(DB3
MO3V52^J2(50SY&/]G$=9W[V7K3/B&AS(RTH67 5J]=<X^FH?"A(HB=X::Y-M
M75ZGAO$(PV/*>QHE U\7SY48UM/B;;.-S*@L1'Q5O&VED0RM>D1CP57$RHS#
MN4]74Y;.YY1=/(#'SVD1LU2<93-R0Y,CI10D5$B2I!$]/#U\\)A(H^-1@D1*
M$DT4ATP^F$P4\_,1(O5*7N0\?4@3FB4W\3U=4KEK8V$<%">)*D\*(8#VNKC#
M>C._'-8CNP#.MGY.8YK%SIUBR[.72@<<>%TH)5C>, "Q^T(>,JZ*XT]6KZ(-
MYT3\YQ7+2QI#2?[3G$4BGG"XI9(CC2!1DB(FPIM7^2 R^P<1D:^OH,PX^R7-
MDG'&NW!:F'NMYE8F)UR5$"S-R)]<D%22:*?LS#@L/H&21VEV)$Q_<S7^Y9L:
M  :U#(:;!T%9Y^.,_*+7.39W)K,KFD6+<N-QP+/BS4I*8'2O6S8[* *[)JH8
M5KBT9:R+%E"[^S-V""&*RYR=74QN*'O@8Y)Y1E:_J0$#+R],JM)HE-BVVD&,
M@ER"U>2"-'9C[958K'<PI5OGZ(29YF(/D-'+-(NR.(T6XN#+V2(JBG260L[.
M<?; ^SI8)N3#Z$-:IA9B:?V-ED2@?M2DS.76+J-D5GU+GC$E<?TUV -.J^_Q
M\M4'L4>W7>O)265[C:"UQ!UA.CD_S8E22FJMZJ95HQ>VRFO-I%$=3@.9LHC/
M>"?L=%VD&85+D?MM)*7X'ERBN*N_^*I:RO *\VTMIJK!;S+#\?HV&ZF93!AI
M=+^"MC/-96[QBZ?X'I(7P^D1>+F]=Z48-A6J>)6[768;)U13(RX6X44L=F2N
MH)9[5(H178X(0=0PUP['%?:Z/(-'/1&(<_)7[<@< U>EZIX7@4H=2XW<Z5B*
M7+4;'NY>1&RQ@95A/I+?T+)<4#E9NJ%9FK,;&J_AYM%..XAJ(B4"90J?X;C%
M=TA1?TADV1.?XO^(;V%N-NY:+79O;\0D1V@C2AUI](G\>Q*]4HF]=[EK#9@Z
M%XF:AT;MY8I02-^ .KN/V-R2>>^J0V*-O+$41"=J%XH?(S4F*L$@6->%8QR[
M/#P3'M<F,V=G:IE3N*#R'C2<+M,(=# 9>;>XUW[0:TG( Y@?+8>->MB4O8K2
MI O:(YE9!1P4&-V*1DX+)!<MK2!0.T@+$!<-5P"DM]] )!W7RLO,Z63&D<W3
M!YKM$FE66N#_9DH/6H]H@63F6VTY[_2JXL@=G\5^,\U,-0^7LH*AU2>6%V+)
M)BMSMCFV1'DZC#E(B!4Y(8)+H6WS^UDD)$@M0HZQ^BP[B'XJ;?D@%":M5]=P
M9&IMVY#;QK!>\3A."J#32+.]AT0=VW&K7SR-,4H>TB)WIMZUG$C2GM>(E!(D
M7YB 6%TA+:Y*!W#(I39*9F/^.5_ T>5BG*:?5PZO-%%BFG%W+,5'2'27KZNX
ML08K%9-*,QF/QV_)YRM,;]FQ]CBN@R5-.9952'Y\&:?)!H?I(S^'X)U[XT-E
MGF5T<4T7L/76=_>L+D^40!!WN5PH+#6O4#"%(I!;@%?W.9]Z/YVF^93&]V<Y
M<W5>JC#AI0D4)U >D4HVVXT>.+CM ^N_Y$;YU3V4#,#R/,W*2]Z7V$-;!YQW
MWW[W'X;(%I%,WG",[ )I N+$/?W ?$O 'Z)I1H+A,7\B3F9G$7.-X:(4/, ,
MY9!IUC+62J>#&.M9PT5Y6LA[-<XJ+DIR>E-=#0K"[/.T6.5%M!@E?ZR+$D1V
MF#(!KD0IXK.F2A-"E.="9"82-[V2((T(9@. ^R5IM%ALSM/%&H+1<0;I$<09
M .<5<TV45+)$$R9_K\2QHD(_;&9'N;'A-2)&EREEC2FN#D"6U>P6[>?GB"[S
M^2*_2S,R.HYY^"4/=.%QT(+)Z)@N)M0QW&*Z<0VQ8[KLS\ 'D-#WOO%+OHK*
M>SB,4Q[ -T-XQRMCM"YS.>7VH-XT+WE'QZ5((Q8,F&NN'YJV%Y*F<##V3Z<T
M&]013(^.(0%=W7)" #*-GOB */+@7D>V,YOMY=\5',V-GD1:>'D:(<(YI&FP
MWM)G&>Q%K/1TN2[ZUA9$(>P5A6U+S;5[&$L'UFW.1,&S^5J<JOXU6CJG0PT(
M)4C./GV5![()R(;@!#ND'K\@0-K-6^,L'N8D+A @C!TNQG>@872G9AB>Y K!
M#3*ODKH98;XM6Y>J[M)@;.%W++74L;*T*H858V];:XZNM^LU "*(0T!P/L5V
M@+<Q6IX76HBR>'>KC):[R=&R?!]UOLHA<^R#+TETRWN(LF_+/1NA;K'I/1NM
M(4J+/^_-XB&M43?[@\%LD?XB9^D\S60/+??8X- ?VO$QH_'?X;)D6)]R3A_H
M(E^!0)6;^RQ:I7R:G?Z3.A*D-6],U/D*2=+HXK^5RA!'(Q]H[KY(T]!D+M=T
M8*99&P33U'%5A0J.0_<<<E(VEL>4)B([09[Q1EBFZE;?N"C6EG'/?)- <%-J
M$T%IW.@3M_U(*C1B,+0'HYF5"HK()*%! 3DB!;&8V /'/&Q6GF'YTN8:O'Z]
M!Y%[6&UU\>0O__;#R?'Q3QV,^$V,U_Q95-P/.W\><XFZ72&VG<IX=UL!<D$Q
M="95YGJTA3V9.Y@;O])'F?B".MZ:@JY74"+-9HO\44( QF3T4:4'H6@/4#G1
M]!.'BZC4'Q3UE2HGC'Y"%1'O<?X2+5<_24?<1?&?D(LB*R*18"Z P9Z;><.M
MG,RJ1!'^7 -T8JRO<FK@TFP+1C_)0 ".$E4B^!3;@N!),,T#(72V6R#, [8+
M!'F347EQK&DI,C;^)HSV<A_Q[TSSTZ&!<3LN%M"%*DB,<1= 4&S"YM&,)(9I
M3D[W&0T/IN$V$H_6U/4&)N&2=5R>K1<+YT:&*$6@6 CKYOF*Q]F;499<_&.=
MKOHVL_G_E>+ !*U*8VZ.66VW- %17*3SK0603[!8$1BI?^#:]V700UKP M'B
MMVBQ=F^TUD7) Y1%Y8[):@MO:JM_V[O5P^J<S[G'RU64,NM5_&;IL182ZSMI
M+;:7T8O3.LV3BZQOR\.(P^F%+>O)J"3G-):;JN_W<J-58KDI(U;N@L8RB%G1
M_"W*UM&^;N?Z-8HV $LXJ # "EM3&*T?-1ENVABQU7P8;5G=)'"_Q+X%H9$)
MH#LU@O!HSP<"L;-'S.<)QNUD/$9(*$<,3 #<7A#->)^7ZCTG P;#/3I0_&P
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MWE,&"Q(#WL)EE3AX)@<%XGE2Q#49 QRS+XR&(Q#(8+"Y!5<&\RY(%!7OJX=
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MB]J9,O60YB]DHM[P+LROFRAXR5!ZB"VK'=PR68U<Y=/\5.[,)GTA!MLZE5U
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MAF@F6G@A+ RA-H$.6BY3W_8H[&\G_SP0R7U:IPN0LZ&V$_^&UFQ=L)PMN)U
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M9QM0@N0/(4GB1E2DB<)PB@<6LW,J+%*2:*(B@1?Z(.T!S#Q&]S@IA+Y@74+
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M)H,$9!S/F-JH')4E+>3)3+%,_)UQE'4(($& G>#%U3VORVJX,@ZTG6)(YMY
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M#\Y^K]&\+A](7S5AZ3S-HH5,&1P##J_QO",7")^<!\)OCUV)A7V5O!*D7F%
MCQ)<I&69+R>S:[@!6AV@<J4--@D@^\J$P!D.& 10$; H2R!P+VKS70' =FG<
MVE^GBT1TN97IKI%^JS"RY=T75^3\SY4KURH5')9JYNC*D>N00\6C-M2X6<NT
M5/D,7+EQ#>5#L!]Z_'/Z0!>YR+(F-F*2%,X:UJW%$0;X*GD52$]<B7&]JRL
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MPQ,3*_TDL"L_LJ$\;HV+=P @!2CC(YBB<-W=J;]J@SM'YXJ'AFH+ KO8L>7
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MV@W?ZU/C+=K&QE?+4K#Z4B=,"[]]V;*R>PCY4B6'(M:KVT7L2XP<BEBO<?L
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M>FOANTN[6+T8E4,+D_U:VB:*#^[;/Y1_P.JRNL69[% 8G1?_@<29[,E^"OB
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MA%^P4LJ0%/4Z05!P0F27(H:RE9GYHM-8CQ.2>B"U[UL&XW3A-)"'P:NL_/'
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MQ\A@=S!M&"GS/BGY:2YA:G>F092:NEE 5V,-#&LF,%(9 ?!49?^]*'[O5<=
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M#:0=;FG:H'1# [F'AS0IM.^I*=E8%"U6HCS>3CD;*F3I$*1=*Q002$)P0;Z
M,/X!"Y(=%'&<!]&IO_I'?7[=%M6V?X7*6 ("9"$& P#X!"3 #P# &0 !VA"Z
MU6RL[F5FSE^H:*5E,&WH# P'\KUM,+GA-\&3(<7&;""5#X;2>[ME-)"DAT.Y
M&*T?/_X(E/@]R5,# *HCB8JQ68$^&" 7XV)D8#*Y$W'57:#Y(1VJ^V@=3K82
MJ0S6:K7M7(2""CL.Q_(R&TBSEK&LS :2ZW L65XMF.$J#EL/E!^?[L2NN./Y
MPWPUOLD,$B#3>HG3A9(G." ;^XF3@OL>ZZ?*UKNJBT"I)TW8_AU$>7'< AG;
M0YAVU9S @*SN(\P:&%1WT4.8[!#)LT0>#GDLKL+@5NQ.Q2::C D54W1)D@7A
MR;"[0Z"R6Q%HQS=H@/R/"#$% M !3(@G$( @($)DNZ4L>_XM-U:LMY\.QRAY
M$B+5CWQ1;OK@@C_@0L7_)BHD"\GI#@!8R%2%RW, P%0F*B3> K?B$,A8FU?\
MI&&^(/J/"%2!$Z MN!QQ0"-P ++BD*.%4URYNM'/*.5_K8OZ0.FG1Z$VLGR+
M!=4-]),G7BT/> !G\91G#P\@,7[R5$?'QR"5Z7I[H\0Q:"J:R5TLM^;&8+;:
M;,R/(*9S0Q+)C7YD^R)C<9V)@]F(0'7!.4JIPGBF(^Q\:9;2Q3CBOGHS#%0R
MG*IP.9%P<H"=3TU62.4 $0M3 =PPG2_R(#,1GAX,@**(L C9*F(@['0($:$"
M(9-CDD3?#?-LK+>S'\M8,M_;S 8J)=K&TIF=/L79OC'9SEAZXPB]W#/7SD#Z
MX]B8"Y"'[C@R8A0E2?@QB/^ZVR@AS.-$75F] 0 D?9<D6<#4UP_,2_A+H>1#
M4:OF2L9!O)%!=!V;1EU%4<0&(Y#31ZLB ZWTP^"W0/]WKD0F-S=:0(;-!_1
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M)$096G>:RZS2U4V@=-##N0BF13X**$/.$R!,E;P4\ <(DR4?!?Q#%*AFZ:N
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MJ'EI8A'P?I ]NK[Y:6("N=>KOHW4S<(P!5S"& 'H9F.8 BY!BP!TLS)4 4^
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M&(0=J^H' </^S<VK!A7 *_SDN:P5" \H7.LISW[U@/*TOO),X-5W8 T@@)5
M$EP"L T!8"&0!)<@.]$HH&8L,)[+"C3F@]S!-IZ+]TTYLJ*@<M-*U& !R8%3
MF,NZ ,#\F(%-F/F*^;$$JS!?8!>Y4L674J^ 8JHC=# .S 8F4"9UA [&8=J"
MZ<<?,!V+@.G'*A =9+]"CH+IQSP0';_RA?DMB5M(_2@*KH;Q0=0%ZT=H<#6,
MCZ,NV,F,IZUF*6 GLZ"6&L9'4Q?L9&;44K.8 VHR36JI>;L0L$"9U'%JWBT%
M[&3*U%+S?BE@)Q.GEIK?N("M2Y-67S@"55AQ,3:DH0_&DQ%UQ-B0@CX83\;3
M%6, YD[$,E&%;:?W44#Q55R,0YA9P;@9RU",.LQ,>-PHN1$W0JU"\Y8&**T*
M"5"OA@4 SB_Z G0K(-1&IL7GX:?R(J^ @JBVP72>MQH.Y?[A8&*/]WI=W(J-
MD _&0(,"2NH.2>*U0"%!J=PA2;U*Q1Y=;^L6)&M5E",U&QPH8.H2I%XC!!"4
MTW%!QBL$Y76'( = )BU<WAD04#X?#F816HWA4 8?#F810HWA4.:V#"8SO.CP
M9CHEZFR6;[)<Z4>ZBZ3X>1NJ/ K+T 4.!@-*Y: ,71AA,*!<#LN0P3#W+G.9
M[@_%EPCEU;7U3Q$:&%#^!F7H@@J# 25M4(8NJ# 84*J&99C N!0_LM(LDZ&A
M&IF($)>PZ@&!LC0LQ"6P>D"@K(T($0&Y"J0JKM^>WGT =2C[ ZE":&#P:Z#V
M9'\@5:B<["@^2S,1H!=?_U<JPZHTJ>G4O(LU*PI7J3YO-G_K$)%%'=_BA=]K
MH/KD7,7D*SC=(78Z,%?Q@B/$3BQF*Z9WR*50\J%HR'PEXR VY:**#B8&M)V&
M^ @S"'T,F)V8^ @S"&$,F)VI> FS!-;J^O<:*%#IJX!G2'8 VEF-KP*>H=D!
MZ& ^+@7T +N;)JUMDT(3S-= 34L_<0;AB8-S<B1$G$%HXN"<? <3YP[.R5T0
M<:I;82WKBM]<TJ+\26C@.%E)1X#!ONH#<+*/C@"#O=,'X&0970%J +?B( +3
M!#V\WZLDW^UO5+*5V9<D30>Q;^ Y>,8H=>3A-Q:\@X.,4D<>NF/!._C).'5L
MP)N785>)LG"KCT%DZKP:[$ 9STG:^ 2]'W0'M1FCC4_(^T%W$)]1VJBA=S;E
M*@[-OC08'?S'*D8>PA 8!_NQBI$')03&P83L8ES!.%B158R,7@OS@C*Z2-0Q
M*5]45NU63B_]@=*A+D&R?2.WV7ZE3ZG0G%3WR85.TMK-.R6*HZN!!? ;+W'V
MX #^XB5.=D@4B:1J+U==./A6O,T$JH-" G2K P( B 4@P' % 'H "= "*)J"
MM5Y>G/8%4+03%R,.)Q@,P !0,>+0@L$ #  7XP7F_F?2X %(@$N26;!U( %$
MP"7)+.0ZD" 2X))D .DF>#)7SALL4,Z'1#B$6G-U_H0#*.F)2G&%@J9]NQ2'
MW6*#@A( 0(H4RND%W"H,955.^350T1.4H TL.P0L[5LD: /*#@%+]C8)'A!Z
M45X@P=(\+,@DK&R L"0/"S(),AL@+,4C@GP!87D>%B1[P>0$!)34= E25>[P
M (2E?5B0JCI'SZZ;))*;IWOQF'W40_XR>+#<#\HQ.>,L<+PX0%^.R0EG@>/%
M!P9R/.#\H:1I:;,U.+Q(P4F 27BU 7AQ@9, DX!J _#*_8T .8#,_IO*6IF?
M5)K/[%\#-33'*J(/.6_ +H[@IX@\1,L7RZLXK-XMMS$"%34]9,G7$87E( ^P
M++_5^B)C<9V)@R%%0,E,'V%^Z]4!YJ 3B#"_%;LOZU^\!NIAN@3YK=0)D(-=
M (),5NA*_^VM>-#G=?%+^WK[Z?!#A*$(FVLX:>M,-W@=9&2:7B;K.\$=#FHS
M3>]RH\-!B";JI75'O+.E4Y0)642(0]P* JB'"8L0!V9C45'$T2! 64U_/)LU
M.)F/DI?^>'[>1RG*8#P[\U$RTA]/_*(SWE54HK5]4>XQ$""/_B$ E$P,!,CC
MO[3GX].=V!V*NK.O@3*3H 23->A 0'/V4(+C*CB2\4""#$)RD)<RV,5)FLF-
MSJNGW\&!4I.@!%T@P1"@7 Q(T 52UZ#?D\BTI&TC@=(R+LAE32R H$2-"W)9
MH08'E+&MX[FL1V,^E+"MX_EY'TK7]O&4YC<V0PFZ&407)MG_[LRW#N%U'.::
MXTB1%LWVXN*Q.(@N=OEM*.]5$(IOP:&Y,P64E)RH;WGPH6P_21_=+G.;.\0.
M%+6<HHSSNEN 0^1BO#*V*ZYI:H,7HB#>.MBN;P<F1$R\=="MYJ,(S7=IIY>;
MK1O=[6:)KX%BF[X*Z-;1&R!$:_P4+& %(>+CJ8 :X'5LBNN:1]\"#42)+*/)
M@Z]G.L1\+*/)PZIG.L1:;*-9F?X&*L]I&TWWEG1H3/.F\0U4@!.3XA3[;2@0
M,T"DR/9"HH3<Q76WETNYW0HE3#&'F@&\@0I?NB3)5D=+R0<1"U.2I7W(OX&J
M60("# $ >1P0( PJ" "0IR$!,@"Y\OG<_@U4D-)/GB[ ?.$!V=Q/GBS\\BQ7
M%>43%_M [<0Z;G^O5D0BD.W=LF2KY@,+*D#IEF6]6E#I20]9(EB?W]U<_GXO
MTF8S 14F^P.IPLMBL#WQ]P=2!8[%8'M^'PRD,M@DN"?3OTFD292;]R07^M^'
M^%.\-Q';.7J!$I$C=) %4I*$/V44-9\+O '*10Y&<C+9GMD'(\FB/WD0*C;+
M_=ET!2L_)S.E-M\ ]1LA 3J?@P#LJ1D2H%^!+TD0IS6'+;N-:!A .45<C'XU
M ##V!(R+T:_,77X\)BI++Y('&;[Z8(  61@4H5\1"P@@,X,B9"MA=NJI+\;&
M%/ )'N4A/Y014I4E,8B U.TG3[9&WO" ;.XG3[IZ[>ZH;X *A_V!I.O1-1A(
MX[V!C#P,9._^0#*#19 )=:_)YI4^Z?\C M6\*02*#R(R=(&"P "*#B(R=.&#
MP0!2-B+# $:2JZ_Z0-RW<  9&Q'B$%86($#61H0X!)8%")2L$2$R($F:7L<;
M9=X&%1<41)J5MXT-$"@MPT)TH84"@?(R+$076H5-#]H2PU2O.^_K#!0H8V-B
MQ*L"@X&R.2;&=F6@](Z*T8')CX4)U4="&@!08' XE#"<AD9#:;P_E"IL?I</
M^DB1H?GM=Y6FP=,I3P"E R$!*J]K>]:Q^/AT_S.Y#8XR[+Q3!NH&(C(\8=A3
M-B)#&$X(#'O"QF3H8-SIO"MB\[G&5LE-T("P)VM0@BJ@KG>'B^"8R9;E]MS<
M'TAF\.&P29KO'"X^?V\LMR=B4((C!'OZ!26H-G#/H+1UF_@-4/$/%F&R#ET0
M]HP,B[!<"7MN1D28@&@0V#,S,)Y)( V^FW@#5/%SR-'!.092&9Y?7K>X4<E1
MJ.SI)@KB[-/?N3R6W^^^ 8KZ><KSAV?/X9[R= ="U[S69@(R.R! OSZF7-U5
MHIKG3@,"2O*P$%,@4*J'A>A#:KV]4>(8/-67TH$R?9  _4H, $!YWB[ < 6@
M' \(\ , I7B[ -6G#4W1K)O@:;,7F[_TN9^)C;F=I?]KIX)#<3W"( *RO:\&
MLETR B*0^7TUD.VC$1"![.^M@11BV:WP#5 9KS6&-MAJ,X&DWHRA#9C:3"!E
MM\9P,!,H*-<:0WN(W@>/9;'IBUPI?:BOXO!2;(7^;W,S$"@FYQ:EC60'*"!+
M.T5IXUY;UOQ( =29&XPD7X>6R5@F;HWDY&4LL[9',C'YHXC%5E87W'(9[];Z
M8;BH#Y VT=U\-PD4FYNEE4O C74%EILG:N42R)7113;"<KM%@MEJ%A"PO&^1
M8+@*0&4[6((:@GG^V^AGO^[[$(/$P0\ 0?*P@@$YN $@2!YDK3(;5LX#E+OS
ME"=?+R<\![? Y0E7K[@H=BG*?U<-0BZ*[_MU0EEM])^;Y%+?)&O!6"F9ZOQC
MGGU/13U7^L'WH?A;XQ*0NSS7G(11\HQN!#G2<\WY,J,1Y%?/-B=7-U:]-H/H
M5,Z_!>J/0)D/#SP<"C*YYY^=[48_DVM!AOG\L[/=_.=Q+5"L\9^9G:EK3Y^C
MC3I0@>J/SS$9U^T^T7$@PS_[9%PW\T3'@8\0YY^,J>-J%E+>S0A'>0]\0GF>
M&;ENVCDNG/9$,WE&KMMWC@NG/<U,GY&I"V_*&PS7\?_(.*S1N;TW[2%FRF1<
MM^]$QTU[6)DR&==-.]%QTQY%)DW&RW&7,CTF:1 Y3YA?@5JL,_4RVX CW#'J
MP<!7+[-M-<(=H^B^MUYB=X25V5EIMO@[E]G317(X)G%Q24^3[@>A,ODC$M^2
M3!@_X.Q]K$+J[3'! 3@!'ZN0>D-,< !.GT<KY'4BF'M^=36L$?ST5Z! [EEG
MH=XLYW+5*/H[;1;J;74N5XTBO!-GX>6J._UL*'Z8@Z1BG_<JB--@4U^.B?)4
MXUMORTI;Z45PE%D0R=3\?OLK4!SX_%,QVXJSG :4'C[_5,PVY3RGC:+'<Z9Z
M24X;1:)G3$5X%[HD0=?Q]UB)3;*+C3WU#9'3I6#C"P>1=FF@/H%\(#JHLDL#
M]7EQ':_B. ^BV^+COE^!RL[6T=2KTS<=9Z>=T=R\CK/%[FART^]$ED5%,>_R
M5+K,Q7UR*8XZS&5QO]<@PDF=CQ+Z\/("BK,Q'R74P7@O5/'IET8#E(4>C*1>
MF[;).$DYC>3D99PB-"/)3-9/34'TZ5&HC<Y:-TIN- 6IKXZLU:W<[8OD!Y1Z
M]I2G"R)?>%!N]Y*G"SA?>%"N]Y,G@Y=J!EPV*'N4!0XH\7<'TH7;R8[+Y!#(
MX@2 $GY_**7151NXN@S'KT#UY^%05D9#^;D_E&Z[9D&\,Z^*RR>"[W$HU*5X
M$%%2U&/I5SG1F( :T*,UT:W3>,A0EA^I:4FK#+&$L9J80C9=:C(17R8_S8D(
MU)\>HX1K./> 0J3"7PG7(.X!A>C%""5T0(MK()\"90I>GAHTKYH;(A]%H-I_
MU?HMPF"'*,DLO80!/M,=$-V9I9=P&\QT!T2DYNE=K#L@BC9++]WK\<KL\L/D
M=5S4P6Y9]DI#!HI]>\B2GP$H+)"EN63)]S(*"V1B3EDNL,P/#GDHL^9MI,$%
M<BZG,)LPM ,#.993F$T@VH&!G,HMS .8.?"!&N.#D4R"K##9P6#JD4S"IS#9
MP3).(YF8W%28^16J)@Y)< F4%@2HF#@D01TX9?F'-@ \E_?&4Z_ T'P\9_?&
M\_#^1=&IWAB/)^;.:!Z>;TS'4V]G-#>OX\FU.YJ%Z>;1J+AT!%7\MHWF$3"-
MZ7AF[8SF$3"-Z7B&[8XF-GT=UW>/+I(XE6%5BDT_3'^1&]/LZ$J8E\Y0<>\Q
M6J@#S!,J5 )\C!;J@/2%BN=R/RW$4&\"&:[CX:<:4!UQ5(PZ1$$P>.*WBU$'
M(0@&IP* &%<P.#FPBU&_@P3!X'3!+O8K"S!W(I:)NA.;W%RC;>Y4@07#W<(\
M#@,0&$XR,&$>!P,(#*<:J#!K8& 9<[<PCP,#!(;3"$R8]/"X$[OR$__.NQ<#
M".$.@!#I80$#07@#($1Z./1LNJY:1?\*UCT'93BM1P,#(0MV&;K5>-#&).K4
M%_=7L-!Y=R"=WP<&0YF_.Y"1AZ&,WAM(;?"MB(+,/!.FK?N48$EQ6(@\5*Q
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MX@[YQ#F ,I9C%;$/ZP8P0+)&*F(?U U@A(J-4<0=\+<D;FUDA-B-5,8^M+O
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MJBN-:==Q>B4&E"FT#R<+(<AX@+U8AY,%CUYZ<[A<Q]=Q)O2ADJTV&Y4'D0$
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M^$()(E<0EB *B1Z_GWD'AG.[@J.07E,X:O_#X"@D-5\][L=L?BL:@PEF<ON
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MTG'0R>"DD![$C6+>#TB%=!QN%.>N%$LMA*K?>S%3Z>"-&A_ G$L_E'-_?*3
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M#K/U8W3"WA5&SA]N^!IPJ/@6N9:951FQ$]9+,5R=;VR]L;M9Z)6__.[%S[/
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MYQJERR%^)VOCSG.^>SZ+;E8ZH44-(971R>C48 D@$^S153<+$!!?..4O(;'
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MO!%P;< 5@J0+P(UUPH$#WDZH=0'_L49XWB#6A6,78(VZFUJX=@'8&2EM%N+
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MI,9N Z3,SK5!:A\V$&URQH)S9[<%B?JIW7]=@E8(?O5\/ZU$>/#F5SLN0L&
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M=>1H5N[#^+&@M*VIYPW2850I9T*L6H)4QRB9.4Y]2ZF?3HTCC73.@>&$9YX
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M+'EYDANSI!TI83P2T'"*QGPU<639& Q"QJ'MA:&D %D"#TA:XY7#:G0^8$1
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MG 2]6U(S]G3,UT0$V?&S.42? U(Q#H&=![=>X 2KM/@@DJ@9DK: 5 VUY;/
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ME.D>HT2!&EC&*-$Q2E0O:%)#01R?0ZM%D*_$#C-,Q7S%5?5M:T[90>$D-@<
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M26L+9L^@*%=+W'\/J!!:A3J= HGE%I;L7[. 7#4).UC%M1"//@0$*53;*9P
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MQM,92=X#CU]VK/EIYP;FF'LA]%;,A)/1]!P]Z-S@N>'(5QO3E;8WR5L2D;=
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M\1M)7X5RXIT,J@(TS'QNN"A>:6&GOBBRU#8-72BK#D!5?*IE)B*)L$T7?<4
M61MM1AT=0DU!N&#UVI%,-+&P6A!5H;R6+4:9M$W'F2RF^%*.-?, 8[Y)HE\0
M[0O5-%<$4<V6K218X YBL='99KJ2FQ<$;J4]'WBM-86N([Y0=BS]8:A\3RB6
MVR.A%):/V/(/BP8_&^!B#F%>&@*?%'/84WD)%'S*S $SG3P-,-9-O-R10$@:
M9GX(V#GM04DYST1 L&D/&N99* +J3'O@D62_P-%?6KHE\=-V!(26]H@/D,LC
M8*VT$2=IXD^)A_4JN#C9J,0!.3T]T+QHR%,J$1CT:H$M=3_'JL3L6(>V3'+-
M-*[*5F@Q,""972525H630U\O1'EH)8*#85H\2[52W$I46^OBEJ/:D%=78@?.
M+G]V:G2F-_F;,*?>KY3M@2<=.4^ZB@4K3C(ZW5;CU3J,/P@!XE3@]@M$>"T?
M ?TEJ]WK1A[9?B=A'KUQA[J$VF?]W"]Q2G<V]D78(T#?NKE375YORRF!^D20
MU%+X&IMY/TY\E13S=EN>)8%9?*!:[Z%6IM>>819R-V-T>3QG7JS'&S18&=\+
MGX*0V;\9,Z3@O0FYT4>:3Z5T%/DU)^A+Z ZW(^RWH[WQTW.;?<.[."I2AG:!
MV?4]8I10*8N)KUE4RJ1W3/67@'G'D4O6DG8<YH:;OV$T3?P@V@7Z2XH*\5L
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M+_0]9R<8"R(B_;RR3L:J(0D!JAZKC1VM6JWK=.A>3<!F.#X;#H,#Y-P"6>4
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M9 =N$^<&J)#0(>ALIV3"OU)E1,7+=]3(^83G)'E)8H\0/WU(XA5+6J?H%9<
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M<_?'YB4\4ZB(K?W/WT[ J_IP/?W2N1" *VX<?X@4X#GTA&-14WR]Z\$_XF%
MX1W40N1.@P@2),<C6=X*T<9$[!KW]?S7'PA7)H87"/#<<;WX\S^YA&BWO%_;
MV;Y7%OX:X(J<UE--]0-X?K8?1M+@&W@0T#*!M6L>@0<:3Z0-P(L X4.=73+6
M.3= *9L^F?81IQ482FMJ]+FM",I?!Z\\!W)4;]>.FT";XY0Z?[.G (A3&XR$
M?:KQS!14H$_!+@V(#;UB!6;.'$%_@(1%+P'20+R1=_*%.?YX/U3A$ SR%C^2
M6:!YHE-=" '$:[H]T=PQQ'OP(?@.SPB,X77^,;#/Z>U]/TV5:6'FC/&4%0$;
MZG[2/O*ADS-7C'6 AZ>)H90SGF3]Y9T+)+#X0(:X-A2)<!Z^'D2>W^&+:[Y[
MG_Q2HNCX8Z[CL_ "7!+C)V>A3REZ(/ I9\+G'AF-'0:.S@7MAP5^LWU 0D]_
MN7%X9-VQS?C*.:A<ZKDBO(Y*$$FK2&T(I0%OQ HCC+2#*L65(L+A#YN3N ZA
M$]SI4]#'0E D=73D_/JWV5A@_N5/\^6Z9, K,[T>WC&A*B\0\ADTK"@P 1X4
M@X?OXE&WLXV%].[3M)!5Y/3Q?6JM9NK]/J-)T8U0MK,"#[*>GV(YBZ$S[Y,8
M8ZPW#II3(89WM(5RPR+V9J^&\%H.N29"#B$WA5PS!\CM1,M=VU#1 0\E.L)/
M0Z3-("U=/*C3$&"J :Q,&HS[D=<V..J>PR95!Y08CIJ3!BHHQ$_)\%,F_1.5
M '[H$^5=<>4P>(2X0J7WAKI]+4;:X5K5T34M9&5AH?)"\%4)?'EHOFU:3K@D
M9A3>]?FSYSIC$Y#JL\[,RCOWPI:^*A]%,;9-[QXQ5CZ,Y6%$MXFQ(/[F<S@1
M4@"I>7$HBJ!M6D)$D&P(RLW.%=?5DE.K;(+)!3$9$[UQV+!2PX8+@O%TYEWH
M'@D(6JO#_^,OQ/<67B.V.7UI!KS1G3*!%\>'9!P?0JCB2($<(P6(1$S[*I#V
M11AC<J\\R3U$*R9Y9$GR*(%%N;,BY11Q,Q8Q3L;.4PV4*:O2W 2\S1S VT#(
M5A>RBUGH1A[I^=WJ2TSDE2Z15RWMB "5$:#%Z,)M 0SSPT7GAU6SI9C?52^_
M6QD[B^ M)7A5T:$XN%#ZP07E525BM P854DCX@"6Q -8E=!WB$#9YLD7H,U*
M/ 0J+4EW8S PH27MA$=ID=B0G^+%:,%7-_F/TP!3 B8S Q'\*%'#>&:T.R3;
MTI;C5*.UC  BK&0(DU>YQPAK(,+*C+#&)@AKY*'#$%>2XVK1>\ICY2SJF_+A
M(@^ONHZX*!TNZKGO#X.X* ,N\MB:8LZ#E3M144X7+BO1\25QU$2'$7U*P? D
M0R4HE]K*D' S[<0DQEI)C'3TA,=W7U^JB9JP>6?7EYB0V ):XB'(!S+@ME!Y
MA;/86,316HDMQ)&4.)+6]UD/1VB]JHV6]:T7>LIHLS:W68@>U#V;ZYYOW;KR
MR(G;B#IG2SH'48.Z9L/HZESXCZKDXE^-K^::BUC:9L8'L836; LC%8@E'+?8
M!I8P\X-HV4#S8+X9<?1&'&$\AJC)0LUGWZ4V<=US9_1(;=V;F2?UN_Y$^@X;
M]8@QM!W+&8!'P/>G8'Q1%7]4"5AEB2!$UHI"0-QM#W=?B:<_@JA'U' OJ#ZP
M'=>#/V_HB'K$K +H5I$ (FY[B+L<TW-][/F,5 AD&8U&7&7AJEG;JMV<+MEF
MNNWJABCD@1C.P*8N,;MDK,/CQ)I<,6?4,?[RJ4OY,W?]8)?&CFW"'_YH'%R\
MH?HCM> )_K&4^BU.?]8ML=5*%;"^12N^1J7RZ]CY^=TS7;MS1D?02$[L!AHW
M:W&_[VAYM2*,_ K!#*AA+OE[(8^.^:?O>LILWXWD#)RZ5WH9>8H1IT019U%H
M.5T5+1@G2A$GIN+D=.<XJ=<PNI,PNDM#0[V6PU8[N_(%XQ65W:'.",B4>KHU
M/\'2OB!C!QP%G4W$8U5 6#%N6V9WS,X$3>\096UF0>@7=SMWS(3OA()68ZBR
ME-#/[@W$_;JX?]#M 9G9X+[GC._ZXC(B?%<(CZ6>W"Q_7O J@SD8N," N90!
M\^L#&U,(K3JP,?/2;@8V<$) *=&6&FCEL*?I::RE,%%3KD3-:_KI=!/]=+I[
M_51K1@/ZF/*1,>7S"JYFLC\K#^C7=C^@O[+^0C2IGT[>KC7#[&%>%E'MU&$)
MAE$0ZCO4I$JC.Y=AH=3)H!>D#QUF?B8V_.'QL^"G,'\@+M&9,>R TT&>B.4D
MCH<O.4XSFAT"9%G#B_8A)9T4FK4T&?%5*GQ)NUPY:QL%Q%>I\"7MU@J;V,>.
M.:(V=;T@V0G"[NJ6(J.^R_&UK.%H'[=F'Q%?TN%+*?N(^)(.7TK9QZ^Z[?=U
M \)]:@] RO_KZQ;(I0( 6]IRM)!;LY"(, D1II2-1(1)B#!IK63F&9'P(+7]
M0) 7U#6"W\2\@X\E!A=B1*8^H@3H5A1%<MKC,FD@$-<RI@A$-8$HK<W-//D;
M@:@D$.4-+](/1:S68IY2K9LI\&A=1(6TJ,CC8-V, U01%=*B(I?C4]= A<IS
MO,HVO2H/C;&.=X'8D <;>?@8ZU@3Q(8\V)#-I@0&M\?$YEG5\S32&H[6!%$A
M!2IDLR.("AE0D8<%R<ST(SXDPX=B"7S$5YGP)6U>?@M9E0K"; U)H(^,N"D)
M;O+PHC?SEQ!!,B*H2AX5(K!T")36YT+<E1UWY<LUX BY-'I),<N(^)(,7_+:
MO6UZ7I6 6+%CLN5$V58C3$09VLKTO&FM'2TUJK43*/MFPZ.N8U$3/FEV/>;S
M)5S$O.0BH"2QLHT:SHVGQ@:.JS0Z6M:6;':QV&H<U-H;K!Z"EW:/+424I(A*
MR[;/(&+7V\?5ZEOPS.,"NG1@0P>"\O>N[2<2' +H7MM=_]&E)M59$F 9&XXK
M ;C=.OMK5&35'EF^";P,^G5##Y$?-)!;'+(&F];(/R&]"D[N(=_DXMMIS+?3
M1JL@ZY78YUG1HQ_*:L-6Z)G"F76Z";-.#QJM'8\DU>*,&ABU@IAUSG0Z^%6W
M+'^$/"J01PO]4#1KZK5-,H0U^'\%6'.K>_2)7! 77D(K5#Q[,OL#6?0ZBQKM
M@EBDYHDX9>60O <_;<2@1KL"#+IUGGQ5#\,K*X^6]@FR:8M9AIUG]3#M4)K<
M'N8A\HVH=LZ]JB4F2L,TS%24FE=535V4AE^8R\@C$MLYSZJ9W"@-RS#;H0#'
MJIS^* W3,!^R$=\2+$-.E!%YB[--YY"SFUWQLH[1P'5@95H')NWI&)OA"U?H
M2+E"1UJ49:TV7,L2]ABU03"?J>,18SAS)E.%C>*J4BG:,Y-TA>)6D/F;8^M<
MU!6&8:H($',[U8:/0'H7>LYARJQ-6%_YI0D!<9>7%9X^K\IJQS>9WQ1Q(!9W
MA\5;YTD_A_L\/V;0 !%&157A<ED@"G>'PNO1R' 2::F* C!3#(B]O*SQMQ]H
MA6?%@-C+"WL7SF>FN]1"^,U* A&X.P1>46=$$R:G\UA%]&5) 9&7'_)^=4#0
M]@ !F"(,Q.'N<'@_=(A-7\#R\$TPSATVKB( LZ2 R-LA\A@=^2Z7M1.<N5Y)
MX*4+ 7&W.]P!R<>.8WVK:IIEL?V(MMVA[:O.S!?,[66* ;&W.^R=6SK[<:,_
M<M/B,(4VH%MW@5JF'!!]>67W*@J]#"$@[O+"W8W_ J)U?#;HZ@QSRZGR0#3F
MA<:9V95=PIZH0=P*3_I;5SJ(U)TC]8&X1&>@*"J/RE1)( +STI7_=*CM_4M,
M2*KRO.@5A8*XW!TNU5RYK\;Z>)5QE]C""A?P>G.;>DF[@EQE1&8<F%#M,;P5
MA8*X3,7EW+E^4/Y Y&CO^@_$@E_F/=0TB<$+RHCA.<SMV.:Y,QKK]J1+#$;X
M0MJYO4.JNL9]J1!#U+XNQE4 NTZMY%UY'W7G=&>&9AXG0!>&?''Q;JR,PBXG
MX!=Z05&<MU##(^"ET_ MI9&/&EX&P,N@X7/!>=99\*CKJPI]6??1DC8.EH%#
M:#5DH$[^5J.<C&D@3Y G!7M7C1R\J^)PCCZ55("7*G[. _G-V"?"40+D0-$<
M6.HE-3?QDIIYC*])P"'TEV2@CF1QA;2,R=S1^G7&?&5WY[I#1\,L>ER!VK(-
MJEO78"^9+R863#?%-DW*>T>WNF/=4&0S[%6H,B>V7?$B2_C1OMQIXB^6(Z7;
MCWL%COR3_5D=9,>-Q1Q.&HYJQ_5&@"/^UX:Z%NSK!?M=M]QA=7"5V?A"<58[
MYI!9$V?!2[O%6?THPAG_ZTTVO5+HD@!3]:,-,!6\)*\-C&.#ZF!JKLEH#W<6
MK2.F,)Z=C6>/HWB6_U4<,+81#AUO$ [-O"2;&XOA$+JI6W53,1R2)1R2UW6M
MQR:A7G*34-_$)-1W;Q(@.CAMUF("?_9=:A/7/7=&C]06J\+66^>YEB?(_DE'
MZFB +-EM>4WHUIW3N5XH8(P>PIS3@V9MIV/T@/,H"D;$(^)S1?QK,?[I!C'^
M#&-V=)9WTK7[JO/]CKR)P')T\=;Q;N"[K#?4[3N;_$%TI@2PDXU]]VEZ/;.]
MA2C-O!<&I4)@7A[@V2:E=$6?Q&4ULCU9N%A/"(J"I8GZ0F9]D?]2<=07I=47
M!>PK$,U^Z< _B<E&B3DP<_YVI31,BGBBXPCG!;1EEQIUVYO@BK@K>;^W4$VA
MFBJ/%[XA7!%W:O;[M0V?&M!'BP22N?.& 1>^.([Y3*WIXH?>LW-/F %-TP?D
MKO^%.:[+MY6S/2=:"* *2%822K2O[>MB4111&0X/(DI)1.7A2C40415"5!XK
M;]]D]:8#=V()&G6)>4&>B.6,>?LO7\;$-BG?2;J2R$H.JJTD'S2#"#'U()9+
MBB%KACZ"366P+0BD+%/_TR :+UJ=RS1T/<;G9%"#S\.P"7.'=/P[]8;7(_U9
M9T25\_:6R2%:U[ZB) I1<@"VHI4<(J@T""JMYHH6+:$.4QF!&RYQFM&!.4RI
M0]R5#W<R)/>_V?" ZUC4Y/-;030^/XN2F)>\XLGIQK?.DZ_JB4RK""$$SU(Q
MJ(J8#&\+L5,F[)33SYI-\]]0_9%:@5P9=:D]N&+.*%3U]J!C>/1I"KWX+<<>
M>(2-/CN,.<_PG!KCU&L)8V;&8(8\%,WK;P5"1'=)XM6* RA5&HK")VM["@12
M:8&TBX"ON'U2T"B6VBB6%(RH"]70A<6,4J(&4TB#R370C;JHM+JHG"F*+0,1
MM9H<6JVD8$1=J(8NE&%P"#58J3687*-%F7/L.K:Y,#G_5_IT9Y//D]ZS\Z"/
MJ=DCKJ<$BE:50CADE"T'M']K)<D0?0JA3]JLV%9TWSTC(^C[Z6+3*D(O0PBH
M]7:G]1!WLN).;7WW%0P+B/Q7G8R<@>4\@E=:;0RN(!#4@[O3@XC'LN%1;?TH
MUJ#=,^=/8JBVP\IJ^$L1 .J_W>D_Q)ML>%-'ORW9CH-1&\3SF3H>,887SF>F
MN]12&WY+]^%8(@_4?MO1?HC&\J.Q"KH1Q#YV'.N;J]PJO74PN"@%U(.[UH.(
M/!F15P6=-VMQONJVW]?YRCIJ#U1:/K@%:YPM&]2/^?J)B-+RH51>73J#S0<0
M.YF99M5SQG=]<5D)B,4-3$Z=FF^CJE.F7NGJSX[G.2/E>SNEF:IV>(:?A%V?
M8]>7TWE9'3IH(! TKWB\J&]D@8ZT;NCJT$%]@Z!)WYQ?9VS"ETB,'-_V.H;A
MCWQQG.X%&3-B4''8+]QD'G6#OVWS>C36*>,"XV.T?!/ZN5*2R$NY'_3#^@/@
M<9'A126@O*L.2#(CLP]6H<@V4A$+8_F)NLUT9@$Q1?[;')6)<^(T\^GFV>>.
M*JLM*DF[X%CTM.Y$XDE&O/@%9SQA=##TW'NHJ2T>%)G=:]OT7>A0W;IG#HC(
MFSR(Q[J$/5&#\,?@*C3#'@0WD+>EY6WBG2W# 7DO*>_#3IU]&"FL (67]"RR
M<:=L1.+LEC@EA&;F?(,2F0R,T50R% 7&:.5,:*I 88SV4 .H$.VA!BE:@V#<
MJ*HR*#)N1%YC!%H&"B+()0 YCNR7@RP[ME<YC^R7E+W(6>1L93F[F//-_X"+
M,G$.,[TJT4ZJV3A(/,S/(F]5S\\B[S&KBA26):M:;38B<23.A18#S<P]:DID
M,C!&4\E0R#H;1]KES"I0&*,]U  J1'NH08K6(!@WJJH,I)V-@[S&"%02"E81
MY)) &\?SRT&1'5NIPL?S\]^BL4R<PUR12K23:CP?B8<9'N2MZAD>Y#WF99#"
MLN1EJLU&)([$V91BH)GS5).L(FTS62H&:_D#?YV>P?A-T9E@NZ4GAG3([LI$
M>:@=,/!#HI<K%JPX9Y%>N=.KC  N:C<+C!VKP@K58L>E$V7DW?A"3:)C%(IZ
M0M$H%/6,A'H&X]D*J0QIYYPC^S$R+A51D0IR4@&GK9>64CNV?;B;9+G3O\AL
M9+84S"XFKYWS$5C(3&2F LQ4\' Z'&="<I9SG GIB:-#R.Z<3&_I1H=0.^"8
M#A*]7&,ZR%D<B2F:7B4$<&$;6:%SBJ22P6:5SCE=.IHC[UYB:NL9=',KI#*D
MG;J$[$>'N51$12K(204<1BTMI79L^V2:NH0<QP%9I+D: [(E);I*]$83KC*W
M)9H)I>!&@FAXD9SE-+Q(3QQL0G;G9'I+-]B$V@&'B)#HY1HB0L[BP$[1]$(
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M*I\3?)&T<AXV6E$>*YWC0D8CHQ5G-&;"4 ^@'D ]4+%\&3(:&:TXHS&KAGH
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MXKF"&8*B@8RY@340C)A$=,1GZ]SK$RZ@.WO=XS$K'D^M(CR,KDJ/\FK'6G*
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MZ'5A?#):7&&N(PZ*Q8$L^B!4BE\^J]GKD<[_\KG"7,<^5I_'8DVE-R3L@0Q
M;.JK\L7&5ICAV/O5L.%A;N7<=SUG1%C"E;/-;RYA\0TE )#6VLB12VUO)30
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M%-*80<#E+R58_B(K3G#Y2RDF]V'^ )>_J(%DS!G@\A<%8(QY ES^H@:2,3>
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M>0^<971!X03$8+0<E,.84S'>8619&O)A *D0\3!,+ ?I,!I4E8$5COER6EV
M,1\2L PQGT(+>C#F0]Z5*^9#\F',5Q'BR1/S(>DPYJLB R6-^12B8\I(_?0]
MI*5< _/S/8/\5)Z?7#TGRT!*%FLI%_L"22@-"9$,"*8=K!)<#U;_(D-J6,2=
MT]0/NCT@,P]^=CS/&=WUQ9V*PFU66%M6I;'(DU],D3JNE)."#SUGC&3(EPSS
M(D<F[(()W'&\[L'ENWZ?&F3.FJ*%2"&%\+6S98:&0B%ZQ&A7:Y+ VNH?]^TJ
MS"NI'-;6=S40:MLU^Q6!W!8,>061MU%>"_$F =X*RH-F'<2$R"D-<I9J*FF/
M_=F-[X\Q\;8C!8R&2^(UKL^(RN=-"Z #)DZ+CZ"0$A)F39$8;R+&%^(,F#X>
M4D.W.HSHKH"UP2>AL,FW;LEQG-JZ=Y_"YIU]ZR):MH"6Z.ZE14?4%C.5[OK7
M4"0+919,:E(C]9D!J>D#JTD!@;=67@&!IP;PI$TKK <\M(_51DLC1DL#U92"
M:JJQ"? :T@$/U52UT;*>&\^#^8Y+]3O6Z3.XI;(Z$HF+Q<:B5[X%YPAQA$[V
M-JP7X@B]H&W9M4N?)[*O;</R^<#--2.6;IO*(VI9L]'6;<G6(;8DPY9"]@^Q
M)1FVY+6)JWI4(U(-9RK9SIUC)I)3D;OF+LT!75^JV==1#NCZ4M$^7F,X OMX
M!WV<_ZX2J+N+UMUY]/D:^7OD]0[ZN"%)'R.O5>QSEWE?]3\==NZ[G@.MGO9U
M=*7$G0V-.UML7=C'L^U3NI.7$QND%(2QX>1AI2'Q*O\Y9I+B6 48",3M69B%
MH86*X_$- RX(R]TX/HC(#3PD!./6,J-B)\)S$9-01?;I6 :UM.96.(>&"% Z
MVY(Q\G;/'-,W/+=CFUW"GJA!$D;'HC87VXW^Z##=<]A$"41D-#FR"!F-QE&W
M=,V2,5L <54*7$D[4R!KAA/BJA2XDG9VTR9V<"K:Z%8%<)75:+2#6[.#B"MI
M<*64'41<28,KI>S@O4-M[ZY_KC,U-GE9#JB%UJ+EVYKE0R2AK=N.K4,DH77+
M&O%0>CA-[F$M629_XQR4BL]!D06(. <%YZ#("DN<@U+M.2CYS4!0&EQR=[(L
MRWC0(ZNX1R8+$-$C0X],5EBB1U9MCZR(P[=-0B]%+3NFR0C?_3[\HS<9!WO]
MPQ.??9?:<.T<2M.-,A]7!(TY6][>=Y_X,ZDMQK3K"A%G?(;"%;5UVZ"Z=4/U
M1VI1CR82^)<OQI ?7J _6J1+;.JP6\=;.+LZ+BNMB'.?,9!FXE:)<9ER!D66
M_**]8I9)<"O*,J5.Z57)Z@FE@UK$.^*]>+SGXC*DX[V*&)4>#P7J/\2#A'C(
M/[Y=S1X&&KQ+#)\1LT?8Z,;1[76LX:UCJPZN5PSB$A'F:PZ7=(6BB-\DXD'$
M(^)W@WA98YX+^-R3[M$GLO#8!(&_#O!?EV25\2^KQD?\(_ZKK/_/'?N),(\^
M6H2G:A#RZT ^57A51KFL6AY1CBA70I=7%*%E0(5D67Y$A12H*%!7=. ?+PT0
MP8TL(QA;@[GW4_Q[\81:F)HV>@%.2;'MRORE"#\[O$J(OUKZ#I&-R*ZPSD9$
M5EVW(0(4U@'K9S)4@<.N$A%EU X9&VX@2N1$R4)C2S$K?+-904_$_H/H#).J
M;YHFL4R*5<ZNRJ]=D0'(@*I;#N0-\D8VRY%'S-9 W"/N)<-]'@<596TEB@Q
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M^0.''^UTUW\@%C^I\QYJ&JU:CQ[[C4R^ZK8^$-MIW!/F.K9-+.@1(9\[!N_
MC33&SA3SV?$\9P1?XG?4(-E2^25/7%U'A+M@WWQ]4OI"T5&$3*N$V$?LYX;]
M<EJ+S/S(]KF#;-B0#55,"!2HR'O.&+6X#%I\OB/0?4'4(^K1<<F;-4@%Z1P7
M:6&9.!,&85DY6&YXU$H.L,3$B!+0+6-B9-&K;N3@51>)>/2E)8&[!!%D+EC/
MS^E /5\*X$N7 )?7,Y*".V@Q)"&.7-D7:5FS\\$BM#.EH(L<\40!BZG0.E01
M[A+$$X4N;D(]7U'@2Q=/2#MS00[NH,60A#ARQ1/2LF8[QQ=5RYA(M0^8# 9C
MT5F2[8REC:"KFBZ7&K<2>/AY@#8SZXF:M^P(ELY5ES:)F2,)4(>KK,-+"G_4
M_&KA7@Z?NX#)/:BO2XU;"7SN/$"[VRW44?-63/,N=3JDG1^?(PE0AZNLPTL*
M?]3\:N%>#I];MEWP45_+CEL)?.Y<-IC?Z?&TJ'DKIGF7.AW2#J[G2 +4X2KK
M\)+"'S6_6KB7P^>6[00/U->RXU8"GSL/T*XS(6J-K8$KKG)SW\U73JTKVXR^
M30%<,<5;.'HET+WRSNM#+5P:'$N7]9!W>E.N5$!]KK@^+RD)T JHB'XY?''9
M9OJA[BX'>B7PQ>6=[X=:N#0XELX7EW?:4ZY40'VNN#XO*0G0"JB(?CE\<=EF
M *+N+@=Z)?#%Y9T'B%JX-#B6SA>7=SI4KE1 ?:ZX/B\I"= *J(A^.7QQV68&
MHNXN!WHE\,7S@&ZSUHJ2@;56XWBJ+WV7VL1USYW1([7U^)QX@>'/U'$GMC=4
M HE9+0V!.-O6PK-IK0VR:?!2XSA'"[X4.Y=C"FSW?$9NZ(AZQ*P"B#(:K:A.
M60,-O^M/I.^P48\80]NQG $E[K5M.&SL,/%HU>SB*T!:45YH("52;0C>MVM!
M!.N;TDGHS4GHS94D'X/8*08[<FF0CL=EX'.9W/4O7\8@/>)^GMSJ7)WWG-Z0
M4';EVP9_($9'O.5_>$S N>-ZKA)065<<(826" 1UT>[Q>.=[KN,S@]J#RD,Q
M71:(PMVCL NN;X_IMMLGK/(PS! &XG#W.+RVGT!$#IN@=0ZPN$0@B,<<K+,W
M).R!N![S#7@.C308Z64B04QF1*^U&).U!":_V29AU@1D>/F7#XV^MKE8N5@Z
M4(UXF/&!&(2./?>U 5LU<+F!4)8/T$J"S7IM$VS62J4O%URGT&R)YZ]'8YTR
M+MB[_KVEVQ[OWS'_K01NM^5MKB.RHC$MK[Y%+:NHEDW-0=9V/^261-2M8^OF
MG[[K<?%Q!]WM]#WN%8T=QJ_=BP]-<X[Z!'K>^''/'(\(_L-? Z:/;AS=5@)-
MJPLDRCJ^+A)%D=2N-9)SFAS&G&>0D+ 4(Q)CYLKQF3<$KMDF;UK/.6?$I%YG
MP B9ZO]-$9G]B!)P3)-J"+S5Y+KE\=^UZ?%:_Q3 C?9!K9&8L[4C;K3KK16X
M0?M(C1U08Q6Q(C/2F-$^J+=VSPP1I2%'D".R<V1IU#A'E]6BQKF7<LV$7-O
MYP%]M$C'=8GG_DZ]X36$3WUJ0^S^S27PT WMSTZC"Y</4)= -/5$+$=$[2(M
M (#QF1JSZ]8137+NVXK2P?3&6D"-%[! + 7%>Q.1,H)X/LX:S4#TAN@N&3J6
M>3T:,^=)*# UDANK"2()R"6R0!#N$H1W_3XUB%J9X/7AERH%!-XN@7?NC,8^
M>$A5AUZ&'!!\NP"?R :'3R1O5@I[00(X4PJ(O!RB$V<\870P]-Q[J"@/%FU3
M3.R -R'09%2WH@YZ$(]U"7L""\4?@ZLZCRB#&TH@=^,P9LMB1.CO'OIA_\R^
M66D4+Y$( C(=D)@?JD9^*'6(.(_UO8UF<&;;;'HY.34%I&BF9I]+"9G@]+7%
MUD[GG&2VMR@0-)J[!T%D]! .\L#A%9,U@XPU3-;TI9V8+#[MY 2GG>S4VN&T
MD^VKVF#:R<FN56TRE0/<&SB,\DQ&.!?W'E@,OV,<GT,)U/8=W_UB^8;CDJ\.
M^#,.7PP1[X(R40+2RX41G9JZNC@4]=C:,]-#<5(&3LHHAV[-8>+T"@GS)^K&
M.WC$&Q,E5YC%SRB!Y(RF)^/?9:TOVL&5-2>S Z"%:Y*AD9:8$##=(XYZ0VK?
MV>0/HC,$Y9:T:[CB>4;<T29SBP)''A3/@Z\.([VACDS(CPFI(D<NK!#8X8K6
M-9F@Y(K67 )$'^)? </+;P_S(!@1W07Y?:*NTVK4C\_@D:BHZ-;<%WAI8746
MRA^-+6="2-9'@M C?&CSS]S#XUF?"&4#?VY>OEA!NK0-XHDW?L!=W@17/+/Y
M-[YU+U[K:WCD3>5_!PA^[UQTEXHJ\=S;/^8&/1/>-ND3J)NYC_-W;OT1G\_@
ML/4%D*Q,5C'\W@6QG1'? S'S(\NZ,?F59$G1];F6O2X@;GPS 27Z03RQ1@_0
MES/&-27W.(9TK/69,WH@??>7=U?\X?#,^OI)K=X^;9^TVXWOC>-WFN>$S]R&
MBX.:]=-6L]9L')V\>_]IXY+K]5T5?;Q0--_FOU:'@@$BS=HZ1<.;4*D:U.ZH
M53_::K&M^G&[U3IJ-FI;$T14[%&S!39\:[7E\FW7C^HGS>.39O/[<7.NY!8_
M10'J?5IOG#1;;REY'F[;*WD!$V\NNLG?;K:SQ=%H']< ,V\H.4L<;R\Y4QR;
M%=T"_AW7:\>MT^^G\^+@<&[4CVI'M6:SV7Y+R6G*:#LEIRJCS8L^K==:IS60
M9.W[W.4FJ"D0\'<@^&('\"HU01^T3M?&XPI?7-#EN_]B"C-V^\7Z:>Y?;.?^
MQ=R1LSW@A#:HU8+ N=68_^!&G&D"DX]Y3>KY52252H54)(UA150DE7B%5"2-
MCV^MR%&C5=\:6$^;-7@VOXID@C7WBF2!->^*9((U]XID@37WBL@"UFUCM=UN
M-\%2'<U]L Z18K-1/YZ_W&HU3DZ;K>^-#-(T:A ^P5,Y5B2=-/E7)(,T!50D
MG30%5"2=-/E71!:L;@^JP9NUUE$+M,)\(F-SBQX6VV[4FO7VZ58L^F9^\-LJ
MLL5([HT5V5Z ][:*;#'N>V-%MA<.OK$BLH!U^UAM-1NGIU/EM -2OTV[;+5^
M6PPU=U._[46@.ZG?%@/3W=1O>_'J;NHG.3]V00\^_+)K];)^0+.3^FTQ.;";
M^FTO9["3^FTQE;";^FTOP[";^DG.CVW3@RNEDZ.35OS!':4I3IK'K?6&\793
MOZR04)+Z928U9*E?5JY#EOIEI4 DJ9_D]-@>.X(Y(XW::1OTTO82)KS")Z"D
M(5H[/3X&=9TVN-^L'[7Y7R>--Q6=/M5H*T5GS#7:3MGS%-UFV?/JZ2UE-QM'
M]9/&4;M]?'KR/>.3C?1/ML%^@L&#_^WDDVD2W/$GTP"QVT^FP7NW7TSCZJ9?
MA*+AO^UVO=%H?V^F:X%&L]4XK:\_ R%9<KH2V$;)&3I@DZ*YTC\"4=;KM<;Q
MK-(_@9OMUE'MZ'CN<J/5;-6:\/3Q MS#XFK'3>#U\?I&Z;3=;M5KJ9,>WUAL
M^^BTG3;I,:78]Z)<<;HN<?DU<65(=)/P.; F??JTM_=Q^H_F>A.+_/+.HC8Y
M&!*^1]E9_;#1?O=)^SADT=U'A\'[9[9CDP_!WP>/CN<YH[/Z^$5S'8N:VJ.E
M&S^BNYXS/FO-W8I*KXU?/AB.Y;"SO_7%_SX\PNT!<WS;/)B]P>?;'^@6'=AG
M!K$]PCZ,=#:@]H%%^MZ9[GM.=$'LSA9<67B)"R?9].PV_\_?ZD>U#VG/+M9D
M_NT/?<?V#OKZB%J3LW_TZ(BXVBUYUAZ<D6[_8U]<V'<)H_W@29?^AYS56V,O
M^/D<E/3H6.:[3Q_=L6Y'GYY].NUF^-&Y;R8_^>Y3]_+\V\-U[_JRN]>YO= N
M_WW^:^?VRZ5V?O?UZW6W>WUW^_$]+_A3_,_F0EBI+;7-V_*[#I2Q!YYC[UT<
MGA]JH%U:IZ]7?[&_-\?#*WQ9 '1-_&^./"-B4G^D)6DE@)UR/<!WR@W.M.3E
M@ ]G0#)-L"&L8P-(]TQ-;WA6;__]PVRE%KMU2Q32E&32U=W#USVNOT'>8AT#
M-<1"@:M0*Q_73QO'M:-Z\_1[[9UFZWR5ETGHV85CB'/7>I,Q>:>%JXE HZ>O
MYWSWJ5$[N!+:>_J=3[L .9(@#Q)D<X':?&'?V4&C==@&#"<M7'AI\0,[4*HK
M(+I5^UY/0_0#&5#78\*9Z7JZ)W;C6 'B6M]A(]W[Y1U]\<[Z](684%/+)5R
MI\>MUH=Y^ =RW>R_BU*9410/EU^NN[V'3@\LX5ZWU^E=?KV\[6GWWQZZWSKP
M1^]. Q/*[VKUQD^//VMW#]I/@Y^#LN^NM-ZOE]K4QD[M:^>\I\'M^FFS-4_>
M-3C\=L=DUS;Y[F$'[2H5-1IIU.C8MJ];P48PFS'"8WY$B*,\"=&YO?W6N=E[
MN+R_>\C@09.3H-[^R?Q90P9\NG+8GC<D6I^ZAFYI$Z(S36Q?J*V&GU8:?H*=
M@RZ#1?/K LB$=PY&\,J0%WQ@ZI,#7JL#8J=C.AEX0EA=.VDWVD?'R6J=^XQ!
MK:Y$$_FZQ^W5C%?J@AAB%7C0V7RI]BS<]U?QNT"4[3113BM]!5?<U5RP1FO1
M!7N[2R8_F*NNSNO?CU)]=[[= >5^SEM4>F%.#O@WM]UKX>*@7E]7KWMQWVO!
M!A$B9Z>]I;O>\M\]SRGLVU77#<=INJ$[),%I0[H]*:5VZ/YZ>7.S=W[W];YS
M^X>&"F)5S' ':,_I:X3O_*@Q\I=/^7Y1FC>DKN9R5  .!"S@)L>%FF( Z(^H
MR_<6VNM3BVBVSUVYLY6\W_KWDR2E+L7&/E=0RJTH9!5?K7; !WED2)AA0BW'
MA%JN.>:CM7+,1[LV0Z>+G(E2<;;']\Y=A3<]QL_HF.Q]IHY'C*$VMHSU222+
M#OKI\D4WO#TN%0TT\E0:F@ZJ>$P,OG^:J5%;HYZK&4.=05TUW38#[RX8CYU]
M\W_^=M*H'W]PA:CA37"[+NV!1=WASV]7+ID#G $S&P)Q,[Z0N/(6G;(Z\M^N
MZ5![[5)[[9I,JRFA>FU1"UW;AL/ TYF.")Q#QWML<NZ8Z^:*#EQBG!%SH#-^
M8*\1E,.31==\_H1MEEA9_=-GU#6IV%>1.Y T*3;-8?#_@6[3_XC?&VD;^;W&
MU_*0K?IIJ]8^.CY-,78=TV3$=<-_;J#^]54LWO5%9^^S[\+CKJO=Z^S'0IHQ
MU6>=KU6]=7Q\TLJLU3G\><=ZSK.]2IT^,WVROR=8,M%^I\8/RWG>K%H-OJPG
MNUKW#M]L]O_2\8I4_-0Y/=G[M7U^LGYM^&$)I\WF\?$2(05TWD0EA)J %ZR&
M-@A%PA7!&'PR@XYU2R,OQ/ ]^L3=&7YTM%LA-3!O:QK?ZS-(XL>1@+=W3YCK
MV#:Q5O-XO\.K,Q@DD0+A$S/$?L#P1*0?PF]$V_QV?5>W]^Y"GQ!NV@XK+^2N
M^;?I:.]\2$E?NZ*V#J@#T 6GE+/R-*1'K+.]_V]%#,T,#G$MW6%$7TT;O@D[
MS78S/9FW2KV;W^LS Q(WCJ%;]T/P;E?-D+RI[O7&\='>Z4FM5EZP7^DO@!'H
MA)424DVQYBQ;UT!I>0K^9,'\ED?P*[@)?).QUE%S2Q[>FP3^1N>0@^BD!L:A
M46\>M;?B'+ZI.6_W*^,6M5IB<OMV_,HW->I-+BEWD%LGQV]W2=_2!/6]6>Z,
M[>^!829C;J7VM<N#D4XMGFM[#Y'ME6ZX=#0=)A YN%!\//\6CJ-IH=BT0/$J
MZOQVP<=GE!^VM\=$WI$P8O+XWW.T1Z(EKHU]YOH\G0EWX"V>%PB:%\Q)!,'Q
MD>J.X9VM+ZE7$H/:?#:\R1N\*-SY2Y[^"+T<9.9^>5<#7A'+&NNF2>U!_!LJ
M:42_4Z274IM @ N5XMT0)?5JM;\GLW8\C3B;Y1.[NG_TPFWF/WIF].V@@&;S
M[Q^>"/,HN%IA&4&2\L/SD'KD@%>: #V?F3Z.-XB'<B1$V,Q;HE(F,<)$TYEO
M0]?P>H$C33V+Q"WA8YJZ,=0,?E+.DB%<[>-[S\Q3B#-)\G9K+D?>;A\V\YLP
ML*)D7YN9PW1.B+C]W<D(;F3(?'/1>XXJ2.7V90&HY,48ZO: :(ZM ;S@RE1W
MOBI$_E^VMD8H@427^$3AXDMPC=JUV8 GM$F3>N-1*(554G3\"6K[Q.QX04@5
M%'\"?YV<' /_.J(*NAW+ZX*,'9=Z.IMHP<DMVD^B(QD9PP]^OH\]T!JK19TY
M]0'4)&QGD*:/PL>YMBX11JM]VCSAIO.D43_ZT F327'][QAH@JE$]K6QSK0G
MW?*)]JW[W[5#D/KIST(BR7I$PD@5@TG=L:5/Q )./BKW:AO"*LX4MEPN<Q/#
M0EK-5W)A]$LQY;5"9H%OUY$D6JCY X6_TH#]P_7G]0A132DWTM3996@A5IP=
ML3@0">]'0=IMIWO1^=_YKHA%]\5R'G5+^ZJS'R1URM>\V7DO7&6,9\)X9C 3
MSVBWH+O*$_\F1  0"IT1: LC&G4U/9P(R*V;\PBU#=1PMC3$5,OUI?&VN6FO
M+EFLG^3E95_;)J@HCXB)V&'& ,3A^!X_PX_K3RTX#BQV!4-A4=?U^7J2< Z/
M$9SYR>\:^A@<#XO#TG!&(X=7RC%^\(E"X;N&Y;@D^A%.^3:<)P[<O<>)N*J+
MY5UA;VX0<Y>!S:&ZO6*Z,>,LS.O;E/3MN1!LE\LU<&;NIAV6IGT#G<O/2A,7
MP\/\-(@ Z$BWW%_>7=]>S4Z9!BP<F(X($O@C?)3E=+]^VMQOG<1S0:.:?]H3
M1[YJ<X[7O,,%+NB+8?D"5#TFCG.+;JV0?WJ]UW:3;]/%P/'\ JI]C8MURVDS
MPR(ZXU'\, J[^80KD7D)?T>;@X@&S;X\U@?DX!'$^N- [X-XSG3K69^X:?N-
M' 0^BM@O9/Z38G>1VG0"%\_U)*9US<TPRYAZ-IW!):.J Q5C# EH)&CQ#XT&
M:HA-9S0*._),+.O@A^T\PX< JF 5S%#G[7--9I(^M8,)CP^^1;16K1TIM*F%
MXA;E<+WE'2N(9HT9B8M3ZW8AV#_ %H>+*F8:NYHWF3*'Y7>0_6]<]-U0\M="
M\*OX\+=.UKJ.<)GOU@U)_CCNBP40>X%M%&BU(WO)7<'I:JK@B7T :8!\;07D
MVTZTT@+0#>Z26'$0%.0N\:.:>_#I&6\J08,H-N!\X+?YPI5J\"(!OHW(D3+0
M^2_'\FV>V.&K.-A*JVVK0(ITY?X\)#PVF,?Y3_5P?XDAJ'*.<%/3+2N&>1+_
MCR1\  J>@[R6#?F]-,AKIA\N7P*OEX%#(3RA>D,3Z[7!/8+R>$SC^N!FNT-'
M3*$/W6-OJ'OSK7C6W46JBI?#AOR\O\='_WYJ)%K["!$V//3X)[2%OR2>AS=Y
M5<+"^)H[5]1$U%1W/>VTIIG@3%2 M*L0L_V]<93BDP=+^!^B )1/SUYM-?P?
M_+3E)01-2OW6F=$IU>,N!S'@=T0]#V!/+, Q<VR>9[,F?*4@Q!1B^AT/39Z(
M=J%[NG85&+$95D_+2%HU[LSMA<[< QGXX<*5[D%/^XG+[?A#H]DXC+T]*M:Z
MC.%S/^^ W7O)*@?UC?D*,1.R,6)CRJ23! 8X!$)R(ANWS$81*UD0.1)--PQ@
M(],YI3A >:!DIUT%$NA\_=#!PKU#,*$DB*UHN&!LCR<3&K4/"\^*B2T97Q;O
MU#_$T5F]\7C0B*QTTC0?:C^=BS9"E/%S[FFFG?3?#1?)7HI(DHO6%_Q1F?_;
MF;9EK^QM>64>':"VU6XWFR>-E,5?PN$_!S$,G,U6=A!1C!"A$18CAEMFJ1C(
M>/GV" N*4.;_7D(+!GP.R( YS]XPVC-@W7 ,[$S*4JFH\"^B['!VW2[VIU#"
MMO1!:^^14&3:;'\$7A"X3F.1+.;KB/OQR@DWVOW0Y4H=T.HP$VX1[9E""=\.
MNX?:ET[G?O5<QQ[W(X7W"!J2)SW Q?)=(IX"V03[BZ7L3!.,:HRM"6^ ^#BO
MN@WMA3N,/%%7:-RHWKRF?C#;0N3G=6:Z&E]O2<V$Y[DWS:=H]>9/^L^IMBI%
M[>W,8OWINQ[M3V1T.1(Q>QCH\EE)W!O0P9WG0.%B!(ER!,&W]($ 3CQ4)0:J
M7'XIDC+I]XGP%.U@DNP>%3 #DVWKEJ R<RR-#U E>G8ZT"@F3\7]!UH\,6.T
MJ[-''8H]N'NQR$1D WZJMP5@SP^UX\81GU[ZLQ:.>LT,X#Y:U-A+X*=/V6B&
M(V+D5^2D3=%6W3>I%];K<*7%&.WOS1D[<VWT68>7XK#.5)97EIXZJ+2='7>V
M"^&\U)@[S6Y"3R0Z;B\E1ZK-3R+.5%-)R*<J/V<Q9VOS,;5@*")XC>=R('3L
M6R+%P\=;'0A^C&@'!F@P82R8-##F&LOQ70B=0R"E??50>\U6SBX%:+2;K>/F
M<>IF3E?4[GHC[Y+7X#RNUZX@5D9PI2)C+T(&MS8"!'P(/>C':?=&8$P 1BB,
M.(_ -:88:9] 0;HU<:F %&"(^X9/Y.!1Y_:+6SABNWHXBF 0N,4SH'OQUY,0
MC#7K_)I:YB:3(@RL[9,N-G(*JQ#:U"1CPAQ+JW98KUT<U($VNS=[Q78KG[\"
M4@\Z(J'N4ZR>[P:IH%#_9VN)69U W5 I;#G W<4Z!Z46-;PRXR_:F:_>F)MG
M+R[D@DKNAP0]P+WG59FVV?S'8.Y"AD"DV8.0GZ23NM]TS,QNZ,>OM"-&X$1R
M/0H,G2X$CP<)M*BTC)PCL#XPS"O/S,Y%DJ&_.M.\N#9344U;IWUVX)^4),).
MUUZ\98NF7>S]RRWX1B3;S5S6?(.\.)4;BB%(T<9CDL(H!B8+')@Q.#.$V[IP
M.$5XJ=I?/K@V +8E_C,5PR,+-A$")#):E@+@XZ>.93G/AVN-I[R2WY4N.WP-
M8MBK'VOB[4^S^-/X3:U^DGI3D4Q#?T_X0S.39EZ9)K-LY&-V$]*?4B:&90X]
M_'RX%L2RQ20=QOA\L%1\W3HAM%8QQ$??FXW%=&MR+^"W!XR+YS[L!.VY2+W'
M<1V<BA&Z%YIC[UU!^S5^X!''ZW0;M& ^"R-]P@C/HHK=%QV?:<D39[1N(N]@
M:Z*H[L%),)I^Z[B'6K/9/.!G_QV?[HL_3]N-9D.DXOC/1KM9.Z[QGWNK%'UU
MT)P6+=YOGA[7ZOM!64?'(%U>5B#FX%KK]+211:-Q),'$5-K%F;2U:./1UT4\
M'QU,>WPL\53<5682)_=;+%!LJ8LJ_NO@ %!!+/,,O$T1U1[TH, / BIGVKC_
M_S\ZYN1PZ(T^\+D><(DOM_M[XZ+&_U,_ZM5JT,@SH+K6Y133:B^U6KW9:9Q\
M_J#=C476Y$S[]]>;>[XTTC%X!OC@X--K1SEJPIW4DC+0E@E!2ZXHT%H\FM0^
M/K+WKVY4J86:6\OZ>E1FN-RY\_GFDF\.?GYWV[N\[75?TT=:JO(*PO#Y6'L^
M%N=Z^S^FT3 ;AD&.:DW2.B&UQW;_M-$W3:-^3%K]Q]D0'3X'T%F0U&Q\K@5X
MUP3@M:0L1%"N!?C65@O+M9/#]@D4,Q<S:"M'HRD"6A:?:">MP],\OW=TV&ZL
M^[W-\74/JFW-M=U9/;!:V%:0^#_JVI!QM^)O]P^772"2.+_L[NKJ^K9S>W[=
MN>G<7MSU?KU\N+[EQQ:*NR"=Q+.<A/'3&C\:5#RO)5[X^%Y?+:62V-!!"W9T
MB$FRM/MGV1/-TZI7I.>^=AY^N^Q=WUY\Z_8>_H@Z[*+3Z[S[%-S;UZ*[B0[B
M#TQ[ID0]$DDZ1Q&?=[YQ('<>_HA/]GNX_-)YN+B^_0(P_QW^.KBYN_L-?L8/
M=-]]FKZF34\$C%_4YMZ<[MT1%U&V_AE1T[3(&[IH]0(RFA<4D-Z\1*%*:(7-
MS5M"[7<>>M>@T>$?[?I5N.5CBE=P--,DN[Q/ES!E[8Y.#FMHP;B&EAS8T()+
M2U7*M1E,4W/Z%Y0/:SK,[1*;.NQK/)4#HL".R6?:,#?(:&GUE4WICA3AVK4.
MG^>9H?B-?2UX1YN^)*+GJ#;1ZSEKOT8)4737[Q/&DPS4A:^Z(,7+E['(]'*R
MB/ FA$ZC:.BL5%7QD#9]2B19HN>T^$%$QJO(^(U,KNT@+0BQ?PB"YHH:?NN=
M/U\;^*TE+BC1GVE?%#O,90@LS'[QU)=V.O;$OSP-]C:[V#G,KW\?"'STB0_:
M8M=MH>L^Y]AUY\'N)>'9($+-7H/">00URV>'8H]NI4?/<R4CWT1@NJ U,*6\
M8[\%N]#<\[0O,;%OM].W%WGV+75_\"V/N?><8_<U2^CW)+P*OB"51(.H@0/4
M*LH!RJ[6] 8?(N3,#>_E[!0U3Z*!&F4IFZ=O]"L$,(Z8?VQJ%^2)6,XXN18C
M[F/LWW(Z4/$9#W=0TA,ES]B59?6<[A*GY.F6UO68;W@^(SGV:/M(^1[-TU\"
M5W<,14SVM7M+YY-O1!KI+Y\*'9QGOQ[OL%]WZTA]LQEQ'0O"^ZZG]_M\*T8^
MCRERI+@M+<:5RJS8](8F[FC1K9P]J?8NU?..\\ECOCB>VJ 0S7@:_P/A]@VN
M *WX&<@Q"-J%YY17K6[\H- $R04*_%EQ,7ZZH.D*[5/E34">_O>TQQ^(ZUM>
MGG%S!;HR3U?[AH+E-ODH(N=IF+GDW>KXS"!Y=NQQ3?F.S3=EZ1*=&</Y(!G<
M-MTCD=]V0T'\+I\W23QC>>VVW-M-Y7L[3Z>\QX@894B,^N77E2WEN_(RS]$C
MOB<$O)]< WGI>A3Z-5]]O,MNW:VGO6S^S.5H;#D30B(_^ZAH/WO%RKXVPT>+
MG\TY(CM6WR'+T[>.^UETZD)78\>6U=,^3VR(DF,OGM25[\4\W6JQ!X%V+[:%
MS3<^.FDHWY%Y>LP)<YE?%ZH?].3I*8MS?[2[9YLP=TC'>79D>7WCK_J?#A.2
M&SJ6"9(#-^.!6'P]][W.O$F/[U<9G,D4N<C'1;O(Z]59/*TE'Q>N5/B")M[0
MDJ\4E)0^V>7XE1S:($_'>;';\U0(ZO=EGK[R,J[FUZ<X$V2;?2HV^B)NL $I
M7W;"PASTN>/;+K'R[-E=1K8[GH()!OGDL!^.L2ZN0CDI;!)F=L6F0\+%+4O9
M:9?+0>8\C>TYJ&+'HJ;0THF->#B?Q=YL6D:G8X>7TR)WX2W:AQ)L3SL7&Y#E
M:8I/:R55U:>'O2$1JT6 &3=\W:4]"#7U:9&:.KU>O9FE+>'EG!7UCKI:#L;F
M.DEGOB.U"^+IU%* MW)T9I[JET^U#=;YNQZCCW[.QE3I?LPS"/JJLQ\DU_ER
M2G==G@,&76*)$TX+RC IW8]YCAI<4 O5YQ;[[BK/0;L7/H1.HH5^XDSW\O?C
M[L.0>NVP8YHT6(2UF#2JUXJ,1;(K-[U<8.9(:?+F&9 $P[7A%'/LP/(%(5_)
MR.'Y G\DPLH.+\TB(I_?<5W'H'GG^$YQR<!V@Q.0*L_8GO/C"G4CWSA%_7EJ
MN4YOBHZ). ^.GLRU*W%!P%;7=N@ON2M6]7LPS[#E@O*S>FTS&!^[U\7!OYU!
ML'PZMTZMU]17L5_R]&?C@Z$>)]&$!NS.K7;GKWF2-#RE3YPF<T'=L:7GN850
M%;KS.D]V^H\N-:G.)@5-0,CJT)G3]SZE'.!B6+KK_O+N\\/]%3\JXS,_!*@#
M_XE/00E.^>$?'\;I('[&CC@8);X2U"VX^&Y9V7&Y"V<.::\>.A2 (D)+=-B0
M-E/#\,G@*):HDQKBL9E36#YH"P<0Q0>TO(\FZ*YYO$Q8Y]S/C9$R"5@__%]^
M1C+E.T _$7!%X*<5_@*%9UB.ZS/BZH^.[P4#57QOQ/# OZAF]7JAN<)-VY!\
M2WAAB?>TQ(MQM40)6E"$QLO(>UUEO;;+!3\YP*UQ>$%<@U%Q0);3[\;'W8L)
M8AZ$IWS7*&\RO3$/M4:A4-ND_HDW>%IL>BN<%<??BJL3O)YX*'>$K;X>:2F8
MY#Z:9#MM5.QH$IUYU_'9)%LZG*3<ZJH)=._K?#>C*%SOL&A\K+"]_9?4++JV
MKT57M0X#YXV!%^>&N[Y V7_YQ#:*T"WM<L.A=1BEP[\ZIICYZM$(#L7M=)Q=
MLSAY/[W(MSP.3K]^X,6Y"8LTT7Y-+(T+-C&/JS/=S!PALPYDVH=1LCW8(,\@
MIA]!IETH9-)K%EV+MNCC5QEJBG6[_>@P.JLCZNRC0CL[69_I*2(Y]^DN]]S=
M;9]VZD>=PXYO4H]O<4H]CY!@+4O<NZ\?[;BC[EU2-7%5BR\GEM\$F6D$P#H
M^ SZTB1._](;TFF_?RZPW^=JQ'^(=93\9_X:N]2=>WYXSRAP8ZQ;X19KNNU=
MQ;U\7F O9U4MOJI-+VM7A$2;1+&G8#,:A,'J,+@XO'PAH^#T]CYS1N GW]#X
M,,BCBP)AD%6UZ56-7Q:N?;2XI\OWB].9&1Q2-&<.BMKBHEXK[Q[MT ^7A_<^
M,X:Z2US0O%&R+X;(98$0R:I:?%58A_D$(Q^ICB=.!XO#.OT^M6BPVT+X+D.X
M; 27J\-@92RU'\B +]3BQR.<QW"Y*A N654+E_)JU-:F-_[G;R>-^O$'5SOG
M5>@'LU5BNY.[E2DU)KZ W\;&#@."?7'@ZS.!Q)<"$9%>L?B:%E_,^T#8DG?X
MKX=?X8FNWB?>)!Y7C'O\UP)[/*-F_*(67$T,A&*GK]/IUX=3R8$>!3<,=.8T
MI%AU?&47O9Y5M<28MQ9?UZX<!D79VC_!87!-&NRYI/6&NJ?=,_+$)[M=V^(H
MCP(W3BLS6((,W3]C:/RSV%0AKXCM4A.<P1[3!03N'8L6,F!4WI-] EG^%G?J
M;\5V*E3D?/((;GPXUB-Q3^*T @6G%4SG%>#$ N#C<:07C@M5"\?)C=BF6W;E
MKAS*O?=>_23JS4)WVN/5P-Y\4V^2^FG4E85MQ27J</DRI(\T][YKU-H9,],U
M+:H&[UN<E;[RK'1-V_OX7P<']P]W?6H1WI1;?P2.&!^%]_X.?_^]_O>___W@
M()K\'S;_[0880&%KU/SEW?W#9??RMM?I7=_=WEU=7=]V;L^O.S>=VXN[WJ^7
M#]>W5W</7\5=> NJVK&-H<.@1A_?\S(^)=_?N[O2XA(T*$(396B)0F;6+:SF
MMV2W^4_?Y=G&$*T1NYM'&4SNN)KO$A/Z#D)6>U\#1L%?M@'QK.=H/(?9J'UX
M)N*/^H?]Z(KO1E?VPBL]1FV>)O],'8\8P_"VYC"1*@\?^@( &$>W*#]+GKI:
MQ[9]<5K>V&$>7S8$X?-(:]0.KK2?$N_./!:6\;/F#G7+TD9$M_?F:J"-+4/D
MYD$I:&ZTC@5"LD,H(]G(Q#?",\_G:Z@'GV9!#:>?U%(^>;B_QPL<ZXR'^490
MX*%VYS/XD=CNLQ_;'3>Q\>=X#.3B\6.Z</C6#V.H!OQK\D=TPP#&\O0B,-$;
M:F)W8#L\)GHO>8@H?WUV@.NGL,W75P_=6)R<U9KN:I0/;9CQ0$>RV.2)6M/2
M@A,]XC([W<]1F7N\#Z!(W73&WK3,2Y^?@ PR_&;S*7;1FY??HO<. [SSW11Y
M%;F8PF^!E"P*)7%I>$/')1KI]WDRY8F(83M]6L$Q8=2!5QX)*#$;KNS]4P>!
MLHE6WP>(-5J'VOGKO0+?8>0OG[*@^M>,ND/-TI\Y>G@/6Y-0_+R>*4W]IH'5
M 7B85.PF2.T] TR,#AW(2'"B:S 2&;T_)WT0YE08T-J@F "_@ ;3&?%:>U +
M)G;\CD#MT1&7@=,/*A3.IK?)\U26>W$5PR_\ZCP3L'_[O!JV8\>;!"6_&<C#
M(D]\_%P E7!L<X7#'Y\CQ7YT?[F4]_JAJHBZ#%KF<OUM+HHX Z4@)RT#;-\.
MM=])5*3F9))Q+]'MT+)OA]U#[<*Q+#V<XTE>##+V^!<<OA+AF4)WB%>F&E0H
M!Y"<QU&FCS@2W0Q-,M0!L8^$V(G&\J]V]\)O'FH=RTKJY/1RIIHZ?"]28+S*
MX9W_CJ\Q 9!OW:AA^X'09C\T+9(3-7QW#[HHO K_-(]:'^8*G2,U_WG(U7G4
MOF Z[=AG8X</KO)O3K% IPL,]^&'8?DBDR94* N6&/7I0"PO$FP9,WZH5PB7
M_80PPP[A].+^!M<1/I^R"0_YMD7<9.>!@>2S?(EYJ*UHAE/6&F[1]?C:>?CM
MLG=]>_&MVWOX(_(X+CJ]3KJK$3R_OQ>]D? P^$O;K>8K'LBKSL:W3.GO)WM?
M*!/0CD$?IIA!N \*U!;*S6=[4 HX/2PX?)?3?13L#\G?#A3O,^@Q<=HR22(K
M4 .C,?&H0!> 4FR4)<H)RH#7^!=]KM#@53 D.O>6X)ED?3D<]WAISK,-+\8'
M"I+HP$E1(@O/DA6Z]9D ]O50[\\T8$!LJ*D%+'FTP@GH\^^[/GLBD^"JZT%C
MX L@$],W0)2!2J=@C8$VGO!WOJ96"2@+SC[EA]$'?!(?!$6K/^G4$@M#9RC)
M&_@#(B:+F -A%_B%F:I#_.&'4VOV8D&Y/G1 4EK\R;B<_6D//1*PZD]"CSQR
M Z.[X&Y +0+G*56L@O.VXP6\?^*+3VF@]<'IXG4C8R) N1><Q!RH.OA6_&+B
M&6AY7 )_70CQ8"P.STC4_Q#<(4T/]U3;3[8YL!!QY4()\8M)247S O;ZON<S
M8>]$V=R)XWUB$]"_+GB!4!]P6_\$]X"+!*)=H!+TV( 1(7W?#IV(\-1I<$I^
M:*9/@H>?N*L+=^#!OAZ>>#E%?N UF6*9W2- !H@B8OCFX<5AI.$#G918^GL@
M_C[3^,9C?/8D7\ZI706%A]HH,@?0E<[SX>:*XJV*)K&7_D@WR>MJ)'9A[&"!
M!^]_(]R_"?J8RYP7QPV@T%Z:&>YS(+H,$# 2H05_5> ]>M=-O.SR8,B,]T<0
MA&$!"H6'0[RH2T(X\7J E@@\, K>$6$C8/-U?^^9FT(KQ&EPG_?GM&Q>/#@K
M(B42N(/SK=_7)HX/L8SC6URUZ('FC)L%01.Q^H$[G5H]OM2%1U:B4ONQZ@U$
M,0FQ%KM%7'7^Q=<*1_R,78W(6>W[T-3(A9RI2J @*%?G1C2Q8K8,P&]J&W>'
MP#=:^?/.-Q[X=Q[^Z/8ZO<NOE[>]A\LOG8>+Z]LO5W</O\-?!S=W=[_!S_B!
M;KH#,"UJ+WY4BPO3YDK3IL7)Y1KT4NG)U9N;#,4\/H;.77<PV;X7Q^T TV<(
M9PXLQ_G!Z3Q](_)<>? 0ABH\<@_C(OY3^/CW8 =YY)28Y'<#_PP"B_5 N(:&
MP%> LWYZVC[4@E!L+DJT"17: 1H#6I'G$(7VY:$4$Y:"<37O[G&MO*#]N;//
M7=7!K#7D+0[X/>M.9+=95"6PO_[8L1.F-&FM1)YB$NJOV,S8P#GPFEUA3H(/
M30T-%XOKC(3Y"5@IOD0F3FCCC& M5*S;(N5K\:[F;\UX>3YCPNSN31T.J('O
M%F@XP+2+!AI\\N=^*/<EDC: T."L\(6C7JS;GAV>I>"QR9#Q<O:$20"='*(U
M[-K]R%J&ET?Z9/[2,[6L^6ODA6<,%JZ&V)B_;G#]'EV,<G6!UI]_E&_MP*?'
M+Q:BT]&JWZ/<ABX4/;9T>_[:G!2BNHT=;H0A'EQL"4_I^(M?=-]SJ%GT!P&/
MR8MB52TVU2X= ;H8F$,>A;H<^R(HS>C3O=>BC]"T[6N/OA=;< L^PLV2Y^S/
M,)'O?W&V662YVMXLW)S\QZB39JM5?^P?-4FKW:CK1XW:,0'IU$Z-QT:=OQ8,
M#EQT[Z_X7/<>+[NXC5W"4D[XZ$5BZ&O)<QGC6J*SCY9.2M!]SUEE5.R3<#H
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M37LYU:G+KIIE[*:!>^.'2"P> <VN@R==J7:-K"M4^%N(9&+FE9B+A$7Y&F;
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M[&SKET5C,LOR08XT4BV[R28^AK^WO7L+D/P&5!Y]XM2OT7S8?6,PJL,B(CM
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M!NKXC_.+U^?_;0C-03'ON[/)UTKHPH; W]O#'+UG%P7ATMA%U+&"+,-"B%;
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MWF!RO=IQ7NR2PES$_(CY<KKGQ8_?OIN\N.#Q!S]2QAX69/*M!?R\@VN^0B6
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M!6Q$IF3;M=9Q(@]4ND&)@GN&-@X/FS_;0TLH'TG+ED+FV9F&\I1H,1ZNF;'
M&:3'3N&^RL7,RBW73KJ.JL[PH&Y9Y.$V+;S/QCL5!D9)#XUI.G$%ZZ8D#6PC
MV+8.D*]V*!TQ!:BWP,@!(V:ML/Y0&RQNDW7CI&?C]^#B(ES2PM. TG3X"E/;
M;@ZM [[N'F?!V>0[M+X-JZ_?KLOO?N6WM!T3N*"1O)R1.'?:2I^<B>E0=L\Y
M']U%F[%CYZ#A;%!W;O">-97WL@M\X"%U*B<\*Y;-AYAX37M<7IW0!.;.O@VQ
MAE\S"=2(IT2'YQZEU28<?S6KPEK";V4D?I4)DOEZQ/>V@@]X6\*Z,UY:Q1#%
MWJ]-6:K$%,GTL2!VQQ1JN\S1Z,4L0'O(=@/JM',A'I62^R2.WNF@.!T4IX/B
M=%"<#HK30?$1%=UDI&_*L\:>OW7L!GZ/0#<U-/NF^6/0$-:#>FC>/>?]G>>X
M*^WD80M,PQM"F"S'HV':&G*X9250"A+H5E_I30?/#T8:8_K-&[</;XS),2^:
MVJ-=+7\KE#4#_GGJ+&N;:6(XV6R=@()K3&."1T(-(MF#]PE9_*5H^[NXX7O=
M.^^0HHF3HD$S9Z:*V4@';D,O#KH.)L/$)RW)N#LJ8,D9@B3<^K3ZU*>>TM$8
M@@*UR(P[OC3ZP>$W_;Z=04>=R87$78*W<,FZV>A]G\6>4(U'J=#I&#'#AX%>
MMFKM4?T8:GBA?R'#$/^#AB$S/YAK"$RX$V*&?#^Y:FXG:S@ZSR87-4B$:K%A
M/5+E#+JE8]0>NXEC]SGXI].KC4?C+BUMU2AV$K9ID-NT4,G#72DJ*_#9Z[WI
M8ZB@IT M__^A75KSS/?9)$3ALLJHD!JE;(C-9P@&< =@:^]D6J#MI^;<\43(
M-1WNK9-1.LSMY EVT_+;@AELFGXCZP;#*#QR&'<)C6I+#];FH->;*T4M?GO9
M+!D _<BTS7[,618(J.33IJH>HI#NV_#X&?3Z(QH>!T<:'CNBAI&&QYA>HN%B
M R?J8@XC?*_WO7;JUKJ[?U^!#Z_< PJPXC*>SXLHUF&4Q,MHED>I7F1P^,[3
M4BUF7VA];C2#U[YOM<7G*[5XAT8SF]8]VYO:/.?[07-JMK=!.@>MJ)W2%'B;
M[1R9P]Z1+HK><=[5)I6I5EUC1R0]JO$.&\JND(['WM6@SACZUF]@W0,CT6%G
MDLS] 3HVG"?6B#U>BI/EK(AUGA;SL(H7.LK",ELF19'-%W&^++Y0^HG?FA1S
ML(4!IY0QQG^LI2M7#YF1[SE$0DS$-M5'^ !]V5 K&/@&3[D2E*G4'CGN8G.%
M =O8X7QJN2KB(LI+T(Q:S^.X"M,J3W26Y&$ZFR^R17F2JR?(U2L;MQ/S2PI$
MO,,;)00[[UV 3:>Q W:<1G^9?/_FGY-67==@XC2@$E\VU<L"S310>]O/IH(B
M7<V*698521K&RU*GLSPKXS2/XK3,YY4^B<H31.4"74GXW*&""5RV.FAN=HUT
ME_^F4XDK7>F4(Z6"GE_3=^I(TV T#EPV9E!<-1*)/:AM]970)Y,IE:;Y/%_F
MBZR(9TF5ISJ;+5*]S$' DOP+9=GYC<C4.S;C+5WD@9^ DE&!>=:P-\>2PM2:
MX+!H&P TA:+?_8!@ED+?73G[&X@5>5 D@W_B.(XFIF)4M?S.P;HNV1SHA7J4
M9XQR7!:MAI>=NF%6(J\7G%<)T+.%>Q;FU-BNM(<'UG%5=5?@?@>>3^C%]NE6
M$L(F1U]NY-NY+J]PIVZ@@(L"#7&K&:S*ICR\<RMU.49Y4!-'D]G#P)F>[)N=
M!')H/DQP821N9EHF"KNO'X1=-9O+EU1_PC$0$U>_;,"&.IN<^]$'N2[@Y]$O
MO #3!P,)QZ/>QPL6'Q-?^)W#N,+9'P;']?B4PX?EYJ!7M7^#L>=(S83+.]U1
M3RUY\"X0T?>NXESJ5GO%2P<=\"AAW%@TY##:VO./38=GJ21XQ&O]H@,L]"A<
MU-VT]!-6V\/2Z[.>"'[B8H=['3BX5C)\5YE-\0NW%&NMMQQAY1^:NO(>RS!-
M""\G*C*+*I7<AG?<3$'/;RFTO9(^WLBARL5-4NKT_/2IU3*KRODR7NK%(LY2
ME2=9LHC"*M?+:KX(JR_3O/O-$)U@_%4.5H=^]K(R$JT8B_H3'3^FB>IBMU)<
M,.;;#(>7#+(A]+4=#L?\;*/=CL/6>=UT&HR>?H+"640>M@6%^'*U*Q!JOFXV
MV'.&?F&O<QWKZUXA7WS8AN11/LP3&+[FBR*+DCB9Z3"NYDJ551+FI2[""CSE
M[ OUBW]30H[)P:DS24N-D"%F_K/2+^<3G7LF\[5% ]!T!4>,"WXKP!3$EE"A
MW0W\Y+/1PV75/-*)FE55%,91FJ1Y#'_.DW(Y4_-B?F*6?+KP$.J'K1C;*01,
M#+7I) 7'<"^7)?VH(?\GD(Z&25'E5;8(51KG<9XML]ERL4SC^2Q/%G%^$HV/
MH5=,)*T#!]< 1UQWGH,6#_UF-_=N(/B,8@):HBS"19Z7D8[GRUDZSU.=SY:S
M*I]GB^AD8WU<,7$'CA2EBLTS6:G=ABG8,*9O$D6?CY8ZG(/:2&;5K "K) _S
M111%1;2<Z>4"K/%G:;;Z!Q,+:8\&YK M*49>,0*_X/DREO;Q=<CT*%3F,RJ3
M(H_*:AFK?!;G1:DJE2\651Y%L4Y5\H6F W]34C-FCFQ)FCR39 2[K'#MMA]H
M\/R<HC$+BWF:I:!$5!RI)%5E$<W!JZ\2,%=U>A*-)XO&6H$#OMV59(B8^ _1
MGI0UQH0^8_>3,LJ683:OE([C957D>55DH!]RG2]U.'^6[O9_H,5_Y:IMK(%)
M 1Q31#-@O2 T25EC!4*^HWH !PUVV3W5;C<.8_+IA6:YA).D*.?PWRJNPBP/
MTRR'_P$=$D99=J(^_UB'2;VY:58W4DY@XQR$[MR P5$PK>B6\9A(?=W6>HOQ
M,VHL;&!+I@Z%2'&*SZALPB)191YA[ZT<3%>5S>+%8@GV[&*QR*KGZ>7\AY0;
M113I)@<!4]H4-1&@D'YAB0&9JM  T7T$_79_S25RR)/#+O!GDY<H+I-LF6<J
MFJLX7.JT ,\WRY:9+I6>ST^=-SZ6O!A^'.K&)P1+SB&>]DL.T7014NQB#WY/
ML2.&F<\?5\O"I)Q'RVJ1JWD<)B V>3X+JWD^G\W3DR'[=- C%4_ZR9L[JE#N
MT6+A&44A5I6>5?DB7\1Q'%9@F>1Z$45EGI9%5>:G1@P?(3]I*Z"=N^LJ32BI
MU]5<D?91I>!9\_EOJE[[;PN$J#OA6[=59)W6[QUM/%?Z;:]:0I^1^E1,^6CZ
MU9OS5<CE:M/%G*_(U>;])+=$W%2!8YL43 Z;%-B1!6//=,^8#N_<[\9E2]G\
M(L =,;=UH.L[1A_L#UH&V!7]X]!:A>$?!@_UD>NRI3H:K 6LRH$M4-9H/B"S
M 7O&5)7V;Q9F[;G&#J^'U9E6M>1ZHZF,$NM_-=&T>NVM/;6#==D".4(8#C:F
M]#:W_U,#A&6$#O?BYN)%8:(8(UVX4NUZ -@4[.&76+5XWJ?64^WV$#;*4[Q'
M\@BOEM"?)Q>-\+"PCL[3UAKN91/*QV7I2LG0.$!OM&M6.PM.)6RR 2WC\15&
M?P$]@\SKS#9CU*W>$"C5JUS$:F^8$FS!;AI06SZ&/E9F52._+XD%04G7R')A
MD58#>?"@+('W%4H*%5]*<-<A8;B=(7[^"]P<:SG9ED; _\;'UF Y.T:%\*?N
M<J&KG/ATE>8]P-K8(J('=@@WPOD N.8%&0"SO[SZ[@?Z5_B7K\PTG$U><]B9
M7@(I>%9=XR X/V@XE$%5K&&?O:[5Y0;<@[KH3!X$CPN$C@=<,J4[C">8S4.X
M7-Q95["?891L$TY-F2H]R @%,;AN"@8 $?2<75,JHO5F&Z;HFVL0V6M"SOV=
M 6]?XO;Z09K/$?;/ER0"L" /II# !B(G#$5G5MS5GH@,]I*(M'W+J$#-$(,(
MJZ1?M]LV;'U_@.7 PQ[Z0PM&(-RT5O@Q <#OHJ2='JH],A#&0-;(C.#4JS&A
MS)X.3*N_IF4E[52]UP;8=2@R"L2,A*ARK$<BMKGC8_&Y7;P&8NXA)IR* =@
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M\"/M(Z3, ,<5^'>RE5Q2N8LM12_^(SH+W4@PJ 3;FKV'-^<7DVB.<Z3-^3C
MUQ_C\_0K&>">@4_-2=/E2FMHXB;]\Q1K,H1MO.<\''"9]K2JW>7.:VKPUYJ$
MCO'C9W>8GY].N5XX=6>UE2$T/L:WRN4@1JRG@1<NTYTQ84H-8LWH=)R NNVU
M!D.V(%+(-0?'NNU+/G]MD-44&MHR*<Z+]K2)Z+5!RT)P_O .^E>]OMY.?3I-
M\B&XNTEKN34GZQWV@M)>8(3:\#+'$1I(W.40@Y]VBDP* (Y@\'U=-99_3AB*
M>3Y8NL.K;2)"'B@*'X%PW*IUEX/F]YUPEB>/!7('1F=;=\IH6F8'=/RA_/UV
M?Q:\._S4Q.;05*.I<=.BAT.N>@I42C1;KG]P.@U['IL^A-8ZZDU[8*:]OVC4
MNI=Z);H3I.N7&\C4ZE(::ZW,Q."6&EODSE]EKE0Q2RS=ELU"@!QN^7TVC4F=
MFXUK"X[.BZ)IN<4A=76\U504T*N(0MM"SG$S4P-NM5[GW8 [)!I8P,&Q<Y^C
M9BIM%GUL@!D/H2OMOG*+2?;U)7;JMFW+ D=6B[K -_]@?\(. 0.]97&1QI@4
M@/%NZM8'S'TN[;$C0NL"UI/=!L]Z!PNMDP)([F]-QM5HP<ZH03YUO/#<A/.N
MKK"?3JEZ=.K]#B7DX]?&/!>;AHL8W0^";YN&A?QUN[L<1NE,_N7;U^<V_^)M
ML*I?R@&_\KZE)U/C3);UK6E241IQ]Q84]+JI'AVZ3/UFYOTW'51C?N:5\!JQ
M#H;IRM .%\7768$WI2:."G: OE&;[9BJK4VBI*&N*V @M\<RPI\3;?#*-7MQ
MC'YNGSNK96V[PF,8[=HT!B>FA/92;>3P,5U2W>9VJ TXN9GB";ZDLE=7?FM[
MU-G30B)B?+>A)@B>5*?\3#+V$V<NL%:TX%A2";=H]Q3JHV#;)1CX/6NJ\&<_
M<$CW_K2YF5Y1>O*2CQ"W2H(E=GF+XW/>#1O4^F8+;@^$0 0'<B P#0K/V'2F
M\"_=+0]GD^_NEI?M_EJ<M 83*&!JX3E$=A[L.O*]=QLVGU8*_ 7>9J;M/#O:
MMG,RAY_VKFV]@A?=E"ON$07#P#?#19#&ABX,9P\Y#HB:8X9.IU:;TD'1WRX5
M[,@O<<P@HMPY6?I4P4NY*D-V5X[,UK]=8,HL7O?AWYOA!UY_CGI3K79<R(PF
M)L^F_! F8\^DT$7=\>I\:U,UOB+@3.10#]1^E;H1 YO9H9$&1T;:#0)VO>K]
M QEE@>ZWDZ9%T&9.L.$WMY,ZJ/MG<Q3<3#1+^F),$19S&W1%1$SL39P8D&&(
M <N!ZC%=RESAL.WN/%)#'!PI(?[\FFK;<AD_1NH[J?TI27$-(0RLTPIV2? D
M",3--A0$4D#7,VYH6XKC0[,N?O?DFUT+LS0EI>C7\OHJ2XX'$"SOV6B_8Q+$
M8VT(N#%(?:VDHGIK57!? [MUAY5<L:QA3>_9Y-6(V!]]Z-@>>=A AF]=Z5L,
M?I&!?HW]S-#HIHU$FJBAD+;=4/0+*H4GW;#F3A.X)<'9(%_3'!#D5;FV*2:\
MAH\GH(T:O LFA8QRI:#D3V0#N@EL*8PL(4\3F\1C"/VKZQ56 1?LY]=8W"PF
M(0YGQ9N+<#4KL]<-+]ON85W5^QN_\NKAF51CM:)0E;35@,/#4#X8>/03-M[O
M/:D[/R5U1]1DZ;&&V-U0\QYOD0>;PQ;"8^+L H.58H 8"S%RKWA1!4\Z,5[F
M.6S?$O!?8=T,Z ;UO\WX\0Q*E8%#O;T[,11:ZV,<'ICLZ5GU9,B@Z?D2- ZS
M.3O6"-%FUZK;6G@<!Z19F:%:+0=6$>Q.T! [T_[,GK\CKQWT,@]W,2G<>@1?
M@A'T"##@I?X3H7_P+(Z\8#=(L,N8;HF]#!<PHW$(+3%-:$LD$LS,P,P_/F&8
M%\?)015;*@W6D:/O:BVK*><O^@O(IV_?).*L4WM3WQAV(6)9":ZX6Z>)TSAS
M M._N]:P[/19#/N!56/,$'E/)^U[K2+G^#P^WDBXL8*=;@X^J)L'GGZ/3.W)
MV<U?."3:<\V)R>0E'G+6'1 1,\AY1$OQ;,"K@MF/BVNR8G 0K8E:6-W:-^M<
M*-;$Z&AGOJ^_".?R'D/&%MWH!WQ=(S#ZROH']C482\*M8C%6FS<E20C^^U)O
MO( [B-LE,S%?XB$ <I>+RWX-:I<KN-TH6%Y4Z_$A"!C1HYLY"S BYK(S?0X8
M^.K[KR?GX2O/ML83 <,L>Z'C8I\* X6].6!V&N.(@9VTVN,>G$[('VN;#:IO
M(JX!0YT:OVT#C0$'39A@)QX4+*-U'Q4N?+_=1DDB<;=!?21Y#C.TMC<2Y9;'
M/L2C\<% N'%9B2O('AL-F6ARQ=3[_:#=@LG0HD)K&&S! W&3@PT;C=="[U^9
M+()E<4$R2*R8 -V"$4>A=B3E8A2K[^A*&-=$>CA+9'2TI'=\;KI>@K9IW]^_
M+N*^VT,008]""#SNJ@NOB_DP>. 1YQQN@BE)$>83,9UN<M3,I=7VJU)PY= 0
M8*]SN'9TKF_VEBG.4&C!:$! UYU=$:^&T"?],1$):T*+G)<!A3>=_-^ SL5T
MPD$LCHXP2^W4"](;J V3+2,::'W-KJ#4 XMK/NB U\LN2>@@&,SR9) ;.#J*
M.[B]#,T3.^XVZT^D;K@9*+5+22(*G1NE&!P&>CLO(8>S24&'BFH"5@33)T>I
MM_E[1Y3;\+UW/+;1<:B!'2IY3;;@>N^1ZG<<\/94FX!/>&M;C<;V*:EMRD^)
M885OXK_XD0BW/4T-+98LE7=_6? ]BQZ:7 5&*)GP7Y?^C7MU'%(H\>LU^L &
M\N[&4(C98KK(!K>JW7"(%)%GG5.92+FP6A&[CRMK@''Z]I_[=:?K?V,(BM)I
M#*ETY5R35ZZ6G0LC!MEP._\!HQ;[(M+7EWX$S$) !%%A4.(F*RNB.';3QF,.
M(]O4Y[4-T&P0-MS:T$F.6$4^LV1/4/IL<:( 4/(DG.)3]Z&+[_Q[HY7(V>#A
M.<I*CBY@KL^M=$T/] E*_:;#_IF*YSBZ^H,"23M^\@<PRHN;J*'T+CG_ 6L7
MTCX4F:4!H'#1&Y?4B[IK),J!@S)!*7G/#E7%^6;/"\%7/R1\88."]\I=&@<"
M7V'*I4]2H%B)Z]$W3*CI/:;T7$J+PG$;ZJI\L>4") $72-%BP+Q_V#9WI6Y9
M#NHU_4VS0-Y,9W:>X98E(L?_!;W4(6Q4+ EQ&-8,4M#>+#(4  D)+:C7$SW*
M'Y\%7/8:3?L'5MD'G[!P",:!456B8YFJCTT?T*FVU)ZBP"7/V^!RNP*>YQF,
M>I[NPHZQUD:[PI-WK784DTU1T*#\?"B/ W=R01Y</P'DF)$P&KA;56Q1!L:/
M9&B@.\N-1O"<8-QWF)CIET ]4WOQA_@KS8;;N^\V#M#GEWV 7K^^T@JQ-]CB
M?=7D9 BH4@?,W^A-5'^AL2JN<D$66RAR@$P4D">=_'7WWHA-S_%@(?5,"+/K
M [/K<=$OFZ;L".@SM4K*ES<QR%C6KRW9))WWM*QT2'3%%2C.%9XE%BCN$F"P
MOF+$7Z_41LH#K<\;$#85MQYEL-@Z=_GZ,;4.7_8<I6G/*#'1 P.R[_M43<]X
ML+4[\+(85X$?45",+ "CZTO=,8Z)BM1\4;6$[./XR[/)!0X 7"O_K)+CQ@;/
M?$[DH4$8# \,-)UE[U!)J!C/'P/,_'N/!,>G2/ CJ1L&<BDI2#&1T-9D<!=L
M%+6]"KB\ 782\E[7&SA0]U,V_%<5Z$P3F#-F#M<D>U%0GUJYCT]TO&'>R6W/
M:+7QHHZFRG@?4,*5$6)L7C- [)+ZXHB];F&MS?T+Y)[IA/G%H"2=O^Q[&N+!
MV 3_#S)#KVF&@G=VA@R0ZH?7[RR0JN>)F+2F;T?93!@H0P]WR%5!3;LJD<MP
M*@8[)_*_9VC(6R,<#H@9G!MXIAW,]V_?65C7(!_@2OA[K_?ZW6"M#Z>'I<)W
M[_ P@=..J(,#:S-Y,NRP\&)(]82Y]*29FAKT9)D B>/WM/+-*,[IQ)8-V6\"
M4RG6(K_(5#"#4I]T9&,=&<@ 8HIIR#YL _.7%,[L[2*\/.!T->P86/YF8UF6
M<&JYF,M5U=J?PM/^68-+Y%'.#\3/+#X!^?Q_?_/S5V &A\O_7,:+KXP@MUJ;
ME+N90K2P+QMA@<$5YKU.!7 4'C&@9D0PH!9QD7-.+("F>;]I;C<HG6KR#U.(
M^'53PC>"0^85<1-%!C+"/GZ%2UY]0Y,Q""+Q*L!9004KJ#/6<B S7LZ\*45<
MR&D!>Q#M@)S*VYR0HF2:5<1XJ:F26]F/ R.XIJ\@ UN$JYM 0#0FS0*Q6IE1
M<-Z#%)G==R2G&&GPO1I)B?!3V+9O[T_7_VQJCU:&>UI<P3KK#;M0TSXD<>PM
M:0\%%;*/D%#4TK(39]QV2FM-61_\FS)QRI9S@Y5[K:U9B\S_7>?!KEI>4@<[
M$.[Q'NHW1U72MAAF1'H"<?ME"XT-&K7(=C(2:T:5,A!<O#."CK>R=./#_>PK
M:)CL<=ZQ2\7K=[TTJ^LQL6%0R5;>&/21YUAR(:<I</?\0R_>*R$6_K8WA<Y$
M\,X#JI%7&WM&#$X5#GY(;"/@^(?;>WW39X "E3%;:V-R:&U,/7/#?F1.4+>6
MF!'?E"9BB(Y38*.4AU;*9UYKG*^#-YU:&@PW'716VC^G^,JWH+,"A7CD2G/Q
M,LPP*+(;+;!$C-CLZNV4#4*W-]!G+ WI@OA*-L(HU5=3CG\J.HX-[[-$_FRP
MO!=$#PSEE6WA,"BH[26F/T[?H"=W:>I;R:Z'Z(!4>AAZ-ST?GDEZQI7"X7BE
M(IQP3D0[CYA[-&FDW1H+O2G:QZJ9S8%S/ U<VQTBXK+1";',ZHY9@*S5+*85
M''Q->]VT5HR\F_?[DY UYJP^_B4V7J7;=$SJ$;@V;;L-BBW9S:5-;K#UP'5C
MTW[N8^J &U-;<;3K".;VDU<V.H(7,4>.*VE!,]?M*'\ZG'3(QNHF.2%I0)=@
M-4^'H>(S--U46ZZ$ 6P-FI:2.J0-"6UB"N8/[ROKR4U1K&Z\;YN,Q[>/G"^*
M+"WR;)$425Q6F4KF\R@NJEFVF!4J"D_M(Y_4/O*U-M#54J])$PX*O#Y;"]EX
ML5"J3(MY7H1Q.$_S*%/A/,SS=%DN9F%Y6O@G+?S?,39L2M8^VR*G2V2?+G64
M9$F<)CHOEXLP*97*BWPY+[+3(C]M=_=(1&KZH_&-G\^V\+#BX;)(YHF*Y_$L
M7< ^3XHRBE48Q;,D.:GUIS:('M3Z>RWD/V<SZ"R<Z:K,\WF2J[B8+52<S>=+
M^)]YDJ9A^2S=%_Y R_YZO">.\Z!L4YR/N_$_=GA!\JF'5FB],68R%AU3Z88Q
M6'IF=Y\%=\@(!I,#2S%?Q']93)/9; HB,'GQ\\5_+*;+98A_?27$OYRN5 6'
MT::&[OZA=T.[76[V$N'GZ!'532EH<WDA@B]TO@N%T6E*Q5*6\1?MX:9Z7?XP
M0KK>]*?'0+K\LD/QI0*;01Z9%QAW@F.FMR"N2"0Y8V8V$B#\Q=+^0EU>8E9\
MJWEJ/HB#]RS+8'15<0(LC3K1>Q%+,N9DC2/CKO.J;.\'8G'XE![;ACK&>S8"
MV_=9VP3:!![HOW8X!\2TA&=L#T71YP<Z6A@0F"=0;T9"03E8&^-W/C-%UP%S
MB!/5 6"MOS(<<@E\8&4/Q/#HX,LS::$?>@D6>-FIT 34H&EN3?"9":[DWRX0
MZ#')*%COS4L.5M(J2@$-1BO*5MUB)$O9$!NE=R:=JC0BSU;:<,AYU_=GV9'7
M7N]:@AH2.(GOAG3D;C>4FK=4@;0?:RH,M D'G]-F:B">%D;?<>BT5V;M,G"E
M11-AT@5FVQ21PRT<7Z!:!3ZS /.$(+C/QLDI=\(A0 KNN]@BOZK KBRVUN<E
M,[2'-T)/=?C2$G'"R E<P$$41-H,0C74ST3E4F39M/T[,]C4+@'.-THOXC[<
M-C4X'9X%VVRW4)V%M,'$T0P&XV]O7M@0^KA^WHSF192[A7!:O:)DJ8R4Y#T-
MJ<Q*<_]K*;>XVL';!Q@PXT@3YR4E036U"M2P I@2_<),IL(7//>6^27'MCG1
M>K""C*M!T=I8J*V%L39M%["V8!2:XE>B()./N#-8W6ZX=+IM&P3.KIO2AYGS
M.O<75L3 BT%Z<A+P*<R9GW>BS)K1X*1,6XDFEPE$\]$S5&E>H1,?4YLCQY.]
M*G#$0]Q]8(0WAMGN4"9$>(S6->AL-*3=9#!##;]0[B5P0/CP'JB3X*)P1D4.
M-$]JWPD''"?G:!FI?)!5WE.RB;]W&%+RQX8AW?>D?>7:L0_+1Q!RJ3P$$<A?
MTS(;^352K?%9&MADFR'?HNRY[;ABVGI+\2BWB?"/5)= -&VCW;6][63N(2!'
MH["9!KFPQ1Z^BJ>-16Q3=4?<L9RG(,WG-RKH9)/S'4V] .-=*+%OQ]^9+8R:
M5]*2LC'59M/LI$%WT+>\_&07C:#/OF(X;/L%*)BK&-C)]IWX]DBG.9*UY%XC
MBFB> _]-M-4_MYB=W]K.':Y!A+N2%H:A]W(#.I"-L35F%4G2U-6N,FX$AR%X
MB(-L)JXWO0:3++1DD9H;6GS2$4.BO\:R?,PUK#V2L:DQ]+EK^J!"A_A6+;\;
MHH(<]9NCU,.[B?'H5_]J_ZTHA(_'_-GD0FM2X2S\XW</>(1$=->'G\+4DF/M
M5LS>NAMI]OZI\HSW=E5^(K>W!3>,R5W9S=XB21.*"V(II&H$<=%$NLK*A0TM
M\A/5BERT[@JAN#A3*^SLVR>O)0JQNB711V2QUUZDSX[Y990*_F(P3"WM*>Z^
M8@B&5]13@J?&[QU#<0]X7]IH!Y,8^)/([HB;D[/)=_*-J^)OB3D$]Q,"$F&4
MU<A=_1H/(@5RTVR&C4+(,92ZX,JA0#H,;C15\EAB<N]BZ;O02,F)P.[/)C^2
M%7@P#7(DX0-U:566V-L;<[?:])G!C^RS @L]M,@KLM:<0%[Z<W/W+!NA=%7X
MB-OK2:BB<]'0ZTXLLVYP"]]@2,=RTDY>#'\U_S,QWBX<%?[!3R+ZR=RQY5NB
M7V:@19'GHWQONO(X/@6?OB'@M'V?GM:QYWCWL<IW1#RE4-4$9@@;)4Z-M]P4
MN,)HFW7#*/1&#E!P.%6H9JT:H)9>8_M[5)5PV"P\6[A)_A]\E)W<Q!$6?^6^
MB_X<$'.Q-_,#OX?<#2/F!]O 5G[RL"W2[2$JRJ+?J'[7:Y(DIXVCM)L.RE,L
MKQ@Q8EWQCJH9L>CQXAT\L-EM5TWS?F!9R!F'@!:JN#/'/X,?99Y-P,Q9:,:@
ML_4CDNEBSMY+@B;I7W6Q,Y8!#4& 9722"Y=83\?3XP(W=9VI(S?Y%)G*L\DK
M,0[]WWK$&-ST728"Y\$;&ZSH94-E+386QLU3!?+'<\@D'ETP;*Q@*(GLM7IS
M4[?-AA4OE?G=+06/*/W#7EV>^_FQFE8]_J#_CK,$VG1S]/@7K?X=>3G+_!EX
M+_>90XX_>V5F(">7=[^9C4%+ # X9.86-CZA3.'3I][<*),<^OD]LEUI#,N\
MPY8@RE+NO^E:I5?4AC ,_S+Y7JT1SP<JBPNV=;<E6Q$UKB#*ITZ%!S<-"JKM
M4L!E@Z5?1C?U0+:D_2=(T'^Y-Q5IW'V /C%$9P3!]2OQ)/IFXVW^EN!)VP=>
M"%I6_ C"Q0(6Z1@]J-W%>#[[]3Z5#F](6)"K^KIS?IWUK*:NP#60B2B)1MBW
MKER4R"/B@??])T^B'A4 %NL!LY\P2O/K^BD*^\/ \^W<<WT^<V&)D[A3(UWQ
M#GE5*>QK7L[40_>[UHPSGU(60'%S#TI)@V%0XD2C3V2J8#:&*T3_>FVH57QZ
M1/,+(^:>=8$\Z?QJ6(9;,XU[J?-M)Z5)X.@UIE(;%H0BVNT^<#SP\#H_>*$^
M]\Z&QH5[M,##.0HK%'M41E'!.[08TN^VIH08JYI77H2T,T!U!!;*+2R/.G%1
M!>)>4N^#@34P(@Q? +'/J5#VCD+9YV%,ON_RO*GN.DC(BJJ;=E#6C0D>W*=V
M]FQC+"].Q H5^R<Z9<;!!IS3B<>M=D3G&M.H6S6W+TM.JI&P2+<6H\6G@=$T
M$X\UN%?4/H!#;W$&T/HDA>N*GMB"0RH7>.56NB';FXAMYFE^HV=*M7^Y;5["
M_PN(-,_$X@Q375^?TEVQ%(N!!Z[ @.LC]FM):Y,B6ZV,N5>1.O!Z['CGB&&P
MZ:O=8$SM$K>*5;K&SCFNO,65HCXEV$-Z>DQQ<^[3FQU#/AL<H,]YM^SD3-QH
MU/8XWY;G>'I7K?;9Y!N,XUH\-R<KM6D],R+'V!2,W&V.XU$3'Q&V(V]-Y'MH
MQ8 1<T4!N'Q77IJ8D'33WC;FT/<X3.DV<.!?D^ZG-F$;)N I,/R*?(#<C(Q#
M9^+["Z<]GBMV_"CW)/:2P>V05.]2"@"9!M!C/:$LI+D4O3UB(CGU>#R6?5G\
ML;,OC_>H+H:'L:\@O?-.;67C8X7AM?)K4DD1JT+H&ZW>]2BYCO[V]JC5.&#;
M^T3D^2-W>.L@,!8C0DW/Z1APKP+3]76+P)$WZ"A@E?!?U1J4#E6MPBM\O:LJ
MM6JF"& ,_J=IW].G?\/SI9N\JM%+^J'N,'-<(PP(HX:NP073JGID$@;&;4I2
MMOWV6W=VWSJ;(+2'[83 <11N^ZUSF+>HE1S H,\$&7D;*R_BBV@+X[)! W=C
M-U6'@2!6FF"(!!YY(G7]=4'%<7D2Y6YJ9P<<2QYY:^^];%VR=PI1]W?+%X]I
M+'"O!UN"^.J/4?AT/G>.[ZX3FX\)<1'UC<D[<F(1K*R&DURN\Y\AA,5N.SV&
M,HJ!2A6ET)7X251Q3^QIC$?0Y0X30%O,0F%/%H3]>1N;2:_/)N?.]> UH?.-
MP6MZLF]VP3%\G*7[LLO_+ZS*Y&WA^I ,,B5](6"99A+?XVRI;%PA9L,3#'0
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MQ5C+\6?1UW4ZLXY\!BV)O@FA$AV-[-IC2]74"YU:#'#CD#4SWU'_]<GNL9G
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MP< B@@NHG$*>XC1??5!-V)'7]+J $!%TJ56?:/?IESSO8FO2<5S:C55(,#,
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M1L;]%B;ZI%CM">\W\C-3:E\%<!W\D0HEBB5M.W(@5@*?5751K<0_-9JE3 ;
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M-,4K?S"NY&#TYS4==I8,.W+CXN:?^A0],A%3M7K&,@H%Q+C ()\86-^4C50
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M>Q7>JT:0[@H]OOS!S(1*.\\+WF6_LSZ\=I3L&6H>:.":0)X)B#5":U^MN:%
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M3Y,PG<RC:+%(EM$LD]DD.@G&/04#/826(CBZ#'0T "$I<-XUR.M3$XPEV2H
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MM3_ MC5][8"?@7:J^B 5+G32PZ5%+-4!!NZY_S_U=N\4"037AG4;0N9BZ1U
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MRL>[TH/;V](1K;'7ENX[;>DXAQ]>>=2)3O29FZY<E[\3\@G\(FUJD?LBAS]
M":P$IBG]Y4Z/!%$:UU*T&JY 5&*U4Y,E.)7W8K7%3+-:'&SM;?IM[[GH!!9\
MM.<>0-<0(# C8?*  73);2GOW-Y\ S.#.$E0,\)O("R$$N 2S2 <ZM9K*5:$
MD^_?J(.%(!?*'4"LY*^N_WND+.((I3Z]MP)K*RPM0DD:O A :##0TB!LHE''
M-->@UE09)-6I0 A9CPAWNO(0GOR1UACS"V>08%"G)4ZB;_T?7_[SF& )J5R5
M4O,&#8NDUN(=M+S#K;;SE4!64)H.1.!(80!:U.$D)WWHR4*=V(Z.HB0<U>P:
MF# 9>^)ZNP9D,4A-UF? E HU[]E.';=FVR)<DUH!ALL@\*M!.5?@CRP9 G-<
M%(T:WM[?/?5W!-5"_DT$#P&E@A<'X*#AM:0TBE+LH%I!PVOR#[Q7$/KCBLTJ
M<X>UV_3L4EP#,3)B!]? VX1(;X@+#6 9#2 X=$ &#&"HHD$\CDX281D^NI&B
M8QK&#JCAJR]33W8?>1R&(HX@AL[6P5;I!>]V&T*QLM2"@ %TA4JXIP_$IJ1]
M(BQFG4#T"(N!L!F$4A:@EV&UG2\PP+H2Z*($L"W J8$_G/MP!XQ(FD%CPTU>
M2>KRZWU?3X)%Q:/)51K2YCY+18O]T3WIZTLUTG=R9\XIT;+LUT2>8Q\*(*3@
M)]6W^*,E<2# M,S:X@0##QY!"=N =2_#+BM3 >%1?J3+S84-(:OJ/="N5_X+
MF3;:HHG.]S00'%N 9%.J^SW4W"#BQGHC&461"%";*]EX=F2TS'H\:O @3VN\
MXPG3&BYA0@CIVW>_7/Y;.)OXZU(=?C7,S;DX]Y\3P,-S-2NH+(9A3H.]8:;R
M"FJ1Z_4:$(^5%FRORXU!-K)'B@U5-:9&J%D *K>K5U'4T;:[C2;C,:__@^5]
MQ[FMVNUFL]H=!)AB."E="?Q1!"[E';\ONZ;FVF]O#WY* Q\9Y*0]@X/@H0!$
M&MV'CNX!$#Q2]0\/_%(4Q2PMXGD8+>=QGF1B*A=1&"_D(IV'ZH(]-5W<KV77
M(HIIX+#'HY--9W(JHV*6S$6<QWDZ2T01IYE<JD\6\_BTU??:ZA]6.\*.NK:5
MB/X3,"D,4)P#=T:8<:@.RI:PU]SOO1>-\O@<1#QK^H$5;#]9*S?D&OS')\XO
MS<!$2BTJB#[U]%&[NR99%DVGJ9QETVD<3J<BG8CY(L_$+)-*TYQ:PN\G?;9B
MTRB:+]_&]8E7[E[7S*JMZ1*F@ <2T=J+D@(M>T%!<./T=>UENGS23QG1\W']
M'4>_]TNYCQ#00[!""['YKCRD+I#U11G2%.F4;0T\)ID;R4)P03T33PN0@R:L
M6;R4>G,L)KU7A&F\C[*I%!FR8+?H>'' ! C2-A#<):)BICSTA?*I-M>[ED-=
M2HDYD)ZE&PI35AM$&-O64K=3B,_86>7^K4M#!$=FS/3C3\'(!8?B;B1"60*O
M4[;:YO+A3;%D$6>1#,-XELI8J<;E3,AEN%S,%NE2IOG\I"'OI2$O;T=SI6T&
M.;W<;:[+%8O<C[+9/*+-MIC,IU&8)ND\R^,HGPH T9A/BDQ.LRR;GMKD[]DF
MS_H/U.;WF[:3T HMFB;P7RFQ6,'ZO-JN-^H_;^L/]48M]1J44> _VP'@ZY58
MU1QY?+--U?Z)P/^GLMQ@*X6C/=5G( *I++7Z2C)5*TN#&<[1N^T7V3Q+TC2+
MXR2>QLMT&N5)++-)7L11,CDAL]Q3VUR\N3Q[5O_S\BSZ%#ML].[O42Z<F8GU
MZD<-2\^)= H:\I>GAOP1W':POPU.^Q">W>2VK25'VF73R!Q8]DR(45:_[];R
M3+WDG<P]2L:T=9,BATC;"DLB\_U/+R\O3%Z8""F8]9:H8M"$ZVJW'(#,.(1&
MQP%3/E1Y"TV.P-8[/)D4D67KLFY:3ST$/04-Q7T\T/!7D HR\ %L Y>:TW#/
M$C7SA$>AK?SB^04)#>>6H/;!&RMVH'S\]^0UH7G]_;:I-_+<?^W:WFV]RO>0
MR ?U!_#X6CDQ#K1\4:O%TTP[%VOP$40;>/0*?/5%6PHRI/?GU3?_<0AN.075
M<_2!L=WJ#J:)!+CK#E?3Q51GR\QC)B&=\MZJ^Y08A +'-<"D/*9J,FEM_%(^
MLJ?XW&4+^'$_@'-<C'M[]'O<"SJDW:-2H)H([6RY4:J+,#-'_<=4_:2/NJ?=
M/^1:/1#UXH@XKDI 7#2KE3).$,2,V1?!0U1^(LH4TH=>JZGX3=EB88Y3"&)B
M;$^4NCJCG\KL*?'[<+N6_V.ZC,()^*8MM#;6%=!EB:*@,,5X*0C.RV:#!,EO
M0WXGN[0P[7#QK?HK< 0H'S2%UD2_W5Z)AK+=]<J#*B%..;4=GD;UEC":^+FZ
M9<[]EYP3A FNH" GVP*<O_72U<-%N1*:L7.+#,=^WTEV5I1R"_#$%AA]KI#W
M.H.CX.'0]1*9L5^M=ID$O"@>\#E/'9X!>ECS9N@-XMT1G=D.Y,.UFP%)H%I=
MI16=1Z8X5OM<KC<"BHT\30/1U2N)95GJ;F B4^(?,B-PY:GO_)OYXH7"H"I'
MU/Z#XZ2)''CD)K=#Y59]0=1)QANU)BNQK;)KG*2K<>N4R:C@CG SGU!UY$>3
M,,3:!6)/N\"O4#U<0 $,H-3>/P!#UHG#-7?G'C^]@8PT7W)(77&G%_3H*]SB
M.;I%^%M&!+=5^;];)=Y2P%J"5E<JR&\U2X2',:"ZZ55M,7USB68$9W=A@=;P
M50#<42(I-9]+AU3W1Q4."GK".O4T[5BP/S#KYB[I&TO0_.39]YXV%,Z00A<Y
MO0P]F;[XX>O?__*TM\CN<R@ZR"J"CC.LD3,FL:GQ5M(,.J!_@;D9+H1<PMW?
M$F$RA>_0VN!<@]TO+2_N7-?JJ&?;E3KI/[IOXR0&Q]K\%@CNY!DXKDZ(1JPV
MUX*9MSL!83HPZ-7LA&<KMX2Z;J[:CF^>ML.\NIJS&;TAZN&%0FE^7&*RD51S
M^;O4OM:M1)H]9QL$SD/:1*-.QB4IX!+7#QWS<:-8_#C8_YU_ 360OR.;G.]H
M)7CHJS+/U;G['BXS=)B(^>VJ!I%LRBMUO6Y;/+'M%EGSBNW*5V(&=B&R:%/1
MU?9*+0+711R0>E"/I/HL3PJJ0TV5TJ%!JC4MEVDX9\'[Y?SRW&>/\)-PM![&
M%'1R-;<E#>[SBB]0J3V24<(#9G[ \\_%55!W;10 ?XLYQE$;X_G$B#[_L=VU
MG5P#J;UR>ZF**JWSG;D*X%K".!8)'/(6DLBH2V]*WJ&N6=['Q=9&*?Y%&Z4!
M#E+/2EE\GJ;??%?!ZT M5TK(5NS$#JDQT?0$VR7KES!B+:G86RW7AM;$0><\
M5GYTV_/"^;3@I%T_LL\+1$XT72(]PV]_!$?@#4K">;XLPCR;A,LXG::I$,EL
M.<^+J4QEG"Q/4<3[(KYOJ[I8;971TV;HT5[T BPO7YCPRJ/E*.;Y?%+,TV6>
M3Y,XB64ZG>:S8C:7819-Y?*4V;\G;JL;;?/[T;;1.-OC<82$H9@4D<PAI9#D
M$^59+])DF2S3+ ]G^5?*;_^'$81?)=!W5SX@K=AVF>_,MC]F=4^>+R(Q#1?S
M>%G$45$LHZ281R):+J)0702G,L+[;?U/$"JFH]\/L/_TTAS[1R_WT7%P8W2A
M(=<+"X]%NDVC'ACIO0"WYP2XP9,EVZD?/B=F<$D6))3K-]J)WFR[P"U]L>81
M%_KJJA7=(>)\ G!Z2]UTZ&&EDJX.AFF\N99;J-8O<_^B4:]3'VTA\]LJSY;^
M_=-V UGA9W)5BHQFU=37E5D5MOL#_Y=5AN[7>^C%XR__0\*DE4L,$3#17I?K
MNC,+ZCW7M2K0P=@H9V_XT..%-_8VY1[!?U/B=3B SW$J2D)1R L?^KX4_<Y,
M2+Y@XMWD.XZ[)H[EWY/6LG727N3,]@^+)NZA?(__7$+""SX,,5MNAE#^':S,
MZ"+M*%N&_*$D^0!);3AY86&<L9%"@2A:0,4)&%##H!#^A4,F3"MOJO74P53[
M!<?UC/#C#^P6^DQUNP&?](@;H%Q$P4'D@*63QMUBP+Y2_AUVIM8;R#5!\P@V
M5_EKIQ;D\K?_^'^C>/[ME9J6J8<;#V:S(L[A.3MIPDNLE>\Q[3]YBCZ>G%+T
M=PCDF):9 7#HD329UB*=4S>Y7X,[!I'/H=Q6G1>U;55GK@BOW4*HMO4OGGT?
M^&F)[<QE#MV;'P2F-4!Q<&KH;'ZV 1UR#;_/Y?4N;T MP6G4)M /\]?/?S0U
M!AB4P@[>%1UKT[='U:LZ)XD:8;,2F<04X5[^>EMV)M4&8H*!&DXOV_H#W6Q(
MY?OO\2'OE8[8R ;C-* 3QY)TV#VJU4J+N7VO:.JUPQK_KLPK:3^DE U.U'>:
M7FU2LK+9/9.C7>U QXM*0(#\<7/?B-3J TBK/\!G/7Z"3M[B3J-MK01QO(K:
M*0OUE J#I(U.CQPV?_80(^ 3SGAR"ILK<ZA4*DH)F/S?+37_N9]2(J&N(DD]
M@0AR .:-&L5O-9?&G%%IC'.[4W!3YW#L62VI)]+"*2C[&BQ03!$;2_S>5>QW
MU6^WH4L\'C:&&UX>@<3XX=7'02Z\^X%<J#?OP5RX>4_N+7Q?*I/10DR0,E(;
M6=7OT:OPX&N,CF%P3B3%[-&O43JP0TR.!T#"\"T2AO>X2!C,=+3=J)'<8-X"
MTIV;#?7\EI 0J_AXPO5N\A''@V?1(A% ;0:M$E69<$JBRGLV:P7;[JY:K]$,
M&K<#SS13"_"IH=:9BGS4<CQ3OJK(2:BP:3A<NM4(MA<92E%,W<G 'U>#6<-8
MMJU)];*DI1*EML8\"1WOU<[C0B!]MVMU0Y@.N-KX6'=LCN3"E=ENTU8IR!X,
M#/HW>#1OZNTJQ]S?-OT-"AK4 !IYM5VQ:Z2N5I0&NFI-&A&+"L!/W)&Y4V#"
MQGS-*3,CV1IY"T(ZB+7$4IC6YM2-O?&#P0CRW]"CX4RT]G;!LWA1H8WQ1L+A
M.#<*D9]!145@SV !$TXB$YMR!5>1QAS",$BI-!<FR6^@:YS2:)3C$BV!12@Y
M5 ;1RB]6ZI-4)&7 >9QU)]M"KM0XFQKM/C  K3)T>Y4-%$*&. !Z8LYF[[\9
M/& H8Z $5N71Y0RW<IV6Y+N*C@$S&G472BJ[TF\O&TS\RH8L.[T1[\J*)$DX
MRZMO?M-PQ*OJY+_5YVBJU&I&JIC3G"WJMYW4(%.8N,0$N^DF:7H0'FHAWM/
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M>2Q#&2?)))G.%DNY%$D81GF^#$^U)O>K.73P5O9U&RM0DXE75Z')\:(D]5+
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MENRO9<!W%?=/&N]QS\!\OCR=@:]HR*<S<.PS$(?!9/J'/P0/9_)]<6/N#JA
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M]VP:./QM1Z8]KY,Z<TB?1G146R SR*4#K\PV?."MF186_0G9<M0(H+*8UX"
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M!@_?& I[\KHAZ59WVA:%"![*)%]3F&@8^4H:T=6'^ORR0S/9>74PN..!\@+
M7K4=K=?U8J4,<;C,L6^=QW'@"&B?B(065J_>=K8G,Q>="+"- (S"#!C,@CNV
MH? >MCT<S-Z#L9V5M&@/S,Z<+F/M/(J'\[)BTTK3GHTNH)5;ZKO PBD'<A-0
M[!"B'C[K652VP1+;UHT^:<L&@$NX)Y@-O;X!=CQV'*2"$C9:A:V<[5Z-2(#&
M,)5^\:%$C4'0?[W9>0+M7$0^8.L7<J2N\1N8G"PA1D)+ B'.J*&LQ6_JKT2@
M T):(D %TT<HTS&P0DCL86.E;#@N#_PP$Q@1O1H7A,/$MFUZ42.0NI&89C[
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M9$"@/$JN'E E"QCH6[7P5<L02UW=P>^NMUT.NV+?"KD '_F;=0F5>IH2WC$
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M:W#+FQ[G7'*03&_!*S7:N@=%#?H( R,$6Y_3\:1!>B2MC23&%1H.,=4U=6K
MA_7H>E6]E(/0^04-"L.!/JR)59I%HZYC7N)4"?N12MCD5 D[$()?*H 5@$IJ
ML"0T/HW2=?(#%P$Z5TX?M+#IZ1:P+-V_>W2&"=W?Z&&+;40I9@;:^$%-<&-P
M(L9<!^:%L$R/X*8:\.%#8R0.A$\8@P.OJU3L%FQ$R28\842H:Z_"8EI$4[0(
MRH_2L/\6-0N3;U:U+5YK+5H13HM@<A%NN%^MKXR%;=-G]*E;2L>ZZSX6C=4
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M-2W#"N$O')C6P-,S-.6V^V6UA+9B0V).9U(O/Z ,].WJRME%7%RWM9$@L%>
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MF-=2#?.GYV^'E (> ?JVK$>:M?:$#C[*>$T$H@OUH5U3N_&ASF13W4A+43N
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MH,:GW'CTR=7OB,8</EK5S*1JO 4V((:5_ZX^H<.G5Q48SJ6HS+ZUDDP-@]B
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MB_1@-R36 ^/-B=9".N9 ./QA[E/S@5!08@>/)EWE+P+-!"#R%H<L:0WMFJ"
M*8 I?>2NO]O'&3ZW*4P!L,H*]>0HG(B,;F<$52.?8W4W_$TW+#A./H.$@D[E
M3VCD_"&%; H"/"-!9$.,@S982ORCD3#D$39XLT9PO<4SDK)&,*AC HURO YR
MU;GLW<, ,+F!H+,S7'#C)])O+"IZ20(\,=(I70Q484*B]#0)S7=2'3)1D$<N
MK3:84' #L%"UGLN(VW=!2(05$F[-P$"&(E>04QGJM@F=")C(B061Q+T]GDZQ
M)@OMUY>B]#CA)/7@DO-AI<U?P9^]ACN4PW7O4Q1FN,4Y<$B_UY7^G"H8;<MK
MC$X]?NFH5)L?E?)AD*2#ML#F]T]*CCH8#9+QL#OJ#T:=?K>?Q-U^O]<[ZO>'
MXUXW'NS@S.\,9R[ZE@U?@>(U8#L$SQPNYPGID!AM3:Y+I_YF?**J&=<2P]N0
ME 0ZJN(X4GF;_R#1Y[49#[LH!GR5BJC@H5^X(QA4_K(:QX7Y"B<^7YZ\W?L8
MF?0N"#?/0[KSZ&,\59W]P\$SH[JXTQMDO6/*/N _3(6[CNC#FJ/$#L ,&XUP
MX6;@+V0R*P4TYHYG6B-2PPU,7C.VR"DMF#)RI$Q E]:,!C7Y1NER1@>3R>AP
MFJ9C.'.#[O HG0PFG4$\[?3ZTV&R8ZR[!V>$]-:K#W$5RCYY9#'&Y+ ; H-!
MB_B+A'KD2C;7=G>_]\QBHF92E,HB1EE%#XU=QX3U;36%>IME#*9( 7%!)%>G
M^='-L5D<''2[W=XP.1CT^_W!T33NP(4[.#J*TT%R!!_L!/'>@LC*M\2&4K=%
MT,$3-O7M)=<$Q!77;AF[::4A+LFF5'"'D&J3\P)]+/6U;;PA<F@["?V:X/\)
M%/HSROJ*06L=-K+/M*%^#!>0MH292RF>5&6MDZ-HY)+";_3 \:6F<@6)FV<"
MEJZ]DSA@[HV+%\7BW@F=+<)Y([)<VRA;+-\;\8(\FB?^XS(Y2[%OBP*(CNO=
M:4]J8X4;.P)Q34$BPC%#W#>L?#:&0^W5+X;'X2\EF,?A:4KMS(0AOUBD5"C\
MBI!R$#%,?@N&:UQ_4A5C>EO%(8VK,ZJ@3>1GUE8I*8&5P\ 6P=]@AN&B N?3
MA=$REWW/N>R[,%-T]):%!I,K<I!,[NRL)+R&A7!)P5//SBS@CE-L:,*Q>!*Q
MR7AB%R1\_JE I@,,63!B.F=B7G!5,;>B.U%X09BIQ6 2XRP)X[,S;/<F?$:S
MUF[PQ$B\K7NIJ"&_^PR]KW *WC*\"I?">NMDEACOI1E$Z864X)=N?*P_H+CM
MPBO<C"V^I%@U I7/);PA%O9F!1; F:)SLP-]C,FAJG J;E5X+#\ (S<A5'KQ
M0 [DUYYO[^SR[>V0[)2 >Y..*PK(@8AW)6:2)0F:][A$X0>PK=ZG>99.2?G_
M4H[#EZC]4!"MGNP&'"6J:ZP#H@/5KCG9EB?''HXBOHV.EHTOHK/$47_N,;%W
MUT*Z"/@!)H[CG$32;/O!.](CN4 LL/'$%8GP2JN+Y("*_T\JB[VBE:_XCIKZ
M5FM<F\B-U065%-AYSF"2XM4JJ[ _@E?B,P^,2Z;:1F*W@@]"\8PG B##Q;/+
M8IJ6W.BD2T/IZG9G:2SF7HW<)]A H^'@;N1TLQV#.XNA:A0^6,BT4@ET!,Z)
M>X<:][Y2\FQ=NJ.6L7&+\B"6L Z#O'I5.E<1$Q]2[A#_7^L%H]$_1*S%@FR\
M$5@FMZ &A"I3N U/6L1/,'@[X>*&4R0E1D%^@I*/CRNT,1+O>VNBQR<E^(62
MOZ6X(:>)]4^F$WHTQ/!AT!X^?.O GGQ0"_R2-ML4VU&KO%KP\CL**E+FRXTK
M_OSVY%A*F;G[/\6R!VW@XI]2</UGZO8\5?!$C3O^_/.IC3MBH8!T632 +SP6
M6&?#:MTPRIYK"0N60Q!*SY3P+B7,'CB +U+K;>PP>3Z\V(3L[2J9O-//;YVQ
MIGD2A<K.C7D'YG.#Q5;:"FE:Y5-A?))@?=.1S5 H5"-A]+;["AL02=I<GPFJ
M-O!Y6BJ*+AU']K%ID@+/B06ZA"6L+5Z?("*3Y5^5A>7RI;4"55G4TJO&N[OZ
M*MU7TC-EY650U(?D!=\/G>&S"JL-FG=,F<; !_JBU(50Y.V'KPTNF<(6#36-
MZ!9+/3>@95QU0PS84@W#[F&C=^0%)]GI%F?"GS*()?'I# !$"FDD091709ZD
MAH2_H1GUN:FKQ98_?<I8EE6JJO$HT3!KYE1BZ3+=PMHTF#I3?$+1,Q:)T<OO
M"29'4%QCQFR7<AP-</&NJU8W/_B1/+G@?]WR=/Y0&RU,,0+8;^4D(V$G[D/_
M*(;/L_UT/[+_S1C0VE:@"HX*9QJ_5# _4](O^R[(+E)9OUX1>05;S:>_8/W1
M-HM&>9/(C0'EIQX8CYN8BYVIWJI!;A;[[[ULP3@U%1,M-(/-8IJX9;R!# 5L
M%[E=N/RZY:OH!$[109"$-,8^S^3NX?"..]9]<"0;.^(FV,<D(:D4B-/- N?A
MR@W!C(<V[;I*0?L$EH7#@I2D>7RI@(16"+G;!Y44 :$D!N:N<9\&YCX-"9&I
M<:-&X3LJ1"&M^))6_3T>*)#7=R_?OV"WW>I@,!H72T-N\KG,/S,3=766FH6(
M#(4F9GHY.0_/"J2CM7:.VWLMS;/XVB[LLG" 4MC,04SPA8M!M6RS+&@B>%ND
M:EQK/1EQ,L6"R;(JTDL#"4DR0+$8%CJ]2>HTI3+(-*.KU7*^T<5-]&$UMZ=2
M@1RM/[_3G DYNIP6#I43HZ;+:./%/8TE4VM1S2*O!(,"50P#'A84.D#IMIB>
MEH4\<$PKO,.+J0 =&FOS-K:6=TJ<P@N](KU#I-D$>T?BQ=R"EAO^0=-A[>1,
M(A:LXPDQHI['A?C(;@?';*[F&>\M9B+I;TY FFB>C/_FXVO@4T4="6[!6F1G
ME_14X-.-U3XN/_-])+P._CW7TEWY)#1+U-2"Z50LS_%*<!L4R5[4S^=U=@+D
M@40M'&(9W3YF-'$ZR==9]VVB8PMX.:+H]0&OO$N>O"=0-@$7?5I\7<;,-IOW
MF>D?2R[3M4*R"J7M.B4M@  <]J"-)AU:B]1^CKFD7N"Y1!H=.;*,DT3Y@4P&
M<ZPM6S@ 9TTB5G+1WGQX2:X)9^_:J$L]J%Y#,-K"L0GW:8S,Q4Y5I,L]RI:O
MP:!E+TBY@V7'FAK"VT /ZA('CDY@@!$T*@&SXZ3+@Q>T;9@-_8VY3*;'A%%0
M_PONPS3.*NZ$)IYL@AC0=@I$/=9::"EU"&!S3?;(K*(W?.K)Y4&S(,Z7U=HQ
MKBZE9WC5VEDCMSQ;K*%KL0;&G*4HVGF6P[FQN89W!9YH8_LZ5494((MU^FIF
MMBEBY4)P3A&UIBZ5A4B$/+ P%F+,/&79MKG!UJJ.6U]) >%DQ_,LR07[7:NP
M":+B!F\5C:(P'SY&B6!M*W:-\1U6>KX"J43'9+W-F[2U7\,"4B%]ZV#\B["@
MJADQD/\#WZB3S!XB4[.96(<HT-;KNFY=KH@!+^2W)#+L9M=B)$4&!NPB-:7<
MFF&CA@FB[9,B J28X!.'?0>FMPB6/EA_07L=V&['PO4KTNQ<8)-0I=]RSD86
M8R<01"!E@.(%0,N6KXPI T'ATY;:_D'5.]SB.U,6$'R!\1BY[4JI*,F6-N!,
MAFK*=\=00'CXTQAC288@.G)=+O]>MAK3D'VLM&KX/W:I@)ENQ"!LDP@&NC_T
M##TN?N^WR)S+-<QF.US,!28Q21M3=X)J>_>[#5(%+-YN$EL&=Z!7V*4&,378
MW:4&;](]ZAB4G$6@/M%_99-/.!HG9? $-Z$.SA_2J:1WL+:9R*]B,(OSLN!H
MO^D3U$C@I0M<%WN1Z07'RA%O^%)[^9 !QN_-K$L&IBZK4+N.F9AZMBP$I#^R
M<4W2F?I?$1NBI"3Y-JE2!#%F?)9,<E@I!\YQILQE;OU0)3J;"QEG1-4?]# 2
M0P'$J40[3:__.AICZ8S+P$A#6UA!$XE2;@9E,*=+C0U^XHF3;6ED!+":PT4Z
M,WE?M]#?T.X@]&_-&I <&8%IP5@738>-3+0XV)3D6Z9=$K(I]\$6'N$<)2Z=
M9V4UQV(0=9BZ$"1JKHMO._B"*V9H5BD25H)<*L LMIKZFN)B@C.YR&;DJ_'@
M+#V>,[PV6L9@59AM?E;QE_D28<\ I3E/DS,S?Y,*K0Q7$<- ,B&[K"QQ-0@#
MNCYQ(A5,X*T$QIAGUX :9#*-JG[G'H3O+%C/N"KCA%IX097.JU0"]9I67NEF
M=D5GZCJ&9]D4[UK;!!.PU4FM//($PTZ#/X0;>L[9^@EB0B[<9:XC6W5 Q7'U
M.19'D:'IEM/!2;F 2<$+YCP#0_5C> P#,P4JRJK%;T9?AUPR@?FCR?'"K9'>
MFM=*GR[-[-2,X8Y</E?73@-,@8!>.1W5J84O$#DXMYUQF:"V/DTD!GLZP.ZJ
M/?#S=?K]DHLIV8\V2P,S*,K)DH(XE26BRP-OL8099LWDH_#GGT_=S&Q,9;$<
M)G?,2N+S.8^K,>@,$Z]3PB!F"VLX+8'$\=P?:HRB;D^BNGX;XP88IQJ[9L&\
MI[.V7$FEMZX;15("[72F;(23@K3W1:JE#]-LX?#H&#IB9P*NTD%_*:ZRO &$
M?L4[ @< 03VF.\S+N%@2C$"?H5ZD<1)IE6*L7,Q-S4\(FPB A&>1BCL)'00.
M/]A[EWOXOXP18K%OX=/E;"DQ0.%"P;5D@Y_/N%)<MS7%.GV[JNS%F@G:9^<$
M3"CPBP63RK7,&A-A$3*X#%2UB5=#+;Z1N#LSN ,O&XY.^@5^3\#ZY(MY!-%8
MK7C%9?>$8">^:6K"XGX(2N)H.--Z4H$X%02C[.J!<;JXP.M(JB5H=B91QB$
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MNB) &:T*+$=\,@X728F0:@?755FI'G9]CGVJE2=B5$7#L"^1&@\))!DM6CN
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M'I]>KJY1EX2<@E:;RN0@4&\9]@HVL-"9I A2S:19^-^HB/$NR:5043%NJ1W
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M10#EOG DUS^Y=8:%OJ9(&K/PGU.M.CZ>@5*9@%WZ_,?E=!KG);4\_ +GJE[
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M!+/$1+6"\2YA,TPMG.7+"4+Y.^@L#A9EY2<2EM*;A$BPDT5;AH+99:FJOR
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MS-5L4NX58,B-BFK3."$WEDPUNG_<ZWH&=Q+678&AB&HLOU06,#8X9EFRQZ5
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M[MJ<+1<+M$#R_+L''7 ;)(\9P?#:=\G]JH^LSL;/#Z(0_^\%/C^DL-JZ(=T
M48NMC?4!L6MO2%29MUCF:7&C)0;MNTCWB"D#C9B+*IX_Y+H__<YW-_BN[=@
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M.+9%(1*D[\,"#?@!C$YJ_TSZ["<G?7:\)GU&2@P>6)0+&V:A@FI8R:VQ/N5
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M6AQB-T9A0\P8J 5_H(HS)%>OT\4BI^@ >WSDCM7UDLW#:3@<'$1PJ072MU.
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M7HXIZZB;2T#Q1\]D2#)WN7+%]K1K5#CB!]N%;\_3LWARZ3Z\G,>+\XR-0UP
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M<WRM=[6:N_#GM[_3?M$]<SR%*R-VT)_U;K4"$A=F3U>N0Y*]R_DYV =UX(-
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M&+L.O2>E(K((9?VK9W\1IC75?M0(*A:K&8' A:4$\\GUE8>0XZK2$_E@I4(
M#@YHL2DP[B7]S#S.F(5%<47.\X)D&X]B;"3V+.!@,Y,A2="\$%&(&Q6IY )U
M6\#O)'\#_N'9B&LI02A,T2.%AG]JH1$2+M_?ZTSY@ZZPH;#929/-X+%UCGW>
MC'4?[3)[+BA->/1"@\P$CO1!J#<V(9P/9=_9 4O0'Z6M\*S+:%U%$L2&%O
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M+^^.-&"H_ZF>EL"J!'B@)UIZ.K:H><E&08>V\SQQ#CZ/V((U<\PL57\F4\.
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M&ZV+WO6@MEX(6K2I@X-#5CA*9M [D6)9;U@'==I4J0QM_LG$BN#577$3#B0
M<W!+,I2/A/Y5&JT24DP*6^VCV<.B 60]D _-U" HXD8%O'? -6!W(H_FA19-
MI&=QT%5/1Q"2S,<QZ"JC^C$M@>+"H):!>@'1AA).OXY$U=*5JW.PU1#""?$5
ME9R9EVM[@/S?H5 )[P+BK?)!PTY..L-^GZ7.DI-Z/0J^V>"P/0G:SL#%<&=#
MR&R*$5,-[4C^6!=>Y BD%;-K&#00N=@F0!D.P@V>]\G%8^^OAQ_\X _73A#F
M(M_UNZM?TO(]'(E7(VW.$TK A>=%N)P;N4@?\X)<*F(XN28X':;.;%PPRB]
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MK*;$SA9%8YNCB<+:ICG0_9!.?-+OAY-^W!N%PUZW/U'A:*IFT<EL&,>G@_A
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MIE_@-DT=!]++L>=@76S3"[+#<@=K7J][+'#/)<U+SDCI4@R)_)/FHP.F:]7
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MI$M=O@VG]IM^UU(JJVXO1-9WC.>7<]@G!&W=:#NS];T_MK.3=P_\]M0IR:K
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MU_A_2EX$+8S08PD-DZ&B/1>!,3$IPHC #[,8RTQ\!"/"7E022OKM[-.KLW_
M]WGT1>P/_V--:7'J+$W"H=1X[L@>V(C=P2XT$UF@RXHGX&$;)8P08432M4PK
MJL:P;F(EX(0FZ2VA0N[+3[VYI(L[4:UNJ4^"#K$VP- 4>"V&%J%3Q %XHSP]
MM> ;3I2!T 2!&T\S_"*@LTURP5]G2CK[NO*>0);P=+V$0F589%*%?^))8*B4
MHH#R3S0KL28&>,Z$'8G8"VG)[[09GZF8TO>E9=\TW+[)YIVU7$.U8SN]FG9=
M3JDEZ7&:O^Y"+2II$?Y3XPDRY&@9>)&XNQ)E31/%=@ WF TX+B:BC)NYV;9F
MW.M,SHFL @H*E;J:.6Q6 6GCPBGF=_JZ??,^WK"-HSI5JA^/U,EX& ZCX71R
MTIVJ06\RZ$;Q\&0T.K1Q=,S9%_O4QA$97&6E8U'?JF?C7>&1$FH!Z(PZTZ*)
MP3MU APL3(WGV";O=A=D^4R@N=9D0TF8..4LYAL-INTN*@"%HH.1> I2#^0U
M4'L#(XPQ=.)SYW1=[B*%ZQIHCIM$L^Q V*71":(F,""3?H&T2VP,NO*[P81^
MYGT"G8)=;'TL(">K96)ZP\/,\C2).8=@4G8&8$-0H$H0?E7#Y&S;!Z/&IU=.
M%1Q&X$#EI& )B'IGB42P+3_<6_L^+=,F\6D\B$:]V4#%PU,UFXYCU0]G)R>C
M;G<\&7:-3(MF5?6-XNQKC4M:!=Z:R-AX;9G]?1WGP#O+W<#'_S]"+]ZG ]Q\
MZUF_>OC=#27,R@W<MCXR9@FP7HQU_->SWK.O+>=K\_SN1U\.T2P95MGH@G+/
M.^=*YAMLVTJH]AHJ=L-"3WCH+3LNMA*19<KS&IO$(V_OE+3,9/KFM;=DQ+:(
MXVTV\E.8AL75]^^Y):U@9GQ_^P-ZH3(U __@]B.!#A(] 4+P!D<^RQK'#;9U
MI8Y1TE-X];((E]]ZUNVG<.WY?RLQWOE$]I80/W 78:S3N#W-:!21:9[5!Q(\
MD.#-]95_+UKP6T;=H !M8=:!70[L\A 2^Q7BIZOX]O2"J%%%,JWOAIC%MSV0
M\8&,MY.D&+6Y/;5@S.5 <P>:VS'-#?:&YC:>ZMW1XOIQTPROZ4NXK9._%JWY
M&H'?9OP-P]_WE+^-)[_I]+;FRYL%86ZRQGNESL-F/_[-/NSK@8@/FWW8[,-F
MW^'Z[L,8NU7/9;+<$\J__^ ?]_I.S3<F6>$%]%%+K.ZK,%!W9@YNN\"[-QIO
MO[5?+8NX28_K&P!5N=;_P_/X;4ZP?<I8Z_NH)IS5B[N?;TN)EBQA<CO:;>'W
M\<EX?YS?NSZ= P?\A3F@/^[^W[\V3>\S^>XQI>Z#6-ZCB.1!*!^$\L[I?S Y
M,, >3?G  +MF@%[0[PT./+!'4S[PP*YYX*3WZ,T@B=7<?:;VCL-^6P.-[WDV
M>$<ANQO"G>]7V&Z/A-Y>B[/M!=7I<%_DU%[IX .AW36AD7SN__C$J>UA".M!
M:.A +@?A=!!.#[ZK!VI[=-1VL+D.A+8;0MN;(,23K3G24'B'@J-M2/(F@8H6
M5,$V2,'[Z2FP+X'00^1VUY';TT/J8I^F?&" 73/ GOE"AS*D_9G;8RI#.I#Q
M_DWY(,P/7'#@@@,7'&SZ P,\I@D_>@88[4T@\*E7(WVVJ/*'(J2-L;UVS/#]
M">3MD33;:SEU PETLB\2:*^4ZX'0#JG\0YW1H<[H()P.PNE ;0=J.]A<!T)[
M?(0VWIOXV@[JC%H[G3Y(\=%9%A?@7[]?)/%%>.<(+:L52+=8]WV4)=W+,?RE
M@AQW?J3W(4+O" 9IWX+"=]C>^-YCQWMC1>R(8 ^,=V"\?6"\/7,6]X_[]F7*
M6S/:X^>I _L\'?;9ZW4<E-=!>3T^JCUPWX'[]H'[#C[;(UW'@?$>-^/M4]NO
M.R186L?.JN^^@@3_!"KJOGV%ASS9(\Z33?9'+^^5<CU0VEU3VMU?Q^^/K6I[
MTB1\**V[(QK<&U/H(.N>M*S;GX;K!T)[TH36"X:30^NN ZWMQ%78GQ;Z&VKJ
MOJ_"::I^\KROF:)?>^#_38OOM579?/A&-5GT&PN2_7_]LT5>9Y5?J#2LP*ZM
M<C^$Q65UZ2^+_"(IDSR#7Q9^-5?^E0H+'VNU8O^5BM1BJ@IOT M\!(GO^)_A
MB5F2A:D?ZC$789*5?EE/_ZFB"L>.\FR6%(NP@F$[=[T8W]VC6VS5LY_.2C^L
MS!KY8/5"<2<*Y5^&I?_[I[^!P1]TNUW_.8*6XP<GHP%^<.2'4534L%.P:MK)
M6'G+\"KPERK#30U@>ZH$M@@+WV!_RP3<"]C>J<K4+*E*L^FQ%,65K?MU#Y3R
M56+\BD/DF\H^VJ_ SQ2L<(E'7OKG19A5L"O3J^;B<)N 3LJH2*:*UDZYL?&/
M9]*RWLN+&(BKN/++>5C "_$ ^L&X.^;]5_^JDXLPQ=V$H7J#;C" C\]>?2J/
M B"[Q;( 6L[.UR:R]MYZB9^-8&0^V:_-8^7-_5/^&;W9SV>S$E8/J]7OA5?,
M5()OAG>I/Y>P 2V3Z >3R;#M];Y^O=?^^MYP$IR8UQ-5_@"C]9A,CSK7,,=V
MI"3B],7'#Z\_A.?J1:'"+V?P/T:L1BE("1*0<U.B6^5+&++K%.WJ<"M^^&S#
MV+_5R'V-P5T*CF#)JH!)HJAO_ZWY'1'LI:PMRT$"I4T9PI\]^^FT]_^^Q_%^
M^NJBS=A+^.1XBA\=AS.8T0]^F%Z&5R4*I'FAGY+PO.B++D:9>2M^\(?+/_F#
MQM9IS=+M?O>CKX^%HM,2DOZ/+OU?6[1:OGKVO5[&;:0!\#'&R"L26J52_IM*
M+?P3_]A_%_X3:/43$N(\3V%Y)2&<?B1=$OL?PJ*Z\C\#HY5A9*C?G]4%BE O
MR6:YJ (?_A_% ?(IB$?Y;&8*@GE<04K=F2 4"M%D,X4E/OOIY<H4;0/&3RI+
M8'GOP@P(PC9=_+9-=P/=WS;"ZD3S&N6-GFPN>^DG)>UZ7L*!@8P$F@2ACL]/
MPU+Y99BBJ,/=A_-!!<;Z:@;2+R^J8R#W!7V[2&+^(PK+.1L0JNSX+YV_?" 3
M_QS46Q&F\(HJ8<&'YQY&\T1=*#TV6A%9E( EL50%$0E8;GZ2Q6"!(35X^,:R
M*H#*SI/(S\F\@%65@9[I%3#7E7]!<X<7XS@H+N!@5I?&U>>H&>JE4&&*?3/Q
M.9"O\%F93),4R!]6 )_A V8;/=G&CO^^L;L-.@9#\@N^&'8Z3,N<ODQIK:P'
MTSP[Y[U+,IPD+@3^26_"Q=-N5WGT1>N0[0VGQJV)P7C##8G;T]K[3&D2^P)[
M#W24%[QC"6GV:9VD,1^#.<ZH3JL:* )/+"Z()B^!-LIYLL3//+"?T(H,:?.O
M](8@58?95<<_8_U[C&<9-S=\D<=P?M4<3#CXK$8M65H9Y=-ZB-1@<H4Z#PLT
M:$/D Y@.423.&L66$5!$<<@JX);!+U,S'S#M(NRU.E5(0D6>IJC9:]+%917.
M9K2^DD7#PH@&H/@BAY\UEO0Y]V=AA,L%PN99K,U;Q=Y7UHTB5@&%Y5=*E>UO
M#U#>:NO6[XW(L.T'='XO<M@//URBS8K; L(??A(OQ+[ "7\ND@R.Q'N1Y)6*
MYO[/\C;6!/Y[HE+_0QJ2 =C%GP%E@X(L%?T^(]U,!+-B2R5E6:._Y#/F3EG#
MZ$L<!]ADT 4ADZ8X]$M4QV09];ML&?5[+889L6K3.NJ,S"!@(1UU_ \.16[<
MV/ 2]H3E5P)<2PX0.C,I2$T@!3H86MEY#ASN"2=,BSS$550J7( VK^;P"/Q
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M:96K6X0,B N[!%=PTT0D$B:NBD1E,+$!#@@7ACA,#5-*E+;J38Y^9Y3Z.R7
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MX=V+<'9Y\;46TKVVK2'YNV$G1]W=^H$<]"9>:UCL81/[+V /K]6P'VP/KV&
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MX>' L_JG)O)(IR9U2!V^II!Z@7,4/HJI58?I_=W72 (CPKDCH5[BN:49\-=
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MBW0N1O.U^%G.\C6263APJI"VQ_3-;%1L?Q>2NCE# ,EK&/HG10D:T\<%&)W
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MKR[%WVTI+Z4XU_8G[]61496?9M6V>:L\NTABKF*^.6%1@WIHS Z$<X&]0K%
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MQOR55_(KZ*:P,I?:.7&K6"_8T+%7*O#G1E:;@0+?S2T2L.HH6=%%I1VBW**
MMB/'X#!H[6A"Y8DRT)T--5-[6)_+2P]@3E]\ /.6MEG4$\/))!Z(83\>S :]
MJ>S/93@5T^YT,A$]V=IFAYHI>XH93^CC V[RYARC>T^0(MO 5=Z1.QCE-;&J
M2XQ06,F=J(#D":>.?"+/9("1T\)93T3K(6]H%A'+C)70,GF'6E&_?SAS:[:Z
M=MI,.Y_/Y0?,B0<&_"O+@&:?S4U9[M;HFW9V>J3)^5Q+EM\ML[[!=73W]\-V
M>+0?))'4CMS.J71OSW XGL:RVQ5A.)T,9K/NI#<8]J?=>#+LAJ+7>H8/UZFT
M03EPJ4N1+!Z"?3U(JG0U@\7$/CFJ#[KF(J'PB(J(_WYR^O;DO_U?%MF,T,XI
M4<<&<(NK)2S;4PZ>SY_>OU9^&A-#C8$'%G"U0$^?B?2+2?%C7;N@ .UK_ +T
M2Z32_\WR+_YO<">R].Y.[%O>-B''HR'<K,DPG _":6\FIQ/1'0Q'L_%X$,9M
M0<W!J@D?%R)E:Z?@%(S#\,_N%([94Y!QTNWUQ;@;=^/9># .Q:PWZ8[">:\7
MR5ZOUV_C$P<;9&1N>QAZ[W5B(^ TC8KOL[R$?US5?33!31+&VR)A_&<N8?H#
M&<5B/!R+T7@0]^*)F ]F<7<<QG%WV)L]2L.69WL)WQ[2)3R5G+#H%D$?Q(U$
M"7/R  '_VU*RF(0ST1L)#'D/AE)TQW,1@J($@D5&\T%+R6[,\) H^6VR:/6C
M!H+NC>+);!R&(I*#L"=F?2EZ81CW9L/>())A2]#.&?]\2 2->5<I5JRJI-OW
M1;&6ATC=>XWD5;U[8;=S8DHS=LK* @+M^/:9S<R7A]F]6]Y2.1M-Y_,(LR1[
M@WDLT)D_Z45BU UG\TF_%3L'ZQ CQ4GWRSO$V_F$LF<T&DSBX;P_[H6CP3">
M I%CR%G&4_AD&+=4?;".I]_D,L. R7JILFO@50L612=%D47)$Z4*[NH&?I.M
M$IXN)3[HZ5-E=T)I3H7_[NMY,DM*>"+D"HIZ9(O+:YQNF5[$.5)H@E.Q$3RA
M9<KKCD^52ZKB.4G-^+UMXW-Y)3V4Y? !Y1)P=@P.GTL"<HIV-GX>HPSC?9X4
MY_ZOXG)O'OQWJB9FFTMF!9]CXL4"RUF*)$[0,T(.E9**HVK[F:2>!B(YHAW%
ML^!#FP2$3.;WPV,\AER>H><F9^H0^*(+K!N+5'6?+IF9F92<>J47DMQ)5&)R
MSJ#C?USG6'!(Y3:TC1X5X=1K;)>P%_Y2)&DIJ)VJG@:5GI6%OZ20*=5Z.9/$
M"6>@'Q)&2TKUR)AE W-3O_?GN:2<Q@CF>B;9G42I8%@]A DW2(C*2;425Y2R
M0Z5LQ1*H' $0F/YG6?:%BLIP?KKV;9FDZY(OF)LIIC35,YG*'$;'6ES]^49I
M<2X]59I+$YM)_PN&GF$/]'DQLH;ZW-1@FT/B@JA:29IY2&\.E=38#<(5IGJ3
MJ&@F6Y<>[U''_\TNRYV[+9:#/YSZ+)5SIU]51#E8H##Z[*J"S];96#P6]2*$
M13:#^\#K_R+ERL-B10RO11&FKG+U,M!R#$-44.I4 AE<+5$"JX<+0%++(095
M-5D?IU[ 1R=,*#LVX4G]-/ XJ:^^F8J^V-=)+DPS"3M&81*<=8D3_KI06!J:
M1,OL3%)&%!4O54 IF/^::^-N5[&QG3#DG-->;6-C(!214Y97A)P!R$I>4*8N
M95<2'5>+=X\H[Q'K)SD?@TZ4E#M&T L\YXLM%"'+Z%A=5'<N\"=+';-.RR\^
M$4&KS-4/3-*U.^!<]=4:MB#R+$'S"6ZR'U7]5SA[K8MF?<,=,2FTQ"_AA9=Y
M4JK24FX([< >+.2%(!027>.*4\*4#QECT2VR"X<RC(>:$F)G$D=U*]TOD.?2
MVDK*6837U!@&XI[4/O(CL/IF"FY2)03J]Q&!>7@WZ#HNL(R>TDZ'7=P&RD;3
MA$\9E^N5.ME(M;FN\1 $F+K2K(YO%OQ"X2EN3G?C5GGO4X,8P+GH%9RS"KM"
M^G+8H%H?L.'Z!L"NEN=$0)3?Z(0&= 6R+9&V9Z/W2!>(5S<H ^F+M:+G]>UY
MV(WQ++O99(3J&6!!IF"U4JG*&H@1PBA"D<VA,T3+8=J5E=*7J'Y;75DGU]/]
MVN.O\;(S/5)>:&SS97,U -T:V-ERG9/H,-N"@OHRH6QHW*XZ5SUQ1,QYQE@(
MP((*!XECCM@6A== #GQC3!6W3[=)/;;"CI2&B*ZE*G7QOLH\2E3REL!B]Q15
MBQ6!36!9,3.S)>9TXY,:(U:1S5&EY'U9R,6%+(ZI_@#&BY."V:QZ+,F=4G%1
M6%&!F?!HDEYIWLF'^@:4<P7*D2,*R+SC-8HY(]R,FN0J'55$ELL\PP]C(.T:
MAV^A@;9EUDZ[+SZS]K96B%O5?2&YI)[N"Z>;QY+LD? G1&;!VQ&OL=I:601,
MW<"J2#HC'AE"/7@$CX7K1(:P!!Y"BDT:*PU*^D?&MEE<;3$KM#H597%"""?"
MP7'^(E$' [9!-A%/Z9CS^BV"#W 0=5?5G*TYL&#U&68!IY3P;6V"!**" [BX
M%1#B([% 99K!5G+)2*D.^(X"!C/ST(@N2D-W"HXE<,OL2C).G9:C?)FSHJ[P
M'[O>W,65"RE*50&D.&)N/@Y 9ZE8%C,'K_+FB#K_9#EIK52$9:%8%$Y10<P/
MDUL=3*)((/8/63'THT#5S!BQE?!CB&V8?)&\LS/XV3I5H"H>EFT0U)*<E?SC
M&>CAZ/6B<AJ]:C6@ Q928'%1&J'462PV)0.3[S_7JDX*@08$(;T4*SR &6/7
M*97-8S"4I:,P&?78'*^SP2#;:'\+F>/5*)RCH\VGESO8296W(NU1!0N3H<;E
MI"OD,87R<%Q-8J$S\"%56R6_(M_7"$HLZE!WHN(DH'!YIJS@X@L1 P'*HA&!
MZ<BD J49UH9HD VS-E+C@=H\<TG(L:,GBWI!1,8J8N<@3A6A+VS2\B:F+3QV
M#L*I*-5M,WNRN-(C*-E?.P*#MJ-TAT!/ <V\/"9HHYJ!8>FD D"C@$5XMWBG
MM6)!IB""9*W!1B"X5(64HS%$\.ZO^3&O_A(V7RTYP;C99>H3UF)YGN0*".,_
M8.HST/KFH+H>K5-21V,$,32H./$QOX@.'3=;5]*XLW7/W*MA'?YC'9\1V1Q=
MBWERS';(19;$!O*G<#%_"C-!0B>C(CA:).'2,AXDP31JPO'(G>-N+BK-<-.;
M"%!5S1%N&1&SHZN198UHCU&21^LEB(@4JZ_0W'(YSXKA4>"B:;7\2YI=@J5U
M)CU5@"7S1),[[(<XIKMCAJA>([(DU)CN),C.(-(I*OR%%G0T.S9@;*)DY)%H
MO1!6ZGC +SNJZ-RZ"VI7"P0L(VJ2 BJHHDWC=2G'"/NB<)+LV0CTPI7?0'U,
MH,XP#;0DS _4;SRQQN9N,!K:Y_@+K52ZO@+M9M+,YHO[Y9PZEY.&>RGQ4/6>
M4)W$FIDU;R+,R9!2Q_\3@90-BPD\=#.>$4O#O7;07'!27Z2I):,*OID\%XOY
M!B(8T:6UH6 S0=J#SFS>OTB$8O+&75DX0X.Q2G#,FXS*<;5JK4/7V>&80'QF
MP"7]?)'A1A=- D@0=2D8T"V>72^CFZHK^NBGEHDHWE!>N;=-6U?DZ1 ^ZJ,&
MC]$J.*"F5*;=H-7,E?D#= 9<"<0@T.-,H2O!5_KK6"P1*ZQ84X\%8HH;^A&K
M/5A4:%R'-"TJ!*]J,ZJ71V"G3M?;W)KZ0O#B'K%BHITRQP@[:8#HBO62<*:
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M((^\3"O+&:M^7V@"_B:N-M?FD\6)XEGDBRN/7"AHFLFR7%3<L?9U#&^F$AE
M >D/.D,+.0XO,CU!&6',?=M&&ZDEHX0I?V1)F5.LPWA;=1A'B^,,#^4I9&,9
M[,$E_ PE%V*7&7AU0VFJN12BKY6"(ZGV8G$80F4B8%LOTK%Z73.,4: P]V-=
MZ?7E8(4S^MH)6*R+AET@_6(#[RP,S4MT4%QK1MG<8X_8@@C]YZ3\UQG2<0QO
MB==HZ;)KF&YRP\C=SL;8=LFD-N#2ZX\YT/9,'I93*-/\BI8)+"9564[*#9P4
MKE=I!Q)8.EV_=E9A\65>@Y*JG48.-@C-/5Y'JC=I_6(ODY0ZD^:8JK-&)]4%
MN@!+FVF'MQ'FL-?>0YO[NM'/@!;SRV\:7!\^^5-<H"JRK*FG@\"[YA 8'JKQ
M,IKM[_A_F*S#$_7+*B]WXBUX9WHNR>%5P9MV+@J/6J,QW[D0R4*[QJIZ."X8
M2;=GF8O*+-#:N>HD<,T>,*,$#4TY6;&=CQV.FE"9"2#ST%DD-D_)1".LQ-1)
M1G/4Y2G48Y''W!.!39PE\&Q:X ,R.D]!2SA+%#"CR=+Q&O=3\R#.47 V=I'
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M)D/F=9(55V@?8O2>?*M.&'U3?/0M?W><'D[GY!AWCOQ2S)2=R5R[-.661:^
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M<3:[ Y6W!#2,29[XWT#!.5L1;QI68,B-RXZY1)S\]9?G'/\ESD1O(@:@QR=
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MV+SACX/(3..F157LF>,X?;_S+H/%>9JQ%#%5F=^QTTG\)H^1#-N'0*9\]^0
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MZ%E$(SA5ILAX8%],J_@.,$H$.'6.XY*J0I7Z79YA!@J<F]9.=^1*S'6[$,Q
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MSH4;O8Z!&P,<FA #X'R$BB4SUK(B&+?E>*O&*'*N\P%_<8=.C_4I"2;D 9!
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M1J3"W<Q4^I1CQ!U&M')R%HC% #@5XGO!AQ%I,"]0"7 +!WY['NQB&8B0#<)
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MD^_L,$J&BPD?MFY;3#?#<_C($1A;0_F!//(P.4__BHF]<SY[!?WIS!AB0<8
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M&[434UYE:R4B4YM24C$EF#46Q]1G3^:+*5Q&0[HOPV\82(F3.TH79(?9&ZR
MWZ LG()1W;'U?3&&@/ @&F/2<.4"6Y7[S!+-[\X+N'T)BG3;2X#^T?;ZSJZ7
MP!5=\QUHM_!41=MQ>U[[.:VY8=]>:UC>QHV(W[XV9N53SHX3RGS03+HD&M1=
M_\;D2HCK&$DCF/_(?92:=Y3&R8HM.@1;5)BBV$@J6V59,2&C%4*1Z5-*I8\)
M(A7_@-<-0"]I),$/4BDZ8U U4TR7\&_:U"6,%U30I]^C))YR6(/Y?92$V-3[
M='9/-09VB(Z2@*K"Q7!.#6AF5J9D"G;P=\+>+?H4X&UC*&9:,-@ JJ3F3_"B
M: HA>JCGH%XH5AW*E=CB%J=\$,;#!2>$A>CH=_ %= .D]<SZN4%I-H!.:N3/
M MF]38][Q$X-\S\3NK&(89![(?5DL>+J.]7\RXDGV&=,0;0^7"G;?:-L]T=*
M41,_XWS8PO+82@/5P0G<58#]MM_SGKN;I0 +Q^HZR3HFOQ+J<%%.&XS)*[3@
MAJWXL&'Q"*_0*!1<B%2/,R2$;3:C[;0[W7UMQFM5V\5]1$8-E;^OF:-JO;VX
MNGZWS*J0IHT16 +TD^6VK"<JQN@"7]U"1AB2(??13+%N^,6=4M6 %S[;+&S
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M#-W-N>XB(ZKF6,A\JD8'F<[*ARDE !'30B)F!?'A!D8L5S.W:Z_2(%72K<&
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M$3Q(7@3&9$36B.S)B&S^?H6[D<P!%\4&)/K,I$4AC)6XKIQ(S?UGE*?$4L>
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M93J::XCC96SH;2B<!Y&/\IR@MG-/5MF! [>9)72D^A;PQ.M']A\W/Z#?V/E
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MK)-'T"ERK7?32:6XV@<(6&G$MX8L(^7[E?("OW\W*2\C#N#YU5=HF6QB2<&
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M O<O408EQ.859="U6[Y1!D89&&50KC(H"*N_1!F4$#E7AGKU;<^O/9RS-LK
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MG)G,J=5DSFIEM<A^W5E8]V>Z=@\./E\E_&.I,6$S^+)8\CDZV6E-%ZO=@>E
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M1[,@13ZZ2#'LL"0D\F_1U6/(8C!FKOT8F+Q"+]JF95IIA+\=H?;BB#&,CLJ
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MNG3,8?JO-E2,.^B[WDCKF/:2J75,-W3,F]V4C..Z3D5[^F&4S*%ZK-;5C)'
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M7#V"QFK6$J\E?D/B!X.JKOSC2GSK6_,5D#8%2- "KZ+ CRM[0XXK\!TH15!
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MN3G:AX8]>E6VUL,7EGK3DJIE/\?]C&[+J@&AM,F-?/:1BM]_?T94=I#76ES
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M5<$L"/UP$OAS7E2@:PHZ75/@M"L(=_P@=P=HZ%Y-P9/&@$O 5);M.N[0S>R
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MA8K)I_CC[V*/B2NB&]PQH.KO43R'/6;^'&YR%=_Z89!P7I;%.'__ZU5>TK/
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MP"_TPO!"Q<(XSWB,EO,IA0_\8 J>]MF?X&VO-_7)NEW1*H W$G?FO98WB.E
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M#3\K$!Z?P</^1=3GOH_N;P*..7NZ4W-4 V]\.!;<]1,8U(V\^4:-1ZG?[[4
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MPAD6_+\7:8^G/N2$W Q:OPR4.(ENPX"Z4KF7AW.@*;=!_AH?PLYO- ]D4[U
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M A1!>EZ?65H-JG[FK\#KI_##-R*!U]_,X %/!--BK4IA5B </5CFF _HZ_=
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M!F0K03ZCS,K#!)".!ZGDL4?/=S9]H1'BN1=+5Q\>%(B,!H0X?$@.L[?Q('I
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MBV9UE@)1$H XY8L,*!@]%DA5A>,%0XEE6"3C,((!&= +0TYX*9@)Y_#D3>&
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M/<IJTM#/;E&L*.WY^:D>C%LU"LA2!N3KXJS_RM>@_54LA@$EW8-*R,0,2BI
M:ZGN/NW,Q<87IWKR*EE>K PSAK4(\"2#,?7O/:I$*;)+M&"5OIE6B5M_[/&A
M;N1;'I0'/U$8(CC%(EN/+#%<)'3Z$ RAY@WKY#DS/Q<1Y/W=$S8N$4)PK,1,
MOIK%^R"LNXB%>L\@)L'\K>"1DL$6P8=!\#[J--PJ9R<2TSB</K$8(;O$&-I!
M=F <.+8L9@LTTZ"Y@%W/0_//0[C'P$)*F\OE;,,@1=6A:$HT$BR_P/)[X*;3
MGD.Z#'!J5U:10Y82NYP.!^<!,-Z%'?D@0,3T(N9_\ @.@9GWV>/E*!R]CL6'
M$6>)QC,7OIC$L)CQ'A8:Q QF8%^S!AZ*&48V#6: FMQU8@/7I%PR(R87B+Z%
MROE@1DLJ62!$AL0SD0PZ*@LN7S9WOI/] A'%$%:3?A$F#'!X"<I&G)P,J^6/
M7T(]L<%765H?B7DE;#1A#XHN)^AFFL.$Q"B@>8+K!>VB%5_G6N=?BXFH@X79
M<)RQ9-)IE2C85V+43"<L?0$]RX]S@'3@.R::,?(I:B_7-T8$+LC&<;FPST0^
M(AM5HF*-/)[>VM1+@XX.T/L488SA5"^'[,/9]*7P&@&F (7J<5 OIE@>X5RF
MO+$;/L>C?(1['_E(^L<YR[@P=#F@PF/MWM!A$TQXUH;+R6-(6U$HE L-'%+$
MLW1$4(9\<;F :P.%R.0F>F]\9Z@8T$$W,)>^D$ILYY&<%%LJGW'/BQH8RC:1
M2!B"G&;]9OZ8R!(;ABOPM44K6?X=L UT5,A2J(9>=[/[D'Y&#I(6P.\B>(HE
MT_653#M=+)G&DFDLF:[=8U>^:%H]Y_R8BZ;=KCWHV_W=0V9LU*G_&:P<[/34
M(ZCV6C@)@F[5(ILH&7P#'I9D 5:?-RTM<%;8N5G@U+3&)Z*;*38Q4VY-W -(
MH+&^>#F\!R)&"T!43.W[N?<2A=.IF/,#""(,&( F1HG(/@3S.9T?_T ^/J7_
MQ;XW_M.[SWA>LTF'E=+&-*<!4ZV#L9\6=*H',N421>GV]IA S94Q*UP_G4W*
MU,JH=4M(952%F:Q8$POG0TE3IBB="B6F(39L&Z38^1BR5'&F4"%,J\G&A=E:
MO$)S!<G&-(AW'?-RYZ*1K=.01GQH/<#L)/(YBFKG3A!F2,)HR-:+^<2UE_7S
MUG*@A#103VB>!/$\Y)4QJX1 ZPU?;6:==YRI^!J6I[S2U#DO#I^P:X16@/MT
MI@-0$8<4J2;D=Y#/<)UH07>:H8C$\#]!@0R=/@H(+98+$E$E&1!^;WQ9W2:*
M(<6C7W&VOAX^E.X2W7BV59E0+LNXI)7HHIH><B!"Q+AHR5=(NODO8+-]&M.-
M!2SD?IU,L'=!PB/81'D7#.?N+.'92"JE LCM1A9(,M.2 IR4@9Q:4P,M$@0\
MP)X7@DZ>ZX ["L=0+X4/"SA10=O Z5N6LT=W:T3[+EZN*0(U&@6J& 7!\U&8
M!(+]TAE/E _1$EA7>SCKI*DA,3,=-'#\FALKEDP?5#Q)P'B;\./@Q_!.8.;E
M9ZI".KU3.-(7/L-PU#SIHK$"-?#N!"HQ[T8U+L.2AJIW1&LOWQ"3^I>F&!8,
M76TST#[>2@93EAD4[\A[XW3VLJZQ;KE!)G4I,T.138!ZC'R&"6^N+I%N=(KT
M_/]"!A4$G)6_S?(GPS)C1,$S'"!19<"G%1%"9M!E!X[L;,(^G+.*R&<?%;S$
M;&<XLO<HT+N@N_O9FP.SXQVFRAUV'%?8.=4:6#6_<9.H>=D9,PE=[KV'PC4
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M\@KR"O(*\HIB!ILVO*'UB!!VF#_8#V[#Z:2J>.-BFD8<^=20R(^3:#%.%A$
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M.<UH0IY3G.>4*E5&< )=0I-0J.P,UH8FG74P;)G@9,U8;+;I#D;J12MU@"7
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MGH;Q(O*O[L[\Q NF_N0BM;)/;\-%<L,W@>,YD#^FWLQ+PNCE$""'C6@4"/2
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M!7VKX9IK\T=Z+5?64?(<ALD:P]77N]X)4GDVFJ07I$2]K?#T>]BT:G]-ALE
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M-[SO/73'_<%OW/O>O^][@U'O _>1ZP]NAE][^RWXM&:UY;0I"]5 $>'G<6J
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M0HP(!&O+)&\93 @!B^L$#*0:,)GTU2\%REC_DWV5U^8IIA+KJ+)R5R/S/L/
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M?!K]G#P;UA,B1806^(B1JR@5XRHV/R1"Z2&_Q,N8%T<195'O)%DQL( ,K=M
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MTR691?R--YC12^YA?<9A6;G9TH$K', CSS#G6^8W$NZD[,-<+L+W]*?M$YF
M<+X7:[,=3*UG+\A,A5,=P ;YJO^%Q)UC:S1!6$:N8O?9N(N4O@(G+X\@B^M3
ML[C^]=D);Q3LE#YN\H" DSE,.@:^YQ!,>?Z7JT"*,$3Z</HWGOP',/0)73PZ
MR/CSPIC!2WXRYJ_&F[N)O^$78I.0/I<?@]7+HB-79!Y>_0\>[?ET70UT)5B=
MQ;;%3$[SU:Z)Y?R9Y<C4IDG!8#CNC;CQD!O_WN-NAH/1\$O_MCONW7)W_4%W
M<-/O?FF-QO#!U]Y@/"(KD==+[I_77=*5_;7?7=_V;GI?/_<>6I( ^R@ORH%@
M;9GD+8-9Z5K:1L3]FM#8C88@8*Y(@L9W=#VEBP]FOP>  80?SGS39VS\!.MG
M;EB&9SMO66)3""R>!3&CEBBNW3OQ&OZ=[+;<!,WG@7'Q/^_X=^1W;#V$OZ<H
M\3_79OV?:]*VMEXQU8SA#!:(I'Z^VQ:3]V\0;!2; ?I"L$C;0.FXC9<8F+'T
M[-1A)<RN(@;9']P,O_:X<???W/O>O^][@U'OP\>;A]YM?WR<W77H3K]3]H.*
M)C!D54'3$\9^7.QOR:Z(IOV5"=1]M)?>S3-H(@(+J1"-2,"2&@"OKQ'^-A,I
M0P;E\.6@H_RRMN&<H#1KFK)5-]*=@!,/H?8M^G'^3DZ'-^*VQ^"SNMQ/-38M
MH_0MCUS^B93B30H!I%LT02^/R/'G!O:S:+BQ?6T_T3PU[_-M]/=__*T#^' %
MFE*$>UU=((L)>F&"+C%!9X)^#H*^X0DS0<]-T ]- **@U4A)2WBS=!P8531J
MS_@91L@^OI\X:&IZN;+[%M7M8S>B5-1BA"(F=3;O;-[K.^_GQ<#>=\P8_?J-
M[2QLOR$F1F=&M7Y4?4!U!Z)[S\@[O"#+DBI*^G<QI6X[V*']F!C>E_VH<5GM
METH^&:<BGYSFFS=5\E-*?K-+?KVI\IC,-T?F]Z=$Q84^K4XTN]07FA8E22JM
M6E"3Y";6WS1*>8(GK$C/P8B%B]\;Q70-8OU,SZ"?Z1J.2FM$XQ&"!J)7B>&L
M4%AX3V->-U/&ABFC=IHR%L'D(ZL4%JPP963*6+B+(:VS1Q^JCH4Z&106Q9Z]
M&](0.H/N%-<>O,3/-DV+<Y"[0!,/-UY:.+C8 B?QNX4X(J4S%U#(2E!+QH%#
MX#6-:'4E>2Y@[ IPA[-[+'+W\!0[K0MS$5Z(P)>+L!34DC*]JZG>'637I%&$
M'JMXA5;+"WJG1BI(M4W#0.'\0.$@3$@[3CD6%(K@XU1+/DRO(GTR,88BCC72
M$R6WU]QL%-O$"_S8D0-U@96*IX0%X)B<,#EA<E*JG 2;_5D'[,:V9\RC$4Y\
M0ZWP>@3F(9R3AZ!FSZ_M6M-,KD-9O93$3LF')2R4QW2R%)W,GOE[BDX6D58@
MJB7G^#"=9#I92GA=/2 S^12M+);9L5.GTR^J0^\L DBEPUSY ,[68Z_7,E4^
M "8GM5BFR@=PMG)R4@2PCN&^E%OBOT=<)[>85]=!TWC9$.<' +G 4'G_6$PH
ML% Q*E=KRG\55K?*UH6M2W[KPNI)UW>.(:R9:1%"E&B<F _?0? VKC''R=T>
M>L&D*<X;-S5GL)$@:X)K3EV$?)YV06;5I_0;;C4)ENDIITJA^;(>+'O 70=,
MZVELQ\2X:TT? N$=SL:AZ-ZN)+?LAG4RA?U0&A))JZ%N5SZ LP:7E..QPL&E
MT(QX1=88NC!TH68 #4.7Q+=2GG@(]J2= A8./D5DWDOB_I-ZJI2*I0WFZ U:
MR./L!7*(?)+V7J4X@RQ5HJ:I$CE"J, GN8E6:#A WC"4R2\@DF7E$<K[J5"H
MRXU@J4M,'_/21^UX?2PDA[ BRX3I(]/'H@(8DJ@*LB+) LS9\=I6;&Z@Q,KR
M66X@RPVL6URE#KD\]5JFR@? Y*06RU3Y ,Y63EB8;[TZ>!K$H/VD0-(VF%4'
M,U?EQ$I$(:W]SK;CCK+"=7R=.(,RKG.N]C53S9JJYD%I$$):@Z #=+/0C 8)
M=RENFI+6+H&! 4%-@> P'#@D)Z&D[().R:V2&*\?B]PQ3YM%9*H> ).36BQ3
MY0,X6SD)-GL6N8M&:!*[+"UNQX'EAZTUTUKB++T@7\^V7-RWP_4,#V%^&9S.
MM_HG%NMC?L21?D1:YP[?:5@Y$3>1. XCD2LI[B?7RJ=@<3^FI@7%_=(:?1RI
MI\56->G-TU<6 F280"4FI,4 CP2%0K,,!;U.!*%4HP*+55+IVE<^@+.-+=1K
MF2H? ).36BQ3Y0,X6SD)=MKSCE4:/Z/Q^>%)')6<FFX0F$33>%QR54'<85F'
MS)TY-A*9UI1DY<:L:!5^,TP+ETH-K=M(( UK4E FXLS\B:87?R''?G=]42,G
MAI4F,LW+K'DIL<43-2^'&"/3/*9YC=>\M C>B:I71&;??JX,*O6/!<NH]"TK
M'\#9.K?U6J;*!\#DI!;+5/D SE9.6+!L/;&/5>(R_R __Z"39,U;/]O_C"PT
M,SV6C,>2\9A6EIAXT]&.54N6>U>++!L& 0P"]D# *G)W* 84G&I7IU@=U2"P
M\FP^>L;C'.$/R%6M[!8%7$N^RTW0?!Y,U?^\X]^1W_%<A+^GC#\E)NB_PF9H
M$"8B7!&>_R6NFM@9NO(]O[_QY#_OMCEK_@W$SJ6DP.TV7;=BM,[86(FX/":&
M9BP].W5<"3$J8I1]B\.6=)OSGA%61%AN"[MZ\ T'Q^@1MW! $1VX$>?9T7"^
M+'^BET=[Z3P1+O8;PS*FQN5V?W!#XG:+6NCPPAQ\XE?^;Z")_'J\F,GB/EG<
M;*1YHBPF8A7^1;A#O#E[*^0%XF+J(.[5<*/1&&MD87X'47O&?1O]?>?&I_"*
M +:JJ$F"JJMY$D-]QS?!]_@-V4^P'3SCJ>PZR'"[/TWW^\1>6I[SUN]MV2#Y
M^ ;)[W-=I3:(V\;.&$W/>VR1?XJ2G?9/B\@KO"AHDBH+FB+FR<E3YK0(FIPZ
M+Q\2$R,>,C$2+PL2KRN2S(N\GB='2:D3P^M[)L9!$_O),EU0*-."W]P%FA"%
MZN,= =">_#^-HN^0650$7E)/8WHY3.NP,3O$\'%#IM-$[E?8PI"3QZ2*<KJT
M;6AA9G *ITF6=5%72M3"(J=)UK6,2IEYGD*TTD1).J1-X\E*6:@XJ<>JJ T;
MMPM#)$KYQ](QW:E)ONP>8IQQT;_Z(Q@L7V ;GASJ'\2NC1]@2"JV [A?$_=.
MKJJ,I5^0%4 )O:,DW%&<)3*WW:6#AK-;Y!GF'$W[EC^=N!\5&*7>,)@%6/3_
MC<\!2   F.'9SEN6P#*"M5N0YR[1NY61Z0<!(OLR@[WI&U8=Y9>DC;@O3V*7
M';IF?&XU-],]UN)=VZN4CN\%V(6]V0PDW_R!$L=4#O@M>9Y-Y13Y$K<]!I\>
MYAY:BDG(!(&H.QN'AB6MT2V:$&3TYT82VM%PL:I5L4[Y9PHP"2E,0B0F(4Q"
M=DJ(2*.$')\]DG=Z)BWI)#C+-QK@(\+!1KQ;$[.-^\??.J(@7&TAB'H/;@"Y
M0KT"NZF8O)/Z)C31F.-%ZVE7Z%=W)'"K4Z);]XX],STLJI^)A((+44X.2HQL
MFF]KTJ;W5Z,VME0??M500RL?P%E!1' @KLB %IKR74BI(<N&$L52TJMM7=08
M2C"4H&8 9XT2:?5NV6"BT*P966IK'69,%)])<ZB75T</KAL_=0?O#,<$#/_8
M;PY"'CAU/H: 9_>I$#^M4.@L%Q;+?Y4":Z38NK!U.;MUJ4N4#Y^YEK-'W"P=
M!\:0.(_[A07LF)U]I)TM\[*H\9+ BYJJ)*M3P)Q^,#SDGP$/9X'DP:?#V;UC
MVLX]W-^>'E9#=K]T4&1S7XAQHUO.:G/SEWK)[>(:8W&G(D7UT\00HT:(L>:9
M2WF!QO9P7CZ@H95<W\) @VJ=K7P 9PT::T5PQZ/&]NA>/JBAEDQ ?TZH04-T
MKSS/+4GW\7[BRSC)]@]S_3\4Y,HU/T9QNJ!?[5K(1*XPQKI@>?*7D@PE50K\
M4$4EI:2J"[-C/*$H:S> U=(]-.%2Z90+FTV!1,KTL&E*7HIQD]9Q*[MF%NT&
M"253\3#-9)I)C6:F91%D5\VB?0VY9%^C*:J95F"7K*P[CH"#<$+ C=#/R7PY
MW4>J\"Z])@]S+ A;2!:"9\"/Q?:2@-A]-NXBI4_LR;,NR!ME(8OK7Y^=\$9!
M)80O2?SBY]5DC@P'2]!SG,(AF!V<Y)^LS%N PET\.LCX\\*8P4M^,N:OQIN[
MZ?V&7]A+6/$QD(PL"^V;^J_^!X_V?)KT"/E+70E69[%M,8_U'=*D8# <]T;<
M>,B-?^]Q-\/!:/BE?]L=]VZYN_Z@.[CI=[^T1F/XX&MO,!Z1E<CK)3,0@>3D
M,MWV;GI?/_<>6I+0CA>F;9GD/:PDBY5GG$6OZT=@ NNCEL=?HFU4+]-(I3.X
M&7[M<>/NO[GWO7_?]P:CWH>/-P^]V_Z8>P]J,^X/OO5NCZ%G.E8&$W7<X2:1
MV#UV5&G["UQ.Y.D9M6;V?&Z_XKH?7Q-PB;LU,>?P+4Q-9"P6<UA1_"\/:+%\
MA%_BE!2X??P2UW5'];^<9Y,OHM!L@@\\8[[Z=S!ZR 6_ 9PO4E/5#MF-=Y:S
MAV$1552%CG!P.?LH?+DP"GUB&7L&;-ZLUS_'\O=2J599@2@K,F<2PHK,F810
M*2&LR+P6)0I]QW2?HQ%.;&=A^T7DV/!C::@L/^24NG'PFF59UI5.2I V\D]R
M/M/<U[I $"^5\\X .23*\Z&X@W&6A<90)J_C(( 811%32\^S ,U11[0,:!C0
M,* Y4Z!)/7?.@#1'G3@SI&D.TM"0(EN>=^GG8$1#M&=<F"7[A@R'LY 7LI99
M3Z0D'FZ%CR<\](+]4.>-FYIP"_C&!/X%GT" _$R>.<M.TFD;\$T/L]S'F7Y3
M&DJP+*":9 'M]2TQV;XLJY+(I[;-CA<?P*]?B&B5E#9[+2B7G9(;<-4A\X?E
MY#52&]=,(S'%!SM (8O(EKT6M$N!*213R/-4R#1?Y0"-+"))]EK@+_62R?@:
MHI'L"&N_DQ'F++D<Z$;4X@,\#@O\#)>=:K$PT(F.AR*K&1R/.[\]8/!I:>Z'
M>JDR.A4*#2(&$<V B(,BQ=)^=V@_3!1;0JA==LZ<2:4^X>,::G_E SAK^,G@
M_.W'GV+K)+7+<^_>4!_\.??C*Y(NR9FD)29IQH,K/ R/>X:!(*>09GHLH%8Y
MJ.)Z)/#[>%Z61)5/U".%($H$PV^5.O;%HNO]3H2B*LX6^9)G,6_&#-$<'3W$
M[I&UW+2TD!,I\5(MV>>J@W(RW3P+W5SCBCQ%.0LYG))*YZ-NB'*RLZF-#C#3
M/Y:N]P+#6+6"27:@7V Z5)(.QPZF6-CGQ(,I1>!Y=7_$)R:5=[93<1^ :_Z2
M9YR\%-I+##F:@1P'!8R5_>=51Z-'T4R8RID?>]<GC%Q#4*A\  U#I3V@)(FJ
MH H=2>FH<G&(5(C[R%\*S)ZAS\6LH_OX\ _C97%U&XT1GR]-'#0UO6*<118B
MJ]B! ]#C^9T-F!Z0BPQG\MRUIK?H!YK;BY<BG3<Q"78S\R>:7OR%'/O=]06M
M,3)ZQ97IPN'A8K4@=3C*&V'JP-2A8@]=W=UJZWB%*)H-7RN9I("YWNR,)LND
M#;UGY*Q.9SSTXG+O'U.Y UCT@D4O,I+?$6M>DOE."OD=D;@$;N.XQ4/ X&T2
M_L7/R'M%R.I.)C UF!_CWK%GI@>P#E_L_5P@RT7^87GIF67:I<+X9FH"]S6$
MBLH'T#"LRL33*2JJ+*1T("P<J@I)K^,O.R7W*Z0-H1BD4#6 <X*4-7]52RM!
M*AQ6"CG942[YDDDKS@A6#G%,$]-TZ.%..EO^]KXJ&PU5XDV#V+%+IMA:@:_"
M8IYL7=BZY+<N+$"87@9J_D")<_C"ZCR9D=P,(WE_3:G*PU\$4173&F3\R-K%
MN-A@GW"I,%?ZJ/4ON-24P<0YP,2:,ZVG=;C(C!1%)V +ZGDC!3L68+C34-Q)
M;7B1&7B*3BV1SSSANC[ L]&K.V/']WB\K7[=W\7.I:24U_X]I?-%7-X30]O2
M_SW^NKBXPIR]E= 2?I"EK\<CFAA+%^%FY,[*)<<7639<!^_BXG8BB1O-3>/1
MG)O>&ZZ^QEW,7< R[H^E8[I3TX>_U3?CERQ(NAQI2F):[G(V,R<F[E\R6WJ
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M6*E.)J>B@Y6JZ[4VB H(Y4R;<'S]!DN_X)Z-*0CRTC/GA 300AYG+Y!CX,9
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MD^(N'__ '-#8QH#I!WF!G<V88BDEH_0M =@XEG./3'/ZBKTBLJO"UFWAW<4
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M?&XX[H=CC@]9ER)&II^-# LD2Y<T1184^7LL=BOR@B3QBM81E,US("+5H?^
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M QEW^9J:[L)VC3EN\K5P<)LO[ZW-X299'F=84P[]=VDN<)4B"_NSL'_^8*@
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M*NK]?&%N#CQ;:YA>^CTK2$)G(<EQ_$P,S<_"K(UC<HNEMW"Q_,26:;QY$"W
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MRDFTTW8Z8MQH4RJ($W,:)SZHR:H$_>79\';*42(&2(!X!\/:#KV=&-(4!D@
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MCF9"YW7LH]RL',Y2F\E659ZQ%S$:*@MAJ&JH1E)@-5@BI7.KT:T>H^0H-PE
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M#\WS4OT)" <(QZ!P'(9PJVP!0%Q-R0"9U5('9D08\ WPK2Q\TP'?&DP_X/4
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M80X6F",(<*I-.)5SRKA3.%5UM8QH&I!M :P"K"H!J_*.^78)K*JL?M%$0U8
MJ "H *A* *J<"I@N 55]I2R:J"D#@"V +8"M$F KIYJ%1]@JIQS8$"6C/= 2
MD0>5*9!9XS^SQ@B383UA/6$]V64RK">L)ZQG/94I'2A#^=UREI;W%O(Q+$+1
M*FE-7^,4DB9'CK3(=98EJ/?@L]Z#Q=% G#ZJT_H/=13\UE$ !@ &E($!4)_
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MH562:"AZ:R B(@\J,""#Q'\&B1$FPWK">L)ZLLMD6$]83UC/>BHP&"BWB.Q
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MF6FBJ@&P K "L/(B>8<":TZE6<>!M8&2,56452CH!9@%F.5%\@Z%V9RJL9;
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M+N?9?) \LXUHLL3H1L*,%D 1!R!=,:3+.UX 2,?2"0,9P [ #L"N#+#+/7<
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MJ'G?-IA*_NDU=[-C2#^!)L"QTG%L=S80H*PM24&&]!-H AP[Q%L_#L@VDI>
M9"SE,#?-.L'',HJ_QKM]QW3X@<.SE(T3T,7#G*HB#0: GMW)_3)D\P!-8!M6
M[N-N9*@!W"I*5 .D 4T :?5 VJ#5D ;H4]8!S:)#LAE/' ^_CV=8C%%"I#7Y
M<^D'U9W7+&NX^"E2Y7H3Y*4H$'QW;D\$(ER2*)!_60#K<JED%*TW\%?/'5\X
M]A#V$:]1^&=TG/X.!;'P7MO3*?*0,T:9 _6[.YNS!] =[:7+ "HP0 ( $[O
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MQ<KG1<BBQN+<0$XPAA,R 0IYA\+6V(?EH)8^$$VC[19<1#245D*)!92^P+K
MNL"ZP+K NL"ZP+K44%I9<1WEQ]"-(M>?VP%^QK@:-RM]%243.Q&N1WV:<_S^
MR".$O;M(N4#)&UHI_T>PG(FP\H"$N4OB.)O^1MW5F8UGD]A+%+')$AAU"G("
M<@)R G+"+@$@)UPL4^,$@)QPL4R-$]!9.3DP;]&"0=NKXWN_6\[2\MY"EH2'
M]]3Z1FS7'<FI,SO,0U)W7V>?M:RN8IQ\Z$VI-ZF[[9;.)'U7]L[!"3Z6&/RU
M=Q>&(1H:LS/PFA/<:KM_ U8QN.0'8M7)9]1:A565'EM;P94L]47=9':D%^ 5
MX!6K>'7ZD;)6 1;+I\Q6>$?0KN;6C3R(?@-HUZH</:-5OO$!,%,:J(8"<-61
MMOTMM2[ FJG2FCGY*%0KX:'BTU$KPT3IBW@M6,6)3EDF@%Q\(=?))Y<81JZ2
M04:6Q;X$T9ZJ>] S5PM;"=.N9OBQ*"$1BZ" =TOA#5F>\/[.#9 PR.5K<X6K
M+!8AL';^E0=UW>OTJM) (^=1#2V[-V"Q=9Z1?^-L;A+4UAOAW^[8*M1DG(G*
M[J8!,^*;5D&@":#J"&-6'N0D00&O&LN.FKK*,X0Q;4\SPR4 5>[$ZS!,S4O4
M JCRE<&]4!D<N,<-QO!.0"6%[HS"5Y*S54Q# 7.P\\G<5@%1-VAJOP%VH%>;
MEUP&'&,AZZR @PL.+F\T ;YNXFM."KS]^%HN% ZTFO/B;9'52G/G/.;%KVU_
MX?I8_!(J74_P4&![B&A!IJ<3G-9M:R53L3RUKLN*_D?\L2IILB;+^%/\#2G&
M=9+P.$\$*S$:G8R/RRN8=S1GW5*U!9BH&B8VRR!E$Z"BGG0QH 7OS^L>6D1&
M!?ZM+@T40 HN<J!=!QJ6;]ZZ$Z*Z/#  &+J98F1"V_E_7O?,BHP3LDKT 80T
MG]V3%7&@,WO:BRO=!BRI'TL&G<&2CJH]'*G<5)R5A"5DAG- H@.5.ARHA'J#
MN@$[/R.5.FR?".TMEM4'-':?'9OZ1E\\=VH']Q[YO+5E"!W-7#&DGT 3X-@Q
MK4/DO):S &9,'L7$-JT"!5I0J\H;35W'W/S,(^!M*S*4.ZII :I;!-6-XS)[
M(,RLMQYG=/N2V<]K)P* "YE?%@TEH D,RJ.<^-S.Q0!RC.>F%;$_Z/,,=F D
M OP"_*;3] "_E:3S=;&OPBG]JI#R^!J$A3698%DY"]_\7%E\Y[+D8/A]3$^*
M)T1:DS^7?E#=2=6B?*MR/W&]"?)2% B^.[<G A%S213(ORQL*.52R6B\8G-#
M47)GUHX]A)WN:Q3^.9IA<'J>W:$@EMYK>SI%'G+&*+.M[.[]S\6&TM$2 P:0
M@@$2 *P8-G_S.O0!6C%:0V!R!%],&\T J "H%5E_^5-U 5#Y+1(  [)8E*!I
M<&,0R9B%K23)KFBRF5<2#X@%678>80C,KHZ:7;GC?P'$F,BB W0!='4)N@X,
MP>4/ .XV=D'@C,G V2'9YC6N5''H/<N4&)B:/53>>-40>R5"C;.$Q>(NW@D
M.>%BF1HG .2$BV5JG "0$RZ6J7$"0$ZX6*;&">BLG$3N6J?+@B]7'<BNT9C&
M%$(VJ3+FKT3FQD%M,,3Z:H[U:;G%P0=%[]B-V359Y;L]]F<8HJ'I$ "$RCG
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MP   8@> H!:2Z5K(EH#%\?FTLJL>6<FY7<WP8U=#1+$("GC3$]Z0Y0GO[]P
M"8-<OD)=)E/Y;$8]24W29%T:R*8V,/)R?%>TI;=_XQPS4UI+&GIK[&)_1T>
M0@4-0P2T#'%VFY8)Y"BZIN6,> +(:2[Y)\J#FIW<<G&(:=N60V!JG("6(>-!
MYP_-O$PDH"/;*4HPZ9C C<8)Z!)PQ>G(@3S0^P9@5M?SE !$#!'0)2#*6E Y
M:5- HR[,UP0,8HB EF'086UDS+S4:?M!"")3_$2F.C^49:4%"9ESEVR=48I5
MKR;%"KU?V]C[=7,#&.2=G4P$[A;+V0,:N\^.3?V_+YX[M8-[CWS>VLVAHTE7
M!CH. N1P"CF'&9V#O,.3@#F,9EWU 71.;#[)"M#(*30>AHRYYSL!&B'E"@8=
MH!8KJ)6D5'59&N04R0%@0;X54 A0J&[;*>\8*D!1UY.M $  0#7%M7+/H78;
M@2 :Q6PTBJDY'D<E6V'4![,%,#RT2.9KF1HG .2$BV5JG "0$RZ6J7$"0$ZX
M6*;&"0 YX6*9&B>@LW(2>72=+I)-3?^X1F,:>@C9I%8Y_P,">UT([*FG#QAA
M.$(' T;:'^H#B .(VP-Q)P\T:17$U3;01!<EK0\P!S ',%<+S)T^0*55.,=2
MJ2Q3 U0 ) $DVP.21<IY*4:J)W=2;R4\0F$NU,4!GAQO=)T\(*:5J-+J 3%@
M0 '@=1?PVFQ&E3V0IB]J2LTS?=L+3DP5]4+%+E0Z0$4,R G("=L$@)QPL4R-
M$P!RPL4R-4X R D7R]0X 9V5D\A=.ZYBM^+RW(^AKTJN/[<#_(QQ-:-#HV!$
M0K9%HQ)^)76ZE8I*O9I1_ZM4B'RP+K NL"ZP+K NL"ZP+IRMR_$6;!'C>B-%
MH\&YM)*]EZ(,;MCQ7<\78RJ%B;M\FJ,"">/R*3_-82W[51BM)]S,ANN\G)XC
MAS[N4+#^&_8.R5W(JMA7:ZZ';A&B<$(F !_WP,?+F;I2@:_2HW,7BB0.=!FP
MK]UD O9QCWW<'+2KQ.IC\3S=A:S5W#NU18A4/!S!!4KR"HG,XE]RB$[5^I+2
M9>BK[*Q<GA\L2S7WB.D@I($MR #P\6T+\G+^KQ) K/B8WX4JJE+-YV=:!"^<
MD DHR#\*\G(H< <*E@)8NBRJFMIRQ(J(/OHLWFGN3ZGG[*"* JI;8%U@76!=
M8%U@76!=F+TY3^L"U9,E5$^J4#T)88-VAPW,DZLGU<:C!DU63S;88;%%.,()
MF0!WW,/=R363/,)=M363LB[*4MOCK9TG$["/>^P[O6:21_!CO&82"HR@9A)J
M)JNLF90ER1CTNPQ];9POT$$@ PN0 ;CCVP(\N5*29QBLNE)2%J6Z.XVW"%XX
M(1-0D'\4/+E2LGD4+ >P#%$Q:Q[<TFREY$^!A9>8Y'"C5&[N'R$_[I8O6+K&
M^=_J]78)^<?Q'%D>H7(6I[8#=W$NK3+=T:M1F=^HILP\9?V/M21ZR(T_EWY@
M3]^V]-K<HD!"I#NY-T_GXU7I@Y'7R#-+0#6Z7?XM1S/4LZB:"^Y4P%:!@#5P
MN1 L#PF+.9H\HXE@^9A!XZ5G!V]$B>BW?.38^*_T<_R5 'DOPMS%!$P]]T7X
M@KPQ6@3V-R1<3K[9ONOY'S95*4>Q2N%[6H387LF<_]\XX_ER@B:]5SN8V0Y&
ML"15@0'&QZM$%\9S_T1C_ /YEF )XP@5A6_6?(G(0GY]_/N>C4!3#%F7,7X/
ME)R\=QS^2Z5*,#A_"9_[V7*L9T0^&WY?(,='>07TDBS)@1N7TF_!:"F-T=(>
MB#9%29-$2<JB= ^#WW@FO"+,&\<-2(-;LL%@N<0L)"0([\E.=5Z<+:JL2E(%
M;%$3MJAEL446]8&1RY8?>^2UE?VOK4J:K,K$-.BK<DY:\.375I+75LIZ;4,<
M])7\U_[0PZCFHRW*0P3D"1%M68D)1C@":HE>!:X0BA3Y-+S40\2.6<D88<P;
M_MT+1DG\N170[R)G$N/HU'8L!UL\\]X;W@ _")<^^5)^:SIR@9]Z/J$386Z.
M X*M+J8W>=)$F& DQM13@C&:N),0<W]>VZJWR+4VD/I:=H'QRLWQ,A+VW4\?
M$$D!4%[Z]\ZU37YZ6L:_(Q!#O_BX]!;SI?^+F_$C"\#!Q>^6L[2\MY -LM@C
M04KRIKG\,3)V".8D1MV$1=.E1QQ:NE2$_]8"L_([%I0 X44JK/7Z0%.3Z"AY
MZ_-+;'V1"VA"A*P-21CO?[_$'G[ C$%KGO<G:NU@3I+?[#1@C34#UMC;KB<+
MBW@?FI.WQ7S=QX,P0HR)UP9&7ZJ8!R-W40$#LNFCF %[; ^P1 I8(D$2.#^C
MD7.\M<9:[R?;K.T3M0S[RQ<Q0Z*\!.EA(TDYN'32H;UM,3$:^QK-+*?T!,&Z
MP.I[FRI\R+;72G0VW&\H^A.DQ\ZS^^Q0/:0 -_[/T@X-[ZW+(D1V/=T=R#W^
M;7U#A")1^(RP\X>O>K''OHB7;"(,%]BE7 38F _O[=-'^?%6&MV*[GX1*73?
MQ/L@]MTCNQ-+@34>N]X$[WLHM$UO?GEX%-0/PB\10$_P@^UY[&OXZP^+;=MO
M]B0TW>Y<O+,J [)W]L@+9-_:1OYJ2WY#>%?XAN]/'%OJJ2Q]NC.3#?@,;\TB
M_EJ\Z],]3)CAG?\)(8>^E#=968SXF>GO$3$A6S"V)<8(FYOX"D+0&AV$^B?L
M/&$-)JO@AM_WB E "&$ A([TVQ/'F.@R^DYQ(9\ZXMG+6US[E7.]R/';Q]A(
M0UXZ0I"YBYH/<B<CH*QG6@,O+GZ>>?&-HMA@&+:1%M_3$8THEB-)/WR,>$<F
M7(;1G+])])^/"VP>GSUYR/KKS)KBESRWYJ_6FY\-_\07[ V3_!1)2*%UI'QX
M#3_ .C_YN"%) SU:G<6VQ5QG\^Y(2LC9,*"2)P5W]Z/AHS"Z%T:_#86K^[O'
M^]N;Z\O1\%KXY>;N\N[JYO*V]SC"'WP>WHT>Z4J4]9(%PD\[I*OX:[^[N!Y>
M#3]_&C[T-EI/;V'RGEA8B@4T9">,T7P>Q06IGT1^)H&_^.<""K"^3AMOFA+J
ME(825GY<Q2F3H'BH'D0QWFT[9!/>,$*MG!,W:4K_N4'J/Q.NEK0XLK)"XG3\
M=HU6:QFX>93N7[7<R/_^X..)PGG,U8>H<-$;[__ZK_?WU_^^N;U-^'1Y=RW<
MW(TN[WZ]^70[%"X?'X>CQUCV5P9I\2>\Q[ RNKG[.KS.3/'-C>*7O4[9C@!Y
M0??45KHC K_+!M@Z46I/E+NB*/+4G<_=5Q*9\$BNQR=UA:GXB>V,EYZW"E\@
M:SR+XQ?1UXDCCXTV^ILHB++ WQW;"VQ!I8,Y<9SD/'=A"Z<-=C=SV,%Z@W!J
M9\!%DS3L3.N:+O=-(R>B=FW[X[GK8W/[?GI-;6+B:H3N LF*/;G+8-/UB(,T
MKO=6)."*L%.RH#[\$KW+\B'<2D+P3G:1 KM*B(]]_8<-*V</AN_:;S8VF3W;
MB&EDIHI+!V3%-E*]V%P3?'=N3X2G.;;'"F9N,_9&)5KUQ7,GR_'J8.8=%J)*
MCF%F[?"B8]OW).V5=X+GOAZ:%MVR0&M61V9TWDD5F5D.U)2_6Q.A])"2)^^G
M?5__^IB_O?F!YSK/%W_'/X=_J_]-_O&WOB*;'VETOL .?*+XY@AK0?&HL("F
MD$X5EF+0LC*U3 4M*T7+:FS'0';]<B?%,MV.X0I_T7:6[M)/R'R>+[$EC807
MU[&Q#4A3@,@G1W$::\W0^!D3]DZ/\'<N1)4EU9 &AMG_(UTF:,J&W->TOBS]
ML2H0H?G +[%/EBH'B#*#_I6UH!O%?]&$9 D+I(*/.\*[TH]?0[7XG&C%*%2*
M$FL#:>$)>Z6!+)8$ R)T Q',,A%AHRB*/41@_&Q7207!AYIC/+:Y^N*A%QMY
M"8TW#K;>ER\T5DEBCY?RF*;#9Q9Z<9_G[I/MN LKF)'\;I765OL;P#&*=^R;
M.I'(KB2UU&-:NE;S,2TF6BOR_[P#]8^W0TILVQK5JJ1AU#QQEI<P#N.VQ6=[
M<A:DC8N4$4'RG[&P0+@&G+-2D-%DSUC!.C#"*O!;2O++0,G6.F! $W-'P=MF
M/YGLV4\5H43.^)LV847G@C6_W?QO0I\_]A!R:'49%M()#<9 )*;%D1B9/>/F
M-_O;O8,^O8U>W0<BA"2NS*5-T]*8",1@*E-&]FR(<I4Q>[R< XT\WAK(J>5I
M:U2&GO9,*(PKQRLQ'<KE:DEN69$R/P9C-Q63S0GL:NP9052?XH=R:?V4J:85
M&C&<D%FMIM8:'*K_37B!(?;,OY)@*#OBO>9T>.U:?E(4J?YA=_6<M!JY6&83
MDL>1#),.%YD>4G58CM7W[V>Q-W_E???KD:6#D%6OTL K!1#[HMYO%A.;:'_,
M  F\=%=NHG,RBYI<I8U44F61J??YU.3]78MS^Q3G'?[/:QT<F23;VBIM:RX3
M-\BI,&Z5Z>:UOU%43C/D KVC\GH?E'3C^IA#],BW?=(@ HN\AV]#^DCX[C1X
M)<VYPB^)JS9B8_P:+I886O+M+Q>+N8U_P(8?^5;@61-$5=JGOW]%3SX6TFPC
MX],:2S#$U6O:F8-V6B,=TT@S4\RDN".G$#<SP@R,.D+Z17O\J;*DZ;HQZ.>T
MPKA,=8 ;S6C_M$]+'[^O[U^Y+T]VV);4W]O%[VA[Z."N?5ES*.G:ES3(BWO)
M><@G/4H)H[+BNNIG%[ZW\!2].&D=E[SY!R'LP1=UH(T: J;Z[I%[$P"SIS8!
MQQR]2+?L\X6%Y05Q@Y6U_GOXLU6/P.'"OHH[ F+Q3[<,I!2MJ,_3PQ>L@CZB
MLI0TALEOUW*8YAS= >O GB1[>V!%?4\*];S*-[[6OBCW<UMC5:+GY-RX8GS<
M7(V#FV'EM1M<,]\J.1D=8S95!R*V,WNQSRM?"WI$)@0('@C>03&B#7O@R2/_
MWV&5K1G1('X@?J<V@\);*MZ$O;=4T]_0<HT,7)!"D,**I? Q=I*L9P_1H0^P
M]8+452UU_PY=;PIV$_N9!,^.WW@+=;_FQ&.G?3<31S#=5CW5KWV"R'0F3$[&
M^5LLO?',HH-'[#&^"/MIX[#?^<)SQ\0/W=K278A]="'MI'_H8>\:HP/V4:/>
M[?14_72M^[O@ALW3\YW=]<ZOY<18BO1.KR6BG.XIW]HP4OHE>S9>WADF9#7)
M@,3H2%T%G6[@!_@/FES%(NF&L^5))"(.B(2CQN:8[F=1>$8._L*<PH UP1)-
M1M-8=,H8"D</^0)YPY(C=,Q(SVI08B_J14&U:WT0!VDI3'[S'(7%*+=(@'N*
M^855<H[9M=-M*>'=N1#3.&[8(PQR*3ZE.4D"QO[RB21LB.3:">_C/B $QJRH
M@[$]%IXLWXX"Q3,LI]\0G9-'@F<>F8R!OT(Z]U*(7MWK@_"X0&-[:H_C(7QQ
MG-KWHV[(J0?'8R?VWO1FB@EYP^2/9_&W"*BC[U%D&RL51NT%^0YY%S(FR4^F
MC&#*:11Q-<6%Q@D)>>T-?9.--/7RJ1$V/EY*1[CZ]:M/IMND]M)PW H5 KK[
MGF&ZR;P1$OM<!B''K4#X?>D@096H9*1"Z6$(=?U":SY>1C&M7OB!/Q.F<_<U
M+ENFT)@\ERP+'9M%;DVF9*U]+>FDC4D/$3/9AC&XHC#$[Z]=0O;CYT0B)E@:
M\*LO$540.EG+(NQY1L*SY[YB2\"C<H-Y](2"5S)$I<#L6465I;ZFY,S6NT;^
MV+,7X9PQTA^;K, #><0E]3DF(_<*,^07S(\O*Z+WC@$Z:/K4EZ6'DKS F9).
M#"C[QD]ED@(_4,85XXELJ$J_09Y\HFG8"MBB9MGRH7>9,RSO&SJC22=\-X0%
M/XB0511"A</;?F3CI@5;3&OAW'6>S^@@TI1\D@<46@)%&YB&OI;#OW5)[S#O
MY5=Z.\+V@W),Y0J3V".8OXR&6@:[P",'6S9:\D<_K/)'= V6--F3H [>*5;F
M1#CM*%R)'KU,Q*Y8*)#A("@KY#<=O8?]B2A5%:]42!-^[EE@?4^NC""$OI5'
M1&]ME.'N!=,431\,-HHNT,CZOJ8G%<[J.V%]93,'+3"WBKVXJFJ:5.F+5P21
MV>J3'WK19-9";Z[+AFP<L^3;2H[K7/+L>,+B2ZZK TE7*GWQBI8\!\E^9,*,
MS/8VK\2P?'27WACY/8RQD6%%%GGIC)$76-C?>&.!%Y69U*N]1)AAXS$<M6=Y
M7NB#8BO ^HML+G1:'HDSD2TAF4$>M3?W5Y-TA84;EBK@G2FL:B";V.K7>%=;
MSH/0"UL9SV'8@$8CR"_(_1V+;G71QO>"B(LTQ[N2]>Q@.Y<,<W$FF'W>FTB<
MKG J(1G%(;A/OHN]PS$9 X@?X9#)O-BP1O1^'X3?W%?B^8GIR;0;FRIQW7JV
M0^[J!/.WE2B$1CK^+O7PB!F$?77JC&#F$(/<(Z\XGM%MTJ7^)69WN*_^A=Z(
MA[9\6826/'I9S-VWT%2@[*;CCB.K*_;XB$QFR9MB-76CJHY<MS?E&)/(2QA>
MH(.,8F<"7SS\=#.ZOA1"V<.&A(."-<-BW0#H40,@7IS),ERM>'E29L9J45_<
M"9IC]QE+.G&?+7RKI4,*4;'92!&)+!!EZMO:8/M$J%ZL/[$A2?VZ%^M->,;O
MTB,E*X3;UHK?:^XW'3+N+N>34)HMP@<_P,^.OTDDQ,EY&&:0^Q+R"OUG:0=O
MN1!X=&1ZQV#&[.5M&MRHP^!&&-S(_.!&@>],9B43&X_6>24#G8?F, O,:*SU
ME8I-1!1VC#5<I=QW'NTK9U'WIK6WLGU/07]F(F*)5>@U6?L;&1H:'"4VRUEL
M@V+[B;A5!3(O'%O]&T:C+T0V66CS1P'Q$%]#HS=((N/A.\;H&QGTD1WKI(VQ
MN>N3R=WAN,E5N?44NUO4J!-[-R\O8U>X3FQZ7[AQQA@V/9('>Q,^V2XIHQ*N
M7>&39_GV7!2NYI;WEW!K8;N!I%7LJ- /?W/ANG-R>:N7+9H(B8AY'0Z.=[T@
M3,%N,CYA^>:\3LSZV.@5XRIPLD;$Y@J3N5&^*TPHI6\<IHG]7GHY=QU#H,4,
M898M(CI\@=B-6-V:^%PA&32Z&-&YZ=OXYSM*#[;/9BTV6O1 ;-V3B"TZ?]10
M#<U0='DM<%1H]&C"FEN\W _1BMP[--Q$YVR@"0PEW7$"KHJCT\?<4SGNGMM/
M[Z\Y??MWV7H*(S*[1T)_>J3F82?VLV][  <K/8"[BQP0AWWBH!XG#B4N_B'M
M-Z([EC2.=]_KE#?U-_\QQ,DHU&6G'7+X]?'OVT=T'G;.NB@:E36DLPR JEJ:
MH@>#0!TC4-6*#PP'R48&L#>:4+CAE6[+!O YD:-Q KHT$B1T]'195[6!.=B<
MUZC*BF&8VA^K-D.KVK*LCQ>>$+]QZ-%Z4B#JH1ER?/L;NJ'YJQ*.X.]O]I:Y
M:=+RC:I02G,P467.79):-2P :(+!(@UA34Z/CWJPYN#&DDUAS4!4U5:A341A
M=T:31%F$A,8XF_#9<I:D@H9VTA%N[1?,NPG,*3EB6D*3*/B^2.>W5ME6D3Q'
M8KPFQ9$0EP=_@H]7&7^-)/,E5L<L-"=\N=G]!C@ HUC8L+K::%[5"3=DR+7$
M+,Y T.P(*RNIV8"X&<3-2D%5M7U&W+4;ZDB92&K4W F<H=@/T 0QLB-PI7W6
M6@6XHIA:FW"E<]&P+Y[]LO03$J]<;P$Q+\YB7H4B_YIB]%?GD#DVE4*))8):
M9EA?YF%J*#RO0\&C1'%U15DUR^#8%BE#<7F;O V!H4P3>')2)Z%P[<0.E%-!
M6.ATO)046>KG-"GCSM"AFI)6D)*KIM2:(^L,13J )H@(%8 4%4.**JN*J0\,
MN;^M:JJY '2)QEFY8-.@F<9P?*CXJ0JF+;CH4'5"X]?'ZBRWFDY/'382O69+
MK>Q#,LWCZ@: :FW(X$5:\;5D*TV1!XU/-:_; &* A..5KKD!OB=3R0E:M"$O
M5PY:-&AF-7'<<(V&$V-D?,=U&B>@DL!2Z]SGQI>I<0(Z*R<'.HH9:"LZ?IUQ
M7W'D!M;*4]SH156'Q[B#<558BOAQPL1=DE9(S+B,!])4R JLIVG"(6:A++'B
M1994^:Y)V9[[=9IT6S6G/L^O"1).T)WF7+_3R>16ZUGQ!LO1>EF4I>RT"2[4
M?MNTSM4?:TT/\UNFKS?1W-H-=EM+Z+46V'$O[2:Z;M+6XQ/W->F$O]F&,^F^
M.2;! _(MVE7S_/ VI4WUIS15K(DYVI=N4KFI5Y^CWOPC=^@$=O &+2AS->VT
M:'YZI4OMCG=*[[B#G9?P>XQU\8)NE:?*PA$2SJDX\-6MDN@HM*KD40BA565%
MM$#W2NA>R7^]=3(K.R8R;V;VCJ'B4'S-5.Z#\1R]KBF&+/VAY,1B'Q"9/4L'
M%=PX8^P?^PC;3_1/=H*N^J#F<V"MRE9V@Z:.%T5OJGI."*AD5:\BTJJ+?34[
MX)QC58\H[-+)=7>!R7Y;.=TDEA@DDSH7--CZWD=(N',#),CRCN%KC!T^AY/M
MAP-1WC&,*SIRU[]Q8F'Y0D3DTID,8P&IR;(PY)K;[]2]/[?T>2T^7[ZI/CG[
M^%'J4\5NK8JFR8,"51M^:,GYH5_BH>^KD 0U!=-[M5K-7ETNE^OS;%@\EE0Q
MV<VAYNX6TO$Q\X&JJ?M;A-T[B;2'_DX]]L:J3W._[OZI9:H88]MIM>V=*V<<
M#W#%6K2F&R>L,*9AJ\U05:5O#O:6T1;!M$J*X^IO!EV[3AX8Q<D<&^ N&,%6
MI(,KWQ36A367+J..1^ 'G/2I$)RK/PUTL$W!R(FAJNGF[7Q!%!4S<JRA.)4U
MFF&&/<]6QM$5IH#<M$Y/KXF#0F4J7L.>"B=D\G(HJ8%7X158\DY.' TL;3F+
M5+O*KOE;)YQ;.O!03GAF9#Q'ED>HG>4=S]EX0DKK_ESZ@3U]^[A^6.J#49NI
M-T.]E($7(#_PA07RB#BAB6 %PN]+!PDJ5F6RU=&,//XP4RT?_M9#_G(>X.ML
M!W\S<U#J"9%QC!X:$]R@7YJZ2T^X^O6K+_;HK,_-D=RB$$T]R X=$@7:YR[3
M=E:D-$9-6;9V,]N]Y+N.6#&T>)\MQWI&A+\]VQ=\A/XB_ U<PO@Y_5Q8>.[4
M#L@'GOLM_(CPT[8"^QN^L37VR,($,^0C 9%S7#8Y!S5S7Q%61'K:C93_X&_B
MQ5KB[X1'X/!?R*)EQ*-'6!_+AA"+A8BA:HKY@26'/@H3A>^ *:&WCD_539?!
MTB._<_]$8R)#8\N?"=.Y^XH)>D5>?#HOH2F^<&QYWAMY<>L%HTV /^[ACVTO
M2D6)485L,",2Z7S##Z:R@N5D/"87^$0BD?V- (88/I6\!OT+*3[!#T/D6^1#
M_"+(\S!Q@?4]NG][Q0OKSGR)%;7W:@<SO/X;9Q_)L<=-[<P=O"J\1NON$:'R
MK3D](DFDX)OM+OWY&X6$\%RO,(WCD2%[4P_LX:N^/OZ]0$;'T U5E92]C=:+
M13^->#N6#%7:LAT;:]NQOF<[ECYDK?P>7H\Y_HN(F3$EXNK&Z5/*Z.G2HU(\
M08%ES]D0NNP)ADK$\'&!^3:UQ[U-@1#&,TQDB$UO>/O% $:VE0S^[.=5>>_/
MB6(3A-S),U$(7EURJ@!YCC7'*CK!NCMW%W3;WCAJ$*(ST:^W:'70)-R%Q]B8
ML_#JA-5\& M>Z&*131]OXF\]#/:39:C&&#7L.8$2<AT%"\*#,W=Z1K:=<.GQ
M_UVLK!12[.AT]O]G.3Z&E[P[A9L&1O\-VL@V9$6V"MDM\-\";QF#%M'';W0?
M_"",Z%:WDCA\';ZE/R.'P2- 3!T<I]_'OZ?/=5S!CP0W@V1IP8T7HI>_$.JV
M7JS'*3SU:]!WBNOEG$7//7\>']>/)3RR[ZG(KBSBQ?;#4JG[9.ZB5M0&0-:-
M35XO+GZ>>?&-(F\W=' D[*JL;/[8ZY&D'SY&+"2YH_4CZ MLJYW19@)GUA2_
MY+DU?[7>_*RC%%^08D(^+W^*Q*&X%Y-RFS?19Z!'J[/8MI@;Y^)W=F]8.U"?
M(P5W]Z/AHS"Z%T:_#86K^[O'^]N;Z\O1\%KXY>;N\N[JYO*V]SC"'WP>WHT>
MZ4J4]9+[^;I+NHJ_]KN+Z^'5\/.GX4-O8R?:PN0MQ,1:O,@H?X@]!3LCG- !
M(27=&\T0UD5\:VN$\ ;1%I=3.U<,:JK0>26#K^FHQQKYUC)P<XC?$K9J[)5^
MO;^__O?-[6U"U>7=M7!S-[J\^_7FT^U0N'Q\'(X>A?=8Z48W=U^'USO*\W8F
MS,I9U+SP93&V[^E7D]KHUG; (@U1-$/5^ZM\ >GRNM8+Y9I:X:0+46CG8[/C
M\LE=!K&I2KV)5,POW.Y3'5)&A,H1UJ5/<W?\5PG]4G;V@&E3/Y60($UMIF-R
M32X/E9^$("*$C7;D+YQWV%<=K6G<]L!/7[7=TEY?I-RP>O/2%?9KXJ*E=&XG
M!\]]+48.&PB1;711R:I2^_+)^ZGZ!@_L- ZGVT!+#NJ.9$GX[<OME7#I6/.W
M_R*O\>Q<#7L!C\T3=L:\$[)N@PE;+3C@0'\[<&)G_D.7=%F59557^Z:>=Z)E
MX\C^5P=OD-=A:'?;$=IB\S$NG4EV8KTL_;:8CV- XWG&,U,'_C-[( ]R^_BV
MF-ESVQ>^N+9# _M7EI?KUS!R<+K(!@:;$WO5\G!R_)@-0U/ZIM;TAA%C!(6(
M^RD!B!(W#:-?\Y$C<(9.@3%_["$4YX[_8;TL/B;T)#UA.#6QP3?B=.&XI@E\
MHVBKTW4CKS:L7M\H0;A,(Y8R1XXJ76Z,EMD>.6U6$-4X92NBN(CN'K3KG=@7
MIZ9N=?;+TA>N7&^17X?)[ J<.D*)V?8/G6CML-K !LJ@W_0&%H+2 ^''_?2K
M'WZSQ*U+KKNG)S?9K)-.337H&Y!3Y8T;'Z6?$BW+EV/Q>#L<J>W$D=KZMS)5
MTO!6INL#;2";)?IB)1W#'^@U=ZAD\[#L"6=F4[7QQ2N<>3DPFRG5B$\MTI-N
M])AASKD9>H5%KO#I02[2UX\<>',]X?]G[VV?TU:2Q>'O_!6J[)Y[DRKLZ!U(
M<E/%L?$>;B5VKDW._IY/+AD&HSU"8B5AQ_O7/STSDI! @ "]C,2<JEW'&(UZ
M>KI[^KWGYN3BQ;$ P\+,0'/GV7*><&T(@KW:SX(5*W%M1Z4OK:L9;!A,04#%
M7[B^!/>-,:=F6.#R%WH#2IS#J9%R.F>Q<%P?L\?;I="W_!FN2P_*,2GPQGAF
M K03 ;ON;$Q7PA09GOFT*LR!0X4]!2]\@1.9D.37=@N74-I^N%M:*P,[P!N!
M97S7F.#R/XM\&_:P,##A+BVRG$G[RI/:53S)$[XA/"'_%7M_,7P_;5)%^. ;
M/J)EF'CG1AMP]8($_"S^,T8GSKTU;+^UM(/*(PPV8:L09F,\1IX7%1D9P=Y\
M1WA&-@(D(\%;3F$9DY0XTII4#X2(=RG\<V:"(,:/X;&CAOU&A)!IX_)86&"Q
M=+TE+"E8YAAOPWYN&:Z+N^Z2FA]R;/!'!^,U/#J,!WAM&U8U 6&>8#N^@'XM
M: 5L'"I X+^7^!\(7NK,S3&@$X"SR:N])3G<9#EL6"1+:KV(NP#.?57YU$[L
M9 8DLU8E12LV+<-/J?DB"(Q5;2:+O6EYDY"A7I/> [K24SM2KY?(M]YW!:RG
M5Q_=HT6,7P[B_L2#MIC2NNZR-<(GB/D_7M^.<1AW%] :ZS<FRC<+$X_)2#\F
M QS(B\2,N5U$8F)SL=C!A=Y :,8;^1ZIC,-R$J,S$"E>^!),B7\,__P8?3!9
M8HE#16>+LKVW1>)-0-;:GN\2&D^7>@O7=$@U+E"12'G&6WH+*J?PWF(B+U8[
M"%"0:D+"8W=_#J\OI%X+$ IOQ 6! +.W?/* I0-^L8-RP'FB@)J"]OQ&)1V@
M@E0Y8GX#50#3'0";(NM6.P'YO["0']05/X/ Q=4'+6.!VP%@-,'98;KP@GI-
MQ_/Q7E>/)40&K;@W,8D31X&'-TV?!- M3%EA4;Z-@B-;%2ZOT/3JN'^!A(<_
MHU9P'+AX$T27#1_'+BTL6RC._P$[6U TI(BIZ 8+I!)AOV-E$G6S],2.VM44
MM6"95$Z<_" 1IW?%=!'77*$5Q6+:+<>.&DL0F@M2J3TL8P3Z)<R9 <EB=0Q$
M_HIK:<^4/6T1?,(OF 0NA2%F''AG5-",X]V@%[: ]6T/=P( :!(I4Q\Q)"'+
M).4%L*Y!2 Z?V=K? E5#>'H3_D_&+]?::_79R6DKJVVT]G1WP.7.5!Y0U1.X
ME&BMP=\#)6KI$X$* N4DOI1469.DKL8D7QX;U#N(/V592>7/5JA\!#H9$(.+
MIA:6BT'S#?(Q_@;8C:0>C'9,P77KID=4P">L<YM!WP\AZ/M!6$#__( LH-3G
M=J"36K07T&0.-$+N*1-D,U9=;4!7BSPC?1;N$[7U^'[Q HZZ%!X00&!Y8:,+
M*8. .59HU$,,@>X4A/JNL/0(&QFT!3RQ@^@HP+PQ=1(;A>1JC[52"4R!X&*,
M"29R7/<DC^8Z7<+%3,^P,X- [!?@69\T*;@ 52Q^'T=<[\\,2F6Q%@TI#1QL
M!^P?6- -[ T"5V30/ %=3<U H3#(/=\Z25(HHM;IZDQ*BL.C)P?)"$G9+R/^
M<Q*'"\QS.-N,3JSS"W@[Y@XX8>P,(<X1HC73[EK8];!\(IHM-O)7#@X!6S?S
M@/D3!@ ^,-K6"I_&OY83ZGU8>3RFC@7&%3$NL U#[!4P"(A;*GX)1#W@/N6@
M]M6R44&&VG2I>ZEHJ=7OA= -YBM9WR@S/;1T_O,F*ZP%"HII.D3H#[V0/H/!
M?8&[Y03=>,+V/2#?]S3?Q%TW-5F3.YVNN!DZZ(,H,ES:TFLY7^ %[J:X>!\S
MQ3UV(68('OR BRF2O!=R7/3*^T3OIM3];=5+VPYOR25NKVCABP?O.+@*GUWG
M%<P ^!9NE68OHT_P[0^FQLP$+?S565I8C0N[Z!G$''=LX+$W4+K_0KBA&KZV
M\<+.T@=S&C-,@&W\< 3.$^E3%',FK'=L7!G3VWH^;NM/E-:5@4L-+C5.DQHK
M@9$EO"AU)4U7Y(0"N%<\_$ N#F48!WJ4BY,8M)%P*#HF :A$)."6G,30"Q4(
M&IY8@+8%"D"2G]>[9=*^G@<(E0BDW<*E-*%2+",>VY<FE4WVM*K)W-(MT69X
M;T>W>C=CZ_!F;+P9&_/-V$Y14W:?TZ%*2B)!B+('9HSJ>K(=<CCQ/FP%-&#;
M>'N^T(<MU]9:K:TZL&UON=;L7FL[&I/M:JD;EQEIUVD1U>FQ[)'064=\)BMG
MGM /NMWB2,W0)CW-3="X?GH(#$_A&VZH?KBO9*>^<!P.2T+93>A):@5ZZ<()
M>GO?F/Y_GK$#$:-O B"XL8@X5L_;Z9DJPG.(>:SC_WSXNVU:))?)3^F+*UQ'
MZZGMZ,GU( AHS:#$VX@:"5&0S1C_>VEZ)G6XP8O_:;S@</1<&.'0.<C39X#X
MOX6K?WR/NL@/%N:5L<!F.G50?T= _O#-N3FFG8+7]M.*[R=]$VJXSPS>;$7I
MJ&)/SE"B'7,W'Y_Q?X<U^M',L#<\UR&JXI@:VN-<,__;7;FW81-AAS9.LPEF
M#V W*;5=(BR;'MZO9\+5ETP($Z:N,P>;AD8M%LC%K9FQ.[N]R@1;V2N3J-,C
M)B4@%'>5?A),/FBWB',6^=@&"KH_[^?]8YDW+@XB<V%'%TM*,:HBRI*FI!2*
MQ%M9AN<;:TZ9Q>X-,]\F?3C%F]@[9?@FGCMZ9+_*:D5:XBGRS@FV58FC_=,2
MAXHP9'#AA]+&<$V2MTCHBYC>2W<\,^B@C)7TH']/%3([>@;F,9UF_>K/V"XT
MH=HVH&OH:8/@"UPZ<ZIX3J^1M[T&:Y&YM^;<]"54U/)RP\U$.B5N'0YQ8EI_
M%95DJX*C;K>FS2.N-@;YK-2Z$*CWB>Z6.UI7'U)X=TK=>N5](NH.0 %=*9@M
M>\*Q2UD2-4431;7W*"4[C(?TWR?DOU+-BLI!*4&3E]NJ>,X=*))2F3EBO4X$
MDXS%PC+1*CK\WD5@#2U<=.$;O_(3M85*L2-UHLPMI0\>=UX/222GS$8>&;]P
M/'0PG8*M#!(EBN*Q(YEV!%WWBJ;N9=XM1(_H^_;;.>IYOPF#WX>CZWX0+R:E
M(KX3P3,)1N<2ETNRB /GMX/%G64: MM*#P?@C-4^-:GV#0P7EY1XOY."J"$V
MDY'G@_2]QMD8.)D:CY>Q)Z 6PJ;_0WX-QTO?..Y*+C,LC=4]TEC3+S6ISGIB
MA=)T/Y8:I+%^<^SG"^"0>3PS\@ ZJ:F*6NGB3=)Y=:FK]"19E#H)&8S):@14
M]0]"5%CM95B8[FWZ>,ELG^.:B,F#&J(<,865Z<J4*$R%XU=7__@9U@.2(;L+
MUT2^X4:M+YRE)SQ;R[&#^Y X0+P."<J_AV<_T#IT3.-O064V;281Q,1(#)Z$
M5K<&QUJF+?RO82_Q"VFY["B<_AZ6SN (^@3A&X%,F%^2<)P1I<G&Y\@#@!-D
M"4\&3@P X>#AK&)2UT9R +#V!=_U$X/G@PK*,,LA:LV1J/HGE?.KFG6BH>&>
M)[ARQP'0@]3;%3K:01D.K>@S! J^8069$.$F,J0%J*JH:KJLEB#-3D\)."%'
M>K,?TV\M*TT7H"02.*W6LJ7WE99$*-7TKIZ\('ZX"&OD^\I(ZH7330?(;ZV
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ML%"QQA$2[5N><6"Q\+)UAJB0P]1$;DUH%6I=S-VB.%KO%*Y:,$2IE8=;*P>
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M+CFPQOPA(V?,8ZC>0YZ30;%OQOR&4G10^@7Y8S0H_@N:%Z$Q_6Y8ACU&ZSR
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MDHL-+C;R\I;C7I"*I"M=I:-*8AD!NER2K)2RV[PRP#C9%9+*&95%KF26!:.
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M8+J'9"^5EIT,UE5;*KOE59[<Q98-PX4 %P([A<"Q5DRA]HLL=MMRV1[?TH5
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M[D9S0^ZO:*:_(BC_U&2YT].TQ[UJ":E/6Q-6"1J[7J('(*K=G8UKKY8TU+/
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M-[IOP/J6A6N::(G9^DY,#VQWYY662P%DY*"%^_"@ UBOX"VXK)U(B(=0F+0
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MR44/;B<J\^A='(F[#.*/4G%7^VWM5CY!+*[)PJS2+YC(>>)@]WVT<]SPT>Q
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MJNI%*6/4H$B566-21T]"3K:L,4E4=;72"N8R5J#8Q#%=ZXB-@OR00DIGAA4
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M\AVW^PB"M/_@R3\?EB";-X\N,O^Z,6?PD._-Q8OYZB6CNM$7CC+_YW#UL\A
M$,5\"5YX=!;3W8BBH82KL]RWF)>&1>-2<#\8]8;<:,"-?NMQMX/[X>!+_ZX[
MZMUQG_OWW?O;?O=+:SB"%[[V[D=#LA)Y/60&H3X@7=D?^\W'N]YM[^NGWD-K
M)VUN#Y./AHRWPNIP$1*0YR9HL0BC_@1G\-\XK!_]G:('*6'PK07;>>28=,=4
M%?-T6\3?G)Q;*1UC][G*+/()G(R?O1RCRUSYSLXY:A%4#G_K/O2XP;=1'S2
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M=AF4G'W>)JH=I:Q@%04Z3 $)#$:J.%#3QH+&LP.U,W&F07WBZDT" X]*CLL
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M.>Z= GPCG[.>G]'4@B>*Z,"7@S=<!$8^XD:N9>,G_V0Y/IK,N1=GM9B&E^/
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M$[944<$FMW"!\2$(8L@C^$W@F[/)MB.7!Z>+;6^R<,< A,(OG;-3M\!=(A2
M#>]G7BY5D#1)2WJOWUQG@M#4^^PZSWWP!T#)(HRF8,5.\U#53LJB1?9X@"OP
MR[/I_H5\;@D0B+@09::@QG@MB$?4.1X=.3?BL7/\OKEP] .O)0C'8C5%1P,R
MJ>5/OK,,RHW"O\-(&A_60X6W6N[/K8]=)W$5*3TP<W'41M 2)2_+C[_,W>A"
M8< X"!/RRQ\?)@MDNC@6.(]BASS_TX>0.SC;8[MJ:PG^_LVCB\R_;LP9/.1[
M<_%BOGK)0]#H"S$FI//RYU LLH3.@F#?2_#"(SB#N[)B*.'J+/<MYDXIV2'&
M;M>@I4C!_6#4&W*C 3?ZK<?=#NZ'@R_]N^ZH=\=][M]W[V_[W2^MX0A>^-J[
M'PW)2N3UD,?Y>DBZLC_VFX]WO=O>UT^]AY8D$$L@DJ\]3-Y#3*2NRX^[*AO4
M%68L)KR@:# FW3OU@]LBGK6:<'/2+AUC][G*+$H) (T?"ARCRUSYSLXI3R&!
MXOM1[Z$W'-U\ZG4?^O>_<E\&W?LAU[V_XSX-'AX&?\!K8(V"?HSZ][_W[E)[
M16^?>R0.':[M5(%[.R&=5,$T26?7"?P(CFBBK9#R4P<PU5HID>\7Y")P79!)
MHMH>9W)SQ_.#&+AE>[Z[(H$_V'[ [NY_?AB&04,PB*93^,ITG9D)W_5]<S)'
MT\ N3/V(BQ;X3BW?@3N!<80=(;!IEBN?!'Q!V1:<L\16$9 VMR;S@,!G9'ID
MP!U8DS/3<D/SU@HL(VQZXMQ<\@P>>+E!L!*NZRQ#@Q1LU0%8G6"_88/711/G
M"?^.+54;L%=0@E.8U&?'4:?P&UY  OXHF)_6=+5K:0>1;IO8;H'1&KV#I2^,
M9B^0Y\4?PYFU_#T,ZW##U:.'_EX!(8O7(T3&N60^.P!>F-X)_OC*6\<69C.$
MCW@P]\#,0/"FBRW+9^3/G6D&N[*FIVY=OQ59T.!O+QW/7 3LG)BN^XJYL[60
M0#B\MK(\D.>T$Z,LYPOAP;JL@X>M[#KKT>7QZ@6AW2#,FYH%LW;5SVE06KQ3
MHTN=9)>_R*OI<%V/L)2@1RBCF,W)V.X<1   X?'X@6?$6D,45&D[T/O%\;R!
M?1>N\< ^G%]$.6</G6>V(QQ:+4CD< $/CIW%2+S7P.5.(VS?E(BA'TMD>VL(
M?05?A4,V_N Z0!6:I6( YRYZ-@$_X3YAB*%U),2 46CW6C(@8/:U522%ETOH
MX'MBO#*U">=I_59.BO*( I\>6,8[IH]/IN%?;^Z\! =ZL*(A-5R,G.8".S9L
MGIWOP9X?BC.*2V-@]SV:"Y  1)0"_ITYBX7SXKTO)XYRK M,%/0-<WT2X3%1
M!(TP1%F5M2VLPR%>4'L 5+R%^*:U0-.^'4@3B$CWT5GY7T/>].U$A/A3P)/>
MCR7\-'W'?3T.D6\X!$*\)!2LT'4VL*FN@<?I=]Y;%_YL3:<+=%5M/6K7S:.V
MC78N;CZ2?!C:5#9)(5-BIL3I2ES/1D(-ZB!T5N'K18165P,06G78_XKRC 7:
M>C/2.O+C?" M=(,I=>(&9>)\-"F-.$>ZHL(OX]C+@B0H@BI+AJR7,(6C_!C"
M:64RHI ,(-0;%*J3R SG;#0SCJ$I0].ST%22947F3T53D:%I#4"!:C3-?[Y2
MV:-WZG^_$P?TU/^!FWZ_FB\H\_[3X70]'KK>^Q$S4IF1FL%(E96$D2HIFF*D
M5!$T(&V &:D4&ZDT,XZA*4/3\]!4D35!.;5K%PN@U@$4J$;3M.Y(V_V0SA[&
M=2@;J]*BA4#L6QZ:D"QN'[G/W,(Q;3I2][+45NU-VMIN4I8_ZW 28-1"":=%
M6K['>:M'SYI:I@M P)&S=&"J99/2@PPEJ8"*B@"FI&I(2?@#;(+O1*TY<HIZ
M!NL_#)9_!*O_!19_!P!_M^/5#D/?74U\_/&>[6]?C'016N)$_UMXV_)Q#QL,
MUWW+^K+,,_=;Z!SH,!.6WB1$FIL0HKB9.2'.*D[<7"<+X^+=H,QD\Q!MT@S(
M_HX\GR1Z@@283_!9\C%X"^<SDX('?*4Y,A?^?&*ZJ-/"N<N8EQQF)LG^G+KF
MB\U-<;XL?#;>BJN3(0]3$71)EG3AT);8#RLK<.7])].SCK32JH.H$ W;\!%G
M'(=K^@@:Q\'>[>)2\>\H*![_%3:NY;II0M!,-L@CE_6;9^#%?&=1'+#0<%;Y
MXI6;KG =#5Y1RT4[2Z2VN;GS@N V+9+Y/(>O>A;.=GA$R.9@14@..]%QD-F5
MBV4KJOOXW]4BN$A "9%#<S)Q5\C;%,/@VAEXV;9Q;0^IC$%_XU_AD@(&NI^X
MY6(5%#0\D;(I%[>*>&N^XQQ Q.#1OO0_#1ZXM[C4R>4"LV8:-5,BCST<?'[@
M0!;@EICV!W*;=6'.S'6>N<'$=X@RZ$$6_CN":V\?R7UP8R&<'D0:#&%:G]LD
M&WS]%!:N[G\E>;F$I 71,!/L(]-=]]CJ)+;4OHT%U48!(A+=PC1'=5-8<P+%
M";/^-VL8ZY71(OVBR ,']4XO<%_3!D2&5S:R1AH-9 )A758-(\4&O2?U8V$#
M$0]W!D#3$J$8/RZL!6FJU_M[!9)&OAZ]_4?PU \(MJCOJ!P8/Z=UC<+O*2_8
MWP'%ZP3F!5$C+(*X*PKZ :1B  Z[%@3?_B-:^XP-V8(%AUU74'8*IH*K?\,7
M'\RBRP[<!VR"Y'7N6--ESZ$)CMI1DB*07C22TAJB 24D&RB;P/\?<<$3;B38
MQF 9](9T\:]X%=MDDP Y1\_6ZAD^"YQ%0=T)8' H^#-GY=Z0LBIB](15H[C5
M#V[QN>E&&:I7<^MS^G8+-EG'G0;E-WA/(96 ^,55T//*\V'S,MVIU][957:Z
M;H*IX<]A;P'; Y8$;YIA58\7%?YL5?]NJMU(#RE<,M?*"$&R),F&6$84.1/D
MY#OM^S0#7Q,[\GX#_RT.][S/BNRR)(M:6H/:W,-)U+-5Y@]T GJW*>DC=9OQ
MR0R+Z(!O7=*6Z!^77M*,[=TVZ6\;E9?OC@SDP'0D/6VGK6QMF\B:RKPAJBE9
M0?N&-EV-YO 'JJ)/5AQ%5$3^,B8W4H\.,3FEM6*@$:$O%D6,0$$>$?X$<9C@
M3;SWO^[L1;"5+X+@TM+Q\16)L^JB0(=08!,LP#EUUVY8B^Q1I)-QNM9M='FM
M>1D;I@6:)XB:D!*)2!&*&/.O1?V$0[W 3U8_55=3:M%/YG1#=5 Y10>W6I^0
M5]81 A(PF&X'"AIM&G\UTZ< D";F&:53$45)36N<F%_;?V7=*A1NEH?X!F[M
MYS#\.[!3.[N>*8Z2?$ >UYUZUJ'HI6L![4ML!)$0&C&T2//Y /)#'G)+9)L+
MG^P6)T]G")=)U;7M=J3?@FL/9M^"BZ<AQCI0G!MV%,K\ [QOASV=<-26Q&OS
MZ$[29'3XC![=*/0M;4.$:=O@/D\P6.*F_98/7)WN''-M N)8LK%%$K3(VCZ4
MB44^=@YE\#5PFXP6#M5B=_SY&3Z ;9J,(B\J@B#I*;[!T?,S"996KUK6U6.A
MT_TH S#B(M-;FYK.RB=1#KP';AA.K$G7^6Y-@W!XYH-)49$40TV!_%]=Q_/(
M<SO/SQ8Y*TLU0^K 7C$E*!WQ-RZCLU7<*.?,R=\K*XCW>)W]1QK!^DR#/2"Z
M7#O3B82HRI*\F647S&H(#R.BR#1NNFY-4@\D2F1^K@<":RLM=E@7&FQ!?\!M
MAXET[G-#-K0WK%\?"<Q-,DK$/'"$D%4=5$4U%.'"$X-RE>+2B+W2D9*C"5N3
ML+-_B#N6NSZ\NYS)X&LJ_'8?NWYP\;-X'5DUM>+Z"><D3;!!!G:K"W*RX$2M
MG=D(P2VIR$N(\X##I!'GRN4^6_Y_GY!K+J8 RE-X,)*8L[!F\+&)A4@8WULM
MEX JC[A?)?*\K;NU5MXY@]$"T55X=6>X3KRK_!#(!!<IO&NJN,IK<95%[51Q
M)9??//_F\7/<+84#C>5#GV>[)RD.,9OQ>-=YK-5!?XV4T$@&$Z\B3AX-'!T*
MS9,6_#B[;-N()OU8YVA!#JEB20XD601;>N?Q5I8-32W.L:= K(_'EHS]:Q$X
MZ"[:<=$+\#.E-$LRR$'R8:_S LJVT3%RQB(_C)"(LV*2XK/?!]O)@^.ZT^^6
MY[A>](P>;!.PYA,3-PANP9=7DQ![=Q,WGL$2>%X] S.^(WN%VR;#3V*(1=8;
M0#BVAG/:SJYV4(3"!D6P01%L4 0;%'&M@R)J-1AA>QRSW(X/ ]Z>?@I;]W+E
M3N8DK$<"&=]QZM=SF-\,.S+:&X -M_7-Q7;V]0[W.]Z$ XMB_2F2]8YU,C"E
M,]J-JB0)O))6MK"Q%1_6 PVZ>%S[)F1VESXM3MZ:$7</U$S)PME/O>_8#NWB
MK0C,4CQUP'Z"Y[*<:7R87V#]=.WI UKG: UFVX>9^00-#^1<X)RP51"#79N&
MS^84UOB[:2VBP_^5%P:K,G-;,E1UNPE]X/3\[I$1BYBY+AK-T>VO7_=GP&S:
M+-/"ZJ-^DGCHG"W(J" ^.U:%@ EI>K/;7SXKVV5!, PEA>W=:#4_.^X=&+L+
M9QGR@"Q!,YAO'.(]F0:R+=CX>.$)V=A1@^=WX0'P.0[@V=+Q2/XD!FO,_FC^
MWVSE^G@:PW3#P77.ZJ]?R='%HP7?M3W\!329V["'/^%6\Z3FIAL"7^RP8^$Y
MT6F'%QQW;)!M88%\3*W@>'6UQ"*360XD5=6V8SO=]86_1-<- >^_M0.\XQ,%
M#QVX$J?NV7S%&<VQPJ='Y+]@] N">W@MX]57<CB,A^1!$PT^+#W$-P[CA&0+
MC4?MIBX*BT;(;KI9\@B*,T>@54GA=9G/>5^3);[NRTQ,%A=Y$Z")V![![-FD
M!D9V!89<L#.B%7B!RV1<ZG8,*6(HT=I!"1SOQ2CAS&; ,ONIN1'R_LZ39;W(
M(4_IS4>[M:6/Z7&EL)8U NJM&!-) SYJ<W;CIBXV/*-+[%/AA#DJ<NL3V2,0
M\0<*=H"H.@P#TP0<)]CU-W5K45AS7;U&QG,%@-2"7Q3NQ5GA("M<V;2F-[#B
M?UGV-)J1:BZ7"W#$\!>CD" I_GM\C0Y\([F-G\?'$H"(_9"H;@O5)9!\/+UL
MCE)(QG6+T>:Y)$ 15/(-@=O!4OISUUD]S;F=M8T-.@-[R%\0[@2?_-;_-ZS2
MFN-X!-C&/6EMK]F6C#SA SBX4"QR:,,BQDOQUK[,]J)&@GP(CQ5>@=U1E55%
M%)24^/0%>)R>XW3ZC/!J,/VT\<WM?4?M.:%(BXP?#RI:TX]]3UAKC<>]E"\\
M8J_G\EX^85XO;HW#<_TV%XR#0BDKC0\<$'" 9.#B'("7>%4F066<H>M'5O<I
M4B$9VH[O6Z%4U&_9.F?$<L^.H,>#P"7=L*!J39QV1*HN<#+N9N]:RW60[X@5
M(/0PUN*_)?JVXZ_'$.*#.N[9F9+#M'B%9I3ME%:WT=H,1H5]>A&G ';SR?I
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M5WW3F]W@!4D1A*V2N^R&6U")%XA=W_XW"%TD94VTR9(5&6W18)X[BPHRJ"D
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M*[ ('DTPL=<]J5S2I17>]#T.7GHF,R;!2 \LGC;\^0*LL9\"@QI_>.8ZSYR
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MZ8XC\;(@"[JD"9*A"XF7%7A5-TK(;-[G 9V7FD"^FFNG0JW6XZ(:I\PTTL0
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M##+-_840+/W<P7 1*!K15*R13XZ#=]RPVYN+,("1:[H(,#T<T+CU'7C% CJ
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M(^;KN>MX 3\OV#,+NFEA#YL_8I?.]X+O6QGK3P60TY/R\D.. MW %)C@7+3
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M(O-I'Y\DOEC%OR@R&%+(E.XD0<FGQ3P3E,8+"FM#7\NZ,]:&OL8Y490>4.%
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M4Y,:=\_;VSC1<M_/UV\"9F]M#!9.P,0)F-)-P%P;8'OP%KU]U?;=H)=B1SF
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MR\1S3M6O3,#(/)5D:)_>YK8<GO4!NNUGIM(^F)H,8AD8 ?HZ7J38CYQC<+8
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M)_<->1:=S7M^L=P/;N+.)>\U\?B":/ 4]*5%B=.HHR<%'C+O'BC!D 7O0F8
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M3S>,/861+VL(&&TS;]8L),S'\9H:()^XY>!CBVI#UV-N)C_IQVWSIEM)Y6%
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MKO]X<\8J[5GZG\S%]HW)]SL-%QO6%5=.$QYVN2'7A\.HH:\9<F64&\NP933
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MHT3QE^TVIT2$-M>_4A]*T1,DXVD];SYY1^T>7;;]V78M=VA;3JKCRB </'G
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M0RE"E8Q0M6NN@ZYUX-^>TC&Z1D7H(SB/AP2P./"Q-Q]THX&.8JGK0>3A76W
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M_ T^KL8W-457S?[J!F_T%=C@%0ER M*(S(J&]TD'V.6M-\XES@:01HSDR09
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MR0&:9N9J3,N#:DD9X)7ENR!3\]C8P!TE;WVDEI]^ZXMM/=B.'=IT8]"MD!X
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MXC('4&_%NW.D.S]6;)ZL]EFL+@M63O-7QA.!K(B:N-Y5LV\J.<ICN.O]<B&
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MAXPI_#,"&E[L< )\ZY G6.1)D#D*_80D...2*9S(J%S^8O\YLT> $BW?#OY
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M\E=3GU>W?H']F&:L^)"RYT_?=^TJ>O9Z'KW8:J^[RMKIA[]/_.1",3)'FJ.
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M&'_QW$=6XBYS&;&FEHRB$BB=!"2@WC=%[S.2'@_0^UI$SO5>R?T&)%!4"4A
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MIG(<_/0IN/Y]!LLV?KW(P1 A3PORUWJR?O<8:C&)8R+SJ^_-IG_]J:>IW8N
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MT2>K3(JJ%IQ)J0M_2/B1\",\_+R6;#H:?C++-.EM"3\2?BI&T[G#3TMI:1K
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M_7VSI0D;]*](P?VAN%;=&'?5"9!YAZ+UL  VH4PDU"214$;RH!YV9771343
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MT=0O("XX+P:\\&5CD" +WR9$@.@;%RA2)O[\,@61YY U<W I0,Z)JBD@*DM
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M0D.FP%L@%TF!0?DS$CH%S1]BF1/J RV$!B96^!7+P<MR9''1;0]C/K=,N-
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MQ7-%O/<03(8*9$0M*\"IO[U1WK"?$8C"GU/D9#,VO+JA:TN2X/Z$*..:KXK
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M"7=UX,M<()E;!&8(>[SKL:O"/J?P#L;<@;?R+LG# JZ'#4;F\?"V\"K4<N;
M:K I\%Q8!68S)K8,2#2 .0UD2=#U9.&%3QB!,6:.3+ !8B+XBK*_3JEA^5R3
MOH"'AGP"B^NAZ0:D(#^ZCD5>#+!YGGP#^ A7@Y4'XJHT$B*#_.\MGCS?L-&8
ML98$_I.T9 ,E G>:!WP=3GWCE.*>6A8=^0OX?.[B53Z 6Z1B<.L,FUWV[+)5
MPX%Q3&[#(&>#K3R_)3BO[ WA K[M(";CQ0B_AU>!/6D\\PZS\*P?(&NPOB[U
M%RZS+Y"?V [#UYV%/U_@<@RG=.?C2?SX1FQ]O@#?LOIK<X*:PX>508D%X5L@
MXSIP@ZD)W HD.O'6LQ7!E?$\![8/GQ?2<>:&_Q DL.&C51M +"PS;#&(J#$:
M.0MFBZ @PZ<&>0K #Y8\0C_"_#!R]_'K(]'YKHXIYMK"WR.[/[&]"S3$&INO
M<&%C%QLTX<*1M< HR#;^9F*,'CY^-J)H>W!@,HCW'5@'.<AQO\,;(9PQ.?>=
M9\I@!;61;_K 1XWDJQ[,^9SO-PYFG1UCT<:J^03ZYX)Y&JMJ?PT?T"CCTRK'
MS#5Q;)MRSGPQ_>D& R%WA?P&W\!=>V87@8)9S&@0Z03& MQT8:?0U1Q1\O:?
M_QI\6;?](DQE-*1P*RK'<P>,V*IJ;)AOBSG*P;YV6U]7]#0_4MIMK]MM@#M+
MP",R-Y8,G1;S@%V=T6CANA1KUV!#1H"*8&> N06KF<3/J]>Y>#=_[A%;[\%?
MVDHO)9)R0[V1:S*3$'82S[$^LS'+'QUWR^8G+O(&]O@.=,Z,FP#LM]L:L#(>
MX&'X[/VI1!2_:E'ZSJ723B9.MD;-U5YQT7P6R>ML<.:)$?WM$)K+2P#XM2\5
M$HHIR"?R;-RX:M)D>BQ0>C80150-PZ7^%$P=3'H23#L!RS3)6_-7=E7P0:"Z
M=NFLL4.Y;T9_CBBH0Z"F>]E6"%A'> &WY&)J#&*!D^4336$ZF8X6[)@YF(/,
MQAH;2VY^O34#2D(E.C9@(:+KN*K=D[#_0X,-R @HU!06/ @I8A<CE3M(8@;=
M]OS)1M[D$%B3LBQE.7J)MO)+R-3,FZ#C>*B*2T<4&),%:I-YDK?<!HH#60$"
M,*<F"(%M24ZH">#X%<U/=&!9L4?@\#B1/@?_"]0N#N2,")H;KF_S2XUGEW)5
MR6WF\%MA<F:^F,W1<5E,P*I8N!C<"/!(:X50-'&=67HL#SV\A&$/KAGL _>
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M7GD-I C?;.:,J14]GVM%L-4,E,!G"M#N,3D>&7,<P71)AO@DVS?L9Q/PED,
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MS:Q9MO287;.6#53K-NB51; /4<Q]:GJ^X[(H6_*I" FP5IPO66(!N $#;$B
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MN.@6 NO>XM)6>VU]Y=S,[<H3'R:#&>:U'U[$%H;6[NJ*M>I N.Z"%8ZOHDZ
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M0'D$=1UA-&HIC"X<-E:3(;X10&1S=;[FYE3-QM$P??8C,8=H5#;8[H)5:=I
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MA22?SU<8BM1D>A*SE@H!J2REO,\-CKG0#.UB-(8$76+]W8/G)Y9:Y21DO1C
MW9)X![9K<OJS$>!=8UW:H+P:\+U$>N:6 !; ]E@(O3>^8G.+IW)*B+Q.42+L
M* F1&.:,"ERS]^^,= NY>GSS:KL"=ZK,RBJSLO29E4])1ER\3_FIB.FLB71&
M%A$'JC V3$5<DB8IY\H_?3/D3,"G9/VMO',;R\L2[9;F!XI%Y>4)<M9)JPV>
M3D=5Q^*)//ABV1"1[7"%:JS$:ENI'%R4S9+<J_[(O"M:#7\Y-B=($76N3?JN
M=W'Y3V<\^73\'HPBDK%!["%25YTF<4 NUTQSNOQ&0M3SRK)#:CPUA&25N)FG
M@M=N"$DHPLM';%KA:4I35D0&RJ%VSKOE20\25K#XLF&V;I,$.%)/)'PDWASL
M8F?>ZJ.VF1M_U-XY[RF3C!&*:6X,!J2N+WJDLK@EC72\Z[.K(4-%;DWUSCU$
MAW7H)D0;D\#?P%5+VT\3]QCW?8$?#']$,X4\= =I<< UT?O7[O[Z2I.M:C2"
M!2E6X,M,PM0S#Q9Q:MQS^+,:+&.]\=@60Y$?C>O=04-GB)40UKP'[(2WAQGK
M44VD@Z79E<!TF$:_49Q^,S2*XOQ)KB<AR2GOUB7!@"BAS0_20"7P-X@)6[GP
MK7.W=81J/ ^-Q 9($YW,%V)V)NP$Q)K C9!A*F6G$G"8@80Y.# :\9@MS9=Z
M]4$\I4MV/EN6 &@)=<ZY7HBK:P4_G]G6C4:ST;":G7D</0N8C_SA(JB<:7K9
M]8@7X?QV*>HF):SBMO2ECM-W.DGE:F&%]UH>0U.O=VQ#Z31<PSE,"6A;C9;"
M$;$> :T](Z!AUPW=RG,U1PA1B>,^A<6]LJ28T7MZZ&,%"JXG8AP0,0"69@U+
MG;2S&]&0K(O(2AUC^::U[$9'5W#]$77.$&/AA%90K-'LM?S;UJ[;;3.G'RR)
M])(06W!["U9(?RKG'D.'0;0>D1M6HZ$(F_3$0Z$Y[XNBKU&W.^IVZS4IFVZV
ML]TK/_<4C\QX_%-^J9&D/Y57E:?%KUSA_Z(I>DQA!:IY+LTUFR-9R(T^EE8&
M@?.!0^P^H'$J]K1Q-\W:H-7\:<-WFI# , R8H?<D[TY\ V0UT.?7I"=B#.@A
M2+/DR1#U;#]&P#*\2B@:';!FY[2UIAO3K+K7+C(<OJ09<+!G^.QR2*)(1-)V
M&*242$^WO)[!)[>!YY$ZB14RO[=$TWTK>FX>MF2/::YOR'C>II$0AS6;GV:W
M;5W7U:?Y77V&<N0K_'7N+5Z)SX8!L<[8Q E$2Z#N,Y,JQ(JD_"L*GO^BP3,&
M?UEG$9*23F#T'(&&^9,O5^L"4[%PQ<(S+,QG2+$V1?A:'WPDM/E= H'V6[$>
MT7H[3(]+E@O'&MI,R9D,MX*KQ)'Z'J_#S/L[YW$;W+JI)U_)2TKG?B5MSREM
MY_TH\%!$4MMEAZ92(I8W'ZY$HA*)?1<)^0 :H@&8*W  P;F!3:3!;VB./$ L
MD3_"RW(@HB661:'=)X!QZYE(E>Q4LK/OLG.>A#RP)H(ITNQ?!CY@#% _"'Z+
MY9 (3-Y A^6(XD4[)7Z-D%][0)G@I*/J]Z)EW'C4@><'_H$H]*,V,71N@1H0
M5@1YCVBLFY;.)!-6>8(>,1[D1@$92X@W%J;<L>I-IQ_<HUS_5IU$6"47B1OQ
M(:[#M$@'-&H:XJ3&!T.=P"'058F-- 67E7;K!0]I5F>-3)HAX0K6@,9AKR@7
M/$+R*XG7XX>)]O/:N?3%0WF9M-X5@LBT@ ;JA5VR?@HY1',+()MX0HU[U=@2
M,_UM&(;A$(;"Z=?N:(/62Q+918&A&.,U.W F9^P2XP V,7@NJD*#\L#E4+O,
M8F<P] CVDFQ8Z@:M@1L4'YD05O&F6F\\'@3:L52PV?,'^%P-P2D[U;ZX 22]
M:,>!]B5T(NCPB_\T"0)/N[F"2XGT=3VL"M.IRE 7!A_% =:+,(AUU;*11M-L
M=FQ5-#03\TD'\O9\$KOIRE,D:4W)*ET7M]#JVU@X='S3I.DRR\DSE9(<@5L9
MO'DU4B>+?SD8!_=\[D9 T!S)_@+%%X0K]([:WNONA>KYA6J\OQS+"B(V2MJ"
M G2#(!^=)XA5!3KH3P_@)VO%!M2F735(1W$Q;R5[MQA$F'/HU5@E"3GSJ-(B
MF4.D8(74JZ3/XC7^//^.UM9&I&[(U#\E9(GD%^,330%DE?VLGX"?CH@)$<\]
MA(=@H .%PT+YDA60+N,\#@(JE.AI;$<,(SJQD35%A.?SAGCI6O'JQQ$+9+$.
M=Y#A%&9)[B'9<&'W0@8>R[RB9=AI#3.\;=;D.=2^D193Q"+ADD'K1SRHKHY%
M-3#;-FZ]T"2^S#:/2!D)-:S2\NQ:W_'(0Z,10C&;^TLKROEX-C'I3/)6IF;-
MV!DB?IS1F:&@U\%&@+(;MC>T%3SI"\Y"2VD-,'_C6MK4+UVW.">AZH@BSZC.
M*I4@8 4V5$(*CT@;HD/M*!:G*!57<902^T;0D&L73:%=:NGWKY@3!8>8;9E-
MT[)5*3WT:3 >.#Y#^.CA[/%O>.,UJUC7.Z=:A\W\D11T;T+$)L8RT7LD&XO9
M<[67MMJ=EI@U 6,%/EZ($O;SVV\A%GI.@*FQPKM>8/-1O.R!*;_MTI'U&,C.
MO>U;T$%WL R)K9AP2<S"32YK#3[1-N03V]9-58++VGRRJ/QW37O&4) NCU$@
M_K ^IS0:+=O2G\ ILV_[!$ZQFFMQBL94YRRSF+Q1$SL$U^&"AM4Q6HJ)(NMS
MP:*"Z#6Y0$46S@5UDF*Q_KYC9K?3X5L;[/OL^SUAWQNJ$3V+- 1D%:9(>FVU
M0*>4IRT]%%\T(@7F-&]QB.V4^ $J"8@F@H>2HVN8-IJ:C# ^AR!V- CQ9L!W
M@TVG^&IH9HEBVB:,_Q%;BP[K(%.5:V[3ZC8A=Z\JUZS*-4M>KJF48C4EEA:]
M5:6?5>GGBJ6?RXL^4U;=?7EH7IA_7\I#2[A.!5L^5>,O4K%HG#H*-86C4"Q'
M81B]$X/B,$_@!Z4%PZHHW$:Z=A\+=W\*TY#4B#JQ&]VZ?$3B; =ZXO1AK5Z@
M!R0I>V29E+2K+IB?4CL1DG[-W5,12NL*:4JY:!<#F9L^&30"'>[PM_R=. /6
M4M6-4J@E&B"2 )C47H[9ZMP1EF(SUDEQN ZB)TT9J6E>(QU[67E1?ZJ9;Q7&
M?#WC[A)XF10>B<:ES/D7DJ@9\<>27CJT"2SQQHJ 6HHW5JN?P7BK:1F&WK8;
M&;S5)4_L^4)FMEV+!]]R_1#DX[HM3EG5#^U\3X63Z_Y;JWD;IJ+5:+:,M:GX
MI(*\YZ5BOF/PO;96US=,K$:CW;;7)I:Y/\1J+R 6EW:(U*X>^VM6L;_9(^@+
MRU:N=8-QW_4)W5;H"/?* GR06T#;OD'C4SBUX)"&9@$\VQL^$/2;337XF":2
M1VD%["_G'I%A3-?0Z@*#K#LR&^PGPH80_FT,"0+?D>/%(]I0]F3B=IT)2?6H
MR?F$:1\$.#_%F3LSHX4W R"] J1>_MH8Q:H&%^F;T;%+M-&'QOE%D_FE7I.;
MY&;ZAK#")JR%[D+BSV,3!>#+[^G<*.+HI7E$ V="FV3<2ED4<%I/DOC5CSCK
M^?(\%JG#?+J9F'U2=V.6'?@LN]]H*D4260819Q1Y3IYBHH_<W*3&JP=%><3,
M.#!BNT)7%GF^6K8M-PEXTQ0N/O^!-DHAGNY,*Q5U+6DZ%D_4UZ6#V-)F,E':
MS)\,#B!%'LI<,&R@#A%K7"Y()Y$4;&5N[O(F'B))JTZ;'=>(PWX2NG 1_Q(R
MGD@,=5;/?:%^," E)-#=(=JB,.TA41>B$D6J01?0K(8$WW.HHF$>PZL/?-X2
MGHW&\^_PEPVIG X1U%I3^]X-AP<0M9Y*;7EX]_F(T *OQ65=%.F"DA!;T@1K
M0#HSV-(#.E"*9#9['M.:LBHD2\G,>1LY>#%I"#P;NDZ?R88J2._'/?F+.:<F
M5R'OD5)Y)HN@)R:YUV  07"?1'+.6F4;S%9PD[.^QL]ZN4=LJANQZ/E!"'(*
M2B6>IF/+ '*"N-Q3I3="WE T]^?I.9!:^W<2L)Q$Z#U%)J:SK&C>AR/=-GR0
M@F'O$F<"B8?-C)$#S":I=];>%?3)K4L&Y4#>D/;NZ[^O+T[?Y[;]ZM!O5IP3
MZ5H>2-];E[6KR)@)LA%"] 7IJ)^]7\N^"VO7>DK&M5B*@VKD8EV ==!4MEH,
MJUZ+DGZ$8/(/E%;+9TYF["L[&1(_Z,/8 J8_P/@@JC>2K"[I4)!&1%R#QX35
M;$<SVBFXK=$70^B J%'\)+DE4%2?Z0M[AY?%IL+R_/=B1ESND_KZ!O-?,9J!
M*3FKS@@K@7*?#<PNC \])8*P.0 "'4#T$K,Q%K<'HIEGI$4?G<%,*VB3,;5]
ML )Z0'2N%O<-4TU%Y_<.Z/YQYQYQ8V#@1?(;1;K?_X09()F$Q)S%1M<(TYP(
MLVR3,G/7!P\!?'$24H$76(=/NH#A11%"1 %LDEY/*I_6C/'-5.RLP%]/_I9E
MG+MCKS>W?&OS,^!F)B+RF6S!(F[A5GZ44=22=OY*',HP5#3-VDP][#6&*%*5
MS;#OQ/79F%,WDL;52>XE>!++F?TFKXBGSD9HP%F5>J(X8V?&KY)T4CJJ3 PM
M/\RK8%KT(]N#?'F>R4O*"3&JG) J)Z3T.2$9NXK_6#A-H:$W#-O _S%UO6%E
M_/['^+C#!CL^I(@_/IF0&19TEE9T\@BCI4DOTU7J=% T<";DP0EZHU[F@A\+
MT\Y*D+CR+-DJL&W?+L]O+F[.CD\NKX]^],Z^7>U$VUFFNHG:]K]I[A1Z2KJ"
MQ"A/S@+:&"; !HDER3NU?ML639'GM:I<;&'44!'D^R-E-((-EL.!3".SG!%T
MLY60$V\@;'K1_ Q\!?CF"6F:W,?&FNN$#.XSE3?7'FV9X;XA7>6]6ZJ[&T;'
MMAJ-IJVH0I 5N!3923UQ4<^_XN^*<<R:.ETDWQS%>%%\/?@<T>V.97;42E_)
MADUF7JRERJE>:-MO<[7OC+J@!R=+,N3'*+;%-,)B6B83D2ONMSD*9J.M?297
MQ1EF [%H&G&X@PIY@,H!E(FC?%TD2(@/.?CP_]X8;Q:3D^V41$]^5KY=F(7V
ME,T9N3'XNIP!PK+Q$#H3]I6FN8_[=<$53[II-(JIK(C=YC[ET;&(K;/RMFX>
M >[%9E+Z=2%(%T[I+\'M'_WPPV<83A%. @K$94$EG[+NA8'2R?A2-S]7;O=K
M\YEW"6CWEOZ $=*8\.MT*%M^D %RV,D!M1N;;HD%8^EVP[(,4]4H'(XR;+L(
M>VR-5N&K&#QI]AFU$)F!^-/Q$YB!02)PI^X8<^V0I:!]9E<*FG.;,G./QFZ:
M=9FI17HY?>RF:35MQ2S6H^$0@CGGMY?BB#\G)_SY[0DVSN(2$"S;QZGDO-H[
M/DIWECOO+YSP=QUZIZ@[5)3[C<@!E++K+W?P&^.=NM:#)E>Y;=^4#M^U#Y]4
M3ZUWII#[GLG&*T[E-6RS/5-#S6V'(V;_%2^]Z6=92 &5 =1<@80GGL5!NB-I
MO]UX;F#I5HR9A7RQ31;+M47G6&S./MFE6V0%K@)GKF7,'Q2"M2X\!TX'KMR*
MYS"AB!8S3*[A]'3^F;<QRZ*TYCS4U)A])J9;5"X@^,TR;4MAF%R$ 0PC(#.8
MSQ]\%$8C=])CR4D2SQ2OXE9J1F NZ[:@F/?R=KM&_]@=#CTDV_TJWEPN!)GG
MK,?BF5L)2Q>UA#R1)9K[28O:CC)8MLP9VKUJ\&<WK7;#5K1/>6;P=\FF*RX!
M?/RR[6,\O=%N-<N'\7+H4N&Z"M>5P$0JG3;KV&;',@K%=3D2R_\\YW*6DH4K
MW/:<_-(PVG;#:NJJ?KD%(;8<WJ$(=%:Y9'DEV_6C0FSE0VS ;VW+:IM*#T$Y
M$)N: 2N45J&T"J45BM(:9MM2#$PN08CN"H7W& ]%&X7J^,U;QW-DP+19/CRW
M!@4KC%=AO!(85:73A1V[:90P=I<CQ<=DJ.I*T&[;AOHK@'@KA>8(T&NT]88R
M5%*:T%P. U4ANKT&? V[H<H.+PO@6YT1]PL$/@WB; /';!MD;7U-KQU1M8U6
M:1#5:?*(I2Q(PKLK)_268:CT:@TNWR)H,MHMA3>T)*!)3:2]@DE&72PP3)#V
M!=HRA?4]1$>G!X9I=L0BTZVI<%$Q&JVIZ[K1LNTRX"*UH$H]J#BQ>0PL[2X<
MW*:%A.2CB!DC56RL&. $Y>G-T@$G-8?)6JA"2WN)EMJ=CF+R6\G0DI+[]@L?
M54&R*DCVXB"=W6P;BIA/,9"NYP^6X3A\R?:PF]5HJAR<)<%N$C7V"K!]<\,X
M2M-/ V>XCVCM3\P441P\^/NX^+/_B 4:C99NUK6;JZ,*9A8',VUK9BQ*03!3
MTBG?::6W(&^7-K6L0&-1H-%JZ>5)JYSGEYO#J\.CPPHE[B5*[.A61^V2*!5*
M3-FM@H85-*R@89'0L*5;EJTH[WHN:-CUG/#WJ=.'OD-D)+ET%I'/TDB*=-%V
M :+9Z#04J>>% <1%--DKC'@=.AGCTXGFFAZ^PY#E_1YB+P7\U028W,/W.?L/
MA9!BF164+!1*=B1#[GFAY"+M4_5=V3>XB<_W5O%P<Q%/$<0YRR!S'9@KQ%E2
MQ-FVVTI_1L&(<P''5:"S IT5Z"P6=+:LM@)Q/1?H_.F$PT=IRE_&PL$?"1)+
MUVP7<AK8OBM34Y4%%-DKQ&EWC#3W\JL3^M$#/H9&6C=(PG@/85G7";VH[RB+
MZLJ^]+3NL6/J>KN*3A8+*4U+;S2+@90+M$M5!5@.H&A:S78)DED7<$H5F=QG
MG&A8MBK,4#A.S&>X"B96,+&"B87"1,.T.P7&)K^X6#D%WHU\"K&_26$2 (;:
MNYB&NE0AKF.,Y/#3$A#^]UN$D+;55)1I%@8A5=3:*^Q8A?0J_+4[_&7HMFYV
MBL%?*M&\PM:,(.M\V(Y$\ZK078&(S+;,5@D0F8IW*BBVUU"L;:A3D N&8@I.
MJS!8A<$J#%8H!C-U6Y52_EP8#!]WXR3JII,I^1E$/Y#J6L05VX-8>KO5*%.4
M+I<8>X6S&OC]Q1)/M);]1Y1,\@0*A!2D*K/\3^E"(JSB/2!!/,(;G$P^:]<H
MQ%I>.4RXY(3YX?B1([$TYJ1]+$O\>2X6V,2"5)4E%@P\C4[+*"CPEZNP-DXD
MA<_@0M>/XC"![UY#YU<H=>LHU=)-56>!YT:IN8Q699?N,U0UC;9>QJXW>>Q6
M#KSZ(7;Z'LH]7FNU/X2Y-7;".]?_2#:2<^-$NE/Z@6^#'[!QZ''@)4/$_L2?
M-?"0$\+D]=$G^E@PW.#1_%<VAIU\&7M:]@G2;<;2^\0[S$N8])RYIUAJGGTR
M0V.&FMVCR><_1B%_$!M%3R56GSQ^DLC%-(*NO_W$A-6$"P(O"#_^0R?_^31Q
M[M!!/T3.[P/G%K_D1\=[<*;1I[XS^'T7!HD_/,C>L'0//C VDK=WL>)XH'_H
M!]Z0/\]#MS$&NX<=F^W.)&\SLV1>K(DH99E"4G#!V?GUR95V?:Y=?S_1NN=G
M5^>GO>.CZY-C[6OO[.BLVSLZK5U=XS_\/#F[OB([L:V77(&W%W#7ZJ_]YO/Q
M2??DYY>3RYIEU#705XRQ<HB<LYA4JG.$FB@+;8 \;^(,(8;Y?V_T-^1W.&KX
M[PIQ4%BZF7V;>7.)R26)!=)F.?U-GJ^%.U8.F_AIBO.Q,"O<,N<,"L6)3I?O
M)'&@6'S.^5U<+/3R_.8B#1R>'9]<7A_]Z)U]N]+>87F[[IW=G!PKZS97<)YN
M9R,7&$]+2*UT[J6'IG3 2<XB,"1</W%2:X4;*B9T?NE8$-QC%Z'A49R]P##L
MEJ4O/O:HEFDR/;J66-(7;MMO<X5GA@Y40WQBAQ+3%_C0T:+ <X=:>-=_I]<U
M^._[W3@TF7: )WQT8[RHP6YBX-ARS #,4+CLM(#X[+:"%!DYV4Y)]-S(V%]K
M<]8'!?/V4IEW4"!)2C^'>2RV"MT6;-]VX/]V=C3K)I@\U<)8:LDHH2 :;\N^
M$3LK.?$3/PZG6#*)GP=_G"(LT1(YF"#NYV=[#TNBJ.5%;OL+$>1O&*1,*.W>
MTA\CVIMLNZ'8EQB":S94HS&?+00W"I#O/GYQ@VLT&('30\3@Z">"QOB2 Y+R
M"!<MS0]9.0[7:'3L4C5HR:?(7@7B#*/9%$N\"I)XQ,<.DNQ'[1?D@>U?_.G<
M^7WO>AY*$Q_/S[33YJEF7[?V\'6ZCN\,G3F$.:,EJT#:[@-I9L-N%Y3!F:]Q
MJ@*ZD@3"&HUV&0)AN8Q"]4B!29ME42S[$/>R.XTRSL;+Y:YR!+ZJ1,V2)&IN
MG2ZO' %:AFDJ],%S(<"O;C!VI2)9UE3\J,_/%G*!(+3<-85=JAU]V2(<M&U3
MD150&!Q<2IZ]0H7'3MJP\[LS'CMA]/NO?_[#;#0_></H7K--93)?R=_JZN2@
M99MBD59+NYE,(L=S]O%='M 0+:E(K #A<P#"MMYJ%0,(E^J<:O!#J?!A4V^;
M#:MX?+B4;[ARJ6!B^6&BI>/?2@@3ES%9A18KM%BAQ=VA19CX5QZTN I,W"8\
MM!H8+Y<8'E:XL$1O5>'""A=N2P';NFU81LMLZ1VKJ'GS^<KFV(U$>JH@LI1,
MM4[\L)Q;0Y;ZSO7%.CWW[\0=.JSQ5BZ"*2]RV6.\VS!S!@,4BW<KH+N70-=J
ME7*N82YW50BW0K@[7E2%>67,V] [JFYIQ4RX/PZ^A$[D>LO&W!\'&KUPB^!7
M;S<5D>*2#+N?)<Q> >!N@ D_< .Q3*3UQG#^. ,GT$[CX3YBQLO$25. 7>_>
MT;XDR _V\$V,PV93%VO\YS_:IF%\TKI_'6J8C3\8\^79>_!.O8D;.O[=/C+6
ME9,*RH63>/O(4EA9_0^4<^50*3C0;K4ZK8(RKQ<?8%47W;*[(6RS58(!F(NY
MB.N9RA6Q!ZZ(5K-9QNZY"SFL<D=4[H@JX+X[YX.M-Q1Y.,4X'VY^8RBZS//P
M[N;'>X"LVW,\F$U+E710$L=#ABA[Y77XZ7I>VA,66IA<(G2/M-/3BWU$5$'L
M^.X@320(DF@?6_7BLS!]!]@A4C&]AR_2=<;]T!W>2=72W2^F9EQ\W\.7N<$2
M+P6W?[C^W3 85ZV'"\/M#:-C%Y0@OT#_ VA/5>H_G?'DDS9VPM\HAFXDI,,P
M71Q^7@7<"P+NMF[KBBR^8H%[AHUN?E2(?1\0>\,P5.6")4/L,FM5<+V"ZU7V
MP',"^':G76!]=6\\'@3JJ=?D(V7*/+YHB^@=_RA3SOP"BNP5>I<BTA=X4?<N
MONPX=._W$?-^26YOG;V,XY[]1RS0:)AFNYI(4S L;-JF50PL7*!8%LVDX2U)
MH:>T.QXG/M(F83!,!M)(&L_I0Z_2()P"?:&-7H4>"T&/'5TWS$Z[!.AQ ;<5
M/D.U+.II'Q!DHUW*F&\^>U4(LD*05<!W5WBQK;=;>J<XO'@6W#M=_'D23J\&
M+OX'W"F=+?!Y&LZA%VKIE=N%CH;=4&58%08=EQ%GK_"CK9MI<?)\B^8]Q&)?
MDA OYBX.EA0JEW+QYWZ,F6T?(3#O_KKP\*ZP[VZ/#L.V6W:GHS>*P;[+-..&
M %BC\UAO$5B(2:0-W0@Y405^BP._MA1U+P[\+F.WJB'UGB#@CF$T;*N4#:F7
M\%@%@RL87,'@G<%@VVHW"FPTEDV@2*]?(?\YO7B[6=!Z6V^6"0RO0**]PL,7
MY^E6!H^:I7?V$(O=W'G89-[['.AOH?P676>*K]C#U_CQ'^/ ,/3&'BZ=TEPL
MLA<!7T558+NPP+9M=](Y#47F.RLU??I'&=X36(^Q_+T;@?T?W&JWKN_@13L>
M^>BUQ;++ALR68/V.H>Z,562:M)+[\I35MOH./J,;)F\-*;NNX,-X2>]25JE_
MF?X8R$CHZ%;Y<]I5>J <+ID/L=/WD&06I=81:Y)*NH;.7$#9LE8C2 DV"CT.
MO&2(/M,_\;T>>,@)8?CS:.F([3?LUIDG2+<92^\3@\#G'2?2<^:>8JEY],D,
M;.K6[$Y,/O\Q"OF#V#1L*J'ZY/&31"ZF 73][2<FG#"-&RN4(/SX#YW\Y]/$
MN4,'_1 YOP^<6_R2'QWOP9E&G_K.X/==&"3^\"![P](]^,"8A;%,;;FB>*!_
MZ ?>D#_/0[?Q1TL_[-AL=R9YFYDE\_KSVF4N.#N_/KG2KL^UZ^\G6O?\[.K\
MM'=\='URK'WMG1V==7M'I[6K:_R'GR=GUU=D)[;UDBOP]@+N6F=0_/%)]^3G
MEY/+FF74-=!/C+%RB)RS&'ZF3.8@T:H$60H[\$.(7M$&R//86/G_>X,! ?P.
MYQ/_?069RF[]#/$D.:&\+H^2?Y/GD.3>Q\,F?H3B'"T,6UGFW'ACQ<E/EP\!
M2,7B<\[YXIPCE^<W%V))-V?')Y?71S]Z9]^NM'=83J][9S<GQW--J5,,M="S
MO)V-7&!D+2&UT@,^=Z1*YZ/D0I6/5VK<<+O&Q&C&L%N6/G,H+CPBJ49J,IU+
MI8^>,$+P5A#$[(&QXB;/"J5T_,*JF)"V[;>Y CE#6ZJM%!+]B9V93)WA,U&+
M L\=:IF+=A)<8"\)3_CHQGB=@]U4:&!#-I-S$ I'N1803_E6W WY%&9,(I%X
M(SCRU"U<'\G,&WUEWF?AET@WF_G%"MC?[2#0G6UYKLMJW[>\BXWT.)SRE"+\
M<1!. CJ'0G@DI<D4%6.\2%WP#8.UB7B/M]J(3HG;T";:?;2=TD9E;Q<4?^_H
MIF$JZE*>,?[>_^(&$?*C()1KF^ #.>3.KH"\\Z453VO$VDU++UFL74V.[4?8
MGY45S59+ZG9U=?CK4.O8?T3))$_T0 N!_&5>2K*6H['C>4"8>(2W/9E\UH[N
MD9^@^JY"L,]*KE^N%P7^O8M?\66\T#FVQ8,T<--IZ2V]W!74BB-W]['GPD+/
MIJEW;,LPVGI!-=6YBB]-*,?G>MI@;HCND1=,X)%U.<%<ZXN'["S8O YK/$O\
M>;G-MOO8GU*1K,)T#:NC#D,]>_19S8!$2:DY"3#&4B)L*9RK8+I]B_"^\-?;
M0),HTI2WITBV<X(]&0_N_$Q;$N:V3<-6MG$H/LRM5#CE"&ZOAHY5+/;4^H.%
MSWT&*=CNJG<JSFNHCR<4/CS]RY_]99]88K$L$/PTKU!.:I#BE9\6'=_D[G5R
M"!8]>!7/D]'I&,WB/$\_ OS-F(%.7?A_D6+(_RSVE7V^-9^39;>-4LV6SR&$
MDK%7R$6JY&'^P;WCH]27R8",=N&$O^LPO%$9MZKHJ'@PB?JDE5B_W,%O+WBH
M:[T0029PY4PJCS/)M-NZ;A;C3,K1:(7W;,^/YE7^HPW\1[1ZP6QU.B7H5)##
M<T(S51ZD35PLI5I,Y>\IQ;&SL,V$CA6"LGRZ<'^/6D&4S]L3!@\K6T(KN7G6
M>6 >UR]_Q@9GZTKNGIU\\^:ON:866<GML_5O?=KK5;Z?O<9HBXPV6[<-TS#T
M-M;5[=)T_?@S</WXWZ0#T*SYEM?[@]RBL7O6<1%MTZNR_+:%#BFV&89N&GI#
MD0)6DH8C"W:G<E%5+JJRT7&[+JKLQR^IS49I,F&%&FQ85J<4C3<6:+SO-+]9
M2H,?8WI,=^FMJEQ3Z[JF.$<9NFTU%2V^BVVLL8"[ECBK7I7GZ76]7N7+*I,O
M2R@0+/7M,@X-656CE,^[M16/UG/;6YNMY[G/[\VI5BY54E1OUI7!T=::8JSD
MJK%-_+,X5\W)Q.TZ$X6QDGZP<JK.W)&^XUU:@;R=AFVW%%E0A3E?<NEM= 2Q
M?CKQ"(5D>DA=^PF 5_N)PA KYKIVG/0Q_22\.[L798>TDZ?*U?,UM5D)UMIZ
M2V\6 VMS>>D21<@)!Z-,NP:II"=7@B?[!&-WSTEKXHPUOGESS-LQFF;QF#>7
M]99AW,G+1$5[S(NK@B7+:*ORB0L'2WFL^ S@:):9*TQ48:(*$VT!$[4;':LX
M3/03Q4X?DV#L#B)I=.O,22=?)2@O7;Z'< EKNX9ME0DNK;85WX/;6[EQ-8VK
M]OP!AE%.'6]$''N(M;.N:]W@$/^/7%&!J)* J$;3:!<#HE;CL I1E=R*W1Q1
M&0U#I?*>&U&MQH<[AE<*1LD;]57!JRW#*]M2I>P5#J]6XLL*:U58J\):^XBU
M.KIEF0J'XG-AK5_./0*M<(T&(Q^3X@Y_V).[C?*3CU\H""_?L;AM81F!%D:Y
M3<6TUL* ULK[<-X/8]\1!!S@YSJ:T:YK;<O0M2O\%7^AT$=_U;4K+[A'OJL8
M'US!JV>&5QW++JA6>&6^VD$CN@I[E1Y[0:5*\=AK92;-5VD5_BHI<ZZ,OSIZ
MJXRY@*OR9J$0+&]6UZJ3N[+2-#\T:'8\4,XW+% Y)@PN,1H-K'(ZK>Q9>.Q&
M R^(,-7.;X^2>!2$;D06^#4(>U&4H)/'B>?X3ARLLLMO-(1)/R$/3Y \)V7C
MN4.*)O 9V9H1#6GRT.R\D\P0E25#B,SVH64KA]?L9L"0M>T!0[M8Y='-]??S
MR][5T77O_$S[>GZI]:ZN;DZ6%(0PB<G(RN)I5BFS+QFK0P<,/4O1QO4(1:A&
M1@* %)!Y"$Z,ANDP6OQ(_ >BS;0'K"$UAXD37!2$F@O2I/6G6CQ"VI? "6%R
MC';LAF@00_-YK)Q_.E/-L,D,,7N.(>1A8 JEL2$]U;, %4/]*/&R-Q=0B4#N
M8I/??-#FGCP-@OX%9OS-C<N6X7#F)7+F]4&!ZVI# 9F6;DP>-3T=R[-P1F#>
M+, W'V!O<\>^K5IS0(E!1V/,S<K;R1[!J>Y &HIRNO?F[/E<LJU1ET.(K1)M
MA(6W/ZT-0,7>@G\E'CFQYL;:&"$LVX[G@>""%(?H[P3++Y5YD/%;%R_X#D09
M'Y]C+,<'7PENXT\8.9$V3+RI-G 2T OPF:0FX)F8)["=A<D)OP<U^!?^NQMI
M1SXV'3R\4##)X"M<_*5]-'*\6Z6N6)/HFXXF*^2L5@ *^C ;/VO)1+CYAY@+
M4,F*SL[=\.5E[ZQW_1_M2^_\^J3[7;LX[:HVFKR5TIF[#IG&[G#HH16F[EF;
MW]IHK7+ODU\%\-[\V*2-7BWO4<4QQ1=EN?QZ1&>.GE7&/!7YJA^B#]J?P<C7
MOKF>A^VEW3%_KHY8SAXK$TC6MYML5Y$[\3.L-J(4&\'APH=J"XK:@N[(1;?:
MR2,:)+%[CS0:H@JKD[GBK:>+MQ.CCQDW0,56E<'W\559?%=)A.\\_^<_VJ;1
M^M0-?#_8H7*M--(2QTZU&R7:#1)[<\<:M4&^<M>S6%!EBU2\5J0MD@GOO,*H
MPQR)UH\Z%!)TX'N9\05#"!D9G7)[@K-RU#[LJ*.VSQ,%Z<5H3)G>Z&PYGIM=
MZ+/'=TX>1V[?C971G354P)YE 70.S?9ZFIEIKY"J9ITF$:B#=,^T970'S@)E
MC&@!6W;TPY;YM&/I>=[S&$6#T)U SHI850 .&O+Z3S^S7@K?JE/LMM-P5<L]
M-)]^#CO:*(1\HU$<3Z*/'SX\/#P<1FAP>!?<?S@*!R/W'D4?T/#."3\,G=CY
MT&ZW6Z;Q 5/),%KMCF&9%OYGQVA^0)0E_FL<&(>C&'.Q<6C\\<%1GM9K2\;J
M9N'+I.5/- Y"QQ\F:9$"1+>/@$@>7A(6R:,H"C!<(7F(^%?6Z$_T/9]X ^V=
M P%VDOH/J3)7$T12:RY1%'@)N9%FW5RA24Q2_S1+)\:I^5Y[Y_H#+QE"6#WB
MXJ_A+1;KB0,M2,+Y0'H:J[]U/7P[S\1IDB=;Y#U<D76(+X , =>'!6)JXG_[
M _3^<"$G+:JU62"S*V,F-4^N"ILJY:%@>.!SV]8;H&\-&Y.-<.O0H>QN'NJ5
MZM@*);_*=4V0$8?E,L*2>W07(I):PT3>(3KD?! '6.PI1YM&73,Z';,.'SKX
MVB'+J8'\9+@)?S ._#N5JL$',>3A.?YO>"R\]7^"\#<\B"W ":?UC"J#Q!^:
M!4U^'6&#!OY]&P9C+<:T OU"?H*J(WEYF,[IP[#"&2!LIT0T$Y!D^X2(I/OD
MJ"ZNL(A^^GK0%*L1:NI/!ZNR<,HP!X'I>J- ?96G)C;47[,NFC(KK^T?K28_
M6G<@SB98/MF]=\JCOO:+ECD Y!)>F^BL*S1(0C+Y44LK&VFB'WQ&S!K#Y$F%
MTM4@R">/@Y'CWR'M:!##)4;':JCU!=[3K(DC5K-E4V<AYU2:8[\/:R9 &(/J
MMM$0 M0X:% !:E28:6NTS)L !4CH:N2$2#LG:D6[\/#*L8#J:LEO'#:XY/,\
M9G+;%:]($*)_=="NIZ+_%?5#R7XPB1(P,D9/94=4VD#%P1;7!F:E#;9$RT7:
MX&0\\8(I0DJU8+24:B'">L%ZDE[ 5DD*@4 U5*Z0UZD%.I9A8IXU&GJK97X8
MMO1VP]:'Z+%A<#5@56I@6\3<7 ]8>>:!L;H:2+7 T21T/68:&+(>,(IT,51Z
MH%#6;4/+ /#IM:P/J*EW6AWKOYAUN1IH5&I@2[3<7 L8.5I@$QWP9^(CYFLE
MZ, P2X .*A50(-N:MMDV]::.P:C9^M!OX#_H)K!M_\ XC!]CT )V^;0 #;=+
M0?6_DBAV;Z?[2.!3Y$3I8")G>9P$.I21R$ ?Q0\(^7C-OIS5ZP3N>$0$^D]W
MK/URO&BD/;CQ:"YNDNE3Q7M\8RT  9<)&L2R_S,@N:C:)$1C-\*TPE?!L%]H
M00U3;.>FU^9HK?ZL5W.9-Q.3E[ZUE3%:]&:EL2J--2-0)M=8S4IC[9+ JVBL
ML^">9'0P<Z.Y@LJJ:W_BO\:C(%NA@#QO!64FE@,65:K"8"D/V*H:!4FT#>UE
MKJJ]Q'J("M,LHU):KUAI42>!;>C05^O#L-W2+<,F3@+A>6V53V?M+35745#'
M:" K*))WIK=V9E.)U>Q$,1T:UH9FE6EG?$%VI:$J#965J0[74.U*0VV-FMWC
MKGC_L\ _.'G$4AU! X(++'1859UBM(4E+2=O[J<SS?IQ<O5"9VV#94X_5'JA
MT@OSG&R*8%&GT@M;HR8TT0VA/W2*'] 0**3U?#^X)U[>B,P#.\S7%%@6T0.^
M1=881\D=!IS,E5*G8"1'9YAJ%XVL();:%.70&=O,.JG4R&X8WQ2):%4*_O;(
M>48TA90TVO.CV(V3F.2S?T>.A['+!H9'%C49+9*QW\G5)&8:I5*JD.;!C]>C
M0?8@;VU[>5$-_,]&NRGE11F[R]G&RN-E)\ _*S5_.2%TSA4DP"(\2? RG0@I
M*V%(V#K*J0&L,_7!:ELTLT4+_'(!2VY\2*Q'87R0Y!9>/+AZ/DN5^+X]E5&R
M$U(4CN@M761G-OYKB-(1S&I5LNOVR/G5#:-491Q!]1XQ'K P,WVB=6D+[@&6
MR*?I%*921%XK% Z2>A>53A%K@@V74^<R?I",(9(^V-Q!S3#K4"":$LS,!UDT
M:"N=&E)U,=A1GR0A)=)1*V(T1B%YL<\=-)Y_\RLT"/SA8NG>AD1S(X$?Y'M2
MC:+<H8)/[6=CD;20K)!LT0*%@Z=VCMSP&62#(V_-M*AP5+)13MG8W+R"[.%&
M2Q<HK],Y2+UCA61A[D.^TC+:I178XITOA# *)Q>/^\\*X 460+#^?KK=0.O]
M^UC['GA@;&%KZ?2TRV23PD_#6 1M.YW#M;QA,\]\2=6;E4YX$E^GYF@A>8Y[
MK1,8[;J!3PB $91XZ=, K_(,2WVN_%JK@,<=RNUK[\?:?$G]6,L,W,/@ 4@[
MWWAY87Z&4GWL=0O-?#HL#!&OX0@L>SO-IW.%RDS8D*Y/-Q'6VJ&R'FN*8) M
M3(+MI1&OQ\W[8Q7DDX].L Y"\<97"1P2KD^+*V<CXM!JR5H2S;+72<M=$L42
MRZI,_U=A^D/7,UO/D?/VORK;?S/B$6?;(E= MGKH"_*)6\ 9R@G]()M?W?A_
M=RATO*'6\X>8'##L7B-#/7R6?D,2]>K91#PBY+3>0 Y9I>4*:@6R''.8C<([
MW%8*HV0G6TLHC(YX-:AI,1N?*OVQ&2VQ*O C-V-1"]U15R;+"6GG#6R_.%/\
M5YJ%-X">#Z>GW;KVR[E'MR#;UV@P\C%"NW,1S_4%D;Z^['T!OV2$_ A&S),/
M9,-#K$?2'ZTM&B Y[2,K-?+BU(AN-6R)]4U=](?3_U6ICR?1\"B*4.KZ!Q&C
M;5\4AHBL2V9#X[DIM_I:&2[43=G(K*<R'5Z?S-OXG^W,GPY,^X#^\<#UA^A1
M: "C-,AC&PEW2[S2^[0W7]W;>$03$!A"N62-\[5NB(:9)OSPZ3>L 1P_GM9G
M2PLU@R().S<2LE(:G3QL[LF*99NNR754S9JNRC(D[):5C^=-:LFN*"07=Z_L
MB1S:[31;?W5KXQFR]2N;HXSZ0.+(M(MT$7FRS_V:*V2\[R3O;P-)*-/QN(X]
MMDQPMO->S\0V(E%6G;KY5*-CZ\9PN82NL?RTV\K)-R=NVCM\PP4*!V@20YDL
M,Z5Y&J#6Z_72#CJG%PO\896,EEY&17S-5*;;5C*Z"O7***-;$='*H'P.AOK'
MM\OSFXN;L^.3R^NC'[VS;U=O/K>+&5/TW/A0]>JG;I1IQ!OAU9 J2FQ?1DD_
M<H>N0P+/>3-89>0&(\TUZ!_L0YZK11+284K9(/"CP'.I>-VZON.30:T1;R=.
M&M/%(S=2SR(K<=^GUR<_6W4R\-'*!<U6WFL'C6CIA&44I4EE,4LEF6"!&TS7
M;,*TQ<!MY5$IJ0"+8=RBN-XP7X?XS;]YVC- SK? ?-P=N0CRF-$@(2;?.>E/
M'T(8-4J8[X5-XV1-S_1T)J<3]AT?10?:^:.'IGP6IZGK9G60E5(.3"$'KR).
M,/_F2^3@JS#9*CEXN7)@B?/ >F7G@;65\\!H:S>'5X?=PZQ$&):-#:<CC&V&
MP02LI5S9Z>C-.=D1HB.#M$J$2BM"IA"AUW646%LY2BH1>JTB]%1H;,EEV/P<
MLU_'.;8+VHE1?[+0D.12+(6#OQ,W9$E@IZ[3=SW2  ,^3\8+<DH75)=4SH47
M(<;B/+#%26B_LI-0O'DW\*,9 >KY0S2!!$I\=-')FB@DQUG?<P=8K@8PE@6\
M=U_=<%SQ>+EYO-/BRK+3>AT'S?R;=SWG 5I3B/5>$+=SI9_+Q;N&;ASVSJY>
M*'_^OR^7IV)!T(G>@0[SQ\$@(1ES[ZXQ&G#YGX?\S\, /]$/8LV93) 3TA D
M7(AULC,@*!^L)F*H:'TT<&"2EHO-'_@Z+7;N(@T*:R!58 CQ%9C7Q9[1\X$4
M8DGD!OZ]\XVA=R47Q;+;5??["V4WU>Y>.X^!'XRGVLECC/R(#,L>C-#8$6SX
M2K;]XO+D-6[[18C UJ.=/$Y=_W<?4I!>V=YWCTY?X]YW'6^0>*][ZT^/OKS&
MK3]U^LA[M9M^?/+U-6YZ>L0?HUO(B'N]@M]XH?O?#>ZEE*H+YP[1QCL,%QP#
M+O@*N. ==-1P8E;?2MF&L@OX,0?X^QS\%_!HBN0K+#FK8("T&^>F$QP6T7'Y
MHQ90=:.[<\B>;3&Y_,'_JD& "1-5B[!]/4P\_#229>I&&G-/:"/G'A ;\K5@
M[)*]F4CQ(I*DVM2-=\[[=_9[\,I=HCM^?E\=_#C4 "]2[QPILP('=']*YSR3
M+[M-0M^-1C4';_!D"D]P_*GXKIEU(:T;C,=N1!1&,@F@^]/?"8K4"F+QMJ4;
MO,JU.Y +UIQ#NPA",BJ2QMK<J#9/^A -L;3DT;[__IVAOW_GWJLV8->$V9N.
MM*V5.]*J7F*V%RU^L(\^L;ZT3*:@!2U)S=9$HUGZ.6GI._<A)^-,U]ILJ]JY
MM<S_9:9KK7BC#_U@./V,?X[BL??Y_P-02P$"% ,4    "  PC:]:3[_GM*H)
M  #+/   $               @ $     97AH:6)I=%\Q,BTQ+FAT;5!+ 0(4
M Q0    ( #"-KUKP$+)0?0@  #4X   0              "  =@)  !E>&AI
M8FET7S$R+3(N:'1M4$L! A0#%     @ ,(VO6@?BWG!%!0  .!,  !
M         ( !@Q(  &5X:&EB:71?,3,M,2YH=&U02P$"% ,4    "  PC:]:
M_LZD&5L%  #2$P  $               @ 'V%P  97AH:6)I=%\Q,RTR+FAT
M;5!+ 0(4 Q0    ( #"-KUI/'"W:900  ,\A   0              "  7\=
M  !E>&AI8FET7S$U+3(N:'1M4$L! A0#%     @ ,(VO6I1O7ZYG$@  *F4
M !               ( !$B(  &5X:&EB:71?-"TQ,RYH=&U02P$"% ,4
M"  PC:]:!]Q7U%<2   K9P  $               @ &G-   97AH:6)I=%\T
M+3$T+FAT;5!+ 0(4 Q0    ( #"-KUI,786'91(  ()I   0
M  "  2Q'  !E>&AI8FET7S0M,C,N:'1M4$L! A0#%     @ ,(VO6F#.<NEH
M=   R\8" !               ( !OUD  &5X:&EB:71?-"TR-"YH=&U02P$"
M% ,4    "  PC:]:^O_([<9P   [@@( $               @ %5S@  97AH
M:6)I=%\T+3(U+FAT;5!+ 0(4 Q0    ( #"-KUI;OA'=2QL  %"I   0
M          "  4D_ 0!E>&AI8FET7SDW+3$N:'1M4$L! A0#%     @ ,(VO
M6OGS+,1%6   J(X$ !$              ( !PEH! '1R:6(M,C R-#$R,S$N
M>'-D4$L! A0#%     @ ,(VO6D '@(-_&0  THX! !4              ( !
M-K,! '1R:6(M,C R-#$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( #"-KUH0\X A
M J(  ,N5#  5              "  >C, 0!T<FEB+3(P,C0Q,C,Q7V1E9BYX
M;6Q02P$"% ,4    "  PC:]:^-<P2WEM @"7)R, %0              @ $=
M;P( =')I8BTR,#(T,3(S,5]L86(N>&UL4$L! A0#%     @ ,(VO6H-G7"PZ
MZ@  2.\1 !4              ( !R=P$ '1R:6(M,C R-#$R,S%?<')E+GAM
M;%!+ 0(4 Q0    ( #"-KUH04V%)9DX' +/$;  -              "  3;'
E!0!Z:S(U,S,Q-3$N:'1M4$L%!@     1 !$ , 0  ,<5#0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>221
<FILENAME>zk2533151_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:currency="http://xbrl.sec.gov/currency/2024"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:trib="http://trinitybiotech.com/20241231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="trib-20241231.xsd" xlink:type="simple"/>
    <context id="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:InventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:InventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:TaxValueOfLossCarryForwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:TaxValueOfLossCarryForwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:OtherItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:OtherItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:InventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:TaxValueOfLossCarryForwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:OtherItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:InventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:TaxValueOfLossCarryForwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:TaxValueOfLossCarryForwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:OtherItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:OtherItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">trib:InventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">trib:ProvisionForInventoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherRegionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherRegionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribUS1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:US1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribUS1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:US1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherRegionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribUS1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:US1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">trib:ProvisionalValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-30</instant>
        </period>
    </context>
    <context id="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">trib:MeasurementPeriodAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-30</instant>
        </period>
    </context>
    <context id="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-30</instant>
        </period>
    </context>
    <context id="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-30</instant>
        </period>
    </context>
    <context id="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-30</instant>
        </period>
    </context>
    <context id="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-30</instant>
        </period>
    </context>
    <context id="C_20240130to20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-30</startDate>
            <endDate>2024-01-30</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240930to20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-30</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_20241031to20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-31</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="C_20240930_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullDefinedBenefitPlansAxis_tribResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullDefinedBenefitPlansAxis_tribResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullDefinedBenefitPlansAxis_tribResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullDefinedBenefitPlansAxis_tribAdministrationAndSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:AdministrationAndSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullDefinedBenefitPlansAxis_tribAdministrationAndSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:AdministrationAndSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullDefinedBenefitPlansAxis_tribAdministrationAndSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:AdministrationAndSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullDefinedBenefitPlansAxis_tribManufacturingAndQualityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:ManufacturingAndQualityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullDefinedBenefitPlansAxis_tribManufacturingAndQualityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:ManufacturingAndQualityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullDefinedBenefitPlansAxis_tribManufacturingAndQualityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">trib:ManufacturingAndQualityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassATreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassATreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassATreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassATreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassATreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220501to20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:MicoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="C_20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:MicoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="C_20240101to20240131_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:WaveformTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20240131_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:WaveformTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="C_20240901to20240924_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:MetabolomicDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-24</endDate>
        </period>
    </context>
    <context id="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribCraigHallumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:CraigHallumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-10</endDate>
        </period>
    </context>
    <context id="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNativeDesignLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:NativeDesignLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-10</endDate>
        </period>
    </context>
    <context id="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-25</endDate>
        </period>
    </context>
    <context id="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovusDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-25</endDate>
        </period>
    </context>
    <context id="C_20240901to20240924_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:MetabolomicDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-24</endDate>
        </period>
    </context>
    <context id="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribCraigHallumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:CraigHallumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-10</endDate>
        </period>
    </context>
    <context id="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNativeDesignLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:NativeDesignLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-10</endDate>
        </period>
    </context>
    <context id="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-25</endDate>
        </period>
    </context>
    <context id="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovusDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareTreasurySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-25</endDate>
        </period>
    </context>
    <context id="C_20241025_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovusDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-25</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechManufacturingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribKonamiteLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:KonamiteLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTribBiosensorsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TribBiosensorsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechInvestmentLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechInvestmentLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovaCenturyScientificIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:NovaCenturyScientificIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribImmcoDiagnosticsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:ImmcoDiagnosticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechUkLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechUkLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechDoBrasilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechDoBrasilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsAbMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:FiomiDiagnosticsAbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsHoldingAbMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:FiomiDiagnosticsHoldingAbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPhoenixBioTechCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:PhoenixBioTechCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPrimusCorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:PrimusCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiopoolUsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiopoolUsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMardxDiagnosticsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:MardxDiagnosticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribClarkLaboratoriesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:ClarkLaboratoriesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechLuxembourgSarlMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechLuxembourgSarlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingServicesLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechManufacturingServicesLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityResearchLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityResearchLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechJointVentureLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:TrinityBiotechJointVentureLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicsDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsAndCompanySecretaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ShareOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhMember_ifrsfullClassesOfFinancialInstrumentsAxis_tribAdditionalSpaceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:MrOCaoimhMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:AdditionalSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribJrjMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:JrjMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhAndDrWalshMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:MrOCaoimhAndDrWalshMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2007-12-01</startDate>
            <endDate>2007-12-31</endDate>
        </period>
    </context>
    <context id="C_20161201to20161231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:MrOCaoimhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220701to20220701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-01</endDate>
        </period>
    </context>
    <context id="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_tribJrjMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:JrjMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2007-12-01</startDate>
            <endDate>2007-12-31</endDate>
        </period>
    </context>
    <context id="C_20161201to20161231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhAndDrWalshMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:MrOCaoimhAndDrWalshMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="C_20210701to20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullCategoriesOfRelatedPartiesAxis_tribDrJimWalshMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DrJimWalshMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="C_20240901to20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullCategoriesOfRelatedPartiesAxis_tribDrJimWalshMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:MetabolomicsDiagnosticsLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:DrJimWalshMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:InstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:InstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTwoPercentageOfGrossInventoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TwoPercentageOfGrossInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTwoPercentageOfGrossInventoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TwoPercentageOfGrossInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTwoPercentageOfGrossInventoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TwoPercentageOfGrossInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230131_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">trib:StrategicPartnershipWithImawareIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">trib:StrategicPartnershipWithImawareIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20230131_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">trib:StrategicPartnershipWithImawareIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">trib:StrategicPartnershipWithImawareIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribHivOneByTwoRapidTestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:HivOneByTwoRapidTestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribHivOneByTwoRapidTestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:HivOneByTwoRapidTestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPremierInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:PremierInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPremierInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:PremierInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribMidTierHaemoglobinsInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:MidTierHaemoglobinsInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribMidTierHaemoglobinsInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:MidTierHaemoglobinsInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribOtherProjectsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:OtherProjectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribOtherProjectsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:OtherProjectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechDoBrasilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TrinityBiotechDoBrasilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechDoBrasilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TrinityBiotechDoBrasilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribBiopoolUsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:BiopoolUsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribBiopoolUsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:BiopoolUsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechManufacturingLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TrinityBiotechManufacturingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechManufacturingLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:TrinityBiotechManufacturingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:DevelopmentCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribWaveformTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:WaveformTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPrimusCorporationCguTradeNameMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:PrimusCorporationCguTradeNameMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPrimusCorporationCguTradeNameMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:PrimusCorporationCguTradeNameMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribImmcoDiagnosticsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:ImmcoDiagnosticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribClarkLaboratoriesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:ClarkLaboratoriesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribClarkLaboratoriesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:ClarkLaboratoriesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribPrimusCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:PrimusCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribPrimusCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:PrimusCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribImmcoDiagnosticsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:ImmcoDiagnosticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230601to20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribContinuousGlucoseMonitoringTestingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:ContinuousGlucoseMonitoringTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribContinuousGlucoseMonitoringTestingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:ContinuousGlucoseMonitoringTestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribT10HplcAnalyzerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:T10HplcAnalyzerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribSyphilisPointOfCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:SyphilisPointOfCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribTrinscreenPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:TrinscreenPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribKansasRightOfUseAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:KansasRightOfUseAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribTrinscreenPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:TrinscreenPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribKansasRightOfUseAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:KansasRightOfUseAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribEpiCaptureLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribMetabolomicDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:MetabolomicDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribWaveformTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:WaveformTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribEpiCaptureLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribWaveformTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">trib:WaveformTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribSyphilisPointOfCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">trib:SyphilisPointOfCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:LaterThanTwoYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:LaterThanTwoYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:LaterThanTwoYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:LaterThanTwoYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">trib:LeaseLiabilitiesRelatedToRightOfUseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trib:DiscontinuedOperationsAxis">trib:FiomiDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trib:DiscontinuedOperationsAxis">trib:FiomiDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trib:DiscontinuedOperationsAxis">trib:FiomiDiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trib:DiscontinuedOperationsAxis">trib:FiomiDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trib:DiscontinuedOperationsAxis">trib:FiomiDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trib:DiscontinuedOperationsAxis">trib:FiomiDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiosynthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230401to20230430_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiosynthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiosynthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiosynthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">trib:PostDisposalAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiosynthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:NoncurrentAssetsHeldForSaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:SE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">trib:BiosynthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:CarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">trib:FairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">trib:FairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:CarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:FinanceLeaseReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:FinanceLeaseReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:FinanceLeaseReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:FinanceLeaseReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:FinanceLeaseReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:FinanceLeaseReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:ContractualCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:ContractualCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_srtCurrencyAxis_currencyEUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_srtCurrencyAxis_currencyGBP">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_srtCurrencyAxis_currencySEK">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_srtCurrencyAxis_currencyCAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_srtCurrencyAxis_currencyBRL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:BRL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_srtCurrencyAxis_currencyXXX">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtCurrencyAxis_currencyXXX">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:XXX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtCurrencyAxis_currencyBRL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:BRL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtCurrencyAxis_currencyCAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtCurrencyAxis_currencySEK">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:SEK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtCurrencyAxis_currencyGBP">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtCurrencyAxis_currencyEUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullTypesOfRisksAxis_tribTenPercentStrengtheningUSDollarMember_srtCurrencyAxis_currencyEUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">trib:TenPercentStrengtheningUSDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullTypesOfRisksAxis_tribTenPercentStrengtheningUSDollarMember_srtCurrencyAxis_currencyEUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">trib:TenPercentStrengtheningUSDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullTypesOfRisksAxis_tribTenPercentWeakeningUSDollarMember_srtCurrencyAxis_currencyEUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">trib:TenPercentWeakeningUSDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullTypesOfRisksAxis_tribTenPercentWeakeningUSDollarMember_srtCurrencyAxis_currencyEUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">trib:TenPercentWeakeningUSDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullGeographicalAreasAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullGeographicalAreasAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullGeographicalAreasAxis_tribEuroZoneCountriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:EuroZoneCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullGeographicalAreasAxis_tribEuroZoneCountriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:EuroZoneCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullGeographicalAreasAxis_countryGB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullGeographicalAreasAxis_countryGB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherRegionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherRegionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullTypesOfCustomersAxis_tribEndUserCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">trib:EndUserCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTypesOfCustomersAxis_tribEndUserCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">trib:EndUserCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullTypesOfCustomersAxis_tribDistributorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">trib:DistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTypesOfCustomersAxis_tribDistributorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">trib:DistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullTypesOfCustomersAxis_ifrsfullNongovernmentCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">ifrs-full:NongovernmentCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullTypesOfCustomersAxis_ifrsfullNongovernmentCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfCustomersAxis">ifrs-full:NongovernmentCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:LaterThanOneMonthsAndNotLaterThanFourMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:LaterThanOneMonthsAndNotLaterThanFourMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:LaterThanOneMonthsAndNotLaterThanFourMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:LaterThanOneMonthsAndNotLaterThanFourMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:LaterThanOneMonthsAndNotLaterThanFourMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:LaterThanOneMonthsAndNotLaterThanFourMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:GreaterThanFourMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:GreaterThanFourMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:GreaterThanFourMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:GreaterThanFourMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:GreaterThanFourMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:LeasePayableOnRightOfUseAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ExchangeableNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:TwoYearToFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:OneYearToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthToTwelveMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:SixMonthOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">trib:GreaterThanFourMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">trib:FairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:CarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:NovusDiagnosticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">trib:GreaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">trib:EquityComponentOfConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ComputerEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ComputerEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ComputerEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ComputerEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ComputerEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ComputerEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ITAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:NetCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">trib:DepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ITAndOfficeEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ITAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ITAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ITAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:ITAndOfficeEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:EliminationOfIntersegmentAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:EliminationOfIntersegmentAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:EliminationOfIntersegmentAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AsiaOrAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AsiaOrAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AsiaOrAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribEuropeIncludingIrelandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:EuropeIncludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribEuropeIncludingIrelandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:EuropeIncludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribEuropeIncludingIrelandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:EuropeIncludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullGeographicalAreasAxis_countryIE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullGeographicalAreasAxis_countryIE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullGeographicalAreasAxis_countryIE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtMajorCustomersAxis_tribCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AsiaOrAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullProductsAndServicesAxis_tribClinicalLaboratoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:ClinicalLaboratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullProductsAndServicesAxis_tribClinicalLaboratoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:ClinicalLaboratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullProductsAndServicesAxis_tribClinicalLaboratoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:ClinicalLaboratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullProductsAndServicesAxis_tribLaboratoryServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:LaboratoryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullProductsAndServicesAxis_tribLaboratoryServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:LaboratoryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullProductsAndServicesAxis_tribLaboratoryServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:LaboratoryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullProductsAndServicesAxis_tribPointOfCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:PointOfCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullProductsAndServicesAxis_tribPointOfCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:PointOfCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullProductsAndServicesAxis_tribPointOfCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">trib:PointOfCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_srtMajorCustomersAxis_tribCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AsiaOrAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtMajorCustomersAxis_tribCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AsiaOrAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">trib:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">trib:AmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:CurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:CurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:CurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:CurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember_ifrsfullClassesOfFinancialAssetsAxis_tribDerivativeFinancialAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember_ifrsfullClassesOfFinancialAssetsAxis_tribDerivativeFinancialAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20220531_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:MicoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="C_20220501to20220531_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SevenYearConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:MicoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:CurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:DerivativeFinancialAssetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanCreditFacilityOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:PerceptiveCreditHoldingsIiiLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:PerceptiveCreditHoldingsIiiLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnconsolidatedStructuredEntitiesAxis">trib:PerceptiveCreditHoldingsIiiLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanCreditFacilityOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="C_20230201to20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanCreditFacilityOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="C_20230401to20230427_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSaleOfFitzgeraldIndustriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SaleOfFitzgeraldIndustriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-27</endDate>
        </period>
    </context>
    <context id="C_20230427_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSaleOfFitzgeraldIndustriesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SaleOfFitzgeraldIndustriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-27</instant>
        </period>
    </context>
    <context id="C_20220501to20220522_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanCreditFacilityOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-22</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanCreditFacilityOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:AmendmentAndRestatementOfTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-31</instant>
        </period>
    </context>
    <context id="C_20240101to20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:AmendmentAndRestatementOfTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="C_20240430_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:AmendmentAndRestatementOfTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20211201to20211210_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ExchangeableSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-10</endDate>
        </period>
    </context>
    <context id="C_20240101to20240331_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:SeniorSecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20240331_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:AmendmentAndRestatementOfTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_20240331_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:AmendmentAndRestatementOfTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:AmendmentAndRestatementOfTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribContingentLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribContingentLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">trib:ContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">trib:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesOneOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesOneOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesTwoOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesTwoOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesFiveOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesFiveOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesOneOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesOneOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesThreeOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesSixOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesThreeOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesFourOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesThreeOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesFourOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesThreeOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">trib:RangesSixOfExercisePricesForOutstandingShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:ClassAOrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">trib:AmericanDepositaryShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20230401to20230427_ifrsfullBusinessCombinationsAxis_tribBiosynthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:BiosynthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-27</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:WaveformTechnologiesIncorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:EpiCaptureLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribBiosynthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:BiosynthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullBusinessCombinationsAxis_tribBiosynthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">trib:BiosynthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribPersonnelRelatedCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:PersonnelRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribOutsourcingCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:OutsourcingCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:SiteTransferCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribInventoryRelatedCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:InventoryRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribOtherRestructuringCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:OtherRestructuringCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241001to20241031_ifrsfullUnderlyingEquityInstrumentAndDepositaryReceiptsAxis_tribAmericanDepositarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnderlyingEquityInstrumentAndDepositaryReceiptsAxis">trib:AmericanDepositarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241031_ifrsfullUnderlyingEquityInstrumentAndDepositaryReceiptsAxis_tribAmericanDepositarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnderlyingEquityInstrumentAndDepositaryReceiptsAxis">trib:AmericanDepositarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_20241031_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribPaycheckProtectionProgramLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_20250227_ifrsfullBorrowingsByNameAxis_tribFourthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">trib:FourthAmendmentToCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-27</instant>
        </period>
    </context>
    <context id="C_20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">trib:FifthAmendmentToCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-14</instant>
        </period>
    </context>
    <context id="C_20250514to20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">trib:FifthAmendmentToCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-14</startDate>
            <endDate>2025-05-14</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribPropertyAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">trib:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullOtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCapitalisedDevelopmentExpenditureMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLifeAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241223_tribCreditAgreementAxis_tribAmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trib:CreditAgreementAxis">trib:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-23</instant>
        </period>
    </context>
    <context id="C_20241223to20241223_tribCreditAgreementAxis_tribAmendedCreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trib:CreditAgreementAxis">trib:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-23</startDate>
            <endDate>2024-12-23</endDate>
        </period>
    </context>
    <context id="C_20250228_ifrsfullBorrowingsByNameAxis_tribFourthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">trib:FourthAmendmentToCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribContinuousGlucoseMonitoringTechnologyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">trib:ContinuousGlucoseMonitoringTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20251031_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">trib:FifthAmendmentToCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">trib:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-31</instant>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_ifrsfullRestructuringProvisionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_ifrsfullRestructuringProvisionMember_tribInstalmentsAxis_tribWithinOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trib:InstalmentsAxis">trib:WithinOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_ifrsfullRestructuringProvisionMember_tribInstalmentsAxis_tribMoreThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="trib:InstalmentsAxis">trib:MoreThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000888721</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">trib:SiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <unit id="EUR">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="Employee">
        <measure>trib:Employee</measure>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Share">
        <measure>trib:Share</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USD_per_ADS">
        <measure>trib:USD_per_ADS</measure>
    </unit>
    <unit id="USD_per_share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Years">
        <measure>trib:Years</measure>
    </unit>
    <trib:NumberOfOrdinarySharesIssuableOnExerciseOfOptions
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20230414123050603"
      unitRef="Shares">0</trib:NumberOfOrdinarySharesIssuableOnExerciseOfOptions>
    <trib:NumberOfOrdinarySharesIssuableOnExerciseOfOptions
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20250512171325106"
      unitRef="Shares">0</trib:NumberOfOrdinarySharesIssuableOnExerciseOfOptions>
    <dei:EntityCentralIndexKey
      contextRef="C_20240101to20241231"
      id="Fdei_EntityCentralIndexKey20220119133932127">0000888721</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_20240101to20241231"
      id="Fdei_AmendmentFlag20220119134034239">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_20240101to20241231"
      id="Fdei_DocumentFiscalPeriodFocus20220119134133105">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType contextRef="C_20240101to20241231" id="F20230427192706139_0">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="C_20240101to20241231" id="F20230427192706140_1">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="C_20240101to20241231" id="F20230427192706140_2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="C_20240101to20241231" id="F20230427192706140_4">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240415110852567">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="C_20240101to20241231" id="F20230427192706140_5">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="C_20240101to20241231" id="F20230427192706141_6">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="C_20240101to20241231" id="F20230427192706141_7">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="C_20240101to20241231" id="F20230427192706141_8">0-2022</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="C_20240101to20241231" id="F20230427192706141_9">Trinity Biotech plc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_20240101to20241231"
      id="F20230427192706141_10">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240414194056799">IDA Business Park</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240414194147784">Bray, County Wicklow</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240414194232994">A98 H5C8</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240415103933774">IE</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="F20230427192706142_14">Susan O&#x2019;Connor</dei:ContactPersonnelName>
    <dei:CityAreaCode
      contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="F20230427192706142_15">353</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="F20230427192706143_16">1276 9800</dei:LocalPhoneNumber>
    <dei:ContactPersonnelFaxNumber
      contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="F20230427192706143_17">1276 9888</dei:ContactPersonnelFaxNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20240415104441463">IDA Business Park</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20230428021721365">Bray, County Wicklow</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20230428021744011">A98 H5C8</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="C_20240101to20241231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20240415104232487">IE</dei:EntityAddressCountry>
    <dei:Security12bTitle
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513124045017">American         Depositary Shares (each representing 20&#x2018;A&#x2019;         Ordinary Shares, par value US$0.0109)         &#160; </dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20240101to20241231"
      id="F20230427192706144_21">TRIB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20240101to20241231"
      id="F20230427192706144_22">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_20241231"
      decimals="INF"
      id="F20230427192706144_23"
      unitRef="Shares">359193482</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_20240101to20241231"
      id="F20230427192706144_24">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_20240101to20241231"
      id="F20230427192706144_25">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_20240101to20241231"
      id="F20230427192706145_26">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_20240101to20241231"
      id="F20230427192706145_27">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240422145533820">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20240101to20241231"
      id="F20230427192706145_29">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_20240101to20241231"
      id="F20230427192706145_30">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240415125347377">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentAccountingStandard
      contextRef="C_20240101to20241231"
      id="F20230427192706145_31">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany
      contextRef="C_20240101to20241231"
      id="F20230427192706146_32">false</dei:EntityShellCompany>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513105949175">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513104449097">

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Risk
management and strategy&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25;font-style:italic"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;We
have not experienced any material cybersecurity incidents that have impacted our operations to date. However, like most
companies, we are subject to frequent and evolving cybersecurity threats and attempted attacks from a range of sources, including opportunistic
hackers, organised threat actors, and internal vulnerabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;To
identify, assess, and mitigate cybersecurity risks, we have implemented a cybersecurity program covering the full scope
of our information systems and data assets. This includes internally managed systems, cloud environments, third party-hosted infrastructure,
and sensitive data such as intellectual property, clinical research information, strategic documents, personal data of employees and trial
participants, and confidential commercial information, collectively referred to as our &#x201c;Information Systems and Data.&#x201d;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Our
cybersecurity program is led by our Chief
Information Officer (CIO), who has over 20 years of IT leadership experience, and is supported by an internal security
function that collaborates with our broader risk management team.&lt;/span&gt; The CIO works across the organisation to ensure
that cybersecurity is embedded within our operations and treated as a core business risk.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;We
use a variety of tools and practices to assess the cybersecurity threat landscape and evaluate our posture. These include internal and
external vulnerability scans, threat intelligence feeds, cyber risk assessments, penetration testing conducted by third-party firms, and
tabletop simulations to evaluate and improve our incident response readiness. We also monitor emerging regulatory developments and industry
standards to ensure our practices remain aligned with evolving expectations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;To
mitigate risks identified through these processes, we implement a combination of technical, administrative, and physical controls. These
include next-generation firewalls, endpoint protection and antivirus software, multi-factor authentication, access control protocols,
encryption of sensitive data, network segmentation, continuous system monitoring, secure configuration standards, data backup and recovery
protocols, and security awareness training for all staff, including phishing simulations. Our cybersecurity practices are regularly reviewed
and enhanced in response to changing threat dynamics.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cybersecurity
risk management is also extended to our third-party
service providers, who perform a wide range of business-critical services including data hosting, software delivery, clinical
research, supply chain management, distribution, and contract manufacturing. We assess the cybersecurity posture of key vendors through
a combination of tools, such as security questionnaires, audits, analysis of certifications (e.g., ISO 27001, SOC 2), reviews of written
security policies, and assessment of penetration test results. Where necessary, we engage in direct discussions with vendors' security
teams to evaluate controls. We also impose contractual obligations related to cybersecurity and data protection, including confidentiality
and breach notification requirements. These measures are designed to reduce the risk of vulnerabilities introduced through our supply
chain or external partners.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Cybersecurity
risks are addressed through our overall approach to operational and strategic risk management. Key risks are discussed at senior management
level and prioritised based on their potential to affect our systems, data, or business continuity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;
</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513174143889">

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;We
have not experienced any material cybersecurity incidents that have impacted our operations to date. However, like most
companies, we are subject to frequent and evolving cybersecurity threats and attempted attacks from a range of sources, including opportunistic
hackers, organised threat actors, and internal vulnerabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513105022356">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513105055391">

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;To
identify, assess, and mitigate cybersecurity risks, we have implemented a cybersecurity program covering the full scope
of our information systems and data assets. This includes internally managed systems, cloud environments, third party-hosted infrastructure,
and sensitive data such as intellectual property, clinical research information, strategic documents, personal data of employees and trial
participants, and confidential commercial information, collectively referred to as our &#x201c;Information Systems and Data.&#x201d;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513105128359">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513105454836">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Our
cybersecurity program is led by our Chief
Information Officer (CIO), who has over 20 years of IT leadership experience, and is supported by an internal security
function that collaborates with our broader risk management team.&lt;/span&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513105515676">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513050721079">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513050642590">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513105819081">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Governance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25;font-style:italic"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Oversight
of cybersecurity risk forms part of the Board of Directors&#x2019; general risk oversight responsibilities. &lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Our
Chief Information Officer (CIO), who has over 20 years of experience in IT and security, is responsible for the day-to-day implementation
and ongoing development of our cybersecurity program.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;


&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The
CIO is involved in reviewing security assessments, monitoring threat activity, approving key cybersecurity controls, and helping coordinate
incident preparedness across the organisation. In the event of a cybersecurity incident, our escalation procedures provide for involvement
of senior management, including the CIO and, where appropriate, other members of the executive team and relevant support functions.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cybersecurity
matters are reported to senior management as needed, particularly in cases where a threat or incident may have a broader
business impact. Our governance structure is designed to support informed decision-making around risk prioritisation, incident response,
and investment in cybersecurity measures. As of the date of this filing, we are not aware of any cybersecurity threats, including past
incidents, that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or
financial condition.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt;  &lt;/div&gt; </cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513105318095">

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Oversight
of cybersecurity risk forms part of the Board of Directors&#x2019; general risk oversight responsibilities. &lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Our
Chief Information Officer (CIO), who has over 20 years of experience in IT and security, is responsible for the day-to-day implementation
and ongoing development of our cybersecurity program.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;
</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513105538428">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Our
Chief Information Officer (CIO), who has over 20 years of experience in IT and security, is responsible for the day-to-day implementation
and ongoing development of our cybersecurity program.&lt;/span&gt;</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513105344323">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Our
Chief Information Officer (CIO), who has over 20 years of experience in IT and security, is responsible for the day-to-day implementation
and ongoing development of our cybersecurity program.&lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513105734275">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The
CIO is involved in reviewing security assessments, monitoring threat activity, approving key cybersecurity controls, and helping coordinate
incident preparedness across the organisation. In the event of a cybersecurity incident, our escalation procedures provide for involvement
of senior management, including the CIO and, where appropriate, other members of the executive team and relevant support functions.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cybersecurity
matters are reported to senior management as needed, particularly in cases where a threat or incident may have a broader
business impact. Our governance structure is designed to support informed decision-making around risk prioritisation, incident response,
and investment in cybersecurity measures. As of the date of this filing, we are not aware of any cybersecurity threats, including past
incidents, that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or
financial condition.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt; </cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513105718381">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cybersecurity
matters are reported to senior management as needed, particularly in cases where a threat or incident may have a broader
business impact. Our governance structure is designed to support informed decision-making around risk prioritisation, incident response,
and investment in cybersecurity measures. As of the date of this filing, we are not aware of any cybersecurity threats, including past
incidents, that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or
financial condition.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513105758035">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <dei:AuditorFirmId
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220501170154287">1402</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220327041219624">GRANT THORNTON</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220327041225533">Dublin, Ireland</dei:AuditorLocation>
    <ifrs-full:Revenue
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114121347800_27"
      unitRef="USD">61555000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_211"
      unitRef="USD">56832000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_215"
      unitRef="USD">62521000</ifrs-full:Revenue>
    <ifrs-full:CostOfSales
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114121347800_37"
      unitRef="USD">40114000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_311"
      unitRef="USD">37382000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_315"
      unitRef="USD">45253000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114121347800_57"
      unitRef="USD">21441000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_511"
      unitRef="USD">19450000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_515"
      unitRef="USD">17268000</ifrs-full:GrossProfit>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114121347800_67"
      unitRef="USD">-1787000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_611"
      unitRef="USD">141000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_615"
      unitRef="USD">343000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114121347800_77"
      unitRef="USD">4543000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_711"
      unitRef="USD">4379000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_715"
      unitRef="USD">4138000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114121347800_87"
      unitRef="USD">28815000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_811"
      unitRef="USD">31152000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_815"
      unitRef="USD">26983000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <trib:SellingGeneralAndAdministrativeExpensesRestructuringCosts
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250512160338671"
      unitRef="USD">4181000</trib:SellingGeneralAndAdministrativeExpensesRestructuringCosts>
    <trib:SellingGeneralAndAdministrativeExpensesRestructuringCosts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250512160348513"
      unitRef="USD">0</trib:SellingGeneralAndAdministrativeExpensesRestructuringCosts>
    <trib:SellingGeneralAndAdministrativeExpensesRestructuringCosts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250512160351673"
      unitRef="USD">0</trib:SellingGeneralAndAdministrativeExpensesRestructuringCosts>
    <trib:OnceOffExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250512160446176_xbrl_20250512160338671"
      unitRef="USD">1872000</trib:OnceOffExpense>
    <trib:OnceOffExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250512160446176_xbrl_20250512160348513"
      unitRef="USD">0</trib:OnceOffExpense>
    <trib:OnceOffExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250512160446176_xbrl_20250512160351673"
      unitRef="USD">0</trib:OnceOffExpense>
    <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114121347800_127"
      unitRef="USD">1408000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
    <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_1211"
      unitRef="USD">11105000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
    <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_1215"
      unitRef="USD">5839000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413004631278"
      unitRef="USD">-21165000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_1411"
      unitRef="USD">-27045000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_1415"
      unitRef="USD">-19349000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114121347800_157"
      unitRef="USD">0</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_1511"
      unitRef="USD">1171000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_1515"
      unitRef="USD">303000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114121347800_167"
      unitRef="USD">9565000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_1611"
      unitRef="USD">11053000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_1615"
      unitRef="USD">24734000</ifrs-full:FinanceCosts>
    <trib:NetFinancingExpenseIncome
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114121347800_187"
      unitRef="USD">-9565000</trib:NetFinancingExpenseIncome>
    <trib:NetFinancingExpenseIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_1811"
      unitRef="USD">-9882000</trib:NetFinancingExpenseIncome>
    <trib:NetFinancingExpenseIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_1815"
      unitRef="USD">-24431000</trib:NetFinancingExpenseIncome>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413005149122"
      unitRef="USD">-30730000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_207"
      unitRef="USD">-36927000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_2015"
      unitRef="USD">-43780000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114121347800_217"
      unitRef="USD">486000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_2111"
      unitRef="USD">-59000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_2115"
      unitRef="USD">-194000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230412225228865"
      unitRef="USD">-31216000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_237"
      unitRef="USD">-36868000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_2315"
      unitRef="USD">-43586000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114121347800_257"
      unitRef="USD">-573000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220326234440814"
      unitRef="USD">12850000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230412225307585"
      unitRef="USD">2577000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230412225131064"
      unitRef="USD">-31789000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114121347800_277"
      unitRef="USD">-24018000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114121347800_2715"
      unitRef="USD">-41009000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:BasicEarningsLossPerShareFromContinuingOperations
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20230414172355559"
      unitRef="USD_per_share">-1.74</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:BasicEarningsLossPerShareFromContinuingOperations
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220114121347800_297"
      unitRef="USD_per_share">-4.81</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:BasicEarningsLossPerShareFromContinuingOperations
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220114121347800_2915"
      unitRef="USD_per_share">-6.46</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20230414172514392"
      unitRef="USD_per_share">-1.74</ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220114121347800_2911"
      unitRef="USD_per_share">-4.81</ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220114121347800_3015"
      unitRef="USD_per_share">-6.46</ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:BasicEarningsLossPerShareFromContinuingOperations
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20230414172630589"
      unitRef="USD_per_share">-0.09</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:BasicEarningsLossPerShareFromContinuingOperations
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20220114121347800_327"
      unitRef="USD_per_share">-0.24</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:BasicEarningsLossPerShareFromContinuingOperations
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20220114121347800_3215"
      unitRef="USD_per_share">-0.32</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20230414172712450"
      unitRef="USD_per_share">-0.09</ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20220114121347800_3211"
      unitRef="USD_per_share">-0.24</ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20220114121347800_3315"
      unitRef="USD_per_share">-0.32</ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20230414172801585"
      unitRef="USD_per_share">-1.77</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220114121347800_357"
      unitRef="USD_per_share">-3.14</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220114121347800_3515"
      unitRef="USD_per_share">-6.08</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20230414172843253"
      unitRef="USD_per_share">-1.77</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220114121347800_3511"
      unitRef="USD_per_share">-3.14</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220114121347800_3615"
      unitRef="USD_per_share">-6.08</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20230414173012858"
      unitRef="USD_per_share">-0.09</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20220114121347800_3811"
      unitRef="USD_per_share">-0.16</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20220114121347800_3815"
      unitRef="USD_per_share">-0.3</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20230414173056858"
      unitRef="USD_per_share">-0.09</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20220114121347800_3911"
      unitRef="USD_per_share">-0.16</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20220114121347800_3915"
      unitRef="USD_per_share">-0.3</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230412230627043"
      unitRef="USD">-31789000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114125028095_210"
      unitRef="USD">-24018000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114125028095_214"
      unitRef="USD">-41009000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114125028095_56"
      unitRef="USD">245000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114125028095_510"
      unitRef="USD">69000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114125028095_514"
      unitRef="USD">-396000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114125028095_76"
      unitRef="USD">245000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114125028095_710"
      unitRef="USD">69000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114125028095_714"
      unitRef="USD">-396000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230412230557342"
      unitRef="USD">-31544000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114125028095_910"
      unitRef="USD">-23949000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114125028095_914"
      unitRef="USD">-41405000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_47"
      unitRef="USD">4621000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_411"
      unitRef="USD">1892000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_57"
      unitRef="USD">51343000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_511"
      unitRef="USD">16270000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250512171126584"
      unitRef="USD">2455000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250512171144361"
      unitRef="USD">0</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_67"
      unitRef="USD">3553000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_611"
      unitRef="USD">1975000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_77"
      unitRef="USD">166000</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_711"
      unitRef="USD">178000</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_87"
      unitRef="USD">28000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_811"
      unitRef="USD">79000</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_107"
      unitRef="USD">62166000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_1011"
      unitRef="USD">20394000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Inventories
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_137"
      unitRef="USD">19374000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_1311"
      unitRef="USD">19933000</ifrs-full:Inventories>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_147"
      unitRef="USD">16065000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_1411"
      unitRef="USD">13901000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:CurrentTaxAssetsCurrent
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_157"
      unitRef="USD">518000</ifrs-full:CurrentTaxAssetsCurrent>
    <ifrs-full:CurrentTaxAssetsCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_1511"
      unitRef="USD">1516000</ifrs-full:CurrentTaxAssetsCurrent>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_167"
      unitRef="USD">5167000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_1611"
      unitRef="USD">3691000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentAssets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_197"
      unitRef="USD">41124000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_1911"
      unitRef="USD">39041000</ifrs-full:CurrentAssets>
    <ifrs-full:Assets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_217"
      unitRef="USD">103290000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_2111"
      unitRef="USD">59435000</ifrs-full:Assets>
    <ifrs-full:IssuedCapital
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_257"
      unitRef="USD">4190000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_2511"
      unitRef="USD">1972000</ifrs-full:IssuedCapital>
    <ifrs-full:SharePremium
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_267"
      unitRef="USD">63397000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_2611"
      unitRef="USD">46619000</ifrs-full:SharePremium>
    <ifrs-full:TreasuryShares
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_277"
      unitRef="USD">24922000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_2711"
      unitRef="USD">24922000</ifrs-full:TreasuryShares>
    <ifrs-full:RetainedEarnings
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20240412211846794"
      unitRef="USD">-79117000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240412211850539"
      unitRef="USD">-48644000</ifrs-full:RetainedEarnings>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_297"
      unitRef="USD">-5461000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_2911"
      unitRef="USD">-5706000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <trib:EquityComponentOfConvertibleNote
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230413015603125"
      unitRef="USD">6709000</trib:EquityComponentOfConvertibleNote>
    <trib:EquityComponentOfConvertibleNote
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230413015823026"
      unitRef="USD">6709000</trib:EquityComponentOfConvertibleNote>
    <ifrs-full:OtherReserves
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_307"
      unitRef="USD">23000</ifrs-full:OtherReserves>
    <ifrs-full:OtherReserves
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_3011"
      unitRef="USD">23000</ifrs-full:OtherReserves>
    <ifrs-full:Equity
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_327"
      unitRef="USD">-35181000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220326225326285"
      unitRef="USD">-23949000</ifrs-full:Equity>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_357"
      unitRef="USD">364000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_3511"
      unitRef="USD">279000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_367"
      unitRef="USD">26782000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_3611"
      unitRef="USD">12802000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:CurrentProvisions
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_377"
      unitRef="USD">2454000</ifrs-full:CurrentProvisions>
    <ifrs-full:CurrentProvisions
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_3711"
      unitRef="USD">50000</ifrs-full:CurrentProvisions>
    <trib:ExchangeableNotesAndOtherBorrowingsCurrent
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220422112458271"
      unitRef="USD">210000</trib:ExchangeableNotesAndOtherBorrowingsCurrent>
    <trib:ExchangeableNotesAndOtherBorrowingsCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220422112507789"
      unitRef="USD">210000</trib:ExchangeableNotesAndOtherBorrowingsCurrent>
    <trib:CurrentFinanceLeaseLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_387"
      unitRef="USD">2285000</trib:CurrentFinanceLeaseLiabilities>
    <trib:CurrentFinanceLeaseLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_3811"
      unitRef="USD">1694000</trib:CurrentFinanceLeaseLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_407"
      unitRef="USD">32095000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_4011"
      unitRef="USD">15035000</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_437"
      unitRef="USD">72391000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_4311"
      unitRef="USD">40109000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_447"
      unitRef="USD">1658000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_4411"
      unitRef="USD">526000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <trib:ConvertibleNote
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230413013920928"
      unitRef="USD">15401000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230413014002813"
      unitRef="USD">14542000</trib:ConvertibleNote>
    <trib:ContingentConsiderationNonCurrent
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250512171243112"
      unitRef="USD">1813000</trib:ContingentConsiderationNonCurrent>
    <trib:ContingentConsiderationNonCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250512171246652"
      unitRef="USD">0</trib:ContingentConsiderationNonCurrent>
    <ifrs-full:NoncurrentProvisions
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250512171258546_xbrl_20250512171243112"
      unitRef="USD">75000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250512171258546_xbrl_20250512171246652"
      unitRef="USD">0</ifrs-full:NoncurrentProvisions>
    <trib:NoncurrentFinanceLeaseLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_457"
      unitRef="USD">10477000</trib:NoncurrentFinanceLeaseLiabilities>
    <trib:NoncurrentFinanceLeaseLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_4511"
      unitRef="USD">10872000</trib:NoncurrentFinanceLeaseLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_467"
      unitRef="USD">4561000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_4611"
      unitRef="USD">2300000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_487"
      unitRef="USD">106376000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_4811"
      unitRef="USD">68349000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_507"
      unitRef="USD">138471000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_5011"
      unitRef="USD">83384000</ifrs-full:Liabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114130013533_527"
      unitRef="USD">103290000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114130013533_5211"
      unitRef="USD">59435000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220326221702067"
      unitRef="USD">1213000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220326221930805"
      unitRef="USD">16187000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220326221959372"
      unitRef="USD">-24922000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220326222018252"
      unitRef="USD">-5379000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512181249289"
      unitRef="USD">0</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20220326222039827"
      unitRef="USD">23000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220326222113535"
      unitRef="USD">12559000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220326222130941"
      unitRef="USD">-319000</ifrs-full:Equity>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512181401830"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512181344387"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512181404761"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512181408897"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512181411617"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512181418109"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220114131757597_1323"
      unitRef="USD">-41009000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114131757597_1327"
      unitRef="USD">-41009000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512181441354"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512181508195"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512181511409"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220114131757597_1415"
      unitRef="USD">-396000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512181536174"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512181542714"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250512181546407"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114131757597_1427"
      unitRef="USD">-396000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512181927844"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512181932710"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512181935111"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20220114131757597_1615"
      unitRef="USD">-396000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512181937549"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512181942061"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220114131757597_1623"
      unitRef="USD">-41009000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114131757597_1627"
      unitRef="USD">-41405000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20240412213820561"
      unitRef="USD">750000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20240412213824956"
      unitRef="USD">30271000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512181953294"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512182004001"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512182006553"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512182015898"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250512182012736"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240412214409737"
      unitRef="USD">31021000</ifrs-full:IssueOfEquity>
    <trib:SharesToBeIssued
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512182024092"
      unitRef="USD">0</trib:SharesToBeIssued>
    <trib:SharesToBeIssued
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512182026212"
      unitRef="USD">0</trib:SharesToBeIssued>
    <trib:SharesToBeIssued
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512182029376"
      unitRef="USD">0</trib:SharesToBeIssued>
    <trib:SharesToBeIssued
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512182031706"
      unitRef="USD">0</trib:SharesToBeIssued>
    <trib:SharesToBeIssued
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512182035326"
      unitRef="USD">0</trib:SharesToBeIssued>
    <trib:SharesToBeIssued
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20240412214349239"
      unitRef="USD">63000</trib:SharesToBeIssued>
    <trib:SharesToBeIssued
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250512182038306"
      unitRef="USD">0</trib:SharesToBeIssued>
    <trib:SharesToBeIssued
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240412214354928"
      unitRef="USD">63000</trib:SharesToBeIssued>
    <trib:IncreasedecreasethroughequityComponentOfConvertibleNote
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512182044816"
      unitRef="USD">0</trib:IncreasedecreasethroughequityComponentOfConvertibleNote>
    <trib:IncreasedecreasethroughequityComponentOfConvertibleNote
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512182050994"
      unitRef="USD">0</trib:IncreasedecreasethroughequityComponentOfConvertibleNote>
    <trib:IncreasedecreasethroughequityComponentOfConvertibleNote
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512182054408"
      unitRef="USD">0</trib:IncreasedecreasethroughequityComponentOfConvertibleNote>
    <trib:IncreasedecreasethroughequityComponentOfConvertibleNote
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512182101492"
      unitRef="USD">0</trib:IncreasedecreasethroughequityComponentOfConvertibleNote>
    <trib:IncreasedecreasethroughequityComponentOfConvertibleNote
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20230414180326524"
      unitRef="USD">6709000</trib:IncreasedecreasethroughequityComponentOfConvertibleNote>
    <trib:IncreasedecreasethroughequityComponentOfConvertibleNote
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512182104424"
      unitRef="USD">0</trib:IncreasedecreasethroughequityComponentOfConvertibleNote>
    <trib:IncreasedecreasethroughequityComponentOfConvertibleNote
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250512182107792"
      unitRef="USD">0</trib:IncreasedecreasethroughequityComponentOfConvertibleNote>
    <trib:IncreasedecreasethroughequityComponentOfConvertibleNote
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413030530424"
      unitRef="USD">6709000</trib:IncreasedecreasethroughequityComponentOfConvertibleNote>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512182131051"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512182147534"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512182152392"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512182155864"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512182159273"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512182203863"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20240412213923866"
      unitRef="USD">1755000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240412213928533"
      unitRef="USD">1755000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20240412213556559"
      unitRef="USD">1963000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20240412213609835"
      unitRef="USD">46458000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20240412213634431"
      unitRef="USD">-24922000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20240412213653897"
      unitRef="USD">-5775000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20240412213703415"
      unitRef="USD">6709000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20240412213711097"
      unitRef="USD">86000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20240412213832971"
      unitRef="USD">-26695000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240412213840106"
      unitRef="USD">-2176000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20240412213558644"
      unitRef="USD">1963000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20240412213618341"
      unitRef="USD">46458000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20240412213637734"
      unitRef="USD">-24922000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20240412213656034"
      unitRef="USD">-5775000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20240421152903111"
      unitRef="USD">6709000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20240412213712964"
      unitRef="USD">86000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20240412213849515"
      unitRef="USD">-26695000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240412213851379"
      unitRef="USD">-2176000</ifrs-full:Equity>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512182231555"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512182235352"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512182238263"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512182248947"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512182252075"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512182254657"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20240412214003549"
      unitRef="USD">-24018000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240412214021938"
      unitRef="USD">-24018000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512182711737"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512182714474"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512182716833"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20240412214031755"
      unitRef="USD">69000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512182720119"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512182727039"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250512182731910"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240412214038654"
      unitRef="USD">69000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512182746597"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512182749154"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512182752181"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20230413023537920"
      unitRef="USD">69000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512182808027"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512182810573"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230413023551717"
      unitRef="USD">-24018000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413023545442"
      unitRef="USD">-23949000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20230413031911904"
      unitRef="USD">9000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20230413031907902"
      unitRef="USD">161000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512182819271"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512182822292"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512182825282"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20230413031930594"
      unitRef="USD">-63000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250512182833128"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413031847251"
      unitRef="USD">107000</ifrs-full:IssueOfEquity>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512182856083"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512182859251"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512182904206"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512182907085"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512182910615"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512182913879"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230413023630175"
      unitRef="USD">2069000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413023637363"
      unitRef="USD">2069000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20230413024018171"
      unitRef="USD">1972000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20230413024041976"
      unitRef="USD">46619000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20230413024050249"
      unitRef="USD">-24922000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20230413024056266"
      unitRef="USD">-5706000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20230413024101890"
      unitRef="USD">6709000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20230413024108326"
      unitRef="USD">23000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230413024114426"
      unitRef="USD">-48644000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230413024121890"
      unitRef="USD">-23949000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512173619169_xbrl_20230413024018171"
      unitRef="USD">1972000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512173619169_xbrl_20230413024041976"
      unitRef="USD">46619000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512173619169_xbrl_20230413024050249"
      unitRef="USD">-24922000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512173619169_xbrl_20230413024056266"
      unitRef="USD">-5706000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512173619169_xbrl_20230413024101890"
      unitRef="USD">6709000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512173619169_xbrl_20230413024108326"
      unitRef="USD">23000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250512173619169_xbrl_20230413024114426"
      unitRef="USD">-48644000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250512173619169_xbrl_20230413024121890"
      unitRef="USD">-23949000</ifrs-full:Equity>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512182333871"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512182340673"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512182343267"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512182345524"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512182347874"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512182350044"
      unitRef="USD">0</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250512174025927"
      unitRef="USD">-31789000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250512174028039"
      unitRef="USD">-31789000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512182611518"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512182615310"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512182623842"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512174057910"
      unitRef="USD">245000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512182628407"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512182631214"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250512182634117"
      unitRef="USD">0</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250512174100591"
      unitRef="USD">245000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512182924505"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512182927011"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512182929560"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512174120783"
      unitRef="USD">245000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512182932703"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512182949260"
      unitRef="USD">0</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250512174125772"
      unitRef="USD">-31789000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250512174131621"
      unitRef="USD">-31544000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:IssueOfEquity
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512175943012"
      unitRef="USD">2218000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512175948019"
      unitRef="USD">16778000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512183019517"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512183022918"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512183026068"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512183029004"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250512183032894"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250512180001700"
      unitRef="USD">18996000</ifrs-full:IssueOfEquity>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512183044208"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512183046611"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512183049772"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512183053868"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512183056172"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512183058870"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20240101to20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250512180012711"
      unitRef="USD">1316000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250512180017636"
      unitRef="USD">1316000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20250512180029954_xbrl_20230413024018171"
      unitRef="USD">4190000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20250512180029954_xbrl_20230413024041976"
      unitRef="USD">63397000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20250512180029954_xbrl_20230413024050249"
      unitRef="USD">-24922000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfExchangeDifferencesOnTranslationMember"
      decimals="-3"
      id="Fxbrl_20250512180029954_xbrl_20230413024056266"
      unitRef="USD">-5461000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_tribEquityComponentOfConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20250512180029954_xbrl_20230413024101890"
      unitRef="USD">6709000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullOtherReservesMember"
      decimals="-3"
      id="Fxbrl_20250512180029954_xbrl_20230413024108326"
      unitRef="USD">23000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250512180029954_xbrl_20230413024114426"
      unitRef="USD">-79117000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250512180029954_xbrl_20230413024121890"
      unitRef="USD">-35181000</ifrs-full:Equity>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413051933911"
      unitRef="USD">-31789000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_310"
      unitRef="USD">-24018000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_314"
      unitRef="USD">-41009000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_56"
      unitRef="USD">675000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_510"
      unitRef="USD">831000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_514"
      unitRef="USD">1410000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_66"
      unitRef="USD">1190000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_610"
      unitRef="USD">946000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_614"
      unitRef="USD">923000</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_76"
      unitRef="USD">486000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_710"
      unitRef="USD">-59000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_714"
      unitRef="USD">-192000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForFinanceIncome
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_86"
      unitRef="USD">0</ifrs-full:AdjustmentsForFinanceIncome>
    <ifrs-full:AdjustmentsForFinanceIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_810"
      unitRef="USD">1171000</ifrs-full:AdjustmentsForFinanceIncome>
    <ifrs-full:AdjustmentsForFinanceIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_814"
      unitRef="USD">303000</ifrs-full:AdjustmentsForFinanceIncome>
    <ifrs-full:AdjustmentsForFinanceCosts
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_96"
      unitRef="USD">9565000</ifrs-full:AdjustmentsForFinanceCosts>
    <ifrs-full:AdjustmentsForFinanceCosts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_910"
      unitRef="USD">11053000</ifrs-full:AdjustmentsForFinanceCosts>
    <ifrs-full:AdjustmentsForFinanceCosts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_914"
      unitRef="USD">24745000</ifrs-full:AdjustmentsForFinanceCosts>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_106"
      unitRef="USD">1316000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1010"
      unitRef="USD">2069000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1014"
      unitRef="USD">1755000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_116"
      unitRef="USD">1010000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1110"
      unitRef="USD">238000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220326224904128"
      unitRef="USD">-76000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413033537164"
      unitRef="USD">0</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413051440145"
      unitRef="USD">0</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1214"
      unitRef="USD">-2000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_136"
      unitRef="USD">2113000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1310"
      unitRef="USD">2291000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1314"
      unitRef="USD">7391000</ifrs-full:AdjustmentsForProvisions>
    <trib:AdjustmentsForInventoryWriteOff
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250513024511057_xbrl_20220114135841083_136"
      unitRef="USD">-1884000</trib:AdjustmentsForInventoryWriteOff>
    <trib:AdjustmentsForInventoryWriteOff
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250513024511057_xbrl_20220114135841083_1310"
      unitRef="USD">0</trib:AdjustmentsForInventoryWriteOff>
    <trib:AdjustmentsForInventoryWriteOff
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250513024511057_xbrl_20220114135841083_1314"
      unitRef="USD">0</trib:AdjustmentsForInventoryWriteOff>
    <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_146"
      unitRef="USD">0</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1410"
      unitRef="USD">0</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1414"
      unitRef="USD">482000</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_156"
      unitRef="USD">612000</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1510"
      unitRef="USD">3772000</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1514"
      unitRef="USD">733000</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_166"
      unitRef="USD">1596000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1610"
      unitRef="USD">5833000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1614"
      unitRef="USD">4624000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240413012243239"
      unitRef="USD">-800000</ifrs-full:ImpairmentLossOnFinancialAssets>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240413012249788"
      unitRef="USD">1500000</ifrs-full:ImpairmentLossOnFinancialAssets>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240413012258145"
      unitRef="USD">0</ifrs-full:ImpairmentLossOnFinancialAssets>
    <trib:AdjustmentsForGainLossOnSaleOfBusiness
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240413012305863"
      unitRef="USD">0</trib:AdjustmentsForGainLossOnSaleOfBusiness>
    <trib:AdjustmentsForGainLossOnSaleOfBusiness
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240413012331457"
      unitRef="USD">12718000</trib:AdjustmentsForGainLossOnSaleOfBusiness>
    <trib:AdjustmentsForGainLossOnSaleOfBusiness
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240413012336820"
      unitRef="USD">0</trib:AdjustmentsForGainLossOnSaleOfBusiness>
    <trib:AdjustmentForRestructuringProvision
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250513024601380_xbrl_20240413012305863"
      unitRef="USD">361000</trib:AdjustmentForRestructuringProvision>
    <trib:AdjustmentForRestructuringProvision
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250513024601380_xbrl_20240413012331457"
      unitRef="USD">0</trib:AdjustmentForRestructuringProvision>
    <trib:AdjustmentForRestructuringProvision
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250513024601380_xbrl_20240413012336820"
      unitRef="USD">0</trib:AdjustmentForRestructuringProvision>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_176"
      unitRef="USD">2505000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220326225125856"
      unitRef="USD">257000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413051605313"
      unitRef="USD">269000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_196"
      unitRef="USD">-9276000</ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital>
    <ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1910"
      unitRef="USD">-9176000</ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital>
    <ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_1914"
      unitRef="USD">754000</ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413052316452"
      unitRef="USD">-2368000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220326225259098"
      unitRef="USD">1047000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413052619964"
      unitRef="USD">-966000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_216"
      unitRef="USD">-1742000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_2110"
      unitRef="USD">-971000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220326225419561"
      unitRef="USD">-877000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220430125903838"
      unitRef="USD">8185000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413052518333"
      unitRef="USD">-2769000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_2214"
      unitRef="USD">181000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413052046301"
      unitRef="USD">-5201000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_2410"
      unitRef="USD">-11869000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_2414"
      unitRef="USD">-908000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_266"
      unitRef="USD">0</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_2610"
      unitRef="USD">0</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_2614"
      unitRef="USD">2000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413052656031"
      unitRef="USD">-1010000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_2710"
      unitRef="USD">-312000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220326225614743"
      unitRef="USD">15000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413052708840"
      unitRef="USD">-4191000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_2910"
      unitRef="USD">-11557000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_2914"
      unitRef="USD">-921000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_336"
      unitRef="USD">9659000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_3310"
      unitRef="USD">1901000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_3314"
      unitRef="USD">4876000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_346"
      unitRef="USD">405000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_3410"
      unitRef="USD">803000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_3414"
      unitRef="USD">1101000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <trib:PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240413012434744"
      unitRef="USD">0</trib:PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities>
    <trib:PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240413012439007"
      unitRef="USD">700000</trib:PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities>
    <trib:PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240413012441535"
      unitRef="USD">0</trib:PaymentsToAcquireFinancialAssetClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240413012513093"
      unitRef="USD">0</ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations>
    <ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240413012519077"
      unitRef="USD">28160000</ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations>
    <ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240413012522250"
      unitRef="USD">0</ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations>
    <trib:PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250513024632161_xbrl_20240413012513093"
      unitRef="USD">12904000</trib:PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities>
    <trib:PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250513024632161_xbrl_20240413012519077"
      unitRef="USD">0</trib:PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities>
    <trib:PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250513024632161_xbrl_20240413012522250"
      unitRef="USD">0</trib:PaymentsToAcquireTradesOrBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_376"
      unitRef="USD">-22968000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_3710"
      unitRef="USD">24756000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_3714"
      unitRef="USD">-5977000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413045351224"
      unitRef="USD">7391000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413045401765"
      unitRef="USD">0</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413045413687"
      unitRef="USD">25336000</ifrs-full:ProceedsFromIssuingShares>
    <trib:ProceedsFromSharesToBeIssued
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413045430592"
      unitRef="USD">0</trib:ProceedsFromSharesToBeIssued>
    <trib:ProceedsFromSharesToBeIssued
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413045503424"
      unitRef="USD">0</trib:ProceedsFromSharesToBeIssued>
    <trib:ProceedsFromSharesToBeIssued
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413045515704"
      unitRef="USD">63000</trib:ProceedsFromSharesToBeIssued>
    <ifrs-full:ProceedsFromNoncurrentBorrowings
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413045755722"
      unitRef="USD">30176000</ifrs-full:ProceedsFromNoncurrentBorrowings>
    <ifrs-full:ProceedsFromNoncurrentBorrowings
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413045817526"
      unitRef="USD">5000000</ifrs-full:ProceedsFromNoncurrentBorrowings>
    <ifrs-full:ProceedsFromNoncurrentBorrowings
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413045830198"
      unitRef="USD">80015000</ifrs-full:ProceedsFromNoncurrentBorrowings>
    <trib:ProceedsForConvertibleNoteIssued
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413045846074"
      unitRef="USD">0</trib:ProceedsForConvertibleNoteIssued>
    <trib:ProceedsForConvertibleNoteIssued
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413045916233"
      unitRef="USD">0</trib:ProceedsForConvertibleNoteIssued>
    <trib:ProceedsForConvertibleNoteIssued
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413045936069"
      unitRef="USD">20000000</trib:ProceedsForConvertibleNoteIssued>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413050229227"
      unitRef="USD">0</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413050248083"
      unitRef="USD">147000</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413050257775"
      unitRef="USD">2356000</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:RepaymentsOfBondsNotesAndDebentures
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413050318613"
      unitRef="USD">0</ifrs-full:RepaymentsOfBondsNotesAndDebentures>
    <ifrs-full:RepaymentsOfBondsNotesAndDebentures
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413050343629"
      unitRef="USD">0</ifrs-full:RepaymentsOfBondsNotesAndDebentures>
    <ifrs-full:RepaymentsOfBondsNotesAndDebentures
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413050355775"
      unitRef="USD">86730000</ifrs-full:RepaymentsOfBondsNotesAndDebentures>
    <ifrs-full:RepaymentsOfNoncurrentBorrowings
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413050411567"
      unitRef="USD">0</ifrs-full:RepaymentsOfNoncurrentBorrowings>
    <ifrs-full:RepaymentsOfNoncurrentBorrowings
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413050440431"
      unitRef="USD">10050000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
    <ifrs-full:RepaymentsOfNoncurrentBorrowings
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413050449332"
      unitRef="USD">34500000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
    <trib:PenaltyForEarlySettlementOfTermLoan
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413050501374"
      unitRef="USD">0</trib:PenaltyForEarlySettlementOfTermLoan>
    <trib:PenaltyForEarlySettlementOfTermLoan
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413050534267"
      unitRef="USD">-905000</trib:PenaltyForEarlySettlementOfTermLoan>
    <trib:PenaltyForEarlySettlementOfTermLoan
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413050547979"
      unitRef="USD">-3450000</trib:PenaltyForEarlySettlementOfTermLoan>
    <trib:RepaymentOfOtherLoan
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413050602612"
      unitRef="USD">0</trib:RepaymentOfOtherLoan>
    <trib:RepaymentOfOtherLoan
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413050619968"
      unitRef="USD">0</trib:RepaymentOfOtherLoan>
    <trib:RepaymentOfOtherLoan
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413050632525"
      unitRef="USD">23000</trib:RepaymentOfOtherLoan>
    <trib:InterestPaidOnSeniorSecuredTermLoan
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413050644860"
      unitRef="USD">-5946000</trib:InterestPaidOnSeniorSecuredTermLoan>
    <trib:InterestPaidOnSeniorSecuredTermLoan
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413050727552"
      unitRef="USD">-7314000</trib:InterestPaidOnSeniorSecuredTermLoan>
    <trib:InterestPaidOnSeniorSecuredTermLoan
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413050740305"
      unitRef="USD">-6424000</trib:InterestPaidOnSeniorSecuredTermLoan>
    <trib:InterestPaidOnConvertibleNote
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413050752339"
      unitRef="USD">300000</trib:InterestPaidOnConvertibleNote>
    <trib:InterestPaidOnConvertibleNote
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413051230516"
      unitRef="USD">300000</trib:InterestPaidOnConvertibleNote>
    <trib:InterestPaidOnConvertibleNote
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413051244252"
      unitRef="USD">199000</trib:InterestPaidOnConvertibleNote>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_426"
      unitRef="USD">8000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_4210"
      unitRef="USD">8000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_4214"
      unitRef="USD">1293000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_456"
      unitRef="USD">2503000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_4510"
      unitRef="USD">2318000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_4514"
      unitRef="USD">2761000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114135841083_476"
      unitRef="USD">28810000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_4710"
      unitRef="USD">-16042000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_4714"
      unitRef="USD">-12322000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220426045940794"
      unitRef="USD">1651000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413051314337"
      unitRef="USD">-2843000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_4914"
      unitRef="USD">-19220000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230414191203012"
      unitRef="USD">-175000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114135841083_5010"
      unitRef="USD">-44000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114135841083_5014"
      unitRef="USD">-112000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <trib:CashAndCashEquivalentsAndShortTermInvestments
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114145212118_xbrl_20220114135841083_506"
      unitRef="USD">3691000</trib:CashAndCashEquivalentsAndShortTermInvestments>
    <trib:CashAndCashEquivalentsAndShortTermInvestments
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220114145212118_xbrl_20220114135841083_5010"
      unitRef="USD">6578000</trib:CashAndCashEquivalentsAndShortTermInvestments>
    <trib:CashAndCashEquivalentsAndShortTermInvestments
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220114145212118_xbrl_20220114135841083_5014"
      unitRef="USD">25910000</trib:CashAndCashEquivalentsAndShortTermInvestments>
    <trib:CashAndCashEquivalentsAndShortTermInvestments
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114145451063_xbrl_20220114145212118_xbrl_20220114135841083_506"
      unitRef="USD">5167000</trib:CashAndCashEquivalentsAndShortTermInvestments>
    <trib:CashAndCashEquivalentsAndShortTermInvestments
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114145451063_xbrl_20220114145212118_xbrl_20220114135841083_5010"
      unitRef="USD">3691000</trib:CashAndCashEquivalentsAndShortTermInvestments>
    <trib:CashAndCashEquivalentsAndShortTermInvestments
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220114145451063_xbrl_20220114145212118_xbrl_20220114135841083_5014"
      unitRef="USD">6578000</trib:CashAndCashEquivalentsAndShortTermInvestments>
    <trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512131539410">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.95pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;BASIS OF PREPARATION AND SIGNIFICANT
        ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
principal accounting policies adopted by Trinity Biotech plc (&#x201c;the Company&#x201d;) and its subsidiaries (together the &#x201c;the
Group&#x201d;) are set out below.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;i)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;General
        information&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trinity
Biotech is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable
biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation,
for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and
to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood and the Company intends to develop
a range of biosensor devices and related services, starting with a continuous glucose monitoring product.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;ii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Statement
        of compliance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (&#x201c;IFRS&#x201d;)
both as issued by the International Accounting Standards Board (&#x201c;IASB&#x201d;) and as subsequently adopted by the European Union
(&#x201c;EU&#x201d;) (together &#x201c;IFRS&#x201d;).&#160;The IFRS applied are those effective for accounting periods beginning January&#160;1,
2024. Consolidated financial statements are required by Irish law to comply with IFRS as adopted by the EU which differ in certain respects
from IFRS as issued by the IASB.&#160;These differences predominantly relate to the timing of adoption of new standards by the EU.&#160;However,
in relation to the 2024 consolidated financial statements there are no differences regarding the effective date of new IFRS relevant to
Trinity Biotech as issued by the IASB and as adopted by the EU. In relation to prior periods presented, none of the differences are relevant
in the context of Trinity Biotech and the consolidated financial statements comply with IFRS both as issued by the IASB and as adopted
by the EU.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;iii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Basis of preparation and going concern&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
consolidated financial statements have been prepared in United States Dollars (US$), rounded to the nearest thousand, under the historical
cost basis of accounting, except for derivative financial instruments, certain balances arising on acquisition of subsidiary entities
and share-based payments which are initially recorded at fair value. Derivative financial instruments are also subsequently revalued and
carried at fair value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
preparation of financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect
the application of policies and amounts reported in the financial statements and accompanying notes. The estimates and associated assumptions
are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of
which form the basis of making the judgements about the carrying value of assets and liabilities that are not readily apparent from other
sources. Actual results may differ from these estimates.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period
in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision
affects both current and future periods. Judgements made by management that have a significant effect on the financial statements and
estimates with a significant risk of material adjustment in the next year are discussed in Note 31.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates
the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;As
reflected in the accompanying consolidated financial statements, for the years ended December 31, 2024 and 2023, the Group recorded a
loss of US$31.8
million and a loss of US$24.0
million, respectively. For the year ended December 31, 2024 we reported cash inflows of US1.7
million compared to cash outflows of US$2.8
million for 2023. As of December 31, 2024, we had net current assets of US$9.0
million but had an accumulated deficit in equity attributable to the equity holders of the Company of US$79.1
million.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;We
have made significant progress on a multi-year transformation plan aimed at improving profitability and simplifying our operating model.
Key actions implemented include the consolidation and outsourcing of global manufacturing, closure of underutilized facilities, relocation
of certain business support functions to lower-cost jurisdictions, and a reduction in overall headcount. These restructuring measures,
largely completed by mid-2025, are expected to deliver significant annualized cost savings. Additionally, the Group retains further levers
to manage liquidity if required, including deferring projected research and development spend.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A
temporary decline in revenue occurred during the first four months of 2025, primarily due to transitional impacts associated with the
Group&#x2019;s restructuring initiatives, including the consolidation of manufacturing operations and the transfer of Point-of-Care/HIV
products to a third-party contract manufacturing partner. These initiatives have since progressed materially. Sales were also affected
by reduced HIV test volumes resulting from uncertainty surrounding potential changes to U.S. foreign aid policy following a presidential
executive order. In light of these temporary factors, the Group sought and received a formal waiver from Perceptive in respect of the
Q1 2025 minimum revenue covenant, to ensure that no breach occurred under the Perceptive credit facility. In May 2025, the Group signed
a buy-sell agreement with a contract manufacturing partner. We also have obtained World Health Organisation (&#x201c;WHO&#x201d;) approval
to commence assembly at the new site. It is expected that WHO approval for full production of our Trinscreen product to be received in
July 2025, with approval for full production of our UniGold product expected in August 2025. The directors have alternative options and
have prepared financial forecasts to address a scenario whereby WHO approval for production with our contract manufacturing partner takes
longer than expected to achieve and the facility takes longer than expected to get up to full operational capacity. In such a scenario,
management remain confident that all revenue covenants will be met through to 31 December 2025. In addition, the minimum revenue covenant
thresholds for Q2, Q3 and Q4 2025 have been renegotiated to align with the Group&#x2019;s updated forecasts. Accordingly, management is
confident in the Group&#x2019;s ability to maintain compliance with its debt covenants for the remainder of the going concern review period.
Furthermore, Perceptive have a track record of supporting the Company and, when required, have provided covenant waivers and amendment
of terms which indicates an appreciation of the Company&#x2019;s circumstances in terms of our transformational plan for the business and
temporary declines in revenue. If a similar need were to recur in the foreseeable future, management are confident of their continued
support.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;We
have also launched a strategic realignment review of our businesses in partnership with Barclays Bank. This process, is expected to make
significant progress by the end of 2025 and may generate material capital proceeds that can be potentially used to reduce debt and support
investment, including CGM investment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In
addition, the Group has continued to benefit from strong support from Perceptive, its principal lender and largest investor. On December
23, 2024, we entered into the third amendment and restatement of the credit agreement governing the Term Loan. As part of this agreement,
an additional US$2.0
million of funding was made available to us. We also agreed that certain interest
payments payable in 2024 and 2025 would be paid-in-kind on the applicable payment date by increasing the outstanding principal
amount of the Term Loan. In February 2025, we entered into a fourth amendment to the credit agreement, which provided for an additional
US$4.0
million in term loan funding. On May 14, 2025, we entered into a fifth amendment to the credit agreement, which provided for a further
US$2.0
million in funding, extended the maturity date of the Term Loan by six months from January
2026 to July 27, 2026, and confirmed that interest
payments for the months of April, May, and June 2025 would be paid-in-kind. There are no material debt maturities until
July 2026. These successive amendments demonstrate Perceptive&#x2019;s continued support and demonstrate their willingness to flex terms
to preserve liquidity while the Company continues to execute its updated strategy, including its comprehensive transformation plan.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;

&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under
the fifth amendment to the credit agreement, the minimum liquidity covenant was reduced to US$1
million through to October 31, 2025, after which it reverts to US$3
million. While management is confident in the Group&#x2019;s ability to maintain compliance with this covenant, it is noted that the Group
has planned significant R&amp;amp;D expenditure related to its CGM development program in the second half of 2025. However, the Group retains
full discretion over the timing and phasing of these activities, which enables management to align expenditure with available funding
and preserve liquidity if required.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;

&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In
addition to lender support, our going concern forecasts include expected equity raises. These funds are expected to support ongoing CGM
development activities. The Group has a strong track record of capital raising, including over US$7
million secured in 2024, and maintains active engagement with existing and potential investors. Management believes that the equity raise
is achievable based on the Group&#x2019;s strategic focus and transformation progress to date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The
directors have considered the Group&#x2019;s current financial position and cash flow projections, taking into account all known events
and developments including the amendment and restatement of the term loan with Perceptive, The directors believe that, based on currently
available information and reasonable assumptions, the Group will be able to continue its operations for at least the next 12 months from
the year-end date, and that it is appropriate to continue to prepare the consolidated financial statements on a going concern basis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
accounting policies set out below have been applied consistently to all periods presented in these consolidated financial statements.
The accounting policies have been applied consistently by all Group entities. The comparative information agrees with the amounts and
other disclosures presented in the prior period consolidated financial statements or, when appropriate, have been restated.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;iv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Basis
        of consolidation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Subsidiaries
are all entities over which the Group has control. The Group controls an entity when the Group is exposed to, or has rights to, variable
returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries
are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control
ceases. A change in the ownership interest of a subsidiary without a change in control is accounted for as an equity transaction. The
Group currently holds a majority of voting rights in all entities in the Group and as a result there are no non-controlling interests
reflected in the consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Transactions
eliminated on consolidation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Intra-group
balances and any unrealised gains or losses or income and expenses arising from intra-group transactions are eliminated in preparing the
consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;v)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Property,
        plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Owned
assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Items
of property, plant and equipment are stated at cost less any accumulated depreciation and any impairment losses (see Note 1(viii)). The
cost of self-constructed assets includes the cost of materials, direct labour and attributable overheads. It is not Group policy to revalue
any items of property, plant and equipment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Depreciation
is charged to the statement of operations on a straight-line basis to write-off the cost of the assets over their expected useful lives
as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5-15&#160;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:81.03%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.97%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Buildings&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;50
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:81.03%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.97%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Office equipment and fittings&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;10
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:81.03%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.97%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3-5
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:81.03%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.97%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5-15
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Land
is not depreciated. The residual values, if not insignificant, useful lives and depreciation methods of property, plant and equipment
are reviewed and adjusted if appropriate on a prospective basis, at each balance sheet date. There were no changes to useful lives in
the year.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group considers whether a contract is or contains a lease. A lease is defined as &#x2018;a contract, or part of a contract, that conveys
the right to use an asset (the underlying asset) for a period of time in exchange for consideration&#x2019;. To apply this definition the
Group assesses whether the contract meets three key evaluations which are whether:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.95pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;the contract contains an identified
        asset, which is either explicitly identified in the contract or implicitly specified by being identified at the time the asset is made
        available to the Group&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.95pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;the Group has the right to obtain
        substantially all of the economic benefits from use of the identified asset throughout the period of use, considering its rights within
        the defined scope of the contract&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.95pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;the Group has the right to direct
        the use of the identified asset throughout the period of use. The Group assess whether it has the right to direct &#x2018;how and for what
        purpose&#x2019; the asset is used throughout the period of use.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;At
lease commencement date, the Group recognises a right-of-use asset and a lease liability on the balance sheet. The right-of-use asset
is measured at cost, which is made up of the initial measurement of the lease liability, any initial direct costs incurred by the Group,
an estimate of any costs to dismantle and remove the asset at the end of the lease, and any lease payments made in advance of the lease
commencement date (net of any incentives received).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group depreciates the right-of-use assets on a straight-line basis from the lease commencement date to the earlier of the end of the useful
life of the right-of-use asset or the end of the lease term. The Group also assesses the right-of-use asset for impairment when such indicators
exist.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;At
the commencement date, the Group measures the lease liability at the present value of the lease payments unpaid at that date, discounted
using the interest rate implicit in the lease if that rate is readily available or the Group&#x2019;s incremental borrowing rate. Lease
payments included in the measurement of the lease liability are made up of fixed payments (including in substance fixed), variable payments
based on an index or rate, amounts expected to be payable under a residual value guarantee and payments arising from options reasonably
certain to be exercised. Subsequent to initial measurement, the liability will be reduced for payments made and increased for interest.
It is remeasured to reflect any reassessment or modification, or if there are changes in in-substance fixed payments. When the lease liability
is remeasured, the corresponding adjustment is reflected in the right-of-use asset, or profit and loss if the right-of-use asset is already
reduced to zero.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group has elected to account for short-term leases and leases of low-value assets using the practical expedients. Instead of recognising
a right-of-use asset and lease liability, the payments in relation to these are recognised as an expense in profit or loss on a straight-line
basis over the lease term. On the statement of financial position, right-of-use assets have been included in property, plant and equipment
and lease liabilities have been included in separate lines within the current liabilities and non-current liabilities sections.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.9pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Leased
assets - as lessor&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group&#x2019;s accounting policy under IFRS 16 has not changed from the comparative period. As a lessor, the Group classifies its leases
as either operating or finance leases. A lease is classified as a finance lease if it transfers substantially all the risks and rewards
incidental to ownership of the underlying asset, and classified as an operating lease if it does not.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;vi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Business
        combinations &amp;amp; goodwill&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;At
the time of each transaction, the Group evaluates whether the acquisition constitutes a business combination in accordance with the definition
in IFRS 3 Business Combinations. A business is defined as an integrated set of activities and assets that is capable of being conducted
and managed for the purpose of providing a return. The assessment considers whether the acquired set includes inputs and substantive processes
that together significantly contribute to the ability to create outputs. Where such criteria are not met, the transaction is accounted
for as an asset acquisition. Transactions assessed as asset acquisitions do not give rise to goodwill.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;In
respect of business combinations that have occurred since January 1, 2004 (being the transition date to IFRS), goodwill represents the
difference between the cost of the acquisition and the fair value of the net identifiable assets acquired. In respect of acquisitions
prior to this date, goodwill is included on the basis of its deemed cost, which represents the amount recorded under Irish GAAP.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;To
the extent that the Group&#x2019;s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities acquired
exceeds the cost of a business combination, the identification and measurement of the related assets, liabilities and contingent liabilities
are revisited accompanied by a reassessment of the cost of the transaction, and any remaining balance is immediately recognised in the
statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;At
the acquisition date, any goodwill is allocated to each of the Group&#x2019;s cash-generating units expected to benefit from the combination&#x2019;s
synergies. Following initial recognition, goodwill is stated at cost less any accumulated impairment losses and is not amortised but is
tested annually for impairment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;This
policy has been applied to acquisitions completed during the year, including the acquisition of the CGM assets of Waveform Technologies,
Inc. in January 2024, and the acquisitions of EpiCapture Limited and Metabolomics Diagnostics Limited, further details of which are disclosed
in Note 29 to the consolidated financial statements losses.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Intangibles,
        including research and development (other than goodwill)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;An
intangible asset, which is an identifiable non-monetary asset without physical substance, is recognised to the extent that it is probable
that the expected future economic benefits attributable to the asset will flow to the Group and that its cost can be measured reliably.
The asset is deemed to be identifiable when it is separable (that is, capable of being divided from the entity and sold, transferred,
licenced, rented or exchanged, either individually or together with a related contract, asset or liability) or when it arises from contractual
or other legal rights, regardless of whether those rights are transferable or separable from the Group or from other rights and obligations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Intangible
assets acquired as part of a business combination are capitalised separately from goodwill if the intangible asset meets the definition
of an asset and the fair value can be reliably measured on initial recognition. In the case of recent acquisitions, the Group has recognised
technology-based intangible assets, comprising know-how, trade secrets and similar intellectual property. These assets are classified
as finite-lived and are initially recognised at fair value as determined by independent valuation.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequent
to initial recognition, these intangible assets are carried at cost less any accumulated amortisation and any accumulated impairment losses
(Note 1(viii)). Intangible assets with definite useful lives are reviewed for indicators of impairment annually while intangible assets
with indefinite useful lives and those not yet brought into use are tested for impairment at least annually, either individually or at
the cash-generating unit level.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expenditure
on development activities, whereby research findings are applied to a plan or design for the production of new or substantially improved
products and processes, is capitalised if the product or process is technically and commercially feasible and the Group has sufficient
resources to complete the development. The expenditure capitalised includes the cost of materials, direct labour and attributable overheads
and third party costs. Subsequent expenditure on capitalised intangible assets is capitalised only when it increases the future economic
benefits embodied in the specific asset to which it relates.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
technical feasibility of a new product is determined by a specific feasibility study undertaken at the first stage of any development
project. The majority of our new product developments involve the transfer of existing product know-how to a new application. Since the
technology is already proven in an existing product which is being used by customers, this facilitates the proving of the technical feasibility
of that same technology in a new product.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
results of the feasibility study are reviewed by a design review committee comprising senior managers. The feasibility study occurs in
the initial research phase of a project and costs in this phase are not capitalised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
commercial feasibility of a new product is determined by preparing a discounted cash flow projection. This projection compares the discounted
sales revenues for future periods with the relevant costs. As part of preparing the cash flow projection, the size of the relevant market
is determined, feedback is sought from customers and the strength of the proposed new product is assessed against competitors&#x2019; offerings.
Once the technical and commercial feasibility has been established and the project has been approved for commencement, the project moves
into the development phase.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;All
other development expenditure is expensed as incurred. Subsequent to initial recognition, the capitalised development expenditure is carried
at cost less any accumulated amortisation and any accumulated impairment losses.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expenditure
on research activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognised
in the statement of operations as an expense as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expenditure
on internally generated goodwill and brands is recognised in the statement of operations as an expense as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Amortisation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Amortisation
is charged to the statement of operations on a straight-line basis over the estimated useful lives of intangible assets, unless such lives
are indefinite. Intangible assets are amortised from the date they are available for use in its intended market. The estimated useful
lives are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Capitalised development costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;15&#160;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Patents and licences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;6-15&#160;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Other (including acquired customer and supplier lists)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;6-15
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group uses a useful economic life of 15
years for capitalised development costs. This is a conservative estimate of the likely life of the products. The Group
is confident that products have a minimum of 15 years life given the inertia that characterizes the medical diagnostics industry and the
barriers to enter into the industry. The following factors have been considered in estimating the useful life of developed products:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.55pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:24.5pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(a)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;once a diagnostic test becomes
        established, customers are reluctant to change to new technology until it is fully proven, thus resulting in relatively long product life
        cycles. There is also reluctance in customers to change to a new product as it can be costly both in terms of the initial changeover cost
        and as new technology is typically more expensive.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.55pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:24.5pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(b)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;demand for the diagnostic tests
        is enduring and robust within a wide geographic base. The diseases that the products diagnose are widely prevalent (HIV, Diabetes and
        Chlamydia being just three examples) in many countries. There is a general consensus that these diseases will continue to be widely prevalent
        in the future. Demand for biosensors is showing high growth in recent years due to the ease of use and the appeal of real time information.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.55pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:24.5pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(c)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;there are significant barriers
        to new entrants in this industry. Patents and/or licences are in place for several of our products, though this is not the only barrier
        to entry. There is a significant cost and time to develop new products, it is necessary to obtain regulatory approval and tests are protected
        by proprietary know-how, manufacturing techniques and trade secrets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During
the year ended December 31, 2024, the Group capitalised US$7.0
million in development costs related to newly acquired intangible assets. As the underlying intellectual property remains at a pre-commercialisation
stage and is not yet available for use, amortisation has not commenced. Amortisation will begin when the assets are brought into use,
in accordance with the Group&#x2019;s stated policy.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Technology-based
intangible assets acquired as part of business combinations are assigned finite useful lives in line with the Group&#x2019;s amortisation
policies, based on independent valuation reports. Amortisation of these assets will commence when they are available for use, i.e., when
they are in the location and condition necessary for them to be capable of operating in the manner intended by management. For technology-based
intangible assets acquired in 2024, amortisation has not commenced as the technologies have not yet been commercialised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Certain
trade names acquired are deemed to have an indefinite useful life as there is no foreseeable limit to the period over which these assets
are expected to generate cash inflows for the Group.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where
amortisation is charged on assets with finite lives, this expense is taken to the statement of operations through the &#x2018;selling,
general and administrative expenses&#x2019; line.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Useful
lives are examined on an annual basis and adjustments, where applicable, are made on a prospective basis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;viii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
carrying amount of the Group&#x2019;s assets, other than inventories, accounts receivable, cash and cash equivalents, short-term investments
and deferred tax assets, are reviewed at each balance sheet date to determine whether there is any indication of impairment. If any such
indication exists, the asset&#x2019;s recoverable amount (being the greater of fair value less costs to sell and value in use) is assessed
at each balance sheet date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Fair
value less costs to sell is defined as the amount obtainable from the sale of an asset or cash-generating unit in an arm&#x2019;s length
transaction between knowledgeable and willing parties, less the costs that would be incurred on disposal. Value in use is defined as the
present value of the future cash flows expected to be derived through the continued use of an asset or cash-generating unit. In assessing
value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current
market assessments of the time value of money and the risks specific to the asset for which the future cash flow estimates have not yet
been adjusted. The estimates of future cash flows exclude cash inflows or outflows attributable to financing activities. For an asset
that does not generate largely independent cash flows, the recoverable amount is determined by reference to the cash-generating unit to
which the asset belongs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;For
goodwill, assets that have an indefinite useful life and intangible assets that are not yet available for use, the recoverable amount
is estimated at each balance sheet date at the cash-generating unit level. The goodwill and indefinite-lived assets were reviewed for
impairment at June 30, 2023, December&#160;31, 2023, June 30, 2024 and December&#160;31, 2024. See Note 12.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;In-process
research and development (IPR&amp;amp;D) is tested for impairment on a bi-annual basis, and always at year end, or more frequently if impairment
indicators are present, using projected discounted cash flow models. If IPR&amp;amp;D becomes impaired or is abandoned, the carrying value
of the IPR&amp;amp;D is written down to its revised fair value with the related impairment charge recognised in the period in which the impairment
occurs. If the fair value of the asset becomes impaired as the result of unfavorable data from any ongoing or future clinical trial, changes
in assumptions that negatively impact projected cash flows, or because of any other information regarding the prospects of successfully
developing or commercializing our programs, we could incur significant charges in the period in which the impairment occurs. The valuation
techniques utilized in performing impairment tests incorporate significant assumptions and judgments to estimate the fair value, as described
above. The use of different valuation techniques or different assumptions could result in materially different fair value estimates.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;An
impairment loss is recognised whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount. Impairment
losses are recognised in the statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Impairment
losses recognised in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash-generating
units and then to reduce the carrying amount of other assets in the cash-generating units on a pro-rata basis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;An
impairment loss is reversed only to the extent that the asset&#x2019;s carrying amount does not exceed the carrying amount that would have
been determined, net of depreciation or amortisation, if no impairment loss had been recognised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;An
impairment loss in respect of goodwill is not reversed.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Following
recognition of any impairment loss (and on recognition of an impairment loss reversal), the depreciation or amortisation charge applicable
to the asset or cash-generating unit is adjusted prospectively with the objective of systematically allocating the revised carrying amount,
net of any residual value, over the remaining useful life.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;ix)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Financial
        Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On
initial recognition, a financial asset is classified as measured at amortised cost and subsequently measured using the effective interest
rate (EIR) method and subject to impairment. Financial assets may also be initially measured at fair value with any movement being reflected
through other comprehensive income or the Consolidated Statement of Operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On
initial recognition of an equity investment that is not held for trading, the Group may irrevocably elect to present subsequent changes
in the investment&#x2019;s fair value in other comprehensive income. This election is made on an investment-by investment&#160;basis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where
such an election is not made, and the investment is not held for trading, the equity instrument is classified as measured at fair value
through profit or loss (FVTPL). Subsequent changes in fair value are recognised in the Consolidated Statement of Operations. During 2024,
the Group acquired a strategic equity interest in an unlisted entity accounted for under this classification. Refer to Note 13.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Financial
assets are written off when there is no reasonable expectation of recovery, such as when the debtor has entered bankruptcy, when collection
efforts have been exhausted, or when the asset has been significantly past due (typically over 365 days) without any recent payments or
active correspondence. The Group considers both quantitative factors (such as aging) and qualitative indicators (e.g., legal or insolvency
proceedings) in making this assessment. Where receivables are written off but remain subject to enforcement activity, such as legal action
or engagement with collection agencies, these efforts are continued until formally closed.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;


&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;x)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Inventories
are stated at the lower of cost and net realisable value. Cost is based on the first-in, first-out principle and includes all expenditure
which has been incurred in bringing the products to their present location and condition and includes an appropriate allocation of manufacturing
overhead based on the normal level of operating capacity. Net realisable value is the estimated selling price of inventory on hand in
the ordinary course of business less all further costs to completion and costs expected to be incurred in selling these products.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group provides for inventory, based on estimates of the expected realisability. The estimated realisability is evaluated on a case-by-case
basis and any inventory that is approaching its &#x201c;use-by&#x201d; date and for which no further re-processing can be performed is written
off. Any reversal of an inventory provision is recognised in the statement of operations in the year in which the reversal occurs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trade
        and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trade
receivables are amounts due from customers for products sold or services provided in the ordinary course of business. Trade and other
receivables are stated at their amortised cost less impairment losses incurred. Cost approximates fair value given the short-term nature
of these assets. The Group records the loss allowance as lifetime expected credit losses.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;These
are the expected shortfalls in contractual cash flows, considering the potential for default at any point during the life of the financial
instrument. Expected credit losses are recorded on all of trade receivables based on an assessment of the probability of default or delinquency
in payments and the probability that debtor will enter into financial difficulties or bankruptcy.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"&gt;&#160;&lt;/p&gt;

&lt;div&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trade
        and other payables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trade
payables are obligations to pay for goods or services that have been acquired in the ordinary course of business. Trade and other payables
are stated at cost. Cost approximates fair value given the short term nature of these liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xiii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash
        and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="text-align:justify;text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash
and cash equivalents comprise cash balances and short-term deposits which are readily available at year-end. Deposits with maturities
less than six months as at the year-end date are recognised as cash and cash equivalents and are carried at fair value when there is no
expected loss in value on early termination. The Group has no short-term bank overdraft facilities. Where restrictions are imposed by
third parties, such as lending institutions, on cash balances held by the Group these are treated as financial assets in the financial
statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xiv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share-based
        payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;For
equity-settled share-based payments (share options), the Group measures the services received and the corresponding increase in equity
at fair value at the measurement date (which is the grant date) using a trinomial model. Given that the share options granted do not vest
until the completion of a specified period of service, the fair value, which is assessed at the grant date, is recognised on the basis
that the services to be rendered by employees as consideration for the granting of share options will be received over the vesting period.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Certain
share options have been granted for which there is a condition that the options only become exercisable into ADSs when the market price
of an ADS reaches a certain level. This is deemed to be a non-vesting condition. The term &#x2018;non-vesting condition&#x2019; is not explicitly
defined in IFRS 2, Share based Payment, but is inferred to be any condition that does not meet the definition of a vesting condition.
The only condition for these options to vest is that the option holder continues service and there were no other conditions which would
be considered non-vesting conditions. Non-vesting conditions are reflected in measuring the grant-date fair value of the share-based payment
and there is no true-up in the measurement of the share-based payment for differences between the expected and the actual outcome of non-vesting
conditions. If all service conditions are met, then the share-based payment cost will be recognized even if the option holder does not
receive the share-based payment due to a failure to meet the non-vesting condition.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
expense in the consolidated statement of operations in relation to share options represents the product of the total number of options
anticipated to vest and the fair value of those options; this amount is allocated to accounting periods on a straight-line basis over
the vesting period.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share
based payments, to the extent they relate to direct labour involved in development activities, are capitalised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when
the options are exercised. The Group does not operate any cash-settled share-based payment schemes or share-based payment transactions
with cash alternatives as defined in IFRS 2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Government
        grants&lt;/span&gt;&#160;&lt;span style="font-style:italic"&gt;and financial support&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The
Group received government-backed Covid-19 financial supports in the form of forgivable loans. Under IAS 20, Accounting for Government
Grants, a forgivable loan from government is treated as a government grant when there is reasonable assurance that the terms for forgiveness
of the loan will be met. Where a loan was received in the financial year but not yet forgiven within the financial year, the loan is treated
as a current liability. The Group has opted to present government grant income for loans that have been forgiven as Other operating income
in the consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;If
it is no longer reasonably assured that the terms of forgiveness will be met, any income previously recognised in respect of such a loan
is reversed in the period in which the change in assessment occurs. Grants that compensate the Group for expenses incurred such as research
and development, employment and training are recognised as income in the statement of operations on a systematic basis in the same periods
in which the expenses are incurred. Grants that compensate the Group for the cost of an asset are recognised in the statement of operations
on a systematic basis over the useful life of the asset. R&amp;amp;D tax credits claimed from tax authorities are credited to the taxation
line in the consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;xvi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Revenue
        recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Goods
sold and services rendered&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group recognises revenue when it transfers control over a good or service to a customer. Revenue is recognised to the extent that it is
probable that economic benefit will flow to the Group and the revenue can be measured. No revenue is recognised if there is uncertainty
regarding recovery of the consideration due at the outset of the transaction. Revenue, including any amounts invoiced for shipping and
handling costs, represents the value of goods and services supplied to external customers, net of discounts and rebates and excluding
sales taxes.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Revenue
from products is generally recorded as of the date of shipment, consistent with typical ex-works shipment terms. Where the shipment terms
do not permit revenue to be recognised as of the date of shipment, revenue is recognised when the Group has satisfied all of its performance
obligations to the customer in accordance with the shipping terms.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Some
contracts oblige the Group to ship product to the customer ahead of the agreed payment schedule. For these shipments, a contract asset
is recognised when control over the goods has transferred to the customer. The financing component is insignificant as invoicing for these
shipments occurs within a short period of time after shipment has occurred and standard 30 day credit terms typically apply.&lt;span style="font-style:italic"&gt;&#160;&lt;/span&gt;Some
contracts could be regarded as offering the customer a right of return. Due to the uncertainty of the magnitude and likelihood of product
returns, there is a level of estimation involved in assessing the amount of revenue to be recognized for these types of contracts. In
accordance with IFRS 15, when estimating the effect of an uncertainty on an amount of variable consideration to which the Group will be
entitled, all information that is reasonably available, including historical, current and forecast, is considered.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Revenue
is recognised on bill-and-hold transactions when all of the criteria in IFRS 15 are met, including: (i) the arrangement is at the customer&#x2019;s
request and has a substantive business reason; (ii) the products are separately identified as belonging to the customer; (iii) the products
are ready for physical transfer to the customer; and (iv) the Group has no ability to use the products or redirect them to another customer.
The Group assesses each bill-and-hold arrangement individually for compliance with these criteria. When all criteria are satisfied, control
is deemed to have transferred and revenue is recognised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group operates a licenced referenced laboratory in the US, which provides testing services to institutional customers and insurance companies.
In the US, there are rules requiring all insurance companies to be billed the same amount per test. However, the amount that each insurance
company pays for a particular test varies according to their own internal policies and this can typically be considerably less than the
amount invoiced. We recognise lab services revenue for insurance companies by taking the invoiced amount and reducing it by an estimated
percentage based on historical payment data. We review the percentage reduction annually based on the latest data. As a practical expedient,
and in accordance with IFRS, we apply a portfolio approach to the insurance companies as they have similar characteristics. We judge that
the effect on the financial statements of using a portfolio approach for the insurance companies will not differ materially from applying
IFRS 15 to the individual contracts within that portfolio.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Revenue
from services rendered is recognised in the statement of operations in proportion to the stage of completion of the transaction at the
balance sheet date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group leases instruments to customers typically as part of a bundled package. Where a contract has multiple performance obligations and
its duration is greater than one year, the transaction price is allocated to the performance obligations in the contract by reference
to their relative standalone selling prices. For contracts where control of the instrument is transferred to the customer, the fair value
of the instrument is recognised as revenue at the commencement of the lease and is matched by the related cost of sale. Fair value is
determined on the basis of standalone selling price. In the case where control of the instrument does not transfer to the customer, revenue
is recognised on the basis of customer usage of the instrument. See also Note 1 (v).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;In
obtaining these contracts, the Group incurs a number of incremental costs, such as sales bonus paid to sales staff commissions paid to
distributors and royalty payments. As the amortisation period of these costs, if capitalised, would be less than one year, the Group makes
use of the practical expedient in IFRS 15.94 and recognised them as expense as they are incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A
receivable is recognised when the goods are delivered as this is the point in time that the consideration is unconditional because only
the passage of time is required before the payment is due.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group&#x2019;s obligation to provide a refund for faulty products under the standard warranty terms is recognised as a provision, see Note
22 for details.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;xvi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Other
        operating income&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other
operating income primarily includes items of income that arise outside the normal course of business, including government grant income
from forgiven loans, insurance proceeds, sublease income, and other non-recurring items. Income is recognised when it is probable that
the economic benefits associated with the transaction will flow to the Group and the amount can be measured reliably.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During
the year ended December 31, 2024, other operating income included the reversal of $1.8
million previously recognised in relation to the forgiveness of Paycheck Protection Program (PPP) loans. This reversal was recognised
following the commencement of a U.S. Department of Justice investigation regarding the eligibility of certain U.S. subsidiaries for loan
forgiveness.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xvii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Employee
        benefits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Defined
contribution plans&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group operates defined contribution schemes in various locations where its subsidiaries are based. Contributions to the defined contribution
schemes are recognised in the statement of operations in the period in which the related service is received from the employee.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other
long-term benefits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where
employees participate in the Group&#x2019;s other long-term benefit schemes (such as permanent health insurance schemes under which the
scheme insures the employees), or where the Group contributes to insurance schemes for employees, the Group pays an annual fee to a service
provider, and accordingly the Group expenses such payments as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Termination
benefits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Termination
benefits are recognised as an expense when the Group is demonstrably committed, without realistic possibility of withdrawal, to a formal
detailed plan to either terminate employment before normal retirement date, or to provide termination benefits as a result of an offer
made to encourage voluntary redundancy.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xviii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Foreign
        currency&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A
majority of the revenue of the Group is generated in US Dollars. The Group&#x2019;s management has determined that the US&#160;Dollar is
the primary currency of the economic environment in which the Company and its subsidiaries (with the exception of the Group&#x2019;s subsidiaries
in Brazil, Canada and Sweden) principally operate. Thus, the functional currency of the Company and its subsidiaries (other than the Brazilian,
Canadian and Swedish subsidiaries) is the US&#160;Dollar. The functional currency of the Brazilian entity is the Brazilian Real and the
functional currency of the Canadian subsidiary is the Canadian Dollar.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
presentation currency of the Company and Group is the US&#160;Dollar. Monetary assets and liabilities denominated in foreign currencies
are translated at the rates of exchange ruling at the balance sheet date. The resulting gains and losses are included in the consolidated
statement of operations. Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated
using the exchange rate at the date of the transaction.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Results
and cash flows of subsidiary undertakings, which have a functional currency other than the US&#160;Dollar, are translated into US Dollars
at average exchange rates for the year, and the related balance sheets have been translated at the rates of exchange ruling on the balance
sheet date. Any exchange differences arising from the translations are recognised in the currency translation reserve via the statement
of changes in equity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where
Euro, Brazilian Real, or Canadian Dollar amounts have been referenced in this document, their corresponding US&#160;Dollar equivalent
has also been included and these equivalents have been calculated with reference to the foreign exchange rates prevailing at December&#160;31,
2024.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xix)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Hedging&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
activities of the Group expose it primarily to changes in foreign exchange rates and interest rates. The Group uses derivative financial
instruments, from time to time, such as forward foreign exchange contracts to hedge these exposures.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group enters into forward contracts to sell US Dollars forward for Euro. The principal exchange risk identified by the Group is with respect
to fluctuations in the Euro as a substantial portion of its expenses are denominated in Euro but its revenues are primarily denominated
in US Dollars. Trinity Biotech monitors its exposure to foreign currency movements and may use these forward contracts as cash flow hedging
instruments whose objective is to cover a portion of this Euro expense.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;At
the inception of a hedging transaction entailing the use of derivatives, the Group documents the relationship between the hedged item
and the hedging instrument together with its risk management objective and the strategy underlying the proposed transaction. The Group
also documents its quarterly assessment of the effectiveness of the hedge in offsetting movements in the cash flows of the hedged items.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Derivative
financial instruments are recognised at fair value. Where derivatives do not fulfil the criteria for hedge accounting, they are classified
as held-for-trading and changes in fair values are reported in the statement of operations. The fair value of forward exchange contracts
is calculated by reference to current forward exchange rates for contracts with similar maturity profiles and equates to the current market
price at the balance sheet date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
portion of the gain or loss on a hedging instrument that is deemed to be an effective cash flow hedge is recognised directly in the hedging
reserve in equity and the ineffective portion is recognised in the statement of operations. As the forward contracts are exercised the
net cumulative gain or loss recognised in the hedging reserve is transferred to the statement of operations and reflected in the same
line as the hedged item.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xx)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Exchangeable
        notes and derivative financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Company&#x2019;s exchangeable notes are treated as a host debt instrument with embedded derivatives attached. On initial recognition, the
host debt instrument is recognised at the residual value of the total net proceeds of the bond issue less fair value of the embedded derivatives.
Subsequently, the host debt instrument is measured at amortised cost using the effective interest rate method.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
embedded derivatives are initially recognised at fair value and are restated at their fair value at each reporting date. The fair value
changes of the embedded derivatives are recognised in the consolidated statement of operations, except for changes in fair value related
to the Group&#x2019;s own credit risk, which are recorded in the statement of comprehensive income.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where
the exchangeable notes are redeemed early or repurchased in a way that does not alter the original conversion privileges, the consideration
paid is allocated to the respective components and the amount of any gain or loss is recognised in the consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Senior
        secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
senior secured term loan is initially recorded at the fair value of the consideration received net of:&#160; a) directly attributable
transaction costs, b) the fair value at the date of issue of the warrants issued to the lender (see Note 1xxii) and c) the fair value
of the option to prepay the loan at the date of issue (see Note 1xxii).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Subsequent
to initial recognition, the term loan is measured at amortised cost employing the effective interest methodology. Borrowing costs, including
any penalties for early settlement of the loan, are recognised as an expense in the period in which they are incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;In
accordance with IFRS 9, the Group assesses any changes to the contractual terms of its borrowings to determine whether such changes result
in a substantial modification. A modification is considered substantial if the revised cash flows differ significantly from those of the
original arrangement, in which case the original liability is derecognised and a new financial liability is recognised. If a modification
is not substantial, the loan is remeasured using the original EIR, with any resulting gain or loss recognised in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During
2024, the Group amended the terms of its senior secured term loan; however, this was assessed under IFRS 9 and determined not to constitute
a substantial modification. Refer to Note 23 for further details.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrants
        and loan prepayment option&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Company has issued warrants to third parties. A warrant contract might be accounted for as an equity instrument or a financial liability
under IFRS depending on the terms of a warrant. A warrant contract that will or might be settled by an entity by delivering a fixed number
of its own equity instruments, in exchange for a fixed amount of cash or another financial asset, is an equity instrument.&#160;As Perceptive
has the option to choose a cashless exercise option, the Company will have to deliver a variable number of ADS, since the number of shares
will vary depending on the ADS traded price. Even though the cashless exercise option is economically comparable to the cash exercise
option, the fact that the Company will issue a variable number of shares under the cashless exercise option results in one settlement
alternative violating the &#x2018;fixed for fixed&#x2019; requirement.&#160; The warrant contract therefore meets the definition of a financial
liability and given the value of the warrant changes in response to the price of the Company&#x2019;s ADS, with no initial investment and
settlement occurring in the future it meets the definition of a derivative liability under IFRS 9. The warrant is issued in a separate
contract, is transferable independently of the term loan and can be exercised while the term loan remains outstanding. Therefore, the
warrant is a separate instrument to the term loan.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
warrant contracts are initially recognised as a derivative liability at fair value and subsequently measured at fair value at each reporting
period with any changes recognised in the consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Company has the option to prepay the senior secured term loan in whole or in part for an amount equal to the principal, accrued interest
and prepayment premium. In accordance with IFRS 9, this option is separated from the term loan and is initially recognised as a derivative
asset at fair value and subsequently measured at fair value at each reporting period with any changes recognised in the consolidated statement
of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;xxiii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Convertible
        Note&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
convertible note is accounted for as a compound financial instrument containing both an equity and liability element. The convertible
note has a contractual obligation to deliver cash on redemption equal to the principal amount plus accrued interest and therefore has
a liability component in line with the definition of a financial liability in IAS 32. The convertible loan note also has a conversion
feature where it mandatorily converts into ADS if the volume weighted average price of the Company&#x2019;s ADSs is at a certain price
for any five consecutive NASDAQ trading days or any other time at the discretion of the Noteholder. Where a derivative that will or may
be settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity's own equity
instruments, the conversion feature represents an equity component of the convertible note.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
equity component is measured as the residual amount that results from deducting the fair value of the liability component from the initial
carrying amount of the instrument as a whole. There is no remeasurement of the equity element following initial recognition. The debt
component is accounted for at amortised cost employing the effective interest methodology.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;


&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;xxiv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Segment
        reporting&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Operating
segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating
decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as
the Board of Directors.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;font-style:italic;width:30pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:auto"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Tax
        (current and deferred)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Income
tax on the profit or loss for the year comprises current and deferred tax. Income tax is recognised in the consolidated statement of operations
except to the extent that it relates to items recognised directly in equity, in which case it is recognised in equity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Current
tax represents the expected tax payable or recoverable on the taxable profit for the year using tax rates enacted or substantively enacted
at the balance sheet date in the countries where the company and its subsidiaries operate and generate income and taking into account
any adjustments stemming from prior years.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred
tax is provided on the basis of the balance sheet liability method on all temporary differences at the balance sheet date which is defined
as the difference between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred tax
assets and liabilities are not subject to discounting and are measured at the tax rates that are anticipated to apply in the period in
which the asset is realised or the liability is settled based on tax rates and tax laws that have been enacted or substantively enacted
at the balance sheet date. Deferred tax assets are recognised when it is probable that future taxable profits will be available to utilize
the associated losses or temporary differences. The amount of deferred tax provided is based on the expected manner of realisation or
settlement of the carrying amount of assets and liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred
tax assets and liabilities are recognised for all temporary differences (that is, differences between the carrying amount of the asset
or liability and its tax base) with the exception of the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.55pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:24.5pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where the deferred tax liability
        arises from goodwill not deductible for tax purposes or the initial recognition of an asset or a liability in a transaction that is not
        a business combination and affects neither the accounting profit nor the taxable profit or loss at the time of the transaction; and&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.55pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:24.5pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;ii.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where, in respect of temporary
        differences associated with investments in subsidiary undertakings, the timing of the reversal of the temporary difference is subject
        to control and it is probable that the temporary difference will not reverse in the foreseeable future.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where
goodwill is tax deductible, a deferred tax liability is not recognised on initial recognition of goodwill. It is recognised subsequently
for the taxable temporary difference which arises when the goodwill is amortised for tax with no corresponding adjustment to the carrying
value of the goodwill.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
carrying amounts of deferred tax assets are subject to review at each balance sheet date and are derecognised to the extent that future
taxable profits are considered to be inadequate to allow all or part of any deferred tax asset to be utilised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxvi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Provisions&lt;/span&gt;&#160;&lt;span style="font-style:italic"&gt;and
        contingent liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A
provision is recognised in the balance sheet when the Group has a present legal or constructive obligation because of a past event, and
it is probable that an outflow of economic benefits will be required to settle the obligation. The status of any significant claim and
legal proceeding in which the Group is involved is reviewed by management on a periodic basis and the Group&#x2019;s potential financial
exposure is assessed. If the potential loss from any claim or legal proceeding is considered probable, and the amount can be reliably
estimated, a liability is recognised for the estimated loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Due
to the uncertainties inherent in such matters, the related provisions are based on the best information available at the time. As additional
information becomes available on pending claims, the potential liability is reassessed and revisions are made to the amounts accrued as
appropriate. Such revisions in the judgments and estimates of the potential liabilities could have an impact on the results of operations
and financial position of the Group in future accounting periods.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Provisions
for restructuring costs are recognised only when the Group has approved a detailed formal plan and has either commenced implementation
or raised a valid expectation among those affected that the restructuring will be carried out. Under IAS 37, restructuring provisions
must only include direct expenditures that are necessarily incurred by the restructuring and not associated with the ongoing activities
of the business.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;xxvii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Cost
        of sales&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cost
of sales comprises product cost including manufacturing and payroll costs, quality control, shipping, handling, and packaging costs and
the cost of services provided.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxviii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Finance
        income and costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Financing
expenses comprise interest costs payable on senior secured term loan, convertible note, leases and exchangeable notes along with non-recurring
financing expenses such as penalty for early settlement of term loan and loss on disposal of exchangeable notes. Interest payable on finance
leases is allocated to each period during the lease term so as to produce a constant periodic rate of interest on the remaining balance
of the liability. Financing expenses also includes the financing element of long term liabilities which have been discounted. Finance
income includes interest income on deposits and is recognised in the consolidated statement of operations as it accrues, using the effective
interest method. Finance income also includes fair value adjustments for derivative assets and liabilities related to the senior secured
term loan and to embedded derivatives associated with exchangeable notes.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxix)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Treasury
        shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;When
the Group purchases its&lt;span style="font-style:italic"&gt;&#160;&lt;/span&gt;own equity instruments (treasury shares), the costs, including any
directly attributable incremental costs, are deducted from equity. No gain or loss is recognised in the consolidated statement of operations
on the purchase, sale, issue or cancellation of the Group&#x2019;s own equity instruments. Any difference between the carrying amount and
the consideration, if reissued, is recognised in share premium. Voting rights related to treasury shares are nullified for the Group and
no dividends are allocated to them.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxx)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Equity&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share
capital represents the nominal (par) value of shares that have been issued. Share premium includes any premiums received on issue of share
capital. Any transaction costs associated with the issuing of shares are deducted from share premium, net of any related income tax benefits.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxxi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Profit
        or loss from discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A
discontinued operation is a component of the Group that either has been disposed of or is classified as held for sale. Profit or loss
from discontinued operations comprises the post-tax profit or loss of discontinued operations and the post-tax gain or loss resulting
from the measurement and disposal of assets classified as held for sale and any gain or loss on disposal.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxxii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Fair
        values&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;For
financial reporting purposes, fair value measurements are categorized into Level&#160;1, 2 or 3 based on the degree to which inputs to
the fair value measurements are observable and the significance of the inputs to the fair value measurement in its entirety, which are
described as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Level&#160;1:
quoted prices (unadjusted) in active markets for identical assets or liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Level&#160;2:
valuation techniques for which the lowest level of inputs which have a significant effect on the recorded fair value are observable, either
directly or indirectly&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Level&#160;3:
valuation techniques for which the lowest level of inputs that have a significant effect on the recorded fair value are not based on observable
market data&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxxiii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;New
        IFRS Standards&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
following new accounting standards and interpretations became effective for annual periods beginning on or after 1 January 2024. The adoption
of these standards did not have a material impact on the Group&#x2019;s consolidated financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Classification of Liabilities
        as Current or Non-current (Amendments to IAS 1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Lease Liability in a Sale and
        Leaseback (Amendments to IFRS 16)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Supplier Finance Arrangements
        (Amendments to IAS 7 and IFRS 7)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Company is currently assessing the impact of the new standards and amendments on the Company&#x2019;s accounting policy disclosure.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxxiv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Standards,
        amendments and interpretations to existing IFRS Standards that are not yet effective&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
standards and amendments that have been issued but are not yet effective as at the date of issuance of the financial statements, and which
may have an impact on the Group's financial statements in future periods, are listed below. The Group intends to adopt these standards,
if applicable, when they become effective:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Lack of Exchangeability (Amendments
        to IAS 21), effective from 1 January 2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Amendments to the Classification
        and Measurement of Financial Instruments (Amendments to IFRS 9 and 7), effective from 1 January 2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Annual Improvements to IFRS
        Accounting Standards, effective from 1 January 2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;IFRS 18 &#x2018;Presentation
        and Disclosure in Financial Statements&#x2019;, effective from 1 January 2027&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;IFRS 19 &#x2018;Subsidiaries
        without Public Accountability: Disclosures&#x2019;, effective from 1 January 2027&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;  &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfBasisOfPreparationAndSignificantAccountingPoliciesExplanatory>
    <trib:DescriptionOfAccountingPolicyForGeneralInformationExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413041607737">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;i)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;General
        information&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trinity
Biotech is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable
biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation,
for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and
to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood and the Company intends to develop
a range of biosensor devices and related services, starting with a continuous glucose monitoring product.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </trib:DescriptionOfAccountingPolicyForGeneralInformationExplanatory>
    <trib:DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413041828192">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;ii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Statement
        of compliance&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (&#x201c;IFRS&#x201d;)
both as issued by the International Accounting Standards Board (&#x201c;IASB&#x201d;) and as subsequently adopted by the European Union
(&#x201c;EU&#x201d;) (together &#x201c;IFRS&#x201d;).&#160;The IFRS applied are those effective for accounting periods beginning January&#160;1,
2024. Consolidated financial statements are required by Irish law to comply with IFRS as adopted by the EU which differ in certain respects
from IFRS as issued by the IASB.&#160;These differences predominantly relate to the timing of adoption of new standards by the EU.&#160;However,
in relation to the 2024 consolidated financial statements there are no differences regarding the effective date of new IFRS relevant to
Trinity Biotech as issued by the IASB and as adopted by the EU. In relation to prior periods presented, none of the differences are relevant
in the context of Trinity Biotech and the consolidated financial statements comply with IFRS both as issued by the IASB and as adopted
by the EU.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </trib:DescriptionOfAccountingPolicyForStatementOfComplianceExplanatory>
    <ifrs-full:DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413041857113">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;iii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Basis of preparation and going concern&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
consolidated financial statements have been prepared in United States Dollars (US$), rounded to the nearest thousand, under the historical
cost basis of accounting, except for derivative financial instruments, certain balances arising on acquisition of subsidiary entities
and share-based payments which are initially recorded at fair value. Derivative financial instruments are also subsequently revalued and
carried at fair value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
preparation of financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect
the application of policies and amounts reported in the financial statements and accompanying notes. The estimates and associated assumptions
are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of
which form the basis of making the judgements about the carrying value of assets and liabilities that are not readily apparent from other
sources. Actual results may differ from these estimates.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period
in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision
affects both current and future periods. Judgements made by management that have a significant effect on the financial statements and
estimates with a significant risk of material adjustment in the next year are discussed in Note 31.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates
the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;As
reflected in the accompanying consolidated financial statements, for the years ended December 31, 2024 and 2023, the Group recorded a
loss of US$31.8
million and a loss of US$24.0
million, respectively. For the year ended December 31, 2024 we reported cash inflows of US1.7
million compared to cash outflows of US$2.8
million for 2023. As of December 31, 2024, we had net current assets of US$9.0
million but had an accumulated deficit in equity attributable to the equity holders of the Company of US$79.1
million.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;We
have made significant progress on a multi-year transformation plan aimed at improving profitability and simplifying our operating model.
Key actions implemented include the consolidation and outsourcing of global manufacturing, closure of underutilized facilities, relocation
of certain business support functions to lower-cost jurisdictions, and a reduction in overall headcount. These restructuring measures,
largely completed by mid-2025, are expected to deliver significant annualized cost savings. Additionally, the Group retains further levers
to manage liquidity if required, including deferring projected research and development spend.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A
temporary decline in revenue occurred during the first four months of 2025, primarily due to transitional impacts associated with the
Group&#x2019;s restructuring initiatives, including the consolidation of manufacturing operations and the transfer of Point-of-Care/HIV
products to a third-party contract manufacturing partner. These initiatives have since progressed materially. Sales were also affected
by reduced HIV test volumes resulting from uncertainty surrounding potential changes to U.S. foreign aid policy following a presidential
executive order. In light of these temporary factors, the Group sought and received a formal waiver from Perceptive in respect of the
Q1 2025 minimum revenue covenant, to ensure that no breach occurred under the Perceptive credit facility. In May 2025, the Group signed
a buy-sell agreement with a contract manufacturing partner. We also have obtained World Health Organisation (&#x201c;WHO&#x201d;) approval
to commence assembly at the new site. It is expected that WHO approval for full production of our Trinscreen product to be received in
July 2025, with approval for full production of our UniGold product expected in August 2025. The directors have alternative options and
have prepared financial forecasts to address a scenario whereby WHO approval for production with our contract manufacturing partner takes
longer than expected to achieve and the facility takes longer than expected to get up to full operational capacity. In such a scenario,
management remain confident that all revenue covenants will be met through to 31 December 2025. In addition, the minimum revenue covenant
thresholds for Q2, Q3 and Q4 2025 have been renegotiated to align with the Group&#x2019;s updated forecasts. Accordingly, management is
confident in the Group&#x2019;s ability to maintain compliance with its debt covenants for the remainder of the going concern review period.
Furthermore, Perceptive have a track record of supporting the Company and, when required, have provided covenant waivers and amendment
of terms which indicates an appreciation of the Company&#x2019;s circumstances in terms of our transformational plan for the business and
temporary declines in revenue. If a similar need were to recur in the foreseeable future, management are confident of their continued
support.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;We
have also launched a strategic realignment review of our businesses in partnership with Barclays Bank. This process, is expected to make
significant progress by the end of 2025 and may generate material capital proceeds that can be potentially used to reduce debt and support
investment, including CGM investment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In
addition, the Group has continued to benefit from strong support from Perceptive, its principal lender and largest investor. On December
23, 2024, we entered into the third amendment and restatement of the credit agreement governing the Term Loan. As part of this agreement,
an additional US$2.0
million of funding was made available to us. We also agreed that certain interest
payments payable in 2024 and 2025 would be paid-in-kind on the applicable payment date by increasing the outstanding principal
amount of the Term Loan. In February 2025, we entered into a fourth amendment to the credit agreement, which provided for an additional
US$4.0
million in term loan funding. On May 14, 2025, we entered into a fifth amendment to the credit agreement, which provided for a further
US$2.0
million in funding, extended the maturity date of the Term Loan by six months from January
2026 to July 27, 2026, and confirmed that interest
payments for the months of April, May, and June 2025 would be paid-in-kind. There are no material debt maturities until
July 2026. These successive amendments demonstrate Perceptive&#x2019;s continued support and demonstrate their willingness to flex terms
to preserve liquidity while the Company continues to execute its updated strategy, including its comprehensive transformation plan.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;

&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under
the fifth amendment to the credit agreement, the minimum liquidity covenant was reduced to US$1
million through to October 31, 2025, after which it reverts to US$3
million. While management is confident in the Group&#x2019;s ability to maintain compliance with this covenant, it is noted that the Group
has planned significant R&amp;amp;D expenditure related to its CGM development program in the second half of 2025. However, the Group retains
full discretion over the timing and phasing of these activities, which enables management to align expenditure with available funding
and preserve liquidity if required.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;

&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;In
addition to lender support, our going concern forecasts include expected equity raises. These funds are expected to support ongoing CGM
development activities. The Group has a strong track record of capital raising, including over US$7
million secured in 2024, and maintains active engagement with existing and potential investors. Management believes that the equity raise
is achievable based on the Group&#x2019;s strategic focus and transformation progress to date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The
directors have considered the Group&#x2019;s current financial position and cash flow projections, taking into account all known events
and developments including the amendment and restatement of the term loan with Perceptive, The directors believe that, based on currently
available information and reasonable assumptions, the Group will be able to continue its operations for at least the next 12 months from
the year-end date, and that it is appropriate to continue to prepare the consolidated financial statements on a going concern basis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
accounting policies set out below have been applied consistently to all periods presented in these consolidated financial statements.
The accounting policies have been applied consistently by all Group entities. The comparative information agrees with the amounts and
other disclosures presented in the prior period consolidated financial statements or, when appropriate, have been restated.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20250514153747421"
      unitRef="USD">-31800000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231"
      decimals="-5"
      id="Fxbrl_20250514153755721"
      unitRef="USD">-24000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20250514153806005"
      unitRef="USD">1700000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20230101to20231231"
      decimals="-5"
      id="Fxbrl_20250514153819750"
      unitRef="USD">-2800000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CurrentAssetsLiabilities
      contextRef="C_20241231"
      decimals="-5"
      id="Fxbrl_20250514153833638"
      unitRef="USD">9000000</ifrs-full:CurrentAssetsLiabilities>
    <trib:AccumulatedDeficitInEquityAttributableToEquityHolders
      contextRef="C_20241231"
      decimals="-5"
      id="Fxbrl_20250514153944560"
      unitRef="USD">-79100000</trib:AccumulatedDeficitInEquityAttributableToEquityHolders>
    <ifrs-full:NotionalAmount
      contextRef="C_20241223_tribCreditAgreementAxis_tribAmendedCreditAgreementMember"
      decimals="-5"
      id="Fxbrl_20250514154729835"
      unitRef="USD">2000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="C_20241223to20241223_tribCreditAgreementAxis_tribAmendedCreditAgreementMember"
      id="Fxbrl_20250514154755374">interest
payments payable in 2024 and 2025 would be paid-in-kind</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:NotionalAmount
      contextRef="C_20250228_ifrsfullBorrowingsByNameAxis_tribFourthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember"
      decimals="-5"
      id="Fxbrl_20250514154840817"
      unitRef="USD">4000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="C_20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember"
      decimals="-5"
      id="Fxbrl_20250514154958198"
      unitRef="USD">2000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsMaturity
      contextRef="C_20250514to20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember"
      id="Fxbrl_20250515125018868">January
2026 to July 27, 2026</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="C_20250514to20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember"
      id="Fxbrl_20250514155053886">interest
payments for the months of April, May, and June 2025 would be paid-in-kind</ifrs-full:BorrowingsInterestRateBasis>
    <trib:MinimumLiquidityCovenant
      contextRef="C_20251031_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember"
      decimals="-6"
      id="Fxbrl_20250515103710859"
      unitRef="USD">1000000</trib:MinimumLiquidityCovenant>
    <trib:RevertsMinimumLiquidityCovenant
      contextRef="C_20251031_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember"
      decimals="-6"
      id="Fxbrl_20250515111954660"
      unitRef="USD">3000000</trib:RevertsMinimumLiquidityCovenant>
    <ifrs-full:CapitalReserve
      contextRef="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribContinuousGlucoseMonitoringTechnologyMember"
      decimals="-6"
      id="Fxbrl_20250514160248880"
      unitRef="USD">7000000</ifrs-full:CapitalReserve>
    <ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413041952130">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;iv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Basis
        of consolidation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Subsidiaries&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Subsidiaries
are all entities over which the Group has control. The Group controls an entity when the Group is exposed to, or has rights to, variable
returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries
are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control
ceases. A change in the ownership interest of a subsidiary without a change in control is accounted for as an equity transaction. The
Group currently holds a majority of voting rights in all entities in the Group and as a result there are no non-controlling interests
reflected in the consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Transactions
eliminated on consolidation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Intra-group
balances and any unrealised gains or losses or income and expenses arising from intra-group transactions are eliminated in preparing the
consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413042030690">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;v)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Property,
        plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Owned
assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Items
of property, plant and equipment are stated at cost less any accumulated depreciation and any impairment losses (see Note 1(viii)). The
cost of self-constructed assets includes the cost of materials, direct labour and attributable overheads. It is not Group policy to revalue
any items of property, plant and equipment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Depreciation
is charged to the statement of operations on a straight-line basis to write-off the cost of the assets over their expected useful lives
as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5-15&#160;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:81.03%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.97%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Buildings&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;50
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:81.03%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.97%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Office equipment and fittings&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;10
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:81.03%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.97%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3-5
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:81.03%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.97%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5-15
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Land
is not depreciated. The residual values, if not insignificant, useful lives and depreciation methods of property, plant and equipment
are reviewed and adjusted if appropriate on a prospective basis, at each balance sheet date. There were no changes to useful lives in
the year.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group considers whether a contract is or contains a lease. A lease is defined as &#x2018;a contract, or part of a contract, that conveys
the right to use an asset (the underlying asset) for a period of time in exchange for consideration&#x2019;. To apply this definition the
Group assesses whether the contract meets three key evaluations which are whether:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.95pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;the contract contains an identified
        asset, which is either explicitly identified in the contract or implicitly specified by being identified at the time the asset is made
        available to the Group&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.95pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;the Group has the right to obtain
        substantially all of the economic benefits from use of the identified asset throughout the period of use, considering its rights within
        the defined scope of the contract&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.95pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;the Group has the right to direct
        the use of the identified asset throughout the period of use. The Group assess whether it has the right to direct &#x2018;how and for what
        purpose&#x2019; the asset is used throughout the period of use.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;At
lease commencement date, the Group recognises a right-of-use asset and a lease liability on the balance sheet. The right-of-use asset
is measured at cost, which is made up of the initial measurement of the lease liability, any initial direct costs incurred by the Group,
an estimate of any costs to dismantle and remove the asset at the end of the lease, and any lease payments made in advance of the lease
commencement date (net of any incentives received).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group depreciates the right-of-use assets on a straight-line basis from the lease commencement date to the earlier of the end of the useful
life of the right-of-use asset or the end of the lease term. The Group also assesses the right-of-use asset for impairment when such indicators
exist.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;At
the commencement date, the Group measures the lease liability at the present value of the lease payments unpaid at that date, discounted
using the interest rate implicit in the lease if that rate is readily available or the Group&#x2019;s incremental borrowing rate. Lease
payments included in the measurement of the lease liability are made up of fixed payments (including in substance fixed), variable payments
based on an index or rate, amounts expected to be payable under a residual value guarantee and payments arising from options reasonably
certain to be exercised. Subsequent to initial measurement, the liability will be reduced for payments made and increased for interest.
It is remeasured to reflect any reassessment or modification, or if there are changes in in-substance fixed payments. When the lease liability
is remeasured, the corresponding adjustment is reflected in the right-of-use asset, or profit and loss if the right-of-use asset is already
reduced to zero.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group has elected to account for short-term leases and leases of low-value assets using the practical expedients. Instead of recognising
a right-of-use asset and lease liability, the payments in relation to these are recognised as an expense in profit or loss on a straight-line
basis over the lease term. On the statement of financial position, right-of-use assets have been included in property, plant and equipment
and lease liabilities have been included in separate lines within the current liabilities and non-current liabilities sections.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.9pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Leased
assets - as lessor&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.95pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group&#x2019;s accounting policy under IFRS 16 has not changed from the comparative period. As a lessor, the Group classifies its leases
as either operating or finance leases. A lease is classified as a finance lease if it transfers substantially all the risks and rewards
incidental to ownership of the underlying asset, and classified as an operating lease if it does not.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <trib:DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512110457883">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5-15&#160;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:81.03%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.97%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Buildings&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;50
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:81.03%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.97%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Office equipment and fittings&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;10
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:81.03%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.97%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3-5
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:81.03%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.97%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="vertical-align:bottom;width:81.03%"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;white-space:nowrap;width:18.97%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5-15
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfOwnedAssetsExplanatory>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      id="Fxbrl_20250513122634045">5-15&#160;years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      id="Fxbrl_20250513122642841">50
        years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      id="Fxbrl_20250513122650716">10
        years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      id="Fxbrl_20250513122712628">3-5
        years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribPropertyAndEquipmentMember"
      id="Fxbrl_20250513122805181">5-15
        years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413042107413">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;vi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Business
        combinations &amp;amp; goodwill&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;At
the time of each transaction, the Group evaluates whether the acquisition constitutes a business combination in accordance with the definition
in IFRS 3 Business Combinations. A business is defined as an integrated set of activities and assets that is capable of being conducted
and managed for the purpose of providing a return. The assessment considers whether the acquired set includes inputs and substantive processes
that together significantly contribute to the ability to create outputs. Where such criteria are not met, the transaction is accounted
for as an asset acquisition. Transactions assessed as asset acquisitions do not give rise to goodwill.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;In
respect of business combinations that have occurred since January 1, 2004 (being the transition date to IFRS), goodwill represents the
difference between the cost of the acquisition and the fair value of the net identifiable assets acquired. In respect of acquisitions
prior to this date, goodwill is included on the basis of its deemed cost, which represents the amount recorded under Irish GAAP.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;To
the extent that the Group&#x2019;s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities acquired
exceeds the cost of a business combination, the identification and measurement of the related assets, liabilities and contingent liabilities
are revisited accompanied by a reassessment of the cost of the transaction, and any remaining balance is immediately recognised in the
statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;At
the acquisition date, any goodwill is allocated to each of the Group&#x2019;s cash-generating units expected to benefit from the combination&#x2019;s
synergies. Following initial recognition, goodwill is stated at cost less any accumulated impairment losses and is not amortised but is
tested annually for impairment.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;This
policy has been applied to acquisitions completed during the year, including the acquisition of the CGM assets of Waveform Technologies,
Inc. in January 2024, and the acquisitions of EpiCapture Limited and Metabolomics Diagnostics Limited, further details of which are disclosed
in Note 29 to the consolidated financial statements losses.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413042359787">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;vii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Intangibles,
        including research and development (other than goodwill)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;An
intangible asset, which is an identifiable non-monetary asset without physical substance, is recognised to the extent that it is probable
that the expected future economic benefits attributable to the asset will flow to the Group and that its cost can be measured reliably.
The asset is deemed to be identifiable when it is separable (that is, capable of being divided from the entity and sold, transferred,
licenced, rented or exchanged, either individually or together with a related contract, asset or liability) or when it arises from contractual
or other legal rights, regardless of whether those rights are transferable or separable from the Group or from other rights and obligations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Intangible
assets acquired as part of a business combination are capitalised separately from goodwill if the intangible asset meets the definition
of an asset and the fair value can be reliably measured on initial recognition. In the case of recent acquisitions, the Group has recognised
technology-based intangible assets, comprising know-how, trade secrets and similar intellectual property. These assets are classified
as finite-lived and are initially recognised at fair value as determined by independent valuation.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subsequent
to initial recognition, these intangible assets are carried at cost less any accumulated amortisation and any accumulated impairment losses
(Note 1(viii)). Intangible assets with definite useful lives are reviewed for indicators of impairment annually while intangible assets
with indefinite useful lives and those not yet brought into use are tested for impairment at least annually, either individually or at
the cash-generating unit level.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expenditure
on development activities, whereby research findings are applied to a plan or design for the production of new or substantially improved
products and processes, is capitalised if the product or process is technically and commercially feasible and the Group has sufficient
resources to complete the development. The expenditure capitalised includes the cost of materials, direct labour and attributable overheads
and third party costs. Subsequent expenditure on capitalised intangible assets is capitalised only when it increases the future economic
benefits embodied in the specific asset to which it relates.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
technical feasibility of a new product is determined by a specific feasibility study undertaken at the first stage of any development
project. The majority of our new product developments involve the transfer of existing product know-how to a new application. Since the
technology is already proven in an existing product which is being used by customers, this facilitates the proving of the technical feasibility
of that same technology in a new product.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
results of the feasibility study are reviewed by a design review committee comprising senior managers. The feasibility study occurs in
the initial research phase of a project and costs in this phase are not capitalised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
commercial feasibility of a new product is determined by preparing a discounted cash flow projection. This projection compares the discounted
sales revenues for future periods with the relevant costs. As part of preparing the cash flow projection, the size of the relevant market
is determined, feedback is sought from customers and the strength of the proposed new product is assessed against competitors&#x2019; offerings.
Once the technical and commercial feasibility has been established and the project has been approved for commencement, the project moves
into the development phase.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;All
other development expenditure is expensed as incurred. Subsequent to initial recognition, the capitalised development expenditure is carried
at cost less any accumulated amortisation and any accumulated impairment losses.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expenditure
on research activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognised
in the statement of operations as an expense as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expenditure
on internally generated goodwill and brands is recognised in the statement of operations as an expense as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Amortisation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Amortisation
is charged to the statement of operations on a straight-line basis over the estimated useful lives of intangible assets, unless such lives
are indefinite. Intangible assets are amortised from the date they are available for use in its intended market. The estimated useful
lives are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Capitalised development costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;15&#160;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Patents and licences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;6-15&#160;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Other (including acquired customer and supplier lists)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;6-15
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group uses a useful economic life of 15
years for capitalised development costs. This is a conservative estimate of the likely life of the products. The Group
is confident that products have a minimum of 15 years life given the inertia that characterizes the medical diagnostics industry and the
barriers to enter into the industry. The following factors have been considered in estimating the useful life of developed products:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.55pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:24.5pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(a)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;once a diagnostic test becomes
        established, customers are reluctant to change to new technology until it is fully proven, thus resulting in relatively long product life
        cycles. There is also reluctance in customers to change to a new product as it can be costly both in terms of the initial changeover cost
        and as new technology is typically more expensive.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.55pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:24.5pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(b)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;demand for the diagnostic tests
        is enduring and robust within a wide geographic base. The diseases that the products diagnose are widely prevalent (HIV, Diabetes and
        Chlamydia being just three examples) in many countries. There is a general consensus that these diseases will continue to be widely prevalent
        in the future. Demand for biosensors is showing high growth in recent years due to the ease of use and the appeal of real time information.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.55pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:24.5pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(c)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;there are significant barriers
        to new entrants in this industry. Patents and/or licences are in place for several of our products, though this is not the only barrier
        to entry. There is a significant cost and time to develop new products, it is necessary to obtain regulatory approval and tests are protected
        by proprietary know-how, manufacturing techniques and trade secrets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During
the year ended December 31, 2024, the Group capitalised US$7.0
million in development costs related to newly acquired intangible assets. As the underlying intellectual property remains at a pre-commercialisation
stage and is not yet available for use, amortisation has not commenced. Amortisation will begin when the assets are brought into use,
in accordance with the Group&#x2019;s stated policy.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Technology-based
intangible assets acquired as part of business combinations are assigned finite useful lives in line with the Group&#x2019;s amortisation
policies, based on independent valuation reports. Amortisation of these assets will commence when they are available for use, i.e., when
they are in the location and condition necessary for them to be capable of operating in the manner intended by management. For technology-based
intangible assets acquired in 2024, amortisation has not commenced as the technologies have not yet been commercialised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Certain
trade names acquired are deemed to have an indefinite useful life as there is no foreseeable limit to the period over which these assets
are expected to generate cash inflows for the Group.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where
amortisation is charged on assets with finite lives, this expense is taken to the statement of operations through the &#x2018;selling,
general and administrative expenses&#x2019; line.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Useful
lives are examined on an annual basis and adjustments, where applicable, are made on a prospective basis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <trib:DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512110519733">

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Capitalised development costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;15&#160;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Patents and licences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;6-15&#160;years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:middle"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="2" style="width:84.23%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-24pt;margin-left:24pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&#160;
        &#160; Other (including acquired customer and supplier lists)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="width:15.77%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;6-15
        years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutEstimatedUsefulLivesOfIntangibleAssetsExplanatory>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCapitalisedDevelopmentExpenditureMember"
      id="Fxbrl_20220424133907146">15&#160;years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      id="Fxbrl_20250513122821525">6-15&#160;years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullOtherIntangibleAssetsMember"
      id="Fxbrl_20250513122831377">6-15
        years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCapitalisedDevelopmentExpenditureMember"
      id="Fxbrl_20220327174731265">15
years</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment>
    <ifrs-full:IntangibleAssetsUnderDevelopment
      contextRef="C_20241231_ifrsfullIntangibleAssetsWithIndefiniteUsefulLifeAxis_ifrsfullCapitalisedDevelopmentExpenditureMember"
      decimals="-5"
      id="Fxbrl_20250513124243560"
      unitRef="USD">7000000</ifrs-full:IntangibleAssetsUnderDevelopment>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413042429756">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;viii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
carrying amount of the Group&#x2019;s assets, other than inventories, accounts receivable, cash and cash equivalents, short-term investments
and deferred tax assets, are reviewed at each balance sheet date to determine whether there is any indication of impairment. If any such
indication exists, the asset&#x2019;s recoverable amount (being the greater of fair value less costs to sell and value in use) is assessed
at each balance sheet date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Fair
value less costs to sell is defined as the amount obtainable from the sale of an asset or cash-generating unit in an arm&#x2019;s length
transaction between knowledgeable and willing parties, less the costs that would be incurred on disposal. Value in use is defined as the
present value of the future cash flows expected to be derived through the continued use of an asset or cash-generating unit. In assessing
value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current
market assessments of the time value of money and the risks specific to the asset for which the future cash flow estimates have not yet
been adjusted. The estimates of future cash flows exclude cash inflows or outflows attributable to financing activities. For an asset
that does not generate largely independent cash flows, the recoverable amount is determined by reference to the cash-generating unit to
which the asset belongs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;For
goodwill, assets that have an indefinite useful life and intangible assets that are not yet available for use, the recoverable amount
is estimated at each balance sheet date at the cash-generating unit level. The goodwill and indefinite-lived assets were reviewed for
impairment at June 30, 2023, December&#160;31, 2023, June 30, 2024 and December&#160;31, 2024. See Note 12.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;In-process
research and development (IPR&amp;amp;D) is tested for impairment on a bi-annual basis, and always at year end, or more frequently if impairment
indicators are present, using projected discounted cash flow models. If IPR&amp;amp;D becomes impaired or is abandoned, the carrying value
of the IPR&amp;amp;D is written down to its revised fair value with the related impairment charge recognised in the period in which the impairment
occurs. If the fair value of the asset becomes impaired as the result of unfavorable data from any ongoing or future clinical trial, changes
in assumptions that negatively impact projected cash flows, or because of any other information regarding the prospects of successfully
developing or commercializing our programs, we could incur significant charges in the period in which the impairment occurs. The valuation
techniques utilized in performing impairment tests incorporate significant assumptions and judgments to estimate the fair value, as described
above. The use of different valuation techniques or different assumptions could result in materially different fair value estimates.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;An
impairment loss is recognised whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount. Impairment
losses are recognised in the statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Impairment
losses recognised in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash-generating
units and then to reduce the carrying amount of other assets in the cash-generating units on a pro-rata basis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;An
impairment loss is reversed only to the extent that the asset&#x2019;s carrying amount does not exceed the carrying amount that would have
been determined, net of depreciation or amortisation, if no impairment loss had been recognised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;An
impairment loss in respect of goodwill is not reversed.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Following
recognition of any impairment loss (and on recognition of an impairment loss reversal), the depreciation or amortisation charge applicable
to the asset or cash-generating unit is adjusted prospectively with the objective of systematically allocating the revised carrying amount,
net of any residual value, over the remaining useful life.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory>
    <trib:FinancialAssetsPolicyTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413042527576">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;ix)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Financial
        Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On
initial recognition, a financial asset is classified as measured at amortised cost and subsequently measured using the effective interest
rate (EIR) method and subject to impairment. Financial assets may also be initially measured at fair value with any movement being reflected
through other comprehensive income or the Consolidated Statement of Operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On
initial recognition of an equity investment that is not held for trading, the Group may irrevocably elect to present subsequent changes
in the investment&#x2019;s fair value in other comprehensive income. This election is made on an investment-by investment&#160;basis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where
such an election is not made, and the investment is not held for trading, the equity instrument is classified as measured at fair value
through profit or loss (FVTPL). Subsequent changes in fair value are recognised in the Consolidated Statement of Operations. During 2024,
the Group acquired a strategic equity interest in an unlisted entity accounted for under this classification. Refer to Note 13.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Financial
assets are written off when there is no reasonable expectation of recovery, such as when the debtor has entered bankruptcy, when collection
efforts have been exhausted, or when the asset has been significantly past due (typically over 365 days) without any recent payments or
active correspondence. The Group considers both quantitative factors (such as aging) and qualitative indicators (e.g., legal or insolvency
proceedings) in making this assessment. Where receivables are written off but remain subject to enforcement activity, such as legal action
or engagement with collection agencies, these efforts are continued until formally closed.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;
</trib:FinancialAssetsPolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044050928">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;x)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Inventories
are stated at the lower of cost and net realisable value. Cost is based on the first-in, first-out principle and includes all expenditure
which has been incurred in bringing the products to their present location and condition and includes an appropriate allocation of manufacturing
overhead based on the normal level of operating capacity. Net realisable value is the estimated selling price of inventory on hand in
the ordinary course of business less all further costs to completion and costs expected to be incurred in selling these products.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group provides for inventory, based on estimates of the expected realisability. The estimated realisability is evaluated on a case-by-case
basis and any inventory that is approaching its &#x201c;use-by&#x201d; date and for which no further re-processing can be performed is written
off. Any reversal of an inventory provision is recognised in the statement of operations in the year in which the reversal occurs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
    <ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250514160753391">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trade
        and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trade
receivables are amounts due from customers for products sold or services provided in the ordinary course of business. Trade and other
receivables are stated at their amortised cost less impairment losses incurred. Cost approximates fair value given the short-term nature
of these assets. The Group records the loss allowance as lifetime expected credit losses.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;These
are the expected shortfalls in contractual cash flows, considering the potential for default at any point during the life of the financial
instrument. Expected credit losses are recorded on all of trade receivables based on an assessment of the probability of default or delinquency
in payments and the probability that debtor will enter into financial difficulties or bankruptcy.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044137702">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trade
        and other payables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trade
payables are obligations to pay for goods or services that have been acquired in the ordinary course of business. Trade and other payables
are stated at cost. Cost approximates fair value given the short term nature of these liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044202548">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xiii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash
        and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="text-align:justify;text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash
and cash equivalents comprise cash balances and short-term deposits which are readily available at year-end. Deposits with maturities
less than six months as at the year-end date are recognised as cash and cash equivalents and are carried at fair value when there is no
expected loss in value on early termination. The Group has no short-term bank overdraft facilities. Where restrictions are imposed by
third parties, such as lending institutions, on cash balances held by the Group these are treated as financial assets in the financial
statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044227700">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xiv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share-based
        payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;For
equity-settled share-based payments (share options), the Group measures the services received and the corresponding increase in equity
at fair value at the measurement date (which is the grant date) using a trinomial model. Given that the share options granted do not vest
until the completion of a specified period of service, the fair value, which is assessed at the grant date, is recognised on the basis
that the services to be rendered by employees as consideration for the granting of share options will be received over the vesting period.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Certain
share options have been granted for which there is a condition that the options only become exercisable into ADSs when the market price
of an ADS reaches a certain level. This is deemed to be a non-vesting condition. The term &#x2018;non-vesting condition&#x2019; is not explicitly
defined in IFRS 2, Share based Payment, but is inferred to be any condition that does not meet the definition of a vesting condition.
The only condition for these options to vest is that the option holder continues service and there were no other conditions which would
be considered non-vesting conditions. Non-vesting conditions are reflected in measuring the grant-date fair value of the share-based payment
and there is no true-up in the measurement of the share-based payment for differences between the expected and the actual outcome of non-vesting
conditions. If all service conditions are met, then the share-based payment cost will be recognized even if the option holder does not
receive the share-based payment due to a failure to meet the non-vesting condition.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
expense in the consolidated statement of operations in relation to share options represents the product of the total number of options
anticipated to vest and the fair value of those options; this amount is allocated to accounting periods on a straight-line basis over
the vesting period.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share
based payments, to the extent they relate to direct labour involved in development activities, are capitalised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when
the options are exercised. The Group does not operate any cash-settled share-based payment schemes or share-based payment transactions
with cash alternatives as defined in IFRS 2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250514161603452">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Government
        grants&lt;/span&gt;&#160;&lt;span style="font-style:italic"&gt;and financial support&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The
Group received government-backed Covid-19 financial supports in the form of forgivable loans. Under IAS 20, Accounting for Government
Grants, a forgivable loan from government is treated as a government grant when there is reasonable assurance that the terms for forgiveness
of the loan will be met. Where a loan was received in the financial year but not yet forgiven within the financial year, the loan is treated
as a current liability. The Group has opted to present government grant income for loans that have been forgiven as Other operating income
in the consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;If
it is no longer reasonably assured that the terms of forgiveness will be met, any income previously recognised in respect of such a loan
is reversed in the period in which the change in assessment occurs. Grants that compensate the Group for expenses incurred such as research
and development, employment and training are recognised as income in the statement of operations on a systematic basis in the same periods
in which the expenses are incurred. Grants that compensate the Group for the cost of an asset are recognised in the statement of operations
on a systematic basis over the useful life of the asset. R&amp;amp;D tax credits claimed from tax authorities are credited to the taxation
line in the consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044323744">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;xvi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Revenue
        recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Goods
sold and services rendered&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group recognises revenue when it transfers control over a good or service to a customer. Revenue is recognised to the extent that it is
probable that economic benefit will flow to the Group and the revenue can be measured. No revenue is recognised if there is uncertainty
regarding recovery of the consideration due at the outset of the transaction. Revenue, including any amounts invoiced for shipping and
handling costs, represents the value of goods and services supplied to external customers, net of discounts and rebates and excluding
sales taxes.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Revenue
from products is generally recorded as of the date of shipment, consistent with typical ex-works shipment terms. Where the shipment terms
do not permit revenue to be recognised as of the date of shipment, revenue is recognised when the Group has satisfied all of its performance
obligations to the customer in accordance with the shipping terms.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Some
contracts oblige the Group to ship product to the customer ahead of the agreed payment schedule. For these shipments, a contract asset
is recognised when control over the goods has transferred to the customer. The financing component is insignificant as invoicing for these
shipments occurs within a short period of time after shipment has occurred and standard 30 day credit terms typically apply.&lt;span style="font-style:italic"&gt;&#160;&lt;/span&gt;Some
contracts could be regarded as offering the customer a right of return. Due to the uncertainty of the magnitude and likelihood of product
returns, there is a level of estimation involved in assessing the amount of revenue to be recognized for these types of contracts. In
accordance with IFRS 15, when estimating the effect of an uncertainty on an amount of variable consideration to which the Group will be
entitled, all information that is reasonably available, including historical, current and forecast, is considered.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Revenue
is recognised on bill-and-hold transactions when all of the criteria in IFRS 15 are met, including: (i) the arrangement is at the customer&#x2019;s
request and has a substantive business reason; (ii) the products are separately identified as belonging to the customer; (iii) the products
are ready for physical transfer to the customer; and (iv) the Group has no ability to use the products or redirect them to another customer.
The Group assesses each bill-and-hold arrangement individually for compliance with these criteria. When all criteria are satisfied, control
is deemed to have transferred and revenue is recognised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group operates a licenced referenced laboratory in the US, which provides testing services to institutional customers and insurance companies.
In the US, there are rules requiring all insurance companies to be billed the same amount per test. However, the amount that each insurance
company pays for a particular test varies according to their own internal policies and this can typically be considerably less than the
amount invoiced. We recognise lab services revenue for insurance companies by taking the invoiced amount and reducing it by an estimated
percentage based on historical payment data. We review the percentage reduction annually based on the latest data. As a practical expedient,
and in accordance with IFRS, we apply a portfolio approach to the insurance companies as they have similar characteristics. We judge that
the effect on the financial statements of using a portfolio approach for the insurance companies will not differ materially from applying
IFRS 15 to the individual contracts within that portfolio.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Revenue
from services rendered is recognised in the statement of operations in proportion to the stage of completion of the transaction at the
balance sheet date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group leases instruments to customers typically as part of a bundled package. Where a contract has multiple performance obligations and
its duration is greater than one year, the transaction price is allocated to the performance obligations in the contract by reference
to their relative standalone selling prices. For contracts where control of the instrument is transferred to the customer, the fair value
of the instrument is recognised as revenue at the commencement of the lease and is matched by the related cost of sale. Fair value is
determined on the basis of standalone selling price. In the case where control of the instrument does not transfer to the customer, revenue
is recognised on the basis of customer usage of the instrument. See also Note 1 (v).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;In
obtaining these contracts, the Group incurs a number of incremental costs, such as sales bonus paid to sales staff commissions paid to
distributors and royalty payments. As the amortisation period of these costs, if capitalised, would be less than one year, the Group makes
use of the practical expedient in IFRS 15.94 and recognised them as expense as they are incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A
receivable is recognised when the goods are delivered as this is the point in time that the consideration is unconditional because only
the passage of time is required before the payment is due.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group&#x2019;s obligation to provide a refund for faulty products under the standard warranty terms is recognised as a provision, see Note
22 for details.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
    <trib:DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512130823706">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;xvi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Other
        operating income&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other
operating income primarily includes items of income that arise outside the normal course of business, including government grant income
from forgiven loans, insurance proceeds, sublease income, and other non-recurring items. Income is recognised when it is probable that
the economic benefits associated with the transaction will flow to the Group and the amount can be measured reliably.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During
the year ended December 31, 2024, other operating income included the reversal of $1.8
million previously recognised in relation to the forgiveness of Paycheck Protection Program (PPP) loans. This reversal was recognised
following the commencement of a U.S. Department of Justice investigation regarding the eligibility of certain U.S. subsidiaries for loan
forgiveness.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </trib:DescriptionOfAccountingPolicyForOtherOperatingIncomeExplanatory>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20250512131432226"
      unitRef="USD">-1800000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044355542">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xvii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Employee
        benefits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Defined
contribution plans&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group operates defined contribution schemes in various locations where its subsidiaries are based. Contributions to the defined contribution
schemes are recognised in the statement of operations in the period in which the related service is received from the employee.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other
long-term benefits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where
employees participate in the Group&#x2019;s other long-term benefit schemes (such as permanent health insurance schemes under which the
scheme insures the employees), or where the Group contributes to insurance schemes for employees, the Group pays an annual fee to a service
provider, and accordingly the Group expenses such payments as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Termination
benefits&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Termination
benefits are recognised as an expense when the Group is demonstrably committed, without realistic possibility of withdrawal, to a formal
detailed plan to either terminate employment before normal retirement date, or to provide termination benefits as a result of an offer
made to encourage voluntary redundancy.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044428933">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xviii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Foreign
        currency&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A
majority of the revenue of the Group is generated in US Dollars. The Group&#x2019;s management has determined that the US&#160;Dollar is
the primary currency of the economic environment in which the Company and its subsidiaries (with the exception of the Group&#x2019;s subsidiaries
in Brazil, Canada and Sweden) principally operate. Thus, the functional currency of the Company and its subsidiaries (other than the Brazilian,
Canadian and Swedish subsidiaries) is the US&#160;Dollar. The functional currency of the Brazilian entity is the Brazilian Real and the
functional currency of the Canadian subsidiary is the Canadian Dollar.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
presentation currency of the Company and Group is the US&#160;Dollar. Monetary assets and liabilities denominated in foreign currencies
are translated at the rates of exchange ruling at the balance sheet date. The resulting gains and losses are included in the consolidated
statement of operations. Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated
using the exchange rate at the date of the transaction.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Results
and cash flows of subsidiary undertakings, which have a functional currency other than the US&#160;Dollar, are translated into US Dollars
at average exchange rates for the year, and the related balance sheets have been translated at the rates of exchange ruling on the balance
sheet date. Any exchange differences arising from the translations are recognised in the currency translation reserve via the statement
of changes in equity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where
Euro, Brazilian Real, or Canadian Dollar amounts have been referenced in this document, their corresponding US&#160;Dollar equivalent
has also been included and these equivalents have been calculated with reference to the foreign exchange rates prevailing at December&#160;31,
2024.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForHedgingExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044449403">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xix)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Hedging&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
activities of the Group expose it primarily to changes in foreign exchange rates and interest rates. The Group uses derivative financial
instruments, from time to time, such as forward foreign exchange contracts to hedge these exposures.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Group enters into forward contracts to sell US Dollars forward for Euro. The principal exchange risk identified by the Group is with respect
to fluctuations in the Euro as a substantial portion of its expenses are denominated in Euro but its revenues are primarily denominated
in US Dollars. Trinity Biotech monitors its exposure to foreign currency movements and may use these forward contracts as cash flow hedging
instruments whose objective is to cover a portion of this Euro expense.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;At
the inception of a hedging transaction entailing the use of derivatives, the Group documents the relationship between the hedged item
and the hedging instrument together with its risk management objective and the strategy underlying the proposed transaction. The Group
also documents its quarterly assessment of the effectiveness of the hedge in offsetting movements in the cash flows of the hedged items.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Derivative
financial instruments are recognised at fair value. Where derivatives do not fulfil the criteria for hedge accounting, they are classified
as held-for-trading and changes in fair values are reported in the statement of operations. The fair value of forward exchange contracts
is calculated by reference to current forward exchange rates for contracts with similar maturity profiles and equates to the current market
price at the balance sheet date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
portion of the gain or loss on a hedging instrument that is deemed to be an effective cash flow hedge is recognised directly in the hedging
reserve in equity and the ineffective portion is recognised in the statement of operations. As the forward contracts are exercised the
net cumulative gain or loss recognised in the hedging reserve is transferred to the statement of operations and reflected in the same
line as the hedged item.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForHedgingExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044514301">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xx)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Exchangeable
        notes and derivative financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Company&#x2019;s exchangeable notes are treated as a host debt instrument with embedded derivatives attached. On initial recognition, the
host debt instrument is recognised at the residual value of the total net proceeds of the bond issue less fair value of the embedded derivatives.
Subsequently, the host debt instrument is measured at amortised cost using the effective interest rate method.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
embedded derivatives are initially recognised at fair value and are restated at their fair value at each reporting date. The fair value
changes of the embedded derivatives are recognised in the consolidated statement of operations, except for changes in fair value related
to the Group&#x2019;s own credit risk, which are recorded in the statement of comprehensive income.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where
the exchangeable notes are redeemed early or repurchased in a way that does not alter the original conversion privileges, the consideration
paid is allocated to the respective components and the amount of any gain or loss is recognised in the consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory>
    <trib:DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044539535">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Senior
        secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
senior secured term loan is initially recorded at the fair value of the consideration received net of:&#160; a) directly attributable
transaction costs, b) the fair value at the date of issue of the warrants issued to the lender (see Note 1xxii) and c) the fair value
of the option to prepay the loan at the date of issue (see Note 1xxii).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Subsequent
to initial recognition, the term loan is measured at amortised cost employing the effective interest methodology. Borrowing costs, including
any penalties for early settlement of the loan, are recognised as an expense in the period in which they are incurred.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;In
accordance with IFRS 9, the Group assesses any changes to the contractual terms of its borrowings to determine whether such changes result
in a substantial modification. A modification is considered substantial if the revised cash flows differ significantly from those of the
original arrangement, in which case the original liability is derecognised and a new financial liability is recognised. If a modification
is not substantial, the loan is remeasured using the original EIR, with any resulting gain or loss recognised in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During
2024, the Group amended the terms of its senior secured term loan; however, this was assessed under IFRS 9 and determined not to constitute
a substantial modification. Refer to Note 23 for further details.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </trib:DescriptionOfAccountingPolicyForSeniorSecuredTermLoanExplanatory>
    <trib:DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044712918">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warrants
        and loan prepayment option&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Company has issued warrants to third parties. A warrant contract might be accounted for as an equity instrument or a financial liability
under IFRS depending on the terms of a warrant. A warrant contract that will or might be settled by an entity by delivering a fixed number
of its own equity instruments, in exchange for a fixed amount of cash or another financial asset, is an equity instrument.&#160;As Perceptive
has the option to choose a cashless exercise option, the Company will have to deliver a variable number of ADS, since the number of shares
will vary depending on the ADS traded price. Even though the cashless exercise option is economically comparable to the cash exercise
option, the fact that the Company will issue a variable number of shares under the cashless exercise option results in one settlement
alternative violating the &#x2018;fixed for fixed&#x2019; requirement.&#160; The warrant contract therefore meets the definition of a financial
liability and given the value of the warrant changes in response to the price of the Company&#x2019;s ADS, with no initial investment and
settlement occurring in the future it meets the definition of a derivative liability under IFRS 9. The warrant is issued in a separate
contract, is transferable independently of the term loan and can be exercised while the term loan remains outstanding. Therefore, the
warrant is a separate instrument to the term loan.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
warrant contracts are initially recognised as a derivative liability at fair value and subsequently measured at fair value at each reporting
period with any changes recognised in the consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Company has the option to prepay the senior secured term loan in whole or in part for an amount equal to the principal, accrued interest
and prepayment premium. In accordance with IFRS 9, this option is separated from the term loan and is initially recognised as a derivative
asset at fair value and subsequently measured at fair value at each reporting period with any changes recognised in the consolidated statement
of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </trib:DescriptionOfAccountingPolicyForWarrantsAndLoanPrepaymentOptionExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044733862">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;xxiii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Convertible
        Note&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
convertible note is accounted for as a compound financial instrument containing both an equity and liability element. The convertible
note has a contractual obligation to deliver cash on redemption equal to the principal amount plus accrued interest and therefore has
a liability component in line with the definition of a financial liability in IAS 32. The convertible loan note also has a conversion
feature where it mandatorily converts into ADS if the volume weighted average price of the Company&#x2019;s ADSs is at a certain price
for any five consecutive NASDAQ trading days or any other time at the discretion of the Noteholder. Where a derivative that will or may
be settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity's own equity
instruments, the conversion feature represents an equity component of the convertible note.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
equity component is measured as the residual amount that results from deducting the fair value of the liability component from the initial
carrying amount of the instrument as a whole. There is no remeasurement of the equity element following initial recognition. The debt
component is accounted for at amortised cost employing the effective interest methodology.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;
</ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044824505">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;xxiv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Segment
        reporting&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Operating
segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating
decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as
the Board of Directors.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044907100">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;font-style:italic;width:30pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:auto"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Tax
        (current and deferred)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Income
tax on the profit or loss for the year comprises current and deferred tax. Income tax is recognised in the consolidated statement of operations
except to the extent that it relates to items recognised directly in equity, in which case it is recognised in equity.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Current
tax represents the expected tax payable or recoverable on the taxable profit for the year using tax rates enacted or substantively enacted
at the balance sheet date in the countries where the company and its subsidiaries operate and generate income and taking into account
any adjustments stemming from prior years.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred
tax is provided on the basis of the balance sheet liability method on all temporary differences at the balance sheet date which is defined
as the difference between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred tax
assets and liabilities are not subject to discounting and are measured at the tax rates that are anticipated to apply in the period in
which the asset is realised or the liability is settled based on tax rates and tax laws that have been enacted or substantively enacted
at the balance sheet date. Deferred tax assets are recognised when it is probable that future taxable profits will be available to utilize
the associated losses or temporary differences. The amount of deferred tax provided is based on the expected manner of realisation or
settlement of the carrying amount of assets and liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred
tax assets and liabilities are recognised for all temporary differences (that is, differences between the carrying amount of the asset
or liability and its tax base) with the exception of the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.55pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:24.5pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where the deferred tax liability
        arises from goodwill not deductible for tax purposes or the initial recognition of an asset or a liability in a transaction that is not
        a business combination and affects neither the accounting profit nor the taxable profit or loss at the time of the transaction; and&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.55pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:24.5pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;ii.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where, in respect of temporary
        differences associated with investments in subsidiary undertakings, the timing of the reversal of the temporary difference is subject
        to control and it is probable that the temporary difference will not reverse in the foreseeable future.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Where
goodwill is tax deductible, a deferred tax liability is not recognised on initial recognition of goodwill. It is recognised subsequently
for the taxable temporary difference which arises when the goodwill is amortised for tax with no corresponding adjustment to the carrying
value of the goodwill.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
carrying amounts of deferred tax assets are subject to review at each balance sheet date and are derecognised to the extent that future
taxable profits are considered to be inadequate to allow all or part of any deferred tax asset to be utilised.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413044936805">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxvi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Provisions&lt;/span&gt;&#160;&lt;span style="font-style:italic"&gt;and
        contingent liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A
provision is recognised in the balance sheet when the Group has a present legal or constructive obligation because of a past event, and
it is probable that an outflow of economic benefits will be required to settle the obligation. The status of any significant claim and
legal proceeding in which the Group is involved is reviewed by management on a periodic basis and the Group&#x2019;s potential financial
exposure is assessed. If the potential loss from any claim or legal proceeding is considered probable, and the amount can be reliably
estimated, a liability is recognised for the estimated loss.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Due
to the uncertainties inherent in such matters, the related provisions are based on the best information available at the time. As additional
information becomes available on pending claims, the potential liability is reassessed and revisions are made to the amounts accrued as
appropriate. Such revisions in the judgments and estimates of the potential liabilities could have an impact on the results of operations
and financial position of the Group in future accounting periods.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Provisions
for restructuring costs are recognised only when the Group has approved a detailed formal plan and has either commenced implementation
or raised a valid expectation among those affected that the restructuring will be carried out. Under IAS 37, restructuring provisions
must only include direct expenditures that are necessarily incurred by the restructuring and not associated with the ongoing activities
of the business.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinanceCostsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413045027626">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;xxvii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-style:italic"&gt;Cost
        of sales&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cost
of sales comprises product cost including manufacturing and payroll costs, quality control, shipping, handling, and packaging costs and
the cost of services provided.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForFinanceCostsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413045101541">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxviii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Finance
        income and costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Financing
expenses comprise interest costs payable on senior secured term loan, convertible note, leases and exchangeable notes along with non-recurring
financing expenses such as penalty for early settlement of term loan and loss on disposal of exchangeable notes. Interest payable on finance
leases is allocated to each period during the lease term so as to produce a constant periodic rate of interest on the remaining balance
of the liability. Financing expenses also includes the financing element of long term liabilities which have been discounted. Finance
income includes interest income on deposits and is recognised in the consolidated statement of operations as it accrues, using the effective
interest method. Finance income also includes fair value adjustments for derivative assets and liabilities related to the senior secured
term loan and to embedded derivatives associated with exchangeable notes.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413045136113">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxix)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Treasury
        shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;When
the Group purchases its&lt;span style="font-style:italic"&gt;&#160;&lt;/span&gt;own equity instruments (treasury shares), the costs, including any
directly attributable incremental costs, are deducted from equity. No gain or loss is recognised in the consolidated statement of operations
on the purchase, sale, issue or cancellation of the Group&#x2019;s own equity instruments. Any difference between the carrying amount and
the consideration, if reissued, is recognised in share premium. Voting rights related to treasury shares are nullified for the Group and
no dividends are allocated to them.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413045238925">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxx)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Equity&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share
capital represents the nominal (par) value of shares that have been issued. Share premium includes any premiums received on issue of share
capital. Any transaction costs associated with the issuing of shares are deducted from share premium, net of any related income tax benefits.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413045320705">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxxi)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Profit
        or loss from discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A
discontinued operation is a component of the Group that either has been disposed of or is classified as held for sale. Profit or loss
from discontinued operations comprises the post-tax profit or loss of discontinued operations and the post-tax gain or loss resulting
from the measurement and disposal of assets classified as held for sale and any gain or loss on disposal.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413045438839">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxxii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Fair
        values&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;For
financial reporting purposes, fair value measurements are categorized into Level&#160;1, 2 or 3 based on the degree to which inputs to
the fair value measurements are observable and the significance of the inputs to the fair value measurement in its entirety, which are
described as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Level&#160;1:
quoted prices (unadjusted) in active markets for identical assets or liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Level&#160;2:
valuation techniques for which the lowest level of inputs which have a significant effect on the recorded fair value are observable, either
directly or indirectly&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Level&#160;3:
valuation techniques for which the lowest level of inputs that have a significant effect on the recorded fair value are not based on observable
market data&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory>
    <trib:DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413045531222">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxxiii)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;New
        IFRS Standards&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
following new accounting standards and interpretations became effective for annual periods beginning on or after 1 January 2024. The adoption
of these standards did not have a material impact on the Group&#x2019;s consolidated financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Classification of Liabilities
        as Current or Non-current (Amendments to IAS 1)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Lease Liability in a Sale and
        Leaseback (Amendments to IFRS 16)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Supplier Finance Arrangements
        (Amendments to IAS 7 and IFRS 7)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
Company is currently assessing the impact of the new standards and amendments on the Company&#x2019;s accounting policy disclosure.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </trib:DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory>
    <ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413045624646">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;xxxiv)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Standards,
        amendments and interpretations to existing IFRS Standards that are not yet effective&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
standards and amendments that have been issued but are not yet effective as at the date of issuance of the financial statements, and which
may have an impact on the Group's financial statements in future periods, are listed below. The Group intends to adopt these standards,
if applicable, when they become effective:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Lack of Exchangeability (Amendments
        to IAS 21), effective from 1 January 2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Amendments to the Classification
        and Measurement of Financial Instruments (Amendments to IFRS 9 and 7), effective from 1 January 2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Annual Improvements to IFRS
        Accounting Standards, effective from 1 January 2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;IFRS 18 &#x2018;Presentation
        and Disclosure in Financial Statements&#x2019;, effective from 1 January 2027&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;IFRS 19 &#x2018;Subsidiaries
        without Public Accountability: Disclosures&#x2019;, effective from 1 January 2027&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations>
    <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20230420120204238">

&lt;div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SEGMENT INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating
segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating
decision-maker, who is responsible for allocating resources and assessing the performance of the operating segments, has been identified
as the Board of Directors. Management has determined the operating segments based on the reports reviewed by the Board of Directors, which
are used to make strategic decisions. The Board considers the business from a geographic perspective based on the Group&#x2019;s management
and internal reporting structure. Sales of product between companies in the Group are made on commercial terms which reflect the nature
of the relationship between the relevant companies. Segment results, assets and liabilities include items directly attributable to a segment
as well as those that can be allocated on a reasonable basis. Unallocated items comprise interest-bearing loans, borrowings and expenses
and corporate expenses. Segment capital expenditure is the total cost during the year to acquire segment plant, property and equipment
and intangible assets that are expected to be used for more than one period, whether acquired on acquisition of a business combination
or through acquisitions as part of the current operations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group comprises two main geographical segments (i)&#160;the Americas and (ii)&#160;Rest of World - Ireland. The Group&#x2019;s geographical
segments are determined by the location of the Group&#x2019;s assets and operations. The Group has also presented a geographical analysis
of the segmental data for Ireland as is consistent with the information used by the Board of Directors.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
reportable operating segments derive their revenue primarily from one source (i.e., the market for diagnostic tests for a range of diseases
and other medical conditions). In determining the nature of its segmentation, the Group has considered the nature of the products, their
risks and rewards, the nature of the production base, the customer base and the nature of the regulatory environment. The Group acquires,
manufactures and markets a range of diagnostic products. The Group&#x2019;s products are sold to a similar customer base and the Group&#x2019;s
products must comply with various regulators worldwide in the markets that we serve.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
following presents revenue and profit information and certain asset and liability information regarding the Group&#x2019;s geographical
segments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The distribution of revenue by geographical area
        based on location of assets was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Eliminations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue
        from external customers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;41,792&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,763&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inter-segment
        revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,815&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;702&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20,517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,607&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,465&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20,517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Eliminations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue
        from external customers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44,984&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,848&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inter-segment
        revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,867&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;872&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,739&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,851&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,720&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,739&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Eliminations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue
        from external customers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,013&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inter-segment
        revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,110&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;828&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,938&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76,618&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,841&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,938&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The distribution of revenue by customers&#x2019;
        geographical area was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,917&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32,282&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35,557&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Asia
        / Africa&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,909&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Europe
        (including Ireland) *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,863&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,641&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,563&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.55pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:12.25pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue from customers in Ireland is not disclosed
        separately due to the immateriality of these revenues.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;iii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The distribution of revenue by major product group
        was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clinical
        laboratory goods&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,372&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,288&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,036&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clinical
        laboratory services&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,750&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,272&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Point-of-care&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,433&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,091&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;iv)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The group has recognised the following amounts
        relating to revenue in the consolidated statement of operations:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue
        from contracts with customers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(v)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disaggregation of revenue from contracts with
        customers:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group derives revenue from the transfer of goods and services over time and at a point in time in the following geographical areas:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Timing
        of revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        a point in time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;41,536&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,763&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,299&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over
        time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;256&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;256&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;41,792&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,763&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Timing
        of revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        a point in time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44,692&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,848&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,540&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over
        time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44,984&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,848&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Timing
        of revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        a point in time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,174&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,013&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,187&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over
        time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,013&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(vi)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Group derives revenue from the transfer of
        goods and services over time and at a point in time based on customers&#x2019; geographical area as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Timing
        of revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Asia
        / Africa&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Europe&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        a point in time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,661&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,863&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,299&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over
        time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;256&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;256&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,917&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,863&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Timing
        of revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Asia
        / Africa&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Europe&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        a point in time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31,990&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,909&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,641&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,540&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over
        time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32,282&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,909&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,641&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Timing
        of revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Asia
        / Africa&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Europe&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        a point in time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35,223&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,563&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,187&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over
        time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35,557&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,563&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(vii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The distribution of segment results by geographical
        area was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Result
        before restructuring costs, impairment and unallocated expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,503&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,386&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(315&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,204&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Restructuring
        costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,156&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,181&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        charges&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(796&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Result
        after impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,140&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,338&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(315&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(17,793&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        expenses *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,372&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating
        loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,165&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        financing expense (Note 6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        before tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(30,730&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax credit (Note 7)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(486&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year on continuing operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(31,216&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year on discontinued operations (Note 8)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(31,789&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Result
        before restructuring costs, impairment and unallocated expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,886&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(104&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,355&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        charges&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Result
        after impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,470&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,886&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(104&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(23,460&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        expenses *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,585&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating
        loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(27,045&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        financing expense (Note 6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,882&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        before tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,927&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax charge (Note 7)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year on continuing operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,868&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Profit
        for the year on discontinued operations (Note 8)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,018&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Result
        before restructuring costs, impairment and unallocated expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,892&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,112&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,037&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,331&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,839&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Result
        after impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,223&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,620&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(16,876&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        expenses *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,473&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating
        loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        financing expense (Note 6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,431&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        before tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax credit (Note 7)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year on continuing operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43,586&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Profit
        for the year on discontinued operations (Note 8)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,577&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(41,009&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated expenses represent head office general
        and administration costs of the Group, which cannot be allocated to the results of any specific geographical area.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;viii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The distribution of segment assets and segment
        liabilities by geographical area was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        at December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Assets
        and liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32,798&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94,052&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax assets (current and deferred)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,071&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        and cash equivalents and short-term investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        assets as reported in the Group balance sheet&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;103,290&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84,863&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;48,621&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;133,546&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax liabilities (current and deferred)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,925&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        liabilities as reported in the Group balance sheet&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;138,471&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        at December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Assets
        and liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,230&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,253&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax assets (current and deferred)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,491&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        and cash equivalents and short-term investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        assets as reported in the Group balance sheet&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59,435&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,398&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31,387&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,805&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax liabilities (current and deferred)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,579&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        liabilities as reported in the Group balance sheet&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83,384&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ix)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The distribution of long-lived assets, which are
        property, plant and equipment, goodwill and intangible assets and other non-current assets (excluding deferred tax assets and derivative
        financial instruments), by geographical area was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43,504&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,448&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,943&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,793&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;58,447&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,241&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;x)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The distribution of depreciation and amortisation
        by geographical area was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;162&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;515&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;668&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,282&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;675&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;830&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,405&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortisation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;770&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;458&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;89&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;420&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,190&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;945&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;889&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;xi)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The distribution of share-based payment expense
        by geographical area was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;br/&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;br/&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;843&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,650&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;632&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;473&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;419&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;See
Note 20 for further information on share-based payments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;xii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The distribution of taxation (expense)/credit
        by geographical area was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;)&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(385&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(235&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(490&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;679&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(88&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(486&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;xiii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During 2024, 2023 and 2022 there were no customers
        generating 10% or more of total revenues.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;xiv)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The distribution of capital expenditure by geographical
        area was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:7px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:73px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37,929&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;251&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:7px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:73px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,753&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,547&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:7px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:73px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:7px;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:73px;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,682&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,798&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capital
expenditure for the year ended December 31, 2024 includes significant additions arising from the acquisitions of Waveform assets, EpiCapture
Limited, and Metabolomics Diagnostic Limited (see Note 29). In addition, capitalised development costs increased from US$1.8
million in 2023 to US$8.6
million in 2024, reflecting investment in development of newly acquired intangible assets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
    <ifrs-full:DisclosureOfGeographicalAreasExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512141235479">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Eliminations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue
        from external customers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;41,792&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,763&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inter-segment
        revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,815&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;702&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20,517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,607&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,465&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20,517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Eliminations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue
        from external customers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44,984&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,848&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inter-segment
        revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,867&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;872&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,739&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,851&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,720&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,739&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Eliminations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue
        from external customers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,013&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inter-segment
        revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,110&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;828&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,938&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76,618&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,841&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,938&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfGeographicalAreasExplanatory>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryUS"
      decimals="-3"
      id="Fxbrl_20220118215805905_33"
      unitRef="USD">41792000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118215805905_37"
      unitRef="USD">19763000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember"
      decimals="-3"
      id="Fxbrl_20220118215805905_315"
      unitRef="USD">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118215805905_319"
      unitRef="USD">61555000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:OtherRevenue
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryUS"
      decimals="-3"
      id="Fxbrl_20220118215805905_43"
      unitRef="USD">19815000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118215805905_47"
      unitRef="USD">702000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember"
      decimals="-3"
      id="Fxbrl_20220118215805905_415"
      unitRef="USD">-20517000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118215805905_419"
      unitRef="USD">0</ifrs-full:OtherRevenue>
    <ifrs-full:Revenue
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryUS"
      decimals="-3"
      id="Fxbrl_20220118215805905_63"
      unitRef="USD">61607000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118215805905_67"
      unitRef="USD">20465000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember"
      decimals="-3"
      id="Fxbrl_20240415003318431"
      unitRef="USD">-20517000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118215805905_619"
      unitRef="USD">61555000</ifrs-full:Revenue>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryUS"
      decimals="-3"
      id="Fxbrl_20220118220231323_xbrl_20220118215805905_33"
      unitRef="USD">44984000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118220231323_xbrl_20220118215805905_37"
      unitRef="USD">11848000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember"
      decimals="-3"
      id="Fxbrl_20220118220231323_xbrl_20220118215805905_315"
      unitRef="USD">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118220231323_xbrl_20220118215805905_319"
      unitRef="USD">56832000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:OtherRevenue
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryUS"
      decimals="-3"
      id="Fxbrl_20220118220231350_xbrl_20220118215805905_43"
      unitRef="USD">21867000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118220231350_xbrl_20220118215805905_47"
      unitRef="USD">872000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember"
      decimals="-3"
      id="Fxbrl_20220118220231350_xbrl_20220118215805905_415"
      unitRef="USD">-22739000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118220231350_xbrl_20220118215805905_419"
      unitRef="USD">0</ifrs-full:OtherRevenue>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryUS"
      decimals="-3"
      id="Fxbrl_20220118220231382_xbrl_20220118215805905_63"
      unitRef="USD">66851000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118220231382_xbrl_20220118215805905_67"
      unitRef="USD">12720000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember"
      decimals="-3"
      id="Fxbrl_20220118220231382_xbrl_20220118215805905_615"
      unitRef="USD">-22739000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118220231382_xbrl_20220118215805905_619"
      unitRef="USD">56832000</ifrs-full:Revenue>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryUS"
      decimals="-3"
      id="Fxbrl_20220118220403210_xbrl_20220118215805905_33"
      unitRef="USD">50508000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118220403210_xbrl_20220118215805905_37"
      unitRef="USD">12013000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember"
      decimals="-3"
      id="Fxbrl_20220118220403210_xbrl_20220118215805905_315"
      unitRef="USD">0</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118220403210_xbrl_20220118215805905_319"
      unitRef="USD">62521000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:OtherRevenue
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryUS"
      decimals="-3"
      id="Fxbrl_20220118220403239_xbrl_20220118215805905_43"
      unitRef="USD">26110000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118220403239_xbrl_20220118215805905_47"
      unitRef="USD">828000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember"
      decimals="-3"
      id="Fxbrl_20220118220403239_xbrl_20220118215805905_415"
      unitRef="USD">-26938000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118220403239_xbrl_20220118215805905_419"
      unitRef="USD">0</ifrs-full:OtherRevenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryUS"
      decimals="-3"
      id="Fxbrl_20220118220403270_xbrl_20220118215805905_63"
      unitRef="USD">76618000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118220403270_xbrl_20220118215805905_67"
      unitRef="USD">12841000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_ifrsfullEliminationOfIntersegmentAmountsMember"
      decimals="-3"
      id="Fxbrl_20220118220403270_xbrl_20220118215805905_615"
      unitRef="USD">-26938000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118220403270_xbrl_20220118215805905_619"
      unitRef="USD">62521000</ifrs-full:Revenue>
    <ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512141325139">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,917&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32,282&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35,557&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Asia
        / Africa&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,909&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Europe
        (including Ireland) *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,863&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,641&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,563&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.55pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:12.25pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue from customers in Ireland is not disclosed
        separately due to the immateriality of these revenues.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118220551225_13"
      unitRef="USD">29917000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118220551225_17"
      unitRef="USD">32282000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118220551225_111"
      unitRef="USD">35557000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember"
      decimals="-3"
      id="Fxbrl_20220118220551225_23"
      unitRef="USD">24775000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember"
      decimals="-3"
      id="Fxbrl_20220118220551225_27"
      unitRef="USD">18909000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember"
      decimals="-3"
      id="Fxbrl_20220118220551225_211"
      unitRef="USD">20401000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribEuropeIncludingIrelandMember"
      decimals="-3"
      id="Fxbrl_20220118220551225_33"
      unitRef="USD">6863000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribEuropeIncludingIrelandMember"
      decimals="-3"
      id="Fxbrl_20220118220551225_37"
      unitRef="USD">5641000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribEuropeIncludingIrelandMember"
      decimals="-3"
      id="Fxbrl_20220118220551225_311"
      unitRef="USD">6563000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118220551225_53"
      unitRef="USD">61555000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118220551225_57"
      unitRef="USD">56832000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118220551225_511"
      unitRef="USD">62521000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:DisclosureOfProductsAndServicesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512141356454">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clinical
        laboratory goods&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39,372&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,288&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,036&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clinical
        laboratory services&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,750&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,272&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Point-of-care&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,433&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,091&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfProductsAndServicesExplanatory>
    <ifrs-full:Revenue
      contextRef="C_20240101to20241231_ifrsfullProductsAndServicesAxis_tribClinicalLaboratoryMember"
      decimals="-3"
      id="Fxbrl_20220421231209911_xbrl_20220118221140215_13"
      unitRef="USD">39372000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231_ifrsfullProductsAndServicesAxis_tribClinicalLaboratoryMember"
      decimals="-3"
      id="Fxbrl_20220421231209911_xbrl_20220118221140215_17"
      unitRef="USD">42288000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231_ifrsfullProductsAndServicesAxis_tribClinicalLaboratoryMember"
      decimals="-3"
      id="Fxbrl_20220421231209911_xbrl_20220118221140215_111"
      unitRef="USD">46036000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20240101to20241231_ifrsfullProductsAndServicesAxis_tribLaboratoryServicesMember"
      decimals="-3"
      id="Fxbrl_20220421231209918_xbrl_20220118221140215_23"
      unitRef="USD">4750000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231_ifrsfullProductsAndServicesAxis_tribLaboratoryServicesMember"
      decimals="-3"
      id="Fxbrl_20220421231209918_xbrl_20220118221140215_27"
      unitRef="USD">5453000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231_ifrsfullProductsAndServicesAxis_tribLaboratoryServicesMember"
      decimals="-3"
      id="Fxbrl_20220421231209918_xbrl_20220118221140215_211"
      unitRef="USD">7272000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20240101to20241231_ifrsfullProductsAndServicesAxis_tribPointOfCareMember"
      decimals="-3"
      id="Fxbrl_20220421231209922_xbrl_20220118221140215_33"
      unitRef="USD">17433000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231_ifrsfullProductsAndServicesAxis_tribPointOfCareMember"
      decimals="-3"
      id="Fxbrl_20220421231209922_xbrl_20220118221140215_37"
      unitRef="USD">9091000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231_ifrsfullProductsAndServicesAxis_tribPointOfCareMember"
      decimals="-3"
      id="Fxbrl_20220421231209922_xbrl_20220118221140215_311"
      unitRef="USD">9213000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220421231209926_xbrl_20220118221140215_53"
      unitRef="USD">61555000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220421231209926_xbrl_20220118221140215_57"
      unitRef="USD">56832000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220421231209926_xbrl_20220118221140215_511"
      unitRef="USD">62521000</ifrs-full:Revenue>
    <trib:DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512141421351">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue
        from contracts with customers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutAmountRelatingFromRevenueExplanatory>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220421231547271_xbrl_20220118221511000_13"
      unitRef="USD">61555000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220421231547271_xbrl_20220118221511000_17"
      unitRef="USD">56832000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220421231547271_xbrl_20220118221511000_111"
      unitRef="USD">62521000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:Revenue
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220421231601331_xbrl_20220118221511000_43"
      unitRef="USD">61555000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220421231601331_xbrl_20220118221511000_47"
      unitRef="USD">56832000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220421231601331_xbrl_20220118221511000_411"
      unitRef="USD">62521000</ifrs-full:Revenue>
    <trib:DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512141501989">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Timing
        of revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        a point in time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;41,536&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,763&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,299&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over
        time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;256&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;256&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;41,792&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,763&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Timing
        of revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        a point in time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44,692&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,848&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,540&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over
        time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44,984&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,848&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Timing
        of revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        a point in time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,174&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,013&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,187&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over
        time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,013&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Timing
        of revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Asia
        / Africa&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Europe&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        a point in time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,661&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,863&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,299&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over
        time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;256&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;256&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,917&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,863&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Timing
        of revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Asia
        / Africa&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Europe&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        a point in time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31,990&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,909&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,641&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,540&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over
        time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32,282&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,909&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,641&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Timing
        of revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Asia
        / Africa&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Europe&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        a point in time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35,223&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,563&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,187&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over
        time&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35,557&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,563&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,521&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutRevenueDerivesFromTransferOfGoodsAndServicesExplanatory>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118222328207_23"
      unitRef="USD">41536000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118222328207_27"
      unitRef="USD">19763000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220118222328207_215"
      unitRef="USD">61299000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118222328207_33"
      unitRef="USD">256000</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118222328207_37"
      unitRef="USD">0</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220118222328207_315"
      unitRef="USD">256000</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118222328207_53"
      unitRef="USD">41792000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118222328207_57"
      unitRef="USD">19763000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220118222328207_515"
      unitRef="USD">61555000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118222926176_xbrl_20220118222328207_23"
      unitRef="USD">44692000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118222926176_xbrl_20220118222328207_27"
      unitRef="USD">11848000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220118222926176_xbrl_20220118222328207_215"
      unitRef="USD">56540000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118222926198_xbrl_20220118222328207_33"
      unitRef="USD">292000</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118222926198_xbrl_20220118222328207_37"
      unitRef="USD">0</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220118222926198_xbrl_20220118222328207_315"
      unitRef="USD">292000</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118222926225_xbrl_20220118222328207_53"
      unitRef="USD">44984000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118222926225_xbrl_20220118222328207_57"
      unitRef="USD">11848000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220118222926225_xbrl_20220118222328207_515"
      unitRef="USD">56832000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118223104983_xbrl_20220118222328207_23"
      unitRef="USD">50174000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118223104983_xbrl_20220118222328207_27"
      unitRef="USD">12013000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220118223104983_xbrl_20220118222328207_215"
      unitRef="USD">62187000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118223105003_xbrl_20220118222328207_33"
      unitRef="USD">334000</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118223105003_xbrl_20220118222328207_37"
      unitRef="USD">0</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220118223105003_xbrl_20220118222328207_315"
      unitRef="USD">334000</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118223105027_xbrl_20220118222328207_53"
      unitRef="USD">50508000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118223105027_xbrl_20220118222328207_57"
      unitRef="USD">12013000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220118223105027_xbrl_20220118222328207_515"
      unitRef="USD">62521000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223732981_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_23"
      unitRef="USD">29661000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223732981_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_27"
      unitRef="USD">24775000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223732981_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_211"
      unitRef="USD">6863000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223732981_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_215"
      unitRef="USD">61299000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223732986_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_33"
      unitRef="USD">256000</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223732986_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_37"
      unitRef="USD">0</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223732986_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_311"
      unitRef="USD">0</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20241231_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223732986_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_315"
      unitRef="USD">256000</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223732990_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_53"
      unitRef="USD">29917000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223732990_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_57"
      unitRef="USD">24775000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223732990_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_511"
      unitRef="USD">6863000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20241231_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223732990_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_515"
      unitRef="USD">61555000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223746781_xbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_23"
      unitRef="USD">31990000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223746781_xbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_27"
      unitRef="USD">18909000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223746781_xbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_211"
      unitRef="USD">5641000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223746781_xbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_215"
      unitRef="USD">56540000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223746785_xbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_33"
      unitRef="USD">292000</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223746785_xbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_37"
      unitRef="USD">0</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223746785_xbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_311"
      unitRef="USD">0</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20231231_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223746785_xbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_315"
      unitRef="USD">292000</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223746789_xbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_53"
      unitRef="USD">32282000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223746789_xbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_57"
      unitRef="USD">18909000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223746789_xbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_511"
      unitRef="USD">5641000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20231231_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20230420223746789_xbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_515"
      unitRef="USD">56832000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_23"
      unitRef="USD">35223000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_27"
      unitRef="USD">20401000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_211"
      unitRef="USD">6563000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:CurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20220118223629676_xbrl_20220118223232732_xbrl_20220118223104983_xbrl_20220118222328207_215"
      unitRef="USD">62187000</ifrs-full:CurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_33"
      unitRef="USD">334000</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_37"
      unitRef="USD">0</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_311"
      unitRef="USD">0</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:NoncurrentReceivablesFromContractsWithCustomers
      contextRef="C_20221231_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20220118223629697_xbrl_20220118223232753_xbrl_20220118223105003_xbrl_20220118222328207_315"
      unitRef="USD">334000</ifrs-full:NoncurrentReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_53"
      unitRef="USD">35557000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_tribAsiaOrAfricaMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_57"
      unitRef="USD">20401000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20221231_ifrsfullGeographicalAreasAxis_srtEuropeMember_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_511"
      unitRef="USD">6563000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:ReceivablesFromContractsWithCustomers
      contextRef="C_20221231_srtMajorCustomersAxis_tribCustomerMember"
      decimals="-3"
      id="Fxbrl_20220118223629723_xbrl_20220118223232780_xbrl_20220118223105027_xbrl_20220118222328207_515"
      unitRef="USD">62521000</ifrs-full:ReceivablesFromContractsWithCustomers>
    <ifrs-full:DisclosureOfOperatingSegmentsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512142457949">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Result
        before restructuring costs, impairment and unallocated expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,503&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,386&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(315&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,204&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Restructuring
        costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,156&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,181&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        charges&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(796&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Result
        after impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,140&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,338&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(315&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(17,793&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        expenses *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,372&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating
        loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,165&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        financing expense (Note 6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        before tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(30,730&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax credit (Note 7)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(486&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year on continuing operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(31,216&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year on discontinued operations (Note 8)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(31,789&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Result
        before restructuring costs, impairment and unallocated expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,886&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(104&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,355&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        charges&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Result
        after impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,470&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,886&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(104&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(23,460&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        expenses *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,585&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating
        loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(27,045&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        financing expense (Note 6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,882&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        before tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,927&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax charge (Note 7)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year on continuing operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,868&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Profit
        for the year on discontinued operations (Note 8)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,018&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year
        ended December&#160;31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Result
        before restructuring costs, impairment and unallocated expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,892&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,112&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,037&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,331&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,839&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Result
        after impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,223&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,620&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(16,876&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        expenses *&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,473&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating
        loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        financing expense (Note 6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,431&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        before tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax credit (Note 7)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year on continuing operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43,586&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Profit
        for the year on discontinued operations (Note 8)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,577&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        for the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(41,009&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated expenses represent head office general
        and administration costs of the Group, which cannot be allocated to the results of any specific geographical area.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
    <trib:ResultBeforeExceptionalExpenses
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20240414135542008_xbrl_20230413111549043"
      unitRef="USD">2503000</trib:ResultBeforeExceptionalExpenses>
    <trib:ResultBeforeExceptionalExpenses
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20240414135542008_xbrl_20230413111633962"
      unitRef="USD">9386000</trib:ResultBeforeExceptionalExpenses>
    <trib:ResultBeforeExceptionalExpenses
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20240414135542008_xbrl_20220118224340376_311"
      unitRef="USD">315000</trib:ResultBeforeExceptionalExpenses>
    <trib:ResultBeforeExceptionalExpenses
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240414135542008_xbrl_20230413111705971"
      unitRef="USD">12204000</trib:ResultBeforeExceptionalExpenses>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20250512144347433_xbrl_20240414135542008_xbrl_20230413111633962"
      unitRef="USD">-2025000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20250512144347433_xbrl_20240414135542008_xbrl_20220118224340376_311"
      unitRef="USD">-2156000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250512144347433_xbrl_20240414135542008_xbrl_20230413111705971"
      unitRef="USD">-4181000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ImpairmentLoss
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20240414135536780_xbrl_20230413111611411"
      unitRef="USD">612000</ifrs-full:ImpairmentLoss>
    <ifrs-full:ImpairmentLoss
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20240414135536780_xbrl_20220118224340376_47"
      unitRef="USD">796000</ifrs-full:ImpairmentLoss>
    <ifrs-full:ImpairmentLoss
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20240414135536780_xbrl_20220118224340376_411"
      unitRef="USD">0</ifrs-full:ImpairmentLoss>
    <ifrs-full:ImpairmentLoss
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240414135536780_xbrl_20220118224340376_415"
      unitRef="USD">1408000</ifrs-full:ImpairmentLoss>
    <trib:ResultAfterExceptionalExpenses
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20240414135445480_xbrl_20230413111622875"
      unitRef="USD">5140000</trib:ResultAfterExceptionalExpenses>
    <trib:ResultAfterExceptionalExpenses
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20240414135445480_xbrl_20230413111649747"
      unitRef="USD">12338000</trib:ResultAfterExceptionalExpenses>
    <trib:ResultAfterExceptionalExpenses
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20240414135445480_xbrl_20220118224340376_611"
      unitRef="USD">315000</trib:ResultAfterExceptionalExpenses>
    <trib:ResultAfterExceptionalExpenses
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240414135445480_xbrl_20240414135432768"
      unitRef="USD">17793000</trib:ResultAfterExceptionalExpenses>
    <trib:UnallocatedExpenses
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240413195541011"
      unitRef="USD">-3372000</trib:UnallocatedExpenses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240414135409100"
      unitRef="USD">-21165000</ifrs-full:ProfitLossFromOperatingActivities>
    <trib:FinancingIncomeBySegment
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240414135358250"
      unitRef="USD">-9565000</trib:FinancingIncomeBySegment>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240414135340664"
      unitRef="USD">-30730000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxesPaidRefund
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118224340376_1315"
      unitRef="USD">486000</ifrs-full:IncomeTaxesPaidRefund>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240414135329561"
      unitRef="USD">-31216000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118224340376_1615"
      unitRef="USD">-573000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240414135247056"
      unitRef="USD">-31789000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <trib:ResultBeforeExceptionalExpenses
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20230413111549043"
      unitRef="USD">4365000</trib:ResultBeforeExceptionalExpenses>
    <trib:ResultBeforeExceptionalExpenses
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20230413111633962"
      unitRef="USD">7886000</trib:ResultBeforeExceptionalExpenses>
    <trib:ResultBeforeExceptionalExpenses
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20220118224340376_311"
      unitRef="USD">104000</trib:ResultBeforeExceptionalExpenses>
    <trib:ResultBeforeExceptionalExpenses
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413111705971"
      unitRef="USD">12355000</trib:ResultBeforeExceptionalExpenses>
    <ifrs-full:ImpairmentLoss
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20230413111611411"
      unitRef="USD">11105000</ifrs-full:ImpairmentLoss>
    <ifrs-full:ImpairmentLoss
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118224340376_47"
      unitRef="USD">0</ifrs-full:ImpairmentLoss>
    <ifrs-full:ImpairmentLoss
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20220118224340376_411"
      unitRef="USD">0</ifrs-full:ImpairmentLoss>
    <ifrs-full:ImpairmentLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118224340376_415"
      unitRef="USD">11105000</ifrs-full:ImpairmentLoss>
    <trib:ResultAfterExceptionalExpenses
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20230413111622875"
      unitRef="USD">15470000</trib:ResultAfterExceptionalExpenses>
    <trib:ResultAfterExceptionalExpenses
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20230413111649747"
      unitRef="USD">7886000</trib:ResultAfterExceptionalExpenses>
    <trib:ResultAfterExceptionalExpenses
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20220118224340376_611"
      unitRef="USD">104000</trib:ResultAfterExceptionalExpenses>
    <trib:ResultAfterExceptionalExpenses
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240415001914388"
      unitRef="USD">23460000</trib:ResultAfterExceptionalExpenses>
    <trib:UnallocatedExpenses
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240413195556956"
      unitRef="USD">-3585000</trib:UnallocatedExpenses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240415001925332"
      unitRef="USD">-27045000</ifrs-full:ProfitLossFromOperatingActivities>
    <trib:FinancingIncomeBySegment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240415001938076"
      unitRef="USD">-9882000</trib:FinancingIncomeBySegment>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240415001952988"
      unitRef="USD">-36927000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxesPaidRefund
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240415002015799"
      unitRef="USD">59000</ifrs-full:IncomeTaxesPaidRefund>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240415002035071"
      unitRef="USD">-36868000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118230546103_xbrl_20220118224340376_1815"
      unitRef="USD">12850000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240415002113635"
      unitRef="USD">-24018000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <trib:ResultBeforeExceptionalExpenses
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20230426150951731_xbrl_20220118230545996_xbrl_20220118224340376_33"
      unitRef="USD">5892000</trib:ResultBeforeExceptionalExpenses>
    <trib:ResultBeforeExceptionalExpenses
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20230426150951731_xbrl_20220118230545996_xbrl_20220118224340376_37"
      unitRef="USD">5112000</trib:ResultBeforeExceptionalExpenses>
    <trib:ResultBeforeExceptionalExpenses
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20230426150951731_xbrl_20220118230545996_xbrl_20220118224340376_311"
      unitRef="USD">33000</trib:ResultBeforeExceptionalExpenses>
    <trib:ResultBeforeExceptionalExpenses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230426150951731_xbrl_20220118230545996_xbrl_20220118224340376_315"
      unitRef="USD">11037000</trib:ResultBeforeExceptionalExpenses>
    <ifrs-full:ImpairmentLoss
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20230426151001436_xbrl_20220118230546016_xbrl_20220118224340376_43"
      unitRef="USD">2331000</ifrs-full:ImpairmentLoss>
    <ifrs-full:ImpairmentLoss
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20230426151001436_xbrl_20230413112701323"
      unitRef="USD">3508000</ifrs-full:ImpairmentLoss>
    <ifrs-full:ImpairmentLoss
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20230426151001436_xbrl_20220118230546016_xbrl_20220118224340376_411"
      unitRef="USD">0</ifrs-full:ImpairmentLoss>
    <ifrs-full:ImpairmentLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230426151001436_xbrl_20220118230546016_xbrl_20220118224340376_415"
      unitRef="USD">5839000</ifrs-full:ImpairmentLoss>
    <trib:ResultAfterExceptionalExpenses
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20230426151012994_xbrl_20220118230546041_xbrl_20220118224340376_63"
      unitRef="USD">8223000</trib:ResultAfterExceptionalExpenses>
    <trib:ResultAfterExceptionalExpenses
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20230426151012994_xbrl_20220118230546041_xbrl_20220118224340376_67"
      unitRef="USD">8620000</trib:ResultAfterExceptionalExpenses>
    <trib:ResultAfterExceptionalExpenses
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20230426151012994_xbrl_20220118230546041_xbrl_20220118224340376_611"
      unitRef="USD">33000</trib:ResultAfterExceptionalExpenses>
    <trib:ResultAfterExceptionalExpenses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230426151012994_xbrl_20220118230546041_xbrl_20220118224340376_615"
      unitRef="USD">16876000</trib:ResultAfterExceptionalExpenses>
    <trib:UnallocatedExpenses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230426151110276_xbrl_20220118230546067_xbrl_20220118224340376_715"
      unitRef="USD">-2473000</trib:UnallocatedExpenses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230426151117428_xbrl_20220118233909154"
      unitRef="USD">-19349000</ifrs-full:ProfitLossFromOperatingActivities>
    <trib:FinancingIncomeBySegment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230426151126699_xbrl_20220118230546074_xbrl_20220118224340376_1015"
      unitRef="USD">-24431000</trib:FinancingIncomeBySegment>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230426151133868_xbrl_20220118230546081_xbrl_20220118224340376_1215"
      unitRef="USD">-43780000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxesPaidRefund
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230426151146427_xbrl_20220118230546087_xbrl_20220118224340376_1315"
      unitRef="USD">194000</ifrs-full:IncomeTaxesPaidRefund>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230426151157267_xbrl_20220118230546095_xbrl_20220118224340376_1515"
      unitRef="USD">-43586000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230426151208799_xbrl_20220327021944791"
      unitRef="USD">2577000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230426151216119_xbrl_20220118230546103_xbrl_20220118224340376_1815"
      unitRef="USD">-41009000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <trib:DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512141741987">

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        at December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Assets
        and liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32,798&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61,254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94,052&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax assets (current and deferred)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,071&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        and cash equivalents and short-term investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        assets as reported in the Group balance sheet&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;103,290&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84,863&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;48,621&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;133,546&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax liabilities (current and deferred)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,925&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        liabilities as reported in the Group balance sheet&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;138,471&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        at December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Assets
        and liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,230&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,253&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax assets (current and deferred)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,491&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        and cash equivalents and short-term investments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        assets as reported in the Group balance sheet&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59,435&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,398&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31,387&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,805&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unallocated
        liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
        tax liabilities (current and deferred)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,579&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        liabilities as reported in the Group balance sheet&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83,384&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutSegmentAssetsAndSegmentLiabilitiesByGeographicalAreaExplanatory>
    <trib:SegmentAssets
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118235330519_43"
      unitRef="USD">32798000</trib:SegmentAssets>
    <trib:SegmentAssets
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118235330519_47"
      unitRef="USD">61254000</trib:SegmentAssets>
    <trib:SegmentAssets
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20220118235330519_411"
      unitRef="USD">0</trib:SegmentAssets>
    <trib:SegmentAssets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220118235330519_415"
      unitRef="USD">94052000</trib:SegmentAssets>
    <trib:IncomeTaxAssetsCurrentAndDeferred
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220118235330519_615"
      unitRef="USD">4071000</trib:IncomeTaxAssetsCurrentAndDeferred>
    <trib:CashAndCashEquivalentsAndShortTermInvestments
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220118235330519_715"
      unitRef="USD">5167000</trib:CashAndCashEquivalentsAndShortTermInvestments>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220118235330519_915"
      unitRef="USD">103290000</ifrs-full:NetDeferredTaxAssets>
    <trib:SegmentLiabilities
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118235330519_113"
      unitRef="USD">84863000</trib:SegmentLiabilities>
    <trib:SegmentLiabilities
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118235330519_117"
      unitRef="USD">48621000</trib:SegmentLiabilities>
    <trib:SegmentLiabilities
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20220118235330519_1111"
      unitRef="USD">62000</trib:SegmentLiabilities>
    <trib:SegmentLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220118235330519_1115"
      unitRef="USD">133546000</trib:SegmentLiabilities>
    <trib:IncomeTaxLiabilitiesCurrentAndDeferred
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220118235330519_1315"
      unitRef="USD">4925000</trib:IncomeTaxLiabilitiesCurrentAndDeferred>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220118235330519_1515"
      unitRef="USD">138471000</ifrs-full:NetDeferredTaxLiabilities>
    <trib:SegmentAssets
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119004658693_xbrl_20220118235330519_43"
      unitRef="USD">26230000</trib:SegmentAssets>
    <trib:SegmentAssets
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119004658693_xbrl_20220118235330519_47"
      unitRef="USD">26023000</trib:SegmentAssets>
    <trib:SegmentAssets
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20220119004658693_xbrl_20220118235330519_411"
      unitRef="USD">0</trib:SegmentAssets>
    <trib:SegmentAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119004658693_xbrl_20220118235330519_415"
      unitRef="USD">52253000</trib:SegmentAssets>
    <trib:IncomeTaxAssetsCurrentAndDeferred
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119004658715_xbrl_20220118235330519_615"
      unitRef="USD">3491000</trib:IncomeTaxAssetsCurrentAndDeferred>
    <trib:CashAndCashEquivalentsAndShortTermInvestments
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119004658722_xbrl_20220118235330519_715"
      unitRef="USD">3691000</trib:CashAndCashEquivalentsAndShortTermInvestments>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119004658729_xbrl_20220118235330519_915"
      unitRef="USD">59435000</ifrs-full:NetDeferredTaxAssets>
    <trib:SegmentLiabilities
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119004756266_xbrl_20220118235330519_113"
      unitRef="USD">49398000</trib:SegmentLiabilities>
    <trib:SegmentLiabilities
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119004756266_xbrl_20220118235330519_117"
      unitRef="USD">31387000</trib:SegmentLiabilities>
    <trib:SegmentLiabilities
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20220119004756266_xbrl_20220118235330519_1111"
      unitRef="USD">20000</trib:SegmentLiabilities>
    <trib:SegmentLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119004756266_xbrl_20220118235330519_1115"
      unitRef="USD">80805000</trib:SegmentLiabilities>
    <trib:IncomeTaxLiabilitiesCurrentAndDeferred
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119004658737_xbrl_20220118235330519_1315"
      unitRef="USD">2579000</trib:IncomeTaxLiabilitiesCurrentAndDeferred>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119004658745_xbrl_20220118235330519_1515"
      unitRef="USD">83384000</ifrs-full:NetDeferredTaxLiabilities>
    <trib:DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512142048020">

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43,504&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,448&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,943&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,793&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;58,447&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,241&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutLongLivedAssetsExplanatory>
    <trib:LongLivedAsstesBySegment
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119004904694_13"
      unitRef="USD">43504000</trib:LongLivedAsstesBySegment>
    <trib:LongLivedAsstesBySegment
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119004904694_17"
      unitRef="USD">12448000</trib:LongLivedAsstesBySegment>
    <trib:LongLivedAsstesBySegment
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119004904694_23"
      unitRef="USD">14943000</trib:LongLivedAsstesBySegment>
    <trib:LongLivedAsstesBySegment
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119004904694_27"
      unitRef="USD">5793000</trib:LongLivedAsstesBySegment>
    <trib:LongLivedAsstesBySegment
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220119004904694_43"
      unitRef="USD">58447000</trib:LongLivedAsstesBySegment>
    <trib:LongLivedAsstesBySegment
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119004904694_47"
      unitRef="USD">18241000</trib:LongLivedAsstesBySegment>
    <trib:DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512142007573">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;162&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;515&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;668&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,282&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;675&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;830&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,405&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortisation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;770&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;458&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;89&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;420&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,190&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;945&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;889&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutDepreciationAndAmortisationExplanatory>
    <ifrs-full:DepreciationExpense
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119005128190_23"
      unitRef="USD">160000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119005128190_27"
      unitRef="USD">162000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119005128190_211"
      unitRef="USD">123000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119005128190_33"
      unitRef="USD">515000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119005128190_37"
      unitRef="USD">668000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119005128190_311"
      unitRef="USD">1282000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220119005128190_53"
      unitRef="USD">675000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220119005128190_57"
      unitRef="USD">830000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220119005128190_511"
      unitRef="USD">1405000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119005128190_73"
      unitRef="USD">770000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119005128190_77"
      unitRef="USD">458000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119005128190_711"
      unitRef="USD">89000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119005128190_83"
      unitRef="USD">420000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119005128190_87"
      unitRef="USD">487000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119005128190_811"
      unitRef="USD">800000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220119005128190_103"
      unitRef="USD">1190000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220119005128190_107"
      unitRef="USD">945000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220119005128190_1011"
      unitRef="USD">889000</ifrs-full:AmortisationExpense>
    <trib:ScheduleOfShareBasedPaymentExpenseByGeographicalArea
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512141923531">

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;br/&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;br/&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;843&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,650&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;632&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;473&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;419&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </trib:ScheduleOfShareBasedPaymentExpenseByGeographicalArea>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119005502995_13"
      unitRef="USD">843000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119005502995_17"
      unitRef="USD">1650000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119005502995_111"
      unitRef="USD">632000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119005502995_23"
      unitRef="USD">473000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119005502995_27"
      unitRef="USD">419000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119005502995_211"
      unitRef="USD">1123000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220119005502995_43"
      unitRef="USD">1316000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220119005502995_47"
      unitRef="USD">2069000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220119005502995_411"
      unitRef="USD">1755000</ifrs-full:AdjustmentsForSharebasedPayments>
    <trib:DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512141852492">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;)&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(385&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(235&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(490&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;679&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(88&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(486&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutTaxationExpenseExplanatory>
    <trib:IncomeTaxExpense
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20250514163005408"
      unitRef="USD">-5000</trib:IncomeTaxExpense>
    <trib:IncomeTaxExpense
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119012342054_17"
      unitRef="USD">-385000</trib:IncomeTaxExpense>
    <trib:IncomeTaxExpense
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119012342054_111"
      unitRef="USD">286000</trib:IncomeTaxExpense>
    <trib:IncomeTaxExpense
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20240427023227523"
      unitRef="USD">9000</trib:IncomeTaxExpense>
    <trib:IncomeTaxExpense
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20220326204428595_xbrl_20220119012342054_27"
      unitRef="USD">-235000</trib:IncomeTaxExpense>
    <trib:IncomeTaxExpense
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="-3"
      id="Fxbrl_20230413120038463"
      unitRef="USD">-4000</trib:IncomeTaxExpense>
    <trib:IncomeTaxExpense
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119012342054_33"
      unitRef="USD">-490000</trib:IncomeTaxExpense>
    <trib:IncomeTaxExpense
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20230413120021632"
      unitRef="USD">679000</trib:IncomeTaxExpense>
    <trib:IncomeTaxExpense
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119012342054_311"
      unitRef="USD">-88000</trib:IncomeTaxExpense>
    <trib:IncomeTaxExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220119012342054_53"
      unitRef="USD">-486000</trib:IncomeTaxExpense>
    <trib:IncomeTaxExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220119012342054_57"
      unitRef="USD">59000</trib:IncomeTaxExpense>
    <trib:IncomeTaxExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220119012342054_511"
      unitRef="USD">194000</trib:IncomeTaxExpense>
    <trib:DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512141826219">

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:7px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:73px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37,929&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;251&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:7px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:73px;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,753&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,547&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:7px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:73px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:7px;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:73px;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,682&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,798&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutCapitalExpenditureExplanatory>
    <ifrs-full:PaymentsForDevelopmentProjectExpenditure
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119012714732_13"
      unitRef="USD">37929000</ifrs-full:PaymentsForDevelopmentProjectExpenditure>
    <ifrs-full:PaymentsForDevelopmentProjectExpenditure
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220119012714732_17"
      unitRef="USD">251000</ifrs-full:PaymentsForDevelopmentProjectExpenditure>
    <ifrs-full:PaymentsForDevelopmentProjectExpenditure
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119012714732_33"
      unitRef="USD">2753000</ifrs-full:PaymentsForDevelopmentProjectExpenditure>
    <ifrs-full:PaymentsForDevelopmentProjectExpenditure
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220119012714732_37"
      unitRef="USD">2547000</ifrs-full:PaymentsForDevelopmentProjectExpenditure>
    <ifrs-full:PaymentsForDevelopmentProjectExpenditure
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220119012714732_53"
      unitRef="USD">40682000</ifrs-full:PaymentsForDevelopmentProjectExpenditure>
    <ifrs-full:PaymentsForDevelopmentProjectExpenditure
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220119012714732_57"
      unitRef="USD">2798000</ifrs-full:PaymentsForDevelopmentProjectExpenditure>
    <trib:CapitalisedDevelopmentCost
      contextRef="C_20230101to20231231"
      decimals="-5"
      id="Fxbrl_20250512145309994"
      unitRef="USD">1800000</trib:CapitalisedDevelopmentCost>
    <trib:CapitalisedDevelopmentCost
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20250512145321997"
      unitRef="USD">8600000</trib:CapitalisedDevelopmentCost>
    <ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240412203235960">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;EMPLOYMENT&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
average number of persons employed by the Group in continuing operations is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research
        and development&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Administration
        and sales&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;82&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacturing
        and quality&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;258&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;253&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;380&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;384&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-indent:-30.6pt;margin-left:61.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
average number of employees, including discontinued operations, was 401
(2023: 383;
2022: 398).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-indent:-30.6pt;margin-left:61.2pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-indent:-30.6pt;margin-left:61.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employment
costs charged in the consolidated statement of operations for continuing operations are analysed as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Wages
        and salaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,570&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23,718&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22,364&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Social
        welfare costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,061&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,965&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pension
        costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;451&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;347&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based
        payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Restructuring
        cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;485&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30,152&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,841&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,705&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employment
costs are shown net of capitalisations and Irish government wage subsidies. There were no Irish government wage subsidies netted against
employment costs in the year ended December 31, 2024.&#160; Total employment costs, inclusive of amounts capitalised for wages and salaries,
social welfare costs and pension costs, for the year ended December&#160;31, 2024, amounted to US$33,584,000
(2023: US$29,975,000)
(2022: US$27,528,000).
Total share-based payments in the balance sheet amounted to US$1,316,000
for the year ended December&#160;31, 2024 (2023: US$2,069,000)
(2022: US$1,755,000).
See Note 20 for further details.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employment
costs including discontinued operations, are analysed as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Wages
        and salaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,570&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,343&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23,608&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Social
        welfare costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,097&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,036&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pension
        costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;451&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;510&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;352&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based
        payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Restructuring
        cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;485&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30,152&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,504&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group operates defined contribution pension schemes for certain of its full-time employees. The benefits under these schemes are financed
by both Group and employee contributions. Total contributions made by the Group in the financial year and charged against income in respect
of continuing operations amounted to US$451,000
(2023: US$508,000)
(2022: US$347,000).
The pension accrual for the Group at December&#160;31, 2024 was US$nil
(2023: US$56,000)
(2022: US$44,000).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory>
    <ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240412194520992">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research
        and development&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Administration
        and sales&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;82&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacturing
        and quality&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;258&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;253&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;380&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;384&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; </ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="C_20240101to20241231_ifrsfullDefinedBenefitPlansAxis_tribResearchAndDevelopmentMember"
      decimals="0"
      id="Fxbrl_20220114161829123_13"
      unitRef="Employee">33</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="C_20230101to20231231_ifrsfullDefinedBenefitPlansAxis_tribResearchAndDevelopmentMember"
      decimals="0"
      id="Fxbrl_20220114161829123_17"
      unitRef="Employee">23</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="C_20220101to20221231_ifrsfullDefinedBenefitPlansAxis_tribResearchAndDevelopmentMember"
      decimals="0"
      id="Fxbrl_20220114161829123_111"
      unitRef="Employee">26</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="C_20240101to20241231_ifrsfullDefinedBenefitPlansAxis_tribAdministrationAndSalesMember"
      decimals="0"
      id="Fxbrl_20220114161829123_23"
      unitRef="Employee">82</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="C_20230101to20231231_ifrsfullDefinedBenefitPlansAxis_tribAdministrationAndSalesMember"
      decimals="0"
      id="Fxbrl_20220114161829123_27"
      unitRef="Employee">99</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="C_20220101to20221231_ifrsfullDefinedBenefitPlansAxis_tribAdministrationAndSalesMember"
      decimals="0"
      id="Fxbrl_20220114161829123_211"
      unitRef="Employee">105</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="C_20240101to20241231_ifrsfullDefinedBenefitPlansAxis_tribManufacturingAndQualityMember"
      decimals="0"
      id="Fxbrl_20220114161829123_33"
      unitRef="Employee">286</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="C_20230101to20231231_ifrsfullDefinedBenefitPlansAxis_tribManufacturingAndQualityMember"
      decimals="0"
      id="Fxbrl_20220114161829123_37"
      unitRef="Employee">258</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="C_20220101to20221231_ifrsfullDefinedBenefitPlansAxis_tribManufacturingAndQualityMember"
      decimals="0"
      id="Fxbrl_20220114161829123_311"
      unitRef="Employee">253</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="C_20240101to20241231"
      decimals="0"
      id="Fxbrl_20220114161829123_53"
      unitRef="Employee">401</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20220114161829123_57"
      unitRef="Employee">380</ifrs-full:AverageNumberOfEmployees>
    <ifrs-full:AverageNumberOfEmployees
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20220114161829123_511"
      unitRef="Employee">384</ifrs-full:AverageNumberOfEmployees>
    <trib:AverageNumberOfEmployeesIncludingDiscontinuedOperations
      contextRef="C_20240101to20241231"
      decimals="0"
      id="Fxbrl_20240412202305296"
      unitRef="Employee">401</trib:AverageNumberOfEmployeesIncludingDiscontinuedOperations>
    <trib:AverageNumberOfEmployeesIncludingDiscontinuedOperations
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20240412202320746"
      unitRef="Employee">383</trib:AverageNumberOfEmployeesIncludingDiscontinuedOperations>
    <trib:AverageNumberOfEmployeesIncludingDiscontinuedOperations
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20240412202342512"
      unitRef="Employee">398</trib:AverageNumberOfEmployeesIncludingDiscontinuedOperations>
    <ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240412194638273">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Wages
        and salaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,570&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23,718&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22,364&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Social
        welfare costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,061&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,965&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pension
        costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;451&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;347&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based
        payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Restructuring
        cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;485&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30,152&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,841&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,705&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; </ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory>
    <ifrs-full:WagesAndSalaries
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240412201956808_13"
      unitRef="USD">25570000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240412201956808_17"
      unitRef="USD">23718000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240412201956808_111"
      unitRef="USD">22364000</ifrs-full:WagesAndSalaries>
    <ifrs-full:SocialSecurityContributions
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240412201956808_23"
      unitRef="USD">2219000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:SocialSecurityContributions
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240412201956808_27"
      unitRef="USD">2061000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:SocialSecurityContributions
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240412201956808_211"
      unitRef="USD">1965000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240412201956808_33"
      unitRef="USD">451000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240412201956808_37"
      unitRef="USD">508000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240412201956808_311"
      unitRef="USD">347000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240412201956808_43"
      unitRef="USD">1316000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240412201956808_47"
      unitRef="USD">2069000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240412201956808_411"
      unitRef="USD">1755000</ifrs-full:AdjustmentsForSharebasedPayments>
    <trib:ExpenseOfRestructuringCost
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240412201956808_53"
      unitRef="USD">596000</trib:ExpenseOfRestructuringCost>
    <trib:ExpenseOfRestructuringCost
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240412201956808_57"
      unitRef="USD">485000</trib:ExpenseOfRestructuringCost>
    <trib:ExpenseOfRestructuringCost
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240412201956808_511"
      unitRef="USD">274000</trib:ExpenseOfRestructuringCost>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240412201956808_73"
      unitRef="USD">30152000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240412201956808_77"
      unitRef="USD">28841000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240412201956808_711"
      unitRef="USD">26705000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250513134643533"
      unitRef="USD">33584000</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250513134703328"
      unitRef="USD">29975000</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250513134713474"
      unitRef="USD">27528000</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <trib:IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250513134747596"
      unitRef="USD">1316000</trib:IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised>
    <trib:IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250513134757648"
      unitRef="USD">2069000</trib:IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised>
    <trib:IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250513134809707"
      unitRef="USD">1755000</trib:IncreaseDecreaseThroughSharebasedPaymentTransactionsInclusiveOfAmountsCapitalised>
    <ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory
      contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      id="Fxbrl_20240412204106528">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Wages
        and salaries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,570&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,343&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23,608&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Social
        welfare costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,097&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,036&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pension
        costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;451&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;510&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;352&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based
        payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Restructuring
        cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;485&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30,152&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,504&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; </ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory>
    <ifrs-full:WagesAndSalaries
      contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203641928_xbrl_20240412201956808_13"
      unitRef="USD">25570000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203641928_xbrl_20240412201956808_17"
      unitRef="USD">24343000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203641928_xbrl_20240412201956808_111"
      unitRef="USD">23608000</ifrs-full:WagesAndSalaries>
    <ifrs-full:SocialSecurityContributions
      contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203710128_xbrl_20240412201956808_23"
      unitRef="USD">2219000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:SocialSecurityContributions
      contextRef="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203710128_xbrl_20240412201956808_27"
      unitRef="USD">2097000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:SocialSecurityContributions
      contextRef="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203710128_xbrl_20240412201956808_211"
      unitRef="USD">2036000</ifrs-full:SocialSecurityContributions>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203749720_xbrl_20240412201956808_33"
      unitRef="USD">451000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203749720_xbrl_20240412201956808_37"
      unitRef="USD">510000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans
      contextRef="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203749720_xbrl_20240412201956808_311"
      unitRef="USD">352000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203756038_xbrl_20240412201956808_43"
      unitRef="USD">1316000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203756038_xbrl_20240412201956808_47"
      unitRef="USD">2069000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203756038_xbrl_20240412201956808_411"
      unitRef="USD">1755000</ifrs-full:AdjustmentsForSharebasedPayments>
    <trib:ExpenseOfRestructuringCost
      contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203803151_xbrl_20240412201956808_53"
      unitRef="USD">596000</trib:ExpenseOfRestructuringCost>
    <trib:ExpenseOfRestructuringCost
      contextRef="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203803151_xbrl_20240412201956808_57"
      unitRef="USD">485000</trib:ExpenseOfRestructuringCost>
    <trib:ExpenseOfRestructuringCost
      contextRef="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203803151_xbrl_20240412201956808_511"
      unitRef="USD">274000</trib:ExpenseOfRestructuringCost>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="C_20240101to20241231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203809191_xbrl_20240412201956808_73"
      unitRef="USD">30152000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="C_20230101to20231231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203809191_xbrl_20240412201956808_77"
      unitRef="USD">29504000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="C_20220101to20221231_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember"
      decimals="-3"
      id="Fxbrl_20240412203809191_xbrl_20240412201956808_711"
      unitRef="USD">28025000</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250513134904818"
      unitRef="USD">451000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250513134912549"
      unitRef="USD">508000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250513134921859"
      unitRef="USD">347000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <trib:ActuarialAssumptionOfExpectedPensionIncreases
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220326133106202"
      unitRef="USD">0</trib:ActuarialAssumptionOfExpectedPensionIncreases>
    <trib:ActuarialAssumptionOfExpectedPensionIncreases
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250513134932045"
      unitRef="USD">56000</trib:ActuarialAssumptionOfExpectedPensionIncreases>
    <trib:ActuarialAssumptionOfExpectedPensionIncreases
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250513134940611"
      unitRef="USD">44000</trib:ActuarialAssumptionOfExpectedPensionIncreases>
    <ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220114163453082">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;OTHER OPERATING (EXPENSE) / INCOME&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;138&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rental
        income from premises&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government
        supports&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,827&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government
        grants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;333&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,787&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;141&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;343&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
other income for year ended December 31, 2024 relates to income from a transition services agreement with the acquirers of Fitzgerald
Industries for the provision of bookkeeping and I.T. services.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
October 2024, the Company was notified that it is the subject of a U.S. Department of Justice (DOJ) investigation relating to second-round
Paycheck Protection Program (PPP) loans received by certain U.S. subsidiaries. At year-end, a payable of US$2,165,000
was recognised, covering the US$1,827,000
in loans and estimated interest of US$338,000.
As the original loan income was recognised in other operating income, the reversal to the extent of the loan to be repaid has been recorded
as a corresponding charge to other operating (expense)/income, noted as &#x201c;Government supports&#x201d;. The interest costs incidental
to the loan repayment has been charged to finance costs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory>
    <ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220114163521142">

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;138&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rental
        income from premises&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government
        supports&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,827&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government
        grants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;333&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,787&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;141&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;343&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory>
    <ifrs-full:OtherIncome
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114164626134_23"
      unitRef="USD">40000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114164626134_27"
      unitRef="USD">138000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114164626134_211"
      unitRef="USD">0</ifrs-full:OtherIncome>
    <trib:RentalIncomeFromPremises
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114164626134_33"
      unitRef="USD">0</trib:RentalIncomeFromPremises>
    <trib:RentalIncomeFromPremises
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114164626134_37"
      unitRef="USD">3000</trib:RentalIncomeFromPremises>
    <trib:RentalIncomeFromPremises
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114164626134_311"
      unitRef="USD">3000</trib:RentalIncomeFromPremises>
    <trib:GovernmentSupportsCovid19
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114164626134_13"
      unitRef="USD">-1827000</trib:GovernmentSupportsCovid19>
    <trib:GovernmentSupportsCovid19
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114164626134_17"
      unitRef="USD">0</trib:GovernmentSupportsCovid19>
    <trib:GovernmentSupportsCovid19
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114164626134_111"
      unitRef="USD">7000</trib:GovernmentSupportsCovid19>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413124458163"
      unitRef="USD">0</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413124512509"
      unitRef="USD">0</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413124938769"
      unitRef="USD">333000</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114164626134_53"
      unitRef="USD">-1787000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114164626134_57"
      unitRef="USD">141000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114164626134_511"
      unitRef="USD">343000</ifrs-full:OtherOperatingIncomeExpense>
    <trib:LoanIncome
      contextRef="C_20241031_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribPaycheckProtectionProgramLoanMember"
      decimals="0"
      id="Fxbrl_20250512163402997"
      unitRef="USD">2165000</trib:LoanIncome>
    <ifrs-full:LoansPayableInDefault
      contextRef="C_20241031_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribPaycheckProtectionProgramLoanMember"
      decimals="0"
      id="Fxbrl_20250512163419692"
      unitRef="USD">1827000</ifrs-full:LoansPayableInDefault>
    <ifrs-full:InterestPayable
      contextRef="C_20241031_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribPaycheckProtectionProgramLoanMember"
      decimals="0"
      id="Fxbrl_20250512163446548"
      unitRef="USD">338000</ifrs-full:InterestPayable>
    <ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240412205107919">

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IMPAIRMENT, RESTRUCTURING AND ONCE OFF COSTS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Impairment
charges&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
accordance with IAS 36, &lt;span style="font-style:italic"&gt;Impairment of Assets&lt;/span&gt;, the Company&#160;carries out periodic impairment
reviews of the asset valuations. A number of factors impacted this calculation including the Company&#x2019;s market capitalization during
the year ended December 31 2024, the cost of capital, cash flow projections and net asset values across each of the Company&#x2019;s cash-generating
units.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
impact of the above items on the consolidated statement of operations for the year ended December 31, 2024, 2023, and 2022 are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Selling,
        general&#160;&amp;amp; administration expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        of PP&amp;amp;E (Note 11)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,772&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;733&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        of goodwill and other intangible&#160;assets (Note 12)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,624&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        of prepayments (Note 17)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;482&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(Reversal)/Impairment
        of financial assets (Note 13)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        impairment loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,839&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Restructuring
costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
the year ended December 31, 2024, the Group undertook a comprehensive business transformation program aimed at improving long-term operational
efficiency and aligning the organization with its strategic priorities. These changes were previously communicated to the market and include
operationally profitability measures, organizational realignment, and changes to business unit structures.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
a result, the Group recognized restructuring costs of US$4.2
million (2023: US$nil)
(2022: US$nil)
which are presented separately in the consolidated statement of operations within &#x2018;Selling, general and administrative expenses
&#x2013; Restructuring costs&#x2019;.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
restructuring costs incurred during the year comprised the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Nature
        of cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Personnel
        related costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,216&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outsourcing
        costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;754&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Site
        transfer costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,281&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory
        related costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;772&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        restructuring costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;158&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        restructuring costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,181&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Included
within Site transfer costs above is US$356,000
related to the impairment of plant &amp;amp; equipment arising as part of the restructuring program. Refer to Note 11. We have provided for
additional restructuring costs of US$1.6
million as at December 31, 2024 (see Note 22).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Once
off costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
the year ended 31 December 2024, the Company&#160;incurred exceptional, non-trading costs totaling US$1.9
million, which is made up as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
October 2024, the Company issued 650,000
American Depositary Shares (&#x201c;ADSs&#x201d;) to a corporate finance advisor as a non-refundable retainer fee in respect of advisory
services provided in connection with a planned future equity raise. The fair value of the ADSs issued, amounting to US$1.1
million, was recognized directly in equity, with a corresponding charge recorded within the consolidated statement of operations as an
exceptional cost.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
the year, the Company&#160;recognized a provision of US$0.7
million in respect of a legacy matter currently subject to resolution. Owing to the sensitive nature of ongoing discussions, further disclosure
has been withheld in accordance with IAS 37.92, as the Directors believe such disclosure could seriously prejudice the Company&#x2019;s
position.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfImpairmentOfAssetsExplanatory>
    <trib:DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240412205129312">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Selling,
        general&#160;&amp;amp; administration expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        of PP&amp;amp;E (Note 11)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,772&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;733&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        of goodwill and other intangible&#160;assets (Note 12)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,624&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        of prepayments (Note 17)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;482&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(Reversal)/Impairment
        of financial assets (Note 13)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        impairment loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,839&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutImpairmentChargesAndInventoryProvisioningExplanatory>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114174152778_43"
      unitRef="USD">612000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114174152778_47"
      unitRef="USD">3772000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114174152778_411"
      unitRef="USD">733000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240412205232256"
      unitRef="USD">1596000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114174152778_57"
      unitRef="USD">5833000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114174152778_511"
      unitRef="USD">4624000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
    <trib:ImpairmentOfPrepayments
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114174152778_63"
      unitRef="USD">0</trib:ImpairmentOfPrepayments>
    <trib:ImpairmentOfPrepayments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114174152778_67"
      unitRef="USD">0</trib:ImpairmentOfPrepayments>
    <trib:ImpairmentOfPrepayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114174152778_611"
      unitRef="USD">482000</trib:ImpairmentOfPrepayments>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240412205448487_xbrl_20240412205232256"
      unitRef="USD">-800000</ifrs-full:ImpairmentLossOnFinancialAssets>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240412205448487_xbrl_20220114174152778_57"
      unitRef="USD">1500000</ifrs-full:ImpairmentLossOnFinancialAssets>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240412205448487_xbrl_20220114174152778_511"
      unitRef="USD">0</ifrs-full:ImpairmentLossOnFinancialAssets>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114174152778_83"
      unitRef="USD">1408000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114174152778_87"
      unitRef="USD">11105000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114174152778_811"
      unitRef="USD">5839000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <trib:RestructuringActivitiesExpense
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20250512221619462"
      unitRef="USD">4200000</trib:RestructuringActivitiesExpense>
    <trib:RestructuringActivitiesExpense
      contextRef="C_20230101to20231231"
      decimals="-6"
      id="Fxbrl_20250512221627665"
      unitRef="USD">0</trib:RestructuringActivitiesExpense>
    <trib:RestructuringActivitiesExpense
      contextRef="C_20220101to20221231"
      decimals="-6"
      id="Fxbrl_20250512221650787"
      unitRef="USD">0</trib:RestructuringActivitiesExpense>
    <ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512201859513">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Nature
        of cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Personnel
        related costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,216&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outsourcing
        costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;754&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Site
        transfer costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,281&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory
        related costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;772&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        restructuring costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;158&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        restructuring costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,181&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribPersonnelRelatedCostsMember"
      decimals="-3"
      id="Fxbrl_20250512201922084_43"
      unitRef="USD">-1216000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribOutsourcingCostsMember"
      decimals="-3"
      id="Fxbrl_20250512201922084_53"
      unitRef="USD">-754000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsMember"
      decimals="-3"
      id="Fxbrl_20250512201922084_63"
      unitRef="USD">-1281000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribInventoryRelatedCostsMember"
      decimals="-3"
      id="Fxbrl_20250512201922084_73"
      unitRef="USD">-772000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribOtherRestructuringCostsMember"
      decimals="-3"
      id="Fxbrl_20250512201922084_83"
      unitRef="USD">-158000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250512201922084_103"
      unitRef="USD">-4181000</ifrs-full:ExpenseOfRestructuringActivities>
    <trib:RestructuringActivitiesExpense
      contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember"
      decimals="-3"
      id="Fxbrl_20250513162352083"
      unitRef="USD">356000</trib:RestructuringActivitiesExpense>
    <trib:AdditionalRestructuringCosts
      contextRef="C_20240101to20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember"
      decimals="-5"
      id="Fxbrl_20250513153245351"
      unitRef="USD">1600000</trib:AdditionalRestructuringCosts>
    <trib:NonRadingCosts
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20250513153550995"
      unitRef="USD">1900000</trib:NonRadingCosts>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20241031_ifrsfullUnderlyingEquityInstrumentAndDepositaryReceiptsAxis_tribAmericanDepositarySharesMember"
      decimals="INF"
      id="Fxbrl_20250513162424475"
      unitRef="Shares">650000</ifrs-full:NumberOfSharesIssued>
    <trib:FairValueOfSharesIssued
      contextRef="C_20241001to20241031_ifrsfullUnderlyingEquityInstrumentAndDepositaryReceiptsAxis_tribAmericanDepositarySharesMember"
      decimals="-5"
      id="Fxbrl_20250512222356490"
      unitRef="USD">1100000</trib:FairValueOfSharesIssued>
    <ifrs-full:LegalProceedingsProvision
      contextRef="C_20241231"
      decimals="-5"
      id="Fxbrl_20250512221823047"
      unitRef="USD">700000</ifrs-full:LegalProceedingsProvision>
    <ifrs-full:DisclosureOfFinanceIncomeExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512154159461">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;FINANCIAL INCOME AND EXPENSES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        income:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        financial income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        expense:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest
        on leases (Note 24)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(592&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(624&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(647&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        on disposal of exchangeable notes (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,678&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Penalty
        for early partial settlement of senior secured term loan (Note 23,28)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(905&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,450&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        interest payable on senior secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,289&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,039&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        interest payable on convertible note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(300&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(300&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(199&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        interest on exchangeable notes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        interest payable on PPP loans (Note 4)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(338&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        interest on exchangeable notes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        interest on senior secured term loan (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,355&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,131&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,772&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        interest on convertible note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(859&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(796&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(495&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        financial expense&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,172&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unwinding
        of discount on deferred contingent consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capitalisation
        of borrowing costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,085&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        loan modification gain (Note 23,28)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,567&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capitalisation
        of unpaid interest on term loan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,247&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,053&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,734&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        financing expense&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,882&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,431&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For
more information on the senior secured term loan, convertible note and exchangeable notes, refer to Note 23 Interest-Bearing Loans and
Borrowings.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
financial expense relates to the fair value loss on warrant liabilities during the year. Refer to Note 23 for further details.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DisclosureOfFinanceIncomeExplanatory>
    <trib:DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512154426399">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        income:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        financial income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        expense:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest
        on leases (Note 24)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(592&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(624&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(647&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        on disposal of exchangeable notes (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,678&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Penalty
        for early partial settlement of senior secured term loan (Note 23,28)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(905&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,450&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        interest payable on senior secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,289&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,039&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        interest payable on convertible note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(300&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(300&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(199&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        interest on exchangeable notes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        interest payable on PPP loans (Note 4)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(338&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        interest on exchangeable notes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        interest on senior secured term loan (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,355&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,131&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,772&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        interest on convertible note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(859&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(796&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(495&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        financial expense&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,172&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unwinding
        of discount on deferred contingent consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capitalisation
        of borrowing costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,085&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        loan modification gain (Note 23,28)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,567&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capitalisation
        of unpaid interest on term loan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,247&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,053&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,734&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        financing expense&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,565&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,882&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,431&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutFinancialIncomeAndExpensesExplanatory>
    <ifrs-full:InterestIncomeOnOtherFinancialAssets
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114174919548_23"
      unitRef="USD">0</ifrs-full:InterestIncomeOnOtherFinancialAssets>
    <ifrs-full:InterestIncomeOnOtherFinancialAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114174919548_27"
      unitRef="USD">1171000</ifrs-full:InterestIncomeOnOtherFinancialAssets>
    <ifrs-full:InterestIncomeOnOtherFinancialAssets
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114174919548_211"
      unitRef="USD">303000</ifrs-full:InterestIncomeOnOtherFinancialAssets>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114174919548_83"
      unitRef="USD">592000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114174919548_87"
      unitRef="USD">624000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114174919548_811"
      unitRef="USD">647000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <trib:LossOnDisposalOfExchangeableNotes
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413155242980"
      unitRef="USD">0</trib:LossOnDisposalOfExchangeableNotes>
    <trib:LossOnDisposalOfExchangeableNotes
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413155258304"
      unitRef="USD">0</trib:LossOnDisposalOfExchangeableNotes>
    <trib:LossOnDisposalOfExchangeableNotes
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413155310528"
      unitRef="USD">9678000</trib:LossOnDisposalOfExchangeableNotes>
    <trib:PenaltyForEarlySettlementOfTermLoan
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413155445294"
      unitRef="USD">-905000</trib:PenaltyForEarlySettlementOfTermLoan>
    <trib:PenaltyForEarlySettlementOfTermLoan
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413155514442"
      unitRef="USD">-3450000</trib:PenaltyForEarlySettlementOfTermLoan>
    <trib:CashInterestPayableOnSeniorSecureTermLoan
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413155548222"
      unitRef="USD">-6293000</trib:CashInterestPayableOnSeniorSecureTermLoan>
    <trib:CashInterestPayableOnSeniorSecureTermLoan
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413155600261"
      unitRef="USD">-7289000</trib:CashInterestPayableOnSeniorSecureTermLoan>
    <trib:CashInterestPayableOnSeniorSecureTermLoan
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413155614258"
      unitRef="USD">-7039000</trib:CashInterestPayableOnSeniorSecureTermLoan>
    <trib:InterestPaidOnConvertibleNote
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413155718296"
      unitRef="USD">300000</trib:InterestPaidOnConvertibleNote>
    <trib:InterestPaidOnConvertibleNote
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413155748449"
      unitRef="USD">300000</trib:InterestPaidOnConvertibleNote>
    <trib:InterestPaidOnConvertibleNote
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413155801400"
      unitRef="USD">199000</trib:InterestPaidOnConvertibleNote>
    <ifrs-full:InterestExpenseOnDebtInstrumentsIssued
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114174919548_103"
      unitRef="USD">8000</ifrs-full:InterestExpenseOnDebtInstrumentsIssued>
    <ifrs-full:InterestExpenseOnDebtInstrumentsIssued
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114174919548_107"
      unitRef="USD">8000</ifrs-full:InterestExpenseOnDebtInstrumentsIssued>
    <ifrs-full:InterestExpenseOnDebtInstrumentsIssued
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114174919548_1011"
      unitRef="USD">296000</ifrs-full:InterestExpenseOnDebtInstrumentsIssued>
    <trib:CashInterestPayableOnPppLoans
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250512160311398_xbrl_20220114174919548_103"
      unitRef="USD">-338000</trib:CashInterestPayableOnPppLoans>
    <trib:CashInterestPayableOnPppLoans
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250512160311398_xbrl_20220114174919548_107"
      unitRef="USD">0</trib:CashInterestPayableOnPppLoans>
    <trib:CashInterestPayableOnPppLoans
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250512160311398_xbrl_20220114174919548_1011"
      unitRef="USD">0</trib:CashInterestPayableOnPppLoans>
    <ifrs-full:InterestExpenseOnOtherFinancialLiabilities
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114174919548_113"
      unitRef="USD">0</ifrs-full:InterestExpenseOnOtherFinancialLiabilities>
    <ifrs-full:InterestExpenseOnOtherFinancialLiabilities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114174919548_117"
      unitRef="USD">0</ifrs-full:InterestExpenseOnOtherFinancialLiabilities>
    <ifrs-full:InterestExpenseOnOtherFinancialLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114174919548_1111"
      unitRef="USD">84000</ifrs-full:InterestExpenseOnOtherFinancialLiabilities>
    <trib:NoncashInterestOnSeniorSecuredTermLoan
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413155934594"
      unitRef="USD">2355000</trib:NoncashInterestOnSeniorSecuredTermLoan>
    <trib:NoncashInterestOnSeniorSecuredTermLoan
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413155951220"
      unitRef="USD">1131000</trib:NoncashInterestOnSeniorSecuredTermLoan>
    <trib:NoncashInterestOnSeniorSecuredTermLoan
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413160004667"
      unitRef="USD">2772000</trib:NoncashInterestOnSeniorSecuredTermLoan>
    <trib:NoncashInterestOnConvertibleNote
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413160047288"
      unitRef="USD">859000</trib:NoncashInterestOnConvertibleNote>
    <trib:NoncashInterestOnConvertibleNote
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413160112347"
      unitRef="USD">796000</trib:NoncashInterestOnConvertibleNote>
    <trib:NoncashInterestOnConvertibleNote
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413160214875"
      unitRef="USD">495000</trib:NoncashInterestOnConvertibleNote>
    <ifrs-full:FinanceIncomeCost
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413134114407"
      unitRef="USD">1172000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413134122278"
      unitRef="USD">0</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230413134134062"
      unitRef="USD">74000</ifrs-full:FinanceIncomeCost>
    <trib:UnwindingOfDiscountOnDeferredContingentConsideration
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250512160313565_xbrl_20220114174919548_103"
      unitRef="USD">-53000</trib:UnwindingOfDiscountOnDeferredContingentConsideration>
    <ifrs-full:BorrowingCostsCapitalised
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250512160315700_xbrl_20220114174919548_103"
      unitRef="USD">2085000</ifrs-full:BorrowingCostsCapitalised>
    <ifrs-full:BorrowingCostsCapitalised
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250512160315700_xbrl_20220114174919548_107"
      unitRef="USD">0</ifrs-full:BorrowingCostsCapitalised>
    <ifrs-full:BorrowingCostsCapitalised
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250512160315700_xbrl_20220114174919548_1011"
      unitRef="USD">0</ifrs-full:BorrowingCostsCapitalised>
    <trib:NoncashLoanModificationGain
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250514011300218_xbrl_20250512160315700_xbrl_20220114174919548_103"
      unitRef="USD">3567000</trib:NoncashLoanModificationGain>
    <trib:NoncashLoanModificationGain
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250514011300218_xbrl_20250512160315700_xbrl_20220114174919548_107"
      unitRef="USD">0</trib:NoncashLoanModificationGain>
    <trib:NoncashLoanModificationGain
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250514011300218_xbrl_20250512160315700_xbrl_20220114174919548_1011"
      unitRef="USD">0</trib:NoncashLoanModificationGain>
    <trib:CapitalisationOfUnpaidInterestOnTermLoan
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250512160322988_xbrl_20220114174919548_103"
      unitRef="USD">-3247000</trib:CapitalisationOfUnpaidInterestOnTermLoan>
    <trib:CapitalisationOfUnpaidInterestOnTermLoan
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250512160322988_xbrl_20220114174919548_107"
      unitRef="USD">0</trib:CapitalisationOfUnpaidInterestOnTermLoan>
    <trib:CapitalisationOfUnpaidInterestOnTermLoan
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250512160322988_xbrl_20220114174919548_1011"
      unitRef="USD">0</trib:CapitalisationOfUnpaidInterestOnTermLoan>
    <ifrs-full:FinanceCosts
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114174919548_143"
      unitRef="USD">9565000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114174919548_147"
      unitRef="USD">11053000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114174919548_1411"
      unitRef="USD">24734000</ifrs-full:FinanceCosts>
    <trib:FinanceIncomeExpenseNet
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114174919548_153"
      unitRef="USD">-9565000</trib:FinanceIncomeExpenseNet>
    <trib:FinanceIncomeExpenseNet
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114174919548_157"
      unitRef="USD">-9882000</trib:FinanceIncomeExpenseNet>
    <trib:FinanceIncomeExpenseNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114174919548_1511"
      unitRef="USD">-24431000</trib:FinanceIncomeExpenseNet>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20230420131708998">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;INCOME TAX (EXPENSE)/CREDIT&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current
        tax expense/(credit)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Irish
        Corporation tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(336&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign
        taxes (a)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;462&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustment
        in respect of prior years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(198&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        current tax expense/(credit)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;285&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;264&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(280&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-style:italic"&gt;Deferred
        tax credit &lt;/span&gt;(b)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Origination
        and reversal of temporary differences (see Note 14)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(41&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(547&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;324&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Origination
        and reversal of net operating losses (see Note 14)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;242&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;224&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(238&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        deferred tax charge/(credit)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;201&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(323&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;86&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        income tax charge/(credit) on continuing operations in statement of operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;486&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax
        charge on discontinued operations (see Note 8)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        tax charge/(credit)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;486&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(192&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(a)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In 2024, the foreign taxes relate primarily to
        Luxembourg and Canada.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(b)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In 2024, there was
        a deferred tax credit of US$43,000
        (2023: charge of US$174,000)
        (2022: charge of US$109,000)
        recognised in respect of Ireland and a deferred tax charge of US$244,000
        (2023: credit of US$497,000)
        (2022: credit of US$26,000)
        recognised in respect of overseas tax jurisdictions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective
        tax rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        before taxation &#x2013; continuing operations (US$&#x2018;000)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(30,730&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,927&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        a percentage of loss before&#160;tax:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current
        tax %&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.93&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        (current and deferred) %&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
following table reconciles the applicable Republic of Ireland statutory tax rate to the effective total tax rate for the Group:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25;margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Irish
        corporation tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect
        of current year net operating losses and temporary differences for which no deferred tax asset was recognised (a)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15.89&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17.19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.97&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect
        of tax rates on overseas earnings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.63&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7.82&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7.30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect
        of Irish income taxable at higher tax rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4.09&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.93&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments
        in respect of prior years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.04&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;R&amp;amp;D
        tax credits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        items (b)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7.55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.88&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.07&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective
        tax rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(a)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No deferred tax asset was recognised because there
        was no reversing deferred tax liability in the same jurisdiction reversing in the same period and insufficient future projected taxable
        income in the same jurisdiction.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(b)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other items comprise items not chargeable to tax
        and expenses not deductible for tax purposes. In 2022, other items mainly related to the loss on disposal of the exchangeable notes which
        was non-recurring.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
distribution of loss before taxes by geographical area was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(17,296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,922&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,354&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(315&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(104&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,119&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(23,901&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,393&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(30,730&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,927&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
December&#160;31, 2024, the Group had unutilised net operating losses for continuing operations as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;107,093&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;69,851&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,731&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,852&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,511&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;448&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22,866&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,840&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,778&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;182,811&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;136,202&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75,957&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
December&#160;31, 2024, the Group had unrecognised deferred tax assets in respect of unused tax losses and unused tax credits as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland &#x2013; unused tax losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;13,275&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;8,464&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;7,489&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Other &#x2013; unused tax losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;14,777&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;14,701&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;124&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas
        &#x2013; unused tax losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,149&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,395&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,163&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas
        &#x2013; unused tax credits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,702&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,806&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unrecognised
        deferred tax asset&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35,903&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32,366&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,434&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
accounting policy for deferred tax is to calculate the deferred tax asset that is deemed recoverable, considering all sources for future
taxable profits. The deferred tax assets in the above table have not been recognised due to uncertainty regarding the full utilization
of these losses in the related tax jurisdiction in future periods. Only when it is probable that future profits will be available to utilize
the forward losses or temporary differences is a deferred tax asset recognised. When there is a reversing deferred tax liability in that
jurisdiction that reverses in the same period, the deferred tax asset is restricted so that it equals the reversing deferred tax liability.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <trib:DisclosureOfDetailedInformationAboutChargeForTaxExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512162046179">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current
        tax expense/(credit)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Irish
        Corporation tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(336&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign
        taxes (a)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;462&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustment
        in respect of prior years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(198&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        current tax expense/(credit)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;285&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;264&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(280&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-style:italic"&gt;Deferred
        tax credit &lt;/span&gt;(b)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Origination
        and reversal of temporary differences (see Note 14)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(41&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(547&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;324&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Origination
        and reversal of net operating losses (see Note 14)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;242&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;224&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(238&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        deferred tax charge/(credit)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;201&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(323&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;86&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        income tax charge/(credit) on continuing operations in statement of operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;486&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax
        charge on discontinued operations (see Note 8)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        tax charge/(credit)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;486&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(192&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(a)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In 2024, the foreign taxes relate primarily to
        Luxembourg and Canada.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(b)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In 2024, there was
        a deferred tax credit of US$43,000
        (2023: charge of US$174,000)
        (2022: charge of US$109,000)
        recognised in respect of Ireland and a deferred tax charge of US$244,000
        (2023: credit of US$497,000)
        (2022: credit of US$26,000)
        recognised in respect of overseas tax jurisdictions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutChargeForTaxExplanatory>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118014436239_23"
      unitRef="USD">21000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118014436239_27"
      unitRef="USD">0</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118014436239_211"
      unitRef="USD">-336000</ifrs-full:CurrentTaxExpenseIncome>
    <trib:CurrentTaxForeignExpenseIncome
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118014436239_33"
      unitRef="USD">254000</trib:CurrentTaxForeignExpenseIncome>
    <trib:CurrentTaxForeignExpenseIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118014436239_37"
      unitRef="USD">462000</trib:CurrentTaxForeignExpenseIncome>
    <trib:CurrentTaxForeignExpenseIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118014436239_311"
      unitRef="USD">-5000</trib:CurrentTaxForeignExpenseIncome>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118014436239_43"
      unitRef="USD">10000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118014436239_47"
      unitRef="USD">-198000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118014436239_411"
      unitRef="USD">61000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118014436239_63"
      unitRef="USD">285000</ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods>
    <ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118014436239_67"
      unitRef="USD">264000</ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods>
    <ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118014436239_611"
      unitRef="USD">-280000</ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118014436239_93"
      unitRef="USD">-41000</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118014436239_97"
      unitRef="USD">-547000</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118014436239_911"
      unitRef="USD">324000</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
    <trib:ReversalOfNetOperatingLoss
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118014436239_103"
      unitRef="USD">242000</trib:ReversalOfNetOperatingLoss>
    <trib:ReversalOfNetOperatingLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118014436239_107"
      unitRef="USD">224000</trib:ReversalOfNetOperatingLoss>
    <trib:ReversalOfNetOperatingLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220326145341160"
      unitRef="USD">-238000</trib:ReversalOfNetOperatingLoss>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118014436239_123"
      unitRef="USD">201000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118014436239_127"
      unitRef="USD">-323000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118014436239_1211"
      unitRef="USD">86000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118014436239_143"
      unitRef="USD">486000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118014436239_147"
      unitRef="USD">-59000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118014436239_1411"
      unitRef="USD">-194000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:TaxExpenseRelatingToGainLossOnDiscontinuance
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118014436239_163"
      unitRef="USD">0</ifrs-full:TaxExpenseRelatingToGainLossOnDiscontinuance>
    <ifrs-full:TaxExpenseRelatingToGainLossOnDiscontinuance
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118014436239_167"
      unitRef="USD">0</ifrs-full:TaxExpenseRelatingToGainLossOnDiscontinuance>
    <ifrs-full:TaxExpenseRelatingToGainLossOnDiscontinuance
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118014436239_1611"
      unitRef="USD">2000</ifrs-full:TaxExpenseRelatingToGainLossOnDiscontinuance>
    <trib:IncomeTaxExpenseBenefits
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220118014436239_183"
      unitRef="USD">486000</trib:IncomeTaxExpenseBenefits>
    <trib:IncomeTaxExpenseBenefits
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118014436239_187"
      unitRef="USD">-59000</trib:IncomeTaxExpenseBenefits>
    <trib:IncomeTaxExpenseBenefits
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118014436239_1811"
      unitRef="USD">-192000</trib:IncomeTaxExpenseBenefits>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="0"
      id="Fxbrl_20250513122731696"
      unitRef="USD">43000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="0"
      id="Fxbrl_20220502173641752"
      unitRef="USD">174000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="0"
      id="Fxbrl_20230413095340209"
      unitRef="USD">109000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="0"
      id="Fxbrl_20230413095510361"
      unitRef="USD">244000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="0"
      id="Fxbrl_20230413095449295"
      unitRef="USD">497000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherCountriesMember"
      decimals="0"
      id="Fxbrl_20220502173723393"
      unitRef="USD">26000</ifrs-full:DeferredTaxExpenseIncome>
    <trib:DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413145551985">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective
        tax rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss
        before taxation &#x2013; continuing operations (US$&#x2018;000)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(30,730&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,927&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        a percentage of loss before&#160;tax:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current
        tax %&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.93&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        (current and deferred) %&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutOverseasTaxJurisdictionsExplanatory>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413095832952"
      unitRef="USD">-30730000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118015402375_17"
      unitRef="USD">-36927000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118015402375_111"
      unitRef="USD">-43780000</ifrs-full:ProfitLossBeforeTax>
    <trib:TaxRateEffectOfCurrentTaxOfPriorPeriods
      contextRef="C_20240101to20241231"
      decimals="4"
      id="Fxbrl_20240427031027657"
      unitRef="Pure">-0.0093</trib:TaxRateEffectOfCurrentTaxOfPriorPeriods>
    <trib:TaxRateEffectOfCurrentTaxOfPriorPeriods
      contextRef="C_20230101to20231231"
      decimals="4"
      id="Fxbrl_20220118015402375_37"
      unitRef="Pure">-0.0072</trib:TaxRateEffectOfCurrentTaxOfPriorPeriods>
    <trib:TaxRateEffectOfCurrentTaxOfPriorPeriods
      contextRef="C_20220101to20221231"
      decimals="4"
      id="Fxbrl_20220118015402375_311"
      unitRef="Pure">-0.0064</trib:TaxRateEffectOfCurrentTaxOfPriorPeriods>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="C_20240101to20241231"
      decimals="4"
      id="Fxbrl_20250513155056256"
      unitRef="Pure">-0.0158</ifrs-full:AverageEffectiveTaxRate>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="C_20230101to20231231"
      decimals="4"
      id="Fxbrl_20220118015402375_47"
      unitRef="Pure">-0.0016</ifrs-full:AverageEffectiveTaxRate>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="C_20220101to20221231"
      decimals="4"
      id="Fxbrl_20220118015402375_411"
      unitRef="Pure">-0.0044</ifrs-full:AverageEffectiveTaxRate>
    <trib:DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513155626181">

&lt;div&gt;

&lt;div style="line-height:1.25;margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Irish
        corporation tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect
        of current year net operating losses and temporary differences for which no deferred tax asset was recognised (a)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15.89&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17.19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.97&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect
        of tax rates on overseas earnings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.63&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7.82&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7.30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effect
        of Irish income taxable at higher tax rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4.09&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.93&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustments
        in respect of prior years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.04&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;R&amp;amp;D
        tax credits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        items (b)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7.55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.88&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.07&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective
        tax rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(a)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No deferred tax asset was recognised because there
        was no reversing deferred tax liability in the same jurisdiction reversing in the same period and insufficient future projected taxable
        income in the same jurisdiction.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(b)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other items comprise items not chargeable to tax
        and expenses not deductible for tax purposes. In 2022, other items mainly related to the loss on disposal of the exchangeable notes which
        was non-recurring.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutStatutoryTaxRateExplanatory>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20240101to20241231"
      decimals="3"
      id="Fxbrl_20230413100444958"
      unitRef="Pure">0.125</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20230101to20231231"
      decimals="3"
      id="Fxbrl_20220118015958552_17"
      unitRef="Pure">0.125</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20220101to20221231"
      decimals="3"
      id="Fxbrl_20220118015958552_111"
      unitRef="Pure">0.125</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxRateEffectOfTaxLosses
      contextRef="C_20240101to20241231"
      decimals="4"
      id="Fxbrl_20230414175446320"
      unitRef="Pure">0.1589</ifrs-full:TaxRateEffectOfTaxLosses>
    <ifrs-full:TaxRateEffectOfTaxLosses
      contextRef="C_20230101to20231231"
      decimals="4"
      id="Fxbrl_20220118015958552_27"
      unitRef="Pure">0.1719</ifrs-full:TaxRateEffectOfTaxLosses>
    <ifrs-full:TaxRateEffectOfTaxLosses
      contextRef="C_20220101to20221231"
      decimals="4"
      id="Fxbrl_20220118015958552_211"
      unitRef="Pure">0.1097</ifrs-full:TaxRateEffectOfTaxLosses>
    <ifrs-full:TaxRateEffectOfForeignTaxRates
      contextRef="C_20240101to20241231"
      decimals="4"
      id="Fxbrl_20230414175454620"
      unitRef="Pure">0.0663</ifrs-full:TaxRateEffectOfForeignTaxRates>
    <ifrs-full:TaxRateEffectOfForeignTaxRates
      contextRef="C_20230101to20231231"
      decimals="4"
      id="Fxbrl_20220118015958552_37"
      unitRef="Pure">-0.0782</ifrs-full:TaxRateEffectOfForeignTaxRates>
    <ifrs-full:TaxRateEffectOfForeignTaxRates
      contextRef="C_20220101to20221231"
      decimals="4"
      id="Fxbrl_20220118015958552_311"
      unitRef="Pure">-0.073</ifrs-full:TaxRateEffectOfForeignTaxRates>
    <trib:EffectOfIrishIncomeTaxableAtHigherTaxRate
      contextRef="C_20240101to20241231"
      decimals="4"
      id="Fxbrl_20250514170043260"
      unitRef="Pure">-0.0409</trib:EffectOfIrishIncomeTaxableAtHigherTaxRate>
    <trib:EffectOfIrishIncomeTaxableAtHigherTaxRate
      contextRef="C_20230101to20231231"
      decimals="4"
      id="Fxbrl_20220118015958552_47"
      unitRef="Pure">0.0262</trib:EffectOfIrishIncomeTaxableAtHigherTaxRate>
    <trib:EffectOfIrishIncomeTaxableAtHigherTaxRate
      contextRef="C_20220101to20221231"
      decimals="4"
      id="Fxbrl_20220118015958552_411"
      unitRef="Pure">0.0393</trib:EffectOfIrishIncomeTaxableAtHigherTaxRate>
    <ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods
      contextRef="C_20240101to20241231"
      decimals="4"
      id="Fxbrl_20230414175510061"
      unitRef="Pure">0.0004</ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods>
    <ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods
      contextRef="C_20230101to20231231"
      decimals="4"
      id="Fxbrl_20220118015958552_57"
      unitRef="Pure">-0.0053</ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods>
    <ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods
      contextRef="C_20220101to20221231"
      decimals="4"
      id="Fxbrl_20220326161835864"
      unitRef="Pure">0.0014</ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods>
    <trib:TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods
      contextRef="C_20240101to20241231"
      decimals="2"
      id="Fxbrl_20230414175616007"
      unitRef="Pure">0</trib:TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods>
    <trib:TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods
      contextRef="C_20230101to20231231"
      decimals="2"
      id="Fxbrl_20220118015958552_67"
      unitRef="Pure">0</trib:TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods>
    <trib:TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods
      contextRef="C_20220101to20221231"
      decimals="4"
      id="Fxbrl_20220118015958552_611"
      unitRef="Pure">-0.0075</trib:TaxRateEffectOfResearchAndDevelopmentTaxOfPriorPeriods>
    <ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="C_20240101to20241231"
      decimals="4"
      id="Fxbrl_20230414175634088"
      unitRef="Pure">-0.0755</ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="C_20230101to20231231"
      decimals="4"
      id="Fxbrl_20230413100256416"
      unitRef="Pure">0.0088</ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="C_20220101to20221231"
      decimals="4"
      id="Fxbrl_20220118015958552_711"
      unitRef="Pure">0.0507</ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="C_20240101to20241231"
      decimals="4"
      id="Fxbrl_20250516020212628"
      unitRef="Pure">-0.0158</ifrs-full:AverageEffectiveTaxRate>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="C_20230101to20231231"
      decimals="4"
      id="Fxbrl_20220118015958552_97"
      unitRef="Pure">-0.0016</ifrs-full:AverageEffectiveTaxRate>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="C_20220101to20221231"
      decimals="4"
      id="Fxbrl_20220118015958552_911"
      unitRef="Pure">-0.0044</ifrs-full:AverageEffectiveTaxRate>
    <ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512162302133">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(17,296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,922&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,354&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(315&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(104&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,119&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(23,901&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,393&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(30,730&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,927&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20230413100948940"
      unitRef="USD">-17296000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118035012541"
      unitRef="USD">-12922000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118035254632"
      unitRef="USD">-22354000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember"
      decimals="-3"
      id="Fxbrl_20230413101032816"
      unitRef="USD">-315000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember"
      decimals="-3"
      id="Fxbrl_20220118035030790"
      unitRef="USD">-104000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember"
      decimals="-3"
      id="Fxbrl_20220118035036165"
      unitRef="USD">-33000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118034929542"
      unitRef="USD">-13119000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118035304150"
      unitRef="USD">-23901000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118035818764"
      unitRef="USD">-21393000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230413101113616"
      unitRef="USD">-30730000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118035731555"
      unitRef="USD">-36927000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118035802269"
      unitRef="USD">-43780000</ifrs-full:ProfitLossBeforeTax>
    <trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512162343604">

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;107,093&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;69,851&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,731&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,852&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,511&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;448&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22,866&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,840&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,778&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;182,811&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;136,202&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75,957&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxesExplanatory>
    <trib:UnutilisedNetOperatingLosses
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20230414175945265"
      unitRef="USD">107093000</trib:UnutilisedNetOperatingLosses>
    <trib:UnutilisedNetOperatingLosses
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118040639298_17"
      unitRef="USD">69851000</trib:UnutilisedNetOperatingLosses>
    <trib:UnutilisedNetOperatingLosses
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118040639298_111"
      unitRef="USD">62731000</trib:UnutilisedNetOperatingLosses>
    <trib:UnutilisedNetOperatingLosses
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember"
      decimals="-3"
      id="Fxbrl_20230414175959407"
      unitRef="USD">52852000</trib:UnutilisedNetOperatingLosses>
    <trib:UnutilisedNetOperatingLosses
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember"
      decimals="-3"
      id="Fxbrl_20220118040639298_27"
      unitRef="USD">52511000</trib:UnutilisedNetOperatingLosses>
    <trib:UnutilisedNetOperatingLosses
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember"
      decimals="-3"
      id="Fxbrl_20220118040639298_211"
      unitRef="USD">448000</trib:UnutilisedNetOperatingLosses>
    <trib:UnutilisedNetOperatingLosses
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20230414180017744"
      unitRef="USD">22866000</trib:UnutilisedNetOperatingLosses>
    <trib:UnutilisedNetOperatingLosses
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118040639298_37"
      unitRef="USD">13840000</trib:UnutilisedNetOperatingLosses>
    <trib:UnutilisedNetOperatingLosses
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20240415102747414"
      unitRef="USD">12778000</trib:UnutilisedNetOperatingLosses>
    <trib:UnutilisedNetOperatingLosses
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230414180101422"
      unitRef="USD">182811000</trib:UnutilisedNetOperatingLosses>
    <trib:UnutilisedNetOperatingLosses
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118040639298_77"
      unitRef="USD">136202000</trib:UnutilisedNetOperatingLosses>
    <trib:UnutilisedNetOperatingLosses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118040639298_711"
      unitRef="USD">75957000</trib:UnutilisedNetOperatingLosses>
    <trib:DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512162401988">

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Ireland &#x2013; unused tax losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;13,275&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;8,464&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;7,489&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest
        of World &#x2013; Other &#x2013; unused tax losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;14,777&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;14,701&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;124&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas
        &#x2013; unused tax losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,149&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,395&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,163&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Americas
        &#x2013; unused tax credits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,702&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,806&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unrecognised
        deferred tax asset&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35,903&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32,366&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,434&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutUnusedTaxLossesAndUnusedTaxCreditsExplanatory>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20230414180115238"
      unitRef="USD">13275000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118043641143_17"
      unitRef="USD">8464000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countryIE"
      decimals="-3"
      id="Fxbrl_20220118043641143_111"
      unitRef="USD">7489000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember"
      decimals="-3"
      id="Fxbrl_20230414180459950"
      unitRef="USD">14777000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember"
      decimals="-3"
      id="Fxbrl_20220118043641143_27"
      unitRef="USD">14701000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember"
      decimals="-3"
      id="Fxbrl_20220118043641143_211"
      unitRef="USD">124000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20230414180514946"
      unitRef="USD">2149000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118043641143_37"
      unitRef="USD">3395000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribAmericaMember"
      decimals="-3"
      id="Fxbrl_20220118043641143_311"
      unitRef="USD">3163000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_tribUS1Member"
      decimals="-3"
      id="Fxbrl_20230414180528804"
      unitRef="USD">5702000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_tribUS1Member"
      decimals="-3"
      id="Fxbrl_20220118043641143_47"
      unitRef="USD">5806000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_tribUS1Member"
      decimals="-3"
      id="Fxbrl_20220118043641143_411"
      unitRef="USD">4658000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230414180538554"
      unitRef="USD">35903000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220118043641143_87"
      unitRef="USD">32366000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220118043641143_811"
      unitRef="USD">15434000</ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset>
    <ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory contextRef="C_20240101to20241231" id="F20220421211806147_0">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;8&lt;span style="font-weight:bold"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;(LOSS)/PROFIT FOR THE YEAR ON DISCONTINUED OPERATIONS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
April 2023, the Company announced the sale of its Fitzgerald Industries life sciences supply business, consisting of Benen Trading Ltd
and Fitzgerald Industries International, Inc, to Biosynth for cash proceeds of approximately US$30
million subject to customary adjustments. The results of Fitzgerald Industries were presented as discontinued operations in the 2023 financial
statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
2024, the Company recognised additional costs related to the 2023 disposal of Fitzgerald Industries, following a settlement agreement
with Biosynth that was finalised prior to year-end and formally signed in January 2025. A provision of US$150,000
was recorded in respect of the full and final settlement of all post-completion claims. In addition, outstanding receivables of US$423,000
from Biosynth relating to completion account adjustments were written off as unrecoverable under the terms of the settlement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
operating profit for the discontinued operations are summarised as follows:&#160;&lt;/span&gt;&lt;/span&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,784&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,258&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating
        expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,679&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax
        expense (Note 7)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Profit
        from operating activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;132&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,577&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(Loss)/Gain
        on sale of discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,718&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(Loss)/Profit
        for the year from discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,850&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,577&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
net cashflows generated from discontinued operations are as follows:&lt;/span&gt;&lt;/span&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash received from sale
        of the discontinued operations net of transaction costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,935&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash sold as a part of
        discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash inflow on date of disposal&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;

&lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;The
following amounts relating to the Biosynth transaction were recognised in 2024 as post-disposal adjustments, reflecting the write-off
of receivables and provision for settlement costs:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        assets disposed in 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Post
        disposal adjustment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        assets disposed/adjusted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property plant &amp;amp;
        equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;103&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;103&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill and intangible
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,309&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(423&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;886&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(864&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,014&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(106&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(106&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current corporation tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(195&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(195&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Total net assets
        disposed&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,730&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
consideration from the sale of Fitzgerald Industries which was receivable as at December 31, 2024 was US$Nil
(2023: US$373,000)
(refer to Note 17).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-indent:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
(loss)/earnings per ordinary share &#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
(loss)/earnings per ordinary share for discontinued operations is computed by dividing the profit/ (loss) after taxation on discontinued
operations of US$(573,000),
(2023: US$12,850,000)
(2022: US$2,577,000)
for the financial year by the weighted average number of &#x2018;A&#x2019; ordinary shares in issue as at December&#160;31, 2024, this amounted
to 359,193,482
shares (2023: 153,099,405
shares) (2022: 134,939,327
shares), see Note 10 for further details.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted
(loss)/earnings/ per ordinary share &#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted
(loss)/earnings per ordinary share for discontinued operations is computed by dividing the profit/ (loss) after taxation on discontinued
operations of US$(573,000),
(2023: US$12,850,000)
(2022: US$2,577,000)
for the financial year by the diluted weighted average number of ordinary shares in issue of 404,096,277
shares (2023: 178,016,062
shares) (2022: 155,498,651&#160;shares),
see Note 10 for further details.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
        (loss)/earnings per &#x2018;A&#x2019; share (US Dollars) &#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.02&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted
        (loss)/earnings per &#x2018;A&#x2019; share (US Dollars) &#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.07&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.02&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-style:italic"&gt;Basic
(loss)/earnings per ADS&lt;/span&gt;&#160;&lt;span style="font-style:italic"&gt;&#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
February 2024, the Company changed the ratio of the ADSs representing its &#x2018;A&#x2019; ordinary shares from one (1) ADS representing
four (4) &#x2018;A&#x2019; ordinary shares to one (1) ADS representing twenty (20) &#x2018;A&#x2019; ordinary shares.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
earnings per ADS for discontinued operations is computed by dividing the profit/(loss) after taxation on discontinued operations of US$(573,000),
(2023: US$12,850,000)
(2022: US$2,577,000)
for the financial year by the weighted average number of ADS in issue of 17,959,674
(2023: 7,654,970)
(2022: 6,746,966),
see Note 10 for further details.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted
(loss)/earnings per ADS &#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted
earnings per ADS for discontinued operations is computed by dividing the profit/ (loss) after taxation on discontinued operations of US$(573,000),
(2023: US$12,850,000)
(2022: US$2,577,000)
for the financial year, by the diluted weighted average number of ADS in issue of 20,204,814
(2023: 8,900,803)
(2022: 7,774,933),
see Note 10 for further details.&lt;/span&gt;&lt;/span&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
        (loss)/earnings per ADS (US Dollars) &#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.03&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted
        (loss)/earnings per ADS (US Dollars) &#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.03&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
flows&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
cash flows attributable to discontinued operations are as follows:&lt;/span&gt;&lt;/span&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        (outflow)/inflow from operating activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(177&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,798&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        inflow from investing activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        outflow&#160;from financing activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;There
were no cash inflows from discontinued operations during the year ended December 31, 2024.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;
</ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory>
    <trib:CashProceedsFromDiscontinuedOperations
      contextRef="C_20230401to20230430_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-6"
      id="Fxbrl_20240415105217717"
      unitRef="USD">30000000</trib:CashProceedsFromDiscontinuedOperations>
    <ifrs-full:CurrentProvisions
      contextRef="C_20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512214626001"
      unitRef="USD">150000</ifrs-full:CurrentProvisions>
    <trib:ReceivablesOutstanding
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512214644990"
      unitRef="USD">423000</trib:ReceivablesOutstanding>
    <trib:DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512214959586">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,784&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,258&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating
        expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,679&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax
        expense (Note 7)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Profit
        from operating activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;132&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,577&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(Loss)/Gain
        on sale of discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,718&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(Loss)/Profit
        for the year from discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,850&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,577&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfOperatingProfitForTheDiscontinuedOperationsTableTextBlock>
    <ifrs-full:Revenue
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182726687"
      unitRef="USD">0</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182734205"
      unitRef="USD">2784000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182747069"
      unitRef="USD">12258000</ifrs-full:Revenue>
    <ifrs-full:OperatingExpense
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182803280_xbrl_20240414182726687"
      unitRef="USD">0</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182803280_xbrl_20240414182734205"
      unitRef="USD">2652000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182803280_xbrl_20240414182747069"
      unitRef="USD">9679000</ifrs-full:OperatingExpense>
    <ifrs-full:TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182810237_xbrl_20240414182726687"
      unitRef="USD">0</ifrs-full:TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations>
    <ifrs-full:TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182810237_xbrl_20240414182734205"
      unitRef="USD">0</ifrs-full:TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations>
    <ifrs-full:TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182810237_xbrl_20240414182747069"
      unitRef="USD">-2000</ifrs-full:TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182812845_xbrl_20240414182726687"
      unitRef="USD">0</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182812845_xbrl_20240414182734205"
      unitRef="USD">132000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182812845_xbrl_20240414182747069"
      unitRef="USD">2577000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182814395_xbrl_20240414182726687"
      unitRef="USD">-573000</ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation>
    <ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182814395_xbrl_20240414182734205"
      unitRef="USD">12718000</ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation>
    <ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182814395_xbrl_20240414182747069"
      unitRef="USD">0</ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182816049_xbrl_20240414182726687"
      unitRef="USD">-573000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182816049_xbrl_20240414182734205"
      unitRef="USD">12850000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20220101to20221231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414182816049_xbrl_20240414182747069"
      unitRef="USD">2577000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <trib:DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512215026803">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash received from sale
        of the discontinued operations net of transaction costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,935&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash sold as a part of
        discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash inflow on date of disposal&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfNetCashflowsGeneratedDiscontinuedOperationsExplanatory>
    <trib:CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414183735555"
      unitRef="USD">0</trib:CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts>
    <trib:CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20250512215746218"
      unitRef="USD">28935000</trib:CashReceivedFromSaleOfTheDiscontinuedOperationsNetOfTransactionCosts>
    <trib:CashSoldAsAPartOfDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414183903131"
      unitRef="USD">0</trib:CashSoldAsAPartOfDiscontinuedOperations>
    <trib:CashSoldAsAPartOfDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20250512215828697"
      unitRef="USD">775000</trib:CashSoldAsAPartOfDiscontinuedOperations>
    <ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240414183926320"
      unitRef="USD">0</ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations>
    <ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20250512215901146"
      unitRef="USD">28160000</ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations>
    <trib:DisclosureOfAssetsAndLiabilitiesDisposedExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512215041070">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        assets disposed in 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Post
        disposal adjustment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        assets disposed/adjusted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property plant &amp;amp;
        equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;103&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;103&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill and intangible
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,309&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(423&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;886&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(864&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,014&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(106&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(106&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current corporation tax&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(195&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(195&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;Total net assets
        disposed&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,730&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfAssetsAndLiabilitiesDisposedExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20240414184656191_13"
      unitRef="USD">103000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512220849491"
      unitRef="USD">0</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221739583"
      unitRef="USD">103000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20240414184656191_23"
      unitRef="USD">14123000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512220927596"
      unitRef="USD">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221754859"
      unitRef="USD">14123000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:Inventories
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20240414184656191_33"
      unitRef="USD">1160000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221036946"
      unitRef="USD">0</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221823708"
      unitRef="USD">1160000</ifrs-full:Inventories>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20240414184656191_43"
      unitRef="USD">775000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221109699"
      unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221837512"
      unitRef="USD">775000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20240414184656191_53"
      unitRef="USD">1309000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221131556"
      unitRef="USD">-423000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221849411"
      unitRef="USD">886000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20240414184656191_63"
      unitRef="USD">864000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221153469"
      unitRef="USD">150000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221915402"
      unitRef="USD">1014000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20240414184656191_73"
      unitRef="USD">106000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221212407"
      unitRef="USD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221940627"
      unitRef="USD">106000</ifrs-full:LeaseLiabilities>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20240414184656191_83"
      unitRef="USD">2000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221237382"
      unitRef="USD">0</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221953708"
      unitRef="USD">2000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20240414184656191_93"
      unitRef="USD">195000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221320412"
      unitRef="USD">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512222012223"
      unitRef="USD">195000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20240414184656191_103"
      unitRef="USD">16303000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_tribPostDisposalAdjustmentMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221337583"
      unitRef="USD">-573000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfullNoncurrentAssetsHeldForSaleMember_ifrsfullGeographicalAreasAxis_countrySE_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250512221410127"
      unitRef="USD">15730000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
    <ifrs-full:ConsiderationPaidReceived
      contextRef="C_20240101to20241231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240422153341118"
      unitRef="USD">0</ifrs-full:ConsiderationPaidReceived>
    <ifrs-full:ConsiderationPaidReceived
      contextRef="C_20230101to20231231_ifrsfullGeographicalAreasAxis_countrySE_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20250513191550398"
      unitRef="USD">373000</ifrs-full:ConsiderationPaidReceived>
    <ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20240422153355871"
      unitRef="USD">-573000</ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20240422153416974"
      unitRef="USD">12850000</ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20240422153426950"
      unitRef="USD">2577000</ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity>
    <trib:WeightedAverageSharesDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20230413134240945"
      unitRef="Shares">359193482</trib:WeightedAverageSharesDiscontinuedOperations>
    <trib:WeightedAverageSharesDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20230413134249849"
      unitRef="Shares">153099405</trib:WeightedAverageSharesDiscontinuedOperations>
    <trib:WeightedAverageSharesDiscontinuedOperations
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20230413134259942"
      unitRef="Shares">134939327</trib:WeightedAverageSharesDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20240422153457086"
      unitRef="USD">573000</ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20240422153511309"
      unitRef="USD">12850000</ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20240422153535549"
      unitRef="USD">2577000</ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <trib:AdjustedWeightedAverageSharesDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20230413134432273"
      unitRef="Shares">404096277</trib:AdjustedWeightedAverageSharesDiscontinuedOperations>
    <trib:AdjustedWeightedAverageSharesDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20230413134441089"
      unitRef="Shares">178016062</trib:AdjustedWeightedAverageSharesDiscontinuedOperations>
    <trib:AdjustedWeightedAverageSharesDiscontinuedOperations
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20230413134452455"
      unitRef="Shares">155498651</trib:AdjustedWeightedAverageSharesDiscontinuedOperations>
    <trib:DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512215111717">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
        (loss)/earnings per &#x2018;A&#x2019; share (US Dollars) &#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.02&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted
        (loss)/earnings per &#x2018;A&#x2019; share (US Dollars) &#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.07&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.02&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
        (loss)/earnings per ADS (US Dollars) &#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.03&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted
        (loss)/earnings per ADS (US Dollars) &#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.03&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutEarningsPerAdsForDiscontinuedOperationsExplanatory>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240421193754154_xbrl_20230420133057815"
      unitRef="USD_per_share">-0</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240421193754154_20220421211806169_58"
      unitRef="USD_per_share">0.08</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240421193754154_xbrl_20230413135313895"
      unitRef="USD_per_share">0.02</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240421193804801_xbrl_20220118201529352_20220421211806151_7"
      unitRef="USD_per_share">-0</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240421193804801_20220421211806169_59"
      unitRef="USD_per_share">0.07</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240421193804801_xbrl_20230413135322718"
      unitRef="USD_per_share">0.02</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20240422153558765"
      unitRef="USD">573</ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20240422153609395"
      unitRef="USD">12850</ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20240422153620458"
      unitRef="USD">2577</ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity>
    <trib:WeightedAverageSharesDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20230413134712792"
      unitRef="Shares">17959674</trib:WeightedAverageSharesDiscontinuedOperations>
    <trib:WeightedAverageSharesDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20230413134733871"
      unitRef="Shares">7654970</trib:WeightedAverageSharesDiscontinuedOperations>
    <trib:WeightedAverageSharesDiscontinuedOperations
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20230413134744343"
      unitRef="Shares">6746966</trib:WeightedAverageSharesDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20240422153634875"
      unitRef="USD">573000</ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20240422153645714"
      unitRef="USD">12850000</ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20240422153702878"
      unitRef="USD">2577000</ifrs-full:ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <trib:AdjustedWeightedAverageSharesDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20230413134920810"
      unitRef="Shares">20204814</trib:AdjustedWeightedAverageSharesDiscontinuedOperations>
    <trib:AdjustedWeightedAverageSharesDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20230413134930384"
      unitRef="Shares">8900803</trib:AdjustedWeightedAverageSharesDiscontinuedOperations>
    <trib:AdjustedWeightedAverageSharesDiscontinuedOperations
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20230413134939403"
      unitRef="Shares">7774933</trib:AdjustedWeightedAverageSharesDiscontinuedOperations>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20230420133057815"
      unitRef="USD_per_share">-0.03</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="F20220421211806169_58"
      unitRef="USD_per_share">1.68</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20230413135313895"
      unitRef="USD_per_share">0.38</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220118201529352_20220421211806151_7"
      unitRef="USD_per_share">-0.03</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="F20220421211806169_59"
      unitRef="USD_per_share">1.44</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20230413135322718"
      unitRef="USD_per_share">0.33</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <trib:DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512215144835">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        (outflow)/inflow from operating activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(177&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,798&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        inflow from investing activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        outflow&#160;from financing activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutCashFlowsAttributableToDiscontinuedOperationsExplanatory>
    <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="C_20240101to20241231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="F20220421211806150_4"
      unitRef="USD">0</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="C_20230101to20231231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="F20220421211806151_5"
      unitRef="USD">-177000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="C_20220101to20221231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="F20220421211806170_60"
      unitRef="USD">3798000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="C_20240101to20241231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240427031301090_20220421211806150_4"
      unitRef="USD">0</ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="C_20230101to20231231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240427031301090_20220421211806151_5"
      unitRef="USD">28160000</ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="C_20220101to20221231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240427031301090_20220421211806170_60"
      unitRef="USD">0</ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="C_20240101to20241231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240427031302968_20220421211806150_4"
      unitRef="USD">0</ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="C_20230101to20231231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240427031302968_20220421211806151_5"
      unitRef="USD">0</ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="C_20220101to20221231_tribDiscontinuedOperationsAxis_tribFiomiDiagnosticsMember"
      decimals="-3"
      id="Fxbrl_20240427031302968_20220421211806170_60"
      unitRef="USD">-10800000</ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations>
    <trib:DisclosureOfLossProfitBeforeTaxExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220426134520145">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;9.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;LOSS BEFORE TAX&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-indent:30.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The
following amounts were charged / (credited) to the statement of operations:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Directors&#x2019;
        emoluments (including non- executive directors):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Remuneration&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,454&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,058&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,639&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Pension&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Share
        based payments (Note 26)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;931&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,601&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,707&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Auditor&#x2019;s
        remuneration&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Audit
        fees&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,082&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;861&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;888&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Tax
        fees&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;175&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;407&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;89&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Depreciation
        (Note 11) &lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;675&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;830&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,405&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortisation
        (Note 12)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,190&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;945&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;889&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Loss&#160;on
        the disposal of property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Net
        foreign exchange differences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;376&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;336&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,210&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;1&lt;/sup&gt;
In 2024, US$204,000
was capitalised to research and development projects (2023: US$Nil)
(2022: US$Nil).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Depreciation
for discontinued operations for the year ended December 31, 2024 is US$Nil
(2023: US$1,000)
(2022:US$5,000)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortisation
for discontinued operations for the year ended December 31, 2024 is US$Nil
(2023: US$1,000)
(2022:US$34,000).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfLossProfitBeforeTaxExplanatory>
    <trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512160626422">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,
        2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Directors&#x2019;
        emoluments (including non- executive directors):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Remuneration&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,454&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,058&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,639&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Pension&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Share
        based payments (Note 26)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;931&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,601&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,707&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Auditor&#x2019;s
        remuneration&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Audit
        fees&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,082&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;861&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;888&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Tax
        fees&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;175&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;407&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;89&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Depreciation
        (Note 11) &lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;675&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;830&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,405&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortisation
        (Note 12)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,190&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;945&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;889&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Loss&#160;on
        the disposal of property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Net
        foreign exchange differences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;376&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;336&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,210&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;1&lt;/sup&gt;
In 2024, US$204,000
was capitalised to research and development projects (2023: US$Nil)
(2022: US$Nil).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutLossProfitBeforeTaxExplanatory>
    <ifrs-full:DirectorsRemunerationExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114180710749_23"
      unitRef="USD">1454000</ifrs-full:DirectorsRemunerationExpense>
    <ifrs-full:DirectorsRemunerationExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114180710749_27"
      unitRef="USD">2058000</ifrs-full:DirectorsRemunerationExpense>
    <ifrs-full:DirectorsRemunerationExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114180710749_211"
      unitRef="USD">1639000</ifrs-full:DirectorsRemunerationExpense>
    <trib:DirectorPensionExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114180710749_33"
      unitRef="USD">39000</trib:DirectorPensionExpense>
    <trib:DirectorPensionExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114180710749_37"
      unitRef="USD">26000</trib:DirectorPensionExpense>
    <trib:DirectorPensionExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114180710749_311"
      unitRef="USD">24000</trib:DirectorPensionExpense>
    <trib:ShareBasedPayments
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114180710749_43"
      unitRef="USD">931000</trib:ShareBasedPayments>
    <trib:ShareBasedPayments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114180710749_47"
      unitRef="USD">1601000</trib:ShareBasedPayments>
    <trib:ShareBasedPayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114180710749_411"
      unitRef="USD">1707000</trib:ShareBasedPayments>
    <ifrs-full:AuditorsRemunerationForTaxServices
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20230426162817545_xbrl_20220114180710749_73"
      unitRef="USD">1082000</ifrs-full:AuditorsRemunerationForTaxServices>
    <ifrs-full:AuditorsRemunerationForTaxServices
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230426162817545_xbrl_20220114180710749_77"
      unitRef="USD">861000</ifrs-full:AuditorsRemunerationForTaxServices>
    <ifrs-full:AuditorsRemunerationForTaxServices
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230426162817545_xbrl_20220114180710749_711"
      unitRef="USD">888000</ifrs-full:AuditorsRemunerationForTaxServices>
    <trib:TaxFees
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114180710749_73"
      unitRef="USD">175000</trib:TaxFees>
    <trib:TaxFees
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114180710749_77"
      unitRef="USD">407000</trib:TaxFees>
    <trib:TaxFees
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114180710749_711"
      unitRef="USD">89000</trib:TaxFees>
    <trib:DepreciationOnIntangibleAssets
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114180710749_93"
      unitRef="USD">675000</trib:DepreciationOnIntangibleAssets>
    <trib:DepreciationOnIntangibleAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114180710749_97"
      unitRef="USD">830000</trib:DepreciationOnIntangibleAssets>
    <trib:DepreciationOnIntangibleAssets
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114180710749_911"
      unitRef="USD">1405000</trib:DepreciationOnIntangibleAssets>
    <trib:AmortisationOnIntangibleAssets
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114180710749_103"
      unitRef="USD">1190000</trib:AmortisationOnIntangibleAssets>
    <trib:AmortisationOnIntangibleAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220114180710749_107"
      unitRef="USD">945000</trib:AmortisationOnIntangibleAssets>
    <trib:AmortisationOnIntangibleAssets
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114180710749_1011"
      unitRef="USD">889000</trib:AmortisationOnIntangibleAssets>
    <ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220501154520791"
      unitRef="USD">0</ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413095514174"
      unitRef="USD">0</ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment>
    <ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220114180710749_1111"
      unitRef="USD">-2000</ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment>
    <trib:NetForeignExchangeGainLoss
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220114180710749_123"
      unitRef="USD">376000</trib:NetForeignExchangeGainLoss>
    <trib:NetForeignExchangeGainLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413095554140"
      unitRef="USD">336000</trib:NetForeignExchangeGainLoss>
    <trib:NetForeignExchangeGainLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220326164438880"
      unitRef="USD">-1210000</trib:NetForeignExchangeGainLoss>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250513182751038"
      unitRef="USD">204000</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240415110630841"
      unitRef="USD">0</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240415110644557"
      unitRef="USD">0</ifrs-full:DepreciationAndAmortisationExpense>
    <trib:DeprecationForDiscontinuedOperations
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240412211603984"
      unitRef="USD">0</trib:DeprecationForDiscontinuedOperations>
    <trib:DeprecationForDiscontinuedOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250513183543859"
      unitRef="USD">1000</trib:DeprecationForDiscontinuedOperations>
    <trib:DeprecationForDiscontinuedOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250513183557442"
      unitRef="USD">5000</trib:DeprecationForDiscontinuedOperations>
    <trib:AmortisationForDiscontinuedOperations
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240412211915818"
      unitRef="USD">0</trib:AmortisationForDiscontinuedOperations>
    <trib:AmortisationForDiscontinuedOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20250513183627911"
      unitRef="USD">1000</trib:AmortisationForDiscontinuedOperations>
    <trib:AmortisationForDiscontinuedOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20250513183636356"
      unitRef="USD">34000</trib:AmortisationForDiscontinuedOperations>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512170129689">

&lt;div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;10.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;LOSS PER SHARE&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
loss per ordinary share&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
loss per ordinary share is calculated by dividing the net loss attributable to owners of the parent of US$31,789,000
(2023: loss of US$24,018,000)
(2022: loss of US$41,009,000)
by the weighted average number of &#x2018;A&#x2019; ordinary shares in issue, net of any Treasury Shares, during the year. Basic loss per
ordinary share from continuing operations is calculated by dividing the loss from continuing operations attributable to owners of the
parent of US$31,216,000
(2023: loss of US$36,868,000)
(2022: loss of US$43,586,000)
by the weighted average number of &#x2018;A&#x2019; ordinary shares in issue, net of any Treasury Shares, during the year.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
at December&#160;31, 2024, the number of &#x2018;A&#x2019; ordinary shares for the purposes of the calculation of basic loss per share are
359,193,482
shares (2023: 153,099,405
shares) (2022: 134,939,327
shares).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;A&#x2019;
        ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;359,193,482&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;153,099,405&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;134,939,327&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
        loss per share denominator&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;359,193,482&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;153,099,405&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;134,939,327&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reconciliation
        to weighted average loss per share denominator:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number
        of &#x2018;A&#x2019; ordinary shares at January&#160;1 (Note 19)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;165,865,882&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;164,985,882&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;96,162,410&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted
        average number of &#x2018;A&#x2019; ordinary shares issued during the year*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;205,883,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;669,123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,332,517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted
        average number of treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,555,600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,555,600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,555,600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
        loss per share denominator&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;359,193,482&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;153,099,405&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;134,939,327&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*The
weighted average number of shares issued during the year is calculated by taking the number of shares issued multiplied by the number
of days in the year each share is in issue, divided by 365 days.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-indent:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted
loss per ordinary share&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted
loss per ordinary share is calculated by dividing the net loss attributable to owners of the parent by the weighted average number of
&#x2018;A&#x2019; ordinary shares in issue, net of any Treasury Shares, during the year, plus the weighted average number of &#x2018;A&#x2019;
ordinary shares that would be issued on the conversion of all the dilutive potential &#x2018;A&#x2019; ordinary shares into &#x2018;A&#x2019;
ordinary shares. As the potentially dilutive instruments were anti-dilutive in all periods presented, basic loss per &#x2018;A&#x2019; ordinary
share and diluted loss per &#x2018;A&#x2019; ordinary share are equivalent.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
following potential &#x2018;A&#x2019; ordinary shares are anti-dilutive and are therefore excluded from the weighted average number of &#x2018;A&#x2019;
ordinary shares for the purposes of calculating diluted loss per &#x2018;A&#x2019; ordinary share.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Potentially
        Dilutive Instruments:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on exercise of options (Note 20)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;186,908&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,752,153&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on exercise of warrants to Perceptive (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,173,151&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on conversion of Exchangeable notes (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,436,463&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on conversion of Convertible notes (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,691,358&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,691,358&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,370,709&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        number of potentially dilutive instruments excluded from the weighted average number of &#x2018;A&#x2019; ordinary shares in calculating
        dilutive loss per &#x2018;A&#x2019; ordinary share&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44,902,900&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,916,657&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,559,325&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Of
the &#x2018;A&#x2019; ordinary shares issuable on exercise of options, &lt;span style="-sec-ix-hidden:Fxbrl_20230414123050603"&gt;NIL&lt;/span&gt; are
contingently issuable as their issue is contingent upon satisfaction of specified performance conditions in addition to the passage of
time. The conditions governing their exercisability have not been satisfied as at the end of the reporting period.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-style:italic"&gt;Loss
per ADS&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
February 2024, the Company changed the ratio of the ADSs representing its &#x2018;A&#x2019; ordinary shares from one (1) ADS representing
four (4) &#x2018;A&#x2019; ordinary shares to one (1) ADS representing twenty (20) &#x2018;A&#x2019; ordinary shares.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
loss per ADS is calculated by dividing the loss attributable to owners of the parent of US$31,789,000
(2023: loss of US$24,018,000)
(2022: loss of US$41,009,000)
by the weighted average number of ADS in issue, net of any Treasury Shares, during the year. Basic loss per ADS from continuing operations
is calculated by dividing the loss of US$31,216,000
(2023: loss of US$36,868,000)
(2022: loss of US$43,586,000)
by the weighted average number of ADS in issue, net of any Treasury Shares, during the year.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
at December&#160;31, 2024, the number of ADS for the purposes of the calculation of basic loss per ADS were 17,959,674
ADS (2023: 7,654,970
ADS) (2022: 6,746,966
ADS).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ADS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,959,674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,654,970&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,746,966&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
        loss per ADS denominator&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,959,674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,654,970&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,746,966&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reconciliation
        to weighted average loss per ADS denominator:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number
        of ADS at January&#160;1 (Note 19)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,293,294&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,249,294&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,808,120&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted
        average number of shares issued during the year*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,294,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,456&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,566,626&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted
        average number of treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(627,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(627,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(627,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
        loss per ADS denominator&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,959,674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,654,970&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,746,966&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*The
weighted average number of ADSs issued during the year is calculated by taking the number of ADSs issued multiplied by the number of days
in the year each share is in issue, divided by 365 days.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-indent:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted
loss per ADS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted
loss per ADS is calculated by dividing the net loss attributable to owners of the parent by the weighted average number of ADS in issue,
net of any Treasury Shares, during the year, plus the weighted average number of ADS that would be issued on the conversion of all the
dilutive potential ADS into ADS. As the potentially dilutive instruments were anti-dilutive in all periods presented, basic loss per ADS
and diluted earnings per ADS are equivalent.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
following potential ADS are anti-dilutive and are therefore excluded from the weighted average number of ADS for the purposes of calculating
dilutive (loss)/earnings per ADS.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Potentially
        Dilutive Instruments:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on exercise of options (Note 20)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;137,608&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on exercise of warrants to Perceptive (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,008,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on conversion of Exchangeable notes (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,920&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,920&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;71,823&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on conversion of Convertible notes (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,234,568&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,234,568&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;818,535&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        number of potentially dilutive instruments excluded from the weighted average number of ADS in calculating dilutive loss per ADS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,245,146&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,245,833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,027,966&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Of
the ADS issuable on exercise of options, &lt;span style="-sec-ix-hidden:Fxbrl_20250512171325106"&gt;NIL&lt;/span&gt; are contingently issuable as
their issue is contingent upon satisfaction of specified performance conditions in addition to the passage of time. The conditions governing
their exercisability have not been satisfied as at the end of the reporting period.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20250513133527396"
      unitRef="USD">31789000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20250513133544787"
      unitRef="USD">24018000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20250513133558307"
      unitRef="USD">41009000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20250513171236813"
      unitRef="USD">31216000</ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20250513171245625"
      unitRef="USD">36868000</ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20250513171254630"
      unitRef="USD">43586000</ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20230414094216646"
      unitRef="Shares">359193482</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20230414094225157"
      unitRef="Shares">153099405</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20230414094233872"
      unitRef="Shares">134939327</ifrs-full:WeightedAverageShares>
    <trib:DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512170805250">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;A&#x2019;
        ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;359,193,482&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;153,099,405&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;134,939,327&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
        loss per share denominator&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;359,193,482&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;153,099,405&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;134,939,327&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reconciliation
        to weighted average loss per share denominator:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number
        of &#x2018;A&#x2019; ordinary shares at January&#160;1 (Note 19)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;165,865,882&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;164,985,882&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;96,162,410&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted
        average number of &#x2018;A&#x2019; ordinary shares issued during the year*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;205,883,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;669,123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,332,517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted
        average number of treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,555,600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,555,600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,555,600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
        loss per share denominator&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;359,193,482&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;153,099,405&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;134,939,327&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*The
weighted average number of shares issued during the year is calculated by taking the number of shares issued multiplied by the number
of days in the year each share is in issue, divided by 365 days.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutBasicEarningsPerOrdinaryShareExplanatory>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20220115161837833_13"
      unitRef="Shares">359193482</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20220115161837833_17"
      unitRef="Shares">153099405</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20220115161837833_111"
      unitRef="Shares">134939327</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20240101to20241231"
      decimals="0"
      id="Fxbrl_20220115161837833_33"
      unitRef="Shares">359193482</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20220115161837833_37"
      unitRef="Shares">153099405</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20220115161837833_311"
      unitRef="Shares">134939327</ifrs-full:WeightedAverageShares>
    <trib:NumberOfAOrdinaryWeightedAverageShares
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20220115161837833_63"
      unitRef="Shares">165865882</trib:NumberOfAOrdinaryWeightedAverageShares>
    <trib:NumberOfAOrdinaryWeightedAverageShares
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20220115161837833_67"
      unitRef="Shares">164985882</trib:NumberOfAOrdinaryWeightedAverageShares>
    <trib:NumberOfAOrdinaryWeightedAverageShares
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20230421011529433"
      unitRef="Shares">96162410</trib:NumberOfAOrdinaryWeightedAverageShares>
    <trib:WeightedAverageNumberOfSharesIssued
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20220115161837833_73"
      unitRef="Shares">205883200</trib:WeightedAverageNumberOfSharesIssued>
    <trib:WeightedAverageNumberOfSharesIssued
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20220115161837833_77"
      unitRef="Shares">669123</trib:WeightedAverageNumberOfSharesIssued>
    <trib:WeightedAverageNumberOfSharesIssued
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20220115161837833_711"
      unitRef="Shares">51332517</trib:WeightedAverageNumberOfSharesIssued>
    <trib:WeightedAverageNumberOfTreasuryShares
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20220115161837833_83"
      unitRef="Shares">-12555600</trib:WeightedAverageNumberOfTreasuryShares>
    <trib:WeightedAverageNumberOfTreasuryShares
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20220115161837833_87"
      unitRef="Shares">-12555600</trib:WeightedAverageNumberOfTreasuryShares>
    <trib:WeightedAverageNumberOfTreasuryShares
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20220115161837833_811"
      unitRef="Shares">-12555600</trib:WeightedAverageNumberOfTreasuryShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20220115161837833_103"
      unitRef="Shares">359193482</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20220115161837833_107"
      unitRef="Shares">153099405</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20220115161837833_1011"
      unitRef="Shares">134939327</ifrs-full:WeightedAverageShares>
    <trib:DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512170828433">

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Potentially
        Dilutive Instruments:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on exercise of options (Note 20)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;186,908&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,752,153&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on exercise of warrants to Perceptive (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,173,151&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on conversion of Exchangeable notes (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,436,463&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on conversion of Convertible notes (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,691,358&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,691,358&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,370,709&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        number of potentially dilutive instruments excluded from the weighted average number of &#x2018;A&#x2019; ordinary shares in calculating
        dilutive loss per &#x2018;A&#x2019; ordinary share&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44,902,900&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,916,657&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,559,325&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutDilutedEarningsPerOrdinaryShareExplanatory>
    <trib:IssuableOnExerciseOfOptions
      contextRef="C_20240101to20241231"
      decimals="INF"
      id="Fxbrl_20230414113950072"
      unitRef="Shares">0</trib:IssuableOnExerciseOfOptions>
    <trib:IssuableOnExerciseOfOptions
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230414114222974"
      unitRef="Shares">186908</trib:IssuableOnExerciseOfOptions>
    <trib:IssuableOnExerciseOfOptions
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20230414114233156"
      unitRef="Shares">2752153</trib:IssuableOnExerciseOfOptions>
    <trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive
      contextRef="C_20240101to20241231"
      decimals="INF"
      id="Fxbrl_20230414114005111"
      unitRef="Shares">20173151</trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive>
    <trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230414114253565"
      unitRef="Shares">0</trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive>
    <trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20230414114303733"
      unitRef="Shares">0</trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive>
    <trib:SharesIssuableOnConversionOfExchangeableNotes
      contextRef="C_20240101to20241231"
      decimals="INF"
      id="Fxbrl_20230414114019788"
      unitRef="Shares">38391</trib:SharesIssuableOnConversionOfExchangeableNotes>
    <trib:SharesIssuableOnConversionOfExchangeableNotes
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230414114322076"
      unitRef="Shares">38391</trib:SharesIssuableOnConversionOfExchangeableNotes>
    <trib:SharesIssuableOnConversionOfExchangeableNotes
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20230414114334333"
      unitRef="Shares">1436463</trib:SharesIssuableOnConversionOfExchangeableNotes>
    <trib:IssuableOnConversionOfConvertibleNotes
      contextRef="C_20240101to20241231"
      decimals="INF"
      id="Fxbrl_20230414114052546"
      unitRef="Shares">24691358</trib:IssuableOnConversionOfConvertibleNotes>
    <trib:IssuableOnConversionOfConvertibleNotes
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230414114352156"
      unitRef="Shares">24691358</trib:IssuableOnConversionOfConvertibleNotes>
    <trib:IssuableOnConversionOfConvertibleNotes
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20230414114402452"
      unitRef="Shares">16370709</trib:IssuableOnConversionOfConvertibleNotes>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="C_20240101to20241231"
      decimals="INF"
      id="Fxbrl_20230414114209545"
      unitRef="Shares">44902900</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230414114435165"
      unitRef="Shares">24916657</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20230414114454084"
      unitRef="Shares">20559325</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20250513133627779"
      unitRef="USD">31789000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20250513133638067"
      unitRef="USD">24018000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20250513133648978"
      unitRef="USD">41009000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20250513171357898"
      unitRef="USD">31216000</ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20250513171408707"
      unitRef="USD">36868000</ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20250513171417568"
      unitRef="USD">43586000</ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20230414105404398"
      unitRef="Shares">17959674</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20230414105424003"
      unitRef="Shares">7654970</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20230414105434386"
      unitRef="Shares">6746966</ifrs-full:WeightedAverageShares>
    <trib:DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512171149745">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ADS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,959,674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,654,970&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,746,966&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
        loss per ADS denominator&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,959,674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,654,970&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,746,966&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reconciliation
        to weighted average loss per ADS denominator:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number
        of ADS at January&#160;1 (Note 19)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,293,294&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,249,294&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,808,120&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted
        average number of shares issued during the year*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,294,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,456&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,566,626&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted
        average number of treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(627,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(627,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(627,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic
        loss per ADS denominator&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,959,674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,654,970&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,746,966&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*The
weighted average number of ADSs issued during the year is calculated by taking the number of ADSs issued multiplied by the number of days
in the year each share is in issue, divided by 365 days.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutBasicEarningPerAdsExplanatory>
    <trib:AmericanDepositoryShares
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20220115165133370"
      unitRef="Shares">17959674</trib:AmericanDepositoryShares>
    <trib:AmericanDepositoryShares
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20220115165144381"
      unitRef="Shares">7654970</trib:AmericanDepositoryShares>
    <trib:AmericanDepositoryShares
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20220115165148677"
      unitRef="Shares">6746966</trib:AmericanDepositoryShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20220115163702535_33"
      unitRef="Shares">17959674</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20220115163702535_37"
      unitRef="Shares">7654970</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20220115163702535_311"
      unitRef="Shares">6746966</ifrs-full:WeightedAverageShares>
    <trib:NumberOfAmericanDepositorySharesWeightedAverageShares
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20220115165218333"
      unitRef="Shares">8293294</trib:NumberOfAmericanDepositorySharesWeightedAverageShares>
    <trib:NumberOfAmericanDepositorySharesWeightedAverageShares
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20220115165227073"
      unitRef="Shares">8249294</trib:NumberOfAmericanDepositorySharesWeightedAverageShares>
    <trib:NumberOfAmericanDepositorySharesWeightedAverageShares
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20220115165248565"
      unitRef="Shares">4808120</trib:NumberOfAmericanDepositorySharesWeightedAverageShares>
    <trib:WeightedAverageNumberOfSharesIssued
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220115163702535_73"
      unitRef="Shares">10294160</trib:WeightedAverageNumberOfSharesIssued>
    <trib:WeightedAverageNumberOfSharesIssued
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220115163702535_77"
      unitRef="Shares">33456</trib:WeightedAverageNumberOfSharesIssued>
    <trib:WeightedAverageNumberOfSharesIssued
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220115163702535_711"
      unitRef="Shares">2566626</trib:WeightedAverageNumberOfSharesIssued>
    <trib:WeightedAverageNumberOfTreasuryShares
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220115163702535_83"
      unitRef="Shares">-627780</trib:WeightedAverageNumberOfTreasuryShares>
    <trib:WeightedAverageNumberOfTreasuryShares
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220115163702535_87"
      unitRef="Shares">-627780</trib:WeightedAverageNumberOfTreasuryShares>
    <trib:WeightedAverageNumberOfTreasuryShares
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220115163702535_811"
      unitRef="Shares">-627780</trib:WeightedAverageNumberOfTreasuryShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220115163702535_103"
      unitRef="Shares">17959674</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220115163702535_107"
      unitRef="Shares">7654970</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220115163702535_1011"
      unitRef="Shares">6746966</ifrs-full:WeightedAverageShares>
    <trib:DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512171250243">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Potentially
        Dilutive Instruments:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on exercise of options (Note 20)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;137,608&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on exercise of warrants to Perceptive (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,008,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on conversion of Exchangeable notes (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,920&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,920&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;71,823&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuable
        on conversion of Convertible notes (Note 23)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,234,568&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,234,568&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;818,535&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        number of potentially dilutive instruments excluded from the weighted average number of ADS in calculating dilutive loss per ADS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,245,146&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,245,833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,027,966&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutDilutedEarningPerAdsExplanatory>
    <trib:IssuableOnExerciseOfOptions
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115639354_xbrl_20230414113950072"
      unitRef="Shares">0</trib:IssuableOnExerciseOfOptions>
    <trib:IssuableOnExerciseOfOptions
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115639354_xbrl_20230414114222974"
      unitRef="Shares">9345</trib:IssuableOnExerciseOfOptions>
    <trib:IssuableOnExerciseOfOptions
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115639354_xbrl_20230414114233156"
      unitRef="Shares">137608</trib:IssuableOnExerciseOfOptions>
    <trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115651914_xbrl_20230414114005111"
      unitRef="Shares">1008658</trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive>
    <trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115651914_xbrl_20230414114253565"
      unitRef="Shares">0</trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive>
    <trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115651914_xbrl_20230414114303733"
      unitRef="Shares">0</trib:NumberOfSharesIssuableOnExerciseOfWarrantsToPerceptive>
    <trib:SharesIssuableOnConversionOfExchangeableNotes
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115705531_xbrl_20230414114019788"
      unitRef="Shares">1920</trib:SharesIssuableOnConversionOfExchangeableNotes>
    <trib:SharesIssuableOnConversionOfExchangeableNotes
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115705531_xbrl_20230414114322076"
      unitRef="Shares">1920</trib:SharesIssuableOnConversionOfExchangeableNotes>
    <trib:SharesIssuableOnConversionOfExchangeableNotes
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115705531_xbrl_20230414114334333"
      unitRef="Shares">71823</trib:SharesIssuableOnConversionOfExchangeableNotes>
    <trib:IssuableOnConversionOfConvertibleNotes
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115717187_xbrl_20230414114052546"
      unitRef="Shares">1234568</trib:IssuableOnConversionOfConvertibleNotes>
    <trib:IssuableOnConversionOfConvertibleNotes
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115717187_xbrl_20230414114352156"
      unitRef="Shares">1234568</trib:IssuableOnConversionOfConvertibleNotes>
    <trib:IssuableOnConversionOfConvertibleNotes
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115717187_xbrl_20230414114402452"
      unitRef="Shares">818535</trib:IssuableOnConversionOfConvertibleNotes>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115726330_xbrl_20230414114209545"
      unitRef="Shares">2245146</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115726330_xbrl_20230414114435165"
      unitRef="Shares">1245833</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20230414115726330_xbrl_20230414114454084"
      unitRef="Shares">1027966</ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512180233902">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;PROPERTY, PLANT AND EQUIPMENT&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:27pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-align:right;line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Land
        &amp;amp; Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold
        Improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer
        &amp;amp; Office Equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Plant
        &amp;amp; Equipment,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,682&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,701&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,540&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,683&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65,606&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;173&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;911&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(480&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(115&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(220&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(855&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reallocations/
        reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchange
        adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;370&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;407&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,268&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,760&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;34,429&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,268&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,760&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;34,429&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;#&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;478&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,380&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions
        through acquisition (Note 29)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;582&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;740&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,373&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Remeasurement
        of ROU assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,764&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,764&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reallocations/
        reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,784&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,811&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,344&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35,686&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;70,625&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Accumulated
        depreciation and Impairment losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,885&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,284&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(31,577&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(59,924&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Charge
        for the year (Note 9)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(272&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(317&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(831&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;385&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;751&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,246&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(339&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(101&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,086&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,772&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchange
        adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(370&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,669&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(33,137&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(64,177&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,669&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(33,137&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(64,177&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Charge
        for the year (Note 9)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(325&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(283&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(675&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        losses*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(410&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(477&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(968&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reallocations/
        reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(179&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(179&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,757&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,728&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,717&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(33,802&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,004&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        amounts&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,027&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;627&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,884&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,621&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;246&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;263&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,892&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
assets of the Group are pledged as security for the senior secured term loan from Perceptive Advisors.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;sup style="font-weight:bold;vertical-align:text-top;line-height:1;font-size:smaller"&gt;#&#160;
&lt;/sup&gt;Additions include US$0.9
million additions in ROU assets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;*&#160;&#160;&lt;/span&gt;The
total impairment charge recognised against Property, Plant &amp;amp; Equipment during the year was US$1.0
million. Of this, US$0.6
million, corresponding to the impairment loss allocated to property, plant and equipment as described above, is presented within &#x2018;Impairment
Charges&#x2019; in the Consolidated Statement of Operations. The remaining US$0.4
million is included within &#x2018;Restructuring Costs&#x2019; (see Note 5).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Remeasurement
of ROU assets during the year includes adjustments arising from rent reviews on leased properties in Bray, Ireland. These relate to leases
with a related party, Mr. O&#x2019;Caoimh, and reflect revised future lease payments following independent valuations. Further details
are provided in Note 26 &#x2013; Related Party Transactions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right-of-use
assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additional
information on the right-of-use assets by class of assets is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;em&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Carrying
        amount At December 31, 2024&lt;/span&gt;&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation
        Charge Year ended December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        Charge Year ended December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,126&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(325&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(356&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:64%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,198&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(381&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(399&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        amount At December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation
        Charge Year ended December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        Charge Year ended December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;229&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(196&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,930&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Plant and Equipment,
        vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(86&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;395&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(273&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,016&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income
from sub-letting right-of-use buildings amounted to US$nil
in the year ended December 31, 2024 (2023: US$3,000).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right-of-Use
        assets at 31 December 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of Right-of-Use leased assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Range
        of remaining term in years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average
        remaining lease term (years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of Leases with extension options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of Leases with options to purchase&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of leases with variable payments linked to index&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of leases with termination options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Building&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0
        to 9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vehicle&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0
        to 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;I.T. and office equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2
        to 5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right-of-Use
        assets at 31 December 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of Right-of-Use leased assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Range
        of remaining term in years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average
        remaining lease term (years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of Leases with extension options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of Leases with options to purchase&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of leases with variable payments linked to index&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of leases with termination options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Building&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1
        to 10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vehicle&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1
        to 3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="margin-right:29.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;I.T.
        and office equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;

&lt;div style="text-align:justify;margin-left:31.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
details of the impairment review are described in Note 12. When an impairment loss is identified in a cash-generating unit, it must be
first allocated to reduce the carrying amount of any goodwill allocated to the cash-generating unit and then to the other assets of the
unit pro rata on the basis of the carrying amount of each asset in the unit. In this manner, an impairment loss of US$0.6
million was allocated to property, plant and equipment as at December 31, 2024 (2023: US$3.8
million). The recoverable amount of property, plant and equipment was determined to be the value in use of each cash-generating unit.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512180513767">

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-align:right;line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Land
        &amp;amp; Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold
        Improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer
        &amp;amp; Office Equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Plant
        &amp;amp; Equipment,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,682&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,701&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,540&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,683&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65,606&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;173&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;911&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(480&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(115&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(220&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(855&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reallocations/
        reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchange
        adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;370&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;407&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,268&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,760&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;34,429&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,268&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,760&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;34,429&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;#&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;478&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,380&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions
        through acquisition (Note 29)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;582&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;740&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,373&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Remeasurement
        of ROU assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,764&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,764&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reallocations/
        reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26,784&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,811&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,344&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;35,686&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;70,625&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Accumulated
        depreciation and Impairment losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21,885&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,284&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(31,577&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(59,924&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Charge
        for the year (Note 9)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(272&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(317&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(831&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;385&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;751&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,246&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(339&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(101&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,086&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,772&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchange
        adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(370&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,669&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(33,137&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(64,177&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,669&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(33,137&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(64,177&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Charge
        for the year (Note 9)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(325&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(283&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(675&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        losses*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(410&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(477&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(968&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reallocations/
        reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(179&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(179&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,757&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,728&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,717&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(33,802&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,004&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        amounts&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,027&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;627&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,884&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,621&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:40%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:40%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;246&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;263&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,892&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_23"
      unitRef="USD">24682000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_27"
      unitRef="USD">2701000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_211"
      unitRef="USD">4540000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_215"
      unitRef="USD">33683000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_219"
      unitRef="USD">65606000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_43"
      unitRef="USD">55000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_47"
      unitRef="USD">87000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_411"
      unitRef="USD">173000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_415"
      unitRef="USD">596000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_419"
      unitRef="USD">911000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_53"
      unitRef="USD">480000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_57"
      unitRef="USD">40000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_511"
      unitRef="USD">115000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_515"
      unitRef="USD">220000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_519"
      unitRef="USD">855000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20240413111252947_xbrl_20230413101850876_xbrl_20220118111332977_53"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20240413111252947_xbrl_20230413101850876_xbrl_20220118111332977_57"
      unitRef="USD">-8000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20240413111252947_xbrl_20230413101850876_xbrl_20220118111332977_511"
      unitRef="USD">8000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20240413111252947_xbrl_20230413101850876_xbrl_20220118111332977_515"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240413111252947_xbrl_20230413101850876_xbrl_20220118111332977_519"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_63"
      unitRef="USD">11000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220326233740292"
      unitRef="USD">20000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220326233958110"
      unitRef="USD">6000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_615"
      unitRef="USD">370000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_619"
      unitRef="USD">407000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_83"
      unitRef="USD">24268000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_87"
      unitRef="USD">2760000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_811"
      unitRef="USD">4612000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_815"
      unitRef="USD">34429000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_819"
      unitRef="USD">66069000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_103"
      unitRef="USD">24268000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_107"
      unitRef="USD">2760000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1011"
      unitRef="USD">4612000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1015"
      unitRef="USD">34429000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1019"
      unitRef="USD">66069000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_113"
      unitRef="USD">752000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_117"
      unitRef="USD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1111"
      unitRef="USD">150000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1115"
      unitRef="USD">478000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1119"
      unitRef="USD">1380000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220327204415354"
      unitRef="USD">0</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_127"
      unitRef="USD">51000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1211"
      unitRef="USD">582000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1215"
      unitRef="USD">740000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1219"
      unitRef="USD">1373000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20250512181607742_xbrl_20220118111332977_53"
      unitRef="USD">0</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20250512181607742_xbrl_20220118111332977_57"
      unitRef="USD">0</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20250512181607742_xbrl_20220118111332977_511"
      unitRef="USD">0</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20250512181607742_xbrl_20220118111332977_515"
      unitRef="USD">14000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20250512181607742_xbrl_20220118111332977_519"
      unitRef="USD">14000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20250515104758943_xbrl_20250512181607742_xbrl_20220118111332977_53"
      unitRef="USD">1764000</ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20250515104758943_xbrl_20250512181607742_xbrl_20220118111332977_57"
      unitRef="USD">0</ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20250515104758943_xbrl_20250512181607742_xbrl_20220118111332977_511"
      unitRef="USD">0</ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20250515104758943_xbrl_20250512181607742_xbrl_20220118111332977_515"
      unitRef="USD">0</ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20250515104758943_xbrl_20250512181607742_xbrl_20220118111332977_519"
      unitRef="USD">1764000</ifrs-full:RevaluationIncreaseDecreasePropertyPlantAndEquipmentIncludingRightofuseAssets>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20230413101850876_xbrl_20220118111332977_53"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20230413101850876_xbrl_20220118111332977_57"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20230413101850876_xbrl_20220118111332977_511"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20230413101850876_xbrl_20220118111332977_515"
      unitRef="USD">53000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20230413101850876_xbrl_20220118111332977_519"
      unitRef="USD">53000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_153"
      unitRef="USD">26784000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_157"
      unitRef="USD">2811000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1511"
      unitRef="USD">5344000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1515"
      unitRef="USD">35686000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1519"
      unitRef="USD">70625000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_183"
      unitRef="USD">-21885000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_187"
      unitRef="USD">-2284000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1811"
      unitRef="USD">-4178000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1815"
      unitRef="USD">-31577000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1819"
      unitRef="USD">-59924000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_193"
      unitRef="USD">272000</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_197"
      unitRef="USD">64000</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1911"
      unitRef="USD">178000</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1915"
      unitRef="USD">317000</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_1919"
      unitRef="USD">831000</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_223"
      unitRef="USD">-385000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_227"
      unitRef="USD">-38000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2211"
      unitRef="USD">-115000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2215"
      unitRef="USD">-213000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2219"
      unitRef="USD">-751000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_213"
      unitRef="USD">2246000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_217"
      unitRef="USD">339000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2111"
      unitRef="USD">101000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2115"
      unitRef="USD">1086000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2119"
      unitRef="USD">3772000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_243"
      unitRef="USD">-4000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20230413102634836"
      unitRef="USD">-20000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20230413102737381"
      unitRef="USD">-7000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2415"
      unitRef="USD">-370000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2419"
      unitRef="USD">-401000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_263"
      unitRef="USD">-24022000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_267"
      unitRef="USD">-2669000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2611"
      unitRef="USD">-4349000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2615"
      unitRef="USD">-33137000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2619"
      unitRef="USD">-64177000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_283"
      unitRef="USD">-24022000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_287"
      unitRef="USD">-2669000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2811"
      unitRef="USD">-4349000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2815"
      unitRef="USD">-33137000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2819"
      unitRef="USD">-64177000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_293"
      unitRef="USD">325000</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_297"
      unitRef="USD">58000</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2911"
      unitRef="USD">283000</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2915"
      unitRef="USD">9000</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_2919"
      unitRef="USD">675000</ifrs-full:IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_313"
      unitRef="USD">0</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_317"
      unitRef="USD">0</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_3111"
      unitRef="USD">5000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_3115"
      unitRef="USD">0</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <trib:DisposalsOrRetirementsPropertyAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_3119"
      unitRef="USD">5000</trib:DisposalsOrRetirementsPropertyAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220326182655798_xbrl_20220118111332977_213"
      unitRef="USD">410000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220326182655798_xbrl_20220118111332977_217"
      unitRef="USD">1000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220326182655798_xbrl_20220118111332977_2111"
      unitRef="USD">80000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220326182655798_xbrl_20220118111332977_2115"
      unitRef="USD">477000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220326182655798_xbrl_20220118111332977_2119"
      unitRef="USD">968000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20250512180732415_xbrl_20230413101850876_xbrl_20220118111332977_53"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20250512180732415_xbrl_20230413101850876_xbrl_20220118111332977_57"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20250512180732415_xbrl_20230413101850876_xbrl_20220118111332977_511"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20250512180732415_xbrl_20230413101850876_xbrl_20220118111332977_515"
      unitRef="USD">-179000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20250512180732415_xbrl_20230413101850876_xbrl_20220118111332977_519"
      unitRef="USD">-179000</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_343"
      unitRef="USD">-24757000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_347"
      unitRef="USD">-2728000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_3411"
      unitRef="USD">-4717000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_3415"
      unitRef="USD">-33802000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_3419"
      unitRef="USD">-66004000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_373"
      unitRef="USD">2027000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_377"
      unitRef="USD">83000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_3711"
      unitRef="USD">627000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_3715"
      unitRef="USD">1884000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_3719"
      unitRef="USD">4621000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLandAndBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_393"
      unitRef="USD">246000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_397"
      unitRef="USD">91000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_3911"
      unitRef="USD">263000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_3915"
      unitRef="USD">1292000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118111332977_3919"
      unitRef="USD">1892000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20250512190321774"
      unitRef="USD">900000</ifrs-full:AdditionsToRightofuseAssets>
    <trib:ImpairmentChargePropertyPlantEquipment
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20250512190303975"
      unitRef="USD">1000000</trib:ImpairmentChargePropertyPlantEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20250512190357910"
      unitRef="USD">600000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <trib:RestructuringCost
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20250512190422567"
      unitRef="USD">400000</trib:RestructuringCost>
    <trib:ScheduleOfAdditionalInformationOnRightOfUseAssets
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512181900446">

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;em&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Carrying
        amount At December 31, 2024&lt;/span&gt;&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation
        Charge Year ended December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        Charge Year ended December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,126&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(325&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(356&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:64%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,198&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(381&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(399&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        amount At December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation
        Charge Year ended December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        Charge Year ended December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buildings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;229&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(196&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,930&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Plant and Equipment,
        vehicles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(86&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;395&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(273&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,016&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </trib:ScheduleOfAdditionalInformationOnRightOfUseAssets>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118101120273_33"
      unitRef="USD">2126000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118101120273_37"
      unitRef="USD">-325000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118101120273_311"
      unitRef="USD">-356000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember"
      decimals="-3"
      id="Fxbrl_20220118101120273_43"
      unitRef="USD">72000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember"
      decimals="-3"
      id="Fxbrl_20220118101120273_47"
      unitRef="USD">-56000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember"
      decimals="-3"
      id="Fxbrl_20220118101120273_411"
      unitRef="USD">-43000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220118101120273_73"
      unitRef="USD">2198000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember"
      decimals="-3"
      id="Fxbrl_20220118101120273_77"
      unitRef="USD">-381000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220118101120273_711"
      unitRef="USD">-399000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118101611093_xbrl_20220118101120273_33"
      unitRef="USD">229000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118101611093_xbrl_20220118101120273_37"
      unitRef="USD">-196000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="-3"
      id="Fxbrl_20220118101611093_xbrl_20220118101120273_311"
      unitRef="USD">-1930000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember"
      decimals="-3"
      id="Fxbrl_20220118101648913_xbrl_20220118101120273_43"
      unitRef="USD">166000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember"
      decimals="-3"
      id="Fxbrl_20220118101648913_xbrl_20220118101120273_47"
      unitRef="USD">-51000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribComputerEquipmentsMember"
      decimals="-3"
      id="Fxbrl_20220118101648913_xbrl_20220118101120273_411"
      unitRef="USD">0</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220326185023005_xbrl_20220118101120273_53"
      unitRef="USD">0</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220326185023005_xbrl_20220118101120273_57"
      unitRef="USD">-26000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220326185023005_xbrl_20220118101120273_511"
      unitRef="USD">-86000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220118101741171_xbrl_20220118101120273_73"
      unitRef="USD">395000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribDepreciationMember"
      decimals="-3"
      id="Fxbrl_20220118101741171_xbrl_20220118101120273_77"
      unitRef="USD">-273000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <trib:RightOfUseAssetsIncludingDepreciationAndImpairment
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220118101741171_xbrl_20220118101120273_711"
      unitRef="USD">-2016000</trib:RightOfUseAssetsIncludingDepreciationAndImpairment>
    <ifrs-full:IncomeFromSubleasingRightofuseAssets
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="0"
      id="Fxbrl_20240413112539513"
      unitRef="USD">0</ifrs-full:IncomeFromSubleasingRightofuseAssets>
    <ifrs-full:IncomeFromSubleasingRightofuseAssets
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="0"
      id="Fxbrl_20240413112550927"
      unitRef="USD">3000</ifrs-full:IncomeFromSubleasingRightofuseAssets>
    <trib:ScheduleOfIncomeFromSubLettingRightOfUseBuildings
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512181933789">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right-of-Use
        assets at 31 December 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of Right-of-Use leased assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Range
        of remaining term in years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average
        remaining lease term (years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of Leases with extension options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of Leases with options to purchase&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of leases with variable payments linked to index&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of leases with termination options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Building&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0
        to 9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vehicle&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0
        to 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;I.T. and office equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2
        to 5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right-of-Use
        assets at 31 December 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of Right-of-Use leased assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Range
        of remaining term in years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Average
        remaining lease term (years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of Leases with extension options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of Leases with options to purchase&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of leases with variable payments linked to index&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of leases with termination options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Building&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1
        to 10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vehicle&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1
        to 3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="margin-right:29.8pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;I.T.
        and office equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:ScheduleOfIncomeFromSubLettingRightOfUseBuildings>
    <trib:NumberOfRightOfUseLeasedAssets
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="0"
      id="Fxbrl_20220118101933618_13"
      unitRef="Pure">10</trib:NumberOfRightOfUseLeasedAssets>
    <trib:RemainingTermInYears
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      id="Fxbrl_20250513174813942">P0Y</trib:RemainingTermInYears>
    <trib:RemainingTermInYears
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      id="Fxbrl_20250513174826581">P9Y</trib:RemainingTermInYears>
    <trib:AverageRemainingLeaseTermYears
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      id="Fxbrl_20230420114918775">P3Y</trib:AverageRemainingLeaseTermYears>
    <trib:NumberOfLeasesWithExtensionOptions
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="0"
      id="Fxbrl_20220118101933618_112"
      unitRef="Pure">1</trib:NumberOfLeasesWithExtensionOptions>
    <trib:NumberOfLeasesWithOptionsToPurchase
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="0"
      id="Fxbrl_20220118101933618_116"
      unitRef="Pure">0</trib:NumberOfLeasesWithOptionsToPurchase>
    <trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="0"
      id="Fxbrl_20220118101933618_120"
      unitRef="Pure">0</trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex>
    <trib:NumberOfLeasesWithTerminationOptions
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="0"
      id="Fxbrl_20220118101933618_124"
      unitRef="Pure">0</trib:NumberOfLeasesWithTerminationOptions>
    <trib:NumberOfRightOfUseLeasedAssets
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember"
      decimals="0"
      id="Fxbrl_20220118101933618_23"
      unitRef="Pure">22</trib:NumberOfRightOfUseLeasedAssets>
    <trib:RemainingTermInYears
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      id="Fxbrl_20230420114807706">P0Y</trib:RemainingTermInYears>
    <trib:RemainingTermInYears
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      id="Fxbrl_20230420114815219">P2Y</trib:RemainingTermInYears>
    <trib:AverageRemainingLeaseTermYears
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember"
      id="Fxbrl_20230420114935547">P1Y</trib:AverageRemainingLeaseTermYears>
    <trib:NumberOfLeasesWithExtensionOptions
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember"
      decimals="0"
      id="Fxbrl_20220118101933618_212"
      unitRef="Pure">0</trib:NumberOfLeasesWithExtensionOptions>
    <trib:NumberOfLeasesWithOptionsToPurchase
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember"
      decimals="0"
      id="Fxbrl_20220118101933618_216"
      unitRef="Pure">22</trib:NumberOfLeasesWithOptionsToPurchase>
    <trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember"
      decimals="0"
      id="Fxbrl_20220118101933618_220"
      unitRef="Pure">0</trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex>
    <trib:NumberOfLeasesWithTerminationOptions
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember"
      decimals="0"
      id="Fxbrl_20220118101933618_224"
      unitRef="Pure">22</trib:NumberOfLeasesWithTerminationOptions>
    <trib:NumberOfRightOfUseLeasedAssets
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220118101933618_33"
      unitRef="Pure">6</trib:NumberOfRightOfUseLeasedAssets>
    <trib:RemainingTermInYears
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      id="Fxbrl_20230420114833243">P2Y</trib:RemainingTermInYears>
    <trib:RemainingTermInYears
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      id="Fxbrl_20250513181642958">P5Y</trib:RemainingTermInYears>
    <trib:AverageRemainingLeaseTermYears
      contextRef="C_20240101to20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember"
      id="Fxbrl_20230420114947533">P3Y</trib:AverageRemainingLeaseTermYears>
    <trib:NumberOfLeasesWithExtensionOptions
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220118101933618_312"
      unitRef="Pure">0</trib:NumberOfLeasesWithExtensionOptions>
    <trib:NumberOfLeasesWithOptionsToPurchase
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220422052805353"
      unitRef="Pure">0</trib:NumberOfLeasesWithOptionsToPurchase>
    <trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220422052817057"
      unitRef="Pure">0</trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex>
    <trib:NumberOfLeasesWithTerminationOptions
      contextRef="C_20241231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220118101933618_324"
      unitRef="Pure">0</trib:NumberOfLeasesWithTerminationOptions>
    <trib:NumberOfRightOfUseLeasedAssets
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="0"
      id="Fxbrl_20220118102816393_xbrl_20220118101933618_13"
      unitRef="Pure">7</trib:NumberOfRightOfUseLeasedAssets>
    <trib:RemainingTermInYears
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      id="Fxbrl_20220118103055176">P1Y</trib:RemainingTermInYears>
    <trib:RemainingTermInYears
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      id="Fxbrl_20220118103110614">P10Y</trib:RemainingTermInYears>
    <trib:AverageRemainingLeaseTermYears
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      id="Fxbrl_20220118102816393_xbrl_20220118101933618_18">P5Y</trib:AverageRemainingLeaseTermYears>
    <trib:NumberOfLeasesWithExtensionOptions
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="0"
      id="Fxbrl_20220118102816393_xbrl_20220118101933618_112"
      unitRef="Pure">1</trib:NumberOfLeasesWithExtensionOptions>
    <trib:NumberOfLeasesWithOptionsToPurchase
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="0"
      id="Fxbrl_20220118102816393_xbrl_20220118101933618_116"
      unitRef="Pure">0</trib:NumberOfLeasesWithOptionsToPurchase>
    <trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="0"
      id="Fxbrl_20220118102816393_xbrl_20220118101933618_120"
      unitRef="Pure">0</trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex>
    <trib:NumberOfLeasesWithTerminationOptions
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullBuildingsMember"
      decimals="0"
      id="Fxbrl_20220118102816393_xbrl_20220118101933618_124"
      unitRef="Pure">0</trib:NumberOfLeasesWithTerminationOptions>
    <trib:NumberOfRightOfUseLeasedAssets
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember"
      decimals="0"
      id="Fxbrl_20220118102816423_xbrl_20220118101933618_23"
      unitRef="Pure">22</trib:NumberOfRightOfUseLeasedAssets>
    <trib:RemainingTermInYears
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      id="Fxbrl_20220118103121160">P1Y</trib:RemainingTermInYears>
    <trib:RemainingTermInYears
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      id="Fxbrl_20220118103130952">P3Y</trib:RemainingTermInYears>
    <trib:AverageRemainingLeaseTermYears
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember"
      id="Fxbrl_20220118102816423_xbrl_20220118101933618_28">P2Y</trib:AverageRemainingLeaseTermYears>
    <trib:NumberOfLeasesWithExtensionOptions
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember"
      decimals="0"
      id="Fxbrl_20220118102816423_xbrl_20220118101933618_212"
      unitRef="Pure">0</trib:NumberOfLeasesWithExtensionOptions>
    <trib:NumberOfLeasesWithOptionsToPurchase
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember"
      decimals="0"
      id="Fxbrl_20220118102816423_xbrl_20220118101933618_216"
      unitRef="Pure">22</trib:NumberOfLeasesWithOptionsToPurchase>
    <trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember"
      decimals="0"
      id="Fxbrl_20220118102816423_xbrl_20220118101933618_220"
      unitRef="Pure">0</trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex>
    <trib:NumberOfLeasesWithTerminationOptions
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullVehiclesMember"
      decimals="0"
      id="Fxbrl_20220118102816423_xbrl_20220118101933618_224"
      unitRef="Pure">22</trib:NumberOfLeasesWithTerminationOptions>
    <trib:NumberOfRightOfUseLeasedAssets
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20240413113153304_xbrl_20220118101933618_33"
      unitRef="Pure">5</trib:NumberOfRightOfUseLeasedAssets>
    <trib:RemainingTermInYears
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember"
      id="Fxbrl_20240413113153304_xbrl_20230420114833243">P3Y</trib:RemainingTermInYears>
    <trib:AverageRemainingLeaseTermYears
      contextRef="C_20230101to20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember"
      id="Fxbrl_20240413113153304_xbrl_20230420114947533">P3Y</trib:AverageRemainingLeaseTermYears>
    <trib:NumberOfLeasesWithExtensionOptions
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20240413113153304_xbrl_20220118101933618_312"
      unitRef="Pure">0</trib:NumberOfLeasesWithExtensionOptions>
    <trib:NumberOfLeasesWithOptionsToPurchase
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20240413113153304_xbrl_20220422052805353"
      unitRef="Pure">0</trib:NumberOfLeasesWithOptionsToPurchase>
    <trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20240413113153304_xbrl_20220422052817057"
      unitRef="Pure">0</trib:NumberOfLeasesWithVariablePaymentsLinkedToIndex>
    <trib:NumberOfLeasesWithTerminationOptions
      contextRef="C_20231231_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_tribITAndOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20240413113153304_xbrl_20220118101933618_324"
      unitRef="Pure">0</trib:NumberOfLeasesWithTerminationOptions>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20220426150404839"
      unitRef="USD">600000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment
      contextRef="C_20230101to20231231"
      decimals="-5"
      id="Fxbrl_20220426150413141"
      unitRef="USD">3800000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220422105749322">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GOODWILL
        AND INTANGIBLE ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Development&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Patents
        and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;licenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Technology&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;based
        intangibles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;79,182&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125,584&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,729&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,580&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;247,075&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,758&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;110&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,887&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,591&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,488&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(27,079&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchange
        adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,645&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;127,365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,694&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,202&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;221,906&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,645&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;127,365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,694&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,202&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;221,906&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,582&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,280&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,863&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions
        through acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,839&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;122&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27,066&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(70&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(70&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,484&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;135,999&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,695&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,482&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;259,765&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Accumulated
        amortisation and Impairment losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,645&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(108,576&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,570&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(28,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(211,806&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Charge
        for the year (Note 9)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(753&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(223&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(946&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,956&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,956&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        losses (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,926&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,898&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchange
        adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,645&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(112,262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,549&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(18,180&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(205,636&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,645&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(112,262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,549&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(18,180&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(205,636&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Charge
        for the year (Note 9)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,190&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,190&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        losses (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,645&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(115,048&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,549&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(18,180&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(208,422&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        amounts&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,839&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,951&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;146&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,302&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,343&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,103&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,270&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25;clear:both;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, serif"&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
assets of the Group are pledged as security for the senior secured term loan from Perceptive Advisors.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Included
within development costs are projects with a carrying value of US$7,040,000
which were not amortised in 2024 (2023: US$1,596,000)
(2022: US$6,982,000).
These development costs are not being amortised as the projects to which the costs relate were not fully complete at the end of the financial
year. As at December&#160;31, 2024 these projects are expected to be completed during the period from January&#160;1,
2025 to December&#160;31, 2026 at an expected further cost of approximately US$20
million to US$25
million.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Included
within technology-based intangibles in 2024 is an amount of US$13.1
million related to the recognition of acquired technology-based intangible assets from the Waveform, Metabolomics, and Epicapture acquisitions.
These assets were recognised at fair value in accordance with IFRS 3. Further details of these acquisitions are provided in Note 29. As
the acquired technologies were not yet available for use at year-end, no amortisation has been recorded in 2024. Amortisation will commence
when the technologies are brought into commercial use.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25;clear:both"&gt;

&lt;div&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="margin-left:30pt;line-height:1.25;font-family:Times New Roman, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
following represents the costs incurred during each period presented for each of the principal development projects:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="width:76%;padding-bottom:0px;vertical-align:bottom;white-space:nowrap;border-bottom:2px solid black"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Product
        Name&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-style:italic;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2024&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;US&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-style:italic;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;padding-bottom:2px;font-style:italic;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-style:italic;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2023&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;US&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Continuous
        glucose monitoring testing&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,040&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Premier
        Instruments for A1c and haemoglobinopathies testing&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,669&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Mid-tier
        haemoglobins instrument&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;HIV
        screening rapid test&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        projects&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        capitalised development costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,582&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,758&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-indent:30.6pt;line-height:1.25;font-weight:bold;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
intangible assets consist primarily of software assets, acquired customer and supplier lists, trade names and websites.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
the year ended December 31, 2024, additions of US$13.2
million were recorded in respect of intangible assets acquired through business combinations. These relate to the fair value of identifiable
intangible assets recognised as part of the acquisitions of Waveform, EpiCapture and Metabolomics. The acquired intangible assets comprise
the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer relationships&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade names and brand assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Proprietary technology and software&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Supplier agreements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Website and digital assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
fair values of these assets were determined as part of the purchase price allocation process in accordance with IFRS 3 Business Combinations.
Refer to Note 29 for further detail on the business combinations.&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortisation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortisation
is charged to the consolidated statement of operations through the selling, general and administrative expenses line.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
testing for intangibles including goodwill and indefinite lived assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill
and other intangibles are subject to impairment testing on a periodic basis and whenever there are indicators of impairment. Specific
assets are assessed for impairment when there are indicators of impairment. If any such indication exists, the Company estimates the recoverable
amount of the asset.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
recoverable amount of seven CGUs is determined based on a value-in-use computation at June 30 and December 31. The value-in-use calculations
use cash flow projections based on the 2025 and 2026 projections for each CGU and a further three years projections using estimated revenue
and cost average growth rates of between 2%
and 3%.
At the end of the five-year forecast period, terminal values for each CGU, based on a long-term growth rate of 2%,
are used in the value-in-use calculations. The value-in-use represents the present value of the future cash flows, including the terminal
value, discounted at a rate appropriate to each CGU. The pre-tax discount rates used range from 17%
to 28%
(2023: 15%
to 22%).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sources
of estimation uncertainty&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
cash flows have been arrived at taking into account the Group&#x2019;s financial position, its recent financial results and cash flow generation
and the nature of the medical diagnostic industry, where product obsolescence can be a feature. However, expected future cash flows are
inherently uncertain and are therefore liable to material change over time. The key assumptions employed in arriving at the estimates
of future cash flows factored into impairment testing are subjective and include projected EBITDA margins, net cash flows, discount rates
used and the duration of the discounted cash flow model. Significant under-performance in any of the Group&#x2019;s major CGUs may give
rise to a material impairment which would have a substantial impact on the Group&#x2019;s income and equity.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
tests of cash-generating units&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
impairment tests performed at June 30, 2024 and at December&#160;31, 2024 resulted in an impairment loss being recorded in four CGUs,
Immco Diagnostics Inc, Trinity Biotech Do Brasil, Clark Laboratories and Biopool Inc&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
table below sets forth the impairment loss recorded for each of the CGU&#x2019;s, comprising both the specific asset impairment charges
recorded in year ended December 31, 2024 as per the below table and the impairments arising from the CGU impairment tests:&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Immco
        Diagnostics Inc.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;101&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,331&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Manufacturing Limited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(120&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Do Brasil&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;162&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Primus
        Corp&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;916&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clark
        Laboratories Inc.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;130&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Biopool
        US Inc.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        impairment loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="margin-left:30pt;line-height:1.25;font-family:Times New Roman, serif;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
table below sets forth the breakdown of the impairment loss for each class of asset:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill
        and other intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property,
        plant and equipment (see Note 11)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,772&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        assets (see Note 13)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        impairment loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman',serif;clear:both"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
impairment tests performed at June 30, 2024 and at December&#160;31, 2024 resulted in an impairment loss being recorded in four CGUs,
Immco Diagnostics Inc, Trinity Biotech Do Brasil, Clark Laboratories Inc, and Biopool Inc.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Management
is seeking to implement profit improvement initiatives across these entities, however the values in use of these CGUs at June 30, 2024
and December 31, 2024, defined as the present value of the future projected cash flows, were below the value of the carrying amount of
their assets, other than inventories, accounts receivable, cash and cash equivalents and deferred tax assets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Included
within the impairment for Trinity Biotech Manufacturing Limited was the reversal of a previously recognised financial asset impairment
of US$0.8
million, refer to Note 13 for further details.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Specific
asset impairment charges in year ended December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
the year ended December 31, 2024, two internally developed intangible assets were fully impaired, and certain plant items in our Bray
production facility and the right-of-use asset associated with the Kansas production facility were both fully impaired as a result of
restructuring activities. These impairments are shown in the table below. There were no specific asset impairment charges in the year
ended December 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:43%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Asset
        name&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:44%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Entity&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;T10 HPLC Analyzer&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity Biotech Manufacturing
        Ltd&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;916&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:43%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Syphilis Point-of-Care&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:44%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity Biotech Manufacturing
        Ltd&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;680&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinscreen plant &amp;amp;
        equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity Biotech Manufacturing
        Ltd&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;223&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:43%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Kansas right-of-use asset&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:44%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Primus Corp.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,952&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25;clear:both;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
T10 HPLC Analyzer project was an internally developed HPLC analyser designed for mid-volume haemoglobin testing laboratories, with the
Chinese market identified as a key commercial opportunity. Although the project achieved technical feasibility and early market validation,
recent developments in global trade relations, particularly increasing tensions between the United States and China, have created significant
uncertainty around market access and the ability to generate sufficient future sales. While the Company continues to pursue a licensing
arrangement with a local Chinese partner, this is not expected to generate adequate economic returns to support the carrying value of
the asset. As a result, the Company has fully impaired the related intangible asset and recognised an impairment charge of US$916,000.
This was recorded in the Primus Corp. entity.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Syphilis Point of Care project is an internally developed lateral flow assay intended for the global syphilis and HIV/syphilis dual testing
markets. Although the project demonstrated technical feasibility prior to 2020, the suspension of development activities during the COVID-19
pandemic and subsequent changes in manufacturing strategy have introduced additional uncertainty around technical completion, regulatory
approval timelines, and cost to completion. As a result of this reassessment, and in light of the need for further development work before
the product can be commercialised, the Group have fully impaired the project and recorded an impairment charge of US$680,000.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinscreen,
one of the Group&#x2019;s HIV screening products, was manufactured at Trinity Biotech Manufacturing Ltd in 2024. In line with the planned
transfer of Point-of-Care/HIV product manufacturing to a contract manufacturing partner by Q2 2025, certain plant and equipment at Trinity
Biotech Manufacturing Limited were assessed as having limited future utility. An impairment charge of US$223,000
was recognised to reflect the revised recoverable amount. This has been included within &#x2018;Selling, general and administrative expenses
&#x2013; Restructuring costs&#x2019;. See also Note 11.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Kansas City facility, operated by Primus Corporation, previously supported the manufacture and R&amp;amp;D of the Group&#x2019;s haemoglobin
product range. At year-end, the Group assessed that the associated right-of-use asset no longer has future economic benefit, and a full
impairment charge of US$133,000
was recognized within &#x2018;Selling, general and administrative expenses &#x2013; Restructuring costs&#x2019;. See also Note 11.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
value-in-use calculations for CGUs are subject to significant estimation, uncertainty and accounting judgements and the following sensitivity
analysis has been performed:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In the event that there was a reduction of 10%
        in the assumed level of future growth in revenue growth rate, which would represent a reasonably likely range of outcomes, there would
        be no additional impairment loss recorded at December&#160;31, 2024.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In the event there was a 10%
        increase in the discount rate used to calculate the potential impairment of the carrying values, which would represent a reasonably likely
        range of outcomes, there would be no additional impairment loss recorded at December&#160;31, 2024.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.35pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25;clear:both"&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Significant
Goodwill and Intangible Assets with Indefinite Useful Lives&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25;text-align:justify"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Following
the disposal of Fitzgerald Industries during 2023, the carrying value of goodwill was US$nil as at December 31, 2023. During 2024, goodwill
was recognised in connection with the acquisitions of Waveform Technologies' CGM assets, EpiCapture, and Metabolomics. The carrying value
of goodwill as at December 31, 2024 was US$13,829,000.
The CGUs for which goodwill is considered significant from a Group perspective, and the additional disclosures required for these CGUs,
are set out below.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Goodwill
arising from the purchase of CGM assets from Waveform Technologies&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying amount of goodwill
        (US$&#x2019;000)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,403&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discount rate applied
        (real pre-tax)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;% EBITDA would need to
        decrease for an impairment to arise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56.51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-term growth rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Waveform CGM CGU includes proprietary continuous glucose monitoring (CGM) technology and related assets acquired from Waveform Technologies
in January 2024. The value-in-use was determined using a discounted cash flow model based on seven years of forecast cash flows, reflecting
the expected development and commercialisation trajectory of the technology, followed by a terminal value using a 2%
long-term growth rate. The pre-tax discount rate of 26%
reflects the high-risk, early-stage nature of the opportunity and incorporates market-based risk adjustments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
assumptions and estimates used are specific to this CGU and were derived from a combination of internal forecasts, external market data,
and management&#x2019;s expectations regarding development timelines, regulatory approvals, and commercial potential.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No
impairment loss was recognised for this CGU in 2024. Management concluded that no reasonably possible change in key assumptions would
lead to the carrying amount exceeding the recoverable amount.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Goodwill
arising from the acquisition of EpiCapture Limited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying amount of goodwill
        (US$&#x2019;000)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,420&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discount rate applied
        (real pre-tax)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;% EBITDA would need to
        decrease for an impairment to arise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84.35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-term growth rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
EpiCapture CGU includes oncology diagnostics technology and associated intellectual property acquired in 2024. The value-in-use was determined
using a discounted cash flow model incorporating probability-weighted scenarios reflecting the early-stage nature of the development pipeline,
projected regulatory milestones, and anticipated commercialisation timelines. The model included ten years of forecast cash flows followed
by a terminal value using a 2.0%
long-term growth rate. The pre-tax discount rate of 29.4%
reflects the significant risk and uncertainty associated with product development, clinical validation, and future market access.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
assumptions and estimates used are specific to this CGU and were developed based on internal forecasts, external market data, and management&#x2019;s
expectations regarding product viability and commercial uptake.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No
impairment loss was recognised for this CGU in 2024. Management concluded that no reasonably possible change in key assumptions would
lead to the carrying amount exceeding the recoverable amount.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Goodwill
arising from the acquisition of Metabolomic Diagnostics Limited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill
of US$6,000
was also recognised in connection with the acquisition of Metabolomics. This amount is not considered individually material to the Group,
and therefore no further disclosures have been provided in accordance with IAS 36.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible
        Assets with Indefinite Useful lives&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(included
        in other intangibles)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Primus
        Corporation CGU&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Primus
        trade name&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;365&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-family:'Times New Roman', serif"&gt;&#160;&lt;/div&gt;
        &lt;div style="font-family:'Times New Roman',serif"&gt;
        &lt;div&gt;
        &lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        2023, an impairment loss of US$2,069,000
        was allocated against the Immco Diagnostic trade name as the carrying value of the CGU&#x2019;s net assets exceeded its discounted future
        cashflows. In 2023, the Group sold the Fitzgerald Industries business and the Fitzgerald trade name and RDI trade name were disposed of
        as part of that divestment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
        trade name assets purchased as part of the acquisition of Fitzgerald in 2004, Primus and RDI in 2005 and Immco Diagnostics in 2013 were
        valued using the relief from royalty method and based on factors such as (1)&#160;the market and competitive trends and (2)&#160;the expected
        usage of the name. It was considered that these trade names will generate net cash inflows for the Group for an indefinite period.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory>
    <ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240414170427820">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Development&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Patents
        and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;licenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Technology&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;based
        intangibles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;79,182&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125,584&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,729&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,580&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;247,075&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,758&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;110&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,887&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,591&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,488&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(27,079&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reclassifications&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchange
        adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,645&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;127,365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,694&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,202&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;221,906&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;66,645&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;127,365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,694&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,202&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;221,906&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,582&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,280&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,863&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions
        through acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,839&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;122&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27,066&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(70&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(70&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,484&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;135,999&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,695&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,482&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;259,765&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Accumulated
        amortisation and Impairment losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,645&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(108,576&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,570&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(28,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(211,806&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Charge
        for the year (Note 9)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(753&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(223&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(946&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposals
        or retirements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,956&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,956&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        losses (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,926&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,898&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchange
        adjustments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,645&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(112,262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,549&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(18,180&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(205,636&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,645&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(112,262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,549&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(18,180&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(205,636&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Charge
        for the year (Note 9)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,190&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,190&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        losses (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,645&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(115,048&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,549&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(18,180&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(208,422&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        amounts&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,839&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,951&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;146&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,302&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51,343&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,103&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;145&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,270&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_23"
      unitRef="USD">79182000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_27"
      unitRef="USD">125584000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_211"
      unitRef="USD">8729000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515110659974"
      unitRef="USD">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_215"
      unitRef="USD">33580000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_219"
      unitRef="USD">247075000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20250513093549850"
      unitRef="USD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_37"
      unitRef="USD">1758000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_311"
      unitRef="USD">19000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111236292"
      unitRef="USD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_315"
      unitRef="USD">110000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_319"
      unitRef="USD">1887000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20250513093615241_xbrl_20250513093549850"
      unitRef="USD">12591000</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20250513093615241_xbrl_20220118142015527_37"
      unitRef="USD">0</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20250513093615241_xbrl_20220118142015527_311"
      unitRef="USD">0</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111307276"
      unitRef="USD">0</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250513093615241_xbrl_20220118142015527_315"
      unitRef="USD">14488000</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20250513093615241_xbrl_20220118142015527_319"
      unitRef="USD">27079000</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:ReclassificationGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20250513093755281_xbrl_20250513093615241_xbrl_20250513093549850"
      unitRef="USD">54000</trib:ReclassificationGoodwillAndIntangibleAssets>
    <trib:ReclassificationGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20250513093755281_xbrl_20250513093615241_xbrl_20220118142015527_37"
      unitRef="USD">0</trib:ReclassificationGoodwillAndIntangibleAssets>
    <trib:ReclassificationGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20250513093755281_xbrl_20250513093615241_xbrl_20220118142015527_311"
      unitRef="USD">-54000</trib:ReclassificationGoodwillAndIntangibleAssets>
    <trib:ReclassificationGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111320991"
      unitRef="USD">0</trib:ReclassificationGoodwillAndIntangibleAssets>
    <trib:ReclassificationGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250513093755281_xbrl_20250513093615241_xbrl_20220118142015527_315"
      unitRef="USD">0</trib:ReclassificationGoodwillAndIntangibleAssets>
    <trib:ReclassificationGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20250513093755281_xbrl_20250513093615241_xbrl_20220118142015527_319"
      unitRef="USD">0</trib:ReclassificationGoodwillAndIntangibleAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_53"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_57"
      unitRef="USD">23000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_511"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111341051"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_515"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_519"
      unitRef="USD">23000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_73"
      unitRef="USD">66645000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_77"
      unitRef="USD">127365000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_711"
      unitRef="USD">8694000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111358707"
      unitRef="USD">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_715"
      unitRef="USD">19202000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_719"
      unitRef="USD">221906000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_93"
      unitRef="USD">66645000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_97"
      unitRef="USD">127365000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_911"
      unitRef="USD">8694000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111524394"
      unitRef="USD">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_915"
      unitRef="USD">19202000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_919"
      unitRef="USD">221906000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20230426172539603"
      unitRef="USD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_107"
      unitRef="USD">8582000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_1011"
      unitRef="USD">1000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111536651"
      unitRef="USD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_1015"
      unitRef="USD">2280000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_1019"
      unitRef="USD">10863000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20250513094253273_xbrl_20230426172539603"
      unitRef="USD">13839000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20250513094253273_xbrl_20220118142015527_107"
      unitRef="USD">122000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20250513094253273_xbrl_20220118142015527_1011"
      unitRef="USD">0</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111600355"
      unitRef="USD">13105000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250513094253273_xbrl_20220118142015527_1015"
      unitRef="USD">0</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20250513094253273_xbrl_20220118142015527_1019"
      unitRef="USD">27066000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220326184407079_xbrl_20220118142015527_33"
      unitRef="USD">0</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220326184407079_xbrl_20220118142015527_37"
      unitRef="USD">70000</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220326184407079_xbrl_20220118142015527_311"
      unitRef="USD">0</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111617442"
      unitRef="USD">0</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220326184407079_xbrl_20220118142015527_315"
      unitRef="USD">0</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220326184407079_xbrl_20220118142015527_319"
      unitRef="USD">70000</trib:DisposalsGoodwillAndIntangibleAssets>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_153"
      unitRef="USD">80484000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_157"
      unitRef="USD">135999000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_1511"
      unitRef="USD">8695000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111634739"
      unitRef="USD">13105000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_1515"
      unitRef="USD">21482000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_1519"
      unitRef="USD">259765000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_263"
      unitRef="USD">-66645000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_267"
      unitRef="USD">-108576000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2611"
      unitRef="USD">-8570000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111709362"
      unitRef="USD">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2615"
      unitRef="USD">-28015000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20221231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2619"
      unitRef="USD">-211806000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20250513094412364"
      unitRef="USD">0</ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_197"
      unitRef="USD">-753000</ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_1911"
      unitRef="USD">30000</ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111727627"
      unitRef="USD">0</ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_1915"
      unitRef="USD">-223000</ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_1919"
      unitRef="USD">-946000</ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20250513094455125_xbrl_20230414114552500"
      unitRef="USD">0</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20250513094455125_xbrl_20220118142015527_217"
      unitRef="USD">0</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20250513094455125_xbrl_20230414115055092"
      unitRef="USD">0</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111751962"
      unitRef="USD">0</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250513094455125_xbrl_20220118142015527_2115"
      unitRef="USD">-12956000</trib:DisposalsGoodwillAndIntangibleAssets>
    <trib:DisposalsGoodwillAndIntangibleAssets
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20250513094455125_xbrl_20220118142015527_2119"
      unitRef="USD">-12956000</trib:DisposalsGoodwillAndIntangibleAssets>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20230414114552500"
      unitRef="USD">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_217"
      unitRef="USD">-2926000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20230414115055092"
      unitRef="USD">-9000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111807897"
      unitRef="USD">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2115"
      unitRef="USD">-2898000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2119"
      unitRef="USD">-5833000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_223"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_227"
      unitRef="USD">-7000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2211"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111824170"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2215"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill
      contextRef="C_20230101to20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2219"
      unitRef="USD">-7000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_243"
      unitRef="USD">-66645000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_247"
      unitRef="USD">-112262000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2411"
      unitRef="USD">-8549000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111839898"
      unitRef="USD">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2415"
      unitRef="USD">-18180000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2419"
      unitRef="USD">-205636000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220327201323223"
      unitRef="USD">-66645000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_187"
      unitRef="USD">-112262000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_1811"
      unitRef="USD">-8549000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111855324"
      unitRef="USD">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_1815"
      unitRef="USD">-18180000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_1819"
      unitRef="USD">-205636000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20240415091749623"
      unitRef="USD">0</ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20240415091725440"
      unitRef="USD">-1190000</ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2711"
      unitRef="USD">0</ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111919586"
      unitRef="USD">0</ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2715"
      unitRef="USD">0</ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2719"
      unitRef="USD">-1190000</ifrs-full:ChangesInIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_293"
      unitRef="USD">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_297"
      unitRef="USD">-1596000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2911"
      unitRef="USD">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515111951090"
      unitRef="USD">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2915"
      unitRef="USD">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_2919"
      unitRef="USD">-1596000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_323"
      unitRef="USD">-66645000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_327"
      unitRef="USD">-115048000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_3211"
      unitRef="USD">-8549000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515112015539"
      unitRef="USD">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_3215"
      unitRef="USD">-18180000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_3219"
      unitRef="USD">-208422000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_353"
      unitRef="USD">13839000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_357"
      unitRef="USD">20951000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_3511"
      unitRef="USD">146000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515112034802"
      unitRef="USD">13105000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_3515"
      unitRef="USD">3302000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_3519"
      unitRef="USD">51343000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullGoodwillMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_373"
      unitRef="USD">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribDevelopmentCostMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_377"
      unitRef="USD">15103000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullCopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_3711"
      unitRef="USD">145000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20250515112100698"
      unitRef="USD">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_3715"
      unitRef="USD">1022000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_tribNetCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220118142015527_3719"
      unitRef="USD">16270000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:PropertyDevelopmentAndProjectManagementExpense
      contextRef="C_20240101to20241231"
      decimals="0"
      id="Fxbrl_20220426151023923"
      unitRef="USD">7040000</ifrs-full:PropertyDevelopmentAndProjectManagementExpense>
    <ifrs-full:PropertyDevelopmentAndProjectManagementExpense
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20220426151031300"
      unitRef="USD">1596000</ifrs-full:PropertyDevelopmentAndProjectManagementExpense>
    <ifrs-full:PropertyDevelopmentAndProjectManagementExpense
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20230413111818317"
      unitRef="USD">6982000</ifrs-full:PropertyDevelopmentAndProjectManagementExpense>
    <ifrs-full:ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220426151049084">January&#160;1,
2025 to December&#160;31, 2026</ifrs-full:ExplanationOfRestrictionsOnDistributionOfRevaluationSurplusForIntangibleAssets>
    <trib:AdditionalProjectCost
      contextRef="C_20240101to20241231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="-6"
      id="Fxbrl_20220426151059438"
      unitRef="USD">20000000</trib:AdditionalProjectCost>
    <trib:AdditionalProjectCost
      contextRef="C_20240101to20241231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="-6"
      id="Fxbrl_20250515141249680"
      unitRef="USD">25000000</trib:AdditionalProjectCost>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullTechnologybasedIntangibleAssetsMember"
      decimals="-5"
      id="Fxbrl_20250515113511004"
      unitRef="USD">13100000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240414154518767">

&lt;div&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="width:76%;padding-bottom:0px;vertical-align:bottom;white-space:nowrap;border-bottom:2px solid black"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Product
        Name&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-style:italic;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2024&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;US&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-style:italic;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;text-align:center;padding-bottom:2px;font-style:italic;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-style:italic;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2023&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;US&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Continuous
        glucose monitoring testing&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,040&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Premier
        Instruments for A1c and haemoglobinopathies testing&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,669&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Mid-tier
        haemoglobins instrument&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;HIV
        screening rapid test&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        projects&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        capitalised development costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,582&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,758&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <trib:PrincipalDevelopmentProjectsCapitalizedCosts
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribContinuousGlucoseMonitoringTestingMember"
      decimals="-3"
      id="Fxbrl_20250513103609678_xbrl_20220117161844810_23"
      unitRef="USD">7040000</trib:PrincipalDevelopmentProjectsCapitalizedCosts>
    <trib:PrincipalDevelopmentProjectsCapitalizedCosts
      contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribContinuousGlucoseMonitoringTestingMember"
      decimals="-3"
      id="Fxbrl_20250513103609678_xbrl_20220117161844810_27"
      unitRef="USD">0</trib:PrincipalDevelopmentProjectsCapitalizedCosts>
    <trib:PrincipalDevelopmentProjectsCapitalizedCosts
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPremierInstrumentMember"
      decimals="-3"
      id="Fxbrl_20220117161844810_23"
      unitRef="USD">1542000</trib:PrincipalDevelopmentProjectsCapitalizedCosts>
    <trib:PrincipalDevelopmentProjectsCapitalizedCosts
      contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPremierInstrumentMember"
      decimals="-3"
      id="Fxbrl_20220117161844810_27"
      unitRef="USD">1669000</trib:PrincipalDevelopmentProjectsCapitalizedCosts>
    <trib:PrincipalDevelopmentProjectsCapitalizedCosts
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribMidTierHaemoglobinsInstrumentMember"
      decimals="-3"
      id="Fxbrl_20220117161844810_73"
      unitRef="USD">0</trib:PrincipalDevelopmentProjectsCapitalizedCosts>
    <trib:PrincipalDevelopmentProjectsCapitalizedCosts
      contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribMidTierHaemoglobinsInstrumentMember"
      decimals="-3"
      id="Fxbrl_20220117161844810_77"
      unitRef="USD">51000</trib:PrincipalDevelopmentProjectsCapitalizedCosts>
    <trib:PrincipalDevelopmentProjectsCapitalizedCosts
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribHivOneByTwoRapidTestMember"
      decimals="-3"
      id="Fxbrl_20220117161844810_13"
      unitRef="USD">0</trib:PrincipalDevelopmentProjectsCapitalizedCosts>
    <trib:PrincipalDevelopmentProjectsCapitalizedCosts
      contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribHivOneByTwoRapidTestMember"
      decimals="-3"
      id="Fxbrl_20220117161844810_17"
      unitRef="USD">6000</trib:PrincipalDevelopmentProjectsCapitalizedCosts>
    <trib:PrincipalDevelopmentProjectsCapitalizedCosts
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribOtherProjectsMember"
      decimals="-3"
      id="Fxbrl_20220117161844810_143"
      unitRef="USD">0</trib:PrincipalDevelopmentProjectsCapitalizedCosts>
    <trib:PrincipalDevelopmentProjectsCapitalizedCosts
      contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribOtherProjectsMember"
      decimals="-3"
      id="Fxbrl_20220117161844810_147"
      unitRef="USD">32000</trib:PrincipalDevelopmentProjectsCapitalizedCosts>
    <trib:PrincipalDevelopmentProjectsCapitalizedCosts
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220117161844810_153"
      unitRef="USD">8582000</trib:PrincipalDevelopmentProjectsCapitalizedCosts>
    <trib:PrincipalDevelopmentProjectsCapitalizedCosts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220117161844810_157"
      unitRef="USD">1758000</trib:PrincipalDevelopmentProjectsCapitalizedCosts>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20250513104556987"
      unitRef="USD">13200000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections
      contextRef="C_20241231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20220118123108420"
      unitRef="Pure">0.02</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections
      contextRef="C_20241231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20220118123116328"
      unitRef="Pure">0.03</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <trib:LongTermGrowthRate
      contextRef="C_20240101to20241231"
      decimals="2"
      id="Fxbrl_20220118123249765"
      unitRef="Pure">0.02</trib:LongTermGrowthRate>
    <trib:PreTaxDiscountRates
      contextRef="C_20240101to20241231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20220118123424599"
      unitRef="Pure">0.17</trib:PreTaxDiscountRates>
    <trib:PreTaxDiscountRates
      contextRef="C_20240101to20241231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20220118123433440"
      unitRef="Pure">0.28</trib:PreTaxDiscountRates>
    <trib:PreTaxDiscountRates
      contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20220118123516169"
      unitRef="Pure">0.15</trib:PreTaxDiscountRates>
    <trib:PreTaxDiscountRates
      contextRef="C_20230101to20231231_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20220118123539052"
      unitRef="Pure">0.22</trib:PreTaxDiscountRates>
    <trib:DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240414163646251">

&lt;div&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Immco
        Diagnostics Inc.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;101&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,331&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Manufacturing Limited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(120&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Do Brasil&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;162&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Primus
        Corp&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;916&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clark
        Laboratories Inc.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;130&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Biopool
        US Inc.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        impairment loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutImpairmentLossRecordedOnDiscontinuedAssetsExplanatory>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribImmcoDiagnosticsIncMember"
      decimals="-3"
      id="Fxbrl_20240414151534979_xbrl_20220117163126674_53"
      unitRef="USD">101000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribImmcoDiagnosticsIncMember"
      decimals="-3"
      id="Fxbrl_20240414151534979_xbrl_20220117163126674_57"
      unitRef="USD">9331000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechManufacturingLimitedMember"
      decimals="-3"
      id="Fxbrl_20220117163126674_53"
      unitRef="USD">-120000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechManufacturingLimitedMember"
      decimals="-3"
      id="Fxbrl_20220117163126674_57"
      unitRef="USD">1500000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechDoBrasilMember"
      decimals="-3"
      id="Fxbrl_20220117163126674_33"
      unitRef="USD">162000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTrinityBiotechDoBrasilMember"
      decimals="-3"
      id="Fxbrl_20220117163126674_37"
      unitRef="USD">274000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribPrimusCorpMember"
      decimals="-3"
      id="Fxbrl_20240414151426852"
      unitRef="USD">916000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribPrimusCorpMember"
      decimals="-3"
      id="Fxbrl_20240414151452299"
      unitRef="USD">0</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribClarkLaboratoriesIncMember"
      decimals="-3"
      id="Fxbrl_20240414151021080"
      unitRef="USD">130000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribClarkLaboratoriesIncMember"
      decimals="-3"
      id="Fxbrl_20230413132759618_xbrl_20220117163126674_33"
      unitRef="USD">0</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribBiopoolUsIncMember"
      decimals="-3"
      id="Fxbrl_20220117163126674_43"
      unitRef="USD">219000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribBiopoolUsIncMember"
      decimals="-3"
      id="Fxbrl_20220117163126674_47"
      unitRef="USD">0</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220117163126674_103"
      unitRef="USD">1408000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220117163126674_107"
      unitRef="USD">11105000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfIntangibleAssetsMaterialToEntityExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240414163731177">

&lt;div&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill
        and other intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,596&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property,
        plant and equipment (see Note 11)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,772&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        assets (see Note 13)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        impairment loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfIntangibleAssetsMaterialToEntityExplanatory>
    <ifrs-full:RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220117163542610_23"
      unitRef="USD">1596000</ifrs-full:RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220117163542610_27"
      unitRef="USD">5833000</ifrs-full:RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ChangesInPropertyPlantAndEquipment
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220117163542610_33"
      unitRef="USD">612000</ifrs-full:ChangesInPropertyPlantAndEquipment>
    <ifrs-full:ChangesInPropertyPlantAndEquipment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220117163542610_37"
      unitRef="USD">3772000</ifrs-full:ChangesInPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240414151934337"
      unitRef="USD">-800000</ifrs-full:ImpairmentLossOnFinancialAssets>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240430163328793"
      unitRef="USD">1500000</ifrs-full:ImpairmentLossOnFinancialAssets>
    <ifrs-full:DecreaseThroughImpairmentContractAssets
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220117163542610_63"
      unitRef="USD">1408000</ifrs-full:DecreaseThroughImpairmentContractAssets>
    <ifrs-full:DecreaseThroughImpairmentContractAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220117163542610_67"
      unitRef="USD">11105000</ifrs-full:DecreaseThroughImpairmentContractAssets>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="C_20230601to20230630"
      decimals="-5"
      id="Fxbrl_20240414165633029"
      unitRef="USD">800000</ifrs-full:ImpairmentLossOnFinancialAssets>
    <trib:DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240414164635863">

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:43%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Asset
        name&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:44%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Entity&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;T10 HPLC Analyzer&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity Biotech Manufacturing
        Ltd&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;916&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:43%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Syphilis Point-of-Care&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:44%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity Biotech Manufacturing
        Ltd&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;680&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinscreen plant &amp;amp;
        equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity Biotech Manufacturing
        Ltd&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;223&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:43%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Kansas right-of-use asset&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:44%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Primus Corp.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:43%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:44%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,952&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutSpecificAssetImpairmentChargesExplanatoryTableTextBlock>
    <ifrs-full:IntangibleAssetsUnderDevelopment
      contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribT10HplcAnalyzerMember"
      decimals="-3"
      id="Fxbrl_20250513113538757"
      unitRef="USD">916000</ifrs-full:IntangibleAssetsUnderDevelopment>
    <ifrs-full:IntangibleAssetsUnderDevelopment
      contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribSyphilisPointOfCareMember"
      decimals="-3"
      id="Fxbrl_20250513113542874"
      unitRef="USD">680000</ifrs-full:IntangibleAssetsUnderDevelopment>
    <ifrs-full:IntangibleAssetsUnderDevelopment
      contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribTrinscreenPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20250513113545569"
      unitRef="USD">223000</ifrs-full:IntangibleAssetsUnderDevelopment>
    <ifrs-full:IntangibleAssetsUnderDevelopment
      contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribKansasRightOfUseAssetMember"
      decimals="-3"
      id="Fxbrl_20250513113549298"
      unitRef="USD">133000</ifrs-full:IntangibleAssetsUnderDevelopment>
    <ifrs-full:IntangibleAssetsUnderDevelopment
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230413155949179"
      unitRef="USD">1952000</ifrs-full:IntangibleAssetsUnderDevelopment>
    <trib:IntangibleAssetsUnderDevelopmentImpairmentCharge
      contextRef="C_20240101to20241231"
      decimals="0"
      id="Fxbrl_20230413163947199"
      unitRef="USD">916000</trib:IntangibleAssetsUnderDevelopmentImpairmentCharge>
    <trib:IntangibleAssetsUnderDevelopmentImpairmentCharge
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribSyphilisPointOfCareMember"
      decimals="0"
      id="Fxbrl_20250513190748534"
      unitRef="USD">680000</trib:IntangibleAssetsUnderDevelopmentImpairmentCharge>
    <trib:IntangibleAssetsUnderDevelopmentImpairmentCharge
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribTrinscreenPlantAndEquipmentMember"
      decimals="0"
      id="Fxbrl_20250513114251185"
      unitRef="USD">223000</trib:IntangibleAssetsUnderDevelopmentImpairmentCharge>
    <trib:IntangibleAssetsUnderDevelopmentImpairmentCharge
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribKansasRightOfUseAssetMember"
      decimals="0"
      id="Fxbrl_20250513114305786"
      unitRef="USD">133000</trib:IntangibleAssetsUnderDevelopmentImpairmentCharge>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="C_20241231"
      decimals="2"
      id="Fxbrl_20220426152527780"
      unitRef="Pure">0.10</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <trib:ActuarialAssumptionOfDiscountRatePercentage
      contextRef="C_20240101to20241231"
      decimals="2"
      id="Fxbrl_20230413151815632"
      unitRef="Pure">0.10</trib:ActuarialAssumptionOfDiscountRatePercentage>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribWaveformTechnologiesIncMember"
      decimals="-3"
      id="Fxbrl_20250513133740924"
      unitRef="USD">13829000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:DisclosureOfGoodwillExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513143021538">

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Goodwill
arising from the purchase of CGM assets from Waveform Technologies&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying amount of goodwill
        (US$&#x2019;000)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,403&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discount rate applied
        (real pre-tax)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;% EBITDA would need to
        decrease for an impairment to arise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56.51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-term growth rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Goodwill
arising from the acquisition of EpiCapture Limited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying amount of goodwill
        (US$&#x2019;000)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,420&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discount rate applied
        (real pre-tax)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;% EBITDA would need to
        decrease for an impairment to arise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84.35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-term growth rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfGoodwillExplanatory>
    <trib:CarryingAmountOfGoodwill
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribWaveformTechnologiesIncMember"
      decimals="-3"
      id="Fxbrl_20220422105350049_13"
      unitRef="USD">12403000</trib:CarryingAmountOfGoodwill>
    <ifrs-full:TaxRateEffectOfImpairmentOfGoodwill
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribWaveformTechnologiesIncMember"
      decimals="3"
      id="Fxbrl_20220422105350049_23"
      unitRef="Pure">0.186</ifrs-full:TaxRateEffectOfImpairmentOfGoodwill>
    <trib:EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribWaveformTechnologiesIncMember"
      decimals="4"
      id="Fxbrl_20220422105350049_43"
      unitRef="Pure">0.5651</trib:EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment>
    <trib:LongTermGrowthRate
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribWaveformTechnologiesIncMember"
      decimals="3"
      id="Fxbrl_20220426183912017"
      unitRef="Pure">0.02</trib:LongTermGrowthRate>
    <trib:LongTermGrowthRate
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribWaveformTechnologiesIncMember"
      decimals="2"
      id="Fxbrl_20250513144045624"
      unitRef="Pure">0.02</trib:LongTermGrowthRate>
    <trib:PreTaxDiscountRates
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribWaveformTechnologiesIncMember"
      decimals="2"
      id="Fxbrl_20250513144056867"
      unitRef="Pure">0.26</trib:PreTaxDiscountRates>
    <trib:CarryingAmountOfGoodwill
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribEpiCaptureLimitedMember"
      decimals="-3"
      id="Fxbrl_20250513142734860"
      unitRef="USD">1420000</trib:CarryingAmountOfGoodwill>
    <ifrs-full:TaxRateEffectOfImpairmentOfGoodwill
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribEpiCaptureLimitedMember"
      decimals="3"
      id="Fxbrl_20250513142801220"
      unitRef="Pure">0.219</ifrs-full:TaxRateEffectOfImpairmentOfGoodwill>
    <trib:EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribEpiCaptureLimitedMember"
      decimals="4"
      id="Fxbrl_20250513142814660"
      unitRef="Pure">0.8435</trib:EarningsBeforeInterestTaxDepreciationAndAmortizationDecreaseForImpairment>
    <trib:LongTermGrowthRate
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribEpiCaptureLimitedMember"
      decimals="3"
      id="Fxbrl_20250513142838588"
      unitRef="Pure">0.02</trib:LongTermGrowthRate>
    <trib:LongTermGrowthRate
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribEpiCaptureLimitedMember"
      decimals="3"
      id="Fxbrl_20250513120239237"
      unitRef="Pure">0.02</trib:LongTermGrowthRate>
    <trib:PreTaxDiscountRates
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribEpiCaptureLimitedMember"
      decimals="3"
      id="Fxbrl_20250513120049866"
      unitRef="Pure">0.294</trib:PreTaxDiscountRates>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribMetabolomicDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250513120943404"
      unitRef="USD">6000000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <trib:DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240414164402454">

&lt;div&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible
        Assets with Indefinite Useful lives&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(included
        in other intangibles)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Primus
        Corporation CGU&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Primus
        trade name&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;365&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutInternalAndExternalFactorsExplanatory>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPrimusCorporationCguTradeNameMember"
      decimals="-3"
      id="Fxbrl_20220422105506152_53"
      unitRef="USD">365000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="C_20231231_ifrsfullClassesOfIntangibleAssetsAndGoodwillAxis_tribPrimusCorporationCguTradeNameMember"
      decimals="-3"
      id="Fxbrl_20220422105506152_57"
      unitRef="USD">365000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220422105506152_83"
      unitRef="USD">365000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220422105506152_87"
      unitRef="USD">365000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="C_20230101to20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribImmcoDiagnosticsIncMember"
      decimals="0"
      id="Fxbrl_20220423023246421"
      unitRef="USD">2069000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfFinancialAssetsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513115430502">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;FINANCIAL ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions
        in year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions
        in year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,562&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Write
        off in the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair
        value remeasured through profit &amp;amp; loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provision
        for impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        in the current year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reversal
        of impairment in the current year (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;800&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(700&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        amounts&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
January 2023, the Company entered into a strategic partnership with imaware Inc. (&#x201c;imaware&#x201d;), combining imaware&#x2019;s digital
health platform with the Company&#x2019;s reference laboratory capabilities to support the delivery of at-home and remote testing programs.
As part of the partnership, the Company agreed to invest US$1.5&#160;million
in imaware through a convertible note arrangement. In addition, a five-year
agreement was signed appointing the Company as imaware&#x2019;s laboratory testing partner. As at December 31, 2023, the Company had paid
US$0.7&#160;million
of the committed US$1.5&#160;million
investment. The remaining US$0.8&#160;million,
which had not yet been funded, was recognised as an accrued liability. The partnership did not generate any income in 2023. Due to continued
uncertainty over imaware&#x2019;s financial performance and the recoverability of the investment, the Company recognised a full impairment
loss of US$1.5&#160;million
in the year ended December 31, 2023. In 2024, following the acquisition of Imaware by SuperTruth, and subsequent engagement with the acquirer,
it was confirmed that the Company is not liable to settle the outstanding US$0.8
million and it was written off against the corresponding impairment previously recognised. No further amounts are expected to be paid
under the original convertible note agreement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
2024, the Company purchased a strategic investment in Novus Diagnostics Limited, a company pioneering a rapid sepsis testing platform,
acquiring a 12.5%
stake at that time. This investment will accelerate the development and commercialization of Novus&#x2019; groundbreaking point-of-care
diagnostic solutions, including its 15-minute bloodstream infection test. The investment was valued at approximately US$2,562,000
and was made through issuance of approximately 1,399,985
ADSs in the Company. The ADS issuance was recognised directly in equity. The investment does not meet the criteria for classification
at amortised cost, as it is not held to collect contractual cash flows. Nor did the Company make the irrevocable election to measure it
at fair value through other comprehensive income (FVOCI). Accordingly, the investment is measured at fair value through profit or loss
(FVTPL) in accordance with IFRS 9. As at December 31, 2024, the investment is classified within Level 3 of the fair value hierarchy under
IFRS 13, as it is not quoted in an active market and the fair value was determined using unobservable inputs. A remeasurement loss of
US$0.1&#160;million
was recognised in profit or loss for the year ended December 31, 2024.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfFinancialAssetsExplanatory>
    <trib:DisclosureOfDetailedInformationAboutFinancialAssets
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240414155237946">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions
        in year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions
        in year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,562&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Write
        off in the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair
        value remeasured through profit &amp;amp; loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provision
        for impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
        in the current year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reversal
        of impairment in the current year (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;800&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(700&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        amounts&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-30.6pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutFinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240414155852862"
      unitRef="USD">0</ifrs-full:FinancialAssets>
    <trib:FinancialAssetsAdditions
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240414160006415"
      unitRef="USD">1500000</trib:FinancialAssetsAdditions>
    <ifrs-full:FinancialAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240414155904544"
      unitRef="USD">1500000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250513115143672_xbrl_20240414155904544"
      unitRef="USD">1500000</ifrs-full:FinancialAssets>
    <trib:FinancialAssetsAdditions
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250513115152342_xbrl_20240414160006415"
      unitRef="USD">2562000</trib:FinancialAssetsAdditions>
    <trib:FinancialAssetsWriteOff
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250513115154383_xbrl_20240414160006415"
      unitRef="USD">-800000</trib:FinancialAssetsWriteOff>
    <trib:FairValueRemeasuredThroughProfitLossOfFinancialAssets
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250513115156679_xbrl_20240414160006415"
      unitRef="USD">-107000</trib:FairValueRemeasuredThroughProfitLossOfFinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250513115146127_xbrl_20240414155904544"
      unitRef="USD">3155000</ifrs-full:FinancialAssets>
    <trib:ProvisionForImpairment
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240414155912198"
      unitRef="USD">0</trib:ProvisionForImpairment>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240414155944093"
      unitRef="USD">1500000</ifrs-full:ImpairmentLossOnFinancialAssets>
    <trib:ProvisionForImpairment
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240414155924121"
      unitRef="USD">-1500000</trib:ProvisionForImpairment>
    <trib:ProvisionForImpairment
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250513115209199_xbrl_20240414155912198"
      unitRef="USD">-1500000</trib:ProvisionForImpairment>
    <trib:ReversalOfImpairmentLossOnFinancialAssets
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20250513132549653"
      unitRef="USD">800000</trib:ReversalOfImpairmentLossOnFinancialAssets>
    <trib:ProvisionForImpairment
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250513115207335_xbrl_20240414155912198"
      unitRef="USD">-700000</trib:ProvisionForImpairment>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20240414160017762"
      unitRef="USD">2455000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250513115230159_xbrl_20240414160017762"
      unitRef="USD">0</ifrs-full:FinancialAssetsAtFairValue>
    <trib:ConvertibleNoteInvestment
      contextRef="C_20230131_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember"
      decimals="-5"
      id="Fxbrl_20240414155314658"
      unitRef="USD">1500000</trib:ConvertibleNoteInvestment>
    <trib:AgreementTerm
      contextRef="C_20230101to20230131_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember"
      id="Fxbrl_20240414155423326">five-year</trib:AgreementTerm>
    <ifrs-full:IssueOfConvertibleInstruments
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember"
      decimals="-5"
      id="Fxbrl_20240414155343034"
      unitRef="USD">700000</ifrs-full:IssueOfConvertibleInstruments>
    <trib:ConvertibleNoteInvestment
      contextRef="C_20230131_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember"
      decimals="-5"
      id="Fxbrl_20240414155414203"
      unitRef="USD">1500000</trib:ConvertibleNoteInvestment>
    <trib:AccruedLiability
      contextRef="C_20241231_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember"
      decimals="-5"
      id="Fxbrl_20240414155509311"
      unitRef="USD">800000</trib:AccruedLiability>
    <ifrs-full:ImpairmentLossOnFinancialAssets
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember"
      decimals="-5"
      id="Fxbrl_20240414155631223"
      unitRef="USD">-1500000</ifrs-full:ImpairmentLossOnFinancialAssets>
    <ifrs-full:DecreaseThroughWriteoffFinancialAssets
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialAssetsAxis_tribStrategicPartnershipWithImawareIncMember"
      decimals="-5"
      id="Fxbrl_20250513105232015"
      unitRef="USD">800000</ifrs-full:DecreaseThroughWriteoffFinancialAssets>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="C_20241231_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember"
      decimals="3"
      id="Fxbrl_20250513105047478"
      unitRef="Pure">0.125</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="C_20241231_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250513105107198"
      unitRef="USD">2562000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <trib:AmericanDepositorySharesIssued
      contextRef="C_20240101to20241231_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember"
      decimals="INF"
      id="Fxbrl_20250513105111119"
      unitRef="Shares">1399985</trib:AmericanDepositorySharesIssued>
    <trib:RemeasurementLossRecognizedInProfitLoss
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20250513152551496"
      unitRef="USD">-100000</trib:RemeasurementLossRecognizedInProfitLoss>
    <ifrs-full:DisclosureOfDeferredTaxesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240414130211974">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;DEFERRED TAX ASSETS AND LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognised
deferred tax assets and liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred
tax assets and liabilities of the Group are attributable to the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;Assets&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;Liabilities&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;Net&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;2023&lt;br/&gt;US$&#x2019;000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;2023&lt;br/&gt;US$&#x2019;000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;2023&lt;br/&gt;US$&#x2019;000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;224&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;168&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;224&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;168&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Intangible assets&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(3,001&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(931&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(3,001&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(931&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Inventories&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;776&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;105&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;776&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;105&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Provisions&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,414&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;558&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,414&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;558&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Tax value of loss carry-forwards&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,026&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,030&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,026&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,030&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Other items&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;113&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;114&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,560&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,369&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,447&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;)&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,255&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Deferred tax assets/(liabilities)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;3,553&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,975&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(4,561&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(2,300&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,008&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(325&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
deferred tax asset at December 31, 2024 is mainly due to deductible temporary differences relating to provisions and loss carry-forwards
In 2024, the deferred tax asset increased by US$1.6
million mainly due to an increase in deductible temporary differences principally attributable to imputed interest provisions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
deferred tax liability is caused by the net book value of non-current assets being greater than the tax written down value of non-current
assets, temporary differences due to the acceleration of the recognition of certain charges in calculating taxable income permitted in
Ireland and the US. The deferred tax liability increased by US$2.3
million in 2024, principally because of temporary differences in relation to acquired intangible assets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred
tax assets and liabilities are only offset when the entity has a legally enforceable right to set off current tax assets against current
tax liabilities and where the intention is to settle current tax liabilities and assets on a net basis or to realise the assets and settle
the liabilities simultaneously. At December 31, 2024 and at December 31, 2023 no deferred tax assets and liabilities are offset as it
is not certain as to whether there is a legally enforceable right to set off current tax assets against current tax liabilities and it
is also uncertain as to what current tax assets may be set off against current tax liabilities and in what periods.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Movement
in temporary differences during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;Balance&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;January 1,&lt;br/&gt;2024&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;Recognised&lt;br/&gt;in income&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;em&gt;Recognised&lt;br/&gt;in discontinued operations&lt;/em&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;Balance&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;December&#160;31,&lt;br/&gt;2024&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;US$&#x2019;000&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;US$&#x2019;000&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;US$&#x2019;000&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;US$&#x2019;000&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;168&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;56&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;224&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Intangible assets&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(931&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(2,070&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(3,001&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Inventories&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;105&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;671&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;776&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Provisions&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;558&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;856&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,414&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Tax value of loss carry-forwards&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,030&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(4&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,026&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Other items&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,255&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(192&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,447&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(325&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(683&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,008&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;em&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;em&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January
        1,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;em&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognised&lt;br/&gt;in
        income&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;em&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognised&lt;br/&gt;in
        discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property,
        plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;224&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;168&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,950&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,827&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;192&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(931&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;423&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,636&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;558&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax
        value of loss carry-forwards&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(224&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,030&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        items&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(985&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(270&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,255&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(840&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;323&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;192&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(325&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unrecognised
deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred
tax assets have not been recognised by the Group in respect of the following items, which have not been tax effected:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capital
        losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        operating losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;180,810&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;136,202&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US
        alternative minimum tax credits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;1,791&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,790&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        temporary timing differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,246&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;57,986&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US
        state credit carry-forwards&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210,140&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;208,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfDeferredTaxesExplanatory>
    <trib:DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20230420125531839">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;Assets&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;Liabilities&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:2px solid black"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;Net&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;2023&lt;br/&gt;US$&#x2019;000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;2023&lt;br/&gt;US$&#x2019;000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;text-align:center"&gt;2023&lt;br/&gt;US$&#x2019;000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;224&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;168&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;224&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;168&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Intangible assets&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(3,001&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(931&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(3,001&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(931&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Inventories&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;776&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;105&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;776&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;105&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Provisions&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,414&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;558&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,414&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;558&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Tax value of loss carry-forwards&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,026&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,030&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,026&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,030&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Other items&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;113&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;114&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,560&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,369&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,447&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;)&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,255&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Deferred tax assets/(liabilities)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;3,553&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,975&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(4,561&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(2,300&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,008&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(325&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesExplanatory>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_23"
      unitRef="USD">224000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_27"
      unitRef="USD">168000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_211"
      unitRef="USD">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_215"
      unitRef="USD">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_219"
      unitRef="USD">224000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_223"
      unitRef="USD">168000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_33"
      unitRef="USD">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_37"
      unitRef="USD">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_311"
      unitRef="USD">3001000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_315"
      unitRef="USD">931000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_319"
      unitRef="USD">-3001000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_323"
      unitRef="USD">-931000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_43"
      unitRef="USD">776000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_47"
      unitRef="USD">105000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_411"
      unitRef="USD">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_415"
      unitRef="USD">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_419"
      unitRef="USD">776000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_423"
      unitRef="USD">105000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_53"
      unitRef="USD">1414000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_57"
      unitRef="USD">558000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_511"
      unitRef="USD">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_515"
      unitRef="USD">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_519"
      unitRef="USD">1414000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_523"
      unitRef="USD">558000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20250514171930374"
      unitRef="USD">1026000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_67"
      unitRef="USD">1030000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_611"
      unitRef="USD">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_615"
      unitRef="USD">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20230413160020714"
      unitRef="USD">1026000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_623"
      unitRef="USD">1030000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_73"
      unitRef="USD">113000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_77"
      unitRef="USD">114000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_711"
      unitRef="USD">1560000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_715"
      unitRef="USD">1369000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20250514181028851"
      unitRef="USD">-1447000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20220115184224890_723"
      unitRef="USD">-1255000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115184224890_93"
      unitRef="USD">3553000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115184224890_97"
      unitRef="USD">1975000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115184224890_911"
      unitRef="USD">4561000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115184224890_915"
      unitRef="USD">2300000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115184224890_919"
      unitRef="USD">-1008000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115184224890_923"
      unitRef="USD">-325000</ifrs-full:DeferredTaxLiabilityAsset>
    <trib:DeferredTaxAssetIncreaseDueToIncreaseInProvision
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20240414131710358"
      unitRef="USD">1600000</trib:DeferredTaxAssetIncreaseDueToIncreaseInProvision>
    <trib:DeferredTaxLiabilityIncreased
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20240414131734731"
      unitRef="USD">2300000</trib:DeferredTaxLiabilityIncreased>
    <trib:DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512171321562">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;Balance&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;January 1,&lt;br/&gt;2024&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;Recognised&lt;br/&gt;in income&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;em&gt;Recognised&lt;br/&gt;in discontinued operations&lt;/em&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;Balance&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;December&#160;31,&lt;br/&gt;2024&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;US$&#x2019;000&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;US$&#x2019;000&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;US$&#x2019;000&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;US$&#x2019;000&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;168&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;56&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;224&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Intangible assets&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(931&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(2,070&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(3,001&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Inventories&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;105&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;671&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;776&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Provisions&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;558&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;856&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,414&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Tax value of loss carry-forwards&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,030&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(4&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,026&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Other items&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,255&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(192&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,447&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(325&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(683&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,008&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;em&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;em&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January
        1,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;em&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognised&lt;br/&gt;in
        income&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;em&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognised&lt;br/&gt;in
        discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property,
        plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;224&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;168&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,950&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,827&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;192&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(931&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;423&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,636&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;558&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax
        value of loss carry-forwards&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(224&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,030&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        items&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(985&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(270&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,255&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(840&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;323&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;192&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(325&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutUnrecognisedDeferredTaxLiabilitiesExplanatory>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_23"
      unitRef="USD">168000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_27"
      unitRef="USD">56000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20240414131103187"
      unitRef="USD">0</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_211"
      unitRef="USD">224000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_33"
      unitRef="USD">-931000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_37"
      unitRef="USD">-2070000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20240414131122455"
      unitRef="USD">0</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_311"
      unitRef="USD">-3001000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20220422095512288"
      unitRef="USD">105000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_47"
      unitRef="USD">671000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20240414131126430"
      unitRef="USD">0</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_411"
      unitRef="USD">776000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_53"
      unitRef="USD">558000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_57"
      unitRef="USD">856000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20240414131133003"
      unitRef="USD">0</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_511"
      unitRef="USD">1414000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_63"
      unitRef="USD">1030000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_67"
      unitRef="USD">-4000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20240414131147291"
      unitRef="USD">0</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20230413163118649"
      unitRef="USD">1026000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_73"
      unitRef="USD">-1255000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20220117164906025_77"
      unitRef="USD">-192000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20240101to20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20240414131157003"
      unitRef="USD">0</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20230428002253052"
      unitRef="USD">-1447000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220117164906025_83"
      unitRef="USD">-325000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220117164906025_87"
      unitRef="USD">-683000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240414131213435"
      unitRef="USD">0</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220117164906025_811"
      unitRef="USD">-1008000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220117165513195_xbrl_20220117164906025_23"
      unitRef="USD">224000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220117165513195_xbrl_20220117164906025_27"
      unitRef="USD">-56000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20240414131402992_xbrl_20240414131103187"
      unitRef="USD">0</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="-3"
      id="Fxbrl_20220117165513195_xbrl_20220117164906025_211"
      unitRef="USD">168000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220117165513208_xbrl_20220117164906025_33"
      unitRef="USD">-3950000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220117165513208_xbrl_20220117164906025_37"
      unitRef="USD">2827000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20240414131402993_xbrl_20240414131122455"
      unitRef="USD">192000</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullOtherIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20220117165513208_xbrl_20220117164906025_311"
      unitRef="USD">-931000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20220117165513223_xbrl_20220117164906025_43"
      unitRef="USD">423000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20230414122127884"
      unitRef="USD">-318000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20240414131402994_xbrl_20240414131126430"
      unitRef="USD">0</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribInventoryMember"
      decimals="-3"
      id="Fxbrl_20220117165513223_xbrl_20220117164906025_411"
      unitRef="USD">105000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20220117165513238_xbrl_20220117164906025_53"
      unitRef="USD">2194000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20220117165513238_xbrl_20220117164906025_57"
      unitRef="USD">-1636000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20240414131402995_xbrl_20240414131133003"
      unitRef="USD">0</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_ifrsfullProvisionForTaxesOtherThanIncomeTaxMember"
      decimals="-3"
      id="Fxbrl_20220117165513238_xbrl_20220117164906025_511"
      unitRef="USD">558000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20220117165513252_xbrl_20220117164906025_63"
      unitRef="USD">1254000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20220117165513252_xbrl_20220117164906025_67"
      unitRef="USD">-224000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20240414131402997_xbrl_20240414131147291"
      unitRef="USD">0</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribTaxValueOfLossCarryForwardsMember"
      decimals="-3"
      id="Fxbrl_20220117165513252_xbrl_20220117164906025_611"
      unitRef="USD">1030000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20221231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20220117165513263_xbrl_20220117164906025_73"
      unitRef="USD">-985000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20220117165513263_xbrl_20220117164906025_77"
      unitRef="USD">-270000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20230101to20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20240414131402998_xbrl_20240414131157003"
      unitRef="USD">0</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_tribOtherItemsMember"
      decimals="-3"
      id="Fxbrl_20220117165513263_xbrl_20220117164906025_711"
      unitRef="USD">-1255000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20250512171348973"
      unitRef="USD">-840000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230413163837410"
      unitRef="USD">323000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240414131426540"
      unitRef="USD">192000</trib:DeferredTaxExpenseIncomeRecognisedDiscontinuedOperations>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220117165635376_xbrl_20220117164906025_811"
      unitRef="USD">-325000</ifrs-full:DeferredTaxLiabilityAsset>
    <trib:DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20230420125833020">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capital
        losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        operating losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;180,810&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;136,202&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US
        alternative minimum tax credits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;1,791&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,790&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        temporary timing differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,246&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;57,986&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US
        state credit carry-forwards&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210,140&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;208,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutDeferredTaxAssetsNotRecognisedExplanatory>
    <trib:DeferredTaxAssetsCapitalLossCarryforward
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220117165725471_23"
      unitRef="USD">8293000</trib:DeferredTaxAssetsCapitalLossCarryforward>
    <trib:DeferredTaxAssetsCapitalLossCarryforward
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220117165725471_27"
      unitRef="USD">8293000</trib:DeferredTaxAssetsCapitalLossCarryforward>
    <trib:DeferredTaxAssetsOperatingLossDomestic
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220117165725471_33"
      unitRef="USD">180810000</trib:DeferredTaxAssetsOperatingLossDomestic>
    <trib:DeferredTaxAssetsOperatingLossDomestic
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220117165725471_37"
      unitRef="USD">136202000</trib:DeferredTaxAssetsOperatingLossDomestic>
    <trib:DeferredTaxAssetsUsAlternativeMinimumTaxCredits
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250513161404099"
      unitRef="USD">1791000</trib:DeferredTaxAssetsUsAlternativeMinimumTaxCredits>
    <trib:DeferredTaxAssetsUsAlternativeMinimumTaxCredits
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220117165725471_47"
      unitRef="USD">1790000</trib:DeferredTaxAssetsUsAlternativeMinimumTaxCredits>
    <trib:DeferredTaxAssetsOtherTemporaryTimingDifferences
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220117165725471_53"
      unitRef="USD">19246000</trib:DeferredTaxAssetsOtherTemporaryTimingDifferences>
    <trib:DeferredTaxAssetsOtherTemporaryTimingDifferences
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220117165725471_57"
      unitRef="USD">57986000</trib:DeferredTaxAssetsOtherTemporaryTimingDifferences>
    <trib:DeferredTaxAssetsOperatingLossCarryforwardsState
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230421022610748"
      unitRef="USD">0</trib:DeferredTaxAssetsOperatingLossCarryforwardsState>
    <trib:DeferredTaxAssetsOperatingLossCarryforwardsState
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220117165725471_67"
      unitRef="USD">4015000</trib:DeferredTaxAssetsOperatingLossCarryforwardsState>
    <trib:DeferredTaxAssetsOperatingLossCarryforward
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220117165725471_83"
      unitRef="USD">210140000</trib:DeferredTaxAssetsOperatingLossCarryforward>
    <trib:DeferredTaxAssetsOperatingLossCarryforward
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220117165725471_87"
      unitRef="USD">208286000</trib:DeferredTaxAssetsOperatingLossCarryforward>
    <ifrs-full:DisclosureOfOtherAssetsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220115170221607">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;OTHER NON-CURRENT ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finance
        lease receivables (see Note 17)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group leases instruments as part of its business. For details of future minimum finance lease receivables with non-cancellable terms,
please refer to Note 17.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfOtherAssetsExplanatory>
    <trib:DisclosureOfDetailedInformationAboutOtherAssetsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240412213107455">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finance
        lease receivables (see Note 17)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutOtherAssetsExplanatory>
    <ifrs-full:NoncurrentFinanceLeaseReceivables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114182948302_13"
      unitRef="USD">0</ifrs-full:NoncurrentFinanceLeaseReceivables>
    <ifrs-full:NoncurrentFinanceLeaseReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114182948302_17"
      unitRef="USD">36000</ifrs-full:NoncurrentFinanceLeaseReceivables>
    <trib:OtherAssetNoncurrent
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20240412212938544"
      unitRef="USD">28000</trib:OtherAssetNoncurrent>
    <trib:OtherAssetNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114182948302_27"
      unitRef="USD">43000</trib:OtherAssetNoncurrent>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114182948302_43"
      unitRef="USD">28000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114182948302_47"
      unitRef="USD">79000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:DisclosureOfInventoriesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220422102056077">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;INVENTORIES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw
        materials and consumables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,053&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Work-in-progress&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,989&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,498&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished
        goods&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,353&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,382&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,374&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,933&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
assets of the Group, including inventories have been pledged as security for the term loan from Perceptive Advisors.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;All
inventories are stated at the lower of cost or net realisable value. Total inventories for the Group are shown net of provisions of US$7,648,000
(2023: US$11,344,000)
(2022: US$16,274,000).
Cost of sales in 2024 includes inventories expensed of US$38,001,000
(2023: US$35,091,000)
(2022: US$45,340,000).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-indent:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
movement on the inventory provision for the three-year period to December&#160;31, 2024 is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Opening
        provision at January&#160;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,344&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,063&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Charged
        during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,113&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,291&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Utilised
        during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,809&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,456&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,180&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Eliminated
        on disposal of business&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,765&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Closing
        provision at December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,648&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,344&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfInventoriesExplanatory>
    <trib:DisclosureOfDetailedInformationAboutInventoriesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413083359963">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw
        materials and consumables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,053&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Work-in-progress&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,989&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,498&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished
        goods&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,353&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,382&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,374&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,933&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutInventoriesExplanatory>
    <ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114183920220_13"
      unitRef="USD">10032000</ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies>
    <ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114183920220_17"
      unitRef="USD">10053000</ifrs-full:CurrentRawMaterialsAndCurrentProductionSupplies>
    <ifrs-full:WorkInProgress
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114183920220_23"
      unitRef="USD">4989000</ifrs-full:WorkInProgress>
    <ifrs-full:WorkInProgress
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114183920220_27"
      unitRef="USD">4498000</ifrs-full:WorkInProgress>
    <ifrs-full:FinishedGoods
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114183920220_33"
      unitRef="USD">4353000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114183920220_37"
      unitRef="USD">5382000</ifrs-full:FinishedGoods>
    <ifrs-full:Inventories
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114183920220_53"
      unitRef="USD">19374000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114183920220_57"
      unitRef="USD">19933000</ifrs-full:Inventories>
    <ifrs-full:InventoriesAtNetRealisableValue
      contextRef="C_20241231"
      decimals="0"
      id="Fxbrl_20220114185015437"
      unitRef="USD">7648000</ifrs-full:InventoriesAtNetRealisableValue>
    <ifrs-full:InventoriesAtNetRealisableValue
      contextRef="C_20231231"
      decimals="0"
      id="Fxbrl_20220426173801289"
      unitRef="USD">11344000</ifrs-full:InventoriesAtNetRealisableValue>
    <ifrs-full:InventoriesAtNetRealisableValue
      contextRef="C_20221231"
      decimals="0"
      id="Fxbrl_20220114185057452"
      unitRef="USD">16274000</ifrs-full:InventoriesAtNetRealisableValue>
    <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod
      contextRef="C_20240101to20241231"
      decimals="0"
      id="Fxbrl_20220114185129584"
      unitRef="USD">38001000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
    <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20220114185158228"
      unitRef="USD">35091000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
    <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20220114185303700"
      unitRef="USD">45340000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
    <trib:DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413083419823">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Opening
        provision at January&#160;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,344&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,063&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Charged
        during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,113&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,291&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Utilised
        during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,809&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,456&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,180&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Eliminated
        on disposal of business&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,765&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Closing
        provision at December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,648&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,344&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutMovementOnInventoryProvisionExplanatory>
    <ifrs-full:OtherProvisions
      contextRef="C_20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20220114184650874"
      unitRef="USD">11344000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="C_20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20220114184702438"
      unitRef="USD">16274000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="C_20211231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20220114184705586"
      unitRef="USD">12063000</ifrs-full:OtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20220114184146045_23"
      unitRef="USD">2113000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="C_20230101to20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20220114184146045_27"
      unitRef="USD">2291000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="C_20220101to20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20220114184146045_211"
      unitRef="USD">7391000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20220114184146045_33"
      unitRef="USD">5809000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="C_20230101to20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20220114184146045_37"
      unitRef="USD">5456000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="C_20220101to20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20220114184146045_311"
      unitRef="USD">3180000</ifrs-full:ProvisionUsedOtherProvisions>
    <trib:EliminatedOnDisposalOfBusiness
      contextRef="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20240413084538336"
      unitRef="USD">0</trib:EliminatedOnDisposalOfBusiness>
    <trib:EliminatedOnDisposalOfBusiness
      contextRef="C_20230101to20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20240430163145534"
      unitRef="USD">1765000</trib:EliminatedOnDisposalOfBusiness>
    <trib:EliminatedOnDisposalOfBusiness
      contextRef="C_20220101to20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20240430163149402"
      unitRef="USD">0</trib:EliminatedOnDisposalOfBusiness>
    <ifrs-full:OtherProvisions
      contextRef="C_20241231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20220114184823076_xbrl_20220114184650874"
      unitRef="USD">7648000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="C_20231231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20220114184823076_xbrl_20220114184702438"
      unitRef="USD">11344000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="C_20221231_ifrsfullClassesOfProvisionsAxis_tribProvisionForInventoriesMember"
      decimals="-3"
      id="Fxbrl_20220114184823076_xbrl_20220114184705586"
      unitRef="USD">16274000</ifrs-full:OtherProvisions>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413091539442">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;17.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;TRADE AND OTHER RECEIVABLES&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trade
        receivables, net of impairment losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,698&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Prepayments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,979&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,036&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Contract
        assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;460&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;525&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Value
        added tax&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;42&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Finance
        lease receivables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;119&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Consideration
        due from sale of business (Note 8)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;373&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other
        receivables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;168&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;107&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;16,065&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,901&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trade
receivables are shown net of an impairment losses provision of US$2,286,000
(2023: US$2,324,000)
(2022: US$2,691,000)
(see Note 27). Prepayments are shown after impairment charges of US$Nil
(2023: US$Nil)
(2022: US$482,000)
(see Note 5).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Long-term
contract receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="line-height:1.25;font-style:italic;margin-left:30pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(i)
Finance lease commitments &#x2013; Group as lessor&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The
Group leases instruments as part of its business. Future minimum receivables with non-cancellable terms are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December
        31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Gross&lt;br/&gt;investment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Unearned&lt;br/&gt;income&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Minimum&lt;br/&gt;payments&lt;br/&gt;receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Less
        than one year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Between
        one and five years (Note 15)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December
        31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Gross&lt;br/&gt;investment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Unearned&lt;br/&gt;income&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Minimum&lt;br/&gt;payments&lt;br/&gt;receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Less
        than one year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;170&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;119&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Between
        one and five years (Note 15)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;54&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;224&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The
Group classified future minimum lease receivables between one and five years of US$Nil
(2023: US$36,000)
as Other Assets, see Note 15. Under the terms of the lease arrangements, no contingent rents are receivable.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(ii)
Operating lease commitments &#x2013; Group as lessor&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The
Group leases instruments under operating leases as part of its business.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Future
minimum rentals receivable under non-cancellable operating leases are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December
        31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Less
        than one year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,461&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,461&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,461&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,461&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(ii)
Operating lease commitments &#x2013; Group as lessor&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December
        31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Less
        than one year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,995&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,995&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,995&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,995&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <trib:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512142116200">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trade
        receivables, net of impairment losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;10,698&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Prepayments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,979&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,036&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Contract
        assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;460&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;525&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Value
        added tax&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;42&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;43&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Finance
        lease receivables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;119&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Consideration
        due from sale of business (Note 8)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;373&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other
        receivables&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;168&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;107&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;16,065&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,901&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115142942808_13"
      unitRef="USD">13416000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115142942808_17"
      unitRef="USD">10698000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentPrepayments
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115142942808_23"
      unitRef="USD">1979000</ifrs-full:CurrentPrepayments>
    <ifrs-full:CurrentPrepayments
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115142942808_27"
      unitRef="USD">2036000</ifrs-full:CurrentPrepayments>
    <ifrs-full:CurrentContractAssets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115142942808_33"
      unitRef="USD">460000</ifrs-full:CurrentContractAssets>
    <ifrs-full:CurrentContractAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115142942808_37"
      unitRef="USD">525000</ifrs-full:CurrentContractAssets>
    <ifrs-full:CurrentValueAddedTaxReceivables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115142942808_43"
      unitRef="USD">42000</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentValueAddedTaxReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115142942808_47"
      unitRef="USD">43000</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentReceivablesFromRentalOfProperties
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115142942808_53"
      unitRef="USD">0</ifrs-full:CurrentReceivablesFromRentalOfProperties>
    <ifrs-full:CurrentReceivablesFromRentalOfProperties
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115142942808_57"
      unitRef="USD">119000</ifrs-full:CurrentReceivablesFromRentalOfProperties>
    <trib:ReceivablesFromConsiderationDueSaleOfBusiness
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20240413095227955_xbrl_20220115142942808_53"
      unitRef="USD">0</trib:ReceivablesFromConsiderationDueSaleOfBusiness>
    <trib:ReceivablesFromConsiderationDueSaleOfBusiness
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240413095227955_xbrl_20220115142942808_57"
      unitRef="USD">373000</trib:ReceivablesFromConsiderationDueSaleOfBusiness>
    <ifrs-full:OtherReceivables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20240413095230165_xbrl_20220115142942808_53"
      unitRef="USD">168000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240413095230165_xbrl_20220115142942808_57"
      unitRef="USD">107000</ifrs-full:OtherReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20240413095332685_xbrl_20230413173736667"
      unitRef="USD">16065000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240413095332685_xbrl_20230413173747389"
      unitRef="USD">13901000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250512142454034"
      unitRef="USD">2286000000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250512142500697"
      unitRef="USD">2324000000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20250512142511779"
      unitRef="USD">2691000000</ifrs-full:TradeReceivables>
    <ifrs-full:Prepayments
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250512142537589"
      unitRef="USD">0</ifrs-full:Prepayments>
    <ifrs-full:Prepayments
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250512142545716"
      unitRef="USD">0</ifrs-full:Prepayments>
    <ifrs-full:Prepayments
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20250512142556264"
      unitRef="USD">482000000</ifrs-full:Prepayments>
    <ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512142405559">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December
        31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Gross&lt;br/&gt;investment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Unearned&lt;br/&gt;income&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Minimum&lt;br/&gt;payments&lt;br/&gt;receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Less
        than one year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Between
        one and five years (Note 15)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December
        31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Gross&lt;br/&gt;investment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Unearned&lt;br/&gt;income&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Minimum&lt;br/&gt;payments&lt;br/&gt;receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Less
        than one year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;170&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;119&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Between
        one and five years (Note 15)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;54&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;224&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory>
    <trib:GrossInvestmentInFinanceLease
      contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20220115143430581_23"
      unitRef="USD">0</trib:GrossInvestmentInFinanceLease>
    <trib:UnearnedFinanceIncomeOnFinanceLease
      contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20220115143430581_27"
      unitRef="USD">0</trib:UnearnedFinanceIncomeOnFinanceLease>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20220115143430581_211"
      unitRef="USD">0</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:GrossInvestmentInFinanceLease
      contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220115143430581_33"
      unitRef="USD">0</trib:GrossInvestmentInFinanceLease>
    <trib:UnearnedFinanceIncomeOnFinanceLease
      contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220115143430581_37"
      unitRef="USD">0</trib:UnearnedFinanceIncomeOnFinanceLease>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220115143430581_311"
      unitRef="USD">0</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:GrossInvestmentInFinanceLease
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115143430581_53"
      unitRef="USD">0</trib:GrossInvestmentInFinanceLease>
    <trib:UnearnedFinanceIncomeOnFinanceLease
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115143430581_57"
      unitRef="USD">0</trib:UnearnedFinanceIncomeOnFinanceLease>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115143430581_511"
      unitRef="USD">0</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:GrossInvestmentInFinanceLease
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20220115143718292_xbrl_20220115143430581_23"
      unitRef="USD">170000</trib:GrossInvestmentInFinanceLease>
    <trib:UnearnedFinanceIncomeOnFinanceLease
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20220115143718292_xbrl_20220115143430581_27"
      unitRef="USD">4000</trib:UnearnedFinanceIncomeOnFinanceLease>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20220115143718292_xbrl_20220115143430581_211"
      unitRef="USD">119000</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:GrossInvestmentInFinanceLease
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220115143718299_xbrl_20220115143430581_33"
      unitRef="USD">54000</trib:GrossInvestmentInFinanceLease>
    <trib:UnearnedFinanceIncomeOnFinanceLease
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220115143718299_xbrl_20220115143430581_37"
      unitRef="USD">3000</trib:UnearnedFinanceIncomeOnFinanceLease>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220115143718299_xbrl_20220115143430581_311"
      unitRef="USD">36000</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:GrossInvestmentInFinanceLease
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115143806876_xbrl_20220115143430581_53"
      unitRef="USD">224000</trib:GrossInvestmentInFinanceLease>
    <trib:UnearnedFinanceIncomeOnFinanceLease
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115143806876_xbrl_20220115143430581_57"
      unitRef="USD">7000</trib:UnearnedFinanceIncomeOnFinanceLease>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115143806876_xbrl_20220115143430581_511"
      unitRef="USD">155000</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20240413094004582"
      unitRef="USD">0</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20250513132821452"
      unitRef="USD">36000</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <ifrs-full:DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512142427208">

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December
        31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Less
        than one year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,461&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,461&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,461&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,461&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(ii)
Operating lease commitments &#x2013; Group as lessor&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December
        31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Less
        than one year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,995&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,995&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,995&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,995&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfMaturityAnalysisOfFinanceLeasePaymentsReceivableExplanatory>
    <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived
      contextRef="C_20241231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20230426182306523_xbrl_20230420100522121"
      unitRef="USD">1461000</ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived>
    <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived
      contextRef="C_20241231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20230426182306523_xbrl_20230420100528944"
      unitRef="USD">1461000</ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived>
    <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived
      contextRef="C_20241231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember"
      decimals="-3"
      id="Fxbrl_20230426182314389_xbrl_20230420100822516"
      unitRef="USD">1461000</ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived>
    <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230426182314389_xbrl_20230420100852441"
      unitRef="USD">1461000</ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived>
    <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20230420100522121"
      unitRef="USD">1995000</ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived>
    <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived
      contextRef="C_20231231_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20230420100528944"
      unitRef="USD">1995000</ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived>
    <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_tribInstrumentsMember"
      decimals="-3"
      id="Fxbrl_20230420100822516"
      unitRef="USD">1995000</ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived>
    <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230420100852441"
      unitRef="USD">1995000</ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived>
    <ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512142719766">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:auto"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CASH AND CASH EQUIVALENTS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        at bank and in hand&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-align:right;line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory>
    <trib:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512142733996">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        at bank and in hand&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-align:right;line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory>
    <ifrs-full:Cash
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114233029161_13"
      unitRef="USD">5167000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114233029161_17"
      unitRef="USD">3691000</ifrs-full:Cash>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220114233029161_43"
      unitRef="USD">5167000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220114233029161_47"
      unitRef="USD">3691000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20230420104649169">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:auto"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CAPITAL AND RESERVES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share
capital&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
February 2024, the Company adjusted its ADS ratio from 1 ADS: 4 ordinary share to 1 ADS: 20 ordinary shares. The 2024 and 2023 ADS amounts
in the below tables reflect this change.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class
        &#x2018;A&#x2019;&lt;br/&gt;Ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;000s&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class
        &#x2018;A&#x2019;&lt;br/&gt;Ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;000s&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        thousands of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        issue at January&#160;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;165,866&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;164,986&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued
        for a cash consideration (a)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81,628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;880&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued
        for non-cash consideration (b)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;124,255&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        period end&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;371,749&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;165,866&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ADS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ADS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        thousands of ADSs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance
        at January&#160;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,249&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued
        for a cash consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,081&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued
        for non-cash consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        period end&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,587&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-indent:30.6pt;line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
amounts in the tables above are inclusive of Treasury Shares. The number of Treasury Shares is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class
        &#x2018;A&#x2019;&lt;br/&gt;Treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;000s&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class
        &#x2018;A&#x2019;&lt;br/&gt;Treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;000s&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        thousands of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance
        at January&#160;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Purchased
        during period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        period end&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class
        &#x2018;A&#x2019;&lt;br/&gt;Treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;000s&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class
        &#x2018;A&#x2019;&lt;br/&gt;Treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;000s&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        thousands of ADSs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance
        at January&#160;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Purchased
        during period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        period end&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:9pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(a)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the year ended December 31, 2024, the Company
        issued 81,628,000
        &#x2018;A&#x2019; Ordinary shares for a consideration of US$7.4
        million settled in cash. The Company incurred expenses of US$0.7
        million in connection with the issuances. No employee share options were exercised during the year.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:9pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(b)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the year ended December 31, 2024, the Company
        issued following shares for a consideration other than cash:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:27pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On January 31, 2024, the Company issued 36,000,000
        &#x2018;A&#x2019; Ordinary shares (1,800,000
        ADS) as a part of the purchase consideration to acquire Waveform Technologies Inc., as a wholly owned subsidiary.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:27pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On September 24, 2024, the Company issued 5,406,000
        &#x2018;A&#x2019; Ordinary shares (270,000
        ADS) as a part of the purchase consideration to acquire Metabolomic Diagnostics Limited, as a wholly owned subsidiary.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:27pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;iii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On October 10, 2024, the Company issued 13,000,000
        &#x2018;A&#x2019; Ordinary shares (650,000
        ADS) to Craig-Hallum pursuant to the Advisory Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:27pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;iv)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On October 10, 2024, the Company issued 7,237,000
        &#x2018;A&#x2019; Ordinary shares (362,000
        ADS) to Native Design Limited pursuant to a design services agreement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:27pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;v)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On October 25, 2024, the Company issued 34,612,000
        &#x2018;A&#x2019; Ordinary shares (1,731,000
        ADS) as a purchase consideration to acquire EpiCapture Limited, as a wholly owned subsidiary.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:27pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;vi)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On October 25, 2024, the Company issued 28,000,000
        &#x2018;A&#x2019; Ordinary shares (1,400,000
        ADS) as a purchase consideration to acquire 12.5%
        equity stake in Novus Diagnostics.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Translation
reserve&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
translation reserve comprises all foreign exchange differences arising from the translation of the financial statements of foreign currency
denominated operations of the Group since January&#160;1, 2004.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
reserves&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
reserves comprise the hedging reserve of US$23,000.
The hedging reserve comprises the effective portion of the cumulative net change in the fair value of cash flow hedging instruments related
to hedged transactions entered into but not yet crystallised. The hedging reserve is shown within Other Reserves in the Consolidated Statement
of Financial Position.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Equity
component of Convertible Note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
May 2022, the Company completed a US$45.2
million investment from MiCo IVD Holdings, LLC&#160;(&#x201c;MiCo&#x201d;). The investment consisted of an equity investment of US$25.2
million and a seven-year,
unsecured junior convertible note of US$20.0
million. The convertible note mandatorily converts into ADSs if the volume weighted average price of the Company&#x2019;s ADSs is at or
above US$16.20
for any five consecutive NASDAQ trading days. The convertible loan is accounted for as a compound financial instrument containing both
an equity and liability element. The equity component of the convertible note is US$6.7
million. There is no remeasurement of the equity element following initial recognition.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Treasury
shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
2024, the Group did not purchase any &#x2018;A&#x2019; Ordinary shares (2023: nil)
(2022: nil)
&#x2018;Treasury shares&#x2019;.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512164828821">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class
        &#x2018;A&#x2019;&lt;br/&gt;Ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;000s&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class
        &#x2018;A&#x2019;&lt;br/&gt;Ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;000s&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        thousands of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        issue at January&#160;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;165,866&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;164,986&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued
        for a cash consideration (a)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81,628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;880&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued
        for non-cash consideration (b)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;124,255&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        period end&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;371,749&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;165,866&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ADS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ADS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        thousands of ADSs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance
        at January&#160;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,249&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued
        for a cash consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,081&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued
        for non-cash consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        period end&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,587&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-indent:30.6pt;line-height:1.25;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
amounts in the tables above are inclusive of Treasury Shares. The number of Treasury Shares is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class
        &#x2018;A&#x2019;&lt;br/&gt;Treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;000s&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class
        &#x2018;A&#x2019;&lt;br/&gt;Treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;000s&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        thousands of shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance
        at January&#160;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Purchased
        during period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        period end&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class
        &#x2018;A&#x2019;&lt;br/&gt;Treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;000s&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Class
        &#x2018;A&#x2019;&lt;br/&gt;Treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;000s&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        thousands of ADSs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance
        at January&#160;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Purchased
        during period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        period end&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20220115000936793_23"
      unitRef="Shares">165866000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20220115000936793_27"
      unitRef="Shares">164986000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20230413172244170"
      unitRef="Shares">81628000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20230413172229470"
      unitRef="Shares">880000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <trib:IssuedForNoncashConsideration
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20250512180527944_xbrl_20230413172244170"
      unitRef="Shares">124255000</trib:IssuedForNoncashConsideration>
    <trib:IssuedForNoncashConsideration
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20250512180527944_xbrl_20230413172229470"
      unitRef="Shares">0</trib:IssuedForNoncashConsideration>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20220115000936793_53"
      unitRef="Shares">371749000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20220115000936793_57"
      unitRef="Shares">165866000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20220115001534477_xbrl_20220115000936793_23"
      unitRef="Shares">8293000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20220115001534477_xbrl_20220115000936793_27"
      unitRef="Shares">8249000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20230413174835986"
      unitRef="Shares">4081000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20230413174847700"
      unitRef="Shares">44000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <trib:IssuedForNoncashConsideration
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20250512180549394_xbrl_20230413174835986"
      unitRef="Shares">6213000</trib:IssuedForNoncashConsideration>
    <trib:IssuedForNoncashConsideration
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20250512180549394_xbrl_20230413174847700"
      unitRef="Shares">0</trib:IssuedForNoncashConsideration>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20220115001556277_xbrl_20220115000936793_53"
      unitRef="Shares">18587000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-3"
      id="Fxbrl_20220115001556277_xbrl_20220115000936793_57"
      unitRef="Shares">8293000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:TreasuryShares
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220115004136546_xbrl_20220115001534477_xbrl_20220115000936793_23"
      unitRef="USD">12556000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220115004136546_xbrl_20220115001534477_xbrl_20220115000936793_27"
      unitRef="USD">12556000</ifrs-full:TreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220115004229488_xbrl_20220115001545580_xbrl_20220115000936793_33"
      unitRef="USD">0</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220115004229488_xbrl_20220115001545580_xbrl_20220115000936793_37"
      unitRef="USD">0</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220115004136554_xbrl_20220115001556277_xbrl_20220115000936793_53"
      unitRef="USD">12556000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassATreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220115004136554_xbrl_20220115001556277_xbrl_20220115000936793_57"
      unitRef="USD">12556000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220115004359377_xbrl_20220115004136546_xbrl_20220115001534477_xbrl_20220115000936793_23"
      unitRef="USD">628000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220115004359377_xbrl_20220115004136546_xbrl_20220115001534477_xbrl_20220115000936793_27"
      unitRef="USD">628000</ifrs-full:TreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220115004359393_xbrl_20220115004229488_xbrl_20220115001545580_xbrl_20220115000936793_33"
      unitRef="USD">0</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220115004359393_xbrl_20220115004229488_xbrl_20220115001545580_xbrl_20220115000936793_37"
      unitRef="USD">0</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220115004359404_xbrl_20220115004136554_xbrl_20220115001556277_xbrl_20220115000936793_53"
      unitRef="USD">628000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember"
      decimals="-3"
      id="Fxbrl_20220115004359404_xbrl_20220115004136554_xbrl_20220115001556277_xbrl_20220115000936793_57"
      unitRef="USD">628000</ifrs-full:TreasuryShares>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-3"
      id="Fxbrl_20250513150355973"
      unitRef="Shares">81628000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-5"
      id="Fxbrl_20230413202751678"
      unitRef="USD">7400000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-5"
      id="Fxbrl_20230413202756252"
      unitRef="USD">700000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20240101to20240131_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncMember"
      decimals="INF"
      id="Fxbrl_20250512164918210"
      unitRef="Shares">36000000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20240101to20240131_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncMember"
      decimals="INF"
      id="Fxbrl_20250512164925713"
      unitRef="Shares">1800000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20240901to20240924_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicDiagnosticsLimitedMember"
      decimals="INF"
      id="Fxbrl_20250512165014645"
      unitRef="Shares">5406000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20240901to20240924_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicDiagnosticsLimitedMember"
      decimals="INF"
      id="Fxbrl_20250512165328850"
      unitRef="Shares">270000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribCraigHallumMember"
      decimals="INF"
      id="Fxbrl_20250512165018859"
      unitRef="Shares">13000000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribCraigHallumMember"
      decimals="INF"
      id="Fxbrl_20250512165332647"
      unitRef="Shares">650000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNativeDesignLimitedMember"
      decimals="INF"
      id="Fxbrl_20250512165023646"
      unitRef="Shares">7237000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20241001to20241010_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNativeDesignLimitedMember"
      decimals="INF"
      id="Fxbrl_20250512165336769"
      unitRef="Shares">362000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember"
      decimals="INF"
      id="Fxbrl_20250512165028494"
      unitRef="Shares">34612000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember"
      decimals="INF"
      id="Fxbrl_20250512165345654"
      unitRef="Shares">1731000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovusDiagnosticsLimitedMember"
      decimals="INF"
      id="Fxbrl_20250512165312406"
      unitRef="Shares">28000000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="C_20241001to20241025_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareTreasurySharesMember_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovusDiagnosticsLimitedMember"
      decimals="INF"
      id="Fxbrl_20250512165349502"
      unitRef="Shares">1400000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="C_20241025_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovusDiagnosticsLimitedMember"
      decimals="3"
      id="Fxbrl_20250512181713449"
      unitRef="Pure">0.125</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:ReserveOfCashFlowHedges
      contextRef="C_20241231"
      decimals="0"
      id="Fxbrl_20230413210434825"
      unitRef="USD">23000</ifrs-full:ReserveOfCashFlowHedges>
    <ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments
      contextRef="C_20220501to20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember"
      decimals="-5"
      id="Fxbrl_20230413210557724"
      unitRef="USD">45200000</ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="C_20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember"
      decimals="-5"
      id="Fxbrl_20230413210837416"
      unitRef="USD">25200000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <ifrs-full:BorrowingsMaturity
      contextRef="C_20220501to20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember"
      id="Fxbrl_20230413211657270">seven-year</ifrs-full:BorrowingsMaturity>
    <ifrs-full:Borrowings
      contextRef="C_20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember"
      decimals="-5"
      id="Fxbrl_20230413210832777"
      unitRef="USD">20000000</ifrs-full:Borrowings>
    <trib:MaximumWeightedAveragePriceOfAmericanDepositoryShares
      contextRef="C_20220501to20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember"
      decimals="2"
      id="Fxbrl_20230413210840939"
      unitRef="USD_per_share">16.2</trib:MaximumWeightedAveragePriceOfAmericanDepositoryShares>
    <ifrs-full:ReserveOfEquityComponentOfConvertibleInstruments
      contextRef="C_20220531_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember"
      decimals="-5"
      id="Fxbrl_20230426184739838"
      unitRef="USD">6700000</ifrs-full:ReserveOfEquityComponentOfConvertibleInstruments>
    <trib:PurchaseOfTreasuryShare
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20230414133842617"
      unitRef="Shares">0</trib:PurchaseOfTreasuryShare>
    <trib:PurchaseOfTreasuryShare
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20230414133903303"
      unitRef="Shares">0</trib:PurchaseOfTreasuryShare>
    <trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory contextRef="C_20240101to20241231" id="F20240413052446065_0">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:auto"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SHARE OPTIONS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under
the terms of the Company&#x2019;s Employee Share Option Plans, options to purchase 40,506,672&#x2018;A&#x2019;
Ordinary Shares (2,025,334
ADS&#x2019;s) were outstanding at December&#160;31, 2024. Under these Plans, options are granted to officers and employees of the Group
at the discretion of the Compensation Committee (designated by the Board of Directors), under the terms outlined below.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share
options are sometimes granted to consultants of the Group and the fair value of the services provided by these consultants is measured
by reference to the fair value of the equity instruments granted. This approach is adopted as it is impractical for the Group to reliably
estimate the fair value of such services. There are 2,000,000
outstanding options for consultants at December 31, 2024.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
terms and conditions of the grants are as follows, whereby all options are settled by physical delivery of shares:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vesting
conditions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
options vest following a period of service by the officer or employee. The required period of service is determined by the Board or any
other relevant delegated committee at the date of grant of the options (usually the date of approval by the Compensation Committee) and
it is generally over a two to four-year period.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-vesting
conditions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Since
2022, share options were granted to directors and certain employees for which there is a condition that the options only become exercisable
into ADSs when the market price of an ADS reaches a certain level. This is deemed to be a non-vesting condition. The term &#x2018;non-vesting
condition&#x2019; is not explicitly defined in IFRS 2, Share based payments, but is inferred to be any condition that does not meet the
definition of a vesting condition. The only condition for these particular options to vest is that the director or employee continues
service and there were no other conditions which would be considered non-vesting conditions. Non-vesting conditions are reflected in measuring
the grant-date fair value of the share-based payment and there is no true-up in the measurement of the share-based payment for differences
between the expected and the actual outcome of non-vesting conditions. If all service conditions are met, then the share-based payment
cost will be recognized even if the director or employee does not receive the share-based payment due to a failure to meet the non-vesting
condition.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contractual
life&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
term of an option is determined by the Board of Directors, typically through its Remuneration Committee and Employee Compensation Committee,
provided that the term may not exceed ten years from the date of grant. All options will terminate 90 days after termination of the option
holder&#x2019;s employment, service or consultancy with the Group (or one year after such termination because of death or disability) except
where a longer period is approved by the Board of Directors. Under certain circumstances involving a change in control of the Group, the
Board may accelerate the exercisability and termination of options.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
number and weighted average exercise price of share options per ordinary share is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;Share Options &#x2018;A&#x2019; Ordinary Shares&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;Weighted- average exercise price US$ Per&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&#x2018;A&#x2019; Ordinary Share&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;Range US$ Per &#x2018;A&#x2019; Ordinary Share&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Outstanding January&#160;1, 2022&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;18,727,990&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.78&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-4.36&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Granted&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;29,400,000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.27&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.27-0.29&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Exercised&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(2,733,328&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-0.19&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Expired / Forfeited&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(579,990&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1.87&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.69-4.36&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Outstanding December 31, 2022&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;44,814,672&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.47&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-2.43&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td rowspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Exercisable December 31, 2022&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;14,138,004&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.89&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-2.43&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Outstanding January&#160;1, 2023&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;44,814,672&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.47&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-2.43&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Granted&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;19,600,000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.14&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.12-0.25&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Exercised&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(880,000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-0.19&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Expired / Forfeited&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(16,620,000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.33&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.27-2.43&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Outstanding December 31, 2023&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;46,914,672&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.39&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.12-1.34&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Exercisable December 31, 2023&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;19,764,672&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.67&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-1.34&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Outstanding January&#160;1, 2024&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;46,914,672&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.39&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.12-1.34&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Granted&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;12,100,000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.14&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.14-0.14&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Expired / Forfeited&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(18,508,000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.50&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.12-1.34&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Outstanding December 31, 2024&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;40,506,672&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.26&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.12-1.29&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Exercisable December 31, 2024&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;17,275,422&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.41&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.12-1.29&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;In
February 2024, the Company adjusted its ADS ratio from 1 ADS: 4 ordinary shares to 1 ADS: 20 ordinary shares.&lt;/span&gt; The 2024 and 2023
ADS amounts in the below tables reflect this change.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
number and weighted average exercise price of share options per ADS is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share
        Options &#x2018;ADS&#x2019; Equivalent&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-
        average exercise price US$ Per &#x2018;ADS&#x2019;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Range
        US$ Per &#x2018;ADS&#x2019;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding
        January&#160;1, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;936,400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-87.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,470,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.40-5.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(136,666&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-3.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired
        / Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(29,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.80-87.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding
        December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,240,734&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-48.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable
        December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;706,900&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-48.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding
        January&#160;1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,240,734&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-48.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;980,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.40-5.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(44,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-3.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired
        / Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(831,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.40-48.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding
        December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,345,734&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.40-26.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable
        December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;988,234&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-26.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding
        January&#160;1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,345,734&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.40-26.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;605,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.80-2.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired
        / Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(925,400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.40-26.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding
        December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,025,334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.40-25.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable
        December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;863,771&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.40-25.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman', serif"&gt;

&lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
opening share price per &#x2018;A&#x2019; Ordinary share at the start of the financial year was US$0.10
or US$2.00
per ADS (2023: US$0.24
per &#x2018;A&#x2019; ordinary share or US$4.8
per ADS) (2022: US$0.36
per &#x2018;A&#x2019; ordinary share or US$7.35
per ADS) and the closing share price at December&#160;31, 2024 was US$0.04
per &#x2018;A&#x2019; ordinary share or US$0.88
per ADS (2023: US$0.11
per &#x2018;A&#x2019; ordinary share or US$2.15
per ADS) (2022: US$0.25
per &#x2018;A&#x2019; ordinary share or US$4.95
per ADS). The average share price for the year ended December&#160;31, 2024 was US$0.10
per &#x2018;A&#x2019; Ordinary share or US$1.96
per ADS.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A
summary of the range of prices for the Company&#x2019;s share options for the year ended December&#160;31, 2024 follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman', Times, serif"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;


&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Exercise
        price range&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of&lt;br/&gt;options&lt;br/&gt;&#x2018;A&#x2019; ordinary&lt;br/&gt;shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of&lt;br/&gt;options&lt;br/&gt;&#x2018;A&#x2019; ordinary&lt;br/&gt;shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$0.12-US$0.99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,356,672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,125,422&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$1.00-US$1.29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.76&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,506,672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,275,422&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Exercise
        price range&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of&lt;br/&gt;options&lt;br/&gt;&#x2018;ADS&lt;br/&gt;equivalent&#x2019;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of&lt;br/&gt;options&lt;br/&gt;&#x2018;ADS&lt;br/&gt;equivalent&#x2019;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$2.40-US$19.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,017,834&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;856,271&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$20.00-US$25.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,025,334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;863,771&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
weighted-average remaining contractual life of options outstanding at December&#160;31, 2024 was 4.98
years (2023: 5.03
years).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A
summary of the range of prices for the Company&#x2019;s share options for the year ended December&#160;31, 2023 follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Exercise price
        range&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of&lt;br/&gt;options&lt;br/&gt;&#x2018;A&#x2019;
        ordinary&lt;br/&gt;shares&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of&lt;br/&gt;options&lt;br/&gt;&#x2018;A&#x2019;
        ordinary&lt;br/&gt;shares&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$0.12-US$0.99&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,266,672&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.28&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.50&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,116,672&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.47&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.16&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$1.00-US$1.74&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,648,000&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.33&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.79&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,648,000&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.33&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.79&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,914,672&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,764,672&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;
        &lt;div style="margin-right:62.3pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Exercise
        price range &lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of&lt;br/&gt;options&lt;br/&gt;&#x2018;ADS&lt;br/&gt;equivalent&#x2019;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of&lt;br/&gt;options&lt;br/&gt;&#x2018;ADS&lt;br/&gt;equivalent&#x2019;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$2.40-US$19.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,113,334&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.64&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.50&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;755,834&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.32&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.16&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$20.00-US$34.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;232,400&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.54&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.79&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;232,400&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.54&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.79&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,345,734&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;988,234&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Charge
for the year under IFRS 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
charge for the year is calculated based on the fair value of the options granted which have not yet vested.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;

&lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;The
fair value of the options is expensed over the vesting period of the option. In 2024, US$1,316,000
(2023: US$2,069,000)
(2022: US$1,755,000)
was charged to the statement of operations split as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based
        payments &#x2013; cost of sales&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based
        payments &#x2013; selling, general and administrative&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        &#x2013; continuing operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based
        payments &#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman', serif"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No
share-based payment expense was capitalised in intangible development project assets during the years ended December 31, 2022, 2023 or
2024.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
fair value of services received in return for share options granted are measured by reference to the fair value of share options granted.
The estimate of the fair value of services received is measured based on a Black-Scholes model. The following are the input assumptions
used in determining the fair value of share options granted in 2024, 2023 and 2022:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30pt;line-height:1.25;font-family:Times New Roman, serif;margin-bottom:0pt"&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Key&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;management&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;personnel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Key&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;management&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;personnel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Key&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;management&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;personnel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average
        fair value at measurement date per &#x2018;A&#x2019; share / (per ADS)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$0.10
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$2.08&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.50
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$10.04&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.19
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$3.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total &#x2018;A&#x2019;
        share options granted / (ADS&#x2019;s equivalent)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,100,000
        / (605,000&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,600,000
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(980,000&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,400,000
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,470,000&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average
        share price per &#x2018;A&#x2019; share / (per ADS)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.14/&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$2.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.14
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$2.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.27
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$5.40&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average
        exercise price per &#x2018;A&#x2019; share / (per ADS)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.14
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$2.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.14
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$2.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.27
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$5.40&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average
        expected volatility&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74.40&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40.21&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76.79&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average
        expected life&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.82&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average
        risk-free interest rate&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.06&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.13&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.59&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
expected life of the options is based on historical data and is not necessarily indicative of exercise patterns that may occur. The expected
volatility is based on the historic volatility (calculated based on the expected life of the options). The Group has considered how future
experience may affect historical volatility. The profile and activities of the Group are not expected to change in the immediate future
and therefore Trinity Biotech would expect estimated volatility to be consistent with historical volatility.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
model assumed an expected dividend yield of 0%, consistent with the Group&#x2019;s current dividend policy.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt; &lt;/div&gt;
&lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfShareOptionsAndShareWarrantsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446439_217"
      unitRef="Share">40506672</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="F20240413052446533_275"
      unitRef="Share">2025334</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20241231"
      decimals="0"
      id="Fxbrl_20250513034239149"
      unitRef="Share">2000000</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory contextRef="C_20240101to20241231" id="F20240413052446074_3">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;Share Options &#x2018;A&#x2019; Ordinary Shares&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;Weighted- average exercise price US$ Per&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&#x2018;A&#x2019; Ordinary Share&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;Range US$ Per &#x2018;A&#x2019; Ordinary Share&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Outstanding January&#160;1, 2022&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;18,727,990&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.78&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-4.36&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Granted&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;29,400,000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.27&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.27-0.29&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Exercised&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(2,733,328&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-0.19&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Expired / Forfeited&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(579,990&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1.87&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.69-4.36&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Outstanding December 31, 2022&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;44,814,672&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.47&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-2.43&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td rowspan="1" style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Exercisable December 31, 2022&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;14,138,004&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.89&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-2.43&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Outstanding January&#160;1, 2023&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;44,814,672&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.47&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-2.43&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Granted&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;19,600,000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.14&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.12-0.25&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Exercised&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(880,000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-0.19&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Expired / Forfeited&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(16,620,000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.33&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.27-2.43&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Outstanding December 31, 2023&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;46,914,672&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.39&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.12-1.34&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Exercisable December 31, 2023&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;19,764,672&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.67&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.19-1.34&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Outstanding January&#160;1, 2024&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;46,914,672&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.39&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.12-1.34&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Granted&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;12,100,000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.14&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.14-0.14&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Expired / Forfeited&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(18,508,000&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.50&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.12-1.34&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Outstanding December 31, 2024&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;40,506,672&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.26&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.12-1.29&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Exercisable December 31, 2024&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;17,275,422&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.41&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;0.12-1.29&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;In
February 2024, the Company adjusted its ADS ratio from 1 ADS: 4 ordinary shares to 1 ADS: 20 ordinary shares.&lt;/span&gt; The 2024 and 2023
ADS amounts in the below tables reflect this change.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
number and weighted average exercise price of share options per ADS is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share
        Options &#x2018;ADS&#x2019; Equivalent&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-
        average exercise price US$ Per &#x2018;ADS&#x2019;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Range
        US$ Per &#x2018;ADS&#x2019;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding
        January&#160;1, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;936,400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-87.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,470,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.40-5.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(136,666&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-3.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired
        / Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(29,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.80-87.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding
        December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,240,734&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-48.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable
        December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;706,900&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-48.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding
        January&#160;1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,240,734&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-48.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;980,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.40-5.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(44,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-3.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired
        / Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(831,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.40-48.60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding
        December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,345,734&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.40-26.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable
        December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;988,234&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.80-26.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding
        January&#160;1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,345,734&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.40-26.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;605,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.80-2.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired
        / Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(925,400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.40-26.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding
        December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,025,334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.40-25.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable
        December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;863,771&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.40-25.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutShareOptionsAndWarrantsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446076_4"
      unitRef="Share">18727990</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20250513024535497"
      unitRef="USD_per_share">0.78</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120539072"
      unitRef="USD_per_share">0.19</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120556071"
      unitRef="USD_per_share">4.36</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20250513024511889"
      unitRef="Share">29400000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20250513024525968"
      unitRef="USD_per_share">0.27</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120605679"
      unitRef="USD_per_share">0.27</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120609063"
      unitRef="USD_per_share">0.29</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446083_8"
      unitRef="Share">2733328</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446118_25"
      unitRef="USD_per_share">0.19</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120623351"
      unitRef="USD_per_share">0.19</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120626640"
      unitRef="USD_per_share">0.19</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446087_9"
      unitRef="Share">579990</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446117_24"
      unitRef="USD_per_share">1.87</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120634520"
      unitRef="USD_per_share">0.69</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120637223"
      unitRef="USD_per_share">4.36</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="Fxbrl_20240413111003291"
      unitRef="Share">44814672</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240413111016987"
      unitRef="USD_per_share">0.47</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120646567"
      unitRef="USD_per_share">0.19</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120652968"
      unitRef="USD_per_share">2.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446079_6"
      unitRef="Share">14138004</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446104_18"
      unitRef="USD_per_share">0.89</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120701719"
      unitRef="USD_per_share">0.19</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120705071"
      unitRef="USD_per_share">2.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446093_12"
      unitRef="Share">44814672</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446108_20"
      unitRef="USD_per_share">0.47</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120718800"
      unitRef="USD_per_share">0.19</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120721584"
      unitRef="USD_per_share">2.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446094_13"
      unitRef="Share">19600000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446120_26"
      unitRef="USD_per_share">0.14</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120728800"
      unitRef="USD_per_share">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120734904"
      unitRef="USD_per_share">0.25</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446099_15"
      unitRef="Share">880000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446125_28"
      unitRef="USD_per_share">0.19</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120744167"
      unitRef="USD_per_share">0.19</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120750559"
      unitRef="USD_per_share">0.19</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446489_249"
      unitRef="Share">16620000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446546_283"
      unitRef="USD_per_share">0.33</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120759920"
      unitRef="USD_per_share">0.27</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120805159"
      unitRef="USD_per_share">2.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446493_252"
      unitRef="Share">46914672</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446552_286"
      unitRef="USD_per_share">0.39</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120814391"
      unitRef="USD_per_share">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120817719"
      unitRef="USD_per_share">1.34</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446495_253"
      unitRef="Share">19764672</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446549_284"
      unitRef="USD_per_share">0.67</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120834487"
      unitRef="USD_per_share">0.19</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513120841479"
      unitRef="USD_per_share">1.34</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446498_254"
      unitRef="Share">46914672</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446550_285"
      unitRef="USD_per_share">0.39</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121026184"
      unitRef="USD_per_share">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121032728"
      unitRef="USD_per_share">1.34</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446096_14"
      unitRef="Share">12100000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446123_27"
      unitRef="USD_per_share">0.14</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121038287"
      unitRef="USD_per_share">0.14</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121041223"
      unitRef="USD_per_share">0.14</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446101_16"
      unitRef="Share">18508000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446128_30"
      unitRef="USD_per_share">0.5</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121047567"
      unitRef="USD_per_share">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121050904"
      unitRef="USD_per_share">1.34</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446091_11"
      unitRef="Share">40506672</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446111_21"
      unitRef="USD_per_share">0.26</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121057044"
      unitRef="USD_per_share">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121100368"
      unitRef="USD_per_share">1.29</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446089_10"
      unitRef="Share">17275422</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="F20240413052446113_22"
      unitRef="USD_per_share">0.41</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121106103"
      unitRef="USD_per_share">0.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121109279"
      unitRef="USD_per_share">1.29</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="F20240413052446133_37"
      unitRef="Share">936400</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="F20240413052446133_36"
      unitRef="USD_per_share">15.6</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121322663"
      unitRef="USD_per_share">3.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20211231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121326864"
      unitRef="USD_per_share">87.2</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20250513031126944_xbrl_20220119161141174_20240413052446094_13"
      unitRef="Share">1470000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20250513031126944_xbrl_20220119161141174_20240413052446120_26"
      unitRef="USD_per_share">5.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121333728"
      unitRef="USD_per_share">5.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121337151"
      unitRef="USD_per_share">5.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20250513031136569_20240413052446148_49"
      unitRef="Share">136666</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20250513031136569_20240413052446150_50"
      unitRef="USD_per_share">3.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121343072"
      unitRef="USD_per_share">3.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121346072"
      unitRef="USD_per_share">3.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="F20240413052446138_41"
      unitRef="Share">29000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="F20240413052446138_40"
      unitRef="USD_per_share">37.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121354519"
      unitRef="USD_per_share">13.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20220101to20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121357264"
      unitRef="USD_per_share">87.2</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220119161141144_20240413052446078_5"
      unitRef="Share">2240734</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220119161141144_20240413052446106_19"
      unitRef="USD_per_share">9.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121402840"
      unitRef="USD_per_share">3.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121408369"
      unitRef="USD_per_share">48.6</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220119161141152_20240413052446079_6"
      unitRef="Share">706900</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220119161141152_20240413052446104_18"
      unitRef="USD_per_share">17.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121414992"
      unitRef="USD_per_share">3.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121419064"
      unitRef="USD_per_share">48.6</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="F20240413052446152_51"
      unitRef="Share">2240734</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="F20240413052446154_52"
      unitRef="USD_per_share">9.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121427937"
      unitRef="USD_per_share">3.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121430768"
      unitRef="USD_per_share">48.6</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220119161141174_20240413052446094_13"
      unitRef="Share">980000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220119161141174_20240413052446120_26"
      unitRef="USD_per_share">2.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121436914"
      unitRef="USD_per_share">2.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121439840"
      unitRef="USD_per_share">5</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="F20240413052446148_49"
      unitRef="Share">44000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="F20240413052446150_50"
      unitRef="USD_per_share">3.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121445399"
      unitRef="USD_per_share">3.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121451976"
      unitRef="USD_per_share">3.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220119161141238_20240413052446101_16"
      unitRef="Share">831000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="F20240413052446501_256"
      unitRef="USD_per_share">6.6</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121458072"
      unitRef="USD_per_share">5.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121501179"
      unitRef="USD_per_share">48.6</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="F20240413052446140_42"
      unitRef="Share">2345734</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="F20240413052446502_257"
      unitRef="USD_per_share">7.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121509200"
      unitRef="USD_per_share">2.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121516912"
      unitRef="USD_per_share">26.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20250513031233216"
      unitRef="Share">988234</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="F20240413052446504_258"
      unitRef="USD_per_share">13.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121524624"
      unitRef="USD_per_share">3.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121528400"
      unitRef="USD_per_share">26.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220119161141213_20240413052446093_12"
      unitRef="Share">2345734</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220119161141213_20240413052446108_20"
      unitRef="USD_per_share">7.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121534176"
      unitRef="USD_per_share">2.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121536952"
      unitRef="USD_per_share">26.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="F20240413052446480_244"
      unitRef="Share">605000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="F20240413052446482_245"
      unitRef="USD_per_share">2.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121544735"
      unitRef="USD_per_share">2.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121547952"
      unitRef="USD_per_share">2.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220327031543955_xbrl_20220119161141238_20240413052446101_16"
      unitRef="Share">925400</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20220327031543955_xbrl_20220119161141238_20240413052446128_30"
      unitRef="USD_per_share">10</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121555672"
      unitRef="USD_per_share">2.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121558904"
      unitRef="USD_per_share">26.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220327031003039_20240413052446140_42"
      unitRef="Share">2025334</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="F20240413052446467_233"
      unitRef="USD_per_share">5.2</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121606808"
      unitRef="USD_per_share">2.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121610456"
      unitRef="USD_per_share">25.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="Fxbrl_20220327031018180_20240413052446141_43"
      unitRef="Share">863771</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="F20240413052446470_235"
      unitRef="USD_per_share">8.2</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121618568"
      unitRef="USD_per_share">2.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="Fxbrl_20250513121621800"
      unitRef="USD_per_share">25.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <trib:OpeningSharePrice
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240421222606767"
      unitRef="USD_per_share">0.1</trib:OpeningSharePrice>
    <trib:OpeningSharePrice
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20240421222613546"
      unitRef="USD_per_share">2</trib:OpeningSharePrice>
    <trib:OpeningSharePrice
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240421222619777"
      unitRef="USD_per_share">0.24</trib:OpeningSharePrice>
    <trib:OpeningSharePrice
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="1"
      id="Fxbrl_20240421222625560"
      unitRef="USD_per_share">4.8</trib:OpeningSharePrice>
    <trib:OpeningSharePrice
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240421222632305"
      unitRef="USD_per_share">0.36</trib:OpeningSharePrice>
    <trib:OpeningSharePrice
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20240421222639361"
      unitRef="USD_per_share">7.35</trib:OpeningSharePrice>
    <trib:ClosingExercisePriceOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240421222653544"
      unitRef="USD_per_share">0.04</trib:ClosingExercisePriceOfOutstandingShareOptions>
    <trib:ClosingExercisePriceOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20240421222702731"
      unitRef="USD_per_share">0.88</trib:ClosingExercisePriceOfOutstandingShareOptions>
    <trib:ClosingExercisePriceOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240421222709321"
      unitRef="USD_per_share">0.11</trib:ClosingExercisePriceOfOutstandingShareOptions>
    <trib:ClosingExercisePriceOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20240421222717178"
      unitRef="USD_per_share">2.15</trib:ClosingExercisePriceOfOutstandingShareOptions>
    <trib:ClosingExercisePriceOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240421222724552"
      unitRef="USD_per_share">0.25</trib:ClosingExercisePriceOfOutstandingShareOptions>
    <trib:ClosingExercisePriceOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20240421222731490"
      unitRef="USD_per_share">4.95</trib:ClosingExercisePriceOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="2"
      id="Fxbrl_20240421222740017"
      unitRef="USD_per_share">0.1</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:WeightedAverageSharePrice2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20240421222745858"
      unitRef="USD_per_share">1.96</ifrs-full:WeightedAverageSharePrice2019>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
      contextRef="C_20240101to20241231"
      id="F20240413052446637_336">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Exercise
        price range&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of&lt;br/&gt;options&lt;br/&gt;&#x2018;A&#x2019; ordinary&lt;br/&gt;shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No.
        of&lt;br/&gt;options&lt;br/&gt;&#x2018;A&#x2019; ordinary&lt;br/&gt;shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$0.12-US$0.99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,356,672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,125,422&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$1.00-US$1.29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.76&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,506,672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,275,422&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Exercise
        price range&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of&lt;br/&gt;options&lt;br/&gt;&#x2018;ADS&lt;br/&gt;equivalent&#x2019;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of&lt;br/&gt;options&lt;br/&gt;&#x2018;ADS&lt;br/&gt;equivalent&#x2019;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$2.40-US$19.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,017,834&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;856,271&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$20.00-US$25.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22.80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,025,334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;863,771&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Exercise price
        range&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of&lt;br/&gt;options&lt;br/&gt;&#x2018;A&#x2019;
        ordinary&lt;br/&gt;shares&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of&lt;br/&gt;options&lt;br/&gt;&#x2018;A&#x2019;
        ordinary&lt;br/&gt;shares&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$0.12-US$0.99&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,266,672&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.28&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.50&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,116,672&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.47&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.16&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$1.00-US$1.74&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,648,000&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.33&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.79&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,648,000&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.33&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.79&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;46,914,672&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,764,672&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;
        &lt;div style="margin-right:62.3pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Exercise
        price range &lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of&lt;br/&gt;options&lt;br/&gt;&#x2018;ADS&lt;br/&gt;equivalent&#x2019;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of&lt;br/&gt;options&lt;br/&gt;&#x2018;ADS&lt;br/&gt;equivalent&#x2019;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&#x2013;&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;life&lt;br/&gt;remaining&lt;br/&gt;(years)&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$2.40-US$19.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,113,334&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.64&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.50&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;755,834&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.32&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.16&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$20.00-US$34.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;232,400&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.54&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.79&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;232,400&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.54&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.79&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,345,734&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;988,234&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember"
      decimals="0"
      id="F20240413052446249_102"
      unitRef="Share">40356672</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:WeightedAverageExercisePriceOutstanding
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446252_103"
      unitRef="USD">0.25</trib:WeightedAverageExercisePriceOutstanding>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446253_104">P5Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <trib:NumberOfShareOptionsExercisableShareBasedPayment
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember"
      decimals="INF"
      id="F20240413052446255_105"
      unitRef="Shares">17125422</trib:NumberOfShareOptionsExercisableShareBasedPayment>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446257_106"
      unitRef="USD_per_share">0.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446258_107">P4Y9M10D</trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember"
      decimals="0"
      id="F20240413052446260_108"
      unitRef="Share">150000</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:WeightedAverageExercisePriceOutstanding
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446266_111"
      unitRef="USD">1.14</trib:WeightedAverageExercisePriceOutstanding>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446270_113">P2Y4M17D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <trib:NumberOfShareOptionsExercisableShareBasedPayment
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember"
      decimals="INF"
      id="F20240413052446274_115"
      unitRef="Shares">150000</trib:NumberOfShareOptionsExercisableShareBasedPayment>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446278_117"
      unitRef="USD_per_share">3.76</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesTwoOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446281_119">P2Y4M9D</trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446265_110"
      unitRef="Share">40506672</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:NumberOfShareOptionsExercisableShareBasedPayment
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="F20240413052446569_296"
      unitRef="Shares">17275422</trib:NumberOfShareOptionsExercisableShareBasedPayment>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember"
      decimals="0"
      id="F20240413052446316_148"
      unitRef="Share">2017834</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:WeightedAverageExercisePriceOutstanding
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446336_159"
      unitRef="USD">5</trib:WeightedAverageExercisePriceOutstanding>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446349_166">P5Y</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <trib:NumberOfShareOptionsExercisableShareBasedPayment
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember"
      decimals="INF"
      id="F20240413052446322_151"
      unitRef="Shares">856271</trib:NumberOfShareOptionsExercisableShareBasedPayment>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446362_173"
      unitRef="USD_per_share">8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446375_180">P4Y9M10D</trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember"
      decimals="0"
      id="F20240413052446317_149"
      unitRef="Share">7500</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:WeightedAverageExercisePriceOutstanding
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446338_160"
      unitRef="USD">22.8</trib:WeightedAverageExercisePriceOutstanding>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446351_167">P2Y4M17D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <trib:NumberOfShareOptionsExercisableShareBasedPayment
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember"
      decimals="INF"
      id="F20240413052446323_152"
      unitRef="Shares">7500</trib:NumberOfShareOptionsExercisableShareBasedPayment>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446364_174"
      unitRef="USD_per_share">22.8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019
      contextRef="C_20240101to20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFourOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446378_181">P3Y4M17D</trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="F20240413052446643_339"
      unitRef="Share">2025334</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:NumberOfShareOptionsExercisableShareBasedPayment
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="F20240413052446644_340"
      unitRef="Shares">863771</trib:NumberOfShareOptionsExercisableShareBasedPayment>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20240101to20241231"
      id="F20240413052446634_334">P4Y11M23D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20230101to20231231"
      id="F20240413052446635_335">P5Y10D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember"
      decimals="0"
      id="F20240413052446300_139"
      unitRef="Share">42266672</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:WeightedAverageExercisePriceOutstanding
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446301_140"
      unitRef="USD">0.28</trib:WeightedAverageExercisePriceOutstanding>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446303_141">P5Y6M</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <trib:NumberOfShareOptionsExercisableShareBasedPayment
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember"
      decimals="INF"
      id="F20240413052446449_223"
      unitRef="Shares">15116672</trib:NumberOfShareOptionsExercisableShareBasedPayment>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446451_224"
      unitRef="USD_per_share">0.47</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesOneOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446453_225">P4Y1M28D</trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember"
      decimals="0"
      id="Fxbrl_20220119170955938_20240413052446260_108"
      unitRef="Share">4648000</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:WeightedAverageExercisePriceOutstanding
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="Fxbrl_20220119170955938_20240413052446266_111"
      unitRef="USD">1.33</trib:WeightedAverageExercisePriceOutstanding>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember"
      id="Fxbrl_20220119170955938_20240413052446270_113">P0Y9M14D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <trib:NumberOfShareOptionsExercisableShareBasedPayment
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember"
      decimals="INF"
      id="Fxbrl_20220119170955938_20240413052446274_115"
      unitRef="Shares">4648000</trib:NumberOfShareOptionsExercisableShareBasedPayment>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="Fxbrl_20220119170955938_20240413052446278_117"
      unitRef="USD_per_share">1.33</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesFiveOfExercisePricesForOutstandingShareOptionsMember"
      id="Fxbrl_20220119170955938_20240413052446281_119">P0Y9M14D</trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="0"
      id="F20240413052446305_142"
      unitRef="Share">46914672</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:NumberOfShareOptionsExercisableShareBasedPayment
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="F20240413052446570_297"
      unitRef="Shares">19764672</trib:NumberOfShareOptionsExercisableShareBasedPayment>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember"
      decimals="0"
      id="F20240413052446306_143"
      unitRef="Share">2113334</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:WeightedAverageExercisePriceOutstanding
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446341_162"
      unitRef="USD">5.64</trib:WeightedAverageExercisePriceOutstanding>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446355_169">P5Y6M</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <trib:NumberOfShareOptionsExercisableShareBasedPayment
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember"
      decimals="INF"
      id="F20240413052446328_155"
      unitRef="Shares">755834</trib:NumberOfShareOptionsExercisableShareBasedPayment>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446368_176"
      unitRef="USD_per_share">9.32</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesThreeOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446381_183">P4Y1M28D</trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember"
      decimals="0"
      id="F20240413052446308_144"
      unitRef="Share">232400</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:WeightedAverageExercisePriceOutstanding
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446344_163"
      unitRef="USD">26.54</trib:WeightedAverageExercisePriceOutstanding>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446357_170">P0Y9M14D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <trib:NumberOfShareOptionsExercisableShareBasedPayment
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember"
      decimals="INF"
      id="F20240413052446327_154"
      unitRef="Shares">232400</trib:NumberOfShareOptionsExercisableShareBasedPayment>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember"
      decimals="2"
      id="F20240413052446370_177"
      unitRef="USD_per_share">26.54</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019
      contextRef="C_20230101to20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_tribRangesSixOfExercisePricesForOutstandingShareOptionsMember"
      id="F20240413052446382_184">P0Y9M14D</trib:WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="0"
      id="F20240413052446314_147"
      unitRef="Share">2345734</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:NumberOfShareOptionsExercisableShareBasedPayment
      contextRef="C_20231231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="F20240413052446334_158"
      unitRef="Shares">988234</trib:NumberOfShareOptionsExercisableShareBasedPayment>
    <trib:ShareBasedPaymentsContinuingOperations
      contextRef="C_20240101to20241231"
      decimals="0"
      id="F20240413052446645_341"
      unitRef="USD">1316000</trib:ShareBasedPaymentsContinuingOperations>
    <trib:ShareBasedPaymentsContinuingOperations
      contextRef="C_20230101to20231231"
      decimals="0"
      id="F20240413052446647_342"
      unitRef="USD">2069000</trib:ShareBasedPaymentsContinuingOperations>
    <trib:ShareBasedPaymentsContinuingOperations
      contextRef="C_20220101to20221231"
      decimals="0"
      id="F20240413052446649_343"
      unitRef="USD">1755000</trib:ShareBasedPaymentsContinuingOperations>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory contextRef="C_20240101to20241231" id="F20240413052446069_2">

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based
        payments &#x2013; cost of sales&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based
        payments &#x2013; selling, general and administrative&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        &#x2013; continuing operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based
        payments &#x2013; discontinued operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,069&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
    <trib:ShareBasedPaymentsCostOfSales
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="F20240413052446221_87"
      unitRef="USD">0</trib:ShareBasedPaymentsCostOfSales>
    <trib:ShareBasedPaymentsCostOfSales
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="F20240413052446223_88"
      unitRef="USD">0</trib:ShareBasedPaymentsCostOfSales>
    <trib:ShareBasedPaymentsCostOfSales
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="F20240413052446224_89"
      unitRef="USD">0</trib:ShareBasedPaymentsCostOfSales>
    <trib:ShareBasedPaymentsSellingGeneralAndAdministrative
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="F20240413052446226_90"
      unitRef="USD">1316000</trib:ShareBasedPaymentsSellingGeneralAndAdministrative>
    <trib:ShareBasedPaymentsSellingGeneralAndAdministrative
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="F20240413052446229_91"
      unitRef="USD">2069000</trib:ShareBasedPaymentsSellingGeneralAndAdministrative>
    <trib:ShareBasedPaymentsSellingGeneralAndAdministrative
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="F20240413052446231_92"
      unitRef="USD">1755000</trib:ShareBasedPaymentsSellingGeneralAndAdministrative>
    <trib:ShareBasedPaymentsContinuingOperations
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="F20240413052446232_93"
      unitRef="USD">1316000</trib:ShareBasedPaymentsContinuingOperations>
    <trib:ShareBasedPaymentsContinuingOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="F20240413052446234_94"
      unitRef="USD">2069000</trib:ShareBasedPaymentsContinuingOperations>
    <trib:ShareBasedPaymentsContinuingOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="F20240413052446236_95"
      unitRef="USD">1755000</trib:ShareBasedPaymentsContinuingOperations>
    <trib:ShareBasedPaymentsDiscontinuedOperations
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="F20240413052446237_96"
      unitRef="USD">0</trib:ShareBasedPaymentsDiscontinuedOperations>
    <trib:ShareBasedPaymentsDiscontinuedOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="F20240413052446240_97"
      unitRef="USD">0</trib:ShareBasedPaymentsDiscontinuedOperations>
    <trib:ShareBasedPaymentsDiscontinuedOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="F20240413052446242_98"
      unitRef="USD">0</trib:ShareBasedPaymentsDiscontinuedOperations>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="F20240413052446244_99"
      unitRef="USD">1316000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="F20240413052446245_100"
      unitRef="USD">2069000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="F20240413052446247_101"
      unitRef="USD">1755000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory contextRef="C_20240101to20241231" id="F20240413052446067_1">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Key&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;management&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;personnel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Key&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;management&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;personnel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Key&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;management&lt;/span&gt;&lt;br/&gt;&lt;span style="font-weight:bold"&gt;personnel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average
        fair value at measurement date per &#x2018;A&#x2019; share / (per ADS)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$0.10
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$2.08&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.50
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$10.04&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.19
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$3.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total &#x2018;A&#x2019;
        share options granted / (ADS&#x2019;s equivalent)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,100,000
        / (605,000&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,600,000
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(980,000&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,400,000
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,470,000&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average
        share price per &#x2018;A&#x2019; share / (per ADS)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.14/&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$2.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.14
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$2.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.27
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$5.40&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average
        exercise price per &#x2018;A&#x2019; share / (per ADS)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.14
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$2.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.14
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$2.80&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&#160;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US0.27
        /&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(US$5.40&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average
        expected volatility&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74.40&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40.21&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76.79&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average
        expected life&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.82&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted average
        risk-free interest rate&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.06&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.13&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.59&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="F20240413052446505_259"
      unitRef="USD">0.1</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="F20240413052446508_260"
      unitRef="USD">2.08</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="F20240413052446388_187"
      unitRef="USD">0.5</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="F20240413052446395_191"
      unitRef="USD">10.04</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="F20240413052446455_226"
      unitRef="USD">0.19</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="F20240413052446457_227"
      unitRef="USD">3.8</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <trib:TotalShareOptionsGrantedAdsEquivalent
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="INF"
      id="F20240413052446512_263"
      unitRef="Shares">12100000</trib:TotalShareOptionsGrantedAdsEquivalent>
    <trib:TotalShareOptionsGrantedAdsEquivalent
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="INF"
      id="Fxbrl_20240427021952282"
      unitRef="Shares">605000</trib:TotalShareOptionsGrantedAdsEquivalent>
    <trib:TotalShareOptionsGrantedAdsEquivalent
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="INF"
      id="F20240413052446390_188"
      unitRef="Shares">19600000</trib:TotalShareOptionsGrantedAdsEquivalent>
    <trib:TotalShareOptionsGrantedAdsEquivalent
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="INF"
      id="F20240413052446396_192"
      unitRef="Shares">980000</trib:TotalShareOptionsGrantedAdsEquivalent>
    <trib:TotalShareOptionsGrantedAdsEquivalent
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="INF"
      id="F20240413052446458_228"
      unitRef="Shares">29400000</trib:TotalShareOptionsGrantedAdsEquivalent>
    <trib:TotalShareOptionsGrantedAdsEquivalent
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="INF"
      id="F20240413052446460_229"
      unitRef="Shares">1470000</trib:TotalShareOptionsGrantedAdsEquivalent>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="F20240413052446520_267"
      unitRef="USD_per_share">0.14</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="F20240413052446521_268"
      unitRef="USD_per_share">2.8</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="F20240413052446392_189"
      unitRef="USD_per_share">0.14</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="F20240413052446399_193"
      unitRef="USD_per_share">2.8</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="F20240413052446461_230"
      unitRef="USD_per_share">0.27</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="F20240413052446463_231"
      unitRef="USD_per_share">5.4</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="F20240413052446579_302"
      unitRef="USD_per_share">0.14</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="F20240413052446576_301"
      unitRef="USD_per_share">2.8</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="F20240413052446572_298"
      unitRef="USD_per_share">0.14</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="F20240413052446575_300"
      unitRef="USD_per_share">2.8</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="2"
      id="F20240413052446466_232"
      unitRef="USD_per_share">0.27</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="2"
      id="F20240413052446573_299"
      unitRef="USD_per_share">5.4</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember"
      decimals="4"
      id="F20240413052446565_294"
      unitRef="Pure">0.744</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember"
      decimals="4"
      id="F20240413052446530_273"
      unitRef="Pure">0.4021</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember"
      decimals="4"
      id="Fxbrl_20220120115232807_20240413052446413_201"
      unitRef="Pure">0.7679</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember"
      decimals="0"
      id="F20240413052446393_190"
      unitRef="Years">7</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember"
      decimals="0"
      id="F20240413052446407_198"
      unitRef="Years">7</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember"
      decimals="2"
      id="Fxbrl_20220120115232839_20240413052446411_200"
      unitRef="Years">6.82</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember"
      decimals="4"
      id="F20240413052446526_271"
      unitRef="Pure">0.0406</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember"
      decimals="4"
      id="F20240413052446400_194"
      unitRef="Pure">0.0413</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_ifrsfullKeyManagementPersonnelOfEntityOrParentMember"
      decimals="4"
      id="Fxbrl_20220120115232851_20240413052446404_196"
      unitRef="Pure">0.0359</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240412232912612">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:auto"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;TRADE AND OTHER PAYABLES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;December&#160;31,&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;2024&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;US$&#x2019;000&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;December&#160;31,&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;2023&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;US$&#x2019;000&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Trade payables&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;6,833&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;3,885&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Accruals and other liabilities&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;13,597&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;7,552&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Amounts payable for financial assets (Note 13)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;800&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Payroll taxes&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;659&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;405&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Employee related social insurance&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;112&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;110&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Contingent consideration&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;5,384&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Deferred income&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;197&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;50&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;26,782&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;12,802&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Included
in trade and other payables at December 31, 2024 was US$185,000
(2023: US$144,000)
relating to contracted licence payments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
    <trib:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240412232944780">

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;December&#160;31,&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;2024&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;US$&#x2019;000&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;December&#160;31,&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;2023&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;US$&#x2019;000&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Trade payables&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;6,833&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;3,885&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Accruals and other liabilities&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;13,597&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;7,552&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Amounts payable for financial assets (Note 13)&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;800&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Payroll taxes&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;659&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;405&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Employee related social insurance&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;112&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;110&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Contingent consideration&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;5,384&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;Deferred income&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;197&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;50&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;26,782&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;12,802&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115011253185_13"
      unitRef="USD">6833000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115011253185_17"
      unitRef="USD">3885000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230413093602863_xbrl_20220115011253185_43"
      unitRef="USD">13597000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230413093602863_xbrl_20220115011253185_47"
      unitRef="USD">7552000</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:AmountsPayableToTransfereeInRespectOfTransferredAssets
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20240413014847971"
      unitRef="USD">0</ifrs-full:AmountsPayableToTransfereeInRespectOfTransferredAssets>
    <ifrs-full:AmountsPayableToTransfereeInRespectOfTransferredAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240413014852495"
      unitRef="USD">800000</ifrs-full:AmountsPayableToTransfereeInRespectOfTransferredAssets>
    <ifrs-full:CurrentValueAddedTaxPayables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115011253185_23"
      unitRef="USD">659000</ifrs-full:CurrentValueAddedTaxPayables>
    <ifrs-full:CurrentValueAddedTaxPayables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115011253185_27"
      unitRef="USD">405000</ifrs-full:CurrentValueAddedTaxPayables>
    <trib:EmployeeRelatedSocialInsurance
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115011253185_33"
      unitRef="USD">112000</trib:EmployeeRelatedSocialInsurance>
    <trib:EmployeeRelatedSocialInsurance
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115011253185_37"
      unitRef="USD">110000</trib:EmployeeRelatedSocialInsurance>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250512172409226_xbrl_20220115011253185_33"
      unitRef="USD">5384000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250512172409226_xbrl_20220115011253185_37"
      unitRef="USD">0</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredIncomeIncludingContractLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115011253185_53"
      unitRef="USD">197000</ifrs-full:DeferredIncomeIncludingContractLiabilities>
    <ifrs-full:DeferredIncomeIncludingContractLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115011253185_57"
      unitRef="USD">50000</ifrs-full:DeferredIncomeIncludingContractLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115011253185_83"
      unitRef="USD">26782000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115011253185_87"
      unitRef="USD">12802000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <trib:AccruedLiabilitiesToContractedLicencePayments
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250513195400990"
      unitRef="USD">185000</trib:AccruedLiabilitiesToContractedLicencePayments>
    <trib:AccruedLiabilitiesToContractedLicencePayments
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250513195410484"
      unitRef="USD">144000</trib:AccruedLiabilitiesToContractedLicencePayments>
    <ifrs-full:DisclosureOfProvisionsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513014611489">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;PROVISIONS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Product
        warranty provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Legal &amp;amp; regulatory
        provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;735&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposal-related warranty
        settlement provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Restructuring provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,594&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,454&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
2024 and 2023 the Group experienced no significant product warranty claims. However, the Group believes that it is appropriate to retain
a product warranty provision to cover any future claims. The provision at December&#160;31, 2024 represents the estimated cost of product
warranties, the exact amount which cannot be determined. US$50,000
represents management&#x2019;s best estimate of these obligations at December&#160;31, 2024.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
the year ended December 31, 2024, the Group recognised a provision of US$150,000
in respect of a post-completion settlement related to the sale of Fitzgerald Industries. The settlement agreement was finalised prior
to year-end and signed in January 2025. The provision is payable in two instalments: US$75,000
within one year and US$75,000
after more than one year. Refer to note 25 for further details.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:41px;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"&gt;During
the year, the Group recognised a provision of US$0.7
million in respect of a legacy matter currently subject to resolution. Owing to the sensitive nature of ongoing discussions, further disclosure
has been withheld in accordance with&#160;&lt;span style="font-style:italic"&gt;IAS 37.92:&#160;seriously prejudicial exemption for non-disclosure
of certain information on&#160;provision&lt;/span&gt;, as the Directors believe such disclosure could seriously prejudice the Group&#x2019;s
position.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:41px;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1.25"&gt;At
31 December 2024, the Company recognised a provision of US$2.9
million (2023: US$nil)
in respect of restructuring activities undertaken as part of the Group&#x2019;s business transformation programme (refer to Note 5). The
restructuring provision is expected to be fully utilised during the next 12 months. No further restructuring provisions are anticipated
at the reporting date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfProvisionsExplanatory>
    <ifrs-full:DisclosureOfOtherProvisionsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513014636905">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Product
        warranty provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Legal &amp;amp; regulatory
        provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;735&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disposal-related warranty
        settlement provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Restructuring provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,594&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,454&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </ifrs-full:DisclosureOfOtherProvisionsExplanatory>
    <ifrs-full:WarrantyProvision
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115013615767_13"
      unitRef="USD">50000</ifrs-full:WarrantyProvision>
    <ifrs-full:WarrantyProvision
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115013615767_17"
      unitRef="USD">50000</ifrs-full:WarrantyProvision>
    <ifrs-full:LegalProceedingsProvision
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250513015802818_xbrl_20220115013615767_13"
      unitRef="USD">735000</ifrs-full:LegalProceedingsProvision>
    <ifrs-full:LegalProceedingsProvision
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250513015802818_xbrl_20220115013615767_17"
      unitRef="USD">0</ifrs-full:LegalProceedingsProvision>
    <ifrs-full:OtherProvisions
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250513015804482_xbrl_20220115013615767_13"
      unitRef="USD">150000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250513015804482_xbrl_20220115013615767_17"
      unitRef="USD">0</ifrs-full:OtherProvisions>
    <ifrs-full:RestructuringProvision
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250513015805985_xbrl_20220115013615767_13"
      unitRef="USD">1594000</ifrs-full:RestructuringProvision>
    <ifrs-full:RestructuringProvision
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250513015805985_xbrl_20220115013615767_17"
      unitRef="USD">0</ifrs-full:RestructuringProvision>
    <ifrs-full:Provisions
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115013615767_33"
      unitRef="USD">2529000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115013615767_37"
      unitRef="USD">50000</ifrs-full:Provisions>
    <ifrs-full:CurrentProvisions
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250513015808146_xbrl_20220115013615767_13"
      unitRef="USD">2454000</ifrs-full:CurrentProvisions>
    <ifrs-full:CurrentProvisions
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250513015808146_xbrl_20220115013615767_17"
      unitRef="USD">50000</ifrs-full:CurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20250513015809825_xbrl_20220115013615767_13"
      unitRef="USD">75000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20250513015809825_xbrl_20220115013615767_17"
      unitRef="USD">0</ifrs-full:NoncurrentProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="C_20240101to20241231"
      decimals="0"
      id="Fxbrl_20220115013748990"
      unitRef="USD">50000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_ifrsfullRestructuringProvisionMember"
      decimals="0"
      id="Fxbrl_20250513022002176"
      unitRef="USD">150000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_ifrsfullRestructuringProvisionMember_tribInstalmentsAxis_tribWithinOneYearMember"
      decimals="0"
      id="Fxbrl_20250513022039625"
      unitRef="USD">75000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="C_20240101to20241231_ifrsfullClassesOfProvisionsAxis_ifrsfullRestructuringProvisionMember_tribInstalmentsAxis_tribMoreThanOneYearMember"
      decimals="0"
      id="Fxbrl_20250513022051867"
      unitRef="USD">75000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:LegalProceedingsProvision
      contextRef="C_20241231_ifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_tribSiteTransferCostsRelatedToTheImpairmentOfPlantEquipmentMember"
      decimals="-5"
      id="Fxbrl_20250514170850817"
      unitRef="USD">700000</ifrs-full:LegalProceedingsProvision>
    <trib:AdditionalRestructuringCosts
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20250514170453148"
      unitRef="USD">2900000</trib:AdditionalRestructuringCosts>
    <trib:AdditionalRestructuringCosts
      contextRef="C_20230101to20231231"
      decimals="-6"
      id="Fxbrl_20250514170504937"
      unitRef="USD">0</trib:AdditionalRestructuringCosts>
    <ifrs-full:DisclosureOfBorrowingsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513100914500">

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:auto"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;INTEREST-BEARING LOANS AND BORROWINGS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
carrying value of interest-bearing loans, borrowings and related balances is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        senior notes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-Current
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative
        financial liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;526&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingent
        liability (Note 29)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,813&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        non-current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;91,263&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55,177&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-Current
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative
        financial asset&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        non-current assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
senior notes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
January 2022, the Company retired approximately US$99.7
million of the Exchangeable Notes as part of a debt re-financing. This represented approximately 99.7%
of the total Exchangeable Notes. Consideration was in cash and an issue of &#x2018;A&#x2019; Ordinary shares. The cash paid was US$86.73
million with each holder that was party to the agreement receiving US$0.87
of cash per US$1
nominal value of the Exchangeable Notes. The shares consideration was 1,066,600
ADSs (21,332,000
&#x2018;A&#x2019; Ordinary shares) representing the equivalent of US$0.40
of the Company&#x2019;s ADS (based upon the 5-day trailing VWAP of the ADSs on NASDAQ on December 10, 2021, discounted by 13%)
per US$1
nominal value of the Exchangeable Notes, as partial consideration for the exchange of the Exchangeable Notes. The shares consideration
is valued at US$6.1
million based on market price on the date of issue.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Exchangeable Notes were treated as a host debt instrument under IFRS with embedded derivatives attached. The embedded derivatives related
to a number of put and call options which were measured at fair value in the consolidated statement of operations. On initial recognition
in 2015, the host debt instrument was recognised at the residual value of the total net proceeds of the note issue less fair value of
the embedded derivatives. Subsequently, the host debt instrument was measured at amortised cost using the effective interest rate method.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
date of disposal, the carrying value of the extinguished Exchangeable Notes was US$83.2
million. As the IFRS measure of consideration was higher by US$9.7
million, the resulting loss on disposal was recorded as a financial expense in the year ended December 31, 2022. The remaining nominal
value of the Exchangeable Notes at December 31, 2024 is US$210,000
and this is shown within Current Liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
movement in the exchangeable notes balance was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Company and its subsidiaries entered into a US$81.3
million senior secured term loan credit facility in December 2021 with Perceptive, an investment manager with an expertise in healthcare.
The Term Loan was drawn down in January 2022. The
Term Loan is secured by a charge over the Group&#x2019;s assets. The 48-month Term Loan was originally due to expire in January 2026, however
this has since been amended to a maturity date of July 2026. The loan accrues interest at an annual rate equal to 11.25% plus the greater
of (a) one-month LIBOR (later changed to the Term SOFR Reference Rate effective from October 28, 2022) and (b) one percent per annum,
and interest is payable monthly in arrears in cash. In connection with the initial draw down of the Term Loan the Company
agreed to issue warrants to Perceptive for 500,000
of the Company&#x2019;s ADSs.&#160; The per ADS exercise price of the Warrants was US$6.50.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Term Loan can be repaid, in part or in full, at a premium before the end of the four-year term at the discretion of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
accordance with IFRS accounting standards, the Term Loan is represented by three separate balances in the statement of financial position,
US$72.4
million (2023: US$40.1
million) is shown as a non-current liability balance representing the carrying value of the loan, a derivative financial asset estimated
at US$0.2
million (2023: US$0.2
million) representing the value to the Company of being able to repay the Term Loan early and potentially refinance at a lower interest
rate and a derivative financial liability estimated at US$1.7
million (2023: US$0.5
million) representing the fair value of the warrants issued to Perceptive.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
May 2022, the Company repaid US$34.5
million of the term loan principal and incurred an early payment penalty of approximately US$3.5
million, which has been recorded as a financial expense in the year ended December 31, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
February 2023, the Company announced that it had entered into an amended and restated senior secured Term Loan credit facility to allow
for an immediate US$5
million increase to the outstanding Term Loan and provide for a US$20
million facility to fund potential acquisitions. In connection with the increased loan facility, 500,000
warrants originally issued under the Term Loan were repriced, with the Warrants having a per ADS exercise price of US$5.36
compared to their initial per ADS exercise price of US$6.50.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On
April 27, 2023, the Company announced that it had closed the sale of our Fitzgerald Industries life sciences supply business, the Company
used approximately US$11
million of the proceeds of this sale to repay approximately US$10.1
million of its senior secured debt held by Perceptive plus an approximately US$0.9
million early repayment penalty, which has been recorded as a financial expense in the year ended December 31, 2023. In connection with
this transaction, the Company entered an amendment to its senior secured Term Loan credit facility with Perceptive Advisors, which significantly
reduced the Company&#x2019;s minimum revenue covenants under that loan.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
January 2024, as part of the agreement to purchase the Waveform assets, we entered into an amended credit agreement with Perceptive. Under
this agreement, an additional US$22
million of funding has been made available to us, with US$12.5
million being used to acquire the Waveform assets. The remaining US$9.5
million was made available for general corporate purposes including for the further development of the CGM and biosensor technologies.
The Amended Term Loan also provides for additional liquidity of up to US$6.5
million, that may be drawn down between April and December 2024 and can be used for general corporate purposes. In April 2024, the Company
drew down the additional funding of US$6.5
million as prescribed in the Amended Term Loan agreement. This funding will be used for general corporate purposes, including the further
development of our CGM offering.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;I&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;n
December 2024, the Company entered into a further amendment to the credit agreement with Perceptive. As part of this amendment, the Company
drew down an additional US$2 million for general corporate purposes. We also agreed that certain interest payments payable in 2024 and
2025 would be paid-in-kind on the applicable payment date by increasing the outstanding principal amount of the Term Loan. This included
the interest payments due for the period from September through December 2024, which were settled through PIK. Additionally, as part of
this amendment the Company granted Perceptive new warrants to purchase an additional &lt;/span&gt;1,500,000&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;
ADSs at an exercise price of US$&lt;/span&gt;0.80&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;
per ADS, and the exercise price of its existing ADS warrants was also reset to US$&lt;/span&gt;0.80&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;
per ADS.&lt;/span&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
issuance of additional warrants and repricing of existing warrants was not considered a modification of the original financial liability
under IFRS. All warrants are classified as financial liabilities and are measured at fair value through profit or loss. For the year ended
December 31, 2024, a non-cash fair value loss of US$2.1
million was recognized in finance expense, reflecting the initial recognition of the newly issued warrants, the repricing of existing
warrants, and subsequent remeasurement of all warrant liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
the year ended December 31, 2024 accretion interest of US$2.4
million (2023: US$1.1
million) was accrued to leave a closing carrying value of US$72.4
million at year end (2023: US$40.1
million).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
movement in the Term Loan was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(44,301&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal amount loaned&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(30,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loan drawdown costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;325&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative financial
        liability at date of drawdown&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;90&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative financial
        asset at date of drawdown&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accretion interest (Note
        6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,355&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,131&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash repayment of principal&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,050&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Payment-in-kind (PIK)
        Interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,291&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash Loan Modification
        Gain&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,567&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
fair value of the derivative financial asset is estimated at US$0.2
million at December 31, 2024 (2023: US$0.2
million). The fair value of the derivative financial liability is estimated at US$1.7
million at December 31, 2023 (2023: $0.5
million) The fair value remeasurement for these two derivative financial balances at December 31, 2024, resulted in the recognition of
net financial income of US$26,000
(2023: US$1.2
million) in the consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
Q1 2024, the
Company negotiated a 2.5% reduction in the base interest rate on its term loan facility, lowering the rate from 11.25% to 8.75%.
In accordance with IFRS 9, this amendment was treated as a non-substantial modification of the financial liability. As a result, the carrying
amount of the loan was remeasured using the original effective interest rate (EIR), and a non-cash gain of $3.6
million was recognised in finance income. This gain reflects the difference between the previous carrying amount of the loan and the present
value of the modified cash flows, discounted at the original EIR, and is presented in the consolidated statement of operations as a &#x201c;Non-cash
loan modification gain.&#x201d;.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingent
liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
part of the consideration for the acquisition of the CGM assets from Waveform Technologies, Inc., the Group recognised a contingent liability
of US$1.8
million at the acquisition date. This relates to potential additional consideration payable upon entering into certain commercial partnering
agreements with designated glucose pump manufacturers within 24 months of the acquisition. As the payment is subject to the occurrence
of uncertain future events, it is disclosed as a contingent liability rather than a recognised financial liability. Refer to Note 29.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
movement in the derivative financial asset in the year was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;128&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative financial
        asset at date of drawdown&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value adjustments
        in the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current asset at
        December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
movement in the derivative financial liability in the year was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(526&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,569&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative financial
        liability at date of drawdown&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,066&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(90&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value adjustments
        in the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current liability
        at December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(526&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7-year
convertible note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
May 2022, the Company completed a US$45.2
million investment from MiCo IVD Holdings, LLC. Based on public filings, we understand that on December 17, 2024, MiCo was acquired by
Dayli Trinity Holdings Limited as a result of a share purchase agreement with Mainstream Holdings Limited. The investment consists of
an equity investment of US$25.2
million and a seven-year, unsecured junior convertible note of US$20.0
million. The
convertible note has an interest rate of 1.5%. The convertible note mandatorily converts into ADSs if the volume weighted average price
of the Company&#x2019;s ADSs is at or above US$16.20 for any five consecutive NASDAQ trading days. For further details
on the convertible note, refer to the Company&#x2019;s Form 6-K filings with the SEC on April 11, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
convertible loan note is accounted for as a compound financial instrument containing both an equity and liability element. The debt component
is accounted for at amortised cost in accordance with IFRS 9. At December 31, 2024, the carrying value of the convertible note&#x2019;s
debt component was US$15.4
million (2023: US$14.5
million) and accretion interest of US$0.9
million (2023: US$0.8
million) has been recognised as a financial expense in the year. The equity component of the convertible note is US$6.7
million and has been recorded in the equity section of the statement of financial position as Equity component of convertible note. There
is no remeasurement of the equity element following initial recognition.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
movement in the 7-year convertible note in the year was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,746&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accretion interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(859&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(796&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current liability
        at December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfBorrowingsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513101130981">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        senior notes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-Current
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative
        financial liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;526&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingent
        liability (Note 29)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,813&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        non-current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;91,263&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55,177&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-Current
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative
        financial asset&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        non-current assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414181301339"
      unitRef="USD">210000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414181318945"
      unitRef="USD">210000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414181322303"
      unitRef="USD">210000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414181325775"
      unitRef="USD">210000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414181349926_xbrl_20230414181301339"
      unitRef="USD">72391000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414181349926_xbrl_20230414181318945"
      unitRef="USD">40109000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414181352315_xbrl_20230414181301339"
      unitRef="USD">1658000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414181352315_xbrl_20230414181318945"
      unitRef="USD">526000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribContingentLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20250513185256289_xbrl_20230414181352315_xbrl_20230414181301339"
      unitRef="USD">1813000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribContingentLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20250513185256289_xbrl_20230414181352315_xbrl_20230414181318945"
      unitRef="USD">0</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414181354329_xbrl_20230414181301339"
      unitRef="USD">15401000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414181354329_xbrl_20230414181318945"
      unitRef="USD">14542000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414181356281_xbrl_20230414181301339"
      unitRef="USD">91263000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414181356281_xbrl_20230414181318945"
      unitRef="USD">55177000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember_ifrsfullClassesOfFinancialAssetsAxis_tribDerivativeFinancialAssetMember"
      decimals="-3"
      id="Fxbrl_20230414181358957_xbrl_20230414181301339"
      unitRef="USD">166000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember_ifrsfullClassesOfFinancialAssetsAxis_tribDerivativeFinancialAssetMember"
      decimals="-3"
      id="Fxbrl_20230414181358957_xbrl_20230414181318945"
      unitRef="USD">178000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember"
      decimals="-3"
      id="Fxbrl_20230414181401574_xbrl_20230414181301339"
      unitRef="USD">166000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfAssetsAxis_tribNonCurrentAssetsMember"
      decimals="-3"
      id="Fxbrl_20230414181401574_xbrl_20230414181318945"
      unitRef="USD">178000</ifrs-full:Borrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember"
      decimals="-5"
      id="Fxbrl_20240430031135602"
      unitRef="USD">99700000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <trib:TotalExchangeableNotesPercentage
      contextRef="C_20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember"
      decimals="3"
      id="Fxbrl_20240430031451722"
      unitRef="Pure">0.997</trib:TotalExchangeableNotesPercentage>
    <trib:CashPaidToEachHolder
      contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember"
      decimals="-4"
      id="Fxbrl_20240430031520538"
      unitRef="USD">86730000</trib:CashPaidToEachHolder>
    <trib:CashReceivedPerNominalValue
      contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember"
      decimals="2"
      id="Fxbrl_20240430031730882"
      unitRef="USD">0.87</trib:CashReceivedPerNominalValue>
    <trib:NominalAmountOfDebt
      contextRef="C_20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember"
      decimals="0"
      id="Fxbrl_20240430031804826"
      unitRef="USD">1</trib:NominalAmountOfDebt>
    <trib:SharesConsideration
      contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="INF"
      id="Fxbrl_20240430031930690"
      unitRef="Shares">1066600</trib:SharesConsideration>
    <trib:SharesConsideration
      contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20240430032040986"
      unitRef="Shares">21332000</trib:SharesConsideration>
    <trib:SharesRepresentationRateComparedToADS
      contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20240430032116498"
      unitRef="USD_per_share">0.4</trib:SharesRepresentationRateComparedToADS>
    <trib:ExchangeableNotesDiscountRate
      contextRef="C_20220101to20220131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember"
      decimals="2"
      id="Fxbrl_20240430032538018"
      unitRef="Pure">0.13</trib:ExchangeableNotesDiscountRate>
    <trib:CashReceivedPerNominalValue
      contextRef="C_20211201to20211210_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember"
      decimals="0"
      id="Fxbrl_20240430032551721"
      unitRef="USD">1</trib:CashReceivedPerNominalValue>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20211201to20211210_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember"
      decimals="-5"
      id="Fxbrl_20240430032613737"
      unitRef="USD">6100000</ifrs-full:ProceedsFromIssuingShares>
    <trib:ExtinguishmentOfDebtAmounts
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember"
      decimals="-5"
      id="Fxbrl_20230414184822058"
      unitRef="USD">83200000</trib:ExtinguishmentOfDebtAmounts>
    <trib:LossOnDisposalOnBorrowings
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember"
      decimals="-5"
      id="Fxbrl_20230414184921630"
      unitRef="USD">9700000</trib:LossOnDisposalOnBorrowings>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember"
      decimals="0"
      id="Fxbrl_20230414184953504"
      unitRef="USD">210000</ifrs-full:Borrowings>
    <trib:DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240422141924647">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutMovementInExchangeableNotesBalanceExplanatory>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422141856422_xbrl_20240413151643948"
      unitRef="USD">210000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422141856422_xbrl_20240413153445408"
      unitRef="USD">210000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422141856445_xbrl_20240413153357597"
      unitRef="USD">210000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribExchangeableSeniorNotesMember_ifrsfullClassesOfLiabilitiesAxis_tribCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422141856445_xbrl_20240413153547159"
      unitRef="USD">210000</ifrs-full:Borrowings>
    <ifrs-full:NotionalAmount
      contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember"
      decimals="-5"
      id="Fxbrl_20240422151759693"
      unitRef="USD">81300000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="C_20220101to20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember"
      id="Fxbrl_20240422151834381">The
Term Loan is secured by a charge over the Group&#x2019;s assets. The 48-month Term Loan was originally due to expire in January 2026, however
this has since been amended to a maturity date of July 2026. The loan accrues interest at an annual rate equal to 11.25% plus the greater
of (a) one-month LIBOR (later changed to the Term SOFR Reference Rate effective from October 28, 2022) and (b) one percent per annum,
and interest is payable monthly in arrears in cash.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember"
      decimals="INF"
      id="Fxbrl_20240422151846999"
      unitRef="Shares">500000</ifrs-full:NumberOfSharesIssued>
    <trib:ExercisePriceOfWarrantsOrRights
      contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribPerceptiveCreditHoldingsIiiLpMember"
      decimals="2"
      id="Fxbrl_20240422151859615"
      unitRef="USD_per_share">6.5</trib:ExercisePriceOfWarrantsOrRights>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422154334927"
      unitRef="USD">72400000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422154342702"
      unitRef="USD">40100000</ifrs-full:Borrowings>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422154409268"
      unitRef="USD">200000</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422154352520"
      unitRef="USD">200000</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422154412711"
      unitRef="USD">1700000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422154356864"
      unitRef="USD">500000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="C_20220501to20220522_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember"
      decimals="-5"
      id="Fxbrl_20240422155223637"
      unitRef="USD">34500000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <trib:PaymentOfPenalty
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember"
      decimals="-5"
      id="Fxbrl_20240422155226871"
      unitRef="USD">3500000</trib:PaymentOfPenalty>
    <ifrs-full:NotionalAmount
      contextRef="C_20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember"
      decimals="-6"
      id="Fxbrl_20240422152511388"
      unitRef="USD">5000000</ifrs-full:NotionalAmount>
    <ifrs-full:GrossLoanCommitments
      contextRef="C_20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember"
      decimals="-6"
      id="Fxbrl_20240422152535967"
      unitRef="USD">20000000</ifrs-full:GrossLoanCommitments>
    <trib:NumberOfWarrantsRepriced
      contextRef="C_20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember"
      decimals="INF"
      id="Fxbrl_20240422152643439"
      unitRef="Shares">500000</trib:NumberOfWarrantsRepriced>
    <trib:ExercisePriceOfWarrantsOrRights
      contextRef="C_20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember"
      decimals="2"
      id="Fxbrl_20240422152656951"
      unitRef="USD_per_share">5.36</trib:ExercisePriceOfWarrantsOrRights>
    <trib:InitialExercisePriceOfWarrantsOrRights
      contextRef="C_20230201to20230228_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember"
      decimals="2"
      id="Fxbrl_20240422152711508"
      unitRef="USD_per_share">6.5</trib:InitialExercisePriceOfWarrantsOrRights>
    <trib:ProceedsFromSaleOfBusiness
      contextRef="C_20230401to20230427_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSaleOfFitzgeraldIndustriesMember"
      decimals="-6"
      id="Fxbrl_20240422152750626"
      unitRef="USD">11000000</trib:ProceedsFromSaleOfBusiness>
    <ifrs-full:NotionalAmount
      contextRef="C_20230427_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSaleOfFitzgeraldIndustriesMember"
      decimals="-5"
      id="Fxbrl_20240422152802294"
      unitRef="USD">10100000</ifrs-full:NotionalAmount>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="C_20230401to20230427_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSaleOfFitzgeraldIndustriesMember"
      decimals="-5"
      id="Fxbrl_20240422152844976"
      unitRef="USD">900000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="C_20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember"
      decimals="-6"
      id="Fxbrl_20240422163310593"
      unitRef="USD">22000000</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <trib:AmountUsedToAcquireTheCGMAssets
      contextRef="C_20240101to20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember"
      decimals="-5"
      id="Fxbrl_20240422163339660"
      unitRef="USD">12500000</trib:AmountUsedToAcquireTheCGMAssets>
    <trib:AmountAvailableForDevelopmentOfTheCGM
      contextRef="C_20240101to20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember"
      decimals="-5"
      id="Fxbrl_20240422163411995"
      unitRef="USD">9500000</trib:AmountAvailableForDevelopmentOfTheCGM>
    <trib:AdditionalLiquidityRecognizedAsOfAcquisitionDate
      contextRef="C_20240131_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember"
      decimals="-5"
      id="Fxbrl_20240422163436676"
      unitRef="USD">6500000</trib:AdditionalLiquidityRecognizedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="C_20240430_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember"
      decimals="-5"
      id="Fxbrl_20240422163508403"
      unitRef="USD">6500000</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember"
      decimals="0"
      id="Fxbrl_20250513164652156"
      unitRef="USD">1500000</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <trib:ExercisePriceOfWarrantsOrRights
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember"
      decimals="2"
      id="Fxbrl_20250513164704394"
      unitRef="USD_per_share">0.8</trib:ExercisePriceOfWarrantsOrRights>
    <trib:ExercisePriceOfWarrantsOrRights
      contextRef="C_20241231_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="2"
      id="Fxbrl_20250513164739760"
      unitRef="USD_per_share">0.8</trib:ExercisePriceOfWarrantsOrRights>
    <trib:NonCashFairValueGainLoss
      contextRef="C_20240101to20241231_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember"
      decimals="-5"
      id="Fxbrl_20250513164756763"
      unitRef="USD">2100000</trib:NonCashFairValueGainLoss>
    <trib:AccretionInterestAccrued
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422151328218"
      unitRef="USD">2400000</trib:AccretionInterestAccrued>
    <trib:AccretionInterestAccrued
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422151340317"
      unitRef="USD">1100000</trib:AccretionInterestAccrued>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422151354398"
      unitRef="USD">72400000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422151409223"
      unitRef="USD">40100000</ifrs-full:Borrowings>
    <trib:ScheduleOfMovementInTermLoanExplanatoryTableTextBlock
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240422142510583">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(44,301&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal amount loaned&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(30,500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loan drawdown costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;325&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative financial
        liability at date of drawdown&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;90&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative financial
        asset at date of drawdown&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accretion interest (Note
        6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,355&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,131&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash repayment of principal&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,050&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Payment-in-kind (PIK)
        Interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,291&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash Loan Modification
        Gain&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,567&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:ScheduleOfMovementInTermLoanExplanatoryTableTextBlock>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449825_xbrl_20240413154956640"
      unitRef="USD">40109000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449825_xbrl_20240413155602222"
      unitRef="USD">44301000</ifrs-full:Borrowings>
    <trib:PrincipalAmountLoaned
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449828_xbrl_20240413155037289"
      unitRef="USD">30500000</trib:PrincipalAmountLoaned>
    <trib:PrincipalAmountLoaned
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449828_xbrl_20240413155624030"
      unitRef="USD">5000000</trib:PrincipalAmountLoaned>
    <trib:LoanOriginationCosts
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449833_xbrl_20240413155138259"
      unitRef="USD">325000</trib:LoanOriginationCosts>
    <trib:LoanOriginationCosts
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449833_xbrl_20240413155633061"
      unitRef="USD">194000</trib:LoanOriginationCosts>
    <trib:DerivativeFinancialLiabilityAtDateOfIssue
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449837_xbrl_20240413155227609"
      unitRef="USD">0</trib:DerivativeFinancialLiabilityAtDateOfIssue>
    <trib:DerivativeFinancialLiabilityAtDateOfIssue
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449837_xbrl_20240413155647846"
      unitRef="USD">90000</trib:DerivativeFinancialLiabilityAtDateOfIssue>
    <trib:DerivativeFinancialAssetAtDateOfIssue
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449841_xbrl_20240413155250033"
      unitRef="USD">-28000</trib:DerivativeFinancialAssetAtDateOfIssue>
    <trib:DerivativeFinancialAssetAtDateOfIssue
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449841_xbrl_20240413155659638"
      unitRef="USD">-11000</trib:DerivativeFinancialAssetAtDateOfIssue>
    <trib:AccretionInterestOnBorrowings
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449845_xbrl_20240413155330514"
      unitRef="USD">2355000</trib:AccretionInterestOnBorrowings>
    <trib:AccretionInterestOnBorrowings
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449845_xbrl_20240413155716819"
      unitRef="USD">1131000</trib:AccretionInterestOnBorrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449850_xbrl_20240413155359262"
      unitRef="USD">0</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449850_xbrl_20240413155723772"
      unitRef="USD">10050000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <trib:PaymentInKindInterest
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20250513190135118_xbrl_20240422142449850_xbrl_20240413155359262"
      unitRef="USD">3291000</trib:PaymentInKindInterest>
    <trib:PaymentInKindInterest
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20250513190135118_xbrl_20240422142449850_xbrl_20240413155723772"
      unitRef="USD">0</trib:PaymentInKindInterest>
    <trib:NoncashLoanModificationGain
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20250513190136889_xbrl_20240422142449850_xbrl_20240413155359262"
      unitRef="USD">3567000</trib:NoncashLoanModificationGain>
    <trib:NoncashLoanModificationGain
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20250513190136889_xbrl_20240422142449850_xbrl_20240413155723772"
      unitRef="USD">0</trib:NoncashLoanModificationGain>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449852_xbrl_20240413155420671"
      unitRef="USD">72391000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142449852_xbrl_20240413155732445"
      unitRef="USD">40109000</ifrs-full:Borrowings>
    <trib:FairValueOfDerivativeFinancialAsset
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422150337522"
      unitRef="USD">200000</trib:FairValueOfDerivativeFinancialAsset>
    <trib:FairValueOfDerivativeFinancialAsset
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422150351309"
      unitRef="USD">200000</trib:FairValueOfDerivativeFinancialAsset>
    <trib:FairValueOfDerivativeFinancialLiability
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422150405751"
      unitRef="USD">1700000</trib:FairValueOfDerivativeFinancialLiability>
    <trib:FairValueOfDerivativeFinancialLiability
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422150416786"
      unitRef="USD">500000</trib:FairValueOfDerivativeFinancialLiability>
    <ifrs-full:Borrowings
      contextRef="C_20240131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="0"
      id="Fxbrl_20240422150436535"
      unitRef="USD">26000</ifrs-full:Borrowings>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="C_20240131_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanCreditFacilityOneMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-5"
      id="Fxbrl_20240422150500521"
      unitRef="USD">1200000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="C_20240101to20240331_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSeniorSecuredTermLoanMember"
      id="Fxbrl_20250513103151445">the
Company negotiated a 2.5% reduction in the base interest rate on its term loan facility, lowering the rate from 11.25% to 8.75%.</ifrs-full:BorrowingsInterestRateBasis>
    <trib:NonCashFairValueGainLoss
      contextRef="C_20240101to20240331_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribAmendmentAndRestatementOfTermLoanMember"
      decimals="-5"
      id="Fxbrl_20250513103447376"
      unitRef="USD">3600000</trib:NonCashFairValueGainLoss>
    <ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20240331_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-5"
      id="Fxbrl_20250513104051435"
      unitRef="USD">1800000</ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate>
    <trib:DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240422142914653">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;128&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative financial
        asset at date of drawdown&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value adjustments
        in the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current asset at
        December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialAssetExplanatory>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember"
      decimals="-3"
      id="Fxbrl_20240422142841318_xbrl_20230414183713981_xbrl_20230414183539889"
      unitRef="USD">178000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember"
      decimals="-3"
      id="Fxbrl_20240422142841318_xbrl_20240413144931606"
      unitRef="USD">128000</ifrs-full:Borrowings>
    <trib:DerivativeFinancialAssetAtDateOfDrawdown
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember"
      decimals="-3"
      id="Fxbrl_20240422142841321_xbrl_20230414183720925_xbrl_20230414183608068"
      unitRef="USD">28000</trib:DerivativeFinancialAssetAtDateOfDrawdown>
    <trib:DerivativeFinancialAssetAtDateOfDrawdown
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember"
      decimals="-3"
      id="Fxbrl_20240422142841321_xbrl_20240413144951574"
      unitRef="USD">11000</trib:DerivativeFinancialAssetAtDateOfDrawdown>
    <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember"
      decimals="-3"
      id="Fxbrl_20240422142841325_xbrl_20230414183726350_xbrl_20230414183623509"
      unitRef="USD">-40000</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember"
      decimals="-3"
      id="Fxbrl_20240422142841325_xbrl_20240413145004422"
      unitRef="USD">39000</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember"
      decimals="-3"
      id="Fxbrl_20240422142841329_xbrl_20230414183733827_xbrl_20230414183647256"
      unitRef="USD">166000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialAssetMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentAssetsMember"
      decimals="-3"
      id="Fxbrl_20240422142841329_xbrl_20240413145026249"
      unitRef="USD">178000</ifrs-full:Borrowings>
    <trib:DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240422142901408">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(526&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,569&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative financial
        liability at date of drawdown&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,066&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(90&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value adjustments
        in the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current liability
        at December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(526&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutMovementInDerivativeFinancialLiabilityExplanatory>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142825814_xbrl_20230414183539889"
      unitRef="USD">526000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142825814_xbrl_20240413144812614"
      unitRef="USD">1569000</ifrs-full:Borrowings>
    <trib:DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142825817_xbrl_20230414183608068"
      unitRef="USD">-1066000</trib:DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan>
    <trib:DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142825817_xbrl_20240413144820918"
      unitRef="USD">-90000</trib:DerivativeFinancialLiabilityAtDateOfIssueOfTermLoan>
    <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142825821_xbrl_20230414183623509"
      unitRef="USD">-66000</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142825821_xbrl_20240413144828509"
      unitRef="USD">1133000</ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142825825_xbrl_20230414183647256"
      unitRef="USD">1658000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribDerivativeFinancialLiabilityMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240422142825825_xbrl_20240413144847981"
      unitRef="USD">526000</ifrs-full:Borrowings>
    <ifrs-full:NotionalAmount
      contextRef="C_20220531_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember"
      decimals="-5"
      id="Fxbrl_20240422140239092"
      unitRef="USD">45200000</ifrs-full:NotionalAmount>
    <trib:EquityComponentOfConvertibleNote
      contextRef="C_20220531_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember"
      decimals="-5"
      id="Fxbrl_20240422140247127"
      unitRef="USD">25200000</trib:EquityComponentOfConvertibleNote>
    <trib:PrincipalAmountLoaned
      contextRef="C_20220501to20220531_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember"
      decimals="-5"
      id="Fxbrl_20240422140255374"
      unitRef="USD">20000000</trib:PrincipalAmountLoaned>
    <ifrs-full:DescriptionOfConversionOfDebtToEquity
      contextRef="C_20220501to20220531_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribMicoLtdMember"
      id="Fxbrl_20240422140308845">The
convertible note has an interest rate of 1.5%. The convertible note mandatorily converts into ADSs if the volume weighted average price
of the Company&#x2019;s ADSs is at or above US$16.20 for any five consecutive NASDAQ trading days.</ifrs-full:DescriptionOfConversionOfDebtToEquity>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember"
      decimals="-5"
      id="Fxbrl_20240413170903945"
      unitRef="USD">15400000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember"
      decimals="-5"
      id="Fxbrl_20230414192959649"
      unitRef="USD">14500000</ifrs-full:Borrowings>
    <trib:AccretionInterestOnBorrowings
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember"
      decimals="-5"
      id="Fxbrl_20230414193014660"
      unitRef="USD">900000</trib:AccretionInterestOnBorrowings>
    <trib:AccretionInterestOnBorrowings
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember"
      decimals="-5"
      id="Fxbrl_20240413170922106"
      unitRef="USD">800000</trib:AccretionInterestOnBorrowings>
    <trib:EquityComponentAtDateOfIssue
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribConvertibleNoteMember"
      decimals="-5"
      id="Fxbrl_20230414193035798"
      unitRef="USD">6700000</trib:EquityComponentAtDateOfIssue>
    <trib:DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413144009342">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at January 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,746&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accretion interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(859&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(796&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current liability
        at December 31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutMovementInTermLoanAndThe7YearConvertibleNotesExplanatory>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413145732182"
      unitRef="USD">14542000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20221231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413150212608"
      unitRef="USD">13746000</ifrs-full:Borrowings>
    <trib:AccretionInterestOnBorrowings
      contextRef="C_20240101to20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413150022221"
      unitRef="USD">-859000</trib:AccretionInterestOnBorrowings>
    <trib:AccretionInterestOnBorrowings
      contextRef="C_20230101to20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413150334085"
      unitRef="USD">-796000</trib:AccretionInterestOnBorrowings>
    <ifrs-full:Borrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413150049140"
      unitRef="USD">15401000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialLiabilitiesAxis_tribSevenYearConvertibleNoteMember_ifrsfullClassesOfLiabilitiesAxis_tribNonCurrentLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413150341084"
      unitRef="USD">14542000</ifrs-full:Borrowings>
    <ifrs-full:DisclosureOfLeasesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220115030203125">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;LEASE LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group has leases for some of its manufacturing plants, all warehouses, offices, motor vehicles and some IT equipment. With the exception
of short-term leases and leases of low-value underlying assets, each lease is reflected on the balance sheet as a right-of-use asset (net
of any depreciation and/or impairment) and a lease liability. Variable lease payments which do not depend on an index or a rate (such
as lease payments based on a percentage of Group sales) are excluded from the initial measurement of the lease liability and asset. The
Group classifies its right-of-use assets in a consistent manner to its property, plant and equipment (see Note 11).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Each
lease generally imposes a restriction that, unless there is a contractual right for the Group to sublet the asset to another party, the
right-of-use asset can only be used by the Group. Leases are either non-cancellable or may only be cancelled by incurring a substantive
termination fee. Some leases contain an option to purchase the underlying leased asset outright at the end of the lease, or to extend
the lease for a further term. The Group is prohibited from selling or pledging the underlying leased assets as security. For leases over
office buildings and factory premises the Group must keep those properties in a good state of repair and return the properties in their
original condition at the end of the lease. Further, the Group must insure items of property, plant and equipment and incur maintenance
fees on such items in accordance with the lease contracts.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
liabilities are payable as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25;margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities related to Right of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,285&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,694&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,285&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,694&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-Current
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities related to Right of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,477&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,872&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities related to&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right
        of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Minimum&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;lease&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less
        than one year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,862&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;577&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,285&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        more than one year, but not more than two&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,214&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;472&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,742&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        more than two years but not more than five&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;955&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,532&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;More
        than five years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;449&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,203&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,215&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities related to&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right
        of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Minimum&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;lease&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less
        than one year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,221&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;577&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,644&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        more than one year, but not more than two&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,243&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,745&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        more than two years but not more than five&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,442&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,017&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,425&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;more
        than five years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;648&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,306&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,740&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25;font-weight:bold;margin-left:30.6pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
payments not recognised as a liability&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No
short-term lease expenses were incurred for the year ended December 31, 2024. Payments made under such leases are expensed on a straight-line
basis. In addition, certain variable lease payments are not permitted to be recognised as lease liabilities and are expensed as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30pt;line-height:1.25"&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;

&lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The total paid in respect
of lease liabilities in the year ended December 31, 2024, was US$2,503,000
(2023: US$2,318,000).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfLeasesExplanatory>
    <trib:DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240422124037901">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities related to Right of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,285&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,694&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,285&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,694&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-Current
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities related to Right of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,477&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,872&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutCarryingValuesOfFinanceLeaseLiabilitiesExplanatory>
    <trib:LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115030252898_23"
      unitRef="USD">2285000</trib:LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent>
    <trib:LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115030252898_27"
      unitRef="USD">1694000</trib:LeaseLiabilitiesRelatedToRightOfUseAssetsCurrent>
    <trib:CurrentFinanceLeaseLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115030252898_53"
      unitRef="USD">2285000</trib:CurrentFinanceLeaseLiabilities>
    <trib:CurrentFinanceLeaseLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115030252898_57"
      unitRef="USD">1694000</trib:CurrentFinanceLeaseLiabilities>
    <trib:LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220115030252898_83"
      unitRef="USD">10477000</trib:LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent>
    <trib:LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220115030252898_87"
      unitRef="USD">10872000</trib:LeaseLiabilitiesRelatedToRightOfUseAssetsNonCurrent>
    <trib:DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413021521911">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities related to&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right
        of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Minimum&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;lease&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less
        than one year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,862&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;577&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,285&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        more than one year, but not more than two&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,214&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;472&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,742&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        more than two years but not more than five&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;955&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,532&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;More
        than five years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;449&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,203&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,215&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December
        31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities related to&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right
        of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Minimum&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;lease&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less
        than one year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,221&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;577&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,644&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        more than one year, but not more than two&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,243&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;498&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,745&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
        more than two years but not more than five&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,442&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,017&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,425&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;more
        than five years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;648&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,306&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,740&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutFinanceLeaseLiabilitiesPayableExplanatory>
    <trib:MinimumFinanceLeasePaymentsPayable
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240413015910226"
      unitRef="USD">2862000</trib:MinimumFinanceLeasePaymentsPayable>
    <trib:InterestExpenseOnLeaseLiabilities1
      contextRef="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240413015918007"
      unitRef="USD">577000</trib:InterestExpenseOnLeaseLiabilities1>
    <trib:MinimumFinanceLeasePaymentsPayableAtPresentValue
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20240413015947753"
      unitRef="USD">2285000</trib:MinimumFinanceLeasePaymentsPayableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsPayable
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240413020019672_xbrl_20240413015910226"
      unitRef="USD">2214000</trib:MinimumFinanceLeasePaymentsPayable>
    <trib:InterestExpenseOnLeaseLiabilities1
      contextRef="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240413020019672_xbrl_20240413015918007"
      unitRef="USD">472000</trib:InterestExpenseOnLeaseLiabilities1>
    <trib:MinimumFinanceLeasePaymentsPayableAtPresentValue
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240413020019672_xbrl_20240413015947753"
      unitRef="USD">1742000</trib:MinimumFinanceLeasePaymentsPayableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsPayable
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20240413020021692_xbrl_20240413015910226"
      unitRef="USD">5487000</trib:MinimumFinanceLeasePaymentsPayable>
    <trib:InterestExpenseOnLeaseLiabilities1
      contextRef="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20240413020021692_xbrl_20240413015918007"
      unitRef="USD">955000</trib:InterestExpenseOnLeaseLiabilities1>
    <trib:MinimumFinanceLeasePaymentsPayableAtPresentValue
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20240413020021692_xbrl_20240413015947753"
      unitRef="USD">4532000</trib:MinimumFinanceLeasePaymentsPayableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsPayable
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20240413020023537_xbrl_20240413015910226"
      unitRef="USD">4652000</trib:MinimumFinanceLeasePaymentsPayable>
    <trib:InterestExpenseOnLeaseLiabilities1
      contextRef="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20240413020023537_xbrl_20240413015918007"
      unitRef="USD">449000</trib:InterestExpenseOnLeaseLiabilities1>
    <trib:MinimumFinanceLeasePaymentsPayableAtPresentValue
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20240413020023537_xbrl_20240413015947753"
      unitRef="USD">4203000</trib:MinimumFinanceLeasePaymentsPayableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsPayable
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember"
      decimals="-3"
      id="Fxbrl_20240413020025218_xbrl_20240413015910226"
      unitRef="USD">15215000</trib:MinimumFinanceLeasePaymentsPayable>
    <trib:InterestExpenseOnLeaseLiabilities1
      contextRef="C_20240101to20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember"
      decimals="-3"
      id="Fxbrl_20240413020025218_xbrl_20240413015918007"
      unitRef="USD">2453000</trib:InterestExpenseOnLeaseLiabilities1>
    <trib:MinimumFinanceLeasePaymentsPayableAtPresentValue
      contextRef="C_20241231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember"
      decimals="-3"
      id="Fxbrl_20240413020025218_xbrl_20240413015947753"
      unitRef="USD">12762000</trib:MinimumFinanceLeasePaymentsPayableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsPayable
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20250512165533728_xbrl_20240413015910226"
      unitRef="USD">2221000</trib:MinimumFinanceLeasePaymentsPayable>
    <trib:InterestExpenseOnLeaseLiabilities1
      contextRef="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20250512165533728_xbrl_20240413015918007"
      unitRef="USD">577000</trib:InterestExpenseOnLeaseLiabilities1>
    <trib:MinimumFinanceLeasePaymentsPayableAtPresentValue
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullNotLaterThanOneYearMember"
      decimals="-3"
      id="Fxbrl_20250512165533728_xbrl_20240413015947753"
      unitRef="USD">1644000</trib:MinimumFinanceLeasePaymentsPayableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsPayable
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20250512165533731_xbrl_20240413020019672_xbrl_20240413015910226"
      unitRef="USD">2243000</trib:MinimumFinanceLeasePaymentsPayable>
    <trib:InterestExpenseOnLeaseLiabilities1
      contextRef="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20250512165533731_xbrl_20240413020019672_xbrl_20240413015918007"
      unitRef="USD">498000</trib:InterestExpenseOnLeaseLiabilities1>
    <trib:MinimumFinanceLeasePaymentsPayableAtPresentValue
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanOneYearAndNotLaterThanTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20250512165533731_xbrl_20240413020019672_xbrl_20240413015947753"
      unitRef="USD">1745000</trib:MinimumFinanceLeasePaymentsPayableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsPayable
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20250512165533734_xbrl_20240413020021692_xbrl_20240413015910226"
      unitRef="USD">5442000</trib:MinimumFinanceLeasePaymentsPayable>
    <trib:InterestExpenseOnLeaseLiabilities1
      contextRef="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20250512165533734_xbrl_20240413020021692_xbrl_20240413015918007"
      unitRef="USD">1017000</trib:InterestExpenseOnLeaseLiabilities1>
    <trib:MinimumFinanceLeasePaymentsPayableAtPresentValue
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_tribLaterThanTwoYearAndNotLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20250512165533734_xbrl_20240413020021692_xbrl_20240413015947753"
      unitRef="USD">4425000</trib:MinimumFinanceLeasePaymentsPayableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsPayable
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20250512165533739_xbrl_20240413020023537_xbrl_20240413015910226"
      unitRef="USD">5400000</trib:MinimumFinanceLeasePaymentsPayable>
    <trib:InterestExpenseOnLeaseLiabilities1
      contextRef="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20250512165533739_xbrl_20240413020023537_xbrl_20240413015918007"
      unitRef="USD">648000</trib:InterestExpenseOnLeaseLiabilities1>
    <trib:MinimumFinanceLeasePaymentsPayableAtPresentValue
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember_ifrsfullMaturityAxis_ifrsfullLaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20250512165533739_xbrl_20240413020023537_xbrl_20240413015947753"
      unitRef="USD">4752000</trib:MinimumFinanceLeasePaymentsPayableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsPayable
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember"
      decimals="-3"
      id="Fxbrl_20250512165718363_xbrl_20240413020025218_xbrl_20240413015910226"
      unitRef="USD">15306000</trib:MinimumFinanceLeasePaymentsPayable>
    <trib:InterestExpenseOnLeaseLiabilities1
      contextRef="C_20230101to20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember"
      decimals="-3"
      id="Fxbrl_20250512165718363_xbrl_20240413020025218_xbrl_20240413015918007"
      unitRef="USD">2740000</trib:InterestExpenseOnLeaseLiabilities1>
    <trib:MinimumFinanceLeasePaymentsPayableAtPresentValue
      contextRef="C_20231231_ifrsfullAssetsAndLiabilitiesAxis_tribLeaseLiabilitiesRelatedToRightOfUseAssetsMember"
      decimals="-3"
      id="Fxbrl_20250512165718363_xbrl_20240413020025218_xbrl_20240413015947753"
      unitRef="USD">12566000</trib:MinimumFinanceLeasePaymentsPayableAtPresentValue>
    <trib:AmountPaidInRespectOfLeaseLiabilities
      contextRef="C_20240101to20241231"
      decimals="0"
      id="Fxbrl_20220422115212946"
      unitRef="USD">2503000</trib:AmountPaidInRespectOfLeaseLiabilities>
    <trib:AmountPaidInRespectOfLeaseLiabilities
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20220115042811316"
      unitRef="USD">2318000</trib:AmountPaidInRespectOfLeaseLiabilities>
    <ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20230420113024134">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(a)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capital
        Commitments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group has capital commitments authorised and contracted for of US$nil
as at December&#160;31, 2024 (2023: US$39,900).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(b)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold;font-style:italic"&gt;Leasing
        Commitments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-indent:0pt;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group&#x2019;s leasing commitments are shown in Note 24.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-indent:0pt;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="text-align:right;vertical-align:top;width:28.35pt"&gt;
        &lt;div style="line-height:1.25;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(c)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td style="text-align:left;vertical-align:top;width:auto"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold;font-style:italic"&gt;Bank
        Security&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Credit Agreement for the senior secured term loan is secured by substantially all of our property and assets, including our equity interests
in our subsidiaries, refer to Note 23.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
2023, the sale and leaseback liability matured as the lease came to an end and was not renewed, as a result, the bank charge against the
equipment for which the borrowings pertained did not exist as at December 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(d)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Group
        Company Guarantees&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant
to the provisions of Section&#160;357, Companies Act, 2014, the Company has guaranteed the liabilities of Trinity Biotech Manufacturing
Limited, Trinity Research Limited and Trinity Biotech Financial Services Limited subsidiary undertakings in the Republic of Ireland, for
the financial year to December&#160;31, 2024 and, as a result, these subsidiary undertakings have been exempted from the filing provisions
of Section&#160;357, Companies Act, 2014. Where the Company enters into these guarantees of the indebtedness of other companies within
its Group, the Company considers these to be insurance arrangements and accounts for them as such.&#160;The Company treats the guarantee
contract as a contingent liability until such time as it becomes probable that the Company will be required to make a payment under the
guarantee.&#160;The Company does not enter into financial guarantees with third parties.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(e)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government
        Grant Contingencies&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group has received training and employment grant income from Irish development agencies. Subject to existence of certain conditions specified
in the grant agreements, this income may become repayable. No such conditions existed as at December&#160;31, 2024. However, if the income
were to become repayable, the maximum amounts repayable as at December&#160;31, 2024 would amount to US$3,313,000
(2023: US$3,410,000).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(f)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingency
        relating to the sale of Fitzgerald Industries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On
April 27, 2023 the Company announced it had closed the sale of Fitzgerald Industries (&#x201c;Fitzgerald&#x201d;) to Biosynth for cash proceeds
of approximately US$30
million subject to customary adjustments. In a telephone call conducted in March 2024, a representative of Biosynth alleged a breach of
certain of the warranties set out in the Share Purchase Agreement for the sale of Fitzgerald. Following negotiations, a settlement agreement
was finalised prior to December 31, 2024 and subsequently signed in January 2025. Under the terms of the settlement, the Company agreed
to pay Biosynth US$150,000
in full and final settlement of all post-completion claims. Accordingly, a provision of US$150,000
has been recorded in the consolidated financial statements as at December 31, 2024, see Note 22. In addition, outstanding receivables
of US$423,000
from Biosynth relating to completion account adjustments were written off as unrecoverable under the terms of the settlement. The settlement
fully resolves all disputes related to the sale of Fitzgerald Industries, and no further liabilities are expected to arise.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(g)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold;font-style:italic"&gt;Contingent
        considerations relating to business combinations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
part of the acquisition of the CGM assets of Waveform Technologies, Inc., the Company may pay up to US$20
million in contingent consideration based on share price, trading volume, and commercial milestones. The fair value of this contingent
consideration is US$6.8
million as of December 31, 2024. Refer to Note 29 for further details.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
part of the acquisition of EpiCapture Limited (see Note 29), contingent consideration of up to US$0.5
million may become payable based on cumulative revenue targets. The fair value of this contingent consideration is US$0.4
million as of December 31, 2024. Refer to Note 29 for further details.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;
        &lt;div style="line-height:1.25"&gt;(h)&lt;/div&gt; &lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold;font-style:italic"&gt;Other
        Contingencies&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Company has other contingencies primarily relating to claims and legal proceedings, onerous contracts, product warranties and employee
related provisions. The status of each significant claim and legal proceeding in which the Company is involved is reviewed by management
on a periodic basis and the Group&#x2019;s potential financial exposure is assessed. If the potential loss from any claim or legal proceeding
is considered probable, and the amount can be reliably estimated, a liability is recognised for the estimated loss. Because of the uncertainties
inherent in such matters, the related provisions are based on the best information available at the time; the issues taken into account
by management and factored into the assessment of legal contingencies include, as applicable, the status of settlement negotiations, interpretations
of contractual obligations, prior experience with similar contingencies/claims, and advice obtained from legal counsel and other third
parties. The Group expects the majority of these provisions will be utilised within one to three years of the balance sheet date; however
due to the nature of the legal provisions there is a level of uncertainty in the timing of settlement as the Group generally cannot determine
the extent and duration of the legal process.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory>
    <ifrs-full:CapitalCommitments
      contextRef="C_20241231"
      decimals="0"
      id="Fxbrl_20220115150301789"
      unitRef="USD">0</ifrs-full:CapitalCommitments>
    <ifrs-full:CapitalCommitments
      contextRef="C_20231231"
      decimals="0"
      id="Fxbrl_20220115150311881"
      unitRef="USD">39900</ifrs-full:CapitalCommitments>
    <trib:GrantContingenciesMaximumAmountPayable
      contextRef="C_20240101to20241231"
      decimals="0"
      id="Fxbrl_20220115150814507"
      unitRef="USD">3313000</trib:GrantContingenciesMaximumAmountPayable>
    <trib:GrantContingenciesMaximumAmountPayable
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20220115150825428"
      unitRef="USD">3410000</trib:GrantContingenciesMaximumAmountPayable>
    <trib:ProceedsFromSaleOfBusiness
      contextRef="C_20230401to20230427_ifrsfullBusinessCombinationsAxis_tribBiosynthMember"
      decimals="-6"
      id="Fxbrl_20240422130046439"
      unitRef="USD">30000000</trib:ProceedsFromSaleOfBusiness>
    <trib:AgreementPayments
      contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribBiosynthMember"
      decimals="0"
      id="Fxbrl_20250512204032555"
      unitRef="USD">150000</trib:AgreementPayments>
    <ifrs-full:OtherProvisions
      contextRef="C_20241231_ifrsfullBusinessCombinationsAxis_tribBiosynthMember"
      decimals="-3"
      id="Fxbrl_20250513142611057"
      unitRef="USD">150000</ifrs-full:OtherProvisions>
    <trib:ReceivablesOutstanding
      contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribBiosynthMember"
      decimals="0"
      id="Fxbrl_20250512213736245"
      unitRef="USD">423000</trib:ReceivablesOutstanding>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="-6"
      id="Fxbrl_20250512203112162"
      unitRef="USD">20000000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <trib:FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-5"
      id="Fxbrl_20250512194624072"
      unitRef="USD">6800000</trib:FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="-5"
      id="Fxbrl_20250512203656693"
      unitRef="USD">500000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-5"
      id="Fxbrl_20250512194611356"
      unitRef="USD">400000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413053357384">

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:auto"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group has related party relationships with its subsidiaries, and with its directors and executive officers.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasing
arrangements with related parties&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group has entered into various arrangements with JRJ Investments (&#x201c;JRJ&#x201d;), a partnership owned by Mr O&#x2019;Caoimh and Dr
Walsh, directors of Trinity Biotech, and directly with Mr O&#x2019;Caoimh, to provide premises at IDA Business Park, Bray, County Wicklow,
Ireland.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group entered into an agreement with JRJ for a 25-year
lease commencing in December 2003 for offices that were adjacent to its then premises at IDA Business Park, Bray, County Wicklow, Ireland
with an annual rent of &#x20ac;381,000
(US$421,000).
Upward-only rent reviews are carried out every five years and there have been no increases arising from these rent reviews.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
2007 we entered into a 25-year
lease agreement with JRJ for a 43,860
square foot manufacturing facility in Bray, Ireland with an annual rent of &#x20ac;787,000
(US$834,000).
Subsequent to the signing of this lease, the ownership of the building transferred from JRJ to Mr O&#x2019;Caoimh solely. A rent review
for this property became effective 1 July 2022 and, following an independent valuation, the annual rent increased to &#x20ac;1,050,000,
with backdated rent accruing from that date. Included within overhead costs in cost of sales is an amount of $686,000
in respect of backdated rent. In 2016, we entered into a 10-year
lease with Mr. O&#x2019;Caoimh for a warehouse adjacent to our leased manufacturing facility in Bray, Ireland. The warehouse is 16,000
square feet with an annual rent of &#x20ac;144,000
(US$159,000).
A rent review for this property became effective on 1 July 2021 and, following an independent valuation, the annual rent increased to
&#x20ac;170,560,
with backdated rent accruing from that date. Included within overhead costs in cost of sales is an amount of $97,000
in respect of backdated rent. Independent valuers advised the Group that the rent in respect of each of the leases represented a fair
market rent.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
late 2020, the Group occupied some additional space adjoining the warehouse owned by Mr O&#x2019;Caoimh. This was a short-term arrangement,
and no payments were made for the additional space during 2020 and 2021. The Company vacated this space in 2021. In 2022, the rent payable
to Mr O&#x2019;Caoimh of US$90,000
was settled.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
the time that the arrangements were entered into, Trinity Biotech and its directors (excepting Mr O&#x2019;Caoimh and Dr Walsh who expressed
no opinion on this point) believed they represented a fair and reasonable basis on which the Group could meet its ongoing requirements
for premises. Dr Walsh has no ownership interest in the additional space adjoining the warehouse owned by Mr O&#x2019;Caoimh and was therefore
entitled to express an opinion on this arrangement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
September 2024, the Company completed the acquisition of Metabolomics Diagnostics Ltd ("Metabolomics") for consideration of approximately
US$0.9
million, satisfied through the issuance of approximately 0.27
million ADSs and the extinguishment of amounts owed to the Company totaling US$0.41
million. At the time of the acquisition, Dr. Jim Walsh, a director of the Company, held a 6%
minority shareholding in Metabolomics. Based on the net assets acquired and goodwill recognised, the value attributable to Dr. Walsh&#x2019;s
interest was estimated at approximately $55,000.
Dr. Walsh fully disclosed his interest, and the acquisition was approved unanimously by the board, with appropriate procedures followed
to manage the potential conflict of interest, including the passing of a resolution under the Company's Constitution to authorise Dr.
Walsh&#x2019;s involvement in the decision-making process. The transaction was conducted at arm&#x2019;s length, and the board determined
that it was in the best interests of the Company.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&#160;&lt;/div&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25;font-style:italic;font-weight:bold;margin-left:30pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Compensation
of key management personnel of the Group&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25;margin-left:30pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
the years ended December 31, 2024 and 2023, the Group&#x2019;s key management personnel comprised directors Mr. Ronan O&#x2019;Caoimh, Dr.
Jim Walsh, and Mr. John Gillard. The Group does not engage a separate management entity, as all key management personnel are employed
directly by the Group. Compensation for the year for these personnel is detailed below:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term
        employee benefits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;843&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,774&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Performance
        related bonus&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;260&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;211&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Post-employment
        benefits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based
        compensation benefits as calculated under IFRS 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;931&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,601&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,073&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
amounts disclosed in respect of directors&#x2019; emoluments in Note 9 includes independent directors&#x2019; fees and non-executive director
fees of US$114,000
(2023: US$73,000)
and share-based compensation benefits of US$Nil
(2023: US$Nil).
Total directors&#x2019; remuneration is also included in &#x201c;employment&#x201d; (Note 3) and &#x201c;(Loss)/profit before tax&#x201d; (Note
9).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Directors&#x2019;
interests in the Company&#x2019;s shares and share option plan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;A&#x2019;
        Ordinary Shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share
        options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,117,777&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30,387,336&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Shares
        purchased during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;200,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,600,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired
        / forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,994,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,317,777&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32,993,336&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;A&#x2019;
        Ordinary Shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share
        options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,117,777&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,547,336&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options
        of retired director&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20,000,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,000,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired
        / forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,160,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,117,777&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30,387,336&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;  &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <trib:TermOfLease
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribJrjMember"
      id="Fxbrl_20230428183528217">25-year</trib:TermOfLease>
    <trib:AnnualRentPayable
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribJrjMember"
      decimals="0"
      id="Fxbrl_20230428182906230"
      unitRef="EUR">381000</trib:AnnualRentPayable>
    <trib:AnnualRentPayable
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribJrjMember"
      decimals="0"
      id="Fxbrl_20250513104142166"
      unitRef="USD">421000</trib:AnnualRentPayable>
    <trib:TermOfLease
      contextRef="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_tribJrjMember"
      id="Fxbrl_20250513104408144">25-year</trib:TermOfLease>
    <trib:RateOfRentPerSqureFoot
      contextRef="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhAndDrWalshMember"
      decimals="0"
      id="Fxbrl_20230515110735061"
      unitRef="USD">43860</trib:RateOfRentPerSqureFoot>
    <trib:AnnualRentPayable
      contextRef="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhAndDrWalshMember"
      decimals="0"
      id="Fxbrl_20230515110806999"
      unitRef="EUR">787000</trib:AnnualRentPayable>
    <trib:AnnualRentPayable
      contextRef="C_20071201to20071231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhAndDrWalshMember"
      decimals="0"
      id="Fxbrl_20230515110812742"
      unitRef="USD">834000</trib:AnnualRentPayable>
    <trib:IncreaseInAnnualRent
      contextRef="C_20220701to20220701"
      decimals="0"
      id="Fxbrl_20250512191408999"
      unitRef="EUR">1050000</trib:IncreaseInAnnualRent>
    <trib:OverheadCosts
      contextRef="C_20220701to20220701"
      decimals="0"
      id="Fxbrl_20250513105608436"
      unitRef="USD">686000</trib:OverheadCosts>
    <trib:TermOfLease
      contextRef="C_20161201to20161231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhAndDrWalshMember"
      id="Fxbrl_20250513105705235">10-year</trib:TermOfLease>
    <trib:RateOfRentPerSqureFoot
      contextRef="C_20161201to20161231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhMember"
      decimals="0"
      id="Fxbrl_20230515110918578"
      unitRef="USD">16000</trib:RateOfRentPerSqureFoot>
    <trib:AnnualRentPayableForWareHouse
      contextRef="C_20161201to20161231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhMember"
      decimals="0"
      id="Fxbrl_20230515110905839"
      unitRef="EUR">144000</trib:AnnualRentPayableForWareHouse>
    <trib:AnnualRentPayableForWareHouse
      contextRef="C_20161201to20161231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhMember"
      decimals="0"
      id="Fxbrl_20230515110912227"
      unitRef="USD">159000</trib:AnnualRentPayableForWareHouse>
    <trib:IncreaseInAnnualRent
      contextRef="C_20210701to20210701"
      decimals="0"
      id="Fxbrl_20250513105822577"
      unitRef="EUR">170560</trib:IncreaseInAnnualRent>
    <trib:OverheadCosts
      contextRef="C_20210701to20210701"
      decimals="0"
      id="Fxbrl_20250513105829777"
      unitRef="USD">97000</trib:OverheadCosts>
    <trib:AnnualRentPayable
      contextRef="C_20220101to20221231_ifrsfullCategoriesOfRelatedPartiesAxis_tribMrOCaoimhMember_ifrsfullClassesOfFinancialInstrumentsAxis_tribAdditionalSpaceMember"
      decimals="0"
      id="Fxbrl_20230414165644800"
      unitRef="USD">90000</trib:AnnualRentPayable>
    <trib:AcquisitionConsideration
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-5"
      id="Fxbrl_20250513120550803"
      unitRef="USD">900000</trib:AcquisitionConsideration>
    <trib:AcquisitionConsideration
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-4"
      id="Fxbrl_20250513120601118"
      unitRef="USD">270000</trib:AcquisitionConsideration>
    <trib:ExtinguishmentOfAmountOwed
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-4"
      id="Fxbrl_20250513120620440"
      unitRef="USD">410000</trib:ExtinguishmentOfAmountOwed>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullCategoriesOfRelatedPartiesAxis_tribDrJimWalshMember"
      decimals="2"
      id="Fxbrl_20250513120644347"
      unitRef="Pure">0.06</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:InterestExpense
      contextRef="C_20240901to20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullCategoriesOfRelatedPartiesAxis_tribDrJimWalshMember"
      decimals="0"
      id="Fxbrl_20250513120723049"
      unitRef="USD">55000</ifrs-full:InterestExpense>
    <trib:DisclosureOfDetailedInformationAboutCompensationExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512183852382">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term
        employee benefits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;843&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,774&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Performance
        related bonus&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;260&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;211&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Post-employment
        benefits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based
        compensation benefits as calculated under IFRS 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;931&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,601&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,073&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutCompensationExplanatory>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220117233701828_23"
      unitRef="USD">843000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220117233701828_27"
      unitRef="USD">1774000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <trib:KeyManagementPersonnelCompensationPerformanceRelatedBonus
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220117233701828_33"
      unitRef="USD">260000</trib:KeyManagementPersonnelCompensationPerformanceRelatedBonus>
    <trib:KeyManagementPersonnelCompensationPerformanceRelatedBonus
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220117233701828_37"
      unitRef="USD">211000</trib:KeyManagementPersonnelCompensationPerformanceRelatedBonus>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220117233701828_43"
      unitRef="USD">39000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220117233701828_47"
      unitRef="USD">26000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220117233701828_53"
      unitRef="USD">931000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220117233701828_57"
      unitRef="USD">1601000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220117233701828_73"
      unitRef="USD">2073000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220117233701828_77"
      unitRef="USD">3612000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:DirectorsRemunerationExpense
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsMember"
      decimals="0"
      id="Fxbrl_20240430024420074"
      unitRef="USD">114000</ifrs-full:DirectorsRemunerationExpense>
    <ifrs-full:DirectorsRemunerationExpense
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsMember"
      decimals="0"
      id="Fxbrl_20240430024511282"
      unitRef="USD">73000</ifrs-full:DirectorsRemunerationExpense>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsMember"
      decimals="0"
      id="Fxbrl_20240430024519562"
      unitRef="USD">0</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsMember"
      decimals="0"
      id="Fxbrl_20240430024524834"
      unitRef="USD">0</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <trib:DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250513103944095">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;A&#x2019;
        Ordinary Shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share
        options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,117,777&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30,387,336&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Shares
        purchased during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;200,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,600,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired
        / forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,994,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,317,777&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32,993,336&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2018;A&#x2019;
        Ordinary Shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share
        options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        January&#160;1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,117,777&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,547,336&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options
        of retired director&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20,000,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,000,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expired
        / forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,160,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
        December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,117,777&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30,387,336&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutSharesAndShareOptionPlanExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20220117234712986"
      unitRef="Shares">11117777</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember"
      decimals="INF"
      id="Fxbrl_20220117234958300"
      unitRef="Shares">30387336</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:SharesPurchasedDuringYear
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20220117235203837"
      unitRef="Shares">200000</trib:SharesPurchasedDuringYear>
    <trib:SharesPurchasedDuringYear
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember"
      decimals="INF"
      id="Fxbrl_20230413171437292"
      unitRef="Shares">0</trib:SharesPurchasedDuringYear>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20220117235210157"
      unitRef="Shares">0</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember"
      decimals="INF"
      id="Fxbrl_20220117235519141"
      unitRef="Shares">5600000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20220117235217132"
      unitRef="Shares">0</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="C_20240101to20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember"
      decimals="INF"
      id="Fxbrl_20220117235650310"
      unitRef="Shares">2994000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20220117235028141"
      unitRef="Shares">11317777</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20241231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember"
      decimals="INF"
      id="Fxbrl_20220117235036627"
      unitRef="Shares">32993336</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20220118000810356_xbrl_20220117234712986"
      unitRef="Shares">11117777</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20221231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember"
      decimals="INF"
      id="Fxbrl_20220118000810356_xbrl_20220117234958300"
      unitRef="Shares">40547336</ifrs-full:NumberOfOutstandingShareOptions>
    <trib:NumberOfRetiredDirectorOptions
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20220118000835467_xbrl_20220117235136070"
      unitRef="Shares">0</trib:NumberOfRetiredDirectorOptions>
    <trib:NumberOfRetiredDirectorOptions
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember"
      decimals="INF"
      id="Fxbrl_20230413171839105"
      unitRef="Shares">-20000000</trib:NumberOfRetiredDirectorOptions>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20220118000921243_xbrl_20220117235210157"
      unitRef="Shares">0</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember"
      decimals="INF"
      id="Fxbrl_20220118000921243_xbrl_20220117235519141"
      unitRef="Shares">14000000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20220118000929252_xbrl_20220117235217132"
      unitRef="Shares">0</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="C_20230101to20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember"
      decimals="INF"
      id="Fxbrl_20220118000929252_xbrl_20220117235650310"
      unitRef="Shares">4160000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20220118000936603_xbrl_20220117235028141"
      unitRef="Shares">11117777</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20231231_ifrsfullCategoriesOfRelatedPartiesAxis_tribDirectorsAndCompanySecretaryMember_ifrsfullClassesOfShareCapitalAxis_tribShareOptionMember"
      decimals="INF"
      id="Fxbrl_20220118000936603_xbrl_20220117235036627"
      unitRef="Shares">30387336</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240415102829322">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CAPITAL AND FINANCIAL RISK MANAGEMENT&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="line-height:1.25;font-weight:bold;margin-left:30pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Capital
Management&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group&#x2019;s policy is to maintain a strong capital base to maintain investor, creditor and market confidence and to sustain future development
of the business. The Board of Directors monitors (loss)/earnings per share as a measure of performance, which the Group defines as (loss)/profit
after tax divided by the weighted average number of shares in issue.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-indent:30.6pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair
Values&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
table below sets out the Group&#x2019;s classification of each class of financial assets/liabilities, their fair values and under which
valuation method they are valued:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level
        1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level
        2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level
        3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;carrying&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;amount&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loans
        and receivables at amortised cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,583&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;-&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,583&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,583&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liabilities
        at amortised cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables (excluding deferred income)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,585&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,585&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,585&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(41,876&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(88,002&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(129,878&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(129,878&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair
        value through profit and loss (FVPL)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative
        liability - warrants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative
        asset &#x2013; prepayment option&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Equity
        investments in Novus&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,492&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(23,293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(89,494&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(110,332&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(110,332&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:28.35pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For
financial reporting purposes, fair value measurements are categorized into Level&#160;1, 2 or 3 based on the degree to which inputs to
the fair value measurements are observable and the significance of the inputs to the fair value measurement in its entirety, which are
described as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-indent:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level&#160;1:
quoted prices (unadjusted) in active markets for identical assets or liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level&#160;2:
valuation techniques for which the lowest level of inputs which have a significant effect on the recorded fair value are observable, either
directly or indirectly&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:28.35pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level&#160;3:
valuation techniques for which the lowest level of inputs that have a significant effect on the recorded fair value are not based on observable
market data.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:28.35pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level
        1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level
        2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level
        3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;carrying&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;amount&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loans
        and receivables at amortised cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finance
        lease receivable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,
        17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liabilities
        at amortised cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        note&#xb9;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables (excluding deferred income)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(25,368&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(54,861&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(80,229&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(80,229&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair
        value through profit and loss (FVPL)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative
        liability - warrants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(526&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(526&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(526&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative
        asset &#x2013; prepayment option&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,824&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(55,209&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,033&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,033&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
valuation techniques used for instruments categorised as level 2 are described below:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
fair values of the options associated with the exchangeable notes are calculated in consultation with third-party valuation specialists
due to the complexity of their nature. There are a number of inputs utilised in the valuation of the options, including share price, historical
share price volatility, risk-free rate and the expected borrowing cost spread over the risk-free rate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
Risk Management&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group uses a range of financial instruments (including cash, finance leases, receivables, payables and derivatives) to fund its operations.
These instruments are used to manage the liquidity of the Group. Working capital management is a key additional element in the effective
management of overall liquidity. The Group does not trade in financial instruments or derivatives. The main risks arising from the utilization
of these financial instruments are interest rate risk, liquidity risk and credit risk.&lt;/span&gt;&lt;/span&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&lt;span style="font-weight:bold;font-style:italic"&gt;Interest
rate risk&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
of December 31, 2024, all of the Group&#x2019;s financial instruments referencing interest rates are based on SOFR, a post-reform benchmark
rate. The Group no longer has exposure to interest rate benchmarks subject to IBOR reform; therefore, the disclosure requirements related
to benchmark interest rate reform are not applicable.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective
and repricing analysis&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
following tables sets out all interest-earning financial assets and interest-bearing financial liabilities held by the Group at December&#160;31,
2024 and 2023, indicating their effective interest rates and the period in which they re-price:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As&#160;at&#160;December&#160;31,&#160;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;interest&lt;br/&gt;rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        mths or less&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        &#x2013;12 mths&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1-2
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2-5
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;gt;
        5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:20.21%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&#160;and&#160;cash&#160;equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        note&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:20.21%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;3&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:20.21%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-9pt;margin-left:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&#160;&#160;&#160;Lease
        payable on Right of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,135&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,742&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,532&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,203&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:20.21%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(95,597&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,017&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,135&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(74,133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,933&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,413&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As&#160;at&#160;December&#160;31,&#160;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;interest&lt;br/&gt;rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        mths or less&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        &#x2013;12 mths&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1-2
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2-5
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;gt;
        5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&#160;and&#160;cash&#160;equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:20.21%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease&#160;receivable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        note&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:20.21%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-2.6pt;margin-left:9.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-1.9pt;margin-left:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;3&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:20.21%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="margin-left:7.1pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        payable on Right of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(812&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,745&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,425&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:20.21%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(63,581&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,941&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(793&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,696&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(44,529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,504&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:31.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;1&lt;/sup&gt;
The maturity of the exchangeable notes is based on the contractual maturity date of April 1, 2045.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:31.2pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;2&lt;/sup&gt;
The senior secured term loan is a variable instrument. In January 2024, the
amended term loan agreement reduced the annual rate of interest on the loan by 2.5% to 8.75% plus the greater of (a) Term Secured Overnight
Financing Rate or (b) 4.0% per annum, and allows for a further 2.5% reduction in the base rate to 6.25% once the outstanding principal
under the term loan falls below US$35 million.&#160; The loan matures in July 2026.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:31.2pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;3&lt;/sup&gt;
The 7-year convertible note was issued in May 2022 and is a fixed rate instrument which bears a fixed rate of interest of 1.5%
per annum.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;In
broad terms, a one-percentage point increase in interest rates would increase interest income by US$Nil
(2023: US$Nil)
as at December 31, 2024 the Company holds no funds in interest-bearing accounts; while the annual impact on the interest expense would
be an increase of US$755,000
(2023: US$417,000)
on the costs of servicing the senior secured term loan. &lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest
rate profile of financial assets / liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
interest rate profile of financial assets/liabilities of the Group was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Variable
        rate instruments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        at bank and in hand&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Variable
        rate financial liabilities (senior secured term loan)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(67,224&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,418&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fixed
        rate instruments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fixed
        rate financial liabilities (exchangeable note)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fixed
        rate financial liabilities (convertible note)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fixed
        rate financial liabilities (lease payables)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        assets (lease receivables)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(28,373&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(27,163&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold;font-style:italic"&gt;&#160;Fair
value sensitivity analysis for fixed rate instruments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group does not account for any fixed rate financial liabilities at fair value through profit and loss. Therefore, a change in interest
rates at December&#160;31, 2024 or December 31, 2023 would not affect profit or loss. There was no significant difference between the
fair value and carrying value of the Group&#x2019;s trade receivables and trade and other payables at December&#160;31, 2024 and December
31, 2023 as all fell due within 6 months.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-style:italic;font-weight:bold"&gt;Liquidity
risk&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
following are the contractual maturities of financial liabilities, including estimated interest payments:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        at December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying&lt;br/&gt;amount&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contractual&lt;br/&gt;cash
        flows&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        mths or&lt;br/&gt;less&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        mths &#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12
        mths&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1-2
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2-5
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;gt;5
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables (excluding deferred income)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        payable on Right of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,214&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,454&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:16%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&#xb9;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81,438&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,703&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,319&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,350&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;300&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;900&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        notes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;380&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;340&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;126,050&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;143,668&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,597&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,881&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78,937&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,411&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,842&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#xb9;
The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December
31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        at December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying&lt;br/&gt;amount&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contractual&lt;br/&gt;cash
        flows&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        mths or&lt;br/&gt;less&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        mths &#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12
        mths&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1-2
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2-5
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;gt;5
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables (excluding deferred income)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        payable on Right of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,306&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,114&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,243&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,442&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:16%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&#xb9;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,121&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,461&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,461&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,922&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,277&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,650&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;300&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;900&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        notes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;389&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,179&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;106,218&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,474&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,729&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,473&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;48,643&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,899&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:31.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#xb9;
The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December
31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign
exchange risk&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
majority of the Group&#x2019;s activities are conducted in US Dollars. Foreign exchange risk arises from the fluctuating value of the Group&#x2019;s
Euro denominated expenses as a result of the movement in the exchange rate between the US&#160;Dollar and the Euro. There were no forward
contracts in place as at December 31, 2024 or December&#160;31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign
currency financial assets and liabilities which expose the Group to currency risk are disclosed below. The amounts shown are those reported
to key management translated into US Dollars at the closing rate:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;EUR&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GBP&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SEK&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CAD&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;BRL&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        at December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;116&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other receivable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,009&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;294&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,019&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,098&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(114&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(135&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,867&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        exposure&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,840&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(329&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;473&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,086&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;EUR&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GBP&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SEK&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CAD&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;BRL&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        at December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;191&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;854&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other receivable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;856&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;533&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,533&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,766&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(220&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(704&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(241&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        exposure&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,040&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;504&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,442&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sensitivity
analysis&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:30pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A 10%
strengthening of the US&#160;Dollar against the Euro at December&#160;31, 2024 would have increased profit and other equity by the amounts
shown below. This analysis assumes that all other variables, in particular interest rates, remain constant.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Profit
        or Loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="1" style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Euro&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="1" style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="1" style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Euro&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,004&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;&#160;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A
10% weakening of the US&#160;Dollar against the Euro at December&#160;31, 2024 would have decreased profit and other equity by the amounts
shown below. This analysis assumes that all other variables, in particular interest rates, remain constant.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Profit
        or Loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Euro&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,427&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Euro&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,227&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
sensitivity analysis is based on the Group&#x2019;s foreign currency exposures at the reporting date and assumes a 10% movement in the
US Dollar against the Euro. The analysis includes monetary assets and liabilities denominated in Euro at the reporting date and assumes
that exchange rate changes occur at the period-end and are applied to the net exposure. Non-monetary items and future forecast transactions
are excluded. The analysis assumes that all other variables, including interest rates, remain constant. The analysis does not incorporate
interdependencies between variables, such as interest rate effects on exchange rates, and is not based on a value-at-risk model.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
objective of this analysis is to assess the potential impact of reasonably possible changes in exchange rates on the Group&#x2019;s profit
or loss and equity, based on exposures at the reporting date. The analysis reflects only monetary assets and liabilities denominated in
foreign currencies and does not include future transactions or embedded derivatives. The analysis has inherent limitations, as it is based
on a hypothetical movement in a single variable (foreign exchange rate) and assumes all other variables remain constant. It does not consider
the potential interdependence between risk factors (such as changes in interest rates or inflation), nor does it reflect management&#x2019;s
dynamic hedging activities or the potential impact on fair value from market volatility occurring after the reporting date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Credit
Risk&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group has no significant concentrations of credit risk. Exposure to credit risk is monitored on an ongoing basis. For trade receivables,
the Group applies the simplified approach to measuring expected credit losses and recognizes a lifetime expected credit loss allowance.
A receivable is considered credit-impaired when it is more than 120 days past due or when there is evidence of significant financial difficulty.
The Group maintains specific provisions for potential credit losses. To date such losses have been within management&#x2019;s expectations.
Due to the large number of customers and the geographical dispersion of these customers, the Group has no significant concentrations of
accounts receivable.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;With
respect to credit risk arising from the other financial assets of the Group, which comprise cash and cash equivalents, the Group&#x2019;s
exposure to credit risk arises from default of the counterparty, with a maximum exposure equal to the carrying amount of these instruments.
The Group&#x2019;s management considers that all of the above financial assets that are not impaired or past due for each of the 31&#160;December
reporting dates under review are of good credit quality.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group maintains cash and cash equivalents with various financial institutions. The Group performs regular and detailed evaluations of
these financial institutions to assess their relative credit standing. The carrying amount reported in the balance sheet for cash and
cash equivalents approximate their fair value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exposure
to credit risk&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
carrying amount of financial assets represents the maximum credit exposure. The maximum exposure to credit risk is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        Value&lt;br/&gt;December&#160;31, &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        Value&lt;br/&gt;December&#160;31, &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Third
        party trade receivables (Note 17)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finance
        lease income receivable (Note 17)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&#160;and
        cash equivalents (Note 18)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,583&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
maximum exposure to credit risk for trade receivables and finance lease income receivable by geographic location is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        Value&lt;br/&gt;December&#160;31, &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        Value&lt;br/&gt;December&#160;31, &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United
        States&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,185&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,041&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Euro-zone
        countries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;742&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;851&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United
        Kingdom&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;741&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;126&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        regions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,748&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,835&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,853&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;&#160;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
maximum exposure to credit risk for trade receivables and finance lease income receivable by type of customer is as follows: &#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        Value&lt;br/&gt;December&#160;31, &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        Value&lt;br/&gt;December&#160;31, &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;End-user
        customers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,828&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,029&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Distributors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,236&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,399&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-governmental
        organisations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,352&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;425&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,853&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Due
to the large number of customers and the geographical dispersion of these customers, the Group has no significant concentrations of accounts
receivable.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment
Losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
ageing of trade receivables at December&#160;31, 2024 is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected
        Credit Loss Rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected
        Credit Loss Rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Not
        past due&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,363&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Past
        due 0-30 days&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,534&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Past
        due 31-120 days&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,753&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;856&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Greater
        than 120 days&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,131&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,255&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;72.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,601&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,302&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;88.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,702&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,324&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;&#160;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group considers that the credit risk of a financial asset may have increased since initial recognition when it is more than 30 days past
due, unless there is evidence to the contrary. As at December 31, 2024, all trade receivables past due more than 30 days were assessed
for changes in credit risk since initial recognition. Based on this assessment:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Receivables past due
        between 31 and 120 days are not automatically considered to have an increased credit risk unless other qualitative indicators are present
        (e.g., known financial difficulty, adverse changes in circumstances, etc.).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Receivables past due more than 120 days are generally
        considered to have a higher credit risk and are assessed for lifetime expected credit losses.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group applies a simplified approach in measuring expected credit losses which uses a provision matrix based on historical credit loss
experience, adjusted for forward-looking factors specific to the debtors and the economic environment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
movement in the allowance for impairment in respect of trade receivables during the year was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance
        at January&#160;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,324&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Charged
        to costs and expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;225&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;715&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amounts
        written off during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(263&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(977&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Eliminated
        on disposal of business&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance
        at December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,324&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
allowance for impairment in respect of trade receivables is used to record impairment losses unless the Group is satisfied that no recovery
of the account owing is possible. At this point the amount is considered irrecoverable and is written off against the financial asset
directly.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group does not provide financing to customers as a main business activity and therefore is not required to present credit risk exposure
disclosures by credit risk grade.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413100740332">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level
        1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level
        2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level
        3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;carrying&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;amount&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loans
        and receivables at amortised cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,583&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;-&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,583&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,583&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liabilities
        at amortised cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables (excluding deferred income)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,585&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,585&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,585&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(41,876&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(88,002&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(129,878&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(129,878&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair
        value through profit and loss (FVPL)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative
        liability - warrants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative
        asset &#x2013; prepayment option&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Equity
        investments in Novus&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,492&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(23,293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(89,494&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(110,332&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(110,332&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level
        1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level
        2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level
        3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;carrying&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;amount&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:7pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loans
        and receivables at amortised cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finance
        lease receivable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,
        17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liabilities
        at amortised cost&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        note&#xb9;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables (excluding deferred income)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(25,368&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(54,861&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(80,229&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(80,229&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair
        value through profit and loss (FVPL)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative
        liability - warrants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(526&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(526&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(526&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Derivative
        asset &#x2013; prepayment option&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28.27%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28.27%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,824&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(55,209&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,033&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.06%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(66,033&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.02%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119025807475"
      unitRef="USD">13416000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119025823748"
      unitRef="USD">0</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105208983"
      unitRef="USD">0</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119025932818"
      unitRef="USD">13416000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119030018593"
      unitRef="USD">13416000</ifrs-full:TradeReceivables>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030101541_xbrl_20220119025807475"
      unitRef="USD">5167000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030101541_xbrl_20220119025823748"
      unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105242084"
      unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119030101541_xbrl_20220119025932818"
      unitRef="USD">5167000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119030101541_xbrl_20220119030018593"
      unitRef="USD">5167000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:MaximumExposureToCreditRisk
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030106788_xbrl_20220119025807475"
      unitRef="USD">18583000</ifrs-full:MaximumExposureToCreditRisk>
    <ifrs-full:MaximumExposureToCreditRisk
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030106788_xbrl_20220119025823748"
      unitRef="USD">0</ifrs-full:MaximumExposureToCreditRisk>
    <ifrs-full:MaximumExposureToCreditRisk
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250514155605134"
      unitRef="USD">0</ifrs-full:MaximumExposureToCreditRisk>
    <ifrs-full:MaximumExposureToCreditRisk
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119030106788_xbrl_20220119025932818"
      unitRef="USD">18583000</ifrs-full:MaximumExposureToCreditRisk>
    <ifrs-full:MaximumExposureToCreditRisk
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119030106788_xbrl_20220119030018593"
      unitRef="USD">18583000</ifrs-full:MaximumExposureToCreditRisk>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025807475"
      unitRef="USD">0</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025823748"
      unitRef="USD">72391000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105309989"
      unitRef="USD">0</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025932818"
      unitRef="USD">72391000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119030018593"
      unitRef="USD">72391000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <trib:ConvertibleNote
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025807475"
      unitRef="USD">0</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025823748"
      unitRef="USD">15401000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105336756"
      unitRef="USD">0</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025932818"
      unitRef="USD">15401000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119030018593"
      unitRef="USD">15401000</trib:ConvertibleNote>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030109342_xbrl_20220119025807475"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030109342_xbrl_20220119025823748"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105359717"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119030109342_xbrl_20220119025932818"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119030109342_xbrl_20220119030018593"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20230414133805048_xbrl_20220119030114460_xbrl_20220119025807475"
      unitRef="USD">12762000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20230414133805048_xbrl_20220119030114460_xbrl_20220119025823748"
      unitRef="USD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105502116"
      unitRef="USD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20230414133805048_xbrl_20220119030114460_xbrl_20220119025932818"
      unitRef="USD">12762000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20230414133805048_xbrl_20220119030114460_xbrl_20220119030018593"
      unitRef="USD">12762000</ifrs-full:LeaseLiabilities>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030114460_xbrl_20220119025807475"
      unitRef="USD">26585000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030114460_xbrl_20220119025823748"
      unitRef="USD">0</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105514614"
      unitRef="USD">0</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119030114460_xbrl_20220119025932818"
      unitRef="USD">26585000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119030114460_xbrl_20220119030018593"
      unitRef="USD">26585000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:Provisions
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030120188_xbrl_20220119025807475"
      unitRef="USD">2529000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030120188_xbrl_20220119025823748"
      unitRef="USD">0</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105532628"
      unitRef="USD">0</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119030120188_xbrl_20220119025932818"
      unitRef="USD">2529000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119030120188_xbrl_20220119030018593"
      unitRef="USD">2529000</ifrs-full:Provisions>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030122116_xbrl_20220119025807475"
      unitRef="USD">41876000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030122116_xbrl_20220119025823748"
      unitRef="USD">88002000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105551364"
      unitRef="USD">0</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119030122116_xbrl_20220119025932818"
      unitRef="USD">129878000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119030122116_xbrl_20220119030018593"
      unitRef="USD">129878000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030124916_xbrl_20220119025807475"
      unitRef="USD">0</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030124916_xbrl_20220119025823748"
      unitRef="USD">1658000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105610996"
      unitRef="USD">0</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119030124916_xbrl_20220119025932818"
      unitRef="USD">1658000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119030124916_xbrl_20220119030018593"
      unitRef="USD">1658000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030127597_xbrl_20220119025807475"
      unitRef="USD">0</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030127597_xbrl_20220119025823748"
      unitRef="USD">166000</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105627844"
      unitRef="USD">0</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119030127597_xbrl_20220119025932818"
      unitRef="USD">166000</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119030127597_xbrl_20220119030018593"
      unitRef="USD">166000</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:NoncontrollingInterests
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250513120708889_xbrl_20220119030127597_xbrl_20220119025807475"
      unitRef="USD">0</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250513120708889_xbrl_20220119030127597_xbrl_20220119025823748"
      unitRef="USD">0</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250513120708889_xbrl_20250513105627844"
      unitRef="USD">2455000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250513120708889_xbrl_20220119030127597_xbrl_20220119025932818"
      unitRef="USD">2455000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember_ifrsfullUnconsolidatedStructuredEntitiesAxis_tribNovusDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250513120708889_xbrl_20220119030127597_xbrl_20220119030018593"
      unitRef="USD">2455000</ifrs-full:NoncontrollingInterests>
    <trib:FairValueThroughProfitAndLoss
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030129707_xbrl_20220119025807475"
      unitRef="USD">0</trib:FairValueThroughProfitAndLoss>
    <trib:FairValueThroughProfitAndLoss
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030129707_xbrl_20220119025823748"
      unitRef="USD">-1492000</trib:FairValueThroughProfitAndLoss>
    <trib:FairValueThroughProfitAndLoss
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105653453"
      unitRef="USD">2455000</trib:FairValueThroughProfitAndLoss>
    <trib:FairValueThroughProfitAndLoss
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119030129707_xbrl_20220119025932818"
      unitRef="USD">963000</trib:FairValueThroughProfitAndLoss>
    <trib:FairValueThroughProfitAndLoss
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119030129707_xbrl_20220119030018593"
      unitRef="USD">963000</trib:FairValueThroughProfitAndLoss>
    <trib:FairValueOfFinancialAssetsLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030132996_xbrl_20220119025807475"
      unitRef="USD">-23293000</trib:FairValueOfFinancialAssetsLiabilities>
    <trib:FairValueOfFinancialAssetsLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119030132996_xbrl_20220119025823748"
      unitRef="USD">-89494000</trib:FairValueOfFinancialAssetsLiabilities>
    <trib:FairValueOfFinancialAssetsLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105715948"
      unitRef="USD">2455000</trib:FairValueOfFinancialAssetsLiabilities>
    <trib:FairValueOfFinancialAssetsLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119030132996_xbrl_20220119025932818"
      unitRef="USD">-110332000</trib:FairValueOfFinancialAssetsLiabilities>
    <trib:FairValueOfFinancialAssetsLiabilities
      contextRef="C_20241231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119030132996_xbrl_20220119030018593"
      unitRef="USD">-110332000</trib:FairValueOfFinancialAssetsLiabilities>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031634202_xbrl_20220119025807475"
      unitRef="USD">10698000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031634202_xbrl_20220119025823748"
      unitRef="USD">0</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513183823266"
      unitRef="USD">0</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119031634202_xbrl_20220119025932818"
      unitRef="USD">10698000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119031634202_xbrl_20220119030018593"
      unitRef="USD">10698000</ifrs-full:TradeReceivables>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031835442_xbrl_20220119031634202_xbrl_20220119025807475"
      unitRef="USD">3691000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031835442_xbrl_20220119031634202_xbrl_20220119025823748"
      unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513183836905"
      unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119031835442_xbrl_20220119031634202_xbrl_20220119025932818"
      unitRef="USD">3691000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119031835442_xbrl_20220119031634202_xbrl_20220119030018593"
      unitRef="USD">3691000</ifrs-full:CashAndCashEquivalents>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031839618_xbrl_20220119031634202_xbrl_20220119025807475"
      unitRef="USD">155000</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031839618_xbrl_20220119031634202_xbrl_20220119025823748"
      unitRef="USD">0</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513183851986"
      unitRef="USD">0</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119031839618_xbrl_20220119031634202_xbrl_20220119025932818"
      unitRef="USD">155000</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119031839618_xbrl_20220119031634202_xbrl_20220119030018593"
      unitRef="USD">155000</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <ifrs-full:MaximumExposureToCreditRisk
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031842018_xbrl_20220119031634202_xbrl_20220119025807475"
      unitRef="USD">14544000</ifrs-full:MaximumExposureToCreditRisk>
    <ifrs-full:MaximumExposureToCreditRisk
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031842018_xbrl_20220119031634202_xbrl_20220119025823748"
      unitRef="USD">0</ifrs-full:MaximumExposureToCreditRisk>
    <ifrs-full:MaximumExposureToCreditRisk
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513184121417"
      unitRef="USD">0</ifrs-full:MaximumExposureToCreditRisk>
    <ifrs-full:MaximumExposureToCreditRisk
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119031842018_xbrl_20220119031634202_xbrl_20220119025932818"
      unitRef="USD">14544000</ifrs-full:MaximumExposureToCreditRisk>
    <ifrs-full:MaximumExposureToCreditRisk
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119031842018_xbrl_20220119031634202_xbrl_20220119030018593"
      unitRef="USD">14544000</ifrs-full:MaximumExposureToCreditRisk>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20240413102621081_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025807475"
      unitRef="USD">0</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20240413102621081_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025823748"
      unitRef="USD">40109000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513184136977"
      unitRef="USD">0</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240413102621081_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025932818"
      unitRef="USD">40109000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20240413102621081_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119030018593"
      unitRef="USD">40109000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <trib:ConvertibleNote
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20240413102632426_xbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025807475"
      unitRef="USD">0</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20240413102632426_xbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025823748"
      unitRef="USD">14542000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513184148657"
      unitRef="USD">0</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240413102632426_xbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119025932818"
      unitRef="USD">14542000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20240413102632426_xbrl_20230413122545448_xbrl_20230413122436932_xbrl_20220119030109342_xbrl_20220119030018593"
      unitRef="USD">14542000</trib:ConvertibleNote>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20240413102647457_xbrl_20220119030109342_xbrl_20220119025807475"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20240422102853731"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513184205194"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240413102647457_xbrl_20220119030109342_xbrl_20220119025932818"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20240413102647457_xbrl_20220119030109342_xbrl_20220119030018593"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031846937_xbrl_20220119031634202_xbrl_20220119025807475"
      unitRef="USD">12566000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031846937_xbrl_20220119031634202_xbrl_20220119025823748"
      unitRef="USD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105945317"
      unitRef="USD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119031846937_xbrl_20220119031634202_xbrl_20220119025932818"
      unitRef="USD">12566000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119031846937_xbrl_20220119031634202_xbrl_20220119030018593"
      unitRef="USD">12566000</ifrs-full:LeaseLiabilities>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031851810_xbrl_20220119031634202_xbrl_20220119025807475"
      unitRef="USD">12752000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031851810_xbrl_20220119031634202_xbrl_20220119025823748"
      unitRef="USD">0</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105929628"
      unitRef="USD">0</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119031851810_xbrl_20220119031634202_xbrl_20220119025932818"
      unitRef="USD">12752000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119031851810_xbrl_20220119031634202_xbrl_20220119030018593"
      unitRef="USD">12752000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:Provisions
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031849186_xbrl_20220119031634202_xbrl_20220119025807475"
      unitRef="USD">50000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031849186_xbrl_20220119031634202_xbrl_20220119025823748"
      unitRef="USD">0</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105907716"
      unitRef="USD">0</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119031849186_xbrl_20220119031634202_xbrl_20220119025932818"
      unitRef="USD">50000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119031849186_xbrl_20220119031634202_xbrl_20220119030018593"
      unitRef="USD">50000</ifrs-full:Provisions>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031856170_xbrl_20220119031634202_xbrl_20220119025807475"
      unitRef="USD">25368000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031856170_xbrl_20220119031634202_xbrl_20220119025823748"
      unitRef="USD">54861000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105856276"
      unitRef="USD">0</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119031856170_xbrl_20220119031634202_xbrl_20220119025932818"
      unitRef="USD">80229000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119031856170_xbrl_20220119031634202_xbrl_20220119030018593"
      unitRef="USD">80229000</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20240413102658793_xbrl_20220119030124916_xbrl_20220119025807475"
      unitRef="USD">0</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20240413102658793_xbrl_20220119030124916_xbrl_20220119025823748"
      unitRef="USD">526000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105836484"
      unitRef="USD">0</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240413102658793_xbrl_20220119030124916_xbrl_20220119025932818"
      unitRef="USD">526000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20240413102658793_xbrl_20220119030124916_xbrl_20220119030018593"
      unitRef="USD">526000</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20240413102711803_xbrl_20220119030127597_xbrl_20220119025807475"
      unitRef="USD">0</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20240413102711803_xbrl_20220119030127597_xbrl_20220119025823748"
      unitRef="USD">178000</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105816668"
      unitRef="USD">0</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20240413102711803_xbrl_20220119030127597_xbrl_20220119025932818"
      unitRef="USD">178000</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20240413102711803_xbrl_20220119030127597_xbrl_20220119030018593"
      unitRef="USD">178000</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <trib:FairValueThroughProfitAndLoss
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031902274_xbrl_20220119031634202_xbrl_20220119025807475"
      unitRef="USD">0</trib:FairValueThroughProfitAndLoss>
    <trib:FairValueThroughProfitAndLoss
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220326220806474"
      unitRef="USD">-348000</trib:FairValueThroughProfitAndLoss>
    <trib:FairValueThroughProfitAndLoss
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105800076"
      unitRef="USD">0</trib:FairValueThroughProfitAndLoss>
    <trib:FairValueThroughProfitAndLoss
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220326221008680"
      unitRef="USD">-348000</trib:FairValueThroughProfitAndLoss>
    <trib:FairValueThroughProfitAndLoss
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220326221127599"
      unitRef="USD">-348000</trib:FairValueThroughProfitAndLoss>
    <trib:FairValueOfFinancialAssetsLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel1OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031904537_xbrl_20220119031634202_xbrl_20220119025807475"
      unitRef="USD">-10824000</trib:FairValueOfFinancialAssetsLiabilities>
    <trib:FairValueOfFinancialAssetsLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel2OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20220119031904537_xbrl_20220119031634202_xbrl_20220119025823748"
      unitRef="USD">-55209000</trib:FairValueOfFinancialAssetsLiabilities>
    <trib:FairValueOfFinancialAssetsLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullLevel3OfFairValueHierarchyMember"
      decimals="-3"
      id="Fxbrl_20250513105744501"
      unitRef="USD">0</trib:FairValueOfFinancialAssetsLiabilities>
    <trib:FairValueOfFinancialAssetsLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_ifrsfullCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119031904537_xbrl_20220119031634202_xbrl_20220119025932818"
      unitRef="USD">-66033000</trib:FairValueOfFinancialAssetsLiabilities>
    <trib:FairValueOfFinancialAssetsLiabilities
      contextRef="C_20231231_ifrsfullLevelsOfFairValueHierarchyAxis_tribFairValueMember"
      decimals="-3"
      id="Fxbrl_20220119031904537_xbrl_20220119031634202_xbrl_20220119030018593"
      unitRef="USD">-66033000</trib:FairValueOfFinancialAssetsLiabilities>
    <ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413100910916">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As&#160;at&#160;December&#160;31,&#160;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;interest&lt;br/&gt;rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        mths or less&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        &#x2013;12 mths&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1-2
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2-5
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;gt;
        5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:20.21%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&#160;and&#160;cash&#160;equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        note&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:20.21%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;3&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:20.21%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-9pt;margin-left:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#160;&#160;&#160;&#160;Lease
        payable on Right of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,135&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,742&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,532&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,203&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="width:20.21%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;vertical-align:bottom;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="width:20.21%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(95,597&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,017&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,135&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(74,133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,933&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,413&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As&#160;at&#160;December&#160;31,&#160;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;interest&lt;br/&gt;rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        mths or less&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        &#x2013;12 mths&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1-2
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2-5
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;gt;
        5 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic;text-indent:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&#160;and&#160;cash&#160;equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.00&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:20.21%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease&#160;receivable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        note&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:20.21%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-2.6pt;margin-left:9.7pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-1.9pt;margin-left:9pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;3&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:20.21%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="margin-left:7.1pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        payable on Right of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(812&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,745&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,425&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:20.21%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:20.21%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(63,581&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,941&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(793&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,696&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(44,529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:7.09%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,504&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:0.99%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:31.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;1&lt;/sup&gt;
The maturity of the exchangeable notes is based on the contractual maturity date of April 1, 2045.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:31.2pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;2&lt;/sup&gt;
The senior secured term loan is a variable instrument. In January 2024, the
amended term loan agreement reduced the annual rate of interest on the loan by 2.5% to 8.75% plus the greater of (a) Term Secured Overnight
Financing Rate or (b) 4.0% per annum, and allows for a further 2.5% reduction in the base rate to 6.25% once the outstanding principal
under the term loan falls below US$35 million.&#160; The loan matures in July 2026.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:31.2pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;3&lt;/sup&gt;
The 7-year convertible note was issued in May 2022 and is a fixed rate instrument which bears a fixed rate of interest of 1.5%
per annum.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory>
    <trib:EffectiveInterestRate
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember"
      decimals="4"
      id="Fxbrl_20220119111701722_xbrl_20220119103015701_17"
      unitRef="Pure">0</trib:EffectiveInterestRate>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember"
      decimals="-3"
      id="Fxbrl_20220119111701722_xbrl_20220119103015701_111"
      unitRef="USD">5167000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember"
      decimals="-3"
      id="Fxbrl_20220119111701722_xbrl_20220119103015701_115"
      unitRef="USD">5167000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember"
      decimals="-3"
      id="Fxbrl_20220119111701722_xbrl_20220119103015701_119"
      unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20220119111701722_xbrl_20220119103015701_123"
      unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119111701722_xbrl_20220119103015701_127"
      unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119111701722_xbrl_20220119103015701_131"
      unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
    <trib:EffectiveInterestRate
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember"
      decimals="3"
      id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17"
      unitRef="Pure">0.04</trib:EffectiveInterestRate>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember"
      decimals="-3"
      id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember"
      decimals="-3"
      id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember"
      decimals="-3"
      id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <trib:EffectiveInterestRate
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember"
      decimals="3"
      id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17"
      unitRef="Pure">0.163</trib:EffectiveInterestRate>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember"
      decimals="-3"
      id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111"
      unitRef="USD">72391000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember"
      decimals="-3"
      id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember"
      decimals="-3"
      id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123"
      unitRef="USD">72391000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <trib:EffectiveInterestRate
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember"
      decimals="3"
      id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17"
      unitRef="Pure">0.015</trib:EffectiveInterestRate>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111"
      unitRef="USD">15401000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember"
      decimals="-3"
      id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember"
      decimals="-3"
      id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127"
      unitRef="USD">15401000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <trib:EffectiveInterestRate
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember"
      decimals="3"
      id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_17"
      unitRef="Pure">0.05</trib:EffectiveInterestRate>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember"
      decimals="-3"
      id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_111"
      unitRef="USD">-12762000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember"
      decimals="-3"
      id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_115"
      unitRef="USD">-1150000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember"
      decimals="-3"
      id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_119"
      unitRef="USD">-1135000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_123"
      unitRef="USD">-1742000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_127"
      unitRef="USD">-4532000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20241231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119111701947_xbrl_20220119104914171_xbrl_20220119103015701_131"
      unitRef="USD">-4203000</trib:LeasePayableOnRightOfUseAssets>
    <trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220119111702063_xbrl_20220119104922500_xbrl_20220119103015701_111"
      unitRef="USD">95597000</trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities>
    <trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember"
      decimals="-3"
      id="Fxbrl_20220119111702063_xbrl_20220119104922500_xbrl_20220119103015701_115"
      unitRef="USD">-4017000</trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities>
    <trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember"
      decimals="-3"
      id="Fxbrl_20220119111702063_xbrl_20220119104922500_xbrl_20220119103015701_119"
      unitRef="USD">1135000</trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities>
    <trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities
      contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20220119111702063_xbrl_20220119104922500_xbrl_20220119103015701_123"
      unitRef="USD">74133000</trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities>
    <trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities
      contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119111702063_xbrl_20220119104922500_xbrl_20220119103015701_127"
      unitRef="USD">19933000</trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities>
    <trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities
      contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119111702063_xbrl_20220119104922500_xbrl_20220119103015701_131"
      unitRef="USD">4413000</trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities>
    <trib:EffectiveInterestRate
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember"
      decimals="4"
      id="Fxbrl_20220119103015701_17"
      unitRef="Pure">0</trib:EffectiveInterestRate>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember"
      decimals="-3"
      id="Fxbrl_20220119103015701_111"
      unitRef="USD">3691000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember"
      decimals="-3"
      id="Fxbrl_20220119103015701_115"
      unitRef="USD">3691000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember"
      decimals="-3"
      id="Fxbrl_20220119103015701_119"
      unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20220119103015701_123"
      unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119103015701_127"
      unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribCashAndCashEquivalentMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119103015701_131"
      unitRef="USD">0</ifrs-full:CashAndCashEquivalents>
    <trib:EffectiveInterestRate
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember"
      decimals="3"
      id="Fxbrl_20220119104859173_xbrl_20220119103015701_17"
      unitRef="Pure">0.04</trib:EffectiveInterestRate>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember"
      decimals="-3"
      id="Fxbrl_20220119104859173_xbrl_20220119103015701_111"
      unitRef="USD">155000</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember"
      decimals="-3"
      id="Fxbrl_20220119104859173_xbrl_20220119103015701_115"
      unitRef="USD">62000</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember"
      decimals="-3"
      id="Fxbrl_20220119104859173_xbrl_20220119103015701_119"
      unitRef="USD">39000</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20220119104859173_xbrl_20220119103015701_123"
      unitRef="USD">49000</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119104859173_xbrl_20220119103015701_127"
      unitRef="USD">5000</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribFinanceLeaseReceivableMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119104859173_xbrl_20220119103015701_131"
      unitRef="USD">0</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:EffectiveInterestRate
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember"
      decimals="3"
      id="Fxbrl_20220119104905700_xbrl_20220119103015701_17"
      unitRef="Pure">0.048</trib:EffectiveInterestRate>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember"
      decimals="-3"
      id="Fxbrl_20220119104905700_xbrl_20220119103015701_111"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember"
      decimals="-3"
      id="Fxbrl_20220119104905700_xbrl_20220119103015701_115"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember"
      decimals="-3"
      id="Fxbrl_20220119104905700_xbrl_20220119103015701_119"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20220119104905700_xbrl_20220119103015701_123"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119104905700_xbrl_20220119103015701_127"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribExchangeableNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119104905700_xbrl_20220119103015701_131"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <trib:EffectiveInterestRate
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember"
      decimals="3"
      id="Fxbrl_20240413104647018"
      unitRef="Pure">0.163</trib:EffectiveInterestRate>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember"
      decimals="-3"
      id="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_115"
      unitRef="USD">40109000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember"
      decimals="-3"
      id="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_119"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember"
      decimals="-3"
      id="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_123"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_127"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_131"
      unitRef="USD">40109000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribSeniorSecuredTermLoanMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20250513120950208"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <trib:EffectiveInterestRate
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember"
      decimals="3"
      id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_17"
      unitRef="Pure">0.015</trib:EffectiveInterestRate>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember"
      decimals="-3"
      id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_111"
      unitRef="USD">14542000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember"
      decimals="-3"
      id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_115"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember"
      decimals="-3"
      id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_119"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_123"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_127"
      unitRef="USD">0</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribConvertibleNoteMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_131"
      unitRef="USD">14542000</ifrs-full:LongtermBorrowings>
    <trib:EffectiveInterestRate
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember"
      decimals="3"
      id="Fxbrl_20220119104914171_xbrl_20220119103015701_17"
      unitRef="Pure">0.05</trib:EffectiveInterestRate>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember"
      decimals="-3"
      id="Fxbrl_20220119104914171_xbrl_20220119103015701_111"
      unitRef="USD">-12566000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthOrLessMember"
      decimals="-3"
      id="Fxbrl_20220119104914171_xbrl_20220119103015701_115"
      unitRef="USD">-812000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember"
      decimals="-3"
      id="Fxbrl_20220119104914171_xbrl_20220119103015701_119"
      unitRef="USD">-832000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20220119104914171_xbrl_20220119103015701_123"
      unitRef="USD">-1745000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119104914171_xbrl_20220119103015701_127"
      unitRef="USD">-4425000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20231231_ifrsfullClassesOfFinancialInstrumentsAxis_tribLeasePayableOnRightOfUseAssetsMember_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220430202446013"
      unitRef="USD">-4752000</trib:LeasePayableOnRightOfUseAssets>
    <trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119104922500_xbrl_20220119103015701_111"
      unitRef="USD">63581000</trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities>
    <trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember"
      decimals="-3"
      id="Fxbrl_20220119104922500_xbrl_20220119103015701_115"
      unitRef="USD">-2941000</trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities>
    <trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember"
      decimals="-3"
      id="Fxbrl_20220119104922500_xbrl_20220119103015701_119"
      unitRef="USD">793000</trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities>
    <trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember"
      decimals="-3"
      id="Fxbrl_20220119104922500_xbrl_20220119103015701_123"
      unitRef="USD">1696000</trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities>
    <trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119104922500_xbrl_20220119103015701_127"
      unitRef="USD">44529000</trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities>
    <trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember"
      decimals="-3"
      id="Fxbrl_20220119104922500_xbrl_20220119103015701_131"
      unitRef="USD">19504000</trib:InterestEarningFinancialAndInterestBearingFinancialLiabilities>
    <trib:TermLoanAgreementDescription
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413122609456">the
amended term loan agreement reduced the annual rate of interest on the loan by 2.5% to 8.75% plus the greater of (a) Term Secured Overnight
Financing Rate or (b) 4.0% per annum, and allows for a further 2.5% reduction in the base rate to 6.25% once the outstanding principal
under the term loan falls below US$35 million.&#160; The loan matures in July 2026.</trib:TermLoanAgreementDescription>
    <trib:SeniorSecuredTermLoanFixedRate
      contextRef="C_20240101to20241231"
      decimals="3"
      id="Fxbrl_20230427044257579"
      unitRef="Pure">0.015</trib:SeniorSecuredTermLoanFixedRate>
    <trib:GrossIncreaseInterestIncome
      contextRef="C_20240101to20241231"
      decimals="0"
      id="Fxbrl_20250513185509177"
      unitRef="USD">0</trib:GrossIncreaseInterestIncome>
    <trib:GrossIncreaseInterestIncome
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20230420182535305"
      unitRef="USD">0</trib:GrossIncreaseInterestIncome>
    <trib:NetInterestIncome
      contextRef="C_20240101to20241231"
      decimals="0"
      id="Fxbrl_20230420182605915"
      unitRef="USD">755000</trib:NetInterestIncome>
    <trib:NetInterestIncome
      contextRef="C_20230101to20231231"
      decimals="0"
      id="Fxbrl_20230420182610651"
      unitRef="USD">417000</trib:NetInterestIncome>
    <trib:DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413101047221">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Variable
        rate instruments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        at bank and in hand&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Variable
        rate financial liabilities (senior secured term loan)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(67,224&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(36,418&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fixed
        rate instruments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fixed
        rate financial liabilities (exchangeable note)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fixed
        rate financial liabilities (convertible note)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fixed
        rate financial liabilities (lease payables)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        assets (lease receivables)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(28,373&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(27,163&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutInterestRateProfileOfFinancialAssetsLiabilitiesExplanatory>
    <ifrs-full:Cash
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230420154242645_xbrl_20220119112358490_33"
      unitRef="USD">5167000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230420154242645_xbrl_20220119112358490_37"
      unitRef="USD">3691000</ifrs-full:Cash>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230420154244413_xbrl_20220119112358490_33"
      unitRef="USD">72391000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230420154244413_xbrl_20220119112358490_37"
      unitRef="USD">40109000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <trib:VariableRateInstruments
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230420154246893_xbrl_20220119112358490_33"
      unitRef="USD">-67224000</trib:VariableRateInstruments>
    <trib:VariableRateInstruments
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230420154246893_xbrl_20220119112358490_37"
      unitRef="USD">-36418000</trib:VariableRateInstruments>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220119112358490_33"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119112358490_37"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <trib:ConvertibleNote
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230420154159505_xbrl_20220119112358490_33"
      unitRef="USD">15401000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230420154159505_xbrl_20220119112358490_37"
      unitRef="USD">14542000</trib:ConvertibleNote>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220119112358490_53"
      unitRef="USD">12762000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119112358490_57"
      unitRef="USD">12566000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <trib:FinancialAssetsLeaseReceivables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220119112358490_73"
      unitRef="USD">0</trib:FinancialAssetsLeaseReceivables>
    <trib:FinancialAssetsLeaseReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119112358490_77"
      unitRef="USD">155000</trib:FinancialAssetsLeaseReceivables>
    <trib:FixedRateInstruments
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220119112358490_93"
      unitRef="USD">28373000</trib:FixedRateInstruments>
    <trib:FixedRateInstruments
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119112358490_97"
      unitRef="USD">27163000</trib:FixedRateInstruments>
    <trib:DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413101250158">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        at December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying&lt;br/&gt;amount&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contractual&lt;br/&gt;cash
        flows&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        mths or&lt;br/&gt;less&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        mths &#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12
        mths&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1-2
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2-5
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;gt;5
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables (excluding deferred income)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        payable on Right of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,762&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,214&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,454&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,487&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:16%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&#xb9;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;72,391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81,438&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,703&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,319&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,401&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,350&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;300&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;900&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        notes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;380&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;340&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;126,050&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;143,668&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,597&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,881&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78,937&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,411&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,842&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        at December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying&lt;br/&gt;amount&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contractual&lt;br/&gt;cash
        flows&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        mths or&lt;br/&gt;less&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6
        mths &#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12
        mths&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1-2
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2-5
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&amp;gt;5
        years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables (excluding deferred income)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        payable on Right of Use assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,566&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,306&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,114&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,243&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,442&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:16%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Senior
        secured term loan&#xb9;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56,121&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,461&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,461&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,922&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42,277&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Convertible
        note&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,542&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,650&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;300&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;900&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20,150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchangeable
        notes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;389&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:16%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:16%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,179&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;106,218&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;17,474&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,729&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,473&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;48,643&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,899&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:31.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#xb9;
The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December
31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutLiquidityRiskEstimatedInterestPaymentsOfMaturitiesExplanatory>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119114428934_23"
      unitRef="USD">25286000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119114428934_27"
      unitRef="USD">25286000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119114428934_211"
      unitRef="USD">25286000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119114428934_215"
      unitRef="USD">0</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119114428934_219"
      unitRef="USD">0</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119114428934_223"
      unitRef="USD">0</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119114428934_227"
      unitRef="USD">0</ifrs-full:TradeAndOtherPayables>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115850913_xbrl_20220119114428934_23"
      unitRef="USD">12762000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115850913_xbrl_20220119114428934_27"
      unitRef="USD">15214000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115850913_xbrl_20220119114428934_211"
      unitRef="USD">1454000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115850913_xbrl_20220119114428934_215"
      unitRef="USD">1408000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115850913_xbrl_20220119114428934_219"
      unitRef="USD">2213000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115850913_xbrl_20220119114428934_223"
      unitRef="USD">5487000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115850913_xbrl_20220119114428934_227"
      unitRef="USD">4652000</trib:LeasePayableOnRightOfUseAssets>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_23"
      unitRef="USD">72391000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_27"
      unitRef="USD">81438000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_211"
      unitRef="USD">1703000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_215"
      unitRef="USD">3319000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_219"
      unitRef="USD">76416000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_223"
      unitRef="USD">0</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_227"
      unitRef="USD">0</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <trib:ConvertibleNote
      contextRef="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_23"
      unitRef="USD">15401000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_27"
      unitRef="USD">21350000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_211"
      unitRef="USD">150000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_215"
      unitRef="USD">150000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_219"
      unitRef="USD">300000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_223"
      unitRef="USD">900000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_227"
      unitRef="USD">19850000</trib:ConvertibleNote>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115857970_xbrl_20220119114428934_23"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115857970_xbrl_20220119114428934_27"
      unitRef="USD">380000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115857970_xbrl_20220119114428934_211"
      unitRef="USD">4000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115857970_xbrl_20220119114428934_215"
      unitRef="USD">4000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115857970_xbrl_20220119114428934_219"
      unitRef="USD">8000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115857970_xbrl_20220119114428934_223"
      unitRef="USD">24000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115857970_xbrl_20220119114428934_227"
      unitRef="USD">340000</ifrs-full:LongtermBorrowings>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20241231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115902530_xbrl_20220119114428934_23"
      unitRef="USD">126050000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20241231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115902530_xbrl_20220119114428934_27"
      unitRef="USD">143668000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115902530_xbrl_20220119114428934_211"
      unitRef="USD">28597000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20241231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115902530_xbrl_20220119114428934_215"
      unitRef="USD">4881000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20241231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115902530_xbrl_20220119114428934_219"
      unitRef="USD">78937000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20241231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115902530_xbrl_20220119114428934_223"
      unitRef="USD">6411000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20241231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119115902530_xbrl_20220119114428934_227"
      unitRef="USD">24842000</ifrs-full:FinancialLiabilities>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500878_xbrl_20220119114428934_23"
      unitRef="USD">12752000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500878_xbrl_20220119114428934_27"
      unitRef="USD">12752000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500878_xbrl_20220119114428934_211"
      unitRef="USD">12752000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500878_xbrl_20220119114428934_215"
      unitRef="USD">0</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500878_xbrl_20220119114428934_219"
      unitRef="USD">0</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500878_xbrl_20220119114428934_223"
      unitRef="USD">0</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500878_xbrl_20220119114428934_227"
      unitRef="USD">0</ifrs-full:TradeAndOtherPayables>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_23"
      unitRef="USD">12566000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_27"
      unitRef="USD">15306000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_211"
      unitRef="USD">1107000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_215"
      unitRef="USD">1114000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_219"
      unitRef="USD">2243000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_223"
      unitRef="USD">5442000</trib:LeasePayableOnRightOfUseAssets>
    <trib:LeasePayableOnRightOfUseAssets
      contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120500937_xbrl_20220119115850913_xbrl_20220119114428934_227"
      unitRef="USD">5400000</trib:LeasePayableOnRightOfUseAssets>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_23"
      unitRef="USD">40109000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_27"
      unitRef="USD">56121000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_211"
      unitRef="USD">3461000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_215"
      unitRef="USD">3461000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_219"
      unitRef="USD">6922000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_223"
      unitRef="USD">42277000</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings
      contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_227"
      unitRef="USD">0</ifrs-full:NoncurrentPortionOfOtherNoncurrentBorrowings>
    <trib:ConvertibleNote
      contextRef="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_23"
      unitRef="USD">14542000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_27"
      unitRef="USD">21650000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_211"
      unitRef="USD">150000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_215"
      unitRef="USD">150000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_219"
      unitRef="USD">300000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_223"
      unitRef="USD">900000</trib:ConvertibleNote>
    <trib:ConvertibleNote
      contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20240413120429417_xbrl_20230420155533701_xbrl_20220119115853217_xbrl_20220119114428934_227"
      unitRef="USD">20150000</trib:ConvertibleNote>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_23"
      unitRef="USD">210000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_27"
      unitRef="USD">389000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_211"
      unitRef="USD">4000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_215"
      unitRef="USD">4000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_219"
      unitRef="USD">8000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_223"
      unitRef="USD">24000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120501076_xbrl_20220119115857970_xbrl_20220119114428934_227"
      unitRef="USD">349000</ifrs-full:LongtermBorrowings>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20231231_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_23"
      unitRef="USD">80179000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_tribContractualCashFlowsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_27"
      unitRef="USD">106218000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthOrLessMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_211"
      unitRef="USD">17474000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_tribSixMonthToTwelveMonthMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_215"
      unitRef="USD">4729000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_tribOneYearToTwoYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_219"
      unitRef="USD">9473000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_tribTwoYearToFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_223"
      unitRef="USD">48643000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="C_20231231_ifrsfullMaturityAxis_tribGreaterThanFiveYearsMember_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="-3"
      id="Fxbrl_20220119120513531_xbrl_20220119115902530_xbrl_20220119114428934_227"
      unitRef="USD">25899000</ifrs-full:FinancialLiabilities>
    <trib:DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413101341323">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;EUR&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GBP&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SEK&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CAD&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;BRL&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        at December&#160;31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;116&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;373&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other receivable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,009&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;74&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;294&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,019&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,098&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(453&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(114&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(135&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6,867&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        exposure&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,840&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(329&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;473&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,086&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td rowspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;EUR&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GBP&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SEK&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CAD&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;BRL&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td rowspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As
        at December&#160;31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;191&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;854&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other receivable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;856&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;533&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,533&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,766&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(100&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(220&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(704&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(241&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        exposure&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11,040&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;504&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,442&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </trib:DisclosureOfDetailedInformationAboutForeignCurrencyRiskShortTermFinancialAssetsAndLiabilitiesExplanatory>
    <ifrs-full:Cash
      contextRef="C_20241231_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220119120834197_23"
      unitRef="USD">116000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20241231_srtCurrencyAxis_currencyGBP"
      decimals="-3"
      id="Fxbrl_20220119120834197_27"
      unitRef="USD">50000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20241231_srtCurrencyAxis_currencySEK"
      decimals="-3"
      id="Fxbrl_20220119120834197_211"
      unitRef="USD">20000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20241231_srtCurrencyAxis_currencyCAD"
      decimals="-3"
      id="Fxbrl_20220119120834197_215"
      unitRef="USD">293000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20241231_srtCurrencyAxis_currencyBRL"
      decimals="-3"
      id="Fxbrl_20220119120834197_219"
      unitRef="USD">373000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20241231_srtCurrencyAxis_currencyXXX"
      decimals="-3"
      id="Fxbrl_20220119120834197_223"
      unitRef="USD">0</ifrs-full:Cash>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="C_20241231_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220119121051965_xbrl_20220119120834197_23"
      unitRef="USD">1009000</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="C_20241231_srtCurrencyAxis_currencyGBP"
      decimals="-3"
      id="Fxbrl_20220119121051965_xbrl_20220119120834197_27"
      unitRef="USD">74000</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="C_20241231_srtCurrencyAxis_currencySEK"
      decimals="-3"
      id="Fxbrl_20220119121051965_xbrl_20220119120834197_211"
      unitRef="USD">0</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="C_20241231_srtCurrencyAxis_currencyCAD"
      decimals="-3"
      id="Fxbrl_20220119121051965_xbrl_20220119120834197_215"
      unitRef="USD">294000</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="C_20241231_srtCurrencyAxis_currencyBRL"
      decimals="-3"
      id="Fxbrl_20220119121051965_xbrl_20220119120834197_219"
      unitRef="USD">1019000</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="C_20241231_srtCurrencyAxis_currencyXXX"
      decimals="-3"
      id="Fxbrl_20220119121051965_xbrl_20220119120834197_223"
      unitRef="USD">0</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220119121054174_xbrl_20220119120834197_23"
      unitRef="USD">7098000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_srtCurrencyAxis_currencyGBP"
      decimals="-3"
      id="Fxbrl_20220119121054174_xbrl_20220119120834197_27"
      unitRef="USD">453000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_srtCurrencyAxis_currencySEK"
      decimals="-3"
      id="Fxbrl_20220119121054174_xbrl_20220119120834197_211"
      unitRef="USD">12000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_srtCurrencyAxis_currencyCAD"
      decimals="-3"
      id="Fxbrl_20220119121054174_xbrl_20220119120834197_215"
      unitRef="USD">114000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_srtCurrencyAxis_currencyBRL"
      decimals="-3"
      id="Fxbrl_20220119121054174_xbrl_20220119120834197_219"
      unitRef="USD">135000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20241231_srtCurrencyAxis_currencyXXX"
      decimals="-3"
      id="Fxbrl_20240422121518838"
      unitRef="USD">1000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20241231_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20230420161312737_xbrl_20220119121054174_xbrl_20220119120834197_23"
      unitRef="USD">6867000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20241231_srtCurrencyAxis_currencyGBP"
      decimals="-3"
      id="Fxbrl_20230420161312737_xbrl_20220119121054174_xbrl_20220119120834197_27"
      unitRef="USD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20241231_srtCurrencyAxis_currencySEK"
      decimals="-3"
      id="Fxbrl_20230420161312737_xbrl_20220119121054174_xbrl_20220119120834197_211"
      unitRef="USD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20241231_srtCurrencyAxis_currencyCAD"
      decimals="-3"
      id="Fxbrl_20230420161312737_xbrl_20220119121054174_xbrl_20220119120834197_215"
      unitRef="USD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20241231_srtCurrencyAxis_currencyBRL"
      decimals="-3"
      id="Fxbrl_20230420161312737_xbrl_20220119121054174_xbrl_20220119120834197_219"
      unitRef="USD">171000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20241231_srtCurrencyAxis_currencyXXX"
      decimals="-3"
      id="Fxbrl_20230420161312737_xbrl_20220119121054174_xbrl_20220119120834197_223"
      unitRef="USD">0</ifrs-full:LeaseLiabilities>
    <trib:TotalExposureFinancialInstruments
      contextRef="C_20241231_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220119121056325_xbrl_20220119120834197_23"
      unitRef="USD">-12840000</trib:TotalExposureFinancialInstruments>
    <trib:TotalExposureFinancialInstruments
      contextRef="C_20241231_srtCurrencyAxis_currencyGBP"
      decimals="-3"
      id="Fxbrl_20220119121056325_xbrl_20220119120834197_27"
      unitRef="USD">-329000</trib:TotalExposureFinancialInstruments>
    <trib:TotalExposureFinancialInstruments
      contextRef="C_20241231_srtCurrencyAxis_currencySEK"
      decimals="-3"
      id="Fxbrl_20220119121056325_xbrl_20220119120834197_211"
      unitRef="USD">-8000</trib:TotalExposureFinancialInstruments>
    <trib:TotalExposureFinancialInstruments
      contextRef="C_20241231_srtCurrencyAxis_currencyCAD"
      decimals="-3"
      id="Fxbrl_20220119121056325_xbrl_20220119120834197_215"
      unitRef="USD">473000</trib:TotalExposureFinancialInstruments>
    <trib:TotalExposureFinancialInstruments
      contextRef="C_20241231_srtCurrencyAxis_currencyBRL"
      decimals="-3"
      id="Fxbrl_20220119121056325_xbrl_20220119120834197_219"
      unitRef="USD">1086000</trib:TotalExposureFinancialInstruments>
    <trib:TotalExposureFinancialInstruments
      contextRef="C_20241231_srtCurrencyAxis_currencyXXX"
      decimals="-3"
      id="Fxbrl_20240422121449118"
      unitRef="USD">-1000</trib:TotalExposureFinancialInstruments>
    <ifrs-full:Cash
      contextRef="C_20231231_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220119121232679_xbrl_20220119120834197_23"
      unitRef="USD">219000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20231231_srtCurrencyAxis_currencyGBP"
      decimals="-3"
      id="Fxbrl_20220119121232679_xbrl_20220119120834197_27"
      unitRef="USD">15000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20231231_srtCurrencyAxis_currencySEK"
      decimals="-3"
      id="Fxbrl_20220119121232679_xbrl_20220119120834197_211"
      unitRef="USD">5000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20231231_srtCurrencyAxis_currencyCAD"
      decimals="-3"
      id="Fxbrl_20220119121232679_xbrl_20220119120834197_215"
      unitRef="USD">191000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20231231_srtCurrencyAxis_currencyBRL"
      decimals="-3"
      id="Fxbrl_20220119121232679_xbrl_20220119120834197_219"
      unitRef="USD">854000</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20231231_srtCurrencyAxis_currencyXXX"
      decimals="-3"
      id="Fxbrl_20220119121232679_xbrl_20220119120834197_223"
      unitRef="USD">0</ifrs-full:Cash>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="C_20231231_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220119121232726_xbrl_20220119121051965_xbrl_20220119120834197_23"
      unitRef="USD">856000</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="C_20231231_srtCurrencyAxis_currencyGBP"
      decimals="-3"
      id="Fxbrl_20220119121232726_xbrl_20220119121051965_xbrl_20220119120834197_27"
      unitRef="USD">100000</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="C_20231231_srtCurrencyAxis_currencySEK"
      decimals="-3"
      id="Fxbrl_20220119121232726_xbrl_20220119121051965_xbrl_20220119120834197_211"
      unitRef="USD">0</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="C_20231231_srtCurrencyAxis_currencyCAD"
      decimals="-3"
      id="Fxbrl_20220119121232726_xbrl_20220119121051965_xbrl_20220119120834197_215"
      unitRef="USD">533000</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="C_20231231_srtCurrencyAxis_currencyBRL"
      decimals="-3"
      id="Fxbrl_20220119121232726_xbrl_20220119121051965_xbrl_20220119120834197_219"
      unitRef="USD">1533000</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="C_20231231_srtCurrencyAxis_currencyXXX"
      decimals="-3"
      id="Fxbrl_20220119121232726_xbrl_20220119121051965_xbrl_20220119120834197_223"
      unitRef="USD">0</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_23"
      unitRef="USD">3766000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_srtCurrencyAxis_currencyGBP"
      decimals="-3"
      id="Fxbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_27"
      unitRef="USD">100000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_srtCurrencyAxis_currencySEK"
      decimals="-3"
      id="Fxbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_211"
      unitRef="USD">12000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_srtCurrencyAxis_currencyCAD"
      decimals="-3"
      id="Fxbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_215"
      unitRef="USD">220000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_srtCurrencyAxis_currencyBRL"
      decimals="-3"
      id="Fxbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_219"
      unitRef="USD">704000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="C_20231231_srtCurrencyAxis_currencyXXX"
      decimals="-3"
      id="Fxbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_223"
      unitRef="USD">1000</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20230420161702836_xbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_23"
      unitRef="USD">8349000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_srtCurrencyAxis_currencyGBP"
      decimals="-3"
      id="Fxbrl_20230420161702836_xbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_27"
      unitRef="USD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_srtCurrencyAxis_currencySEK"
      decimals="-3"
      id="Fxbrl_20230420161702836_xbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_211"
      unitRef="USD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_srtCurrencyAxis_currencyCAD"
      decimals="-3"
      id="Fxbrl_20230420161702836_xbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_215"
      unitRef="USD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_srtCurrencyAxis_currencyBRL"
      decimals="-3"
      id="Fxbrl_20230420161702836_xbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_219"
      unitRef="USD">241000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20231231_srtCurrencyAxis_currencyXXX"
      decimals="-3"
      id="Fxbrl_20230420161702836_xbrl_20220119121232783_xbrl_20220119121054174_xbrl_20220119120834197_223"
      unitRef="USD">0</ifrs-full:LeaseLiabilities>
    <trib:TotalExposureFinancialInstruments
      contextRef="C_20231231_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220119121232843_xbrl_20220119121056325_xbrl_20220119120834197_23"
      unitRef="USD">-11040000</trib:TotalExposureFinancialInstruments>
    <trib:TotalExposureFinancialInstruments
      contextRef="C_20231231_srtCurrencyAxis_currencyGBP"
      decimals="-3"
      id="Fxbrl_20220119121232843_xbrl_20220119121056325_xbrl_20220119120834197_27"
      unitRef="USD">15000</trib:TotalExposureFinancialInstruments>
    <trib:TotalExposureFinancialInstruments
      contextRef="C_20231231_srtCurrencyAxis_currencySEK"
      decimals="-3"
      id="Fxbrl_20240422121605984"
      unitRef="USD">-7000</trib:TotalExposureFinancialInstruments>
    <trib:TotalExposureFinancialInstruments
      contextRef="C_20231231_srtCurrencyAxis_currencyCAD"
      decimals="-3"
      id="Fxbrl_20220119121232843_xbrl_20220119121056325_xbrl_20220119120834197_215"
      unitRef="USD">504000</trib:TotalExposureFinancialInstruments>
    <trib:TotalExposureFinancialInstruments
      contextRef="C_20231231_srtCurrencyAxis_currencyBRL"
      decimals="-3"
      id="Fxbrl_20220119121232843_xbrl_20220119121056325_xbrl_20220119120834197_219"
      unitRef="USD">1442000</trib:TotalExposureFinancialInstruments>
    <trib:TotalExposureFinancialInstruments
      contextRef="C_20231231_srtCurrencyAxis_currencyXXX"
      decimals="-3"
      id="Fxbrl_20220119121232843_xbrl_20220119121056325_xbrl_20220119120834197_223"
      unitRef="USD">-1000</trib:TotalExposureFinancialInstruments>
    <ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413101524956">

&lt;div&gt;

&lt;div style="margin-left:30pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A 10%
strengthening of the US&#160;Dollar against the Euro at December&#160;31, 2024 would have increased profit and other equity by the amounts
shown below. This analysis assumes that all other variables, in particular interest rates, remain constant.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Profit
        or Loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="1" style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Euro&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="1" style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan="1" style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Euro&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,004&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;&#160;

&lt;div style="margin-left:30.6pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A
10% weakening of the US&#160;Dollar against the Euro at December&#160;31, 2024 would have decreased profit and other equity by the amounts
shown below. This analysis assumes that all other variables, in particular interest rates, remain constant.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Profit
        or Loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Euro&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,427&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,
        2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Euro&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,227&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk>
    <ifrs-full:ProfitLoss
      contextRef="C_20240101to20241231_ifrsfullTypesOfRisksAxis_tribTenPercentStrengtheningUSDollarMember_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220119121630891_23"
      unitRef="USD">1167000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20231231_ifrsfullTypesOfRisksAxis_tribTenPercentStrengtheningUSDollarMember_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220119121630891_53"
      unitRef="USD">1004000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20240101to20241231_ifrsfullTypesOfRisksAxis_tribTenPercentWeakeningUSDollarMember_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220119121818191_23"
      unitRef="USD">-1427000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20231231_ifrsfullTypesOfRisksAxis_tribTenPercentWeakeningUSDollarMember_srtCurrencyAxis_currencyEUR"
      decimals="-3"
      id="Fxbrl_20220119121818191_53"
      unitRef="USD">-1227000</ifrs-full:ProfitLoss>
    <ifrs-full:DisclosureOfCreditRiskExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413101833924">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        Value&lt;br/&gt;December&#160;31, &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        Value&lt;br/&gt;December&#160;31, &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Third
        party trade receivables (Note 17)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finance
        lease income receivable (Note 17)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&#160;and
        cash equivalents (Note 18)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,583&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; </ifrs-full:DisclosureOfCreditRiskExplanatory>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230420162205892"
      unitRef="USD">13416000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119122448537_17"
      unitRef="USD">10698000</ifrs-full:CurrentTradeReceivables>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230420162212669"
      unitRef="USD">0</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119122448537_27"
      unitRef="USD">155000</trib:MinimumFinanceLeasePaymentsReceivableAtPresentValue>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230420162225100"
      unitRef="USD">5167000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119122448537_37"
      unitRef="USD">3691000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:MaximumExposureToCreditRisk
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230420162231253"
      unitRef="USD">18583000</ifrs-full:MaximumExposureToCreditRisk>
    <ifrs-full:MaximumExposureToCreditRisk
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119122448537_67"
      unitRef="USD">14544000</ifrs-full:MaximumExposureToCreditRisk>
    <trib:DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413102053189">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        Value&lt;br/&gt;December&#160;31, &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        Value&lt;br/&gt;December&#160;31, &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United
        States&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,185&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,041&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Euro-zone
        countries&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;742&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;851&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United
        Kingdom&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;741&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;126&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other
        regions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,748&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,835&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,853&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByGeographicLocationExplanatory>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryUS"
      decimals="-3"
      id="Fxbrl_20220119122643528_13"
      unitRef="USD">4185000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryUS"
      decimals="-3"
      id="Fxbrl_20220119122643528_17"
      unitRef="USD">4041000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribEuroZoneCountriesMember"
      decimals="-3"
      id="Fxbrl_20220119122643528_23"
      unitRef="USD">742000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribEuroZoneCountriesMember"
      decimals="-3"
      id="Fxbrl_20220119122643528_27"
      unitRef="USD">851000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_countryGB"
      decimals="-3"
      id="Fxbrl_20220119122643528_33"
      unitRef="USD">741000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_countryGB"
      decimals="-3"
      id="Fxbrl_20220119122643528_37"
      unitRef="USD">126000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20241231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember"
      decimals="-3"
      id="Fxbrl_20220119122643528_53"
      unitRef="USD">7748000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20231231_ifrsfullGeographicalAreasAxis_tribOtherRegionsMember"
      decimals="-3"
      id="Fxbrl_20220119122643528_57"
      unitRef="USD">5835000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230420162359949"
      unitRef="USD">13416000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119122643528_77"
      unitRef="USD">10853000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <trib:DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413102123268">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        Value&lt;br/&gt;December&#160;31, &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carrying
        Value&lt;br/&gt;December&#160;31, &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;End-user
        customers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,828&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,029&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Distributors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,236&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,399&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-governmental
        organisations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,352&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;425&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,853&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutExposureOfTradeReceivablesByCustomerExplanatory>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20241231_ifrsfullTypesOfCustomersAxis_tribEndUserCustomersMember"
      decimals="-3"
      id="Fxbrl_20220119122855472_13"
      unitRef="USD">3828000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20231231_ifrsfullTypesOfCustomersAxis_tribEndUserCustomersMember"
      decimals="-3"
      id="Fxbrl_20220119122855472_17"
      unitRef="USD">5029000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20241231_ifrsfullTypesOfCustomersAxis_tribDistributorsMember"
      decimals="-3"
      id="Fxbrl_20220119122855472_23"
      unitRef="USD">8236000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20231231_ifrsfullTypesOfCustomersAxis_tribDistributorsMember"
      decimals="-3"
      id="Fxbrl_20220119122855472_27"
      unitRef="USD">5399000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20241231_ifrsfullTypesOfCustomersAxis_ifrsfullNongovernmentCustomersMember"
      decimals="-3"
      id="Fxbrl_20220119122855472_33"
      unitRef="USD">1352000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20231231_ifrsfullTypesOfCustomersAxis_ifrsfullNongovernmentCustomersMember"
      decimals="-3"
      id="Fxbrl_20220119122855472_37"
      unitRef="USD">425000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20230420162449037"
      unitRef="USD">13416000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119122855472_57"
      unitRef="USD">10853000</ifrs-full:MaximumExposureToCreditRiskOfLoansOrReceivables>
    <trib:DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413102145899">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected
        Credit Loss Rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gross&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected
        Credit Loss Rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Not
        past due&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,363&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Past
        due 0-30 days&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,455&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,534&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Past
        due 31-120 days&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,753&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;856&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Greater
        than 120 days&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,131&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,255&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;72.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,601&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,302&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;88.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:28%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,702&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,324&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutAgeingOfTradeReceivablesExplanatory>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_33"
      unitRef="USD">9363000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_37"
      unitRef="USD">0</ifrs-full:TradeReceivables>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="C_20241231_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember"
      decimals="2"
      id="Fxbrl_20220119123450796_311"
      unitRef="Pure">0</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_315"
      unitRef="USD">8031000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_319"
      unitRef="USD">0</ifrs-full:TradeReceivables>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="C_20231231_ifrsfullPastDueStatusAxis_ifrsfullCurrentMember"
      decimals="2"
      id="Fxbrl_20220119123450796_323"
      unitRef="Pure">0</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_43"
      unitRef="USD">1455000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_47"
      unitRef="USD">0</ifrs-full:TradeReceivables>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="C_20241231_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember"
      decimals="2"
      id="Fxbrl_20220119123450796_411"
      unitRef="Pure">0</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_415"
      unitRef="USD">1534000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_419"
      unitRef="USD">0</ifrs-full:TradeReceivables>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="C_20231231_ifrsfullPastDueStatusAxis_ifrsfullLaterThanOneMonthAndNotLaterThanTwoMonthsMember"
      decimals="2"
      id="Fxbrl_20220119123450796_423"
      unitRef="Pure">0</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_53"
      unitRef="USD">1753000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_57"
      unitRef="USD">31000</ifrs-full:TradeReceivables>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="C_20241231_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember"
      decimals="3"
      id="Fxbrl_20220119123450796_511"
      unitRef="Pure">0.018</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_515"
      unitRef="USD">856000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_519"
      unitRef="USD">22000</ifrs-full:TradeReceivables>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="C_20231231_ifrsfullPastDueStatusAxis_tribLaterThanOneMonthsAndNotLaterThanFourMonthsMember"
      decimals="3"
      id="Fxbrl_20220119123450796_523"
      unitRef="Pure">0.026</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_63"
      unitRef="USD">3131000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_67"
      unitRef="USD">2255000</ifrs-full:TradeReceivables>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="C_20241231_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember"
      decimals="3"
      id="Fxbrl_20220119123450796_611"
      unitRef="Pure">0.72</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_615"
      unitRef="USD">2601000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_619"
      unitRef="USD">2302000</ifrs-full:TradeReceivables>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="C_20231231_ifrsfullPastDueStatusAxis_tribGreaterThanFourMonthsMember"
      decimals="3"
      id="Fxbrl_20240413121411538"
      unitRef="Pure">0.885</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20230420162704565"
      unitRef="USD">15702000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20241231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember"
      decimals="-3"
      id="Fxbrl_20230420162743757"
      unitRef="USD">2286000</ifrs-full:TradeReceivables>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="C_20241231"
      decimals="2"
      id="Fxbrl_20230420162805813"
      unitRef="Pure">0</ifrs-full:ExpectedCreditLossRate>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_83"
      unitRef="USD">13022000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="C_20231231_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedImpairmentMember"
      decimals="-3"
      id="Fxbrl_20220119123450796_87"
      unitRef="USD">2324000</ifrs-full:TradeReceivables>
    <ifrs-full:ExpectedCreditLossRate
      contextRef="C_20231231"
      decimals="2"
      id="Fxbrl_20230420162819174"
      unitRef="Pure">0</ifrs-full:ExpectedCreditLossRate>
    <trib:DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240413102210635">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance
        at January&#160;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,324&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Charged
        to costs and expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;225&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;715&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amounts
        written off during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(263&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(977&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Eliminated
        on disposal of business&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(105&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance
        at December&#160;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,324&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </trib:DisclosureOfDetailedInformationAboutMovementInAllowanceForImpairmentOfTradeReceivablesExplanatory>
    <trib:AllowanceForImpairmentOfReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119124612102_23"
      unitRef="USD">2324000</trib:AllowanceForImpairmentOfReceivables>
    <trib:AllowanceForImpairmentOfReceivables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220119124612102_27"
      unitRef="USD">2691000</trib:AllowanceForImpairmentOfReceivables>
    <ifrs-full:IncreaseThroughOriginationOrPurchaseFinancialAssets
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220119124612102_33"
      unitRef="USD">225000</ifrs-full:IncreaseThroughOriginationOrPurchaseFinancialAssets>
    <ifrs-full:IncreaseThroughOriginationOrPurchaseFinancialAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220119124612102_37"
      unitRef="USD">715000</ifrs-full:IncreaseThroughOriginationOrPurchaseFinancialAssets>
    <ifrs-full:DecreaseThroughWriteoffFinancialAssets
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20220119124612102_43"
      unitRef="USD">263000</ifrs-full:DecreaseThroughWriteoffFinancialAssets>
    <ifrs-full:DecreaseThroughWriteoffFinancialAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20220119124612102_47"
      unitRef="USD">977000</ifrs-full:DecreaseThroughWriteoffFinancialAssets>
    <trib:EliminatedOnDisposalsOfBusiness
      contextRef="C_20240101to20241231"
      decimals="-3"
      id="Fxbrl_20240413122053217"
      unitRef="USD">0</trib:EliminatedOnDisposalsOfBusiness>
    <trib:EliminatedOnDisposalsOfBusiness
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240413122104395"
      unitRef="USD">105000</trib:EliminatedOnDisposalsOfBusiness>
    <trib:AllowanceForImpairmentOfReceivables
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20220119124612102_63"
      unitRef="USD">2286000</trib:AllowanceForImpairmentOfReceivables>
    <trib:AllowanceForImpairmentOfReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20220119124612102_67"
      unitRef="USD">2324000</trib:AllowanceForImpairmentOfReceivables>
    <ifrs-full:DisclosureOfCashFlowStatementExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220117145818621">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;28.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;
        &lt;p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;RECONCILIATION OF LIABILITIES ARISING FROM
        FINANCING ACTIVITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The
changes in the Group&#x2019;s liabilities arising from financing activities can be classified as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:85%"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Borrowings
        &amp;amp; derivative&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;financial
        instruments&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Lease
        liabilities&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Balance
        at January 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;23,24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;55,387&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;12,566&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash-flows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Principal
        amount loaned &#x2013; term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;30,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Loan
        origination costs paid&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(324&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Interest
        paid for senior secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(6,253&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Interest
        paid for convertible note&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(300&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Interest
        paid for exchangeable notes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Repayment
        of leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2,503&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Non-cash:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Interest
        charged&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;6,561&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Derivative
        financial asset at date of issue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Remeasurement
        of ROU assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,764&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Additions
        (related to Right of Use assets)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;855&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Exchange
        adjustment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(512&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Accretion
        interest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,214&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;592&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Fair
        value of derivative liability - warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;66&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Fair
        value of additional derivative liability - warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,066&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Payment-in-kind
        (PIK) Interest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,291&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Contingent
        liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,813&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Non-cash
        loan modification gain&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(3,567&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Balance
        at December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;23,24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;91,474&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;12,762&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Borrowings
        &amp;amp; derivative&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;financial
        instruments&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease
        liabilities&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance
        at January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;23,24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;59,826&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,943&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cash-flows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Principal
        amount loaned &#x2013; term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Loan
        origination costs paid&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(194&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest
        paid for senior secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(7,314&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest
        paid for convertible note&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(300&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest
        paid for exchangeable notes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Repayment
        of term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(10,050&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Repayment
        of leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(2,318&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Penalty
        paid for early settlement of term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(905&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Non-cash:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest
        charged&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,622&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Penalty
        for early settlement charged&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;905&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derivative
        financial asset at date of issue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Disposals
        (related to Right of Use assets)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(106&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions
        (related to Right of Use assets)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;112&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Exchange
        adjustment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;311&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Accretion
        interest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,927&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;624&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair
        value of derivative liability - warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,133&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance at
        December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;23,24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;55,387&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,566&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfCashFlowStatementExplanatory>
    <ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512224504358">

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:85%"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Borrowings
        &amp;amp; derivative&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;financial
        instruments&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Lease
        liabilities&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Balance
        at January 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;23,24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;55,387&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;12,566&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash-flows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Principal
        amount loaned &#x2013; term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;30,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Loan
        origination costs paid&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(324&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Interest
        paid for senior secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(6,253&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Interest
        paid for convertible note&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(300&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Interest
        paid for exchangeable notes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Repayment
        of leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2,503&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Non-cash:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Interest
        charged&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;6,561&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Derivative
        financial asset at date of issue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Remeasurement
        of ROU assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,764&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Additions
        (related to Right of Use assets)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;855&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Exchange
        adjustment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(512&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Accretion
        interest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,214&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;592&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Fair
        value of derivative liability - warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;66&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Fair
        value of additional derivative liability - warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,066&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Payment-in-kind
        (PIK) Interest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,291&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Contingent
        liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,813&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Non-cash
        loan modification gain&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(3,567&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:66%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:center;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Balance
        at December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;23,24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;91,474&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align:right;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:9%"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;12,762&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Note&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Borrowings
        &amp;amp; derivative&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;financial
        instruments&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease
        liabilities&lt;br/&gt;US$&#x2019;000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance
        at January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;23,24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;59,826&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,943&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cash-flows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Principal
        amount loaned &#x2013; term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Loan
        origination costs paid&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(194&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest
        paid for senior secured term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(7,314&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest
        paid for convertible note&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(300&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest
        paid for exchangeable notes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Repayment
        of term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(10,050&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Repayment
        of leases&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(2,318&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Penalty
        paid for early settlement of term loan&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(905&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Non-cash:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest
        charged&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,622&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Penalty
        for early settlement charged&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;905&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Derivative
        financial asset at date of issue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Disposals
        (related to Right of Use assets)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(106&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions
        (related to Right of Use assets)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;112&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Exchange
        adjustment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;311&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Accretion
        interest&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,927&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;624&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fair
        value of derivative liability - warrants&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,133&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;width:64.66%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;font-size:1pt"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64.66%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance at
        December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;padding-bottom:4px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-style:italic;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;23,24&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;55,387&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9.08%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,566&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1.04%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133537494_xbrl_20220117153657356_27"
      unitRef="USD">55387000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133537494_xbrl_20220117153657356_211"
      unitRef="USD">12566000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133544310_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67"
      unitRef="USD">30500000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133544310_xbrl_20240413133138207"
      unitRef="USD">0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <trib:PrincipalAmountLoaned
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133553242_xbrl_20230414075105281_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67"
      unitRef="USD">-324000</trib:PrincipalAmountLoaned>
    <trib:PrincipalAmountLoaned
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133553242_xbrl_20230414075105281_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611"
      unitRef="USD">0</trib:PrincipalAmountLoaned>
    <trib:InterestPaidOnSeniorSecuredTermLoan
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133602470_xbrl_20230420112110106"
      unitRef="USD">6253000</trib:InterestPaidOnSeniorSecuredTermLoan>
    <trib:InterestPaidOnSeniorSecuredTermLoan
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133602470_xbrl_20230420112138686"
      unitRef="USD">0</trib:InterestPaidOnSeniorSecuredTermLoan>
    <trib:InterestPaidOnConvertibleNote
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133615821_xbrl_20230420112238075_xbrl_20230420112138686"
      unitRef="USD">-300000</trib:InterestPaidOnConvertibleNote>
    <trib:InterestPaidOnConvertibleNote
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133615821_xbrl_20240413133308772"
      unitRef="USD">0</trib:InterestPaidOnConvertibleNote>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133626501_xbrl_20230420112239729_xbrl_20230420112138686"
      unitRef="USD">8000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133626501_xbrl_20240413133332978"
      unitRef="USD">0</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133809268_xbrl_20230420112414641_xbrl_20220117153657356_97"
      unitRef="USD">0</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133809268_xbrl_20230420112414641_xbrl_20220117153657356_911"
      unitRef="USD">2503000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <trib:IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133831248_xbrl_20230421023512172"
      unitRef="USD">6561000</trib:IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities>
    <trib:IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133831248_xbrl_20230421025317005"
      unitRef="USD">0</trib:IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities>
    <trib:DerivativeFinancialAssetAtDateOfIssue
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133851425_xbrl_20230414075122996_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67"
      unitRef="USD">28000</trib:DerivativeFinancialAssetAtDateOfIssue>
    <trib:DerivativeFinancialAssetAtDateOfIssue
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133851425_xbrl_20230414075122996_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611"
      unitRef="USD">0</trib:DerivativeFinancialAssetAtDateOfIssue>
    <trib:RemeasurementOfRightOfUseAssets
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20250515105125930_xbrl_20240413133851425_xbrl_20230414075122996_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67"
      unitRef="USD">0</trib:RemeasurementOfRightOfUseAssets>
    <trib:RemeasurementOfRightOfUseAssets
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20250515105125930_xbrl_20240413133851425_xbrl_20230414075122996_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611"
      unitRef="USD">1764000</trib:RemeasurementOfRightOfUseAssets>
    <trib:AdditionsRelatedToRightOfUseAssets
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133910392_xbrl_20230421023957817_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67"
      unitRef="USD">0</trib:AdditionsRelatedToRightOfUseAssets>
    <trib:AdditionsRelatedToRightOfUseAssets
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133910392_xbrl_20230421023957817_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611"
      unitRef="USD">855000</trib:AdditionsRelatedToRightOfUseAssets>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133919737_xbrl_20230421024838106"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133919737_xbrl_20230421023050399"
      unitRef="USD">-512000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <trib:IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133930855_xbrl_20230421024003622_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67"
      unitRef="USD">3214000</trib:IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities>
    <trib:IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133930855_xbrl_20230421024003622_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611"
      unitRef="USD">592000</trib:IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133939669_xbrl_20230414071356785_xbrl_20220327190830086"
      unitRef="USD">66000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133939669_xbrl_20230414071356785_xbrl_20220117153657356_1411"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <trib:IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20250513000757642"
      unitRef="USD">1066000</trib:IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities>
    <trib:IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20250513000812364"
      unitRef="USD">0</trib:IncreaseDecreaseThroughChangesInAdditionalFairValueLiabilitiesWarrantsArisingFromFinancingActivities>
    <trib:IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20250513000839337"
      unitRef="USD">3291000</trib:IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities>
    <trib:IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20250513000905420"
      unitRef="USD">0</trib:IncreaseDecreaseThroughChangesInPaymentInKindInterestArisingFromFinancingActivities>
    <trib:IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20250513000845086"
      unitRef="USD">1813000</trib:IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities>
    <trib:IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20250513000908445"
      unitRef="USD">0</trib:IncreaseDecreaseThroughChangesInContingentLiabilitiesArisingFromFinancingActivities>
    <trib:NoncashLoanModificationGain
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20250513000849128"
      unitRef="USD">-3567000</trib:NoncashLoanModificationGain>
    <trib:NoncashLoanModificationGain
      contextRef="C_20240101to20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20250513000920202"
      unitRef="USD">0</trib:NoncashLoanModificationGain>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133947363_xbrl_20230421024150500_xbrl_20230421023618201_xbrl_20220117153657356_47"
      unitRef="USD">91474000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20241231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133947363_xbrl_20230421024150500_xbrl_20230421023618201_xbrl_20220117153657356_411"
      unitRef="USD">12762000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20220117153657356_27"
      unitRef="USD">59826000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20221231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20220117153657356_211"
      unitRef="USD">13943000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67"
      unitRef="USD">5000000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133138207"
      unitRef="USD">0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <trib:PrincipalAmountLoaned
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20230414075105281_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67"
      unitRef="USD">-194000</trib:PrincipalAmountLoaned>
    <trib:PrincipalAmountLoaned
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414075105281_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611"
      unitRef="USD">0</trib:PrincipalAmountLoaned>
    <trib:InterestPaidOnSeniorSecuredTermLoan
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20250513001140156"
      unitRef="USD">7314000</trib:InterestPaidOnSeniorSecuredTermLoan>
    <trib:InterestPaidOnConvertibleNote
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20230420112238075_xbrl_20230420112138686"
      unitRef="USD">-300000</trib:InterestPaidOnConvertibleNote>
    <trib:InterestPaidOnConvertibleNote
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133308772"
      unitRef="USD">0</trib:InterestPaidOnConvertibleNote>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20230420112239729_xbrl_20230420112138686"
      unitRef="USD">8000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20240413133332978"
      unitRef="USD">0</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20240413133414191"
      unitRef="USD">10050000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20250513001212487"
      unitRef="USD">0</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20250513001227792"
      unitRef="USD">2318000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <trib:PenaltyPaidForEarlySettlement
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20230420112457803_xbrl_20220117153657356_97"
      unitRef="USD">-905000</trib:PenaltyPaidForEarlySettlement>
    <trib:PenaltyPaidForEarlySettlement
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230420112457803_xbrl_20220117153657356_911"
      unitRef="USD">0</trib:PenaltyPaidForEarlySettlement>
    <trib:IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20230421023512172"
      unitRef="USD">7622000</trib:IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities>
    <trib:IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230421025317005"
      unitRef="USD">0</trib:IncreaseDecreaseThroughChangesInInterestChargedLiabilitiesArisingFromFinancingActivities>
    <trib:PenaltyForEarlySettlementCharged
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20230414075114554_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67"
      unitRef="USD">905000</trib:PenaltyForEarlySettlementCharged>
    <trib:PenaltyForEarlySettlementCharged
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414075114554_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611"
      unitRef="USD">0</trib:PenaltyForEarlySettlementCharged>
    <trib:DerivativeFinancialAssetAtDateOfIssue
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20230414075122996_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67"
      unitRef="USD">11000</trib:DerivativeFinancialAssetAtDateOfIssue>
    <trib:DerivativeFinancialAssetAtDateOfIssue
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414075122996_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611"
      unitRef="USD">0</trib:DerivativeFinancialAssetAtDateOfIssue>
    <trib:DisposalsRelatedToRightOfUseAssets
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20250513001245005"
      unitRef="USD">0</trib:DisposalsRelatedToRightOfUseAssets>
    <trib:DisposalsRelatedToRightOfUseAssets
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20250513001302002"
      unitRef="USD">-106000</trib:DisposalsRelatedToRightOfUseAssets>
    <trib:AdditionsRelatedToRightOfUseAssets
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20250513001334884"
      unitRef="USD">0</trib:AdditionsRelatedToRightOfUseAssets>
    <trib:AdditionsRelatedToRightOfUseAssets
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230421023957817_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611"
      unitRef="USD">112000</trib:AdditionsRelatedToRightOfUseAssets>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20230421024838106"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230421023050399"
      unitRef="USD">311000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <trib:IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20230421024003622_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_67"
      unitRef="USD">1927000</trib:IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities>
    <trib:IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230421024003622_xbrl_20230414075125810_xbrl_20230414075032589_xbrl_20230414071356762_xbrl_20220117153657356_611"
      unitRef="USD">624000</trib:IncreaseDecreaseThroughChangesInAccretionInterestLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20230414071356785_xbrl_20220327190830086"
      unitRef="USD">-1133000</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities
      contextRef="C_20230101to20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230414071356785_xbrl_20220117153657356_1411"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLongtermBorrowingsMember"
      decimals="-3"
      id="Fxbrl_20230421024150500_xbrl_20230421023618201_xbrl_20220117153657356_47"
      unitRef="USD">55387000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="C_20231231_ifrsfullLiabilitiesArisingFromFinancingActivitiesAxis_ifrsfullLeaseLiabilitiesMember"
      decimals="-3"
      id="Fxbrl_20230421024150500_xbrl_20230421023618201_xbrl_20220117153657356_411"
      unitRef="USD">12566000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:DisclosureOfBusinessCombinationsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512154900931">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;BUSINESS COMBINATIONS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Acquisition
of the CGM assets of Waveform Technologies, Inc.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On
January 30, 2024, the Company purchased the biosensor and continuous glucose monitoring (&#x201c;CGM&#x201d;)&#160; assets of privately
held Waveform Technologies, Inc. (&#x201c;Waveform&#x201d;) for the initial consideration of US$12.5
million in cash and 36
million &#x2018;A&#x2019; Ordinary shares (represented by 1.8
million ADSs) of the Company, which had a fair value of US$3,960,000
on the date of acquisition. In addition contingent consideration of a maximum of US$20
million. We intend to update the Waveform CGM device, which is not being marketed, and optimize it for broad adoption and then evolve
this platform technology to measure and analyze other valuable biomarkers and related datapoints. Our vision is to develop a portfolio
of technologies that can offer users and clinicians valuable actionable health and wellness insights. Control was obtained through the
acquisition of substantially all of Waveform&#x2019;s operational assets and intellectual property, representing an integrated set of activities
and assets capable of being conducted and managed to provide a return in the form of outputs. The integrated set of activities and assets
purchased will significantly contribute to achieving our vision and its associated outputs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;This
transaction has been accounted for as a business combination under IFRS 3. The determination was based on the acquisition of an integrated
set of activities and assets, including intellectual property, technical processes, and a skilled workforce, that together constitute
a business capable of being conducted and managed to provide returns&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
fair value of non-cash consideration in the form of ADSs issued in connection with the acquisition was determined using the volume-weighted
average price (VWAP) of the Company&#x2019;s ADSs on the acquisition date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingent
consideration of up to US$20
million may be payable upon the occurrence of certain events, including;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:36.05pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$5.0 million payment
        if, within the next 12 months after closing, (i) the closing price of the Company&#x2019;s ADSs does not exceed US$7.50 per ADS for at
        a least 20 consecutive trading days and (ii) the average daily trading volume of the Company&#x2019;s ADSs does not equal or exceed 20,000
        ADSs for 20 consecutive trading days, and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:36.05pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50% of the proceeds
        received by the Company (up to a maximum payment of additional consideration of US$15.0 million) on our entering into certain commercial
        partnering agreements with certain glucose pump manufacturers in the 24 months from date of acquisition. The fair value assigned to this
        element of the contingent consideration was US$1.8 million at the acquisition date. This is disclosed as a contingent liability in Note
        23.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
fair value of the contingent consideration at date of acquisition was US$6.8
million. Of this, US$5.0
million is classified as a current liability &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(Note
21)&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;, while the US$1.8
million is disclosed as a contingent liability (see Note 23). As of December 31, 2024, there have been no changes to the amount recognized
or to the assumptions used in its initial measurement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Acquisition-related
costs amounting to US$1.5
million in respect of the Waveform transaction are not included as part of consideration transferred and have been recognised as an expense
in the condensed consolidated statement of operations, within &#x2018;Selling, general and administrative expenses&#x2019;.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
initial assignment of fair values to identifiable net assets acquired has been performed on a provisional basis in respect of the above
acquisitions. Any amendments to these acquisition fair values within the 12-month timeframe from the date of acquisition will be disclosed
in the relevant Annual Report as stipulated by IFRS 3 Business Combinations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisional
        value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Measurement
        period adjustment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjusted
        values&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property,
        plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,569&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(206&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,363&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible
        assets &#x2013; arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;9,360&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;9,360&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;9&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;9&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;1,296&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,296&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;135&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;135&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;(50&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(50&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred
        tax liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;(1,170&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,170&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        assets acquired&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;11,149&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;(332&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;10,817&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;12,071&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;332&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;12,403&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;23,220&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;23,220&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Satisfied
        by:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;12,500&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;12,500&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;3,960&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;3,960&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred
        contingent consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;6,760&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;6,760&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;23,220&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;23,220&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash outflow &#x2013; arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;12,500&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;12,500&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash outflow&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;12,500&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;12,500&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
accordance with IFRS 3 Business Combinations, the Group finalised the fair value assessments relating to the acquisition of the Waveform
CGM assets during the year. As part of this process, the Group reassessed the fair value of several acquired balances based on new information
obtained during the measurement period.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
fair value of intellectual property related to the acquired technology at the Closing Date was derived using the multi-period excess earnings
method. Significant assumptions used in the valuation including CGM cash flow projections which were based on estimates used to price
the Waveform acquisition, and the discount rate applied was benchmarked with reference to the implied rate of return to the Company&#x2019;s
pricing model and the weighted-average cost of capital. The intangible asset for acquired technology will be amortized over the respective
estimated periods for which the intangible assets will provide economic benefit to the Company, which is 15 years.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Following
further evaluation, the deferred tax liability of US$1.2
million initially recognised on acquisition was reversed. This adjustment was based on a more detailed analysis of the tax base of the
acquired intangible assets, which concluded that a deferred tax liability was not required.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
addition, the fair value of inventory was reduced by US$1.3
million. This reduction reflects a revised assessment of net realisable value. Although initial discussions with management and potential
buyers such as Bayer India suggested a potential market in emerging economies, further exploration indicated that the additional expenditure
required to bring the acquired raw materials, finished goods and work-in-progress to market would render the inventory commercially unviable.
As a result, the inventory was deemed to have no recoverable value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
value of property, plant and equipment was also reduced by US$0.2
million. These assets were found to be specific to the legacy CGM product and, following further technical review, were determined to
have no future economic value. Accordingly, their fair value was adjusted to nil.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These
adjustments have been accounted for retrospectively as measurement period adjustments in accordance with IFRS 3. These measurement period
adjustments resulted in a corresponding increase in goodwill of US$0.3
million. Comparative figures have not been restated as the acquisition occurred during the current financial year.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
goodwill recognised from the acquisition of the Waveform CGM assets primarily reflects expected synergies from integrating Waveform&#x2019;s
European-approved CGM technology with Trinity Biotech&#x2019;s global manufacturing and diabetes expertise. The platform is expected to
accelerate the development of a next-generation, affordable, and user-friendly CGM device, and supports the Group&#x2019;s strategy to
expand into adjacent biosensor markets. None of the goodwill is expected to be deductible for tax purposes.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Waveform
was acquired on January 30, 2024. As of December 31, 2024, the acquiree had not generated any revenue since the acquisition date, and
therefore no revenue has been included in the Group&#x2019;s consolidated statement of comprehensive income for the reporting period. In
addition, the acquired business incurred a net loss of US$1.3
million, which has been included in the Group&#x2019;s consolidated results. The reported loss excludes interest on intercompany funding
arrangements in order to reflect the underlying performance of the acquired business. Waveform Technologies, Inc. was a privately held
company in the late stages of product development and commercial readiness. Although the company was not generating revenue, it had developed
a CE-marked CGM device. It did not maintain financial information in accordance with IFRS, and as such, the Group is unable to reliably
reconstruct the required historical information for pro forma disclosure without incurring undue cost or effort.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Acquisition
of Metabolomics Diagnostics Limited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
September 2024, the Company completed the acquisition of 100%
of Metabolomics Diagnostics Ltd (&#x201c;Metabolomics&#x201d;), a privately-owned Irish deep-tech company, specializing in the development
of novel biomarker-based diagnostic solutions for complex diseases, with the initial focus being screening for preeclampsia risk using
the company&#x2019;s PrePsia test. Control was obtained through the execution of a share purchase agreement, resulting in the acquisition
of 100%
of the voting interests. The primary reason for the acquisition was to enter a new area of medical diagnostics with significant long-term
growth potential. The acquisition aligns with the Group&#x2019;s strategy of combining its established capabilities with innovative technologies
to unlock new revenue opportunities. The Group intends to leverage this platform to commercialise the PrePsia test in the U.S. through
its Immco laboratory and to explore opportunities in international markets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Company acquired Metabolomics for consideration of approximately US$0.9
million paid through the issuance of approximately 0.27
million ADSs of the Company alongside the extinguishment of monies owed to the Company totalling US$0.4
million. The fair value of non-cash consideration in the form of ADSs issued in connection with the acquisition was determined using the
volume-weighted average price (VWAP) of the Company&#x2019;s ADSs on the acquisition date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Metabolomics&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisional
        value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property,
        plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible
        assets &#x2013; arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;144&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;181&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(494&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred
        tax liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        acquired&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        assets acquired&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;900&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;906&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Satisfied
        by:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;412&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;494&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;906&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash outflow &#x2013; arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;412&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less:
        Cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash outflow&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;404&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transaction
costs associated with the acquisition of Metabolomics amounted to US$0.3
million, relating to the disbursement of agreed fees and closing bonuses. These costs have been expensed as incurred in accordance with
IFRS 3 and have been recognised in the condensed consolidated statement of operations, within &#x2018;Selling, general and administrative
expenses&#x2019;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
goodwill recognised in respect of the Metabolomics acquisition is attributable to expected synergies arising from the combination of operations,
as well as the assembled workforce of the acquired business. None of the goodwill recognised is expected to be deductible for tax purposes.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Metabolomics
was acquired in September 2024. As of December 31, 2024, the acquiree had not generated any revenue since the acquisition date, and therefore
no revenue has been included in the Group&#x2019;s consolidated statement of comprehensive income for the reporting period. The acquired
business incurred a net loss of US$0.3
million, primarily relating to ongoing development and administrative costs, which has been included in the Group&#x2019;s consolidated
results. Metabolomics was a privately held, early-stage Irish entity focused on biomarker-based diagnostics. The company did not prepare
its financial information in accordance with IFRS, and the Group is therefore unable to reliably reconstruct the necessary historical
financial information to provide pro forma consolidated revenue and profit or loss data without incurring undue cost or effort.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Acquisition
of EpiCapture Limited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
October 2024, the Company completed the acquisition of 100%
of EpiCapture Limited (&#x201c;EpiCapture&#x201d;), a company developing a non-invasive test for monitoring the risk of aggressive prostate
cancer. Control was obtained through the execution of a share purchase agreement, resulting in the acquisition of 100%
of the voting interests. The primary reason for the acquisition was to strengthen the Group&#x2019;s oncology diagnostics pipeline by acquiring
a novel, epigenetics-based prostate cancer test aligned with our strategy of combining Trinity&#x2019;s established capabilities with cutting-edge
technologies to address large-scale, urgent, and important clinical issues.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Company acquired EpiCapture for an initial consideration of approximately US$3.0
million, with an additional consideration of US$0.5
million contingent (Note 21) on the achievement of future milestones. The initial consideration was paid through the issuance of approximately
1.7
million ADS in Trinity Biotech. The fair value of non-cash consideration in the form of Company ADSs issued in connection with the acquisition
was determined using the volume-weighted average price (VWAP) of the Company&#x2019;s ADSs on the acquisition date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;EpiCapture&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisional
        value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible
        assets &#x2013; arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,668&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(406&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred
        tax liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(333&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        assets acquired&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,929&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,420&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Satisfied
        by:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,965&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred
        contingent consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;384&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash outflow &#x2013; arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash outflow&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
contingent consideration related to the acquisition of EpiCapture Limited comprises deferred consideration with a fair value of US$0.4
million. An
amount of US$0.5 million will become payable if cumulative revenues from EpiCapture&#x2019;s operations reach US$1.0 million within a period
of three years, commencing from the date on which the Company obtains validation of the EpiCapture prostate test under
the New York State Department of Health&#x2019;s Clinical Laboratory Evaluation Programme. As of December 31, 2024, there have been no
changes to the amount recognized or to the assumptions used in its initial measurement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transaction
costs associated with the acquisition of EpiCapture amounted to US$26,000,
have been expensed as incurred in accordance with IFRS 3 and have been recognised in the condensed consolidated statement of profit or
loss, within &#x2018;Selling, general and administrative expenses&#x2019;.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
goodwill recognised in respect of the EpiCapture acquisition is attributable to expected synergies arising from the combination of operations.
None of the goodwill recognised is expected to be deductible for tax purposes.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;EpiCapture
was acquired in October 2024. As of December 31, 2024, the acquiree had not generated any revenue since the acquisition date, and therefore
no revenue has been included in the Group&#x2019;s consolidated statement of comprehensive income for the reporting period. The acquired
business incurred a net loss of US$20,000,
mainly comprising transaction-related expenses, which has been included in the Group&#x2019;s consolidated results. EpiCapture Limited
was a privately held, early-stage Irish company developing a novel epigenetics-based diagnostic test. As the entity did not prepare its
financial information in accordance with IFRS, it is not practicable for the Group to reconstruct the required historical financial information
to present pro forma consolidated results for the year ended December 31, 2024, without undue cost or effort&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
initial assignment of fair values to the identifiable net assets acquired in respect of the Metabolomics and EpiCapture acquisitions has
been performed on a provisional basis. Any amendments to these acquisition fair values within the 12-month timeframe from the respective
dates of acquisition will be disclosed in future financial statements in accordance with IFRS 3 Business Combinations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;It
is impracticable for the Group to disclose the pro forma consolidated revenue and profit or loss for the year ended December 31, 2024,
as if the acquisitions of Waveform, Metabolomics, and EpiCapture had occurred on January 1, 2024. All three entities were privately held,
early-stage businesses that did not maintain financial information in accordance with IFRS. As a result, the Group is unable to reliably
reconstruct the required historical financial information without incurring undue cost or effort.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;There
were no individually immaterial business combinations that are collectively material during the year. All business combinations completed
during the year have been assessed as individually material and have been disclosed separately in the notes to the consolidated financial
statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfBusinessCombinationsExplanatory>
    <ifrs-full:CashTransferred
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-5"
      id="Fxbrl_20250512173130947"
      unitRef="USD">12500000</ifrs-full:CashTransferred>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullClassesOfShareCapitalAxis_tribClassAOrdinarySharesMember"
      decimals="-6"
      id="Fxbrl_20250512175227543"
      unitRef="USD">36000000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-5"
      id="Fxbrl_20250512175211650"
      unitRef="USD">1800000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250513130555942"
      unitRef="USD">3960000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="-6"
      id="Fxbrl_20250512175642139"
      unitRef="USD">20000000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="-6"
      id="Fxbrl_20250512175930343"
      unitRef="USD">20000000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets
      contextRef="C_20240130to20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      id="Fxbrl_20250512180255087">





    &#160;
    &#x2022;

        US$5.0 million payment
        if, within the next 12 months after closing, (i) the closing price of the Company&#x2019;s ADSs does not exceed US$7.50 per ADS for at
        a least 20 consecutive trading days and (ii) the average daily trading volume of the Company&#x2019;s ADSs does not equal or exceed 20,000
        ADSs for 20 consecutive trading days, and


&#160;



    &#160;
    &#x2022;

        50% of the proceeds
        received by the Company (up to a maximum payment of additional consideration of US$15.0 million) on our entering into certain commercial
        partnering agreements with certain glucose pump manufacturers in the 24 months from date of acquisition. The fair value assigned to this
        element of the contingent consideration was US$1.8 million at the acquisition date. This is disclosed as a contingent liability in Note
        23.
    </ifrs-full:DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets>
    <trib:FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-5"
      id="Fxbrl_20250512182124569"
      unitRef="USD">6800000</trib:FairValueOfContingentConsiderationRecognisedAsOfAcquisitionDate>
    <trib:ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-5"
      id="Fxbrl_20250512182248061"
      unitRef="USD">5000000</trib:ContingentConsiderationClassifiedAsACurrentLiabilityRecognisedAsOfAcquisitionDate>
    <trib:ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-5"
      id="Fxbrl_20250512182301892"
      unitRef="USD">1800000</trib:ContingentConsiderationClassifiedAsContingentLiabilityRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20240130to20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-5"
      id="Fxbrl_20250512182312631"
      unitRef="USD">1500000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory
      contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      id="Fxbrl_20250512155003854">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisional
        value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Measurement
        period adjustment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjusted
        values&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property,
        plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,569&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(206&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,363&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible
        assets &#x2013; arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;9,360&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;9,360&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial
        assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;9&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;9&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;1,296&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(1,296&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;135&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;135&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;(50&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;(50&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred
        tax liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;(1,170&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;1,170&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        assets acquired&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;11,149&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;(332&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;10,817&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;12,071&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;332&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;12,403&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;23,220&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;23,220&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Satisfied
        by:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;12,500&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;12,500&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;3,960&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;3,960&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred
        contingent consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;6,760&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;6,760&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;23,220&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;23,220&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash outflow &#x2013; arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;12,500&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;12,500&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash outflow&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;12,500&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;-&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;12,500&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163217141"
      unitRef="USD">-1569000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163258763"
      unitRef="USD">206000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163302909"
      unitRef="USD">-1363000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_2"
      unitRef="USD">-9360000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_2"
      unitRef="USD">0</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_2"
      unitRef="USD">-9360000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_3"
      unitRef="USD">-9000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_3"
      unitRef="USD">0</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_3"
      unitRef="USD">-9000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_4"
      unitRef="USD">-1296000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_4"
      unitRef="USD">1296000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_4"
      unitRef="USD">0</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
    <trib:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_5"
      unitRef="USD">-135000</trib:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate>
    <trib:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_5"
      unitRef="USD">0</trib:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate>
    <trib:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_5"
      unitRef="USD">-135000</trib:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_6"
      unitRef="USD">-50000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_6"
      unitRef="USD">0</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_6"
      unitRef="USD">-50000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_7"
      unitRef="USD">-1170000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_7"
      unitRef="USD">1170000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_7"
      unitRef="USD">0</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_8"
      unitRef="USD">-11149000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_8"
      unitRef="USD">332000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_8"
      unitRef="USD">-10817000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_9"
      unitRef="USD">-12071000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_9"
      unitRef="USD">-332000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_9"
      unitRef="USD">-12403000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_10"
      unitRef="USD">23220000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_10"
      unitRef="USD">0</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_10"
      unitRef="USD">23220000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_13"
      unitRef="USD">12500000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_13"
      unitRef="USD">0</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_13"
      unitRef="USD">12500000</ifrs-full:CashTransferred>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_14"
      unitRef="USD">3960000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_14"
      unitRef="USD">0</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_14"
      unitRef="USD">3960000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_15"
      unitRef="USD">6760000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_15"
      unitRef="USD">0</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_15"
      unitRef="USD">6760000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_16"
      unitRef="USD">23220000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_16"
      unitRef="USD">0</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_16"
      unitRef="USD">23220000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_19"
      unitRef="USD">12500000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_19"
      unitRef="USD">0</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_19"
      unitRef="USD">12500000</ifrs-full:CashTransferred>
    <trib:NetCashOutFlowOnBusinessCombination
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribProvisionalValueMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_3_20"
      unitRef="USD">12500000</trib:NetCashOutFlowOnBusinessCombination>
    <trib:NetCashOutFlowOnBusinessCombination
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_7_20"
      unitRef="USD">0</trib:NetCashOutFlowOnBusinessCombination>
    <trib:NetCashOutFlowOnBusinessCombination
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-3"
      id="Fxbrl_20250512163328997_11_20"
      unitRef="USD">12500000</trib:NetCashOutFlowOnBusinessCombination>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-5"
      id="Fxbrl_20250512182723983"
      unitRef="USD">1200000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-5"
      id="Fxbrl_20250512182733294"
      unitRef="USD">1300000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-5"
      id="Fxbrl_20250512182957042"
      unitRef="USD">200000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20240130_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember_ifrsfullTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_tribMeasurementPeriodAdjustmentMember"
      decimals="-5"
      id="Fxbrl_20250512183106157"
      unitRef="USD">-300000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination
      contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="-2"
      id="Fxbrl_20250512183502513"
      unitRef="USD">-1300</ifrs-full:GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="2"
      id="Fxbrl_20250512184019569"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="2"
      id="Fxbrl_20250512184102617"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-5"
      id="Fxbrl_20250515012312741"
      unitRef="USD">900000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-4"
      id="Fxbrl_20250515012336609"
      unitRef="USD">270000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <trib:ExtinguishmentOfAmountOwed
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-5"
      id="Fxbrl_20250515012351853"
      unitRef="USD">400000</trib:ExtinguishmentOfAmountOwed>
    <ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory
      contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      id="Fxbrl_20250512155117536">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Metabolomics&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisional
        value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property,
        plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible
        assets &#x2013; arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;144&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other receivables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;181&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(494&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred
        tax liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        acquired&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        assets acquired&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;900&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;906&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Satisfied
        by:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;412&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;494&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;906&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash outflow &#x2013; arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;412&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less:
        Cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash outflow&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;404&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458829_xbrl_20250512163302909"
      unitRef="USD">-10000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458830_xbrl_20250512163328997_11_2"
      unitRef="USD">-1200000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458831_xbrl_20250512163328997_11_4"
      unitRef="USD">-144000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
    <trib:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458833_xbrl_20250512163328997_11_5"
      unitRef="USD">-181000</trib:TradeAndOtherReceivablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458834_xbrl_20250512163328997_11_6"
      unitRef="USD">-494000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458835_xbrl_20250512163328997_11_7"
      unitRef="USD">-150000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <trib:CashAcquiredAsOfAcquisitionDate
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170625411_73"
      unitRef="USD">-9000</trib:CashAcquiredAsOfAcquisitionDate>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458836_xbrl_20250512163328997_11_8"
      unitRef="USD">-900000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458837_xbrl_20250512163328997_11_9"
      unitRef="USD">-6000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458838_xbrl_20250512163328997_11_10"
      unitRef="USD">906000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458838_xbrl_20250512163328997_11_13"
      unitRef="USD">412000</ifrs-full:CashTransferred>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458839_xbrl_20250512163328997_11_14"
      unitRef="USD">494000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458839_xbrl_20250512163328997_11_16"
      unitRef="USD">906000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458840_xbrl_20250512163328997_11_19"
      unitRef="USD">412000</ifrs-full:CashTransferred>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170625411_193"
      unitRef="USD">8000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <trib:NetCashOutFlowOnBusinessCombination
      contextRef="C_20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512170458840_xbrl_20250512163328997_11_20"
      unitRef="USD">404000</trib:NetCashOutFlowOnBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20240930to20240930_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-5"
      id="Fxbrl_20250512184840078"
      unitRef="USD">300000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination
      contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="-2"
      id="Fxbrl_20250512184956108"
      unitRef="USD">-300</ifrs-full:GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="2"
      id="Fxbrl_20250512185037002"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="2"
      id="Fxbrl_20250512185111174"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:CashTransferred
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-5"
      id="Fxbrl_20250515013059389"
      unitRef="USD">3000000</ifrs-full:CashTransferred>
    <trib:AdditionalConsiderationContingentOnAchievementOfFutureMilestone
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-5"
      id="Fxbrl_20250515013120835"
      unitRef="USD">500000</trib:AdditionalConsiderationContingentOnAchievementOfFutureMilestone>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember_ifrsfullClassesOfShareCapitalAxis_tribAmericanDepositaryShareMember"
      decimals="-5"
      id="Fxbrl_20250515013135745"
      unitRef="USD">1700000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory
      contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      id="Fxbrl_20250512155132986">

&lt;table border="0" cellpadding="0" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;EpiCapture&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provisional
        value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:center;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US$&#x2018;000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible
        assets &#x2013; arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,668&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade
        and other payables&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(406&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred
        tax liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(333&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        assets acquired&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,929&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,420&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Satisfied
        by:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-cash
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,965&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred
        contingent consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;384&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total
        consideration&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash outflow &#x2013; arising on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
        &lt;div style="text-indent:-12pt;margin-left:12pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net
        cash outflow&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512171445560_xbrl_20250512170458830_xbrl_20250512163328997_11_2"
      unitRef="USD">-2668000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512171445561_xbrl_20250512170458834_xbrl_20250512163328997_11_6"
      unitRef="USD">-406000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512171445563_xbrl_20250512170458835_xbrl_20250512163328997_11_7"
      unitRef="USD">-333000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512171445563_xbrl_20250512170458836_xbrl_20250512163328997_11_8"
      unitRef="USD">-1929000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512171445564_xbrl_20250512170458837_xbrl_20250512163328997_11_9"
      unitRef="USD">-1420000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512171445564_xbrl_20250512170458838_xbrl_20250512163328997_11_10"
      unitRef="USD">3349000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512171445565_xbrl_20250512170458839_xbrl_20250512163328997_11_14"
      unitRef="USD">2965000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512171557048"
      unitRef="USD">384000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512171445566_xbrl_20250512170458839_xbrl_20250512163328997_11_16"
      unitRef="USD">3349000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <trib:NetCashOutFlowOnBusinessCombination
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512171445567_xbrl_20250512170458840_xbrl_20250512163328997_11_20"
      unitRef="USD">0</trib:NetCashOutFlowOnBusinessCombination>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="C_20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-5"
      id="Fxbrl_20250512185620603"
      unitRef="USD">400000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <trib:DescriptionOfCumulativeRevenuesPayable
      contextRef="C_20241031to20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      id="Fxbrl_20250512185858023">An
amount of US$0.5 million will become payable if cumulative revenues from EpiCapture&#x2019;s operations reach US$1.0 million within a period
of three years</trib:DescriptionOfCumulativeRevenuesPayable>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="C_20241031to20241031_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512185951572"
      unitRef="USD">26000000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination
      contextRef="C_20240101to20241231_ifrsfullBusinessCombinationsAxis_tribEpiCaptureLimitedMember"
      decimals="-3"
      id="Fxbrl_20250512190118327"
      unitRef="USD">-20000000</ifrs-full:GainLossThatRelatesToIdentifiableAssetsAcquiredOrLiabilitiesAssumedInBusinessCombination>
    <ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512143804581">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;POST BALANCE SHEET EVENTS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amendment
and Restatement of Term Loan&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
2025, the Company entered into further amendments to its senior secured term loan credit agreement with its principal lender, Perceptive,
to access additional funding and enhance its financial position.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On
February 27, 2025, the Company entered into a fourth amendment to the credit agreement, pursuant to which Perceptive provided an additional
US$4.0
million in term loan funding. This funding will be used for general corporate purposes, including the further development of our CGM offering.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On
May 14, 2025, the Company entered into a fifth amendment to the credit agreement, which provided for a further US$2.0
million in term loan funding, extended the maturity date of the Term Loan from January
2026 to July 27, 2026, and confirmed that interest
payments for the months of April, May, and June 2025 would be paid-in-kind. This funding is also intended to support general
corporate purposes and continued investment in the Company&#x2019;s CGM and biosensor development programs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;These
2025 amendments reflect the ongoing support of Perceptive and have further strengthened the Company&#x2019;s liquidity position, while
providing greater operational and financial flexibility to support the execution of its strategic and commercial objectives.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory>
    <ifrs-full:NotionalAmount
      contextRef="C_20250227_ifrsfullBorrowingsByNameAxis_tribFourthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember"
      decimals="-5"
      id="Fxbrl_20250512145552888"
      unitRef="USD">4000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="C_20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember"
      decimals="-5"
      id="Fxbrl_20250512145704200"
      unitRef="USD">2000000</ifrs-full:NotionalAmount>
    <ifrs-full:BorrowingsMaturity
      contextRef="C_20250514to20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember"
      id="Fxbrl_20250515124951112">January
2026 to July 27, 2026</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="C_20250514to20250514_ifrsfullBorrowingsByNameAxis_tribFifthAmendmentToCreditAgreementMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_tribEventsAfterReportingPeriodMember"
      id="Fxbrl_20250512145808323">interest
payments for the months of April, May, and June 2025 would be paid-in-kind</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20250512133133514">

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;margin-top:0pt;margin-bottom:0pt"&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;31.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ACCOUNTING ESTIMATES AND JUDGEMENTS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
preparation of these financial statements requires the Group to make estimates and judgements that affect the reported amount of assets,
liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On
an on-going basis, the Group evaluates these estimates, including those related to intangible assets, contingencies and litigation. The
estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances,
the results of which form the basis for making judgements about the carrying values of assets and liabilities that are not readily apparent
from other sources. Actual results may differ from these estimates under different assumptions or conditions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Key
sources of estimation uncertainty&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note
12 contains information about the assumptions and the risk factors relating to the impairment of goodwill, other intangible assets, property,
plant and equipment and financial asset. Note 20 outlines information regarding the valuation of share options. Note 23 outlines the valuation
techniques used by the Company in determining the fair value of the Group&#x2019;s interest-bearing loans and borrowings. In Note 27, detailed
analysis is given about the interest rate risk, credit risk, liquidity risk and foreign exchange risk of the Group.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Critical
accounting judgements in applying the Group&#x2019;s accounting policies&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Certain
critical accounting judgements in applying the Group&#x2019;s accounting policies are described below:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-indent:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue
Recognition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-indent:30.6pt;line-height:1.25;font-style:italic"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No
revenue is recognised if there is uncertainty regarding recovery of the consideration due at the outset of the transaction. We make a
judgement as to the collectability of invoiced sales based on an assessment of the individual debtor taking into account past payment
history, the probability of default or delinquency in payments and the probability that debtor will enter into financial difficulties
or bankruptcy.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Some
customer contracts could be regarded as offering the customer a right of return. Due to the uncertainty of the magnitude and likelihood
of product returns, there is a level of estimation involved in assessing the amount of revenue to be recognized for these types of contracts.
In accordance with IFRS 15, when estimating the effect of an uncertainty on an amount of variable consideration to which the Group will
be entitled, all information that is reasonably available, including historical, current and forecast, is considered.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;We
operate a licenced reference laboratory in New York, USA that specializes in diagnostics for autoimmune diseases. The laboratory provides
testing services to two types of customers. Firstly, institutional customers, such as hospitals and commercial diagnostic testing providers,
and secondly insurance companies on behalf of their policyholders. The revenue recognition for services provided to insurance companies
requires some judgement. In the US, there are rules requiring all insurance companies to be billed the same amount per test. However,
the amount that each insurance company pays for a particular test varies according to their own internal policies and this can typically
be considerably less than the amount invoiced. We recognise lab services revenue for insurance companies by taking the invoiced amount
and reducing it by an estimated percentage based on historical payment data. We review the percentage reduction annually based on the
latest data. As a practical expedient, and in accordance with IFRS, we apply a portfolio approach to the insurance companies as they have
similar characteristics. We judge that the effect on the financial statements of using a portfolio approach for the insurance companies
will not differ materially from applying IFRS 15 to the individual contracts within that portfolio.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
December 31, 2024 US$nil
(2023: US$50,000)
(2022: US$114,000)
of revenue was deferred in accordance with IFRS15.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research
and development expenditure &#x2013; capitalized development costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30pt;line-height:1.25;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under
IFRS as issued by IASB, the Group writes off research and development expenditure as incurred, with the exception of expenditure on projects
whose outcome has been assessed with reasonable certainty as to technical feasibility, commercial viability and recovery of costs through
future revenues. Such
expenditure is capitalised at cost within intangible assets and amortised over its expected useful life of 15 years, which
commences when commercial production starts. For further information, refer to Note 12.&lt;/span&gt;&lt;/span&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div style="margin-bottom:0px"&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Acquired
in-process research and development (IPR&amp;amp;D) is valued at its fair value at acquisition date in accordance with IFRS 3. The Company
determines this fair value by adopting the income approach valuation technique. Once the fair value has been determined, the Company will
recognise the IPR&amp;amp;D as an intangible asset when it: (a)&#160;meets the definition of an asset and (b)&#160;is identifiable (i.e.,
is separable or arises from contractual or other legal rights).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Factors
which impact our judgement to capitalise certain research and development expenditure include the degree of regulatory approval for products
and the results of any market research to determine the likely future commercial success of products being developed. We review these
factors each year to determine whether our previous estimates as to feasibility, viability and recovery should be changed.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At
December 31, 2024 the carrying value of capitalised development costs was US$20,951,000
(2023: US$15,103,000)
(see&#160; Note 12 to the consolidated financial statements). The increase in 2024 was mainly as a result of additions of US$8,582,000,
partially offset by impairment losses of US$1,596,000
recognised during the year.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-style:italic"&gt;Impairment
of intangible assets and goodwill&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Definite
lived intangible assets are reviewed for indicators of impairment periodically while goodwill and indefinite lived assets are tested for
impairment at least annually, individually or at the cash-generating unit level.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Factors
considered important, as part of an impairment review, include the following:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:36.7pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Significant underperformance relative to expected
        historical or projected future operating results;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:36.7pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Significant changes in the manner of our use of
        the acquired assets or the strategy for our overall business;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:36.7pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.35pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width:36.7pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Obsolescence of products;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:36.7pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.35pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width:36.7pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Significant decline in our stock price for a sustained
        period; and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:36.7pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.35pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width:36.7pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:18.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Our market capitalisation relative to net book
        value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;When
we determine that the carrying value of intangibles and non-current assets may not be recoverable based upon the existence of one or more
of the above indicators of impairment, any impairment is measured based on our estimates of projected net discounted cash flows expected
to result from that asset, including eventual disposition. Our estimated impairment could prove insufficient if our analysis overestimated
the cash flows or conditions change in the future.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
impairment testing performed during the year ended December 31, 2024 resulted in impairment losses being recorded&#160; in four cash generating
units, namely Immco Diagnostics Inc, Trinity Biotech Do Brasil, Biopool US Inc and Clark Laboratories Inc totalling US$1.4
million. For further information, refer to Note 12.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Allowance
for slow-moving and obsolete inventory&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;We
evaluate the realisability of our inventory on a case-by-case basis and make adjustments to our inventory provision based on our estimates
of expected losses. We write off inventory that is approaching its &#x201c;use-by&#x201d; date and for which no further re-processing can
be performed. We also consider recent trends in revenues for various inventory items and instances where the realisable value of inventory
is likely to be less than its carrying value. Given the allowance is calculated on the basis of the actual inventory on hand at the particular
balance sheet date, there were no material changes in estimates made during 2024, 2023 or 2022 which would have an impact on the carrying
values of inventory during those periods, except as discussed below. At December&#160;31, 2024 our allowance for slow moving and obsolete
inventory was US$7.6
million which represents approximately 28.3%
of gross inventory value. At December 31, 2023 our allowance for slow moving and obsolete inventory was US$11.3
million which represented approximately 36.3%
of gross inventory value and at December 31, 2022 the provision was US$16.3
million, or approximately 42.0%
of gross inventory value. The estimated allowance for slow moving and obsolete inventory as a percentage of gross inventory has decreased
between 2023 and 2024 due to the physical scrapping of obsolete inventory and better inventory management.&lt;/span&gt;&lt;/span&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt;

&lt;div style="margin-bottom:0px"&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Management
is satisfied that the assumptions made with respect to future sales and production levels of these products are reasonable to ensure the
adequacy of this provision. In the event that the estimate of the provision required for slow moving and obsolete inventory was to increase
or decrease by 2% of gross inventory, which would represent a reasonably likely range of outcomes, then a change in allowance of US$0.5
million at December&#160;31, 2024 (2023: US$0.6
million) (2022: US$0.8
million) would result. For further information, refer to Note 16.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Business
Combinations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
Group completed three business combinations during the year: the acquisitions of Waveform Technologies, Metabolomics Health, and EpiCapture.
Significant judgement was required in determining whether each transaction met the definition of a business under IFRS 3 Business Combinations,
based on the acquisition of an integrated set of activities and assets capable of generating outputs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In
accounting for these transactions, management was required to make key estimates in the determination of the fair value of the identifiable
assets acquired and liabilities assumed, including the recognition and measurement of separately identifiable intangible assets and contingent
consideration. The valuations involved the use of discounted cash flow models and required management to estimate future cash flows, apply
appropriate discount rates reflecting the Group&#x2019;s weighted average cost of capital, and assess the probability of meeting contingent
consideration milestones. The Group engaged an independent third-party valuation specialist to assist with the purchase price allocation
for all three acquisitions. These estimates had a material impact on the allocation of consideration between identifiable intangible assets
and goodwill.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investment
in Novus Diagnostics&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During
the year, the Group acquired a minority equity interest in a privately held company that is not quoted in an active market. The investment
is classified as a financial asset at fair value through profit or loss (FVTPL) in accordance with IFRS 9. The fair value of the investment
was initially based on the transaction price. As the investment is classified within Level 3 of the fair value hierarchy under IFRS 13,
subsequent remeasurement requires the use of unobservable inputs and significant management judgement. This includes consideration of
investee-specific developments, commercial progress, and market conditions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Going
Concern&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:30.6pt;line-height:1.25"&gt;

&lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates
the realization of assets and the discharge of liabilities in the normal course of business for the foreseeable future.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;

&lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Management&#x2019;s
assessment of the Group&#x2019;s ability to continue as a going concern involves significant judgement. For details of the assumptions
and considerations underpinning this assessment, refer to the &#x201c;Going concern&#x201d; section of Note 1, which outlines the basis
of preparation..&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory>
    <ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities
      contextRef="C_20241231"
      decimals="0"
      id="Fxbrl_20230413152043027"
      unitRef="USD">0</ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities>
    <ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities
      contextRef="C_20231231"
      decimals="0"
      id="Fxbrl_20230413152052490"
      unitRef="USD">50000</ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities>
    <ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities
      contextRef="C_20221231"
      decimals="0"
      id="Fxbrl_20230413152057124"
      unitRef="USD">114000</ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities>
    <ifrs-full:DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220422034250338">Such
expenditure is capitalised at cost within intangible assets and amortised over its expected useful life of 15 years</ifrs-full:DescriptionOfUsefulLifeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember"
      decimals="0"
      id="Fxbrl_20230428014644369"
      unitRef="USD">20951000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="C_20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember"
      decimals="0"
      id="Fxbrl_20230428014653478"
      unitRef="USD">15103000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AmortisationExpense
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember"
      decimals="0"
      id="Fxbrl_20230428014754909"
      unitRef="USD">8582000</ifrs-full:AmortisationExpense>
    <ifrs-full:ImpairmentLoss
      contextRef="C_20240101to20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrsfullCapitalisedDevelopmentExpenditureMember"
      decimals="0"
      id="Fxbrl_20230428014743440"
      unitRef="USD">1596000</ifrs-full:ImpairmentLoss>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncome
      contextRef="C_20240101to20241231"
      decimals="-5"
      id="Fxbrl_20230413154626958"
      unitRef="USD">1400000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncome>
    <ifrs-full:InventoriesAtNetRealisableValue
      contextRef="C_20241231"
      decimals="-5"
      id="Fxbrl_20230413155326235"
      unitRef="USD">7600000</ifrs-full:InventoriesAtNetRealisableValue>
    <trib:PercentageOfGrossInventory1
      contextRef="C_20241231"
      decimals="3"
      id="Fxbrl_20230413155338972"
      unitRef="Pure">0.283</trib:PercentageOfGrossInventory1>
    <ifrs-full:InventoriesAtNetRealisableValue
      contextRef="C_20231231"
      decimals="-5"
      id="Fxbrl_20230413155355020"
      unitRef="USD">11300000</ifrs-full:InventoriesAtNetRealisableValue>
    <trib:PercentageOfGrossInventory1
      contextRef="C_20231231"
      decimals="3"
      id="Fxbrl_20230413155447530"
      unitRef="Pure">0.363</trib:PercentageOfGrossInventory1>
    <ifrs-full:InventoriesAtNetRealisableValue
      contextRef="C_20221231"
      decimals="-5"
      id="Fxbrl_20230413155439173"
      unitRef="USD">16300000</ifrs-full:InventoriesAtNetRealisableValue>
    <trib:PercentageOfGrossInventory1
      contextRef="C_20221231"
      decimals="3"
      id="Fxbrl_20230413155502588"
      unitRef="Pure">0.42</trib:PercentageOfGrossInventory1>
    <trib:ChangeInAllowance
      contextRef="C_20241231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTwoPercentageOfGrossInventoryMember"
      decimals="-5"
      id="Fxbrl_20230413163110854"
      unitRef="USD">500000</trib:ChangeInAllowance>
    <trib:ChangeInAllowance
      contextRef="C_20231231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTwoPercentageOfGrossInventoryMember"
      decimals="-5"
      id="Fxbrl_20230413163134671"
      unitRef="USD">600000</trib:ChangeInAllowance>
    <trib:ChangeInAllowance
      contextRef="C_20221231_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_tribTwoPercentageOfGrossInventoryMember"
      decimals="-5"
      id="Fxbrl_20230413163144885"
      unitRef="USD">800000</trib:ChangeInAllowance>
    <trib:DisclosureOfGroupUndertakingsExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240415111120043">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)"&gt;
  &lt;tr&gt;
    &lt;td style="width:30.6pt;vertical-align:top;font-family:'Times New Roman', serif"&gt;&lt;span id="GROUPUNDERTAKINGS"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;32&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div style="font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GROUP
        UNDERTAKINGS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The
consolidated financial statements include the financial statements of Trinity Biotech plc and the following principal subsidiary undertakings:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table cellpadding="0" cellspacing="0" style="width:85%"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Name
        and registered office&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal
        activity&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal&#160;Country&#160;of&lt;br/&gt;incorporation
        and&lt;br/&gt;operation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Group&#160;%&#160;holding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Manufacturing Limited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IDA
        Business Park, Bray&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;County
        Wicklow, Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacture
        and sale&lt;br/&gt;of diagnostic test kits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Research Limited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IDA
        Business Park, Bray&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;County
        Wicklow, Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research
        and&lt;br/&gt;development&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Ireland&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Manufacturing Services Limited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IDA
        Business Park, Bray&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;County
        Wicklow, Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dormant&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Luxembourg Sarl&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,
        rue Bender,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;L-1229
        Luxembourg&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investment
        and&lt;br/&gt;provision of financial&lt;br/&gt;services&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Luxembourg&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Inc&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Girts
        Road,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Jamestown,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NY
        14702, USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Holding
        Company&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;U.S.A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clark
        Laboratories Inc&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trading
        as Trinity Biotech (USA)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Girts
        Road, Jamestown&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NY14702,
        USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacture
        and sale&lt;br/&gt;of diagnostic test kits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;U.S.A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Mardx
        Diagnostics Inc&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5919
        Farnsworth Court&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carlsbad&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CA
        92008, USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dormant&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;U.S.A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Biopool
        US Inc (trading as Trinity Biotech Distribution)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Girts
        Road, Jamestown&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NY14702,
        USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sale
        of diagnostic test&lt;br/&gt;kits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;U.S.A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Primus
        Corporation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4231
        E 75&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;th&lt;/sup&gt; Terrace&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Kansas
        City,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;MO
        64132, USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacture
        and sale&lt;br/&gt;of diagnostic test kits&lt;br/&gt;and instrumentation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;U.S.A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table cellpadding="0" cellspacing="0" style="width:85%"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Name
        and registered office&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal&#160;activity&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;em&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Principal
        Country of&lt;br/&gt;incorporation and&lt;br/&gt;operation&lt;/span&gt;&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Group&#160;%&#160;holding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Phoenix
        Bio-tech Corp.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1166
        South Service Road West&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Oakville,
        ON L6L 5T7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Canada.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dormant&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fiomi
        Diagnostics Holding AB&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dag
        Hammarskj&#xf6;ldsv 52A&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SE-752
        37 Uppsala&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sweden&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Holding
        Company&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Sweden&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fiomi
        Diagnostics AB&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dag
        Hammarskj&#xf6;ldsv 52A&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SE-752
        37 Uppsala&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sweden&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discontinued
        operation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;(in
        liquidation)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Sweden&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Do Brasil&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Comercio
        e Importacao Ltda&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rua
        Silva Bueno&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.660
        &#x2013; Cj. 101/102&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ipiranga&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sao
        Paulo&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Brazil&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sale
        of diagnostic test&lt;br/&gt;kits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Brazil&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech (UK) Ltd&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Mills
        and Reeve LLP&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Botanic
        House&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100
        Hills Road&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cambridge,
        CB2 1PH&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United
        Kingdom&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sales
        &amp;amp; marketing&lt;br/&gt;activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;UK&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Immco
        Diagnostics Inc&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;60
        Pineview Drive&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buffalo&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NY
        14228, USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacture
        and sale of&lt;br/&gt;autoimmune products&lt;br/&gt;and laboratory services&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;U.S.A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Nova
        Century Scientific Inc&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5022
        South Service Road&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Burlington&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ontario&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacture
        and sale of&lt;br/&gt;autoimmune products and infectious diseases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Investment Ltd&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;PO
        Box 309&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ugland
        House&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grand
        Cayman&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;KY1-1104&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cayman
        Islands&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investment
        and&lt;br/&gt;provision of financial&lt;br/&gt;services&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cayman
        Islands&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt; &lt;/div&gt;&#160;

&lt;div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:85%"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Name
        and registered office&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal
        activity&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal
        Country of&lt;br/&gt;incorporation and&lt;br/&gt;operation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Group
        % holding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trib
        Biosensors Inc.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27700
        S.W. 95&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;th&lt;/sup&gt; Avenue,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Wilsonville,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Oregon
        97070, USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacturing,
        development, and sale of biosensors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0)"&gt;USA&lt;/span&gt;&lt;br/&gt;&lt;span style="color:rgb(0, 0, 0)"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Konamite
        Limited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;IDA
        Business Park, Bray&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;County
        Wicklow, Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sales
        &amp;amp; marketing&lt;br/&gt;activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0)"&gt;Ireland&lt;/span&gt;&lt;br/&gt;&lt;span style="color:rgb(0, 0, 0)"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td rowspan="1" style="vertical-align:top;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td rowspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td rowspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td rowspan="1" style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Trinity
        Biotech Joint Venture Limited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;IDA
        Business Park, Bray&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;County
        Wicklow, Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Holding
        Company&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0)"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;EpiCapture
        Limited&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"&gt;19
        Mather Road, Mount Merrion, Dublin, Ireland&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Research
        and development&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;Ireland&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;100%&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Metabolomics
        Diagnostics Limited&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"&gt;Hoffman
        Park, Inchera, Little Island, Co. Cork, Ireland&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Research
        and development&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;Ireland&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;100%&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Waveform
        Technologies Inc.&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"&gt;Obrtna
        cesta 18, 8310 Sentjernej, Slovenia&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Manufacturing,
        development, and sale of biosensors&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;Slovenia&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;100%&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt; </trib:DisclosureOfGroupUndertakingsExplanatory>
    <ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20240414195344650">

&lt;div style="margin-left:36pt"&gt;

&lt;table cellpadding="0" cellspacing="0" style="width:85%"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Name
        and registered office&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal
        activity&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal&#160;Country&#160;of&lt;br/&gt;incorporation
        and&lt;br/&gt;operation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Group&#160;%&#160;holding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Manufacturing Limited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IDA
        Business Park, Bray&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;County
        Wicklow, Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacture
        and sale&lt;br/&gt;of diagnostic test kits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Research Limited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IDA
        Business Park, Bray&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;County
        Wicklow, Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research
        and&lt;br/&gt;development&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Ireland&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Manufacturing Services Limited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;IDA
        Business Park, Bray&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;County
        Wicklow, Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dormant&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Luxembourg Sarl&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,
        rue Bender,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;L-1229
        Luxembourg&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investment
        and&lt;br/&gt;provision of financial&lt;br/&gt;services&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Luxembourg&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Inc&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Girts
        Road,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Jamestown,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NY
        14702, USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Holding
        Company&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;U.S.A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Clark
        Laboratories Inc&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trading
        as Trinity Biotech (USA)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Girts
        Road, Jamestown&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NY14702,
        USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacture
        and sale&lt;br/&gt;of diagnostic test kits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;U.S.A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Mardx
        Diagnostics Inc&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5919
        Farnsworth Court&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carlsbad&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;CA
        92008, USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dormant&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;U.S.A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Biopool
        US Inc (trading as Trinity Biotech Distribution)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Girts
        Road, Jamestown&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NY14702,
        USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sale
        of diagnostic test&lt;br/&gt;kits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;U.S.A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Primus
        Corporation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4231
        E 75&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;th&lt;/sup&gt; Terrace&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Kansas
        City,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;MO
        64132, USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacture
        and sale&lt;br/&gt;of diagnostic test kits&lt;br/&gt;and instrumentation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;U.S.A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table cellpadding="0" cellspacing="0" style="width:85%"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Name
        and registered office&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal&#160;activity&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;em&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Principal
        Country of&lt;br/&gt;incorporation and&lt;br/&gt;operation&lt;/span&gt;&lt;/em&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Group&#160;%&#160;holding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Phoenix
        Bio-tech Corp.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1166
        South Service Road West&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Oakville,
        ON L6L 5T7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Canada.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dormant&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fiomi
        Diagnostics Holding AB&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dag
        Hammarskj&#xf6;ldsv 52A&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SE-752
        37 Uppsala&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sweden&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Holding
        Company&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Sweden&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fiomi
        Diagnostics AB&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dag
        Hammarskj&#xf6;ldsv 52A&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SE-752
        37 Uppsala&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sweden&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Discontinued
        operation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;(in
        liquidation)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Sweden&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Do Brasil&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Comercio
        e Importacao Ltda&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rua
        Silva Bueno&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.660
        &#x2013; Cj. 101/102&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ipiranga&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sao
        Paulo&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Brazil&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sale
        of diagnostic test&lt;br/&gt;kits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Brazil&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech (UK) Ltd&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Mills
        and Reeve LLP&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Botanic
        House&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100
        Hills Road&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cambridge,
        CB2 1PH&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United
        Kingdom&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sales
        &amp;amp; marketing&lt;br/&gt;activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;UK&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Immco
        Diagnostics Inc&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;60
        Pineview Drive&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Buffalo&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NY
        14228, USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacture
        and sale of&lt;br/&gt;autoimmune products&lt;br/&gt;and laboratory services&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;U.S.A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Nova
        Century Scientific Inc&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5022
        South Service Road&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Burlington&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ontario&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacture
        and sale of&lt;br/&gt;autoimmune products and infectious diseases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:middle;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;text-align:center;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:middle;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:middle;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trinity
        Biotech Investment Ltd&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;PO
        Box 309&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ugland
        House&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grand
        Cayman&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;KY1-1104&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cayman
        Islands&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Investment
        and&lt;br/&gt;provision of financial&lt;br/&gt;services&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cayman
        Islands&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="margin-left:36pt"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:85%"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Name
        and registered office&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal
        activity&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:23%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principal
        Country of&lt;br/&gt;incorporation and&lt;br/&gt;operation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);padding-bottom:2px;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:bottom;color:rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Group
        % holding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trib
        Biosensors Inc.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27700
        S.W. 95&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;th&lt;/sup&gt; Avenue,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Wilsonville,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Oregon
        97070, USA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Manufacturing,
        development, and sale of biosensors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0)"&gt;USA&lt;/span&gt;&lt;br/&gt;&lt;span style="color:rgb(0, 0, 0)"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Konamite
        Limited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;IDA
        Business Park, Bray&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;County
        Wicklow, Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sales
        &amp;amp; marketing&lt;br/&gt;activities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0)"&gt;Ireland&lt;/span&gt;&lt;br/&gt;&lt;span style="color:rgb(0, 0, 0)"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td rowspan="1" style="vertical-align:top;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td rowspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;color:rgb(0, 0, 0);white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td rowspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" rowspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td rowspan="1" style="vertical-align:top;color:rgb(0, 0, 0);text-align:center;white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;margin-top:0pt;margin-bottom:0pt;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Trinity
        Biotech Joint Venture Limited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;IDA
        Business Park, Bray&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;County
        Wicklow, Ireland&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Holding
        Company&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0)"&gt;Ireland&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;color:rgb(0, 0, 0);text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;EpiCapture
        Limited&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"&gt;19
        Mather Road, Mount Merrion, Dublin, Ireland&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Research
        and development&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;Ireland&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;100%&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Metabolomics
        Diagnostics Limited&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"&gt;Hoffman
        Park, Inchera, Little Island, Co. Cork, Ireland&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Research
        and development&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;Ireland&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;100%&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;text-align:center;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align:top;width:30%"&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Waveform
        Technologies Inc.&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:Times New Roman, serif;color:rgb(0, 0, 0)"&gt;Obrtna
        cesta 18, 8310 Sentjernej, Slovenia&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:22%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Manufacturing,
        development, and sale of biosensors&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;white-space:nowrap;width:23%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0)"&gt;Slovenia&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td colspan="1" style="vertical-align:top;white-space:nowrap;text-align:center;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;color:rgb(0, 0, 0);white-space:nowrap;width:22%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;100%&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember"
      id="Fxbrl_20240413054331240">Trinity
        Biotech Manufacturing Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember"
      id="Fxbrl_20240413055623654">

        IDA
        Business Park, Bray
        County
        Wicklow, Ireland  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember"
      id="Fxbrl_20240413054345280">Manufacture
        and saleof diagnostic test kits</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember"
      id="Fxbrl_20240413054415131">Ireland</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingLimitedMember"
      decimals="2"
      id="Fxbrl_20240413054432534"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityResearchLimitedMember"
      id="Fxbrl_20240413055638453">Trinity
        Research Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityResearchLimitedMember"
      id="Fxbrl_20240413055604876">

        IDA
        Business Park, Bray
        County
        Wicklow, Ireland  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityResearchLimitedMember"
      id="Fxbrl_20240413055952931">Research
        anddevelopment</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityResearchLimitedMember"
      id="Fxbrl_20240414185436058">Ireland</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityResearchLimitedMember"
      decimals="2"
      id="Fxbrl_20240414185833821"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingServicesLimitedMember"
      id="Fxbrl_20240413055642839">Trinity
        Biotech Manufacturing Services Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingServicesLimitedMember"
      id="Fxbrl_20240413055549092">

        IDA
        Business Park, Bray
        County
        Wicklow, Ireland  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingServicesLimitedMember"
      id="Fxbrl_20240413055956180">Dormant</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingServicesLimitedMember"
      id="Fxbrl_20240414185448044">Ireland</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechManufacturingServicesLimitedMember"
      decimals="2"
      id="Fxbrl_20240414185845450"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechLuxembourgSarlMember"
      id="Fxbrl_20240413055648179">Trinity
        Biotech Luxembourg Sarl</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechLuxembourgSarlMember"
      id="Fxbrl_20240413055541878">

        1,
        rue Bender,
        L-1229
        Luxembourg  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechLuxembourgSarlMember"
      id="Fxbrl_20240413060001755">Investment
        andprovision of financialservices</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechLuxembourgSarlMember"
      id="Fxbrl_20240414185511164">Luxembourg</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechLuxembourgSarlMember"
      decimals="2"
      id="Fxbrl_20240414185848995"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechIncMember"
      id="Fxbrl_20240413055656812">Trinity
        Biotech Inc</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechIncMember"
      id="Fxbrl_20240413055534644">

        Girts
        Road,
        Jamestown,
        NY
        14702, USA  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechIncMember"
      id="Fxbrl_20240413060005354">Holding
        Company</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechIncMember"
      id="Fxbrl_20240414185513708">U.S.A.</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechIncMember"
      decimals="2"
      id="Fxbrl_20240414185903964"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribClarkLaboratoriesIncMember"
      id="Fxbrl_20240413055703356">Clark
        Laboratories Inc</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribClarkLaboratoriesIncMember"
      id="Fxbrl_20240413055524941">

        Trading
        as Trinity Biotech (USA)
        Girts
        Road, Jamestown
        NY14702,
        USA  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribClarkLaboratoriesIncMember"
      id="Fxbrl_20240413060009964">Manufacture
        and saleof diagnostic test kits</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribClarkLaboratoriesIncMember"
      id="Fxbrl_20240414185517037">U.S.A</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribClarkLaboratoriesIncMember"
      decimals="2"
      id="Fxbrl_20240414185908588"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMardxDiagnosticsIncMember"
      id="Fxbrl_20240413055707381">Mardx
        Diagnostics Inc</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMardxDiagnosticsIncMember"
      id="Fxbrl_20240413055519966">

        5919
        Farnsworth Court
        Carlsbad
        CA
        92008, USA  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMardxDiagnosticsIncMember"
      id="Fxbrl_20240413060023046">Dormant</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMardxDiagnosticsIncMember"
      id="Fxbrl_20240414185523684">U.S.A.</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMardxDiagnosticsIncMember"
      decimals="2"
      id="Fxbrl_20240414185913556"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiopoolUsIncMember"
      id="Fxbrl_20240413055712596">Biopool
        US Inc (trading as Trinity Biotech Distribution)</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiopoolUsIncMember"
      id="Fxbrl_20240413055515369">

        Girts
        Road, Jamestown
        NY14702,
        USA  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiopoolUsIncMember"
      id="Fxbrl_20240413060105029">Sale
        of diagnostic testkits</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiopoolUsIncMember"
      id="Fxbrl_20240414185553274">U.S.A.</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribBiopoolUsIncMember"
      decimals="2"
      id="Fxbrl_20240414185918108"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPrimusCorporationMember"
      id="Fxbrl_20240413055720564">Primus
        Corporation</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPrimusCorporationMember"
      id="Fxbrl_20240413055508746">

        4231
        E 75th Terrace
        Kansas
        City,
        MO
        64132, USA  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPrimusCorporationMember"
      id="Fxbrl_20240413060119716">Manufacture
        and saleof diagnostic test kitsand instrumentation</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPrimusCorporationMember"
      id="Fxbrl_20240414185530212">U.S.A</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPrimusCorporationMember"
      decimals="2"
      id="Fxbrl_20240414185921805"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPhoenixBioTechCorpMember"
      id="Fxbrl_20240413055726421">Phoenix
        Bio-tech Corp.</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPhoenixBioTechCorpMember"
      id="Fxbrl_20240413055449541">

        1166
        South Service Road West
        Oakville,
        ON L6L 5T7
        Canada.
         </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPhoenixBioTechCorpMember"
      id="Fxbrl_20240413060124589">Dormant</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPhoenixBioTechCorpMember"
      id="Fxbrl_20240414185534482">Canada</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribPhoenixBioTechCorpMember"
      decimals="2"
      id="Fxbrl_20240414185925940"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsHoldingAbMember"
      id="Fxbrl_20240413055731220">Fiomi
        Diagnostics Holding AB</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsHoldingAbMember"
      id="Fxbrl_20240413055445525">

        Dag
        Hammarskj&#xf6;ldsv 52A
        SE-752
        37 Uppsala
        Sweden
         </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsHoldingAbMember"
      id="Fxbrl_20240413060128077">Holding
        Company</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsHoldingAbMember"
      id="Fxbrl_20240414185608243">Sweden</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsHoldingAbMember"
      decimals="2"
      id="Fxbrl_20240414185930202"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsAbMember"
      id="Fxbrl_20240413055735565">Fiomi
        Diagnostics AB</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsAbMember"
      id="Fxbrl_20240413055434731">

        Dag
        Hammarskj&#xf6;ldsv 52A
        SE-752
        37 Uppsala
        Sweden
         </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsAbMember"
      id="Fxbrl_20250513172709355">Discontinued
        operation</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsAbMember"
      id="Fxbrl_20240414185642588">Sweden</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribFiomiDiagnosticsAbMember"
      decimals="2"
      id="Fxbrl_20240414185933764"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechDoBrasilMember"
      id="Fxbrl_20240413055740974">Trinity
        Biotech Do Brasil</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechDoBrasilMember"
      id="Fxbrl_20240413055430860">

        Comercio
        e Importacao Ltda
        Rua
        Silva Bueno
        1.660
        &#x2013; Cj. 101/102
        Ipiranga
        Sao
        Paulo
        Brazil
         </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechDoBrasilMember"
      id="Fxbrl_20240413060137979">Sale
        of diagnostic testkits</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechDoBrasilMember"
      id="Fxbrl_20240414185645277">Brazil</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechDoBrasilMember"
      decimals="2"
      id="Fxbrl_20240414185937668"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechUkLtdMember"
      id="Fxbrl_20240413055745042">Trinity
        Biotech (UK) Ltd</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechUkLtdMember"
      id="Fxbrl_20240413055426365">

        Mills
        and Reeve LLP
        Botanic
        House
        100
        Hills Road
        Cambridge,
        CB2 1PH
        United
        Kingdom  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechUkLtdMember"
      id="Fxbrl_20240413060141957">Sales
        &amp; marketingactivities</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechUkLtdMember"
      id="Fxbrl_20240414185650501">UK</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechUkLtdMember"
      decimals="2"
      id="Fxbrl_20240414185941125"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribImmcoDiagnosticsIncMember"
      id="Fxbrl_20240413055748980">Immco
        Diagnostics Inc</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribImmcoDiagnosticsIncMember"
      id="Fxbrl_20240413055421301">

        60
        Pineview Drive
        Buffalo
        NY
        14228, USA  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribImmcoDiagnosticsIncMember"
      id="Fxbrl_20240413060146523">Manufacture
        and sale ofautoimmune productsand laboratory services</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribImmcoDiagnosticsIncMember"
      id="Fxbrl_20240414190012981">U.S.A.</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribImmcoDiagnosticsIncMember"
      decimals="2"
      id="Fxbrl_20240414185944868"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovaCenturyScientificIncMember"
      id="Fxbrl_20240413055808709">Nova
        Century Scientific Inc</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovaCenturyScientificIncMember"
      id="Fxbrl_20240413055415477">

        5022
        South Service Road
        Burlington
        Ontario
        Canada
         </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovaCenturyScientificIncMember"
      id="Fxbrl_20240413155759904">Manufacture
        and sale ofautoimmune products and infectious diseases</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovaCenturyScientificIncMember"
      id="Fxbrl_20240414190015957">Canada</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribNovaCenturyScientificIncMember"
      decimals="2"
      id="Fxbrl_20240414191145340"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechInvestmentLtdMember"
      id="Fxbrl_20240413055853845">Trinity
        Biotech Investment Ltd</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechInvestmentLtdMember"
      id="Fxbrl_20240413055408067">

        PO
        Box 309
        Ugland
        House
        Grand
        Cayman
        KY1-1104
        Cayman
        Islands  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechInvestmentLtdMember"
      id="Fxbrl_20240413060155920">Investment
        andprovision of financialservices</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechInvestmentLtdMember"
      id="Fxbrl_20240414190019164">Cayman
        Islands</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechInvestmentLtdMember"
      decimals="2"
      id="Fxbrl_20240414185949035"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTribBiosensorsIncMember"
      id="Fxbrl_20240413055902128">Trib
        Biosensors Inc.</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTribBiosensorsIncMember"
      id="Fxbrl_20240413055402307">

        27700
        S.W. 95th Avenue,
        Wilsonville,
        Oregon
        97070, USA  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTribBiosensorsIncMember"
      id="Fxbrl_20240422095311803">Manufacturing,
        development, and sale of biosensors</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTribBiosensorsIncMember"
      id="Fxbrl_20240422095343935">USA</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTribBiosensorsIncMember"
      decimals="2"
      id="Fxbrl_20240414185952151"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribKonamiteLimitedMember"
      id="Fxbrl_20240413055919916">Konamite
        Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribKonamiteLimitedMember"
      id="Fxbrl_20240413055358131">

        IDA
        Business Park, Bray
        County
        Wicklow, Ireland  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribKonamiteLimitedMember"
      id="Fxbrl_20240422095258002">Sales
        &amp; marketingactivities</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribKonamiteLimitedMember"
      id="Fxbrl_20240414190027997">Ireland</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribKonamiteLimitedMember"
      decimals="2"
      id="Fxbrl_20240414190002067"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechJointVentureLimitedMember"
      id="Fxbrl_20250512110841485">Trinity
        Biotech Joint Venture Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechJointVentureLimitedMember"
      id="Fxbrl_20250512111021048">

        IDA
        Business Park, Bray
        County
        Wicklow, Ireland  </ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechJointVentureLimitedMember"
      id="Fxbrl_20250512111043390">Holding
        Company</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechJointVentureLimitedMember"
      id="Fxbrl_20250512111105369">Ireland</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribTrinityBiotechJointVentureLimitedMember"
      decimals="2"
      id="Fxbrl_20250512111124188"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember"
      id="Fxbrl_20250512110852121">EpiCapture
        Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember"
      id="Fxbrl_20250512110945576">19
        Mather Road, Mount Merrion, Dublin, Ireland</ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember"
      id="Fxbrl_20250512111050706">Research
        and development</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember"
      id="Fxbrl_20250512111109162">Ireland</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribEpiCaptureLimitedMember"
      decimals="2"
      id="Fxbrl_20250512111131816"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicsDiagnosticsLimitedMember"
      id="Fxbrl_20250512110858493">Metabolomics
        Diagnostics Limited</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicsDiagnosticsLimitedMember"
      id="Fxbrl_20250512111004536">Hoffman
        Park, Inchera, Little Island, Co. Cork, Ireland</ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicsDiagnosticsLimitedMember"
      id="Fxbrl_20250512111054618">Research
        and development</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicsDiagnosticsLimitedMember"
      id="Fxbrl_20250512111114136">Ireland</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribMetabolomicsDiagnosticsLimitedMember"
      decimals="2"
      id="Fxbrl_20250512111135385"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncorporationMember"
      id="Fxbrl_20250512110903322">Waveform
        Technologies Inc.</ifrs-full:NameOfSubsidiary>
    <ifrs-full:AddressOfRegisteredOfficeOfEntity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncorporationMember"
      id="Fxbrl_20250512111010860">Obrtna
        cesta 18, 8310 Sentjernej, Slovenia</ifrs-full:AddressOfRegisteredOfficeOfEntity>
    <trib:PrincipalActivity
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncorporationMember"
      id="Fxbrl_20250512111059352">Manufacturing,
        development, and sale of biosensors</trib:PrincipalActivity>
    <ifrs-full:PrincipalPlaceOfBusiness
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncorporationMember"
      id="Fxbrl_20250512111118414">Slovenia</ifrs-full:PrincipalPlaceOfBusiness>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20240101to20241231_ifrsfullSignificantInvestmentsInSubsidiariesAxis_tribWaveformTechnologiesIncorporationMember"
      decimals="2"
      id="Fxbrl_20250512111139078"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <trib:DisclosureOfAuthorisationForIssueExplanatory
      contextRef="C_20240101to20241231"
      id="Fxbrl_20220115144118972">

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:28.35pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;AUTHORISATION FOR ISSUE&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="margin-left:30.6pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These
Group consolidated financial statements were authorised for issue by the Board of Directors on May 15, 2025.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;
</trib:DisclosureOfAuthorisationForIssueExplanatory>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20220118015958552_27"
          xlink:label="Fxbrl_20220118015958552_27"
          xlink:type="locator"/>
        <link:footnote id="FN20250513194303268" xlink:label="FN20250513194303268" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">No deferred tax asset was recognised because there was no reversing deferred tax liability in the same jurisdiction reversing in the same period and insufficient future projected taxable income in the same jurisdiction.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220118015958552_27"
          xlink:to="FN20250513194303268"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220118015958552_211"
          xlink:label="Fxbrl_20220118015958552_211"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220118015958552_211"
          xlink:to="FN20250513194303268"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220118015958552_711"
          xlink:label="Fxbrl_20220118015958552_711"
          xlink:type="locator"/>
        <link:footnote id="FN20230420130342130" xlink:label="FN20230420130342130" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other items comprise items not chargeable to tax and expenses not deductible for tax purposes. In 2022, other items mainly related to the loss on disposal of the exchangeable notes which was non-recurring. In 2021 other items mainly related to the US$4.4 million income from the Paycheck Protection Program loans which was not chargeable for tax purposes. There was no Paycheck Protection Program income in 2023 or 2022.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220118015958552_711"
          xlink:to="FN20230420130342130"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230413100256416"
          xlink:label="Fxbrl_20230413100256416"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230413100256416"
          xlink:to="FN20230420130342130"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230414175446320"
          xlink:label="Fxbrl_20230414175446320"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230414175446320"
          xlink:to="FN20250513194303268"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230414175634088"
          xlink:label="Fxbrl_20230414175634088"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230414175634088"
          xlink:to="FN20230420130342130"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220115161837833_73"
          xlink:label="Fxbrl_20220115161837833_73"
          xlink:type="locator"/>
        <link:footnote id="FN20240427025912834" xlink:label="FN20240427025912834" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The weighted average number of shares issued during the year is calculated by taking the number of shares issued multiplied by the number of days in the year each share is in issue, divided by 365 days.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220115161837833_73"
          xlink:to="FN20240427025912834"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220115161837833_77"
          xlink:label="Fxbrl_20220115161837833_77"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220115161837833_77"
          xlink:to="FN20240427025912834"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220115161837833_711"
          xlink:label="Fxbrl_20220115161837833_711"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220115161837833_711"
          xlink:to="FN20240427025912834"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220115163702535_73"
          xlink:label="Fxbrl_20220115163702535_73"
          xlink:type="locator"/>
        <link:footnote id="FN20240427025257016" xlink:label="FN20240427025257016" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The weighted average number of ADSs issued during the year is calculated by taking the number of ADSs issued multiplied by the number of days in the year each share is in issue, divided by 365 days.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220115163702535_73"
          xlink:to="FN20240427025257016"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220115163702535_77"
          xlink:label="Fxbrl_20220115163702535_77"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220115163702535_77"
          xlink:to="FN20240427025257016"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220115163702535_711"
          xlink:label="Fxbrl_20220115163702535_711"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220115163702535_711"
          xlink:to="FN20240427025257016"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220114180710749_93"
          xlink:label="Fxbrl_20220114180710749_93"
          xlink:type="locator"/>
        <link:footnote id="FN20250512160603335" xlink:label="FN20250512160603335" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In 2024, US$204,000 was capitalised to research and development projects (2023: US$Nil) (2022: US$Nil).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220114180710749_93"
          xlink:to="FN20250512160603335"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220114180710749_97"
          xlink:label="Fxbrl_20220114180710749_97"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220114180710749_97"
          xlink:to="FN20250512160603335"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220114180710749_911"
          xlink:label="Fxbrl_20220114180710749_911"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220114180710749_911"
          xlink:to="FN20250512160603335"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:label="Fxbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:type="locator"/>
        <link:footnote id="FN20240414183320494" xlink:label="FN20240414183320494" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The maturity of the exchangeable notes is based on the contractual maturity date of April 1, 2045.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:label="Fxbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:label="Fxbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:label="Fxbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:label="Fxbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:label="Fxbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:label="Fxbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:label="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:type="locator"/>
        <link:footnote id="FN20240413114732041" xlink:label="FN20240413114732041" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The senior secured term loan is a variable instrument. In January 2024, the amended term loan agreement reduced the annual rate of interest on the loan by 2.5% to 8.75% plus the greater of (a) Term Secured Overnight Financing Rate or (b) 4.0% per annum, and allows for a further 2.5% reduction in the base rate to 6.25% once the outstanding principal under the term loan falls below US$35 million. The loan matures in July 2026.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:label="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:label="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:label="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:label="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420134441242_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:label="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:type="locator"/>
        <link:footnote id="FN20240413114930201" xlink:label="FN20240413114930201" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The 7-year convertible note was issued in May 2022 and is a fixed rate instrument which bears a fixed rate of interest of 1.5% per annum.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:label="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:label="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:label="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:label="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:label="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:label="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420134446241_xbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_227"
          xlink:label="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_227"
          xlink:type="locator"/>
        <link:footnote id="FN20240413120034144" xlink:label="FN20240413120034144" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December 31, 2023</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_227"
          xlink:to="FN20240413120034144"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_223"
          xlink:label="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_223"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_223"
          xlink:to="FN20240413120034144"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_219"
          xlink:label="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_219"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_219"
          xlink:to="FN20240413120034144"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_215"
          xlink:label="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_215"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_215"
          xlink:to="FN20240413120034144"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_211"
          xlink:label="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_211"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_211"
          xlink:to="FN20240413120034144"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_27"
          xlink:label="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_27"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_27"
          xlink:to="FN20240413120034144"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_23"
          xlink:label="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_23"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_23"
          xlink:to="FN20240413120034144"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413104647018"
          xlink:label="Fxbrl_20240413104647018"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413104647018"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:label="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:label="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:label="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:label="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:label="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:label="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:label="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:to="FN20240414183320494"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:label="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:label="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:label="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:label="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:label="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:label="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:label="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105432996_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:label="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_131"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:label="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_127"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:label="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_123"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:label="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_119"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:label="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_115"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:label="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_111"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:label="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413105435131_xbrl_20240413105203159_xbrl_20220119104905700_xbrl_20220119103015701_17"
          xlink:to="FN20240413114930201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_227"
          xlink:label="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_227"
          xlink:type="locator"/>
        <link:footnote id="FN20240413120837416" xlink:label="FN20240413120837416" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The contractual cash flows of interest on the senior secured term loan is estimated based on the prevailing interest rate at December 31, 2022.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_227"
          xlink:to="FN20240413120837416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_223"
          xlink:label="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_223"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_223"
          xlink:to="FN20240413120837416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_219"
          xlink:label="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_219"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_219"
          xlink:to="FN20240413120837416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_215"
          xlink:label="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_215"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_215"
          xlink:to="FN20240413120837416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_211"
          xlink:label="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_211"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_211"
          xlink:to="FN20240413120837416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_27"
          xlink:label="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_27"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_27"
          xlink:to="FN20240413120837416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_23"
          xlink:label="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_23"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413120418684_xbrl_20230420155531836_xbrl_20220119115853217_xbrl_20220119114428934_23"
          xlink:to="FN20240413120837416"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250513120950208"
          xlink:label="Fxbrl_20250513120950208"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250513120950208"
          xlink:to="FN20240413114732041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220118111332977_113"
          xlink:label="Fxbrl_20220118111332977_113"
          xlink:type="locator"/>
        <link:footnote id="FN20250513165025082" xlink:label="FN20250513165025082" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Additions include US$0.9 million additions in ROU assets.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220118111332977_113"
          xlink:to="FN20250513165025082"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220118111332977_117"
          xlink:label="Fxbrl_20220118111332977_117"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220118111332977_117"
          xlink:to="FN20250513165025082"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220118111332977_1111"
          xlink:label="Fxbrl_20220118111332977_1111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220118111332977_1111"
          xlink:to="FN20250513165025082"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220118111332977_1115"
          xlink:label="Fxbrl_20220118111332977_1115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220118111332977_1115"
          xlink:to="FN20250513165025082"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220118111332977_1119"
          xlink:label="Fxbrl_20220118111332977_1119"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220118111332977_1119"
          xlink:to="FN20250513165025082"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220326182655798_xbrl_20220118111332977_2119"
          xlink:label="Fxbrl_20220326182655798_xbrl_20220118111332977_2119"
          xlink:type="locator"/>
        <link:footnote id="FN20250515105302222" xlink:label="FN20250515105302222" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The total impairment charge recognised against Property, Plant &amp; Equipment during the year was US$1.0 million. Of this, US$0.6 million, corresponding to the impairment loss allocated to property, plant and equipment as described above, is presented within &#x2018;Impairment Charges&#x2019; in the Consolidated Statement of Operations. The remaining US$0.4 million is included within &#x2018;Restructuring Costs&#x2019; (see Note 5).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220326182655798_xbrl_20220118111332977_2119"
          xlink:to="FN20250515105302222"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220326182655798_xbrl_20220118111332977_2115"
          xlink:label="Fxbrl_20220326182655798_xbrl_20220118111332977_2115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220326182655798_xbrl_20220118111332977_2115"
          xlink:to="FN20250515105302222"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220326182655798_xbrl_20220118111332977_2111"
          xlink:label="Fxbrl_20220326182655798_xbrl_20220118111332977_2111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220326182655798_xbrl_20220118111332977_2111"
          xlink:to="FN20250515105302222"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220326182655798_xbrl_20220118111332977_217"
          xlink:label="Fxbrl_20220326182655798_xbrl_20220118111332977_217"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220326182655798_xbrl_20220118111332977_217"
          xlink:to="FN20250515105302222"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220326182655798_xbrl_20220118111332977_213"
          xlink:label="Fxbrl_20220326182655798_xbrl_20220118111332977_213"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220326182655798_xbrl_20220118111332977_213"
          xlink:to="FN20250515105302222"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220118220551225_33"
          xlink:label="Fxbrl_20220118220551225_33"
          xlink:type="locator"/>
        <link:footnote id="FN20250513123429194" xlink:label="FN20250513123429194" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Revenue from customers in Ireland is not disclosed separately due to the immateriality of these revenues.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220118220551225_33"
          xlink:to="FN20250513123429194"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220118220551225_37"
          xlink:label="Fxbrl_20220118220551225_37"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220118220551225_37"
          xlink:to="FN20250513123429194"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220118220551225_311"
          xlink:label="Fxbrl_20220118220551225_311"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220118220551225_311"
          xlink:to="FN20250513123429194"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230426151110276_xbrl_20220118230546067_xbrl_20220118224340376_715"
          xlink:label="Fxbrl_20230426151110276_xbrl_20220118230546067_xbrl_20220118224340376_715"
          xlink:type="locator"/>
        <link:footnote id="FN20230426150735027" xlink:label="FN20230426150735027" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Unallocated expenses represent head office general and administration costs of the Group, which cannot be allocated to the results of any specific geographical area.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230426151110276_xbrl_20220118230546067_xbrl_20220118224340376_715"
          xlink:to="FN20230426150735027"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413195541011"
          xlink:label="Fxbrl_20240413195541011"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413195541011"
          xlink:to="FN20230426150735027"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240413195556956"
          xlink:label="Fxbrl_20240413195556956"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240413195556956"
          xlink:to="FN20230426150735027"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
